,Target,Ligand,AE,GENERIC_NAME,INCHI_KEY,Target_Description,Protein_Class,Organism,Short_description
139184,6w9c,DB12983,-14.7,Phthalocyanine,IEQIEDJGQAUEQZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
62035,6crv,DB12983,-13.6,Phthalocyanine,IEQIEDJGQAUEQZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87534,6m3m,DB12457,-12.8,Rimegepant,KRNAOFGYEFKHPB-ANJVHQHFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
78901,6m2n,DB12424,-12.5,MK-3207,AZAANWYREOQRFB-SETSBSEESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61364,6crv,DB11977,-12.4,Golvatinib,UQRCJCNVNUFYDX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87870,6m3m,DB12983,-12.4,Phthalocyanine,IEQIEDJGQAUEQZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
60886,6crv,DB09280,-12.3,Lumacaftor,UFSKUSARDNFIRC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60458,6crv,DB08674,-12.2,"(20S)-19,20,21,22-TETRAHYDRO-19-OXO-5H-18,20-ETHANO-12,14-ETHENO-6,10-METHENO-18H-BENZ[D]IMIDAZO[4,3-K][1,6,9,12]OXATRIAZA-CYCLOOCTADECOSINE-9-CARBONITRILE",USPFJPDEADLGIG-HSZRJFAPSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165769,7bv1,DB12983,-12.2,Phthalocyanine,IEQIEDJGQAUEQZ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
62977,6crv,DB14859,-12.2,Fosifloxuridine nafalbenamide,BIOWRMNRHMERIO-ZVAHOJSLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
132350,6w9c,DB00320,-12.1,Dihydroergotamine,LUZRJRNZXALNLM-JGRZULCMSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138327,6w9c,DB11399,-12.1,Dirlotapide,TUOSYWCFRFNJBS-BHVANESWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
61171,6crv,DB11691,-12.1,Naldemedine,AXQACEQYCPKDMV-RZAWKFBISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61406,6crv,DB12042,-12.0,Ibodutant,YQYSVMKCMIUCHY-WJOKGBTCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88779,6m3m,DB14773,-12.0,Lifirafenib,NGFFVZQXSRKHBM-FKBYEOEOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
109267,6vxx,DB12983,-11.9,Phthalocyanine,IEQIEDJGQAUEQZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61852,6crv,DB12694,-11.9,CE-326597,UBNMGTSDHSQBEL-PMERELPUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109137,6vxx,DB12424,-11.9,MK-3207,AZAANWYREOQRFB-SETSBSEESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62995,6crv,DB14894,-11.9,Galicaftor,QVDYQHXNAQHIKH-TZIWHRDSSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56104,6crv,DB01879,-11.9,(S)-2-{Methyl-[2-(Naphthalene-2-Sulfonylamino)-5-(Naphthalene-2-Sulfonyloxy)-Benzoyl]-Amino}-Succinicacid,JOAALZBSMWLOPQ-LJAQVGFWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
70648,6lxt,DB12983,-11.8,Phthalocyanine,IEQIEDJGQAUEQZ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
136142,6w9c,DB06638,-11.8,Quarfloxin,WOQIDNWTQOYDLF-CGAIIQECSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
122166,6w4b,DB12983,-11.8,Phthalocyanine,IEQIEDJGQAUEQZ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
58566,6crv,DB05984,-11.8,RAF-265,YABJJWZLRMPFSI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58255,6crv,DB04760,-11.8,"PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-(4-FLUORO-3-METHYL-BENZYLAMIDE)",PYFRREJCFXFNRR-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61895,6crv,DB12760,-11.7,GW-493838,ZQYJPMPXQLNTPQ-QCUYGVNKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62048,6crv,DB13005,-11.7,Rebastinib,WVXNSAVVKYZVOE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61976,6crv,DB12895,-11.7,TD-139,YGIDGBAHDZEYMT-MQFIMZJJSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27475,6cs2,DB07020,-11.7,"N-{3-[5-(1H-1,2,4-triazol-3-yl)-1H-indazol-3-yl]phenyl}furan-2-carboxamide",LMDMJDCLPIVGQD-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
63023,6crv,DB14943,-11.7,LGH-447,VRQXRVAKPDCRCI-ZNMIVQPWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57155,6crv,DB03268,-11.7,RU82197,WKTQBTSOHBKBRW-VMPREFPWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80276,6m2n,DB15039,-11.7,ITI-214,BBIPVJCGIASXJB-PKTZIBPZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
63151,6crv,DB15232,-11.7,Telaglenastat,PRAAPINBUWJLGA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79489,6m2n,DB13345,-11.7,Dihydroergocristine,DEQITUUQPICUMR-HJPBWRTMSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79259,6m2n,DB12983,-11.7,Phthalocyanine,IEQIEDJGQAUEQZ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
87512,6m3m,DB12424,-11.7,MK-3207,AZAANWYREOQRFB-SETSBSEESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
56672,6crv,DB02629,-11.7,Inhibitor Bea403,LYHLPPXMBKMSSZ-JQFCFGFHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114153,6vxx,DB12817,-11.6,Zoliflodacin,ZSWMIFNWDQEXDT-ZESJGQACSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109308,6vxx,DB13050,-11.6,Tirilazad,RBKASMJPSJDQKY-RBFSKHHSSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85740,6m3m,DB08010,-11.6,"(3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-[(E)-2-phenylethenyl]-1H-indole-2,3-dione 3-oxime",DDHASJXGNUWZTM-ZLEWNXFRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58734,6crv,DB06515,-11.6,Resiniferatoxin,DSDNAKHZNJAGHN-MXTYGGKSSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
148132,6w9q,DB12983,-11.6,Phthalocyanine,IEQIEDJGQAUEQZ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
132657,6w9c,DB00696,-11.6,Ergotamine,XCGSFFUVFURLIX-VFGNJEKYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
57704,6crv,DB04016,-11.6,2-[3-({Methyl[1-(2-Naphthoyl)Piperidin-4-Yl]Amino}Carbonyl)-2-Naphthyl]-1-(1-Naphthyl)-2-Oxoethylphosphonic Acid,XUJQPDQURBZEGJ-KXQOOQHDSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62348,6crv,DB13454,-11.6,Nicomorphine,HNDXBGYRMHRUFN-CIVUWBIHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72394,6m2n,DB00696,-11.6,Ergotamine,XCGSFFUVFURLIX-VFGNJEKYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
84308,6m3m,DB05450,-11.6,Smilagenin,GMBQZIIUCVWOCD-UQHLGXRBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58351,6crv,DB04881,-11.5,Elacridar,OSFCMRGOZNQUSW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78214,6m2n,DB11273,-11.5,Dihydroergocornine,SEALOBQTUQIVGU-QNIJNHAOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78737,6m2n,DB12198,-11.5,Fosdagrocorat,BVXLAHSJXXSWFF-KEKPKEOLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
28252,6cs2,DB07833,-11.5,"N-(3-cyanophenyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)-4-biphenylcarboxamide",PMMLSQFPBFKLHH-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
26686,6cs2,DB04868,-11.5,Nilotinib,HHZIURLSWUIHRB-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
75566,6m2n,DB04868,-11.5,Nilotinib,HHZIURLSWUIHRB-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
58240,6crv,DB04739,-11.5,4-[(4-METHYL-1-PIPERAZINYL)METHYL]-N-[3-[[4-(3-PYRIDINYL)-2-PYRIMIDINYL]AMINO]PHENYL]-BENZAMIDE,JHMBUEWQJDGKGS-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56559,6crv,DB02483,-11.5,Etheno-Nad,JCDBQDNBEQHDHK-BSLNIGMPSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
89014,6m3m,DB15291,-11.5,BMS-986142,ZRYMMWAJAFUANM-INIZCTEOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
61281,6crv,DB11852,-11.5,Tegobuvir,XBEQSQDCBSKCHJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80250,6m2n,DB14946,-11.5,PCO-371,LDZJFVOUPUFOHX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80172,6m2n,DB14785,-11.4,Fenebrutinib,WNEODWDFDXWOLU-QHCPKHFHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79272,6m2n,DB13005,-11.4,Rebastinib,WVXNSAVVKYZVOE-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
58254,6crv,DB04759,-11.4,"PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-(3-METHYL-BENZYLAMIDE)",GTBUZLPQANSGGE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30791,6cs2,DB12983,-11.4,Phthalocyanine,IEQIEDJGQAUEQZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
62053,6crv,DB13014,-11.4,Hypericin,BTXNYTINYBABQR-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106665,6vxx,DB00872,-11.4,Conivaptan,IKENVDNFQMCRTR-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113596,6vxx,DB11618,-11.4,Zorubicin,FBTUMDXHSRTGRV-BJISBDEGSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56997,6crv,DB03067,-11.4,"4-{2,4-Bis[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid",VFYAZSTYKPFSFL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87911,6m3m,DB13050,-11.4,Tirilazad,RBKASMJPSJDQKY-RBFSKHHSSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
139345,6w9c,DB13345,-11.4,Dihydroergocristine,DEQITUUQPICUMR-HJPBWRTMSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
57414,6crv,DB03642,-11.4,Benzofuran-2-Carboxylic Acid {(S)-3-Methyl-1-[3-Oxo-1-(Pyridin-2-Ylsulfonyl)Azepan-4-Ylcarbamoyl]Butyl}Amide,VBPPNJCVXGAZDD-PMACEKPBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109127,6vxx,DB12411,-11.4,R-428,KXMZDGSRSGHMMK-VWLOTQADSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
139199,6w9c,DB13109,-11.4,PKI-179,WXUUCRLKXQMWRY-OYRHEFFESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
109005,6vxx,DB11896,-11.3,Gedatolisib,DWZAEMINVBZMHQ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30317,6cs2,DB12323,-11.3,Radotinib,DUPWHXBITIZIKZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
113882,6vxx,DB12225,-11.3,Beclabuvir,ZTTKEBYSXUCBSE-QDFUAKMASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111547,6vxx,DB04016,-11.3,2-[3-({Methyl[1-(2-Naphthoyl)Piperidin-4-Yl]Amino}Carbonyl)-2-Naphthyl]-1-(1-Naphthyl)-2-Oxoethylphosphonic Acid,XUJQPDQURBZEGJ-KXQOOQHDSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88317,6m3m,DB13640,-11.3,Acetoxolone,FTQDJVZNPJRVPG-XWEVEMRCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
55984,6crv,DB01721,-11.3,Analogue of Indinavir Drug,MJIRDPUZGGHJMX-OIVSQUILSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87752,6m3m,DB12799,-11.3,Laniquidar,TULGGJGJQXESOO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
138892,6w9c,DB12411,-11.3,R-428,KXMZDGSRSGHMMK-VWLOTQADSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
73207,6m2n,DB01721,-11.3,Analogue of Indinavir Drug,MJIRDPUZGGHJMX-OIVSQUILSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
114781,6vxx,DB14850,-11.3,Deleobuvir,BMAIGAHXAJEULY-UKTHLTGXSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
123739,6w4h,DB00320,-11.3,Dihydroergotamine,LUZRJRNZXALNLM-JGRZULCMSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
88909,6m3m,DB15085,-11.3,Fulacimstat,JDARDSVOVYVQST-MRXNPFEDSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87595,6m3m,DB12550,-11.3,Taladegib,SZBGQDXLNMELTB-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58709,6crv,DB06448,-11.3,Lonafarnib,DHMTURDWPRKSOA-RUZDIDTESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
105092,6vxs,DB12983,-11.3,Phthalocyanine,IEQIEDJGQAUEQZ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
63026,6crv,DB14946,-11.3,PCO-371,LDZJFVOUPUFOHX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114143,6vxx,DB12799,-11.3,Laniquidar,TULGGJGJQXESOO-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114200,6vxx,DB12892,-11.3,MGB-BP-3,OEKXCVYZBVOWBR-BQYQJAHWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87006,6m3m,DB11691,-11.3,Naldemedine,AXQACEQYCPKDMV-RZAWKFBISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
96481,6m71,DB12983,-11.2,Phthalocyanine,IEQIEDJGQAUEQZ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
78261,6m2n,DB11399,-11.2,Dirlotapide,TUOSYWCFRFNJBS-BHVANESWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
85923,6m3m,DB08220,-11.2,"(8alpha,10alpha,13alpha,17beta)-17-[(4-hydroxyphenyl)carbonyl]androsta-3,5-diene-3-carboxylic acid",RPNNXCYIESWDSC-JRZBRKEGSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
57907,6crv,DB04285,-11.2,"{4-[(2s,4e)-2-(1,3-Benzothiazol-2-Yl)-2-(1h-1,2,3-Benzotriazol-1-Yl)-5-Phenylpent-4-Enyl]Phenyl}(Difluoro)Methylphosphonic Acid",GBLDYRVJENYQNH-AGLOJYHOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111981,6vxx,DB05038,-11.2,Anatibant,XUHBBTKJWIBQMY-MHZLTWQESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80444,6m2n,DB15367,-11.2,LY-2623091,YPCLDHGBEKZGEB-RUDKWAFVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
58059,6crv,DB04495,-11.2,RU81843,GGPXNASQNUOIPB-NSOVKSMOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140776,6w9c,DB15291,-11.2,BMS-986142,ZRYMMWAJAFUANM-INIZCTEOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
63052,6crv,DB15039,-11.2,ITI-214,BBIPVJCGIASXJB-PKTZIBPZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80431,6m2n,DB15343,-11.2,HM-43239,FZLSDZZNPXXBBB-KDURUIRLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
109942,6vxx,DB00619,-11.2,Imatinib,KTUFNOKKBVMGRW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56275,6crv,DB02112,-11.2,Zk-806450,DZLGSWPXZYDHBD-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
82109,6m3m,DB02112,-11.2,Zk-806450,DZLGSWPXZYDHBD-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80425,6m2n,DB15328,-11.2,Ubrogepant,DDOOFTLHJSMHLN-ZQHRPCGSSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
56071,6crv,DB01836,-11.2,"[4-(6-Chloro-Naphthalene-2-Sulfonyl)-Piperazin-1-Yl]-(3,4,5,6-Tetrahydro-2h-[1,4']Bipyridinyl-4-Yl)-Methanone",ZLAKCKVFSRSENR-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78832,6m2n,DB12323,-11.2,Radotinib,DUPWHXBITIZIKZ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
87502,6m3m,DB12411,-11.2,R-428,KXMZDGSRSGHMMK-VWLOTQADSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
17150,6cs2,HMDB0006706,-11.2,Lacto-N-fucopentaose V,TVVLIFCVJJSLBL-SEHWTJTBSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
87805,6m3m,DB12886,-11.2,GSK-1521498,WIEDUMBCZQRGSY-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
82995,6m3m,DB03276,-11.2,"4-[(10s,14s,18s)-18-(2-Amino-2-Oxoethyl)-14-(1-Naphthylmethyl)-8,17,20-Trioxo-7,16,19-Triazaspiro[5.14]Icos-11-En-10-Yl]Benzylphosphonic Acid",RHYFMOCFCFUTNH-GZNVFMSSSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
61680,6crv,DB12427,-11.2,Orvepitant,XWNBGDJPEXZSQM-VZOBGQTKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80168,6m2n,DB14773,-11.2,Lifirafenib,NGFFVZQXSRKHBM-FKBYEOEOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79300,6m2n,DB13050,-11.2,Tirilazad,RBKASMJPSJDQKY-RBFSKHHSSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78630,6m2n,DB12042,-11.2,Ibodutant,YQYSVMKCMIUCHY-WJOKGBTCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
63169,6crv,DB15269,-11.2,ALK-4290,DWKNOLCXIFYNFV-HSZRJFAPSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78891,6m2n,DB12411,-11.2,R-428,KXMZDGSRSGHMMK-VWLOTQADSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
57835,6crv,DB04190,-11.1,Inhibitor Bea425,AHAVBKNGKPWROK-UMFPTGFGSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114889,6vxx,DB15343,-11.1,HM-43239,FZLSDZZNPXXBBB-KDURUIRLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78588,6m2n,DB11977,-11.1,Golvatinib,UQRCJCNVNUFYDX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137880,6w9c,DB08827,-11.1,Lomitapide,MBBCVAKAJPKAKM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
55731,6crv,DB01419,-11.1,Antrafenine,NWGGKKGAFZIVBJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79343,6m2n,DB13109,-11.1,PKI-179,WXUUCRLKXQMWRY-OYRHEFFESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
140404,6w9c,DB05984,-11.1,RAF-265,YABJJWZLRMPFSI-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
58884,6crv,DB06817,-11.1,Raltegravir,CZFFBEXEKNGXKS-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112016,6vxx,DB06011,-11.1,AMG-222,NVSWJKWHLUTHLP-CPJSRVTESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114796,6vxx,DB14878,-11.1,Liafensine,VCIBGDSRPUOBOG-QFIPXVFZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88747,6m3m,DB14703,-11.1,Dexamethasone metasulfobenzoate,TWQWRHIQRAZHPR-XNXCGYEVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
61308,6crv,DB11894,-11.1,Efatutazone,JCYNMRJCUYVDBC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
25856,6cs2,DB03878,-11.1,N-[4-Methyl-3-[[4-(3-Pyridinyl)-2-Pyrimidinyl]Amino]Phenyl]-3-Pyridinecarboxamide,YWQVBESSYLICRX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
63214,6crv,DB15356,-11.1,SLV-334,LOFDNSDPZTVIIO-VPUSJEBWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61855,6crv,DB12703,-11.1,Omipalisib,CGBJSGAELGCMKE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81443,6m3m,DB01199,-11.1,Tubocurarine,JFJZZMVDLULRGK-URLMMPGGSA-O,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
140630,6w9c,DB13014,-11.1,Hypericin,BTXNYTINYBABQR-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
62108,6crv,DB13095,-11.1,JTK-853,JQLOVYLALGSISI-HXUWFJFHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
73418,6m2n,DB02009,-11.1,"L-756,423",AOMZDQMIOCTPQP-QHQMVRJISA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
87685,6m3m,DB12690,-11.1,LY-2584702,FYXRSVDHGLUMHB-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87321,6m3m,DB12154,-11.1,Itacitinib,KTBSXLIQKWEBRB-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85484,6m3m,DB07716,-11.1,"(4Z)-2,8:7,12:11,15:14,18:17,22-PENTAANHYDRO-4,5,6,9,10,13,19,20,21-NONADEOXY-D-ARABINO-D-ALLO-D-ALLO-DOCOSA-4,9,20-TRIENITOL",VDRIXSJOPKVWKM-HXGIDPQASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
114861,6vxx,DB15291,-11.1,BMS-986142,ZRYMMWAJAFUANM-INIZCTEOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87368,6m3m,DB12228,-11.1,Telcagepant,CGDZXLJGHVKVIE-DNVCBOLYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
114883,6vxx,DB15328,-11.1,Ubrogepant,DDOOFTLHJSMHLN-ZQHRPCGSSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88807,6m3m,DB14850,-11.1,Deleobuvir,BMAIGAHXAJEULY-UKTHLTGXSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88183,6m3m,DB13454,-11.1,Nicomorphine,HNDXBGYRMHRUFN-CIVUWBIHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58987,6crv,DB06938,-11.1,4-[[2-[[4-chloro-3-(trifluoromethyl)phenyl]amino]-3H-benzimidazol-5-yl]oxy]-N-methyl-pyridine-2-carboxamide,ZJLSMLDOCGOURY-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60525,6crv,DB08749,-11.1,3-(2-AMINO-6-BENZOYLQUINAZOLIN-3(4H)-YL)-N-CYCLOHEXYL-N-METHYLPROPANAMIDE,KTRFBFMYAJOXLG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85745,6m3m,DB08015,-11.1,"(3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-phenyl-1H-indole-2,3-dione 3-oxime",SZYREAUDQRVVLV-DAFNUICNSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88727,6m3m,DB14664,-11.1,Difluocortolone pivalate,UWGRWFCLGQWKPR-GSTUPEFVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
140110,6w9c,DB14989,-11.1,Umbralisib,IUVCFHHAEHNCFT-INIZCTEOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
28016,6cs2,DB07586,-11.1,"5-(4-METHYL-BENZOYLAMINO)-BIPHENYL-3,4'-DICARBOXYLIC ACID 3-DIMETHYLAMIDE-4'-HYDROXYAMIDE",DOPFUKKMSDUVTQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
86080,6m3m,DB08418,-11.1,"(4aS,4bR,10bS,12aS)-12a-methyl-1,3-dioxo-2-(pyridin-3-ylmethyl)-1,2,3,4,4a,4b,5,6,10b,11,12,12a-dodecahydronaphtho[2,1-f]isoquinolin-8-yl sulfamate",LSJKARAMQNGZDF-YOEKFXIASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59869,6crv,DB07970,-11.0,5-[(2-methyl-5-{[3-(trifluoromethyl)phenyl]carbamoyl}phenyl)amino]pyridine-3-carboxamide,SAAYRHKJHDIDPH-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81529,6m3m,DB01349,-11.0,Tasosartan,ADXGNEYLLLSOAR-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
107992,6vxx,DB06666,-11.0,Lixivaptan,PPHTXRNHTVLQED-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109060,6vxx,DB11977,-11.0,Golvatinib,UQRCJCNVNUFYDX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
63067,6crv,DB15068,-11.0,Agerafenib,DKNUPRMJNUQNHR-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130952,6w4h,DB13050,-11.0,Tirilazad,RBKASMJPSJDQKY-RBFSKHHSSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
78860,6m2n,DB12369,-11.0,Sotrastaurin,OAVGBZOFDPFGPJ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
111998,6vxx,DB05129,-11.0,Elsamitrucin,MGQRRMONVLMKJL-KWJIQSIXSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
137748,6w9c,DB08674,-11.0,"(20S)-19,20,21,22-TETRAHYDRO-19-OXO-5H-18,20-ETHANO-12,14-ETHENO-6,10-METHENO-18H-BENZ[D]IMIDAZO[4,3-K][1,6,9,12]OXATRIAZA-CYCLOOCTADECOSINE-9-CARBONITRILE",USPFJPDEADLGIG-HSZRJFAPSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
58346,6crv,DB04875,-11.0,Pralnacasan,CXAGHAZMQSCAKJ-WAHHBDPQSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78757,6m2n,DB12228,-11.0,Telcagepant,CGDZXLJGHVKVIE-DNVCBOLYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
111920,6vxx,DB04868,-11.0,Nilotinib,HHZIURLSWUIHRB-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81005,6m3m,DB00696,-11.0,Ergotamine,XCGSFFUVFURLIX-VFGNJEKYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84562,6m3m,DB06486,-11.0,Enzastaurin,AXRCEOKUDYDWLF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
78215,6m2n,DB11274,-11.0,Dihydro-alpha-ergocryptine,PBUNVLRHZGSROC-VTIMJTGVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
89024,6m3m,DB15305,-11.0,Risdiplam,ASKZRYGFUPSJPN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81549,6m3m,DB01395,-11.0,Drospirenone,METQSPRSQINEEU-HXCATZOESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59262,6crv,DB07261,-11.0,"THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [1-(1-AMINO-ISOQUINOLIN-7-YLMETHYL)-2-OXO-PYRROLDIN-3-YL]-AMIDE",NVKDOURNRJCKJE-INIZCTEOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80219,6m2n,DB14894,-11.0,Galicaftor,QVDYQHXNAQHIKH-TZIWHRDSSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
85470,6m3m,DB07700,-11.0,"3-CARBOXAMIDO-1,3,5(10)-ESTRATRIEN-17(R)-SPIRO-2'(5',5'-DIMETHYL-6'OXO)TETRAHYDROPYRAN",YVAJWBACBRSVPR-NDUHRLLKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85217,6m3m,DB07397,-11.0,"(5S)-5-(2-amino-2-oxoethyl)-4-oxo-N-[(3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl)methyl]-3,4,5,6,7,8-hexahydro[1]benzothieno[2,3-d]pyrimidine-2-carboxamide",ITADELAVAWJACR-NSHDSACASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59227,6crv,DB07220,-11.0,"N-[5-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-1H-INDAZOL-3-YL]-2-(4-PIPERIDIN-1-YLPHENYL)ACETAMIDE",ZXYIRNXOAJYLCU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
161250,7bv1,DB13454,-11.0,Nicomorphine,HNDXBGYRMHRUFN-CIVUWBIHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
87505,6m3m,DB12415,-11.0,Galeterone,PAFKTGFSEFKSQG-PAASFTFBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
113986,6vxx,DB12550,-11.0,Taladegib,SZBGQDXLNMELTB-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61237,6crv,DB11791,-11.0,Capmatinib,LIOLIMKSCNQPLV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130543,6w4h,DB12411,-11.0,R-428,KXMZDGSRSGHMMK-VWLOTQADSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
133758,6w9c,DB02112,-11.0,Zk-806450,DZLGSWPXZYDHBD-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
55405,6crv,DB00966,-11.0,Telmisartan,RMMXLENWKUUMAY-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80415,6m2n,DB15308,-11.0,Ridinilazole,UHQFBTAJFNVZIV-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
58474,6crv,DB05454,-11.0,Paliroden,CNEWKIDCGDXBDE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
24207,6cs2,DB01897,-11.0,2-(2f-Benzothiazolyl)-5-Styryl-3-(4f-Phthalhydrazidyl)Tetrazolium Chloride,BEIGFKLRGRRJJA-JLHYYAGUSA-O,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
60219,6crv,DB08386,-11.0,2-{[4-(4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline,VRWJZGHUCOFGPZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
133787,6w9c,DB02152,-11.0,K-252a,KOZFSFOOLUUIGY-SOLYNIJKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
62996,6crv,DB14895,-11.0,Vibegron,DJXRIQMCROIRCZ-XOEOCAAJSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79141,6m2n,DB12799,-11.0,Laniquidar,TULGGJGJQXESOO-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61467,6crv,DB12127,-11.0,Sultamicillin,OPYGFNJSCUDTBT-PMLPCWDUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110006,6vxx,DB00696,-11.0,Ergotamine,XCGSFFUVFURLIX-VFGNJEKYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
63225,6crv,DB15385,-11.0,Acebilustat,GERJIEKMNDGSCS-DQEYMECFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58665,6crv,DB06311,-11.0,Darapladib,WDPFJWLDPVQCAJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80265,6m2n,DB15023,-11.0,BMS-791826,DZBKAUMYTFPJIS-QHCPKHFHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
87199,6m3m,DB11977,-11.0,Golvatinib,UQRCJCNVNUFYDX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
70666,6lxt,DB13014,-10.9,Hypericin,BTXNYTINYBABQR-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
138972,6w9c,DB12651,-10.9,Bardoxolone,TXGZJQLMVSIZEI-UQMAOPSPSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
62944,6crv,DB14773,-10.9,Lifirafenib,NGFFVZQXSRKHBM-FKBYEOEOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111540,6vxx,DB04006,-10.9,"[2-Amino-6-(2,6-Difluoro-Benzoyl)-Imidazo[1,2-a]Pyridin-3-Yl]-Phenyl-Methanone",WUGJIPFLBOATGL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59555,6crv,DB07605,-10.9,"2-({4-[(5-CHLORO-1H-INDOL-2-YL)SULFONYL]PIPERAZIN-1-YL}CARBONYL)THIENO[3,2-B]PYRIDINE 4-OXIDE",DHDQMXPAANQKDC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88826,6m3m,DB14883,-10.9,Lorecivivint,AQDWDWAYVBQMAM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
106901,6vxx,DB01721,-10.9,Analogue of Indinavir Drug,MJIRDPUZGGHJMX-OIVSQUILSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
98281,6vxs,DB00762,-10.9,Irinotecan,UWKQSNNFCGGAFS-XIFFEERXSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
85442,6m3m,DB07666,-10.9,"(3R,4S)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE",OAWGQHXWGXOUKV-BEFAXECRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
140075,6w9c,DB14894,-10.9,Galicaftor,QVDYQHXNAQHIKH-TZIWHRDSSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139066,6w9c,DB12799,-10.9,Laniquidar,TULGGJGJQXESOO-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
84401,6m3m,DB05984,-10.9,RAF-265,YABJJWZLRMPFSI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
76022,6m2n,DB06666,-10.9,Lixivaptan,PPHTXRNHTVLQED-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
58727,6crv,DB06486,-10.9,Enzastaurin,AXRCEOKUDYDWLF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136241,6w9c,DB06888,-10.9,"(13R,15S)-13-METHYL-16-OXA-8,9,12,22,24-PENTAAZAHEXACYCLO[15.6.2.16,9.1,12,15.0,2,7.0,21,25]HEPTACOSA-1(24),2,4,6,17(25),18,20-HEPTAENE-23,26-DIONE",KBLPHMRCKHFBJB-OLZOCXBDSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
62615,6crv,DB13814,-10.9,Talampicillin,SOROUYSPFADXSN-SUWVAFIASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84633,6m3m,DB06666,-10.9,Lixivaptan,PPHTXRNHTVLQED-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86032,6m3m,DB08358,-10.9,"2-(2-QUINOLIN-3-YLPYRIDIN-4-YL)-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE",OWFLADWRSCINST-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
28254,6cs2,DB07834,-10.9,"N-(cyclopropylmethyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-4-carboxamide",FOHZGCHKLPIBBX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
138458,6w9c,DB11691,-10.9,Naldemedine,AXQACEQYCPKDMV-RZAWKFBISA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
61815,6crv,DB12640,-10.9,CP-609754,JAHDAIPFBPPQHQ-GDLZYMKVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
82046,6m3m,DB02033,-10.9,"N-(3-Cyclopropyl(5,6,7,8,9,10-Hexahydro-2-Oxo-2h-Cycloocta[B]Pyran-3-Yl)Methyl)Phenylbenzensulfonamide",GDRNWAKVNIROCG-DEOSSOPVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
89026,6m3m,DB15308,-10.9,Ridinilazole,UHQFBTAJFNVZIV-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
28831,6cs2,DB08450,-10.9,N-1H-indazol-5-yl-2-(6-methylpyridin-2-yl)quinazolin-4-amine,HNHRWNUXTCATSG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
81847,6m3m,DB01761,-10.9,4-[5-[2-(1-Phenyl-Ethylamino)-Pyrimidin-4-Yl]-1-Methyl-4-(3-Trifluoromethylphenyl)-1h-Imidazol-2-Yl]-Piperidine,QICPQLFMWYQJGX-SFHVURJKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
76013,6m2n,DB06638,-10.9,Quarfloxin,WOQIDNWTQOYDLF-CGAIIQECSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
63074,6crv,DB15085,-10.9,Fulacimstat,JDARDSVOVYVQST-MRXNPFEDSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84462,6m3m,DB06229,-10.9,Ocaperidone,ZZQNEJILGNNOEP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
62076,6crv,DB13050,-10.9,Tirilazad,RBKASMJPSJDQKY-RBFSKHHSSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80196,6m2n,DB14850,-10.9,Deleobuvir,BMAIGAHXAJEULY-UKTHLTGXSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80215,6m2n,DB14883,-10.9,Lorecivivint,AQDWDWAYVBQMAM-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
60755,6crv,DB09074,-10.9,Olaparib,FDLYAMZZIXQODN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60089,6crv,DB08221,-10.9,N-{4-METHYL-3-[(3-PYRIMIDIN-4-YLPYRIDIN-2-YL)AMINO]PHENYL}-3-(TRIFLUOROMETHYL)BENZAMIDE,NESXBRNDMQUVNG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60465,6crv,DB08683,-10.9,"REL-(9R,12S)-9,10,11,12-TETRAHYDRO-9,12-EPOXY-1H-DIINDOLO[1,2,3-FG:3',2',1'-KL]PYRROLO[3,4-I][1,6]BENZODIAZOCINE-1,3(2H)-DIONE",OTPNDVKVEAIXTI-IYBDPMFKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78540,6m2n,DB11904,-10.9,Flumatinib,BJCJYEYYYGBROF-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
140653,6w9c,DB13050,-10.9,Tirilazad,RBKASMJPSJDQKY-RBFSKHHSSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
113947,6vxx,DB12309,-10.9,GI-181771X,CABBMMXFOOZVMS-PMERELPUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30588,6cs2,DB12694,-10.9,CE-326597,UBNMGTSDHSQBEL-PMERELPUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
130911,6w4h,DB12983,-10.9,Phthalocyanine,IEQIEDJGQAUEQZ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
79060,6m2n,DB12669,-10.9,4SC-203,MAFACRSJGNJHCF-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80128,6m2n,DB14676,-10.9,Fagrocorat,QJJBNCHSWFGXML-KEKPKEOLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
87158,6m3m,DB11913,-10.9,LY-2090314,HRJWTAWVFDCTGO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86979,6m3m,DB11652,-10.9,Tucatinib,SDEAXTCZPQIFQM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
61196,6crv,DB11734,-10.9,Fedovapagon,RUOLFWZIFNQQGH-DEOSSOPVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
63121,6crv,DB15177,-10.9,VX-659,IGEOJNMYRZUKIK-IBGZPJMESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114753,6vxx,DB14773,-10.9,Lifirafenib,NGFFVZQXSRKHBM-FKBYEOEOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78868,6m2n,DB12381,-10.9,Merestinib,QHADVLVFMKEIIP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
56067,6crv,DB01831,-10.9,Tryptophanyl-5'amp,IFQVDHDRFCKAAW-SQIXAUHQSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61037,6crv,DB11399,-10.9,Dirlotapide,TUOSYWCFRFNJBS-BHVANESWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114800,6vxx,DB14883,-10.9,Lorecivivint,AQDWDWAYVBQMAM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114804,6vxx,DB14894,-10.9,Galicaftor,QVDYQHXNAQHIKH-TZIWHRDSSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113518,6vxx,DB09298,-10.9,Silibinin,SEBFKMXJBCUCAI-HKTJVKLFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57381,6crv,DB03591,-10.9,RU82209,LVZDQVATAQEMCX-NSOVKSMOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
63100,6crv,DB15133,-10.9,Tepotinib,AHYMHWXQRWRBKT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113819,6vxx,DB12128,-10.9,Ulimorelin,WGYPAJVJMXQXTR-ABNZCKJZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
131820,6w4h,DB14773,-10.8,Lifirafenib,NGFFVZQXSRKHBM-FKBYEOEOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
60514,6crv,DB08738,-10.8,1-{3-oxo-3-[(2S)-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]propyl}-3-phenylquinoxalin-2(1H)-one,KWCKZIJGKMCYCI-QFIPXVFZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111651,6vxx,DB04330,-10.8,Bilh 434,KNRVCCXHLSHTFW-HGPRPZRGSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30586,6cs2,DB12693,-10.8,Ritanserin,JUQLTPCYUFPYKE-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
88067,6m3m,DB13307,-10.8,Proscillaridin,MYEJFUXQJGHEQK-ALRJYLEOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80259,6m2n,DB15006,-10.8,Flufenoxuron,RYLHNOVXKPXDIP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
131902,6w4h,DB14946,-10.8,PCO-371,LDZJFVOUPUFOHX-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
113593,6vxx,DB11611,-10.8,Lifitegrast,JFOZKMSJYSPYLN-QHCPKHFHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
63035,6crv,DB15006,-10.8,Flufenoxuron,RYLHNOVXKPXDIP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109280,6vxx,DB13005,-10.8,Rebastinib,WVXNSAVVKYZVOE-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62121,6crv,DB13113,-10.8,JNJ-38877605,JRWCBEOAFGHNNU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113506,6vxx,DB09280,-10.8,Lumacaftor,UFSKUSARDNFIRC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138430,6w9c,DB11651,-10.8,Dactolisib,JOGKUKXHTYWRGZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
58685,6crv,DB06393,-10.8,Xaliproden,WJJYZXPHLSLMGE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59382,6crv,DB07397,-10.8,"(5S)-5-(2-amino-2-oxoethyl)-4-oxo-N-[(3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl)methyl]-3,4,5,6,7,8-hexahydro[1]benzothieno[2,3-d]pyrimidine-2-carboxamide",ITADELAVAWJACR-NSHDSACASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55322,6crv,DB00872,-10.8,Conivaptan,IKENVDNFQMCRTR-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114835,6vxx,DB14946,-10.8,PCO-371,LDZJFVOUPUFOHX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
63254,6crv,DB15444,-10.8,Elexacaftor,MVRHVFSOIWFBTE-INIZCTEOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138902,6w9c,DB12424,-10.8,MK-3207,AZAANWYREOQRFB-SETSBSEESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
74604,6m2n,DB03591,-10.8,RU82209,LVZDQVATAQEMCX-NSOVKSMOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
63231,6crv,DB15399,-10.8,BMS-754807,LQVXSNNAFNGRAH-QHCPKHFHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72448,6m2n,DB00762,-10.8,Irinotecan,UWKQSNNFCGGAFS-XIFFEERXSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61677,6crv,DB12424,-10.8,MK-3207,AZAANWYREOQRFB-SETSBSEESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84164,6m3m,DB04852,-10.8,Implitapide,AMNXBQPRODZJQR-DITALETJSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
139076,6w9c,DB12817,-10.8,Zoliflodacin,ZSWMIFNWDQEXDT-ZESJGQACSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
58786,6crv,DB06634,-10.8,Casopitant,XGGTZCKQRWXCHW-WMTVXVAQSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78594,6m2n,DB11986,-10.8,Entrectinib,HAYYBYPASCDWEQ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
85037,6m3m,DB07189,-10.8,"(1S,3R,6S)-4-oxo-6-{4-[(2-phenylquinolin-4-yl)methoxy]phenyl}-5-azaspiro[2.4]heptane-1-carboxylic acid",BFZXMIUWGSTUAL-ZSOKXDGFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
135814,6w9c,DB05129,-10.8,Elsamitrucin,MGQRRMONVLMKJL-KWJIQSIXSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
79151,6m2n,DB12817,-10.8,Zoliflodacin,ZSWMIFNWDQEXDT-ZESJGQACSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
114208,6vxx,DB13095,-10.8,JTK-853,JQLOVYLALGSISI-HXUWFJFHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108487,6vxx,DB08044,-10.8,ABT-341,NVVSPGQEXMJZIR-BMIGLBTASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114186,6vxx,DB12874,-10.8,Quizartinib,CVWXJKQAOSCOAB-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
83538,6m3m,DB04016,-10.8,2-[3-({Methyl[1-(2-Naphthoyl)Piperidin-4-Yl]Amino}Carbonyl)-2-Naphthyl]-1-(1-Naphthyl)-2-Oxoethylphosphonic Acid,XUJQPDQURBZEGJ-KXQOOQHDSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
79200,6m2n,DB12895,-10.8,TD-139,YGIDGBAHDZEYMT-MQFIMZJJSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79332,6m2n,DB13095,-10.8,JTK-853,JQLOVYLALGSISI-HXUWFJFHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
114078,6vxx,DB12694,-10.8,CE-326597,UBNMGTSDHSQBEL-PMERELPUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57365,6crv,DB03571,-10.8,"3-(5-Amino-7-Hydroxy-[1,2,3]Triazolo[4,5-D]Pyrimidin-2-Yl)-N-(3,5-Dichlorobenzyl)-Benzamide",JMQTXEWNXSPEKX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
135987,6w9c,DB06240,-10.8,Tariquidar,LGGHDPFKSSRQNS-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
56745,6crv,DB02723,-10.8,"4-Oxo-2-Phenylmethanesulfonyl-Octahydro-Pyrrolo[1,2-a]Pyrazine-6-Carboxylic Acid [1-(N-Hydroxycarbamimidoyl)-Piperidin-4-Ylmethyl]-Amide",DHTSUHWLPAEEQB-OALUTQOASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78510,6m2n,DB11863,-10.8,Alvelestat,QNQZWEGMKJBHEM-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
136118,6w9c,DB06595,-10.8,Midostaurin,BMGQWWVMWDBQGC-IIFHNQTCSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
62041,6crv,DB12996,-10.8,Acteoside,FBSKJMQYURKNSU-ZLSOWSIRSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87034,6m3m,DB11737,-10.8,Icotinib,QQLKULDARVNMAL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
73327,6m2n,DB01879,-10.8,(S)-2-{Methyl-[2-(Naphthalene-2-Sulfonylamino)-5-(Naphthalene-2-Sulfonyloxy)-Benzoyl]-Amino}-Succinicacid,JOAALZBSMWLOPQ-LJAQVGFWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
86961,6m3m,DB11618,-10.8,Zorubicin,FBTUMDXHSRTGRV-BJISBDEGSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58164,6crv,DB04632,-10.8,4-(2-HYDROXYBENZYLAMINO)-N-(3-(4-FLUOROPHENOXY)PHENYL)PIPERIDINE-1-SULFONAMIDE,JHHBGNIRSUTQAS-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56195,6crv,DB02009,-10.8,"L-756,423",AOMZDQMIOCTPQP-QHQMVRJISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27752,6cs2,DB07307,-10.8,N-cyclopropyl-4-methyl-3-[1-(2-methylphenyl)phthalazin-6-yl]benzamide,GQXMJOSCBRZMKE-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
111812,6vxx,DB04727,-10.8,"N-(4-{4-AMINO-6-[4-(METHYLOXY)PHENYL]FURO[2,3-D]PYRIMIDIN-5-YL}PHENYL)-N'-[2-FLUORO-5-(TRIFLUOROMETHYL)PHENYL]UREA",FGZIONRFHVNRJB-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
63048,6crv,DB15034,-10.8,PRI-724,VHOZWHQPEJGPCC-AZXNYEMZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31858,6cs2,DB14894,-10.8,Galicaftor,QVDYQHXNAQHIKH-TZIWHRDSSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
88742,6m3m,DB14679,-10.8,Quingestanol acetate,FLGJKPPXEKYCBY-AKCFYGDASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
60102,6crv,DB08237,-10.8,2'-deoxy-N-(naphthalen-1-ylmethyl)guanosine 5'-(dihydrogen phosphate),COMPKRGNHXOXMN-GVDBMIGSSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165787,7bv1,DB13014,-10.8,Hypericin,BTXNYTINYBABQR-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
69873,6lxt,DB11822,-10.8,TMC-647055,UOBYJVFBFSLCTQ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
81395,6m3m,DB01147,-10.8,Cloxacillin,LQOLIRLGBULYKD-JKIFEVAISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
112106,6vxx,DB06295,-10.8,Pramiconazole,AEKNYBWUEYNWMJ-QWOOXDRHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81376,6m3m,DB01126,-10.8,Dutasteride,JWJOTENAMICLJG-QWBYCMEYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
31849,6cs2,DB14878,-10.8,Liafensine,VCIBGDSRPUOBOG-QFIPXVFZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
73337,6m2n,DB01897,-10.8,2-(2f-Benzothiazolyl)-5-Styryl-3-(4f-Phthalhydrazidyl)Tetrazolium Chloride,BEIGFKLRGRRJJA-JLHYYAGUSA-O,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
111987,6vxx,DB05075,-10.8,TG-100801,JMGXJHWTVBGOKG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86721,6m3m,DB09280,-10.8,Lumacaftor,UFSKUSARDNFIRC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
75444,6m2n,DB04708,-10.8,"(S)-TETRAHYDROFURAN-3-YL (2S,3S)-4-((S)-4-((1R,3R)-3-(2-AMINO-2-OXOETHYL)-2,3-DIHYDRO-1H-INDEN-1-YL)-2-BENZYL-3-OXO-2,3-DIHYDRO-1H-PYRROL-2-YL)-3-HYDROXY-1-PHENYLBUTAN-2-YLCARBAMATE",SYNSHNDQFWMLJW-YZGRCXSVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
32168,6cs2,DB00210,-10.8,Adapalene,LZCDAPDGXCYOEH-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
57599,6crv,DB03878,-10.7,N-[4-Methyl-3-[[4-(3-Pyridinyl)-2-Pyrimidinyl]Amino]Phenyl]-3-Pyridinecarboxamide,YWQVBESSYLICRX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
33438,6cs2,T3D4673,-10.7,Adapalene,LZCDAPDGXCYOEH-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
83130,6m3m,DB03466,-10.7,BMS184394,AYAJZQYENGWICE-QHCPKHFHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
61291,6crv,DB11870,-10.7,RG-4733,OJPLJFIFUQPSJR-INIZCTEOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76801,6m2n,DB07629,-10.7,"N-((1R,2S)-2-(5-CHLORO-1H-INDOLE-2-CARBOXAMIDO)CYCLOHEXYL)-5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE-2-CARBOXAMIDE",ARPFWVKYXJZULB-DLBZAZTESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61473,6crv,DB12134,-10.7,Gepotidacin,PZFAZQUREQIODZ-LJQANCHMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62939,6crv,DB14766,-10.7,Etrasimod,MVGWUTBTXDYMND-QGZVFWFLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86948,6m3m,DB11577,-10.7,Indigotindisulfonic Acid,CFZXDJWFRVEWSR-BUHFOSPRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58393,6crv,DB04983,-10.7,Denufosol,FPNPSEMJLALQSA-MIYUEGBISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86054,6m3m,DB08386,-10.7,2-{[4-(4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline,VRWJZGHUCOFGPZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87777,6m3m,DB12843,-10.7,Oleandrin,JLPDBLFIVFSOCC-XYXFTTADSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58215,6crv,DB04703,-10.7,Hesperidin,QUQPHWDTPGMPEX-QJBIFVCTSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
137755,6w9c,DB08683,-10.7,"REL-(9R,12S)-9,10,11,12-TETRAHYDRO-9,12-EPOXY-1H-DIINDOLO[1,2,3-FG:3',2',1'-KL]PYRROLO[3,4-I][1,6]BENZODIAZOCINE-1,3(2H)-DIONE",OTPNDVKVEAIXTI-IYBDPMFKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
88526,6m3m,DB13953,-10.7,Estradiol benzoate,UYIFTLBWAOGQBI-BZDYCCQFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87121,6m3m,DB11863,-10.7,Alvelestat,QNQZWEGMKJBHEM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
78395,6m2n,DB11691,-10.7,Naldemedine,AXQACEQYCPKDMV-RZAWKFBISA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75790,6m2n,DB05984,-10.7,RAF-265,YABJJWZLRMPFSI-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
58762,6crv,DB06589,-10.7,Pazopanib,CUIHSIWYWATEQL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
133840,6w9c,DB02226,-10.7,"3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-4-Yl]Hexyl]-Phenanthridinium",NAARZDJZGYBXKL-UHFFFAOYSA-O,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
72627,6m2n,DB00966,-10.7,Telmisartan,RMMXLENWKUUMAY-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
140154,6w9c,DB15085,-10.7,Fulacimstat,JDARDSVOVYVQST-MRXNPFEDSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
14148,6lzg,T3D3767,-10.7,Lolitrem B,HGBZMCXKHKZYBF-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
111705,6vxx,DB04408,-10.7,Ncs-Chromophore,QZGIWPZCWHMVQL-UIYAJPBUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86730,6m3m,DB09291,-10.7,Rolapitant,FIVSJYGQAIEMOC-ZGNKEGEESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59052,6crv,DB07020,-10.7,"N-{3-[5-(1H-1,2,4-triazol-3-yl)-1H-indazol-3-yl]phenyl}furan-2-carboxamide",LMDMJDCLPIVGQD-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79184,6m2n,DB12874,-10.7,Quizartinib,CVWXJKQAOSCOAB-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
87471,6m3m,DB12369,-10.7,Sotrastaurin,OAVGBZOFDPFGPJ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
100217,6vxs,DB03276,-10.7,"4-[(10s,14s,18s)-18-(2-Amino-2-Oxoethyl)-14-(1-Naphthylmethyl)-8,17,20-Trioxo-7,16,19-Triazaspiro[5.14]Icos-11-En-10-Yl]Benzylphosphonic Acid",RHYFMOCFCFUTNH-GZNVFMSSSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
55327,6crv,DB00878,-10.7,Chlorhexidine,GHXZTYHSJHQHIJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61260,6crv,DB11822,-10.7,TMC-647055,UOBYJVFBFSLCTQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30720,6cs2,DB12886,-10.7,GSK-1521498,WIEDUMBCZQRGSY-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
87072,6m3m,DB11791,-10.7,Capmatinib,LIOLIMKSCNQPLV-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
78533,6m2n,DB11896,-10.7,Gedatolisib,DWZAEMINVBZMHQ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61144,6crv,DB11652,-10.7,Tucatinib,SDEAXTCZPQIFQM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59748,6crv,DB07827,-10.7,"4-{[1-METHYL-2,4-DIOXO-6-(3-PHENYLPROP-1-YN-1-YL)-1,4-DIHYDROQUINAZOLIN-3(2H)-YL]METHYL}BENZOIC ACID",FLTYDFYSVZBKOB-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
139197,6w9c,DB13005,-10.7,Rebastinib,WVXNSAVVKYZVOE-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
80202,6m2n,DB14860,-10.7,Ensartinib,GLYMPHUVMRFTFV-QLFBSQMISA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
72003,6m2n,DB00224,-10.7,Indinavir,CBVCZFGXHXORBI-PXQQMZJSSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
84593,6m3m,DB06581,-10.7,Bevirimat,YJEJKUQEXFSVCJ-WRFMNRASSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
131848,6w4h,DB14850,-10.7,Deleobuvir,BMAIGAHXAJEULY-UKTHLTGXSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
62106,6crv,DB13093,-10.7,TAK-593,DZFZXPPHBWCXPQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84624,6m3m,DB06638,-10.7,Quarfloxin,WOQIDNWTQOYDLF-CGAIIQECSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
112236,6vxx,DB06638,-10.7,Quarfloxin,WOQIDNWTQOYDLF-CGAIIQECSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
63054,6crv,DB15046,-10.7,LY-2881835,FHRWHNJJQGSCQC-LJAQVGFWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61247,6crv,DB11804,-10.7,AZD-5672,SCXSQUUTGCWHFU-WJOKGBTCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55695,6crv,DB01349,-10.7,Tasosartan,ADXGNEYLLLSOAR-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138964,6w9c,DB12640,-10.7,CP-609754,JAHDAIPFBPPQHQ-GDLZYMKVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
88884,6m3m,DB15035,-10.7,Zanubrutinib,RNOAOAWBMHREKO-QFIPXVFZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
134593,6w9c,DB03276,-10.7,"4-[(10s,14s,18s)-18-(2-Amino-2-Oxoethyl)-14-(1-Naphthylmethyl)-8,17,20-Trioxo-7,16,19-Triazaspiro[5.14]Icos-11-En-10-Yl]Benzylphosphonic Acid",RHYFMOCFCFUTNH-GZNVFMSSSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
32086,6cs2,DB15327,-10.7,Abivertinib,UOFYSRZSLXWIQB-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
32093,6cs2,DB15343,-10.7,HM-43239,FZLSDZZNPXXBBB-KDURUIRLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
56729,6crv,DB02704,-10.7,"(2r,3r,4r,5r)-3,4-Dihydroxy-N,N'-Bis[(1s,2r)-2-Hydroxy-2,3-Dihydro-1h-Inden-1-Yl]-2,5-Bis(2-Phenylethyl)Hexanediamide",GQKBYZPVKVXMJL-LAFNQVRVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61368,6crv,DB11984,-10.7,Letaxaban,GEHAEMCVKDPMKO-HXUWFJFHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79079,6m2n,DB12703,-10.7,Omipalisib,CGBJSGAELGCMKE-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
106831,6vxx,DB01349,-10.6,Tasosartan,ADXGNEYLLLSOAR-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87647,6m3m,DB12635,-10.6,Aleplasinin,HSXLMAFNWCSZGP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88885,6m3m,DB15036,-10.6,Sitravatinib,WLAVZAAODLTUSW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
17422,6cs2,HMDB0007335,-10.6,"DG(18:4(6Z,9Z,12Z,15Z)/18:2(9Z,12Z)/0:0)",QSEJQXZIIUGBTF-PXHWHCHQSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
84494,6m3m,DB06295,-10.6,Pramiconazole,AEKNYBWUEYNWMJ-QWOOXDRHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
28406,6cs2,DB07994,-10.6,"N-3-[5-(1H-INDOL-6-YL)-2-(PYRIDIN-2-YLMETHOXY)BENZYL]PYRIDINE-2,3-DIAMINE",KMBPJSHPAXOXBT-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
84867,6m3m,DB06997,-10.6,"2-(4-fluorophenyl)-N-{[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]carbamoyl}acetamide",BMPOCDJEXAXXEZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
72544,6m2n,DB00872,-10.6,Conivaptan,IKENVDNFQMCRTR-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
86606,6m3m,DB09095,-10.6,Difluocortolone,OGPWIDANBSLJPC-RFPWEZLHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
134205,6w9c,DB02704,-10.6,"(2r,3r,4r,5r)-3,4-Dihydroxy-N,N'-Bis[(1s,2r)-2-Hydroxy-2,3-Dihydro-1h-Inden-1-Yl]-2,5-Bis(2-Phenylethyl)Hexanediamide",GQKBYZPVKVXMJL-LAFNQVRVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
85880,6m3m,DB08164,-10.6,"(3R,4R)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN-3-AMINE",GOBIXGZJSMAOFV-QRWLVFNGSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
139984,6w9c,DB14676,-10.6,Fagrocorat,QJJBNCHSWFGXML-KEKPKEOLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
132711,6w9c,DB00762,-10.6,Irinotecan,UWKQSNNFCGGAFS-XIFFEERXSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
72833,6m2n,DB01200,-10.6,Bromocriptine,OZVBMTJYIDMWIL-AYFBDAFISA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75926,6m2n,DB06435,-10.6,Tarazepide,CZPILLBHPRAPCB-AREMUKBSSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
15241,6lzg,T3D0631,-10.6,Ovalene,LSQODMMMSXHVCN-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
58431,6crv,DB05220,-10.6,Alisertib,ZLHFILGSQDJULK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75883,6m2n,DB06295,-10.6,Pramiconazole,AEKNYBWUEYNWMJ-QWOOXDRHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
58478,6crv,DB05470,-10.6,VX-702,FYSRKRZDBHOFAY-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87310,6m3m,DB12137,-10.6,GSK-256066,JFHROPTYMMSOLG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87305,6m3m,DB12130,-10.6,Lorlatinib,IIXWYSCJSQVBQM-LLVKDONJSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
75858,6m2n,DB06240,-10.6,Tariquidar,LGGHDPFKSSRQNS-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
56383,6crv,DB02258,-10.6,SR11254,RNZIUDLOJHVHLZ-VYIQYICTSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57697,6crv,DB04006,-10.6,"[2-Amino-6-(2,6-Difluoro-Benzoyl)-Imidazo[1,2-a]Pyridin-3-Yl]-Phenyl-Methanone",WUGJIPFLBOATGL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
96123,6m71,DB12424,-10.6,MK-3207,AZAANWYREOQRFB-SETSBSEESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
85924,6m3m,DB08221,-10.6,N-{4-METHYL-3-[(3-PYRIMIDIN-4-YLPYRIDIN-2-YL)AMINO]PHENYL}-3-(TRIFLUOROMETHYL)BENZAMIDE,NESXBRNDMQUVNG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
61927,6crv,DB12817,-10.6,Zoliflodacin,ZSWMIFNWDQEXDT-ZESJGQACSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75464,6m2n,DB04739,-10.6,4-[(4-METHYL-1-PIPERAZINYL)METHYL]-N-[3-[[4-(3-PYRIDINYL)-2-PYRIMIDINYL]AMINO]PHENYL]-BENZAMIDE,JHMBUEWQJDGKGS-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
55169,6crv,DB00693,-10.6,Fluorescein,GNBHRKFJIUUOQI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75633,6m2n,DB05075,-10.6,TG-100801,JMGXJHWTVBGOKG-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
72954,6m2n,DB01419,-10.6,Antrafenine,NWGGKKGAFZIVBJ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
104665,6vxs,DB12323,-10.6,Radotinib,DUPWHXBITIZIKZ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
58752,6crv,DB06558,-10.6,Tezosentan,TUYWTLTWNJOZNY-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62778,6crv,DB14128,-10.6,Nadide,BAWFJGJZGIEFAR-NNYOXOHSSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86918,6m3m,DB11487,-10.6,Dexamethasone isonicotinate,BQTXJHAJMDGOFI-NJLPOHDGSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87813,6m3m,DB12897,-10.6,MK-7622,JUVQLZBJFOGEEO-GOTSBHOMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
57296,6crv,DB03466,-10.6,BMS184394,AYAJZQYENGWICE-QHCPKHFHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58732,6crv,DB06510,-10.6,Muraglitazar,IRLWJILLXJGJTD-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58206,6crv,DB04689,-10.6,2-{5-[3-(6-BENZOYL-1-PROPYLNAPHTHALEN-2-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID,ZXWVCCFKIRBLDP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62512,6crv,DB13676,-10.6,Mosapramine,PXUIZULXJVRBPC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86422,6m3m,DB08822,-10.6,Azilsartan medoxomil,QJFSABGVXDWMIW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
56455,6crv,DB02354,-10.6,4-{[1-Methyl-5-(2-Methyl-Benzoimidazol-1-Ylmethyl)-1h-Benzoimidazol-2-Ylmethyl]-Amino}-Benzamidine,IRKPNOLLMNHSOU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140132,6w9c,DB15039,-10.6,ITI-214,BBIPVJCGIASXJB-PKTZIBPZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
62000,6crv,DB12929,-10.6,JNJ-39220675,IQOWHZHNGJXGHG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86958,6m3m,DB11611,-10.6,Lifitegrast,JFOZKMSJYSPYLN-QHCPKHFHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
75627,6m2n,DB05038,-10.6,Anatibant,XUHBBTKJWIBQMY-MHZLTWQESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
62675,6crv,DB13931,-10.6,Netarsudil,OURRXQUGYQRVML-AREMUKBSSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
74220,6m2n,DB03067,-10.6,"4-{2,4-Bis[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid",VFYAZSTYKPFSFL-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78710,6m2n,DB12154,-10.6,Itacitinib,KTBSXLIQKWEBRB-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
84042,6m3m,DB04690,-10.6,Camptothecin,VSJKWCGYPAHWDS-FQEVSTJZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
60704,6crv,DB08995,-10.6,Diosmin,GZSOSUNBTXMUFQ-YFAPSIMESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79198,6m2n,DB12892,-10.6,MGB-BP-3,OEKXCVYZBVOWBR-BQYQJAHWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
63209,6crv,DB15345,-10.6,GSK-945237,SRICOHRDRMZREQ-MRXNPFEDSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80702,6m3m,DB00324,-10.6,Fluorometholone,FAOZLTXFLGPHNG-KNAQIMQKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
30872,6cs2,DB13095,-10.6,JTK-853,JQLOVYLALGSISI-HXUWFJFHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
80698,6m3m,DB00320,-10.6,Dihydroergotamine,LUZRJRNZXALNLM-JGRZULCMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
71536,6lxt,DB14729,-10.6,Rebeccamycin,QEHOIJJIZXRMAN-QZQSLCQPSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
60232,6crv,DB08400,-10.6,4-(3-{[5-(trifluoromethyl)pyridin-2-yl]oxy}benzyl)piperidine-1-carboxylic acid,KUEKMTNOUPAOBS-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80602,6m3m,DB00210,-10.6,Adapalene,LZCDAPDGXCYOEH-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80186,6m2n,DB14822,-10.6,SB-649868,ZJXIUGNEAIHSBI-IBGZPJMESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138869,6w9c,DB12381,-10.6,Merestinib,QHADVLVFMKEIIP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140681,6w9c,DB13089,-10.6,Enoxolone,MPDGHEJMBKOTSU-YKLVYJNSSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
110266,6vxx,DB01167,-10.6,Itraconazole,VHVPQPYKVGDNFY-ZPGVKDDISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59322,6crv,DB07326,-10.6,"6-chloro-N-pyrimidin-5-yl-3-{[3-(trifluoromethyl)phenyl]amino}-1,2-benzisoxazole-7-carboxamide",FEGRQUWSKADGSP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81600,6m3m,DB01459,-10.6,Bezitramide,FLKWNFFCSSJANB-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
109637,6vxx,DB15039,-10.6,ITI-214,BBIPVJCGIASXJB-PKTZIBPZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110070,6vxx,DB00773,-10.6,Etoposide,VJJPUSNTGOMMGY-MRVIYFEKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81948,6m3m,DB01897,-10.6,2-(2f-Benzothiazolyl)-5-Styryl-3-(4f-Phthalhydrazidyl)Tetrazolium Chloride,BEIGFKLRGRRJJA-JLHYYAGUSA-O,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
135745,6w9c,DB04881,-10.6,Elacridar,OSFCMRGOZNQUSW-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137378,6w9c,DB08220,-10.6,"(8alpha,10alpha,13alpha,17beta)-17-[(4-hydroxyphenyl)carbonyl]androsta-3,5-diene-3-carboxylic acid",RPNNXCYIESWDSC-JRZBRKEGSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
82217,6m3m,DB02258,-10.6,SR11254,RNZIUDLOJHVHLZ-VYIQYICTSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
109842,6vxx,DB00320,-10.6,Dihydroergotamine,LUZRJRNZXALNLM-JGRZULCMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30502,6cs2,DB12571,-10.6,Rimacalib,MYTIJGWONQOOLC-HNNXBMFYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
30660,6cs2,DB12799,-10.6,Laniquidar,TULGGJGJQXESOO-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
30651,6cs2,DB12784,-10.6,NS-018,UQTPDWDAYHAZNT-AWEZNQCLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
108905,6vxx,DB11363,-10.6,Alectinib,KDGFLJKFZUIJMX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59512,6crv,DB07549,-10.6,"2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUORO-3-METHYL-6-PYRIDINYL)METHYL]ACETAMIDE",WOYBPRBUPLYTPY-UHFFFAOYSA-P,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136055,6w9c,DB06435,-10.6,Tarazepide,CZPILLBHPRAPCB-AREMUKBSSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
54928,6crv,DB00398,-10.6,Sorafenib,MLDQJTXFUGDVEO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127285,6w4h,DB05075,-10.6,TG-100801,JMGXJHWTVBGOKG-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
31921,6cs2,DB15039,-10.6,ITI-214,BBIPVJCGIASXJB-PKTZIBPZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
113352,6vxx,DB09030,-10.6,Vorapaxar,ZBGXUVOIWDMMJE-QHNZEKIYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108928,6vxx,DB11399,-10.6,Dirlotapide,TUOSYWCFRFNJBS-BHVANESWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138895,6w9c,DB12415,-10.6,Galeterone,PAFKTGFSEFKSQG-PAASFTFBSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
61266,6crv,DB11829,-10.6,Ruboxistaurin,ZCBUQCWBWNUWSU-SFHVURJKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60895,6crv,DB09291,-10.6,Rolapitant,FIVSJYGQAIEMOC-ZGNKEGEESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109748,6vxx,DB15257,-10.6,Milademetan,RYAYYVTWKAOAJF-QISPRATLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
54865,6crv,DB00320,-10.6,Dihydroergotamine,LUZRJRNZXALNLM-JGRZULCMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78984,6m2n,DB12550,-10.6,Taladegib,SZBGQDXLNMELTB-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
81009,6m3m,DB00700,-10.6,Eplerenone,JUKPWJGBANNWMW-VWBFHTRKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
113566,6vxx,DB11526,-10.6,Masitinib,WJEOLQLKVOPQFV-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
63224,6crv,DB15382,-10.6,SAR-125844,ODIUNTQOXRXOIV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87092,6m3m,DB11819,-10.5,ASP-4058,NJNXCJPSMWKXHO-VIFPVBQESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
63032,6crv,DB14995,-10.5,NP-G2-044,XLLRLAABUFOJPC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60253,6crv,DB08429,-10.5,N-({(2S)-1-[(3R)-3-amino-4-(3-chlorophenyl)butanoyl]pyrrolidin-2-yl}methyl)-3-(methylsulfonyl)benzamide,QRGBOABBMKYMLG-UXHICEINSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59528,6crv,DB07570,-10.5,3-CYCLOHEXYL-1-(2-MORPHOLIN-4-YL-2-OXOETHYL)-2-PHENYL-1H-INDOLE-6-CARBOXYLIC ACID,ZKEZEXYKYHYIMQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
82589,6m3m,DB02741,-10.5,CD564,RWYREGSYPCNZTL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
138610,6w9c,DB11913,-10.5,LY-2090314,HRJWTAWVFDCTGO-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
73580,6m2n,DB02226,-10.5,"3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-4-Yl]Hexyl]-Phenanthridinium",NAARZDJZGYBXKL-UHFFFAOYSA-O,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
98227,6vxs,DB00696,-10.5,Ergotamine,XCGSFFUVFURLIX-VFGNJEKYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
82015,6m3m,DB01988,-10.5,6((S)-3-Benzylpiperazin-1-Yl)-3-(Naphthalen-2-Yl)-4-(Pyridin-4-Yl)Pyrazine,WFSFNKVFXLIZIY-MHZLTWQESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
109634,6vxx,DB15035,-10.5,Zanubrutinib,RNOAOAWBMHREKO-QFIPXVFZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113211,6vxx,DB08674,-10.5,"(20S)-19,20,21,22-TETRAHYDRO-19-OXO-5H-18,20-ETHANO-12,14-ETHENO-6,10-METHENO-18H-BENZ[D]IMIDAZO[4,3-K][1,6,9,12]OXATRIAZA-CYCLOOCTADECOSINE-9-CARBONITRILE",USPFJPDEADLGIG-HSZRJFAPSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85591,6m3m,DB07837,-10.5,"[4-(5-naphthalen-2-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)phenyl]acetic acid",SWXKLXXVFMYMDP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
82218,6m3m,DB02259,-10.5,"3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid (4-Sulfamoyl-Phenyl)-Amide",VSYGXLAJQDAWCZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85712,6m3m,DB07978,-10.5,"2-({[2,3,5,6-TETRAFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)CYCLOPENTA-1,3-DIENE-1-CARBOXYLIC ACID",ULMUPVXFUDHRGH-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
63027,6crv,DB14982,-10.5,Miransertib,HNFMVVHMKGFCMB-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57993,6crv,DB04408,-10.5,Ncs-Chromophore,QZGIWPZCWHMVQL-UIYAJPBUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59628,6crv,DB07692,-10.5,"1-[(2,6-difluorophenyl)sulfonyl]-4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)piperazine",SHWNKRPMUBFWKE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
25598,6cs2,DB03571,-10.5,"3-(5-Amino-7-Hydroxy-[1,2,3]Triazolo[4,5-D]Pyrimidin-2-Yl)-N-(3,5-Dichlorobenzyl)-Benzamide",JMQTXEWNXSPEKX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
88675,6m3m,DB14555,-10.5,Ursadiol,RTLXJEJRLWILSU-GWNGJUQLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88491,6m3m,DB13867,-10.5,Fluticasone,MGNNYOODZCAHBA-GQKYHHCASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
135307,6w9c,DB04285,-10.5,"{4-[(2s,4e)-2-(1,3-Benzothiazol-2-Yl)-2-(1h-1,2,3-Benzotriazol-1-Yl)-5-Phenylpent-4-Enyl]Phenyl}(Difluoro)Methylphosphonic Acid",GBLDYRVJENYQNH-AGLOJYHOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
80453,6m2n,DB15396,-10.5,PF-114,SLIVDYMORZGPLW-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
55813,6crv,DB01514,-10.5,Furazabol,RGLLOUBXMOGLDQ-IVEVATEUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78350,6m2n,DB11618,-10.5,Zorubicin,FBTUMDXHSRTGRV-BJISBDEGSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
140228,6w9c,DB15401,-10.5,Danicopan,PIBARDGJJAGJAJ-NQIIRXRSSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
88813,6m3m,DB14860,-10.5,Ensartinib,GLYMPHUVMRFTFV-QLFBSQMISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81311,6m3m,DB01051,-10.5,Novobiocin,YJQPYGGHQPGBLI-KGSXXDOSSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
140600,6w9c,DB12513,-10.5,Omaveloxolone,RJCWBNBKOKFWNY-IDPLTSGASA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
88818,6m3m,DB14870,-10.5,PF-5190457,ZIUDADZJCKGWKR-AREMUKBSSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80976,6m3m,DB00663,-10.5,Flumethasone,WXURHACBFYSXBI-GQKYHHCASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
73294,6m2n,DB01836,-10.5,"[4-(6-Chloro-Naphthalene-2-Sulfonyl)-Piperazin-1-Yl]-(3,4,5,6-Tetrahydro-2h-[1,4']Bipyridinyl-4-Yl)-Methanone",ZLAKCKVFSRSENR-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
81059,6m3m,DB00762,-10.5,Irinotecan,UWKQSNNFCGGAFS-XIFFEERXSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
111505,6vxx,DB03957,-10.5,SP2456,SSSXBBASYYVGCI-HSZRJFAPSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62374,6crv,DB13490,-10.5,Hidrosmin,XYFLWVOTXWXNAM-WTNNCJBMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59966,6crv,DB08079,-10.5,AMG-208,HEAIZQNMNCHNFD-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81155,6m3m,DB00872,-10.5,Conivaptan,IKENVDNFQMCRTR-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
111510,6vxx,DB03966,-10.5,Clorobiocin,FJAQNRBDVKIIKK-LFLQOBSNSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
73404,6m2n,DB01988,-10.5,6((S)-3-Benzylpiperazin-1-Yl)-3-(Naphthalen-2-Yl)-4-(Pyridin-4-Yl)Pyrazine,WFSFNKVFXLIZIY-MHZLTWQESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
140623,6w9c,DB12550,-10.5,Taladegib,SZBGQDXLNMELTB-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138543,6w9c,DB11818,-10.5,Retosiban,PLVGDGRBPMVYPB-FDUHJNRSSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
88783,6m3m,DB14785,-10.5,Fenebrutinib,WNEODWDFDXWOLU-QHCPKHFHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86539,6m3m,DB08995,-10.5,Diosmin,GZSOSUNBTXMUFQ-YFAPSIMESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
132760,6w9c,DB00820,-10.5,Tadalafil,WOXKDUGGOYFFRN-IIBYNOLFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
80455,6m2n,DB15399,-10.5,BMS-754807,LQVXSNNAFNGRAH-QHCPKHFHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80456,6m2n,DB15401,-10.5,Danicopan,PIBARDGJJAGJAJ-NQIIRXRSSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
87205,6m3m,DB11986,-10.5,Entrectinib,HAYYBYPASCDWEQ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
62325,6crv,DB13422,-10.5,Nicofuranose,FUWFSXZKBMCSKF-ZASNTINBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
89095,6m3m,DB15450,-10.5,PF-05105679,BXNMZRPTQFVRFA-QGZVFWFLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
61300,6crv,DB11883,-10.5,SB-705498,JYILLRHXRVTRSH-GFCCVEGCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86546,6m3m,DB09003,-10.5,Clocapramine,QAZKXHSIKKNOHH-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
73183,6m2n,DB01690,-10.5,Bis(Adenosine)-5'-Triphosphate,QCICUPZZLIQAPA-XPWFQUROSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
136868,6w9c,DB07629,-10.5,"N-((1R,2S)-2-(5-CHLORO-1H-INDOLE-2-CARBOXAMIDO)CYCLOHEXYL)-5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE-2-CARBOXAMIDE",ARPFWVKYXJZULB-DLBZAZTESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
80682,6m3m,DB00301,-10.5,Flucloxacillin,UIOFUWFRIANQPC-JKIFEVAISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
63061,6crv,DB15057,-10.5,NUC-1031,NHTKGYOMICWFQZ-KKQYNPQSSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61390,6crv,DB12012,-10.5,PF-04457845,BATCTBJIJJEPHM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112156,6vxx,DB06448,-10.5,Lonafarnib,DHMTURDWPRKSOA-RUZDIDTESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58234,6crv,DB04727,-10.5,"N-(4-{4-AMINO-6-[4-(METHYLOXY)PHENYL]FURO[2,3-D]PYRIMIDIN-5-YL}PHENYL)-N'-[2-FLUORO-5-(TRIFLUOROMETHYL)PHENYL]UREA",FGZIONRFHVNRJB-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80923,6m3m,DB00596,-10.5,Ulobetasol,LEHFPXVYPMWYQD-XHIJKXOTSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
110522,6vxx,DB01879,-10.5,(S)-2-{Methyl-[2-(Naphthalene-2-Sulfonylamino)-5-(Naphthalene-2-Sulfonyloxy)-Benzoyl]-Amino}-Succinicacid,JOAALZBSMWLOPQ-LJAQVGFWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61505,6crv,DB12186,-10.5,SRT-2104,LAMQVIQMVKWXOC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59508,6crv,DB07545,-10.5,N-{3-[(4-{[3-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-2-YL)AMINO]PHENYL}CYCLOPROPANECARBOXAMIDE,RDTDWGQDFJPTPD-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88356,6m3m,DB13685,-10.5,Quingestanol,PCJFRMOEZQQSAX-AIOSZGMZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87553,6m3m,DB12480,-10.5,Betulinic Acid,QGJZLNKBHJESQX-FZFNOLFKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84897,6m3m,DB07031,-10.5,"3-Fluoro-4-{[(2R)-2-hydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthalenyl)acetyl]amino}benzoic acid",AANFHDFOMFRLLR-LJQANCHMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
101759,6vxs,DB06435,-10.5,Tarazepide,CZPILLBHPRAPCB-AREMUKBSSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
11355,6lzg,DB11852,-10.5,Tegobuvir,XBEQSQDCBSKCHJ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
133816,6w9c,DB02194,-10.5,"8-Benzyl-2-Hydroxy-2-(4-Hydroxy-Benzyl)-6-(4-Hydroxy-Phenyl)-2h-Imidazo[1,2-a]Pyrazin-3-One",ULLMMKZQNNBLRN-SANMLTNESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
74378,6m2n,DB03268,-10.5,RU82197,WKTQBTSOHBKBRW-VMPREFPWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
166391,7bv1,DB14792,-10.5,AZD-5991,KBQCEQAXHPIRTF-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
85100,6m3m,DB07265,-10.5,"3-(9-HYDROXY-1,3-DIOXO-4-PHENYL-2,3-DIHYDROPYRROLO[3,4-C]CARBAZOL-6(1H)-YL)PROPANOIC ACID",JDARUOOLJCFUOY-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
30394,6cs2,DB12424,-10.5,MK-3207,AZAANWYREOQRFB-SETSBSEESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
61244,6crv,DB11799,-10.5,Bictegravir,SOLUWJRYJLAZCX-LYOVBCGYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62072,6crv,DB13042,-10.5,Fenoverine,UBAJTZKNDCEGKL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59137,6crv,DB07117,-10.5,"5-(4-PHENOXYPHENYL)-5-(4-PYRIMIDIN-2-YLPIPERAZIN-1-YL)PYRIMIDINE-2,4,6(2H,3H)-TRIONE",FMKQJGOROFNCGM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
134429,6w9c,DB03067,-10.5,"4-{2,4-Bis[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid",VFYAZSTYKPFSFL-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
87888,6m3m,DB13014,-10.5,Hypericin,BTXNYTINYBABQR-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
104974,6vxs,DB12799,-10.5,Laniquidar,TULGGJGJQXESOO-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
79456,6m2n,DB13307,-10.5,Proscillaridin,MYEJFUXQJGHEQK-ALRJYLEOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
107851,6vxx,DB04703,-10.5,Hesperidin,QUQPHWDTPGMPEX-QJBIFVCTSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84244,6m3m,DB05075,-10.5,TG-100801,JMGXJHWTVBGOKG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87482,6m3m,DB12385,-10.5,10-hydroxycamptothecin,HAWSQZCWOQZXHI-FQEVSTJZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
66316,6lxt,DB04016,-10.5,2-[3-({Methyl[1-(2-Naphthoyl)Piperidin-4-Yl]Amino}Carbonyl)-2-Naphthyl]-1-(1-Naphthyl)-2-Oxoethylphosphonic Acid,XUJQPDQURBZEGJ-KXQOOQHDSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
56821,6crv,DB02830,-10.5,FR236913,KCCUBLLGAMGDJL-HXUWFJFHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107982,6vxx,DB05984,-10.5,RAF-265,YABJJWZLRMPFSI-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106001,6vxs,DB14773,-10.5,Lifirafenib,NGFFVZQXSRKHBM-FKBYEOEOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
61223,6crv,DB11772,-10.5,Pilaralisib,QINPEPAQOBZPOF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113959,6vxx,DB12323,-10.5,Radotinib,DUPWHXBITIZIKZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
74384,6m2n,DB03276,-10.5,"4-[(10s,14s,18s)-18-(2-Amino-2-Oxoethyl)-14-(1-Naphthylmethyl)-8,17,20-Trioxo-7,16,19-Triazaspiro[5.14]Icos-11-En-10-Yl]Benzylphosphonic Acid",RHYFMOCFCFUTNH-GZNVFMSSSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
58947,6crv,DB06896,-10.5,"1-(4-fluorophenyl)-N-[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]-2-oxo-1,2-dihydropyridine-3-carboxamide",OBSFXHDOLBYWRJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
83215,6m3m,DB03591,-10.5,RU82209,LVZDQVATAQEMCX-NSOVKSMOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
57715,6crv,DB04030,-10.5,"1,3,4,9-Tetrahydro-2-(Hydroxybenzoyl)-9-[(4-Hydroxyphenyl)Methyl]-6-Methoxy-2h-Pyrido[3,4-B]Indole",ADXYEWMDAGIULV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75935,6m2n,DB06455,-10.5,Meclinertant,DYLJVOXRWLXDIG-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
108976,6vxx,DB11851,-10.5,Bafetinib,ZGBAJMQHJDFTQJ-DEOSSOPVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
70710,6lxt,DB13078,-10.5,KOSN-1724,JAYGOFBXDFAXBW-CYEKYUJNSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
106983,6vxx,DB01830,-10.5,"{4-[2-Acetylamino-2-(3-Carbamoyl-2-Cyclohexylmethoxy-6,7,8,9-Tetrahydro-5h-Benzocyclohepten-5ylcarbamoyl)-Ethyl]-2-Phosphono-Phenyl}-Phosphonic Acid",SPSGYTWOIGAABK-DQEYMECFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107053,6vxx,DB02226,-10.5,"3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-4-Yl]Hexyl]-Phenanthridinium",NAARZDJZGYBXKL-UHFFFAOYSA-O,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
63017,6crv,DB14935,-10.5,Serabelisib,BLGWHBSBBJNKJO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
164559,7bv1,DB08143,-10.5,"5-CHLORO-THIOPHENE-2-CARBOXYLIC ACID ((3S,4S)-4-FLUORO- 1-{[2-FLUORO-4-(2-OXO-2H-PYRIDIN-1-YL)-PHENYLCARBAMOYL]-METHYL}-PYRROLIDIN-3-YL)-AMIDE",SXIYSYYSKHUTQQ-RDJZCZTQSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
75217,6m2n,DB04408,-10.5,Ncs-Chromophore,QZGIWPZCWHMVQL-UIYAJPBUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
114792,6vxx,DB14870,-10.5,PF-5190457,ZIUDADZJCKGWKR-AREMUKBSSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84186,6m3m,DB04881,-10.5,Elacridar,OSFCMRGOZNQUSW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
78953,6m2n,DB12504,-10.5,JNJ-40346527,BNVPFDRNGHMRJS-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
63241,6crv,DB15414,-10.5,CM-4307,MLDQJTXFUGDVEO-FIBGUPNXSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60985,6crv,DB11262,-10.5,Bisoctrizole,FQUNFJULCYSSOP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87348,6m3m,DB12198,-10.5,Fosdagrocorat,BVXLAHSJXXSWFF-KEKPKEOLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
61723,6crv,DB12491,-10.5,Fasiglifam,BZCALJIHZVNMGJ-HSZRJFAPSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61626,6crv,DB12355,-10.5,Netazepide,YDZYKNJZCVIKPP-VWLOTQADSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
137563,6w9c,DB08450,-10.4,N-1H-indazol-5-yl-2-(6-methylpyridin-2-yl)quinazolin-4-amine,HNHRWNUXTCATSG-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
56037,6crv,DB01792,-10.4,Adenylyl-3'-5'-Phospho-Uridine-3'-Monophosphate,FZCSEXOMUJFOHQ-KPKSGTNCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88738,6m3m,DB14675,-10.4,Temsavir,QRPZBKAMSFHVRW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
61176,6crv,DB11697,-10.4,Pacritinib,HWXVIOGONBBTBY-ONEGZZNKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61143,6crv,DB11651,-10.4,Dactolisib,JOGKUKXHTYWRGZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57103,6crv,DB03207,-10.4,"2-(Biphenyl-4-Sulfonyl)-1,2,3,4-Tetrahydro-Isoquinoline-3-Carboxylic Acid",BNVMUDXGABBWGP-OAQYLSRUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79270,6m2n,DB13003,-10.4,Cortivazol,RKHQGWMMUURILY-UHRZLXHJSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
60711,6crv,DB09003,-10.4,Clocapramine,QAZKXHSIKKNOHH-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87650,6m3m,DB12640,-10.4,CP-609754,JAHDAIPFBPPQHQ-GDLZYMKVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
114873,6vxx,DB15308,-10.4,Ridinilazole,UHQFBTAJFNVZIV-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86881,6m3m,DB11424,-10.4,Lufenuron,PWPJGUXAGUPAHP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
78728,6m2n,DB12185,-10.4,Exatecan,ZVYVPGLRVWUPMP-FYSMJZIKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
56114,6crv,DB01897,-10.4,2-(2f-Benzothiazolyl)-5-Styryl-3-(4f-Phthalhydrazidyl)Tetrazolium Chloride,BEIGFKLRGRRJJA-JLHYYAGUSA-O,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62071,6crv,DB13040,-10.4,Gandotinib,SQSZANZGUXWJEA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80941,6m3m,DB00619,-10.4,Imatinib,KTUFNOKKBVMGRW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87640,6m3m,DB12622,-10.4,Lupeol,MQYXUWHLBZFQQO-QGTGJCAVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
130922,6w4h,DB13003,-10.4,Cortivazol,RKHQGWMMUURILY-UHRZLXHJSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
163623,7bv1,DB04868,-10.4,Nilotinib,HHZIURLSWUIHRB-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
56181,6crv,DB01988,-10.4,6((S)-3-Benzylpiperazin-1-Yl)-3-(Naphthalen-2-Yl)-4-(Pyridin-4-Yl)Pyrazine,WFSFNKVFXLIZIY-MHZLTWQESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87079,6m3m,DB11799,-10.4,Bictegravir,SOLUWJRYJLAZCX-LYOVBCGYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
130726,6w4h,DB12690,-10.4,LY-2584702,FYXRSVDHGLUMHB-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
80207,6m2n,DB14870,-10.4,PF-5190457,ZIUDADZJCKGWKR-AREMUKBSSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
689,6lzg,HMDB0006706,-10.4,Lacto-N-fucopentaose V,TVVLIFCVJJSLBL-SEHWTJTBSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
57968,6crv,DB04373,-10.4,"4-Amino-N-{4-[2-(2,6-Dimethyl-Phenoxy)-Acetylamino]-3-Hydroxy-1-Isobutyl-5-Phenyl-Pentyl}-Benzamide",WQUBEIMCFHCJCO-AWCRTANDSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60360,6crv,DB08553,-10.4,"(1E)-5-(1-piperidin-4-yl-3-pyridin-4-yl-1H-pyrazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime",KWEFZSZCLBHIEQ-YYADALCUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60312,6crv,DB08497,-10.4,"(1S)-2-oxo-1-phenyl-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate",NKBDSMREMMRFSI-INIZCTEOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60222,6crv,DB08389,-10.4,"6,7-DIMETHOXY-4-[(3R)-3-(2-NAPHTHYLOXY)PYRROLIDIN-1-YL]QUINAZOLINE",UPTQSRGSSJRBKJ-LJQANCHMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112743,6vxx,DB07794,-10.4,"5-(2-PHENYLPYRAZOLO[1,5-A]PYRIDIN-3-YL)-1H-PYRAZOLO[3,4-C]PYRIDAZIN-3-AMINE",XVECMUKVOMUNLE-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87116,6m3m,DB11852,-10.4,Tegobuvir,XBEQSQDCBSKCHJ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
113595,6vxx,DB11616,-10.4,Pirarubicin,KMSKQZKKOZQFFG-YXRRJAAWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
131950,6w4h,DB15085,-10.4,Fulacimstat,JDARDSVOVYVQST-MRXNPFEDSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
60302,6crv,DB08487,-10.4,3-({4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-2-OXOPIPERAZIN-1-YL}METHYL)BENZENECARBOXIMIDAMIDE,PRMSFVUWLBPPLY-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88297,6m3m,DB13610,-10.4,Flumedroxone,CDZJOBWKHSYNMO-SCUQKFFVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
73842,6m2n,DB02555,-10.4,SP4160,VCXMTWSYQSVWRK-AREMUKBSSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
60273,6crv,DB08450,-10.4,N-1H-indazol-5-yl-2-(6-methylpyridin-2-yl)quinazolin-4-amine,HNHRWNUXTCATSG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78502,6m2n,DB11847,-10.4,Cadazolid,XWFCFMXQTBGXQW-GOSISDBHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
63122,6crv,DB15183,-10.4,Fosmanogepix,JQONJQKKVAHONF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87362,6m3m,DB12221,-10.4,Canrenone,UJVLDDZCTMKXJK-WNHSNXHDSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87044,6m3m,DB11750,-10.4,Clobetasol,FCSHDIVRCWTZOX-DVTGEIKXSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
63195,6crv,DB15319,-10.4,VM4-037,QGYZPMXIVNIGKA-GMAHTHKFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86960,6m3m,DB11616,-10.4,Pirarubicin,KMSKQZKKOZQFFG-YXRRJAAWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80457,6m2n,DB15403,-10.4,Ziritaxestat,REQQVBGILUTQNN-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
88713,6m3m,DB14649,-10.4,Dexamethasone acetate,AKUJBENLRBOFTD-RPRRAYFGSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87479,6m3m,DB12381,-10.4,Merestinib,QHADVLVFMKEIIP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58259,6crv,DB04764,-10.4,[4-(3-AMINOMETHYL-PHENYL)-PIPERIDIN-1-YL]-(5-PHENETHYL- PYRIDIN-3-YL)-METHANONE,CCLHROFBSWWOQO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87443,6m3m,DB12323,-10.4,Radotinib,DUPWHXBITIZIKZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87075,6m3m,DB11794,-10.4,Berzosertib,JZCWLJDSIRUGIN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
61978,6crv,DB12897,-10.4,MK-7622,JUVQLZBJFOGEEO-GOTSBHOMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113879,6vxx,DB12222,-10.4,Lurtotecan,RVFGKBWWUQOIOU-NDEPHWFRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
63130,6crv,DB15197,-10.4,RSV-604,MTPVBMVUENFFLL-HXUWFJFHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
73498,6m2n,DB02112,-10.4,Zk-806450,DZLGSWPXZYDHBD-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80136,6m2n,DB14703,-10.4,Dexamethasone metasulfobenzoate,TWQWRHIQRAZHPR-XNXCGYEVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75458,6m2n,DB04727,-10.4,"N-(4-{4-AMINO-6-[4-(METHYLOXY)PHENYL]FURO[2,3-D]PYRIMIDIN-5-YL}PHENYL)-N'-[2-FLUORO-5-(TRIFLUOROMETHYL)PHENYL]UREA",FGZIONRFHVNRJB-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80176,6m2n,DB14792,-10.4,AZD-5991,KBQCEQAXHPIRTF-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
73606,6m2n,DB02258,-10.4,SR11254,RNZIUDLOJHVHLZ-VYIQYICTSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
113884,6vxx,DB12228,-10.4,Telcagepant,CGDZXLJGHVKVIE-DNVCBOLYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61884,6crv,DB12742,-10.4,Amuvatinib,FOFDIMHVKGYHRU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84469,6m3m,DB06240,-10.4,Tariquidar,LGGHDPFKSSRQNS-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59511,6crv,DB07548,-10.4,"2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUORO-6-PYRIDINYL)METHYL]ACETAMIDE",JXHWVKOKYDAROD-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
139125,6w9c,DB12895,-10.4,TD-139,YGIDGBAHDZEYMT-MQFIMZJJSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
61518,6crv,DB12207,-10.4,Verdinexor,OPAKEJZFFCECPN-XQRVVYSFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
135955,6w9c,DB06176,-10.4,Romidepsin,OHRURASPPZQGQM-GCCNXGTGSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
108746,6vxx,DB08901,-10.4,Ponatinib,PHXJVRSECIGDHY-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61514,6crv,DB12200,-10.4,Tivantinib,UCEQXRCJXIVODC-PMACEKPBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
13147,6lzg,DB14773,-10.4,Lifirafenib,NGFFVZQXSRKHBM-FKBYEOEOSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
59492,6crv,DB07528,-10.4,3-(2-aminoquinazolin-6-yl)-4-methyl-1-[3-(trifluoromethyl)phenyl]pyridin-2(1H)-one,HXUZQEYFKAZBPX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
133587,6w9c,DB01879,-10.4,(S)-2-{Methyl-[2-(Naphthalene-2-Sulfonylamino)-5-(Naphthalene-2-Sulfonyloxy)-Benzoyl]-Amino}-Succinicacid,JOAALZBSMWLOPQ-LJAQVGFWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
33088,6cs2,T3D4068,-10.4,C-Curarine,DWELRYDMYVJVSL-GQBJSJAWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
61873,6crv,DB12725,-10.4,TD-8954,MZOITCJKGUIQEI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
98163,6vxs,DB00619,-10.4,Imatinib,KTUFNOKKBVMGRW-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
63030,6crv,DB14989,-10.4,Umbralisib,IUVCFHHAEHNCFT-INIZCTEOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
97625,6m71,DB15291,-10.4,BMS-986142,ZRYMMWAJAFUANM-INIZCTEOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59570,6crv,DB07622,-10.4,"1-(3-(2,4-DIMETHYLTHIAZOL-5-YL)-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)-3-(4-METHYLPIPERAZIN-1-YL)UREA",KRKQVGZXTNLQSV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138617,6w9c,DB11923,-10.4,Decoglurant,DMJHZVARRXJSEG-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
82425,6m3m,DB02519,-10.4,Indirubin-5-Sulphonate,IHBOEHLUIBMBMY-YPKPFQOOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85772,6m3m,DB08044,-10.4,ABT-341,NVVSPGQEXMJZIR-BMIGLBTASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
61782,6crv,DB12580,-10.4,Tradipitant,CAVRKWRKTNINFF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55579,6crv,DB01167,-10.4,Itraconazole,VHVPQPYKVGDNFY-ZPGVKDDISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28927,6cs2,DB08553,-10.4,"(1E)-5-(1-piperidin-4-yl-3-pyridin-4-yl-1H-pyrazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime",KWEFZSZCLBHIEQ-YYADALCUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
59635,6crv,DB07700,-10.4,"3-CARBOXAMIDO-1,3,5(10)-ESTRATRIEN-17(R)-SPIRO-2'(5',5'-DIMETHYL-6'OXO)TETRAHYDROPYRAN",YVAJWBACBRSVPR-NDUHRLLKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61462,6crv,DB12121,-10.4,Entospletinib,XSMSNFMDVXXHGJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140071,6w9c,DB14883,-10.4,Lorecivivint,AQDWDWAYVBQMAM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
77313,6m2n,DB08221,-10.4,N-{4-METHYL-3-[(3-PYRIMIDIN-4-YLPYRIDIN-2-YL)AMINO]PHENYL}-3-(TRIFLUOROMETHYL)BENZAMIDE,NESXBRNDMQUVNG-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
28737,6cs2,DB08349,-10.4,"N-cyclopropyl-3-{[1-(2,4-difluorophenyl)-7-methyl-6-oxo-6,7-dihydro-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}-4-methylbenzamide",WMEYCLAVMZKZCS-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
59354,6crv,DB07362,-10.4,"1-(5-{2-[(1-methyl-1H-pyrazolo[4,3-d]pyrimidin-7-yl)amino]ethyl}-1,3-thiazol-2-yl)-3-[3-(trifluoromethyl)phenyl]urea",UOLCZAFAGDOUFX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59329,6crv,DB07333,-10.4,"N-(CYCLOPROPYLMETHYL)-4-(METHYLOXY)-3-({5-[3-(3-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-YL}AMINO)BENZENESULFONAMIDE",KRGKAARWVPUWSY-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59057,6crv,DB07026,-10.4,"(1S,5S,7R)-N-7-(BIPHENYL-4-YLMETHYL)-N-3-HYDROXY-6,8-DIOXA-3-AZABICYCLO[3.2.1]OCTANE-3,7-DICARBOXAMIDE",PPLDARNGJSQINK-OKZBNKHCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106930,6vxx,DB01761,-10.4,4-[5-[2-(1-Phenyl-Ethylamino)-Pyrimidin-4-Yl]-1-Methyl-4-(3-Trifluoromethylphenyl)-1h-Imidazol-2-Yl]-Piperidine,QICPQLFMWYQJGX-SFHVURJKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72188,6m2n,DB00444,-10.4,Teniposide,NRUKOCRGYNPUPR-QBPJDGROSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
59072,6crv,DB07041,-10.4,"N-[2-(2,4-diaminopyrido[2,3-d]pyrimidin-7-yl)-2-methylpropyl]-4-phenoxybenzamide",FDJWFDQRPKKBFA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76606,6m2n,DB07397,-10.4,"(5S)-5-(2-amino-2-oxoethyl)-4-oxo-N-[(3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl)methyl]-3,4,5,6,7,8-hexahydro[1]benzothieno[2,3-d]pyrimidine-2-carboxamide",ITADELAVAWJACR-NSHDSACASA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
107322,6vxx,DB03161,-10.4,Thymidine-5'-Diphospho-Beta-D-Xylose,AJUADKZRQSBUAK-KDGZBOQCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
135272,6w9c,DB04238,-10.4,N-Alpha-(2-Naphthylsulfonyl)-N-(3-Amidino-L-Phenylalaninyl)-D-Pipecolinic Acid,GNANSBQAIRJZPA-XZOQPEGZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
127442,6w4h,DB05984,-10.4,RAF-265,YABJJWZLRMPFSI-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
87690,6m3m,DB12703,-10.4,Omipalisib,CGBJSGAELGCMKE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
107436,6vxx,DB03591,-10.4,RU82209,LVZDQVATAQEMCX-NSOVKSMOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106618,6vxx,DB00820,-10.4,Tadalafil,WOXKDUGGOYFFRN-IIBYNOLFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
82226,6m3m,DB02269,-10.4,[4-({[5-Benzyloxy-1-(3-Carbamimidoyl-Benzyl)-1h-Indole-2-Carbonyl]-Amino}-Methyl)-Phenyl]-Trimethyl-Ammonium,UFKJQTGPBFWMGT-UHFFFAOYSA-O,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58941,6crv,DB06888,-10.4,"(13R,15S)-13-METHYL-16-OXA-8,9,12,22,24-PENTAAZAHEXACYCLO[15.6.2.16,9.1,12,15.0,2,7.0,21,25]HEPTACOSA-1(24),2,4,6,17(25),18,20-HEPTAENE-23,26-DIONE",KBLPHMRCKHFBJB-OLZOCXBDSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84807,6m3m,DB06922,-10.4,"2-[(1R)-1-carboxy-2-naphthalen-1-ylethyl]-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylic acid",CZNPWASYMRBJCX-GOSISDBHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
164843,7bv1,DB08674,-10.4,"(20S)-19,20,21,22-TETRAHYDRO-19-OXO-5H-18,20-ETHANO-12,14-ETHENO-6,10-METHENO-18H-BENZ[D]IMIDAZO[4,3-K][1,6,9,12]OXATRIAZA-CYCLOOCTADECOSINE-9-CARBONITRILE",USPFJPDEADLGIG-HSZRJFAPSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
76941,6m2n,DB07794,-10.4,"5-(2-PHENYLPYRAZOLO[1,5-A]PYRIDIN-3-YL)-1H-PYRAZOLO[3,4-C]PYRIDAZIN-3-AMINE",XVECMUKVOMUNLE-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
59203,6crv,DB07190,-10.4,3-cyclohexyl-D-alanyl-N-(3-chlorobenzyl)-L-prolinamide,JGFCNVHEEMBVJG-MOPGFXCFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84069,6m3m,DB04727,-10.4,"N-(4-{4-AMINO-6-[4-(METHYLOXY)PHENYL]FURO[2,3-D]PYRIMIDIN-5-YL}PHENYL)-N'-[2-FLUORO-5-(TRIFLUOROMETHYL)PHENYL]UREA",FGZIONRFHVNRJB-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84066,6m3m,DB04724,-10.4,"(S)-2-((S)-3-ISOBUTYL-2,5-DIOXO-4-QUINOLIN-3-YLMETHYL-[1,4]DIAZEPAN-1YL)-N-METHYL-3-NAPHTALEN-2-YL-PROPIONAMIDE",COVPLULNDBDXTN-KYJUHHDHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59248,6crv,DB07247,-10.4,"[2'-HYDROXY-3'-(1H-PYRROLO[3,2-C]PYRIDIN-2-YL)-BIPHENYL-3-YLMETHYL]-UREA",SRPOHNDQBDHONJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
17314,6cs2,HMDB0007191,-10.4,"DG(18:1(11Z)/18:3(6Z,9Z,12Z)/0:0)",ITGRMIJUDWFPJB-YYHNHJMXSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
83981,6m3m,DB04608,-10.4,"9-HYDROXY-4-PHENYL-6H-PYRROLO[3,4-C]CARBAZOLE-1,3-DIONE",IAUZTOZLTFSMIE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58784,6crv,DB06630,-10.4,Anacetrapib,MZZLGJHLQGUVPN-HAWMADMCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28626,6cs2,DB08221,-10.4,N-{4-METHYL-3-[(3-PYRIMIDIN-4-YLPYRIDIN-2-YL)AMINO]PHENYL}-3-(TRIFLUOROMETHYL)BENZAMIDE,NESXBRNDMQUVNG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
84782,6m3m,DB06896,-10.4,"1-(4-fluorophenyl)-N-[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]-2-oxo-1,2-dihydropyridine-3-carboxamide",OBSFXHDOLBYWRJ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
109633,6vxx,DB15034,-10.4,PRI-724,VHOZWHQPEJGPCC-AZXNYEMZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59905,6crv,DB08010,-10.4,"(3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-[(E)-2-phenylethenyl]-1H-indole-2,3-dione 3-oxime",DDHASJXGNUWZTM-ZLEWNXFRSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81269,6m3m,DB01003,-10.4,Cromoglicic acid,IMZMKUWMOSJXDT-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
61850,6crv,DB12690,-10.4,LY-2584702,FYXRSVDHGLUMHB-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110532,6vxx,DB01897,-10.4,2-(2f-Benzothiazolyl)-5-Styryl-3-(4f-Phthalhydrazidyl)Tetrazolium Chloride,BEIGFKLRGRRJJA-JLHYYAGUSA-O,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
89042,6m3m,DB15343,-10.4,HM-43239,FZLSDZZNPXXBBB-KDURUIRLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
140562,6w9c,DB12457,-10.4,Rimegepant,KRNAOFGYEFKHPB-ANJVHQHFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
88876,6m3m,DB15023,-10.4,BMS-791826,DZBKAUMYTFPJIS-QHCPKHFHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
78110,6m2n,DB09280,-10.4,Lumacaftor,UFSKUSARDNFIRC-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
59900,6crv,DB08005,-10.4,4-{[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino}-N-ethylpiperidine-1-carboxamide,ARMFMDYRYOKSOW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86380,6m3m,DB08772,-10.4,"3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL-2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID",BCSVCWVQNOXFGL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
110693,6vxx,DB02112,-10.4,Zk-806450,DZLGSWPXZYDHBD-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86468,6m3m,DB08901,-10.4,Ponatinib,PHXJVRSECIGDHY-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
24281,6cs2,DB01988,-10.4,6((S)-3-Benzylpiperazin-1-Yl)-3-(Naphthalen-2-Yl)-4-(Pyridin-4-Yl)Pyrazine,WFSFNKVFXLIZIY-MHZLTWQESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
73236,6m2n,DB01761,-10.4,4-[5-[2-(1-Phenyl-Ethylamino)-Pyrimidin-4-Yl]-1-Methyl-4-(3-Trifluoromethylphenyl)-1h-Imidazol-2-Yl]-Piperidine,QICPQLFMWYQJGX-SFHVURJKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
88865,6m3m,DB14989,-10.4,Umbralisib,IUVCFHHAEHNCFT-INIZCTEOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
26907,6cs2,DB05835,-10.4,NS-3728,OQRAKHDEGGGWQO-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
140024,6w9c,DB14773,-10.4,Lifirafenib,NGFFVZQXSRKHBM-FKBYEOEOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
88858,6m3m,DB14943,-10.4,LGH-447,VRQXRVAKPDCRCI-ZNMIVQPWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
133028,6w9c,DB01126,-10.4,Dutasteride,JWJOTENAMICLJG-QWBYCMEYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
77814,6m2n,DB08827,-10.4,Lomitapide,MBBCVAKAJPKAKM-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
58497,6crv,DB05553,-10.4,Regrelor,NXHAXEBZOXCDKD-XIXRRVGJSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138567,6w9c,DB11851,-10.4,Bafetinib,ZGBAJMQHJDFTQJ-DEOSSOPVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
81238,6m3m,DB00966,-10.4,Telmisartan,RMMXLENWKUUMAY-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81938,6m3m,DB01879,-10.4,(S)-2-{Methyl-[2-(Naphthalene-2-Sulfonylamino)-5-(Naphthalene-2-Sulfonyloxy)-Benzoyl]-Amino}-Succinicacid,JOAALZBSMWLOPQ-LJAQVGFWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
31919,6cs2,DB15036,-10.4,Sitravatinib,WLAVZAAODLTUSW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
129999,6w4h,DB11611,-10.4,Lifitegrast,JFOZKMSJYSPYLN-QHCPKHFHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
81554,6m3m,DB01406,-10.4,Danazol,POZRVZJJTULAOH-LHZXLZLDSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86484,6m3m,DB08930,-10.4,Dolutegravir,RHWKPHLQXYSBKR-BMIGLBTASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
140052,6w9c,DB14850,-10.4,Deleobuvir,BMAIGAHXAJEULY-UKTHLTGXSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
134148,6w9c,DB02629,-10.3,Inhibitor Bea403,LYHLPPXMBKMSSZ-JQFCFGFHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
58802,6crv,DB06677,-10.3,Clazosentan,LFWCJABOXHSRGC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59256,6crv,DB07255,-10.3,"N'-(5-CHLORO-1,3-BENZODIOXOL-4-YL)-N-(3-MORPHOLIN-4-YLPHENYL)PYRIMIDINE-2,4-DIAMINE",PNEWIQAEGKQNCE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87514,6m3m,DB12426,-10.3,Bitopertin,YUUGYIUSCYNSQR-LBPRGKRZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
138833,6w9c,DB12323,-10.3,Radotinib,DUPWHXBITIZIKZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
79360,6m2n,DB13138,-10.3,Neladenoson bialanate,WESNEIGKOAXSGX-VXKWHMMOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
160963,7bv1,DB12323,-10.3,Radotinib,DUPWHXBITIZIKZ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
86517,6m3m,DB08971,-10.3,Fluocortolone,GAKMQHDJQHZUTJ-ULHLPKEOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
60637,6crv,DB08907,-10.3,Canagliflozin,XTNGUQKDFGDXSJ-ZXGKGEBGSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61585,6crv,DB12297,-10.3,GLPG-0187,CXHCNOMGODVIKB-VWLOTQADSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59890,6crv,DB07993,-10.3,"N-3-[3-(1H-INDOL-6-YL)BENZYL]PYRIDINE-2,3-DIAMINE",LPQUIIHPUGDHJK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80881,6m3m,DB00547,-10.3,Desoximetasone,VWVSBHGCDBMOOT-IIEHVVJPSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84246,6m3m,DB05087,-10.3,Ganaxolone,PGTVWKLGGCQMBR-FLBATMFCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
60201,6crv,DB08362,-10.3,"N-(3-(8-CYANO-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZIN-2-YLAMINO)PHENYL)ACETAMIDE",QVKXQLGRDOMAGC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84805,6m3m,DB06920,-10.3,Eribaxaban,QQBKAVAGLMGMHI-WIYYLYMNSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
61124,6crv,DB11614,-10.3,Rupatadine,WUZYKBABMWJHDL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86739,6m3m,DB09319,-10.3,Carindacillin,JIRBAUWICKGBFE-MNRDOXJOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86872,6m3m,DB11399,-10.3,Dirlotapide,TUOSYWCFRFNJBS-BHVANESWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84516,6m3m,DB06367,-10.3,Relacatib,BWYBBMQLUKXECQ-GIVPXCGWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
76451,6m2n,DB07220,-10.3,"N-[5-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-1H-INDAZOL-3-YL]-2-(4-PIPERIDIN-1-YLPHENYL)ACETAMIDE",ZXYIRNXOAJYLCU-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
58992,6crv,DB06945,-10.3,N-hydroxy-4-({4-[4-(trifluoromethyl)phenoxy]phenyl}sulfonyl)tetrahydro-2H-pyran-4-carboxamide,FOSWRYKPHVPIDJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
139004,6w9c,DB12703,-10.3,Omipalisib,CGBJSGAELGCMKE-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
84597,6m3m,DB06589,-10.3,Pazopanib,CUIHSIWYWATEQL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
57187,6crv,DB03311,-10.3,"3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid [4-(Thiazol-2-Ylsulfamoyl)-Phenyl]-Amide",SXKBTDJJEQQEGE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84619,6m3m,DB06630,-10.3,Anacetrapib,MZZLGJHLQGUVPN-HAWMADMCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58342,6crv,DB04868,-10.3,Nilotinib,HHZIURLSWUIHRB-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79047,6m2n,DB12651,-10.3,Bardoxolone,TXGZJQLMVSIZEI-UQMAOPSPSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
87572,6m3m,DB12513,-10.3,Omaveloxolone,RJCWBNBKOKFWNY-IDPLTSGASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
27358,6cs2,DB06896,-10.3,"1-(4-fluorophenyl)-N-[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]-2-oxo-1,2-dihydropyridine-3-carboxamide",OBSFXHDOLBYWRJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
78600,6m2n,DB11995,-10.3,Avatrombopag,OFZJKCQENFPZBH-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78321,6m2n,DB11526,-10.3,Masitinib,WJEOLQLKVOPQFV-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
74923,6m2n,DB04011,-10.3,"2'-(4-Dimethylaminophenyl)-5-(4-Methyl-1-Piperazinyl)-2,5'-Bi-Benzimidazole",VMCOQLKKSNQANE-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61381,6crv,DB12002,-10.3,AZD-4818,HVTUHSABWJPWNK-SFHVURJKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84703,6m3m,DB06786,-10.3,Halcinonide,MUQNGPZZQDCDFT-JNQJZLCISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84770,6m3m,DB06882,-10.3,1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-naphthalen-1-ylurea,HJWMLCDGRWWLAQ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81347,6m3m,DB01092,-10.3,Ouabain,LPMXVESGRSUGHW-HBYQJFLCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81037,6m3m,DB00734,-10.3,Risperidone,RAPZEAPATHNIPO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
60045,6crv,DB08164,-10.3,"(3R,4R)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN-3-AMINE",GOBIXGZJSMAOFV-QRWLVFNGSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
135780,6w9c,DB04960,-10.3,Tipifarnib,PLHJCIYEEKOWNM-HHHXNRCGSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
80833,6m3m,DB00485,-10.3,Dicloxacillin,YFAGHNZHGGCZAX-JKIFEVAISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85588,6m3m,DB07833,-10.3,"N-(3-cyanophenyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)-4-biphenylcarboxamide",PMMLSQFPBFKLHH-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87193,6m3m,DB11965,-10.3,SJG-136,RWZVMMQNDHPRQD-SFTDATJTSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81502,6m3m,DB01289,-10.3,Glisoxepide,ZKUDBRCEOBOWLF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
60189,6crv,DB08349,-10.3,"N-cyclopropyl-3-{[1-(2,4-difluorophenyl)-7-methyl-6-oxo-6,7-dihydro-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}-4-methylbenzamide",WMEYCLAVMZKZCS-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57772,6crv,DB04107,-10.3,[(1-{2[(4-Carbamimidoyl-Phenylamino)-Methyl]-1-Methyl-1h-Benzoimidazol-5-Yl}-Cyclopropyl)-Pyridin-2-Yl-Methyleneaminooxy]-Acetic Acid Ethyl Ester,RNOYCNIZOAIUSV-LSWMGQQCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80382,6m2n,DB15245,-10.3,Olorofim,SUFPWYYDCOKDLL-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
57826,6crv,DB04177,-10.3,"4-(3,14-Dihydroxy-10,13-Dimethyl-Hexadecahydro-Cyclopenta[a]Phenanthren-17-Yl)-5h-Furan-2-One",XZTUSOXSLKTKJQ-CESUGQOBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59567,6crv,DB07618,-10.3,"2-(4-(AMINOMETHYL)PIPERIDIN-1-YL)-N-(3_CYCLOHEXYL-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)ACETAMIDE",AITZHKQVQNLKHI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78505,6m2n,DB11852,-10.3,Tegobuvir,XBEQSQDCBSKCHJ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
87126,6m3m,DB11870,-10.3,RG-4733,OJPLJFIFUQPSJR-INIZCTEOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
78504,6m2n,DB11851,-10.3,Bafetinib,ZGBAJMQHJDFTQJ-DEOSSOPVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
85736,6m3m,DB08006,-10.3,"N-anthracen-2-yl-5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7-amine",OXYDLVAOXASTMW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80460,6m2n,DB15407,-10.3,Acalisib,DOCINCLJNAXZQF-LBPRGKRZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
86349,6m3m,DB08738,-10.3,1-{3-oxo-3-[(2S)-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]propyl}-3-phenylquinoxalin-2(1H)-one,KWCKZIJGKMCYCI-QFIPXVFZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59607,6crv,DB07666,-10.3,"(3R,4S)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE",OAWGQHXWGXOUKV-BEFAXECRSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
133181,6w9c,DB01349,-10.3,Tasosartan,ADXGNEYLLLSOAR-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
86342,6m3m,DB08731,-10.3,"2-[(1R)-2-carboxy-1-(naphthalen-1-ylmethyl)ethyl]-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylic acid",GPOKTQCDBPECSS-MRXNPFEDSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
132807,6w9c,DB00872,-10.3,Conivaptan,IKENVDNFQMCRTR-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
60197,6crv,DB08358,-10.3,"2-(2-QUINOLIN-3-YLPYRIDIN-4-YL)-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE",OWFLADWRSCINST-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60220,6crv,DB08387,-10.3,2-{[4-(1-methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline,AZEXWHKOMMASPA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61298,6crv,DB11878,-10.3,Filibuvir,SLVAPEZTBDBAPI-GDLZYMKVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61139,6crv,DB11645,-10.3,PF-4191834,DVNQWYLVSNPCJZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
82989,6m3m,DB03268,-10.3,RU82197,WKTQBTSOHBKBRW-VMPREFPWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58403,6crv,DB05038,-10.3,Anatibant,XUHBBTKJWIBQMY-MHZLTWQESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85316,6m3m,DB07514,-10.3,"3-(2-aminoquinazolin-6-yl)-1-(3,3-dimethylindolin-6-yl)-4-methylpyridin-2(1H)-one",LHLGUOHREUTYTO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85062,6m3m,DB07220,-10.3,"N-[5-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-1H-INDAZOL-3-YL]-2-(4-PIPERIDIN-1-YLPHENYL)ACETAMIDE",ZXYIRNXOAJYLCU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85066,6m3m,DB07226,-10.3,"N-[4-(2-CHLOROPHENYL)-1,3-DIOXO-1,2,3,6-TETRAHYDROPYRROLO[3,4-C]CARBAZOL-9-YL]FORMAMIDE",JWZVNUNTFNELHL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
61572,6crv,DB12280,-10.3,AZD-5423,FCNQMDSJHADDFT-WNSKOXEYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80067,6m2n,DB14568,-10.3,Ivosidenib,WIJZXSAJMHAVGX-DHLKQENFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
87366,6m3m,DB12225,-10.3,Beclabuvir,ZTTKEBYSXUCBSE-QDFUAKMASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87031,6m3m,DB11734,-10.3,Fedovapagon,RUOLFWZIFNQQGH-DEOSSOPVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86471,6m3m,DB08906,-10.3,Fluticasone furoate,XTULMSXFIHGYFS-VLSRWLAYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83617,6m3m,DB04125,-10.3,N-Alpha-(2-Naphthylsulfonyl)-N(3-Amidino-L-Phenylalaninyl)-4-Acetyl-Piperazine,ZUWBXGHMVKDMQO-DEOSSOPVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
61556,6crv,DB12260,-10.3,Radiprodil,GKGRZLGAQZPEHO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
83501,6m3m,DB03966,-10.3,Clorobiocin,FJAQNRBDVKIIKK-LFLQOBSNSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83956,6m3m,DB04575,-10.3,Quinestrol,PWZUUYSISTUNDW-VAFBSOEGSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
131867,6w4h,DB14883,-10.3,Lorecivivint,AQDWDWAYVBQMAM-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
80246,6m2n,DB14942,-10.3,BMS-986141,KEEBLYWBELVGPQ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
87311,6m3m,DB12138,-10.3,PF-03715455,VGEXRDWWPSGZDH-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80247,6m2n,DB14943,-10.3,LGH-447,VRQXRVAKPDCRCI-ZNMIVQPWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
83496,6m3m,DB03957,-10.3,SP2456,SSSXBBASYYVGCI-HSZRJFAPSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
138701,6w9c,DB12138,-10.3,PF-03715455,VGEXRDWWPSGZDH-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
80672,6m3m,DB00288,-10.3,Amcinonide,ILKJAFIWWBXGDU-MOGDOJJUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
75953,6m2n,DB06497,-10.3,Aplaviroc,GWNOTCOIYUNTQP-FQLXRVMXSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
83021,6m3m,DB03311,-10.3,"3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid [4-(Thiazol-2-Ylsulfamoyl)-Phenyl]-Amide",SXKBTDJJEQQEGE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81494,6m3m,DB01267,-10.3,Paliperidone,PMXMIIMHBWHSKN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80477,6m2n,DB15442,-10.3,Trilaciclib,PDGKHKMBHVFCMG-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
86465,6m3m,DB08896,-10.3,Regorafenib,FNHKPVJBJVTLMP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86733,6m3m,DB09298,-10.3,Silibinin,SEBFKMXJBCUCAI-HKTJVKLFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
57721,6crv,DB04042,-10.3,"2-[4-(Hydroxy-Methoxy-Methyl)-Benzyl]-7-(4-Hydroxymethyl-Benzyl)-1,1-Dioxo-3,6-Bis-Phenoxymethyl-1lambda6-[1,2,7]Thiadiazepane-4,5-Diol",XLJNZONSWKENRP-VABIIVNOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110230,6vxx,DB01126,-10.3,Dutasteride,JWJOTENAMICLJG-QWBYCMEYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62972,6crv,DB14850,-10.3,Deleobuvir,BMAIGAHXAJEULY-UKTHLTGXSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
71792,6lxt,DB15291,-10.3,BMS-986142,ZRYMMWAJAFUANM-INIZCTEOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
112123,6vxx,DB06350,-10.3,Elinogrel,LGSDFTPAICUONK-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112122,6vxx,DB06347,-10.3,Cenisertib,KSOVGRCOLZZTPF-QMKUDKLTSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88100,6m3m,DB13345,-10.3,Dihydroergocristine,DEQITUUQPICUMR-HJPBWRTMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
55298,6crv,DB00845,-10.3,Clofazimine,WDQPAMHFFCXSNU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62731,6crv,DB14034,-10.3,Darglitazone,QQKNSPHAFATFNQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62991,6crv,DB14883,-10.3,Lorecivivint,AQDWDWAYVBQMAM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111929,6vxx,DB04881,-10.3,Elacridar,OSFCMRGOZNQUSW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
99439,6vxs,DB02258,-10.3,SR11254,RNZIUDLOJHVHLZ-VYIQYICTSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
62994,6crv,DB14889,-10.3,Derazantinib,KPJDVVCDVBFRMU-AREMUKBSSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114891,6vxx,DB15345,-10.3,GSK-945237,SRICOHRDRMZREQ-MRXNPFEDSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
8431,6lzg,DB05984,-10.3,RAF-265,YABJJWZLRMPFSI-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
31854,6cs2,DB14883,-10.3,Lorecivivint,AQDWDWAYVBQMAM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
87914,6m3m,DB13053,-10.3,CP-195543,NZQDWKCNBOELAI-KSFYIVLOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
114797,6vxx,DB14879,-10.3,Cefiderocol,DBPPRLRVDVJOCL-FQRUVTKNSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111907,6vxx,DB04852,-10.3,Implitapide,AMNXBQPRODZJQR-DITALETJSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111818,6vxx,DB04739,-10.3,4-[(4-METHYL-1-PIPERAZINYL)METHYL]-N-[3-[[4-(3-PYRIDINYL)-2-PYRIMIDINYL]AMINO]PHENYL]-BENZAMIDE,JHMBUEWQJDGKGS-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56000,6crv,DB01745,-10.3,N-Alpha-(2-Naphthylsulfonyl)-N(3-Amidino-L-Phenylalaninyl)Isopipecolinic Acid Methyl Ester,JJLGQWCKMHPBEB-DEOSSOPVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107934,6vxx,DB05678,-10.3,SLx-4090,AZUIUVJESCFSLJ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114915,6vxx,DB15403,-10.3,Ziritaxestat,REQQVBGILUTQNN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62748,6crv,DB14067,-10.3,Dofequidar,KLWUUPVJTLHYIM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113707,6vxx,DB11791,-10.3,Capmatinib,LIOLIMKSCNQPLV-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30825,6cs2,DB13029,-10.3,MK-0873,JJWKQXNHYDJXKF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
127578,6w4h,DB06435,-10.3,Tarazepide,CZPILLBHPRAPCB-AREMUKBSSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
30837,6cs2,DB13050,-10.3,Tirilazad,RBKASMJPSJDQKY-RBFSKHHSSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
11579,6lzg,DB12154,-10.3,Itacitinib,KTBSXLIQKWEBRB-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
11772,6lzg,DB12411,-10.3,R-428,KXMZDGSRSGHMMK-VWLOTQADSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
29999,6cs2,DB11913,-10.3,LY-2090314,HRJWTAWVFDCTGO-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
62923,6crv,DB14729,-10.3,Rebeccamycin,QEHOIJJIZXRMAN-QZQSLCQPSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
90549,6m71,DB01879,-10.3,(S)-2-{Methyl-[2-(Naphthalene-2-Sulfonylamino)-5-(Naphthalene-2-Sulfonyloxy)-Benzoyl]-Amino}-Succinicacid,JOAALZBSMWLOPQ-LJAQVGFWSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
112661,6vxx,DB07514,-10.3,"3-(2-aminoquinazolin-6-yl)-1-(3,3-dimethylindolin-6-yl)-4-methylpyridin-2(1H)-one",LHLGUOHREUTYTO-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111783,6vxx,DB04514,-10.3,Phosphoric Acid-2'-[2'-Deoxy-Uridine]Ester-5'-Guanosine Ester,DFYLLEBFVZTKHD-VMIOUTBZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62815,6crv,DB14214,-10.3,Rose bengal lactone,IICCLYANAQEHCI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104726,6vxs,DB12414,-10.3,Usistapide,WSYALRNYQFNNGP-WJOKGBTCSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
56459,6crv,DB02360,-10.3,Bis-Napthyl Beta-Ketophosphonic Acid,OFHMUASCSJJNNA-JOCHJYFZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
63227,6crv,DB15393,-10.3,Telatinib,QFCXANHHBCGMAS-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140685,6w9c,DB13095,-10.3,JTK-853,JQLOVYLALGSISI-HXUWFJFHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
163951,7bv1,DB06896,-10.3,"1-(4-fluorophenyl)-N-[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]-2-oxo-1,2-dihydropyridine-3-carboxamide",OBSFXHDOLBYWRJ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
56212,6crv,DB02033,-10.3,"N-(3-Cyclopropyl(5,6,7,8,9,10-Hexahydro-2-Oxo-2h-Cycloocta[B]Pyran-3-Yl)Methyl)Phenylbenzensulfonamide",GDRNWAKVNIROCG-DEOSSOPVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88716,6m3m,DB14652,-10.3,Clocortolone acetate,ARPLCFGLEYFDCN-CDACMRRYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
56522,6crv,DB02432,-10.3,RU90395,RLLAUERCSKPFGD-VMPREFPWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114713,6vxx,DB14676,-10.3,Fagrocorat,QJJBNCHSWFGXML-KEKPKEOLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107206,6vxx,DB02704,-10.3,"(2r,3r,4r,5r)-3,4-Dihydroxy-N,N'-Bis[(1s,2r)-2-Hydroxy-2,3-Dihydro-1h-Inden-1-Yl]-2,5-Bis(2-Phenylethyl)Hexanediamide",GQKBYZPVKVXMJL-LAFNQVRVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113827,6vxx,DB12138,-10.3,PF-03715455,VGEXRDWWPSGZDH-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113727,6vxx,DB11819,-10.3,ASP-4058,NJNXCJPSMWKXHO-VIFPVBQESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56392,6crv,DB02269,-10.3,[4-({[5-Benzyloxy-1-(3-Carbamimidoyl-Benzyl)-1h-Indole-2-Carbonyl]-Amino}-Methyl)-Phenyl]-Trimethyl-Ammonium,UFKJQTGPBFWMGT-UHFFFAOYSA-O,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87762,6m3m,DB12817,-10.3,Zoliflodacin,ZSWMIFNWDQEXDT-ZESJGQACSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
89044,6m3m,DB15345,-10.3,GSK-945237,SRICOHRDRMZREQ-MRXNPFEDSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
66606,6lxt,DB04408,-10.3,Ncs-Chromophore,QZGIWPZCWHMVQL-UIYAJPBUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
88887,6m3m,DB15039,-10.3,ITI-214,BBIPVJCGIASXJB-PKTZIBPZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
114816,6vxx,DB14916,-10.3,Selonsertib,YIDDLAAKOYYGJG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130955,6w4h,DB13053,-10.3,CP-195543,NZQDWKCNBOELAI-KSFYIVLOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
109659,6vxx,DB15085,-10.3,Fulacimstat,JDARDSVOVYVQST-MRXNPFEDSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55960,6crv,DB01690,-10.3,Bis(Adenosine)-5'-Triphosphate,QCICUPZZLIQAPA-XPWFQUROSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114850,6vxx,DB15023,-10.3,BMS-791826,DZBKAUMYTFPJIS-QHCPKHFHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109126,6vxx,DB12410,-10.3,Sabarubicin,VQHRZZISQVWPLK-UIRGBLDSSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
70144,6lxt,DB12225,-10.3,Beclabuvir,ZTTKEBYSXUCBSE-QDFUAKMASA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
139801,6w9c,DB14017,-10.3,H3B-8800,YOIQWBAHJZGRFW-WVRLKXNASA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
73189,6m2n,DB01698,-10.3,Rutin,IKGXIBQEEMLURG-NVPNHPEKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
91851,6m71,DB03632,-10.3,Argifin,UHBHXSDKGLPPGO-HTDHLNIYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
55457,6crv,DB01026,-10.3,Ketoconazole,XMAYWYJOQHXEEK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88937,6m3m,DB15137,-10.3,VK-2809,LGGPZDRLTDGYSQ-JADSYQMUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
62577,6crv,DB13764,-10.2,Monoxerutin,MBHXKZDTQCSVPM-BDAFLREQSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
26573,6cs2,DB04739,-10.2,4-[(4-METHYL-1-PIPERAZINYL)METHYL]-N-[3-[[4-(3-PYRIDINYL)-2-PYRIMIDINYL]AMINO]PHENYL]-BENZAMIDE,JHMBUEWQJDGKGS-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
85040,6m3m,DB07193,-10.2,"(2R,3R)-7-(methylsulfonyl)-3-(2,4,5-trifluorophenyl)-1,2,3,4-tetrahydropyrido[1,2-a]benzimidazol-2-amine",HJJAYSSCWGUPKO-ABAIWWIYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
61821,6crv,DB12649,-10.2,Ibipinabant,AXJQVVLKUYCICH-OAQYLSRUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61705,6crv,DB12465,-10.2,Ketanserin,FPCCSQOGAWCVBH-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85083,6m3m,DB07247,-10.2,"[2'-HYDROXY-3'-(1H-PYRROLO[3,2-C]PYRIDIN-2-YL)-BIPHENYL-3-YLMETHYL]-UREA",SRPOHNDQBDHONJ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58507,6crv,DB05611,-10.2,Apilimod,HSKAZIJJKRAJAV-KOEQRZSOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80273,6m2n,DB15035,-10.2,Zanubrutinib,RNOAOAWBMHREKO-QFIPXVFZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
14402,6lzg,T3D4128,-10.2,Brevetoxin B,LYTCVQQGCSNFJU-FGRVLNGBSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
55204,6crv,DB00734,-10.2,Risperidone,RAPZEAPATHNIPO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
24244,6cs2,DB01948,-10.2,"1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperidin-4-Yl-3,4-Dihydroquinolin-2(1h)-One",VXIYTVJEIXMAQF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
113613,6vxx,DB11651,-10.2,Dactolisib,JOGKUKXHTYWRGZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55669,6crv,DB01289,-10.2,Glisoxepide,ZKUDBRCEOBOWLF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58904,6crv,DB06844,-10.2,"4-[(7-OXO-7H-THIAZOLO[5,4-E]INDOL-8-YLMETHYL)-AMINO]-N-PYRIDIN-2-YL-BENZENESULFONAMIDE",MBXKBJLIESPLIK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
134497,6w9c,DB03157,-10.2,"N,O-Didansyl-L-Tyrosine",LUBOPDUYHWABFG-NDEPHWFRSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140181,6w9c,DB15297,-10.2,Petesicatib,KXAAIORSMACJSI-AEFFLSMTSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
106248,6vxs,DB15308,-10.2,Ridinilazole,UHQFBTAJFNVZIV-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
79368,6m2n,DB13164,-10.2,Olmutinib,FDMQDKQUTRLUBU-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
58830,6crv,DB06717,-10.2,Fosaprepitant,BARDROPHSZEBKC-OITMNORJSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80342,6m2n,DB15169,-10.2,H3B-6527,MBWRLLRCTIYXDW-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
72497,6m2n,DB00820,-10.2,Tadalafil,WOXKDUGGOYFFRN-IIBYNOLFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
105105,6vxs,DB13005,-10.2,Rebastinib,WVXNSAVVKYZVOE-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
134095,6w9c,DB02555,-10.2,SP4160,VCXMTWSYQSVWRK-AREMUKBSSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
58451,6crv,DB05327,-10.2,Ranirestat,QCVNMNYRNIMDKV-QGZVFWFLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
132766,6w9c,DB00826,-10.2,Natamycin,NCXMLFZGDNKEPB-FFPOYIOWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
30785,6cs2,DB12973,-10.2,Serlopitant,FLNYCRJBCNNHRH-OIYLJQICSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
161479,7bv1,DB14883,-10.2,Lorecivivint,AQDWDWAYVBQMAM-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
58789,6crv,DB06638,-10.2,Quarfloxin,WOQIDNWTQOYDLF-CGAIIQECSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61699,6crv,DB12457,-10.2,Rimegepant,KRNAOFGYEFKHPB-ANJVHQHFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85127,6m3m,DB07294,-10.2,"3-fluoro-4-[2-hydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8,-tetrahydro-naphtalen-2-yl)-acetylamino]-benzoic acid",AANFHDFOMFRLLR-IBGZPJMESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
166383,7bv1,DB14773,-10.2,Lifirafenib,NGFFVZQXSRKHBM-FKBYEOEOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
58515,6crv,DB05667,-10.2,Levoketoconazole,XMAYWYJOQHXEEK-ZEQKJWHPSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84739,6m3m,DB06844,-10.2,"4-[(7-OXO-7H-THIAZOLO[5,4-E]INDOL-8-YLMETHYL)-AMINO]-N-PYRIDIN-2-YL-BENZENESULFONAMIDE",MBXKBJLIESPLIK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
96554,6m71,DB13095,-10.2,JTK-853,JQLOVYLALGSISI-HXUWFJFHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
113759,6vxx,DB12044,-10.2,MK-0893,DNTVJEMGHBIUMW-IBGZPJMESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85765,6m3m,DB08036,-10.2,"6,7,12,13-tetrahydro-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazol-5-one",MEXUTNIFSHFQRG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
28213,6cs2,DB07794,-10.2,"5-(2-PHENYLPYRAZOLO[1,5-A]PYRIDIN-3-YL)-1H-PYRAZOLO[3,4-C]PYRIDAZIN-3-AMINE",XVECMUKVOMUNLE-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
140076,6w9c,DB14895,-10.2,Vibegron,DJXRIQMCROIRCZ-XOEOCAAJSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
97061,6m71,DB13814,-10.2,Talampicillin,SOROUYSPFADXSN-SUWVAFIASA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
99127,6vxs,DB01836,-10.2,"[4-(6-Chloro-Naphthalene-2-Sulfonyl)-Piperazin-1-Yl]-(3,4,5,6-Tetrahydro-2h-[1,4']Bipyridinyl-4-Yl)-Methanone",ZLAKCKVFSRSENR-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
85462,6m3m,DB07691,-10.2,"2-({[3-(3,4-dihydroisoquinolin-2(1H)-ylsulfonyl)phenyl]carbonyl}amino)benzoic acid",GYILVHHTCYNIOS-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
55409,6crv,DB00972,-10.2,Azelastine,MBUVEWMHONZEQD-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60507,6crv,DB08731,-10.2,"2-[(1R)-2-carboxy-1-(naphthalen-1-ylmethyl)ethyl]-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylic acid",GPOKTQCDBPECSS-MRXNPFEDSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61768,6crv,DB12562,-10.2,Setipiprant,IHAXLPDVOWLUOS-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55493,6crv,DB01067,-10.2,Glipizide,ZJJXGWJIGJFDTL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85681,6m3m,DB07943,-10.2,2-{4-[5-(4-chlorophenyl)-4-pyrimidin-4-yl-1H-pyrazol-3-yl]piperidin-1-yl}-2-oxoethanol,CATQHDWESBRRQA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
63173,6crv,DB15281,-10.2,Ravoxertinib,RZUOCXOYPYGSKL-GOSISDBHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140077,6w9c,DB14896,-10.2,Selitrectinib,OEBIHOVSAMBXIB-SJKOYZFVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
67347,6lxt,DB06515,-10.2,Resiniferatoxin,DSDNAKHZNJAGHN-MXTYGGKSSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
133618,6w9c,DB01933,-10.2,7-Hydroxystaurosporine,PBCZSGKMGDDXIJ-HQCWYSJUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
61707,6crv,DB12467,-10.2,TU-100,KAYRGFYBCCETPE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85268,6m3m,DB07456,-10.2,"3-(1H-indol-3-yl)-4-(1-{2-[(2S)-1-methylpyrrolidinyl]ethyl}-1H-indol-3-yl)-1H-pyrrole-2,5-dione",LBFDERUQORUFIN-QGZVFWFLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
72801,6m2n,DB01167,-10.2,Itraconazole,VHVPQPYKVGDNFY-ZPGVKDDISA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
12169,6lzg,DB12983,-10.2,Phthalocyanine,IEQIEDJGQAUEQZ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
128198,6w4h,DB07326,-10.2,"6-chloro-N-pyrimidin-5-yl-3-{[3-(trifluoromethyl)phenyl]amino}-1,2-benzisoxazole-7-carboxamide",FEGRQUWSKADGSP-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
140771,6w9c,DB15282,-10.2,Fluorofuranylnorprogesterone F-18,VJKRBRUNEOHPBS-JQKUZGBFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
79736,6m2n,DB13676,-10.2,Mosapramine,PXUIZULXJVRBPC-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61812,6crv,DB12635,-10.2,Aleplasinin,HSXLMAFNWCSZGP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
63159,6crv,DB15246,-10.2,Salvianolic acid A,YMGFTDKNIWPMGF-UCPJVGPRSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
95431,6m71,DB11262,-10.2,Bisoctrizole,FQUNFJULCYSSOP-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
140067,6w9c,DB14878,-10.2,Liafensine,VCIBGDSRPUOBOG-QFIPXVFZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
67033,6lxt,DB05129,-10.2,Elsamitrucin,MGQRRMONVLMKJL-KWJIQSIXSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
140128,6w9c,DB15034,-10.2,PRI-724,VHOZWHQPEJGPCC-AZXNYEMZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
133679,6w9c,DB02010,-10.2,Staurosporine,HKSZLNNOFSGOKW-FYTWVXJKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
78013,6m2n,DB09143,-10.2,Sonidegib,VZZJRYRQSPEMTK-CALCHBBNSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
67402,6lxt,DB06638,-10.2,Quarfloxin,WOQIDNWTQOYDLF-CGAIIQECSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
100966,6vxs,DB04289,-10.2,Genz-10850,YYMZSGIXLQPFAC-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
61793,6crv,DB12598,-10.2,Nafamostat,MQQNFDZXWVTQEH-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85782,6m3m,DB08057,-10.2,"N-(2-chloro-6-methylphenyl)-8-[(3S)-3-methylpiperazin-1-yl]imidazo[1,5-a]quinoxalin-4-amine",VWJPPYCULHDHBB-HNNXBMFYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
30382,6cs2,DB12411,-10.2,R-428,KXMZDGSRSGHMMK-VWLOTQADSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
85262,6m3m,DB07450,-10.2,(R)-minalrestat,BMHZAHGTGIZZCT-LJQANCHMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58751,6crv,DB06555,-10.2,Siramesine,XWAONOGAGZNUSF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107046,6vxx,DB02217,-10.2,Dpb-T,WTZFKHNHHRPQOU-WSMBLCCSSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106624,6vxx,DB00826,-10.2,Natamycin,NCXMLFZGDNKEPB-FFPOYIOWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111151,6vxx,DB03067,-10.2,"4-{2,4-Bis[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid",VFYAZSTYKPFSFL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111200,6vxx,DB03331,-10.2,"N-Naphthalen-1-Ylmethyl-2'-[3,5-Dimethoxybenzamido]-2'-Deoxy-Adenosine",OARVXDFNTLYMCJ-JVUUKAHWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77497,6m2n,DB08450,-10.2,N-1H-indazol-5-yl-2-(6-methylpyridin-2-yl)quinazolin-4-amine,HNHRWNUXTCATSG-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
109104,6vxx,DB12381,-10.2,Merestinib,QHADVLVFMKEIIP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81258,6m3m,DB00990,-10.2,Exemestane,BFYIZQONLCFLEV-DAELLWKTSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
109072,6vxx,DB11995,-10.2,Avatrombopag,OFZJKCQENFPZBH-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111543,6vxx,DB04011,-10.2,"2'-(4-Dimethylaminophenyl)-5-(4-Methyl-1-Piperazinyl)-2,5'-Bi-Benzimidazole",VMCOQLKKSNQANE-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81217,6m3m,DB00941,-10.2,Hexafluronium,HDZAQYPYABGTCL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
109019,6vxx,DB11913,-10.2,LY-2090314,HRJWTAWVFDCTGO-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165714,7bv1,DB12703,-10.2,Omipalisib,CGBJSGAELGCMKE-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
111621,6vxx,DB04289,-10.2,Genz-10850,YYMZSGIXLQPFAC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108977,6vxx,DB11852,-10.2,Tegobuvir,XBEQSQDCBSKCHJ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108860,6vxx,DB11176,-10.2,Zeaxanthin,JKQXZKUSFCKOGQ-QAYBQHTQSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108700,6vxx,DB08822,-10.2,Azilsartan medoxomil,QJFSABGVXDWMIW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
83208,6m3m,DB03583,-10.2,"(2e,3s)-3-Hydroxy-5'-[(4-Hydroxypiperidin-1-Yl)Sulfonyl]-3-Methyl-1,3-Dihydro-2,3'-Biindol-2'(1'h)-One",AYOAIABDFUJDKQ-SQJPUDIVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83271,6m3m,DB03671,-10.2,"4-(3,12,14-Trihydroxy-10,13-Dimethyl-Hexadecahydro-Cyclopenta[a]Phenanthren-17-Yl)-5h-Furan-2-One",SHIBSTMRCDJXLN-KCZCNTNESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
138413,6w9c,DB11618,-10.2,Zorubicin,FBTUMDXHSRTGRV-BJISBDEGSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
108569,6vxx,DB08407,-10.2,PLATENSIMYCIN,CSOMAHTTWTVBFL-OFBLZTNGSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
83570,6m3m,DB04064,-10.2,Nogalaviketone,QHNJNOBWURJIEK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
78373,6m2n,DB11663,-10.2,Pictilisib,LHNIIDJUOCFXAP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138718,6w9c,DB12165,-10.2,Presatovir,GOFXWTVKPWJNGD-UWJYYQICSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
82453,6m3m,DB02555,-10.2,SP4160,VCXMTWSYQSVWRK-AREMUKBSSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83640,6m3m,DB04154,-10.2,"N-Methyl-N-[3-(6-Phenyl[1,2,4]Triazolo[4,3-B]Pyridazin-3-Yl)Phenyl]Acetamide",ALBWBHNFOJJMCV-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
140504,6w9c,DB11977,-10.2,Golvatinib,UQRCJCNVNUFYDX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
59627,6crv,DB07691,-10.2,"2-({[3-(3,4-dihydroisoquinolin-2(1H)-ylsulfonyl)phenyl]carbonyl}amino)benzoic acid",GYILVHHTCYNIOS-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81470,6m3m,DB01234,-10.2,Dexamethasone,UREBDLICKHMUKA-CXSFZGCWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81458,6m3m,DB01216,-10.2,Finasteride,DBEPLOCGEIEOCV-WSBQPABSSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81905,6m3m,DB01836,-10.2,"[4-(6-Chloro-Naphthalene-2-Sulfonyl)-Piperazin-1-Yl]-(3,4,5,6-Tetrahydro-2h-[1,4']Bipyridinyl-4-Yl)-Methanone",ZLAKCKVFSRSENR-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
61416,6crv,DB12055,-10.2,MK-0767,ORZMUVMQJPGFOM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110599,6vxx,DB01988,-10.2,6((S)-3-Benzylpiperazin-1-Yl)-3-(Naphthalen-2-Yl)-4-(Pyridin-4-Yl)Pyrazine,WFSFNKVFXLIZIY-MHZLTWQESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
32121,6cs2,DB15401,-10.2,Danicopan,PIBARDGJJAGJAJ-NQIIRXRSSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
110818,6vxx,DB02449,-10.2,3-(1h-Indol-3-Yl)-2-[4-(4-Phenyl-Piperidin-1-Yl)-Benzenesulfonylamino]-Propionic Acid,ULOTXPTWJAUGGE-MHZLTWQESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
32142,6cs2,DB15437,-10.2,Rocacetrapib,GBHPDJQHZADVAA-SOKVYYICSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
109663,6vxx,DB15092,-10.2,LY-2624803,UEFWDVMEDFCHGW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59703,6crv,DB07779,-10.2,N-({(2S)-1-[(3R)-3-AMINO-4-(2-FLUOROPHENYL)BUTANOYL]PYRROLIDIN-2-YL}METHYL)BENZAMIDE,ANQHSFFUNMTTRS-MOPGFXCFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81355,6m3m,DB01100,-10.2,Pimozide,YVUQSNJEYSNKRX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
109500,6vxx,DB13997,-10.2,Baloxavir marboxil,RZVPBGBYGMDSBG-GGAORHGYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61448,6crv,DB12101,-10.2,CC-220,IXZOHGPZAQLIBH-NRFANRHFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109351,6vxx,DB13454,-10.2,Nicomorphine,HNDXBGYRMHRUFN-CIVUWBIHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138596,6w9c,DB11896,-10.2,Gedatolisib,DWZAEMINVBZMHQ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
59910,6crv,DB08015,-10.2,"(3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-phenyl-1H-indole-2,3-dione 3-oxime",SZYREAUDQRVVLV-DAFNUICNSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109329,6vxx,DB13078,-10.2,KOSN-1724,JAYGOFBXDFAXBW-CYEKYUJNSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111119,6vxx,DB03020,-10.2,5-Beta-D-Ribofuranosylnicotinamide Adenine Dinucleotide,UINNILASBHZOTM-KMXXXSRASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138608,6w9c,DB11911,-10.2,Galunisertib,IVRXNBXKWIJUQB-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
82386,6m3m,DB02473,-10.2,"6-[N-(1-Isopropyl-3,4-Dihydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine",XRHANBWAKSYPEN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81308,6m3m,DB01047,-10.2,Fluocinonide,WJOHZNCJWYWUJD-IUGZLZTKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
70540,6lxt,DB12817,-10.2,Zoliflodacin,ZSWMIFNWDQEXDT-ZESJGQACSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
72330,6m2n,DB00619,-10.2,Imatinib,KTUFNOKKBVMGRW-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61566,6crv,DB12272,-10.2,Vidupiprant,PFWVGKROPKKEDW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
83774,6m3m,DB04330,-10.2,Bilh 434,KNRVCCXHLSHTFW-HGPRPZRGSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
107415,6vxx,DB03276,-10.2,"4-[(10s,14s,18s)-18-(2-Amino-2-Oxoethyl)-14-(1-Naphthylmethyl)-8,17,20-Trioxo-7,16,19-Triazaspiro[5.14]Icos-11-En-10-Yl]Benzylphosphonic Acid",RHYFMOCFCFUTNH-GZNVFMSSSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138894,6w9c,DB12414,-10.2,Usistapide,WSYALRNYQFNNGP-WJOKGBTCSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
84377,6m3m,DB05835,-10.2,NS-3728,OQRAKHDEGGGWQO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84389,6m3m,DB05936,-10.2,CVT-6883,KOYXXLLNCXWUNF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
112484,6vxx,DB07307,-10.2,N-cyclopropyl-4-methyl-3-[1-(2-methylphenyl)phthalazin-6-yl]benzamide,GQXMJOSCBRZMKE-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
24036,6cs2,DB01691,-10.2,Indole Naphthyridinone,VAZMNDXVXVUKFY-JXMROGBWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
112595,6vxx,DB07435,-10.2,"1,2,3-TRIHYDROXY-1,2,3,4-TETRAHYDROBENZO[A]PYRENE",GFANZDFKCCJYRF-NSISKUIASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84439,6m3m,DB06178,-10.2,Talotrexin,NYQPLPNEESYGNO-IBGZPJMESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59062,6crv,DB07031,-10.2,"3-Fluoro-4-{[(2R)-2-hydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthalenyl)acetyl]amino}benzoic acid",AANFHDFOMFRLLR-LJQANCHMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30912,6cs2,DB13164,-10.2,Olmutinib,FDMQDKQUTRLUBU-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
61636,6crv,DB12369,-10.2,Sotrastaurin,OAVGBZOFDPFGPJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30885,6cs2,DB13109,-10.2,PKI-179,WXUUCRLKXQMWRY-OYRHEFFESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
54988,6crv,DB00471,-10.2,Montelukast,UCHDWCPVSPXUMX-TZIWLTJVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84527,6m3m,DB06409,-10.2,Morphine glucuronide,GNJCUHZOSOYIEC-GAROZEBRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59003,6crv,DB06963,-10.2,"3-[3-(3-methyl-6-{[(1S)-1-phenylethyl]amino}-1H-pyrazolo[4,3-c]pyridin-1-yl)phenyl]propanamide",ZFGCLYUGFRNYFE-INIZCTEOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84570,6m3m,DB06518,-10.2,R-1487,KKKRKRMVJRHDMG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
139001,6w9c,DB12694,-10.2,CE-326597,UBNMGTSDHSQBEL-PMERELPUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
106786,6vxx,DB01251,-10.2,Gliquidone,LLJFMFZYVVLQKT-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
134806,6w9c,DB03583,-10.2,"(2e,3s)-3-Hydroxy-5'-[(4-Hydroxypiperidin-1-Yl)Sulfonyl]-3-Methyl-1,3-Dihydro-2,3'-Biindol-2'(1'h)-One",AYOAIABDFUJDKQ-SQJPUDIVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
60267,6crv,DB08444,-10.2,"3-[2-bromo-4-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)phenoxy]-5-methylbenzonitrile",YYGZQXRLQMFHDH-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58966,6crv,DB06916,-10.2,"N-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-1-[2-(1H-IMIDAZOL-1-YL)-6-METHYLPYRIMIDIN-4-YL]-D-PROLINAMIDE",LBCGUKCXRVUULK-QGZVFWFLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
135309,6w9c,DB04289,-10.2,Genz-10850,YYMZSGIXLQPFAC-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
83754,6m3m,DB04301,-10.2,Bis(5-Amidino-2-Benzimidazolyl)Methane Ketone Hydrate,ZLAHDRAQCSQPOC-UHFFFAOYSA-P,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
62962,6crv,DB14822,-10.2,SB-649868,ZJXIUGNEAIHSBI-IBGZPJMESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84316,6m3m,DB05490,-10.2,AMG-131,NMRWDFUZLLQSBN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
112081,6vxx,DB06240,-10.2,Tariquidar,LGGHDPFKSSRQNS-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
71742,6lxt,DB15193,-10.2,BMS-955176,XDMUFNNPLXHNKA-ZTESCHFWSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
83894,6m3m,DB04495,-10.2,RU81843,GGPXNASQNUOIPB-NSOVKSMOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
135736,6w9c,DB04868,-10.2,Nilotinib,HHZIURLSWUIHRB-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
126579,6w4h,DB04016,-10.2,2-[3-({Methyl[1-(2-Naphthoyl)Piperidin-4-Yl]Amino}Carbonyl)-2-Naphthyl]-1-(1-Naphthyl)-2-Oxoethylphosphonic Acid,XUJQPDQURBZEGJ-KXQOOQHDSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
61318,6crv,DB11907,-10.2,Rociletinib,HUFOZJXAKZVRNJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80798,6m3m,DB00443,-10.2,Betamethasone,UREBDLICKHMUKA-DVTGEIKXSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83980,6m3m,DB04607,-10.2,"PHENYLAMINOIMIDAZO(1,2-ALPHA)PYRIDINE",UQAWGIKJINAKIZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
78461,6m2n,DB11791,-10.2,Capmatinib,LIOLIMKSCNQPLV-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61309,6crv,DB11896,-10.2,Gedatolisib,DWZAEMINVBZMHQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112174,6vxx,DB06486,-10.2,Enzastaurin,AXRCEOKUDYDWLF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84177,6m3m,DB04868,-10.2,Nilotinib,HHZIURLSWUIHRB-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
29222,6cs2,DB08883,-10.2,Perampanel,PRMWGUBFXWROHD-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
136869,6w9c,DB07630,-10.2,"N-((1R,2R)-2-(5-CHLORO-1H-INDOLE-2-CARBOXAMIDO)CYCLOHEXYL)-5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE-2-CARBOXAMIDE",ARPFWVKYXJZULB-IAGOWNOFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
71814,6lxt,DB15328,-10.2,Ubrogepant,DDOOFTLHJSMHLN-ZQHRPCGSSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
80613,6m3m,DB00223,-10.2,Diflorasone,WXURHACBFYSXBI-XHIJKXOTSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80478,6m2n,DB15444,-10.2,Elexacaftor,MVRHVFSOIWFBTE-INIZCTEOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80475,6m2n,DB15437,-10.2,Rocacetrapib,GBHPDJQHZADVAA-SOKVYYICSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
84275,6m3m,DB05263,-10.2,Caprospinol,VMOZFSWFUBLCNN-AAPULDEBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
31487,6cs2,DB13874,-10.2,Enasidenib,DYLUUSLLRIQKOE-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
112231,6vxx,DB06630,-10.2,Anacetrapib,MZZLGJHLQGUVPN-HAWMADMCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84353,6m3m,DB05678,-10.2,SLx-4090,AZUIUVJESCFSLJ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
89064,6m3m,DB15396,-10.2,PF-114,SLIVDYMORZGPLW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
29888,6cs2,DB11772,-10.2,Pilaralisib,QINPEPAQOBZPOF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
57867,6crv,DB04232,-10.2,N-Hydroxy-1-(4-Methoxyphenyl)Sulfonyl-4-Benzyloxycarbonyl-Piperazine-2-Carboxamide,DNGGPLKVDUPXFN-GOSISDBHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79119,6m2n,DB12760,-10.2,GW-493838,ZQYJPMPXQLNTPQ-QCUYGVNKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
130484,6w4h,DB12323,-10.2,Radotinib,DUPWHXBITIZIKZ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
87881,6m3m,DB13003,-10.2,Cortivazol,RKHQGWMMUURILY-UHRZLXHJSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88210,6m3m,DB13491,-10.2,Fluperolone,SLVCCRYLKTYUQP-DVTGEIKXSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
56013,6crv,DB01761,-10.2,4-[5-[2-(1-Phenyl-Ethylamino)-Pyrimidin-4-Yl]-1-Methyl-4-(3-Trifluoromethylphenyl)-1h-Imidazol-2-Yl]-Piperidine,QICPQLFMWYQJGX-SFHVURJKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60641,6crv,DB08912,-10.2,Dabrafenib,BFSMGDJOXZAERB-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88852,6m3m,DB14935,-10.2,Serabelisib,BLGWHBSBBJNKJO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
114914,6vxx,DB15401,-10.2,Danicopan,PIBARDGJJAGJAJ-NQIIRXRSSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87286,6m3m,DB12108,-10.2,Taselisib,BEUQXVWXFDOSAQ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
57662,6crv,DB03957,-10.2,SP2456,SSSXBBASYYVGCI-HSZRJFAPSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30265,6cs2,DB12269,-10.2,PF-06273340,BPIWZDNVMQQBQX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
137904,6w9c,DB08867,-10.2,Ulipristal,HKDLNTKNLJPAIY-WKWWZUSTSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
114757,6vxx,DB14785,-10.2,Fenebrutinib,WNEODWDFDXWOLU-QHCPKHFHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
137923,6w9c,DB08901,-10.2,Ponatinib,PHXJVRSECIGDHY-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
75439,6m2n,DB04703,-10.2,Hesperidin,QUQPHWDTPGMPEX-QJBIFVCTSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
29984,6cs2,DB11896,-10.2,Gedatolisib,DWZAEMINVBZMHQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
131859,6w4h,DB14870,-10.2,PF-5190457,ZIUDADZJCKGWKR-AREMUKBSSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
75617,6m2n,DB04983,-10.2,Denufosol,FPNPSEMJLALQSA-MIYUEGBISA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
55966,6crv,DB01698,-10.2,Rutin,IKGXIBQEEMLURG-NVPNHPEKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
74890,6m2n,DB03966,-10.2,Clorobiocin,FJAQNRBDVKIIKK-LFLQOBSNSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75267,6m2n,DB04477,-10.2,"N-1,2,3,4-Tetrahydronaphth-1-Yl-2'-[3,5-Dimethoxybenzamido]-2'-Deoxy-Adenosine",FDZQGEIYGFPMOB-ZUURFMEUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61904,6crv,DB12776,-10.2,E-6005,BBTFKAOFCSOZMB-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87977,6m3m,DB13158,-10.2,Clobetasone,XXIFVOHLGBURIG-OZCCCYNHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87045,6m3m,DB11751,-10.2,Cabotegravir,WCWSTNLSLKSJPK-LKFCYVNXSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88774,6m3m,DB14766,-10.2,Etrasimod,MVGWUTBTXDYMND-QGZVFWFLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
57466,6crv,DB03712,-10.2,RU85053,CEKLBQMULVLLTD-VMPREFPWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
64222,6lxt,DB01200,-10.2,Bromocriptine,OZVBMTJYIDMWIL-AYFBDAFISA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
78850,6m2n,DB12355,-10.2,Netazepide,YDZYKNJZCVIKPP-VWLOTQADSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
88705,6m3m,DB14640,-10.2,Isoflupredone acetate,ZOCUOMKMBMEYQV-GSLJADNHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
56690,6crv,DB02651,-10.2,"{[2-(1h-1,2,3-Benzotriazol-1-Yl)-2-(3,4-Difluorophenyl)Propane-1,3-Diyl]Bis[4,1-Phenylene(Difluoromethylene)]}Bis(Phosphonic Acid)",BTAGTGWPDROBMG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86964,6m3m,DB11622,-10.2,Dehydrocholic acid,OHXPGWPVLFPUSM-KLRNGDHRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87391,6m3m,DB12260,-10.2,Radiprodil,GKGRZLGAQZPEHO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
75059,6m2n,DB04190,-10.2,Inhibitor Bea425,AHAVBKNGKPWROK-UMFPTGFGSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
88721,6m3m,DB14657,-10.2,Paramethasone acetate,HYRKAAMZBDSJFJ-LFDBJOOHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58132,6crv,DB04591,-10.2,"N-{2,2-DIFLUORO-2-[(2R)-PIPERIDIN-2-YL]ETHYL}-2-[2-(1H-1,2,4-TRIAZOL-1-YL)BENZYL][1,3]OXAZOLO[4,5-C]PYRIDIN-4-AMINE",VYJOAYZRCNHDNG-GOSISDBHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86590,6m3m,DB09074,-10.2,Olaparib,FDLYAMZZIXQODN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
114204,6vxx,DB12897,-10.2,MK-7622,JUVQLZBJFOGEEO-GOTSBHOMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87956,6m3m,DB13113,-10.2,JNJ-38877605,JRWCBEOAFGHNNU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
56304,6crv,DB02152,-10.2,K-252a,KOZFSFOOLUUIGY-SOLYNIJKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87037,6m3m,DB11740,-10.2,MK-1775,BKWJAKQVGHWELA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88739,6m3m,DB14676,-10.2,Fagrocorat,QJJBNCHSWFGXML-KEKPKEOLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
79127,6m2n,DB12774,-10.2,AZD-8055,KVLFRAWTRWDEDF-IRXDYDNUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
63242,6crv,DB15416,-10.2,PX-102,XBUXXJUEBFDQHD-NHCUHLMSSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114171,6vxx,DB12848,-10.2,PF-04217903,PDMUGYOXRHVNMO-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78809,6m2n,DB12297,-10.2,GLPG-0187,CXHCNOMGODVIKB-VWLOTQADSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
86899,6m3m,DB11450,-10.2,Pimobendan,GLBJJMFZWDBELO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
164007,7bv1,DB06963,-10.2,"3-[3-(3-methyl-6-{[(1S)-1-phenylethyl]amino}-1H-pyrazolo[4,3-c]pyridin-1-yl)phenyl]propanamide",ZFGCLYUGFRNYFE-INIZCTEOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
131824,6w4h,DB14785,-10.2,Fenebrutinib,WNEODWDFDXWOLU-QHCPKHFHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
87203,6m3m,DB11984,-10.2,Letaxaban,GEHAEMCVKDPMKO-HXUWFJFHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
27085,6cs2,DB06435,-10.2,Tarazepide,CZPILLBHPRAPCB-AREMUKBSSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
87570,6m3m,DB12511,-10.2,Imiglitazar,ULVDFHLHKNJICZ-QCWLDUFUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
140028,6w9c,DB14785,-10.2,Fenebrutinib,WNEODWDFDXWOLU-QHCPKHFHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
87602,6m3m,DB12561,-10.2,WNT-974,XXYGTCZJJLTAGH-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
132593,6w9c,DB00619,-10.2,Imatinib,KTUFNOKKBVMGRW-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
61097,6crv,DB11526,-10.2,Masitinib,WJEOLQLKVOPQFV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57805,6crv,DB04154,-10.2,"N-Methyl-N-[3-(6-Phenyl[1,2,4]Triazolo[4,3-B]Pyridazin-3-Yl)Phenyl]Acetamide",ALBWBHNFOJJMCV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86475,6m3m,DB08911,-10.2,Trametinib,LIRYPHYGHXZJBZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
79074,6m2n,DB12690,-10.2,LY-2584702,FYXRSVDHGLUMHB-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
88960,6m3m,DB15189,-10.2,Birabresib,GNMUEVRJHCWKTO-FQEVSTJZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
57005,6crv,DB03076,-10.2,AHA047,CGBDAHCDSVOMCF-FYZVQMPESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87141,6m3m,DB11892,-10.2,Prulifloxacin,PWNMXPDKBYZCOO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88995,6m3m,DB15247,-10.2,Vorolanib,KMIOJWCYOHBUJS-HAKPAVFJSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
114365,6vxx,DB13345,-10.2,Dihydroergocristine,DEQITUUQPICUMR-HJPBWRTMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79039,6m2n,DB12640,-10.2,CP-609754,JAHDAIPFBPPQHQ-GDLZYMKVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
27140,6cs2,DB06555,-10.2,Siramesine,XWAONOGAGZNUSF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
62029,6crv,DB12973,-10.2,Serlopitant,FLNYCRJBCNNHRH-OIYLJQICSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86453,6m3m,DB08875,-10.2,Cabozantinib,ONIQOQHATWINJY-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
57878,6crv,DB04244,-10.2,(2R)-2-(3-Biphenylyl)-N-{(2R)-2-hydroxy-3-[(2-pyridinylsulfonyl)amino]propyl}-4-methylpentanamide,YCDHZDINQZLSRR-DNQXCXABSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114874,6vxx,DB15310,-10.2,Vactosertib,FJCDSQATIJKQKA-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61134,6crv,DB11637,-10.2,Delamanid,XDAOLTSRNUSPPH-XMMPIXPASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
73782,6m2n,DB02483,-10.2,Etheno-Nad,JCDBQDNBEQHDHK-BSLNIGMPSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
74410,6m2n,DB03311,-10.2,"3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid [4-(Thiazol-2-Ylsulfamoyl)-Phenyl]-Amide",SXKBTDJJEQQEGE-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
114332,6vxx,DB13307,-10.2,Proscillaridin,MYEJFUXQJGHEQK-ALRJYLEOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114221,6vxx,DB13113,-10.2,JNJ-38877605,JRWCBEOAFGHNNU-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
25169,6cs2,DB03044,-10.2,1-(5-Tert-Butyl-2-P-Tolyl-2h-Pyrazol-3-Yl)-3-[4-(2-Morpholin-4-Yl-Ethoxy)-Naphthalen-1-Yl]-Urea,MVCOAUNKQVWQHZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
87573,6m3m,DB12515,-10.2,9-aminocamptothecin,FUXVKZWTXQUGMW-FQEVSTJZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
74846,6m2n,DB03907,-10.2,"N-{3-[5-(6-Amino-Purin-9-Yl)-3,4-Dihydroxy-Tetrahydro-Furan-2-Yl]-Allyl}-2,3-Dihydroxy-5-Nitro-Benzamide",UHHBFOLQOQSPLU-WGRQDFERSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78555,6m2n,DB11925,-10.2,Vistusertib,JUSFANSTBFGBAF-IRXDYDNUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
63264,6crv,DB15460,-10.2,AGG-523,JWQMTWCFNZSLNR-DEOSSOPVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58357,6crv,DB04888,-10.2,Bifeprunox,CYGODHVAJQTCBG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78608,6m2n,DB12006,-10.2,BMS-906024,AYOUDDAETNMCBW-GSHUGGBRSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
108386,6vxx,DB07700,-10.1,"3-CARBOXAMIDO-1,3,5(10)-ESTRATRIEN-17(R)-SPIRO-2'(5',5'-DIMETHYL-6'OXO)TETRAHYDROPYRAN",YVAJWBACBRSVPR-NDUHRLLKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59294,6crv,DB07296,-10.1,(5Z)-3-(4-CHLOROPHENYL)-4-HYDROXY-5-(1-NAPHTHYLMETHYLENE)FURAN-2(5H)-ONE,PLGHLEBIWUQEPR-PDGQHHTCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59295,6crv,DB07297,-10.1,"5,6-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-D]PYRIMIDIN-4-AMINE",PTILEOLOGGMFCS-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57846,6crv,DB04204,-10.1,[(4-{4-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Butyl}-Phenyl)-Difluoro-Methyl]-Phosphonic Acid,SRHSAABKYJDBDV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61952,6crv,DB12858,-10.1,LY-377604,RBSGUQYXRDKPAE-QFIPXVFZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84457,6m3m,DB06212,-10.1,Tolvaptan,GYHCTFXIZSNGJT-XMMPIXPASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
107029,6vxx,DB02194,-10.1,"8-Benzyl-2-Hydroxy-2-(4-Hydroxy-Benzyl)-6-(4-Hydroxy-Phenyl)-2h-Imidazo[1,2-a]Pyrazin-3-One",ULLMMKZQNNBLRN-SANMLTNESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80466,6m2n,DB15416,-10.1,PX-102,XBUXXJUEBFDQHD-NHCUHLMSSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
87950,6m3m,DB13104,-10.1,X-396,ONPGOSVDVDPBCY-CQSZACIVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
112199,6vxx,DB06558,-10.1,Tezosentan,TUYWTLTWNJOZNY-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87349,6m3m,DB12200,-10.1,Tivantinib,UCEQXRCJXIVODC-PMACEKPBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
54839,6crv,DB00288,-10.1,Amcinonide,ILKJAFIWWBXGDU-MOGDOJJUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
135121,6w9c,DB04011,-10.1,"2'-(4-Dimethylaminophenyl)-5-(4-Methyl-1-Piperazinyl)-2,5'-Bi-Benzimidazole",VMCOQLKKSNQANE-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
88406,6m3m,DB13756,-10.1,Peruvoside,PMTSPAGBAFCORP-HBUONDEYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
60857,6crv,DB09233,-10.1,Cronidipine,CNIJVNPIIHWRRP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86418,6m3m,DB08815,-10.1,Lurasidone,PQXKDMSYBGKCJA-CVTJIBDQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
135088,6w9c,DB03966,-10.1,Clorobiocin,FJAQNRBDVKIIKK-LFLQOBSNSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
87706,6m3m,DB12721,-10.1,RO-5028442,QZXVLRCMAHJVIP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
112253,6vxx,DB06888,-10.1,"(13R,15S)-13-METHYL-16-OXA-8,9,12,22,24-PENTAAZAHEXACYCLO[15.6.2.16,9.1,12,15.0,2,7.0,21,25]HEPTACOSA-1(24),2,4,6,17(25),18,20-HEPTAENE-23,26-DIONE",KBLPHMRCKHFBJB-OLZOCXBDSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59043,6crv,DB07008,-10.1,"4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMIDAZOL-1-YL)PHENOXY]PYRIMIDINE",XPXGYINSBORUMM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61603,6crv,DB12318,-10.1,BMS-599626,LUJZZYWHBDHDQX-QFIPXVFZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
135746,6w9c,DB04882,-10.1,Edotecarin,QMVPQBFHUJZJCS-NTKFZFFISA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
56443,6crv,DB02338,-10.1,Nadph Dihydro-Nicotinamide-Adenine-Dinucleotidephosphate,ACFIXJIJDZMPPO-NNYOXOHSSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29994,6cs2,DB11907,-10.1,Rociletinib,HUFOZJXAKZVRNJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
87144,6m3m,DB11896,-10.1,Gedatolisib,DWZAEMINVBZMHQ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
73859,6m2n,DB02581,-10.1,"5-[2,3-Dichloro-4-(5-{1-[2-(2-Guanidino-4-Methyl-Pentanoylamino)-Acetyl]-Piperidin-4-Yl}-1-Methyl-1h-Pyrazol-3-Yl)-Phenoxymethyl]-Furan-2-Carboxylic Acid",VNZHOIDQBPFEJU-OAQYLSRUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138758,6w9c,DB12228,-10.1,Telcagepant,CGDZXLJGHVKVIE-DNVCBOLYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
80433,6m2n,DB15345,-10.1,GSK-945237,SRICOHRDRMZREQ-MRXNPFEDSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
87240,6m3m,DB12041,-10.1,Mapracorat,VJGFOYBQOIPQFY-XMMPIXPASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
139923,6w9c,DB14568,-10.1,Ivosidenib,WIJZXSAJMHAVGX-DHLKQENFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
53426,2fxp,DB12983,-10.1,Phthalocyanine,IEQIEDJGQAUEQZ-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
78890,6m2n,DB12410,-10.1,Sabarubicin,VQHRZZISQVWPLK-UIRGBLDSSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138739,6w9c,DB12200,-10.1,Tivantinib,UCEQXRCJXIVODC-PMACEKPBSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
114902,6vxx,DB15367,-10.1,LY-2623091,YPCLDHGBEKZGEB-RUDKWAFVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
135740,6w9c,DB04875,-10.1,Pralnacasan,CXAGHAZMQSCAKJ-WAHHBDPQSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
28607,6cs2,DB08197,-10.1,"(5E,7S)-2-amino-7-(4-fluoro-2-pyridin-3-ylphenyl)-4-methyl-7,8-dihydroquinazolin-5(6H)-one oxime",KYIXUSLGFINPTC-WVFAEZDRSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
31074,6cs2,DB13371,-10.1,Difenpiramide,PWHROYKAGRUWDQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
27639,6cs2,DB07189,-10.1,"(1S,3R,6S)-4-oxo-6-{4-[(2-phenylquinolin-4-yl)methoxy]phenyl}-5-azaspiro[2.4]heptane-1-carboxylic acid",BFZXMIUWGSTUAL-ZSOKXDGFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
59255,6crv,DB07254,-10.1,"N-[3-[[4-[(5-CHLORO-1,3-BENZODIOXOL-4-YL)AMINO]PYRIMIDIN-2-YL]AMINO]PHENYL]METHANESULFONAMIDE",KQGTYXRWSIBDOZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57611,6crv,DB03893,-10.1,Thionicotinamide-Adenine-Dinucleotide,UQYPZLRUJKCREN-NNYOXOHSSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
139592,6w9c,DB13676,-10.1,Mosapramine,PXUIZULXJVRBPC-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
84413,6m3m,DB06117,-10.1,"1alpha,24S-Dihydroxyvitamin D2",ODZFJAXAEXQSKL-WRJREGAQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
75283,6m2n,DB04495,-10.1,RU81843,GGPXNASQNUOIPB-NSOVKSMOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
73795,6m2n,DB02498,-10.1,Carba-Nicotinamide-Adenine-Dinucleotide,DGPLSUKWXXSBCU-VGXGLJSLSA-O,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
84372,6m3m,DB05812,-10.1,Abiraterone,GZOSMCIZMLWJML-VJLLXTKPSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
140276,6w9c,DB02524,-10.1,"2',3'-O-{4-[Hydroxy(oxido)-lambda5-azanylidene]-2,6-dinitro-2,5-cyclohexadiene-1,1-diyl}adenosine 5'-(tetrahydrogen triphosphate)",XFMMHXLUHKBKQE-UHEGPQQHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
56591,6crv,DB02519,-10.1,Indirubin-5-Sulphonate,IHBOEHLUIBMBMY-YPKPFQOOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
83963,6m3m,DB04583,-10.1,"5-Carbamoyl-1,1':4',1''-terphenyl-3-carboxylic acid",LAZPCGBRHLARSI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
112718,6vxx,DB07765,-10.1,"METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL](METHYL)AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE",UKCFUFHREWUXJJ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77269,6m2n,DB08164,-10.1,"(3R,4R)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN-3-AMINE",GOBIXGZJSMAOFV-QRWLVFNGSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
87774,6m3m,DB12836,-10.1,Grapiprant,HZVLFTCYCLXTGV-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
74689,6m2n,DB03712,-10.1,RU85053,CEKLBQMULVLLTD-VMPREFPWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
74822,6m2n,DB03878,-10.1,N-[4-Methyl-3-[[4-(3-Pyridinyl)-2-Pyrimidinyl]Amino]Phenyl]-3-Pyridinecarboxamide,YWQVBESSYLICRX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
32702,6cs2,T3D3608,-10.1,Microcystin-YR,OWHASZQTEFAUJC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
74885,6m2n,DB03957,-10.1,SP2456,SSSXBBASYYVGCI-HSZRJFAPSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
82393,6m3m,DB02483,-10.1,Etheno-Nad,JCDBQDNBEQHDHK-BSLNIGMPSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87795,6m3m,DB12874,-10.1,Quizartinib,CVWXJKQAOSCOAB-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
163057,7bv1,DB03712,-10.1,RU85053,CEKLBQMULVLLTD-VMPREFPWSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
81293,6m3m,DB01030,-10.1,Topotecan,UCFGDBYHRUNTLO-QHCPKHFHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
109285,6vxx,DB13014,-10.1,Hypericin,BTXNYTINYBABQR-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29090,6cs2,DB08730,-10.1,3-FLUORO-5-MORPHOLIN-4-YL-N-[1-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-6-YL]BENZAMIDE,CPFBZMFUCGHBAP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
87809,6m3m,DB12892,-10.1,MGB-BP-3,OEKXCVYZBVOWBR-BQYQJAHWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
78238,6m2n,DB11363,-10.1,Alectinib,KDGFLJKFZUIJMX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
109128,6vxx,DB12412,-10.1,Gemigliptin,ZWPRRQZNBDYKLH-VIFPVBQESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
82563,6m3m,DB02704,-10.1,"(2r,3r,4r,5r)-3,4-Dihydroxy-N,N'-Bis[(1s,2r)-2-Hydroxy-2,3-Dihydro-1h-Inden-1-Yl]-2,5-Bis(2-Phenylethyl)Hexanediamide",GQKBYZPVKVXMJL-LAFNQVRVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87540,6m3m,DB12465,-10.1,Ketanserin,FPCCSQOGAWCVBH-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
111226,6vxx,DB03363,-10.1,3-Acetylpyridine Adenine Dinucleotide,KPVQNXLUPNWQHM-RBEMOOQDSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87597,6m3m,DB12553,-10.1,Fluocinolone,UUOUOERPONYGOS-CLCRDYEYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
109114,6vxx,DB12394,-10.1,Eleclazine,YNUAEEJQYHYLMS-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77807,6m2n,DB08815,-10.1,Lurasidone,PQXKDMSYBGKCJA-CVTJIBDQSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
136270,6w9c,DB06920,-10.1,Eribaxaban,QQBKAVAGLMGMHI-WIYYLYMNSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
77972,6m2n,DB09063,-10.1,Ceritinib,VERWOWGGCGHDQE-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
110502,6vxx,DB01678,-10.1,RU84687,SAFPHFWYRLLBFO-NSOVKSMOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57054,6crv,DB03141,-10.1,"3-{[(5R,6R)-5-Benzyl-6-hydroxy-2,4-bis(4-hydroxybenzyl)-3-oxo-1,2,4-triazepan-1-yl]sulfonyl}benzonitril",UYUWNNRWESUYOB-FIRIVFDPSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87687,6m3m,DB12694,-10.1,CE-326597,UBNMGTSDHSQBEL-PMERELPUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
78729,6m2n,DB12186,-10.1,SRT-2104,LAMQVIQMVKWXOC-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
62032,6crv,DB12978,-10.1,Pexidartinib,JGWRKYUXBBNENE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109884,6vxx,DB00549,-10.1,Zafirlukast,YEEZWCHGZNKEEK-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77860,6m2n,DB08906,-10.1,Fluticasone furoate,XTULMSXFIHGYFS-VLSRWLAYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
59888,6crv,DB07991,-10.1,N-[(1R)-3-(4-HYDROXYPHENYL)-1-METHYLPROPYL]-2-(2-PHENYL-1H-INDOL-3-YL)ACETAMIDE,APLJSSOXDWUNGV-GOSISDBHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59722,6crv,DB07800,-10.1,N-(2-(((5-CHLORO-2-PYRIDINYL)AMINO)SULFONYL)PHENYL)-4-(2-OXO-1(2H)-PYRIDINYL)BENZAMIDE,MIJGLXFQYBTIFY-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81384,6m3m,DB01134,-10.1,Desoxycorticosterone pivalate,VVOIQBFMTVCINR-WWMZEODYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87653,6m3m,DB12644,-10.1,AZD-2066,SXWHYTICXCLKDG-GFCCVEGCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
138568,6w9c,DB11852,-10.1,Tegobuvir,XBEQSQDCBSKCHJ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
59702,6crv,DB07778,-10.1,FAMOXADONE,PCCSBWNGDMYFCW-QFIPXVFZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59901,6crv,DB08006,-10.1,"N-anthracen-2-yl-5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7-amine",OXYDLVAOXASTMW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57001,6crv,DB03072,-10.1,"2-{3-[4-(4-Fluorophenyl)-3,6-Dihydro-1(2h)-Pyridinyl]Propyl}-8-Methyl-4(3h)-Quinazolinone",LOFDUAJQRUYHBR-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
74629,6m2n,DB03632,-10.1,Argifin,UHBHXSDKGLPPGO-HTDHLNIYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
110921,6vxx,DB02581,-10.1,"5-[2,3-Dichloro-4-(5-{1-[2-(2-Guanidino-4-Methyl-Pentanoylamino)-Acetyl]-Piperidin-4-Yl}-1-Methyl-1h-Pyrazol-3-Yl)-Phenoxymethyl]-Furan-2-Carboxylic Acid",VNZHOIDQBPFEJU-OAQYLSRUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
63107,6crv,DB15145,-10.1,Ziresovir,GAAICKUTDBZCMT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
74310,6m2n,DB03186,-10.1,U-Pi-a-Pi,JIAJERGOUFOENU-LNAOLWRRSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
82579,6m3m,DB02723,-10.1,"4-Oxo-2-Phenylmethanesulfonyl-Octahydro-Pyrrolo[1,2-a]Pyrazine-6-Carboxylic Acid [1-(N-Hydroxycarbamimidoyl)-Piperidin-4-Ylmethyl]-Amide",DHTSUHWLPAEEQB-OALUTQOASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
28751,6cs2,DB08362,-10.1,"N-(3-(8-CYANO-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZIN-2-YLAMINO)PHENYL)ACETAMIDE",QVKXQLGRDOMAGC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
63009,6crv,DB14918,-10.1,Branaplam,STWTUEAWRAIWJG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
63102,6crv,DB15137,-10.1,VK-2809,LGGPZDRLTDGYSQ-JADSYQMUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
73968,6m2n,DB02723,-10.1,"4-Oxo-2-Phenylmethanesulfonyl-Octahydro-Pyrrolo[1,2-a]Pyrazine-6-Carboxylic Acid [1-(N-Hydroxycarbamimidoyl)-Piperidin-4-Ylmethyl]-Amide",DHTSUHWLPAEEQB-OALUTQOASA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
162908,7bv1,DB03276,-10.1,"4-[(10s,14s,18s)-18-(2-Amino-2-Oxoethyl)-14-(1-Naphthylmethyl)-8,17,20-Trioxo-7,16,19-Triazaspiro[5.14]Icos-11-En-10-Yl]Benzylphosphonic Acid",RHYFMOCFCFUTNH-GZNVFMSSSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
74927,6m2n,DB04016,-10.1,2-[3-({Methyl[1-(2-Naphthoyl)Piperidin-4-Yl]Amino}Carbonyl)-2-Naphthyl]-1-(1-Naphthyl)-2-Oxoethylphosphonic Acid,XUJQPDQURBZEGJ-KXQOOQHDSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
135063,6w9c,DB03932,-10.1,LFA703,WPVRNXUYVXQXPY-YFAYRSKXSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
83433,6m3m,DB03878,-10.1,N-[4-Methyl-3-[[4-(3-Pyridinyl)-2-Pyrimidinyl]Amino]Phenyl]-3-Pyridinecarboxamide,YWQVBESSYLICRX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
111922,6vxx,DB04872,-10.1,Osanetant,DZOJBGLFWINFBF-UMSFTDKQSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80942,6m3m,DB00620,-10.1,Triamcinolone,GFNANZIMVAIWHM-OBYCQNJPSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
111924,6vxx,DB04875,-10.1,Pralnacasan,CXAGHAZMQSCAKJ-WAHHBDPQSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78368,6m2n,DB11652,-10.1,Tucatinib,SDEAXTCZPQIFQM-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
71604,6lxt,DB14883,-10.1,Lorecivivint,AQDWDWAYVBQMAM-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
138711,6w9c,DB12154,-10.1,Itacitinib,KTBSXLIQKWEBRB-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
59369,6crv,DB07382,-10.1,"N-2-1H-benzimidazol-5-yl-N-4-(3-cyclopropyl-1H-pyrazol-5-yl)pyrimidine-2,4-diamine",WJNBSTLIALIIEW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78818,6m2n,DB12307,-10.1,Foretinib,CXQHYVUVSFXTMY-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
59359,6crv,DB07369,-10.1,"N-(3-chlorophenyl)-N-methyl-2-oxo-3-[(3,4,5-trimethyl-1H-pyrrol-2-yl)methyl]-2H-indole-5-sulfonamide",YMJLSOJLEXWATP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111734,6vxx,DB04452,-10.1,Aminoquinuride,HOUSDILKOJMENG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29937,6cs2,DB11830,-10.1,Mocetinostat,HRNLUBSXIHFDHP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
56750,6crv,DB02732,-10.1,Nicotinamide Adenine Dinucleotide Acetone Adduct,SGHBFOOIAAJJMI-YDKVLQLQSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87883,6m3m,DB13005,-10.1,Rebastinib,WVXNSAVVKYZVOE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
138676,6w9c,DB12108,-10.1,Taselisib,BEUQXVWXFDOSAQ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
130846,6w4h,DB12886,-10.1,GSK-1521498,WIEDUMBCZQRGSY-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
136070,6w9c,DB06469,-10.1,Lestaurtinib,UIARLYUEJFELEN-DMVVYWCZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136062,6w9c,DB06448,-10.1,Lonafarnib,DHMTURDWPRKSOA-RUZDIDTESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
78785,6m2n,DB12267,-10.1,Brigatinib,AILRADAXUVEEIR-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
31898,6cs2,DB14993,-10.1,Pyrotinib,SADXACCFNXBCFY-IYNHSRRRSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
136033,6w9c,DB06364,-10.1,XR5944,SFOADSRLCHRTKT-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
82862,6m3m,DB03104,-10.1,RU82129,NKMPOVPTYDXGEC-MNRBYUMSSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
108978,6vxx,DB11853,-10.1,Relugolix,AOMXMOCNKJTRQP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108944,6vxx,DB11431,-10.1,Moxidectin,YZBLFMPOMVTDJY-LSGXYNIPSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
63012,6crv,DB14929,-10.1,Elsulfavirine,ULTDEARCBRNRGR-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78348,6m2n,DB11614,-10.1,Rupatadine,WUZYKBABMWJHDL-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
83035,6m3m,DB03331,-10.1,"N-Naphthalen-1-Ylmethyl-2'-[3,5-Dimethoxybenzamido]-2'-Deoxy-Adenosine",OARVXDFNTLYMCJ-JVUUKAHWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
56755,6crv,DB02741,-10.1,CD564,RWYREGSYPCNZTL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
83064,6m3m,DB03367,-10.1,PF-00356231,VMTJQZUZINLEKC-JOCHJYFZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83126,6m3m,DB03460,-10.1,Violaxanthin,SZCBXWMUOPQSOX-WVJDLNGLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81087,6m3m,DB00796,-10.1,Candesartan cilexetil,GHOSNRCGJFBJIB-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
138687,6w9c,DB12121,-10.1,Entospletinib,XSMSNFMDVXXHGJ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
80996,6m3m,DB00687,-10.1,Fludrocortisone,AAXVEMMRQDVLJB-BULBTXNYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
55292,6crv,DB00838,-10.1,Clocortolone,YMTMADLUXIRMGX-RFPWEZLHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
135020,6w9c,DB03878,-10.1,N-[4-Methyl-3-[[4-(3-Pyridinyl)-2-Pyrimidinyl]Amino]Phenyl]-3-Pyridinecarboxamide,YWQVBESSYLICRX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
80212,6m2n,DB14879,-10.1,Cefiderocol,DBPPRLRVDVJOCL-FQRUVTKNSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
113730,6vxx,DB11822,-10.1,TMC-647055,UOBYJVFBFSLCTQ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79277,6m2n,DB13014,-10.1,Hypericin,BTXNYTINYBABQR-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
86825,6m3m,DB11273,-10.1,Dihydroergocornine,SEALOBQTUQIVGU-QNIJNHAOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
75570,6m2n,DB04875,-10.1,Pralnacasan,CXAGHAZMQSCAKJ-WAHHBDPQSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
98787,6vxs,DB01419,-10.1,Antrafenine,NWGGKKGAFZIVBJ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
72873,6m2n,DB01251,-10.1,Gliquidone,LLJFMFZYVVLQKT-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79280,6m2n,DB13019,-10.1,Henatinib,MCTXSDCWFQAGFS-UEXNTNOUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
73342,6m2n,DB01908,-10.1,RU85493,MWEWSHNGVWABKG-SVBPBHIXSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
97666,6m71,DB15367,-10.1,LY-2623091,YPCLDHGBEKZGEB-RUDKWAFVSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
88861,6m3m,DB14946,-10.1,PCO-371,LDZJFVOUPUFOHX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58638,6crv,DB06248,-10.1,Amelubant,SBVYURPQULDJTI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58333,6crv,DB04859,-10.1,Zanapezil,PMBLXLOXUGVTGB-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30267,6cs2,DB12270,-10.1,Losmapimod,KKYABQBFGDZVNQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
75905,6m2n,DB06367,-10.1,Relacatib,BWYBBMQLUKXECQ-GIVPXCGWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
86677,6m3m,DB09215,-10.1,Droxicam,OEHFRZLKGRKFAS-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58627,6crv,DB06229,-10.1,Ocaperidone,ZZQNEJILGNNOEP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88830,6m3m,DB14894,-10.1,Galicaftor,QVDYQHXNAQHIKH-TZIWHRDSSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
97390,6m71,DB14773,-10.1,Lifirafenib,NGFFVZQXSRKHBM-FKBYEOEOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
63201,6crv,DB15328,-10.1,Ubrogepant,DDOOFTLHJSMHLN-ZQHRPCGSSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
166468,7bv1,DB15193,-10.1,BMS-955176,XDMUFNNPLXHNKA-ZTESCHFWSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
682,6lzg,HMDB0006612,-10.1,Monofucosyllacto-N-hexaose,GKEWHGPIQCSUCC-JJGOEJEFSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
134070,6w9c,DB02524,-10.1,"2',3'-O-{4-[Hydroxy(oxido)-??5-azanylidene]-2,6-dinitro-2,5-cyclohexadiene-1,1-diyl}adenosine 5'-(tetrahydrogen triphosphate)",XFMMHXLUHKBKQE-UHEGPQQHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
79145,6m2n,DB12805,-10.1,Ataciguat,PQHLRGARXNPFCF-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
58145,6crv,DB04607,-10.1,"PHENYLAMINOIMIDAZO(1,2-ALPHA)PYRIDINE",UQAWGIKJINAKIZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80291,6m2n,DB15068,-10.1,Agerafenib,DKNUPRMJNUQNHR-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
85049,6m3m,DB07204,-10.1,"(1S)-1-(1H-INDOL-3-YLMETHYL)-2-(2-PYRIDIN-4-YL-[1,7]NAPHTYRIDIN-5-YLOXY)-EHYLAMINE",DQIXTEDFNFZMCM-SFHVURJKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88699,6m3m,DB14634,-10.1,Fluprednidene acetate,DEFOZIFYUBUHHU-IYQKUMFPSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80274,6m2n,DB15036,-10.1,Sitravatinib,WLAVZAAODLTUSW-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
56194,6crv,DB02008,-10.1,1-(2-Fluorobenzyl)-3-Butyl-8-(N-Acetyl-4-Aminobenzyl)-Xanthine,JHSHXKJSPVHPCJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104373,6vxs,DB11904,-10.1,Flumatinib,BJCJYEYYYGBROF-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
113641,6vxx,DB11691,-10.1,Naldemedine,AXQACEQYCPKDMV-RZAWKFBISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56148,6crv,DB01948,-10.1,"1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperidin-4-Yl-3,4-Dihydroquinolin-2(1h)-One",VXIYTVJEIXMAQF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
22961,6cs2,HMDB0055590,-10.1,"TG(20:4(8Z,11Z,14Z,17Z)/18:1(9Z)/o-18:0)",HEIAOQGWRROSQN-CNVGNDOZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
88732,6m3m,DB14669,-10.1,Betamethasone phosphate,VQODGRNSFPNSQE-DVTGEIKXSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
106877,6vxx,DB01690,-10.1,Bis(Adenosine)-5'-Triphosphate,QCICUPZZLIQAPA-XPWFQUROSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30585,6cs2,DB12690,-10.1,LY-2584702,FYXRSVDHGLUMHB-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
101575,6vxs,DB05678,-10.1,SLx-4090,AZUIUVJESCFSLJ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
161913,7bv1,DB00966,-10.1,Telmisartan,RMMXLENWKUUMAY-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
58043,6crv,DB04477,-10.1,"N-1,2,3,4-Tetrahydronaphth-1-Yl-2'-[3,5-Dimethoxybenzamido]-2'-Deoxy-Adenosine",FDZQGEIYGFPMOB-ZUURFMEUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
141418,6w9q,DB00872,-10.1,Conivaptan,IKENVDNFQMCRTR-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
79906,6m2n,DB13941,-10.1,Piperaquine,UCRHFBCYFMIWHC-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75742,6m2n,DB05678,-10.1,SLx-4090,AZUIUVJESCFSLJ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
55661,6crv,DB01267,-10.1,Paliperidone,PMXMIIMHBWHSKN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75721,6m2n,DB05553,-10.1,Regrelor,NXHAXEBZOXCDKD-XIXRRVGJSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
86160,6m3m,DB08512,-10.1,"6-amino-2-[(1-naphthylmethyl)amino]-3,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",MCEZMMDIEXECTI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
79339,6m2n,DB13104,-10.1,X-396,ONPGOSVDVDPBCY-CQSZACIVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
58386,6crv,DB04960,-10.1,Tipifarnib,PLHJCIYEEKOWNM-HHHXNRCGSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58390,6crv,DB04971,-10.1,Reglitazar,QBQLYIISSRXYKL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
161483,7bv1,DB14894,-10.1,Galicaftor,QVDYQHXNAQHIKH-TZIWHRDSSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
89036,6m3m,DB15328,-10.1,Ubrogepant,DDOOFTLHJSMHLN-ZQHRPCGSSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
29624,6cs2,DB11262,-10.1,Bisoctrizole,FQUNFJULCYSSOP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
63191,6crv,DB15308,-10.1,Ridinilazole,UHQFBTAJFNVZIV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
89055,6m3m,DB15367,-10.1,LY-2623091,YPCLDHGBEKZGEB-RUDKWAFVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
92149,6m71,DB04016,-10.1,2-[3-({Methyl[1-(2-Naphthoyl)Piperidin-4-Yl]Amino}Carbonyl)-2-Naphthyl]-1-(1-Naphthyl)-2-Oxoethylphosphonic Acid,XUJQPDQURBZEGJ-KXQOOQHDSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
90626,6m71,DB01988,-10.1,6((S)-3-Benzylpiperazin-1-Yl)-3-(Naphthalen-2-Yl)-4-(Pyridin-4-Yl)Pyrazine,WFSFNKVFXLIZIY-MHZLTWQESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
61845,6crv,DB12682,-10.1,Mubritinib,ZTFBIUXIQYRUNT-MDWZMJQESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
73173,6m2n,DB01678,-10.1,RU84687,SAFPHFWYRLLBFO-NSOVKSMOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
114041,6vxx,DB12640,-10.1,CP-609754,JAHDAIPFBPPQHQ-GDLZYMKVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58477,6crv,DB05465,-10.1,Tandutinib,UXXQOJXBIDBUAC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86624,6m3m,DB09143,-10.1,Sonidegib,VZZJRYRQSPEMTK-CALCHBBNSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
93012,6m71,DB05984,-10.1,RAF-265,YABJJWZLRMPFSI-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
78547,6m2n,DB11913,-10.1,LY-2090314,HRJWTAWVFDCTGO-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
63200,6crv,DB15327,-10.1,Abivertinib,UOFYSRZSLXWIQB-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55870,6crv,DB01573,-10.1,Benzylmorphine,RDJGWRFTDZZXSM-RNWLQCGYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28090,6cs2,DB07665,-10.1,"N-[2-(carbamimidamidooxy)ethyl]-2-{6-cyano-3-[(2,2-difluoro-2-pyridin-2-ylethyl)amino]-2-fluorophenyl}acetamide",STHCHQXQLDMISY-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
86589,6m3m,DB09073,-10.1,Palbociclib,AHJRHEGDXFFMBM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
73289,6m2n,DB01830,-10.1,"{4-[2-Acetylamino-2-(3-Carbamoyl-2-Cyclohexylmethoxy-6,7,8,9-Tetrahydro-5h-Benzocyclohepten-5ylcarbamoyl)-Ethyl]-2-Phosphono-Phenyl}-Phosphonic Acid",SPSGYTWOIGAABK-DQEYMECFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75851,6m2n,DB06229,-10.1,Ocaperidone,ZZQNEJILGNNOEP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
55563,6crv,DB01148,-10.1,Flavoxate,SPIUTQOUKAMGCX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55588,6crv,DB01177,-10.1,Idarubicin,XDXDZDZNSLXDNA-TZNDIEGXSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
133096,6w9c,DB01200,-10.1,Bromocriptine,OZVBMTJYIDMWIL-AYFBDAFISA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
96373,6m71,DB12817,-10.1,Zoliflodacin,ZSWMIFNWDQEXDT-ZESJGQACSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
75748,6m2n,DB05713,-10.1,LY-517717,VYNKVNDKAOGAAQ-RUZDIDTESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
60622,6crv,DB08881,-10.1,Vemurafenib,GPXBXXGIAQBQNI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
117834,6w4b,DB04016,-10.1,2-[3-({Methyl[1-(2-Naphthoyl)Piperidin-4-Yl]Amino}Carbonyl)-2-Naphthyl]-1-(1-Naphthyl)-2-Oxoethylphosphonic Acid,XUJQPDQURBZEGJ-KXQOOQHDSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
58518,6crv,DB05678,-10.1,SLx-4090,AZUIUVJESCFSLJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61851,6crv,DB12693,-10.1,Ritanserin,JUQLTPCYUFPYKE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79683,6m2n,DB13607,-10.1,Picloxydine,YNCLPFSAZFGQCD-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
28030,6cs2,DB00696,-10.1,Ergotamine,XCGSFFUVFURLIX-VFGNJEKYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
140057,6w9c,DB14859,-10.1,Fosifloxuridine nafalbenamide,BIOWRMNRHMERIO-ZVAHOJSLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
105027,6vxs,DB12886,-10.1,GSK-1521498,WIEDUMBCZQRGSY-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
114187,6vxx,DB12875,-10.1,Mavatrep,ORDHXXHTBUZRCN-NTEUORMPSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62912,6crv,DB14703,-10.1,Dexamethasone metasulfobenzoate,TWQWRHIQRAZHPR-XNXCGYEVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
132067,6w4h,DB15308,-10.1,Ridinilazole,UHQFBTAJFNVZIV-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
24386,6cs2,DB02112,-10.1,Zk-806450,DZLGSWPXZYDHBD-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
61916,6crv,DB12798,-10.1,Relenopride,KGMMSPVVHZGPHL-NRFANRHFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140196,6w9c,DB15327,-10.1,Abivertinib,UOFYSRZSLXWIQB-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
84586,6m3m,DB06555,-10.1,Siramesine,XWAONOGAGZNUSF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84822,6m3m,DB06938,-10.1,4-[[2-[[4-chloro-3-(trifluoromethyl)phenyl]amino]-3H-benzimidazol-5-yl]oxy]-N-methyl-pyridine-2-carboxamide,ZJLSMLDOCGOURY-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
158661,7bv1,DB01761,-10.1,4-[5-[2-(1-Phenyl-Ethylamino)-Pyrimidin-4-Yl]-1-Methyl-4-(3-Trifluoromethylphenyl)-1h-Imidazol-2-Yl]-Piperidine,QICPQLFMWYQJGX-SFHVURJKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
73745,6m2n,DB02432,-10.1,RU90395,RLLAUERCSKPFGD-VMPREFPWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
140722,6w9c,DB15189,-10.1,Birabresib,GNMUEVRJHCWKTO-FQEVSTJZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
61654,6crv,DB12394,-10.1,Eleclazine,YNUAEEJQYHYLMS-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106290,6vxs,DB15403,-10.1,Ziritaxestat,REQQVBGILUTQNN-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
84810,6m3m,DB06925,-10.1,3-(2-AMINOQUINAZOLIN-6-YL)-4-METHYL-N-[3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE,YEIASMOUYNOXGA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
137650,6w9c,DB08553,-10.1,"(1E)-5-(1-piperidin-4-yl-3-pyridin-4-yl-1H-pyrazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime",KWEFZSZCLBHIEQ-YYADALCUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
84564,6m3m,DB06497,-10.1,Aplaviroc,GWNOTCOIYUNTQP-FQLXRVMXSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
113324,6vxx,DB08995,-10.1,Diosmin,GZSOSUNBTXMUFQ-YFAPSIMESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113093,6vxx,DB08366,-10.1,"3-({3-[(1S,4aS,6S,7S,9S,9aR)-1,6-dimethyl-2-oxodecahydro-6,9-epoxy-4a,7-methanobenzo[7]annulen-1-yl]propanoyl}amino)-2,4-dihydroxybenzoic acid",XADCWKSMHQPTGH-OFBLZTNGSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28405,6cs2,DB07993,-10.1,"N-3-[3-(1H-INDOL-6-YL)BENZYL]PYRIDINE-2,3-DIAMINE",LPQUIIHPUGDHJK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
158710,7bv1,DB02112,-10.1,Zk-806450,DZLGSWPXZYDHBD-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
75427,6m2n,DB04685,-10.1,"1-{(2S,5S)-4-FLUORO-5-[(TRITYLOXY)METHYL]TETRAHYDROFURAN-2-YL}PYRIMIDINE-2,4(1H,3H)-DIONE",GJNIPWYJQUGERM-BFLUCZKCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
140187,6w9c,DB15308,-10.1,Ridinilazole,UHQFBTAJFNVZIV-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
79100,6m2n,DB12729,-10.1,ASP-3026,MGGBYMDAPCCKCT-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
140197,6w9c,DB15328,-10.1,Ubrogepant,DDOOFTLHJSMHLN-ZQHRPCGSSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140188,6w9c,DB15310,-10.1,Vactosertib,FJCDSQATIJKQKA-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
80376,6m2n,DB15233,-10.1,Avapritinib,DWYRIWUZIJHQKQ-SANMLTNESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
88527,6m3m,DB13954,-10.1,Estradiol cypionate,UOACKFBJUYNSLK-XRKIENNPSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
62897,6crv,DB14669,-10.1,Betamethasone phosphate,VQODGRNSFPNSQE-DVTGEIKXSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30044,6cs2,DB11977,-10.1,Golvatinib,UQRCJCNVNUFYDX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
60271,6crv,DB08448,-10.1,"(4aS)-5-[(2,4-diaminopteridin-6-yl)methyl]-4a,5-dihydro-2H-dibenzo[b,f]azepin-8-ol",PCBWLKUEKANDCL-INIZCTEOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58897,6crv,DB06834,-10.1,"N-(2-hydroxy-1,1-dimethylethyl)-1-methyl-3-(1H-pyrrolo[2,3-b]pyridin-2-yl)-1H-indole-5-carboxamide",XZRYCTLOGNCQDG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84836,6m3m,DB06959,-10.1,(2S)-1-(3H-Indol-3-yl)-3-{[5-(6-isoquinolinyl)-3-pyridinyl]oxy}-2-propanamine,BUCZDJYEOAQTHL-KEKNWZKVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58939,6crv,DB06886,-10.1,N-BENZYLOXYCARBONYL-ALA-PRO-3-AMINO-4-PHENYL-BUTAN-2-OL,MACLRJNEKXUAJK-YDLSIGKMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140220,6w9c,DB15382,-10.1,SAR-125844,ODIUNTQOXRXOIV-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138275,6w9c,DB11262,-10.1,Bisoctrizole,FQUNFJULCYSSOP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
62265,6crv,DB13345,-10.1,Dihydroergocristine,DEQITUUQPICUMR-HJPBWRTMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80341,6m2n,DB15168,-10.1,Cilofexor,KZSKGLFYQAYZCO-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137621,6w9c,DB08520,-10.1,"(21S)-1AZA-4,4-DIMETHYL-6,19-DIOXA-2,3,7,20-TETRAOXOBICYCLO[19.4.0] PENTACOSANE",VUCSBBBCFXBFFY-IBGZPJMESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
134177,6w9c,DB02668,-10.1,"Je-2147, Ag1776, Kni-764",CUFQBQOBLVLKRF-RZDMPUFOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
61675,6crv,DB12420,-10.1,Diazepinomicin,SALVHVNECODMJP-GNUCVDFRSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112782,6vxx,DB07837,-10.1,"[4-(5-naphthalen-2-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)phenyl]acetic acid",SWXKLXXVFMYMDP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84887,6m3m,DB07020,-10.1,"N-{3-[5-(1H-1,2,4-triazol-3-yl)-1H-indazol-3-yl]phenyl}furan-2-carboxamide",LMDMJDCLPIVGQD-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87113,6m3m,DB11847,-10.1,Cadazolid,XWFCFMXQTBGXQW-GOSISDBHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59002,6crv,DB06962,-10.1,"(5-(aminomethyl)-2H-spiro[benzofuran-3,4'-piperidine]-1'-yl)(5-(phenylethynyl)furan-2-yl)methanone",YKTUSHSSKIWDRY-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
158614,7bv1,DB01698,-10.1,Rutin,IKGXIBQEEMLURG-NVPNHPEKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
87056,6m3m,DB11769,-10.1,Funapide,NEBUOXBYNAHKFV-NRFANRHFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
61917,6crv,DB12799,-10.1,Laniquidar,TULGGJGJQXESOO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138194,6w9c,DB09319,-10.1,Carindacillin,JIRBAUWICKGBFE-MNRDOXJOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137479,6w9c,DB08349,-10.0,"N-cyclopropyl-3-{[1-(2,4-difluorophenyl)-7-methyl-6-oxo-6,7-dihydro-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}-4-methylbenzamide",WMEYCLAVMZKZCS-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
29799,6cs2,DB11651,-10.0,Dactolisib,JOGKUKXHTYWRGZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
78582,6m2n,DB11965,-10.0,SJG-136,RWZVMMQNDHPRQD-SFTDATJTSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
165619,7bv1,DB12550,-10.0,Taladegib,SZBGQDXLNMELTB-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
63251,6crv,DB15437,-10.0,Rocacetrapib,GBHPDJQHZADVAA-SOKVYYICSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112299,6vxx,DB06938,-10.0,4-[[2-[[4-chloro-3-(trifluoromethyl)phenyl]amino]-3H-benzimidazol-5-yl]oxy]-N-methyl-pyridine-2-carboxamide,ZJLSMLDOCGOURY-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60269,6crv,DB08446,-10.0,"3-[6-bromo-2-fluoro-3-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)phenoxy]-5-chlorobenzonitrile",OHQMEDBYNUAVNE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80448,6m2n,DB15382,-10.0,SAR-125844,ODIUNTQOXRXOIV-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78086,6m2n,DB09238,-10.0,Manidipine,ANEBWFXPVPTEET-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
81542,6m3m,DB01380,-10.0,Cortisone acetate,ITRJWOMZKQRYTA-RFZYENFJSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81544,6m3m,DB01384,-10.0,Paramethasone,MKPDWECBUAZOHP-AFYJWTTESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
138281,6w9c,DB11274,-10.0,Dihydro-alpha-ergocryptine,PBUNVLRHZGSROC-VTIMJTGVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
32096,6cs2,DB15345,-10.0,GSK-945237,SRICOHRDRMZREQ-MRXNPFEDSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
140692,6w9c,DB13104,-10.0,X-396,ONPGOSVDVDPBCY-CQSZACIVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140546,6w9c,DB12042,-10.0,Ibodutant,YQYSVMKCMIUCHY-WJOKGBTCSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
61242,6crv,DB11796,-10.0,Fostemsavir,SWMDAPWAQQTBOG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60618,6crv,DB08875,-10.0,Cabozantinib,ONIQOQHATWINJY-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140700,6w9c,DB15138,-10.0,AZD-9496,DFBDRVGWBHBJNR-BBNFHIFMSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
110807,6vxx,DB02432,-10.0,RU90395,RLLAUERCSKPFGD-VMPREFPWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79572,6m2n,DB13454,-10.0,Nicomorphine,HNDXBGYRMHRUFN-CIVUWBIHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
69936,6lxt,DB11913,-10.0,LY-2090314,HRJWTAWVFDCTGO-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
110904,6vxx,DB02555,-10.0,SP4160,VCXMTWSYQSVWRK-AREMUKBSSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81428,6m3m,DB01184,-10.0,Domperidone,FGXWKSZFVQUSTL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
79598,6m2n,DB13490,-10.0,Hidrosmin,XYFLWVOTXWXNAM-WTNNCJBMSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
114533,6vxx,DB13756,-10.0,Peruvoside,PMTSPAGBAFCORP-HBUONDEYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110722,6vxx,DB02152,-10.0,K-252a,KOZFSFOOLUUIGY-SOLYNIJKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110559,6vxx,DB01940,-10.0,Balanol Analog 2,SQLYTJZXRRDERK-ISKFKSNPSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
8882,6lzg,DB06938,-10.0,4-[[2-[[4-chloro-3-(trifluoromethyl)phenyl]amino]-3H-benzimidazol-5-yl]oxy]-N-methyl-pyridine-2-carboxamide,ZJLSMLDOCGOURY-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
69078,6lxt,DB08683,-10.0,"REL-(9R,12S)-9,10,11,12-TETRAHYDRO-9,12-EPOXY-1H-DIINDOLO[1,2,3-FG:3',2',1'-KL]PYRROLO[3,4-I][1,6]BENZODIAZOCINE-1,3(2H)-DIONE",OTPNDVKVEAIXTI-IYBDPMFKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
60217,6crv,DB08384,-10.0,2-({4-[4-(pyridin-4-ylmethyl)-1H-pyrazol-3-yl]phenoxy}methyl)quinoline,RQDDHVVAAJVVKM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30832,6cs2,DB13040,-10.0,Gandotinib,SQSZANZGUXWJEA-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
63179,6crv,DB15291,-10.0,BMS-986142,ZRYMMWAJAFUANM-INIZCTEOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79709,6m2n,DB13643,-10.0,Loprazolam,UTEFBSAVJNEPTR-RGEXLXHISA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
111109,6vxx,DB03005,-10.0,"3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-5-Yl]Hexyl]-Phenanthridinium",ISUOMOOYAOQQPZ-UHFFFAOYSA-O,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29997,6cs2,DB11911,-10.0,Galunisertib,IVRXNBXKWIJUQB-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
60827,6crv,DB09199,-10.0,Netoglitazone,PKWDZWYVIHVNKS-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80424,6m2n,DB15327,-10.0,Abivertinib,UOFYSRZSLXWIQB-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
60055,6crv,DB08174,-10.0,"5-CHLORO-N-((1R,2S)-2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO) CYCLOPENTYL)THIOPHENE-2-CARBOXAMIDE",QCPYHSAHOYXXQK-DLBZAZTESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78614,6m2n,DB12012,-10.0,PF-04457845,BATCTBJIJJEPHM-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
3687,6lzg,HMDB0048517,-10.0,"TG(16:1(9Z)/20:0/18:4(6Z,9Z,12Z,15Z))",GQZRZDIDOJKGLP-SIPNAMALSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
79195,6m2n,DB12887,-10.0,Tazemetostat,NSQSAUGJQHDYNO-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78817,6m2n,DB12306,-10.0,Cipargamin,CKLPLPZSUQEDRT-WPCRTTGESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61256,6crv,DB11818,-10.0,Retosiban,PLVGDGRBPMVYPB-FDUHJNRSSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78532,6m2n,DB11894,-10.0,Efatutazone,JCYNMRJCUYVDBC-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
31796,6cs2,DB14766,-10.0,Etrasimod,MVGWUTBTXDYMND-QGZVFWFLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
114196,6vxx,DB12886,-10.0,GSK-1521498,WIEDUMBCZQRGSY-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80759,6m3m,DB00396,-10.0,Progesterone,RJKFOVLPORLFTN-LEKSSAKUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
30091,6cs2,DB12042,-10.0,Ibodutant,YQYSVMKCMIUCHY-WJOKGBTCSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
114909,6vxx,DB15393,-10.0,Telatinib,QFCXANHHBCGMAS-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
137047,6w9c,DB07837,-10.0,"[4-(5-naphthalen-2-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)phenyl]acetic acid",SWXKLXXVFMYMDP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
78827,6m2n,DB12318,-10.0,BMS-599626,LUJZZYWHBDHDQX-QFIPXVFZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137873,6w9c,DB08815,-10.0,Lurasidone,PQXKDMSYBGKCJA-CVTJIBDQSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
112175,6vxx,DB06494,-10.0,Sufugolix,UCQSBGOFELXYIN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113619,6vxx,DB11663,-10.0,Pictilisib,LHNIIDJUOCFXAP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78529,6m2n,DB11891,-10.0,CUDC-907,JOWXJLIFIIOYMS-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
113409,6vxx,DB09143,-10.0,Sonidegib,VZZJRYRQSPEMTK-CALCHBBNSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114789,6vxx,DB14866,-10.0,Amcasertib,QDWKGEFGLQMDAM-ULJHMMPZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60325,6crv,DB08512,-10.0,"6-amino-2-[(1-naphthylmethyl)amino]-3,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",MCEZMMDIEXECTI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61334,6crv,DB11934,-10.0,Epelsiban,UWHCWRQFNKUYCG-QUZACWSFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80298,6m2n,DB15085,-10.0,Fulacimstat,JDARDSVOVYVQST-MRXNPFEDSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
60072,6crv,DB08197,-10.0,"(5E,7S)-2-amino-7-(4-fluoro-2-pyridin-3-ylphenyl)-4-methyl-7,8-dihydroquinazolin-5(6H)-one oxime",KYIXUSLGFINPTC-WVFAEZDRSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60308,6crv,DB08493,-10.0,"5-METHYL-3-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.013,18]NONADECA-12(19),13,15,17-TETRAEN-10-YLCARBAMOYL)-HEXANOIC ACID",AKWKBACKRMYPRV-NQIIRXRSSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165810,7bv1,DB13050,-10.0,Tirilazad,RBKASMJPSJDQKY-RBFSKHHSSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
80324,6m2n,DB15133,-10.0,Tepotinib,AHYMHWXQRWRBKT-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
60925,6crv,DB09383,-10.0,Meprednisone,PIDANAQULIKBQS-RNUIGHNZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80821,6m3m,DB00471,-10.0,Montelukast,UCHDWCPVSPXUMX-TZIWLTJVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
78515,6m2n,DB11870,-10.0,RG-4733,OJPLJFIFUQPSJR-INIZCTEOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
114648,6vxx,DB13947,-10.0,Testosterone enantate benzilic acid hydrazone,PTVXYACXDYZNID-JKXGKYMWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
63167,6crv,DB15266,-10.0,TAK-580,VWMJHAFYPMOMGF-ZCFIWIBFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
64887,6lxt,DB02112,-10.0,Zk-806450,DZLGSWPXZYDHBD-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
30402,6cs2,DB12432,-10.0,CC-401,XDJCLCLBSGGNKS-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
80127,6m2n,DB14675,-10.0,Temsavir,QRPZBKAMSFHVRW-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
112212,6vxx,DB06595,-10.0,Midostaurin,BMGQWWVMWDBQGC-IIFHNQTCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78522,6m2n,DB11878,-10.0,Filibuvir,SLVAPEZTBDBAPI-GDLZYMKVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
60771,6crv,DB09095,-10.0,Difluocortolone,OGPWIDANBSLJPC-RFPWEZLHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138045,6w9c,DB09074,-10.0,Olaparib,FDLYAMZZIXQODN-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
31904,6cs2,DB15011,-10.0,Avacopan,PUKBOVABABRILL-YZNIXAGQSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
113837,6vxx,DB12154,-10.0,Itacitinib,KTBSXLIQKWEBRB-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81189,6m3m,DB00910,-10.0,Paricalcitol,BPKAHTKRCLCHEA-UBFJEZKGSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
78697,6m2n,DB12134,-10.0,Gepotidacin,PZFAZQUREQIODZ-LJQANCHMSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78471,6m2n,DB11804,-10.0,AZD-5672,SCXSQUUTGCWHFU-WJOKGBTCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
111619,6vxx,DB04285,-10.0,"{4-[(2s,4e)-2-(1,3-Benzothiazol-2-Yl)-2-(1h-1,2,3-Benzotriazol-1-Yl)-5-Phenylpent-4-Enyl]Phenyl}(Difluoro)Methylphosphonic Acid",GBLDYRVJENYQNH-AGLOJYHOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30216,6cs2,DB12207,-10.0,Verdinexor,OPAKEJZFFCECPN-XQRVVYSFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
112181,6vxx,DB06515,-10.0,Resiniferatoxin,DSDNAKHZNJAGHN-MXTYGGKSSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30483,6cs2,DB12547,-10.0,LY-2886721,NIDRNVHMMDAAIK-YPMLDQLKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
113813,6vxx,DB12121,-10.0,Entospletinib,XSMSNFMDVXXHGJ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113802,6vxx,DB12108,-10.0,Taselisib,BEUQXVWXFDOSAQ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78626,6m2n,DB12036,-10.0,Naquotinib,QKDCLUARMDUUKN-XMMPIXPASA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
81111,6m3m,DB00823,-10.0,Ethynodiol diacetate,ONKUMRGIYFNPJW-KIEAKMPYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
138176,6w9c,DB09280,-10.0,Lumacaftor,UFSKUSARDNFIRC-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
80201,6m2n,DB14859,-10.0,Fosifloxuridine nafalbenamide,BIOWRMNRHMERIO-ZVAHOJSLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
60649,6crv,DB08930,-10.0,Dolutegravir,RHWKPHLQXYSBKR-BMIGLBTASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61221,6crv,DB11769,-10.0,Funapide,NEBUOXBYNAHKFV-NRFANRHFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29220,6cs2,DB08881,-10.0,Vemurafenib,GPXBXXGIAQBQNI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
60279,6crv,DB08459,-10.0,"3-chloro-5-[2-chloro-5-(1H-pyrazolo[3,4-b]pyridin-3-ylmethoxy)phenoxy]benzonitrile",SVMHTBVIPYVDIL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60674,6crv,DB08962,-10.0,Glibornuride,RMTYNAPTNBJHQI-LLDVTBCESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
63276,6crv,DB03453,-10.0,Methyl (2S)-2-[[2-[(3R)-1-carbamimidoylpiperidin-3-yl]acetyl]amino]-3-[4-(2-phenylethynyl)phenyl]propanoate,MRNGXYMKYHNMLV-PKTZIBPZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
142454,6w9q,DB02226,-10.0,"3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-4-Yl]Hexyl]-Phenanthridinium",NAARZDJZGYBXKL-UHFFFAOYSA-O,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
107599,6vxx,DB04071,-10.0,Cpad,LFERELMXERXKKQ-KMXXXSRASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59765,6crv,DB07848,-10.0,5-Chloro-N-{(3S)-1-[(2S)-1-(4-morpholinyl)-1-oxo-2-propanyl]-2-oxo-3-pyrrolidinyl}-1H-indole-2-sulfonamide,BHNMMFGOJRIAEZ-LRDDRELGSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58661,6crv,DB06302,-10.0,Glesatinib,YRCHYHRCBXNYNU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55410,6crv,DB00973,-10.0,Ezetimibe,OLNTVTPDXPETLC-XPWALMASSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
128777,6w4h,DB08006,-10.0,"N-anthracen-2-yl-5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7-amine",OXYDLVAOXASTMW-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
26694,6cs2,DB04879,-10.0,Vatalanib,YCOYDOIWSSHVCK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
61767,6crv,DB12561,-10.0,WNT-974,XXYGTCZJJLTAGH-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
97433,6m71,DB14878,-10.0,Liafensine,VCIBGDSRPUOBOG-QFIPXVFZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97167,6m71,DB14017,-10.0,H3B-8800,YOIQWBAHJZGRFW-WVRLKXNASA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
133217,6w9c,DB01419,-10.0,Antrafenine,NWGGKKGAFZIVBJ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
96499,6m71,DB13014,-10.0,Hypericin,BTXNYTINYBABQR-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
62598,6crv,DB13791,-10.0,Penfluridol,MDLAAYDRRZXJIF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
94904,6m71,DB08674,-10.0,"(20S)-19,20,21,22-TETRAHYDRO-19-OXO-5H-18,20-ETHANO-12,14-ETHENO-6,10-METHENO-18H-BENZ[D]IMIDAZO[4,3-K][1,6,9,12]OXATRIAZA-CYCLOOCTADECOSINE-9-CARBONITRILE",USPFJPDEADLGIG-HSZRJFAPSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
86024,6m3m,DB08349,-10.0,"N-cyclopropyl-3-{[1-(2,4-difluorophenyl)-7-methyl-6-oxo-6,7-dihydro-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}-4-methylbenzamide",WMEYCLAVMZKZCS-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
94535,6m71,DB08221,-10.0,N-{4-METHYL-3-[(3-PYRIMIDIN-4-YLPYRIDIN-2-YL)AMINO]PHENYL}-3-(TRIFLUOROMETHYL)BENZAMIDE,NESXBRNDMQUVNG-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
86039,6m3m,DB08366,-10.0,"3-({3-[(1S,4aS,6S,7S,9S,9aR)-1,6-dimethyl-2-oxodecahydro-6,9-epoxy-4a,7-methanobenzo[7]annulen-1-yl]propanoyl}amino)-2,4-dihydroxybenzoic acid",XADCWKSMHQPTGH-OFBLZTNGSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86052,6m3m,DB08384,-10.0,2-({4-[4-(pyridin-4-ylmethyl)-1H-pyrazol-3-yl]phenoxy}methyl)quinoline,RQDDHVVAAJVVKM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86072,6m3m,DB08407,-10.0,PLATENSIMYCIN,CSOMAHTTWTVBFL-OFBLZTNGSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
16636,6cs2,HMDB0003265,-10.0,Hesperidin,QUQPHWDTPGMPEX-UNZJSITISA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
92788,6m71,DB04868,-10.0,Nilotinib,HHZIURLSWUIHRB-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
86293,6m3m,DB08674,-10.0,"(20S)-19,20,21,22-TETRAHYDRO-19-OXO-5H-18,20-ETHANO-12,14-ETHENO-6,10-METHENO-18H-BENZ[D]IMIDAZO[4,3-K][1,6,9,12]OXATRIAZA-CYCLOOCTADECOSINE-9-CARBONITRILE",USPFJPDEADLGIG-HSZRJFAPSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
139428,6w9c,DB13454,-10.0,Nicomorphine,HNDXBGYRMHRUFN-CIVUWBIHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
129913,6w4h,DB11399,-10.0,Dirlotapide,TUOSYWCFRFNJBS-BHVANESWSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
89068,6m3m,DB15403,-10.0,Ziritaxestat,REQQVBGILUTQNN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
89059,6m3m,DB15382,-10.0,SAR-125844,ODIUNTQOXRXOIV-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
130025,6w4h,DB11663,-10.0,Pictilisib,LHNIIDJUOCFXAP-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
86519,6m3m,DB08973,-10.0,Fluclorolone acetonide,NJNWEGFJCGYWQT-VSXGLTOVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88928,6m3m,DB15121,-10.0,AT-001,YRGPAXAVTDMKDK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86567,6m3m,DB09030,-10.0,Vorapaxar,ZBGXUVOIWDMMJE-QHNZEKIYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
130156,6w4h,DB11851,-10.0,Bafetinib,ZGBAJMQHJDFTQJ-DEOSSOPVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
86576,6m3m,DB09053,-10.0,Ibrutinib,XYFPWWZEPKGCCK-GOSISDBHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
133496,6w9c,DB01761,-10.0,4-[5-[2-(1-Phenyl-Ethylamino)-Pyrimidin-4-Yl]-1-Methyl-4-(3-Trifluoromethylphenyl)-1h-Imidazol-2-Yl]-Piperidine,QICPQLFMWYQJGX-SFHVURJKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
58327,6crv,DB04849,-10.0,Cediranib,XXJWYDDUDKYVKI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
13200,6lzg,DB14883,-10.0,Lorecivivint,AQDWDWAYVBQMAM-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
85327,6m3m,DB07528,-10.0,3-(2-aminoquinazolin-6-yl)-4-methyl-1-[3-(trifluoromethyl)phenyl]pyridin-2(1H)-one,HXUZQEYFKAZBPX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
76333,6m2n,DB07084,-10.0,"N-(6,7,9,10,17,18,20,21-octahydrodibenzo[b,k][1,4,7,10,13,16]hexaoxacyclooctadecin-2-yl)acetamide",YHKGWOJTUMJPNW-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
24094,6cs2,DB01761,-10.0,4-[5-[2-(1-Phenyl-Ethylamino)-Pyrimidin-4-Yl]-1-Methyl-4-(3-Trifluoromethylphenyl)-1h-Imidazol-2-Yl]-Piperidine,QICPQLFMWYQJGX-SFHVURJKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
134437,6w9c,DB03076,-10.0,AHA047,CGBDAHCDSVOMCF-FYZVQMPESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
84848,6m3m,DB06976,-10.0,"1-(5-OXO-2,3,5,9B-TETRAHYDRO-1H-PYRROLO[2,1-A]ISOINDOL-9-YL)-3-(5-PYRROLIDIN-2-YL-1H-PYRAZOL-3-YL)-UREA",IWOOJEZSDPRYAZ-WFASDCNBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
61674,6crv,DB12419,-10.0,HSD-016,ZWASRJHIEFYJGL-BFUOFWGJSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84870,6m3m,DB07000,-10.0,"N-{2,4-difluoro-3-[(5-pyridin-3-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)carbonyl]phenyl}ethanesulfonamide",ILXJWLWSYAWJKZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
106109,6vxs,DB15039,-10.0,ITI-214,BBIPVJCGIASXJB-PKTZIBPZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
84895,6m3m,DB07029,-10.0,"4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMIDAZOL-1-YL)PHENOXY]-6-METHYLPYRIMIDINE",QQBNDYARFVOEGW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
62855,6crv,DB14625,-10.0,Meprednisone acetate,RZAMUHXEOMZXET-ABQXZQTJSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76199,6m2n,DB06925,-10.0,3-(2-AMINOQUINAZOLIN-6-YL)-4-METHYL-N-[3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE,YEIASMOUYNOXGA-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
55127,6crv,DB00641,-10.0,Simvastatin,RYMZZMVNJRMUDD-HGQWONQESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104734,6vxs,DB12424,-10.0,MK-3207,AZAANWYREOQRFB-SETSBSEESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104724,6vxs,DB12411,-10.0,R-428,KXMZDGSRSGHMMK-VWLOTQADSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
58780,6crv,DB06624,-10.0,Taranabant,QLYKJCMUNUWAGO-GAJHUEQPSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104590,6vxs,DB12228,-10.0,Telcagepant,CGDZXLJGHVKVIE-DNVCBOLYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
62809,6crv,DB14207,-10.0,Fosinoprilat,WOIWWYDXDVSWAZ-RTWAWAEBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
133853,6w9c,DB02241,-10.0,"8-Benzyl-2-Hydroperoxy-2-(4-Hydroxy-Benzyl)-6-(4-Hydroxy-Phenyl)-2h-Imidazo[1,2-a]Pyrazin-3-One",HOSWCJDTHOAORT-SANMLTNESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
104421,6vxs,DB11977,-10.0,Golvatinib,UQRCJCNVNUFYDX-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
85165,6m3m,DB07334,-10.0,"N-[5-(ETHYLSULFONYL)-2-METHOXYPHENYL]-5-[3-(2-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-AMINE",HTIZPBXCJPQDEM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
55281,6crv,DB00826,-10.0,Natamycin,NCXMLFZGDNKEPB-FFPOYIOWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140135,6w9c,DB15047,-10.0,BMS-919373,XGKULQQVQWCASY-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
72700,6m2n,DB01051,-10.0,Novobiocin,YJQPYGGHQPGBLI-KGSXXDOSSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
133695,6w9c,DB02033,-10.0,"N-(3-Cyclopropyl(5,6,7,8,9,10-Hexahydro-2-Oxo-2h-Cycloocta[B]Pyran-3-Yl)Methyl)Phenylbenzensulfonamide",GDRNWAKVNIROCG-DEOSSOPVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
72765,6m2n,DB01126,-10.0,Dutasteride,JWJOTENAMICLJG-QWBYCMEYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
140103,6w9c,DB14943,-10.0,LGH-447,VRQXRVAKPDCRCI-ZNMIVQPWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
133597,6w9c,DB01897,-10.0,2-(2f-Benzothiazolyl)-5-Styryl-3-(4f-Phthalhydrazidyl)Tetrazolium Chloride,BEIGFKLRGRRJJA-JLHYYAGUSA-O,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
128629,6w4h,DB07833,-10.0,"N-(3-cyanophenyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)-4-biphenylcarboxamide",PMMLSQFPBFKLHH-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
128632,6w4h,DB07837,-10.0,"[4-(5-naphthalen-2-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)phenyl]acetic acid",SWXKLXXVFMYMDP-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
58671,6crv,DB06334,-10.0,Tucidinostat,SZMJVTADHFNAIS-BJMVGYQFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85391,6m3m,DB07607,-10.0,4-[5-(3-IODO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-1H-IMIDAZOL-4-YL]-PYRIDINE,RXDZANYWRNIAOR-HHHXNRCGSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58321,6crv,DB04841,-10.0,Flunarizine,SMANXXCATUTDDT-QPJJXVBHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88842,6m3m,DB14916,-10.0,Selonsertib,YIDDLAAKOYYGJG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86854,6m3m,DB11371,-10.0,Alfaxalone,DUHUCHOQIDJXAT-OLVMNOGESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
56572,6crv,DB02498,-10.0,Carba-Nicotinamide-Adenine-Dinucleotide,DGPLSUKWXXSBCU-VGXGLJSLSA-O,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88231,6m3m,DB13520,-10.0,Metergoline,WZHJKEUHNJHDLS-QTGUNEKASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87241,6m3m,DB12042,-10.0,Ibodutant,YQYSVMKCMIUCHY-WJOKGBTCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87297,6m3m,DB12121,-10.0,Entospletinib,XSMSNFMDVXXHGJ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
61960,6crv,DB12874,-10.0,Quizartinib,CVWXJKQAOSCOAB-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62113,6crv,DB13101,-10.0,4SC-202,PRXXYMVLYKJITB-IZZDOVSWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27228,6cs2,DB06717,-10.0,Fosaprepitant,BARDROPHSZEBKC-OITMNORJSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
87971,6m3m,DB13138,-10.0,Neladenoson bialanate,WESNEIGKOAXSGX-VXKWHMMOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
62107,6crv,DB13094,-10.0,Pruvanserin,AQRLDDAFYYAIJP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87920,6m3m,DB13061,-10.0,MLN8054,HHFBDROWDBDFBR-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87919,6m3m,DB13060,-10.0,CEP-37440,BCSHRERPHLTPEE-NRFANRHFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87915,6m3m,DB13055,-10.0,Oteseconazole,IDUYJRXRDSPPRC-NRFANRHFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
130793,6w4h,DB12799,-10.0,Laniquidar,TULGGJGJQXESOO-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
73978,6m2n,DB02741,-10.0,CD564,RWYREGSYPCNZTL-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
24515,6cs2,DB02269,-10.0,[4-({[5-Benzyloxy-1-(3-Carbamimidoyl-Benzyl)-1h-Indole-2-Carbonyl]-Amino}-Methyl)-Phenyl]-Trimethyl-Ammonium,UFKJQTGPBFWMGT-UHFFFAOYSA-O,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
87876,6m3m,DB12996,-10.0,Acteoside,FBSKJMQYURKNSU-ZLSOWSIRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
139866,6w9c,DB14152,-10.0,Ginsenosides,NLHQJXWYMZLQJY-SWIZOJJJSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
130852,6w4h,DB12895,-10.0,TD-139,YGIDGBAHDZEYMT-MQFIMZJJSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
87822,6m3m,DB12910,-10.0,Emicerfont,JFHJGXQFESYQGY-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
57287,6crv,DB03453,-10.0,Methyl (2S)-2-[[2-[(3R)-1-carbamimidoylpiperidin-3-yl]acetyl]amino]-3-[4-(2-phenylethynyl)phenyl]propanoate,MRNGXYMKYHNMLV-PKTZIBPZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56965,6crv,DB03020,-10.0,5-Beta-D-Ribofuranosylnicotinamide Adenine Dinucleotide,UINNILASBHZOTM-KMXXXSRASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87585,6m3m,DB12535,-10.0,AC-430,DCRWIATZWHLIPN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87609,6m3m,DB12571,-10.0,Rimacalib,MYTIJGWONQOOLC-HNNXBMFYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87739,6m3m,DB12776,-10.0,E-6005,BBTFKAOFCSOZMB-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87660,6m3m,DB12655,-10.0,Patidegib,HZLFFNCLTRVYJG-WWGOJCOQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87720,6m3m,DB12743,-10.0,Z-160,VCPMZDWBEWTGNW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
74424,6m2n,DB03331,-10.0,"N-Naphthalen-1-Ylmethyl-2'-[3,5-Dimethoxybenzamido]-2'-Deoxy-Adenosine",OARVXDFNTLYMCJ-JVUUKAHWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
87686,6m3m,DB12693,-10.0,Ritanserin,JUQLTPCYUFPYKE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
74519,6m2n,DB03466,-10.0,BMS184394,AYAJZQYENGWICE-QHCPKHFHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
57707,6crv,DB04020,-10.0,"4-(2-{[4-{[3-(4-Chlorophenyl)Propyl]Sulfanyl}-6-(1-Piperazinyl)-1,3,5-Triazin-2-Yl]Amino}Ethyl)Phenol",AIBKIFHSQQYXLG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87231,6m3m,DB12024,-10.0,PF-04418948,LWJGMYMNSNVCEM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88336,6m3m,DB13664,-10.0,Formocortal,QNXUUBBKHBYRFW-QWAPGEGQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88445,6m3m,DB13806,-10.0,Linopirdine,YEJCDKJIEMIWRQ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
24316,6cs2,DB02033,-10.0,"N-(3-Cyclopropyl(5,6,7,8,9,10-Hexahydro-2-Oxo-2h-Cycloocta[B]Pyran-3-Yl)Methyl)Phenylbenzensulfonamide",GDRNWAKVNIROCG-DEOSSOPVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
139992,6w9c,DB14703,-10.0,Dexamethasone metasulfobenzoate,TWQWRHIQRAZHPR-XNXCGYEVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
130246,6w4h,DB11986,-10.0,Entrectinib,HAYYBYPASCDWEQ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
88797,6m3m,DB14822,-10.0,SB-649868,ZJXIUGNEAIHSBI-IBGZPJMESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
56096,6crv,DB01871,-10.0,[1-(1-Benzyl-3-Hydroxy-2-Oxo-Propylcarbamoyl)-2-Phenyl-Ethyl]-Carbamic Acid Benzyl Ester,OACUXIVGLLCILS-ZEQRLZLVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56119,6crv,DB01908,-10.0,RU85493,MWEWSHNGVWABKG-SVBPBHIXSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86931,6m3m,DB11522,-10.0,Isoflupredone,WAIJIHDWAKJCBX-BULBTXNYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
61893,6crv,DB12756,-10.0,TAK-901,WKDACQVEJIVHMZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86932,6m3m,DB11526,-10.0,Masitinib,WJEOLQLKVOPQFV-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88736,6m3m,DB14673,-10.0,Flurandrenolide acetate,AUDPKCCPWYXNEV-XTLNBZDDSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86933,6m3m,DB11529,-10.0,Melengestrol,OKHAOBQKCCIRLO-IBVJIVQJSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88702,6m3m,DB14637,-10.0,Fluprednisolone acetate,CYMBAKFTWRNHPS-APRQOCPKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88696,6m3m,DB14631,-10.0,Prednisolone phosphate,JDOZJEUDSLGTLU-VWUMJDOOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88691,6m3m,DB14626,-10.0,Pregnenolone acetate,CRRKVZVYZQXICQ-RJJCNJEVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
61669,6crv,DB12414,-10.0,Usistapide,WSYALRNYQFNNGP-WJOKGBTCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88662,6m3m,DB14512,-10.0,Mometasone furoate,WOFMFGQZHJDGCX-ZULDAHANSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
73664,6m2n,DB02336,-10.0,RU83876,WCMLXBUNHNAMNH-UIOOFZCWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61909,6crv,DB12784,-10.0,NS-018,UQTPDWDAYHAZNT-AWEZNQCLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87095,6m3m,DB11822,-10.0,TMC-647055,UOBYJVFBFSLCTQ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
57954,6crv,DB04350,-10.0,Argadin,FOZYKTUSOWWQGR-KNPYFFGGSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
132077,6w4h,DB15328,-10.0,Ubrogepant,DDOOFTLHJSMHLN-ZQHRPCGSSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
87102,6m3m,DB11830,-10.0,Mocetinostat,HRNLUBSXIHFDHP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
139539,6w9c,DB13607,-10.0,Picloxydine,YNCLPFSAZFGQCD-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
87119,6m3m,DB11859,-10.0,Brexanolone,AURFZBICLPNKBZ-SYBPFIFISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
56441,6crv,DB02336,-10.0,RU83876,WCMLXBUNHNAMNH-UIOOFZCWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88504,6m3m,DB13919,-10.0,Candesartan,HTQMVQVXFRQIKW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87132,6m3m,DB11877,-10.0,Basmisanil,VCGRFBXVSFAGGA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
62166,6crv,DB13215,-10.0,Sulfobromophthalein,OHTXTCNTQJFRIG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61939,6crv,DB12836,-10.0,Grapiprant,HZVLFTCYCLXTGV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
162402,7bv1,DB02009,-10.0,"L-756,423",AOMZDQMIOCTPQP-QHQMVRJISA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
58008,6crv,DB04432,-10.0,ZK-805623,ZXIHYCYAQUQHSG-UHFFFAOYSA-O,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61667,6crv,DB12411,-10.0,R-428,KXMZDGSRSGHMMK-VWLOTQADSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84998,6m3m,DB07145,-10.0,(2R)-N-HYDROXY-2-[(3S)-3-METHYL-3-{4-[(2-METHYLQUINOLIN-4-YL)METHOXY]PHENYL}-2-OXOPYRROLIDIN-1-YL]PROPANAMIDE,YDMIPBHQKFOFQW-NSYGIPOTSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
109066,6vxx,DB11986,-10.0,Entrectinib,HAYYBYPASCDWEQ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84055,6m3m,DB04708,-10.0,"(S)-TETRAHYDROFURAN-3-YL (2S,3S)-4-((S)-4-((1R,3R)-3-(2-AMINO-2-OXOETHYL)-2,3-DIHYDRO-1H-INDEN-1-YL)-2-BENZYL-3-OXO-2,3-DIHYDRO-1H-PYRROL-2-YL)-3-HYDROXY-1-PHENYLBUTAN-2-YLCARBAMATE",SYNSHNDQFWMLJW-YZGRCXSVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
108078,6vxx,DB06817,-10.0,Raltegravir,CZFFBEXEKNGXKS-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84075,6m3m,DB04739,-10.0,4-[(4-METHYL-1-PIPERAZINYL)METHYL]-N-[3-[[4-(3-PYRIDINYL)-2-PYRIMIDINYL]AMINO]PHENYL]-BENZAMIDE,JHMBUEWQJDGKGS-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
77161,6m2n,DB08044,-10.0,ABT-341,NVVSPGQEXMJZIR-BMIGLBTASA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
84157,6m3m,DB04842,-10.0,Fluspirilene,QOYHHIBFXOOADH-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59202,6crv,DB07189,-10.0,"(1S,3R,6S)-4-oxo-6-{4-[(2-phenylquinolin-4-yl)methoxy]phenyl}-5-azaspiro[2.4]heptane-1-carboxylic acid",BFZXMIUWGSTUAL-ZSOKXDGFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
54780,6crv,DB00223,-10.0,Diflorasone,WXURHACBFYSXBI-XHIJKXOTSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76980,6m2n,DB07837,-10.0,"[4-(5-naphthalen-2-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)phenyl]acetic acid",SWXKLXXVFMYMDP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
82799,6m3m,DB03020,-10.0,5-Beta-D-Ribofuranosylnicotinamide Adenine Dinucleotide,UINNILASBHZOTM-KMXXXSRASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
138573,6w9c,DB11863,-10.0,Alvelestat,QNQZWEGMKJBHEM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138695,6w9c,DB12130,-10.0,Lorlatinib,IIXWYSCJSQVBQM-LLVKDONJSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138821,6w9c,DB12309,-10.0,GI-181771X,CABBMMXFOOZVMS-PMERELPUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
83248,6m3m,DB03642,-10.0,Benzofuran-2-Carboxylic Acid {(S)-3-Methyl-1-[3-Oxo-1-(Pyridin-2-Ylsulfonyl)Azepan-4-Ylcarbamoyl]Butyl}Amide,VBPPNJCVXGAZDD-PMACEKPBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
82029,6m3m,DB02009,-10.0,"L-756,423",AOMZDQMIOCTPQP-QHQMVRJISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83244,6m3m,DB03638,-10.0,Cytidyl-2'-5'-Phospho-Guanosine,QZDUXDLOEVJGDG-VMIOUTBZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59433,6crv,DB07456,-10.0,"3-(1H-indol-3-yl)-4-(1-{2-[(2S)-1-methylpyrrolidinyl]ethyl}-1H-indol-3-yl)-1H-pyrrole-2,5-dione",LBFDERUQORUFIN-QGZVFWFLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
82028,6m3m,DB02008,-10.0,1-(2-Fluorobenzyl)-3-Butyl-8-(N-Acetyl-4-Aminobenzyl)-Xanthine,JHSHXKJSPVHPCJ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
107883,6vxx,DB05423,-10.0,ORG-34517,DFELGYQKEOCHOA-BZAFBGKRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
54806,6crv,DB00251,-10.0,Terconazole,BLSQLHNBWJLIBQ-OZXSUGGESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109129,6vxx,DB12414,-10.0,Usistapide,WSYALRNYQFNNGP-WJOKGBTCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
54808,6crv,DB00253,-10.0,Medrysone,GZENKSODFLBBHQ-ILSZZQPISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84052,6m3m,DB04705,-10.0,"(3BETA)-CHOLEST-5-ENE-3,25-DIOL",INBGSXNNRGWLJU-ZHHJOTBYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
77747,6m2n,DB08747,-10.0,"(11R)-10-acetyl-11-(2,4-dichlorophenyl)-6-hydroxy-3,3-dimethyl-2,3,4,5,10,11-hexahydro-1H-dibenzo[b,e][1,4]diazepin-1-one",JJTPPGUNMJMPLY-QFIPXVFZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
82460,6m3m,DB02567,-10.0,PD173955,VAARYSWULJUGST-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
108549,6vxx,DB08384,-10.0,2-({4-[4-(pyridin-4-ylmethyl)-1H-pyrazol-3-yl]phenoxy}methyl)quinoline,RQDDHVVAAJVVKM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
2681,6lzg,HMDB0042817,-10.0,"TG(14:0/20:4(8Z,11Z,14Z,17Z)/24:0)",JXLIWOMLOAXJKY-LCFREUINSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
55010,6crv,DB00496,-10.0,Darifenacin,HXGBXQDTNZMWGS-RUZDIDTESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140484,6w9c,DB11431,-10.0,Moxidectin,YZBLFMPOMVTDJY-LSGXYNIPSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
108427,6vxx,DB07978,-10.0,"2-({[2,3,5,6-TETRAFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)CYCLOPENTA-1,3-DIENE-1-CARBOXYLIC ACID",ULMUPVXFUDHRGH-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
83347,6m3m,DB03768,-10.0,"N-[2-Hydroxy-2-(8-Isopropyl-6,9-Dioxo-2-Oxa-7,10-Diaza-Bicyclo[11.2.2]Heptadeca-1(16),13(17),14-Trien-11-Yl)-Ethyl]-N-(3-Methyl-Butyl)-Benzenesulfonamide,Inhibitor 3",WRUVOSYKHXGAQN-GKRYNVPLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
26203,6cs2,DB04289,-10.0,Genz-10850,YYMZSGIXLQPFAC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
70530,6lxt,DB12799,-10.0,Laniquidar,TULGGJGJQXESOO-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
83878,6m3m,DB04477,-10.0,"N-1,2,3,4-Tetrahydronaphth-1-Yl-2'-[3,5-Dimethoxybenzamido]-2'-Deoxy-Adenosine",FDZQGEIYGFPMOB-ZUURFMEUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59269,6crv,DB07270,-10.0,"N-[7-(3-AMINOPHENYL)-5-METHOXY-1,3-BENZOXAZOL-2-YL]-2,5-DICHLOROBENZENESULFONAMIDE",GAYYMURZGLJDCT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108289,6vxx,DB07583,-10.0,"(4R,2S)-5'-(4-(4-CHLOROBENZYLOXY)PYRROLIDIN-2-YLMETHANESULFONYL)ISOQUINOLINE",RLNNFNGBXLTQOB-RBUKOAKNSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108236,6vxx,DB07261,-10.0,"THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [1-(1-AMINO-ISOQUINOLIN-7-YLMETHYL)-2-OXO-PYRROLDIN-3-YL]-AMIDE",NVKDOURNRJCKJE-INIZCTEOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59257,6crv,DB07256,-10.0,"3-({4-[(5-CHLORO-1,3-BENZODIOXOL-4-YL)AMINO]PYRIMIDIN-2-YL}AMINO)BENZAMIDE",ZVQZIVCQLFGXFZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108176,6vxx,DB07189,-10.0,"(1S,3R,6S)-4-oxo-6-{4-[(2-phenylquinolin-4-yl)methoxy]phenyl}-5-azaspiro[2.4]heptane-1-carboxylic acid",BFZXMIUWGSTUAL-ZSOKXDGFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108137,6vxx,DB07145,-10.0,(2R)-N-HYDROXY-2-[(3S)-3-METHYL-3-{4-[(2-METHYLQUINOLIN-4-YL)METHOXY]PHENYL}-2-OXOPYRROLIDIN-1-YL]PROPANAMIDE,YDMIPBHQKFOFQW-NSYGIPOTSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136205,6w9c,DB06747,-10.0,ginkgolide-M,KDKROYXEHCYLJQ-FJFAJXJPSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
109167,6vxx,DB12467,-10.0,TU-100,KAYRGFYBCCETPE-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62975,6crv,DB14856,-10.0,PF-05089771,ZYSCOUXLBXGGIM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109564,6vxx,DB14128,-10.0,Nadide,BAWFJGJZGIEFAR-NNYOXOHSSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
125940,6w4h,DB03157,-10.0,"N,O-Didansyl-L-Tyrosine",LUBOPDUYHWABFG-NDEPHWFRSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
109273,6vxx,DB12996,-10.0,Acteoside,FBSKJMQYURKNSU-ZLSOWSIRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84266,6m3m,DB05220,-10.0,Alisertib,ZLHFILGSQDJULK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
110117,6vxx,DB00997,-10.0,Doxorubicin,AOJJSUZBOXZQNB-TZSSRYMLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
135125,6w9c,DB04016,-10.0,2-[3-({Methyl[1-(2-Naphthoyl)Piperidin-4-Yl]Amino}Carbonyl)-2-Naphthyl]-1-(1-Naphthyl)-2-Oxoethylphosphonic Acid,XUJQPDQURBZEGJ-KXQOOQHDSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
32848,6cs2,T3D3763,-10.0,Janthitrem C,HVLXXQDJGPKVMK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
59758,6crv,DB07839,-10.0,"N-2-1,3-BENZOXAZOL-2-YL-3-CYCLOHEXYL-N-{2-[(4-METHOXYPHENYL)AMINO]ETHYL}-L-ALANINAMIDE",VFNWTXUFNNOQHD-QFIPXVFZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77425,6m2n,DB08362,-10.0,"N-(3-(8-CYANO-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZIN-2-YLAMINO)PHENYL)ACETAMIDE",QVKXQLGRDOMAGC-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
84497,6m3m,DB06306,-10.0,Onalespib,IFRGXKKQHBVPCQ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84511,6m3m,DB06350,-10.0,Elinogrel,LGSDFTPAICUONK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59762,6crv,DB07844,-10.0,6-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1-BENZOTHIOPHENE-2-SULFONAMIDE,PHLKBODTBJLXRD-WFASDCNBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
63022,6crv,DB14942,-10.0,BMS-986141,KEEBLYWBELVGPQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62920,6crv,DB14723,-10.0,Larotrectinib,NYNZQNWKBKUAII-KBXCAEBGSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136080,6w9c,DB06486,-10.0,Enzastaurin,AXRCEOKUDYDWLF-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
77966,6m2n,DB09054,-10.0,Idelalisib,IFSDAJWBUCMOAH-HNNXBMFYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
106823,6vxx,DB01336,-10.0,Metocurine,JFXBEKISTKFVAB-AJQTZOPKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
70290,6lxt,DB12424,-10.0,MK-3207,AZAANWYREOQRFB-SETSBSEESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
109012,6vxx,DB11904,-10.0,Flumatinib,BJCJYEYYYGBROF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
70689,6lxt,DB13050,-10.0,Tirilazad,RBKASMJPSJDQKY-RBFSKHHSSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
76387,6m2n,DB07145,-10.0,(2R)-N-HYDROXY-2-[(3S)-3-METHYL-3-{4-[(2-METHYLQUINOLIN-4-YL)METHOXY]PHENYL}-2-OXOPYRROLIDIN-1-YL]PROPANAMIDE,YDMIPBHQKFOFQW-NSYGIPOTSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
62909,6crv,DB14681,-10.0,Cortisone,MFYSYFVPBJMHGN-ZPOLXVRWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109054,6vxx,DB11965,-10.0,SJG-136,RWZVMMQNDHPRQD-SFTDATJTSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59481,6crv,DB07514,-10.0,"3-(2-aminoquinazolin-6-yl)-1-(3,3-dimethylindolin-6-yl)-4-methylpyridin-2(1H)-one",LHLGUOHREUTYTO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
70312,6lxt,DB12457,-10.0,Rimegepant,KRNAOFGYEFKHPB-ANJVHQHFSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
54947,6crv,DB00421,-10.0,Spironolactone,LXMSZDCAJNLERA-ZHYRCANASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77928,6m2n,DB08995,-10.0,Diosmin,GZSOSUNBTXMUFQ-YFAPSIMESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
59161,6crv,DB07143,-10.0,D-phenylalanyl-N-benzyl-L-prolinamide,MEPJWLFTTFHOQO-MOPGFXCFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76802,6m2n,DB07630,-10.0,"N-((1R,2R)-2-(5-CHLORO-1H-INDOLE-2-CARBOXAMIDO)CYCLOHEXYL)-5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE-2-CARBOXAMIDE",ARPFWVKYXJZULB-IAGOWNOFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
59731,6crv,DB07809,-10.0,4-({[4-(3-METHYLBENZOYL)PYRIDIN-2-YL]AMINO}METHYL)BENZENECARBOXIMIDAMIDE,MBJYEMUMDMGQQC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61614,6crv,DB12336,-10.0,GDC-0917,HSHPBORBOJIXSQ-HARLFGEKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108703,6vxx,DB08827,-10.0,Lomitapide,MBBCVAKAJPKAKM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59144,6crv,DB07124,-10.0,"(2S)-1-(6H-INDOL-3-YL)-3-{[5-(7H-PYRAZOLO[3,4-C]PYRIDIN-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE",CCIACUJJBPSOHE-KRWDZBQOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
160491,7bv1,DB08450,-10.0,N-1H-indazol-5-yl-2-(6-methylpyridin-2-yl)quinazolin-4-amine,HNHRWNUXTCATSG-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
81969,6m3m,DB01933,-10.0,7-Hydroxystaurosporine,PBCZSGKMGDDXIJ-HQCWYSJUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59060,6crv,DB07029,-10.0,"4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMIDAZOL-1-YL)PHENOXY]-6-METHYLPYRIMIDINE",QQBNDYARFVOEGW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59128,6crv,DB07107,-10.0,(1S)-2-(1H-INDOL-3-YL)-1-[({5-[(E)-2-PYRIDIN-4-YLVINYL]PYRIDIN-3-YL}OXY)METHYL]ETHYLAMINE,SGHXFHRRWFLILP-XJDXJNMNSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107409,6vxx,DB03268,-10.0,RU82197,WKTQBTSOHBKBRW-VMPREFPWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
63049,6crv,DB15035,-10.0,Zanubrutinib,RNOAOAWBMHREKO-QFIPXVFZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84400,6m3m,DB05983,-10.0,Bardoxolone methyl,WPTTVJLTNAWYAO-KPOXMGGZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
110004,6vxx,DB00694,-10.0,Daunorubicin,STQGQHZAVUOBTE-VGBVRHCVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
11093,6lzg,DB11399,-10.0,Dirlotapide,TUOSYWCFRFNJBS-BHVANESWSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
81901,6m3m,DB01831,-10.0,Tryptophanyl-5'amp,IFQVDHDRFCKAAW-SQIXAUHQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
107362,6vxx,DB03213,-10.0,Bis(5-Amidino-2-Benzimidazolyl)Methane Ketone,VVVXDHROXQUONB-UHFFFAOYSA-P,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107282,6vxx,DB03104,-10.0,RU82129,NKMPOVPTYDXGEC-MNRBYUMSSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28771,6cs2,DB08386,-10.0,2-{[4-(4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline,VRWJZGHUCOFGPZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
61489,6crv,DB12158,-9.9,Filorexant,NPFDWHQSDBWQLH-QZTJIDSGSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61922,6crv,DB12806,-9.9,GSK-1004723,YANGEESWIGIKOP-UUWRZZSWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138618,6w9c,DB11925,-9.9,Vistusertib,JUSFANSTBFGBAF-IRXDYDNUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
63088,6crv,DB15110,-9.9,Onvansertib,QHLVBNKYJGBCQJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72282,6m2n,DB00559,-9.9,Bosentan,GJPICJJJRGTNOD-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61380,6crv,DB12001,-9.9,Abemaciclib,UZWDCWONPYILKI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
70280,6lxt,DB12411,-9.9,R-428,KXMZDGSRSGHMMK-VWLOTQADSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
78081,6m2n,DB09233,-9.9,Cronidipine,CNIJVNPIIHWRRP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138508,6w9c,DB11769,-9.9,Funapide,NEBUOXBYNAHKFV-NRFANRHFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
70257,6lxt,DB12381,-9.9,Merestinib,QHADVLVFMKEIIP-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
70249,6lxt,DB12369,-9.9,Sotrastaurin,OAVGBZOFDPFGPJ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
61408,6crv,DB12044,-9.9,MK-0893,DNTVJEMGHBIUMW-IBGZPJMESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78122,6m2n,DB09298,-9.9,Silibinin,SEBFKMXJBCUCAI-HKTJVKLFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78700,6m2n,DB12138,-9.9,PF-03715455,VGEXRDWWPSGZDH-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138513,6w9c,DB11775,-9.9,PF-03758309,AYCPARAPKDAOEN-LJQANCHMSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
73924,6m2n,DB02668,-9.9,"Je-2147, Ag1776, Kni-764",CUFQBQOBLVLKRF-RZDMPUFOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
139562,6w9c,DB13640,-9.9,Acetoxolone,FTQDJVZNPJRVPG-XWEVEMRCSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
62095,6crv,DB13074,-9.9,Macimorelin,UJVDJAPJQWZRFR-DHIUTWEWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
143052,6w9q,DB03005,-9.9,"3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-5-Yl]Hexyl]-Phenanthridinium",ISUOMOOYAOQQPZ-UHFFFAOYSA-O,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
62098,6crv,DB13080,-9.9,Roluperidone,RNRYULFRLCBRQS-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
74987,6m2n,DB04098,-9.9,Balanol,XYUFCXJZFZPEJD-PGRDOPGGSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75163,6m2n,DB04330,-9.9,Bilh 434,KNRVCCXHLSHTFW-HGPRPZRGSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77857,6m2n,DB08901,-9.9,Ponatinib,PHXJVRSECIGDHY-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
70350,6lxt,DB12513,-9.9,Omaveloxolone,RJCWBNBKOKFWNY-IDPLTSGASA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
69922,6lxt,DB11896,-9.9,Gedatolisib,DWZAEMINVBZMHQ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
138603,6w9c,DB11904,-9.9,Flumatinib,BJCJYEYYYGBROF-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139568,6w9c,DB13648,-9.9,Alcuronium,MUQUYTSLDVKIOF-CHJKCJHBSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
62134,6crv,DB13135,-9.9,AGN-201904,PPCGSVWOZKNPCX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78694,6m2n,DB12130,-9.9,Lorlatinib,IIXWYSCJSQVBQM-LLVKDONJSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
70438,6lxt,DB12655,-9.9,Patidegib,HZLFFNCLTRVYJG-WWGOJCOQSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
75610,6m2n,DB04960,-9.9,Tipifarnib,PLHJCIYEEKOWNM-HHHXNRCGSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
143801,6w9q,DB04016,-9.9,2-[3-({Methyl[1-(2-Naphthoyl)Piperidin-4-Yl]Amino}Carbonyl)-2-Naphthyl]-1-(1-Naphthyl)-2-Oxoethylphosphonic Acid,XUJQPDQURBZEGJ-KXQOOQHDSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
67378,6lxt,DB06595,-9.9,Midostaurin,BMGQWWVMWDBQGC-IIFHNQTCSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
71945,6m2n,DB00157,-9.9,NADH,BOPGDPNILDQYTO-NNYOXOHSSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138868,6w9c,DB12380,-9.9,GDC-0152,WZRFLSDVFPIXOV-LRQRDZAKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139132,6w9c,DB12903,-9.9,DEBIO-1347,BEMNJULZEQTDJY-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
63160,6crv,DB15247,-9.9,Vorolanib,KMIOJWCYOHBUJS-HAKPAVFJSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
139109,6w9c,DB12874,-9.9,Quizartinib,CVWXJKQAOSCOAB-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
72681,6m2n,DB01029,-9.9,Irbesartan,YOSHYTLCDANDAN-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76108,6m2n,DB06817,-9.9,Raltegravir,CZFFBEXEKNGXKS-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
71991,6m2n,DB00210,-9.9,Adapalene,LZCDAPDGXCYOEH-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138931,6w9c,DB12580,-9.9,Tradipitant,CAVRKWRKTNINFF-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
72598,6m2n,DB00932,-9.9,Tipranavir,SUJUHGSWHZTSEU-FYBSXPHGSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
69603,6lxt,DB11273,-9.9,Dihydroergocornine,SEALOBQTUQIVGU-QNIJNHAOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
77978,6m2n,DB09073,-9.9,Palbociclib,AHJRHEGDXFFMBM-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138282,6w9c,DB11275,-9.9,Epicriptine,SBFXHXZNBNFPHV-PXXBSISHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
76226,6m2n,DB06962,-9.9,"(5-(aminomethyl)-2H-spiro[benzofuran-3,4'-piperidine]-1'-yl)(5-(phenylethynyl)furan-2-yl)methanone",YKTUSHSSKIWDRY-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
140227,6w9c,DB15399,-9.9,BMS-754807,LQVXSNNAFNGRAH-QHCPKHFHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
69071,6lxt,DB08674,-9.9,"(20S)-19,20,21,22-TETRAHYDRO-19-OXO-5H-18,20-ETHANO-12,14-ETHENO-6,10-METHENO-18H-BENZ[D]IMIDAZO[4,3-K][1,6,9,12]OXATRIAZA-CYCLOOCTADECOSINE-9-CARBONITRILE",USPFJPDEADLGIG-HSZRJFAPSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
61275,6crv,DB11844,-9.9,Pritelivir,IVZKZONQVYTCKC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76426,6m2n,DB07189,-9.9,"(1S,3R,6S)-4-oxo-6-{4-[(2-phenylquinolin-4-yl)methoxy]phenyl}-5-azaspiro[2.4]heptane-1-carboxylic acid",BFZXMIUWGSTUAL-ZSOKXDGFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
140179,6w9c,DB15295,-9.9,Tenalisib,HDXDQPRPFRKGKZ-INIZCTEOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
63149,6crv,DB15229,-9.9,CNV-2197944,BLFJGFDZMABYMY-ZDUSSCGKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140216,6w9c,DB15367,-9.9,LY-2623091,YPCLDHGBEKZGEB-RUDKWAFVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
76276,6m2n,DB07020,-9.9,"N-{3-[5-(1H-1,2,4-triazol-3-yl)-1H-indazol-3-yl]phenyl}furan-2-carboxamide",LMDMJDCLPIVGQD-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
139007,6w9c,DB12706,-9.9,Seletalisib,LNLJHGXOFYUARS-OAQYLSRUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139097,6w9c,DB12854,-9.9,BMS-908662,MMNNTJYFHUDSKL-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
73615,6m2n,DB02269,-9.9,[4-({[5-Benzyloxy-1-(3-Carbamimidoyl-Benzyl)-1h-Indole-2-Carbonyl]-Amino}-Methyl)-Phenyl]-Trimethyl-Ammonium,UFKJQTGPBFWMGT-UHFFFAOYSA-O,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
63125,6crv,DB15189,-9.9,Birabresib,GNMUEVRJHCWKTO-FQEVSTJZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75921,6m2n,DB06420,-9.9,Annamycin,CIDNKDMVSINJCG-GKXONYSUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
63220,6crv,DB15367,-9.9,LY-2623091,YPCLDHGBEKZGEB-RUDKWAFVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61210,6crv,DB11751,-9.9,Cabotegravir,WCWSTNLSLKSJPK-LKFCYVNXSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61359,6crv,DB11966,-9.9,BMS-986094,YFXGICNMLCGLHJ-RSKRLRQZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75553,6m2n,DB04852,-9.9,Implitapide,AMNXBQPRODZJQR-DITALETJSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61533,6crv,DB12228,-9.9,Telcagepant,CGDZXLJGHVKVIE-DNVCBOLYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61538,6crv,DB12234,-9.9,BMS-214662,OLCWFLWEHWLBTO-HSZRJFAPSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
71360,6lxt,DB14066,-9.9,Tetrandrine,WVTKBKWTSCPRNU-KYJUHHDHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
71596,6lxt,DB14870,-9.9,PF-5190457,ZIUDADZJCKGWKR-AREMUKBSSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
61347,6crv,DB11949,-9.9,Vestipitant,SBBYBXSFWOLDDG-JLTOFOAXSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75575,6m2n,DB04881,-9.9,Elacridar,OSFCMRGOZNQUSW-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
140003,6w9c,DB14729,-9.9,Rebeccamycin,QEHOIJJIZXRMAN-QZQSLCQPSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
78484,6m2n,DB11822,-9.9,TMC-647055,UOBYJVFBFSLCTQ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
140375,6w9c,DB05812,-9.9,Abiraterone,GZOSMCIZMLWJML-VJLLXTKPSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
78554,6m2n,DB11923,-9.9,Decoglurant,DMJHZVARRXJSEG-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
139405,6w9c,DB13422,-9.9,Nicofuranose,FUWFSXZKBMCSKF-ZASNTINBSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
61833,6crv,DB12665,-9.9,Isoquercetin,OVSQVDMCBVZWGM-QSOFNFLRSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
63120,6crv,DB15173,-9.9,JNJ-42165279,YWGYNGCRVZLMCS-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
66964,6lxt,DB04881,-9.9,Elacridar,OSFCMRGOZNQUSW-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
71833,6lxt,DB15367,-9.9,LY-2623091,YPCLDHGBEKZGEB-RUDKWAFVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
61608,6crv,DB12323,-9.9,Radotinib,DUPWHXBITIZIKZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
69650,6lxt,DB11399,-9.9,Dirlotapide,TUOSYWCFRFNJBS-BHVANESWSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
139201,6w9c,DB13113,-9.9,JNJ-38877605,JRWCBEOAFGHNNU-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
72906,6m2n,DB01329,-9.9,Cefoperazone,GCFBRXLSHGKWDP-XCGNWRKASA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61304,6crv,DB11890,-9.9,Cilengitide,AMLYAMJWYAIXIA-VWNVYAMZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138730,6w9c,DB12186,-9.9,SRT-2104,LAMQVIQMVKWXOC-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
74450,6m2n,DB03363,-9.9,3-Acetylpyridine Adenine Dinucleotide,KPVQNXLUPNWQHM-RBEMOOQDSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
134387,6w9c,DB03005,-9.9,"3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-5-Yl]Hexyl]-Phenanthridinium",ISUOMOOYAOQQPZ-UHFFFAOYSA-O,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
110613,6vxx,DB02009,-9.9,"L-756,423",AOMZDQMIOCTPQP-QHQMVRJISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
161022,7bv1,DB12411,-9.9,R-428,KXMZDGSRSGHMMK-VWLOTQADSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
85139,6m3m,DB07307,-9.9,N-cyclopropyl-4-methyl-3-[1-(2-methylphenyl)phthalazin-6-yl]benzamide,GQXMJOSCBRZMKE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
32820,6cs2,T3D3733,-9.9,Penitrem B,CRPJNVUYZRFGAK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
85029,6m3m,DB07181,-9.9,"4'-[(1R)-1-amino-2-(2,5-difluorophenyl)ethyl]biphenyl-3-carboxamide",JYKFWUXBFJJDTP-HXUWFJFHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
109140,6vxx,DB12427,-9.9,Orvepitant,XWNBGDJPEXZSQM-VZOBGQTKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109278,6vxx,DB13003,-9.9,Cortivazol,RKHQGWMMUURILY-UHRZLXHJSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84981,6m3m,DB07126,-9.9,O6-CYCLOHEXYLMETHOXY-2-(4'-SULPHAMOYLANILINO) PURINE,OWXORKPNCHJYOF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
32763,6cs2,T3D3676,-9.9,Cytochalasin A,APAAWKRGRLFEPA-LFKALUBKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
26551,6cs2,DB04708,-9.9,"(S)-TETRAHYDROFURAN-3-YL (2S,3S)-4-((S)-4-((1R,3R)-3-(2-AMINO-2-OXOETHYL)-2,3-DIHYDRO-1H-INDEN-1-YL)-2-BENZYL-3-OXO-2,3-DIHYDRO-1H-PYRROL-2-YL)-3-HYDROXY-1-PHENYLBUTAN-2-YLCARBAMATE",SYNSHNDQFWMLJW-YZGRCXSVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
97678,6m71,DB15401,-9.9,Danicopan,PIBARDGJJAGJAJ-NQIIRXRSSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
109304,6vxx,DB13042,-9.9,Fenoverine,UBAJTZKNDCEGKL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109317,6vxx,DB13061,-9.9,MLN8054,HHFBDROWDBDFBR-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84892,6m3m,DB07026,-9.9,"(1S,5S,7R)-N-7-(BIPHENYL-4-YLMETHYL)-N-3-HYDROXY-6,8-DIOXA-3-AZABICYCLO[3.2.1]OCTANE-3,7-DICARBOXAMIDE",PPLDARNGJSQINK-OKZBNKHCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84865,6m3m,DB06995,-9.9,N-({4-[(2-aminopyridin-4-yl)oxy]-3-fluorophenyl}carbamoyl)-2-(4-fluorophenyl)acetamide,USBSTVPJNQLYEM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
63258,6crv,DB15448,-9.9,Acumapimod,VGUSQKZDZHAAEE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85194,6m3m,DB07369,-9.9,"N-(3-chlorophenyl)-N-methyl-2-oxo-3-[(3,4,5-trimethyl-1H-pyrrol-2-yl)methyl]-2H-indole-5-sulfonamide",YMJLSOJLEXWATP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58895,6crv,DB06831,-9.9,2-((9H-PURIN-6-YLTHIO)METHYL)-5-CHLORO-3-(2-METHOXYPHENYL)QUINAZOLIN-4(3H)-ONE,UMMYTDJYDSTEMB-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109105,6vxx,DB12382,-9.9,R-306465,MUTBJZVSRNUIHA-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88485,6m3m,DB13856,-9.9,Fluclorolone,VTWKPILBIUBMDS-OTJLYDAYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85704,6m3m,DB07970,-9.9,5-[(2-methyl-5-{[3-(trifluoromethyl)phenyl]carbamoyl}phenyl)amino]pyridine-3-carboxamide,SAAYRHKJHDIDPH-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85630,6m3m,DB07879,-9.9,"N-hydroxy-5-[(3-phenyl-5,6-dihydroimidazo[1,2-a]pyrazin-7(8H)-yl)carbonyl]thiophene-2-carboxamide",SMSIXMLQOONOQQ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88279,6m3m,DB13587,-9.9,Mesterolone,UXYRZJKIQKRJCF-TZPFWLJSSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85585,6m3m,DB07830,-9.9,"(4R,5R)-5-AMINO-1-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN-2-ONE",DIRIFWIKLRTNMB-DYVFJYSZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
106052,6vxs,DB14894,-9.9,Galicaftor,QVDYQHXNAQHIKH-TZIWHRDSSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
85551,6m3m,DB07793,-9.9,"(2S)-N-[(3S)-1-(2-AMINO-2-OXOETHYL)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL]-2-CHLORO-2H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE",ACSGSLPOHKRZCY-GXTWGEPZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
161102,7bv1,DB12886,-9.9,GSK-1521498,WIEDUMBCZQRGSY-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
108993,6vxx,DB11877,-9.9,Basmisanil,VCGRFBXVSFAGGA-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85310,6m3m,DB07507,-9.9,"2-(4-hydroxybiphenyl-3-yl)-4-methyl-1H-isoindole-1,3(2H)-dione",ROMNEYAQUBNRLR-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58700,6crv,DB06429,-9.9,Talnetant,BIAVGWDGIJKWRM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109014,6vxx,DB11907,-9.9,Rociletinib,HUFOZJXAKZVRNJ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
133664,6w9c,DB01988,-9.9,6((S)-3-Benzylpiperazin-1-Yl)-3-(Naphthalen-2-Yl)-4-(Pyridin-4-Yl)Pyrazine,WFSFNKVFXLIZIY-MHZLTWQESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
161059,7bv1,DB12817,-9.9,Zoliflodacin,ZSWMIFNWDQEXDT-ZESJGQACSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
58710,6crv,DB06454,-9.9,Sarizotan,HKFMQJUJWSFOLY-OAQYLSRUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
11710,6lzg,DB12323,-9.9,Radotinib,DUPWHXBITIZIKZ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
58717,6crv,DB06469,-9.9,Lestaurtinib,UIARLYUEJFELEN-DMVVYWCZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85709,6m3m,DB07975,-9.9,"2-({[3,5-DIFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)CYCLOPENT-1-ENE-1-CARBOXYLIC ACID",VTGXLCZUWFYELR-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
109639,6vxx,DB15046,-9.9,LY-2881835,FHRWHNJJQGSCQC-LJAQVGFWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84666,6m3m,DB06718,-9.9,Stanozolol,LKAJKIOFIWVMDJ-IYRCEVNGSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
32069,6cs2,DB15297,-9.9,Petesicatib,KXAAIORSMACJSI-AEFFLSMTSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
84309,6m3m,DB05454,-9.9,Paliroden,CNEWKIDCGDXBDE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84297,6m3m,DB05412,-9.9,Talmapimod,ZMELOYOKMZBMRB-DLBZAZTESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84255,6m3m,DB05129,-9.9,Elsamitrucin,MGQRRMONVLMKJL-KWJIQSIXSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
26297,6cs2,DB04408,-9.9,Ncs-Chromophore,QZGIWPZCWHMVQL-UIYAJPBUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
84239,6m3m,DB05039,-9.9,Indacaterol,QZZUEBNBZAPZLX-QFIPXVFZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84238,6m3m,DB05038,-9.9,Anatibant,XUHBBTKJWIBQMY-MHZLTWQESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
110519,6vxx,DB01876,-9.9,Bis(5-Amidino-2-Benzimidazolyl)Methanone,VVVXDHROXQUONB-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
9713,6lzg,DB07833,-9.9,"N-(3-cyanophenyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)-4-biphenylcarboxamide",PMMLSQFPBFKLHH-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
84192,6m3m,DB04888,-9.9,Bifeprunox,CYGODHVAJQTCBG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
32032,6cs2,DB15233,-9.9,Avapritinib,DWYRIWUZIJHQKQ-SANMLTNESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
87749,6m3m,DB12794,-9.9,p-Quaterphenyl,GPRIERYVMZVKTC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88574,6m3m,DB14054,-9.9,Asiatic acid,JXSVIVRDWWRQRT-UYDOISQJSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
104971,6vxs,DB12794,-9.9,p-Quaterphenyl,GPRIERYVMZVKTC-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104786,6vxs,DB12504,-9.9,JNJ-40346527,BNVPFDRNGHMRJS-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
124046,6w4h,DB00696,-9.9,Ergotamine,XCGSFFUVFURLIX-VFGNJEKYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130553,6w4h,DB12424,-9.9,MK-3207,AZAANWYREOQRFB-SETSBSEESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
135354,6w9c,DB04350,-9.9,Argadin,FOZYKTUSOWWQGR-KNPYFFGGSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
59106,6crv,DB07081,-9.9,"(2R)-4-[(8R)-8-METHYL-2-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[1,5-A]PYRAZIN-7(8H)-YL]-4-OXO-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE",FDEXEPZGMKFCTG-PSASIEDQSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109714,6vxx,DB15193,-9.9,BMS-955176,XDMUFNNPLXHNKA-ZTESCHFWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58972,6crv,DB06922,-9.9,"2-[(1R)-1-carboxy-2-naphthalen-1-ylethyl]-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylic acid",CZNPWASYMRBJCX-GOSISDBHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88510,6m3m,DB13931,-9.9,Netarsudil,OURRXQUGYQRVML-AREMUKBSSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
109826,6vxx,DB00301,-9.9,Flucloxacillin,UIOFUWFRIANQPC-JKIFEVAISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
32131,6cs2,DB15414,-9.9,CM-4307,MLDQJTXFUGDVEO-FIBGUPNXSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
84544,6m3m,DB06448,-9.9,Lonafarnib,DHMTURDWPRKSOA-RUZDIDTESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
110165,6vxx,DB01051,-9.9,Novobiocin,YJQPYGGHQPGBLI-KGSXXDOSSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84520,6m3m,DB06393,-9.9,Xaliproden,WJJYZXPHLSLMGE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84498,6m3m,DB06307,-9.9,Apoptone,CKAXZOYFIHQCBN-JRRMKBMNSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
135083,6w9c,DB03957,-9.9,SP2456,SSSXBBASYYVGCI-HSZRJFAPSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
84432,6m3m,DB06160,-9.9,Garenoxacin,NJDRXTDGYFKORP-LLVKDONJSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84431,6m3m,DB06159,-9.9,Rubitecan,VHXNKPBCCMUMSW-FQEVSTJZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
135204,6w9c,DB04125,-9.9,N-Alpha-(2-Naphthylsulfonyl)-N(3-Amidino-L-Phenylalaninyl)-4-Acetyl-Piperazine,ZUWBXGHMVKDMQO-DEOSSOPVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
88566,6m3m,DB14034,-9.9,Darglitazone,QQKNSPHAFATFNQ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
32075,6cs2,DB15307,-9.9,Atabecestat,VLLFGVHGKLDDLW-SFHVURJKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
84370,6m3m,DB05804,-9.9,Prasterone sulfate,CZWCKYRVOZZJNM-USOAJAOKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
104543,6vxs,DB12154,-9.9,Itacitinib,KTBSXLIQKWEBRB-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
88235,6m3m,DB13528,-9.9,Chlormadinone,VUHJZBBCZGVNDZ-TTYLFXKOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58604,6crv,DB06178,-9.9,Talotrexin,NYQPLPNEESYGNO-IBGZPJMESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106988,6vxx,DB01836,-9.9,"[4-(6-Chloro-Naphthalene-2-Sulfonyl)-Piperazin-1-Yl]-(3,4,5,6-Tetrahydro-2h-[1,4']Bipyridinyl-4-Yl)-Methanone",ZLAKCKVFSRSENR-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87811,6m3m,DB12895,-9.9,TD-139,YGIDGBAHDZEYMT-MQFIMZJJSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
131899,6w4h,DB14943,-9.9,LGH-447,VRQXRVAKPDCRCI-ZNMIVQPWSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
107167,6vxx,DB02651,-9.9,"{[2-(1h-1,2,3-Benzotriazol-1-Yl)-2-(3,4-Difluorophenyl)Propane-1,3-Diyl]Bis[4,1-Phenylene(Difluoromethylene)]}Bis(Phosphonic Acid)",BTAGTGWPDROBMG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87243,6m3m,DB12044,-9.9,MK-0893,DNTVJEMGHBIUMW-IBGZPJMESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87818,6m3m,DB12903,-9.9,DEBIO-1347,BEMNJULZEQTDJY-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87228,6m3m,DB12020,-9.9,Tecovirimat,CSKDFZIMJXRJGH-VWLPUNTISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87226,6m3m,DB12015,-9.9,Alpelisib,STUWGJZDJHPWGZ-LBPRGKRZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
106521,6vxx,DB00444,-9.9,Teniposide,NRUKOCRGYNPUPR-QBPJDGROSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27174,6cs2,DB06626,-9.9,Axitinib,RITAVMQDGBJQJZ-FMIVXFBMSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
107227,6vxx,DB02732,-9.9,Nicotinamide Adenine Dinucleotide Acetone Adduct,SGHBFOOIAAJJMI-YDKVLQLQSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87151,6m3m,DB11904,-9.9,Flumatinib,BJCJYEYYYGBROF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87133,6m3m,DB11878,-9.9,Filibuvir,SLVAPEZTBDBAPI-GDLZYMKVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
127218,6w4h,DB04868,-9.9,Nilotinib,HHZIURLSWUIHRB-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
87115,6m3m,DB11851,-9.9,Bafetinib,ZGBAJMQHJDFTQJ-DEOSSOPVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
56975,6crv,DB03038,-9.9,LY341770,MXAFDBCLWLMXSI-ZDUSSCGKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107429,6vxx,DB03583,-9.9,"(2e,3s)-3-Hydroxy-5'-[(4-Hydroxypiperidin-1-Yl)Sulfonyl]-3-Methyl-1,3-Dihydro-2,3'-Biindol-2'(1'h)-One",AYOAIABDFUJDKQ-SQJPUDIVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87396,6m3m,DB12267,-9.9,Brigatinib,AILRADAXUVEEIR-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87429,6m3m,DB12307,-9.9,Foretinib,CXQHYVUVSFXTMY-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
27419,6cs2,DB06962,-9.9,"(5-(aminomethyl)-2H-spiro[benzofuran-3,4'-piperidine]-1'-yl)(5-(phenylethynyl)furan-2-yl)methanone",YKTUSHSSKIWDRY-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
106746,6vxx,DB01200,-9.9,Bromocriptine,OZVBMTJYIDMWIL-AYFBDAFISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87675,6m3m,DB12673,-9.9,ATX-914,ALANRBCCCQEPFZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87658,6m3m,DB12651,-9.9,Bardoxolone,TXGZJQLMVSIZEI-UQMAOPSPSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
106796,6vxx,DB01267,-9.9,Paliperidone,PMXMIIMHBWHSKN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87780,6m3m,DB12848,-9.9,PF-04217903,PDMUGYOXRHVNMO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
28422,6cs2,DB08010,-9.9,"(3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-[(E)-2-phenylethenyl]-1H-indole-2,3-dione 3-oxime",DDHASJXGNUWZTM-ZLEWNXFRSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
57198,6crv,DB03325,-9.9,Tyrosyladenylate,MJZAZMKENKZBAJ-QTOWJTHWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106867,6vxx,DB01419,-9.9,Antrafenine,NWGGKKGAFZIVBJ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87787,6m3m,DB12858,-9.9,LY-377604,RBSGUQYXRDKPAE-QFIPXVFZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
57227,6crv,DB03363,-9.9,3-Acetylpyridine Adenine Dinucleotide,KPVQNXLUPNWQHM-RBEMOOQDSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57293,6crv,DB03461,-9.9,2'-Monophosphoadenosine 5'-Diphosphoribose,XJLXINKUBYWONI-NNYOXOHSSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87509,6m3m,DB12419,-9.9,HSD-016,ZWASRJHIEFYJGL-BFUOFWGJSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
54960,6crv,DB00438,-9.9,Ceftazidime,ORFOPKXBNMVMKC-DWVKKRMSSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28447,6cs2,DB08034,-9.9,"(E)-3,4-DIHYDROXY-N'-[(2-METHOXYNAPHTHALEN-1-YL)METHYLENE]BENZOHYDRAZIDE",TVOPERZEGKBKAY-RGVLZGJSSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
87407,6m3m,DB12280,-9.9,AZD-5423,FCNQMDSJHADDFT-WNSKOXEYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58622,6crv,DB06212,-9.9,Tolvaptan,GYHCTFXIZSNGJT-XMMPIXPASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87825,6m3m,DB12914,-9.9,MGL-3196,FDBYIYFVSAHJLY-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
132085,6w4h,DB15345,-9.9,GSK-945237,SRICOHRDRMZREQ-MRXNPFEDSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
86300,6m3m,DB08683,-9.9,"REL-(9R,12S)-9,10,11,12-TETRAHYDRO-9,12-EPOXY-1H-DIINDOLO[1,2,3-FG:3',2',1'-KL]PYRROLO[3,4-I][1,6]BENZODIAZOCINE-1,3(2H)-DIONE",OTPNDVKVEAIXTI-IYBDPMFKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
56701,6crv,DB02668,-9.9,"Je-2147, Ag1776, Kni-764",CUFQBQOBLVLKRF-RZDMPUFOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108455,6vxx,DB08010,-9.9,"(3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-[(E)-2-phenylethenyl]-1H-indole-2,3-dione 3-oxime",DDHASJXGNUWZTM-ZLEWNXFRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86166,6m3m,DB08520,-9.9,"(21S)-1AZA-4,4-DIMETHYL-6,19-DIOXA-2,3,7,20-TETRAOXOBICYCLO[19.4.0] PENTACOSANE",VUCSBBBCFXBFFY-IBGZPJMESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86144,6m3m,DB08494,-9.9,"S-{2-[(2-chloro-4-sulfamoylphenyl)amino]-2-oxoethyl} 6-methyl-3,4-dihydroquinoline-1(2H)-carbothioate",AWAKIULNKVOBKE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
108475,6vxx,DB08031,-9.9,"N-[(13-CYCLOHEXYL-6,7-DIHYDROINDOLO[1,2-D][1,4]BENZOXAZEPIN-10-YL)CARBONYL]-2-METHYL-L-ALANINE",LNQWELVSNCYKDU-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108491,6vxx,DB08051,-9.9,"(2R)-4-(2-BENZOYL-1,2-DIAZEPAN-1-YL)-4-OXO-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE",XXRHRPGYYNOBHO-QGZVFWFLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87942,6m3m,DB13094,-9.9,Pruvanserin,AQRLDDAFYYAIJP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86079,6m3m,DB08416,-9.9,"(9BETA,13ALPHA,14BETA,17ALPHA)-2-METHOX1TRA-1,3,5(10)-TRIENE-3,17-DIYL DISULFAMATE",AQSNIXKAKUZPSI-SSTWWWIQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58552,6crv,DB05913,-9.9,OSI-930,FGTCROZDHDSNIO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28739,6cs2,DB08351,-9.9,N-cyclopropyl-4-methyl-3-{2-[(2-morpholin-4-ylethyl)amino]quinazolin-6-yl}benzamide,MNEXDVSJIUQQRH-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
163700,7bv1,DB05984,-9.9,RAF-265,YABJJWZLRMPFSI-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
58574,6crv,DB06090,-9.9,Bradanicline,OXKRFEWMSWPKKV-GHTZIAJQSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55060,6crv,DB00559,-9.9,Bosentan,GJPICJJJRGTNOD-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108605,6vxx,DB08450,-9.9,N-1H-indazol-5-yl-2-(6-methylpyridin-2-yl)quinazolin-4-amine,HNHRWNUXTCATSG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86320,6m3m,DB08708,-9.9,"N-cyclohexyl-3-[3-(trifluoromethyl)phenyl][1,2,4]triazolo[4,3-b]pyridazin-6-amine",XYYDXQCAYXOGQT-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
27114,6cs2,DB06486,-9.9,Enzastaurin,AXRCEOKUDYDWLF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
11444,6lzg,DB11977,-9.9,Golvatinib,UQRCJCNVNUFYDX-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
87941,6m3m,DB13093,-9.9,TAK-593,DZFZXPPHBWCXPQ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
56855,6crv,DB02873,-9.9,"1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperazin-1-Yl-3,4-Dihydroquinazolin-2(1h)-One",YAWZIQKDHQIHOS-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130850,6w4h,DB12892,-9.9,MGB-BP-3,OEKXCVYZBVOWBR-BQYQJAHWSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
107913,6vxx,DB05553,-9.9,Regrelor,NXHAXEBZOXCDKD-XIXRRVGJSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87029,6m3m,DB11730,-9.9,Ribociclib,RHXHGRAEPCAFML-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
132324,6w9c,DB00288,-9.9,Amcinonide,ILKJAFIWWBXGDU-MOGDOJJUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
58203,6crv,DB04685,-9.9,"1-{(2S,5S)-4-FLUORO-5-[(TRITYLOXY)METHYL]TETRAHYDROFURAN-2-YL}PYRIMIDINE-2,4(1H,3H)-DIONE",GJNIPWYJQUGERM-BFLUCZKCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58220,6crv,DB04708,-9.9,"(S)-TETRAHYDROFURAN-3-YL (2S,3S)-4-((S)-4-((1R,3R)-3-(2-AMINO-2-OXOETHYL)-2,3-DIHYDRO-1H-INDEN-1-YL)-2-BENZYL-3-OXO-2,3-DIHYDRO-1H-PYRROL-2-YL)-3-HYDROXY-1-PHENYLBUTAN-2-YLCARBAMATE",SYNSHNDQFWMLJW-YZGRCXSVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86886,6m3m,DB11429,-9.9,Mibolerone,PTQMMNYJKCSPET-OMHQDGTGSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86849,6m3m,DB11363,-9.9,Alectinib,KDGFLJKFZUIJMX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87867,6m3m,DB12978,-9.9,Pexidartinib,JGWRKYUXBBNENE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
26934,6cs2,DB05984,-9.9,RAF-265,YABJJWZLRMPFSI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
86717,6m3m,DB09272,-9.9,Eluxadoline,QFNHIDANIVGXPE-FNZWTVRRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86594,6m3m,DB09079,-9.9,Nintedanib,XZXHXSATPCNXJR-ZIADKAODSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
106435,6vxx,DB00210,-9.9,Adapalene,LZCDAPDGXCYOEH-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106370,6vxx,DB00137,-9.9,Lutein,KBPHJBAIARWVSC-RGZFRNHPSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86421,6m3m,DB08820,-9.9,Ivacaftor,PURKAOJPTOLRMP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83744,6m3m,DB04289,-9.9,Genz-10850,YYMZSGIXLQPFAC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87719,6m3m,DB12742,-9.9,Amuvatinib,FOFDIMHVKGYHRU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59344,6crv,DB07351,-9.9,O-(((1R)-((N-(PHENYL-METHOXY-CARBONYL)-ALANYL)-AMINO)METHYL)HYDROXYPHOSPHINYL)3-L-PHENYLLACTATE,ICACWKLCNCPHAM-YJBOKZPZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
99811,6vxs,DB02741,-9.9,CD564,RWYREGSYPCNZTL-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
113954,6vxx,DB12318,-9.9,BMS-599626,LUJZZYWHBDHDQX-QFIPXVFZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30347,6cs2,DB12368,-9.9,AZD-3839,MRXBCEQZNKUUIP-DEOSSOPVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
88918,6m3m,DB15102,-9.9,Pemigatinib,HCDMJFOHIXMBOV-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
25643,6cs2,DB03632,-9.9,Argifin,UHBHXSDKGLPPGO-HTDHLNIYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
88939,6m3m,DB15141,-9.9,Deutivacaftor,PURKAOJPTOLRMP-ASMGOKTBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80593,6m3m,DB00197,-9.9,Troglitazone,GXPHKUHSUJUWKP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80413,6m2n,DB15305,-9.9,Risdiplam,ASKZRYGFUPSJPN-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
114062,6vxx,DB12669,-9.9,4SC-203,MAFACRSJGNJHCF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80384,6m2n,DB15247,-9.9,Vorolanib,KMIOJWCYOHBUJS-HAKPAVFJSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
60268,6crv,DB08445,-9.9,"(3R,4S)-1-[6-(6-METHOXYPYRIDIN-3-YL)PYRIMIDIN-4-YL]-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE",IFKWHPAWYJARQJ-DYVFJYSZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
8262,6lzg,DB05075,-9.9,TG-100801,JMGXJHWTVBGOKG-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
80354,6m2n,DB15197,-9.9,RSV-604,MTPVBMVUENFFLL-HXUWFJFHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80350,6m2n,DB15190,-9.9,GLPG-0259,YBFGSJUVEOYPIS-OALUTQOASA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
60236,6crv,DB08406,-9.9,"[N-(2,4-DIAMINOPTERIDIN-6-YL)-METHYL]-DIBENZ[B,F]AZEPINE",NXCCIJQEAKMFGW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60084,6crv,DB08213,-9.9,"1-METHYL-5-(2-PHENOXYMETHYL-PYRROLIDINE-1-SULFONYL)-1H-INDOLE-2,3-DIONE",PFAYCUAUBOGVDX-AWEZNQCLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80761,6m3m,DB00398,-9.9,Sorafenib,MLDQJTXFUGDVEO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136819,6w9c,DB07570,-9.9,3-CYCLOHEXYL-1-(2-MORPHOLIN-4-YL-2-OXOETHYL)-2-PHENYL-1H-INDOLE-6-CARBOXYLIC ACID,ZKEZEXYKYHYIMQ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
59975,6crv,DB08091,-9.9,3-FLUORO-5-MORPHOLIN-4-YL-N-[3-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-5-YL]BENZAMIDE,HIUFYIOMUILESI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81061,6m3m,DB00764,-9.9,Mometasone,QLIIKPVHVRXHRI-CXSFZGCWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
113666,6vxx,DB11734,-9.9,Fedovapagon,RUOLFWZIFNQQGH-DEOSSOPVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88870,6m3m,DB15006,-9.9,Flufenoxuron,RYLHNOVXKPXDIP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
56288,6crv,DB02128,-9.9,[1-(3-Hydroxy-2-Oxo-1-Phenethyl-Propylcarbamoyl)2-Phenyl-Ethyl]-Carbamic Acid Pyridin-4-Ylmethyl Ester,QCUBCTPTNWPFBC-ZEQRLZLVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29514,6cs2,DB09280,-9.9,Lumacaftor,UFSKUSARDNFIRC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
80919,6m3m,DB00591,-9.9,Fluocinolone acetonide,FEBLZLNTKCEFIT-VSXGLTOVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
29523,6cs2,DB09291,-9.9,Rolapitant,FIVSJYGQAIEMOC-ZGNKEGEESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
113712,6vxx,DB11796,-9.9,Fostemsavir,SWMDAPWAQQTBOG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113719,6vxx,DB11806,-9.9,VTP-194204,BOOOLEGQBVUTKC-NVQSDHBMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113765,6vxx,DB12052,-9.9,Icariin,TZJALUIVHRYQQB-XLRXWWTNSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88883,6m3m,DB15034,-9.9,PRI-724,VHOZWHQPEJGPCC-AZXNYEMZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
101399,6vxs,DB04868,-9.9,Nilotinib,HHZIURLSWUIHRB-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
113855,6vxx,DB12185,-9.9,Exatecan,ZVYVPGLRVWUPMP-FYSMJZIKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88902,6m3m,DB15068,-9.9,Agerafenib,DKNUPRMJNUQNHR-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
99608,6vxs,DB02473,-9.9,"6-[N-(1-Isopropyl-3,4-Dihydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine",XRHANBWAKSYPEN-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
29681,6cs2,DB11399,-9.9,Dirlotapide,TUOSYWCFRFNJBS-BHVANESWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
80339,6m2n,DB15163,-9.9,Selatogrel,FYXHWMQPCJOJCH-GMAHTHKFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80310,6m2n,DB15108,-9.9,Tipranavir C-14,SUJUHGSWHZTSEU-MWQIXQBFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
96113,6m71,DB12411,-9.9,R-428,KXMZDGSRSGHMMK-VWLOTQADSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
114906,6vxx,DB15382,-9.9,SAR-125844,ODIUNTQOXRXOIV-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60823,6crv,DB09195,-9.9,Lorpiprazole,BNRMWKUVWLKDQJ-YJBOKZPZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
166559,7bv1,DB15367,-9.9,LY-2623091,YPCLDHGBEKZGEB-RUDKWAFVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
29953,6cs2,DB11852,-9.9,Tegobuvir,XBEQSQDCBSKCHJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
78923,6m2n,DB12457,-9.9,Rimegepant,KRNAOFGYEFKHPB-ANJVHQHFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78893,6m2n,DB12414,-9.9,Usistapide,WSYALRNYQFNNGP-WJOKGBTCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
114882,6vxx,DB15327,-9.9,Abivertinib,UOFYSRZSLXWIQB-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78892,6m2n,DB12412,-9.9,Gemigliptin,ZWPRRQZNBDYKLH-VIFPVBQESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
96522,6m71,DB13050,-9.9,Tirilazad,RBKASMJPSJDQKY-RBFSKHHSSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
29922,6cs2,DB11816,-9.9,Omecamtiv Mecarbil,RFUBTTPMWSKEIW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
60992,6crv,DB11275,-9.9,Epicriptine,SBFXHXZNBNFPHV-PXXBSISHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78804,6m2n,DB12289,-9.9,Darexaban,IJNIQYINMSGIPS-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78790,6m2n,DB12272,-9.9,Vidupiprant,PFWVGKROPKKEDW-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
114871,6vxx,DB15305,-9.9,Risdiplam,ASKZRYGFUPSJPN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79194,6m2n,DB12886,-9.9,GSK-1521498,WIEDUMBCZQRGSY-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
81114,6m3m,DB00826,-9.9,Natamycin,NCXMLFZGDNKEPB-FFPOYIOWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
25370,6cs2,DB03276,-9.9,"4-[(10s,14s,18s)-18-(2-Amino-2-Oxoethyl)-14-(1-Naphthylmethyl)-8,17,20-Trioxo-7,16,19-Triazaspiro[5.14]Icos-11-En-10-Yl]Benzylphosphonic Acid",RHYFMOCFCFUTNH-GZNVFMSSSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
99331,6vxs,DB02112,-9.9,Zk-806450,DZLGSWPXZYDHBD-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
114168,6vxx,DB12843,-9.9,Oleandrin,JLPDBLFIVFSOCC-XYXFTTADSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
89077,6m3m,DB15416,-9.9,PX-102,XBUXXJUEBFDQHD-NHCUHLMSSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80233,6m2n,DB14918,-9.9,Branaplam,STWTUEAWRAIWJG-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
129631,6w4h,DB09074,-9.9,Olaparib,FDLYAMZZIXQODN-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
80220,6m2n,DB14895,-9.9,Vibegron,DJXRIQMCROIRCZ-XOEOCAAJSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
114219,6vxx,DB13109,-9.9,PKI-179,WXUUCRLKXQMWRY-OYRHEFFESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
8189,6lzg,DB04868,-9.9,Nilotinib,HHZIURLSWUIHRB-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
28230,6cs2,DB07811,-9.9,"N-cyclopropyl-2',6-dimethyl-4'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-3-carboxamide",UBVTVSINEVHYSY-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
93180,6m71,DB06515,-9.9,Resiniferatoxin,DSDNAKHZNJAGHN-MXTYGGKSSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
79885,6m2n,DB13874,-9.9,Enasidenib,DYLUUSLLRIQKOE-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79839,6m2n,DB13814,-9.9,Talampicillin,SOROUYSPFADXSN-SUWVAFIASA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
30019,6cs2,DB11942,-9.9,Selinexor,DEVSOMFAQLZNKR-RJRFIUFISA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
93421,6m71,DB06925,-9.9,3-(2-AMINOQUINAZOLIN-6-YL)-4-METHYL-N-[3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE,YEIASMOUYNOXGA-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60587,6crv,DB08822,-9.9,Azilsartan medoxomil,QJFSABGVXDWMIW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60623,6crv,DB08882,-9.9,Linagliptin,LTXREWYXXSTFRX-QGZVFWFLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
95617,6m71,DB11691,-9.9,Naldemedine,AXQACEQYCPKDMV-RZAWKFBISA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
130192,6w4h,DB11904,-9.9,Flumatinib,BJCJYEYYYGBROF-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
136772,6w9c,DB07514,-9.9,"3-(2-aminoquinazolin-6-yl)-1-(3,3-dimethylindolin-6-yl)-4-methylpyridin-2(1H)-one",LHLGUOHREUTYTO-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136595,6w9c,DB07307,-9.9,N-cyclopropyl-4-methyl-3-[1-(2-methylphenyl)phthalazin-6-yl]benzamide,GQXMJOSCBRZMKE-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
59599,6crv,DB07653,-9.9,"N-(5,6-DIPHENYLFURO[2,3-D]PYRIMIDIN-4-YL)GLYCINE",VXTCEUDVOCLEJG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
82552,6m3m,DB02691,-9.9,Glycocholic acid,RFDAIACWWDREDC-FRVQLJSFSA-M,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88796,6m3m,DB14821,-9.9,Macozinone,BJDZBXGJNBMCAV-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
82380,6m3m,DB02466,-9.9,"4-[3-Oxo-3-(5,5,8,8-Tetramethyl-5,6,7,8-Tetrahydro-Naphthalen-2-Yl)-Propenyl]-Benzoic Acid",ZXQHMEUGMCXKLO-KPKJPENVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
82367,6m3m,DB02449,-9.9,3-(1h-Indol-3-Yl)-2-[4-(4-Phenyl-Piperidin-1-Yl)-Benzenesulfonylamino]-Propionic Acid,ULOTXPTWJAUGGE-MHZLTWQESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
31801,6cs2,DB14773,-9.9,Lifirafenib,NGFFVZQXSRKHBM-FKBYEOEOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
82289,6m3m,DB02354,-9.9,4-{[1-Methyl-5-(2-Methyl-Benzoimidazol-1-Ylmethyl)-1h-Benzoimidazol-2-Ylmethyl]-Amino}-Benzamidine,IRKPNOLLMNHSOU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
82275,6m3m,DB02336,-9.9,RU83876,WCMLXBUNHNAMNH-UIOOFZCWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
175,6lzg,HMDB0003265,-9.9,Hesperidin,QUQPHWDTPGMPEX-UNZJSITISA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
29232,6cs2,DB08901,-9.9,Ponatinib,PHXJVRSECIGDHY-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
112195,6vxx,DB06543,-9.9,Astaxanthin,MQZIGYBFDRPAKN-UWFIBFSHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
25974,6cs2,DB04016,-9.9,2-[3-({Methyl[1-(2-Naphthoyl)Piperidin-4-Yl]Amino}Carbonyl)-2-Naphthyl]-1-(1-Naphthyl)-2-Oxoethylphosphonic Acid,XUJQPDQURBZEGJ-KXQOOQHDSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
81232,6m3m,DB00959,-9.9,Methylprednisolone,VHRSUDSXCMQTMA-PJHHCJLFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
165842,7bv1,DB13095,-9.9,JTK-853,JQLOVYLALGSISI-HXUWFJFHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
82118,6m3m,DB02123,-9.9,Glycochenodeoxycholic Acid,GHCZAUBVMUEKKP-GYPHWSFCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59597,6crv,DB07651,-9.9,N-ACETYL-L-PHENYLALANYL-4-[DIFLUORO(PHOSPHONO)METHYL]-L-PHENYLALANINAMIDE,KPMMESISHWWXNM-ROUUACIJSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112045,6vxx,DB06163,-9.9,Plevitrexed,IEJSCSAMMLUINT-NRFANRHFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56112,6crv,DB01893,-9.9,N6-Benzyl Adenosine-5'-Diphosphate,MRHGMAGSDAQUFH-LSCFUAHRSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111755,6vxx,DB04477,-9.9,"N-1,2,3,4-Tetrahydronaphth-1-Yl-2'-[3,5-Dimethoxybenzamido]-2'-Deoxy-Adenosine",FDZQGEIYGFPMOB-ZUURFMEUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
83576,6m3m,DB04071,-9.9,Cpad,LFERELMXERXKKQ-KMXXXSRASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83552,6m3m,DB04038,-9.9,Ergosterol,DNVPQKQSNYMLRS-APGDWVJJSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
135867,6w9c,DB05450,-9.9,Smilagenin,GMBQZIIUCVWOCD-UQHLGXRBSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
111216,6vxx,DB03351,-9.9,Sri-9439,KMSATRJZEXNGDP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
83457,6m3m,DB03907,-9.9,"N-{3-[5-(6-Amino-Purin-9-Yl)-3,4-Dihydroxy-Tetrahydro-Furan-2-Yl]-Allyl}-2,3-Dihydroxy-5-Nitro-Benzamide",UHHBFOLQOQSPLU-WGRQDFERSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
111442,6vxx,DB03878,-9.9,N-[4-Methyl-3-[[4-(3-Pyridinyl)-2-Pyrimidinyl]Amino]Phenyl]-3-Pyridinecarboxamide,YWQVBESSYLICRX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
83300,6m3m,DB03712,-9.9,RU85053,CEKLBQMULVLLTD-VMPREFPWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
82030,6m3m,DB02010,-9.9,Staurosporine,HKSZLNNOFSGOKW-FYTWVXJKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
135912,6w9c,DB05678,-9.9,SLx-4090,AZUIUVJESCFSLJ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
83199,6m3m,DB03571,-9.9,"3-(5-Amino-7-Hydroxy-[1,2,3]Triazolo[4,5-D]Pyrimidin-2-Yl)-N-(3,5-Dichlorobenzyl)-Benzamide",JMQTXEWNXSPEKX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59475,6crv,DB07507,-9.9,"2-(4-hydroxybiphenyl-3-yl)-4-methyl-1H-isoindole-1,3(2H)-dione",ROMNEYAQUBNRLR-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
82899,6m3m,DB03157,-9.9,"N,O-Didansyl-L-Tyrosine",LUBOPDUYHWABFG-NDEPHWFRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
31901,6cs2,DB15003,-9.9,PF-06700841,BUWBRTXGQRBBHG-MJBXVCDLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
82831,6m3m,DB03067,-9.9,"4-{2,4-Bis[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid",VFYAZSTYKPFSFL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136087,6w9c,DB06515,-9.9,Resiniferatoxin,DSDNAKHZNJAGHN-MXTYGGKSSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
111666,6vxx,DB04350,-9.9,Argadin,FOZYKTUSOWWQGR-KNPYFFGGSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
83225,6m3m,DB03605,-9.9,"(2s)-2-[(2,4-Dichloro-Benzoyl)-(3-Trifluoromethyl-Benzyl)-Amino]-3-Phenyl-Propionic Acid",LAJJKGIZTCCOHY-NRFANRHFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81976,6m3m,DB01941,-9.9,"6-[1-(3,5,5,8,8-Pentamethyl-5,6,7,8-Tetrahydronaphthalen-2-Yl)Cyclopropyl]Pyridine-3-Carboxylic Acid",SLXTWXQUEZSSTJ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
82184,6m3m,DB02217,-9.9,Dpb-T,WTZFKHNHHRPQOU-WSMBLCCSSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
56020,6crv,DB01768,-9.9,Methylumbelliferyl Sialic Acid,KKDWIUJBUSOPGC-GKHMPSLRSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81429,6m3m,DB01185,-9.9,Fluoxymesterone,YLRFCQOZQXIBAB-RBZZARIASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81484,6m3m,DB01251,-9.9,Gliquidone,LLJFMFZYVVLQKT-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81488,6m3m,DB01259,-9.9,Lapatinib,BCFGMOOMADDAQU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
112562,6vxx,DB07397,-9.9,"(5S)-5-(2-amino-2-oxoethyl)-4-oxo-N-[(3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl)methyl]-3,4,5,6,7,8-hexahydro[1]benzothieno[2,3-d]pyrimidine-2-carboxamide",ITADELAVAWJACR-NSHDSACASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112198,6vxx,DB06555,-9.9,Siramesine,XWAONOGAGZNUSF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56015,6crv,DB01763,-9.9,7-thionicotinamide-adenine-dinucleotide phosphate,OJNFDOAQUXJWED-NNYOXOHSSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27832,6cs2,DB07390,-9.9,"2-[3-(5-MERCAPTO-[1,3,4]THIADIAZOL-2-YL)-UREIDO]-N-METHYL-3-PHENYL-PROPIONAMIDE",RKWXKADYTDWZIJ-VIFPVBQESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
81612,6m3m,DB01471,-9.9,Bolasterone,IVFYLRMMHVYGJH-VLOLGRDOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88822,6m3m,DB14878,-9.9,Liafensine,VCIBGDSRPUOBOG-QFIPXVFZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59930,6crv,DB08036,-9.9,"6,7,12,13-tetrahydro-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazol-5-one",MEXUTNIFSHFQRG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112934,6vxx,DB08164,-9.9,"(3R,4R)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN-3-AMINE",GOBIXGZJSMAOFV-QRWLVFNGSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59764,6crv,DB07847,-9.9,6-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-(4-MORPHOLINYL)-2-OXO ETHYL]-2-OXO-3-PYRROLIDINYL}-2-NAPHTHALENESULFONAMIDE,ICLOZQFWTRAYPX-LIRRHRJNSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113359,6vxx,DB09048,-9.9,Netupitant,WAXQNWCZJDTGBU-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81794,6m3m,DB01690,-9.9,Bis(Adenosine)-5'-Triphosphate,QCICUPZZLIQAPA-XPWFQUROSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81849,6m3m,DB01763,-9.9,7-thionicotinamide-adenine-dinucleotide phosphate,OJNFDOAQUXJWED-NNYOXOHSSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81900,6m3m,DB01830,-9.9,"{4-[2-Acetylamino-2-(3-Carbamoyl-2-Cyclohexylmethoxy-6,7,8,9-Tetrahydro-5h-Benzocyclohepten-5ylcarbamoyl)-Ethyl]-2-Phosphono-Phenyl}-Phosphonic Acid",SPSGYTWOIGAABK-DQEYMECFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
31560,6cs2,DB14029,-9.9,Furafylline,HMZQULPVMKITSP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
136355,6w9c,DB07024,-9.9,"2-(3,4-DIHYDROXYPHENYL)-8-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-3-HYDROXY-6-METHYL-4H-CHROMEN-4-ONE",CEXBEGBNDJVZPK-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
81953,6m3m,DB01908,-9.9,RU85493,MWEWSHNGVWABKG-SVBPBHIXSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
159422,7bv1,DB04125,-9.9,N-Alpha-(2-Naphthylsulfonyl)-N(3-Amidino-L-Phenylalaninyl)-4-Acetyl-Piperazine,ZUWBXGHMVKDMQO-DEOSSOPVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
81716,6m3m,DB01591,-9.9,Solifenacin,FBOUYBDGKBSUES-VXKWHMMOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59935,6crv,DB08042,-9.9,"N-4-methyl-N-4-(3-methyl-1H-indazol-6-yl)-N-2-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine",FLXGQDHYCWXTAI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59936,6crv,DB08043,-9.9,1-[4-(PYRIDIN-4-YLOXY)PHENYL]-3-[3-(TRIFLUOROMETHYL)PHENYL]UREA,DDDLGNOZDKDSEG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106246,6vxs,DB15305,-9.8,Risdiplam,ASKZRYGFUPSJPN-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104447,6vxs,DB12012,-9.8,PF-04457845,BATCTBJIJJEPHM-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
106040,6vxs,DB14870,-9.8,PF-5190457,ZIUDADZJCKGWKR-AREMUKBSSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
72503,6m2n,DB00826,-9.8,Natamycin,NCXMLFZGDNKEPB-FFPOYIOWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
98716,6vxs,DB01267,-9.8,Paliperidone,PMXMIIMHBWHSKN-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
72549,6m2n,DB00878,-9.8,Chlorhexidine,GHXZTYHSJHQHIJ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
140168,6w9c,DB15110,-9.8,Onvansertib,QHLVBNKYJGBCQJ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
102994,6vxs,DB08044,-9.8,ABT-341,NVVSPGQEXMJZIR-BMIGLBTASA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
105110,6vxs,DB13014,-9.8,Hypericin,BTXNYTINYBABQR-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
140111,6w9c,DB14993,-9.8,Pyrotinib,SADXACCFNXBCFY-IYNHSRRRSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
127480,6w4h,DB06178,-9.8,Talotrexin,NYQPLPNEESYGNO-IBGZPJMESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
13228,6lzg,DB14935,-9.8,Serabelisib,BLGWHBSBBJNKJO-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
106733,6vxx,DB00948,-9.8,Mezlocillin,YPBATNHYBCGSSN-VWPFQQQWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
101684,6vxs,DB06229,-9.8,Ocaperidone,ZZQNEJILGNNOEP-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
128417,6w4h,DB07586,-9.8,"5-(4-METHYL-BENZOYLAMINO)-BIPHENYL-3,4'-DICARBOXYLIC ACID 3-DIMETHYLAMIDE-4'-HYDROXYAMIDE",DOPFUKKMSDUVTQ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
101277,6vxs,DB04708,-9.8,"(S)-TETRAHYDROFURAN-3-YL (2S,3S)-4-((S)-4-((1R,3R)-3-(2-AMINO-2-OXOETHYL)-2,3-DIHYDRO-1H-INDEN-1-YL)-2-BENZYL-3-OXO-2,3-DIHYDRO-1H-PYRROL-2-YL)-3-HYDROXY-1-PHENYLBUTAN-2-YLCARBAMATE",SYNSHNDQFWMLJW-YZGRCXSVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101791,6vxs,DB06515,-9.8,Resiniferatoxin,DSDNAKHZNJAGHN-MXTYGGKSSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101733,6vxs,DB06350,-9.8,Elinogrel,LGSDFTPAICUONK-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
106465,6vxx,DB00377,-9.8,Palonosetron,CPZBLNMUGSZIPR-NVXWUHKLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
99785,6vxs,DB02704,-9.8,"(2r,3r,4r,5r)-3,4-Dihydroxy-N,N'-Bis[(1s,2r)-2-Hydroxy-2,3-Dihydro-1h-Inden-1-Yl]-2,5-Bis(2-Phenylethyl)Hexanediamide",GQKBYZPVKVXMJL-LAFNQVRVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
106483,6vxx,DB00398,-9.8,Sorafenib,MLDQJTXFUGDVEO-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127510,6w4h,DB06240,-9.8,Tariquidar,LGGHDPFKSSRQNS-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
72810,6m2n,DB01177,-9.8,Idarubicin,XDXDZDZNSLXDNA-TZNDIEGXSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
106509,6vxx,DB00430,-9.8,Cefpiramide,PWAUCHMQEXVFJR-PMAPCBKXSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
101623,6vxs,DB05984,-9.8,RAF-265,YABJJWZLRMPFSI-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
78738,6m2n,DB12200,-9.8,Tivantinib,UCEQXRCJXIVODC-PMACEKPBSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
124989,6w4h,DB01897,-9.8,2-(2f-Benzothiazolyl)-5-Styryl-3-(4f-Phthalhydrazidyl)Tetrazolium Chloride,BEIGFKLRGRRJJA-JLHYYAGUSA-O,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
106819,6vxx,DB01329,-9.8,Cefoperazone,GCFBRXLSHGKWDP-XCGNWRKASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113824,6vxx,DB12134,-9.8,Gepotidacin,PZFAZQUREQIODZ-LJQANCHMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113710,6vxx,DB11794,-9.8,Berzosertib,JZCWLJDSIRUGIN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113693,6vxx,DB11772,-9.8,Pilaralisib,QINPEPAQOBZPOF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113614,6vxx,DB11652,-9.8,Tucatinib,SDEAXTCZPQIFQM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112774,6vxx,DB07827,-9.8,"4-{[1-METHYL-2,4-DIOXO-6-(3-PHENYLPROP-1-YN-1-YL)-1,4-DIHYDROQUINAZOLIN-3(2H)-YL]METHYL}BENZOIC ACID",FLTYDFYSVZBKOB-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112368,6vxx,DB07025,-9.8,3-(5-{[4-(AMINOMETHYL)PIPERIDIN-1-YL]METHYL}-1H-INDOL-2-YL)QUINOLIN-2(1H)-ONE,KBIHHEGEALBUMT-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140697,6w9c,DB15133,-9.8,Tepotinib,AHYMHWXQRWRBKT-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
113826,6vxx,DB12137,-9.8,GSK-256066,JFHROPTYMMSOLG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112325,6vxx,DB06976,-9.8,"1-(5-OXO-2,3,5,9B-TETRAHYDRO-1H-PYRROLO[2,1-A]ISOINDOL-9-YL)-3-(5-PYRROLIDIN-2-YL-1H-PYRAZOL-3-YL)-UREA",IWOOJEZSDPRYAZ-WFASDCNBSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112259,6vxx,DB06896,-9.8,"1-(4-fluorophenyl)-N-[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]-2-oxo-1,2-dihydropyridine-3-carboxamide",OBSFXHDOLBYWRJ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140656,6w9c,DB13053,-9.8,CP-195543,NZQDWKCNBOELAI-KSFYIVLOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
69784,6lxt,DB11691,-9.8,Naldemedine,AXQACEQYCPKDMV-RZAWKFBISA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
112049,6vxx,DB06176,-9.8,Romidepsin,OHRURASPPZQGQM-GCCNXGTGSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111968,6vxx,DB04971,-9.8,Reglitazar,QBQLYIISSRXYKL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
69893,6lxt,DB11851,-9.8,Bafetinib,ZGBAJMQHJDFTQJ-DEOSSOPVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
140613,6w9c,DB12535,-9.8,AC-430,DCRWIATZWHLIPN-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
112287,6vxx,DB06925,-9.8,3-(2-AMINOQUINAZOLIN-6-YL)-4-METHYL-N-[3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE,YEIASMOUYNOXGA-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113912,6vxx,DB12267,-9.8,Brigatinib,AILRADAXUVEEIR-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113922,6vxx,DB12279,-9.8,OBP-801,XFLBOEMFLGLWFF-HDXRNPEWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113945,6vxx,DB12307,-9.8,Foretinib,CXQHYVUVSFXTMY-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114801,6vxx,DB14885,-9.8,PF-05180999,CLGCHUKGBICQTE-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
63476,6lxt,DB00320,-9.8,Dihydroergotamine,LUZRJRNZXALNLM-JGRZULCMSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
63837,6lxt,DB00762,-9.8,Irinotecan,UWKQSNNFCGGAFS-XIFFEERXSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
63892,6lxt,DB00826,-9.8,Natamycin,NCXMLFZGDNKEPB-FFPOYIOWSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
64221,6lxt,DB01199,-9.8,Tubocurarine,JFJZZMVDLULRGK-URLMMPGGSA-O,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
114748,6vxx,DB14766,-9.8,Etrasimod,MVGWUTBTXDYMND-QGZVFWFLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114623,6vxx,DB13874,-9.8,Enasidenib,DYLUUSLLRIQKOE-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114286,6vxx,DB13240,-9.8,Cymarin,XQCGNURMLWFQJR-ZNDDOCHDSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114236,6vxx,DB13138,-9.8,Neladenoson bialanate,WESNEIGKOAXSGX-VXKWHMMOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
64747,6lxt,DB01933,-9.8,7-Hydroxystaurosporine,PBCZSGKMGDDXIJ-HQCWYSJUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
114215,6vxx,DB13104,-9.8,X-396,ONPGOSVDVDPBCY-CQSZACIVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114140,6vxx,DB12794,-9.8,p-Quaterphenyl,GPRIERYVMZVKTC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114049,6vxx,DB12651,-9.8,Bardoxolone,TXGZJQLMVSIZEI-UQMAOPSPSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
64916,6lxt,DB02152,-9.8,K-252a,KOZFSFOOLUUIGY-SOLYNIJKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
114034,6vxx,DB12627,-9.8,GSK-1292263,AYJRTVVIBJSSKN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113992,6vxx,DB12558,-9.8,AEE-788,OONFNUWBHFSNBT-HXUWFJFHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
66522,6lxt,DB04289,-9.8,Genz-10850,YYMZSGIXLQPFAC-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
111134,6vxx,DB03044,-9.8,1-(5-Tert-Butyl-2-P-Tolyl-2h-Pyrazol-3-Yl)-3-[4-(2-Morpholin-4-Yl-Ethoxy)-Naphthalen-1-Yl]-Urea,MVCOAUNKQVWQHZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110916,6vxx,DB02573,-9.8,"2'-Deoxycytidine-2'-Deoxyadenosine-3',5'-Monophosphate",LYWWDKIADIGKTH-IDMWBNCISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110868,6vxx,DB02510,-9.8,'5'-O-(N-(L-Prolyl)-Sulfamoyl)Adenosine,LKVJEMXWEODCAY-JVEUSOJLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
69929,6lxt,DB11904,-9.8,Flumatinib,BJCJYEYYYGBROF-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
71665,6lxt,DB15039,-9.8,ITI-214,BBIPVJCGIASXJB-PKTZIBPZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
126341,6w4h,DB03712,-9.8,RU85053,CEKLBQMULVLLTD-VMPREFPWSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
108399,6vxx,DB07716,-9.8,"(4Z)-2,8:7,12:11,15:14,18:17,22-PENTAANHYDRO-4,5,6,9,10,13,19,20,21-NONADEOXY-D-ARABINO-D-ALLO-D-ALLO-DOCOSA-4,9,20-TRIENITOL",VDRIXSJOPKVWKM-HXGIDPQASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
126542,6w4h,DB03966,-9.8,Clorobiocin,FJAQNRBDVKIIKK-LFLQOBSNSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
126785,6w4h,DB04289,-9.8,Genz-10850,YYMZSGIXLQPFAC-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
108049,6vxx,DB06755,-9.8,Beta carotene,OENHQHLEOONYIE-JLTXGRSLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107996,6vxx,DB06677,-9.8,Clazosentan,LFWCJABOXHSRGC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107894,6vxx,DB05470,-9.8,VX-702,FYSRKRZDBHOFAY-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107693,6vxx,DB04190,-9.8,Inhibitor Bea425,AHAVBKNGKPWROK-UMFPTGFGSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107521,6vxx,DB03712,-9.8,RU85053,CEKLBQMULVLLTD-VMPREFPWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72087,6m2n,DB00320,-9.8,Dihydroergotamine,LUZRJRNZXALNLM-JGRZULCMSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
140238,6w9c,DB15416,-9.8,PX-102,XBUXXJUEBFDQHD-NHCUHLMSSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
72176,6m2n,DB00430,-9.8,Cefpiramide,PWAUCHMQEXVFJR-PMAPCBKXSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
140229,6w9c,DB15403,-9.8,Ziritaxestat,REQQVBGILUTQNN-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
107137,6vxx,DB02336,-9.8,RU83876,WCMLXBUNHNAMNH-UIOOFZCWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106984,6vxx,DB01831,-9.8,Tryptophanyl-5'amp,IFQVDHDRFCKAAW-SQIXAUHQSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127373,6w4h,DB05553,-9.8,Regrelor,NXHAXEBZOXCDKD-XIXRRVGJSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
140403,6w9c,DB05983,-9.8,Bardoxolone methyl,WPTTVJLTNAWYAO-KPOXMGGZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
72210,6m2n,DB00471,-9.8,Montelukast,UCHDWCPVSPXUMX-TZIWLTJVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
108424,6vxx,DB07975,-9.8,"2-({[3,5-DIFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)CYCLOPENT-1-ENE-1-CARBOXYLIC ACID",VTGXLCZUWFYELR-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
7104,6lzg,DB03231,-9.8,"3-(5-Amino-7-oxo-3,7-dihydro-2H-[1,2,3]triazolo[4,5-d]pyrimidin-2-yl)-N-(2-{[2-(hydroxymethyl)phenyl]sulfanyl}benzyl)benzamide",IXDQOBDHBWEZOH-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
110844,6vxx,DB02483,-9.8,Etheno-Nad,JCDBQDNBEQHDHK-BSLNIGMPSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110537,6vxx,DB01908,-9.8,RU85493,MWEWSHNGVWABKG-SVBPBHIXSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110496,6vxx,DB01669,-9.8,Virginiamycin M1,DAIKHDNSXMZDCU-FQTGFAPKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110318,6vxx,DB01459,-9.8,Bezitramide,FLKWNFFCSSJANB-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109743,6vxx,DB15245,-9.8,Olorofim,SUFPWYYDCOKDLL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
70436,6lxt,DB12651,-9.8,Bardoxolone,TXGZJQLMVSIZEI-UQMAOPSPSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
109096,6vxx,DB12369,-9.8,Sotrastaurin,OAVGBZOFDPFGPJ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109026,6vxx,DB11923,-9.8,Decoglurant,DMJHZVARRXJSEG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109004,6vxx,DB11894,-9.8,Efatutazone,JCYNMRJCUYVDBC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108974,6vxx,DB11847,-9.8,Cadazolid,XWFCFMXQTBGXQW-GOSISDBHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108937,6vxx,DB11424,-9.8,Lufenuron,PWPJGUXAGUPAHP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108881,6vxx,DB11273,-9.8,Dihydroergocornine,SEALOBQTUQIVGU-QNIJNHAOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108696,6vxx,DB08815,-9.8,Lurasidone,PQXKDMSYBGKCJA-CVTJIBDQSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108657,6vxx,DB08512,-9.8,"6-amino-2-[(1-naphthylmethyl)amino]-3,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",MCEZMMDIEXECTI-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
70734,6lxt,DB13113,-9.8,JNJ-38877605,JRWCBEOAFGHNNU-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
108600,6vxx,DB08445,-9.8,"(3R,4S)-1-[6-(6-METHOXYPYRIDIN-3-YL)PYRIMIDIN-4-YL]-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE",IFKWHPAWYJARQJ-DYVFJYSZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108577,6vxx,DB08418,-9.8,"(4aS,4bR,10bS,12aS)-12a-methyl-1,3-dioxo-2-(pyridin-3-ylmethyl)-1,2,3,4,4a,4b,5,6,10b,11,12,12a-dodecahydronaphtho[2,1-f]isoquinolin-8-yl sulfamate",LSJKARAMQNGZDF-YOEKFXIASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108451,6vxx,DB08006,-9.8,"N-anthracen-2-yl-5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7-amine",OXYDLVAOXASTMW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
97653,6m71,DB15343,-9.8,HM-43239,FZLSDZZNPXXBBB-KDURUIRLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
87503,6m3m,DB12412,-9.8,Gemigliptin,ZWPRRQZNBDYKLH-VIFPVBQESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
96678,6m71,DB13307,-9.8,Proscillaridin,MYEJFUXQJGHEQK-ALRJYLEOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
138700,6w9c,DB12137,-9.8,GSK-256066,JFHROPTYMMSOLG-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
77443,6m2n,DB08386,-9.8,2-{[4-(4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline,VRWJZGHUCOFGPZ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77444,6m2n,DB08387,-9.8,2-{[4-(1-methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline,AZEXWHKOMMASPA-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77492,6m2n,DB08445,-9.8,"(3R,4S)-1-[6-(6-METHOXYPYRIDIN-3-YL)PYRIMIDIN-4-YL]-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE",IFKWHPAWYJARQJ-DYVFJYSZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77495,6m2n,DB08448,-9.8,"(4aS)-5-[(2,4-diaminopteridin-6-yl)methyl]-4a,5-dihydro-2H-dibenzo[b,f]azepin-8-ol",PCBWLKUEKANDCL-INIZCTEOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
82564,6m3m,DB02705,-9.8,"6-[N-(1-Isopropyl-1,2,3,4-Tetrahydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine",DARQQJKHXPXSRO-QFIPXVFZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
82506,6m3m,DB02629,-9.8,Inhibitor Bea403,LYHLPPXMBKMSSZ-JQFCFGFHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136155,6w9c,DB06677,-9.8,Clazosentan,LFWCJABOXHSRGC-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
82450,6m3m,DB02551,-9.8,"6-[N-(4-Ethyl-1,2,3,4-Tetrahydro-6-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine",LVNMYQLXKMSQTG-AWEZNQCLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
82293,6m3m,DB02360,-9.8,Bis-Napthyl Beta-Ketophosphonic Acid,OFHMUASCSJJNNA-JOCHJYFZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
82265,6m3m,DB02323,-9.8,EM-1745,CKSDYJASHNGOOS-KTXOUVACSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
138578,6w9c,DB11870,-9.8,RG-4733,OJPLJFIFUQPSJR-INIZCTEOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
82261,6m3m,DB02319,-9.8,"5,6-Dihydroxy-Nadp",LRAVAOPKUBJONV-IVCJQJMGSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
82155,6m3m,DB02177,-9.8,1-Acetyl-4-(4-{4-[(2-Ethoxyphenyl)Thio]-3-Nitrophenyl}Pyridin-2-Yl)Piperazine,GKGJFUXSTSUKPB-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
77864,6m2n,DB08911,-9.8,Trametinib,LIRYPHYGHXZJBZ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138539,6w9c,DB11814,-9.8,PF-03882845,XNULRSOGWPFPBL-REWPJTCUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136409,6w9c,DB07084,-9.8,"N-(6,7,9,10,17,18,20,21-octahydrodibenzo[b,k][1,4,7,10,13,16]hexaoxacyclooctadecin-2-yl)acetamide",YHKGWOJTUMJPNW-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
81647,6m3m,DB01514,-9.8,Furazabol,RGLLOUBXMOGLDQ-IVEVATEUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81572,6m3m,DB01426,-9.8,Ajmaline,CJDRUOGAGYHKKD-HEFSZTOGSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81546,6m3m,DB01392,-9.8,Yohimbine,BLGXFZZNTVWLAY-SCYLSFHTSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81535,6m3m,DB01357,-9.8,Mestranol,IMSSROKUHAOUJS-MJCUULBUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83309,6m3m,DB03723,-9.8,2'-Deoxy-Thymidine-Beta-L-Rhamnose,ZOSQFDVXNQFKBY-CGAXJHMRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136502,6w9c,DB07189,-9.8,"(1S,3R,6S)-4-oxo-6-{4-[(2-phenylquinolin-4-yl)methoxy]phenyl}-5-azaspiro[2.4]heptane-1-carboxylic acid",BFZXMIUWGSTUAL-ZSOKXDGFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
77326,6m2n,DB08237,-9.8,2'-deoxy-N-(naphthalen-1-ylmethyl)guanosine 5'-(dihydrogen phosphate),COMPKRGNHXOXMN-GVDBMIGSSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
135803,6w9c,DB05075,-9.8,TG-100801,JMGXJHWTVBGOKG-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
84767,6m3m,DB06879,-9.8,"5-(4'-AMINO-1'-ETHYL-5',8'-DIFLUORO-1'H-SPIRO[PIPERIDINE-4,2'-QUINAZOLINE]-1-YLCARBONYL)PICOLINONITRILE",QCFIRACCCDFXIP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
134633,6w9c,DB03331,-9.8,"N-Naphthalen-1-Ylmethyl-2'-[3,5-Dimethoxybenzamido]-2'-Deoxy-Adenosine",OARVXDFNTLYMCJ-JVUUKAHWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
84617,6m3m,DB06626,-9.8,Axitinib,RITAVMQDGBJQJZ-FMIVXFBMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
134797,6w9c,DB03571,-9.8,"3-(5-Amino-7-Hydroxy-[1,2,3]Triazolo[4,5-D]Pyrimidin-2-Yl)-N-(3,5-Dichlorobenzyl)-Benzamide",JMQTXEWNXSPEKX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
84587,6m3m,DB06558,-9.8,Tezosentan,TUYWTLTWNJOZNY-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84583,6m3m,DB06543,-9.8,Astaxanthin,MQZIGYBFDRPAKN-UWFIBFSHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84537,6m3m,DB06435,-9.8,Tarazepide,CZPILLBHPRAPCB-AREMUKBSSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
135210,6w9c,DB04131,-9.8,"10-(4-Dimethylamino-5-Hydroxy-6-Methyl-Tetrahydro-Pyran-2-Yloxy)-8-Ethyl-1,8,11-Trihydroxy-7,8,9,10-Tetrahydro-Naphthacene-5,12-Dione",BLGDWFJQIHBUJY-NWJGULHDSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
84402,6m3m,DB05990,-9.8,Obeticholic acid,ZXERDUOLZKYMJM-ZWECCWDJSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84320,6m3m,DB05511,-9.8,Piclidenoson,HUJXGQILHAUCCV-MOROJQBDSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84313,6m3m,DB05470,-9.8,VX-702,FYSRKRZDBHOFAY-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84225,6m3m,DB04971,-9.8,Reglitazar,QBQLYIISSRXYKL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
76946,6m2n,DB07800,-9.8,N-(2-(((5-CHLORO-2-PYRIDINYL)AMINO)SULFONYL)PHENYL)-4-(2-OXO-1(2H)-PYRIDINYL)BENZAMIDE,MIJGLXFQYBTIFY-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138805,6w9c,DB12289,-9.8,Darexaban,IJNIQYINMSGIPS-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
76977,6m2n,DB07833,-9.8,"N-(3-cyanophenyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)-4-biphenylcarboxamide",PMMLSQFPBFKLHH-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
135603,6w9c,DB04685,-9.8,"1-{(2S,5S)-4-FLUORO-5-[(TRITYLOXY)METHYL]TETRAHYDROFURAN-2-YL}PYRIMIDINE-2,4(1H,3H)-DIONE",GJNIPWYJQUGERM-BFLUCZKCSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
135634,6w9c,DB04739,-9.8,4-[(4-METHYL-1-PIPERAZINYL)METHYL]-N-[3-[[4-(3-PYRIDINYL)-2-PYRIMIDINYL]AMINO]PHENYL]-BENZAMIDE,JHMBUEWQJDGKGS-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
84094,6m3m,DB04764,-9.8,[4-(3-AMINOMETHYL-PHENYL)-PIPERIDIN-1-YL]-(5-PHENETHYL- PYRIDIN-3-YL)-METHANONE,CCLHROFBSWWOQO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84016,6m3m,DB04652,-9.8,Corticosterone,OMFXVFTZEKFJBZ-HJTSIMOOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83857,6m3m,DB04452,-9.8,Aminoquinuride,HOUSDILKOJMENG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83828,6m3m,DB04408,-9.8,Ncs-Chromophore,QZGIWPZCWHMVQL-UIYAJPBUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
138714,6w9c,DB12158,-9.8,Filorexant,NPFDWHQSDBWQLH-QZTJIDSGSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138468,6w9c,DB11704,-9.8,Adomeglivant,FASLTMSUPQDLIB-MHZLTWQESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
81326,6m3m,DB01067,-9.8,Glipizide,ZJJXGWJIGJFDTL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81281,6m3m,DB01016,-9.8,Glyburide,ZNNLBTZKUZBEKO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80279,6m2n,DB15047,-9.8,BMS-919373,XGKULQQVQWCASY-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80254,6m2n,DB14989,-9.8,Umbralisib,IUVCFHHAEHNCFT-INIZCTEOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137182,6w9c,DB07994,-9.8,"N-3-[5-(1H-INDOL-6-YL)-2-(PYRIDIN-2-YLMETHOXY)BENZYL]PYRIDINE-2,3-DIAMINE",KMBPJSHPAXOXBT-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137221,6w9c,DB08036,-9.8,"6,7,12,13-tetrahydro-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazol-5-one",MEXUTNIFSHFQRG-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
80169,6m2n,DB14774,-9.8,Balipodect,KVHRYLNQDWXAGI-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78542,6m2n,DB11907,-9.8,Rociletinib,HUFOZJXAKZVRNJ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79945,6m2n,DB14017,-9.8,H3B-8800,YOIQWBAHJZGRFW-WVRLKXNASA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79648,6m2n,DB13556,-9.8,Sulfamazone,BGLHAKAJGYLSOX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79410,6m2n,DB13240,-9.8,Cymarin,XQCGNURMLWFQJR-ZNDDOCHDSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79309,6m2n,DB13061,-9.8,MLN8054,HHFBDROWDBDFBR-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137487,6w9c,DB08358,-9.8,"2-(2-QUINOLIN-3-YLPYRIDIN-4-YL)-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE",OWFLADWRSCINST-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
78592,6m2n,DB11984,-9.8,Letaxaban,GEHAEMCVKDPMKO-HXUWFJFHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79166,6m2n,DB12843,-9.8,Oleandrin,JLPDBLFIVFSOCC-XYXFTTADSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79082,6m2n,DB12706,-9.8,Seletalisib,LNLJHGXOFYUARS-OAQYLSRUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78605,6m2n,DB12002,-9.8,AZD-4818,HVTUHSABWJPWNK-SFHVURJKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78978,6m2n,DB12540,-9.8,Lecozotan,NRPQELCNMADTOZ-OAQYLSRUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137796,6w9c,DB08730,-9.8,3-FLUORO-5-MORPHOLIN-4-YL-N-[1-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-6-YL]BENZAMIDE,CPFBZMFUCGHBAP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137813,6w9c,DB08747,-9.8,"(11R)-10-acetyl-11-(2,4-dichlorophenyl)-6-hydroxy-3,3-dimethyl-2,3,4,5,10,11-hexahydro-1H-dibenzo[b,e][1,4]diazepin-1-one",JJTPPGUNMJMPLY-QFIPXVFZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
78686,6m2n,DB12121,-9.8,Entospletinib,XSMSNFMDVXXHGJ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78861,6m2n,DB12371,-9.8,Siponimod,KIHYPELVXPAIDH-HNSNBQBZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78773,6m2n,DB12247,-9.8,AZD-4547,VRQMAABPASPXMW-HDICACEKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78516,6m2n,DB11871,-9.8,PF-00610355,YPHDIMUXXABSSO-YTTGMZPUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80349,6m2n,DB15189,-9.8,Birabresib,GNMUEVRJHCWKTO-FQEVSTJZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80360,6m2n,DB15205,-9.8,Capromorelin,KVLLHLWBPNCVNR-SKCUWOTOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137010,6w9c,DB07796,-9.8,"(3ASR,4RS,8ASR,8BRS)-4-(2-(4-FLUOROBENZYL)-1,3-DIOXODEACAHYDROPYRROLO[3,4-A] PYRROLIZIN-4-YL)BENZAMIDINE",GJYCQHGTXMVIBG-MUGJNUQGSA-O,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
81125,6m3m,DB00838,-9.8,Clocortolone,YMTMADLUXIRMGX-RFPWEZLHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81008,6m3m,DB00699,-9.8,Nicergoline,YSEXMKHXIOCEJA-FVFQAYNVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81003,6m3m,DB00694,-9.8,Daunorubicin,STQGQHZAVUOBTE-VGBVRHCVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136783,6w9c,DB07528,-9.8,3-(2-aminoquinazolin-6-yl)-4-methyl-1-[3-(trifluoromethyl)phenyl]pyridin-2(1H)-one,HXUZQEYFKAZBPX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
80883,6m3m,DB00549,-9.8,Zafirlukast,YEEZWCHGZNKEEK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
78397,6m2n,DB11694,-9.8,Ilorasertib,WPHKIQPVPYJNAX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80860,6m3m,DB00522,-9.8,Bentiromide,SPPTWHFVYKCNNK-FQEVSTJZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
78404,6m2n,DB11703,-9.8,Acalabrutinib,WDENQIQQYWYTPO-IBGZPJMESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78420,6m2n,DB11734,-9.8,Fedovapagon,RUOLFWZIFNQQGH-DEOSSOPVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78445,6m2n,DB11769,-9.8,Funapide,NEBUOXBYNAHKFV-NRFANRHFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76256,6m2n,DB06997,-9.8,"2-(4-fluorophenyl)-N-{[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]carbamoyl}acetamide",BMPOCDJEXAXXEZ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78447,6m2n,DB11772,-9.8,Pilaralisib,QINPEPAQOBZPOF-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78450,6m2n,DB11775,-9.8,PF-03758309,AYCPARAPKDAOEN-LJQANCHMSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80799,6m3m,DB00444,-9.8,Teniposide,NRUKOCRGYNPUPR-QBPJDGROSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80556,6m3m,DB00157,-9.8,NADH,BOPGDPNILDQYTO-NNYOXOHSSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80537,6m3m,DB00137,-9.8,Lutein,KBPHJBAIARWVSC-RGZFRNHPSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80494,6m2n,DB02524,-9.8,"2',3'-O-{4-[Hydroxy(oxido)-lambda5-azanylidene]-2,6-dinitro-2,5-cyclohexadiene-1,1-diyl}adenosine 5'-(tetrahydrogen triphosphate)",XFMMHXLUHKBKQE-UHEGPQQHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80465,6m2n,DB15414,-9.8,CM-4307,MLDQJTXFUGDVEO-FIBGUPNXSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80416,6m2n,DB15310,-9.8,Vactosertib,FJCDSQATIJKQKA-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80407,6m2n,DB15295,-9.8,Tenalisib,HDXDQPRPFRKGKZ-INIZCTEOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78491,6m2n,DB11830,-9.8,Mocetinostat,HRNLUBSXIHFDHP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80394,6m2n,DB15273,-9.8,VS-4718,IGUBBWJDMLCRIK-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78448,6m2n,DB11773,-9.8,BMS-903452,OGIAVRWXUPYGGC-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
84927,6m3m,DB07063,-9.8,"{3-[(4,5,7-TRIFLUORO-1,3-BENZOTHIAZOL-2-YL)METHYL]-1H-INDOL-1-YL}ACETIC ACID",KYHVTMFADJNSGS-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84934,6m3m,DB07072,-9.8,"(1S,2R,5S)-5-[3-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7(8H)-YL]-2-(2,4,5-TRIFLUOROPHENYL)CYCLOHEXANAMINE",CNKRZILQBKJWDS-WMFXKJRFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
134166,6w9c,DB02651,-9.8,"{[2-(1h-1,2,3-Benzotriazol-1-Yl)-2-(3,4-Difluorophenyl)Propane-1,3-Diyl]Bis[4,1-Phenylene(Difluoromethylene)]}Bis(Phosphonic Acid)",BTAGTGWPDROBMG-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
130575,6w4h,DB12457,-9.8,Rimegepant,KRNAOFGYEFKHPB-ANJVHQHFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
88413,6m3m,DB13766,-9.8,Lidoflazine,ZBIAKUMOEKILTF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
139920,6w9c,DB14555,-9.8,Ursadiol,RTLXJEJRLWILSU-GWNGJUQLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
88216,6m3m,DB13499,-9.8,Cefsulodin,SYLKGLMBLAAGSC-QLVMHMETSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88195,6m3m,DB13471,-9.8,Nalfurafine,XGZZHZMWIXFATA-UEZBDDGYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
73895,6m2n,DB02629,-9.8,Inhibitor Bea403,LYHLPPXMBKMSSZ-JQFCFGFHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
87918,6m3m,DB13059,-9.8,PF-03814735,RYYNGWLOYLRZLK-RBUKOAKNSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87906,6m3m,DB13040,-9.8,Gandotinib,SQSZANZGUXWJEA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87891,6m3m,DB13019,-9.8,Henatinib,MCTXSDCWFQAGFS-UEXNTNOUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87878,6m3m,DB12999,-9.8,MK-6186,FZBAOOQVQXATRL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87863,6m3m,DB12972,-9.8,Sepranolone,AURFZBICLPNKBZ-FZCSVUEKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
74203,6m2n,DB03044,-9.8,1-(5-Tert-Butyl-2-P-Tolyl-2h-Pyrazol-3-Yl)-3-[4-(2-Morpholin-4-Yl-Ethoxy)-Naphthalen-1-Yl]-Urea,MVCOAUNKQVWQHZ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
74251,6m2n,DB03104,-9.8,RU82129,NKMPOVPTYDXGEC-MNRBYUMSSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
74318,6m2n,DB03199,-9.8,4-Methoxy-E-Rhodomycin T,XSSVYBYWQBNYOH-QJIXERIWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
87807,6m3m,DB12888,-9.8,Ezutromid,KSGCNXAZROJSNW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87711,6m3m,DB12729,-9.8,ASP-3026,MGGBYMDAPCCKCT-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87705,6m3m,DB12720,-9.8,Nivocasan,VYFGDLGHHBUDTQ-ZLGUVYLKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87656,6m3m,DB12649,-9.8,Ibipinabant,AXJQVVLKUYCICH-OAQYLSRUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87641,6m3m,DB12623,-9.8,Taprenepag,MFFBXYNKZHTCEY-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
131300,6w4h,DB13556,-9.8,Sulfamazone,BGLHAKAJGYLSOX-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
87590,6m3m,DB12542,-9.8,GSK-356278,AWDJJMXJUOHGLC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
73817,6m2n,DB02524,-9.8,"2',3'-O-{4-[Hydroxy(oxido)-??5-azanylidene]-2,6-dinitro-2,5-cyclohexadiene-1,1-diyl}adenosine 5'-(tetrahydrogen triphosphate)",XFMMHXLUHKBKQE-UHEGPQQHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
88450,6m3m,DB13814,-9.8,Talampicillin,SOROUYSPFADXSN-SUWVAFIASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88568,6m3m,DB14037,-9.8,Madecassic acid,PRAUVHZJPXOEIF-AOLYGAPISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
73650,6m2n,DB02319,-9.8,"5,6-Dihydroxy-Nadp",LRAVAOPKUBJONV-IVCJQJMGSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
72913,6m2n,DB01339,-9.8,Vecuronium,BGSZAXLLHYERSY-XQIGCQGXSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
129095,6w4h,DB08386,-9.8,2-{[4-(4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline,VRWJZGHUCOFGPZ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
95769,6m71,DB11913,-9.8,LY-2090314,HRJWTAWVFDCTGO-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
72918,6m2n,DB01349,-9.8,Tasosartan,ADXGNEYLLLSOAR-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
92855,6m71,DB05075,-9.8,TG-100801,JMGXJHWTVBGOKG-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
89076,6m3m,DB15414,-9.8,CM-4307,MLDQJTXFUGDVEO-FIBGUPNXSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
89066,6m3m,DB15399,-9.8,BMS-754807,LQVXSNNAFNGRAH-QHCPKHFHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
89049,6m3m,DB15356,-9.8,SLV-334,LOFDNSDPZTVIIO-VPUSJEBWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
130113,6w4h,DB11791,-9.8,Capmatinib,LIOLIMKSCNQPLV-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
88917,6m3m,DB15099,-9.8,GW-468816,XDKRVNKVAKCFGW-WXWBBQJKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87578,6m3m,DB12523,-9.8,Mizolastine,PVLJETXTTWAYEW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88905,6m3m,DB15075,-9.8,4-demethyl-4-cholesteryloxycarbonylpenclomedine,ZJUUIXYKTPSIOH-LEZJFEBPSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
130173,6w4h,DB11877,-9.8,Basmisanil,VCGRFBXVSFAGGA-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
88857,6m3m,DB14942,-9.8,BMS-986141,KEEBLYWBELVGPQ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
73364,6m2n,DB01940,-9.8,Balanol Analog 2,SQLYTJZXRRDERK-ISKFKSNPSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
88821,6m3m,DB14876,-9.8,TAS-116,NVVPMZUGELHVMH-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
73435,6m2n,DB02033,-9.8,"N-(3-Cyclopropyl(5,6,7,8,9,10-Hexahydro-2-Oxo-2h-Cycloocta[B]Pyran-3-Yl)Methyl)Phenylbenzensulfonamide",GDRNWAKVNIROCG-DEOSSOPVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
130380,6w4h,DB12185,-9.8,Exatecan,ZVYVPGLRVWUPMP-FYSMJZIKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
88697,6m3m,DB14632,-9.8,Prednisolone tebutate,HUMXXHTVHHLNRO-KAJVQRHHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
73593,6m2n,DB02241,-9.8,"8-Benzyl-2-Hydroperoxy-2-(4-Hydroxy-Benzyl)-6-(4-Hydroxy-Phenyl)-2h-Imidazo[1,2-a]Pyrazin-3-One",HOSWCJDTHOAORT-SANMLTNESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
88666,6m3m,DB14539,-9.8,Hydrocortisone acetate,ALEXXDVDDISNDU-JZYPGELDSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88600,6m3m,DB14097,-9.8,13-cis-12-(3'-Carboxyphenyl)retinoic acid,XKKDQOHDTASHCE-PAZAWXFKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
130157,6w4h,DB11852,-9.8,Tegobuvir,XBEQSQDCBSKCHJ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
97023,6m71,DB13764,-9.8,Monoxerutin,MBHXKZDTQCSVPM-BDAFLREQSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
78724,6m2n,DB12180,-9.8,Apitolisib,YOVVNQKCSKSHKT-HNNXBMFYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
87356,6m3m,DB12211,-9.8,PSI-697,DIEPFYNZGUUVHD-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86110,6m3m,DB08454,-9.8,N-(5-METHYL-1H-PYRAZOL-3-YL)-2-PHENYLQUINAZOLIN-4-AMINE,JYCUVOXSZBECAY-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86103,6m3m,DB08445,-9.8,"(3R,4S)-1-[6-(6-METHOXYPYRIDIN-3-YL)PYRIMIDIN-4-YL]-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE",IFKWHPAWYJARQJ-DYVFJYSZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86016,6m3m,DB08339,-9.8,"6-(2,6-DICHLOROPHENYL)-2-{[3-(HYDROXYMETHYL)PHENYL]AMINO}-8-METHYLPYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE",ZIQFYVPVJZEOFS-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85816,6m3m,DB08097,-9.8,"2-(2,6-DIFLUOROPHENOXY)-N-(2-FLUOROPHENYL)-9-ISOPROPYL-9H-PURIN-8-AMINE",OGWSGDLIXOEZJG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85801,6m3m,DB08079,-9.8,AMG-208,HEAIZQNMNCHNFD-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
75846,6m2n,DB06212,-9.8,Tolvaptan,GYHCTFXIZSNGJT-XMMPIXPASA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
85783,6m3m,DB08058,-9.8,"4-[3-(1,4-diazepan-1-ylcarbonyl)-4-fluorobenzyl]phthalazin-1(2H)-one",HGEPGGJUGUMFHT-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
75899,6m2n,DB06347,-9.8,Cenisertib,KSOVGRCOLZZTPF-QMKUDKLTSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
85726,6m3m,DB07994,-9.8,"N-3-[5-(1H-INDOL-6-YL)-2-(PYRIDIN-2-YLMETHOXY)BENZYL]PYRIDINE-2,3-DIAMINE",KMBPJSHPAXOXBT-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85599,6m3m,DB07847,-9.8,6-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-(4-MORPHOLINYL)-2-OXO ETHYL]-2-OXO-3-PYRROLIDINYL}-2-NAPHTHALENESULFONAMIDE,ICLOZQFWTRAYPX-LIRRHRJNSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85571,6m3m,DB07814,-9.8,Gibberellic acid,IXORZMNAPKEEDV-OBDJNFEBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85544,6m3m,DB07786,-9.8,"1-((1R,2S)-1-{2-[2-(4-CHLOROPHENYL)-1,3-BENZOXAZOL-7-YL]ETHYL}-2-HYDROXYPROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE",SMFRBBHLVBWHGB-DJJJIMSYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
75951,6m2n,DB06486,-9.8,Enzastaurin,AXRCEOKUDYDWLF-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75975,6m2n,DB06555,-9.8,Siramesine,XWAONOGAGZNUSF-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75976,6m2n,DB06558,-9.8,Tezosentan,TUYWTLTWNJOZNY-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
85250,6m3m,DB07435,-9.8,"1,2,3-TRIHYDROXY-1,2,3,4-TETRAHYDROBENZO[A]PYRENE",GFANZDFKCCJYRF-NSISKUIASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
139123,6w9c,DB12892,-9.8,MGB-BP-3,OEKXCVYZBVOWBR-BQYQJAHWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
76105,6m2n,DB06809,-9.8,Plerixafor,YIQPUIGJQJDJOS-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
133866,6w9c,DB02258,-9.8,SR11254,RNZIUDLOJHVHLZ-VYIQYICTSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
84991,6m3m,DB07138,-9.8,Neflamapimod,VEPKQEUBKLEPRA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
76171,6m2n,DB06896,-9.8,"1-(4-fluorophenyl)-N-[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]-2-oxo-1,2-dihydropyridine-3-carboxamide",OBSFXHDOLBYWRJ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
86139,6m3m,DB08489,-9.8,"N4-HYDROXY-2-ISOBUTYL-N1-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.013,18]NONADECA-12(19),13,15,17-TETRAEN-10-YL)-SUCCINAMIDE",GCBPAPVOMPJQHK-NQIIRXRSSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
75686,6m2n,DB05412,-9.8,Talmapimod,ZMELOYOKMZBMRB-DLBZAZTESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
86239,6m3m,DB08607,-9.8,"(5R)-5-(4-{[(2R)-6-HYDROXY-2,5,7,8-TETRAMETHYL-3,4-DIHYDRO-2H-CHROMEN-2-YL]METHOXY}BENZYL)-1,3-THIAZOLIDINE-2,4-DIONE",GXPHKUHSUJUWKP-NTKDMRAZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86360,6m3m,DB08749,-9.8,3-(2-AMINO-6-BENZOYLQUINAZOLIN-3(4H)-YL)-N-CYCLOHEXYL-N-METHYLPROPANAMIDE,KTRFBFMYAJOXLG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
75012,6m2n,DB04131,-9.8,"10-(4-Dimethylamino-5-Hydroxy-6-Methyl-Tetrahydro-Pyran-2-Yloxy)-8-Ethyl-1,8,11-Trihydroxy-7,8,9,10-Tetrahydro-Naphthacene-5,12-Dione",BLGDWFJQIHBUJY-NWJGULHDSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
87353,6m3m,DB12207,-9.8,Verdinexor,OPAKEJZFFCECPN-XQRVVYSFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87339,6m3m,DB12185,-9.8,Exatecan,ZVYVPGLRVWUPMP-FYSMJZIKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
75205,6m2n,DB04392,-9.8,"Bishydroxy[2h-1-Benzopyran-2-One,1,2-Benzopyrone]",HIZKPJUTKKJDGA-BETUJISGSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
87308,6m3m,DB12134,-9.8,Gepotidacin,PZFAZQUREQIODZ-LJQANCHMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
75225,6m2n,DB04421,-9.8,Nicotinamide Adenine Dinucleotide 3-Pentanone Adduct,BZJFKYRGSZWSLT-YLIVDTKOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
87215,6m3m,DB12001,-9.8,Abemaciclib,UZWDCWONPYILKI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87153,6m3m,DB11907,-9.8,Rociletinib,HUFOZJXAKZVRNJ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87118,6m3m,DB11855,-9.8,Revefenacin,FYDWDCIFZSGNBU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87111,6m3m,DB11845,-9.8,Lucitanib,CUDVHEFYRIWYQD-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87438,6m3m,DB12318,-9.8,BMS-599626,LUJZZYWHBDHDQX-QFIPXVFZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
139542,6w9c,DB13610,-9.8,Flumedroxone,CDZJOBWKHSYNMO-SCUQKFFVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
132105,6w4h,DB15396,-9.8,PF-114,SLIVDYMORZGPLW-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
87077,6m3m,DB11796,-9.8,Fostemsavir,SWMDAPWAQQTBOG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87059,6m3m,DB11773,-9.8,BMS-903452,OGIAVRWXUPYGGC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86969,6m3m,DB11637,-9.8,Delamanid,XDAOLTSRNUSPPH-XMMPIXPASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86820,6m3m,DB11262,-9.8,Bisoctrizole,FQUNFJULCYSSOP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86732,6m3m,DB09295,-9.8,Talniflumate,ANMLJLFWUCQGKZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
132473,6w9c,DB00471,-9.8,Montelukast,UCHDWCPVSPXUMX-TZIWLTJVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
86572,6m3m,DB09042,-9.8,Tedizolid phosphate,QCGUSIANLFXSGE-GFCCVEGCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86516,6m3m,DB08970,-9.8,Fluprednidene,YVHXHNGGPURVOS-SBTDHBFYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86458,6m3m,DB08882,-9.8,Linagliptin,LTXREWYXXSTFRX-QGZVFWFLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87082,6m3m,DB11804,-9.8,AZD-5672,SCXSQUUTGCWHFU-WJOKGBTCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
63260,6crv,DB15450,-9.8,PF-05105679,BXNMZRPTQFVRFA-QGZVFWFLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80231,6m2n,DB14916,-9.8,Selonsertib,YIDDLAAKOYYGJG-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
59388,6crv,DB07404,-9.8,"(1-HYDROXY-1-PHOSPHONO-2-[1,1';3',1'']TERPHENYL-3-YL-ETHYL)-PHOSPHONIC ACID",YXQQNSYZOQHKHD-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55048,6crv,DB00547,-9.8,Desoximetasone,VWVSBHGCDBMOOT-IIEHVVJPSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57722,6crv,DB04044,-9.8,4-{2-[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid,NAQUAVBNIYTIIS-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27402,6cs2,DB06938,-9.8,4-[[2-[[4-chloro-3-(trifluoromethyl)phenyl]amino]-3H-benzimidazol-5-yl]oxy]-N-methyl-pyridine-2-carboxamide,ZJLSMLDOCGOURY-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
60480,6crv,DB08703,-9.8,"12-(2-hydroxyethyl)-2-(1-methylethoxy)-13,14-dihydronaphtho[2,1-a]pyrrolo[3,4-c]carbazol-5(12H)-one",FGKKIHITEICGMN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27307,6cs2,DB00619,-9.8,Imatinib,KTUFNOKKBVMGRW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
59513,6crv,DB07550,-9.8,"2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(1-OXIDO-2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUOROPHENYL)METHYL]ACETAMIDE",ZIGSBBKEPNQXRG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60452,6crv,DB08664,-9.8,({3-[1-(4-HYDROXY-2-OXO-2H-CHROMEN-3-YL)-PROPYL]-PHENYLCARBAMOYL}-METHYL)-CARBAMIC ACID TERT-BUTYL ESTER,QUQQVMVIWCUYFV-KRWDZBQOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
164623,7bv1,DB08220,-9.8,"(8alpha,10alpha,13alpha,17beta)-17-[(4-hydroxyphenyl)carbonyl]androsta-3,5-diene-3-carboxylic acid",RPNNXCYIESWDSC-JRZBRKEGSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
63008,6crv,DB14917,-9.8,Ceralasertib,DTTJKLNXNZAVSM-JYCIKRDWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
26831,6cs2,DB05454,-9.8,Paliroden,CNEWKIDCGDXBDE-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
62817,6crv,DB14218,-9.8,Telotristat,NCLGDOBQAWBXRA-PGRDOPGGSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
63018,6crv,DB14937,-9.8,MK-8666,CODQKEMYZZKQAE-QPVYNBJUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58430,6crv,DB05212,-9.8,HE3286,JJKOQZHWYLMASZ-FJWDNACWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61475,6crv,DB12137,-9.8,GSK-256066,JFHROPTYMMSOLG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61257,6crv,DB11819,-9.8,ASP-4058,NJNXCJPSMWKXHO-VIFPVBQESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60485,6crv,DB08708,-9.8,"N-cyclohexyl-3-[3-(trifluoromethyl)phenyl][1,2,4]triazolo[4,3-b]pyridazin-6-amine",XYYDXQCAYXOGQT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62889,6crv,DB14661,-9.8,Loperamide oxide,KXVSBTJVTUVNPM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61647,6crv,DB12385,-9.8,10-hydroxycamptothecin,HAWSQZCWOQZXHI-FQEVSTJZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165709,7bv1,DB12690,-9.8,LY-2584702,FYXRSVDHGLUMHB-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60224,6crv,DB08391,-9.8,"6,7-DIMETHOXY-4-[(3R)-3-(QUINOXALIN-2-YLOXY)PYRROLIDIN-1-YL]QUINAZOLINE",UBIIFKJMNRPNMT-CQSZACIVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28469,6cs2,DB08058,-9.8,"4-[3-(1,4-diazepan-1-ylcarbonyl)-4-fluorobenzyl]phthalazin-1(2H)-one",HGEPGGJUGUMFHT-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
59389,6crv,DB07405,-9.8,"1-(6-CYANO-3-PYRIDYLCARBONYL)-5',8'-DIFLUOROSPIRO[PIPERIDINE-4,2'(1'H)-QUINAZOLINE]-4'-AMINE",GIZYIOOBBUHOBS-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61459,6crv,DB12116,-9.8,Epigallocatechin gallate,WMBWREPUVVBILR-WIYYLYMNSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28450,6cs2,DB08036,-9.8,"6,7,12,13-tetrahydro-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazol-5-one",MEXUTNIFSHFQRG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
59403,6crv,DB07422,-9.8,(2S)-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]-3-(pentafluorophenoxy)propanamide,MMNRWNREMUMYQG-INIZCTEOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62669,6crv,DB13919,-9.8,Candesartan,HTQMVQVXFRQIKW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58404,6crv,DB05039,-9.8,Indacaterol,QZZUEBNBZAPZLX-QFIPXVFZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
54965,6crv,DB00443,-9.8,Betamethasone,UREBDLICKHMUKA-DVTGEIKXSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
158054,7bv1,DB00320,-9.8,Dihydroergotamine,LUZRJRNZXALNLM-JGRZULCMSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
54966,6crv,DB00444,-9.8,Teniposide,NRUKOCRGYNPUPR-QBPJDGROSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60523,6crv,DB08747,-9.8,"(11R)-10-acetyl-11-(2,4-dichlorophenyl)-6-hydroxy-3,3-dimethyl-2,3,4,5,10,11-hexahydro-1H-dibenzo[b,e][1,4]diazepin-1-one",JJTPPGUNMJMPLY-QFIPXVFZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31903,6cs2,DB15009,-9.8,PF-04937319,MASKQITXHVYVFL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
60521,6crv,DB08745,-9.8,4-[[(1E)-2-(4-CHLOROPHENYL)ETHENYL]SULFONYL]-1-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]PIPERAZINONE,QLHUDNKWOSQSMK-CXUHLZMHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55651,6crv,DB01251,-9.8,Gliquidone,LLJFMFZYVVLQKT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61195,6crv,DB11732,-9.8,Lasmiditan,XEDHVZKDSYZQBF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58569,6crv,DB06011,-9.8,AMG-222,NVSWJKWHLUTHLP-CPJSRVTESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61458,6crv,DB12115,-9.8,AZD-9164,FNYFFCOCVNTJCD-NNMXADRKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60368,6crv,DB08561,-9.8,"BENZYL 6-BENZYL-5,7-DIOXO-6,7-DIHYDRO-5H-[1,3]THIAZOLO[3,2-C]PYRIMIDINE-2-CARBOXYLATE",PLBINCOCFGQAJM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59606,6crv,DB07665,-9.8,"N-[2-(carbamimidamidooxy)ethyl]-2-{6-cyano-3-[(2,2-difluoro-2-pyridin-2-ylethyl)amino]-2-fluorophenyl}acetamide",STHCHQXQLDMISY-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59788,6crv,DB07872,-9.8,5-chloro-N-[(3R)-1-(2-{[2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl]amino}-2-oxoethyl)pyrrolidin-3-yl]thiophene-2-carboxamide,IYGIXVNAMZPBDK-CQSZACIVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61288,6crv,DB11865,-9.8,Brivanib alaninate,LTEJRLHKIYCEOX-OCCSQVGLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163614,7bv1,DB04859,-9.8,Zanapezil,PMBLXLOXUGVTGB-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
62661,6crv,DB13874,-9.8,Enasidenib,DYLUUSLLRIQKOE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27015,6cs2,DB06248,-9.8,Amelubant,SBVYURPQULDJTI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
58157,6crv,DB04623,-9.8,"2-ETHOXYETHYL (2S,3S)-4-((S)-2-BENZYL-3-OXO-4-((3AR,8R,8AS)-2-OXO-3,3A,8,8A-TETRAHYDRO-2H-INDENO[1,2-D]OXAZOL-8-YL)-2,3-DIHYDRO-1H-PYRROL-2-YL)-3-HYDROXY-1-PHENYLBUTAN-2-YLCARBAMATE",CGBRFCVAMLJVEA-ZGURCIGKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165558,7bv1,DB12457,-9.8,Rimegepant,KRNAOFGYEFKHPB-ANJVHQHFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
55778,6crv,DB01471,-9.8,Bolasterone,IVFYLRMMHVYGJH-VLOLGRDOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60251,6crv,DB08426,-9.8,"THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [2-OXO-1-(1H-PYRROLO[2,3-C]PYRIDIN-2-YLMETHYL)-PYRROLIDIN-3-YL]-AMIDE",PLXOQMHGHDZMSX-AWEZNQCLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60249,6crv,DB08423,-9.8,[5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL][3-(PIPERIDIN-4-YLOXY)PHENYL]METHANONE,QKZZJXRGCHXIAI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
159765,7bv1,DB06486,-9.8,Enzastaurin,AXRCEOKUDYDWLF-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
58146,6crv,DB04608,-9.8,"9-HYDROXY-4-PHENYL-6H-PYRROLO[3,4-C]CARBAZOLE-1,3-DIONE",IAUZTOZLTFSMIE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58071,6crv,DB04514,-9.8,Phosphoric Acid-2'-[2'-Deoxy-Uridine]Ester-5'-Guanosine Ester,DFYLLEBFVZTKHD-VMIOUTBZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59761,6crv,DB07843,-9.8,5-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1-BENZOTHIOPHENE-2-SULFONAMIDE,LTJNKFUIOOJXNJ-WFASDCNBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30574,6cs2,DB12673,-9.8,ATX-914,ALANRBCCCQEPFZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
61576,6crv,DB12285,-9.8,Verubecestat,YHYKUSGACIYRML-KRWDZBQOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59712,6crv,DB07789,-9.8,"1-[5-methyl-2-(trifluoromethyl)furan-3-yl]-3-[(2Z)-5-(2-{[6-(1H-1,2,4-triazol-3-ylamino)pyrimidin-4-yl]amino}ethyl)-1,3-thiazol-2(3H)-ylidene]urea",KNTGXMNWVXZIMW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58231,6crv,DB04724,-9.8,"(S)-2-((S)-3-ISOBUTYL-2,5-DIOXO-4-QUINOLIN-3-YLMETHYL-[1,4]DIAZEPAN-1YL)-N-METHYL-3-NAPHTALEN-2-YL-PROPIONAMIDE",COVPLULNDBDXTN-KYJUHHDHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59709,6crv,DB07786,-9.8,"1-((1R,2S)-1-{2-[2-(4-CHLOROPHENYL)-1,3-BENZOXAZOL-7-YL]ETHYL}-2-HYDROXYPROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE",SMFRBBHLVBWHGB-DJJJIMSYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30328,6cs2,DB12341,-9.8,LY-2456302,ZHPMYDSXGRRERG-DEOSSOPVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
55275,6crv,DB00820,-9.8,Tadalafil,WOXKDUGGOYFFRN-IIBYNOLFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56619,6crv,DB02555,-9.8,SP4160,VCXMTWSYQSVWRK-AREMUKBSSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60355,6crv,DB08546,-9.8,"4-[(3AS,4R,7R,8AS,8BR)-2-(1,3-BENZODIOXOL-5-YLMETHYL)-7-HYDROXY-1,3-DIOXODECAHYDROPYRROLO[3,4-A]PYRROLIZIN-4-YL]BENZENECARBOXIMIDAMIDE",CETLUACQMGBMFH-ZALSBGIRSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
149288,6w9q,DB15308,-9.8,Ridinilazole,UHQFBTAJFNVZIV-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
58352,6crv,DB04882,-9.8,Edotecarin,QMVPQBFHUJZJCS-NTKFZFFISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60194,6crv,DB08354,-9.8,"2-(4-CHLOROBENZYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE",QCVULERVJOYHCP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62877,6crv,DB14648,-9.8,Acetyl simvastatin,OHVWRJDVJRNCPE-BIKFJBPRSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55163,6crv,DB00687,-9.8,Fludrocortisone,AAXVEMMRQDVLJB-BULBTXNYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60330,6crv,DB08519,-9.8,"N-4-(3-methyl-1H-indazol-6-yl)-N-2-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine",SQQAPOSROFWHIB-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165522,7bv1,DB12228,-9.8,Telcagepant,CGDZXLJGHVKVIE-DNVCBOLYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
63117,6crv,DB15168,-9.8,Cilofexor,KZSKGLFYQAYZCO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
63039,6crv,DB15013,-9.8,TAK-243,KJDAGXLMHXUAGV-DGWLBADLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58330,6crv,DB04853,-9.8,Binodenoson,XJFMHMFFBSOEPR-DNZQAUTHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55236,6crv,DB00773,-9.8,Etoposide,VJJPUSNTGOMMGY-MRVIYFEKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55254,6crv,DB00796,-9.8,Candesartan cilexetil,GHOSNRCGJFBJIB-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30368,6cs2,DB12394,-9.8,Eleclazine,YNUAEEJQYHYLMS-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
61442,6crv,DB12095,-9.8,Telotristat ethyl,MDSQOJYHHZBZKA-GBXCKJPGSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
32114,6cs2,DB15391,-9.8,Elenbecestat,AACUJFVOHGRMTR-DPXNYUHVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
28477,6cs2,DB08068,-9.8,N-[4-CHLORO-3-(PYRIDIN-3-YLOXYMETHYL)-PHENYL]-3-FLUORO-,YQJVDUKATDECHF-ICSRJNTNSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
57542,6crv,DB03802,-9.8,"1-[4-(Octahydro-Pyrido[1,2-a]Pyrazin-2-Yl)-Phenyl]-2-Phenyl-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol",ZGHFWBDHZZKWSI-LITSAYRRSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55804,6crv,DB01501,-9.8,Difenoxin,UFIVBRCCIRTJTN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
26566,6cs2,DB04727,-9.8,"N-(4-{4-AMINO-6-[4-(METHYLOXY)PHENYL]FURO[2,3-D]PYRIMIDIN-5-YL}PHENYL)-N'-[2-FLUORO-5-(TRIFLUOROMETHYL)PHENYL]UREA",FGZIONRFHVNRJB-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
32004,6cs2,DB15191,-9.8,MAX-40279,AVIOBQFPAGEICQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
63232,6crv,DB15401,-9.8,Danicopan,PIBARDGJJAGJAJ-NQIIRXRSSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58787,6crv,DB06635,-9.8,Otamixaban,PFGVNLZDWRZPJW-OPAMFIHVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
25771,6cs2,DB03777,-9.8,Rbt205 Inhibitor,QMGUOJYZJKLOLH-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
33939,6cs2,T3D0624,-9.8,Coronene,VPUGDVKSAQVFFS-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
58782,6crv,DB06626,-9.8,Axitinib,RITAVMQDGBJQJZ-FMIVXFBMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59109,6crv,DB07084,-9.8,"N-(6,7,9,10,17,18,20,21-octahydrodibenzo[b,k][1,4,7,10,13,16]hexaoxacyclooctadecin-2-yl)acetamide",YHKGWOJTUMJPNW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29952,6cs2,DB11851,-9.8,Bafetinib,ZGBAJMQHJDFTQJ-DEOSSOPVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
33946,6cs2,T3D0632,-9.8,Anthanthrene,YFIJJNAKSZUOLT-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
62986,6crv,DB14876,-9.8,TAS-116,NVVPMZUGELHVMH-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
156111,6wiq,DB12424,-9.8,MK-3207,AZAANWYREOQRFB-SETSBSEESA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
55891,6crv,DB01604,-9.8,Pivampicillin,ZEMIJUDPLILVNQ-ZXFNITATSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
63065,6crv,DB15063,-9.8,Inarigivir soproxil,CJCYTUJOSMYXLE-JDLSZIHUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60897,6crv,DB09295,-9.8,Talniflumate,ANMLJLFWUCQGKZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61402,6crv,DB12036,-9.8,Naquotinib,QKDCLUARMDUUKN-XMMPIXPASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62042,6crv,DB12998,-9.8,PF-00217830,QGNOXTFZOLDODX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28833,6cs2,DB08454,-9.8,N-(5-METHYL-1H-PYRAZOL-3-YL)-2-PHENYLQUINAZOLIN-4-AMINE,JYCUVOXSZBECAY-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
58975,6crv,DB06925,-9.8,3-(2-AMINOQUINAZOLIN-6-YL)-4-METHYL-N-[3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE,YEIASMOUYNOXGA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27302,6cs2,DB06834,-9.8,"N-(2-hydroxy-1,1-dimethylethyl)-1-methyl-3-(1H-pyrrolo[2,3-b]pyridin-2-yl)-1H-indole-5-carboxamide",XZRYCTLOGNCQDG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
160795,7bv1,DB11737,-9.8,Icotinib,QQLKULDARVNMAL-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
55724,6crv,DB01411,-9.8,Pranlukast,NBQKINXMPLXUET-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62061,6crv,DB13024,-9.8,MK-8245,UJEAABFSXKCSGI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31830,6cs2,DB14845,-9.8,Filgotinib,RIJLVEAXPNLDTC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
160877,7bv1,DB11852,-9.8,Tegobuvir,XBEQSQDCBSKCHJ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
58868,6crv,DB06786,-9.8,Halcinonide,MUQNGPZZQDCDFT-JNQJZLCISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60882,6crv,DB09272,-9.8,Eluxadoline,QFNHIDANIVGXPE-FNZWTVRRSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62969,6crv,DB14845,-9.8,Filgotinib,RIJLVEAXPNLDTC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59013,6crv,DB06976,-9.8,"1-(5-OXO-2,3,5,9B-TETRAHYDRO-1H-PYRROLO[2,1-A]ISOINDOL-9-YL)-3-(5-PYRROLIDIN-2-YL-1H-PYRAZOL-3-YL)-UREA",IWOOJEZSDPRYAZ-WFASDCNBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57305,6crv,DB03478,-9.8,2'-O-Acetyl Adenosine-5-Diphosphoribose,BFNOPXRXIQJDHO-DLFWLGJNSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55723,6crv,DB01410,-9.8,Ciclesonide,LUKZNWIVRBCLON-GXOBDPJESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61712,6crv,DB12474,-9.8,Lynestrenol,YNVGQYHLRCDXFQ-XGXHKTLJSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29236,6cs2,DB08907,-9.8,Canagliflozin,XTNGUQKDFGDXSJ-ZXGKGEBGSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
54778,6crv,DB00220,-9.8,Nelfinavir,QAGYKUNXZHXKMR-HKWSIXNMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29800,6cs2,DB11652,-9.8,Tucatinib,SDEAXTCZPQIFQM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
27768,6cs2,DB07321,-9.8,"2,5-DICHLORO-N-[5-METHOXY-7-(6-METHOXYPYRIDIN-3-YL)-1,3-BENZOXAZOL-2-YL]BENZENESULFONAMIDE",KOKQLKWXOFRTHE-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
32703,6cs2,T3D3609,-9.8,Microcystin-RR,JIGDOBKZMULDHS-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
60632,6crv,DB08899,-9.8,Enzalutamide,WXCXUHSOUPDCQV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
54830,6crv,DB00278,-9.8,Argatroban,KXNPVXPOPUZYGB-IOVMHBDKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61743,6crv,DB12523,-9.8,Mizolastine,PVLJETXTTWAYEW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59925,6crv,DB08031,-9.8,"N-[(13-CYCLOHEXYL-6,7-DIHYDROINDOLO[1,2-D][1,4]BENZOXAZEPIN-10-YL)CARBONYL]-2-METHYL-L-ALANINE",LNQWELVSNCYKDU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62998,6crv,DB14898,-9.8,Retagliptin,WIIAMRXFUJLYEF-SNVBAGLBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31889,6cs2,DB14943,-9.8,LGH-447,VRQXRVAKPDCRCI-ZNMIVQPWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
60590,6crv,DB08827,-9.8,Lomitapide,MBBCVAKAJPKAKM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56016,6crv,DB01764,-9.8,Dalfopristin,SUYRLXYYZQTJHF-VMBLUXKRSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59937,6crv,DB08044,-9.8,ABT-341,NVVSPGQEXMJZIR-BMIGLBTASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62997,6crv,DB14896,-9.8,Selitrectinib,OEBIHOVSAMBXIB-SJKOYZFVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
54783,6crv,DB00227,-9.8,Lovastatin,PCZOHLXUXFIOCF-BXMDZJJMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31883,6cs2,DB01100,-9.8,Pimozide,YVUQSNJEYSNKRX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
61172,6crv,DB11692,-9.8,Pavinetant,QYTBBBAHNIWFOD-NRFANRHFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61777,6crv,DB12574,-9.8,LY-295501,VAMFSFIPDOODFH-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58634,6crv,DB06240,-9.8,Tariquidar,LGGHDPFKSSRQNS-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
54911,6crv,DB00378,-9.8,Dydrogesterone,JGMOKGBVKVMRFX-HQZYFCCVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
24651,6cs2,DB00320,-9.8,Dihydroergotamine,LUZRJRNZXALNLM-JGRZULCMSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
58697,6crv,DB06420,-9.8,Annamycin,CIDNKDMVSINJCG-GKXONYSUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27389,6cs2,DB06925,-9.8,3-(2-AMINOQUINAZOLIN-6-YL)-4-METHYL-N-[3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE,YEIASMOUYNOXGA-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
58692,6crv,DB06409,-9.8,Morphine glucuronide,GNJCUHZOSOYIEC-GAROZEBRSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61323,6crv,DB11913,-9.8,LY-2090314,HRJWTAWVFDCTGO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
164064,7bv1,DB07029,-9.8,"4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMIDAZOL-1-YL)PHENOXY]-6-METHYLPYRIMIDINE",QQBNDYARFVOEGW-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
31871,6cs2,DB14916,-9.8,Selonsertib,YIDDLAAKOYYGJG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
62289,6crv,DB13371,-9.8,Difenpiramide,PWHROYKAGRUWDQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165754,7bv1,DB12760,-9.8,GW-493838,ZQYJPMPXQLNTPQ-QCUYGVNKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
63056,6crv,DB15048,-9.8,Licogliflozin,XFJAMQQAAMJFGB-ZQGJOIPISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
98460,6vxs,DB00966,-9.7,Telmisartan,RMMXLENWKUUMAY-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
96492,6m71,DB13003,-9.7,Cortivazol,RKHQGWMMUURILY-UHRZLXHJSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
78468,6m2n,DB11799,-9.7,Bictegravir,SOLUWJRYJLAZCX-LYOVBCGYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61315,6crv,DB11903,-9.7,GW842166,TWQYWUXBZHPIIV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138463,6w9c,DB11697,-9.7,Pacritinib,HWXVIOGONBBTBY-ONEGZZNKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
55522,6crv,DB01100,-9.7,Pimozide,YVUQSNJEYSNKRX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
97494,6m71,DB15034,-9.7,PRI-724,VHOZWHQPEJGPCC-AZXNYEMZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
61376,6crv,DB11995,-9.7,Avatrombopag,OFZJKCQENFPZBH-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
13457,6lzg,DB15399,-9.7,BMS-754807,LQVXSNNAFNGRAH-QHCPKHFHSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
78466,6m2n,DB11796,-9.7,Fostemsavir,SWMDAPWAQQTBOG-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78349,6m2n,DB11616,-9.7,Pirarubicin,KMSKQZKKOZQFFG-YXRRJAAWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
98259,6vxs,DB00734,-9.7,Risperidone,RAPZEAPATHNIPO-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
97920,6vxs,DB00320,-9.7,Dihydroergotamine,LUZRJRNZXALNLM-JGRZULCMSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
138436,6w9c,DB11663,-9.7,Pictilisib,LHNIIDJUOCFXAP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138384,6w9c,DB11526,-9.7,Masitinib,WJEOLQLKVOPQFV-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
63249,6crv,DB15435,-9.7,BMS-986158,KGERZPVQIRYWRK-GDLZYMKVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
14070,6lzg,T3D3688,-9.7,Ergocristine,HEFIYUQVAZFDEE-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
61297,6crv,DB11877,-9.7,Basmisanil,VCGRFBXVSFAGGA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61117,6crv,DB11591,-9.7,Bilastine,ACCMWZWAEFYUGZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
93080,6m71,DB06240,-9.7,Tariquidar,LGGHDPFKSSRQNS-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
61111,6crv,DB11562,-9.7,Bicuculline,IYGYMKDQCDOMRE-ZWKOTPCHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
129509,6w4h,DB08901,-9.7,Ponatinib,PHXJVRSECIGDHY-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
78752,6m2n,DB12222,-9.7,Lurtotecan,RVFGKBWWUQOIOU-NDEPHWFRSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
92775,6m71,DB04852,-9.7,Implitapide,AMNXBQPRODZJQR-DITALETJSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
78797,6m2n,DB12282,-9.7,Defactinib,FWLMVFUGMHIOAA-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
25202,6cs2,DB03082,-9.7,6-[(Z)-Amino(Imino)Methyl]-N-[4-(Aminomethyl)Phenyl]-4-(Pyrimidin-2-Ylamino)-2-Naphthamide,CSWQJKHBMACTGB-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
90411,6m71,DB01698,-9.7,Rutin,IKGXIBQEEMLURG-NVPNHPEKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
156101,6wiq,DB12411,-9.7,R-428,KXMZDGSRSGHMMK-VWLOTQADSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
89616,6m71,DB00696,-9.7,Ergotamine,XCGSFFUVFURLIX-VFGNJEKYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
78859,6m2n,DB12368,-9.7,AZD-3839,MRXBCEQZNKUUIP-DEOSSOPVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
60923,6crv,DB09371,-9.7,Norethynodrel,ICTXHFFSOAJUMG-SLHNCBLASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78869,6m2n,DB12382,-9.7,R-306465,MUTBJZVSRNUIHA-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
55701,6crv,DB01357,-9.7,Mestranol,IMSSROKUHAOUJS-MJCUULBUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
89088,6m3m,DB15442,-9.7,Trilaciclib,PDGKHKMBHVFCMG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
89072,6m3m,DB15408,-9.7,Silmitasertib,MUOKSQABCJCOPU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
78967,6m2n,DB12523,-9.7,Mizolastine,PVLJETXTTWAYEW-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78983,6m2n,DB12548,-9.7,Sparsentan,WRFHGDPIDHPWIQ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78717,6m2n,DB12165,-9.7,Presatovir,GOFXWTVKPWJNGD-UWJYYQICSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78691,6m2n,DB12127,-9.7,Sultamicillin,OPYGFNJSCUDTBT-PMLPCWDUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137994,6w9c,DB08995,-9.7,Diosmin,GZSOSUNBTXMUFQ-YFAPSIMESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
129334,6w4h,DB08674,-9.7,"(20S)-19,20,21,22-TETRAHYDRO-19-OXO-5H-18,20-ETHANO-12,14-ETHENO-6,10-METHENO-18H-BENZ[D]IMIDAZO[4,3-K][1,6,9,12]OXATRIAZA-CYCLOOCTADECOSINE-9-CARBONITRILE",USPFJPDEADLGIG-HSZRJFAPSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
138280,6w9c,DB11273,-9.7,Dihydroergocornine,SEALOBQTUQIVGU-QNIJNHAOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
96206,6m71,DB12550,-9.7,Taladegib,SZBGQDXLNMELTB-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96145,6m71,DB12457,-9.7,Rimegepant,KRNAOFGYEFKHPB-ANJVHQHFSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
164410,7bv1,DB07800,-9.7,N-(2-(((5-CHLORO-2-PYRIDINYL)AMINO)SULFONYL)PHENYL)-4-(2-OXO-1(2H)-PYRIDINYL)BENZAMIDE,MIJGLXFQYBTIFY-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
78507,6m2n,DB11855,-9.7,Revefenacin,FYDWDCIFZSGNBU-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61283,6crv,DB11855,-9.7,Revefenacin,FYDWDCIFZSGNBU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61269,6crv,DB11832,-9.7,Crenolanib,DYNHJHQFHQTFTP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61267,6crv,DB11830,-9.7,Mocetinostat,HRNLUBSXIHFDHP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
96081,6m71,DB12368,-9.7,AZD-3839,MRXBCEQZNKUUIP-DEOSSOPVSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96341,6m71,DB12760,-9.7,GW-493838,ZQYJPMPXQLNTPQ-QCUYGVNKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96060,6m71,DB12336,-9.7,GDC-0917,HSHPBORBOJIXSQ-HARLFGEKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95861,6m71,DB12054,-9.7,BQ-123,VYCMAAOURFJIHD-PJNXIOHISA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
84637,6m3m,DB06677,-9.7,Clazosentan,LFWCJABOXHSRGC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
138132,6w9c,DB09215,-9.7,Droxicam,OEHFRZLKGRKFAS-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
78583,6m2n,DB11966,-9.7,BMS-986094,YFXGICNMLCGLHJ-RSKRLRQZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61202,6crv,DB11740,-9.7,MK-1775,BKWJAKQVGHWELA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61199,6crv,DB11737,-9.7,Icotinib,QQLKULDARVNMAL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61183,6crv,DB11706,-9.7,Raxatrigine,JESCETIFNOFKEU-SJORKVTESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61178,6crv,DB11701,-9.7,Amenamevir,MNHNIVNAFBSLLX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78632,6m2n,DB12044,-9.7,MK-0893,DNTVJEMGHBIUMW-IBGZPJMESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
129143,6w4h,DB08444,-9.7,"3-[2-bromo-4-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)phenoxy]-5-methylbenzonitrile",YYGZQXRLQMFHDH-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
61397,6crv,DB12025,-9.7,Triptolide,DFBIRQPKNDILPW-CIVMWXNOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138663,6w9c,DB12085,-9.7,LCL-161,UFPFGVNKHCLJJO-SSKFGXFMSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
78078,6m2n,DB09230,-9.7,Azelnidipine,ZKFQEACEUNWPMT-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75900,6m2n,DB06350,-9.7,Elinogrel,LGSDFTPAICUONK-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
107847,6vxx,DB04696,-9.7,"4-CHLORO-3',3''-DIBROMOPHENOL-1,8-NAPHTHALEIN",GFGZCXHXQCQRFP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61750,6crv,DB12535,-9.7,AC-430,DCRWIATZWHLIPN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127116,6w4h,DB04739,-9.7,4-[(4-METHYL-1-PIPERAZINYL)METHYL]-N-[3-[[4-(3-PYRIDINYL)-2-PYRIMIDINYL]AMINO]PHENYL]-BENZAMIDE,JHMBUEWQJDGKGS-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
75933,6m2n,DB06448,-9.7,Lonafarnib,DHMTURDWPRKSOA-RUZDIDTESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75941,6m2n,DB06469,-9.7,Lestaurtinib,UIARLYUEJFELEN-DMVVYWCZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61742,6crv,DB12522,-9.7,Toreforant,FCRFVPZAXGJLPW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
54849,6crv,DB00301,-9.7,Flucloxacillin,UIOFUWFRIANQPC-JKIFEVAISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61737,6crv,DB12513,-9.7,Omaveloxolone,RJCWBNBKOKFWNY-IDPLTSGASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28499,6cs2,DB08091,-9.7,3-FLUORO-5-MORPHOLIN-4-YL-N-[3-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-5-YL]BENZAMIDE,HIUFYIOMUILESI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
76004,6m2n,DB06624,-9.7,Taranabant,QLYKJCMUNUWAGO-GAJHUEQPSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
54892,6crv,DB00354,-9.7,Buclizine,MOYGZHXDRJNJEP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
139224,6w9c,DB13164,-9.7,Olmutinib,FDMQDKQUTRLUBU-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
61725,6crv,DB12494,-9.7,SGI-1776,MHXGEROHKGDZGO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107207,6vxx,DB02705,-9.7,"6-[N-(1-Isopropyl-1,2,3,4-Tetrahydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine",DARQQJKHXPXSRO-QFIPXVFZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107132,6vxx,DB02329,-9.7,Carbenoxolone,OBZHEBDUNPOCJG-WBXJDKIVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107079,6vxx,DB02258,-9.7,SR11254,RNZIUDLOJHVHLZ-VYIQYICTSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
11186,6lzg,DB11618,-9.7,Zorubicin,FBTUMDXHSRTGRV-BJISBDEGSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
61679,6crv,DB12426,-9.7,Bitopertin,YUUGYIUSCYNSQR-LBPRGKRZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106883,6vxx,DB01698,-9.7,Rutin,IKGXIBQEEMLURG-NVPNHPEKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
54972,6crv,DB00450,-9.7,Droperidol,RMEDXOLNCUSCGS-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106859,6vxx,DB01410,-9.7,Ciclesonide,LUKZNWIVRBCLON-GXOBDPJESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
139042,6w9c,DB12756,-9.7,TAK-901,WKDACQVEJIVHMZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
106851,6vxx,DB01395,-9.7,Drospirenone,METQSPRSQINEEU-HXCATZOESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
164949,7bv1,DB08995,-9.7,Diosmin,GZSOSUNBTXMUFQ-YFAPSIMESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
106824,6vxx,DB01337,-9.7,Pancuronium,GVEAYVLWDAFXET-XGHATYIMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
139119,6w9c,DB12886,-9.7,GSK-1521498,WIEDUMBCZQRGSY-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
61645,6crv,DB12382,-9.7,R-306465,MUTBJZVSRNUIHA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
54769,6crv,DB00210,-9.7,Adapalene,LZCDAPDGXCYOEH-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
126877,6w4h,DB04421,-9.7,Nicotinamide Adenine Dinucleotide 3-Pentanone Adduct,BZJFKYRGSZWSLT-YLIVDTKOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
125494,6w4h,DB02555,-9.7,SP4160,VCXMTWSYQSVWRK-AREMUKBSSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
74637,6m2n,DB03642,-9.7,Benzofuran-2-Carboxylic Acid {(S)-3-Methyl-1-[3-Oxo-1-(Pyridin-2-Ylsulfonyl)Azepan-4-Ylcarbamoyl]Butyl}Amide,VBPPNJCVXGAZDD-PMACEKPBSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
108982,6vxx,DB11863,-9.7,Alvelestat,QNQZWEGMKJBHEM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
33078,6cs2,T3D4056,-9.7,Debromoaplysiatoxin,REAZZDPREXHWNV-HJUJCDCNSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
108876,6vxx,DB11262,-9.7,Bisoctrizole,FQUNFJULCYSSOP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
74888,6m2n,DB03962,-9.7,Nicotinamide 8-Bromo-Adenine Dinucleotide Phosphate,MDKMTCCUJSRQGW-NAJQWHGHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
28769,6cs2,DB08384,-9.7,2-({4-[4-(pyridin-4-ylmethyl)-1H-pyrazol-3-yl]phenoxy}methyl)quinoline,RQDDHVVAAJVVKM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
61983,6crv,DB12903,-9.7,DEBIO-1347,BEMNJULZEQTDJY-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
139633,6w9c,DB13728,-9.7,Halometasone,GGXMRPUKBWXVHE-MIHLVHIWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
28747,6cs2,DB08358,-9.7,"2-(2-QUINOLIN-3-YLPYRIDIN-4-YL)-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE",OWFLADWRSCINST-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
75032,6m2n,DB04158,-9.7,"6-(Adenosine Tetraphosphate-Methyl)-7,8-Dihydropterin",ZKRKFZJAQKKHKL-SUGPNEFASA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
125903,6w4h,DB03104,-9.7,RU82129,NKMPOVPTYDXGEC-MNRBYUMSSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
75828,6m2n,DB06178,-9.7,Talotrexin,NYQPLPNEESYGNO-IBGZPJMESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
125999,6w4h,DB03231,-9.7,"3-(5-Amino-7-oxo-3,7-dihydro-2H-[1,2,3]triazolo[4,5-d]pyrimidin-2-yl)-N-(2-{[2-(hydroxymethyl)phenyl]sulfanyl}benzyl)benzamide",IXDQOBDHBWEZOH-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
108525,6vxx,DB08091,-9.7,3-FLUORO-5-MORPHOLIN-4-YL-N-[3-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-5-YL]BENZAMIDE,HIUFYIOMUILESI-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
33945,6cs2,T3D0631,-9.7,Ovalene,LSQODMMMSXHVCN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
147742,6w9q,DB12381,-9.7,Merestinib,QHADVLVFMKEIIP-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
75568,6m2n,DB04872,-9.7,Osanetant,DZOJBGLFWINFBF-UMSFTDKQSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61869,6crv,DB12719,-9.7,Turofexorate isopropyl,INASOKQDNHHMRE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108358,6vxx,DB07666,-9.7,"(3R,4S)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE",OAWGQHXWGXOUKV-BEFAXECRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108292,6vxx,DB07586,-9.7,"5-(4-METHYL-BENZOYLAMINO)-BIPHENYL-3,4'-DICARBOXYLIC ACID 3-DIMETHYLAMIDE-4'-HYDROXYAMIDE",DOPFUKKMSDUVTQ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75655,6m2n,DB05220,-9.7,Alisertib,ZLHFILGSQDJULK-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75739,6m2n,DB05667,-9.7,Levoketoconazole,XMAYWYJOQHXEEK-ZEQKJWHPSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
139312,6w9c,DB13307,-9.7,Proscillaridin,MYEJFUXQJGHEQK-ALRJYLEOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
54723,6crv,DB00157,-9.7,NADH,BOPGDPNILDQYTO-NNYOXOHSSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108034,6vxx,DB06732,-9.7,beta-Naphthoflavone,OUGIDAPQYNCXRA-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108551,6vxx,DB08386,-9.7,2-{[4-(4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline,VRWJZGHUCOFGPZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138999,6w9c,DB12690,-9.7,LY-2584702,FYXRSVDHGLUMHB-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
61637,6crv,DB12371,-9.7,Siponimod,KIHYPELVXPAIDH-HNSNBQBZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106266,6vxs,DB15345,-9.7,GSK-945237,SRICOHRDRMZREQ-MRXNPFEDSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
61513,6crv,DB12198,-9.7,Fosdagrocorat,BVXLAHSJXXSWFF-KEKPKEOLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
103032,6vxs,DB08091,-9.7,3-FLUORO-5-MORPHOLIN-4-YL-N-[3-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-5-YL]BENZAMIDE,HIUFYIOMUILESI-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
61504,6crv,DB12185,-9.7,Exatecan,ZVYVPGLRVWUPMP-FYSMJZIKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77460,6m2n,DB08406,-9.7,"[N-(2,4-DIAMINOPTERIDIN-6-YL)-METHYL]-DIBENZ[B,F]AZEPINE",NXCCIJQEAKMFGW-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
102813,6vxs,DB07837,-9.7,"[4-(5-naphthalen-2-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)phenyl]acetic acid",SWXKLXXVFMYMDP-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
128258,6w4h,DB07397,-9.7,"(5S)-5-(2-amino-2-oxoethyl)-4-oxo-N-[(3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl)methyl]-3,4,5,6,7,8-hexahydro[1]benzothieno[2,3-d]pyrimidine-2-carboxamide",ITADELAVAWJACR-NSHDSACASA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
77584,6m2n,DB08553,-9.7,"(1E)-5-(1-piperidin-4-yl-3-pyridin-4-yl-1H-pyrazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime",KWEFZSZCLBHIEQ-YYADALCUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61483,6crv,DB12149,-9.7,S-3304,YWCLDDLVLSQGSZ-JOCHJYFZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77689,6m2n,DB08683,-9.7,"REL-(9R,12S)-9,10,11,12-TETRAHYDRO-9,12-EPOXY-1H-DIINDOLO[1,2,3-FG:3',2',1'-KL]PYRROLO[3,4-I][1,6]BENZODIAZOCINE-1,3(2H)-DIONE",OTPNDVKVEAIXTI-IYBDPMFKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138605,6w9c,DB11907,-9.7,Rociletinib,HUFOZJXAKZVRNJ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
77709,6m2n,DB08708,-9.7,"N-cyclohexyl-3-[3-(trifluoromethyl)phenyl][1,2,4]triazolo[4,3-b]pyridazin-6-amine",XYYDXQCAYXOGQT-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77847,6m2n,DB08882,-9.7,Linagliptin,LTXREWYXXSTFRX-QGZVFWFLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138693,6w9c,DB12128,-9.7,Ulimorelin,WGYPAJVJMXQXTR-ABNZCKJZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
100352,6vxs,DB03466,-9.7,BMS184394,AYAJZQYENGWICE-QHCPKHFHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
24918,6cs2,DB02741,-9.7,CD564,RWYREGSYPCNZTL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
100180,6vxs,DB03231,-9.7,"3-(5-Amino-7-oxo-3,7-dihydro-2H-[1,2,3]triazolo[4,5-d]pyrimidin-2-yl)-N-(2-{[2-(hydroxymethyl)phenyl]sulfanyl}benzyl)benzamide",IXDQOBDHBWEZOH-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
61423,6crv,DB12064,-9.7,BMS-777607,VNBRGSXVFBYQNN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138547,6w9c,DB11822,-9.7,TMC-647055,UOBYJVFBFSLCTQ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
100084,6vxs,DB03104,-9.7,RU82129,NKMPOVPTYDXGEC-MNRBYUMSSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
77865,6m2n,DB08912,-9.7,Dabrafenib,BFSMGDJOXZAERB-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
99786,6vxs,DB02705,-9.7,"6-[N-(1-Isopropyl-1,2,3,4-Tetrahydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine",DARQQJKHXPXSRO-QFIPXVFZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
138531,6w9c,DB11799,-9.7,Bictegravir,SOLUWJRYJLAZCX-LYOVBCGYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
13152,6lzg,DB14785,-9.7,Fenebrutinib,WNEODWDFDXWOLU-QHCPKHFHSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
61405,6crv,DB12041,-9.7,Mapracorat,VJGFOYBQOIPQFY-XMMPIXPASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
13179,6lzg,DB14850,-9.7,Deleobuvir,BMAIGAHXAJEULY-UKTHLTGXSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
55376,6crv,DB00932,-9.7,Tipranavir,SUJUHGSWHZTSEU-FYBSXPHGSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77854,6m2n,DB08896,-9.7,Regorafenib,FNHKPVJBJVTLMP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
103943,6vxs,DB09280,-9.7,Lumacaftor,UFSKUSARDNFIRC-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104181,6vxs,DB11614,-9.7,Rupatadine,WUZYKBABMWJHDL-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
77312,6m2n,DB08220,-9.7,"(8alpha,10alpha,13alpha,17beta)-17-[(4-hydroxyphenyl)carbonyl]androsta-3,5-diene-3-carboxylic acid",RPNNXCYIESWDSC-JRZBRKEGSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
106226,6vxs,DB15269,-9.7,ALK-4290,DWKNOLCXIFYNFV-HSZRJFAPSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
61635,6crv,DB12368,-9.7,AZD-3839,MRXBCEQZNKUUIP-DEOSSOPVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127603,6w4h,DB06486,-9.7,Enzastaurin,AXRCEOKUDYDWLF-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
55086,6crv,DB00591,-9.7,Fluocinolone acetonide,FEBLZLNTKCEFIT-VSXGLTOVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76605,6m2n,DB07396,-9.7,"1-{2-[3-(2-Chloro-4,5-difluoro-benzoyl)-ureido]-4-fluoro-phenyl}-piperidine-4-carboxylic acid",KAJJGOCSAXKXBD-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
24764,6cs2,DB02551,-9.7,"6-[N-(4-Ethyl-1,2,3,4-Tetrahydro-6-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine",LVNMYQLXKMSQTG-AWEZNQCLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
106053,6vxs,DB14895,-9.7,Vibegron,DJXRIQMCROIRCZ-XOEOCAAJSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
55090,6crv,DB00596,-9.7,Ulobetasol,LEHFPXVYPMWYQD-XHIJKXOTSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76651,6m2n,DB07450,-9.7,(R)-minalrestat,BMHZAHGTGIZZCT-LJQANCHMSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138899,6w9c,DB12419,-9.7,HSD-016,ZWASRJHIEFYJGL-BFUOFWGJSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
55108,6crv,DB00619,-9.7,Imatinib,KTUFNOKKBVMGRW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138861,6w9c,DB12369,-9.7,Sotrastaurin,OAVGBZOFDPFGPJ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138860,6w9c,DB12368,-9.7,AZD-3839,MRXBCEQZNKUUIP-DEOSSOPVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
76794,6m2n,DB07622,-9.7,"1-(3-(2,4-DIMETHYLTHIAZOL-5-YL)-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)-3-(4-METHYLPIPERAZIN-1-YL)UREA",KRKQVGZXTNLQSV-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
11783,6lzg,DB12424,-9.7,MK-3207,AZAANWYREOQRFB-SETSBSEESA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
76852,6m2n,DB07692,-9.7,"1-[(2,6-difluorophenyl)sulfonyl]-4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)piperazine",SHWNKRPMUBFWKE-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76859,6m2n,DB07700,-9.7,"3-CARBOXAMIDO-1,3,5(10)-ESTRATRIEN-17(R)-SPIRO-2'(5',5'-DIMETHYL-6'OXO)TETRAHYDROPYRAN",YVAJWBACBRSVPR-NDUHRLLKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61611,6crv,DB12327,-9.7,Salvinorin A,OBSYBRPAKCASQB-AGQYDFLVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138818,6w9c,DB12306,-9.7,Cipargamin,CKLPLPZSUQEDRT-WPCRTTGESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
104701,6vxs,DB12381,-9.7,Merestinib,QHADVLVFMKEIIP-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
138797,6w9c,DB12280,-9.7,AZD-5423,FCNQMDSJHADDFT-WNSKOXEYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
77075,6m2n,DB07949,-9.7,"({[(3E)-2'-OXO-2',7'-DIHYDRO-2,3'-BIINDOL-3(7H)-YLIDENE]AMINO}OXY)ACETIC ACID",BFQRPTKOSYMPOL-LALPNIDTSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138756,6w9c,DB12225,-9.7,Beclabuvir,ZTTKEBYSXUCBSE-QDFUAKMASA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138753,6w9c,DB12222,-9.7,Lurtotecan,RVFGKBWWUQOIOU-NDEPHWFRSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
61573,6crv,DB12282,-9.7,Defactinib,FWLMVFUGMHIOAA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138738,6w9c,DB12198,-9.7,Fosdagrocorat,BVXLAHSJXXSWFF-KEKPKEOLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
104230,6vxs,DB11694,-9.7,Ilorasertib,WPHKIQPVPYJNAX-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
55413,6crv,DB00977,-9.7,Ethinylestradiol,BFPYWIDHMRZLRN-SLHNCBLASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
89003,6m3m,DB15268,-9.7,Afabicin,HFYMDQMXVPJNTH-VQHVLOKHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88719,6m3m,DB14655,-9.7,Drostanolone propionate,NOTIQUSPUUHHEH-UXOVVSIBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88987,6m3m,DB15233,-9.7,Avapritinib,DWYRIWUZIJHQKQ-SANMLTNESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
132721,6w9c,DB00773,-9.7,Etoposide,VJJPUSNTGOMMGY-MRVIYFEKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
86203,6m3m,DB08561,-9.7,"BENZYL 6-BENZYL-5,7-DIOXO-6,7-DIHYDRO-5H-[1,3]THIAZOLO[3,2-C]PYRIMIDINE-2-CARBOXYLATE",PLBINCOCFGQAJM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58467,6crv,DB05423,-9.7,ORG-34517,DFELGYQKEOCHOA-BZAFBGKRSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86158,6m3m,DB08510,-9.7,5-ALPHA-PREGNANE-3-BETA-OL-HEMISUCCINATE,UVTGFMKBPVLATL-DSOJQRAMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86149,6m3m,DB08499,-9.7,"N-[3-(2-fluoroethoxy)phenyl]-N'-(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-6-yl)butanediamide",DQXBKUVWJSZHSI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
161474,7bv1,DB14876,-9.7,TAS-116,NVVPMZUGELHVMH-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
86114,6m3m,DB08459,-9.7,"3-chloro-5-[2-chloro-5-(1H-pyrazolo[3,4-b]pyridin-3-ylmethoxy)phenoxy]benzonitrile",SVMHTBVIPYVDIL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86107,6m3m,DB08449,-9.7,"2-(3-((4,5,7-trifluorobenzo[d]thiazol-2-yl)methyl)-1H-pyrrolo[2,3-b]pyridin-1-yl)acetic acid",IEVFQDJUDLCOQY-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86086,6m3m,DB08426,-9.7,"THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [2-OXO-1-(1H-PYRROLO[2,3-C]PYRIDIN-2-YLMETHYL)-PYRROLIDIN-3-YL]-AMIDE",PLXOQMHGHDZMSX-AWEZNQCLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
82900,6m3m,DB03159,-9.7,CRA_8696,GAVRMVQHHVMXFD-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86055,6m3m,DB08387,-9.7,2-{[4-(1-methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline,AZEXWHKOMMASPA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136012,6w9c,DB06295,-9.7,Pramiconazole,AEKNYBWUEYNWMJ-QWOOXDRHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
58438,6crv,DB05255,-9.7,Ronacaleret,FQJISUPNMFRIFZ-HXUWFJFHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59501,6crv,DB07537,-9.7,"N'-(6-aminopyridin-3-yl)-N-(2-cyclopentylethyl)-4-methyl-benzene-1,3-dicarboxamide",CLEGTVIMOPPIBR-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86029,6m3m,DB08354,-9.7,"2-(4-CHLOROBENZYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE",QCVULERVJOYHCP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85983,6m3m,DB08299,-9.7,"4-[8-(3-nitrophenyl)-1,7-naphthyridin-6-yl]benzoic acid",QTNUWEKKZHSUQO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
133073,6w9c,DB01177,-9.7,Idarubicin,XDXDZDZNSLXDNA-TZNDIEGXSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
83141,6m3m,DB03480,-9.7,Brequinar Analog,WYKKHJQZENLZID-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
135957,6w9c,DB06178,-9.7,Talotrexin,NYQPLPNEESYGNO-IBGZPJMESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
133095,6w9c,DB01199,-9.7,Tubocurarine,JFJZZMVDLULRGK-URLMMPGGSA-O,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
85842,6m3m,DB08124,-9.7,"3-{[(2,2-DIOXIDO-1,3-DIHYDRO-2-BENZOTHIEN-5-YL)AMINO]METHYLENE}-5-(1,3-OXAZOL-5-YL)-1,3-DIHYDRO-2H-INDOL-2-ONE",FTQYGMLRLRXBPT-IDUWFGFVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83276,6m3m,DB03678,-9.7,"(6,7-Difluoro-Quinazolin-4-Yl)-(1-Methyl-2,2-Diphenyl-Ethyl)-Amine",WVGZKPGUHOZIJQ-HNNXBMFYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58600,6crv,DB06169,-9.7,Indibulin,SOLIIYNRSAWTSQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85768,6m3m,DB08039,-9.7,"(3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE",LOGJQOUIVKBFGH-YBEGLDIGSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
133201,6w9c,DB01395,-9.7,Drospirenone,METQSPRSQINEEU-HXCATZOESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
58610,6crv,DB06194,-9.7,Elocalcitol,LRLWXBHFPGSUOX-GJQYOBCGSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
132999,6w9c,DB01092,-9.7,Ouabain,LPMXVESGRSUGHW-HBYQJFLCSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
86315,6m3m,DB08703,-9.7,"12-(2-hydroxyethyl)-2-(1-methylethoxy)-13,14-dihydronaphtho[2,1-a]pyrrolo[3,4-c]carbazol-5(12H)-one",FGKKIHITEICGMN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86322,6m3m,DB08710,-9.7,"(5Z)-5-[(5-ETHYL-2-FURYL)METHYLENE]-2-{[(S)-(4-FLUOROPHENYL)(1H-TETRAZOL-5-YL)METHYL]AMINO}-1,3-THIAZOL-4(5H)-ONE",BKZOQCGDCHOGOQ-MZLJFPOFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86353,6m3m,DB08742,-9.7,"1,3-CYCLOHEXANEDIOL, 4-METHYLENE-5-[(2E)-[(1S,3AS,7AS)-OCTAHYDRO-1-(5-HYDROXY-5-METHYL-1,3-HEXADIYNYL)-7A-METHYL-4H-INDEN-4-YLIDENE]ETHYLIDENE]-, (1R,3S,5Z)",CEEUUHVULXTFGS-BQXVGYHGSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81695,6m3m,DB01564,-9.7,Calusterone,IVFYLRMMHVYGJH-PVPPCFLZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
25928,6cs2,DB03957,-9.7,SP2456,SSSXBBASYYVGCI-HSZRJFAPSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
136352,6w9c,DB07020,-9.7,"N-{3-[5-(1H-1,2,4-triazol-3-yl)-1H-indazol-3-yl]phenyl}furan-2-carboxamide",LMDMJDCLPIVGQD-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
58147,6crv,DB04609,-9.7,INHIBITOR Q8467 OF DUPONT MERCK,HFLCERPZYCWLSZ-VKONIRKNSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
16231,6lzg,DB03276,-9.7,"4-[(10s,14s,18s)-18-(2-Amino-2-Oxoethyl)-14-(1-Naphthylmethyl)-8,17,20-Trioxo-7,16,19-Triazaspiro[5.14]Icos-11-En-10-Yl]Benzylphosphonic Acid",RHYFMOCFCFUTNH-GZNVFMSSSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
86974,6m3m,DB11645,-9.7,PF-4191834,DVNQWYLVSNPCJZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59728,6crv,DB07806,-9.7,"(2R,4S)-2-[(R)-BENZYLCARBAMOYL-PHENYLACETYL-METHYL]-5,5-DIMETHYL-THIAZOLIDINE-4-CARBOXYLIC ACID",UDMBRVGTYILYDX-SVFBPWRDSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58180,6crv,DB04651,-9.7,BIOTINOL-5-AMP,KBOGUFFJCBPJEH-SQGSUPJISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59717,6crv,DB07794,-9.7,"5-(2-PHENYLPYRAZOLO[1,5-A]PYRIDIN-3-YL)-1H-PYRAZOLO[3,4-C]PYRIDAZIN-3-AMINE",XVECMUKVOMUNLE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
82112,6m3m,DB02115,-9.7,Daidzin,KYQZWONCHDNPDP-QNDFHXLGSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
82114,6m3m,DB02118,-9.7,CP-271485,CIUMOGWIMXNXSQ-GOSISDBHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58280,6crv,DB04793,-9.7,"1,4:3,6-Dianhydro-2-O-(3-carbamimidoylphenyl)-5-O-(4-carbamimidoylphenyl)-D-glucitol",DKBAWRNTUZFJKV-XMTFNYHQSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
159822,7bv1,DB06630,-9.7,Anacetrapib,MZZLGJHLQGUVPN-HAWMADMCSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
82249,6m3m,DB02300,-9.7,Calcipotriol,LWQQLNNNIPYSNX-UROSTWAQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
82270,6m3m,DB02329,-9.7,Carbenoxolone,OBZHEBDUNPOCJG-WBXJDKIVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
82271,6m3m,DB02331,-9.7,"(2s)-2-[(5-Benzofuran-2-Yl-Thiophen-2-Ylmethyl)-(2,4-Dichloro-Benzoyl)-Amino]-3-Phenyl-Propionic Acid",YBULOUKTPCHXAL-DEOSSOPVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86618,6m3m,DB09124,-9.7,Medrogestone,HCFSGRMEEXUOSS-JXEXPEPMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58349,6crv,DB04879,-9.7,Vatalanib,YCOYDOIWSSHVCK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136202,6w9c,DB06744,-9.7,ginkgolide-B,SQOJOAFXDQDRGF-MMQTXUMRSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
86541,6m3m,DB08997,-9.7,Dexetimide,LQQIVYSCPWCSSD-HSZRJFAPSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58364,6crv,DB04903,-9.7,Pagoclone,HIUPRQPBWVEQJJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
161538,7bv1,DB15036,-9.7,Sitravatinib,WLAVZAAODLTUSW-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
136151,6w9c,DB06666,-9.7,Lixivaptan,PPHTXRNHTVLQED-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
82470,6m3m,DB02581,-9.7,"5-[2,3-Dichloro-4-(5-{1-[2-(2-Guanidino-4-Methyl-Pentanoylamino)-Acetyl]-Piperidin-4-Yl}-1-Methyl-1h-Pyrazol-3-Yl)-Phenoxymethyl]-Furan-2-Carboxylic Acid",VNZHOIDQBPFEJU-OAQYLSRUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136139,6w9c,DB06634,-9.7,Casopitant,XGGTZCKQRWXCHW-WMTVXVAQSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136137,6w9c,DB06630,-9.7,Anacetrapib,MZZLGJHLQGUVPN-HAWMADMCSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
132654,6w9c,DB00693,-9.7,Fluorescein,GNBHRKFJIUUOQI-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
83534,6m3m,DB04011,-9.7,"2'-(4-Dimethylaminophenyl)-5-(4-Methyl-1-Piperazinyl)-2,5'-Bi-Benzimidazole",VMCOQLKKSNQANE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85733,6m3m,DB08003,-9.7,ISOTHIAZOLIDINONE ANALOG,UILYPHAKDBTKQV-UFYCRDLUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83599,6m3m,DB04099,-9.7,Deamido-Nad+,SENPVEZBRZQVST-HISDBWNOSA-O,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59321,6crv,DB07325,-9.7,N-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)METHYL]-3-{[(E)-(2-OXODIHYDROFURAN-3(2H)-YLIDENE)METHYL]AMINO}BENZENESULFONAMIDE,VCOKUBHAJVTVNG-FMIVXFBMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85238,6m3m,DB07422,-9.7,(2S)-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]-3-(pentafluorophenoxy)propanamide,MMNRWNREMUMYQG-INIZCTEOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58728,6crv,DB06494,-9.7,Sufugolix,UCQSBGOFELXYIN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85097,6m3m,DB07261,-9.7,"THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [1-(1-AMINO-ISOQUINOLIN-7-YLMETHYL)-2-OXO-PYRROLDIN-3-YL]-AMIDE",NVKDOURNRJCKJE-INIZCTEOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85091,6m3m,DB07255,-9.7,"N'-(5-CHLORO-1,3-BENZODIOXOL-4-YL)-N-(3-MORPHOLIN-4-YLPHENYL)PYRIMIDINE-2,4-DIAMINE",PNEWIQAEGKQNCE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84350,6m3m,DB05667,-9.7,Levoketoconazole,XMAYWYJOQHXEEK-ZEQKJWHPSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85088,6m3m,DB07252,-9.7,"3-({4-[(5-chloro-1,3-benzodioxol-4-yl)amino]pyrimidin-2-yl}amino)benzenesulfonamide",TZHCXOMEOHEZDX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84378,6m3m,DB05838,-9.7,OPC-51803,INGXCNVWWKKWOO-LJQANCHMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
160991,7bv1,DB12369,-9.7,Sotrastaurin,OAVGBZOFDPFGPJ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
135256,6w9c,DB04190,-9.7,Inhibitor Bea425,AHAVBKNGKPWROK-UMFPTGFGSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
84997,6m3m,DB07144,-9.7,"5-[(3R)-3-(5-methoxy-2',6'-dimethylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",XZXVRKHUCSXVBM-AWEZNQCLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84941,6m3m,DB07081,-9.7,"(2R)-4-[(8R)-8-METHYL-2-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[1,5-A]PYRAZIN-7(8H)-YL]-4-OXO-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE",FDEXEPZGMKFCTG-PSASIEDQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59055,6crv,DB07024,-9.7,"2-(3,4-DIHYDROXYPHENYL)-8-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-3-HYDROXY-6-METHYL-4H-CHROMEN-4-ONE",CEXBEGBNDJVZPK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84937,6m3m,DB07076,-9.7,6-[(Z)-AMINO(IMINO)METHYL]-N-[3-(CYCLOPENTYLOXY)PHENYL]-2-NAPHTHAMIDE,FWTQOPWAMQXIMI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84930,6m3m,DB07066,-9.7,"2-CHLORO-N-[(3R)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL]-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE",LJAHIGGEXIWVJG-LLVKDONJSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
134231,6w9c,DB02741,-9.7,CD564,RWYREGSYPCNZTL-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
58840,6crv,DB06732,-9.7,beta-Naphthoflavone,OUGIDAPQYNCXRA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84878,6m3m,DB07008,-9.7,"4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMIDAZOL-1-YL)PHENOXY]PYRIMIDINE",XPXGYINSBORUMM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84856,6m3m,DB06985,-9.7,2-[({4-[2-(trifluoromethyl)phenyl]piperidin-1-yl}carbonyl)amino]benzoic acid,MEAQCLPMSVEOQF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
134963,6w9c,DB03802,-9.7,"1-[4-(Octahydro-Pyrido[1,2-a]Pyrazin-2-Yl)-Phenyl]-2-Phenyl-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol",ZGHFWBDHZZKWSI-LITSAYRRSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
134412,6w9c,DB03044,-9.7,1-(5-Tert-Butyl-2-P-Tolyl-2h-Pyrazol-3-Yl)-3-[4-(2-Morpholin-4-Yl-Ethoxy)-Naphthalen-1-Yl]-Urea,MVCOAUNKQVWQHZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
84543,6m3m,DB06446,-9.7,Dotarizine,LRMJAFKKJLRDLE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58900,6crv,DB06837,-9.7,"(2R)-N-4-hydroxy-2-(3-hydroxybenzyl)-N-1-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]butanediamide",VXDKQRWTOJFQKH-BJZITVGISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84552,6m3m,DB06469,-9.7,Lestaurtinib,UIARLYUEJFELEN-DMVVYWCZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58989,6crv,DB06942,-9.7,N-(4-carbamimidoylbenzyl)-1-(3-phenylpropanoyl)-L-prolinamide,RNZKCCPFUWHBFY-IBGZPJMESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58958,6crv,DB06908,-9.7,"(2S)-3-(1-{[2-(2-CHLOROPHENYL)-5-METHYL-1,3-OXAZOL-4-YL]METHYL}-1H-INDOL-5-YL)-2-ETHOXYPROPANOIC ACID",PAWOPJKHTZCKMT-QFIPXVFZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84628,6m3m,DB06652,-9.7,Vicriviroc,CNPVJJQCETWNEU-CYFREDJKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84632,6m3m,DB06660,-9.7,Saredutant,PGKXDIMONUAMFR-AREMUKBSSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84265,6m3m,DB05212,-9.7,HE3286,JJKOQZHWYLMASZ-FJWDNACWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81692,6m3m,DB01561,-9.7,Androstanedione,RAJWOBJTTGJROA-WZNAKSSCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84261,6m3m,DB05171,-9.7,E-2012,PUOAETJYKQITMO-LANLRWRYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59194,6crv,DB07181,-9.7,"4'-[(1R)-1-amino-2-(2,5-difluorophenyl)ethyl]biphenyl-3-carboxamide",JYKFWUXBFJJDTP-HXUWFJFHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85583,6m3m,DB07827,-9.7,"4-{[1-METHYL-2,4-DIOXO-6-(3-PHENYLPROP-1-YN-1-YL)-1,4-DIHYDROQUINAZOLIN-3(2H)-YL]METHYL}BENZOIC ACID",FLTYDFYSVZBKOB-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
160310,7bv1,DB07994,-9.7,"N-3-[5-(1H-INDOL-6-YL)-2-(PYRIDIN-2-YLMETHOXY)BENZYL]PYRIDINE-2,3-DIAMINE",KMBPJSHPAXOXBT-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
85547,6m3m,DB07789,-9.7,"1-[5-methyl-2-(trifluoromethyl)furan-3-yl]-3-[(2Z)-5-(2-{[6-(1H-1,2,4-triazol-3-ylamino)pyrimidin-4-yl]amino}ethyl)-1,3-thiazol-2(3H)-ylidene]urea",KNTGXMNWVXZIMW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
135738,6w9c,DB04872,-9.7,Osanetant,DZOJBGLFWINFBF-UMSFTDKQSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
85494,6m3m,DB07728,-9.7,"2-[2-(2-FLUOROPHENYL)PYRIDIN-4-YL]-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE",XJJYJNMNYDNXNO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83967,6m3m,DB04591,-9.7,"N-{2,2-DIFLUORO-2-[(2R)-PIPERIDIN-2-YL]ETHYL}-2-[2-(1H-1,2,4-TRIAZOL-1-YL)BENZYL][1,3]OXAZOLO[4,5-C]PYRIDIN-4-AMINE",VYJOAYZRCNHDNG-GOSISDBHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59254,6crv,DB07253,-9.7,"N'-(5-chloro-1,3-benzodioxol-4-yl)-N-(3-methylsulfonylphenyl)pyrimidine-2,4-diamine",QTFCKBFCXDAZIU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59253,6crv,DB07252,-9.7,"3-({4-[(5-chloro-1,3-benzodioxol-4-yl)amino]pyrimidin-2-yl}amino)benzenesulfonamide",TZHCXOMEOHEZDX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85463,6m3m,DB07692,-9.7,"1-[(2,6-difluorophenyl)sulfonyl]-4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)piperazine",SHWNKRPMUBFWKE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83999,6m3m,DB04632,-9.7,4-(2-HYDROXYBENZYLAMINO)-N-(3-(4-FLUOROPHENOXY)PHENYL)PIPERIDINE-1-SULFONAMIDE,JHHBGNIRSUTQAS-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
133406,6w9c,DB01640,-9.7,"(5r)-6-(4-{[2-(3-Iodobenzyl)-3-Oxocyclohex-1-En-1-Yl]Amino}Phenyl)-5-Methyl-4,5-Dihydropyridazin-3(2h)-One",QNURTFDBHAQRSI-OAHLLOKOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
133427,6w9c,DB01669,-9.7,Virginiamycin M1,DAIKHDNSXMZDCU-FQTGFAPKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
84047,6m3m,DB04698,-9.7,"N-(1,4-DIHYDRO-5H-TETRAZOL-5-YLIDENE)-9-OXO-9H-XANTHENE-2-SULFONAMIDE",HJWYZPGYPZNDTN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84051,6m3m,DB04704,-9.7,20-hydroxycholesterol,MCKLJFJEQRYRQT-MGNSQDQZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85452,6m3m,DB07678,-9.7,"(9ALPHA,13BETA,17BETA)-2-[(1Z)-BUT-1-EN-1-YL]ESTRA-1,3,5(10)-TRIENE-3,17-DIOL",ANAMDWGJXBYJEB-OPWFCKQNSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59226,6crv,DB07219,-9.7,"BENZYL N-({(2S,3S)-3-[(PROPYLAMINO)CARBONYL]OXIRAN-2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINATE",OMQNYWZURFTFHE-MQBSTWLZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
26270,6cs2,DB04373,-9.7,"4-Amino-N-{4-[2-(2,6-Dimethyl-Phenoxy)-Acetylamino]-3-Hydroxy-1-Isobutyl-5-Phenyl-Pentyl}-Benzamide",WQUBEIMCFHCJCO-AWCRTANDSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
26664,6cs2,DB04842,-9.7,Fluspirilene,QOYHHIBFXOOADH-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
135668,6w9c,DB04785,-9.7,Streptolydigin,KVTPRMV1KLIG-NCAOFHFGSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
85390,6m3m,DB07605,-9.7,"2-({4-[(5-CHLORO-1H-INDOL-2-YL)SULFONYL]PIPERAZIN-1-YL}CARBONYL)THIENO[3,2-B]PYRIDINE 4-OXIDE",DHDQMXPAANQKDC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58667,6crv,DB06314,-9.7,SGX-523,BCZUAADEACICHN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
135628,6w9c,DB04727,-9.7,"N-(4-{4-AMINO-6-[4-(METHYLOXY)PHENYL]FURO[2,3-D]PYRIMIDIN-5-YL}PHENYL)-N'-[2-FLUORO-5-(TRIFLUOROMETHYL)PHENYL]UREA",FGZIONRFHVNRJB-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
58674,6crv,DB06346,-9.7,Fiboflapon,DFQGDHBGRSTTHX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84181,6m3m,DB04875,-9.7,Pralnacasan,CXAGHAZMQSCAKJ-WAHHBDPQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58688,6crv,DB06401,-9.7,Bazedoxifene,UCJGJABZCDBEDK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59196,6crv,DB07183,-9.7,N-(4-phenoxyphenyl)-2-[(pyridin-4-ylmethyl)amino]nicotinamide,CPVRYQAOUPSUDO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
135607,6w9c,DB04690,-9.7,Camptothecin,VSJKWCGYPAHWDS-FQEVSTJZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
58702,6crv,DB06435,-9.7,Tarazepide,CZPILLBHPRAPCB-AREMUKBSSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57990,6crv,DB04405,-9.7,"2-[2-(1,3-Dioxo-1,3-Dihydro-2h-Isoindol-2-Yl)Ethyl]-4-(4'-Ethoxy-1,1'-Biphenyl-4-Yl)-4-Oxobutanoic Acid",AQYSXARQCHHHLK-NRFANRHFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87087,6m3m,DB11814,-9.7,PF-03882845,XNULRSOGWPFPBL-REWPJTCUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
132083,6w4h,DB15343,-9.7,HM-43239,FZLSDZZNPXXBBB-KDURUIRLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
137438,6w9c,DB08299,-9.7,"4-[8-(3-nitrophenyl)-1,7-naphthyridin-6-yl]benzoic acid",QTNUWEKKZHSUQO-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
88698,6m3m,DB14633,-9.7,Prednisolone hemisuccinate,APGDTXUMTIZLCJ-CGVGKPPMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88690,6m3m,DB14625,-9.7,Meprednisone acetate,RZAMUHXEOMZXET-ABQXZQTJSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88689,6m3m,DB14624,-9.7,Nandrolone hydrogen sulfate,SKZMVWBZTQNCKW-IZPLOLCNSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
60545,6crv,DB08772,-9.7,"3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL-2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID",BCSVCWVQNOXFGL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60537,6crv,DB08762,-9.7,O-(((1R)-((N-PHENYLMETHOXYCARBONYL-L-ALANYL)AMINO)ETHYL)HYDROXYPHOSPHONO)-L-BENZYLACETIC ACID,UPJNMOBJDSFRTI-FCEWJHQRSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88621,6m3m,DB14152,-9.7,Ginsenosides,NLHQJXWYMZLQJY-SWIZOJJJSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
60515,6crv,DB08739,-9.7,"2-{3-[(2S)-4,4-difluoro-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]-3-oxopropyl}-isoindole-1,3(2H)-dione",ZSXNPAWXICXNGZ-HNNXBMFYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79912,6m2n,DB13950,-9.7,WIN 55212-2,HQVHOQAKMCMIIM-HXUWFJFHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80041,6m2n,DB14218,-9.7,Telotristat,NCLGDOBQAWBXRA-PGRDOPGGSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
88539,6m3m,DB13981,-9.7,Nomegestrol acetate,IIVBFTNIGYRNQY-YQLZSBIMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80144,6m2n,DB14723,-9.7,Larotrectinib,NYNZQNWKBKUAII-KBXCAEBGSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80166,6m2n,DB14770,-9.7,Lanraplenib,XCIGZBVOUQVIPI-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
56446,6crv,DB02341,-9.7,"Mdl 101,146",XQAMVCHQGHAELT-YPAWHYETSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56546,6crv,DB02466,-9.7,"4-[3-Oxo-3-(5,5,8,8-Tetramethyl-5,6,7,8-Tetrahydro-Naphthalen-2-Yl)-Propenyl]-Benzoic Acid",ZXQHMEUGMCXKLO-KPKJPENVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80211,6m2n,DB14878,-9.7,Liafensine,VCIBGDSRPUOBOG-QFIPXVFZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
88259,6m3m,DB13556,-9.7,Sulfamazone,BGLHAKAJGYLSOX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
163761,7bv1,DB06229,-9.7,Ocaperidone,ZZQNEJILGNNOEP-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60386,6crv,DB08584,-9.7,"6-{[6-(1-methyl-1H-pyrazol-4-yl)[1,2,4]triazolo[4,3-b]pyridazin-3-yl]sulfanyl}quinoline",BCZUAADEACICHN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88209,6m3m,DB13490,-9.7,Hidrosmin,XYFLWVOTXWXNAM-WTNNCJBMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88008,6m3m,DB13223,-9.7,Fluocortin,PUWHHWCHAVXSIG-NCLPIGKXSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80256,6m2n,DB14995,-9.7,NP-G2-044,XLLRLAABUFOJPC-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
60358,6crv,DB08549,-9.7,"(3R)-METHYLCARBAMOYL-7-SULFOAMINO-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLIC ACID BENZYL ESTER",MFDBNNQUDZFSES-KRWDZBQOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87943,6m3m,DB13095,-9.7,JTK-853,JQLOVYLALGSISI-HXUWFJFHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
56666,6crv,DB02621,-9.7,Latrunculin A,DDVBPZROPPMBLW-IZGXTMSKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80307,6m2n,DB15102,-9.7,Pemigatinib,HCDMJFOHIXMBOV-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80312,6m2n,DB15110,-9.7,Onvansertib,QHLVBNKYJGBCQJ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
88710,6m3m,DB14646,-9.7,Prednisone acetate,MOVRKLZUVNCBIP-RFZYENFJSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87880,6m3m,DB13002,-9.7,HKI-357,NERXPXBELDBEPZ-RMKNXTFCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
60595,6crv,DB08834,-9.7,Tauroursodeoxycholic acid,BHTRKEVKTKCXOH-LBSADWJPSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62043,6crv,DB12999,-9.7,MK-6186,FZBAOOQVQXATRL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88975,6m3m,DB15209,-9.7,MK-0736,ORQZQBUNAMJFCY-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88965,6m3m,DB15197,-9.7,RSV-604,MTPVBMVUENFFLL-HXUWFJFHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88964,6m3m,DB15193,-9.7,BMS-955176,XDMUFNNPLXHNKA-ZTESCHFWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
79081,6m2n,DB12705,-9.7,Cenerimod,KJKKMMMRWISKRF-FQEVSTJZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
88961,6m3m,DB15190,-9.7,GLPG-0259,YBFGSJUVEOYPIS-OALUTQOASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
79096,6m2n,DB12724,-9.7,AZD-7295,MAQDQJWCSSCURR-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
27949,6cs2,DB07514,-9.7,"3-(2-aminoquinazolin-6-yl)-1-(3,3-dimethylindolin-6-yl)-4-methylpyridin-2(1H)-one",LHLGUOHREUTYTO-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
88934,6m3m,DB15132,-9.7,AZD-8165,YUHNXUAATAMVKD-PZJWPPBQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
27944,6cs2,DB07508,-9.7,4-(5-BENZENESULFONYLAMINO-1-METHYL-1H-BENZOIMIDAZOL-2-YLMETHYL)-BENZAMIDINE,MEUAVGJWGDPTLF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
88927,6m3m,DB15120,-9.7,GSK-239512,YFRBKEVUUCQYOW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88923,6m3m,DB15110,-9.7,Onvansertib,QHLVBNKYJGBCQJ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88921,6m3m,DB15108,-9.7,Tipranavir C-14,SUJUHGSWHZTSEU-MWQIXQBFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
27898,6cs2,DB07457,-9.7,"3-[1-(3-AMINOPROPYL)-1H-INDOL-3-YL]-4-(1H-INDOL-3-YL)-1H-PYRROLE-2,5-DIONE",APYXQTXFRIDSGE-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
88880,6m3m,DB15029,-9.7,AZD-8186,LMJFJIDLEAWOQJ-CQSZACIVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88874,6m3m,DB15013,-9.7,TAK-243,KJDAGXLMHXUAGV-DGWLBADLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
79176,6m2n,DB12858,-9.7,LY-377604,RBSGUQYXRDKPAE-QFIPXVFZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
88871,6m3m,DB15009,-9.7,PF-04937319,MASKQITXHVYVFL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88867,6m3m,DB14995,-9.7,NP-G2-044,XLLRLAABUFOJPC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
55961,6crv,DB01691,-9.7,Indole Naphthyridinone,VAZMNDXVXVUKFY-JXMROGBWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55995,6crv,DB01737,-9.7,"Nalpha-(2-Naphthylsulfonylglycyl)-3-Amidino-D,L-Phenylalanine-Isopropylester",YAEIKQDHLCFGAA-KRWDZBQOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88847,6m3m,DB14929,-9.7,Elsulfavirine,ULTDEARCBRNRGR-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
137527,6w9c,DB08407,-9.7,PLATENSIMYCIN,CSOMAHTTWTVBFL-OFBLZTNGSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
88832,6m3m,DB14896,-9.7,Selitrectinib,OEBIHOVSAMBXIB-SJKOYZFVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88831,6m3m,DB14895,-9.7,Vibegron,DJXRIQMCROIRCZ-XOEOCAAJSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88829,6m3m,DB14889,-9.7,Derazantinib,KPJDVVCDVBFRMU-AREMUKBSSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
130240,6w4h,DB11977,-9.7,Golvatinib,UQRCJCNVNUFYDX-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
27825,6cs2,DB07382,-9.7,"N-2-1H-benzimidazol-5-yl-N-4-(3-cyclopropyl-1H-pyrazol-5-yl)pyrimidine-2,4-diamine",WJNBSTLIALIIEW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
88717,6m3m,DB14653,-9.7,Clocortolone caproate,MMTRTBFDFNRBQO-ANHDKODLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88998,6m3m,DB15257,-9.7,Milademetan,RYAYYVTWKAOAJF-QISPRATLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87814,6m3m,DB12899,-9.7,TT-301,ZPJGUEPHFXPAQF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80379,6m2n,DB15238,-9.7,Olinciguat,YWQFJNWMWZMXRW-HXUWFJFHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
81209,6m3m,DB00932,-9.7,Tipranavir,SUJUHGSWHZTSEU-FYBSXPHGSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87293,6m3m,DB12115,-9.7,AZD-9164,FNYFFCOCVNTJCD-NNMXADRKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87292,6m3m,DB12114,-9.7,Poziotinib,LPFWVDIFUFFKJU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
57652,6crv,DB03944,-9.7,"5-[1-(3,4-Dimethoxy-Benzoyl)-1,2,3,4-Tetrahydro-Quinolin-6-Yl]-6-Methyl-3,6-Dihydro-[1,3,4]Thiadiazin-2-One",IZLRMTJLQCLMKF-CYBMUJFWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59941,6crv,DB08051,-9.7,"(2R)-4-(2-BENZOYL-1,2-DIAZEPAN-1-YL)-4-OXO-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE",XXRHRPGYYNOBHO-QGZVFWFLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87278,6m3m,DB12096,-9.7,PF-05175157,BDXXSFOJPYSYOC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81362,6m3m,DB01108,-9.7,Trilostane,KVJXBPDAXMEYOA-CXANFOAXSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59891,6crv,DB07994,-9.7,"N-3-[5-(1H-INDOL-6-YL)-2-(PYRIDIN-2-YLMETHOXY)BENZYL]PYRIDINE-2,3-DIAMINE",KMBPJSHPAXOXBT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87225,6m3m,DB12012,-9.7,PF-04457845,BATCTBJIJJEPHM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87219,6m3m,DB12006,-9.7,BMS-906024,AYOUDDAETNMCBW-GSHUGGBRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136548,6w9c,DB07247,-9.7,"[2'-HYDROXY-3'-(1H-PYRROLO[3,2-C]PYRIDIN-2-YL)-BIPHENYL-3-YLMETHYL]-UREA",SRPOHNDQBDHONJ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
87216,6m3m,DB12002,-9.7,AZD-4818,HVTUHSABWJPWNK-SFHVURJKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81412,6m3m,DB01167,-9.7,Itraconazole,VHVPQPYKVGDNFY-ZPGVKDDISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59877,6crv,DB07978,-9.7,"2-({[2,3,5,6-TETRAFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)CYCLOPENTA-1,3-DIENE-1-CARBOXYLIC ACID",ULMUPVXFUDHRGH-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87196,6m3m,DB11968,-9.7,MK-7145,OCKGFTQIICXDQW-ZEQRLZLVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87183,6m3m,DB11950,-9.7,Teneligliptin,WGRQANOPCQRCME-PMACEKPBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87176,6m3m,DB11942,-9.7,Selinexor,DEVSOMFAQLZNKR-RJRFIUFISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81489,6m3m,DB01260,-9.7,Desonide,WBGKWQHBNHJJPZ-LECWWXJVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
132002,6w4h,DB15190,-9.7,GLPG-0259,YBFGSJUVEOYPIS-OALUTQOASA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
87163,6m3m,DB11921,-9.7,Deflazacort,FBHSPRKOSMHSIF-GRMWVWQJSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81521,6m3m,DB01336,-9.7,Metocurine,JFXBEKISTKFVAB-AJQTZOPKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
57764,6crv,DB04098,-9.7,Balanol,XYUFCXJZFZPEJD-PGRDOPGGSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57765,6crv,DB04099,-9.7,Deamido-Nad+,SENPVEZBRZQVST-HISDBWNOSA-O,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81557,6m3m,DB01410,-9.7,Ciclesonide,LUKZNWIVRBCLON-GXOBDPJESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87143,6m3m,DB11894,-9.7,Efatutazone,JCYNMRJCUYVDBC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
162321,7bv1,DB01897,-9.7,2-(2f-Benzothiazolyl)-5-Styryl-3-(4f-Phthalhydrazidyl)Tetrazolium Chloride,BEIGFKLRGRRJJA-JLHYYAGUSA-O,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59772,6crv,DB07856,-9.7,6-{4-[4-(4-CHLOROPHENYL)PIPERIDIN-4-YL]PHENYL}-9H-PURINE,HPWBHQIUIBFTQC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
131898,6w4h,DB14942,-9.7,BMS-986141,KEEBLYWBELVGPQ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
87806,6m3m,DB12887,-9.7,Tazemetostat,NSQSAUGJQHDYNO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81175,6m3m,DB00896,-9.7,Rimexolone,QTTRZHGPGKRAFB-OOKHYKNYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59954,6crv,DB08064,-9.7,N-(3-TERT-BUTYL-1H-PYRAZOL-5-YL)-N'-{4-CHLORO-3-[(PYRIDIN-3-YLOXY)METHYL]PHENYL}UREA,NTMADESEDXKNFZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
137008,6w9c,DB07794,-9.7,"5-(2-PHENYLPYRAZOLO[1,5-A]PYRIDIN-3-YL)-1H-PYRAZOLO[3,4-C]PYRIDAZIN-3-AMINE",XVECMUKVOMUNLE-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
80393,6m2n,DB15269,-9.7,ALK-4290,DWKNOLCXIFYNFV-HSZRJFAPSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
163496,7bv1,DB04703,-9.7,Hesperidin,QUQPHWDTPGMPEX-QJBIFVCTSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
87730,6m3m,DB12760,-9.7,GW-493838,ZQYJPMPXQLNTPQ-QCUYGVNKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87717,6m3m,DB12740,-9.7,CC-115,GMYLVKUGJMYTFB-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87704,6m3m,DB12719,-9.7,Turofexorate isopropyl,INASOKQDNHHMRE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
57066,6crv,DB03159,-9.7,CRA_8696,GAVRMVQHHVMXFD-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60190,6crv,DB08350,-9.7,"5-[3-(2-METHOXYPHENYL)-1H-PYRROLO[2,3-B]PYRIDIN-5-YL]-N,N-DIMETHYLPYRIDINE-3-CARBOXAMIDE",GYQRHHQPEMOLKH-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57087,6crv,DB03186,-9.7,U-Pi-a-Pi,JIAJERGOUFOENU-LNAOLWRRSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87643,6m3m,DB12627,-9.7,GSK-1292263,AYJRTVVIBJSSKN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87622,6m3m,DB12590,-9.7,Indiplon,CBIAWPMZSFFRGN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
60112,6crv,DB08248,-9.7,3-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)-BENZENESULFONAMIDE,BKDUVKJYBJDZQW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60106,6crv,DB08241,-9.7,4-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)--BENZAMIDE,RUUOIINPNMNPIU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87577,6m3m,DB12522,-9.7,Toreforant,FCRFVPZAXGJLPW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136846,6w9c,DB07605,-9.7,"2-({4-[(5-CHLORO-1H-INDOL-2-YL)SULFONYL]PIPERAZIN-1-YL}CARBONYL)THIENO[3,2-B]PYRIDINE 4-OXIDE",DHDQMXPAANQKDC-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
57240,6crv,DB03383,-9.7,5-Chloro-1h-Indole-2-Carboxylic Acid [1-(4-Fluorobenzyl)-2-(4-Hydroxypiperidin-1yl)-2-Oxoethyl]Amide,YDCGVASFVACWKF-NRFANRHFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136832,6w9c,DB07586,-9.7,"5-(4-METHYL-BENZOYLAMINO)-BIPHENYL-3,4'-DICARBOXYLIC ACID 3-DIMETHYLAMIDE-4'-HYDROXYAMIDE",DOPFUKKMSDUVTQ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
27345,6cs2,DB06882,-9.7,1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-naphthalen-1-ylurea,HJWMLCDGRWWLAQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
80791,6m3m,DB00436,-9.7,Bendroflumethiazide,HDWIHXWEUNVBIY-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87501,6m3m,DB12410,-9.7,Sabarubicin,VQHRZZISQVWPLK-UIRGBLDSSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80916,6m3m,DB00588,-9.7,Fluticasone propionate,WMWTYOKRWGGJOA-CENSZEJFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87483,6m3m,DB12388,-9.7,Evocalcet,RZNUIYPHQFXBAN-XLIONFOSSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87480,6m3m,DB12382,-9.7,R-306465,MUTBJZVSRNUIHA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
60020,6crv,DB08138,-9.7,"{[(2,6-difluorophenyl)carbonyl]amino}-N-(4-fluorophenyl)-1H-pyrazole-3-carboxamide",BDRDBXXWQDFXEC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
853,6lzg,HMDB0007191,-9.7,"DG(18:1(11Z)/18:3(6Z,9Z,12Z)/0:0)",ITGRMIJUDWFPJB-YYHNHJMXSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
81044,6m3m,DB00741,-9.7,Hydrocortisone,JYGXADMDTFJGBT-VWUMJDOOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136673,6w9c,DB07397,-9.7,"(5S)-5-(2-amino-2-oxoethyl)-4-oxo-N-[(3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl)methyl]-3,4,5,6,7,8-hexahydro[1]benzothieno[2,3-d]pyrimidine-2-carboxamide",ITADELAVAWJACR-NSHDSACASA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
87312,6m3m,DB12141,-9.7,Gilteritinib,GYQYAJJFPNQOOW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
109030,6vxx,DB11934,-9.7,Epelsiban,UWHCWRQFNKUYCG-QUZACWSFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
160840,7bv1,DB11799,-9.7,Bictegravir,SOLUWJRYJLAZCX-LYOVBCGYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
62732,6crv,DB14035,-9.7,Englitazone,MVDXXGIBARMXSA-PYUWXLGESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30292,6cs2,DB12297,-9.7,GLPG-0187,CXHCNOMGODVIKB-VWLOTQADSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
140319,6w9c,DB02804,-9.7,A-98881,PMBZSBGCSQGJAQ-GRKNLSHJSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140548,6w9c,DB12044,-9.7,MK-0893,DNTVJEMGHBIUMW-IBGZPJMESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140749,6w9c,DB15233,-9.7,Avapritinib,DWYRIWUZIJHQKQ-SANMLTNESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
110092,6vxx,DB00966,-9.7,Telmisartan,RMMXLENWKUUMAY-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30314,6cs2,DB12320,-9.7,Palovarotene,YTFHCXIPDIHOIA-DHZHZOJOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
73726,6m2n,DB02411,-9.7,"2-(11-{2-[Benzenesulfonyl-(3-Methyl-Butyl)-Amino]-1-Hydroxy-Ethyl}-6,9-Dioxo-2-Oxa-7,10-Diaza-Bicyclo[11.2.2]Heptadeca-1(16),13(17),14-Trien-8-Yl)-Acetamide, Inhibitor 2",HOUHLOFMBSYNBO-KKUQBAQOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
31806,6cs2,DB14785,-9.7,Fenebrutinib,WNEODWDFDXWOLU-QHCPKHFHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
112112,6vxx,DB06311,-9.7,Darapladib,WDPFJWLDPVQCAJ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140365,6w9c,DB04703,-9.7,Hesperidin,QUQPHWDTPGMPEX-QJBIFVCTSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
112127,6vxx,DB06364,-9.7,XR5944,SFOADSRLCHRTKT-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109303,6vxx,DB13040,-9.7,Gandotinib,SQSZANZGUXWJEA-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114008,6vxx,DB12580,-9.7,Tradipitant,CAVRKWRKTNINFF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
71687,6lxt,DB15085,-9.7,Fulacimstat,JDARDSVOVYVQST-MRXNPFEDSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
63146,6crv,DB15222,-9.7,GS-6620,YAAQYJCOIFNMKX-RSTNYOGXSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62987,6crv,DB14878,-9.7,Liafensine,VCIBGDSRPUOBOG-QFIPXVFZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113931,6vxx,DB12289,-9.7,Darexaban,IJNIQYINMSGIPS-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62655,6crv,DB13866,-9.7,Etynodiol,JYILPERKVHXLNF-QMNUTNMBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140757,6w9c,DB15247,-9.7,Vorolanib,KMIOJWCYOHBUJS-HAKPAVFJSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
24196,6cs2,DB01879,-9.7,(S)-2-{Methyl-[2-(Naphthalene-2-Sulfonylamino)-5-(Naphthalene-2-Sulfonyloxy)-Benzoyl]-Amino}-Succinicacid,JOAALZBSMWLOPQ-LJAQVGFWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
62968,6crv,DB14844,-9.7,ONC-201,VLULRUCCHYVXOH-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30007,6cs2,DB11923,-9.7,Decoglurant,DMJHZVARRXJSEG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
140225,6w9c,DB15396,-9.7,PF-114,SLIVDYMORZGPLW-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
111798,6vxx,DB04708,-9.7,"(S)-TETRAHYDROFURAN-3-YL (2S,3S)-4-((S)-4-((1R,3R)-3-(2-AMINO-2-OXOETHYL)-2,3-DIHYDRO-1H-INDEN-1-YL)-2-BENZYL-3-OXO-2,3-DIHYDRO-1H-PYRROL-2-YL)-3-HYDROXY-1-PHENYLBUTAN-2-YLCARBAMATE",SYNSHNDQFWMLJW-YZGRCXSVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140232,6w9c,DB15407,-9.7,Acalisib,DOCINCLJNAXZQF-LBPRGKRZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
109130,6vxx,DB12415,-9.7,Galeterone,PAFKTGFSEFKSQG-PAASFTFBSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111852,6vxx,DB04785,-9.7,Streptolydigin,KVTPRMV1KLIG-NCAOFHFGSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165763,7bv1,DB12973,-9.7,Serlopitant,FLNYCRJBCNNHRH-OIYLJQICSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
124100,6w4h,DB00762,-9.7,Irinotecan,UWKQSNNFCGGAFS-XIFFEERXSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
113917,6vxx,DB12272,-9.7,Vidupiprant,PFWVGKROPKKEDW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114206,6vxx,DB13093,-9.7,TAK-593,DZFZXPPHBWCXPQ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109159,6vxx,DB12457,-9.7,Rimegepant,KRNAOFGYEFKHPB-ANJVHQHFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72061,6m2n,DB00288,-9.7,Amcinonide,ILKJAFIWWBXGDU-MOGDOJJUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
140256,6w9c,DB15450,-9.7,PF-05105679,BXNMZRPTQFVRFA-QGZVFWFLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
62961,6crv,DB14821,-9.7,Macozinone,BJDZBXGJNBMCAV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62142,6crv,DB13158,-9.7,Clobetasone,XXIFVOHLGBURIG-OZCCCYNHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109261,6vxx,DB12973,-9.7,Serlopitant,FLNYCRJBCNNHRH-OIYLJQICSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114121,6vxx,DB12760,-9.7,GW-493838,ZQYJPMPXQLNTPQ-QCUYGVNKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72883,6m2n,DB01267,-9.7,Paliperidone,PMXMIIMHBWHSKN-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
63162,6crv,DB15254,-9.7,RO-5126766 free base,LMMJFBMMJUMSJS-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111771,6vxx,DB04495,-9.7,RU81843,GGPXNASQNUOIPB-NSOVKSMOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
71636,6lxt,DB14943,-9.7,LGH-447,VRQXRVAKPDCRCI-ZNMIVQPWSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
124352,6w4h,DB01051,-9.7,Novobiocin,YJQPYGGHQPGBLI-KGSXXDOSSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
29430,6cs2,DB09183,-9.7,Dasabuvir,NBRBXGKOEOGLOI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
63086,6crv,DB15108,-9.7,Tipranavir C-14,SUJUHGSWHZTSEU-MWQIXQBFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
63085,6crv,DB15106,-9.7,Surufatinib,TTZSNFLLYPYKIL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
63068,6crv,DB15071,-9.7,Omidenepag isopropyl,VIQCWEGEHRBLAC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109535,6vxx,DB14068,-9.7,Dexniguldipine,SVJMLYUFVDMUHP-MGBGTMOVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30805,6cs2,DB13005,-9.7,Rebastinib,WVXNSAVVKYZVOE-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
109703,6vxx,DB15169,-9.7,H3B-6527,MBWRLLRCTIYXDW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140516,6w9c,DB11995,-9.7,Avatrombopag,OFZJKCQENFPZBH-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
73161,6m2n,DB01661,-9.7,1-(5-phospho-D-ribosyl)-ATP,RKNHJBVBFHDXGR-MRUDJCSFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
63045,6crv,DB15029,-9.7,AZD-8186,LMJFJIDLEAWOQJ-CQSZACIVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62459,6crv,DB13607,-9.7,Picloxydine,YNCLPFSAZFGQCD-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113157,6vxx,DB08607,-9.7,"(5R)-5-(4-{[(2R)-6-HYDROXY-2,5,7,8-TETRAMETHYL-3,4-DIHYDRO-2H-CHROMEN-2-YL]METHOXY}BENZYL)-1,3-THIAZOLIDINE-2,4-DIONE",GXPHKUHSUJUWKP-NTKDMRAZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140025,6w9c,DB14774,-9.7,Balipodect,KVHRYLNQDWXAGI-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
113113,6vxx,DB08553,-9.7,"(1E)-5-(1-piperidin-4-yl-3-pyridin-4-yl-1H-pyrazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime",KWEFZSZCLBHIEQ-YYADALCUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
63050,6crv,DB15036,-9.7,Sitravatinib,WLAVZAAODLTUSW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62518,6crv,DB13682,-9.7,Cefpirome,DKOQGJHPHLTOJR-WHRDSVKCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62521,6crv,DB13685,-9.7,Quingestanol,PCJFRMOEZQQSAX-AIOSZGMZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113477,6vxx,DB09233,-9.7,Cronidipine,CNIJVNPIIHWRRP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
63031,6crv,DB14993,-9.7,Pyrotinib,SADXACCFNXBCFY-IYNHSRRRSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
63093,6crv,DB15121,-9.7,AT-001,YRGPAXAVTDMKDK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140487,6w9c,DB11949,-9.7,Vestipitant,SBBYBXSFWOLDDG-JLTOFOAXSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
31192,6cs2,DB13520,-9.7,Metergoline,WZHJKEUHNJHDLS-QTGUNEKASA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
139983,6w9c,DB14675,-9.7,Temsavir,QRPZBKAMSFHVRW-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
71575,6lxt,DB14822,-9.7,SB-649868,ZJXIUGNEAIHSBI-IBGZPJMESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
30493,6cs2,DB12561,-9.7,WNT-974,XXYGTCZJJLTAGH-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
112344,6vxx,DB06997,-9.7,"2-(4-fluorophenyl)-N-{[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]carbamoyl}acetamide",BMPOCDJEXAXXEZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
71557,6lxt,DB14773,-9.7,Lifirafenib,NGFFVZQXSRKHBM-FKBYEOEOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
109427,6vxx,DB13556,-9.7,Sulfamazone,BGLHAKAJGYLSOX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112411,6vxx,DB07072,-9.7,"(1S,2R,5S)-5-[3-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7(8H)-YL]-2-(2,4,5-TRIFLUOROPHENYL)CYCLOHEXANAMINE",CNKRZILQBKJWDS-WMFXKJRFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
73530,6m2n,DB02155,-9.7,Balanol Analog 8,XVLMXAUKCDSMMW-YXLARRHKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
69605,6lxt,DB11275,-9.7,Epicriptine,SBFXHXZNBNFPHV-PXXBSISHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
69666,6lxt,DB11431,-9.7,Moxidectin,YZBLFMPOMVTDJY-LSGXYNIPSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
62420,6crv,DB13552,-9.7,Trifluperidol,GPMXUUPHFNMNDH-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113741,6vxx,DB12012,-9.7,PF-04457845,BATCTBJIJJEPHM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113717,6vxx,DB11804,-9.7,AZD-5672,SCXSQUUTGCWHFU-WJOKGBTCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
63113,6crv,DB15157,-9.7,Voruciclib,MRPGRAKIAJJGMM-OCCSQVGLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
70732,6lxt,DB13109,-9.7,PKI-179,WXUUCRLKXQMWRY-OYRHEFFESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
140649,6w9c,DB13042,-9.7,Fenoverine,UBAJTZKNDCEGKL-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
109737,6vxx,DB15233,-9.7,Avapritinib,DWYRIWUZIJHQKQ-SANMLTNESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
125434,6w4h,DB02483,-9.7,Etheno-Nad,JCDBQDNBEQHDHK-BSLNIGMPSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
110495,6vxx,DB01668,-9.7,Nanaomycin D,XUWPJKDMEZSVTP-UOSCCXBLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114066,6vxx,DB12673,-9.7,ATX-914,ALANRBCCCQEPFZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114831,6vxx,DB14942,-9.7,BMS-986141,KEEBLYWBELVGPQ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111229,6vxx,DB03367,-9.7,PF-00356231,VMTJQZUZINLEKC-JOCHJYFZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72426,6m2n,DB00734,-9.7,Risperidone,RAPZEAPATHNIPO-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
63192,6crv,DB15310,-9.7,Vactosertib,FJCDSQATIJKQKA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72612,6m2n,DB00948,-9.7,Mezlocillin,YPBATNHYBCGSSN-VWPFQQQWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
66552,6lxt,DB04330,-9.7,Bilh 434,KNRVCCXHLSHTFW-HGPRPZRGSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
63185,6crv,DB15297,-9.7,Petesicatib,KXAAIORSMACJSI-AEFFLSMTSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31917,6cs2,DB15034,-9.7,PRI-724,VHOZWHQPEJGPCC-AZXNYEMZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
140185,6w9c,DB15305,-9.7,Risdiplam,ASKZRYGFUPSJPN-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140126,6w9c,DB15031,-9.7,Nemorexant,NBGABHGMJVIVBW-QHCPKHFHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
110837,6vxx,DB02473,-9.7,"6-[N-(1-Isopropyl-3,4-Dihydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine",XRHANBWAKSYPEN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
32859,6cs2,T3D3777,-9.7,Paspalitrem A,WCISYVSWAOUFIY-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
140147,6w9c,DB15068,-9.7,Agerafenib,DKNUPRMJNUQNHR-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140203,6w9c,DB15343,-9.7,HM-43239,FZLSDZZNPXXBBB-KDURUIRLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
62688,6crv,DB13950,-9.7,WIN 55212-2,HQVHOQAKMCMIIM-HXUWFJFHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
123959,6w4h,DB00590,-9.7,Doxazosin,RUZYUOTYCVRMRZ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
62881,6crv,DB14652,-9.7,Clocortolone acetate,ARPLCFGLEYFDCN-CDACMRRYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29964,6cs2,DB11870,-9.7,RG-4733,OJPLJFIFUQPSJR-INIZCTEOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
114935,6vxx,DB15442,-9.7,Trilaciclib,PDGKHKMBHVFCMG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72307,6m2n,DB00590,-9.7,Doxazosin,RUZYUOTYCVRMRZ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
72346,6m2n,DB00637,-9.7,Astemizole,GXDALQBWZGODGZ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
166530,7bv1,DB15308,-9.7,Ridinilazole,UHQFBTAJFNVZIV-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
114924,6vxx,DB15416,-9.7,PX-102,XBUXXJUEBFDQHD-NHCUHLMSSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109095,6vxx,DB12368,-9.7,AZD-3839,MRXBCEQZNKUUIP-DEOSSOPVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
65813,6lxt,DB03331,-9.7,"N-Naphthalen-1-Ylmethyl-2'-[3,5-Dimethoxybenzamido]-2'-Deoxy-Adenosine",OARVXDFNTLYMCJ-JVUUKAHWSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
114923,6vxx,DB15414,-9.7,CM-4307,MLDQJTXFUGDVEO-FIBGUPNXSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111437,6vxx,DB03869,-9.7,5'-O-(N-(L-Seryl)-Sulfamoyl)Adenosine,HQXFJGONGJPTLZ-YTMOPEAISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114721,6vxx,DB14703,-9.7,Dexamethasone metasulfobenzoate,TWQWRHIQRAZHPR-XNXCGYEVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114844,6vxx,DB15006,-9.7,Flufenoxuron,RYLHNOVXKPXDIP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114761,6vxx,DB14792,-9.7,AZD-5991,KBQCEQAXHPIRTF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114652,6vxx,DB14568,-9.7,Ivosidenib,WIJZXSAJMHAVGX-DHLKQENFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
63219,6crv,DB15362,-9.7,LSZ-102,SJXNPGGVGZXKKI-NYYWCZLTSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
66955,6lxt,DB04868,-9.7,Nilotinib,HHZIURLSWUIHRB-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
140106,6w9c,DB14946,-9.7,PCO-371,LDZJFVOUPUFOHX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
63933,6lxt,DB00872,-9.7,Conivaptan,IKENVDNFQMCRTR-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
140121,6w9c,DB15023,-9.7,BMS-791826,DZBKAUMYTFPJIS-QHCPKHFHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
73991,6m2n,DB02759,-9.7,4-Methylumbelliferyl Chitobiose,UPSFMJHZUCSEHU-JYGUBCOQSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
114840,6vxx,DB14993,-9.7,Pyrotinib,SADXACCFNXBCFY-IYNHSRRRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
73973,6m2n,DB02732,-9.7,Nicotinamide Adenine Dinucleotide Acetone Adduct,SGHBFOOIAAJJMI-YDKVLQLQSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
130470,6w4h,DB12307,-9.6,Foretinib,CXQHYVUVSFXTMY-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
97441,6m71,DB14894,-9.6,Galicaftor,QVDYQHXNAQHIKH-TZIWHRDSSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
71301,6lxt,DB13950,-9.6,WIN 55212-2,HQVHOQAKMCMIIM-HXUWFJFHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
112533,6vxx,DB07360,-9.6,"1-{5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)ethyl]-1,3-thiazol-2-yl}-3-[3-(trifluoromethyl)phenyl]urea",JJHXPDTVQKWKHA-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
137201,6w9c,DB08015,-9.6,"(3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-phenyl-1H-indole-2,3-dione 3-oxime",SZYREAUDQRVVLV-DAFNUICNSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
88518,6m3m,DB13943,-9.6,Testosterone cypionate,HPFVBGJFAYZEBE-ZLQWOROUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
112686,6vxx,DB07729,-9.6,3-fluoro-N-[3-(1H-tetrazol-5-yl)phenyl]benzamide,GAKOBKPDJJGRIL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
137335,6w9c,DB08164,-9.6,"(3R,4R)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN-3-AMINE",GOBIXGZJSMAOFV-QRWLVFNGSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
79801,6m2n,DB13764,-9.6,Monoxerutin,MBHXKZDTQCSVPM-BDAFLREQSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
60388,6crv,DB08588,-9.6,2-({2-[(3R)-3-AMINOPIPERIDIN-1-YL]-4-OXOQUINAZOLIN-3(4H)-YL}METHYL)BENZONITRILE,OYNURZXTLNNKAP-QGZVFWFLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130636,6w4h,DB12550,-9.6,Taladegib,SZBGQDXLNMELTB-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
62843,6crv,DB14568,-9.6,Ivosidenib,WIJZXSAJMHAVGX-DHLKQENFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31962,6cs2,DB15110,-9.6,Onvansertib,QHLVBNKYJGBCQJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
79910,6m2n,DB13947,-9.6,Testosterone enantate benzilic acid hydrazone,PTVXYACXDYZNID-JKXGKYMWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
60428,6crv,DB08639,-9.6,Dapivirine,ILAYIAGXTHKHNT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88371,6m3m,DB13710,-9.6,Metenolone,ANJQEDFWRSLVBR-VHUDCFPWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
70878,6lxt,DB13345,-9.6,Dihydroergocristine,DEQITUUQPICUMR-HJPBWRTMSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
61321,6crv,DB11911,-9.6,Galunisertib,IVRXNBXKWIJUQB-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
158181,7bv1,DB00696,-9.6,Ergotamine,XCGSFFUVFURLIX-VFGNJEKYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60486,6crv,DB08709,-9.6,"2,3-diphenyl-1H-indole-7-carboxylic acid",OLUDUXWVPIEHDA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88521,6m3m,DB13947,-9.6,Testosterone enantate benzilic acid hydrazone,PTVXYACXDYZNID-JKXGKYMWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
55529,6crv,DB01108,-9.6,Trilostane,KVJXBPDAXMEYOA-CXANFOAXSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111129,6vxx,DB03038,-9.6,LY341770,MXAFDBCLWLMXSI-ZDUSSCGKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88523,6m3m,DB13950,-9.6,WIN 55212-2,HQVHOQAKMCMIIM-HXUWFJFHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
112617,6vxx,DB07460,-9.6,2-({5-CHLORO-2-[(2-METHOXY-4-MORPHOLIN-4-YLPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)-N-METHYLBENZAMIDE,UYJNQQDJUOUFQJ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29367,6cs2,DB09074,-9.6,Olaparib,FDLYAMZZIXQODN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
78451,6m2n,DB11778,-9.6,Danusertib,XKFTZKGMDDZMJI-HSZRJFAPSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
130520,6w4h,DB12381,-9.6,Merestinib,QHADVLVFMKEIIP-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
80002,6m2n,DB14128,-9.6,Nadide,BAWFJGJZGIEFAR-NNYOXOHSSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
60445,6crv,DB08657,-9.6,2-(4-(2-((3-(5-(PYRIDIN-2-YLTHIO)THIAZOL-2-YL)UREIDO)METHYL)-1H-IMIDAZOL-4-YL)PHENOXY)ACETIC ACID,SSXCWVOQWRUMGN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78457,6m2n,DB11786,-9.6,Pefcalcitol,SVCSMAZYWOQCBW-NVJMFHFGSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
56503,6crv,DB02411,-9.6,"2-(11-{2-[Benzenesulfonyl-(3-Methyl-Butyl)-Amino]-1-Hydroxy-Ethyl}-6,9-Dioxo-2-Oxa-7,10-Diaza-Bicyclo[11.2.2]Heptadeca-1(16),13(17),14-Trien-8-Yl)-Acetamide, Inhibitor 2",HOUHLOFMBSYNBO-KKUQBAQOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27630,6cs2,DB07181,-9.6,"4'-[(1R)-1-amino-2-(2,5-difluorophenyl)ethyl]biphenyl-3-carboxamide",JYKFWUXBFJJDTP-HXUWFJFHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
130479,6w4h,DB12318,-9.6,BMS-599626,LUJZZYWHBDHDQX-QFIPXVFZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
88515,6m3m,DB13939,-9.6,RAD-140,XMBUPPIEVAFYHO-KPZWWZAWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
78683,6m2n,DB12116,-9.6,Epigallocatechin gallate,WMBWREPUVVBILR-WIYYLYMNSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80241,6m2n,DB14935,-9.6,Serabelisib,BLGWHBSBBJNKJO-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137013,6w9c,DB07800,-9.6,N-(2-(((5-CHLORO-2-PYRIDINYL)AMINO)SULFONYL)PHENYL)-4-(2-OXO-1(2H)-PYRIDINYL)BENZAMIDE,MIJGLXFQYBTIFY-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
13425,6lzg,DB15328,-9.6,Ubrogepant,DDOOFTLHJSMHLN-ZQHRPCGSSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
8838,6lzg,DB06896,-9.6,"1-(4-fluorophenyl)-N-[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]-2-oxo-1,2-dihydropyridine-3-carboxamide",OBSFXHDOLBYWRJ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
87757,6m3m,DB12806,-9.6,GSK-1004723,YANGEESWIGIKOP-UUWRZZSWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
138431,6w9c,DB11652,-9.6,Tucatinib,SDEAXTCZPQIFQM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
87744,6m3m,DB12784,-9.6,NS-018,UQTPDWDAYHAZNT-AWEZNQCLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
30833,6cs2,DB13042,-9.6,Fenoverine,UBAJTZKNDCEGKL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
13414,6lzg,DB15308,-9.6,Ridinilazole,UHQFBTAJFNVZIV-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
60204,6crv,DB08366,-9.6,"3-({3-[(1S,4aS,6S,7S,9S,9aR)-1,6-dimethyl-2-oxodecahydro-6,9-epoxy-4a,7-methanobenzo[7]annulen-1-yl]propanoyl}amino)-2,4-dihydroxybenzoic acid",XADCWKSMHQPTGH-OFBLZTNGSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113015,6vxx,DB08268,-9.6,"6-AMINO-4-[2-(4-METHYLPHENYL)ETHYL]-1,7-DIHYDRO-8H-IMIDAZO[4,5-G]QUINAZOLIN-8-ONE",SPVJRTJUEVXOMS-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163375,7bv1,DB04330,-9.6,Bilh 434,KNRVCCXHLSHTFW-HGPRPZRGSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
72679,6m2n,DB01026,-9.6,Ketoconazole,XMAYWYJOQHXEEK-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
140530,6w9c,DB12012,-9.6,PF-04457845,BATCTBJIJJEPHM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
70293,6lxt,DB12427,-9.6,Orvepitant,XWNBGDJPEXZSQM-VZOBGQTKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
140533,6w9c,DB12020,-9.6,Tecovirimat,CSKDFZIMJXRJGH-VWLPUNTISA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
98105,6vxs,DB00549,-9.6,Zafirlukast,YEEZWCHGZNKEEK-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
136926,6w9c,DB07700,-9.6,"3-CARBOXAMIDO-1,3,5(10)-ESTRATRIEN-17(R)-SPIRO-2'(5',5'-DIMETHYL-6'OXO)TETRAHYDROPYRAN",YVAJWBACBRSVPR-NDUHRLLKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136918,6w9c,DB07691,-9.6,"2-({[3-(3,4-dihydroisoquinolin-2(1H)-ylsulfonyl)phenyl]carbonyl}amino)benzoic acid",GYILVHHTCYNIOS-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
113037,6vxx,DB08299,-9.6,"4-[8-(3-nitrophenyl)-1,7-naphthyridin-6-yl]benzoic acid",QTNUWEKKZHSUQO-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
159047,7bv1,DB03076,-9.6,AHA047,CGBDAHCDSVOMCF-FYZVQMPESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
164501,7bv1,DB08079,-9.6,AMG-208,HEAIZQNMNCHNFD-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
163515,7bv1,DB04727,-9.6,"N-(4-{4-AMINO-6-[4-(METHYLOXY)PHENYL]FURO[2,3-D]PYRIMIDIN-5-YL}PHENYL)-N'-[2-FLUORO-5-(TRIFLUOROMETHYL)PHENYL]UREA",FGZIONRFHVNRJB-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
138426,6w9c,DB11645,-9.6,PF-4191834,DVNQWYLVSNPCJZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
97647,6m71,DB15328,-9.6,Ubrogepant,DDOOFTLHJSMHLN-ZQHRPCGSSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
87804,6m3m,DB12885,-9.6,CF-102,IPSYPUKKXMNCNQ-PFHKOEEOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
97472,6m71,DB14946,-9.6,PCO-371,LDZJFVOUPUFOHX-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
80242,6m2n,DB14937,-9.6,MK-8666,CODQKEMYZZKQAE-QPVYNBJUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
60584,6crv,DB08816,-9.6,Ticagrelor,OEKWJQXRCDYSHL-FNOIDJSQSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
137168,6w9c,DB07978,-9.6,"2-({[2,3,5,6-TETRAFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)CYCLOPENTA-1,3-DIENE-1-CARBOXYLIC ACID",ULMUPVXFUDHRGH-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
158452,7bv1,DB01199,-9.6,Tubocurarine,JFJZZMVDLULRGK-URLMMPGGSA-O,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97498,6m71,DB15039,-9.6,ITI-214,BBIPVJCGIASXJB-PKTZIBPZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
140499,6w9c,DB11966,-9.6,BMS-986094,YFXGICNMLCGLHJ-RSKRLRQZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138411,6w9c,DB11614,-9.6,Rupatadine,WUZYKBABMWJHDL-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
80261,6m2n,DB15011,-9.6,Avacopan,PUKBOVABABRILL-YZNIXAGQSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61350,6crv,DB11952,-9.6,Duvelisib,SJVQHLPISAIATJ-ZDUSSCGKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88160,6m3m,DB13422,-9.6,Nicofuranose,FUWFSXZKBMCSKF-ZASNTINBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
112779,6vxx,DB07833,-9.6,"N-(3-cyanophenyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)-4-biphenylcarboxamide",PMMLSQFPBFKLHH-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
97637,6m71,DB15308,-9.6,Ridinilazole,UHQFBTAJFNVZIV-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
78347,6m2n,DB11611,-9.6,Lifitegrast,JFOZKMSJYSPYLN-QHCPKHFHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
56702,6crv,DB02669,-9.6,RB106,ZWDQTNWLXALTOV-QYZOEREBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130771,6w4h,DB12760,-9.6,GW-493838,ZQYJPMPXQLNTPQ-QCUYGVNKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
63041,6crv,DB15023,-9.6,BMS-791826,DZBKAUMYTFPJIS-QHCPKHFHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87904,6m3m,DB13036,-9.6,Ramatroban,LDXDSHIEDAPSSA-OAHLLOKOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80321,6m2n,DB15126,-9.6,IMG-7289,KQKBMHGOHXOHTD-KKUQBAQOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
60310,6crv,DB08495,-9.6,4-({4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-2-OXOPIPERAZIN-1-YL}METHYL)BENZENECARBOXIMIDAMIDE,VXONTEUOQXFJJS-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60305,6crv,DB08490,-9.6,CTS-1027,ROSNVSQTEGHUKU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60275,6crv,DB08454,-9.6,N-(5-METHYL-1H-PYRAZOL-3-YL)-2-PHENYLQUINAZOLIN-4-AMINE,JYCUVOXSZBECAY-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80272,6m2n,DB15034,-9.6,PRI-724,VHOZWHQPEJGPCC-AZXNYEMZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
25415,6cs2,DB03331,-9.6,"N-Naphthalen-1-Ylmethyl-2'-[3,5-Dimethoxybenzamido]-2'-Deoxy-Adenosine",OARVXDFNTLYMCJ-JVUUKAHWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
137484,6w9c,DB08354,-9.6,"2-(4-CHLOROBENZYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE",QCVULERVJOYHCP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
96416,6m71,DB12886,-9.6,GSK-1521498,WIEDUMBCZQRGSY-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
140245,6w9c,DB15435,-9.6,BMS-986158,KGERZPVQIRYWRK-GDLZYMKVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
89096,6m3m,DB15456,-9.6,Vericiguat,QZFHIXARHDBPBY-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
129774,6w4h,DB09298,-9.6,Silibinin,SEBFKMXJBCUCAI-HKTJVKLFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
31840,6cs2,DB14860,-9.6,Ensartinib,GLYMPHUVMRFTFV-QLFBSQMISA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
60891,6crv,DB09286,-9.6,Pipamperone,AXKPFOAXAHJUAG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
89089,6m3m,DB15444,-9.6,Elexacaftor,MVRHVFSOIWFBTE-INIZCTEOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
55719,6crv,DB01405,-9.6,Temafloxacin,QKDHBVNJCZBTMR-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27983,6cs2,DB07548,-9.6,"2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUORO-6-PYRIDINYL)METHYL]ACETAMIDE",JXHWVKOKYDAROD-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
27980,6cs2,DB07545,-9.6,N-{3-[(4-{[3-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-2-YL)AMINO]PHENYL}CYCLOPROPANECARBOXAMIDE,RDTDWGQDFJPTPD-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
137835,6w9c,DB08772,-9.6,"3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL-2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID",BCSVCWVQNOXFGL-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
89029,6m3m,DB15317,-9.6,Posiphen,PBHFNBQPZCRWQP-AZUAARDMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
123075,6w4b,DB14773,-9.6,Lifirafenib,NGFFVZQXSRKHBM-FKBYEOEOSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
89027,6m3m,DB15310,-9.6,Vactosertib,FJCDSQATIJKQKA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
14116,6lzg,T3D3733,-9.6,Penitrem B,CRPJNVUYZRFGAK-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
89015,6m3m,DB15292,-9.6,Foliglurax,ZTEDNASHAWNBKQ-NCELDCMTSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
71989,6m2n,DB00206,-9.6,Reserpine,QEVHRUUCFGRFIF-MDEJGZGSSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
88997,6m3m,DB15254,-9.6,RO-5126766 free base,LMMJFBMMJUMSJS-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88996,6m3m,DB15250,-9.6,Vercirnon,JRWROCIMSDXGOZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
62904,6crv,DB14676,-9.6,Fagrocorat,QJJBNCHSWFGXML-KEKPKEOLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88993,6m3m,DB15245,-9.6,Olorofim,SUFPWYYDCOKDLL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
60852,6crv,DB09227,-9.6,Barnidipine,VXMOONUMYLCFJD-DHLKQENFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60978,6crv,DB11219,-9.6,Enzacamene,HEOCBCNFKCOKBX-SDNWHVSQSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31859,6cs2,DB14895,-9.6,Vibegron,DJXRIQMCROIRCZ-XOEOCAAJSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
89725,6m71,DB00826,-9.6,Natamycin,NCXMLFZGDNKEPB-FFPOYIOWSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
6309,6lzg,DB01897,-9.6,2-(2f-Benzothiazolyl)-5-Styryl-3-(4f-Phthalhydrazidyl)Tetrazolium Chloride,BEIGFKLRGRRJJA-JLHYYAGUSA-O,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
78667,6m2n,DB12096,-9.6,PF-05175157,BDXXSFOJPYSYOC-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
14384,6lzg,T3D4068,-9.6,C-Curarine,DWELRYDMYVJVSL-GQBJSJAWSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
55655,6crv,DB01259,-9.6,Lapatinib,BCFGMOOMADDAQU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
93173,6m71,DB06486,-9.6,Enzastaurin,AXRCEOKUDYDWLF-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
61118,6crv,DB11592,-9.6,Nitrocefin,LHNIIDJCEODSHA-OQRUQETBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
93155,6m71,DB06448,-9.6,Lonafarnib,DHMTURDWPRKSOA-RUZDIDTESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
78666,6m2n,DB12095,-9.6,Telotristat ethyl,MDSQOJYHHZBZKA-GBXCKJPGSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
94534,6m71,DB08220,-9.6,"(8alpha,10alpha,13alpha,17beta)-17-[(4-hydroxyphenyl)carbonyl]androsta-3,5-diene-3-carboxylic acid",RPNNXCYIESWDSC-JRZBRKEGSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
137930,6w9c,DB08911,-9.6,Trametinib,LIRYPHYGHXZJBZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
78653,6m2n,DB12073,-9.6,Albaconazole,UHIXWHUVLCAJQL-MPBGBICISA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
92680,6m71,DB04727,-9.6,"N-(4-{4-AMINO-6-[4-(METHYLOXY)PHENYL]FURO[2,3-D]PYRIMIDIN-5-YL}PHENYL)-N'-[2-FLUORO-5-(TRIFLUOROMETHYL)PHENYL]UREA",FGZIONRFHVNRJB-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
92107,6m71,DB03957,-9.6,SP2456,SSSXBBASYYVGCI-HSZRJFAPSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
78787,6m2n,DB12269,-9.6,PF-06273340,BPIWZDNVMQQBQX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61046,6crv,DB11424,-9.6,Lufenuron,PWPJGUXAGUPAHP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78808,6m2n,DB12295,-9.6,Evodenoson,SQJXTUJMBYVDBB-RQXXJAGISA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
90559,6m71,DB01897,-9.6,2-(2f-Benzothiazolyl)-5-Styryl-3-(4f-Phthalhydrazidyl)Tetrazolium Chloride,BEIGFKLRGRRJJA-JLHYYAGUSA-O,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
55653,6crv,DB01254,-9.6,Dasatinib,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
89766,6m71,DB00872,-9.6,Conivaptan,IKENVDNFQMCRTR-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
138032,6w9c,DB09054,-9.6,Idelalisib,IFSDAJWBUCMOAH-HNNXBMFYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
60990,6crv,DB11273,-9.6,Dihydroergocornine,SEALOBQTUQIVGU-QNIJNHAOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88990,6m3m,DB15238,-9.6,Olinciguat,YWQFJNWMWZMXRW-HXUWFJFHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
96552,6m71,DB13093,-9.6,TAK-593,DZFZXPPHBWCXPQ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
78612,6m2n,DB12010,-9.6,Fostamatinib,GKDRMWXFWHEQQT-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
112069,6vxx,DB06212,-9.6,Tolvaptan,GYHCTFXIZSNGJT-XMMPIXPASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88833,6m3m,DB14898,-9.6,Retagliptin,WIIAMRXFUJLYEF-SNVBAGLBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
79265,6m2n,DB12996,-9.6,Acteoside,FBSKJMQYURKNSU-ZLSOWSIRSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
62990,6crv,DB14882,-9.6,CEP-9722,CTLOSZHDGZLOQE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112242,6vxx,DB06876,-9.6,"N-{5-[4-(4-METHYLPIPERAZIN-1-YL)PHENYL]-1H-PYRROLO[2,3-B]PYRIDIN-3-YL}NICOTINAMIDE",YJWJKKXGAPWLGT-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55596,6crv,DB01185,-9.6,Fluoxymesterone,YLRFCQOZQXIBAB-RBZZARIASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88814,6m3m,DB14862,-9.6,PF-06815345,QTBYVAZRKWOIDU-FUHWJXTLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
79296,6m2n,DB13042,-9.6,Fenoverine,UBAJTZKNDCEGKL-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
112295,6vxx,DB06933,-9.6,N-(tert-butyl)-4-[5-(pyridin-2-ylamino)quinolin-3-yl]benzenesulfonamide,GJTCKUKIFXWJKG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
94199,6m71,DB07833,-9.6,"N-(3-cyanophenyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)-4-biphenylcarboxamide",PMMLSQFPBFKLHH-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60682,6crv,DB08971,-9.6,Fluocortolone,GAKMQHDJQHZUTJ-ULHLPKEOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79319,6m2n,DB13074,-9.6,Macimorelin,UJVDJAPJQWZRFR-DHIUTWEWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
72458,6m2n,DB00773,-9.6,Etoposide,VJJPUSNTGOMMGY-MRVIYFEKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
60624,6crv,DB08883,-9.6,Perampanel,PRMWGUBFXWROHD-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88724,6m3m,DB14661,-9.6,Loperamide oxide,KXVSBTJVTUVNPM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
96269,6m71,DB12651,-9.6,Bardoxolone,TXGZJQLMVSIZEI-UQMAOPSPSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
62847,6crv,DB14575,-9.6,Eslicarbazepine,BMPDWHIDQYTSHX-AWEZNQCLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79355,6m2n,DB13126,-9.6,BMS-986115,SRJNRAQUSAVENA-GSHUGGBRSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
140431,6w9c,DB06831,-9.6,2-((9H-PURIN-6-YLTHIO)METHYL)-5-CHLORO-3-(2-METHOXYPHENYL)QUINAZOLIN-4(3H)-ONE,UMMYTDJYDSTEMB-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
61292,6crv,DB11871,-9.6,PF-00610355,YPHDIMUXXABSSO-YTTGMZPUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138304,6w9c,DB11363,-9.6,Alectinib,KDGFLJKFZUIJMX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
61286,6crv,DB11863,-9.6,Alvelestat,QNQZWEGMKJBHEM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88834,6m3m,DB14899,-9.6,Tavapadon,AKQXQLUNFKDZBN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88844,6m3m,DB14918,-9.6,Branaplam,STWTUEAWRAIWJG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
79208,6m2n,DB12904,-9.6,ZSTK-474,HGVNLRPZOWWDKD-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79075,6m2n,DB12693,-9.6,Ritanserin,JUQLTPCYUFPYKE-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78604,6m2n,DB12001,-9.6,Abemaciclib,UZWDCWONPYILKI-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
71844,6lxt,DB15399,-9.6,BMS-754807,LQVXSNNAFNGRAH-QHCPKHFHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
88952,6m3m,DB15168,-9.6,Cilofexor,KZSKGLFYQAYZCO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88945,6m3m,DB15151,-9.6,RO-6870810,PKQXLRYFPSZKDU-QFIPXVFZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88935,6m3m,DB15133,-9.6,Tepotinib,AHYMHWXQRWRBKT-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
79117,6m2n,DB12756,-9.6,TAK-901,WKDACQVEJIVHMZ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78573,6m2n,DB11951,-9.6,Lemborexant,MUGXRYIUWFITCP-PGRDOPGGSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
95706,6m71,DB11822,-9.6,TMC-647055,UOBYJVFBFSLCTQ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
79146,6m2n,DB12806,-9.6,GSK-1004723,YANGEESWIGIKOP-UUWRZZSWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
112149,6vxx,DB06435,-9.6,Tarazepide,CZPILLBHPRAPCB-AREMUKBSSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
129144,6w4h,DB08445,-9.6,"(3R,4S)-1-[6-(6-METHOXYPYRIDIN-3-YL)PYRIMIDIN-4-YL]-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE",IFKWHPAWYJARQJ-DYVFJYSZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
112176,6vxx,DB06497,-9.6,Aplaviroc,GWNOTCOIYUNTQP-FQLXRVMXSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61248,6crv,DB11805,-9.6,Saracatinib,OUKYUETWWIPKQR-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112182,6vxx,DB06518,-9.6,R-1487,KKKRKRMVJRHDMG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79170,6m2n,DB12850,-9.6,Etalocib,YFIZRWPXUYFCSN-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
140380,6w9c,DB05835,-9.6,NS-3728,OQRAKHDEGGGWQO-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
79185,6m2n,DB12875,-9.6,Mavatrep,ORDHXXHTBUZRCN-NTEUORMPSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
55990,6crv,DB01732,-9.6,"(4r,5s,6s,7r)-1,3-Dibenzyl-4,7-Bis(Phenoxymethyl)-5,6-Dihydroxy-1,3 Diazepan-2-One",SQBOSZXDOHQFAA-ZRTHHSRSSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31521,6cs2,DB13953,-9.6,Estradiol benzoate,UYIFTLBWAOGQBI-BZDYCCQFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
60684,6crv,DB08973,-9.6,Fluclorolone acetonide,NJNWEGFJCGYWQT-VSXGLTOVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31808,6cs2,DB14790,-9.6,BPN-14770,KRRGWHSEDYQKDQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
113043,6vxx,DB08305,-9.6,"(3R)-3-cyclopentyl-6-methyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2-benzothiazine 1,1-dioxide",KQAGZLQCEURCKJ-QGZVFWFLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
74400,6m2n,DB03300,-9.6,Pterin Cytosine Dinucleotide,WKSPNQYEWZEMMI-FEFZDOOUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80614,6m3m,DB00224,-9.6,Indinavir,CBVCZFGXHXORBI-PXQQMZJSSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59387,6crv,DB07403,-9.6,"4-[(3-CHLORO-4-{[(2R)-3,3,3-TRIFLUORO-2-HYDROXY-2-METHYLPROPANOYL]AMINO}PHENYL)SULFONYL]-N,N-DIMETHYLBENZAMIDE",DTDZLJHKVNTQGZ-GOSISDBHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
135861,6w9c,DB05423,-9.6,ORG-34517,DFELGYQKEOCHOA-BZAFBGKRSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
29746,6cs2,DB11521,-9.6,Imidocarb,SCEVFJUWLLRELN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
83531,6m3m,DB04006,-9.6,"[2-Amino-6-(2,6-Difluoro-Benzoyl)-Imidazo[1,2-a]Pyridin-3-Yl]-Phenyl-Methanone",WUGJIPFLBOATGL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
67315,6lxt,DB06435,-9.6,Tarazepide,CZPILLBHPRAPCB-AREMUKBSSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
30074,6cs2,DB12012,-9.6,PF-04457845,BATCTBJIJJEPHM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
26696,6cs2,DB04881,-9.6,Elacridar,OSFCMRGOZNQUSW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
83544,6m3m,DB04023,-9.6,"Guanosine 5'-(Trihydrogen Diphosphate), P'-D-Mannopyranosyl Ester",DNBSDUDYNPJVCN-ZXTXFPBHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
141322,6w9q,DB00762,-9.6,Irinotecan,UWKQSNNFCGGAFS-XIFFEERXSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
85683,6m3m,DB07945,-9.6,"5-(3-carbamoylbenzyl)-5,6,7,8,9,10-hexahydrocyclohepta[b]indole-4-carboxylic acid",GKBQRPKZHUFGOB-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
30051,6cs2,DB11986,-9.6,Entrectinib,HAYYBYPASCDWEQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
85623,6m3m,DB07872,-9.6,5-chloro-N-[(3R)-1-(2-{[2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl]amino}-2-oxoethyl)pyrrolidin-3-yl]thiophene-2-carboxamide,IYGIXVNAMZPBDK-CQSZACIVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
67330,6lxt,DB06469,-9.6,Lestaurtinib,UIARLYUEJFELEN-DMVVYWCZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
116234,6w4b,DB01879,-9.6,(S)-2-{Methyl-[2-(Naphthalene-2-Sulfonylamino)-5-(Naphthalene-2-Sulfonyloxy)-Benzoyl]-Amino}-Succinicacid,JOAALZBSMWLOPQ-LJAQVGFWSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
58646,6crv,DB06263,-9.6,Amrubicin,VJZITPJGSQKZMX-XDPRQOKASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85572,6m3m,DB07815,-9.6,GIBBERELLIN A4,RSQSQJNRHICNNH-NFMPGMCNSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83816,6m3m,DB04392,-9.6,"Bishydroxy[2h-1-Benzopyran-2-One,1,2-Benzopyrone]",HIZKPJUTKKJDGA-BETUJISGSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85557,6m3m,DB07800,-9.6,N-(2-(((5-CHLORO-2-PYRIDINYL)AMINO)SULFONYL)PHENYL)-4-(2-OXO-1(2H)-PYRIDINYL)BENZAMIDE,MIJGLXFQYBTIFY-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58650,6crv,DB06268,-9.6,Sitaxentan,PHWXUGHIIBDVKD-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59292,6crv,DB07294,-9.6,"3-fluoro-4-[2-hydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8,-tetrahydro-naphtalen-2-yl)-acetylamino]-benzoic acid",AANFHDFOMFRLLR-IBGZPJMESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
135751,6w9c,DB04888,-9.6,Bifeprunox,CYGODHVAJQTCBG-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
161115,7bv1,DB12903,-9.6,DEBIO-1347,BEMNJULZEQTDJY-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
83955,6m3m,DB04574,-9.6,Estrone sulfate,JKKFKPJIXZFSSB-CBZIJGRNSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
114483,6vxx,DB13685,-9.6,Quingestanol,PCJFRMOEZQQSAX-AIOSZGMZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85469,6m3m,DB07698,-9.6,"3-(3-aminophenyl)-N-(3-chlorophenyl)pyrazolo[1,5-a]pyrimidin-5-amine",JDNMRPIWJIDDAY-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
29991,6cs2,DB11904,-9.6,Flumatinib,BJCJYEYYYGBROF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
26201,6cs2,DB04285,-9.6,"{4-[(2s,4e)-2-(1,3-Benzothiazol-2-Yl)-2-(1h-1,2,3-Benzotriazol-1-Yl)-5-Phenylpent-4-Enyl]Phenyl}(Difluoro)Methylphosphonic Acid",GBLDYRVJENYQNH-AGLOJYHOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
67340,6lxt,DB06486,-9.6,Enzastaurin,AXRCEOKUDYDWLF-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
83424,6m3m,DB03865,-9.6,6-Chloro-2-(2-Hydroxy-Biphenyl-3-Yl)-1h-Indole-5-Carboxamidine,FEKRWNWZMOSVBX-UHFFFAOYSA-O,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59414,6crv,DB07434,-9.6,HONH-BENZYLMALONYL-L-ALANYLGLYCINE-P-NITROANILIDE,TZWQPWGUQCSKDW-GUYCJALGSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
67875,6lxt,DB07261,-9.6,"THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [1-(1-AMINO-ISOQUINOLIN-7-YLMETHYL)-2-OXO-PYRROLDIN-3-YL]-AMIDE",NVKDOURNRJCKJE-INIZCTEOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
86148,6m3m,DB08498,-9.6,"(1S)-1-(3-chlorophenyl)-2-oxo-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate",OVSAMUIBGQSLDC-INIZCTEOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
82814,6m3m,DB03044,-9.6,1-(5-Tert-Butyl-2-P-Tolyl-2h-Pyrazol-3-Yl)-3-[4-(2-Morpholin-4-Yl-Ethoxy)-Naphthalen-1-Yl]-Urea,MVCOAUNKQVWQHZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136041,6w9c,DB06401,-9.6,Bazedoxifene,UCJGJABZCDBEDK-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
114110,6vxx,DB12742,-9.6,Amuvatinib,FOFDIMHVKGYHRU-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86108,6m3m,DB08450,-9.6,N-1H-indazol-5-yl-2-(6-methylpyridin-2-yl)quinazolin-4-amine,HNHRWNUXTCATSG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
132890,6w9c,DB00966,-9.6,Telmisartan,RMMXLENWKUUMAY-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
132963,6w9c,DB01051,-9.6,Novobiocin,YJQPYGGHQPGBLI-KGSXXDOSSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
86067,6m3m,DB08400,-9.6,4-(3-{[5-(trifluoromethyl)pyridin-2-yl]oxy}benzyl)piperidine-1-carboxylic acid,KUEKMTNOUPAOBS-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86059,6m3m,DB08391,-9.6,"6,7-DIMETHOXY-4-[(3R)-3-(QUINOXALIN-2-YLOXY)PYRROLIDIN-1-YL]QUINAZOLINE",UBIIFKJMNRPNMT-CQSZACIVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
82958,6m3m,DB03231,-9.6,"3-(5-Amino-7-oxo-3,7-dihydro-2H-[1,2,3]triazolo[4,5-d]pyrimidin-2-yl)-N-(2-{[2-(hydroxymethyl)phenyl]sulfanyl}benzyl)benzamide",IXDQOBDHBWEZOH-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
67600,6lxt,DB06938,-9.6,4-[[2-[[4-chloro-3-(trifluoromethyl)phenyl]amino]-3H-benzimidazol-5-yl]oxy]-N-methyl-pyridine-2-carboxamide,ZJLSMLDOCGOURY-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
136008,6w9c,DB06281,-9.6,Torcetrapib,CMSGWTNRGKRWGS-NQIIRXRSSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
114148,6vxx,DB12806,-9.6,GSK-1004723,YANGEESWIGIKOP-UUWRZZSWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58508,6crv,DB05616,-9.6,"4'-Methylene-5,8,10-trideazaaminopterin",NAWXUBYGYWOOIX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86030,6m3m,DB08355,-9.6,"1-methyl-8-(phenylamino)-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxylic acid",ZOBRPBVIEUWYJR-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86026,6m3m,DB08351,-9.6,N-cyclopropyl-4-methyl-3-{2-[(2-morpholin-4-ylethyl)amino]quinazolin-6-yl}benzamide,MNEXDVSJIUQQRH-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86025,6m3m,DB08350,-9.6,"5-[3-(2-METHOXYPHENYL)-1H-PYRROLO[2,3-B]PYRIDIN-5-YL]-N,N-DIMETHYLPYRIDINE-3-CARBOXAMIDE",GYQRHHQPEMOLKH-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58524,6crv,DB05713,-9.6,LY-517717,VYNKVNDKAOGAAQ-RUZDIDTESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58554,6crv,DB05936,-9.6,CVT-6883,KOYXXLLNCXWUNF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
83054,6m3m,DB03355,-9.6,5'-O-(N-(L-Threonyl)-Sulfamoyl)Adenosine,UPVAPSGKXAAHBG-CKTDUXNWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
140773,6w9c,DB15287,-9.6,Elismetrep,CWEFDWIKLABKBX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
114165,6vxx,DB12836,-9.6,Grapiprant,HZVLFTCYCLXTGV-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85890,6m3m,DB08174,-9.6,"5-CHLORO-N-((1R,2S)-2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO) CYCLOPENTYL)THIOPHENE-2-CARBOXAMIDE",QCPYHSAHOYXXQK-DLBZAZTESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85882,6m3m,DB08166,-9.6,"(4R)-7-chloro-9-methyl-1-oxo-1,2,4,9-tetrahydrospiro[beta-carboline-3,4'-piperidine]-4-carbonitrile",LPFQFJAOMCGYCP-GFCCVEGCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
114177,6vxx,DB12857,-9.6,NVP-LEQ-506,POERAARDVFVDLO-QGZVFWFLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59415,6crv,DB07435,-9.6,"1,2,3-TRIHYDROXY-1,2,3,4-TETRAHYDROBENZO[A]PYRENE",GFANZDFKCCJYRF-NSISKUIASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85461,6m3m,DB07689,-9.6,"METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE",NYNAFINLHQEHKU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86150,6m3m,DB08500,-9.6,"(3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(2-naphthyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol",ZCJBDRSKHARECB-PYTCMNEWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
133433,6w9c,DB01678,-9.6,RU84687,SAFPHFWYRLLBFO-NSOVKSMOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
133449,6w9c,DB01698,-9.6,Rutin,IKGXIBQEEMLURG-NVPNHPEKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
135157,6w9c,DB04064,-9.6,Nogalaviketone,QHNJNOBWURJIEK-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
84475,6m3m,DB06250,-9.6,Fluasterone,VHZXNQKVFDBFIK-NBBHSKLNSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84918,6m3m,DB07053,-9.6,2-{5-[3-(7-PROPYL-3-TRIFLUOROMETHYLBENZO[D]ISOXAZOL-6-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID,TWVYNPULGKGJOS-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58838,6crv,DB06730,-9.6,Gestodene,SIGSPDASOTUPFS-XUDSTZEESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84891,6m3m,DB07025,-9.6,3-(5-{[4-(AMINOMETHYL)PIPERIDIN-1-YL]METHYL}-1H-INDOL-2-YL)QUINOLIN-2(1H)-ONE,KBIHHEGEALBUMT-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59040,6crv,DB07005,-9.6,D-phenylalanyl-N-{4-[amino(iminio)methyl]benzyl}-L-prolinamide,VZFTWWJAUZOJDH-MOPGFXCFSA-O,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84506,6m3m,DB06334,-9.6,Tucidinostat,SZMJVTADHFNAIS-BJMVGYQFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59030,6crv,DB06995,-9.6,N-({4-[(2-aminopyridin-4-yl)oxy]-3-fluorophenyl}carbamoyl)-2-(4-fluorophenyl)acetamide,USBSTVPJNQLYEM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
23709,6cs2,HMDB0112265,-9.6,13-cis-beta-Carotene,OENHQHLEOONYIE-MZMZTKINSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
84528,6m3m,DB06410,-9.6,Doxercalciferol,HKXBNHCUPKIYDM-CGMHZMFXSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84529,6m3m,DB06412,-9.6,Oxymetholone,ICMWWNHDUZJFDW-DHODBPELSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84535,6m3m,DB06429,-9.6,Talnetant,BIAVGWDGIJKWRM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84979,6m3m,DB07124,-9.6,"(2S)-1-(6H-INDOL-3-YL)-3-{[5-(7H-PYRAZOLO[3,4-C]PYRIDIN-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE",CCIACUJJBPSOHE-KRWDZBQOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
143436,6w9q,DB03523,-9.6,Brequinar,PHEZJEYUWHETKO-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
160856,7bv1,DB11822,-9.6,TMC-647055,UOBYJVFBFSLCTQ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
134556,6w9c,DB03231,-9.6,"3-(5-Amino-7-oxo-3,7-dihydro-2H-[1,2,3]triazolo[4,5-d]pyrimidin-2-yl)-N-(2-{[2-(hydroxymethyl)phenyl]sulfanyl}benzyl)benzamide",IXDQOBDHBWEZOH-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
84569,6m3m,DB06515,-9.6,Resiniferatoxin,DSDNAKHZNJAGHN-MXTYGGKSSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84572,6m3m,DB06521,-9.6,Ertiprotafib,FONCZICQWCUXEB-RUZDIDTESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
134838,6w9c,DB03632,-9.6,Argifin,UHBHXSDKGLPPGO-HTDHLNIYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
84574,6m3m,DB06525,-9.6,Ganstigmine,ZOBDWFRKFSPCRB-UNMCSNQZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84735,6m3m,DB06837,-9.6,"(2R)-N-4-hydroxy-2-(3-hydroxybenzyl)-N-1-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]butanediamide",VXDKQRWTOJFQKH-BJZITVGISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
160819,7bv1,DB11772,-9.6,Pilaralisib,QINPEPAQOBZPOF-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
23773,6cs2,DB01411,-9.6,Pranlukast,NBQKINXMPLXUET-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
58970,6crv,DB06920,-9.6,Eribaxaban,QQBKAVAGLMGMHI-WIYYLYMNSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84719,6m3m,DB06817,-9.6,Raltegravir,CZFFBEXEKNGXKS-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
23781,6cs2,DB01419,-9.6,Antrafenine,NWGGKKGAFZIVBJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
114832,6vxx,DB14943,-9.6,LGH-447,VRQXRVAKPDCRCI-ZNMIVQPWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84435,6m3m,DB06169,-9.6,Indibulin,SOLIIYNRSAWTSQ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84433,6m3m,DB06163,-9.6,Plevitrexed,IEJSCSAMMLUINT-NRFANRHFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85003,6m3m,DB07152,-9.6,N-[4-(5-fluoro-6-methylpyridin-2-yl)-5-quinoxalin-6-yl-1H-imidazol-2-yl]acetamide,TYPILNNEZPSNTI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
66828,6lxt,DB04703,-9.6,Hesperidin,QUQPHWDTPGMPEX-QJBIFVCTSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
84050,6m3m,DB04703,-9.6,Hesperidin,QUQPHWDTPGMPEX-QJBIFVCTSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85454,6m3m,DB07680,-9.6,[(1S)-1-(5-CHLORO-1-BENZOTHIEN-3-YL)-2-(2-NAPHTHYLAMINO)-2-OXOETHYL]PHOSPHONIC ACID,HUJXISJLAPAFBO-IBGZPJMESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85440,6m3m,DB07664,-9.6,"5-AMINO-3-{[4-(AMINOSULFONYL)PHENYL]AMINO}-N-(2,6-DIFLUOROPHENYL)-1H-1,2,4-TRIAZOLE-1-CARBOTHIOAMIDE",ARIOBGGRZJITQX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
133467,6w9c,DB01721,-9.6,Analogue of Indinavir Drug,MJIRDPUZGGHJMX-OIVSQUILSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
84090,6m3m,DB04760,-9.6,"PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-(4-FLUORO-3-METHYL-BENZYLAMIDE)",PYFRREJCFXFNRR-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84118,6m3m,DB04796,-9.6,Inecalcitol,HHGRMHMXKPQNGF-WNSNRMDMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58663,6crv,DB06307,-9.6,Apoptone,CKAXZOYFIHQCBN-JRRMKBMNSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84168,6m3m,DB04859,-9.6,Zanapezil,PMBLXLOXUGVTGB-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
133554,6w9c,DB01836,-9.6,"[4-(6-Chloro-Naphthalene-2-Sulfonyl)-Piperazin-1-Yl]-(3,4,5,6-Tetrahydro-2h-[1,4']Bipyridinyl-4-Yl)-Methanone",ZLAKCKVFSRSENR-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
59195,6crv,DB07182,-9.6,(2S)-2-(3-{[AMINO(IMINO)METHYL]AMINO}PHENYL)-3-[(S)-HYDROXY(3-PHENYLPROPYL)PHOSPHORYL]PROPANOIC ACID,HFRHWTYCVGKGIE-KRWDZBQOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85280,6m3m,DB07471,-9.6,"5-[5,6-BIS(METHYLOXY)-1H-BENZIMIDAZOL-1-YL]-3-{[1-(2-CHLOROPHENYL)ETHYL]OXY}-2-THIOPHENECARBOXAMIDE",UHCHLTQBLNUYRT-GFCCVEGCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85270,6m3m,DB07458,-9.6,"3-(1H-indol-3-yl)-4-{1-[2-(1-methylpyrrolidin-2-yl)ethyl]-1H-indol-3-yl}-1H-pyrrole-2,5-dione",LBFDERUQORUFIN-KRWDZBQOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84228,6m3m,DB04983,-9.6,Denufosol,FPNPSEMJLALQSA-MIYUEGBISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85228,6m3m,DB07409,-9.6,"(1-HYDROXY-1-PHOSPHONO-2-[1,1';4',1'']TERPHENYL-3-YL-ETHYL)-PHOSPHONIC ACID",MPBUFKZCEBTBSK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
135422,6w9c,DB04452,-9.6,Aminoquinuride,HOUSDILKOJMENG-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
85157,6m3m,DB07326,-9.6,"6-chloro-N-pyrimidin-5-yl-3-{[3-(trifluoromethyl)phenyl]amino}-1,2-benzisoxazole-7-carboxamide",FEGRQUWSKADGSP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85130,6m3m,DB07297,-9.6,"5,6-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-D]PYRIMIDIN-4-AMINE",PTILEOLOGGMFCS-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
135393,6w9c,DB04408,-9.6,Ncs-Chromophore,QZGIWPZCWHMVQL-UIYAJPBUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
166563,7bv1,DB15382,-9.6,SAR-125844,ODIUNTQOXRXOIV-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
84348,6m3m,DB05653,-9.6,IRX-5183,PNAWUIKCVQSLFG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84357,6m3m,DB05706,-9.6,13-deoxydoxorubicin,RGVRUQHYQSORBY-JIGXQNLBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
64808,6lxt,DB02010,-9.6,Staurosporine,HKSZLNNOFSGOKW-FYTWVXJKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
135339,6w9c,DB04330,-9.6,Bilh 434,KNRVCCXHLSHTFW-HGPRPZRGSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
59113,6crv,DB07088,-9.6,(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclopentyloxy)ethanoyl)pyrrolidine-2-carboxamide,ZWXWAYUCJVQHOR-KRWDZBQOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59101,6crv,DB07074,-9.6,6-CARBAMIMIDOYL-4-(3-HYDROXY-2-METHYL-BENZOYLAMINO)-NAPHTHALENE-2-CARBOXYLIC ACID METHYL ESTER,OUBRALHIKGRAMA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29943,6cs2,DB11841,-9.6,Entinostat,INVTYAOGFAGBOE-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
133443,6w9c,DB01690,-9.6,Bis(Adenosine)-5'-Triphosphate,QCICUPZZLIQAPA-XPWFQUROSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
70221,6lxt,DB12323,-9.6,Radotinib,DUPWHXBITIZIKZ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
159978,7bv1,DB07147,-9.6,"methyl (1R,2S)-2-(hydroxycarbamoyl)-1-{4-[(2-methylquinolin-4-yl)methoxy]benzyl}cyclopropanecarboxylate",HJWMYFBKJRVWJY-YKSBVNFPSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
30297,6cs2,DB12302,-9.6,CP-724714,LLVZBTWPGQVVLW-SNAWJCMRSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
81143,6m3m,DB00858,-9.6,Drostanolone,IKXILDNPCZPPRV-RFMGOVQKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
57570,6crv,DB03837,-9.6,Morpholine-4-Carboxylic Acid (1-(3-Benzenesulfonyl-1-Phenethylallylcarbamoyl)-3-Methylbutyl)-Amide,YUMYYTORLYHUFW-ZUDLOMHPSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113402,6vxx,DB09123,-9.6,Dienogest,AZFLJNIPTRTECV-FUMNGEBKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59947,6crv,DB08057,-9.6,"N-(2-chloro-6-methylphenyl)-8-[(3S)-3-methylpiperazin-1-yl]imidazo[1,5-a]quinoxalin-4-amine",VWJPPYCULHDHBB-HNNXBMFYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57623,6crv,DB03907,-9.6,"N-{3-[5-(6-Amino-Purin-9-Yl)-3,4-Dihydroxy-Tetrahydro-Furan-2-Yl]-Allyl}-2,3-Dihydroxy-5-Nitro-Benzamide",UHHBFOLQOQSPLU-WGRQDFERSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81246,6m3m,DB00977,-9.6,Ethinylestradiol,BFPYWIDHMRZLRN-SLHNCBLASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
30788,6cs2,DB12978,-9.6,Pexidartinib,JGWRKYUXBBNENE-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
87270,6m3m,DB12082,-9.6,Vesnarinone,ZVNYJIZDIRKMBF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
57665,6crv,DB03962,-9.6,Nicotinamide 8-Bromo-Adenine Dinucleotide Phosphate,MDKMTCCUJSRQGW-NAJQWHGHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81329,6m3m,DB01070,-9.6,Dihydrotachysterol,ILYCWAKSDCYMBB-OPCMSESCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
57667,6crv,DB03966,-9.6,Clorobiocin,FJAQNRBDVKIIKK-LFLQOBSNSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113582,6vxx,DB11577,-9.6,Indigotindisulfonic Acid,CFZXDJWFRVEWSR-BUHFOSPRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140592,6w9c,DB12504,-9.6,JNJ-40346527,BNVPFDRNGHMRJS-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
30730,6cs2,DB12899,-9.6,TT-301,ZPJGUEPHFXPAQF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
87211,6m3m,DB11995,-9.6,Avatrombopag,OFZJKCQENFPZBH-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87206,6m3m,DB11987,-9.6,GSK-2018682,NFIGDBFIDKDNIG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
140643,6w9c,DB13029,-9.6,MK-0873,JJWKQXNHYDJXKF-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
113651,6vxx,DB11704,-9.6,Adomeglivant,FASLTMSUPQDLIB-MHZLTWQESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113672,6vxx,DB11740,-9.6,MK-1775,BKWJAKQVGHWELA-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59848,6crv,DB07945,-9.6,"5-(3-carbamoylbenzyl)-5,6,7,8,9,10-hexahydrocyclohepta[b]indole-4-carboxylic acid",GKBQRPKZHUFGOB-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57758,6crv,DB04092,-9.6,Apstatin,YVUUZAPYLPWFHE-HXFGRODQSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81524,6m3m,DB01339,-9.6,Vecuronium,BGSZAXLLHYERSY-XQIGCQGXSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
5541,6lzg,HMDB0001917,-9.6,Digoxin,LTMHDMANZUZIPE-PUGKRICDSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
69756,6lxt,DB11651,-9.6,Dactolisib,JOGKUKXHTYWRGZ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
81558,6m3m,DB01411,-9.6,Pranlukast,NBQKINXMPLXUET-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81565,6m3m,DB01419,-9.6,Antrafenine,NWGGKKGAFZIVBJ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
113604,6vxx,DB11637,-9.6,Delamanid,XDAOLTSRNUSPPH-XMMPIXPASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87340,6m3m,DB12186,-9.6,SRT-2104,LAMQVIQMVKWXOC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
57528,6crv,DB03788,-9.6,GC-24,JYHIGYLGYNCMGI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81069,6m3m,DB00773,-9.6,Etoposide,VJJPUSNTGOMMGY-MRVIYFEKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87603,6m3m,DB12562,-9.6,Setipiprant,IHAXLPDVOWLUOS-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80683,6m3m,DB00303,-9.6,Ertapenem,JUZNIMUFDBIJCM-ANEDZVCMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87601,6m3m,DB12558,-9.6,AEE-788,OONFNUWBHFSNBT-HXUWFJFHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
113078,6vxx,DB08349,-9.6,"N-cyclopropyl-3-{[1-(2,4-difluorophenyl)-7-methyl-6-oxo-6,7-dihydro-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}-4-methylbenzamide",WMEYCLAVMZKZCS-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113086,6vxx,DB08358,-9.6,"2-(2-QUINOLIN-3-YLPYRIDIN-4-YL)-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE",OWFLADWRSCINST-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87565,6m3m,DB12505,-9.6,E-7820,LWGUASZLXHYWIV-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
60078,6crv,DB08204,-9.6,3-DIPHENOL-6-NITRO-3H-BENZO[DE]ISOCHROMEN-1-ONE,FLWABCQDXUKNQY-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
159132,7bv1,DB03466,-9.6,BMS184394,AYAJZQYENGWICE-QHCPKHFHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
87519,6m3m,DB12432,-9.6,CC-401,XDJCLCLBSGGNKS-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
113125,6vxx,DB08569,-9.6,"3-PYRIDIN-4-YL-2,4-DIHYDRO-INDENO[1,2-.C.] PYRAZOLE",VLPMRZSKJUTRBQ-IBGZPJMESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80843,6m3m,DB00496,-9.6,Darifenacin,HXGBXQDTNZMWGS-RUZDIDTESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
18948,6cs2,HMDB0041761,-9.6,Naringenin 7-O-glucuronide,BDCRTIDKZGEVEN-DNPGXZAYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
80893,6m3m,DB00559,-9.6,Bosentan,GJPICJJJRGTNOD-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
27310,6cs2,DB06844,-9.6,"4-[(7-OXO-7H-THIAZOLO[5,4-E]INDOL-8-YLMETHYL)-AMINO]-N-PYRIDIN-2-YL-BENZENESULFONAMIDE",MBXKBJLIESPLIK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
162948,7bv1,DB03331,-9.6,"N-Naphthalen-1-Ylmethyl-2'-[3,5-Dimethoxybenzamido]-2'-Deoxy-Adenosine",OARVXDFNTLYMCJ-JVUUKAHWSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
113233,6vxx,DB08703,-9.6,"12-(2-hydroxyethyl)-2-(1-methylethoxy)-13,14-dihydronaphtho[2,1-a]pyrrolo[3,4-c]carbazol-5(12H)-one",FGKKIHITEICGMN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80989,6m3m,DB00678,-9.6,Losartan,PSIFNNKUMBGKDQ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
60009,6crv,DB08126,-9.6,"3-{[4-([AMINO(IMINO)METHYL]AMINOSULFONYL)ANILINO]METHYLENE}-2-OXO-2,3-DIHYDRO-1H-INDOLE",DMCRNUMVSATRTP-LCYFTJDESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87425,6m3m,DB12302,-9.6,CP-724714,LLVZBTWPGQVVLW-SNAWJCMRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
60008,6crv,DB08125,-9.6,"4-{[(2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]AMINO}-N-(1,3-THIAZOL-2-YL)BENZENESULFONAMIDE",BOMPRXSVSIPRDT-PTNGSMBKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136726,6w9c,DB07458,-9.6,"3-(1H-indol-3-yl)-4-{1-[2-(1-methylpyrrolidin-2-yl)ethyl]-1H-indol-3-yl}-1H-pyrrole-2,5-dione",LBFDERUQORUFIN-KRWDZBQOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
60004,6crv,DB08121,-9.6,(2S)-2-(biphenyl-4-yloxy)-3-phenylpropanoic acid,TZTPJJNNACUQQR-FQEVSTJZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87415,6m3m,DB12289,-9.6,Darexaban,IJNIQYINMSGIPS-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
57374,6crv,DB03583,-9.6,"(2e,3s)-3-Hydroxy-5'-[(4-Hydroxypiperidin-1-Yl)Sulfonyl]-3-Methyl-1,3-Dihydro-2,3'-Biindol-2'(1'h)-One",AYOAIABDFUJDKQ-SQJPUDIVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61384,6crv,DB12006,-9.6,BMS-906024,AYOUDDAETNMCBW-GSHUGGBRSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113267,6vxx,DB08738,-9.6,1-{3-oxo-3-[(2S)-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]propyl}-3-phenylquinoxalin-2(1H)-one,KWCKZIJGKMCYCI-QFIPXVFZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136701,6w9c,DB07430,-9.6,"(10R)-10-methyl-3-(6-methylpyridin-3-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one",CMWRPDHVGMHLSZ-GFCCVEGCSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
81593,6m3m,DB01451,-9.6,1-Androstenedione,WJIQCDPCDVWDDE-WZNAKSSCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86198,6m3m,DB08556,-9.6,"5'-ACETYL-4-{[(2,4-DIMETHYLPHENYL)SULFONYL]AMINO}-2,2'-BITHIOPHENE-5-CARBOXYLIC ACID",CMHHNHDPPWDNAH-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
69739,6lxt,DB11618,-9.6,Zorubicin,FBTUMDXHSRTGRV-BJISBDEGSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
57960,6crv,DB04362,-9.6,Adenosine Diphosphate 5-(Beta-Ethyl)-4-Methyl-Thiazole-2-Carboxylic Acid,VGXBGQACJQRWLV-LKGUXBDMSA-K,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86662,6m3m,DB09199,-9.6,Netoglitazone,PKWDZWYVIHVNKS-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86658,6m3m,DB09195,-9.6,Lorpiprazole,BNRMWKUVWLKDQJ-YJBOKZPZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
82317,6m3m,DB02388,-9.6,"Cyclohexyl-{4-[5-(3,4-Dichlorophenyl)-2-Piperidin-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine",UQFRSHRWRKYNDE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
82337,6m3m,DB02411,-9.6,"2-(11-{2-[Benzenesulfonyl-(3-Methyl-Butyl)-Amino]-1-Hydroxy-Ethyl}-6,9-Dioxo-2-Oxa-7,10-Diaza-Bicyclo[11.2.2]Heptadeca-1(16),13(17),14-Trien-8-Yl)-Acetamide, Inhibitor 2",HOUHLOFMBSYNBO-KKUQBAQOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86573,6m3m,DB09047,-9.6,Finafloxacin,FYMHQCNFKNMJAV-HOTGVXAUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
113932,6vxx,DB12290,-9.6,Puerarin,HKEAFJYKMMKDOR-VPRICQMDSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59633,6crv,DB07697,-9.6,"1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-4-[(4-methoxyphenyl)sulfonyl]piperazine",HMGDKYUJSFVHIY-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140726,6w9c,DB15193,-9.6,BMS-955176,XDMUFNNPLXHNKA-ZTESCHFWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
86485,6m3m,DB08931,-9.6,Riociguat,WXXSNCNJFUAIDG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59625,6crv,DB07688,-9.6,"4-{[5-(CYCLOHEXYLOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE",RPJIMTALCNCQLV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58366,6crv,DB04908,-9.6,Flibanserin,PPRRDFIXUUSXRA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59624,6crv,DB07686,-9.6,"4-{[5-(CYCLOHEXYLAMINO)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE",VPOGRVWIIVMWRI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
82277,6m3m,DB02338,-9.6,Nadph Dihydro-Nicotinamide-Adenine-Dinucleotidephosphate,ACFIXJIJDZMPPO-NNYOXOHSSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58374,6crv,DB04930,-9.6,Permethrin,RLLPVAHGXHCWKJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86430,6m3m,DB08834,-9.6,Tauroursodeoxycholic acid,BHTRKEVKTKCXOH-LBSADWJPSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86429,6m3m,DB08833,-9.6,Taurochenodeoxycholic acid,BHTRKEVKTKCXOH-BJLOMENOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
63152,6crv,DB15233,-9.6,Avapritinib,DWYRIWUZIJHQKQ-SANMLTNESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
82539,6m3m,DB02673,-9.6,"(4ar,6s,8ar)-11-[8-(1,3-Dioxo-1,3-Dihydro-2h-Isoindol-2-Yl)Octyl]-6-Hydroxy-3-Methoxy-5,6,9,10-Tetrahydro-4ah-[1]Benzofuro[3a,3,2-Ef][2]Benzazepin-11-Ium",VLGAHTYYCHWLNI-BHRZLAGCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
68543,6lxt,DB08036,-9.6,"6,7,12,13-tetrahydro-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazol-5-one",MEXUTNIFSHFQRG-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
86419,6m3m,DB08816,-9.6,Ticagrelor,OEKWJQXRCDYSHL-FNOIDJSQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
161514,7bv1,DB14946,-9.6,PCO-371,LDZJFVOUPUFOHX-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
114019,6vxx,DB12598,-9.6,Nafamostat,MQQNFDZXWVTQEH-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59588,6crv,DB07642,-9.6,"5-{[1-(2-fluorobenzyl)piperidin-4-yl]methoxy}quinazoline-2,4-diamine",GYKIQIOWVKCVBP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
132661,6w9c,DB00700,-9.6,Eplerenone,JUKPWJGBANNWMW-VWBFHTRKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
86341,6m3m,DB08730,-9.6,3-FLUORO-5-MORPHOLIN-4-YL-N-[1-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-6-YL]BENZAMIDE,CPFBZMFUCGHBAP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
82629,6m3m,DB02799,-9.6,N-[2-(1-Maleimidyl)Ethyl]-7-Diethylaminocoumarin-3-Carboxamide,OJBZDUMTXGGVSP-KTKRTIGZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
82465,6m3m,DB02573,-9.6,"2'-Deoxycytidine-2'-Deoxyadenosine-3',5'-Monophosphate",LYWWDKIADIGKTH-IDMWBNCISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58336,6crv,DB04862,-9.6,Merimepodib,JBPUGFODGPKTDW-SFHVURJKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86694,6m3m,DB09235,-9.6,Efonidipine,NSVFSAJIGAJDMR-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
159827,7bv1,DB06638,-9.6,Quarfloxin,WOQIDNWTQOYDLF-CGAIIQECSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
113744,6vxx,DB12020,-9.6,Tecovirimat,CSKDFZIMJXRJGH-VWLPUNTISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57981,6crv,DB04392,-9.6,"Bishydroxy[2h-1-Benzopyran-2-One,1,2-Benzopyrone]",HIZKPJUTKKJDGA-BETUJISGSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87070,6m3m,DB11789,-9.6,Hyodeoxycholic Acid,DGABKXLVXPYZII-SIBKNCMHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87062,6m3m,DB11778,-9.6,Danusertib,XKFTZKGMDDZMJI-HSZRJFAPSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81778,6m3m,DB01669,-9.6,Virginiamycin M1,DAIKHDNSXMZDCU-FQTGFAPKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59756,6crv,DB07837,-9.6,"[4-(5-naphthalen-2-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)phenyl]acetic acid",SWXKLXXVFMYMDP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27051,6cs2,DB06334,-9.6,Tucidinostat,SZMJVTADHFNAIS-BJMVGYQFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
69627,6lxt,DB11363,-9.6,Alectinib,KDGFLJKFZUIJMX-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
159750,7bv1,DB05608,-9.6,MKC-1,OVSKGTONMLKNPZ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59750,6crv,DB07830,-9.6,"(4R,5R)-5-AMINO-1-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN-2-ONE",DIRIFWIKLRTNMB-DYVFJYSZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30510,6cs2,DB12580,-9.6,Tradipitant,CAVRKWRKTNINFF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
59739,6crv,DB07817,-9.6,"1-{3-[(4-pyridin-2-ylpiperazin-1-yl)sulfonyl]phenyl}-3-(1,3-thiazol-2-yl)urea",NJPVZSIGDRLLTD-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86984,6m3m,DB11663,-9.6,Pictilisib,LHNIIDJUOCFXAP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86981,6m3m,DB11656,-9.6,Rebamipide,ALLWOAVDORUJLA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
113818,6vxx,DB12127,-9.6,Sultamicillin,OPYGFNJSCUDTBT-PMLPCWDUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
82016,6m3m,DB01990,-9.6,Cholesterol sulfate,BHYOQNUELFTYRT-DPAQBDIFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59719,6crv,DB07796,-9.6,"(3ASR,4RS,8ASR,8BRS)-4-(2-(4-FLUOROBENZYL)-1,3-DIOXODEACAHYDROPYRROLO[3,4-A] PYRROLIZIN-4-YL)BENZAMIDINE",GJYCQHGTXMVIBG-MUGJNUQGSA-O,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
132349,6w9c,DB00319,-9.6,Piperacillin,IVBHGBMCVLDMKU-GXNBUGAJSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140704,6w9c,DB15145,-9.6,Ziresovir,GAAICKUTDBZCMT-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
113856,6vxx,DB12186,-9.6,SRT-2104,LAMQVIQMVKWXOC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
82169,6m3m,DB02196,-9.6,Uridine-Diphosphate-N-Acetylgalactosamine,LFTYTUAZOPRMMI-NESSUJCYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
26955,6cs2,DB06144,-9.6,Sertindole,GZKLJWGUPQBVJQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
86827,6m3m,DB11275,-9.6,Epicriptine,SBFXHXZNBNFPHV-PXXBSISHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136287,6w9c,DB06938,-9.6,4-[[2-[[4-chloro-3-(trifluoromethyl)phenyl]amino]-3H-benzimidazol-5-yl]oxy]-N-methyl-pyridine-2-carboxamide,ZJLSMLDOCGOURY-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136275,6w9c,DB06925,-9.6,3-(2-AMINOQUINAZOLIN-6-YL)-4-METHYL-N-[3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE,YEIASMOUYNOXGA-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
86804,6m3m,DB11176,-9.6,Zeaxanthin,JKQXZKUSFCKOGQ-QAYBQHTQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
140714,6w9c,DB15168,-9.6,Cilofexor,KZSKGLFYQAYZCO-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
57947,6crv,DB04342,-9.6,7-((Carboxy(4-Hydroxyphenyl)Acetyl)Amino)-7-Methoxy-(3-((1-Methyl-1h-Tetrazol-5-Yl)Thio)Methyl)-8-Oxo-5-Oxa-1-Azabicyclo[4.2.0]Oct-2-Ene-2-Carboxylic Acid,JWCSIUVGFCSJCK-LIUKBUMOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87401,6m3m,DB12272,-9.6,Vidupiprant,PFWVGKROPKKEDW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
79822,6m2n,DB13791,-9.6,Penfluridol,MDLAAYDRRZXJIF-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75862,6m2n,DB06248,-9.6,Amelubant,SBVYURPQULDJTI-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
73953,6m2n,DB02705,-9.6,"6-[N-(1-Isopropyl-1,2,3,4-Tetrahydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine",DARQQJKHXPXSRO-QFIPXVFZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61897,6crv,DB12764,-9.6,ABC-294640,CAOTVXGYTWCKQE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77738,6m2n,DB08738,-9.6,1-{3-oxo-3-[(2S)-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]propyl}-3-phenylquinoxalin-2(1H)-one,KWCKZIJGKMCYCI-QFIPXVFZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
139018,6w9c,DB12719,-9.6,Turofexorate isopropyl,INASOKQDNHHMRE-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
76361,6m2n,DB07117,-9.6,"5-(4-PHENOXYPHENYL)-5-(4-PYRIMIDIN-2-YLPIPERAZIN-1-YL)PYRIMIDINE-2,4,6(2H,3H)-TRIONE",FMKQJGOROFNCGM-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77730,6m2n,DB08730,-9.6,3-FLUORO-5-MORPHOLIN-4-YL-N-[1-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-6-YL]BENZAMIDE,CPFBZMFUCGHBAP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
101565,6vxs,DB05616,-9.6,"4'-Methylene-5,8,10-trideazaaminopterin",NAWXUBYGYWOOIX-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
34018,6cs2,T3D0009,-9.6,Benzo[a]pyrene,FMMWHPNWAFZXNH-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
11974,6lzg,DB12694,-9.6,CE-326597,UBNMGTSDHSQBEL-PMERELPUSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
104653,6vxs,DB12309,-9.6,GI-181771X,CABBMMXFOOZVMS-PMERELPUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
76987,6m2n,DB07845,-9.6,"2-fluoro-6-{[2-({2-methoxy-4-[(methylsulfonyl)methyl]phenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide",VGYXXQRDIVRILX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61907,6crv,DB12781,-9.6,Balaglitazone,IETKPTYAGKZLKY-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
101661,6vxs,DB06178,-9.6,Talotrexin,NYQPLPNEESYGNO-IBGZPJMESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
28256,6cs2,DB07837,-9.6,"[4-(5-naphthalen-2-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)phenyl]acetic acid",SWXKLXXVFMYMDP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
77682,6m2n,DB08674,-9.6,"(20S)-19,20,21,22-TETRAHYDRO-19-OXO-5H-18,20-ETHANO-12,14-ETHENO-6,10-METHENO-18H-BENZ[D]IMIDAZO[4,3-K][1,6,9,12]OXATRIAZA-CYCLOOCTADECOSINE-9-CARBONITRILE",USPFJPDEADLGIG-HSZRJFAPSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
28692,6cs2,DB08299,-9.6,"4-[8-(3-nitrophenyl)-1,7-naphthyridin-6-yl]benzoic acid",QTNUWEKKZHSUQO-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
28647,6cs2,DB08242,-9.6,"N,4-dimethyl-3-[(1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl)amino]benzamide",OYTBZXSFNNAVKU-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
165274,7bv1,DB11691,-9.6,Naldemedine,AXQACEQYCPKDMV-RZAWKFBISA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
54997,6crv,DB00481,-9.6,Raloxifene,GZUITABIAKMVPG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109507,6vxx,DB14017,-9.6,H3B-8800,YOIQWBAHJZGRFW-WVRLKXNASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127389,6w4h,DB05653,-9.6,IRX-5183,PNAWUIKCVQSLFG-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
165252,7bv1,DB11663,-9.6,Pictilisib,LHNIIDJUOCFXAP-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
128368,6w4h,DB07528,-9.6,3-(2-aminoquinazolin-6-yl)-4-methyl-1-[3-(trifluoromethyl)phenyl]pyridin-2(1H)-one,HXUZQEYFKAZBPX-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
75697,6m2n,DB05450,-9.6,Smilagenin,GMBQZIIUCVWOCD-UQHLGXRBSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
128431,6w4h,DB07605,-9.6,"2-({4-[(5-CHLORO-1H-INDOL-2-YL)SULFONYL]PIPERAZIN-1-YL}CARBONYL)THIENO[3,2-B]PYRIDINE 4-OXIDE",DHDQMXPAANQKDC-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
75381,6m2n,DB04623,-9.6,"2-ETHOXYETHYL (2S,3S)-4-((S)-2-BENZYL-3-OXO-4-((3AR,8R,8AS)-2-OXO-3,3A,8,8A-TETRAHYDRO-2H-INDENO[1,2-D]OXAZOL-8-YL)-2,3-DIHYDRO-1H-PYRROL-2-YL)-3-HYDROXY-1-PHENYLBUTAN-2-YLCARBAMATE",CGBRFCVAMLJVEA-ZGURCIGKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
109517,6vxx,DB14034,-9.6,Darglitazone,QQKNSPHAFATFNQ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
74188,6m2n,DB03020,-9.6,5-Beta-D-Ribofuranosylnicotinamide Adenine Dinucleotide,UINNILASBHZOTM-KMXXXSRASA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
100121,6vxs,DB03157,-9.6,"N,O-Didansyl-L-Tyrosine",LUBOPDUYHWABFG-NDEPHWFRSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
75050,6m2n,DB04177,-9.6,"4-(3,14-Dihydroxy-10,13-Dimethyl-Hexadecahydro-Cyclopenta[a]Phenanthren-17-Yl)-5h-Furan-2-One",XZTUSOXSLKTKJQ-CESUGQOBSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138553,6w9c,DB11829,-9.6,Ruboxistaurin,ZCBUQCWBWNUWSU-SFHVURJKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138554,6w9c,DB11830,-9.6,Mocetinostat,HRNLUBSXIHFDHP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
32063,6cs2,DB15291,-9.6,BMS-986142,ZRYMMWAJAFUANM-INIZCTEOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
106531,6vxx,DB00455,-9.6,Loratadine,JCCNYMKQOSZNPW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55151,6crv,DB00673,-9.6,Aprepitant,ATALOFNDEOCMKK-OITMNORJSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106543,6vxx,DB00471,-9.6,Montelukast,UCHDWCPVSPXUMX-TZIWLTJVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
100821,6vxs,DB04099,-9.6,Deamido-Nad+,SENPVEZBRZQVST-HISDBWNOSA-O,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101116,6vxs,DB04495,-9.6,RU81843,GGPXNASQNUOIPB-NSOVKSMOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
75178,6m2n,DB04350,-9.6,Argadin,FOZYKTUSOWWQGR-KNPYFFGGSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
165312,7bv1,DB11913,-9.6,LY-2090314,HRJWTAWVFDCTGO-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
104952,6vxs,DB12760,-9.6,GW-493838,ZQYJPMPXQLNTPQ-QCUYGVNKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
128495,6w4h,DB07680,-9.6,[(1S)-1-(5-CHLORO-1-BENZOTHIEN-3-YL)-2-(2-NAPHTHYLAMINO)-2-OXOETHYL]PHOSPHONIC ACID,HUJXISJLAPAFBO-IBGZPJMESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
61957,6crv,DB12869,-9.6,Eliprodil,GGUSQTSTQSHJAH-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138819,6w9c,DB12307,-9.6,Foretinib,CXQHYVUVSFXTMY-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
101297,6vxs,DB04739,-9.6,4-[(4-METHYL-1-PIPERAZINYL)METHYL]-N-[3-[[4-(3-PYRIDINYL)-2-PYRIMIDINYL]AMINO]PHENYL]-BENZAMIDE,JHMBUEWQJDGKGS-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
77808,6m2n,DB08816,-9.6,Ticagrelor,OEKWJQXRCDYSHL-FNOIDJSQSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61948,6crv,DB12854,-9.6,BMS-908662,MMNNTJYFHUDSKL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109706,6vxx,DB15177,-9.6,VX-659,IGEOJNMYRZUKIK-IBGZPJMESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77769,6m2n,DB08772,-9.6,"3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL-2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID",BCSVCWVQNOXFGL-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
104882,6vxs,DB12655,-9.6,Patidegib,HZLFFNCLTRVYJG-WWGOJCOQSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
61931,6crv,DB12823,-9.6,Tecarfarin,QFLNTQDOVCLQKW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
126036,6w4h,DB03276,-9.6,"4-[(10s,14s,18s)-18-(2-Amino-2-Oxoethyl)-14-(1-Naphthylmethyl)-8,17,20-Trioxo-7,16,19-Triazaspiro[5.14]Icos-11-En-10-Yl]Benzylphosphonic Acid",RHYFMOCFCFUTNH-GZNVFMSSSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
55291,6crv,DB00836,-9.6,Loperamide,RDOIQAHITMMDAJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109462,6vxx,DB13607,-9.6,Picloxydine,YNCLPFSAZFGQCD-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110566,6vxx,DB01948,-9.6,"1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperidin-4-Yl-3,4-Dihydroquinolin-2(1h)-One",VXIYTVJEIXMAQF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62360,6crv,DB13471,-9.6,Nalfurafine,XGZZHZMWIXFATA-UEZBDDGYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75702,6m2n,DB05470,-9.6,VX-702,FYSRKRZDBHOFAY-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75904,6m2n,DB06364,-9.6,XR5944,SFOADSRLCHRTKT-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
103302,6vxs,DB08418,-9.6,"(4aS,4bR,10bS,12aS)-12a-methyl-1,3-dioxo-2-(pyridin-3-ylmethyl)-1,2,3,4,4a,4b,5,6,10b,11,12,12a-dodecahydronaphtho[2,1-f]isoquinolin-8-yl sulfamate",LSJKARAMQNGZDF-YOEKFXIASA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
103371,6vxs,DB08499,-9.6,"N-[3-(2-fluoroethoxy)phenyl]-N'-(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-6-yl)butanediamide",DQXBKUVWJSZHSI-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
107222,6vxx,DB02723,-9.6,"4-Oxo-2-Phenylmethanesulfonyl-Octahydro-Pyrrolo[1,2-a]Pyrazine-6-Carboxylic Acid [1-(N-Hydroxycarbamimidoyl)-Piperidin-4-Ylmethyl]-Amide",DHTSUHWLPAEEQB-OALUTQOASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75909,6m2n,DB06393,-9.6,Xaliproden,WJJYZXPHLSLMGE-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
139127,6w9c,DB12897,-9.6,MK-7622,JUVQLZBJFOGEEO-GOTSBHOMSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
107793,6vxx,DB04623,-9.6,"2-ETHOXYETHYL (2S,3S)-4-((S)-2-BENZYL-3-OXO-4-((3AR,8R,8AS)-2-OXO-3,3A,8,8A-TETRAHYDRO-2H-INDENO[1,2-D]OXAZOL-8-YL)-2,3-DIHYDRO-1H-PYRROL-2-YL)-3-HYDROXY-1-PHENYLBUTAN-2-YLCARBAMATE",CGBRFCVAMLJVEA-ZGURCIGKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61755,6crv,DB12542,-9.6,GSK-356278,AWDJJMXJUOHGLC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76026,6m2n,DB06677,-9.6,Clazosentan,LFWCJABOXHSRGC-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61732,6crv,DB12507,-9.6,Atecegatran metoxil,XSNMGLZVFNDDPW-ZWKOTPCHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104154,6vxs,DB11526,-9.6,Masitinib,WJEOLQLKVOPQFV-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
103276,6vxs,DB08386,-9.6,2-{[4-(4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline,VRWJZGHUCOFGPZ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
77199,6m2n,DB08091,-9.6,3-FLUORO-5-MORPHOLIN-4-YL-N-[3-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-5-YL]BENZAMIDE,HIUFYIOMUILESI-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
104294,6vxs,DB11791,-9.6,Capmatinib,LIOLIMKSCNQPLV-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
107702,6vxx,DB04201,-9.6,Histidyl-Adenosine Monophosphate,XTFBSLZFYLGYAT-OPYVMVOTSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
124310,6w4h,DB01003,-9.6,Cromoglicic acid,IMZMKUWMOSJXDT-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
61735,6crv,DB12511,-9.6,Imiglitazar,ULVDFHLHKNJICZ-QCWLDUFUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
32754,6cs2,T3D3667,-9.6,Cytochalasin B,GBOGMAARMMDZGR-LFKALUBKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
107637,6vxx,DB04121,-9.6,Guanosine-3'-Monophosphate-5'-Diphosphate,HEYSFDAMRDTCJM-UUOKFMHZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165464,7bv1,DB12137,-9.6,GSK-256066,JFHROPTYMMSOLG-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
138729,6w9c,DB12185,-9.6,Exatecan,ZVYVPGLRVWUPMP-FYSMJZIKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139169,6w9c,DB12960,-9.6,INCB-9471,ZMCJFJZOSKEMOM-DNKZPPIMSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
73607,6m2n,DB02259,-9.6,"3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid (4-Sulfamoyl-Phenyl)-Amide",VSYGXLAJQDAWCZ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
109311,6vxx,DB13053,-9.6,CP-195543,NZQDWKCNBOELAI-KSFYIVLOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
128124,6w4h,DB07247,-9.6,"[2'-HYDROXY-3'-(1H-PYRROLO[3,2-C]PYRIDIN-2-YL)-BIPHENYL-3-YLMETHYL]-UREA",SRPOHNDQBDHONJ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
125056,6w4h,DB01988,-9.6,6((S)-3-Benzylpiperazin-1-Yl)-3-(Naphthalen-2-Yl)-4-(Pyridin-4-Yl)Pyrazine,WFSFNKVFXLIZIY-MHZLTWQESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
77413,6m2n,DB08349,-9.6,"N-cyclopropyl-3-{[1-(2,4-difluorophenyl)-7-methyl-6-oxo-6,7-dihydro-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}-4-methylbenzamide",WMEYCLAVMZKZCS-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
73556,6m2n,DB02194,-9.6,"8-Benzyl-2-Hydroxy-2-(4-Hydroxy-Benzyl)-6-(4-Hydroxy-Phenyl)-2h-Imidazo[1,2-a]Pyrazin-3-One",ULLMMKZQNNBLRN-SANMLTNESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61827,6crv,DB12658,-9.6,AFN-1252,QXTWSUQCXCWEHF-JXMROGBWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106889,6vxx,DB01705,-9.6,Bis(5-Amidino-Benzimidazolyl)Methane,QZKOOEFIMWKZPK-UHFFFAOYSA-Q,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77115,6m2n,DB07994,-9.6,"N-3-[5-(1H-INDOL-6-YL)-2-(PYRIDIN-2-YLMETHOXY)BENZYL]PYRIDINE-2,3-DIAMINE",KMBPJSHPAXOXBT-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61684,6crv,DB12432,-9.6,CC-401,XDJCLCLBSGGNKS-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76211,6m2n,DB06938,-9.6,4-[[2-[[4-chloro-3-(trifluoromethyl)phenyl]amino]-3H-benzimidazol-5-yl]oxy]-N-methyl-pyridine-2-carboxamide,ZJLSMLDOCGOURY-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77129,6m2n,DB08010,-9.6,"(3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-[(E)-2-phenylethenyl]-1H-indole-2,3-dione 3-oxime",DDHASJXGNUWZTM-ZLEWNXFRSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
102810,6vxs,DB07833,-9.6,"N-(3-cyanophenyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)-4-biphenylcarboxamide",PMMLSQFPBFKLHH-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
77469,6m2n,DB08418,-9.6,"(4aS,4bR,10bS,12aS)-12a-methyl-1,3-dioxo-2-(pyridin-3-ylmethyl)-1,2,3,4,4a,4b,5,6,10b,11,12,12a-dodecahydronaphtho[2,1-f]isoquinolin-8-yl sulfamate",LSJKARAMQNGZDF-YOEKFXIASA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61687,6crv,DB12436,-9.6,Vofopitant,XILNRORTJVDYRH-HKUYNNGSSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106954,6vxx,DB01792,-9.6,Adenylyl-3'-5'-Phospho-Uridine-3'-Monophosphate,FZCSEXOMUJFOHQ-KPKSGTNCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108075,6vxx,DB06809,-9.6,Plerixafor,YIQPUIGJQJDJOS-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109399,6vxx,DB13520,-9.6,Metergoline,WZHJKEUHNJHDLS-QTGUNEKASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
102934,6vxs,DB07978,-9.6,"2-({[2,3,5,6-TETRAFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)CYCLOPENTA-1,3-DIENE-1-CARBOXYLIC ACID",ULMUPVXFUDHRGH-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
109190,6vxx,DB12505,-9.6,E-7820,LWGUASZLXHYWIV-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
139091,6w9c,DB12843,-9.6,Oleandrin,JLPDBLFIVFSOCC-XYXFTTADSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
75820,6m2n,DB06159,-9.6,Rubitecan,VHXNKPBCCMUMSW-FQEVSTJZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
110038,6vxx,DB00734,-9.6,Risperidone,RAPZEAPATHNIPO-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107938,6vxx,DB05706,-9.6,13-deoxydoxorubicin,RGVRUQHYQSORBY-JIGXQNLBSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77421,6m2n,DB08358,-9.6,"2-(2-QUINOLIN-3-YLPYRIDIN-4-YL)-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE",OWFLADWRSCINST-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
109315,6vxx,DB13059,-9.6,PF-03814735,RYYNGWLOYLRZLK-RBUKOAKNSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75870,6m2n,DB06263,-9.6,Amrubicin,VJZITPJGSQKZMX-XDPRQOKASA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76079,6m2n,DB06755,-9.6,Beta carotene,OENHQHLEOONYIE-JLTXGRSLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
62578,6crv,DB13766,-9.6,Lidoflazine,ZBIAKUMOEKILTF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138752,6w9c,DB12221,-9.6,Canrenone,UJVLDDZCTMKXJK-WNHSNXHDSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
73775,6m2n,DB02473,-9.6,"6-[N-(1-Isopropyl-3,4-Dihydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine",XRHANBWAKSYPEN-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138640,6w9c,DB12054,-9.6,BQ-123,VYCMAAOURFJIHD-PJNXIOHISA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
62714,6crv,DB13997,-9.6,Baloxavir marboxil,RZVPBGBYGMDSBG-GGAORHGYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
54869,6crv,DB00324,-9.6,Fluorometholone,FAOZLTXFLGPHNG-KNAQIMQKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78083,6m2n,DB09235,-9.6,Efonidipine,NSVFSAJIGAJDMR-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
20266,6cs2,HMDB0046432,-9.6,TG(22:0/14:1(9Z)/24:0),NIPVPXGEDBBOMK-XTKDRUTHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
61413,6crv,DB12050,-9.6,LY-3039478,YCBAQKQAINQRFW-UGSOOPFHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76657,6m2n,DB07456,-9.6,"3-(1H-indol-3-yl)-4-(1-{2-[(2S)-1-methylpyrrolidinyl]ethyl}-1H-indol-3-yl)-1H-pyrrole-2,5-dione",LBFDERUQORUFIN-QGZVFWFLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
139829,6w9c,DB14068,-9.6,Dexniguldipine,SVJMLYUFVDMUHP-MGBGTMOVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
77963,6m2n,DB09048,-9.6,Netupitant,WAXQNWCZJDTGBU-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138486,6w9c,DB11737,-9.6,Icotinib,QQLKULDARVNMAL-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
108743,6vxx,DB08896,-9.6,Regorafenib,FNHKPVJBJVTLMP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165379,7bv1,DB12012,-9.6,PF-04457845,BATCTBJIJJEPHM-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
62036,6crv,DB12985,-9.6,Quisinostat,PAWIYAYFNXQGAP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
139768,6w9c,DB13950,-9.6,WIN 55212-2,HQVHOQAKMCMIIM-HXUWFJFHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
109084,6vxx,DB12010,-9.6,Fostamatinib,GKDRMWXFWHEQQT-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106092,6vxs,DB15006,-9.6,Flufenoxuron,RYLHNOVXKPXDIP-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
74588,6m2n,DB03571,-9.6,"3-(5-Amino-7-Hydroxy-[1,2,3]Triazolo[4,5-D]Pyrimidin-2-Yl)-N-(3,5-Dichlorobenzyl)-Benzamide",JMQTXEWNXSPEKX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
32002,6cs2,DB15189,-9.6,Birabresib,GNMUEVRJHCWKTO-FQEVSTJZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
74834,6m2n,DB03893,-9.6,Thionicotinamide-Adenine-Dinucleotide,UQYPZLRUJKCREN-NNYOXOHSSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77983,6m2n,DB09079,-9.6,Nintedanib,XZXHXSATPCNXJR-ZIADKAODSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
62017,6crv,DB12952,-9.6,Methylprednisone,SVYCRJXQZUCUND-PQXSVQADSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76559,6m2n,DB07340,-9.6,"N-6-cyclohexyl-N-2-(4-morpholin-4-ylphenyl)-9H-purine-2,6-diamine",ZFLJHSQHILSNCM-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
106083,6vxs,DB14946,-9.6,PCO-371,LDZJFVOUPUFOHX-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
74633,6m2n,DB03638,-9.6,Cytidyl-2'-5'-Phospho-Guanosine,QZDUXDLOEVJGDG-VMIOUTBZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
109097,6vxx,DB12371,-9.6,Siponimod,KIHYPELVXPAIDH-HNSNBQBZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
128628,6w4h,DB07832,-9.6,"4-{4-[(5-hydroxy-2-methylphenyl)amino]quinolin-7-yl}-1,3-thiazole-2-carbaldehyde",VKQPTVJDZIILPG-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
106258,6vxs,DB15328,-9.6,Ubrogepant,DDOOFTLHJSMHLN-ZQHRPCGSSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
138524,6w9c,DB11791,-9.6,Capmatinib,LIOLIMKSCNQPLV-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
61398,6crv,DB12027,-9.6,Serdemetan,CEGSUK1LWKJP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76546,6m2n,DB07326,-9.6,"6-chloro-N-pyrimidin-5-yl-3-{[3-(trifluoromethyl)phenyl]amino}-1,2-benzisoxazole-7-carboxamide",FEGRQUWSKADGSP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77956,6m2n,DB09030,-9.6,Vorapaxar,ZBGXUVOIWDMMJE-QHNZEKIYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
99016,6vxs,DB01690,-9.6,Bis(Adenosine)-5'-Triphosphate,QCICUPZZLIQAPA-XPWFQUROSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
165641,7bv1,DB12580,-9.6,Tradipitant,CAVRKWRKTNINFF-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
125311,6w4h,DB02329,-9.6,Carbenoxolone,OBZHEBDUNPOCJG-WBXJDKIVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
110731,6vxx,DB02341,-9.6,"Mdl 101,146",XQAMVCHQGHAELT-YPAWHYETSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28207,6cs2,DB07789,-9.6,"1-[5-methyl-2-(trifluoromethyl)furan-3-yl]-3-[(2Z)-5-(2-{[6-(1H-1,2,4-triazol-3-ylamino)pyrimidin-4-yl]amino}ethyl)-1,3-thiazol-2(3H)-ylidene]urea",KNTGXMNWVXZIMW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
9669,6lzg,DB07789,-9.6,"1-[5-methyl-2-(trifluoromethyl)furan-3-yl]-3-[(2Z)-5-(2-{[6-(1H-1,2,4-triazol-3-ylamino)pyrimidin-4-yl]amino}ethyl)-1,3-thiazol-2(3H)-ylidene]urea",KNTGXMNWVXZIMW-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
32862,6cs2,T3D3780,-9.6,Paxilline,ACNHBCIZLNNLRS-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
28162,6cs2,DB07743,-9.6,"S-[5-(TRIFLUOROMETHYL)-4H-1,2,4-TRIAZOL-3-YL] 5-(PHENYLETHYNYL)FURAN-2-CARBOTHIOATE",VNGWUVBXUIDQTK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
61411,6crv,DB12048,-9.6,Savolitinib,XYDNMOZJKOGZLS-NSHDSACASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
147407,6w9q,DB11896,-9.6,Gedatolisib,DWZAEMINVBZMHQ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
109640,6vxx,DB15047,-9.6,BMS-919373,XGKULQQVQWCASY-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109027,6vxx,DB11925,-9.6,Vistusertib,JUSFANSTBFGBAF-IRXDYDNUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
11399,6lzg,DB11913,-9.6,LY-2090314,HRJWTAWVFDCTGO-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
76716,6m2n,DB07528,-9.6,3-(2-aminoquinazolin-6-yl)-4-methyl-1-[3-(trifluoromethyl)phenyl]pyridin-2(1H)-one,HXUZQEYFKAZBPX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61972,6crv,DB12888,-9.6,Ezutromid,KSGCNXAZROJSNW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76831,6m2n,DB07666,-9.6,"(3R,4S)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE",OAWGQHXWGXOUKV-BEFAXECRSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76700,6m2n,DB07508,-9.6,4-(5-BENZENESULFONYLAMINO-1-METHYL-1H-BENZOIMIDAZOL-2-YLMETHYL)-BENZAMIDINE,MEUAVGJWGDPTLF-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
124535,6w4h,DB01267,-9.6,Paliperidone,PMXMIIMHBWHSKN-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
127863,6w4h,DB06938,-9.6,4-[[2-[[4-chloro-3-(trifluoromethyl)phenyl]amino]-3H-benzimidazol-5-yl]oxy]-N-methyl-pyridine-2-carboxamide,ZJLSMLDOCGOURY-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
108883,6vxx,DB11275,-9.6,Epicriptine,SBFXHXZNBNFPHV-PXXBSISHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60035,6crv,DB08154,-9.5,3-chloro-5-[2-chloro-5-(1H-indazol-3-ylmethoxy)phenoxy]benzonitrile,WHCLIFOVZDANCU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81834,6m3m,DB01745,-9.5,N-Alpha-(2-Naphthylsulfonyl)-N(3-Amidino-L-Phenylalaninyl)Isopipecolinic Acid Methyl Ester,JJLGQWCKMHPBEB-DEOSSOPVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
57318,6crv,DB03496,-9.5,Alvocidib,BIIVYFLTOXDAOV-YVEFUNNKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109635,6vxx,DB15036,-9.5,Sitravatinib,WLAVZAAODLTUSW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
63064,6crv,DB15062,-9.5,Inarigivir,LYMICVBGNUEHGE-FUQPUAIBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76254,6m2n,DB06995,-9.5,N-({4-[(2-aminopyridin-4-yl)oxy]-3-fluorophenyl}carbamoyl)-2-(4-fluorophenyl)acetamide,USBSTVPJNQLYEM-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
87049,6m3m,DB11759,-9.5,Pevonedistat,MPUQHZXIXSTTDU-QXGSTGNESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
109377,6vxx,DB13490,-9.5,Hidrosmin,XYFLWVOTXWXNAM-WTNNCJBMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113821,6vxx,DB12130,-9.5,Lorlatinib,IIXWYSCJSQVBQM-LLVKDONJSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27067,6cs2,DB06393,-9.5,Xaliproden,WJJYZXPHLSLMGE-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
113774,6vxx,DB12064,-9.5,BMS-777607,VNBRGSXVFBYQNN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86968,6m3m,DB11636,-9.5,Nomegestrol,KZUIYQJTUIACIG-YBZCJVABSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87510,6m3m,DB12420,-9.5,Diazepinomicin,SALVHVNECODMJP-GNUCVDFRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
113767,6vxx,DB12055,-9.5,MK-0767,ORZMUVMQJPGFOM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
63127,6crv,DB15191,-9.5,MAX-40279,AVIOBQFPAGEICQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76612,6m2n,DB07404,-9.5,"(1-HYDROXY-1-PHOSPHONO-2-[1,1';3',1'']TERPHENYL-3-YL-ETHYL)-PHOSPHONIC ACID",YXQQNSYZOQHKHD-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
113844,6vxx,DB12165,-9.5,Presatovir,GOFXWTVKPWJNGD-UWJYYQICSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76207,6m2n,DB06933,-9.5,N-(tert-butyl)-4-[5-(pyridin-2-ylamino)quinolin-3-yl]benzenesulfonamide,GJTCKUKIFXWJKG-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
106094,6vxs,DB15011,-9.5,Avacopan,PUKBOVABABRILL-YZNIXAGQSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
76165,6m2n,DB06888,-9.5,"(13R,15S)-13-METHYL-16-OXA-8,9,12,22,24-PENTAAZAHEXACYCLO[15.6.2.16,9.1,12,15.0,2,7.0,21,25]HEPTACOSA-1(24),2,4,6,17(25),18,20-HEPTAENE-23,26-DIONE",KBLPHMRCKHFBJB-OLZOCXBDSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
87542,6m3m,DB12467,-9.5,TU-100,KAYRGFYBCCETPE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87547,6m3m,DB12474,-9.5,Lynestrenol,YNVGQYHLRCDXFQ-XGXHKTLJSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
132254,6w9c,DB00210,-9.5,Adapalene,LZCDAPDGXCYOEH-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
165000,7bv1,DB09074,-9.5,Olaparib,FDLYAMZZIXQODN-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
166362,7bv1,DB14729,-9.5,Rebeccamycin,QEHOIJJIZXRMAN-QZQSLCQPSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
69604,6lxt,DB11274,-9.5,Dihydro-alpha-ergocryptine,PBUNVLRHZGSROC-VTIMJTGVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
81856,6m3m,DB01772,-9.5,"3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl]-4-(5-Fluoro-1-Methyl-1h-Indol-3-Yl)-Pyrrole-2,5-Dione",RPGZQOOZHIEPJW-HNNXBMFYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87040,6m3m,DB11743,-9.5,Ipatasertib,GRZXWCHAXNAUHY-NSISKUIASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
60054,6crv,DB08173,-9.5,5-CHLORO-N-(2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO)ETHYL)THIOPHENE-2-CARBOXAMIDE,UCKHUNHXYMAFQM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
11392,6lzg,DB11904,-9.5,Flumatinib,BJCJYEYYYGBROF-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
70209,6lxt,DB12309,-9.5,GI-181771X,CABBMMXFOOZVMS-PMERELPUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
107066,6vxx,DB02241,-9.5,"8-Benzyl-2-Hydroperoxy-2-(4-Hydroxy-Benzyl)-6-(4-Hydroxy-Phenyl)-2h-Imidazo[1,2-a]Pyrazin-3-One",HOSWCJDTHOAORT-SANMLTNESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87627,6m3m,DB12597,-9.5,ABL-001,VOVZXURTCKPRDQ-CQSZACIVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
132535,6w9c,DB00549,-9.5,Zafirlukast,YEEZWCHGZNKEEK-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
87628,6m3m,DB12598,-9.5,Nafamostat,MQQNFDZXWVTQEH-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59639,6crv,DB07704,-9.5,"6-AMINO-4-[2-(4-METHOXYPHENYL)ETHYL]-1,7-DIHYDRO-8H-IMIDAZO[4,5-G]QUINAZOLIN-8-ONE",UKRVQKUVWNDGMN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
1008,6lzg,HMDB0007424,-9.5,"DG(20:2(11Z,14Z)/18:3(9Z,12Z,15Z)/0:0)",YPKNZQFRRNHQIM-CNWVQWJYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
87634,6m3m,DB12612,-9.5,Ozanimod,XRVDGNKRPOAQTN-FQEVSTJZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
163214,7bv1,DB03907,-9.5,"N-{3-[5-(6-Amino-Purin-9-Yl)-3,4-Dihydroxy-Tetrahydro-Furan-2-Yl]-Allyl}-2,3-Dihydroxy-5-Nitro-Benzamide",UHHBFOLQOQSPLU-WGRQDFERSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
80552,6m3m,DB00153,-9.5,Ergocalciferol,MECHNRXZTMCUDQ-RKHKHRCZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
148173,6w9q,DB13050,-9.5,Tirilazad,RBKASMJPSJDQKY-RBFSKHHSSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
27398,6cs2,DB06933,-9.5,N-(tert-butyl)-4-[5-(pyridin-2-ylamino)quinolin-3-yl]benzenesulfonamide,GJTCKUKIFXWJKG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
76008,6m2n,DB06630,-9.5,Anacetrapib,MZZLGJHLQGUVPN-HAWMADMCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
58356,6crv,DB04886,-9.5,Calanolide A,NIDRYBLTWYFCFV-FMTVUPSXSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138891,6w9c,DB12410,-9.5,Sabarubicin,VQHRZZISQVWPLK-UIRGBLDSSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
62267,6crv,DB13347,-9.5,Diphenadione,JYGLAHSAISAEAL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80485,6m2n,DB15456,-9.5,Vericiguat,QZFHIXARHDBPBY-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
161540,7bv1,DB15039,-9.5,ITI-214,BBIPVJCGIASXJB-PKTZIBPZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
75987,6m2n,DB06590,-9.5,Ceftaroline fosamil,ZCCUWMICIWSJIX-NQJJCJBVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
63055,6crv,DB15047,-9.5,BMS-919373,XGKULQQVQWCASY-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
54901,6crv,DB00367,-9.5,Levonorgestrel,WWYNJERNGUHSAO-XUDSTZEESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86953,6m3m,DB11592,-9.5,Nitrocefin,LHNIIDJCEODSHA-OQRUQETBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
61618,6crv,DB12341,-9.5,LY-2456302,ZHPMYDSXGRRERG-DEOSSOPVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140718,6w9c,DB15177,-9.5,VX-659,IGEOJNMYRZUKIK-IBGZPJMESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
165475,7bv1,DB12154,-9.5,Itacitinib,KTBSXLIQKWEBRB-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
107149,6vxx,DB02629,-9.5,Inhibitor Bea403,LYHLPPXMBKMSSZ-JQFCFGFHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
131551,6w4h,DB13931,-9.5,Netarsudil,OURRXQUGYQRVML-AREMUKBSSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
86894,6m3m,DB11443,-9.5,Orbifloxacin,QIPQASLPWJVQMH-DTORHVGOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
27359,6cs2,DB06897,-9.5,"3-[3-chloro-5-(5-{[(1S)-1-phenylethyl]amino}isoxazolo[5,4-c]pyridin-3-yl)phenyl]propan-1-ol",MMGKIHLBFPJYJL-HNNXBMFYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
109312,6vxx,DB13055,-9.5,Oteseconazole,IDUYJRXRDSPPRC-NRFANRHFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
82204,6m3m,DB02241,-9.5,"8-Benzyl-2-Hydroperoxy-2-(4-Hydroxy-Benzyl)-6-(4-Hydroxy-Phenyl)-2h-Imidazo[1,2-a]Pyrazin-3-One",HOSWCJDTHOAORT-SANMLTNESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
138905,6w9c,DB12427,-9.5,Orvepitant,XWNBGDJPEXZSQM-VZOBGQTKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
80609,6m3m,DB00218,-9.5,Moxifloxacin,FABPRXSRWADJSP-MEDUHNTESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
76638,6m2n,DB07434,-9.5,HONH-BENZYLMALONYL-L-ALANYLGLYCINE-P-NITROANILIDE,TZWQPWGUQCSKDW-GUYCJALGSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
86759,6m3m,DB09378,-9.5,Fluprednisolone,MYYIMZRZXIQBGI-HVIRSNARSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
132451,6w9c,DB00444,-9.5,Teniposide,NRUKOCRGYNPUPR-QBPJDGROSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
105996,6vxs,DB14766,-9.5,Etrasimod,MVGWUTBTXDYMND-QGZVFWFLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
8384,6lzg,DB05713,-9.5,LY-517717,VYNKVNDKAOGAAQ-RUZDIDTESA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
30383,6cs2,DB12412,-9.5,Gemigliptin,ZWPRRQZNBDYKLH-VIFPVBQESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
80611,6m3m,DB00220,-9.5,Nelfinavir,QAGYKUNXZHXKMR-HKWSIXNMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
147135,6w9q,DB11399,-9.5,Dirlotapide,TUOSYWCFRFNJBS-BHVANESWSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
107319,6vxx,DB03157,-9.5,"N,O-Didansyl-L-Tyrosine",LUBOPDUYHWABFG-NDEPHWFRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80676,6m3m,DB00294,-9.5,Etonogestrel,GCKFUYQCUCGESZ-BPIQYHPVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
144732,6w9q,DB06240,-9.5,Tariquidar,LGGHDPFKSSRQNS-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
139044,6w9c,DB12760,-9.5,GW-493838,ZQYJPMPXQLNTPQ-QCUYGVNKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139063,6w9c,DB12794,-9.5,p-Quaterphenyl,GPRIERYVMZVKTC-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
127552,6w4h,DB06350,-9.5,Elinogrel,LGSDFTPAICUONK-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
62458,6crv,DB13606,-9.5,Phenazocine,ZQHYKVKNPWDQSL-KNXBSLHKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106299,6vxs,DB15416,-9.5,PX-102,XBUXXJUEBFDQHD-NHCUHLMSSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
57537,6crv,DB03797,-9.5,3-Aminomethyl-Pyridinium-Adenine-Dinucleotide,HMCRLFVYYFBZEZ-PLEFRAQWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81386,6m3m,DB01137,-9.5,Levofloxacin,GSDSWSVVBLHKDQ-JTQLQIEISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
113580,6vxx,DB11562,-9.5,Bicuculline,IYGYMKDQCDOMRE-ZWKOTPCHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
139000,6w9c,DB12693,-9.5,Ritanserin,JUQLTPCYUFPYKE-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
55050,6crv,DB00549,-9.5,Zafirlukast,YEEZWCHGZNKEEK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
131872,6w4h,DB14895,-9.5,Vibegron,DJXRIQMCROIRCZ-XOEOCAAJSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
76486,6m2n,DB07261,-9.5,"THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [1-(1-AMINO-ISOQUINOLIN-7-YLMETHYL)-2-OXO-PYRROLDIN-3-YL]-AMIDE",NVKDOURNRJCKJE-INIZCTEOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76489,6m2n,DB07265,-9.5,"3-(9-HYDROXY-1,3-DIOXO-4-PHENYL-2,3-DIHYDROPYRROLO[3,4-C]CARBAZOL-6(1H)-YL)PROPANOIC ACID",JDARUOOLJCFUOY-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
73290,6m2n,DB01831,-9.5,Tryptophanyl-5'amp,IFQVDHDRFCKAAW-SQIXAUHQSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
81408,6m3m,DB01162,-9.5,Terazosin,VCKUSRYTPJJLNI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87360,6m3m,DB12219,-9.5,GSK-424887,DRXBWLBZWAJIEF-IBGZPJMESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
106281,6vxs,DB15382,-9.5,SAR-125844,ODIUNTQOXRXOIV-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
136544,6w9c,DB07242,-9.5,"(4R)-7,8-dichloro-1',9-dimethyl-1-oxo-1,2,4,9-tetrahydrospiro[beta-carboline-3,4'-piperidine]-4-carbonitrile",XGUIMGJMQKZRGM-LLVKDONJSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
76392,6m2n,DB07152,-9.5,N-[4-(5-fluoro-6-methylpyridin-2-yl)-5-quinoxalin-6-yl-1H-imidazol-2-yl]acetamide,TYPILNNEZPSNTI-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
161536,7bv1,DB15034,-9.5,PRI-724,VHOZWHQPEJGPCC-AZXNYEMZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
30811,6cs2,DB13014,-9.5,Hypericin,BTXNYTINYBABQR-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
136531,6w9c,DB07226,-9.5,"N-[4-(2-CHLOROPHENYL)-1,3-DIOXO-1,2,3,6-TETRAHYDROPYRROLO[3,4-C]CARBAZOL-9-YL]FORMAMIDE",JWZVNUNTFNELHL-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
57406,6crv,DB03632,-9.5,Argifin,UHBHXSDKGLPPGO-HTDHLNIYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87237,6m3m,DB12036,-9.5,Naquotinib,QKDCLUARMDUUKN-XMMPIXPASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
106308,6vxs,DB15437,-9.5,Rocacetrapib,GBHPDJQHZADVAA-SOKVYYICSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
127474,6w4h,DB06163,-9.5,Plevitrexed,IEJSCSAMMLUINT-NRFANRHFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
59908,6crv,DB08013,-9.5,(METHYLPYRIDAZINE PIPERIDINE PROPYLOXYPHENYL)ETHYLACETATE,UEIUDEUUVLYRFV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28377,6cs2,DB07966,-9.5,[4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]quinazolin-2-yl}amino)phenyl]acetonitrile,NVMCVWOODOWOLT-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
81223,6m3m,DB00948,-9.5,Mezlocillin,YPBATNHYBCGSSN-VWPFQQQWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81225,6m3m,DB00950,-9.5,Fexofenadine,RWTNPBWLLIMQHL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81180,6m3m,DB00901,-9.5,Bitolterol,FZGVEKPRDOIXJY-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
28378,6cs2,DB07967,-9.5,9-CYCLOPENTYL-6-[2-(3-IMIDAZOL-1-YL-PROPOXY)-PHENYLAMINO]-9H-PURINE-2-CARBONITRILE,JJNKDTWKWYLERH-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
81174,6m3m,DB00894,-9.5,Testolactone,BPEWUONYVDABNZ-DZBHQSCQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
131911,6w4h,DB15006,-9.5,Flufenoxuron,RYLHNOVXKPXDIP-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
81242,6m3m,DB00972,-9.5,Azelastine,MBUVEWMHONZEQD-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
127514,6w4h,DB06248,-9.5,Amelubant,SBVYURPQULDJTI-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
106310,6vxs,DB15442,-9.5,Trilaciclib,PDGKHKMBHVFCMG-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
76493,6m2n,DB07270,-9.5,"N-[7-(3-AMINOPHENYL)-5-METHOXY-1,3-BENZOXAZOL-2-YL]-2,5-DICHLOROBENZENESULFONAMIDE",GAYYMURZGLJDCT-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
81156,6m3m,DB00873,-9.5,Loteprednol,YPZVAYHNBBHPTO-MXRBDKCISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
28381,6cs2,DB07970,-9.5,5-[(2-methyl-5-{[3-(trifluoromethyl)phenyl]carbamoyl}phenyl)amino]pyridine-3-carboxamide,SAAYRHKJHDIDPH-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
113482,6vxx,DB09238,-9.5,Manidipine,ANEBWFXPVPTEET-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113483,6vxx,DB09239,-9.5,Niguldipine,SVJMLYUFVDMUHP-XIFFEERXSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81279,6m3m,DB01013,-9.5,Clobetasol propionate,CBGUOGMQLZIXBE-XGQKBEPLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81290,6m3m,DB01026,-9.5,Ketoconazole,XMAYWYJOQHXEEK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81292,6m3m,DB01029,-9.5,Irbesartan,YOSHYTLCDANDAN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
113379,6vxx,DB09079,-9.5,Nintedanib,XZXHXSATPCNXJR-ZIADKAODSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87318,6m3m,DB12149,-9.5,S-3304,YWCLDDLVLSQGSZ-JOCHJYFZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59917,6crv,DB08022,-9.5,"(2S)-1,3-benzothiazol-2-yl{2-[(2-pyridin-3-ylethyl)amino]pyrimidin-4-yl}ethanenitrile",RCYPVQCPYKNSTG-OAHLLOKOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136569,6w9c,DB07270,-9.5,"N-[7-(3-AMINOPHENYL)-5-METHOXY-1,3-BENZOXAZOL-2-YL]-2,5-DICHLOROBENZENESULFONAMIDE",GAYYMURZGLJDCT-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
113431,6vxx,DB09183,-9.5,Dasabuvir,NBRBXGKOEOGLOI-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81784,6m3m,DB01678,-9.5,RU84687,SAFPHFWYRLLBFO-NSOVKSMOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81020,6m3m,DB00713,-9.5,Oxacillin,UWYHMGVUTGAWSP-JKIFEVAISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81444,6m3m,DB01200,-9.5,Bromocriptine,OZVBMTJYIDMWIL-AYFBDAFISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
127418,6w4h,DB05835,-9.5,NS-3728,OQRAKHDEGGGWQO-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
87140,6m3m,DB11891,-9.5,CUDC-907,JOWXJLIFIIOYMS-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
57808,6crv,DB04158,-9.5,"6-(Adenosine Tetraphosphate-Methyl)-7,8-Dihydropterin",ZKRKFZJAQKKHKL-SUGPNEFASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59777,6crv,DB07861,-9.5,(2R)-N-hydroxy-3-naphthalen-2-yl-2-[(naphthalen-2-ylsulfonyl)amino]propanamide,MMOUXLMPQFMDRD-JOCHJYFZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87127,6m3m,DB11871,-9.5,PF-00610355,YPHDIMUXXABSSO-YTTGMZPUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
62424,6crv,DB13556,-9.5,Sulfamazone,BGLHAKAJGYLSOX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30820,6cs2,DB13024,-9.5,MK-8245,UJEAABFSXKCSGI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
140578,6w9c,DB12477,-9.5,Perfluoro tert-butylcyclohexane,VLTXBOGHSBHSAC-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
59771,6crv,DB07855,-9.5,(S)-1-PHENYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE,CWHMAWBXRCDOEB-HNNXBMFYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87104,6m3m,DB11832,-9.5,Crenolanib,DYNHJHQFHQTFTP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136437,6w9c,DB07117,-9.5,"5-(4-PHENOXYPHENYL)-5-(4-PYRIMIDIN-2-YLPIPERAZIN-1-YL)PYRIMIDINE-2,4,6(2H,3H)-TRIONE",FMKQJGOROFNCGM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
106179,6vxs,DB15183,-9.5,Fosmanogepix,JQONJQKKVAHONF-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
140000,6w9c,DB14723,-9.5,Larotrectinib,NYNZQNWKBKUAII-KBXCAEBGSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
109519,6vxx,DB14037,-9.5,Madecassic acid,PRAUVHZJPXOEIF-AOLYGAPISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
139046,6w9c,DB12764,-9.5,ABC-294640,CAOTVXGYTWCKQE-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
113197,6vxx,DB08656,-9.5,5-amino-2-methyl-N-[(1R)-1-naphthalen-1-ylethyl]benzamide,UVERBUNNCOKGNZ-CQSZACIVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62381,6crv,DB13499,-9.5,Cefsulodin,SYLKGLMBLAAGSC-QLVMHMETSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81672,6m3m,DB01541,-9.5,Boldenone,RSIHSRDYCUFFLA-DYKIIFRCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
30515,6cs2,DB12588,-9.5,AZD-1480,PDOQBOJDRPLBQU-QMMMGPOBSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
109435,6vxx,DB13571,-9.5,Pentamycin,AGJUUQSLGVCRQA-SWOUQTJZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59763,6crv,DB07845,-9.5,"2-fluoro-6-{[2-({2-methoxy-4-[(methylsulfonyl)methyl]phenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide",VGYXXQRDIVRILX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80931,6m3m,DB00606,-9.5,Cyclothiazide,BOCUKUHCLICSIY-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
113218,6vxx,DB08683,-9.5,"REL-(9R,12S)-9,10,11,12-TETRAHYDRO-9,12-EPOXY-1H-DIINDOLO[1,2,3-FG:3',2',1'-KL]PYRROLO[3,4-I][1,6]BENZODIAZOCINE-1,3(2H)-DIONE",OTPNDVKVEAIXTI-IYBDPMFKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80943,6m3m,DB00621,-9.5,Oxandrolone,QSLJIVKCVHQPLV-PEMPUTJUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87452,6m3m,DB12339,-9.5,Radezolid,BTTNOGHPGJANSW-IBGZPJMESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
106582,6vxx,DB00522,-9.5,Bentiromide,SPPTWHFVYKCNNK-FQEVSTJZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59873,6crv,DB07974,-9.5,1-{2-[(4-CHLOROPHENYL)AMINO]-2-OXOETHYL}-N-(1-ISOPROPYLPIPERIDIN-4-YL)-1H-INDOLE-2-CARBOXAMIDE,BDLMBQRBNPDCSS-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109629,6vxx,DB15028,-9.5,MK-1064,CKTWQGHVNRYNCM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61668,6crv,DB12412,-9.5,Gemigliptin,ZWPRRQZNBDYKLH-VIFPVBQESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
159647,7bv1,DB05038,-9.5,Anatibant,XUHBBTKJWIBQMY-MHZLTWQESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
87408,6m3m,DB12282,-9.5,Defactinib,FWLMVFUGMHIOAA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
30625,6cs2,DB12743,-9.5,Z-160,VCPMZDWBEWTGNW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
59849,6crv,DB07946,-9.5,"N-[2-({[amino(imino)methyl]amino}oxy)ethyl]-2-{6-chloro-3-[(2,2-difluoro-2-phenylethyl)amino]-2-fluorophenyl}acetamide",DZEJHPMTDNDECN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55073,6crv,DB00578,-9.5,Carbenicillin,FPPNZSSZRUTDAP-UWFZAAFLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87164,6m3m,DB11922,-9.5,Danirixin,NGYNBSHYFOFVLS-LBPRGKRZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87210,6m3m,DB11994,-9.5,Diacerein,TYNLGDBUJLVSMA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
76553,6m2n,DB07333,-9.5,"N-(CYCLOPROPYLMETHYL)-4-(METHYLOXY)-3-({5-[3-(3-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-YL}AMINO)BENZENESULFONAMIDE",KRGKAARWVPUWSY-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
81522,6m3m,DB01337,-9.5,Pancuronium,GVEAYVLWDAFXET-XGHATYIMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87431,6m3m,DB12309,-9.5,GI-181771X,CABBMMXFOOZVMS-PMERELPUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
28956,6cs2,DB08584,-9.5,"6-{[6-(1-methyl-1H-pyrazol-4-yl)[1,2,4]triazolo[4,3-b]pyridazin-3-yl]sulfanyl}quinoline",BCZUAADEACICHN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
61670,6crv,DB12415,-9.5,Galeterone,PAFKTGFSEFKSQG-PAASFTFBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106745,6vxx,DB01199,-9.5,Tubocurarine,JFJZZMVDLULRGK-URLMMPGGSA-O,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81527,6m3m,DB01347,-9.5,Saprisartan,DUEWVPTZCSAMNB-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80955,6m3m,DB00635,-9.5,Prednisone,XOFYZVNMUHMLCC-ZPOLXVRWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
113686,6vxx,DB11763,-9.5,Momelotinib,ZVHNDZWQTBEVRY-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59791,6crv,DB07875,-9.5,"5-Chloro-thiophene-2-carboxylic acid ((3S,4S)-1-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-methyl}-4-hydroxy-pyrrolidin-3-yl)-amide",ARAVOODWJJJNBY-IRXDYDNUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55000,6crv,DB00485,-9.5,Dicloxacillin,YFAGHNZHGGCZAX-JKIFEVAISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113678,6vxx,DB11749,-9.5,(R)-Praziquantel,FSVJFNAIGNNGKK-KRWDZBQOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59879,6crv,DB07982,-9.5,2-{4-[4-({4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]pyrimidin-2-yl}amino)phenyl]piperazin-1-yl}-2-oxoethanol,PVTKDXZNSUHUMO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78128,6m2n,DB09319,-9.5,Carindacillin,JIRBAUWICKGBFE-MNRDOXJOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
73654,6m2n,DB02323,-9.5,EM-1745,CKSDYJASHNGOOS-KTXOUVACSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
85224,6m3m,DB07405,-9.5,"1-(6-CYANO-3-PYRIDYLCARBONYL)-5',8'-DIFLUOROSPIRO[PIPERIDINE-4,2'(1'H)-QUINAZOLINE]-4'-AMINE",GIZYIOOBBUHOBS-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
62069,6crv,DB13036,-9.5,Ramatroban,LDXDSHIEDAPSSA-OAHLLOKOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58729,6crv,DB06497,-9.5,Aplaviroc,GWNOTCOIYUNTQP-FQLXRVMXSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
135459,6w9c,DB04495,-9.5,RU81843,GGPXNASQNUOIPB-NSOVKSMOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
161032,7bv1,DB12424,-9.5,MK-3207,AZAANWYREOQRFB-SETSBSEESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
85170,6m3m,DB07340,-9.5,"N-6-cyclohexyl-N-2-(4-morpholin-4-ylphenyl)-9H-purine-2,6-diamine",ZFLJHSQHILSNCM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85164,6m3m,DB07333,-9.5,"N-(CYCLOPROPYLMETHYL)-4-(METHYLOXY)-3-({5-[3-(3-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-YL}AMINO)BENZENESULFONAMIDE",KRGKAARWVPUWSY-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
125258,6w4h,DB02258,-9.5,SR11254,RNZIUDLOJHVHLZ-VYIQYICTSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
74988,6m2n,DB04099,-9.5,Deamido-Nad+,SENPVEZBRZQVST-HISDBWNOSA-O,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
59155,6crv,DB07136,-9.5,(2S)-2-[3-(AMINOMETHYL)PHENYL]-3-{(R)-HYDROXY[(1R)-2-METHYL-1-{[(3-PHENYLPROPYL)SULFONYL]AMINO}PROPYL]PHOSPHORYL}PROPANOIC ACID,WFFOOKSVFDUPDH-FCHUYYIVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58772,6crv,DB06609,-9.5,Odiparcil,JRHNIQQUVJOPQC-AQNFWKISSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
139651,6w9c,DB13756,-9.5,Peruvoside,PMTSPAGBAFCORP-HBUONDEYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
85092,6m3m,DB07256,-9.5,"3-({4-[(5-CHLORO-1,3-BENZODIOXOL-4-YL)AMINO]PYRIMIDIN-2-YL}AMINO)BENZAMIDE",ZVQZIVCQLFGXFZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
133918,6w9c,DB02329,-9.5,Carbenoxolone,OBZHEBDUNPOCJG-WBXJDKIVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
61974,6crv,DB12892,-9.5,MGB-BP-3,OEKXCVYZBVOWBR-BQYQJAHWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108664,6vxx,DB08521,-9.5,4-[5-(4-FLUORO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-3H-IMIDAZOL-4-YL]-PYRIDINE,CDMGBJANTYXAIV-HHHXNRCGSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29958,6cs2,DB11863,-9.5,Alvelestat,QNQZWEGMKJBHEM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
85089,6m3m,DB07253,-9.5,"N'-(5-chloro-1,3-benzodioxol-4-yl)-N-(3-methylsulfonylphenyl)pyrimidine-2,4-diamine",QTFCKBFCXDAZIU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
74945,6m2n,DB04044,-9.5,4-{2-[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid,NAQUAVBNIYTIIS-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
59146,6crv,DB07126,-9.5,O6-CYCLOHEXYLMETHOXY-2-(4'-SULPHAMOYLANILINO) PURINE,OWXORKPNCHJYOF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108724,6vxx,DB08861,-9.5,DPDPE,MCMMCRYPQBNCPH-WMIMKTLMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108731,6vxx,DB08875,-9.5,Cabozantinib,ONIQOQHATWINJY-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
63216,6crv,DB15358,-9.5,JNJ-54175446,CWFVVQFVGMFTBD-SECBINFHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59099,6crv,DB07072,-9.5,"(1S,2R,5S)-5-[3-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7(8H)-YL]-2-(2,4,5-TRIFLUOROPHENYL)CYCLOHEXANAMINE",CNKRZILQBKJWDS-WMFXKJRFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29835,6cs2,DB11697,-9.5,Pacritinib,HWXVIOGONBBTBY-ONEGZZNKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
84280,6m3m,DB05288,-9.5,Anecortave acetate,YUWPMEXLKGOSBF-GACAOOTBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
166571,7bv1,DB15401,-9.5,Danicopan,PIBARDGJJAGJAJ-NQIIRXRSSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
29979,6cs2,DB11891,-9.5,CUDC-907,JOWXJLIFIIOYMS-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
114911,6vxx,DB15396,-9.5,PF-114,SLIVDYMORZGPLW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85439,6m3m,DB07663,-9.5,"2-[(1R)-1-CARBOXY-2-(4-HYDROXYPHENYL)ETHYL]-1,3-DIOXOISOINDOLINE-5-CARBOXYLIC ACID",QISJEFYTLZTWIQ-CQSZACIVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84109,6m3m,DB04785,-9.5,Streptolydigin,KVTPRMV1KLIG-NCAOFHFGSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85405,6m3m,DB07622,-9.5,"1-(3-(2,4-DIMETHYLTHIAZOL-5-YL)-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)-3-(4-METHYLPIPERAZIN-1-YL)UREA",KRKQVGZXTNLQSV-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
114936,6vxx,DB15444,-9.5,Elexacaftor,MVRHVFSOIWFBTE-INIZCTEOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61945,6crv,DB12848,-9.5,PF-04217903,PDMUGYOXRHVNMO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59205,6crv,DB07193,-9.5,"(2R,3R)-7-(methylsulfonyl)-3-(2,4,5-trifluorophenyl)-1,2,3,4-tetrahydropyrido[1,2-a]benzimidazol-2-amine",HJJAYSSCWGUPKO-ABAIWWIYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108581,6vxx,DB08423,-9.5,[5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL][3-(PIPERIDIN-4-YLOXY)PHENYL]METHANONE,QKZZJXRGCHXIAI-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84171,6m3m,DB04862,-9.5,Merimepodib,JBPUGFODGPKTDW-SFHVURJKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85343,6m3m,DB07545,-9.5,N-{3-[(4-{[3-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-2-YL)AMINO]PHENYL}CYCLOPROPANECARBOXAMIDE,RDTDWGQDFJPTPD-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
114930,6vxx,DB15431,-9.5,M-2698,HXAUJHZZPCBFPN-QGZVFWFLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62079,6crv,DB13053,-9.5,CP-195543,NZQDWKCNBOELAI-KSFYIVLOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
166540,7bv1,DB15328,-9.5,Ubrogepant,DDOOFTLHJSMHLN-ZQHRPCGSSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
108636,6vxx,DB08489,-9.5,"N4-HYDROXY-2-ISOBUTYL-N1-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.013,18]NONADECA-12(19),13,15,17-TETRAEN-10-YL)-SUCCINAMIDE",GCBPAPVOMPJQHK-NQIIRXRSSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108647,6vxx,DB08500,-9.5,"(3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(2-naphthyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol",ZCJBDRSKHARECB-PYTCMNEWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75141,6m2n,DB04298,-9.5,"3-(4-Amino-2-Tert-Butyl-5-Methyl-Phenylsulfanyl)-6-Cyclopentyl-4-Hydroxy-6-[2-(4-Hydroxy-Phenyl)-Ethyl]-5,6-Dihydro-Pyran-2-One",ZEBFKFGJWHOOST-LJAQVGFWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75133,6m2n,DB04289,-9.5,Genz-10850,YYMZSGIXLQPFAC-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
84201,6m3m,DB04908,-9.5,Flibanserin,PPRRDFIXUUSXRA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
166548,7bv1,DB15345,-9.5,GSK-945237,SRICOHRDRMZREQ-MRXNPFEDSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
62075,6crv,DB13048,-9.5,PAC-1,YQNRVGJCPCNMKT-LFVJCYFKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84233,6m3m,DB05016,-9.5,Ataluren,OOUGLTULBSNHNF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58708,6crv,DB06446,-9.5,Dotarizine,LRMJAFKKJLRDLE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
160438,7bv1,DB08387,-9.5,2-{[4-(1-methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline,AZEXWHKOMMASPA-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59177,6crv,DB07162,-9.5,4-(3-amino-1H-indazol-5-yl)-N-tert-butylbenzenesulfonamide,KFJCXIOVAGJCKB-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59175,6crv,DB07159,-9.5,Tamatinib,NHHQJBCNYHBUSI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
65171,6lxt,DB02483,-9.5,Etheno-Nad,JCDBQDNBEQHDHK-BSLNIGMPSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
161046,7bv1,DB12794,-9.5,p-Quaterphenyl,GPRIERYVMZVKTC-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
75295,6m2n,DB04514,-9.5,Phosphoric Acid-2'-[2'-Deoxy-Uridine]Ester-5'-Guanosine Ester,DFYLLEBFVZTKHD-VMIOUTBZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
85034,6m3m,DB07186,-9.5,"4-(4-METHYLPIPERAZIN-1-YL)-N-[5-(2-THIENYLACETYL)-1,5-DIHYDROPYRROLO[3,4-C]PYRAZOL-3-YL]BENZAMIDE",TYYNSDQVFIOSFH-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84404,6m3m,DB06011,-9.5,AMG-222,NVSWJKWHLUTHLP-CPJSRVTESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
29904,6cs2,DB11791,-9.5,Capmatinib,LIOLIMKSCNQPLV-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
108985,6vxx,DB11867,-9.5,JNJ-39393406,IURMHZBQEYNQOH-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114858,6vxx,DB15287,-9.5,Elismetrep,CWEFDWIKLABKBX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
166599,7bv1,DB15450,-9.5,PF-05105679,BXNMZRPTQFVRFA-QGZVFWFLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
63577,6lxt,DB00444,-9.5,Teniposide,NRUKOCRGYNPUPR-QBPJDGROSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
58898,6crv,DB06835,-9.5,(2S)-2-[3-(AMINOMETHYL)PHENYL]-3-{(S)-HYDROXY[(1R)-2-METHYL-1-{[(2-PHENYLETHYL)SULFONYL]AMINO}PROPYL]PHOSPHORYL}PROPANOIC ACID,CTQDLSDUHUFBQW-LEWJYISDSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108994,6vxx,DB11878,-9.5,Filibuvir,SLVAPEZTBDBAPI-GDLZYMKVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84776,6m3m,DB06888,-9.5,"(13R,15S)-13-METHYL-16-OXA-8,9,12,22,24-PENTAAZAHEXACYCLO[15.6.2.16,9.1,12,15.0,2,7.0,21,25]HEPTACOSA-1(24),2,4,6,17(25),18,20-HEPTAENE-23,26-DIONE",KBLPHMRCKHFBJB-OLZOCXBDSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84563,6m3m,DB06494,-9.5,Sufugolix,UCQSBGOFELXYIN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
165382,7bv1,DB12020,-9.5,Tecovirimat,CSKDFZIMJXRJGH-VWLPUNTISA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
58906,6crv,DB06847,-9.5,"5-[(3S)-3-(2-methoxybiphenyl-4-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",YYCPXVRHQUEVAW-CQSZACIVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28826,6cs2,DB08446,-9.5,"3-[6-bromo-2-fluoro-3-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)phenoxy]-5-chlorobenzonitrile",OHQMEDBYNUAVNE-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
109076,6vxx,DB12001,-9.5,Abemaciclib,UZWDCWONPYILKI-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58925,6crv,DB06871,-9.5,17-METHYL-17-ALPHA-DIHYDROEQUILENIN,FQMQOMRDADWGJJ-GBESFXJTSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
134813,6w9c,DB03591,-9.5,RU82209,LVZDQVATAQEMCX-NSOVKSMOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
134609,6w9c,DB03300,-9.5,Pterin Cytosine Dinucleotide,WKSPNQYEWZEMMI-FEFZDOOUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139794,6w9c,DB13997,-9.5,Baloxavir marboxil,RZVPBGBYGMDSBG-GGAORHGYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
84701,6m3m,DB06781,-9.5,Difluprednate,WYQPLTPSGFELIB-JTQPXKBDSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84605,6m3m,DB06605,-9.5,Apixaban,QNZCBYKSOIHPEH-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84613,6m3m,DB06622,-9.5,7-beta-Hydroxyepiandrosterone,VFPMCLQMAUVEHD-UCPSWNCLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84699,6m3m,DB06777,-9.5,Chenodeoxycholic acid,RUDATBOHQWOJDD-BSWAIDMHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84690,6m3m,DB06755,-9.5,Beta carotene,OENHQHLEOONYIE-JLTXGRSLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
109043,6vxx,DB11949,-9.5,Vestipitant,SBBYBXSFWOLDDG-JLTOFOAXSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84667,6m3m,DB06721,-9.5,Gimatecan,UIVFUQKYVFCEKJ-OPTOVBNMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
134714,6w9c,DB03447,-9.5,Uridylyl-2'-5'-Phospho-Adenosine,QARCCHXXGAIRFS-KPKSGTNCSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
114818,6vxx,DB14918,-9.5,Branaplam,STWTUEAWRAIWJG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108750,6vxx,DB08907,-9.5,Canagliflozin,XTNGUQKDFGDXSJ-ZXGKGEBGSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
160893,7bv1,DB11877,-9.5,Basmisanil,VCGRFBXVSFAGGA-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
74760,6m2n,DB03797,-9.5,3-Aminomethyl-Pyridinium-Adenine-Dinucleotide,HMCRLFVYYFBZEZ-PLEFRAQWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
59084,6crv,DB07054,-9.5,(2R)-1-(DIMETHYLAMINO)-3-{4-[(6-{[2-FLUORO-5-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-4-YL)AMINO]PHENOXY}PROPAN-2-OL,OSCWQKTUILTARV-MRXNPFEDSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84995,6m3m,DB07142,-9.5,"5-[(3R)-3-(5-methoxy-3',5'-dimethylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",ATFDKOLABYIYCC-INIZCTEOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
166580,7bv1,DB15414,-9.5,CM-4307,MLDQJTXFUGDVEO-FIBGUPNXSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
84994,6m3m,DB07141,-9.5,"5-[(3R)-3-(5-methoxy-4'-methylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",QVXYJVHNRPNRJL-HNNXBMFYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
134112,6w9c,DB02581,-9.5,"5-[2,3-Dichloro-4-(5-{1-[2-(2-Guanidino-4-Methyl-Pentanoylamino)-Acetyl]-Piperidin-4-Yl}-1-Methyl-1h-Pyrazol-3-Yl)-Phenoxymethyl]-Furan-2-Carboxylic Acid",VNZHOIDQBPFEJU-OAQYLSRUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
32832,6cs2,T3D3746,-9.5,Territrem A,LCJHAHVVYAVVPA-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
135185,6w9c,DB04098,-9.5,Balanol,XYUFCXJZFZPEJD-PGRDOPGGSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
84972,6m3m,DB07117,-9.5,"5-(4-PHENOXYPHENYL)-5-(4-PYRIMIDIN-2-YLPIPERAZIN-1-YL)PYRIMIDINE-2,4,6(2H,3H)-TRIONE",FMKQJGOROFNCGM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
125630,6w4h,DB02741,-9.5,CD564,RWYREGSYPCNZTL-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
84445,6m3m,DB06194,-9.5,Elocalcitol,LRLWXBHFPGSUOX-GJQYOBCGSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84944,6m3m,DB07084,-9.5,"N-(6,7,9,10,17,18,20,21-octahydrodibenzo[b,k][1,4,7,10,13,16]hexaoxacyclooctadecin-2-yl)acetamide",YHKGWOJTUMJPNW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
139730,6w9c,DB13856,-9.5,Fluclorolone,VTWKPILBIUBMDS-OTJLYDAYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
58807,6crv,DB06684,-9.5,Vilazodone,SGEGOXDYSFKCPT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59056,6crv,DB07025,-9.5,3-(5-{[4-(AMINOMETHYL)PIPERIDIN-1-YL]METHYL}-1H-INDOL-2-YL)QUINOLIN-2(1H)-ONE,KBIHHEGEALBUMT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59054,6crv,DB07022,-9.5,3-Hydroxypropyl 3-[(7-carbamimidoyl-1-naphthyl)carbamoyl]benzenesulfonate,PXERBGNIBOFZOW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114803,6vxx,DB14889,-9.5,Derazantinib,KPJDVVCDVBFRMU-AREMUKBSSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28772,6cs2,DB08387,-9.5,2-{[4-(1-methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline,AZEXWHKOMMASPA-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
114810,6vxx,DB14902,-9.5,JHU-75528 C-11,MCNQUWLLXZZZAC-BJUDXGSMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84907,6m3m,DB07041,-9.5,"N-[2-(2,4-diaminopyrido[2,3-d]pyrimidin-7-yl)-2-methylpropyl]-4-phenoxybenzamide",FDJWFDQRPKKBFA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
160685,7bv1,DB09280,-9.5,Lumacaftor,UFSKUSARDNFIRC-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
33096,6cs2,T3D4082,-9.5,Cyclopamine,QASFUMOKHFSJGL-LAFRSMQTSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
134287,6w9c,DB02873,-9.5,"1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperazin-1-Yl-3,4-Dihydroquinazolin-2(1h)-One",YAWZIQKDHQIHOS-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
84502,6m3m,DB06314,-9.5,SGX-523,BCZUAADEACICHN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84876,6m3m,DB07006,-9.5,"9-HYDROXY-6-(3-HYDROXYPROPYL)-4-(2-METHOXYPHENYL)PYRROLO[3,4-C]CARBAZOLE-1,3(2H,6H)-DIONE",AOGOZJCRIFBTTN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84510,6m3m,DB06347,-9.5,Cenisertib,KSOVGRCOLZZTPF-QMKUDKLTSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84515,6m3m,DB06364,-9.5,XR5944,SFOADSRLCHRTKT-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86472,6m3m,DB08907,-9.5,Canagliflozin,XTNGUQKDFGDXSJ-ZXGKGEBGSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
114712,6vxx,DB14675,-9.5,Temsavir,QRPZBKAMSFHVRW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
63183,6crv,DB15295,-9.5,Tenalisib,HDXDQPRPFRKGKZ-INIZCTEOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140759,6w9c,DB15254,-9.5,RO-5126766 free base,LMMJFBMMJUMSJS-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
87662,6m3m,DB12658,-9.5,AFN-1252,QXTWSUQCXCWEHF-JXMROGBWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86106,6m3m,DB08448,-9.5,"(4aS)-5-[(2,4-diaminopteridin-6-yl)methyl]-4a,5-dihydro-2H-dibenzo[b,f]azepin-8-ol",PCBWLKUEKANDCL-INIZCTEOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
82846,6m3m,DB03084,-9.5,"Cyclopropyl-{4-[5-(3,4-Dichlorophenyl)-2-[(1-Methyl)-Piperidin]-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine",XCTKFTOEAKJMII-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86084,6m3m,DB08423,-9.5,[5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL][3-(PIPERIDIN-4-YLOXY)PHENYL]METHANONE,QKZZJXRGCHXIAI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
61781,6crv,DB12579,-9.5,JNJ-37822681,UVUYWJWYRLJHEN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
82937,6m3m,DB03207,-9.5,"2-(Biphenyl-4-Sulfonyl)-1,2,3,4-Tetrahydro-Isoquinoline-3-Carboxylic Acid",BNVMUDXGABBWGP-OAQYLSRUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86038,6m3m,DB08365,-9.5,"8-bromo-4-(2-chlorophenyl)-N-(2-hydroxyethyl)-6-methyl-1,3-dioxo-1,2,3,6-tetrahydropyrrolo[3,4-e]indole-7-carboxamide",XUAHLMVOYLUYSB-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
54760,6crv,DB00197,-9.5,Troglitazone,GXPHKUHSUJUWKP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86036,6m3m,DB08362,-9.5,"N-(3-(8-CYANO-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZIN-2-YLAMINO)PHENYL)ACETAMIDE",QVKXQLGRDOMAGC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
62131,6crv,DB13126,-9.5,BMS-986115,SRJNRAQUSAVENA-GSHUGGBRSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30211,6cs2,DB12200,-9.5,Tivantinib,UCEQXRCJXIVODC-PMACEKPBSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
126830,6w4h,DB04350,-9.5,Argadin,FOZYKTUSOWWQGR-KNPYFFGGSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
63155,6crv,DB15238,-9.5,Olinciguat,YWQFJNWMWZMXRW-HXUWFJFHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86028,6m3m,DB08353,-9.5,"2-(CYCLOHEXYLMETHYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE",NCVMTHVSAJMOPI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83039,6m3m,DB03336,-9.5,BIA,KVIVJQWOYSWCCZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
75782,6m2n,DB05944,-9.5,Varlitinib,UWXSAYUXVSFDBQ-CYBMUJFWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
54719,6crv,DB00153,-9.5,Ergocalciferol,MECHNRXZTMCUDQ-RKHKHRCZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85989,6m3m,DB08305,-9.5,"(3R)-3-cyclopentyl-6-methyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2-benzothiazine 1,1-dioxide",KQAGZLQCEURCKJ-QGZVFWFLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85987,6m3m,DB08303,-9.5,"(3S)-3-cyclopentyl-6-methyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide",CUMKMTBOHBENJI-SFHVURJKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85942,6m3m,DB08242,-9.5,"N,4-dimethyl-3-[(1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl)amino]benzamide",OYTBZXSFNNAVKU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83084,6m3m,DB03397,-9.5,Uridine-Diphosphate-N-Acetylglucosamine,LFTYTUAZOPRMMI-CFRASDGPSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83127,6m3m,DB03461,-9.5,2'-Monophosphoadenosine 5'-Diphosphoribose,XJLXINKUBYWONI-NNYOXOHSSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
63158,6crv,DB15245,-9.5,Olorofim,SUFPWYYDCOKDLL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75737,6m2n,DB05653,-9.5,IRX-5183,PNAWUIKCVQSLFG-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
62191,6crv,DB13246,-9.5,Quinupramine,JCBQCKFFSPGEDY-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58558,6crv,DB05944,-9.5,Varlitinib,UWXSAYUXVSFDBQ-CYBMUJFWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
82835,6m3m,DB03072,-9.5,"2-{3-[4-(4-Fluorophenyl)-3,6-Dihydro-1(2h)-Pyridinyl]Propyl}-8-Methyl-4(3h)-Quinazolinone",LOFDUAJQRUYHBR-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
107922,6vxx,DB05608,-9.5,MKC-1,OVSKGTONMLKNPZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30348,6cs2,DB12369,-9.5,Sotrastaurin,OAVGBZOFDPFGPJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
107469,6vxx,DB03642,-9.5,Benzofuran-2-Carboxylic Acid {(S)-3-Methyl-1-[3-Oxo-1-(Pyridin-2-Ylsulfonyl)Azepan-4-Ylcarbamoyl]Butyl}Amide,VBPPNJCVXGAZDD-PMACEKPBSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165465,7bv1,DB12138,-9.5,PF-03715455,VGEXRDWWPSGZDH-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
114018,6vxx,DB12597,-9.5,ABL-001,VOVZXURTCKPRDQ-CQSZACIVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86425,6m3m,DB08827,-9.5,Lomitapide,MBBCVAKAJPKAKM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
82529,6m3m,DB02659,-9.5,Cholic Acid,BHQCQFFYRZLCQQ-OELDTZBJSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
73678,6m2n,DB02354,-9.5,4-{[1-Methyl-5-(2-Methyl-Benzoimidazol-1-Ylmethyl)-1h-Benzoimidazol-2-Ylmethyl]-Amino}-Benzamidine,IRKPNOLLMNHSOU-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
139190,6w9c,DB12996,-9.5,Acteoside,FBSKJMQYURKNSU-ZLSOWSIRSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
75920,6m2n,DB06414,-9.5,Etravirine,PYGWGZALEOIKDF-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
132689,6w9c,DB00734,-9.5,Risperidone,RAPZEAPATHNIPO-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
82623,6m3m,DB02789,-9.5,Pregnenolone,ORNBQBCIOKFOEO-QGVNFLHTSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
114038,6vxx,DB12635,-9.5,Aleplasinin,HSXLMAFNWCSZGP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86321,6m3m,DB08709,-9.5,"2,3-diphenyl-1H-indole-7-carboxylic acid",OLUDUXWVPIEHDA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136105,6w9c,DB06558,-9.5,Tezosentan,TUYWTLTWNJOZNY-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
26844,6cs2,DB00568,-9.5,Cinnarizine,DERZBLKQOCDDDZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
58434,6crv,DB05239,-9.5,Cobimetinib,BSMCAPRUBJMWDF-KRWDZBQOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
132739,6w9c,DB00796,-9.5,Candesartan cilexetil,GHOSNRCGJFBJIB-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
86250,6m3m,DB08619,-9.5,Testosterone succinate,CJQNBXFUHQZFOE-VYAQIDIUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
68094,6lxt,DB07514,-9.5,"3-(2-aminoquinazolin-6-yl)-1-(3,3-dimethylindolin-6-yl)-4-methylpyridin-2(1H)-one",LHLGUOHREUTYTO-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
86221,6m3m,DB08584,-9.5,"6-{[6-(1-methyl-1H-pyrazol-4-yl)[1,2,4]triazolo[4,3-b]pyridazin-3-yl]sulfanyl}quinoline",BCZUAADEACICHN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86190,6m3m,DB08546,-9.5,"4-[(3AS,4R,7R,8AS,8BR)-2-(1,3-BENZODIOXOL-5-YLMETHYL)-7-HYDROXY-1,3-DIOXODECAHYDROPYRROLO[3,4-A]PYRROLIZIN-4-YL]BENZENECARBOXIMIDAMIDE",CETLUACQMGBMFH-ZALSBGIRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
54801,6crv,DB00246,-9.5,Ziprasidone,MVWVFYHBGMAFLY-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86154,6m3m,DB08504,-9.5,"6-(4-{(1S,2S)-2-AMINO-1-[(DIMETHYLAMINO)CARBONYL]-3-[(3S)-3-FLUOROPYRROLIDIN-1-YL]-3-OXOPROPYL}PHENYL)-1H-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-4-IUM",ZNHVIJAGMFQGMS-IHPCNDPISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
140755,6w9c,DB15245,-9.5,Olorofim,SUFPWYYDCOKDLL-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
82809,6m3m,DB03038,-9.5,LY341770,MXAFDBCLWLMXSI-ZDUSSCGKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58468,6crv,DB05424,-9.5,Canertinib,OMZCMEYTWSXEPZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108552,6vxx,DB08387,-9.5,2-{[4-(1-methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline,AZEXWHKOMMASPA-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108136,6vxx,DB07144,-9.5,"5-[(3R)-3-(5-methoxy-2',6'-dimethylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",XZXVRKHUCSXVBM-AWEZNQCLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
135951,6w9c,DB06163,-9.5,Plevitrexed,IEJSCSAMMLUINT-NRFANRHFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
85631,6m3m,DB07882,-9.5,"4-{4-[2-(1A,7A-DIMETHYL-4-OXY-OCTAHYDRO-1-OXA-4-AZA-CYCLOPROPA[A]NAPHTHALEN-4-YL) -ACETYLAMINO]-PHENYLCARBAMOYL}-BUTYRIC ACID",VFIZFTGABDUGCF-UPVHCHBVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83643,6m3m,DB04158,-9.5,"6-(Adenosine Tetraphosphate-Methyl)-7,8-Dihydropterin",ZKRKFZJAQKKHKL-SUGPNEFASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
108377,6vxx,DB07689,-9.5,"METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE",NYNAFINLHQEHKU-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28889,6cs2,DB08512,-9.5,"6-amino-2-[(1-naphthylmethyl)amino]-3,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",MCEZMMDIEXECTI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
161122,7bv1,DB12914,-9.5,MGL-3196,FDBYIYFVSAHJLY-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
126256,6w4h,DB03591,-9.5,RU82209,LVZDQVATAQEMCX-NSOVKSMOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
85561,6m3m,DB07804,-9.5,"5-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1H-1,2,4-TRIAZOLE-3-SULFONAMIDE",FKCQUVAGEOSYRU-QWRGUYRKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
126240,6w4h,DB03571,-9.5,"3-(5-Amino-7-Hydroxy-[1,2,3]Triazolo[4,5-D]Pyrimidin-2-Yl)-N-(3,5-Dichlorobenzyl)-Benzamide",JMQTXEWNXSPEKX-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
59304,6crv,DB07307,-9.5,N-cyclopropyl-4-methyl-3-[1-(2-methylphenyl)phthalazin-6-yl]benzamide,GQXMJOSCBRZMKE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114444,6vxx,DB13640,-9.5,Acetoxolone,FTQDJVZNPJRVPG-XWEVEMRCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
10662,6lzg,DB08901,-9.5,Ponatinib,PHXJVRSECIGDHY-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
63174,6crv,DB15282,-9.5,Fluorofuranylnorprogesterone F-18,VJKRBRUNEOHPBS-JQKUZGBFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
24585,6cs2,DB02354,-9.5,4-{[1-Methyl-5-(2-Methyl-Benzoimidazol-1-Ylmethyl)-1h-Benzoimidazol-2-Ylmethyl]-Amino}-Benzamidine,IRKPNOLLMNHSOU-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
75546,6m2n,DB04842,-9.5,Fluspirilene,QOYHHIBFXOOADH-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
85531,6m3m,DB07770,-9.5,5-(4-FLUOROPHENYL)-3-{[(4-METHYLPHENYL)SULFONYL]AMINO}THIOPHENE-2-CARBOXYLIC ACID,DJPFUQBNQLKCAB-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
75479,6m2n,DB04760,-9.5,"PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-(4-FLUORO-3-METHYL-BENZYLAMIDE)",PYFRREJCFXFNRR-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
85527,6m3m,DB07765,-9.5,"METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL](METHYL)AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE",UKCFUFHREWUXJJ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
26672,6cs2,DB04852,-9.5,Implitapide,AMNXBQPRODZJQR-DITALETJSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
63176,6crv,DB15287,-9.5,Elismetrep,CWEFDWIKLABKBX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
63182,6crv,DB15294,-9.5,SB-1578,NNXDIGHYPZHXTR-ONEGZZNKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108480,6vxx,DB08036,-9.5,"6,7,12,13-tetrahydro-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazol-5-one",MEXUTNIFSHFQRG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85460,6m3m,DB07688,-9.5,"4-{[5-(CYCLOHEXYLOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE",RPJIMTALCNCQLV-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
126171,6w4h,DB03466,-9.5,BMS184394,AYAJZQYENGWICE-QHCPKHFHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
62080,6crv,DB13055,-9.5,Oteseconazole,IDUYJRXRDSPPRC-NRFANRHFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75385,6m2n,DB04628,-9.5,Allosamidin,MDWNFWDBQGOKNZ-XYUDZHFQSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
59335,6crv,DB07340,-9.5,"N-6-cyclohexyl-N-2-(4-morpholin-4-ylphenyl)-9H-purine-2,6-diamine",ZFLJHSQHILSNCM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
83161,6m3m,DB03507,-9.5,"6-[3-(4-Morpholinyl)Propyl]-2-(3-Nitrophenyl)-5-Thioxo-5,6,-Dihydro-7h-Thienol[2',3':4,5]Pyrrolo[1,2-C]Imidazol-7-One",UXGUZFZBZPPZGL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
165440,7bv1,DB12108,-9.5,Taselisib,BEUQXVWXFDOSAQ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
133249,6w9c,DB01459,-9.5,Bezitramide,FLKWNFFCSSJANB-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
108179,6vxx,DB07193,-9.5,"(2R,3R)-7-(methylsulfonyl)-3-(2,4,5-trifluorophenyl)-1,2,3,4-tetrahydropyrido[1,2-a]benzimidazol-2-amine",HJJAYSSCWGUPKO-ABAIWWIYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
67411,6lxt,DB06666,-9.5,Lixivaptan,PPHTXRNHTVLQED-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
85859,6m3m,DB08143,-9.5,"5-CHLORO-THIOPHENE-2-CARBOXYLIC ACID ((3S,4S)-4-FLUORO- 1-{[2-FLUORO-4-(2-OXO-2H-PYRIDIN-1-YL)-PHENYLCARBAMOYL]-METHYL}-PYRROLIDIN-3-YL)-AMIDE",SXIYSYYSKHUTQQ-RDJZCZTQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
133136,6w9c,DB01251,-9.5,Gliquidone,LLJFMFZYVVLQKT-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
75705,6m2n,DB05490,-9.5,AMG-131,NMRWDFUZLLQSBN-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
85815,6m3m,DB08096,-9.5,"8-(2-CHLOROPHENYLAMINO)-2-(2,6-DIFLUOROPHENYLAMINO)-9-ETHYL-9H-PURINE-1,7-DIIUM",ZWKOUFZHPNIQSH-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85813,6m3m,DB08094,-9.5,"(4-AMINO-2-{[1-(METHYLSULFONYL)PIPERIDIN-4-YL]AMINO}PYRIMIDIN-5-YL)(2,3-DIFLUORO-6-METHOXYPHENYL)METHANONE",JRNJNYBQQYBCLE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85811,6m3m,DB08092,-9.5,3-fluoro-N-1H-indol-5-yl-5-morpholin-4-ylbenzamide,VMLSXFMXUNVCSK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59406,6crv,DB07426,-9.5,"[1-HYDROXY-2-(1,1':3',1''-TERPHENYL-3-YLOXY)ETHANE-1,1-DIYL]BIS(PHOSPHONIC ACID)",NWIARQRYIRVYCM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114197,6vxx,DB12887,-9.5,Tazemetostat,NSQSAUGJQHDYNO-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
135900,6w9c,DB05608,-9.5,MKC-1,OVSKGTONMLKNPZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
59394,6crv,DB07410,-9.5,[2-(3-DIBENZOFURAN-4-YL-PHENYL)-1-HYDROXY-1-PHOSPHONO-ETHYL]-PHOSPHONIC ACID,BYVXAUZOTGITQZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114202,6vxx,DB12895,-9.5,TD-139,YGIDGBAHDZEYMT-MQFIMZJJSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108222,6vxx,DB07247,-9.5,"[2'-HYDROXY-3'-(1H-PYRROLO[3,2-C]PYRIDIN-2-YL)-BIPHENYL-3-YLMETHYL]-UREA",SRPOHNDQBDHONJ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30094,6cs2,DB12044,-9.5,MK-0893,DNTVJEMGHBIUMW-IBGZPJMESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
85766,6m3m,DB08037,-9.5,"(2S)-4-(2,5-difluorophenyl)-N-[(3R,4S)-3-fluoro-1-methylpiperidin-4-yl]-2-(hydroxymethyl)-N-methyl-2-phenyl-2,5-dihydro-1H-pyrrole-1-carboxamide",MYBGWENAVMIGMM-GIFXNVAJSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
108227,6vxx,DB07252,-9.5,"3-({4-[(5-chloro-1,3-benzodioxol-4-yl)amino]pyrimidin-2-yl}amino)benzenesulfonamide",TZHCXOMEOHEZDX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
83486,6m3m,DB03944,-9.5,"5-[1-(3,4-Dimethoxy-Benzoyl)-1,2,3,4-Tetrahydro-Quinolin-6-Yl]-6-Methyl-3,6-Dihydro-[1,3,4]Thiadiazin-2-One",IZLRMTJLQCLMKF-CYBMUJFWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
133209,6w9c,DB01410,-9.5,Ciclesonide,LUKZNWIVRBCLON-GXOBDPJESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
108252,6vxx,DB07537,-9.5,"N'-(6-aminopyridin-3-yl)-N-(2-cyclopentylethyl)-4-methyl-benzene-1,3-dicarboxamide",CLEGTVIMOPPIBR-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75658,6m2n,DB05239,-9.5,Cobimetinib,BSMCAPRUBJMWDF-KRWDZBQOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61836,6crv,DB12669,-9.5,4SC-203,MAFACRSJGNJHCF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85711,6m3m,DB07977,-9.5,"3-({[3,5-DIFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)THIOPHENE-2-CARBOXYLIC ACID",CGNHUSCKOHDSMR-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59352,6crv,DB07359,-9.5,"3-[(4-fluorophenyl)sulfanyl]-N-(4-methyl-1,3-thiazol-2-yl)-6-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]pyridine-2-carboxamide",SJTQKYKXCYVFHX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108329,6vxx,DB07630,-9.5,"N-((1R,2R)-2-(5-CHLORO-1H-INDOLE-2-CARBOXAMIDO)CYCLOHEXYL)-5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE-2-CARBOXAMIDE",ARPFWVKYXJZULB-IAGOWNOFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85703,6m3m,DB07969,-9.5,3-[3-(4-methylpiperazin-1-yl)-7-(trifluoromethyl)quinoxalin-5-yl]phenol,QNCYYRHIUFGGJX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87678,6m3m,DB12680,-9.5,Intepirdine,JJZFWROHYSMCMU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87374,6m3m,DB12235,-9.5,Estetrol,AJIPIJNNOJSSQC-NYLIRDPKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
137565,6w9c,DB08454,-9.5,N-(5-METHYL-1H-PYRAZOL-3-YL)-2-PHENYLQUINAZOLIN-4-AMINE,JYCUVOXSZBECAY-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
88957,6m3m,DB15183,-9.5,Fosmanogepix,JQONJQKKVAHONF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
112074,6vxx,DB06229,-9.5,Ocaperidone,ZZQNEJILGNNOEP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112093,6vxx,DB06263,-9.5,Amrubicin,VJZITPJGSQKZMX-XDPRQOKASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88956,6m3m,DB15177,-9.5,VX-659,IGEOJNMYRZUKIK-IBGZPJMESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88955,6m3m,DB15173,-9.5,JNJ-42165279,YWGYNGCRVZLMCS-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
77428,6m2n,DB08366,-9.5,"3-({3-[(1S,4aS,6S,7S,9S,9aR)-1,6-dimethyl-2-oxodecahydro-6,9-epoxy-4a,7-methanobenzo[7]annulen-1-yl]propanoyl}amino)-2,4-dihydroxybenzoic acid",XADCWKSMHQPTGH-OFBLZTNGSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
130128,6w4h,DB11814,-9.5,PF-03882845,XNULRSOGWPFPBL-REWPJTCUSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
79128,6m2n,DB12776,-9.5,E-6005,BBTFKAOFCSOZMB-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137605,6w9c,DB08500,-9.5,"(3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(2-naphthyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol",ZCJBDRSKHARECB-PYTCMNEWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
128180,6w4h,DB07307,-9.5,N-cyclopropyl-4-methyl-3-[1-(2-methylphenyl)phthalazin-6-yl]benzamide,GQXMJOSCBRZMKE-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
112128,6vxx,DB06367,-9.5,Relacatib,BWYBBMQLUKXECQ-GIVPXCGWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60752,6crv,DB09070,-9.5,Tibolone,WZDGZWOAQTVYBX-XOINTXKNSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88894,6m3m,DB15055,-9.5,ABT-639,AGPIHNZOZNKRGT-CYBMUJFWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88889,6m3m,DB15046,-9.5,LY-2881835,FHRWHNJJQGSCQC-LJAQVGFWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
79163,6m2n,DB12836,-9.5,Grapiprant,HZVLFTCYCLXTGV-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
140068,6w9c,DB14879,-9.5,Cefiderocol,DBPPRLRVDVJOCL-FQRUVTKNSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
128145,6w4h,DB07270,-9.5,"N-[7-(3-AMINOPHENYL)-5-METHOXY-1,3-BENZOXAZOL-2-YL]-2,5-DICHLOROBENZENESULFONAMIDE",GAYYMURZGLJDCT-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
88869,6m3m,DB15003,-9.5,PF-06700841,BUWBRTXGQRBBHG-MJBXVCDLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
71712,6lxt,DB15132,-9.5,AZD-8165,YUHNXUAATAMVKD-PZJWPPBQSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
12248,6lzg,DB13095,-9.5,JTK-853,JQLOVYLALGSISI-HXUWFJFHSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
88853,6m3m,DB14937,-9.5,MK-8666,CODQKEMYZZKQAE-QPVYNBJUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
79207,6m2n,DB12903,-9.5,DEBIO-1347,BEMNJULZEQTDJY-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
104180,6vxs,DB11611,-9.5,Lifitegrast,JFOZKMSJYSPYLN-QHCPKHFHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
137645,6w9c,DB08546,-9.5,"4-[(3AS,4R,7R,8AS,8BR)-2-(1,3-BENZODIOXOL-5-YLMETHYL)-7-HYDROXY-1,3-DIOXODECAHYDROPYRROLO[3,4-A]PYRROLIZIN-4-YL]BENZENECARBOXIMIDAMIDE",CETLUACQMGBMFH-ZALSBGIRSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
79076,6m2n,DB12694,-9.5,CE-326597,UBNMGTSDHSQBEL-PMERELPUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
124196,6w4h,DB00872,-9.5,Conivaptan,IKENVDNFQMCRTR-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
77461,6m2n,DB08407,-9.5,PLATENSIMYCIN,CSOMAHTTWTVBFL-OFBLZTNGSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78925,6m2n,DB12459,-9.5,Belotecan,LNHWXBUNXOXMRL-VWLOTQADSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
60856,6crv,DB09232,-9.5,Cilnidipine,KJEBULYHNRNJTE-DHZHZOJOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
89060,6m3m,DB15385,-9.5,Acebilustat,GERJIEKMNDGSCS-DQEYMECFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
137775,6w9c,DB08708,-9.5,"N-cyclohexyl-3-[3-(trifluoromethyl)phenyl][1,2,4]triazolo[4,3-b]pyridazin-6-amine",XYYDXQCAYXOGQT-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
31825,6cs2,DB14840,-9.5,Ripretinib,CEFJVGZHQAGLHS-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
77556,6m2n,DB08521,-9.5,4-[5-(4-FLUORO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-3H-IMIDAZOL-4-YL]-PYRIDINE,CDMGBJANTYXAIV-HHHXNRCGSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
140270,6w9c,DB02336,-9.5,RU83876,WCMLXBUNHNAMNH-UIOOFZCWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
102004,6vxs,DB06896,-9.5,"1-(4-fluorophenyl)-N-[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]-2-oxo-1,2-dihydropyridine-3-carboxamide",OBSFXHDOLBYWRJ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
77549,6m2n,DB08512,-9.5,"6-amino-2-[(1-naphthylmethyl)amino]-3,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",MCEZMMDIEXECTI-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77499,6m2n,DB08454,-9.5,N-(5-METHYL-1H-PYRAZOL-3-YL)-2-PHENYLQUINAZOLIN-4-AMINE,JYCUVOXSZBECAY-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
89011,6m3m,DB15287,-9.5,Elismetrep,CWEFDWIKLABKBX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
112217,6vxx,DB06605,-9.5,Apixaban,QNZCBYKSOIHPEH-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
89008,6m3m,DB15281,-9.5,Ravoxertinib,RZUOCXOYPYGSKL-GOSISDBHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
31810,6cs2,DB14792,-9.5,AZD-5991,KBQCEQAXHPIRTF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
6626,6lzg,DB00320,-9.5,Dihydroergotamine,LUZRJRNZXALNLM-JGRZULCMSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
110123,6vxx,DB01003,-9.5,Cromoglicic acid,IMZMKUWMOSJXDT-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
102684,6vxs,DB07691,-9.5,"2-({[3-(3,4-dihydroisoquinolin-2(1H)-ylsulfonyl)phenyl]carbonyl}amino)benzoic acid",GYILVHHTCYNIOS-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102769,6vxs,DB07789,-9.5,"1-[5-methyl-2-(trifluoromethyl)furan-3-yl]-3-[(2Z)-5-(2-{[6-(1H-1,2,4-triazol-3-ylamino)pyrimidin-4-yl]amino}ethyl)-1,3-thiazol-2(3H)-ylidene]urea",KNTGXMNWVXZIMW-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
138654,6w9c,DB12073,-9.5,Albaconazole,UHIXWHUVLCAJQL-MPBGBICISA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
79042,6m2n,DB12644,-9.5,AZD-2066,SXWHYTICXCLKDG-GFCCVEGCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
60842,6crv,DB09215,-9.5,Droxicam,OEHFRZLKGRKFAS-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
71926,6m2n,DB00137,-9.5,Lutein,KBPHJBAIARWVSC-RGZFRNHPSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
60826,6crv,DB09198,-9.5,Lobeglitazone,CHHXEZSCHQVSRE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60809,6crv,DB09181,-9.5,Trefentanil,RJSCINHYBGMIFT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78998,6m2n,DB12571,-9.5,Rimacalib,MYTIJGWONQOOLC-HNNXBMFYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61561,6crv,DB12267,-9.5,Brigatinib,AILRADAXUVEEIR-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165855,7bv1,DB13113,-9.5,JNJ-38877605,JRWCBEOAFGHNNU-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
104228,6vxs,DB11691,-9.5,Naldemedine,AXQACEQYCPKDMV-RZAWKFBISA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
137379,6w9c,DB08221,-9.5,N-{4-METHYL-3-[(3-PYRIMIDIN-4-YLPYRIDIN-2-YL)AMINO]PHENYL}-3-(TRIFLUOROMETHYL)BENZAMIDE,NESXBRNDMQUVNG-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
165545,7bv1,DB12434,-9.5,Steviolbioside,OMHUCGDTACNQEX-OSHKXICASA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60531,6crv,DB08755,-9.5,N-[(1S)-2-{[(1R)-2-(benzyloxy)-1-cyano-1-methylethyl]amino}-1-(cyclohexylmethyl)-2-oxoethyl]morpholine-4-carboxamide,MQWUTQCRGGBPBT-WIOPSUGQSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56307,6crv,DB02155,-9.5,Balanol Analog 8,XVLMXAUKCDSMMW-YXLARRHKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88668,6m3m,DB14541,-9.5,Hydrocortisone cypionate,DLVOSEUFIRPIRM-KAQKJVHQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
112449,6vxx,DB07117,-9.5,"5-(4-PHENOXYPHENYL)-5-(4-PYRIMIDIN-2-YLPIPERAZIN-1-YL)PYRIMIDINE-2,4,6(2H,3H)-TRIONE",FMKQJGOROFNCGM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79712,6m2n,DB13648,-9.5,Alcuronium,MUQUYTSLDVKIOF-CHJKCJHBSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
60522,6crv,DB08746,-9.5,1-[[(1E)-2-(4-CHLOROPHENYL)ETHENYL]SULFONYL]-4-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]PIPERAZINE,ZOSSOFIFNGGDKG-GIJQJNRQSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79795,6m2n,DB13756,-9.5,Peruvoside,PMTSPAGBAFCORP-HBUONDEYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
165900,7bv1,DB13215,-9.5,Sulfobromophthalein,OHTXTCNTQJFRIG-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
77134,6m2n,DB08015,-9.5,"(3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-phenyl-1H-indole-2,3-dione 3-oxime",SZYREAUDQRVVLV-DAFNUICNSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
29342,6cs2,DB09030,-9.5,Vorapaxar,ZBGXUVOIWDMMJE-QHNZEKIYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
77125,6m2n,DB08006,-9.5,"N-anthracen-2-yl-5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7-amine",OXYDLVAOXASTMW-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
12108,6lzg,DB12895,-9.5,TD-139,YGIDGBAHDZEYMT-MQFIMZJJSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
71101,6lxt,DB13648,-9.5,Alcuronium,MUQUYTSLDVKIOF-CHJKCJHBSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
79936,6m2n,DB13993,-9.5,MRK-409,GOIFCXRIFSYPFG-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
27689,6cs2,DB07245,-9.5,6-[2-(3'-METHOXYBIPHENYL-3-YL)ETHYL]PYRIDIN-2-AMINE,AEVBKBAFFJKFJZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
88569,6m3m,DB14038,-9.5,beta-Sitosterol,KZJWDPNRJALLNS-VJSFXXLFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
79973,6m2n,DB14068,-9.5,Dexniguldipine,SVJMLYUFVDMUHP-MGBGTMOVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
56370,6crv,DB02241,-9.5,"8-Benzyl-2-Hydroperoxy-2-(4-Hydroxy-Benzyl)-6-(4-Hydroxy-Phenyl)-2h-Imidazo[1,2-a]Pyrazin-3-One",HOSWCJDTHOAORT-SANMLTNESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88547,6m3m,DB13993,-9.5,MRK-409,GOIFCXRIFSYPFG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
112573,6vxx,DB07409,-9.5,"(1-HYDROXY-1-PHOSPHONO-2-[1,1';4',1'']TERPHENYL-3-YL-ETHYL)-PHOSPHONIC ACID",MPBUFKZCEBTBSK-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130512,6w4h,DB12369,-9.5,Sotrastaurin,OAVGBZOFDPFGPJ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
12102,6lzg,DB12886,-9.5,GSK-1521498,WIEDUMBCZQRGSY-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
88613,6m3m,DB14128,-9.5,Nadide,BAWFJGJZGIEFAR-NNYOXOHSSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
72877,6m2n,DB01259,-9.5,Lapatinib,BCFGMOOMADDAQU-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
88679,6m3m,DB14569,-9.5,Tedizolid,XFALPSLJIHVRKE-GFCCVEGCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88683,6m3m,DB14581,-9.5,CPI-1205,HPODOLXTMDHLLC-QGZVFWFLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
164047,7bv1,DB07008,-9.5,"4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMIDAZOL-1-YL)PHENOXY]PYRIMIDINE",XPXGYINSBORUMM-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
32120,6cs2,DB15399,-9.5,BMS-754807,LQVXSNNAFNGRAH-QHCPKHFHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
88803,6m3m,DB14844,-9.5,ONC-201,VLULRUCCHYVXOH-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
137491,6w9c,DB08362,-9.5,"N-(3-(8-CYANO-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZIN-2-YLAMINO)PHENYL)ACETAMIDE",QVKXQLGRDOMAGC-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
164036,7bv1,DB06997,-9.5,"2-(4-fluorophenyl)-N-{[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]carbamoyl}acetamide",BMPOCDJEXAXXEZ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
88787,6m3m,DB14792,-9.5,AZD-5991,KBQCEQAXHPIRTF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88777,6m3m,DB14770,-9.5,Lanraplenib,XCIGZBVOUQVIPI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88757,6m3m,DB14726,-9.5,Dabigatran,YBSJFWOBGCMAKL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88744,6m3m,DB14681,-9.5,Cortisone,MFYSYFVPBJMHGN-ZPOLXVRWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88725,6m3m,DB14662,-9.5,Flunisolide acetate,WEGNFRKBIKYVLC-XTLNBZDDSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
79330,6m2n,DB13093,-9.5,TAK-593,DZFZXPPHBWCXPQ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137394,6w9c,DB08239,-9.5,"(2S)-4-(2,5-DIFLUOROPHENYL)-N-METHYL-2-PHENYL-N-PIPERIDIN-4-YL-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDE",NKLVBHMAIMEVEH-QFIPXVFZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
31138,6cs2,DB13454,-9.5,Nicomorphine,HNDXBGYRMHRUFN-CIVUWBIHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
79345,6m2n,DB13113,-9.5,JNJ-38877605,JRWCBEOAFGHNNU-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
104326,6vxs,DB11832,-9.5,Crenolanib,DYNHJHQFHQTFTP-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
112326,6vxx,DB06977,-9.5,(2S)-1-{[5-(1H-Indazol-5-yl)-3-pyridinyl]oxy}-3-(7aH-indol-3-yl)-2-propanamine,CAASENZOSQYNPX-HSTJUUNISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56226,6crv,DB02049,-9.5,2-{4-[4-(4-Chloro-Phenoxy)-Benzenesulfonyl]-Tetrahydro-Pyran-4-Yl}-N-Hydroxy-Acetamide,QOPFTBAEAJQKSY-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56267,6crv,DB02102,-9.5,DMP450,KYRSNWPSSXSNEP-ZRTHHSRSSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61575,6crv,DB12284,-9.5,LY-2608204,QIIVJLHCZUTGSD-CUBQBAPOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77149,6m2n,DB08031,-9.5,"N-[(13-CYCLOHEXYL-6,7-DIHYDROINDOLO[1,2-D][1,4]BENZOXAZEPIN-10-YL)CARBONYL]-2-METHYL-L-ALANINE",LNQWELVSNCYKDU-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
112363,6vxx,DB07019,-9.5,"N-[(5R,14R)-5-AMINO-5,14-DIMETHYL-4-OXO-3-OXA-18-AZATRICYCLO[15.3.1.1-7,11-]DOCOSA-1(21),7(22),8,10,17,19-HEXAEN-19-YL]-N-METHYLMETHANESULFONAMIDE",QWDOKZPZLWNULU-MZNJEOGPSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
15254,6lzg,T3D0677,-9.5,Hydroxocobalamin,YOZNUFWCRFCGIH-WZHZPDAFSA-K,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
88685,6m3m,DB14584,-9.5,Segesterone,SFLXYFZGKSGFKA-XUDSTZEESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
112364,6vxx,DB07020,-9.5,"N-{3-[5-(1H-1,2,4-triazol-3-yl)-1H-indazol-3-yl]phenyl}furan-2-carboxamide",LMDMJDCLPIVGQD-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130352,6w4h,DB12138,-9.5,PF-03715455,VGEXRDWWPSGZDH-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
137804,6w9c,DB08738,-9.5,1-{3-oxo-3-[(2S)-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]propyl}-3-phenylquinoxalin-2(1H)-one,KWCKZIJGKMCYCI-QFIPXVFZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
89078,6m3m,DB15418,-9.5,AZD-9977,MBKYLPOPYYLTNW-ZDUSSCGKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
89083,6m3m,DB15431,-9.5,M-2698,HXAUJHZZPCBFPN-QGZVFWFLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
78429,6m2n,DB11743,-9.5,Ipatasertib,GRZXWCHAXNAUHY-NSISKUIASA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77980,6m2n,DB09075,-9.5,Edoxaban,HGVDHZBSSITLCT-JLJPHGGASA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138510,6w9c,DB11772,-9.5,Pilaralisib,QINPEPAQOBZPOF-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
99487,6vxs,DB02323,-9.5,EM-1745,CKSDYJASHNGOOS-KTXOUVACSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
78464,6m2n,DB11794,-9.5,Berzosertib,JZCWLJDSIRUGIN-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77965,6m2n,DB09053,-9.5,Ibrutinib,XYFPWWZEPKGCCK-GOSISDBHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
72520,6m2n,DB00845,-9.5,Clofazimine,WDQPAMHFFCXSNU-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
28218,6cs2,DB07800,-9.5,N-(2-(((5-CHLORO-2-PYRIDINYL)AMINO)SULFONYL)PHENYL)-4-(2-OXO-1(2H)-PYRIDINYL)BENZAMIDE,MIJGLXFQYBTIFY-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
96363,6m71,DB12799,-9.5,Laniquidar,TULGGJGJQXESOO-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
111155,6vxx,DB03072,-9.5,"2-{3-[4-(4-Fluorophenyl)-3,6-Dihydro-1(2h)-Pyridinyl]Propyl}-8-Methyl-4(3h)-Quinazolinone",LOFDUAJQRUYHBR-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
129065,6w4h,DB08349,-9.5,"N-cyclopropyl-3-{[1-(2,4-difluorophenyl)-7-methyl-6-oxo-6,7-dihydro-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}-4-methylbenzamide",WMEYCLAVMZKZCS-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
138370,6w9c,DB11487,-9.5,Dexamethasone isonicotinate,BQTXJHAJMDGOFI-NJLPOHDGSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
77957,6m2n,DB09034,-9.5,Suvorexant,JYTNQNCOQXFQPK-MRXNPFEDSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
96296,6m71,DB12690,-9.5,LY-2584702,FYXRSVDHGLUMHB-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
29099,6cs2,DB08738,-9.5,1-{3-oxo-3-[(2S)-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]propyl}-3-phenylquinoxalin-2(1H)-one,KWCKZIJGKMCYCI-QFIPXVFZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
62864,6crv,DB14634,-9.5,Fluprednidene acetate,DEFOZIFYUBUHHU-IYQKUMFPSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138526,6w9c,DB11793,-9.5,Niraparib,PCHKPVIQAHNQLW-CQSZACIVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
96083,6m71,DB12371,-9.5,Siponimod,KIHYPELVXPAIDH-HNSNBQBZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
61280,6crv,DB11851,-9.5,Bafetinib,ZGBAJMQHJDFTQJ-DEOSSOPVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
96082,6m71,DB12369,-9.5,Sotrastaurin,OAVGBZOFDPFGPJ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
111292,6vxx,DB03460,-9.5,Violaxanthin,SZCBXWMUOPQSOX-WVJDLNGLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111293,6vxx,DB03461,-9.5,2'-Monophosphoadenosine 5'-Diphosphoribose,XJLXINKUBYWONI-NNYOXOHSSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72391,6m2n,DB00693,-9.5,Fluorescein,GNBHRKFJIUUOQI-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61265,6crv,DB11828,-9.5,Neratinib,JWNPDZNEKVCWMY-VQHVLOKHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
96298,6m71,DB12694,-9.5,CE-326597,UBNMGTSDHSQBEL-PMERELPUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
111296,6vxx,DB03466,-9.5,BMS184394,AYAJZQYENGWICE-QHCPKHFHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78426,6m2n,DB11740,-9.5,MK-1775,BKWJAKQVGHWELA-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61330,6crv,DB11923,-9.5,Decoglurant,DMJHZVARRXJSEG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110901,6vxx,DB02551,-9.5,"6-[N-(4-Ethyl-1,2,3,4-Tetrahydro-6-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine",LVNMYQLXKMSQTG-AWEZNQCLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
98447,6vxs,DB00950,-9.5,Fexofenadine,RWTNPBWLLIMQHL-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
98377,6vxs,DB00872,-9.5,Conivaptan,IKENVDNFQMCRTR-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
98491,6vxs,DB01003,-9.5,Cromoglicic acid,IMZMKUWMOSJXDT-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
55448,6crv,DB01016,-9.5,Glyburide,ZNNLBTZKUZBEKO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31986,6cs2,DB15151,-9.5,RO-6870810,PKQXLRYFPSZKDU-QFIPXVFZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
72697,6m2n,DB01047,-9.5,Fluocinonide,WJOHZNCJWYWUJD-IUGZLZTKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61370,6crv,DB11986,-9.5,Entrectinib,HAYYBYPASCDWEQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31982,6cs2,DB15145,-9.5,Ziresovir,GAAICKUTDBZCMT-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
97778,6vxs,DB00157,-9.5,NADH,BOPGDPNILDQYTO-NNYOXOHSSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
99006,6vxs,DB01678,-9.5,RU84687,SAFPHFWYRLLBFO-NSOVKSMOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
78423,6m2n,DB11737,-9.5,Icotinib,QQLKULDARVNMAL-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78087,6m2n,DB09239,-9.5,Niguldipine,SVJMLYUFVDMUHP-XIFFEERXSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
28149,6cs2,DB07729,-9.5,3-fluoro-N-[3-(1H-tetrazol-5-yl)phenyl]benzamide,GAKOBKPDJJGRIL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
31999,6cs2,DB15183,-9.5,Fosmanogepix,JQONJQKKVAHONF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
72670,6m2n,DB01016,-9.5,Glyburide,ZNNLBTZKUZBEKO-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
128664,6w4h,DB07872,-9.5,5-chloro-N-[(3R)-1-(2-{[2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl]amino}-2-oxoethyl)pyrrolidin-3-yl]thiophene-2-carboxamide,IYGIXVNAMZPBDK-CQSZACIVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
78035,6m2n,DB09183,-9.5,Dasabuvir,NBRBXGKOEOGLOI-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78358,6m2n,DB11637,-9.5,Delamanid,XDAOLTSRNUSPPH-XMMPIXPASA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78033,6m2n,DB09181,-9.5,Trefentanil,RJSCINHYBGMIFT-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61341,6crv,DB11942,-9.5,Selinexor,DEVSOMFAQLZNKR-RJRFIUFISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61338,6crv,DB11939,-9.5,Henagliflozin,HYTPDMFFHVZBOR-VNXMGFANSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
97455,6m71,DB14918,-9.5,Branaplam,STWTUEAWRAIWJG-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
128883,6w4h,DB08124,-9.5,"3-{[(2,2-DIOXIDO-1,3-DIHYDRO-2-BENZOTHIEN-5-YL)AMINO]METHYLENE}-5-(1,3-OXAZOL-5-YL)-1,3-DIHYDRO-2H-INDOL-2-ONE",FTQYGMLRLRXBPT-IDUWFGFVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
97687,6m71,DB15414,-9.5,CM-4307,MLDQJTXFUGDVEO-FIBGUPNXSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
88524,6m3m,DB13951,-9.5,Stanolone acetate,ILCTUFVQFCIIDS-NGFSFWIMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
61254,6crv,DB11816,-9.5,Omecamtiv Mecarbil,RFUBTTPMWSKEIW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138147,6w9c,DB09233,-9.5,Cronidipine,CNIJVNPIIHWRRP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
77745,6m2n,DB08745,-9.5,4-[[(1E)-2-(4-CHLOROPHENYL)ETHENYL]SULFONYL]-1-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]PIPERAZINONE,QLHUDNKWOSQSMK-CXUHLZMHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77739,6m2n,DB08739,-9.5,"2-{3-[(2S)-4,4-difluoro-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]-3-oxopropyl}-isoindole-1,3(2H)-dione",ZSXNPAWXICXNGZ-HNNXBMFYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61051,6crv,DB11429,-9.5,Mibolerone,PTQMMNYJKCSPET-OMHQDGTGSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72169,6m2n,DB00421,-9.5,Spironolactone,LXMSZDCAJNLERA-ZHYRCANASA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
72150,6m2n,DB00398,-9.5,Sorafenib,MLDQJTXFUGDVEO-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
72103,6m2n,DB00342,-9.5,Terfenadine,GUGOEEXESWIERI-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
90211,6m71,DB01459,-9.5,Bezitramide,FLKWNFFCSSJANB-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
90176,6m71,DB01419,-9.5,Antrafenine,NWGGKKGAFZIVBJ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
140097,6w9c,DB14935,-9.5,Serabelisib,BLGWHBSBBJNKJO-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
32103,6cs2,DB15358,-9.5,JNJ-54175446,CWFVVQFVGMFTBD-SECBINFHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
78835,6m2n,DB12327,-9.5,Salvinorin A,OBSYBRPAKCASQB-AGQYDFLVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
92400,6m71,DB04350,-9.5,Argadin,FOZYKTUSOWWQGR-KNPYFFGGSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
89309,6m71,DB00320,-9.5,Dihydroergotamine,LUZRJRNZXALNLM-JGRZULCMSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110201,6vxx,DB01092,-9.5,Ouabain,LPMXVESGRSUGHW-HBYQJFLCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110198,6vxx,DB01089,-9.5,Deserpidine,CVBMAZKKCSYWQR-WCGOZPBSSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
129762,6w4h,DB09280,-9.5,Lumacaftor,UFSKUSARDNFIRC-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
165782,7bv1,DB13005,-9.5,Rebastinib,WVXNSAVVKYZVOE-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
111935,6vxx,DB04888,-9.5,Bifeprunox,CYGODHVAJQTCBG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110171,6vxx,DB01058,-9.5,Praziquantel,FSVJFNAIGNNGKK-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60904,6crv,DB09319,-9.5,Carindacillin,JIRBAUWICKGBFE-MNRDOXJOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60898,6crv,DB09298,-9.5,Silibinin,SEBFKMXJBCUCAI-HKTJVKLFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61486,6crv,DB12154,-9.5,Itacitinib,KTBSXLIQKWEBRB-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
32112,6cs2,DB15382,-9.5,SAR-125844,ODIUNTQOXRXOIV-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
89084,6m3m,DB15435,-9.5,BMS-986158,KGERZPVQIRYWRK-GDLZYMKVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
31857,6cs2,DB14889,-9.5,Derazantinib,KPJDVVCDVBFRMU-AREMUKBSSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
138149,6w9c,DB09235,-9.5,Efonidipine,NSVFSAJIGAJDMR-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
78755,6m2n,DB12225,-9.5,Beclabuvir,ZTTKEBYSXUCBSE-QDFUAKMASA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
31882,6cs2,DB14935,-9.5,Serabelisib,BLGWHBSBBJNKJO-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
95816,6m71,DB11986,-9.5,Entrectinib,HAYYBYPASCDWEQ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95810,6m71,DB11977,-9.5,Golvatinib,UQRCJCNVNUFYDX-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
78565,6m2n,DB11942,-9.5,Selinexor,DEVSOMFAQLZNKR-RJRFIUFISA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61414,6crv,DB12052,-9.5,Icariin,TZJALUIVHRYQQB-XLRXWWTNSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78574,6m2n,DB11952,-9.5,Duvelisib,SJVQHLPISAIATJ-ZDUSSCGKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
111365,6vxx,DB03571,-9.5,"3-(5-Amino-7-Hydroxy-[1,2,3]Triazolo[4,5-D]Pyrimidin-2-Yl)-N-(3,5-Dichlorobenzyl)-Benzamide",JMQTXEWNXSPEKX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
95483,6m71,DB11399,-9.5,Dirlotapide,TUOSYWCFRFNJBS-BHVANESWSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
61214,6crv,DB11759,-9.5,Pevonedistat,MPUQHZXIXSTTDU-QXGSTGNESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61209,6crv,DB11750,-9.5,Clobetasol,FCSHDIVRCWTZOX-DVTGEIKXSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72813,6m2n,DB01180,-9.5,Rescinnamine,SZLZWPPUNLXJEA-LAFLMMDJSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
140112,6w9c,DB14995,-9.5,NP-G2-044,XLLRLAABUFOJPC-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
111833,6vxx,DB04760,-9.5,"PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-(4-FLUORO-3-METHYL-BENZYLAMIDE)",PYFRREJCFXFNRR-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
14115,6lzg,T3D3732,-9.5,Penitrem A,JDUWHZOLEDOQSR-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
61180,6crv,DB11703,-9.5,Acalabrutinib,WDENQIQQYWYTPO-IBGZPJMESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140205,6w9c,DB15345,-9.5,GSK-945237,SRICOHRDRMZREQ-MRXNPFEDSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
14155,6lzg,T3D3777,-9.5,Paspalitrem A,WCISYVSWAOUFIY-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
78675,6m2n,DB12108,-9.5,Taselisib,BEUQXVWXFDOSAQ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
100892,6vxs,DB04190,-9.5,Inhibitor Bea425,AHAVBKNGKPWROK-UMFPTGFGSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
111693,6vxx,DB04392,-9.5,"Bishydroxy[2h-1-Benzopyran-2-One,1,2-Benzopyrone]",HIZKPJUTKKJDGA-BETUJISGSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
137974,6w9c,DB08973,-9.5,Fluclorolone acetonide,NJNWEGFJCGYWQT-VSXGLTOVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
78699,6m2n,DB12137,-9.5,GSK-256066,JFHROPTYMMSOLG-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
93387,6m71,DB06888,-9.5,"(13R,15S)-13-METHYL-16-OXA-8,9,12,22,24-PENTAAZAHEXACYCLO[15.6.2.16,9.1,12,15.0,2,7.0,21,25]HEPTACOSA-1(24),2,4,6,17(25),18,20-HEPTAENE-23,26-DIONE",KBLPHMRCKHFBJB-OLZOCXBDSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
32076,6cs2,DB15308,-9.5,Ridinilazole,UHQFBTAJFNVZIV-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
72189,6m2n,DB00445,-9.5,Epirubicin,AOJJSUZBOXZQNB-VTZDEGQISA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
100283,6vxs,DB03363,-9.5,3-Acetylpyridine Adenine Dinucleotide,KPVQNXLUPNWQHM-RBEMOOQDSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
6701,6lzg,DB02555,-9.5,SP4160,VCXMTWSYQSVWRK-AREMUKBSSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
95726,6m71,DB11851,-9.5,Bafetinib,ZGBAJMQHJDFTQJ-DEOSSOPVSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
112924,6vxx,DB08154,-9.5,3-chloro-5-[2-chloro-5-(1H-indazol-3-ylmethoxy)phenoxy]benzonitrile,WHCLIFOVZDANCU-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56730,6crv,DB02705,-9.5,"6-[N-(1-Isopropyl-1,2,3,4-Tetrahydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine",DARQQJKHXPXSRO-QFIPXVFZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104984,6vxs,DB12817,-9.5,Zoliflodacin,ZSWMIFNWDQEXDT-ZESJGQACSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
60280,6crv,DB08460,-9.5,"3-{5-[(6-amino-1H-pyrazolo[3,4-b]pyridin-3-yl)methoxy]-2-chlorophenoxy}-5-chlorobenzonitrile",KXDIHAQCVNNLIB-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
11960,6lzg,DB12673,-9.5,ATX-914,ALANRBCCCQEPFZ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
11971,6lzg,DB12690,-9.5,LY-2584702,FYXRSVDHGLUMHB-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
112817,6vxx,DB07875,-9.5,"5-Chloro-thiophene-2-carboxylic acid ((3S,4S)-1-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-methyl}-4-hydroxy-pyrrolidin-3-yl)-amide",ARAVOODWJJJNBY-IRXDYDNUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76765,6m2n,DB07586,-9.5,"5-(4-METHYL-BENZOYLAMINO)-BIPHENYL-3,4'-DICARBOXYLIC ACID 3-DIMETHYLAMIDE-4'-HYDROXYAMIDE",DOPFUKKMSDUVTQ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137044,6w9c,DB07833,-9.5,"N-(3-cyanophenyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)-4-biphenylcarboxamide",PMMLSQFPBFKLHH-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
149088,6w9q,DB14883,-9.5,Lorecivivint,AQDWDWAYVBQMAM-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
112672,6vxx,DB07528,-9.5,3-(2-aminoquinazolin-6-yl)-4-methyl-1-[3-(trifluoromethyl)phenyl]pyridin-2(1H)-one,HXUZQEYFKAZBPX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109711,6vxx,DB15190,-9.5,GLPG-0259,YBFGSJUVEOYPIS-OALUTQOASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112896,6vxx,DB08124,-9.5,"3-{[(2,2-DIOXIDO-1,3-DIHYDRO-2-BENZOTHIEN-5-YL)AMINO]METHYLENE}-5-(1,3-OXAZOL-5-YL)-1,3-DIHYDRO-2H-INDOL-2-ONE",FTQYGMLRLRXBPT-IDUWFGFVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60313,6crv,DB08498,-9.5,"(1S)-1-(3-chlorophenyl)-2-oxo-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate",OVSAMUIBGQSLDC-INIZCTEOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104908,6vxs,DB12693,-9.5,Ritanserin,JUQLTPCYUFPYKE-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
70589,6lxt,DB12895,-9.5,TD-139,YGIDGBAHDZEYMT-MQFIMZJJSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
104620,6vxs,DB12269,-9.5,PF-06273340,BPIWZDNVMQQBQX-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
56616,6crv,DB02551,-9.5,"6-[N-(4-Ethyl-1,2,3,4-Tetrahydro-6-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine",LVNMYQLXKMSQTG-AWEZNQCLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27601,6cs2,DB07152,-9.5,N-[4-(5-fluoro-6-methylpyridin-2-yl)-5-quinoxalin-6-yl-1H-imidazol-2-yl]acetamide,TYPILNNEZPSNTI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
88433,6m3m,DB13791,-9.5,Penfluridol,MDLAAYDRRZXJIF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80289,6m2n,DB15063,-9.5,Inarigivir soproxil,CJCYTUJOSMYXLE-JDLSZIHUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
112752,6vxx,DB07804,-9.5,"5-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1H-1,2,4-TRIAZOLE-3-SULFONAMIDE",FKCQUVAGEOSYRU-QWRGUYRKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109698,6vxx,DB15157,-9.5,Voruciclib,MRPGRAKIAJJGMM-OCCSQVGLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76779,6m2n,DB07605,-9.5,"2-({4-[(5-CHLORO-1H-INDOL-2-YL)SULFONYL]PIPERAZIN-1-YL}CARBONYL)THIENO[3,2-B]PYRIDINE 4-OXIDE",DHDQMXPAANQKDC-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138857,6w9c,DB12364,-9.5,Betrixaban,XHOLNRLADUSQLD-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
87797,6m3m,DB12877,-9.5,Oxatomide,BAINIUMDFURPJM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87760,6m3m,DB12812,-9.5,Palomid 529,YEAHTLOYHVWAKW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
124525,6w4h,DB01251,-9.5,Gliquidone,LLJFMFZYVVLQKT-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
121412,6w4b,DB11852,-9.5,Tegobuvir,XBEQSQDCBSKCHJ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
130961,6w4h,DB13061,-9.5,MLN8054,HHFBDROWDBDFBR-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
127806,6w4h,DB06876,-9.5,"N-{5-[4-(4-METHYLPIPERAZIN-1-YL)PHENYL]-1H-PYRROLO[2,3-B]PYRIDIN-3-YL}NICOTINAMIDE",YJWJKKXGAPWLGT-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
88294,6m3m,DB13607,-9.5,Picloxydine,YNCLPFSAZFGQCD-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
56950,6crv,DB02998,-9.5,Metribolone,CCCIJQPRIXGQOE-XWSJACJDSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60352,6crv,DB08543,-9.5,1-[2-HYDROXY-3-(4-CYCLOHEXYL-PHENOXY)-PROPYL]-4-(2-PYRIDYL)-PIPERAZINE,BZJHCQBNFUNZPJ-QFIPXVFZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104702,6vxs,DB12382,-9.5,R-306465,MUTBJZVSRNUIHA-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
60404,6crv,DB08607,-9.5,"(5R)-5-(4-{[(2R)-6-HYDROXY-2,5,7,8-TETRAMETHYL-3,4-DIHYDRO-2H-CHROMEN-2-YL]METHOXY}BENZYL)-1,3-THIAZOLIDINE-2,4-DIONE",GXPHKUHSUJUWKP-NTKDMRAZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
70373,6lxt,DB12550,-9.5,Taladegib,SZBGQDXLNMELTB-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
112780,6vxx,DB07834,-9.5,"N-(cyclopropylmethyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-4-carboxamide",FOHZGCHKLPIBBX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30845,6cs2,DB13059,-9.5,PF-03814735,RYYNGWLOYLRZLK-RBUKOAKNSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
88221,6m3m,DB13506,-9.5,Carfecillin,NZDASSHFKWDBBU-KVMCETHSSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
163671,7bv1,DB05812,-9.5,Abiraterone,GZOSMCIZMLWJML-VJLLXTKPSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
105118,6vxs,DB13024,-9.5,MK-8245,UJEAABFSXKCSGI-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
87907,6m3m,DB13042,-9.5,Fenoverine,UBAJTZKNDCEGKL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
56431,6crv,DB02323,-9.5,EM-1745,CKSDYJASHNGOOS-KTXOUVACSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88490,6m3m,DB13866,-9.5,Etynodiol,JYILPERKVHXLNF-QMNUTNMBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
163638,7bv1,DB04888,-9.5,Bifeprunox,CYGODHVAJQTCBG-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
80146,6m2n,DB14726,-9.5,Dabigatran,YBSJFWOBGCMAKL-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
104530,6vxs,DB12134,-9.5,Gepotidacin,PZFAZQUREQIODZ-LJQANCHMSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
87707,6m3m,DB12724,-9.5,AZD-7295,MAQDQJWCSSCURR-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80387,6m2n,DB15257,-9.5,Milademetan,RYAYYVTWKAOAJF-QISPRATLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
55191,6crv,DB00717,-9.5,Norethisterone,VIKNJXKGJWUCNN-XGXHKTLJSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130694,6w4h,DB12644,-9.5,AZD-2066,SXWHYTICXCLKDG-GFCCVEGCSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
80347,6m2n,DB15186,-9.5,GDC-0084,LGWACEZVCMBSKW-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
27420,6cs2,DB06963,-9.5,"3-[3-(3-methyl-6-{[(1S)-1-phenylethyl]amino}-1H-pyrazolo[4,3-c]pyridin-1-yl)phenyl]propanamide",ZFGCLYUGFRNYFE-INIZCTEOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
12045,6lzg,DB12799,-9.5,Laniquidar,TULGGJGJQXESOO-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
56818,6crv,DB02827,-9.5,"7-(1,1-Dioxo-1h-Benzo[D]Isothiazol-3-Yloxymethyl)-2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Pyran-3-Carboxylic Acid",MDYIGSPVMWSFEZ-JTQLQIEISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
121440,6w4b,DB11896,-9.5,Gedatolisib,DWZAEMINVBZMHQ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
80345,6m2n,DB15177,-9.5,VX-659,IGEOJNMYRZUKIK-IBGZPJMESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
140510,6w9c,DB11986,-9.5,Entrectinib,HAYYBYPASCDWEQ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137258,6w9c,DB08080,-9.5,LATRUNCULIN B,NSHPHXHGRHSMIK-JRIKCGFMSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
60303,6crv,DB08488,-9.5,"4-{[(E)-2-(5-CHLOROTHIEN-2-YL)VINYL]SULFONYL}-1-(1H-PYRROLO[3,2-C]PYRIDIN-2-YLMETHYL)PIPERAZIN-2-ONE",PLWVUIRWJVKSSD-XBXARRHUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
105748,6vxs,DB13953,-9.5,Estradiol benzoate,UYIFTLBWAOGQBI-BZDYCCQFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
57068,6crv,DB03161,-9.5,Thymidine-5'-Diphospho-Beta-D-Xylose,AJUADKZRQSBUAK-KDGZBOQCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
25615,6cs2,DB03591,-9.5,RU82209,LVZDQVATAQEMCX-NSOVKSMOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
158997,7bv1,DB03005,-9.5,"3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-5-Yl]Hexyl]-Phenanthridinium",ISUOMOOYAOQQPZ-UHFFFAOYSA-O,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
10071,6lzg,DB00762,-9.5,Irinotecan,UWKQSNNFCGGAFS-XIFFEERXSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
130997,6w4h,DB13113,-9.5,JNJ-38877605,JRWCBEOAFGHNNU-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
112776,6vxx,DB07830,-9.5,"(4R,5R)-5-AMINO-1-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN-2-ONE",DIRIFWIKLRTNMB-DYVFJYSZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80331,6m2n,DB15145,-9.5,Ziresovir,GAAICKUTDBZCMT-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80438,6m2n,DB15356,-9.5,SLV-334,LOFDNSDPZTVIIO-VPUSJEBWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
57028,6crv,DB03104,-9.5,RU82129,NKMPOVPTYDXGEC-MNRBYUMSSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60301,6crv,DB08486,-9.5,Efaproxiral,BNFRJXLZYUTIII-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109752,6vxx,DB15266,-9.5,TAK-580,VWMJHAFYPMOMGF-ZCFIWIBFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
12021,6lzg,DB12760,-9.5,GW-493838,ZQYJPMPXQLNTPQ-QCUYGVNKSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
57044,6crv,DB03126,-9.5,Mant-Adp,QPKUEBLEGWBRHC-BFHYXJOUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76791,6m2n,DB07618,-9.5,"2-(4-(AMINOMETHYL)PIPERIDIN-1-YL)-N-(3_CYCLOHEXYL-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)ACETAMIDE",AITZHKQVQNLKHI-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
87838,6m3m,DB12933,-9.5,RO-4987655,FIMYFEGKMOCQKT-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80391,6m2n,DB15266,-9.5,TAK-580,VWMJHAFYPMOMGF-ZCFIWIBFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
158879,7bv1,DB02581,-9.5,"5-[2,3-Dichloro-4-(5-{1-[2-(2-Guanidino-4-Methyl-Pentanoylamino)-Acetyl]-Piperidin-4-Yl}-1-Methyl-1h-Pyrazol-3-Yl)-Phenoxymethyl]-Furan-2-Carboxylic Acid",VNZHOIDQBPFEJU-OAQYLSRUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
111750,6vxx,DB04471,-9.4,"2-Phenyl-1-[4-(2-Piperidin-1-Yl-Ethoxy)-Phenyl]-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol",FMWVCTJKLAVRPB-MUUNZHRXSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
100421,6vxs,DB03571,-9.4,"3-(5-Amino-7-Hydroxy-[1,2,3]Triazolo[4,5-D]Pyrimidin-2-Yl)-N-(3,5-Dichlorobenzyl)-Benzamide",JMQTXEWNXSPEKX-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
161049,7bv1,DB12799,-9.4,Laniquidar,TULGGJGJQXESOO-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
165626,7bv1,DB12561,-9.4,WNT-974,XXYGTCZJJLTAGH-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
85265,6m3m,DB07453,-9.4,2-PHENYL-4H-BENZO[H]CHROMEN-4-ONE,VFMMPHCGEFXGIP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
93927,6m71,DB07514,-9.4,"3-(2-aminoquinazolin-6-yl)-1-(3,3-dimethylindolin-6-yl)-4-methylpyridin-2(1H)-one",LHLGUOHREUTYTO-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
129234,6w4h,DB08549,-9.4,"(3R)-METHYLCARBAMOYL-7-SULFOAMINO-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLIC ACID BENZYL ESTER",MFDBNNQUDZFSES-KRWDZBQOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
85229,6m3m,DB07410,-9.4,[2-(3-DIBENZOFURAN-4-YL-PHENYL)-1-HYDROXY-1-PHOSPHONO-ETHYL]-PHOSPHONIC ACID,BYVXAUZOTGITQZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87489,6m3m,DB12394,-9.4,Eleclazine,YNUAEEJQYHYLMS-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87453,6m3m,DB12341,-9.4,LY-2456302,ZHPMYDSXGRRERG-DEOSSOPVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
55296,6crv,DB00843,-9.4,Donepezil,ADEBPBSSDYVVLD-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
94665,6m71,DB08386,-9.4,2-{[4-(4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline,VRWJZGHUCOFGPZ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
109685,6vxx,DB15133,-9.4,Tepotinib,AHYMHWXQRWRBKT-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87786,6m3m,DB12857,-9.4,NVP-LEQ-506,POERAARDVFVDLO-QGZVFWFLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58679,6crv,DB06362,-9.4,Becatecarin,JSKFWUPVIZYJMR-UDOAKELVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85245,6m3m,DB07430,-9.4,"(10R)-10-methyl-3-(6-methylpyridin-3-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one",CMWRPDHVGMHLSZ-GFCCVEGCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
100760,6vxs,DB04016,-9.4,2-[3-({Methyl[1-(2-Naphthoyl)Piperidin-4-Yl]Amino}Carbonyl)-2-Naphthyl]-1-(1-Naphthyl)-2-Oxoethylphosphonic Acid,XUJQPDQURBZEGJ-KXQOOQHDSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
31897,6cs2,DB14989,-9.4,Umbralisib,IUVCFHHAEHNCFT-INIZCTEOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
163501,7bv1,DB04708,-9.4,"(S)-TETRAHYDROFURAN-3-YL (2S,3S)-4-((S)-4-((1R,3R)-3-(2-AMINO-2-OXOETHYL)-2,3-DIHYDRO-1H-INDEN-1-YL)-2-BENZYL-3-OXO-2,3-DIHYDRO-1H-PYRROL-2-YL)-3-HYDROXY-1-PHENYLBUTAN-2-YLCARBAMATE",SYNSHNDQFWMLJW-YZGRCXSVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
133678,6w9c,DB02009,-9.4,"L-756,423",AOMZDQMIOCTPQP-QHQMVRJISA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
100655,6vxs,DB03878,-9.4,N-[4-Methyl-3-[[4-(3-Pyridinyl)-2-Pyrimidinyl]Amino]Phenyl]-3-Pyridinecarboxamide,YWQVBESSYLICRX-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
133631,6w9c,DB01948,-9.4,"1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperidin-4-Yl-3,4-Dihydroquinolin-2(1h)-One",VXIYTVJEIXMAQF-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
106185,6vxs,DB15192,-9.4,ABT-288,GNIRITULTPTAQW-KNQAVFIVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
87458,6m3m,DB12350,-9.4,Rostafuroxin,AEAPORIZZWBIEX-DTBDINHYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87467,6m3m,DB12364,-9.4,Betrixaban,XHOLNRLADUSQLD-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
93954,6m71,DB07545,-9.4,N-{3-[(4-{[3-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-2-YL)AMINO]PHENYL}CYCLOPROPANECARBOXAMIDE,RDTDWGQDFJPTPD-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
111553,6vxx,DB04023,-9.4,"Guanosine 5'-(Trihydrogen Diphosphate), P'-D-Mannopyranosyl Ester",DNBSDUDYNPJVCN-ZXTXFPBHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85292,6m3m,DB07486,-9.4,"3-({4-[(1E)-3-morpholin-4-yl-3-oxoprop-1-en-1-yl]-2,3-bis(trifluoromethyl)phenyl}sulfanyl)aniline",KLSZVPNVFKKIRD-FNORWQNLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
111672,6vxx,DB04362,-9.4,Adenosine Diphosphate 5-(Beta-Ethyl)-4-Methyl-Thiazole-2-Carboxylic Acid,VGXBGQACJQRWLV-LKGUXBDMSA-K,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85299,6m3m,DB07493,-9.4,"(2Z)-5'-BROMO-2,3'-BIINDOLE-2',3(1H,1'H)-DIONE AMMONIATE",IEQQJQHHJMQETK-YPKPFQOOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
114913,6vxx,DB15399,-9.4,BMS-754807,LQVXSNNAFNGRAH-QHCPKHFHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29806,6cs2,DB11663,-9.4,Pictilisib,LHNIIDJUOCFXAP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
114759,6vxx,DB14790,-9.4,BPN-14770,KRRGWHSEDYQKDQ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
100798,6vxs,DB04071,-9.4,Cpad,LFERELMXERXKKQ-KMXXXSRASA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
12056,6lzg,DB12817,-9.4,Zoliflodacin,ZSWMIFNWDQEXDT-ZESJGQACSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
55657,6crv,DB01261,-9.4,Sitagliptin,MFFMDFFZMYYVKS-SECBINFHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
166518,7bv1,DB15291,-9.4,BMS-986142,ZRYMMWAJAFUANM-INIZCTEOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110278,6vxx,DB01180,-9.4,Rescinnamine,SZLZWPPUNLXJEA-LAFLMMDJSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85485,6m3m,DB07717,-9.4,"(5S,8R,9S,10S,13R,14S,17S)-13-{2-[(3,5-DIFLUOROBENZYL)OXY]ETHYL}-17-HYDROXY-10-METHYLHEXADECAHYDRO-3H-CYCLOPENTA[A]PHENANTHREN-3-ONE",AJODXHGZHBERGJ-JLYQOUBASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
115451,6w4b,DB00872,-9.4,Conivaptan,IKENVDNFQMCRTR-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
33965,6cs2,T3D0070,-9.4,Benzofluoranthene,OQDXASJSCOTNQS-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
90881,6m71,DB02329,-9.4,Carbenoxolone,OBZHEBDUNPOCJG-WBXJDKIVSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
90720,6m71,DB02112,-9.4,Zk-806450,DZLGSWPXZYDHBD-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
101488,6vxs,DB05220,-9.4,Alisertib,ZLHFILGSQDJULK-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
85537,6m3m,DB07778,-9.4,FAMOXADONE,PCCSBWNGDMYFCW-QFIPXVFZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85542,6m3m,DB07783,-9.4,1-((1R)-1-(HYDROXYMETHYL)-3-{6-[(3-PHENYLPROPANOYL)AMINO]-1H-INDOL-1-YL}PROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE,GUYYFMCFEPDDFL-OAQYLSRUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
27497,6cs2,DB07041,-9.4,"N-[2-(2,4-diaminopyrido[2,3-d]pyrimidin-7-yl)-2-methylpropyl]-4-phenoxybenzamide",FDJWFDQRPKKBFA-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
130836,6w4h,DB12874,-9.4,Quizartinib,CVWXJKQAOSCOAB-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
55055,6crv,DB00554,-9.4,Piroxicam,QYSPLQLAKJAUJT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
162871,7bv1,DB03231,-9.4,"3-(5-Amino-7-oxo-3,7-dihydro-2H-[1,2,3]triazolo[4,5-d]pyrimidin-2-yl)-N-(2-{[2-(hydroxymethyl)phenyl]sulfanyl}benzyl)benzamide",IXDQOBDHBWEZOH-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
89372,6m71,DB00398,-9.4,Sorafenib,MLDQJTXFUGDVEO-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
113259,6vxx,DB08730,-9.4,3-FLUORO-5-MORPHOLIN-4-YL-N-[1-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-6-YL]BENZAMIDE,CPFBZMFUCGHBAP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87384,6m3m,DB12247,-9.4,AZD-4547,VRQMAABPASPXMW-HDICACEKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
98475,6vxs,DB00984,-9.4,Nandrolone phenpropionate,UBWXUGDQUBIEIZ-QNTYDACNSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
108379,6vxx,DB07692,-9.4,"1-[(2,6-difluorophenyl)sulfonyl]-4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)piperazine",SHWNKRPMUBFWKE-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58640,6crv,DB06250,-9.4,Fluasterone,VHZXNQKVFDBFIK-NBBHSKLNSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85596,6m3m,DB07843,-9.4,5-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1-BENZOTHIOPHENE-2-SULFONAMIDE,LTJNKFUIOOJXNJ-WFASDCNBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85598,6m3m,DB07845,-9.4,"2-fluoro-6-{[2-({2-methoxy-4-[(methylsulfonyl)methyl]phenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide",VGYXXQRDIVRILX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58639,6crv,DB06249,-9.4,Arzoxifene,MCGDSOGUHLTADD-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
91117,6m71,DB02629,-9.4,Inhibitor Bea403,LYHLPPXMBKMSSZ-JQFCFGFHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
108583,6vxx,DB08426,-9.4,"THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [2-OXO-1-(1H-PYRROLO[2,3-C]PYRIDIN-2-YLMETHYL)-PYRROLIDIN-3-YL]-AMIDE",PLXOQMHGHDZMSX-AWEZNQCLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
91442,6m71,DB03067,-9.4,"4-{2,4-Bis[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid",VFYAZSTYKPFSFL-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
55682,6crv,DB01328,-9.4,Cefonicid,DYAIAHUQIPBDIP-AXAPSJFSSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85348,6m3m,DB07550,-9.4,"2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(1-OXIDO-2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUOROPHENYL)METHYL]ACETAMIDE",ZIGSBBKEPNQXRG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85376,6m3m,DB07586,-9.4,"5-(4-METHYL-BENZOYLAMINO)-BIPHENYL-3,4'-DICARBOXYLIC ACID 3-DIMETHYLAMIDE-4'-HYDROXYAMIDE",DOPFUKKMSDUVTQ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
126030,6w4h,DB03268,-9.4,RU82197,WKTQBTSOHBKBRW-VMPREFPWSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
85402,6m3m,DB07618,-9.4,"2-(4-(AMINOMETHYL)PIPERIDIN-1-YL)-N-(3_CYCLOHEXYL-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)ACETAMIDE",AITZHKQVQNLKHI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
109692,6vxx,DB15145,-9.4,Ziresovir,GAAICKUTDBZCMT-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
101311,6vxs,DB04759,-9.4,"PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-(3-METHYL-BENZYLAMIDE)",GTBUZLPQANSGGE-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
92877,6m71,DB05220,-9.4,Alisertib,ZLHFILGSQDJULK-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
92798,6m71,DB04882,-9.4,Edotecarin,QMVPQBFHUJZJCS-NTKFZFFISA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
101312,6vxs,DB04760,-9.4,"PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-(4-FLUORO-3-METHYL-BENZYLAMIDE)",PYFRREJCFXFNRR-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101331,6vxs,DB04785,-9.4,Streptolydigin,KVTPRMV1KLIG-NCAOFHFGSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
92797,6m71,DB04881,-9.4,Elacridar,OSFCMRGOZNQUSW-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
112874,6vxx,DB07945,-9.4,"5-(3-carbamoylbenzyl)-5,6,7,8,9,10-hexahydrocyclohepta[b]indole-4-carboxylic acid",GKBQRPKZHUFGOB-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165307,7bv1,DB11907,-9.4,Rociletinib,HUFOZJXAKZVRNJ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
131788,6w4h,DB14703,-9.4,Dexamethasone metasulfobenzoate,TWQWRHIQRAZHPR-XNXCGYEVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
101414,6vxs,DB04888,-9.4,Bifeprunox,CYGODHVAJQTCBG-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
108526,6vxx,DB08092,-9.4,3-fluoro-N-1H-indol-5-yl-5-morpholin-4-ylbenzamide,VMLSXFMXUNVCSK-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
92661,6m71,DB04703,-9.4,Hesperidin,QUQPHWDTPGMPEX-QJBIFVCTSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
106220,6vxs,DB15257,-9.4,Milademetan,RYAYYVTWKAOAJF-QISPRATLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
92281,6m71,DB04190,-9.4,Inhibitor Bea425,AHAVBKNGKPWROK-UMFPTGFGSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
164315,7bv1,DB07691,-9.4,"2-({[3-(3,4-dihydroisoquinolin-2(1H)-ylsulfonyl)phenyl]carbonyl}amino)benzoic acid",GYILVHHTCYNIOS-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
32819,6cs2,T3D3732,-9.4,Penitrem A,JDUWHZOLEDOQSR-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
114701,6vxx,DB14664,-9.4,Difluocortolone pivalate,UWGRWFCLGQWKPR-GSTUPEFVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109630,6vxx,DB15029,-9.4,AZD-8186,LMJFJIDLEAWOQJ-CQSZACIVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108478,6vxx,DB08034,-9.4,"(E)-3,4-DIHYDROXY-N'-[(2-METHOXYNAPHTHALEN-1-YL)METHYLENE]BENZOHYDRAZIDE",TVOPERZEGKBKAY-RGVLZGJSSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106157,6vxs,DB15133,-9.4,Tepotinib,AHYMHWXQRWRBKT-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
100011,6vxs,DB03005,-9.4,"3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-5-Yl]Hexyl]-Phenanthridinium",ISUOMOOYAOQQPZ-UHFFFAOYSA-O,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
85215,6m3m,DB07395,-9.4,"4-[3-(2-Chloro-4,5-difluoro-benzoyl)ureido]-3-trifluoromethoxybenzoic acid",NWQGDIBCFLDHDO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84838,6m3m,DB06963,-9.4,"3-[3-(3-methyl-6-{[(1S)-1-phenylethyl]amino}-1H-pyrazolo[4,3-c]pyridin-1-yl)phenyl]propanamide",ZFGCLYUGFRNYFE-INIZCTEOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
128900,6w4h,DB08143,-9.4,"5-CHLORO-THIOPHENE-2-CARBOXYLIC ACID ((3S,4S)-4-FLUORO- 1-{[2-FLUORO-4-(2-OXO-2H-PYRIDIN-1-YL)-PHENYLCARBAMOYL]-METHYL}-PYRROLIDIN-3-YL)-AMIDE",SXIYSYYSKHUTQQ-RDJZCZTQSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
87605,6m3m,DB12565,-9.4,Abexinostat,MAUCONCHVWBMHK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87604,6m3m,DB12563,-9.4,MK-0686,WZZIQHIQMWJNLU-LLVKDONJSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
32150,6cs2,DB15448,-9.4,Acumapimod,VGUSQKZDZHAAEE-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
84854,6m3m,DB06983,-9.4,"(5-phenyl-7-(pyridin-3-ylmethylamino)pyrazolo[1,5-a]pyrimidin-3-yl)methanol",RBLKWWBHDUBPFN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
97394,6m71,DB14785,-9.4,Fenebrutinib,WNEODWDFDXWOLU-QHCPKHFHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
114867,6vxx,DB15297,-9.4,Petesicatib,KXAAIORSMACJSI-AEFFLSMTSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
125316,6w4h,DB02336,-9.4,RU83876,WCMLXBUNHNAMNH-UIOOFZCWSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
84862,6m3m,DB06992,-9.4,"(3,3-dimethylpiperidin-1-yl)(6-(3-fluoro-4-methylphenyl)pyridin-2-yl)methanone",SIDDLTBLAQYZIZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
106029,6vxs,DB14850,-9.4,Deleobuvir,BMAIGAHXAJEULY-UKTHLTGXSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
131388,6w4h,DB13676,-9.4,Mosapramine,PXUIZULXJVRBPC-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
29911,6cs2,DB11799,-9.4,Bictegravir,SOLUWJRYJLAZCX-LYOVBCGYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
55367,6crv,DB00921,-9.4,Buprenorphine,RMRJXGBAOAMLHD-IHFGGWKQSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84888,6m3m,DB07021,-9.4,"(7R,8R)-8-(2,4,5-trifluorophenyl)-6,7,8,9-tetrahydroimidazo[1,2-a:4,5-c']dipyridin-7-amine",SOSYXEPELJIJHZ-RNCFNFMXSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
163190,7bv1,DB03878,-9.4,N-[4-Methyl-3-[[4-(3-Pyridinyl)-2-Pyrimidinyl]Amino]Phenyl]-3-Pyridinecarboxamide,YWQVBESSYLICRX-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
33266,6cs2,T3D4439,-9.4,Protoporphyrinogen IX,UHSGPDMIQQYNAX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
114872,6vxx,DB15307,-9.4,Atabecestat,VLLFGVHGKLDDLW-SFHVURJKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87728,6m3m,DB12756,-9.4,TAK-901,WKDACQVEJIVHMZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
105165,6vxs,DB13095,-9.4,JTK-853,JQLOVYLALGSISI-HXUWFJFHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
29858,6cs2,DB11734,-9.4,Fedovapagon,RUOLFWZIFNQQGH-DEOSSOPVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
31957,6cs2,DB15105,-9.4,PF-06751979,ZLZUHACSRMOLLV-RAALSFIWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
27379,6cs2,DB06916,-9.4,"N-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-1-[2-(1H-IMIDAZOL-1-YL)-6-METHYLPYRIMIDIN-4-YL]-D-PROLINAMIDE",LBCGUKCXRVUULK-QGZVFWFLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
134204,6w9c,DB02703,-9.4,Fusidic acid,IECPWNUMDGFDKC-MZJAQBGESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
55554,6crv,DB01138,-9.4,Sulfinpyrazone,MBGGBVCUIVRRBF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58811,6crv,DB06693,-9.4,Mevastatin,AJLFOPYRIVGYMJ-INTXDZFKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106035,6vxs,DB14860,-9.4,Ensartinib,GLYMPHUVMRFTFV-QLFBSQMISA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
131335,6w4h,DB13607,-9.4,Picloxydine,YNCLPFSAZFGQCD-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
58865,6crv,DB06780,-9.4,Desoxycorticosterone acetate,VPGRYOFKCNULNK-ACXQXYJUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113070,6vxx,DB08339,-9.4,"6-(2,6-DICHLOROPHENYL)-2-{[3-(HYDROXYMETHYL)PHENYL]AMINO}-8-METHYLPYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE",ZIQFYVPVJZEOFS-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87617,6m3m,DB12580,-9.4,Tradipitant,CAVRKWRKTNINFF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
105805,6vxs,DB14067,-9.4,Dofequidar,KLWUUPVJTLHYIM-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
131141,6w4h,DB13345,-9.4,Dihydroergocristine,DEQITUUQPICUMR-HJPBWRTMSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
165403,7bv1,DB12052,-9.4,Icariin,TZJALUIVHRYQQB-XLRXWWTNSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
114841,6vxx,DB14995,-9.4,NP-G2-044,XLLRLAABUFOJPC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
134672,6w9c,DB03383,-9.4,5-Chloro-1h-Indole-2-Carboxylic Acid [1-(4-Fluorobenzyl)-2-(4-Hydroxypiperidin-1yl)-2-Oxoethyl]Amide,YDCGVASFVACWKF-NRFANRHFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
27418,6cs2,DB06959,-9.4,(2S)-1-(3H-Indol-3-yl)-3-{[5-(6-isoquinolinyl)-3-pyridinyl]oxy}-2-propanamine,BUCZDJYEOAQTHL-KEKNWZKVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
128745,6w4h,DB07970,-9.4,5-[(2-methyl-5-{[3-(trifluoromethyl)phenyl]carbamoyl}phenyl)amino]pyridine-3-carboxamide,SAAYRHKJHDIDPH-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
105732,6vxs,DB13931,-9.4,Netarsudil,OURRXQUGYQRVML-AREMUKBSSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
57114,6crv,DB03220,-9.4,FR233623,OODDZQQDDOVCFD-SCLBCKFNSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55459,6crv,DB01029,-9.4,Irbesartan,YOSHYTLCDANDAN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
131224,6w4h,DB13454,-9.4,Nicomorphine,HNDXBGYRMHRUFN-CIVUWBIHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
98780,6vxs,DB01411,-9.4,Pranlukast,NBQKINXMPLXUET-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
113042,6vxx,DB08304,-9.4,"(3R)-3-cyclopentyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2-benzothiazine 1,1-dioxide",QZBQVXXESPXFPZ-QGZVFWFLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55591,6crv,DB01180,-9.4,Rescinnamine,SZLZWPPUNLXJEA-LAFLMMDJSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
13415,6lzg,DB15310,-9.4,Vactosertib,FJCDSQATIJKQKA-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
13449,6lzg,DB15382,-9.4,SAR-125844,ODIUNTQOXRXOIV-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
109001,6vxx,DB11891,-9.4,CUDC-907,JOWXJLIFIIOYMS-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84765,6m3m,DB06876,-9.4,"N-{5-[4-(4-METHYLPIPERAZIN-1-YL)PHENYL]-1H-PYRROLO[2,3-B]PYRIDIN-3-YL}NICOTINAMIDE",YJWJKKXGAPWLGT-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
110831,6vxx,DB02466,-9.4,"4-[3-Oxo-3-(5,5,8,8-Tetramethyl-5,6,7,8-Tetrahydro-Naphthalen-2-Yl)-Propenyl]-Benzoic Acid",ZXQHMEUGMCXKLO-KPKJPENVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111009,6vxx,DB02873,-9.4,"1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperazin-1-Yl-3,4-Dihydroquinazolin-2(1h)-One",YAWZIQKDHQIHOS-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
97622,6m71,DB15287,-9.4,Elismetrep,CWEFDWIKLABKBX-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
87721,6m3m,DB12744,-9.4,CGI-1842,ZXBFYBLSJMEBEP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
125511,6w4h,DB02581,-9.4,"5-[2,3-Dichloro-4-(5-{1-[2-(2-Guanidino-4-Methyl-Pentanoylamino)-Acetyl]-Piperidin-4-Yl}-1-Methyl-1h-Pyrazol-3-Yl)-Phenoxymethyl]-Furan-2-Carboxylic Acid",VNZHOIDQBPFEJU-OAQYLSRUSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
84801,6m3m,DB06916,-9.4,"N-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-1-[2-(1H-IMIDAZOL-1-YL)-6-METHYLPYRIMIDIN-4-YL]-D-PROLINAMIDE",LBCGUKCXRVUULK-QGZVFWFLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
97495,6m71,DB15035,-9.4,Zanubrutinib,RNOAOAWBMHREKO-QFIPXVFZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
111112,6vxx,DB03010,-9.4,Patupilone,QXRSDHAAWVKZLJ-PVYNADRNSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106005,6vxs,DB14785,-9.4,Fenebrutinib,WNEODWDFDXWOLU-QHCPKHFHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
108988,6vxx,DB11871,-9.4,PF-00610355,YPHDIMUXXABSSO-YTTGMZPUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
105176,6vxs,DB13109,-9.4,PKI-179,WXUUCRLKXQMWRY-OYRHEFFESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
165699,7bv1,DB12673,-9.4,ATX-914,ALANRBCCCQEPFZ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
29929,6cs2,DB11822,-9.4,TMC-647055,UOBYJVFBFSLCTQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
84938,6m3m,DB07078,-9.4,"(3Z)-6-(4-HYDROXY-3-METHOXYPHENYL)-3-(1H-PYRROL-2-YLMETHYLENE)-1,3-DIHYDRO-2H-INDOL-2-ONE",AYSXURJZVXBSRV-WJDWOHSUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
160999,7bv1,DB12381,-9.4,Merestinib,QHADVLVFMKEIIP-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96042,6m71,DB12309,-9.4,GI-181771X,CABBMMXFOOZVMS-PMERELPUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
133979,6w9c,DB02411,-9.4,"2-(11-{2-[Benzenesulfonyl-(3-Methyl-Butyl)-Amino]-1-Hydroxy-Ethyl}-6,9-Dioxo-2-Oxa-7,10-Diaza-Bicyclo[11.2.2]Heptadeca-1(16),13(17),14-Trien-8-Yl)-Acetamide, Inhibitor 2",HOUHLOFMBSYNBO-KKUQBAQOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
58777,6crv,DB06620,-9.4,Aplindore,DYJIKHYBKVODAC-ZDUSSCGKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
33519,6cs2,T3D4771,-9.4,Celecoxib,RZEKVGVHFLEQIL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
111317,6vxx,DB03495,-9.4,"4,6-Dideoxy-4-{[4,5,6-Trihydroxy-3-(Hydroxymethyl)Cyclohex-2-En-1-Yl]Amino}-Alpha-D-Lyxo-Hexopyranosyl-(1->4)-Alpha-D-Threo-Hexopyranosyl-(1->6)-Alpha-L-Threo-Hexopyranose",FZLCJZILHGFQLM-PISLJJGOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
95977,6m71,DB12225,-9.4,Beclabuvir,ZTTKEBYSXUCBSE-QDFUAKMASA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
27456,6cs2,DB07000,-9.4,"N-{2,4-difluoro-3-[(5-pyridin-3-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)carbonyl]phenyl}ethanesulfonamide",ILXJWLWSYAWJKZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
127823,6w4h,DB06896,-9.4,"1-(4-fluorophenyl)-N-[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]-2-oxo-1,2-dihydropyridine-3-carboxamide",OBSFXHDOLBYWRJ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
106105,6vxs,DB15034,-9.4,PRI-724,VHOZWHQPEJGPCC-AZXNYEMZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
87504,6m3m,DB12414,-9.4,Usistapide,WSYALRNYQFNNGP-WJOKGBTCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
111322,6vxx,DB03501,-9.4,Galactose-uridine-5'-diphosphate,HSCJRCZFDFQWRP-ABVWGUQPSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
133296,6w9c,DB01514,-9.4,Furazabol,RGLLOUBXMOGLDQ-IVEVATEUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
133875,6w9c,DB02269,-9.4,[4-({[5-Benzyloxy-1-(3-Carbamimidoyl-Benzyl)-1h-Indole-2-Carbonyl]-Amino}-Methyl)-Phenyl]-Trimethyl-Ammonium,UFKJQTGPBFWMGT-UHFFFAOYSA-O,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
32821,6cs2,T3D3734,-9.4,Penitrem C,BVVRIERIEDMORG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
85129,6m3m,DB07296,-9.4,(5Z)-3-(4-CHLOROPHENYL)-4-HYDROXY-5-(1-NAPHTHYLMETHYLENE)FURAN-2(5H)-ONE,PLGHLEBIWUQEPR-PDGQHHTCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
100053,6vxs,DB03067,-9.4,"4-{2,4-Bis[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid",VFYAZSTYKPFSFL-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
113139,6vxx,DB08584,-9.4,"6-{[6-(1-methyl-1H-pyrazol-4-yl)[1,2,4]triazolo[4,3-b]pyridazin-3-yl]sulfanyl}quinoline",BCZUAADEACICHN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58737,6crv,DB06521,-9.4,Ertiprotafib,FONCZICQWCUXEB-RUZDIDTESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55628,6crv,DB01219,-9.4,Dantrolene,OZOMQRBLCMDCEG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
95589,6m71,DB11651,-9.4,Dactolisib,JOGKUKXHTYWRGZ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
14001,6lzg,T3D3611,-9.4,Microcystin-LF,FEVBMCJUKWWWBT-QVWKUIOOSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
127641,6w4h,DB06595,-9.4,Midostaurin,BMGQWWVMWDBQGC-IIFHNQTCSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
87500,6m3m,DB12408,-9.4,PF-03635659,WGOJWDWKHJHXSV-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58731,6crv,DB06506,-9.4,Repinotan,YGYBFMRFXNDIPO-QGZVFWFLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85198,6m3m,DB07375,-9.4,"5-BETA-ANDROSTANE-3,17-DIONE",RAJWOBJTTGJROA-QJISAEMRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
55630,6crv,DB01222,-9.4,Budesonide,VOVIALXJUBGFJZ-KWVAZRHASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85057,6m3m,DB07215,-9.4,"2-METHYL-2-(4-{[({4-METHYL-2-[4-(TRIFLUOROMETHYL)PHENYL]-1,3-THIAZOL-5-YL}CARBONYL)AMINO]METHYL}PHENOXY)PROPANOIC ACID",ILUPZUOBHCUBKB-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
96054,6m71,DB12323,-9.4,Radotinib,DUPWHXBITIZIKZ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
87515,6m3m,DB12427,-9.4,Orvepitant,XWNBGDJPEXZSQM-VZOBGQTKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
160998,7bv1,DB12380,-9.4,GDC-0152,WZRFLSDVFPIXOV-LRQRDZAKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
87742,6m3m,DB12781,-9.4,Balaglitazone,IETKPTYAGKZLKY-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84940,6m3m,DB07080,-9.4,"N-(2,2,2-TRIFLUOROETHYL)-N-{4-[2,2,2-TRIFLUORO-1-HYDROXY-1-(TRIFLUOROMETHYL)ETHYL]PHENYL}BENZENESULFONAMIDE",SGIWFELWJPNFDH-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
130980,6w4h,DB13089,-9.4,Enoxolone,MPDGHEJMBKOTSU-YKLVYJNSSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
111186,6vxx,DB03311,-9.4,"3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid [4-(Thiazol-2-Ylsulfamoyl)-Phenyl]-Amide",SXKBTDJJEQQEGE-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
134142,6w9c,DB02621,-9.4,Latrunculin A,DDVBPZROPPMBLW-IZGXTMSKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
99497,6vxs,DB02336,-9.4,RU83876,WCMLXBUNHNAMNH-UIOOFZCWSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
109652,6vxx,DB15068,-9.4,Agerafenib,DKNUPRMJNUQNHR-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58797,6crv,DB06660,-9.4,Saredutant,PGKXDIMONUAMFR-AREMUKBSSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31946,6cs2,DB15085,-9.4,Fulacimstat,JDARDSVOVYVQST-MRXNPFEDSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
87559,6m3m,DB12492,-9.4,Piritramide,IHEHEFLXQFOQJO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
113108,6vxx,DB08546,-9.4,"4-[(3AS,4R,7R,8AS,8BR)-2-(1,3-BENZODIOXOL-5-YLMETHYL)-7-HYDROXY-1,3-DIOXODECAHYDROPYRROLO[3,4-A]PYRROLIZIN-4-YL]BENZENECARBOXIMIDAMIDE",CETLUACQMGBMFH-ZALSBGIRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87550,6m3m,DB12477,-9.4,Perfluoro tert-butylcyclohexane,VLTXBOGHSBHSAC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
55347,6crv,DB00901,-9.4,Bitolterol,FZGVEKPRDOIXJY-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57231,6crv,DB03368,-9.4,"5-Methyl-5-(4-Phenoxy-Phenyl)-Pyrimidine-2,4,6-Trione",RTBMLCLTYAPKIF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
123840,6w4h,DB00444,-9.4,Teniposide,NRUKOCRGYNPUPR-QBPJDGROSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
29842,6cs2,DB11704,-9.4,Adomeglivant,FASLTMSUPQDLIB-MHZLTWQESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
160951,7bv1,DB12309,-9.4,GI-181771X,CABBMMXFOOZVMS-PMERELPUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
108776,6vxx,DB08950,-9.4,Indoramin,JXZZEXZZKAWDSP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85007,6m3m,DB07156,-9.4,"(4Z)-6-bromo-4-({[4-(pyrrolidin-1-ylmethyl)phenyl]amino}methylidene)isoquinoline-1,3(2H,4H)-dione",JFEKAVPMVOLVTH-UNOMPAQXSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85010,6m3m,DB07159,-9.4,Tamatinib,NHHQJBCNYHBUSI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
27453,6cs2,DB06997,-9.4,"2-(4-fluorophenyl)-N-{[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]carbamoyl}acetamide",BMPOCDJEXAXXEZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
129113,6w4h,DB08407,-9.4,PLATENSIMYCIN,CSOMAHTTWTVBFL-OFBLZTNGSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
57299,6crv,DB03471,-9.4,6-Phenyl-4(R)-(7-Phenyl-Heptanoylamino)-Hexanoic Acid,SMNHQYPORNSAQH-HSZRJFAPSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87522,6m3m,DB12436,-9.4,Vofopitant,XILNRORTJVDYRH-HKUYNNGSSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
17284,6cs2,HMDB0007159,-9.4,DG(18:0/18:1(11Z)/0:0),YJORXFQCYXMMHL-KDKAWYBRSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
130929,6w4h,DB13014,-9.4,Hypericin,BTXNYTINYBABQR-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
128598,6w4h,DB07800,-9.4,N-(2-(((5-CHLORO-2-PYRIDINYL)AMINO)SULFONYL)PHENYL)-4-(2-OXO-1(2H)-PYRIDINYL)BENZAMIDE,MIJGLXFQYBTIFY-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
114795,6vxx,DB14876,-9.4,TAS-116,NVVPMZUGELHVMH-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106087,6vxs,DB14989,-9.4,Umbralisib,IUVCFHHAEHNCFT-INIZCTEOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
85600,6m3m,DB07848,-9.4,5-Chloro-N-{(3S)-1-[(2S)-1-(4-morpholinyl)-1-oxo-2-propanyl]-2-oxo-3-pyrrolidinyl}-1H-indole-2-sulfonamide,BHNMMFGOJRIAEZ-LRDDRELGSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
89070,6m3m,DB15406,-9.4,GLPG-0974,MPMKMQHJHDHPBE-RUZDIDTESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
161167,7bv1,DB13345,-9.4,Dihydroergocristine,DEQITUUQPICUMR-HJPBWRTMSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
113936,6vxx,DB12297,-9.4,GLPG-0187,CXHCNOMGODVIKB-VWLOTQADSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27781,6cs2,DB07333,-9.4,"N-(CYCLOPROPYLMETHYL)-4-(METHYLOXY)-3-({5-[3-(3-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-YL}AMINO)BENZENESULFONAMIDE",KRGKAARWVPUWSY-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
104284,6vxs,DB11778,-9.4,Danusertib,XKFTZKGMDDZMJI-HSZRJFAPSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
88737,6m3m,DB14674,-9.4,Estramustine phosphate,ADFOJJHRTBFFOF-RBRWEJTLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
109841,6vxx,DB00319,-9.4,Piperacillin,IVBHGBMCVLDMKU-GXNBUGAJSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87209,6m3m,DB11992,-9.4,Omarigliptin,MKMPWKUAHLTIBJ-ISTRZQFTSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
112685,6vxx,DB07728,-9.4,"2-[2-(2-FLUOROPHENYL)PYRIDIN-4-YL]-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE",XJJYJNMNYDNXNO-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112304,6vxx,DB06945,-9.4,N-hydroxy-4-({4-[4-(trifluoromethyl)phenoxy]phenyl}sulfonyl)tetrahydro-2H-pyran-4-carboxamide,FOSWRYKPHVPIDJ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58344,6crv,DB04872,-9.4,Osanetant,DZOJBGLFWINFBF-UMSFTDKQSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30636,6cs2,DB12760,-9.4,GW-493838,ZQYJPMPXQLNTPQ-QCUYGVNKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
132512,6w9c,DB00522,-9.4,Bentiromide,SPPTWHFVYKCNNK-FQEVSTJZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
87182,6m3m,DB11949,-9.4,Vestipitant,SBBYBXSFWOLDDG-JLTOFOAXSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
104335,6vxs,DB11847,-9.4,Cadazolid,XWFCFMXQTBGXQW-GOSISDBHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
86681,6m3m,DB09219,-9.4,Bisoxatin,BPKUDUSVDVLOPY-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
165072,7bv1,DB09199,-9.4,Netoglitazone,PKWDZWYVIHVNKS-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
112342,6vxx,DB06995,-9.4,N-({4-[(2-aminopyridin-4-yl)oxy]-3-fluorophenyl}carbamoyl)-2-(4-fluorophenyl)acetamide,USBSTVPJNQLYEM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107232,6vxx,DB02741,-9.4,CD564,RWYREGSYPCNZTL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
161652,7bv1,DB00224,-9.4,Indinavir,CBVCZFGXHXORBI-PXQQMZJSSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
54910,6crv,DB00377,-9.4,Palonosetron,CPZBLNMUGSZIPR-NVXWUHKLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
164886,7bv1,DB08912,-9.4,Dabrafenib,BFSMGDJOXZAERB-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
104337,6vxs,DB11851,-9.4,Bafetinib,ZGBAJMQHJDFTQJ-DEOSSOPVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
132452,6w9c,DB00445,-9.4,Epirubicin,AOJJSUZBOXZQNB-VTZDEGQISA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
109713,6vxx,DB15192,-9.4,ABT-288,GNIRITULTPTAQW-KNQAVFIVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106632,6vxx,DB00834,-9.4,Mifepristone,VKHAHZOOUSRJNA-GCNJZUOMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
124946,6w4h,DB01836,-9.4,"[4-(6-Chloro-Naphthalene-2-Sulfonyl)-Piperazin-1-Yl]-(3,4,5,6-Tetrahydro-2h-[1,4']Bipyridinyl-4-Yl)-Methanone",ZLAKCKVFSRSENR-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
113900,6vxx,DB12247,-9.4,AZD-4547,VRQMAABPASPXMW-HDICACEKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87166,6m3m,DB11925,-9.4,Vistusertib,JUSFANSTBFGBAF-IRXDYDNUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88258,6m3m,DB13555,-9.4,Prajmaline,UAUHEPXILIZYCU-ALHOSYKFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
166413,7bv1,DB15085,-9.4,Fulacimstat,JDARDSVOVYVQST-MRXNPFEDSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
104259,6vxs,DB11740,-9.4,MK-1775,BKWJAKQVGHWELA-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104233,6vxs,DB11697,-9.4,Pacritinib,HWXVIOGONBBTBY-ONEGZZNKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
132655,6w9c,DB00694,-9.4,Daunorubicin,STQGQHZAVUOBTE-VGBVRHCVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
104191,6vxs,DB11637,-9.4,Delamanid,XDAOLTSRNUSPPH-XMMPIXPASA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
107697,6vxx,DB04196,-9.4,Pteroic Acid,JOAQINSXLLMRCV-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
166217,7bv1,DB14128,-9.4,Nadide,BAWFJGJZGIEFAR-NNYOXOHSSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
124994,6w4h,DB01908,-9.4,RU85493,MWEWSHNGVWABKG-SVBPBHIXSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
104200,6vxs,DB11651,-9.4,Dactolisib,JOGKUKXHTYWRGZ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
12183,6lzg,DB13005,-9.4,Rebastinib,WVXNSAVVKYZVOE-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
26868,6cs2,DB05611,-9.4,Apilimod,HSKAZIJJKRAJAV-KOEQRZSOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
56578,6crv,DB02505,-9.4,N-(R-Carboxy-Ethyl)-Alpha-(S)-(2-Phenylethyl),JJVQUUYZGJWBPW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112247,6vxx,DB06882,-9.4,1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-naphthalen-1-ylurea,HJWMLCDGRWWLAQ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86426,6m3m,DB08828,-9.4,Vismodegib,BPQMGSKTAYIVFO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
31223,6cs2,DB13556,-9.4,Sulfamazone,BGLHAKAJGYLSOX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
30728,6cs2,DB12897,-9.4,MK-7622,JUVQLZBJFOGEEO-GOTSBHOMSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
56552,6crv,DB02473,-9.4,"6-[N-(1-Isopropyl-3,4-Dihydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine",XRHANBWAKSYPEN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88812,6m3m,DB14859,-9.4,Fosifloxuridine nafalbenamide,BIOWRMNRHMERIO-ZVAHOJSLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88810,6m3m,DB14856,-9.4,PF-05089771,ZYSCOUXLBXGGIM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
130266,6w4h,DB12012,-9.4,PF-04457845,BATCTBJIJJEPHM-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
29625,6cs2,DB11263,-9.4,Polydatin,HSTZMXCBWJGKHG-CUYWLFDKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
86448,6m3m,DB08865,-9.4,Crizotinib,KTEIFNKAUNYNJU-GFCCVEGCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
132628,6w9c,DB00663,-9.4,Flumethasone,WXURHACBFYSXBI-GQKYHHCASA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
86467,6m3m,DB08899,-9.4,Enzalutamide,WXCXUHSOUPDCQV-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
54851,6crv,DB00304,-9.4,Desogestrel,RPLCPCMSCLEKRS-BPIQYHPVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163756,7bv1,DB06212,-9.4,Tolvaptan,GYHCTFXIZSNGJT-XMMPIXPASA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
124973,6w4h,DB01873,-9.4,Epothilone D,XOZIUKBZLSUILX-GIQCAXHBSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
113616,6vxx,DB11656,-9.4,Rebamipide,ALLWOAVDORUJLA-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127908,6w4h,DB06997,-9.4,"2-(4-fluorophenyl)-N-{[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]carbamoyl}acetamide",BMPOCDJEXAXXEZ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
55172,6crv,DB00696,-9.4,Ergotamine,XCGSFFUVFURLIX-VFGNJEKYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
161537,7bv1,DB15035,-9.4,Zanubrutinib,RNOAOAWBMHREKO-QFIPXVFZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
30887,6cs2,DB13113,-9.4,JNJ-38877605,JRWCBEOAFGHNNU-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
113885,6vxx,DB12229,-9.4,Cerlapirdine,NXQGEDVQXVTCDA-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
8955,6lzg,DB07020,-9.4,"N-{3-[5-(1H-1,2,4-triazol-3-yl)-1H-indazol-3-yl]phenyl}furan-2-carboxamide",LMDMJDCLPIVGQD-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
88353,6m3m,DB13682,-9.4,Cefpirome,DKOQGJHPHLTOJR-WHRDSVKCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
104338,6vxs,DB11852,-9.4,Tegobuvir,XBEQSQDCBSKCHJ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
54958,6crv,DB00436,-9.4,Bendroflumethiazide,HDWIHXWEUNVBIY-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87030,6m3m,DB11732,-9.4,Lasmiditan,XEDHVZKDSYZQBF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58128,6crv,DB04583,-9.4,"5-Carbamoyl-1,1':4',1''-terphenyl-3-carboxylic acid",LAZPCGBRHLARSI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109513,6vxx,DB14029,-9.4,Furafylline,HMZQULPVMKITSP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88517,6m3m,DB13941,-9.4,Piperaquine,UCRHFBCYFMIWHC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
27667,6cs2,DB07220,-9.4,"N-[5-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-1H-INDAZOL-3-YL]-2-(4-PIPERIDIN-1-YLPHENYL)ACETAMIDE",ZXYIRNXOAJYLCU-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
12106,6lzg,DB12892,-9.4,MGB-BP-3,OEKXCVYZBVOWBR-BQYQJAHWSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
58038,6crv,DB04471,-9.4,"2-Phenyl-1-[4-(2-Piperidin-1-Yl-Ethoxy)-Phenyl]-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol",FMWVCTJKLAVRPB-MUUNZHRXSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104508,6vxs,DB12108,-9.4,Taselisib,BEUQXVWXFDOSAQ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
162311,7bv1,DB01879,-9.4,(S)-2-{Methyl-[2-(Naphthalene-2-Sulfonylamino)-5-(Naphthalene-2-Sulfonyloxy)-Benzoyl]-Amino}-Succinicacid,JOAALZBSMWLOPQ-LJAQVGFWSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
58022,6crv,DB04452,-9.4,Aminoquinuride,HOUSDILKOJMENG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88567,6m3m,DB14035,-9.4,Englitazone,MVDXXGIBARMXSA-PYUWXLGESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
54954,6crv,DB00430,-9.4,Cefpiramide,PWAUCHMQEXVFJR-PMAPCBKXSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109804,6vxx,DB00275,-9.4,Olmesartan,VTRAEEWXHOVJFV-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88562,6m3m,DB14029,-9.4,Furafylline,HMZQULPVMKITSP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
112590,6vxx,DB07430,-9.4,"(10R)-10-methyl-3-(6-methylpyridin-3-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one",CMWRPDHVGMHLSZ-GFCCVEGCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87074,6m3m,DB11793,-9.4,Niraparib,PCHKPVIQAHNQLW-CQSZACIVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
132113,6w4h,DB15408,-9.4,Silmitasertib,MUOKSQABCJCOPU-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
166351,7bv1,DB14703,-9.4,Dexamethasone metasulfobenzoate,TWQWRHIQRAZHPR-XNXCGYEVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
58001,6crv,DB04421,-9.4,Nicotinamide Adenine Dinucleotide 3-Pentanone Adduct,BZJFKYRGSZWSLT-YLIVDTKOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57885,6crv,DB04258,-9.4,Seocalcitol,LVLLALCJVJNGQQ-SEODYNFXSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88531,6m3m,DB13958,-9.4,Trestolone acetate,IVCRCPJOLWECJU-XQVQQVTHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
27115,6cs2,DB06494,-9.4,Sufugolix,UCQSBGOFELXYIN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
87080,6m3m,DB11800,-9.4,Tivozanib,SPMVMDHWKHCIDT-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
132101,6w4h,DB15385,-9.4,Acebilustat,GERJIEKMNDGSCS-DQEYMECFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
109477,6vxx,DB13953,-9.4,Estradiol benzoate,UYIFTLBWAOGQBI-BZDYCCQFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27675,6cs2,DB07229,-9.4,"3-{5-[AMINO(IMINIO)METHYL]-1H-INDOL-2-YL}-5-METHOXY-1,1'-BIPHENYL-2-OLATE",MINVOLKUPZPDNX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
31046,6cs2,DB13345,-9.4,Dihydroergocristine,DEQITUUQPICUMR-HJPBWRTMSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
31417,6cs2,DB13791,-9.4,Penfluridol,MDLAAYDRRZXJIF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
29526,6cs2,DB09295,-9.4,Talniflumate,ANMLJLFWUCQGKZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
87012,6m3m,DB11698,-9.4,Ipragliflozin,AHFWIQIYAXSLBA-RQXATKFSSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86826,6m3m,DB11274,-9.4,Dihydro-alpha-ergocryptine,PBUNVLRHZGSROC-VTIMJTGVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88684,6m3m,DB14583,-9.4,Segesterone acetate,CKFBRGLGTWAVLG-GOMYTPFNSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
107201,6vxx,DB02698,-9.4,"N-(M-Trifluoromethylphenyl) Phenoxazine-4,6-Dicarboxylic Acid",NQOOJFXBGLOGTC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27625,6cs2,DB07175,-9.4,N-{2-methyl-5-[(6-phenylpyrimidin-4-yl)amino]phenyl}methanesulfonamide,CXQRKICWSCAUGW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
28476,6cs2,DB08064,-9.4,N-(3-TERT-BUTYL-1H-PYRAZOL-5-YL)-N'-{4-CHLORO-3-[(PYRIDIN-3-YLOXY)METHYL]PHENYL}UREA,NTMADESEDXKNFZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
58256,6crv,DB04761,-9.4,"PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-[(PYRIDIN-3-YLMETHYL)-AMIDE]",NHPBWKYFMTXWAA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113865,6vxx,DB12200,-9.4,Tivantinib,UCEQXRCJXIVODC-PMACEKPBSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86892,6m3m,DB11440,-9.4,Norgestomet,IWSXBCZCPVUWHT-VIFKTUCRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58207,6crv,DB04690,-9.4,Camptothecin,VSJKWCGYPAHWDS-FQEVSTJZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30418,6cs2,DB12457,-9.4,Rimegepant,KRNAOFGYEFKHPB-ANJVHQHFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
88680,6m3m,DB14570,-9.4,Hydroxyprogesterone,DBPWSSGDRRHUNT-CEGNMAFCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
113851,6vxx,DB12180,-9.4,Apitolisib,YOVVNQKCSKSHKT-HNNXBMFYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58181,6crv,DB04652,-9.4,Corticosterone,OMFXVFTZEKFJBZ-HJTSIMOOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87015,6m3m,DB11703,-9.4,Acalabrutinib,WDENQIQQYWYTPO-IBGZPJMESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87157,6m3m,DB11912,-9.4,Lanopepden,SWHNZGMQMGFQGW-MSOLQXFVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88678,6m3m,DB14568,-9.4,Ivosidenib,WIJZXSAJMHAVGX-DHLKQENFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
57763,6crv,DB04097,-9.4,Uridine-5'-Diphosphate-4-Deoxy-4-Fluoro-Alpha-D-Galactose,OAPPZHVTNHJVAL-JZMIEXBBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58162,6crv,DB04630,-9.4,Aldosterone,PQSUYGKTWSAVDQ-ZVIOFETBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88669,6m3m,DB14542,-9.4,Hydrocortisone phosphate,BGSOJVFOEQLVMH-VWUMJDOOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87150,6m3m,DB11903,-9.4,GW842166,TWQYWUXBZHPIIV-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
55005,6crv,DB00490,-9.4,Buspirone,QWCRAEMEVRGPNT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86978,6m3m,DB11651,-9.4,Dactolisib,JOGKUKXHTYWRGZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
5987,6lzg,DB01411,-9.4,Pranlukast,NBQKINXMPLXUET-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
88651,6m3m,DB14217,-9.4,Quinaprilat,FLSLEGPOVLMJMN-YSSFQJQWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
109745,6vxx,DB15247,-9.4,Vorolanib,KMIOJWCYOHBUJS-HAKPAVFJSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109816,6vxx,DB00288,-9.4,Amcinonide,ILKJAFIWWBXGDU-MOGDOJJUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87011,6m3m,DB11697,-9.4,Pacritinib,HWXVIOGONBBTBY-ONEGZZNKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
113711,6vxx,DB11795,-9.4,GSK-2636771,XTKLTGBKIDQGQL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30474,6cs2,DB12535,-9.4,AC-430,DCRWIATZWHLIPN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
55111,6crv,DB00622,-9.4,Nicardipine,ZBBHBTPTTSWHBA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86357,6m3m,DB08746,-9.4,1-[[(1E)-2-(4-CHLOROPHENYL)ETHENYL]SULFONYL]-4-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]PIPERAZINE,ZOSSOFIFNGGDKG-GIJQJNRQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
110003,6vxx,DB00693,-9.4,Fluorescein,GNBHRKFJIUUOQI-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85810,6m3m,DB08091,-9.4,3-FLUORO-5-MORPHOLIN-4-YL-N-[3-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-5-YL]BENZAMIDE,HIUFYIOMUILESI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
89045,6m3m,DB15346,-9.4,GLPG-1205,IRBAWVGZNJIROV-SFHVURJKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
55745,6crv,DB01434,-9.4,19-norandrostenedione,JRIZOGLBRPZBLQ-QXUSFIETSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87913,6m3m,DB13052,-9.4,Upamostat,HUASEDVYRABWCV-NDEPHWFRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
102044,6vxs,DB06938,-9.4,4-[[2-[[4-chloro-3-(trifluoromethyl)phenyl]amino]-3H-benzimidazol-5-yl]oxy]-N-methyl-pyridine-2-carboxamide,ZJLSMLDOCGOURY-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102349,6vxs,DB07294,-9.4,"3-fluoro-4-[2-hydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8,-tetrahydro-naphtalen-2-yl)-acetylamino]-benzoic acid",AANFHDFOMFRLLR-IBGZPJMESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
114178,6vxx,DB12858,-9.4,LY-377604,RBSGUQYXRDKPAE-QFIPXVFZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
102634,6vxs,DB07629,-9.4,"N-((1R,2S)-2-(5-CHLORO-1H-INDOLE-2-CARBOXAMIDO)CYCLOHEXYL)-5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE-2-CARBOXAMIDE",ARPFWVKYXJZULB-DLBZAZTESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
85830,6m3m,DB08111,-9.4,"4-[(6-phenyl[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl]phenol",ZGJYGQLGSXWEMY-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85841,6m3m,DB08123,-9.4,"N-METHYL-{4-[2-(7-OXO-6,7-DIHYDRO-8H-[1,3]THIAZOLO[5,4-E]INDOL-8-YLIDENE)HYDRAZINO]PHENYL}METHANESULFONAMIDE",GEWPSTLKJDIUHW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
162645,7bv1,DB02732,-9.4,Nicotinamide Adenine Dinucleotide Acetone Adduct,SGHBFOOIAAJJMI-YDKVLQLQSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
89006,6m3m,DB15275,-9.4,GDC-0077,SGEUNORSOZVTOL-CABZTGNLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
89005,6m3m,DB15273,-9.4,VS-4718,IGUBBWJDMLCRIK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
108168,6vxx,DB07181,-9.4,"4'-[(1R)-1-amino-2-(2,5-difluorophenyl)ethyl]biphenyl-3-carboxamide",JYKFWUXBFJJDTP-HXUWFJFHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85886,6m3m,DB08170,-9.4,"(1R)-N,6-DIHYDROXY-7-METHOXY-2-[(4-METHOXYPHENYL)SULFONYL]-1,2,3,4-TETRAHYDROISOQUINOLINE-1-CARBOXAMIDE",AYFCYVLVRYQGME-QGZVFWFLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
89004,6m3m,DB15269,-9.4,ALK-4290,DWKNOLCXIFYNFV-HSZRJFAPSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87933,6m3m,DB13080,-9.4,Roluperidone,RNRYULFRLCBRQS-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85902,6m3m,DB08191,-9.4,"4-(5-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl)benzoic acid",KSFDVNIKNYXUIP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
163676,7bv1,DB05835,-9.4,NS-3728,OQRAKHDEGGGWQO-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
30202,6cs2,DB12186,-9.4,SRT-2104,LAMQVIQMVKWXOC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
57621,6crv,DB03903,-9.4,Tmr,KGFLZYXDJDOIEE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
133064,6w9c,DB01167,-9.4,Itraconazole,VHVPQPYKVGDNFY-ZPGVKDDISA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
85937,6m3m,DB08237,-9.4,2'-deoxy-N-(naphthalen-1-ylmethyl)guanosine 5'-(dihydrogen phosphate),COMPKRGNHXOXMN-GVDBMIGSSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87303,6m3m,DB12128,-9.4,Ulimorelin,WGYPAJVJMXQXTR-ABNZCKJZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
165451,7bv1,DB12121,-9.4,Entospletinib,XSMSNFMDVXXHGJ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
88973,6m3m,DB15207,-9.4,Esaxerenone,NOSNHVJANRODGR-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85988,6m3m,DB08304,-9.4,"(3R)-3-cyclopentyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2-benzothiazine 1,1-dioxide",QZBQVXXESPXFPZ-QGZVFWFLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85788,6m3m,DB08063,-9.4,"1-BENZYL-3-(4-METHOXYPHENYLAMINO)-4-PHENYLPYRROLE-2,5-DIONE",HLZMYWLMBBLASX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
133169,6w9c,DB01329,-9.4,Cefoperazone,GCFBRXLSHGKWDP-XCGNWRKASA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
106389,6vxx,DB00157,-9.4,NADH,BOPGDPNILDQYTO-NNYOXOHSSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
133174,6w9c,DB01337,-9.4,Pancuronium,GVEAYVLWDAFXET-XGHATYIMSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
57467,6crv,DB03714,-9.4,4-Carbamoyl-4-{[6-(Difluoro-Phosphono-Methyl)-Naphthalene-2-Carbonyl]-Amino}-Butyric Acid,OWWCIKSGGKYNHT-ZDUSSCGKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57475,6crv,DB03723,-9.4,2'-Deoxy-Thymidine-Beta-L-Rhamnose,ZOSQFDVXNQFKBY-CGAXJHMRSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130803,6w4h,DB12817,-9.4,Zoliflodacin,ZSWMIFNWDQEXDT-ZESJGQACSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
125232,6w4h,DB02226,-9.4,"3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-4-Yl]Hexyl]-Phenanthridinium",NAARZDJZGYBXKL-UHFFFAOYSA-O,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
101841,6vxs,DB06630,-9.4,Anacetrapib,MZZLGJHLQGUVPN-HAWMADMCSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101846,6vxs,DB06638,-9.4,Quarfloxin,WOQIDNWTQOYDLF-CGAIIQECSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
27520,6cs2,DB07064,-9.4,"(4R)-4-(3-HYDROXYPHENYL)-N,N,7,8-TETRAMETHYL-3,4-DIHYDROISOQUINOLINE-2(1H)-CARBOXAMIDE",HPVCRUIDFODATB-LJQANCHMSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
58628,6crv,DB06230,-9.4,Nalmefene,WJBLNOPPDWQMCH-MBPVOVBZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163632,7bv1,DB04881,-9.4,Elacridar,OSFCMRGOZNQUSW-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
16894,6cs2,HMDB0005014,-9.4,Celecoxib,RZEKVGVHFLEQIL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
111976,6vxx,DB05016,-9.4,Ataluren,OOUGLTULBSNHNF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85723,6m3m,DB07991,-9.4,N-[(1R)-3-(4-HYDROXYPHENYL)-1-METHYLPROPYL]-2-(2-PHENYL-1H-INDOL-3-YL)ACETAMIDE,APLJSSOXDWUNGV-GOSISDBHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87335,6m3m,DB12180,-9.4,Apitolisib,YOVVNQKCSKSHKT-HNNXBMFYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
108120,6vxx,DB07126,-9.4,O6-CYCLOHEXYLMETHOXY-2-(4'-SULPHAMOYLANILINO) PURINE,OWXORKPNCHJYOF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108328,6vxx,DB07629,-9.4,"N-((1R,2S)-2-(5-CHLORO-1H-INDOLE-2-CARBOXAMIDO)CYCLOHEXYL)-5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE-2-CARBOXAMIDE",ARPFWVKYXJZULB-DLBZAZTESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
32774,6cs2,T3D3688,-9.4,Ergocristine,HEFIYUQVAZFDEE-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
26703,6cs2,DB04888,-9.4,Bifeprunox,CYGODHVAJQTCBG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
87329,6m3m,DB12167,-9.4,LY-3023414,ACCFLVVUVBJNGT-AWEZNQCLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
123118,6w4b,DB14878,-9.4,Liafensine,VCIBGDSRPUOBOG-QFIPXVFZSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
126575,6w4h,DB04011,-9.4,"2'-(4-Dimethylaminophenyl)-5-(4-Methyl-1-Piperazinyl)-2,5'-Bi-Benzimidazole",VMCOQLKKSNQANE-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
165246,7bv1,DB11651,-9.4,Dactolisib,JOGKUKXHTYWRGZ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
129959,6w4h,DB11487,-9.4,Dexamethasone isonicotinate,BQTXJHAJMDGOFI-NJLPOHDGSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
85760,6m3m,DB08031,-9.4,"N-[(13-CYCLOHEXYL-6,7-DIHYDROINDOLO[1,2-D][1,4]BENZOXAZEPIN-10-YL)CARBONYL]-2-METHYL-L-ALANINE",LNQWELVSNCYKDU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
55122,6crv,DB00635,-9.4,Prednisone,XOFYZVNMUHMLCC-ZPOLXVRWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
105031,6vxs,DB12892,-9.4,MGB-BP-3,OEKXCVYZBVOWBR-BQYQJAHWSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
112814,6vxx,DB07872,-9.4,5-chloro-N-[(3R)-1-(2-{[2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl]amino}-2-oxoethyl)pyrrolidin-3-yl]thiophene-2-carboxamide,IYGIXVNAMZPBDK-CQSZACIVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
129987,6w4h,DB11562,-9.4,Bicuculline,IYGYMKDQCDOMRE-ZWKOTPCHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
58599,6crv,DB06166,-9.4,Fosdevirine,CGBYTKOSZYQOPV-CCEZBSFNSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
126537,6w4h,DB03957,-9.4,SP2456,SSSXBBASYYVGCI-HSZRJFAPSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
28324,6cs2,DB07909,-9.4,"(1S,2S,5S)2-(4-GLUTARIDYLBENZYL)-5-PHENYL-1-CYCLOHEXANOL",OBWILOKKNDYPLX-HBMCJLEFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
86018,6m3m,DB08341,-9.4,"4-{[4-{[(1R,2R)-2-(dimethylamino)cyclopentyl]amino}-5-(trifluoromethyl)pyrimidin-2-yl]amino}-N-methylbenzenesulfonamide",CAUFYHKGKDJMQG-HZPDHXFCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
109175,6vxx,DB12477,-9.4,Perfluoro tert-butylcyclohexane,VLTXBOGHSBHSAC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130162,6w4h,DB11863,-9.4,Alvelestat,QNQZWEGMKJBHEM-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
107889,6vxx,DB05450,-9.4,Smilagenin,GMBQZIIUCVWOCD-UQHLGXRBSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27592,6cs2,DB07141,-9.4,"5-[(3R)-3-(5-methoxy-4'-methylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",QVXYJVHNRPNRJL-HNNXBMFYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
87990,6m3m,DB13185,-9.4,Oxabolone cipionate,KHKDIUPVDIEHAH-KXLSUQFWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
112184,6vxx,DB06521,-9.4,Ertiprotafib,FONCZICQWCUXEB-RUZDIDTESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114081,6vxx,DB12703,-9.4,Omipalisib,CGBJSGAELGCMKE-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
103382,6vxs,DB08512,-9.4,"6-amino-2-[(1-naphthylmethyl)amino]-3,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",MCEZMMDIEXECTI-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
86183,6m3m,DB08538,-9.4,"N-((2-aminopyrimidin-5-yl)methyl)-5-(2,6-difluorophenyl)-3-ethylpyrazolo[1,5-a]pyrimidin-7-amine",HQPVGVSQPQVZLD-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
112205,6vxx,DB06581,-9.4,Bevirimat,YJEJKUQEXFSVCJ-WRFMNRASSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86195,6m3m,DB08553,-9.4,"(1E)-5-(1-piperidin-4-yl-3-pyridin-4-yl-1H-pyrazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime",KWEFZSZCLBHIEQ-YYADALCUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
57702,6crv,DB04014,-9.4,Alsterpaullone,OLUKILHGKRVDCT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
132783,6w9c,DB00845,-9.4,Clofazimine,WDQPAMHFFCXSNU-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
28535,6cs2,DB08124,-9.4,"3-{[(2,2-DIOXIDO-1,3-DIHYDRO-2-BENZOTHIEN-5-YL)AMINO]METHYLENE}-5-(1,3-OXAZOL-5-YL)-1,3-DIHYDRO-2H-INDOL-2-ONE",FTQYGMLRLRXBPT-IDUWFGFVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
86147,6m3m,DB08497,-9.4,"(1S)-2-oxo-1-phenyl-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate",NKBDSMREMMRFSI-INIZCTEOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
165462,7bv1,DB12134,-9.4,Gepotidacin,PZFAZQUREQIODZ-LJQANCHMSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
112748,6vxx,DB07800,-9.4,N-(2-(((5-CHLORO-2-PYRIDINYL)AMINO)SULFONYL)PHENYL)-4-(2-OXO-1(2H)-PYRIDINYL)BENZAMIDE,MIJGLXFQYBTIFY-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88021,6m3m,DB13240,-9.4,Cymarin,XQCGNURMLWFQJR-ZNDDOCHDSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
103794,6vxs,DB09042,-9.4,Tedizolid phosphate,QCGUSIANLFXSGE-GFCCVEGCSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
130199,6w4h,DB11913,-9.4,LY-2090314,HRJWTAWVFDCTGO-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
57718,6crv,DB04038,-9.4,Ergosterol,DNVPQKQSNYMLRS-APGDWVJJSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113552,6vxx,DB11487,-9.4,Dexamethasone isonicotinate,BQTXJHAJMDGOFI-NJLPOHDGSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114051,6vxx,DB12655,-9.4,Patidegib,HZLFFNCLTRVYJG-WWGOJCOQSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30311,6cs2,DB12318,-9.4,BMS-599626,LUJZZYWHBDHDQX-QFIPXVFZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
107768,6vxx,DB04591,-9.4,"N-{2,2-DIFLUORO-2-[(2R)-PIPERIDIN-2-YL]ETHYL}-2-[2-(1H-1,2,4-TRIAZOL-1-YL)BENZYL][1,3]OXAZOLO[4,5-C]PYRIDIN-4-AMINE",VYJOAYZRCNHDNG-GOSISDBHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
124279,6w4h,DB00966,-9.4,Telmisartan,RMMXLENWKUUMAY-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
12214,6lzg,DB13050,-9.4,Tirilazad,RBKASMJPSJDQKY-RBFSKHHSSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
56612,6crv,DB02547,-9.4,Guanosine-5'-Diphosphate-Rhamnose,LQEBEXMHBLQMDB-GDJBGNAASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112735,6vxx,DB07786,-9.4,"1-((1R,2S)-1-{2-[2-(4-CHLOROPHENYL)-1,3-BENZOXAZOL-7-YL]ETHYL}-2-HYDROXYPROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE",SMFRBBHLVBWHGB-DJJJIMSYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
105788,6vxs,DB14034,-9.4,Darglitazone,QQKNSPHAFATFNQ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
107764,6vxx,DB04583,-9.4,"5-Carbamoyl-1,1':4',1''-terphenyl-3-carboxylic acid",LAZPCGBRHLARSI-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109264,6vxx,DB12978,-9.4,Pexidartinib,JGWRKYUXBBNENE-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55866,6crv,DB01569,-9.4,Formebolone,AMVODTGMYSRMNP-GNIMZFFESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87945,6m3m,DB13097,-9.4,1alpha-Hydroxyvitamin D5,NWFOBODUYTUMNC-VPSCEVSQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87948,6m3m,DB13101,-9.4,4SC-202,PRXXYMVLYKJITB-IZZDOVSWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
28382,6cs2,DB00734,-9.4,Risperidone,RAPZEAPATHNIPO-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
87954,6m3m,DB13109,-9.4,PKI-179,WXUUCRLKXQMWRY-OYRHEFFESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88963,6m3m,DB15192,-9.4,ABT-288,GNIRITULTPTAQW-KNQAVFIVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
28272,6cs2,DB07855,-9.4,(S)-1-PHENYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE,CWHMAWBXRCDOEB-HNNXBMFYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
55786,6crv,DB01480,-9.4,Cyprenorphine,VSKIOMHXEUHYSI-KNLIIKEYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106522,6vxx,DB00445,-9.4,Epirubicin,AOJJSUZBOXZQNB-VTZDEGQISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87275,6m3m,DB12092,-9.4,Naftopidil,HRRBJVNMSRJFHQ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
104996,6vxs,DB12836,-9.4,Grapiprant,HZVLFTCYCLXTGV-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
87273,6m3m,DB12085,-9.4,LCL-161,UFPFGVNKHCLJJO-SSKFGXFMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
29673,6cs2,DB00872,-9.4,Conivaptan,IKENVDNFQMCRTR-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
30775,6cs2,DB12960,-9.4,INCB-9471,ZMCJFJZOSKEMOM-DNKZPPIMSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
127498,6w4h,DB06212,-9.4,Tolvaptan,GYHCTFXIZSNGJT-XMMPIXPASA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
54764,6crv,DB00203,-9.4,Sildenafil,BNRNXUUZRGQAQC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109215,6vxx,DB12903,-9.4,DEBIO-1347,BEMNJULZEQTDJY-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110060,6vxx,DB00762,-9.4,Irinotecan,UWKQSNNFCGGAFS-XIFFEERXSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
103064,6vxs,DB08124,-9.4,"3-{[(2,2-DIOXIDO-1,3-DIHYDRO-2-BENZOTHIEN-5-YL)AMINO]METHYLENE}-5-(1,3-OXAZOL-5-YL)-1,3-DIHYDRO-2H-INDOL-2-ONE",FTQYGMLRLRXBPT-IDUWFGFVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
58485,6crv,DB05511,-9.4,Piclidenoson,HUJXGQILHAUCCV-MOROJQBDSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
132915,6w9c,DB00997,-9.4,Doxorubicin,AOJJSUZBOXZQNB-TZSSRYMLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
114114,6vxx,DB12746,-9.4,AKN-028,JLRIJKVMMZEKDF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
128193,6w4h,DB07321,-9.4,"2,5-DICHLORO-N-[5-METHOXY-7-(6-METHOXYPYRIDIN-3-YL)-1,3-BENZOXAZOL-2-YL]BENZENESULFONAMIDE",KOKQLKWXOFRTHE-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
112114,6vxx,DB06314,-9.4,SGX-523,BCZUAADEACICHN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87966,6m3m,DB13126,-9.4,BMS-986115,SRJNRAQUSAVENA-GSHUGGBRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
103159,6vxs,DB08237,-9.4,2'-deoxy-N-(naphthalen-1-ylmethyl)guanosine 5'-(dihydrogen phosphate),COMPKRGNHXOXMN-GVDBMIGSSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
87251,6m3m,DB12055,-9.4,MK-0767,ORZMUVMQJPGFOM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87249,6m3m,DB12052,-9.4,Icariin,TZJALUIVHRYQQB-XLRXWWTNSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
161471,7bv1,DB14870,-9.4,PF-5190457,ZIUDADZJCKGWKR-AREMUKBSSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
109197,6vxx,DB12513,-9.4,Omaveloxolone,RJCWBNBKOKFWNY-IDPLTSGASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87668,6m3m,DB12665,-9.4,Isoquercetin,OVSQVDMCBVZWGM-QSOFNFLRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58633,6crv,DB06237,-9.4,Avanafil,WEAJZXNPAWBCOA-INIZCTEOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80353,6m2n,DB15193,-9.4,BMS-955176,XDMUFNNPLXHNKA-ZTESCHFWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75455,6m2n,DB04724,-9.4,"(S)-2-((S)-3-ISOBUTYL-2,5-DIOXO-4-QUINOLIN-3-YLMETHYL-[1,4]DIAZEPAN-1YL)-N-METHYL-3-NAPHTALEN-2-YL-PROPIONAMIDE",COVPLULNDBDXTN-KYJUHHDHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61914,6crv,DB12794,-9.4,p-Quaterphenyl,GPRIERYVMZVKTC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136566,6w9c,DB07267,-9.4,2-(6-methylpyridin-2-yl)-N-pyridin-4-ylquinazolin-4-amine,JONFDFIXMPXTRH-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
160096,7bv1,DB07507,-9.4,"2-(4-hydroxybiphenyl-3-yl)-4-methyl-1H-isoindole-1,3(2H)-dione",ROMNEYAQUBNRLR-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
78701,6m2n,DB12141,-9.4,Gilteritinib,GYQYAJJFPNQOOW-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61955,6crv,DB12867,-9.4,Benperidol,FEBOTPHFXYHVPL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
159485,7bv1,DB04477,-9.4,"N-1,2,3,4-Tetrahydronaphth-1-Yl-2'-[3,5-Dimethoxybenzamido]-2'-Deoxy-Adenosine",FDZQGEIYGFPMOB-ZUURFMEUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
78713,6m2n,DB12158,-9.4,Filorexant,NPFDWHQSDBWQLH-QZTJIDSGSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
59427,6crv,DB07450,-9.4,(R)-minalrestat,BMHZAHGTGIZZCT-LJQANCHMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61970,6crv,DB12886,-9.4,GSK-1521498,WIEDUMBCZQRGSY-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
137931,6w9c,DB08912,-9.4,Dabrafenib,BFSMGDJOXZAERB-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136583,6w9c,DB07294,-9.4,"3-fluoro-4-[2-hydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8,-tetrahydro-naphtalen-2-yl)-acetylamino]-benzoic acid",AANFHDFOMFRLLR-IBGZPJMESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
159404,7bv1,DB04099,-9.4,Deamido-Nad+,SENPVEZBRZQVST-HISDBWNOSA-O,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
137927,6w9c,DB08907,-9.4,Canagliflozin,XTNGUQKDFGDXSJ-ZXGKGEBGSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
74920,6m2n,DB04006,-9.4,"[2-Amino-6-(2,6-Difluoro-Benzoyl)-Imidazo[1,2-a]Pyridin-3-Yl]-Phenyl-Methanone",WUGJIPFLBOATGL-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
139695,6w9c,DB13814,-9.4,Talampicillin,SOROUYSPFADXSN-SUWVAFIASA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136586,6w9c,DB07297,-9.4,"5,6-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-D]PYRIMIDIN-4-AMINE",PTILEOLOGGMFCS-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
61064,6crv,DB11450,-9.4,Pimobendan,GLBJJMFZWDBELO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81253,6m3m,DB00984,-9.4,Nandrolone phenpropionate,UBWXUGDQUBIEIZ-QNTYDACNSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
74793,6m2n,DB03837,-9.4,Morpholine-4-Carboxylic Acid (1-(3-Benzenesulfonyl-1-Phenethylallylcarbamoyl)-3-Methylbutyl)-Amide,YUMYYTORLYHUFW-ZUDLOMHPSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
135891,6w9c,DB05553,-9.4,Regrelor,NXHAXEBZOXCDKD-XIXRRVGJSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
81243,6m3m,DB00973,-9.4,Ezetimibe,OLNTVTPDXPETLC-XPWALMASSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83365,6m3m,DB03791,-9.4,"(3-{3-[[2-Chloro-3-(Trifluoromethyl)Benzyl](2,2-Diphenylethyl)Amino]Propoxy}Phenyl)Acetic Acid",NAXSRXHZFIBFMI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
62024,6crv,DB12966,-9.4,Falnidamol,FTFRZXFNZVCRSK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61025,6crv,DB11385,-9.4,Cefalonium,FMZXNVLFJHCSAF-DNVCBOLYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
147765,6w9q,DB12411,-9.4,R-428,KXMZDGSRSGHMMK-VWLOTQADSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
59459,6crv,DB07488,-9.4,"{(2Z)-4-AMINO-2-[(4-METHOXYPHENYL)IMINO]-2,3-DIHYDRO-1,3-THIAZOL-5-YL}(4-METHOXYPHENYL)METHANONE",XQKUGFIWKSKCDL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61885,6crv,DB12743,-9.4,Z-160,VCPMZDWBEWTGNW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
135975,6w9c,DB06212,-9.4,Tolvaptan,GYHCTFXIZSNGJT-XMMPIXPASA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
61762,6crv,DB12553,-9.4,Fluocinolone,UUOUOERPONYGOS-CLCRDYEYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
148067,6w9q,DB12886,-9.4,GSK-1521498,WIEDUMBCZQRGSY-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
59870,6crv,DB07971,-9.4,"5-AMINO-2-{4-[(4-AMINOPHENYL)SULFANYL]PHENYL}-1H-ISOINDOLE-1,3(2H)-DIONE",FQQVTDIBUYSVHM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61226,6crv,DB11775,-9.4,PF-03758309,AYCPARAPKDAOEN-LJQANCHMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81463,6m3m,DB01222,-9.4,Budesonide,VOVIALXJUBGFJZ-KWVAZRHASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
75826,6m2n,DB06176,-9.4,Romidepsin,OHRURASPPZQGQM-GCCNXGTGSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75822,6m2n,DB06163,-9.4,Plevitrexed,IEJSCSAMMLUINT-NRFANRHFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61216,6crv,DB11763,-9.4,Momelotinib,ZVHNDZWQTBEVRY-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81454,6m3m,DB01212,-9.4,Ceftriaxone,VAAUVRVFOQPIGI-SPQHTLEESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
75698,6m2n,DB05454,-9.4,Paliroden,CNEWKIDCGDXBDE-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
160027,7bv1,DB07204,-9.4,"(1S)-1-(1H-INDOL-3-YLMETHYL)-2-(2-PYRIDIN-4-YL-[1,7]NAPHTYRIDIN-5-YLOXY)-EHYLAMINE",DQIXTEDFNFZMCM-SFHVURJKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
81421,6m3m,DB01177,-9.4,Idarubicin,XDXDZDZNSLXDNA-TZNDIEGXSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
137877,6w9c,DB08822,-9.4,Azilsartan medoxomil,QJFSABGVXDWMIW-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
59485,6crv,DB07519,-9.4,"(6R)-2-amino-6-[2-(3'-methoxybiphenyl-3-yl)ethyl]-3,6-dimethyl-5,6-dihydropyrimidin-4(3H)-one",VDFBMQAUECXNKR-OAQYLSRUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
83040,6m3m,DB03337,-9.4,1-(2-Amidinophenyl)-3-(Phenoxyphenyl)Urea,ZHCAYBOLUMAUQX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
135991,6w9c,DB06248,-9.4,Amelubant,SBVYURPQULDJTI-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
135989,6w9c,DB06246,-9.4,Exisulind,MVGSNCBCUWPVDA-MFOYZWKCSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
61834,6crv,DB12666,-9.4,Emapunil,NBMBIEOUVBHEBM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138046,6w9c,DB09075,-9.4,Edoxaban,HGVDHZBSSITLCT-JLJPHGGASA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
83061,6m3m,DB03363,-9.4,3-Acetylpyridine Adenine Dinucleotide,KPVQNXLUPNWQHM-RBEMOOQDSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
147912,6w9q,DB12640,-9.4,CP-609754,JAHDAIPFBPPQHQ-GDLZYMKVSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
75576,6m2n,DB04882,-9.4,Edotecarin,QMVPQBFHUJZJCS-NTKFZFFISA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78647,6m2n,DB12064,-9.4,BMS-777607,VNBRGSXVFBYQNN-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
139454,6w9c,DB13490,-9.4,Hidrosmin,XYFLWVOTXWXNAM-WTNNCJBMSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
78662,6m2n,DB12085,-9.4,LCL-161,UFPFGVNKHCLJJO-SSKFGXFMSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
59898,6crv,DB08003,-9.4,ISOTHIAZOLIDINONE ANALOG,UILYPHAKDBTKQV-UFYCRDLUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
147947,6w9q,DB12690,-9.4,LY-2584702,FYXRSVDHGLUMHB-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
139192,6w9c,DB12999,-9.4,MK-6186,FZBAOOQVQXATRL-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
78867,6m2n,DB12380,-9.4,GDC-0152,WZRFLSDVFPIXOV-LRQRDZAKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
139813,6w9c,DB14037,-9.4,Madecassic acid,PRAUVHZJPXOEIF-AOLYGAPISA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
59995,6crv,DB08111,-9.4,"4-[(6-phenyl[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl]phenol",ZGJYGQLGSXWEMY-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
83873,6m3m,DB04471,-9.4,"2-Phenyl-1-[4-(2-Piperidin-1-Yl-Ethoxy)-Phenyl]-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol",FMWVCTJKLAVRPB-MUUNZHRXSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
140032,6w9c,DB14792,-9.4,AZD-5991,KBQCEQAXHPIRTF-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
59293,6crv,DB07295,-9.4,2-[(7-HYDROXY-NAPHTHALEN-1-YL)-OXALYL-AMINO]-BENZOIC ACID,IGOULVZYQKJJKC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
83954,6m3m,DB04573,-9.4,Estriol,PROQIPRRNZUXQM-ZXXIGWHRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
79049,6m2n,DB12655,-9.4,Patidegib,HZLFFNCLTRVYJG-WWGOJCOQSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
73093,6m2n,DB01573,-9.4,Benzylmorphine,RDJGWRFTDZZXSM-RNWLQCGYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
59265,6crv,DB07265,-9.4,"3-(9-HYDROXY-1,3-DIOXO-4-PHENYL-2,3-DIHYDROPYRROLO[3,4-C]CARBAZOL-6(1H)-YL)PROPANOIC ACID",JDARUOOLJCFUOY-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72946,6m2n,DB01410,-9.4,Ciclesonide,LUKZNWIVRBCLON-GXOBDPJESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
60789,6crv,DB09143,-9.4,Sonidegib,VZZJRYRQSPEMTK-CALCHBBNSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79097,6m2n,DB12725,-9.4,TD-8954,MZOITCJKGUIQEI-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
83992,6m3m,DB04623,-9.4,"2-ETHOXYETHYL (2S,3S)-4-((S)-2-BENZYL-3-OXO-4-((3AR,8R,8AS)-2-OXO-3,3A,8,8A-TETRAHYDRO-2H-INDENO[1,2-D]OXAZOL-8-YL)-2,3-DIHYDRO-1H-PYRROL-2-YL)-3-HYDROXY-1-PHENYLBUTAN-2-YLCARBAMATE",CGBRFCVAMLJVEA-ZGURCIGKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
79108,6m2n,DB12742,-9.4,Amuvatinib,FOFDIMHVKGYHRU-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
140058,6w9c,DB14860,-9.4,Ensartinib,GLYMPHUVMRFTFV-QLFBSQMISA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
59996,6crv,DB08112,-9.4,N-({6-[(4-CYANO-2-FLUOROBENZYL)OXY]NAPHTHALEN-2-YL}SULFONYL)-D-GLUTAMIC ACID,IRJUSGUHNFMVCK-OAQYLSRUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140063,6w9c,DB14870,-9.4,PF-5190457,ZIUDADZJCKGWKR-AREMUKBSSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136724,6w9c,DB07456,-9.4,"3-(1H-indol-3-yl)-4-(1-{2-[(2S)-1-methylpyrrolidinyl]ethyl}-1H-indol-3-yl)-1H-pyrrole-2,5-dione",LBFDERUQORUFIN-QGZVFWFLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
79109,6m2n,DB12743,-9.4,Z-160,VCPMZDWBEWTGNW-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
140070,6w9c,DB14882,-9.4,CEP-9722,CTLOSZHDGZLOQE-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
72911,6m2n,DB01337,-9.4,Pancuronium,GVEAYVLWDAFXET-XGHATYIMSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
25311,6cs2,DB03213,-9.4,Bis(5-Amidino-2-Benzimidazolyl)Methane Ketone,VVVXDHROXQUONB-UHFFFAOYSA-P,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
24192,6cs2,DB01876,-9.4,Bis(5-Amidino-2-Benzimidazolyl)Methanone,VVVXDHROXQUONB-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
140087,6w9c,DB14916,-9.4,Selonsertib,YIDDLAAKOYYGJG-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
84053,6m3m,DB04706,-9.4,"(3BETA,7BETA)-CHOLEST-5-ENE-3,7-DIOL",OYXZMSRRJOYLLO-KGZHIOMZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81002,6m3m,DB00693,-9.4,Fluorescein,GNBHRKFJIUUOQI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
79037,6m2n,DB12637,-9.4,Onapristone,IEXUMDBQLIVNHZ-YOUGDJEHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
59317,6crv,DB07321,-9.4,"2,5-DICHLORO-N-[5-METHOXY-7-(6-METHOXYPYRIDIN-3-YL)-1,3-BENZOXAZOL-2-YL]BENZENESULFONAMIDE",KOKQLKWXOFRTHE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59992,6crv,DB08108,-9.4,N-({6-[(4-CYANOBENZYL)OXY]NAPHTHALEN-2-YL}SULFONYL)-D-GLUTAMIC ACID,PUHRQSFXADUGJW-OAQYLSRUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
73260,6m2n,DB01792,-9.4,Adenylyl-3'-5'-Phospho-Uridine-3'-Monophosphate,FZCSEXOMUJFOHQ-KPKSGTNCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
139819,6w9c,DB14054,-9.4,Asiatic acid,JXSVIVRDWWRQRT-UYDOISQJSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
62059,6crv,DB13022,-9.4,LY-2874455,GKJCVYLDJWTWQU-CXLRFSCWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59948,6crv,DB08058,-9.4,"4-[3-(1,4-diazepan-1-ylcarbonyl)-4-fluorobenzyl]phthalazin-1(2H)-one",HGEPGGJUGUMFHT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
74267,6m2n,DB03126,-9.4,Mant-Adp,QPKUEBLEGWBRHC-BFHYXJOUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
83536,6m3m,DB04014,-9.4,Alsterpaullone,OLUKILHGKRVDCT-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
62083,6crv,DB13059,-9.4,PF-03814735,RYYNGWLOYLRZLK-RBUKOAKNSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59378,6crv,DB07393,-9.4,"2-(2-PHENYL-3-PYRIDIN-2-YL-4,5,6,7-TETRAHYDRO-2H-ISOPHOSPHINDOL-1-YL)PYRIDINE",GSKNNHAAFLPYHG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62119,6crv,DB13109,-9.4,PKI-179,WXUUCRLKXQMWRY-OYRHEFFESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81124,6m3m,DB00836,-9.4,Loperamide,RDOIQAHITMMDAJ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83611,6m3m,DB04115,-9.4,Berberine,YBHILYKTIRIUTE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136679,6w9c,DB07404,-9.4,"(1-HYDROXY-1-PHOSPHONO-2-[1,1';3',1'']TERPHENYL-3-YL-ETHYL)-PHOSPHONIC ACID",YXQQNSYZOQHKHD-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
156404,6wiq,DB13050,-9.4,Tirilazad,RBKASMJPSJDQKY-RBFSKHHSSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
81231,6m3m,DB00957,-9.4,Norgestimate,KIQQMECNKUGGKA-NMYWJIRASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
78961,6m2n,DB12513,-9.4,Omaveloxolone,RJCWBNBKOKFWNY-IDPLTSGASA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
59726,6crv,DB07804,-9.4,"5-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1H-1,2,4-TRIAZOLE-3-SULFONAMIDE",FKCQUVAGEOSYRU-QWRGUYRKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
83707,6m3m,DB04238,-9.4,N-Alpha-(2-Naphthylsulfonyl)-N-(3-Amidino-L-Phenylalaninyl)-D-Pipecolinic Acid,GNANSBQAIRJZPA-XZOQPEGZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81072,6m3m,DB00776,-9.4,Oxcarbazepine,CTRLABGOLIVAIY-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83709,6m3m,DB04240,-9.4,"(1S)-1-C-{(2R)-6-[(2R)-2-Butanyl]-5,10-dihydroxy-4-oxo-1,2,3,4-tetrahydro-2-anthracenyl}-5-deoxy-1-O-methyl-D-xylulose",XGORHSPGULYMCV-HHYQQTLHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83713,6m3m,DB04244,-9.4,(2R)-2-(3-Biphenylyl)-N-{(2R)-2-hydroxy-3-[(2-pyridinylsulfonyl)amino]propyl}-4-methylpentanamide,YCDHZDINQZLSRR-DNQXCXABSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83720,6m3m,DB04258,-9.4,Seocalcitol,LVLLALCJVJNGQQ-SEODYNFXSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
78990,6m2n,DB12558,-9.4,AEE-788,OONFNUWBHFSNBT-HXUWFJFHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78991,6m2n,DB12561,-9.4,WNT-974,XXYGTCZJJLTAGH-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
73371,6m2n,DB01948,-9.4,"1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperidin-4-Yl-3,4-Dihydroquinolin-2(1h)-One",VXIYTVJEIXMAQF-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
62419,6crv,DB13551,-9.4,Cinchophen,YTRMTPPVNRALON-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62452,6crv,DB13600,-9.4,Deltamethrin,OWZREIFADZCYQD-NSHGMRRFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
83787,6m3m,DB04348,-9.4,Taurocholic Acid,WBWWGRHZICKQGZ-HZAMXZRMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
73660,6m2n,DB02331,-9.4,"(2s)-2-[(5-Benzofuran-2-Yl-Thiophen-2-Ylmethyl)-(2,4-Dichloro-Benzoyl)-Amino]-3-Phenyl-Propionic Acid",YBULOUKTPCHXAL-DEOSSOPVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
59866,6crv,DB07967,-9.4,9-CYCLOPENTYL-6-[2-(3-IMIDAZOL-1-YL-PROPOXY)-PHENYLAMINO]-9H-PURINE-2-CARBONITRILE,JJNKDTWKWYLERH-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78552,6m2n,DB11921,-9.4,Deflazacort,FBHSPRKOSMHSIF-GRMWVWQJSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
136029,6w9c,DB06350,-9.4,Elinogrel,LGSDFTPAICUONK-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
61393,6crv,DB12020,-9.4,Tecovirimat,CSKDFZIMJXRJGH-VWLPUNTISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81704,6m3m,DB01573,-9.4,Benzylmorphine,RDJGWRFTDZZXSM-RNWLQCGYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
159840,7bv1,DB06677,-9.4,Clazosentan,LFWCJABOXHSRGC-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
81703,6m3m,DB01572,-9.4,Methyl-1-testosterone,JRNSSSJKIGAFCT-YDSAWKJFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
138459,6w9c,DB11692,-9.4,Pavinetant,QYTBBBAHNIWFOD-NRFANRHFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
78193,6m2n,DB11176,-9.4,Zeaxanthin,JKQXZKUSFCKOGQ-QAYBQHTQSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
136203,6w9c,DB06745,-9.4,ginkgolide-C,AMOGMTLMADGEOQ-DTDWCABLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136201,6w9c,DB06743,-9.4,Ginkgolide A,FPUXKXIZEIDQKW-VKMVSBOZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
76936,6m2n,DB07789,-9.4,"1-[5-methyl-2-(trifluoromethyl)furan-3-yl]-3-[(2Z)-5-(2-{[6-(1H-1,2,4-triazol-3-ylamino)pyrimidin-4-yl]amino}ethyl)-1,3-thiazol-2(3H)-ylidene]urea",KNTGXMNWVXZIMW-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
81671,6m3m,DB01540,-9.4,17alpha-methyl-4-hydroxynandrolone,CLNUZOCYKSHICX-FAHHUNKHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
138828,6w9c,DB12318,-9.4,BMS-599626,LUJZZYWHBDHDQX-QFIPXVFZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
76873,6m2n,DB07716,-9.4,"(4Z)-2,8:7,12:11,15:14,18:17,22-PENTAANHYDRO-4,5,6,9,10,13,19,20,21-NONADEOXY-D-ARABINO-D-ALLO-D-ALLO-DOCOSA-4,9,20-TRIENITOL",VDRIXSJOPKVWKM-HXGIDPQASA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76851,6m2n,DB07691,-9.4,"2-({[3-(3,4-dihydroisoquinolin-2(1H)-ylsulfonyl)phenyl]carbonyl}amino)benzoic acid",GYILVHHTCYNIOS-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61366,6crv,DB11979,-9.4,Elagolix,HEAUOKZIVMZVQL-VWLOTQADSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76823,6m2n,DB07653,-9.4,"N-(5,6-DIPHENYLFURO[2,3-D]PYRIMIDIN-4-YL)GLYCINE",VXTCEUDVOCLEJG-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
136184,6w9c,DB06718,-9.4,Stanozolol,LKAJKIOFIWVMDJ-IYRCEVNGSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
78270,6m2n,DB11424,-9.4,Lufenuron,PWPJGUXAGUPAHP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
136183,6w9c,DB06717,-9.4,Fosaprepitant,BARDROPHSZEBKC-OITMNORJSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138439,6w9c,DB11666,-9.4,Buparlisib,CWHUFRVAEUJCEF-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
76780,6m2n,DB07607,-9.4,4-[5-(3-IODO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-1H-IMIDAZOL-4-YL]-PYRIDINE,RXDZANYWRNIAOR-HHHXNRCGSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78307,6m2n,DB11487,-9.4,Dexamethasone isonicotinate,BQTXJHAJMDGOFI-NJLPOHDGSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61617,6crv,DB12339,-9.4,Radezolid,BTTNOGHPGJANSW-IBGZPJMESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59623,6crv,DB07685,-9.4,"4-{[5-(CYCLOHEXYLMETHOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE",NMAZGYDYIYLSLJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76750,6m2n,DB07567,-9.4,"(2R,3R,4S)-3-(4-HYDROXYPHENYL)-4-METHYL-2-[4-(2-PYRROLIDIN-1-YLETHOXY)PHENYL]CHROMAN-6-OL",XPVKGTWRXBSJKO-LHXLBICKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76732,6m2n,DB07545,-9.4,N-{3-[(4-{[3-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-2-YL)AMINO]PHENYL}CYCLOPROPANECARBOXAMIDE,RDTDWGQDFJPTPD-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78108,6m2n,DB09274,-9.4,Artesunate,FIHJKUPKCHIPAT-AHIGJZGOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77089,6m2n,DB07966,-9.4,[4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]quinazolin-2-yl}amino)phenyl]acetonitrile,NVMCVWOODOWOLT-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77090,6m2n,DB07967,-9.4,9-CYCLOPENTYL-6-[2-(3-IMIDAZOL-1-YL-PROPOXY)-PHENYLAMINO]-9H-PURINE-2-CARBONITRILE,JJNKDTWKWYLERH-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77093,6m2n,DB07970,-9.4,5-[(2-methyl-5-{[3-(trifluoromethyl)phenyl]carbamoyl}phenyl)amino]pyridine-3-carboxamide,SAAYRHKJHDIDPH-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
82038,6m3m,DB02021,-9.4,Fidarestat,WAAPEIZFCHNLKK-UFBFGSQYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
77710,6m2n,DB08709,-9.4,"2,3-diphenyl-1H-indole-7-carboxylic acid",OLUDUXWVPIEHDA-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
136341,6w9c,DB07006,-9.4,"9-HYDROXY-6-(3-HYDROXYPROPYL)-4-(2-METHOXYPHENYL)PYRROLO[3,4-C]CARBAZOLE-1,3(2H,6H)-DIONE",AOGOZJCRIFBTTN-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
77842,6m2n,DB08875,-9.4,Cabozantinib,ONIQOQHATWINJY-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77628,6m2n,DB08607,-9.4,"(5R)-5-(4-{[(2R)-6-HYDROXY-2,5,7,8-TETRAMETHYL-3,4-DIHYDRO-2H-CHROMEN-2-YL]METHOXY}BENZYL)-1,3-THIAZOLIDINE-2,4-DIONE",GXPHKUHSUJUWKP-NTKDMRAZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
136351,6w9c,DB07019,-9.4,"N-[(5R,14R)-5-AMINO-5,14-DIMETHYL-4-OXO-3-OXA-18-AZATRICYCLO[15.3.1.1-7,11-]DOCOSA-1(21),7(22),8,10,17,19-HEXAEN-19-YL]-N-METHYLMETHANESULFONAMIDE",QWDOKZPZLWNULU-MZNJEOGPSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138529,6w9c,DB11796,-9.4,Fostemsavir,SWMDAPWAQQTBOG-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
149286,6w9q,DB15305,-9.4,Risdiplam,ASKZRYGFUPSJPN-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
81892,6m3m,DB01820,-9.4,"Compound 12, N-Acetyl-4-[(Carboxycarbonyl)(2-Carboxyphenyl)Amino]-N-Pentyl-1-Napthylalaniamide",UESXELNYBIOROE-QHCPKHFHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
77935,6m2n,DB09003,-9.4,Clocapramine,QAZKXHSIKKNOHH-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77961,6m2n,DB09042,-9.4,Tedizolid phosphate,QCGUSIANLFXSGE-GFCCVEGCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
24847,6cs2,DB02651,-9.4,"{[2-(1h-1,2,3-Benzotriazol-1-Yl)-2-(3,4-Difluorophenyl)Propane-1,3-Diyl]Bis[4,1-Phenylene(Difluoromethylene)]}Bis(Phosphonic Acid)",BTAGTGWPDROBMG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
138410,6w9c,DB11611,-9.4,Lifitegrast,JFOZKMSJYSPYLN-QHCPKHFHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
61407,6crv,DB12043,-9.4,Sepetaprost,BKVUSNOUTQMSBE-XCMGCKIWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61521,6crv,DB12211,-9.4,PSI-697,DIEPFYNZGUUVHD-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77336,6m2n,DB08248,-9.4,3-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)-BENZENESULFONAMIDE,BKDUVKJYBJDZQW-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61534,6crv,DB12229,-9.4,Cerlapirdine,NXQGEDVQXVTCDA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59672,6crv,DB07743,-9.4,"S-[5-(TRIFLUOROMETHYL)-4H-1,2,4-TRIAZOL-3-YL] 5-(PHENYLETHYNYL)FURAN-2-CARBOTHIOATE",VNGWUVBXUIDQTK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77979,6m2n,DB09074,-9.4,Olaparib,FDLYAMZZIXQODN-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77248,6m2n,DB08143,-9.4,"5-CHLORO-THIOPHENE-2-CARBOXYLIC ACID ((3S,4S)-4-FLUORO- 1-{[2-FLUORO-4-(2-OXO-2H-PYRIDIN-1-YL)-PHENYLCARBAMOYL]-METHYL}-PYRROLIDIN-3-YL)-AMIDE",SXIYSYYSKHUTQQ-RDJZCZTQSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77103,6m2n,DB07982,-9.4,2-{4-[4-({4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]pyrimidin-2-yl}amino)phenyl]piperazin-1-yl}-2-oxoethanol,PVTKDXZNSUHUMO-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77101,6m2n,DB07978,-9.4,"2-({[2,3,5,6-TETRAFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)CYCLOPENTA-1,3-DIENE-1-CARBOXYLIC ACID",ULMUPVXFUDHRGH-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78079,6m2n,DB09231,-9.4,Benidipine,QZVNQOLPLYWLHQ-ZEQKJWHPSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77098,6m2n,DB07975,-9.4,"2-({[3,5-DIFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)CYCLOPENT-1-ENE-1-CARBOXYLIC ACID",VTGXLCZUWFYELR-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
81808,6m3m,DB01708,-9.4,Prasterone,FMGSKLZLMKYGDP-USOAJAOKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81795,6m3m,DB01691,-9.4,Indole Naphthyridinone,VAZMNDXVXVUKFY-JXMROGBWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
77372,6m2n,DB08299,-9.4,"4-[8-(3-nitrophenyl)-1,7-naphthyridin-6-yl]benzoic acid",QTNUWEKKZHSUQO-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76659,6m2n,DB07458,-9.4,"3-(1H-indol-3-yl)-4-{1-[2-(1-methylpyrrolidin-2-yl)ethyl]-1H-indol-3-yl}-1H-pyrrole-2,5-dione",LBFDERUQORUFIN-KRWDZBQOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61349,6crv,DB11951,-9.4,Lemborexant,MUGXRYIUWFITCP-PGRDOPGGSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138400,6w9c,DB11577,-9.4,Indigotindisulfonic Acid,CFZXDJWFRVEWSR-BUHFOSPRSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
61301,6crv,DB11885,-9.4,Anlotinib,KSMZEXLVHXZPEF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78493,6m2n,DB11832,-9.4,Crenolanib,DYNHJHQFHQTFTP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76296,6m2n,DB07041,-9.4,"N-[2-(2,4-diaminopyrido[2,3-d]pyrimidin-7-yl)-2-methylpropyl]-4-phenoxybenzamide",FDJWFDQRPKKBFA-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76286,6m2n,DB07031,-9.4,"3-Fluoro-4-{[(2R)-2-hydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthalenyl)acetyl]amino}benzoic acid",AANFHDFOMFRLLR-LJQANCHMSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61671,6crv,DB12416,-9.4,VTP-27999,NXWASIVXQMMPLM-ZXMXYHOLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
82784,6m3m,DB02998,-9.4,Metribolone,CCCIJQPRIXGQOE-XWSJACJDSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136468,6w9c,DB07152,-9.4,N-[4-(5-fluoro-6-methylpyridin-2-yl)-5-quinoxalin-6-yl-1H-imidazol-2-yl]acetamide,TYPILNNEZPSNTI-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
76194,6m2n,DB06920,-9.4,Eribaxaban,QQBKAVAGLMGMHI-WIYYLYMNSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76159,6m2n,DB06882,-9.4,1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-naphthalen-1-ylurea,HJWMLCDGRWWLAQ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76128,6m2n,DB06844,-9.4,"4-[(7-OXO-7H-THIAZOLO[5,4-E]INDOL-8-YLMETHYL)-AMINO]-N-PYRIDIN-2-YL-BENZENESULFONAMIDE",MBXKBJLIESPLIK-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
59817,6crv,DB07909,-9.4,"(1S,2S,5S)2-(4-GLUTARIDYLBENZYL)-5-PHENYL-1-CYCLOHEXANOL",OBWILOKKNDYPLX-HBMCJLEFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136053,6w9c,DB06429,-9.4,Talnetant,BIAVGWDGIJKWRM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
76384,6m2n,DB07142,-9.4,"5-[(3R)-3-(5-methoxy-3',5'-dimethylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",ATFDKOLABYIYCC-INIZCTEOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61273,6crv,DB11841,-9.4,Entinostat,INVTYAOGFAGBOE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
82812,6m3m,DB03041,-9.4,UDP-alpha-D-glucuronic acid,HDYANYHVCAPMJV-LXQIFKJMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
78521,6m2n,DB11877,-9.4,Basmisanil,VCGRFBXVSFAGGA-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61720,6crv,DB12483,-9.4,Copanlisib,PZBCKZWLPGJMAO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78526,6m2n,DB11886,-9.4,Infigratinib,QADPYRIHXKWUSV-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76056,6m2n,DB06721,-9.4,Gimatecan,UIVFUQKYVFCEKJ-OPTOVBNMSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76055,6m2n,DB06718,-9.4,Stanozolol,LKAJKIOFIWVMDJ-IYRCEVNGSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61249,6crv,DB11806,-9.4,VTP-194204,BOOOLEGQBVUTKC-NVQSDHBMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136034,6w9c,DB06367,-9.4,Relacatib,BWYBBMQLUKXECQ-GIVPXCGWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
61738,6crv,DB12515,-9.4,9-aminocamptothecin,FUXVKZWTXQUGMW-FQEVSTJZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61241,6crv,DB11795,-9.4,GSK-2636771,XTKLTGBKIDQGQL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136032,6w9c,DB06362,-9.4,Becatecarin,JSKFWUPVIZYJMR-UDOAKELVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
81516,6m3m,DB01328,-9.4,Cefonicid,DYAIAHUQIPBDIP-AXAPSJFSSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
18249,6cs2,HMDB0015016,-9.4,Chlorhexidine,GHXZTYHSJHQHIJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
72832,6m2n,DB01199,-9.4,Tubocurarine,JFJZZMVDLULRGK-URLMMPGGSA-O,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61648,6crv,DB12388,-9.4,Evocalcet,RZNUIYPHQFXBAN-XLIONFOSSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76477,6m2n,DB07252,-9.4,"3-({4-[(5-chloro-1,3-benzodioxol-4-yl)amino]pyrimidin-2-yl}amino)benzenesulfonamide",TZHCXOMEOHEZDX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61623,6crv,DB12350,-9.4,Rostafuroxin,AEAPORIZZWBIEX-DTBDINHYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78400,6m2n,DB11697,-9.4,Pacritinib,HWXVIOGONBBTBY-ONEGZZNKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
82535,6m3m,DB02668,-9.4,"Je-2147, Ag1776, Kni-764",CUFQBQOBLVLKRF-RZDMPUFOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
138909,6w9c,DB12432,-9.4,CC-401,XDJCLCLBSGGNKS-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
76618,6m2n,DB07410,-9.4,[2-(3-DIBENZOFURAN-4-YL-PHENYL)-1-HYDROXY-1-PHOSPHONO-ETHYL]-PHOSPHONIC ACID,BYVXAUZOTGITQZ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
82562,6m3m,DB02703,-9.4,Fusidic acid,IECPWNUMDGFDKC-MZJAQBGESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59600,6crv,DB07654,-9.4,"(5,6-DIPHENYL-FURO[2,3-D]PYRIMIDIN-4-YLAMINO)-ACETIC",VDJWWYRYKMXMKA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138915,6w9c,DB12558,-9.4,AEE-788,OONFNUWBHFSNBT-HXUWFJFHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
78418,6m2n,DB11730,-9.4,Ribociclib,RHXHGRAEPCAFML-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138923,6w9c,DB12571,-9.4,Rimacalib,MYTIJGWONQOOLC-HNNXBMFYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
81619,6m3m,DB01479,-9.4,BA-2664,QGKQXZFZOIQFBI-XSWYFRFISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
78428,6m2n,DB11742,-9.4,Ebastine,MJJALKDDGIKVBE-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78476,6m2n,DB11814,-9.4,PF-03882845,XNULRSOGWPFPBL-REWPJTCUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
59541,6crv,DB07586,-9.4,"5-(4-METHYL-BENZOYLAMINO)-BIPHENYL-3,4'-DICARBOXYLIC ACID 3-DIMETHYLAMIDE-4'-HYDROXYAMIDE",DOPFUKKMSDUVTQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61306,6crv,DB11892,-9.4,Prulifloxacin,PWNMXPDKBYZCOO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138942,6w9c,DB12598,-9.4,Nafamostat,MQQNFDZXWVTQEH-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
82624,6m3m,DB02790,-9.4,Phenyl-Uridine-5'-Diphosphate,ZHUWBKDWWGKIEN-FMKGYKFTSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
76519,6m2n,DB07297,-9.4,"5,6-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-D]PYRIMIDIN-4-AMINE",PTILEOLOGGMFCS-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76516,6m2n,DB07294,-9.4,"3-fluoro-4-[2-hydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8,-tetrahydro-naphtalen-2-yl)-acetylamino]-benzoic acid",AANFHDFOMFRLLR-IBGZPJMESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
82652,6m3m,DB02827,-9.4,"7-(1,1-Dioxo-1h-Benzo[D]Isothiazol-3-Yloxymethyl)-2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Pyran-3-Carboxylic Acid",MDYIGSPVMWSFEZ-JTQLQIEISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
76481,6m2n,DB07256,-9.4,"3-({4-[(5-CHLORO-1,3-BENZODIOXOL-4-YL)AMINO]PYRIMIDIN-2-YL}AMINO)BENZAMIDE",ZVQZIVCQLFGXFZ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
136090,6w9c,DB06521,-9.4,Ertiprotafib,FONCZICQWCUXEB-RUZDIDTESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138970,6w9c,DB12649,-9.4,Ibipinabant,AXJQVVLKUYCICH-OAQYLSRUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
82690,6m3m,DB02877,-9.4,Arotinoid acid,FOIVPCKZDPCJJY-JQIJEIRASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
61305,6crv,DB11891,-9.4,CUDC-907,JOWXJLIFIIOYMS-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
82695,6m3m,DB02882,-9.4,Cyanocinnoline,CUWRVIIPSSUUDJ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
76541,6m2n,DB07321,-9.4,"2,5-DICHLORO-N-[5-METHOXY-7-(6-METHOXYPYRIDIN-3-YL)-1,3-BENZOXAZOL-2-YL]BENZENESULFONAMIDE",KOKQLKWXOFRTHE-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
159278,7bv1,DB03678,-9.4,"(6,7-Difluoro-Quinazolin-4-Yl)-(1-Methyl-2,2-Diphenyl-Ethyl)-Amine",WVGZKPGUHOZIJQ-HNNXBMFYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
82005,6m3m,DB01975,-9.4,AMPCPR,ZPZRETFSCSWNDT-DBXCYWGHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80641,6m3m,DB00253,-9.4,Medrysone,GZENKSODFLBBHQ-ILSZZQPISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
63002,6crv,DB14903,-9.4,Rovafovir etalafenamide,OCJRRXHWPBXZSU-BJBBEUPESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84327,6m3m,DB05532,-9.4,BMS-488043,DBPMWRYLTBNCCE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
79337,6m2n,DB13101,-9.4,4SC-202,PRXXYMVLYKJITB-IZZDOVSWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
140779,6w9c,DB15294,-9.4,SB-1578,NNXDIGHYPZHXTR-ONEGZZNKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
67560,6lxt,DB06896,-9.4,"1-(4-fluorophenyl)-N-[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]-2-oxo-1,2-dihydropyridine-3-carboxamide",OBSFXHDOLBYWRJ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
71517,6lxt,DB14676,-9.4,Fagrocorat,QJJBNCHSWFGXML-KEKPKEOLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
140752,6w9c,DB15238,-9.4,Olinciguat,YWQFJNWMWZMXRW-HXUWFJFHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136848,6w9c,DB07608,-9.4,N-(5-{[(2S)-4-amino-2-(3-chlorophenyl)butanoyl]amino}-1H-indazol-3-yl)benzamide,JDGOPNUGILVNJZ-IBGZPJMESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
67399,6lxt,DB06634,-9.4,Casopitant,XGGTZCKQRWXCHW-WMTVXVAQSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
84523,6m3m,DB06401,-9.4,Bazedoxifene,UCJGJABZCDBEDK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84359,6m3m,DB05713,-9.4,LY-517717,VYNKVNDKAOGAAQ-RUZDIDTESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59133,6crv,DB07113,-9.4,"(2S)-6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2-(3,5-DIFLUOROPHENYL)-4-(3-METHOXYPROPYL)-2H-1,4-BENZOXAZIN-3(4H)-ONE",KHZQOXQOUCGGGA-NRFANRHFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140483,6w9c,DB11430,-9.4,Monensin,GAOZTHIDHYLHMS-KEOBGNEYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
158007,7bv1,DB00266,-9.4,Dicoumarol,DOBMPNYZJYQDGZ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60104,6crv,DB08239,-9.4,"(2S)-4-(2,5-DIFLUOROPHENYL)-N-METHYL-2-PHENYL-N-PIPERIDIN-4-YL-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDE",NKLVBHMAIMEVEH-QFIPXVFZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
70661,6lxt,DB13005,-9.4,Rebastinib,WVXNSAVVKYZVOE-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
70587,6lxt,DB12892,-9.4,MGB-BP-3,OEKXCVYZBVOWBR-BQYQJAHWSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
68538,6lxt,DB08031,-9.4,"N-[(13-CYCLOHEXYL-6,7-DIHYDROINDOLO[1,2-D][1,4]BENZOXAZEPIN-10-YL)CARBONYL]-2-METHYL-L-ALANINE",LNQWELVSNCYKDU-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
60234,6crv,DB08402,-9.4,"2-[(2,4-DICHLOROBENZOYL)AMINO]-5-(PYRIMIDIN-2-YLOXY)BENZOIC ACID",VNDRRWBKNSHALL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
70573,6lxt,DB12874,-9.4,Quizartinib,CVWXJKQAOSCOAB-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
80409,6m2n,DB15297,-9.4,Petesicatib,KXAAIORSMACJSI-AEFFLSMTSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79327,6m2n,DB13088,-9.4,AZD-0424,MVWATCATLSSVBH-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79307,6m2n,DB13059,-9.4,PF-03814735,RYYNGWLOYLRZLK-RBUKOAKNSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
63190,6crv,DB15307,-9.4,Atabecestat,VLLFGVHGKLDDLW-SFHVURJKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
137003,6w9c,DB07789,-9.4,"1-[5-methyl-2-(trifluoromethyl)furan-3-yl]-3-[(2Z)-5-(2-{[6-(1H-1,2,4-triazol-3-ylamino)pyrimidin-4-yl]amino}ethyl)-1,3-thiazol-2(3H)-ylidene]urea",KNTGXMNWVXZIMW-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
80744,6m3m,DB00378,-9.4,Dydrogesterone,JGMOKGBVKVMRFX-HQZYFCCVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
71820,6lxt,DB15343,-9.4,HM-43239,FZLSDZZNPXXBBB-KDURUIRLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
80278,6m2n,DB15046,-9.4,LY-2881835,FHRWHNJJQGSCQC-LJAQVGFWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
60351,6crv,DB08542,-9.4,"3,4-dihydroxy-9,10-secoandrosta-1(10),2,4-triene-9,17-dione",YUHVBHDSVLKFNI-NJSLBKSFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80270,6m2n,DB15031,-9.4,Nemorexant,NBGABHGMJVIVBW-QHCPKHFHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80687,6m3m,DB00307,-9.4,Bexarotene,NAVMQTYZDKMPEU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80269,6m2n,DB15029,-9.4,AZD-8186,LMJFJIDLEAWOQJ-CQSZACIVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
140381,6w9c,DB05838,-9.4,OPC-51803,INGXCNVWWKKWOO-LJQANCHMSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
79318,6m2n,DB13072,-9.4,GDC-0349,RGJOJUGRHPQXGF-INIZCTEOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80113,6m2n,DB14661,-9.4,Loperamide oxide,KXVSBTJVTUVNPM-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
71650,6lxt,DB15011,-9.4,Avacopan,PUKBOVABABRILL-YZNIXAGQSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
71610,6lxt,DB14896,-9.4,Selitrectinib,OEBIHOVSAMBXIB-SJKOYZFVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
67182,6lxt,DB06011,-9.4,AMG-222,NVSWJKWHLUTHLP-CPJSRVTESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
67247,6lxt,DB06240,-9.4,Tariquidar,LGGHDPFKSSRQNS-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
80263,6m2n,DB15013,-9.4,TAK-243,KJDAGXLMHXUAGV-DGWLBADLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
67179,6lxt,DB05984,-9.4,RAF-265,YABJJWZLRMPFSI-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
60237,6crv,DB08407,-9.4,PLATENSIMYCIN,CSOMAHTTWTVBFL-OFBLZTNGSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60375,6crv,DB08572,-9.4,4-{[4-AMINO-6-(CYCLOHEXYLMETHOXY)-5-NITROSOPYRIMIDIN-2-YL]AMINO}BENZAMIDE,YBKLJTXDSBEVRV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
70468,6lxt,DB12703,-9.4,Omipalisib,CGBJSGAELGCMKE-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
140581,6w9c,DB12480,-9.4,Betulinic Acid,QGJZLNKBHJESQX-FZFNOLFKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
144664,6w9q,DB05984,-9.4,RAF-265,YABJJWZLRMPFSI-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
69977,6lxt,DB11977,-9.4,Golvatinib,UQRCJCNVNUFYDX-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
22779,6cs2,HMDB0001846,-9.4,Tetrahydrofolic acid,MSTNYGQPCMXVAQ-PXYINDEMSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
79915,6m2n,DB13953,-9.4,Estradiol benzoate,UYIFTLBWAOGQBI-BZDYCCQFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
69971,6lxt,DB11965,-9.4,SJG-136,RWZVMMQNDHPRQD-SFTDATJTSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
60511,6crv,DB08735,-9.4,"R,S-Warfarin alcohol",ZUJMMGHIYSAEOU-SWLSCSKDSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59047,6crv,DB07014,-9.4,"2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4-methoxybenzyl)sulfanyl]-1,3,4-oxadiazole",TUTZKAQTSPMEBI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140570,6w9c,DB12467,-9.4,TU-100,KAYRGFYBCCETPE-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
79955,6m2n,DB14034,-9.4,Darglitazone,QQKNSPHAFATFNQ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
84473,6m3m,DB06248,-9.4,Amelubant,SBVYURPQULDJTI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
140662,6w9c,DB13061,-9.4,MLN8054,HHFBDROWDBDFBR-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
80488,6m2n,DB15460,-9.4,AGG-523,JWQMTWCFNZSLNR-DEOSSOPVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
158235,7bv1,DB00762,-9.4,Irinotecan,UWKQSNNFCGGAFS-XIFFEERXSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60153,6crv,DB08304,-9.4,"(3R)-3-cyclopentyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2-benzothiazine 1,1-dioxide",QZBQVXXESPXFPZ-QGZVFWFLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
63119,6crv,DB15170,-9.4,Evobrutinib,QUIWHXQETADMGN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80147,6m2n,DB14729,-9.4,Rebeccamycin,QEHOIJJIZXRMAN-QZQSLCQPSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
69815,6lxt,DB11740,-9.4,MK-1775,BKWJAKQVGHWELA-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
69894,6lxt,DB11852,-9.4,Tegobuvir,XBEQSQDCBSKCHJ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
59102,6crv,DB07076,-9.4,6-[(Z)-AMINO(IMINO)METHYL]-N-[3-(CYCLOPENTYLOXY)PHENYL]-2-NAPHTHAMIDE,FWTQOPWAMQXIMI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59035,6crv,DB07000,-9.4,"N-{2,4-difluoro-3-[(5-pyridin-3-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)carbonyl]phenyl}ethanesulfonamide",ILXJWLWSYAWJKZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
70146,6lxt,DB12228,-9.4,Telcagepant,CGDZXLJGHVKVIE-DNVCBOLYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
114839,6vxx,DB14989,-9.4,Umbralisib,IUVCFHHAEHNCFT-INIZCTEOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
158827,7bv1,DB02269,-9.4,[4-({[5-Benzyloxy-1-(3-Carbamimidoyl-Benzyl)-1h-Indole-2-Carbonyl]-Amino}-Methyl)-Phenyl]-Trimethyl-Ammonium,UFKJQTGPBFWMGT-UHFFFAOYSA-O,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
26371,6cs2,DB04495,-9.4,RU81843,GGPXNASQNUOIPB-NSOVKSMOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
80210,6m2n,DB14876,-9.4,TAS-116,NVVPMZUGELHVMH-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
70465,6lxt,DB12694,-9.4,CE-326597,UBNMGTSDHSQBEL-PMERELPUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
79599,6m2n,DB13491,-9.4,Fluperolone,SLVCCRYLKTYUQP-DVTGEIKXSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
63046,6crv,DB15031,-9.4,Nemorexant,NBGABHGMJVIVBW-QHCPKHFHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
63143,6crv,DB15219,-9.4,Tomivosertib,HKTBYUWLRDZAJK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
25652,6cs2,DB03642,-9.4,Benzofuran-2-Carboxylic Acid {(S)-3-Methyl-1-[3-Oxo-1-(Pyridin-2-Ylsulfonyl)Azepan-4-Ylcarbamoyl]Butyl}Amide,VBPPNJCVXGAZDD-PMACEKPBSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
135227,6w9c,DB04154,-9.4,"N-Methyl-N-[3-(6-Phenyl[1,2,4]Triazolo[4,3-B]Pyridazin-3-Yl)Phenyl]Acetamide",ALBWBHNFOJJMCV-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
60200,6crv,DB08361,-9.4,"2-{[(1R,2S)-2-aminocyclohexyl]amino}-4-[(3-methylphenyl)amino]pyrimidine-5-carboxamide",NZNTWOVDIXCHHS-LSDHHAIUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84407,6m3m,DB06077,-9.4,Lumateperone,HOIIHACBCFLJET-SFTDATJTSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
145073,6w9q,DB06925,-9.4,3-(2-AMINOQUINAZOLIN-6-YL)-4-METHYL-N-[3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE,YEIASMOUYNOXGA-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
136961,6w9c,DB07741,-9.4,"4-(1R,3AS,4R,8AS,8BR)-[1-DIFLUOROMETHYL-2-(4-FLUOROBENZYL)-3-OXODECAHYDROPYRROLO[3,4-A]PYRROLIZIN-4-YL]BENZAMIDINE",VPNYXOTTXAXSIH-SXYSDOLCSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137392,6w9c,DB08237,-9.4,2'-deoxy-N-(naphthalen-1-ylmethyl)guanosine 5'-(dihydrogen phosphate),COMPKRGNHXOXMN-GVDBMIGSSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
80634,6m3m,DB00246,-9.4,Ziprasidone,MVWVFYHBGMAFLY-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
63059,6crv,DB15055,-9.4,ABT-639,AGPIHNZOZNKRGT-CYBMUJFWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59083,6crv,DB07053,-9.4,2-{5-[3-(7-PROPYL-3-TRIFLUOROMETHYLBENZO[D]ISOXAZOL-6-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID,TWVYNPULGKGJOS-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80443,6m2n,DB15362,-9.4,LSZ-102,SJXNPGGVGZXKKI-NYYWCZLTSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
59160,6crv,DB07142,-9.4,"5-[(3R)-3-(5-methoxy-3',5'-dimethylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",ATFDKOLABYIYCC-INIZCTEOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
71661,6lxt,DB15034,-9.4,PRI-724,VHOZWHQPEJGPCC-AZXNYEMZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
136766,6w9c,DB07507,-9.4,"2-(4-hydroxybiphenyl-3-yl)-4-methyl-1H-isoindole-1,3(2H)-dione",ROMNEYAQUBNRLR-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
63237,6crv,DB15408,-9.4,Silmitasertib,MUOKSQABCJCOPU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
146186,6w9q,DB08220,-9.4,"(8alpha,10alpha,13alpha,17beta)-17-[(4-hydroxyphenyl)carbonyl]androsta-3,5-diene-3-carboxylic acid",RPNNXCYIESWDSC-JRZBRKEGSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
79290,6m2n,DB13029,-9.4,MK-0873,JJWKQXNHYDJXKF-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137535,6w9c,DB08418,-9.4,"(4aS,4bR,10bS,12aS)-12a-methyl-1,3-dioxo-2-(pyridin-3-ylmethyl)-1,2,3,4,4a,4b,5,6,10b,11,12,12a-dodecahydronaphtho[2,1-f]isoquinolin-8-yl sulfamate",LSJKARAMQNGZDF-YOEKFXIASA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140125,6w9c,DB15029,-9.4,AZD-8186,LMJFJIDLEAWOQJ-CQSZACIVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137526,6w9c,DB08406,-9.4,"[N-(2,4-DIAMINOPTERIDIN-6-YL)-METHYL]-DIBENZ[B,F]AZEPINE",NXCCIJQEAKMFGW-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
64793,6lxt,DB01988,-9.4,6((S)-3-Benzylpiperazin-1-Yl)-3-(Naphthalen-2-Yl)-4-(Pyridin-4-Yl)Pyrazine,WFSFNKVFXLIZIY-MHZLTWQESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
64726,6lxt,DB01897,-9.4,2-(2f-Benzothiazolyl)-5-Styryl-3-(4f-Phthalhydrazidyl)Tetrazolium Chloride,BEIGFKLRGRRJJA-JLHYYAGUSA-O,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
64716,6lxt,DB01879,-9.4,(S)-2-{Methyl-[2-(Naphthalene-2-Sulfonylamino)-5-(Naphthalene-2-Sulfonyloxy)-Benzoyl]-Amino}-Succinicacid,JOAALZBSMWLOPQ-LJAQVGFWSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
64556,6lxt,DB01669,-9.4,Virginiamycin M1,DAIKHDNSXMZDCU-FQTGFAPKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
136767,6w9c,DB07508,-9.4,4-(5-BENZENESULFONYLAMINO-1-METHYL-1H-BENZOIMIDAZOL-2-YLMETHYL)-BENZAMIDINE,MEUAVGJWGDPTLF-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
60282,6crv,DB08462,-9.4,N-(4-PHENYLAMINO-QUINAZOLIN-6-YL)-ACRYLAMIDE,JGWHILNNHLDARR-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59173,6crv,DB07157,-9.4,"(5R,6S,8S)-8-[3-(AMINOMETHYL)PHENYL]-6-HYDROXY-5-ISOPROPYL-3-OXO-1-PHENYL-2,7-DIOXA-4-AZA-6-PHOSPHANONAN-9-OIC ACID 6-OXIDE",RTFGEFWZCFCODU-RBUKOAKNSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60309,6crv,DB08494,-9.4,"S-{2-[(2-chloro-4-sulfamoylphenyl)amino]-2-oxoethyl} 6-methyl-3,4-dihydroquinoline-1(2H)-carbothioate",AWAKIULNKVOBKE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
159217,7bv1,DB03591,-9.4,RU82209,LVZDQVATAQEMCX-NSOVKSMOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
72000,6m2n,DB00220,-9.4,Nelfinavir,QAGYKUNXZHXKMR-HKWSIXNMSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
60734,6crv,DB09038,-9.4,Empagliflozin,OBWASQILIWPZMG-QZMOQZSNSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
135546,6w9c,DB04608,-9.4,"9-HYDROXY-4-PHENYL-6H-PYRROLO[3,4-C]CARBAZOLE-1,3-DIONE",IAUZTOZLTFSMIE-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
72652,6m2n,DB00997,-9.4,Doxorubicin,AOJJSUZBOXZQNB-TZSSRYMLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
160437,7bv1,DB08386,-9.4,2-{[4-(4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline,VRWJZGHUCOFGPZ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
135557,6w9c,DB04623,-9.4,"2-ETHOXYETHYL (2S,3S)-4-((S)-2-BENZYL-3-OXO-4-((3AR,8R,8AS)-2-OXO-3,3A,8,8A-TETRAHYDRO-2H-INDENO[1,2-D]OXAZOL-8-YL)-2,3-DIHYDRO-1H-PYRROL-2-YL)-3-HYDROXY-1-PHENYLBUTAN-2-YLCARBAMATE",CGBRFCVAMLJVEA-ZGURCIGKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
59189,6crv,DB07175,-9.4,N-{2-methyl-5-[(6-phenylpyrimidin-4-yl)amino]phenyl}methanesulfonamide,CXQRKICWSCAUGW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140210,6w9c,DB15356,-9.4,SLV-334,LOFDNSDPZTVIIO-VPUSJEBWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
60681,6crv,DB08970,-9.4,Fluprednidene,YVHXHNGGPURVOS-SBTDHBFYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
142769,6w9q,DB02629,-9.4,Inhibitor Bea403,LYHLPPXMBKMSSZ-JQFCFGFHSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
140221,6w9c,DB15385,-9.4,Acebilustat,GERJIEKMNDGSCS-DQEYMECFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
60067,6crv,DB08191,-9.4,"4-(5-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl)benzoic acid",KSFDVNIKNYXUIP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60737,6crv,DB09042,-9.4,Tedizolid phosphate,QCGUSIANLFXSGE-GFCCVEGCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80946,6m3m,DB00624,-9.4,Testosterone,MUMGGOZAMZWBJJ-DYKIIFRCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80285,6m2n,DB15057,-9.4,NUC-1031,NHTKGYOMICWFQZ-KKQYNPQSSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137561,6w9c,DB08448,-9.4,"(4aS)-5-[(2,4-diaminopteridin-6-yl)methyl]-4a,5-dihydro-2H-dibenzo[b,f]azepin-8-ol",PCBWLKUEKANDCL-INIZCTEOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
80957,6m3m,DB00637,-9.4,Astemizole,GXDALQBWZGODGZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
140162,6w9c,DB15099,-9.4,GW-468816,XDKRVNKVAKCFGW-WXWBBQJKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
65609,6lxt,DB03067,-9.4,"4-{2,4-Bis[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid",VFYAZSTYKPFSFL-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
80918,6m3m,DB00590,-9.4,Doxazosin,RUZYUOTYCVRMRZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
65048,6lxt,DB02329,-9.4,Carbenoxolone,OBZHEBDUNPOCJG-WBXJDKIVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
62865,6crv,DB14635,-9.4,Curcumin sulfate,NEJVQQBBTRFOHB-FCXRPNKRSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72028,6m2n,DB00251,-9.4,Terconazole,BLSQLHNBWJLIBQ-OZXSUGGESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
140250,6w9c,DB15444,-9.4,Elexacaftor,MVRHVFSOIWFBTE-INIZCTEOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137494,6w9c,DB08366,-9.4,"3-({3-[(1S,4aS,6S,7S,9S,9aR)-1,6-dimethyl-2-oxodecahydro-6,9-epoxy-4a,7-methanobenzo[7]annulen-1-yl]propanoyl}amino)-2,4-dihydroxybenzoic acid",XADCWKSMHQPTGH-OFBLZTNGSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
80351,6m2n,DB15191,-9.4,MAX-40279,AVIOBQFPAGEICQ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80787,6m3m,DB00430,-9.4,Cefpiramide,PWAUCHMQEXVFJR-PMAPCBKXSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80317,6m2n,DB15121,-9.4,AT-001,YRGPAXAVTDMKDK-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
59164,6crv,DB07146,-9.4,"2,3-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-B]PYRIDIN-4-AMINE",QUIQCYFSBGOBKE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
135611,6w9c,DB04696,-9.4,"4-CHLORO-3',3''-DIBROMOPHENOL-1,8-NAPHTHALEIN",GFGZCXHXQCQRFP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140115,6w9c,DB15006,-9.4,Flufenoxuron,RYLHNOVXKPXDIP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
62948,6crv,DB14785,-9.4,Fenebrutinib,WNEODWDFDXWOLU-QHCPKHFHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
26452,6cs2,DB04591,-9.4,"N-{2,2-DIFLUORO-2-[(2R)-PIPERIDIN-2-YL]ETHYL}-2-[2-(1H-1,2,4-TRIAZOL-1-YL)BENZYL][1,3]OXAZOLO[4,5-C]PYRIDIN-4-AMINE",VYJOAYZRCNHDNG-GOSISDBHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
140244,6w9c,DB15431,-9.4,M-2698,HXAUJHZZPCBFPN-QGZVFWFLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
63194,6crv,DB15317,-9.4,Posiphen,PBHFNBQPZCRWQP-AZUAARDMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
63248,6crv,DB15431,-9.4,M-2698,HXAUJHZZPCBFPN-QGZVFWFLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
135612,6w9c,DB04698,-9.4,"N-(1,4-DIHYDRO-5H-TETRAZOL-5-YLIDENE)-9-OXO-9H-XANTHENE-2-SULFONAMIDE",HJWYZPGYPZNDTN-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
79253,6m2n,DB12973,-9.4,Serlopitant,FLNYCRJBCNNHRH-OIYLJQICSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
62692,6crv,DB13954,-9.4,Estradiol cypionate,UOACKFBJUYNSLK-XRKIENNPSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88338,6m3m,DB13667,-9.3,Cefozopran,QDUIJCOKQCCXQY-WHJQOFBOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
138565,6w9c,DB11847,-9.3,Cadazolid,XWFCFMXQTBGXQW-GOSISDBHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
97398,6m71,DB14792,-9.3,AZD-5991,KBQCEQAXHPIRTF-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60298,6crv,DB08481,-9.3,"4-METHYL-N-{(5E)-5-[(5-METHYL-2-FURYL)METHYLENE]-4-OXO-4,5-DIHYDRO-1,3-THIAZOL-2-YL}BENZENESULFONAMIDE",MXAPQGDBWFYKKX-ZROIWOOFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88347,6m3m,DB13676,-9.3,Mosapramine,PXUIZULXJVRBPC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
61438,6crv,DB12085,-9.3,LCL-161,UFPFGVNKHCLJJO-SSKFGXFMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60417,6crv,DB08622,-9.3,"4-(4-CHLORO-PHENYL)-1-{3-[2-(4-FLUORO-PHENYL)-[1,3]DITHIOLAN-2-YL]-PROPYL}-PIPERIDIN-4-OL",KVDKNVPAAQKHKD-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
97160,6m71,DB13997,-9.3,Baloxavir marboxil,RZVPBGBYGMDSBG-GGAORHGYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
87930,6m3m,DB13074,-9.3,Macimorelin,UJVDJAPJQWZRFR-DHIUTWEWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
61320,6crv,DB11910,-9.3,MK-0249,DDDZBLNULGDPGA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78481,6m2n,DB11819,-9.3,ASP-4058,NJNXCJPSMWKXHO-VIFPVBQESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
56846,6crv,DB02861,-9.3,"4-(Aminosulfonyl)-N-[(3,4,5-Trifluorophenyl)Methyl]-Benzamide",DEHMSTGBNAXEGX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163819,7bv1,DB06393,-9.3,Xaliproden,WJJYZXPHLSLMGE-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
55564,6crv,DB01149,-9.3,Nefazodone,VRBKIVRKKCLPHA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88496,6m3m,DB13874,-9.3,Enasidenib,DYLUUSLLRIQKOE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
138592,6w9c,DB11891,-9.3,CUDC-907,JOWXJLIFIIOYMS-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
61457,6crv,DB12114,-9.3,Poziotinib,LPFWVDIFUFFKJU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
6565,6lzg,DB02336,-9.3,RU83876,WCMLXBUNHNAMNH-UIOOFZCWSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
80174,6m2n,DB14790,-9.3,BPN-14770,KRRGWHSEDYQKDQ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
55543,6crv,DB01126,-9.3,Dutasteride,JWJOTENAMICLJG-QWBYCMEYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88489,6m3m,DB13865,-9.3,Dehydroemetine,XXLZPUYGHQWHRN-RPBOFIJWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
77819,6m2n,DB08834,-9.3,Tauroursodeoxycholic acid,BHTRKEVKTKCXOH-LBSADWJPSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
88435,6m3m,DB13793,-9.3,Vinburnine,WYJAPUKIYAZSEM-MOPGFXCFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
100437,6vxs,DB03591,-9.3,RU82209,LVZDQVATAQEMCX-NSOVKSMOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101079,6vxs,DB04452,-9.3,Aminoquinuride,HOUSDILKOJMENG-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
137228,6w9c,DB08044,-9.3,ABT-341,NVVSPGQEXMJZIR-BMIGLBTASA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
55297,6crv,DB00844,-9.3,Nalbuphine,NETZHAKZCGBWSS-CEDHKZHLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56823,6crv,DB02833,-9.3,[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(3-Nitro-Phenyl)-Amine,DYTKVFHLKPDNRW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
164444,7bv1,DB07837,-9.3,"[4-(5-naphthalen-2-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)phenyl]acetic acid",SWXKLXXVFMYMDP-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
138569,6w9c,DB11853,-9.3,Relugolix,AOMXMOCNKJTRQP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
88312,6m3m,DB13631,-9.3,Methoserpidine,ULBNWNUHGJLQHO-VKMIBBQISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87852,6m3m,DB12952,-9.3,Methylprednisone,SVYCRJXQZUCUND-PQXSVQADSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
77848,6m2n,DB08883,-9.3,Perampanel,PRMWGUBFXWROHD-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80251,6m2n,DB14982,-9.3,Miransertib,HNFMVVHMKGFCMB-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
87967,6m3m,DB13129,-9.3,Trimegestone,JUNDJWOLDSCTFK-MTZCLOFQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80258,6m2n,DB15003,-9.3,PF-06700841,BUWBRTXGQRBBHG-MJBXVCDLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
99363,6vxs,DB02155,-9.3,Balanol Analog 8,XVLMXAUKCDSMMW-YXLARRHKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
80260,6m2n,DB15009,-9.3,PF-04937319,MASKQITXHVYVFL-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
128767,6w4h,DB07994,-9.3,"N-3-[5-(1H-INDOL-6-YL)-2-(PYRIDIN-2-YLMETHOXY)BENZYL]PYRIDINE-2,3-DIAMINE",KMBPJSHPAXOXBT-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
56631,6crv,DB02573,-9.3,"2'-Deoxycytidine-2'-Deoxyadenosine-3',5'-Monophosphate",LYWWDKIADIGKTH-IDMWBNCISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
13204,6lzg,DB14894,-9.3,Galicaftor,QVDYQHXNAQHIKH-TZIWHRDSSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
56662,6crv,DB02616,-9.3,FR117016,CKJGKHXCUDWFDC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87901,6m3m,DB13029,-9.3,MK-0873,JJWKQXNHYDJXKF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
128667,6w4h,DB07875,-9.3,"5-Chloro-thiophene-2-carboxylic acid ((3S,4S)-1-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-methyl}-4-hydroxy-pyrrolidin-3-yl)-amide",ARAVOODWJJJNBY-IRXDYDNUSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
27529,6cs2,DB07076,-9.3,6-[(Z)-AMINO(IMINO)METHYL]-N-[3-(CYCLOPENTYLOXY)PHENYL]-2-NAPHTHAMIDE,FWTQOPWAMQXIMI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
61391,6crv,DB12015,-9.3,Alpelisib,STUWGJZDJHPWGZ-LBPRGKRZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80288,6m2n,DB15062,-9.3,Inarigivir,LYMICVBGNUEHGE-FUQPUAIBSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
128753,6w4h,DB07978,-9.3,"2-({[2,3,5,6-TETRAFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)CYCLOPENTA-1,3-DIENE-1-CARBOXYLIC ACID",ULMUPVXFUDHRGH-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
78119,6m2n,DB09291,-9.3,Rolapitant,FIVSJYGQAIEMOC-ZGNKEGEESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
13261,6lzg,DB15035,-9.3,Zanubrutinib,RNOAOAWBMHREKO-QFIPXVFZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
61396,6crv,DB12024,-9.3,PF-04418948,LWJGMYMNSNVCEM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60326,6crv,DB08513,-9.3,[4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENYL]ACETIC ACID,PAIQRYUOBBCBSE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87932,6m3m,DB13078,-9.3,KOSN-1724,JAYGOFBXDFAXBW-CYEKYUJNSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
130728,6w4h,DB12694,-9.3,CE-326597,UBNMGTSDHSQBEL-PMERELPUSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
13156,6lzg,DB14792,-9.3,AZD-5991,KBQCEQAXHPIRTF-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
97700,6m71,DB15444,-9.3,Elexacaftor,MVRHVFSOIWFBTE-INIZCTEOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
88133,6m3m,DB13386,-9.3,Epimestrol,UHQGCIIQUZBJAE-RRQVMCLOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
77873,6m2n,DB08930,-9.3,Dolutegravir,RHWKPHLQXYSBKR-BMIGLBTASA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
99728,6vxs,DB02629,-9.3,Inhibitor Bea403,LYHLPPXMBKMSSZ-JQFCFGFHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
99672,6vxs,DB02551,-9.3,"6-[N-(4-Ethyl-1,2,3,4-Tetrahydro-6-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine",LVNMYQLXKMSQTG-AWEZNQCLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
99628,6vxs,DB02498,-9.3,Carba-Nicotinamide-Adenine-Dinucleotide,DGPLSUKWXXSBCU-VGXGLJSLSA-O,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
88264,6m3m,DB13563,-9.3,Norgestrienone,GVDMJXQHPUYPHP-FYQPLNBISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
97453,6m71,DB14916,-9.3,Selonsertib,YIDDLAAKOYYGJG-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
80216,6m2n,DB14885,-9.3,PF-05180999,CLGCHUKGBICQTE-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
99589,6vxs,DB02449,-9.3,3-(1h-Indol-3-Yl)-2-[4-(4-Phenyl-Piperidin-1-Yl)-Benzenesulfonylamino]-Propionic Acid,ULOTXPTWJAUGGE-MHZLTWQESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
138398,6w9c,DB11562,-9.3,Bicuculline,IYGYMKDQCDOMRE-ZWKOTPCHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
99511,6vxs,DB02354,-9.3,4-{[1-Methyl-5-(2-Methyl-Benzoimidazol-1-Ylmethyl)-1h-Benzoimidazol-2-Ylmethyl]-Amino}-Benzamidine,IRKPNOLLMNHSOU-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
138528,6w9c,DB11795,-9.3,GSK-2636771,XTKLTGBKIDQGQL-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
130645,6w4h,DB12563,-9.3,MK-0686,WZZIQHIQMWJNLU-LLVKDONJSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
56799,6crv,DB02804,-9.3,A-98881,PMBZSBGCSQGJAQ-GRKNLSHJSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
97575,6m71,DB15193,-9.3,BMS-955176,XDMUFNNPLXHNKA-ZTESCHFWSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
137063,6w9c,DB07856,-9.3,6-{4-[4-(4-CHLOROPHENYL)PIPERIDIN-4-YL]PHENYL}-9H-PURINE,HPWBHQIUIBFTQC-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
61353,6crv,DB11960,-9.3,Carboxyamidotriazole,WNRZHQBJSXRYJK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61361,6crv,DB11968,-9.3,MK-7145,OCKGFTQIICXDQW-ZEQRLZLVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78335,6m2n,DB11562,-9.3,Bicuculline,IYGYMKDQCDOMRE-ZWKOTPCHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
88204,6m3m,DB13484,-9.3,Quinbolone,IUVKMZGDUIUOCP-BTNSXGMBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
130650,6w4h,DB12571,-9.3,Rimacalib,MYTIJGWONQOOLC-HNNXBMFYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
97695,6m71,DB15435,-9.3,BMS-986158,KGERZPVQIRYWRK-GDLZYMKVSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97437,6m71,DB14883,-9.3,Lorecivivint,AQDWDWAYVBQMAM-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
137240,6w9c,DB08059,-9.3,Wortmannin,QDLHCMPXEPAAMD-QAIWCSMKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
164136,7bv1,DB07297,-9.3,"5,6-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-D]PYRIMIDIN-4-AMINE",PTILEOLOGGMFCS-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
61289,6crv,DB11867,-9.3,JNJ-39393406,IURMHZBQEYNQOH-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
89051,6m3m,DB15358,-9.3,JNJ-54175446,CWFVVQFVGMFTBD-SECBINFHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
137770,6w9c,DB08703,-9.3,"12-(2-hydroxyethyl)-2-(1-methylethoxy)-13,14-dihydronaphtho[2,1-a]pyrrolo[3,4-c]carbazol-5(12H)-one",FGKKIHITEICGMN-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
89062,6m3m,DB15393,-9.3,Telatinib,QFCXANHHBCGMAS-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
78908,6m2n,DB12432,-9.3,CC-401,XDJCLCLBSGGNKS-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
56058,6crv,DB01820,-9.3,"Compound 12, N-Acetyl-4-[(Carboxycarbonyl)(2-Carboxyphenyl)Amino]-N-Pentyl-1-Napthylalaniamide",UESXELNYBIOROE-QHCPKHFHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55712,6crv,DB01392,-9.3,Yohimbine,BLGXFZZNTVWLAY-SCYLSFHTSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
129868,6w4h,DB11275,-9.3,Epicriptine,SBFXHXZNBNFPHV-PXXBSISHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
55708,6crv,DB01380,-9.3,Cortisone acetate,ITRJWOMZKQRYTA-RFZYENFJSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78894,6m2n,DB12415,-9.3,Galeterone,PAFKTGFSEFKSQG-PAASFTFBSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
60884,6crv,DB09274,-9.3,Artesunate,FIHJKUPKCHIPAT-AHIGJZGOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88801,6m3m,DB14840,-9.3,Ripretinib,CEFJVGZHQAGLHS-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
56066,6crv,DB01830,-9.3,"{4-[2-Acetylamino-2-(3-Carbamoyl-2-Cyclohexylmethoxy-6,7,8,9-Tetrahydro-5h-Benzocyclohepten-5ylcarbamoyl)-Ethyl]-2-Phosphono-Phenyl}-Phosphonic Acid",SPSGYTWOIGAABK-DQEYMECFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
89093,6m3m,DB15448,-9.3,Acumapimod,VGUSQKZDZHAAEE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
79304,6m2n,DB13055,-9.3,Oteseconazole,IDUYJRXRDSPPRC-NRFANRHFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
60991,6crv,DB11274,-9.3,Dihydro-alpha-ergocryptine,PBUNVLRHZGSROC-VTIMJTGVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
90105,6m71,DB01267,-9.3,Paliperidone,PMXMIIMHBWHSKN-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
90132,6m71,DB01336,-9.3,Metocurine,JFXBEKISTKFVAB-AJQTZOPKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
78829,6m2n,DB12320,-9.3,Palovarotene,YTFHCXIPDIHOIA-DHZHZOJOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
88785,6m3m,DB14790,-9.3,BPN-14770,KRRGWHSEDYQKDQ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
90640,6m71,DB02009,-9.3,"L-756,423",AOMZDQMIOCTPQP-QHQMVRJISA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
27808,6cs2,DB07362,-9.3,"1-(5-{2-[(1-methyl-1H-pyrazolo[4,3-d]pyrimidin-7-yl)amino]ethyl}-1,3-thiazol-2-yl)-3-[3-(trifluoromethyl)phenyl]urea",UOLCZAFAGDOUFX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
78815,6m2n,DB12303,-9.3,Motolimod,QSPOQCXMGPDIHI-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137903,6w9c,DB08865,-9.3,Crizotinib,KTEIFNKAUNYNJU-GFCCVEGCSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
79308,6m2n,DB13060,-9.3,CEP-37440,BCSHRERPHLTPEE-NRFANRHFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
129613,6w4h,DB09042,-9.3,Tedizolid phosphate,QCGUSIANLFXSGE-GFCCVEGCSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
88758,6m3m,DB14729,-9.3,Rebeccamycin,QEHOIJJIZXRMAN-QZQSLCQPSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
91200,6m71,DB02741,-9.3,CD564,RWYREGSYPCNZTL-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
88751,6m3m,DB14716,-9.3,Clonazolam,XJRGLCAWBRZUFC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
79310,6m2n,DB13062,-9.3,ME-344,QVCAATSEPLQVBX-FPOVZHCZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78968,6m2n,DB12524,-9.3,BI-671800,XEOSTBFUCNZKGS-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
88815,6m3m,DB14866,-9.3,Amcasertib,QDWKGEFGLQMDAM-ULJHMMPZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
60855,6crv,DB09231,-9.3,Benidipine,QZVNQOLPLYWLHQ-ZEQKJWHPSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60640,6crv,DB08911,-9.3,Trametinib,LIRYPHYGHXZJBZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79133,6m2n,DB12784,-9.3,NS-018,UQTPDWDAYHAZNT-AWEZNQCLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
130136,6w4h,DB11822,-9.3,TMC-647055,UOBYJVFBFSLCTQ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
79121,6m2n,DB12764,-9.3,ABC-294640,CAOTVXGYTWCKQE-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
130123,6w4h,DB11804,-9.3,AZD-5672,SCXSQUUTGCWHFU-WJOKGBTCSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
55861,6crv,DB01564,-9.3,Calusterone,IVFYLRMMHVYGJH-PVPPCFLZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130163,6w4h,DB11864,-9.3,Preladenant,DTYWJKSSUANMHD-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
79155,6m2n,DB12823,-9.3,Tecarfarin,QFLNTQDOVCLQKW-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
25329,6cs2,DB03231,-9.3,"3-(5-Amino-7-oxo-3,7-dihydro-2H-[1,2,3]triazolo[4,5-d]pyrimidin-2-yl)-N-(2-{[2-(hydroxymethyl)phenyl]sulfanyl}benzyl)benzamide",IXDQOBDHBWEZOH-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
88881,6m3m,DB15031,-9.3,Nemorexant,NBGABHGMJVIVBW-QHCPKHFHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
79094,6m2n,DB12720,-9.3,Nivocasan,VYFGDLGHHBUDTQ-ZLGUVYLKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
130184,6w4h,DB11894,-9.3,Efatutazone,JCYNMRJCUYVDBC-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
55950,6crv,DB01678,-9.3,RU84687,SAFPHFWYRLLBFO-NSOVKSMOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55959,6crv,DB01689,-9.3,Inhibitor Idd 384,CJKKMQCZOLCXAM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130100,6w4h,DB11773,-9.3,BMS-903452,OGIAVRWXUPYGGC-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
56135,6crv,DB01933,-9.3,7-Hydroxystaurosporine,PBCZSGKMGDDXIJ-HQCWYSJUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79052,6m2n,DB12659,-9.3,SJ-733,VKCPFWKTFZAOTO-LEWJYISDSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137676,6w9c,DB08584,-9.3,"6-{[6-(1-methyl-1H-pyrazol-4-yl)[1,2,4]triazolo[4,3-b]pyridazin-3-yl]sulfanyl}quinoline",BCZUAADEACICHN-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
130075,6w4h,DB11737,-9.3,Icotinib,QQLKULDARVNMAL-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
27846,6cs2,DB07404,-9.3,"(1-HYDROXY-1-PHOSPHONO-2-[1,1';3',1'']TERPHENYL-3-YL-ETHYL)-PHOSPHONIC ACID",YXQQNSYZOQHKHD-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
88994,6m3m,DB15246,-9.3,Salvianolic acid A,YMGFTDKNIWPMGF-UCPJVGPRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
60699,6crv,DB08990,-9.3,Eprazinone,BSHWLCACYCVCJE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79036,6m2n,DB12635,-9.3,Aleplasinin,HSXLMAFNWCSZGP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79269,6m2n,DB13002,-9.3,HKI-357,NERXPXBELDBEPZ-RMKNXTFCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
89002,6m3m,DB15266,-9.3,TAK-580,VWMJHAFYPMOMGF-ZCFIWIBFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
79032,6m2n,DB12627,-9.3,GSK-1292263,AYJRTVVIBJSSKN-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
56019,6crv,DB01767,-9.3,Hemi-Babim,KKJYVDXDZURHMA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
89009,6m3m,DB15282,-9.3,Fluorofuranylnorprogesterone F-18,VJKRBRUNEOHPBS-JQKUZGBFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
60646,6crv,DB08922,-9.3,Perospirone,FBVFZWUMDDXLLG-HDICACEKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27954,6cs2,DB07519,-9.3,"(6R)-2-amino-6-[2-(3'-methoxybiphenyl-3-yl)ethyl]-3,6-dimethyl-5,6-dihydropyrimidin-4(3H)-one",VDFBMQAUECXNKR-OAQYLSRUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
55781,6crv,DB01474,-9.3,"17alpha-methyl-3beta,17beta-dihydroxyandrost-4-ene",BNUOCVTVOYWNJC-DTMQFJJTSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79045,6m2n,DB12649,-9.3,Ibipinabant,AXJQVVLKUYCICH-OAQYLSRUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80116,6m2n,DB14664,-9.3,Difluocortolone pivalate,UWGRWFCLGQWKPR-GSTUPEFVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
92593,6m71,DB04609,-9.3,INHIBITOR Q8467 OF DUPONT MERCK,HFLCERPZYCWLSZ-VKONIRKNSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
164323,7bv1,DB07700,-9.3,"3-CARBOXAMIDO-1,3,5(10)-ESTRATRIEN-17(R)-SPIRO-2'(5',5'-DIMETHYL-6'OXO)TETRAHYDROPYRAN",YVAJWBACBRSVPR-NDUHRLLKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
78571,6m2n,DB11949,-9.3,Vestipitant,SBBYBXSFWOLDDG-JLTOFOAXSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
95713,6m71,DB11830,-9.3,Mocetinostat,HRNLUBSXIHFDHP-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95715,6m71,DB11832,-9.3,Crenolanib,DYNHJHQFHQTFTP-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
138138,6w9c,DB09223,-9.3,Blonanserin,XVGOZDAJGBALKS-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
55812,6crv,DB01513,-9.3,"17Alpha-methyl-3beta,17beta-dihydroxy-5alpha-androstane",QGKQXZFZOIQFBI-UYEYMFBJSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
95727,6m71,DB11852,-9.3,Tegobuvir,XBEQSQDCBSKCHJ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
61235,6crv,DB11789,-9.3,Hyodeoxycholic Acid,DGABKXLVXPYZII-SIBKNCMHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61240,6crv,DB11794,-9.3,Berzosertib,JZCWLJDSIRUGIN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79610,6m2n,DB13506,-9.3,Carfecillin,NZDASSHFKWDBBU-KVMCETHSSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
95836,6m71,DB12012,-9.3,PF-04457845,BATCTBJIJJEPHM-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
137368,6w9c,DB08204,-9.3,3-DIPHENOL-6-NITRO-3H-BENZO[DE]ISOCHROMEN-1-ONE,FLWABCQDXUKNQY-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137362,6w9c,DB08197,-9.3,"(5E,7S)-2-amino-7-(4-fluoro-2-pyridin-3-ylphenyl)-4-methyl-7,8-dihydroquinazolin-5(6H)-one oxime",KYIXUSLGFINPTC-WVFAEZDRSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
56333,6crv,DB02194,-9.3,"8-Benzyl-2-Hydroxy-2-(4-Hydroxy-Benzyl)-6-(4-Hydroxy-Phenyl)-2h-Imidazo[1,2-a]Pyrazin-3-One",ULLMMKZQNNBLRN-SANMLTNESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78545,6m2n,DB11911,-9.3,Galunisertib,IVRXNBXKWIJUQB-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61252,6crv,DB11814,-9.3,PF-03882845,XNULRSOGWPFPBL-REWPJTCUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79899,6m2n,DB13931,-9.3,Netarsudil,OURRXQUGYQRVML-AREMUKBSSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
56336,6crv,DB02197,-9.3,"4-[(4-Imidazo[1,2-a]Pyridin-3-Ylpyrimidin-2-Yl)Amino]Benzenesulfonamide",NKORVPQBJCGYEC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88583,6m3m,DB14067,-9.3,Dofequidar,KLWUUPVJTLHYIM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
96090,6m71,DB12381,-9.3,Merestinib,QHADVLVFMKEIIP-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
56350,6crv,DB02217,-9.3,Dpb-T,WTZFKHNHHRPQOU-WSMBLCCSSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138259,6w9c,DB11176,-9.3,Zeaxanthin,JKQXZKUSFCKOGQ-QAYBQHTQSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
60487,6crv,DB08710,-9.3,"(5Z)-5-[(5-ETHYL-2-FURYL)METHYLENE]-2-{[(S)-(4-FLUOROPHENYL)(1H-TETRAZOL-5-YL)METHYL]AMINO}-1,3-THIAZOL-4(5H)-ONE",BKZOQCGDCHOGOQ-MZLJFPOFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
96126,6m71,DB12427,-9.3,Orvepitant,XWNBGDJPEXZSQM-VZOBGQTKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
80079,6m2n,DB14625,-9.3,Meprednisone acetate,RZAMUHXEOMZXET-ABQXZQTJSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
129077,6w4h,DB08362,-9.3,"N-(3-(8-CYANO-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZIN-2-YLAMINO)PHENYL)ACETAMIDE",QVKXQLGRDOMAGC-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
96189,6m71,DB12523,-9.3,Mizolastine,PVLJETXTTWAYEW-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
78500,6m2n,DB11845,-9.3,Lucitanib,CUDVHEFYRIWYQD-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80081,6m2n,DB14627,-9.3,Oxyphenisatin acetate,PHPUXYRXPHEJDF-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
56384,6crv,DB02259,-9.3,"3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid (4-Sulfamoyl-Phenyl)-Amide",VSYGXLAJQDAWCZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130432,6w4h,DB12260,-9.3,Radiprodil,GKGRZLGAQZPEHO-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
95194,6m71,DB09063,-9.3,Ceritinib,VERWOWGGCGHDQE-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95148,6m71,DB08993,-9.3,Enviomycin,HPWIIERXAFODPP-GHBBWTPBSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
129236,6w4h,DB08553,-9.3,"(1E)-5-(1-piperidin-4-yl-3-pyridin-4-yl-1H-pyrazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime",KWEFZSZCLBHIEQ-YYADALCUSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
163991,7bv1,DB06938,-9.3,4-[[2-[[4-chloro-3-(trifluoromethyl)phenyl]amino]-3H-benzimidazol-5-yl]oxy]-N-methyl-pyridine-2-carboxamide,ZJLSMLDOCGOURY-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93011,6m71,DB05983,-9.3,Bardoxolone methyl,WPTTVJLTNAWYAO-KPOXMGGZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
137939,6w9c,DB08930,-9.3,Dolutegravir,RHWKPHLQXYSBKR-BMIGLBTASA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
27773,6cs2,DB07326,-9.3,"6-chloro-N-pyrimidin-5-yl-3-{[3-(trifluoromethyl)phenyl]amino}-1,2-benzisoxazole-7-carboxamide",FEGRQUWSKADGSP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
93230,6m71,DB06630,-9.3,Anacetrapib,MZZLGJHLQGUVPN-HAWMADMCSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
79328,6m2n,DB13089,-9.3,Enoxolone,MPDGHEJMBKOTSU-YKLVYJNSSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
93235,6m71,DB06638,-9.3,Quarfloxin,WOQIDNWTQOYDLF-CGAIIQECSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
130338,6w4h,DB12121,-9.3,Entospletinib,XSMSNFMDVXXHGJ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
93459,6m71,DB06976,-9.3,"1-(5-OXO-2,3,5,9B-TETRAHYDRO-1H-PYRROLO[2,1-A]ISOINDOL-9-YL)-3-(5-PYRROLIDIN-2-YL-1H-PYRAZOL-3-YL)-UREA",IWOOJEZSDPRYAZ-WFASDCNBSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
61148,6crv,DB11662,-9.3,Rabusertib,SYYBDNPGDKKJDU-ZDUSSCGKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
93583,6m71,DB07117,-9.3,"5-(4-PHENOXYPHENYL)-5-(4-PYRIMIDIN-2-YLPIPERAZIN-1-YL)PYRIMIDINE-2,4,6(2H,3H)-TRIONE",FMKQJGOROFNCGM-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93708,6m71,DB07261,-9.3,"THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [1-(1-AMINO-ISOQUINOLIN-7-YLMETHYL)-2-OXO-PYRROLDIN-3-YL]-AMIDE",NVKDOURNRJCKJE-INIZCTEOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
14355,6lzg,T3D4021,-9.3,Digitoxin,WDJUZGPOPHTGOT-XUDUSOBPSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
93738,6m71,DB07294,-9.3,"3-fluoro-4-[2-hydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8,-tetrahydro-naphtalen-2-yl)-acetylamino]-benzoic acid",AANFHDFOMFRLLR-IBGZPJMESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
56144,6crv,DB01944,-9.3,(S)-blebbistatin,LZAXPYOBKSJSEX-GOSISDBHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130349,6w4h,DB12134,-9.3,Gepotidacin,PZFAZQUREQIODZ-LJQANCHMSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
94163,6m71,DB07794,-9.3,"5-(2-PHENYLPYRAZOLO[1,5-A]PYRIDIN-3-YL)-1H-PYRAZOLO[3,4-C]PYRIDAZIN-3-AMINE",XVECMUKVOMUNLE-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
56223,6crv,DB02046,-9.3,N-[(Furan-2-Yl)Carbonyl]-(S)-Leucyl-(R)-[1-Amino-2(1h-Indol-3-Yl)Ethyl]-Phosphonic Acid,WHPKSASOSKNDPY-PKOBYXMFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
94347,6m71,DB08006,-9.3,"N-anthracen-2-yl-5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7-amine",OXYDLVAOXASTMW-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
88708,6m3m,DB14644,-9.3,Methylprednisolone hemisuccinate,IMBXEJJVJRTNOW-XYMSELFBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88706,6m3m,DB14641,-9.3,Estriol tripropionate,ONMZMZJEZHMWQL-REUUDLSRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
79387,6m2n,DB13212,-9.3,Phenolsulfonphthalein,BELBBZDIHDAJOR-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
130390,6w4h,DB12200,-9.3,Tivantinib,UCEQXRCJXIVODC-PMACEKPBSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
14145,6lzg,T3D3764,-9.3,Janthitrem E,TVRIMSLYKUNOPS-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
56284,6crv,DB02123,-9.3,Glycochenodeoxycholic Acid,GHCZAUBVMUEKKP-GYPHWSFCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55641,6crv,DB01238,-9.3,Aripiprazole,CEUORZQYGODEFX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130404,6w4h,DB12222,-9.3,Lurtotecan,RVFGKBWWUQOIOU-NDEPHWFRSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
94911,6m71,DB08683,-9.3,"REL-(9R,12S)-9,10,11,12-TETRAHYDRO-9,12-EPOXY-1H-DIINDOLO[1,2,3-FG:3',2',1'-KL]PYRROLO[3,4-I][1,6]BENZODIAZOCINE-1,3(2H)-DIONE",OTPNDVKVEAIXTI-IYBDPMFKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
79549,6m2n,DB13422,-9.3,Nicofuranose,FUWFSXZKBMCSKF-ZASNTINBSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78617,6m2n,DB12020,-9.3,Tecovirimat,CSKDFZIMJXRJGH-VWLPUNTISA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
60610,6crv,DB08860,-9.3,Pitavastatin,VGYFMXBACGZSIL-MCBHFWOFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130020,6w4h,DB11652,-9.3,Tucatinib,SDEAXTCZPQIFQM-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
134724,6w9c,DB03460,-9.3,Violaxanthin,SZCBXWMUOPQSOX-WVJDLNGLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
61461,6crv,DB12120,-9.3,Avoralstat,TUWMKPVJGGWGNL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
24024,6cs2,DB01678,-9.3,RU84687,SAFPHFWYRLLBFO-NSOVKSMOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
31818,6cs2,DB14810,-9.3,AZD-1656,FJEJHJINOKKDCW-INIZCTEOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
140257,6w9c,DB15456,-9.3,Vericiguat,QZFHIXARHDBPBY-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140247,6w9c,DB15437,-9.3,Rocacetrapib,GBHPDJQHZADVAA-SOKVYYICSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
111927,6vxx,DB04879,-9.3,Vatalanib,YCOYDOIWSSHVCK-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62959,6crv,DB14810,-9.3,AZD-1656,FJEJHJINOKKDCW-INIZCTEOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
24048,6cs2,DB01705,-9.3,Bis(5-Amidino-Benzimidazolyl)Methane,QZKOOEFIMWKZPK-UHFFFAOYSA-Q,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
62917,6crv,DB14717,-9.3,Nitrazolam,OYRPNABWTHDOFK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31892,6cs2,DB14946,-9.3,PCO-371,LDZJFVOUPUFOHX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
140212,6w9c,DB15358,-9.3,JNJ-54175446,CWFVVQFVGMFTBD-SECBINFHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
165735,7bv1,DB12729,-9.3,ASP-3026,MGGBYMDAPCCKCT-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
111565,6vxx,DB04044,-9.3,4-{2-[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid,NAQUAVBNIYTIIS-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
9497,6lzg,DB07605,-9.3,"2-({4-[(5-CHLORO-1H-INDOL-2-YL)SULFONYL]PIPERAZIN-1-YL}CARBONYL)THIENO[3,2-B]PYRIDINE 4-OXIDE",DHDQMXPAANQKDC-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
72272,6m2n,DB00549,-9.3,Zafirlukast,YEEZWCHGZNKEEK-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
111508,6vxx,DB03962,-9.3,Nicotinamide 8-Bromo-Adenine Dinucleotide Phosphate,MDKMTCCUJSRQGW-NAJQWHGHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31923,6cs2,DB15046,-9.3,LY-2881835,FHRWHNJJQGSCQC-LJAQVGFWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
62875,6crv,DB14646,-9.3,Prednisone acetate,MOVRKLZUVNCBIP-RFZYENFJSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72392,6m2n,DB00694,-9.3,Daunorubicin,STQGQHZAVUOBTE-VGBVRHCVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
111235,6vxx,DB03376,-9.3,'5'-O-(N-(L-Alanyl)-Sulfamoyl)Adenosine,CWWYMWDIYBJVLP-YTMOPEAISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
71866,6lxt,DB15442,-9.3,Trilaciclib,PDGKHKMBHVFCMG-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
31937,6cs2,DB15068,-9.3,Agerafenib,DKNUPRMJNUQNHR-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
71837,6lxt,DB15382,-9.3,SAR-125844,ODIUNTQOXRXOIV-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
71822,6lxt,DB15345,-9.3,GSK-945237,SRICOHRDRMZREQ-MRXNPFEDSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
70961,6lxt,DB13454,-9.3,Nicomorphine,HNDXBGYRMHRUFN-CIVUWBIHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
112586,6vxx,DB07426,-9.3,"[1-HYDROXY-2-(1,1':3',1''-TERPHENYL-3-YLOXY)ETHANE-1,1-DIYL]BIS(PHOSPHONIC ACID)",NWIARQRYIRVYCM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112582,6vxx,DB07421,-9.3,"4-{[(1R,2S)-1,2-dihydroxy-2-methyl-3-(4-nitrophenoxy)propyl]amino}-2-(trifluoromethyl)benzonitrile",INVUBEGZQHQAMY-SJORKVTESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112421,6vxx,DB07084,-9.3,"N-(6,7,9,10,17,18,20,21-octahydrodibenzo[b,k][1,4,7,10,13,16]hexaoxacyclooctadecin-2-yl)acetamide",YHKGWOJTUMJPNW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112413,6vxx,DB07074,-9.3,6-CARBAMIMIDOYL-4-(3-HYDROXY-2-METHYL-BENZOYLAMINO)-NAPHTHALENE-2-CARBOXYLIC ACID METHYL ESTER,OUBRALHIKGRAMA-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
71525,6lxt,DB14703,-9.3,Dexamethasone metasulfobenzoate,TWQWRHIQRAZHPR-XNXCGYEVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
71561,6lxt,DB14785,-9.3,Fenebrutinib,WNEODWDFDXWOLU-QHCPKHFHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
71565,6lxt,DB14792,-9.3,AZD-5991,KBQCEQAXHPIRTF-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
71585,6lxt,DB14850,-9.3,Deleobuvir,BMAIGAHXAJEULY-UKTHLTGXSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
121981,6w4b,DB12690,-9.3,LY-2584702,FYXRSVDHGLUMHB-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
112314,6vxx,DB06962,-9.3,"(5-(aminomethyl)-2H-spiro[benzofuran-3,4'-piperidine]-1'-yl)(5-(phenylethynyl)furan-2-yl)methanone",YKTUSHSSKIWDRY-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140417,6w9c,DB06809,-9.3,Plerixafor,YIQPUIGJQJDJOS-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
63001,6crv,DB14902,-9.3,JHU-75528 C-11,MCNQUWLLXZZZAC-BJUDXGSMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31562,6cs2,DB01067,-9.3,Glipizide,ZJJXGWJIGJFDTL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
62978,6crv,DB14860,-9.3,Ensartinib,GLYMPHUVMRFTFV-QLFBSQMISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112158,6vxx,DB06455,-9.3,Meclinertant,DYLJVOXRWLXDIG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31766,6cs2,DB14703,-9.3,Dexamethasone metasulfobenzoate,TWQWRHIQRAZHPR-XNXCGYEVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
112135,6vxx,DB06401,-9.3,Bazedoxifene,UCJGJABZCDBEDK-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112118,6vxx,DB06334,-9.3,Tucidinostat,SZMJVTADHFNAIS-BJMVGYQFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29185,6cs2,DB08827,-9.3,Lomitapide,MBBCVAKAJPKAKM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
112655,6vxx,DB07507,-9.3,"2-(4-hydroxybiphenyl-3-yl)-4-methyl-1H-isoindole-1,3(2H)-dione",ROMNEYAQUBNRLR-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72476,6m2n,DB00796,-9.3,Candesartan cilexetil,GHOSNRCGJFBJIB-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
62834,6crv,DB14542,-9.3,Hydrocortisone phosphate,BGSOJVFOEQLVMH-VWUMJDOOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
32118,6cs2,DB15396,-9.3,PF-114,SLIVDYMORZGPLW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
140060,6w9c,DB14866,-9.3,Amcasertib,QDWKGEFGLQMDAM-ULJHMMPZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
109755,6vxx,DB15275,-9.3,GDC-0077,SGEUNORSOZVTOL-CABZTGNLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109751,6vxx,DB15265,-9.3,USL-311,XNUNVQKARNSSEO-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165543,7bv1,DB12432,-9.3,CC-401,XDJCLCLBSGGNKS-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
140050,6w9c,DB14846,-9.3,Bimiralisib,ADGGYDAFIHSYFI-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
109715,6vxx,DB15197,-9.3,RSV-604,MTPVBMVUENFFLL-HXUWFJFHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72989,6m2n,DB01459,-9.3,Bezitramide,FLKWNFFCSSJANB-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
109689,6vxx,DB15141,-9.3,Deutivacaftor,PURKAOJPTOLRMP-ASMGOKTBSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140033,6w9c,DB14793,-9.3,RO-5045337,QBGKPEROWUKSBK-QPPIDDCLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
10074,6lzg,DB08221,-9.3,N-{4-METHYL-3-[(3-PYRIMIDIN-4-YLPYRIDIN-2-YL)AMINO]PHENYL}-3-(TRIFLUOROMETHYL)BENZAMIDE,NESXBRNDMQUVNG-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
32144,6cs2,DB15442,-9.3,Trilaciclib,PDGKHKMBHVFCMG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
124570,6w4h,DB01349,-9.3,Tasosartan,ADXGNEYLLLSOAR-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
62485,6crv,DB13643,-9.3,Loprazolam,UTEFBSAVJNEPTR-RGEXLXHISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
32228,6cs2,DB01199,-9.3,Tubocurarine,JFJZZMVDLULRGK-URLMMPGGSA-O,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
124606,6w4h,DB01419,-9.3,Antrafenine,NWGGKKGAFZIVBJ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
73281,6m2n,DB01820,-9.3,"Compound 12, N-Acetyl-4-[(Carboxycarbonyl)(2-Carboxyphenyl)Amino]-N-Pentyl-1-Napthylalaniamide",UESXELNYBIOROE-QHCPKHFHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
62429,6crv,DB13563,-9.3,Norgestrienone,GVDMJXQHPUYPHP-FYQPLNBISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
124825,6w4h,DB01678,-9.3,RU84687,SAFPHFWYRLLBFO-NSOVKSMOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
110021,6vxx,DB00713,-9.3,Oxacillin,UWYHMGVUTGAWSP-JKIFEVAISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62848,6crv,DB14581,-9.3,CPI-1205,HPODOLXTMDHLLC-QGZVFWFLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110132,6vxx,DB01012,-9.3,Cinacalcet,VDHAWDNDOKGFTD-MRXNPFEDSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110250,6vxx,DB01148,-9.3,Flavoxate,SPIUTQOUKAMGCX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62786,6crv,DB14152,-9.3,Ginsenosides,NLHQJXWYMZLQJY-SWIZOJJJSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31977,6cs2,DB15137,-9.3,VK-2809,LGGPZDRLTDGYSQ-JADSYQMUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
31997,6cs2,DB15173,-9.3,JNJ-42165279,YWGYNGCRVZLMCS-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
123724,6w4h,DB00303,-9.3,Ertapenem,JUZNIMUFDBIJCM-ANEDZVCMSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
29068,6cs2,DB08710,-9.3,"(5Z)-5-[(5-ETHYL-2-FURYL)METHYLENE]-2-{[(S)-(4-FLUOROPHENYL)(1H-TETRAZOL-5-YL)METHYL]AMINO}-1,3-THIAZOL-4(5H)-ONE",BKZOQCGDCHOGOQ-MZLJFPOFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
29066,6cs2,DB08708,-9.3,"N-cyclohexyl-3-[3-(trifluoromethyl)phenyl][1,2,4]triazolo[4,3-b]pyridazin-6-amine",XYYDXQCAYXOGQT-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
29065,6cs2,DB08707,-9.3,"4-[3-(4-chlorophenyl)-2,1-benzisoxazol-5-yl]pyrimidin-2-amine",AQVFETGXIRKVAQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
72733,6m2n,DB01089,-9.3,Deserpidine,CVBMAZKKCSYWQR-WCGOZPBSSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
72744,6m2n,DB01100,-9.3,Pimozide,YVUQSNJEYSNKRX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
62727,6crv,DB14029,-9.3,Furafylline,HMZQULPVMKITSP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29044,6cs2,DB08683,-9.3,"REL-(9R,12S)-9,10,11,12-TETRAHYDRO-9,12-EPOXY-1H-DIINDOLO[1,2,3-FG:3',2',1'-KL]PYRROLO[3,4-I][1,6]BENZODIAZOCINE-1,3(2H)-DIONE",OTPNDVKVEAIXTI-IYBDPMFKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
140107,6w9c,DB14982,-9.3,Miransertib,HNFMVVHMKGFCMB-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
110530,6vxx,DB01893,-9.3,N6-Benzyl Adenosine-5'-Diphosphate,MRHGMAGSDAQUFH-LSCFUAHRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165609,7bv1,DB12535,-9.3,AC-430,DCRWIATZWHLIPN-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
62677,6crv,DB13936,-9.3,JNJ-28330835,RYBKPGYFXRNMMU-LBPRGKRZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140102,6w9c,DB14942,-9.3,BMS-986141,KEEBLYWBELVGPQ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
110275,6vxx,DB01177,-9.3,Idarubicin,XDXDZDZNSLXDNA-TZNDIEGXSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
32077,6cs2,DB15310,-9.3,Vactosertib,FJCDSQATIJKQKA-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
140096,6w9c,DB14934,-9.3,GDC-0927,KJAAPZIFCQQQKX-NDEPHWFRSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
72859,6m2n,DB01234,-9.3,Dexamethasone,UREBDLICKHMUKA-CXSFZGCWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
62375,6crv,DB13491,-9.3,Fluperolone,SLVCCRYLKTYUQP-DVTGEIKXSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112665,6vxx,DB07519,-9.3,"(6R)-2-amino-6-[2-(3'-methoxybiphenyl-3-yl)ethyl]-3,6-dimethyl-5,6-dihydropyrimidin-4(3H)-one",VDFBMQAUECXNKR-OAQYLSRUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140490,6w9c,DB11952,-9.3,Duvelisib,SJVQHLPISAIATJ-ZDUSSCGKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
114450,6vxx,DB13648,-9.3,Alcuronium,MUQUYTSLDVKIOF-CHJKCJHBSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29778,6cs2,DB11614,-9.3,Rupatadine,WUZYKBABMWJHDL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
30038,6cs2,DB11965,-9.3,SJG-136,RWZVMMQNDHPRQD-SFTDATJTSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
29748,6cs2,DB11526,-9.3,Masitinib,WJEOLQLKVOPQFV-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
67322,6lxt,DB06448,-9.3,Lonafarnib,DHMTURDWPRKSOA-RUZDIDTESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
30152,6cs2,DB12120,-9.3,Avoralstat,TUWMKPVJGGWGNL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
144440,6w9q,DB04868,-9.3,Nilotinib,HHZIURLSWUIHRB-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
30168,6cs2,DB12138,-9.3,PF-03715455,VGEXRDWWPSGZDH-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
30181,6cs2,DB12154,-9.3,Itacitinib,KTBSXLIQKWEBRB-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
67554,6lxt,DB06888,-9.3,"(13R,15S)-13-METHYL-16-OXA-8,9,12,22,24-PENTAAZAHEXACYCLO[15.6.2.16,9.1,12,15.0,2,7.0,21,25]HEPTACOSA-1(24),2,4,6,17(25),18,20-HEPTAENE-23,26-DIONE",KBLPHMRCKHFBJB-OLZOCXBDSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
67588,6lxt,DB06925,-9.3,3-(2-AMINOQUINAZOLIN-6-YL)-4-METHYL-N-[3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE,YEIASMOUYNOXGA-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
30250,6cs2,DB12247,-9.3,AZD-4547,VRQMAABPASPXMW-HDICACEKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
114047,6vxx,DB12649,-9.3,Ibipinabant,AXJQVVLKUYCICH-OAQYLSRUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
68366,6lxt,DB07833,-9.3,"N-(3-cyanophenyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)-4-biphenylcarboxamide",PMMLSQFPBFKLHH-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
114031,6vxx,DB12622,-9.3,Lupeol,MQYXUWHLBZFQQO-QGTGJCAVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
68658,6lxt,DB08164,-9.3,"(3R,4R)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN-3-AMINE",GOBIXGZJSMAOFV-QRWLVFNGSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
68761,6lxt,DB08299,-9.3,"4-[8-(3-nitrophenyl)-1,7-naphthyridin-6-yl]benzoic acid",QTNUWEKKZHSUQO-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
68938,6lxt,DB08512,-9.3,"6-amino-2-[(1-naphthylmethyl)amino]-3,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",MCEZMMDIEXECTI-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
68973,6lxt,DB08553,-9.3,"(1E)-5-(1-piperidin-4-yl-3-pyridin-4-yl-1H-pyrazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime",KWEFZSZCLBHIEQ-YYADALCUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
67164,6lxt,DB05903,-9.3,KOS-1584,XAYAKDZVINDZGB-BMVMHAJPSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
113935,6vxx,DB12295,-9.3,Evodenoson,SQJXTUJMBYVDBB-RQXXJAGISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
67131,6lxt,DB05678,-9.3,SLx-4090,AZUIUVJESCFSLJ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
66999,6lxt,DB04960,-9.3,Tipifarnib,PLHJCIYEEKOWNM-HHHXNRCGSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
143404,6w9q,DB03480,-9.3,Brequinar Analog,WYKKHJQZENLZID-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
114833,6vxx,DB14944,-9.3,Tarloxotinib,MUJMYVFVAWFUJL-SNAWJCMRSA-O,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
23772,6cs2,DB01410,-9.3,Ciclesonide,LUKZNWIVRBCLON-GXOBDPJESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
114845,6vxx,DB15009,-9.3,PF-04937319,MASKQITXHVYVFL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
23708,6cs2,HMDB0112264,-9.3,9-cis-beta-Carotene,OENHQHLEOONYIE-BVZAMQQESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
23703,6cs2,HMDB0112256,-9.3,Lactucaxanthin,BIPAHAFBQLWRMC-SUOWZELTSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
63783,6lxt,DB00696,-9.3,Ergotamine,XCGSFFUVFURLIX-VFGNJEKYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
29926,6cs2,DB11819,-9.3,ASP-4058,NJNXCJPSMWKXHO-VIFPVBQESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
64154,6lxt,DB01126,-9.3,Dutasteride,JWJOTENAMICLJG-QWBYCMEYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
63207,6crv,DB15343,-9.3,HM-43239,FZLSDZZNPXXBBB-KDURUIRLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114787,6vxx,DB14860,-9.3,Ensartinib,GLYMPHUVMRFTFV-QLFBSQMISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
64969,6lxt,DB02226,-9.3,"3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-4-Yl]Hexyl]-Phenanthridinium",NAARZDJZGYBXKL-UHFFFAOYSA-O,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
114907,6vxx,DB15385,-9.3,Acebilustat,GERJIEKMNDGSCS-DQEYMECFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
65699,6lxt,DB03186,-9.3,U-Pi-a-Pi,JIAJERGOUFOENU-LNAOLWRRSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
65773,6lxt,DB03276,-9.3,"4-[(10s,14s,18s)-18-(2-Amino-2-Oxoethyl)-14-(1-Naphthylmethyl)-8,17,20-Trioxo-7,16,19-Triazaspiro[5.14]Icos-11-En-10-Yl]Benzylphosphonic Acid",RHYFMOCFCFUTNH-GZNVFMSSSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
65986,6lxt,DB03583,-9.3,"(2e,3s)-3-Hydroxy-5'-[(4-Hydroxypiperidin-1-Yl)Sulfonyl]-3-Methyl-1,3-Dihydro-2,3'-Biindol-2'(1'h)-One",AYOAIABDFUJDKQ-SQJPUDIVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
166531,7bv1,DB15310,-9.3,Vactosertib,FJCDSQATIJKQKA-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
114750,6vxx,DB14769,-9.3,Pamiparib,DENYZIUJOTUUNY-MRXNPFEDSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
66520,6lxt,DB04285,-9.3,"{4-[(2s,4e)-2-(1,3-Benzothiazol-2-Yl)-2-(1h-1,2,3-Benzotriazol-1-Yl)-5-Phenylpent-4-Enyl]Phenyl}(Difluoro)Methylphosphonic Acid",GBLDYRVJENYQNH-AGLOJYHOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
114577,6vxx,DB13814,-9.3,Talampicillin,SOROUYSPFADXSN-SUWVAFIASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
70717,6lxt,DB13089,-9.3,Enoxolone,MPDGHEJMBKOTSU-YKLVYJNSSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
69119,6lxt,DB08730,-9.3,3-FLUORO-5-MORPHOLIN-4-YL-N-[1-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-6-YL]BENZAMIDE,CPFBZMFUCGHBAP-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
69317,6lxt,DB08995,-9.3,Diosmin,GZSOSUNBTXMUFQ-YFAPSIMESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
140601,6w9c,DB12515,-9.3,9-aminocamptothecin,FUXVKZWTXQUGMW-FQEVSTJZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
113357,6vxx,DB09042,-9.3,Tedizolid phosphate,QCGUSIANLFXSGE-GFCCVEGCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30817,6cs2,DB00991,-9.3,Oxaprozin,OFPXSFXSNFPTHF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
113278,6vxx,DB08749,-9.3,3-(2-AMINO-6-BENZOYLQUINAZOLIN-3(4H)-YL)-N-CYCLOHEXYL-N-METHYLPROPANAMIDE,KTRFBFMYAJOXLG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113276,6vxx,DB08747,-9.3,"(11R)-10-acetyl-11-(2,4-dichlorophenyl)-6-hydroxy-3,3-dimethyl-2,3,4,5,10,11-hexahydro-1H-dibenzo[b,e][1,4]diazepin-1-one",JJTPPGUNMJMPLY-QFIPXVFZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
69983,6lxt,DB11986,-9.3,Entrectinib,HAYYBYPASCDWEQ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
70075,6lxt,DB12121,-9.3,Entospletinib,XSMSNFMDVXXHGJ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
113128,6vxx,DB08572,-9.3,4-{[4-AMINO-6-(CYCLOHEXYLMETHOXY)-5-NITROSOPYRIMIDIN-2-YL]AMINO}BENZAMIDE,YBKLJTXDSBEVRV-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
121168,6w4b,DB11399,-9.3,Dirlotapide,TUOSYWCFRFNJBS-BHVANESWSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
70248,6lxt,DB12368,-9.3,AZD-3839,MRXBCEQZNKUUIP-DEOSSOPVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
70279,6lxt,DB12410,-9.3,Sabarubicin,VQHRZZISQVWPLK-UIRGBLDSSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
112996,6vxx,DB08242,-9.3,"N,4-dimethyl-3-[(1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl)amino]benzamide",OYTBZXSFNNAVKU-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112944,6vxx,DB08174,-9.3,"5-CHLORO-N-((1R,2S)-2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO) CYCLOPENTYL)THIOPHENE-2-CARBOXAMIDE",QCPYHSAHOYXXQK-DLBZAZTESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112913,6vxx,DB08143,-9.3,"5-CHLORO-THIOPHENE-2-CARBOXYLIC ACID ((3S,4S)-4-FLUORO- 1-{[2-FLUORO-4-(2-OXO-2H-PYRIDIN-1-YL)-PHENYLCARBAMOYL]-METHYL}-PYRROLIDIN-3-YL)-AMIDE",SXIYSYYSKHUTQQ-RDJZCZTQSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112884,6vxx,DB08111,-9.3,"4-[(6-phenyl[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl]phenol",ZGJYGQLGSXWEMY-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30841,6cs2,DB13053,-9.3,CP-195543,NZQDWKCNBOELAI-KSFYIVLOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
70508,6lxt,DB12760,-9.3,GW-493838,ZQYJPMPXQLNTPQ-QCUYGVNKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
112790,6vxx,DB07847,-9.3,6-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-(4-MORPHOLINYL)-2-OXO ETHYL]-2-OXO-3-PYRROLIDINYL}-2-NAPHTHALENESULFONAMIDE,ICLOZQFWTRAYPX-LIRRHRJNSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112721,6vxx,DB07769,-9.3,S-3-(4-FLUOROPHENOXY)-2-HYDROXY-2-METHYL-N-[4-NITRO-3-(TRIFLUOROMETHYL)PHENYL]PROPANAMIDE,KJMFOTCDISOHDX-INIZCTEOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
69895,6lxt,DB11853,-9.3,Relugolix,AOMXMOCNKJTRQP-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
113862,6vxx,DB12194,-9.3,Atamestane,PEPMWUSGRKINHX-TXTPUJOMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113524,6vxx,DB09319,-9.3,Carindacillin,JIRBAUWICKGBFE-MNRDOXJOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
69879,6lxt,DB11829,-9.3,Ruboxistaurin,ZCBUQCWBWNUWSU-SFHVURJKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
166387,7bv1,DB14785,-9.3,Fenebrutinib,WNEODWDFDXWOLU-QHCPKHFHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
63141,6crv,DB15212,-9.3,Pemafibrate,ZHKNLJLMDFQVHJ-RUZDIDTESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113820,6vxx,DB12129,-9.3,Tideglusib,PMJIHLSCWIDGMD-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
69424,6lxt,DB09183,-9.3,Dasabuvir,NBRBXGKOEOGLOI-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
63129,6crv,DB15193,-9.3,BMS-955176,XDMUFNNPLXHNKA-ZTESCHFWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
69499,6lxt,DB09280,-9.3,Lumacaftor,UFSKUSARDNFIRC-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
140671,6w9c,DB13072,-9.3,GDC-0349,RGJOJUGRHPQXGF-INIZCTEOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
113753,6vxx,DB12036,-9.3,Naquotinib,QKDCLUARMDUUKN-XMMPIXPASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113726,6vxx,DB11818,-9.3,Retosiban,PLVGDGRBPMVYPB-FDUHJNRSSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113714,6vxx,DB11799,-9.3,Bictegravir,SOLUWJRYJLAZCX-LYOVBCGYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
8506,6lzg,DB06240,-9.3,Tariquidar,LGGHDPFKSSRQNS-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
113697,6vxx,DB11778,-9.3,Danusertib,XKFTZKGMDDZMJI-HSZRJFAPSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113684,6vxx,DB11759,-9.3,Pevonedistat,MPUQHZXIXSTTDU-QXGSTGNESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113669,6vxx,DB11737,-9.3,Icotinib,QQLKULDARVNMAL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
69812,6lxt,DB11737,-9.3,Icotinib,QQLKULDARVNMAL-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
113665,6vxx,DB11732,-9.3,Lasmiditan,XEDHVZKDSYZQBF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113646,6vxx,DB11697,-9.3,Pacritinib,HWXVIOGONBBTBY-ONEGZZNKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
69853,6lxt,DB11794,-9.3,Berzosertib,JZCWLJDSIRUGIN-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
63105,6crv,DB15143,-9.3,PF-06650833,JKDGKIBAOAFRPJ-ZBINZKHDSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29443,6cs2,DB09195,-9.3,Lorpiprazole,BNRMWKUVWLKDQJ-YJBOKZPZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
73449,6m2n,DB02049,-9.3,2-{4-[4-(4-Chloro-Phenoxy)-Benzenesulfonyl]-Tetrahydro-Pyran-4-Yl}-N-Hydroxy-Acetamide,QOPFTBAEAJQKSY-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
62334,6crv,DB13434,-9.3,Fenticonazole,ZCJYUTQZBAIHBS-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
32440,6cs2,T3D0174,-9.3,"Indeno(1,2,3-cd)pyrene",SXQBHARYMNFBPS-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
127627,6w4h,DB06555,-9.3,Siramesine,XWAONOGAGZNUSF-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
76602,6m2n,DB07393,-9.3,"2-(2-PHENYL-3-PYRIDIN-2-YL-4,5,6,7-TETRAHYDRO-2H-ISOPHOSPHINDOL-1-YL)PYRIDINE",GSKNNHAAFLPYHG-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
106107,6vxs,DB15036,-9.3,Sitravatinib,WLAVZAAODLTUSW-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
76634,6m2n,DB07430,-9.3,"(10R)-10-methyl-3-(6-methylpyridin-3-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one",CMWRPDHVGMHLSZ-GFCCVEGCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61630,6crv,DB12361,-9.3,Piclozotan,URMTUEWUIGOJBW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55103,6crv,DB00611,-9.3,Butorphanol,IFKLAQQSCNILHL-PWRODBHTSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
11629,6lzg,DB12228,-9.3,Telcagepant,CGDZXLJGHVKVIE-DNVCBOLYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
105835,6vxs,DB14128,-9.3,Nadide,BAWFJGJZGIEFAR-NNYOXOHSSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
76661,6m2n,DB07460,-9.3,2-({5-CHLORO-2-[(2-METHOXY-4-MORPHOLIN-4-YLPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)-N-METHYLBENZAMIDE,UYJNQQDJUOUFQJ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76705,6m2n,DB07514,-9.3,"3-(2-aminoquinazolin-6-yl)-1-(3,3-dimethylindolin-6-yl)-4-methylpyridin-2(1H)-one",LHLGUOHREUTYTO-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
127760,6w4h,DB06817,-9.3,Raltegravir,CZFFBEXEKNGXKS-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
105655,6vxs,DB13791,-9.3,Penfluridol,MDLAAYDRRZXJIF-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
105170,6vxs,DB13101,-9.3,4SC-202,PRXXYMVLYKJITB-IZZDOVSWSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
127811,6w4h,DB06882,-9.3,1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-naphthalen-1-ylurea,HJWMLCDGRWWLAQ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
105129,6vxs,DB13042,-9.3,Fenoverine,UBAJTZKNDCEGKL-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
76781,6m2n,DB07608,-9.3,N-(5-{[(2S)-4-amino-2-(3-chlorophenyl)butanoyl]amino}-1H-indazol-3-yl)benzamide,JDGOPNUGILVNJZ-IBGZPJMESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
55110,6crv,DB00621,-9.3,Oxandrolone,QSLJIVKCVHQPLV-PEMPUTJUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
149092,6w9q,DB14894,-9.3,Galicaftor,QVDYQHXNAQHIKH-TZIWHRDSSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
127851,6w4h,DB06925,-9.3,3-(2-AMINOQUINAZOLIN-6-YL)-4-METHYL-N-[3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE,YEIASMOUYNOXGA-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
127624,6w4h,DB06543,-9.3,Astaxanthin,MQZIGYBFDRPAKN-UWFIBFSHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
104950,6vxs,DB12756,-9.3,TAK-901,WKDACQVEJIVHMZ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
76583,6m2n,DB07369,-9.3,"N-(3-chlorophenyl)-N-methyl-2-oxo-3-[(3,4,5-trimethyl-1H-pyrrol-2-yl)methyl]-2H-indole-5-sulfonamide",YMJLSOJLEXWATP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
127610,6w4h,DB06515,-9.3,Resiniferatoxin,DSDNAKHZNJAGHN-MXTYGGKSSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
54926,6crv,DB00396,-9.3,Progesterone,RJKFOVLPORLFTN-LEKSSAKUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61695,6crv,DB12447,-9.3,Nadifloxacin,JYJTVFIEFKZWCJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107127,6vxx,DB02323,-9.3,EM-1745,CKSDYJASHNGOOS-KTXOUVACSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61692,6crv,DB12443,-9.3,Sonedenoson,WUCQGGOGHZRELS-LSCFUAHRSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61686,6crv,DB12434,-9.3,Steviolbioside,OMHUCGDTACNQEX-OSHKXICASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
139058,6w9c,DB12784,-9.3,NS-018,UQTPDWDAYHAZNT-AWEZNQCLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139052,6w9c,DB12774,-9.3,AZD-8055,KVLFRAWTRWDEDF-IRXDYDNUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
76280,6m2n,DB07025,-9.3,3-(5-{[4-(AMINOMETHYL)PIPERIDIN-1-YL]METHYL}-1H-INDOL-2-YL)QUINOLIN-2(1H)-ONE,KBIHHEGEALBUMT-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
11236,6lzg,DB11691,-9.3,Naldemedine,AXQACEQYCPKDMV-RZAWKFBISA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
28416,6cs2,DB00737,-9.3,Meclizine,OCJYIGYOJCODJL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
28402,6cs2,DB07991,-9.3,N-[(1R)-3-(4-HYDROXYPHENYL)-1-METHYLPROPYL]-2-(2-PHENYL-1H-INDOL-3-YL)ACETAMIDE,APLJSSOXDWUNGV-GOSISDBHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
55027,6crv,DB00522,-9.3,Bentiromide,SPPTWHFVYKCNNK-FQEVSTJZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
11354,6lzg,DB11851,-9.3,Bafetinib,ZGBAJMQHJDFTQJ-DEOSSOPVSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
28380,6cs2,DB07969,-9.3,3-[3-(4-methylpiperazin-1-yl)-7-(trifluoromethyl)quinoxalin-5-yl]phenol,QNCYYRHIUFGGJX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
138974,6w9c,DB12655,-9.3,Patidegib,HZLFFNCLTRVYJG-WWGOJCOQSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
164850,7bv1,DB08683,-9.3,"REL-(9R,12S)-9,10,11,12-TETRAHYDRO-9,12-EPOXY-1H-DIINDOLO[1,2,3-FG:3',2',1'-KL]PYRROLO[3,4-I][1,6]BENZODIAZOCINE-1,3(2H)-DIONE",OTPNDVKVEAIXTI-IYBDPMFKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
76478,6m2n,DB07253,-9.3,"N'-(5-chloro-1,3-benzodioxol-4-yl)-N-(3-methylsulfonylphenyl)pyrimidine-2,4-diamine",QTFCKBFCXDAZIU-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
106257,6vxs,DB15327,-9.3,Abivertinib,UOFYSRZSLXWIQB-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
106208,6vxs,DB15232,-9.3,Telaglenastat,PRAAPINBUWJLGA-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
56861,6crv,DB02882,-9.3,Cyanocinnoline,CUWRVIIPSSUUDJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107139,6vxx,DB02338,-9.3,Nadph Dihydro-Nicotinamide-Adenine-Dinucleotidephosphate,ACFIXJIJDZMPPO-NNYOXOHSSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104909,6vxs,DB12694,-9.3,CE-326597,UBNMGTSDHSQBEL-PMERELPUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
127928,6w4h,DB07020,-9.3,"N-{3-[5-(1H-1,2,4-triazol-3-yl)-1H-indazol-3-yl]phenyl}furan-2-carboxamide",LMDMJDCLPIVGQD-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
102361,6vxs,DB07307,-9.3,N-cyclopropyl-4-methyl-3-[1-(2-methylphenyl)phthalazin-6-yl]benzamide,GQXMJOSCBRZMKE-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
77504,6m2n,DB08460,-9.3,"3-{5-[(6-amino-1H-pyrazolo[3,4-b]pyridin-3-yl)methoxy]-2-chlorophenoxy}-5-chlorobenzonitrile",KXDIHAQCVNNLIB-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
102284,6vxs,DB07220,-9.3,"N-[5-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-1H-INDAZOL-3-YL]-2-(4-PIPERIDIN-1-YLPHENYL)ACETAMIDE",ZXYIRNXOAJYLCU-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102256,6vxs,DB07186,-9.3,"4-(4-METHYLPIPERAZIN-1-YL)-N-[5-(2-THIENYLACETYL)-1,5-DIHYDROPYRROLO[3,4-C]PYRAZOL-3-YL]BENZAMIDE",TYYNSDQVFIOSFH-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102251,6vxs,DB07181,-9.3,"4'-[(1R)-1-amino-2-(2,5-difluorophenyl)ethyl]biphenyl-3-carboxamide",JYKFWUXBFJJDTP-HXUWFJFHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102119,6vxs,DB07031,-9.3,"3-Fluoro-4-{[(2R)-2-hydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthalenyl)acetyl]amino}benzoic acid",AANFHDFOMFRLLR-LJQANCHMSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
77533,6m2n,DB08494,-9.3,"S-{2-[(2-chloro-4-sulfamoylphenyl)amino]-2-oxoethyl} 6-methyl-3,4-dihydroquinoline-1(2H)-carbothioate",AWAKIULNKVOBKE-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138636,6w9c,DB12048,-9.3,Savolitinib,XYDNMOZJKOGZLS-NSHDSACASA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
101938,6vxs,DB06809,-9.3,Plerixafor,YIQPUIGJQJDJOS-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
138628,6w9c,DB11942,-9.3,Selinexor,DEVSOMFAQLZNKR-RJRFIUFISA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
101844,6vxs,DB06635,-9.3,Otamixaban,PFGVNLZDWRZPJW-OPAMFIHVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101839,6vxs,DB06626,-9.3,Axitinib,RITAVMQDGBJQJZ-FMIVXFBMSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101784,6vxs,DB06486,-9.3,Enzastaurin,AXRCEOKUDYDWLF-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101766,6vxs,DB06448,-9.3,Lonafarnib,DHMTURDWPRKSOA-RUZDIDTESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
28263,6cs2,DB07845,-9.3,"2-fluoro-6-{[2-({2-methoxy-4-[(methylsulfonyl)methyl]phenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide",VGYXXQRDIVRILX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
101742,6vxs,DB06393,-9.3,Xaliproden,WJJYZXPHLSLMGE-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
77700,6m2n,DB08698,-9.3,"1-[(3S)-5-PHENYL-3-THIOPHEN-2-YL-3H-1,4-BENZODIAZEPIN-2-YL]AZETIDIN-3-OL",BKSGACYTXOQQNI-OAQYLSRUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
28255,6cs2,DB07835,-9.3,"N-3-cyclopropyl-N-4-'-(cyclopropylmethyl)-6-methylbiphenyl-3,4'-dicarboxamide",BOPSUAHGQHFKGG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
55289,6crv,DB00834,-9.3,Mifepristone,VKHAHZOOUSRJNA-GCNJZUOMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
102416,6vxs,DB07369,-9.3,"N-(3-chlorophenyl)-N-methyl-2-oxo-3-[(3,4,5-trimethyl-1H-pyrrol-2-yl)methyl]-2H-indole-5-sulfonamide",YMJLSOJLEXWATP-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104875,6vxs,DB12644,-9.3,AZD-2066,SXWHYTICXCLKDG-GFCCVEGCSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102624,6vxs,DB07618,-9.3,"2-(4-(AMINOMETHYL)PIPERIDIN-1-YL)-N-(3_CYCLOHEXYL-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)ACETAMIDE",AITZHKQVQNLKHI-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102805,6vxs,DB07827,-9.3,"4-{[1-METHYL-2,4-DIOXO-6-(3-PHENYLPROP-1-YN-1-YL)-1,4-DIHYDROQUINAZOLIN-3(2H)-YL]METHYL}BENZOIC ACID",FLTYDFYSVZBKOB-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104762,6vxs,DB12465,-9.3,Ketanserin,FPCCSQOGAWCVBH-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
61595,6crv,DB12308,-9.3,Eltanolone,AURFZBICLPNKBZ-YZRLXODZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104727,6vxs,DB12415,-9.3,Galeterone,PAFKTGFSEFKSQG-PAASFTFBSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
55176,6crv,DB00700,-9.3,Eplerenone,JUKPWJGBANNWMW-VWBFHTRKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61593,6crv,DB12306,-9.3,Cipargamin,CKLPLPZSUQEDRT-WPCRTTGESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61590,6crv,DB12302,-9.3,CP-724714,LLVZBTWPGQVVLW-SNAWJCMRSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55187,6crv,DB00713,-9.3,Oxacillin,UWYHMGVUTGAWSP-JKIFEVAISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127969,6w4h,DB07064,-9.3,"(4R)-4-(3-HYDROXYPHENYL)-N,N,7,8-TETRAMETHYL-3,4-DIHYDROISOQUINOLINE-2(1H)-CARBOXAMIDE",HPVCRUIDFODATB-LJQANCHMSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
55207,6crv,DB00737,-9.3,Meclizine,OCJYIGYOJCODJL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
128035,6w4h,DB07141,-9.3,"5-[(3R)-3-(5-methoxy-4'-methylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",QVXYJVHNRPNRJL-HNNXBMFYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
104387,6vxs,DB11923,-9.3,Decoglurant,DMJHZVARRXJSEG-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104366,6vxs,DB11896,-9.3,Gedatolisib,DWZAEMINVBZMHQ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104340,6vxs,DB11855,-9.3,Revefenacin,FYDWDCIFZSGNBU-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
77302,6m2n,DB08204,-9.3,3-DIPHENOL-6-NITRO-3H-BENZO[DE]ISOCHROMEN-1-ONE,FLWABCQDXUKNQY-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77330,6m2n,DB08241,-9.3,4-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)--BENZAMIDE,RUUOIINPNMNPIU-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
104094,6vxs,DB11399,-9.3,Dirlotapide,TUOSYWCFRFNJBS-BHVANESWSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
77378,6m2n,DB08305,-9.3,"(3R)-3-cyclopentyl-6-methyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2-benzothiazine 1,1-dioxide",KQAGZLQCEURCKJ-QGZVFWFLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
103164,6vxs,DB08242,-9.3,"N,4-dimethyl-3-[(1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl)amino]benzamide",OYTBZXSFNNAVKU-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
77418,6m2n,DB08354,-9.3,"2-(4-CHLOROBENZYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE",QCVULERVJOYHCP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77485,6m2n,DB08437,-9.3,Puromycin,RXWNCPJZOCPEPQ-NVWDDTSBSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76092,6m2n,DB06786,-9.3,Halcinonide,MUQNGPZZQDCDFT-JNQJZLCISA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
107308,6vxx,DB03141,-9.3,"3-{[(5R,6R)-5-Benzyl-6-hydroxy-2,4-bis(4-hydroxybenzyl)-3-oxo-1,2,4-triazepan-1-yl]sulfonyl}benzonitril",UYUWNNRWESUYOB-FIRIVFDPSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107378,6vxx,DB03231,-9.3,"3-(5-Amino-7-oxo-3,7-dihydro-2H-[1,2,3]triazolo[4,5-d]pyrimidin-2-yl)-N-(2-{[2-(hydroxymethyl)phenyl]sulfanyl}benzyl)benzamide",IXDQOBDHBWEZOH-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62045,6crv,DB13002,-9.3,HKI-357,NERXPXBELDBEPZ-RMKNXTFCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
74463,6m2n,DB03383,-9.3,5-Chloro-1h-Indole-2-Carboxylic Acid [1-(4-Fluorobenzyl)-2-(4-Hydroxypiperidin-1yl)-2-Oxoethyl]Amide,YDCGVASFVACWKF-NRFANRHFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
74505,6m2n,DB03447,-9.3,Uridylyl-2'-5'-Phospho-Adenosine,QARCCHXXGAIRFS-KPKSGTNCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
139771,6w9c,DB13953,-9.3,Estradiol benzoate,UYIFTLBWAOGQBI-BZDYCCQFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
74597,6m2n,DB03583,-9.3,"(2e,3s)-3-Hydroxy-5'-[(4-Hydroxypiperidin-1-Yl)Sulfonyl]-3-Methyl-1,3-Dihydro-2,3'-Biindol-2'(1'h)-One",AYOAIABDFUJDKQ-SQJPUDIVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
28825,6cs2,DB08445,-9.3,"(3R,4S)-1-[6-(6-METHOXYPYRIDIN-3-YL)PYRIMIDIN-4-YL]-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE",IFKWHPAWYJARQJ-DYVFJYSZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
74660,6m2n,DB03671,-9.3,"4-(3,12,14-Trihydroxy-10,13-Dimethyl-Hexadecahydro-Cyclopenta[a]Phenanthren-17-Yl)-5h-Furan-2-One",SHIBSTMRCDJXLN-KCZCNTNESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
108979,6vxx,DB11855,-9.3,Revefenacin,FYDWDCIFZSGNBU-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
139741,6w9c,DB13874,-9.3,Enasidenib,DYLUUSLLRIQKOE-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
165359,7bv1,DB11986,-9.3,Entrectinib,HAYYBYPASCDWEQ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
108955,6vxx,DB11450,-9.3,Pimobendan,GLBJJMFZWDBELO-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165353,7bv1,DB11977,-9.3,Golvatinib,UQRCJCNVNUFYDX-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
62005,6crv,DB12937,-9.3,Quercetin-3'-O-phosphate,UWJBYNLLMAPJMM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108799,6vxx,DB08975,-9.3,Florantyrone,QOBAOSCOLAGPKI-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
33416,6cs2,T3D4647,-9.3,Loprazolam,UTEFBSAVJNEPTR-RGEXLXHISA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
108735,6vxx,DB08881,-9.3,Vemurafenib,GPXBXXGIAQBQNI-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
139678,6w9c,DB13791,-9.3,Penfluridol,MDLAAYDRRZXJIF-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
108720,6vxx,DB08846,-9.3,Ellagic Acid,AFSDNFLWKVMVRB-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
33466,6cs2,T3D4715,-9.3,Teniposide,NRUKOCRGYNPUPR-PSZSYXFXSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
24476,6cs2,DB02226,-9.3,"3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-4-Yl]Hexyl]-Phenanthridinium",NAARZDJZGYBXKL-UHFFFAOYSA-O,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
74965,6m2n,DB04071,-9.3,Cpad,LFERELMXERXKKQ-KMXXXSRASA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
125427,6w4h,DB02473,-9.3,"6-[N-(1-Isopropyl-3,4-Dihydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine",XRHANBWAKSYPEN-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
74347,6m2n,DB03231,-9.3,"3-(5-Amino-7-oxo-3,7-dihydro-2H-[1,2,3]triazolo[4,5-d]pyrimidin-2-yl)-N-(2-{[2-(hydroxymethyl)phenyl]sulfanyl}benzyl)benzamide",IXDQOBDHBWEZOH-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
62321,6crv,DB13418,-9.3,Moxestrol,MTMZZIPTQITGCY-OLGWUGKESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
73558,6m2n,DB02196,-9.3,Uridine-Diphosphate-N-Acetylgalactosamine,LFTYTUAZOPRMMI-NESSUJCYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
62250,6crv,DB13327,-9.3,Picotamide,KYWCWBXGRWWINE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
73659,6m2n,DB02329,-9.3,Carbenoxolone,OBZHEBDUNPOCJG-WBXJDKIVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
73666,6m2n,DB02338,-9.3,Nadph Dihydro-Nicotinamide-Adenine-Dinucleotidephosphate,ACFIXJIJDZMPPO-NNYOXOHSSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
109298,6vxx,DB13029,-9.3,MK-0873,JJWKQXNHYDJXKF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109288,6vxx,DB13019,-9.3,Henatinib,MCTXSDCWFQAGFS-UEXNTNOUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
125016,6w4h,DB01940,-9.3,Balanol Analog 2,SQLYTJZXRRDERK-ISKFKSNPSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
165457,7bv1,DB12128,-9.3,Ulimorelin,WGYPAJVJMXQXTR-ABNZCKJZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
73756,6m2n,DB02449,-9.3,3-(1h-Indol-3-Yl)-2-[4-(4-Phenyl-Piperidin-1-Yl)-Benzenesulfonylamino]-Propionic Acid,ULOTXPTWJAUGGE-MHZLTWQESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
109252,6vxx,DB12960,-9.3,INCB-9471,ZMCJFJZOSKEMOM-DNKZPPIMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
10272,6lzg,DB08450,-9.3,N-1H-indazol-5-yl-2-(6-methylpyridin-2-yl)quinazolin-4-amine,HNHRWNUXTCATSG-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
73839,6m2n,DB02551,-9.3,"6-[N-(4-Ethyl-1,2,3,4-Tetrahydro-6-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine",LVNMYQLXKMSQTG-AWEZNQCLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
109189,6vxx,DB12504,-9.3,JNJ-40346527,BNVPFDRNGHMRJS-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109146,6vxx,DB12434,-9.3,Steviolbioside,OMHUCGDTACNQEX-OSHKXICASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62103,6crv,DB13088,-9.3,AZD-0424,MVWATCATLSSVBH-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62086,6crv,DB13062,-9.3,ME-344,QVCAATSEPLQVBX-FPOVZHCZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
73952,6m2n,DB02704,-9.3,"(2r,3r,4r,5r)-3,4-Dihydroxy-N,N'-Bis[(1s,2r)-2-Hydroxy-2,3-Dihydro-1h-Inden-1-Yl]-2,5-Bis(2-Phenylethyl)Hexanediamide",GQKBYZPVKVXMJL-LAFNQVRVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
139828,6w9c,DB14067,-9.3,Dofequidar,KLWUUPVJTLHYIM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
125397,6w4h,DB02432,-9.3,RU90395,RLLAUERCSKPFGD-VMPREFPWSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
165319,7bv1,DB11923,-9.3,Decoglurant,DMJHZVARRXJSEG-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
61969,6crv,DB12885,-9.3,CF-102,IPSYPUKKXMNCNQ-PFHKOEEOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108607,6vxx,DB08454,-9.3,N-(5-METHYL-1H-PYRAZOL-3-YL)-2-PHENYLQUINAZOLIN-4-AMINE,JYCUVOXSZBECAY-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75732,6m2n,DB05616,-9.3,"4'-Methylene-5,8,10-trideazaaminopterin",NAWXUBYGYWOOIX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61818,6crv,DB12644,-9.3,AZD-2066,SXWHYTICXCLKDG-GFCCVEGCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75766,6m2n,DB05835,-9.3,NS-3728,OQRAKHDEGGGWQO-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
107940,6vxx,DB05713,-9.3,LY-517717,VYNKVNDKAOGAAQ-RUZDIDTESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107923,6vxx,DB05611,-9.3,Apilimod,HSKAZIJJKRAJAV-KOEQRZSOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75898,6m2n,DB06346,-9.3,Fiboflapon,DFQGDHBGRSTTHX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
107890,6vxx,DB05454,-9.3,Paliroden,CNEWKIDCGDXBDE-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107879,6vxx,DB05414,-9.3,Pipendoxifene,JICOGKJOQXTAIP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75912,6m2n,DB06401,-9.3,Bazedoxifene,UCJGJABZCDBEDK-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
107848,6vxx,DB04698,-9.3,"N-(1,4-DIHYDRO-5H-TETRAZOL-5-YLIDENE)-9-OXO-9H-XANTHENE-2-SULFONAMIDE",HJWYZPGYPZNDTN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127088,6w4h,DB04698,-9.3,"N-(1,4-DIHYDRO-5H-TETRAZOL-5-YLIDENE)-9-OXO-9H-XANTHENE-2-SULFONAMIDE",HJWYZPGYPZNDTN-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
148071,6w9q,DB12892,-9.3,MGB-BP-3,OEKXCVYZBVOWBR-BQYQJAHWSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
61748,6crv,DB12532,-9.3,Oxetacaine,FTLDJPRFCGDUFH-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127131,6w4h,DB04760,-9.3,"PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-(4-FLUORO-3-METHYL-BENZYLAMIDE)",PYFRREJCFXFNRR-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
107530,6vxx,DB03723,-9.3,2'-Deoxy-Thymidine-Beta-L-Rhamnose,ZOSQFDVXNQFKBY-CGAXJHMRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107492,6vxx,DB03671,-9.3,"4-(3,12,14-Trihydroxy-10,13-Dimethyl-Hexadecahydro-Cyclopenta[a]Phenanthren-17-Yl)-5h-Furan-2-One",SHIBSTMRCDJXLN-KCZCNTNESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75959,6m2n,DB06518,-9.3,R-1487,KKKRKRMVJRHDMG-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75972,6m2n,DB06543,-9.3,Astaxanthin,MQZIGYBFDRPAKN-UWFIBFSHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75986,6m2n,DB06589,-9.3,Pazopanib,CUIHSIWYWATEQL-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
108142,6vxx,DB07152,-9.3,N-[4-(5-fluoro-6-methylpyridin-2-yl)-5-quinoxalin-6-yl-1H-imidazol-2-yl]acetamide,TYPILNNEZPSNTI-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108196,6vxx,DB07215,-9.3,"2-METHYL-2-(4-{[({4-METHYL-2-[4-(TRIFLUOROMETHYL)PHENYL]-1,3-THIAZOL-5-YL}CARBONYL)AMINO]METHYL}PHENOXY)PROPANOIC ACID",ILUPZUOBHCUBKB-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108201,6vxx,DB07220,-9.3,"N-[5-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-1H-INDAZOL-3-YL]-2-(4-PIPERIDIN-1-YLPHENYL)ACETAMIDE",ZXYIRNXOAJYLCU-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108228,6vxx,DB07253,-9.3,"N'-(5-chloro-1,3-benzodioxol-4-yl)-N-(3-methylsulfonylphenyl)pyrimidine-2,4-diamine",QTFCKBFCXDAZIU-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28742,6cs2,DB08354,-9.3,"2-(4-CHLOROBENZYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE",QCVULERVJOYHCP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
108604,6vxx,DB08449,-9.3,"2-(3-((4,5,7-trifluorobenzo[d]thiazol-2-yl)methyl)-1H-pyrrolo[2,3-b]pyridin-1-yl)acetic acid",IEVFQDJUDLCOQY-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
126062,6w4h,DB03311,-9.3,"3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid [4-(Thiazol-2-Ylsulfamoyl)-Phenyl]-Amide",SXKBTDJJEQQEGE-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
75356,6m2n,DB04591,-9.3,"N-{2,2-DIFLUORO-2-[(2R)-PIPERIDIN-2-YL]ETHYL}-2-[2-(1H-1,2,4-TRIAZOL-1-YL)BENZYL][1,3]OXAZOLO[4,5-C]PYRIDIN-4-AMINE",VYJOAYZRCNHDNG-GOSISDBHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
126076,6w4h,DB03331,-9.3,"N-Naphthalen-1-Ylmethyl-2'-[3,5-Dimethoxybenzamido]-2'-Deoxy-Adenosine",OARVXDFNTLYMCJ-JVUUKAHWSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
108568,6vxx,DB08406,-9.3,"[N-(2,4-DIAMINOPTERIDIN-6-YL)-METHYL]-DIBENZ[B,F]AZEPINE",NXCCIJQEAKMFGW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
147706,6w9q,DB12323,-9.3,Radotinib,DUPWHXBITIZIKZ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
33938,6cs2,T3D0622,-9.3,Benzo[j]fluoranthene,KHNYNFUTFKJLDD-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
108505,6vxx,DB08068,-9.3,N-[4-CHLORO-3-(PYRIDIN-3-YLOXYMETHYL)-PHENYL]-3-FLUORO-,YQJVDUKATDECHF-ICSRJNTNSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77731,6m2n,DB08731,-9.3,"2-[(1R)-2-carboxy-1-(naphthalen-1-ylmethyl)ethyl]-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylic acid",GPOKTQCDBPECSS-MRXNPFEDSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
108498,6vxx,DB08058,-9.3,"4-[3-(1,4-diazepan-1-ylcarbonyl)-4-fluorobenzyl]phthalazin-1(2H)-one",HGEPGGJUGUMFHT-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108456,6vxx,DB08011,-9.3,"(3E)-5-fluoro-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-1H-indole-2,3-dione 3-oxime",DXIHOIDYHQSQKJ-HMMYKYKNSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
126249,6w4h,DB03583,-9.3,"(2e,3s)-3-Hydroxy-5'-[(4-Hydroxypiperidin-1-Yl)Sulfonyl]-3-Methyl-1,3-Dihydro-2,3'-Biindol-2'(1'h)-One",AYOAIABDFUJDKQ-SQJPUDIVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
108440,6vxx,DB07993,-9.3,"N-3-[3-(1H-INDOL-6-YL)BENZYL]PYRIDINE-2,3-DIAMINE",LPQUIIHPUGDHJK-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61877,6crv,DB12731,-9.3,Daporinad,KPBNHDGDUADAGP-VAWYXSNFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108385,6vxx,DB07698,-9.3,"3-(3-aminophenyl)-N-(3-chlorophenyl)pyrazolo[1,5-a]pyrimidin-5-amine",JDNMRPIWJIDDAY-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75650,6m2n,DB05171,-9.3,E-2012,PUOAETJYKQITMO-LANLRWRYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75675,6m2n,DB05327,-9.3,Ranirestat,QCVNMNYRNIMDKV-QGZVFWFLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
108243,6vxx,DB07270,-9.3,"N-[7-(3-AMINOPHENYL)-5-METHOXY-1,3-BENZOXAZOL-2-YL]-2,5-DICHLOROBENZENESULFONAMIDE",GAYYMURZGLJDCT-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108229,6vxx,DB07254,-9.3,"N-[3-[[4-[(5-CHLORO-1,3-BENZODIOXOL-4-YL)AMINO]PYRIMIDIN-2-YL]AMINO]PHENYL]METHANESULFONAMIDE",KQGTYXRWSIBDOZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61910,6crv,DB12787,-9.3,Norethandrolone,ZDHCJEIGTNNEMY-XGXHKTLJSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106187,6vxs,DB15197,-9.3,RSV-604,MTPVBMVUENFFLL-HXUWFJFHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
96420,6m71,DB12892,-9.3,MGB-BP-3,OEKXCVYZBVOWBR-BQYQJAHWSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
114836,6vxx,DB14982,-9.3,Miransertib,HNFMVVHMKGFCMB-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
83836,6m3m,DB04421,-9.3,Nicotinamide Adenine Dinucleotide 3-Pentanone Adduct,BZJFKYRGSZWSLT-YLIVDTKOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85552,6m3m,DB07794,-9.3,"5-(2-PHENYLPYRAZOLO[1,5-A]PYRIDIN-3-YL)-1H-PYRAZOLO[3,4-C]PYRIDAZIN-3-AMINE",XVECMUKVOMUNLE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85550,6m3m,DB07792,-9.3,"(S)-2-CHLORO-N-(1-(2-(2-HYDROXYETHYLAMINO)-2-OXOETHYL)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL)-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE",VUKPNWLGSLOHIF-AWEZNQCLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83926,6m3m,DB04540,-9.3,Cholesterol,HVYWMOMLDIMFJA-DPAQBDIFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59268,6crv,DB07269,-9.3,(2S)-2-[3-(AMINOMETHYL)PHENYL]-3-[(R)-[(1R)-1-{[(BENZYLOXY)CARBONYL]AMINO}-2-METHYLPROPYL](HYDROXY)PHOSPHORYL]PROPANOIC ACID,SFUOOKBZBVUDBC-VQTJNVASSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85468,6m3m,DB07697,-9.3,"1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-4-[(4-methoxyphenyl)sulfonyl]piperazine",HMGDKYUJSFVHIY-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136608,6w9c,DB07321,-9.3,"2,5-DICHLORO-N-[5-METHOXY-7-(6-METHOXYPYRIDIN-3-YL)-1,3-BENZOXAZOL-2-YL]BENZENESULFONAMIDE",KOKQLKWXOFRTHE-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
58655,6crv,DB06281,-9.3,Torcetrapib,CMSGWTNRGKRWGS-NQIIRXRSSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57636,6crv,DB03925,-9.3,Freselestat,HMPQTEPEMQZWQH-QZTJIDSGSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136613,6w9c,DB07326,-9.3,"6-chloro-N-pyrimidin-5-yl-3-{[3-(trifluoromethyl)phenyl]amino}-1,2-benzisoxazole-7-carboxamide",FEGRQUWSKADGSP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
59221,6crv,DB07212,-9.3,N-(7-CARBAMIMIDOYL-NAPHTHALEN-1-YL)-3-HYDROXY-2-METHYL-BENZAMIDE,NNGZRCYXFBHMRM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84089,6m3m,DB04759,-9.3,"PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-(3-METHYL-BENZYLAMIDE)",GTBUZLPQANSGGE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
57629,6crv,DB03916,-9.3,4-{2-[4-(2-Aminoethyl)Piperazin-1-Yl]Pyridin-4-Yl}-N-(3-Chloro-4-Methylphenyl)Pyrimidin-2-Amine,RHOOHUMOHVIXEF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85413,6m3m,DB07630,-9.3,"N-((1R,2R)-2-(5-CHLORO-1H-INDOLE-2-CARBOXAMIDO)CYCLOHEXYL)-5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE-2-CARBOXAMIDE",ARPFWVKYXJZULB-IAGOWNOFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85392,6m3m,DB07608,-9.3,N-(5-{[(2S)-4-amino-2-(3-chlorophenyl)butanoyl]amino}-1H-indazol-3-yl)benzamide,JDGOPNUGILVNJZ-IBGZPJMESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81163,6m3m,DB00881,-9.3,Quinapril,JSDRRTOADPPCHY-HSQYWUDLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59213,6crv,DB07203,-9.3,6-CYCLOHEXYLMETHOXY-2-(3'-CHLOROANILINO) PURINE,OUEGMEMDEAOAEG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85378,6m3m,DB07588,-9.3,"3,4-DI-1H-INDOL-3-YL-1H-PYRROLE-2,5-DICARBOXYLIC ACID",FZDVNXHYGMEEDT-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85370,6m3m,DB07578,-9.3,"3-[4-(2-METHYL-IMIDAZO[4,5-C]PYRIDIN-1-YL)BENZYL]-3H-BENZOTHIAZOL-2-ONE",WUOLYUKMMRCXGH-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84163,6m3m,DB04850,-9.3,Posizolid,HBUJYEUPIIJJOS-PBHICJAKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59960,6crv,DB08073,-9.3,(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE,YWTBGJGMTBHQTM-IBGZPJMESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84170,6m3m,DB04861,-9.3,Nebivolol,KOHIRBRYDXPAMZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85344,6m3m,DB07546,-9.3,[1-(6-{6-[(1-methylethyl)amino]-1H-indazol-1-yl}pyrazin-2-yl)-1H-pyrrol-3-yl]acetic acid,BBYRUZKRFAIQSR-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87269,6m3m,DB12081,-9.3,Anecortave,BCFCRXOJOFDUMZ-ONKRVSLGSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85342,6m3m,DB07544,-9.3,N'-(5-CHLOROBENZOFURAN-2-CARBONYL)-2-(TRIFLUOROMETHYL)BENZENESULFONOHYDRAZIDE,ZLQBZYKAQQWOTK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85570,6m3m,DB07813,-9.3,GLYCYLALANYL-N-2-NAPHTHYL-L-PROLINEAMIDE,KCELZXZDIUJGNM-GUYCJALGSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85587,6m3m,DB07832,-9.3,"4-{4-[(5-hydroxy-2-methylphenyl)amino]quinolin-7-yl}-1,3-thiazole-2-carbaldehyde",VKQPTVJDZIILPG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58608,6crv,DB06190,-9.3,Solabegron,LLDXOPKUNJTIRF-QFIPXVFZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57742,6crv,DB04071,-9.3,Cpad,LFERELMXERXKKQ-KMXXXSRASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27182,6cs2,DB06638,-9.3,Quarfloxin,WOQIDNWTQOYDLF-CGAIIQECSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
133210,6w9c,DB01411,-9.3,Pranlukast,NBQKINXMPLXUET-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
81442,6m3m,DB01198,-9.3,Zopiclone,GBBSUAFBMRNDJC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81402,6m3m,DB01155,-9.3,Gemifloxacin,ZRCVYEYHRGVLOC-HYARGMPZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87223,6m3m,DB12010,-9.3,Fostamatinib,GKDRMWXFWHEQQT-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58626,6crv,DB06228,-9.3,Rivaroxaban,KGFYHTZWPPHNLQ-AWEZNQCLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85735,6m3m,DB08005,-9.3,4-{[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino}-N-ethylpiperidine-1-carboxamide,ARMFMDYRYOKSOW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
27196,6cs2,DB06677,-9.3,Clazosentan,LFWCJABOXHSRGC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
59380,6crv,DB07395,-9.3,"4-[3-(2-Chloro-4,5-difluoro-benzoyl)ureido]-3-trifluoromethoxybenzoic acid",NWQGDIBCFLDHDO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
161227,7bv1,DB13422,-9.3,Nicofuranose,FUWFSXZKBMCSKF-ZASNTINBSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
83597,6m3m,DB04097,-9.3,Uridine-5'-Diphosphate-4-Deoxy-4-Fluoro-Alpha-D-Galactose,OAPPZHVTNHJVAL-JZMIEXBBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87232,6m3m,DB12025,-9.3,Triptolide,DFBIRQPKNDILPW-CIVMWXNOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85699,6m3m,DB07965,-9.3,6-(cyclohexylamino)-9-[2-(4-methylpiperazin-1-yl)-ethyl]-9H-purine-2-carbonitrile,OGODDSLNRULSMM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59907,6crv,DB08012,-9.3,(METHYLPYRIDAZINE PIPERIDINE ETHYLOXYPHENYL)ETHYLACETATE,KCHIOGFOPPOUJC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85686,6m3m,DB07949,-9.3,"({[(3E)-2'-OXO-2',7'-DIHYDRO-2,3'-BIINDOL-3(7H)-YLIDENE]AMINO}OXY)ACETIC ACID",BFQRPTKOSYMPOL-LALPNIDTSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85679,6m3m,DB07941,-9.3,PH-797804,KCAJXIDMCNPGHZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85637,6m3m,DB07891,-9.3,"4-{[(14beta,17alpha)-3-hydrox1tra-1,3,5(10)-trien-17-yl]oxy}-4-oxobutanoic acid",YJPIDPAGJSWWBE-FNIAAEIWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85612,6m3m,DB07861,-9.3,(2R)-N-hydroxy-3-naphthalen-2-yl-2-[(naphthalen-2-ylsulfonyl)amino]propanamide,MMOUXLMPQFMDRD-JOCHJYFZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81320,6m3m,DB01061,-9.3,Azlocillin,JTWOMNBEOCYFNV-NFFDBFGFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83742,6m3m,DB04285,-9.3,"{4-[(2s,4e)-2-(1,3-Benzothiazol-2-Yl)-2-(1h-1,2,3-Benzotriazol-1-Yl)-5-Phenylpent-4-Enyl]Phenyl}(Difluoro)Methylphosphonic Acid",GBLDYRVJENYQNH-AGLOJYHOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59332,6crv,DB07337,-9.3,"4-[4-AMINO-6-(5-CHLORO-1H-INDOL-4-YLMETHYL)-[1,3,5]TRIAZIN-2-YLAMINO]-BENZONITRILE",SOKOHDQTKSROQZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
83782,6m3m,DB04342,-9.3,7-((Carboxy(4-Hydroxyphenyl)Acetyl)Amino)-7-Methoxy-(3-((1-Methyl-1h-Tetrazol-5-Yl)Thio)Methyl)-8-Oxo-5-Oxa-1-Azabicyclo[4.2.0]Oct-2-Ene-2-Carboxylic Acid,JWCSIUVGFCSJCK-LIUKBUMOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
135874,6w9c,DB05482,-9.3,7-ethyl-10-hydroxycamptothecin,FJHBVJOVLFPMQE-QFIPXVFZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
84184,6m3m,DB04879,-9.3,Vatalanib,YCOYDOIWSSHVCK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81108,6m3m,DB00820,-9.3,Tadalafil,WOXKDUGGOYFFRN-IIBYNOLFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59159,6crv,DB07141,-9.3,"5-[(3R)-3-(5-methoxy-4'-methylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",QVXYJVHNRPNRJL-HNNXBMFYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87455,6m3m,DB12345,-9.3,MBX-2982,NFTMKHWBOINJGM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58755,6crv,DB06578,-9.3,Tonabersat,XLIIRNOPGJTBJD-ROUUACIJSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84312,6m3m,DB05465,-9.3,Tandutinib,UXXQOJXBIDBUAC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59153,6crv,DB07133,-9.3,D-phenylalanyl-N-(3-methylbenzyl)-L-prolinamide,CHKWABXWPATIIG-UXHICEINSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87470,6m3m,DB12368,-9.3,AZD-3839,MRXBCEQZNKUUIP-DEOSSOPVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85108,6m3m,DB07274,-9.3,"N-cyclopropyl-6-[(6,7-dimethoxyquinolin-4-yl)oxy]naphthalene-1-carboxamide",ZATGFXTWDKIEKC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
26589,6cs2,DB04760,-9.3,"PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-(4-FLUORO-3-METHYL-BENZYLAMIDE)",PYFRREJCFXFNRR-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
87472,6m3m,DB12371,-9.3,Siponimod,KIHYPELVXPAIDH-HNSNBQBZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85104,6m3m,DB07270,-9.3,"N-[7-(3-AMINOPHENYL)-5-METHOXY-1,3-BENZOXAZOL-2-YL]-2,5-DICHLOROBENZENESULFONAMIDE",GAYYMURZGLJDCT-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85099,6m3m,DB07263,-9.3,"[{2-bromo-4-[(2R)-3-oxo-2,3-diphenylpropyl]phenyl}(difluoro)methyl]phosphonic acid",WDTMVBQZDFMOIK-GOSISDBHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136798,6w9c,DB07544,-9.3,N'-(5-CHLOROBENZOFURAN-2-CARBONYL)-2-(TRIFLUOROMETHYL)BENZENESULFONOHYDRAZIDE,ZLQBZYKAQQWOTK-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
57317,6crv,DB03495,-9.3,"4,6-Dideoxy-4-{[4,5,6-Trihydroxy-3-(Hydroxymethyl)Cyclohex-2-En-1-Yl]Amino}-Alpha-D-Lyxo-Hexopyranosyl-(1->4)-Alpha-D-Threo-Hexopyranosyl-(1->6)-Alpha-L-Threo-Hexopyranose",FZLCJZILHGFQLM-PISLJJGOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59147,6crv,DB07127,-9.3,"{4-[2,2-BIS(5-METHYL-1,2,4-OXADIAZOL-3-YL)-3-PHENYLPROPYL]PHENYL}SULFAMIC ACID",SXDBFKLPNPUPRI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85069,6m3m,DB07229,-9.3,"3-{5-[AMINO(IMINIO)METHYL]-1H-INDOL-2-YL}-5-METHOXY-1,1'-BIPHENYL-2-OLATE",MINVOLKUPZPDNX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59116,6crv,DB07091,-9.3,(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclohexyloxy)ethanoyl)pyrrolidine-2-carboxamide,IWPMQJKXKKKSEY-SFHVURJKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57300,6crv,DB03472,-9.3,Cyclohexyl-Hexyl-Beta-D-Maltoside,WUCWJXGMSXTDAV-QKMCSOCLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84376,6m3m,DB05830,-9.3,Trestolone,YSGQGNQWBLYHPE-CFUSNLFHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87530,6m3m,DB12447,-9.3,Nadifloxacin,JYJTVFIEFKZWCJ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84394,6m3m,DB05959,-9.3,ENMD-1198,YQJWOUQGXATDAE-ACNBBOPNSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59098,6crv,DB07070,-9.3,(2S)-2-{3-[({[2-fluoro-4-(trifluoromethyl)phenyl]carbonyl}amino)methyl]-4-methoxybenzyl}butanoic acid,BDLLIPYDNFENMY-ZDUSSCGKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87537,6m3m,DB12461,-9.3,GLPG-0492,VAJGULUVTFDTAS-GOSISDBHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59093,6crv,DB07064,-9.3,"(4R)-4-(3-HYDROXYPHENYL)-N,N,7,8-TETRAMETHYL-3,4-DIHYDROISOQUINOLINE-2(1H)-CARBOXAMIDE",HPVCRUIDFODATB-LJQANCHMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58735,6crv,DB06518,-9.3,R-1487,KKKRKRMVJRHDMG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
131871,6w4h,DB14894,-9.3,Galicaftor,QVDYQHXNAQHIKH-TZIWHRDSSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
27301,6cs2,DB06833,-9.3,1-CYCLOHEXYL-N-{[1-(4-METHYLPHENYL)-1H-INDOL-3-YL]METHYL}METHANAMINE,MMIJMYOYKAKQPN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
85182,6m3m,DB07354,-9.3,"2,3-DIMETHOXY-12H-[1,3]DIOXOLO[5,6]INDENO[1,2-C]ISOQUINOLIN-6-IUM",LXDREMZQGAILJU-UHFFFAOYSA-O,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
57504,6crv,DB03758,-9.3,Radicicol,WYZWZEOGROVVHK-GTMNPGAYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57501,6crv,DB03755,-9.3,"Adenosine-5'-[Beta, Gamma-Methylene]Tetraphosphate",ARRGHMSEJJFDME-IOSLPCCCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
135614,6w9c,DB04708,-9.3,"(S)-TETRAHYDROFURAN-3-YL (2S,3S)-4-((S)-4-((1R,3R)-3-(2-AMINO-2-OXOETHYL)-2,3-DIHYDRO-1H-INDEN-1-YL)-2-BENZYL-3-OXO-2,3-DIHYDRO-1H-PYRROL-2-YL)-3-HYDROXY-1-PHENYLBUTAN-2-YLCARBAMATE",SYNSHNDQFWMLJW-YZGRCXSVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
57492,6crv,DB03744,-9.3,"Cp403700, (S)-1-{2-[(5-Chloro-1h-Indole-2-Carbonyl)-Amino]-3-Phenyl-Propionyl}-Azetidine-3-Carboxylate",RONLONYAIBUEKT-IBGZPJMESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59980,6crv,DB08096,-9.3,"8-(2-CHLOROPHENYLAMINO)-2-(2,6-DIFLUOROPHENYLAMINO)-9-ETHYL-9H-PURINE-1,7-DIIUM",ZWKOUFZHPNIQSH-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
131854,6w4h,DB14860,-9.3,Ensartinib,GLYMPHUVMRFTFV-QLFBSQMISA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
81066,6m3m,DB00769,-9.3,Hydrocortamate,FWFVLWGEFDIZMJ-FOMYWIRZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
57457,6crv,DB03701,-9.3,Vanoxerine,NAUWTFJOPJWYOT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84212,6m3m,DB04942,-9.3,Tamibarotene,MUTNCGKQJGXKEM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85249,6m3m,DB07434,-9.3,HONH-BENZYLMALONYL-L-ALANYLGLYCINE-P-NITROANILIDE,TZWQPWGUQCSKDW-GUYCJALGSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87363,6m3m,DB12222,-9.3,Lurtotecan,RVFGKBWWUQOIOU-NDEPHWFRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
131838,6w4h,DB14822,-9.3,SB-649868,ZJXIUGNEAIHSBI-IBGZPJMESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131837,6w4h,DB14821,-9.3,Macozinone,BJDZBXGJNBMCAV-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
87387,6m3m,DB12252,-9.3,PG-701,OKRSVUYYCJPECG-LFGMFVMYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84269,6m3m,DB05239,-9.3,Cobimetinib,BSMCAPRUBJMWDF-KRWDZBQOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85223,6m3m,DB07404,-9.3,"(1-HYDROXY-1-PHOSPHONO-2-[1,1';3',1'']TERPHENYL-3-YL-ETHYL)-PHOSPHONIC ACID",YXQQNSYZOQHKHD-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85222,6m3m,DB07403,-9.3,"4-[(3-CHLORO-4-{[(2R)-3,3,3-TRIFLUORO-2-HYDROXY-2-METHYLPROPANOYL]AMINO}PHENYL)SULFONYL]-N,N-DIMETHYLBENZAMIDE",DTDZLJHKVNTQGZ-GOSISDBHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
135471,6w9c,DB04514,-9.3,Phosphoric Acid-2'-[2'-Deoxy-Uridine]Ester-5'-Guanosine Ester,DFYLLEBFVZTKHD-VMIOUTBZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
159306,7bv1,DB03966,-9.3,Clorobiocin,FJAQNRBDVKIIKK-LFLQOBSNSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
84295,6m3m,DB05408,-9.3,Emricasan,SCVHJVCATBPIHN-SJCJKPOMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87420,6m3m,DB12297,-9.3,GLPG-0187,CXHCNOMGODVIKB-VWLOTQADSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
133767,6w9c,DB02123,-9.3,Glycochenodeoxycholic Acid,GHCZAUBVMUEKKP-GYPHWSFCSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
85189,6m3m,DB07362,-9.3,"1-(5-{2-[(1-methyl-1H-pyrazolo[4,3-d]pyrimidin-7-yl)amino]ethyl}-1,3-thiazol-2-yl)-3-[3-(trifluoromethyl)phenyl]urea",UOLCZAFAGDOUFX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87430,6m3m,DB12308,-9.3,Eltanolone,AURFZBICLPNKBZ-YZRLXODZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84403,6m3m,DB05992,-9.3,Plinabulin,UNRCMCRRFYFGFX-TYPNBTCFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59393,6crv,DB07409,-9.3,"(1-HYDROXY-1-PHOSPHONO-2-[1,1';4',1'']TERPHENYL-3-YL-ETHYL)-PHOSPHONIC ACID",MPBUFKZCEBTBSK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85771,6m3m,DB08043,-9.3,1-[4-(PYRIDIN-4-YLOXY)PHENYL]-3-[3-(TRIFLUOROMETHYL)PHENYL]UREA,DDDLGNOZDKDSEG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59543,6crv,DB07588,-9.3,"3,4-DI-1H-INDOL-3-YL-1H-PYRROLE-2,5-DICARBOXYLIC ACID",FZDVNXHYGMEEDT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
26857,6cs2,DB05553,-9.3,Regrelor,NXHAXEBZOXCDKD-XIXRRVGJSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
86361,6m3m,DB08750,-9.3,"1-[4-(AMINOMETHYL)BENZOYL]-5'-FLUORO-1'H-SPIRO[PIPERIDINE-4,2'-QUINAZOLIN]-4'-AMINE",SFPCNWQWKOUNRT-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58212,6crv,DB04698,-9.3,"N-(1,4-DIHYDRO-5H-TETRAZOL-5-YLIDENE)-9-OXO-9H-XANTHENE-2-SULFONAMIDE",HJWYZPGYPZNDTN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
132354,6w9c,DB00324,-9.3,Fluorometholone,FAOZLTXFLGPHNG-KNAQIMQKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
86350,6m3m,DB08739,-9.3,"2-{3-[(2S)-4,4-difluoro-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]-3-oxopropyl}-isoindole-1,3(2H)-dione",ZSXNPAWXICXNGZ-HNNXBMFYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59716,6crv,DB07793,-9.3,"(2S)-N-[(3S)-1-(2-AMINO-2-OXOETHYL)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL]-2-CHLORO-2H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE",ACSGSLPOHKRZCY-GXTWGEPZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59539,6crv,DB07584,-9.3,"N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine",OKGCSZUKOGMZAL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
82602,6m3m,DB02759,-9.3,4-Methylumbelliferyl Chitobiose,UPSFMJHZUCSEHU-JYGUBCOQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
159790,7bv1,DB06558,-9.3,Tezosentan,TUYWTLTWNJOZNY-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
27011,6cs2,DB06240,-9.3,Tariquidar,LGGHDPFKSSRQNS-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
59735,6crv,DB07813,-9.3,GLYCYLALANYL-N-2-NAPHTHYL-L-PROLINEAMIDE,KCELZXZDIUJGNM-GUYCJALGSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86231,6m3m,DB08597,-9.3,"6-[4-(2-piperidin-1-ylethoxy)phenyl]-3-pyridin-4-ylpyrazolo[1,5-a]pyrimidine",XHBVYDAKJHETMP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59736,6crv,DB07814,-9.3,Gibberellic acid,IXORZMNAPKEEDV-OBDJNFEBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86997,6m3m,DB11679,-9.3,Fruquintinib,BALLNEJQLSTPIO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58453,6crv,DB05351,-9.3,Dexlansoprazole,MJIHNNLFOKEZEW-RUZDIDTESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81946,6m3m,DB01893,-9.3,N6-Benzyl Adenosine-5'-Diphosphate,MRHGMAGSDAQUFH-LSCFUAHRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87008,6m3m,DB11694,-9.3,Ilorasertib,WPHKIQPVPYJNAX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86210,6m3m,DB08572,-9.3,4-{[4-AMINO-6-(CYCLOHEXYLMETHOXY)-5-NITROSOPYRIMIDIN-2-YL]AMINO}BENZAMIDE,YBKLJTXDSBEVRV-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
132776,6w9c,DB00836,-9.3,Loperamide,RDOIQAHITMMDAJ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
132265,6w9c,DB00223,-9.3,Diflorasone,WXURHACBFYSXBI-XHIJKXOTSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
82770,6m3m,DB02976,-9.3,Uridine-5'-monophosphate 2-deoxy-2-fluoro-galactopyranosyl-monophosphate ester,NGTCPFGWXMBZEP-KBQKSTHMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81945,6m3m,DB01889,-9.3,"16,17-Androstene-3-Ol",KRVXMNNRSSQZJP-PHFHYRSDSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136300,6w9c,DB06955,-9.3,"3,4-bis(7-chloro-1H-indol-3-yl)-1H-pyrrole-2,5-dicarboxylic acid",OAMCCJASDLMTOO-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136064,6w9c,DB06455,-9.3,Meclinertant,DYLJVOXRWLXDIG-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
59604,6crv,DB07663,-9.3,"2-[(1R)-1-CARBOXY-2-(4-HYDROXYPHENYL)ETHYL]-1,3-DIOXOISOINDOLINE-5-CARBOXYLIC ACID",QISJEFYTLZTWIQ-CQSZACIVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
82524,6m3m,DB02651,-9.3,"{[2-(1h-1,2,3-Benzotriazol-1-Yl)-2-(3,4-Difluorophenyl)Propane-1,3-Diyl]Bis[4,1-Phenylene(Difluoromethylene)]}Bis(Phosphonic Acid)",BTAGTGWPDROBMG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59671,6crv,DB07742,-9.3,"N-(2,3-DIFLUORO-BENZYL)-4-SULFAMOYL-BENZAMIDE",QASSMVGOSBNFQY-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86689,6m3m,DB09230,-9.3,Azelnidipine,ZKFQEACEUNWPMT-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136235,6w9c,DB06882,-9.3,1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-naphthalen-1-ylurea,HJWMLCDGRWWLAQ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
25989,6cs2,DB00471,-9.3,Montelukast,UCHDWCPVSPXUMX-TZIWLTJVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
59659,6crv,DB07728,-9.3,"2-[2-(2-FLUOROPHENYL)PYRIDIN-4-YL]-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE",XJJYJNMNYDNXNO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
161594,7bv1,DB00157,-9.3,NADH,BOPGDPNILDQYTO-NNYOXOHSSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
82356,6m3m,DB02432,-9.3,RU90395,RLLAUERCSKPFGD-VMPREFPWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86583,6m3m,DB09063,-9.3,Ceritinib,VERWOWGGCGHDQE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
82406,6m3m,DB02498,-9.3,Carba-Nicotinamide-Adenine-Dinucleotide,DGPLSUKWXXSBCU-VGXGLJSLSA-O,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
132571,6w9c,DB00591,-9.3,Fluocinolone acetonide,FEBLZLNTKCEFIT-VSXGLTOVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
86779,6m3m,DB09534,-9.3,Ecamsule,HEAHZSUCFKFERC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136185,6w9c,DB06721,-9.3,Gimatecan,UIVFUQKYVFCEKJ-OPTOVBNMSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
82446,6m3m,DB02547,-9.3,Guanosine-5'-Diphosphate-Rhamnose,LQEBEXMHBLQMDB-GDJBGNAASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
82452,6m3m,DB02554,-9.3,"Sulfoquinovose-Uridine-C1,5'-Diphosphate",FQANCGQCBCUSMI-JZMIEXBBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86470,6m3m,DB08905,-9.3,Formestane,OSVMTWJCGUFAOD-KZQROQTASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58379,6crv,DB04946,-9.3,Iloperidone,XMXHEBAFVSFQEX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59619,6crv,DB07680,-9.3,[(1S)-1-(5-CHLORO-1-BENZOTHIEN-3-YL)-2-(2-NAPHTHYLAMINO)-2-OXOETHYL]PHOSPHONIC ACID,HUJXISJLAPAFBO-IBGZPJMESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136283,6w9c,DB06933,-9.3,N-(tert-butyl)-4-[5-(pyridin-2-ylamino)quinolin-3-yl]benzenesulfonamide,GJTCKUKIFXWJKG-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
161529,7bv1,DB15023,-9.3,BMS-791826,DZBKAUMYTFPJIS-QHCPKHFHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59692,6crv,DB07765,-9.3,"METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL](METHYL)AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE",UKCFUFHREWUXJJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136154,6w9c,DB06673,-9.3,Almorexant,DKMACHNQISHMDN-RPLLCQBOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
86447,6m3m,DB08864,-9.3,Rilpivirine,YIBOMRUWOWDFLG-ONEGZZNKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59605,6crv,DB07664,-9.3,"5-AMINO-3-{[4-(AMINOSULFONYL)PHENYL]AMINO}-N-(2,6-DIFLUOROPHENYL)-1H-1,2,4-TRIAZOLE-1-CARBOTHIOAMIDE",ARIOBGGRZJITQX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
26969,6cs2,DB06163,-9.3,Plevitrexed,IEJSCSAMMLUINT-NRFANRHFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
87184,6m3m,DB11951,-9.3,Lemborexant,MUGXRYIUWFITCP-PGRDOPGGSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81935,6m3m,DB01876,-9.3,Bis(5-Amidino-2-Benzimidazolyl)Methanone,VVVXDHROXQUONB-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136362,6w9c,DB07031,-9.3,"3-Fluoro-4-{[(2R)-2-hydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthalenyl)acetyl]amino}benzoic acid",AANFHDFOMFRLLR-LJQANCHMSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
85947,6m3m,DB08248,-9.3,3-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)-BENZENESULFONAMIDE,BKDUVKJYBJDZQW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85941,6m3m,DB08241,-9.3,4-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)--BENZAMIDE,RUUOIINPNMNPIU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87124,6m3m,DB11867,-9.3,JNJ-39393406,IURMHZBQEYNQOH-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
27141,6cs2,DB06558,-9.3,Tezosentan,TUYWTLTWNJOZNY-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
59457,6crv,DB07486,-9.3,"3-({4-[(1E)-3-morpholin-4-yl-3-oxoprop-1-en-1-yl]-2,3-bis(trifluoromethyl)phenyl}sulfanyl)aniline",KLSZVPNVFKKIRD-FNORWQNLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57828,6crv,DB04180,-9.3,"4-(Aminosulfonyl)-N-[(2,4-Difluorophenyl)Methyl]-Benzamide",NTDFJEKGSGSXME-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59445,6crv,DB07471,-9.3,"5-[5,6-BIS(METHYLOXY)-1H-BENZIMIDAZOL-1-YL]-3-{[1-(2-CHLOROPHENYL)ETHYL]OXY}-2-THIOPHENECARBOXAMIDE",UHCHLTQBLNUYRT-GFCCVEGCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85907,6m3m,DB08197,-9.3,"(5E,7S)-2-amino-7-(4-fluoro-2-pyridin-3-ylphenyl)-4-methyl-7,8-dihydroquinazolin-5(6H)-one oxime",KYIXUSLGFINPTC-WVFAEZDRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83156,6m3m,DB03501,-9.3,Galactose-uridine-5'-diphosphate,HSCJRCZFDFQWRP-ABVWGUQPSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59441,6crv,DB07467,-9.3,"4-chloro-N-[(2S)-2-methyl-2,3-dihydro-1H-indol-1-yl]-3-sulfamoylbenzamide",NDDAHWYSQHTHNT-JTQLQIEISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57783,6crv,DB04125,-9.3,N-Alpha-(2-Naphthylsulfonyl)-N(3-Amidino-L-Phenylalaninyl)-4-Acetyl-Piperazine,ZUWBXGHMVKDMQO-DEOSSOPVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
83233,6m3m,DB03619,-9.3,Deoxycholic Acid,KXGVEGMKQFWNSR-LLQZFEROSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87148,6m3m,DB11901,-9.3,Apalutamide,HJBWBFZLDZWPHF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
26145,6cs2,DB04215,-9.3,CRA_9076,BVTBOJXEAPSOEB-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
132028,6w4h,DB15233,-9.3,Avapritinib,DWYRIWUZIJHQKQ-SANMLTNESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
58572,6crv,DB06077,-9.3,Lumateperone,HOIIHACBCFLJET-SFTDATJTSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
135918,6w9c,DB05713,-9.3,LY-517717,VYNKVNDKAOGAAQ-RUZDIDTESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
133146,6w9c,DB01267,-9.3,Paliperidone,PMXMIIMHBWHSKN-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
132024,6w4h,DB15227,-9.3,Tirabrutinib,SEJLPXCPMNSRAM-GOSISDBHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
81517,6m3m,DB01329,-9.3,Cefoperazone,GCFBRXLSHGKWDP-XCGNWRKASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87165,6m3m,DB11923,-9.3,Decoglurant,DMJHZVARRXJSEG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58582,6crv,DB06134,-9.3,SNS-314,FAYAUAZLLLJJGH-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
135901,6w9c,DB05611,-9.3,Apilimod,HSKAZIJJKRAJAV-KOEQRZSOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
135980,6w9c,DB06229,-9.3,Ocaperidone,ZZQNEJILGNNOEP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
58463,6crv,DB05414,-9.3,Pipendoxifene,JICOGKJOQXTAIP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27125,6cs2,DB06521,-9.3,Ertiprotafib,FONCZICQWCUXEB-RUZDIDTESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
81625,6m3m,DB01485,-9.3,4-Hydroxytestosterone,BQOIJSIMMIDHMO-FBPKJDBXSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
132252,6w9c,DB00206,-9.3,Reserpine,QEVHRUUCFGRFIF-MDEJGZGSSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
87021,6m3m,DB11712,-9.3,Tezacaftor,MJUVRTYWUMPBTR-MRXNPFEDSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
27047,6cs2,DB06314,-9.3,SGX-523,BCZUAADEACICHN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
136050,6w9c,DB06420,-9.3,Annamycin,CIDNKDMVSINJCG-GKXONYSUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
82807,6m3m,DB03035,-9.3,"1,8-Di-Hydroxy-4-Nitro-Anthraquinone",RIYCICFDXLNQPV-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86143,6m3m,DB08493,-9.3,"5-METHYL-3-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.013,18]NONADECA-12(19),13,15,17-TETRAEN-10-YLCARBAMOYL)-HEXANOIC ACID",AKWKBACKRMYPRV-NQIIRXRSSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59509,6crv,DB07546,-9.3,[1-(6-{6-[(1-methylethyl)amino]-1H-indazol-1-yl}pyrazin-2-yl)-1H-pyrrol-3-yl]acetic acid,BBYRUZKRFAIQSR-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136038,6w9c,DB06393,-9.3,Xaliproden,WJJYZXPHLSLMGE-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
81818,6m3m,DB01721,-9.3,Analogue of Indinavir Drug,MJIRDPUZGGHJMX-OIVSQUILSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
132875,6w9c,DB00948,-9.3,Mezlocillin,YPBATNHYBCGSSN-VWPFQQQWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
82844,6m3m,DB03082,-9.3,6-[(Z)-Amino(Imino)Methyl]-N-[4-(Aminomethyl)Phenyl]-4-(Pyrimidin-2-Ylamino)-2-Naphthamide,CSWQJKHBMACTGB-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58003,6crv,DB04424,-9.3,RPR128515,XFKVLKLCLYJKNF-MZNJEOGPSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87076,6m3m,DB11795,-9.3,GSK-2636771,XTKLTGBKIDQGQL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
26088,6cs2,DB04154,-9.3,"N-Methyl-N-[3-(6-Phenyl[1,2,4]Triazolo[4,3-B]Pyridazin-3-Yl)Phenyl]Acetamide",ALBWBHNFOJJMCV-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
58492,6crv,DB05532,-9.3,BMS-488043,DBPMWRYLTBNCCE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136020,6w9c,DB06314,-9.3,SGX-523,BCZUAADEACICHN-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
82942,6m3m,DB03213,-9.3,Bis(5-Amidino-2-Benzimidazolyl)Methane Ketone,VVVXDHROXQUONB-UHFFFAOYSA-P,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
159717,7bv1,DB05450,-9.3,Smilagenin,GMBQZIIUCVWOCD-UQHLGXRBSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
86057,6m3m,DB08389,-9.3,"6,7-DIMETHOXY-4-[(3R)-3-(2-NAPHTHYLOXY)PYRROLIDIN-1-YL]QUINAZOLINE",UPTQSRGSSJRBKJ-LJQANCHMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
27094,6cs2,DB06454,-9.3,Sarizotan,HKFMQJUJWSFOLY-OAQYLSRUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
81638,6m3m,DB01501,-9.3,Difenoxin,UFIVBRCCIRTJTN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83011,6m3m,DB03300,-9.3,Pterin Cytosine Dinucleotide,WKSPNQYEWZEMMI-FEFZDOOUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
135999,6w9c,DB06263,-9.3,Amrubicin,VJZITPJGSQKZMX-XDPRQOKASA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
81621,6m3m,DB01481,-9.3,1-Testosterone,OKJCFMUGMSVJBG-ABEVXSGRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85012,6m3m,DB07162,-9.3,4-(3-amino-1H-indazol-5-yl)-N-tert-butylbenzenesulfonamide,KFJCXIOVAGJCKB-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
160349,7bv1,DB08036,-9.3,"6,7,12,13-tetrahydro-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazol-5-one",MEXUTNIFSHFQRG-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
84882,6m3m,DB07014,-9.3,"2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4-methoxybenzyl)sulfanyl]-1,3,4-oxadiazole",TUTZKAQTSPMEBI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84600,6m3m,DB06595,-9.3,Midostaurin,BMGQWWVMWDBQGC-IIFHNQTCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87783,6m3m,DB12854,-9.3,BMS-908662,MMNNTJYFHUDSKL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
60107,6crv,DB08242,-9.3,"N,4-dimethyl-3-[(1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl)amino]benzamide",OYTBZXSFNNAVKU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57201,6crv,DB03331,-9.3,"N-Naphthalen-1-Ylmethyl-2'-[3,5-Dimethoxybenzamido]-2'-Deoxy-Adenosine",OARVXDFNTLYMCJ-JVUUKAHWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
134952,6w9c,DB03791,-9.3,"(3-{3-[[2-Chloro-3-(Trifluoromethyl)Benzyl](2,2-Diphenylethyl)Amino]Propoxy}Phenyl)Acetic Acid",NAXSRXHZFIBFMI-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
80370,6m2n,DB15222,-9.3,GS-6620,YAAQYJCOIFNMKX-RSTNYOGXSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137039,6w9c,DB07827,-9.3,"4-{[1-METHYL-2,4-DIOXO-6-(3-PHENYLPROP-1-YN-1-YL)-1,4-DIHYDROQUINAZOLIN-3(2H)-YL]METHYL}BENZOIC ACID",FLTYDFYSVZBKOB-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
60193,6crv,DB08353,-9.3,"2-(CYCLOHEXYLMETHYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE",NCVMTHVSAJMOPI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
134194,6w9c,DB02691,-9.3,Glycocholic acid,RFDAIACWWDREDC-FRVQLJSFSA-M,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
135042,6w9c,DB03903,-9.3,Tmr,KGFLZYXDJDOIEE-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136890,6w9c,DB07653,-9.3,"N-(5,6-DIPHENYLFURO[2,3-D]PYRIMIDIN-4-YL)GLYCINE",VXTCEUDVOCLEJG-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
158933,7bv1,DB02651,-9.3,"{[2-(1h-1,2,3-Benzotriazol-1-Yl)-2-(3,4-Difluorophenyl)Propane-1,3-Diyl]Bis[4,1-Phenylene(Difluoromethylene)]}Bis(Phosphonic Acid)",BTAGTGWPDROBMG-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160876,7bv1,DB11851,-9.3,Bafetinib,ZGBAJMQHJDFTQJ-DEOSSOPVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
84806,6m3m,DB06921,-9.3,(2S)-2-[3-(AMINOMETHYL)PHENYL]-3-[(R)-HYDROXY{(1R)-2-METHYL-1-[(PHENYLSULFONYL)AMINO]PROPYL}PHOSPHORYL]PROPANOIC ACID,FNZHLCNFXRRIIC-RBUKOAKNSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
134898,6w9c,DB03712,-9.3,RU85053,CEKLBQMULVLLTD-VMPREFPWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
87693,6m3m,DB12706,-9.3,Seletalisib,LNLJHGXOFYUARS-OAQYLSRUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84993,6m3m,DB07140,-9.3,"5-[(3R)-3-(5-methoxybiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",JPENSYBRTSIYGO-AWEZNQCLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
56955,6crv,DB03005,-9.3,"3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-5-Yl]Hexyl]-Phenanthridinium",ISUOMOOYAOQQPZ-UHFFFAOYSA-O,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84436,6m3m,DB06174,-9.3,Noscapine,AKNNEGZIBPJZJG-MSOLQXFVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59058,6crv,DB07027,-9.3,D-phenylalanyl-N-(3-fluorobenzyl)-L-prolinamide,JGZSVYZIJHGHMA-MOPGFXCFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
159017,7bv1,DB03038,-9.3,LY341770,MXAFDBCLWLMXSI-ZDUSSCGKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
87796,6m3m,DB12875,-9.3,Mavatrep,ORDHXXHTBUZRCN-NTEUORMPSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80684,6m3m,DB00304,-9.3,Desogestrel,RPLCPCMSCLEKRS-BPIQYHPVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58798,6crv,DB06666,-9.3,Lixivaptan,PPHTXRNHTVLQED-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
135141,6w9c,DB04040,-9.3,"N-(2-Morpholin-4-Yl-1-Morpholin-4-Ylmethyl-Ethyl)-3-Nitro-5-(3,4,5-Trihydroxy-6-Hydroxymethyl-Tetrahydro-Pyran-2-Yloxy)-Benzamide",MCMWCTMAKPQTPI-WGNYYXNJSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
84496,6m3m,DB06302,-9.3,Glesatinib,YRCHYHRCBXNYNU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84827,6m3m,DB06945,-9.3,N-hydroxy-4-({4-[4-(trifluoromethyl)phenoxy]phenyl}sulfonyl)tetrahydro-2H-pyran-4-carboxamide,FOSWRYKPHVPIDJ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
160874,7bv1,DB11847,-9.3,Cadazolid,XWFCFMXQTBGXQW-GOSISDBHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
57161,6crv,DB03276,-9.3,"4-[(10s,14s,18s)-18-(2-Amino-2-Oxoethyl)-14-(1-Naphthylmethyl)-8,17,20-Trioxo-7,16,19-Triazaspiro[5.14]Icos-11-En-10-Yl]Benzylphosphonic Acid",RHYFMOCFCFUTNH-GZNVFMSSSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
135142,6w9c,DB04042,-9.3,"2-[4-(Hydroxy-Methoxy-Methyl)-Benzyl]-7-(4-Hydroxymethyl-Benzyl)-1,1-Dioxo-3,6-Bis-Phenoxymethyl-1lambda6-[1,2,7]Thiadiazepane-4,5-Diol",XLJNZONSWKENRP-VABIIVNOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
60129,6crv,DB08272,-9.3,(4S)-4-(2-NAPHTHYLMETHYL)-D-GLUTAMIC ACID,YDWIUFASTTZKNI-UONOGXRCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
158792,7bv1,DB02226,-9.3,"3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-4-Yl]Hexyl]-Phenanthridinium",NAARZDJZGYBXKL-UHFFFAOYSA-O,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
80375,6m2n,DB15232,-9.3,Telaglenastat,PRAAPINBUWJLGA-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
87594,6m3m,DB12548,-9.3,Sparsentan,WRFHGDPIDHPWIQ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136858,6w9c,DB07618,-9.3,"2-(4-(AMINOMETHYL)PIPERIDIN-1-YL)-N-(3_CYCLOHEXYL-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)ACETAMIDE",AITZHKQVQNLKHI-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
160918,7bv1,DB12269,-9.3,PF-06273340,BPIWZDNVMQQBQX-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
84601,6m3m,DB06597,-9.3,Estradiol sulfamate,YXYXCSOJKUAPJI-ZBRFXRBCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84484,6m3m,DB06267,-9.3,Udenafil,IYFNEFQTYQPVOC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58852,6crv,DB06747,-9.3,ginkgolide-M,KDKROYXEHCYLJQ-FJFAJXJPSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60098,6crv,DB08233,-9.3,6-CYCLOHEXYLMETHYLOXY-2-(4'-HYDROXYANILINO)PURINE,RFSDQDHHBKYQOD-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84804,6m3m,DB06919,-9.3,D-phenylalanyl-N-(3-chlorobenzyl)-L-prolinamide,CJHLRGCXPGIPCB-MOPGFXCFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80403,6m2n,DB15291,-9.3,BMS-986142,ZRYMMWAJAFUANM-INIZCTEOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
56978,6crv,DB03041,-9.3,UDP-alpha-D-glucuronic acid,HDYANYHVCAPMJV-LXQIFKJMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60148,6crv,DB08299,-9.3,"4-[8-(3-nitrophenyl)-1,7-naphthyridin-6-yl]benzoic acid",QTNUWEKKZHSUQO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
26544,6cs2,DB04703,-9.3,Hesperidin,QUQPHWDTPGMPEX-QJBIFVCTSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
80404,6m2n,DB15292,-9.3,Foliglurax,ZTEDNASHAWNBKQ-NCELDCMTSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
84485,6m3m,DB06268,-9.3,Sitaxentan,PHWXUGHIIBDVKD-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87607,6m3m,DB12567,-9.3,Camicinal,RZKDEGZIFSJVNA-IBGZPJMESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80714,6m3m,DB00342,-9.3,Terfenadine,GUGOEEXESWIERI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84741,6m3m,DB06847,-9.3,"5-[(3S)-3-(2-methoxybiphenyl-4-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",YYCPXVRHQUEVAW-CQSZACIVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
57124,6crv,DB03231,-9.3,"3-(5-Amino-7-oxo-3,7-dihydro-2H-[1,2,3]triazolo[4,5-d]pyrimidin-2-yl)-N-(2-{[2-(hydroxymethyl)phenyl]sulfanyl}benzyl)benzamide",IXDQOBDHBWEZOH-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84846,6m3m,DB06972,-9.3,"7A-[(4-cyanophenyl)methyl]-6-(3,5-dichlorophenyl)-5-oxo-2,3,5,7A-tetrahydro-1H-pyrrolo[1,2-A]pyrrole-7-carbonitrile",TZCXQSNBTXDAJG-QFIPXVFZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84420,6m3m,DB06144,-9.3,Sertindole,GZKLJWGUPQBVJQ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87560,6m3m,DB12494,-9.3,SGI-1776,MHXGEROHKGDZGO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
60149,6crv,DB08300,-9.3,"1-methyl-3-naphthalen-2-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine",UOKGZPYGRJDACN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130959,6w4h,DB13059,-9.3,PF-03814735,RYYNGWLOYLRZLK-RBUKOAKNSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
163555,7bv1,DB04785,-9.3,Streptolydigin,KVTPRMV1KLIG-NCAOFHFGSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
84760,6m3m,DB06871,-9.3,17-METHYL-17-ALPHA-DIHYDROEQUILENIN,FQMQOMRDADWGJJ-GBESFXJTSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84675,6m3m,DB06732,-9.3,beta-Naphthoflavone,OUGIDAPQYNCXRA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80639,6m3m,DB00251,-9.3,Terconazole,BLSQLHNBWJLIBQ-OZXSUGGESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87751,6m3m,DB12798,-9.3,Relenopride,KGMMSPVVHZGPHL-NRFANRHFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
160792,7bv1,DB11734,-9.3,Fedovapagon,RUOLFWZIFNQQGH-DEOSSOPVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
80449,6m2n,DB15385,-9.3,Acebilustat,GERJIEKMNDGSCS-DQEYMECFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
57077,6crv,DB03173,-9.3,CRA_10433,CFSQPEBVGUSQII-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84500,6m3m,DB06311,-9.3,Darapladib,WDPFJWLDPVQCAJ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58848,6crv,DB06743,-9.3,Ginkgolide A,FPUXKXIZEIDQKW-VKMVSBOZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59074,6crv,DB07043,-9.3,"7-amino-2-tert-butyl-4-(4-pyrimidin-2-ylpiperazin-1-yl)pyrido[2,3-d]pyrimidine-6-carboxamide",CKLCIJCZOIDJQU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84849,6m3m,DB06977,-9.3,(2S)-1-{[5-(1H-Indazol-5-yl)-3-pyridinyl]oxy}-3-(7aH-indol-3-yl)-2-propanamine,CAASENZOSQYNPX-HSTJUUNISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
25709,6cs2,DB03712,-9.3,RU85053,CEKLBQMULVLLTD-VMPREFPWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
59092,6crv,DB07063,-9.3,"{3-[(4,5,7-TRIFLUORO-1,3-BENZOTHIAZOL-2-YL)METHYL]-1H-INDOL-1-YL}ACETIC ACID",KYHVTMFADJNSGS-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57131,6crv,DB03239,-9.3,"3',5'-Dinitro-N-Acetyl-L-Thyronine",VZSQTOXQXPKQJX-ZDUSSCGKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87766,6m3m,DB12823,-9.3,Tecarfarin,QFLNTQDOVCLQKW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59027,6crv,DB06992,-9.3,"(3,3-dimethylpiperidin-1-yl)(6-(3-fluoro-4-methylphenyl)pyridin-2-yl)methanone",SIDDLTBLAQYZIZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
135136,6w9c,DB04030,-9.3,"1,3,4,9-Tetrahydro-2-(Hydroxybenzoyl)-9-[(4-Hydroxyphenyl)Methyl]-6-Methoxy-2h-Pyrido[3,4-B]Indole",ADXYEWMDAGIULV-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
134476,6w9c,DB03126,-9.2,Mant-Adp,QPKUEBLEGWBRHC-BFHYXJOUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
54818,6crv,DB00266,-9.2,Dicoumarol,DOBMPNYZJYQDGZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107783,6vxx,DB04609,-9.2,INHIBITOR Q8467 OF DUPONT MERCK,HFLCERPZYCWLSZ-VKONIRKNSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
82911,6m3m,DB03173,-9.2,CRA_10433,CFSQPEBVGUSQII-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
30046,6cs2,DB11979,-9.2,Elagolix,HEAUOKZIVMZVQL-VWLOTQADSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
58481,6crv,DB05490,-9.2,AMG-131,NMRWDFUZLLQSBN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107757,6vxx,DB04575,-9.2,Quinestrol,PWZUUYSISTUNDW-VAFBSOEGSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
139195,6w9c,DB13003,-9.2,Cortivazol,RKHQGWMMUURILY-UHRZLXHJSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
107781,6vxx,DB04607,-9.2,"PHENYLAMINOIMIDAZO(1,2-ALPHA)PYRIDINE",UQAWGIKJINAKIZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
16673,6cs2,HMDB0003415,-9.2,"(3R,3'S,6'R)-b,e-Carotene-3,3'-diol",KBPHJBAIARWVSC-IRHPOQNPSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
107684,6vxx,DB04177,-9.2,"4-(3,14-Dihydroxy-10,13-Dimethyl-Hexadecahydro-Cyclopenta[a]Phenanthren-17-Yl)-5h-Furan-2-One",XZTUSOXSLKTKJQ-CESUGQOBSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
63047,6crv,DB15033,-9.2,Flortaucipir,GETAAWDSFUCLBS-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86102,6m3m,DB08444,-9.2,"3-[2-bromo-4-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)phenoxy]-5-methylbenzonitrile",YYGZQXRLQMFHDH-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136063,6w9c,DB06454,-9.2,Sarizotan,HKFMQJUJWSFOLY-OAQYLSRUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
76154,6m2n,DB06876,-9.2,"N-{5-[4-(4-METHYLPIPERAZIN-1-YL)PHENYL]-1H-PYRROLO[2,3-B]PYRIDIN-3-YL}NICOTINAMIDE",YJWJKKXGAPWLGT-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
107088,6vxx,DB02269,-9.2,[4-({[5-Benzyloxy-1-(3-Carbamimidoyl-Benzyl)-1h-Indole-2-Carbonyl]-Amino}-Methyl)-Phenyl]-Trimethyl-Ammonium,UFKJQTGPBFWMGT-UHFFFAOYSA-O,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
67178,6lxt,DB05983,-9.2,Bardoxolone methyl,WPTTVJLTNAWYAO-KPOXMGGZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
114443,6vxx,DB13638,-9.2,Cefbuperazone,SMSRCGPDNDCXFR-CYWZMYCQSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76124,6m2n,DB06837,-9.2,"(2R)-N-4-hydroxy-2-(3-hydroxybenzyl)-N-1-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]butanediamide",VXDKQRWTOJFQKH-BJZITVGISA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76119,6m2n,DB06831,-9.2,2-((9H-PURIN-6-YLTHIO)METHYL)-5-CHLORO-3-(2-METHOXYPHENYL)QUINAZOLIN-4(3H)-ONE,UMMYTDJYDSTEMB-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61717,6crv,DB12479,-9.2,Zabofloxacin,ZNPOCLHDJCAZAH-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107205,6vxx,DB02703,-9.2,Fusidic acid,IECPWNUMDGFDKC-MZJAQBGESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
132852,6w9c,DB00921,-9.2,Buprenorphine,RMRJXGBAOAMLHD-IHFGGWKQSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139120,6w9c,DB12887,-9.2,Tazemetostat,NSQSAUGJQHDYNO-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
61730,6crv,DB12505,-9.2,E-7820,LWGUASZLXHYWIV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86137,6m3m,DB08487,-9.2,3-({4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-2-OXOPIPERAZIN-1-YL}METHYL)BENZENECARBOXIMIDAMIDE,PRMSFVUWLBPPLY-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86133,6m3m,DB08481,-9.2,"4-METHYL-N-{(5E)-5-[(5-METHYL-2-FURYL)METHYLENE]-4-OXO-4,5-DIHYDRO-1,3-THIAZOL-2-YL}BENZENESULFONAMIDE",MXAPQGDBWFYKKX-ZROIWOOFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
127110,6w4h,DB04727,-9.2,"N-(4-{4-AMINO-6-[4-(METHYLOXY)PHENYL]FURO[2,3-D]PYRIMIDIN-5-YL}PHENYL)-N'-[2-FLUORO-5-(TRIFLUOROMETHYL)PHENYL]UREA",FGZIONRFHVNRJB-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
139139,6w9c,DB12914,-9.2,MGL-3196,FDBYIYFVSAHJLY-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
107370,6vxx,DB03222,-9.2,dATP,SUYVUBYJARFZHO-RRKCRQDMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86115,6m3m,DB08460,-9.2,"3-{5-[(6-amino-1H-pyrazolo[3,4-b]pyridin-3-yl)methoxy]-2-chlorophenoxy}-5-chlorobenzonitrile",KXDIHAQCVNNLIB-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
114287,6vxx,DB13242,-9.2,Bucladesine,CJGYSWNGNKCJSB-YVLZZHOMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75982,6m2n,DB06581,-9.2,Bevirimat,YJEJKUQEXFSVCJ-WRFMNRASSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
165139,7bv1,DB11399,-9.2,Dirlotapide,TUOSYWCFRFNJBS-BHVANESWSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
58473,6crv,DB05450,-9.2,Smilagenin,GMBQZIIUCVWOCD-UQHLGXRBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127022,6w4h,DB04608,-9.2,"9-HYDROXY-4-PHENYL-6H-PYRROLO[3,4-C]CARBAZOLE-1,3-DIONE",IAUZTOZLTFSMIE-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
107461,6vxx,DB03632,-9.2,Argifin,UHBHXSDKGLPPGO-HTDHLNIYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
54838,6crv,DB00287,-9.2,Travoprost,MKPLKVHSHYCHOC-AHTXBMBWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114266,6vxx,DB13215,-9.2,Sulfobromophthalein,OHTXTCNTQJFRIG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
132895,6w9c,DB00973,-9.2,Ezetimibe,OLNTVTPDXPETLC-XPWALMASSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
107568,6vxx,DB03768,-9.2,"N-[2-Hydroxy-2-(8-Isopropyl-6,9-Dioxo-2-Oxa-7,10-Diaza-Bicyclo[11.2.2]Heptadeca-1(16),13(17),14-Trien-11-Yl)-Ethyl]-N-(3-Methyl-Butyl)-Benzenesulfonamide,Inhibitor 3",WRUVOSYKHXGAQN-GKRYNVPLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
134486,6w9c,DB03141,-9.2,"3-{[(5R,6R)-5-Benzyl-6-hydroxy-2,4-bis(4-hydroxybenzyl)-3-oxo-1,2,4-triazepan-1-yl]sulfonyl}benzonitril",UYUWNNRWESUYOB-FIRIVFDPSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
161460,7bv1,DB14850,-9.2,Deleobuvir,BMAIGAHXAJEULY-UKTHLTGXSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
76007,6m2n,DB06629,-9.2,Zibotentan,FJHHZXWJVIEFGJ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
59507,6crv,DB07544,-9.2,N'-(5-CHLOROBENZOFURAN-2-CARBONYL)-2-(TRIFLUOROMETHYL)BENZENESULFONOHYDRAZIDE,ZLQBZYKAQQWOTK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
126815,6w4h,DB04330,-9.2,Bilh 434,KNRVCCXHLSHTFW-HGPRPZRGSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
139216,6w9c,DB13138,-9.2,Neladenoson bialanate,WESNEIGKOAXSGX-VXKWHMMOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139504,6w9c,DB13556,-9.2,Sulfamazone,BGLHAKAJGYLSOX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
75478,6m2n,DB04759,-9.2,"PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-(3-METHYL-BENZYLAMIDE)",GTBUZLPQANSGGE-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75498,6m2n,DB04785,-9.2,Streptolydigin,KVTPRMV1KLIG-NCAOFHFGSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
114130,6vxx,DB12776,-9.2,E-6005,BBTFKAOFCSOZMB-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
139480,6w9c,DB13528,-9.2,Chlormadinone,VUHJZBBCZGVNDZ-TTYLFXKOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
85940,6m3m,DB08240,-9.2,N-(4-CHLOROPHENYL)-3-(PHOSPHONOOXY)NAPHTHALENE-2-CARBOXAMIDE,RQAQWBFHPMSXKR-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
114119,6vxx,DB12756,-9.2,TAK-901,WKDACQVEJIVHMZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114135,6vxx,DB12784,-9.2,NS-018,UQTPDWDAYHAZNT-AWEZNQCLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
160887,7bv1,DB11870,-9.2,RG-4733,OJPLJFIFUQPSJR-INIZCTEOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
139466,6w9c,DB13506,-9.2,Carfecillin,NZDASSHFKWDBBU-KVMCETHSSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
165279,7bv1,DB11697,-9.2,Pacritinib,HWXVIOGONBBTBY-ONEGZZNKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
108419,6vxx,DB07970,-9.2,5-[(2-methyl-5-{[3-(trifluoromethyl)phenyl]carbamoyl}phenyl)amino]pyridine-3-carboxamide,SAAYRHKJHDIDPH-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
83074,6m3m,DB03383,-9.2,5-Chloro-1h-Indole-2-Carboxylic Acid [1-(4-Fluorobenzyl)-2-(4-Hydroxypiperidin-1yl)-2-Oxoethyl]Amide,YDCGVASFVACWKF-NRFANRHFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
61876,6crv,DB12729,-9.2,ASP-3026,MGGBYMDAPCCKCT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108441,6vxx,DB07994,-9.2,"N-3-[5-(1H-INDOL-6-YL)-2-(PYRIDIN-2-YLMETHOXY)BENZYL]PYRIDINE-2,3-DIAMINE",KMBPJSHPAXOXBT-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114111,6vxx,DB12743,-9.2,Z-160,VCPMZDWBEWTGNW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
67861,6lxt,DB07247,-9.2,"[2'-HYDROXY-3'-(1H-PYRROLO[3,2-C]PYRIDIN-2-YL)-BIPHENYL-3-YLMETHYL]-UREA",SRPOHNDQBDHONJ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
58565,6crv,DB05983,-9.2,Bardoxolone methyl,WPTTVJLTNAWYAO-KPOXMGGZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85844,6m3m,DB08126,-9.2,"3-{[4-([AMINO(IMINO)METHYL]AMINOSULFONYL)ANILINO]METHYLENE}-2-OXO-2,3-DIHYDRO-1H-INDOLE",DMCRNUMVSATRTP-LCYFTJDESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
125962,6w4h,DB03186,-9.2,U-Pi-a-Pi,JIAJERGOUFOENU-LNAOLWRRSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
85854,6m3m,DB08137,-9.2,(4E)-N-(4-fluorophenyl)-4-[(phenylcarbonyl)imino]-4H-pyrazole-3-carboxamide,ZMWYSLJBNJUCRK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
75246,6m2n,DB04452,-9.2,Aminoquinuride,HOUSDILKOJMENG-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
68002,6lxt,DB07405,-9.2,"1-(6-CYANO-3-PYRIDYLCARBONYL)-5',8'-DIFLUOROSPIRO[PIPERIDINE-4,2'(1'H)-QUINAZOLINE]-4'-AMINE",GIZYIOOBBUHOBS-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
67917,6lxt,DB07307,-9.2,N-cyclopropyl-4-methyl-3-[1-(2-methylphenyl)phthalazin-6-yl]benzamide,GQXMJOSCBRZMKE-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
161390,7bv1,DB13950,-9.2,WIN 55212-2,HQVHOQAKMCMIIM-HXUWFJFHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
75369,6m2n,DB04607,-9.2,"PHENYLAMINOIMIDAZO(1,2-ALPHA)PYRIDINE",UQAWGIKJINAKIZ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
135949,6w9c,DB06159,-9.2,Rubitecan,VHXNKPBCCMUMSW-FQEVSTJZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
83173,6m3m,DB03523,-9.2,Brequinar,PHEZJEYUWHETKO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
114084,6vxx,DB12706,-9.2,Seletalisib,LNLJHGXOFYUARS-OAQYLSRUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108516,6vxx,DB08079,-9.2,AMG-208,HEAIZQNMNCHNFD-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
83146,6m3m,DB03488,-9.2,Uridine-5'-diphosphate-2-deoxy-2-fluoro-alpha-D-galactose,NGTCPFGWXMBZEP-NQQHDEILSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
114102,6vxx,DB12729,-9.2,ASP-3026,MGGBYMDAPCCKCT-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75388,6m2n,DB04632,-9.2,4-(2-HYDROXYBENZYLAMINO)-N-(3-(4-FLUOROPHENOXY)PHENYL)PIPERIDINE-1-SULFONAMIDE,JHHBGNIRSUTQAS-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
85985,6m3m,DB08301,-9.2,N-({[4-(AMINOSULFONYL)PHENYL]AMINO}CARBONYL)-4-METHYLBENZENESULFONAMIDE,HDCXQTPVTAIPNZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59460,6crv,DB07489,-9.2,"4-Amino-2-[(3-chlorophenyl)amino]-5-(4-fluorobenzoyl)-1,3-thiazol-3-ium",WWGPTHOMFHDEEC-UHFFFAOYSA-O,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61872,6crv,DB12724,-9.2,AZD-7295,MAQDQJWCSSCURR-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108368,6vxx,DB07678,-9.2,"(9ALPHA,13BETA,17BETA)-2-[(1Z)-BUT-1-EN-1-YL]ESTRA-1,3,5(10)-TRIENE-3,17-DIOL",ANAMDWGJXBYJEB-OPWFCKQNSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108133,6vxx,DB07141,-9.2,"5-[(3R)-3-(5-methoxy-4'-methylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",QVXYJVHNRPNRJL-HNNXBMFYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
63170,6crv,DB15273,-9.2,VS-4718,IGUBBWJDMLCRIK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108085,6vxx,DB06827,-9.2,Viomycin,GXFAIFRPOKBQRV-GHXCTMGLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28457,6cs2,DB08044,-9.2,ABT-341,NVVSPGQEXMJZIR-BMIGLBTASA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
75746,6m2n,DB05706,-9.2,13-deoxydoxorubicin,RGVRUQHYQSORBY-JIGXQNLBSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75789,6m2n,DB05983,-9.2,Bardoxolone methyl,WPTTVJLTNAWYAO-KPOXMGGZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75809,6m2n,DB06144,-9.2,Sertindole,GZKLJWGUPQBVJQ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
107987,6vxx,DB06652,-9.2,Vicriviroc,CNPVJJQCETWNEU-CYFREDJKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
126898,6w4h,DB04452,-9.2,Aminoquinuride,HOUSDILKOJMENG-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
114222,6vxx,DB13114,-9.2,Amitriptylinoxide,ZPMKQFOGINQDAM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
126935,6w4h,DB04495,-9.2,RU81843,GGPXNASQNUOIPB-NSOVKSMOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
148019,6w9q,DB12806,-9.2,GSK-1004723,YANGEESWIGIKOP-UUWRZZSWSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
132960,6w9c,DB01047,-9.2,Fluocinonide,WJOHZNCJWYWUJD-IUGZLZTKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
54781,6crv,DB00224,-9.2,Indinavir,CBVCZFGXHXORBI-PXQQMZJSSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107897,6vxx,DB05490,-9.2,AMG-131,NMRWDFUZLLQSBN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136014,6w9c,DB06302,-9.2,Glesatinib,YRCHYHRCBXNYNU-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
86071,6m3m,DB08406,-9.2,"[N-(2,4-DIAMINOPTERIDIN-6-YL)-METHYL]-DIBENZ[B,F]AZEPINE",NXCCIJQEAKMFGW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
28601,6cs2,DB08191,-9.2,"4-(5-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl)benzoic acid",KSFDVNIKNYXUIP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
147952,6w9q,DB12703,-9.2,Omipalisib,CGBJSGAELGCMKE-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
108339,6vxx,DB07642,-9.2,"5-{[1-(2-fluorobenzyl)piperidin-4-yl]methoxy}quinazoline-2,4-diamine",GYKIQIOWVKCVBP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114151,6vxx,DB12812,-9.2,Palomid 529,YEAHTLOYHVWAKW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140770,6w9c,DB15281,-9.2,Ravoxertinib,RZUOCXOYPYGSKL-GOSISDBHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
75644,6m2n,DB05129,-9.2,Elsamitrucin,MGQRRMONVLMKJL-KWJIQSIXSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
108318,6vxx,DB07618,-9.2,"2-(4-(AMINOMETHYL)PIPERIDIN-1-YL)-N-(3_CYCLOHEXYL-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)ACETAMIDE",AITZHKQVQNLKHI-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108258,6vxx,DB07544,-9.2,N'-(5-CHLOROBENZOFURAN-2-CARBONYL)-2-(TRIFLUOROMETHYL)BENZENESULFONOHYDRAZIDE,ZLQBZYKAQQWOTK-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59476,6crv,DB07508,-9.2,4-(5-BENZENESULFONYLAMINO-1-METHYL-1H-BENZOIMIDAZOL-2-YLMETHYL)-BENZAMIDINE,MEUAVGJWGDPTLF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
160784,7bv1,DB11262,-9.2,Bisoctrizole,FQUNFJULCYSSOP-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
108247,6vxx,DB07274,-9.2,"N-cyclopropyl-6-[(6,7-dimethoxyquinolin-4-yl)oxy]naphthalene-1-carboxamide",ZATGFXTWDKIEKC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75691,6m2n,DB05423,-9.2,ORG-34517,DFELGYQKEOCHOA-BZAFBGKRSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
108232,6vxx,DB07257,-9.2,"4-(2-chlorophenyl)-8-(2-hydroxyethyl)-6-methylpyrrolo[3,4-e]indole-1,3(2H,6H)-dione",WHMQZCPGFZBLBG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30153,6cs2,DB12121,-9.2,Entospletinib,XSMSNFMDVXXHGJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
82985,6m3m,DB03262,-9.2,"Al-6619, [2h-Thieno[3,2-E]-1,2-Thiazine-6-Sulfonamide,2-(3-Hydroxyphenyl)-3-(4-Morpholinyl)-, 1,1-Dioxide]",PZLYYZPXSSNGJS-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
126639,6w4h,DB04098,-9.2,Balanol,XYUFCXJZFZPEJD-PGRDOPGGSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
84539,6m3m,DB06440,-9.2,Ravuconazole,OPAHEYNNJWPQPX-RCDICMHDSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58496,6crv,DB05552,-9.2,TG100-115,UJIAQDJKSXQLIT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
11184,6lzg,DB11614,-9.2,Rupatadine,WUZYKBABMWJHDL-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
76281,6m2n,DB07026,-9.2,"(1S,5S,7R)-N-7-(BIPHENYL-4-YLMETHYL)-N-3-HYDROXY-6,8-DIOXA-3-AZABICYCLO[3.2.1]OCTANE-3,7-DICARBOXAMIDE",PPLDARNGJSQINK-OKZBNKHCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
127353,6w4h,DB05465,-9.2,Tandutinib,UXXQOJXBIDBUAC-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
149084,6w9q,DB14878,-9.2,Liafensine,VCIBGDSRPUOBOG-QFIPXVFZSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
105133,6vxs,DB13050,-9.2,Tirilazad,RBKASMJPSJDQKY-RBFSKHHSSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
58969,6crv,DB06919,-9.2,D-phenylalanyl-N-(3-chlorobenzyl)-L-prolinamide,CJHLRGCXPGIPCB-MOPGFXCFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86476,6m3m,DB08912,-9.2,Dabrafenib,BFSMGDJOXZAERB-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86504,6m3m,DB08956,-9.2,Hydroxydione,USPYDUPOCUYHQL-VEVMSBRDSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
114865,6vxx,DB15295,-9.2,Tenalisib,HDXDQPRPFRKGKZ-INIZCTEOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
105142,6vxs,DB13061,-9.2,MLN8054,HHFBDROWDBDFBR-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
138845,6w9c,DB12345,-9.2,MBX-2982,NFTMKHWBOINJGM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
114856,6vxx,DB15282,-9.2,Fluorofuranylnorprogesterone F-18,VJKRBRUNEOHPBS-JQKUZGBFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59634,6crv,DB07698,-9.2,"3-(3-aminophenyl)-N-(3-chlorophenyl)pyrazolo[1,5-a]pyrimidin-5-amine",JDNMRPIWJIDDAY-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61609,6crv,DB12325,-9.2,Idasanutlin,TVTXCJFHQKSQQM-LJQIRTBHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
11849,6lzg,DB12513,-9.2,Omaveloxolone,RJCWBNBKOKFWNY-IDPLTSGASA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
159868,7bv1,DB06717,-9.2,Fosaprepitant,BARDROPHSZEBKC-OITMNORJSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
76933,6m2n,DB07786,-9.2,"1-((1R,2S)-1-{2-[2-(4-CHLOROPHENYL)-1,3-BENZOXAZOL-7-YL]ETHYL}-2-HYDROXYPROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE",SMFRBBHLVBWHGB-DJJJIMSYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
105033,6vxs,DB12895,-9.2,TD-139,YGIDGBAHDZEYMT-MQFIMZJJSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
11748,6lzg,DB12381,-9.2,Merestinib,QHADVLVFMKEIIP-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
63847,6lxt,DB00773,-9.2,Etoposide,VJJPUSNTGOMMGY-MRVIYFEKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
29853,6cs2,DB11725,-9.2,Latrepirdine,JNODQFNWMXFMEV-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
84730,6m3m,DB06831,-9.2,2-((9H-PURIN-6-YLTHIO)METHYL)-5-CHLORO-3-(2-METHOXYPHENYL)QUINAZOLIN-4(3H)-ONE,UMMYTDJYDSTEMB-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84716,6m3m,DB06809,-9.2,Plerixafor,YIQPUIGJQJDJOS-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
106048,6vxs,DB14883,-9.2,Lorecivivint,AQDWDWAYVBQMAM-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
136135,6w9c,DB06626,-9.2,Axitinib,RITAVMQDGBJQJZ-FMIVXFBMSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
64307,6lxt,DB01349,-9.2,Tasosartan,ADXGNEYLLLSOAR-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
11594,6lzg,DB12180,-9.2,Apitolisib,YOVVNQKCSKSHKT-HNNXBMFYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
29939,6cs2,DB11832,-9.2,Crenolanib,DYNHJHQFHQTFTP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
61620,6crv,DB12345,-9.2,MBX-2982,NFTMKHWBOINJGM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
64016,6lxt,DB00966,-9.2,Telmisartan,RMMXLENWKUUMAY-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
86457,6m3m,DB08881,-9.2,Vemurafenib,GPXBXXGIAQBQNI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58397,6crv,DB05015,-9.2,Belinostat,NCNRHFGMJRPRSK-MDZDMXLPSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
105672,6vxs,DB13814,-9.2,Talampicillin,SOROUYSPFADXSN-SUWVAFIASA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
166581,7bv1,DB15416,-9.2,PX-102,XBUXXJUEBFDQHD-NHCUHLMSSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
63236,6crv,DB15407,-9.2,Acalisib,DOCINCLJNAXZQF-LBPRGKRZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
160833,7bv1,DB11791,-9.2,Capmatinib,LIOLIMKSCNQPLV-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
86568,6m3m,DB09034,-9.2,Suvorexant,JYTNQNCOQXFQPK-MRXNPFEDSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
106066,6vxs,DB14918,-9.2,Branaplam,STWTUEAWRAIWJG-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
76939,6m2n,DB07792,-9.2,"(S)-2-CHLORO-N-(1-(2-(2-HYDROXYETHYLAMINO)-2-OXOETHYL)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL)-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE",VUKPNWLGSLOHIF-AWEZNQCLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
104865,6vxs,DB12627,-9.2,GSK-1292263,AYJRTVVIBJSSKN-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
59660,6crv,DB07729,-9.2,3-fluoro-N-[3-(1H-tetrazol-5-yl)phenyl]benzamide,GAKOBKPDJJGRIL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104450,6vxs,DB12020,-9.2,Tecovirimat,CSKDFZIMJXRJGH-VWLPUNTISA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
55226,6crv,DB00762,-9.2,Irinotecan,UWKQSNNFCGGAFS-XIFFEERXSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104427,6vxs,DB11986,-9.2,Entrectinib,HAYYBYPASCDWEQ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
138781,6w9c,DB12260,-9.2,Radiprodil,GKGRZLGAQZPEHO-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
104415,6vxs,DB11965,-9.2,SJG-136,RWZVMMQNDHPRQD-SFTDATJTSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
58948,6crv,DB06897,-9.2,"3-[3-chloro-5-(5-{[(1S)-1-phenylethyl]amino}isoxazolo[5,4-c]pyridin-3-yl)phenyl]propan-1-ol",MMGKIHLBFPJYJL-HNNXBMFYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77097,6m2n,DB07974,-9.2,1-{2-[(4-CHLOROPHENYL)AMINO]-2-OXOETHYL}-N-(1-ISOPROPYLPIPERIDIN-4-YL)-1H-INDOLE-2-CARBOXAMIDE,BDLMBQRBNPDCSS-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
134728,6w9c,DB03466,-9.2,BMS184394,AYAJZQYENGWICE-QHCPKHFHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
63271,6crv,DB02524,-9.2,"2',3'-O-{4-[Hydroxy(oxido)-lambda5-azanylidene]-2,6-dinitro-2,5-cyclohexadiene-1,1-diyl}adenosine 5'-(tetrahydrogen triphosphate)",XFMMHXLUHKBKQE-UHEGPQQHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86690,6m3m,DB09231,-9.2,Benidipine,QZVNQOLPLYWLHQ-ZEQKJWHPSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
77171,6m2n,DB08057,-9.2,"N-(2-chloro-6-methylphenyl)-8-[(3S)-3-methylpiperazin-1-yl]imidazo[1,5-a]quinoxalin-4-amine",VWJPPYCULHDHBB-HNNXBMFYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77184,6m2n,DB08073,-9.2,(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE,YWTBGJGMTBHQTM-IBGZPJMESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77190,6m2n,DB08079,-9.2,AMG-208,HEAIZQNMNCHNFD-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
161640,7bv1,DB00210,-9.2,Adapalene,LZCDAPDGXCYOEH-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
104463,6vxs,DB12042,-9.2,Ibodutant,YQYSVMKCMIUCHY-WJOKGBTCSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
6715,6lzg,DB02581,-9.2,"5-[2,3-Dichloro-4-(5-{1-[2-(2-Guanidino-4-Methyl-Pentanoylamino)-Acetyl]-Piperidin-4-Yl}-1-Methyl-1h-Pyrazol-3-Yl)-Phenoxymethyl]-Furan-2-Carboxylic Acid",VNZHOIDQBPFEJU-OAQYLSRUSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
138786,6w9c,DB12267,-9.2,Brigatinib,AILRADAXUVEEIR-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
61596,6crv,DB12309,-9.2,GI-181771X,CABBMMXFOOZVMS-PMERELPUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136204,6w9c,DB06746,-9.2,ginkgolide-J,LMEHVEUFNRJAAV-UKWFQYJJSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
114827,6vxx,DB14937,-9.2,MK-8666,CODQKEMYZZKQAE-QPVYNBJUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104756,6vxs,DB12457,-9.2,Rimegepant,KRNAOFGYEFKHPB-ANJVHQHFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
11930,6lzg,DB12635,-9.2,Aleplasinin,HSXLMAFNWCSZGP-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
86587,6m3m,DB09070,-9.2,Tibolone,WZDGZWOAQTVYBX-XOINTXKNSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
23728,6cs2,DB01329,-9.2,Cefoperazone,GCFBRXLSHGKWDP-XCGNWRKASA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
104674,6vxs,DB12339,-9.2,Radezolid,BTTNOGHPGJANSW-IBGZPJMESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
114846,6vxx,DB15011,-9.2,Avacopan,PUKBOVABABRILL-YZNIXAGQSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136221,6w9c,DB06786,-9.2,Halcinonide,MUQNGPZZQDCDFT-JNQJZLCISA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
104630,6vxs,DB12282,-9.2,Defactinib,FWLMVFUGMHIOAA-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
76988,6m2n,DB07847,-9.2,6-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-(4-MORPHOLINYL)-2-OXO ETHYL]-2-OXO-3-PYRROLIDINYL}-2-NAPHTHALENESULFONAMIDE,ICLOZQFWTRAYPX-LIRRHRJNSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77015,6m2n,DB07875,-9.2,"5-Chloro-thiophene-2-carboxylic acid ((3S,4S)-1-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-methyl}-4-hydroxy-pyrrolidin-3-yl)-amide",ARAVOODWJJJNBY-IRXDYDNUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
104571,6vxs,DB12200,-9.2,Tivantinib,UCEQXRCJXIVODC-PMACEKPBSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
161595,7bv1,DB00158,-9.2,Folic acid,OVBPIULPVIDEAO-LBPRGKRZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
86574,6m3m,DB09048,-9.2,Netupitant,WAXQNWCZJDTGBU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84546,6m3m,DB06455,-9.2,Meclinertant,DYLJVOXRWLXDIG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
127665,6w4h,DB06638,-9.2,Quarfloxin,WOQIDNWTQOYDLF-CGAIIQECSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
76617,6m2n,DB07409,-9.2,"(1-HYDROXY-1-PHOSPHONO-2-[1,1';4',1'']TERPHENYL-3-YL-ETHYL)-PHOSPHONIC ACID",MPBUFKZCEBTBSK-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
66970,6lxt,DB04888,-9.2,Bifeprunox,CYGODHVAJQTCBG-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
106792,6vxx,DB01261,-9.2,Sitagliptin,MFFMDFFZMYYVKS-SECBINFHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
11274,6lzg,DB11745,-9.2,Otenabant,UNAZAADNBYXMIV-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
139021,6w9c,DB12724,-9.2,AZD-7295,MAQDQJWCSSCURR-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
114653,6vxx,DB14569,-9.2,Tedizolid,XFALPSLJIHVRKE-GFCCVEGCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
134886,6w9c,DB03696,-9.2,Lanosterol,CAHGCLMLTWQZNJ-BQNIITSRSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
28418,6cs2,DB08006,-9.2,"N-anthracen-2-yl-5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7-amine",OXYDLVAOXASTMW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
106656,6vxx,DB00861,-9.2,Diflunisal,HUPFGZXOMWLGNK-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76370,6m2n,DB07126,-9.2,O6-CYCLOHEXYLMETHOXY-2-(4'-SULPHAMOYLANILINO) PURINE,OWXORKPNCHJYOF-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
66333,6lxt,DB04042,-9.2,"2-[4-(Hydroxy-Methoxy-Methyl)-Benzyl]-7-(4-Hydroxymethyl-Benzyl)-1,1-Dioxo-3,6-Bis-Phenoxymethyl-1lambda6-[1,2,7]Thiadiazepane-4,5-Diol",XLJNZONSWKENRP-VABIIVNOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
84774,6m3m,DB06886,-9.2,N-BENZYLOXYCARBONYL-ALA-PRO-3-AMINO-4-PHENYL-BUTAN-2-OL,MACLRJNEKXUAJK-YDLSIGKMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58447,6crv,DB05294,-9.2,Vandetanib,UHTHHESEBZOYNR-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76413,6m2n,DB07175,-9.2,N-{2-methyl-5-[(6-phenylpyrimidin-4-yl)amino]phenyl}methanesulfonamide,CXQRKICWSCAUGW-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
82711,6m3m,DB02901,-9.2,Stanolone,NVKAWKQGWWIWPM-ABEVXSGRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
166528,7bv1,DB15305,-9.2,Risdiplam,ASKZRYGFUPSJPN-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
136081,6w9c,DB06494,-9.2,Sufugolix,UCQSBGOFELXYIN-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
76284,6m2n,DB07029,-9.2,"4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMIDAZOL-1-YL)PHENOXY]-6-METHYLPYRIMIDINE",QQBNDYARFVOEGW-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
106825,6vxx,DB01338,-9.2,Pipecuronium,OWWLUIWOFHMHOQ-XGHATYIMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
161476,7bv1,DB14879,-9.2,Cefiderocol,DBPPRLRVDVJOCL-FQRUVTKNSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
114463,6vxx,DB13664,-9.2,Formocortal,QNXUUBBKHBYRFW-QWAPGEGQSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114474,6vxx,DB13676,-9.2,Mosapramine,PXUIZULXJVRBPC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106936,6vxx,DB01767,-9.2,Hemi-Babim,KKJYVDXDZURHMA-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84794,6m3m,DB06909,-9.2,"1-ethyl-N-(phenylmethyl)-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridine-5-carboxamide",QZGJNFBMYYEFGM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84793,6m3m,DB06908,-9.2,"(2S)-3-(1-{[2-(2-CHLOROPHENYL)-5-METHYL-1,3-OXAZOL-4-YL]METHYL}-1H-INDOL-5-YL)-2-ETHOXYPROPANOIC ACID",PAWOPJKHTZCKMT-QFIPXVFZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
76237,6m2n,DB06976,-9.2,"1-(5-OXO-2,3,5,9B-TETRAHYDRO-1H-PYRROLO[2,1-A]ISOINDOL-9-YL)-3-(5-PYRROLIDIN-2-YL-1H-PYRAZOL-3-YL)-UREA",IWOOJEZSDPRYAZ-WFASDCNBSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
114539,6vxx,DB13764,-9.2,Monoxerutin,MBHXKZDTQCSVPM-BDAFLREQSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114540,6vxx,DB13766,-9.2,Lidoflazine,ZBIAKUMOEKILTF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76259,6m2n,DB07000,-9.2,"N-{2,4-difluoro-3-[(5-pyridin-3-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)carbonyl]phenyl}ethanesulfonamide",ILXJWLWSYAWJKZ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
106860,6vxx,DB01411,-9.2,Pranlukast,NBQKINXMPLXUET-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
82733,6m3m,DB02929,-9.2,K201,KCWGETCFOVJEPI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
76279,6m2n,DB07024,-9.2,"2-(3,4-DIHYDROXYPHENYL)-8-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-3-HYDROXY-6-METHYL-4H-CHROMEN-4-ONE",CEXBEGBNDJVZPK-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
106855,6vxx,DB01405,-9.2,Temafloxacin,QKDHBVNJCZBTMR-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106826,6vxx,DB01339,-9.2,Vecuronium,BGSZAXLLHYERSY-XQIGCQGXSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
164878,7bv1,DB08901,-9.2,Ponatinib,PHXJVRSECIGDHY-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
82558,6m3m,DB02698,-9.2,"N-(M-Trifluoromethylphenyl) Phenoxazine-4,6-Dicarboxylic Acid",NQOOJFXBGLOGTC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
61644,6crv,DB12381,-9.2,Merestinib,QHADVLVFMKEIIP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127503,6w4h,DB06229,-9.2,Ocaperidone,ZZQNEJILGNNOEP-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
58422,6crv,DB05137,-9.2,Lobeline,MXYUKLILVYORSK-HBMCJLEFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76554,6m2n,DB07334,-9.2,"N-[5-(ETHYLSULFONYL)-2-METHOXYPHENYL]-5-[3-(2-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-AMINE",HTIZPBXCJPQDEM-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76577,6m2n,DB07360,-9.2,"1-{5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)ethyl]-1,3-thiazol-2-yl}-3-[3-(trifluoromethyl)phenyl]urea",JJHXPDTVQKWKHA-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
65231,6lxt,DB02555,-9.2,SP4160,VCXMTWSYQSVWRK-AREMUKBSSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
29971,6cs2,DB11877,-9.2,Basmisanil,VCGRFBXVSFAGGA-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
11493,6lzg,DB12044,-9.2,MK-0893,DNTVJEMGHBIUMW-IBGZPJMESA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
142211,6w9q,DB01897,-9.2,2-(2f-Benzothiazolyl)-5-Styryl-3-(4f-Phthalhydrazidyl)Tetrazolium Chloride,BEIGFKLRGRRJJA-JLHYYAGUSA-O,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
136115,6w9c,DB06589,-9.2,Pazopanib,CUIHSIWYWATEQL-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
58412,6crv,DB05095,-9.2,Cimicoxib,KYXDNECMRLFQMZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58980,6crv,DB06930,-9.2,"N-[amino(imino)methyl]-2-(2,5-diphenyl-1H-pyrrol-1-yl)acetamide",WVLDNAVUCUAGDP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58977,6crv,DB06927,-9.2,[5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-YL]ACETONITRILE,ZKJVCUXZMYKTLT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106111,6vxs,DB15046,-9.2,LY-2881835,FHRWHNJJQGSCQC-LJAQVGFWSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
138917,6w9c,DB12562,-9.2,Setipiprant,IHAXLPDVOWLUOS-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
106098,6vxs,DB15023,-9.2,BMS-791826,DZBKAUMYTFPJIS-QHCPKHFHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
76578,6m2n,DB07362,-9.2,"1-(5-{2-[(1-methyl-1H-pyrazolo[4,3-d]pyrimidin-7-yl)amino]ethyl}-1,3-thiazol-2-yl)-3-[3-(trifluoromethyl)phenyl]urea",UOLCZAFAGDOUFX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
58905,6crv,DB06845,-9.2,(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclopentylamino)ethanoyl)pyrrolidine-2-carboxamide,WXYKSWZWRHMJTE-KRWDZBQOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136108,6w9c,DB06578,-9.2,Tonabersat,XLIIRNOPGJTBJD-ROUUACIJSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136104,6w9c,DB06555,-9.2,Siramesine,XWAONOGAGZNUSF-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
24757,6cs2,DB02545,-9.2,Fexaramine,VLQTUNDJHLEFEQ-KGENOOAVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
138985,6w9c,DB12669,-9.2,4SC-203,MAFACRSJGNJHCF-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
86245,6m3m,DB08613,-9.2,"2,2,2-TRIFLUORO-1-{5-[(3-PHENYL-5,6-DIHYDROIMIDAZO[1,2-A]PYRAZIN-7(8H)-YL)CARBONYL]THIOPHEN-2-YL}ETHANE-1,1-DIOL",OFBFUNBBOQCNFX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
138976,6w9c,DB12658,-9.2,AFN-1252,QXTWSUQCXCWEHF-JXMROGBWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
59538,6crv,DB07583,-9.2,"(4R,2S)-5'-(4-(4-CHLOROBENZYLOXY)PYRROLIDIN-2-YLMETHANESULFONYL)ISOQUINOLINE",RLNNFNGBXLTQOB-RBUKOAKNSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106426,6vxx,DB00197,-9.2,Troglitazone,GXPHKUHSUJUWKP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61638,6crv,DB12375,-9.2,Oglemilast,OKFDRAHPFKMAJH-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86263,6m3m,DB08639,-9.2,Dapivirine,ILAYIAGXTHKHNT-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
106315,6vxs,DB15448,-9.2,Acumapimod,VGUSQKZDZHAAEE-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
76480,6m2n,DB07255,-9.2,"N'-(5-CHLORO-1,3-BENZODIOXOL-4-YL)-N-(3-MORPHOLIN-4-YLPHENYL)PYRIMIDINE-2,4-DIAMINE",PNEWIQAEGKQNCE-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
82655,6m3m,DB02830,-9.2,FR236913,KCCUBLLGAMGDJL-HXUWFJFHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
138961,6w9c,DB12635,-9.2,Aleplasinin,HSXLMAFNWCSZGP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
66312,6lxt,DB04011,-9.2,"2'-(4-Dimethylaminophenyl)-5-(4-Methyl-1-Piperazinyl)-2,5'-Bi-Benzimidazole",VMCOQLKKSNQANE-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
138954,6w9c,DB12622,-9.2,Lupeol,MQYXUWHLBZFQQO-QGTGJCAVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
84771,6m3m,DB06883,-9.2,1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-phenylurea,DHNYNLNKNQJSHF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
76446,6m2n,DB07215,-9.2,"2-METHYL-2-(4-{[({4-METHYL-2-[4-(TRIFLUOROMETHYL)PHENYL]-1,3-THIAZOL-5-YL}CARBONYL)AMINO]METHYL}PHENOXY)PROPANOIC ACID",ILUPZUOBHCUBKB-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
133122,6w9c,DB01234,-9.2,Dexamethasone,UREBDLICKHMUKA-CXSFZGCWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
83331,6m3m,DB03751,-9.2,2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose,YSYKRGRSMLTJNL-URARBOGNSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83240,6m3m,DB03632,-9.2,Argifin,UHBHXSDKGLPPGO-HTDHLNIYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
140605,6w9c,DB12522,-9.2,Toreforant,FCRFVPZAXGJLPW-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
84461,6m3m,DB06228,-9.2,Rivaroxaban,KGFYHTZWPPHNLQ-AWEZNQCLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
135521,6w9c,DB04575,-9.2,Quinestrol,PWZUUYSISTUNDW-VAFBSOEGSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
62936,6crv,DB14761,-9.2,Remdesivir,RWWYLEGWBNMMLJ-YSOARWBDSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
9430,6lzg,DB07530,-9.2,"(1R,3R)-5-[(2E)-3-{(1S,3R)-2,2,3-trimethyl-3-[6,6,6-trifluoro-5-hydroxy-5-(trifluoromethyl)hex-3-yn-1-yl]cyclopentyl}prop-2-en-1-ylidene]cyclohexane-1,3-diol",PCHUQQNKOFNVDU-OSXMSNBXSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
59172,6crv,DB07156,-9.2,"(4Z)-6-bromo-4-({[4-(pyrrolidin-1-ylmethyl)phenyl]amino}methylidene)isoquinoline-1,3(2H,4H)-dione",JFEKAVPMVOLVTH-UNOMPAQXSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111827,6vxx,DB04750,-9.2,OREGON GREEN 488 CARBOXYLATE,BRJCLSQFZSHLRL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
160656,7bv1,DB09233,-9.2,Cronidipine,CNIJVNPIIHWRRP-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
135561,6w9c,DB04628,-9.2,Allosamidin,MDWNFWDBQGOKNZ-XYUDZHFQSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
111664,6vxx,DB04348,-9.2,Taurocholic Acid,WBWWGRHZICKQGZ-HZAMXZRMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84196,6m3m,DB04892,-9.2,Phenserine,PBHFNBQPZCRWQP-QUCCMNQESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84195,6m3m,DB04891,-9.2,Becocalcidiol,QSLUXQQUPXBIHH-YHSKWIAJSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
63097,6crv,DB15126,-9.2,IMG-7289,KQKBMHGOHXOHTD-KKUQBAQOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72254,6m2n,DB00528,-9.2,Lercanidipine,ZDXUKAKRHYTAKV-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
140622,6w9c,DB12548,-9.2,Sparsentan,WRFHGDPIDHPWIQ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
62950,6crv,DB14790,-9.2,BPN-14770,KRRGWHSEDYQKDQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62954,6crv,DB14795,-9.2,AZD-3759,MXDSJQHFFDGFDK-CYBMUJFWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
7484,6lzg,DB03878,-9.2,N-[4-Methyl-3-[[4-(3-Pyridinyl)-2-Pyrimidinyl]Amino]Phenyl]-3-Pyridinecarboxamide,YWQVBESSYLICRX-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
84298,6m3m,DB05414,-9.2,Pipendoxifene,JICOGKJOQXTAIP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
140288,6w9c,DB02759,-9.2,4-Methylumbelliferyl Chitobiose,UPSFMJHZUCSEHU-JYGUBCOQSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
69954,6lxt,DB11942,-9.2,Selinexor,DEVSOMFAQLZNKR-RJRFIUFISA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
113375,6vxx,DB09074,-9.2,Olaparib,FDLYAMZZIXQODN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72002,6m2n,DB00223,-9.2,Diflorasone,WXURHACBFYSXBI-XHIJKXOTSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
62960,6crv,DB14820,-9.2,Profoxydim,KRQUFUKTQHISJB-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113376,6vxx,DB09075,-9.2,Edoxaban,HGVDHZBSSITLCT-JLJPHGGASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
144863,6w9q,DB06595,-9.2,Midostaurin,BMGQWWVMWDBQGC-IIFHNQTCSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
111964,6vxx,DB04960,-9.2,Tipifarnib,PLHJCIYEEKOWNM-HHHXNRCGSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72086,6m2n,DB00319,-9.2,Piperacillin,IVBHGBMCVLDMKU-GXNBUGAJSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
84282,6m3m,DB05294,-9.2,Vandetanib,UHTHHESEBZOYNR-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
8668,6lzg,DB06638,-9.2,Quarfloxin,WOQIDNWTQOYDLF-CGAIIQECSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
140239,6w9c,DB15418,-9.2,AZD-9977,MBKYLPOPYYLTNW-ZDUSSCGKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
111914,6vxx,DB04862,-9.2,Merimepodib,JBPUGFODGPKTDW-SFHVURJKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31870,6cs2,DB14914,-9.2,Flortaucipir F-18,GETAAWDSFUCLBS-SJPDSGJFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
84931,6m3m,DB07067,-9.2,"(2S,3S)-3-{3-[4-(METHYLSULFONYL)PHENYL]-1,2,4-OXADIAZOL-5-YL}-1-OXO-1-PYRROLIDIN-1-YLBUTAN-2-AMINE",SQCDMTZMCHZYGO-FZMZJTMJSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
112083,6vxx,DB06246,-9.2,Exisulind,MVGSNCBCUWPVDA-MFOYZWKCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31915,6cs2,DB15033,-9.2,Flortaucipir,GETAAWDSFUCLBS-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
85277,6m3m,DB07468,-9.2,"(3aS)-3a-hydroxy-5-methyl-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one",NJBBBRZNBVLTRZ-GOSISDBHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
62740,6crv,DB14055,-9.2,(S)-Warfarin,PJVWKTKQMONHTI-HNNXBMFYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84176,6m3m,DB04867,-9.2,Lintitript,ILNRQFBVVQUOLP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
72709,6m2n,DB01061,-9.2,Azlocillin,JTWOMNBEOCYFNV-NFFDBFGFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
30691,6cs2,DB12848,-9.2,PF-04217903,PDMUGYOXRHVNMO-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
113642,6vxx,DB11692,-9.2,Pavinetant,QYTBBBAHNIWFOD-NRFANRHFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113650,6vxx,DB11703,-9.2,Acalabrutinib,WDENQIQQYWYTPO-IBGZPJMESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85337,6m3m,DB07538,-9.2,"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}-2-(TRIFLUOROMETHYL)BENZENESULFONAMIDE",RGVVHQNJKUNSFQ-WDZFZDKYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
140129,6w9c,DB15035,-9.2,Zanubrutinib,RNOAOAWBMHREKO-QFIPXVFZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
85353,6m3m,DB07557,-9.2,"(5BETA)-PREGNANE-3,20-DIONE",XMRPGKVKISIQBV-XWOJZHJZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84162,6m3m,DB04849,-9.2,Cediranib,XXJWYDDUDKYVKI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
32003,6cs2,DB15190,-9.2,GLPG-0259,YBFGSJUVEOYPIS-OALUTQOASA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
140648,6w9c,DB13040,-9.2,Gandotinib,SQSZANZGUXWJEA-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
69809,6lxt,DB11734,-9.2,Fedovapagon,RUOLFWZIFNQQGH-DEOSSOPVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
30624,6cs2,DB12742,-9.2,Amuvatinib,FOFDIMHVKGYHRU-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
134200,6w9c,DB02698,-9.2,"N-(M-Trifluoromethylphenyl) Phenoxazine-4,6-Dicarboxylic Acid",NQOOJFXBGLOGTC-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
31975,6cs2,DB15133,-9.2,Tepotinib,AHYMHWXQRWRBKT-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
140150,6w9c,DB15075,-9.2,4-demethyl-4-cholesteryloxycarbonylpenclomedine,ZJUUIXYKTPSIOH-LEZJFEBPSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
111132,6vxx,DB03041,-9.2,UDP-alpha-D-glucuronic acid,HDYANYHVCAPMJV-LXQIFKJMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62886,6crv,DB14657,-9.2,Paramethasone acetate,HYRKAAMZBDSJFJ-LFDBJOOHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85278,6m3m,DB07469,-9.2,"(3aS)-3a-hydroxy-7-methyl-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one",KAJFGRLMKVNMLH-GOSISDBHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
72331,6m2n,DB00620,-9.2,Triamcinolone,GFNANZIMVAIWHM-OBYCQNJPSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
111303,6vxx,DB03476,-9.2,Trans-6-(2-Phenylcyclopropyl)-Naphthalene-2-Carboxamidine,NQRIWXVAIWPBEM-OALUTQOASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84190,6m3m,DB04885,-9.2,Cilansetron,NCNFDKWULDWJDS-OAHLLOKOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
63099,6crv,DB15132,-9.2,AZD-8165,YUHNXUAATAMVKD-PZJWPPBQSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62870,6crv,DB14640,-9.2,Isoflupredone acetate,ZOCUOMKMBMEYQV-GSLJADNHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58683,6crv,DB06370,-9.2,Indisulam,SETFNECMODOHTO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84477,6m3m,DB06257,-9.2,HE-2200,OEVZKEVBDIDVOI-YSZCXEEOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
140633,6w9c,DB13019,-9.2,Henatinib,MCTXSDCWFQAGFS-UEXNTNOUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
123597,6w4h,DB00157,-9.2,NADH,BOPGDPNILDQYTO-NNYOXOHSSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
85311,6m3m,DB07508,-9.2,4-(5-BENZENESULFONYLAMINO-1-METHYL-1H-BENZOIMIDAZOL-2-YLMETHYL)-BENZAMIDINE,MEUAVGJWGDPTLF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
69865,6lxt,DB11814,-9.2,PF-03882845,XNULRSOGWPFPBL-REWPJTCUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
30709,6cs2,DB12875,-9.2,Mavatrep,ORDHXXHTBUZRCN-NTEUORMPSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
160415,7bv1,DB08358,-9.2,"2-(2-QUINOLIN-3-YLPYRIDIN-4-YL)-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE",OWFLADWRSCINST-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
85272,6m3m,DB07460,-9.2,2-({5-CHLORO-2-[(2-METHOXY-4-MORPHOLIN-4-YLPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)-N-METHYLBENZAMIDE,UYJNQQDJUOUFQJ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
140117,6w9c,DB15011,-9.2,Avacopan,PUKBOVABABRILL-YZNIXAGQSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
85187,6m3m,DB07359,-9.2,"3-[(4-fluorophenyl)sulfanyl]-N-(4-methyl-1,3-thiazol-2-yl)-6-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]pyridine-2-carboxamide",SJTQKYKXCYVFHX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
71804,6lxt,DB15308,-9.2,Ridinilazole,UHQFBTAJFNVZIV-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
113084,6vxx,DB08355,-9.2,"1-methyl-8-(phenylamino)-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxylic acid",ZOBRPBVIEUWYJR-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30870,6cs2,DB13093,-9.2,TAK-593,DZFZXPPHBWCXPQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
112738,6vxx,DB07789,-9.2,"1-[5-methyl-2-(trifluoromethyl)furan-3-yl]-3-[(2Z)-5-(2-{[6-(1H-1,2,4-triazol-3-ylamino)pyrimidin-4-yl]amino}ethyl)-1,3-thiazol-2(3H)-ylidene]urea",KNTGXMNWVXZIMW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
161000,7bv1,DB12382,-9.2,R-306465,MUTBJZVSRNUIHA-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
84430,6m3m,DB06157,-9.2,Istaroxime,MPYLDWFDPHRTEG-PAAYLBSLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85076,6m3m,DB07238,-9.2,Nesbuvir,WTDWVLJJJOTABN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
63034,6crv,DB15003,-9.2,PF-06700841,BUWBRTXGQRBBHG-MJBXVCDLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
133959,6w9c,DB02388,-9.2,"Cyclohexyl-{4-[5-(3,4-Dichlorophenyl)-2-Piperidin-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine",UQFRSHRWRKYNDE-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
133931,6w9c,DB02354,-9.2,4-{[1-Methyl-5-(2-Methyl-Benzoimidazol-1-Ylmethyl)-1h-Benzoimidazol-2-Ylmethyl]-Amino}-Benzamidine,IRKPNOLLMNHSOU-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
70779,6lxt,DB13215,-9.2,Sulfobromophthalein,OHTXTCNTQJFRIG-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
112607,6vxx,DB07450,-9.2,(R)-minalrestat,BMHZAHGTGIZZCT-LJQANCHMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
135370,6w9c,DB04376,-9.2,13-Acetylphorbol,SDSVJYOOAPRSDA-RPCQODIISA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
113111,6vxx,DB08549,-9.2,"(3R)-METHYLCARBAMOYL-7-SULFOAMINO-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLIC ACID BENZYL ESTER",MFDBNNQUDZFSES-KRWDZBQOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112565,6vxx,DB07401,-9.2,METHYL (2Z)-2-(2-{[6-(2-CYANOPHENOXY)PYRIMIDIN-4-YL]OXY}PHENYL)-3-METHOXYACRYLATE,WFDXOXNFNRHQEC-GHRIWEEISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
70131,6lxt,DB12207,-9.2,Verdinexor,OPAKEJZFFCECPN-XQRVVYSFSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
140501,6w9c,DB11968,-9.2,MK-7145,OCKGFTQIICXDQW-ZEQRLZLVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
30847,6cs2,DB13061,-9.2,MLN8054,HHFBDROWDBDFBR-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
140503,6w9c,DB11971,-9.2,Vilaprisan,JUFWQQVHQFDUOD-ANRPBIDPSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
70428,6lxt,DB12640,-9.2,CP-609754,JAHDAIPFBPPQHQ-GDLZYMKVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
112920,6vxx,DB08150,-9.2,"4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-aminium",RZIDZIGAXXNODG-UHFFFAOYSA-O,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
121391,6w4b,DB11822,-9.2,TMC-647055,UOBYJVFBFSLCTQ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
58791,6crv,DB06645,-9.2,Anamorelin,VQPFSIRUEPQQPP-MXBOTTGLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112898,6vxx,DB08126,-9.2,"3-{[4-([AMINO(IMINO)METHYL]AMINOSULFONYL)ANILINO]METHYLENE}-2-OXO-2,3-DIHYDRO-1H-INDOLE",DMCRNUMVSATRTP-LCYFTJDESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85024,6m3m,DB07175,-9.2,N-{2-methyl-5-[(6-phenylpyrimidin-4-yl)amino]phenyl}methanesulfonamide,CXQRKICWSCAUGW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
70463,6lxt,DB12690,-9.2,LY-2584702,FYXRSVDHGLUMHB-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
85000,6m3m,DB07147,-9.2,"methyl (1R,2S)-2-(hydroxycarbamoyl)-1-{4-[(2-methylquinolin-4-yl)methoxy]benzyl}cyclopropanecarboxylate",HJWMYFBKJRVWJY-YKSBVNFPSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
8790,6lzg,DB00619,-9.2,Imatinib,KTUFNOKKBVMGRW-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
70206,6lxt,DB12306,-9.2,Cipargamin,CKLPLPZSUQEDRT-WPCRTTGESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
112816,6vxx,DB07874,-9.2,"(6S)-2-amino-6-(3'-methoxybiphenyl-3-yl)-3,6-dimethyl-5,6-dihydropyrimidin-4(3H)-one",LQOCXPOKEPYGTJ-IBGZPJMESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
133998,6w9c,DB02432,-9.2,RU90395,RLLAUERCSKPFGD-VMPREFPWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
135317,6w9c,DB04298,-9.2,"3-(4-Amino-2-Tert-Butyl-5-Methyl-Phenylsulfanyl)-6-Cyclopentyl-4-Hydroxy-6-[2-(4-Hydroxy-Phenyl)-Ethyl]-5,6-Dihydro-Pyran-2-One",ZEBFKFGJWHOOST-LJAQVGFWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
70583,6lxt,DB12886,-9.2,GSK-1521498,WIEDUMBCZQRGSY-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
63037,6crv,DB15011,-9.2,Avacopan,PUKBOVABABRILL-YZNIXAGQSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112549,6vxx,DB07382,-9.2,"N-2-1H-benzimidazol-5-yl-N-4-(3-cyclopropyl-1H-pyrazol-5-yl)pyrimidine-2,4-diamine",WJNBSTLIALIIEW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113331,6vxx,DB09003,-9.2,Clocapramine,QAZKXHSIKKNOHH-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112534,6vxx,DB07362,-9.2,"1-(5-{2-[(1-methyl-1H-pyrazolo[4,3-d]pyrimidin-7-yl)amino]ethyl}-1,3-thiazol-2-yl)-3-[3-(trifluoromethyl)phenyl]urea",UOLCZAFAGDOUFX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112510,6vxx,DB07334,-9.2,"N-[5-(ETHYLSULFONYL)-2-METHOXYPHENYL]-5-[3-(2-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-AMINE",HTIZPBXCJPQDEM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
135163,6w9c,DB04071,-9.2,Cpad,LFERELMXERXKKQ-KMXXXSRASA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140390,6w9c,DB05913,-9.2,OSI-930,FGTCROZDHDSNIO-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
112209,6vxx,DB06589,-9.2,Pazopanib,CUIHSIWYWATEQL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
71733,6lxt,DB15173,-9.2,JNJ-42165279,YWGYNGCRVZLMCS-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
31554,6cs2,DB14017,-9.2,H3B-8800,YOIQWBAHJZGRFW-WVRLKXNASA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
112179,6vxx,DB06510,-9.2,Muraglitazar,IRLWJILLXJGJTD-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113260,6vxx,DB08731,-9.2,"2-[(1R)-2-carboxy-1-(naphthalen-1-ylmethyl)ethyl]-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylic acid",GPOKTQCDBPECSS-MRXNPFEDSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112147,6vxx,DB06429,-9.2,Talnetant,BIAVGWDGIJKWRM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85167,6m3m,DB07337,-9.2,"4-[4-AMINO-6-(5-CHLORO-1H-INDOL-4-YLMETHYL)-[1,3,5]TRIAZIN-2-YLAMINO]-BENZONITRILE",SOKOHDQTKSROQZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
112132,6vxx,DB06393,-9.2,Xaliproden,WJJYZXPHLSLMGE-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
71782,6lxt,DB15269,-9.2,ALK-4290,DWKNOLCXIFYNFV-HSZRJFAPSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
62973,6crv,DB14854,-9.2,TC-6987,UAKZGMMGIMKFMV-RBUKOAKNSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31799,6cs2,DB14770,-9.2,Lanraplenib,XCIGZBVOUQVIPI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
84302,6m3m,DB05423,-9.2,ORG-34517,DFELGYQKEOCHOA-BZAFBGKRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
112144,6vxx,DB06420,-9.2,Annamycin,CIDNKDMVSINJCG-GKXONYSUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
71639,6lxt,DB14946,-9.2,PCO-371,LDZJFVOUPUFOHX-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
70003,6lxt,DB12012,-9.2,PF-04457845,BATCTBJIJJEPHM-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
112282,6vxx,DB06920,-9.2,Eribaxaban,QQBKAVAGLMGMHI-WIYYLYMNSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
121808,6w4b,DB12424,-9.2,MK-3207,AZAANWYREOQRFB-SETSBSEESA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
112502,6vxx,DB07326,-9.2,"6-chloro-N-pyrimidin-5-yl-3-{[3-(trifluoromethyl)phenyl]amino}-1,2-benzisoxazole-7-carboxamide",FEGRQUWSKADGSP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
9046,6lzg,DB07117,-9.2,"5-(4-PHENOXYPHENYL)-5-(4-PYRIMIDIN-2-YLPIPERAZIN-1-YL)PYRIMIDINE-2,4,6(2H,3H)-TRIONE",FMKQJGOROFNCGM-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
63006,6crv,DB14914,-9.2,Flortaucipir F-18,GETAAWDSFUCLBS-SJPDSGJFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112472,6vxx,DB07294,-9.2,"3-fluoro-4-[2-hydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8,-tetrahydro-naphtalen-2-yl)-acetylamino]-benzoic acid",AANFHDFOMFRLLR-IBGZPJMESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
71453,6lxt,DB14555,-9.2,Ursadiol,RTLXJEJRLWILSU-GWNGJUQLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
84332,6m3m,DB05553,-9.2,Regrelor,NXHAXEBZOXCDKD-XIXRRVGJSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
112372,6vxx,DB07029,-9.2,"4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMIDAZOL-1-YL)PHENOXY]-6-METHYLPYRIMIDINE",QQBNDYARFVOEGW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59148,6crv,DB07128,-9.2,"N7-BUTYL-N2-(5-CHLORO-2-METHYLPHENYL)-5-METHYL[1,2,4]TRIAZOLO[1,5-A]PYRIMIDINE-2,7-DIAMINE",ZTYBIJUAAWLJNU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
160626,7bv1,DB08865,-9.2,Crizotinib,KTEIFNKAUNYNJU-GFCCVEGCSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
113163,6vxx,DB08613,-9.2,"2,2,2-TRIFLUORO-1-{5-[(3-PHENYL-5,6-DIHYDROIMIDAZO[1,2-A]PYRAZIN-7(8H)-YL)CARBONYL]THIOPHEN-2-YL}ETHANE-1,1-DIOL",OFBFUNBBOQCNFX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
70028,6lxt,DB12054,-9.2,BQ-123,VYCMAAOURFJIHD-PJNXIOHISA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
17225,6cs2,HMDB0007098,-9.2,DG(16:0/16:0/0:0),JEJLGIQLPYYGEE-XIFFEERXSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
71608,6lxt,DB14894,-9.2,Galicaftor,QVDYQHXNAQHIKH-TZIWHRDSSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
112284,6vxx,DB06922,-9.2,"2-[(1R)-1-carboxy-2-naphthalen-1-ylethyl]-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylic acid",CZNPWASYMRBJCX-GOSISDBHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112515,6vxx,DB07340,-9.2,"N-6-cyclohexyl-N-2-(4-morpholin-4-ylphenyl)-9H-purine-2,6-diamine",ZFLJHSQHILSNCM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84154,6m3m,DB04839,-9.2,Cyproterone acetate,UWFYSQMTEOIJJG-FDTZYFLXSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
32044,6cs2,DB15257,-9.2,Milademetan,RYAYYVTWKAOAJF-QISPRATLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
123982,6w4h,DB00619,-9.2,Imatinib,KTUFNOKKBVMGRW-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
118605,6w4b,DB05454,-9.2,Paliroden,CNEWKIDCGDXBDE-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
140723,6w9c,DB15190,-9.2,GLPG-0259,YBFGSJUVEOYPIS-OALUTQOASA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
147376,6w9q,DB11847,-9.2,Cadazolid,XWFCFMXQTBGXQW-GOSISDBHSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
135857,6w9c,DB05414,-9.2,Pipendoxifene,JICOGKJOQXTAIP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
59381,6crv,DB07396,-9.2,"1-{2-[3-(2-Chloro-4,5-difluoro-benzoyl)-ureido]-4-fluoro-phenyl}-piperidine-4-carboxylic acid",KAJJGOCSAXKXBD-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85741,6m3m,DB08011,-9.2,"(3E)-5-fluoro-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-1H-indole-2,3-dione 3-oxime",DXIHOIDYHQSQKJ-HMMYKYKNSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
139827,6w9c,DB14066,-9.2,Tetrandrine,WVTKBKWTSCPRNU-KYJUHHDHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140724,6w9c,DB15191,-9.2,MAX-40279,AVIOBQFPAGEICQ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
109059,6vxx,DB11971,-9.2,Vilaprisan,JUFWQQVHQFDUOD-ANRPBIDPSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113946,6vxx,DB12308,-9.2,Eltanolone,AURFZBICLPNKBZ-YZRLXODZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
32937,6cs2,T3D3865,-9.2,Iodosulfuron-methyl-sodium,JUJFQMPKBJPSFZ-UHFFFAOYSA-M,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
62054,6crv,DB13016,-9.2,LY-2300559,DWQVYDLTPMGYNE-DEOSSOPVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109037,6vxx,DB11942,-9.2,Selinexor,DEVSOMFAQLZNKR-RJRFIUFISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30357,6cs2,DB12381,-9.2,Merestinib,QHADVLVFMKEIIP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
74374,6m2n,DB03262,-9.2,"Al-6619, [2h-Thieno[3,2-E]-1,2-Thiazine-6-Sulfonamide,2-(3-Hydroxyphenyl)-3-(4-Morpholinyl)-, 1,1-Dioxide]",PZLYYZPXSSNGJS-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
109098,6vxx,DB12375,-9.2,Oglemilast,OKFDRAHPFKMAJH-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
8366,6lzg,DB05611,-9.2,Apilimod,HSKAZIJJKRAJAV-KOEQRZSOSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
113923,6vxx,DB12280,-9.2,AZD-5423,FCNQMDSJHADDFT-WNSKOXEYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
144572,6w9q,DB05454,-9.2,Paliroden,CNEWKIDCGDXBDE-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
58849,6crv,DB06744,-9.2,ginkgolide-B,SQOJOAFXDQDRGF-MMQTXUMRSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113864,6vxx,DB12198,-9.2,Fosdagrocorat,BVXLAHSJXXSWFF-KEKPKEOLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109232,6vxx,DB12929,-9.2,JNJ-39220675,IQOWHZHNGJXGHG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
135825,6w9c,DB05220,-9.2,Alisertib,ZLHFILGSQDJULK-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
62127,6crv,DB13119,-9.2,GSK-364735,QWLNINWUBHHOLU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
135834,6w9c,DB05263,-9.2,Caprospinol,VMOZFSWFUBLCNN-AAPULDEBSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
125179,6w4h,DB02152,-9.2,K-252a,KOZFSFOOLUUIGY-SOLYNIJKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
140710,6w9c,DB15157,-9.2,Voruciclib,MRPGRAKIAJJGMM-OCCSQVGLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
28890,6cs2,DB08513,-9.2,[4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENYL]ACETIC ACID,PAIQRYUOBBCBSE-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
85718,6m3m,DB07986,-9.2,[4-(4-PHENYL-PIPERIDIN-1-YL)-BENZENESULFONYLAMINO]-ACETIC ACID,GNSLACGSDSJAIQ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
69200,6lxt,DB08822,-9.2,Azilsartan medoxomil,QJFSABGVXDWMIW-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
74224,6m2n,DB03072,-9.2,"2-{3-[4-(4-Fluorophenyl)-3,6-Dihydro-1(2h)-Pyridinyl]Propyl}-8-Methyl-4(3h)-Quinazolinone",LOFDUAJQRUYHBR-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
109107,6vxx,DB12385,-9.2,10-hydroxycamptothecin,HAWSQZCWOQZXHI-FQEVSTJZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
69127,6lxt,DB08738,-9.2,1-{3-oxo-3-[(2S)-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]propyl}-3-phenylquinoxalin-2(1H)-one,KWCKZIJGKMCYCI-QFIPXVFZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
83463,6m3m,DB03916,-9.2,4-{2-[4-(2-Aminoethyl)Piperazin-1-Yl]Pyridin-4-Yl}-N-(3-Chloro-4-Methylphenyl)Pyrimidin-2-Amine,RHOOHUMOHVIXEF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
28915,6cs2,DB08539,-9.2,"3-cyclopropyl-5-phenyl-N-(pyridin-3-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",CCDIUVLNHCGSMH-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
165397,7bv1,DB12044,-9.2,MK-0893,DNTVJEMGHBIUMW-IBGZPJMESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
74473,6m2n,DB03397,-9.2,Uridine-Diphosphate-N-Acetylglucosamine,LFTYTUAZOPRMMI-CFRASDGPSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
74859,6m2n,DB03925,-9.2,Freselestat,HMPQTEPEMQZWQH-QZTJIDSGSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
160888,7bv1,DB11871,-9.2,PF-00610355,YPHDIMUXXABSSO-YTTGMZPUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
85790,6m3m,DB08068,-9.2,N-[4-CHLORO-3-(PYRIDIN-3-YLOXYMETHYL)-PHENYL]-3-FLUORO-,YQJVDUKATDECHF-ICSRJNTNSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
108835,6vxx,DB09534,-9.2,Ecamsule,HEAHZSUCFKFERC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59410,6crv,DB07430,-9.2,"(10R)-10-methyl-3-(6-methylpyridin-3-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one",CMWRPDHVGMHLSZ-GFCCVEGCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
134397,6w9c,DB03020,-9.2,5-Beta-D-Ribofuranosylnicotinamide Adenine Dinucleotide,UINNILASBHZOTM-KMXXXSRASA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
24505,6cs2,DB02258,-9.2,SR11254,RNZIUDLOJHVHLZ-VYIQYICTSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
68248,6lxt,DB07700,-9.2,"3-CARBOXAMIDO-1,3,5(10)-ESTRATRIEN-17(R)-SPIRO-2'(5',5'-DIMETHYL-6'OXO)TETRAHYDROPYRAN",YVAJWBACBRSVPR-NDUHRLLKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
68220,6lxt,DB07666,-9.2,"(3R,4S)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE",OAWGQHXWGXOUKV-BEFAXECRSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
108707,6vxx,DB08833,-9.2,Taurochenodeoxycholic acid,BHTRKEVKTKCXOH-BJLOMENOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140748,6w9c,DB15232,-9.2,Telaglenastat,PRAAPINBUWJLGA-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
74938,6m2n,DB04030,-9.2,"1,3,4,9-Tetrahydro-2-(Hydroxybenzoyl)-9-[(4-Hydroxyphenyl)Methyl]-6-Methoxy-2h-Pyrido[3,4-B]Indole",ADXYEWMDAGIULV-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
85839,6m3m,DB08121,-9.2,(2S)-2-(biphenyl-4-yloxy)-3-phenylpropanoic acid,TZTPJJNNACUQQR-FQEVSTJZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
74995,6m2n,DB04107,-9.2,[(1-{2[(4-Carbamimidoyl-Phenylamino)-Methyl]-1-Methyl-1h-Benzoimidazol-5-Yl}-Cyclopropyl)-Pyridin-2-Yl-Methyleneaminooxy]-Acetic Acid Ethyl Ester,RNOYCNIZOAIUSV-LSWMGQQCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
114044,6vxx,DB12644,-9.2,AZD-2066,SXWHYTICXCLKDG-GFCCVEGCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140740,6w9c,DB15219,-9.2,Tomivosertib,HKTBYUWLRDZAJK-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
74844,6m2n,DB03903,-9.2,Tmr,KGFLZYXDJDOIEE-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
125605,6w4h,DB02705,-9.2,"6-[N-(1-Isopropyl-1,2,3,4-Tetrahydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine",DARQQJKHXPXSRO-QFIPXVFZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
139772,6w9c,DB13954,-9.2,Estradiol cypionate,UOACKFBJUYNSLK-XRKIENNPSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
109002,6vxx,DB11892,-9.2,Prulifloxacin,PWNMXPDKBYZCOO-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
125491,6w4h,DB02551,-9.2,"6-[N-(4-Ethyl-1,2,3,4-Tetrahydro-6-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine",LVNMYQLXKMSQTG-AWEZNQCLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
74516,6m2n,DB03461,-9.2,2'-Monophosphoadenosine 5'-Diphosphoribose,XJLXINKUBYWONI-NNYOXOHSSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
74550,6m2n,DB03507,-9.2,"6-[3-(4-Morpholinyl)Propyl]-2-(3-Nitrophenyl)-5-Thioxo-5,6,-Dihydro-7h-Thienol[2',3':4,5]Pyrrolo[1,2-C]Imidazol-7-One",UXGUZFZBZPPZGL-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
140727,6w9c,DB15197,-9.2,RSV-604,MTPVBMVUENFFLL-HXUWFJFHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
118460,6w4b,DB04852,-9.2,Implitapide,AMNXBQPRODZJQR-DITALETJSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
62028,6crv,DB12972,-9.2,Sepranolone,AURFZBICLPNKBZ-FZCSVUEKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
83371,6m3m,DB03797,-9.2,3-Aminomethyl-Pyridinium-Adenine-Dinucleotide,HMCRLFVYYFBZEZ-PLEFRAQWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85770,6m3m,DB08042,-9.2,"N-4-methyl-N-4-(3-methyl-1H-indazol-6-yl)-N-2-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine",FLXGQDHYCWXTAI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
113993,6vxx,DB12561,-9.2,WNT-974,XXYGTCZJJLTAGH-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
133176,6w9c,DB01339,-9.2,Vecuronium,BGSZAXLLHYERSY-XQIGCQGXSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
7166,6lzg,DB03331,-9.2,"N-Naphthalen-1-Ylmethyl-2'-[3,5-Dimethoxybenzamido]-2'-Deoxy-Adenosine",OARVXDFNTLYMCJ-JVUUKAHWSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
133173,6w9c,DB01336,-9.2,Metocurine,JFXBEKISTKFVAB-AJQTZOPKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
165352,7bv1,DB11971,-9.2,Vilaprisan,JUFWQQVHQFDUOD-ANRPBIDPSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
109016,6vxx,DB11910,-9.2,MK-0249,DDDZBLNULGDPGA-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
160188,7bv1,DB07618,-9.2,"2-(4-(AMINOMETHYL)PIPERIDIN-1-YL)-N-(3_CYCLOHEXYL-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)ACETAMIDE",AITZHKQVQNLKHI-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
83623,6m3m,DB04131,-9.2,"10-(4-Dimethylamino-5-Hydroxy-6-Methyl-Tetrahydro-Pyran-2-Yloxy)-8-Ethyl-1,8,11-Trihydroxy-7,8,9,10-Tetrahydro-Naphthacene-5,12-Dione",BLGDWFJQIHBUJY-NWJGULHDSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
113828,6vxx,DB12141,-9.2,Gilteritinib,GYQYAJJFPNQOOW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84487,6m3m,DB06274,-9.2,Alvimopan,UPNUIXSCZBYVBB-JVFUWBCBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
109919,6vxx,DB00590,-9.2,Doxazosin,RUZYUOTYCVRMRZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84010,6m3m,DB04645,-9.2,"5-{3-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-2-METHYL-PHENOXY}-PENTANOIC ACID",NJJIFGCFUDDBSP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
140059,6w9c,DB14862,-9.2,PF-06815345,QTBYVAZRKWOIDU-FUHWJXTLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
113715,6vxx,DB11800,-9.2,Tivozanib,SPMVMDHWKHCIDT-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72931,6m2n,DB01380,-9.2,Cortisone acetate,ITRJWOMZKQRYTA-RFZYENFJSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
62596,6crv,DB13788,-9.2,Chlorbenzoxamine,VEVSKUJZSMGTMM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140055,6w9c,DB14856,-9.2,PF-05089771,ZYSCOUXLBXGGIM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140660,6w9c,DB13059,-9.2,PF-03814735,RYYNGWLOYLRZLK-RBUKOAKNSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
109754,6vxx,DB15273,-9.2,VS-4718,IGUBBWJDMLCRIK-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62554,6crv,DB13729,-9.2,Camostat,XASIMHXSUQUHLV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30553,6cs2,DB12649,-9.2,Ibipinabant,AXJQVVLKUYCICH-OAQYLSRUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
77231,6m2n,DB08124,-9.2,"3-{[(2,2-DIOXIDO-1,3-DIHYDRO-2-BENZOTHIEN-5-YL)AMINO]METHYLENE}-5-(1,3-OXAZOL-5-YL)-1,3-DIHYDRO-2H-INDOL-2-ONE",FTQYGMLRLRXBPT-IDUWFGFVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
32140,6cs2,DB15435,-9.2,BMS-986158,KGERZPVQIRYWRK-GDLZYMKVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
72938,6m2n,DB01395,-9.2,Drospirenone,METQSPRSQINEEU-HXCATZOESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
109982,6vxx,DB00670,-9.2,Pirenzepine,RMHMFHUVIITRHF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84038,6m3m,DB04685,-9.2,"1-{(2S,5S)-4-FLUORO-5-[(TRITYLOXY)METHYL]TETRAHYDROFURAN-2-YL}PYRIMIDINE-2,4(1H,3H)-DIONE",GJNIPWYJQUGERM-BFLUCZKCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59240,6crv,DB07237,-9.2,{4-[(2R)-pyrrolidin-2-ylmethoxy]phenyl}(4-thiophen-3-ylphenyl)methanone,VUWFJUJWAWMRQN-HXUWFJFHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72817,6m2n,DB01184,-9.2,Domperidone,FGXWKSZFVQUSTL-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
32066,6cs2,DB15294,-9.2,SB-1578,NNXDIGHYPZHXTR-ONEGZZNKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
85407,6m3m,DB07624,-9.2,"1-{[(3R)-3-methyl-4-({4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]phenyl}sulfonyl)piperazin-1-yl]methyl}cyclopropanecarboxamide",YJFULAYRAKPBCY-DYVFJYSZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
110422,6vxx,DB01573,-9.2,Benzylmorphine,RDJGWRFTDZZXSM-RNWLQCGYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59220,6crv,DB07211,-9.2,(2R)-2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}PROPENE-1-SULFONAMIDE,YMJHMJLNQLVUAV-GHYUOPHCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110282,6vxx,DB01184,-9.2,Domperidone,FGXWKSZFVQUSTL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85434,6m3m,DB07653,-9.2,"N-(5,6-DIPHENYLFURO[2,3-D]PYRIMIDIN-4-YL)GLYCINE",VXTCEUDVOCLEJG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59223,6crv,DB07216,-9.2,"(11S)-8-CHLORO-11-[1-(METHYLSULFONYL)PIPERIDIN-4-YL]-6-PIPERAZIN-1-YL-11H-BENZO[5,6]CYCLOHEPTA[1,2-B]PYRIDINE",ZMGCFGGMTCMSDP-QHCPKHFHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72843,6m2n,DB01212,-9.2,Ceftriaxone,VAAUVRVFOQPIGI-SPQHTLEESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
161106,7bv1,DB12892,-9.2,MGB-BP-3,OEKXCVYZBVOWBR-BQYQJAHWSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
140657,6w9c,DB13055,-9.2,Oteseconazole,IDUYJRXRDSPPRC-NRFANRHFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140088,6w9c,DB14917,-9.2,Ceralasertib,DTTJKLNXNZAVSM-JYCIKRDWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
85458,6m3m,DB07685,-9.2,"4-{[5-(CYCLOHEXYLMETHOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE",NMAZGYDYIYLSLJ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
72878,6m2n,DB01260,-9.2,Desonide,WBGKWQHBNHJJPZ-LECWWXJVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
62651,6crv,DB13857,-9.2,Demegestone,JWAHBTQSSMYISL-MHTWAQMVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109733,6vxx,DB15227,-9.2,Tirabrutinib,SEJLPXCPMNSRAM-GOSISDBHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
124485,6w4h,DB01200,-9.2,Bromocriptine,OZVBMTJYIDMWIL-AYFBDAFISA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
59266,6crv,DB07267,-9.2,2-(6-methylpyridin-2-yl)-N-pyridin-4-ylquinazolin-4-amine,JONFDFIXMPXTRH-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140048,6w9c,DB14844,-9.2,ONC-201,VLULRUCCHYVXOH-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
146731,6w9q,DB08901,-9.2,Ponatinib,PHXJVRSECIGDHY-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
85574,6m3m,DB07817,-9.2,"1-{3-[(4-pyridin-2-ylpiperazin-1-yl)sulfonyl]phenyl}-3-(1,3-thiazol-2-yl)urea",NJPVZSIGDRLLTD-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
113809,6vxx,DB12115,-9.2,AZD-9164,FNYFFCOCVNTJCD-NNMXADRKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58648,6crv,DB06266,-9.2,Lonidamine,WDRYRZXSPDWGEB-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
124835,6w4h,DB01690,-9.2,Bis(Adenosine)-5'-Triphosphate,QCICUPZZLIQAPA-XPWFQUROSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
165502,7bv1,DB12198,-9.2,Fosdagrocorat,BVXLAHSJXXSWFF-KEKPKEOLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
85586,6m3m,DB07831,-9.2,"2-{[(6-OXO-1,6-DIHYDROPYRIDIN-3-YL)METHYL]AMINO}-N-[4-PROPYL-3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE",SHSORWZDEKFFLP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83780,6m3m,DB04338,-9.2,SB220025,VSPFURGQAYMVAN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
62346,6crv,DB13451,-9.2,Tioclomarol,WRGOVNKNTPWHLZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109403,6vxx,DB13528,-9.2,Chlormadinone,VUHJZBBCZGVNDZ-TTYLFXKOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59034,6crv,DB06999,-9.2,"N-{3-[(5-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)carbonyl]-2,4-difluorophenyl}propane-1-sulfonamide",YZDJQTHVDDOVHR-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85607,6m3m,DB07856,-9.2,6-{4-[4-(4-CHLOROPHENYL)PIPERIDIN-4-YL]PHENYL}-9H-PURINE,HPWBHQIUIBFTQC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
73527,6m2n,DB02152,-9.2,K-252a,KOZFSFOOLUUIGY-SOLYNIJKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
69368,6lxt,DB09074,-9.2,Olaparib,FDLYAMZZIXQODN-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
30447,6cs2,DB12494,-9.2,SGI-1776,MHXGEROHKGDZGO-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
140021,6w9c,DB14769,-9.2,Pamiparib,DENYZIUJOTUUNY-MRXNPFEDSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
84837,6m3m,DB06962,-9.2,"(5-(aminomethyl)-2H-spiro[benzofuran-3,4'-piperidine]-1'-yl)(5-(phenylethynyl)furan-2-yl)methanone",YKTUSHSSKIWDRY-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
113766,6vxx,DB12054,-9.2,BQ-123,VYCMAAOURFJIHD-PJNXIOHISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
7296,6lzg,DB03571,-9.2,"3-(5-Amino-7-Hydroxy-[1,2,3]Triazolo[4,5-D]Pyrimidin-2-Yl)-N-(3,5-Dichlorobenzyl)-Benzamide",JMQTXEWNXSPEKX-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
72947,6m2n,DB01411,-9.2,Pranlukast,NBQKINXMPLXUET-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
140042,6w9c,DB14822,-9.2,SB-649868,ZJXIUGNEAIHSBI-IBGZPJMESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
85518,6m3m,DB07756,-9.2,"1-[3-({[(4-AMINO-5-FLUORO-2-METHYLQUINOLIN-3-YL)METHYL]THIO}METHYL)PHENYL]-2,2,2-TRIFLUOROETHANE-1,1-DIOL",GPBGHVRNVGXPNM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
73036,6m2n,DB01514,-9.2,Furazabol,RGLLOUBXMOGLDQ-IVEVATEUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
59267,6crv,DB07268,-9.2,2-({2-[(3-HYDROXYPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)BENZAMIDE,QHPKKGUGRGRSGA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
73167,6m2n,DB01669,-9.2,Virginiamycin M1,DAIKHDNSXMZDCU-FQTGFAPKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
109678,6vxx,DB15121,-9.2,AT-001,YRGPAXAVTDMKDK-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109673,6vxx,DB15110,-9.2,Onvansertib,QHLVBNKYJGBCQJ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113737,6vxx,DB11830,-9.2,Mocetinostat,HRNLUBSXIHFDHP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59270,6crv,DB07271,-9.2,"4-[(3R)-3-Amino-4-(2,4,5-trifluorophenyl)butanoyl]-3-(2,2,2-trifluoroethyl)-1,4-diazepan-2-one",RMDAPSXWBVPVOG-IAPIXIRKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
69696,6lxt,DB11487,-9.2,Dexamethasone isonicotinate,BQTXJHAJMDGOFI-NJLPOHDGSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
109655,6vxx,DB15075,-9.2,4-demethyl-4-cholesteryloxycarbonylpenclomedine,ZJUUIXYKTPSIOH-LEZJFEBPSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62511,6crv,DB13675,-9.2,Metahexamide,XXYTXQGCRQLRHA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109651,6vxx,DB15065,-9.2,PF-06291874,IBDYYOQKQCCSDP-QFIPXVFZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
26408,6cs2,DB00522,-9.2,Bentiromide,SPPTWHFVYKCNNK-FQEVSTJZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
85569,6m3m,DB07812,-9.2,"N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyrrolo[2,3-b]pyridin-4-yl)thiophene-2-carboxamide",TWYNGDRSMHRPSY-MRXNPFEDSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86692,6m3m,DB09233,-9.2,Cronidipine,CNIJVNPIIHWRRP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
27483,6cs2,DB07029,-9.2,"4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMIDAZOL-1-YL)PHENOXY]-6-METHYLPYRIMIDINE",QQBNDYARFVOEGW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
61053,6crv,DB11431,-9.2,Moxidectin,YZBLFMPOMVTDJY-LSGXYNIPSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
13402,6lzg,DB15291,-9.2,BMS-986142,ZRYMMWAJAFUANM-INIZCTEOSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
88913,6m3m,DB15092,-9.2,LY-2624803,UEFWDVMEDFCHGW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
97824,6vxs,DB00210,-9.2,Adapalene,LZCDAPDGXCYOEH-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
128804,6w4h,DB08034,-9.2,"(E)-3,4-DIHYDROXY-N'-[(2-METHOXYNAPHTHALEN-1-YL)METHYLENE]BENZOHYDRAZIDE",TVOPERZEGKBKAY-RGVLZGJSSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
81661,6m3m,DB01530,-9.2,"5alpha-androstane-3alpha,17beta-diol",CBMYJHIOYJEBSB-KHOSGYARSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
129506,6w4h,DB08896,-9.2,Regorafenib,FNHKPVJBJVTLMP-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
88925,6m3m,DB15114,-9.2,Vamorolone,ZYTXTXAMMDTYDQ-DGEXFFLYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
13372,6lzg,DB15233,-9.2,Avapritinib,DWYRIWUZIJHQKQ-SANMLTNESA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
98043,6vxs,DB00471,-9.2,Montelukast,UCHDWCPVSPXUMX-TZIWLTJVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
60757,6crv,DB09076,-9.2,Umeclidinium,FVTWTVQXNAJTQP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59920,6crv,DB08026,-9.2,"2-{4-[(4-imidazo[1,2-a]pyridin-3-ylpyrimidin-2-yl)amino]piperidin-1-yl}-N-methylacetamide",AJLILYAPRHIFAS-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55837,6crv,DB01540,-9.2,17alpha-methyl-4-hydroxynandrolone,CLNUZOCYKSHICX-FAHHUNKHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55460,6crv,DB01030,-9.2,Topotecan,UCFGDBYHRUNTLO-QHCPKHFHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60152,6crv,DB08303,-9.2,"(3S)-3-cyclopentyl-6-methyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide",CUMKMTBOHBENJI-SFHVURJKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61083,6crv,DB11487,-9.2,Dexamethasone isonicotinate,BQTXJHAJMDGOFI-NJLPOHDGSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
92790,6m71,DB04872,-9.2,Osanetant,DZOJBGLFWINFBF-UMSFTDKQSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
80484,6m2n,DB15450,-9.2,PF-05105679,BXNMZRPTQFVRFA-QGZVFWFLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
132108,6w4h,DB15401,-9.2,Danicopan,PIBARDGJJAGJAJ-NQIIRXRSSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
80981,6m3m,DB00670,-9.2,Pirenzepine,RMHMFHUVIITRHF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87277,6m3m,DB12095,-9.2,Telotristat ethyl,MDSQOJYHHZBZKA-GBXCKJPGSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
61082,6crv,DB11485,-9.2,Ceftiofur,ZBHXIWJRIFEVQY-IHMPYVIRSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
132109,6w4h,DB15403,-9.2,Ziritaxestat,REQQVBGILUTQNN-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
80099,6m2n,DB14646,-9.2,Prednisone acetate,MOVRKLZUVNCBIP-RFZYENFJSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78131,6m2n,DB09330,-9.2,Osimertinib,DUYJMQONPNNFPI-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
162148,7bv1,DB01496,-9.2,Barbituric acid derivative,DNZPLHRZXUJATK-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
159718,7bv1,DB05454,-9.2,Paliroden,CNEWKIDCGDXBDE-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
78277,6m2n,DB11431,-9.2,Moxidectin,YZBLFMPOMVTDJY-LSGXYNIPSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
92970,6m71,DB05713,-9.2,LY-517717,VYNKVNDKAOGAAQ-RUZDIDTESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97604,6m71,DB15245,-9.2,Olorofim,SUFPWYYDCOKDLL-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60740,6crv,DB09050,-9.2,Ceftolozane,JHFNIHVVXRKLEF-DCZLAGFPSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27691,6cs2,DB07247,-9.2,"[2'-HYDROXY-3'-(1H-PYRROLO[3,2-C]PYRIDIN-2-YL)-BIPHENYL-3-YLMETHYL]-UREA",SRPOHNDQBDHONJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
6443,6lzg,DB02112,-9.2,Zk-806450,DZLGSWPXZYDHBD-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
88652,6m3m,DB14218,-9.2,Telotristat,NCLGDOBQAWBXRA-PGRDOPGGSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
164472,7bv1,DB08044,-9.2,ABT-341,NVVSPGQEXMJZIR-BMIGLBTASA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
79745,6m2n,DB13685,-9.2,Quingestanol,PCJFRMOEZQQSAX-AIOSZGMZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78353,6m2n,DB11622,-9.2,Dehydrocholic acid,OHXPGWPVLFPUSM-KLRNGDHRSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
93174,6m71,DB06494,-9.2,Sufugolix,UCQSBGOFELXYIN-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
129459,6w4h,DB08815,-9.2,Lurasidone,PQXKDMSYBGKCJA-CVTJIBDQSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
87259,6m3m,DB12066,-9.2,Orteronel,OZPFIJIOIVJZMN-SFHVURJKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87442,6m3m,DB12322,-9.2,GW-870086,WUBKGTSFJSEIEM-NSHBDUGJSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87091,6m3m,DB11818,-9.2,Retosiban,PLVGDGRBPMVYPB-FDUHJNRSSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87260,6m3m,DB12068,-9.2,T-900607,FSXLOWIFSZNIMV-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
93148,6m71,DB06435,-9.2,Tarazepide,CZPILLBHPRAPCB-AREMUKBSSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
87448,6m3m,DB12332,-9.2,Rucaparib,HMABYWSNWIZPAG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
60512,6crv,DB08736,-9.2,"S,R-Warfarin alcohol",ZUJMMGHIYSAEOU-DOMZBBRYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
150889,6wiq,DB01988,-9.2,6((S)-3-Benzylpiperazin-1-Yl)-3-(Naphthalen-2-Yl)-4-(Pyridin-4-Yl)Pyrazine,WFSFNKVFXLIZIY-MHZLTWQESA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
164347,7bv1,DB07728,-9.2,"2-[2-(2-FLUOROPHENYL)PYRIDIN-4-YL]-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE",XJJYJNMNYDNXNO-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
57972,6crv,DB04378,-9.2,"3-Amino-N-{4-[2-(2,6-Dimethyl-Phenoxy)-Acetylamino]-3-Hydroxy-1-Isobutyl-5-Phenyl-Pentyl}-Benzamide",APJAEXGNDLFGPD-AWCRTANDSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87264,6m3m,DB12073,-9.2,Albaconazole,UHIXWHUVLCAJQL-MPBGBICISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88584,6m3m,DB14068,-9.2,Dexniguldipine,SVJMLYUFVDMUHP-MGBGTMOVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
13424,6lzg,DB15327,-9.2,Abivertinib,UOFYSRZSLXWIQB-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
132100,6w4h,DB15382,-9.2,SAR-125844,ODIUNTQOXRXOIV-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
79802,6m2n,DB13766,-9.2,Lidoflazine,ZBIAKUMOEKILTF-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78121,6m2n,DB09295,-9.2,Talniflumate,ANMLJLFWUCQGKZ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61067,6crv,DB11457,-9.2,Rotenone,JUVIOZPCNVVQFO-HBGVWJBISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80102,6m2n,DB14649,-9.2,Dexamethasone acetate,AKUJBENLRBOFTD-RPRRAYFGSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
87426,6m3m,DB12303,-9.2,Motolimod,QSPOQCXMGPDIHI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
99440,6vxs,DB02259,-9.2,"3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid (4-Sulfamoyl-Phenyl)-Amide",VSYGXLAJQDAWCZ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
132208,6w9c,DB00157,-9.2,NADH,BOPGDPNILDQYTO-NNYOXOHSSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
92112,6m71,DB03966,-9.2,Clorobiocin,FJAQNRBDVKIIKK-LFLQOBSNSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
137914,6w9c,DB08883,-9.2,Perampanel,PRMWGUBFXWROHD-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
92068,6m71,DB03907,-9.2,"N-{3-[5-(6-Amino-Purin-9-Yl)-3,4-Dihydroxy-Tetrahydro-Furan-2-Yl]-Allyl}-2,3-Dihydroxy-5-Nitro-Benzamide",UHHBFOLQOQSPLU-WGRQDFERSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
163343,7bv1,DB04285,-9.2,"{4-[(2s,4e)-2-(1,3-Benzothiazol-2-Yl)-2-(1h-1,2,3-Benzotriazol-1-Yl)-5-Phenylpent-4-Enyl]Phenyl}(Difluoro)Methylphosphonic Acid",GBLDYRVJENYQNH-AGLOJYHOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
163345,7bv1,DB04289,-9.2,Genz-10850,YYMZSGIXLQPFAC-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
91976,6m71,DB03791,-9.2,"(3-{3-[[2-Chloro-3-(Trifluoromethyl)Benzyl](2,2-Diphenylethyl)Amino]Propoxy}Phenyl)Acetic Acid",NAXSRXHZFIBFMI-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
55799,6crv,DB01496,-9.2,Barbituric acid derivative,DNZPLHRZXUJATK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55798,6crv,DB01493,-9.2,Ethylestrenol,AOXRBFRFYPMWLR-XGXHKTLJSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
149879,6wiq,DB00696,-9.2,Ergotamine,XCGSFFUVFURLIX-VFGNJEKYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
55341,6crv,DB00894,-9.2,Testolactone,BPEWUONYVDABNZ-DZBHQSCQSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56472,6crv,DB02375,-9.2,Myricetin,IKMDFBPHZNJCSN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56483,6crv,DB02388,-9.2,"Cyclohexyl-{4-[5-(3,4-Dichlorophenyl)-2-Piperidin-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine",UQFRSHRWRKYNDE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
164555,7bv1,DB08138,-9.2,"{[(2,6-difluorophenyl)carbonyl]amino}-N-(4-fluorophenyl)-1H-pyrazole-3-carboxamide",BDRDBXXWQDFXEC-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
87416,6m3m,DB12290,-9.2,Puerarin,HKEAFJYKMMKDOR-VPRICQMDSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136356,6w9c,DB07025,-9.2,3-(5-{[4-(AMINOMETHYL)PIPERIDIN-1-YL]METHYL}-1H-INDOL-2-YL)QUINOLIN-2(1H)-ONE,KBIHHEGEALBUMT-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
28235,6cs2,DB07815,-9.2,GIBBERELLIN A4,RSQSQJNRHICNNH-NFMPGMCNSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
77930,6m2n,DB08997,-9.2,Dexetimide,LQQIVYSCPWCSSD-HSZRJFAPSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
60784,6crv,DB09128,-9.2,Brexpiprazole,ZKIAIYBUSXZPLP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28237,6cs2,DB07817,-9.2,"1-{3-[(4-pyridin-2-ylpiperazin-1-yl)sulfonyl]phenyl}-3-(1,3-thiazol-2-yl)urea",NJPVZSIGDRLLTD-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
77874,6m2n,DB08931,-9.2,Riociguat,WXXSNCNJFUAIDG-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
5938,6lzg,HMDB0112257,-9.2,"(13Z,13'Z,3R,3'R,6'R)-Lutein",KBPHJBAIARWVSC-GUPHUWDZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
91450,6m71,DB03076,-9.2,AHA047,CGBDAHCDSVOMCF-FYZVQMPESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
57754,6crv,DB04086,-9.2,"2',4'-Dinitrophenyl-2deoxy-2-Fluro-B-D-Cellobioside",WFVCNOHOODVBQK-IUBYCILNSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87039,6m3m,DB11742,-9.2,Ebastine,MJJALKDDGIKVBE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
77259,6m2n,DB08154,-9.2,3-chloro-5-[2-chloro-5-(1H-indazol-3-ylmethoxy)phenoxy]benzonitrile,WHCLIFOVZDANCU-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
129516,6w4h,DB08911,-9.2,Trametinib,LIRYPHYGHXZJBZ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
162902,7bv1,DB03268,-9.2,RU82197,WKTQBTSOHBKBRW-VMPREFPWSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
98598,6vxs,DB01126,-9.2,Dutasteride,JWJOTENAMICLJG-QWBYCMEYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
88525,6m3m,DB13952,-9.2,Estradiol acetate,FHXBMXJMKMWVRG-SLHNCBLASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
132129,6w4h,DB15442,-9.2,Trilaciclib,PDGKHKMBHVFCMG-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
132130,6w4h,DB15444,-9.2,Elexacaftor,MVRHVFSOIWFBTE-INIZCTEOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
55420,6crv,DB00984,-9.2,Nandrolone phenpropionate,UBWXUGDQUBIEIZ-QNTYDACNSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87068,6m3m,DB11786,-9.2,Pefcalcitol,SVCSMAZYWOQCBW-NVJMFHFGSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
60154,6crv,DB08305,-9.2,"(3R)-3-cyclopentyl-6-methyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2-benzothiazine 1,1-dioxide",KQAGZLQCEURCKJ-QGZVFWFLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
131924,6w4h,DB15034,-9.2,PRI-724,VHOZWHQPEJGPCC-AZXNYEMZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
80140,6m2n,DB14716,-9.2,Clonazolam,XJRGLCAWBRZUFC-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
92439,6m71,DB04408,-9.2,Ncs-Chromophore,QZGIWPZCWHMVQL-UIYAJPBUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
80473,6m2n,DB15435,-9.2,BMS-986158,KGERZPVQIRYWRK-GDLZYMKVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78106,6m2n,DB09272,-9.2,Eluxadoline,QFNHIDANIVGXPE-FNZWTVRRSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
87681,6m3m,DB12685,-9.2,K-134,ULGNGSQNNMKROG-WOJBJXKFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
99069,6vxs,DB01761,-9.2,4-[5-[2-(1-Phenyl-Ethylamino)-Pyrimidin-4-Yl]-1-Methyl-4-(3-Trifluoromethylphenyl)-1h-Imidazol-2-Yl]-Piperidine,QICPQLFMWYQJGX-SFHVURJKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
92427,6m71,DB04392,-9.2,"Bishydroxy[2h-1-Benzopyran-2-One,1,2-Benzopyrone]",HIZKPJUTKKJDGA-BETUJISGSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
80160,6m2n,DB14761,-9.2,Remdesivir,RWWYLEGWBNMMLJ-YSOARWBDSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
88931,6m3m,DB15124,-9.2,PF-05241328,RVTSXVZXEGFIPW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59754,6crv,DB07834,-9.2,"N-(cyclopropylmethyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-4-carboxamide",FOHZGCHKLPIBBX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
137615,6w9c,DB08512,-9.2,"6-amino-2-[(1-naphthylmethyl)amino]-3,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",MCEZMMDIEXECTI-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
78072,6m2n,DB09223,-9.2,Blonanserin,XVGOZDAJGBALKS-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
88507,6m3m,DB13927,-9.2,anle138b,RCQIIBJSUWYYFU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
138493,6w9c,DB11745,-9.2,Otenabant,UNAZAADNBYXMIV-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
92353,6m71,DB04285,-9.2,"{4-[(2s,4e)-2-(1,3-Benzothiazol-2-Yl)-2-(1h-1,2,3-Benzotriazol-1-Yl)-5-Phenylpent-4-Enyl]Phenyl}(Difluoro)Methylphosphonic Acid",GBLDYRVJENYQNH-AGLOJYHOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
137345,6w9c,DB08174,-9.2,"5-CHLORO-N-((1R,2S)-2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO) CYCLOPENTYL)THIOPHENE-2-CARBOXAMIDE",QCPYHSAHOYXXQK-DLBZAZTESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
87291,6m3m,DB12113,-9.2,CE-224535,FUCKCIVGBCBZNP-MRXNPFEDSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80597,6m3m,DB00203,-9.2,Sildenafil,BNRNXUUZRGQAQC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
79670,6m2n,DB13591,-9.2,Metopimazine,BQDBKDMTIJBJLA-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
60634,6crv,DB08903,-9.2,Bedaquiline,QUIJNHUBAXPXFS-XLJNKUFUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
96007,6m71,DB12267,-9.2,Brigatinib,AILRADAXUVEEIR-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
88859,6m3m,DB14944,-9.2,Tarloxotinib,MUJMYVFVAWFUJL-SNAWJCMRSA-O,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
78639,6m2n,DB12054,-9.2,BQ-123,VYCMAAOURFJIHD-PJNXIOHISA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
59844,6crv,DB07941,-9.2,PH-797804,KCAJXIDMCNPGHZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130264,6w4h,DB12010,-9.2,Fostamatinib,GKDRMWXFWHEQQT-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
94647,6m71,DB08362,-9.2,"N-(3-(8-CYANO-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZIN-2-YLAMINO)PHENYL)ACETAMIDE",QVKXQLGRDOMAGC-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
25846,6cs2,DB03865,-9.2,6-Chloro-2-(2-Hydroxy-Biphenyl-3-Yl)-1h-Indole-5-Carboxamidine,FEKRWNWZMOSVBX-UHFFFAOYSA-O,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
79303,6m2n,DB13053,-9.2,CP-195543,NZQDWKCNBOELAI-KSFYIVLOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
57281,6crv,DB03446,-9.2,N-Benzyl-3-(alpha-D-galactopyranosyloxy)benzamide,FSMWGHKWKYCPKE-QTVCLEQKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78530,6m2n,DB11892,-9.2,Prulifloxacin,PWNMXPDKBYZCOO-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
81396,6m3m,DB01148,-9.2,Flavoxate,SPIUTQOUKAMGCX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
138023,6w9c,DB09034,-9.2,Suvorexant,JYTNQNCOQXFQPK-MRXNPFEDSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
88794,6m3m,DB14810,-9.2,AZD-1656,FJEJHJINOKKDCW-INIZCTEOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87155,6m3m,DB11910,-9.2,MK-0249,DDDZBLNULGDPGA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59838,6crv,DB07934,-9.2,[[CYCLOHEXANESULFONYL-GLYCYL]-3[PYRIDIN-4-YL-AMINOMETHYL]ALANYL]PIPERIDINE,KMUXFASJKPVMGU-HXUWFJFHSA-O,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88789,6m3m,DB14795,-9.2,AZD-3759,MXDSJQHFFDGFDK-CYBMUJFWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59837,6crv,DB07933,-9.2,Erteberel,XIESSJVMWNJCGZ-VKJFTORMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
96112,6m71,DB12410,-9.2,Sabarubicin,VQHRZZISQVWPLK-UIRGBLDSSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
136818,6w9c,DB07568,-9.2,"(2S)-2-[(2,1,3-BENZOTHIADIAZOL-4-YLSULFONYL)AMINO]-2-PHENYL-N-PYRIDIN-4-YLACETAMIDE",ADRNPUSZBRQDBG-KRWDZBQOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
78506,6m2n,DB11853,-9.2,Relugolix,AOMXMOCNKJTRQP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
94209,6m71,DB07845,-9.2,"2-fluoro-6-{[2-({2-methoxy-4-[(methylsulfonyl)methyl]phenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide",VGYXXQRDIVRILX-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96115,6m71,DB12414,-9.2,Usistapide,WSYALRNYQFNNGP-WJOKGBTCSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
87552,6m3m,DB12479,-9.2,Zabofloxacin,ZNPOCLHDJCAZAH-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87230,6m3m,DB12022,-9.2,Evatanepag,WOHRHWDYFNWPNG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
56087,6crv,DB01858,-9.2,[1-(4-Fluorobenzyl)Cyclobutyl]Methyl (1s)-1-[Oxo(1h-Pyrazol-5-Ylamino)Acetyl]Pentylcarbamate,QTPYRNAKLBXKNP-SFHVURJKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79295,6m2n,DB13040,-9.2,Gandotinib,SQSZANZGUXWJEA-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137509,6w9c,DB08386,-9.2,2-{[4-(4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline,VRWJZGHUCOFGPZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
95150,6m71,DB08995,-9.2,Diosmin,GZSOSUNBTXMUFQ-YFAPSIMESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
138099,6w9c,DB09181,-9.2,Trefentanil,RJSCINHYBGMIFT-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
79267,6m2n,DB12999,-9.2,MK-6186,FZBAOOQVQXATRL-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
164061,7bv1,DB07026,-9.2,"(1S,5S,7R)-N-7-(BIPHENYL-4-YLMETHYL)-N-3-HYDROXY-6,8-DIOXA-3-AZABICYCLO[3.2.1]OCTANE-3,7-DICARBOXAMIDE",PPLDARNGJSQINK-OKZBNKHCSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60047,6crv,DB08166,-9.2,"(4R)-7-chloro-9-methyl-1-oxo-1,2,4,9-tetrahydrospiro[beta-carboline-3,4'-piperidine]-4-carbonitrile",LPFQFJAOMCGYCP-GFCCVEGCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138061,6w9c,DB09095,-9.2,Difluocortolone,OGPWIDANBSLJPC-RFPWEZLHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
88825,6m3m,DB14882,-9.2,CEP-9722,CTLOSZHDGZLOQE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
95648,6m71,DB11740,-9.2,MK-1775,BKWJAKQVGHWELA-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60686,6crv,DB08975,-9.2,Florantyrone,QOBAOSCOLAGPKI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
95683,6m71,DB11791,-9.2,Capmatinib,LIOLIMKSCNQPLV-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
81451,6m3m,DB01208,-9.2,Sparfloxacin,DZZWHBIBMUVIIW-DTORHVGOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
132005,6w4h,DB15193,-9.2,BMS-955176,XDMUFNNPLXHNKA-ZTESCHFWSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130237,6w4h,DB11968,-9.2,MK-7145,OCKGFTQIICXDQW-ZEQRLZLVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
81464,6m3m,DB01224,-9.2,Quetiapine,URKOMYMAXPYINW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
95724,6m71,DB11847,-9.2,Cadazolid,XWFCFMXQTBGXQW-GOSISDBHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
80811,6m3m,DB00457,-9.2,Prazosin,IENZQIKPVFGBNW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59872,6crv,DB07973,-9.2,N-(1-ISOPROPYLPIPERIDIN-4-YL)-1-(3-METHOXYBENZYL)-1H-INDOLE-2-CARBOXAMIDE,GIPCBGDQVGKMPO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60687,6crv,DB08976,-9.2,Floctafenine,APQPGQGAWABJLN-GFCCVEGCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
132001,6w4h,DB15189,-9.2,Birabresib,GNMUEVRJHCWKTO-FQEVSTJZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
88820,6m3m,DB14875,-9.2,AZD-4017,NCDZABJPWMBMIQ-INIZCTEOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
60040,6crv,DB08159,-9.2,"4-(5,11-DIOXO-5H-INDENO[1,2-C]ISOQUINOLIN-6(11H)-YL)BUTANOATE",AHIJTWCJGCWHMT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55610,6crv,DB01199,-9.2,Tubocurarine,JFJZZMVDLULRGK-URLMMPGGSA-O,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79193,6m2n,DB12885,-9.2,CF-102,IPSYPUKKXMNCNQ-PFHKOEEOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
60062,6crv,DB08184,-9.2,2-(2-METHYLPHENYL)-1H-INDOLE-5-CARBOXIMIDAMIDE,YOZKTHGEOJHIDP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
131997,6w4h,DB15177,-9.2,VX-659,IGEOJNMYRZUKIK-IBGZPJMESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
59800,6crv,DB07889,-9.2,"(2S)-1-(Dimethylamino)-3-(4-{[4-(2-methylimidazo[1,2-a]pyridin-3-yl)-2-pyrimidinyl]amino}phenoxy)-2-propanol",VCPXSBULBDYRLT-SFHVURJKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
94202,6m71,DB07837,-9.2,"[4-(5-naphthalen-2-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)phenyl]acetic acid",SWXKLXXVFMYMDP-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
27798,6cs2,DB00673,-9.2,Aprepitant,ATALOFNDEOCMKK-OITMNORJSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
81587,6m3m,DB01443,-9.2,19-Nor-5-androstenedione,WELNRNVZXWUOGT-QXUSFIETSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87593,6m3m,DB12547,-9.2,LY-2886721,NIDRNVHMMDAAIK-YPMLDQLKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
128978,6w4h,DB08237,-9.2,2'-deoxy-N-(naphthalen-1-ylmethyl)guanosine 5'-(dihydrogen phosphate),COMPKRGNHXOXMN-GVDBMIGSSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
57857,6crv,DB04216,-9.2,Quercetin,REFJWTPEDVJJIY-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61322,6crv,DB11912,-9.2,Lanopepden,SWHNZGMQMGFQGW-MSOLQXFVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79390,6m2n,DB13215,-9.2,Sulfobromophthalein,OHTXTCNTQJFRIG-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
136861,6w9c,DB07622,-9.2,"1-(3-(2,4-DIMETHYLTHIAZOL-5-YL)-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)-3-(4-METHYLPIPERAZIN-1-YL)UREA",KRKQVGZXTNLQSV-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
27714,6cs2,DB07270,-9.2,"N-[7-(3-AMINOPHENYL)-5-METHOXY-1,3-BENZOXAZOL-2-YL]-2,5-DICHLOROBENZENESULFONAMIDE",GAYYMURZGLJDCT-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
57872,6crv,DB04238,-9.2,N-Alpha-(2-Naphthylsulfonyl)-N-(3-Amidino-L-Phenylalaninyl)-D-Pipecolinic Acid,GNANSBQAIRJZPA-XZOQPEGZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
131358,6w4h,DB13640,-9.2,Acetoxolone,FTQDJVZNPJRVPG-XWEVEMRCSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
55501,6crv,DB01076,-9.2,Atorvastatin,XUKUURHRXDUEBC-KAYWLYCHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79169,6m2n,DB12848,-9.2,PF-04217903,PDMUGYOXRHVNMO-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79160,6m2n,DB12832,-9.2,Prednimustine,HFVNWDWLWUCIHC-GUPDPFMOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78410,6m2n,DB11712,-9.2,Tezacaftor,MJUVRTYWUMPBTR-MRXNPFEDSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
60019,6crv,DB08137,-9.2,(4E)-N-(4-fluorophenyl)-4-[(phenylcarbonyl)imino]-4H-pyrazole-3-carboxamide,ZMWYSLJBNJUCRK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
137600,6w9c,DB08495,-9.2,4-({4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-2-OXOPIPERAZIN-1-YL}METHYL)BENZENECARBOXIMIDAMIDE,VXONTEUOQXFJJS-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
87247,6m3m,DB12049,-9.2,Dasolampanel etibutil,HPBRMCFZIGUGTK-ZMMAXQRCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
79491,6m2n,DB13347,-9.2,Diphenadione,JYGLAHSAISAEAL-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
159070,7bv1,DB03104,-9.2,RU82129,NKMPOVPTYDXGEC-MNRBYUMSSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
25142,6cs2,DB03005,-9.2,"3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-5-Yl]Hexyl]-Phenanthridinium",ISUOMOOYAOQQPZ-UHFFFAOYSA-O,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
61342,6crv,DB11943,-9.2,Delafloxacin,DYDCPNMLZGFQTM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88895,6m3m,DB15056,-9.2,Bifenthrin,OMFRMAHOUUJSGP-IRHGGOMRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87258,6m3m,DB12064,-9.2,BMS-777607,VNBRGSXVFBYQNN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
97567,6m71,DB15177,-9.2,VX-659,IGEOJNMYRZUKIK-IBGZPJMESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
87110,6m3m,DB11844,-9.2,Pritelivir,IVZKZONQVYTCKC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
163962,7bv1,DB06908,-9.2,"(2S)-3-(1-{[2-(2-CHLOROPHENYL)-5-METHYL-1,3-OXAZOL-4-YL]METHYL}-1H-INDOL-5-YL)-2-ETHOXYPROPANOIC ACID",PAWOPJKHTZCKMT-QFIPXVFZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60620,6crv,DB08878,-9.2,Aminopterin,TVZGACDUOSZQKY-LBPRGKRZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79175,6m2n,DB12857,-9.2,NVP-LEQ-506,POERAARDVFVDLO-QGZVFWFLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
159242,7bv1,DB03632,-9.2,Argifin,UHBHXSDKGLPPGO-HTDHLNIYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
25032,6cs2,DB02877,-9.2,Arotinoid acid,FOIVPCKZDPCJJY-JQIJEIRASA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
96175,6m71,DB12504,-9.2,JNJ-40346527,BNVPFDRNGHMRJS-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
130194,6w4h,DB11907,-9.2,Rociletinib,HUFOZJXAKZVRNJ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
60633,6crv,DB08901,-9.2,Ponatinib,PHXJVRSECIGDHY-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136463,6w9c,DB07145,-9.2,(2R)-N-HYDROXY-2-[(3S)-3-METHYL-3-{4-[(2-METHYLQUINOLIN-4-YL)METHOXY]PHENYL}-2-OXOPYRROLIDIN-1-YL]PROPANAMIDE,YDMIPBHQKFOFQW-NSYGIPOTSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
94185,6m71,DB07817,-9.2,"1-{3-[(4-pyridin-2-ylpiperazin-1-yl)sulfonyl]phenyl}-3-(1,3-thiazol-2-yl)urea",NJPVZSIGDRLLTD-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
131558,6w4h,DB13941,-9.2,Piperaquine,UCRHFBCYFMIWHC-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
57709,6crv,DB04022,-9.2,"Guanosine-5',3'-Tetraphosphate",BUFLLCUFNHESEH-UUOKFMHZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
132043,6w4h,DB15266,-9.2,TAK-580,VWMJHAFYPMOMGF-ZCFIWIBFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130185,6w4h,DB11896,-9.2,Gedatolisib,DWZAEMINVBZMHQ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
80689,6m3m,DB00310,-9.2,Chlorthalidone,JIVPVXMEBJLZRO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
96301,6m71,DB12703,-9.2,Omipalisib,CGBJSGAELGCMKE-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
129067,6w4h,DB08351,-9.2,N-cyclopropyl-4-methyl-3-{2-[(2-morpholin-4-ylethyl)amino]quinazolin-6-yl}benzamide,MNEXDVSJIUQQRH-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
78490,6m2n,DB11829,-9.2,Ruboxistaurin,ZCBUQCWBWNUWSU-SFHVURJKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
96330,6m71,DB12742,-9.2,Amuvatinib,FOFDIMHVKGYHRU-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
87136,6m3m,DB11885,-9.2,Anlotinib,KSMZEXLVHXZPEF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136460,6w9c,DB07142,-9.2,"5-[(3R)-3-(5-methoxy-3',5'-dimethylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",ATFDKOLABYIYCC-INIZCTEOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
130181,6w4h,DB11891,-9.2,CUDC-907,JOWXJLIFIIOYMS-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
88723,6m3m,DB14660,-9.2,Trenbolone acetate,CMRJPMODSSEAPL-FYQPLNBISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
129057,6w4h,DB08339,-9.2,"6-(2,6-DICHLOROPHENYL)-2-{[3-(HYDROXYMETHYL)PHENYL]AMINO}-8-METHYLPYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE",ZIQFYVPVJZEOFS-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
78472,6m2n,DB11805,-9.2,Saracatinib,OUKYUETWWIPKQR-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
84659,6m3m,DB06710,-9.2,Methyltestosterone,GCKMFJBGXUYNAG-HLXURNFRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81579,6m3m,DB01434,-9.2,19-norandrostenedione,JRIZOGLBRPZBLQ-QXUSFIETSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88722,6m3m,DB14659,-9.2,Melengestrol acetate,UDKABVSQKJNZBH-DWNQPYOZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
79701,6m2n,DB13631,-9.2,Methoserpidine,ULBNWNUHGJLQHO-VKMIBBQISA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61422,6crv,DB12063,-9.2,CERC-301,RECBFDWSXWAXHY-IAGOWNOFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
95332,6m71,DB09280,-9.2,Lumacaftor,UFSKUSARDNFIRC-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
138544,6w9c,DB11819,-9.2,ASP-4058,NJNXCJPSMWKXHO-VIFPVBQESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
78841,6m2n,DB12339,-9.2,Radezolid,BTTNOGHPGJANSW-IBGZPJMESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
57437,6crv,DB03671,-9.2,"4-(3,12,14-Trihydroxy-10,13-Dimethyl-Hexadecahydro-Cyclopenta[a]Phenanthren-17-Yl)-5h-Furan-2-One",SHIBSTMRCDJXLN-KCZCNTNESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87939,6m3m,DB13089,-9.2,Enoxolone,MPDGHEJMBKOTSU-YKLVYJNSSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
60986,6crv,DB11263,-9.2,Polydatin,HSTZMXCBWJGKHG-CUYWLFDKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
137694,6w9c,DB08607,-9.2,"(5R)-5-(4-{[(2R)-6-HYDROXY-2,5,7,8-TETRAMETHYL-3,4-DIHYDRO-2H-CHROMEN-2-YL]METHOXY}BENZYL)-1,3-THIAZOLIDINE-2,4-DIONE",GXPHKUHSUJUWKP-NTKDMRAZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
159381,7bv1,DB04071,-9.2,Cpad,LFERELMXERXKKQ-KMXXXSRASA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
136272,6w9c,DB06922,-9.2,"2-[(1R)-1-carboxy-2-naphthalen-1-ylethyl]-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylic acid",CZNPWASYMRBJCX-GOSISDBHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
102692,6vxs,DB07700,-9.2,"3-CARBOXAMIDO-1,3,5(10)-ESTRATRIEN-17(R)-SPIRO-2'(5',5'-DIMETHYL-6'OXO)TETRAHYDROPYRAN",YVAJWBACBRSVPR-NDUHRLLKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102707,6vxs,DB07717,-9.2,"(5S,8R,9S,10S,13R,14S,17S)-13-{2-[(3,5-DIFLUOROBENZYL)OXY]ETHYL}-17-HYDROXY-10-METHYLHEXADECAHYDRO-3H-CYCLOPENTA[A]PHENANTHREN-3-ONE",AJODXHGZHBERGJ-JLYQOUBASA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
86760,6m3m,DB09383,-9.2,Meprednisone,PIDANAQULIKBQS-RNUIGHNZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136940,6w9c,DB07716,-9.2,"(4Z)-2,8:7,12:11,15:14,18:17,22-PENTAANHYDRO-4,5,6,9,10,13,19,20,21-NONADEOXY-D-ARABINO-D-ALLO-D-ALLO-DOCOSA-4,9,20-TRIENITOL",VDRIXSJOPKVWKM-HXGIDPQASA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
102807,6vxs,DB07830,-9.2,"(4R,5R)-5-AMINO-1-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN-2-ONE",DIRIFWIKLRTNMB-DYVFJYSZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
77475,6m2n,DB08426,-9.2,"THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [2-OXO-1-(1H-PYRROLO[2,3-C]PYRIDIN-2-YLMETHYL)-PYRROLIDIN-3-YL]-AMIDE",PLXOQMHGHDZMSX-AWEZNQCLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
130760,6w4h,DB12742,-9.2,Amuvatinib,FOFDIMHVKGYHRU-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130047,6w4h,DB11691,-9.2,Naldemedine,AXQACEQYCPKDMV-RZAWKFBISA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
56718,6crv,DB02691,-9.2,Glycocholic acid,RFDAIACWWDREDC-FRVQLJSFSA-M,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56724,6crv,DB02698,-9.2,"N-(M-Trifluoromethylphenyl) Phenoxazine-4,6-Dicarboxylic Acid",NQOOJFXBGLOGTC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
12505,6lzg,DB13454,-9.2,Nicomorphine,HNDXBGYRMHRUFN-CIVUWBIHSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
87359,6m3m,DB12218,-9.2,AZD-5363,JDUBGYFRJFOXQC-KRWDZBQOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
60315,6crv,DB08500,-9.2,"(3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(2-naphthyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol",ZCJBDRSKHARECB-PYTCMNEWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
89018,6m3m,DB15295,-9.2,Tenalisib,HDXDQPRPFRKGKZ-INIZCTEOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80294,6m2n,DB15075,-9.2,4-demethyl-4-cholesteryloxycarbonylpenclomedine,ZJUUIXYKTPSIOH-LEZJFEBPSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80386,6m2n,DB15254,-9.2,RO-5126766 free base,LMMJFBMMJUMSJS-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
55264,6crv,DB00808,-9.2,Indapamide,NDDAHWYSQHTHNT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80268,6m2n,DB15028,-9.2,MK-1064,CKTWQGHVNRYNCM-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
25620,6cs2,DB03596,-9.2,N-[2-(1h-Indol-5-Yl)-Butyl]-4-Sulfamoyl-Benzamide,FSRPBGBMEKDSIJ-CYBMUJFWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
131906,6w4h,DB14989,-9.2,Umbralisib,IUVCFHHAEHNCFT-INIZCTEOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
87750,6m3m,DB12796,-9.2,MRX-I,SULYVXZZUMRQAX-NSHDSACASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
102089,6vxs,DB06997,-9.2,"2-(4-fluorophenyl)-N-{[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]carbamoyl}acetamide",BMPOCDJEXAXXEZ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
90055,6m71,DB01200,-9.2,Bromocriptine,OZVBMTJYIDMWIL-AYFBDAFISA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
25528,6cs2,DB03476,-9.2,Trans-6-(2-Phenylcyclopropyl)-Naphthalene-2-Carboxamidine,NQRIWXVAIWPBEM-OALUTQOASA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
90054,6m71,DB01199,-9.2,Tubocurarine,JFJZZMVDLULRGK-URLMMPGGSA-O,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
58249,6crv,DB04750,-9.2,OREGON GREEN 488 CARBOXYLATE,BRJCLSQFZSHLRL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
137170,6w9c,DB07982,-9.2,2-{4-[4-({4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]pyrimidin-2-yl}amino)phenyl]piperazin-1-yl}-2-oxoethanol,PVTKDXZNSUHUMO-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
102156,6vxs,DB07072,-9.2,"(1S,2R,5S)-5-[3-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7(8H)-YL]-2-(2,4,5-TRIFLUOROPHENYL)CYCLOHEXANAMINE",CNKRZILQBKJWDS-WMFXKJRFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
80248,6m2n,DB14944,-9.2,Tarloxotinib,MUJMYVFVAWFUJL-SNAWJCMRSA-O,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
87758,6m3m,DB12808,-9.2,Trifarotene,MFBCDACCJCDGBA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88015,6m3m,DB13230,-9.2,Gestonorone,GTFUITFQDGVJSK-XGXHKTLJSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
137164,6w9c,DB07974,-9.2,1-{2-[(4-CHLOROPHENYL)AMINO]-2-OXOETHYL}-N-(1-ISOPROPYLPIPERIDIN-4-YL)-1H-INDOLE-2-CARBOXAMIDE,BDLMBQRBNPDCSS-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
82170,6m3m,DB02197,-9.2,"4-[(4-Imidazo[1,2-a]Pyridin-3-Ylpyrimidin-2-Yl)Amino]Benzenesulfonamide",NKORVPQBJCGYEC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87979,6m3m,DB13164,-9.2,Olmutinib,FDMQDKQUTRLUBU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
89958,6m71,DB01092,-9.2,Ouabain,LPMXVESGRSUGHW-HBYQJFLCSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
80255,6m2n,DB14993,-9.2,Pyrotinib,SADXACCFNXBCFY-IYNHSRRRSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137160,6w9c,DB07970,-9.2,5-[(2-methyl-5-{[3-(trifluoromethyl)phenyl]carbamoyl}phenyl)amino]pyridine-3-carboxamide,SAAYRHKJHDIDPH-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
163429,7bv1,DB04408,-9.2,Ncs-Chromophore,QZGIWPZCWHMVQL-UIYAJPBUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
130712,6w4h,DB12669,-9.2,4SC-203,MAFACRSJGNJHCF-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
57009,6crv,DB03081,-9.2,Crc200 (Chiron-Behring),ZOXOKTJHZSUHRJ-XZOQPEGZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
102438,6vxs,DB07396,-9.2,"1-{2-[3-(2-Chloro-4,5-difluoro-benzoyl)-ureido]-4-fluoro-phenyl}-piperidine-4-carboxylic acid",KAJJGOCSAXKXBD-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
60363,6crv,DB08556,-9.2,"5'-ACETYL-4-{[(2,4-DIMETHYLPHENYL)SULFONYL]AMINO}-2,2'-BITHIOPHENE-5-CARBOXYLIC ACID",CMHHNHDPPWDNAH-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
89091,6m3m,DB15446,-9.2,Vidofludimus,XPRDUGXOWVXZLL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
77441,6m2n,DB08384,-9.2,2-({4-[4-(pyridin-4-ylmethyl)-1H-pyrazol-3-yl]phenoxy}methyl)quinoline,RQDDHVVAAJVVKM-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
81160,6m3m,DB00878,-9.2,Chlorhexidine,GHXZTYHSJHQHIJ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
104047,6vxs,DB11273,-9.2,Dihydroergocornine,SEALOBQTUQIVGU-QNIJNHAOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104049,6vxs,DB11275,-9.2,Epicriptine,SBFXHXZNBNFPHV-PXXBSISHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
136266,6w9c,DB06916,-9.2,"N-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-1-[2-(1H-IMIDAZOL-1-YL)-6-METHYLPYRIMIDIN-4-YL]-D-PROLINAMIDE",LBCGUKCXRVUULK-QGZVFWFLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136247,6w9c,DB06896,-9.2,"1-(4-fluorophenyl)-N-[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]-2-oxo-1,2-dihydropyridine-3-carboxamide",OBSFXHDOLBYWRJ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
55715,6crv,DB01395,-9.2,Drospirenone,METQSPRSQINEEU-HXCATZOESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87843,6m3m,DB12941,-9.2,ODM-201,BLIJXOOIHRSQRB-PXYINDEMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87842,6m3m,DB12939,-9.2,Nikkomycin Z,WWJFFVUVFNBJTN-VHDFTHOZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
24827,6cs2,DB02629,-9.2,Inhibitor Bea403,LYHLPPXMBKMSSZ-JQFCFGFHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
87840,6m3m,DB12937,-9.2,Quercetin-3'-O-phosphate,UWJBYNLLMAPJMM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
149149,6w9q,DB15039,-9.2,ITI-214,BBIPVJCGIASXJB-PKTZIBPZSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
103914,6vxs,DB09233,-9.2,Cronidipine,CNIJVNPIIHWRRP-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
136680,6w9c,DB07405,-9.2,"1-(6-CYANO-3-PYRIDYLCARBONYL)-5',8'-DIFLUOROSPIRO[PIPERIDINE-4,2'(1'H)-QUINAZOLINE]-4'-AMINE",GIZYIOOBBUHOBS-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
12189,6lzg,DB13014,-9.2,Hypericin,BTXNYTINYBABQR-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
87808,6m3m,DB12890,-9.2,Dihydrexidine,BGOQGUHWXBGXJW-YOEHRIQHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
89061,6m3m,DB15391,-9.2,Elenbecestat,AACUJFVOHGRMTR-DPXNYUHVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
104201,6vxs,DB11652,-9.2,Tucatinib,SDEAXTCZPQIFQM-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
138725,6w9c,DB12180,-9.2,Apitolisib,YOVVNQKCSKSHKT-HNNXBMFYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
87830,6m3m,DB12924,-9.2,Ozenoxacin,XPIJWUTXQAGSLK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
78947,6m2n,DB12491,-9.2,Fasiglifam,BZCALJIHZVNMGJ-HSZRJFAPSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
56887,6crv,DB02915,-9.2,"4-(2,4-Dimethyl-1,3-thiazol-5-yl)-N-[4-(trifluoromethyl)phenyl]-2-pyrimidinamine",MEZFDQUDLQCVNX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27479,6cs2,DB07025,-9.2,3-(5-{[4-(AMINOMETHYL)PIPERIDIN-1-YL]METHYL}-1H-INDOL-2-YL)QUINOLIN-2(1H)-ONE,KBIHHEGEALBUMT-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
61571,6crv,DB12279,-9.2,OBP-801,XFLBOEMFLGLWFF-HDXRNPEWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56889,6crv,DB02917,-9.2,N-Hydroxy-4-(Methyl{[5-(2-Pyridinyl)-2-Thienyl]Sulfonyl}Amino)Benzamide,LFGYSFPVLMPUPE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
12260,6lzg,DB13109,-9.2,PKI-179,WXUUCRLKXQMWRY-OYRHEFFESA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
55713,6crv,DB01393,-9.2,Bezafibrate,IIBYAHWJQTYFKB-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78974,6m2n,DB12535,-9.2,AC-430,DCRWIATZWHLIPN-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
89086,6m3m,DB15437,-9.2,Rocacetrapib,GBHPDJQHZADVAA-SOKVYYICSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
60311,6crv,DB08496,-9.2,(R)-warfarin,PJVWKTKQMONHTI-HNNXBMFYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86758,6m3m,DB09371,-9.2,Norethynodrel,ICTXHFFSOAJUMG-SLHNCBLASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
129845,6w4h,DB11176,-9.2,Zeaxanthin,JKQXZKUSFCKOGQ-QAYBQHTQSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
132432,6w9c,DB00421,-9.2,Spironolactone,LXMSZDCAJNLERA-ZHYRCANASA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
87789,6m3m,DB12863,-9.2,Sivelestat,BTGNGJJLZOIYID-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
89035,6m3m,DB15327,-9.2,Abivertinib,UOFYSRZSLXWIQB-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87889,6m3m,DB13016,-9.2,LY-2300559,DWQVYDLTPMGYNE-DEOSSOPVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80334,6m2n,DB15151,-9.2,RO-6870810,PKQXLRYFPSZKDU-QFIPXVFZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80337,6m2n,DB15157,-9.2,Voruciclib,MRPGRAKIAJJGMM-OCCSQVGLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78903,6m2n,DB12426,-9.2,Bitopertin,YUUGYIUSCYNSQR-LBPRGKRZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
56789,6crv,DB02789,-9.2,Pregnenolone,ORNBQBCIOKFOEO-QGVNFLHTSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
129866,6w4h,DB11273,-9.2,Dihydroergocornine,SEALOBQTUQIVGU-QNIJNHAOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
87877,6m3m,DB12998,-9.2,PF-00217830,QGNOXTFZOLDODX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58305,6crv,DB04824,-9.2,Phenolphthalein,KJFMBFZCATUALV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
129890,6w4h,DB11363,-9.2,Alectinib,KDGFLJKFZUIJMX-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
137054,6w9c,DB07845,-9.2,"2-fluoro-6-{[2-({2-methoxy-4-[(methylsulfonyl)methyl]phenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide",VGYXXQRDIVRILX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
103563,6vxs,DB08730,-9.2,3-FLUORO-5-MORPHOLIN-4-YL-N-[1-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-6-YL]BENZAMIDE,CPFBZMFUCGHBAP-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
138698,6w9c,DB12134,-9.2,Gepotidacin,PZFAZQUREQIODZ-LJQANCHMSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
103582,6vxs,DB08749,-9.2,3-(2-AMINO-6-BENZOYLQUINAZOLIN-3(4H)-YL)-N-CYCLOHEXYL-N-METHYLPROPANAMIDE,KTRFBFMYAJOXLG-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
87871,6m3m,DB12985,-9.2,Quisinostat,PAWIYAYFNXQGAP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
164221,7bv1,DB07395,-9.2,"4-[3-(2-Chloro-4,5-difluoro-benzoyl)ureido]-3-trifluoromethoxybenzoic acid",NWQGDIBCFLDHDO-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
103675,6vxs,DB08875,-9.2,Cabozantinib,ONIQOQHATWINJY-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102058,6vxs,DB06959,-9.2,(2S)-1-(3H-Indol-3-yl)-3-{[5-(6-isoquinolinyl)-3-pyridinyl]oxy}-2-propanamine,BUCZDJYEOAQTHL-KEKNWZKVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
80238,6m2n,DB14932,-9.2,Coleneuramide,CHMRTBYTCBDIRG-JQZMMWJVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
102635,6vxs,DB07630,-9.2,"N-((1R,2R)-2-(5-CHLORO-1H-INDOLE-2-CARBOXAMIDO)CYCLOHEXYL)-5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE-2-CARBOXAMIDE",ARPFWVKYXJZULB-IAGOWNOFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
59944,6crv,DB08054,-9.2,"1-(1-methylethyl)-3-quinolin-6-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine",GEZALMMCQYDFML-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
128483,6w4h,DB07666,-9.2,"(3R,4S)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE",OAWGQHXWGXOUKV-BEFAXECRSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
81034,6m3m,DB00728,-9.2,Rocuronium,YXRDKMPIGHSVRX-OOJCLDBCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88324,6m3m,DB13649,-9.2,Proquazone,JTIGKVIOEQASGT-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
90978,6m71,DB02449,-9.2,3-(1h-Indol-3-Yl)-2-[4-(4-Phenyl-Piperidin-1-Yl)-Benzenesulfonylamino]-Propionic Acid,ULOTXPTWJAUGGE-MHZLTWQESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59734,6crv,DB07812,-9.2,"N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyrrolo[2,3-b]pyridin-4-yl)thiophene-2-carboxamide",TWYNGDRSMHRPSY-MRXNPFEDSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80450,6m2n,DB15391,-9.2,Elenbecestat,AACUJFVOHGRMTR-DPXNYUHVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
131012,6w4h,DB13138,-9.2,Neladenoson bialanate,WESNEIGKOAXSGX-VXKWHMMOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
60411,6crv,DB08614,-9.2,"3-[[(METHYLAMINO)SULFONYL]AMINO]-2-OXO-6-PHENYL-N-[3,3,3-TRIFLUORO-1-(1-METHYLETHYL)-2-OXOPHENYL]-1(2H)-PYRIDINE ACETAMIDE",MYFMPKCOIMRDDD-KRWDZBQOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58149,6crv,DB04612,-9.2,"N-METHYLALANYL-3-METHYLVALYL-4-PHENOXY-N-(1,2,3,4-TETRAHYDRONAPHTHALEN-1-YL)PROLINAMIDE",QKPXPZYQPBWDHS-MCJAPYMPSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80451,6m2n,DB15393,-9.2,Telatinib,QFCXANHHBCGMAS-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
100929,6vxs,DB04238,-9.2,N-Alpha-(2-Naphthylsulfonyl)-N-(3-Amidino-L-Phenylalaninyl)-D-Pipecolinic Acid,GNANSBQAIRJZPA-XZOQPEGZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
88359,6m3m,DB13689,-9.2,Tacalcitol,BJYLYJCXYAMOFT-RSFVBTMBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
158290,7bv1,DB00826,-9.2,Natamycin,NCXMLFZGDNKEPB-FFPOYIOWSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
80218,6m2n,DB14889,-9.2,Derazantinib,KPJDVVCDVBFRMU-AREMUKBSSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
25520,6cs2,DB03466,-9.2,BMS184394,AYAJZQYENGWICE-QHCPKHFHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
87398,6m3m,DB12269,-9.2,PF-06273340,BPIWZDNVMQQBQX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
27288,6cs2,DB06817,-9.2,Raltegravir,CZFFBEXEKNGXKS-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
101221,6vxs,DB04632,-9.2,4-(2-HYDROXYBENZYLAMINO)-N-(3-(4-FLUOROPHENOXY)PHENYL)PIPERIDINE-1-SULFONAMIDE,JHHBGNIRSUTQAS-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
86946,6m3m,DB11562,-9.2,Bicuculline,IYGYMKDQCDOMRE-ZWKOTPCHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
158859,7bv1,DB02551,-9.2,"6-[N-(4-Ethyl-1,2,3,4-Tetrahydro-6-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine",LVNMYQLXKMSQTG-AWEZNQCLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
61463,6crv,DB12122,-9.2,Figopitant,HUTHJVYJUPXHDF-DEOSSOPVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
101392,6vxs,DB04861,-9.2,Nebivolol,KOHIRBRYDXPAMZ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
149326,6w9q,DB15396,-9.2,PF-114,SLIVDYMORZGPLW-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
129635,6w4h,DB09079,-9.2,Nintedanib,XZXHXSATPCNXJR-ZIADKAODSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
87397,6m3m,DB12268,-9.2,Carmegliptin,GUYMHFIHHOEFOA-ZCPGHIKRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
60391,6crv,DB08591,-9.2,"5-(4-METHOXYBIPHENYL-3-YL)-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDE",IGXKSKWHHHYBFM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80440,6m2n,DB15358,-9.2,JNJ-54175446,CWFVVQFVGMFTBD-SECBINFHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
87294,6m3m,DB12116,-9.2,Epigallocatechin gallate,WMBWREPUVVBILR-WIYYLYMNSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
164295,7bv1,DB07666,-9.2,"(3R,4S)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE",OAWGQHXWGXOUKV-BEFAXECRSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
80232,6m2n,DB14917,-9.2,Ceralasertib,DTTJKLNXNZAVSM-JYCIKRDWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138591,6w9c,DB11890,-9.2,Cilengitide,AMLYAMJWYAIXIA-VWNVYAMZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
61045,6crv,DB11423,-9.2,Lasalocid,BBMULGJBVDDDNI-OWKLGTHSSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88972,6m3m,DB15206,-9.2,Uprifosbuvir,SFPFZQKYPOWCSI-KHFYHRBSSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
60797,6crv,DB09168,-9.2,4-Phenylfentanyl,BXCJXJLHYMWMQU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138576,6w9c,DB11867,-9.2,JNJ-39393406,IURMHZBQEYNQOH-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
28250,6cs2,DB07831,-9.2,"2-{[(6-OXO-1,6-DIHYDROPYRIDIN-3-YL)METHYL]AMINO}-N-[4-PROPYL-3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE",SHSORWZDEKFFLP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
88278,6m3m,DB13586,-9.2,Metandienone,XWALNWXLMVGSFR-HLXURNFRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58191,6crv,DB04664,-9.2,Cyclohexyl-pentyl-maltoside,RVTGFZGNOSKUDA-ZNGNCRBCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77704,6m2n,DB08703,-9.2,"12-(2-hydroxyethyl)-2-(1-methylethoxy)-13,14-dihydronaphtho[2,1-a]pyrrolo[3,4-c]carbazol-5(12H)-one",FGKKIHITEICGMN-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
56594,6crv,DB02524,-9.2,"2',3'-O-{4-[Hydroxy(oxido)-??5-azanylidene]-2,6-dinitro-2,5-cyclohexadiene-1,1-diyl}adenosine 5'-(tetrahydrogen triphosphate)",XFMMHXLUHKBKQE-UHEGPQQHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
100756,6vxs,DB04011,-9.2,"2'-(4-Dimethylaminophenyl)-5-(4-Methyl-1-Piperazinyl)-2,5'-Bi-Benzimidazole",VMCOQLKKSNQANE-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
137192,6w9c,DB08006,-9.2,"N-anthracen-2-yl-5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7-amine",OXYDLVAOXASTMW-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
77846,6m2n,DB08881,-9.2,Vemurafenib,GPXBXXGIAQBQNI-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
90516,6m71,DB01836,-9.2,"[4-(6-Chloro-Naphthalene-2-Sulfonyl)-Piperazin-1-Yl]-(3,4,5,6-Tetrahydro-2h-[1,4']Bipyridinyl-4-Yl)-Methanone",ZLAKCKVFSRSENR-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
100593,6vxs,DB03797,-9.2,3-Aminomethyl-Pyridinium-Adenine-Dinucleotide,HMCRLFVYYFBZEZ-PLEFRAQWSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
91146,6m71,DB02668,-9.2,"Je-2147, Ag1776, Kni-764",CUFQBQOBLVLKRF-RZDMPUFOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
87007,6m3m,DB11692,-9.2,Pavinetant,QYTBBBAHNIWFOD-NRFANRHFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
61019,6crv,DB11371,-9.2,Alfaxalone,DUHUCHOQIDJXAT-OLVMNOGESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
90405,6m71,DB01690,-9.2,Bis(Adenosine)-5'-Triphosphate,QCICUPZZLIQAPA-XPWFQUROSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
55785,6crv,DB01479,-9.2,BA-2664,QGKQXZFZOIQFBI-XSWYFRFISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81024,6m3m,DB00717,-9.2,Norethisterone,VIKNJXKGJWUCNN-XGXHKTLJSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
79093,6m2n,DB12719,-9.2,Turofexorate isopropyl,INASOKQDNHHMRE-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
136706,6w9c,DB07435,-9.2,"1,2,3-TRIHYDROXY-1,2,3,4-TETRAHYDROBENZO[A]PYRENE",GFANZDFKCCJYRF-NSISKUIASA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
100286,6vxs,DB03367,-9.2,PF-00356231,VMTJQZUZINLEKC-JOCHJYFZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
130973,6w4h,DB13078,-9.2,KOSN-1724,JAYGOFBXDFAXBW-CYEKYUJNSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
56583,6crv,DB02510,-9.2,'5'-O-(N-(L-Prolyl)-Sulfamoyl)Adenosine,LKVJEMXWEODCAY-JVEUSOJLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80193,6m2n,DB14845,-9.2,Filgotinib,RIJLVEAXPNLDTC-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
26976,6cs2,DB06178,-9.2,Talotrexin,NYQPLPNEESYGNO-IBGZPJMESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
137678,6w9c,DB08588,-9.2,2-({2-[(3R)-3-AMINOPIPERIDIN-1-YL]-4-OXOQUINAZOLIN-3(4H)-YL}METHYL)BENZONITRILE,OYNURZXTLNNKAP-QGZVFWFLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
101827,6vxs,DB06605,-9.2,Apixaban,QNZCBYKSOIHPEH-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101855,6vxs,DB06666,-9.2,Lixivaptan,PPHTXRNHTVLQED-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
88417,6m3m,DB13772,-9.2,Rufloxacin,NJCJBUHJQLFDSW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
128357,6w4h,DB07514,-9.2,"3-(2-aminoquinazolin-6-yl)-1-(3,3-dimethylindolin-6-yl)-4-methylpyridin-2(1H)-one",LHLGUOHREUTYTO-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
100667,6vxs,DB03893,-9.2,Thionicotinamide-Adenine-Dinucleotide,UQYPZLRUJKCREN-NNYOXOHSSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
131917,6w4h,DB15023,-9.2,BMS-791826,DZBKAUMYTFPJIS-QHCPKHFHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
77668,6m2n,DB08656,-9.2,5-amino-2-methyl-N-[(1R)-1-naphthalen-1-ylethyl]benzamide,UVERBUNNCOKGNZ-CQSZACIVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
88194,6m3m,DB13470,-9.2,Cefodizime,XDZKBRJLTGRPSS-BGZQYGJUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136303,6w9c,DB06963,-9.2,"3-[3-(3-methyl-6-{[(1S)-1-phenylethyl]amino}-1H-pyrazolo[4,3-c]pyridin-1-yl)phenyl]propanamide",ZFGCLYUGFRNYFE-INIZCTEOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
27433,6cs2,DB06977,-9.2,(2S)-1-{[5-(1H-Indazol-5-yl)-3-pyridinyl]oxy}-3-(7aH-indol-3-yl)-2-propanamine,CAASENZOSQYNPX-HSTJUUNISA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
77861,6m2n,DB08907,-9.2,Canagliflozin,XTNGUQKDFGDXSJ-ZXGKGEBGSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
56580,6crv,DB02507,-9.2,4-Hydroxy-3-[(1s)-3-Oxo-1-Phenylbutyl]-2h-Chromen-2-One,PJVWKTKQMONHTI-HNNXBMFYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72365,6m2n,DB00663,-9.1,Flumethasone,WXURHACBFYSXBI-GQKYHHCASA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
84338,6m3m,DB05590,-9.1,Bedoradrine,OANCEOSLKSTLTA-REWPJTCUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84285,6m3m,DB05316,-9.1,Pimavanserin,RKEWSXXUOLRFBX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
31829,6cs2,DB14844,-9.1,ONC-201,VLULRUCCHYVXOH-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
72344,6m2n,DB00635,-9.1,Prednisone,XOFYZVNMUHMLCC-ZPOLXVRWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
111339,6vxx,DB03523,-9.1,Brequinar,PHEZJEYUWHETKO-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
71095,6lxt,DB13640,-9.1,Acetoxolone,FTQDJVZNPJRVPG-XWEVEMRCSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
62883,6crv,DB14654,-9.1,Bisoxatin acetate,ZCBJDQBSLZREAA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79211,6m2n,DB12910,-9.1,Emicerfont,JFHJGXQFESYQGY-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
81013,6m3m,DB00705,-9.1,Delavirdine,WHBIGIKBNXZKFE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
71075,6lxt,DB13610,-9.1,Flumedroxone,CDZJOBWKHSYNMO-SCUQKFFVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
55758,6crv,DB01450,-9.1,Dihydroetorphine,BRTSNYPDACNMIP-FAWZKKEFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78960,6m2n,DB12512,-9.1,Verucerfont,VKHVAUKFLBBZFJ-SFHVURJKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
87350,6m3m,DB12203,-9.1,Tozadenant,XNBRWUQWSKXMPW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
71327,6lxt,DB13997,-9.1,Baloxavir marboxil,RZVPBGBYGMDSBG-GGAORHGYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
78966,6m2n,DB12522,-9.1,Toreforant,FCRFVPZAXGJLPW-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
60033,6crv,DB08152,-9.1,{(2S)-1-[N-(tert-butoxycarbonyl)glycyl]pyrrolidin-2-yl}methyl (3-chlorophenyl)acetate,ONXGIEJBNQLITK-INIZCTEOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
89054,6m3m,DB15362,-9.1,LSZ-102,SJXNPGGVGZXKKI-NYYWCZLTSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
112509,6vxx,DB07333,-9.1,"N-(CYCLOPROPYLMETHYL)-4-(METHYLOXY)-3-({5-[3-(3-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-YL}AMINO)BENZENESULFONAMIDE",KRGKAARWVPUWSY-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58681,6crv,DB06367,-9.1,Relacatib,BWYBBMQLUKXECQ-GIVPXCGWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112044,6vxx,DB06160,-9.1,Garenoxacin,NJDRXTDGYFKORP-LLVKDONJSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112474,6vxx,DB07296,-9.1,(5Z)-3-(4-CHLOROPHENYL)-4-HYDROXY-5-(1-NAPHTHYLMETHYLENE)FURAN-2(5H)-ONE,PLGHLEBIWUQEPR-PDGQHHTCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84286,6m3m,DB05327,-9.1,Ranirestat,QCVNMNYRNIMDKV-QGZVFWFLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
55743,6crv,DB01431,-9.1,Allylestrenol,ATXHVCQZZJYMCF-XUDSTZEESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111239,6vxx,DB03383,-9.1,5-Chloro-1h-Indole-2-Carboxylic Acid [1-(4-Fluorobenzyl)-2-(4-Hydroxypiperidin-1yl)-2-Oxoethyl]Amide,YDCGVASFVACWKF-NRFANRHFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55972,6crv,DB01705,-9.1,Bis(5-Amidino-Benzimidazolyl)Methane,QZKOOEFIMWKZPK-UHFFFAOYSA-Q,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57399,6crv,DB03619,-9.1,Deoxycholic Acid,KXGVEGMKQFWNSR-LLQZFEROSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59200,6crv,DB07187,-9.1,6-[(5-CHLORO-3-METHYL-1-BENZOFURAN-2-YL)SULFONYL]PYRIDAZIN-3(2H)-ONE,FXFPQPNUMWQRAO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84301,6m3m,DB05422,-9.1,OPC-14523,TZZGTNZBLPCBIS-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
112043,6vxx,DB06159,-9.1,Rubitecan,VHXNKPBCCMUMSW-FQEVSTJZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112560,6vxx,DB07395,-9.1,"4-[3-(2-Chloro-4,5-difluoro-benzoyl)ureido]-3-trifluoromethoxybenzoic acid",NWQGDIBCFLDHDO-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79110,6m2n,DB12744,-9.1,CGI-1842,ZXBFYBLSJMEBEP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
60758,6crv,DB09078,-9.1,Lenvatinib,WOSKHXYHFSIKNG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112488,6vxx,DB07311,-9.1,"18-CHLORO-11,12,13,14-TETRAHYDRO-1H,10H-8,4-(AZENO)-9,15,1,3,6-BENZODIOXATRIAZACYCLOHEPTADECIN-2-ONE",JRSWWYITYIOHOP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
25265,6cs2,DB03159,-9.1,CRA_8696,GAVRMVQHHVMXFD-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
85241,6m3m,DB07426,-9.1,"[1-HYDROXY-2-(1,1':3',1''-TERPHENYL-3-YLOXY)ETHANE-1,1-DIYL]BIS(PHOSPHONIC ACID)",NWIARQRYIRVYCM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
60800,6crv,DB09171,-9.1,??-Methylfentanyl,UXIGUKSHASXDNI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111720,6vxx,DB04432,-9.1,ZK-805623,ZXIHYCYAQUQHSG-UHFFFAOYSA-O,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60846,6crv,DB09219,-9.1,Bisoxatin,BPKUDUSVDVLOPY-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111832,6vxx,DB04759,-9.1,"PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-(3-METHYL-BENZYLAMIDE)",GTBUZLPQANSGGE-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87465,6m3m,DB12361,-9.1,Piclozotan,URMTUEWUIGOJBW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58714,6crv,DB06460,-9.1,Enrasentan,GLCKXJLCYIJMRB-UPRLRBBYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27899,6cs2,DB07458,-9.1,"3-(1H-indol-3-yl)-4-{1-[2-(1-methylpyrrolidin-2-yl)ethyl]-1H-indol-3-yl}-1H-pyrrole-2,5-dione",LBFDERUQORUFIN-KRWDZBQOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
72198,6m2n,DB00455,-9.1,Loratadine,JCCNYMKQOSZNPW-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
112230,6vxx,DB06629,-9.1,Zibotentan,FJHHZXWJVIEFGJ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31395,6cs2,DB13766,-9.1,Lidoflazine,ZBIAKUMOEKILTF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
112233,6vxx,DB06634,-9.1,Casopitant,XGGTZCKQRWXCHW-WMTVXVAQSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88983,6m3m,DB15227,-9.1,Tirabrutinib,SEJLPXCPMNSRAM-GOSISDBHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
111862,6vxx,DB04797,-9.1,Triazolopyridine,OVCXRBARSPBVMC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112241,6vxx,DB06875,-9.1,3-(3-FLUORO-4-HYDROXYPHENYL)-7-HYDROXY-1-NAPHTHONITRILE,NSSOSHDCWCMNDM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55881,6crv,DB01589,-9.1,Quazepam,IKMPWMZBZSAONZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
71654,6lxt,DB15023,-9.1,BMS-791826,DZBKAUMYTFPJIS-QHCPKHFHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
85152,6m3m,DB07321,-9.1,"2,5-DICHLORO-N-[5-METHOXY-7-(6-METHOXYPYRIDIN-3-YL)-1,3-BENZOXAZOL-2-YL]BENZENESULFONAMIDE",KOKQLKWXOFRTHE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
31797,6cs2,DB14768,-9.1,PF-06459988,ODMXWZROLKITMS-RISCZKNCSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
59158,6crv,DB07140,-9.1,"5-[(3R)-3-(5-methoxybiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",JPENSYBRTSIYGO-AWEZNQCLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62922,6crv,DB14726,-9.1,Dabigatran,YBSJFWOBGCMAKL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29215,6cs2,DB08875,-9.1,Cabozantinib,ONIQOQHATWINJY-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
71765,6lxt,DB15233,-9.1,Avapritinib,DWYRIWUZIJHQKQ-SANMLTNESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
31756,6cs2,DB14675,-9.1,Temsavir,QRPZBKAMSFHVRW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
84303,6m3m,DB05424,-9.1,Canertinib,OMZCMEYTWSXEPZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
71771,6lxt,DB15245,-9.1,Olorofim,SUFPWYYDCOKDLL-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
31695,6cs2,DB14581,-9.1,CPI-1205,HPODOLXTMDHLLC-QGZVFWFLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
57410,6crv,DB03638,-9.1,Cytidyl-2'-5'-Phospho-Guanosine,QZDUXDLOEVJGDG-VMIOUTBZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55823,6crv,DB01526,-9.1,4-Androstenediol,BTTWKVFKBPAFDK-LOVVWNRFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79139,6m2n,DB12796,-9.1,MRX-I,SULYVXZZUMRQAX-NSHDSACASA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
111809,6vxx,DB04724,-9.1,"(S)-2-((S)-3-ISOBUTYL-2,5-DIOXO-4-QUINOLIN-3-YLMETHYL-[1,4]DIAZEPAN-1YL)-N-METHYL-3-NAPHTALEN-2-YL-PROPIONAMIDE",COVPLULNDBDXTN-KYJUHHDHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85239,6m3m,DB07423,-9.1,(2S)-3-[4-(acetylamino)phenoxy]-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide,YVXVTLGIDOACBJ-SFHVURJKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
79131,6m2n,DB12781,-9.1,Balaglitazone,IETKPTYAGKZLKY-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
62916,6crv,DB14716,-9.1,Clonazolam,XJRGLCAWBRZUFC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
71738,6lxt,DB15189,-9.1,Birabresib,GNMUEVRJHCWKTO-FQEVSTJZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
55889,6crv,DB01602,-9.1,Bacampicillin,PFOLLRNADZZWEX-FFGRCDKISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60031,6crv,DB08150,-9.1,"4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-aminium",RZIDZIGAXXNODG-UHFFFAOYSA-O,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31893,6cs2,DB14982,-9.1,Miransertib,HNFMVVHMKGFCMB-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
29311,6cs2,DB08995,-9.1,Diosmin,GZSOSUNBTXMUFQ-YFAPSIMESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
78986,6m2n,DB12553,-9.1,Fluocinolone,UUOUOERPONYGOS-CLCRDYEYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
26588,6cs2,DB04759,-9.1,"PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-(3-METHYL-BENZYLAMIDE)",GTBUZLPQANSGGE-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
62901,6crv,DB14673,-9.1,Flurandrenolide acetate,AUDPKCCPWYXNEV-XTLNBZDDSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112359,6vxx,DB07014,-9.1,"2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4-methoxybenzyl)sulfanyl]-1,3,4-oxadiazole",TUTZKAQTSPMEBI-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55776,6crv,DB01469,-9.1,Acetorphine,LFYBMMHFJIAKFE-PMEKXCSPSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
71533,6lxt,DB14723,-9.1,Larotrectinib,NYNZQNWKBKUAII-KBXCAEBGSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
79051,6m2n,DB12658,-9.1,AFN-1252,QXTWSUQCXCWEHF-JXMROGBWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80928,6m3m,DB00603,-9.1,Medroxyprogesterone acetate,PSGAAPLEWMOORI-PEINSRQWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
60706,6crv,DB08997,-9.1,Dexetimide,LQQIVYSCPWCSSD-HSZRJFAPSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112108,6vxx,DB06302,-9.1,Glesatinib,YRCHYHRCBXNYNU-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85232,6m3m,DB07415,-9.1,4-[(1S)-1-(3-fluoro-4-methoxyphenyl)-2-(2-methoxy-5-nitrophenyl)ethyl]-1H-imidazol-2-amine,RFLOFHKRBGKCOB-AWEZNQCLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
79186,6m2n,DB12877,-9.1,Oxatomide,BAINIUMDFURPJM-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
85093,6m3m,DB07257,-9.1,"4-(2-chlorophenyl)-8-(2-hydroxyethyl)-6-methylpyrrolo[3,4-e]indole-1,3(2H,6H)-dione",WHMQZCPGFZBLBG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84335,6m3m,DB05575,-9.1,Motesanib,RAHBGWKEPAQNFF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
60848,6crv,DB09223,-9.1,Blonanserin,XVGOZDAJGBALKS-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87473,6m3m,DB12375,-9.1,Oglemilast,OKFDRAHPFKMAJH-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
72270,6m2n,DB00547,-9.1,Desoximetasone,VWVSBHGCDBMOOT-IIEHVVJPSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
62970,6crv,DB14846,-9.1,Bimiralisib,ADGGYDAFIHSYFI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111906,6vxx,DB04850,-9.1,Posizolid,HBUJYEUPIIJJOS-PBHICJAKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31265,6cs2,DB13610,-9.1,Flumedroxone,CDZJOBWKHSYNMO-SCUQKFFVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
79012,6m2n,DB12591,-9.1,BMS-911543,JCINBYQJBYJGDM-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
112278,6vxx,DB06916,-9.1,"N-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-1-[2-(1H-IMIDAZOL-1-YL)-6-METHYLPYRIMIDIN-4-YL]-D-PROLINAMIDE",LBCGUKCXRVUULK-QGZVFWFLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
25748,6cs2,DB00444,-9.1,Teniposide,NRUKOCRGYNPUPR-QBPJDGROSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
62906,6crv,DB14678,-9.1,Norethindrone enanthate,APTGJECXMIKIET-WOSSHHRXSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88976,6m3m,DB15212,-9.1,Pemafibrate,ZHKNLJLMDFQVHJ-RUZDIDTESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
31902,6cs2,DB15006,-9.1,Flufenoxuron,RYLHNOVXKPXDIP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
78992,6m2n,DB12562,-9.1,Setipiprant,IHAXLPDVOWLUOS-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
88879,6m3m,DB15028,-9.1,MK-1064,CKTWQGHVNRYNCM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
62999,6crv,DB14899,-9.1,Tavapadon,AKQXQLUNFKDZBN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58763,6crv,DB06590,-9.1,Ceftaroline fosamil,ZCCUWMICIWSJIX-NQJJCJBVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55943,6crv,DB01668,-9.1,Nanaomycin D,XUWPJKDMEZSVTP-UOSCCXBLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
71591,6lxt,DB14860,-9.1,Ensartinib,GLYMPHUVMRFTFV-QLFBSQMISA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
26590,6cs2,DB04761,-9.1,"PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-[(PYRIDIN-3-YLMETHYL)-AMIDE]",NHPBWKYFMTXWAA-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
79017,6m2n,DB12598,-9.1,Nafamostat,MQQNFDZXWVTQEH-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
28273,6cs2,DB07856,-9.1,6-{4-[4-(4-CHLOROPHENYL)PIPERIDIN-4-YL]PHENYL}-9H-PURINE,HPWBHQIUIBFTQC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
69918,6lxt,DB11891,-9.1,CUDC-907,JOWXJLIFIIOYMS-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
85090,6m3m,DB07254,-9.1,"N-[3-[[4-[(5-CHLORO-1,3-BENZODIOXOL-4-YL)AMINO]PYRIMIDIN-2-YL]AMINO]PHENYL]METHANESULFONAMIDE",KQGTYXRWSIBDOZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
25510,6cs2,DB03453,-9.1,Methyl (2S)-2-[[2-[(3R)-1-carbamimidoylpiperidin-3-yl]acetyl]amino]-3-[4-(2-phenylethynyl)phenyl]propanoate,MRNGXYMKYHNMLV-PKTZIBPZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
88289,6m3m,DB13602,-9.1,Promegestone,QFFCYTLOTYIJMR-XMGTWHOFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
114083,6vxx,DB12705,-9.1,Cenerimod,KJKKMMMRWISKRF-FQEVSTJZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30275,6cs2,DB12280,-9.1,AZD-5423,FCNQMDSJHADDFT-WNSKOXEYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
88281,6m3m,DB13591,-9.1,Metopimazine,BQDBKDMTIJBJLA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
114095,6vxx,DB12719,-9.1,Turofexorate isopropyl,INASOKQDNHHMRE-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114098,6vxx,DB12724,-9.1,AZD-7295,MAQDQJWCSSCURR-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56566,6crv,DB02491,-9.1,4-[4-(1-Amino-1-Methylethyl)Phenyl]-5-Chloro-N-[4-(2-Morpholin-4-Ylethyl)Phenyl]Pyrimidin-2-Amine,CJSSYVIHFXDFFC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30269,6cs2,DB12272,-9.1,Vidupiprant,PFWVGKROPKKEDW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
67840,6lxt,DB07220,-9.1,"N-[5-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-1H-INDAZOL-3-YL]-2-(4-PIPERIDIN-1-YLPHENYL)ACETAMIDE",ZXYIRNXOAJYLCU-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
87732,6m3m,DB12764,-9.1,ABC-294640,CAOTVXGYTWCKQE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
67775,6lxt,DB07144,-9.1,"5-[(3R)-3-(5-methoxy-2',6'-dimethylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",XZXVRKHUCSXVBM-AWEZNQCLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
80223,6m2n,DB14899,-9.1,Tavapadon,AKQXQLUNFKDZBN-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
114147,6vxx,DB12805,-9.1,Ataciguat,PQHLRGARXNPFCF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27432,6cs2,DB06976,-9.1,"1-(5-OXO-2,3,5,9B-TETRAHYDRO-1H-PYRROLO[2,1-A]ISOINDOL-9-YL)-3-(5-PYRROLIDIN-2-YL-1H-PYRAZOL-3-YL)-UREA",IWOOJEZSDPRYAZ-WFASDCNBSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
114157,6vxx,DB12823,-9.1,Tecarfarin,QFLNTQDOVCLQKW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60226,6crv,DB08393,-9.1,"2-[(5,6-DIPHENYLFURO[2,3-D]PYRIMIDIN-4-YL)AMINO]ETHANOL",UQHINZSKNAAVOZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30196,6cs2,DB12180,-9.1,Apitolisib,YOVVNQKCSKSHKT-HNNXBMFYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
23177,6cs2,HMDB0059759,-9.1,1-Hydroxypyrene glucuronide,BUCREAQPYGLZLI-SXFAUFNYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
59011,6crv,DB06972,-9.1,"7A-[(4-cyanophenyl)methyl]-6-(3,5-dichlorophenyl)-5-oxo-2,3,5,7A-tetrahydro-1H-pyrrolo[1,2-A]pyrrole-7-carbonitrile",TZCXQSNBTXDAJG-QFIPXVFZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58876,6crv,DB06800,-9.1,Methylnaltrexone,JVLBPIPGETUEET-WIXLDOGYSA-O,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84817,6m3m,DB06932,-9.1,"10,11-dimethoxy-4-methyldibenzo[c,f]-2,7-naphthyridine-3,6-diamine",NVINUNQBDNEMSY-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
114188,6vxx,DB12877,-9.1,Oxatomide,BAINIUMDFURPJM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84815,6m3m,DB06930,-9.1,"N-[amino(imino)methyl]-2-(2,5-diphenyl-1H-pyrrol-1-yl)acetamide",WVLDNAVUCUAGDP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
67350,6lxt,DB06521,-9.1,Ertiprotafib,FONCZICQWCUXEB-RUZDIDTESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
114054,6vxx,DB12659,-9.1,SJ-733,VKCPFWKTFZAOTO-LEWJYISDSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
67341,6lxt,DB06494,-9.1,Sufugolix,UCQSBGOFELXYIN-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
88323,6m3m,DB13648,-9.1,Alcuronium,MUQUYTSLDVKIOF-CHJKCJHBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
56544,6crv,DB02463,-9.1,2-(2-Hydroxy-Phenyl)-1h-Indole-5-Carboxamidine,JPGNPKIYCTXJPG-UHFFFAOYSA-O,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56437,6crv,DB02331,-9.1,"(2s)-2-[(5-Benzofuran-2-Yl-Thiophen-2-Ylmethyl)-(2,4-Dichloro-Benzoyl)-Amino]-3-Phenyl-Propionic Acid",YBULOUKTPCHXAL-DEOSSOPVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60156,6crv,DB08307,-9.1,"2-{HYDROXY[2-NITRO-4-(TRIFLUOROMETHYL)PHENYL]METHYLENE}CYCLOHEXANE-1,3-DIONE",PMHVFNYNPNKNRO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
69246,6lxt,DB08901,-9.1,Ponatinib,PHXJVRSECIGDHY-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
113869,6vxx,DB12207,-9.1,Verdinexor,OPAKEJZFFCECPN-XQRVVYSFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30392,6cs2,DB12420,-9.1,Diazepinomicin,SALVHVNECODMJP-GNUCVDFRSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
30385,6cs2,DB12415,-9.1,Galeterone,PAFKTGFSEFKSQG-PAASFTFBSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
30384,6cs2,DB12414,-9.1,Usistapide,WSYALRNYQFNNGP-WJOKGBTCSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
88486,6m3m,DB13857,-9.1,Demegestone,JWAHBTQSSMYISL-MHTWAQMVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58850,6crv,DB06745,-9.1,ginkgolide-C,AMOGMTLMADGEOQ-DTDWCABLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58851,6crv,DB06746,-9.1,ginkgolide-J,LMEHVEUFNRJAAV-UKWFQYJJSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
63145,6crv,DB15221,-9.1,PF-06260414,ZKAVFOXYJCREBQ-SNVBAGLBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56447,6crv,DB02342,-9.1,2-Methox1tradiol,CQOQDQWUFQDJMK-SSTWWWIQSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
68999,6lxt,DB08584,-9.1,"6-{[6-(1-methyl-1H-pyrazol-4-yl)[1,2,4]triazolo[4,3-b]pyridazin-3-yl]sulfanyl}quinoline",BCZUAADEACICHN-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
88438,6m3m,DB13796,-9.1,Dibunate,WBEBQCINXJDZCX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84864,6m3m,DB06994,-9.1,"(2S,3S)-3-{3-[2-chloro-4-(methylsulfonyl)phenyl]-1,2,4-oxadiazol-5-yl}-1-cyclopentylidene-4-cyclopropyl-1-fluorobutan-2-amine",XCCSSVMRGIQMGF-LPHOPBHVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
30358,6cs2,DB12382,-9.1,R-306465,MUTBJZVSRNUIHA-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
80192,6m2n,DB14844,-9.1,ONC-201,VLULRUCCHYVXOH-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
113958,6vxx,DB12322,-9.1,GW-870086,WUBKGTSFJSEIEM-NSHBDUGJSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113968,6vxx,DB12339,-9.1,Radezolid,BTTNOGHPGJANSW-IBGZPJMESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113971,6vxx,DB12345,-9.1,MBX-2982,NFTMKHWBOINJGM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84509,6m3m,DB06346,-9.1,Fiboflapon,DFQGDHBGRSTTHX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
68886,6lxt,DB08450,-9.1,N-1H-indazol-5-yl-2-(6-methylpyridin-2-yl)quinazolin-4-amine,HNHRWNUXTCATSG-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
27628,6cs2,DB07179,-9.1,"3-((3-bromo-5-o-tolylpyrazolo[1,5-a]pyrimidin-7-ylamino)methyl)pyridine 1-oxide",DXUJQXZHHGJMFM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
88389,6m3m,DB13729,-9.1,Camostat,XASIMHXSUQUHLV-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59021,6crv,DB06985,-9.1,2-[({4-[2-(trifluoromethyl)phenyl]piperidin-1-yl}carbonyl)amino]benzoic acid,MEAQCLPMSVEOQF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30304,6cs2,DB12309,-9.1,GI-181771X,CABBMMXFOOZVMS-PMERELPUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
30077,6cs2,DB12020,-9.1,Tecovirimat,CSKDFZIMJXRJGH-VWLPUNTISA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
67280,6lxt,DB06314,-9.1,SGX-523,BCZUAADEACICHN-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
114231,6vxx,DB13126,-9.1,BMS-986115,SRJNRAQUSAVENA-GSHUGGBRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114775,6vxx,DB14840,-9.1,Ripretinib,CEFJVGZHQAGLHS-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80385,6m2n,DB15250,-9.1,Vercirnon,JRWROCIMSDXGOZ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
84731,6m3m,DB06833,-9.1,1-CYCLOHEXYL-N-{[1-(4-METHYLPHENYL)-1H-INDOL-3-YL]METHYL}METHANAMINE,MMIJMYOYKAKQPN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80326,6m2n,DB15137,-9.1,VK-2809,LGGPZDRLTDGYSQ-JADSYQMUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
58929,6crv,DB06875,-9.1,3-(3-FLUORO-4-HYDROXYPHENYL)-7-HYDROXY-1-NAPHTHONITRILE,NSSOSHDCWCMNDM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27522,6cs2,DB07066,-9.1,"2-CHLORO-N-[(3R)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL]-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE",LJAHIGGEXIWVJG-LLVKDONJSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
58935,6crv,DB06882,-9.1,1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-naphthalen-1-ylurea,HJWMLCDGRWWLAQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60272,6crv,DB08449,-9.1,"2-(3-((4,5,7-trifluorobenzo[d]thiazol-2-yl)methyl)-1H-pyrrolo[2,3-b]pyridin-1-yl)acetic acid",IEVFQDJUDLCOQY-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56790,6crv,DB02790,-9.1,Phenyl-Uridine-5'-Diphosphate,ZHUWBKDWWGKIEN-FMKGYKFTSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
63886,6lxt,DB00820,-9.1,Tadalafil,WOXKDUGGOYFFRN-IIBYNOLFSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
114807,6vxx,DB14898,-9.1,Retagliptin,WIIAMRXFUJLYEF-SNVBAGLBSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56807,6crv,DB02812,-9.1,"(2s,4r)-1-Acetyl-N-[(1s)-4-[(Aminoiminomethyl)Amino]-1-(2-Benzothiazolylcarbonyl)Butyl]-4-Hydroxy-2-Pyrrolidinecarboxamide",VXDAVYUFYPFGDX-SNPRPXQTSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84697,6m3m,DB06771,-9.1,Besifloxacin,QFFGVLORLPOAEC-SNVBAGLBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
29862,6cs2,DB11737,-9.1,Icotinib,QQLKULDARVNMAL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
80346,6m2n,DB15183,-9.1,Fosmanogepix,JQONJQKKVAHONF-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
84682,6m3m,DB06741,-9.1,Gavestinel,WZBNEZWCNKUOSM-VOTSOKGWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87859,6m3m,DB12966,-9.1,Falnidamol,FTFRZXFNZVCRSK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84622,6m3m,DB06635,-9.1,Otamixaban,PFGVNLZDWRZPJW-OPAMFIHVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84679,6m3m,DB06737,-9.1,Zaltoprofen,MUXFZBHBYYYLTH-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
63697,6lxt,DB00591,-9.1,Fluocinolone acetonide,FEBLZLNTKCEFIT-VSXGLTOVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
114826,6vxx,DB14935,-9.1,Serabelisib,BLGWHBSBBJNKJO-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
23742,6cs2,DB01349,-9.1,Tasosartan,ADXGNEYLLLSOAR-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
63287,6crv,DB09171,-9.1,β-Methylfentanyl,UXIGUKSHASXDNI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84673,6m3m,DB06730,-9.1,Gestodene,SIGSPDASOTUPFS-XUDSTZEESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
29886,6cs2,DB11769,-9.1,Funapide,NEBUOXBYNAHKFV-NRFANRHFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
84578,6m3m,DB06532,-9.1,Pafuramidine,UKOQVLAXCBRRGH-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80308,6m2n,DB15105,-9.1,PF-06751979,ZLZUHACSRMOLLV-RAALSFIWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
114768,6vxx,DB14810,-9.1,AZD-1656,FJEJHJINOKKDCW-INIZCTEOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
64995,6lxt,DB02258,-9.1,SR11254,RNZIUDLOJHVHLZ-VYIQYICTSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
88085,6m3m,DB13327,-9.1,Picotamide,KYWCWBXGRWWINE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
114244,6vxx,DB13164,-9.1,Olmutinib,FDMQDKQUTRLUBU-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114425,6vxx,DB13422,-9.1,Nicofuranose,FUWFSXZKBMCSKF-ZASNTINBSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114439,6vxx,DB13631,-9.1,Methoserpidine,ULBNWNUHGJLQHO-VKMIBBQISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56980,6crv,DB03044,-9.1,1-(5-Tert-Butyl-2-P-Tolyl-2h-Pyrazol-3-Yl)-3-[4-(2-Morpholin-4-Yl-Ethoxy)-Naphthalen-1-Yl]-Urea,MVCOAUNKQVWQHZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
67091,6lxt,DB05470,-9.1,VX-702,FYSRKRZDBHOFAY-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
84783,6m3m,DB06897,-9.1,"3-[3-chloro-5-(5-{[(1S)-1-phenylethyl]amino}isoxazolo[5,4-c]pyridin-3-yl)phenyl]propan-1-ol",MMGKIHLBFPJYJL-HNNXBMFYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
114616,6vxx,DB13865,-9.1,Dehydroemetine,XXLZPUYGHQWHRN-RPBOFIJWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27455,6cs2,DB06999,-9.1,"N-{3-[(5-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)carbonyl]-2,4-difluorophenyl}propane-1-sulfonamide",YZDJQTHVDDOVHR-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
66959,6lxt,DB04875,-9.1,Pralnacasan,CXAGHAZMQSCAKJ-WAHHBDPQSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
87938,6m3m,DB13088,-9.1,AZD-0424,MVWATCATLSSVBH-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
66847,6lxt,DB04727,-9.1,"N-(4-{4-AMINO-6-[4-(METHYLOXY)PHENYL]FURO[2,3-D]PYRIMIDIN-5-YL}PHENYL)-N'-[2-FLUORO-5-(TRIFLUOROMETHYL)PHENYL]UREA",FGZIONRFHVNRJB-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
69297,6lxt,DB08973,-9.1,Fluclorolone acetonide,NJNWEGFJCGYWQT-VSXGLTOVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
114706,6vxx,DB14669,-9.1,Betamethasone phosphate,VQODGRNSFPNSQE-DVTGEIKXSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87781,6m3m,DB12850,-9.1,Etalocib,YFIZRWPXUYFCSN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
114716,6vxx,DB14679,-9.1,Quingestanol acetate,FLGJKPPXEKYCBY-AKCFYGDASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
66401,6lxt,DB04131,-9.1,"10-(4-Dimethylamino-5-Hydroxy-6-Methyl-Tetrahydro-Pyran-2-Yloxy)-8-Ethyl-1,8,11-Trihydroxy-7,8,9,10-Tetrahydro-Naphthacene-5,12-Dione",BLGDWFJQIHBUJY-NWJGULHDSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
80390,6m2n,DB15265,-9.1,USL-311,XNUNVQKARNSSEO-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
66279,6lxt,DB03966,-9.1,Clorobiocin,FJAQNRBDVKIIKK-LFLQOBSNSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
59000,6crv,DB06955,-9.1,"3,4-bis(7-chloro-1H-indol-3-yl)-1H-pyrrole-2,5-dicarboxylic acid",OAMCCJASDLMTOO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84567,6m3m,DB06510,-9.1,Muraglitazar,IRLWJILLXJGJTD-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58995,6crv,DB06948,-9.1,2-ANILINO-6-CYCLOHEXYLMETHOXYPURINE,XWWRLKIBRPJQJX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
65666,6lxt,DB03141,-9.1,"3-{[(5R,6R)-5-Benzyl-6-hydroxy-2,4-bis(4-hydroxybenzyl)-3-oxo-1,2,4-triazepan-1-yl]sulfonyl}benzonitril",UYUWNNRWESUYOB-FIRIVFDPSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
65592,6lxt,DB03044,-9.1,1-(5-Tert-Butyl-2-P-Tolyl-2h-Pyrazol-3-Yl)-3-[4-(2-Morpholin-4-Yl-Ethoxy)-Naphthalen-1-Yl]-Urea,MVCOAUNKQVWQHZ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
27536,6cs2,DB07084,-9.1,"N-(6,7,9,10,17,18,20,21-octahydrodibenzo[b,k][1,4,7,10,13,16]hexaoxacyclooctadecin-2-yl)acetamide",YHKGWOJTUMJPNW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
84758,6m3m,DB06869,-9.1,1-[2-AMINO-2-CYCLOHEXYL-ACETYL]-PYRROLIDINE-3-CARBOXYLIC ACID 5-CHLORO-2-(2-ETHYLCARBAMOYL-ETHOXY)-BENZYLAMIDE,BMHVHOJXEQTIEA-SIKLNZKXSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80395,6m2n,DB15275,-9.1,GDC-0077,SGEUNORSOZVTOL-CABZTGNLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
84503,6m3m,DB06321,-9.1,R-348,IGLNXKVGKIFNBQ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
69352,6lxt,DB09048,-9.1,Netupitant,WAXQNWCZJDTGBU-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
60477,6crv,DB08699,-9.1,"1-tert-butyl-3-(3-methylbenzyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine",FYCOTGCSHZKHPR-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58792,6crv,DB06649,-9.1,Priralfinamide,BHJIBOFHEFDSAU-LBPRGKRZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56101,6crv,DB01876,-9.1,Bis(5-Amidino-2-Benzimidazolyl)Methanone,VVVXDHROXQUONB-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87564,6m3m,DB12504,-9.1,JNJ-40346527,BNVPFDRNGHMRJS-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
113083,6vxx,DB08354,-9.1,"2-(4-CHLOROBENZYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE",QCVULERVJOYHCP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79321,6m2n,DB13078,-9.1,KOSN-1724,JAYGOFBXDFAXBW-CYEKYUJNSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
56146,6crv,DB01946,-9.1,"3-[1-(3-Aminopropyl)-1h-Indol-3-Yl]-4-(1-Methyl-1h-Indol-3-Yl)-1h-Pyrrole-2,5-Dione",UQHKJRCFSLMWIA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113090,6vxx,DB08362,-9.1,"N-(3-(8-CYANO-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZIN-2-YLAMINO)PHENYL)ACETAMIDE",QVKXQLGRDOMAGC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80697,6m3m,DB00319,-9.1,Piperacillin,IVBHGBMCVLDMKU-GXNBUGAJSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
29413,6cs2,DB00845,-9.1,Clofazimine,WDQPAMHFFCXSNU-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
57217,6crv,DB03351,-9.1,Sri-9439,KMSATRJZEXNGDP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
70126,6lxt,DB12198,-9.1,Fosdagrocorat,BVXLAHSJXXSWFF-KEKPKEOLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
70081,6lxt,DB12128,-9.1,Ulimorelin,WGYPAJVJMXQXTR-ABNZCKJZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
58794,6crv,DB06654,-9.1,Safinamide,NEMGRZFTLSKBAP-LBPRGKRZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57205,6crv,DB03336,-9.1,BIA,KVIVJQWOYSWCCZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
25399,6cs2,DB03311,-9.1,"3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid [4-(Thiazol-2-Ylsulfamoyl)-Phenyl]-Amide",SXKBTDJJEQQEGE-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
70027,6lxt,DB12052,-9.1,Icariin,TZJALUIVHRYQQB-XLRXWWTNSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
84988,6m3m,DB07133,-9.1,D-phenylalanyl-N-(3-methylbenzyl)-L-prolinamide,CHKWABXWPATIIG-UXHICEINSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
113238,6vxx,DB08708,-9.1,"N-cyclohexyl-3-[3-(trifluoromethyl)phenyl][1,2,4]triazolo[4,3-b]pyridazin-6-amine",XYYDXQCAYXOGQT-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87591,6m3m,DB12543,-9.1,Samidorphan,RYIDHLJADOKWFM-MAODMQOUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59067,6crv,DB07036,-9.1,"(3aS,4R,9bR)-2,2-difluoro-4-(4-hydroxyphenyl)-6-(methoxymethyl)-1,2,3,3a,4,9b-hexahydrocyclopenta[c]chromen-8-ol",GPFRMIHXGMVMGF-BZSNNMDCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79366,6m2n,DB13158,-9.1,Clobetasone,XXIFVOHLGBURIG-OZCCCYNHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
87599,6m3m,DB12555,-9.1,Nelotanserin,COSPVUFTLGQDQL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
56239,6crv,DB02069,-9.1,N-(2-Flouro-Benzyl)-4-Sulfamoyl-Benzamide,ULYMHSXFSKOHGH-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56250,6crv,DB02081,-9.1,Bis-Benzamidine,BXYGSMRTHHSAHZ-PMACEKPBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56280,6crv,DB02118,-9.1,CP-271485,CIUMOGWIMXNXSQ-GOSISDBHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
63058,6crv,DB15052,-9.1,Ansofaxine,QKYBZJLEMOZFFU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
70299,6lxt,DB12434,-9.1,Steviolbioside,OMHUCGDTACNQEX-OSHKXICASA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
84418,6m3m,DB06137,-9.1,KX-01,HUNGUWOZPQBXGX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
112978,6vxx,DB08221,-9.1,N-{4-METHYL-3-[(3-PYRIMIDIN-4-YLPYRIDIN-2-YL)AMINO]PHENYL}-3-(TRIFLUOROMETHYL)BENZAMIDE,NESXBRNDMQUVNG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31010,6cs2,DB13307,-9.1,Proscillaridin,MYEJFUXQJGHEQK-ALRJYLEOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
57327,6crv,DB03507,-9.1,"6-[3-(4-Morpholinyl)Propyl]-2-(3-Nitrophenyl)-5-Thioxo-5,6,-Dihydro-7h-Thienol[2',3':4,5]Pyrrolo[1,2-C]Imidazol-7-One",UXGUZFZBZPPZGL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80865,6m3m,DB00528,-9.1,Lercanidipine,ZDXUKAKRHYTAKV-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
63007,6crv,DB14916,-9.1,Selonsertib,YIDDLAAKOYYGJG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60667,6crv,DB08954,-9.1,Ifenprodil,UYNVMODNBIQBMV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
63024,6crv,DB14944,-9.1,Tarloxotinib,MUJMYVFVAWFUJL-SNAWJCMRSA-O,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
70686,6lxt,DB13044,-9.1,Gossypol,QBKSWRVVCFFDOT-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
88823,6m3m,DB14879,-9.1,Cefiderocol,DBPPRLRVDVJOCL-FQRUVTKNSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
57303,6crv,DB03476,-9.1,Trans-6-(2-Phenylcyclopropyl)-Naphthalene-2-Carboxamidine,NQRIWXVAIWPBEM-OALUTQOASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56023,6crv,DB01774,-9.1,Adenosine-5'-Monophosphate Glucopyranosyl-Monophosphate Ester,WFPZSXYXPSUOPY-ROYWQJLOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112757,6vxx,DB07809,-9.1,4-({[4-(3-METHYLBENZOYL)PYRIDIN-2-YL]AMINO}METHYL)BENZENECARBOXIMIDAMIDE,MBJYEMUMDMGQQC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56028,6crv,DB01780,-9.1,Fusicoccin,KXTYBXCEQOANSX-WYKQKOHHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113361,6vxx,DB09053,-9.1,Ibrutinib,XYFPWWZEPKGCCK-GOSISDBHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80805,6m3m,DB00450,-9.1,Droperidol,RMEDXOLNCUSCGS-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
112787,6vxx,DB07843,-9.1,5-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1-BENZOTHIOPHENE-2-SULFONAMIDE,LTJNKFUIOOJXNJ-WFASDCNBSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112797,6vxx,DB07855,-9.1,(S)-1-PHENYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE,CWHMAWBXRCDOEB-HNNXBMFYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112798,6vxx,DB07856,-9.1,6-{4-[4-(4-CHLOROPHENYL)PIPERIDIN-4-YL]PHENYL}-9H-PURINE,HPWBHQIUIBFTQC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88808,6m3m,DB14854,-9.1,TC-6987,UAKZGMMGIMKFMV-RBUKOAKNSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85056,6m3m,DB07212,-9.1,N-(7-CARBAMIMIDOYL-NAPHTHALEN-1-YL)-3-HYDROXY-2-METHYL-BENZAMIDE,NNGZRCYXFBHMRM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87536,6m3m,DB12459,-9.1,Belotecan,LNHWXBUNXOXMRL-VWLOTQADSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80780,6m3m,DB00421,-9.1,Spironolactone,LXMSZDCAJNLERA-ZHYRCANASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
112893,6vxx,DB08121,-9.1,(2S)-2-(biphenyl-4-yloxy)-3-phenylpropanoic acid,TZTPJJNNACUQQR-FQEVSTJZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88790,6m3m,DB14799,-9.1,PF-06821497,RXCVUHMIWHRLDF-HXUWFJFHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
60096,6crv,DB08230,-9.1,"5,7-DIHYDROXY-2-(3,4,5-TRIHYDROXYPHENYL)-4H-CHROMEN-4-ONE",ARSRJFRKVXALTF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87558,6m3m,DB12491,-9.1,Fasiglifam,BZCALJIHZVNMGJ-HSZRJFAPSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80722,6m3m,DB00351,-9.1,Megestrol acetate,RQZAXGRLVPAYTJ-GQFGMJRRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
112777,6vxx,DB07831,-9.1,"2-{[(6-OXO-1,6-DIHYDROPYRIDIN-3-YL)METHYL]AMINO}-N-[4-PROPYL-3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE",SHSORWZDEKFFLP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79256,6m2n,DB12978,-9.1,Pexidartinib,JGWRKYUXBBNENE-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
27711,6cs2,DB07267,-9.1,2-(6-methylpyridin-2-yl)-N-pyridin-4-ylquinazolin-4-amine,JONFDFIXMPXTRH-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
84458,6m3m,DB06213,-9.1,Regadenoson,LZPZPHGJDAGEJZ-AKAIJSEGSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
56356,6crv,DB02224,-9.1,Taxifolin,CXQWRCVTCMQVQX-LSDHHAIUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84914,6m3m,DB07049,-9.1,(2R)-1-[(4-tert-butylphenyl)sulfonyl]-2-methyl-4-(4-nitrophenyl)piperazine,SOFGQQQVQZQJFS-MRXNPFEDSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
79974,6m2n,DB14069,-9.1,ONT-093,RSJCLODJSVZNQA-BQYQJAHWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80010,6m2n,DB14152,-9.1,Ginsenosides,NLHQJXWYMZLQJY-SWIZOJJJSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80057,6m2n,DB14541,-9.1,Hydrocortisone cypionate,DLVOSEUFIRPIRM-KAQKJVHQSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
84490,6m3m,DB06281,-9.1,Torcetrapib,CMSGWTNRGKRWGS-NQIIRXRSSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84900,6m3m,DB07034,-9.1,"2,2'-{[9-(HYDROXYIMINO)-9H-FLUORENE-2,7-DIYL]BIS(OXY)}DIACETIC ACID",VOKATEXROYSXDW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88556,6m3m,DB14017,-9.1,H3B-8800,YOIQWBAHJZGRFW-WVRLKXNASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
30516,6cs2,DB12590,-9.1,Indiplon,CBIAWPMZSFFRGN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
113732,6vxx,DB11824,-9.1,Tofogliflozin,VWVKUNOPTJGDOB-BDHVOXNPSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113736,6vxx,DB11829,-9.1,Ruboxistaurin,ZCBUQCWBWNUWSU-SFHVURJKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
69736,6lxt,DB11611,-9.1,Lifitegrast,JFOZKMSJYSPYLN-QHCPKHFHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
113742,6vxx,DB12015,-9.1,Alpelisib,STUWGJZDJHPWGZ-LBPRGKRZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27408,6cs2,DB06945,-9.1,N-hydroxy-4-({4-[4-(trifluoromethyl)phenoxy]phenyl}sulfonyl)tetrahydro-2H-pyran-4-carboxamide,FOSWRYKPHVPIDJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
84893,6m3m,DB07027,-9.1,D-phenylalanyl-N-(3-fluorobenzyl)-L-prolinamide,JGZSVYZIJHGHMA-MOPGFXCFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80088,6m2n,DB14634,-9.1,Fluprednidene acetate,DEFOZIFYUBUHHU-IYQKUMFPSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
63126,6crv,DB15190,-9.1,GLPG-0259,YBFGSJUVEOYPIS-OALUTQOASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
8448,6lzg,DB06134,-9.1,SNS-314,FAYAUAZLLLJJGH-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
84890,6m3m,DB07024,-9.1,"2-(3,4-DIHYDROXYPHENYL)-8-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-3-HYDROXY-6-METHYL-4H-CHROMEN-4-ONE",CEXBEGBNDJVZPK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
69436,6lxt,DB09195,-9.1,Lorpiprazole,BNRMWKUVWLKDQJ-YJBOKZPZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
80121,6m2n,DB14669,-9.1,Betamethasone phosphate,VQODGRNSFPNSQE-DVTGEIKXSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
30492,6cs2,DB12558,-9.1,AEE-788,OONFNUWBHFSNBT-HXUWFJFHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
84879,6m3m,DB07011,-9.1,"(3S)-1-(1,3-BENZODIOXOL-5-YLMETHYL)-3-[4-(1H-IMIDAZOL-1-YL)PHENOXY]PIPERIDINE",HHOPJGKEAIIIDF-FQEVSTJZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
30441,6cs2,DB12483,-9.1,Copanlisib,PZBCKZWLPGJMAO-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
113834,6vxx,DB12149,-9.1,S-3304,YWCLDDLVLSQGSZ-JOCHJYFZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80545,6m3m,DB00146,-9.1,Calcifediol,JWUBBDSIWDLEOM-DTOXIADCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
30587,6cs2,DB00966,-9.1,Telmisartan,RMMXLENWKUUMAY-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
30591,6cs2,DB12703,-9.1,Omipalisib,CGBJSGAELGCMKE-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
84919,6m3m,DB07054,-9.1,(2R)-1-(DIMETHYLAMINO)-3-{4-[(6-{[2-FLUORO-5-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-4-YL)AMINO]PHENOXY}PROPAN-2-OL,OSCWQKTUILTARV-MRXNPFEDSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
79419,6m2n,DB13252,-9.1,Tropatepine,JOQKFRLFXDPXHX-HDICACEKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
113443,6vxx,DB09195,-9.1,Lorpiprazole,BNRMWKUVWLKDQJ-YJBOKZPZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113472,6vxx,DB09227,-9.1,Barnidipine,VXMOONUMYLCFJD-DHLKQENFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111164,6vxx,DB03082,-9.1,6-[(Z)-Amino(Imino)Methyl]-N-[4-(Aminomethyl)Phenyl]-4-(Pyrimidin-2-Ylamino)-2-Naphthamide,CSWQJKHBMACTGB-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113479,6vxx,DB09235,-9.1,Efonidipine,NSVFSAJIGAJDMR-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
69899,6lxt,DB11863,-9.1,Alvelestat,QNQZWEGMKJBHEM-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
63087,6crv,DB15109,-9.1,Ingenol disoxate,GLIUZQUNUNICGS-XUBYYPQFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79423,6m2n,DB13256,-9.1,Clothiapine,KAAZGXDPUNNEFN-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
60562,6crv,DB08791,-9.1,"1-[(2-NITROPHENYL)SULFONYL]-1H-PYRROLO[3,2-B]PYRIDINE-6-CARBOXAMIDE",USLOIFPDNUDIEG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
8604,6lzg,DB06486,-9.1,Enzastaurin,AXRCEOKUDYDWLF-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
27386,6cs2,DB06922,-9.1,"2-[(1R)-1-carboxy-2-naphthalen-1-ylethyl]-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylic acid",CZNPWASYMRBJCX-GOSISDBHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
87612,6m3m,DB12574,-9.1,LY-295501,VAMFSFIPDOODFH-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
69921,6lxt,DB11894,-9.1,Efatutazone,JCYNMRJCUYVDBC-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
88672,6m3m,DB14545,-9.1,Hydrocortisone succinate,VWQWXZAWFPZJDA-CGVGKPPMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
30721,6cs2,DB12887,-9.1,Tazemetostat,NSQSAUGJQHDYNO-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
69850,6lxt,DB11791,-9.1,Capmatinib,LIOLIMKSCNQPLV-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
88646,6m3m,DB14209,-9.1,Trandolaprilat,AHYHTSYNOHNUSH-HXFGRODQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84928,6m3m,DB07064,-9.1,"(4R)-4-(3-HYDROXYPHENYL)-N,N,7,8-TETRAMETHYL-3,4-DIHYDROISOQUINOLINE-2(1H)-CARBOXAMIDE",HPVCRUIDFODATB-LJQANCHMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88645,6m3m,DB14208,-9.1,Ramiprilat,KEDYTOTWMPBSLG-HILJTLORSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
113656,6vxx,DB11712,-9.1,Tezacaftor,MJUVRTYWUMPBTR-MRXNPFEDSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80578,6m3m,DB00180,-9.1,Flunisolide,XSFJVAJPIHIPKU-XWCQMRHXSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
26541,6cs2,DB04698,-9.1,"N-(1,4-DIHYDRO-5H-TETRAZOL-5-YLIDENE)-9-OXO-9H-XANTHENE-2-SULFONAMIDE",HJWYZPGYPZNDTN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
26539,6cs2,DB04696,-9.1,"4-CHLORO-3',3''-DIBROMOPHENOL-1,8-NAPHTHALEIN",GFGZCXHXQCQRFP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
80567,6m3m,DB00169,-9.1,Cholecalciferol,QYSXJUFSXHHAJI-YRZJJWOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84926,6m3m,DB07061,-9.1,"1-(CYCLOHEXYLAMINO)-3-(6-METHYL-3,4-DIHYDRO-1H-CARBAZOL-9(2H)-YL)PROPAN-2-OL",AXYFCRIRLKSCRR-SFHVURJKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
69789,6lxt,DB11697,-9.1,Pacritinib,HWXVIOGONBBTBY-ONEGZZNKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
113594,6vxx,DB11614,-9.1,Rupatadine,WUZYKBABMWJHDL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72513,6m2n,DB00836,-9.1,Loperamide,RDOIQAHITMMDAJ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78776,6m2n,DB12252,-9.1,PG-701,OKRSVUYYCJPECG-LFGMFVMYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
62821,6crv,DB14471,-9.1,2-Ethylhexyl 4-phenylbenzophenone-2'-carboxylate,TWAOKHHZKFMFMD-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
100057,6vxs,DB03072,-9.1,"2-{3-[4-(4-Fluorophenyl)-3,6-Dihydro-1(2h)-Pyridinyl]Propyl}-8-Methyl-4(3h)-Quinazolinone",LOFDUAJQRUYHBR-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
77882,6m2n,DB08942,-9.1,Isoxicam,YYUAYBYLJSNDCX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76265,6m2n,DB07006,-9.1,"9-HYDROXY-6-(3-HYDROXYPROPYL)-4-(2-METHOXYPHENYL)PYRROLO[3,4-C]CARBAZOLE-1,3(2H,6H)-DIONE",AOGOZJCRIFBTTN-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
99615,6vxs,DB02483,-9.1,Etheno-Nad,JCDBQDNBEQHDHK-BSLNIGMPSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
11206,6lzg,DB11652,-9.1,Tucatinib,SDEAXTCZPQIFQM-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
76219,6m2n,DB06948,-9.1,2-ANILINO-6-CYCLOHEXYLMETHOXYPURINE,XWWRLKIBRPJQJX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
106933,6vxx,DB01764,-9.1,Dalfopristin,SUYRLXYYZQTJHF-VMBLUXKRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59751,6crv,DB07831,-9.1,"2-{[(6-OXO-1,6-DIHYDROPYRIDIN-3-YL)METHYL]AMINO}-N-[4-PROPYL-3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE",SHSORWZDEKFFLP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81872,6m3m,DB01793,-9.1,SB-409513,ONVZFCHLOZUXRP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
61690,6crv,DB12441,-9.1,Tavilermide,DVJXNXPFYJIACK-ULQDDVLXSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76190,6m2n,DB06916,-9.1,"N-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-1-[2-(1H-IMIDAZOL-1-YL)-6-METHYLPYRIMIDIN-4-YL]-D-PROLINAMIDE",LBCGUKCXRVUULK-QGZVFWFLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
28456,6cs2,DB08043,-9.1,1-[4-(PYRIDIN-4-YLOXY)PHENYL]-3-[3-(TRIFLUOROMETHYL)PHENYL]UREA,DDDLGNOZDKDSEG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
86165,6m3m,DB08519,-9.1,"N-4-(3-methyl-1H-indazol-6-yl)-N-2-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine",SQQAPOSROFWHIB-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59535,6crv,DB07578,-9.1,"3-[4-(2-METHYL-IMIDAZO[4,5-C]PYRIDIN-1-YL)BENZYL]-3H-BENZOTHIAZOL-2-ONE",WUOLYUKMMRCXGH-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77964,6m2n,DB09050,-9.1,Ceftolozane,JHFNIHVVXRKLEF-DCZLAGFPSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
54936,6crv,DB00408,-9.1,Loxapine,XJGVXQDUIWGIRW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59529,6crv,DB07571,-9.1,"N-2-[(BENZYLOXY)CARBONYL]-N-[(1S,2S)-2-HYDROXY-1-(4-HYDROXYBENZYL)PROPYL]-L-LEUCINAMIDE",ZUWYQZGBCBSHFK-HSQYWUDLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59526,6crv,DB07567,-9.1,"(2R,3R,4S)-3-(4-HYDROXYPHENYL)-4-METHYL-2-[4-(2-PYRROLIDIN-1-YLETHOXY)PHENYL]CHROMAN-6-OL",XPVKGTWRXBSJKO-LHXLBICKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
11156,6lzg,DB11526,-9.1,Masitinib,WJEOLQLKVOPQFV-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
20241,6cs2,HMDB0046329,-9.1,"TG(22:0/16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))",PSQNMLIGVNKGBS-QCRPGBDUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
81854,6m3m,DB01768,-9.1,Methylumbelliferyl Sialic Acid,KKDWIUJBUSOPGC-GKHMPSLRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81851,6m3m,DB01765,-9.1,"(5-Oxo-5,6-Dihydro-Indolo[1,2-a]Quinazolin-7-Yl)-Acetic Acid",INSBKYCYLCEBOD-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
99175,6vxs,DB01908,-9.1,RU85493,MWEWSHNGVWABKG-SVBPBHIXSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
107195,6vxx,DB02691,-9.1,Glycocholic acid,RFDAIACWWDREDC-FRVQLJSFSA-M,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
99170,6vxs,DB01897,-9.1,2-(2f-Benzothiazolyl)-5-Styryl-3-(4f-Phthalhydrazidyl)Tetrazolium Chloride,BEIGFKLRGRRJJA-JLHYYAGUSA-O,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
76073,6m2n,DB06744,-9.1,ginkgolide-B,SQOJOAFXDQDRGF-MMQTXUMRSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
55406,6crv,DB00967,-9.1,Desloratadine,JAUOIFJMECXRGI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76072,6m2n,DB06743,-9.1,Ginkgolide A,FPUXKXIZEIDQKW-VKMVSBOZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
81857,6m3m,DB01774,-9.1,Adenosine-5'-Monophosphate Glucopyranosyl-Monophosphate Ester,WFPZSXYXPSUOPY-ROYWQJLOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86202,6m3m,DB08560,-9.1,3-FLUORO-N-[1-(4-FLUOROPHENYL)-3-(2-THIENYL)-1H-PYRAZOL-5-YL]BENZENESULFONAMIDE,GULUFDCOGAXLEP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
55310,6crv,DB00858,-9.1,Drostanolone,IKXILDNPCZPPRV-RFMGOVQKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
100243,6vxs,DB03311,-9.1,"3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid [4-(Thiazol-2-Ylsulfamoyl)-Phenyl]-Amide",SXKBTDJJEQQEGE-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101408,6vxs,DB04881,-9.1,Elacridar,OSFCMRGOZNQUSW-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
82689,6m3m,DB02873,-9.1,"1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperazin-1-Yl-3,4-Dihydroquinazolin-2(1h)-One",YAWZIQKDHQIHOS-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86287,6m3m,DB08664,-9.1,({3-[1-(4-HYDROXY-2-OXO-2H-CHROMEN-3-YL)-PROPYL]-PHENYLCARBAMOYL}-METHYL)-CARBAMIC ACID TERT-BUTYL ESTER,QUQQVMVIWCUYFV-KRWDZBQOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
77746,6m2n,DB08746,-9.1,1-[[(1E)-2-(4-CHLOROPHENYL)ETHENYL]SULFONYL]-4-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]PIPERAZINE,ZOSSOFIFNGGDKG-GIJQJNRQSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77755,6m2n,DB08755,-9.1,N-[(1S)-2-{[(1R)-2-(benzyloxy)-1-cyano-1-methylethyl]amino}-1-(cyclohexylmethyl)-2-oxoethyl]morpholine-4-carboxamide,MQWUTQCRGGBPBT-WIOPSUGQSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
81982,6m3m,DB01948,-9.1,"1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperidin-4-Yl-3,4-Dihydroquinolin-2(1h)-One",VXIYTVJEIXMAQF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81978,6m3m,DB01944,-9.1,(S)-blebbistatin,LZAXPYOBKSJSEX-GOSISDBHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
101288,6vxs,DB04724,-9.1,"(S)-2-((S)-3-ISOBUTYL-2,5-DIOXO-4-QUINOLIN-3-YLMETHYL-[1,4]DIAZEPAN-1YL)-N-METHYL-3-NAPHTALEN-2-YL-PROPIONAMIDE",COVPLULNDBDXTN-KYJUHHDHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
76472,6m2n,DB07247,-9.1,"[2'-HYDROXY-3'-(1H-PYRROLO[3,2-C]PYRIDIN-2-YL)-BIPHENYL-3-YLMETHYL]-UREA",SRPOHNDQBDHONJ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76458,6m2n,DB07229,-9.1,"3-{5-[AMINO(IMINIO)METHYL]-1H-INDOL-2-YL}-5-METHOXY-1,1'-BIPHENYL-2-OLATE",MINVOLKUPZPDNX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
86240,6m3m,DB08608,-9.1,"4-({(2R,5S)-2,5-DIMETHYL-4-[(2R)-3,3,3-TRIFLUORO-2-HYDROXY-2-METHYLPROPANOYL]PIPERAZIN-1-YL}CARBONYL)BENZONITRILE",IWFSHKKFDSWNLZ-BWACUDIHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
76455,6m2n,DB07226,-9.1,"N-[4-(2-CHLOROPHENYL)-1,3-DIOXO-1,2,3,6-TETRAHYDROPYRROLO[3,4-C]CARBAZOL-9-YL]FORMAMIDE",JWZVNUNTFNELHL-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61447,6crv,DB12100,-9.1,Abediterol,SFYAXIFVXBKRPK-QFIPXVFZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76438,6m2n,DB07204,-9.1,"(1S)-1-(1H-INDOL-3-YLMETHYL)-2-(2-PYRIDIN-4-YL-[1,7]NAPHTYRIDIN-5-YLOXY)-EHYLAMINE",DQIXTEDFNFZMCM-SFHVURJKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
28387,6cs2,DB07975,-9.1,"2-({[3,5-DIFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)CYCLOPENT-1-ENE-1-CARBOXYLIC ACID",VTGXLCZUWFYELR-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
81975,6m3m,DB01940,-9.1,Balanol Analog 2,SQLYTJZXRRDERK-ISKFKSNPSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
101047,6vxs,DB04405,-9.1,"2-[2-(1,3-Dioxo-1,3-Dihydro-2h-Isoindol-2-Yl)Ethyl]-4-(4'-Ethoxy-1,1'-Biphenyl-4-Yl)-4-Oxobutanoic Acid",AQYSXARQCHHHLK-NRFANRHFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
76423,6m2n,DB07186,-9.1,"4-(4-METHYLPIPERAZIN-1-YL)-N-[5-(2-THIENYLACETYL)-1,5-DIHYDROPYRROLO[3,4-C]PYRAZOL-3-YL]BENZAMIDE",TYYNSDQVFIOSFH-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
106556,6vxx,DB00486,-9.1,Nabilone,GECBBEABIDMGGL-RTBURBONSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27480,6cs2,DB07026,-9.1,"(1S,5S,7R)-N-7-(BIPHENYL-4-YLMETHYL)-N-3-HYDROXY-6,8-DIOXA-3-AZABICYCLO[3.2.1]OCTANE-3,7-DICARBOXAMIDE",PPLDARNGJSQINK-OKZBNKHCSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
100865,6vxs,DB04158,-9.1,"6-(Adenosine Tetraphosphate-Methyl)-7,8-Dihydropterin",ZKRKFZJAQKKHKL-SUGPNEFASA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
61440,6crv,DB12092,-9.1,Naftopidil,HRRBJVNMSRJFHQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28390,6cs2,DB07978,-9.1,"2-({[2,3,5,6-TETRAFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)CYCLOPENTA-1,3-DIENE-1-CARBOXYLIC ACID",ULMUPVXFUDHRGH-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
106710,6vxx,DB00921,-9.1,Buprenorphine,RMRJXGBAOAMLHD-IHFGGWKQSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
82721,6m3m,DB02915,-9.1,"4-(2,4-Dimethyl-1,3-thiazol-5-yl)-N-[4-(trifluoromethyl)phenyl]-2-pyrimidinamine",MEZFDQUDLQCVNX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
76330,6m2n,DB07081,-9.1,"(2R)-4-[(8R)-8-METHYL-2-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[1,5-A]PYRAZIN-7(8H)-YL]-4-OXO-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE",FDEXEPZGMKFCTG-PSASIEDQSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76323,6m2n,DB07072,-9.1,"(1S,2R,5S)-5-[3-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7(8H)-YL]-2-(2,4,5-TRIFLUOROPHENYL)CYCLOHEXANAMINE",CNKRZILQBKJWDS-WMFXKJRFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61431,6crv,DB12078,-9.1,Enobosarm,JNGVJMBLXIUVRD-SFHVURJKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
100257,6vxs,DB03331,-9.1,"N-Naphthalen-1-Ylmethyl-2'-[3,5-Dimethoxybenzamido]-2'-Deoxy-Adenosine",OARVXDFNTLYMCJ-JVUUKAHWSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
81777,6m3m,DB01668,-9.1,Nanaomycin D,XUWPJKDMEZSVTP-UOSCCXBLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86962,6m3m,DB11619,-9.1,Gestrinone,BJJXHLWLUDYTGC-ANULTFPQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
13238,6lzg,DB14982,-9.1,Miransertib,HNFMVVHMKGFCMB-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
13253,6lzg,DB15023,-9.1,BMS-791826,DZBKAUMYTFPJIS-QHCPKHFHSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
107953,6vxx,DB05812,-9.1,Abiraterone,GZOSMCIZMLWJML-VJLLXTKPSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75850,6m2n,DB06228,-9.1,Rivaroxaban,KGFYHTZWPPHNLQ-AWEZNQCLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
55478,6crv,DB01051,-9.1,Novobiocin,YJQPYGGHQPGBLI-KGSXXDOSSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86063,6m3m,DB08395,-9.1,2-(ETHOXYMETHYL)-4-(4-FLUOROPHENYL)-3-[2-(2-HYDROXYPHENOXY)PYRIMIDIN-4-YL]ISOXAZOL-5(2H)-ONE,ZSOXFJURLPCSOO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
97655,6m71,DB15345,-9.1,GSK-945237,SRICOHRDRMZREQ-MRXNPFEDSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
75793,6m2n,DB06011,-9.1,AMG-222,NVSWJKWHLUTHLP-CPJSRVTESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61784,6crv,DB12585,-9.1,Ondelopran,QWNDOCKIKKQJNN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55487,6crv,DB01061,-9.1,Azlocillin,JTWOMNBEOCYFNV-NFFDBFGFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
82949,6m3m,DB03221,-9.1,AL7099A,RMOXCYSVWCHXII-GFCCVEGCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
97646,6m71,DB15327,-9.1,Abivertinib,UOFYSRZSLXWIQB-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
81646,6m3m,DB01513,-9.1,"17Alpha-methyl-3beta,17beta-dihydroxy-5alpha-androstane",QGKQXZFZOIQFBI-UYEYMFBJSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
28577,6cs2,DB08164,-9.1,"(3R,4R)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN-3-AMINE",GOBIXGZJSMAOFV-QRWLVFNGSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
108090,6vxx,DB06833,-9.1,1-CYCLOHEXYL-N-{[1-(4-METHYLPHENYL)-1H-INDOL-3-YL]METHYL}METHANAMINE,MMIJMYOYKAKQPN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61362,6crv,DB11969,-9.1,Uprosertib,AXTAPYRUEKNRBA-JTQLQIEISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
97628,6m71,DB15294,-9.1,SB-1578,NNXDIGHYPZHXTR-ONEGZZNKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
108146,6vxx,DB07156,-9.1,"(4Z)-6-bromo-4-({[4-(pyrrolidin-1-ylmethyl)phenyl]amino}methylidene)isoquinoline-1,3(2H,4H)-dione",JFEKAVPMVOLVTH-UNOMPAQXSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
10829,6lzg,DB09143,-9.1,Sonidegib,VZZJRYRQSPEMTK-CALCHBBNSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
40353,6lu7,DB12411,-9.1,R-428,KXMZDGSRSGHMMK-VWLOTQADSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
75720,6m2n,DB05552,-9.1,TG100-115,UJIAQDJKSXQLIT-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
108195,6vxx,DB07212,-9.1,N-(7-CARBAMIMIDOYL-NAPHTHALEN-1-YL)-3-HYDROXY-2-METHYL-BENZAMIDE,NNGZRCYXFBHMRM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58506,6crv,DB05608,-9.1,MKC-1,OVSKGTONMLKNPZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
26779,6cs2,DB05171,-9.1,E-2012,PUOAETJYKQITMO-LANLRWRYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
108205,6vxx,DB07226,-9.1,"N-[4-(2-CHLOROPHENYL)-1,3-DIOXO-1,2,3,6-TETRAHYDROPYRROLO[3,4-C]CARBAZOL-9-YL]FORMAMIDE",JWZVNUNTFNELHL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75701,6m2n,DB05465,-9.1,Tandutinib,UXXQOJXBIDBUAC-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
97534,6m71,DB15110,-9.1,Onvansertib,QHLVBNKYJGBCQJ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
82988,6m3m,DB03267,-9.1,1-Allyl-3-Butyl-8-(N-Acetyl-4-Aminobenzyl)-Xanthine,XFOWZKUTPKXWIE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
108230,6vxx,DB07255,-9.1,"N'-(5-CHLORO-1,3-BENZODIOXOL-4-YL)-N-(3-MORPHOLIN-4-YLPHENYL)PYRIMIDINE-2,4-DIAMINE",PNEWIQAEGKQNCE-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87097,6m3m,DB11824,-9.1,Tofogliflozin,VWVKUNOPTJGDOB-BDHVOXNPSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
27093,6cs2,DB06448,-9.1,Lonafarnib,DHMTURDWPRKSOA-RUZDIDTESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
61774,6crv,DB12571,-9.1,Rimacalib,MYTIJGWONQOOLC-HNNXBMFYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81655,6m3m,DB01524,-9.1,Androstenediol,QADHLRWLCPCEKT-LOVVWNRFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86069,6m3m,DB08402,-9.1,"2-[(2,4-DICHLOROBENZOYL)AMINO]-5-(PYRIMIDIN-2-YLOXY)BENZOIC ACID",VNDRRWBKNSHALL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
28489,6cs2,DB08079,-9.1,AMG-208,HEAIZQNMNCHNFD-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
107368,6vxx,DB03220,-9.1,FR233623,OODDZQQDDOVCFD-SCLBCKFNSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
13260,6lzg,DB15034,-9.1,PRI-724,VHOZWHQPEJGPCC-AZXNYEMZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
61394,6crv,DB12021,-9.1,Dinaciclib,PIMQWRZWLQKKBJ-SFHVURJKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
13280,6lzg,DB15068,-9.1,Agerafenib,DKNUPRMJNUQNHR-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
107465,6vxx,DB03638,-9.1,Cytidyl-2'-5'-Phospho-Guanosine,QZDUXDLOEVJGDG-VMIOUTBZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81712,6m3m,DB01586,-9.1,Ursodeoxycholic acid,RUDATBOHQWOJDD-UZVSRGJWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86104,6m3m,DB08446,-9.1,"3-[6-bromo-2-fluoro-3-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)phenoxy]-5-chlorobenzonitrile",OHQMEDBYNUAVNE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
107497,6vxx,DB03678,-9.1,"(6,7-Difluoro-Quinazolin-4-Yl)-(1-Methyl-2,2-Diphenyl-Ethyl)-Amine",WVGZKPGUHOZIJQ-HNNXBMFYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75952,6m2n,DB06494,-9.1,Sufugolix,UCQSBGOFELXYIN-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
11037,6lzg,DB11262,-9.1,Bisoctrizole,FQUNFJULCYSSOP-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
61744,6crv,DB12524,-9.1,BI-671800,XEOSTBFUCNZKGS-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107646,6vxx,DB04131,-9.1,"10-(4-Dimethylamino-5-Hydroxy-6-Methyl-Tetrahydro-Pyran-2-Yloxy)-8-Ethyl-1,8,11-Trihydroxy-7,8,9,10-Tetrahydro-Naphthacene-5,12-Dione",BLGDWFJQIHBUJY-NWJGULHDSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
13340,6lzg,DB15183,-9.1,Fosmanogepix,JQONJQKKVAHONF-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
61374,6crv,DB11992,-9.1,Omarigliptin,MKMPWKUAHLTIBJ-ISTRZQFTSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78216,6m2n,DB11275,-9.1,Epicriptine,SBFXHXZNBNFPHV-PXXBSISHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
26087,6cs2,DB00481,-9.1,Raloxifene,GZUITABIAKMVPG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
81667,6m3m,DB01536,-9.1,Androstenedione,AEMFNILZOJDQLW-QAGGRKNESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
75916,6m2n,DB06409,-9.1,Morphine glucuronide,GNJCUHZOSOYIEC-GAROZEBRSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
13371,6lzg,DB15232,-9.1,Telaglenastat,PRAAPINBUWJLGA-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
86085,6m3m,DB08424,-9.1,"[5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL](3-{[(2R)-2,3-DIHYDROXYPROPYL]OXY}PHENYL)METHANONE",IJDQETGUEUJVTB-HNNXBMFYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
82902,6m3m,DB03161,-9.1,Thymidine-5'-Diphospho-Beta-D-Xylose,AJUADKZRQSBUAK-KDGZBOQCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
97936,6vxs,DB00342,-9.1,Terfenadine,GUGOEEXESWIERI-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
61766,6crv,DB12558,-9.1,AEE-788,OONFNUWBHFSNBT-HXUWFJFHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
24671,6cs2,DB02449,-9.1,3-(1h-Indol-3-Yl)-2-[4-(4-Phenyl-Piperidin-1-Yl)-Benzenesulfonylamino]-Propionic Acid,ULOTXPTWJAUGGE-MHZLTWQESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
78272,6m2n,DB11426,-9.1,Marbofloxacin,BPFYOAJNDMUVBL-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
107896,6vxx,DB05482,-9.1,7-ethyl-10-hydroxycamptothecin,FJHBVJOVLFPMQE-QFIPXVFZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107901,6vxx,DB05511,-9.1,Piclidenoson,HUJXGQILHAUCCV-MOROJQBDSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78306,6m2n,DB11485,-9.1,Ceftiofur,ZBHXIWJRIFEVQY-IHMPYVIRSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
13247,6lzg,DB15006,-9.1,Flufenoxuron,RYLHNOVXKPXDIP-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
81632,6m3m,DB01493,-9.1,Ethylestrenol,AOXRBFRFYPMWLR-XGXHKTLJSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
101531,6vxs,DB05454,-9.1,Paliroden,CNEWKIDCGDXBDE-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
55066,6crv,DB00568,-9.1,Cinnarizine,DERZBLKQOCDDDZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104677,6vxs,DB12345,-9.1,MBX-2982,NFTMKHWBOINJGM-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
76963,6m2n,DB07817,-9.1,"1-{3-[(4-pyridin-2-ylpiperazin-1-yl)sulfonyl]phenyl}-3-(1,3-thiazol-2-yl)urea",NJPVZSIGDRLLTD-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
82347,6m3m,DB02421,-9.1,Uridine-5'-Diphosphate-Mannose,HSCJRCZFDFQWRP-NYYOCOOHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
76957,6m2n,DB07811,-9.1,"N-cyclopropyl-2',6-dimethyl-4'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-3-carboxamide",UBVTVSINEVHYSY-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
104711,6vxs,DB12394,-9.1,Eleclazine,YNUAEEJQYHYLMS-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
55180,6crv,DB00705,-9.1,Delavirdine,WHBIGIKBNXZKFE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
26902,6cs2,DB05812,-9.1,Abiraterone,GZOSMCIZMLWJML-VJLLXTKPSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
11937,6lzg,DB12644,-9.1,AZD-2066,SXWHYTICXCLKDG-GFCCVEGCSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
104732,6vxs,DB12420,-9.1,Diazepinomicin,SALVHVNECODMJP-GNUCVDFRSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
12416,6lzg,DB13345,-9.1,Dihydroergocristine,DEQITUUQPICUMR-HJPBWRTMSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
59683,6crv,DB07756,-9.1,"1-[3-({[(4-AMINO-5-FLUORO-2-METHYLQUINOLIN-3-YL)METHYL]THIO}METHYL)PHENYL]-2,2,2-TRIFLUOROETHANE-1,1-DIOL",GPBGHVRNVGXPNM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
103102,6vxs,DB08164,-9.1,"(3R,4R)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN-3-AMINE",GOBIXGZJSMAOFV-QRWLVFNGSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
61511,6crv,DB12194,-9.1,Atamestane,PEPMWUSGRKINHX-TXTPUJOMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77414,6m2n,DB08350,-9.1,"5-[3-(2-METHOXYPHENYL)-1H-PYRROLO[2,3-B]PYRIDIN-5-YL]-N,N-DIMETHYLPYRIDINE-3-CARBOXAMIDE",GYQRHHQPEMOLKH-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
104817,6vxs,DB12550,-9.1,Taladegib,SZBGQDXLNMELTB-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
11874,6lzg,DB12550,-9.1,Taladegib,SZBGQDXLNMELTB-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
102987,6vxs,DB08036,-9.1,"6,7,12,13-tetrahydro-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazol-5-one",MEXUTNIFSHFQRG-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102957,6vxs,DB08005,-9.1,4-{[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino}-N-ethylpiperidine-1-carboxamide,ARMFMDYRYOKSOW-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104885,6vxs,DB12659,-9.1,SJ-733,VKCPFWKTFZAOTO-LEWJYISDSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104897,6vxs,DB12673,-9.1,ATX-914,ALANRBCCCQEPFZ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
77446,6m2n,DB08389,-9.1,"6,7-DIMETHOXY-4-[(3R)-3-(2-NAPHTHYLOXY)PYRROLIDIN-1-YL]QUINAZOLINE",UPTQSRGSSJRBKJ-LJQANCHMSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
102931,6vxs,DB07975,-9.1,"2-({[3,5-DIFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)CYCLOPENT-1-ENE-1-CARBOXYLIC ACID",VTGXLCZUWFYELR-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104941,6vxs,DB12742,-9.1,Amuvatinib,FOFDIMHVKGYHRU-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
58363,6crv,DB04898,-9.1,Ximelagatran,ZXIBCJHYVWYIKI-PZJWPPBQSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76916,6m2n,DB07765,-9.1,"METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL](METHYL)AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE",UKCFUFHREWUXJJ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
55159,6crv,DB00682,-9.1,Warfarin,PJVWKTKQMONHTI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77477,6m2n,DB08429,-9.1,N-({(2S)-1-[(3R)-3-amino-4-(3-chlorophenyl)butanoyl]pyrrolidin-2-yl}methyl)-3-(methylsulfonyl)benzamide,QRGBOABBMKYMLG-UXHICEINSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76874,6m2n,DB07717,-9.1,"(5S,8R,9S,10S,13R,14S,17S)-13-{2-[(3,5-DIFLUOROBENZYL)OXY]ETHYL}-17-HYDROXY-10-METHYLHEXADECAHYDRO-3H-CYCLOPENTA[A]PHENANTHREN-3-ONE",AJODXHGZHBERGJ-JLYQOUBASA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61502,6crv,DB12183,-9.1,Sapitinib,DFJSJLGUIXFDJP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
103254,6vxs,DB08358,-9.1,"2-(2-QUINOLIN-3-YLPYRIDIN-4-YL)-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE",OWFLADWRSCINST-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
76979,6m2n,DB07835,-9.1,"N-3-cyclopropyl-N-4-'-(cyclopropylmethyl)-6-methylbiphenyl-3,4'-dicarboxamide",BOPSUAHGQHFKGG-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
86617,6m3m,DB09123,-9.1,Dienogest,AZFLJNIPTRTECV-FUMNGEBKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
77244,6m2n,DB08138,-9.1,"{[(2,6-difluorophenyl)carbonyl]amino}-N-(4-fluorophenyl)-1H-pyrazole-3-carboxamide",BDRDBXXWQDFXEC-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61568,6crv,DB12275,-9.1,Seviteronel,ZBRAJOQFSNYJMF-SFHVURJKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104313,6vxs,DB11818,-9.1,Retosiban,PLVGDGRBPMVYPB-FDUHJNRSSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104314,6vxs,DB11819,-9.1,ASP-4058,NJNXCJPSMWKXHO-VIFPVBQESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
77291,6m2n,DB08191,-9.1,"4-(5-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl)benzoic acid",KSFDVNIKNYXUIP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77124,6m2n,DB08005,-9.1,4-{[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino}-N-ethylpiperidine-1-carboxamide,ARMFMDYRYOKSOW-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
104349,6vxs,DB11871,-9.1,PF-00610355,YPHDIMUXXABSSO-YTTGMZPUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104363,6vxs,DB11892,-9.1,Prulifloxacin,PWNMXPDKBYZCOO-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
59670,6crv,DB07741,-9.1,"4-(1R,3AS,4R,8AS,8BR)-[1-DIFLUOROMETHYL-2-(4-FLUOROBENZYL)-3-OXODECAHYDROPYRROLO[3,4-A]PYRROLIZIN-4-YL]BENZAMIDINE",VPNYXOTTXAXSIH-SXYSDOLCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61553,6crv,DB12253,-9.1,GDC-0810,BURHGPHDEVGCEZ-KJGLQBJMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61542,6crv,DB12238,-9.1,MK-0777,QKIWQBLNTSQOLY-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77096,6m2n,DB07973,-9.1,N-(1-ISOPROPYLPIPERIDIN-4-YL)-1-(3-METHOXYBENZYL)-1H-INDOLE-2-CARBOXAMIDE,GIPCBGDQVGKMPO-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
104375,6vxs,DB11907,-9.1,Rociletinib,HUFOZJXAKZVRNJ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104378,6vxs,DB11911,-9.1,Galunisertib,IVRXNBXKWIJUQB-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104380,6vxs,DB11913,-9.1,LY-2090314,HRJWTAWVFDCTGO-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
86663,6m3m,DB09200,-9.1,Rivoglitazone,XMSXOLDPMGMWTH-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
104418,6vxs,DB11968,-9.1,MK-7145,OCKGFTQIICXDQW-ZEQRLZLVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
82280,6m3m,DB02341,-9.1,"Mdl 101,146",XQAMVCHQGHAELT-YPAWHYETSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
61540,6crv,DB12236,-9.1,Bexagliflozin,BTCRKOKVYTVOLU-SJSRKZJXSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77331,6m2n,DB08242,-9.1,"N,4-dimethyl-3-[(1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl)amino]benzamide",OYTBZXSFNNAVKU-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
104465,6vxs,DB12044,-9.1,MK-0893,DNTVJEMGHBIUMW-IBGZPJMESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
77092,6m2n,DB07969,-9.1,3-[3-(4-methylpiperazin-1-yl)-7-(trifluoromethyl)quinoxalin-5-yl]phenol,QNCYYRHIUFGGJX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
86641,6m3m,DB09178,-9.1,Phenaridine,ODPKHHGQKIYCTJ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58329,6crv,DB04852,-9.1,Implitapide,AMNXBQPRODZJQR-DITALETJSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
26925,6cs2,DB05944,-9.1,Varlitinib,UWXSAYUXVSFDBQ-CYBMUJFWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
104648,6vxs,DB12303,-9.1,Motolimod,QSPOQCXMGPDIHI-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104651,6vxs,DB12307,-9.1,Foretinib,CXQHYVUVSFXTMY-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
61584,6crv,DB12295,-9.1,Evodenoson,SQJXTUJMBYVDBB-RQXXJAGISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58304,6crv,DB04823,-9.1,Oxyphenisatin,SJDACOMXKWHBOW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
105009,6vxs,DB12858,-9.1,LY-377604,RBSGUQYXRDKPAE-QFIPXVFZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
106271,6vxs,DB15356,-9.1,SLV-334,LOFDNSDPZTVIIO-VPUSJEBWSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
82412,6m3m,DB02505,-9.1,N-(R-Carboxy-Ethyl)-Alpha-(S)-(2-Phenylethyl),JJVQUUYZGJWBPW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
102779,6vxs,DB07800,-9.1,N-(2-(((5-CHLORO-2-PYRIDINYL)AMINO)SULFONYL)PHENYL)-4-(2-OXO-1(2H)-PYRIDINYL)BENZAMIDE,MIJGLXFQYBTIFY-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
76630,6m2n,DB07426,-9.1,"[1-HYDROXY-2-(1,1':3',1''-TERPHENYL-3-YLOXY)ETHANE-1,1-DIYL]BIS(PHOSPHONIC ACID)",NWIARQRYIRVYCM-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
102032,6vxs,DB06925,-9.1,3-(2-AMINOQUINAZOLIN-6-YL)-4-METHYL-N-[3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE,YEIASMOUYNOXGA-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
82141,6m3m,DB02155,-9.1,Balanol Analog 8,XVLMXAUKCDSMMW-YXLARRHKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
106075,6vxs,DB14937,-9.1,MK-8666,CODQKEMYZZKQAE-QPVYNBJUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
77579,6m2n,DB08546,-9.1,"4-[(3AS,4R,7R,8AS,8BR)-2-(1,3-BENZODIOXOL-5-YLMETHYL)-7-HYDROXY-1,3-DIOXODECAHYDROPYRROLO[3,4-A]PYRROLIZIN-4-YL]BENZENECARBOXIMIDAMIDE",CETLUACQMGBMFH-ZALSBGIRSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76614,6m2n,DB07406,-9.1,"(4R)-N-[4-({[2-(DIMETHYLAMINO)ETHYL]AMINO}CARBONYL)-1,3-THIAZOL-2-YL]-4-METHYL-1-OXO-2,3,4,9-TETRAHYDRO-1H-BETA-CARBOLINE-6-CARBOXAMIDE",QWFFPYQWUWLDBV-NSHDSACASA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
82573,6m3m,DB02716,-9.1,7-Methyl-Guanosine-5'-Triphosphate,DKVRNHPCAOHRSI-KQYNXXCUSA-O,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86902,6m3m,DB11457,-9.1,Rotenone,JUVIOZPCNVVQFO-HBGVWJBISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58409,6crv,DB05075,-9.1,TG-100801,JMGXJHWTVBGOKG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76604,6m2n,DB07395,-9.1,"4-[3-(2-Chloro-4,5-difluoro-benzoyl)ureido]-3-trifluoromethoxybenzoic acid",NWQGDIBCFLDHDO-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
86399,6m3m,DB08794,-9.1,Ethyl biscoumacetate,JCLHQFUTFHUXNN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
82138,6m3m,DB02152,-9.1,K-252a,KOZFSFOOLUUIGY-SOLYNIJKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86926,6m3m,DB11512,-9.1,Dihydrostreptomycin,ASXBYYWOLISCLQ-HZYVHMACSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
28350,6cs2,DB07937,-9.1,"2-butoxy-9-(2,6-difluorobenzyl)-N-(2-morpholin-4-ylethyl)-9H-purin-6-amine",UGZWPZWADDDTRN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
106177,6vxs,DB15173,-9.1,JNJ-42165279,YWGYNGCRVZLMCS-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101819,6vxs,DB06589,-9.1,Pazopanib,CUIHSIWYWATEQL-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101785,6vxs,DB06494,-9.1,Sufugolix,UCQSBGOFELXYIN-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
58226,6crv,DB04716,-9.1,"2-(1,1-DIMETHYLETHYL)9-FLUORO-3,6-DIHYDRO-7H-BENZ[H]-IMIDAZ[4,5-F]ISOQUINOLIN-7-ONE",VNDWQCSOSCCWIP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
11490,6lzg,DB12042,-9.1,Ibodutant,YQYSVMKCMIUCHY-WJOKGBTCSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
58413,6crv,DB05100,-9.1,Prinomastat,YKPYIPVDTNNYCN-INIZCTEOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106209,6vxs,DB15233,-9.1,Avapritinib,DWYRIWUZIJHQKQ-SANMLTNESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101695,6vxs,DB06248,-9.1,Amelubant,SBVYURPQULDJTI-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
76576,6m2n,DB07359,-9.1,"3-[(4-fluorophenyl)sulfanyl]-N-(4-methyl-1,3-thiazol-2-yl)-6-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]pyridine-2-carboxamide",SJTQKYKXCYVFHX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
106224,6vxs,DB15266,-9.1,TAK-580,VWMJHAFYPMOMGF-ZCFIWIBFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
106225,6vxs,DB15268,-9.1,Afabicin,HFYMDQMXVPJNTH-VQHVLOKHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
58199,6crv,DB04679,-9.1,H TYPE I TRISACCHARIDE,MGSDFCKWGHNUSM-QVPNGJTFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106239,6vxs,DB15294,-9.1,SB-1578,NNXDIGHYPZHXTR-ONEGZZNKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
55085,6crv,DB00590,-9.1,Doxazosin,RUZYUOTYCVRMRZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
101822,6vxs,DB06595,-9.1,Midostaurin,BMGQWWVMWDBQGC-IIFHNQTCSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
55099,6crv,DB00607,-9.1,Nafcillin,GPXLMGHLHQJAGZ-JTDSTZFVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
102071,6vxs,DB06977,-9.1,(2S)-1-{[5-(1H-Indazol-5-yl)-3-pyridinyl]oxy}-3-(7aH-indol-3-yl)-2-propanamine,CAASENZOSQYNPX-HSTJUUNISA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102109,6vxs,DB07020,-9.1,"N-{3-[5-(1H-1,2,4-triazol-3-yl)-1H-indazol-3-yl]phenyl}furan-2-carboxamide",LMDMJDCLPIVGQD-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
55124,6crv,DB00637,-9.1,Astemizole,GXDALQBWZGODGZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
82444,6m3m,DB02545,-9.1,Fexaramine,VLQTUNDJHLEFEQ-KGENOOAVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86481,6m3m,DB08922,-9.1,Perospirone,FBVFZWUMDDXLLG-HDICACEKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
26887,6cs2,DB05713,-9.1,LY-517717,VYNKVNDKAOGAAQ-RUZDIDTESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
105123,6vxs,DB13029,-9.1,MK-0873,JJWKQXNHYDJXKF-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
77493,6m2n,DB08446,-9.1,"3-[6-bromo-2-fluoro-3-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)phenoxy]-5-chlorobenzonitrile",OHQMEDBYNUAVNE-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
102664,6vxs,DB07666,-9.1,"(3R,4S)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE",OAWGQHXWGXOUKV-BEFAXECRSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
61487,6crv,DB12155,-9.1,Napabucasin,DPHUWDIXHNQOSY-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77503,6m2n,DB08459,-9.1,"3-chloro-5-[2-chloro-5-(1H-pyrazolo[3,4-b]pyridin-3-ylmethoxy)phenoxy]benzonitrile",SVMHTBVIPYVDIL-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
105154,6vxs,DB13078,-9.1,KOSN-1724,JAYGOFBXDFAXBW-CYEKYUJNSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
105163,6vxs,DB13093,-9.1,TAK-593,DZFZXPPHBWCXPQ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
58284,6crv,DB04797,-9.1,Triazolopyridine,OVCXRBARSPBVMC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
102439,6vxs,DB07397,-9.1,"(5S)-5-(2-amino-2-oxoethyl)-4-oxo-N-[(3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl)methyl]-3,4,5,6,7,8-hexahydro[1]benzothieno[2,3-d]pyrimidine-2-carboxamide",ITADELAVAWJACR-NSHDSACASA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
105172,6vxs,DB13104,-9.1,X-396,ONPGOSVDVDPBCY-CQSZACIVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
76759,6m2n,DB07578,-9.1,"3-[4-(2-METHYL-IMIDAZO[4,5-C]PYRIDIN-1-YL)BENZYL]-3H-BENZOTHIAZOL-2-ONE",WUOLYUKMMRCXGH-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
105322,6vxs,DB13345,-9.1,Dihydroergocristine,DEQITUUQPICUMR-HJPBWRTMSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
59691,6crv,DB07764,-9.1,FLUORESCIN,MURGITYSBWUQTI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
105453,6vxs,DB13520,-9.1,Metergoline,WZHJKEUHNJHDLS-QTGUNEKASA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102387,6vxs,DB07334,-9.1,"N-[5-(ETHYLSULFONYL)-2-METHOXYPHENYL]-5-[3-(2-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-AMINE",HTIZPBXCJPQDEM-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102351,6vxs,DB07296,-9.1,(5Z)-3-(4-CHLOROPHENYL)-4-HYDROXY-5-(1-NAPHTHYLMETHYLENE)FURAN-2(5H)-ONE,PLGHLEBIWUQEPR-PDGQHHTCSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
58279,6crv,DB04792,-9.1,"2,5-O,O-BIS-{4',4''-AMIDINOPHENYL}-1,4:3,6-DIANHYDRO-D-SORBITOL",CDEVHSIVANGYRI-XMTFNYHQSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
105743,6vxs,DB13947,-9.1,Testosterone enantate benzilic acid hydrazone,PTVXYACXDYZNID-JKXGKYMWSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
82167,6m3m,DB02194,-9.1,"8-Benzyl-2-Hydroxy-2-(4-Hydroxy-Benzyl)-6-(4-Hydroxy-Phenyl)-2h-Imidazo[1,2-a]Pyrazin-3-One",ULLMMKZQNNBLRN-SANMLTNESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58398,6crv,DB05016,-9.1,Ataluren,OOUGLTULBSNHNF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59618,6crv,DB07679,-9.1,"(9S,12S)-9-(1-methylethyl)-7,10-dioxo-2-oxa-8,11-diazabicyclo[12.2.2]octadeca-1(16),14,17-triene-12-carboxylic acid",RRAAROKJUVKWAF-RDJZCZTQSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
102129,6vxs,DB07041,-9.1,"N-[2-(2,4-diaminopyrido[2,3-d]pyrimidin-7-yl)-2-methylpropyl]-4-phenoxybenzamide",FDJWFDQRPKKBFA-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
105960,6vxs,DB14675,-9.1,Temsavir,QRPZBKAMSFHVRW-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102114,6vxs,DB07026,-9.1,"(1S,5S,7R)-N-7-(BIPHENYL-4-YLMETHYL)-N-3-HYDROXY-6,8-DIOXA-3-AZABICYCLO[3.2.1]OCTANE-3,7-DICARBOXAMIDE",PPLDARNGJSQINK-OKZBNKHCSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
82512,6m3m,DB02639,-9.1,4-methylumbelliferyl ??-D-glucoside,YUDPTGPSBJVHCN-JZYAIQKZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
76843,6m2n,DB07680,-9.1,[(1S)-1-(5-CHLORO-1-BENZOTHIEN-3-YL)-2-(2-NAPHTHYLAMINO)-2-OXOETHYL]PHOSPHONIC ACID,HUJXISJLAPAFBO-IBGZPJMESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
108238,6vxx,DB07263,-9.1,"[{2-bromo-4-[(2R)-3-oxo-2,3-diphenylpropyl]phenyl}(difluoro)methyl]phosphonic acid",WDTMVBQZDFMOIK-GOSISDBHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57919,6crv,DB04301,-9.1,Bis(5-Amidino-2-Benzimidazolyl)Methane Ketone Hydrate,ZLAHDRAQCSQPOC-UHFFFAOYSA-P,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
40352,6lu7,DB14773,-9.1,Lifirafenib,NGFFVZQXSRKHBM-FKBYEOEOSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
109603,6vxx,DB14218,-9.1,Telotristat,NCLGDOBQAWBXRA-PGRDOPGGSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109626,6vxx,DB14555,-9.1,Ursadiol,RTLXJEJRLWILSU-GWNGJUQLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
73246,6m2n,DB01774,-9.1,Adenosine-5'-Monophosphate Glucopyranosyl-Monophosphate Ester,WFPZSXYXPSUOPY-ROYWQJLOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61085,6crv,DB11491,-9.1,Sarafloxacin,XBHBWNFJWIASRO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
32277,6cs2,DB01259,-9.1,Lapatinib,BCFGMOOMADDAQU-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
92866,6m71,DB05129,-9.1,Elsamitrucin,MGQRRMONVLMKJL-KWJIQSIXSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
62482,6crv,DB13640,-9.1,Acetoxolone,FTQDJVZNPJRVPG-XWEVEMRCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78739,6m2n,DB12203,-9.1,Tozadenant,XNBRWUQWSKXMPW-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
32211,6cs2,DB01184,-9.1,Domperidone,FGXWKSZFVQUSTL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
55680,6crv,DB01326,-9.1,Cefamandole,OLVCFLKTBJRLHI-AXAPSJFSSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85535,6m3m,DB07775,-9.1,"3',5'-DIBROMO-2',4,4',6'-TETRAHYDROXY AURONE",BRPKBUNFOZFULQ-SGAXSIHGSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
92649,6m71,DB04685,-9.1,"1-{(2S,5S)-4-FLUORO-5-[(TRITYLOXY)METHYL]TETRAHYDROFURAN-2-YL}PYRIMIDINE-2,4(1H,3H)-DIONE",GJNIPWYJQUGERM-BFLUCZKCSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
109669,6vxx,DB15105,-9.1,PF-06751979,ZLZUHACSRMOLLV-RAALSFIWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
32284,6cs2,DB01267,-9.1,Paliperidone,PMXMIIMHBWHSKN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
85529,6m3m,DB07768,-9.1,Epitestosterone,MUMGGOZAMZWBJJ-KZYORJDKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87283,6m3m,DB12101,-9.1,CC-220,IXZOHGPZAQLIBH-NRFANRHFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
109697,6vxx,DB15156,-9.1,ABT-072,XMZSTQYSBYEENY-RMKNXTFCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
73027,6m2n,DB01501,-9.1,Difenoxin,UFIVBRCCIRTJTN-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
62546,6crv,DB13721,-9.1,Cypermethrin,KAATUXNTWXVJKI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78796,6m2n,DB12280,-9.1,AZD-5423,FCNQMDSJHADDFT-WNSKOXEYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
58652,6crv,DB06274,-9.1,Alvimopan,UPNUIXSCZBYVBB-JVFUWBCBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
91819,6m71,DB03583,-9.1,"(2e,3s)-3-Hydroxy-5'-[(4-Hydroxypiperidin-1-Yl)Sulfonyl]-3-Methyl-1,3-Dihydro-2,3'-Biindol-2'(1'h)-One",AYOAIABDFUJDKQ-SQJPUDIVSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
83970,6m3m,DB04596,-9.1,"4-O-{4,6-O-[(1S)-1-Carboxyethylidene]-??-D-mannopyranosyl}-D-glucopyranuronic acid",GZJXZKGVHLWBOW-AISSFXTFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
78799,6m2n,DB12284,-9.1,LY-2608204,QIIVJLHCZUTGSD-CUBQBAPOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
91420,6m71,DB03038,-9.1,LY341770,MXAFDBCLWLMXSI-ZDUSSCGKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
84009,6m3m,DB04644,-9.1,"4-{4-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-2,3-DIMETHYL-PHENOXY}-BUTYRIC ACID",FCEMCUPAYRPTLS-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
109758,6vxx,DB00224,-9.1,Indinavir,CBVCZFGXHXORBI-PXQQMZJSSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109778,6vxx,DB00246,-9.1,Ziprasidone,MVWVFYHBGMAFLY-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
73131,6m2n,DB01623,-9.1,Thiothixene,GFBKORZTTCHDGY-UWVJOHFNSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
92919,6m71,DB05450,-9.1,Smilagenin,GMBQZIIUCVWOCD-UQHLGXRBSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
83807,6m3m,DB04378,-9.1,"3-Amino-N-{4-[2-(2,6-Dimethyl-Phenoxy)-Acetylamino]-3-Hydroxy-1-Isobutyl-5-Phenyl-Pentyl}-Benzamide",APJAEXGNDLFGPD-AWCRTANDSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
61113,6crv,DB11577,-9.1,Indigotindisulfonic Acid,CFZXDJWFRVEWSR-BUHFOSPRSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
73769,6m2n,DB02466,-9.1,"4-[3-Oxo-3-(5,5,8,8-Tetramethyl-5,6,7,8-Tetrahydro-Naphthalen-2-Yl)-Propenyl]-Benzoic Acid",ZXQHMEUGMCXKLO-KPKJPENVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
93700,6m71,DB07253,-9.1,"N'-(5-chloro-1,3-benzodioxol-4-yl)-N-(3-methylsulfonylphenyl)pyrimidine-2,4-diamine",QTFCKBFCXDAZIU-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
28912,6cs2,DB08536,-9.1,"3-bromo-5-phenyl-N-(pyrimidin-5-ylmethyl)pyrazolo[1,5-a]pyridin-7-amine",IBUPHWYGVDAASU-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
93673,6m71,DB07220,-9.1,"N-[5-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-1H-INDAZOL-3-YL]-2-(4-PIPERIDIN-1-YLPHENYL)ACETAMIDE",ZXYIRNXOAJYLCU-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
14371,6lzg,T3D4051,-9.1,Gymnodimine,DVXZVCNEGRKLMW-DCJZOFSYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
62195,6crv,DB13252,-9.1,Tropatepine,JOQKFRLFXDPXHX-HDICACEKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
73706,6m2n,DB02388,-9.1,"Cyclohexyl-{4-[5-(3,4-Dichlorophenyl)-2-Piperidin-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine",UQFRSHRWRKYNDE-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78698,6m2n,DB12135,-9.1,Elubrixin,YQYFEGTYCUQBEI-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
57679,6crv,DB03984,-9.1,Morpholine-4-Carboxylic Acid [1-(2-Benzylsulfanyl-1-Formyl-Ethylcarbamoyl)-2-Phenyl-Ethyl]-Amide,MWTQNXVXPLTHJB-YADHBBJMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109293,6vxx,DB13024,-9.1,MK-8245,UJEAABFSXKCSGI-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
73682,6m2n,DB02360,-9.1,Bis-Napthyl Beta-Ketophosphonic Acid,OFHMUASCSJJNNA-JOCHJYFZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
85675,6m3m,DB07936,-9.1,N-(4-{[(3S)-3-(dimethylamino)pyrrolidin-1-yl]carbonyl}phenyl)-5-fluoro-4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]pyrimidin-2-amine,BACSZMCLZIDTIO-IBGZPJMESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81338,6m3m,DB01082,-9.1,Streptomycin,UCSJYZPVAKXKNQ-HZYVHMACSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
62203,6crv,DB13266,-9.1,Cefatrizine,UOCJDOLVGGIYIQ-PBFPGSCMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59333,6crv,DB07338,-9.1,Acifluorfen,NUFNQYOELLVIPL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
10212,6lzg,DB08386,-9.1,2-{[4-(4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline,VRWJZGHUCOFGPZ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
83702,6m3m,DB04232,-9.1,N-Hydroxy-1-(4-Methoxyphenyl)Sulfonyl-4-Benzyloxycarbonyl-Piperazine-2-Carboxamide,DNGGPLKVDUPXFN-GOSISDBHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
62232,6crv,DB13307,-9.1,Proscillaridin,MYEJFUXQJGHEQK-ALRJYLEOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85626,6m3m,DB07875,-9.1,"5-Chloro-thiophene-2-carboxylic acid ((3S,4S)-1-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-methyl}-4-hydroxy-pyrrolidin-3-yl)-amide",ARAVOODWJJJNBY-IRXDYDNUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87246,6m3m,DB12048,-9.1,Savolitinib,XYDNMOZJKOGZLS-NSHDSACASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
73536,6m2n,DB02164,-9.1,N-Sulfo-Flavin Mononucleotide,ZLPUGFBBLGQWBS-SCRDCRAPSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
109326,6vxx,DB13072,-9.1,GDC-0349,RGJOJUGRHPQXGF-INIZCTEOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
32293,6cs2,DB01289,-9.1,Glisoxepide,ZKUDBRCEOBOWLF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
10181,6lzg,DB08351,-9.1,N-cyclopropyl-4-methyl-3-{2-[(2-morpholin-4-ylethyl)amino]quinazolin-6-yl}benzamide,MNEXDVSJIUQQRH-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
55659,6crv,DB01264,-9.1,Darunavir,CJBJHOAVZSMMDJ-HEXNFIEUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59330,6crv,DB07334,-9.1,"N-[5-(ETHYLSULFONYL)-2-METHOXYPHENYL]-5-[3-(2-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-AMINE",HTIZPBXCJPQDEM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109449,6vxx,DB13591,-9.1,Metopimazine,BQDBKDMTIJBJLA-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
93138,6m71,DB06409,-9.1,Morphine glucuronide,GNJCUHZOSOYIEC-GAROZEBRSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
62422,6crv,DB13554,-9.1,Moperone,AGAHNABIDCTLHW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109807,6vxx,DB00278,-9.1,Argatroban,KXNPVXPOPUZYGB-IOVMHBDKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62187,6crv,DB13242,-9.1,Bucladesine,CJGYSWNGNKCJSB-YVLZZHOMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
91061,6m71,DB02551,-9.1,"6-[N-(4-Ethyl-1,2,3,4-Tetrahydro-6-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine",LVNMYQLXKMSQTG-AWEZNQCLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
109831,6vxx,DB00307,-9.1,Bexarotene,NAVMQTYZDKMPEU-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85400,6m3m,DB07616,-9.1,"4-{[4-(4-fluoro-3-methylphenyl)-1,3-thiazol-2-yl]amino}-2-hydroxybenzoic acid",LKZZDHKJFDTYCH-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
78878,6m2n,DB12394,-9.1,Eleclazine,YNUAEEJQYHYLMS-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
110553,6vxx,DB01933,-9.1,7-Hydroxystaurosporine,PBCZSGKMGDDXIJ-HQCWYSJUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29036,6cs2,DB08674,-9.1,"(20S)-19,20,21,22-TETRAHYDRO-19-OXO-5H-18,20-ETHANO-12,14-ETHENO-6,10-METHENO-18H-BENZ[D]IMIDAZO[4,3-K][1,6,9,12]OXATRIAZA-CYCLOOCTADECOSINE-9-CARBONITRILE",USPFJPDEADLGIG-HSZRJFAPSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
32037,6cs2,DB15242,-9.1,MK-0533,STWITCBWQHTJFJ-XMMPIXPASA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
78889,6m2n,DB12408,-9.1,PF-03635659,WGOJWDWKHJHXSV-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
81202,6m3m,DB00923,-9.1,Ceforanide,SLAYUXIURFNXPG-CRAIPNDOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
110650,6vxx,DB02058,-9.1,SU4984,AZGZGRJOCKSSHA-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110669,6vxx,DB02082,-9.1,Phosphoaminophosphonic Acid Guanylate Ester,UQABYHGXWYXDTK-UUOKFMHZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110681,6vxx,DB02098,-9.1,Adenosine-2'-5'-Diphosphate,AEOBEOJCBAYXBA-KQYNXXCUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110702,6vxx,DB02123,-9.1,Glycochenodeoxycholic Acid,GHCZAUBVMUEKKP-GYPHWSFCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78899,6m2n,DB12420,-9.1,Diazepinomicin,SALVHVNECODMJP-GNUCVDFRSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
25252,6cs2,DB03141,-9.1,"3-{[(5R,6R)-5-Benzyl-6-hydroxy-2,4-bis(4-hydroxybenzyl)-3-oxo-1,2,4-triazepan-1-yl]sulfonyl}benzonitril",UYUWNNRWESUYOB-FIRIVFDPSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
84119,6m3m,DB04797,-9.1,Triazolopyridine,OVCXRBARSPBVMC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
110757,6vxx,DB02375,-9.1,Myricetin,IKMDFBPHZNJCSN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85361,6m3m,DB07567,-9.1,"(2R,3R,4S)-3-(4-HYDROXYPHENYL)-4-METHYL-2-[4-(2-PYRROLIDIN-1-YLETHOXY)PHENYL]CHROMAN-6-OL",XPVKGTWRXBSJKO-LHXLBICKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
24158,6cs2,DB01836,-9.1,"[4-(6-Chloro-Naphthalene-2-Sulfonyl)-Piperazin-1-Yl]-(3,4,5,6-Tetrahydro-2h-[1,4']Bipyridinyl-4-Yl)-Methanone",ZLAKCKVFSRSENR-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
81147,6m3m,DB00862,-9.1,Vardenafil,SECKRCOLJRRGGV-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
110863,6vxx,DB02505,-9.1,N-(R-Carboxy-Ethyl)-Alpha-(S)-(2-Phenylethyl),JJVQUUYZGJWBPW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87328,6m3m,DB12165,-9.1,Presatovir,GOFXWTVKPWJNGD-UWJYYQICSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
24154,6cs2,DB01831,-9.1,Tryptophanyl-5'amp,IFQVDHDRFCKAAW-SQIXAUHQSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
59973,6crv,DB08087,-9.1,"4-[(7R,7AS)-7-HYDROXY-1,3-DIOXOTETRAHYDRO-1H-PYRROLO[1,2-C]IMIDAZOL-2(3H)-YL]-1-NAPHTHONITRILE",NHBIWLQQJPSMNP-CABCVRRESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78919,6m2n,DB12447,-9.1,Nadifloxacin,JYJTVFIEFKZWCJ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
62765,6crv,DB14097,-9.1,13-cis-12-(3'-Carboxyphenyl)retinoic acid,XKKDQOHDTASHCE-PAZAWXFKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110980,6vxx,DB02836,-9.1,Guanosine 5'-Diphosphate 2':3'-Cyclic Monophosphate,NGYWTCOGOZELRS-UUOKFMHZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78931,6m2n,DB12467,-9.1,TU-100,KAYRGFYBCCETPE-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
85335,6m3m,DB07536,-9.1,"N-{(1S,2R)-2-hydroxy-1-[(hydroxyamino)carbonyl]propyl}-4-{[4-(morpholin-4-ylmethyl)phenyl]ethynyl}benzamide",FQYBTYFKOHPWQT-VGSWGCGISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59978,6crv,DB08094,-9.1,"(4-AMINO-2-{[1-(METHYLSULFONYL)PIPERIDIN-4-YL]AMINO}PYRIMIDIN-5-YL)(2,3-DIFLUORO-6-METHOXYPHENYL)METHANONE",JRNJNYBQQYBCLE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110801,6vxx,DB02424,-9.1,Geldanamycin,QTQAWLPCGQOSGP-KSRBKZBZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60907,6crv,DB09330,-9.1,Osimertinib,DUYJMQONPNNFPI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84115,6m3m,DB04793,-9.1,"1,4:3,6-Dianhydro-2-O-(3-carbamimidoylphenyl)-5-O-(4-carbamimidoylphenyl)-D-glucitol",DKBAWRNTUZFJKV-XMTFNYHQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
32048,6cs2,DB15266,-9.1,TAK-580,VWMJHAFYPMOMGF-ZCFIWIBFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
32122,6cs2,DB15403,-9.1,Ziritaxestat,REQQVBGILUTQNN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
9928,6lzg,DB08064,-9.1,N-(3-TERT-BUTYL-1H-PYRAZOL-5-YL)-N'-{4-CHLORO-3-[(PYRIDIN-3-YLOXY)METHYL]PHENYL}UREA,NTMADESEDXKNFZ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
55692,6crv,DB01342,-9.1,Forasartan,YONOBYIBNBCDSJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59246,6crv,DB07245,-9.1,6-[2-(3'-METHOXYBIPHENYL-3-YL)ETHYL]PYRIDIN-2-AMINE,AEVBKBAFFJKFJZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72916,6m2n,DB01347,-9.1,Saprisartan,DUEWVPTZCSAMNB-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
32116,6cs2,DB01126,-9.1,Dutasteride,JWJOTENAMICLJG-QWBYCMEYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
62597,6crv,DB13790,-9.1,Fipexide,BFUJHVVEMMWLHC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84041,6m3m,DB04689,-9.1,2-{5-[3-(6-BENZOYL-1-PROPYLNAPHTHALEN-2-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID,ZXWVCCFKIRBLDP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
9904,6lzg,DB08036,-9.1,"6,7,12,13-tetrahydro-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazol-5-one",MEXUTNIFSHFQRG-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
85459,6m3m,DB07686,-9.1,"4-{[5-(CYCLOHEXYLAMINO)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE",VPOGRVWIIVMWRI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
110052,6vxx,DB00751,-9.1,Epinastine,WHWZLSFABNNENI-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62628,6crv,DB13828,-9.1,Cyfluthrin,QQODLKZGRKWIFG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62638,6crv,DB13843,-9.1,Cloprednol,YTJIBEDMAQUYSZ-FDNPDPBUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28002,6cs2,DB07570,-9.1,3-CYCLOHEXYL-1-(2-MORPHOLIN-4-YL-2-OXOETHYL)-2-PHENYL-1H-INDOLE-6-CARBOXYLIC ACID,ZKEZEXYKYHYIMQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
32113,6cs2,DB15385,-9.1,Acebilustat,GERJIEKMNDGSCS-DQEYMECFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
84043,6m3m,DB04693,-9.1,"(13S)-13-METHYLDODECAHYDRO-1H-CYCLOPENTA[A]PHENANTHRENE-3,17(2H,4H)-DIONE",CRDKSBHJIGNEOH-IMRIKWHGSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59239,6crv,DB07235,-9.1,"N-[(1S)-2-AMINO-1-(2,4-DICHLOROBENZYL)ETHYL]-5-[2-(METHYLAMINO)PYRIMIDIN-4-YL]THIOPHENE-2-CARBOXAMIDE",HHOVRZGUSBMKKU-ZDUSSCGKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110180,6vxx,DB01067,-9.1,Glipizide,ZJJXGWJIGJFDTL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87302,6m3m,DB12127,-9.1,Sultamicillin,OPYGFNJSCUDTBT-PMLPCWDUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
90168,6m71,DB01410,-9.1,Ciclesonide,LUKZNWIVRBCLON-GXOBDPJESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
90140,6m71,DB01349,-9.1,Tasosartan,ADXGNEYLLLSOAR-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
57634,6crv,DB03921,-9.1,4-(3-Pyridin-2-Yl-1h-Pyrazol-4-Yl)Quinoline,IBCXZJCWDGCXQT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85420,6m3m,DB07638,-9.1,"(3AS,4R,9BR)-2,2-DIFLUORO-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL",QJSMFUTULGSHNQ-ZOBUZTSGSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
78838,6m2n,DB12336,-9.1,GDC-0917,HSHPBORBOJIXSQ-HARLFGEKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
110328,6vxx,DB01469,-9.1,Acetorphine,LFYBMMHFJIAKFE-PMEKXCSPSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
32074,6cs2,DB15305,-9.1,Risdiplam,ASKZRYGFUPSJPN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
110431,6vxx,DB01587,-9.1,Ketazolam,PWAJCNITSBZRBL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78842,6m2n,DB12341,-9.1,LY-2456302,ZHPMYDSXGRRERG-DEOSSOPVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
89115,6m3m,DB04596,-9.1,"4-O-{4,6-O-[(1S)-1-Carboxyethylidene]-β-D-mannopyranosyl}-D-glucopyranuronic acid",GZJXZKGVHLWBOW-AISSFXTFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
109827,6vxx,DB00303,-9.1,Ertapenem,JUZNIMUFDBIJCM-ANEDZVCMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59903,6crv,DB08008,-9.1,"5-methyl-N-[4-(trifluoromethyl)phenyl][1,2,4]triazolo[1,5-a]pyrimidin-7-amine",LRHHXKBKRNNFRV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109249,6vxx,DB12952,-9.1,Methylprednisone,SVYCRJXQZUCUND-PQXSVQADSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61149,6crv,DB11663,-9.1,Pictilisib,LHNIIDJUOCFXAP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
96322,6m71,DB12729,-9.1,ASP-3026,MGGBYMDAPCCKCT-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
87139,6m3m,DB11890,-9.1,Cilengitide,AMLYAMJWYAIXIA-VWNVYAMZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
33936,6cs2,T3D0621,-9.1,Benzo[ghi]perylene,GYFAGKUZYNFMBN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
75370,6m2n,DB04608,-9.1,"9-HYDROXY-4-PHENYL-6H-PYRROLO[3,4-C]CARBAZOLE-1,3-DIONE",IAUZTOZLTFSMIE-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
25031,6cs2,DB02873,-9.1,"1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperazin-1-Yl-3,4-Dihydroquinazolin-2(1h)-One",YAWZIQKDHQIHOS-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
108564,6vxx,DB08400,-9.1,4-(3-{[5-(trifluoromethyl)pyridin-2-yl]oxy}benzyl)piperidine-1-carboxylic acid,KUEKMTNOUPAOBS-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81566,6m3m,DB01420,-9.1,Testosterone propionate,PDMMFKSKQVNJMI-BLQWBTBKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85863,6m3m,DB08147,-9.1,"4-[3-(dibenzylamino)phenyl]-2,4-dioxobutanoic acid",RMWVENXKUQXLPW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59430,6crv,DB07453,-9.1,2-PHENYL-4H-BENZO[H]CHROMEN-4-ONE,VFMMPHCGEFXGIP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28741,6cs2,DB08353,-9.1,"2-(CYCLOHEXYLMETHYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE",NCVMTHVSAJMOPI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
61925,6crv,DB12812,-9.1,Palomid 529,YEAHTLOYHVWAKW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75262,6m2n,DB04471,-9.1,"2-Phenyl-1-[4-(2-Piperidin-1-Yl-Ethoxy)-Phenyl]-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol",FMWVCTJKLAVRPB-MUUNZHRXSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
85858,6m3m,DB08142,-9.1,AT-7519,OVPNQJVDAFNBDN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
108489,6vxx,DB08049,-9.1,"7,8-dihydroxy-4-phenyl-2H-chromen-2-one",JRVIIPJSVKTPBK-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61961,6crv,DB12875,-9.1,Mavatrep,ORDHXXHTBUZRCN-NTEUORMPSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75196,6m2n,DB04378,-9.1,"3-Amino-N-{4-[2-(2,6-Dimethyl-Phenoxy)-Acetylamino]-3-Hydroxy-1-Isobutyl-5-Phenyl-Pentyl}-Benzamide",APJAEXGNDLFGPD-AWCRTANDSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
96183,6m71,DB12513,-9.1,Omaveloxolone,RJCWBNBKOKFWNY-IDPLTSGASA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
85843,6m3m,DB08125,-9.1,"4-{[(2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]AMINO}-N-(1,3-THIAZOL-2-YL)BENZENESULFONAMIDE",BOMPRXSVSIPRDT-PTNGSMBKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
108612,6vxx,DB08460,-9.1,"3-{5-[(6-amino-1H-pyrazolo[3,4-b]pyridin-3-yl)methoxy]-2-chlorophenoxy}-5-chlorobenzonitrile",KXDIHAQCVNNLIB-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61962,6crv,DB12877,-9.1,Oxatomide,BAINIUMDFURPJM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55595,6crv,DB01184,-9.1,Domperidone,FGXWKSZFVQUSTL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
96116,6m71,DB12415,-9.1,Galeterone,PAFKTGFSEFKSQG-PAASFTFBSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
108663,6vxx,DB08520,-9.1,"(21S)-1AZA-4,4-DIMETHYL-6,19-DIOXA-2,3,7,20-TETRAOXOBICYCLO[19.4.0] PENTACOSANE",VUCSBBBCFXBFFY-IBGZPJMESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28749,6cs2,DB08360,-9.1,"2-(4-ETHYLPIPERAZIN-1-YL)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE",BIFHJPUTQBOBGJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
78511,6m2n,DB11864,-9.1,Preladenant,DTYWJKSSUANMHD-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
108708,6vxx,DB08834,-9.1,Tauroursodeoxycholic acid,BHTRKEVKTKCXOH-LBSADWJPSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
74933,6m2n,DB04023,-9.1,"Guanosine 5'-(Trihydrogen Diphosphate), P'-D-Mannopyranosyl Ester",DNBSDUDYNPJVCN-ZXTXFPBHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
83288,6m3m,DB03696,-9.1,Lanosterol,CAHGCLMLTWQZNJ-BQNIITSRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
108594,6vxx,DB08439,-9.1,Parecoxib,TZRHLKRLEZJVIJ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75436,6m2n,DB04698,-9.1,"N-(1,4-DIHYDRO-5H-TETRAZOL-5-YLIDENE)-9-OXO-9H-XANTHENE-2-SULFONAMIDE",HJWYZPGYPZNDTN-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
108486,6vxx,DB08043,-9.1,1-[4-(PYRIDIN-4-YLOXY)PHENYL]-3-[3-(TRIFLUOROMETHYL)PHENYL]UREA,DDDLGNOZDKDSEG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
96407,6m71,DB12875,-9.1,Mavatrep,ORDHXXHTBUZRCN-NTEUORMPSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
61331,6crv,DB11925,-9.1,Vistusertib,JUSFANSTBFGBAF-IRXDYDNUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59461,6crv,DB07490,-9.1,"2-[1-(4-CHLORO-PHENYL)-ETHYL]-4,6-DINITRO-PHENOL",MOZUMFSUQQHSCO-MRVPVSSYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75664,6m2n,DB05263,-9.1,Caprospinol,VMOZFSWFUBLCNN-AAPULDEBSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
37672,6lu7,DB05984,-9.1,RAF-265,YABJJWZLRMPFSI-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
26767,6cs2,DB05105,-9.1,Pleconaril,KQOXLKOJHVFTRN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
83051,6m3m,DB03351,-9.1,Sri-9439,KMSATRJZEXNGDP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
108306,6vxx,DB07605,-9.1,"2-({4-[(5-CHLORO-1H-INDOL-2-YL)SULFONYL]PIPERAZIN-1-YL}CARBONYL)THIENO[3,2-B]PYRIDINE 4-OXIDE",DHDQMXPAANQKDC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108321,6vxx,DB07622,-9.1,"1-(3-(2,4-DIMETHYLTHIAZOL-5-YL)-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)-3-(4-METHYLPIPERAZIN-1-YL)UREA",KRKQVGZXTNLQSV-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
97424,6m71,DB14860,-9.1,Ensartinib,GLYMPHUVMRFTFV-QLFBSQMISA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
55505,6crv,DB01082,-9.1,Streptomycin,UCSJYZPVAKXKNQ-HZYVHMACSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61843,6crv,DB12680,-9.1,Intepirdine,JJZFWROHYSMCMU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
97338,6m71,DB14664,-9.1,Difluocortolone pivalate,UWGRWFCLGQWKPR-GSTUPEFVSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
108369,6vxx,DB07679,-9.1,"(9S,12S)-9-(1-methylethyl)-7,10-dioxo-2-oxa-8,11-diazabicyclo[12.2.2]octadeca-1(16),14,17-triene-12-carboxylic acid",RRAAROKJUVKWAF-RDJZCZTQSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108374,6vxx,DB07685,-9.1,"4-{[5-(CYCLOHEXYLMETHOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE",NMAZGYDYIYLSLJ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108378,6vxx,DB07691,-9.1,"2-({[3-(3,4-dihydroisoquinolin-2(1H)-ylsulfonyl)phenyl]carbonyl}amino)benzoic acid",GYILVHHTCYNIOS-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
97132,6m71,DB13947,-9.1,Testosterone enantate benzilic acid hydrazone,PTVXYACXDYZNID-JKXGKYMWSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
28113,6cs2,DB07691,-9.1,"2-({[3-(3,4-dihydroisoquinolin-2(1H)-ylsulfonyl)phenyl]carbonyl}amino)benzoic acid",GYILVHHTCYNIOS-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
85977,6m3m,DB08292,-9.1,"(5Z)-12-CHLORO-13,15-DIHYDROXY-4,7,8,9-TETRAHYDRO-2-BENZOXACYCLOTRIDECINE-1,10(3H,11H)-DIONE",AQKZYZQONWDDLS-IWQZZHSRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
108415,6vxx,DB07966,-9.1,[4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]quinazolin-2-yl}amino)phenyl]acetonitrile,NVMCVWOODOWOLT-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
96958,6m71,DB13676,-9.1,Mosapramine,PXUIZULXJVRBPC-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
108426,6vxx,DB07977,-9.1,"3-({[3,5-DIFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)THIOPHENE-2-CARBOXYLIC ACID",CGNHUSCKOHDSMR-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28698,6cs2,DB08305,-9.1,"(3R)-3-cyclopentyl-6-methyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2-benzothiazine 1,1-dioxide",KQAGZLQCEURCKJ-QGZVFWFLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
28104,6cs2,DB07680,-9.1,[(1S)-1-(5-CHLORO-1-BENZOTHIEN-3-YL)-2-(2-NAPHTHYLAMINO)-2-OXOETHYL]PHOSPHONIC ACID,HUJXISJLAPAFBO-IBGZPJMESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
96565,6m71,DB13109,-9.1,PKI-179,WXUUCRLKXQMWRY-OYRHEFFESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
27137,6cs2,DB06543,-9.1,Astaxanthin,MQZIGYBFDRPAKN-UWFIBFSHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
81581,6m3m,DB01436,-9.1,Alfacalcidol,OFHCOWSQAMBJIW-AVJTYSNKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
78469,6m2n,DB11800,-9.1,Tivozanib,SPMVMDHWKHCIDT-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
96494,6m71,DB13005,-9.1,Rebastinib,WVXNSAVVKYZVOE-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
83115,6m3m,DB03446,-9.1,N-Benzyl-3-(alpha-D-galactopyranosyloxy)benzamide,FSMWGHKWKYCPKE-QTVCLEQKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
61984,6crv,DB12904,-9.1,ZSTK-474,HGVNLRPZOWWDKD-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
96049,6m71,DB12318,-9.1,BMS-599626,LUJZZYWHBDHDQX-QFIPXVFZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
108771,6vxx,DB08942,-9.1,Isoxicam,YYUAYBYLJSNDCX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
83325,6m3m,DB03742,-9.1,Compound 4-D,TWZNCTCQAGRUGQ-RRPNLBNLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
95201,6m71,DB09074,-9.1,Olaparib,FDLYAMZZIXQODN-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
83499,6m3m,DB03962,-9.1,Nicotinamide 8-Bromo-Adenine Dinucleotide Phosphate,MDKMTCCUJSRQGW-NAJQWHGHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
61204,6crv,DB11742,-9.1,Ebastine,MJJALKDDGIKVBE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109064,6vxx,DB11984,-9.1,Letaxaban,GEHAEMCVKDPMKO-HXUWFJFHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109070,6vxx,DB11992,-9.1,Omarigliptin,MKMPWKUAHLTIBJ-ISTRZQFTSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
32860,6cs2,T3D3778,-9.1,Paspalitrem B,BZJWARDOYGJZHQ-PKNBQFBNSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
74326,6m2n,DB03207,-9.1,"2-(Biphenyl-4-Sulfonyl)-1,2,3,4-Tetrahydro-Isoquinoline-3-Carboxylic Acid",BNVMUDXGABBWGP-OAQYLSRUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
95086,6m71,DB08911,-9.1,Trametinib,LIRYPHYGHXZJBZ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59874,6crv,DB07975,-9.1,"2-({[3,5-DIFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)CYCLOPENT-1-ENE-1-CARBOXYLIC ACID",VTGXLCZUWFYELR-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78621,6m2n,DB12025,-9.1,Triptolide,DFBIRQPKNDILPW-CIVMWXNOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
74277,6m2n,DB03141,-9.1,"3-{[(5R,6R)-5-Benzyl-6-hydroxy-2,4-bis(4-hydroxybenzyl)-3-oxo-1,2,4-triazepan-1-yl]sulfonyl}benzonitril",UYUWNNRWESUYOB-FIRIVFDPSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
14143,6lzg,T3D3762,-9.1,Janthitrem B,FYYNBFCZCKFSKS-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
109103,6vxx,DB12380,-9.1,GDC-0152,WZRFLSDVFPIXOV-LRQRDZAKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78638,6m2n,DB12052,-9.1,Icariin,TZJALUIVHRYQQB-XLRXWWTNSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
73928,6m2n,DB02673,-9.1,"(4ar,6s,8ar)-11-[8-(1,3-Dioxo-1,3-Dihydro-2h-Isoindol-2-Yl)Octyl]-6-Hydroxy-3-Methoxy-5,6,9,10-Tetrahydro-4ah-[1]Benzofuro[3a,3,2-Ef][2]Benzazepin-11-Ium",VLGAHTYYCHWLNI-BHRZLAGCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
32775,6cs2,T3D3689,-9.1,Ergocornine,UJYGDMFEEDNVBF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
59363,6crv,DB07375,-9.1,"5-BETA-ANDROSTANE-3,17-DIONE",RAJWOBJTTGJROA-QJISAEMRSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109134,6vxx,DB12419,-9.1,HSD-016,ZWASRJHIEFYJGL-BFUOFWGJSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62115,6crv,DB13104,-9.1,X-396,ONPGOSVDVDPBCY-CQSZACIVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
32769,6cs2,T3D3682,-9.1,Dihydrocytochalasin B,ZFGBJIDXDYHNLX-RIYZIHGNSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
109143,6vxx,DB12430,-9.1,BC-3781,KPVIXBKIJXZQJX-IJUBVZAWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78681,6m2n,DB12114,-9.1,Poziotinib,LPFWVDIFUFFKJU-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61177,6crv,DB11698,-9.1,Ipragliflozin,AHFWIQIYAXSLBA-RQXATKFSSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
73854,6m2n,DB02573,-9.1,"2'-Deoxycytidine-2'-Deoxyadenosine-3',5'-Monophosphate",LYWWDKIADIGKTH-IDMWBNCISA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78687,6m2n,DB12122,-9.1,Figopitant,HUTHJVYJUPXHDF-DEOSSOPVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
63259,6crv,DB15449,-9.1,Citarinostat,VLIUIBXPEDFJRF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
73835,6m2n,DB02547,-9.1,Guanosine-5'-Diphosphate-Rhamnose,LQEBEXMHBLQMDB-GDJBGNAASA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
85701,6m3m,DB07967,-9.1,9-CYCLOPENTYL-6-[2-(3-IMIDAZOL-1-YL-PROPOXY)-PHENYLAMINO]-9H-PURINE-2-CARBONITRILE,JJNKDTWKWYLERH-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
73833,6m2n,DB02545,-9.1,Fexaramine,VLQTUNDJHLEFEQ-KGENOOAVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
109048,6vxx,DB11958,-9.1,Brivanib,WCWUXEGQKLTGDX-LLVKDONJSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85329,6m3m,DB07530,-9.1,"(1R,3R)-5-[(2E)-3-{(1S,3R)-2,2,3-trimethyl-3-[6,6,6-trifluoro-5-hydroxy-5-(trifluoromethyl)hex-3-yn-1-yl]cyclopentyl}prop-2-en-1-ylidene]cyclohexane-1,3-diol",PCHUQQNKOFNVDU-OSXMSNBXSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
78587,6m2n,DB11971,-9.1,Vilaprisan,JUFWQQVHQFDUOD-ANRPBIDPSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
95504,6m71,DB11442,-9.1,Oleandomycin,RZPAKFUAFGMUPI-QESOVKLGSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
108797,6vxx,DB08973,-9.1,Fluclorolone acetonide,NJNWEGFJCGYWQT-VSXGLTOVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58578,6crv,DB06117,-9.1,"1alpha,24S-Dihydroxyvitamin D2",ODZFJAXAEXQSKL-WRJREGAQSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81523,6m3m,DB01338,-9.1,Pipecuronium,OWWLUIWOFHMHOQ-XGHATYIMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
62007,6crv,DB12939,-9.1,Nikkomycin Z,WWJFFVUVFNBJTN-VHDFTHOZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
96019,6m71,DB12282,-9.1,Defactinib,FWLMVFUGMHIOAA-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95914,6m71,DB12128,-9.1,Ulimorelin,WGYPAJVJMXQXTR-ABNZCKJZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
62008,6crv,DB12941,-9.1,ODM-201,BLIJXOOIHRSQRB-PXYINDEMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78553,6m2n,DB11922,-9.1,Danirixin,NGYNBSHYFOFVLS-LBPRGKRZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
87173,6m3m,DB11939,-9.1,Henagliflozin,HYTPDMFFHVZBOR-VNXMGFANSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
108943,6vxx,DB11430,-9.1,Monensin,GAOZTHIDHYLHMS-KEOBGNEYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
33234,6cs2,T3D4350,-9.1,Bilirubin,BPYKTIZUTYGOLE-KDUUSRDASA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
81490,6m3m,DB01261,-9.1,Sitagliptin,MFFMDFFZMYYVKS-SECBINFHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
95764,6m71,DB11907,-9.1,Rociletinib,HUFOZJXAKZVRNJ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95728,6m71,DB11853,-9.1,Relugolix,AOMXMOCNKJTRQP-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
58583,6crv,DB06137,-9.1,KX-01,HUNGUWOZPQBXGX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
33074,6cs2,T3D4050,-9.1,alpha-Chaconine,TYNQWWGVEGFKRU-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
74715,6m2n,DB03744,-9.1,"Cp403700, (S)-1-{2-[(5-Chloro-1h-Indole-2-Carbonyl)-Amino]-3-Phenyl-Propionyl}-Azetidine-3-Carboxylate",RONLONYAIBUEKT-IBGZPJMESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
108987,6vxx,DB11870,-9.1,RG-4733,OJPLJFIFUQPSJR-INIZCTEOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
95698,6m71,DB11814,-9.1,PF-03882845,XNULRSOGWPFPBL-REWPJTCUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
108998,6vxx,DB11886,-9.1,Infigratinib,QADPYRIHXKWUSV-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
95680,6m71,DB11787,-9.1,Ralimetinib,XPPBBJCBDOEXDN-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95622,6m71,DB11697,-9.1,Pacritinib,HWXVIOGONBBTBY-ONEGZZNKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
83445,6m3m,DB03893,-9.1,Thionicotinamide-Adenine-Dinucleotide,UQYPZLRUJKCREN-NNYOXOHSSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
78580,6m2n,DB11963,-9.1,Dacomitinib,LVXJQMNHJWSHET-AATRIKPKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
26712,6cs2,DB04908,-9.1,Flibanserin,PPRRDFIXUUSXRA-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
27177,6cs2,DB06630,-9.1,Anacetrapib,MZZLGJHLQGUVPN-HAWMADMCSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
95569,6m71,DB11611,-9.1,Lifitegrast,JFOZKMSJYSPYLN-QHCPKHFHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
28838,6cs2,DB08460,-9.1,"3-{5-[(6-amino-1H-pyrazolo[3,4-b]pyridin-3-yl)methoxy]-2-chlorophenoxy}-5-chlorobenzonitrile",KXDIHAQCVNNLIB-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
85763,6m3m,DB08034,-9.1,"(E)-3,4-DIHYDROXY-N'-[(2-METHOXYNAPHTHALEN-1-YL)METHYLENE]BENZOHYDRAZIDE",TVOPERZEGKBKAY-RGVLZGJSSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
95499,6m71,DB11431,-9.1,Moxidectin,YZBLFMPOMVTDJY-LSGXYNIPSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
28389,6cs2,DB07977,-9.1,"3-({[3,5-DIFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)THIOPHENE-2-CARBOXYLIC ACID",CGNHUSCKOHDSMR-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
83301,6m3m,DB03714,-9.1,4-Carbamoyl-4-{[6-(Difluoro-Phosphono-Methyl)-Naphthalene-2-Carbonyl]-Amino}-Butyric Acid,OWWCIKSGGKYNHT-ZDUSSCGKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
89106,6m3m,DB02639,-9.1,4-methylumbelliferyl alpha-D-glucoside,YUDPTGPSBJVHCN-JZYAIQKZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
158592,7bv1,DB01669,-9.1,Virginiamycin M1,DAIKHDNSXMZDCU-FQTGFAPKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
158739,7bv1,DB02152,-9.1,K-252a,KOZFSFOOLUUIGY-SOLYNIJKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
6365,6lzg,DB01988,-9.1,6((S)-3-Benzylpiperazin-1-Yl)-3-(Naphthalen-2-Yl)-4-(Pyridin-4-Yl)Pyrazine,WFSFNKVFXLIZIY-MHZLTWQESA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
129121,6w4h,DB08418,-9.1,"(4aS,4bR,10bS,12aS)-12a-methyl-1,3-dioxo-2-(pyridin-3-ylmethyl)-1,2,3,4,4a,4b,5,6,10b,11,12,12a-dodecahydronaphtho[2,1-f]isoquinolin-8-yl sulfamate",LSJKARAMQNGZDF-YOEKFXIASA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
129080,6w4h,DB08366,-9.1,"3-({3-[(1S,4aS,6S,7S,9S,9aR)-1,6-dimethyl-2-oxodecahydro-6,9-epoxy-4a,7-methanobenzo[7]annulen-1-yl]propanoyl}amino)-2,4-dihydroxybenzoic acid",XADCWKSMHQPTGH-OFBLZTNGSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
159246,7bv1,DB03638,-9.1,Cytidyl-2'-5'-Phospho-Guanosine,QZDUXDLOEVJGDG-VMIOUTBZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
159359,7bv1,DB04040,-9.1,"N-(2-Morpholin-4-Yl-1-Morpholin-4-Ylmethyl-Ethyl)-3-Nitro-5-(3,4,5-Trihydroxy-6-Hydroxymethyl-Tetrahydro-Pyran-2-Yloxy)-Benzamide",MCMWCTMAKPQTPI-WGNYYXNJSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
159704,7bv1,DB05408,-9.1,Emricasan,SCVHJVCATBPIHN-SJCJKPOMSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
128813,6w4h,DB08044,-9.1,ABT-341,NVVSPGQEXMJZIR-BMIGLBTASA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
159800,7bv1,DB06589,-9.1,Pazopanib,CUIHSIWYWATEQL-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160007,7bv1,DB07181,-9.1,"4'-[(1R)-1-amino-2-(2,5-difluorophenyl)ethyl]biphenyl-3-carboxamide",JYKFWUXBFJJDTP-HXUWFJFHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
128588,6w4h,DB07789,-9.1,"1-[5-methyl-2-(trifluoromethyl)furan-3-yl]-3-[(2Z)-5-(2-{[6-(1H-1,2,4-triazol-3-ylamino)pyrimidin-4-yl]amino}ethyl)-1,3-thiazol-2(3H)-ylidene]urea",KNTGXMNWVXZIMW-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
160162,7bv1,DB07586,-9.1,"5-(4-METHYL-BENZOYLAMINO)-BIPHENYL-3,4'-DICARBOXYLIC ACID 3-DIMETHYLAMIDE-4'-HYDROXYAMIDE",DOPFUKKMSDUVTQ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160295,7bv1,DB07977,-9.1,"3-({[3,5-DIFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)THIOPHENE-2-CARBOXYLIC ACID",CGNHUSCKOHDSMR-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160366,7bv1,DB08299,-9.1,"4-[8-(3-nitrophenyl)-1,7-naphthyridin-6-yl]benzoic acid",QTNUWEKKZHSUQO-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
6577,6lzg,DB02354,-9.1,4-{[1-Methyl-5-(2-Methyl-Benzoimidazol-1-Ylmethyl)-1h-Benzoimidazol-2-Ylmethyl]-Amino}-Benzamidine,IRKPNOLLMNHSOU-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
128384,6w4h,DB07545,-9.1,N-{3-[(4-{[3-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-2-YL)AMINO]PHENYL}CYCLOPROPANECARBOXAMIDE,RDTDWGQDFJPTPD-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
160624,7bv1,DB08861,-9.1,DPDPE,MCMMCRYPQBNCPH-WMIMKTLMSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160654,7bv1,DB09231,-9.1,Benidipine,QZVNQOLPLYWLHQ-ZEQKJWHPSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160694,7bv1,DB09291,-9.1,Rolapitant,FIVSJYGQAIEMOC-ZGNKEGEESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160697,7bv1,DB09298,-9.1,Silibinin,SEBFKMXJBCUCAI-HKTJVKLFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160800,7bv1,DB11742,-9.1,Ebastine,MJJALKDDGIKVBE-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160882,7bv1,DB11863,-9.1,Alvelestat,QNQZWEGMKJBHEM-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
161074,7bv1,DB12843,-9.1,Oleandrin,JLPDBLFIVFSOCC-XYXFTTADSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
161093,7bv1,DB12875,-9.1,Mavatrep,ORDHXXHTBUZRCN-NTEUORMPSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
161110,7bv1,DB12897,-9.1,MK-7622,JUVQLZBJFOGEEO-GOTSBHOMSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
161393,7bv1,DB13953,-9.1,Estradiol benzoate,UYIFTLBWAOGQBI-BZDYCCQFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
161416,7bv1,DB13997,-9.1,Baloxavir marboxil,RZVPBGBYGMDSBG-GGAORHGYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
128098,6w4h,DB07215,-9.1,"2-METHYL-2-(4-{[({4-METHYL-2-[4-(TRIFLUOROMETHYL)PHENYL]-1,3-THIAZOL-5-YL}CARBONYL)AMINO]METHYL}PHENOXY)PROPANOIC ACID",ILUPZUOBHCUBKB-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
158385,7bv1,DB01126,-9.1,Dutasteride,JWJOTENAMICLJG-QWBYCMEYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
157389,6wiq,DB15308,-9.1,Ridinilazole,UHQFBTAJFNVZIV-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
129382,6w4h,DB08730,-9.1,3-FLUORO-5-MORPHOLIN-4-YL-N-[1-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-6-YL]BENZAMIDE,CPFBZMFUCGHBAP-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
129494,6w4h,DB08875,-9.1,Cabozantinib,ONIQOQHATWINJY-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131894,6w4h,DB14937,-9.1,MK-8666,CODQKEMYZZKQAE-QPVYNBJUSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131893,6w4h,DB14935,-9.1,Serabelisib,BLGWHBSBBJNKJO-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131863,6w4h,DB14878,-9.1,Liafensine,VCIBGDSRPUOBOG-QFIPXVFZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131845,6w4h,DB14845,-9.1,Filgotinib,RIJLVEAXPNLDTC-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131815,6w4h,DB14766,-9.1,Etrasimod,MVGWUTBTXDYMND-QGZVFWFLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131799,6w4h,DB14729,-9.1,Rebeccamycin,QEHOIJJIZXRMAN-QZQSLCQPSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131779,6w4h,DB14675,-9.1,Temsavir,QRPZBKAMSFHVRW-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131062,6w4h,DB13240,-9.1,Cymarin,XQCGNURMLWFQJR-ZNDDOCHDSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130984,6w4h,DB13095,-9.1,JTK-853,JQLOVYLALGSISI-HXUWFJFHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130960,6w4h,DB13060,-9.1,CEP-37440,BCSHRERPHLTPEE-NRFANRHFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130932,6w4h,DB13019,-9.1,Henatinib,MCTXSDCWFQAGFS-UEXNTNOUSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130919,6w4h,DB12999,-9.1,MK-6186,FZBAOOQVQXATRL-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130905,6w4h,DB12973,-9.1,Serlopitant,FLNYCRJBCNNHRH-OIYLJQICSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130752,6w4h,DB12729,-9.1,ASP-3026,MGGBYMDAPCCKCT-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
161475,7bv1,DB14878,-9.1,Liafensine,VCIBGDSRPUOBOG-QFIPXVFZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
130688,6w4h,DB12635,-9.1,Aleplasinin,HSXLMAFNWCSZGP-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
147335,6w9q,DB11791,-9.1,Capmatinib,LIOLIMKSCNQPLV-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
130642,6w4h,DB12558,-9.1,AEE-788,OONFNUWBHFSNBT-HXUWFJFHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130626,6w4h,DB12535,-9.1,AC-430,DCRWIATZWHLIPN-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130496,6w4h,DB12345,-9.1,MBX-2982,NFTMKHWBOINJGM-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130409,6w4h,DB12228,-9.1,Telcagepant,CGDZXLJGHVKVIE-DNVCBOLYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
148014,6w9q,DB12799,-9.1,Laniquidar,TULGGJGJQXESOO-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
130189,6w4h,DB11901,-9.1,Apalutamide,HJBWBFZLDZWPHF-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130120,6w4h,DB11799,-9.1,Bictegravir,SOLUWJRYJLAZCX-LYOVBCGYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
148218,6w9q,DB13113,-9.1,JNJ-38877605,JRWCBEOAFGHNNU-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
130019,6w4h,DB11651,-9.1,Dactolisib,JOGKUKXHTYWRGZ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
129780,6w4h,DB09319,-9.1,Carindacillin,JIRBAUWICKGBFE-MNRDOXJOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
149142,6w9q,DB15029,-9.1,AZD-8186,LMJFJIDLEAWOQJ-CQSZACIVSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
149197,6w9q,DB15133,-9.1,Tepotinib,AHYMHWXQRWRBKT-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
129580,6w4h,DB08995,-9.1,Diosmin,GZSOSUNBTXMUFQ-YFAPSIMESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130684,6w4h,DB12627,-9.1,GSK-1292263,AYJRTVVIBJSSKN-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
128078,6w4h,DB07189,-9.1,"(1S,3R,6S)-4-oxo-6-{4-[(2-phenylquinolin-4-yl)methoxy]phenyl}-5-azaspiro[2.4]heptane-1-carboxylic acid",BFZXMIUWGSTUAL-ZSOKXDGFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
161511,7bv1,DB14943,-9.1,LGH-447,VRQXRVAKPDCRCI-ZNMIVQPWSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
128039,6w4h,DB07145,-9.1,(2R)-N-HYDROXY-2-[(3S)-3-METHYL-3-{4-[(2-METHYLQUINOLIN-4-YL)METHOXY]PHENYL}-2-OXOPYRROLIDIN-1-YL]PROPANAMIDE,YDMIPBHQKFOFQW-NSYGIPOTSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
126617,6w4h,DB04071,-9.1,Cpad,LFERELMXERXKKQ-KMXXXSRASA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
126102,6w4h,DB03363,-9.1,3-Acetylpyridine Adenine Dinucleotide,KPVQNXLUPNWQHM-RBEMOOQDSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
125978,6w4h,DB03207,-9.1,"2-(Biphenyl-4-Sulfonyl)-1,2,3,4-Tetrahydro-Isoquinoline-3-Carboxylic Acid",BNVMUDXGABBWGP-OAQYLSRUSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
125872,6w4h,DB03067,-9.1,"4-{2,4-Bis[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid",VFYAZSTYKPFSFL-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
125696,6w4h,DB02830,-9.1,FR236913,KCCUBLLGAMGDJL-HXUWFJFHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
125565,6w4h,DB02651,-9.1,"{[2-(1h-1,2,3-Benzotriazol-1-Yl)-2-(3,4-Difluorophenyl)Propane-1,3-Diyl]Bis[4,1-Phenylene(Difluoromethylene)]}Bis(Phosphonic Acid)",BTAGTGWPDROBMG-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
164421,7bv1,DB07811,-9.1,"N-cyclopropyl-2',6-dimethyl-4'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-3-carboxamide",UBVTVSINEVHYSY-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
125469,6w4h,DB02524,-9.1,"2',3'-O-{4-[Hydroxy(oxido)-??5-azanylidene]-2,6-dinitro-2,5-cyclohexadiene-1,1-diyl}adenosine 5'-(tetrahydrogen triphosphate)",XFMMHXLUHKBKQE-UHEGPQQHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
125447,6w4h,DB02498,-9.1,Carba-Nicotinamide-Adenine-Dinucleotide,DGPLSUKWXXSBCU-VGXGLJSLSA-O,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
164624,7bv1,DB08221,-9.1,N-{4-METHYL-3-[(3-PYRIMIDIN-4-YLPYRIDIN-2-YL)AMINO]PHENYL}-3-(TRIFLUOROMETHYL)BENZAMIDE,NESXBRNDMQUVNG-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
124859,6w4h,DB01721,-9.1,Analogue of Indinavir Drug,MJIRDPUZGGHJMX-OIVSQUILSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
164697,7bv1,DB08497,-9.1,"(1S)-2-oxo-1-phenyl-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate",NKBDSMREMMRFSI-INIZCTEOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
124484,6w4h,DB01199,-9.1,Tubocurarine,JFJZZMVDLULRGK-URLMMPGGSA-O,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
124201,6w4h,DB00878,-9.1,Chlorhexidine,GHXZTYHSJHQHIJ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
126640,6w4h,DB04099,-9.1,Deamido-Nad+,SENPVEZBRZQVST-HISDBWNOSA-O,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
124155,6w4h,DB00826,-9.1,Natamycin,NCXMLFZGDNKEPB-FFPOYIOWSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
165226,7bv1,DB11611,-9.1,Lifitegrast,JFOZKMSJYSPYLN-QHCPKHFHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
123924,6w4h,DB00549,-9.1,Zafirlukast,YEEZWCHGZNKEEK-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
123738,6w4h,DB00319,-9.1,Piperacillin,IVBHGBMCVLDMKU-GXNBUGAJSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
123675,6w4h,DB00246,-9.1,Ziprasidone,MVWVFYHBGMAFLY-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
165298,7bv1,DB11896,-9.1,Gedatolisib,DWZAEMINVBZMHQ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
165404,7bv1,DB12054,-9.1,BQ-123,VYCMAAOURFJIHD-PJNXIOHISA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
165493,7bv1,DB12185,-9.1,Exatecan,ZVYVPGLRVWUPMP-FYSMJZIKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
165494,7bv1,DB12186,-9.1,SRT-2104,LAMQVIQMVKWXOC-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
165520,7bv1,DB12225,-9.1,Beclabuvir,ZTTKEBYSXUCBSE-QDFUAKMASA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
122252,6w4b,DB13113,-9.1,JNJ-38877605,JRWCBEOAFGHNNU-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
7540,6lzg,DB03966,-9.1,Clorobiocin,FJAQNRBDVKIIKK-LFLQOBSNSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
121798,6w4b,DB12411,-9.1,R-428,KXMZDGSRSGHMMK-VWLOTQADSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
165711,7bv1,DB12694,-9.1,CE-326597,UBNMGTSDHSQBEL-PMERELPUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
120721,6w4b,DB08827,-9.1,Lomitapide,MBBCVAKAJPKAKM-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
165116,7bv1,DB11363,-9.1,Alectinib,KDGFLJKFZUIJMX-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
146073,6w9q,DB08091,-9.1,3-FLUORO-5-MORPHOLIN-4-YL-N-[3-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-5-YL]BENZAMIDE,HIUFYIOMUILESI-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
164017,7bv1,DB06976,-9.1,"1-(5-OXO-2,3,5,9B-TETRAHYDRO-1H-PYRROLO[2,1-A]ISOINDOL-9-YL)-3-(5-PYRROLIDIN-2-YL-1H-PYRAZOL-3-YL)-UREA",IWOOJEZSDPRYAZ-WFASDCNBSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
126947,6w4h,DB04514,-9.1,Phosphoric Acid-2'-[2'-Deoxy-Uridine]Ester-5'-Guanosine Ester,DFYLLEBFVZTKHD-VMIOUTBZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
161762,7bv1,DB00568,-9.1,Cinnarizine,DERZBLKQOCDDDZ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
127936,6w4h,DB07029,-9.1,"4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMIDAZOL-1-YL)PHENOXY]-6-METHYLPYRIMIDINE",QQBNDYARFVOEGW-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
127933,6w4h,DB07026,-9.1,"(1S,5S,7R)-N-7-(BIPHENYL-4-YLMETHYL)-N-3-HYDROXY-6,8-DIOXA-3-AZABICYCLO[3.2.1]OCTANE-3,7-DICARBOXAMIDE",PPLDARNGJSQINK-OKZBNKHCSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
127932,6w4h,DB07025,-9.1,3-(5-{[4-(AMINOMETHYL)PIPERIDIN-1-YL]METHYL}-1H-INDOL-2-YL)QUINOLIN-2(1H)-ONE,KBIHHEGEALBUMT-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
127929,6w4h,DB07021,-9.1,"(7R,8R)-8-(2,4,5-trifluorophenyl)-6,7,8,9-tetrahydroimidazo[1,2-a:4,5-c']dipyridin-7-amine",SOSYXEPELJIJHZ-RNCFNFMXSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
161898,7bv1,DB00948,-9.1,Mezlocillin,YPBATNHYBCGSSN-VWPFQQQWSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
161918,7bv1,DB00973,-9.1,Ezetimibe,OLNTVTPDXPETLC-XPWALMASSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
161995,7bv1,DB01061,-9.1,Azlocillin,JTWOMNBEOCYFNV-NFFDBFGFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
162031,7bv1,DB01328,-9.1,Cefonicid,DYAIAHUQIPBDIP-AXAPSJFSSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
127848,6w4h,DB06922,-9.1,"2-[(1R)-1-carboxy-2-naphthalen-1-ylethyl]-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylic acid",CZNPWASYMRBJCX-GOSISDBHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
162219,7bv1,DB01573,-9.1,Benzylmorphine,RDJGWRFTDZZXSM-RNWLQCGYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
162244,7bv1,DB01792,-9.1,Adenylyl-3'-5'-Phospho-Uridine-3'-Monophosphate,FZCSEXOMUJFOHQ-KPKSGTNCSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
162355,7bv1,DB01948,-9.1,"1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperidin-4-Yl-3,4-Dihydroquinolin-2(1h)-One",VXIYTVJEIXMAQF-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
162388,7bv1,DB01988,-9.1,6((S)-3-Benzylpiperazin-1-Yl)-3-(Naphthalen-2-Yl)-4-(Pyridin-4-Yl)Pyrazine,WFSFNKVFXLIZIY-MHZLTWQESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
126919,6w4h,DB04477,-9.1,"N-1,2,3,4-Tetrahydronaphth-1-Yl-2'-[3,5-Dimethoxybenzamido]-2'-Deoxy-Adenosine",FDZQGEIYGFPMOB-ZUURFMEUSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
162569,7bv1,DB02432,-9.1,RU90395,RLLAUERCSKPFGD-VMPREFPWSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
127638,6w4h,DB06589,-9.1,Pazopanib,CUIHSIWYWATEQL-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
163512,7bv1,DB04724,-9.1,"(S)-2-((S)-3-ISOBUTYL-2,5-DIOXO-4-QUINOLIN-3-YLMETHYL-[1,4]DIAZEPAN-1YL)-N-METHYL-3-NAPHTALEN-2-YL-PROPIONAMIDE",COVPLULNDBDXTN-KYJUHHDHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
127382,6w4h,DB05608,-9.1,MKC-1,OVSKGTONMLKNPZ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
127357,6w4h,DB05490,-9.1,AMG-131,NMRWDFUZLLQSBN-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
127350,6w4h,DB05454,-9.1,Paliroden,CNEWKIDCGDXBDE-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
127338,6w4h,DB05412,-9.1,Talmapimod,ZMELOYOKMZBMRB-DLBZAZTESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
127279,6w4h,DB05038,-9.1,Anatibant,XUHBBTKJWIBQMY-MHZLTWQESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
127227,6w4h,DB04881,-9.1,Elacridar,OSFCMRGOZNQUSW-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
127222,6w4h,DB04875,-9.1,Pralnacasan,CXAGHAZMQSCAKJ-WAHHBDPQSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
163738,7bv1,DB06178,-9.1,Talotrexin,NYQPLPNEESYGNO-IBGZPJMESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
163768,7bv1,DB06240,-9.1,Tariquidar,LGGHDPFKSSRQNS-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
127135,6w4h,DB04764,-9.1,[4-(3-AMINOMETHYL-PHENYL)-PIPERIDIN-1-YL]-(5-PHENETHYL- PYRIDIN-3-YL)-METHANONE,CCLHROFBSWWOQO-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
163813,7bv1,DB06362,-9.1,Becatecarin,JSKFWUPVIZYJMR-UDOAKELVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
127082,6w4h,DB04689,-9.1,2-{5-[3-(6-BENZOYL-1-PROPYLNAPHTHALEN-2-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID,ZXWVCCFKIRBLDP-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
127674,6w4h,DB06666,-9.1,Lixivaptan,PPHTXRNHTVLQED-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
165966,7bv1,DB13307,-9.1,Proscillaridin,MYEJFUXQJGHEQK-ALRJYLEOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
132027,6w4h,DB15232,-9.1,Telaglenastat,PRAAPINBUWJLGA-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
132146,6w4h,DB02524,-9.1,"2',3'-O-{4-[Hydroxy(oxido)-lambda5-azanylidene]-2,6-dinitro-2,5-cyclohexadiene-1,1-diyl}adenosine 5'-(tetrahydrogen triphosphate)",XFMMHXLUHKBKQE-UHEGPQQHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
138029,6w9c,DB09048,-9.1,Netupitant,WAXQNWCZJDTGBU-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137920,6w9c,DB08896,-9.1,Regorafenib,FNHKPVJBJVTLMP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137884,6w9c,DB08833,-9.1,Taurochenodeoxycholic acid,BHTRKEVKTKCXOH-BJLOMENOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139928,6w9c,DB14581,-9.1,CPI-1205,HPODOLXTMDHLLC-QGZVFWFLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139935,6w9c,DB14625,-9.1,Meprednisone acetate,RZAMUHXEOMZXET-ABQXZQTJSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139977,6w9c,DB14669,-9.1,Betamethasone phosphate,VQODGRNSFPNSQE-DVTGEIKXSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139989,6w9c,DB14681,-9.1,Cortisone,MFYSYFVPBJMHGN-ZPOLXVRWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137648,6w9c,DB08549,-9.1,"(3R)-METHYLCARBAMOYL-7-SULFOAMINO-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLIC ACID BENZYL ESTER",MFDBNNQUDZFSES-KRWDZBQOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140030,6w9c,DB14790,-9.1,BPN-14770,KRRGWHSEDYQKDQ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140037,6w9c,DB14802,-9.1,ONO-2952,ZBQMTQGDBFZUBG-NRFANRHFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137483,6w9c,DB08353,-9.1,"2-(CYCLOHEXYLMETHYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE",NCVMTHVSAJMOPI-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137444,6w9c,DB08305,-9.1,"(3R)-3-cyclopentyl-6-methyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2-benzothiazine 1,1-dioxide",KQAGZLQCEURCKJ-QGZVFWFLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140066,6w9c,DB14876,-9.1,TAS-116,NVVPMZUGELHVMH-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137416,6w9c,DB08268,-9.1,"6-AMINO-4-[2-(4-METHYLPHENYL)ETHYL]-1,7-DIHYDRO-8H-IMIDAZO[4,5-G]QUINAZOLIN-8-ONE",SPVJRTJUEVXOMS-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140166,6w9c,DB15108,-9.1,Tipranavir C-14,SUJUHGSWHZTSEU-MWQIXQBFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137246,6w9c,DB08068,-9.1,N-[4-CHLORO-3-(PYRIDIN-3-YLOXYMETHYL)-PHENYL]-3-FLUORO-,YQJVDUKATDECHF-ICSRJNTNSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137238,6w9c,DB08057,-9.1,"N-(2-chloro-6-methylphenyl)-8-[(3S)-3-methylpiperazin-1-yl]imidazo[1,5-a]quinoxalin-4-amine",VWJPPYCULHDHBB-HNNXBMFYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140177,6w9c,DB15126,-9.1,IMG-7289,KQKBMHGOHXOHTD-KKUQBAQOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137196,6w9c,DB08010,-9.1,"(3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-[(E)-2-phenylethenyl]-1H-indole-2,3-dione 3-oxime",DDHASJXGNUWZTM-ZLEWNXFRSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137165,6w9c,DB07975,-9.1,"2-({[3,5-DIFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)CYCLOPENT-1-ENE-1-CARBOXYLIC ACID",VTGXLCZUWFYELR-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137140,6w9c,DB07946,-9.1,"N-[2-({[amino(imino)methyl]amino}oxy)ethyl]-2-{6-chloro-3-[(2,2-difluoro-2-phenylethyl)amino]-2-fluorophenyl}acetamide",DZEJHPMTDNDECN-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140215,6w9c,DB15362,-9.1,LSZ-102,SJXNPGGVGZXKKI-NYYWCZLTSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137028,6w9c,DB07815,-9.1,GIBBERELLIN A4,RSQSQJNRHICNNH-NFMPGMCNSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136950,6w9c,DB07728,-9.1,"2-[2-(2-FLUOROPHENYL)PYRIDIN-4-YL]-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE",XJJYJNMNYDNXNO-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140275,6w9c,DB02341,-9.1,"Mdl 101,146",XQAMVCHQGHAELT-YPAWHYETSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140407,6w9c,DB06011,-9.1,AMG-222,NVSWJKWHLUTHLP-CPJSRVTESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136621,6w9c,DB07334,-9.1,"N-[5-(ETHYLSULFONYL)-2-METHOXYPHENYL]-5-[3-(2-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-AMINE",HTIZPBXCJPQDEM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136599,6w9c,DB07311,-9.1,"18-CHLORO-11,12,13,14-TETRAHYDRO-1H,10H-8,4-(AZENO)-9,15,1,3,6-BENZODIOXATRIAZACYCLOHEPTADECIN-2-ONE",JRSWWYITYIOHOP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136585,6w9c,DB07296,-9.1,(5Z)-3-(4-CHLOROPHENYL)-4-HYDROXY-5-(1-NAPHTHYLMETHYLENE)FURAN-2(5H)-ONE,PLGHLEBIWUQEPR-PDGQHHTCSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138113,6w9c,DB09195,-9.1,Lorpiprazole,BNRMWKUVWLKDQJ-YJBOKZPZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138172,6w9c,DB09272,-9.1,Eluxadoline,QFNHIDANIVGXPE-FNZWTVRRSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139790,6w9c,DB13991,-9.1,Pipequaline,AMEWZCMTSIONOX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139766,6w9c,DB13947,-9.1,Testosterone enantate benzilic acid hydrazone,PTVXYACXDYZNID-JKXGKYMWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139053,6w9c,DB12776,-9.1,E-6005,BBTFKAOFCSOZMB-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139020,6w9c,DB12721,-9.1,RO-5028442,QZXVLRCMAHJVIP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138989,6w9c,DB12673,-9.1,ATX-914,ALANRBCCCQEPFZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139133,6w9c,DB12904,-9.1,ZSTK-474,HGVNLRPZOWWDKD-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138977,6w9c,DB12659,-9.1,SJ-733,VKCPFWKTFZAOTO-LEWJYISDSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138967,6w9c,DB12644,-9.1,AZD-2066,SXWHYTICXCLKDG-GFCCVEGCSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139166,6w9c,DB12952,-9.1,Methylprednisone,SVYCRJXQZUCUND-PQXSVQADSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139178,6w9c,DB12973,-9.1,Serlopitant,FLNYCRJBCNNHRH-OIYLJQICSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139186,6w9c,DB12986,-9.1,VS-5584,QYBGBLQCOOISAR-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139211,6w9c,DB13126,-9.1,BMS-986115,SRJNRAQUSAVENA-GSHUGGBRSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138872,6w9c,DB12385,-9.1,10-hydroxycamptothecin,HAWSQZCWOQZXHI-FQEVSTJZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138863,6w9c,DB12375,-9.1,Oglemilast,OKFDRAHPFKMAJH-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139246,6w9c,DB13215,-9.1,Sulfobromophthalein,OHTXTCNTQJFRIG-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138843,6w9c,DB12341,-9.1,LY-2456302,ZHPMYDSXGRRERG-DEOSSOPVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136557,6w9c,DB07256,-9.1,"3-({4-[(5-CHLORO-1,3-BENZODIOXOL-4-YL)AMINO]PYRIMIDIN-2-YL}AMINO)BENZAMIDE",ZVQZIVCQLFGXFZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138788,6w9c,DB12269,-9.1,PF-06273340,BPIWZDNVMQQBQX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139381,6w9c,DB13393,-9.1,Emetine,AUVVAXYIELKVAI-CKBKHPSWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138746,6w9c,DB12211,-9.1,PSI-697,DIEPFYNZGUUVHD-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138668,6w9c,DB12096,-9.1,PF-05175157,BDXXSFOJPYSYOC-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138615,6w9c,DB11921,-9.1,Deflazacort,FBHSPRKOSMHSIF-GRMWVWQJSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139657,6w9c,DB13764,-9.1,Monoxerutin,MBHXKZDTQCSVPM-BDAFLREQSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138534,6w9c,DB11804,-9.1,AZD-5672,SCXSQUUTGCWHFU-WJOKGBTCSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138497,6w9c,DB11751,-9.1,Cabotegravir,WCWSTNLSLKSJPK-LKFCYVNXSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139690,6w9c,DB13806,-9.1,Linopirdine,YEJCDKJIEMIWRQ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139718,6w9c,DB13843,-9.1,Cloprednol,YTJIBEDMAQUYSZ-FDNPDPBUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139734,6w9c,DB13865,-9.1,Dehydroemetine,XXLZPUYGHQWHRN-RPBOFIJWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138473,6w9c,DB11712,-9.1,Tezacaftor,MJUVRTYWUMPBTR-MRXNPFEDSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139749,6w9c,DB13919,-9.1,Candesartan,HTQMVQVXFRQIKW-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138421,6w9c,DB11637,-9.1,Delamanid,XDAOLTSRNUSPPH-XMMPIXPASA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138412,6w9c,DB11616,-9.1,Pirarubicin,KMSKQZKKOZQFFG-YXRRJAAWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138774,6w9c,DB12247,-9.1,AZD-4547,VRQMAABPASPXMW-HDICACEKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136527,6w9c,DB07220,-9.1,"N-[5-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-1H-INDAZOL-3-YL]-2-(4-PIPERIDIN-1-YLPHENYL)ACETAMIDE",ZXYIRNXOAJYLCU-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136523,6w9c,DB07216,-9.1,"(11S)-8-CHLORO-11-[1-(METHYLSULFONYL)PIPERIDIN-4-YL]-6-PIPERAZIN-1-YL-11H-BENZO[5,6]CYCLOHEPTA[1,2-B]PYRIDINE",ZMGCFGGMTCMSDP-QHCPKHFHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136462,6w9c,DB07144,-9.1,"5-[(3R)-3-(5-methoxy-2',6'-dimethylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",XZXVRKHUCSXVBM-AWEZNQCLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140756,6w9c,DB15246,-9.1,Salvianolic acid A,YMGFTDKNIWPMGF-UCPJVGPRSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
134509,6w9c,DB03173,-9.1,CRA_10433,CFSQPEBVGUSQII-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
134498,6w9c,DB03159,-9.1,CRA_8696,GAVRMVQHHVMXFD-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
134460,6w9c,DB03104,-9.1,RU82129,NKMPOVPTYDXGEC-MNRBYUMSSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
134442,6w9c,DB03082,-9.1,6-[(Z)-Amino(Imino)Methyl]-N-[4-(Aminomethyl)Phenyl]-4-(Pyrimidin-2-Ylamino)-2-Naphthamide,CSWQJKHBMACTGB-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140767,6w9c,DB15273,-9.1,VS-4718,IGUBBWJDMLCRIK-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
134239,6w9c,DB02812,-9.1,"(2s,4r)-1-Acetyl-N-[(1s)-4-[(Aminoiminomethyl)Amino]-1-(2-Benzothiazolylcarbonyl)Butyl]-4-Hydroxy-2-Pyrrolidinecarboxamide",VXDAVYUFYPFGDX-SNPRPXQTSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
134221,6w9c,DB02723,-9.1,"4-Oxo-2-Phenylmethanesulfonyl-Octahydro-Pyrrolo[1,2-a]Pyrazine-6-Carboxylic Acid [1-(N-Hydroxycarbamimidoyl)-Piperidin-4-Ylmethyl]-Amide",DHTSUHWLPAEEQB-OALUTQOASA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
134116,6w9c,DB02587,-9.1,Colforsin,OHCQJHSOBUTRHG-KGGHGJDLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
134067,6w9c,DB02519,-9.1,Indirubin-5-Sulphonate,IHBOEHLUIBMBMY-YPKPFQOOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
141204,6w9q,DB00619,-9.1,Imatinib,KTUFNOKKBVMGRW-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
133833,6w9c,DB02217,-9.1,Dpb-T,WTZFKHNHHRPQOU-WSMBLCCSSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
133804,6w9c,DB02177,-9.1,1-Acetyl-4-(4-{4-[(2-Ethoxyphenyl)Thio]-3-Nitrophenyl}Pyridin-2-Yl)Piperazine,GKGJFUXSTSUKPB-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
133602,6w9c,DB01908,-9.1,RU85493,MWEWSHNGVWABKG-SVBPBHIXSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
134587,6w9c,DB03268,-9.1,RU82197,WKTQBTSOHBKBRW-VMPREFPWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
133550,6w9c,DB01831,-9.1,Tryptophanyl-5'amp,IFQVDHDRFCKAAW-SQIXAUHQSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
133353,6w9c,DB01573,-9.1,Benzylmorphine,RDJGWRFTDZZXSM-RNWLQCGYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
133205,6w9c,DB01405,-9.1,Temafloxacin,QKDHBVNJCZBTMR-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
133140,6w9c,DB01259,-9.1,Lapatinib,BCFGMOOMADDAQU-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
132972,6w9c,DB01061,-9.1,Azlocillin,JTWOMNBEOCYFNV-NFFDBFGFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
142716,6w9q,DB02555,-9.1,SP4160,VCXMTWSYQSVWRK-AREMUKBSSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
132894,6w9c,DB00972,-9.1,Azelastine,MBUVEWMHONZEQD-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
132861,6w9c,DB00932,-9.1,Tipranavir,SUJUHGSWHZTSEU-FYBSXPHGSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
132594,6w9c,DB00620,-9.1,Triamcinolone,GFNANZIMVAIWHM-OBYCQNJPSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
132582,6w9c,DB00605,-9.1,Sulindac,MLKXDPUZXIRXEP-MFOYZWKCSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
132570,6w9c,DB00590,-9.1,Doxazosin,RUZYUOTYCVRMRZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
144449,6w9q,DB04881,-9.1,Elacridar,OSFCMRGOZNQUSW-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
132482,6w9c,DB00481,-9.1,Raloxifene,GZUITABIAKMVPG-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
132315,6w9c,DB00278,-9.1,Argatroban,KXNPVXPOPUZYGB-IOVMHBDKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
132245,6w9c,DB00197,-9.1,Troglitazone,GXPHKUHSUJUWKP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
133499,6w9c,DB01764,-9.1,Dalfopristin,SUYRLXYYZQTJHF-VMBLUXKRSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
132096,6w4h,DB15367,-9.1,LY-2623091,YPCLDHGBEKZGEB-RUDKWAFVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
134619,6w9c,DB03311,-9.1,"3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid [4-(Thiazol-2-Ylsulfamoyl)-Phenyl]-Amide",SXKBTDJJEQQEGE-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
134869,6w9c,DB03671,-9.1,"4-(3,12,14-Trihydroxy-10,13-Dimethyl-Hexadecahydro-Cyclopenta[a]Phenanthren-17-Yl)-5h-Furan-2-One",SHIBSTMRCDJXLN-KCZCNTNESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136459,6w9c,DB07141,-9.1,"5-[(3R)-3-(5-methoxy-4'-methylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",QVXYJVHNRPNRJL-HNNXBMFYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136399,6w9c,DB07072,-9.1,"(1S,2R,5S)-5-[3-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7(8H)-YL]-2-(2,4,5-TRIFLUOROPHENYL)CYCLOHEXANAMINE",CNKRZILQBKJWDS-WMFXKJRFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140506,6w9c,DB11979,-9.1,Elagolix,HEAUOKZIVMZVQL-VWLOTQADSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136230,6w9c,DB06876,-9.1,"N-{5-[4-(4-METHYLPIPERAZIN-1-YL)PHENYL]-1H-PYRROLO[2,3-B]PYRIDIN-3-YL}NICOTINAMIDE",YJWJKKXGAPWLGT-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136140,6w9c,DB06635,-9.1,Otamixaban,PFGVNLZDWRZPJW-OPAMFIHVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136123,6w9c,DB06605,-9.1,Apixaban,QNZCBYKSOIHPEH-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136101,6w9c,DB06543,-9.1,Astaxanthin,MQZIGYBFDRPAKN-UWFIBFSHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140564,6w9c,DB12459,-9.1,Belotecan,LNHWXBUNXOXMRL-VWLOTQADSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136088,6w9c,DB06518,-9.1,R-1487,KKKRKRMVJRHDMG-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136045,6w9c,DB06409,-9.1,Morphine glucuronide,GNJCUHZOSOYIEC-GAROZEBRSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140568,6w9c,DB12465,-9.1,Ketanserin,FPCCSQOGAWCVBH-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140586,6w9c,DB12491,-9.1,Fasiglifam,BZCALJIHZVNMGJ-HSZRJFAPSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140588,6w9c,DB12494,-9.1,SGI-1776,MHXGEROHKGDZGO-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140606,6w9c,DB12523,-9.1,Mizolastine,PVLJETXTTWAYEW-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
134846,6w9c,DB03642,-9.1,Benzofuran-2-Carboxylic Acid {(S)-3-Methyl-1-[3-Oxo-1-(Pyridin-2-Ylsulfonyl)Azepan-4-Ylcarbamoyl]Butyl}Amide,VBPPNJCVXGAZDD-PMACEKPBSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
135927,6w9c,DB06090,-9.1,Bradanicline,OXKRFEWMSWPKKV-GHTZIAJQSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
135875,6w9c,DB05490,-9.1,AMG-131,NMRWDFUZLLQSBN-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
135797,6w9c,DB05038,-9.1,Anatibant,XUHBBTKJWIBQMY-MHZLTWQESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
135758,6w9c,DB04903,-9.1,Pagoclone,HIUPRQPBWVEQJJ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
135723,6w9c,DB04852,-9.1,Implitapide,AMNXBQPRODZJQR-DITALETJSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140715,6w9c,DB15169,-9.1,H3B-6527,MBWRLLRCTIYXDW-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
135625,6w9c,DB04724,-9.1,"(S)-2-((S)-3-ISOBUTYL-2,5-DIOXO-4-QUINOLIN-3-YLMETHYL-[1,4]DIAZEPAN-1YL)-N-METHYL-3-NAPHTALEN-2-YL-PROPIONAMIDE",COVPLULNDBDXTN-KYJUHHDHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140720,6w9c,DB15186,-9.1,GDC-0084,LGWACEZVCMBSKW-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
135528,6w9c,DB04583,-9.1,"5-Carbamoyl-1,1':4',1''-terphenyl-3-carboxylic acid",LAZPCGBRHLARSI-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
135443,6w9c,DB04477,-9.1,"N-1,2,3,4-Tetrahydronaphth-1-Yl-2'-[3,5-Dimethoxybenzamido]-2'-Deoxy-Adenosine",FDZQGEIYGFPMOB-ZUURFMEUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
135401,6w9c,DB04421,-9.1,Nicotinamide Adenine Dinucleotide 3-Pentanone Adduct,BZJFKYRGSZWSLT-YLIVDTKOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
135143,6w9c,DB04044,-9.1,4-{2-[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid,NAQUAVBNIYTIIS-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
135118,6w9c,DB04006,-9.1,"[2-Amino-6-(2,6-Difluoro-Benzoyl)-Imidazo[1,2-a]Pyridin-3-Yl]-Phenyl-Methanone",WUGJIPFLBOATGL-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140743,6w9c,DB15222,-9.1,GS-6620,YAAQYJCOIFNMKX-RSTNYOGXSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
134924,6w9c,DB03744,-9.1,"Cp403700, (S)-1-{2-[(5-Chloro-1h-Indole-2-Carbonyl)-Amino]-3-Phenyl-Propionyl}-Azetidine-3-Carboxylate",RONLONYAIBUEKT-IBGZPJMESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140625,6w9c,DB12553,-9.1,Fluocinolone,UUOUOERPONYGOS-CLCRDYEYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
166464,7bv1,DB15189,-9.1,Birabresib,GNMUEVRJHCWKTO-FQEVSTJZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
139070,6w9c,DB12805,-9.1,Ataciguat,PQHLRGARXNPFCF-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
166592,7bv1,DB15442,-9.1,Trilaciclib,PDGKHKMBHVFCMG-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
114919,6vxx,DB15408,-9.1,Silmitasertib,MUOKSQABCJCOPU-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114843,6vxx,DB15003,-9.1,PF-06700841,BUWBRTXGQRBBHG-MJBXVCDLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114855,6vxx,DB15281,-9.1,Ravoxertinib,RZUOCXOYPYGSKL-GOSISDBHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114892,6vxx,DB15346,-9.1,GLPG-1205,IRBAWVGZNJIROV-SFHVURJKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
166502,7bv1,DB15257,-9.1,Milademetan,RYAYYVTWKAOAJF-QISPRATLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
140674,6w9c,DB13078,-9.0,KOSN-1724,JAYGOFBXDFAXBW-CYEKYUJNSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
87309,6m3m,DB12135,-9.0,Elubrixin,YQYFEGTYCUQBEI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85286,6m3m,DB07479,-9.0,"(1S)-1,2,3,4-TETRAHYDRO-BENZO[C]PHENANTHRENE-2,3,4-TRIOL",WCUHTHVUZQCBTI-KBAYOESNSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
102538,6vxs,DB07514,-9.0,"3-(2-aminoquinazolin-6-yl)-1-(3,3-dimethylindolin-6-yl)-4-methylpyridin-2(1H)-one",LHLGUOHREUTYTO-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
108341,6vxx,DB07644,-9.0,"5-[(1S)-1-(3-chlorophenyl)ethoxy]quinazoline-2,4-diamine",IDHINEMSCUFEIP-VIFPVBQESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81289,6m3m,DB01025,-9.0,Amlexanox,SGRYPYWGNKJSDL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
95935,6m71,DB12158,-9.0,Filorexant,NPFDWHQSDBWQLH-QZTJIDSGSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
78640,6m2n,DB12055,-9.0,MK-0767,ORZMUVMQJPGFOM-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
95919,6m71,DB12134,-9.0,Gepotidacin,PZFAZQUREQIODZ-LJQANCHMSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
32813,6cs2,T3D3726,-9.0,Aflatrem,YVDJBQQJIDPRKP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
78637,6m2n,DB12050,-9.0,LY-3039478,YCBAQKQAINQRFW-UGSOOPFHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
74044,6m2n,DB02830,-9.0,FR236913,KCCUBLLGAMGDJL-HXUWFJFHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
129149,6w4h,DB08450,-9.0,N-1H-indazol-5-yl-2-(6-methylpyridin-2-yl)quinazolin-4-amine,HNHRWNUXTCATSG-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
95908,6m71,DB12121,-9.0,Entospletinib,XSMSNFMDVXXHGJ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95897,6m71,DB12108,-9.0,Taselisib,BEUQXVWXFDOSAQ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
102565,6vxs,DB07545,-9.0,N-{3-[(4-{[3-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-2-YL)AMINO]PHENYL}CYCLOPROPANECARBOXAMIDE,RDTDWGQDFJPTPD-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
26520,6cs2,DB04669,-9.0,TRIAZOLOPYRIMIDINE,YWBFPKPWMSWWEA-UHFFFAOYSA-O,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
160901,7bv1,DB11891,-9.0,CUDC-907,JOWXJLIFIIOYMS-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
87316,6m3m,DB12147,-9.0,Erdafitinib,OLAHOMJCDNXHFI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
66816,6lxt,DB04685,-9.0,"1-{(2S,5S)-4-FLUORO-5-[(TRITYLOXY)METHYL]TETRAHYDROFURAN-2-YL}PYRIMIDINE-2,4(1H,3H)-DIONE",GJNIPWYJQUGERM-BFLUCZKCSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
27871,6cs2,DB07430,-9.0,"(10R)-10-methyl-3-(6-methylpyridin-3-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one",CMWRPDHVGMHLSZ-GFCCVEGCSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
87304,6m3m,DB12129,-9.0,Tideglusib,PMJIHLSCWIDGMD-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
102410,6vxs,DB07360,-9.0,"1-{5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)ethyl]-1,3-thiazol-2-yl}-3-[3-(trifluoromethyl)phenyl]urea",JJHXPDTVQKWKHA-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
131926,6w4h,DB15036,-9.0,Sitravatinib,WLAVZAAODLTUSW-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
102411,6vxs,DB07362,-9.0,"1-(5-{2-[(1-methyl-1H-pyrazolo[4,3-d]pyrimidin-7-yl)amino]ethyl}-1,3-thiazol-2-yl)-3-[3-(trifluoromethyl)phenyl]urea",UOLCZAFAGDOUFX-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
66567,6lxt,DB04350,-9.0,Argadin,FOZYKTUSOWWQGR-KNPYFFGGSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
111819,6vxx,DB04740,-9.0,MOXALACTAM (HYDROLYZED),ZTOQXKUYWZBJLG-XNAIMREJSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60183,6crv,DB08341,-9.0,"4-{[4-{[(1R,2R)-2-(dimethylamino)cyclopentyl]amino}-5-(trifluoromethyl)pyrimidin-2-yl]amino}-N-methylbenzenesulfonamide",CAUFYHKGKDJMQG-HZPDHXFCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60185,6crv,DB08345,-9.0,"4-(2-(1H-IMIDAZOL-4-YL)ETHYLAMINO)-2-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE",IWUUKHQIKFHWIW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60186,6crv,DB08346,-9.0,"(5Z)-13-CHLORO-14,16-DIHYDROXY-3,4,7,8,9,10-HEXAHYDRO-1H-2-BENZOXACYCLOTETRADECINE-1,11(12H)-DIONE",YUZYDHRGGDTZLG-DUXPYHPUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62816,6crv,DB14217,-9.0,Quinaprilat,FLSLEGPOVLMJMN-YSSFQJQWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85336,6m3m,DB07537,-9.0,"N'-(6-aminopyridin-3-yl)-N-(2-cyclopentylethyl)-4-methyl-benzene-1,3-dicarboxamide",CLEGTVIMOPPIBR-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
96022,6m71,DB12285,-9.0,Verubecestat,YHYKUSGACIYRML-KRWDZBQOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
81247,6m3m,DB00978,-9.0,Lomefloxacin,ZEKZLJVOYLTDKK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
108376,6vxx,DB07688,-9.0,"4-{[5-(CYCLOHEXYLOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE",RPJIMTALCNCQLV-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60195,6crv,DB08355,-9.0,"1-methyl-8-(phenylamino)-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxylic acid",ZOBRPBVIEUWYJR-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
139895,6w9c,DB14214,-9.0,Rose bengal lactone,IICCLYANAQEHCI-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
114925,6vxx,DB15418,-9.0,AZD-9977,MBKYLPOPYYLTNW-ZDUSSCGKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78672,6m2n,DB12101,-9.0,CC-220,IXZOHGPZAQLIBH-NRFANRHFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
81263,6m3m,DB00997,-9.0,Doxorubicin,AOJJSUZBOXZQNB-TZSSRYMLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
66760,6lxt,DB04609,-9.0,INHIBITOR Q8467 OF DUPONT MERCK,HFLCERPZYCWLSZ-VKONIRKNSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
126474,6w4h,DB03878,-9.0,N-[4-Methyl-3-[[4-(3-Pyridinyl)-2-Pyrimidinyl]Amino]Phenyl]-3-Pyridinecarboxamide,YWQVBESSYLICRX-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
78661,6m2n,DB12084,-9.0,ADP-597,WPDCHTSXOPUOII-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
136565,6w9c,DB07265,-9.0,"3-(9-HYDROXY-1,3-DIOXO-4-PHENYL-2,3-DIHYDROPYRROLO[3,4-C]CARBAZOL-6(1H)-YL)PROPANOIC ACID",JDARUOOLJCFUOY-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138049,6w9c,DB09079,-9.0,Nintedanib,XZXHXSATPCNXJR-ZIADKAODSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
128266,6w4h,DB07406,-9.0,"(4R)-N-[4-({[2-(DIMETHYLAMINO)ETHYL]AMINO}CARBONYL)-1,3-THIAZOL-2-YL]-4-METHYL-1-OXO-2,3,4,9-TETRAHYDRO-1H-BETA-CARBOLINE-6-CARBOXAMIDE",QWFFPYQWUWLDBV-NSHDSACASA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
27896,6cs2,DB07456,-9.0,"3-(1H-indol-3-yl)-4-(1-{2-[(2S)-1-methylpyrrolidinyl]ethyl}-1H-indol-3-yl)-1H-pyrrole-2,5-dione",LBFDERUQORUFIN-QGZVFWFLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
160936,7bv1,DB12290,-9.0,Puerarin,HKEAFJYKMMKDOR-VPRICQMDSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
74233,6m2n,DB03082,-9.0,6-[(Z)-Amino(Imino)Methyl]-N-[4-(Aminomethyl)Phenyl]-4-(Pyrimidin-2-Ylamino)-2-Naphthamide,CSWQJKHBMACTGB-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
27839,6cs2,DB07397,-9.0,"(5S)-5-(2-amino-2-oxoethyl)-4-oxo-N-[(3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl)methyl]-3,4,5,6,7,8-hexahydro[1]benzothieno[2,3-d]pyrimidine-2-carboxamide",ITADELAVAWJACR-NSHDSACASA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
62712,6crv,DB13993,-9.0,MRK-409,GOIFCXRIFSYPFG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
95750,6m71,DB11890,-9.0,Cilengitide,AMLYAMJWYAIXIA-VWNVYAMZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
108239,6vxx,DB07265,-9.0,"3-(9-HYDROXY-1,3-DIOXO-4-PHENYL-2,3-DIHYDROPYRROLO[3,4-C]CARBAZOL-6(1H)-YL)PROPANOIC ACID",JDARUOOLJCFUOY-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87399,6m3m,DB12270,-9.0,Losmapimod,KKYABQBFGDZVNQ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
62710,6crv,DB13991,-9.0,Pipequaline,AMEWZCMTSIONOX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
15922,6lzg,DB01908,-9.0,RU85493,MWEWSHNGVWABKG-SVBPBHIXSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
74232,6m2n,DB03081,-9.0,Crc200 (Chiron-Behring),ZOXOKTJHZSUHRJ-XZOQPEGZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
129181,6w4h,DB08490,-9.0,CTS-1027,ROSNVSQTEGHUKU-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
78537,6m2n,DB11901,-9.0,Apalutamide,HJBWBFZLDZWPHF-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
108231,6vxx,DB07256,-9.0,"3-({4-[(5-CHLORO-1,3-BENZODIOXOL-4-YL)AMINO]PYRIMIDIN-2-YL}AMINO)BENZAMIDE",ZVQZIVCQLFGXFZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
71391,6lxt,DB14128,-9.0,Nadide,BAWFJGJZGIEFAR-NNYOXOHSSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
71352,6lxt,DB14054,-9.0,Asiatic acid,JXSVIVRDWWRQRT-UYDOISQJSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
95712,6m71,DB11829,-9.0,Ruboxistaurin,ZCBUQCWBWNUWSU-SFHVURJKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
74289,6m2n,DB03159,-9.0,CRA_8696,GAVRMVQHHVMXFD-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
67126,6lxt,DB05653,-9.0,IRX-5183,PNAWUIKCVQSLFG-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
164060,7bv1,DB07025,-9.0,3-(5-{[4-(AMINOMETHYL)PIPERIDIN-1-YL]METHYL}-1H-INDOL-2-YL)QUINOLIN-2(1H)-ONE,KBIHHEGEALBUMT-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
67137,6lxt,DB05713,-9.0,LY-517717,VYNKVNDKAOGAAQ-RUZDIDTESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
85154,6m3m,DB07323,-9.0,"2-[({2-[(1Z)-3-(DIMETHYLAMINO)PROP-1-ENYL]-4-FLUOROPHENYL}SULFONYL)AMINO]-5,6,7,8-TETRAHYDRONAPHTHALENE-1-CARBOXYLIC ACID",CTZLIARLNXSXGL-ALCCZGGFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
78615,6m2n,DB12015,-9.0,Alpelisib,STUWGJZDJHPWGZ-LBPRGKRZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
85156,6m3m,DB07325,-9.0,N-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)METHYL]-3-{[(E)-(2-OXODIHYDROFURAN-3(2H)-YLIDENE)METHYL]AMINO}BENZENESULFONAMIDE,VCOKUBHAJVTVNG-FMIVXFBMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
128256,6w4h,DB07395,-9.0,"4-[3-(2-Chloro-4,5-difluoro-benzoyl)ureido]-3-trifluoromethoxybenzoic acid",NWQGDIBCFLDHDO-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
85225,6m3m,DB07406,-9.0,"(4R)-N-[4-({[2-(DIMETHYLAMINO)ETHYL]AMINO}CARBONYL)-1,3-THIAZOL-2-YL]-4-METHYL-1-OXO-2,3,4,9-TETRAHYDRO-1H-BETA-CARBOLINE-6-CARBOXAMIDE",QWFFPYQWUWLDBV-NSHDSACASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
60228,6crv,DB08395,-9.0,2-(ETHOXYMETHYL)-4-(4-FLUOROPHENYL)-3-[2-(2-HYDROXYPHENOXY)PYRIMIDIN-4-YL]ISOXAZOL-5(2H)-ONE,ZSOXFJURLPCSOO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
32776,6cs2,T3D3690,-9.0,Ergocryptine,YDOTUXAWKBPQJW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
111971,6vxx,DB04983,-9.0,Denufosol,FPNPSEMJLALQSA-MIYUEGBISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81337,6m3m,DB01081,-9.0,Diphenoxylate,HYPPXZBJBPSRLK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
138079,6w9c,DB09143,-9.0,Sonidegib,VZZJRYRQSPEMTK-CALCHBBNSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
95852,6m71,DB12042,-9.0,Ibodutant,YQYSVMKCMIUCHY-WJOKGBTCSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
67022,6lxt,DB05075,-9.0,TG-100801,JMGXJHWTVBGOKG-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
95848,6m71,DB12036,-9.0,Naquotinib,QKDCLUARMDUUKN-XMMPIXPASA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
87380,6m3m,DB12242,-9.0,AZD-7762,IAYGCINLNONXHY-LBPRGKRZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
164089,7bv1,DB07247,-9.0,"[2'-HYDROXY-3'-(1H-PYRROLO[3,2-C]PYRIDIN-2-YL)-BIPHENYL-3-YLMETHYL]-UREA",SRPOHNDQBDHONJ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
87346,6m3m,DB12194,-9.0,Atamestane,PEPMWUSGRKINHX-TXTPUJOMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
62747,6crv,DB14066,-9.0,Tetrandrine,WVTKBKWTSCPRNU-KYJUHHDHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78585,6m2n,DB11968,-9.0,MK-7145,OCKGFTQIICXDQW-ZEQRLZLVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
112004,6vxx,DB05171,-9.0,E-2012,PUOAETJYKQITMO-LANLRWRYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87377,6m3m,DB12238,-9.0,MK-0777,QKIWQBLNTSQOLY-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
28914,6cs2,DB08538,-9.0,"N-((2-aminopyrimidin-5-yl)methyl)-5-(2,6-difluorophenyl)-3-ethylpyrazolo[1,5-a]pyrimidin-7-amine",HQPVGVSQPQVZLD-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
85188,6m3m,DB07360,-9.0,"1-{5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)ethyl]-1,3-thiazol-2-yl}-3-[3-(trifluoromethyl)phenyl]urea",JJHXPDTVQKWKHA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
23307,6cs2,HMDB0001917,-9.0,Digoxin,LTMHDMANZUZIPE-PUGKRICDSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
158702,7bv1,DB02102,-9.0,DMP450,KYRSNWPSSXSNEP-ZRTHHSRSSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
136556,6w9c,DB07255,-9.0,"N'-(5-CHLORO-1,3-BENZODIOXOL-4-YL)-N-(3-MORPHOLIN-4-YLPHENYL)PYRIMIDINE-2,4-DIAMINE",PNEWIQAEGKQNCE-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
17090,6cs2,HMDB0006224,-9.0,17-beta-Estradiol-3-glucuronide,MUOHJTRCBBDUOW-BFXFFQJBSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
137936,6w9c,DB08922,-9.0,Perospirone,FBVFZWUMDDXLLG-HDICACEKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
62686,6crv,DB13947,-9.0,Testosterone enantate benzilic acid hydrazone,PTVXYACXDYZNID-JKXGKYMWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111312,6vxx,DB03488,-9.0,Uridine-5'-diphosphate-2-deoxy-2-fluoro-alpha-D-galactose,NGTCPFGWXMBZEP-NQQHDEILSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136685,6w9c,DB07410,-9.0,[2-(3-DIBENZOFURAN-4-YL-PHENYL)-1-HYDROXY-1-PHOSPHONO-ETHYL]-PHOSPHONIC ACID,BYVXAUZOTGITQZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
108556,6vxx,DB08391,-9.0,"6,7-DIMETHOXY-4-[(3R)-3-(QUINOXALIN-2-YLOXY)PYRROLIDIN-1-YL]QUINAZOLINE",UBIIFKJMNRPNMT-CQSZACIVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27961,6cs2,DB07528,-9.0,3-(2-aminoquinazolin-6-yl)-4-methyl-1-[3-(trifluoromethyl)phenyl]pyridin-2(1H)-one,HXUZQEYFKAZBPX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
87142,6m3m,DB11893,-9.0,Avagacestat,XEAOPVUAMONVLA-QGZVFWFLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85477,6m3m,DB07707,-9.0,"(9BETA,11ALPHA,13ALPHA,14BETA,17ALPHA)-11-(METHOXYMETHYL)ESTRA-1(10),2,4-TRIENE-3,17-DIOL",LEOPSILMAOYZBO-IUTAEKPZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
132036,6w4h,DB15247,-9.0,Vorolanib,KMIOJWCYOHBUJS-HAKPAVFJSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
85472,6m3m,DB07702,-9.0,17alpha-Estriol,PROQIPRRNZUXQM-PNVOZDDCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
111408,6vxx,DB03830,-9.0,Phosphorylated Dihydropteroate,DNKVHXNVVYQUDC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136697,6w9c,DB07426,-9.0,"[1-HYDROXY-2-(1,1':3',1''-TERPHENYL-3-YLOXY)ETHANE-1,1-DIYL]BIS(PHOSPHONIC ACID)",NWIARQRYIRVYCM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
128306,6w4h,DB07453,-9.0,2-PHENYL-4H-BENZO[H]CHROMEN-4-ONE,VFMMPHCGEFXGIP-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
136672,6w9c,DB07396,-9.0,"1-{2-[3-(2-Chloro-4,5-difluoro-benzoyl)-ureido]-4-fluoro-phenyl}-piperidine-4-carboxylic acid",KAJJGOCSAXKXBD-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
108528,6vxx,DB08094,-9.0,"(4-AMINO-2-{[1-(METHYLSULFONYL)PIPERIDIN-4-YL]AMINO}PYRIMIDIN-5-YL)(2,3-DIFLUORO-6-METHOXYPHENYL)METHANONE",JRNJNYBQQYBCLE-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81131,6m3m,DB00845,-9.0,Clofazimine,WDQPAMHFFCXSNU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
60051,6crv,DB08170,-9.0,"(1R)-N,6-DIHYDROXY-7-METHOXY-2-[(4-METHOXYPHENYL)SULFONYL]-1,2,3,4-TETRAHYDROISOQUINOLINE-1-CARBOXAMIDE",AYFCYVLVRYQGME-QGZVFWFLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78856,6m2n,DB12364,-9.0,Betrixaban,XHOLNRLADUSQLD-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
111495,6vxx,DB03944,-9.0,"5-[1-(3,4-Dimethoxy-Benzoyl)-1,2,3,4-Tetrahydro-Quinolin-6-Yl]-6-Methyl-3,6-Dihydro-[1,3,4]Thiadiazin-2-One",IZLRMTJLQCLMKF-CYBMUJFWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
96408,6m71,DB12877,-9.0,Oxatomide,BAINIUMDFURPJM-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96406,6m71,DB12874,-9.0,Quizartinib,CVWXJKQAOSCOAB-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
62903,6crv,DB14675,-9.0,Temsavir,QRPZBKAMSFHVRW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
129029,6w4h,DB08304,-9.0,"(3R)-3-cyclopentyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2-benzothiazine 1,1-dioxide",QZBQVXXESPXFPZ-QGZVFWFLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
59014,6crv,DB06977,-9.0,(2S)-1-{[5-(1H-Indazol-5-yl)-3-pyridinyl]oxy}-3-(7aH-indol-3-yl)-2-propanamine,CAASENZOSQYNPX-HSTJUUNISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
137805,6w9c,DB08739,-9.0,"2-{3-[(2S)-4,4-difluoro-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]-3-oxopropyl}-isoindole-1,3(2H)-dione",ZSXNPAWXICXNGZ-HNNXBMFYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
87135,6m3m,DB11883,-9.0,SB-705498,JYILLRHXRVTRSH-GFCCVEGCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
33746,6cs2,T3D4995,-9.0,"22,23-dihydroavermectin b1a",AZSNMRSAGSSBNP-XPNPUAGNSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
136718,6w9c,DB07450,-9.0,(R)-minalrestat,BMHZAHGTGIZZCT-LJQANCHMSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
166508,7bv1,DB15269,-9.0,ALK-4290,DWKNOLCXIFYNFV-HSZRJFAPSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
164210,7bv1,DB07382,-9.0,"N-2-1H-benzimidazol-5-yl-N-4-(3-cyclopropyl-1H-pyrazol-5-yl)pyrimidine-2,4-diamine",WJNBSTLIALIIEW-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
108611,6vxx,DB08459,-9.0,"3-chloro-5-[2-chloro-5-(1H-pyrazolo[3,4-b]pyridin-3-ylmethoxy)phenoxy]benzonitrile",SVMHTBVIPYVDIL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78929,6m2n,DB12465,-9.0,Ketanserin,FPCCSQOGAWCVBH-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
27971,6cs2,DB07537,-9.0,"N'-(6-aminopyridin-3-yl)-N-(2-cyclopentylethyl)-4-methyl-benzene-1,3-dicarboxamide",CLEGTVIMOPPIBR-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
85538,6m3m,DB07779,-9.0,N-({(2S)-1-[(3R)-3-AMINO-4-(2-FLUOROPHENYL)BUTANOYL]PYRROLIDIN-2-YL}METHYL)BENZAMIDE,ANQHSFFUNMTTRS-MOPGFXCFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
111205,6vxx,DB03337,-9.0,1-(2-Amidinophenyl)-3-(Phenoxyphenyl)Urea,ZHCAYBOLUMAUQX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
96711,6m71,DB13345,-9.0,Dihydroergocristine,DEQITUUQPICUMR-HJPBWRTMSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
128983,6w4h,DB08242,-9.0,"N,4-dimethyl-3-[(1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl)amino]benzamide",OYTBZXSFNNAVKU-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
59029,6crv,DB06994,-9.0,"(2S,3S)-3-{3-[2-chloro-4-(methylsulfonyl)phenyl]-1,2,4-oxadiazol-5-yl}-1-cyclopentylidene-4-cyclopropyl-1-fluorobutan-2-amine",XCCSSVMRGIQMGF-LPHOPBHVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81039,6m3m,DB00736,-9.0,Esomeprazole,SUBDBMMJDZJVOS-DEOSSOPVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
28732,6cs2,DB00773,-9.0,Etoposide,VJJPUSNTGOMMGY-MRVIYFEKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
60007,6crv,DB08124,-9.0,"3-{[(2,2-DIOXIDO-1,3-DIHYDRO-2-BENZOTHIEN-5-YL)AMINO]METHYLENE}-5-(1,3-OXAZOL-5-YL)-1,3-DIHYDRO-2H-INDOL-2-ONE",FTQYGMLRLRXBPT-IDUWFGFVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85530,6m3m,DB07769,-9.0,S-3-(4-FLUOROPHENOXY)-2-HYDROXY-2-METHYL-N-[4-NITRO-3-(TRIFLUOROMETHYL)PHENYL]PROPANAMIDE,KJMFOTCDISOHDX-INIZCTEOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59028,6crv,DB06993,-9.0,"(2S,3S)-4-cyclopropyl-3-{(3R,5R)-3-[2-fluoro-4-(methylsulfonyl)phenyl]-1,2,4-oxadiazolidin-5-yl}-1-[(3S)-3-fluoropyrrolidin-1-yl]-1-oxobutan-2-amine",PTAHVQJZNFGPHN-WFWWEWPISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
96567,6m71,DB13113,-9.0,JNJ-38877605,JRWCBEOAFGHNNU-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
133362,6w9c,DB01587,-9.0,Ketazolam,PWAJCNITSBZRBL-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
123577,6w4h,DB00136,-9.0,Calcitriol,GMRQFYUYWCNGIN-NKMMMXOESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
128351,6w4h,DB07507,-9.0,"2-(4-hydroxybiphenyl-3-yl)-4-methyl-1H-isoindole-1,3(2H)-dione",ROMNEYAQUBNRLR-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
73801,6m2n,DB02505,-9.0,N-(R-Carboxy-Ethyl)-Alpha-(S)-(2-Phenylethyl),JJVQUUYZGJWBPW-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
111539,6vxx,DB04005,-9.0,Uridine 5'-triphosphate,PGAVKCOVUIYSFO-XVFCMESISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
24080,6cs2,DB01745,-9.0,N-Alpha-(2-Naphthylsulfonyl)-N(3-Amidino-L-Phenylalaninyl)Isopipecolinic Acid Methyl Ester,JJLGQWCKMHPBEB-DEOSSOPVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
85428,6m3m,DB07647,-9.0,"(2R)-1-[(5,6-DIPHENYL-7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)AMINO]PROPAN-2-OL",VBASHTSSQNDDAS-CQSZACIVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87214,6m3m,DB12000,-9.0,Apabetalone,NETXMUIMUZJUTB-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58957,6crv,DB06907,-9.0,"2-(2,6-DICHLOROPHENYL)-1,3-BENZOXAZOLE-6-CARBOXYLIC ACID",XVNRKPCHMYOPPL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87224,6m3m,DB12011,-9.0,Fevipiprant,GFPPXZDRVCSVNR-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
96204,6m71,DB12547,-9.0,LY-2886721,NIDRNVHMMDAAIK-YPMLDQLKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
108448,6vxx,DB08003,-9.0,ISOTHIAZOLIDINONE ANALOG,UILYPHAKDBTKQV-UFYCRDLUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60126,6crv,DB08268,-9.0,"6-AMINO-4-[2-(4-METHYLPHENYL)ETHYL]-1,7-DIHYDRO-8H-IMIDAZO[4,5-G]QUINAZOLIN-8-ONE",SPVJRTJUEVXOMS-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85385,6m3m,DB07596,-9.0,"(17beta)-17-(cyanomethyl)-2-methox1tra-1(10),2,4-trien-3-yl sulfamate",NTSPHKOMJMBWOU-NNKXXINSSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
164135,7bv1,DB07296,-9.0,(5Z)-3-(4-CHLOROPHENYL)-4-HYDROXY-5-(1-NAPHTHYLMETHYLENE)FURAN-2(5H)-ONE,PLGHLEBIWUQEPR-PDGQHHTCSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
111706,6vxx,DB04409,-9.0,Naphthalene Trisulfonate,ZPBSAMLXSQCSOX-UHFFFAOYSA-K,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85373,6m3m,DB07583,-9.0,"(4R,2S)-5'-(4-(4-CHLOROBENZYLOXY)PYRROLIDIN-2-YLMETHANESULFONYL)ISOQUINOLINE",RLNNFNGBXLTQOB-RBUKOAKNSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85363,6m3m,DB07570,-9.0,3-CYCLOHEXYL-1-(2-MORPHOLIN-4-YL-2-OXOETHYL)-2-PHENYL-1H-INDOLE-6-CARBOXYLIC ACID,ZKEZEXYKYHYIMQ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
71600,6lxt,DB14878,-9.0,Liafensine,VCIBGDSRPUOBOG-QFIPXVFZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
108434,6vxx,DB07987,-9.0,"[2-(5-MERCAPTO-[1,3,4]THIADIAZOL-2-YLCARBAMOYL)-1-PHENYL-ETHYL]-CARBAMIC ACID BENZYL ESTER",AWAKNMKLVLWIIQ-OAHLLOKOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
71599,6lxt,DB14876,-9.0,TAS-116,NVVPMZUGELHVMH-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
78751,6m2n,DB12221,-9.0,Canrenone,UJVLDDZCTMKXJK-WNHSNXHDSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
66485,6lxt,DB04238,-9.0,N-Alpha-(2-Naphthylsulfonyl)-N-(3-Amidino-L-Phenylalaninyl)-D-Pipecolinic Acid,GNANSBQAIRJZPA-XZOQPEGZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
87242,6m3m,DB12043,-9.0,Sepetaprost,BKVUSNOUTQMSBE-XCMGCKIWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
78742,6m2n,DB12207,-9.0,Verdinexor,OPAKEJZFFCECPN-XQRVVYSFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
85358,6m3m,DB07563,-9.0,"1-{7-cyclohexyl-6-[4-(4-methylpiperazin-1-yl)benzyl]-7H-pyrrolo[2,3-d]pyrimidin-2-yl}methanamine",GCJSOJRPNOWSEH-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
131943,6w4h,DB15068,-9.0,Agerafenib,DKNUPRMJNUQNHR-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
159022,7bv1,DB03044,-9.0,1-(5-Tert-Butyl-2-P-Tolyl-2h-Pyrazol-3-Yl)-3-[4-(2-Morpholin-4-Yl-Ethoxy)-Naphthalen-1-Yl]-Urea,MVCOAUNKQVWQHZ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
58959,6crv,DB06909,-9.0,"1-ethyl-N-(phenylmethyl)-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridine-5-carboxamide",QZGJNFBMYYEFGM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
139907,6w9c,DB14512,-9.0,Mometasone furoate,WOFMFGQZHJDGCX-ZULDAHANSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
131976,6w4h,DB15133,-9.0,Tepotinib,AHYMHWXQRWRBKT-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131978,6w4h,DB15137,-9.0,VK-2809,LGGPZDRLTDGYSQ-JADSYQMUSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
111545,6vxx,DB04014,-9.0,Alsterpaullone,OLUKILHGKRVDCT-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28790,6cs2,DB08406,-9.0,"[N-(2,4-DIAMINOPTERIDIN-6-YL)-METHYL]-DIBENZ[B,F]AZEPINE",NXCCIJQEAKMFGW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
81145,6m3m,DB00860,-9.0,Prednisolone,OIGNJSKKLXVSLS-VWUMJDOOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
159139,7bv1,DB03476,-9.0,Trans-6-(2-Phenylcyclopropyl)-Naphthalene-2-Carboxamidine,NQRIWXVAIWPBEM-OALUTQOASA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
73814,6m2n,DB02519,-9.0,Indirubin-5-Sulphonate,IHBOEHLUIBMBMY-YPKPFQOOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
108492,6vxx,DB08052,-9.0,"1-cyclopentyl-3-(1H-pyrrolo[2,3-b]pyridin-5-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine",NVRXTLZYXZNATH-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
73841,6m2n,DB02554,-9.0,"Sulfoquinovose-Uridine-C1,5'-Diphosphate",FQANCGQCBCUSMI-JZMIEXBBSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
62892,6crv,DB14664,-9.0,Difluocortolone pivalate,UWGRWFCLGQWKPR-GSTUPEFVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78814,6m2n,DB12302,-9.0,CP-724714,LLVZBTWPGQVVLW-SNAWJCMRSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
133498,6w9c,DB01763,-9.0,7-thionicotinamide-adenine-dinucleotide phosphate,OJNFDOAQUXJWED-NNYOXOHSSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
102259,6vxs,DB07189,-9.0,"(1S,3R,6S)-4-oxo-6-{4-[(2-phenylquinolin-4-yl)methoxy]phenyl}-5-azaspiro[2.4]heptane-1-carboxylic acid",BFZXMIUWGSTUAL-ZSOKXDGFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
60092,6crv,DB08224,-9.0,"(1S,7S,8S,8AR)-1,2,3,7,8,8A-HEXAHYDRO-7-METHYL-8-[2-[(2R,4R)-TETRAHYDRO-4-HY DROXY-6-OXO-2H-PYRAN-2-YL]ETHYL]-1-NAPHTHALENOL",WWSNTLOVYSRDEL-TVKPWXLESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
33075,6cs2,T3D4051,-9.0,Gymnodimine,DVXZVCNEGRKLMW-DCJZOFSYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
87197,6m3m,DB11969,-9.0,Uprosertib,AXTAPYRUEKNRBA-JTQLQIEISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87198,6m3m,DB11971,-9.0,Vilaprisan,JUFWQQVHQFDUOD-ANRPBIDPSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
96297,6m71,DB12693,-9.0,Ritanserin,JUQLTPCYUFPYKE-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
166570,7bv1,DB15399,-9.0,BMS-754807,LQVXSNNAFNGRAH-QHCPKHFHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
108460,6vxx,DB08015,-9.0,"(3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-phenyl-1H-indole-2,3-dione 3-oxime",SZYREAUDQRVVLV-DAFNUICNSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
129073,6w4h,DB08358,-9.0,"2-(2-QUINOLIN-3-YLPYRIDIN-4-YL)-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE",OWFLADWRSCINST-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
136650,6w9c,DB07369,-9.0,"N-(3-chlorophenyl)-N-methyl-2-oxo-3-[(3,4,5-trimethyl-1H-pyrrol-2-yl)methyl]-2H-indole-5-sulfonamide",YMJLSOJLEXWATP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
96261,6m71,DB12640,-9.0,CP-609754,JAHDAIPFBPPQHQ-GDLZYMKVSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
85396,6m3m,DB07612,-9.0,6-(3-AMINOPHENYL)-N-(TERT-BUTYL)-2-(TRIFLUOROMETHYL)QUINAZOLIN-4-AMINE,XQKJVNGGVLHNLA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
160973,7bv1,DB12341,-9.0,LY-2456302,ZHPMYDSXGRRERG-DEOSSOPVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
32334,6cs2,T3D0015,-9.0,"Dibenzo[a,h]anthracene",LHRCREOYAASXPZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
133935,6w9c,DB02360,-9.0,Bis-Napthyl Beta-Ketophosphonic Acid,OFHMUASCSJJNNA-JOCHJYFZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
94806,6m71,DB08553,-9.0,"(1E)-5-(1-piperidin-4-yl-3-pyridin-4-yl-1H-pyrazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime",KWEFZSZCLBHIEQ-YYADALCUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
107929,6vxx,DB05653,-9.0,IRX-5183,PNAWUIKCVQSLFG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112384,6vxx,DB07041,-9.0,"N-[2-(2,4-diaminopyrido[2,3-d]pyrimidin-7-yl)-2-methylpropyl]-4-phenoxybenzamide",FDJWFDQRPKKBFA-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60538,6crv,DB08763,-9.0,[N-(BENZYLOXYCARBONYL)AMINO](4-AMIDINOPHENYL)METHANE-PHOSPHONATE,FSNDLCSOLUMYRH-OAHLLOKOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
70679,6lxt,DB13029,-9.0,MK-0873,JJWKQXNHYDJXKF-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
56278,6crv,DB02115,-9.0,Daidzin,KYQZWONCHDNPDP-QNDFHXLGSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78070,6m2n,DB09219,-9.0,Bisoxatin,BPKUDUSVDVLOPY-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
136401,6w9c,DB07074,-9.0,6-CARBAMIMIDOYL-4-(3-HYDROXY-2-METHYL-BENZOYLAMINO)-NAPHTHALENE-2-CARBOXYLIC ACID METHYL ESTER,OUBRALHIKGRAMA-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
78051,6m2n,DB09199,-9.0,Netoglitazone,PKWDZWYVIHVNKS-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
87671,6m3m,DB12669,-9.0,4SC-203,MAFACRSJGNJHCF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
127004,6w4h,DB04583,-9.0,"5-Carbamoyl-1,1':4',1''-terphenyl-3-carboxylic acid",LAZPCGBRHLARSI-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
14147,6lzg,T3D3766,-9.0,Janthitrem G,PGYSJEQVCATFBQ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
103359,6vxs,DB08487,-9.0,3-({4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-2-OXOPIPERAZIN-1-YL}METHYL)BENZENECARBOXIMIDAMIDE,PRMSFVUWLBPPLY-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
84910,6m3m,DB07045,-9.0,"(2R,3R,4S,5R)-2-[6-amino-8-[(3,4-dichlorophenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol",VBJKVZXRYLCYGQ-XNIJJKJLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
112414,6vxx,DB07076,-9.0,6-[(Z)-AMINO(IMINO)METHYL]-N-[3-(CYCLOPENTYLOXY)PHENYL]-2-NAPHTHAMIDE,FWTQOPWAMQXIMI-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87689,6m3m,DB12696,-9.0,BMS-582949,GDTQLZHHDRRBEB-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
74875,6m2n,DB03944,-9.0,"5-[1-(3,4-Dimethoxy-Benzoyl)-1,2,3,4-Tetrahydro-Quinolin-6-Yl]-6-Methyl-3,6-Dihydro-[1,3,4]Thiadiazin-2-One",IZLRMTJLQCLMKF-CYBMUJFWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
25419,6cs2,DB03336,-9.0,BIA,KVIVJQWOYSWCCZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
87691,6m3m,DB12704,-9.0,Spiradoline,NYKCGQQJNVPOLU-ONTIZHBOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
112422,6vxx,DB07085,-9.0,2-{[N-(2-ACETYL-5-CHLORO-4-FLUOROPHENYL)GLYCYL]AMINO}BENZOIC ACID,LBMZLHCAPBBOFS-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78047,6m2n,DB09195,-9.0,Lorpiprazole,BNRMWKUVWLKDQJ-YJBOKZPZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
107880,6vxx,DB05416,-9.0,Cardarine,YDBLKRPLXZNVNB-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112374,6vxx,DB07031,-9.0,"3-Fluoro-4-{[(2R)-2-hydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthalenyl)acetyl]amino}benzoic acid",AANFHDFOMFRLLR-LJQANCHMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112369,6vxx,DB07026,-9.0,"(1S,5S,7R)-N-7-(BIPHENYL-4-YLMETHYL)-N-3-HYDROXY-6,8-DIOXA-3-AZABICYCLO[3.2.1]OCTANE-3,7-DICARBOXAMIDE",PPLDARNGJSQINK-OKZBNKHCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78291,6m2n,DB11457,-9.0,Rotenone,JUVIOZPCNVVQFO-HBGVWJBISA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
107981,6vxx,DB05983,-9.0,Bardoxolone methyl,WPTTVJLTNAWYAO-KPOXMGGZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81674,6m3m,DB01543,-9.0,18-methyl-19-nortestosterone,FBYZQDCRLYHHHP-ZOFHRBRSSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
134135,6w9c,DB02611,-9.0,Balanol Analog 1,FZJQHARRQUNVGZ-QZTJIDSGSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
60519,6crv,DB08743,-9.0,"2-({8-[(3R)-3-AMINOPIPERIDIN-1-YL]-1,3-DIMETHYL-2,6-DIOXO-1,2,3,6-TETRAHYDRO-7H-PURIN-7-YL}METHYL)BENZONITRILE",XJNKUWDMCBZMTG-OAHLLOKOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
70692,6lxt,DB13053,-9.0,CP-195543,NZQDWKCNBOELAI-KSFYIVLOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
32052,6cs2,DB15269,-9.0,ALK-4290,DWKNOLCXIFYNFV-HSZRJFAPSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
103274,6vxs,DB08384,-9.0,2-({4-[4-(pyridin-4-ylmethyl)-1H-pyrazol-3-yl]phenoxy}methyl)quinoline,RQDDHVVAAJVVKM-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
112346,6vxx,DB06999,-9.0,"N-{3-[(5-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)carbonyl]-2,4-difluorophenyl}propane-1-sulfonamide",YZDJQTHVDDOVHR-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87669,6m3m,DB12666,-9.0,Emapunil,NBMBIEOUVBHEBM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
107958,6vxx,DB05835,-9.0,NS-3728,OQRAKHDEGGGWQO-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84961,6m3m,DB07105,-9.0,2-[2-(4-CHLORO-PHENYLSULFANYL)-ACETYLAMINO]-3-(4-GUANIDINO-PHENYL)-PROPIONAMIDE,IEEYGOJDTRVYGR-HNNXBMFYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
62457,6crv,DB13605,-9.0,Phenoperidine,IPOPQVVNCFQFRK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78168,6m2n,DB09534,-9.0,Ecamsule,HEAHZSUCFKFERC-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138460,6w9c,DB11694,-9.0,Ilorasertib,WPHKIQPVPYJNAX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
103294,6vxs,DB08407,-9.0,PLATENSIMYCIN,CSOMAHTTWTVBFL-OFBLZTNGSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
87666,6m3m,DB12663,-9.0,Letrazuril,XQKYUBTUOHHNDV-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
32041,6cs2,DB15247,-9.0,Vorolanib,KMIOJWCYOHBUJS-HAKPAVFJSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
114799,6vxx,DB14882,-9.0,CEP-9722,CTLOSZHDGZLOQE-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60536,6crv,DB08761,-9.0,"(3S,6S)-3,6-bis(4-hydroxybenzyl)piperazine-2,5-dione",NGPCLOGFGKJCBP-HOTGVXAUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
139752,6w9c,DB13927,-9.0,anle138b,RCQIIBJSUWYYFU-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
87692,6m3m,DB12705,-9.0,Cenerimod,KJKKMMMRWISKRF-FQEVSTJZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
107878,6vxx,DB05412,-9.0,Talmapimod,ZMELOYOKMZBMRB-DLBZAZTESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114664,6vxx,DB14625,-9.0,Meprednisone acetate,RZAMUHXEOMZXET-ABQXZQTJSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87741,6m3m,DB12780,-9.0,Quinfamide,SBJGFIXQRZOVTO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
165684,7bv1,DB12655,-9.0,Patidegib,HZLFFNCLTRVYJG-WWGOJCOQSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94627,6m71,DB08339,-9.0,"6-(2,6-DICHLOROPHENYL)-2-{[3-(HYDROXYMETHYL)PHENYL]AMINO}-8-METHYLPYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE",ZIQFYVPVJZEOFS-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60635,6crv,DB08905,-9.0,Formestane,OSVMTWJCGUFAOD-KZQROQTASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107782,6vxx,DB04608,-9.0,"9-HYDROXY-4-PHENYL-6H-PYRROLO[3,4-C]CARBAZOLE-1,3-DIONE",IAUZTOZLTFSMIE-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
103564,6vxs,DB08731,-9.0,"2-[(1R)-2-carboxy-1-(naphthalen-1-ylmethyl)ethyl]-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylic acid",GPOKTQCDBPECSS-MRXNPFEDSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
81842,6m3m,DB01755,-9.0,N-[Isoleucinyl]-N'-[Adenosyl]-Diaminosufone,XVTRBLLRODNOJV-VBJYJYTRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81850,6m3m,DB01764,-9.0,Dalfopristin,SUYRLXYYZQTJHF-VMBLUXKRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87772,6m3m,DB12833,-9.0,Tandospirone,CEIJFEGBUDEYSX-FZDBZEDMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
139658,6w9c,DB13766,-9.0,Lidoflazine,ZBIAKUMOEKILTF-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
60663,6crv,DB08950,-9.0,Indoramin,JXZZEXZZKAWDSP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138552,6w9c,DB11828,-9.0,Neratinib,JWNPDZNEKVCWMY-VQHVLOKHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
27682,6cs2,DB07237,-9.0,{4-[(2R)-pyrrolidin-2-ylmethoxy]phenyl}(4-thiophen-3-ylphenyl)methanone,VUWFJUJWAWMRQN-HXUWFJFHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
163844,7bv1,DB06454,-9.0,Sarizotan,HKFMQJUJWSFOLY-OAQYLSRUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
130924,6w4h,DB13005,-9.0,Rebastinib,WVXNSAVVKYZVOE-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
31940,6cs2,DB15071,-9.0,Omidenepag isopropyl,VIQCWEGEHRBLAC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
60685,6crv,DB08974,-9.0,Flubendazole,CPEUVMUXAHMANV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58602,6crv,DB06176,-9.0,Romidepsin,OHRURASPPZQGQM-GCCNXGTGSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112569,6vxx,DB07405,-9.0,"1-(6-CYANO-3-PYRIDYLCARBONYL)-5',8'-DIFLUOROSPIRO[PIPERIDINE-4,2'(1'H)-QUINAZOLINE]-4'-AMINE",GIZYIOOBBUHOBS-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84834,6m3m,DB06954,-9.0,"2-(cycloheptylmethyl)-1,1-dioxido-1-benzothiophen-6-yl sulfamate",BIASYWBGUYOWJR-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
686,6lzg,HMDB0006694,-9.0,Difucosyllacto-N-hexaose,SUSQQDGHFAOUBW-PVLJGHBYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
112500,6vxx,DB07324,-9.0,"3-({2-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)ETHYNYL]BENZYL}AMINO)-1,3-OXAZOL-2(3H)-ONE",ZUJWSOPIDUWELP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58613,6crv,DB06199,-9.0,Atrasentan,MOTJMGVDPWRKOC-QPVYNBJUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112497,6vxx,DB07321,-9.0,"2,5-DICHLORO-N-[5-METHOXY-7-(6-METHOXYPYRIDIN-3-YL)-1,3-BENZOXAZOL-2-YL]BENZENESULFONAMIDE",KOKQLKWXOFRTHE-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62406,6crv,DB13534,-9.0,Gedocarnil,SLYDYLLJUXFULK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29061,6cs2,DB08703,-9.0,"12-(2-hydroxyethyl)-2-(1-methylethoxy)-13,14-dihydronaphtho[2,1-a]pyrrolo[3,4-c]carbazol-5(12H)-one",FGKKIHITEICGMN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
77995,6m2n,DB09095,-9.0,Difluocortolone,OGPWIDANBSLJPC-RFPWEZLHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
84883,6m3m,DB07015,-9.0,"(3R,4R)-4-(pyrrolidin-1-ylcarbonyl)-1-(quinoxalin-2-ylcarbonyl)pyrrolidin-3-amine",XDSKICAQKGYYJF-OLZOCXBDSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
62396,6crv,DB13520,-9.0,Metergoline,WZHJKEUHNJHDLS-QTGUNEKASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
32000,6cs2,DB15186,-9.0,GDC-0084,LGWACEZVCMBSKW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
165671,7bv1,DB12635,-9.0,Aleplasinin,HSXLMAFNWCSZGP-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
56314,6crv,DB02166,-9.0,Propidium,ZDWVWKDAWBGPDN-UHFFFAOYSA-O,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84869,6m3m,DB06999,-9.0,"N-{3-[(5-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)carbonyl]-2,4-difluorophenyl}propane-1-sulfonamide",YZDJQTHVDDOVHR-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
103515,6vxs,DB08674,-9.0,"(20S)-19,20,21,22-TETRAHYDRO-19-OXO-5H-18,20-ETHANO-12,14-ETHENO-6,10-METHENO-18H-BENZ[D]IMIDAZO[4,3-K][1,6,9,12]OXATRIAZA-CYCLOOCTADECOSINE-9-CARBONITRILE",USPFJPDEADLGIG-HSZRJFAPSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
134321,6w9c,DB02917,-9.0,N-Hydroxy-4-(Methyl{[5-(2-Pyridinyl)-2-Thienyl]Sulfonyl}Amino)Benzamide,LFGYSFPVLMPUPE-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
103537,6vxs,DB08703,-9.0,"12-(2-hydroxyethyl)-2-(1-methylethoxy)-13,14-dihydronaphtho[2,1-a]pyrrolo[3,4-c]carbazol-5(12H)-one",FGKKIHITEICGMN-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
130991,6w4h,DB13104,-9.0,X-396,ONPGOSVDVDPBCY-CQSZACIVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
161276,7bv1,DB13490,-9.0,Hidrosmin,XYFLWVOTXWXNAM-WTNNCJBMSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
27700,6cs2,DB07255,-9.0,"N'-(5-CHLORO-1,3-BENZODIOXOL-4-YL)-N-(3-MORPHOLIN-4-YLPHENYL)PYRIMIDINE-2,4-DIAMINE",PNEWIQAEGKQNCE-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
60617,6crv,DB08873,-9.0,Boceprevir,LHHCSNFAOIFYRV-DOVBMPENSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81806,6m3m,DB01705,-9.0,Bis(5-Amidino-Benzimidazolyl)Methane,QZKOOEFIMWKZPK-UHFFFAOYSA-Q,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
165680,7bv1,DB12649,-9.0,Ibipinabant,AXJQVVLKUYCICH-OAQYLSRUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
107800,6vxx,DB04632,-9.0,4-(2-HYDROXYBENZYLAMINO)-N-(3-(4-FLUOROPHENOXY)PHENYL)PIPERIDINE-1-SULFONAMIDE,JHHBGNIRSUTQAS-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136393,6w9c,DB07064,-9.0,"(4R)-4-(3-HYDROXYPHENYL)-N,N,7,8-TETRAMETHYL-3,4-DIHYDROISOQUINOLINE-2(1H)-CARBOXAMIDE",HPVCRUIDFODATB-LJQANCHMSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
81812,6m3m,DB01713,-9.0,Udp-Alpha-D-Xylopyranose,DQQDLYVHOTZLOR-OCIMBMBZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
60513,6crv,DB08737,-9.0,"(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-9-OL",FSYFYSFYUHBIHE-GLJUWKHASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85101,6m3m,DB07267,-9.0,2-(6-methylpyridin-2-yl)-N-pyridin-4-ylquinazolin-4-amine,JONFDFIXMPXTRH-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
138422,6w9c,DB11638,-9.0,Artenimol,BJDCWCLMFKKGEE-HVDUHBCDSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
84982,6m3m,DB07127,-9.0,"{4-[2,2-BIS(5-METHYL-1,2,4-OXADIAZOL-3-YL)-3-PHENYLPROPYL]PHENYL}SULFAMIC ACID",SXDBFKLPNPUPRI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
102962,6vxs,DB08010,-9.0,"(3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-[(E)-2-phenylethenyl]-1H-indole-2,3-dione 3-oxime",DDHASJXGNUWZTM-ZLEWNXFRSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
112140,6vxx,DB06410,-9.0,Doxercalciferol,HKXBNHCUPKIYDM-CGMHZMFXSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87461,6m3m,DB12355,-9.0,Netazepide,YDZYKNJZCVIKPP-VWLOTQADSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
95557,6m71,DB11562,-9.0,Bicuculline,IYGYMKDQCDOMRE-ZWKOTPCHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
87477,6m3m,DB12379,-9.0,Indirubin,CRDNMYFJWFXOCH-BUHFOSPRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
32152,6cs2,DB15450,-9.0,PF-05105679,BXNMZRPTQFVRFA-QGZVFWFLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
81515,6m3m,DB01327,-9.0,Cefazolin,MLYYVTUWGNIJIB-BXKDBHETSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
95510,6m71,DB11450,-9.0,Pimobendan,GLBJJMFZWDBELO-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
108139,6vxx,DB07147,-9.0,"methyl (1R,2S)-2-(hydroxycarbamoyl)-1-{4-[(2-methylquinolin-4-yl)methoxy]benzyl}cyclopropanecarboxylate",HJWMYFBKJRVWJY-YKSBVNFPSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
129201,6w4h,DB08512,-9.0,"6-amino-2-[(1-naphthylmethyl)amino]-3,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",MCEZMMDIEXECTI-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
136494,6w9c,DB07181,-9.0,"4'-[(1R)-1-amino-2-(2,5-difluorophenyl)ethyl]biphenyl-3-carboxamide",JYKFWUXBFJJDTP-HXUWFJFHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
108134,6vxx,DB07142,-9.0,"5-[(3R)-3-(5-methoxy-3',5'-dimethylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",ATFDKOLABYIYCC-INIZCTEOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108132,6vxx,DB07140,-9.0,"5-[(3R)-3-(5-methoxybiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",JPENSYBRTSIYGO-AWEZNQCLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
74453,6m2n,DB03367,-9.0,PF-00356231,VMTJQZUZINLEKC-JOCHJYFZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
108130,6vxx,DB07138,-9.0,Neflamapimod,VEPKQEUBKLEPRA-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
95460,6m71,DB11363,-9.0,Alectinib,KDGFLJKFZUIJMX-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
78434,6m2n,DB11751,-9.0,Cabotegravir,WCWSTNLSLKSJPK-LKFCYVNXSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78430,6m2n,DB11745,-9.0,Otenabant,UNAZAADNBYXMIV-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
67292,6lxt,DB06362,-9.0,Becatecarin,JSKFWUPVIZYJMR-UDOAKELVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
56142,6crv,DB01941,-9.0,"6-[1-(3,5,5,8,8-Pentamethyl-5,6,7,8-Tetrahydronaphthalen-2-Yl)Cyclopropyl]Pyridine-3-Carboxylic Acid",SLXTWXQUEZSSTJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
128206,6w4h,DB07334,-9.0,"N-[5-(ETHYLSULFONYL)-2-METHOXYPHENYL]-5-[3-(2-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-AMINE",HTIZPBXCJPQDEM-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
138377,6w9c,DB11511,-9.0,Difloxacin,NOCJXYPHIIZEHN-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
60344,6crv,DB08534,-9.0,"5-(2-fluorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",ZAIYYXVHGBMLEC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60331,6crv,DB08520,-9.0,"(21S)-1AZA-4,4-DIMETHYL-6,19-DIOXA-2,3,7,20-TETRAOXOBICYCLO[19.4.0] PENTACOSANE",VUCSBBBCFXBFFY-IBGZPJMESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108208,6vxx,DB07229,-9.0,"3-{5-[AMINO(IMINIO)METHYL]-1H-INDOL-2-YL}-5-METHOXY-1,1'-BIPHENYL-2-OLATE",MINVOLKUPZPDNX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
123643,6w4h,DB00210,-9.0,Adapalene,LZCDAPDGXCYOEH-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
56049,6crv,DB01810,-9.0,"[1-(1-Methyl-4,5-Dioxo-Pent-2-Enylcarbamoyl)-2-Phenyl-Ethyl]-Carbamic Acid Benzyl Ester",NOXVWFAAXREWMI-GURWAVDKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85085,6m3m,DB07249,-9.0,"N-(5-chloro-1,3-benzodioxol-4-yl)-6-methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-amine",QHIMVPIOWKYPSO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85084,6m3m,DB07248,-9.0,"7-PYRIDIN-2-YL-N-(3,4,5-TRIMETHOXYPHENYL)-7H-PYRROLO[2,3-D]PYRIMIDIN-2-AMINE",YENZSPIOXMNEFF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
102926,6vxs,DB07970,-9.0,5-[(2-methyl-5-{[3-(trifluoromethyl)phenyl]carbamoyl}phenyl)amino]pyridine-3-carboxamide,SAAYRHKJHDIDPH-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
85080,6m3m,DB07244,-9.0,"5-{4-[(3,5-DIFLUOROBENZYL)AMINO]PHENYL}-6-ETHYLPYRIMIDINE-2,4-DIAMINE",SRRWXMSVQYQCRX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
126684,6w4h,DB04158,-9.0,"6-(Adenosine Tetraphosphate-Methyl)-7,8-Dihydropterin",ZKRKFZJAQKKHKL-SUGPNEFASA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
60314,6crv,DB08499,-9.0,"N-[3-(2-fluoroethoxy)phenyl]-N'-(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-6-yl)butanediamide",DQXBKUVWJSZHSI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27806,6cs2,DB07359,-9.0,"3-[(4-fluorophenyl)sulfanyl]-N-(4-methyl-1,3-thiazol-2-yl)-6-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]pyridine-2-carboxamide",SJTQKYKXCYVFHX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
62680,6crv,DB13939,-9.0,RAD-140,XMBUPPIEVAFYHO-KPZWWZAWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
25568,6cs2,DB03523,-9.0,Brequinar,PHEZJEYUWHETKO-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
67211,6lxt,DB06163,-9.0,Plevitrexed,IEJSCSAMMLUINT-NRFANRHFSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
32273,6cs2,DB01251,-9.0,Gliquidone,LLJFMFZYVVLQKT-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
24189,6cs2,DB01873,-9.0,Epothilone D,XOZIUKBZLSUILX-GIQCAXHBSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
32248,6cs2,DB01219,-9.0,Dantrolene,OZOMQRBLCMDCEG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
108173,6vxx,DB07186,-9.0,"4-(4-METHYLPIPERAZIN-1-YL)-N-[5-(2-THIENYLACETYL)-1,5-DIHYDROPYRROLO[3,4-C]PYRAZOL-3-YL]BENZAMIDE",TYYNSDQVFIOSFH-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85075,6m3m,DB07237,-9.0,{4-[(2R)-pyrrolidin-2-ylmethoxy]phenyl}(4-thiophen-3-ylphenyl)methanone,VUWFJUJWAWMRQN-HXUWFJFHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
102936,6vxs,DB07982,-9.0,2-{4-[4-({4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]pyrimidin-2-yl}amino)phenyl]piperazin-1-yl}-2-oxoethanol,PVTKDXZNSUHUMO-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
158493,7bv1,DB01251,-9.0,Gliquidone,LLJFMFZYVVLQKT-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
71190,6lxt,DB13764,-9.0,Monoxerutin,MBHXKZDTQCSVPM-BDAFLREQSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
85048,6m3m,DB07203,-9.0,6-CYCLOHEXYLMETHOXY-2-(3'-CHLOROANILINO) PURINE,OUEGMEMDEAOAEG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
67310,6lxt,DB06420,-9.0,Annamycin,CIDNKDMVSINJCG-GKXONYSUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
7536,6lzg,DB03957,-9.0,SP2456,SSSXBBASYYVGCI-HSZRJFAPSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
81633,6m3m,DB01496,-9.0,Barbituric acid derivative,DNZPLHRZXUJATK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
108035,6vxx,DB06733,-9.0,Bafilomycin A1,XDHNQDDQEHDUTM-JQWOJBOSSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81637,6m3m,DB01500,-9.0,Oxabolone,GXHBCWCMYVTJOW-YGRHGMIBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87571,6m3m,DB12512,-9.0,Verucerfont,VKHVAUKFLBBZFJ-SFHVURJKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
60483,6crv,DB08706,-9.0,"(2S)-({(5Z)-5-[(5-ETHYL-2-FURYL)METHYLENE]-4-OXO-4,5-DIHYDRO-1,3-THIAZOL-2-YL}AMINO)(4-FLUOROPHENYL)ACETIC ACID",RNEACARJKXYVND-MZLJFPOFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78337,6m2n,DB11577,-9.0,Indigotindisulfonic Acid,CFZXDJWFRVEWSR-BUHFOSPRSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
81640,6m3m,DB01503,-9.0,1-Androstenediol,RZFGPAMUAXASRE-YSZCXEEOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
131537,6w4h,DB13874,-9.0,Enasidenib,DYLUUSLLRIQKOE-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
70721,6lxt,DB13095,-9.0,JTK-853,JQLOVYLALGSISI-HXUWFJFHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
87563,6m3m,DB12500,-9.0,Fedratinib,JOOXLOJCABQBSG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
70719,6lxt,DB13093,-9.0,TAK-593,DZFZXPPHBWCXPQ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
165594,7bv1,DB12511,-9.0,Imiglitazar,ULVDFHLHKNJICZ-QCWLDUFUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
81652,6m3m,DB01521,-9.0,Clostebol,KCZCIYZKSLLNNH-FBPKJDBXSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81657,6m3m,DB01526,-9.0,4-Androstenediol,BTTWKVFKBPAFDK-LOVVWNRFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
122045,6w4b,DB12794,-9.0,p-Quaterphenyl,GPRIERYVMZVKTC-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
126869,6w4h,DB04408,-9.0,Ncs-Chromophore,QZGIWPZCWHMVQL-UIYAJPBUSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
81663,6m3m,DB01532,-9.0,??-Methylacetylfentanyl,OKTLVZBUKMRPLL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
14092,6lzg,T3D3709,-9.0,Roridin A,NSFWWJIQIKBZMJ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
131361,6w4h,DB13643,-9.0,Loprazolam,UTEFBSAVJNEPTR-RGEXLXHISA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
87606,6m3m,DB12566,-9.0,Decernotinib,ASUGUQWIHMTFJL-QGZVFWFLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
95079,6m71,DB08901,-9.0,Ponatinib,PHXJVRSECIGDHY-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
114657,6vxx,DB14581,-9.0,CPI-1205,HPODOLXTMDHLLC-QGZVFWFLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
131564,6w4h,DB13950,-9.0,WIN 55212-2,HQVHOQAKMCMIIM-HXUWFJFHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
86199,6m3m,DB08557,-9.0,"2-[(2-methoxyethyl)amino]-4-(4-oxo-1,2,3,4-tetrahydro-9H-carbazol-9-yl)benzamide",XQKFKSJUBJPOLY-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81577,6m3m,DB01431,-9.0,Allylestrenol,ATXHVCQZZJYMCF-XUDSTZEESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
131654,6w4h,DB14128,-9.0,Nadide,BAWFJGJZGIEFAR-NNYOXOHSSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
136456,6w9c,DB07138,-9.0,Neflamapimod,VEPKQEUBKLEPRA-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
32132,6cs2,DB15416,-9.0,PX-102,XBUXXJUEBFDQHD-NHCUHLMSSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
85028,6m3m,DB07180,-9.0,"5-[(Z)-(5-Chloro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-N,2,4-trimethyl-1H-pyrrole-3-carboxamide",FIRPCWHHIWFKCD-GHXNOFRVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
161055,7bv1,DB12808,-9.0,Trifarotene,MFBCDACCJCDGBA-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
87521,6m3m,DB12434,-9.0,Steviolbioside,OMHUCGDTACNQEX-OSHKXICASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
32126,6cs2,DB15408,-9.0,Silmitasertib,MUOKSQABCJCOPU-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
81598,6m3m,DB01456,-9.0,5-androstenedione,SQGZFRITSMYKRH-QAGGRKNESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
74528,6m2n,DB03478,-9.0,2'-O-Acetyl Adenosine-5-Diphosphoribose,BFNOPXRXIQJDHO-DLFWLGJNSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
165571,7bv1,DB12474,-9.0,Lynestrenol,YNVGQYHLRCDXFQ-XGXHKTLJSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
158284,7bv1,DB00820,-9.0,Tadalafil,WOXKDUGGOYFFRN-IIBYNOLFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
87538,6m3m,DB12463,-9.0,Semagacestat,PKXWXXPNHIWQHW-RCBQFDQVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
161071,7bv1,DB12836,-9.0,Grapiprant,HZVLFTCYCLXTGV-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
122105,6w4b,DB12892,-9.0,MGB-BP-3,OEKXCVYZBVOWBR-BQYQJAHWSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
122101,6w4b,DB12886,-9.0,GSK-1521498,WIEDUMBCZQRGSY-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
81615,6m3m,DB01474,-9.0,"17alpha-methyl-3beta,17beta-dihydroxyandrost-4-ene",BNUOCVTVOYWNJC-DTMQFJJTSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136444,6w9c,DB07124,-9.0,"(2S)-1-(6H-INDOL-3-YL)-3-{[5-(7H-PYRAZOLO[3,4-C]PYRIDIN-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE",CCIACUJJBPSOHE-KRWDZBQOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
67397,6lxt,DB06630,-9.0,Anacetrapib,MZZLGJHLQGUVPN-HAWMADMCSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
78367,6m2n,DB11651,-9.0,Dactolisib,JOGKUKXHTYWRGZ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
108045,6vxx,DB06746,-9.0,ginkgolide-J,LMEHVEUFNRJAAV-UKWFQYJJSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
103246,6vxs,DB08349,-9.0,"N-cyclopropyl-3-{[1-(2,4-difluorophenyl)-7-methyl-6-oxo-6,7-dihydro-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}-4-methylbenzamide",WMEYCLAVMZKZCS-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
62945,6crv,DB14774,-9.0,Balipodect,KVHRYLNQDWXAGI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78944,6m2n,DB12483,-9.0,Copanlisib,PZBCKZWLPGJMAO-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
132065,6w4h,DB15305,-9.0,Risdiplam,ASKZRYGFUPSJPN-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
137297,6w9c,DB08124,-9.0,"3-{[(2,2-DIOXIDO-1,3-DIHYDRO-2-BENZOTHIEN-5-YL)AMINO]METHYLENE}-5-(1,3-OXAZOL-5-YL)-1,3-DIHYDRO-2H-INDOL-2-ONE",FTQYGMLRLRXBPT-IDUWFGFVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
109196,6vxx,DB12512,-9.0,Verucerfont,VKHVAUKFLBBZFJ-SFHVURJKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55043,6crv,DB00542,-9.0,Benazepril,XPCFTKFZXHTYIP-PMACEKPBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72536,6m2n,DB00862,-9.0,Vardenafil,SECKRCOLJRRGGV-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
59637,6crv,DB07702,-9.0,17alpha-Estriol,PROQIPRRNZUXQM-PNVOZDDCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59641,6crv,DB07706,-9.0,2-Hydrox1tradiol,DILDHNKDVHLEQB-XSSYPUMDSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
137299,6w9c,DB08126,-9.0,"3-{[4-([AMINO(IMINO)METHYL]AMINOSULFONYL)ANILINO]METHYLENE}-2-OXO-2,3-DIHYDRO-1H-INDOLE",DMCRNUMVSATRTP-LCYFTJDESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
63180,6crv,DB15292,-9.0,Foliglurax,ZTEDNASHAWNBKQ-NCELDCMTSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59285,6crv,DB07287,-9.0,"2-(2,4-DICHLOROPHENOXY)-5-(PYRIDIN-2-YLMETHYL)PHENOL",AOVDSWPGWPRTSR-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
64190,6lxt,DB01167,-9.0,Itraconazole,VHVPQPYKVGDNFY-ZPGVKDDISA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
109188,6vxx,DB12500,-9.0,Fedratinib,JOOXLOJCABQBSG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109900,6vxx,DB00568,-9.0,Cinnarizine,DERZBLKQOCDDDZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79972,6m2n,DB14067,-9.0,Dofequidar,KLWUUPVJTLHYIM-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
109918,6vxx,DB00589,-9.0,Lisuride,BKRGVLQUQGGVSM-KBXCAEBGSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
64199,6lxt,DB01177,-9.0,Idarubicin,XDXDZDZNSLXDNA-TZNDIEGXSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
144338,6w9q,DB04739,-9.0,4-[(4-METHYL-1-PIPERAZINYL)METHYL]-N-[3-[[4-(3-PYRIDINYL)-2-PYRIMIDINYL]AMINO]PHENYL]-BENZAMIDE,JHMBUEWQJDGKGS-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
86021,6m3m,DB08346,-9.0,"(5Z)-13-CHLORO-14,16-DIHYDROXY-3,4,7,8,9,10-HEXAHYDRO-1H-2-BENZOXACYCLOTETRADECINE-1,11(12H)-DIONE",YUZYDHRGGDTZLG-DUXPYHPUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
109183,6vxx,DB12491,-9.0,Fasiglifam,BZCALJIHZVNMGJ-HSZRJFAPSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55016,6crv,DB00502,-9.0,Haloperidol,LNEPOXFFQSENCJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
63171,6crv,DB15275,-9.0,GDC-0077,SGEUNORSOZVTOL-CABZTGNLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59649,6crv,DB07716,-9.0,"(4Z)-2,8:7,12:11,15:14,18:17,22-PENTAANHYDRO-4,5,6,9,10,13,19,20,21-NONADEOXY-D-ARABINO-D-ALLO-D-ALLO-DOCOSA-4,9,20-TRIENITOL",VDRIXSJOPKVWKM-HXGIDPQASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79957,6m2n,DB14037,-9.0,Madecassic acid,PRAUVHZJPXOEIF-AOLYGAPISA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80058,6m2n,DB14542,-9.0,Hydrocortisone phosphate,BGSOJVFOEQLVMH-VWUMJDOOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80414,6m2n,DB15307,-9.0,Atabecestat,VLLFGVHGKLDDLW-SFHVURJKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
132944,6w9c,DB01029,-9.0,Irbesartan,YOSHYTLCDANDAN-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
132945,6w9c,DB01030,-9.0,Topotecan,UCFGDBYHRUNTLO-QHCPKHFHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
28354,6cs2,DB07941,-9.0,PH-797804,KCAJXIDMCNPGHZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
28174,6cs2,DB07756,-9.0,"1-[3-({[(4-AMINO-5-FLUORO-2-METHYLQUINOLIN-3-YL)METHYL]THIO}METHYL)PHENYL]-2,2,2-TRIFLUOROETHANE-1,1-DIOL",GPBGHVRNVGXPNM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
160296,7bv1,DB07978,-9.0,"2-({[2,3,5,6-TETRAFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)CYCLOPENTA-1,3-DIENE-1-CARBOXYLIC ACID",ULMUPVXFUDHRGH-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
80094,6m2n,DB14640,-9.0,Isoflupredone acetate,ZOCUOMKMBMEYQV-GSLJADNHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
59617,6crv,DB07678,-9.0,"(9ALPHA,13BETA,17BETA)-2-[(1Z)-BUT-1-EN-1-YL]ESTRA-1,3,5(10)-TRIENE-3,17-DIOL",ANAMDWGJXBYJEB-OPWFCKQNSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
98706,6vxs,DB01251,-9.0,Gliquidone,LLJFMFZYVVLQKT-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
8077,6lzg,DB04739,-9.0,4-[(4-METHYL-1-PIPERAZINYL)METHYL]-N-[3-[[4-(3-PYRIDINYL)-2-PYRIMIDINYL]AMINO]PHENYL]-BENZAMIDE,JHMBUEWQJDGKGS-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
100721,6vxs,DB03962,-9.0,Nicotinamide 8-Bromo-Adenine Dinucleotide Phosphate,MDKMTCCUJSRQGW-NAJQWHGHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
98666,6vxs,DB01200,-9.0,Bromocriptine,OZVBMTJYIDMWIL-AYFBDAFISA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
160309,7bv1,DB07993,-9.0,"N-3-[3-(1H-INDOL-6-YL)BENZYL]PYRIDINE-2,3-DIAMINE",LPQUIIHPUGDHJK-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
137007,6w9c,DB07793,-9.0,"(2S)-N-[(3S)-1-(2-AMINO-2-OXOETHYL)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL]-2-CHLORO-2H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE",ACSGSLPOHKRZCY-GXTWGEPZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
114637,6vxx,DB13931,-9.0,Netarsudil,OURRXQUGYQRVML-AREMUKBSSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
137285,6w9c,DB08111,-9.0,"4-[(6-phenyl[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl]phenol",ZGJYGQLGSXWEMY-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
109210,6vxx,DB12535,-9.0,AC-430,DCRWIATZWHLIPN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
160317,7bv1,DB08003,-9.0,ISOTHIAZOLIDINONE ANALOG,UILYPHAKDBTKQV-UFYCRDLUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
80068,6m2n,DB14569,-9.0,Tedizolid,XFALPSLJIHVRKE-GFCCVEGCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
109203,6vxx,DB12523,-9.0,Mizolastine,PVLJETXTTWAYEW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80061,6m2n,DB14545,-9.0,Hydrocortisone succinate,VWQWXZAWFPZJDA-CGVGKPPMSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
132990,6w9c,DB01082,-9.0,Streptomycin,UCSJYZPVAKXKNQ-HZYVHMACSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
59273,6crv,DB07274,-9.0,"N-cyclopropyl-6-[(6,7-dimethoxyquinolin-4-yl)oxy]naphthalene-1-carboxamide",ZATGFXTWDKIEKC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
160320,7bv1,DB08006,-9.0,"N-anthracen-2-yl-5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7-amine",OXYDLVAOXASTMW-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
72091,6m2n,DB00324,-9.0,Fluorometholone,FAOZLTXFLGPHNG-KNAQIMQKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137337,6w9c,DB08166,-9.0,"(4R)-7-chloro-9-methyl-1-oxo-1,2,4,9-tetrahydrospiro[beta-carboline-3,4'-piperidine]-4-carbonitrile",LPFQFJAOMCGYCP-GFCCVEGCSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
55517,6crv,DB01095,-9.0,Fluvastatin,FJLGEFLZQAZZCD-JUFISIKESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140124,6w9c,DB15028,-9.0,MK-1064,CKTWQGHVNRYNCM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
72041,6m2n,DB00267,-9.0,Cefmenoxime,HJJDBAOLQAWBMH-YCRCPZNHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
9890,6lzg,DB08022,-9.0,"(2S)-1,3-benzothiazol-2-yl{2-[(2-pyridin-3-ylethyl)amino]pyrimidin-4-yl}ethanenitrile",RCYPVQCPYKNSTG-OAHLLOKOSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
28122,6cs2,DB07700,-9.0,"3-CARBOXAMIDO-1,3,5(10)-ESTRATRIEN-17(R)-SPIRO-2'(5',5'-DIMETHYL-6'OXO)TETRAHYDROPYRAN",YVAJWBACBRSVPR-NDUHRLLKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
128499,6w4h,DB07685,-9.0,"4-{[5-(CYCLOHEXYLMETHOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE",NMAZGYDYIYLSLJ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
85978,6m3m,DB08293,-9.0,"(5E)-12-CHLORO-13,15-DIHYDROXY-4,7,8,9-TETRAHYDRO-2-BENZOXACYCLOTRIDECINE-1,10(3H,11H)-DIONE",AQKZYZQONWDDLS-HNQUOIGGSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
79727,6m2n,DB13667,-9.0,Cefozopran,QDUIJCOKQCCXQY-WHJQOFBOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
136917,6w9c,DB07689,-9.0,"METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE",NYNAFINLHQEHKU-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
110096,6vxx,DB00972,-9.0,Azelastine,MBUVEWMHONZEQD-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
97861,6vxs,DB00251,-9.0,Terconazole,BLSQLHNBWJLIBQ-OZXSUGGESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
136908,6w9c,DB07678,-9.0,"(9ALPHA,13BETA,17BETA)-2-[(1Z)-BUT-1-EN-1-YL]ESTRA-1,3,5(10)-TRIENE-3,17-DIOL",ANAMDWGJXBYJEB-OPWFCKQNSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
166491,7bv1,DB15233,-9.0,Avapritinib,DWYRIWUZIJHQKQ-SANMLTNESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
9873,6lzg,DB08006,-9.0,"N-anthracen-2-yl-5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7-amine",OXYDLVAOXASTMW-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
71982,6m2n,DB00197,-9.0,Troglitazone,GXPHKUHSUJUWKP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
85948,6m3m,DB08250,-9.0,"(5S)-5-(3-AMINOPROPYL)-3-(2,5-DIFLUOROPHENYL)-N-ETHYL-5-PHENYL-4,5-DIHYDRO-1H-PYRAZOLE-1-CARBOXAMIDE",OQMVLDZJPRSNOG-NRFANRHFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
128806,6w4h,DB08036,-9.0,"6,7,12,13-tetrahydro-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazol-5-one",MEXUTNIFSHFQRG-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
140114,6w9c,DB15003,-9.0,PF-06700841,BUWBRTXGQRBBHG-MJBXVCDLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
110144,6vxx,DB01026,-9.0,Ketoconazole,XMAYWYJOQHXEEK-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80536,6m3m,DB00136,-9.0,Calcitriol,GMRQFYUYWCNGIN-NKMMMXOESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
21938,6cs2,HMDB0052458,-9.0,"TG(18:2(9Z,12Z)/20:0/20:2n6)",CYKZBIMIYCZCIP-MRTMRHDRSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
86633,6m3m,DB09169,-9.0,3-Allylfentanyl,BZXKQFFMDLTPJL-LADGPHEKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59696,6crv,DB07770,-9.0,5-(4-FLUOROPHENYL)-3-{[(4-METHYLPHENYL)SULFONYL]AMINO}THIOPHENE-2-CARBOXYLIC ACID,DJPFUQBNQLKCAB-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86575,6m3m,DB09050,-9.0,Ceftolozane,JHFNIHVVXRKLEF-DCZLAGFPSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
114635,6vxx,DB13929,-9.0,Relcovaptan,CEBYCSRFKCEUSW-NAYZPBBASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55475,6crv,DB01047,-9.0,Fluocinonide,WJOHZNCJWYWUJD-IUGZLZTKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
13343,6lzg,DB15189,-9.0,Birabresib,GNMUEVRJHCWKTO-FQEVSTJZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
86020,6m3m,DB08345,-9.0,"4-(2-(1H-IMIDAZOL-4-YL)ETHYLAMINO)-2-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE",IWUUKHQIKFHWIW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
54998,6crv,DB00482,-9.0,Celecoxib,RZEKVGVHFLEQIL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
98235,6vxs,DB00705,-9.0,Delavirdine,WHBIGIKBNXZKFE-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
140249,6w9c,DB15442,-9.0,Trilaciclib,PDGKHKMBHVFCMG-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
128781,6w4h,DB08010,-9.0,"(3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-[(E)-2-phenylethenyl]-1H-indole-2,3-dione 3-oxime",DDHASJXGNUWZTM-ZLEWNXFRSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
80461,6m2n,DB15408,-9.0,Silmitasertib,MUOKSQABCJCOPU-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
26238,6cs2,DB04330,-9.0,Bilh 434,KNRVCCXHLSHTFW-HGPRPZRGSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
86593,6m3m,DB09078,-9.0,Lenvatinib,WOSKHXYHFSIKNG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80467,6m2n,DB15418,-9.0,AZD-9977,MBKYLPOPYYLTNW-ZDUSSCGKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
63157,6crv,DB15242,-9.0,MK-0533,STWITCBWQHTJFJ-XMMPIXPASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59261,6crv,DB07260,-9.0,N-benzyl-4-[(2R)-pyrrolidin-2-ylmethoxy]aniline,HITMFLNAOQIZSN-QGZVFWFLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110009,6vxx,DB00699,-9.0,Nicergoline,YSEXMKHXIOCEJA-FVFQAYNVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110010,6vxx,DB00700,-9.0,Eplerenone,JUKPWJGBANNWMW-VWBFHTRKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109139,6vxx,DB12426,-9.0,Bitopertin,YUUGYIUSCYNSQR-LBPRGKRZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
100935,6vxs,DB04244,-9.0,(2R)-2-(3-Biphenylyl)-N-{(2R)-2-hydroxy-3-[(2-pyridinylsulfonyl)amino]propyl}-4-methylpentanamide,YCDHZDINQZLSRR-DNQXCXABSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
140130,6w9c,DB15036,-9.0,Sitravatinib,WLAVZAAODLTUSW-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
72715,6m2n,DB01067,-9.0,Glipizide,ZJJXGWJIGJFDTL-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
132609,6w9c,DB00637,-9.0,Astemizole,GXDALQBWZGODGZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
64327,6lxt,DB01395,-9.0,Drospirenone,METQSPRSQINEEU-HXCATZOESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
98771,6vxs,DB01395,-9.0,Drospirenone,METQSPRSQINEEU-HXCATZOESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
55408,6crv,DB00969,-9.0,Alosetron,JSWZEAMFRNKZNL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55193,6crv,DB00719,-9.0,Azatadine,SEBMTIQKRHYNIT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109631,6vxx,DB15031,-9.0,Nemorexant,NBGABHGMJVIVBW-QHCPKHFHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109632,6vxx,DB15033,-9.0,Flortaucipir,GETAAWDSFUCLBS-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72249,6m2n,DB00522,-9.0,Bentiromide,SPPTWHFVYKCNNK-FQEVSTJZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
28299,6cs2,DB07879,-9.0,"N-hydroxy-5-[(3-phenyl-5,6-dihydroimidazo[1,2-a]pyrazin-7(8H)-yl)carbonyl]thiophene-2-carboxamide",SMSIXMLQOONOQQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
86313,6m3m,DB08701,-9.0,"2-(3-BROMOPHENYL)-6-[(2-HYDROXYETHYL)AMINO]-1H-BENZO[DE]ISOQUINOLINE-1,3(2H)-DIONE",JZCUVYNOSDWORZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80214,6m2n,DB14882,-9.0,CEP-9722,CTLOSZHDGZLOQE-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
100021,6vxs,DB03020,-9.0,5-Beta-D-Ribofuranosylnicotinamide Adenine Dinucleotide,UINNILASBHZOTM-KMXXXSRASA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
86145,6m3m,DB08495,-9.0,4-({4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-2-OXOPIPERAZIN-1-YL}METHYL)BENZENECARBOXIMIDAMIDE,VXONTEUOQXFJJS-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
99334,6vxs,DB02115,-9.0,Daidzin,KYQZWONCHDNPDP-QNDFHXLGSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
80323,6m2n,DB15132,-9.0,AZD-8165,YUHNXUAATAMVKD-PZJWPPBQSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
160018,7bv1,DB07193,-9.0,"(2R,3R)-7-(methylsulfonyl)-3-(2,4,5-trifluorophenyl)-1,2,3,4-tetrahydropyrido[1,2-a]benzimidazol-2-amine",HJJAYSSCWGUPKO-ABAIWWIYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
140173,6w9c,DB15121,-9.0,AT-001,YRGPAXAVTDMKDK-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
23706,6cs2,HMDB0112261,-9.0,"2',3'-Anhydrolutein",HBHHQQIZEXNSHZ-AJGOZXJMSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
109336,6vxx,DB13089,-9.0,Enoxolone,MPDGHEJMBKOTSU-YKLVYJNSSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86319,6m3m,DB08707,-9.0,"4-[3-(4-chlorophenyl)-2,1-benzisoxazol-5-yl]pyrimidin-2-amine",AQVFETGXIRKVAQ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
160015,7bv1,DB07189,-9.0,"(1S,3R,6S)-4-oxo-6-{4-[(2-phenylquinolin-4-yl)methoxy]phenyl}-5-azaspiro[2.4]heptane-1-carboxylic acid",BFZXMIUWGSTUAL-ZSOKXDGFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
80199,6m2n,DB14856,-9.0,PF-05089771,ZYSCOUXLBXGGIM-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
164711,7bv1,DB08513,-9.0,[4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENYL]ACETIC ACID,PAIQRYUOBBCBSE-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
99197,6vxs,DB01940,-9.0,Balanol Analog 2,SQLYTJZXRRDERK-ISKFKSNPSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
80204,6m2n,DB14866,-9.0,Amcasertib,QDWKGEFGLQMDAM-ULJHMMPZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
55170,6crv,DB00694,-9.0,Daunorubicin,STQGQHZAVUOBTE-VGBVRHCVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
63696,6lxt,DB00590,-9.0,Doxazosin,RUZYUOTYCVRMRZ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
63661,6lxt,DB00549,-9.0,Zafirlukast,YEEZWCHGZNKEEK-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
128609,6w4h,DB07811,-9.0,"N-cyclopropyl-2',6-dimethyl-4'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-3-carboxamide",UBVTVSINEVHYSY-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
99602,6vxs,DB02466,-9.0,"4-[3-Oxo-3-(5,5,8,8-Tetramethyl-5,6,7,8-Tetrahydro-Naphthalen-2-Yl)-Propenyl]-Benzoic Acid",ZXQHMEUGMCXKLO-KPKJPENVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
128624,6w4h,DB07827,-9.0,"4-{[1-METHYL-2,4-DIOXO-6-(3-PHENYLPROP-1-YN-1-YL)-1,4-DIHYDROQUINAZOLIN-3(2H)-YL]METHYL}BENZOIC ACID",FLTYDFYSVZBKOB-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
109498,6vxx,DB13993,-9.0,MRK-409,GOIFCXRIFSYPFG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
132774,6w9c,DB00834,-9.0,Mifepristone,VKHAHZOOUSRJNA-GCNJZUOMSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
80280,6m2n,DB15048,-9.0,Licogliflozin,XFJAMQQAAMJFGB-ZQGJOIPISA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137139,6w9c,DB07945,-9.0,"5-(3-carbamoylbenzyl)-5,6,7,8,9,10-hexahydrocyclohepta[b]indole-4-carboxylic acid",GKBQRPKZHUFGOB-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
99502,6vxs,DB02341,-9.0,"Mdl 101,146",XQAMVCHQGHAELT-YPAWHYETSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
23738,6cs2,DB01342,-9.0,Forasartan,YONOBYIBNBCDSJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
80236,6m2n,DB14929,-9.0,Elsulfavirine,ULTDEARCBRNRGR-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
160055,7bv1,DB07457,-9.0,"3-[1-(3-AMINOPROPYL)-1H-INDOL-3-YL]-4-(1H-INDOL-3-YL)-1H-PYRROLE-2,5-DIONE",APYXQTXFRIDSGE-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
86184,6m3m,DB08539,-9.0,"3-cyclopropyl-5-phenyl-N-(pyridin-3-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",CCDIUVLNHCGSMH-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
160051,7bv1,DB07453,-9.0,2-PHENYL-4H-BENZO[H]CHROMEN-4-ONE,VFMMPHCGEFXGIP-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
86225,6m3m,DB08590,-9.0,1-(3-HYDROXYPROPYL)-2-[(3-NITROBENZOYL)AMINO]-1H-BENZIMIDAZOL-5-YL PIVALATE,CEAYRKIZESVQSN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
26106,6cs2,DB04172,-9.0,"[2,4,6-Triisopropyl-Phenylsulfonyl-L-[3-Amidino-Phenylalanine]]-Piperazine-N'-Beta-Alanine",WATXEHGLYJKXOF-NDEPHWFRSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
86177,6m3m,DB08532,-9.0,"6-(2-fluorophenyl)-N-(pyridin-3-ylmethyl)imidazo[1,2-a]pyrazin-8-amine",WCNPGRRMPFCHEO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80295,6m2n,DB15078,-9.0,Rogaratinib,HNLRRJSKGXOYNO-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
99806,6vxs,DB02732,-9.0,Nicotinamide Adenine Dinucleotide Acetone Adduct,SGHBFOOIAAJJMI-YDKVLQLQSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
13112,6lzg,DB14703,-9.0,Dexamethasone metasulfobenzoate,TWQWRHIQRAZHPR-XNXCGYEVSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
86167,6m3m,DB08521,-9.0,4-[5-(4-FLUORO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-3H-IMIDAZOL-4-YL]-PYRIDINE,CDMGBJANTYXAIV-HHHXNRCGSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
72312,6m2n,DB00596,-9.0,Ulobetasol,LEHFPXVYPMWYQD-XHIJKXOTSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
55165,6crv,DB00689,-9.0,Cephaloglycin,FUBBGQLTSCSAON-PBFPGSCMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
137222,6w9c,DB08037,-9.0,"(2S)-4-(2,5-difluorophenyl)-N-[(3R,4S)-3-fluoro-1-methylpiperidin-4-yl]-2-(hydroxymethyl)-N-methyl-2-phenyl-2,5-dihydro-1H-pyrrole-1-carboxamide",MYBGWENAVMIGMM-GIFXNVAJSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
143221,6w9q,DB03231,-9.0,"3-(5-Amino-7-oxo-3,7-dihydro-2H-[1,2,3]triazolo[4,5-d]pyrimidin-2-yl)-N-(2-{[2-(hydroxymethyl)phenyl]sulfanyl}benzyl)benzamide",IXDQOBDHBWEZOH-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
86099,6m3m,DB08441,-9.0,"6-BROMO-13-THIA-2,4,8,12,19-PENTAAZATRICYCLO[12.3.1.1-3,7-]NONADECA-1(18),3(19),4,6,14,16-HEXAENE 13,13-DIOXIDE",AWSQADBSXFTFKL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86096,6m3m,DB08437,-9.0,Puromycin,RXWNCPJZOCPEPQ-NVWDDTSBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80141,6m2n,DB14717,-9.0,Nitrazolam,OYRPNABWTHDOFK-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
26050,6cs2,DB04107,-9.0,[(1-{2[(4-Carbamimidoyl-Phenylamino)-Methyl]-1-Methyl-1h-Benzoimidazol-5-Yl}-Cyclopropyl)-Pyridin-2-Yl-Methyleneaminooxy]-Acetic Acid Ethyl Ester,RNOYCNIZOAIUSV-LSWMGQQCSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
86442,6m3m,DB08846,-9.0,Ellagic Acid,AFSDNFLWKVMVRB-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
13249,6lzg,DB15011,-9.0,Avacopan,PUKBOVABABRILL-YZNIXAGQSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
59585,6crv,DB07638,-9.0,"(3AS,4R,9BR)-2,2-DIFLUORO-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL",QJSMFUTULGSHNQ-ZOBUZTSGSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
160287,7bv1,DB07969,-9.0,3-[3-(4-methylpiperazin-1-yl)-7-(trifluoromethyl)quinoxalin-5-yl]phenol,QNCYYRHIUFGGJX-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
124469,6w4h,DB01184,-9.0,Domperidone,FGXWKSZFVQUSTL-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
55143,6crv,DB00663,-9.0,Flumethasone,WXURHACBFYSXBI-GQKYHHCASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109740,6vxx,DB15238,-9.0,Olinciguat,YWQFJNWMWZMXRW-HXUWFJFHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59593,6crv,DB07647,-9.0,"(2R)-1-[(5,6-DIPHENYL-7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)AMINO]PROPAN-2-OL",VBASHTSSQNDDAS-CQSZACIVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
13256,6lzg,DB15028,-9.0,MK-1064,CKTWQGHVNRYNCM-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
109746,6vxx,DB15250,-9.0,Vercirnon,JRWROCIMSDXGOZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114758,6vxx,DB14787,-9.0,BMS-830216,YDTUJCNTIMWHPJ-NRFANRHFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
124449,6w4h,DB01162,-9.0,Terazosin,VCKUSRYTPJJLNI-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
59319,6crv,DB07323,-9.0,"2-[({2-[(1Z)-3-(DIMETHYLAMINO)PROP-1-ENYL]-4-FLUOROPHENYL}SULFONYL)AMINO]-5,6,7,8-TETRAHYDRONAPHTHALENE-1-CARBOXYLIC ACID",CTZLIARLNXSXGL-ALCCZGGFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28184,6cs2,DB07765,-9.0,"METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL](METHYL)AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE",UKCFUFHREWUXJJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
86455,6m3m,DB08878,-9.0,Aminopterin,TVZGACDUOSZQKY-LBPRGKRZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
63226,6crv,DB15391,-9.0,Elenbecestat,AACUJFVOHGRMTR-DPXNYUHVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109742,6vxx,DB15242,-9.0,MK-0533,STWITCBWQHTJFJ-XMMPIXPASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72187,6m2n,DB00443,-9.0,Betamethasone,UREBDLICKHMUKA-DVTGEIKXSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137239,6w9c,DB08058,-9.0,"4-[3-(1,4-diazepan-1-ylcarbonyl)-4-fluorobenzyl]phthalazin-1(2H)-one",HGEPGGJUGUMFHT-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
109710,6vxx,DB15189,-9.0,Birabresib,GNMUEVRJHCWKTO-FQEVSTJZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109327,6vxx,DB13074,-9.0,Macimorelin,UJVDJAPJQWZRFR-DHIUTWEWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30008,6cs2,DB11925,-9.0,Vistusertib,JUSFANSTBFGBAF-IRXDYDNUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
72402,6m2n,DB00705,-9.0,Delavirdine,WHBIGIKBNXZKFE-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80185,6m2n,DB14821,-9.0,Macozinone,BJDZBXGJNBMCAV-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
86348,6m3m,DB08737,-9.0,"(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-9-OL",FSYFYSFYUHBIHE-GLJUWKHASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80178,6m2n,DB14795,-9.0,AZD-3759,MXDSJQHFFDGFDK-CYBMUJFWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
72219,6m2n,DB00481,-9.0,Raloxifene,GZUITABIAKMVPG-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
86356,6m3m,DB08745,-9.0,4-[[(1E)-2-(4-CHLOROPHENYL)ETHENYL]SULFONYL]-1-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]PIPERAZINONE,QLHUDNKWOSQSMK-CXUHLZMHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
7309,6lzg,DB03591,-9.0,RU82209,LVZDQVATAQEMCX-NSOVKSMOSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
109316,6vxx,DB13060,-9.0,CEP-37440,BCSHRERPHLTPEE-NRFANRHFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80173,6m2n,DB14787,-9.0,BMS-830216,YDTUJCNTIMWHPJ-NRFANRHFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
86136,6m3m,DB08486,-9.0,Efaproxiral,BNFRJXLZYUTIII-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
100211,6vxs,DB03268,-9.0,RU82197,WKTQBTSOHBKBRW-VMPREFPWSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
80348,6m2n,DB15187,-9.0,Dubermatinib,YUAALFPUEOYPNX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
109700,6vxx,DB15163,-9.0,Selatogrel,FYXHWMQPCJOJCH-GMAHTHKFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
128583,6w4h,DB07783,-9.0,1-((1R)-1-(HYDROXYMETHYL)-3-{6-[(3-PHENYLPROPANOYL)AMINO]-1H-INDOL-1-YL}PROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE,GUYYFMCFEPDDFL-OAQYLSRUSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
109705,6vxx,DB15173,-9.0,JNJ-42165279,YWGYNGCRVZLMCS-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80163,6m2n,DB14766,-9.0,Etrasimod,MVGWUTBTXDYMND-QGZVFWFLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
109707,6vxx,DB15183,-9.0,Fosmanogepix,JQONJQKKVAHONF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28202,6cs2,DB07783,-9.0,1-((1R)-1-(HYDROXYMETHYL)-3-{6-[(3-PHENYLPROPANOYL)AMINO]-1H-INDOL-1-YL}PROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE,GUYYFMCFEPDDFL-OAQYLSRUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
142826,6w9q,DB02704,-9.0,"(2r,3r,4r,5r)-3,4-Dihydroxy-N,N'-Bis[(1s,2r)-2-Hydroxy-2,3-Dihydro-1h-Inden-1-Yl]-2,5-Bis(2-Phenylethyl)Hexanediamide",GQKBYZPVKVXMJL-LAFNQVRVSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
137027,6w9c,DB07814,-9.0,Gibberellic acid,IXORZMNAPKEEDV-OBDJNFEBSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
30101,6cs2,DB12054,-9.0,BQ-123,VYCMAAOURFJIHD-PJNXIOHISA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
125330,6w4h,DB02354,-9.0,4-{[1-Methyl-5-(2-Methyl-Benzoimidazol-1-Ylmethyl)-1h-Benzoimidazol-2-Ylmethyl]-Amino}-Benzamidine,IRKPNOLLMNHSOU-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
109080,6vxx,DB12006,-9.0,BMS-906024,AYOUDDAETNMCBW-GSHUGGBRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110687,6vxx,DB02104,-9.0,"2,4-Diamino-5-Methyl-6-[(3,4,5-Trimethoxy-N-Methylanilino)Methyl]Pyrido[2,3-D]Pyrimidine",PEGMMEYCSOZKIT-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110696,6vxx,DB02115,-9.0,Daidzin,KYQZWONCHDNPDP-QNDFHXLGSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59918,6crv,DB08023,-9.0,"N-cyclohexyl-4-imidazo[1,2-a]pyridin-3-yl-N-methylpyrimidin-2-amine",HYNNWLVWJXWXFO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55691,6crv,DB01340,-9.0,Cilazapril,HHHKFGXWKKUNCY-FHWLQOOXSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
159464,7bv1,DB04452,-9.0,Aminoquinuride,HOUSDILKOJMENG-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97369,6m71,DB14729,-9.0,Rebeccamycin,QEHOIJJIZXRMAN-QZQSLCQPSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
18942,6cs2,HMDB0041742,-9.0,"Hesperetin 3',7-O-diglucuronide",DRQALSJOSDMKCR-HXPBIGRZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
123828,6w4h,DB00430,-9.0,Cefpiramide,PWAUCHMQEXVFJR-PMAPCBKXSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
28645,6cs2,DB08241,-9.0,4-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)--BENZAMIDE,RUUOIINPNMNPIU-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
145402,6w9q,DB07307,-9.0,N-cyclopropyl-4-methyl-3-[1-(2-methylphenyl)phthalazin-6-yl]benzamide,GQXMJOSCBRZMKE-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
123802,6w4h,DB00398,-9.0,Sorafenib,MLDQJTXFUGDVEO-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
59931,6crv,DB08037,-9.0,"(2S)-4-(2,5-difluorophenyl)-N-[(3R,4S)-3-fluoro-1-methylpiperidin-4-yl]-2-(hydroxymethyl)-N-methyl-2-phenyl-2,5-dihydro-1H-pyrrole-1-carboxamide",MYBGWENAVMIGMM-GIFXNVAJSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85657,6m3m,DB07917,-9.0,4-(BENZHYDRYLOXY)-1-[3-(1H-TETRAAZOL-5-YL)PROPYL]PIPERIDINE,TZQGXAHOROZEKN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
137638,6w9c,DB08538,-9.0,"N-((2-aminopyrimidin-5-yl)methyl)-5-(2,6-difluorophenyl)-3-ethylpyrazolo[1,5-a]pyrimidin-7-amine",HQPVGVSQPQVZLD-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
87038,6m3m,DB11741,-9.0,Famitinib,GKEYKDOLBLYGRB-LGMDPLHJSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
160603,7bv1,DB08827,-9.0,Lomitapide,MBBCVAKAJPKAKM-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
164292,7bv1,DB07663,-9.0,"2-[(1R)-1-CARBOXY-2-(4-HYDROXYPHENYL)ETHYL]-1,3-DIOXOISOINDOLINE-5-CARBOXYLIC ACID",QISJEFYTLZTWIQ-CQSZACIVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
108745,6vxx,DB08899,-9.0,Enzalutamide,WXCXUHSOUPDCQV-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
101793,6vxs,DB06519,-9.0,Edaglitazone,HAAXAFNSRADSMK-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101825,6vxs,DB06603,-9.0,Panobinostat,FPOHNWQLNRZRFC-ZHACJKMWSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
110740,6vxx,DB02354,-9.0,4-{[1-Methyl-5-(2-Methyl-Benzoimidazol-1-Ylmethyl)-1h-Benzoimidazol-2-Ylmethyl]-Amino}-Benzamidine,IRKPNOLLMNHSOU-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79064,6m2n,DB12673,-9.0,ATX-914,ALANRBCCCQEPFZ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
128921,6w4h,DB08164,-9.0,"(3R,4R)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN-3-AMINE",GOBIXGZJSMAOFV-QRWLVFNGSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
65336,6lxt,DB02698,-9.0,"N-(M-Trifluoromethylphenyl) Phenoxazine-4,6-Dicarboxylic Acid",NQOOJFXBGLOGTC-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
85716,6m3m,DB07984,-9.0,2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]-n-[(1S)-1-(hydroxymethyl)propyl]acetamide,GKJWXEORYGBJFS-KRWDZBQOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80838,6m3m,DB00490,-9.0,Buspirone,QWCRAEMEVRGPNT-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
97470,6m71,DB14944,-9.0,Tarloxotinib,MUJMYVFVAWFUJL-SNAWJCMRSA-O,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97469,6m71,DB14943,-9.0,LGH-447,VRQXRVAKPDCRCI-ZNMIVQPWSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
108800,6vxx,DB08976,-9.0,Floctafenine,APQPGQGAWABJLN-GFCCVEGCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
159570,7bv1,DB04583,-9.0,"5-Carbamoyl-1,1':4',1''-terphenyl-3-carboxylic acid",LAZPCGBRHLARSI-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
86977,6m3m,DB11650,-9.0,HT-0712,ABEJDMOBAFLQNJ-NHCUHLMSSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
140022,6w9c,DB14770,-9.0,Lanraplenib,XCIGZBVOUQVIPI-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
164311,7bv1,DB07685,-9.0,"4-{[5-(CYCLOHEXYLMETHOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE",NMAZGYDYIYLSLJ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
79138,6m2n,DB12794,-9.0,p-Quaterphenyl,GPRIERYVMZVKTC-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
85702,6m3m,DB07968,-9.0,N-(2-CHLORO-4-FLUOROBENZOYL)-N'-(5-HYDROXY-2-METHOXYPHENYL)UREA,RFOBTYLRURSVJE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
137594,6w9c,DB08489,-9.0,"N4-HYDROXY-2-ISOBUTYL-N1-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.013,18]NONADECA-12(19),13,15,17-TETRAEN-10-YL)-SUCCINAMIDE",GCBPAPVOMPJQHK-NQIIRXRSSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
145300,6w9q,DB07189,-9.0,"(1S,3R,6S)-4-oxo-6-{4-[(2-phenylquinolin-4-yl)methoxy]phenyl}-5-azaspiro[2.4]heptane-1-carboxylic acid",BFZXMIUWGSTUAL-ZSOKXDGFSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
59105,6crv,DB07080,-9.0,"N-(2,2,2-TRIFLUOROETHYL)-N-{4-[2,2,2-TRIFLUORO-1-HYDROXY-1-(TRIFLUOROMETHYL)ETHYL]PHENYL}BENZENESULFONAMIDE",SGIWFELWJPNFDH-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110628,6vxx,DB02030,-9.0,Alpha-Ribazole-5'-Phosphate,ZMRGXEJKZPRBPJ-SYQHCUMBSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
97432,6m71,DB14876,-9.0,TAS-116,NVVPMZUGELHVMH-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
87003,6m3m,DB11687,-9.0,E-6201,MWUFVYLAWAXDHQ-HMNLTAHHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
97418,6m71,DB14850,-9.0,Deleobuvir,BMAIGAHXAJEULY-UKTHLTGXSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
159513,7bv1,DB04514,-9.0,Phosphoric Acid-2'-[2'-Deoxy-Uridine]Ester-5'-Guanosine Ester,DFYLLEBFVZTKHD-VMIOUTBZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
63004,6crv,DB14906,-9.0,Adafosbuvir,NIJYGVDQZBBONK-SEUXLIJBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
9698,6lzg,DB07817,-9.0,"1-{3-[(4-pyridin-2-ylpiperazin-1-yl)sulfonyl]phenyl}-3-(1,3-thiazol-2-yl)urea",NJPVZSIGDRLLTD-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
159361,7bv1,DB04044,-9.0,4-{2-[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid,NAQUAVBNIYTIIS-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
79057,6m2n,DB12665,-9.0,Isoquercetin,OVSQVDMCBVZWGM-QSOFNFLRSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
110851,6vxx,DB02491,-9.0,4-[4-(1-Amino-1-Methylethyl)Phenyl]-5-Chloro-N-[4-(2-Morpholin-4-Ylethyl)Phenyl]Pyrimidin-2-Amine,CJSSYVIHFXDFFC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
97017,6m71,DB13756,-9.0,Peruvoside,PMTSPAGBAFCORP-HBUONDEYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59981,6crv,DB08097,-9.0,"2-(2,6-DIFLUOROPHENOXY)-N-(2-FLUOROPHENYL)-9-ISOPROPYL-9H-PURIN-8-AMINE",OGWSGDLIXOEZJG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87086,6m3m,DB11811,-9.0,Arhalofenate,BJBCSGQLZQGGIQ-QGZVFWFLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59044,6crv,DB07011,-9.0,"(3S)-1-(1,3-BENZODIOXOL-5-YLMETHYL)-3-[4-(1H-IMIDAZOL-1-YL)PHENOXY]PIPERIDINE",HHOPJGKEAIIIDF-FQEVSTJZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59041,6crv,DB07006,-9.0,"9-HYDROXY-6-(3-HYDROXYPROPYL)-4-(2-METHOXYPHENYL)PYRROLO[3,4-C]CARBAZOLE-1,3(2H,6H)-DIONE",AOGOZJCRIFBTTN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
139970,6w9c,DB14662,-9.0,Flunisolide acetate,WEGNFRKBIKYVLC-XTLNBZDDSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
65904,6lxt,DB03460,-9.0,Violaxanthin,SZCBXWMUOPQSOX-WVJDLNGLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
108644,6vxx,DB08497,-9.0,"(1S)-2-oxo-1-phenyl-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate",NKBDSMREMMRFSI-INIZCTEOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
139969,6w9c,DB14661,-9.0,Loperamide oxide,KXVSBTJVTUVNPM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
80991,6m3m,DB00680,-9.0,Moricizine,FUBVWMNBEHXPSU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
73559,6m2n,DB02197,-9.0,"4-[(4-Imidazo[1,2-a]Pyridin-3-Ylpyrimidin-2-Yl)Amino]Benzenesulfonamide",NKORVPQBJCGYEC-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
87105,6m3m,DB11833,-9.0,Basimglurant,UPZWINBEAHDTLA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
101987,6vxs,DB06876,-9.0,"N-{5-[4-(4-METHYLPIPERAZIN-1-YL)PHENYL]-1H-PYRROLO[2,3-B]PYRIDIN-3-YL}NICOTINAMIDE",YJWJKKXGAPWLGT-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
33953,6cs2,T3D0062,-9.0,Benzo[k]fluoranthene,HAXBIWFMXWRORI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
159339,7bv1,DB04011,-9.0,"2'-(4-Dimethylaminophenyl)-5-(4-Methyl-1-Piperazinyl)-2,5'-Bi-Benzimidazole",VMCOQLKKSNQANE-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
108637,6vxx,DB08490,-9.0,CTS-1027,ROSNVSQTEGHUKU-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
160696,7bv1,DB09295,-9.0,Talniflumate,ANMLJLFWUCQGKZ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
132068,6w4h,DB15310,-9.0,Vactosertib,FJCDSQATIJKQKA-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
33943,6cs2,T3D0629,-9.0,Pentacene,SLIUAWYAILUBJU-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
112574,6vxx,DB07410,-9.0,[2-(3-DIBENZOFURAN-4-YL-PHENYL)-1-HYDROXY-1-PHOSPHONO-ETHYL]-PHOSPHONIC ACID,BYVXAUZOTGITQZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
137766,6w9c,DB08698,-9.0,"1-[(3S)-5-PHENYL-3-THIOPHEN-2-YL-3H-1,4-BENZODIAZEPIN-2-YL]AZETIDIN-3-OL",BKSGACYTXOQQNI-OAQYLSRUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
29865,6cs2,DB11740,-9.0,MK-1775,BKWJAKQVGHWELA-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
110977,6vxx,DB02833,-9.0,[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(3-Nitro-Phenyl)-Amine,DYTKVFHLKPDNRW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80984,6m3m,DB00673,-9.0,Aprepitant,ATALOFNDEOCMKK-OITMNORJSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
125840,6w4h,DB03020,-9.0,5-Beta-D-Ribofuranosylnicotinamide Adenine Dinucleotide,UINNILASBHZOTM-KMXXXSRASA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
110857,6vxx,DB02498,-9.0,Carba-Nicotinamide-Adenine-Dinucleotide,DGPLSUKWXXSBCU-VGXGLJSLSA-O,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85606,6m3m,DB07855,-9.0,(S)-1-PHENYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE,CWHMAWBXRCDOEB-HNNXBMFYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
16191,6lzg,DB03104,-9.0,RU82129,NKMPOVPTYDXGEC-MNRBYUMSSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
87061,6m3m,DB11775,-9.0,PF-03758309,AYCPARAPKDAOEN-LJQANCHMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85597,6m3m,DB07844,-9.0,6-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1-BENZOTHIOPHENE-2-SULFONAMIDE,PHLKBODTBJLXRD-WFASDCNBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85589,6m3m,DB07834,-9.0,"N-(cyclopropylmethyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-4-carboxamide",FOHZGCHKLPIBBX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
65736,6lxt,DB03231,-9.0,"3-(5-Amino-7-oxo-3,7-dihydro-2H-[1,2,3]triazolo[4,5-d]pyrimidin-2-yl)-N-(2-{[2-(hydroxymethyl)phenyl]sulfanyl}benzyl)benzamide",IXDQOBDHBWEZOH-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
73419,6m2n,DB02010,-9.0,Staurosporine,HKSZLNNOFSGOKW-FYTWVXJKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
139987,6w9c,DB14679,-9.0,Quingestanol acetate,FLGJKPPXEKYCBY-AKCFYGDASA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
125876,6w4h,DB03072,-9.0,"2-{3-[4-(4-Fluorophenyl)-3,6-Dihydro-1(2h)-Pyridinyl]Propyl}-8-Methyl-4(3h)-Quinazolinone",LOFDUAJQRUYHBR-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
97179,6m71,DB14037,-9.0,Madecassic acid,PRAUVHZJPXOEIF-AOLYGAPISA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
101887,6vxs,DB06717,-9.0,Fosaprepitant,BARDROPHSZEBKC-OITMNORJSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
128965,6w4h,DB08221,-9.0,N-{4-METHYL-3-[(3-PYRIMIDIN-4-YLPYRIDIN-2-YL)AMINO]PHENYL}-3-(TRIFLUOROMETHYL)BENZAMIDE,NESXBRNDMQUVNG-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
59967,6crv,DB08080,-9.0,LATRUNCULIN B,NSHPHXHGRHSMIK-JRIKCGFMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
132117,6w4h,DB15414,-9.0,CM-4307,MLDQJTXFUGDVEO-FIBGUPNXSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
25780,6cs2,DB03791,-9.0,"(3-{3-[[2-Chloro-3-(Trifluoromethyl)Benzyl](2,2-Diphenylethyl)Amino]Propoxy}Phenyl)Acetic Acid",NAXSRXHZFIBFMI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
79000,6m2n,DB12573,-9.0,LY-2452473,IHIWYQYVBNODSV-KRWDZBQOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
73507,6m2n,DB02123,-9.0,Glycochenodeoxycholic Acid,GHCZAUBVMUEKKP-GYPHWSFCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
85568,6m3m,DB07811,-9.0,"N-cyclopropyl-2',6-dimethyl-4'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-3-carboxamide",UBVTVSINEVHYSY-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
110972,6vxx,DB02827,-9.0,"7-(1,1-Dioxo-1h-Benzo[D]Isothiazol-3-Yloxymethyl)-2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Pyran-3-Carboxylic Acid",MDYIGSPVMWSFEZ-JTQLQIEISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80830,6m3m,DB00481,-9.0,Raloxifene,GZUITABIAKMVPG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85933,6m3m,DB08233,-9.0,6-CYCLOHEXYLMETHYLOXY-2-(4'-HYDROXYANILINO)PURINE,RFSDQDHHBKYQOD-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
140034,6w9c,DB14795,-9.0,AZD-3759,MXDSJQHFFDGFDK-CYBMUJFWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
28032,6cs2,DB07605,-9.0,"2-({4-[(5-CHLORO-1H-INDOL-2-YL)SULFONYL]PIPERAZIN-1-YL}CARBONYL)THIENO[3,2-B]PYRIDINE 4-OXIDE",DHDQMXPAANQKDC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
13431,6lzg,DB15343,-9.0,HM-43239,FZLSDZZNPXXBBB-KDURUIRLSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
109055,6vxx,DB11966,-9.0,BMS-986094,YFXGICNMLCGLHJ-RSKRLRQZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72891,6m2n,DB01289,-9.0,Glisoxepide,ZKUDBRCEOBOWLF-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
63110,6crv,DB15151,-9.0,RO-6870810,PKQXLRYFPSZKDU-QFIPXVFZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
164441,7bv1,DB07833,-9.0,"N-(3-cyanophenyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)-4-biphenylcarboxamide",PMMLSQFPBFKLHH-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59790,6crv,DB07874,-9.0,"(6S)-2-amino-6-(3'-methoxybiphenyl-3-yl)-3,6-dimethyl-5,6-dihydropyrimidin-4(3H)-one",LQOCXPOKEPYGTJ-IBGZPJMESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
71864,6lxt,DB15437,-9.0,Rocacetrapib,GBHPDJQHZADVAA-SOKVYYICSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
109045,6vxx,DB11951,-9.0,Lemborexant,MUGXRYIUWFITCP-PGRDOPGGSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
54870,6crv,DB00327,-9.0,Hydromorphone,WVLOADHCBXTIJK-YNHQPCIGSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109058,6vxx,DB11969,-9.0,Uprosertib,AXTAPYRUEKNRBA-JTQLQIEISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
124078,6w4h,DB00734,-9.0,Risperidone,RAPZEAPATHNIPO-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
128824,6w4h,DB08058,-9.0,"4-[3-(1,4-diazepan-1-ylcarbonyl)-4-fluorobenzyl]phthalazin-1(2H)-one",HGEPGGJUGUMFHT-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
80651,6m3m,DB00266,-9.0,Dicoumarol,DOBMPNYZJYQDGZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
55562,6crv,DB01147,-9.0,Cloxacillin,LQOLIRLGBULYKD-JKIFEVAISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72910,6m2n,DB01336,-9.0,Metocurine,JFXBEKISTKFVAB-AJQTZOPKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
64578,6lxt,DB01698,-9.0,Rutin,IKGXIBQEEMLURG-NVPNHPEKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
80660,6m3m,DB00275,-9.0,Olmesartan,VTRAEEWXHOVJFV-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
110310,6vxx,DB01450,-9.0,Dihydroetorphine,BRTSNYPDACNMIP-FAWZKKEFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
54864,6crv,DB00319,-9.0,Piperacillin,IVBHGBMCVLDMKU-GXNBUGAJSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
71854,6lxt,DB15414,-9.0,CM-4307,MLDQJTXFUGDVEO-FIBGUPNXSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
59795,6crv,DB07879,-9.0,"N-hydroxy-5-[(3-phenyl-5,6-dihydroimidazo[1,2-a]pyrazin-7(8H)-yl)carbonyl]thiophene-2-carboxamide",SMSIXMLQOONOQQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55578,6crv,DB01166,-9.0,Cilostazol,RRGUKTPIGVIEKM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80635,6m3m,DB00247,-9.0,Methysergide,KPJZHOPZRAFDTN-NQUBZZJWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80632,6m3m,DB00243,-9.0,Ranolazine,XKLMZUWKNUAPSZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
101272,6vxs,DB04703,-9.0,Hesperidin,QUQPHWDTPGMPEX-QJBIFVCTSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
110162,6vxx,DB01047,-9.0,Fluocinonide,WJOHZNCJWYWUJD-IUGZLZTKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140098,6w9c,DB14937,-9.0,MK-8666,CODQKEMYZZKQAE-QPVYNBJUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
128809,6w4h,DB08039,-9.0,"(3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE",LOGJQOUIVKBFGH-YBEGLDIGSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
86671,6m3m,DB09209,-9.0,Pholcodine,GPFAJKDEDBRFOS-FKQDBXSBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136898,6w9c,DB07666,-9.0,"(3R,4S)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE",OAWGQHXWGXOUKV-BEFAXECRSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
160407,7bv1,DB08349,-9.0,"N-cyclopropyl-3-{[1-(2,4-difluorophenyl)-7-methyl-6-oxo-6,7-dihydro-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}-4-methylbenzamide",WMEYCLAVMZKZCS-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59214,6crv,DB07204,-9.0,"(1S)-1-(1H-INDOL-3-YLMETHYL)-2-(2-PYRIDIN-4-YL-[1,7]NAPHTYRIDIN-5-YLOXY)-EHYLAMINE",DQIXTEDFNFZMCM-SFHVURJKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110183,6vxx,DB01070,-9.0,Dihydrotachysterol,ILYCWAKSDCYMBB-OPCMSESCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140081,6w9c,DB14902,-9.0,JHU-75528 C-11,MCNQUWLLXZZZAC-BJUDXGSMSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
80600,6m3m,DB00206,-9.0,Reserpine,QEVHRUUCFGRFIF-MDEJGZGSSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
64335,6lxt,DB01410,-9.0,Ciclesonide,LUKZNWIVRBCLON-GXOBDPJESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
59209,6crv,DB07198,-9.0,5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-CARBONITRILE,GGEKOZPXKBYLNK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165068,7bv1,DB09195,-9.0,Lorpiprazole,BNRMWKUVWLKDQJ-YJBOKZPZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
133081,6w9c,DB01185,-9.0,Fluoxymesterone,YLRFCQOZQXIBAB-RBZZARIASA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
63137,6crv,DB15206,-9.0,Uprifosbuvir,SFPFZQKYPOWCSI-KHFYHRBSSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85888,6m3m,DB08172,-9.0,(2Z)-N-(3-chloro-2'-methoxybiphenyl-4-yl)-2-cyano-3-hydroxybut-2-enamide,YUDQXOMZBLEWBH-KAMYIIQDSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
110209,6vxx,DB01100,-9.0,Pimozide,YVUQSNJEYSNKRX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
97699,6m71,DB15442,-9.0,Trilaciclib,PDGKHKMBHVFCMG-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
132450,6w9c,DB00443,-9.0,Betamethasone,UREBDLICKHMUKA-DVTGEIKXSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
85913,6m3m,DB08204,-9.0,3-DIPHENOL-6-NITRO-3H-BENZO[DE]ISOCHROMEN-1-ONE,FLWABCQDXUKNQY-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
101447,6vxs,DB04971,-9.0,Reglitazar,QBQLYIISSRXYKL-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
63095,6crv,DB15123,-9.0,Dorzagliatin,HMUMWSORCUWQJO-QAPCUYQASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59181,6crv,DB07167,-9.0,5-CYANO-FURAN-2-CARBOXYLIC ACID [5-HYDROXYMETHYL-2-(4-METHYL-PIPERIDIN-1-YL)-PHENYL]-AMIDE,NNPCFFIJVKYGHR-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85774,6m3m,DB08049,-9.0,"7,8-dihydroxy-4-phenyl-2H-chromen-2-one",JRVIIPJSVKTPBK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
54745,6crv,DB00180,-9.0,Flunisolide,XSFJVAJPIHIPKU-XWCQMRHXSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
137512,6w9c,DB08389,-9.0,"6,7-DIMETHOXY-4-[(3R)-3-(2-NAPHTHYLOXY)PYRROLIDIN-1-YL]QUINAZOLINE",UPTQSRGSSJRBKJ-LJQANCHMSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
80774,6m3m,DB00414,-9.0,Acetohexamide,VGZSUPCWNCWDAN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86928,6m3m,DB11519,-9.0,Fluprostenol,WWSWYXNVCBLWNZ-QIZQQNKQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
63044,6crv,DB15028,-9.0,MK-1064,CKTWQGHVNRYNCM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110475,6vxx,DB01640,-9.0,"(5r)-6-(4-{[2-(3-Iodobenzyl)-3-Oxocyclohex-1-En-1-Yl]Amino}Phenyl)-5-Methyl-4,5-Dihydropyridazin-3(2h)-One",QNURTFDBHAQRSI-OAHLLOKOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
65053,6lxt,DB02336,-9.0,RU83876,WCMLXBUNHNAMNH-UIOOFZCWSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
54724,6crv,DB00158,-9.0,Folic acid,OVBPIULPVIDEAO-LBPRGKRZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
137510,6w9c,DB08387,-9.0,2-{[4-(1-methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline,AZEXWHKOMMASPA-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
13522,6lzg,DB01167,-9.0,Itraconazole,VHVPQPYKVGDNFY-ZPGVKDDISA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
128433,6w4h,DB07608,-9.0,N-(5-{[(2S)-4-amino-2-(3-chlorophenyl)butanoyl]amino}-1H-indazol-3-yl)benzamide,JDGOPNUGILVNJZ-IBGZPJMESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
110508,6vxx,DB01861,-9.0,Uridine diphosphate glucose,HSCJRCZFDFQWRP-JZMIEXBBSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28034,6cs2,DB07608,-9.0,N-(5-{[(2S)-4-amino-2-(3-chlorophenyl)butanoyl]amino}-1H-indazol-3-yl)benzamide,JDGOPNUGILVNJZ-IBGZPJMESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
63029,6crv,DB14987,-9.0,Difamilast,VFBILHPIHUPBPZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108882,6vxx,DB11274,-9.0,Dihydro-alpha-ergocryptine,PBUNVLRHZGSROC-VTIMJTGVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59885,6crv,DB07988,-9.0,"2-[3-(5-MERCAPTO-[1,3,4]THIADIAZOL-2YL)-UREIDO]-N-METHYL-3-PENTAFLUOROPHENYL-PROPIONAMIDE",HZAXNPDJVFUGDS-BYPYZUCNSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85750,6m3m,DB08020,-9.0,"(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-6-(METHOXYMETHYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL",RHQLNMNKTIOREN-AOIWGVFYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
97487,6m71,DB15023,-9.0,BMS-791826,DZBKAUMYTFPJIS-QHCPKHFHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59126,6crv,DB07105,-9.0,2-[2-(4-CHLORO-PHENYLSULFANYL)-ACETYLAMINO]-3-(4-GUANIDINO-PHENYL)-PROPIONAMIDE,IEEYGOJDTRVYGR-HNNXBMFYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165229,7bv1,DB11618,-9.0,Zorubicin,FBTUMDXHSRTGRV-BJISBDEGSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
159653,7bv1,DB05075,-9.0,TG-100801,JMGXJHWTVBGOKG-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
86913,6m3m,DB11478,-9.0,Zeranol,DWTTZBARDOXEAM-GXTWGEPZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
101572,6vxs,DB05667,-9.0,Levoketoconazole,XMAYWYJOQHXEEK-ZEQKJWHPSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
136834,6w9c,DB07588,-9.0,"3,4-DI-1H-INDOL-3-YL-1H-PYRROLE-2,5-DICARBOXYLIC ACID",FZDVNXHYGMEEDT-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
63083,6crv,DB15102,-9.0,Pemigatinib,HCDMJFOHIXMBOV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86821,6m3m,DB11263,-9.0,Polydatin,HSTZMXCBWJGKHG-CUYWLFDKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80710,6m3m,DB00338,-9.0,Omeprazole,SUBDBMMJDZJVOS-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
165166,7bv1,DB11450,-9.0,Pimobendan,GLBJJMFZWDBELO-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
54828,6crv,DB00276,-9.0,Amsacrine,XCPGHVQEEXUHNC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85808,6m3m,DB08087,-9.0,"4-[(7R,7AS)-7-HYDROXY-1,3-DIOXOTETRAHYDRO-1H-PYRROLO[1,2-C]IMIDAZOL-2(3H)-YL]-1-NAPHTHONITRILE",NHBIWLQQJPSMNP-CABCVRRESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80725,6m3m,DB00354,-9.0,Buclizine,MOYGZHXDRJNJEP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86855,6m3m,DB11372,-9.0,Altrenogest,VWAUPFMBXBWEQY-ANULTFPQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
97606,6m71,DB15247,-9.0,Vorolanib,KMIOJWCYOHBUJS-HAKPAVFJSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
140046,6w9c,DB14840,-9.0,Ripretinib,CEFJVGZHQAGLHS-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
101538,6vxs,DB05490,-9.0,AMG-131,NMRWDFUZLLQSBN-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
54796,6crv,DB00240,-9.0,Alclometasone,FJXOGVLKCZQRDN-PHCHRAKRSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
97598,6m71,DB15233,-9.0,Avapritinib,DWYRIWUZIJHQKQ-SANMLTNESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
144882,6w9q,DB06630,-9.0,Anacetrapib,MZZLGJHLQGUVPN-HAWMADMCSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
85781,6m3m,DB08056,-9.0,"N-(2,6-dimethylphenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine",KKYYLKPGILUPOA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
165199,7bv1,DB11526,-9.0,Masitinib,WJEOLQLKVOPQFV-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
85780,6m3m,DB08055,-9.0,"N-(2-chlorophenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine",NNBICZMPIJMWGC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
108963,6vxx,DB11464,-9.0,Sulfaquinoxaline,NHZLNPMOSADWGC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
63060,6crv,DB15056,-9.0,Bifenthrin,OMFRMAHOUUJSGP-IRHGGOMRSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28554,6cs2,DB08143,-9.0,"5-CHLORO-THIOPHENE-2-CARBOXYLIC ACID ((3S,4S)-4-FLUORO- 1-{[2-FLUORO-4-(2-OXO-2H-PYRIDIN-1-YL)-PHENYLCARBAMOYL]-METHYL}-PYRROLIDIN-3-YL)-AMIDE",SXIYSYYSKHUTQQ-RDJZCZTQSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
79202,6m2n,DB12897,-9.0,MK-7622,JUVQLZBJFOGEEO-GOTSBHOMSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138563,6w9c,DB11845,-9.0,Lucitanib,CUDVHEFYRIWYQD-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
109478,6vxx,DB13954,-9.0,Estradiol cypionate,UOACKFBJUYNSLK-XRKIENNPSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104660,6vxs,DB12318,-9.0,BMS-599626,LUJZZYWHBDHDQX-QFIPXVFZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
106182,6vxs,DB15189,-9.0,Birabresib,GNMUEVRJHCWKTO-FQEVSTJZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
106756,6vxx,DB01212,-9.0,Ceftriaxone,VAAUVRVFOQPIGI-SPQHTLEESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
3343,6lzg,HMDB0046148,-9.0,"TG(20:0/20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z))",OSJAITDJSAAPCD-BJFZWASFSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
77122,6m2n,DB08003,-9.0,ISOTHIAZOLIDINONE ANALOG,UILYPHAKDBTKQV-UFYCRDLUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
84112,6m3m,DB04790,-9.0,"2,5-bis-O-{3-[amino(imino)methyl]phenyl}-1,4:3,6-dianhydro-D-glucitol",IBIUTOFGXGGVKQ-XMTFNYHQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
82584,6m3m,DB02732,-9.0,Nicotinamide Adenine Dinucleotide Acetone Adduct,SGHBFOOIAAJJMI-YDKVLQLQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
29350,6cs2,DB09048,-9.0,Netupitant,WAXQNWCZJDTGBU-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
113296,6vxx,DB08770,-9.0,"4-{2-[(7-amino-2-furan-2-yl[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-yl)amino]ethyl}phenol",PWTBZOIUWZOPFT-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88473,6m3m,DB13843,-9.0,Cloprednol,YTJIBEDMAQUYSZ-FDNPDPBUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
61194,6crv,DB11730,-9.0,Ribociclib,RHXHGRAEPCAFML-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
135247,6w9c,DB04177,-9.0,"4-(3,14-Dihydroxy-10,13-Dimethyl-Hexadecahydro-Cyclopenta[a]Phenanthren-17-Yl)-5h-Furan-2-One",XZTUSOXSLKTKJQ-CESUGQOBSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
58355,6crv,DB04885,-9.0,Cilansetron,NCNFDKWULDWJDS-OAHLLOKOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
90564,6m71,DB01908,-9.0,RU85493,MWEWSHNGVWABKG-SVBPBHIXSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
88872,6m3m,DB15011,-9.0,Avacopan,PUKBOVABABRILL-YZNIXAGQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
77100,6m2n,DB07977,-9.0,"3-({[3,5-DIFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)THIOPHENE-2-CARBOXYLIC ACID",CGNHUSCKOHDSMR-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
57400,6crv,DB03622,-9.0,"2-Hydroxy-5-[4-(2-Hydroxy-Ethyl)-Piperidin-1-Yl]-5-Phenyl-1h-Pyrimidine-4,6-Dione",IPBPOBHSNJFRFT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61971,6crv,DB12887,-9.0,Tazemetostat,NSQSAUGJQHDYNO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
83362,6m3m,DB03788,-9.0,GC-24,JYHIGYLGYNCMGI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
30451,6cs2,DB12504,-9.0,JNJ-40346527,BNVPFDRNGHMRJS-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
69235,6lxt,DB08881,-9.0,Vemurafenib,GPXBXXGIAQBQNI-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
118697,6w4b,DB05984,-9.0,RAF-265,YABJJWZLRMPFSI-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
61167,6crv,DB11686,-9.0,Iferanserin,UXIPFQUBOVWAQW-UEBLJOKOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
135674,6w9c,DB04793,-9.0,"1,4:3,6-Dianhydro-2-O-(3-carbamimidoylphenyl)-5-O-(4-carbamimidoylphenyl)-D-glucitol",DKBAWRNTUZFJKV-XMTFNYHQSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
26867,6cs2,DB05608,-9.0,MKC-1,OVSKGTONMLKNPZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
106159,6vxs,DB15137,-9.0,VK-2809,LGGPZDRLTDGYSQ-JADSYQMUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
5937,6lzg,HMDB0112256,-9.0,Lactucaxanthin,BIPAHAFBQLWRMC-SUOWZELTSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
61168,6crv,DB11687,-9.0,E-6201,MWUFVYLAWAXDHQ-HMNLTAHHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84468,6m3m,DB06237,-9.0,Avanafil,WEAJZXNPAWBCOA-INIZCTEOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
61987,6crv,DB12910,-9.0,Emicerfont,JFHJGXQFESYQGY-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113243,6vxx,DB08713,-9.0,"2,6-DIMETHYL-1-(3-[3-METHYL-5-ISOXAZOLYL]-PROPANYL)-4-[2N-METHYL-2H-TETRAZOL-5-YL]-PHENOL",RVZKQTQAFHEOKT-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77154,6m2n,DB08036,-9.0,"6,7,12,13-tetrahydro-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazol-5-one",MEXUTNIFSHFQRG-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
57442,6crv,DB03678,-9.0,"(6,7-Difluoro-Quinazolin-4-Yl)-(1-Methyl-2,2-Diphenyl-Ethyl)-Amine",WVGZKPGUHOZIJQ-HNNXBMFYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
149298,6w9q,DB15328,-9.0,Ubrogepant,DDOOFTLHJSMHLN-ZQHRPCGSSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
88891,6m3m,DB15048,-9.0,Licogliflozin,XFJAMQQAAMJFGB-ZQGJOIPISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
70216,6lxt,DB12318,-9.0,BMS-599626,LUJZZYWHBDHDQX-QFIPXVFZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
138777,6w9c,DB12252,-9.0,PG-701,OKRSVUYYCJPECG-LFGMFVMYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
130182,6w4h,DB11892,-9.0,Prulifloxacin,PWNMXPDKBYZCOO-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
138778,6w9c,DB12253,-9.0,GDC-0810,BURHGPHDEVGCEZ-KJGLQBJMSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
135909,6w9c,DB05667,-9.0,Levoketoconazole,XMAYWYJOQHXEEK-ZEQKJWHPSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
130205,6w4h,DB11922,-9.0,Danirixin,NGYNBSHYFOFVLS-LBPRGKRZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
161583,7bv1,DB00146,-9.0,Calcifediol,JWUBBDSIWDLEOM-DTOXIADCSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
136089,6w9c,DB06519,-9.0,Edaglitazone,HAAXAFNSRADSMK-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
30485,6cs2,DB12550,-9.0,Taladegib,SZBGQDXLNMELTB-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
127859,6w4h,DB06933,-9.0,N-(tert-butyl)-4-[5-(pyridin-2-ylamino)quinolin-3-yl]benzenesulfonamide,GJTCKUKIFXWJKG-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
30878,6cs2,DB13101,-9.0,4SC-202,PRXXYMVLYKJITB-IZZDOVSWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
61233,6crv,DB11786,-9.0,Pefcalcitol,SVCSMAZYWOQCBW-NVJMFHFGSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76528,6m2n,DB07307,-9.0,N-cyclopropyl-4-methyl-3-[1-(2-methylphenyl)phthalazin-6-yl]benzamide,GQXMJOSCBRZMKE-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
106215,6vxs,DB15245,-9.0,Olorofim,SUFPWYYDCOKDLL-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
61456,6crv,DB12113,-9.0,CE-224535,FUCKCIVGBCBZNP-MRXNPFEDSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30509,6cs2,DB12579,-9.0,JNJ-37822681,UVUYWJWYRLJHEN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
92782,6m71,DB04862,-9.0,Merimepodib,JBPUGFODGPKTDW-SFHVURJKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
130521,6w4h,DB12382,-9.0,R-306465,MUTBJZVSRNUIHA-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
90829,6m71,DB02259,-9.0,"3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid (4-Sulfamoyl-Phenyl)-Amide",VSYGXLAJQDAWCZ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
84384,6m3m,DB05884,-9.0,HCV-086,VBRUONUESYTIDA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
105040,6vxs,DB12903,-9.0,DEBIO-1347,BEMNJULZEQTDJY-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
130198,6w4h,DB11912,-9.0,Lanopepden,SWHNZGMQMGFQGW-MSOLQXFVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
113377,6vxx,DB09076,-9.0,Umeclidinium,FVTWTVQXNAJTQP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140558,6w9c,DB12447,-9.0,Nadifloxacin,JYJTVFIEFKZWCJ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
147574,6w9q,DB12138,-9.0,PF-03715455,VGEXRDWWPSGZDH-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
75704,6m2n,DB05482,-9.0,7-ethyl-10-hydroxycamptothecin,FJHBVJOVLFPMQE-QFIPXVFZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
29369,6cs2,DB09076,-9.0,Umeclidinium,FVTWTVQXNAJTQP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
61776,6crv,DB12573,-9.0,LY-2452473,IHIWYQYVBNODSV-KRWDZBQOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57386,6crv,DB03598,-9.0,"Al-6629, [2h-Thieno[3,2-E]-1,2-Thiazine-6-Sulfonamide,2-(3-Methoxyphenyl)-3-(4-Morpholinyl)-, 1,1-Dioxide]",XSUAVPPTKHUTDX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88509,6m3m,DB13930,-9.0,Ulixertinib,KSERXGMCDHOLSS-LJQANCHMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
18072,6cs2,HMDB0012166,-9.0,4alpha-Carboxy-5alpha-cholesta-8-en-3beta-ol,RODBXVVNKJCWQR-KLZNZPMLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
135907,6w9c,DB05653,-9.0,IRX-5183,PNAWUIKCVQSLFG-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
104546,6vxs,DB12158,-9.0,Filorexant,NPFDWHQSDBWQLH-QZTJIDSGSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
130546,6w4h,DB12415,-9.0,Galeterone,PAFKTGFSEFKSQG-PAASFTFBSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
148011,6w9q,DB12794,-9.0,p-Quaterphenyl,GPRIERYVMZVKTC-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
113374,6vxx,DB09073,-9.0,Palbociclib,AHJRHEGDXFFMBM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88862,6m3m,DB14982,-9.0,Miransertib,HNFMVVHMKGFCMB-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
135671,6w9c,DB04790,-9.0,"2,5-bis-O-{3-[amino(imino)methyl]phenyl}-1,4:3,6-dianhydro-D-glucitol",IBIUTOFGXGGVKQ-XMTFNYHQSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
77064,6m2n,DB07936,-9.0,N-(4-{[(3S)-3-(dimethylamino)pyrrolidin-1-yl]carbonyl}phenyl)-5-fluoro-4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]pyrimidin-2-amine,BACSZMCLZIDTIO-IBGZPJMESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77068,6m2n,DB07941,-9.0,PH-797804,KCAJXIDMCNPGHZ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
113825,6vxx,DB12135,-9.0,Elubrixin,YQYFEGTYCUQBEI-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
105116,6vxs,DB13022,-9.0,LY-2874455,GKJCVYLDJWTWQU-CXLRFSCWSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
69245,6lxt,DB08899,-9.0,Enzalutamide,WXCXUHSOUPDCQV-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
93211,6m71,DB06595,-9.0,Midostaurin,BMGQWWVMWDBQGC-IIFHNQTCSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
82418,6m3m,DB02511,-9.0,2-Hydroxy-5-({1-[(2-Naphthyloxy)Methyl]-3-Oxoprop-1-Enyl}Amino)Tyrosine,PZWMZAFFUAWVDN-CQXYXCHQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
61531,6crv,DB12225,-9.0,Beclabuvir,ZTTKEBYSXUCBSE-QDFUAKMASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75581,6m2n,DB04888,-9.0,Bifeprunox,CYGODHVAJQTCBG-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
25164,6cs2,DB03038,-9.0,LY341770,MXAFDBCLWLMXSI-ZDUSSCGKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
135868,6w9c,DB05454,-9.0,Paliroden,CNEWKIDCGDXBDE-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
93198,6m71,DB06558,-9.0,Tezosentan,TUYWTLTWNJOZNY-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
77296,6m2n,DB08197,-9.0,"(5E,7S)-2-amino-7-(4-fluoro-2-pyridin-3-ylphenyl)-4-methyl-7,8-dihydroquinazolin-5(6H)-one oxime",KYIXUSLGFINPTC-WVFAEZDRSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
93197,6m71,DB06555,-9.0,Siramesine,XWAONOGAGZNUSF-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
61525,6crv,DB12219,-9.0,GSK-424887,DRXBWLBZWAJIEF-IBGZPJMESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
69827,6lxt,DB11759,-9.0,Pevonedistat,MPUQHZXIXSTTDU-QXGSTGNESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
104404,6vxs,DB11949,-9.0,Vestipitant,SBBYBXSFWOLDDG-JLTOFOAXSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
82430,6m3m,DB02527,-9.0,Cyclic adenosine monophosphate,IVOMOUWHDPKRLL-KQYNXXCUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
31394,6cs2,DB13764,-9.0,Monoxerutin,MBHXKZDTQCSVPM-BDAFLREQSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
58418,6crv,DB05116,-9.0,Thymectacin,CFBLUORPOFELCE-BACVZHSASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
139440,6w9c,DB13471,-9.0,Nalfurafine,XGZZHZMWIXFATA-UEZBDDGYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
57522,6crv,DB03777,-9.0,Rbt205 Inhibitor,QMGUOJYZJKLOLH-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113965,6vxx,DB12336,-9.0,GDC-0917,HSHPBORBOJIXSQ-HARLFGEKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
135715,6w9c,DB04841,-9.0,Flunarizine,SMANXXCATUTDDT-QPJJXVBHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
31503,6cs2,DB13931,-9.0,Netarsudil,OURRXQUGYQRVML-AREMUKBSSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
75560,6m2n,DB04862,-9.0,Merimepodib,JBPUGFODGPKTDW-SFHVURJKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
93358,6m71,DB06856,-9.0,6-FLUORO-2-[2-HYDROXY-3-(2-METHYL-CYCLOHEXYLOXY)-PHENYL]-1H-INDOLE-5-CARBOXAMIDINE,HUYQYLFFFNSAAX-BUXKBTBVSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
106934,6vxx,DB01765,-9.0,"(5-Oxo-5,6-Dihydro-Indolo[1,2-a]Quinazolin-7-Yl)-Acetic Acid",INSBKYCYLCEBOD-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58429,6crv,DB05197,-9.0,Sofalcone,GFWRVVCDTLRWPK-KPKJPENVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
11749,6lzg,DB12382,-9.0,R-306465,MUTBJZVSRNUIHA-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
68240,6lxt,DB07691,-9.0,"2-({[3-(3,4-dihydroisoquinolin-2(1H)-ylsulfonyl)phenyl]carbonyl}amino)benzoic acid",GYILVHHTCYNIOS-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
135716,6w9c,DB04842,-9.0,Fluspirilene,QOYHHIBFXOOADH-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
88267,6m3m,DB13571,-9.0,Pentamycin,AGJUUQSLGVCRQA-SWOUQTJZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58425,6crv,DB05154,-9.0,Pretomanid,ZLHZLMOSPGACSZ-NSHDSACASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
93244,6m71,DB06666,-9.0,Lixivaptan,PPHTXRNHTVLQED-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
61759,6crv,DB12548,-9.0,Sparsentan,WRFHGDPIDHPWIQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127805,6w4h,DB06875,-9.0,3-(3-FLUORO-4-HYDROXYPHENYL)-7-HYDROXY-1-NAPHTHONITRILE,NSSOSHDCWCMNDM-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
76399,6m2n,DB07159,-9.0,Tamatinib,NHHQJBCNYHBUSI-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
17601,6cs2,HMDB0007765,-9.0,"DG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/16:0/0:0)",YSSOTPCOKHYQLF-ZOLFRYQZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
82417,6m3m,DB02510,-9.0,'5'-O-(N-(L-Prolyl)-Sulfamoyl)Adenosine,LKVJEMXWEODCAY-JVEUSOJLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
6229,6lzg,DB01761,-9.0,4-[5-[2-(1-Phenyl-Ethylamino)-Pyrimidin-4-Yl]-1-Methyl-4-(3-Trifluoromethylphenyl)-1h-Imidazol-2-Yl]-Piperidine,QICPQLFMWYQJGX-SFHVURJKSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
161510,7bv1,DB14942,-9.0,BMS-986141,KEEBLYWBELVGPQ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
61123,6crv,DB11611,-9.0,Lifitegrast,JFOZKMSJYSPYLN-QHCPKHFHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127400,6w4h,DB05713,-9.0,LY-517717,VYNKVNDKAOGAAQ-RUZDIDTESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
106131,6vxs,DB15085,-9.0,Fulacimstat,JDARDSVOVYVQST-MRXNPFEDSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
61146,6crv,DB11656,-9.0,Rebamipide,ALLWOAVDORUJLA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88369,6m3m,DB13708,-9.0,Fenquizone,DBDTUXMDTSTPQZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88900,6m3m,DB15063,-9.0,Inarigivir soproxil,CJCYTUJOSMYXLE-JDLSZIHUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
61152,6crv,DB11666,-9.0,Buparlisib,CWHUFRVAEUJCEF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104437,6vxs,DB12001,-9.0,Abemaciclib,UZWDCWONPYILKI-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
77191,6m2n,DB08080,-9.0,LATRUNCULIN B,NSHPHXHGRHSMIK-JRIKCGFMSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
84481,6m3m,DB06263,-9.0,Amrubicin,VJZITPJGSQKZMX-XDPRQOKASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
77179,6m2n,DB08068,-9.0,N-[4-CHLORO-3-(PYRIDIN-3-YLOXYMETHYL)-PHENYL]-3-FLUORO-,YQJVDUKATDECHF-ICSRJNTNSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
83437,6m3m,DB03882,-9.0,"5-Alpha-Androstane-3-Beta,17beta-Diol",CBMYJHIOYJEBSB-YSZCXEEOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
57497,6crv,DB03751,-9.0,2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose,YSYKRGRSMLTJNL-URARBOGNSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27510,6cs2,DB07054,-9.0,(2R)-1-(DIMETHYLAMINO)-3-{4-[(6-{[2-FLUORO-5-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-4-YL)AMINO]PHENOXY}PROPAN-2-OL,OSCWQKTUILTARV-MRXNPFEDSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
77172,6m2n,DB08058,-9.0,"4-[3-(1,4-diazepan-1-ylcarbonyl)-4-fluorobenzyl]phthalazin-1(2H)-one",HGEPGGJUGUMFHT-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
148057,6w9q,DB12874,-9.0,Quizartinib,CVWXJKQAOSCOAB-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
75635,6m2n,DB05087,-9.0,Ganaxolone,PGTVWKLGGCQMBR-FLBATMFCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
27057,6cs2,DB06350,-9.0,Elinogrel,LGSDFTPAICUONK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
106124,6vxs,DB15068,-9.0,Agerafenib,DKNUPRMJNUQNHR-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
93122,6m71,DB06350,-9.0,Elinogrel,LGSDFTPAICUONK-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
88316,6m3m,DB13638,-9.0,Cefbuperazone,SMSRCGPDNDCXFR-CYWZMYCQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
139118,6w9c,DB12885,-9.0,CF-102,IPSYPUKKXMNCNQ-PFHKOEEOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
61126,6crv,DB11618,-9.0,Zorubicin,FBTUMDXHSRTGRV-BJISBDEGSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
135872,6w9c,DB05470,-9.0,VX-702,FYSRKRZDBHOFAY-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
57513,6crv,DB03768,-9.0,"N-[2-Hydroxy-2-(8-Isopropyl-6,9-Dioxo-2-Oxa-7,10-Diaza-Bicyclo[11.2.2]Heptadeca-1(16),13(17),14-Trien-11-Yl)-Ethyl]-N-(3-Methyl-Butyl)-Benzenesulfonamide,Inhibitor 3",WRUVOSYKHXGAQN-GKRYNVPLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27256,6cs2,DB06755,-9.0,Beta carotene,OENHQHLEOONYIE-JLTXGRSLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
31333,6cs2,DB13687,-9.0,Niaprazine,RSKQGBFMNPDPLR-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
31153,6cs2,DB13472,-9.0,Cyclofenil,GVOUFPWUYJWQSK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
61765,6crv,DB12557,-9.0,FK-614,UYGZODVVDUIDDQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106118,6vxs,DB15057,-9.0,NUC-1031,NHTKGYOMICWFQZ-KKQYNPQSSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
130154,6w4h,DB11847,-9.0,Cadazolid,XWFCFMXQTBGXQW-GOSISDBHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
127394,6w4h,DB05678,-9.0,SLx-4090,AZUIUVJESCFSLJ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
104425,6vxs,DB11984,-9.0,Letaxaban,GEHAEMCVKDPMKO-HXUWFJFHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
75628,6m2n,DB05039,-9.0,Indacaterol,QZZUEBNBZAPZLX-QFIPXVFZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
30391,6cs2,DB12419,-9.0,HSD-016,ZWASRJHIEFYJGL-BFUOFWGJSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
135086,6w9c,DB03962,-9.0,Nicotinamide 8-Bromo-Adenine Dinucleotide Phosphate,MDKMTCCUJSRQGW-NAJQWHGHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
135547,6w9c,DB04609,-9.0,INHIBITOR Q8467 OF DUPONT MERCK,HFLCERPZYCWLSZ-VKONIRKNSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
88239,6m3m,DB13532,-9.0,Cyclopenthiazide,BKYKPTRYDKTTJY-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
61954,6crv,DB12863,-9.0,Sivelestat,BTGNGJJLZOIYID-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88529,6m3m,DB13956,-9.0,Estradiol valerate,RSEPBGGWRJCQGY-RBRWEJTLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
57268,6crv,DB03421,-9.0,"2-Phenethyl-2,3-Dihydro-Phthalazine-1,4-Dione",JSSVIGGKHIJEHO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
135953,6w9c,DB06169,-9.0,Indibulin,SOLIIYNRSAWTSQ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
76850,6m2n,DB07689,-9.0,"METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE",NYNAFINLHQEHKU-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
104907,6vxs,DB12690,-9.0,LY-2584702,FYXRSVDHGLUMHB-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
147768,6w9q,DB12415,-9.0,Galeterone,PAFKTGFSEFKSQG-PAASFTFBSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
61328,6crv,DB11921,-9.0,Deflazacort,FBHSPRKOSMHSIF-GRMWVWQJSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
161804,7bv1,DB00619,-9.0,Imatinib,KTUFNOKKBVMGRW-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
29883,6cs2,DB11765,-9.0,PF-04991532,GKMLFBRLRVQVJO-ZDUSSCGKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
26971,6cs2,DB06169,-9.0,Indibulin,SOLIIYNRSAWTSQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
58241,6crv,DB04740,-9.0,MOXALACTAM (HYDROLYZED),ZTOQXKUYWZBJLG-XNAIMREJSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104785,6vxs,DB12500,-9.0,Fedratinib,JOOXLOJCABQBSG-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
68968,6lxt,DB08546,-9.0,"4-[(3AS,4R,7R,8AS,8BR)-2-(1,3-BENZODIOXOL-5-YLMETHYL)-7-HYDROXY-1,3-DIOXODECAHYDROPYRROLO[3,4-A]PYRROLIZIN-4-YL]BENZENECARBOXIMIDAMIDE",CETLUACQMGBMFH-ZALSBGIRSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
147826,6w9q,DB12504,-9.0,JNJ-40346527,BNVPFDRNGHMRJS-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
114815,6vxx,DB14914,-9.0,Flortaucipir F-18,GETAAWDSFUCLBS-SJPDSGJFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57151,6crv,DB03262,-9.0,"Al-6619, [2h-Thieno[3,2-E]-1,2-Thiazine-6-Sulfonamide,2-(3-Hydroxyphenyl)-3-(4-Morpholinyl)-, 1,1-Dioxide]",PZLYYZPXSSNGJS-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138839,6w9c,DB12336,-9.0,GDC-0917,HSHPBORBOJIXSQ-HARLFGEKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
113661,6vxx,DB11725,-9.0,Latrepirdine,JNODQFNWMXFMEV-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
91135,6m71,DB02651,-9.0,"{[2-(1h-1,2,3-Benzotriazol-1-Yl)-2-(3,4-Difluorophenyl)Propane-1,3-Diyl]Bis[4,1-Phenylene(Difluoromethylene)]}Bis(Phosphonic Acid)",BTAGTGWPDROBMG-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
70019,6lxt,DB12042,-9.0,Ibodutant,YQYSVMKCMIUCHY-WJOKGBTCSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
135643,6w9c,DB04750,-9.0,OREGON GREEN 488 CARBOXYLATE,BRJCLSQFZSHLRL-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
92210,6m71,DB04099,-9.0,Deamido-Nad+,SENPVEZBRZQVST-HISDBWNOSA-O,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
135408,6w9c,DB04432,-9.0,ZK-805623,ZXIHYCYAQUQHSG-UHFFFAOYSA-O,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
5993,6lzg,DB01419,-9.0,Antrafenine,NWGGKKGAFZIVBJ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
130437,6w4h,DB12267,-9.0,Brigatinib,AILRADAXUVEEIR-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
127938,6w4h,DB07031,-9.0,"3-Fluoro-4-{[(2R)-2-hydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthalenyl)acetyl]amino}benzoic acid",AANFHDFOMFRLLR-LJQANCHMSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
30734,6cs2,DB12903,-9.0,DEBIO-1347,BEMNJULZEQTDJY-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
113761,6vxx,DB12046,-9.0,Atopaxar,QWKAUGRRIXBIPO-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114690,6vxx,DB14652,-9.0,Clocortolone acetate,ARPLCFGLEYFDCN-CDACMRRYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30724,6cs2,DB12892,-9.0,MGB-BP-3,OEKXCVYZBVOWBR-BQYQJAHWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
61412,6crv,DB12049,-9.0,Dasolampanel etibutil,HPBRMCFZIGUGTK-ZMMAXQRCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84172,6m3m,DB04863,-9.0,Lefradafiban,PGCFXITVMNNKON-ROUUACIJSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
130425,6w4h,DB12247,-9.0,AZD-4547,VRQMAABPASPXMW-HDICACEKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
139191,6w9c,DB12998,-9.0,PF-00217830,QGNOXTFZOLDODX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
61316,6crv,DB11904,-9.0,Flumatinib,BJCJYEYYYGBROF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138834,6w9c,DB12325,-9.0,Idasanutlin,TVTXCJFHQKSQQM-LJQIRTBHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
130327,6w4h,DB12108,-9.0,Taselisib,BEUQXVWXFDOSAQ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
113739,6vxx,DB11832,-9.0,Crenolanib,DYNHJHQFHQTFTP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113664,6vxx,DB11730,-9.0,Ribociclib,RHXHGRAEPCAFML-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30628,6cs2,DB12746,-9.0,AKN-028,JLRIJKVMMZEKDF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
130284,6w4h,DB12044,-9.0,MK-0893,DNTVJEMGHBIUMW-IBGZPJMESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
91606,6m71,DB03276,-9.0,"4-[(10s,14s,18s)-18-(2-Amino-2-Oxoethyl)-14-(1-Naphthylmethyl)-8,17,20-Trioxo-7,16,19-Triazaspiro[5.14]Icos-11-En-10-Yl]Benzylphosphonic Acid",RHYFMOCFCFUTNH-GZNVFMSSSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
113694,6vxx,DB11773,-9.0,BMS-903452,OGIAVRWXUPYGGC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113696,6vxx,DB11775,-9.0,PF-03758309,AYCPARAPKDAOEN-LJQANCHMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104831,6vxs,DB12571,-9.0,Rimacalib,MYTIJGWONQOOLC-HNNXBMFYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
75891,6m2n,DB06314,-9.0,SGX-523,BCZUAADEACICHN-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
58216,6crv,DB04704,-9.0,20-hydroxycholesterol,MCKLJFJEQRYRQT-MGNSQDQZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61848,6crv,DB12687,-9.0,Vesatolimod,VFOKSTCIRGDTBR-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57230,6crv,DB03367,-9.0,PF-00356231,VMTJQZUZINLEKC-JOCHJYFZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
7729,6lzg,DB04285,-9.0,"{4-[(2s,4e)-2-(1,3-Benzothiazol-2-Yl)-2-(1h-1,2,3-Benzotriazol-1-Yl)-5-Phenylpent-4-Enyl]Phenyl}(Difluoro)Methylphosphonic Acid",GBLDYRVJENYQNH-AGLOJYHOSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
61858,6crv,DB12706,-9.0,Seletalisib,LNLJHGXOFYUARS-OAQYLSRUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61854,6crv,DB12696,-9.0,BMS-582949,GDTQLZHHDRRBEB-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113709,6vxx,DB11793,-9.0,Niraparib,PCHKPVIQAHNQLW-CQSZACIVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106390,6vxx,DB00158,-9.0,Folic acid,OVBPIULPVIDEAO-LBPRGKRZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57245,6crv,DB03388,-9.0,"3-[(2,4-Dichlorobenzoyl)(Isopropyl)Amino]-5-Phenylthiophene-2-Carboxylic Acid",UKNZREOUDLFUFF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58218,6crv,DB04706,-9.0,"(3BETA,7BETA)-CHOLEST-5-ENE-3,7-DIOL",OYXZMSRRJOYLLO-KGZHIOMZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104824,6vxs,DB12561,-9.0,WNT-974,XXYGTCZJJLTAGH-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
150822,6wiq,DB01897,-9.0,2-(2f-Benzothiazolyl)-5-Styryl-3-(4f-Phthalhydrazidyl)Tetrazolium Chloride,BEIGFKLRGRRJJA-JLHYYAGUSA-O,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
76718,6m2n,DB07530,-9.0,"(1R,3R)-5-[(2E)-3-{(1S,3R)-2,2,3-trimethyl-3-[6,6,6-trifluoro-5-hydroxy-5-(trifluoromethyl)hex-3-yn-1-yl]cyclopentyl}prop-2-en-1-ylidene]cyclohexane-1,3-diol",PCHUQQNKOFNVDU-OSXMSNBXSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61352,6crv,DB11958,-9.0,Brivanib,WCWUXEGQKLTGDX-LLVKDONJSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88798,6m3m,DB14828,-9.0,ABX-464,OZOGDCZJYVSUBR-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
11385,6lzg,DB11896,-9.0,Gedatolisib,DWZAEMINVBZMHQ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
91741,6m71,DB03466,-9.0,BMS184394,AYAJZQYENGWICE-QHCPKHFHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
106298,6vxs,DB15414,-9.0,CM-4307,MLDQJTXFUGDVEO-FIBGUPNXSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104884,6vxs,DB12658,-9.0,AFN-1252,QXTWSUQCXCWEHF-JXMROGBWSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
82917,6m3m,DB03181,-9.0,"2-[4-(4-Hydroxy-3-Isopropyl-Phenoxy)-3,5-Dimethyl-Phenyl]-2h-[1,2,4]Triazine-3,5-Dione",RXQAVKWRCZYGMV-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
106444,6vxx,DB00220,-9.0,Nelfinavir,QAGYKUNXZHXKMR-HKWSIXNMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130301,6w4h,DB12068,-9.0,T-900607,FSXLOWIFSZNIMV-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
26980,6cs2,DB06190,-9.0,Solabegron,LLDXOPKUNJTIRF-QFIPXVFZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
84252,6m3m,DB05107,-9.0,16-Bromoepiandrosterone,CWVMWSZEMZOUPC-JUAXIXHSSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84199,6m3m,DB04903,-9.0,Pagoclone,HIUPRQPBWVEQJJ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
24942,6cs2,DB00354,-9.0,Buclizine,MOYGZHXDRJNJEP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
61363,6crv,DB11971,-9.0,Vilaprisan,JUFWQQVHQFDUOD-ANRPBIDPSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84214,6m3m,DB04946,-9.0,Iloperidone,XMXHEBAFVSFQEX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
61357,6crv,DB11964,-9.0,Ilaprazole,HRRXCXABAPSOCP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
83291,6m3m,DB03701,-9.0,Vanoxerine,NAUWTFJOPJWYOT-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
130456,6w4h,DB12289,-9.0,Darexaban,IJNIQYINMSGIPS-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
68701,6lxt,DB08220,-9.0,"(8alpha,10alpha,13alpha,17beta)-17-[(4-hydroxyphenyl)carbonyl]androsta-3,5-diene-3-carboxylic acid",RPNNXCYIESWDSC-JRZBRKEGSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
58337,6crv,DB04863,-9.0,Lefradafiban,PGCFXITVMNNKON-ROUUACIJSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84368,6m3m,DB05796,-9.0,Daglutril,XMQODGUTLZXUGZ-RPBOFIJWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88549,6m3m,DB13997,-9.0,Baloxavir marboxil,RZVPBGBYGMDSBG-GGAORHGYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
104618,6vxs,DB12267,-9.0,Brigatinib,AILRADAXUVEEIR-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
113474,6vxx,DB09230,-9.0,Azelnidipine,ZKFQEACEUNWPMT-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104623,6vxs,DB12272,-9.0,Vidupiprant,PFWVGKROPKKEDW-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
61434,6crv,DB12081,-9.0,Anecortave,BCFCRXOJOFDUMZ-ONKRVSLGSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75960,6m2n,DB06519,-9.0,Edaglitazone,HAAXAFNSRADSMK-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76972,6m2n,DB07827,-9.0,"4-{[1-METHYL-2,4-DIOXO-6-(3-PHENYLPROP-1-YN-1-YL)-1,4-DIHYDROQUINAZOLIN-3(2H)-YL]METHYL}BENZOIC ACID",FLTYDFYSVZBKOB-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
120350,6w4b,DB08386,-9.0,2-{[4-(4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline,VRWJZGHUCOFGPZ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
24913,6cs2,DB02732,-9.0,Nicotinamide Adenine Dinucleotide Acetone Adduct,SGHBFOOIAAJJMI-YDKVLQLQSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
30839,6cs2,DB13052,-9.0,Upamostat,HUASEDVYRABWCV-NDEPHWFRSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
129517,6w4h,DB08912,-9.0,Dabrafenib,BFSMGDJOXZAERB-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
113793,6vxx,DB12095,-9.0,Telotristat ethyl,MDSQOJYHHZBZKA-GBXCKJPGSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106641,6vxx,DB00845,-9.0,Clofazimine,WDQPAMHFFCXSNU-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
135653,6w9c,DB04764,-9.0,[4-(3-AMINOMETHYL-PHENYL)-PIPERIDIN-1-YL]-(5-PHENETHYL- PYRIDIN-3-YL)-METHANONE,CCLHROFBSWWOQO-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
57312,6crv,DB03488,-9.0,Uridine-5'-diphosphate-2-deoxy-2-fluoro-alpha-D-galactose,NGTCPFGWXMBZEP-NQQHDEILSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
90902,6m71,DB02358,-9.0,LY374571,SZHRIPFGZWWRKW-VIFPVBQESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
76978,6m2n,DB07834,-9.0,"N-(cyclopropylmethyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-4-carboxamide",FOHZGCHKLPIBBX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
11474,6lzg,DB12012,-9.0,PF-04457845,BATCTBJIJJEPHM-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
58124,6crv,DB04578,-9.0,"(S)-2-[(R)-3-amino-4-(2-fluorophenyl)butyryl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide",OEVYDSSAPNIURZ-AEFFLSMTSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61451,6crv,DB12108,-9.0,Taselisib,BEUQXVWXFDOSAQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136082,6w9c,DB06497,-9.0,Aplaviroc,GWNOTCOIYUNTQP-FQLXRVMXSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
76989,6m2n,DB07848,-9.0,5-Chloro-N-{(3S)-1-[(2S)-1-(4-morpholinyl)-1-oxo-2-propanyl]-2-oxo-3-pyrrolidinyl}-1H-indole-2-sulfonamide,BHNMMFGOJRIAEZ-LRDDRELGSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
90876,6m71,DB02323,-9.0,EM-1745,CKSDYJASHNGOOS-KTXOUVACSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
82723,6m3m,DB02917,-9.0,N-Hydroxy-4-(Methyl{[5-(2-Pyridinyl)-2-Thienyl]Sulfonyl}Amino)Benzamide,LFGYSFPVLMPUPE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
135347,6w9c,DB04342,-9.0,7-((Carboxy(4-Hydroxyphenyl)Acetyl)Amino)-7-Methoxy-(3-((1-Methyl-1h-Tetrazol-5-Yl)Thio)Methyl)-8-Oxo-5-Oxa-1-Azabicyclo[4.2.0]Oct-2-Ene-2-Carboxylic Acid,JWCSIUVGFCSJCK-LIUKBUMOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
30861,6cs2,DB13080,-9.0,Roluperidone,RNRYULFRLCBRQS-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
75989,6m2n,DB06595,-9.0,Midostaurin,BMGQWWVMWDBQGC-IIFHNQTCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
92720,6m71,DB04785,-9.0,Streptolydigin,KVTPRMV1KLIG-NCAOFHFGSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
57333,6crv,DB03515,-9.0,Equilenin,PDRGHUMCVRDZLQ-WMZOPIPTSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88545,6m3m,DB13991,-9.0,Pipequaline,AMEWZCMTSIONOX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
75985,6m2n,DB06588,-9.0,Triphendiol,KQCJZAUNKSGEFM-UNMCSNQZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138798,6w9c,DB12282,-9.0,Defactinib,FWLMVFUGMHIOAA-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
61443,6crv,DB12096,-9.0,PF-05175157,BDXXSFOJPYSYOC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88582,6m3m,DB14066,-9.0,Tetrandrine,WVTKBKWTSCPRNU-KYJUHHDHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
113502,6vxx,DB09272,-9.0,Eluxadoline,QFNHIDANIVGXPE-FNZWTVRRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76613,6m2n,DB07405,-9.0,"1-(6-CYANO-3-PYRIDYLCARBONYL)-5',8'-DIFLUOROSPIRO[PIPERIDINE-4,2'(1'H)-QUINAZOLINE]-4'-AMINE",GIZYIOOBBUHOBS-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138816,6w9c,DB12303,-9.0,Motolimod,QSPOQCXMGPDIHI-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
11340,6lzg,DB11830,-9.0,Mocetinostat,HRNLUBSXIHFDHP-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
127887,6w4h,DB06972,-9.0,"7A-[(4-cyanophenyl)methyl]-6-(3,5-dichlorophenyl)-5-oxo-2,3,5,7A-tetrahydro-1H-pyrrolo[1,2-A]pyrrole-7-carbonitrile",TZCXQSNBTXDAJG-QFIPXVFZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
83220,6m3m,DB03598,-9.0,"Al-6629, [2h-Thieno[3,2-E]-1,2-Thiazine-6-Sulfonamide,2-(3-Methoxyphenyl)-3-(4-Morpholinyl)-, 1,1-Dioxide]",XSUAVPPTKHUTDX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
129617,6w4h,DB09053,-9.0,Ibrutinib,XYFPWWZEPKGCCK-GOSISDBHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
30792,6cs2,DB12985,-9.0,Quisinostat,PAWIYAYFNXQGAP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
166150,7bv1,DB13756,-9.0,Peruvoside,PMTSPAGBAFCORP-HBUONDEYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
92355,6m71,DB04289,-9.0,Genz-10850,YYMZSGIXLQPFAC-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
130461,6w4h,DB12297,-9.0,GLPG-0187,CXHCNOMGODVIKB-VWLOTQADSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
20668,6cs2,HMDB0001035,-9.0,Angiotensin II,CZGUSIXMZVURDU-JZXHSEFVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
84165,6m3m,DB04853,-9.0,Binodenoson,XJFMHMFFBSOEPR-DNZQAUTHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
29899,6cs2,DB11786,-9.0,Pefcalcitol,SVCSMAZYWOQCBW-NVJMFHFGSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
76907,6m2n,DB07756,-9.0,"1-[3-({[(4-AMINO-5-FLUORO-2-METHYLQUINOLIN-3-YL)METHYL]THIO}METHYL)PHENYL]-2,2,2-TRIFLUOROETHANE-1,1-DIOL",GPBGHVRNVGXPNM-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
30761,6cs2,DB12941,-9.0,ODM-201,BLIJXOOIHRSQRB-PXYINDEMSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
91064,6m71,DB02555,-9.0,SP4160,VCXMTWSYQSVWRK-AREMUKBSSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
140736,6w9c,DB15208,-9.0,NOP-1A,MZBCQWLYUQJXKA-KRWDZBQOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
104954,6vxs,DB12764,-9.0,ABC-294640,CAOTVXGYTWCKQE-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
76627,6m2n,DB07422,-9.0,(2S)-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]-3-(pentafluorophenoxy)propanamide,MMNRWNREMUMYQG-INIZCTEOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75776,6m2n,DB05913,-9.0,OSI-930,FGTCROZDHDSNIO-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138806,6w9c,DB12290,-9.0,Puerarin,HKEAFJYKMMKDOR-VPRICQMDSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
61937,6crv,DB12833,-9.0,Tandospirone,CEIJFEGBUDEYSX-FZDBZEDMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127877,6w4h,DB06959,-9.0,(2S)-1-(3H-Indol-3-yl)-3-{[5-(6-isoquinolinyl)-3-pyridinyl]oxy}-2-propanamine,BUCZDJYEOAQTHL-KEKNWZKVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
127878,6w4h,DB06962,-9.0,"(5-(aminomethyl)-2H-spiro[benzofuran-3,4'-piperidine]-1'-yl)(5-(phenylethynyl)furan-2-yl)methanone",YKTUSHSSKIWDRY-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
84341,6m3m,DB05608,-9.0,MKC-1,OVSKGTONMLKNPZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
135372,6w9c,DB04378,-9.0,"3-Amino-N-{4-[2-(2,6-Dimethyl-Phenoxy)-Acetylamino]-3-Hydroxy-1-Isobutyl-5-Phenyl-Pentyl}-Benzamide",APJAEXGNDLFGPD-AWCRTANDSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
166064,7bv1,DB13643,-9.0,Loprazolam,UTEFBSAVJNEPTR-RGEXLXHISA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
61415,6crv,DB12054,-9.0,BQ-123,VYCMAAOURFJIHD-PJNXIOHISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
8163,6lzg,DB00549,-9.0,Zafirlukast,YEEZWCHGZNKEEK-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
75956,6m2n,DB06510,-9.0,Muraglitazar,IRLWJILLXJGJTD-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
136039,6w9c,DB06395,-9.0,Abafungin,TYBHXIFFPVFXQW-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
61284,6crv,DB11859,-9.0,Brexanolone,AURFZBICLPNKBZ-SYBPFIFISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61425,6crv,DB12068,-9.0,T-900607,FSXLOWIFSZNIMV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
82839,6m3m,DB03076,-9.0,AHA047,CGBDAHCDSVOMCF-FYZVQMPESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
162977,7bv1,DB03367,-9.0,PF-00356231,VMTJQZUZINLEKC-JOCHJYFZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
135649,6w9c,DB04760,-9.0,"PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-(4-FLUORO-3-METHYL-BENZYLAMIDE)",PYFRREJCFXFNRR-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
61426,6crv,DB12070,-9.0,Letermovir,FWYSMLBETOMXAG-QHCPKHFHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136194,6w9c,DB06733,-9.0,Bafilomycin A1,XDHNQDDQEHDUTM-JQWOJBOSSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
93157,6m71,DB06455,-9.0,Meclinertant,DYLJVOXRWLXDIG-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
106938,6vxx,DB01771,-9.0,CRA_10991,QXAURVOBXQBPAP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60859,6crv,DB09235,-9.0,Efonidipine,NSVFSAJIGAJDMR-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58527,6crv,DB05738,-9.0,Vapitadine,VQWGYPVNVICKFC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31821,6cs2,DB14822,-9.0,SB-649868,ZJXIUGNEAIHSBI-IBGZPJMESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
58533,6crv,DB05796,-9.0,Daglutril,XMQODGUTLZXUGZ-RPBOFIJWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
105999,6vxs,DB14770,-9.0,Lanraplenib,XCIGZBVOUQVIPI-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
77580,6m2n,DB08547,-9.0,PROGESTERONE-11-ALPHA-OL-HEMISUCCINATE,JBBNFGYRYNBDIH-DBGGZKJISA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
89213,6m71,DB00210,-9.0,Adapalene,LZCDAPDGXCYOEH-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93921,6m71,DB07507,-9.0,"2-(4-hydroxybiphenyl-3-yl)-4-methyl-1H-isoindole-1,3(2H)-dione",ROMNEYAQUBNRLR-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
130716,6w4h,DB12673,-9.0,ATX-914,ALANRBCCCQEPFZ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
87949,6m3m,DB13102,-9.0,AZD-8418,MCPBSUCAISQZQK-JTQLQIEISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
130727,6w4h,DB12693,-9.0,Ritanserin,JUQLTPCYUFPYKE-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
77610,6m2n,DB08584,-9.0,"6-{[6-(1-methyl-1H-pyrazol-4-yl)[1,2,4]triazolo[4,3-b]pyridazin-3-yl]sulfanyl}quinoline",BCZUAADEACICHN-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
136313,6w9c,DB06976,-9.0,"1-(5-OXO-2,3,5,9B-TETRAHYDRO-1H-PYRROLO[2,1-A]ISOINDOL-9-YL)-3-(5-PYRROLIDIN-2-YL-1H-PYRAZOL-3-YL)-UREA",IWOOJEZSDPRYAZ-WFASDCNBSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
30210,6cs2,DB12198,-9.0,Fosdagrocorat,BVXLAHSJXXSWFF-KEKPKEOLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
105635,6vxs,DB13766,-9.0,Lidoflazine,ZBIAKUMOEKILTF-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
31836,6cs2,DB14856,-9.0,PF-05089771,ZYSCOUXLBXGGIM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
60836,6crv,DB09209,-9.0,Pholcodine,GPFAJKDEDBRFOS-FKQDBXSBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58537,6crv,DB05812,-9.0,Abiraterone,GZOSMCIZMLWJML-VJLLXTKPSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
82100,6m3m,DB02101,-9.0,"(S,R)-fidarestat",WAAPEIZFCHNLKK-QPUJVOFHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
114123,6vxx,DB12764,-9.0,ABC-294640,CAOTVXGYTWCKQE-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112736,6vxx,DB07787,-9.0,"5-FLUORO-1-[4-(4-PHENYL-3,6-DIHYDROPYRIDIN-1(2H)-YL)BUTYL]QUINAZOLINE-2,4(1H,3H)-DIONE",PNPFDRCIGCUCMN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
139088,6w9c,DB12836,-9.0,Grapiprant,HZVLFTCYCLXTGV-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139565,6w9c,DB13643,-9.0,Loprazolam,UTEFBSAVJNEPTR-RGEXLXHISA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
69724,6lxt,DB11562,-9.0,Bicuculline,IYGYMKDQCDOMRE-ZWKOTPCHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
27617,6cs2,DB07168,-9.0,[4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-6-(methylamino)pyrimidin-2-yl}amino)phenyl]acetonitrile,MFMSRHREFZCFSN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
112741,6vxx,DB07792,-9.0,"(S)-2-CHLORO-N-(1-(2-(2-HYDROXYETHYLAMINO)-2-OXOETHYL)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL)-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE",VUKPNWLGSLOHIF-AWEZNQCLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
82103,6m3m,DB02104,-9.0,"2,4-Diamino-5-Methyl-6-[(3,4,5-Trimethoxy-N-Methylanilino)Methyl]Pyrido[2,3-D]Pyrimidine",PEGMMEYCSOZKIT-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
107396,6vxx,DB03251,-9.0,RWJ-51084,NQABUEUFRXDDFI-AWEZNQCLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60828,6crv,DB09200,-9.0,Rivoglitazone,XMSXOLDPMGMWTH-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30063,6cs2,DB12001,-9.0,Abemaciclib,UZWDCWONPYILKI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
61715,6crv,DB12477,-9.0,Perfluoro tert-butylcyclohexane,VLTXBOGHSBHSAC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130052,6w4h,DB11697,-9.0,Pacritinib,HWXVIOGONBBTBY-ONEGZZNKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
56584,6crv,DB02511,-9.0,2-Hydroxy-5-({1-[(2-Naphthyloxy)Methyl]-3-Oxoprop-1-Enyl}Amino)Tyrosine,PZWMZAFFUAWVDN-CQXYXCHQSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87983,6m3m,DB13169,-9.0,Nandrolone,NPAGDVCDWIYMMC-IZPLOLCNSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
134637,6w9c,DB03336,-9.0,BIA,KVIVJQWOYSWCCZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
75398,6m2n,DB04644,-9.0,"4-{4-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-2,3-DIMETHYL-PHENOXY}-BUTYRIC ACID",FCEMCUPAYRPTLS-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77530,6m2n,DB08491,-9.0,N-HYDROXY-2-[4-(4-PHENOXY-BENZENESULFONYL)-TETRAHYDRO-PYRAN-4-YL]-ACETAMIDE,ARIRIZBKMKMEBD-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76303,6m2n,DB07049,-9.0,(2R)-1-[(4-tert-butylphenyl)sulfonyl]-2-methyl-4-(4-nitrophenyl)piperazine,SOFGQQQVQZQJFS-MRXNPFEDSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
88974,6m3m,DB15208,-9.0,NOP-1A,MZBCQWLYUQJXKA-KRWDZBQOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
139526,6w9c,DB13591,-9.0,Metopimazine,BQDBKDMTIJBJLA-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
112863,6vxx,DB07933,-9.0,Erteberel,XIESSJVMWNJCGZ-VKJFTORMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84665,6m3m,DB06717,-9.0,Fosaprepitant,BARDROPHSZEBKC-OITMNORJSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
57917,6crv,DB04298,-9.0,"3-(4-Amino-2-Tert-Butyl-5-Methyl-Phenylsulfanyl)-6-Cyclopentyl-4-Hydroxy-6-[2-(4-Hydroxy-Phenyl)-Ethyl]-5,6-Dihydro-Pyran-2-One",ZEBFKFGJWHOOST-LJAQVGFWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29210,6cs2,DB08865,-9.0,Crizotinib,KTEIFNKAUNYNJU-GFCCVEGCSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
82187,6m3m,DB02220,-9.0,AL7089A,RMOXCYSVWCHXII-LBPRGKRZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
130092,6w4h,DB11763,-9.0,Momelotinib,ZVHNDZWQTBEVRY-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
138639,6w9c,DB12052,-9.0,Icariin,TZJALUIVHRYQQB-XLRXWWTNSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
82190,6m3m,DB02224,-9.0,Taxifolin,CXQWRCVTCMQVQX-LSDHHAIUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
114057,6vxx,DB12663,-9.0,Letrazuril,XQKYUBTUOHHNDV-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29208,6cs2,DB08861,-9.0,DPDPE,MCMMCRYPQBNCPH-WMIMKTLMSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
58542,6crv,DB05835,-9.0,NS-3728,OQRAKHDEGGGWQO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
93703,6m71,DB07256,-9.0,"3-({4-[(5-CHLORO-1,3-BENZODIOXOL-4-YL)AMINO]PYRIMIDIN-2-YL}AMINO)BENZAMIDE",ZVQZIVCQLFGXFZ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
104183,6vxs,DB11618,-9.0,Zorubicin,FBTUMDXHSRTGRV-BJISBDEGSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
156363,6wiq,DB12983,-9.0,Phthalocyanine,IEQIEDJGQAUEQZ-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
57689,6crv,DB03996,-9.0,"3-[(5s)-1-Acetyl-3-(2-Chlorophenyl)-4,5-Dihydro-1h-Pyrazol-5-Yl]Phenol",QBZAPFWYAPXRGQ-KRWDZBQOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
89058,6m3m,DB15381,-9.0,Menaquinone,HYPYXGZDOYTYDR-HAJWAVTHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87996,6m3m,DB13208,-9.0,Prednylidene,WSVOMANDJDYYEY-CWNVBEKCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84685,6m3m,DB06745,-9.0,ginkgolide-C,AMOGMTLMADGEOQ-DTDWCABLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
104168,6vxs,DB11562,-9.0,Bicuculline,IYGYMKDQCDOMRE-ZWKOTPCHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
76156,6m2n,DB06879,-9.0,"5-(4'-AMINO-1'-ETHYL-5',8'-DIFLUORO-1'H-SPIRO[PIPERIDINE-4,2'-QUINAZOLINE]-1-YLCARBONYL)PICOLINONITRILE",QCFIRACCCDFXIP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61728,6crv,DB12500,-9.0,Fedratinib,JOOXLOJCABQBSG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77550,6m2n,DB08513,-9.0,[4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENYL]ACETIC ACID,PAIQRYUOBBCBSE-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
88001,6m3m,DB13215,-9.0,Sulfobromophthalein,OHTXTCNTQJFRIG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
67995,6lxt,DB07397,-9.0,"(5S)-5-(2-amino-2-oxoethyl)-4-oxo-N-[(3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl)methyl]-3,4,5,6,7,8-hexahydro[1]benzothieno[2,3-d]pyrimidine-2-carboxamide",ITADELAVAWJACR-NSHDSACASA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
83626,6m3m,DB04137,-9.0,Guanosine-5'-Triphosphate,XKMLYUALXHKNFT-UUOKFMHZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88984,6m3m,DB15229,-9.0,CNV-2197944,BLFJGFDZMABYMY-ZDUSSCGKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84676,6m3m,DB06733,-9.0,Bafilomycin A1,XDHNQDDQEHDUTM-JQWOJBOSSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
104170,6vxs,DB11577,-9.0,Indigotindisulfonic Acid,CFZXDJWFRVEWSR-BUHFOSPRSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
57939,6crv,DB04330,-9.0,Bilh 434,KNRVCCXHLSHTFW-HGPRPZRGSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84743,6m3m,DB06849,-9.0,"1-[1'-(3-phenylacryloyl)spiro[1-benzofuran-3,4'-piperidin]-5-yl]methanamine",RQWYWHUKHYFIPB-VQHVLOKHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
56533,6crv,DB02449,-9.0,3-(1h-Indol-3-Yl)-2-[4-(4-Phenyl-Piperidin-1-Yl)-Benzenesulfonylamino]-Propionic Acid,ULOTXPTWJAUGGE-MHZLTWQESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140763,6w9c,DB15265,-9.0,USL-311,XNUNVQKARNSSEO-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
163820,7bv1,DB06395,-9.0,Abafungin,TYBHXIFFPVFXQW-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
114666,6vxx,DB14627,-9.0,Oxyphenisatin acetate,PHPUXYRXPHEJDF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
70561,6lxt,DB12854,-9.0,BMS-908662,MMNNTJYFHUDSKL-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
127130,6w4h,DB04759,-9.0,"PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-(3-METHYL-BENZYLAMIDE)",GTBUZLPQANSGGE-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
20972,6cs2,HMDB0049221,-9.0,TG(18:1(11Z)/14:1(9Z)/20:1(11Z)),SEJBPZVTMDKZMT-WWAUBUJQSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
163826,7bv1,DB06409,-9.0,Morphine glucuronide,GNJCUHZOSOYIEC-GAROZEBRSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
103706,6vxs,DB08930,-9.0,Dolutegravir,RHWKPHLQXYSBKR-BMIGLBTASA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
166469,7bv1,DB15197,-9.0,RSV-604,MTPVBMVUENFFLL-HXUWFJFHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
130845,6w4h,DB12885,-9.0,CF-102,IPSYPUKKXMNCNQ-PFHKOEEOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
103694,6vxs,DB08907,-9.0,Canagliflozin,XTNGUQKDFGDXSJ-ZXGKGEBGSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
107640,6vxx,DB04125,-9.0,N-Alpha-(2-Naphthylsulfonyl)-N(3-Amidino-L-Phenylalaninyl)-4-Acetyl-Piperazine,ZUWBXGHMVKDMQO-DEOSSOPVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114149,6vxx,DB12808,-9.0,Trifarotene,MFBCDACCJCDGBA-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61672,6crv,DB12417,-9.0,Anagliptin,LDXYBEHACFJIEL-HNNXBMFYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81924,6m3m,DB01861,-9.0,Uridine diphosphate glucose,HSCJRCZFDFQWRP-JZMIEXBBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
103690,6vxs,DB08901,-9.0,Ponatinib,PHXJVRSECIGDHY-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
76196,6m2n,DB06922,-9.0,"2-[(1R)-1-carboxy-2-naphthalen-1-ylethyl]-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylic acid",CZNPWASYMRBJCX-GOSISDBHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
129973,6w4h,DB11526,-9.0,Masitinib,WJEOLQLKVOPQFV-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
29111,6cs2,DB08749,-9.0,3-(2-AMINO-6-BENZOYLQUINAZOLIN-3(4H)-YL)-N-CYCLOHEXYL-N-METHYLPROPANAMIDE,KTRFBFMYAJOXLG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
67722,6lxt,DB07084,-9.0,"N-(6,7,9,10,17,18,20,21-octahydrodibenzo[b,k][1,4,7,10,13,16]hexaoxacyclooctadecin-2-yl)acetamide",YHKGWOJTUMJPNW-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
135804,6w9c,DB05076,-9.0,Fenretinide,AKJHMTWEGVYYSE-FXILSDISSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
130855,6w4h,DB12899,-9.0,TT-301,ZPJGUEPHFXPAQF-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
69598,6lxt,DB11262,-9.0,Bisoctrizole,FQUNFJULCYSSOP-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
67815,6lxt,DB07189,-9.0,"(1S,3R,6S)-4-oxo-6-{4-[(2-phenylquinolin-4-yl)methoxy]phenyl}-5-azaspiro[2.4]heptane-1-carboxylic acid",BFZXMIUWGSTUAL-ZSOKXDGFSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
157446,6wiq,DB06515,-9.0,Resiniferatoxin,DSDNAKHZNJAGHN-MXTYGGKSSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
112602,6vxx,DB07444,-9.0,"6-(3-AMINOPROPYL)-4,9-DIMETHYLPYRROLO[3,4-C]CARBAZOLE-1,3(2H,6H)-DIONE",PKPNSCZPIWCHMW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130854,6w4h,DB12897,-9.0,MK-7622,JUVQLZBJFOGEEO-GOTSBHOMSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
103679,6vxs,DB08881,-9.0,Vemurafenib,GPXBXXGIAQBQNI-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
30165,6cs2,DB12134,-9.0,Gepotidacin,PZFAZQUREQIODZ-LJQANCHMSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
57789,6crv,DB04131,-9.0,"10-(4-Dimethylamino-5-Hydroxy-6-Methyl-Tetrahydro-Pyran-2-Yloxy)-8-Ethyl-1,8,11-Trihydroxy-7,8,9,10-Tetrahydro-Naphthacene-5,12-Dione",BLGDWFJQIHBUJY-NWJGULHDSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
105901,6vxs,DB14569,-9.0,Tedizolid,XFALPSLJIHVRKE-GFCCVEGCSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
77837,6m2n,DB08865,-9.0,Crizotinib,KTEIFNKAUNYNJU-GFCCVEGCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
58568,6crv,DB05992,-9.0,Plinabulin,UNRCMCRRFYFGFX-TYPNBTCFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107593,6vxx,DB04064,-9.0,Nogalaviketone,QHNJNOBWURJIEK-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61666,6crv,DB12410,-9.0,Sabarubicin,VQHRZZISQVWPLK-UIRGBLDSSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60756,6crv,DB09075,-9.0,Edoxaban,HGVDHZBSSITLCT-JLJPHGGASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60759,6crv,DB09079,-9.0,Nintedanib,XZXHXSATPCNXJR-ZIADKAODSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87896,6m3m,DB13024,-9.0,MK-8245,UJEAABFSXKCSGI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
130780,6w4h,DB12776,-9.0,E-6005,BBTFKAOFCSOZMB-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
87908,6m3m,DB13044,-9.0,Gossypol,QBKSWRVVCFFDOT-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
77711,6m2n,DB08710,-9.0,"(5Z)-5-[(5-ETHYL-2-FURYL)METHYLENE]-2-{[(S)-(4-FLUOROPHENYL)(1H-TETRAZOL-5-YL)METHYL]AMINO}-1,3-THIAZOL-4(5H)-ONE",BKZOQCGDCHOGOQ-MZLJFPOFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138599,6w9c,DB11900,-9.0,OC-459,FATGTHLOZSXOBC-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
69511,6lxt,DB09298,-9.0,Silibinin,SEBFKMXJBCUCAI-HKTJVKLFSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
75192,6m2n,DB04373,-9.0,"4-Amino-N-{4-[2-(2,6-Dimethyl-Phenoxy)-Acetylamino]-3-Hydroxy-1-Isobutyl-5-Phenyl-Pentyl}-Benzamide",WQUBEIMCFHCJCO-AWCRTANDSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
139581,6w9c,DB13664,-9.0,Formocortal,QNXUUBBKHBYRFW-QWAPGEGQSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
84747,6m3m,DB06856,-9.0,6-FLUORO-2-[2-HYDROXY-3-(2-METHYL-CYCLOHEXYLOXY)-PHENYL]-1H-INDOLE-5-CARBOXAMIDINE,HUYQYLFFFNSAAX-BUXKBTBVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
60795,6crv,DB09166,-9.0,Etizolam,VMZUTJCNQWMAGF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
89017,6m3m,DB15294,-9.0,SB-1578,NNXDIGHYPZHXTR-ONEGZZNKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
105745,6vxs,DB13950,-9.0,WIN 55212-2,HQVHOQAKMCMIIM-HXUWFJFHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
87909,6m3m,DB13046,-9.0,Tocladesine,CLLFEJLEDNXZNR-UUOKFMHZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
82067,6m3m,DB02059,-9.0,Adenosine-5-Diphosphoribose,SRNWOUGRCWSEMX-ZQSHOCFMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
56519,6crv,DB02429,-9.0,4-(Aminosulfonyl)-N-[(4-Fluorophenyl)Methyl]-Benzamide,IXDVPACDZDRCTN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84755,6m3m,DB06865,-9.0,6-CARBAMIMIDOYL-2-[2-HYDROXY-6-(4-HYDROXY-PHENYL)-INDAN-1-YL]-HEXANOIC ACID,ZSRRBAKATXAISL-LMNJBCLMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
134519,6w9c,DB03186,-9.0,U-Pi-a-Pi,JIAJERGOUFOENU-LNAOLWRRSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
61665,6crv,DB12408,-9.0,PF-03635659,WGOJWDWKHJHXSV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
134535,6w9c,DB03207,-9.0,"2-(Biphenyl-4-Sulfonyl)-1,2,3,4-Tetrahydro-Isoquinoline-3-Carboxylic Acid",BNVMUDXGABBWGP-OAQYLSRUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136332,6w9c,DB06997,-9.0,"2-(4-fluorophenyl)-N-{[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]carbamoyl}acetamide",BMPOCDJEXAXXEZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
130821,6w4h,DB12848,-9.0,PF-04217903,PDMUGYOXRHVNMO-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
87874,6m3m,DB12988,-9.0,LY-518674,PNHFDVSKDSLUFH-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
89101,6m3m,DB01532,-9.0,alpha-Methylacetylfentanyl,OKTLVZBUKMRPLL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
60741,6crv,DB09053,-9.0,Ibrutinib,XYFPWWZEPKGCCK-GOSISDBHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
128133,6w4h,DB07256,-9.0,"3-({4-[(5-CHLORO-1,3-BENZODIOXOL-4-YL)AMINO]PYRIMIDIN-2-YL}AMINO)BENZAMIDE",ZVQZIVCQLFGXFZ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
31888,6cs2,DB14942,-9.0,BMS-986141,KEEBLYWBELVGPQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
29805,6cs2,DB11662,-9.0,Rabusertib,SYYBDNPGDKKJDU-ZDUSSCGKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
57736,6crv,DB04064,-9.0,Nogalaviketone,QHNJNOBWURJIEK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140669,6w9c,DB13070,-9.0,Surinabant,HMXDWDSNPRNUKI-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
89025,6m3m,DB15307,-9.0,Atabecestat,VLLFGVHGKLDDLW-SFHVURJKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84764,6m3m,DB06875,-9.0,3-(3-FLUORO-4-HYDROXYPHENYL)-7-HYDROXY-1-NAPHTHONITRILE,NSSOSHDCWCMNDM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88072,6m3m,DB13312,-9.0,Delapril,WOUOLAUOZXOLJQ-MBSDFSHPSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
107349,6vxx,DB03199,-9.0,4-Methoxy-E-Rhodomycin T,XSSVYBYWQBNYOH-QJIXERIWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
129609,6w4h,DB09034,-9.0,Suvorexant,JYTNQNCOQXFQPK-MRXNPFEDSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
77448,6m2n,DB08391,-9.0,"6,7-DIMETHOXY-4-[(3R)-3-(QUINOXALIN-2-YLOXY)PYRROLIDIN-1-YL]QUINAZOLINE",UBIIFKJMNRPNMT-CQSZACIVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75488,6m2n,DB04771,-9.0,1-GUANIDINO-4-(N-NITRO-BENZOYLAMINO-L-LEUCYL-L-PROLYLAMINO)BUTANE,FIZYZWLGMGGGBJ-OALUTQOASA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
88140,6m3m,DB13397,-9.0,Prenoxdiazine,PXZDWASDNFWKSD-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
24449,6cs2,DB02194,-9.0,"8-Benzyl-2-Hydroxy-2-(4-Hydroxy-Benzyl)-6-(4-Hydroxy-Phenyl)-2h-Imidazo[1,2-a]Pyrazin-3-One",ULLMMKZQNNBLRN-SANMLTNESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
89742,6m71,DB00845,-9.0,Clofazimine,WDQPAMHFFCXSNU-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
84598,6m3m,DB06590,-9.0,Ceftaroline fosamil,ZCCUWMICIWSJIX-NQJJCJBVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
112909,6vxx,DB08138,-9.0,"{[(2,6-difluorophenyl)carbonyl]amino}-N-(4-fluorophenyl)-1H-pyrazole-3-carboxamide",BDRDBXXWQDFXEC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77415,6m2n,DB08351,-9.0,N-cyclopropyl-4-methyl-3-{2-[(2-morpholin-4-ylethyl)amino]quinazolin-6-yl}benzamide,MNEXDVSJIUQQRH-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
130109,6w4h,DB11786,-9.0,Pefcalcitol,SVCSMAZYWOQCBW-NVJMFHFGSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
105212,6vxs,DB13185,-9.0,Oxabolone cipionate,KHKDIUPVDIEHAH-KXLSUQFWSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
107133,6vxx,DB02331,-9.0,"(2s)-2-[(5-Benzofuran-2-Yl-Thiophen-2-Ylmethyl)-(2,4-Dichloro-Benzoyl)-Amino]-3-Phenyl-Propionic Acid",YBULOUKTPCHXAL-DEOSSOPVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138688,6w9c,DB12122,-9.0,Figopitant,HUTHJVYJUPXHDF-DEOSSOPVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
93609,6m71,DB07145,-9.0,(2R)-N-HYDROXY-2-[(3S)-3-METHYL-3-{4-[(2-METHYLQUINOLIN-4-YL)METHOXY]PHENYL}-2-OXOPYRROLIDIN-1-YL]PROPANAMIDE,YDMIPBHQKFOFQW-NSYGIPOTSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
76326,6m2n,DB07076,-9.0,6-[(Z)-AMINO(IMINO)METHYL]-N-[3-(CYCLOPENTYLOXY)PHENYL]-2-NAPHTHAMIDE,FWTQOPWAMQXIMI-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
30330,6cs2,DB12345,-9.0,MBX-2982,NFTMKHWBOINJGM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
104324,6vxs,DB11830,-9.0,Mocetinostat,HRNLUBSXIHFDHP-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
83588,6m3m,DB04086,-9.0,"2',4'-Dinitrophenyl-2deoxy-2-Fluro-B-D-Cellobioside",WFVCNOHOODVBQK-IUBYCILNSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
148075,6w9q,DB12897,-9.0,MK-7622,JUVQLZBJFOGEEO-GOTSBHOMSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
139094,6w9c,DB12848,-9.0,PF-04217903,PDMUGYOXRHVNMO-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
104261,6vxs,DB11742,-9.0,Ebastine,MJJALKDDGIKVBE-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
83994,6m3m,DB04626,-9.0,Apramycin,XZNUGFQTQHRASN-XQENGBIVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88962,6m3m,DB15191,-9.0,MAX-40279,AVIOBQFPAGEICQ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
139025,6w9c,DB12729,-9.0,ASP-3026,MGGBYMDAPCCKCT-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
77417,6m2n,DB08353,-9.0,"2-(CYCLOHEXYLMETHYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE",NCVMTHVSAJMOPI-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
114030,6vxx,DB12621,-9.0,ST-101,QZWYXEBIQWJXAR-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29241,6cs2,DB08912,-9.0,Dabrafenib,BFSMGDJOXZAERB-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
88169,6m3m,DB13434,-9.0,Fenticonazole,ZCJYUTQZBAIHBS-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
62084,6crv,DB13060,-9.0,CEP-37440,BCSHRERPHLTPEE-NRFANRHFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
93502,6m71,DB07025,-9.0,3-(5-{[4-(AMINOMETHYL)PIPERIDIN-1-YL]METHYL}-1H-INDOL-2-YL)QUINOLIN-2(1H)-ONE,KBIHHEGEALBUMT-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
89849,6m71,DB00966,-9.0,Telmisartan,RMMXLENWKUUMAY-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
112967,6vxx,DB08204,-9.0,3-DIPHENOL-6-NITRO-3H-BENZO[DE]ISOCHROMEN-1-ONE,FLWABCQDXUKNQY-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29962,6cs2,DB11867,-9.0,JNJ-39393406,IURMHZBQEYNQOH-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
105201,6vxs,DB13164,-9.0,Olmutinib,FDMQDKQUTRLUBU-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
88948,6m3m,DB15157,-9.0,Voruciclib,MRPGRAKIAJJGMM-OCCSQVGLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
106069,6vxs,DB14929,-9.0,Elsulfavirine,ULTDEARCBRNRGR-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
129398,6w4h,DB08746,-9.0,1-[[(1E)-2-(4-CHLOROPHENYL)ETHENYL]SULFONYL]-4-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]PIPERAZINE,ZOSSOFIFNGGDKG-GIJQJNRQSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
114000,6vxx,DB12571,-9.0,Rimacalib,MYTIJGWONQOOLC-HNNXBMFYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84579,6m3m,DB06533,-9.0,Ragaglitazar,WMUIIGVAWPWQAW-XMMPIXPASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88954,6m3m,DB15170,-9.0,Evobrutinib,QUIWHXQETADMGN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
166439,7bv1,DB15133,-9.0,Tepotinib,AHYMHWXQRWRBKT-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
112977,6vxx,DB08220,-9.0,"(8alpha,10alpha,13alpha,17beta)-17-[(4-hydroxyphenyl)carbonyl]androsta-3,5-diene-3-carboxylic acid",RPNNXCYIESWDSC-JRZBRKEGSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107123,6vxx,DB02319,-9.0,"5,6-Dihydroxy-Nadp",LRAVAOPKUBJONV-IVCJQJMGSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
134823,6w9c,DB03605,-9.0,"(2s)-2-[(2,4-Dichloro-Benzoyl)-(3-Trifluoromethyl-Benzyl)-Amino]-3-Phenyl-Propionic Acid",LAJJKGIZTCCOHY-NRFANRHFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
127307,6w4h,DB05220,-9.0,Alisertib,ZLHFILGSQDJULK-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
84571,6m3m,DB06519,-9.0,Edaglitazone,HAAXAFNSRADSMK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
61564,6crv,DB12270,-9.0,Losmapimod,KKYABQBFGDZVNQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112987,6vxx,DB08233,-9.0,6-CYCLOHEXYLMETHYLOXY-2-(4'-HYDROXYANILINO)PURINE,RFSDQDHHBKYQOD-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127336,6w4h,DB05408,-9.0,Emricasan,SCVHJVCATBPIHN-SJCJKPOMSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
88150,6m3m,DB13411,-9.0,Lofepramine,SAPNXPWPAUFAJU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
161465,7bv1,DB14859,-9.0,Fosifloxuridine nafalbenamide,BIOWRMNRHMERIO-ZVAHOJSLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
88942,6m3m,DB15145,-9.0,Ziresovir,GAAICKUTDBZCMT-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88953,6m3m,DB15169,-9.0,H3B-6527,MBWRLLRCTIYXDW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
128103,6w4h,DB07220,-9.0,"N-[5-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-1H-INDAZOL-3-YL]-2-(4-PIPERIDIN-1-YLPHENYL)ACETAMIDE",ZXYIRNXOAJYLCU-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
104237,6vxs,DB11703,-9.0,Acalabrutinib,WDENQIQQYWYTPO-IBGZPJMESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
138692,6w9c,DB12127,-9.0,Sultamicillin,OPYGFNJSCUDTBT-PMLPCWDUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
8332,6lzg,DB05454,-9.0,Paliroden,CNEWKIDCGDXBDE-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
93433,6m71,DB06938,-9.0,4-[[2-[[4-chloro-3-(trifluoromethyl)phenyl]amino]-3H-benzimidazol-5-yl]oxy]-N-methyl-pyridine-2-carboxamide,ZJLSMLDOCGOURY-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
104362,6vxs,DB11891,-9.0,CUDC-907,JOWXJLIFIIOYMS-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
68239,6lxt,DB07689,-9.0,"METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE",NYNAFINLHQEHKU-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
88930,6m3m,DB15123,-9.0,Dorzagliatin,HMUMWSORCUWQJO-QAPCUYQASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
61014,6crv,DB11363,-9.0,Alectinib,KDGFLJKFZUIJMX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
8175,6lzg,DB04852,-9.0,Implitapide,AMNXBQPRODZJQR-DITALETJSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
69345,6lxt,DB09030,-9.0,Vorapaxar,ZBGXUVOIWDMMJE-QHNZEKIYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
84028,6m3m,DB04669,-9.0,TRIAZOLOPYRIMIDINE,YWBFPKPWMSWWEA-UHFFFAOYSA-O,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
127349,6w4h,DB05450,-9.0,Smilagenin,GMBQZIIUCVWOCD-UQHLGXRBSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
84621,6m3m,DB06634,-9.0,Casopitant,XGGTZCKQRWXCHW-WMTVXVAQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
147378,6w9q,DB11851,-9.0,Bafetinib,ZGBAJMQHJDFTQJ-DEOSSOPVSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
27083,6cs2,DB06429,-9.0,Talnetant,BIAVGWDGIJKWRM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
61580,6crv,DB12289,-9.0,Darexaban,IJNIQYINMSGIPS-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163657,7bv1,DB05713,-9.0,LY-517717,VYNKVNDKAOGAAQ-RUZDIDTESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
130121,6w4h,DB11800,-9.0,Tivozanib,SPMVMDHWKHCIDT-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
61552,6crv,DB12252,-9.0,PG-701,OKRSVUYYCJPECG-LFGMFVMYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
149133,6w9q,DB15009,-9.0,PF-04937319,MASKQITXHVYVFL-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
56636,6crv,DB02581,-9.0,"5-[2,3-Dichloro-4-(5-{1-[2-(2-Guanidino-4-Methyl-Pentanoylamino)-Acetyl]-Piperidin-4-Yl}-1-Methyl-1h-Pyrazol-3-Yl)-Phenoxymethyl]-Furan-2-Carboxylic Acid",VNZHOIDQBPFEJU-OAQYLSRUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59168,6crv,DB07152,-8.9,N-[4-(5-fluoro-6-methylpyridin-2-yl)-5-quinoxalin-6-yl-1H-imidazol-2-yl]acetamide,TYPILNNEZPSNTI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55314,6crv,DB00862,-8.9,Vardenafil,SECKRCOLJRRGGV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
164400,7bv1,DB07789,-8.9,"1-[5-methyl-2-(trifluoromethyl)furan-3-yl]-3-[(2Z)-5-(2-{[6-(1H-1,2,4-triazol-3-ylamino)pyrimidin-4-yl]amino}ethyl)-1,3-thiazol-2(3H)-ylidene]urea",KNTGXMNWVXZIMW-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
64879,6lxt,DB02102,-8.9,DMP450,KYRSNWPSSXSNEP-ZRTHHSRSSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
160113,7bv1,DB07528,-8.9,3-(2-aminoquinazolin-6-yl)-4-methyl-1-[3-(trifluoromethyl)phenyl]pyridin-2(1H)-one,HXUZQEYFKAZBPX-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
133198,6w9c,DB01392,-8.9,Yohimbine,BLGXFZZNTVWLAY-SCYLSFHTSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
86035,6m3m,DB08361,-8.9,"2-{[(1R,2S)-2-aminocyclohexyl]amino}-4-[(3-methylphenyl)amino]pyrimidine-5-carboxamide",NZNTWOVDIXCHHS-LSDHHAIUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86027,6m3m,DB08352,-8.9,"6-[4-(2-fluorophenyl)-1,3-oxazol-5-yl]-N-(1-methylethyl)-1,3-benzothiazol-2-amine",FQYJTHIYAQQJAB-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
26997,6cs2,DB06212,-8.9,Tolvaptan,GYHCTFXIZSNGJT-XMMPIXPASA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
160486,7bv1,DB08445,-8.9,"(3R,4S)-1-[6-(6-METHOXYPYRIDIN-3-YL)PYRIMIDIN-4-YL]-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE",IFKWHPAWYJARQJ-DYVFJYSZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
28247,6cs2,DB07827,-8.9,"4-{[1-METHYL-2,4-DIOXO-6-(3-PHENYLPROP-1-YN-1-YL)-1,4-DIHYDROQUINAZOLIN-3(2H)-YL]METHYL}BENZOIC ACID",FLTYDFYSVZBKOB-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
160293,7bv1,DB07975,-8.9,"2-({[3,5-DIFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)CYCLOPENT-1-ENE-1-CARBOXYLIC ACID",VTGXLCZUWFYELR-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
125070,6w4h,DB02009,-8.9,"L-756,423",AOMZDQMIOCTPQP-QHQMVRJISA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
140237,6w9c,DB15414,-8.9,CM-4307,MLDQJTXFUGDVEO-FIBGUPNXSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
164641,7bv1,DB08241,-8.9,4-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)--BENZAMIDE,RUUOIINPNMNPIU-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
109222,6vxx,DB12914,-8.9,MGL-3196,FDBYIYFVSAHJLY-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86161,6m3m,DB08513,-8.9,[4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENYL]ACETIC ACID,PAIQRYUOBBCBSE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
109017,6vxx,DB11911,-8.9,Galunisertib,IVRXNBXKWIJUQB-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140716,6w9c,DB15170,-8.9,Evobrutinib,QUIWHXQETADMGN-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
83116,6m3m,DB03447,-8.9,Uridylyl-2'-5'-Phospho-Adenosine,QARCCHXXGAIRFS-KPKSGTNCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
71846,6lxt,DB15403,-8.9,Ziritaxestat,REQQVBGILUTQNN-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
162483,7bv1,DB02329,-8.9,Carbenoxolone,OBZHEBDUNPOCJG-WBXJDKIVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
132942,6w9c,DB01026,-8.9,Ketoconazole,XMAYWYJOQHXEEK-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
83555,6m3m,DB04042,-8.9,"2-[4-(Hydroxy-Methoxy-Methyl)-Benzyl]-7-(4-Hydroxymethyl-Benzyl)-1,1-Dioxo-3,6-Bis-Phenoxymethyl-1lambda6-[1,2,7]Thiadiazepane-4,5-Diol",XLJNZONSWKENRP-VABIIVNOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136847,6w9c,DB07607,-8.9,4-[5-(3-IODO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-1H-IMIDAZOL-4-YL]-PYRIDINE,RXDZANYWRNIAOR-HHHXNRCGSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
80793,6m3m,DB00438,-8.9,Ceftazidime,ORFOPKXBNMVMKC-DWVKKRMSSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83728,6m3m,DB04270,-8.9,(S)-3-(4-(2-Carbazol-9-Yl-Ethoxy)-Phenyl)-2-Ethoxy-Propionic Acid,WUZIMDSVRIBNNI-DEOSSOPVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
127561,6w4h,DB06393,-8.9,Xaliproden,WJJYZXPHLSLMGE-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
85755,6m3m,DB08026,-8.9,"2-{4-[(4-imidazo[1,2-a]pyridin-3-ylpyrimidin-2-yl)amino]piperidin-1-yl}-N-methylacetamide",AJLILYAPRHIFAS-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
17999,6cs2,HMDB0011628,-8.9,Glycyrrhetinic acid,MPDGHEJMBKOTSU-WFJWTYAKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
104930,6vxs,DB12725,-8.9,TD-8954,MZOITCJKGUIQEI-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
83692,6m3m,DB04216,-8.9,Quercetin,REFJWTPEDVJJIY-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85835,6m3m,DB08116,-8.9,"(3R)-4-{[(3,4-dihydroxyphenyl)acetyl]oxy}-N-(2-formylindolizin-3-yl)-3-sulfino-D-valine",DEOZLEGRVHDNKC-UGKGYDQZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
128443,6w4h,DB07618,-8.9,"2-(4-(AMINOMETHYL)PIPERIDIN-1-YL)-N-(3_CYCLOHEXYL-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)ACETAMIDE",AITZHKQVQNLKHI-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
71787,6lxt,DB15282,-8.9,Fluorofuranylnorprogesterone F-18,VJKRBRUNEOHPBS-JQKUZGBFSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
13102,6lzg,DB14675,-8.9,Temsavir,QRPZBKAMSFHVRW-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
125599,6w4h,DB02698,-8.9,"N-(M-Trifluoromethylphenyl) Phenoxazine-4,6-Dicarboxylic Acid",NQOOJFXBGLOGTC-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
84187,6m3m,DB04882,-8.9,Edotecarin,QMVPQBFHUJZJCS-NTKFZFFISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86187,6m3m,DB08543,-8.9,1-[2-HYDROXY-3-(4-CYCLOHEXYL-PHENOXY)-PROPYL]-4-(2-PYRIDYL)-PIPERAZINE,BZJHCQBNFUNZPJ-QFIPXVFZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
106289,6vxs,DB15401,-8.9,Danicopan,PIBARDGJJAGJAJ-NQIIRXRSSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
137086,6w9c,DB07879,-8.9,"N-hydroxy-5-[(3-phenyl-5,6-dihydroimidazo[1,2-a]pyrazin-7(8H)-yl)carbonyl]thiophene-2-carboxamide",SMSIXMLQOONOQQ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
68944,6lxt,DB08520,-8.9,"(21S)-1AZA-4,4-DIMETHYL-6,19-DIOXA-2,3,7,20-TETRAOXOBICYCLO[19.4.0] PENTACOSANE",VUCSBBBCFXBFFY-IBGZPJMESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
104878,6vxs,DB12649,-8.9,Ibipinabant,AXJQVVLKUYCICH-OAQYLSRUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
59437,6crv,DB07460,-8.9,2-({5-CHLORO-2-[(2-METHOXY-4-MORPHOLIN-4-YLPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)-N-METHYLBENZAMIDE,UYJNQQDJUOUFQJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55611,6crv,DB01200,-8.9,Bromocriptine,OZVBMTJYIDMWIL-AYFBDAFISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80757,6m3m,DB00394,-8.9,Beclomethasone dipropionate,KUVIULQEHSCUHY-XYWKZLDCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
108972,6vxx,DB11845,-8.9,Lucitanib,CUDVHEFYRIWYQD-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
160097,7bv1,DB07508,-8.9,4-(5-BENZENESULFONYLAMINO-1-METHYL-1H-BENZOIMIDAZOL-2-YLMETHYL)-BENZAMIDINE,MEUAVGJWGDPTLF-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
80406,6m2n,DB15294,-8.9,SB-1578,NNXDIGHYPZHXTR-ONEGZZNKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
86179,6m3m,DB08534,-8.9,"5-(2-fluorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",ZAIYYXVHGBMLEC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86061,6m3m,DB08393,-8.9,"2-[(5,6-DIPHENYLFURO[2,3-D]PYRIMIDIN-4-YL)AMINO]ETHANOL",UQHINZSKNAAVOZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
57531,6crv,DB03791,-8.9,"(3-{3-[[2-Chloro-3-(Trifluoromethyl)Benzyl](2,2-Diphenylethyl)Amino]Propoxy}Phenyl)Acetic Acid",NAXSRXHZFIBFMI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86049,6m3m,DB08379,-8.9,6-(4-chloro-2-fluoro-3-phenoxybenzyl)pyridazin-3(2H)-one,NOVPOXGMADEKPP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
72154,6m2n,DB00402,-8.9,Eszopiclone,GBBSUAFBMRNDJC-INIZCTEOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
64089,6lxt,DB01051,-8.9,Novobiocin,YJQPYGGHQPGBLI-KGSXXDOSSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
69943,6lxt,DB11923,-8.9,Decoglurant,DMJHZVARRXJSEG-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
55621,6crv,DB01212,-8.9,Ceftriaxone,VAAUVRVFOQPIGI-SPQHTLEESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
135845,6w9c,DB05327,-8.9,Ranirestat,QCVNMNYRNIMDKV-QGZVFWFLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
84008,6m3m,DB04643,-8.9,"4-{3-CHLORO-4-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-PHENOXY}-BUTYRIC ACID",FYQVFMLCZJZZEM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85777,6m3m,DB08052,-8.9,"1-cyclopentyl-3-(1H-pyrrolo[2,3-b]pyridin-5-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine",NVRXTLZYXZNATH-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58193,6crv,DB04669,-8.9,TRIAZOLOPYRIMIDINE,YWBFPKPWMSWWEA-UHFFFAOYSA-O,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106321,6vxs,DB15460,-8.9,AGG-523,JWQMTWCFNZSLNR-DEOSSOPVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
83471,6m3m,DB03926,-8.9,"5-Alpha-Androstane-3-Beta,17-Alpha-Diol",CBMYJHIOYJEBSB-MFXFBURESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
133168,6w9c,DB01328,-8.9,Cefonicid,DYAIAHUQIPBDIP-AXAPSJFSSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
29935,6cs2,DB11829,-8.9,Ruboxistaurin,ZCBUQCWBWNUWSU-SFHVURJKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
109461,6vxx,DB13606,-8.9,Phenazocine,ZQHYKVKNPWDQSL-KNXBSLHKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140331,6w9c,DB03758,-8.9,Radicicol,WYZWZEOGROVVHK-GTMNPGAYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
69517,6lxt,DB09319,-8.9,Carindacillin,JIRBAUWICKGBFE-MNRDOXJOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
127890,6w4h,DB06977,-8.9,(2S)-1-{[5-(1H-Indazol-5-yl)-3-pyridinyl]oxy}-3-(7aH-indol-3-yl)-2-propanamine,CAASENZOSQYNPX-HSTJUUNISA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
106080,6vxs,DB14943,-8.9,LGH-447,VRQXRVAKPDCRCI-ZNMIVQPWSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
59163,6crv,DB07145,-8.9,(2R)-N-HYDROXY-2-[(3S)-3-METHYL-3-{4-[(2-METHYLQUINOLIN-4-YL)METHOXY]PHENYL}-2-OXOPYRROLIDIN-1-YL]PROPANAMIDE,YDMIPBHQKFOFQW-NSYGIPOTSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86176,6m3m,DB08531,-8.9,"5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",CVYWYUAQFJMLEO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83554,6m3m,DB04040,-8.9,"N-(2-Morpholin-4-Yl-1-Morpholin-4-Ylmethyl-Ethyl)-3-Nitro-5-(3,4,5-Trihydroxy-6-Hydroxymethyl-Tetrahydro-Pyran-2-Yloxy)-Benzamide",MCMWCTMAKPQTPI-WGNYYXNJSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83530,6m3m,DB04005,-8.9,Uridine 5'-triphosphate,PGAVKCOVUIYSFO-XVFCMESISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83121,6m3m,DB03453,-8.9,Methyl (2S)-2-[[2-[(3R)-1-carbamimidoylpiperidin-3-yl]acetyl]amino]-3-[4-(2-phenylethynyl)phenyl]propanoate,MRNGXYMKYHNMLV-PKTZIBPZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59162,6crv,DB07144,-8.9,"5-[(3R)-3-(5-methoxy-2',6'-dimethylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",XZXVRKHUCSXVBM-AWEZNQCLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57575,6crv,DB03844,-8.9,"N-(2,6-Diflouro-Benzyl)-4-Sulfamoyl-Benzamide",ZFNCKGXGCCDDFN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
137093,6w9c,DB07891,-8.9,"4-{[(14beta,17alpha)-3-hydrox1tra-1,3,5(10)-trien-17-yl]oxy}-4-oxobutanoic acid",YJPIDPAGJSWWBE-FNIAAEIWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
127646,6w4h,DB06605,-8.9,Apixaban,QNZCBYKSOIHPEH-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
108983,6vxx,DB11864,-8.9,Preladenant,DTYWJKSSUANMHD-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80380,6m2n,DB15241,-8.9,Methylsamidorphan,ATCVVCBJNHXIEX-ZAHKBLQYSA-O,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
59434,6crv,DB07457,-8.9,"3-[1-(3-AMINOPROPYL)-1H-INDOL-3-YL]-4-(1H-INDOL-3-YL)-1H-PYRROLE-2,5-DIONE",APYXQTXFRIDSGE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80734,6m3m,DB00367,-8.9,Levonorgestrel,WWYNJERNGUHSAO-XUDSTZEESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
64125,6lxt,DB01092,-8.9,Ouabain,LPMXVESGRSUGHW-HBYQJFLCSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
71802,6lxt,DB15305,-8.9,Risdiplam,ASKZRYGFUPSJPN-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
105193,6vxs,DB13138,-8.9,Neladenoson bialanate,WESNEIGKOAXSGX-VXKWHMMOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
16681,6cs2,HMDB0003448,-8.9,"3-Hydroxy-b,e-caroten-3'-one",OABQIJAIRYEICK-DKLMTRRASA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
127612,6w4h,DB06519,-8.9,Edaglitazone,HAAXAFNSRADSMK-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
71855,6lxt,DB15416,-8.9,PX-102,XBUXXJUEBFDQHD-NHCUHLMSSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
83959,6m3m,DB04578,-8.9,"(S)-2-[(R)-3-amino-4-(2-fluorophenyl)butyryl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide",OEVYDSSAPNIURZ-AEFFLSMTSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
101189,6vxs,DB04591,-8.9,"N-{2,2-DIFLUORO-2-[(2R)-PIPERIDIN-2-YL]ETHYL}-2-[2-(1H-1,2,4-TRIAZOL-1-YL)BENZYL][1,3]OXAZOLO[4,5-C]PYRIDIN-4-AMINE",VYJOAYZRCNHDNG-GOSISDBHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101202,6vxs,DB04607,-8.9,"PHENYLAMINOIMIDAZO(1,2-ALPHA)PYRIDINE",UQAWGIKJINAKIZ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
105065,6vxs,DB12941,-8.9,ODM-201,BLIJXOOIHRSQRB-PXYINDEMSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
80557,6m3m,DB00158,-8.9,Folic acid,OVBPIULPVIDEAO-LBPRGKRZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59231,6crv,DB07226,-8.9,"N-[4-(2-CHLOROPHENYL)-1,3-DIOXO-1,2,3,6-TETRAHYDROPYRROLO[3,4-C]CARBAZOL-9-YL]FORMAMIDE",JWZVNUNTFNELHL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55484,6crv,DB01058,-8.9,Praziquantel,FSVJFNAIGNNGKK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
135820,6w9c,DB05171,-8.9,E-2012,PUOAETJYKQITMO-LANLRWRYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
71986,6m2n,DB00203,-8.9,Sildenafil,BNRNXUUZRGQAQC-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
132884,6w9c,DB00959,-8.9,Methylprednisolone,VHRSUDSXCMQTMA-PJHHCJLFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
57366,6crv,DB03572,-8.9,FR230513,URGFTPMACWKJKU-OAHLLOKOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127628,6w4h,DB06558,-8.9,Tezosentan,TUYWTLTWNJOZNY-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
57889,6crv,DB04263,-8.9,Geneticin,BRZYSWJRSDMWLG-DJWUNRQOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109141,6vxx,DB12428,-8.9,PAC-14028,UKGJZDSUJSPAJL-YPUOHESYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86141,6m3m,DB08491,-8.9,N-HYDROXY-2-[4-(4-PHENOXY-BENZENESULFONYL)-TETRAHYDRO-PYRAN-4-YL]-ACETAMIDE,ARIRIZBKMKMEBD-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
105086,6vxs,DB12973,-8.9,Serlopitant,FLNYCRJBCNNHRH-OIYLJQICSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
105089,6vxs,DB12978,-8.9,Pexidartinib,JGWRKYUXBBNENE-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
106174,6vxs,DB15168,-8.9,Cilofexor,KZSKGLFYQAYZCO-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
69227,6lxt,DB08867,-8.9,Ulipristal,HKDLNTKNLJPAIY-WKWWZUSTSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
58119,6crv,DB04573,-8.9,Estriol,PROQIPRRNZUXQM-ZXXIGWHRSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
69203,6lxt,DB08827,-8.9,Lomitapide,MBBCVAKAJPKAKM-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
83629,6m3m,DB04140,-8.9,1-Benzyl-3-(4-Methoxy-Benzenesulfonyl)-6-Oxo-Hexahydro-Pyrimidine-4-Carboxylic Acid Hydroxyamide,SUSMVCKSLVPRCL-QGZVFWFLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
109275,6vxx,DB12999,-8.9,MK-6186,FZBAOOQVQXATRL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
105028,6vxs,DB12887,-8.9,Tazemetostat,NSQSAUGJQHDYNO-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
72220,6m2n,DB00482,-8.9,Celecoxib,RZEKVGVHFLEQIL-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80397,6m2n,DB15281,-8.9,Ravoxertinib,RZUOCXOYPYGSKL-GOSISDBHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
71967,6m2n,DB00180,-8.9,Flunisolide,XSFJVAJPIHIPKU-XWCQMRHXSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
26162,6cs2,DB04238,-8.9,N-Alpha-(2-Naphthylsulfonyl)-N-(3-Amidino-L-Phenylalaninyl)-D-Pipecolinic Acid,GNANSBQAIRJZPA-XZOQPEGZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
100159,6vxs,DB03207,-8.9,"2-(Biphenyl-4-Sulfonyl)-1,2,3,4-Tetrahydro-Isoquinoline-3-Carboxylic Acid",BNVMUDXGABBWGP-OAQYLSRUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
83311,6m3m,DB03725,-8.9,Phosphomethylphosphonic Acid-Guanylate Ester,PHBDHXOBFUBCJD-KQYNXXCUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
72049,6m2n,DB00275,-8.9,Olmesartan,VTRAEEWXHOVJFV-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
83338,6m3m,DB03758,-8.9,Radicicol,WYZWZEOGROVVHK-GTMNPGAYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80482,6m2n,DB15448,-8.9,Acumapimod,VGUSQKZDZHAAEE-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
136915,6w9c,DB07686,-8.9,"4-{[5-(CYCLOHEXYLAMINO)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE",VPOGRVWIIVMWRI-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
106047,6vxs,DB14882,-8.9,CEP-9722,CTLOSZHDGZLOQE-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
84114,6m3m,DB04792,-8.9,"2,5-O,O-BIS-{4',4''-AMIDINOPHENYL}-1,4:3,6-DIANHYDRO-D-SORBITOL",CDEVHSIVANGYRI-XMTFNYHQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
16731,6cs2,HMDB0003993,-8.9,Alpha-Carotene,ANVAOWXLWRTKGA-JLTXGRSLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
109291,6vxx,DB13022,-8.9,LY-2874455,GKJCVYLDJWTWQU-CXLRFSCWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55496,6crv,DB01070,-8.9,Dihydrotachysterol,ILYCWAKSDCYMBB-OPCMSESCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85992,6m3m,DB08308,-8.9,"SUCCINIC ACID MONO-(13-METHYL-3-OXO-2,3,6,7,8,9,10,11,12,13,14,15,16,17-TETRADECAHYDRO-1H-CYCLOPENTA[A]PHENANTHREN-17-YL) ESTER",IRQUJNVGEAJGSD-KIEDKLRZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
10213,6lzg,DB08387,-8.9,2-{[4-(1-methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline,AZEXWHKOMMASPA-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
100261,6vxs,DB03336,-8.9,BIA,KVIVJQWOYSWCCZ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
100349,6vxs,DB03461,-8.9,2'-Monophosphoadenosine 5'-Diphosphoribose,XJLXINKUBYWONI-NNYOXOHSSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
133047,6w9c,DB01147,-8.9,Cloxacillin,LQOLIRLGBULYKD-JKIFEVAISA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
100996,6vxs,DB04330,-8.9,Bilh 434,KNRVCCXHLSHTFW-HGPRPZRGSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
127683,6w4h,DB06684,-8.9,Vilazodone,SGEGOXDYSFKCPT-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
109109,6vxx,DB12389,-8.9,Zamicastat,ZSSLCFLHEFXANG-GOSISDBHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
64262,6lxt,DB01251,-8.9,Gliquidone,LLJFMFZYVVLQKT-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
83598,6m3m,DB04098,-8.9,Balanol,XYUFCXJZFZPEJD-PGRDOPGGSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
57385,6crv,DB03596,-8.9,N-[2-(1h-Indol-5-Yl)-Butyl]-4-Sulfamoyl-Benzamide,FSRPBGBMEKDSIJ-CYBMUJFWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
105405,6vxs,DB13454,-8.9,Nicomorphine,HNDXBGYRMHRUFN-CIVUWBIHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
125267,6w4h,DB02269,-8.9,[4-({[5-Benzyloxy-1-(3-Carbamimidoyl-Benzyl)-1h-Indole-2-Carbonyl]-Amino}-Methyl)-Phenyl]-Trimethyl-Ammonium,UFKJQTGPBFWMGT-UHFFFAOYSA-O,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
80363,6m2n,DB15208,-8.9,NOP-1A,MZBCQWLYUQJXKA-KRWDZBQOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80344,6m2n,DB15173,-8.9,JNJ-42165279,YWGYNGCRVZLMCS-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
55358,6crv,DB00912,-8.9,Repaglinide,FAEKWTJYAYMJKF-QHCPKHFHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
125290,6w4h,DB02300,-8.9,Calcipotriol,LWQQLNNNIPYSNX-UROSTWAQSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
69737,6lxt,DB11614,-8.9,Rupatadine,WUZYKBABMWJHDL-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
72071,6m2n,DB00301,-8.9,Flucloxacillin,UIOFUWFRIANQPC-JKIFEVAISA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
109024,6vxx,DB11921,-8.9,Deflazacort,FBHSPRKOSMHSIF-GRMWVWQJSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72222,6m2n,DB00485,-8.9,Dicloxacillin,YFAGHNZHGGCZAX-JKIFEVAISA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
86088,6m3m,DB08429,-8.9,N-({(2S)-1-[(3R)-3-amino-4-(3-chlorophenyl)butanoyl]pyrrolidin-2-yl}methyl)-3-(methylsulfonyl)benzamide,QRGBOABBMKYMLG-UXHICEINSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83838,6m3m,DB04424,-8.9,RPR128515,XFKVLKLCLYJKNF-MZNJEOGPSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
28188,6cs2,DB07769,-8.9,S-3-(4-FLUOROPHENOXY)-2-HYDROXY-2-METHYL-N-[4-NITRO-3-(TRIFLUOROMETHYL)PHENYL]PROPANAMIDE,KJMFOTCDISOHDX-INIZCTEOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
160435,7bv1,DB08384,-8.9,2-({4-[4-(pyridin-4-ylmethyl)-1H-pyrazol-3-yl]phenoxy}methyl)quinoline,RQDDHVVAAJVVKM-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
164442,7bv1,DB07834,-8.9,"N-(cyclopropylmethyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-4-carboxamide",FOHZGCHKLPIBBX-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59276,6crv,DB07278,-8.9,2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}ETHENESULFONAMIDE,ACEFOQMQINFMRW-DYCFVMESSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
16630,6cs2,HMDB0003233,-8.9,Lutein,KBPHJBAIARWVSC-RTIVXWJOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
63719,6lxt,DB00619,-8.9,Imatinib,KTUFNOKKBVMGRW-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
11457,6lzg,DB11995,-8.9,Avatrombopag,OFZJKCQENFPZBH-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
80372,6m2n,DB15227,-8.9,Tirabrutinib,SEJLPXCPMNSRAM-GOSISDBHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
69846,6lxt,DB11786,-8.9,Pefcalcitol,SVCSMAZYWOQCBW-NVJMFHFGSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
109180,6vxx,DB12483,-8.9,Copanlisib,PZBCKZWLPGJMAO-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
105731,6vxs,DB13930,-8.9,Ulixertinib,KSERXGMCDHOLSS-LJQANCHMSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
55553,6crv,DB01137,-8.9,Levofloxacin,GSDSWSVVBLHKDQ-JTQLQIEISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27048,6cs2,DB06321,-8.9,R-348,IGLNXKVGKIFNBQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
80316,6m2n,DB15120,-8.9,GSK-239512,YFRBKEVUUCQYOW-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
164554,7bv1,DB08137,-8.9,(4E)-N-(4-fluorophenyl)-4-[(phenylcarbonyl)imino]-4H-pyrazole-3-carboxamide,ZMWYSLJBNJUCRK-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
69757,6lxt,DB11652,-8.9,Tucatinib,SDEAXTCZPQIFQM-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
99945,6vxs,DB02917,-8.9,N-Hydroxy-4-(Methyl{[5-(2-Pyridinyl)-2-Thienyl]Sulfonyl}Amino)Benzamide,LFGYSFPVLMPUPE-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
83670,6m3m,DB04190,-8.9,Inhibitor Bea425,AHAVBKNGKPWROK-UMFPTGFGSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
164438,7bv1,DB07830,-8.9,"(4R,5R)-5-AMINO-1-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN-2-ONE",DIRIFWIKLRTNMB-DYVFJYSZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
55565,6crv,DB01150,-8.9,Cefprozil,WDLWHQDACQUCJR-PBFPGSCMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
83556,6m3m,DB04044,-8.9,4-{2-[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid,NAQUAVBNIYTIIS-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
27153,6cs2,DB06590,-8.9,Ceftaroline fosamil,ZCCUWMICIWSJIX-NQJJCJBVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
59418,6crv,DB07439,-8.9,"1-((2-HYDROXYETHOXY)METHYL)-5-(3-(BENZYLOXY)BENZYL)-6-HYDROXYPYRIMIDINE-2,4(1H,3H)-DIONE",CAWXCABXSPTFRN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
71862,6lxt,DB15435,-8.9,BMS-986158,KGERZPVQIRYWRK-GDLZYMKVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
136983,6w9c,DB07765,-8.9,"METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL](METHYL)AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE",UKCFUFHREWUXJJ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
100430,6vxs,DB03583,-8.9,"(2e,3s)-3-Hydroxy-5'-[(4-Hydroxypiperidin-1-Yl)Sulfonyl]-3-Methyl-1,3-Dihydro-2,3'-Biindol-2'(1'h)-One",AYOAIABDFUJDKQ-SQJPUDIVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
109053,6vxx,DB11964,-8.9,Ilaprazole,HRRXCXABAPSOCP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
162326,7bv1,DB01908,-8.9,RU85493,MWEWSHNGVWABKG-SVBPBHIXSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
72114,6m2n,DB00354,-8.9,Buclizine,MOYGZHXDRJNJEP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
72072,6m2n,DB00303,-8.9,Ertapenem,JUZNIMUFDBIJCM-ANEDZVCMSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
83881,6m3m,DB04480,-8.9,"3-(4-Fluorophenyl)-2-(6-Methylpyridin-2-Yl)-5,6-Dihydro-4h-Pyrrolo[1,2-B]Pyrazole",NBDZLUOYAAVYHF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
106227,6vxs,DB15273,-8.9,VS-4718,IGUBBWJDMLCRIK-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
83578,6m3m,DB04073,-8.9,N-{3-[4-(3-aminopropyl)piperazin-1-yl]propyl}-3-(beta-D-galactopyranosyloxy)-5-nitrobenzamide,UEIGEWJJVQHIAX-DLBZZEGUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
114698,6vxx,DB14661,-8.9,Loperamide oxide,KXVSBTJVTUVNPM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
71883,6lxt,DB02524,-8.9,"2',3'-O-{4-[Hydroxy(oxido)-lambda5-azanylidene]-2,6-dinitro-2,5-cyclohexadiene-1,1-diyl}adenosine 5'-(tetrahydrogen triphosphate)",XFMMHXLUHKBKQE-UHEGPQQHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
23705,6cs2,HMDB0112260,-8.9,"(3R,6'R)-3-Hydroxy-3',4'-didehydro-beta,gamma-carotene",UIUSQYGQZRBKCC-NHWXEJKLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
69910,6lxt,DB11877,-8.9,Basmisanil,VCGRFBXVSFAGGA-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
69402,6lxt,DB09143,-8.9,Sonidegib,VZZJRYRQSPEMTK-CALCHBBNSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
140696,6w9c,DB15132,-8.9,AZD-8165,YUHNXUAATAMVKD-PZJWPPBQSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
109335,6vxx,DB13088,-8.9,AZD-0424,MVWATCATLSSVBH-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58135,6crv,DB04596,-8.9,"4-O-{4,6-O-[(1S)-1-Carboxyethylidene]-??-D-mannopyranosyl}-D-glucopyranuronic acid",GZJXZKGVHLWBOW-AISSFXTFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57864,6crv,DB04226,-8.9,Dihydro-Acarbose,CUAQESWNTOXZJZ-RTNAABQMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
69243,6lxt,DB08896,-8.9,Regorafenib,FNHKPVJBJVTLMP-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
160411,7bv1,DB08353,-8.9,"2-(CYCLOHEXYLMETHYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE",NCVMTHVSAJMOPI-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
162974,7bv1,DB03363,-8.9,3-Acetylpyridine Adenine Dinucleotide,KPVQNXLUPNWQHM-RBEMOOQDSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
57710,6crv,DB04023,-8.9,"Guanosine 5'-(Trihydrogen Diphosphate), P'-D-Mannopyranosyl Ester",DNBSDUDYNPJVCN-ZXTXFPBHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80629,6m3m,DB00240,-8.9,Alclometasone,FJXOGVLKCZQRDN-PHCHRAKRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
106236,6vxs,DB15291,-8.9,BMS-986142,ZRYMMWAJAFUANM-INIZCTEOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
160324,7bv1,DB08010,-8.9,"(3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-[(E)-2-phenylethenyl]-1H-indole-2,3-dione 3-oxime",DDHASJXGNUWZTM-ZLEWNXFRSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
57491,6crv,DB03742,-8.9,Compound 4-D,TWZNCTCQAGRUGQ-RRPNLBNLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
83843,6m3m,DB04432,-8.9,ZK-805623,ZXIHYCYAQUQHSG-UHFFFAOYSA-O,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
57603,6crv,DB03882,-8.9,"5-Alpha-Androstane-3-Beta,17beta-Diol",CBMYJHIOYJEBSB-YSZCXEEOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72232,6m2n,DB00496,-8.9,Darifenacin,HXGBXQDTNZMWGS-RUZDIDTESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
84156,6m3m,DB04841,-8.9,Flunarizine,SMANXXCATUTDDT-QPJJXVBHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
109057,6vxx,DB11968,-8.9,MK-7145,OCKGFTQIICXDQW-ZEQRLZLVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
125408,6w4h,DB02449,-8.9,3-(1h-Indol-3-Yl)-2-[4-(4-Phenyl-Piperidin-1-Yl)-Benzenesulfonylamino]-Propionic Acid,ULOTXPTWJAUGGE-MHZLTWQESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
135750,6w9c,DB04886,-8.9,Calanolide A,NIDRYBLTWYFCFV-FMTVUPSXSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
127817,6w4h,DB06888,-8.9,"(13R,15S)-13-METHYL-16-OXA-8,9,12,22,24-PENTAAZAHEXACYCLO[15.6.2.16,9.1,12,15.0,2,7.0,21,25]HEPTACOSA-1(24),2,4,6,17(25),18,20-HEPTAENE-23,26-DIONE",KBLPHMRCKHFBJB-OLZOCXBDSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
84826,6m3m,DB06944,-8.9,N-(3-cyclopropyl-1H-pyrazol-5-yl)-2-(2-naphthyl)acetamide,RIGZCVNCFXYBEG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85752,6m3m,DB08022,-8.9,"(2S)-1,3-benzothiazol-2-yl{2-[(2-pyridin-3-ylethyl)amino]pyrimidin-4-yl}ethanenitrile",RCYPVQCPYKNSTG-OAHLLOKOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85064,6m3m,DB07222,-8.9,(3S)-N-(5-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE,RJWMDETWDDESBP-ZDUSSCGKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136505,6w9c,DB07193,-8.9,"(2R,3R)-7-(methylsulfonyl)-3-(2,4,5-trifluorophenyl)-1,2,3,4-tetrahydropyrido[1,2-a]benzimidazol-2-amine",HJJAYSSCWGUPKO-ABAIWWIYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
108163,6vxx,DB07175,-8.9,N-{2-methyl-5-[(6-phenylpyrimidin-4-yl)amino]phenyl}methanesulfonamide,CXQRKICWSCAUGW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136232,6w9c,DB06879,-8.9,"5-(4'-AMINO-1'-ETHYL-5',8'-DIFLUORO-1'H-SPIRO[PIPERIDINE-4,2'-QUINAZOLINE]-1-YLCARBONYL)PICOLINONITRILE",QCFIRACCCDFXIP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
58758,6crv,DB06581,-8.9,Bevirimat,YJEJKUQEXFSVCJ-WRFMNRASSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163699,7bv1,DB05983,-8.9,Bardoxolone methyl,WPTTVJLTNAWYAO-KPOXMGGZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
84576,6m3m,DB06529,-8.9,Ocinaplon,OQJFBUOFGHPMSR-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
134842,6w9c,DB03638,-8.9,Cytidyl-2'-5'-Phospho-Guanosine,QZDUXDLOEVJGDG-VMIOUTBZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
107080,6vxx,DB02259,-8.9,"3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid (4-Sulfamoyl-Phenyl)-Amide",VSYGXLAJQDAWCZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58450,6crv,DB05316,-8.9,Pimavanserin,RKEWSXXUOLRFBX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
82291,6m3m,DB02358,-8.9,LY374571,SZHRIPFGZWWRKW-VIFPVBQESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
68154,6lxt,DB07586,-8.9,"5-(4-METHYL-BENZOYLAMINO)-BIPHENYL-3,4'-DICARBOXYLIC ACID 3-DIMETHYLAMIDE-4'-HYDROXYAMIDE",DOPFUKKMSDUVTQ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
107052,6vxx,DB02224,-8.9,Taxifolin,CXQWRCVTCMQVQX-LSDHHAIUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85081,6m3m,DB07245,-8.9,6-[2-(3'-METHOXYBIPHENYL-3-YL)ETHYL]PYRIDIN-2-AMINE,AEVBKBAFFJKFJZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58766,6crv,DB06597,-8.9,Estradiol sulfamate,YXYXCSOJKUAPJI-ZBRFXRBCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
68180,6lxt,DB07618,-8.9,"2-(4-(AMINOMETHYL)PIPERIDIN-1-YL)-N-(3_CYCLOHEXYL-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)ACETAMIDE",AITZHKQVQNLKHI-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
126681,6w4h,DB04154,-8.9,"N-Methyl-N-[3-(6-Phenyl[1,2,4]Triazolo[4,3-B]Pyridazin-3-Yl)Phenyl]Acetamide",ALBWBHNFOJJMCV-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
81424,6m3m,DB01180,-8.9,Rescinnamine,SZLZWPPUNLXJEA-LAFLMMDJSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58771,6crv,DB06608,-8.9,Tafenoquine,LBHLFPGPEGDCJG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85086,6m3m,DB07250,-8.9,"N'-(5-CHLORO-1,3-BENZODIOXOL-4-YL)-N-(3,4,5- TRIMETHOXYPHENYL)PYRIMIDINE-2,4-DIAMINE",HMKLUOPMOJOUDZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
68183,6lxt,DB07622,-8.9,"1-(3-(2,4-DIMETHYLTHIAZOL-5-YL)-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)-3-(4-METHYLPIPERAZIN-1-YL)UREA",KRKQVGZXTNLQSV-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
104304,6vxs,DB11804,-8.9,AZD-5672,SCXSQUUTGCWHFU-WJOKGBTCSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
71125,6lxt,DB13676,-8.9,Mosapramine,PXUIZULXJVRBPC-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
164025,7bv1,DB06985,-8.9,2-[({4-[2-(trifluoromethyl)phenyl]piperidin-1-yl}carbonyl)amino]benzoic acid,MEAQCLPMSVEOQF-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
81514,6m3m,DB01326,-8.9,Cefamandole,OLVCFLKTBJRLHI-AXAPSJFSSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
107216,6vxx,DB02716,-8.9,7-Methyl-Guanosine-5'-Triphosphate,DKVRNHPCAOHRSI-KQYNXXCUSA-O,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
67342,6lxt,DB06497,-8.9,Aplaviroc,GWNOTCOIYUNTQP-FQLXRVMXSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
104238,6vxs,DB11704,-8.9,Adomeglivant,FASLTMSUPQDLIB-MHZLTWQESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
161041,7bv1,DB12784,-8.9,NS-018,UQTPDWDAYHAZNT-AWEZNQCLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
67324,6lxt,DB06455,-8.9,Meclinertant,DYLJVOXRWLXDIG-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
136458,6w9c,DB07140,-8.9,"5-[(3R)-3-(5-methoxybiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",JPENSYBRTSIYGO-AWEZNQCLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
107182,6vxx,DB02673,-8.9,"(4ar,6s,8ar)-11-[8-(1,3-Dioxo-1,3-Dihydro-2h-Isoindol-2-Yl)Octyl]-6-Hydroxy-3-Methoxy-5,6,9,10-Tetrahydro-4ah-[1]Benzofuro[3a,3,2-Ef][2]Benzazepin-11-Ium",VLGAHTYYCHWLNI-BHRZLAGCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
103024,6vxs,DB08080,-8.9,LATRUNCULIN B,NSHPHXHGRHSMIK-JRIKCGFMSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
134035,6w9c,DB02483,-8.9,Etheno-Nad,JCDBQDNBEQHDHK-BSLNIGMPSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
134028,6w9c,DB02473,-8.9,"6-[N-(1-Isopropyl-3,4-Dihydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine",XRHANBWAKSYPEN-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
56679,6crv,DB02640,-8.9,Fumagillin,NGGMYCMLYOUNGM-CSDLUJIJSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85038,6m3m,DB07190,-8.9,3-cyclohexyl-D-alanyl-N-(3-chlorobenzyl)-L-prolinamide,JGFCNVHEEMBVJG-MOPGFXCFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
134750,6w9c,DB03496,-8.9,Alvocidib,BIIVYFLTOXDAOV-YVEFUNNKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
84612,6m3m,DB06620,-8.9,Aplindore,DYJIKHYBKVODAC-ZDUSSCGKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58466,6crv,DB05422,-8.9,OPC-14523,TZZGTNZBLPCBIS-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56139,6crv,DB01938,-8.9,L-Histidine Beta Naphthylamide,DKDILZBBFKZMRO-OAHLLOKOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56647,6crv,DB02596,-8.9,"Alpha,Beta-Methyleneadenosine-5'-Triphosphate",CAWZRIXWFRFUQB-IOSLPCCCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136475,6w9c,DB07159,-8.9,Tamatinib,NHHQJBCNYHBUSI-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
68105,6lxt,DB07528,-8.9,3-(2-aminoquinazolin-6-yl)-4-methyl-1-[3-(trifluoromethyl)phenyl]pyridin-2(1H)-one,HXUZQEYFKAZBPX-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
81526,6m3m,DB01342,-8.9,Forasartan,YONOBYIBNBCDSJ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
161025,7bv1,DB12415,-8.9,Galeterone,PAFKTGFSEFKSQG-PAASFTFBSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
84590,6m3m,DB06578,-8.9,Tonabersat,XLIIRNOPGJTBJD-ROUUACIJSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
70356,6lxt,DB12523,-8.9,Mizolastine,PVLJETXTTWAYEW-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
56164,6crv,DB01965,-8.9,"2'-Deoxyuridine 5'-Alpha,Beta-Imido-Triphosphate",XZLLMTSKYYYJLH-SHYZEUOFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58783,6crv,DB06629,-8.9,Zibotentan,FJHHZXWJVIEFGJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136217,6w9c,DB06777,-8.9,Chenodeoxycholic acid,RUDATBOHQWOJDD-BSWAIDMHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
81344,6m3m,DB01089,-8.9,Deserpidine,CVBMAZKKCSYWQR-WCGOZPBSSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
108274,6vxx,DB07563,-8.9,"1-{7-cyclohexyl-6-[4-(4-methylpiperazin-1-yl)benzyl]-7H-pyrrolo[2,3-d]pyrimidin-2-yl}methanamine",GCJSOJRPNOWSEH-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
164095,7bv1,DB07253,-8.9,"N'-(5-chloro-1,3-benzodioxol-4-yl)-N-(3-methylsulfonylphenyl)pyrimidine-2,4-diamine",QTFCKBFCXDAZIU-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
84514,6m3m,DB06362,-8.9,Becatecarin,JSKFWUPVIZYJMR-UDOAKELVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
108279,6vxx,DB07570,-8.9,3-CYCLOHEXYL-1-(2-MORPHOLIN-4-YL-2-OXOETHYL)-2-PHENYL-1H-INDOLE-6-CARBOXYLIC ACID,ZKEZEXYKYHYIMQ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
102645,6vxs,DB07642,-8.9,"5-{[1-(2-fluorobenzyl)piperidin-4-yl]methoxy}quinazoline-2,4-diamine",GYKIQIOWVKCVBP-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
108290,6vxx,DB07584,-8.9,"N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine",OKGCSZUKOGMZAL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58416,6crv,DB05105,-8.9,Pleconaril,KQOXLKOJHVFTRN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
164098,7bv1,DB07256,-8.9,"3-({4-[(5-CHLORO-1,3-BENZODIOXOL-4-YL)AMINO]PYRIMIDIN-2-YL}AMINO)BENZAMIDE",ZVQZIVCQLFGXFZ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
85259,6m3m,DB07447,-8.9,5beta-dihydrotestosterone,NVKAWKQGWWIWPM-MISPCMORSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81317,6m3m,DB01058,-8.9,Praziquantel,FSVJFNAIGNNGKK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
12081,6lzg,DB12857,-8.9,NVP-LEQ-506,POERAARDVFVDLO-QGZVFWFLSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
135044,6w9c,DB03907,-8.9,"N-{3-[5-(6-Amino-Purin-9-Yl)-3,4-Dihydroxy-Tetrahydro-Furan-2-Yl]-Allyl}-2,3-Dihydroxy-5-Nitro-Benzamide",UHHBFOLQOQSPLU-WGRQDFERSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140542,6w9c,DB12036,-8.9,Naquotinib,QKDCLUARMDUUKN-XMMPIXPASA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
12583,6lzg,DB13552,-8.9,Trifluperidol,GPMXUUPHFNMNDH-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
135050,6w9c,DB03916,-8.9,4-{2-[4-(2-Aminoethyl)Piperazin-1-Yl]Pyridin-4-Yl}-N-(3-Chloro-4-Methylphenyl)Pyrimidin-2-Amine,RHOOHUMOHVIXEF-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
58881,6crv,DB06809,-8.9,Plerixafor,YIQPUIGJQJDJOS-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84493,6m3m,DB06292,-8.9,Dapagliflozin,JVHXJTBJCFBINQ-ADAARDCZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
27867,6cs2,DB07426,-8.9,"[1-HYDROXY-2-(1,1':3',1''-TERPHENYL-3-YLOXY)ETHANE-1,1-DIYL]BIS(PHOSPHONIC ACID)",NWIARQRYIRVYCM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
126486,6w4h,DB03893,-8.9,Thionicotinamide-Adenine-Dinucleotide,UQYPZLRUJKCREN-NNYOXOHSSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
82495,6m3m,DB02615,-8.9,Compound 19,UZOOIPXOYYJULJ-BLIZRMSTSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81349,6m3m,DB01094,-8.9,Hesperetin,AIONOLUJZLIMTK-AWEZNQCLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
55974,6crv,DB01708,-8.9,Prasterone,FMGSKLZLMKYGDP-USOAJAOKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85204,6m3m,DB07382,-8.9,"N-2-1H-benzimidazol-5-yl-N-4-(3-cyclopropyl-1H-pyrazol-5-yl)pyrimidine-2,4-diamine",WJNBSTLIALIIEW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85196,6m3m,DB07373,-8.9,"ANDROSTA-1,4-DIENE-3,17-DIONE",LUJVUUWNAPIQQI-QAGGRKNESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
71346,6lxt,DB14037,-8.9,Madecassic acid,PRAUVHZJPXOEIF-AOLYGAPISA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
108220,6vxx,DB07245,-8.9,6-[2-(3'-METHOXYBIPHENYL-3-YL)ETHYL]PYRIDIN-2-AMINE,AEVBKBAFFJKFJZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
128075,6w4h,DB07186,-8.9,"4-(4-METHYLPIPERAZIN-1-YL)-N-[5-(2-THIENYLACETYL)-1,5-DIHYDROPYRROLO[3,4-C]PYRAZOL-3-YL]BENZAMIDE",TYYNSDQVFIOSFH-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
160958,7bv1,DB12318,-8.9,BMS-599626,LUJZZYWHBDHDQX-QFIPXVFZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
84532,6m3m,DB06420,-8.9,Annamycin,CIDNKDMVSINJCG-GKXONYSUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
161497,7bv1,DB14918,-8.9,Branaplam,STWTUEAWRAIWJG-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
102766,6vxs,DB07786,-8.9,"1-((1R,2S)-1-{2-[2-(4-CHLOROPHENYL)-1,3-BENZOXAZOL-7-YL]ETHYL}-2-HYDROXYPROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE",SMFRBBHLVBWHGB-DJJJIMSYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
134934,6w9c,DB03768,-8.9,"N-[2-Hydroxy-2-(8-Isopropyl-6,9-Dioxo-2-Oxa-7,10-Diaza-Bicyclo[11.2.2]Heptadeca-1(16),13(17),14-Trien-11-Yl)-Ethyl]-N-(3-Methyl-Butyl)-Benzenesulfonamide,Inhibitor 3",WRUVOSYKHXGAQN-GKRYNVPLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
106940,6vxx,DB01774,-8.9,Adenosine-5'-Monophosphate Glucopyranosyl-Monophosphate Ester,WFPZSXYXPSUOPY-ROYWQJLOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
161505,7bv1,DB14935,-8.9,Serabelisib,BLGWHBSBBJNKJO-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
56692,6crv,DB02656,-8.9,LY-294002,CZQHHVNHHHRRDU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56738,6crv,DB02715,-8.9,Compound 18,UZOOIPXOYYJULJ-RHLLTPQKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
82395,6m3m,DB02485,-8.9,Cytidine-5'-Monophosphate-5-N-Acetylneuraminic Acid,TXCIAUNLDRJGJZ-BILDWYJOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
127361,6w4h,DB05511,-8.9,Piclidenoson,HUJXGQILHAUCCV-MOROJQBDSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
85172,6m3m,DB07343,-8.9,"4-[4-AMINO-6-(2,6-DICHLORO-PHENOXY)-[1,3,5]TRIAZIN-2-YLAMINO]-BENZONITRILE",NFNNMVVXXITVGD-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
55983,6crv,DB01720,-8.9,(2z)-2-(Benzoylamino)-3-[4-(2-Bromophenoxy)Phenyl]-2-Propenoic Acid,WLPJLQNKCJWAFL-RGEXLXHISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108253,6vxx,DB07538,-8.9,"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}-2-(TRIFLUOROMETHYL)BENZENESULFONAMIDE",RGVVHQNJKUNSFQ-WDZFZDKYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
161506,7bv1,DB14937,-8.9,MK-8666,CODQKEMYZZKQAE-QPVYNBJUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
81371,6m3m,DB01120,-8.9,Gliclazide,BOVGTQGAOIONJV-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81368,6m3m,DB01116,-8.9,Trimethaphan,CHQOEHPMXSHGCL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
133789,6w9c,DB02154,-8.9,"2,3-Bis-Benzo[1,3]Dioxol-5-Ylmethyl-Succinic Acid",FFYBYVPVYLMLAR-KBPBESRZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
108259,6vxx,DB07545,-8.9,N-{3-[(4-{[3-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-2-YL)AMINO]PHENYL}CYCLOPROPANECARBOXAMIDE,RDTDWGQDFJPTPD-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
67086,6lxt,DB05450,-8.9,Smilagenin,GMBQZIIUCVWOCD-UQHLGXRBSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
140440,6w9c,DB06844,-8.9,"4-[(7-OXO-7H-THIAZOLO[5,4-E]INDOL-8-YLMETHYL)-AMINO]-N-PYRIDIN-2-YL-BENZENESULFONAMIDE",MBXKBJLIESPLIK-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
103061,6vxs,DB08121,-8.9,(2S)-2-(biphenyl-4-yloxy)-3-phenylpropanoic acid,TZTPJJNNACUQQR-FQEVSTJZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
85015,6m3m,DB07165,-8.9,N-(5-CHLORO-BENZO[B]THIOPHEN-3-YLMETHYL)-2-[6-CHLORO-OXO-3-(2-PYRIDIN-2-YL-ETHYLAMINO)-2H-PYRAZIN-1-YL]-ACETAMIDE,SOBGXPPOYFFGTK-UGKGYDQZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81793,6m3m,DB01689,-8.9,Inhibitor Idd 384,CJKKMQCZOLCXAM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84875,6m3m,DB07005,-8.9,D-phenylalanyl-N-{4-[amino(iminio)methyl]benzyl}-L-prolinamide,VZFTWWJAUZOJDH-MOPGFXCFSA-O,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
103472,6vxs,DB08619,-8.9,Testosterone succinate,CJQNBXFUHQZFOE-VYAQIDIUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
26690,6cs2,DB04875,-8.9,Pralnacasan,CXAGHAZMQSCAKJ-WAHHBDPQSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
17470,6cs2,HMDB0007424,-8.9,"DG(20:2(11Z,14Z)/18:3(9Z,12Z,15Z)/0:0)",YPKNZQFRRNHQIM-CNWVQWJYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
114732,6vxx,DB14729,-8.9,Rebeccamycin,QEHOIJJIZXRMAN-QZQSLCQPSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
161414,7bv1,DB13993,-8.9,MRK-409,GOIFCXRIFSYPFG-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
103461,6vxs,DB08607,-8.9,"(5R)-5-(4-{[(2R)-6-HYDROXY-2,5,7,8-TETRAMETHYL-3,4-DIHYDRO-2H-CHROMEN-2-YL]METHOXY}BENZYL)-1,3-THIAZOLIDINE-2,4-DIONE",GXPHKUHSUJUWKP-NTKDMRAZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
107864,6vxx,DB05295,-8.9,Eldecalcitol,FZEXGDDBXLBRTD-AYIMTCTASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
134277,6w9c,DB02859,-8.9,Soraphen A,WPMGNXPRKGXGBO-OFQQMTDKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
84889,6m3m,DB07022,-8.9,3-Hydroxypropyl 3-[(7-carbamimidoyl-1-naphthyl)carbamoyl]benzenesulfonate,PXERBGNIBOFZOW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58546,6crv,DB05864,-8.9,PPI-2458,QBDVVYNLLXGUGN-XGTBZJOHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
128131,6w4h,DB07254,-8.9,"N-[3-[[4-[(5-CHLORO-1,3-BENZODIOXOL-4-YL)AMINO]PYRIMIDIN-2-YL]AMINO]PHENYL]METHANESULFONAMIDE",KQGTYXRWSIBDOZ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
128168,6w4h,DB07294,-8.9,"3-fluoro-4-[2-hydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8,-tetrahydro-naphtalen-2-yl)-acetylamino]-benzoic acid",AANFHDFOMFRLLR-IBGZPJMESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
136314,6w9c,DB06977,-8.9,(2S)-1-{[5-(1H-Indazol-5-yl)-3-pyridinyl]oxy}-3-(7aH-indol-3-yl)-2-propanamine,CAASENZOSQYNPX-HSTJUUNISA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
103366,6vxs,DB08494,-8.9,"S-{2-[(2-chloro-4-sulfamoylphenyl)amino]-2-oxoethyl} 6-methyl-3,4-dihydroquinoline-1(2H)-carbothioate",AWAKIULNKVOBKE-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
140514,6w9c,DB11992,-8.9,Omarigliptin,MKMPWKUAHLTIBJ-ISTRZQFTSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
82057,6m3m,DB02046,-8.9,N-[(Furan-2-Yl)Carbonyl]-(S)-Leucyl-(R)-[1-Amino-2(1h-Indol-3-Yl)Ethyl]-Phosphonic Acid,WHPKSASOSKNDPY-PKOBYXMFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
114659,6vxx,DB14584,-8.9,Segesterone,SFLXYFZGKSGFKA-XUDSTZEESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58545,6crv,DB05861,-8.9,Tasquinimod,ONDYALNGTUAJDX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
134206,6w9c,DB02705,-8.9,"6-[N-(1-Isopropyl-1,2,3,4-Tetrahydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine",DARQQJKHXPXSRO-QFIPXVFZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
163808,7bv1,DB06346,-8.9,Fiboflapon,DFQGDHBGRSTTHX-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
67664,6lxt,DB07019,-8.9,"N-[(5R,14R)-5-AMINO-5,14-DIMETHYL-4-OXO-3-OXA-18-AZATRICYCLO[15.3.1.1-7,11-]DOCOSA-1(21),7(22),8,10,17,19-HEXAEN-19-YL]-N-METHYLMETHANESULFONAMIDE",QWDOKZPZLWNULU-MZNJEOGPSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
67844,6lxt,DB07226,-8.9,"N-[4-(2-CHLOROPHENYL)-1,3-DIOXO-1,2,3,6-TETRAHYDROPYRROLO[3,4-C]CARBAZOL-9-YL]FORMAMIDE",JWZVNUNTFNELHL-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
107547,6vxx,DB03744,-8.9,"Cp403700, (S)-1-{2-[(5-Chloro-1h-Indole-2-Carbonyl)-Amino]-3-Phenyl-Propionyl}-Azetidine-3-Carboxylate",RONLONYAIBUEKT-IBGZPJMESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84830,6m3m,DB06948,-8.9,2-ANILINO-6-CYCLOHEXYLMETHOXYPURINE,XWWRLKIBRPJQJX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
56415,6crv,DB02300,-8.9,Calcipotriol,LWQQLNNNIPYSNX-UROSTWAQSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58598,6crv,DB06163,-8.9,Plevitrexed,IEJSCSAMMLUINT-NRFANRHFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
103640,6vxs,DB08815,-8.9,Lurasidone,PQXKDMSYBGKCJA-CVTJIBDQSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
136374,6w9c,DB07043,-8.9,"7-amino-2-tert-butyl-4-(4-pyrimidin-2-ylpiperazin-1-yl)pyrido[2,3-d]pyrimidine-6-carboxamide",CKLCIJCZOIDJQU-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
81871,6m3m,DB01792,-8.9,Adenylyl-3'-5'-Phospho-Uridine-3'-Monophosphate,FZCSEXOMUJFOHQ-KPKSGTNCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
140498,6w9c,DB11965,-8.9,SJG-136,RWZVMMQNDHPRQD-SFTDATJTSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
81855,6m3m,DB01771,-8.9,CRA_10991,QXAURVOBXQBPAP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
163843,7bv1,DB06448,-8.9,Lonafarnib,DHMTURDWPRKSOA-RUZDIDTESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
134407,6w9c,DB03038,-8.9,LY341770,MXAFDBCLWLMXSI-ZDUSSCGKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
107908,6vxx,DB05532,-8.9,BMS-488043,DBPMWRYLTBNCCE-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56357,6crv,DB02226,-8.9,"3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-4-Yl]Hexyl]-Phenanthridinium",NAARZDJZGYBXKL-UHFFFAOYSA-O,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
103579,6vxs,DB08746,-8.9,1-[[(1E)-2-(4-CHLOROPHENYL)ETHENYL]SULFONYL]-4-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]PIPERAZINE,ZOSSOFIFNGGDKG-GIJQJNRQSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
58593,6crv,DB06155,-8.9,Rimonabant,JZCPYUJPEARBJL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
103578,6vxs,DB08745,-8.9,4-[[(1E)-2-(4-CHLOROPHENYL)ETHENYL]SULFONYL]-1-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]PIPERAZINONE,QLHUDNKWOSQSMK-CXUHLZMHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
81926,6m3m,DB01864,-8.9,5'-Guanosine-Diphosphate-Monothiophosphate,XOFLBQFBSOEHOG-UUOKFMHZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
134444,6w9c,DB03084,-8.9,"Cyclopropyl-{4-[5-(3,4-Dichlorophenyl)-2-[(1-Methyl)-Piperidin]-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine",XCTKFTOEAKJMII-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
81829,6m3m,DB01737,-8.9,"Nalpha-(2-Naphthylsulfonylglycyl)-3-Amidino-D,L-Phenylalanine-Isopropylester",YAEIKQDHLCFGAA-KRWDZBQOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
107785,6vxx,DB04612,-8.9,"N-METHYLALANYL-3-METHYLVALYL-4-PHENOXY-N-(1,2,3,4-TETRAHYDRONAPHTHALEN-1-YL)PROLINAMIDE",QKPXPZYQPBWDHS-MCJAPYMPSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
103761,6vxs,DB08995,-8.9,Diosmin,GZSOSUNBTXMUFQ-YFAPSIMESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
67665,6lxt,DB07020,-8.9,"N-{3-[5-(1H-1,2,4-triazol-3-yl)-1H-indazol-3-yl]phenyl}furan-2-carboxamide",LMDMJDCLPIVGQD-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
84863,6m3m,DB06993,-8.9,"(2S,3S)-4-cyclopropyl-3-{(3R,5R)-3-[2-fluoro-4-(methylsulfonyl)phenyl]-1,2,4-oxadiazolidin-5-yl}-1-[(3S)-3-fluoropyrrolidin-1-yl]-1-oxobutan-2-amine",PTAHVQJZNFGPHN-WFWWEWPISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
103687,6vxs,DB08896,-8.9,Regorafenib,FNHKPVJBJVTLMP-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
140464,6w9c,DB06874,-8.9,"(6-[4-(AMINOMETHYL)-2,6-DIMETHYLPHENOXY]-2-{[4-(AMINOMETHYL)PHENYL]AMINO}-5-BROMOPYRIMIDIN-4-YL)METHANOL",LSIZSSASMKSUIU-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
107912,6vxx,DB05552,-8.9,TG100-115,UJIAQDJKSXQLIT-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
11085,6lzg,DB00872,-8.9,Conivaptan,IKENVDNFQMCRTR-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
107320,6vxx,DB03159,-8.9,CRA_8696,GAVRMVQHHVMXFD-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
134086,6w9c,DB02545,-8.9,Fexaramine,VLQTUNDJHLEFEQ-KGENOOAVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
27743,6cs2,DB07297,-8.9,"5,6-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-D]PYRIMIDIN-4-AMINE",PTILEOLOGGMFCS-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
161434,7bv1,DB14035,-8.9,Englitazone,MVDXXGIBARMXSA-PYUWXLGESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
103146,6vxs,DB08221,-8.9,N-{4-METHYL-3-[(3-PYRIMIDIN-4-YLPYRIDIN-2-YL)AMINO]PHENYL}-3-(TRIFLUOROMETHYL)BENZAMIDE,NESXBRNDMQUVNG-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
107298,6vxx,DB03126,-8.9,Mant-Adp,QPKUEBLEGWBRHC-BFHYXJOUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127233,6w4h,DB04888,-8.9,Bifeprunox,CYGODHVAJQTCBG-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
103145,6vxs,DB08220,-8.9,"(8alpha,10alpha,13alpha,17beta)-17-[(4-hydroxyphenyl)carbonyl]androsta-3,5-diene-3-carboxylic acid",RPNNXCYIESWDSC-JRZBRKEGSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
82168,6m3m,DB02195,-8.9,"3-(4-Fluorophenyl)-1-Hydroxy-2-(Pyridin-4-Yl)-1h-Pyrrolo[3,2-B]Pyridine",ZSMYZLKEZDYVPI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
108042,6vxx,DB06743,-8.9,Ginkgolide A,FPUXKXIZEIDQKW-VKMVSBOZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58693,6crv,DB06410,-8.9,Doxercalciferol,HKXBNHCUPKIYDM-CGMHZMFXSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
134725,6w9c,DB03461,-8.9,2'-Monophosphoadenosine 5'-Diphosphoribose,XJLXINKUBYWONI-NNYOXOHSSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
58483,6crv,DB05498,-8.9,KW-7158,NAFSYPCVPLWHFY-HNNXBMFYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107245,6vxx,DB02759,-8.9,4-Methylumbelliferyl Chitobiose,UPSFMJHZUCSEHU-JYGUBCOQSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27593,6cs2,DB07142,-8.9,"5-[(3R)-3-(5-methoxy-3',5'-dimethylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",ATFDKOLABYIYCC-INIZCTEOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
108046,6vxx,DB06747,-8.9,ginkgolide-M,KDKROYXEHCYLJQ-FJFAJXJPSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
70749,6lxt,DB13138,-8.9,Neladenoson bialanate,WESNEIGKOAXSGX-VXKWHMMOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
27591,6cs2,DB07140,-8.9,"5-[(3R)-3-(5-methoxybiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",JPENSYBRTSIYGO-AWEZNQCLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
108062,6vxx,DB06786,-8.9,Halcinonide,MUQNGPZZQDCDFT-JNQJZLCISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107230,6vxx,DB02738,-8.9,Adenosine-5'-Pentaphosphate,WYJWVZZCMBUPSP-KQYNXXCUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
67371,6lxt,DB06581,-8.9,Bevirimat,YJEJKUQEXFSVCJ-WRFMNRASSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
134092,6w9c,DB02551,-8.9,"6-[N-(4-Ethyl-1,2,3,4-Tetrahydro-6-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine",LVNMYQLXKMSQTG-AWEZNQCLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
58675,6crv,DB06347,-8.9,Cenisertib,KSOVGRCOLZZTPF-QMKUDKLTSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
26773,6cs2,DB05129,-8.9,Elsamitrucin,MGQRRMONVLMKJL-KWJIQSIXSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
134649,6w9c,DB03351,-8.9,Sri-9439,KMSATRJZEXNGDP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
82101,6m3m,DB02102,-8.9,DMP450,KYRSNWPSSXSNEP-ZRTHHSRSSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
107931,6vxx,DB05667,-8.9,Levoketoconazole,XMAYWYJOQHXEEK-ZEQKJWHPSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81702,6m3m,DB01571,-8.9,3-Methylfentanyl,MLQRZXNZHAOCHQ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
134171,6w9c,DB02659,-8.9,Cholic Acid,BHQCQFFYRZLCQQ-OELDTZBJSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
67497,6lxt,DB06817,-8.9,Raltegravir,CZFFBEXEKNGXKS-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
128170,6w4h,DB07296,-8.9,(5Z)-3-(4-CHLOROPHENYL)-4-HYDROXY-5-(1-NAPHTHYLMETHYLENE)FURAN-2(5H)-ONE,PLGHLEBIWUQEPR-PDGQHHTCSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
67481,6lxt,DB06786,-8.9,Halcinonide,MUQNGPZZQDCDFT-JNQJZLCISA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
84949,6m3m,DB07089,-8.9,N-[amino(imino)methyl]-2-[2-(2-chlorophenyl)-4-(4-propoxyphenyl)-3-thienyl]acetamide,VZSMTBLDWPKVRW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
56233,6crv,DB02059,-8.9,Adenosine-5-Diphosphoribose,SRNWOUGRCWSEMX-ZQSHOCFMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
26663,6cs2,DB04841,-8.9,Flunarizine,SMANXXCATUTDDT-QPJJXVBHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
70684,6lxt,DB13040,-8.9,Gandotinib,SQSZANZGUXWJEA-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
104043,6vxs,DB11263,-8.9,Polydatin,HSTZMXCBWJGKHG-CUYWLFDKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
140493,6w9c,DB11960,-8.9,Carboxyamidotriazole,WNRZHQBJSXRYJK-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
81688,6m3m,DB01557,-8.9,??-Methylfentanyl,NGTVDHYUFBKWID-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84968,6m3m,DB07113,-8.9,"(2S)-6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2-(3,5-DIFLUOROPHENYL)-4-(3-METHOXYPROPYL)-2H-1,4-BENZOXAZIN-3(4H)-ONE",KHZQOXQOUCGGGA-NRFANRHFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
30026,6cs2,DB11949,-8.9,Vestipitant,SBBYBXSFWOLDDG-JLTOFOAXSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
140520,6w9c,DB12001,-8.9,Abemaciclib,UZWDCWONPYILKI-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
104048,6vxs,DB11274,-8.9,Dihydro-alpha-ergocryptine,PBUNVLRHZGSROC-VTIMJTGVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104103,6vxs,DB11424,-8.9,Lufenuron,PWPJGUXAGUPAHP-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
58672,6crv,DB06335,-8.9,Saxagliptin,QGJUIPDUBHWZPV-SGTAVMJGSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
70698,6lxt,DB13061,-8.9,MLN8054,HHFBDROWDBDFBR-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
82140,6m3m,DB02154,-8.9,"2,3-Bis-Benzo[1,3]Dioxol-5-Ylmethyl-Succinic Acid",FFYBYVPVYLMLAR-KBPBESRZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
103261,6vxs,DB08366,-8.9,"3-({3-[(1S,4aS,6S,7S,9S,9aR)-1,6-dimethyl-2-oxodecahydro-6,9-epoxy-4a,7-methanobenzo[7]annulen-1-yl]propanoyl}amino)-2,4-dihydroxybenzoic acid",XADCWKSMHQPTGH-OFBLZTNGSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
163088,7bv1,DB03751,-8.9,2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose,YSYKRGRSMLTJNL-URARBOGNSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
106829,6vxx,DB01347,-8.9,Saprisartan,DUEWVPTZCSAMNB-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
160863,7bv1,DB11830,-8.9,Mocetinostat,HRNLUBSXIHFDHP-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
108645,6vxx,DB08498,-8.9,"(1S)-1-(3-chlorophenyl)-2-oxo-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate",OVSAMUIBGQSLDC-INIZCTEOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58277,6crv,DB04790,-8.9,"2,5-bis-O-{3-[amino(imino)methyl]phenyl}-1,4:3,6-dianhydro-D-glucitol",IBIUTOFGXGGVKQ-XMTFNYHQSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85553,6m3m,DB07795,-8.9,Fisetin,XHEFDIBZLJXQHF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85563,6m3m,DB07806,-8.9,"(2R,4S)-2-[(R)-BENZYLCARBAMOYL-PHENYLACETYL-METHYL]-5,5-DIMETHYL-THIAZOLIDINE-4-CARBOXYLIC ACID",UDMBRVGTYILYDX-SVFBPWRDSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
101940,6vxs,DB06816,-8.9,Pyrvinium,QMHSXPLYMTVAMK-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
127948,6w4h,DB07041,-8.9,"N-[2-(2,4-diaminopyrido[2,3-d]pyrimidin-7-yl)-2-methylpropyl]-4-phenoxybenzamide",FDJWFDQRPKKBFA-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
114687,6vxx,DB14649,-8.9,Dexamethasone acetate,AKUJBENLRBOFTD-RPRRAYFGSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
68691,6lxt,DB08204,-8.9,3-DIPHENOL-6-NITRO-3H-BENZO[DE]ISOCHROMEN-1-ONE,FLWABCQDXUKNQY-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
85566,6m3m,DB07809,-8.9,4-({[4-(3-METHYLBENZOYL)PYRIDIN-2-YL]AMINO}METHYL)BENZENECARBOXIMIDAMIDE,MBJYEMUMDMGQQC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
57065,6crv,DB03157,-8.9,"N,O-Didansyl-L-Tyrosine",LUBOPDUYHWABFG-NDEPHWFRSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106542,6vxx,DB00470,-8.9,Dronabinol,CYQFCXCEBYINGO-IAGOWNOFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80969,6m3m,DB00655,-8.9,Estrone,DNXHEGUUPJUMQT-CBZIJGRNSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
65810,6lxt,DB03325,-8.9,Tyrosyladenylate,MJZAZMKENKZBAJ-QTOWJTHWSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
55720,6crv,DB01406,-8.9,Danazol,POZRVZJJTULAOH-LHZXLZLDSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
65799,6lxt,DB03311,-8.9,"3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid [4-(Thiazol-2-Ylsulfamoyl)-Phenyl]-Amide",SXKBTDJJEQQEGE-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
71668,6lxt,DB15047,-8.9,BMS-919373,XGKULQQVQWCASY-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
82921,6m3m,DB03186,-8.9,U-Pi-a-Pi,JIAJERGOUFOENU-LNAOLWRRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
163271,7bv1,DB04190,-8.9,Inhibitor Bea425,AHAVBKNGKPWROK-UMFPTGFGSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
106527,6vxx,DB00450,-8.9,Droperidol,RMEDXOLNCUSCGS-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
70021,6lxt,DB12044,-8.9,MK-0893,DNTVJEMGHBIUMW-IBGZPJMESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
106525,6vxx,DB00448,-8.9,Lansoprazole,MJIHNNLFOKEZEW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58278,6crv,DB04791,-8.9,"2-O-(4'-AMIDINOPHENYL)-5-O-(3''-AMIDINOPHENYL)-1,4:3,6-DIANHYDRO-D-SORBITOL",DKBAWRNTUZFJKV-BSDSXHPESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
11956,6lzg,DB12669,-8.9,4SC-203,MAFACRSJGNJHCF-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
108642,6vxx,DB08495,-8.9,4-({4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-2-OXOPIPERAZIN-1-YL}METHYL)BENZENECARBOXIMIDAMIDE,VXONTEUOQXFJJS-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27981,6cs2,DB07546,-8.9,[1-(6-{6-[(1-methylethyl)amino]-1H-indazol-1-yl}pyrazin-2-yl)-1H-pyrrol-3-yl]acetic acid,BBYRUZKRFAIQSR-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
58328,6crv,DB04850,-8.9,Posizolid,HBUJYEUPIIJJOS-PBHICJAKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55760,6crv,DB01452,-8.9,Diamorphine,GVGLGOZIDCSQPN-PVHGPHFFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81040,6m3m,DB00737,-8.9,Meclizine,OCJYIGYOJCODJL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
70106,6lxt,DB12165,-8.9,Presatovir,GOFXWTVKPWJNGD-UWJYYQICSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
82806,6m3m,DB03034,-8.9,D-Levofloxacin,GSDSWSVVBLHKDQ-SNVBAGLBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
108601,6vxx,DB08446,-8.9,"3-[6-bromo-2-fluoro-3-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)phenoxy]-5-chlorobenzonitrile",OHQMEDBYNUAVNE-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
65977,6lxt,DB03571,-8.9,"3-(5-Amino-7-Hydroxy-[1,2,3]Triazolo[4,5-D]Pyrimidin-2-Yl)-N-(3,5-Dichlorobenzyl)-Benzamide",JMQTXEWNXSPEKX-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
127102,6w4h,DB04716,-8.9,"2-(1,1-DIMETHYLETHYL)9-FLUORO-3,6-DIHYDRO-7H-BENZ[H]-IMIDAZ[4,5-F]ISOQUINOLIN-7-ONE",VNDWQCSOSCCWIP-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
106621,6vxx,DB00823,-8.9,Ethynodiol diacetate,ONKUMRGIYFNPJW-KIEAKMPYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
135368,6w9c,DB04373,-8.9,"4-Amino-N-{4-[2-(2,6-Dimethyl-Phenoxy)-Acetylamino]-3-Hydroxy-1-Isobutyl-5-Phenyl-Pentyl}-Benzamide",WQUBEIMCFHCJCO-AWCRTANDSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
27403,6cs2,DB06940,-8.9,"N-ethyl-4-{[5-(methoxycarbamoyl)-2-methylphenyl]amino}-5-methylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide",ZZTMFGIGOADCFX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
108615,6vxx,DB08463,-8.9,(2R)-2-({9-(1-methylethyl)-6-[(4-pyridin-2-ylbenzyl)amino]-9H-purin-2-yl}amino)butan-1-ol,HOCBJBNQIQQQGT-LJQANCHMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84343,6m3m,DB05616,-8.9,"4'-Methylene-5,8,10-trideazaaminopterin",NAWXUBYGYWOOIX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
55747,6crv,DB01436,-8.9,Alfacalcidol,OFHCOWSQAMBJIW-AVJTYSNKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
135381,6w9c,DB04392,-8.9,"Bishydroxy[2h-1-Benzopyran-2-One,1,2-Benzopyrone]",HIZKPJUTKKJDGA-BETUJISGSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
82816,6m3m,DB03046,-8.9,7-Methoxy-8-[1-(Methylsulfonyl)-1h-Pyrazol-4-Yl]Naphthalene-2-Carboximidamide,KQUXAFOLFXHVQN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81012,6m3m,DB00704,-8.9,Naltrexone,DQCKKXVULJGBQN-XFWGSAIBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84331,6m3m,DB05552,-8.9,TG100-115,UJIAQDJKSXQLIT-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85545,6m3m,DB07787,-8.9,"5-FLUORO-1-[4-(4-PHENYL-3,6-DIHYDROPYRIDIN-1(2H)-YL)BUTYL]QUINAZOLINE-2,4(1H,3H)-DIONE",PNPFDRCIGCUCMN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
106597,6vxx,DB00796,-8.9,Candesartan cilexetil,GHOSNRCGJFBJIB-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
70072,6lxt,DB12116,-8.9,Epigallocatechin gallate,WMBWREPUVVBILR-WIYYLYMNSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
71662,6lxt,DB15035,-8.9,Zanubrutinib,RNOAOAWBMHREKO-QFIPXVFZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
71657,6lxt,DB15028,-8.9,MK-1064,CKTWQGHVNRYNCM-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
55763,6crv,DB01455,-8.9,19-Nor-5-androstenediol,VVUQRXPUVKXAIO-XFUVECHXSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29779,6cs2,DB11616,-8.9,Pirarubicin,KMSKQZKKOZQFFG-YXRRJAAWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
58265,6crv,DB04772,-8.9,1-GUANIDINO-4-(N-PHENYLMETHANESULFONYL-L-LEUCYL-L-PROLYLAMINO)BUTANE,DSVCYWOHJLRGMK-PMACEKPBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
101737,6vxs,DB06364,-8.9,XR5944,SFOADSRLCHRTKT-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
140370,6w9c,DB05796,-8.9,Daglutril,XMQODGUTLZXUGZ-RPBOFIJWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
80850,6m3m,DB00504,-8.9,Levallorphan,OZYUPQUCAUTOBP-QXAKKESOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85707,6m3m,DB07973,-8.9,N-(1-ISOPROPYLPIPERIDIN-4-YL)-1-(3-METHOXYBENZYL)-1H-INDOLE-2-CARBOXAMIDE,GIPCBGDQVGKMPO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
68858,6lxt,DB08418,-8.9,"(4aS,4bR,10bS,12aS)-12a-methyl-1,3-dioxo-2-(pyridin-3-ylmethyl)-1,2,3,4,4a,4b,5,6,10b,11,12,12a-dodecahydronaphtho[2,1-f]isoquinolin-8-yl sulfamate",LSJKARAMQNGZDF-YOEKFXIASA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
101703,6vxs,DB06263,-8.9,Amrubicin,VJZITPJGSQKZMX-XDPRQOKASA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
26353,6cs2,DB04477,-8.9,"N-1,2,3,4-Tetrahydronaphth-1-Yl-2'-[3,5-Dimethoxybenzamido]-2'-Deoxy-Adenosine",FDZQGEIYGFPMOB-ZUURFMEUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
58217,6crv,DB04705,-8.9,"(3BETA)-CHOLEST-5-ENE-3,25-DIOL",INBGSXNNRGWLJU-ZHHJOTBYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106433,6vxx,DB00206,-8.9,Reserpine,QEVHRUUCFGRFIF-MDEJGZGSSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85710,6m3m,DB07976,-8.9,3-{[(3-FLUORO-3'-METHOXYBIPHENYL-4-YL)AMINO]CARBONYL}THIOPHENE-2-CARBOXYLIC ACID,GIUMGVUBDBDTDX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
101691,6vxs,DB06240,-8.9,Tariquidar,LGGHDPFKSSRQNS-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
65206,6lxt,DB02524,-8.9,"2',3'-O-{4-[Hydroxy(oxido)-??5-azanylidene]-2,6-dinitro-2,5-cyclohexadiene-1,1-diyl}adenosine 5'-(tetrahydrogen triphosphate)",XFMMHXLUHKBKQE-UHEGPQQHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
85725,6m3m,DB07993,-8.9,"N-3-[3-(1H-INDOL-6-YL)BENZYL]PYRIDINE-2,3-DIAMINE",LPQUIIHPUGDHJK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
65203,6lxt,DB02519,-8.9,Indirubin-5-Sulphonate,IHBOEHLUIBMBMY-YPKPFQOOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
59123,6crv,DB07102,-8.9,(2S)-2-amino-5-oxo-5-[(4-phenylmethoxyphenyl)amino]pentanoic acid,BYSBXIPCDJNEBG-INIZCTEOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57206,6crv,DB03337,-8.9,1-(2-Amidinophenyl)-3-(Phenoxyphenyl)Urea,ZHCAYBOLUMAUQX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
135545,6w9c,DB04607,-8.9,"PHENYLAMINOIMIDAZO(1,2-ALPHA)PYRIDINE",UQAWGIKJINAKIZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
71776,6lxt,DB15257,-8.9,Milademetan,RYAYYVTWKAOAJF-QISPRATLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
84241,6m3m,DB05048,-8.9,Cannabinor,GSTZHANFXAKPSE-MXTREEOPSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
108875,6vxx,DB11260,-8.9,Diacetyl benzoyl lathyrol,JPYYWXPAHJBKJX-VWSFRBHVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
133206,6w9c,DB01406,-8.9,Danazol,POZRVZJJTULAOH-LHZXLZLDSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
83056,6m3m,DB03358,-8.9,7n-Methyl-8-Hydroguanosine-5'-Triphosphate,BUJQMJUTTBGELS-KQYNXXCUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
71739,6lxt,DB15190,-8.9,GLPG-0259,YBFGSJUVEOYPIS-OALUTQOASA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
68849,6lxt,DB08406,-8.9,"[N-(2,4-DIAMINOPTERIDIN-6-YL)-METHYL]-DIBENZ[B,F]AZEPINE",NXCCIJQEAKMFGW-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
114295,6vxx,DB13252,-8.9,Tropatepine,JOQKFRLFXDPXHX-HDICACEKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58264,6crv,DB04771,-8.9,1-GUANIDINO-4-(N-NITRO-BENZOYLAMINO-L-LEUCYL-L-PROLYLAMINO)BUTANE,FIZYZWLGMGGGBJ-OALUTQOASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55711,6crv,DB01388,-8.9,Mibefradil,HBNPJJILLOYFJU-VMPREFPWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
65457,6lxt,DB02859,-8.9,Soraphen A,WPMGNXPRKGXGBO-OFQQMTDKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
108736,6vxx,DB08882,-8.9,Linagliptin,LTXREWYXXSTFRX-QGZVFWFLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85635,6m3m,DB07889,-8.9,"(2S)-1-(Dimethylamino)-3-(4-{[4-(2-methylimidazo[1,2-a]pyridin-3-yl)-2-pyrimidinyl]amino}phenoxy)-2-propanol",VCPXSBULBDYRLT-SFHVURJKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
127526,6w4h,DB06268,-8.9,Sitaxentan,PHWXUGHIIBDVKD-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
80899,6m3m,DB00568,-8.9,Cinnarizine,DERZBLKQOCDDDZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
82948,6m3m,DB03220,-8.9,FR233623,OODDZQQDDOVCFD-SCLBCKFNSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
68810,6lxt,DB08358,-8.9,"2-(2-QUINOLIN-3-YLPYRIDIN-4-YL)-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE",OWFLADWRSCINST-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
65357,6lxt,DB02723,-8.9,"4-Oxo-2-Phenylmethanesulfonyl-Octahydro-Pyrrolo[1,2-a]Pyrazine-6-Carboxylic Acid [1-(N-Hydroxycarbamimidoyl)-Piperidin-4-Ylmethyl]-Amide",DHTSUHWLPAEEQB-OALUTQOASA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
84293,6m3m,DB05395,-8.9,Amibegron,RDJQCOBTKKAQAH-FPOVZHCZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
71734,6lxt,DB15177,-8.9,VX-659,IGEOJNMYRZUKIK-IBGZPJMESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
68833,6lxt,DB08387,-8.9,2-{[4-(1-methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline,AZEXWHKOMMASPA-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
80873,6m3m,DB00537,-8.9,Ciprofloxacin,MYSWGUAQZAJSOK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85673,6m3m,DB07934,-8.9,[[CYCLOHEXANESULFONYL-GLYCYL]-3[PYRIDIN-4-YL-AMINOMETHYL]ALANYL]PIPERIDINE,KMUXFASJKPVMGU-HXUWFJFHSA-O,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
11381,6lzg,DB11891,-8.9,CUDC-907,JOWXJLIFIIOYMS-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
59091,6crv,DB07061,-8.9,"1-(CYCLOHEXYLAMINO)-3-(6-METHYL-3,4-DIHYDRO-1H-CARBAZOL-9(2H)-YL)PROPAN-2-OL",AXYFCRIRLKSCRR-SFHVURJKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85678,6m3m,DB07940,-8.9,"9-(3-IODOBENZYLAMINO)-1,2,3,4-TETRAHYDROACRIDINE",ZUCWQTWGZGIYPV-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
57157,6crv,DB03272,-8.9,4-Bromo-3-(5'-Carboxy-4'-Chloro-2'-Fluorophenyl)-1-Methyl-5-Trifluoromethyl-Pyrazol,YNMHKERYELPEEF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84264,6m3m,DB05197,-8.9,Sofalcone,GFWRVVCDTLRWPK-KPKJPENVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
65302,6lxt,DB02651,-8.9,"{[2-(1h-1,2,3-Benzotriazol-1-Yl)-2-(3,4-Difluorophenyl)Propane-1,3-Diyl]Bis[4,1-Phenylene(Difluoromethylene)]}Bis(Phosphonic Acid)",BTAGTGWPDROBMG-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
69976,6lxt,DB11971,-8.9,Vilaprisan,JUFWQQVHQFDUOD-ANRPBIDPSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
70001,6lxt,DB12010,-8.9,Fostamatinib,GKDRMWXFWHEQQT-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
84486,6m3m,DB06272,-8.9,Maxacalcitol,DTXXSJZBSTYZKE-ZDQKKZTESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59022,6crv,DB06986,-8.9,"2-CHLORO-N-[(1R,2R)-1-HYDROXY-2,3-DIHYDRO-1H-INDEN-2-YL]-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE",LRHOLHTVXXSIMG-BXUZGUMPSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27441,6cs2,DB06985,-8.9,2-[({4-[2-(trifluoromethyl)phenyl]piperidin-1-yl}carbonyl)amino]benzoic acid,MEAQCLPMSVEOQF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
27901,6cs2,DB07460,-8.9,2-({5-CHLORO-2-[(2-METHOXY-4-MORPHOLIN-4-YLPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)-N-METHYLBENZAMIDE,UYJNQQDJUOUFQJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
12036,6lzg,DB12784,-8.9,NS-018,UQTPDWDAYHAZNT-AWEZNQCLSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
56859,6crv,DB02880,-8.9,N-[1-(4-Bromophenyl)Ethyl]-5-Fluoro Salicylamide,KFTNEILVDDUXGR-SECBINFHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84419,6m3m,DB06140,-8.9,SUVN-502,GWCYPEHWIZXYFZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
82572,6m3m,DB02715,-8.9,Compound 18,UZOOIPXOYYJULJ-RHLLTPQKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
11267,6lzg,DB11737,-8.9,Icotinib,QQLKULDARVNMAL-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
71590,6lxt,DB14859,-8.9,Fosifloxuridine nafalbenamide,BIOWRMNRHMERIO-ZVAHOJSLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
126285,6w4h,DB03638,-8.9,Cytidyl-2'-5'-Phospho-Guanosine,QZDUXDLOEVJGDG-VMIOUTBZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
108429,6vxx,DB07982,-8.9,2-{4-[4-({4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]pyrimidin-2-yl}amino)phenyl]piperazin-1-yl}-2-oxoethanol,PVTKDXZNSUHUMO-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85362,6m3m,DB07568,-8.9,"(2S)-2-[(2,1,3-BENZOTHIADIAZOL-4-YLSULFONYL)AMINO]-2-PHENYL-N-PYRIDIN-4-YLACETAMIDE",ADRNPUSZBRQDBG-KRWDZBQOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
68490,6lxt,DB07978,-8.9,"2-({[2,3,5,6-TETRAFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)CYCLOPENTA-1,3-DIENE-1-CARBOXYLIC ACID",ULMUPVXFUDHRGH-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
136643,6w9c,DB07359,-8.9,"3-[(4-fluorophenyl)sulfanyl]-N-(4-methyl-1,3-thiazol-2-yl)-6-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]pyridine-2-carboxamide",SJTQKYKXCYVFHX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
85374,6m3m,DB07584,-8.9,"N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine",OKGCSZUKOGMZAL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
66418,6lxt,DB04154,-8.9,"N-Methyl-N-[3-(6-Phenyl[1,2,4]Triazolo[4,3-B]Pyridazin-3-Yl)Phenyl]Acetamide",ALBWBHNFOJJMCV-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
84405,6m3m,DB06040,-8.9,Filanesib,LLXISKGBWFTGEI-FQEVSTJZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
161543,7bv1,DB15047,-8.9,BMS-919373,XGKULQQVQWCASY-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
136111,6w9c,DB06581,-8.9,Bevirimat,YJEJKUQEXFSVCJ-WRFMNRASSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
55858,6crv,DB01561,-8.9,Androstanedione,RAJWOBJTTGJROA-WZNAKSSCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108450,6vxx,DB08005,-8.9,4-{[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino}-N-ethylpiperidine-1-carboxamide,ARMFMDYRYOKSOW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84393,6m3m,DB05944,-8.9,Varlitinib,UWXSAYUXVSFDBQ-CYBMUJFWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81176,6m3m,DB00897,-8.9,Triazolam,JOFWLTCLBGQGBO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
71579,6lxt,DB14840,-8.9,Ripretinib,CEFJVGZHQAGLHS-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
140420,6w9c,DB06817,-8.9,Raltegravir,CZFFBEXEKNGXKS-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136626,6w9c,DB07340,-8.9,"N-6-cyclohexyl-N-2-(4-morpholin-4-ylphenyl)-9H-purine-2,6-diamine",ZFLJHSQHILSNCM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
106788,6vxx,DB01254,-8.9,Dasatinib,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
102494,6vxs,DB07460,-8.9,2-({5-CHLORO-2-[(2-METHOXY-4-MORPHOLIN-4-YLPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)-N-METHYLBENZAMIDE,UYJNQQDJUOUFQJ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
84471,6m3m,DB06246,-8.9,Exisulind,MVGSNCBCUWPVDA-MFOYZWKCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
126417,6w4h,DB03802,-8.9,"1-[4-(Octahydro-Pyrido[1,2-a]Pyrazin-2-Yl)-Phenyl]-2-Phenyl-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol",ZGHFWBDHZZKWSI-LITSAYRRSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
140433,6w9c,DB06834,-8.9,"N-(2-hydroxy-1,1-dimethylethyl)-1-methyl-3-(1H-pyrrolo[2,3-b]pyridin-2-yl)-1H-indole-5-carboxamide",XZRYCTLOGNCQDG-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
58406,6crv,DB05048,-8.9,Cannabinor,GSTZHANFXAKPSE-MXTREEOPSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
161518,7bv1,DB14989,-8.9,Umbralisib,IUVCFHHAEHNCFT-INIZCTEOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160862,7bv1,DB11829,-8.9,Ruboxistaurin,ZCBUQCWBWNUWSU-SFHVURJKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
102472,6vxs,DB07435,-8.9,"1,2,3-TRIHYDROXY-1,2,3,4-TETRAHYDROBENZO[A]PYRENE",GFANZDFKCCJYRF-NSISKUIASA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
108384,6vxx,DB07697,-8.9,"1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-4-[(4-methoxyphenyl)sulfonyl]piperazine",HMGDKYUJSFVHIY-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85320,6m3m,DB07519,-8.9,"(6R)-2-amino-6-[2-(3'-methoxybiphenyl-3-yl)ethyl]-3,6-dimethyl-5,6-dihydropyrimidin-4(3H)-one",VDFBMQAUECXNKR-OAQYLSRUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
68518,6lxt,DB08010,-8.9,"(3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-[(E)-2-phenylethenyl]-1H-indole-2,3-dione 3-oxime",DDHASJXGNUWZTM-ZLEWNXFRSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
71566,6lxt,DB14793,-8.9,RO-5045337,QBGKPEROWUKSBK-QPPIDDCLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
136620,6w9c,DB07333,-8.9,"N-(CYCLOPROPYLMETHYL)-4-(METHYLOXY)-3-({5-[3-(3-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-YL}AMINO)BENZENESULFONAMIDE",KRGKAARWVPUWSY-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
70222,6lxt,DB12325,-8.9,Idasanutlin,TVTXCJFHQKSQQM-LJQIRTBHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
108398,6vxx,DB07715,-8.9,Emodin,RHMXXJGYXNZAPX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140545,6w9c,DB12041,-8.9,Mapracorat,VJGFOYBQOIPQFY-XMMPIXPASA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
27893,6cs2,DB07453,-8.9,2-PHENYL-4H-BENZO[H]CHROMEN-4-ONE,VFMMPHCGEFXGIP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
26869,6cs2,DB05616,-8.9,"4'-Methylene-5,8,10-trideazaaminopterin",NAWXUBYGYWOOIX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
135193,6w9c,DB04107,-8.9,[(1-{2[(4-Carbamimidoyl-Phenylamino)-Methyl]-1-Methyl-1h-Benzoimidazol-5-Yl}-Cyclopropyl)-Pyridin-2-Yl-Methyleneaminooxy]-Acetic Acid Ethyl Ester,RNOYCNIZOAIUSV-LSWMGQQCSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
68482,6lxt,DB07970,-8.9,5-[(2-methyl-5-{[3-(trifluoromethyl)phenyl]carbamoyl}phenyl)amino]pyridine-3-carboxamide,SAAYRHKJHDIDPH-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
85346,6m3m,DB07548,-8.9,"2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUORO-6-PYRIDINYL)METHYL]ACETAMIDE",JXHWVKOKYDAROD-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
108420,6vxx,DB07971,-8.9,"5-AMINO-2-{4-[(4-AMINOPHENYL)SULFANYL]PHENYL}-1H-ISOINDOLE-1,3(2H)-DIONE",FQQVTDIBUYSVHM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
102451,6vxs,DB07410,-8.9,[2-(3-DIBENZOFURAN-4-YL-PHENYL)-1-HYDROXY-1-PHOSPHONO-ETHYL]-PHOSPHONIC ACID,BYVXAUZOTGITQZ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
84362,6m3m,DB05738,-8.9,Vapitadine,VQWGYPVNVICKFC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58968,6crv,DB06918,-8.9,2-(2-METHYLPHENYL)-1H-INDOLE-6-CARBOXIMIDAMIDE,ZRYXDGAKQGRHFG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
71609,6lxt,DB14895,-8.9,Vibegron,DJXRIQMCROIRCZ-XOEOCAAJSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
70117,6lxt,DB12185,-8.9,Exatecan,ZVYVPGLRVWUPMP-FYSMJZIKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
133473,6w9c,DB01732,-8.9,"(4r,5s,6s,7r)-1,3-Dibenzyl-4,7-Bis(Phenoxymethyl)-5,6-Dihydroxy-1,3 Diazepan-2-One",SQBOSZXDOHQFAA-ZRTHHSRSSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
164170,7bv1,DB07333,-8.9,"N-(CYCLOPROPYLMETHYL)-4-(METHYLOXY)-3-({5-[3-(3-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-YL}AMINO)BENZENESULFONAMIDE",KRGKAARWVPUWSY-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
55791,6crv,DB01485,-8.9,4-Hydroxytestosterone,BQOIJSIMMIDHMO-FBPKJDBXSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
102201,6vxs,DB07124,-8.9,"(2S)-1-(6H-INDOL-3-YL)-3-{[5-(7H-PYRAZOLO[3,4-C]PYRIDIN-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE",CCIACUJJBPSOHE-KRWDZBQOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
81129,6m3m,DB00843,-8.9,Donepezil,ADEBPBSSDYVVLD-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
27450,6cs2,DB06995,-8.9,N-({4-[(2-aminopyridin-4-yl)oxy]-3-fluorophenyl}carbamoyl)-2-(4-fluorophenyl)acetamide,USBSTVPJNQLYEM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
108531,6vxx,DB08097,-8.9,"2-(2,6-DIFLUOROPHENOXY)-N-(2-FLUOROPHENYL)-9-ISOPROPYL-9H-PURIN-8-AMINE",OGWSGDLIXOEZJG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
66211,6lxt,DB03878,-8.9,N-[4-Methyl-3-[[4-(3-Pyridinyl)-2-Pyrimidinyl]Amino]Phenyl]-3-Pyridinecarboxamide,YWQVBESSYLICRX-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
136681,6w9c,DB07406,-8.9,"(4R)-N-[4-({[2-(DIMETHYLAMINO)ETHYL]AMINO}CARBONYL)-1,3-THIAZOL-2-YL]-4-METHYL-1-OXO-2,3,4,9-TETRAHYDRO-1H-BETA-CARBOLINE-6-CARBOXAMIDE",QWFFPYQWUWLDBV-NSHDSACASA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
85476,6m3m,DB07706,-8.9,2-Hydrox1tradiol,DILDHNKDVHLEQB-XSSYPUMDSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
11304,6lzg,DB11786,-8.9,Pefcalcitol,SVCSMAZYWOQCBW-NVJMFHFGSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
126092,6w4h,DB03351,-8.9,Sri-9439,KMSATRJZEXNGDP-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
102113,6vxs,DB07025,-8.9,3-(5-{[4-(AMINOMETHYL)PIPERIDIN-1-YL]METHYL}-1H-INDOL-2-YL)QUINOLIN-2(1H)-ONE,KBIHHEGEALBUMT-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
85492,6m3m,DB07724,-8.9,Indeglitazar,YMPALHOKRBVHOJ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85495,6m3m,DB07729,-8.9,3-fluoro-N-[3-(1H-tetrazol-5-yl)phenyl]benzamide,GAKOBKPDJJGRIL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
55766,6crv,DB01459,-8.9,Bezitramide,FLKWNFFCSSJANB-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81077,6m3m,DB00783,-8.9,Estradiol,VOXZDWNPVJITMN-ZBRFXRBCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
128333,6w4h,DB07486,-8.9,"3-({4-[(1E)-3-morpholin-4-yl-3-oxoprop-1-en-1-yl]-2,3-bis(trifluoromethyl)phenyl}sulfanyl)aniline",KLSZVPNVFKKIRD-FNORWQNLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
85505,6m3m,DB07741,-8.9,"4-(1R,3AS,4R,8AS,8BR)-[1-DIFLUOROMETHYL-2-(4-FLUOROBENZYL)-3-OXODECAHYDROPYRROLO[3,4-A]PYRROLIZIN-4-YL]BENZAMIDINE",VPNYXOTTXAXSIH-SXYSDOLCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
160785,7bv1,DB11263,-8.9,Polydatin,HSTZMXCBWJGKHG-CUYWLFDKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
70118,6lxt,DB12186,-8.9,SRT-2104,LAMQVIQMVKWXOC-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
85436,6m3m,DB07655,-8.9,"3-AMINO-3-BENZYL-[4.3.0]BICYCLO-1,6-DIAZANONAN-2-ONE",MPJYGQHMIFDQIN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
108503,6vxx,DB08063,-8.9,"1-BENZYL-3-(4-METHOXYPHENYLAMINO)-4-PHENYLPYRROLE-2,5-DIONE",HLZMYWLMBBLASX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104588,6vxs,DB12225,-8.9,Beclabuvir,ZTTKEBYSXUCBSE-QDFUAKMASA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
68523,6lxt,DB08015,-8.9,"(3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-phenyl-1H-indole-2,3-dione 3-oxime",SZYREAUDQRVVLV-DAFNUICNSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
85411,6m3m,DB07628,-8.9,"6-(2-fluorobenzyl)-2,4-dimethyl-4,6-dihydro-5H-thieno[2',3':4,5]pyrrolo[2,3-d]pyridazin-5-one",IEWYEWDDQWYJLU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
55827,6crv,DB01530,-8.9,"5alpha-androstane-3alpha,17beta-diol",CBMYJHIOYJEBSB-KHOSGYARSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106719,6vxx,DB00932,-8.9,Tipranavir,SUJUHGSWHZTSEU-FYBSXPHGSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
102262,6vxs,DB07193,-8.9,"(2R,3R)-7-(methylsulfonyl)-3-(2,4,5-trifluorophenyl)-1,2,3,4-tetrahydropyrido[1,2-a]benzimidazol-2-amine",HJJAYSSCWGUPKO-ABAIWWIYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
55818,6crv,DB01521,-8.9,Clostebol,KCZCIYZKSLLNNH-FBPKJDBXSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84387,6m3m,DB05913,-8.9,OSI-930,FGTCROZDHDSNIO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58982,6crv,DB06932,-8.9,"10,11-dimethoxy-4-methyldibenzo[c,f]-2,7-naphthyridine-3,6-diamine",NVINUNQBDNEMSY-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
82658,6m3m,DB02834,-8.9,IDD552,ZCAGEXZTORJQDZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
26448,6cs2,DB04583,-8.9,"5-Carbamoyl-1,1':4',1''-terphenyl-3-carboxylic acid",LAZPCGBRHLARSI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
58971,6crv,DB06921,-8.9,(2S)-2-[3-(AMINOMETHYL)PHENYL]-3-[(R)-HYDROXY{(1R)-2-METHYL-1-[(PHENYLSULFONYL)AMINO]PROPYL}PHOSPHORYL]PROPANOIC ACID,FNZHLCNFXRRIIC-RBUKOAKNSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
126168,6w4h,DB03461,-8.9,2'-Monophosphoadenosine 5'-Diphosphoribose,XJLXINKUBYWONI-NNYOXOHSSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
85423,6m3m,DB07642,-8.9,"5-{[1-(2-fluorobenzyl)piperidin-4-yl]methoxy}quinazoline-2,4-diamine",GYKIQIOWVKCVBP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
30045,6cs2,DB11978,-8.9,Glasdegib,SFNSLLSYNZWZQG-VQIMIIECSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
114726,6vxx,DB14717,-8.9,Nitrazolam,OYRPNABWTHDOFK-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104561,6vxs,DB12185,-8.9,Exatecan,ZVYVPGLRVWUPMP-FYSMJZIKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104562,6vxs,DB12186,-8.9,SRT-2104,LAMQVIQMVKWXOC-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
70127,6lxt,DB12200,-8.9,Tivantinib,UCEQXRCJXIVODC-PMACEKPBSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
108497,6vxx,DB08057,-8.9,"N-(2-chloro-6-methylphenyl)-8-[(3S)-3-methylpiperazin-1-yl]imidazo[1,5-a]quinoxalin-4-amine",VWJPPYCULHDHBB-HNNXBMFYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58341,6crv,DB04867,-8.9,Lintitript,ILNRQFBVVQUOLP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
66327,6lxt,DB04030,-8.9,"1,3,4,9-Tetrahydro-2-(Hydroxybenzoyl)-9-[(4-Hydroxyphenyl)Methyl]-6-Methoxy-2h-Pyrido[3,4-B]Indole",ADXYEWMDAGIULV-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
27943,6cs2,DB07507,-8.9,"2-(4-hydroxybiphenyl-3-yl)-4-methyl-1H-isoindole-1,3(2H)-dione",ROMNEYAQUBNRLR-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
136669,6w9c,DB07393,-8.9,"2-(2-PHENYL-3-PYRIDIN-2-YL-4,5,6,7-TETRAHYDRO-2H-ISOPHOSPHINDOL-1-YL)PYRIDINE",GSKNNHAAFLPYHG-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
58696,6crv,DB06414,-8.9,Etravirine,PYGWGZALEOIKDF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
129971,6w4h,DB11521,-8.9,Imidocarb,SCEVFJUWLLRELN-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
55269,6crv,DB00813,-8.9,Fentanyl,PJMPHNIQZUBGLI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77962,6m2n,DB09047,-8.9,Finafloxacin,FYMHQCNFKNMJAV-HOTGVXAUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
165667,7bv1,DB12627,-8.9,GSK-1292263,AYJRTVVIBJSSKN-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
138521,6w9c,DB11787,-8.9,Ralimetinib,XPPBBJCBDOEXDN-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
31996,6cs2,DB15170,-8.9,Evobrutinib,QUIWHXQETADMGN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
74943,6m2n,DB04040,-8.9,"N-(2-Morpholin-4-Yl-1-Morpholin-4-Ylmethyl-Ethyl)-3-Nitro-5-(3,4,5-Trihydroxy-6-Hydroxymethyl-Tetrahydro-Pyran-2-Yloxy)-Benzamide",MCMWCTMAKPQTPI-WGNYYXNJSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
31993,6cs2,DB15168,-8.9,Cilofexor,KZSKGLFYQAYZCO-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
15704,6lzg,DB00878,-8.9,Chlorhexidine,GHXZTYHSJHQHIJ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
112475,6vxx,DB07297,-8.9,"5,6-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-D]PYRIMIDIN-4-AMINE",PTILEOLOGGMFCS-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87723,6m3m,DB12746,-8.9,AKN-028,JLRIJKVMMZEKDF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
130989,6w4h,DB13101,-8.9,4SC-202,PRXXYMVLYKJITB-IZZDOVSWSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
94643,6m71,DB08358,-8.9,"2-(2-QUINOLIN-3-YLPYRIDIN-4-YL)-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE",OWFLADWRSCINST-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94640,6m71,DB08354,-8.9,"2-(4-CHLOROBENZYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE",QCVULERVJOYHCP-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
31967,6cs2,DB15121,-8.9,AT-001,YRGPAXAVTDMKDK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
138520,6w9c,DB11786,-8.9,Pefcalcitol,SVCSMAZYWOQCBW-NVJMFHFGSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
112499,6vxx,DB07323,-8.9,"2-[({2-[(1Z)-3-(DIMETHYLAMINO)PROP-1-ENYL]-4-FLUOROPHENYL}SULFONYL)AMINO]-5,6,7,8-TETRAHYDRONAPHTHALENE-1-CARBOXYLIC ACID",CTZLIARLNXSXGL-ALCCZGGFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60658,6crv,DB08942,-8.9,Isoxicam,YYUAYBYLJSNDCX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
94491,6m71,DB08164,-8.9,"(3R,4R)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN-3-AMINE",GOBIXGZJSMAOFV-QRWLVFNGSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
114805,6vxx,DB14895,-8.9,Vibegron,DJXRIQMCROIRCZ-XOEOCAAJSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29954,6cs2,DB11853,-8.9,Relugolix,AOMXMOCNKJTRQP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
60664,6crv,DB08951,-8.9,Indoprofen,RJMIEHBSYVWVIN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114562,6vxx,DB13793,-8.9,Vinburnine,WYJAPUKIYAZSEM-MOPGFXCFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
94412,6m71,DB08079,-8.9,AMG-208,HEAIZQNMNCHNFD-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
31936,6cs2,DB15065,-8.9,PF-06291874,IBDYYOQKQCCSDP-QFIPXVFZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
75029,6m2n,DB04154,-8.9,"N-Methyl-N-[3-(6-Phenyl[1,2,4]Triazolo[4,3-B]Pyridazin-3-Yl)Phenyl]Acetamide",ALBWBHNFOJJMCV-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
62305,6crv,DB13397,-8.9,Prenoxdiazine,PXZDWASDNFWKSD-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112570,6vxx,DB07406,-8.9,"(4R)-N-[4-({[2-(DIMETHYLAMINO)ETHYL]AMINO}CARBONYL)-1,3-THIAZOL-2-YL]-4-METHYL-1-OXO-2,3,4,9-TETRAHYDRO-1H-BETA-CARBOLINE-6-CARBOXAMIDE",QWFFPYQWUWLDBV-NSHDSACASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31930,6cs2,DB15056,-8.9,Bifenthrin,OMFRMAHOUUJSGP-IRHGGOMRSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
75061,6m2n,DB04194,-8.9,Chitotriose,WZZVUHWLNMNWLW-VFCSDQTKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
130942,6w4h,DB13029,-8.9,MK-0873,JJWKQXNHYDJXKF-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
77982,6m2n,DB09078,-8.9,Lenvatinib,WOSKHXYHFSIKNG-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
9078,6lzg,DB07152,-8.9,N-[4-(5-fluoro-6-methylpyridin-2-yl)-5-quinoxalin-6-yl-1H-imidazol-2-yl]acetamide,TYPILNNEZPSNTI-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
112418,6vxx,DB07081,-8.9,"(2R)-4-[(8R)-8-METHYL-2-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[1,5-A]PYRAZIN-7(8H)-YL]-4-OXO-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE",FDEXEPZGMKFCTG-PSASIEDQSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60492,6crv,DB08715,-8.9,"2,6-DIMETHYL-1-(3-[3-METHYL-5-ISOXAZOLYL]-PROPANYL)-4-[2-METHYL-4-ISOXAZOLYL]-PHENOL",SLPKYEWAKMNCPT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62503,6crv,DB13667,-8.9,Cefozopran,QDUIJCOKQCCXQY-WHJQOFBOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165602,7bv1,DB12523,-8.9,Mizolastine,PVLJETXTTWAYEW-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
87600,6m3m,DB12557,-8.9,FK-614,UYGZODVVDUIDDQ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
24273,6cs2,DB01977,-8.9,6-(N-Phenylcarbamyl)-2-Naphthalenecarboxamidine,AECPTICWHONWNW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
87616,6m3m,DB12579,-8.9,JNJ-37822681,UVUYWJWYRLJHEN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
78288,6m2n,DB11450,-8.9,Pimobendan,GLBJJMFZWDBELO-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
32053,6cs2,DB15273,-8.9,VS-4718,IGUBBWJDMLCRIK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
74680,6m2n,DB03701,-8.9,Vanoxerine,NAUWTFJOPJWYOT-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
158143,7bv1,DB00430,-8.9,Cefpiramide,PWAUCHMQEXVFJR-PMAPCBKXSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
112341,6vxx,DB06994,-8.9,"(2S,3S)-3-{3-[2-chloro-4-(methylsulfonyl)phenyl]-1,2,4-oxadiazol-5-yl}-1-cyclopentylidene-4-cyclopropyl-1-fluorobutan-2-amine",XCCSSVMRGIQMGF-LPHOPBHVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138451,6w9c,DB11682,-8.9,Daprodustat,RUEYEZADQJCKGV-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
112347,6vxx,DB07000,-8.9,"N-{2,4-difluoro-3-[(5-pyridin-3-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)carbonyl]phenyl}ethanesulfonamide",ILXJWLWSYAWJKZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62449,6crv,DB13596,-8.9,Oxycinchophen,XAPRFLSJBSXESP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
7565,6lzg,DB04016,-8.9,2-[3-({Methyl[1-(2-Naphthoyl)Piperidin-4-Yl]Amino}Carbonyl)-2-Naphthyl]-1-(1-Naphthyl)-2-Oxoethylphosphonic Acid,XUJQPDQURBZEGJ-KXQOOQHDSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
131108,6w4h,DB13307,-8.9,Proscillaridin,MYEJFUXQJGHEQK-ALRJYLEOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
9115,6lzg,DB07189,-8.9,"(1S,3R,6S)-4-oxo-6-{4-[(2-phenylquinolin-4-yl)methoxy]phenyl}-5-azaspiro[2.4]heptane-1-carboxylic acid",BFZXMIUWGSTUAL-ZSOKXDGFSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
74765,6m2n,DB03802,-8.9,"1-[4-(Octahydro-Pyrido[1,2-a]Pyrazin-2-Yl)-Phenyl]-2-Phenyl-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol",ZGHFWBDHZZKWSI-LITSAYRRSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138481,6w9c,DB11730,-8.9,Ribociclib,RHXHGRAEPCAFML-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138483,6w9c,DB11734,-8.9,Fedovapagon,RUOLFWZIFNQQGH-DEOSSOPVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
87674,6m3m,DB12672,-8.9,Icaritin,TUUXBSASAQJECY-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
112387,6vxx,DB07045,-8.9,"(2R,3R,4S,5R)-2-[6-amino-8-[(3,4-dichlorophenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol",VBJKVZXRYLCYGQ-XNIJJKJLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112395,6vxx,DB07053,-8.9,2-{5-[3-(7-PROPYL-3-TRIFLUOROMETHYLBENZO[D]ISOXAZOL-6-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID,TWVYNPULGKGJOS-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78066,6m2n,DB09215,-8.9,Droxicam,OEHFRZLKGRKFAS-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
60543,6crv,DB08770,-8.9,"4-{2-[(7-amino-2-furan-2-yl[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-yl)amino]ethyl}phenol",PWTBZOIUWZOPFT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
14144,6lzg,T3D3763,-8.9,Janthitrem C,HVLXXQDJGPKVMK-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
14146,6lzg,T3D3765,-8.9,Janthitrem F,SHMYDSYGDWIPKT-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
60564,6crv,DB08794,-8.9,Ethyl biscoumacetate,JCLHQFUTFHUXNN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
74865,6m2n,DB03932,-8.9,LFA703,WPVRNXUYVXQXPY-YFAYRSKXSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
31924,6cs2,DB15047,-8.9,BMS-919373,XGKULQQVQWCASY-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
112583,6vxx,DB07422,-8.9,(2S)-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]-3-(pentafluorophenoxy)propanamide,MMNRWNREMUMYQG-INIZCTEOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112584,6vxx,DB07423,-8.9,(2S)-3-[4-(acetylamino)phenoxy]-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide,YVXVTLGIDOACBJ-SFHVURJKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
157532,6wiq,DB09280,-8.9,Lumacaftor,UFSKUSARDNFIRC-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
60805,6crv,DB09177,-8.9,p-Fluorofentanyl,KXUBAVLIJFTASZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
8933,6lzg,DB06997,-8.9,"2-(4-fluorophenyl)-N-{[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]carbamoyl}acetamide",BMPOCDJEXAXXEZ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
62163,6crv,DB13212,-8.9,Phenolsulfonphthalein,BELBBZDIHDAJOR-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77635,6m2n,DB08614,-8.9,"3-[[(METHYLAMINO)SULFONYL]AMINO]-2-OXO-6-PHENYL-N-[3,3,3-TRIFLUORO-1-(1-METHYLETHYL)-2-OXOPHENYL]-1(2H)-PYRIDINE ACETAMIDE",MYFMPKCOIMRDDD-KRWDZBQOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
112742,6vxx,DB07793,-8.9,"(2S)-N-[(3S)-1-(2-AMINO-2-OXOETHYL)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL]-2-CHLORO-2H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE",ACSGSLPOHKRZCY-GXTWGEPZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130731,6w4h,DB12703,-8.9,Omipalisib,CGBJSGAELGCMKE-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
60851,6crv,DB09226,-8.9,RP-5063,PMKMNTBZJOXTJW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
93881,6m71,DB07458,-8.9,"3-(1H-indol-3-yl)-4-{1-[2-(1-methylpyrrolidin-2-yl)ethyl]-1H-indol-3-yl}-1H-pyrrole-2,5-dione",LBFDERUQORUFIN-KRWDZBQOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93879,6m71,DB07456,-8.9,"3-(1H-indol-3-yl)-4-(1-{2-[(2S)-1-methylpyrrolidinyl]ethyl}-1H-indol-3-yl)-1H-pyrrole-2,5-dione",LBFDERUQORUFIN-QGZVFWFLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
31820,6cs2,DB14821,-8.9,Macozinone,BJDZBXGJNBMCAV-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
29175,6cs2,DB08815,-8.9,Lurasidone,PQXKDMSYBGKCJA-CVTJIBDQSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
87984,6m3m,DB13174,-8.9,Rhein,FCDLCPWAQCPTKC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87986,6m3m,DB13177,-8.9,4-methylumbelliferyl beta-D-glucoside,YUDPTGPSBJVHCN-YMILTQATSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
60885,6crv,DB09279,-8.9,Fimasartan,AMEROGPZOLAFBN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
93800,6m71,DB07362,-8.9,"1-(5-{2-[(1-methyl-1H-pyrazolo[4,3-d]pyrimidin-7-yl)amino]ethyl}-1,3-thiazol-2-yl)-3-[3-(trifluoromethyl)phenyl]urea",UOLCZAFAGDOUFX-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93776,6m71,DB07334,-8.9,"N-[5-(ETHYLSULFONYL)-2-METHOXYPHENYL]-5-[3-(2-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-AMINE",HTIZPBXCJPQDEM-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
112803,6vxx,DB07861,-8.9,(2R)-N-hydroxy-3-naphthalen-2-yl-2-[(naphthalen-2-ylsulfonyl)amino]propanamide,MMOUXLMPQFMDRD-JOCHJYFZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88003,6m3m,DB13217,-8.9,Fentiazac,JIEKMACRVQTPRC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
60900,6crv,DB09304,-8.9,Setiptiline,GVPIXRLYKVFFMK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60944,6crv,DB09534,-8.9,Ecamsule,HEAHZSUCFKFERC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60957,6crv,DB11115,-8.9,Ensulizole,UVCJGUGAGLDPAA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112822,6vxx,DB07882,-8.9,"4-{4-[2-(1A,7A-DIMETHYL-4-OXY-OCTAHYDRO-1-OXA-4-AZA-CYCLOPROPA[A]NAPHTHALEN-4-YL) -ACETYLAMINO]-PHENYLCARBAMOYL}-BUTYRIC ACID",VFIZFTGABDUGCF-UPVHCHBVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
93699,6m71,DB07252,-8.9,"3-({4-[(5-chloro-1,3-benzodioxol-4-yl)amino]pyrimidin-2-yl}amino)benzenesulfonamide",TZHCXOMEOHEZDX-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60971,6crv,DB11184,-8.9,Oftasceine,DEGAKNSWVGKMLS-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60984,6crv,DB11260,-8.9,Diacetyl benzoyl lathyrol,JPYYWXPAHJBKJX-VWSFRBHVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77507,6m2n,DB08463,-8.9,(2R)-2-({9-(1-methylethyl)-6-[(4-pyridin-2-ylbenzyl)amino]-9H-purin-2-yl}amino)butan-1-ol,HOCBJBNQIQQQGT-LJQANCHMSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
93648,6m71,DB07189,-8.9,"(1S,3R,6S)-4-oxo-6-{4-[(2-phenylquinolin-4-yl)methoxy]phenyl}-5-azaspiro[2.4]heptane-1-carboxylic acid",BFZXMIUWGSTUAL-ZSOKXDGFSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
77491,6m2n,DB08444,-8.9,"3-[2-bromo-4-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)phenoxy]-5-methylbenzonitrile",YYGZQXRLQMFHDH-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
88102,6m3m,DB13347,-8.9,Diphenadione,JYGLAHSAISAEAL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
24400,6cs2,DB02128,-8.9,[1-(3-Hydroxy-2-Oxo-1-Phenethyl-Propylcarbamoyl)2-Phenyl-Ethyl]-Carbamic Acid Pyridin-4-Ylmethyl Ester,QCUBCTPTNWPFBC-ZEQRLZLVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
78320,6m2n,DB11522,-8.9,Isoflupredone,WAIJIHDWAKJCBX-BULBTXNYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
60802,6crv,DB09173,-8.9,Butyrfentanyl,QQOMYEQLWQJRKK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114806,6vxx,DB14896,-8.9,Selitrectinib,OEBIHOVSAMBXIB-SJKOYZFVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62298,6crv,DB13386,-8.9,Epimestrol,UHQGCIIQUZBJAE-RRQVMCLOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
129341,6w4h,DB08683,-8.9,"REL-(9R,12S)-9,10,11,12-TETRAHYDRO-9,12-EPOXY-1H-DIINDOLO[1,2,3-FG:3',2',1'-KL]PYRROLO[3,4-I][1,6]BENZODIAZOCINE-1,3(2H)-DIONE",OTPNDVKVEAIXTI-IYBDPMFKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
112610,6vxx,DB07453,-8.9,2-PHENYL-4H-BENZO[H]CHROMEN-4-ONE,VFMMPHCGEFXGIP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60715,6crv,DB09008,-8.9,Cefaloridine,CZTQZXZIADLWOZ-CRAIPNDOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87835,6m3m,DB12929,-8.9,JNJ-39220675,IQOWHZHNGJXGHG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
130847,6w4h,DB12887,-8.9,Tazemetostat,NSQSAUGJQHDYNO-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
77815,6m2n,DB08828,-8.9,Vismodegib,BPQMGSKTAYIVFO-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
112615,6vxx,DB07458,-8.9,"3-(1H-indol-3-yl)-4-{1-[2-(1-methylpyrrolidin-2-yl)ethyl]-1H-indol-3-yl}-1H-pyrrole-2,5-dione",LBFDERUQORUFIN-KRWDZBQOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75102,6m2n,DB04244,-8.9,(2R)-2-(3-Biphenylyl)-N-{(2R)-2-hydroxy-3-[(2-pyridinylsulfonyl)amino]propyl}-4-methylpentanamide,YCDHZDINQZLSRR-DNQXCXABSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
60729,6crv,DB09022,-8.9,Benfluorex,CJAVTWRYCDNHSM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
94315,6m71,DB07970,-8.9,5-[(2-methyl-5-{[3-(trifluoromethyl)phenyl]carbamoyl}phenyl)amino]pyridine-3-carboxamide,SAAYRHKJHDIDPH-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60732,6crv,DB09030,-8.9,Vorapaxar,ZBGXUVOIWDMMJE-QHNZEKIYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112636,6vxx,DB07485,-8.9,"4,4'-cyclohexane-1,1-diyldiphenol",SDDLEVPIDBLVHC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31899,6cs2,DB14995,-8.9,NP-G2-044,XLLRLAABUFOJPC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
87864,6m3m,DB12973,-8.9,Serlopitant,FLNYCRJBCNNHRH-OIYLJQICSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
138585,6w9c,DB11878,-8.9,Filibuvir,SLVAPEZTBDBAPI-GDLZYMKVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
112656,6vxx,DB07508,-8.9,4-(5-BENZENESULFONYLAMINO-1-METHYL-1H-BENZOIMIDAZOL-2-YLMETHYL)-BENZAMIDINE,MEUAVGJWGDPTLF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77752,6m2n,DB08752,-8.9,N-[(1S)-2-[(4-cyano-1-methylpiperidin-4-yl)amino]-1-(cyclohexylmethyl)-2-oxoethyl]morpholine-4-carboxamide,IRSOCWQJNYLTDD-SFHVURJKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
165731,7bv1,DB12724,-8.9,AZD-7295,MAQDQJWCSSCURR-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94194,6m71,DB07827,-8.9,"4-{[1-METHYL-2,4-DIOXO-6-(3-PHENYLPROP-1-YN-1-YL)-1,4-DIHYDROQUINAZOLIN-3(2H)-YL]METHYL}BENZOIC ACID",FLTYDFYSVZBKOB-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
165745,7bv1,DB12744,-8.9,CGI-1842,ZXBFYBLSJMEBEP-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
138594,6w9c,DB11893,-8.9,Avagacestat,XEAOPVUAMONVLA-QGZVFWFLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
60742,6crv,DB09054,-8.9,Idelalisib,IFSDAJWBUCMOAH-HNNXBMFYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87884,6m3m,DB13008,-8.9,"2,2-bis(4-hydroxy-3-tert-butylphenyl)propane",ZDRSNHRWLQQICP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
24382,6cs2,DB02106,-8.9,"[3,5-Dibromo-4-(4-Hydroxy-3-Phenethylcarbamoyl-Phenoxy)-Phenyl]-Acetic Acid",KIRQJXNQGZAKGR-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
25306,6cs2,DB03207,-8.9,"2-(Biphenyl-4-Sulfonyl)-1,2,3,4-Tetrahydro-Isoquinoline-3-Carboxylic Acid",BNVMUDXGABBWGP-OAQYLSRUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
157202,6wiq,DB14773,-8.9,Lifirafenib,NGFFVZQXSRKHBM-FKBYEOEOSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
165775,7bv1,DB12996,-8.9,Acteoside,FBSKJMQYURKNSU-ZLSOWSIRSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94073,6m71,DB07691,-8.9,"2-({[3-(3,4-dihydroisoquinolin-2(1H)-ylsulfonyl)phenyl]carbonyl}amino)benzoic acid",GYILVHHTCYNIOS-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
165780,7bv1,DB13003,-8.9,Cortivazol,RKHQGWMMUURILY-UHRZLXHJSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
24259,6cs2,DB00278,-8.9,Argatroban,KXNPVXPOPUZYGB-IOVMHBDKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
95083,6m71,DB08907,-8.9,Canagliflozin,XTNGUQKDFGDXSJ-ZXGKGEBGSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
32087,6cs2,DB15328,-8.9,Ubrogepant,DDOOFTLHJSMHLN-ZQHRPCGSSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
60218,6crv,DB08385,-8.9,4-(quinolin-3-ylmethyl)piperidine-1-carboxylic acid,QUAGUFNCKDDJFZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111944,6vxx,DB04908,-8.9,Flibanserin,PPRRDFIXUUSXRA-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
131883,6w4h,DB14916,-8.9,Selonsertib,YIDDLAAKOYYGJG-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
62757,6crv,DB14083,-8.9,Bisphenol A diglycidyl ether,LCFVJGUPQDGYKZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111955,6vxx,DB04942,-8.9,Tamibarotene,MUTNCGKQJGXKEM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138073,6w9c,DB09124,-8.9,Medrogestone,HCFSGRMEEXUOSS-JXEXPEPMSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
74112,6m2n,DB02917,-8.9,N-Hydroxy-4-(Methyl{[5-(2-Pyridinyl)-2-Thienyl]Sulfonyl}Amino)Benzamide,LFGYSFPVLMPUPE-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
165448,7bv1,DB12116,-8.9,Epigallocatechin gallate,WMBWREPUVVBILR-WIYYLYMNSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95854,6m71,DB12044,-8.9,MK-0893,DNTVJEMGHBIUMW-IBGZPJMESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
123103,6w4b,DB14850,-8.9,Deleobuvir,BMAIGAHXAJEULY-UKTHLTGXSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
111988,6vxx,DB05076,-8.9,Fenretinide,AKJHMTWEGVYYSE-FXILSDISSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62750,6crv,DB14069,-8.9,ONT-093,RSJCLODJSVZNQA-BQYQJAHWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87345,6m3m,DB12193,-8.9,Ajulemic acid,YCHYFHOSGQABSW-RTBURBONSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
111994,6vxx,DB05105,-8.9,Pleconaril,KQOXLKOJHVFTRN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
95807,6m71,DB11968,-8.9,MK-7145,OCKGFTQIICXDQW-ZEQRLZLVSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
32766,6cs2,T3D3679,-8.9,Cytochalasin E,NYLMKKSTMIJWJC-GYZZCKOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
87373,6m3m,DB12234,-8.9,BMS-214662,OLCWFLWEHWLBTO-HSZRJFAPSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
112015,6vxx,DB05992,-8.9,Plinabulin,UNRCMCRRFYFGFX-TYPNBTCFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60261,6crv,DB08437,-8.9,Puromycin,RXWNCPJZOCPEPQ-NVWDDTSBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60264,6crv,DB08441,-8.9,"6-BROMO-13-THIA-2,4,8,12,19-PENTAAZATRICYCLO[12.3.1.1-3,7-]NONADECA-1(18),3(19),4,6,14,16-HEXAENE 13,13-DIOXIDE",AWSQADBSXFTFKL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78572,6m2n,DB11950,-8.9,Teneligliptin,WGRQANOPCQRCME-PMACEKPBSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138136,6w9c,DB09219,-8.9,Bisoxatin,BPKUDUSVDVLOPY-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
95762,6m71,DB11904,-8.9,Flumatinib,BJCJYEYYYGBROF-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95755,6m71,DB11896,-8.9,Gedatolisib,DWZAEMINVBZMHQ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95754,6m71,DB11894,-8.9,Efatutazone,JCYNMRJCUYVDBC-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
78538,6m2n,DB11902,-8.9,Gisadenafil,YPFZMBHKIVDSNR-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
62694,6crv,DB13956,-8.9,Estradiol valerate,RSEPBGGWRJCQGY-RBRWEJTLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60300,6crv,DB08485,-8.9,"(1S,4S,5S)-1,4,5-TRIHYDROXY-3-[3-(PHENYLTHIO)PHENYL]CYCLOHEX-2-ENE-1-CARBOXYLIC ACID",QMNMNSINKIFYBV-LMMKCTJWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112070,6vxx,DB06213,-8.9,Regadenoson,LZPZPHGJDAGEJZ-AKAIJSEGSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78618,6m2n,DB12021,-8.9,Dinaciclib,PIMQWRZWLQKKBJ-SFHVURJKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
74291,6m2n,DB03161,-8.9,Thymidine-5'-Diphospho-Beta-D-Xylose,AJUADKZRQSBUAK-KDGZBOQCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
62759,6crv,DB14086,-8.9,Cianidanol,PFTAWBLQPZVEMU-DZGCQCFKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
74030,6m2n,DB02812,-8.9,"(2s,4r)-1-Acetyl-N-[(1s)-4-[(Aminoiminomethyl)Amino]-1-(2-Benzothiazolylcarbonyl)Butyl]-4-Hydroxy-2-Pyrrolidinecarboxamide",VXDAVYUFYPFGDX-SNPRPXQTSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
96163,6m71,DB12479,-8.9,Zabofloxacin,ZNPOCLHDJCAZAH-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96130,6m71,DB12432,-8.9,CC-401,XDJCLCLBSGGNKS-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
73913,6m2n,DB02651,-8.9,"{[2-(1h-1,2,3-Benzotriazol-1-Yl)-2-(3,4-Difluorophenyl)Propane-1,3-Diyl]Bis[4,1-Phenylene(Difluoromethylene)]}Bis(Phosphonic Acid)",BTAGTGWPDROBMG-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
165391,7bv1,DB12036,-8.9,Naquotinib,QKDCLUARMDUUKN-XMMPIXPASA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60150,6crv,DB08301,-8.9,N-({[4-(AMINOSULFONYL)PHENYL]AMINO}CARBONYL)-4-METHYLBENZENESULFONAMIDE,HDCXQTPVTAIPNZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62854,6crv,DB14624,-8.9,Nandrolone hydrogen sulfate,SKZMVWBZTQNCKW-IZPLOLCNSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87253,6m3m,DB12058,-8.9,Recoflavone,BCPQOBQIVJZOFL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
62844,6crv,DB14569,-8.9,Tedizolid,XFALPSLJIHVRKE-GFCCVEGCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
131931,6w4h,DB15047,-8.9,BMS-919373,XGKULQQVQWCASY-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
137964,6w9c,DB08962,-8.9,Glibornuride,RMTYNAPTNBJHQI-LLDVTBCESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
131930,6w4h,DB15046,-8.9,LY-2881835,FHRWHNJJQGSCQC-LJAQVGFWSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
60182,6crv,DB08340,-8.9,"N,N'-DIPHENYLPYRAZOLO[1,5-A][1,3,5]TRIAZINE-2,4-DIAMINE",LLYYAUZAGCZEKV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
139897,6w9c,DB14218,-8.9,Telotristat,NCLGDOBQAWBXRA-PGRDOPGGSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
60191,6crv,DB08351,-8.9,N-cyclopropyl-4-methyl-3-{2-[(2-morpholin-4-ylethyl)amino]quinazolin-6-yl}benzamide,MNEXDVSJIUQQRH-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
137996,6w9c,DB08997,-8.9,Dexetimide,LQQIVYSCPWCSSD-HSZRJFAPSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
28867,6cs2,DB08490,-8.9,CTS-1027,ROSNVSQTEGHUKU-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
32847,6cs2,T3D3762,-8.9,Janthitrem B,FYYNBFCZCKFSKS-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
158915,7bv1,DB02629,-8.9,Inhibitor Bea403,LYHLPPXMBKMSSZ-JQFCFGFHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
111855,6vxx,DB04790,-8.9,"2,5-bis-O-{3-[amino(imino)methyl]phenyl}-1,4:3,6-dianhydro-D-glucitol",IBIUTOFGXGGVKQ-XMTFNYHQSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111856,6vxx,DB04791,-8.9,"2-O-(4'-AMIDINOPHENYL)-5-O-(3''-AMIDINOPHENYL)-1,4:3,6-DIANHYDRO-D-SORBITOL",DKBAWRNTUZFJKV-BSDSXHPESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78682,6m2n,DB12115,-8.9,AZD-9164,FNYFFCOCVNTJCD-NNMXADRKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78680,6m2n,DB12113,-8.9,CE-224535,FUCKCIVGBCBZNP-MRXNPFEDSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138022,6w9c,DB09030,-8.9,Vorapaxar,ZBGXUVOIWDMMJE-QHNZEKIYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138027,6w9c,DB09042,-8.9,Tedizolid phosphate,QCGUSIANLFXSGE-GFCCVEGCSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
32833,6cs2,T3D3747,-8.9,Territrem C,FTTNXWIFPFEOQT-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
95979,6m71,DB12228,-8.9,Telcagepant,CGDZXLJGHVKVIE-DNVCBOLYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
111903,6vxx,DB04845,-8.9,Ixabepilone,FABUFPQFXZVHFB-PVYNADRNSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62775,6crv,DB14125,-8.9,Benazeprilat,MADRIHWFJGRSBP-ROUUACIJSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
123172,6w4b,DB15023,-8.9,BMS-791826,DZBKAUMYTFPJIS-QHCPKHFHSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
95921,6m71,DB12137,-8.9,GSK-256066,JFHROPTYMMSOLG-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
138651,6w9c,DB12070,-8.9,Letermovir,FWYSMLBETOMXAG-QHCPKHFHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
62690,6crv,DB13952,-8.9,Estradiol acetate,FHXBMXJMKMWVRG-SLHNCBLASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
95690,6m71,DB11799,-8.9,Bictegravir,SOLUWJRYJLAZCX-LYOVBCGYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
138378,6w9c,DB11512,-8.9,Dihydrostreptomycin,ASXBYYWOLISCLQ-HZYVHMACSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
95344,6m71,DB09298,-8.9,Silibinin,SEBFKMXJBCUCAI-HKTJVKLFSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60390,6crv,DB08590,-8.9,1-(3-HYDROXYPROPYL)-2-[(3-NITROBENZOYL)AMINO]-1H-BENZIMIDAZOL-5-YL PIVALATE,CEAYRKIZESVQSN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
158356,7bv1,DB00901,-8.9,Bitolterol,FZGVEKPRDOIXJY-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
25516,6cs2,DB03460,-8.9,Violaxanthin,SZCBXWMUOPQSOX-WVJDLNGLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
60396,6crv,DB08597,-8.9,"6-[4-(2-piperidin-1-ylethoxy)phenyl]-3-pyridin-4-ylpyrazolo[1,5-a]pyrimidine",XHBVYDAKJHETMP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78401,6m2n,DB11698,-8.9,Ipragliflozin,AHFWIQIYAXSLBA-RQXATKFSSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138383,6w9c,DB11522,-8.9,Isoflupredone,WAIJIHDWAKJCBX-BULBTXNYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138385,6w9c,DB11529,-8.9,Melengestrol,OKHAOBQKCCIRLO-IBVJIVQJSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
24236,6cs2,DB01940,-8.9,Balanol Analog 2,SQLYTJZXRRDERK-ISKFKSNPSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
60444,6crv,DB08656,-8.9,5-amino-2-methyl-N-[(1R)-1-naphthalen-1-ylethyl]benzamide,UVERBUNNCOKGNZ-CQSZACIVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
74530,6m2n,DB03480,-8.9,Brequinar Analog,WYKKHJQZENLZID-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
146458,6w9q,DB08553,-8.9,"(1E)-5-(1-piperidin-4-yl-3-pyridin-4-yl-1H-pyrazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime",KWEFZSZCLBHIEQ-YYADALCUSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
131607,6w4h,DB14034,-8.9,Darglitazone,QQKNSPHAFATFNQ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
112237,6vxx,DB06871,-8.9,17-METHYL-17-ALPHA-DIHYDROEQUILENIN,FQMQOMRDADWGJJ-GBESFXJTSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112244,6vxx,DB06879,-8.9,"5-(4'-AMINO-1'-ETHYL-5',8'-DIFLUORO-1'H-SPIRO[PIPERIDINE-4,2'-QUINAZOLINE]-1-YLCARBONYL)PICOLINONITRILE",QCFIRACCCDFXIP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
74540,6m2n,DB03495,-8.9,"4,6-Dideoxy-4-{[4,5,6-Trihydroxy-3-(Hydroxymethyl)Cyclohex-2-En-1-Yl]Amino}-Alpha-D-Lyxo-Hexopyranosyl-(1->4)-Alpha-D-Threo-Hexopyranosyl-(1->6)-Alpha-L-Threo-Hexopyranose",FZLCJZILHGFQLM-PISLJJGOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
32115,6cs2,DB15393,-8.9,Telatinib,QFCXANHHBCGMAS-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
62567,6crv,DB13752,-8.9,Tetramethrin,CXBMCYHAMVGWJQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62561,6crv,DB13739,-8.9,Penamecillin,NLOOMWLTUVBWAW-HLLBOEOZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
95183,6m71,DB09042,-8.9,Tedizolid phosphate,QCGUSIANLFXSGE-GFCCVEGCSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
158213,7bv1,DB00734,-8.9,Risperidone,RAPZEAPATHNIPO-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
131562,6w4h,DB13947,-8.9,Testosterone enantate benzilic acid hydrazone,PTVXYACXDYZNID-JKXGKYMWSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
9177,6lzg,DB07261,-8.9,"THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [1-(1-AMINO-ISOQUINOLIN-7-YLMETHYL)-2-OXO-PYRROLDIN-3-YL]-AMIDE",NVKDOURNRJCKJE-INIZCTEOSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
165587,7bv1,DB12500,-8.9,Fedratinib,JOOXLOJCABQBSG-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
32101,6cs2,DB15356,-8.9,SLV-334,LOFDNSDPZTVIIO-VPUSJEBWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
14073,6lzg,T3D3691,-8.9,Ergovaline,BGHDUTQZGWOQIA-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
137134,6w9c,DB07940,-8.9,"9-(3-IODOBENZYLAMINO)-1,2,3,4-TETRAHYDROACRIDINE",ZUCWQTWGZGIYPV-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
60484,6crv,DB08707,-8.9,"4-[3-(4-chlorophenyl)-2,1-benzisoxazol-5-yl]pyrimidin-2-amine",AQVFETGXIRKVAQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
95436,6m71,DB11273,-8.9,Dihydroergocornine,SEALOBQTUQIVGU-QNIJNHAOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
78525,6m2n,DB11885,-8.9,Anlotinib,KSMZEXLVHXZPEF-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78427,6m2n,DB11741,-8.9,Famitinib,GKEYKDOLBLYGRB-LGMDPLHJSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
112183,6vxx,DB06519,-8.9,Edaglitazone,HAAXAFNSRADSMK-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87419,6m3m,DB12295,-8.9,Evodenoson,SQJXTUJMBYVDBB-RQXXJAGISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
28944,6cs2,DB08572,-8.9,4-{[4-AMINO-6-(CYCLOHEXYLMETHOXY)-5-NITROSOPYRIMIDIN-2-YL]AMINO}BENZAMIDE,YBKLJTXDSBEVRV-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
114198,6vxx,DB12888,-8.9,Ezutromid,KSGCNXAZROJSNW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112095,6vxx,DB06266,-8.9,Lonidamine,WDRYRZXSPDWGEB-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
158571,7bv1,DB01640,-8.9,"(5r)-6-(4-{[2-(3-Iodobenzyl)-3-Oxocyclohex-1-En-1-Yl]Amino}Phenyl)-5-Methyl-4,5-Dihydropyridazin-3(2h)-One",QNURTFDBHAQRSI-OAHLLOKOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
138188,6w9c,DB09298,-8.9,Silibinin,SEBFKMXJBCUCAI-HKTJVKLFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
9279,6lzg,DB07362,-8.9,"1-(5-{2-[(1-methyl-1H-pyrazolo[4,3-d]pyrimidin-7-yl)amino]ethyl}-1,3-thiazol-2-yl)-3-[3-(trifluoromethyl)phenyl]urea",UOLCZAFAGDOUFX-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
78513,6m2n,DB11867,-8.9,JNJ-39393406,IURMHZBQEYNQOH-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138213,6w9c,DB09371,-8.9,Norethynodrel,ICTXHFFSOAJUMG-SLHNCBLASA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
28950,6cs2,DB00799,-8.9,Tazarotene,OGQICQVSFDPSEI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
95642,6m71,DB11734,-8.9,Fedovapagon,RUOLFWZIFNQQGH-DEOSSOPVSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
112120,6vxx,DB06345,-8.9,AR-9281,HUDQLWBKJOMXSZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112121,6vxx,DB06346,-8.9,Fiboflapon,DFQGDHBGRSTTHX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78489,6m2n,DB11828,-8.9,Neratinib,JWNPDZNEKVCWMY-VQHVLOKHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
62654,6crv,DB13865,-8.9,Dehydroemetine,XXLZPUYGHQWHRN-RPBOFIJWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60342,6crv,DB08532,-8.9,"6-(2-fluorophenyl)-N-(pyridin-3-ylmethyl)imidazo[1,2-a]pyrazin-8-amine",WCNPGRRMPFCHEO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60348,6crv,DB08538,-8.9,"N-((2-aminopyrimidin-5-yl)methyl)-5-(2,6-difluorophenyl)-3-ethylpyrazolo[1,5-a]pyrimidin-7-amine",HQPVGVSQPQVZLD-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
13998,6lzg,T3D3608,-8.9,Microcystin-YR,OWHASZQTEFAUJC-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
60364,6crv,DB08557,-8.9,"2-[(2-methoxyethyl)amino]-4-(4-oxo-1,2,3,4-tetrahydro-9H-carbazol-9-yl)benzamide",XQKFKSJUBJPOLY-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
74421,6m2n,DB03325,-8.9,Tyrosyladenylate,MJZAZMKENKZBAJ-QTOWJTHWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78465,6m2n,DB11795,-8.9,GSK-2636771,XTKLTGBKIDQGQL-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
24212,6cs2,DB01908,-8.9,RU85493,MWEWSHNGVWABKG-SVBPBHIXSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
146371,6w9q,DB08450,-8.9,N-1H-indazol-5-yl-2-(6-methylpyridin-2-yl)quinazolin-4-amine,HNHRWNUXTCATSG-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
60371,6crv,DB08568,-8.9,(2S)-1-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}-3-PHENYLPROPAN-2-AMINE,BPNUQXPIQBZCMR-IBGZPJMESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112164,6vxx,DB06469,-8.9,Lestaurtinib,UIARLYUEJFELEN-DMVVYWCZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138351,6w9c,DB11450,-8.9,Pimobendan,GLBJJMFZWDBELO-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
87486,6m3m,DB12391,-8.9,Sagopilone,BFZKMNSQCNVFGM-UCEYFQQTSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
78440,6m2n,DB11763,-8.9,Momelotinib,ZVHNDZWQTBEVRY-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
62610,6crv,DB13806,-8.9,Linopirdine,YEJCDKJIEMIWRQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
95437,6m71,DB11274,-8.9,Dihydro-alpha-ergocryptine,PBUNVLRHZGSROC-VTIMJTGVSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
9446,6lzg,DB07545,-8.9,N-{3-[(4-{[3-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-2-YL)AMINO]PHENYL}CYCLOPROPANECARBOXAMIDE,RDTDWGQDFJPTPD-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
88114,6m3m,DB13360,-8.9,Tolciclate,CANCCLAKQQHLNK-LSDHHAIUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88124,6m3m,DB13371,-8.9,Difenpiramide,PWHROYKAGRUWDQ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
118929,6w4b,DB06666,-8.9,Lixivaptan,PPHTXRNHTVLQED-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
75994,6m2n,DB06605,-8.9,Apixaban,QNZCBYKSOIHPEH-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76543,6m2n,DB07323,-8.9,"2-[({2-[(1Z)-3-(DIMETHYLAMINO)PROP-1-ENYL]-4-FLUOROPHENYL}SULFONYL)AMINO]-5,6,7,8-TETRAHYDRONAPHTHALENE-1-CARBOXYLIC ACID",CTZLIARLNXSXGL-ALCCZGGFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61792,6crv,DB12597,-8.9,ABL-001,VOVZXURTCKPRDQ-CQSZACIVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
118896,6w4b,DB06595,-8.9,Midostaurin,BMGQWWVMWDBQGC-IIFHNQTCSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
88856,6m3m,DB14941,-8.9,BMS-817399,GTDPZONCGOCXOD-JPYJTQIMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
24891,6cs2,DB02705,-8.9,"6-[N-(1-Isopropyl-1,2,3,4-Tetrahydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine",DARQQJKHXPXSRO-QFIPXVFZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
166378,7bv1,DB14766,-8.9,Etrasimod,MVGWUTBTXDYMND-QGZVFWFLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
90657,6m71,DB02033,-8.9,"N-(3-Cyclopropyl(5,6,7,8,9,10-Hexahydro-2-Oxo-2h-Cycloocta[B]Pyran-3-Yl)Methyl)Phenylbenzensulfonamide",GDRNWAKVNIROCG-DEOSSOPVSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
30467,6cs2,DB12523,-8.9,Mizolastine,PVLJETXTTWAYEW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
118816,6w4b,DB06393,-8.9,Xaliproden,WJJYZXPHLSLMGE-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
30465,6cs2,DB12522,-8.9,Toreforant,FCRFVPZAXGJLPW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
88866,6m3m,DB14993,-8.9,Pyrotinib,SADXACCFNXBCFY-IYNHSRRRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
76556,6m2n,DB07337,-8.9,"4-[4-AMINO-6-(5-CHLORO-1H-INDOL-4-YLMETHYL)-[1,3,5]TRIAZIN-2-YLAMINO]-BENZONITRILE",SOKOHDQTKSROQZ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61770,6crv,DB12565,-8.9,Abexinostat,MAUCONCHVWBMHK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
129665,6w4h,DB09143,-8.9,Sonidegib,VZZJRYRQSPEMTK-CALCHBBNSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130165,6w4h,DB11867,-8.9,JNJ-39393406,IURMHZBQEYNQOH-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
113890,6vxx,DB12235,-8.9,Estetrol,AJIPIJNNOJSSQC-NYLIRDPKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61477,6crv,DB12141,-8.9,Gilteritinib,GYQYAJJFPNQOOW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
166381,7bv1,DB14770,-8.9,Lanraplenib,XCIGZBVOUQVIPI-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
76479,6m2n,DB07254,-8.9,"N-[3-[[4-[(5-CHLORO-1,3-BENZODIOXOL-4-YL)AMINO]PYRIMIDIN-2-YL]AMINO]PHENYL]METHANESULFONAMIDE",KQGTYXRWSIBDOZ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
149304,6w9q,DB15343,-8.9,HM-43239,FZLSDZZNPXXBBB-KDURUIRLSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
130159,6w4h,DB11855,-8.9,Revefenacin,FYDWDCIFZSGNBU-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
61493,6crv,DB12165,-8.9,Presatovir,GOFXWTVKPWJNGD-UWJYYQICSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
139128,6w9c,DB12899,-8.9,TT-301,ZPJGUEPHFXPAQF-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
88896,6m3m,DB15057,-8.9,NUC-1031,NHTKGYOMICWFQZ-KKQYNPQSSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
90315,6m71,DB01573,-8.9,Benzylmorphine,RDJGWRFTDZZXSM-RNWLQCGYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
129699,6w4h,DB09195,-8.9,Lorpiprazole,BNRMWKUVWLKDQJ-YJBOKZPZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
76488,6m2n,DB07263,-8.9,"[{2-bromo-4-[(2R)-3-oxo-2,3-diphenylpropyl]phenyl}(difluoro)methyl]phosphonic acid",WDTMVBQZDFMOIK-GOSISDBHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
8434,6lzg,DB06011,-8.9,AMG-222,NVSWJKWHLUTHLP-CPJSRVTESA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
149339,6w9q,DB15416,-8.9,PX-102,XBUXXJUEBFDQHD-NHCUHLMSSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
75963,6m2n,DB06525,-8.9,Ganstigmine,ZOBDWFRKFSPCRB-UNMCSNQZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61371,6crv,DB11987,-8.9,GSK-2018682,NFIGDBFIDKDNIG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88776,6m3m,DB14769,-8.9,Pamiparib,DENYZIUJOTUUNY-MRXNPFEDSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
91410,6m71,DB03020,-8.9,5-Beta-D-Ribofuranosylnicotinamide Adenine Dinucleotide,UINNILASBHZOTM-KMXXXSRASA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
61388,6crv,DB12010,-8.9,Fostamatinib,GKDRMWXFWHEQQT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61389,6crv,DB12011,-8.9,Fevipiprant,GFPPXZDRVCSVNR-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75895,6m2n,DB06334,-8.9,Tucidinostat,SZMJVTADHFNAIS-BJMVGYQFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61395,6crv,DB12022,-8.9,Evatanepag,WOHRHWDYFNWPNG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76731,6m2n,DB07544,-8.9,N'-(5-CHLOROBENZOFURAN-2-CARBONYL)-2-(TRIFLUOROMETHYL)BENZENESULFONOHYDRAZIDE,ZLQBZYKAQQWOTK-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
88792,6m3m,DB14802,-8.9,ONO-2952,ZBQMTQGDBFZUBG-NRFANRHFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
91184,6m71,DB02716,-8.9,7-Methyl-Guanosine-5'-Triphosphate,DKVRNHPCAOHRSI-KQYNXXCUSA-O,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
61838,6crv,DB12671,-8.9,Beloranib,ZEZFKUBILQRZCK-MJSCXXSSSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30590,6cs2,DB12696,-8.9,BMS-582949,GDTQLZHHDRRBEB-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
138876,6w9c,DB12391,-8.9,Sagopilone,BFZKMNSQCNVFGM-UCEYFQQTSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
113745,6vxx,DB12021,-8.9,Dinaciclib,PIMQWRZWLQKKBJ-SFHVURJKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76699,6m2n,DB07507,-8.9,"2-(4-hydroxybiphenyl-3-yl)-4-methyl-1H-isoindole-1,3(2H)-dione",ROMNEYAQUBNRLR-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
88804,6m3m,DB14845,-8.9,Filgotinib,RIJLVEAXPNLDTC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
75917,6m2n,DB06410,-8.9,Doxercalciferol,HKXBNHCUPKIYDM-CGMHZMFXSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75924,6m2n,DB06429,-8.9,Talnetant,BIAVGWDGIJKWRM-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61825,6crv,DB12655,-8.9,Patidegib,HZLFFNCLTRVYJG-WWGOJCOQSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130250,6w4h,DB11992,-8.9,Omarigliptin,MKMPWKUAHLTIBJ-ISTRZQFTSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
61807,6crv,DB12625,-8.9,Evogliptin,LCDDAGSJHKEABN-MLGOLLRUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113776,6vxx,DB12068,-8.9,T-900607,FSXLOWIFSZNIMV-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
91017,6m71,DB02498,-8.9,Carba-Nicotinamide-Adenine-Dinucleotide,DGPLSUKWXXSBCU-VGXGLJSLSA-O,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
138911,6w9c,DB12434,-8.9,Steviolbioside,OMHUCGDTACNQEX-OSHKXICASA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
61429,6crv,DB12073,-8.9,Albaconazole,UHIXWHUVLCAJQL-MPBGBICISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88836,6m3m,DB14902,-8.9,JHU-75528 C-11,MCNQUWLLXZZZAC-BJUDXGSMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
30547,6cs2,DB12640,-8.9,CP-609754,JAHDAIPFBPPQHQ-GDLZYMKVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
30543,6cs2,DB12635,-8.9,Aleplasinin,HSXLMAFNWCSZGP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
61437,6crv,DB12084,-8.9,ADP-597,WPDCHTSXOPUOII-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61510,6crv,DB12193,-8.9,Ajulemic acid,YCHYFHOSGQABSW-RTBURBONSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
166388,7bv1,DB14787,-8.9,BMS-830216,YDTUJCNTIMWHPJ-NRFANRHFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
88901,6m3m,DB15065,-8.9,PF-06291874,IBDYYOQKQCCSDP-QFIPXVFZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
118604,6w4b,DB05450,-8.9,Smilagenin,GMBQZIIUCVWOCD-UQHLGXRBSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
89568,6m71,DB00637,-8.9,Astemizole,GXDALQBWZGODGZ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
89552,6m71,DB00619,-8.9,Imatinib,KTUFNOKKBVMGRW-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
130090,6w4h,DB11759,-8.9,Pevonedistat,MPUQHZXIXSTTDU-QXGSTGNESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
114069,6vxx,DB12680,-8.9,Intepirdine,JJZFWROHYSMCMU-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
149123,6w9q,DB14946,-8.9,PCO-371,LDZJFVOUPUFOHX-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
139033,6w9c,DB12742,-8.9,Amuvatinib,FOFDIMHVKGYHRU-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
30230,6cs2,DB12225,-8.9,Beclabuvir,ZTTKEBYSXUCBSE-QDFUAKMASA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
148182,6w9q,DB13061,-8.9,MLN8054,HHFBDROWDBDFBR-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
149069,6w9q,DB14850,-8.9,Deleobuvir,BMAIGAHXAJEULY-UKTHLTGXSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
89283,6m71,DB00288,-8.9,Amcinonide,ILKJAFIWWBXGDU-MOGDOJJUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
30220,6cs2,DB12214,-8.9,Luseogliflozin,WHSOLWOTCHFFBK-ZQGJOIPISA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
61718,6crv,DB12480,-8.9,Betulinic Acid,QGJZLNKBHJESQX-FZFNOLFKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61632,6crv,DB12364,-8.9,Betrixaban,XHOLNRLADUSQLD-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76275,6m2n,DB07019,-8.9,"N-[(5R,14R)-5-AMINO-5,14-DIMETHYL-4-OXO-3-OXA-18-AZATRICYCLO[15.3.1.1-7,11-]DOCOSA-1(21),7(22),8,10,17,19-HEXAEN-19-YL]-N-METHYLMETHANESULFONAMIDE",QWDOKZPZLWNULU-MZNJEOGPSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
114112,6vxx,DB12744,-8.9,CGI-1842,ZXBFYBLSJMEBEP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
148216,6w9q,DB13109,-8.9,PKI-179,WXUUCRLKXQMWRY-OYRHEFFESA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
76163,6m2n,DB06886,-8.9,N-BENZYLOXYCARBONYL-ALA-PRO-3-AMINO-4-PHENYL-BUTAN-2-OL,MACLRJNEKXUAJK-YDLSIGKMSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
166546,7bv1,DB15343,-8.9,HM-43239,FZLSDZZNPXXBBB-KDURUIRLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
114131,6vxx,DB12779,-8.9,Higenamine,WZRCQWQRFZITDX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
89120,6m3m,DB09171,-8.9,β-Methylfentanyl,UXIGUKSHASXDNI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
89110,6m3m,DB03453,-8.9,Methyl (2S)-2-[[2-[(3R)-1-carbamimidoylpiperidin-3-yl]acetyl]amino]-3-[4-(2-phenylethynyl)phenyl]propanoate,MRNGXYMKYHNMLV-PKTZIBPZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
89102,6m3m,DB01557,-8.9,alpha-Methylfentanyl,NGTVDHYUFBKWID-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
76252,6m2n,DB06993,-8.9,"(2S,3S)-4-cyclopropyl-3-{(3R,5R)-3-[2-fluoro-4-(methylsulfonyl)phenyl]-1,2,4-oxadiazolidin-5-yl}-1-[(3S)-3-fluoropyrrolidin-1-yl]-1-oxobutan-2-amine",PTAHVQJZNFGPHN-WFWWEWPISA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
130010,6w4h,DB11637,-8.9,Delamanid,XDAOLTSRNUSPPH-XMMPIXPASA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
89037,6m3m,DB15333,-8.9,AZD-1386,FPGNKXCEPARJDI-ZDUSSCGKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
76227,6m2n,DB06963,-8.9,"3-[3-(3-methyl-6-{[(1S)-1-phenylethyl]amino}-1H-pyrazolo[4,3-c]pyridin-1-yl)phenyl]propanamide",ZFGCLYUGFRNYFE-INIZCTEOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
89046,6m3m,DB15347,-8.9,Branebrutinib,VJPPLCNBDLZIFG-ZDUSSCGKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
89067,6m3m,DB15401,-8.9,Danicopan,PIBARDGJJAGJAJ-NQIIRXRSSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
129940,6w4h,DB11450,-8.9,Pimobendan,GLBJJMFZWDBELO-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
61581,6crv,DB12290,-8.9,Puerarin,HKEAFJYKMMKDOR-VPRICQMDSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138870,6w9c,DB12382,-8.9,R-306465,MUTBJZVSRNUIHA-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
61736,6crv,DB12512,-8.9,Verucerfont,VKHVAUKFLBBZFJ-SFHVURJKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
89719,6m71,DB00820,-8.9,Tadalafil,WOXKDUGGOYFFRN-IIBYNOLFSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
29605,6cs2,DB11176,-8.9,Zeaxanthin,JKQXZKUSFCKOGQ-QAYBQHTQSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
88906,6m3m,DB15078,-8.9,Rogaratinib,HNLRRJSKGXOYNO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
139121,6w9c,DB12888,-8.9,Ezutromid,KSGCNXAZROJSNW-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
88912,6m3m,DB15091,-8.9,Upadacitinib,WYQFJHHDOKWSHR-MNOVXSKESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
113944,6vxx,DB12306,-8.9,Cipargamin,CKLPLPZSUQEDRT-WPCRTTGESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88914,6m3m,DB15096,-8.9,18-methoxycoronaridine,DTJQBBHYRQYDEG-SVBQBFEESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
113956,6vxx,DB12320,-8.9,Palovarotene,YTFHCXIPDIHOIA-DHZHZOJOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61527,6crv,DB12221,-8.9,Canrenone,UJVLDDZCTMKXJK-WNHSNXHDSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61528,6crv,DB12222,-8.9,Lurtotecan,RVFGKBWWUQOIOU-NDEPHWFRSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61760,6crv,DB12550,-8.9,Taladegib,SZBGQDXLNMELTB-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76401,6m2n,DB07162,-8.9,4-(3-amino-1H-indazol-5-yl)-N-tert-butylbenzenesulfonamide,KFJCXIOVAGJCKB-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61539,6crv,DB12235,-8.9,Estetrol,AJIPIJNNOJSSQC-NYLIRDPKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76090,6m2n,DB06781,-8.9,Difluprednate,WYQPLTPSGFELIB-JTQPXKBDSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
166424,7bv1,DB15106,-8.9,Surufatinib,TTZSNFLLYPYKIL-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
88920,6m3m,DB15106,-8.9,Surufatinib,TTZSNFLLYPYKIL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
166427,7bv1,DB15110,-8.9,Onvansertib,QHLVBNKYJGBCQJ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
61758,6crv,DB12547,-8.9,LY-2886721,NIDRNVHMMDAAIK-YPMLDQLKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29983,6cs2,DB11894,-8.9,Efatutazone,JCYNMRJCUYVDBC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
30337,6cs2,DB12355,-8.9,Netazepide,YDZYKNJZCVIKPP-VWLOTQADSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
89922,6m71,DB01051,-8.9,Novobiocin,YJQPYGGHQPGBLI-KGSXXDOSSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
89919,6m71,DB01047,-8.9,Fluocinonide,WJOHZNCJWYWUJD-IUGZLZTKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
30322,6cs2,DB12332,-8.9,Rucaparib,HMABYWSNWIZPAG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
61563,6crv,DB12269,-8.9,PF-06273340,BPIWZDNVMQQBQX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
166436,7bv1,DB15126,-8.9,IMG-7289,KQKBMHGOHXOHTD-KKUQBAQOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
139019,6w9c,DB12720,-8.9,Nivocasan,VYFGDLGHHBUDTQ-ZLGUVYLKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
114014,6vxx,DB12591,-8.9,BMS-911543,JCINBYQJBYJGDM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61567,6crv,DB12273,-8.9,Ecopipam,DMJWENQHWZZWDF-PKOBYXMFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30302,6cs2,DB12307,-8.9,Foretinib,CXQHYVUVSFXTMY-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
114848,6vxx,DB15013,-8.9,TAK-243,KJDAGXLMHXUAGV-DGWLBADLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130103,6w4h,DB11778,-8.9,Danusertib,XKFTZKGMDDZMJI-HSZRJFAPSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
76767,6m2n,DB07588,-8.9,"3,4-DI-1H-INDOL-3-YL-1H-PYRROLE-2,5-DICARBOXYLIC ACID",FZDVNXHYGMEEDT-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
30658,6cs2,DB12796,-8.9,MRX-I,SULYVXZZUMRQAX-NSHDSACASA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
91569,6m71,DB03231,-8.9,"3-(5-Amino-7-oxo-3,7-dihydro-2H-[1,2,3]triazolo[4,5-d]pyrimidin-2-yl)-N-(2-{[2-(hydroxymethyl)phenyl]sulfanyl}benzyl)benzamide",IXDQOBDHBWEZOH-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
129419,6w4h,DB08770,-8.9,"4-{2-[(7-amino-2-furan-2-yl[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-yl)amino]ethyl}phenol",PWTBZOIUWZOPFT-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
76216,6m2n,DB06945,-8.9,N-hydroxy-4-({4-[4-(trifluoromethyl)phenoxy]phenyl}sulfonyl)tetrahydro-2H-pyran-4-carboxamide,FOSWRYKPHVPIDJ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
113115,6vxx,DB08555,-8.9,"1-(3-bromophenyl)-7-chloro-6-methoxy-3,4-dihydroisoquinoline",IKGXHBGCVQTQBH-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165853,7bv1,DB13109,-8.9,PKI-179,WXUUCRLKXQMWRY-OYRHEFFESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
77279,6m2n,DB08174,-8.9,"5-CHLORO-N-((1R,2S)-2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO) CYCLOPENTYL)THIOPHENE-2-CARBOXAMIDE",QCPYHSAHOYXXQK-DLBZAZTESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
130608,6w4h,DB12507,-8.9,Atecegatran metoxil,XSNMGLZVFNDDPW-ZWKOTPCHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
93163,6m71,DB06469,-8.9,Lestaurtinib,UIARLYUEJFELEN-DMVVYWCZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
88320,6m3m,DB13643,-8.9,Loprazolam,UTEFBSAVJNEPTR-RGEXLXHISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
147462,6w9q,DB11977,-8.9,Golvatinib,UQRCJCNVNUFYDX-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
61140,6crv,DB11648,-8.9,Afuresertib,AFJRDFWMXUECEW-LBPRGKRZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130596,6w4h,DB12483,-8.9,Copanlisib,PZBCKZWLPGJMAO-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
62003,6crv,DB12933,-8.9,RO-4987655,FIMYFEGKMOCQKT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77202,6m2n,DB08094,-8.9,"(4-AMINO-2-{[1-(METHYLSULFONYL)PIPERIDIN-4-YL]AMINO}PYRIMIDIN-5-YL)(2,3-DIFLUORO-6-METHOXYPHENYL)METHANONE",JRNJNYBQQYBCLE-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
93073,6m71,DB06229,-8.9,Ocaperidone,ZZQNEJILGNNOEP-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
61993,6crv,DB12921,-8.9,Chlorsulfaquinoxaline,CTSNHMQGVWXIEG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77178,6m2n,DB08064,-8.9,N-(3-TERT-BUTYL-1H-PYRAZOL-5-YL)-N'-{4-CHLORO-3-[(PYRIDIN-3-YLOXY)METHYL]PHENYL}UREA,NTMADESEDXKNFZ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
88388,6m3m,DB13728,-8.9,Halometasone,GGXMRPUKBWXVHE-MIHLVHIWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88431,6m3m,DB13788,-8.9,Chlorbenzoxamine,VEVSKUJZSMGTMM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88432,6m3m,DB13790,-8.9,Fipexide,BFUJHVVEMMWLHC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
92988,6m71,DB05835,-8.9,NS-3728,OQRAKHDEGGGWQO-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
88439,6m3m,DB13797,-8.9,Iodocholesterol (131I),FIOAEFCJGZJUPW-ODFYUTSGSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
31099,6cs2,DB13407,-8.9,Nifenazone,BRZANEXCSZCZCI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
138750,6w9c,DB12219,-8.9,GSK-424887,DRXBWLBZWAJIEF-IBGZPJMESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
77144,6m2n,DB08026,-8.9,"2-{4-[(4-imidazo[1,2-a]pyridin-3-ylpyrimidin-2-yl)amino]piperidin-1-yl}-N-methylacetamide",AJLILYAPRHIFAS-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
88452,6m3m,DB13816,-8.9,Aspoxicillin,BHELIUBJHYAEDK-OAIUPTLZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
61979,6crv,DB12899,-8.9,TT-301,ZPJGUEPHFXPAQF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113271,6vxx,DB08742,-8.9,"1,3-CYCLOHEXANEDIOL, 4-METHYLENE-5-[(2E)-[(1S,3AS,7AS)-OCTAHYDRO-1-(5-HYDROXY-5-METHYL-1,3-HEXADIYNYL)-7A-METHYL-4H-INDEN-4-YLIDENE]ETHYLIDENE]-, (1R,3S,5Z)",CEEUUHVULXTFGS-BQXVGYHGSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113274,6vxx,DB08745,-8.9,4-[[(1E)-2-(4-CHLOROPHENYL)ETHENYL]SULFONYL]-1-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]PIPERAZINONE,QLHUDNKWOSQSMK-CXUHLZMHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138763,6w9c,DB12234,-8.9,BMS-214662,OLCWFLWEHWLBTO-HSZRJFAPSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
93232,6m71,DB06634,-8.9,Casopitant,XGGTZCKQRWXCHW-WMTVXVAQSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
166521,7bv1,DB15294,-8.9,SB-1578,NNXDIGHYPZHXTR-ONEGZZNKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
113081,6vxx,DB08352,-8.9,"6-[4-(2-fluorophenyl)-1,3-oxazol-5-yl]-N-(1-methylethyl)-1,3-benzothiazol-2-amine",FQYJTHIYAQQJAB-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75552,6m2n,DB04850,-8.9,Posizolid,HBUJYEUPIIJJOS-PBHICJAKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77458,6m2n,DB08402,-8.9,"2-[(2,4-DICHLOROBENZOYL)AMINO]-5-(PYRIMIDIN-2-YLOXY)BENZOIC ACID",VNDRRWBKNSHALL-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
62092,6crv,DB13070,-8.9,Surinabant,HMXDWDSNPRNUKI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88136,6m3m,DB13393,-8.9,Emetine,AUVVAXYIELKVAI-CKBKHPSWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
75483,6m2n,DB04764,-8.9,[4-(3-AMINOMETHYL-PHENYL)-PIPERIDIN-1-YL]-(5-PHENETHYL- PYRIDIN-3-YL)-METHANONE,CCLHROFBSWWOQO-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
93548,6m71,DB07076,-8.9,6-[(Z)-AMINO(IMINO)METHYL]-N-[3-(CYCLOPENTYLOXY)PHENYL]-2-NAPHTHAMIDE,FWTQOPWAMQXIMI-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
88156,6m3m,DB13418,-8.9,Moxestrol,MTMZZIPTQITGCY-OLGWUGKESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
112929,6vxx,DB08159,-8.9,"4-(5,11-DIOXO-5H-INDENO[1,2-C]ISOQUINOLIN-6(11H)-YL)BUTANOATE",AHIJTWCJGCWHMT-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29243,6cs2,DB08916,-8.9,Afatinib,ULXXDDBFHOBEHA-CWDCEQMOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
31617,6cs2,DB14128,-8.9,Nadide,BAWFJGJZGIEFAR-NNYOXOHSSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
112951,6vxx,DB08184,-8.9,2-(2-METHYLPHENYL)-1H-INDOLE-5-CARBOXIMIDAMIDE,YOZKTHGEOJHIDP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77423,6m2n,DB08360,-8.9,"2-(4-ETHYLPIPERAZIN-1-YL)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE",BIFHJPUTQBOBGJ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
88181,6m3m,DB13451,-8.9,Tioclomarol,WRGOVNKNTPWHLZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88206,6m3m,DB13487,-8.9,Iodine (131I) norcholesterol,QJHZPCLORSPENH-DRTKWHMQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
147365,6w9q,DB11830,-8.9,Mocetinostat,HRNLUBSXIHFDHP-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
112985,6vxx,DB08230,-8.9,"5,7-DIHYDROXY-2-(3,4,5-TRIHYDROXYPHENYL)-4H-CHROMEN-4-ONE",ARSRJFRKVXALTF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112991,6vxx,DB08237,-8.9,2'-deoxy-N-(naphthalen-1-ylmethyl)guanosine 5'-(dihydrogen phosphate),COMPKRGNHXOXMN-GVDBMIGSSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
129399,6w4h,DB08747,-8.9,"(11R)-10-acetyl-11-(2,4-dichlorophenyl)-6-hydroxy-3,3-dimethyl-2,3,4,5,10,11-hexahydro-1H-dibenzo[b,e][1,4]diazepin-1-one",JJTPPGUNMJMPLY-QFIPXVFZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
138690,6w9c,DB12124,-8.9,Namitecan,IBTISPLPBBHVSU-UVOOVGFISA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
113001,6vxx,DB08248,-8.9,3-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)-BENZENESULFONAMIDE,BKDUVKJYBJDZQW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77406,6m2n,DB08340,-8.9,"N,N'-DIPHENYLPYRAZOLO[1,5-A][1,3,5]TRIAZINE-2,4-DIAMINE",LLYYAUZAGCZEKV-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
29965,6cs2,DB11871,-8.9,PF-00610355,YPHDIMUXXABSSO-YTTGMZPUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
25188,6cs2,DB03067,-8.9,"4-{2,4-Bis[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid",VFYAZSTYKPFSFL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
147367,6w9q,DB11832,-8.9,Crenolanib,DYNHJHQFHQTFTP-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
31542,6cs2,DB13991,-8.9,Pipequaline,AMEWZCMTSIONOX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
129401,6w4h,DB08749,-8.9,3-(2-AMINO-6-BENZOYLQUINAZOLIN-3(4H)-YL)-N-CYCLOHEXYL-N-METHYLPROPANAMIDE,KTRFBFMYAJOXLG-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
62060,6crv,DB13023,-8.9,IPI-493,XYFFWTYOFPSZRM-TWNAANEASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31517,6cs2,DB13950,-8.9,WIN 55212-2,HQVHOQAKMCMIIM-HXUWFJFHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
77376,6m2n,DB08303,-8.9,"(3S)-3-cyclopentyl-6-methyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide",CUMKMTBOHBENJI-SFHVURJKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61078,6crv,DB11478,-8.9,Zeranol,DWTTZBARDOXEAM-GXTWGEPZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113080,6vxx,DB08351,-8.9,N-cyclopropyl-4-methyl-3-{2-[(2-morpholin-4-ylethyl)amino]quinazolin-6-yl}benzamide,MNEXDVSJIUQQRH-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
129397,6w4h,DB08745,-8.9,4-[[(1E)-2-(4-CHLOROPHENYL)ETHENYL]SULFONYL]-1-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]PIPERAZINONE,QLHUDNKWOSQSMK-CXUHLZMHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
77112,6m2n,DB07991,-8.9,N-[(1R)-3-(4-HYDROXYPHENYL)-1-METHYLPROPYL]-2-(2-PHENYL-1H-INDOL-3-YL)ACETAMIDE,APLJSSOXDWUNGV-GOSISDBHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75687,6m2n,DB05414,-8.9,Pipendoxifene,JICOGKJOQXTAIP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
113559,6vxx,DB11511,-8.9,Difloxacin,NOCJXYPHIIZEHN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
166177,7bv1,DB13791,-8.9,Penfluridol,MDLAAYDRRZXJIF-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
88647,6m3m,DB14210,-8.9,Moexiprilat,CMPAGYDKASJORH-YSSFQJQWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
130457,6w4h,DB12290,-8.9,Puerarin,HKEAFJYKMMKDOR-VPRICQMDSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
61295,6crv,DB11875,-8.9,"3,3'-diindolylmethane",VFTRKSBEFQDZKX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88682,6m3m,DB14575,-8.9,Eslicarbazepine,BMPDWHIDQYTSHX-AWEZNQCLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
138832,6w9c,DB12322,-8.9,GW-870086,WUBKGTSFJSEIEM-NSHBDUGJSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
88687,6m3m,DB14596,-8.9,Loteprednol etabonate,DMKSVUSAATWOCU-HROMYWEYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
61903,6crv,DB12774,-8.9,AZD-8055,KVLFRAWTRWDEDF-IRXDYDNUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30708,6cs2,DB12874,-8.9,Quizartinib,CVWXJKQAOSCOAB-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
76857,6m2n,DB07697,-8.9,"1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-4-[(4-methoxyphenyl)sulfonyl]piperazine",HMGDKYUJSFVHIY-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
113638,6vxx,DB11687,-8.9,E-6201,MWUFVYLAWAXDHQ-HMNLTAHHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88701,6m3m,DB14636,-8.9,Triciribine phosphate,URLYINUFLXOMHP-HTVVRFAVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
76847,6m2n,DB07685,-8.9,"4-{[5-(CYCLOHEXYLMETHOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE",NMAZGYDYIYLSLJ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61887,6crv,DB12745,-8.9,GSK-690693,KGPGFQWBCSZGEL-ZDUSSCGKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76842,6m2n,DB07679,-8.9,"(9S,12S)-9-(1-methylethyl)-7,10-dioxo-2-oxa-8,11-diazabicyclo[12.2.2]octadeca-1(16),14,17-triene-12-carboxylic acid",RRAAROKJUVKWAF-RDJZCZTQSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
130362,6w4h,DB12154,-8.9,Itacitinib,KTBSXLIQKWEBRB-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
61886,6crv,DB12744,-8.9,CGI-1842,ZXBFYBLSJMEBEP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61348,6crv,DB11950,-8.9,Teneligliptin,WGRQANOPCQRCME-PMACEKPBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130324,6w4h,DB12101,-8.9,CC-220,IXZOHGPZAQLIBH-NRFANRHFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130319,6w4h,DB12096,-8.9,PF-05175157,BDXXSFOJPYSYOC-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
29882,6cs2,DB11764,-8.9,Spebrutinib,KXBDTLQSDKGAEB-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
61355,6crv,DB11962,-8.9,GSK-1059615,QDITZBLZQQZVEE-YBEGLDIGSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75857,6m2n,DB06237,-8.9,Avanafil,WEAJZXNPAWBCOA-INIZCTEOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
119766,6w4b,DB07700,-8.9,"3-CARBOXAMIDO-1,3,5(10)-ESTRATRIEN-17(R)-SPIRO-2'(5',5'-DIMETHYL-6'OXO)TETRAHYDROPYRAN",YVAJWBACBRSVPR-NDUHRLLKSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
61860,6crv,DB12708,-8.9,Sulprostone,UQZVCDCIMBLVNR-TWYODKAFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88752,6m3m,DB14717,-8.9,Nitrazolam,OYRPNABWTHDOFK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88755,6m3m,DB14723,-8.9,Larotrectinib,NYNZQNWKBKUAII-KBXCAEBGSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
113691,6vxx,DB11769,-8.9,Funapide,NEBUOXBYNAHKFV-NRFANRHFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138815,6w9c,DB12302,-8.9,CP-724714,LLVZBTWPGQVVLW-SNAWJCMRSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
130560,6w4h,DB12432,-8.9,CC-401,XDJCLCLBSGGNKS-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
88644,6m3m,DB14207,-8.9,Fosinoprilat,WOIWWYDXDVSWAZ-RTWAWAEBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
61923,6crv,DB12808,-8.9,Trifarotene,MFBCDACCJCDGBA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75692,6m2n,DB05424,-8.9,Canertinib,OMZCMEYTWSXEPZ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61208,6crv,DB11749,-8.9,(R)-Praziquantel,FSVJFNAIGNNGKK-KRWDZBQOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
92832,6m71,DB04960,-8.9,Tipifarnib,PLHJCIYEEKOWNM-HHHXNRCGSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
8678,6lzg,DB06666,-8.9,Lixivaptan,PPHTXRNHTVLQED-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
139347,6w9c,DB13347,-8.9,Diphenadione,JYGLAHSAISAEAL-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
88512,6m3m,DB13936,-8.9,JNJ-28330835,RYBKPGYFXRNMMU-LBPRGKRZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
61218,6crv,DB11765,-8.9,PF-04991532,GKMLFBRLRVQVJO-ZDUSSCGKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75709,6m2n,DB05511,-8.9,Piclidenoson,HUJXGQILHAUCCV-MOROJQBDSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
130545,6w4h,DB12414,-8.9,Usistapide,WSYALRNYQFNNGP-WJOKGBTCSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
29729,6cs2,DB00878,-8.9,Chlorhexidine,GHXZTYHSJHQHIJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
150,6lzg,HMDB0003154,-8.9,Canthaxanthin,FDSDTBUPSURDBL-DKLMTRRASA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
61231,6crv,DB11784,-8.9,NRX-1074,DVBUEXCIEIAXPM-PJUQSVSOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30871,6cs2,DB13094,-8.9,Pruvanserin,AQRLDDAFYYAIJP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
77014,6m2n,DB07874,-8.9,"(6S)-2-amino-6-(3'-methoxybiphenyl-3-yl)-3,6-dimethyl-5,6-dihydropyrimidin-4(3H)-one",LQOCXPOKEPYGTJ-IBGZPJMESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76996,6m2n,DB07856,-8.9,6-{4-[4-(4-CHLOROPHENYL)PIPERIDIN-4-YL]PHENYL}-9H-PURINE,HPWBHQIUIBFTQC-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
113447,6vxx,DB09199,-8.9,Netoglitazone,PKWDZWYVIHVNKS-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130513,6w4h,DB12371,-8.9,Siponimod,KIHYPELVXPAIDH-HNSNBQBZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
20635,6cs2,HMDB0001008,-8.9,Biliverdin,QBUVFDKTZJNUPP-BBROENKCSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
76976,6m2n,DB07832,-8.9,"4-{4-[(5-hydroxy-2-methylphenyl)amino]quinolin-7-yl}-1,3-thiazole-2-carbaldehyde",VKQPTVJDZIILPG-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
92686,6m71,DB04739,-8.9,4-[(4-METHYL-1-PIPERAZINYL)METHYL]-N-[3-[[4-(3-PYRIDINYL)-2-PYRIMIDINYL]AMINO]PHENYL]-BENZAMIDE,JHMBUEWQJDGKGS-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
130494,6w4h,DB12341,-8.9,LY-2456302,ZHPMYDSXGRRERG-DEOSSOPVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
61262,6crv,DB11824,-8.9,Tofogliflozin,VWVKUNOPTJGDOB-BDHVOXNPSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61264,6crv,DB11827,-8.9,Ertugliflozin,MCIACXAZCBVDEE-CUUWFGFTSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113500,6vxx,DB09268,-8.9,Picosulfuric acid,UJIDKYTZIQTXPM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
166038,7bv1,DB13607,-8.9,Picloxydine,YNCLPFSAZFGQCD-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
76955,6m2n,DB07809,-8.9,4-({[4-(3-METHYLBENZOYL)PYRIDIN-2-YL]AMINO}METHYL)BENZENECARBOXIMIDAMIDE,MBJYEMUMDMGQQC-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
88598,6m3m,DB14093,-8.9,"(1,2,6,7-3H)Testosterone",MUMGGOZAMZWBJJ-JQSYSRDDSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
92505,6m71,DB04495,-8.9,RU81843,GGPXNASQNUOIPB-NSOVKSMOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
88610,6m3m,DB14125,-8.9,Benazeprilat,MADRIHWFJGRSBP-ROUUACIJSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
76940,6m2n,DB07793,-8.9,"(2S)-N-[(3S)-1-(2-AMINO-2-OXOETHYL)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL]-2-CHLORO-2H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE",ACSGSLPOHKRZCY-GXTWGEPZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
62857,6crv,DB14627,-8.9,Oxyphenisatin acetate,PHPUXYRXPHEJDF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165588,7bv1,DB12504,-8.9,JNJ-40346527,BNVPFDRNGHMRJS-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
73358,6m2n,DB01933,-8.9,7-Hydroxystaurosporine,PBCZSGKMGDDXIJ-HQCWYSJUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80072,6m2n,DB14581,-8.9,CPI-1205,HPODOLXTMDHLLC-QGZVFWFLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
132575,6w9c,DB00596,-8.9,Ulobetasol,LEHFPXVYPMWYQD-XHIJKXOTSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137613,6w9c,DB08510,-8.9,5-ALPHA-PREGNANE-3-BETA-OL-HEMISUCCINATE,UVTGFMKBPVLATL-DSOJQRAMSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
59919,6crv,DB08024,-8.9,1-[2-(S)-AMINO-3-BIPHENYL-4-YL-PROPIONYL]-PYRROLIDINE-2-(S)-CARBONITRILE,MUUVLSCVDXKQQV-OALUTQOASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28641,6cs2,DB08237,-8.9,2'-deoxy-N-(naphthalen-1-ylmethyl)guanosine 5'-(dihydrogen phosphate),COMPKRGNHXOXMN-GVDBMIGSSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
86498,6m3m,DB08950,-8.9,Indoramin,JXZZEXZZKAWDSP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
97368,6m71,DB14726,-8.9,Dabigatran,YBSJFWOBGCMAKL-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
132584,6w9c,DB00607,-8.9,Nafcillin,GPXLMGHLHQJAGZ-JTDSTZFVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
86483,6m3m,DB08927,-8.9,Amperozide,NNAIYOXJNVGUOM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59615,6crv,DB07676,-8.9,"3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)-1H,2'H-2,3'-biindol-2'-one",CKLAPOFDFZKCPB-LBPRGKRZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
144007,6w9q,DB04289,-8.9,Genz-10850,YYMZSGIXLQPFAC-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
73335,6m2n,DB01893,-8.9,N6-Benzyl Adenosine-5'-Diphosphate,MRHGMAGSDAQUFH-LSCFUAHRSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
62979,6crv,DB14862,-8.9,PF-06815345,QTBYVAZRKWOIDU-FUHWJXTLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114634,6vxx,DB13927,-8.9,anle138b,RCQIIBJSUWYYFU-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59938,6crv,DB08046,-8.9,2-chloro-5-[(1S)-1-hydroxy-3-oxo-2H-isoindol-1-yl]benzenesulfonamide,JIVPVXMEBJLZRO-AWEZNQCLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
36299,1r42,DB02741,-8.9,CD564,RWYREGSYPCNZTL-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
87043,6m3m,DB11749,-8.9,(R)-Praziquantel,FSVJFNAIGNNGKK-KRWDZBQOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80110,6m2n,DB14657,-8.9,Paramethasone acetate,HYRKAAMZBDSJFJ-LFDBJOOHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
132189,6w9c,DB00137,-8.9,Lutein,KBPHJBAIARWVSC-RGZFRNHPSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
59915,6crv,DB08020,-8.9,"(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-6-(METHOXYMETHYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL",RHQLNMNKTIOREN-AOIWGVFYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
63221,6crv,DB15377,-8.9,ATB-346,YCNMAPLPQYQJFC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
97403,6m71,DB14802,-8.9,ONO-2952,ZBQMTQGDBFZUBG-NRFANRHFSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
86986,6m3m,DB11665,-8.9,BMS-690514,CSGQVNMSRKWUSH-IAGOWNOFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
97478,6m71,DB14995,-8.9,NP-G2-044,XLLRLAABUFOJPC-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
165245,7bv1,DB11650,-8.9,HT-0712,ABEJDMOBAFLQNJ-NHCUHLMSSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
140026,6w9c,DB14775,-8.9,Cavosonstat,BXSZILNGNMDGSL-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
165247,7bv1,DB11652,-8.9,Tucatinib,SDEAXTCZPQIFQM-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
40351,6lu7,DB08450,-8.9,N-1H-indazol-5-yl-2-(6-methylpyridin-2-yl)quinazolin-4-amine,HNHRWNUXTCATSG-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
9716,6lzg,DB07837,-8.9,"[4-(5-naphthalen-2-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)phenyl]acetic acid",SWXKLXXVFMYMDP-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
40350,6lu7,DB11791,-8.9,Capmatinib,LIOLIMKSCNQPLV-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
86970,6m3m,DB11638,-8.9,Artenimol,BJDCWCLMFKKGEE-HVDUHBCDSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86522,6m3m,DB08976,-8.9,Floctafenine,APQPGQGAWABJLN-GFCCVEGCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
137558,6w9c,DB08445,-8.9,"(3R,4S)-1-[6-(6-METHOXYPYRIDIN-3-YL)PYRIMIDIN-4-YL]-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE",IFKWHPAWYJARQJ-DYVFJYSZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
28615,6cs2,DB08207,-8.9,"2-(3,5-DIMETHYLPHENYL)-1,3-BENZOXAZOLE",BIHLSRJPJFOESJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
40349,6lu7,DB12323,-8.9,Radotinib,DUPWHXBITIZIKZ-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
79172,6m2n,DB12854,-8.9,BMS-908662,MMNNTJYFHUDSKL-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
97442,6m71,DB14895,-8.9,Vibegron,DJXRIQMCROIRCZ-XOEOCAAJSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
128885,6w4h,DB08126,-8.9,"3-{[4-([AMINO(IMINO)METHYL]AMINOSULFONYL)ANILINO]METHYLENE}-2-OXO-2,3-DIHYDRO-1H-INDOLE",DMCRNUMVSATRTP-LCYFTJDESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
73238,6m2n,DB01763,-8.9,7-thionicotinamide-adenine-dinucleotide phosphate,OJNFDOAQUXJWED-NNYOXOHSSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
159878,7bv1,DB06732,-8.9,beta-Naphthoflavone,OUGIDAPQYNCXRA-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
80064,6m2n,DB14555,-8.9,Ursadiol,RTLXJEJRLWILSU-GWNGJUQLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
29830,6cs2,DB11691,-8.9,Naldemedine,AXQACEQYCPKDMV-RZAWKFBISA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
140158,6w9c,DB15092,-8.9,LY-2624803,UEFWDVMEDFCHGW-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
59946,6crv,DB08056,-8.9,"N-(2,6-dimethylphenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine",KKYYLKPGILUPOA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109783,6vxx,DB00251,-8.9,Terconazole,BLSQLHNBWJLIBQ-OZXSUGGESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80114,6m2n,DB14662,-8.9,Flunisolide acetate,WEGNFRKBIKYVLC-XTLNBZDDSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
87099,6m3m,DB11827,-8.9,Ertugliflozin,MCIACXAZCBVDEE-CUUWFGFTSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
139972,6w9c,DB14664,-8.9,Difluocortolone pivalate,UWGRWFCLGQWKPR-GSTUPEFVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
96931,6m71,DB13643,-8.9,Loprazolam,UTEFBSAVJNEPTR-RGEXLXHISA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96928,6m71,DB13640,-8.9,Acetoxolone,FTQDJVZNPJRVPG-XWEVEMRCSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
87101,6m3m,DB11829,-8.9,Ruboxistaurin,ZCBUQCWBWNUWSU-SFHVURJKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
98979,6vxs,DB01640,-8.9,"(5r)-6-(4-{[2-(3-Iodobenzyl)-3-Oxocyclohex-1-En-1-Yl]Amino}Phenyl)-5-Methyl-4,5-Dihydropyridazin-3(2h)-One",QNURTFDBHAQRSI-OAHLLOKOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
111045,6vxx,DB02919,-8.9,"2,4-Diamino-6-[N-(3',4',5'-Trimethoxybenzyl)-N-Methylamino]Pyrido[2,3-D]Pyrimidine",PUOZHLHNKHRTOW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
143478,6w9q,DB03591,-8.9,RU82209,LVZDQVATAQEMCX-NSOVKSMOSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
132076,6w4h,DB15327,-8.9,Abivertinib,UOFYSRZSLXWIQB-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
78962,6m2n,DB12515,-8.9,9-aminocamptothecin,FUXVKZWTXQUGMW-FQEVSTJZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137776,6w9c,DB08709,-8.9,"2,3-diphenyl-1H-indole-7-carboxylic acid",OLUDUXWVPIEHDA-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
87108,6m3m,DB11841,-8.9,Entinostat,INVTYAOGFAGBOE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
111127,6vxx,DB03035,-8.9,"1,8-Di-Hydroxy-4-Nitro-Anthraquinone",RIYCICFDXLNQPV-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78952,6m2n,DB12500,-8.9,Fedratinib,JOOXLOJCABQBSG-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78949,6m2n,DB12494,-8.9,SGI-1776,MHXGEROHKGDZGO-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
109712,6vxx,DB15191,-8.9,MAX-40279,AVIOBQFPAGEICQ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
73573,6m2n,DB02217,-8.9,Dpb-T,WTZFKHNHHRPQOU-WSMBLCCSSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
114908,6vxx,DB15391,-8.9,Elenbecestat,AACUJFVOHGRMTR-DPXNYUHVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111176,6vxx,DB03300,-8.9,Pterin Cytosine Dinucleotide,WKSPNQYEWZEMMI-FEFZDOOUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
34169,6cs2,T3D1032,-8.9,Cyhalothrin,ZXQYGBMAQZUVMI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
109723,6vxx,DB15207,-8.9,Esaxerenone,NOSNHVJANRODGR-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110995,6vxx,DB02854,-8.9,Aetiocholanolone,QGXBDMJGAMFCBF-BNSUEQOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62957,6crv,DB14802,-8.9,ONO-2952,ZBQMTQGDBFZUBG-NRFANRHFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79067,6m2n,DB12680,-8.9,Intepirdine,JJZFWROHYSMCMU-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
164752,7bv1,DB08560,-8.9,3-FLUORO-N-[1-(4-FLUOROPHENYL)-3-(2-THIENYL)-1H-PYRAZOL-5-YL]BENZENESULFONAMIDE,GULUFDCOGAXLEP-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
55096,6crv,DB00604,-8.9,Cisapride,DCSUBABJRXZOMT-IRLDBZIGSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
143797,6w9q,DB04011,-8.9,"2'-(4-Dimethylaminophenyl)-5-(4-Methyl-1-Piperazinyl)-2,5'-Bi-Benzimidazole",VMCOQLKKSNQANE-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
10003,6lzg,DB08143,-8.9,"5-CHLORO-THIOPHENE-2-CARBOXYLIC ACID ((3S,4S)-4-FLUORO- 1-{[2-FLUORO-4-(2-OXO-2H-PYRIDIN-1-YL)-PHENYLCARBAMOYL]-METHYL}-PYRROLIDIN-3-YL)-AMIDE",SXIYSYYSKHUTQQ-RDJZCZTQSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
55109,6crv,DB00620,-8.9,Triamcinolone,GFNANZIMVAIWHM-OBYCQNJPSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114770,6vxx,DB14821,-8.9,Macozinone,BJDZBXGJNBMCAV-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
13262,6lzg,DB15036,-8.9,Sitravatinib,WLAVZAAODLTUSW-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
63235,6crv,DB15406,-8.9,GLPG-0974,MPMKMQHJHDHPBE-RUZDIDTESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79203,6m2n,DB12899,-8.9,TT-301,ZPJGUEPHFXPAQF-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
29912,6cs2,DB11800,-8.9,Tivozanib,SPMVMDHWKHCIDT-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
97193,6m71,DB14066,-8.9,Tetrandrine,WVTKBKWTSCPRNU-KYJUHHDHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59953,6crv,DB08063,-8.9,"1-BENZYL-3-(4-METHOXYPHENYLAMINO)-4-PHENYLPYRROLE-2,5-DIONE",HLZMYWLMBBLASX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
132633,6w9c,DB00670,-8.9,Pirenzepine,RMHMFHUVIITRHF-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
110911,6vxx,DB02567,-8.9,PD173955,VAARYSWULJUGST-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
159360,7bv1,DB04042,-8.9,"2-[4-(Hydroxy-Methoxy-Methyl)-Benzyl]-7-(4-Hydroxymethyl-Benzyl)-1,1-Dioxo-3,6-Bis-Phenoxymethyl-1lambda6-[1,2,7]Thiadiazepane-4,5-Diol",XLJNZONSWKENRP-VABIIVNOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
87066,6m3m,DB11784,-8.9,NRX-1074,DVBUEXCIEIAXPM-PJUQSVSOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
110947,6vxx,DB02616,-8.9,FR117016,CKJGKHXCUDWFDC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
137700,6w9c,DB08613,-8.9,"2,2,2-TRIFLUORO-1-{5-[(3-PHENYL-5,6-DIHYDROIMIDAZO[1,2-A]PYRAZIN-7(8H)-YL)CARBONYL]THIOPHEN-2-YL}ETHANE-1,1-DIOL",OFBFUNBBOQCNFX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
55136,6crv,DB00655,-8.9,Estrone,DNXHEGUUPJUMQT-CBZIJGRNSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109747,6vxx,DB15254,-8.9,RO-5126766 free base,LMMJFBMMJUMSJS-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
139966,6w9c,DB14657,-8.9,Paramethasone acetate,HYRKAAMZBDSJFJ-LFDBJOOHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
86959,6m3m,DB11614,-8.9,Rupatadine,WUZYKBABMWJHDL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86557,6m3m,DB09015,-8.9,Canrenoic acid,PBKZPPIHUVSDNM-WNHSNXHDSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
137403,6w9c,DB08250,-8.9,"(5S)-5-(3-AMINOPROPYL)-3-(2,5-DIFLUOROPHENYL)-N-ETHYL-5-PHENYL-4,5-DIHYDRO-1H-PYRAZOLE-1-CARBOXAMIDE",OQMVLDZJPRSNOG-NRFANRHFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
59718,6crv,DB07795,-8.9,Fisetin,XHEFDIBZLJXQHF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59715,6crv,DB07792,-8.9,"(S)-2-CHLORO-N-(1-(2-(2-HYDROXYETHYLAMINO)-2-OXOETHYL)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL)-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE",VUKPNWLGSLOHIF-AWEZNQCLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59711,6crv,DB07788,-8.9,"(3R,5Z,8S,9S,11E)-8,9,16-TRIHYDROXY-14-METHOXY-3-METHYL-3,4,9,10-TETRAHYDRO-1H-2-BENZOXACYCLOTETRADECINE-1,7(8H)-DIONE",NEQZWEXWOFPKOT-QHSZRYGNSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
128836,6w4h,DB08073,-8.9,(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE,YWTBGJGMTBHQTM-IBGZPJMESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
79742,6m2n,DB13682,-8.9,Cefpirome,DKOQGJHPHLTOJR-WHRDSVKCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
29789,6cs2,DB11637,-8.9,Delamanid,XDAOLTSRNUSPPH-XMMPIXPASA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
63103,6crv,DB15138,-8.9,AZD-9496,DFBDRVGWBHBJNR-BBNFHIFMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
13455,6lzg,DB15396,-8.9,PF-114,SLIVDYMORZGPLW-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
114772,6vxx,DB14828,-8.9,ABX-464,OZOGDCZJYVSUBR-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110073,6vxx,DB00776,-8.9,Oxcarbazepine,CTRLABGOLIVAIY-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
54957,6crv,DB00434,-8.9,Cyproheptadine,JJCFRYNCJDLXIK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165384,7bv1,DB12022,-8.9,Evatanepag,WOHRHWDYFNWPNG-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
28444,6cs2,DB08031,-8.9,"N-[(13-CYCLOHEXYL-6,7-DIHYDROINDOLO[1,2-D][1,4]BENZOXAZEPIN-10-YL)CARBONYL]-2-METHYL-L-ALANINE",LNQWELVSNCYKDU-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
13381,6lzg,DB15247,-8.9,Vorolanib,KMIOJWCYOHBUJS-HAKPAVFJSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
54854,6crv,DB00307,-8.9,Bexarotene,NAVMQTYZDKMPEU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86635,6m3m,DB09171,-8.9,??-Methylfentanyl,UXIGUKSHASXDNI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59822,6crv,DB07917,-8.9,4-(BENZHYDRYLOXY)-1-[3-(1H-TETRAAZOL-5-YL)PROPYL]PIPERIDINE,TZQGXAHOROZEKN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
132413,6w9c,DB00398,-8.9,Sorafenib,MLDQJTXFUGDVEO-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
144560,6w9q,DB05412,-8.9,Talmapimod,ZMELOYOKMZBMRB-DLBZAZTESA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
54844,6crv,DB00295,-8.9,Morphine,BQJCRHHNABKAKU-KBQPJGBKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
97856,6vxs,DB00246,-8.9,Ziprasidone,MVWVFYHBGMAFLY-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
137357,6w9c,DB08191,-8.9,"4-(5-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl)benzoic acid",KSFDVNIKNYXUIP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
159755,7bv1,DB06469,-8.9,Lestaurtinib,UIARLYUEJFELEN-DMVVYWCZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
140089,6w9c,DB14918,-8.9,Branaplam,STWTUEAWRAIWJG-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137396,6w9c,DB08241,-8.9,4-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)--BENZAMIDE,RUUOIINPNMNPIU-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
72852,6m2n,DB01222,-8.9,Budesonide,VOVIALXJUBGFJZ-KWVAZRHASA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
86697,6m3m,DB09238,-8.9,Manidipine,ANEBWFXPVPTEET-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
72831,6m2n,DB01198,-8.9,Zopiclone,GBBSUAFBMRNDJC-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
63115,6crv,DB15163,-8.9,Selatogrel,FYXHWMQPCJOJCH-GMAHTHKFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79570,6m2n,DB13451,-8.9,Tioclomarol,WRGOVNKNTPWHLZ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
165091,7bv1,DB11273,-8.9,Dihydroergocornine,SEALOBQTUQIVGU-QNIJNHAOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97677,6m71,DB15399,-8.9,BMS-754807,LQVXSNNAFNGRAH-QHCPKHFHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
165092,7bv1,DB11274,-8.9,Dihydro-alpha-ergocryptine,PBUNVLRHZGSROC-VTIMJTGVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110147,6vxx,DB01030,-8.9,Topotecan,UCFGDBYHRUNTLO-QHCPKHFHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140116,6w9c,DB15009,-8.9,PF-04937319,MASKQITXHVYVFL-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140079,6w9c,DB14899,-8.9,Tavapadon,AKQXQLUNFKDZBN-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
132439,6w9c,DB00430,-8.9,Cefpiramide,PWAUCHMQEXVFJR-PMAPCBKXSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
54933,6crv,DB00404,-8.9,Alprazolam,VREFGVBLTWBCJP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79706,6m2n,DB13640,-8.9,Acetoxolone,FTQDJVZNPJRVPG-XWEVEMRCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
54941,6crv,DB00414,-8.9,Acetohexamide,VGZSUPCWNCWDAN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140119,6w9c,DB15013,-8.9,TAK-243,KJDAGXLMHXUAGV-DGWLBADLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
63142,6crv,DB15214,-8.9,BMS-986104,BPMMYKAHRIEVDH-VOQZNFBZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59708,6crv,DB07785,-8.9,"1-{(1R,2S)-2-HYDROXY-1-[2-(2-NAPHTHYLOXY)ETHYL]PROPYL}-1H-IMIDAZONE-4-CARBOXAMIDE",UYAJDVNLQJVRHD-SCLBCKFNSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59707,6crv,DB07783,-8.9,1-((1R)-1-(HYDROXYMETHYL)-3-{6-[(3-PHENYLPROPANOYL)AMINO]-1H-INDOL-1-YL}PROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE,GUYYFMCFEPDDFL-OAQYLSRUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
97983,6vxs,DB00398,-8.9,Sorafenib,MLDQJTXFUGDVEO-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
159655,7bv1,DB05087,-8.9,Ganaxolone,PGTVWKLGGCQMBR-FLBATMFCSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
137319,6w9c,DB08148,-8.9,"1-[4-(4-chlorophenyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine",QOZMRRGNAZNWDN-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
114777,6vxx,DB14844,-8.9,ONC-201,VLULRUCCHYVXOH-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140683,6w9c,DB13093,-8.9,TAK-593,DZFZXPPHBWCXPQ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
63040,6crv,DB15021,-8.9,Leriglitazone,OXVFDZYQLGRLCD-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
97520,6m71,DB15085,-8.9,Fulacimstat,JDARDSVOVYVQST-MRXNPFEDSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
72635,6m2n,DB00977,-8.9,Ethinylestradiol,BFPYWIDHMRZLRN-SLHNCBLASA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
86939,6m3m,DB11551,-8.9,Trenbolone,MEHHPFQKXOUFFV-OWSLCNJRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
63166,6crv,DB15265,-8.9,USL-311,XNUNVQKARNSSEO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
97513,6m71,DB15068,-8.9,Agerafenib,DKNUPRMJNUQNHR-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
79241,6m2n,DB12952,-8.9,Methylprednisone,SVYCRJXQZUCUND-PQXSVQADSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137310,6w9c,DB08138,-8.9,"{[(2,6-difluorophenyl)carbonyl]amino}-N-(4-fluorophenyl)-1H-pyrazole-3-carboxamide",BDRDBXXWQDFXEC-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
110511,6vxx,DB01865,-8.9,3-(6-Aminopyridin-3-Yl)-N-Methyl-N-[(1-Methyl-1h-Indol-2-Yl)Methyl]Acrylamide,AKFPMLBVLWZSQX-CSKARUKUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72614,6m2n,DB00950,-8.9,Fexofenadine,RWTNPBWLLIMQHL-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
98346,6vxs,DB00836,-8.9,Loperamide,RDOIQAHITMMDAJ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
59884,6crv,DB07987,-8.9,"[2-(5-MERCAPTO-[1,3,4]THIADIAZOL-2-YLCARBAMOYL)-1-PHENYL-ETHYL]-CARBAMIC ACID BENZYL ESTER",AWAKNMKLVLWIIQ-OAHLLOKOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86952,6m3m,DB11591,-8.9,Bilastine,ACCMWZWAEFYUGZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
79971,6m2n,DB14066,-8.9,Tetrandrine,WVTKBKWTSCPRNU-KYJUHHDHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
28398,6cs2,DB07987,-8.9,"[2-(5-MERCAPTO-[1,3,4]THIADIAZOL-2-YLCARBAMOYL)-1-PHENYL-ETHYL]-CARBAMIC ACID BENZYL ESTER",AWAKNMKLVLWIIQ-OAHLLOKOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
59868,6crv,DB07969,-8.9,3-[3-(4-methylpiperazin-1-yl)-7-(trifluoromethyl)quinoxalin-5-yl]phenol,QNCYYRHIUFGGJX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140139,6w9c,DB15055,-8.9,ABT-639,AGPIHNZOZNKRGT-CYBMUJFWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137481,6w9c,DB08351,-8.9,N-cyclopropyl-4-methyl-3-{2-[(2-morpholin-4-ylethyl)amino]quinazolin-6-yl}benzamide,MNEXDVSJIUQQRH-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137480,6w9c,DB08350,-8.9,"5-[3-(2-METHOXYPHENYL)-1H-PYRROLO[2,3-B]PYRIDIN-5-YL]-N,N-DIMETHYLPYRIDINE-3-CARBOXAMIDE",GYQRHHQPEMOLKH-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
159675,7bv1,DB05220,-8.9,Alisertib,ZLHFILGSQDJULK-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
86630,6m3m,DB09166,-8.9,Etizolam,VMZUTJCNQWMAGF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
165155,7bv1,DB11431,-8.9,Moxidectin,YZBLFMPOMVTDJY-LSGXYNIPSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
86818,6m3m,DB11259,-8.9,Diosmetin,MBNGWHIJMBWFHU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
132395,6w9c,DB00377,-8.9,Palonosetron,CPZBLNMUGSZIPR-NVXWUHKLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
54827,6crv,DB00275,-8.9,Olmesartan,VTRAEEWXHOVJFV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
98065,6vxs,DB00496,-8.9,Darifenacin,HXGBXQDTNZMWGS-RUZDIDTESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
124266,6w4h,DB00950,-8.9,Fexofenadine,RWTNPBWLLIMQHL-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
86851,6m3m,DB11366,-8.9,Roquinimex,SGOOQMRIPALTEL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86550,6m3m,DB09008,-8.9,Cefaloridine,CZTQZXZIADLWOZ-CRAIPNDOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59690,6crv,DB07763,-8.9,"(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE",OZZFJGCAYWBVBI-INIZCTEOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86866,6m3m,DB11393,-8.9,Danofloxacin,QMLVECGLEOSESV-RYUDHWBXSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
25977,6cs2,DB04020,-8.9,"4-(2-{[4-{[3-(4-Chlorophenyl)Propyl]Sulfanyl}-6-(1-Piperazinyl)-1,3,5-Triazin-2-Yl]Amino}Ethyl)Phenol",AIBKIFHSQQYXLG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
86880,6m3m,DB11423,-8.9,Lasalocid,BBMULGJBVDDDNI-OWKLGTHSSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
28428,6cs2,DB08015,-8.9,"(3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-phenyl-1H-indole-2,3-dione 3-oxime",SZYREAUDQRVVLV-DAFNUICNSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
79880,6m2n,DB13867,-8.9,Fluticasone,MGNNYOODZCAHBA-GQKYHHCASA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
86888,6m3m,DB11431,-8.9,Moxidectin,YZBLFMPOMVTDJY-LSGXYNIPSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
109994,6vxx,DB00683,-8.9,Midazolam,DDLIGBOFAVUZHB-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
25872,6cs2,DB03895,-8.9,Malachite Green,VFCNQNZNPKRXIT-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
59851,6crv,DB07949,-8.9,"({[(3E)-2'-OXO-2',7'-DIHYDRO-2,3'-BIINDOL-3(7H)-YLIDENE]AMINO}OXY)ACETIC ACID",BFQRPTKOSYMPOL-LALPNIDTSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140049,6w9c,DB14845,-8.9,Filgotinib,RIJLVEAXPNLDTC-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
33745,6cs2,T3D4994,-8.9,Dibenzylideneacetone,WMKGGPCROCCUDY-PHEQNACWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
128811,6w4h,DB08042,-8.9,"N-4-methyl-N-4-(3-methyl-1H-indazol-6-yl)-N-2-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine",FLXGQDHYCWXTAI-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131998,6w4h,DB15183,-8.9,Fosmanogepix,JQONJQKKVAHONF-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
96487,6m71,DB12996,-8.9,Acteoside,FBSKJMQYURKNSU-ZLSOWSIRSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
124557,6w4h,DB01328,-8.9,Cefonicid,DYAIAHUQIPBDIP-AXAPSJFSSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
132686,6w9c,DB00728,-8.9,Rocuronium,YXRDKMPIGHSVRX-OOJCLDBCSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
109671,6vxx,DB15108,-8.9,Tipranavir C-14,SUJUHGSWHZTSEU-MWQIXQBFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
137908,6w9c,DB08875,-8.9,Cabozantinib,ONIQOQHATWINJY-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
63282,6crv,DB04596,-8.9,"4-O-{4,6-O-[(1S)-1-Carboxyethylidene]-β-D-mannopyranosyl}-D-glucopyranuronic acid",GZJXZKGVHLWBOW-AISSFXTFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80183,6m2n,DB14810,-8.9,AZD-1656,FJEJHJINOKKDCW-INIZCTEOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
129070,6w4h,DB08354,-8.9,"2-(4-CHLOROBENZYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE",QCVULERVJOYHCP-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
114762,6vxx,DB14793,-8.9,RO-5045337,QBGKPEROWUKSBK-QPPIDDCLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86358,6m3m,DB08747,-8.9,"(11R)-10-acetyl-11-(2,4-dichlorophenyl)-6-hydroxy-3,3-dimethyl-2,3,4,5,10,11-hexahydro-1H-dibenzo[b,e][1,4]diazepin-1-one",JJTPPGUNMJMPLY-QFIPXVFZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
132038,6w4h,DB15254,-8.9,RO-5126766 free base,LMMJFBMMJUMSJS-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
86226,6m3m,DB08591,-8.9,"5-(4-METHOXYBIPHENYL-3-YL)-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDE",IGXKSKWHHHYBFM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
128639,6w4h,DB07845,-8.9,"2-fluoro-6-{[2-({2-methoxy-4-[(methylsulfonyl)methyl]phenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide",VGYXXQRDIVRILX-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
139944,6w9c,DB14634,-8.9,Fluprednidene acetate,DEFOZIFYUBUHHU-IYQKUMFPSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
124745,6w4h,DB01573,-8.9,Benzylmorphine,RDJGWRFTDZZXSM-RNWLQCGYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
96502,6m71,DB13019,-8.9,Henatinib,MCTXSDCWFQAGFS-UEXNTNOUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
137811,6w9c,DB08745,-8.9,4-[[(1E)-2-(4-CHLOROPHENYL)ETHENYL]SULFONYL]-1-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]PIPERAZINONE,QLHUDNKWOSQSMK-CXUHLZMHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
30005,6cs2,DB11921,-8.9,Deflazacort,FBHSPRKOSMHSIF-GRMWVWQJSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
96264,6m71,DB12644,-8.9,AZD-2066,SXWHYTICXCLKDG-GFCCVEGCSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96517,6m71,DB13040,-8.9,Gandotinib,SQSZANZGUXWJEA-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
159973,7bv1,DB07142,-8.9,"5-[(3R)-3-(5-methoxy-3',5'-dimethylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",ATFDKOLABYIYCC-INIZCTEOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96519,6m71,DB13044,-8.9,Gossypol,QBKSWRVVCFFDOT-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
55156,6crv,DB00678,-8.9,Losartan,PSIFNNKUMBGKDQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
33059,6cs2,T3D4021,-8.9,Digitoxin,WDJUZGPOPHTGOT-XUDUSOBPSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
33057,6cs2,T3D4019,-8.9,Paclitaxel,RCINICONZNJXQF-MZXODVADSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
132044,6w4h,DB15268,-8.9,Afabicin,HFYMDQMXVPJNTH-VQHVLOKHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
137161,6w9c,DB07971,-8.9,"5-AMINO-2-{4-[(4-AMINOPHENYL)SULFANYL]PHENYL}-1H-ISOINDOLE-1,3(2H)-DIONE",FQQVTDIBUYSVHM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
111318,6vxx,DB03496,-8.9,Alvocidib,BIIVYFLTOXDAOV-YVEFUNNKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
129024,6w4h,DB08299,-8.9,"4-[8-(3-nitrophenyl)-1,7-naphthyridin-6-yl]benzoic acid",QTNUWEKKZHSUQO-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
72398,6m2n,DB00700,-8.9,Eplerenone,JUKPWJGBANNWMW-VWBFHTRKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
159110,7bv1,DB03161,-8.9,Thymidine-5'-Diphospho-Beta-D-Xylose,AJUADKZRQSBUAK-KDGZBOQCSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
78871,6m2n,DB12385,-8.9,10-hydroxycamptothecin,HAWSQZCWOQZXHI-FQEVSTJZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
55211,6crv,DB00741,-8.9,Hydrocortisone,JYGXADMDTFJGBT-VWUMJDOOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
33176,6cs2,T3D4235,-8.9,Aplysiatoxin,RHJPBGWFGOAEID-BEDNPZBZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
87192,6m3m,DB11964,-8.9,Ilaprazole,HRRXCXABAPSOCP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
137181,6w9c,DB07993,-8.9,"N-3-[3-(1H-INDOL-6-YL)BENZYL]PYRIDINE-2,3-DIAMINE",LPQUIIHPUGDHJK-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
80225,6m2n,DB14902,-8.9,JHU-75528 C-11,MCNQUWLLXZZZAC-BJUDXGSMSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
87187,6m3m,DB11958,-8.9,Brivanib,WCWUXEGQKLTGDX-LLVKDONJSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
96385,6m71,DB12836,-8.9,Grapiprant,HZVLFTCYCLXTGV-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
137885,6w9c,DB08834,-8.9,Tauroursodeoxycholic acid,BHTRKEVKTKCXOH-LBSADWJPSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
73789,6m2n,DB02491,-8.9,4-[4-(1-Amino-1-Methylethyl)Phenyl]-5-Chloro-N-[4-(2-Morpholin-4-Ylethyl)Phenyl]Pyrimidin-2-Amine,CJSSYVIHFXDFFC-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78844,6m2n,DB12345,-8.9,MBX-2982,NFTMKHWBOINJGM-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
63380,6lxt,DB00210,-8.9,Adapalene,LZCDAPDGXCYOEH-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
80221,6m2n,DB14896,-8.9,Selitrectinib,OEBIHOVSAMBXIB-SJKOYZFVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
59495,6crv,DB07531,-8.9,"4-{5-[(Z)-(2,4-DIOXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE",JNPRTUHVCHGFHJ-GHXNOFRVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
33410,6cs2,T3D4627,-8.9,"7H-Dibenzo[c,g]carbazole",STJXCDGCXVZHDU-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
111477,6vxx,DB03921,-8.9,4-(3-Pyridin-2-Yl-1h-Pyrazol-4-Yl)Quinoline,IBCXZJCWDGCXQT-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165336,7bv1,DB11949,-8.9,Vestipitant,SBBYBXSFWOLDDG-JLTOFOAXSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
78813,6m2n,DB12301,-8.9,Doravirine,ZIAOVIPSKUPPQW-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
23764,6cs2,DB01395,-8.9,Drospirenone,METQSPRSQINEEU-HXCATZOESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
111464,6vxx,DB03903,-8.9,Tmr,KGFLZYXDJDOIEE-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
99250,6vxs,DB02008,-8.9,1-(2-Fluorobenzyl)-3-Butyl-8-(N-Acetyl-4-Aminobenzyl)-Xanthine,JHSHXKJSPVHPCJ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
109645,6vxx,DB15056,-8.9,Bifenthrin,OMFRMAHOUUJSGP-IRHGGOMRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
137216,6w9c,DB08031,-8.9,"N-[(13-CYCLOHEXYL-6,7-DIHYDROINDOLO[1,2-D][1,4]BENZOXAZEPIN-10-YL)CARBONYL]-2-METHYL-L-ALANINE",LNQWELVSNCYKDU-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
96425,6m71,DB12899,-8.9,TT-301,ZPJGUEPHFXPAQF-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59486,6crv,DB07520,-8.9,"N-[1-(AMINOMETHYL)CYCLOPROPYL]-3-(MORPHOLIN-4-YLSULFONYL)-N-2-[(1S)-2,2,2-TRIFLUORO-1-(4-FLUOROPHENYL)ETHYL]-L-ALANINAMIDE",BJIKKEHGGYGGIX-HOTGVXAUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109572,6vxx,DB14152,-8.9,Ginsenosides,NLHQJXWYMZLQJY-SWIZOJJJSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
159201,7bv1,DB03571,-8.9,"3-(5-Amino-7-Hydroxy-[1,2,3]Triazolo[4,5-D]Pyrimidin-2-Yl)-N-(3,5-Dichlorobenzyl)-Benzamide",JMQTXEWNXSPEKX-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
86317,6m3m,DB08705,-8.9,"6-(5-BROMO-2-HYDROXYPHENYL)-2-OXO-4-PHENYL-1,2-DIHYDROPYRIDINE-3-CARBONITRILE",SVSYJTYGPLVUOZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
137166,6w9c,DB07976,-8.9,3-{[(3-FLUORO-3'-METHOXYBIPHENYL-4-YL)AMINO]CARBONYL}THIOPHENE-2-CARBOXYLIC ACID,GIUMGVUBDBDTDX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
165365,7bv1,DB11995,-8.9,Avatrombopag,OFZJKCQENFPZBH-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
137159,6w9c,DB07969,-8.9,3-[3-(4-methylpiperazin-1-yl)-7-(trifluoromethyl)quinoxalin-5-yl]phenol,QNCYYRHIUFGGJX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
78904,6m2n,DB12427,-8.9,Orvepitant,XWNBGDJPEXZSQM-VZOBGQTKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
59527,6crv,DB07568,-8.9,"(2S)-2-[(2,1,3-BENZOTHIADIAZOL-4-YLSULFONYL)AMINO]-2-PHENYL-N-PYRIDIN-4-YLACETAMIDE",ADRNPUSZBRQDBG-KRWDZBQOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78911,6m2n,DB12436,-8.9,Vofopitant,XILNRORTJVDYRH-HKUYNNGSSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
132660,6w9c,DB00699,-8.9,Nicergoline,YSEXMKHXIOCEJA-FVFQAYNVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
128626,6w4h,DB07830,-8.9,"(4R,5R)-5-AMINO-1-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN-2-ONE",DIRIFWIKLRTNMB-DYVFJYSZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
165305,7bv1,DB11904,-8.9,Flumatinib,BJCJYEYYYGBROF-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96794,6m71,DB13454,-8.9,Nicomorphine,HNDXBGYRMHRUFN-CIVUWBIHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
86215,6m3m,DB08577,-8.9,3-[(3-(2-CARBOXYETHYL)-4-METHYLPYRROL-2-YL)METHYLENE]-2-INDOLINONE,JNDVEAXZWJIOKB-JYRVWZFOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
60028,6crv,DB08147,-8.9,"4-[3-(dibenzylamino)phenyl]-2,4-dioxobutanoic acid",RMWVENXKUQXLPW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60125,6crv,DB08267,-8.9,"6-amino-4-(2-phenylethyl)-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",PBZAIUVFRISTSZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
137797,6w9c,DB08731,-8.9,"2-[(1R)-2-carboxy-1-(naphthalen-1-ylmethyl)ethyl]-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylic acid",GPOKTQCDBPECSS-MRXNPFEDSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
87122,6m3m,DB11864,-8.9,Preladenant,DTYWJKSSUANMHD-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
123578,6w4h,DB00137,-8.9,Lutein,KBPHJBAIARWVSC-RGZFRNHPSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
111219,6vxx,DB03355,-8.9,5'-O-(N-(L-Threonyl)-Sulfamoyl)Adenosine,UPVAPSGKXAAHBG-CKTDUXNWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
16582,6cs2,HMDB0002950,-8.9,"(3R,3'R,6'R,9'-cis)-beta,epsilon-Carotene-3,3'-diol",KBPHJBAIARWVSC-VKIKRWDYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
96543,6m71,DB13078,-8.9,KOSN-1724,JAYGOFBXDFAXBW-CYEKYUJNSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
111307,6vxx,DB03480,-8.9,Brequinar Analog,WYKKHJQZENLZID-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
13233,6lzg,DB14942,-8.9,BMS-986141,KEEBLYWBELVGPQ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
139963,6w9c,DB14654,-8.9,Bisoxatin acetate,ZCBJDQBSLZREAA-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
159043,7bv1,DB03072,-8.9,"2-{3-[4-(4-Fluorophenyl)-3,6-Dihydro-1(2h)-Pyridinyl]Propyl}-8-Methyl-4(3h)-Quinazolinone",LOFDUAJQRUYHBR-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
132777,6w9c,DB00838,-8.9,Clocortolone,YMTMADLUXIRMGX-RFPWEZLHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
159971,7bv1,DB07140,-8.9,"5-[(3R)-3-(5-methoxybiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",JPENSYBRTSIYGO-AWEZNQCLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
78780,6m2n,DB12260,-8.9,Radiprodil,GKGRZLGAQZPEHO-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
96529,6m71,DB13059,-8.9,PF-03814735,RYYNGWLOYLRZLK-RBUKOAKNSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59464,6crv,DB07493,-8.9,"(2Z)-5'-BROMO-2,3'-BIINDOLE-2',3(1H,1'H)-DIONE AMMONIATE",IEQQJQHHJMQETK-YPKPFQOOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
131964,6w4h,DB15110,-8.9,Onvansertib,QHLVBNKYJGBCQJ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
87137,6m3m,DB11886,-8.9,Infigratinib,QADPYRIHXKWUSV-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59688,6crv,DB07761,-8.8,"(2R)-1-[4-({6-[(2,6-Difluorophenyl)amino]-4-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol",ZVSBKYYVBCKDBO-OAHLLOKOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104692,6vxs,DB12368,-8.8,AZD-3839,MRXBCEQZNKUUIP-DEOSSOPVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
68620,6lxt,DB08124,-8.8,"3-{[(2,2-DIOXIDO-1,3-DIHYDRO-2-BENZOTHIEN-5-YL)AMINO]METHYLENE}-5-(1,3-OXAZOL-5-YL)-1,3-DIHYDRO-2H-INDOL-2-ONE",FTQYGMLRLRXBPT-IDUWFGFVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
104694,6vxs,DB12371,-8.8,Siponimod,KIHYPELVXPAIDH-HNSNBQBZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
129525,6w4h,DB08930,-8.8,Dolutegravir,RHWKPHLQXYSBKR-BMIGLBTASA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
63450,6lxt,DB00288,-8.8,Amcinonide,ILKJAFIWWBXGDU-MOGDOJJUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
63460,6lxt,DB00301,-8.8,Flucloxacillin,UIOFUWFRIANQPC-JKIFEVAISA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
61657,6crv,DB12399,-8.8,Polmacoxib,IJWPAFMIFNSIGD-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
129487,6w4h,DB08861,-8.8,DPDPE,MCMMCRYPQBNCPH-WMIMKTLMSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
161706,7bv1,DB00496,-8.8,Darifenacin,HXGBXQDTNZMWGS-RUZDIDTESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
84342,6m3m,DB05611,-8.8,Apilimod,HSKAZIJJKRAJAV-KOEQRZSOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
135131,6w9c,DB04023,-8.8,"Guanosine 5'-(Trihydrogen Diphosphate), P'-D-Mannopyranosyl Ester",DNBSDUDYNPJVCN-ZXTXFPBHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
59737,6crv,DB07815,-8.8,GIBBERELLIN A4,RSQSQJNRHICNNH-NFMPGMCNSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88999,6m3m,DB15261,-8.8,Butafenacil,JEDYYFXHPAIBGR-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59250,6crv,DB07249,-8.8,"N-(5-chloro-1,3-benzodioxol-4-yl)-6-methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-amine",QHIMVPIOWKYPSO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
105481,6vxs,DB13556,-8.8,Sulfamazone,BGLHAKAJGYLSOX-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
61282,6crv,DB11853,-8.8,Relugolix,AOMXMOCNKJTRQP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27121,6cs2,DB00598,-8.8,Labetalol,SGUAFYQXFOLMHL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
88991,6m3m,DB15241,-8.8,Methylsamidorphan,ATCVVCBJNHXIEX-ZAHKBLQYSA-O,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
92468,6m71,DB04452,-8.8,Aminoquinuride,HOUSDILKOJMENG-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
162274,7bv1,DB01831,-8.8,Tryptophanyl-5'amp,IFQVDHDRFCKAAW-SQIXAUHQSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
11704,6lzg,DB12318,-8.8,BMS-599626,LUJZZYWHBDHDQX-QFIPXVFZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
129994,6w4h,DB11592,-8.8,Nitrocefin,LHNIIDJCEODSHA-OQRUQETBSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
64266,6lxt,DB01259,-8.8,Lapatinib,BCFGMOOMADDAQU-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
68376,6lxt,DB07845,-8.8,"2-fluoro-6-{[2-({2-methoxy-4-[(methylsulfonyl)methyl]phenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide",VGYXXQRDIVRILX-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
59216,6crv,DB07206,-8.8,6-[2-(1H-INDOL-6-YL)ETHYL]PYRIDIN-2-AMINE,OSHSZKRWKLQZBV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
26274,6cs2,DB04378,-8.8,"3-Amino-N-{4-[2-(2,6-Dimethyl-Phenoxy)-Acetylamino]-3-Hydroxy-1-Isobutyl-5-Phenyl-Pentyl}-Benzamide",APJAEXGNDLFGPD-AWCRTANDSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
152412,6wiq,DB04016,-8.8,2-[3-({Methyl[1-(2-Naphthoyl)Piperidin-4-Yl]Amino}Carbonyl)-2-Naphthyl]-1-(1-Naphthyl)-2-Oxoethylphosphonic Acid,XUJQPDQURBZEGJ-KXQOOQHDSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
135429,6w9c,DB04461,-8.8,Coproporphyrinogen III,NIUVHXTXUXOFEB-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
57909,6crv,DB04289,-8.8,Genz-10850,YYMZSGIXLQPFAC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88978,6m3m,DB15219,-8.8,Tomivosertib,HKTBYUWLRDZAJK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59680,6crv,DB07753,-8.8,"3',5'-DIFLUOROBIPHENYL-4-CARBOXYLIC ACID",VCEFNMHMLWBFNV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
13412,6lzg,DB15305,-8.8,Risdiplam,ASKZRYGFUPSJPN-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
83962,6m3m,DB04582,-8.8,IMAZAQUIN,CABMTIJINOIHOD-QGZVFWFLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
92166,6m71,DB04042,-8.8,"2-[4-(Hydroxy-Methoxy-Methyl)-Benzyl]-7-(4-Hydroxymethyl-Benzyl)-1,1-Dioxo-3,6-Bis-Phenoxymethyl-1lambda6-[1,2,7]Thiadiazepane-4,5-Diol",XLJNZONSWKENRP-VABIIVNOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
88981,6m3m,DB15222,-8.8,GS-6620,YAAQYJCOIFNMKX-RSTNYOGXSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
92209,6m71,DB04098,-8.8,Balanol,XYUFCXJZFZPEJD-PGRDOPGGSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
61918,6crv,DB12802,-8.8,Picropodophyllin,YJGVMLPVUAXIQN-HAEOHBJNSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
68369,6lxt,DB07837,-8.8,"[4-(5-naphthalen-2-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)phenyl]acetic acid",SWXKLXXVFMYMDP-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
128036,6w4h,DB07142,-8.8,"5-[(3R)-3-(5-methoxy-3',5'-dimethylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",ATFDKOLABYIYCC-INIZCTEOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
68702,6lxt,DB08221,-8.8,N-{4-METHYL-3-[(3-PYRIMIDIN-4-YLPYRIDIN-2-YL)AMINO]PHENYL}-3-(TRIFLUOROMETHYL)BENZAMIDE,NESXBRNDMQUVNG-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
86193,6m3m,DB08549,-8.8,"(3R)-METHYLCARBAMOYL-7-SULFOAMINO-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLIC ACID BENZYL ESTER",MFDBNNQUDZFSES-KRWDZBQOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88654,6m3m,DB14221,-8.8,Beclomethasone 17-monopropionate,OHYGPBKGZGRQKT-XGQKBEPLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
160409,7bv1,DB08351,-8.8,N-cyclopropyl-4-methyl-3-{2-[(2-morpholin-4-ylethyl)amino]quinazolin-6-yl}benzamide,MNEXDVSJIUQQRH-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
69365,6lxt,DB09070,-8.8,Tibolone,WZDGZWOAQTVYBX-XOINTXKNSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
92385,6m71,DB04330,-8.8,Bilh 434,KNRVCCXHLSHTFW-HGPRPZRGSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
61287,6crv,DB11864,-8.8,Preladenant,DTYWJKSSUANMHD-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88412,6m3m,DB13764,-8.8,Monoxerutin,MBHXKZDTQCSVPM-BDAFLREQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
128503,6w4h,DB07691,-8.8,"2-({[3-(3,4-dihydroisoquinolin-2(1H)-ylsulfonyl)phenyl]carbonyl}amino)benzoic acid",GYILVHHTCYNIOS-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
86279,6m3m,DB08656,-8.8,5-amino-2-methyl-N-[(1R)-1-naphthalen-1-ylethyl]benzamide,UVERBUNNCOKGNZ-CQSZACIVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
129526,6w4h,DB08931,-8.8,Riociguat,WXXSNCNJFUAIDG-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
153051,6wiq,DB04868,-8.8,Nilotinib,HHZIURLSWUIHRB-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
135743,6w9c,DB04879,-8.8,Vatalanib,YCOYDOIWSSHVCK-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
23862,6cs2,DB01501,-8.8,Difenoxin,UFIVBRCCIRTJTN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
127728,6w4h,DB06747,-8.8,ginkgolide-M,KDKROYXEHCYLJQ-FJFAJXJPSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
128034,6w4h,DB07140,-8.8,"5-[(3R)-3-(5-methoxybiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",JPENSYBRTSIYGO-AWEZNQCLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
89432,6m71,DB00471,-8.8,Montelukast,UCHDWCPVSPXUMX-TZIWLTJVSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
86164,6m3m,DB08517,-8.8,"(2S)-5-hydroxy-2-(4-hydroxyphenyl)-7-methoxy-2,3-dihydro-4H-chromen-4-one",DJOJDHGQRNZXQQ-AWEZNQCLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
11948,6lzg,DB12659,-8.8,SJ-733,VKCPFWKTFZAOTO-LEWJYISDSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
25970,6cs2,DB04011,-8.8,"2'-(4-Dimethylaminophenyl)-5-(4-Methyl-1-Piperazinyl)-2,5'-Bi-Benzimidazole",VMCOQLKKSNQANE-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
135352,6w9c,DB04348,-8.8,Taurocholic Acid,WBWWGRHZICKQGZ-HZAMXZRMSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
114699,6vxx,DB14662,-8.8,Flunisolide acetate,WEGNFRKBIKYVLC-XTLNBZDDSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88463,6m3m,DB13828,-8.8,Cyfluthrin,QQODLKZGRKWIFG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59733,6crv,DB07811,-8.8,"N-cyclopropyl-2',6-dimethyl-4'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-3-carboxamide",UBVTVSINEVHYSY-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
92730,6m71,DB04797,-8.8,Triazolopyridine,OVCXRBARSPBVMC-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
85984,6m3m,DB08300,-8.8,"1-methyl-3-naphthalen-2-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine",UOKGZPYGRJDACN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
129513,6w4h,DB08907,-8.8,Canagliflozin,XTNGUQKDFGDXSJ-ZXGKGEBGSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
166539,7bv1,DB15327,-8.8,Abivertinib,UOFYSRZSLXWIQB-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
92792,6m71,DB04875,-8.8,Pralnacasan,CXAGHAZMQSCAKJ-WAHHBDPQSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
83825,6m3m,DB04405,-8.8,"2-[2-(1,3-Dioxo-1,3-Dihydro-2h-Isoindol-2-Yl)Ethyl]-4-(4'-Ethoxy-1,1'-Biphenyl-4-Yl)-4-Oxobutanoic Acid",AQYSXARQCHHHLK-NRFANRHFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83789,6m3m,DB04350,-8.8,Argadin,FOZYKTUSOWWQGR-KNPYFFGGSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
61227,6crv,DB11778,-8.8,Danusertib,XKFTZKGMDDZMJI-HSZRJFAPSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130542,6w4h,DB12410,-8.8,Sabarubicin,VQHRZZISQVWPLK-UIRGBLDSSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
135786,6w9c,DB04982,-8.8,Talampanel,JACAAXNEHGBPOQ-LLVKDONJSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
61642,6crv,DB12379,-8.8,Indirubin,CRDNMYFJWFXOCH-BUHFOSPRSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57832,6crv,DB04186,-8.8,"N'-(Pyrrolidino[2,1-B]Isoindolin-4-On-8-Yl)-N-(Pyridin-2-Yl)Urea",KLVYMYQTRZCMLE-CYBMUJFWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
83845,6m3m,DB04434,-8.8,Naphthyridine Inhibitor,YRBHUKMLAGQYHS-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
135216,6w9c,DB04140,-8.8,1-Benzyl-3-(4-Methoxy-Benzenesulfonyl)-6-Oxo-Hexahydro-Pyrimidine-4-Carboxylic Acid Hydroxyamide,SUSMVCKSLVPRCL-QGZVFWFLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
64300,6lxt,DB01337,-8.8,Pancuronium,GVEAYVLWDAFXET-XGHATYIMSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
83802,6m3m,DB04371,-8.8,AL6528,FBBLOSCXOZYUSS-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
99448,6vxs,DB02269,-8.8,[4-({[5-Benzyloxy-1-(3-Carbamimidoyl-Benzyl)-1h-Indole-2-Carbonyl]-Amino}-Methyl)-Phenyl]-Trimethyl-Ammonium,UFKJQTGPBFWMGT-UHFFFAOYSA-O,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
83795,6m3m,DB04362,-8.8,Adenosine Diphosphate 5-(Beta-Ethyl)-4-Methyl-Thiazole-2-Carboxylic Acid,VGXBGQACJQRWLV-LKGUXBDMSA-K,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84417,6m3m,DB06134,-8.8,SNS-314,FAYAUAZLLLJJGH-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
26122,6cs2,DB04190,-8.8,Inhibitor Bea425,AHAVBKNGKPWROK-UMFPTGFGSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
85962,6m3m,DB08270,-8.8,"N-(2-AMINOETHYL)-N-2-{(1S)-1-[4'-(AMINOSULFONYL)BIPHENYL-4-YL]-2,2,2-TRIFLUOROETHYL}-L-LEUCINAMIDE",QPXXBNKMAHUXBB-PMACEKPBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85961,6m3m,DB08268,-8.8,"6-AMINO-4-[2-(4-METHYLPHENYL)ETHYL]-1,7-DIHYDRO-8H-IMIDAZO[4,5-G]QUINAZOLIN-8-ONE",SPVJRTJUEVXOMS-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
99687,6vxs,DB02573,-8.8,"2'-Deoxycytidine-2'-Deoxyadenosine-3',5'-Monophosphate",LYWWDKIADIGKTH-IDMWBNCISA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
92943,6m71,DB05553,-8.8,Regrelor,NXHAXEBZOXCDKD-XIXRRVGJSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
147560,6w9q,DB12121,-8.8,Entospletinib,XSMSNFMDVXXHGJ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
61205,6crv,DB11743,-8.8,Ipatasertib,GRZXWCHAXNAUHY-NSISKUIASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61190,6crv,DB11721,-8.8,Mitoglitazone,IRNJSRAGRIZIHD-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104519,6vxs,DB12121,-8.8,Entospletinib,XSMSNFMDVXXHGJ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
61219,6crv,DB11766,-8.8,AZD-1305,BLLNYXOLLAVTRF-HDICACEKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
128807,6w4h,DB08037,-8.8,"(2S)-4-(2,5-difluorophenyl)-N-[(3R,4S)-3-fluoro-1-methylpiperidin-4-yl]-2-(hydroxymethyl)-N-methyl-2-phenyl-2,5-dihydro-1H-pyrrole-1-carboxamide",MYBGWENAVMIGMM-GIFXNVAJSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
61307,6crv,DB11893,-8.8,Avagacestat,XEAOPVUAMONVLA-QGZVFWFLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
26881,6cs2,DB05678,-8.8,SLx-4090,AZUIUVJESCFSLJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
92603,6m71,DB04623,-8.8,"2-ETHOXYETHYL (2S,3S)-4-((S)-2-BENZYL-3-OXO-4-((3AR,8R,8AS)-2-OXO-3,3A,8,8A-TETRAHYDRO-2H-INDENO[1,2-D]OXAZOL-8-YL)-2,3-DIHYDRO-1H-PYRROL-2-YL)-3-HYDROXY-1-PHENYLBUTAN-2-YLCARBAMATE",CGBRFCVAMLJVEA-ZGURCIGKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
84455,6m3m,DB06209,-8.8,Prasugrel,DTGLZDAWLRGWQN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58322,6crv,DB04842,-8.8,Fluspirilene,QOYHHIBFXOOADH-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
159803,7bv1,DB06595,-8.8,Midostaurin,BMGQWWVMWDBQGC-IIFHNQTCSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
68561,6lxt,DB08058,-8.8,"4-[3-(1,4-diazepan-1-ylcarbonyl)-4-fluorobenzyl]phthalazin-1(2H)-one",HGEPGGJUGUMFHT-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
27156,6cs2,DB06595,-8.8,Midostaurin,BMGQWWVMWDBQGC-IIFHNQTCSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
86241,6m3m,DB08609,-8.8,"(2R)-N-{4-[Ethyl(phenyl)sulfamoyl]-2-methylphenyl}-3,3,3-trifluoro-2-hydroxy-2-methylpropanamide",SHEIQJGQDUYUBE-GOSISDBHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
129867,6w4h,DB11274,-8.8,Dihydro-alpha-ergocryptine,PBUNVLRHZGSROC-VTIMJTGVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
104642,6vxs,DB12297,-8.8,GLPG-0187,CXHCNOMGODVIKB-VWLOTQADSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
92964,6m71,DB05678,-8.8,SLx-4090,AZUIUVJESCFSLJ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
83864,6m3m,DB04461,-8.8,Coproporphyrinogen III,NIUVHXTXUXOFEB-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
132795,6w9c,DB00858,-8.8,Drostanolone,IKXILDNPCZPPRV-RFMGOVQKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
92666,6m71,DB04708,-8.8,"(S)-TETRAHYDROFURAN-3-YL (2S,3S)-4-((S)-4-((1R,3R)-3-(2-AMINO-2-OXOETHYL)-2,3-DIHYDRO-1H-INDEN-1-YL)-2-BENZYL-3-OXO-2,3-DIHYDRO-1H-PYRROL-2-YL)-3-HYDROXY-1-PHENYLBUTAN-2-YLCARBAMATE",SYNSHNDQFWMLJW-YZGRCXSVSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
12042,6lzg,DB12794,-8.8,p-Quaterphenyl,GPRIERYVMZVKTC-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
147504,6w9q,DB12042,-8.8,Ibodutant,YQYSVMKCMIUCHY-WJOKGBTCSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
92677,6m71,DB04724,-8.8,"(S)-2-((S)-3-ISOBUTYL-2,5-DIOXO-4-QUINOLIN-3-YLMETHYL-[1,4]DIAZEPAN-1YL)-N-METHYL-3-NAPHTALEN-2-YL-PROPIONAMIDE",COVPLULNDBDXTN-KYJUHHDHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
101058,6vxs,DB04421,-8.8,Nicotinamide Adenine Dinucleotide 3-Pentanone Adduct,BZJFKYRGSZWSLT-YLIVDTKOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
61239,6crv,DB11793,-8.8,Niraparib,PCHKPVIQAHNQLW-CQSZACIVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58339,6crv,DB04865,-8.8,Omacetaxine mepesuccinate,HYFHYPWGAURHIV-JFIAXGOJSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
161532,7bv1,DB15028,-8.8,MK-1064,CKTWQGHVNRYNCM-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
86636,6m3m,DB09172,-8.8,Brifentanil,KKMGCTVJCQYQPV-WBVHZDCISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
104606,6vxs,DB12247,-8.8,AZD-4547,VRQMAABPASPXMW-HDICACEKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104488,6vxs,DB12078,-8.8,Enobosarm,JNGVJMBLXIUVRD-SFHVURJKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
130472,6w4h,DB12309,-8.8,GI-181771X,CABBMMXFOOZVMS-PMERELPUSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
132485,6w9c,DB00485,-8.8,Dicloxacillin,YFAGHNZHGGCZAX-JKIFEVAISA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
89225,6m71,DB00224,-8.8,Indinavir,CBVCZFGXHXORBI-PXQQMZJSSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
85931,6m3m,DB08230,-8.8,"5,7-DIHYDROXY-2-(3,4,5-TRIHYDROXYPHENYL)-4H-CHROMEN-4-ONE",ARSRJFRKVXALTF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
133039,6w9c,DB01138,-8.8,Sulfinpyrazone,MBGGBVCUIVRRBF-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
149041,6w9q,DB14773,-8.8,Lifirafenib,NGFFVZQXSRKHBM-FKBYEOEOSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
104613,6vxs,DB12260,-8.8,Radiprodil,GKGRZLGAQZPEHO-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
88559,6m3m,DB14025,-8.8,Clinafloxacin,QGPKADBNRMWEQR-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
132763,6w9c,DB00823,-8.8,Ethynodiol diacetate,ONKUMRGIYFNPJW-KIEAKMPYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
61915,6crv,DB12796,-8.8,MRX-I,SULYVXZZUMRQAX-NSHDSACASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
69224,6lxt,DB08861,-8.8,DPDPE,MCMMCRYPQBNCPH-WMIMKTLMSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
114516,6vxx,DB13729,-8.8,Camostat,XASIMHXSUQUHLV-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27062,6cs2,DB06367,-8.8,Relacatib,BWYBBMQLUKXECQ-GIVPXCGWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
63267,6crv,DB01532,-8.8,alpha-Methylacetylfentanyl,OKTLVZBUKMRPLL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104982,6vxs,DB12812,-8.8,Palomid 529,YEAHTLOYHVWAKW-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
63261,6crv,DB15456,-8.8,Vericiguat,QZFHIXARHDBPBY-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
24907,6cs2,DB02723,-8.8,"4-Oxo-2-Phenylmethanesulfonyl-Octahydro-Pyrrolo[1,2-a]Pyrazine-6-Carboxylic Acid [1-(N-Hydroxycarbamimidoyl)-Piperidin-4-Ylmethyl]-Amide",DHTSUHWLPAEEQB-OALUTQOASA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
99040,6vxs,DB01721,-8.8,Analogue of Indinavir Drug,MJIRDPUZGGHJMX-OIVSQUILSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
135699,6w9c,DB04824,-8.8,Phenolphthalein,KJFMBFZCATUALV-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
61805,6crv,DB12622,-8.8,Lupeol,MQYXUWHLBZFQQO-QGTGJCAVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88841,6m3m,DB14914,-8.8,Flortaucipir F-18,GETAAWDSFUCLBS-SJPDSGJFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
98822,6vxs,DB01459,-8.8,Bezitramide,FLKWNFFCSSJANB-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
58121,6crv,DB04575,-8.8,Quinestrol,PWZUUYSISTUNDW-VAFBSOEGSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
105018,6vxs,DB12875,-8.8,Mavatrep,ORDHXXHTBUZRCN-NTEUORMPSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
59595,6crv,DB07649,-8.8,"(3R,4S)-1-[(4-amino-5H-pyrrolo[3,2-d]pyrimidin-7-yl)methyl]-4-[(benzylsulfanyl)methyl]pyrrolidin-3-ol",DIGGNILBPCEZIV-CVEARBPZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
11807,6lzg,DB12457,-8.8,Rimegepant,KRNAOFGYEFKHPB-ANJVHQHFSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
88843,6m3m,DB14917,-8.8,Ceralasertib,DTTJKLNXNZAVSM-JYCIKRDWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
143696,6w9q,DB03878,-8.8,N-[4-Methyl-3-[[4-(3-Pyridinyl)-2-Pyrimidinyl]Amino]Phenyl]-3-Pyridinecarboxamide,YWQVBESSYLICRX-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
84150,6m3m,DB04834,-8.8,Rapacuronium,HTIKWNNIPGXLGM-YLINKJIISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
149329,6w9q,DB15401,-8.8,Danicopan,PIBARDGJJAGJAJ-NQIIRXRSSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
84160,6m3m,DB04845,-8.8,Ixabepilone,FABUFPQFXZVHFB-PVYNADRNSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
64086,6lxt,DB01047,-8.8,Fluocinonide,WJOHZNCJWYWUJD-IUGZLZTKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
58161,6crv,DB04628,-8.8,Allosamidin,MDWNFWDBQGOKNZ-XYUDZHFQSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130257,6w4h,DB12002,-8.8,AZD-4818,HVTUHSABWJPWNK-SFHVURJKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
98738,6vxs,DB01328,-8.8,Cefonicid,DYAIAHUQIPBDIP-AXAPSJFSSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
64122,6lxt,DB01089,-8.8,Deserpidine,CVBMAZKKCSYWQR-WCGOZPBSSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
135709,6w9c,DB04834,-8.8,Rapacuronium,HTIKWNNIPGXLGM-YLINKJIISA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
127889,6w4h,DB06976,-8.8,"1-(5-OXO-2,3,5,9B-TETRAHYDRO-1H-PYRROLO[2,1-A]ISOINDOL-9-YL)-3-(5-PYRROLIDIN-2-YL-1H-PYRAZOL-3-YL)-UREA",IWOOJEZSDPRYAZ-WFASDCNBSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
11840,6lzg,DB12504,-8.8,JNJ-40346527,BNVPFDRNGHMRJS-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
84046,6m3m,DB04696,-8.8,"4-CHLORO-3',3''-DIBROMOPHENOL-1,8-NAPHTHALEIN",GFGZCXHXQCQRFP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58031,6crv,DB04463,-8.8,"3-(4-Amino-1-Tert-Butyl-1h-Pyrazolo[3,4-D]Pyrimidin-3-Yl)Phenol",CPLGZXQPPYRNRC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
132607,6w9c,DB00635,-8.8,Prednisone,XOFYZVNMUHMLCC-ZPOLXVRWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
162022,7bv1,DB01092,-8.8,Ouabain,LPMXVESGRSUGHW-HBYQJFLCSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
130234,6w4h,DB11965,-8.8,SJG-136,RWZVMMQNDHPRQD-SFTDATJTSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
61524,6crv,DB12218,-8.8,AZD-5363,JDUBGYFRJFOXQC-KRWDZBQOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61424,6crv,DB12066,-8.8,Orteronel,OZPFIJIOIVJZMN-SFHVURJKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86050,6m3m,DB08382,-8.8,Gosogliptin,QWEWGXUTRTXFRF-KBPBESRZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
69120,6lxt,DB08731,-8.8,"2-[(1R)-2-carboxy-1-(naphthalen-1-ylmethyl)ethyl]-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylic acid",GPOKTQCDBPECSS-MRXNPFEDSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
61824,6crv,DB12654,-8.8,GSK-376501,OIDYMQICWGYEDR-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84179,6m3m,DB04872,-8.8,Osanetant,DZOJBGLFWINFBF-UMSFTDKQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
135698,6w9c,DB04823,-8.8,Oxyphenisatin,SJDACOMXKWHBOW-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
105035,6vxs,DB12897,-8.8,MK-7622,JUVQLZBJFOGEEO-GOTSBHOMSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
86118,6m3m,DB08463,-8.8,(2R)-2-({9-(1-methylethyl)-6-[(4-pyridin-2-ylbenzyl)amino]-9H-purin-2-yl}amino)butan-1-ol,HOCBJBNQIQQQGT-LJQANCHMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
13237,6lzg,DB14946,-8.8,PCO-371,LDZJFVOUPUFOHX-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
130158,6w4h,DB11853,-8.8,Relugolix,AOMXMOCNKJTRQP-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
160178,7bv1,DB07608,-8.8,N-(5-{[(2S)-4-amino-2-(3-chlorophenyl)butanoyl]amino}-1H-indazol-3-yl)benzamide,JDGOPNUGILVNJZ-IBGZPJMESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
84086,6m3m,DB04754,-8.8,"GUANOSINE-2',3'-O-ETHYLIDENEPHOSPHONATE",HYAPEMYRVFIHDJ-QWEIRQIHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88890,6m3m,DB15047,-8.8,BMS-919373,XGKULQQVQWCASY-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
90389,6m71,DB01669,-8.8,Virginiamycin M1,DAIKHDNSXMZDCU-FQTGFAPKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
84068,6m3m,DB04726,-8.8,"7,8,10-TRIMETHYLBENZO[G]PTERIDINE-2,4(3H,10H)-DIONE",KPDQZGKJTJRBGU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
61494,6crv,DB12167,-8.8,LY-3023414,ACCFLVVUVBJNGT-AWEZNQCLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84091,6m3m,DB04761,-8.8,"PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-[(PYRIDIN-3-YLMETHYL)-AMIDE]",NHPBWKYFMTXWAA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
90458,6m71,DB01761,-8.8,4-[5-[2-(1-Phenyl-Ethylamino)-Pyrimidin-4-Yl]-1-Methyl-4-(3-Trifluoromethylphenyl)-1h-Imidazol-2-Yl]-Piperidine,QICPQLFMWYQJGX-SFHVURJKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
128568,6w4h,DB07765,-8.8,"METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL](METHYL)AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE",UKCFUFHREWUXJJ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
63243,6crv,DB15418,-8.8,AZD-9977,MBKYLPOPYYLTNW-ZDUSSCGKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
142827,6w9q,DB02705,-8.8,"6-[N-(1-Isopropyl-1,2,3,4-Tetrahydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine",DARQQJKHXPXSRO-QFIPXVFZSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
63791,6lxt,DB00705,-8.8,Delavirdine,WHBIGIKBNXZKFE-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
59353,6crv,DB07360,-8.8,"1-{5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)ethyl]-1,3-thiazol-2-yl}-3-[3-(trifluoromethyl)phenyl]urea",JJHXPDTVQKWKHA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
105072,6vxs,DB12949,-8.8,PF-03382792,AGMOFKKOVMRGAK-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
86397,6m3m,DB08791,-8.8,"1-[(2-NITROPHENYL)SULFONYL]-1H-PYRROLO[3,2-B]PYRIDINE-6-CARBOXAMIDE",USLOIFPDNUDIEG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
24863,6cs2,DB02673,-8.8,"(4ar,6s,8ar)-11-[8-(1,3-Dioxo-1,3-Dihydro-2h-Isoindol-2-Yl)Octyl]-6-Hydroxy-3-Methoxy-5,6,9,10-Tetrahydro-4ah-[1]Benzofuro[3a,3,2-Ef][2]Benzazepin-11-Ium",VLGAHTYYCHWLNI-BHRZLAGCSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
132891,6w9c,DB00967,-8.8,Desloratadine,JAUOIFJMECXRGI-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
90749,6m71,DB02152,-8.8,K-252a,KOZFSFOOLUUIGY-SOLYNIJKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59320,6crv,DB07324,-8.8,"3-({2-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)ETHYNYL]BENZYL}AMINO)-1,3-OXAZOL-2(3H)-ONE",ZUJWSOPIDUWELP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86446,6m3m,DB08861,-8.8,DPDPE,MCMMCRYPQBNCPH-WMIMKTLMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
61516,6crv,DB12204,-8.8,Terbogrel,XUTLOCQNGLJNSA-RGVLZGJSSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
132643,6w9c,DB00680,-8.8,Moricizine,FUBVWMNBEHXPSU-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
59572,6crv,DB07624,-8.8,"1-{[(3R)-3-methyl-4-({4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]phenyl}sulfonyl)piperazin-1-yl]methyl}cyclopropanecarboxamide",YJFULAYRAKPBCY-DYVFJYSZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
63787,6lxt,DB00700,-8.8,Eplerenone,JUKPWJGBANNWMW-VWBFHTRKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
88882,6m3m,DB15033,-8.8,Flortaucipir,GETAAWDSFUCLBS-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58091,6crv,DB04540,-8.8,Cholesterol,HVYWMOMLDIMFJA-DPAQBDIFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84060,6m3m,DB04715,-8.8,IMIDAZOPYRIDAZIN 1,IVUBNTNWKIPCPS-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
132898,6w9c,DB00977,-8.8,Ethinylestradiol,BFPYWIDHMRZLRN-SLHNCBLASA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
61771,6crv,DB12566,-8.8,Decernotinib,ASUGUQWIHMTFJL-QGZVFWFLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61500,6crv,DB12180,-8.8,Apitolisib,YOVVNQKCSKSHKT-HNNXBMFYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84061,6m3m,DB04716,-8.8,"2-(1,1-DIMETHYLETHYL)9-FLUORO-3,6-DIHYDRO-7H-BENZ[H]-IMIDAZ[4,5-F]ISOQUINOLIN-7-ONE",VNDWQCSOSCCWIP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
61474,6crv,DB12135,-8.8,Elubrixin,YQYFEGTYCUQBEI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
13242,6lzg,DB14989,-8.8,Umbralisib,IUVCFHHAEHNCFT-INIZCTEOSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
132648,6w9c,DB00687,-8.8,Fludrocortisone,AAXVEMMRQDVLJB-BULBTXNYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
13349,6lzg,DB15197,-8.8,RSV-604,MTPVBMVUENFFLL-HXUWFJFHSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
84180,6m3m,DB04873,-8.8,Piboserod,KVCSJPATKXABRQ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
130267,6w4h,DB12015,-8.8,Alpelisib,STUWGJZDJHPWGZ-LBPRGKRZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
26227,6cs2,DB00496,-8.8,Darifenacin,HXGBXQDTNZMWGS-RUZDIDTESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
105093,6vxs,DB12985,-8.8,Quisinostat,PAWIYAYFNXQGAP-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
86282,6m3m,DB08659,-8.8,2-(hydrazinocarbonyl)-3-phenyl-1H-indole-5-sulfonamide,PPDLAUCFAOODER-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88741,6m3m,DB14678,-8.8,Norethindrone enanthate,APTGJECXMIKIET-WOSSHHRXSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
114691,6vxx,DB14653,-8.8,Clocortolone caproate,MMTRTBFDFNRBQO-ANHDKODLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61356,6crv,DB11963,-8.8,Dacomitinib,LVXJQMNHJWSHET-AATRIKPKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
148150,6w9q,DB13014,-8.8,Hypericin,BTXNYTINYBABQR-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
130343,6w4h,DB12127,-8.8,Sultamicillin,OPYGFNJSCUDTBT-PMLPCWDUSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
132560,6w9c,DB00580,-8.8,Valdecoxib,LNPDTQAFDNKSHK-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
128593,6w4h,DB07794,-8.8,"5-(2-PHENYLPYRAZOLO[1,5-A]PYRIDIN-3-YL)-1H-PYRAZOLO[3,4-C]PYRIDAZIN-3-AMINE",XVECMUKVOMUNLE-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
91643,6m71,DB03325,-8.8,Tyrosyladenylate,MJZAZMKENKZBAJ-QTOWJTHWSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
91632,6m71,DB03311,-8.8,"3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid [4-(Thiazol-2-Ylsulfamoyl)-Phenyl]-Amide",SXKBTDJJEQQEGE-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
100778,6vxs,DB04044,-8.8,4-{2-[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid,NAQUAVBNIYTIIS-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
99268,6vxs,DB02033,-8.8,"N-(3-Cyclopropyl(5,6,7,8,9,10-Hexahydro-2-Oxo-2h-Cycloocta[B]Pyran-3-Yl)Methyl)Phenylbenzensulfonamide",GDRNWAKVNIROCG-DEOSSOPVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
132713,6w9c,DB00764,-8.8,Mometasone,QLIIKPVHVRXHRI-CXSFZGCWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
130292,6w4h,DB12055,-8.8,MK-0767,ORZMUVMQJPGFOM-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130299,6w4h,DB12064,-8.8,BMS-777607,VNBRGSXVFBYQNN-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
84245,6m3m,DB05076,-8.8,Fenretinide,AKJHMTWEGVYYSE-FXILSDISSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
57952,6crv,DB04348,-8.8,Taurocholic Acid,WBWWGRHZICKQGZ-HZAMXZRMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
68835,6lxt,DB08389,-8.8,"6,7-DIMETHOXY-4-[(3R)-3-(2-NAPHTHYLOXY)PYRROLIDIN-1-YL]QUINAZOLINE",UPTQSRGSSJRBKJ-LJQANCHMSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
61319,6crv,DB11909,-8.8,Varespladib,BHLXTPHDSZUFHR-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84299,6m3m,DB05416,-8.8,Cardarine,YDBLKRPLXZNVNB-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
114303,6vxx,DB13266,-8.8,Cefatrizine,UOCJDOLVGGIYIQ-PBFPGSCMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
100862,6vxs,DB04154,-8.8,"N-Methyl-N-[3-(6-Phenyl[1,2,4]Triazolo[4,3-B]Pyridazin-3-Yl)Phenyl]Acetamide",ALBWBHNFOJJMCV-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
86592,6m3m,DB09076,-8.8,Umeclidinium,FVTWTVQXNAJTQP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59498,6crv,DB07534,-8.8,"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE",BKUMVXIXUVYKDQ-GHXNOFRVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86591,6m3m,DB09075,-8.8,Edoxaban,HGVDHZBSSITLCT-JLJPHGGASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
91826,6m71,DB03591,-8.8,RU82209,LVZDQVATAQEMCX-NSOVKSMOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
13339,6lzg,DB15177,-8.8,VX-659,IGEOJNMYRZUKIK-IBGZPJMESA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
147775,6w9q,DB12424,-8.8,MK-3207,AZAANWYREOQRFB-SETSBSEESA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
84276,6m3m,DB05265,-8.8,Ecabet,IWCWQNVIUXZOMJ-MISYRCLQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
128647,6w4h,DB07855,-8.8,(S)-1-PHENYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE,CWHMAWBXRCDOEB-HNNXBMFYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
13334,6lzg,DB15168,-8.8,Cilofexor,KZSKGLFYQAYZCO-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
83993,6m3m,DB04624,-8.8,DERIVATIVE OF AKLANONIC ACID METHYL ESTER (AAME),SIHNJMGWRHPFAZ-XHDPSFHLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
100820,6vxs,DB04098,-8.8,Balanol,XYUFCXJZFZPEJD-PGRDOPGGSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
159836,7bv1,DB06666,-8.8,Lixivaptan,PPHTXRNHTVLQED-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
91987,6m71,DB03802,-8.8,"1-[4-(Octahydro-Pyrido[1,2-a]Pyrazin-2-Yl)-Phenyl]-2-Phenyl-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol",ZGHFWBDHZZKWSI-LITSAYRRSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
114692,6vxx,DB14654,-8.8,Bisoxatin acetate,ZCBJDQBSLZREAA-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
100031,6vxs,DB03038,-8.8,LY341770,MXAFDBCLWLMXSI-ZDUSSCGKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
63186,6crv,DB15299,-8.8,AMG-232,DRLCSJFKKILATL-YWCVFVGNSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84220,6m3m,DB04957,-8.8,Azimilide,MREBEPTUUMTTIA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
13195,6lzg,DB14878,-8.8,Liafensine,VCIBGDSRPUOBOG-QFIPXVFZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
98533,6vxs,DB01051,-8.8,Novobiocin,YJQPYGGHQPGBLI-KGSXXDOSSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
88791,6m3m,DB14801,-8.8,Lanifibranor,OQDQIFQRNZIEEJ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
105164,6vxs,DB13094,-8.8,Pruvanserin,AQRLDDAFYYAIJP-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
61840,6crv,DB12673,-8.8,ATX-914,ALANRBCCCQEPFZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127906,6w4h,DB06995,-8.8,N-({4-[(2-aminopyridin-4-yl)oxy]-3-fluorophenyl}carbamoyl)-2-(4-fluorophenyl)acetamide,USBSTVPJNQLYEM-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
132996,6w9c,DB01089,-8.8,Deserpidine,CVBMAZKKCSYWQR-WCGOZPBSSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
132694,6w9c,DB00739,-8.8,Hetacillin,DXVUYOAEDJXBPY-NFFDBFGFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
61839,6crv,DB12672,-8.8,Icaritin,TUUXBSASAQJECY-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
162072,7bv1,DB01410,-8.8,Ciclesonide,LUKZNWIVRBCLON-GXOBDPJESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
159883,7bv1,DB07039,-8.8,(2S)-N-(4-cyano-3-iodophenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide,RXSZCFAPSDTELY-SFHVURJKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
98643,6vxs,DB01177,-8.8,Idarubicin,XDXDZDZNSLXDNA-TZNDIEGXSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
27009,6cs2,DB06237,-8.8,Avanafil,WEAJZXNPAWBCOA-INIZCTEOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
130269,6w4h,DB12020,-8.8,Tecovirimat,CSKDFZIMJXRJGH-VWLPUNTISA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
91169,6m71,DB02698,-8.8,"N-(M-Trifluoromethylphenyl) Phenoxazine-4,6-Dicarboxylic Acid",NQOOJFXBGLOGTC-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
58175,6crv,DB04645,-8.8,"5-{3-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-2-METHYL-PHENOXY}-PENTANOIC ACID",NJJIFGCFUDDBSP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
63356,6lxt,DB00180,-8.8,Flunisolide,XSFJVAJPIHIPKU-XWCQMRHXSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
127919,6w4h,DB07008,-8.8,"4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMIDAZOL-1-YL)PHENOXY]PYRIMIDINE",XPXGYINSBORUMM-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
11881,6lzg,DB12561,-8.8,WNT-974,XXYGTCZJJLTAGH-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
59638,6crv,DB07703,-8.8,"(3R,4S,5S,7R,9E,11R,12R)-12-ETHYL-4-HYDROXY-3,5,7,11-TETRAMETHYLOXACYCLODODEC-9-ENE-2,8-DIONE",NZUJVBSYQXETNF-PQWITYJESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
24686,6cs2,DB02466,-8.8,"4-[3-Oxo-3-(5,5,8,8-Tetramethyl-5,6,7,8-Tetrahydro-Naphthalen-2-Yl)-Propenyl]-Benzoic Acid",ZXQHMEUGMCXKLO-KPKJPENVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
13191,6lzg,DB14870,-8.8,PF-5190457,ZIUDADZJCKGWKR-AREMUKBSSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
16633,6cs2,HMDB0003249,-8.8,Rutin,IKGXIBQEEMLURG-NVPNHPEKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
59286,6crv,DB07288,-8.8,N-(4-chlorophenyl)-2-[(pyridin-4-ylmethyl)amino]benzamide,GGPZCOONYBPZEW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86521,6m3m,DB08975,-8.8,Florantyrone,QOBAOSCOLAGPKI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88771,6m3m,DB14761,-8.8,Remdesivir,RWWYLEGWBNMMLJ-YSOARWBDSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58006,6crv,DB04429,-8.8,4'-Hydroxyflavanone,ZLHVIYHWWQYJID-HNNXBMFYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
98512,6vxs,DB01026,-8.8,Ketoconazole,XMAYWYJOQHXEEK-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
68881,6lxt,DB08445,-8.8,"(3R,4S)-1-[6-(6-METHOXYPYRIDIN-3-YL)PYRIMIDIN-4-YL]-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE",IFKWHPAWYJARQJ-DYVFJYSZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
89987,6m71,DB01126,-8.8,Dutasteride,JWJOTENAMICLJG-QWBYCMEYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
127780,6w4h,DB06844,-8.8,"4-[(7-OXO-7H-THIAZOLO[5,4-E]INDOL-8-YLMETHYL)-AMINO]-N-PYRIDIN-2-YL-BENZENESULFONAMIDE",MBXKBJLIESPLIK-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
104850,6vxs,DB12598,-8.8,Nafamostat,MQQNFDZXWVTQEH-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
68884,6lxt,DB08448,-8.8,"(4aS)-5-[(2,4-diaminopteridin-6-yl)methyl]-4a,5-dihydro-2H-dibenzo[b,f]azepin-8-ol",PCBWLKUEKANDCL-INIZCTEOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
27080,6cs2,DB06420,-8.8,Annamycin,CIDNKDMVSINJCG-GKXONYSUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
130132,6w4h,DB11818,-8.8,Retosiban,PLVGDGRBPMVYPB-FDUHJNRSSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
91425,6m71,DB03044,-8.8,1-(5-Tert-Butyl-2-P-Tolyl-2h-Pyrazol-3-Yl)-3-[4-(2-Morpholin-4-Yl-Ethoxy)-Naphthalen-1-Yl]-Urea,MVCOAUNKQVWQHZ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96164,6m71,DB12480,-8.8,Betulinic Acid,QGJZLNKBHJESQX-FZFNOLFKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
144800,6w9q,DB06435,-8.8,Tarazepide,CZPILLBHPRAPCB-AREMUKBSSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
1787,6lzg,HMDB0015016,-8.8,Chlorhexidine,GHXZTYHSJHQHIJ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
101998,6vxs,DB06888,-8.8,"(13R,15S)-13-METHYL-16-OXA-8,9,12,22,24-PENTAAZAHEXACYCLO[15.6.2.16,9.1,12,15.0,2,7.0,21,25]HEPTACOSA-1(24),2,4,6,17(25),18,20-HEPTAENE-23,26-DIONE",KBLPHMRCKHFBJB-OLZOCXBDSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
87117,6m3m,DB11853,-8.8,Relugolix,AOMXMOCNKJTRQP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85039,6m3m,DB07192,-8.8,(3S)-N-(3-BROMOPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE,MVPIURCUINFSAB-LBPRGKRZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
65908,6lxt,DB03466,-8.8,BMS184394,AYAJZQYENGWICE-QHCPKHFHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
23232,6cs2,HMDB0001898,-8.8,Mesobilirubinogen,OBHRVMZSZIDDEK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
60000,6crv,DB08116,-8.8,"(3R)-4-{[(3,4-dihydroxyphenyl)acetyl]oxy}-N-(2-formylindolizin-3-yl)-3-sulfino-D-valine",DEOZLEGRVHDNKC-UGKGYDQZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
159301,7bv1,DB03957,-8.8,SP2456,SSSXBBASYYVGCI-HSZRJFAPSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
25504,6cs2,DB03446,-8.8,N-Benzyl-3-(alpha-D-galactopyranosyloxy)benzamide,FSMWGHKWKYCPKE-QTVCLEQKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
62579,6crv,DB13767,-8.8,Vorozole,XLMPPFTZALNBFS-INIZCTEOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58720,6crv,DB06472,-8.8,Fradafiban,IKZACQMAVUIGPY-HOTGVXAUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
96820,6m71,DB13490,-8.8,Hidrosmin,XYFLWVOTXWXNAM-WTNNCJBMSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95257,6m71,DB09183,-8.8,Dasabuvir,NBRBXGKOEOGLOI-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95235,6m71,DB09143,-8.8,Sonidegib,VZZJRYRQSPEMTK-CALCHBBNSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95205,6m71,DB09079,-8.8,Nintedanib,XZXHXSATPCNXJR-ZIADKAODSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
24242,6cs2,DB01946,-8.8,"3-[1-(3-Aminopropyl)-1h-Indol-3-Yl]-4-(1-Methyl-1h-Indol-3-Yl)-1h-Pyrrole-2,5-Dione",UQHKJRCFSLMWIA-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
115825,6w4b,DB01349,-8.8,Tasosartan,ADXGNEYLLLSOAR-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
87100,6m3m,DB11828,-8.8,Neratinib,JWNPDZNEKVCWMY-VQHVLOKHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
62534,6crv,DB13708,-8.8,Fenquizone,DBDTUXMDTSTPQZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
65862,6lxt,DB03397,-8.8,Uridine-Diphosphate-N-Acetylglucosamine,LFTYTUAZOPRMMI-CFRASDGPSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
95157,6m71,DB09003,-8.8,Clocapramine,QAZKXHSIKKNOHH-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
101941,6vxs,DB06817,-8.8,Raltegravir,CZFFBEXEKNGXKS-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
67305,6lxt,DB06409,-8.8,Morphine glucuronide,GNJCUHZOSOYIEC-GAROZEBRSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
133352,6w9c,DB01572,-8.8,Methyl-1-testosterone,JRNSSSJKIGAFCT-YDSAWKJFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
161030,7bv1,DB12420,-8.8,Diazepinomicin,SALVHVNECODMJP-GNUCVDFRSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96612,6m71,DB13215,-8.8,Sulfobromophthalein,OHTXTCNTQJFRIG-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60306,6crv,DB08491,-8.8,N-HYDROXY-2-[4-(4-PHENOXY-BENZENESULFONYL)-TETRAHYDRO-PYRAN-4-YL]-ACETAMIDE,ARIRIZBKMKMEBD-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
158511,7bv1,DB01289,-8.8,Glisoxepide,ZKUDBRCEOBOWLF-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60030,6crv,DB08149,-8.8,"1-[4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine",KCWPSUKJCKZEAO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87424,6m3m,DB12301,-8.8,Doravirine,ZIAOVIPSKUPPQW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
131798,6w4h,DB14726,-8.8,Dabigatran,YBSJFWOBGCMAKL-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
85079,6m3m,DB07242,-8.8,"(4R)-7,8-dichloro-1',9-dimethyl-1-oxo-1,2,4,9-tetrahydrospiro[beta-carboline-3,4'-piperidine]-4-carbonitrile",XGUIMGJMQKZRGM-LLVKDONJSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
95657,6m71,DB11753,-8.8,Rifamycin,HJYYPODYNSCCOU-ODRIEIDWSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
85507,6m3m,DB07743,-8.8,"S-[5-(TRIFLUOROMETHYL)-4H-1,2,4-TRIAZOL-3-YL] 5-(PHENYLETHYNYL)FURAN-2-CARBOTHIOATE",VNGWUVBXUIDQTK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
67235,6lxt,DB06212,-8.8,Tolvaptan,GYHCTFXIZSNGJT-XMMPIXPASA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
60354,6crv,DB08545,-8.8,(1R)-1-PHENYLETHYL 4-(ACETYLAMINO)BENZYLPHOSPHONATE,YPTMOJMDCPUCJT-ZDUSSCGKSA-M,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87567,6m3m,DB12507,-8.8,Atecegatran metoxil,XSNMGLZVFNDDPW-ZWKOTPCHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
62650,6crv,DB13856,-8.8,Fluclorolone,VTWKPILBIUBMDS-OTJLYDAYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
67287,6lxt,DB06346,-8.8,Fiboflapon,DFQGDHBGRSTTHX-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
102967,6vxs,DB08015,-8.8,"(3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-phenyl-1H-indole-2,3-dione 3-oxime",SZYREAUDQRVVLV-DAFNUICNSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
58741,6crv,DB06529,-8.8,Ocinaplon,OQJFBUOFGHPMSR-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62942,6crv,DB14770,-8.8,Lanraplenib,XCIGZBVOUQVIPI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
24042,6cs2,DB01698,-8.8,Rutin,IKGXIBQEEMLURG-NVPNHPEKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
132055,6w4h,DB15291,-8.8,BMS-986142,ZRYMMWAJAFUANM-INIZCTEOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
158430,7bv1,DB01177,-8.8,Idarubicin,XDXDZDZNSLXDNA-TZNDIEGXSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
58736,6crv,DB06519,-8.8,Edaglitazone,HAAXAFNSRADSMK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87123,6m3m,DB11865,-8.8,Brivanib alaninate,LTEJRLHKIYCEOX-OCCSQVGLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
60372,6crv,DB08569,-8.8,"3-PYRIDIN-4-YL-2,4-DIHYDRO-INDENO[1,2-.C.] PYRAZOLE",VLPMRZSKJUTRBQ-IBGZPJMESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62941,6crv,DB14769,-8.8,Pamiparib,DENYZIUJOTUUNY-MRXNPFEDSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58770,6crv,DB06605,-8.8,Apixaban,QNZCBYKSOIHPEH-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
131545,6w4h,DB13919,-8.8,Candesartan,HTQMVQVXFRQIKW-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
132103,6w4h,DB15393,-8.8,Telatinib,QFCXANHHBCGMAS-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
103306,6vxs,DB08423,-8.8,[5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL][3-(PIPERIDIN-4-YLOXY)PHENYL]METHANONE,QKZZJXRGCHXIAI-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
97294,6m71,DB14581,-8.8,CPI-1205,HPODOLXTMDHLLC-QGZVFWFLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
133287,6w9c,DB01501,-8.8,Difenoxin,UFIVBRCCIRTJTN-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
85625,6m3m,DB07874,-8.8,"(6S)-2-amino-6-(3'-methoxybiphenyl-3-yl)-3,6-dimethyl-5,6-dihydropyrimidin-4(3H)-one",LQOCXPOKEPYGTJ-IBGZPJMESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59075,6crv,DB07045,-8.8,"(2R,3R,4S,5R)-2-[6-amino-8-[(3,4-dichlorophenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol",VBJKVZXRYLCYGQ-XNIJJKJLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84936,6m3m,DB07074,-8.8,6-CARBAMIMIDOYL-4-(3-HYDROXY-2-METHYL-BENZOYLAMINO)-NAPHTHALENE-2-CARBOXYLIC ACID METHYL ESTER,OUBRALHIKGRAMA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84933,6m3m,DB07070,-8.8,(2S)-2-{3-[({[2-fluoro-4-(trifluoromethyl)phenyl]carbonyl}amino)methyl]-4-methoxybenzyl}butanoic acid,BDLLIPYDNFENMY-ZDUSSCGKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58658,6crv,DB06292,-8.8,Dapagliflozin,JVHXJTBJCFBINQ-ADAARDCZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59945,6crv,DB08055,-8.8,"N-(2-chlorophenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine",NNBICZMPIJMWGC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84929,6m3m,DB07065,-8.8,"5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)-3-thiocyanatopyrazolo[1,5-a]pyrimidin-7-amine",AHPKUZJCNHGFQA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
94777,6m71,DB08520,-8.8,"(21S)-1AZA-4,4-DIMETHYL-6,19-DIOXA-2,3,7,20-TETRAOXOBICYCLO[19.4.0] PENTACOSANE",VUCSBBBCFXBFFY-IBGZPJMESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
65367,6lxt,DB02741,-8.8,CD564,RWYREGSYPCNZTL-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
103330,6vxs,DB08450,-8.8,N-1H-indazol-5-yl-2-(6-methylpyridin-2-yl)quinazolin-4-amine,HNHRWNUXTCATSG-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
146830,6w9q,DB09030,-8.8,Vorapaxar,ZBGXUVOIWDMMJE-QHNZEKIYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
67545,6lxt,DB06879,-8.8,"5-(4'-AMINO-1'-ETHYL-5',8'-DIFLUORO-1'H-SPIRO[PIPERIDINE-4,2'-QUINAZOLINE]-1-YLCARBONYL)PICOLINONITRILE",QCFIRACCCDFXIP-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
58654,6crv,DB06280,-8.8,Senicapoc,SCTZUZTYRMOMKT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
94771,6m71,DB08512,-8.8,"6-amino-2-[(1-naphthylmethyl)amino]-3,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",MCEZMMDIEXECTI-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
85652,6m3m,DB07909,-8.8,"(1S,2S,5S)2-(4-GLUTARIDYLBENZYL)-5-PHENYL-1-CYCLOHEXANOL",OBWILOKKNDYPLX-HBMCJLEFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
140768,6w9c,DB15275,-8.8,GDC-0077,SGEUNORSOZVTOL-CABZTGNLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
84905,6m3m,DB07039,-8.8,(2S)-N-(4-cyano-3-iodophenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide,RXSZCFAPSDTELY-SFHVURJKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
14156,6lzg,T3D3778,-8.8,Paspalitrem B,BZJWARDOYGJZHQ-PKNBQFBNSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
97290,6m71,DB14569,-8.8,Tedizolid,XFALPSLJIHVRKE-GFCCVEGCSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
24297,6cs2,DB02009,-8.8,"L-756,423",AOMZDQMIOCTPQP-QHQMVRJISA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
94933,6m71,DB08710,-8.8,"(5Z)-5-[(5-ETHYL-2-FURYL)METHYLENE]-2-{[(S)-(4-FLUOROPHENYL)(1H-TETRAZOL-5-YL)METHYL]AMINO}-1,3-THIAZOL-4(5H)-ONE",BKZOQCGDCHOGOQ-MZLJFPOFSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94952,6m71,DB08730,-8.8,3-FLUORO-5-MORPHOLIN-4-YL-N-[1-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-6-YL]BENZAMIDE,CPFBZMFUCGHBAP-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
159343,7bv1,DB04016,-8.8,2-[3-({Methyl[1-(2-Naphthoyl)Piperidin-4-Yl]Amino}Carbonyl)-2-Naphthyl]-1-(1-Naphthyl)-2-Oxoethylphosphonic Acid,XUJQPDQURBZEGJ-KXQOOQHDSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59048,6crv,DB07015,-8.8,"(3R,4R)-4-(pyrrolidin-1-ylcarbonyl)-1-(quinoxalin-2-ylcarbonyl)pyrrolidin-3-amine",XDSKICAQKGYYJF-OLZOCXBDSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
134088,6w9c,DB02547,-8.8,Guanosine-5'-Diphosphate-Rhamnose,LQEBEXMHBLQMDB-GDJBGNAASA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
25777,6cs2,DB03788,-8.8,GC-24,JYHIGYLGYNCMGI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
161080,7bv1,DB12854,-8.8,BMS-908662,MMNNTJYFHUDSKL-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
134107,6w9c,DB02573,-8.8,"2'-Deoxycytidine-2'-Deoxyadenosine-3',5'-Monophosphate",LYWWDKIADIGKTH-IDMWBNCISA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
158155,7bv1,DB00444,-8.8,Teniposide,NRUKOCRGYNPUPR-QBPJDGROSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
62490,6crv,DB13651,-8.8,Lorajmine,LAHDERDHXJFFJU-ZWNKPRIXSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
131272,6w4h,DB13520,-8.8,Metergoline,WZHJKEUHNJHDLS-QTGUNEKASA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
94991,6m71,DB08772,-8.8,"3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL-2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID",BCSVCWVQNOXFGL-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
58687,6crv,DB06397,-8.8,Nicaraven,KTXBOOWDLPUROC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84980,6m3m,DB07125,-8.8,"4-(6-{[(1R)-1-(hydroxymethyl)propyl]amino}imidazo[1,2-b]pyridazin-3-yl)benzoic acid",KKZYGUVAFJCULH-CYBMUJFWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
160631,7bv1,DB08875,-8.8,Cabozantinib,ONIQOQHATWINJY-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
85593,6m3m,DB07839,-8.8,"N-2-1,3-BENZOXAZOL-2-YL-3-CYCLOHEXYL-N-{2-[(4-METHOXYPHENYL)AMINO]ETHYL}-L-ALANINAMIDE",VFNWTXUFNNOQHD-QFIPXVFZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
62477,6crv,DB13631,-8.8,Methoserpidine,ULBNWNUHGJLQHO-VKMIBBQISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
97194,6m71,DB14067,-8.8,Dofequidar,KLWUUPVJTLHYIM-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
131250,6w4h,DB13490,-8.8,Hidrosmin,XYFLWVOTXWXNAM-WTNNCJBMSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
132151,6w4h,DB03453,-8.8,Methyl (2S)-2-[[2-[(3R)-1-carbamimidoylpiperidin-3-yl]acetyl]amino]-3-[4-(2-phenylethynyl)phenyl]propanoate,MRNGXYMKYHNMLV-PKTZIBPZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
65587,6lxt,DB03038,-8.8,LY341770,MXAFDBCLWLMXSI-ZDUSSCGKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
87639,6m3m,DB12621,-8.8,ST-101,QZWYXEBIQWJXAR-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
14117,6lzg,T3D3734,-8.8,Penitrem C,BVVRIERIEDMORG-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
114405,6vxx,DB13397,-8.8,Prenoxdiazine,PXZDWASDNFWKSD-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
67463,6lxt,DB06745,-8.8,ginkgolide-C,AMOGMTLMADGEOQ-DTDWCABLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
58642,6crv,DB06257,-8.8,HE-2200,OEVZKEVBDIDVOI-YSZCXEEOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60032,6crv,DB08151,-8.8,"(5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-phenyl-1,6-dioxa-2-azaspiro[4.5]dec-2-ene-8,9,10-triol",YLTDNVVQKRHCJP-RKQHYHRCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
66154,6lxt,DB03802,-8.8,"1-[4-(Octahydro-Pyrido[1,2-a]Pyrazin-2-Yl)-Phenyl]-2-Phenyl-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol",ZGHFWBDHZZKWSI-LITSAYRRSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
96282,6m71,DB12669,-8.8,4SC-203,MAFACRSJGNJHCF-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
66758,6lxt,DB04607,-8.8,"PHENYLAMINOIMIDAZO(1,2-ALPHA)PYRIDINE",UQAWGIKJINAKIZ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
131910,6w4h,DB15003,-8.8,PF-06700841,BUWBRTXGQRBBHG-MJBXVCDLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
85313,6m3m,DB07511,-8.8,"4-(4-methyl-1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)benzonitrile",MVYDBJXCIFMINH-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87200,6m3m,DB11978,-8.8,Glasdegib,SFNSLLSYNZWZQG-VQIMIIECSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
131908,6w4h,DB14995,-8.8,NP-G2-044,XLLRLAABUFOJPC-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
102271,6vxs,DB07204,-8.8,"(1S)-1-(1H-INDOL-3-YLMETHYL)-2-(2-PYRIDIN-4-YL-[1,7]NAPHTYRIDIN-5-YLOXY)-EHYLAMINE",DQIXTEDFNFZMCM-SFHVURJKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
87306,6m3m,DB12131,-8.8,Vinpocetine,DDNCQMVWWZOMLN-IRLDBZIGSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
62777,6crv,DB14127,-8.8,Sacubitrilat,DOBNVUFHFMVMDB-BEFAXECRSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
66820,6lxt,DB04690,-8.8,Camptothecin,VSJKWCGYPAHWDS-FQEVSTJZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
160822,7bv1,DB11775,-8.8,PF-03758309,AYCPARAPKDAOEN-LJQANCHMSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96331,6m71,DB12743,-8.8,Z-160,VCPMZDWBEWTGNW-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
87195,6m3m,DB11967,-8.8,Binimetinib,ACWZRVQXLIRSDF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
95951,6m71,DB12186,-8.8,SRT-2104,LAMQVIQMVKWXOC-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96339,6m71,DB12756,-8.8,TAK-901,WKDACQVEJIVHMZ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95950,6m71,DB12185,-8.8,Exatecan,ZVYVPGLRVWUPMP-FYSMJZIKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
66825,6lxt,DB04698,-8.8,"N-(1,4-DIHYDRO-5H-TETRAZOL-5-YLIDENE)-9-OXO-9H-XANTHENE-2-SULFONAMIDE",HJWYZPGYPZNDTN-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
158862,7bv1,DB02555,-8.8,SP4160,VCXMTWSYQSVWRK-AREMUKBSSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
87317,6m3m,DB12148,-8.8,Menatetrenone,DKHGMERMDICWDU-GHDNBGIDSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
158855,7bv1,DB02547,-8.8,Guanosine-5'-Diphosphate-Rhamnose,LQEBEXMHBLQMDB-GDJBGNAASA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
131885,6w4h,DB14918,-8.8,Branaplam,STWTUEAWRAIWJG-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
160835,7bv1,DB11793,-8.8,Niraparib,PCHKPVIQAHNQLW-CQSZACIVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
87298,6m3m,DB12122,-8.8,Figopitant,HUTHJVYJUPXHDF-DEOSSOPVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
159086,7bv1,DB03126,-8.8,Mant-Adp,QPKUEBLEGWBRHC-BFHYXJOUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96271,6m71,DB12655,-8.8,Patidegib,HZLFFNCLTRVYJG-WWGOJCOQSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
102379,6vxs,DB07326,-8.8,"6-chloro-N-pyrimidin-5-yl-3-{[3-(trifluoromethyl)phenyl]amino}-1,2-benzisoxazole-7-carboxamide",FEGRQUWSKADGSP-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
25682,6cs2,DB03678,-8.8,"(6,7-Difluoro-Quinazolin-4-Yl)-(1-Methyl-2,2-Diphenyl-Ethyl)-Amine",WVGZKPGUHOZIJQ-HNNXBMFYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
131961,6w4h,DB15106,-8.8,Surufatinib,TTZSNFLLYPYKIL-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
87229,6m3m,DB12021,-8.8,Dinaciclib,PIMQWRZWLQKKBJ-SFHVURJKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
60132,6crv,DB08281,-8.8,"O-[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethyl] (4-bromophenyl)thiocarbamate",BDVAWAILQCYMQE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
129096,6w4h,DB08387,-8.8,2-{[4-(1-methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline,AZEXWHKOMMASPA-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
158973,7bv1,DB02705,-8.8,"6-[N-(1-Isopropyl-1,2,3,4-Tetrahydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine",DARQQJKHXPXSRO-QFIPXVFZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96212,6m71,DB12558,-8.8,AEE-788,OONFNUWBHFSNBT-HXUWFJFHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60158,6crv,DB08309,-8.8,3-({2-[(4-{[6-(CYCLOHEXYLMETHOXY)-9H-PURIN-2-YL]AMINO}PHENYL)SULFONYL]ETHYL}AMINO)PROPAN-1-OL,AMFGILNPFBVREA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
25699,6cs2,DB03701,-8.8,Vanoxerine,NAUWTFJOPJWYOT-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
102570,6vxs,DB07550,-8.8,"2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(1-OXIDO-2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUOROPHENYL)METHYL]ACETAMIDE",ZIGSBBKEPNQXRG-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
62827,6crv,DB14512,-8.8,Mometasone furoate,WOFMFGQZHJDGCX-ZULDAHANSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
102319,6vxs,DB07261,-8.8,"THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [1-(1-AMINO-ISOQUINOLIN-7-YLMETHYL)-2-OXO-PYRROLDIN-3-YL]-AMIDE",NVKDOURNRJCKJE-INIZCTEOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
131928,6w4h,DB15039,-8.8,ITI-214,BBIPVJCGIASXJB-PKTZIBPZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
87276,6m3m,DB12093,-8.8,Tetrahydropalmatine,AEQDJSLRWYMAQI-KRWDZBQOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
102314,6vxs,DB07256,-8.8,"3-({4-[(5-CHLORO-1,3-BENZODIOXOL-4-YL)AMINO]PYRIMIDIN-2-YL}AMINO)BENZAMIDE",ZVQZIVCQLFGXFZ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
62812,6crv,DB14210,-8.8,Moexiprilat,CMPAGYDKASJORH-YSSFQJQWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58908,6crv,DB06849,-8.8,"1-[1'-(3-phenylacryloyl)spiro[1-benzofuran-3,4'-piperidin]-5-yl]methanamine",RQWYWHUKHYFIPB-VQHVLOKHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
102460,6vxs,DB07422,-8.8,(2S)-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]-3-(pentafluorophenoxy)propanamide,MMNRWNREMUMYQG-INIZCTEOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
129147,6w4h,DB08448,-8.8,"(4aS)-5-[(2,4-diaminopteridin-6-yl)methyl]-4a,5-dihydro-2H-dibenzo[b,f]azepin-8-ol",PCBWLKUEKANDCL-INIZCTEOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
133500,6w9c,DB01765,-8.8,"(5-Oxo-5,6-Dihydro-Indolo[1,2-a]Quinazolin-7-Yl)-Acetic Acid",INSBKYCYLCEBOD-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
102467,6vxs,DB07430,-8.8,"(10R)-10-methyl-3-(6-methylpyridin-3-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one",CMWRPDHVGMHLSZ-GFCCVEGCSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
96220,6m71,DB12571,-8.8,Rimacalib,MYTIJGWONQOOLC-HNNXBMFYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
58778,6crv,DB06622,-8.8,7-beta-Hydroxyepiandrosterone,VFPMCLQMAUVEHD-UCPSWNCLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58862,6crv,DB06771,-8.8,Besifloxacin,QFFGVLORLPOAEC-SNVBAGLBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58983,6crv,DB06933,-8.8,N-(tert-butyl)-4-[5-(pyridin-2-ylamino)quinolin-3-yl]benzenesulfonamide,GJTCKUKIFXWJKG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
67087,6lxt,DB05454,-8.8,Paliroden,CNEWKIDCGDXBDE-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
25599,6cs2,DB03572,-8.8,FR230513,URGFTPMACWKJKU-OAHLLOKOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
60050,6crv,DB08169,-8.8,(2Z)-N-biphenyl-4-yl-2-cyano-3-cyclopropyl-3-hydroxyprop-2-enamide,CAGGGMPTWTUYHZ-ZCXUNETKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
102759,6vxs,DB07778,-8.8,FAMOXADONE,PCCSBWNGDMYFCW-QFIPXVFZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
131826,6w4h,DB14790,-8.8,BPN-14770,KRRGWHSEDYQKDQ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
87156,6m3m,DB11911,-8.8,Galunisertib,IVRXNBXKWIJUQB-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
131818,6w4h,DB14770,-8.8,Lanraplenib,XCIGZBVOUQVIPI-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
85143,6m3m,DB07311,-8.8,"18-CHLORO-11,12,13,14-TETRAHYDRO-1H,10H-8,4-(AZENO)-9,15,1,3,6-BENZODIOXATRIAZACYCLOHEPTADECIN-2-ONE",JRSWWYITYIOHOP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
15915,6lzg,DB01879,-8.8,(S)-2-{Methyl-[2-(Naphthalene-2-Sulfonylamino)-5-(Naphthalene-2-Sulfonyloxy)-Benzoyl]-Amino}-Succinicacid,JOAALZBSMWLOPQ-LJAQVGFWSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
85132,6m3m,DB07300,-8.8,"2-(1H-imidazol-1-yl)-9-methoxy-8-(2-methoxyethoxy)benzo[c][2,7]naphthyridin-4-amine",QSSGYSRUMIOURP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
133819,6w9c,DB02197,-8.8,"4-[(4-Imidazo[1,2-a]Pyridin-3-Ylpyrimidin-2-Yl)Amino]Benzenesulfonamide",NKORVPQBJCGYEC-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
85471,6m3m,DB07701,-8.8,"1-BENZYL-4-[(5,6-DIMETHOXY-1-INDANON-2-YL)METHYL]PIPERIDINE",ADEBPBSSDYVVLD-HXUWFJFHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
158598,7bv1,DB01678,-8.8,RU84687,SAFPHFWYRLLBFO-NSOVKSMOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
128235,6w4h,DB07369,-8.8,"N-(3-chlorophenyl)-N-methyl-2-oxo-3-[(3,4,5-trimethyl-1H-pyrrol-2-yl)methyl]-2H-indole-5-sulfonamide",YMJLSOJLEXWATP-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
67150,6lxt,DB05812,-8.8,Abiraterone,GZOSMCIZMLWJML-VJLLXTKPSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
129189,6w4h,DB08498,-8.8,"(1S)-1-(3-chlorophenyl)-2-oxo-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate",OVSAMUIBGQSLDC-INIZCTEOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
59001,6crv,DB06959,-8.8,(2S)-1-(3H-Indol-3-yl)-3-{[5-(6-isoquinolinyl)-3-pyridinyl]oxy}-2-propanamine,BUCZDJYEOAQTHL-KEKNWZKVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
67155,6lxt,DB05835,-8.8,NS-3728,OQRAKHDEGGGWQO-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
85102,6m3m,DB07268,-8.8,2-({2-[(3-HYDROXYPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)BENZAMIDE,QHPKKGUGRGRSGA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
62682,6crv,DB13941,-8.8,Piperaquine,UCRHFBCYFMIWHC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60304,6crv,DB08489,-8.8,"N4-HYDROXY-2-ISOBUTYL-N1-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.013,18]NONADECA-12(19),13,15,17-TETRAEN-10-YL)-SUCCINAMIDE",GCBPAPVOMPJQHK-NQIIRXRSSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
102160,6vxs,DB07078,-8.8,"(3Z)-6-(4-HYDROXY-3-METHOXYPHENYL)-3-(1H-PYRROL-2-YLMETHYLENE)-1,3-DIHYDRO-2H-INDOL-2-ONE",AYSXURJZVXBSRV-WJDWOHSUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
67080,6lxt,DB05423,-8.8,ORG-34517,DFELGYQKEOCHOA-BZAFBGKRSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
26556,6cs2,DB04715,-8.8,IMIDAZOPYRIDAZIN 1,IVUBNTNWKIPCPS-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
160928,7bv1,DB12282,-8.8,Defactinib,FWLMVFUGMHIOAA-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
102598,6vxs,DB07586,-8.8,"5-(4-METHYL-BENZOYLAMINO)-BIPHENYL-3,4'-DICARBOXYLIC ACID 3-DIMETHYLAMIDE-4'-HYDROXYAMIDE",DOPFUKKMSDUVTQ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
141639,6w9q,DB01126,-8.8,Dutasteride,JWJOTENAMICLJG-QWBYCMEYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
58847,6crv,DB06741,-8.8,Gavestinel,WZBNEZWCNKUOSM-VOTSOKGWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87324,6m3m,DB12158,-8.8,Filorexant,NPFDWHQSDBWQLH-QZTJIDSGSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87191,6m3m,DB11963,-8.8,Dacomitinib,LVXJQMNHJWSHET-AATRIKPKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87188,6m3m,DB11960,-8.8,Carboxyamidotriazole,WNRZHQBJSXRYJK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85424,6m3m,DB07643,-8.8,"5-{[1-(2,3-dichlorobenzyl)piperidin-4-yl]methoxy}quinazoline-2,4-diamine",XVLUVRFYGVJKGJ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
102646,6vxs,DB07643,-8.8,"5-{[1-(2,3-dichlorobenzyl)piperidin-4-yl]methoxy}quinazoline-2,4-diamine",XVLUVRFYGVJKGJ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
158818,7bv1,DB02258,-8.8,SR11254,RNZIUDLOJHVHLZ-VYIQYICTSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60068,6crv,DB08192,-8.8,2-(4-CARCOXY-5-ISOPROPYLTHIAZOLYL)BENZOPIPERIDINE,HCUGCUQZFBURHR-LBPRGKRZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60215,6crv,DB08382,-8.8,Gosogliptin,QWEWGXUTRTXFRF-KBPBESRZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
133733,6w9c,DB02081,-8.8,Bis-Benzamidine,BXYGSMRTHHSAHZ-PMACEKPBSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
85432,6m3m,DB07651,-8.8,N-ACETYL-L-PHENYLALANYL-4-[DIFLUORO(PHOSPHONO)METHYL]-L-PHENYLALANINAMIDE,KPMMESISHWWXNM-ROUUACIJSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
62749,6crv,DB14068,-8.8,Dexniguldipine,SVJMLYUFVDMUHP-MGBGTMOVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
145846,6w9q,DB07827,-8.8,"4-{[1-METHYL-2,4-DIOXO-6-(3-PHENYLPROP-1-YN-1-YL)-1,4-DIHYDROQUINAZOLIN-3(2H)-YL]METHYL}BENZOIC ACID",FLTYDFYSVZBKOB-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
131853,6w4h,DB14859,-8.8,Fosifloxuridine nafalbenamide,BIOWRMNRHMERIO-ZVAHOJSLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
95809,6m71,DB11971,-8.8,Vilaprisan,JUFWQQVHQFDUOD-ANRPBIDPSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
85441,6m3m,DB07665,-8.8,"N-[2-(carbamimidamidooxy)ethyl]-2-{6-cyano-3-[(2,2-difluoro-2-pyridin-2-ylethyl)amino]-2-fluorophenyl}acetamide",STHCHQXQLDMISY-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
95777,6m71,DB11925,-8.8,Vistusertib,JUSFANSTBFGBAF-IRXDYDNUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
85450,6m3m,DB07676,-8.8,"3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)-1H,2'H-2,3'-biindol-2'-one",CKLAPOFDFZKCPB-LBPRGKRZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
62918,6crv,DB14718,-8.8,Pyrazolam,BGRWSFIQQPVEML-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
133444,6w9c,DB01691,-8.8,Indole Naphthyridinone,VAZMNDXVXVUKFY-JXMROGBWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
85430,6m3m,DB07649,-8.8,"(3R,4S)-1-[(4-amino-5H-pyrrolo[3,2-d]pyrimidin-7-yl)methyl]-4-[(benzylsulfanyl)methyl]pyrrolidin-3-ol",DIGGNILBPCEZIV-CVEARBPZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
104431,6vxs,DB11992,-8.8,Omarigliptin,MKMPWKUAHLTIBJ-ISTRZQFTSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
15717,6lzg,DB00932,-8.8,Tipranavir,SUJUHGSWHZTSEU-FYBSXPHGSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
103412,6vxs,DB08546,-8.8,"4-[(3AS,4R,7R,8AS,8BR)-2-(1,3-BENZODIOXOL-5-YLMETHYL)-7-HYDROXY-1,3-DIOXODECAHYDROPYRROLO[3,4-A]PYRROLIZIN-4-YL]BENZENECARBOXIMIDAMIDE",CETLUACQMGBMFH-ZALSBGIRSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104256,6vxs,DB11737,-8.8,Icotinib,QQLKULDARVNMAL-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101466,6vxs,DB05075,-8.8,TG-100801,JMGXJHWTVBGOKG-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
144849,6w9q,DB06555,-8.8,Siramesine,XWAONOGAGZNUSF-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
97635,6m71,DB15305,-8.8,Risdiplam,ASKZRYGFUPSJPN-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
101434,6vxs,DB04942,-8.8,Tamibarotene,MUTNCGKQJGXKEM-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
58464,6crv,DB05416,-8.8,Cardarine,YDBLKRPLXZNVNB-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61039,6crv,DB11409,-8.8,Febantel,HMCCXLBXIJMERM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84591,6m3m,DB06579,-8.8,Adipiplon,UAMAIHOEGLEXSV-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88144,6m3m,DB13403,-8.8,Oxypertine,XCWPUUGSGHNIDZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85855,6m3m,DB08138,-8.8,"{[(2,6-difluorophenyl)carbonyl]amino}-N-(4-fluorophenyl)-1H-pyrazole-3-carboxamide",BDRDBXXWQDFXEC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
93545,6m71,DB07072,-8.8,"(1S,2R,5S)-5-[3-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7(8H)-YL]-2-(2,4,5-TRIFLUOROPHENYL)CYCLOHEXANAMINE",CNKRZILQBKJWDS-WMFXKJRFSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
104302,6vxs,DB11800,-8.8,Tivozanib,SPMVMDHWKHCIDT-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
133106,6w9c,DB01212,-8.8,Ceftriaxone,VAAUVRVFOQPIGI-SPQHTLEESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
144783,6w9q,DB06393,-8.8,Xaliproden,WJJYZXPHLSLMGE-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
15475,6lzg,T3D1044,-8.8,Emamectin B1b,DXIOOXFZLKCVHK-UTAOKEBVSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
128842,6w4h,DB08079,-8.8,AMG-208,HEAIZQNMNCHNFD-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
85864,6m3m,DB08148,-8.8,"1-[4-(4-chlorophenyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine",QOZMRRGNAZNWDN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
62078,6crv,DB13052,-8.8,Upamostat,HUASEDVYRABWCV-NDEPHWFRSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
101403,6vxs,DB04875,-8.8,Pralnacasan,CXAGHAZMQSCAKJ-WAHHBDPQSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
25192,6cs2,DB03072,-8.8,"2-{3-[4-(4-Fluorophenyl)-3,6-Dihydro-1(2h)-Pyridinyl]Propyl}-8-Methyl-4(3h)-Quinazolinone",LOFDUAJQRUYHBR-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
64596,6lxt,DB01721,-8.8,Analogue of Indinavir Drug,MJIRDPUZGGHJMX-OIVSQUILSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
104253,6vxs,DB11734,-8.8,Fedovapagon,RUOLFWZIFNQQGH-DEOSSOPVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
12166,6lzg,DB12978,-8.8,Pexidartinib,JGWRKYUXBBNENE-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
166568,7bv1,DB15396,-8.8,PF-114,SLIVDYMORZGPLW-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59170,6crv,DB07154,-8.8,"(3R)-4-[(3R)-3-AMINO-4-(2,4,5-TRIFLUOROPHENYL)BUTANOYL]-3-METHYL-1,4-DIAZEPAN-2-ONE",SWKGZJAAGSVROJ-MWLCHTKSSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62136,6crv,DB13138,-8.8,Neladenoson bialanate,WESNEIGKOAXSGX-VXKWHMMOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
128441,6w4h,DB07616,-8.8,"4-{[4-(4-fluoro-3-methylphenyl)-1,3-thiazol-2-yl]amino}-2-hydroxybenzoic acid",LKZZDHKJFDTYCH-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
15530,6lzg,DB00137,-8.8,Lutein,KBPHJBAIARWVSC-RGZFRNHPSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
86860,6m3m,DB11385,-8.8,Cefalonium,FMZXNVLFJHCSAF-DNVCBOLYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
63078,6crv,DB15092,-8.8,LY-2624803,UEFWDVMEDFCHGW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
24421,6cs2,DB02155,-8.8,Balanol Analog 8,XVLMXAUKCDSMMW-YXLARRHKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
26314,6cs2,DB04432,-8.8,ZK-805623,ZXIHYCYAQUQHSG-UHFFFAOYSA-O,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
93702,6m71,DB07255,-8.8,"N'-(5-CHLORO-1,3-BENZODIOXOL-4-YL)-N-(3-MORPHOLIN-4-YLPHENYL)PYRIMIDINE-2,4-DIAMINE",PNEWIQAEGKQNCE-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
15514,6lzg,T3D1188,-8.8,Chlorophyllin,UVOXKYYHMDAWNK-UHFFFAOYSA-L,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
68023,6lxt,DB07430,-8.8,"(10R)-10-methyl-3-(6-methylpyridin-3-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one",CMWRPDHVGMHLSZ-GFCCVEGCSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
59802,6crv,DB07891,-8.8,"4-{[(14beta,17alpha)-3-hydrox1tra-1,3,5(10)-trien-17-yl]oxy}-4-oxobutanoic acid",YJPIDPAGJSWWBE-FNIAAEIWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
63082,6crv,DB15099,-8.8,GW-468816,XDKRVNKVAKCFGW-WXWBBQJKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
156171,6wiq,DB12513,-8.8,Omaveloxolone,RJCWBNBKOKFWNY-IDPLTSGASA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
60983,6crv,DB11259,-8.8,Diosmetin,MBNGWHIJMBWFHU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
161456,7bv1,DB14844,-8.8,ONC-201,VLULRUCCHYVXOH-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
147293,6w9q,DB11732,-8.8,Lasmiditan,XEDHVZKDSYZQBF-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
62110,6crv,DB13097,-8.8,1alpha-Hydroxyvitamin D5,NWFOBODUYTUMNC-VPSCEVSQSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62100,6crv,DB13083,-8.8,Talarozole,SNFYYXUGUBUECJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104235,6vxs,DB11701,-8.8,Amenamevir,MNHNIVNAFBSLLX-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
93651,6m71,DB07193,-8.8,"(2R,3R)-7-(methylsulfonyl)-3-(2,4,5-trifluorophenyl)-1,2,3,4-tetrahydropyrido[1,2-a]benzimidazol-2-amine",HJJAYSSCWGUPKO-ABAIWWIYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
14377,6lzg,T3D4061,-8.8,Veratridine,FVECELJHCSPHKY-UIHGVQCZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
84618,6m3m,DB06629,-8.8,Zibotentan,FJHHZXWJVIEFGJ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
62122,6crv,DB13114,-8.8,Amitriptylinoxide,ZPMKQFOGINQDAM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84686,6m3m,DB06746,-8.8,ginkgolide-J,LMEHVEUFNRJAAV-UKWFQYJJSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
93467,6m71,DB06985,-8.8,2-[({4-[2-(trifluoromethyl)phenyl]piperidin-1-yl}carbonyl)amino]benzoic acid,MEAQCLPMSVEOQF-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
128081,6w4h,DB07193,-8.8,"(2R,3R)-7-(methylsulfonyl)-3-(2,4,5-trifluorophenyl)-1,2,3,4-tetrahydropyrido[1,2-a]benzimidazol-2-amine",HJJAYSSCWGUPKO-ABAIWWIYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
61093,6crv,DB11519,-8.8,Fluprostenol,WWSWYXNVCBLWNZ-QIZQQNKQSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130613,6w4h,DB12513,-8.8,Omaveloxolone,RJCWBNBKOKFWNY-IDPLTSGASA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
58421,6crv,DB05134,-8.8,Tanespimycin,AYUNIORJHRXIBJ-TXHRRWQRSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
128044,6w4h,DB07152,-8.8,N-[4-(5-fluoro-6-methylpyridin-2-yl)-5-quinoxalin-6-yl-1H-imidazol-2-yl]acetamide,TYPILNNEZPSNTI-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
93204,6m71,DB06581,-8.8,Bevirimat,YJEJKUQEXFSVCJ-WRFMNRASSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
159708,7bv1,DB05416,-8.8,Cardarine,YDBLKRPLXZNVNB-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
64550,6lxt,DB01661,-8.8,1-(5-phospho-D-ribosyl)-ATP,RKNHJBVBFHDXGR-MRUDJCSFSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
88301,6m3m,DB13616,-8.8,Melagatran,DKWNMCUOEDMMIN-PKOBYXMFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
135011,6w9c,DB03865,-8.8,6-Chloro-2-(2-Hydroxy-Biphenyl-3-Yl)-1h-Indole-5-Carboxamidine,FEKRWNWZMOSVBX-UHFFFAOYSA-O,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
26856,6cs2,DB05552,-8.8,TG100-115,UJIAQDJKSXQLIT-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
30027,6cs2,DB11950,-8.8,Teneligliptin,WGRQANOPCQRCME-PMACEKPBSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
61127,6crv,DB11619,-8.8,Gestrinone,BJJXHLWLUDYTGC-ANULTFPQSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59757,6crv,DB07838,-8.8,(Z)-3-BENZYL-5-(2-HYDROXY-3-NITROBENZYLIDENE)-2-THIOXOTHIAZOLIDIN-4-ONE,ZTWBCEZQPRYIGY-ZROIWOOFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62022,6crv,DB12962,-8.8,CP-547632,HXHAJRMTJXHJJZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
135055,6w9c,DB03921,-8.8,4-(3-Pyridin-2-Yl-1h-Pyrazol-4-Yl)Quinoline,IBCXZJCWDGCXQT-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
135073,6w9c,DB03944,-8.8,"5-[1-(3,4-Dimethoxy-Benzoyl)-1,2,3,4-Tetrahydro-Quinolin-6-Yl]-6-Methyl-3,6-Dihydro-[1,3,4]Thiadiazin-2-One",IZLRMTJLQCLMKF-CYBMUJFWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
147461,6w9q,DB11971,-8.8,Vilaprisan,JUFWQQVHQFDUOD-ANRPBIDPSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
159741,7bv1,DB05553,-8.8,Regrelor,NXHAXEBZOXCDKD-XIXRRVGJSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
86686,6m3m,DB09226,-8.8,RP-5063,PMKMNTBZJOXTJW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
62006,6crv,DB12938,-8.8,Isoxaflutole,OYIKARCXOQLFHF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
101316,6vxs,DB04764,-8.8,[4-(3-AMINOMETHYL-PHENYL)-PIPERIDIN-1-YL]-(5-PHENETHYL- PYRIDIN-3-YL)-METHANONE,CCLHROFBSWWOQO-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
62047,6crv,DB13004,-8.8,Mavoglurant,ZFPZEYHRWGMJCV-ZHALLVOQSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61090,6crv,DB11511,-8.8,Difloxacin,NOCJXYPHIIZEHN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
97675,6m71,DB15396,-8.8,PF-114,SLIVDYMORZGPLW-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
61089,6crv,DB11507,-8.8,Cloprostenol,VJGGHXVGBSZVMZ-QIZQQNKQSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61059,6crv,DB11443,-8.8,Orbifloxacin,QIPQASLPWJVQMH-DTORHVGOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84555,6m3m,DB06472,-8.8,Fradafiban,IKZACQMAVUIGPY-HOTGVXAUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58446,6crv,DB05289,-8.8,Tarenflurbil,SYTBZMRGLBWNTM-SNVBAGLBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84549,6m3m,DB06460,-8.8,Enrasentan,GLCKXJLCYIJMRB-UPRLRBBYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
132421,6w9c,DB00408,-8.8,Loxapine,XJGVXQDUIWGIRW-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
64572,6lxt,DB01690,-8.8,Bis(Adenosine)-5'-Triphosphate,QCICUPZZLIQAPA-XPWFQUROSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
144769,6w9q,DB06334,-8.8,Tucidinostat,SZMJVTADHFNAIS-BJMVGYQFSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
68190,6lxt,DB07629,-8.8,"N-((1R,2S)-2-(5-CHLORO-1H-INDOLE-2-CARBOXAMIDO)CYCLOHEXYL)-5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE-2-CARBOXAMIDE",ARPFWVKYXJZULB-DLBZAZTESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
128070,6w4h,DB07181,-8.8,"4'-[(1R)-1-amino-2-(2,5-difluorophenyl)ethyl]biphenyl-3-carboxamide",JYKFWUXBFJJDTP-HXUWFJFHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
104343,6vxs,DB11863,-8.8,Alvelestat,QNQZWEGMKJBHEM-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
63104,6crv,DB15141,-8.8,Deutivacaftor,PURKAOJPTOLRMP-ASMGOKTBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
134907,6w9c,DB03723,-8.8,2'-Deoxy-Thymidine-Beta-L-Rhamnose,ZOSQFDVXNQFKBY-CGAXJHMRSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
62066,6crv,DB13029,-8.8,MK-0873,JJWKQXNHYDJXKF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86742,6m3m,DB09330,-8.8,Osimertinib,DUYJMQONPNNFPI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
155893,6wiq,DB11904,-8.8,Flumatinib,BJCJYEYYYGBROF-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
101390,6vxs,DB04859,-8.8,Zanapezil,PMBLXLOXUGVTGB-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
97673,6m71,DB15393,-8.8,Telatinib,QFCXANHHBCGMAS-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
101386,6vxs,DB04852,-8.8,Implitapide,AMNXBQPRODZJQR-DITALETJSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
147379,6w9q,DB11852,-8.8,Tegobuvir,XBEQSQDCBSKCHJ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
93381,6m71,DB06882,-8.8,1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-naphthalen-1-ylurea,HJWMLCDGRWWLAQ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
101385,6vxs,DB04850,-8.8,Posizolid,HBUJYEUPIIJJOS-PBHICJAKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
88240,6m3m,DB13533,-8.8,Methylestrenolone,ZXSWTMLNIIZPET-ZOFHRBRSSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59794,6crv,DB07878,-8.8,"N-[(1S)-1-{1-[(1R,3E)-1-ACETYLPENT-3-EN-1-YL]-1H-1,2,3-TRIAZOL-4-YL}-1,2-DIMETHYLPROPYL]BENZAMIDE",OEHUTYXPQSSKAK-RVLLMHTFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62983,6crv,DB14870,-8.8,PF-5190457,ZIUDADZJCKGWKR-AREMUKBSSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
64945,6lxt,DB02194,-8.8,"8-Benzyl-2-Hydroxy-2-(4-Hydroxy-Benzyl)-6-(4-Hydroxy-Phenyl)-2h-Imidazo[1,2-a]Pyrazin-3-One",ULLMMKZQNNBLRN-SANMLTNESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
62141,6crv,DB13155,-8.8,Esculin,XHCADAYNFIFUHF-TVKJYDDYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130948,6w4h,DB13042,-8.8,Fenoverine,UBAJTZKNDCEGKL-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
101719,6vxs,DB06306,-8.8,Onalespib,IFRGXKKQHBVPCQ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101716,6vxs,DB06295,-8.8,Pramiconazole,AEKNYBWUEYNWMJ-QWOOXDRHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
128143,6w4h,DB07268,-8.8,2-({2-[(3-HYDROXYPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)BENZAMIDE,QHPKKGUGRGRSGA-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
25364,6cs2,DB03268,-8.8,RU82197,WKTQBTSOHBKBRW-VMPREFPWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
132287,6w9c,DB00247,-8.8,Methysergide,KPJZHOPZRAFDTN-NQUBZZJWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
103602,6vxs,DB08772,-8.8,"3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL-2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID",BCSVCWVQNOXFGL-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
13547,6lzg,DB01200,-8.8,Bromocriptine,OZVBMTJYIDMWIL-AYFBDAFISA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
60688,6crv,DB08979,-8.8,Fenspiride,FVNFBBAOMBJTST-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62301,6crv,DB13393,-8.8,Emetine,AUVVAXYIELKVAI-CKBKHPSWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85714,6m3m,DB07982,-8.8,2-{4-[4-({4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]pyrimidin-2-yl}amino)phenyl]piperazin-1-yl}-2-oxoethanol,PVTKDXZNSUHUMO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
103644,6vxs,DB08822,-8.8,Azilsartan medoxomil,QJFSABGVXDWMIW-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
85719,6m3m,DB07987,-8.8,"[2-(5-MERCAPTO-[1,3,4]THIADIAZOL-2-YLCARBAMOYL)-1-PHENYL-ETHYL]-CARBAMIC ACID BENZYL ESTER",AWAKNMKLVLWIIQ-OAHLLOKOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85732,6m3m,DB08001,-8.8,5-(3-{3-[3-HYDROXY-2-(METHOXYCARBONYL)PHENOXY]PROPENYL}PHENYL)-4-(HYDROXYMETHYL)ISOXAZOLE-3-CARBOXYLIC ACID,DQSRCEFDWMQCCV-GQCTYLIASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
97485,6m71,DB15013,-8.8,TAK-243,KJDAGXLMHXUAGV-DGWLBADLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
134441,6w9c,DB03081,-8.8,Crc200 (Chiron-Behring),ZOXOKTJHZSUHRJ-XZOQPEGZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
101640,6vxs,DB06137,-8.8,KX-01,HUNGUWOZPQBXGX-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
94337,6m71,DB07994,-8.8,"N-3-[5-(1H-INDOL-6-YL)-2-(PYRIDIN-2-YLMETHOXY)BENZYL]PYRIDINE-2,3-DIAMINE",KMBPJSHPAXOXBT-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
25338,6cs2,DB00398,-8.8,Sorafenib,MLDQJTXFUGDVEO-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
159599,7bv1,DB04623,-8.8,"2-ETHOXYETHYL (2S,3S)-4-((S)-2-BENZYL-3-OXO-4-((3AR,8R,8AS)-2-OXO-3,3A,8,8A-TETRAHYDRO-2H-INDENO[1,2-D]OXAZOL-8-YL)-2,3-DIHYDRO-1H-PYRROL-2-YL)-3-HYDROXY-1-PHENYLBUTAN-2-YLCARBAMATE",CGBRFCVAMLJVEA-ZGURCIGKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
62257,6crv,DB13335,-8.8,Pinazepam,MFZOSKPPVCIFMT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
67667,6lxt,DB07022,-8.8,3-Hydroxypropyl 3-[(7-carbamimidoyl-1-naphthyl)carbamoyl]benzenesulfonate,PXERBGNIBOFZOW-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
60643,6crv,DB08916,-8.8,Afatinib,ULXXDDBFHOBEHA-CWDCEQMOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87756,6m3m,DB12805,-8.8,Ataciguat,PQHLRGARXNPFCF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
130979,6w4h,DB13088,-8.8,AZD-0424,MVWATCATLSSVBH-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
94719,6m71,DB08450,-8.8,N-1H-indazol-5-yl-2-(6-methylpyridin-2-yl)quinazolin-4-amine,HNHRWNUXTCATSG-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
25411,6cs2,DB03325,-8.8,Tyrosyladenylate,MJZAZMKENKZBAJ-QTOWJTHWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
134288,6w9c,DB02877,-8.8,Arotinoid acid,FOIVPCKZDPCJJY-JQIJEIRASA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
103453,6vxs,DB08597,-8.8,"6-[4-(2-piperidin-1-ylethoxy)phenyl]-3-pyridin-4-ylpyrazolo[1,5-a]pyrimidine",XHBVYDAKJHETMP-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
87708,6m3m,DB12725,-8.8,TD-8954,MZOITCJKGUIQEI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
97358,6m71,DB14703,-8.8,Dexamethasone metasulfobenzoate,TWQWRHIQRAZHPR-XNXCGYEVSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
87016,6m3m,DB11704,-8.8,Adomeglivant,FASLTMSUPQDLIB-MHZLTWQESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59086,6crv,DB07056,-8.8,"2-(6-{[(3-chloro-2-methylphenyl)sulfonyl]amino}pyridin-2-yl)-N,N-diethylacetamide",JNWQLOFSMUGRNY-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
161191,7bv1,DB13371,-8.8,Difenpiramide,PWHROYKAGRUWDQ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
62386,6crv,DB13506,-8.8,Carfecillin,NZDASSHFKWDBBU-KVMCETHSSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87850,6m3m,DB12949,-8.8,PF-03382792,AGMOFKKOVMRGAK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87713,6m3m,DB12732,-8.8,Firategrast,YLFZHHDVRSYTKT-NRFANRHFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
160596,7bv1,DB08815,-8.8,Lurasidone,PQXKDMSYBGKCJA-CVTJIBDQSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60613,6crv,DB08865,-8.8,Crizotinib,KTEIFNKAUNYNJU-GFCCVEGCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
13577,6lzg,DB01259,-8.8,Lapatinib,BCFGMOOMADDAQU-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
94666,6m71,DB08387,-8.8,2-{[4-(1-methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline,AZEXWHKOMMASPA-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94650,6m71,DB08366,-8.8,"3-({3-[(1S,4aS,6S,7S,9S,9aR)-1,6-dimethyl-2-oxodecahydro-6,9-epoxy-4a,7-methanobenzo[7]annulen-1-yl]propanoyl}amino)-2,4-dihydroxybenzoic acid",XADCWKSMHQPTGH-OFBLZTNGSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
86998,6m3m,DB11681,-8.8,Tofimilast,DHCOPPHTVOXDKU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86994,6m3m,DB11675,-8.8,Mosapride,YPELFRMCRYSPKZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
130982,6w4h,DB13093,-8.8,TAK-593,DZFZXPPHBWCXPQ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
101731,6vxs,DB06346,-8.8,Fiboflapon,DFQGDHBGRSTTHX-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
128149,6w4h,DB07274,-8.8,"N-cyclopropyl-6-[(6,7-dimethoxyquinolin-4-yl)oxy]naphthalene-1-carboxamide",ZATGFXTWDKIEKC-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
60597,6crv,DB08836,-8.8,Temocapril,FIQOFIRCTOWDOW-BJLQDIEVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
67935,6lxt,DB07326,-8.8,"6-chloro-N-pyrimidin-5-yl-3-{[3-(trifluoromethyl)phenyl]amino}-1,2-benzisoxazole-7-carboxamide",FEGRQUWSKADGSP-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
132334,6w9c,DB00301,-8.8,Flucloxacillin,UIOFUWFRIANQPC-JKIFEVAISA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
58584,6crv,DB06140,-8.8,SUVN-502,GWCYPEHWIZXYFZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
26329,6cs2,DB04452,-8.8,Aminoquinuride,HOUSDILKOJMENG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
94081,6m71,DB07700,-8.8,"3-CARBOXAMIDO-1,3,5(10)-ESTRATRIEN-17(R)-SPIRO-2'(5',5'-DIMETHYL-6'OXO)TETRAHYDROPYRAN",YVAJWBACBRSVPR-NDUHRLLKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
145033,6w9q,DB06882,-8.8,1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-naphthalen-1-ylurea,HJWMLCDGRWWLAQ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
65039,6lxt,DB02319,-8.8,"5,6-Dihydroxy-Nadp",LRAVAOPKUBJONV-IVCJQJMGSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
86917,6m3m,DB11485,-8.8,Ceftiofur,ZBHXIWJRIFEVQY-IHMPYVIRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
97576,6m71,DB15197,-8.8,RSV-604,MTPVBMVUENFFLL-HXUWFJFHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
85776,6m3m,DB08051,-8.8,"(2R)-4-(2-BENZOYL-1,2-DIAZEPAN-1-YL)-4-OXO-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE",XXRHRPGYYNOBHO-QGZVFWFLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
23941,6cs2,DB00246,-8.8,Ziprasidone,MVWVFYHBGMAFLY-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
25284,6cs2,DB03181,-8.8,"2-[4-(4-Hydroxy-3-Isopropyl-Phenoxy)-3,5-Dimethyl-Phenyl]-2h-[1,2,4]Triazine-3,5-Dione",RXQAVKWRCZYGMV-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
104042,6vxs,DB11262,-8.8,Bisoctrizole,FQUNFJULCYSSOP-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
94001,6m71,DB07605,-8.8,"2-({4-[(5-CHLORO-1H-INDOL-2-YL)SULFONYL]PIPERAZIN-1-YL}CARBONYL)THIENO[3,2-B]PYRIDINE 4-OXIDE",DHDQMXPAANQKDC-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
25277,6cs2,DB03173,-8.8,CRA_10433,CFSQPEBVGUSQII-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
128130,6w4h,DB07253,-8.8,"N'-(5-chloro-1,3-benzodioxol-4-yl)-N-(3-methylsulfonylphenyl)pyrimidine-2,4-diamine",QTFCKBFCXDAZIU-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
97595,6m71,DB15229,-8.8,CNV-2197944,BLFJGFDZMABYMY-ZDUSSCGKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
87962,6m3m,DB13119,-8.8,GSK-364735,QWLNINWUBHHOLU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
114673,6vxx,DB14634,-8.8,Fluprednidene acetate,DEFOZIFYUBUHHU-IYQKUMFPSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85795,6m3m,DB08073,-8.8,(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE,YWTBGJGMTBHQTM-IBGZPJMESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
134630,6w9c,DB03325,-8.8,Tyrosyladenylate,MJZAZMKENKZBAJ-QTOWJTHWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
86887,6m3m,DB11430,-8.8,Monensin,GAOZTHIDHYLHMS-KEOBGNEYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
93856,6m71,DB07430,-8.8,"(10R)-10-methyl-3-(6-methylpyridin-3-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one",CMWRPDHVGMHLSZ-GFCCVEGCSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160463,7bv1,DB08418,-8.8,"(4aS,4bR,10bS,12aS)-12a-methyl-1,3-dioxo-2-(pyridin-3-ylmethyl)-1,2,3,4,4a,4b,5,6,10b,11,12,12a-dodecahydronaphtho[2,1-f]isoquinolin-8-yl sulfamate",LSJKARAMQNGZDF-YOEKFXIASA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
87910,6m3m,DB13048,-8.8,PAC-1,YQNRVGJCPCNMKT-LFVJCYFKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
159642,7bv1,DB05016,-8.8,Ataluren,OOUGLTULBSNHNF-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97546,6m71,DB15133,-8.8,Tepotinib,AHYMHWXQRWRBKT-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
133187,6w9c,DB01357,-8.8,Mestranol,IMSSROKUHAOUJS-MJCUULBUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
60733,6crv,DB09034,-8.8,Suvorexant,JYTNQNCOQXFQPK-MRXNPFEDSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
161374,7bv1,DB13927,-8.8,anle138b,RCQIIBJSUWYYFU-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
87855,6m3m,DB12960,-8.8,INCB-9471,ZMCJFJZOSKEMOM-DNKZPPIMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87857,6m3m,DB12962,-8.8,CP-547632,HXHAJRMTJXHJJZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
67836,6lxt,DB07216,-8.8,"(11S)-8-CHLORO-11-[1-(METHYLSULFONYL)PIPERIDIN-4-YL]-6-PIPERAZIN-1-YL-11H-BENZO[5,6]CYCLOHEPTA[1,2-B]PYRIDINE",ZMGCFGGMTCMSDP-QHCPKHFHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
58567,6crv,DB05990,-8.8,Obeticholic acid,ZXERDUOLZKYMJM-ZWECCWDJSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140760,6w9c,DB15257,-8.8,Milademetan,RYAYYVTWKAOAJF-QISPRATLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
103812,6vxs,DB09074,-8.8,Olaparib,FDLYAMZZIXQODN-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
59883,6crv,DB07986,-8.8,[4-(4-PHENYL-PIPERIDIN-1-YL)-BENZENESULFONYLAMINO]-ACETIC ACID,GNSLACGSDSJAIQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140758,6w9c,DB15250,-8.8,Vercirnon,JRWROCIMSDXGOZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
65055,6lxt,DB02338,-8.8,Nadph Dihydro-Nicotinamide-Adenine-Dinucleotidephosphate,ACFIXJIJDZMPPO-NNYOXOHSSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
114335,6vxx,DB13310,-8.8,Ormeloxifene,XZEUAXYWNKYKPL-WDYNHAJCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
67867,6lxt,DB07253,-8.8,"N'-(5-chloro-1,3-benzodioxol-4-yl)-N-(3-methylsulfonylphenyl)pyrimidine-2,4-diamine",QTFCKBFCXDAZIU-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
67869,6lxt,DB07255,-8.8,"N'-(5-CHLORO-1,3-BENZODIOXOL-4-YL)-N-(3-MORPHOLIN-4-YLPHENYL)PYRIMIDINE-2,4-DIAMINE",PNEWIQAEGKQNCE-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
103880,6vxs,DB09195,-8.8,Lorpiprazole,BNRMWKUVWLKDQJ-YJBOKZPZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
59876,6crv,DB07977,-8.8,"3-({[3,5-DIFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)THIOPHENE-2-CARBOXYLIC ACID",CGNHUSCKOHDSMR-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59143,6crv,DB07123,-8.8,N-(4-METHYLBENZOYL)-4-BENZYLPIPERIDINE,DVOLWKZEIDCCES-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
12246,6lzg,DB13093,-8.8,TAK-593,DZFZXPPHBWCXPQ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
86930,6m3m,DB11521,-8.8,Imidocarb,SCEVFJUWLLRELN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
26753,6cs2,DB05038,-8.8,Anatibant,XUHBBTKJWIBQMY-MHZLTWQESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
84749,6m3m,DB06858,-8.8,N-cyclooctylglycyl-N-(4-carbamimidoylbenzyl)-L-prolinamide,MMLOIDMSBRJZAE-FQEVSTJZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
60754,6crv,DB09073,-8.8,Palbociclib,AHJRHEGDXFFMBM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87865,6m3m,DB12974,-8.8,Roniciclib,UELYDGOOJPRWGF-SRQXXRKNSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
128766,6w4h,DB07993,-8.8,"N-3-[3-(1H-INDOL-6-YL)BENZYL]PYRIDINE-2,3-DIAMINE",LPQUIIHPUGDHJK-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
83631,6m3m,DB04142,-8.8,"3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid Dimethylamide",FEYGJZKVMASWJB-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
164875,7bv1,DB08896,-8.8,Regorafenib,FNHKPVJBJVTLMP-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
9172,6lzg,DB07256,-8.8,"3-({4-[(5-CHLORO-1,3-BENZODIOXOL-4-YL)AMINO]PYRIMIDIN-2-YL}AMINO)BENZAMIDE",ZVQZIVCQLFGXFZ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
10793,6lzg,DB09075,-8.8,Edoxaban,HGVDHZBSSITLCT-JLJPHGGASA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
18720,6cs2,HMDB0033844,-8.8,beta-Cryptoxanthin,DMASLKHVQRHNES-QQGJMDNJSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
164059,7bv1,DB07024,-8.8,"2-(3,4-DIHYDROXYPHENYL)-8-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-3-HYDROXY-6-METHYL-4H-CHROMEN-4-ONE",CEXBEGBNDJVZPK-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
32097,6cs2,DB15346,-8.8,GLPG-1205,IRBAWVGZNJIROV-SFHVURJKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
126597,6w4h,DB04044,-8.8,4-{2-[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid,NAQUAVBNIYTIIS-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
78370,6m2n,DB11656,-8.8,Rebamipide,ALLWOAVDORUJLA-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
74541,6m2n,DB03496,-8.8,Alvocidib,BIIVYFLTOXDAOV-YVEFUNNKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
27838,6cs2,DB07396,-8.8,"1-{2-[3-(2-Chloro-4,5-difluoro-benzoyl)-ureido]-4-fluoro-phenyl}-piperidine-4-carboxylic acid",KAJJGOCSAXKXBD-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
112224,6vxx,DB06620,-8.8,Aplindore,DYJIKHYBKVODAC-ZDUSSCGKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165564,7bv1,DB12465,-8.8,Ketanserin,FPCCSQOGAWCVBH-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
122207,6w4b,DB13050,-8.8,Tirilazad,RBKASMJPSJDQKY-RBFSKHHSSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
78419,6m2n,DB11732,-8.8,Lasmiditan,XEDHVZKDSYZQBF-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78422,6m2n,DB11736,-8.8,PF-00489791,ZUHZNKJIJDAJFD-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138365,6w9c,DB11478,-8.8,Zeranol,DWTTZBARDOXEAM-GXTWGEPZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
27847,6cs2,DB07405,-8.8,"1-(6-CYANO-3-PYRIDYLCARBONYL)-5',8'-DIFLUOROSPIRO[PIPERIDINE-4,2'(1'H)-QUINAZOLINE]-4'-AMINE",GIZYIOOBBUHOBS-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
126545,6w4h,DB03970,-8.8,"(7R)-7-(6,7-Dihydro-5H-cyclopenta[d]imidazo[2,1-b][1,3]thiazol-2-yl)-2,7-dihydro-1,4-thiazepine-3,6-dicarboxylic acid",CHNMLWCTGYMVFH-GFCCVEGCSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
32139,6cs2,DB15431,-8.8,M-2698,HXAUJHZZPCBFPN-QGZVFWFLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
78438,6m2n,DB11759,-8.8,Pevonedistat,MPUQHZXIXSTTDU-QXGSTGNESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
81353,6m3m,DB01098,-8.8,Rosuvastatin,BPRHUIZQVSMCRT-VEUZHWNKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
108270,6vxx,DB07559,-8.8,"(2Z)-2-cyano-N-(2,2'-dichlorobiphenyl-4-yl)-3-hydroxybut-2-enamide",DDSLONVJHZPSBB-UVTDQMKNSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138354,6w9c,DB11457,-8.8,Rotenone,JUVIOZPCNVVQFO-HBGVWJBISA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136564,6w9c,DB07263,-8.8,"[{2-bromo-4-[(2R)-3-oxo-2,3-diphenylpropyl]phenyl}(difluoro)methyl]phosphonic acid",WDTMVBQZDFMOIK-GOSISDBHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
108286,6vxx,DB07578,-8.8,"3-[4-(2-METHYL-IMIDAZO[4,5-C]PYRIDIN-1-YL)BENZYL]-3H-BENZOTHIAZOL-2-ONE",WUOLYUKMMRCXGH-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
126540,6w4h,DB03962,-8.8,Nicotinamide 8-Bromo-Adenine Dinucleotide Phosphate,MDKMTCCUJSRQGW-NAJQWHGHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
74440,6m2n,DB03351,-8.8,Sri-9439,KMSATRJZEXNGDP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
55947,6crv,DB01674,-8.8,[2-(1-Amino-2-Hydroxy-Propyl)-4-(4-Fluoro-1h-Indol-3-Ylmethyl)-5-Hydroxy-Imidazol-1-Yl]-Acetic Acid,AYMRQIHECFEMIQ-AYVTZFPOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112139,6vxx,DB06409,-8.8,Morphine glucuronide,GNJCUHZOSOYIEC-GAROZEBRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28968,6cs2,DB08597,-8.8,"6-[4-(2-piperidin-1-ylethoxy)phenyl]-3-pyridin-4-ylpyrazolo[1,5-a]pyrimidine",XHBVYDAKJHETMP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
122048,6w4b,DB12799,-8.8,Laniquidar,TULGGJGJQXESOO-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
112294,6vxx,DB06932,-8.8,"10,11-dimethoxy-4-methyldibenzo[c,f]-2,7-naphthyridine-3,6-diamine",NVINUNQBDNEMSY-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
164057,7bv1,DB07021,-8.8,"(7R,8R)-8-(2,4,5-trifluorophenyl)-6,7,8,9-tetrahydroimidazo[1,2-a:4,5-c']dipyridin-7-amine",SOSYXEPELJIJHZ-RNCFNFMXSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
71334,6lxt,DB14017,-8.8,H3B-8800,YOIQWBAHJZGRFW-WVRLKXNASA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
112447,6vxx,DB07115,-8.8,"N-(4-chlorobenzyl)-N-methylbenzene-1,4-disulfonamide",IPPUTOHDQOYDIL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56172,6crv,DB01976,-8.8,Aminoanthracene,YUENFNPLGJCNRB-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138514,6w9c,DB11778,-8.8,Danusertib,XKFTZKGMDDZMJI-HSZRJFAPSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
74925,6m2n,DB04014,-8.8,Alsterpaullone,OLUKILHGKRVDCT-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
81594,6m3m,DB01452,-8.8,Diamorphine,GVGLGOZIDCSQPN-PVHGPHFFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
70808,6lxt,DB13252,-8.8,Tropatepine,JOQKFRLFXDPXHX-HDICACEKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
108100,6vxx,DB06847,-8.8,"5-[(3S)-3-(2-methoxybiphenyl-4-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",YYCPXVRHQUEVAW-CQSZACIVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
70845,6lxt,DB13307,-8.8,Proscillaridin,MYEJFUXQJGHEQK-ALRJYLEOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
27772,6cs2,DB07325,-8.8,N-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)METHYL]-3-{[(E)-(2-OXODIHYDROFURAN-3(2H)-YLIDENE)METHYL]AMINO}BENZENESULFONAMIDE,VCOKUBHAJVTVNG-FMIVXFBMSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
32008,6cs2,DB15197,-8.8,RSV-604,MTPVBMVUENFFLL-HXUWFJFHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
139731,6w9c,DB13857,-8.8,Demegestone,JWAHBTQSSMYISL-MHTWAQMVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
108114,6vxx,DB06865,-8.8,6-CARBAMIMIDOYL-2-[2-HYDROXY-6-(4-HYDROXY-PHENYL)-INDAN-1-YL]-HEXANOIC ACID,ZSRRBAKATXAISL-LMNJBCLMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163996,7bv1,DB06945,-8.8,N-hydroxy-4-({4-[4-(trifluoromethyl)phenoxy]phenyl}sulfonyl)tetrahydro-2H-pyran-4-carboxamide,FOSWRYKPHVPIDJ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
112400,6vxx,DB07058,-8.8,"5-[1-(4-methoxyphenyl)-1H-benzimidazol-6-yl]-1,3,4-oxadiazole-2(3H)-thione",QBVJMUOTMRYUKR-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108316,6vxx,DB07616,-8.8,"4-{[4-(4-fluoro-3-methylphenyl)-1,3-thiazol-2-yl]amino}-2-hydroxybenzoic acid",LKZZDHKJFDTYCH-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
71098,6lxt,DB13643,-8.8,Loprazolam,UTEFBSAVJNEPTR-RGEXLXHISA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
138482,6w9c,DB11732,-8.8,Lasmiditan,XEDHVZKDSYZQBF-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
32031,6cs2,DB15232,-8.8,Telaglenastat,PRAAPINBUWJLGA-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
81492,6m3m,DB01264,-8.8,Darunavir,CJBJHOAVZSMMDJ-HEXNFIEUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
74736,6m2n,DB03768,-8.8,"N-[2-Hydroxy-2-(8-Isopropyl-6,9-Dioxo-2-Oxa-7,10-Diaza-Bicyclo[11.2.2]Heptadeca-1(16),13(17),14-Trien-11-Yl)-Ethyl]-N-(3-Methyl-Butyl)-Benzenesulfonamide,Inhibitor 3",WRUVOSYKHXGAQN-GKRYNVPLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
112355,6vxx,DB07008,-8.8,"4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMIDAZOL-1-YL)PHENOXY]PYRIMIDINE",XPXGYINSBORUMM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27807,6cs2,DB07360,-8.8,"1-{5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)ethyl]-1,3-thiazol-2-yl}-3-[3-(trifluoromethyl)phenyl]urea",JJHXPDTVQKWKHA-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
81486,6m3m,DB01254,-8.8,Dasatinib,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
78209,6m2n,DB11262,-8.8,Bisoctrizole,FQUNFJULCYSSOP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78210,6m2n,DB11263,-8.8,Polydatin,HSTZMXCBWJGKHG-CUYWLFDKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
74677,6m2n,DB03696,-8.8,Lanosterol,CAHGCLMLTWQZNJ-BQNIITSRSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
81440,6m3m,DB01196,-8.8,Estramustine,FRPJXPJMRWBBIH-RBRWEJTLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136534,6w9c,DB07229,-8.8,"3-{5-[AMINO(IMINIO)METHYL]-1H-INDOL-2-YL}-5-METHOXY-1,1'-BIPHENYL-2-OLATE",MINVOLKUPZPDNX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
112311,6vxx,DB06954,-8.8,"2-(cycloheptylmethyl)-1,1-dioxido-1-benzothiophen-6-yl sulfamate",BIASYWBGUYOWJR-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
164056,7bv1,DB07020,-8.8,"N-{3-[5-(1H-1,2,4-triazol-3-yl)-1H-indazol-3-yl]phenyl}furan-2-carboxamide",LMDMJDCLPIVGQD-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
108144,6vxx,DB07154,-8.8,"(3R)-4-[(3R)-3-AMINO-4-(2,4,5-TRIFLUOROPHENYL)BUTANOYL]-3-METHYL-1,4-DIAZEPAN-2-ONE",SWKGZJAAGSVROJ-MWLCHTKSSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31991,6cs2,DB15163,-8.8,Selatogrel,FYXHWMQPCJOJCH-GMAHTHKFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
136573,6w9c,DB07274,-8.8,"N-cyclopropyl-6-[(6,7-dimethoxyquinolin-4-yl)oxy]naphthalene-1-carboxamide",ZATGFXTWDKIEKC-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
78478,6m2n,DB11816,-8.8,Omecamtiv Mecarbil,RFUBTTPMWSKEIW-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
74222,6m2n,DB03069,-8.8,Cytidine-5'-Diphospho-Beta-D-Xylose,NWSKPSPTJOAICE-OCIMBMBZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
55851,6crv,DB01554,-8.8,Bolandiol,CMXKUJNZWYTFJN-XFUVECHXSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112011,6vxx,DB05234,-8.8,LGD2941,HWLLYFXDDGGHOE-BCSUUIJWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114898,6vxx,DB15358,-8.8,JNJ-54175446,CWFVVQFVGMFTBD-SECBINFHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55833,6crv,DB01536,-8.8,Androstenedione,AEMFNILZOJDQLW-QAGGRKNESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114755,6vxx,DB14775,-8.8,Cavosonstat,BXSZILNGNMDGSL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55829,6crv,DB01532,-8.8,??-Methylacetylfentanyl,OKTLVZBUKMRPLL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55828,6crv,DB01531,-8.8,Desomorphine,LNNWVNGFPYWNQE-GMIGKAJZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
74201,6m2n,DB03041,-8.8,UDP-alpha-D-glucuronic acid,HDYANYHVCAPMJV-LXQIFKJMSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
81158,6m3m,DB00875,-8.8,Flupentixol,NJMYODHXAKYRHW-DVZOWYKESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
55806,6crv,DB01503,-8.8,1-Androstenediol,RZFGPAMUAXASRE-YSZCXEEOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108485,6vxx,DB08042,-8.8,"N-4-methyl-N-4-(3-methyl-1H-indazol-6-yl)-N-2-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine",FLXGQDHYCWXTAI-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136660,6w9c,DB07382,-8.8,"N-2-1H-benzimidazol-5-yl-N-4-(3-cyclopropyl-1H-pyrazol-5-yl)pyrimidine-2,4-diamine",WJNBSTLIALIIEW-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
126162,6w4h,DB03453,-8.8,Methyl (2S)-2-[[2-[(3R)-1-carbamimidoylpiperidin-3-yl]acetyl]amino]-3-[4-(2-phenylethynyl)phenyl]propanoate,MRNGXYMKYHNMLV-PKTZIBPZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
138087,6w9c,DB09168,-8.8,4-Phenylfentanyl,BXCJXJLHYMWMQU-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
78597,6m2n,DB11990,-8.8,MK-0812,UNVWTBOGMHPKJM-CWKRKGSWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
55800,6crv,DB01497,-8.8,Etorphine,CAHCBJPUTCKATP-HBDRVVKHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78598,6m2n,DB11992,-8.8,Omarigliptin,MKMPWKUAHLTIBJ-ISTRZQFTSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
71614,6lxt,DB14902,-8.8,JHU-75528 C-11,MCNQUWLLXZZZAC-BJUDXGSMSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
111982,6vxx,DB05039,-8.8,Indacaterol,QZZUEBNBZAPZLX-QFIPXVFZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
10615,6lzg,DB08827,-8.8,Lomitapide,MBBCVAKAJPKAKM-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
74078,6m2n,DB02873,-8.8,"1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperazin-1-Yl-3,4-Dihydroquinazolin-2(1h)-One",YAWZIQKDHQIHOS-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
111938,6vxx,DB04891,-8.8,Becocalcidiol,QSLUXQQUPXBIHH-YHSKWIAJSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81130,6m3m,DB00844,-8.8,Nalbuphine,NETZHAKZCGBWSS-CEDHKZHLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
28897,6cs2,DB08521,-8.8,4-[5-(4-FLUORO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-3H-IMIDAZOL-4-YL]-PYRIDINE,CDMGBJANTYXAIV-HHHXNRCGSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
126105,6w4h,DB03367,-8.8,PF-00356231,VMTJQZUZINLEKC-JOCHJYFZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
78619,6m2n,DB12022,-8.8,Evatanepag,WOHRHWDYFNWPNG-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138044,6w9c,DB09073,-8.8,Palbociclib,AHJRHEGDXFFMBM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
78629,6m2n,DB12041,-8.8,Mapracorat,VJGFOYBQOIPQFY-XMMPIXPASA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
10658,6lzg,DB00826,-8.8,Natamycin,NCXMLFZGDNKEPB-FFPOYIOWSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
32764,6cs2,T3D3677,-8.8,Cytochalasin C,NAIODHJWOHMDJX-BBXOWAOSSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
10659,6lzg,DB08896,-8.8,Regorafenib,FNHKPVJBJVTLMP-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
112032,6vxx,DB06144,-8.8,Sertindole,GZKLJWGUPQBVJQ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
71529,6lxt,DB14716,-8.8,Clonazolam,XJRGLCAWBRZUFC-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
138309,6w9c,DB11371,-8.8,Alfaxalone,DUHUCHOQIDJXAT-OLVMNOGESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
32229,6cs2,DB01200,-8.8,Bromocriptine,OZVBMTJYIDMWIL-AYFBDAFISA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
108346,6vxx,DB07649,-8.8,"(3R,4S)-1-[(4-amino-5H-pyrrolo[3,2-d]pyrimidin-7-yl)methyl]-4-[(benzylsulfanyl)methyl]pyrrolidin-3-ol",DIGGNILBPCEZIV-CVEARBPZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138276,6w9c,DB11263,-8.8,Polydatin,HSTZMXCBWJGKHG-CUYWLFDKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
71555,6lxt,DB14770,-8.8,Lanraplenib,XCIGZBVOUQVIPI-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
108357,6vxx,DB07665,-8.8,"N-[2-(carbamimidamidooxy)ethyl]-2-{6-cyano-3-[(2,2-difluoro-2-pyridin-2-ylethyl)amino]-2-fluorophenyl}acetamide",STHCHQXQLDMISY-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108365,6vxx,DB07675,-8.8,(2S)-2-ETHOXY-3-{4-[2-(10H-PHENOXAZIN-10-YL)ETHOXY]PHENYL}PROPANOIC ACID,WMUIIGVAWPWQAW-DEOSSOPVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108375,6vxx,DB07686,-8.8,"4-{[5-(CYCLOHEXYLAMINO)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE",VPOGRVWIIVMWRI-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
126379,6w4h,DB03758,-8.8,Radicicol,WYZWZEOGROVVHK-GTMNPGAYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
74331,6m2n,DB03213,-8.8,Bis(5-Amidino-2-Benzimidazolyl)Methane Ketone,VVVXDHROXQUONB-UHFFFAOYSA-P,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
140432,6w9c,DB06833,-8.8,1-CYCLOHEXYL-N-{[1-(4-METHYLPHENYL)-1H-INDOL-3-YL]METHYL}METHANAMINE,MMIJMYOYKAKQPN-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
164106,7bv1,DB07265,-8.8,"3-(9-HYDROXY-1,3-DIOXO-4-PHENYL-2,3-DIHYDROPYRROLO[3,4-C]CARBAZOL-6(1H)-YL)PROPANOIC ACID",JDARUOOLJCFUOY-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
108390,6vxx,DB07704,-8.8,"6-AMINO-4-[2-(4-METHOXYPHENYL)ETHYL]-1,7-DIHYDRO-8H-IMIDAZO[4,5-G]QUINAZOLIN-8-ONE",UKRVQKUVWNDGMN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140443,6w9c,DB06848,-8.8,"1-(1'-{[3-(methylsulfanyl)-2-benzothiophen-1-yl]carbonyl}spiro[1-benzofuran-3,4'-piperidin]-5-yl)methanamine",VCUDZTCDUDDJGG-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138215,6w9c,DB09383,-8.8,Meprednisone,PIDANAQULIKBQS-RNUIGHNZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
32485,6cs2,T3D1843,-8.8,Bifenthrin,OMFRMAHOUUJSGP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
81230,6m3m,DB00956,-8.8,Hydrocodone,LLPOLZWFYMWNKH-CMKMFDCUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
32489,6cs2,T3D1847,-8.8,Flucythrinate,GBIHOLCMZGAKNG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
55880,6crv,DB01588,-8.8,Prazepam,MWQCHHACWWAQLJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108418,6vxx,DB07969,-8.8,3-[3-(4-methylpiperazin-1-yl)-7-(trifluoromethyl)quinoxalin-5-yl]phenol,QNCYYRHIUFGGJX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78531,6m2n,DB11893,-8.8,Avagacestat,XEAOPVUAMONVLA-QGZVFWFLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
112057,6vxx,DB06194,-8.8,Elocalcitol,LRLWXBHFPGSUOX-GJQYOBCGSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112051,6vxx,DB06178,-8.8,Talotrexin,NYQPLPNEESYGNO-IBGZPJMESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78539,6m2n,DB11903,-8.8,GW842166,TWQYWUXBZHPIIV-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138170,6w9c,DB09268,-8.8,Picosulfuric acid,UJIDKYTZIQTXPM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
126281,6w4h,DB03632,-8.8,Argifin,UHBHXSDKGLPPGO-HTDHLNIYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
71603,6lxt,DB14882,-8.8,CEP-9722,CTLOSZHDGZLOQE-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
74235,6m2n,DB03084,-8.8,"Cyclopropyl-{4-[5-(3,4-Dichlorophenyl)-2-[(1-Methyl)-Piperidin]-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine",XCTKFTOEAKJMII-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
55859,6crv,DB01562,-8.8,1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine,BVURVTVDNWSNFN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
32324,6cs2,T3D0137,-8.8,Chrysene,WDECIBYCCFPHNR-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
164176,7bv1,DB07340,-8.8,"N-6-cyclohexyl-N-2-(4-morpholin-4-ylphenyl)-9H-purine-2,6-diamine",ZFLJHSQHILSNCM-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
138527,6w9c,DB11794,-8.8,Berzosertib,JZCWLJDSIRUGIN-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
108044,6vxx,DB06745,-8.8,ginkgolide-C,AMOGMTLMADGEOQ-DTDWCABLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138648,6w9c,DB12064,-8.8,BMS-777607,VNBRGSXVFBYQNN-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
75456,6m2n,DB04725,-8.8,Licofelone,UAWXGRJVZSAUSZ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
70483,6lxt,DB12720,-8.8,Nivocasan,VYFGDLGHHBUDTQ-ZLGUVYLKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
31716,6cs2,DB00203,-8.8,Sildenafil,BNRNXUUZRGQAQC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
136321,6w9c,DB06985,-8.8,2-[({4-[2-(trifluoromethyl)phenyl]piperidin-1-yl}carbonyl)amino]benzoic acid,MEAQCLPMSVEOQF-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140513,6w9c,DB11990,-8.8,MK-0812,UNVWTBOGMHPKJM-CWKRKGSWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138641,6w9c,DB12055,-8.8,MK-0767,ORZMUVMQJPGFOM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
107493,6vxx,DB03672,-8.8,9-N-Phenylmethylamino-Tacrine,JYJAEHAURXXPSD-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165819,7bv1,DB13061,-8.8,MLN8054,HHFBDROWDBDFBR-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
77534,6m2n,DB08495,-8.8,4-({4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-2-OXOPIPERAZIN-1-YL}METHYL)BENZENECARBOXIMIDAMIDE,VXONTEUOQXFJJS-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
81997,6m3m,DB01964,-8.8,AL5424,ZWTSOJQGEWPWGO-NSHDSACASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
77537,6m2n,DB08498,-8.8,"(1S)-1-(3-chlorophenyl)-2-oxo-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate",OVSAMUIBGQSLDC-INIZCTEOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77538,6m2n,DB08499,-8.8,"N-[3-(2-fluoroethoxy)phenyl]-N'-(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-6-yl)butanediamide",DQXBKUVWJSZHSI-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
107526,6vxx,DB03719,-8.8,N-Ethyl-5'-Carboxamido Adenosine,JADDQZYHOWSFJD-BMYQGPEFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127150,6w4h,DB04785,-8.8,Streptolydigin,KVTPRMV1KLIG-NCAOFHFGSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
136335,6w9c,DB07000,-8.8,"N-{2,4-difluoro-3-[(5-pyridin-3-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)carbonyl]phenyl}ethanesulfonamide",ILXJWLWSYAWJKZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
77539,6m2n,DB08500,-8.8,"(3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(2-naphthyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol",ZCJBDRSKHARECB-PYTCMNEWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
163810,7bv1,DB06350,-8.8,Elinogrel,LGSDFTPAICUONK-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
136343,6w9c,DB07008,-8.8,"4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMIDAZOL-1-YL)PHENOXY]PYRIMIDINE",XPXGYINSBORUMM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
77543,6m2n,DB08504,-8.8,"6-(4-{(1S,2S)-2-AMINO-1-[(DIMETHYLAMINO)CARBONYL]-3-[(3S)-3-FLUOROPYRROLIDIN-1-YL]-3-OXOPROPYL}PHENYL)-1H-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-4-IUM",ZNHVIJAGMFQGMS-IHPCNDPISA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77554,6m2n,DB08519,-8.8,"N-4-(3-methyl-1H-indazol-6-yl)-N-2-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine",SQQAPOSROFWHIB-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75383,6m2n,DB04626,-8.8,Apramycin,XZNUGFQTQHRASN-XQENGBIVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
107611,6vxx,DB04086,-8.8,"2',4'-Dinitrophenyl-2deoxy-2-Fluro-B-D-Cellobioside",WFVCNOHOODVBQK-IUBYCILNSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
139538,6w9c,DB13606,-8.8,Phenazocine,ZQHYKVKNPWDQSL-KNXBSLHKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
121495,6w4b,DB11977,-8.8,Golvatinib,UQRCJCNVNUFYDX-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
29176,6cs2,DB08816,-8.8,Ticagrelor,OEKWJQXRCDYSHL-FNOIDJSQSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
121501,6w4b,DB11986,-8.8,Entrectinib,HAYYBYPASCDWEQ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
112763,6vxx,DB07815,-8.8,GIBBERELLIN A4,RSQSQJNRHICNNH-NFMPGMCNSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114731,6vxx,DB14726,-8.8,Dabigatran,YBSJFWOBGCMAKL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138649,6w9c,DB12066,-8.8,Orteronel,OZPFIJIOIVJZMN-SFHVURJKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
75473,6m2n,DB04750,-8.8,OREGON GREEN 488 CARBOXYLATE,BRJCLSQFZSHLRL-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
107438,6vxx,DB03593,-8.8,N7-Methyl-Guanosine-5'-Monophosphate,AOKQNZVJJXPUQA-KQYNXXCUSA-O,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
139500,6w9c,DB13552,-8.8,Trifluperidol,GPMXUUPHFNMNDH-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
75543,6m2n,DB04839,-8.8,Cyproterone acetate,UWFYSQMTEOIJJG-FDTZYFLXSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
121274,6w4b,DB11651,-8.8,Dactolisib,JOGKUKXHTYWRGZ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
75529,6m2n,DB04824,-8.8,Phenolphthalein,KJFMBFZCATUALV-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
27596,6cs2,DB07145,-8.8,(2R)-N-HYDROXY-2-[(3S)-3-METHYL-3-{4-[(2-METHYLQUINOLIN-4-YL)METHOXY]PHENYL}-2-OXOPYRROLIDIN-1-YL]PROPANAMIDE,YDMIPBHQKFOFQW-NSYGIPOTSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
29265,6cs2,DB08950,-8.8,Indoramin,JXZZEXZZKAWDSP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
136298,6w9c,DB06953,-8.8,2-CHLORO-5-(3-CHLORO-PHENYL)-6-[(4-CYANO-PHENYL)-(3-METHYL-3H-IMIDAZOL-4-YL)- METHOXYMETHYL]-NICOTINONITRILE,JVWHVGIRXILXMU-XMMPIXPASA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
77405,6m2n,DB08339,-8.8,"6-(2,6-DICHLOROPHENYL)-2-{[3-(HYDROXYMETHYL)PHENYL]AMINO}-8-METHYLPYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE",ZIQFYVPVJZEOFS-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
82162,6m3m,DB02187,-8.8,Equilin,WKRLQDKEXYKHJB-HFTRVMKXSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
112993,6vxx,DB08239,-8.8,"(2S)-4-(2,5-DIFLUOROPHENYL)-N-METHYL-2-PHENYL-N-PIPERIDIN-4-YL-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDE",NKLVBHMAIMEVEH-QFIPXVFZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
82158,6m3m,DB02181,-8.8,2'-Deoxyguanosine-5'-Triphosphate,HAAZLUGHYHWQIW-KVQBGUIXSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
77419,6m2n,DB08355,-8.8,"1-methyl-8-(phenylamino)-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxylic acid",ZOBRPBVIEUWYJR-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138684,6w9c,DB12116,-8.8,Epigallocatechin gallate,WMBWREPUVVBILR-WIYYLYMNSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
82151,6m3m,DB02170,-8.8,"1,8-Di-Hydroxy-4-Nitro-Xanthen-9-One",ZOHCDJRFYXKEQW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
29248,6cs2,DB08927,-8.8,Amperozide,NNAIYOXJNVGUOM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
27662,6cs2,DB07215,-8.8,"2-METHYL-2-(4-{[({4-METHYL-2-[4-(TRIFLUOROMETHYL)PHENYL]-1,3-THIAZOL-5-YL}CARBONYL)AMINO]METHYL}PHENOXY)PROPANOIC ACID",ILUPZUOBHCUBKB-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
77424,6m2n,DB08361,-8.8,"2-{[(1R,2S)-2-aminocyclohexyl]amino}-4-[(3-methylphenyl)amino]pyrimidine-5-carboxamide",NZNTWOVDIXCHHS-LSDHHAIUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
112943,6vxx,DB08173,-8.8,5-CHLORO-N-(2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO)ETHYL)THIOPHENE-2-CARBOXAMIDE,UCKHUNHXYMAFQM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112936,6vxx,DB08166,-8.8,"(4R)-7-chloro-9-methyl-1-oxo-1,2,4,9-tetrahydrospiro[beta-carboline-3,4'-piperidine]-4-carbonitrile",LPFQFJAOMCGYCP-GFCCVEGCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
82147,6m3m,DB02164,-8.8,N-Sulfo-Flavin Mononucleotide,ZLPUGFBBLGQWBS-SCRDCRAPSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
3391,6lzg,HMDB0046432,-8.8,TG(22:0/14:1(9Z)/24:0),NIPVPXGEDBBOMK-XTKDRUTHSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
107357,6vxx,DB03207,-8.8,"2-(Biphenyl-4-Sulfonyl)-1,2,3,4-Tetrahydro-Isoquinoline-3-Carboxylic Acid",BNVMUDXGABBWGP-OAQYLSRUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138682,6w9c,DB12114,-8.8,Poziotinib,LPFWVDIFUFFKJU-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
82131,6m3m,DB02140,-8.8,N1-(1-Dimethylcarbamoyl-2-Phenyl-Ethyl)-2-Oxo-N4-(2-Pyridin-2-Yl-Ethyl)-Succinamide,ZPFPZRVOBBMZMP-SFHVURJKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
82126,6m3m,DB02132,-8.8,Zenarestat,SXONDGSPUVNZLO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
70434,6lxt,DB12649,-8.8,Ibipinabant,AXJQVVLKUYCICH-OAQYLSRUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
31678,6cs2,DB14541,-8.8,Hydrocortisone cypionate,DLVOSEUFIRPIRM-KAQKJVHQSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
136311,6w9c,DB06972,-8.8,"7A-[(4-cyanophenyl)methyl]-6-(3,5-dichlorophenyl)-5-oxo-2,3,5,7A-tetrahydro-1H-pyrrolo[1,2-A]pyrrole-7-carbonitrile",TZCXQSNBTXDAJG-QFIPXVFZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
127209,6w4h,DB04859,-8.8,Zanapezil,PMBLXLOXUGVTGB-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
70446,6lxt,DB12665,-8.8,Isoquercetin,OVSQVDMCBVZWGM-QSOFNFLRSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
112904,6vxx,DB08133,-8.8,N-(4-sulfamoylphenyl)-1H-indazole-3-carboxamide,MNHPHKFLWAPNOV-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138683,6w9c,DB12115,-8.8,AZD-9164,FNYFFCOCVNTJCD-NNMXADRKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
77906,6m2n,DB08971,-8.8,Fluocortolone,GAKMQHDJQHZUTJ-ULHLPKEOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75345,6m2n,DB04575,-8.8,Quinestrol,PWZUUYSISTUNDW-VAFBSOEGSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77620,6m2n,DB08597,-8.8,"6-[4-(2-piperidin-1-ylethoxy)phenyl]-3-pyridin-4-ylpyrazolo[1,5-a]pyrimidine",XHBVYDAKJHETMP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77838,6m2n,DB08867,-8.8,Ulipristal,HKDLNTKNLJPAIY-WKWWZUSTSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
31918,6cs2,DB15035,-8.8,Zanubrutinib,RNOAOAWBMHREKO-QFIPXVFZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
165710,7bv1,DB12693,-8.8,Ritanserin,JUQLTPCYUFPYKE-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
136402,6w9c,DB07076,-8.8,6-[(Z)-AMINO(IMINO)METHYL]-N-[3-(CYCLOPENTYLOXY)PHENYL]-2-NAPHTHAMIDE,FWTQOPWAMQXIMI-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138570,6w9c,DB11855,-8.8,Revefenacin,FYDWDCIFZSGNBU-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
112568,6vxx,DB07404,-8.8,"(1-HYDROXY-1-PHOSPHONO-2-[1,1';3',1'']TERPHENYL-3-YL-ETHYL)-PHOSPHONIC ACID",YXQQNSYZOQHKHD-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81701,6m3m,DB01570,-8.8,Ohmefentanyl,FRPRNNRJTCONEC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
166498,7bv1,DB15246,-8.8,Salvianolic acid A,YMGFTDKNIWPMGF-UCPJVGPRSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
81700,6m3m,DB01569,-8.8,Formebolone,AMVODTGMYSRMNP-GNIMZFFESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
139616,6w9c,DB13710,-8.8,Metenolone,ANJQEDFWRSLVBR-VHUDCFPWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138556,6w9c,DB11832,-8.8,Crenolanib,DYNHJHQFHQTFTP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
112561,6vxx,DB07396,-8.8,"1-{2-[3-(2-Chloro-4,5-difluoro-benzoyl)-ureido]-4-fluoro-phenyl}-piperidine-4-carboxylic acid",KAJJGOCSAXKXBD-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29100,6cs2,DB08739,-8.8,"2-{3-[(2S)-4,4-difluoro-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]-3-oxopropyl}-isoindole-1,3(2H)-dione",ZSXNPAWXICXNGZ-HNNXBMFYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
112539,6vxx,DB07369,-8.8,"N-(3-chlorophenyl)-N-methyl-2-oxo-3-[(3,4,5-trimethyl-1H-pyrrol-2-yl)methyl]-2H-indole-5-sulfonamide",YMJLSOJLEXWATP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27734,6cs2,DB07289,-8.8,5-[3-(BENZYLAMINO)PHENYL]-4-BROMO-3-(CARBOXYMETHOXY)THIOPHENE-2-CARBOXYLIC ACID,XEQPGVUGYAUMSA-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
107968,6vxx,DB05913,-8.8,OSI-930,FGTCROZDHDSNIO-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81685,6m3m,DB01554,-8.8,Bolandiol,CMXKUJNZWYTFJN-XFUVECHXSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
107970,6vxx,DB05936,-8.8,CVT-6883,KOYXXLLNCXWUNF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30123,6cs2,DB12082,-8.8,Vesnarinone,ZVNYJIZDIRKMBF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
107995,6vxx,DB06673,-8.8,Almorexant,DKMACHNQISHMDN-RPLLCQBOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
121801,6w4b,DB12415,-8.8,Galeterone,PAFKTGFSEFKSQG-PAASFTFBSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
29091,6cs2,DB08731,-8.8,"2-[(1R)-2-carboxy-1-(naphthalen-1-ylmethyl)ethyl]-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylic acid",GPOKTQCDBPECSS-MRXNPFEDSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
165682,7bv1,DB12651,-8.8,Bardoxolone,TXGZJQLMVSIZEI-UQMAOPSPSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
27739,6cs2,DB07294,-8.8,"3-fluoro-4-[2-hydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8,-tetrahydro-naphtalen-2-yl)-acetylamino]-benzoic acid",AANFHDFOMFRLLR-IBGZPJMESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
112496,6vxx,DB07319,-8.8,"6-(3-BROMO-2-NAPHTHYL)-1,3,5-TRIAZINE-2,4-DIAMINE",RXSSKAZHCZWJPP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108024,6vxx,DB06717,-8.8,Fosaprepitant,BARDROPHSZEBKC-OITMNORJSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108026,6vxx,DB06721,-8.8,Gimatecan,UIVFUQKYVFCEKJ-OPTOVBNMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136433,6w9c,DB07113,-8.8,"(2S)-6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2-(3,5-DIFLUOROPHENYL)-4-(3-METHOXYPROPYL)-2H-1,4-BENZOXAZIN-3(4H)-ONE",KHZQOXQOUCGGGA-NRFANRHFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
108043,6vxx,DB06744,-8.8,ginkgolide-B,SQOJOAFXDQDRGF-MMQTXUMRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
70669,6lxt,DB13019,-8.8,Henatinib,MCTXSDCWFQAGFS-UEXNTNOUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
31909,6cs2,DB15023,-8.8,BMS-791826,DZBKAUMYTFPJIS-QHCPKHFHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
27710,6cs2,DB07265,-8.8,"3-(9-HYDROXY-1,3-DIOXO-4-PHENYL-2,3-DIHYDROPYRROLO[3,4-C]CARBAZOL-6(1H)-YL)PROPANOIC ACID",JDARUOOLJCFUOY-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
81726,6m3m,DB01605,-8.8,Pivmecillinam,NPGNOVNWUSPMDP-HLLBOEOZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
31838,6cs2,DB14859,-8.8,Fosifloxuridine nafalbenamide,BIOWRMNRHMERIO-ZVAHOJSLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
138625,6w9c,DB11939,-8.8,Henagliflozin,HYTPDMFFHVZBOR-VNXMGFANSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
127091,6w4h,DB04703,-8.8,Hesperidin,QUQPHWDTPGMPEX-QJBIFVCTSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
107729,6vxx,DB04542,-8.8,3'-Azido-3'-Deoxythymidine-5'-Diphosphate,QOYVAFWJURKBJG-XLPZGREQSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56380,6crv,DB02255,-8.8,GM6001,NITYDPDXAAFEIT-DYVFJYSZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
70591,6lxt,DB12897,-8.8,MK-7622,JUVQLZBJFOGEEO-GOTSBHOMSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
107756,6vxx,DB04574,-8.8,Estrone sulfate,JKKFKPJIXZFSSB-CBZIJGRNSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107760,6vxx,DB04578,-8.8,"(S)-2-[(R)-3-amino-4-(2-fluorophenyl)butyryl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide",OEVYDSSAPNIURZ-AEFFLSMTSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81853,6m3m,DB01767,-8.8,Hemi-Babim,KKJYVDXDZURHMA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
138616,6w9c,DB11922,-8.8,Danirixin,NGYNBSHYFOFVLS-LBPRGKRZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
70596,6lxt,DB12903,-8.8,DEBIO-1347,BEMNJULZEQTDJY-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
107784,6vxx,DB04610,-8.8,"7,8-dihydro-6-hydroxymethyl-7-methyl-7-[2-phenylethyl]-pterin",XMFJTCGUDFSWSW-INIZCTEOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
70603,6lxt,DB12914,-8.8,MGL-3196,FDBYIYFVSAHJLY-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
81811,6m3m,DB01712,-8.8,"(3r)-4-(P-Toluenesulfonyl)-1,4-Thiazane-3-Carboxylicacid-L-Phenylalanine Ethyl Ester",NDDSSAGSYFVBTG-SFTDATJTSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
77599,6m2n,DB08572,-8.8,4-{[4-AMINO-6-(CYCLOHEXYLMETHOXY)-5-NITROSOPYRIMIDIN-2-YL]AMINO}BENZAMIDE,YBKLJTXDSBEVRV-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
27699,6cs2,DB07254,-8.8,"N-[3-[[4-[(5-CHLORO-1,3-BENZODIOXOL-4-YL)AMINO]PYRIMIDIN-2-YL]AMINO]PHENYL]METHANESULFONAMIDE",KQGTYXRWSIBDOZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
107843,6vxx,DB04690,-8.8,Camptothecin,VSJKWCGYPAHWDS-FQEVSTJZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112678,6vxx,DB07534,-8.8,"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE",BKUMVXIXUVYKDQ-GHXNOFRVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112675,6vxx,DB07531,-8.8,"4-{5-[(Z)-(2,4-DIOXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE",JNPRTUHVCHGFHJ-GHXNOFRVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107856,6vxx,DB05263,-8.8,Caprospinol,VMOZFSWFUBLCNN-AAPULDEBSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112674,6vxx,DB07530,-8.8,"(1R,3R)-5-[(2E)-3-{(1S,3R)-2,2,3-trimethyl-3-[6,6,6-trifluoro-5-hydroxy-5-(trifluoromethyl)hex-3-yn-1-yl]cyclopentyl}prop-2-en-1-ylidene]cyclohexane-1,3-diol",PCHUQQNKOFNVDU-OSXMSNBXSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107867,6vxx,DB05327,-8.8,Ranirestat,QCVNMNYRNIMDKV-QGZVFWFLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75176,6m2n,DB04348,-8.8,Taurocholic Acid,WBWWGRHZICKQGZ-HZAMXZRMSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77749,6m2n,DB08749,-8.8,3-(2-AMINO-6-BENZOYLQUINAZOLIN-3(4H)-YL)-N-CYCLOHEXYL-N-METHYLPROPANAMIDE,KTRFBFMYAJOXLG-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
81761,6m3m,DB01644,-8.8,"3,6-dihydroxy-xanthene-9-propionic acid",PFQGLFBMMPZYEU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
112637,6vxx,DB07486,-8.8,"3-({4-[(1E)-3-morpholin-4-yl-3-oxoprop-1-en-1-yl]-2,3-bis(trifluoromethyl)phenyl}sulfanyl)aniline",KLSZVPNVFKKIRD-FNORWQNLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75143,6m2n,DB04301,-8.8,Bis(5-Amidino-2-Benzimidazolyl)Methane Ketone Hydrate,ZLAHDRAQCSQPOC-UHFFFAOYSA-P,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
112631,6vxx,DB07479,-8.8,"(1S)-1,2,3,4-TETRAHYDRO-BENZO[C]PHENANTHRENE-2,3,4-TRIOL",WCUHTHVUZQCBTI-KBAYOESNSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81743,6m3m,DB01624,-8.8,Zuclopenthixol,WFPIAZLQTJBIFN-DVZOWYKESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
77811,6m2n,DB08822,-8.8,Azilsartan medoxomil,QJFSABGVXDWMIW-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
112696,6vxx,DB07741,-8.8,"4-(1R,3AS,4R,8AS,8BR)-[1-DIFLUOROMETHYL-2-(4-FLUOROBENZYL)-3-OXODECAHYDROPYRROLO[3,4-A]PYRROLIZIN-4-YL]BENZAMIDINE",VPNYXOTTXAXSIH-SXYSDOLCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
74047,6m2n,DB02834,-8.8,IDD552,ZCAGEXZTORJQDZ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
71630,6lxt,DB14935,-8.8,Serabelisib,BLGWHBSBBJNKJO-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
78634,6m2n,DB12046,-8.8,Atopaxar,QWKAUGRRIXBIPO-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
124979,6w4h,DB01879,-8.8,(S)-2-{Methyl-[2-(Naphthalene-2-Sulfonylamino)-5-(Naphthalene-2-Sulfonyloxy)-Benzoyl]-Amino}-Succinicacid,JOAALZBSMWLOPQ-LJAQVGFWSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
109306,6vxx,DB13046,-8.8,Tocladesine,CLLFEJLEDNXZNR-UUOKFMHZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165185,7bv1,DB11487,-8.8,Dexamethasone isonicotinate,BQTXJHAJMDGOFI-NJLPOHDGSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
79358,6m2n,DB13135,-8.8,AGN-201904,PPCGSVWOZKNPCX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
114901,6vxx,DB15362,-8.8,LSZ-102,SJXNPGGVGZXKKI-NYYWCZLTSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55359,6crv,DB00913,-8.8,Anileridine,LKYQLAWMNBFNJT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110352,6vxx,DB01497,-8.8,Etorphine,CAHCBJPUTCKATP-HBDRVVKHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72200,6m2n,DB00457,-8.8,Prazosin,IENZQIKPVFGBNW-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
110351,6vxx,DB01496,-8.8,Barbituric acid derivative,DNZPLHRZXUJATK-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
137442,6w9c,DB08303,-8.8,"(3S)-3-cyclopentyl-6-methyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide",CUMKMTBOHBENJI-SFHVURJKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
124941,6w4h,DB01830,-8.8,"{4-[2-Acetylamino-2-(3-Carbamoyl-2-Cyclohexylmethoxy-6,7,8,9-Tetrahydro-5h-Benzocyclohepten-5ylcarbamoyl)-Ethyl]-2-Phosphono-Phenyl}-Phosphonic Acid",SPSGYTWOIGAABK-DQEYMECFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
140053,6w9c,DB14854,-8.8,TC-6987,UAKZGMMGIMKFMV-RBUKOAKNSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
80336,6m2n,DB15156,-8.8,ABT-072,XMZSTQYSBYEENY-RMKNXTFCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
55352,6crv,DB00906,-8.8,Tiagabine,PBJUNZJWGZTSKL-MRXNPFEDSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79397,6m2n,DB13223,-8.8,Fluocortin,PUWHHWCHAVXSIG-NCLPIGKXSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
72915,6m2n,DB01342,-8.8,Forasartan,YONOBYIBNBCDSJ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
28504,6cs2,DB08095,-8.8,"3-(2-CHLOROPHENYL)-1-(2-{[(1S)-2-HYDROXY-1,2-DIMETHYLPROPYL]AMINO}PYRIMIDIN-4-YL)-1-(4-METHOXYPHENYL)UREA",ZWYFTKPEHRQCCW-HNNXBMFYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
140074,6w9c,DB14889,-8.8,Derazantinib,KPJDVVCDVBFRMU-AREMUKBSSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
109363,6vxx,DB13471,-8.8,Nalfurafine,XGZZHZMWIXFATA-UEZBDDGYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79457,6m2n,DB13308,-8.8,Oxametacin,AJRNYCDWNITGHF-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
165093,7bv1,DB11275,-8.8,Epicriptine,SBFXHXZNBNFPHV-PXXBSISHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
72905,6m2n,DB01328,-8.8,Cefonicid,DYAIAHUQIPBDIP-AXAPSJFSSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
54871,6crv,DB00328,-8.8,Indometacin,CGIGDMFJXJATDK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55325,6crv,DB00875,-8.8,Flupentixol,NJMYODHXAKYRHW-DVZOWYKESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80306,6m2n,DB15099,-8.8,GW-468816,XDKRVNKVAKCFGW-WXWBBQJKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
124890,6w4h,DB01763,-8.8,7-thionicotinamide-adenine-dinucleotide phosphate,OJNFDOAQUXJWED-NNYOXOHSSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
72898,6m2n,DB01319,-8.8,Fosamprenavir,MLBVMOWEQCZNCC-OEMFJLHTSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
54891,6crv,DB00353,-8.8,Methylergometrine,UNBRKDKAWYKMIV-QWQRMKEZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55293,6crv,DB00839,-8.8,Tolazamide,OUDSBRTVNLOZBN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79356,6m2n,DB13129,-8.8,Trimegestone,JUNDJWOLDSCTFK-MTZCLOFQSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
55369,6crv,DB00923,-8.8,Ceforanide,SLAYUXIURFNXPG-CRAIPNDOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
125010,6w4h,DB01933,-8.8,7-Hydroxystaurosporine,PBCZSGKMGDDXIJ-HQCWYSJUSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
110397,6vxx,DB01548,-8.8,Diprenorphine,OIJXLIIMXHRJJH-KNLIIKEYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79149,6m2n,DB12812,-8.8,Palomid 529,YEAHTLOYHVWAKW-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
140252,6w9c,DB15446,-8.8,Vidofludimus,XPRDUGXOWVXZLL-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
110614,6vxx,DB02010,-8.8,Staurosporine,HKSZLNNOFSGOKW-FYTWVXJKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136951,6w9c,DB07729,-8.8,3-fluoro-N-[3-(1H-tetrazol-5-yl)phenyl]benzamide,GAKOBKPDJJGRIL-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
109165,6vxx,DB12465,-8.8,Ketanserin,FPCCSQOGAWCVBH-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55470,6crv,DB01041,-8.8,Thalidomide,UEJJHQNACJXSKW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140240,6w9c,DB15424,-8.8,Bfpet F-18,QWPLCHDPESWJRN-FNNGWQQSSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
109178,6vxx,DB12480,-8.8,Betulinic Acid,QGJZLNKBHJESQX-FZFNOLFKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
137569,6w9c,DB08459,-8.8,"3-chloro-5-[2-chloro-5-(1H-pyrazolo[3,4-b]pyridin-3-ylmethoxy)phenoxy]benzonitrile",SVMHTBVIPYVDIL-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
80434,6m2n,DB15346,-8.8,GLPG-1205,IRBAWVGZNJIROV-SFHVURJKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79196,6m2n,DB12888,-8.8,Ezutromid,KSGCNXAZROJSNW-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
136993,6w9c,DB07778,-8.8,FAMOXADONE,PCCSBWNGDMYFCW-QFIPXVFZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137000,6w9c,DB07786,-8.8,"1-((1R,2S)-1-{2-[2-(4-CHLOROPHENYL)-1,3-BENZOXAZOL-7-YL]ETHYL}-2-HYDROXYPROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE",SMFRBBHLVBWHGB-DJJJIMSYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
109211,6vxx,DB12899,-8.8,TT-301,ZPJGUEPHFXPAQF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72881,6m2n,DB01264,-8.8,Darunavir,CJBJHOAVZSMMDJ-HEXNFIEUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
109216,6vxx,DB12904,-8.8,ZSTK-474,HGVNLRPZOWWDKD-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79229,6m2n,DB12937,-8.8,Quercetin-3'-O-phosphate,UWJBYNLLMAPJMM-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79231,6m2n,DB12939,-8.8,Nikkomycin Z,WWJFFVUVFNBJTN-VHDFTHOZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79239,6m2n,DB12949,-8.8,PF-03382792,AGMOFKKOVMRGAK-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
54703,6crv,DB00136,-8.8,Calcitriol,GMRQFYUYWCNGIN-NKMMMXOESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
137539,6w9c,DB08423,-8.8,[5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL][3-(PIPERIDIN-4-YLOXY)PHENYL]METHANONE,QKZZJXRGCHXIAI-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
109247,6vxx,DB12949,-8.8,PF-03382792,AGMOFKKOVMRGAK-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80381,6m2n,DB15242,-8.8,MK-0533,STWITCBWQHTJFJ-XMMPIXPASA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
164516,7bv1,DB08097,-8.8,"2-(2,6-DIFLUOROPHENOXY)-N-(2-FLUOROPHENYL)-9-ISOPROPYL-9H-PURIN-8-AMINE",OGWSGDLIXOEZJG-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110447,6vxx,DB01608,-8.8,Periciazine,LUALIOATIOESLM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80371,6m2n,DB15224,-8.8,Lisavanbulin,NIPZLALJRAHABJ-IBGZPJMESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137030,6w9c,DB07817,-8.8,"1-{3-[(4-pyridin-2-ylpiperazin-1-yl)sulfonyl]phenyl}-3-(1,3-thiazol-2-yl)urea",NJPVZSIGDRLLTD-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
79285,6m2n,DB13024,-8.8,MK-8245,UJEAABFSXKCSGI-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
73001,6m2n,DB01471,-8.8,Bolasterone,IVFYLRMMHVYGJH-VLOLGRDOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
140041,6w9c,DB14821,-8.8,Macozinone,BJDZBXGJNBMCAV-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
109219,6vxx,DB12910,-8.8,Emicerfont,JFHJGXQFESYQGY-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55479,6crv,DB01053,-8.8,Benzylpenicillin,JGSARLDLIJGVTE-MBNYWOFBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
164619,7bv1,DB08213,-8.8,"1-METHYL-5-(2-PHENOXYMETHYL-PYRROLIDINE-1-SULFONYL)-1H-INDOLE-2,3-DIONE",PFAYCUAUBOGVDX-AWEZNQCLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110191,6vxx,DB01081,-8.8,Diphenoxylate,HYPPXZBJBPSRLK-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
137224,6w9c,DB08039,-8.8,"(3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE",LOGJQOUIVKBFGH-YBEGLDIGSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
55001,6crv,DB00486,-8.8,Nabilone,GECBBEABIDMGGL-RTBURBONSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79963,6m2n,DB14054,-8.8,Asiatic acid,JXSVIVRDWWRQRT-UYDOISQJSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
109920,6vxx,DB00591,-8.8,Fluocinolone acetonide,FEBLZLNTKCEFIT-VSXGLTOVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55030,6crv,DB00525,-8.8,Tolnaftate,FUSNMLFNXJSCDI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72591,6m2n,DB00923,-8.8,Ceforanide,SLAYUXIURFNXPG-CRAIPNDOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
55160,6crv,DB00683,-8.8,Midazolam,DDLIGBOFAVUZHB-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
124543,6w4h,DB01289,-8.8,Glisoxepide,ZKUDBRCEOBOWLF-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
80054,6m2n,DB14538,-8.8,Hydrocortisone aceponate,MFBMYAOAMQLLPK-FZNHGJLXSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
55044,6crv,DB00543,-8.8,Amoxapine,QWGDMFLQWFTERH-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
124529,6w4h,DB01259,-8.8,Lapatinib,BCFGMOOMADDAQU-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
72409,6m2n,DB00713,-8.8,Oxacillin,UWYHMGVUTGAWSP-JKIFEVAISA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
164865,7bv1,DB08703,-8.8,"12-(2-hydroxyethyl)-2-(1-methylethoxy)-13,14-dihydronaphtho[2,1-a]pyrrolo[3,4-c]carbazol-5(12H)-one",FGKKIHITEICGMN-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
124527,6w4h,DB01254,-8.8,Dasatinib,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
72511,6m2n,DB00834,-8.8,Mifepristone,VKHAHZOOUSRJNA-GCNJZUOMSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80164,6m2n,DB14768,-8.8,PF-06459988,ODMXWZROLKITMS-RISCZKNCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
55148,6crv,DB00670,-8.8,Pirenzepine,RMHMFHUVIITRHF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55063,6crv,DB00564,-8.8,Carbamazepine,FFGPTBGBLSHEPO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55137,6crv,DB00656,-8.8,Trazodone,PHLBKPHSAVXXEF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55065,6crv,DB00567,-8.8,Cephalexin,ZAIPMKNFIOOWCQ-UEKVPHQBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
137272,6w9c,DB08097,-8.8,"2-(2,6-DIFLUOROPHENOXY)-N-(2-FLUOROPHENYL)-9-ISOPROPYL-9H-PURIN-8-AMINE",OGWSGDLIXOEZJG-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
109736,6vxx,DB15232,-8.8,Telaglenastat,PRAAPINBUWJLGA-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80131,6m2n,DB14679,-8.8,Quingestanol acetate,FLGJKPPXEKYCBY-AKCFYGDASA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137257,6w9c,DB08079,-8.8,AMG-208,HEAIZQNMNCHNFD-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
55128,6crv,DB00643,-8.8,Mebendazole,OPXLLQIJSORQAM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140165,6w9c,DB15106,-8.8,Surufatinib,TTZSNFLLYPYKIL-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
80125,6m2n,DB14673,-8.8,Flurandrenolide acetate,AUDPKCCPWYXNEV-XTLNBZDDSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
124417,6w4h,DB01126,-8.8,Dutasteride,JWJOTENAMICLJG-QWBYCMEYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
164745,7bv1,DB08553,-8.8,"(1E)-5-(1-piperidin-4-yl-3-pyridin-4-yl-1H-pyrazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime",KWEFZSZCLBHIEQ-YYADALCUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
124563,6w4h,DB01337,-8.8,Pancuronium,GVEAYVLWDAFXET-XGHATYIMSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
79904,6m2n,DB13939,-8.8,RAD-140,XMBUPPIEVAFYHO-KPZWWZAWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
55179,6crv,DB00704,-8.8,Naltrexone,DQCKKXVULJGBQN-XFWGSAIBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55186,6crv,DB00712,-8.8,Flurbiprofen,SYTBZMRGLBWNTM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140092,6w9c,DB14929,-8.8,Elsulfavirine,ULTDEARCBRNRGR-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140104,6w9c,DB14944,-8.8,Tarloxotinib,MUJMYVFVAWFUJL-SNAWJCMRSA-O,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137135,6w9c,DB07941,-8.8,PH-797804,KCAJXIDMCNPGHZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
109496,6vxx,DB13991,-8.8,Pipequaline,AMEWZCMTSIONOX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72785,6m2n,DB01148,-8.8,Flavoxate,SPIUTQOUKAMGCX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
110097,6vxx,DB00973,-8.8,Ezetimibe,OLNTVTPDXPETLC-XPWALMASSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110089,6vxx,DB00962,-8.8,Zaleplon,HUNXMJYCHXQEGX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72751,6m2n,DB01108,-8.8,Trilostane,KVJXBPDAXMEYOA-CXANFOAXSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
109525,6vxx,DB14054,-8.8,Asiatic acid,JXSVIVRDWWRQRT-UYDOISQJSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109533,6vxx,DB14066,-8.8,Tetrandrine,WVTKBKWTSCPRNU-KYJUHHDHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140127,6w9c,DB15033,-8.8,Flortaucipir,GETAAWDSFUCLBS-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
79812,6m2n,DB13778,-8.8,Cefazedone,VTLCNEGVSVJLDN-MLGOLLRUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
109536,6vxx,DB14069,-8.8,ONT-093,RSJCLODJSVZNQA-BQYQJAHWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55239,6crv,DB00776,-8.8,Oxcarbazepine,CTRLABGOLIVAIY-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140086,6w9c,DB14914,-8.8,Flortaucipir F-18,GETAAWDSFUCLBS-SJPDSGJFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
109551,6vxx,DB14097,-8.8,13-cis-12-(3'-Carboxyphenyl)retinoic acid,XKKDQOHDTASHCE-PAZAWXFKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109597,6vxx,DB14209,-8.8,Trandolaprilat,AHYHTSYNOHNUSH-HXFGRODQSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109601,6vxx,DB14214,-8.8,Rose bengal lactone,IICCLYANAQEHCI-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79834,6m2n,DB13806,-8.8,Linopirdine,YEJCDKJIEMIWRQ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
109613,6vxx,DB14512,-8.8,Mometasone furoate,WOFMFGQZHJDGCX-ZULDAHANSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80228,6m2n,DB14906,-8.8,Adafosbuvir,NIJYGVDQZBBONK-SEUXLIJBSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
140136,6w9c,DB15048,-8.8,Licogliflozin,XFJAMQQAAMJFGB-ZQGJOIPISA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137189,6w9c,DB08003,-8.8,ISOTHIAZOLIDINONE ANALOG,UILYPHAKDBTKQV-UFYCRDLUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
72373,6m2n,DB00673,-8.8,Aprepitant,ATALOFNDEOCMKK-OITMNORJSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
72380,6m2n,DB00680,-8.8,Moricizine,FUBVWMNBEHXPSU-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
109641,6vxx,DB15048,-8.8,Licogliflozin,XFJAMQQAAMJFGB-ZQGJOIPISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72385,6m2n,DB00687,-8.8,Fludrocortisone,AAXVEMMRQDVLJB-BULBTXNYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79893,6m2n,DB13919,-8.8,Candesartan,HTQMVQVXFRQIKW-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
164956,7bv1,DB09003,-8.8,Clocapramine,QAZKXHSIKKNOHH-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
79898,6m2n,DB13930,-8.8,Ulixertinib,KSERXGMCDHOLSS-LJQANCHMSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
72371,6m2n,DB00671,-8.8,Cefixime,OKBVVJOGVLARMR-QSWIMTSFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80468,6m2n,DB15424,-8.8,Bfpet F-18,QWPLCHDPESWJRN-FNNGWQQSSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
140019,6w9c,DB14766,-8.8,Etrasimod,MVGWUTBTXDYMND-QGZVFWFLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137602,6w9c,DB08497,-8.8,"(1S)-2-oxo-1-phenyl-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate",NKBDSMREMMRFSI-INIZCTEOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
80930,6m3m,DB00605,-8.8,Sulindac,MLKXDPUZXIRXEP-MFOYZWKCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
28824,6cs2,DB08444,-8.8,"3-[2-bromo-4-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)phenoxy]-5-methylbenzonitrile",YYGZQXRLQMFHDH-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
80929,6m3m,DB00604,-8.8,Cisapride,DCSUBABJRXZOMT-IRLDBZIGSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
33019,6cs2,T3D3951,-8.8,Demeclocycline,FMTDIUIBLCQGJB-SEYHBJAFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
80917,6m3m,DB00589,-8.8,Lisuride,BKRGVLQUQGGVSM-KBXCAEBGSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
71726,6lxt,DB15157,-8.8,Voruciclib,MRPGRAKIAJJGMM-OCCSQVGLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
137924,6w9c,DB08903,-8.8,Bedaquiline,QUIJNHUBAXPXFS-XLJNKUFUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
80888,6m3m,DB00554,-8.8,Piroxicam,QYSPLQLAKJAUJT-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
55694,6crv,DB01348,-8.8,Spirapril,HRWCVUIFMSZDJS-SZMVWBNQSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
18944,6cs2,HMDB0041744,-8.8,"Hesperetin 5,7-O-diglucuronide",DDHZYRQUEFLRIC-HXPBIGRZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
139917,6w9c,DB14545,-8.8,Hydrocortisone succinate,VWQWXZAWFPZJDA-CGVGKPPMSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139924,6w9c,DB14569,-8.8,Tedizolid,XFALPSLJIHVRKE-GFCCVEGCSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
55690,6crv,DB01339,-8.8,Vecuronium,BGSZAXLLHYERSY-XQIGCQGXSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108762,6vxx,DB08930,-8.8,Dolutegravir,RHWKPHLQXYSBKR-BMIGLBTASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111631,6vxx,DB04301,-8.8,Bis(5-Amidino-2-Benzimidazolyl)Methane Ketone Hydrate,ZLAHDRAQCSQPOC-UHFFFAOYSA-P,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78788,6m2n,DB12270,-8.8,Losmapimod,KKYABQBFGDZVNQ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
71740,6lxt,DB15191,-8.8,MAX-40279,AVIOBQFPAGEICQ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
111594,6vxx,DB04254,-8.8,"8-Benzo[1,3]Dioxol-,5-Ylmethyl-9-Butyl-2-Fluoro-9h-Purin-6-Ylamine",ARWHTQLGMWHTAZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
9481,6lzg,DB07586,-8.8,"5-(4-METHYL-BENZOYLAMINO)-BIPHENYL-3,4'-DICARBOXYLIC ACID 3-DIMETHYLAMIDE-4'-HYDROXYAMIDE",DOPFUKKMSDUVTQ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
18951,6cs2,HMDB0041787,-8.8,Urolithin B 3-O-glucuronide,MHBWCULXQBVPQT-KSPMYQCISA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
140368,6w9c,DB04706,-8.8,"(3BETA,7BETA)-CHOLEST-5-ENE-3,7-DIOL",OYXZMSRRJOYLLO-KGZHIOMZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
78805,6m2n,DB12290,-8.8,Puerarin,HKEAFJYKMMKDOR-VPRICQMDSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
33081,6cs2,T3D4061,-8.8,Veratridine,FVECELJHCSPHKY-UIHGVQCZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
137901,6w9c,DB08861,-8.8,DPDPE,MCMMCRYPQBNCPH-WMIMKTLMSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
111564,6vxx,DB04042,-8.8,"2-[4-(Hydroxy-Methoxy-Methyl)-Benzyl]-7-(4-Hydroxymethyl-Benzyl)-1,1-Dioxo-3,6-Bis-Phenoxymethyl-1lambda6-[1,2,7]Thiadiazepane-4,5-Diol",XLJNZONSWKENRP-VABIIVNOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111550,6vxx,DB04020,-8.8,"4-(2-{[4-{[3-(4-Chlorophenyl)Propyl]Sulfanyl}-6-(1-Piperazinyl)-1,3,5-Triazin-2-Yl]Amino}Ethyl)Phenol",AIBKIFHSQQYXLG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
125693,6w4h,DB02827,-8.8,"7-(1,1-Dioxo-1h-Benzo[D]Isothiazol-3-Yloxymethyl)-2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Pyran-3-Carboxylic Acid",MDYIGSPVMWSFEZ-JTQLQIEISA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
108814,6vxx,DB09371,-8.8,Norethynodrel,ICTXHFFSOAJUMG-SLHNCBLASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
73806,6m2n,DB02510,-8.8,'5'-O-(N-(L-Prolyl)-Sulfamoyl)Adenosine,LKVJEMXWEODCAY-JVEUSOJLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
165377,7bv1,DB12010,-8.8,Fostamatinib,GKDRMWXFWHEQQT-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
123320,6w4b,DB15305,-8.8,Risdiplam,ASKZRYGFUPSJPN-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
80936,6m3m,DB00611,-8.8,Butorphanol,IFKLAQQSCNILHL-PWRODBHTSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
111713,6vxx,DB04421,-8.8,Nicotinamide Adenine Dinucleotide 3-Pentanone Adduct,BZJFKYRGSZWSLT-YLIVDTKOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
123157,6w4b,DB14946,-8.8,PCO-371,LDZJFVOUPUFOHX-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
108554,6vxx,DB08389,-8.8,"6,7-DIMETHOXY-4-[(3R)-3-(2-NAPHTHYLOXY)PYRROLIDIN-1-YL]QUINAZOLINE",UPTQSRGSSJRBKJ-LJQANCHMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138030,6w9c,DB09050,-8.8,Ceftolozane,JHFNIHVVXRKLEF-DCZLAGFPSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
74041,6m2n,DB02827,-8.8,"7-(1,1-Dioxo-1h-Benzo[D]Isothiazol-3-Yloxymethyl)-2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Pyran-3-Carboxylic Acid",MDYIGSPVMWSFEZ-JTQLQIEISA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
29867,6cs2,DB11742,-8.8,Ebastine,MJJALKDDGIKVBE-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
74022,6m2n,DB02804,-8.8,A-98881,PMBZSBGCSQGJAQ-GRKNLSHJSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
111899,6vxx,DB04841,-8.8,Flunarizine,SMANXXCATUTDDT-QPJJXVBHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138028,6w9c,DB09047,-8.8,Finafloxacin,FYMHQCNFKNMJAV-HOTGVXAUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
78659,6m2n,DB12082,-8.8,Vesnarinone,ZVNYJIZDIRKMBF-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
111858,6vxx,DB04793,-8.8,"1,4:3,6-Dianhydro-2-O-(3-carbamimidoylphenyl)-5-O-(4-carbamimidoylphenyl)-D-glucitol",DKBAWRNTUZFJKV-XMTFNYHQSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55761,6crv,DB01453,-8.8,Beta-hydroxyfentanyl,JEFVHLMGRUJLET-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78692,6m2n,DB12128,-8.8,Ulimorelin,WGYPAJVJMXQXTR-ABNZCKJZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137971,6w9c,DB08970,-8.8,Fluprednidene,YVHXHNGGPURVOS-SBTDHBFYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140396,6w9c,DB05944,-8.8,Varlitinib,UWXSAYUXVSFDBQ-CYBMUJFWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
123373,6w4b,DB15416,-8.8,PX-102,XBUXXJUEBFDQHD-NHCUHLMSSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
78707,6m2n,DB12149,-8.8,S-3304,YWCLDDLVLSQGSZ-JOCHJYFZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
164229,7bv1,DB07404,-8.8,"(1-HYDROXY-1-PHOSPHONO-2-[1,1';3',1'']TERPHENYL-3-YL-ETHYL)-PHOSPHONIC ACID",YXQQNSYZOQHKHD-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
108646,6vxx,DB08499,-8.8,"N-[3-(2-fluoroethoxy)phenyl]-N'-(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-6-yl)butanediamide",DQXBKUVWJSZHSI-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111804,6vxx,DB04716,-8.8,"2-(1,1-DIMETHYLETHYL)9-FLUORO-3,6-DIHYDRO-7H-BENZ[H]-IMIDAZ[4,5-F]ISOQUINOLIN-7-ONE",VNDWQCSOSCCWIP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114199,6vxx,DB12890,-8.8,Dihydrexidine,BGOQGUHWXBGXJW-YOEHRIQHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
137938,6w9c,DB08927,-8.8,Amperozide,NNAIYOXJNVGUOM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
165400,7bv1,DB12048,-8.8,Savolitinib,XYDNMOZJKOGZLS-NSHDSACASA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
136733,6w9c,DB07468,-8.8,"(3aS)-3a-hydroxy-5-methyl-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one",NJBBBRZNBVLTRZ-GOSISDBHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
80970,6m3m,DB00656,-8.8,Trazodone,PHLBKPHSAVXXEF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
164244,7bv1,DB07422,-8.8,(2S)-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]-3-(pentafluorophenoxy)propanamide,MMNRWNREMUMYQG-INIZCTEOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
136736,6w9c,DB07471,-8.8,"5-[5,6-BIS(METHYLOXY)-1H-BENZIMIDAZOL-1-YL]-3-{[1-(2-CHLOROPHENYL)ETHYL]OXY}-2-THIOPHENECARBOXAMIDE",UHCHLTQBLNUYRT-GFCCVEGCSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
108699,6vxx,DB08820,-8.8,Ivacaftor,PURKAOJPTOLRMP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
116405,6w4b,DB02112,-8.8,Zk-806450,DZLGSWPXZYDHBD-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
123310,6w4b,DB15291,-8.8,BMS-986142,ZRYMMWAJAFUANM-INIZCTEOSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
125850,6w4h,DB03038,-8.8,LY341770,MXAFDBCLWLMXSI-ZDUSSCGKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
55738,6crv,DB01426,-8.8,Ajmaline,CJDRUOGAGYHKKD-HEFSZTOGSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55681,6crv,DB01327,-8.8,Cefazolin,MLYYVTUWGNIJIB-BXKDBHETSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114784,6vxx,DB14856,-8.8,PF-05089771,ZYSCOUXLBXGGIM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
10471,6lzg,DB08674,-8.8,"(20S)-19,20,21,22-TETRAHYDRO-19-OXO-5H-18,20-ETHANO-12,14-ETHENO-6,10-METHENO-18H-BENZ[D]IMIDAZO[4,3-K][1,6,9,12]OXATRIAZA-CYCLOOCTADECOSINE-9-CARBONITRILE",USPFJPDEADLGIG-HSZRJFAPSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
111010,6vxx,DB02877,-8.8,Arotinoid acid,FOIVPCKZDPCJJY-JQIJEIRASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
34170,6cs2,T3D1033,-8.8,Cyphenothrin,FJDPATXIBIBRIM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
78996,6m2n,DB12567,-8.8,Camicinal,RZKDEGZIFSJVNA-IBGZPJMESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
28091,6cs2,DB07666,-8.8,"(3R,4S)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE",OAWGQHXWGXOUKV-BEFAXECRSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
34218,6cs2,T3D1188,-8.8,Chlorophyllin,UVOXKYYHMDAWNK-UHFFFAOYSA-L,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
79001,6m2n,DB12574,-8.8,LY-295501,VAMFSFIPDOODFH-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
71867,6lxt,DB15444,-8.8,Elexacaftor,MVRHVFSOIWFBTE-INIZCTEOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
73501,6m2n,DB02115,-8.8,Daidzin,KYQZWONCHDNPDP-QNDFHXLGSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80620,6m3m,DB00231,-8.8,Temazepam,SEQDDYPDSLOBDC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
55538,6crv,DB01120,-8.8,Gliclazide,BOVGTQGAOIONJV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
73446,6m2n,DB02046,-8.8,N-[(Furan-2-Yl)Carbonyl]-(S)-Leucyl-(R)-[1-Amino-2(1h-Indol-3-Yl)Ethyl]-Phosphonic Acid,WHPKSASOSKNDPY-PKOBYXMFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
136897,6w9c,DB07665,-8.8,"N-[2-(carbamimidamidooxy)ethyl]-2-{6-cyano-3-[(2,2-difluoro-2-pyridin-2-ylethyl)amino]-2-fluorophenyl}acetamide",STHCHQXQLDMISY-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
34502,1r42,DB00320,-8.8,Dihydroergotamine,LUZRJRNZXALNLM-JGRZULCMSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
137657,6w9c,DB08560,-8.8,3-FLUORO-N-[1-(4-FLUOROPHENYL)-3-(2-THIENYL)-1H-PYRAZOL-5-YL]BENZENESULFONAMIDE,GULUFDCOGAXLEP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137735,6w9c,DB08657,-8.8,2-(4-(2-((3-(5-(PYRIDIN-2-YLTHIO)THIAZOL-2-YL)UREIDO)METHYL)-1H-IMIDAZOL-4-YL)PHENOXY)ACETIC ACID,SSXCWVOQWRUMGN-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
80583,6m3m,DB00186,-8.8,Lorazepam,DIWRORZWFLOCLC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
109083,6vxx,DB12009,-8.8,GW-406381,NXMZBNYLCVTRGB-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28652,6cs2,DB08248,-8.8,3-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)-BENZENESULFONAMIDE,BKDUVKJYBJDZQW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
109092,6vxx,DB12364,-8.8,Betrixaban,XHOLNRLADUSQLD-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136909,6w9c,DB07679,-8.8,"(9S,12S)-9-(1-methylethyl)-7,10-dioxo-2-oxa-8,11-diazabicyclo[12.2.2]octadeca-1(16),14,17-triene-12-carboxylic acid",RRAAROKJUVKWAF-RDJZCZTQSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136910,6w9c,DB07680,-8.8,[(1S)-1-(5-CHLORO-1-BENZOTHIEN-3-YL)-2-(2-NAPHTHYLAMINO)-2-OXOETHYL]PHOSPHONIC ACID,HUJXISJLAPAFBO-IBGZPJMESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
28119,6cs2,DB07697,-8.8,"1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-4-[(4-methoxyphenyl)sulfonyl]piperazine",HMGDKYUJSFVHIY-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
110742,6vxx,DB02358,-8.8,LY374571,SZHRIPFGZWWRKW-VIFPVBQESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
37248,1r42,DB04016,-8.8,2-[3-({Methyl[1-(2-Naphthoyl)Piperidin-4-Yl]Amino}Carbonyl)-2-Naphthyl]-1-(1-Naphthyl)-2-Oxoethylphosphonic Acid,XUJQPDQURBZEGJ-KXQOOQHDSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
109108,6vxx,DB12388,-8.8,Evocalcet,RZNUIYPHQFXBAN-XLIONFOSSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
73324,6m2n,DB01876,-8.8,Bis(5-Amidino-2-Benzimidazolyl)Methanone,VVVXDHROXQUONB-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
136919,6w9c,DB07692,-8.8,"1-[(2,6-difluorophenyl)sulfonyl]-4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)piperazine",SHWNKRPMUBFWKE-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
110685,6vxx,DB02102,-8.8,DMP450,KYRSNWPSSXSNEP-ZRTHHSRSSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
137603,6w9c,DB08498,-8.8,"(1S)-1-(3-chlorophenyl)-2-oxo-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate",OVSAMUIBGQSLDC-INIZCTEOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
80472,6m2n,DB15431,-8.8,M-2698,HXAUJHZZPCBFPN-QGZVFWFLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
114778,6vxx,DB14845,-8.8,Filgotinib,RIJLVEAXPNLDTC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107267,6vxx,DB02790,-8.8,Phenyl-Uridine-5'-Diphosphate,ZHUWBKDWWGKIEN-FMKGYKFTSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
73544,6m2n,DB02177,-8.8,1-Acetyl-4-(4-{4-[(2-Ethoxyphenyl)Thio]-3-Nitrophenyl}Pyridin-2-Yl)Piperazine,GKGJFUXSTSUKPB-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
109009,6vxx,DB11901,-8.8,Apalutamide,HJBWBFZLDZWPHF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55676,6crv,DB01319,-8.8,Fosamprenavir,MLBVMOWEQCZNCC-OEMFJLHTSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28033,6cs2,DB07607,-8.8,4-[5-(3-IODO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-1H-IMIDAZOL-4-YL]-PYRIDINE,RXDZANYWRNIAOR-HHHXNRCGSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
125625,6w4h,DB02732,-8.8,Nicotinamide Adenine Dinucleotide Acetone Adduct,SGHBFOOIAAJJMI-YDKVLQLQSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
80800,6m3m,DB00445,-8.8,Epirubicin,AOJJSUZBOXZQNB-VTZDEGQISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
55652,6crv,DB01252,-8.8,Mitiglinide,WPGGHFDDFPHPOB-BBWFWOEESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
164398,7bv1,DB07787,-8.8,"5-FLUORO-1-[4-(4-PHENYL-3,6-DIHYDROPYRIDIN-1(2H)-YL)BUTYL]QUINAZOLINE-2,4(1H,3H)-DIONE",PNPFDRCIGCUCMN-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
78866,6m2n,DB12379,-8.8,Indirubin,CRDNMYFJWFXOCH-BUHFOSPRSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
55637,6crv,DB01234,-8.8,Dexamethasone,UREBDLICKHMUKA-CXSFZGCWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78896,6m2n,DB12417,-8.8,Anagliptin,LDXYBEHACFJIEL-HNNXBMFYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
111314,6vxx,DB03490,-8.8,"3-Pyridin-4-Yl-2,4-Dihydro-Indeno[1,2-.C.]Pyrazole",NHOACLCXCKJMAK-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111305,6vxx,DB03478,-8.8,2'-O-Acetyl Adenosine-5-Diphosphoribose,BFNOPXRXIQJDHO-DLFWLGJNSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136826,6w9c,DB07578,-8.8,"3-[4-(2-METHYL-IMIDAZO[4,5-C]PYRIDIN-1-YL)BENZYL]-3H-BENZOTHIAZOL-2-ONE",WUOLYUKMMRCXGH-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
123481,6w4b,DB00210,-8.8,Adapalene,LZCDAPDGXCYOEH-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
78910,6m2n,DB12434,-8.8,Steviolbioside,OMHUCGDTACNQEX-OSHKXICASA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137774,6w9c,DB08707,-8.8,"4-[3-(4-chlorophenyl)-2,1-benzisoxazol-5-yl]pyrimidin-2-amine",AQVFETGXIRKVAQ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
80743,6m3m,DB00377,-8.8,Palonosetron,CPZBLNMUGSZIPR-NVXWUHKLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
139958,6w9c,DB14649,-8.8,Dexamethasone acetate,AKUJBENLRBOFTD-RPRRAYFGSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136830,6w9c,DB07584,-8.8,"N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine",OKGCSZUKOGMZAL-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139961,6w9c,DB14652,-8.8,Clocortolone acetate,ARPLCFGLEYFDCN-CDACMRRYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
78926,6m2n,DB12461,-8.8,GLPG-0492,VAJGULUVTFDTAS-GOSISDBHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
28063,6cs2,DB00699,-8.8,Nicergoline,YSEXMKHXIOCEJA-FVFQAYNVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
109000,6vxx,DB11890,-8.8,Cilengitide,AMLYAMJWYAIXIA-VWNVYAMZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111204,6vxx,DB03336,-8.8,BIA,KVIVJQWOYSWCCZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28728,6cs2,DB08339,-8.8,"6-(2,6-DICHLOROPHENYL)-2-{[3-(HYDROXYMETHYL)PHENYL]AMINO}-8-METHYLPYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE",ZIQFYVPVJZEOFS-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
9578,6lzg,DB07691,-8.8,"2-({[3-(3,4-dihydroisoquinolin-2(1H)-ylsulfonyl)phenyl]carbonyl}amino)benzoic acid",GYILVHHTCYNIOS-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
111190,6vxx,DB03315,-8.8,Guanosine 3'-monophosphate,ZDPUTNZENXVHJC-UUOKFMHZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
71842,6lxt,DB15396,-8.8,PF-114,SLIVDYMORZGPLW-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
78939,6m2n,DB12477,-8.8,Perfluoro tert-butylcyclohexane,VLTXBOGHSBHSAC-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
111159,6vxx,DB03076,-8.8,AHA047,CGBDAHCDSVOMCF-FYZVQMPESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
137782,6w9c,DB08715,-8.8,"2,6-DIMETHYL-1-(3-[3-METHYL-5-ISOXAZOLYL]-PROPANYL)-4-[2-METHYL-4-ISOXAZOLYL]-PHENOL",SLPKYEWAKMNCPT-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
55606,6crv,DB01195,-8.8,Flecainide,DJBNUMBKLMJRSA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31511,6cs2,DB13941,-8.8,Piperaquine,UCRHFBCYFMIWHC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
137266,6w9c,DB08091,-8.8,3-FLUORO-5-MORPHOLIN-4-YL-N-[3-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-5-YL]BENZAMIDE,HIUFYIOMUILESI-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
76751,6m2n,DB07568,-8.8,"(2S)-2-[(2,1,3-BENZOTHIADIAZOL-4-YLSULFONYL)AMINO]-2-PHENYL-N-PYRIDIN-4-YLACETAMIDE",ADRNPUSZBRQDBG-KRWDZBQOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
82935,6m3m,DB03205,-8.8,Pyrroloquinoline Quinone,MMXZSJMASHPLLR-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
11366,6lzg,DB11870,-8.8,RG-4733,OJPLJFIFUQPSJR-INIZCTEOSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
113468,6vxx,DB09223,-8.8,Blonanserin,XVGOZDAJGBALKS-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138862,6w9c,DB12371,-8.8,Siponimod,KIHYPELVXPAIDH-HNSNBQBZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
30671,6cs2,DB12817,-8.8,Zoliflodacin,ZSWMIFNWDQEXDT-ZESJGQACSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
82536,6m3m,DB02669,-8.8,RB106,ZWDQTNWLXALTOV-QYZOEREBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
114053,6vxx,DB12658,-8.8,AFN-1252,QXTWSUQCXCWEHF-JXMROGBWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30282,6cs2,DB12285,-8.8,Verubecestat,YHYKUSGACIYRML-KRWDZBQOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
56824,6crv,DB02834,-8.8,IDD552,ZCAGEXZTORJQDZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30667,6cs2,DB12808,-8.8,Trifarotene,MFBCDACCJCDGBA-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
136133,6w9c,DB06624,-8.8,Taranabant,QLYKJCMUNUWAGO-GAJHUEQPSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
106804,6vxx,DB01289,-8.8,Glisoxepide,ZKUDBRCEOBOWLF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30665,6cs2,DB12805,-8.8,Ataciguat,PQHLRGARXNPFCF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
139313,6w9c,DB13308,-8.8,Oxametacin,AJRNYCDWNITGHF-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
56795,6crv,DB02799,-8.8,N-[2-(1-Maleimidyl)Ethyl]-7-Diethylaminocoumarin-3-Carboxamide,OJBZDUMTXGGVSP-KTKRTIGZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
166446,7bv1,DB15145,-8.8,Ziresovir,GAAICKUTDBZCMT-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
29891,6cs2,DB11775,-8.8,PF-03758309,AYCPARAPKDAOEN-LJQANCHMSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
77012,6m2n,DB07872,-8.8,5-chloro-N-[(3R)-1-(2-{[2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl]amino}-2-oxoethyl)pyrrolidin-3-yl]thiophene-2-carboxamide,IYGIXVNAMZPBDK-CQSZACIVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
57108,6crv,DB03213,-8.8,Bis(5-Amidino-2-Benzimidazolyl)Methane Ketone,VVVXDHROXQUONB-UHFFFAOYSA-P,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127585,6w4h,DB06448,-8.8,Lonafarnib,DHMTURDWPRKSOA-RUZDIDTESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
139243,6w9c,DB13212,-8.8,Phenolsulfonphthalein,BELBBZDIHDAJOR-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136116,6w9c,DB06590,-8.8,Ceftaroline fosamil,ZCCUWMICIWSJIX-NQJJCJBVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
163314,7bv1,DB04244,-8.8,(2R)-2-(3-Biphenylyl)-N-{(2R)-2-hydroxy-3-[(2-pyridinylsulfonyl)amino]propyl}-4-methylpentanamide,YCDHZDINQZLSRR-DNQXCXABSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
113907,6vxx,DB12260,-8.8,Radiprodil,GKGRZLGAQZPEHO-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27484,6cs2,DB00637,-8.8,Astemizole,GXDALQBWZGODGZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
106089,6vxs,DB14995,-8.8,NP-G2-044,XLLRLAABUFOJPC-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
69807,6lxt,DB11730,-8.8,Ribociclib,RHXHGRAEPCAFML-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
114025,6vxx,DB12612,-8.8,Ozanimod,XRVDGNKRPOAQTN-FQEVSTJZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
8532,6lzg,DB06295,-8.8,Pramiconazole,AEKNYBWUEYNWMJ-QWOOXDRHSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
11263,6lzg,DB11734,-8.8,Fedovapagon,RUOLFWZIFNQQGH-DEOSSOPVSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
57083,6crv,DB03181,-8.8,"2-[4-(4-Hydroxy-3-Isopropyl-Phenoxy)-3,5-Dimethyl-Phenyl]-2h-[1,2,4]Triazine-3,5-Dione",RXQAVKWRCZYGMV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
82565,6m3m,DB02706,-8.8,Mercaptocarboxylate Inhibitor,DUKDFMPUZRDWLT-CQSZACIVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
140617,6w9c,DB12540,-8.8,Lecozotan,NRPQELCNMADTOZ-OAQYLSRUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
75757,6m2n,DB05796,-8.8,Daglutril,XMQODGUTLZXUGZ-RPBOFIJWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
57098,6crv,DB03202,-8.8,"2-[5-Methanesulfonylamino-2-(4-Aminophenyl)-6-Oxo-1,6-Dihydro-1-Pyrimidinyl]-N-(3,3,3-Trifluoro-1-Isopropyl-2-Oxopropyl)Acetamide",JWSWTHSJMGVOKE-HNNXBMFYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106790,6vxx,DB01259,-8.8,Lapatinib,BCFGMOOMADDAQU-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
135916,6w9c,DB05706,-8.8,13-deoxydoxorubicin,RGVRUQHYQSORBY-JIGXQNLBSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
106512,6vxx,DB00434,-8.8,Cyproheptadine,JJCFRYNCJDLXIK-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
83606,6m3m,DB04107,-8.8,[(1-{2[(4-Carbamimidoyl-Phenylamino)-Methyl]-1-Methyl-1h-Benzoimidazol-5-Yl}-Cyclopropyl)-Pyridin-2-Yl-Methyleneaminooxy]-Acetic Acid Ethyl Ester,RNOYCNIZOAIUSV-LSWMGQQCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
139222,6w9c,DB13158,-8.8,Clobetasone,XXIFVOHLGBURIG-OZCCCYNHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
76747,6m2n,DB07563,-8.8,"1-{7-cyclohexyl-6-[4-(4-methylpiperazin-1-yl)benzyl]-7H-pyrrolo[2,3-d]pyrimidin-2-yl}methanamine",GCJSOJRPNOWSEH-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
119623,6w4b,DB07528,-8.8,3-(2-aminoquinazolin-6-yl)-4-methyl-1-[3-(trifluoromethyl)phenyl]pyridin-2(1H)-one,HXUZQEYFKAZBPX-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
76491,6m2n,DB07268,-8.8,2-({2-[(3-HYDROXYPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)BENZAMIDE,QHPKKGUGRGRSGA-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
166287,7bv1,DB14581,-8.8,CPI-1205,HPODOLXTMDHLLC-QGZVFWFLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
29352,6cs2,DB09053,-8.8,Ibrutinib,XYFPWWZEPKGCCK-GOSISDBHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
75892,6m2n,DB06321,-8.8,R-348,IGLNXKVGKIFNBQ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
162599,7bv1,DB02473,-8.8,"6-[N-(1-Isopropyl-3,4-Dihydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine",XRHANBWAKSYPEN-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
57637,6crv,DB03926,-8.8,"5-Alpha-Androstane-3-Beta,17-Alpha-Diol",CBMYJHIOYJEBSB-MFXFBURESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56753,6crv,DB02738,-8.8,Adenosine-5'-Pentaphosphate,WYJWVZZCMBUPSP-KQYNXXCUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113724,6vxx,DB11816,-8.8,Omecamtiv Mecarbil,RFUBTTPMWSKEIW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140663,6w9c,DB13062,-8.8,ME-344,QVCAATSEPLQVBX-FPOVZHCZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
29878,6cs2,DB11759,-8.8,Pevonedistat,MPUQHZXIXSTTDU-QXGSTGNESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
30459,6cs2,DB12512,-8.8,Verucerfont,VKHVAUKFLBBZFJ-SFHVURJKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
163028,7bv1,DB03446,-8.8,N-Benzyl-3-(alpha-D-galactopyranosyloxy)benzamide,FSMWGHKWKYCPKE-QTVCLEQKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
140537,6w9c,DB12025,-8.8,Triptolide,DFBIRQPKNDILPW-CIVMWXNOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
106252,6vxs,DB15319,-8.8,VM4-037,QGYZPMXIVNIGKA-GMAHTHKFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
83032,6m3m,DB03325,-8.8,Tyrosyladenylate,MJZAZMKENKZBAJ-QTOWJTHWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
76490,6m2n,DB07267,-8.8,2-(6-methylpyridin-2-yl)-N-pyridin-4-ylquinazolin-4-amine,JONFDFIXMPXTRH-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
136150,6w9c,DB06660,-8.8,Saredutant,PGKXDIMONUAMFR-AREMUKBSSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
113360,6vxx,DB09050,-8.8,Ceftolozane,JHFNIHVVXRKLEF-DCZLAGFPSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56774,6crv,DB02766,-8.8,(3r)-3-{[(Benzyloxy)Carbonyl]Amino}-2-Oxo-4-Phenylbutane-1-Diazonium,VLIGBVLLNSWVMI-MRXNPFEDSA-O,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114710,6vxx,DB14673,-8.8,Flurandrenolide acetate,AUDPKCCPWYXNEV-XTLNBZDDSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75885,6m2n,DB06302,-8.8,Glesatinib,YRCHYHRCBXNYNU-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77020,6m2n,DB07882,-8.8,"4-{4-[2-(1A,7A-DIMETHYL-4-OXY-OCTAHYDRO-1-OXA-4-AZA-CYCLOPROPA[A]NAPHTHALEN-4-YL) -ACETYLAMINO]-PHENYLCARBAMOYL}-BUTYRIC ACID",VFIZFTGABDUGCF-UPVHCHBVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
30880,6cs2,DB13104,-8.8,X-396,ONPGOSVDVDPBCY-CQSZACIVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
75716,6m2n,DB05532,-8.8,BMS-488043,DBPMWRYLTBNCCE-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76316,6m2n,DB07063,-8.8,"{3-[(4,5,7-TRIFLUORO-1,3-BENZOTHIAZOL-2-YL)METHYL]-1H-INDOL-1-YL}ACETIC ACID",KYHVTMFADJNSGS-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
113878,6vxx,DB12221,-8.8,Canrenone,UJVLDDZCTMKXJK-WNHSNXHDSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57127,6crv,DB03235,-8.8,N-{3-[4-(3-aminopropyl)piperazin-1-yl]propyl}-3-(alpha-D-galactopyranosyloxy)-5-nitrobenzamide,UEIGEWJJVQHIAX-MKQKURRLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106037,6vxs,DB14866,-8.8,Amcasertib,QDWKGEFGLQMDAM-ULJHMMPZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
82500,6m3m,DB02621,-8.8,Latrunculin A,DDVBPZROPPMBLW-IZGXTMSKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
82496,6m3m,DB02616,-8.8,FR117016,CKJGKHXCUDWFDC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
30898,6cs2,DB13126,-8.8,BMS-986115,SRJNRAQUSAVENA-GSHUGGBRSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
82492,6m3m,DB02610,-8.8,"N-(2,3,4,5,6-Pentaflouro-Benzyl)-4-Sulfamoyl-Benzamide",LRKSHOLYETXPGY-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
82965,6m3m,DB03239,-8.8,"3',5'-Dinitro-N-Acetyl-L-Thyronine",VZSQTOXQXPKQJX-ZDUSSCGKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
162606,7bv1,DB02483,-8.8,Etheno-Nad,JCDBQDNBEQHDHK-BSLNIGMPSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
113368,6vxx,DB09063,-8.8,Ceritinib,VERWOWGGCGHDQE-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113505,6vxx,DB09279,-8.8,Fimasartan,AMEROGPZOLAFBN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113511,6vxx,DB09286,-8.8,Pipamperone,AXKPFOAXAHJUAG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136024,6w9c,DB06334,-8.8,Tucidinostat,SZMJVTADHFNAIS-BJMVGYQFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
76821,6m2n,DB07651,-8.8,N-ACETYL-L-PHENYLALANYL-4-[DIFLUORO(PHOSPHONO)METHYL]-L-PHENYLALANINAMIDE,KPMMESISHWWXNM-ROUUACIJSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
163445,7bv1,DB04632,-8.8,4-(2-HYDROXYBENZYLAMINO)-N-(3-(4-FLUOROPHENOXY)PHENYL)PIPERIDINE-1-SULFONAMIDE,JHHBGNIRSUTQAS-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
11308,6lzg,DB11791,-8.8,Capmatinib,LIOLIMKSCNQPLV-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
118540,6w4b,DB05075,-8.8,TG-100801,JMGXJHWTVBGOKG-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
56999,6crv,DB03069,-8.8,Cytidine-5'-Diphospho-Beta-D-Xylose,NWSKPSPTJOAICE-OCIMBMBZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106145,6vxs,DB15110,-8.8,Onvansertib,QHLVBNKYJGBCQJ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
83428,6m3m,DB03869,-8.8,5'-O-(N-(L-Seryl)-Sulfamoyl)Adenosine,HQXFJGONGJPTLZ-YTMOPEAISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
76418,6m2n,DB07181,-8.8,"4'-[(1R)-1-amino-2-(2,5-difluorophenyl)ethyl]biphenyl-3-carboxamide",JYKFWUXBFJJDTP-HXUWFJFHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
30738,6cs2,DB12910,-8.8,Emicerfont,JFHJGXQFESYQGY-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
8583,6lzg,DB06448,-8.8,Lonafarnib,DHMTURDWPRKSOA-RUZDIDTESA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
135879,6w9c,DB05511,-8.8,Piclidenoson,HUJXGQILHAUCCV-MOROJQBDSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138842,6w9c,DB12339,-8.8,Radezolid,BTTNOGHPGJANSW-IBGZPJMESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
135877,6w9c,DB05498,-8.8,KW-7158,NAFSYPCVPLWHFY-HNNXBMFYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
30361,6cs2,DB12388,-8.8,Evocalcet,RZNUIYPHQFXBAN-XLIONFOSSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
75798,6m2n,DB06090,-8.8,Bradanicline,OXKRFEWMSWPKKV-GHTZIAJQSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
69839,6lxt,DB11775,-8.8,PF-03758309,AYCPARAPKDAOEN-LJQANCHMSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
83455,6m3m,DB03903,-8.8,Tmr,KGFLZYXDJDOIEE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
76417,6m2n,DB07180,-8.8,"5-[(Z)-(5-Chloro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-N,2,4-trimethyl-1H-pyrrole-3-carboxamide",FIRPCWHHIWFKCD-GHXNOFRVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
114938,6vxx,DB15446,-8.8,Vidofludimus,XPRDUGXOWVXZLL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106642,6vxx,DB00846,-8.8,Flurandrenolide,POPFMWWJOGLOIF-XWCQMRHXSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30719,6cs2,DB12885,-8.8,CF-102,IPSYPUKKXMNCNQ-PFHKOEEOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
57438,6crv,DB03672,-8.8,9-N-Phenylmethylamino-Tacrine,JYJAEHAURXXPSD-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76437,6m2n,DB07203,-8.8,6-CYCLOHEXYLMETHOXY-2-(3'-CHLOROANILINO) PURINE,OUEGMEMDEAOAEG-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
136049,6w9c,DB06414,-8.8,Etravirine,PYGWGZALEOIKDF-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
76429,6m2n,DB07193,-8.8,"(2R,3R)-7-(methylsulfonyl)-3-(2,4,5-trifluorophenyl)-1,2,3,4-tetrahydropyrido[1,2-a]benzimidazol-2-amine",HJJAYSSCWGUPKO-ABAIWWIYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
113643,6vxx,DB11694,-8.8,Ilorasertib,WPHKIQPVPYJNAX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136057,6w9c,DB06440,-8.8,Ravuconazole,OPAHEYNNJWPQPX-RCDICMHDSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
120022,6w4b,DB07994,-8.8,"N-3-[5-(1H-INDOL-6-YL)-2-(PYRIDIN-2-YLMETHOXY)BENZYL]PYRIDINE-2,3-DIAMINE",KMBPJSHPAXOXBT-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
82808,6m3m,DB03037,-8.8,Oxidized Acetyl Dithranol,IKFRFGXQHSBCQM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136047,6w9c,DB06412,-8.8,Oxymetholone,ICMWWNHDUZJFDW-DHODBPELSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
83399,6m3m,DB03830,-8.8,Phosphorylated Dihydropteroate,DNKVHXNVVYQUDC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
113941,6vxx,DB12302,-8.8,CP-724714,LLVZBTWPGQVVLW-SNAWJCMRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
135890,6w9c,DB05552,-8.8,TG100-115,UJIAQDJKSXQLIT-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
113924,6vxx,DB12282,-8.8,Defactinib,FWLMVFUGMHIOAA-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140637,6w9c,DB13023,-8.8,IPI-493,XYFFWTYOFPSZRM-TWNAANEASA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140638,6w9c,DB13024,-8.8,MK-8245,UJEAABFSXKCSGI-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
76849,6m2n,DB07688,-8.8,"4-{[5-(CYCLOHEXYLOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE",RPJIMTALCNCQLV-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
29847,6cs2,DB11712,-8.8,Tezacaftor,MJUVRTYWUMPBTR-MRXNPFEDSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
76416,6m2n,DB07179,-8.8,"3-((3-bromo-5-o-tolylpyrazolo[1,5-a]pyrimidin-7-ylamino)methyl)pyridine 1-oxide",DXUJQXZHHGJMFM-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
70258,6lxt,DB12382,-8.8,R-306465,MUTBJZVSRNUIHA-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
30751,6cs2,DB00984,-8.8,Nandrolone phenpropionate,UBWXUGDQUBIEIZ-QNTYDACNSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
30699,6cs2,DB12858,-8.8,LY-377604,RBSGUQYXRDKPAE-QFIPXVFZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
138810,6w9c,DB12297,-8.8,GLPG-0187,CXHCNOMGODVIKB-VWLOTQADSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
113984,6vxx,DB12547,-8.8,LY-2886721,NIDRNVHMMDAAIK-YPMLDQLKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30694,6cs2,DB12854,-8.8,BMS-908662,MMNNTJYFHUDSKL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
113914,6vxx,DB12269,-8.8,PF-06273340,BPIWZDNVMQQBQX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
166091,7bv1,DB13676,-8.8,Mosapramine,PXUIZULXJVRBPC-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
70056,6lxt,DB12096,-8.8,PF-05175157,BDXXSFOJPYSYOC-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
118473,6w4b,DB04868,-8.8,Nilotinib,HHZIURLSWUIHRB-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
30812,6cs2,DB13016,-8.8,LY-2300559,DWQVYDLTPMGYNE-DEOSSOPVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
30818,6cs2,DB13022,-8.8,LY-2874455,GKJCVYLDJWTWQU-CXLRFSCWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
163537,7bv1,DB04761,-8.8,"PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-[(PYRIDIN-3-YLMETHYL)-AMIDE]",NHPBWKYFMTXWAA-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
29629,6cs2,DB11273,-8.8,Dihydroergocornine,SEALOBQTUQIVGU-QNIJNHAOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
83523,6m3m,DB03996,-8.8,"3-[(5s)-1-Acetyl-3-(2-Chlorophenyl)-4,5-Dihydro-1h-Pyrazol-5-Yl]Phenol",QBZAPFWYAPXRGQ-KRWDZBQOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
135856,6w9c,DB05412,-8.8,Talmapimod,ZMELOYOKMZBMRB-DLBZAZTESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
82896,6m3m,DB03154,-8.8,{[7-(Difluoro-Phosphono-Methyl)-Naphthalen-2-Yl]-Difluoro-Methyl}-Phosphonic Acid,VHKBLEYUHBIBNR-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
76031,6m2n,DB06684,-8.8,Vilazodone,SGEGOXDYSFKCPT-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
29631,6cs2,DB11274,-8.8,Dihydro-alpha-ergocryptine,PBUNVLRHZGSROC-VTIMJTGVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
82888,6m3m,DB03141,-8.8,"3-{[(5R,6R)-5-Benzyl-6-hydroxy-2,4-bis(4-hydroxybenzyl)-3-oxo-1,2,4-triazepan-1-yl]sulfonyl}benzonitril",UYUWNNRWESUYOB-FIRIVFDPSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
70141,6lxt,DB12222,-8.8,Lurtotecan,RVFGKBWWUQOIOU-NDEPHWFRSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
76390,6m2n,DB07148,-8.8,"(6S)-1-chloro-3-[(4-fluorobenzyl)oxy]-6-(pyrrolidin-1-ylcarbonyl)pyrrolo[1,2-a]pyrazin-4(6H)-one",HPAFVLDARQIHPU-HNNXBMFYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
106219,6vxs,DB15254,-8.8,RO-5126766 free base,LMMJFBMMJUMSJS-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
127605,6w4h,DB06497,-8.8,Aplaviroc,GWNOTCOIYUNTQP-FQLXRVMXSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
75792,6m2n,DB05992,-8.8,Plinabulin,UNRCMCRRFYFGFX-TYPNBTCFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
118482,6w4b,DB04881,-8.8,Elacridar,OSFCMRGOZNQUSW-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
166156,7bv1,DB13764,-8.8,Monoxerutin,MBHXKZDTQCSVPM-BDAFLREQSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
56974,6crv,DB03037,-8.8,Oxidized Acetyl Dithranol,IKFRFGXQHSBCQM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57042,6crv,DB03124,-8.8,5-[4-(1-Carboxymethyl-2-Oxo-Propylcarbamoyl)-Benzylsulfamoyl]-2-Hydroxy-Benzoic Acid,LBAHOXPDTNUYCX-INIZCTEOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
82675,6m3m,DB02854,-8.8,Aetiocholanolone,QGXBDMJGAMFCBF-BNSUEQOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
8549,6lzg,DB06350,-8.8,Elinogrel,LGSDFTPAICUONK-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
113982,6vxx,DB12543,-8.8,Samidorphan,RYIDHLJADOKWFM-MAODMQOUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76064,6m2n,DB06732,-8.8,beta-Naphthoflavone,OUGIDAPQYNCXRA-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
139275,6w9c,DB13252,-8.8,Tropatepine,JOQKFRLFXDPXHX-HDICACEKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
27461,6cs2,DB07005,-8.8,D-phenylalanyl-N-{4-[amino(iminio)methyl]benzyl}-L-prolinamide,VZFTWWJAUZOJDH-MOPGFXCFSA-O,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
57560,6crv,DB03823,-8.8,Epigallocatechin,XMOCLSLCDHWDHP-IUODEOHRSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
69889,6lxt,DB11845,-8.8,Lucitanib,CUDVHEFYRIWYQD-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
76926,6m2n,DB07778,-8.8,FAMOXADONE,PCCSBWNGDMYFCW-QFIPXVFZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
119887,6w4b,DB07837,-8.8,"[4-(5-naphthalen-2-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)phenyl]acetic acid",SWXKLXXVFMYMDP-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
83148,6m3m,DB03490,-8.8,"3-Pyridin-4-Yl-2,4-Dihydro-Indeno[1,2-.C.]Pyrazole",NHOACLCXCKJMAK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
82833,6m3m,DB03069,-8.8,Cytidine-5'-Diphospho-Beta-D-Xylose,NWSKPSPTJOAICE-OCIMBMBZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
76725,6m2n,DB07537,-8.8,"N'-(6-aminopyridin-3-yl)-N-(2-cyclopentylethyl)-4-methyl-benzene-1,3-dicarboxamide",CLEGTVIMOPPIBR-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
83394,6m3m,DB03823,-8.8,Epigallocatechin,XMOCLSLCDHWDHP-IUODEOHRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
76298,6m2n,DB07043,-8.8,"7-amino-2-tert-butyl-4-(4-pyrimidin-2-ylpiperazin-1-yl)pyrido[2,3-d]pyrimidine-6-carboxamide",CKLCIJCZOIDJQU-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76182,6m2n,DB06908,-8.8,"(2S)-3-(1-{[2-(2-CHLOROPHENYL)-5-METHYL-1,3-OXAZOL-4-YL]METHYL}-1H-INDOL-5-YL)-2-ETHOXYPROPANOIC ACID",PAWOPJKHTZCKMT-QFIPXVFZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
166342,7bv1,DB14675,-8.8,Temsavir,QRPZBKAMSFHVRW-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
105946,6vxs,DB14661,-8.8,Loperamide oxide,KXVSBTJVTUVNPM-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
30177,6cs2,DB12149,-8.8,S-3304,YWCLDDLVLSQGSZ-JOCHJYFZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
30570,6cs2,DB12669,-8.8,4SC-203,MAFACRSJGNJHCF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
138904,6w9c,DB12426,-8.8,Bitopertin,YUUGYIUSCYNSQR-LBPRGKRZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
135950,6w9c,DB06160,-8.8,Garenoxacin,NJDRXTDGYFKORP-LLVKDONJSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
76518,6m2n,DB07296,-8.8,(5Z)-3-(4-CHLOROPHENYL)-4-HYDROXY-5-(1-NAPHTHYLMETHYLENE)FURAN-2(5H)-ONE,PLGHLEBIWUQEPR-PDGQHHTCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
7959,6lzg,DB04591,-8.8,"N-{2,2-DIFLUORO-2-[(2R)-PIPERIDIN-2-YL]ETHYL}-2-[2-(1H-1,2,4-TRIAZOL-1-YL)BENZYL][1,3]OXAZOLO[4,5-C]PYRIDIN-4-AMINE",VYJOAYZRCNHDNG-GOSISDBHSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
83167,6m3m,DB03515,-8.8,Equilenin,PDRGHUMCVRDZLQ-WMZOPIPTSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
31331,6cs2,DB13685,-8.8,Quingestanol,PCJFRMOEZQQSAX-AIOSZGMZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
76245,6m2n,DB06985,-8.8,2-[({4-[2-(trifluoromethyl)phenyl]piperidin-1-yl}carbonyl)amino]benzoic acid,MEAQCLPMSVEOQF-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75601,6m2n,DB04942,-8.8,Tamibarotene,MUTNCGKQJGXKEM-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
135969,6w9c,DB06202,-8.8,Lasofoxifene,GXESHMAMLJKROZ-IAPPQJPRSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
83120,6m3m,DB03451,-8.8,"1-alpha, 25-dihydroxyl-20-epi-22-oxa-24, 26 ,27-trihomovitamin D3",KLZOTDOJMRMLDX-YBBVPDDNSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
107049,6vxx,DB02220,-8.8,AL7089A,RMOXCYSVWCHXII-LBPRGKRZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30560,6cs2,DB12658,-8.8,AFN-1252,QXTWSUQCXCWEHF-JXMROGBWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
82306,6m3m,DB02375,-8.8,Myricetin,IKMDFBPHZNJCSN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
77230,6m2n,DB08123,-8.8,"N-METHYL-{4-[2-(7-OXO-6,7-DIHYDRO-8H-[1,3]THIAZOLO[5,4-E]INDOL-8-YLIDENE)HYDRAZINO]PHENYL}METHANESULFONAMIDE",GEWPSTLKJDIUHW-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
166461,7bv1,DB15183,-8.8,Fosmanogepix,JQONJQKKVAHONF-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
114113,6vxx,DB12745,-8.8,GSK-690693,KGPGFQWBCSZGEL-ZDUSSCGKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
166465,7bv1,DB15190,-8.8,GLPG-0259,YBFGSJUVEOYPIS-OALUTQOASA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
105969,6vxs,DB14703,-8.8,Dexamethasone metasulfobenzoate,TWQWRHIQRAZHPR-XNXCGYEVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
30200,6cs2,DB12185,-8.8,Exatecan,ZVYVPGLRVWUPMP-FYSMJZIKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
114129,6vxx,DB12774,-8.8,AZD-8055,KVLFRAWTRWDEDF-IRXDYDNUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
8741,6lzg,DB06755,-8.8,Beta carotene,OENHQHLEOONYIE-JLTXGRSLSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
76267,6m2n,DB07008,-8.8,"4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMIDAZOL-1-YL)PHENOXY]PYRIMIDINE",XPXGYINSBORUMM-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
82355,6m3m,DB02431,-8.8,Cytidine-5'-Triphosphate,PCDQPRRSZKQHHS-XVFCMESISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
75641,6m2n,DB05107,-8.8,16-Bromoepiandrosterone,CWVMWSZEMZOUPC-JUAXIXHSSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
83065,6m3m,DB03368,-8.8,"5-Methyl-5-(4-Phenoxy-Phenyl)-Pyrimidine-2,4,6-Trione",RTBMLCLTYAPKIF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
114133,6vxx,DB12781,-8.8,Balaglitazone,IETKPTYAGKZLKY-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31299,6cs2,DB13653,-8.8,Lorcainide,XHOJAWVAWFHGHL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
83661,6m3m,DB04177,-8.8,"4-(3,14-Dihydroxy-10,13-Dimethyl-Hexadecahydro-Cyclopenta[a]Phenanthren-17-Yl)-5h-Furan-2-One",XZTUSOXSLKTKJQ-CESUGQOBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
139181,6w9c,DB12978,-8.8,Pexidartinib,JGWRKYUXBBNENE-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
31321,6cs2,DB13676,-8.8,Mosapramine,PXUIZULXJVRBPC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
76243,6m2n,DB06983,-8.8,"(5-phenyl-7-(pyridin-3-ylmethylamino)pyrazolo[1,5-a]pyrimidin-3-yl)methanol",RBLKWWBHDUBPFN-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
113101,6vxx,DB08538,-8.8,"N-((2-aminopyrimidin-5-yl)methyl)-5-(2,6-difluorophenyl)-3-ethylpyrazolo[1,5-a]pyrimidin-7-amine",HQPVGVSQPQVZLD-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165849,7bv1,DB13104,-8.8,X-396,ONPGOSVDVDPBCY-CQSZACIVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
107189,6vxx,DB02684,-8.8,5'-O-(N-(L-Cysteinyl)-Sulfamoyl)Adenosine,FTSDEWPMACCNGN-YTMOPEAISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127266,6w4h,DB04971,-8.8,Reglitazar,QBQLYIISSRXYKL-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
76225,6m2n,DB06959,-8.8,(2S)-1-(3H-Indol-3-yl)-3-{[5-(6-isoquinolinyl)-3-pyridinyl]oxy}-2-propanamine,BUCZDJYEOAQTHL-KEKNWZKVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75565,6m2n,DB04867,-8.8,Lintitript,ILNRQFBVVQUOLP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
30160,6cs2,DB12128,-8.8,Ulimorelin,WGYPAJVJMXQXTR-ABNZCKJZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
114174,6vxx,DB12854,-8.8,BMS-908662,MMNNTJYFHUDSKL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
83682,6m3m,DB04205,-8.8,"Thymidine-3',5'-Diphosphate",CSNCBOPUCJOHLS-XLPZGREQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
163041,7bv1,DB03461,-8.8,2'-Monophosphoadenosine 5'-Diphosphoribose,XJLXINKUBYWONI-NNYOXOHSSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
140524,6w9c,DB12006,-8.8,BMS-906024,AYOUDDAETNMCBW-GSHUGGBRSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139071,6w9c,DB12806,-8.8,GSK-1004723,YANGEESWIGIKOP-UUWRZZSWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
75554,6m2n,DB04853,-8.8,Binodenoson,XJFMHMFFBSOEPR-DNZQAUTHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75545,6m2n,DB04841,-8.8,Flunarizine,SMANXXCATUTDDT-QPJJXVBHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
105874,6vxs,DB14218,-8.8,Telotristat,NCLGDOBQAWBXRA-PGRDOPGGSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
140672,6w9c,DB13074,-8.8,Macimorelin,UJVDJAPJQWZRFR-DHIUTWEWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
162478,7bv1,DB02323,-8.8,EM-1745,CKSDYJASHNGOOS-KTXOUVACSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
138941,6w9c,DB12597,-8.8,ABL-001,VOVZXURTCKPRDQ-CQSZACIVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
57250,6crv,DB03397,-8.8,Uridine-Diphosphate-N-Acetylglucosamine,LFTYTUAZOPRMMI-CFRASDGPSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27578,6cs2,DB07126,-8.8,O6-CYCLOHEXYLMETHOXY-2-(4'-SULPHAMOYLANILINO) PURINE,OWXORKPNCHJYOF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
139455,6w9c,DB13491,-8.8,Fluperolone,SLVCCRYLKTYUQP-DVTGEIKXSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
75958,6m2n,DB06515,-8.8,Resiniferatoxin,DSDNAKHZNJAGHN-MXTYGGKSSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
82259,6m3m,DB02316,-8.8,"1-(5-Carboxypentyl)-5-[(2,6-Dichlorobenzyl)Oxy]-1 H-Indole-2-Carboxylic Acid",JTGPYFFQVOIJKR-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
113840,6vxx,DB12158,-8.8,Filorexant,NPFDWHQSDBWQLH-QZTJIDSGSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
69947,6lxt,DB11934,-8.8,Epelsiban,UWHCWRQFNKUYCG-QUZACWSFSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
82243,6m3m,DB02292,-8.8,Irosustat,DSLPMJSGSBLWRE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
139072,6w9c,DB12808,-8.8,Trifarotene,MFBCDACCJCDGBA-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
114167,6vxx,DB12840,-8.8,Pirnabine,AADNQNOXNWEYHS-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138886,6w9c,DB12404,-8.8,Remimazolam,CYHWMBVXXDIZNZ-KRWDZBQOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
76532,6m2n,DB07311,-8.8,"18-CHLORO-11,12,13,14-TETRAHYDRO-1H,10H-8,4-(AZENO)-9,15,1,3,6-BENZODIOXATRIAZACYCLOHEPTADECIN-2-ONE",JRSWWYITYIOHOP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
135952,6w9c,DB06166,-8.8,Fosdevirine,CGBYTKOSZYQOPV-CCEZBSFNSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
57282,6crv,DB03447,-8.8,Uridylyl-2'-5'-Phospho-Adenosine,QARCCHXXGAIRFS-KPKSGTNCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29290,6cs2,DB08975,-8.8,Florantyrone,QOBAOSCOLAGPKI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
77328,6m2n,DB08239,-8.8,"(2S)-4-(2,5-DIFLUOROPHENYL)-N-METHYL-2-PHENYL-N-PIPERIDIN-4-YL-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDE",NKLVBHMAIMEVEH-QFIPXVFZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
69944,6lxt,DB11925,-8.8,Vistusertib,JUSFANSTBFGBAF-IRXDYDNUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
82214,6m3m,DB02255,-8.8,GM6001,NITYDPDXAAFEIT-DYVFJYSZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83679,6m3m,DB04201,-8.8,Histidyl-Adenosine Monophosphate,XTFBSLZFYLGYAT-OPYVMVOTSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
113092,6vxx,DB08365,-8.8,"8-bromo-4-(2-chlorophenyl)-N-(2-hydroxyethyl)-6-methyl-1,3-dioxo-1,2,3,6-tetrahydropyrrolo[3,4-e]indole-7-carboxamide",XUAHLMVOYLUYSB-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114104,6vxx,DB12732,-8.8,Firategrast,YLFZHHDVRSYTKT-NRFANRHFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
69963,6lxt,DB11952,-8.8,Duvelisib,SJVQHLPISAIATJ-ZDUSSCGKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
77159,6m2n,DB08042,-8.8,"N-4-methyl-N-4-(3-methyl-1H-indazol-6-yl)-N-2-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine",FLXGQDHYCWXTAI-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
136193,6w9c,DB06732,-8.8,beta-Naphthoflavone,OUGIDAPQYNCXRA-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
76681,6m2n,DB07486,-8.8,"3-({4-[(1E)-3-morpholin-4-yl-3-oxoprop-1-en-1-yl]-2,3-bis(trifluoromethyl)phenyl}sulfanyl)aniline",KLSZVPNVFKKIRD-FNORWQNLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
82389,6m3m,DB02479,-8.8,(R)-N-(3-Indol-1-Yl-2-Methyl-Propyl)-4-Sulfamoyl-Benzamide,ZFWHOUCRVSOZJE-CQSZACIVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
31168,6cs2,DB13490,-8.8,Hidrosmin,XYFLWVOTXWXNAM-WTNNCJBMSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
113747,6vxx,DB12024,-8.8,PF-04418948,LWJGMYMNSNVCEM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
139036,6w9c,DB12745,-8.8,GSK-690693,KGPGFQWBCSZGEL-ZDUSSCGKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
77130,6m2n,DB08011,-8.8,"(3E)-5-fluoro-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-1H-indole-2,3-dione 3-oxime",DXIHOIDYHQSQKJ-HMMYKYKNSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
118833,6w4b,DB06435,-8.8,Tarazepide,CZPILLBHPRAPCB-AREMUKBSSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
77141,6m2n,DB08022,-8.8,"(2S)-1,3-benzothiazol-2-yl{2-[(2-pyridin-3-ylethyl)amino]pyrimidin-4-yl}ethanenitrile",RCYPVQCPYKNSTG-OAHLLOKOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
57700,6crv,DB04011,-8.8,"2'-(4-Dimethylaminophenyl)-5-(4-Methyl-1-Piperazinyl)-2,5'-Bi-Benzimidazole",VMCOQLKKSNQANE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136208,6w9c,DB06755,-8.8,Beta carotene,OENHQHLEOONYIE-JLTXGRSLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
135815,6w9c,DB05134,-8.8,Tanespimycin,AYUNIORJHRXIBJ-TXHRRWQRSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
69726,6lxt,DB11577,-8.8,Indigotindisulfonic Acid,CFZXDJWFRVEWSR-BUHFOSPRSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
70283,6lxt,DB12415,-8.8,Galeterone,PAFKTGFSEFKSQG-PAASFTFBSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
119453,6w4b,DB07326,-8.8,"6-chloro-N-pyrimidin-5-yl-3-{[3-(trifluoromethyl)phenyl]amino}-1,2-benzisoxazole-7-carboxamide",FEGRQUWSKADGSP-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
106002,6vxs,DB14774,-8.8,Balipodect,KVHRYLNQDWXAGI-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
31509,6cs2,DB13939,-8.8,RAD-140,XMBUPPIEVAFYHO-KPZWWZAWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
76665,6m2n,DB07467,-8.8,"4-chloro-N-[(2S)-2-methyl-2,3-dihydro-1H-indol-1-yl]-3-sulfamoylbenzamide",NDDAHWYSQHTHNT-JTQLQIEISA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75910,6m2n,DB06395,-8.8,Abafungin,TYBHXIFFPVFXQW-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
119333,6w4b,DB07189,-8.8,"(1S,3R,6S)-4-oxo-6-{4-[(2-phenylquinolin-4-yl)methoxy]phenyl}-5-azaspiro[2.4]heptane-1-carboxylic acid",BFZXMIUWGSTUAL-ZSOKXDGFSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
106007,6vxs,DB14790,-8.8,BPN-14770,KRRGWHSEDYQKDQ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
77203,6m2n,DB08095,-8.8,"3-(2-CHLOROPHENYL)-1-(2-{[(1S)-2-HYDROXY-1,2-DIMETHYLPROPYL]AMINO}PYRIMIDIN-4-YL)-1-(4-METHOXYPHENYL)UREA",ZWYFTKPEHRQCCW-HNNXBMFYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
127569,6w4h,DB06410,-8.8,Doxercalciferol,HKXBNHCUPKIYDM-CGMHZMFXSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
127723,6w4h,DB06741,-8.8,Gavestinel,WZBNEZWCNKUOSM-VOTSOKGWSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
69711,6lxt,DB11529,-8.8,Melengestrol,OKHAOBQKCCIRLO-IBVJIVQJSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
135986,6w9c,DB06237,-8.8,Avanafil,WEAJZXNPAWBCOA-INIZCTEOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
77200,6m2n,DB08092,-8.8,3-fluoro-N-1H-indol-5-yl-5-morpholin-4-ylbenzamide,VMLSXFMXUNVCSK-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
106264,6vxs,DB15343,-8.8,HM-43239,FZLSDZZNPXXBBB-KDURUIRLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
83200,6m3m,DB03572,-8.8,FR230513,URGFTPMACWKJKU-OAHLLOKOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
138742,6w9c,DB12206,-8.8,N-6022,YVPGZQLRPAGKLA-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
75654,6m2n,DB05212,-8.8,HE3286,JJKOQZHWYLMASZ-FJWDNACWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
114103,6vxx,DB12731,-8.8,Daporinad,KPBNHDGDUADAGP-VAWYXSNFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30043,6cs2,DB11971,-8.8,Vilaprisan,JUFWQQVHQFDUOD-ANRPBIDPSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
33678,6cs2,T3D4921,-8.7,Diflubenzuron,QQQYTWIFVNKMRW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
165330,7bv1,DB11942,-8.7,Selinexor,DEVSOMFAQLZNKR-RJRFIUFISA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
132137,6w4h,DB15456,-8.7,Vericiguat,QZFHIXARHDBPBY-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
166600,7bv1,DB15456,-8.7,Vericiguat,QZFHIXARHDBPBY-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
165320,7bv1,DB11925,-8.7,Vistusertib,JUSFANSTBFGBAF-IRXDYDNUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
139950,6w9c,DB14640,-8.7,Isoflupredone acetate,ZOCUOMKMBMEYQV-GSLJADNHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
25794,6cs2,DB03802,-8.7,"1-[4-(Octahydro-Pyrido[1,2-a]Pyrazin-2-Yl)-Phenyl]-2-Phenyl-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol",ZGHFWBDHZZKWSI-LITSAYRRSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
96582,6m71,DB13138,-8.7,Neladenoson bialanate,WESNEIGKOAXSGX-VXKWHMMOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
79030,6m2n,DB12623,-8.7,Taprenepag,MFFBXYNKZHTCEY-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78881,6m2n,DB12399,-8.7,Polmacoxib,IJWPAFMIFNSIGD-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78820,6m2n,DB12309,-8.7,GI-181771X,CABBMMXFOOZVMS-PMERELPUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
111266,6vxx,DB03420,-8.7,"2,4-Deoxy-4-Guanidino-5-N-Acetyl-Neuraminic Acid",DAAUVSVERFXBSX-IHICSVBISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130180,6w4h,DB11890,-8.7,Cilengitide,AMLYAMJWYAIXIA-VWNVYAMZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
76447,6m2n,DB07216,-8.7,"(11S)-8-CHLORO-11-[1-(METHYLSULFONYL)PIPERIDIN-4-YL]-6-PIPERAZIN-1-YL-11H-BENZO[5,6]CYCLOHEPTA[1,2-B]PYRIDINE",ZMGCFGGMTCMSDP-QHCPKHFHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
97224,6m71,DB14128,-8.7,Nadide,BAWFJGJZGIEFAR-NNYOXOHSSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110876,6vxx,DB02519,-8.7,Indirubin-5-Sulphonate,IHBOEHLUIBMBMY-YPKPFQOOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
129028,6w4h,DB08303,-8.7,"(3S)-3-cyclopentyl-6-methyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide",CUMKMTBOHBENJI-SFHVURJKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
28697,6cs2,DB08304,-8.7,"(3R)-3-cyclopentyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2-benzothiazine 1,1-dioxide",QZBQVXXESPXFPZ-QGZVFWFLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
76065,6m2n,DB06733,-8.7,Bafilomycin A1,XDHNQDDQEHDUTM-JQWOJBOSSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
96350,6m71,DB12776,-8.7,E-6005,BBTFKAOFCSOZMB-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
34406,1r42,DB00210,-8.7,Adapalene,LZCDAPDGXCYOEH-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
28733,6cs2,DB08345,-8.7,"4-(2-(1H-IMIDAZOL-4-YL)ETHYLAMINO)-2-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE",IWUUKHQIKFHWIW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
33485,6cs2,T3D4741,-8.7,Aminopterin,TVZGACDUOSZQKY-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
111281,6vxx,DB03447,-8.7,Uridylyl-2'-5'-Phospho-Adenosine,QARCCHXXGAIRFS-KPKSGTNCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
166389,7bv1,DB14790,-8.7,BPN-14770,KRRGWHSEDYQKDQ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96531,6m71,DB13061,-8.7,MLN8054,HHFBDROWDBDFBR-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
90886,6m71,DB02336,-8.7,RU83876,WCMLXBUNHNAMNH-UIOOFZCWSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
76443,6m2n,DB07210,-8.7,"3-bromo-5-phenyl-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",JECHSYMSTXETFI-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
132045,6w4h,DB15269,-8.7,ALK-4290,DWKNOLCXIFYNFV-HSZRJFAPSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
118649,6w4b,DB05678,-8.7,SLx-4090,AZUIUVJESCFSLJ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
137639,6w9c,DB08539,-8.7,"3-cyclopropyl-5-phenyl-N-(pyridin-3-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",CCDIUVLNHCGSMH-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
62940,6crv,DB14768,-8.7,PF-06459988,ODMXWZROLKITMS-RISCZKNCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28806,6cs2,DB08426,-8.7,"THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [2-OXO-1-(1H-PYRROLO[2,3-C]PYRIDIN-2-YLMETHYL)-PYRROLIDIN-3-YL]-AMIDE",PLXOQMHGHDZMSX-AWEZNQCLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
60101,6crv,DB08236,-8.7,"(2S)-2-(3-bromophenyl)-3-(5-chloro-2-hydroxyphenyl)-1,3-thiazolidin-4-one",KEGQNJITMFBVAC-HNNXBMFYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
129630,6w4h,DB09073,-8.7,Palbociclib,AHJRHEGDXFFMBM-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
138937,6w9c,DB12591,-8.7,BMS-911543,JCINBYQJBYJGDM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
113866,6vxx,DB12203,-8.7,Tozadenant,XNBRWUQWSKXMPW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59942,6crv,DB08052,-8.7,"1-cyclopentyl-3-(1H-pyrrolo[2,3-b]pyridin-5-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine",NVRXTLZYXZNATH-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88899,6m3m,DB15062,-8.7,Inarigivir,LYMICVBGNUEHGE-FUQPUAIBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
33671,6cs2,T3D4914,-8.7,Fd&c red no. 3,IINNWAYUJNWZRM-UHFFFAOYSA-L,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
36163,1r42,DB02555,-8.7,SP4160,VCXMTWSYQSVWRK-AREMUKBSSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
96561,6m71,DB13104,-8.7,X-396,ONPGOSVDVDPBCY-CQSZACIVSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
139136,6w9c,DB12910,-8.7,Emicerfont,JFHJGXQFESYQGY-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
30458,6cs2,DB12511,-8.7,Imiglitazar,ULVDFHLHKNJICZ-QCWLDUFUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
118920,6w4b,DB06638,-8.7,Quarfloxin,WOQIDNWTQOYDLF-CGAIIQECSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
24010,6cs2,DB01659,-8.7,"3-(1,10-Phenanthrol-2-Yl)-L-Alanine",LODBCIBKOKOGNL-LBPRGKRZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
166346,7bv1,DB14679,-8.7,Quingestanol acetate,FLGJKPPXEKYCBY-AKCFYGDASA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
139996,6w9c,DB14716,-8.7,Clonazolam,XJRGLCAWBRZUFC-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139981,6w9c,DB14673,-8.7,Flurandrenolide acetate,AUDPKCCPWYXNEV-XTLNBZDDSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
73405,6m2n,DB01990,-8.7,Cholesterol sulfate,BHYOQNUELFTYRT-DPAQBDIFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
111579,6vxx,DB04232,-8.7,N-Hydroxy-1-(4-Methoxyphenyl)Sulfonyl-4-Benzyloxycarbonyl-Piperazine-2-Carboxamide,DNGGPLKVDUPXFN-GOSISDBHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111287,6vxx,DB03453,-8.7,Methyl (2S)-2-[[2-[(3R)-1-carbamimidoylpiperidin-3-yl]acetyl]amino]-3-[4-(2-phenylethynyl)phenyl]propanoate,MRNGXYMKYHNMLV-PKTZIBPZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111344,6vxx,DB03532,-8.7,Phosphomethylphosphonic Acid Guanylate Ester,GXTIEXDFEKYVGY-KQYNXXCUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
34769,1r42,DB00762,-8.7,Irinotecan,UWKQSNNFCGGAFS-XIFFEERXSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
33613,6cs2,T3D0039,-8.7,Benzo[a]anthracene,DXBHBZVCASKNBY-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
139925,6w9c,DB14570,-8.7,Hydroxyprogesterone,DBPWSSGDRRHUNT-CEGNMAFCSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
76011,6m2n,DB06635,-8.7,Otamixaban,PFGVNLZDWRZPJW-OPAMFIHVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
96489,6m71,DB12999,-8.7,MK-6186,FZBAOOQVQXATRL-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
6107,6lzg,DB01573,-8.7,Benzylmorphine,RDJGWRFTDZZXSM-RNWLQCGYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
60027,6crv,DB08146,-8.7,"7-(2,5-dihydropyrrol-1-yl)-6-phenyl-pyrido[6,5-d]pyrimidin-2-amine",QFWNOFXQNCLFBC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
34175,6cs2,T3D1039,-8.7,Fluvalinate,INISTDXBRIBGOC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
61492,6crv,DB12163,-8.7,Sarpogrelate,FFYNAVGJSYHHFO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87084,6m3m,DB11806,-8.7,VTP-194204,BOOOLEGQBVUTKC-NVQSDHBMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
111472,6vxx,DB03916,-8.7,4-{2-[4-(2-Aminoethyl)Piperazin-1-Yl]Pyridin-4-Yl}-N-(3-Chloro-4-Methylphenyl)Pyrimidin-2-Amine,RHOOHUMOHVIXEF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
90482,6m71,DB01792,-8.7,Adenylyl-3'-5'-Phospho-Uridine-3'-Monophosphate,FZCSEXOMUJFOHQ-KPKSGTNCSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
129030,6w4h,DB08305,-8.7,"(3R)-3-cyclopentyl-6-methyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2-benzothiazine 1,1-dioxide",KQAGZLQCEURCKJ-QGZVFWFLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
96422,6m71,DB12895,-8.7,TD-139,YGIDGBAHDZEYMT-MQFIMZJJSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
87089,6m3m,DB11816,-8.7,Omecamtiv Mecarbil,RFUBTTPMWSKEIW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
130197,6w4h,DB11911,-8.7,Galunisertib,IVRXNBXKWIJUQB-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
113889,6vxx,DB12234,-8.7,BMS-214662,OLCWFLWEHWLBTO-HSZRJFAPSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
132092,6w4h,DB15358,-8.7,JNJ-54175446,CWFVVQFVGMFTBD-SECBINFHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
62952,6crv,DB14792,-8.7,AZD-5991,KBQCEQAXHPIRTF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
139941,6w9c,DB14631,-8.7,Prednisolone phosphate,JDOZJEUDSLGTLU-VWUMJDOOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138966,6w9c,DB12643,-8.7,Nelivaptan,NJXZWIIMWNEOGJ-WEWKHQNJSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
123380,6w4b,DB15435,-8.7,BMS-986158,KGERZPVQIRYWRK-GDLZYMKVSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
111043,6vxx,DB02917,-8.7,N-Hydroxy-4-(Methyl{[5-(2-Pyridinyl)-2-Thienyl]Sulfonyl}Amino)Benzamide,LFGYSFPVLMPUPE-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111090,6vxx,DB02976,-8.7,Uridine-5'-monophosphate 2-deoxy-2-fluoro-galactopyranosyl-monophosphate ester,NGTCPFGWXMBZEP-KBQKSTHMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30450,6cs2,DB12500,-8.7,Fedratinib,JOOXLOJCABQBSG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
87106,6m3m,DB11836,-8.7,Sapanisertib,GYLDXIAOMVERTK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
76028,6m2n,DB06680,-8.7,Asoprisnil,GJMNAFGEUJBOCE-MEQIQULJSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78862,6m2n,DB12375,-8.7,Oglemilast,OKFDRAHPFKMAJH-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78954,6m2n,DB12505,-8.7,E-7820,LWGUASZLXHYWIV-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
62946,6crv,DB14775,-8.7,Cavosonstat,BXSZILNGNMDGSL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
24062,6cs2,DB01721,-8.7,Analogue of Indinavir Drug,MJIRDPUZGGHJMX-OIVSQUILSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
137777,6w9c,DB08710,-8.7,"(5Z)-5-[(5-ETHYL-2-FURYL)METHYLENE]-2-{[(S)-(4-FLUOROPHENYL)(1H-TETRAZOL-5-YL)METHYL]AMINO}-1,3-THIAZOL-4(5H)-ONE",BKZOQCGDCHOGOQ-MZLJFPOFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
61484,6crv,DB12150,-8.7,Pelubiprofen,AUZUGWXLBGZUPP-GXDHUFHOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
90429,6m71,DB01721,-8.7,Analogue of Indinavir Drug,MJIRDPUZGGHJMX-OIVSQUILSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
76021,6m2n,DB06660,-8.7,Saredutant,PGKXDIMONUAMFR-AREMUKBSSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
110978,6vxx,DB02834,-8.7,IDD552,ZCAGEXZTORJQDZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
145626,6w9q,DB07570,-8.7,3-CYCLOHEXYL-1-(2-MORPHOLIN-4-YL-2-OXOETHYL)-2-PHENYL-1H-INDOLE-6-CARBOXYLIC ACID,ZKEZEXYKYHYIMQ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
123634,6w4h,DB00197,-8.7,Troglitazone,GXPHKUHSUJUWKP-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
110744,6vxx,DB02360,-8.7,Bis-Napthyl Beta-Ketophosphonic Acid,OFHMUASCSJJNNA-JOCHJYFZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61788,6crv,DB12591,-8.7,BMS-911543,JCINBYQJBYJGDM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
159357,7bv1,DB04038,-8.7,Ergosterol,DNVPQKQSNYMLRS-APGDWVJJSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
87147,6m3m,DB11900,-8.7,OC-459,FATGTHLOZSXOBC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
16085,6lzg,DB02629,-8.7,Inhibitor Bea403,LYHLPPXMBKMSSZ-JQFCFGFHSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
90368,6m71,DB01640,-8.7,"(5r)-6-(4-{[2-(3-Iodobenzyl)-3-Oxocyclohex-1-En-1-Yl]Amino}Phenyl)-5-Methyl-4,5-Dihydropyridazin-3(2h)-One",QNURTFDBHAQRSI-OAHLLOKOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
29590,6cs2,DB00862,-8.7,Vardenafil,SECKRCOLJRRGGV-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
62928,6crv,DB14737,-8.7,Cannabinol,VBGLYOIFKLUMQG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62967,6crv,DB14841,-8.7,Centanafadine,HKHCSWPSUSWGLI-CABCVRRESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61787,6crv,DB12590,-8.7,Indiplon,CBIAWPMZSFFRGN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62966,6crv,DB14840,-8.7,Ripretinib,CEFJVGZHQAGLHS-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87185,6m3m,DB11952,-8.7,Duvelisib,SJVQHLPISAIATJ-ZDUSSCGKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
76497,6m2n,DB07274,-8.7,"N-cyclopropyl-6-[(6,7-dimethoxyquinolin-4-yl)oxy]naphthalene-1-carboxamide",ZATGFXTWDKIEKC-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
132112,6w4h,DB15407,-8.7,Acalisib,DOCINCLJNAXZQF-LBPRGKRZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
165350,7bv1,DB11968,-8.7,MK-7145,OCKGFTQIICXDQW-ZEQRLZLVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
29566,6cs2,DB09488,-8.7,Acrivastine,PWACSDKDOHSSQD-IUTFFREVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
139934,6w9c,DB14624,-8.7,Nandrolone hydrogen sulfate,SKZMVWBZTQNCKW-IZPLOLCNSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
90641,6m71,DB02010,-8.7,Staurosporine,HKSZLNNOFSGOKW-FYTWVXJKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97107,6m71,DB13874,-8.7,Enasidenib,DYLUUSLLRIQKOE-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
75998,6m2n,DB06616,-8.7,Bosutinib,UBPYILGKFZZVDX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
62963,6crv,DB14828,-8.7,ABX-464,OZOGDCZJYVSUBR-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110949,6vxx,DB02799,-8.7,N-[2-(1-Maleimidyl)Ethyl]-7-Diethylaminocoumarin-3-Carboxamide,OJBZDUMTXGGVSP-KTKRTIGZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62907,6crv,DB14679,-8.7,Quingestanol acetate,FLGJKPPXEKYCBY-AKCFYGDASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138957,6w9c,DB12627,-8.7,GSK-1292263,AYJRTVVIBJSSKN-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139144,6w9c,DB12924,-8.7,Ozenoxacin,XPIJWUTXQAGSLK-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
62914,6crv,DB14714,-8.7,Tenivastatin,XWLXKKNPFMNSFA-HGQWONQESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60005,6crv,DB08122,-8.7,"N-METHYL-4-{[(2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]AMINO}BENZENESULFONAMIDE",IKASAFLVQIJQOK-UVTDQMKNSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
139937,6w9c,DB14627,-8.7,Oxyphenisatin acetate,PHPUXYRXPHEJDF-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
123598,6w4h,DB00158,-8.7,Folic acid,OVBPIULPVIDEAO-LBPRGKRZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
138982,6w9c,DB12665,-8.7,Isoquercetin,OVSQVDMCBVZWGM-QSOFNFLRSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
114617,6vxx,DB13866,-8.7,Etynodiol,JYILPERKVHXLNF-QMNUTNMBSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
93393,6m71,DB06896,-8.7,"1-(4-fluorophenyl)-N-[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]-2-oxo-1,2-dihydropyridine-3-carboxamide",OBSFXHDOLBYWRJ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
145154,6w9q,DB07025,-8.7,3-(5-{[4-(AMINOMETHYL)PIPERIDIN-1-YL]METHYL}-1H-INDOL-2-YL)QUINOLIN-2(1H)-ONE,KBIHHEGEALBUMT-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
2258,6lzg,HMDB0033844,-8.7,beta-Cryptoxanthin,DMASLKHVQRHNES-QQGJMDNJSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
72784,6m2n,DB01147,-8.7,Cloxacillin,LQOLIRLGBULYKD-JKIFEVAISA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
59714,6crv,DB07791,-8.7,4-{[4-(1-CYCLOPROPYL-2-METHYL-1H-IMIDAZOL-5-YL)PYRIMIDIN-2-YL]AMINO}-N-METHYLBENZENESULFONAMIDE,MZWCVBFANHIPTJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
13384,6lzg,DB15257,-8.7,Milademetan,RYAYYVTWKAOAJF-QISPRATLSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
89410,6m71,DB00444,-8.7,Teniposide,NRUKOCRGYNPUPR-QBPJDGROSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
164984,7bv1,DB09048,-8.7,Netupitant,WAXQNWCZJDTGBU-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
24700,6cs2,DB02483,-8.7,Etheno-Nad,JCDBQDNBEQHDHK-BSLNIGMPSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
72736,6m2n,DB01092,-8.7,Ouabain,LPMXVESGRSUGHW-HBYQJFLCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
30226,6cs2,DB12221,-8.7,Canrenone,UJVLDDZCTMKXJK-WNHSNXHDSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
88992,6m3m,DB15242,-8.7,MK-0533,STWITCBWQHTJFJ-XMMPIXPASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
130071,6w4h,DB11732,-8.7,Lasmiditan,XEDHVZKDSYZQBF-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
137330,6w9c,DB08159,-8.7,"4-(5,11-DIOXO-5H-INDENO[1,2-C]ISOQUINOLIN-6(11H)-YL)BUTANOATE",AHIJTWCJGCWHMT-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
159789,7bv1,DB06555,-8.7,Siramesine,XWAONOGAGZNUSF-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110035,6vxx,DB00728,-8.7,Rocuronium,YXRDKMPIGHSVRX-OOJCLDBCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86632,6m3m,DB09168,-8.7,4-Phenylfentanyl,BXCJXJLHYMWMQU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
72718,6m2n,DB01070,-8.7,Dihydrotachysterol,ILYCWAKSDCYMBB-OPCMSESCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
124264,6w4h,DB00948,-8.7,Mezlocillin,YPBATNHYBCGSSN-VWPFQQQWSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
114096,6vxx,DB12720,-8.7,Nivocasan,VYFGDLGHHBUDTQ-ZLGUVYLKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59695,6crv,DB07769,-8.7,S-3-(4-FLUOROPHENOXY)-2-HYDROXY-2-METHYL-N-[4-NITRO-3-(TRIFLUOROMETHYL)PHENYL]PROPANAMIDE,KJMFOTCDISOHDX-INIZCTEOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114099,6vxx,DB12725,-8.7,TD-8954,MZOITCJKGUIQEI-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
63153,6crv,DB15235,-8.7,Di-2-pyridylketone 4-cyclohexyl-4-methyl-3-thiosemicarbazone,GNLZNQJBZNOUBM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79841,6m2n,DB13816,-8.7,Aspoxicillin,BHELIUBJHYAEDK-OAIUPTLZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
159819,7bv1,DB06625,-8.7,Vipadenant,HQSBCDPYXDGTCL-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
54987,6crv,DB00470,-8.7,Dronabinol,CYQFCXCEBYINGO-IAGOWNOFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79874,6m2n,DB13856,-8.7,Fluclorolone,VTWKPILBIUBMDS-OTJLYDAYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
166460,7bv1,DB15177,-8.7,VX-659,IGEOJNMYRZUKIK-IBGZPJMESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
86609,6m3m,DB09101,-8.7,Elvitegravir,JUZYLCPPVHEVSV-LJQANCHMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86646,6m3m,DB09183,-8.7,Dasabuvir,NBRBXGKOEOGLOI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
79725,6m2n,DB13664,-8.7,Formocortal,QNXUUBBKHBYRFW-QWAPGEGQSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
9838,6lzg,DB07970,-8.7,5-[(2-methyl-5-{[3-(trifluoromethyl)phenyl]carbamoyl}phenyl)amino]pyridine-3-carboxamide,SAAYRHKJHDIDPH-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
79583,6m2n,DB13470,-8.7,Cefodizime,XDZKBRJLTGRPSS-BGZQYGJUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
86698,6m3m,DB09239,-8.7,Niguldipine,SVJMLYUFVDMUHP-XIFFEERXSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
159721,7bv1,DB05465,-8.7,Tandutinib,UXXQOJXBIDBUAC-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
79584,6m2n,DB13471,-8.7,Nalfurafine,XGZZHZMWIXFATA-UEZBDDGYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
63136,6crv,DB15205,-8.7,Capromorelin,KVLLHLWBPNCVNR-SKCUWOTOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
159729,7bv1,DB05511,-8.7,Piclidenoson,HUJXGQILHAUCCV-MOROJQBDSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
137397,6w9c,DB08242,-8.7,"N,4-dimethyl-3-[(1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl)amino]benzamide",OYTBZXSFNNAVKU-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
79605,6m2n,DB13499,-8.7,Cefsulodin,SYLKGLMBLAAGSC-QLVMHMETSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
9846,6lzg,DB07977,-8.7,"3-({[3,5-DIFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)THIOPHENE-2-CARBOXYLIC ACID",CGNHUSCKOHDSMR-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
72875,6m2n,DB01254,-8.7,Dasatinib,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
88986,6m3m,DB15232,-8.7,Telaglenastat,PRAAPINBUWJLGA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88980,6m3m,DB15221,-8.7,PF-06260414,ZKAVFOXYJCREBQ-SNVBAGLBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
132483,6w9c,DB00482,-8.7,Celecoxib,RZEKVGVHFLEQIL-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
110174,6vxx,DB01061,-8.7,Azlocillin,JTWOMNBEOCYFNV-NFFDBFGFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86669,6m3m,DB09206,-8.7,Trimazosin,YNZXWQJZEDLQEG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
97815,6vxs,DB00197,-8.7,Troglitazone,GXPHKUHSUJUWKP-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
79682,6m2n,DB13606,-8.7,Phenazocine,ZQHYKVKNPWDQSL-KNXBSLHKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76299,6m2n,DB07045,-8.7,"(2R,3R,4S,5R)-2-[6-amino-8-[(3,4-dichlorophenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol",VBJKVZXRYLCYGQ-XNIJJKJLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
63140,6crv,DB15209,-8.7,MK-0736,ORQZQBUNAMJFCY-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59723,6crv,DB07801,-8.7,N-butyl-3-{[6-(9H-purin-6-ylamino)hexanoyl]amino}benzamide,WOYITRCGMUXUDE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
9877,6lzg,DB08010,-8.7,"(3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-[(E)-2-phenylethenyl]-1H-indole-2,3-dione 3-oxime",DDHASJXGNUWZTM-ZLEWNXFRSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
79714,6m2n,DB13651,-8.7,Lorajmine,LAHDERDHXJFFJU-ZWNKPRIXSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
30254,6cs2,DB12253,-8.7,GDC-0810,BURHGPHDEVGCEZ-KJGLQBJMSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
110188,6vxx,DB01076,-8.7,Atorvastatin,XUKUURHRXDUEBC-KAYWLYCHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72879,6m2n,DB01261,-8.7,Sitagliptin,MFFMDFFZMYYVKS-SECBINFHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
86604,6m3m,DB09091,-8.7,Tixocortol,YWDBSCORAARPPF-VWUMJDOOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86595,6m3m,DB09080,-8.7,Olodaterol,COUYJEVMBVSIHV-SFHVURJKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86520,6m3m,DB08974,-8.7,Flubendazole,CPEUVMUXAHMANV-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
72521,6m2n,DB00846,-8.7,Flurandrenolide,POPFMWWJOGLOIF-XWCQMRHXSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
148807,6w9q,DB13991,-8.7,Pipequaline,AMEWZCMTSIONOX-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
89030,6m3m,DB15319,-8.7,VM4-037,QGYZPMXIVNIGKA-GMAHTHKFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
98551,6vxs,DB01070,-8.7,Dihydrotachysterol,ILYCWAKSDCYMBB-OPCMSESCSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
139074,6w9c,DB12812,-8.7,Palomid 529,YEAHTLOYHVWAKW-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
76232,6m2n,DB06969,-8.7,"2-amino-4-[2,4-dichloro-5-(2-pyrrolidin-1-ylethoxy)phenyl]-N-ethylthieno[2,3-d]pyrimidine-6-carboxamide",WJUNQSYQHHIVFX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
63202,6crv,DB15333,-8.7,AZD-1386,FPGNKXCEPARJDI-ZDUSSCGKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86502,6m3m,DB08954,-8.7,Ifenprodil,UYNVMODNBIQBMV-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
124367,6w4h,DB01067,-8.7,Glipizide,ZJJXGWJIGJFDTL-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
98634,6vxs,DB01167,-8.7,Itraconazole,VHVPQPYKVGDNFY-ZPGVKDDISA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
30175,6cs2,DB12147,-8.7,Erdafitinib,OLAHOMJCDNXHFI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
61696,6crv,DB12448,-8.7,Lifibrol,LNXBEIZREVRNTF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80085,6m2n,DB14631,-8.7,Prednisolone phosphate,JDOZJEUDSLGTLU-VWUMJDOOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
109821,6vxx,DB00295,-8.7,Morphine,BQJCRHHNABKAKU-KBQPJGBKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
98665,6vxs,DB01199,-8.7,Tubocurarine,JFJZZMVDLULRGK-URLMMPGGSA-O,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
132588,6w9c,DB00611,-8.7,Butorphanol,IFKLAQQSCNILHL-PWRODBHTSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
130002,6w4h,DB11618,-8.7,Zorubicin,FBTUMDXHSRTGRV-BJISBDEGSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
86478,6m3m,DB08916,-8.7,Afatinib,ULXXDDBFHOBEHA-CWDCEQMOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80091,6m2n,DB14637,-8.7,Fluprednisolone acetate,CYMBAKFTWRNHPS-APRQOCPKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
63210,6crv,DB15346,-8.7,GLPG-1205,IRBAWVGZNJIROV-SFHVURJKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80097,6m2n,DB14644,-8.7,Methylprednisolone hemisuccinate,IMBXEJJVJRTNOW-XYMSELFBSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80105,6m2n,DB14652,-8.7,Clocortolone acetate,ARPLCFGLEYFDCN-CDACMRRYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137267,6w9c,DB08092,-8.7,3-fluoro-N-1H-indol-5-yl-5-morpholin-4-ylbenzamide,VMLSXFMXUNVCSK-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
86493,6m3m,DB08942,-8.7,Isoxicam,YYUAYBYLJSNDCX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
144475,6w9q,DB04942,-8.7,Tamibarotene,MUTNCGKQJGXKEM-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
13304,6lzg,DB15110,-8.7,Onvansertib,QHLVBNKYJGBCQJ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
80060,6m2n,DB14544,-8.7,Hydrocortisone valerate,FZCHYNWYXKICIO-FZNHGJLXSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
59679,6crv,DB07751,-8.7,"(2S)-1-[4-({6-[(2,6-Difluorophenyl)amino]-4-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol",ZVSBKYYVBCKDBO-HNNXBMFYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140141,6w9c,DB15057,-8.7,NUC-1031,NHTKGYOMICWFQZ-KKQYNPQSSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
13348,6lzg,DB15193,-8.7,BMS-955176,XDMUFNNPLXHNKA-ZTESCHFWSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
13344,6lzg,DB15190,-8.7,GLPG-0259,YBFGSJUVEOYPIS-OALUTQOASA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
72647,6m2n,DB00990,-8.7,Exemestane,BFYIZQONLCFLEV-DAELLWKTSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
130022,6w4h,DB11656,-8.7,Rebamipide,ALLWOAVDORUJLA-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
132533,6w9c,DB00547,-8.7,Desoximetasone,VWVSBHGCDBMOOT-IIEHVVJPSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
61652,6crv,DB12392,-8.7,Resminostat,FECGNJPYVFEKOD-VMPITWQZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79928,6m2n,DB13981,-8.7,Nomegestrol acetate,IIVBFTNIGYRNQY-YQLZSBIMSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
9934,6lzg,DB08073,-8.7,(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE,YWTBGJGMTBHQTM-IBGZPJMESA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
159831,7bv1,DB06652,-8.7,Vicriviroc,CNPVJJQCETWNEU-CYFREDJKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
28376,6cs2,DB07965,-8.7,6-(cyclohexylamino)-9-[2-(4-methylpiperazin-1-yl)-ethyl]-9H-purine-2-carbonitrile,OGODDSLNRULSMM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
76253,6m2n,DB06994,-8.7,"(2S,3S)-3-{3-[2-chloro-4-(methylsulfonyl)phenyl]-1,2,4-oxadiazol-5-yl}-1-cyclopentylidene-4-cyclopropyl-1-fluorobutan-2-amine",XCCSSVMRGIQMGF-LPHOPBHVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
59642,6crv,DB07707,-8.7,"(9BETA,11ALPHA,13ALPHA,14BETA,17ALPHA)-11-(METHOXYMETHYL)ESTRA-1(10),2,4-TRIENE-3,17-DIOL",LEOPSILMAOYZBO-IUTAEKPZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
98431,6vxs,DB00932,-8.7,Tipranavir,SUJUHGSWHZTSEU-FYBSXPHGSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
72578,6m2n,DB00910,-8.7,Paricalcitol,BPKAHTKRCLCHEA-UBFJEZKGSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
109894,6vxx,DB00559,-8.7,Bosentan,GJPICJJJRGTNOD-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114141,6vxx,DB12796,-8.7,MRX-I,SULYVXZZUMRQAX-NSHDSACASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72563,6m2n,DB00894,-8.7,Testolactone,BPEWUONYVDABNZ-DZBHQSCQSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
72547,6m2n,DB00875,-8.7,Flupentixol,NJMYODHXAKYRHW-DVZOWYKESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61659,6crv,DB12401,-8.7,Bromperidol,RKLNONIVDFXQRX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
128752,6w4h,DB07977,-8.7,"3-({[3,5-DIFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)THIOPHENE-2-CARBOXYLIC ACID",CGNHUSCKOHDSMR-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
76251,6m2n,DB06992,-8.7,"(3,3-dimethylpiperidin-1-yl)(6-(3-fluoro-4-methylphenyl)pyridin-2-yl)methanone",SIDDLTBLAQYZIZ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
26017,6cs2,DB04071,-8.7,Cpad,LFERELMXERXKKQ-KMXXXSRASA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
89099,6m3m,DB15460,-8.7,AGG-523,JWQMTWCFNZSLNR-DEOSSOPVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
9834,6lzg,DB07966,-8.7,[4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]quinazolin-2-yl}amino)phenyl]acetonitrile,NVMCVWOODOWOLT-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
13433,6lzg,DB15345,-8.7,GSK-945237,SRICOHRDRMZREQ-MRXNPFEDSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
166454,7bv1,DB15163,-8.7,Selatogrel,FYXHWMQPCJOJCH-GMAHTHKFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59897,6crv,DB08001,-8.7,5-(3-{3-[3-HYDROXY-2-(METHOXYCARBONYL)PHENOXY]PROPENYL}PHENYL)-4-(HYDROXYMETHYL)ISOXAZOLE-3-CARBOXYLIC ACID,DQSRCEFDWMQCCV-GQCTYLIASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114631,6vxx,DB13919,-8.7,Candesartan,HTQMVQVXFRQIKW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
137543,6w9c,DB08429,-8.7,N-({(2S)-1-[(3R)-3-amino-4-(3-chlorophenyl)butanoyl]pyrrolidin-2-yl}methyl)-3-(methylsulfonyl)benzamide,QRGBOABBMKYMLG-UXHICEINSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
76075,6m2n,DB06746,-8.7,ginkgolide-J,LMEHVEUFNRJAAV-UKWFQYJJSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76076,6m2n,DB06747,-8.7,ginkgolide-M,KDKROYXEHCYLJQ-FJFAJXJPSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79214,6m2n,DB12914,-8.7,MGL-3196,FDBYIYFVSAHJLY-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
73146,6m2n,DB01640,-8.7,"(5r)-6-(4-{[2-(3-Iodobenzyl)-3-Oxocyclohex-1-En-1-Yl]Amino}Phenyl)-5-Methyl-4,5-Dihydropyridazin-3(2h)-One",QNURTFDBHAQRSI-OAHLLOKOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
130143,6w4h,DB11830,-8.7,Mocetinostat,HRNLUBSXIHFDHP-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
88922,6m3m,DB15109,-8.7,Ingenol disoxate,GLIUZQUNUNICGS-XUBYYPQFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
140036,6w9c,DB14801,-8.7,Lanifibranor,OQDQIFQRNZIEEJ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
61757,6crv,DB12545,-8.7,Indobufen,AYDXAULLCROVIT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
97476,6m71,DB14989,-8.7,Umbralisib,IUVCFHHAEHNCFT-INIZCTEOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
79232,6m2n,DB12941,-8.7,ODM-201,BLIJXOOIHRSQRB-PXYINDEMSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
128871,6w4h,DB08111,-8.7,"4-[(6-phenyl[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl]phenol",ZGJYGQLGSXWEMY-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
90035,6m71,DB01180,-8.7,Rescinnamine,SZLZWPPUNLXJEA-LAFLMMDJSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
130133,6w4h,DB11819,-8.7,ASP-4058,NJNXCJPSMWKXHO-VIFPVBQESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
110490,6vxx,DB01661,-8.7,1-(5-phospho-D-ribosyl)-ATP,RKNHJBVBFHDXGR-MRUDJCSFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
54742,6crv,DB00177,-8.7,Valsartan,ACWBQPMHZXGDFX-QFIPXVFZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79263,6m2n,DB12988,-8.7,LY-518674,PNHFDVSKDSLUFH-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76389,6m2n,DB07147,-8.7,"methyl (1R,2S)-2-(hydroxycarbamoyl)-1-{4-[(2-methylquinolin-4-yl)methoxy]benzyl}cyclopropanecarboxylate",HJWMYFBKJRVWJY-YKSBVNFPSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
59875,6crv,DB07976,-8.7,3-{[(3-FLUORO-3'-METHOXYBIPHENYL-4-YL)AMINO]CARBONYL}THIOPHENE-2-CARBOXYLIC ACID,GIUMGVUBDBDTDX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
132356,6w9c,DB00328,-8.7,Indometacin,CGIGDMFJXJATDK-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
79266,6m2n,DB12998,-8.7,PF-00217830,QGNOXTFZOLDODX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
110460,6vxx,DB01623,-8.7,Thiothixene,GFBKORZTTCHDGY-UWVJOHFNSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
159621,7bv1,DB04942,-8.7,Tamibarotene,MUTNCGKQJGXKEM-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
145100,6w9q,DB06962,-8.7,"(5-(aminomethyl)-2H-spiro[benzofuran-3,4'-piperidine]-1'-yl)(5-(phenylethynyl)furan-2-yl)methanone",YKTUSHSSKIWDRY-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
132313,6w9c,DB00276,-8.7,Amsacrine,XCPGHVQEEXUHNC-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
73201,6m2n,DB01713,-8.7,Udp-Alpha-D-Xylopyranose,DQQDLYVHOTZLOR-OCIMBMBZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
59933,6crv,DB08039,-8.7,"(3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE",LOGJQOUIVKBFGH-YBEGLDIGSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62988,6crv,DB14879,-8.7,Cefiderocol,DBPPRLRVDVJOCL-FQRUVTKNSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87026,6m3m,DB11725,-8.7,Latrepirdine,JNODQFNWMXFMEV-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
132249,6w9c,DB00203,-8.7,Sildenafil,BNRNXUUZRGQAQC-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
79095,6m2n,DB12721,-8.7,RO-5028442,QZXVLRCMAHJVIP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
97385,6m71,DB14766,-8.7,Etrasimod,MVGWUTBTXDYMND-QGZVFWFLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
87013,6m3m,DB11701,-8.7,Amenamevir,MNHNIVNAFBSLLX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59923,6crv,DB08029,-8.7,N-2-(biphenyl-4-ylsulfonyl)-N-hydroxy-N-2-(2-hydroxyethyl)glycinamide,QQDWEVONJRXVDB-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
166406,7bv1,DB15068,-8.7,Agerafenib,DKNUPRMJNUQNHR-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
13575,6lzg,DB01251,-8.7,Gliquidone,LLJFMFZYVVLQKT-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
73311,6m2n,DB01859,-8.7,4-Diphosphocytidyl-2-C-Methyl-D-Erythritol 2-Phosphate,HTJXTKBIUVFUAR-XHIBXCGHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
110563,6vxx,DB01945,-8.7,4-Carbamoyl-1-Beta-D-Ribofuranosyl-Imidazolium-5-Olate-5'-Phosphate,KTKAFSMJDTUUAN-UUOKFMHZSA-L,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28625,6cs2,DB08220,-8.7,"(8alpha,10alpha,13alpha,17beta)-17-[(4-hydroxyphenyl)carbonyl]androsta-3,5-diene-3-carboxylic acid",RPNNXCYIESWDSC-JRZBRKEGSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
87005,6m3m,DB11689,-8.7,Selumetinib,CYOHGALHFOKKQC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
76424,6m2n,DB07187,-8.7,6-[(5-CHLORO-3-METHYL-1-BENZOFURAN-2-YL)SULFONYL]PYRIDAZIN-3(2H)-ONE,FXFPQPNUMWQRAO-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
90128,6m71,DB01329,-8.7,Cefoperazone,GCFBRXLSHGKWDP-XCGNWRKASA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110644,6vxx,DB02049,-8.7,2-{4-[4-(4-Chloro-Phenoxy)-Benzenesulfonyl]-Tetrahydro-Pyran-4-Yl}-N-Hydroxy-Acetamide,QOPFTBAEAJQKSY-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
90126,6m71,DB01327,-8.7,Cefazolin,MLYYVTUWGNIJIB-BXKDBHETSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
79161,6m2n,DB12833,-8.7,Tandospirone,CEIJFEGBUDEYSX-FZDBZEDMSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137590,6w9c,DB08485,-8.7,"(1S,4S,5S)-1,4,5-TRIHYDROXY-3-[3-(PHENYLTHIO)PHENYL]CYCLOHEX-2-ENE-1-CARBOXYLIC ACID",QMNMNSINKIFYBV-LMMKCTJWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
148068,6w9q,DB12887,-8.7,Tazemetostat,NSQSAUGJQHDYNO-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
73213,6m2n,DB01732,-8.7,"(4r,5s,6s,7r)-1,3-Dibenzyl-4,7-Bis(Phenoxymethyl)-5,6-Dihydroxy-1,3 Diazepan-2-One",SQBOSZXDOHQFAA-ZRTHHSRSSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
132293,6w9c,DB00253,-8.7,Medrysone,GZENKSODFLBBHQ-ILSZZQPISA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
40348,6lu7,DB03231,-8.7,"3-(5-Amino-7-oxo-3,7-dihydro-2H-[1,2,3]triazolo[4,5-d]pyrimidin-2-yl)-N-(2-{[2-(hydroxymethyl)phenyl]sulfanyl}benzyl)benzamide",IXDQOBDHBWEZOH-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
79140,6m2n,DB12798,-8.7,Relenopride,KGMMSPVVHZGPHL-NRFANRHFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
165221,7bv1,DB11592,-8.7,Nitrocefin,LHNIIDJCEODSHA-OQRUQETBSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
137507,6w9c,DB08384,-8.7,2-({4-[4-(pyridin-4-ylmethyl)-1H-pyrazol-3-yl]phenoxy}methyl)quinoline,RQDDHVVAAJVVKM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137489,6w9c,DB08360,-8.7,"2-(4-ETHYLPIPERAZIN-1-YL)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE",BIFHJPUTQBOBGJ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
79379,6m2n,DB13185,-8.7,Oxabolone cipionate,KHKDIUPVDIEHAH-KXLSUQFWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
114050,6vxx,DB12654,-8.7,GSK-376501,OIDYMQICWGYEDR-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
124054,6w4h,DB00705,-8.7,Delavirdine,WHBIGIKBNXZKFE-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
79411,6m2n,DB13242,-8.7,Bucladesine,CJGYSWNGNKCJSB-YVLZZHOMSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
54862,6crv,DB00317,-8.7,Gefitinib,XGALLCVXEZPNRQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
97638,6m71,DB15310,-8.7,Vactosertib,FJCDSQATIJKQKA-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
13453,6lzg,DB01126,-8.7,Dutasteride,JWJOTENAMICLJG-QWBYCMEYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
130097,6w4h,DB11769,-8.7,Funapide,NEBUOXBYNAHKFV-NRFANRHFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
159684,7bv1,DB05263,-8.7,Caprospinol,VMOZFSWFUBLCNN-AAPULDEBSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
140072,6w9c,DB14885,-8.7,PF-05180999,CLGCHUKGBICQTE-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
30271,6cs2,DB12275,-8.7,Seviteronel,ZBRAJOQFSNYJMF-SFHVURJKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
30276,6cs2,DB12282,-8.7,Defactinib,FWLMVFUGMHIOAA-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
149132,6w9q,DB15006,-8.7,Flufenoxuron,RYLHNOVXKPXDIP-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
76318,6m2n,DB07065,-8.7,"5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)-3-thiocyanatopyrazolo[1,5-a]pyrimidin-7-amine",AHPKUZJCNHGFQA-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
8287,6lzg,DB05220,-8.7,Alisertib,ZLHFILGSQDJULK-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
137402,6w9c,DB08248,-8.7,3-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)-BENZENESULFONAMIDE,BKDUVKJYBJDZQW-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
54881,6crv,DB00342,-8.7,Terfenadine,GUGOEEXESWIERI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
54883,6crv,DB00344,-8.7,Protriptyline,BWPIARFWQZKAIA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
15043,6lzg,T3D4996,-8.7,"22,23-dihydroavermectin b1b",VARHUCVRRNANBD-PVVXTEPVSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
15042,6lzg,T3D4995,-8.7,"22,23-dihydroavermectin b1a",AZSNMRSAGSSBNP-XPNPUAGNSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
124110,6w4h,DB00773,-8.7,Etoposide,VJJPUSNTGOMMGY-MRVIYFEKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
114447,6vxx,DB13643,-8.7,Loprazolam,UTEFBSAVJNEPTR-RGEXLXHISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
97670,6m71,DB15382,-8.7,SAR-125844,ODIUNTQOXRXOIV-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
89504,6m71,DB00559,-8.7,Bosentan,GJPICJJJRGTNOD-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
140078,6w9c,DB14898,-8.7,Retagliptin,WIIAMRXFUJLYEF-SNVBAGLBSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
89648,6m71,DB00734,-8.7,Risperidone,RAPZEAPATHNIPO-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
89670,6m71,DB00762,-8.7,Irinotecan,UWKQSNNFCGGAFS-XIFFEERXSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
54847,6crv,DB00298,-8.7,Dapiprazole,RFWZESUMWJKKRN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110417,6vxx,DB01568,-8.7,Codeine-N-oxide,BDLSDHWCOJPHIE-KFUGMXNISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59864,6crv,DB07965,-8.7,6-(cyclohexylamino)-9-[2-(4-methylpiperazin-1-yl)-ethyl]-9H-purine-2-carbonitrile,OGODDSLNRULSMM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76388,6m2n,DB07146,-8.7,"2,3-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-B]PYRIDIN-4-AMINE",QUIQCYFSBGOBKE-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
110403,6vxx,DB01554,-8.7,Bolandiol,CMXKUJNZWYTFJN-XFUVECHXSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79331,6m2n,DB13094,-8.7,Pruvanserin,AQRLDDAFYYAIJP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
88944,6m3m,DB15149,-8.7,Futibatinib,KEIPNCCJPRMIAX-HNNXBMFYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
72951,6m2n,DB01415,-8.7,Ceftibuten,UNJFKXSSGBWRBZ-BJCIPQKHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
139006,6w9c,DB12705,-8.7,Cenerimod,KJKKMMMRWISKRF-FQEVSTJZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137460,6w9c,DB08322,-8.7,"2-DEOXY-3,4-BIS-O-[3-(4-HYDROXYPHENYL)PROPANOYL]-L-THREO-PENTARIC ACID",VJLMRHSHSNLOGC-NOPZTHQXSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
86883,6m3m,DB11426,-8.7,Marbofloxacin,BPFYOAJNDMUVBL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
54802,6crv,DB00247,-8.7,Methysergide,KPJZHOPZRAFDTN-NQUBZZJWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86871,6m3m,DB11398,-8.7,Diclazuril,ZSZFUDFOPOMEET-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
72943,6m2n,DB01406,-8.7,Danazol,POZRVZJJTULAOH-LHZXLZLDSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
139110,6w9c,DB12875,-8.7,Mavatrep,ORDHXXHTBUZRCN-NTEUORMPSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
76371,6m2n,DB07127,-8.7,"{4-[2,2-BIS(5-METHYL-1,2,4-OXADIAZOL-3-YL)-3-PHENYLPROPYL]PHENYL}SULFAMIC ACID",SXDBFKLPNPUPRI-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
86848,6m3m,DB11362,-8.7,Selexipag,QXWZQTURMXZVHJ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59841,6crv,DB07937,-8.7,"2-butoxy-9-(2,6-difluorobenzyl)-N-(2-morpholin-4-ylethyl)-9H-purin-6-amine",UGZWPZWADDDTRN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130117,6w4h,DB11795,-8.7,GSK-2636771,XTKLTGBKIDQGQL-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
139100,6w9c,DB12857,-8.7,NVP-LEQ-506,POERAARDVFVDLO-QGZVFWFLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
76368,6m2n,DB07124,-8.7,"(2S)-1-(6H-INDOL-3-YL)-3-{[5-(7H-PYRAZOLO[3,4-C]PYRIDIN-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE",CCIACUJJBPSOHE-KRWDZBQOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137443,6w9c,DB08304,-8.7,"(3R)-3-cyclopentyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2-benzothiazine 1,1-dioxide",QZBQVXXESPXFPZ-QGZVFWFLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
76131,6m2n,DB06848,-8.7,"1-(1'-{[3-(methylsulfanyl)-2-benzothiophen-1-yl]carbonyl}spiro[1-benzofuran-3,4'-piperidin]-5-yl)methanamine",VCUDZTCDUDDJGG-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
29802,6cs2,DB11656,-8.7,Rebamipide,ALLWOAVDORUJLA-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
76152,6m2n,DB06874,-8.7,"(6-[4-(AMINOMETHYL)-2,6-DIMETHYLPHENOXY]-2-{[4-(AMINOMETHYL)PHENYL]AMINO}-5-BROMOPYRIMIDIN-4-YL)METHANOL",LSIZSSASMKSUIU-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
30300,6cs2,DB12306,-8.7,Cipargamin,CKLPLPZSUQEDRT-WPCRTTGESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
97343,6m71,DB14669,-8.7,Betamethasone phosphate,VQODGRNSFPNSQE-DVTGEIKXSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
131983,6w4h,DB15145,-8.7,Ziresovir,GAAICKUTDBZCMT-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
78685,6m2n,DB12120,-8.7,Avoralstat,TUWMKPVJGGWGNL-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76593,6m2n,DB07382,-8.7,"N-2-1H-benzimidazol-5-yl-N-4-(3-cyclopropyl-1H-pyrazol-5-yl)pyrimidine-2,4-diamine",WJNBSTLIALIIEW-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
130859,6w4h,DB12903,-8.7,DEBIO-1347,BEMNJULZEQTDJY-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
62290,6crv,DB13374,-8.7,Vincamine,RXPRRQLKFXBCSJ-GIVPXCGWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
94382,6m71,DB08043,-8.7,1-[4-(PYRIDIN-4-YLOXY)PHENYL]-3-[3-(TRIFLUOROMETHYL)PHENYL]UREA,DDDLGNOZDKDSEG-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
77088,6m2n,DB07965,-8.7,6-(cyclohexylamino)-9-[2-(4-methylpiperazin-1-yl)-ethyl]-9H-purine-2-carbonitrile,OGODDSLNRULSMM-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
130550,6w4h,DB12419,-8.7,HSD-016,ZWASRJHIEFYJGL-BFUOFWGJSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
62303,6crv,DB13395,-8.7,Eprozinol,QSRHLIUOSXVKTG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
154404,6wiq,DB07833,-8.7,"N-(3-cyanophenyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)-4-biphenylcarboxamide",PMMLSQFPBFKLHH-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
113378,6vxx,DB09078,-8.7,Lenvatinib,WOSKHXYHFSIKNG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87790,6m3m,DB12867,-8.7,Benperidol,FEBOTPHFXYHVPL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
112558,6vxx,DB07393,-8.7,"2-(2-PHENYL-3-PYRIDIN-2-YL-4,5,6,7-TETRAHYDRO-2H-ISOPHOSPHINDOL-1-YL)PYRIDINE",GSKNNHAAFLPYHG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31942,6cs2,DB15075,-8.7,4-demethyl-4-cholesteryloxycarbonylpenclomedine,ZJUUIXYKTPSIOH-LEZJFEBPSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
62279,6crv,DB13360,-8.7,Tolciclate,CANCCLAKQQHLNK-LSDHHAIUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31958,6cs2,DB15106,-8.7,Surufatinib,TTZSNFLLYPYKIL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
75730,6m2n,DB05608,-8.7,MKC-1,OVSKGTONMLKNPZ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
74986,6m2n,DB04097,-8.7,Uridine-5'-Diphosphate-4-Deoxy-4-Fluoro-Alpha-D-Galactose,OAPPZHVTNHJVAL-JZMIEXBBSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
60653,6crv,DB08934,-8.7,Sofosbuvir,TTZHDVOVKQGIBA-IQWMDFIBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60650,6crv,DB08931,-8.7,Riociguat,WXXSNCNJFUAIDG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112527,6vxx,DB07354,-8.7,"2,3-DIMETHOXY-12H-[1,3]DIOXOLO[5,6]INDENO[1,2-C]ISOQUINOLIN-6-IUM",LXDREMZQGAILJU-UHFFFAOYSA-O,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62327,6crv,DB13425,-8.7,Flutrimazole,QHMWCHQXCUNUAK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112525,6vxx,DB07352,-8.7,Apigenin,KZNIFHPLKGYRTM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
146984,6w9q,DB09280,-8.7,Lumacaftor,UFSKUSARDNFIRC-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
75731,6m2n,DB05611,-8.7,Apilimod,HSKAZIJJKRAJAV-KOEQRZSOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
94598,6m71,DB08303,-8.7,"(3S)-3-cyclopentyl-6-methyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide",CUMKMTBOHBENJI-SFHVURJKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
154033,6wiq,DB07397,-8.7,"(5S)-5-(2-amino-2-oxoethyl)-4-oxo-N-[(3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl)methyl]-3,4,5,6,7,8-hexahydro[1]benzothieno[2,3-d]pyrimidine-2-carboxamide",ITADELAVAWJACR-NSHDSACASA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
120404,6w4b,DB08450,-8.7,N-1H-indazol-5-yl-2-(6-methylpyridin-2-yl)quinazolin-4-amine,HNHRWNUXTCATSG-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
130556,6w4h,DB12427,-8.7,Orvepitant,XWNBGDJPEXZSQM-VZOBGQTKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
129499,6w4h,DB08882,-8.7,Linagliptin,LTXREWYXXSTFRX-QGZVFWFLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
31011,6cs2,DB13308,-8.7,Oxametacin,AJRNYCDWNITGHF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
61188,6crv,DB11718,-8.7,Encorafenib,CMJCXYNUCSMDBY-ZDUSSCGKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77742,6m2n,DB08742,-8.7,"1,3-CYCLOHEXANEDIOL, 4-METHYLENE-5-[(2E)-[(1S,3AS,7AS)-OCTAHYDRO-1-(5-HYDROXY-5-METHYL-1,3-HEXADIYNYL)-7A-METHYL-4H-INDEN-4-YLIDENE]ETHYLIDENE]-, (1R,3S,5Z)",CEEUUHVULXTFGS-BQXVGYHGSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
129358,6w4h,DB08705,-8.7,"6-(5-BROMO-2-HYDROXYPHENYL)-2-OXO-4-PHENYL-1,2-DIHYDROPYRIDINE-3-CARBONITRILE",SVSYJTYGPLVUOZ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
62233,6crv,DB13308,-8.7,Oxametacin,AJRNYCDWNITGHF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
129356,6w4h,DB08703,-8.7,"12-(2-hydroxyethyl)-2-(1-methylethoxy)-13,14-dihydronaphtho[2,1-a]pyrrolo[3,4-c]carbazol-5(12H)-one",FGKKIHITEICGMN-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
75684,6m2n,DB05408,-8.7,Emricasan,SCVHJVCATBPIHN-SJCJKPOMSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
130815,6w4h,DB12836,-8.7,Grapiprant,HZVLFTCYCLXTGV-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
113298,6vxx,DB08772,-8.7,"3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL-2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID",BCSVCWVQNOXFGL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29133,6cs2,DB08772,-8.7,"3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL-2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID",BCSVCWVQNOXFGL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
62237,6crv,DB13312,-8.7,Delapril,WOUOLAUOZXOLJQ-MBSDFSHPSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61191,6crv,DB11725,-8.7,Latrepirdine,JNODQFNWMXFMEV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138584,6w9c,DB11877,-8.7,Basmisanil,VCGRFBXVSFAGGA-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
31030,6cs2,DB13327,-8.7,Picotamide,KYWCWBXGRWWINE-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
139601,6w9c,DB13685,-8.7,Quingestanol,PCJFRMOEZQQSAX-AIOSZGMZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
77786,6m2n,DB08791,-8.7,"1-[(2-NITROPHENYL)SULFONYL]-1H-PYRROLO[3,2-B]PYRIDINE-6-CARBOXAMIDE",USLOIFPDNUDIEG-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61973,6crv,DB12890,-8.7,Dihydrexidine,BGOQGUHWXBGXJW-YOEHRIQHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130837,6w4h,DB12875,-8.7,Mavatrep,ORDHXXHTBUZRCN-NTEUORMPSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
75131,6m2n,DB04285,-8.7,"{4-[(2s,4e)-2-(1,3-Benzothiazol-2-Yl)-2-(1h-1,2,3-Benzotriazol-1-Yl)-5-Phenylpent-4-Enyl]Phenyl}(Difluoro)Methylphosphonic Acid",GBLDYRVJENYQNH-AGLOJYHOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77810,6m2n,DB08820,-8.7,Ivacaftor,PURKAOJPTOLRMP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
31907,6cs2,DB15013,-8.7,TAK-243,KJDAGXLMHXUAGV-DGWLBADLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
112613,6vxx,DB07456,-8.7,"3-(1H-indol-3-yl)-4-(1-{2-[(2S)-1-methylpyrrolidinyl]ethyl}-1H-indol-3-yl)-1H-pyrrole-2,5-dione",LBFDERUQORUFIN-QGZVFWFLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77108,6m2n,DB07987,-8.7,"[2-(5-MERCAPTO-[1,3,4]THIADIAZOL-2-YLCARBAMOYL)-1-PHENYL-ETHYL]-CARBAMIC ACID BENZYL ESTER",AWAKNMKLVLWIIQ-OAHLLOKOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
92886,6m71,DB05263,-8.7,Caprospinol,VMOZFSWFUBLCNN-AAPULDEBSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
77834,6m2n,DB08860,-8.7,Pitavastatin,VGYFMXBACGZSIL-MCBHFWOFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
121739,6w4b,DB12323,-8.7,Radotinib,DUPWHXBITIZIKZ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
77867,6m2n,DB08916,-8.7,Afatinib,ULXXDDBFHOBEHA-CWDCEQMOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
62351,6crv,DB13458,-8.7,Thebacon,RRJQTGHQFYTZOW-ILWKUFEGSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87745,6m3m,DB12787,-8.7,Norethandrolone,ZDHCJEIGTNNEMY-XGXHKTLJSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
76986,6m2n,DB07844,-8.7,6-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1-BENZOTHIOPHENE-2-SULFONAMIDE,PHLKBODTBJLXRD-WFASDCNBSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
8625,6lzg,DB06543,-8.7,Astaxanthin,MQZIGYBFDRPAKN-UWFIBFSHSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
78050,6m2n,DB09198,-8.7,Lobeglitazone,CHHXEZSCHQVSRE-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78060,6m2n,DB09209,-8.7,Pholcodine,GPFAJKDEDBRFOS-FKQDBXSBSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
98779,6vxs,DB01410,-8.7,Ciclesonide,LUKZNWIVRBCLON-GXOBDPJESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
112391,6vxx,DB07049,-8.7,(2R)-1-[(4-tert-butylphenyl)sulfonyl]-2-methyl-4-(4-nitrophenyl)piperazine,SOFGQQQVQZQJFS-MRXNPFEDSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
25432,6cs2,DB03351,-8.7,Sri-9439,KMSATRJZEXNGDP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
61271,6crv,DB11836,-8.7,Sapanisertib,GYLDXIAOMVERTK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138489,6w9c,DB11740,-8.7,MK-1775,BKWJAKQVGHWELA-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
87672,6m3m,DB12670,-8.7,Rolofylline,PJBFVWGQFLYWCB-QUYAXPHCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
113514,6vxx,DB09290,-8.7,Ramosetron,NTHPAPBPFQJABD-LLVKDONJSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
14130,6lzg,T3D3748,-8.7,Paspalinine,BPTIXFRJAOKMRK-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
88585,6m3m,DB14069,-8.7,ONT-093,RSJCLODJSVZNQA-BQYQJAHWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87661,6m3m,DB12657,-8.7,JNJ-42396302,BPLVDYJDAVYLRQ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88594,6m3m,DB14086,-8.7,Cianidanol,PFTAWBLQPZVEMU-DZGCQCFKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
129262,6w4h,DB08584,-8.7,"6-{[6-(1-methyl-1H-pyrazol-4-yl)[1,2,4]triazolo[4,3-b]pyridazin-3-yl]sulfanyl}quinoline",BCZUAADEACICHN-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
62444,6crv,DB13587,-8.7,Mesterolone,UXYRZJKIQKRJCF-TZPFWLJSSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113517,6vxx,DB09295,-8.7,Talniflumate,ANMLJLFWUCQGKZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
131201,6w4h,DB13422,-8.7,Nicofuranose,FUWFSXZKBMCSKF-ZASNTINBSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
32047,6cs2,DB15265,-8.7,USL-311,XNUNVQKARNSSEO-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
139283,6w9c,DB13266,-8.7,Cefatrizine,UOCJDOLVGGIYIQ-PBFPGSCMSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
62466,6crv,DB13616,-8.7,Melagatran,DKWNMCUOEDMMIN-PKOBYXMFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76942,6m2n,DB07795,-8.7,Fisetin,XHEFDIBZLJXQHF-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
87623,6m3m,DB12591,-8.7,BMS-911543,JCINBYQJBYJGDM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
14103,6lzg,T3D3720,-8.7,Verrucarin A,NLUGUZJQJYVUHS-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
25447,6cs2,DB03367,-8.7,PF-00356231,VMTJQZUZINLEKC-JOCHJYFZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
129266,6w4h,DB08590,-8.7,1-(3-HYDROXYPROPYL)-2-[(3-NITROBENZOYL)AMINO]-1H-BENZIMIDAZOL-5-YL PIVALATE,CEAYRKIZESVQSN-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
75671,6m2n,DB05294,-8.7,Vandetanib,UHTHHESEBZOYNR-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
112407,6vxx,DB07066,-8.7,"2-CHLORO-N-[(3R)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL]-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE",LJAHIGGEXIWVJG-LLVKDONJSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
74852,6m2n,DB03916,-8.7,4-{2-[4-(2-Aminoethyl)Piperazin-1-Yl]Pyridin-4-Yl}-N-(3-Chloro-4-Methylphenyl)Pyrimidin-2-Amine,RHOOHUMOHVIXEF-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77877,6m2n,DB08934,-8.7,Sofosbuvir,TTZHDVOVKQGIBA-IQWMDFIBSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138535,6w9c,DB11805,-8.7,Saracatinib,OUKYUETWWIPKQR-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
30860,6cs2,DB13078,-8.7,KOSN-1724,JAYGOFBXDFAXBW-CYEKYUJNSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
77898,6m2n,DB08962,-8.7,Glibornuride,RMTYNAPTNBJHQI-LLDVTBCESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
113456,6vxx,DB09209,-8.7,Pholcodine,GPFAJKDEDBRFOS-FKQDBXSBSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
157961,6wiq,DB15382,-8.7,SAR-125844,ODIUNTQOXRXOIV-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
25066,6cs2,DB02915,-8.7,"4-(2,4-Dimethyl-1,3-thiazol-5-yl)-N-[4-(trifluoromethyl)phenyl]-2-pyrimidinamine",MEZFDQUDLQCVNX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
130995,6w4h,DB13109,-8.7,PKI-179,WXUUCRLKXQMWRY-OYRHEFFESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
94683,6m71,DB08407,-8.7,PLATENSIMYCIN,CSOMAHTTWTVBFL-OFBLZTNGSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
77958,6m2n,DB09038,-8.7,Empagliflozin,OBWASQILIWPZMG-QZMOQZSNSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
30846,6cs2,DB13060,-8.7,CEP-37440,BCSHRERPHLTPEE-NRFANRHFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
30842,6cs2,DB13055,-8.7,Oteseconazole,IDUYJRXRDSPPRC-NRFANRHFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
76974,6m2n,DB07830,-8.7,"(4R,5R)-5-AMINO-1-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN-2-ONE",DIRIFWIKLRTNMB-DYVFJYSZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
62403,6crv,DB13531,-8.7,Nicofetamide,DWODOIKZDGJOPQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62405,6crv,DB13533,-8.7,Methylestrenolone,ZXSWTMLNIIZPET-ZOFHRBRSSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29972,6cs2,DB11878,-8.7,Filibuvir,SLVAPEZTBDBAPI-GDLZYMKVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
60586,6crv,DB08820,-8.7,Ivacaftor,PURKAOJPTOLRMP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
74912,6m2n,DB03996,-8.7,"3-[(5s)-1-Acetyl-3-(2-Chlorophenyl)-4,5-Dihydro-1h-Pyrazol-5-Yl]Phenol",QBZAPFWYAPXRGQ-KRWDZBQOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
74902,6m2n,DB03984,-8.7,Morpholine-4-Carboxylic Acid [1-(2-Benzylsulfanyl-1-Formyl-Ethylcarbamoyl)-2-Phenyl-Ethyl]-Amide,MWTQNXVXPLTHJB-YADHBBJMSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
139697,6w9c,DB13816,-8.7,Aspoxicillin,BHELIUBJHYAEDK-OAIUPTLZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
88575,6m3m,DB14055,-8.7,(S)-Warfarin,PJVWKTKQMONHTI-HNNXBMFYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
92653,6m71,DB04690,-8.7,Camptothecin,VSJKWCGYPAHWDS-FQEVSTJZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60583,6crv,DB08815,-8.7,Lurasidone,PQXKDMSYBGKCJA-CVTJIBDQSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29055,6cs2,DB08697,-8.7,"4-(2-aminoethoxy)-N-(3-chloro-5-piperidin-1-ylphenyl)-3,5-dimethylbenzamide",JDYIYIRPQKMWMM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
131042,6w4h,DB13215,-8.7,Sulfobromophthalein,OHTXTCNTQJFRIG-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
166037,7bv1,DB13606,-8.7,Phenazocine,ZQHYKVKNPWDQSL-KNXBSLHKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
112677,6vxx,DB07533,-8.7,"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]-2-FURYL}-N-METHYLBENZENESULFONAMIDE",FJJJERLTHDXEPT-JYRVWZFOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165752,7bv1,DB12756,-8.7,TAK-901,WKDACQVEJIVHMZ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
87903,6m3m,DB13032,-8.7,Enecadin,SZSHJTJCJOWMHM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
93228,6m71,DB06626,-8.7,Axitinib,RITAVMQDGBJQJZ-FMIVXFBMSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
77452,6m2n,DB08395,-8.7,2-(ETHOXYMETHYL)-4-(4-FLUOROPHENYL)-3-[2-(2-HYDROXYPHENOXY)PYRIMIDIN-4-YL]ISOXAZOL-5(2H)-ONE,ZSOXFJURLPCSOO-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
155857,6wiq,DB11851,-8.7,Bafetinib,ZGBAJMQHJDFTQJ-DEOSSOPVSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
77456,6m2n,DB08400,-8.7,4-(3-{[5-(trifluoromethyl)pyridin-2-yl]oxy}benzyl)piperidine-1-carboxylic acid,KUEKMTNOUPAOBS-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
93216,6m71,DB06605,-8.7,Apixaban,QNZCBYKSOIHPEH-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
61104,6crv,DB11551,-8.7,Trenbolone,MEHHPFQKXOUFFV-OWSLCNJRSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77473,6m2n,DB08423,-8.7,[5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL][3-(PIPERIDIN-4-YLOXY)PHENYL]METHANONE,QKZZJXRGCHXIAI-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61016,6crv,DB11366,-8.7,Roquinimex,SGOOQMRIPALTEL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75585,6m2n,DB04892,-8.7,Phenserine,PBHFNBQPZCRWQP-QUCCMNQESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75590,6m2n,DB04908,-8.7,Flibanserin,PPRRDFIXUUSXRA-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75609,6m2n,DB04957,-8.7,Azimilide,MREBEPTUUMTTIA-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77264,6m2n,DB08159,-8.7,"4-(5,11-DIOXO-5H-INDENO[1,2-C]ISOQUINOLIN-6(11H)-YL)BUTANOATE",AHIJTWCJGCWHMT-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77258,6m2n,DB08153,-8.7,"(5E)-14-CHLORO-15,17-DIHYDROXY-4,7,8,9,10,11-HEXAHYDRO-2-BENZOXACYCLOPENTADECINE-1,12(3H,13H)-DIONE",VZTAZMSAAIUZJV-HWKANZROSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
130606,6w4h,DB12505,-8.7,E-7820,LWGUASZLXHYWIV-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
165831,7bv1,DB13078,-8.7,KOSN-1724,JAYGOFBXDFAXBW-CYEKYUJNSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
77233,6m2n,DB08126,-8.7,"3-{[4-([AMINO(IMINO)METHYL]AMINOSULFONYL)ANILINO]METHYLENE}-2-OXO-2,3-DIHYDRO-1H-INDOLE",DMCRNUMVSATRTP-LCYFTJDESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
165829,7bv1,DB13074,-8.7,Macimorelin,UJVDJAPJQWZRFR-DHIUTWEWSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
130669,6w4h,DB12598,-8.7,Nafamostat,MQQNFDZXWVTQEH-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
75431,6m2n,DB04690,-8.7,Camptothecin,VSJKWCGYPAHWDS-FQEVSTJZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
31794,6cs2,DB01092,-8.7,Ouabain,LPMXVESGRSUGHW-HBYQJFLCSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
75404,6m2n,DB04651,-8.7,BIOTINOL-5-AMP,KBOGUFFJCBPJEH-SQGSUPJISA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
112837,6vxx,DB07901,-8.7,5-CHLORO-6-METHYL-N-(2-PHENYLETHYL)-2-PYRIDIN-2-YLPYRIMIDIN-4-AMINE,HIUOABSWQSUEGK-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
25153,6cs2,DB03020,-8.7,5-Beta-D-Ribofuranosylnicotinamide Adenine Dinucleotide,UINNILASBHZOTM-KMXXXSRASA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
113141,6vxx,DB08588,-8.7,2-({2-[(3R)-3-AMINOPIPERIDIN-1-YL]-4-OXOQUINAZOLIN-3(4H)-YL}METHYL)BENZONITRILE,OYNURZXTLNNKAP-QGZVFWFLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77536,6m2n,DB08497,-8.7,"(1S)-2-oxo-1-phenyl-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate",NKBDSMREMMRFSI-INIZCTEOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77322,6m2n,DB08233,-8.7,6-CYCLOHEXYLMETHYLOXY-2-(4'-HYDROXYANILINO)PURINE,RFSDQDHHBKYQOD-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
129466,6w4h,DB08827,-8.7,Lomitapide,MBBCVAKAJPKAKM-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
29240,6cs2,DB08911,-8.7,Trametinib,LIRYPHYGHXZJBZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
88147,6m3m,DB13407,-8.7,Nifenazone,BRZANEXCSZCZCI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
129402,6w4h,DB08750,-8.7,"1-[4-(AMINOMETHYL)BENZOYL]-5'-FLUORO-1'H-SPIRO[PIPERIDINE-4,2'-QUINAZOLIN]-4'-AMINE",SFPCNWQWKOUNRT-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
147381,6w9q,DB11855,-8.7,Revefenacin,FYDWDCIFZSGNBU-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
61072,6crv,DB11464,-8.7,Sulfaquinoxaline,NHZLNPMOSADWGC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31522,6cs2,DB13954,-8.7,Estradiol cypionate,UOACKFBJUYNSLK-XRKIENNPSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
31500,6cs2,DB13927,-8.7,anle138b,RCQIIBJSUWYYFU-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
93350,6m71,DB06844,-8.7,"4-[(7-OXO-7H-THIAZOLO[5,4-E]INDOL-8-YLMETHYL)-AMINO]-N-PYRIDIN-2-YL-BENZENESULFONAMIDE",MBXKBJLIESPLIK-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
61065,6crv,DB11455,-8.7,Robenacoxib,ZEXGDYFACFXQPF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31544,6cs2,DB13993,-8.7,MRK-409,GOIFCXRIFSYPFG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
77382,6m2n,DB08309,-8.7,3-({2-[(4-{[6-(CYCLOHEXYLMETHOXY)-9H-PURIN-2-YL]AMINO}PHENYL)SULFONYL]ETHYL}AMINO)PROPAN-1-OL,AMFGILNPFBVREA-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77407,6m2n,DB08341,-8.7,"4-{[4-{[(1R,2R)-2-(dimethylamino)cyclopentyl]amino}-5-(trifluoromethyl)pyrimidin-2-yl]amino}-N-methylbenzenesulfonamide",CAUFYHKGKDJMQG-HZPDHXFCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
31497,6cs2,DB13919,-8.7,Candesartan,HTQMVQVXFRQIKW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
112995,6vxx,DB08241,-8.7,4-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)--BENZAMIDE,RUUOIINPNMNPIU-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130643,6w4h,DB12561,-8.7,WNT-974,XXYGTCZJJLTAGH-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
93330,6m71,DB06817,-8.7,Raltegravir,CZFFBEXEKNGXKS-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
139476,6w9c,DB13520,-8.7,Metergoline,WZHJKEUHNJHDLS-QTGUNEKASA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
112961,6vxx,DB08197,-8.7,"(5E,7S)-2-amino-7-(4-fluoro-2-pyridin-3-ylphenyl)-4-methyl-7,8-dihydroquinazolin-5(6H)-one oxime",KYIXUSLGFINPTC-WVFAEZDRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112956,6vxx,DB08191,-8.7,"4-(5-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl)benzoic acid",KSFDVNIKNYXUIP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
93498,6m71,DB07020,-8.7,"N-{3-[5-(1H-1,2,4-triazol-3-yl)-1H-indazol-3-yl]phenyl}furan-2-carboxamide",LMDMJDCLPIVGQD-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
61091,6crv,DB11512,-8.7,Dihydrostreptomycin,ASXBYYWOLISCLQ-HZYVHMACSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
93503,6m71,DB07026,-8.7,"(1S,5S,7R)-N-7-(BIPHENYL-4-YLMETHYL)-N-3-HYDROXY-6,8-DIOXA-3-AZABICYCLO[3.2.1]OCTANE-3,7-DICARBOXAMIDE",PPLDARNGJSQINK-OKZBNKHCSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
130618,6w4h,DB12522,-8.7,Toreforant,FCRFVPZAXGJLPW-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
138702,6w9c,DB12141,-8.7,Gilteritinib,GYQYAJJFPNQOOW-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
147414,6w9q,DB11904,-8.7,Flumatinib,BJCJYEYYYGBROF-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
61096,6crv,DB11522,-8.7,Isoflupredone,WAIJIHDWAKJCBX-BULBTXNYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138673,6w9c,DB12101,-8.7,CC-220,IXZOHGPZAQLIBH-NRFANRHFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
14393,6lzg,T3D4083,-8.7,Jervine,CLEXYFLHGFJONT-DNMILWOZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
138433,6w9c,DB11656,-8.7,Rebamipide,ALLWOAVDORUJLA-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
88038,6m3m,DB13266,-8.7,Cefatrizine,UOCJDOLVGGIYIQ-PBFPGSCMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
77232,6m2n,DB08125,-8.7,"4-{[(2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]AMINO}-N-(1,3-THIAZOL-2-YL)BENZENESULFONAMIDE",BOMPRXSVSIPRDT-PTNGSMBKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
93050,6m71,DB06178,-8.7,Talotrexin,NYQPLPNEESYGNO-IBGZPJMESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
121537,6w4b,DB12042,-8.7,Ibodutant,YQYSVMKCMIUCHY-WJOKGBTCSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
93987,6m71,DB07586,-8.7,"5-(4-METHYL-BENZOYLAMINO)-BIPHENYL-3,4'-DICARBOXYLIC ACID 3-DIMETHYLAMIDE-4'-HYDROXYAMIDE",DOPFUKKMSDUVTQ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
88423,6m3m,DB13778,-8.7,Cefazedone,VTLCNEGVSVJLDN-MLGOLLRUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
77634,6m2n,DB08613,-8.7,"2,2,2-TRIFLUORO-1-{5-[(3-PHENYL-5,6-DIHYDROIMIDAZO[1,2-A]PYRAZIN-7(8H)-YL)CARBONYL]THIOPHEN-2-YL}ETHANE-1,1-DIOL",OFBFUNBBOQCNFX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
112740,6vxx,DB07791,-8.7,4-{[4-(1-CYCLOPROPYL-2-METHYL-1H-IMIDAZOL-5-YL)PYRIMIDIN-2-YL]AMINO}-N-METHYLBENZENESULFONAMIDE,MZWCVBFANHIPTJ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88427,6m3m,DB13783,-8.7,Acemetacin,FSQKKOOTNAMONP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
77669,6m2n,DB08657,-8.7,2-(4-(2-((3-(5-(PYRIDIN-2-YLTHIO)THIAZOL-2-YL)UREIDO)METHYL)-1H-IMIDAZOL-4-YL)PHENOXY)ACETIC ACID,SSXCWVOQWRUMGN-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
139426,6w9c,DB13451,-8.7,Tioclomarol,WRGOVNKNTPWHLZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
60806,6crv,DB09178,-8.7,Phenaridine,ODPKHHGQKIYCTJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31152,6cs2,DB13471,-8.7,Nalfurafine,XGZZHZMWIXFATA-UEZBDDGYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
29160,6cs2,DB00820,-8.7,Tadalafil,WOXKDUGGOYFFRN-IIBYNOLFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
77166,6m2n,DB08052,-8.7,"1-cyclopentyl-3-(1H-pyrrolo[2,3-b]pyridin-5-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine",NVRXTLZYXZNATH-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
130758,6w4h,DB12740,-8.7,CC-115,GMYLVKUGJMYTFB-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
5939,6lzg,HMDB0112260,-8.7,"(3R,6'R)-3-Hydroxy-3',4'-didehydro-beta,gamma-carotene",UIUSQYGQZRBKCC-NHWXEJKLSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
77160,6m2n,DB08043,-8.7,1-[4-(PYRIDIN-4-YLOXY)PHENYL]-3-[3-(TRIFLUOROMETHYL)PHENYL]UREA,DDDLGNOZDKDSEG-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75227,6m2n,DB04424,-8.7,RPR128515,XFKVLKLCLYJKNF-MZNJEOGPSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61173,6crv,DB11694,-8.7,Ilorasertib,WPHKIQPVPYJNAX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130769,6w4h,DB12756,-8.7,TAK-901,WKDACQVEJIVHMZ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
75194,6m2n,DB04376,-8.7,13-Acetylphorbol,SDSVJYOOAPRSDA-RPCQODIISA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
31862,6cs2,DB14898,-8.7,Retagliptin,WIIAMRXFUJLYEF-SNVBAGLBSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
31863,6cs2,DB14899,-8.7,Tavapadon,AKQXQLUNFKDZBN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
31874,6cs2,DB14918,-8.7,Branaplam,STWTUEAWRAIWJG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
113240,6vxx,DB08710,-8.7,"(5Z)-5-[(5-ETHYL-2-FURYL)METHYLENE]-2-{[(S)-(4-FLUOROPHENYL)(1H-TETRAZOL-5-YL)METHYL]AMINO}-1,3-THIAZOL-4(5H)-ONE",BKZOQCGDCHOGOQ-MZLJFPOFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31091,6cs2,DB13397,-8.7,Prenoxdiazine,PXZDWASDNFWKSD-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
88378,6m3m,DB13718,-8.7,Hydroquinine,LJOQGZACKSYWCH-WZBLMQSHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88325,6m3m,DB13651,-8.7,Lorajmine,LAHDERDHXJFFJU-ZWNKPRIXSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
129361,6w4h,DB08708,-8.7,"N-cyclohexyl-3-[3-(trifluoromethyl)phenyl][1,2,4]triazolo[4,3-b]pyridazin-6-amine",XYYDXQCAYXOGQT-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
61995,6crv,DB12924,-8.7,Ozenoxacin,XPIJWUTXQAGSLK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130601,6w4h,DB12494,-8.7,SGI-1776,MHXGEROHKGDZGO-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
60934,6crv,DB09488,-8.7,Acrivastine,PWACSDKDOHSSQD-IUTFFREVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
156257,6wiq,DB12651,-8.7,Bardoxolone,TXGZJQLMVSIZEI-UQMAOPSPSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
75634,6m2n,DB05076,-8.7,Fenretinide,AKJHMTWEGVYYSE-FXILSDISSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61142,6crv,DB11650,-8.7,HT-0712,ABEJDMOBAFLQNJ-NHCUHLMSSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77547,6m2n,DB08510,-8.7,5-ALPHA-PREGNANE-3-BETA-OL-HEMISUCCINATE,UVTGFMKBPVLATL-DSOJQRAMSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
165813,7bv1,DB13053,-8.7,CP-195543,NZQDWKCNBOELAI-KSFYIVLOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
77219,6m2n,DB08111,-8.7,"4-[(6-phenyl[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl]phenol",ZGJYGQLGSXWEMY-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
31814,6cs2,DB14801,-8.7,Lanifibranor,OQDQIFQRNZIEEJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
130691,6w4h,DB12640,-8.7,CP-609754,JAHDAIPFBPPQHQ-GDLZYMKVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
31815,6cs2,DB14802,-8.7,ONO-2952,ZBQMTQGDBFZUBG-NRFANRHFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
112789,6vxx,DB07845,-8.7,"2-fluoro-6-{[2-({2-methoxy-4-[(methylsulfonyl)methyl]phenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide",VGYXXQRDIVRILX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77568,6m2n,DB08534,-8.7,"5-(2-fluorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",ZAIYYXVHGBMLEC-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
62148,6crv,DB13169,-8.7,Nandrolone,NPAGDVCDWIYMMC-IZPLOLCNSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130697,6w4h,DB12649,-8.7,Ibipinabant,AXJQVVLKUYCICH-OAQYLSRUSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
60880,6crv,DB09268,-8.7,Picosulfuric acid,UJIDKYTZIQTXPM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113164,6vxx,DB08614,-8.7,"3-[[(METHYLAMINO)SULFONYL]AMINO]-2-OXO-6-PHENYL-N-[3,3,3-TRIFLUORO-1-(1-METHYLETHYL)-2-OXOPHENYL]-1(2H)-PYRIDINE ACETAMIDE",MYFMPKCOIMRDDD-KRWDZBQOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130699,6w4h,DB12651,-8.7,Bardoxolone,TXGZJQLMVSIZEI-UQMAOPSPSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
93098,6m71,DB06274,-8.7,Alvimopan,UPNUIXSCZBYVBB-JVFUWBCBSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
77572,6m2n,DB08538,-8.7,"N-((2-aminopyrimidin-5-yl)methyl)-5-(2,6-difluorophenyl)-3-ethylpyrazolo[1,5-a]pyrimidin-7-amine",HQPVGVSQPQVZLD-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
139557,6w9c,DB13631,-8.7,Methoserpidine,ULBNWNUHGJLQHO-VKMIBBQISA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
62154,6crv,DB13182,-8.7,Daidzein,ZQSIJRDFPHDXIC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60854,6crv,DB09230,-8.7,Azelnidipine,ZKFQEACEUNWPMT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
93922,6m71,DB07508,-8.7,4-(5-BENZENESULFONYLAMINO-1-METHYL-1H-BENZOIMIDAZOL-2-YLMETHYL)-BENZAMIDINE,MEUAVGJWGDPTLF-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93938,6m71,DB07528,-8.7,3-(2-aminoquinazolin-6-yl)-4-methyl-1-[3-(trifluoromethyl)phenyl]pyridin-2(1H)-one,HXUZQEYFKAZBPX-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
138629,6w9c,DB11943,-8.7,Delafloxacin,DYDCPNMLZGFQTM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139149,6w9c,DB12929,-8.7,JNJ-39220675,IQOWHZHNGJXGHG-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
112315,6vxx,DB06963,-8.7,"3-[3-(3-methyl-6-{[(1S)-1-phenylethyl]amino}-1H-pyrazolo[4,3-c]pyridin-1-yl)phenyl]propanamide",ZFGCLYUGFRNYFE-INIZCTEOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30800,6cs2,DB12999,-8.7,MK-6186,FZBAOOQVQXATRL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
62753,6crv,DB14075,-8.7,Imidurea,ZCTXEAQXZGPWFG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111952,6vxx,DB04930,-8.7,Permethrin,RLLPVAHGXHCWKJ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
129587,6w4h,DB09003,-8.7,Clocapramine,QAZKXHSIKKNOHH-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
88773,6m3m,DB14765,-8.7,Rivoceranib,WPEWQEMJFLWMLV-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
95884,6m71,DB12085,-8.7,LCL-161,UFPFGVNKHCLJJO-SSKFGXFMSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
111934,6vxx,DB04886,-8.7,Calanolide A,NIDRYBLTWYFCFV-FMTVUPSXSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130290,6w4h,DB12052,-8.7,Icariin,TZJALUIVHRYQQB-XLRXWWTNSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
30642,6cs2,DB00973,-8.7,Ezetimibe,OLNTVTPDXPETLC-XPWALMASSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
62763,6crv,DB14093,-8.7,"(1,2,6,7-3H)Testosterone",MUMGGOZAMZWBJJ-JQSYSRDDSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76737,6m2n,DB07550,-8.7,"2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(1-OXIDO-2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUOROPHENYL)METHYL]ACETAMIDE",ZIGSBBKEPNQXRG-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
111930,6vxx,DB04882,-8.7,Edotecarin,QMVPQBFHUJZJCS-NTKFZFFISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
91473,6m71,DB03104,-8.7,RU82129,NKMPOVPTYDXGEC-MNRBYUMSSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
150317,6wiq,DB01199,-8.7,Tubocurarine,JFJZZMVDLULRGK-URLMMPGGSA-O,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
95932,6m71,DB12154,-8.7,Itacitinib,KTBSXLIQKWEBRB-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
147909,6w9q,DB12635,-8.7,Aleplasinin,HSXLMAFNWCSZGP-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
111911,6vxx,DB04859,-8.7,Zanapezil,PMBLXLOXUGVTGB-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
150029,6wiq,DB00872,-8.7,Conivaptan,IKENVDNFQMCRTR-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
95959,6m71,DB12198,-8.7,Fosdagrocorat,BVXLAHSJXXSWFF-KEKPKEOLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
111900,6vxx,DB04842,-8.7,Fluspirilene,QOYHHIBFXOOADH-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30615,6cs2,DB12729,-8.7,ASP-3026,MGGBYMDAPCCKCT-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
61403,6crv,DB12039,-8.7,Epicatechin,PFTAWBLQPZVEMU-UKRRQHHQSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
95984,6m71,DB12234,-8.7,BMS-214662,OLCWFLWEHWLBTO-HSZRJFAPSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
158874,7bv1,DB02573,-8.7,"2'-Deoxycytidine-2'-Deoxyadenosine-3',5'-Monophosphate",LYWWDKIADIGKTH-IDMWBNCISA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
111857,6vxx,DB04792,-8.7,"2,5-O,O-BIS-{4',4''-AMIDINOPHENYL}-1,4:3,6-DIANHYDRO-D-SORBITOL",CDEVHSIVANGYRI-XMTFNYHQSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
95922,6m71,DB12138,-8.7,PF-03715455,VGEXRDWWPSGZDH-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
32777,6cs2,T3D3691,-8.7,Ergovaline,BGHDUTQZGWOQIA-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
74084,6m2n,DB02882,-8.7,Cyanocinnoline,CUWRVIIPSSUUDJ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61375,6crv,DB11994,-8.7,Diacerein,TYNLGDBUJLVSMA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62713,6crv,DB13994,-8.7,AZD-7325,KYDURMHFWXCKMW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
74228,6m2n,DB03076,-8.7,AHA047,CGBDAHCDSVOMCF-FYZVQMPESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75847,6m2n,DB06213,-8.7,Regadenoson,LZPZPHGJDAGEJZ-AKAIJSEGSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
112025,6vxx,DB06117,-8.7,"1alpha,24S-Dihydroxyvitamin D2",ODZFJAXAEXQSKL-WRJREGAQSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62720,6crv,DB14014,-8.7,SR-9011,PPUYOYQTTWJTIU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
91685,6m71,DB03383,-8.7,5-Chloro-1h-Indole-2-Carboxylic Acid [1-(4-Fluorobenzyl)-2-(4-Hydroxypiperidin-1yl)-2-Oxoethyl]Amide,YDCGVASFVACWKF-NRFANRHFSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
138851,6w9c,DB12355,-8.7,Netazepide,YDZYKNJZCVIKPP-VWLOTQADSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139845,6w9c,DB14097,-8.7,13-cis-12-(3'-Carboxyphenyl)retinoic acid,XKKDQOHDTASHCE-PAZAWXFKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
87369,6m3m,DB12229,-8.7,Cerlapirdine,NXQGEDVQXVTCDA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
60248,6crv,DB08422,-8.7,[PHENYLALANINYL-PROLINYL]-[2-(PYRIDIN-4-YLAMINO)-ETHYL]-AMINE,GEIDRYBJURDUSW-MOPGFXCFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113680,6vxx,DB11751,-8.7,Cabotegravir,WCWSTNLSLKSJPK-LKFCYVNXSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138101,6w9c,DB09183,-8.7,Dasabuvir,NBRBXGKOEOGLOI-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
30685,6cs2,DB12836,-8.7,Grapiprant,HZVLFTCYCLXTGV-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
62733,6crv,DB14037,-8.7,Madecassic acid,PRAUVHZJPXOEIF-AOLYGAPISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
129156,6w4h,DB08460,-8.7,"3-{5-[(6-amino-1H-pyrazolo[3,4-b]pyridin-3-yl)methoxy]-2-chlorophenoxy}-5-chlorobenzonitrile",KXDIHAQCVNNLIB-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
62741,6crv,DB14059,-8.7,SC-236,NSQNZEUFHPTJME-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
95826,6m71,DB12001,-8.7,Abemaciclib,UZWDCWONPYILKI-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
78590,6m2n,DB11979,-8.7,Elagolix,HEAUOKZIVMZVQL-VWLOTQADSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
91646,6m71,DB03331,-8.7,"N-Naphthalen-1-Ylmethyl-2'-[3,5-Dimethoxybenzamido]-2'-Deoxy-Adenosine",OARVXDFNTLYMCJ-JVUUKAHWSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
129155,6w4h,DB08459,-8.7,"3-chloro-5-[2-chloro-5-(1H-pyrazolo[3,4-b]pyridin-3-ylmethoxy)phenoxy]benzonitrile",SVMHTBVIPYVDIL-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131873,6w4h,DB14896,-8.7,Selitrectinib,OEBIHOVSAMBXIB-SJKOYZFVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
60231,6crv,DB08399,-8.7,PICEATANNOL,CDRPUGZCRXZLFL-OWOJBTEDSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75873,6m2n,DB06267,-8.7,Udenafil,IYFNEFQTYQPVOC-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61369,6crv,DB11985,-8.7,Dapaconazole,FUAHXHWSMYFWGE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60229,6crv,DB08397,-8.7,6-(DIFLUORO-PHOSPHONO-METHYL)-NAPHTHALENE-2-CARBOXYLIC ACID,NKGNOWNPXBURRW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
96009,6m71,DB12269,-8.7,PF-06273340,BPIWZDNVMQQBQX-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
28870,6cs2,DB08493,-8.7,"5-METHYL-3-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.013,18]NONADECA-12(19),13,15,17-TETRAEN-10-YLCARBAMOYL)-HEXANOIC ACID",AKWKBACKRMYPRV-NQIIRXRSSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
131915,6w4h,DB15013,-8.7,TAK-243,KJDAGXLMHXUAGV-DGWLBADLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
111837,6vxx,DB04764,-8.7,[4-(3-AMINOMETHYL-PHENYL)-PIPERIDIN-1-YL]-(5-PHENETHYL- PYRIDIN-3-YL)-METHANONE,CCLHROFBSWWOQO-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
159039,7bv1,DB03067,-8.7,"4-{2,4-Bis[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid",VFYAZSTYKPFSFL-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
139914,6w9c,DB14542,-8.7,Hydrocortisone phosphate,BGSOJVFOEQLVMH-VWUMJDOOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
9450,6lzg,DB07549,-8.7,"2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUORO-3-METHYL-6-PYRIDINYL)METHYL]ACETAMIDE",WOYBPRBUPLYTPY-UHFFFAOYSA-P,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
113773,6vxx,DB12063,-8.7,CERC-301,RECBFDWSXWAXHY-IAGOWNOFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
73882,6m2n,DB02611,-8.7,Balanol Analog 1,FZJQHARRQUNVGZ-QZTJIDSGSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
60133,6crv,DB08282,-8.7,"O-[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethyl] (4-chlorophenyl)thiocarbamate",BWRRXOIACQYNEK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30558,6cs2,DB12655,-8.7,Patidegib,HZLFFNCLTRVYJG-WWGOJCOQSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
24101,6cs2,DB01767,-8.7,Hemi-Babim,KKJYVDXDZURHMA-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
123322,6w4b,DB15308,-8.7,Ridinilazole,UHQFBTAJFNVZIV-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
61806,6crv,DB12623,-8.7,Taprenepag,MFFBXYNKZHTCEY-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113786,6vxx,DB12082,-8.7,Vesnarinone,ZVNYJIZDIRKMBF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87218,6m3m,DB12005,-8.7,Nirogacestat,VFCRKLWBYMDAED-REWPJTCUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
30551,6cs2,DB12645,-8.7,Givinostat,YALNUENQHAQXEA-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
90967,6m71,DB02432,-8.7,RU90395,RLLAUERCSKPFGD-VMPREFPWSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
30550,6cs2,DB12644,-8.7,AZD-2066,SXWHYTICXCLKDG-GFCCVEGCSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
145967,6w9q,DB07970,-8.7,5-[(2-methyl-5-{[3-(trifluoromethyl)phenyl]carbamoyl}phenyl)amino]pyridine-3-carboxamide,SAAYRHKJHDIDPH-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
62878,6crv,DB14649,-8.7,Dexamethasone acetate,AKUJBENLRBOFTD-RPRRAYFGSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28817,6cs2,DB08437,-8.7,Puromycin,RXWNCPJZOCPEPQ-NVWDDTSBSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
60108,6crv,DB08244,-8.7,"(1S)-1-CYCLOPROPYL-2-[(2S)-4-(2,5-DIFLUOROPHENYL)-2-PHENYL-2,5-DIHYDRO-1H-PYRROL-1-YL]-2-OXOETHANAMINE",VCOUEHUEFUDZIS-PMACEKPBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30539,6cs2,DB12627,-8.7,GSK-1292263,AYJRTVVIBJSSKN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
96254,6m71,DB12627,-8.7,GSK-1292263,AYJRTVVIBJSSKN-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
113808,6vxx,DB12114,-8.7,Poziotinib,LPFWVDIFUFFKJU-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75961,6m2n,DB06521,-8.7,Ertiprotafib,FONCZICQWCUXEB-RUZDIDTESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
73849,6m2n,DB02567,-8.7,PD173955,VAARYSWULJUGST-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
96267,6m71,DB12649,-8.7,Ibipinabant,AXJQVVLKUYCICH-OAQYLSRUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
78749,6m2n,DB12219,-8.7,GSK-424887,DRXBWLBZWAJIEF-IBGZPJMESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61866,6crv,DB12715,-8.7,MSX-122,PXZXYRKDDXKDTK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78745,6m2n,DB12211,-8.7,PSI-697,DIEPFYNZGUUVHD-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
129093,6w4h,DB08384,-8.7,2-({4-[4-(pyridin-4-ylmethyl)-1H-pyrazol-3-yl]phenoxy}methyl)quinoline,RQDDHVVAAJVVKM-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
60192,6crv,DB08352,-8.7,"6-[4-(2-fluorophenyl)-1,3-oxazol-5-yl]-N-(1-methylethyl)-1,3-benzothiazol-2-amine",FQYJTHIYAQQJAB-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
137992,6w9c,DB08993,-8.7,Enviomycin,HPWIIERXAFODPP-GHBBWTPBSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
96026,6m71,DB12289,-8.7,Darexaban,IJNIQYINMSGIPS-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
62810,6crv,DB14208,-8.7,Ramiprilat,KEDYTOTWMPBSLG-HILJTLORSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30606,6cs2,DB12719,-8.7,Turofexorate isopropyl,INASOKQDNHHMRE-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
123183,6w4b,DB15039,-8.7,ITI-214,BBIPVJCGIASXJB-PKTZIBPZSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
32849,6cs2,T3D3764,-8.7,Janthitrem E,TVRIMSLYKUNOPS-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
75903,6m2n,DB06362,-8.7,Becatecarin,JSKFWUPVIZYJMR-UDOAKELVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
32851,6cs2,T3D3766,-8.7,Janthitrem G,PGYSJEQVCATFBQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
29506,6cs2,DB09268,-8.7,Picosulfuric acid,UJIDKYTZIQTXPM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
73963,6m2n,DB02717,-8.7,Cellotetraose,LUEWUZLMQUOBSB-HGDSAIHNSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78705,6m2n,DB12147,-8.7,Erdafitinib,OLAHOMJCDNXHFI-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
87272,6m3m,DB12084,-8.7,ADP-597,WPDCHTSXOPUOII-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
32861,6cs2,T3D3779,-8.7,Paspalicine,HSFKQYJRJBEWKH-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
78718,6m2n,DB12167,-8.7,LY-3023414,ACCFLVVUVBJNGT-AWEZNQCLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
62840,6crv,DB14555,-8.7,Ursadiol,RTLXJEJRLWILSU-GWNGJUQLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
115672,6w4b,DB01126,-8.7,Dutasteride,JWJOTENAMICLJG-QWBYCMEYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
137940,6w9c,DB08931,-8.7,Riociguat,WXXSNCNJFUAIDG-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
87250,6m3m,DB12054,-8.7,BQ-123,VYCMAAOURFJIHD-PJNXIOHISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
145999,6w9q,DB08006,-8.7,"N-anthracen-2-yl-5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7-amine",OXYDLVAOXASTMW-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
75932,6m2n,DB06446,-8.7,Dotarizine,LRMJAFKKJLRDLE-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
145989,6w9q,DB07994,-8.7,"N-3-[5-(1H-INDOL-6-YL)-2-(PYRIDIN-2-YLMETHOXY)BENZYL]PYRIDINE-2,3-DIAMINE",KMBPJSHPAXOXBT-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
32956,6cs2,T3D3887,-8.7,Milbemectin (mixture),VOZIAWLUULBIPN-LRBNAKOISA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
137933,6w9c,DB08916,-8.7,Afatinib,ULXXDDBFHOBEHA-CWDCEQMOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
73930,6m2n,DB02675,-8.7,(4-Hydroxymaltosephenyl)Glycine,PHPOPZGUOBMSPZ-QHJSCRBTSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
88816,6m3m,DB14867,-8.7,Parsaclisib,ZQPDJCIXJHUERQ-QWRGUYRKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
138152,6w9c,DB09238,-8.7,Manidipine,ANEBWFXPVPTEET-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
95744,6m71,DB11878,-8.7,Filibuvir,SLVAPEZTBDBAPI-GDLZYMKVSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95743,6m71,DB11877,-8.7,Basmisanil,VCGRFBXVSFAGGA-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
112225,6vxx,DB06622,-8.7,7-beta-Hydroxyepiandrosterone,VFPMCLQMAUVEHD-UCPSWNCLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
152618,6wiq,DB04289,-8.7,Genz-10850,YYMZSGIXLQPFAC-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
122179,6w4b,DB13005,-8.7,Rebastinib,WVXNSAVVKYZVOE-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
138382,6w9c,DB11521,-8.7,Imidocarb,SCEVFJUWLLRELN-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
78405,6m2n,DB11704,-8.7,Adomeglivant,FASLTMSUPQDLIB-MHZLTWQESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
131662,6w4h,DB14152,-8.7,Ginsenosides,NLHQJXWYMZLQJY-SWIZOJJJSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
87506,6m3m,DB12416,-8.7,VTP-27999,NXWASIVXQMMPLM-ZXMXYHOLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
158331,7bv1,DB00872,-8.7,Conivaptan,IKENVDNFQMCRTR-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
74510,6m2n,DB03453,-8.7,Methyl (2S)-2-[[2-[(3R)-1-carbamimidoylpiperidin-3-yl]acetyl]amino]-3-[4-(2-phenylethynyl)phenyl]propanoate,MRNGXYMKYHNMLV-PKTZIBPZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76894,6m2n,DB07741,-8.7,"4-(1R,3AS,4R,8AS,8BR)-[1-DIFLUOROMETHYL-2-(4-FLUOROBENZYL)-3-OXODECAHYDROPYRROLO[3,4-A]PYRROLIZIN-4-YL]BENZAMIDINE",VPNYXOTTXAXSIH-SXYSDOLCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
131720,6w4h,DB14569,-8.7,Tedizolid,XFALPSLJIHVRKE-GFCCVEGCSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
87497,6m3m,DB12405,-8.7,Triciribine,HOGVTUZUJGHKPL-HTVVRFAVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
62604,6crv,DB13797,-8.7,Iodocholesterol (131I),FIOAEFCJGZJUPW-ODFYUTSGSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87494,6m3m,DB12401,-8.7,Bromperidol,RKLNONIVDFXQRX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
76883,6m2n,DB07728,-8.7,"2-[2-(2-FLUOROPHENYL)PYRIDIN-4-YL]-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE",XJJYJNMNYDNXNO-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
113599,6vxx,DB11622,-8.7,Dehydrocholic acid,OHXPGWPVLFPUSM-KLRNGDHRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
92167,6m71,DB04044,-8.7,4-{2-[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid,NAQUAVBNIYTIIS-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
87488,6m3m,DB12393,-8.7,Fanapanel,WZMQMKNCWDCCMT-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
30722,6cs2,DB12888,-8.7,Ezutromid,KSGCNXAZROJSNW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
95492,6m71,DB11424,-8.7,Lufenuron,PWPJGUXAGUPAHP-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
114896,6vxx,DB15356,-8.7,SLV-334,LOFDNSDPZTVIIO-VPUSJEBWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75808,6m2n,DB06140,-8.7,SUVN-502,GWCYPEHWIZXYFZ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
92142,6m71,DB04006,-8.7,"[2-Amino-6-(2,6-Difluoro-Benzoyl)-Imidazo[1,2-a]Pyridin-3-Yl]-Phenyl-Methanone",WUGJIPFLBOATGL-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
129206,6w4h,DB08519,-8.7,"N-4-(3-methyl-1H-indazol-6-yl)-N-2-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine",SQQAPOSROFWHIB-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
78455,6m2n,DB11784,-8.7,NRX-1074,DVBUEXCIEIAXPM-PJUQSVSOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
112234,6vxx,DB06635,-8.7,Otamixaban,PFGVNLZDWRZPJW-OPAMFIHVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
25533,6cs2,DB03480,-8.7,Brequinar Analog,WYKKHJQZENLZID-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
78376,6m2n,DB11666,-8.7,Buparlisib,CWHUFRVAEUJCEF-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
131597,6w4h,DB14017,-8.7,H3B-8800,YOIQWBAHJZGRFW-WVRLKXNASA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
32064,6cs2,DB15292,-8.7,Foliglurax,ZTEDNASHAWNBKQ-NCELDCMTSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
61285,6crv,DB11861,-8.7,Litronesib,YVAFBXLHPINSIK-QHCPKHFHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
131400,6w4h,DB13689,-8.7,Tacalcitol,BJYLYJCXYAMOFT-RSFVBTMBSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
29022,6cs2,DB08657,-8.7,2-(4-(2-((3-(5-(PYRIDIN-2-YLTHIO)THIAZOL-2-YL)UREIDO)METHYL)-1H-IMIDAZOL-4-YL)PHENOXY)ACETIC ACID,SSXCWVOQWRUMGN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
60506,6crv,DB08730,-8.7,3-FLUORO-5-MORPHOLIN-4-YL-N-[1-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-6-YL]BENZAMIDE,CPFBZMFUCGHBAP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112303,6vxx,DB06944,-8.7,N-(3-cyclopropyl-1H-pyrazol-5-yl)-2-(2-naphthyl)acetamide,RIGZCVNCFXYBEG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
139760,6w9c,DB13939,-8.7,RAD-140,XMBUPPIEVAFYHO-KPZWWZAWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
60500,6crv,DB08724,-8.7,5-(5-(4-(5-hydro-4-methyl-2-oxazolyl)phenoxy)pentyl)-3-methyl isoxazole,UXIYKMARWUSIKU-HNNXBMFYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165596,7bv1,DB12513,-8.7,Omaveloxolone,RJCWBNBKOKFWNY-IDPLTSGASA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
9163,6lzg,DB07247,-8.7,"[2'-HYDROXY-3'-(1H-PYRROLO[3,2-C]PYRIDIN-2-YL)-BIPHENYL-3-YLMETHYL]-UREA",SRPOHNDQBDHONJ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
32088,6cs2,DB15333,-8.7,AZD-1386,FPGNKXCEPARJDI-ZDUSSCGKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
158179,7bv1,DB00694,-8.7,Daunorubicin,STQGQHZAVUOBTE-VGBVRHCVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
29906,6cs2,DB11793,-8.7,Niraparib,PCHKPVIQAHNQLW-CQSZACIVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
78338,6m2n,DB11582,-8.7,Thiocolchicoside,LEQAKWQJCITZNK-AXHKHJLKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
62523,6crv,DB13687,-8.7,Niaprazine,RSKQGBFMNPDPLR-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112280,6vxx,DB06918,-8.7,2-(2-METHYLPHENYL)-1H-INDOLE-6-CARBOXIMIDAMIDE,ZRYXDGAKQGRHFG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76912,6m2n,DB07761,-8.7,"(2R)-1-[4-({6-[(2,6-Difluorophenyl)amino]-4-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol",ZVSBKYYVBCKDBO-OAHLLOKOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
60478,6crv,DB08701,-8.7,"2-(3-BROMOPHENYL)-6-[(2-HYDROXYETHYL)AMINO]-1H-BENZO[DE]ISOQUINOLINE-1,3(2H)-DIONE",JZCUVYNOSDWORZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
139763,6w9c,DB13943,-8.7,Testosterone cypionate,HPFVBGJFAYZEBE-ZLQWOROUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139271,6w9c,DB13246,-8.7,Quinupramine,JCBQCKFFSPGEDY-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
112262,6vxx,DB06899,-8.7,"N-{2-[6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2,2-DIMETHYL-3-OXO-2,3-DIHYDRO-4H-1,4-BENZOTHIAZIN-4-YL]ETHYL}ACETAMIDE",RMEVNJZCKDVVND-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
32107,6cs2,DB15362,-8.7,LSZ-102,SJXNPGGVGZXKKI-NYYWCZLTSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
95178,6m71,DB09030,-8.7,Vorapaxar,ZBGXUVOIWDMMJE-QHNZEKIYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
30753,6cs2,DB12929,-8.7,JNJ-39220675,IQOWHZHNGJXGHG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
112251,6vxx,DB06886,-8.7,N-BENZYLOXYCARBONYL-ALA-PRO-3-AMINO-4-PHENYL-BUTAN-2-OL,MACLRJNEKXUAJK-YDLSIGKMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
92254,6m71,DB04158,-8.7,"6-(Adenosine Tetraphosphate-Methyl)-7,8-Dihydropterin",ZKRKFZJAQKKHKL-SUGPNEFASA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
112313,6vxx,DB06959,-8.7,(2S)-1-(3H-Indol-3-yl)-3-{[5-(6-isoquinolinyl)-3-pyridinyl]oxy}-2-propanamine,BUCZDJYEOAQTHL-KEKNWZKVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
92110,6m71,DB03962,-8.7,Nicotinamide 8-Bromo-Adenine Dinucleotide Phosphate,MDKMTCCUJSRQGW-NAJQWHGHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
139792,6w9c,DB13993,-8.7,MRK-409,GOIFCXRIFSYPFG-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
61888,6crv,DB12746,-8.7,AKN-028,JLRIJKVMMZEKDF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
24994,6cs2,DB02833,-8.7,[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(3-Nitro-Phenyl)-Amine,DYTKVFHLKPDNRW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
87428,6m3m,DB12306,-8.7,Cipargamin,CKLPLPZSUQEDRT-WPCRTTGESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
95669,6m71,DB11772,-8.7,Pilaralisib,QINPEPAQOBZPOF-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
32280,6cs2,DB01261,-8.7,Sitagliptin,MFFMDFFZMYYVKS-SECBINFHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
158503,7bv1,DB01267,-8.7,Paliperidone,PMXMIIMHBWHSKN-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
131793,6w4h,DB14717,-8.7,Nitrazolam,OYRPNABWTHDOFK-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
24989,6cs2,DB02827,-8.7,"7-(1,1-Dioxo-1h-Benzo[D]Isothiazol-3-Yloxymethyl)-2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Pyran-3-Carboxylic Acid",MDYIGSPVMWSFEZ-JTQLQIEISA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
9278,6lzg,DB07360,-8.7,"1-{5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)ethyl]-1,3-thiazol-2-yl}-3-[3-(trifluoromethyl)phenyl]urea",JJHXPDTVQKWKHA-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
147778,6w9q,DB12427,-8.7,Orvepitant,XWNBGDJPEXZSQM-VZOBGQTKSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
61878,6crv,DB12732,-8.7,Firategrast,YLFZHHDVRSYTKT-NRFANRHFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28941,6cs2,DB08569,-8.7,"3-PYRIDIN-4-YL-2,4-DIHYDRO-INDENO[1,2-.C.] PYRAZOLE",VLPMRZSKJUTRBQ-IBGZPJMESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
62683,6crv,DB13943,-8.7,Testosterone cypionate,HPFVBGJFAYZEBE-ZLQWOROUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28937,6cs2,DB08562,-8.7,4-(4-STYRYL-PHENYLCARBAMOYL)-BUTYRIC ACID,FTXJWRRYLLRFMG-MDZDMXLPSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
74300,6m2n,DB03173,-8.7,CRA_10433,CFSQPEBVGUSQII-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
112073,6vxx,DB06228,-8.7,Rivaroxaban,KGFYHTZWPPHNLQ-AWEZNQCLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76830,6m2n,DB07665,-8.7,"N-[2-(carbamimidamidooxy)ethyl]-2-{6-cyano-3-[(2,2-difluoro-2-pyridin-2-ylethyl)amino]-2-fluorophenyl}acetamide",STHCHQXQLDMISY-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76829,6m2n,DB07664,-8.7,"5-AMINO-3-{[4-(AMINOSULFONYL)PHENYL]AMINO}-N-(2,6-DIFLUOROPHENYL)-1H-1,2,4-TRIAZOLE-1-CARBOTHIOAMIDE",ARIOBGGRZJITQX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
74288,6m2n,DB03157,-8.7,"N,O-Didansyl-L-Tyrosine",LUBOPDUYHWABFG-NDEPHWFRSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
129185,6w4h,DB08494,-8.7,"S-{2-[(2-chloro-4-sulfamoylphenyl)amino]-2-oxoethyl} 6-methyl-3,4-dihydroquinoline-1(2H)-carbothioate",AWAKIULNKVOBKE-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
78536,6m2n,DB11900,-8.7,OC-459,FATGTHLOZSXOBC-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61351,6crv,DB11957,-8.7,Idalopirdine,YBAWYTYNMZWMMJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61354,6crv,DB11961,-8.7,AZD-1236,SFJFBTPHDHUUPU-OAHLLOKOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78546,6m2n,DB11912,-8.7,Lanopepden,SWHNZGMQMGFQGW-MSOLQXFVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
165478,7bv1,DB12158,-8.7,Filorexant,NPFDWHQSDBWQLH-QZTJIDSGSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
113648,6vxx,DB11701,-8.7,Amenamevir,MNHNIVNAFBSLLX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
95543,6m71,DB11526,-8.7,Masitinib,WJEOLQLKVOPQFV-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
131780,6w4h,DB14676,-8.7,Fagrocorat,QJJBNCHSWFGXML-KEKPKEOLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
113647,6vxx,DB11698,-8.7,Ipragliflozin,AHFWIQIYAXSLBA-RQXATKFSSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
95559,6m71,DB11577,-8.7,Indigotindisulfonic Acid,CFZXDJWFRVEWSR-BUHFOSPRSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
146318,6w9q,DB08387,-8.7,2-{[4-(1-methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline,AZEXWHKOMMASPA-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
87469,6m3m,DB12367,-8.7,Selurampanel,MCECSFFXUPEPDB-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
112141,6vxx,DB06412,-8.7,Oxymetholone,ICMWWNHDUZJFDW-DHODBPELSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165516,7bv1,DB12221,-8.7,Canrenone,UJVLDDZCTMKXJK-WNHSNXHDSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
147701,6w9q,DB12318,-8.7,BMS-599626,LUJZZYWHBDHDQX-QFIPXVFZSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
95571,6m71,DB11616,-8.7,Pirarubicin,KMSKQZKKOZQFFG-YXRRJAAWSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
130411,6w4h,DB12230,-8.7,Bunazosin,RHLJLALHBZGAFM-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
113622,6vxx,DB11666,-8.7,Buparlisib,CWHUFRVAEUJCEF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
95572,6m71,DB11618,-8.7,Zorubicin,FBTUMDXHSRTGRV-BJISBDEGSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
113632,6vxx,DB11679,-8.7,Fruquintinib,BALLNEJQLSTPIO-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60349,6crv,DB08539,-8.7,"3-cyclopropyl-5-phenyl-N-(pyridin-3-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",CCDIUVLNHCGSMH-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
95585,6m71,DB11645,-8.7,PF-4191834,DVNQWYLVSNPCJZ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
32194,6cs2,DB01167,-8.7,Itraconazole,VHVPQPYKVGDNFY-ZPGVKDDISA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
139811,6w9c,DB14034,-8.7,Darglitazone,QQKNSPHAFATFNQ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
61901,6crv,DB12770,-8.7,Lafutidine,KMZQAVXSMUKBPD-DJWKRKHSSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60341,6crv,DB08531,-8.7,"5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",CVYWYUAQFJMLEO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
95619,6m71,DB11694,-8.7,Ilorasertib,WPHKIQPVPYJNAX-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60332,6crv,DB08521,-8.7,4-[5-(4-FLUORO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-3H-IMIDAZOL-4-YL]-PYRIDINE,CDMGBJANTYXAIV-HHHXNRCGSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78486,6m2n,DB11824,-8.7,Tofogliflozin,VWVKUNOPTJGDOB-BDHVOXNPSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
95627,6m71,DB11704,-8.7,Adomeglivant,FASLTMSUPQDLIB-MHZLTWQESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
146246,6w9q,DB08299,-8.7,"4-[8-(3-nitrophenyl)-1,7-naphthyridin-6-yl]benzoic acid",QTNUWEKKZHSUQO-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
114590,6vxx,DB13828,-8.7,Cyfluthrin,QQODLKZGRKWIFG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130391,6w4h,DB12203,-8.7,Tozadenant,XNBRWUQWSKXMPW-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
139814,6w9c,DB14038,-8.7,beta-Sitosterol,KZJWDPNRJALLNS-VJSFXXLFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
95645,6m71,DB11737,-8.7,Icotinib,QQLKULDARVNMAL-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
24300,6cs2,DB02014,-8.7,"5-(2-Fluoro-5-{(1E)-3-[3-hydroxy-2-(methoxycarbonyl)phenoxy]-1-propen-1-yl}phenyl)-1,2-oxazole-3-carboxylic acid",QKHWJUMLYAYZFS-ONEGZZNKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
116885,6w4b,DB02741,-8.7,CD564,RWYREGSYPCNZTL-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
163353,7bv1,DB04298,-8.7,"3-(4-Amino-2-Tert-Butyl-5-Methyl-Phenylsulfanyl)-6-Cyclopentyl-4-Hydroxy-6-[2-(4-Hydroxy-Phenyl)-Ethyl]-5,6-Dihydro-Pyran-2-One",ZEBFKFGJWHOOST-LJAQVGFWSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
27425,6cs2,DB06969,-8.7,"2-amino-4-[2,4-dichloro-5-(2-pyrrolidin-1-ylethoxy)phenyl]-N-ethylthieno[2,3-d]pyrimidine-6-carboxamide",WJUNQSYQHHIVFX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
102027,6vxs,DB06920,-8.7,Eribaxaban,QQBKAVAGLMGMHI-WIYYLYMNSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102029,6vxs,DB06922,-8.7,"2-[(1R)-1-carboxy-2-naphthalen-1-ylethyl]-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylic acid",CZNPWASYMRBJCX-GOSISDBHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
8070,6lzg,DB04727,-8.7,"N-(4-{4-AMINO-6-[4-(METHYLOXY)PHENYL]FURO[2,3-D]PYRIMIDIN-5-YL}PHENYL)-N'-[2-FLUORO-5-(TRIFLUOROMETHYL)PHENYL]UREA",FGZIONRFHVNRJB-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
108593,6vxx,DB08437,-8.7,Puromycin,RXWNCPJZOCPEPQ-NVWDDTSBSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81751,6m3m,DB01633,-8.7,Deoxy-2-fluoro-beta-D-cellotrioside,BZNXZJAUEMJQJB-QSCMNUSVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58281,6crv,DB04794,-8.7,Bifonazole,OCAPBUJLXMYKEJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84325,6m3m,DB05524,-8.7,Pelitinib,WVUNYSQLFKLYNI-AATRIKPKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
55764,6crv,DB01456,-8.7,5-androstenedione,SQGZFRITSMYKRH-QAGGRKNESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85525,6m3m,DB07763,-8.7,"(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE",OZZFJGCAYWBVBI-INIZCTEOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136028,6w9c,DB06347,-8.7,Cenisertib,KSOVGRCOLZZTPF-QMKUDKLTSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
102060,6vxs,DB06963,-8.7,"3-[3-(3-methyl-6-{[(1S)-1-phenylethyl]amino}-1H-pyrazolo[4,3-c]pyridin-1-yl)phenyl]propanamide",ZFGCLYUGFRNYFE-INIZCTEOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
70658,6lxt,DB13002,-8.7,HKI-357,NERXPXBELDBEPZ-RMKNXTFCSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
104683,6vxs,DB12355,-8.7,Netazepide,YDZYKNJZCVIKPP-VWLOTQADSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
136703,6w9c,DB07432,-8.7,"[[(3R,4R,5S,6R)-3-(butanoylamino)-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-ylidene]amino] N-phenylcarbamate",ITVRELFVFCOUMV-ZVZWZHPPSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
71644,6lxt,DB14993,-8.7,Pyrotinib,SADXACCFNXBCFY-IYNHSRRRSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
58283,6crv,DB04796,-8.7,Inecalcitol,HHGRMHMXKPQNGF-WNSNRMDMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
67585,6lxt,DB06922,-8.7,"2-[(1R)-1-carboxy-2-naphthalen-1-ylethyl]-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylic acid",CZNPWASYMRBJCX-GOSISDBHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
108576,6vxx,DB08416,-8.7,"(9BETA,13ALPHA,14BETA,17ALPHA)-2-METHOX1TRA-1,3,5(10)-TRIENE-3,17-DIYL DISULFAMATE",AQSNIXKAKUZPSI-SSTWWWIQSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
71643,6lxt,DB14989,-8.7,Umbralisib,IUVCFHHAEHNCFT-INIZCTEOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
127021,6w4h,DB04607,-8.7,"PHENYLAMINOIMIDAZO(1,2-ALPHA)PYRIDINE",UQAWGIKJINAKIZ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
71640,6lxt,DB14982,-8.7,Miransertib,HNFMVVHMKGFCMB-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
59019,6crv,DB06983,-8.7,"(5-phenyl-7-(pyridin-3-ylmethylamino)pyrazolo[1,5-a]pyrimidin-3-yl)methanol",RBLKWWBHDUBPFN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
70064,6lxt,DB12108,-8.7,Taselisib,BEUQXVWXFDOSAQ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
102015,6vxs,DB06908,-8.7,"(2S)-3-(1-{[2-(2-CHLOROPHENYL)-5-METHYL-1,3-OXAZOL-4-YL]METHYL}-1H-INDOL-5-YL)-2-ETHOXYPROPANOIC ACID",PAWOPJKHTZCKMT-QFIPXVFZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
114233,6vxx,DB13132,-8.7,Artemisinin,BLUAFEHZUWYNDE-NNWCWBAJSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
82929,6m3m,DB03199,-8.7,4-Methoxy-E-Rhodomycin T,XSSVYBYWQBNYOH-QJIXERIWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
127255,6w4h,DB04946,-8.7,Iloperidone,XMXHEBAFVSFQEX-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
108678,6vxx,DB08795,-8.7,Azidocillin,ODFHGIPNGIAMDK-NJBDSQKTSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
164247,7bv1,DB07426,-8.7,"[1-HYDROXY-2-(1,1':3',1''-TERPHENYL-3-YLOXY)ETHANE-1,1-DIYL]BIS(PHOSPHONIC ACID)",NWIARQRYIRVYCM-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
125885,6w4h,DB03082,-8.7,6-[(Z)-Amino(Imino)Methyl]-N-[4-(Aminomethyl)Phenyl]-4-(Pyrimidin-2-Ylamino)-2-Naphthamide,CSWQJKHBMACTGB-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
108659,6vxx,DB08514,-8.7,"6-amino-2-[(thiophen-2-ylmethyl)amino]-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",IQKMJWDYMFWZRF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
12755,6lzg,DB01051,-8.7,Novobiocin,YJQPYGGHQPGBLI-KGSXXDOSSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
135438,6w9c,DB04471,-8.7,"2-Phenyl-1-[4-(2-Piperidin-1-Yl-Ethoxy)-Phenyl]-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol",FMWVCTJKLAVRPB-MUUNZHRXSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
27984,6cs2,DB07549,-8.7,"2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUORO-3-METHYL-6-PYRIDINYL)METHYL]ACETAMIDE",WOYBPRBUPLYTPY-UHFFFAOYSA-P,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
27584,6cs2,DB07131,-8.7,(S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclohexylpropanoyl)pyrrolidine-2-carboxamide,DOTBZTLJSXFKCP-IBGZPJMESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
104725,6vxs,DB12412,-8.7,Gemigliptin,ZWPRRQZNBDYKLH-VIFPVBQESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104722,6vxs,DB12408,-8.7,PF-03635659,WGOJWDWKHJHXSV-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101961,6vxs,DB06844,-8.7,"4-[(7-OXO-7H-THIAZOLO[5,4-E]INDOL-8-YLMETHYL)-AMINO]-N-PYRIDIN-2-YL-BENZENESULFONAMIDE",MBXKBJLIESPLIK-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
27708,6cs2,DB07263,-8.7,"[{2-bromo-4-[(2R)-3-oxo-2,3-diphenylpropyl]phenyl}(difluoro)methyl]phosphonic acid",WDTMVBQZDFMOIK-GOSISDBHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
6738,6lzg,DB02616,-8.7,FR117016,CKJGKHXCUDWFDC-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
114389,6vxx,DB13371,-8.7,Difenpiramide,PWHROYKAGRUWDQ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
82066,6m3m,DB02058,-8.7,SU4984,AZGZGRJOCKSSHA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136728,6w9c,DB07460,-8.7,2-({5-CHLORO-2-[(2-METHOXY-4-MORPHOLIN-4-YLPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)-N-METHYLBENZAMIDE,UYJNQQDJUOUFQJ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
134250,6w9c,DB02827,-8.7,"7-(1,1-Dioxo-1h-Benzo[D]Isothiazol-3-Yloxymethyl)-2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Pyran-3-Carboxylic Acid",MDYIGSPVMWSFEZ-JTQLQIEISA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136721,6w9c,DB07453,-8.7,2-PHENYL-4H-BENZO[H]CHROMEN-4-ONE,VFMMPHCGEFXGIP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
103383,6vxs,DB08513,-8.7,[4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENYL]ACETIC ACID,PAIQRYUOBBCBSE-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
82878,6m3m,DB03126,-8.7,Mant-Adp,QPKUEBLEGWBRHC-BFHYXJOUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84318,6m3m,DB05498,-8.7,KW-7158,NAFSYPCVPLWHFY-HNNXBMFYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
7110,6lzg,DB00398,-8.7,Sorafenib,MLDQJTXFUGDVEO-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
85590,6m3m,DB07835,-8.7,"N-3-cyclopropyl-N-4-'-(cyclopropylmethyl)-6-methylbiphenyl-3,4'-dicarboxamide",BOPSUAHGQHFKGG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
26676,6cs2,DB04859,-8.7,Zanapezil,PMBLXLOXUGVTGB-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
66087,6lxt,DB03723,-8.7,2'-Deoxy-Thymidine-Beta-L-Rhamnose,ZOSQFDVXNQFKBY-CGAXJHMRSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
108496,6vxx,DB08056,-8.7,"N-(2,6-dimethylphenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine",KKYYLKPGILUPOA-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85429,6m3m,DB07648,-8.7,"(2R)-3-{[(4Z)-5,6-DIPHENYL-6,7-DIHYDRO-4H-PYRROLO[2,3-D]PYRIMIDIN-4-YLIDENE]AMINO}PROPANE-1,2-DIOL",TWEONIHFGKSPLC-MRXNPFEDSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136671,6w9c,DB07395,-8.7,"4-[3-(2-Chloro-4,5-difluoro-benzoyl)ureido]-3-trifluoromethoxybenzoic acid",NWQGDIBCFLDHDO-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
26920,6cs2,DB05936,-8.7,CVT-6883,KOYXXLLNCXWUNF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
57010,6crv,DB03082,-8.7,6-[(Z)-Amino(Imino)Methyl]-N-[4-(Aminomethyl)Phenyl]-4-(Pyrimidin-2-Ylamino)-2-Naphthamide,CSWQJKHBMACTGB-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
26918,6cs2,DB05913,-8.7,OSI-930,FGTCROZDHDSNIO-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
68560,6lxt,DB08057,-8.7,"N-(2-chloro-6-methylphenyl)-8-[(3S)-3-methylpiperazin-1-yl]imidazo[1,5-a]quinoxalin-4-amine",VWJPPYCULHDHBB-HNNXBMFYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
103325,6vxs,DB08445,-8.7,"(3R,4S)-1-[6-(6-METHOXYPYRIDIN-3-YL)PYRIMIDIN-4-YL]-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE",IFKWHPAWYJARQJ-DYVFJYSZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
128291,6w4h,DB07435,-8.7,"1,2,3-TRIHYDROXY-1,2,3,4-TETRAHYDROBENZO[A]PYRENE",GFANZDFKCCJYRF-NSISKUIASA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
104629,6vxs,DB12280,-8.7,AZD-5423,FCNQMDSJHADDFT-WNSKOXEYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
11318,6lzg,DB11804,-8.7,AZD-5672,SCXSQUUTGCWHFU-WJOKGBTCSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
82735,6m3m,DB02932,-8.7,(R)-Bicalutamide,LKJPYSCBVHEWIU-KRWDZBQOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
55821,6crv,DB01524,-8.7,Androstenediol,QADHLRWLCPCEKT-LOVVWNRFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56271,6crv,DB02106,-8.7,"[3,5-Dibromo-4-(4-Hydroxy-3-Phenethylcarbamoyl-Phenoxy)-Phenyl]-Acetic Acid",KIRQJXNQGZAKGR-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58659,6crv,DB06295,-8.7,Pramiconazole,AEKNYBWUEYNWMJ-QWOOXDRHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84363,6m3m,DB05767,-8.7,Andrographolide,BOJKULTULYSRAS-OTESTREVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
160823,7bv1,DB11778,-8.7,Danusertib,XKFTZKGMDDZMJI-HSZRJFAPSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
163474,7bv1,DB04669,-8.7,TRIAZOLOPYRIMIDINE,YWBFPKPWMSWWEA-UHFFFAOYSA-O,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
106670,6vxx,DB00878,-8.7,Chlorhexidine,GHXZTYHSJHQHIJ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55842,6crv,DB01545,-8.7,Ethyl loflazepate,CUCHJCMWNFEYOM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163484,7bv1,DB04685,-8.7,"1-{(2S,5S)-4-FLUORO-5-[(TRITYLOXY)METHYL]TETRAHYDROFURAN-2-YL}PYRIMIDINE-2,4(1H,3H)-DIONE",GJNIPWYJQUGERM-BFLUCZKCSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
10934,6lzg,DB09280,-8.7,Lumacaftor,UFSKUSARDNFIRC-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
108483,6vxx,DB08039,-8.7,"(3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE",LOGJQOUIVKBFGH-YBEGLDIGSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108504,6vxx,DB08064,-8.7,N-(3-TERT-BUTYL-1H-PYRAZOL-5-YL)-N'-{4-CHLORO-3-[(PYRIDIN-3-YLOXY)METHYL]PHENYL}UREA,NTMADESEDXKNFZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
67517,6lxt,DB06844,-8.7,"4-[(7-OXO-7H-THIAZOLO[5,4-E]INDOL-8-YLMETHYL)-AMINO]-N-PYRIDIN-2-YL-BENZENESULFONAMIDE",MBXKBJLIESPLIK-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
163910,7bv1,DB06847,-8.7,"5-[(3S)-3-(2-methoxybiphenyl-4-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",YYCPXVRHQUEVAW-CQSZACIVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
107893,6vxx,DB05465,-8.7,Tandutinib,UXXQOJXBIDBUAC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
160791,7bv1,DB11732,-8.7,Lasmiditan,XEDHVZKDSYZQBF-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160798,7bv1,DB11740,-8.7,MK-1775,BKWJAKQVGHWELA-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
67548,6lxt,DB06882,-8.7,1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-naphthalen-1-ylurea,HJWMLCDGRWWLAQ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
106607,6vxx,DB00808,-8.7,Indapamide,NDDAHWYSQHTHNT-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
70099,6lxt,DB12154,-8.7,Itacitinib,KTBSXLIQKWEBRB-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
84924,6m3m,DB07059,-8.7,"N-{2-[6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2,2-DIMETHYL-3-OXO-2,3-DIHYDRO-4H-1,4-BENZOXAZIN-4-YL]ETHYL}ACETAMIDE",GBXSOZDYCSBLQX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
11325,6lzg,DB11816,-8.7,Omecamtiv Mecarbil,RFUBTTPMWSKEIW-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
27957,6cs2,DB07524,-8.7,"N-phenyl-1H-pyrrolo[2,3-b]pyridin-3-amine",CQFGXDQUQWRXLE-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
55783,6crv,DB01476,-8.7,Haloxazolam,XDKCGKQHVBOOHC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
71620,6lxt,DB14916,-8.7,Selonsertib,YIDDLAAKOYYGJG-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
58999,6crv,DB06954,-8.7,"2-(cycloheptylmethyl)-1,1-dioxido-1-benzothiophen-6-yl sulfamate",BIASYWBGUYOWJR-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
66233,6lxt,DB03903,-8.7,Tmr,KGFLZYXDJDOIEE-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
55788,6crv,DB01482,-8.7,Fenethylline,NMCHYWGKBADVMK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81717,6m3m,DB01594,-8.7,Cinolazepam,XAXMYHMKTCNRRZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
102163,6vxs,DB07081,-8.7,"(2R)-4-[(8R)-8-METHYL-2-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[1,5-A]PYRAZIN-7(8H)-YL]-4-OXO-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE",FDEXEPZGMKFCTG-PSASIEDQSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
58998,6crv,DB06953,-8.7,2-CHLORO-5-(3-CHLORO-PHENYL)-6-[(4-CYANO-PHENYL)-(3-METHYL-3H-IMIDAZOL-4-YL)- METHOXYMETHYL]-NICOTINONITRILE,JVWHVGIRXILXMU-XMMPIXPASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85456,6m3m,DB07683,-8.7,"N-(dibenzo[b,d]thiophen-3-ylsulfonyl)-L-valine",RZWYSEXQXOXWKA-INIZCTEOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
133455,6w9c,DB01705,-8.7,Bis(5-Amidino-Benzimidazolyl)Methane,QZKOOEFIMWKZPK-UHFFFAOYSA-Q,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
85453,6m3m,DB07679,-8.7,"(9S,12S)-9-(1-methylethyl)-7,10-dioxo-2-oxa-8,11-diazabicyclo[12.2.2]octadeca-1(16),14,17-triene-12-carboxylic acid",RRAAROKJUVKWAF-RDJZCZTQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
108523,6vxx,DB08087,-8.7,"4-[(7R,7AS)-7-HYDROXY-1,3-DIOXOTETRAHYDRO-1H-PYRROLO[1,2-C]IMIDAZOL-2(3H)-YL]-1-NAPHTHONITRILE",NHBIWLQQJPSMNP-CABCVRRESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57012,6crv,DB03084,-8.7,"Cyclopropyl-{4-[5-(3,4-Dichlorophenyl)-2-[(1-Methyl)-Piperidin]-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine",XCTKFTOEAKJMII-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
67521,6lxt,DB06849,-8.7,"1-[1'-(3-phenylacryloyl)spiro[1-benzofuran-3,4'-piperidin]-5-yl]methanamine",RQWYWHUKHYFIPB-VQHVLOKHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
81089,6m3m,DB00799,-8.7,Tazarotene,OGQICQVSFDPSEI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
127978,6w4h,DB07076,-8.7,6-[(Z)-AMINO(IMINO)METHYL]-N-[3-(CYCLOPENTYLOXY)PHENYL]-2-NAPHTHAMIDE,FWTQOPWAMQXIMI-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
70642,6lxt,DB12973,-8.7,Serlopitant,FLNYCRJBCNNHRH-OIYLJQICSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
107869,6vxx,DB05351,-8.7,Dexlansoprazole,MJIHNNLFOKEZEW-RUZDIDTESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
65164,6lxt,DB02473,-8.7,"6-[N-(1-Isopropyl-3,4-Dihydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine",XRHANBWAKSYPEN-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
83059,6m3m,DB03361,-8.7,"2-{(9as)-9a-[(1s)-1-Hydroxyethyl]-2,7-Dimethyl-9a,10-Dihydro-5h-Pyrimido[4,5-D][1,3]Thiazolo[3,2-a]Pyrimidin-8-Yl}Ethyl Trihydrogen Diphosphate",UQFVHIGKDHNMJT-XPTSAGLGSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
101653,6vxs,DB06159,-8.7,Rubitecan,VHXNKPBCCMUMSW-FQEVSTJZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
161450,7bv1,DB14067,-8.7,Dofequidar,KLWUUPVJTLHYIM-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
11897,6lzg,DB12580,-8.7,Tradipitant,CAVRKWRKTNINFF-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
85730,6m3m,DB07999,-8.7,"{4-[(CARBOXYMETHOXY)CARBONYL]-3,3-DIOXIDO-1-OXONAPHTHO[1,2-D]ISOTHIAZOL-2(1H)-YL}ACETIC ACID",IXLBOIRSEDMRPI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
71775,6lxt,DB15254,-8.7,RO-5126766 free base,LMMJFBMMJUMSJS-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
101665,6vxs,DB06190,-8.7,Solabegron,LLDXOPKUNJTIRF-QFIPXVFZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
11394,6lzg,DB11907,-8.7,Rociletinib,HUFOZJXAKZVRNJ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
71773,6lxt,DB15247,-8.7,Vorolanib,KMIOJWCYOHBUJS-HAKPAVFJSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
160493,7bv1,DB08454,-8.7,N-(5-METHYL-1H-PYRAZOL-3-YL)-2-PHENYLQUINAZOLIN-4-AMINE,JYCUVOXSZBECAY-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
80835,6m3m,DB00487,-8.7,Pefloxacin,FHFYDNQZQSQIAI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
55683,6crv,DB01329,-8.7,Cefoperazone,GCFBRXLSHGKWDP-XCGNWRKASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
18178,6cs2,HMDB0000054,-8.7,Bilirubin,BPYKTIZUTYGOLE-KDUUSRDASA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
84253,6m3m,DB05116,-8.7,Thymectacin,CFBLUORPOFELCE-BACVZHSASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
103522,6vxs,DB08683,-8.7,"REL-(9R,12S)-9,10,11,12-TETRAHYDRO-9,12-EPOXY-1H-DIINDOLO[1,2,3-FG:3',2',1'-KL]PYRROLO[3,4-I][1,6]BENZODIAZOCINE-1,3(2H)-DIONE",OTPNDVKVEAIXTI-IYBDPMFKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
65278,6lxt,DB02621,-8.7,Latrunculin A,DDVBPZROPPMBLW-IZGXTMSKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
68040,6lxt,DB07450,-8.7,(R)-minalrestat,BMHZAHGTGIZZCT-LJQANCHMSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
107844,6vxx,DB04693,-8.7,"(13S)-13-METHYLDODECAHYDRO-1H-CYCLOPENTA[A]PHENANTHRENE-3,17(2H,4H)-DIONE",CRDKSBHJIGNEOH-IMRIKWHGSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
161452,7bv1,DB14069,-8.7,ONT-093,RSJCLODJSVZNQA-BQYQJAHWSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
80849,6m3m,DB00502,-8.7,Haloperidol,LNEPOXFFQSENCJ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
68046,6lxt,DB07456,-8.7,"3-(1H-indol-3-yl)-4-(1-{2-[(2S)-1-methylpyrrolidinyl]ethyl}-1H-indol-3-yl)-1H-pyrrole-2,5-dione",LBFDERUQORUFIN-QGZVFWFLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
101683,6vxs,DB06228,-8.7,Rivaroxaban,KGFYHTZWPPHNLQ-AWEZNQCLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
161207,7bv1,DB13397,-8.7,Prenoxdiazine,PXZDWASDNFWKSD-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
136395,6w9c,DB07066,-8.7,"2-CHLORO-N-[(3R)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL]-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE",LJAHIGGEXIWVJG-LLVKDONJSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
108877,6vxx,DB11263,-8.7,Polydatin,HSTZMXCBWJGKHG-CUYWLFDKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
71805,6lxt,DB15310,-8.7,Vactosertib,FJCDSQATIJKQKA-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
108966,6vxx,DB11833,-8.7,Basimglurant,UPZWINBEAHDTLA-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106317,6vxs,DB15450,-8.7,PF-05105679,BXNMZRPTQFVRFA-QGZVFWFLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
108958,6vxx,DB11457,-8.7,Rotenone,JUVIOZPCNVVQFO-HBGVWJBISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55624,6crv,DB01215,-8.7,Estazolam,CDCHDCWJMGXXRH-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106327,6vxs,DB02524,-8.7,"2',3'-O-{4-[Hydroxy(oxido)-lambda5-azanylidene]-2,6-dinitro-2,5-cyclohexadiene-1,1-diyl}adenosine 5'-(tetrahydrogen triphosphate)",XFMMHXLUHKBKQE-UHEGPQQHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
134713,6w9c,DB03446,-8.7,N-Benzyl-3-(alpha-D-galactopyranosyloxy)benzamide,FSMWGHKWKYCPKE-QTVCLEQKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
80766,6m3m,DB00404,-8.7,Alprazolam,VREFGVBLTWBCJP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
134719,6w9c,DB03453,-8.7,Methyl (2S)-2-[[2-[(3R)-1-carbamimidoylpiperidin-3-yl]acetyl]amino]-3-[4-(2-phenylethynyl)phenyl]propanoate,MRNGXYMKYHNMLV-PKTZIBPZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
83111,6m3m,DB03435,-8.7,Uridine-5'-Diphosphate,XCCTYIAWTASOJW-XVFCMESISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
108949,6vxx,DB11442,-8.7,Oleandomycin,RZPAKFUAFGMUPI-QESOVKLGSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58500,6crv,DB05575,-8.7,Motesanib,RAHBGWKEPAQNFF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127543,6w4h,DB06314,-8.7,SGX-523,BCZUAADEACICHN-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
28045,6cs2,DB07618,-8.7,"2-(4-(AMINOMETHYL)PIPERIDIN-1-YL)-N-(3_CYCLOHEXYL-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)ACETAMIDE",AITZHKQVQNLKHI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
56695,6crv,DB02659,-8.7,Cholic Acid,BHQCQFFYRZLCQQ-OELDTZBJSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
71795,6lxt,DB15294,-8.7,SB-1578,NNXDIGHYPZHXTR-ONEGZZNKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
136394,6w9c,DB07065,-8.7,"5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)-3-thiocyanatopyrazolo[1,5-a]pyrimidin-7-amine",AHPKUZJCNHGFQA-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
69961,6lxt,DB11950,-8.7,Teneligliptin,WGRQANOPCQRCME-PMACEKPBSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
114943,6vxx,DB15456,-8.7,Vericiguat,QZFHIXARHDBPBY-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104838,6vxs,DB12579,-8.7,JNJ-37822681,UVUYWJWYRLJHEN-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
135979,6w9c,DB06228,-8.7,Rivaroxaban,KGFYHTZWPPHNLQ-AWEZNQCLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
11397,6lzg,DB11911,-8.7,Galunisertib,IVRXNBXKWIJUQB-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
85753,6m3m,DB08023,-8.7,"N-cyclohexyl-4-imidazo[1,2-a]pyridin-3-yl-N-methylpyrimidin-2-amine",HYNNWLVWJXWXFO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136800,6w9c,DB07546,-8.7,[1-(6-{6-[(1-methylethyl)amino]-1H-indazol-1-yl}pyrazin-2-yl)-1H-pyrrol-3-yl]acetic acid,BBYRUZKRFAIQSR-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
125855,6w4h,DB03044,-8.7,1-(5-Tert-Butyl-2-P-Tolyl-2h-Pyrazol-3-Yl)-3-[4-(2-Morpholin-4-Yl-Ethoxy)-Naphthalen-1-Yl]-Urea,MVCOAUNKQVWQHZ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
101718,6vxs,DB06302,-8.7,Glesatinib,YRCHYHRCBXNYNU-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101722,6vxs,DB06311,-8.7,Darapladib,WDPFJWLDPVQCAJ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
81772,6m3m,DB01661,-8.7,1-(5-phospho-D-ribosyl)-ATP,RKNHJBVBFHDXGR-MRUDJCSFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
104780,6vxs,DB12491,-8.7,Fasiglifam,BZCALJIHZVNMGJ-HSZRJFAPSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
71731,6lxt,DB15169,-8.7,H3B-6527,MBWRLLRCTIYXDW-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
80894,6m3m,DB00561,-8.7,Doxapram,XFDJYSQDBULQSI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
71701,6lxt,DB15110,-8.7,Onvansertib,QHLVBNKYJGBCQJ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
68830,6lxt,DB08384,-8.7,2-({4-[4-(pyridin-4-ylmethyl)-1H-pyrazol-3-yl]phenoxy}methyl)quinoline,RQDDHVVAAJVVKM-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
65411,6lxt,DB02804,-8.7,A-98881,PMBZSBGCSQGJAQ-GRKNLSHJSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
82960,6m3m,DB03234,-8.7,"(4'-{[Allyl(Methyl)Amino]Methyl}-1,1'-Biphenyl-4-Yl)(4-Bromophenyl)Methanone",YATCZCSDJCQNAL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
71691,6lxt,DB15092,-8.7,LY-2624803,UEFWDVMEDFCHGW-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
56618,6crv,DB02554,-8.7,"Sulfoquinovose-Uridine-C1,5'-Diphosphate",FQANCGQCBCUSMI-JZMIEXBBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127242,6w4h,DB04908,-8.7,Flibanserin,PPRRDFIXUUSXRA-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
17756,6cs2,HMDB0010335,-8.7,Estriol-3-glucuronide,UZKIAJMSMKLBQE-WTSDUJKYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
65567,6lxt,DB03005,-8.7,"3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-5-Yl]Hexyl]-Phenanthridinium",ISUOMOOYAOQQPZ-UHFFFAOYSA-O,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
103445,6vxs,DB08588,-8.7,2-({2-[(3R)-3-AMINOPIPERIDIN-1-YL]-4-OXOQUINAZOLIN-3(4H)-YL}METHYL)BENZONITRILE,OYNURZXTLNNKAP-QGZVFWFLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
65577,6lxt,DB03020,-8.7,5-Beta-D-Ribofuranosylnicotinamide Adenine Dinucleotide,UINNILASBHZOTM-KMXXXSRASA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
107866,6vxx,DB05316,-8.7,Pimavanserin,RKEWSXXUOLRFBX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
135491,6w9c,DB04540,-8.7,Cholesterol,HVYWMOMLDIMFJA-DPAQBDIFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
67634,6lxt,DB06985,-8.7,2-[({4-[2-(trifluoromethyl)phenyl]piperidin-1-yl}carbonyl)amino]benzoic acid,MEAQCLPMSVEOQF-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
106513,6vxx,DB00436,-8.7,Bendroflumethiazide,HDWIHXWEUNVBIY-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
68804,6lxt,DB08351,-8.7,N-cyclopropyl-4-methyl-3-{2-[(2-morpholin-4-ylethyl)amino]quinazolin-6-yl}benzamide,MNEXDVSJIUQQRH-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
103417,6vxs,DB08553,-8.7,"(1E)-5-(1-piperidin-4-yl-3-pyridin-4-yl-1H-pyrazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime",KWEFZSZCLBHIEQ-YYADALCUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104737,6vxs,DB12427,-8.7,Orvepitant,XWNBGDJPEXZSQM-VZOBGQTKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
134739,6w9c,DB03480,-8.7,Brequinar Analog,WYKKHJQZENLZID-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
68832,6lxt,DB08386,-8.7,2-{[4-(4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline,VRWJZGHUCOFGPZ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
65342,6lxt,DB02705,-8.7,"6-[N-(1-Isopropyl-1,2,3,4-Tetrahydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine",DARQQJKHXPXSRO-QFIPXVFZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
108755,6vxx,DB08915,-8.7,Aleglitazar,DAYKLWSKQJBGCS-NRFANRHFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85705,6m3m,DB07971,-8.7,"5-AMINO-2-{4-[(4-AMINOPHENYL)SULFANYL]PHENYL}-1H-ISOINDOLE-1,3(2H)-DIONE",FQQVTDIBUYSVHM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58232,6crv,DB04725,-8.7,Licofelone,UAWXGRJVZSAUSZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56328,6crv,DB02187,-8.7,Equilin,WKRLQDKEXYKHJB-HFTRVMKXSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
160527,7bv1,DB08738,-8.7,1-{3-oxo-3-[(2S)-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]propyl}-3-phenylquinoxalin-2(1H)-one,KWCKZIJGKMCYCI-QFIPXVFZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
104795,6vxs,DB12515,-8.7,9-aminocamptothecin,FUXVKZWTXQUGMW-FQEVSTJZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104794,6vxs,DB12513,-8.7,Omaveloxolone,RJCWBNBKOKFWNY-IDPLTSGASA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
58631,6crv,DB06235,-8.7,Vadimezan,XGOYIMQSIKSOBS-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
134735,6w9c,DB03476,-8.7,Trans-6-(2-Phenylcyclopropyl)-Naphthalene-2-Carboxamidine,NQRIWXVAIWPBEM-OALUTQOASA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
69979,6lxt,DB11979,-8.7,Elagolix,HEAUOKZIVMZVQL-VWLOTQADSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
160556,7bv1,DB08770,-8.7,"4-{2-[(7-amino-2-furan-2-yl[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-yl)amino]ethyl}phenol",PWTBZOIUWZOPFT-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
70381,6lxt,DB12562,-8.7,Setipiprant,IHAXLPDVOWLUOS-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
68048,6lxt,DB07458,-8.7,"3-(1H-indol-3-yl)-4-{1-[2-(1-methylpyrrolidin-2-yl)ethyl]-1H-indol-3-yl}-1H-pyrrole-2,5-dione",LBFDERUQORUFIN-KRWDZBQOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
69989,6lxt,DB11995,-8.7,Avatrombopag,OFZJKCQENFPZBH-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
108763,6vxx,DB08931,-8.7,Riociguat,WXXSNCNJFUAIDG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85684,6m3m,DB07946,-8.7,"N-[2-({[amino(imino)methyl]amino}oxy)ethyl]-2-{6-chloro-3-[(2,2-difluoro-2-phenylethyl)amino]-2-fluorophenyl}acetamide",DZEJHPMTDNDECN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
161877,7bv1,DB00923,-8.7,Ceforanide,SLAYUXIURFNXPG-CRAIPNDOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
85682,6m3m,DB07944,-8.7,N-{3-METHYL-5-[2-(PYRIDIN-4-YLAMINO)-ETHOXY]-PHENYL}-BENZENESULFONAMIDE,MPTWCWHNLVMCRW-UHFFFAOYSA-O,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
108761,6vxx,DB08927,-8.7,Amperozide,NNAIYOXJNVGUOM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
18945,6cs2,HMDB0041745,-8.7,Hesperetin 7-O-glucuronide,NEAWXAXVQDDFJL-PLEVBHNASA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
59089,6crv,DB07059,-8.7,"N-{2-[6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2,2-DIMETHYL-3-OXO-2,3-DIHYDRO-4H-1,4-BENZOXAZIN-4-YL]ETHYL}ACETAMIDE",GBXSOZDYCSBLQX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107857,6vxx,DB05265,-8.7,Ecabet,IWCWQNVIUXZOMJ-MISYRCLQSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
101774,6vxs,DB06469,-8.7,Lestaurtinib,UIARLYUEJFELEN-DMVVYWCZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
85672,6m3m,DB07933,-8.7,Erteberel,XIESSJVMWNJCGZ-VKJFTORMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
106447,6vxx,DB00354,-8.7,Buclizine,MOYGZHXDRJNJEP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
71813,6lxt,DB15327,-8.7,Abivertinib,UOFYSRZSLXWIQB-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
66354,6lxt,DB04071,-8.7,Cpad,LFERELMXERXKKQ-KMXXXSRASA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
114242,6vxx,DB13158,-8.7,Clobetasone,XXIFVOHLGBURIG-OZCCCYNHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
68309,6lxt,DB07770,-8.7,5-(4-FLUOROPHENYL)-3-{[(4-METHYLPHENYL)SULFONYL]AMINO}THIOPHENE-2-CARBOXYLIC ACID,DJPFUQBNQLKCAB-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
56008,6crv,DB01755,-8.7,N-[Isoleucinyl]-N'-[Adenosyl]-Diaminosufone,XVTRBLLRODNOJV-VBJYJYTRSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
103107,6vxs,DB08169,-8.7,(2Z)-N-biphenyl-4-yl-2-cyano-3-cyclopropyl-3-hydroxyprop-2-enamide,CAGGGMPTWTUYHZ-ZCXUNETKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
56017,6crv,DB01765,-8.7,"(5-Oxo-5,6-Dihydro-Indolo[1,2-a]Quinazolin-7-Yl)-Acetic Acid",INSBKYCYLCEBOD-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81404,6m3m,DB01157,-8.7,Trimetrexate,NOYPYLRCIDNJJB-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
82281,6m3m,DB02342,-8.7,2-Methox1tradiol,CQOQDQWUFQDJMK-SSTWWWIQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
27558,6cs2,DB07107,-8.7,(1S)-2-(1H-INDOL-3-YL)-1-[({5-[(E)-2-PYRIDIN-4-YLVINYL]PYRIDIN-3-YL}OXY)METHYL]ETHYLAMINE,SGHXFHRRWFLILP-XJDXJNMNSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
134991,6w9c,DB03837,-8.7,Morpholine-4-Carboxylic Acid (1-(3-Benzenesulfonyl-1-Phenethylallylcarbamoyl)-3-Methylbutyl)-Amide,YUMYYTORLYHUFW-ZUDLOMHPSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
108215,6vxx,DB07238,-8.7,Nesbuvir,WTDWVLJJJOTABN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
160975,7bv1,DB12345,-8.7,MBX-2982,NFTMKHWBOINJGM-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
163627,7bv1,DB04875,-8.7,Pralnacasan,CXAGHAZMQSCAKJ-WAHHBDPQSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
104317,6vxs,DB11822,-8.7,TMC-647055,UOBYJVFBFSLCTQ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
56182,6crv,DB01990,-8.7,Cholesterol sulfate,BHYOQNUELFTYRT-DPAQBDIFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
133867,6w9c,DB02259,-8.7,"3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid (4-Sulfamoyl-Phenyl)-Amide",VSYGXLAJQDAWCZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136446,6w9c,DB07126,-8.7,O6-CYCLOHEXYLMETHOXY-2-(4'-SULPHAMOYLANILINO) PURINE,OWXORKPNCHJYOF-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
102828,6vxs,DB07855,-8.7,(S)-1-PHENYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE,CWHMAWBXRCDOEB-HNNXBMFYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
23275,6cs2,HMDB0059992,-8.7,5-(4'-Hydroxyphenyl)-gamma-valerolactone-4'-O-glucuronide,DCVIOAHIQDCAHO-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
106900,6vxx,DB01720,-8.7,(2z)-2-(Benzoylamino)-3-[4-(2-Bromophenoxy)Phenyl]-2-Propenoic Acid,WLPJLQNKCJWAFL-RGEXLXHISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84518,6m3m,DB06370,-8.7,Indisulam,SETFNECMODOHTO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
133913,6w9c,DB02323,-8.7,EM-1745,CKSDYJASHNGOOS-KTXOUVACSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
102857,6vxs,DB07889,-8.7,"(2S)-1-(Dimethylamino)-3-(4-{[4-(2-methylimidazo[1,2-a]pyridin-3-yl)-2-pyrimidinyl]amino}phenoxy)-2-propanol",VCPXSBULBDYRLT-SFHVURJKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
56678,6crv,DB02639,-8.7,4-methylumbelliferyl ??-D-glucoside,YUDPTGPSBJVHCN-JZYAIQKZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108214,6vxx,DB07237,-8.7,{4-[(2R)-pyrrolidin-2-ylmethoxy]phenyl}(4-thiophen-3-ylphenyl)methanone,VUWFJUJWAWMRQN-HXUWFJFHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114254,6vxx,DB13182,-8.7,Daidzein,ZQSIJRDFPHDXIC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
160940,7bv1,DB12297,-8.7,GLPG-0187,CXHCNOMGODVIKB-VWLOTQADSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
84508,6m3m,DB06345,-8.7,AR-9281,HUDQLWBKJOMXSZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84489,6m3m,DB06280,-8.7,Senicapoc,SCTZUZTYRMOMKT-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
108244,6vxx,DB07271,-8.7,"4-[(3R)-3-Amino-4-(2,4,5-trifluorophenyl)butanoyl]-3-(2,2,2-trifluoroethyl)-1,4-diazepan-2-one",RMDAPSXWBVPVOG-IAPIXIRKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
82485,6m3m,DB02602,-8.7,AL7182,ICIXQGGQPKFQRL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
70227,6lxt,DB12336,-8.7,GDC-0917,HSHPBORBOJIXSQ-HARLFGEKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
27568,6cs2,DB07117,-8.7,"5-(4-PHENOXYPHENYL)-5-(4-PYRIMIDIN-2-YLPIPERAZIN-1-YL)PYRIMIDINE-2,4,6(2H,3H)-TRIONE",FMKQJGOROFNCGM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
136146,6w9c,DB06652,-8.7,Vicriviroc,CNPVJJQCETWNEU-CYFREDJKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
56658,6crv,DB02610,-8.7,"N-(2,3,4,5,6-Pentaflouro-Benzyl)-4-Sulfamoyl-Benzamide",LRKSHOLYETXPGY-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56002,6crv,DB01748,-8.7,N-Benzyl-4-Sulfamoyl-Benzamide,CZKNSZUJCJHTTM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81387,6m3m,DB01138,-8.7,Sulfinpyrazone,MBGGBVCUIVRRBF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
10776,6lzg,DB09050,-8.7,Ceftolozane,JHFNIHVVXRKLEF-DCZLAGFPSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
68330,6lxt,DB07794,-8.7,"5-(2-PHENYLPYRAZOLO[1,5-A]PYRIDIN-3-YL)-1H-PYRAZOLO[3,4-C]PYRIDAZIN-3-AMINE",XVECMUKVOMUNLE-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
26860,6cs2,DB05575,-8.7,Motesanib,RAHBGWKEPAQNFF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
85155,6m3m,DB07324,-8.7,"3-({2-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)ETHYNYL]BENZYL}AMINO)-1,3-OXAZOL-2(3H)-ONE",ZUJWSOPIDUWELP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
71456,6lxt,DB14568,-8.7,Ivosidenib,WIJZXSAJMHAVGX-DHLKQENFSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
85148,6m3m,DB07316,-8.7,"N-{1-[(1-carbamoylcyclopropyl)methyl]piperidin-4-yl}-N-cyclopropyl-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide",FAVXIEFZKPJZRT-NRFANRHFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
104420,6vxs,DB11971,-8.7,Vilaprisan,JUFWQQVHQFDUOD-ANRPBIDPSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102767,6vxs,DB07787,-8.7,"5-FLUORO-1-[4-(4-PHENYL-3,6-DIHYDROPYRIDIN-1(2H)-YL)BUTYL]QUINAZOLINE-2,4(1H,3H)-DIONE",PNPFDRCIGCUCMN-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
6632,6lzg,DB02432,-8.7,RU90395,RLLAUERCSKPFGD-VMPREFPWSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
106856,6vxx,DB01406,-8.7,Danazol,POZRVZJJTULAOH-LHZXLZLDSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56671,6crv,DB02628,-8.7,"1-[3,3-Dimethyl-2-(2-Methylamino-Propionylamino)-Butyryl]-Pyrrolidine-2-Carboxylic Acid(1,2,3,4-Tetrahydro-Naphthalen-1-Yl)-Amide",JUJIMRZGUBTJRV-NASSWSRMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56189,6crv,DB02001,-8.7,"5-(4-Morpholin-4-Yl-Phenylsulfanyl)-2,4-Quinazolinediamine",CZLWCJRHDBTCGQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85147,6m3m,DB07315,-8.7,"5-chloro-N-{4-[(1R)-1,2-dihydroxyethyl]phenyl}-1H-indole-2-carboxamide",SHCHFGSUYJUEBR-INIZCTEOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
104416,6vxs,DB11966,-8.7,BMS-986094,YFXGICNMLCGLHJ-RSKRLRQZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
58781,6crv,DB06625,-8.7,Vipadenant,HQSBCDPYXDGTCL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84996,6m3m,DB07143,-8.7,D-phenylalanyl-N-benzyl-L-prolinamide,MEPJWLFTTFHOQO-MOPGFXCFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58779,6crv,DB06623,-8.7,Flupirtine,JUUFBMODXQKSTD-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
164051,7bv1,DB07014,-8.7,"2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4-methoxybenzyl)sulfanyl]-1,3,4-oxadiazole",TUTZKAQTSPMEBI-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
107020,6vxx,DB02181,-8.7,2'-Deoxyguanosine-5'-Triphosphate,HAAZLUGHYHWQIW-KVQBGUIXSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107000,6vxx,DB01852,-8.7,Kaempherol,IYRMWMYZSQPJKC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85030,6m3m,DB07182,-8.7,(2S)-2-(3-{[AMINO(IMINO)METHYL]AMINO}PHENYL)-3-[(S)-HYDROXY(3-PHENYLPROPYL)PHOSPHORYL]PROPANOIC ACID,HFRHWTYCVGKGIE-KRWDZBQOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
102958,6vxs,DB08006,-8.7,"N-anthracen-2-yl-5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7-amine",OXYDLVAOXASTMW-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104348,6vxs,DB11870,-8.7,RG-4733,OJPLJFIFUQPSJR-INIZCTEOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
136451,6w9c,DB07131,-8.7,(S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclohexylpropanoyl)pyrrolidine-2-carboxamide,DOTBZTLJSXFKCP-IBGZPJMESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
71134,6lxt,DB13685,-8.7,Quingestanol,PCJFRMOEZQQSAX-AIOSZGMZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
84547,6m3m,DB06457,-8.7,Tecastemizole,SFOVDSLXFUGAIV-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81509,6m3m,DB01319,-8.7,Fosamprenavir,MLBVMOWEQCZNCC-OEMFJLHTSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81510,6m3m,DB01320,-8.7,Fosphenytoin,XWLUWCNOOVRFPX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
161023,7bv1,DB12412,-8.7,Gemigliptin,ZWPRRQZNBDYKLH-VIFPVBQESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
102982,6vxs,DB08031,-8.7,"N-[(13-CYCLOHEXYL-6,7-DIHYDROINDOLO[1,2-D][1,4]BENZOXAZEPIN-10-YL)CARBONYL]-2-METHYL-L-ALANINE",LNQWELVSNCYKDU-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102988,6vxs,DB08037,-8.7,"(2S)-4-(2,5-difluorophenyl)-N-[(3R,4S)-3-fluoro-1-methylpiperidin-4-yl]-2-(hydroxymethyl)-N-methyl-2-phenyl-2,5-dihydro-1H-pyrrole-1-carboxamide",MYBGWENAVMIGMM-GIFXNVAJSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
163979,7bv1,DB06925,-8.7,3-(2-AMINOQUINAZOLIN-6-YL)-4-METHYL-N-[3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE,YEIASMOUYNOXGA-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
85059,6m3m,DB07217,-8.7,"N-(3-cyano-4,5,6,7-tetrahydro-1-benzothien-2-yl)-2-fluorobenzamide",YVYPYORTKAIUGJ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
71045,6lxt,DB13571,-8.7,Pentamycin,AGJUUQSLGVCRQA-SWOUQTJZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
136464,6w9c,DB07146,-8.7,"2,3-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-B]PYRIDIN-4-AMINE",QUIQCYFSBGOBKE-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
163995,7bv1,DB06944,-8.7,N-(3-cyclopropyl-1H-pyrazol-5-yl)-2-(2-naphthyl)acetamide,RIGZCVNCFXYBEG-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
134014,6w9c,DB02455,-8.7,Fluoresceinylthioureido,VHJFQSRUDVDTEO-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
58441,6crv,DB05265,-8.7,Ecabet,IWCWQNVIUXZOMJ-MISYRCLQSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56705,6crv,DB02673,-8.7,"(4ar,6s,8ar)-11-[8-(1,3-Dioxo-1,3-Dihydro-2h-Isoindol-2-Yl)Octyl]-6-Hydroxy-3-Methoxy-5,6,9,10-Tetrahydro-4ah-[1]Benzofuro[3a,3,2-Ef][2]Benzazepin-11-Ium",VLGAHTYYCHWLNI-BHRZLAGCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140528,6w9c,DB12010,-8.7,Fostamatinib,GKDRMWXFWHEQQT-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
116311,6w4b,DB01988,-8.7,6((S)-3-Benzylpiperazin-1-Yl)-3-(Naphthalen-2-Yl)-4-(Pyridin-4-Yl)Pyrazine,WFSFNKVFXLIZIY-MHZLTWQESA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
67259,6lxt,DB06263,-8.7,Amrubicin,VJZITPJGSQKZMX-XDPRQOKASA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
68232,6lxt,DB07680,-8.7,[(1S)-1-(5-CHLORO-1-BENZOTHIEN-3-YL)-2-(2-NAPHTHYLAMINO)-2-OXOETHYL]PHOSPHONIC ACID,HUJXISJLAPAFBO-IBGZPJMESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
67240,6lxt,DB06229,-8.7,Ocaperidone,ZZQNEJILGNNOEP-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
106907,6vxx,DB01732,-8.7,"(4r,5s,6s,7r)-1,3-Dibenzyl-4,7-Bis(Phenoxymethyl)-5,6-Dihydroxy-1,3 Diazepan-2-One",SQBOSZXDOHQFAA-ZRTHHSRSSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
128051,6w4h,DB07159,-8.7,Tamatinib,NHHQJBCNYHBUSI-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
114747,6vxx,DB14765,-8.7,Rivoceranib,WPEWQEMJFLWMLV-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136191,6w9c,DB06730,-8.7,Gestodene,SIGSPDASOTUPFS-XUDSTZEESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
82400,6m3m,DB02491,-8.7,4-[4-(1-Amino-1-Methylethyl)Phenyl]-5-Chloro-N-[4-(2-Morpholin-4-Ylethyl)Phenyl]Pyrimidin-2-Amine,CJSSYVIHFXDFFC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81461,6m3m,DB01219,-8.7,Dantrolene,OZOMQRBLCMDCEG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136229,6w9c,DB06875,-8.7,3-(3-FLUORO-4-HYDROXYPHENYL)-7-HYDROXY-1-NAPHTHONITRILE,NSSOSHDCWCMNDM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
103081,6vxs,DB08143,-8.7,"5-CHLORO-THIOPHENE-2-CARBOXYLIC ACID ((3S,4S)-4-FLUORO- 1-{[2-FLUORO-4-(2-OXO-2H-PYRIDIN-1-YL)-PHENYLCARBAMOYL]-METHYL}-PYRROLIDIN-3-YL)-AMIDE",SXIYSYYSKHUTQQ-RDJZCZTQSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
84524,6m3m,DB06403,-8.7,Ambrisentan,OUJTZYPIHDYQMC-LJQANCHMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
161487,7bv1,DB14899,-8.7,Tavapadon,AKQXQLUNFKDZBN-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
82325,6m3m,DB02398,-8.7,6-[N-(4-(Aminomethyl)Phenyl)Carbamyl]-2-Naphthalenecarboxamidine,NLBDETRVUYOIHQ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
26594,6cs2,DB04764,-8.7,[4-(3-AMINOMETHYL-PHENYL)-PIPERIDIN-1-YL]-(5-PHENETHYL- PYRIDIN-3-YL)-METHANONE,CCLHROFBSWWOQO-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
104365,6vxs,DB11894,-8.7,Efatutazone,JCYNMRJCUYVDBC-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
70288,6lxt,DB12420,-8.7,Diazepinomicin,SALVHVNECODMJP-GNUCVDFRSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
161057,7bv1,DB12812,-8.7,Palomid 529,YEAHTLOYHVWAKW-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
108174,6vxx,DB07187,-8.7,6-[(5-CHLORO-3-METHYL-1-BENZOFURAN-2-YL)SULFONYL]PYRIDAZIN-3(2H)-ONE,FXFPQPNUMWQRAO-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106968,6vxx,DB01812,-8.7,Adenosine-3'-5'-Diphosphate,WHTCPDAXWFLDIH-KQYNXXCUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56165,6crv,DB01967,-8.7,"N-{3-[(7ar,12as,12bs)-7-Oxo-1,3,4,6,7,7a,12a,12b-Octahydroindolo[2,3-a]Quinolizin-12(2h)-Yl]Propyl}Propane-2-Sulfonamide",LICJTIDRHJECTD-SFHVURJKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81597,6m3m,DB01455,-8.7,19-Nor-5-androstenediol,VVUQRXPUVKXAIO-XFUVECHXSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85074,6m3m,DB07235,-8.7,"N-[(1S)-2-AMINO-1-(2,4-DICHLOROBENZYL)ETHYL]-5-[2-(METHYLAMINO)PYRIMIDIN-4-YL]THIOPHENE-2-CARBOXAMIDE",HHOVRZGUSBMKKU-ZDUSSCGKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
140167,6w9c,DB15109,-8.7,Ingenol disoxate,GLIUZQUNUNICGS-XUBYYPQFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
126795,6w4h,DB04301,-8.7,Bis(5-Amidino-2-Benzimidazolyl)Methane Ketone Hydrate,ZLAHDRAQCSQPOC-UHFFFAOYSA-P,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
81595,6m3m,DB01453,-8.7,Beta-hydroxyfentanyl,JEFVHLMGRUJLET-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
82414,6m3m,DB02507,-8.7,4-Hydroxy-3-[(1s)-3-Oxo-1-Phenylbutyl]-2h-Chromen-2-One,PJVWKTKQMONHTI-HNNXBMFYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84616,6m3m,DB06625,-8.7,Vipadenant,HQSBCDPYXDGTCL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136554,6w9c,DB07253,-8.7,"N'-(5-chloro-1,3-benzodioxol-4-yl)-N-(3-methylsulfonylphenyl)pyrimidine-2,4-diamine",QTFCKBFCXDAZIU-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
70707,6lxt,DB13072,-8.7,GDC-0349,RGJOJUGRHPQXGF-INIZCTEOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
127985,6w4h,DB07084,-8.7,"N-(6,7,9,10,17,18,20,21-octahydrodibenzo[b,k][1,4,7,10,13,16]hexaoxacyclooctadecin-2-yl)acetamide",YHKGWOJTUMJPNW-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
71567,6lxt,DB14795,-8.7,AZD-3759,MXDSJQHFFDGFDK-CYBMUJFWSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
102426,6vxs,DB07382,-8.7,"N-2-1H-benzimidazol-5-yl-N-4-(3-cyclopropyl-1H-pyrazol-5-yl)pyrimidine-2,4-diamine",WJNBSTLIALIIEW-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
68089,6lxt,DB07508,-8.7,4-(5-BENZENESULFONYLAMINO-1-METHYL-1H-BENZOIMIDAZOL-2-YLMETHYL)-BENZAMIDINE,MEUAVGJWGDPTLF-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
68514,6lxt,DB08006,-8.7,"N-anthracen-2-yl-5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7-amine",OXYDLVAOXASTMW-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
66656,6lxt,DB04477,-8.7,"N-1,2,3,4-Tetrahydronaphth-1-Yl-2'-[3,5-Dimethoxybenzamido]-2'-Deoxy-Adenosine",FDZQGEIYGFPMOB-ZUURFMEUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
68511,6lxt,DB08003,-8.7,ISOTHIAZOLIDINONE ANALOG,UILYPHAKDBTKQV-UFYCRDLUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
58911,6crv,DB06853,-8.7,N-cycloheptylglycyl-N-(4-carbamimidoylbenzyl)-L-prolinamide,BYTJPDBCLWUEBU-IBGZPJMESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85330,6m3m,DB07531,-8.7,"4-{5-[(Z)-(2,4-DIOXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE",JNPRTUHVCHGFHJ-GHXNOFRVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
27732,6cs2,DB07287,-8.7,"2-(2,4-DICHLOROPHENOXY)-5-(PYRIDIN-2-YLMETHYL)PHENOL",AOVDSWPGWPRTSR-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
84604,6m3m,DB06604,-8.7,Ilepatril,FXKFFTMLFPWYFH-RDGPPVDQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
70174,6lxt,DB12267,-8.7,Brigatinib,AILRADAXUVEEIR-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
102457,6vxs,DB07419,-8.7,S-23,SSFVOEAXHZGTRJ-KRWDZBQOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
107959,6vxx,DB05838,-8.7,OPC-51803,INGXCNVWWKKWOO-LJQANCHMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
102463,6vxs,DB07426,-8.7,"[1-HYDROXY-2-(1,1':3',1''-TERPHENYL-3-YLOXY)ETHANE-1,1-DIYL]BIS(PHOSPHONIC ACID)",NWIARQRYIRVYCM-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
136610,6w9c,DB07323,-8.7,"2-[({2-[(1Z)-3-(DIMETHYLAMINO)PROP-1-ENYL]-4-FLUOROPHENYL}SULFONYL)AMINO]-5,6,7,8-TETRAHYDRONAPHTHALENE-1-CARBOXYLIC ACID",CTZLIARLNXSXGL-ALCCZGGFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
133584,6w9c,DB01876,-8.7,Bis(5-Amidino-2-Benzimidazolyl)Methanone,VVVXDHROXQUONB-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
70176,6lxt,DB12269,-8.7,PF-06273340,BPIWZDNVMQQBQX-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
84409,6m3m,DB06090,-8.7,Bradanicline,OXKRFEWMSWPKKV-GHTZIAJQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
160853,7bv1,DB11819,-8.7,ASP-4058,NJNXCJPSMWKXHO-VIFPVBQESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
55923,6crv,DB01640,-8.7,"(5r)-6-(4-{[2-(3-Iodobenzyl)-3-Oxocyclohex-1-En-1-Yl]Amino}Phenyl)-5-Methyl-4,5-Dihydropyridazin-3(2h)-One",QNURTFDBHAQRSI-OAHLLOKOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58377,6crv,DB04942,-8.7,Tamibarotene,MUTNCGKQJGXKEM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
164107,7bv1,DB07267,-8.7,2-(6-methylpyridin-2-yl)-N-pyridin-4-ylquinazolin-4-amine,JONFDFIXMPXTRH-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
82633,6m3m,DB02804,-8.7,A-98881,PMBZSBGCSQGJAQ-GRKNLSHJSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84606,6m3m,DB06608,-8.7,Tafenoquine,LBHLFPGPEGDCJG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
133549,6w9c,DB01830,-8.7,"{4-[2-Acetylamino-2-(3-Carbamoyl-2-Cyclohexylmethoxy-6,7,8,9-Tetrahydro-5h-Benzocyclohepten-5ylcarbamoyl)-Ethyl]-2-Phosphono-Phenyl}-Phosphonic Acid",SPSGYTWOIGAABK-DQEYMECFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
104585,6vxs,DB12222,-8.7,Lurtotecan,RVFGKBWWUQOIOU-NDEPHWFRSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102313,6vxs,DB07255,-8.7,"N'-(5-CHLORO-1,3-BENZODIOXOL-4-YL)-N-(3-MORPHOLIN-4-YLPHENYL)PYRIMIDINE-2,4-DIAMINE",PNEWIQAEGKQNCE-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
71605,6lxt,DB14885,-8.7,PF-05180999,CLGCHUKGBICQTE-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
81699,6m3m,DB01568,-8.7,Codeine-N-oxide,BDLSDHWCOJPHIE-KFUGMXNISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
140738,6w9c,DB15212,-8.7,Pemafibrate,ZHKNLJLMDFQVHJ-RUZDIDTESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
81183,6m3m,DB00904,-8.7,Ondansetron,FELGMEQIXOGIFQ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
26469,6cs2,DB04609,-8.7,INHIBITOR Q8467 OF DUPONT MERCK,HFLCERPZYCWLSZ-VKONIRKNSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
85384,6m3m,DB07595,-8.7,"(5Z)-5-(3-BROMOCYCLOHEXA-2,5-DIEN-1-YLIDENE)-N-(PYRIDIN-4-YLMETHYL)-1,5-DIHYDROPYRAZOLO[1,5-A]PYRIMIDIN-7-AMINE",WSIQKQLAGWVKSL-UHFFFAOYSA-O,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
135319,6w9c,DB04301,-8.7,Bis(5-Amidino-2-Benzimidazolyl)Methane Ketone Hydrate,ZLAHDRAQCSQPOC-UHFFFAOYSA-P,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
84380,6m3m,DB05861,-8.7,Tasquinimod,ONDYALNGTUAJDX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
82680,6m3m,DB02861,-8.7,"4-(Aminosulfonyl)-N-[(3,4,5-Trifluorophenyl)Methyl]-Benzamide",DEHMSTGBNAXEGX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84950,6m3m,DB07090,-8.7,(3S)-N-(3-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE,NJNMAZNXKKBTPS-ZDUSSCGKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
160843,7bv1,DB11804,-8.7,AZD-5672,SCXSQUUTGCWHFU-WJOKGBTCSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
104559,6vxs,DB12183,-8.7,Sapitinib,DFJSJLGUIXFDJP-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104278,6vxs,DB11769,-8.7,Funapide,NEBUOXBYNAHKFV-NRFANRHFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
84386,6m3m,DB05903,-8.7,KOS-1584,XAYAKDZVINDZGB-BMVMHAJPSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58932,6crv,DB06879,-8.7,"5-(4'-AMINO-1'-ETHYL-5',8'-DIFLUORO-1'H-SPIRO[PIPERIDINE-4,2'-QUINAZOLINE]-1-YLCARBONYL)PICOLINONITRILE",QCFIRACCCDFXIP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136406,6w9c,DB07081,-8.7,"(2R)-4-[(8R)-8-METHYL-2-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[1,5-A]PYRAZIN-7(8H)-YL]-4-OXO-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE",FDEXEPZGMKFCTG-PSASIEDQSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
56936,6crv,DB02976,-8.7,Uridine-5'-monophosphate 2-deoxy-2-fluoro-galactopyranosyl-monophosphate ester,NGTCPFGWXMBZEP-KBQKSTHMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
102386,6vxs,DB07333,-8.7,"N-(CYCLOPROPYLMETHYL)-4-(METHYLOXY)-3-({5-[3-(3-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-YL}AMINO)BENZENESULFONAMIDE",KRGKAARWVPUWSY-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
55868,6crv,DB01571,-8.7,3-Methylfentanyl,MLQRZXNZHAOCHQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27470,6cs2,DB07015,-8.7,"(3R,4R)-4-(pyrrolidin-1-ylcarbonyl)-1-(quinoxalin-2-ylcarbonyl)pyrrolidin-3-amine",XDSKICAQKGYYJF-OLZOCXBDSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
55878,6crv,DB01586,-8.7,Ursodeoxycholic acid,RUDATBOHQWOJDD-UZVSRGJWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
67465,6lxt,DB06747,-8.7,ginkgolide-M,KDKROYXEHCYLJQ-FJFAJXJPSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
27514,6cs2,DB07058,-8.7,"5-[1-(4-methoxyphenyl)-1H-benzimidazol-6-yl]-1,3,4-oxadiazole-2(3H)-thione",QBVJMUOTMRYUKR-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
71552,6lxt,DB14766,-8.7,Etrasimod,MVGWUTBTXDYMND-QGZVFWFLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
106763,6vxx,DB01219,-8.7,Dantrolene,OZOMQRBLCMDCEG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84437,6m3m,DB06176,-8.7,Romidepsin,OHRURASPPZQGQM-GCCNXGTGSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
68461,6lxt,DB07945,-8.7,"5-(3-carbamoylbenzyl)-5,6,7,8,9,10-hexahydrocyclohepta[b]indole-4-carboxylic acid",GKBQRPKZHUFGOB-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
58844,6crv,DB06737,-8.7,Zaltoprofen,MUXFZBHBYYYLTH-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
103205,6vxs,DB08299,-8.7,"4-[8-(3-nitrophenyl)-1,7-naphthyridin-6-yl]benzoic acid",QTNUWEKKZHSUQO-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
58676,6crv,DB06350,-8.7,Elinogrel,LGSDFTPAICUONK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
133709,6w9c,DB02049,-8.7,2-{4-[4-(4-Chloro-Phenoxy)-Benzenesulfonyl]-Tetrahydro-Pyran-4-Yl}-N-Hydroxy-Acetamide,QOPFTBAEAJQKSY-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
82526,6m3m,DB02656,-8.7,LY-294002,CZQHHVNHHHRRDU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136136,6w9c,DB06629,-8.7,Zibotentan,FJHHZXWJVIEFGJ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
160911,7bv1,DB12260,-8.7,Radiprodil,GKGRZLGAQZPEHO-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
136562,6w9c,DB07261,-8.7,"THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [1-(1-AMINO-ISOQUINOLIN-7-YLMETHYL)-2-OXO-PYRROLDIN-3-YL]-AMIDE",NVKDOURNRJCKJE-INIZCTEOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
67444,6lxt,DB06718,-8.7,Stanozolol,LKAJKIOFIWVMDJ-IYRCEVNGSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
85216,6m3m,DB07396,-8.7,"1-{2-[3-(2-Chloro-4,5-difluoro-benzoyl)-ureido]-4-fluoro-phenyl}-piperidine-4-carboxylic acid",KAJJGOCSAXKXBD-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
114729,6vxx,DB14723,-8.7,Larotrectinib,NYNZQNWKBKUAII-KBXCAEBGSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108251,6vxx,DB07536,-8.7,"N-{(1S,2R)-2-hydroxy-1-[(hydroxyamino)carbonyl]propyl}-4-{[4-(morpholin-4-ylmethyl)phenyl]ethynyl}benzamide",FQYBTYFKOHPWQT-VGSWGCGISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
133796,6w9c,DB02164,-8.7,N-Sulfo-Flavin Mononucleotide,ZLPUGFBBLGQWBS-SCRDCRAPSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
128257,6w4h,DB07396,-8.7,"1-{2-[3-(2-Chloro-4,5-difluoro-benzoyl)-ureido]-4-fluoro-phenyl}-piperidine-4-carboxylic acid",KAJJGOCSAXKXBD-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
82510,6m3m,DB02636,-8.7,"9-Hydroxy-8-Methoxy-6-Nitro-Phenanthrol[3,4-D][1,3]Dioxole-5-Carboxylic Acid",UCLGCTLOEZZSLA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136144,6w9c,DB06645,-8.7,Anamorelin,VQPFSIRUEPQQPP-MXBOTTGLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
58824,6crv,DB06710,-8.7,Methyltestosterone,GCKMFJBGXUYNAG-HLXURNFRSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84474,6m3m,DB06249,-8.7,Arzoxifene,MCGDSOGUHLTADD-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
82505,6m3m,DB02628,-8.7,"1-[3,3-Dimethyl-2-(2-Methylamino-Propionylamino)-Butyryl]-Pyrrolidine-2-Carboxylic Acid(1,2,3,4-Tetrahydro-Naphthalen-1-Yl)-Amide",JUJIMRZGUBTJRV-NASSWSRMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
126857,6w4h,DB04392,-8.7,"Bishydroxy[2h-1-Benzopyran-2-One,1,2-Benzopyrone]",HIZKPJUTKKJDGA-BETUJISGSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
104453,6vxs,DB12024,-8.7,PF-04418948,LWJGMYMNSNVCEM-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
164097,7bv1,DB07255,-8.7,"N'-(5-CHLORO-1,3-BENZODIOXOL-4-YL)-N-(3-MORPHOLIN-4-YLPHENYL)PYRIMIDINE-2,4-DIAMINE",PNEWIQAEGKQNCE-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
107985,6vxx,DB06645,-8.7,Anamorelin,VQPFSIRUEPQQPP-MXBOTTGLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58460,6crv,DB05408,-8.7,Emricasan,SCVHJVCATBPIHN-SJCJKPOMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
134771,6w9c,DB03523,-8.7,Brequinar,PHEZJEYUWHETKO-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140436,6w9c,DB06837,-8.7,"(2R)-N-4-hydroxy-2-(3-hydroxybenzyl)-N-1-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]butanediamide",VXDKQRWTOJFQKH-BJZITVGISA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
102533,6vxs,DB07508,-8.7,4-(5-BENZENESULFONYLAMINO-1-METHYL-1H-BENZOIMIDAZOL-2-YLMETHYL)-BENZAMIDINE,MEUAVGJWGDPTLF-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104499,6vxs,DB12095,-8.7,Telotristat ethyl,MDSQOJYHHZBZKA-GBXCKJPGSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
108336,6vxx,DB07638,-8.7,"(3AS,4R,9BR)-2,2-DIFLUORO-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL",QJSMFUTULGSHNQ-ZOBUZTSGSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56841,6crv,DB02854,-8.7,Aetiocholanolone,QGXBDMJGAMFCBF-BNSUEQOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
133627,6w9c,DB01944,-8.7,(S)-blebbistatin,LZAXPYOBKSJSEX-GOSISDBHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
107974,6vxx,DB05944,-8.7,Varlitinib,UWXSAYUXVSFDBQ-CYBMUJFWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85276,6m3m,DB07467,-8.7,"4-chloro-N-[(2S)-2-methyl-2,3-dihydro-1H-indol-1-yl]-3-sulfamoylbenzamide",NDDAHWYSQHTHNT-JTQLQIEISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81679,6m3m,DB01548,-8.7,Diprenorphine,OIJXLIIMXHRJJH-KNLIIKEYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
82554,6m3m,DB02694,-8.7,Pantoyl Adenylate,GDPVENOGSVMRJL-FSRKKXLISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
126504,6w4h,DB03916,-8.7,4-{2-[4-(2-Aminoethyl)Piperazin-1-Yl]Pyridin-4-Yl}-N-(3-Chloro-4-Methylphenyl)Pyrimidin-2-Amine,RHOOHUMOHVIXEF-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
66853,6lxt,DB04739,-8.7,4-[(4-METHYL-1-PIPERAZINYL)METHYL]-N-[3-[[4-(3-PYRIDINYL)-2-PYRIMIDINYL]AMINO]PHENYL]-BENZAMIDE,JHMBUEWQJDGKGS-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
136248,6w9c,DB06897,-8.7,"3-[3-chloro-5-(5-{[(1S)-1-phenylethyl]amino}isoxazolo[5,4-c]pyridin-3-yl)phenyl]propan-1-ol",MMGKIHLBFPJYJL-HNNXBMFYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
163945,7bv1,DB06888,-8.7,"(13R,15S)-13-METHYL-16-OXA-8,9,12,22,24-PENTAAZAHEXACYCLO[15.6.2.16,9.1,12,15.0,2,7.0,21,25]HEPTACOSA-1(24),2,4,6,17(25),18,20-HEPTAENE-23,26-DIONE",KBLPHMRCKHFBJB-OLZOCXBDSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
133656,6w9c,DB01977,-8.7,6-(N-Phenylcarbamyl)-2-Naphthalenecarboxamidine,AECPTICWHONWNW-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
108308,6vxx,DB07608,-8.7,N-(5-{[(2S)-4-amino-2-(3-chlorophenyl)butanoyl]amino}-1H-indazol-3-yl)benzamide,JDGOPNUGILVNJZ-IBGZPJMESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
133677,6w9c,DB02008,-8.7,1-(2-Fluorobenzyl)-3-Butyl-8-(N-Acetyl-4-Aminobenzyl)-Xanthine,JHSHXKJSPVHPCJ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
66957,6lxt,DB04872,-8.7,Osanetant,DZOJBGLFWINFBF-UMSFTDKQSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
81319,6m3m,DB01060,-8.7,Amoxicillin,LSQZJLSUYDQPKJ-NJBDSQKTSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
135186,6w9c,DB04099,-8.7,Deamido-Nad+,SENPVEZBRZQVST-HISDBWNOSA-O,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
102612,6vxs,DB07605,-8.7,"2-({4-[(5-CHLORO-1H-INDOL-2-YL)SULFONYL]PIPERAZIN-1-YL}CARBONYL)THIENO[3,2-B]PYRIDINE 4-OXIDE",DHDQMXPAANQKDC-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102614,6vxs,DB07608,-8.7,N-(5-{[(2S)-4-amino-2-(3-chlorophenyl)butanoyl]amino}-1H-indazol-3-yl)benzamide,JDGOPNUGILVNJZ-IBGZPJMESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
58896,6crv,DB06833,-8.7,1-CYCLOHEXYL-N-{[1-(4-METHYLPHENYL)-1H-INDOL-3-YL]METHYL}METHANAMINE,MMIJMYOYKAKQPN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
133175,6w9c,DB01338,-8.7,Pipecuronium,OWWLUIWOFHMHOQ-XGHATYIMSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
135549,6w9c,DB04612,-8.7,"N-METHYLALANYL-3-METHYLVALYL-4-PHENOXY-N-(1,2,3,4-TETRAHYDRONAPHTHALEN-1-YL)PROLINAMIDE",QKPXPZYQPBWDHS-MCJAPYMPSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
85789,6m3m,DB08064,-8.7,N-(3-TERT-BUTYL-1H-PYRAZOL-5-YL)-N'-{4-CHLORO-3-[(PYRIDIN-3-YLOXY)METHYL]PHENYL}UREA,NTMADESEDXKNFZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
72308,6m2n,DB00591,-8.7,Fluocinolone acetonide,FEBLZLNTKCEFIT-VSXGLTOVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
27652,6cs2,DB07203,-8.7,6-CYCLOHEXYLMETHOXY-2-(3'-CHLOROANILINO) PURINE,OUEGMEMDEAOAEG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
136347,6w9c,DB07014,-8.7,"2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4-methoxybenzyl)sulfanyl]-1,3,4-oxadiazole",TUTZKAQTSPMEBI-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
83592,6m3m,DB04092,-8.7,Apstatin,YVUUZAPYLPWFHE-HXFGRODQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
8199,6lzg,DB04881,-8.7,Elacridar,OSFCMRGOZNQUSW-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
83997,6m3m,DB04630,-8.7,Aldosterone,PQSUYGKTWSAVDQ-ZVIOFETBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
143094,6w9q,DB03067,-8.7,"4-{2,4-Bis[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid",VFYAZSTYKPFSFL-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
59444,6crv,DB07470,-8.7,"(3aS)-3a-hydroxy-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one",DOMYOVZXZIZTRD-QGZVFWFLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29839,6cs2,DB11701,-8.7,Amenamevir,MNHNIVNAFBSLLX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
59443,6crv,DB07469,-8.7,"(3aS)-3a-hydroxy-7-methyl-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one",KAJFGRLMKVNMLH-GOSISDBHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59451,6crv,DB07479,-8.7,"(1S)-1,2,3,4-TETRAHYDRO-BENZO[C]PHENANTHRENE-2,3,4-TRIOL",WCUHTHVUZQCBTI-KBAYOESNSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
69747,6lxt,DB11637,-8.7,Delamanid,XDAOLTSRNUSPPH-XMMPIXPASA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
109442,6vxx,DB13580,-8.7,Succinylsulfathiazole,SKVLYVHULOWXTD-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59436,6crv,DB07459,-8.7,4-PHENOXY-N-(PYRIDIN-2-YLMETHYL)BENZAMIDE,HVLSCZSVTCNAQX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27092,6cs2,DB06446,-8.7,Dotarizine,LRMJAFKKJLRDLE-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
162640,7bv1,DB02723,-8.7,"4-Oxo-2-Phenylmethanesulfonyl-Octahydro-Pyrrolo[1,2-a]Pyrazine-6-Carboxylic Acid [1-(N-Hydroxycarbamimidoyl)-Piperidin-4-Ylmethyl]-Amide",DHTSUHWLPAEEQB-OALUTQOASA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59435,6crv,DB07458,-8.7,"3-(1H-indol-3-yl)-4-{1-[2-(1-methylpyrrolidin-2-yl)ethyl]-1H-indol-3-yl}-1H-pyrrole-2,5-dione",LBFDERUQORUFIN-KRWDZBQOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109441,6vxx,DB13579,-8.7,Mepixanox,PYSOHOOUXFWCFF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
124888,6w4h,DB01761,-8.7,4-[5-[2-(1-Phenyl-Ethylamino)-Pyrimidin-4-Yl]-1-Methyl-4-(3-Trifluoromethylphenyl)-1h-Imidazol-2-Yl]-Piperidine,QICPQLFMWYQJGX-SFHVURJKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
80301,6m2n,DB15091,-8.7,Upadacitinib,WYQFJHHDOKWSHR-MNOVXSKESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
63611,6lxt,DB00485,-8.7,Dicloxacillin,YFAGHNZHGGCZAX-JKIFEVAISA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
16611,6cs2,HMDB0003154,-8.7,Canthaxanthin,FDSDTBUPSURDBL-DKLMTRRASA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
137113,6w9c,DB07917,-8.7,4-(BENZHYDRYLOXY)-1-[3-(1H-TETRAAZOL-5-YL)PROPYL]PIPERIDINE,TZQGXAHOROZEKN-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
106051,6vxs,DB14889,-8.7,Derazantinib,KPJDVVCDVBFRMU-AREMUKBSSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
83987,6m3m,DB04616,-8.7,TACRINE(8)-4-AMINOQUINOLINE,UNVOAAWEEGAXTN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
99650,6vxs,DB02524,-8.7,"2',3'-O-{4-[Hydroxy(oxido)-??5-azanylidene]-2,6-dinitro-2,5-cyclohexadiene-1,1-diyl}adenosine 5'-(tetrahydrogen triphosphate)",XFMMHXLUHKBKQE-UHEGPQQHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
137157,6w9c,DB07967,-8.7,9-CYCLOPENTYL-6-[2-(3-IMIDAZOL-1-YL-PROPOXY)-PHENYLAMINO]-9H-PURINE-2-CARBONITRILE,JJNKDTWKWYLERH-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
69367,6lxt,DB09073,-8.7,Palbociclib,AHJRHEGDXFFMBM-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
99499,6vxs,DB02338,-8.7,Nadph Dihydro-Nicotinamide-Adenine-Dinucleotidephosphate,ACFIXJIJDZMPPO-NNYOXOHSSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
127708,6w4h,DB06721,-8.7,Gimatecan,UIVFUQKYVFCEKJ-OPTOVBNMSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
105477,6vxs,DB13552,-8.7,Trifluperidol,GPMXUUPHFNMNDH-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
83957,6m3m,DB04576,-8.7,Fleroxacin,XBJBPGROQZJDOJ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
135729,6w9c,DB04861,-8.7,Nebivolol,KOHIRBRYDXPAMZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
84779,6m3m,DB06891,-8.7,"5-{[(4-AMINO-3-CHLORO-5-FLUOROPHENYL)SULFONYL]AMINO}-1,3,4-THIADIAZOLE-2-SULFONAMIDE",HOLJYLOVIHBQHO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83982,6m3m,DB04609,-8.7,INHIBITOR Q8467 OF DUPONT MERCK,HFLCERPZYCWLSZ-VKONIRKNSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136344,6w9c,DB07011,-8.7,"(3S)-1-(1,3-BENZODIOXOL-5-YLMETHYL)-3-[4-(1H-IMIDAZOL-1-YL)PHENOXY]PIPERIDINE",HHOPJGKEAIIIDF-FQEVSTJZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
124841,6w4h,DB01698,-8.7,Rutin,IKGXIBQEEMLURG-NVPNHPEKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
55261,6crv,DB00805,-8.7,Minaprine,LDMWSLGGVTVJPG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109499,6vxx,DB13994,-8.7,AZD-7325,KYDURMHFWXCKMW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
23737,6cs2,DB01340,-8.7,Cilazapril,HHHKFGXWKKUNCY-FHWLQOOXSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
164647,7bv1,DB08248,-8.7,3-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)-BENZENESULFONAMIDE,BKDUVKJYBJDZQW-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
135824,6w9c,DB05212,-8.7,HE3286,JJKOQZHWYLMASZ-FJWDNACWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
132782,6w9c,DB00844,-8.7,Nalbuphine,NETZHAKZCGBWSS-CEDHKZHLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
164642,7bv1,DB08242,-8.7,"N,4-dimethyl-3-[(1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl)amino]benzamide",OYTBZXSFNNAVKU-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
69738,6lxt,DB11616,-8.7,Pirarubicin,KMSKQZKKOZQFFG-YXRRJAAWSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
63578,6lxt,DB00445,-8.7,Epirubicin,AOJJSUZBOXZQNB-VTZDEGQISA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
83986,6m3m,DB04615,-8.7,(S)-tacrine(10)-hupyridone,ROTFGKJJMRTWBD-MHZLTWQESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
109469,6vxx,DB13616,-8.7,Melagatran,DKWNMCUOEDMMIN-PKOBYXMFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30039,6cs2,DB11966,-8.7,BMS-986094,YFXGICNMLCGLHJ-RSKRLRQZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
11045,6lzg,DB11275,-8.7,Epicriptine,SBFXHXZNBNFPHV-PXXBSISHSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
109518,6vxx,DB14035,-8.7,Englitazone,MVDXXGIBARMXSA-PYUWXLGESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
132799,6w9c,DB00862,-8.7,Vardenafil,SECKRCOLJRRGGV-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
109407,6vxx,DB13532,-8.7,Cyclopenthiazide,BKYKPTRYDKTTJY-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86140,6m3m,DB08490,-8.7,CTS-1027,ROSNVSQTEGHUKU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59385,6crv,DB07401,-8.7,METHYL (2Z)-2-(2-{[6-(2-CYANOPHENOXY)PYRIMIDIN-4-YL]OXY}PHENYL)-3-METHOXYACRYLATE,WFDXOXNFNRHQEC-GHRIWEEISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86138,6m3m,DB08488,-8.7,"4-{[(E)-2-(5-CHLOROTHIEN-2-YL)VINYL]SULFONYL}-1-(1H-PYRROLO[3,2-C]PYRIDIN-2-YLMETHYL)PIPERAZIN-2-ONE",PLWVUIRWJVKSSD-XBXARRHUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
105178,6vxs,DB13113,-8.7,JNJ-38877605,JRWCBEOAFGHNNU-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
11042,6lzg,DB11273,-8.7,Dihydroergocornine,SEALOBQTUQIVGU-QNIJNHAOSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
69791,6lxt,DB11701,-8.7,Amenamevir,MNHNIVNAFBSLLX-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
84711,6m3m,DB06800,-8.7,Methylnaltrexone,JVLBPIPGETUEET-WIXLDOGYSA-O,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
127547,6w4h,DB06334,-8.7,Tucidinostat,SZMJVTADHFNAIS-BJMVGYQFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
107337,6vxx,DB03181,-8.7,"2-[4-(4-Hydroxy-3-Isopropyl-Phenoxy)-3,5-Dimethyl-Phenyl]-2h-[1,2,4]Triazine-3,5-Dione",RXQAVKWRCZYGMV-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59361,6crv,DB07373,-8.7,"ANDROSTA-1,4-DIENE-3,17-DIONE",LUJVUUWNAPIQQI-QAGGRKNESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
164542,7bv1,DB08124,-8.7,"3-{[(2,2-DIOXIDO-1,3-DIHYDRO-2-BENZOTHIEN-5-YL)AMINO]METHYLENE}-5-(1,3-OXAZOL-5-YL)-1,3-DIHYDRO-2H-INDOL-2-ONE",FTQYGMLRLRXBPT-IDUWFGFVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
28204,6cs2,DB07786,-8.7,"1-((1R,2S)-1-{2-[2-(4-CHLOROPHENYL)-1,3-BENZOXAZOL-7-YL]ETHYL}-2-HYDROXYPROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE",SMFRBBHLVBWHGB-DJJJIMSYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
84026,6m3m,DB04664,-8.7,Cyclohexyl-pentyl-maltoside,RVTGFZGNOSKUDA-ZNGNCRBCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
127788,6w4h,DB06856,-8.7,6-FLUORO-2-[2-HYDROXY-3-(2-METHYL-CYCLOHEXYLOXY)-PHENYL]-1H-INDOLE-5-CARBOXAMIDINE,HUYQYLFFFNSAAX-BUXKBTBVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
80361,6m2n,DB15206,-8.7,Uprifosbuvir,SFPFZQKYPOWCSI-KHFYHRBSSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
136353,6w9c,DB07021,-8.7,"(7R,8R)-8-(2,4,5-trifluorophenyl)-6,7,8,9-tetrahydroimidazo[1,2-a:4,5-c']dipyridin-7-amine",SOSYXEPELJIJHZ-RNCFNFMXSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
63815,6lxt,DB00734,-8.7,Risperidone,RAPZEAPATHNIPO-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
11751,6lzg,DB12385,-8.7,10-hydroxycamptothecin,HAWSQZCWOQZXHI-FQEVSTJZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
55388,6crv,DB00946,-8.7,Phenprocoumon,DQDAYGNAKTZFIW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55390,6crv,DB00948,-8.7,Mezlocillin,YPBATNHYBCGSSN-VWPFQQQWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107620,6vxx,DB04097,-8.7,Uridine-5'-Diphosphate-4-Deoxy-4-Fluoro-Alpha-D-Galactose,OAPPZHVTNHJVAL-JZMIEXBBSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58010,6crv,DB04434,-8.7,Naphthyridine Inhibitor,YRBHUKMLAGQYHS-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
135853,6w9c,DB05399,-8.7,Succinobucol,RKSMVPNZHBRNNS-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
84015,6m3m,DB04651,-8.7,BIOTINOL-5-AMP,KBOGUFFJCBPJEH-SQGSUPJISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
160129,7bv1,DB07545,-8.7,N-{3-[(4-{[3-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-2-YL)AMINO]PHENYL}CYCLOPROPANECARBOXAMIDE,RDTDWGQDFJPTPD-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
80328,6m2n,DB15141,-8.7,Deutivacaftor,PURKAOJPTOLRMP-ASMGOKTBSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80303,6m2n,DB15096,-8.7,18-methoxycoronaridine,DTJQBBHYRQYDEG-SVBQBFEESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
84728,6m3m,DB06829,-8.7,4-BROMO-3-(CARBOXYMETHOXY)-5-[3-(CYCLOHEXYLAMINO)PHENYL]THIOPHENE-2-CARBOXYLIC ACID,RXDVFLTWXCTCEX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
13103,6lzg,DB14676,-8.7,Fagrocorat,QJJBNCHSWFGXML-KEKPKEOLSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
80309,6m2n,DB15106,-8.7,Surufatinib,TTZSNFLLYPYKIL-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
84792,6m3m,DB06907,-8.7,"2-(2,6-DICHLOROPHENYL)-1,3-BENZOXAZOLE-6-CARBOXYLIC ACID",XVNRKPCHMYOPPL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
140206,6w9c,DB15346,-8.7,GLPG-1205,IRBAWVGZNJIROV-SFHVURJKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
86153,6m3m,DB08503,-8.7,"(3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(4-methylphenyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol",HRCKGDOSPBFICB-MZHQWRCYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
99957,6vxs,DB02932,-8.7,(R)-Bicalutamide,LKJPYSCBVHEWIU-KRWDZBQOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
163730,7bv1,DB06159,-8.7,Rubitecan,VHXNKPBCCMUMSW-FQEVSTJZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
28228,6cs2,DB07809,-8.7,4-({[4-(3-METHYLBENZOYL)PYRIDIN-2-YL]AMINO}METHYL)BENZENECARBOXIMIDAMIDE,MBJYEMUMDMGQQC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
160124,7bv1,DB07539,-8.7,"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZOIC ACID",JLRKRQCTYQGDKJ-GHXNOFRVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
55343,6crv,DB00897,-8.7,Triazolam,JOFWLTCLBGQGBO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
100036,6vxs,DB03044,-8.7,1-(5-Tert-Butyl-2-P-Tolyl-2h-Pyrazol-3-Yl)-3-[4-(2-Morpholin-4-Yl-Ethoxy)-Naphthalen-1-Yl]-Urea,MVCOAUNKQVWQHZ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
161363,7bv1,DB13874,-8.7,Enasidenib,DYLUUSLLRIQKOE-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
67943,6lxt,DB07334,-8.7,"N-[5-(ETHYLSULFONYL)-2-METHOXYPHENYL]-5-[3-(2-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-AMINE",HTIZPBXCJPQDEM-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
59404,6crv,DB07423,-8.7,(2S)-3-[4-(acetylamino)phenoxy]-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide,YVXVTLGIDOACBJ-SFHVURJKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86146,6m3m,DB08496,-8.7,(R)-warfarin,PJVWKTKQMONHTI-HNNXBMFYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
124898,6w4h,DB01774,-8.7,Adenosine-5'-Monophosphate Glucopyranosyl-Monophosphate Ester,WFPZSXYXPSUOPY-ROYWQJLOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
114670,6vxx,DB14631,-8.7,Prednisolone phosphate,JDOZJEUDSLGTLU-VWUMJDOOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109349,6vxx,DB13451,-8.7,Tioclomarol,WRGOVNKNTPWHLZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
11563,6lzg,DB12134,-8.7,Gepotidacin,PZFAZQUREQIODZ-LJQANCHMSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
59397,6crv,DB07415,-8.7,4-[(1S)-1-(3-fluoro-4-methoxyphenyl)-2-(2-methoxy-5-nitrophenyl)ethyl]-1H-imidazol-2-amine,RFLOFHKRBGKCOB-AWEZNQCLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
161317,7bv1,DB13814,-8.7,Talampicillin,SOROUYSPFADXSN-SUWVAFIASA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
58570,6crv,DB06040,-8.7,Filanesib,LLXISKGBWFTGEI-FQEVSTJZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56436,6crv,DB02329,-8.7,Carbenoxolone,OBZHEBDUNPOCJG-WBXJDKIVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55244,6crv,DB00783,-8.7,Estradiol,VOXZDWNPVJITMN-ZBRFXRBCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57670,6crv,DB03970,-8.7,"(7R)-7-(6,7-Dihydro-5H-cyclopenta[d]imidazo[2,1-b][1,3]thiazol-2-yl)-2,7-dihydro-1,4-thiazepine-3,6-dicarboxylic acid",CHNMLWCTGYMVFH-GFCCVEGCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
63245,6crv,DB15425,-8.7,CYC-065,DLPIYBKBHMZCJI-WBVHZDCISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27159,6cs2,DB06603,-8.7,Panobinostat,FPOHNWQLNRZRFC-ZHACJKMWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
127725,6w4h,DB06744,-8.7,ginkgolide-B,SQOJOAFXDQDRGF-MMQTXUMRSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
59561,6crv,DB07612,-8.7,6-(3-AMINOPHENYL)-N-(TERT-BUTYL)-2-(TRIFLUOROMETHYL)QUINAZOLIN-4-AMINE,XQKJVNGGVLHNLA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59557,6crv,DB07608,-8.7,N-(5-{[(2S)-4-amino-2-(3-chlorophenyl)butanoyl]amino}-1H-indazol-3-yl)benzamide,JDGOPNUGILVNJZ-IBGZPJMESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
19316,6cs2,HMDB0043962,-8.7,"TG(16:0/20:0/18:3(9Z,12Z,15Z))",XALHWTWEHSQIBY-ZBQQGBJQSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
86378,6m3m,DB08770,-8.7,"4-{2-[(7-amino-2-furan-2-yl[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-yl)amino]ethyl}phenol",PWTBZOIUWZOPFT-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
105749,6vxs,DB13954,-8.7,Estradiol cypionate,UOACKFBJUYNSLK-XRKIENNPSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
124531,6w4h,DB01261,-8.7,Sitagliptin,MFFMDFFZMYYVKS-SECBINFHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
59544,6crv,DB07589,-8.7,"N-[1-(AMINOMETHYL)CYCLOPROPYL]-3-(BENZYLSULFONYL)-N-2-[(1S)-2,2,2-TRIFLUORO-1-(4-HYDROXYPHENYL)ETHYL]-L-ALANINAMIDE",DWWVPKCSDHDILN-OALUTQOASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136330,6w9c,DB06995,-8.7,N-({4-[(2-aminopyridin-4-yl)oxy]-3-fluorophenyl}carbamoyl)-2-(4-fluorophenyl)acetamide,USBSTVPJNQLYEM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
11627,6lzg,DB12225,-8.7,Beclabuvir,ZTTKEBYSXUCBSE-QDFUAKMASA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
109695,6vxx,DB15151,-8.7,RO-6870810,PKQXLRYFPSZKDU-QFIPXVFZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
16513,6cs2,HMDB0002472,-8.7,"(3a,5b,7a,12a)-24-[(carboxymethyl)amino]-1,12-dihydroxy-24-oxocholan-3-yl-b-D-Glucopyranosiduronic acid",BWWWIHHYPYDOJQ-BSGVGGAOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
70464,6lxt,DB12693,-8.7,Ritanserin,JUQLTPCYUFPYKE-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
57720,6crv,DB04040,-8.7,"N-(2-Morpholin-4-Yl-1-Morpholin-4-Ylmethyl-Ethyl)-3-Nitro-5-(3,4,5-Trihydroxy-6-Hydroxymethyl-Tetrahydro-Pyran-2-Yloxy)-Benzamide",MCMWCTMAKPQTPI-WGNYYXNJSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140690,6w9c,DB13101,-8.7,4SC-202,PRXXYMVLYKJITB-IZZDOVSWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
132672,6w9c,DB00713,-8.7,Oxacillin,UWYHMGVUTGAWSP-JKIFEVAISA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137227,6w9c,DB08043,-8.7,1-[4-(PYRIDIN-4-YLOXY)PHENYL]-3-[3-(TRIFLUOROMETHYL)PHENYL]UREA,DDDLGNOZDKDSEG-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
105739,6vxs,DB13941,-8.7,Piperaquine,UCRHFBCYFMIWHC-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
63272,6crv,DB02639,-8.7,4-methylumbelliferyl alpha-D-glucoside,YUDPTGPSBJVHCN-JZYAIQKZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
6501,6lzg,DB02226,-8.7,"3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-4-Yl]Hexyl]-Phenanthridinium",NAARZDJZGYBXKL-UHFFFAOYSA-O,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
27192,6cs2,DB06666,-8.7,Lixivaptan,PPHTXRNHTVLQED-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
109708,6vxx,DB15186,-8.7,GDC-0084,LGWACEZVCMBSKW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27161,6cs2,DB06605,-8.7,Apixaban,QNZCBYKSOIHPEH-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
27162,6cs2,DB06608,-8.7,Tafenoquine,LBHLFPGPEGDCJG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
128741,6w4h,DB07966,-8.7,[4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]quinazolin-2-yl}amino)phenyl]acetonitrile,NVMCVWOODOWOLT-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
82040,6m3m,DB02023,-8.7,8-Oxo-2'-Deoxy-Guanosine-5'-Monophosphate,AQIVLFLYHYFRKU-VPENINKCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
109753,6vxx,DB15268,-8.7,Afabicin,HFYMDQMXVPJNTH-VQHVLOKHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
98819,6vxs,DB01455,-8.7,19-Nor-5-androstenediol,VVUQRXPUVKXAIO-XFUVECHXSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
72455,6m2n,DB00769,-8.7,Hydrocortamate,FWFVLWGEFDIZMJ-FOMYWIRZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
83752,6m3m,DB04298,-8.7,"3-(4-Amino-2-Tert-Butyl-5-Methyl-Phenylsulfanyl)-6-Cyclopentyl-4-Hydroxy-6-[2-(4-Hydroxy-Phenyl)-Ethyl]-5,6-Dihydro-Pyran-2-One",ZEBFKFGJWHOOST-LJAQVGFWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
124453,6w4h,DB01167,-8.7,Itraconazole,VHVPQPYKVGDNFY-ZPGVKDDISA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
26754,6cs2,DB05039,-8.7,Indacaterol,QZZUEBNBZAPZLX-QFIPXVFZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
128132,6w4h,DB07255,-8.7,"N'-(5-CHLORO-1,3-BENZODIOXOL-4-YL)-N-(3-MORPHOLIN-4-YLPHENYL)PYRIMIDINE-2,4-DIAMINE",PNEWIQAEGKQNCE-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
27172,6cs2,DB06624,-8.7,Taranabant,QLYKJCMUNUWAGO-GAJHUEQPSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
136329,6w9c,DB06994,-8.7,"(2S,3S)-3-{3-[2-chloro-4-(methylsulfonyl)phenyl]-1,2,4-oxadiazol-5-yl}-1-cyclopentylidene-4-cyclopropyl-1-fluorobutan-2-amine",XCCSSVMRGIQMGF-LPHOPBHVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
116114,6w4b,DB01721,-8.7,Analogue of Indinavir Drug,MJIRDPUZGGHJMX-OIVSQUILSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
59594,6crv,DB07648,-8.7,"(2R)-3-{[(4Z)-5,6-DIPHENYL-6,7-DIHYDRO-4H-PYRROLO[2,3-D]PYRIMIDIN-4-YLIDENE]AMINO}PROPANE-1,2-DIOL",TWEONIHFGKSPLC-MRXNPFEDSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109734,6vxx,DB15229,-8.7,CNV-2197944,BLFJGFDZMABYMY-ZDUSSCGKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
166494,7bv1,DB15238,-8.7,Olinciguat,YWQFJNWMWZMXRW-HXUWFJFHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
13248,6lzg,DB15009,-8.7,PF-04937319,MASKQITXHVYVFL-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
137251,6w9c,DB08073,-8.7,(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE,YWTBGJGMTBHQTM-IBGZPJMESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
162380,7bv1,DB01977,-8.7,6-(N-Phenylcarbamyl)-2-Naphthalenecarboxamidine,AECPTICWHONWNW-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
105900,6vxs,DB14568,-8.7,Ivosidenib,WIJZXSAJMHAVGX-DHLKQENFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
103899,6vxs,DB09215,-8.7,Droxicam,OEHFRZLKGRKFAS-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
109725,6vxx,DB15209,-8.7,MK-0736,ORQZQBUNAMJFCY-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
83678,6m3m,DB04200,-8.7,Matairesinol,MATGKVZWFZHCLI-LSDHHAIUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
137244,6w9c,DB08063,-8.7,"1-BENZYL-3-(4-METHOXYPHENYLAMINO)-4-PHENYLPYRROLE-2,5-DIONE",HLZMYWLMBBLASX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
103884,6vxs,DB09199,-8.7,Netoglitazone,PKWDZWYVIHVNKS-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
99483,6vxs,DB02319,-8.7,"5,6-Dihydroxy-Nadp",LRAVAOPKUBJONV-IVCJQJMGSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
134583,6w9c,DB03262,-8.7,"Al-6619, [2h-Thieno[3,2-E]-1,2-Thiazine-6-Sulfonamide,2-(3-Hydroxyphenyl)-3-(4-Morpholinyl)-, 1,1-Dioxide]",PZLYYZPXSSNGJS-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
105734,6vxs,DB13936,-8.7,JNJ-28330835,RYBKPGYFXRNMMU-LBPRGKRZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
80205,6m2n,DB14867,-8.7,Parsaclisib,ZQPDJCIXJHUERQ-QWRGUYRKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137197,6w9c,DB08011,-8.7,"(3E)-5-fluoro-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-1H-indole-2,3-dione 3-oxime",DXIHOIDYHQSQKJ-HMMYKYKNSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
57699,6crv,DB04010,-8.7,2-(3'-Methoxyphenyl) Benzimidazole-4-Carboxamide,NVVWVYYHTKCIAE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
26747,6cs2,DB05015,-8.7,Belinostat,NCNRHFGMJRPRSK-MDZDMXLPSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
127211,6w4h,DB04861,-8.7,Nebivolol,KOHIRBRYDXPAMZ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
124622,6w4h,DB01436,-8.7,Alfacalcidol,OFHCOWSQAMBJIW-AVJTYSNKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
105569,6vxs,DB13676,-8.7,Mosapramine,PXUIZULXJVRBPC-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
27124,6cs2,DB06519,-8.7,Edaglitazone,HAAXAFNSRADSMK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
128641,6w4h,DB07848,-8.7,5-Chloro-N-{(3S)-1-[(2S)-1-(4-morpholinyl)-1-oxo-2-propanyl]-2-oxo-3-pyrrolidinyl}-1H-indole-2-sulfonamide,BHNMMFGOJRIAEZ-LRDDRELGSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
137186,6w9c,DB07999,-8.7,"{4-[(CARBOXYMETHOXY)CARBONYL]-3,3-DIOXIDO-1-OXONAPHTHO[1,2-D]ISOTHIAZOL-2(1H)-YL}ACETIC ACID",IXLBOIRSEDMRPI-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
99237,6vxs,DB01988,-8.7,6((S)-3-Benzylpiperazin-1-Yl)-3-(Naphthalen-2-Yl)-4-(Pyridin-4-Yl)Pyrazine,WFSFNKVFXLIZIY-MHZLTWQESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
128129,6w4h,DB07252,-8.7,"3-({4-[(5-chloro-1,3-benzodioxol-4-yl)amino]pyrimidin-2-yl}amino)benzenesulfonamide",TZHCXOMEOHEZDX-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
27122,6cs2,DB06515,-8.7,Resiniferatoxin,DSDNAKHZNJAGHN-MXTYGGKSSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
80240,6m2n,DB14934,-8.7,GDC-0927,KJAAPZIFCQQQKX-NDEPHWFRSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
63439,6lxt,DB00276,-8.7,Amsacrine,XCPGHVQEEXUHNC-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
143125,6w9q,DB03104,-8.7,RU82129,NKMPOVPTYDXGEC-MNRBYUMSSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
106009,6vxs,DB14792,-8.7,AZD-5991,KBQCEQAXHPIRTF-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
134540,6w9c,DB03213,-8.7,Bis(5-Amidino-2-Benzimidazolyl)Methane Ketone,VVVXDHROXQUONB-UHFFFAOYSA-P,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
72370,6m2n,DB00670,-8.7,Pirenzepine,RMHMFHUVIITRHF-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
70555,6lxt,DB12843,-8.7,Oleandrin,JLPDBLFIVFSOCC-XYXFTTADSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
63539,6lxt,DB00398,-8.7,Sorafenib,MLDQJTXFUGDVEO-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
56457,6crv,DB02358,-8.7,LY374571,SZHRIPFGZWWRKW-VIFPVBQESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
83906,6m3m,DB04514,-8.7,Phosphoric Acid-2'-[2'-Deoxy-Uridine]Ester-5'-Guanosine Ester,DFYLLEBFVZTKHD-VMIOUTBZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
109650,6vxx,DB15063,-8.7,Inarigivir soproxil,CJCYTUJOSMYXLE-JDLSZIHUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
137219,6w9c,DB08034,-8.7,"(E)-3,4-DIHYDROXY-N'-[(2-METHOXYNAPHTHALEN-1-YL)METHYLENE]BENZOHYDRAZIDE",TVOPERZEGKBKAY-RGVLZGJSSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
86318,6m3m,DB08706,-8.7,"(2S)-({(5Z)-5-[(5-ETHYL-2-FURYL)METHYLENE]-4-OXO-4,5-DIHYDRO-1,3-THIAZOL-2-YL}AMINO)(4-FLUOROPHENYL)ACETIC ACID",RNEACARJKXYVND-MZLJFPOFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
132676,6w9c,DB00717,-8.7,Norethisterone,VIKNJXKGJWUCNN-XGXHKTLJSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
159981,7bv1,DB07152,-8.7,N-[4-(5-fluoro-6-methylpyridin-2-yl)-5-quinoxalin-6-yl-1H-imidazol-2-yl]acetamide,TYPILNNEZPSNTI-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
109682,6vxx,DB15126,-8.7,IMG-7289,KQKBMHGOHXOHTD-KKUQBAQOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
105949,6vxs,DB14664,-8.7,Difluocortolone pivalate,UWGRWFCLGQWKPR-GSTUPEFVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
99160,6vxs,DB01879,-8.7,(S)-2-{Methyl-[2-(Naphthalene-2-Sulfonylamino)-5-(Naphthalene-2-Sulfonyloxy)-Benzoyl]-Amino}-Succinicacid,JOAALZBSMWLOPQ-LJAQVGFWSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
162490,7bv1,DB02338,-8.7,Nadph Dihydro-Nicotinamide-Adenine-Dinucleotidephosphate,ACFIXJIJDZMPPO-NNYOXOHSSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
105961,6vxs,DB14676,-8.7,Fagrocorat,QJJBNCHSWFGXML-KEKPKEOLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
83829,6m3m,DB04409,-8.7,Naphthalene Trisulfonate,ZPBSAMLXSQCSOX-UHFFFAOYSA-K,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
109677,6vxx,DB15120,-8.7,GSK-239512,YFRBKEVUUCQYOW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109672,6vxx,DB15109,-8.7,Ingenol disoxate,GLIUZQUNUNICGS-XUBYYPQFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58541,6crv,DB05830,-8.7,Trestolone,YSGQGNQWBLYHPE-CFUSNLFHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
135784,6w9c,DB04971,-8.7,Reglitazar,QBQLYIISSRXYKL-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
162502,7bv1,DB02354,-8.7,4-{[1-Methyl-5-(2-Methyl-Benzoimidazol-1-Ylmethyl)-1h-Benzoimidazol-2-Ylmethyl]-Amino}-Benzamidine,IRKPNOLLMNHSOU-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
69449,6lxt,DB09209,-8.7,Pholcodine,GPFAJKDEDBRFOS-FKQDBXSBSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
57717,6crv,DB04037,-8.7,"N,N-Bis(4-Chlorobenzyl)-1h-1,2,3,4-Tetraazol-5-Amine",UOUXILZUBDIWQU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
63334,6lxt,DB00157,-8.7,NADH,BOPGDPNILDQYTO-NNYOXOHSSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
161412,7bv1,DB13991,-8.7,Pipequaline,AMEWZCMTSIONOX-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
80194,6m2n,DB14846,-8.7,Bimiralisib,ADGGYDAFIHSYFI-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
166509,7bv1,DB15273,-8.7,VS-4718,IGUBBWJDMLCRIK-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
11613,6lzg,DB12207,-8.7,Verdinexor,OPAKEJZFFCECPN-XQRVVYSFSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
135771,6w9c,DB04942,-8.7,Tamibarotene,MUTNCGKQJGXKEM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
160009,7bv1,DB07183,-8.7,N-(4-phenoxyphenyl)-2-[(pyridin-4-ylmethyl)amino]nicotinamide,CPVRYQAOUPSUDO-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
72397,6m2n,DB00699,-8.7,Nicergoline,YSEXMKHXIOCEJA-FVFQAYNVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
67870,6lxt,DB07256,-8.7,"3-({4-[(5-CHLORO-1,3-BENZODIOXOL-4-YL)AMINO]PYRIMIDIN-2-YL}AMINO)BENZAMIDE",ZVQZIVCQLFGXFZ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
109277,6vxx,DB13002,-8.7,HKI-357,NERXPXBELDBEPZ-RMKNXTFCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
100254,6vxs,DB03325,-8.7,Tyrosyladenylate,MJZAZMKENKZBAJ-QTOWJTHWSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
11551,6lzg,DB12121,-8.7,Entospletinib,XSMSNFMDVXXHGJ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
140598,6w9c,DB12511,-8.7,Imiglitazar,ULVDFHLHKNJICZ-QCWLDUFUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
101264,6vxs,DB04690,-8.7,Camptothecin,VSJKWCGYPAHWDS-FQEVSTJZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
69093,6lxt,DB08703,-8.7,"12-(2-hydroxyethyl)-2-(1-methylethoxy)-13,14-dihydronaphtho[2,1-a]pyrrolo[3,4-c]carbazol-5(12H)-one",FGKKIHITEICGMN-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
28114,6cs2,DB07692,-8.7,"1-[(2,6-difluorophenyl)sulfonyl]-4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)piperazine",SHWNKRPMUBFWKE-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
85930,6m3m,DB08229,-8.7,[N-(3-DIBENZYLCARBAMOYL-OXIRANECARBONYL)-HYDRAZINO]-ACETIC ACID,JGMMFVVACJREFE-KRWDZBQOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
28112,6cs2,DB07689,-8.7,"METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE",NYNAFINLHQEHKU-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
140505,6w9c,DB11978,-8.7,Glasdegib,SFNSLLSYNZWZQG-VQIMIIECSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
160408,7bv1,DB08350,-8.7,"5-[3-(2-METHOXYPHENYL)-1H-PYRROLO[2,3-B]PYRIDIN-5-YL]-N,N-DIMETHYLPYRIDINE-3-CARBOXAMIDE",GYQRHHQPEMOLKH-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
107316,6vxx,DB03154,-8.7,{[7-(Difluoro-Phosphono-Methyl)-Naphthalen-2-Yl]-Difluoro-Methyl}-Phosphonic Acid,VHKBLEYUHBIBNR-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109077,6vxx,DB12002,-8.7,AZD-4818,HVTUHSABWJPWNK-SFHVURJKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
125332,6w4h,DB02358,-8.7,LY374571,SZHRIPFGZWWRKW-VIFPVBQESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
140719,6w9c,DB15183,-8.7,Fosmanogepix,JQONJQKKVAHONF-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
133076,6w9c,DB01180,-8.7,Rescinnamine,SZLZWPPUNLXJEA-LAFLMMDJSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
28108,6cs2,DB07685,-8.7,"4-{[5-(CYCLOHEXYLMETHOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE",NMAZGYDYIYLSLJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
11847,6lzg,DB12511,-8.7,Imiglitazar,ULVDFHLHKNJICZ-QCWLDUFUSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
55535,6crv,DB01116,-8.7,Trimethaphan,CHQOEHPMXSHGCL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
69934,6lxt,DB11911,-8.7,Galunisertib,IVRXNBXKWIJUQB-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
84835,6m3m,DB06955,-8.7,"3,4-bis(7-chloro-1H-indol-3-yl)-1H-pyrrole-2,5-dicarboxylic acid",OAMCCJASDLMTOO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
140309,6w9c,DB02789,-8.7,Pregnenolone,ORNBQBCIOKFOEO-QGVNFLHTSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
85906,6m3m,DB08195,-8.7,(1R)-2-[(CYANOMETHYL)AMINO]-1-({[2-(DIFLUOROMETHOXY)BENZYL]SULFONYL}METHYL)-2-OXOETHYL MORPHOLINE-4-CARBOXYLATE,YKWHKILAGONYKL-HNNXBMFYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85889,6m3m,DB08173,-8.7,5-CHLORO-N-(2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO)ETHYL)THIOPHENE-2-CARBOXAMIDE,UCKHUNHXYMAFQM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
164443,7bv1,DB07835,-8.7,"N-3-cyclopropyl-N-4-'-(cyclopropylmethyl)-6-methylbiphenyl-3,4'-dicarboxamide",BOPSUAHGQHFKGG-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
83163,6m3m,DB03509,-8.7,2-(4-Chlorophenyl)-5-Quinoxalinecarboxamide,FLYGLPYJEQPCFY-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
101263,6vxs,DB04689,-8.7,2-{5-[3-(6-BENZOYL-1-PROPYLNAPHTHALEN-2-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID,ZXWVCCFKIRBLDP-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101260,6vxs,DB04685,-8.7,"1-{(2S,5S)-4-FLUORO-5-[(TRITYLOXY)METHYL]TETRAHYDROFURAN-2-YL}PYRIMIDINE-2,4(1H,3H)-DIONE",GJNIPWYJQUGERM-BFLUCZKCSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
83210,6m3m,DB03585,-8.7,Oxyphenbutazone,HFHZKZSRXITVMK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80576,6m3m,DB00178,-8.7,Ramipril,HDACQVRGBOVJII-JBDAPHQKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
55516,6crv,DB01094,-8.7,Hesperetin,AIONOLUJZLIMTK-AWEZNQCLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106231,6vxs,DB15282,-8.7,Fluorofuranylnorprogesterone F-18,VJKRBRUNEOHPBS-JQKUZGBFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101060,6vxs,DB04424,-8.7,RPR128515,XFKVLKLCLYJKNF-MZNJEOGPSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
58139,6crv,DB04600,-8.7,"4-[(3-BROMO-4-O-SULFAMOYLBENZYL)(4-CYANOPHENYL)AMINO]-4H-[1,2,4]-TRIAZOLE",GHDKYBCUDPSXGJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81907,6m3m,DB01838,-8.7,"6,4'-Dihydroxy-3-Methyl-3',5'-Dibromoflavone",GKDYOXMZSXVKPP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
27027,6cs2,DB06267,-8.7,Udenafil,IYFNEFQTYQPVOC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
69917,6lxt,DB11890,-8.7,Cilengitide,AMLYAMJWYAIXIA-VWNVYAMZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
162036,7bv1,DB01336,-8.7,Metocurine,JFXBEKISTKFVAB-AJQTZOPKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
140707,6w9c,DB15151,-8.7,RO-6870810,PKQXLRYFPSZKDU-QFIPXVFZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
80499,6m2n,DB03453,-8.7,Methyl (2S)-2-[[2-[(3R)-1-carbamimidoylpiperidin-3-yl]acetyl]amino]-3-[4-(2-phenylethynyl)phenyl]propanoate,MRNGXYMKYHNMLV-PKTZIBPZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
101100,6vxs,DB04477,-8.7,"N-1,2,3,4-Tetrahydronaphth-1-Yl-2'-[3,5-Dimethoxybenzamido]-2'-Deoxy-Adenosine",FDZQGEIYGFPMOB-ZUURFMEUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
135620,6w9c,DB04716,-8.7,"2-(1,1-DIMETHYLETHYL)9-FLUORO-3,6-DIHYDRO-7H-BENZ[H]-IMIDAZ[4,5-F]ISOQUINOLIN-7-ONE",VNDWQCSOSCCWIP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
163719,7bv1,DB06144,-8.7,Sertindole,GZKLJWGUPQBVJQ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
136360,6w9c,DB07029,-8.7,"4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMIDAZOL-1-YL)PHENOXY]-6-METHYLPYRIMIDINE",QQBNDYARFVOEGW-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
106242,6vxs,DB15297,-8.7,Petesicatib,KXAAIORSMACJSI-AEFFLSMTSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
109102,6vxx,DB12379,-8.7,Indirubin,CRDNMYFJWFXOCH-BUHFOSPRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57307,6crv,DB03480,-8.7,Brequinar Analog,WYKKHJQZENLZID-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29850,6cs2,DB11718,-8.7,Encorafenib,CMJCXYNUCSMDBY-ZDUSSCGKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
59232,6crv,DB07227,-8.7,4-[(5-{[4-(3-CHLOROPHENYL)-3-OXOPIPERAZIN-1-YL]METHYL}-1H-IMIDAZOL-1-YL)METHYL]BENZONITRILE,JNUGFGAVPBYSHF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104964,6vxs,DB12781,-8.7,Balaglitazone,IETKPTYAGKZLKY-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
109086,6vxx,DB12355,-8.7,Netazepide,YDZYKNJZCVIKPP-VWLOTQADSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
135648,6w9c,DB04759,-8.7,"PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-(3-METHYL-BENZYLAMIDE)",GTBUZLPQANSGGE-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136372,6w9c,DB07041,-8.7,"N-[2-(2,4-diaminopyrido[2,3-d]pyrimidin-7-yl)-2-methylpropyl]-4-phenoxybenzamide",FDJWFDQRPKKBFA-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
134410,6w9c,DB03041,-8.7,UDP-alpha-D-glucuronic acid,HDYANYHVCAPMJV-LXQIFKJMSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
72023,6m2n,DB00246,-8.7,Ziprasidone,MVWVFYHBGMAFLY-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
84823,6m3m,DB06940,-8.7,"N-ethyl-4-{[5-(methoxycarbamoyl)-2-methylphenyl]amino}-5-methylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide",ZZTMFGIGOADCFX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
161433,7bv1,DB14034,-8.7,Darglitazone,QQKNSPHAFATFNQ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160419,7bv1,DB08362,-8.7,"N-(3-(8-CYANO-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZIN-2-YLAMINO)PHENYL)ACETAMIDE",QVKXQLGRDOMAGC-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
83151,6m3m,DB03495,-8.7,"4,6-Dideoxy-4-{[4,5,6-Trihydroxy-3-(Hydroxymethyl)Cyclohex-2-En-1-Yl]Amino}-Alpha-D-Lyxo-Hexopyranosyl-(1->4)-Alpha-D-Threo-Hexopyranosyl-(1->6)-Alpha-L-Threo-Hexopyranose",FZLCJZILHGFQLM-PISLJJGOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
140593,6w9c,DB12505,-8.7,E-7820,LWGUASZLXHYWIV-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
58607,6crv,DB06188,-8.7,Ispinesib,QJZRFPJCWMNVAV-HHHXNRCGSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140325,6w9c,DB03453,-8.7,Methyl (2S)-2-[[2-[(3R)-1-carbamimidoylpiperidin-3-yl]acetyl]amino]-3-[4-(2-phenylethynyl)phenyl]propanoate,MRNGXYMKYHNMLV-PKTZIBPZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
64760,6lxt,DB01948,-8.7,"1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperidin-4-Yl-3,4-Dihydroquinolin-2(1h)-One",VXIYTVJEIXMAQF-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
85818,6m3m,DB08099,-8.7,"6-ethyl-5-[(2S)-1-(3-methoxypropyl)-2-phenyl-1,2,3,4-tetrahydroquinolin-7-yl]pyrimidine-2,4-diamine",UOYVKYJWAXJTTE-NRFANRHFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
104893,6vxs,DB12669,-8.7,4SC-203,MAFACRSJGNJHCF-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
133141,6w9c,DB01260,-8.7,Desonide,WBGKWQHBNHJJPZ-LECWWXJVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
30079,6cs2,DB12022,-8.7,Evatanepag,WOHRHWDYFNWPNG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
80703,6m3m,DB00327,-8.7,Hydromorphone,WVLOADHCBXTIJK-YNHQPCIGSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
142480,6w9q,DB02258,-8.7,SR11254,RNZIUDLOJHVHLZ-VYIQYICTSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
59165,6crv,DB07147,-8.7,"methyl (1R,2S)-2-(hydroxycarbamoyl)-1-{4-[(2-methylquinolin-4-yl)methoxy]benzyl}cyclopropanecarboxylate",HJWMYFBKJRVWJY-YKSBVNFPSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58174,6crv,DB04644,-8.7,"4-{4-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-2,3-DIMETHYL-PHENOXY}-BUTYRIC ACID",FCEMCUPAYRPTLS-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55603,6crv,DB01192,-8.7,Oxymorphone,UQCNKQCJZOAFTQ-ISWURRPUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
83139,6m3m,DB03478,-8.7,2'-O-Acetyl Adenosine-5-Diphosphoribose,BFNOPXRXIQJDHO-DLFWLGJNSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80729,6m3m,DB00358,-8.7,Mefloquine,XEEQGYMUWCZPDN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83137,6m3m,DB03476,-8.7,Trans-6-(2-Phenylcyclopropyl)-Naphthalene-2-Carboxamidine,NQRIWXVAIWPBEM-OALUTQOASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
64947,6lxt,DB02196,-8.7,Uridine-Diphosphate-N-Acetylgalactosamine,LFTYTUAZOPRMMI-NESSUJCYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
58502,6crv,DB05586,-8.7,Facinicline,TXCYUSKWBHUVEP-CYBMUJFWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27003,6cs2,DB06229,-8.7,Ocaperidone,ZZQNEJILGNNOEP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
101554,6vxs,DB05553,-8.7,Regrelor,NXHAXEBZOXCDKD-XIXRRVGJSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
70600,6lxt,DB12910,-8.7,Emicerfont,JFHJGXQFESYQGY-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
140733,6w9c,DB15205,-8.7,Capromorelin,KVLLHLWBPNCVNR-SKCUWOTOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
83152,6m3m,DB03496,-8.7,Alvocidib,BIIVYFLTOXDAOV-YVEFUNNKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
64683,6lxt,DB01836,-8.7,"[4-(6-Chloro-Naphthalene-2-Sulfonyl)-Piperazin-1-Yl]-(3,4,5,6-Tetrahydro-2h-[1,4']Bipyridinyl-4-Yl)-Methanone",ZLAKCKVFSRSENR-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
85850,6m3m,DB08133,-8.7,N-(4-sulfamoylphenyl)-1H-indazole-3-carboxamide,MNHPHKFLWAPNOV-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80695,6m3m,DB00317,-8.7,Gefitinib,XGALLCVXEZPNRQ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
101384,6vxs,DB04849,-8.7,Cediranib,XXJWYDDUDKYVKI-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
80636,6m3m,DB00248,-8.7,Cabergoline,KORNTPPJEAJQIU-KJXAQDMKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
109051,6vxx,DB11962,-8.7,GSK-1059615,QDITZBLZQQZVEE-YBEGLDIGSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104915,6vxs,DB12706,-8.7,Seletalisib,LNLJHGXOFYUARS-OAQYLSRUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
28089,6cs2,DB07664,-8.7,"5-AMINO-3-{[4-(AMINOSULFONYL)PHENYL]AMINO}-N-(2,6-DIFLUOROPHENYL)-1H-1,2,4-TRIAZOLE-1-CARBOTHIOAMIDE",ARIOBGGRZJITQX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
104912,6vxs,DB12703,-8.7,Omipalisib,CGBJSGAELGCMKE-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
128454,6w4h,DB07630,-8.7,"N-((1R,2R)-2-(5-CHLORO-1H-INDOLE-2-CARBOXAMIDO)CYCLOHEXYL)-5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE-2-CARBOXAMIDE",ARPFWVKYXJZULB-IAGOWNOFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
101393,6vxs,DB04862,-8.7,Merimepodib,JBPUGFODGPKTDW-SFHVURJKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101394,6vxs,DB04863,-8.7,Lefradafiban,PGCFXITVMNNKON-ROUUACIJSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
55556,6crv,DB01140,-8.7,Cefadroxil,BOEGTKLJZSQCCD-UEKVPHQBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80652,6m3m,DB00267,-8.7,Cefmenoxime,HJJDBAOLQAWBMH-YCRCPZNHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
109061,6vxx,DB11978,-8.7,Glasdegib,SFNSLLSYNZWZQG-VQIMIIECSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85866,6m3m,DB08150,-8.7,"4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-aminium",RZIDZIGAXXNODG-UHFFFAOYSA-O,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80663,6m3m,DB00278,-8.7,Argatroban,KXNPVXPOPUZYGB-IOVMHBDKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
1302,6lzg,HMDB0010356,-8.7,Estriol 3-sulfate 16-glucuronide,ATNWFRGUDKUYOG-SUPAOECSSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
80671,6m3m,DB00287,-8.7,Travoprost,MKPLKVHSHYCHOC-AHTXBMBWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
109018,6vxx,DB11912,-8.7,Lanopepden,SWHNZGMQMGFQGW-MSOLQXFVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84188,6m3m,DB04883,-8.7,Darusentan,FEJVSJIALLTFRP-LJQANCHMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84191,6m3m,DB04886,-8.7,Calanolide A,NIDRYBLTWYFCFV-FMTVUPSXSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85857,6m3m,DB08141,-8.7,"4-{[(2,6-difluorophenyl)carbonyl]amino}-N-[(3S)-piperidin-3-yl]-1H-pyrazole-3-carboxamide",KOMNQBZWMCFDTQ-VIFPVBQESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
71850,6lxt,DB15408,-8.7,Silmitasertib,MUOKSQABCJCOPU-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
135593,6w9c,DB04669,-8.7,TRIAZOLOPYRIMIDINE,YWBFPKPWMSWWEA-UHFFFAOYSA-O,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136856,6w9c,DB07616,-8.7,"4-{[4-(4-fluoro-3-methylphenyl)-1,3-thiazol-2-yl]amino}-2-hydroxybenzoic acid",LKZZDHKJFDTYCH-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
107313,6vxx,DB03148,-8.7,Phosphomethylphosphonic Acid Adenosyl Ester,OLCWZBFDIYXLAA-IOSLPCCCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80661,6m3m,DB00276,-8.7,Amsacrine,XCPGHVQEEXUHNC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
69138,6lxt,DB08749,-8.7,3-(2-AMINO-6-BENZOYLQUINAZOLIN-3(4H)-YL)-N-CYCLOHEXYL-N-METHYLPROPANAMIDE,KTRFBFMYAJOXLG-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
135931,6w9c,DB06117,-8.7,"1alpha,24S-Dihydroxyvitamin D2",ODZFJAXAEXQSKL-WRJREGAQSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
84683,6m3m,DB06743,-8.7,Ginkgolide A,FPUXKXIZEIDQKW-VKMVSBOZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
137024,6w9c,DB07811,-8.7,"N-cyclopropyl-2',6-dimethyl-4'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-3-carboxamide",UBVTVSINEVHYSY-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
106153,6vxs,DB15124,-8.7,PF-05241328,RVTSXVZXEGFIPW-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
136357,6w9c,DB07026,-8.7,"(1S,5S,7R)-N-7-(BIPHENYL-4-YLMETHYL)-N-3-HYDROXY-6,8-DIOXA-3-AZABICYCLO[3.2.1]OCTANE-3,7-DICARBOXAMIDE",PPLDARNGJSQINK-OKZBNKHCSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
100587,6vxs,DB03791,-8.7,"(3-{3-[[2-Chloro-3-(Trifluoromethyl)Benzyl](2,2-Diphenylethyl)Amino]Propoxy}Phenyl)Acetic Acid",NAXSRXHZFIBFMI-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
128535,6w4h,DB07728,-8.7,"2-[2-(2-FLUOROPHENYL)PYRIDIN-4-YL]-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE",XJJYJNMNYDNXNO-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
84088,6m3m,DB04757,-8.7,"GUANOSINE-2',3'-O-METHYLIDENEPHOSPHONATE",GKAPYWCOOQBBHV-KXSYMAMXSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
109235,6vxx,DB12933,-8.7,RO-4987655,FIMYFEGKMOCQKT-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
135673,6w9c,DB04792,-8.7,"2,5-O,O-BIS-{4',4''-AMIDINOPHENYL}-1,4:3,6-DIANHYDRO-D-SORBITOL",CDEVHSIVANGYRI-XMTFNYHQSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
109230,6vxx,DB12927,-8.7,Theodrenaline,WMCMJIGLYZDKRN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109229,6vxx,DB12926,-8.7,Cafedrine,UJSKUDDDPKGBJY-WFASDCNBSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140233,6w9c,DB15408,-8.7,Silmitasertib,MUOKSQABCJCOPU-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
56427,6crv,DB02319,-8.7,"5,6-Dihydroxy-Nadp",LRAVAOPKUBJONV-IVCJQJMGSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
64173,6lxt,DB01147,-8.7,Cloxacillin,LQOLIRLGBULYKD-JKIFEVAISA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
69857,6lxt,DB11799,-8.7,Bictegravir,SOLUWJRYJLAZCX-LYOVBCGYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
55446,6crv,DB01013,-8.7,Clobetasol propionate,CBGUOGMQLZIXBE-XGQKBEPLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
69860,6lxt,DB11804,-8.7,AZD-5672,SCXSQUUTGCWHFU-WJOKGBTCSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
59287,6crv,DB07289,-8.7,5-[3-(BENZYLAMINO)PHENYL]-4-BROMO-3-(CARBOXYMETHOXY)THIOPHENE-2-CARBOXYLIC ACID,XEQPGVUGYAUMSA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80418,6m2n,DB15317,-8.7,Posiphen,PBHFNBQPZCRWQP-AZUAARDMSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
128511,6w4h,DB07700,-8.7,"3-CARBOXAMIDO-1,3,5(10)-ESTRATRIEN-17(R)-SPIRO-2'(5',5'-DIMETHYL-6'OXO)TETRAHYDROPYRAN",YVAJWBACBRSVPR-NDUHRLLKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
80419,6m2n,DB15319,-8.7,VM4-037,QGYZPMXIVNIGKA-GMAHTHKFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
133014,6w9c,DB01108,-8.7,Trilostane,KVJXBPDAXMEYOA-CXANFOAXSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
106149,6vxs,DB15120,-8.7,GSK-239512,YFRBKEVUUCQYOW-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
84067,6m3m,DB04725,-8.7,Licofelone,UAWXGRJVZSAUSZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
106143,6vxs,DB15108,-8.7,Tipranavir C-14,SUJUHGSWHZTSEU-MWQIXQBFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
86058,6m3m,DB08390,-8.7,"(6S)-6-CYCLOPENTYL-6-[2-(3-FLUORO-4-ISOPROPOXYPHENYL)ETHYL]-4-HYDROXY-5,6-DIHYDRO-2H-PYRAN-2-ONE",AKNIHFDXRAOPAI-NRFANRHFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86097,6m3m,DB08439,-8.7,Parecoxib,TZRHLKRLEZJVIJ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
72182,6m2n,DB00438,-8.7,Ceftazidime,ORFOPKXBNMVMKC-DWVKKRMSSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
135862,6w9c,DB05424,-8.7,Canertinib,OMZCMEYTWSXEPZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
69834,6lxt,DB11769,-8.7,Funapide,NEBUOXBYNAHKFV-NRFANRHFSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
106106,6vxs,DB15035,-8.7,Zanubrutinib,RNOAOAWBMHREKO-QFIPXVFZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
109274,6vxx,DB12998,-8.7,PF-00217830,QGNOXTFZOLDODX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
105137,6vxs,DB13055,-8.7,Oteseconazole,IDUYJRXRDSPPRC-NRFANRHFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
58587,6crv,DB06148,-8.7,Mianserin,UEQUQVLFIPOEMF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
63900,6lxt,DB00834,-8.7,Mifepristone,VKHAHZOOUSRJNA-GCNJZUOMSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
163827,7bv1,DB06410,-8.7,Doxercalciferol,HKXBNHCUPKIYDM-CGMHZMFXSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
72148,6m2n,DB00396,-8.7,Progesterone,RJKFOVLPORLFTN-LEKSSAKUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80373,6m2n,DB15229,-8.7,CNV-2197944,BLFJGFDZMABYMY-ZDUSSCGKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
109262,6vxx,DB12974,-8.7,Roniciclib,UELYDGOOJPRWGF-SRQXXRKNSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
132933,6w9c,DB01016,-8.7,Glyburide,ZNNLBTZKUZBEKO-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
162064,7bv1,DB01395,-8.7,Drospirenone,METQSPRSQINEEU-HXCATZOESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
67750,6lxt,DB07117,-8.7,"5-(4-PHENOXYPHENYL)-5-(4-PYRIMIDIN-2-YLPIPERAZIN-1-YL)PYRIMIDINE-2,4,6(2H,3H)-TRIONE",FMKQJGOROFNCGM-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
69253,6lxt,DB08911,-8.7,Trametinib,LIRYPHYGHXZJBZ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
83458,6m3m,DB03909,-8.7,"Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate",UFZTZBNSLXELAL-IOSLPCCCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
164530,7bv1,DB08111,-8.7,"4-[(6-phenyl[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl]phenol",ZGJYGQLGSXWEMY-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
69250,6lxt,DB08907,-8.7,Canagliflozin,XTNGUQKDFGDXSJ-ZXGKGEBGSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
114644,6vxx,DB13941,-8.7,Piperaquine,UCRHFBCYFMIWHC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
26725,6cs2,DB04942,-8.7,Tamibarotene,MUTNCGKQJGXKEM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
128536,6w4h,DB07729,-8.7,3-fluoro-N-[3-(1H-tetrazol-5-yl)phenyl]benzamide,GAKOBKPDJJGRIL-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
135672,6w9c,DB04791,-8.7,"2-O-(4'-AMIDINOPHENYL)-5-O-(3''-AMIDINOPHENYL)-1,4:3,6-DIANHYDRO-D-SORBITOL",DKBAWRNTUZFJKV-BSDSXHPESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
84104,6m3m,DB04778,-8.7,SC45647,LPSXGZAUAOMRNU-FZKQIMNGSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
106183,6vxs,DB15190,-8.7,GLPG-0259,YBFGSJUVEOYPIS-OALUTQOASA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
106217,6vxs,DB15247,-8.7,Vorolanib,KMIOJWCYOHBUJS-HAKPAVFJSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
69891,6lxt,DB11847,-8.7,Cadazolid,XWFCFMXQTBGXQW-GOSISDBHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
70418,6lxt,DB12622,-8.7,Lupeol,MQYXUWHLBZFQQO-QGTGJCAVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
109144,6vxx,DB12432,-8.7,CC-401,XDJCLCLBSGGNKS-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84818,6m3m,DB06933,-8.7,N-(tert-butyl)-4-[5-(pyridin-2-ylamino)quinolin-3-yl]benzenesulfonamide,GJTCKUKIFXWJKG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83376,6m3m,DB03802,-8.7,"1-[4-(Octahydro-Pyrido[1,2-a]Pyrazin-2-Yl)-Phenyl]-2-Phenyl-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol",ZGHFWBDHZZKWSI-LITSAYRRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
133036,6w9c,DB01134,-8.7,Desoxycorticosterone pivalate,VVOIQBFMTVCINR-WWMZEODYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
142649,6w9q,DB02473,-8.7,"6-[N-(1-Isopropyl-3,4-Dihydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine",XRHANBWAKSYPEN-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
28138,6cs2,DB07717,-8.7,"(5S,8R,9S,10S,13R,14S,17S)-13-{2-[(3,5-DIFLUOROBENZYL)OXY]ETHYL}-17-HYDROXY-10-METHYLHEXADECAHYDRO-3H-CYCLOPENTA[A]PHENANTHREN-3-ONE",AJODXHGZHBERGJ-JLYQOUBASA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
84126,6m3m,DB04807,-8.7,4-NITROPHENYL-(6-S-ALPHA-D-XYLOPYRANOSYL)-BETA-D-GLUCOPYRANOSIDE,HQYVHBCTLFPWRQ-ZMFOIVQCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
72052,6m2n,DB00278,-8.7,Argatroban,KXNPVXPOPUZYGB-IOVMHBDKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
85998,6m3m,DB08315,-8.7,"2-AMINO-N,N-BIS(PHENYLMETHYL)-1,3-OXAZOLE-5-CARBOXAMIDE",KIJXWOGFYAWTNC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59251,6crv,DB07250,-8.7,"N'-(5-CHLORO-1,3-BENZODIOXOL-4-YL)-N-(3,4,5- TRIMETHOXYPHENYL)PYRIMIDINE-2,4-DIAMINE",HMKLUOPMOJOUDZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58597,6crv,DB06160,-8.7,Garenoxacin,NJDRXTDGYFKORP-LLVKDONJSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27034,6cs2,DB06281,-8.7,Torcetrapib,CMSGWTNRGKRWGS-NQIIRXRSSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
81917,6m3m,DB01852,-8.7,Kaempherol,IYRMWMYZSQPJKC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
128502,6w4h,DB07689,-8.7,"METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE",NYNAFINLHQEHKU-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
106213,6vxs,DB15241,-8.7,Methylsamidorphan,ATCVVCBJNHXIEX-ZAHKBLQYSA-O,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
58596,6crv,DB06159,-8.7,Rubitecan,VHXNKPBCCMUMSW-FQEVSTJZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140531,6w9c,DB12015,-8.7,Alpelisib,STUWGJZDJHPWGZ-LBPRGKRZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
162934,7bv1,DB03311,-8.7,"3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid [4-(Thiazol-2-Ylsulfamoyl)-Phenyl]-Amide",SXKBTDJJEQQEGE-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
81932,6m3m,DB01873,-8.7,Epothilone D,XOZIUKBZLSUILX-GIQCAXHBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
107663,6vxx,DB04154,-8.7,"N-Methyl-N-[3-(6-Phenyl[1,2,4]Triazolo[4,3-B]Pyridazin-3-Yl)Phenyl]Acetamide",ALBWBHNFOJJMCV-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55469,6crv,DB01039,-8.7,Fenofibrate,YMTINGFKWWXKFG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
83326,6m3m,DB03744,-8.7,"Cp403700, (S)-1-{2-[(5-Chloro-1h-Indole-2-Carbonyl)-Amino]-3-Phenyl-Propionyl}-Azetidine-3-Carboxylate",RONLONYAIBUEKT-IBGZPJMESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84113,6m3m,DB04791,-8.7,"2-O-(4'-AMIDINOPHENYL)-5-O-(3''-AMIDINOPHENYL)-1,4:3,6-DIANHYDRO-D-SORBITOL",DKBAWRNTUZFJKV-BSDSXHPESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
107680,6vxx,DB04172,-8.7,"[2,4,6-Triisopropyl-Phenylsulfonyl-L-[3-Amidino-Phenylalanine]]-Piperazine-N'-Beta-Alanine",WATXEHGLYJKXOF-NDEPHWFRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75504,6m2n,DB04793,-8.6,"1,4:3,6-Dianhydro-2-O-(3-carbamimidoylphenyl)-5-O-(4-carbamimidoylphenyl)-D-glucitol",DKBAWRNTUZFJKV-XMTFNYHQSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
134682,6w9c,DB03397,-8.6,Uridine-Diphosphate-N-Acetylglucosamine,LFTYTUAZOPRMMI-CFRASDGPSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
84707,6m3m,DB06794,-8.6,Lodoxamide,RVGLGHVJXCETIO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88122,6m3m,DB13369,-8.6,Benzilone,ZKCWITXZGWUJAV-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
82122,6m3m,DB02128,-8.6,[1-(3-Hydroxy-2-Oxo-1-Phenethyl-Propylcarbamoyl)2-Phenyl-Ethyl]-Carbamic Acid Pyridin-4-Ylmethyl Ester,QCUBCTPTNWPFBC-ZEQRLZLVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
82200,6m3m,DB02237,-8.6,Maltotetraose,UYQJCPNSAVWAFU-KVXMBEGHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
68028,6lxt,DB07435,-8.6,"1,2,3-TRIHYDROXY-1,2,3,4-TETRAHYDROBENZO[A]PYRENE",GFANZDFKCCJYRF-NSISKUIASA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
88170,6m3m,DB13435,-8.6,Endralazine,ALAXZYHFVBSJKZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
134652,6w9c,DB03355,-8.6,5'-O-(N-(L-Threonyl)-Sulfamoyl)Adenosine,UPVAPSGKXAAHBG-CKTDUXNWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
24491,6cs2,DB02241,-8.6,"8-Benzyl-2-Hydroperoxy-2-(4-Hydroxy-Benzyl)-6-(4-Hydroxy-Phenyl)-2h-Imidazo[1,2-a]Pyrazin-3-One",HOSWCJDTHOAORT-SANMLTNESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
84672,6m3m,DB06729,-8.6,Sulfaphenazole,QWCJHSGMANYXCW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84642,6m3m,DB06684,-8.6,Vilazodone,SGEGOXDYSFKCPT-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
70351,6lxt,DB12515,-8.6,9-aminocamptothecin,FUXVKZWTXQUGMW-FQEVSTJZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
75501,6m2n,DB04790,-8.6,"2,5-bis-O-{3-[amino(imino)methyl]phenyl}-1,4:3,6-dianhydro-D-glucitol",IBIUTOFGXGGVKQ-XMTFNYHQSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
70425,6lxt,DB12635,-8.6,Aleplasinin,HSXLMAFNWCSZGP-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
134889,6w9c,DB03701,-8.6,Vanoxerine,NAUWTFJOPJWYOT-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
134746,6w9c,DB03490,-8.6,"3-Pyridin-4-Yl-2,4-Dihydro-Indeno[1,2-.C.]Pyrazole",NHOACLCXCKJMAK-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
70320,6lxt,DB12467,-8.6,TU-100,KAYRGFYBCCETPE-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
70395,6lxt,DB12580,-8.6,Tradipitant,CAVRKWRKTNINFF-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
136239,6w9c,DB06886,-8.6,N-BENZYLOXYCARBONYL-ALA-PRO-3-AMINO-4-PHENYL-BUTAN-2-OL,MACLRJNEKXUAJK-YDLSIGKMSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
68098,6lxt,DB07519,-8.6,"(6R)-2-amino-6-[2-(3'-methoxybiphenyl-3-yl)ethyl]-3,6-dimethyl-5,6-dihydropyrimidin-4(3H)-one",VDFBMQAUECXNKR-OAQYLSRUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
62097,6crv,DB13078,-8.6,KOSN-1724,JAYGOFBXDFAXBW-CYEKYUJNSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
70363,6lxt,DB12535,-8.6,AC-430,DCRWIATZWHLIPN-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
70372,6lxt,DB12548,-8.6,Sparsentan,WRFHGDPIDHPWIQ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
77247,6m2n,DB08142,-8.6,AT-7519,OVPNQJVDAFNBDN-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
88241,6m3m,DB13534,-8.6,Gedocarnil,SLYDYLLJUXFULK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
75622,6m2n,DB05016,-8.6,Ataluren,OOUGLTULBSNHNF-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77468,6m2n,DB08416,-8.6,"(9BETA,13ALPHA,14BETA,17ALPHA)-2-METHOX1TRA-1,3,5(10)-TRIENE-3,17-DIYL DISULFAMATE",AQSNIXKAKUZPSI-SSTWWWIQSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77334,6m2n,DB08246,-8.6,"(2S)-4-(2,5-DIFLUOROPHENYL)-N,N-DIMETHYL-2-PHENYL-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDE",WFFMEXQHWXEKBV-SFHVURJKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
134662,6w9c,DB03367,-8.6,PF-00356231,VMTJQZUZINLEKC-JOCHJYFZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
134831,6w9c,DB03619,-8.6,Deoxycholic Acid,KXGVEGMKQFWNSR-LLQZFEROSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
88255,6m3m,DB13552,-8.6,Trifluperidol,GPMXUUPHFNMNDH-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
140521,6w9c,DB12002,-8.6,AZD-4818,HVTUHSABWJPWNK-SFHVURJKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
84636,6m3m,DB06673,-8.6,Almorexant,DKMACHNQISHMDN-RPLLCQBOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84687,6m3m,DB06747,-8.6,ginkgolide-M,KDKROYXEHCYLJQ-FJFAJXJPSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88167,6m3m,DB13432,-8.6,Lonazolac,XVUQHFRQHBLHQD-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
130605,6w4h,DB12504,-8.6,JNJ-40346527,BNVPFDRNGHMRJS-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
136258,6w9c,DB06908,-8.6,"(2S)-3-(1-{[2-(2-CHLOROPHENYL)-5-METHYL-1,3-OXAZOL-4-YL]METHYL}-1H-INDOL-5-YL)-2-ETHOXYPROPANOIC ACID",PAWOPJKHTZCKMT-QFIPXVFZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
147384,6w9q,DB11863,-8.6,Alvelestat,QNQZWEGMKJBHEM-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
29841,6cs2,DB11703,-8.6,Acalabrutinib,WDENQIQQYWYTPO-IBGZPJMESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
70331,6lxt,DB12480,-8.6,Betulinic Acid,QGJZLNKBHJESQX-FZFNOLFKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
62039,6crv,DB12988,-8.6,LY-518674,PNHFDVSKDSLUFH-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
82327,6m3m,DB02400,-8.6,"5-Methoxy-1,2-Dimethyl-3-(4-Nitrophenoxymethyl)Indole-4,7-Dione",IBLWSLZYYZHSRG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88125,6m3m,DB13374,-8.6,Vincamine,RXPRRQLKFXBCSJ-GIVPXCGWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
18405,6cs2,HMDB0029164,-8.6,(-)-epicatechin-3'-O-glucuronide,ZZTOVZGFHZQEAT-JUZNXHDUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
84607,6m3m,DB06609,-8.6,Odiparcil,JRHNIQQUVJOPQC-AQNFWKISSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
147358,6w9q,DB11822,-8.6,TMC-647055,UOBYJVFBFSLCTQ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
75603,6m2n,DB04946,-8.6,Iloperidone,XMXHEBAFVSFQEX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
67908,6lxt,DB07297,-8.6,"5,6-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-D]PYRIMIDIN-4-AMINE",PTILEOLOGGMFCS-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
3,6lzg,HMDB0002268,-8.6,Alpha-Cryptoxanthin,ORAKUVXRZWMARG-DWADUKLPSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
77427,6m2n,DB08365,-8.6,"8-bromo-4-(2-chlorophenyl)-N-(2-hydroxyethyl)-6-methyl-1,3-dioxo-1,2,3,6-tetrahydropyrrolo[3,4-e]indole-7-carboxamide",XUAHLMVOYLUYSB-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
140754,6w9c,DB15242,-8.6,MK-0533,STWITCBWQHTJFJ-XMMPIXPASA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
130611,6w4h,DB12511,-8.6,Imiglitazar,ULVDFHLHKNJICZ-QCWLDUFUSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130599,6w4h,DB12491,-8.6,Fasiglifam,BZCALJIHZVNMGJ-HSZRJFAPSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
114730,6vxx,DB14725,-8.6,Cefamandole nafate,RRJHESVQVSRQEX-SUYBPPKGSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
70338,6lxt,DB12494,-8.6,SGI-1776,MHXGEROHKGDZGO-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
77308,6m2n,DB08213,-8.6,"1-METHYL-5-(2-PHENOXYMETHYL-PYRROLIDINE-1-SULFONYL)-1H-INDOLE-2,3-DIONE",PFAYCUAUBOGVDX-AWEZNQCLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77377,6m2n,DB08304,-8.6,"(3R)-3-cyclopentyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2-benzothiazine 1,1-dioxide",QZBQVXXESPXFPZ-QGZVFWFLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
88254,6m3m,DB13551,-8.6,Cinchophen,YTRMTPPVNRALON-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
63229,6crv,DB15396,-8.6,PF-114,SLIVDYMORZGPLW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77205,6m2n,DB08097,-8.6,"2-(2,6-DIFLUOROPHENOXY)-N-(2-FLUOROPHENYL)-9-ISOPROPYL-9H-PURIN-8-AMINE",OGWSGDLIXOEZJG-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76006,6m2n,DB06626,-8.6,Axitinib,RITAVMQDGBJQJZ-FMIVXFBMSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
69931,6lxt,DB11907,-8.6,Rociletinib,HUFOZJXAKZVRNJ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
83179,6m3m,DB03534,-8.6,3-[(Acetyl-Methyl-Amino)-Methyl]-4-Amino-N-Methyl-N-(1-Methyl-1h-Indol-2-Ylmethyl)-Benzamide,AWTBJNJPBKTHEV-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83219,6m3m,DB03596,-8.6,N-[2-(1h-Indol-5-Yl)-Butyl]-4-Sulfamoyl-Benzamide,FSRPBGBMEKDSIJ-CYBMUJFWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
135938,6w9c,DB06144,-8.6,Sertindole,GZKLJWGUPQBVJQ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
135936,6w9c,DB06137,-8.6,KX-01,HUNGUWOZPQBXGX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138955,6w9c,DB12623,-8.6,Taprenepag,MFFBXYNKZHTCEY-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138962,6w9c,DB12637,-8.6,Onapristone,IEXUMDBQLIVNHZ-YOUGDJEHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
83282,6m3m,DB03687,-8.6,4-Diphosphocytidyl-2-C-Methyl-D-Erythritol,YFAUKWZNPVBCFF-XHIBXCGHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
69196,6lxt,DB08815,-8.6,Lurasidone,PQXKDMSYBGKCJA-CVTJIBDQSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
84132,6m3m,DB04816,-8.6,Dantron,QBPFLULOKWLNNW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88851,6m3m,DB14934,-8.6,GDC-0927,KJAAPZIFCQQQKX-NDEPHWFRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
76474,6m2n,DB07249,-8.6,"N-(5-chloro-1,3-benzodioxol-4-yl)-6-methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-amine",QHIMVPIOWKYPSO-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
84125,6m3m,DB04806,-8.6,(5-BROMO-4-CHLORO-3-INDOLYL)-A-D-MANNOSE,OPIFSICVWOWJMJ-HAAGFXOZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
76469,6m2n,DB07244,-8.6,"5-{4-[(3,5-DIFLUOROBENZYL)AMINO]PHENYL}-6-ETHYLPYRIMIDINE-2,4-DIAMINE",SRRWXMSVQYQCRX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
140712,6w9c,DB15163,-8.6,Selatogrel,FYXHWMQPCJOJCH-GMAHTHKFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
135911,6w9c,DB05676,-8.6,Apremilast,IMOZEMNVLZVGJZ-QGZVFWFLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
84116,6m3m,DB04794,-8.6,Bifonazole,OCAPBUJLXMYKEJ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
135902,6w9c,DB05616,-8.6,"4'-Methylene-5,8,10-trideazaaminopterin",NAWXUBYGYWOOIX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
76445,6m2n,DB07212,-8.6,N-(7-CARBAMIMIDOYL-NAPHTHALEN-1-YL)-3-HYDROXY-2-METHYL-BENZAMIDE,NNGZRCYXFBHMRM-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
148058,6w9q,DB12875,-8.6,Mavatrep,ORDHXXHTBUZRCN-NTEUORMPSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
69855,6lxt,DB11796,-8.6,Fostemsavir,SWMDAPWAQQTBOG-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
83419,6m3m,DB03860,-8.6,"N-Butyl-11-[(7r,8r,9s,13s,14s,17s)-3,17-Dihydroxy-13-Methyl-7,8,9,11,12,13,14,15,16,17-Decahydro-6h-Cyclopenta[a]Phenanthren-7-Yl]-N-Methylundecanamide",BVVFOLSZMQVDKV-KXQIQQEYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83435,6m3m,DB03880,-8.6,Batimastat,XFILPEOLDIKJHX-QYZOEREBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84128,6m3m,DB04812,-8.6,Benoxaprofen,MITFXPHMIHQXPI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
130147,6w4h,DB11836,-8.6,Sapanisertib,GYLDXIAOMVERTK-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
84182,6m3m,DB04876,-8.6,Vildagliptin,SYOKIDBDQMKNDQ-XWTIBIIYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
75979,6m2n,DB06578,-8.6,Tonabersat,XLIIRNOPGJTBJD-ROUUACIJSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
135524,6w9c,DB04578,-8.6,"(S)-2-[(R)-3-amino-4-(2-fluorophenyl)butyryl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide",OEVYDSSAPNIURZ-AEFFLSMTSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
76735,6m2n,DB07548,-8.6,"2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUORO-6-PYRIDINYL)METHYL]ACETAMIDE",JXHWVKOKYDAROD-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
84263,6m3m,DB05187,-8.6,Elafibranor,AFLFKFHDSCQHOL-IZZDOVSWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
139214,6w9c,DB13135,-8.6,AGN-201904,PPCGSVWOZKNPCX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
83049,6m3m,DB03348,-8.6,Huperzine B,YYWGABLTRMRUIT-HWWQOWPSSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84257,6m3m,DB05137,-8.6,Lobeline,MXYUKLILVYORSK-HBMCJLEFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83050,6m3m,DB03349,-8.6,8-Bromo-Adenosine-5'-Monophosphate,DNPIJKNXFSPNNY-UUOKFMHZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
61842,6crv,DB12679,-8.6,WP 1066,VFUAJMPDXIRPKO-LQELWAHVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
139213,6w9c,DB13132,-8.6,Artemisinin,BLUAFEHZUWYNDE-NNWCWBAJSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
84251,6m3m,DB05105,-8.6,Pleconaril,KQOXLKOJHVFTRN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
138879,6w9c,DB12394,-8.6,Eleclazine,YNUAEEJQYHYLMS-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
75990,6m2n,DB06597,-8.6,Estradiol sulfamate,YXYXCSOJKUAPJI-ZBRFXRBCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
84248,6m3m,DB05100,-8.6,Prinomastat,YKPYIPVDTNNYCN-INIZCTEOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
69960,6lxt,DB11949,-8.6,Vestipitant,SBBYBXSFWOLDDG-JLTOFOAXSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
139177,6w9c,DB12972,-8.6,Sepranolone,AURFZBICLPNKBZ-FZCSVUEKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
83102,6m3m,DB03421,-8.6,"2-Phenethyl-2,3-Dihydro-Phthalazine-1,4-Dione",JSSVIGGKHIJEHO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
147973,6w9q,DB12729,-8.6,ASP-3026,MGGBYMDAPCCKCT-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
139164,6w9c,DB12949,-8.6,PF-03382792,AGMOFKKOVMRGAK-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
68888,6lxt,DB08454,-8.6,N-(5-METHYL-1H-PYRAZOL-3-YL)-2-PHENYLQUINAZOLIN-4-AMINE,JYCUVOXSZBECAY-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
135564,6w9c,DB04632,-8.6,4-(2-HYDROXYBENZYLAMINO)-N-(3-(4-FLUOROPHENOXY)PHENYL)PIPERIDINE-1-SULFONAMIDE,JHHBGNIRSUTQAS-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
135963,6w9c,DB06194,-8.6,Elocalcitol,LRLWXBHFPGSUOX-GJQYOBCGSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138916,6w9c,DB12561,-8.6,WNT-974,XXYGTCZJJLTAGH-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138926,6w9c,DB12574,-8.6,LY-295501,VAMFSFIPDOODFH-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
61804,6crv,DB12621,-8.6,ST-101,QZWYXEBIQWJXAR-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
135981,6w9c,DB06230,-8.6,Nalmefene,WJBLNOPPDWQMCH-MBPVOVBZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
69837,6lxt,DB11773,-8.6,BMS-903452,OGIAVRWXUPYGGC-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
76396,6m2n,DB07156,-8.6,"(4Z)-6-bromo-4-({[4-(pyrrolidin-1-ylmethyl)phenyl]amino}methylidene)isoquinoline-1,3(2H,4H)-dione",JFEKAVPMVOLVTH-UNOMPAQXSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
139003,6w9c,DB12696,-8.6,BMS-582949,GDTQLZHHDRRBEB-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
83938,6m3m,DB04554,-8.6,8-Bromoadenosine-5'-Diphosphate,KVVVTFSHHQCHNZ-UUOKFMHZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
139035,6w9c,DB12744,-8.6,CGI-1842,ZXBFYBLSJMEBEP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
69372,6lxt,DB09079,-8.6,Nintedanib,XZXHXSATPCNXJR-ZIADKAODSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
130072,6w4h,DB11734,-8.6,Fedovapagon,RUOLFWZIFNQQGH-DEOSSOPVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
83902,6m3m,DB04509,-8.6,N-Methylnaloxonium,PCSQOABIHJXZMR-YNUHATHGSA-O,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
139037,6w9c,DB12746,-8.6,AKN-028,JLRIJKVMMZEKDF-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
89001,6m3m,DB15265,-8.6,USL-311,XNUNVQKARNSSEO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
76278,6m2n,DB07022,-8.6,3-Hydroxypropyl 3-[(7-carbamimidoyl-1-naphthyl)carbamoyl]benzenesulfonate,PXERBGNIBOFZOW-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
69677,6lxt,DB11450,-8.6,Pimobendan,GLBJJMFZWDBELO-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
130049,6w4h,DB11694,-8.6,Ilorasertib,WPHKIQPVPYJNAX-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
76268,6m2n,DB07011,-8.6,"(3S)-1-(1,3-BENZODIOXOL-5-YLMETHYL)-3-[4-(1H-IMIDAZOL-1-YL)PHENOXY]PIPERIDINE",HHOPJGKEAIIIDF-FQEVSTJZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
139031,6w9c,DB12740,-8.6,CC-115,GMYLVKUGJMYTFB-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
89020,6m3m,DB15297,-8.6,Petesicatib,KXAAIORSMACJSI-AEFFLSMTSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
6175,6lzg,DB01678,-8.6,RU84687,SAFPHFWYRLLBFO-NSOVKSMOSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
76183,6m2n,DB06909,-8.6,"1-ethyl-N-(phenylmethyl)-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridine-5-carboxamide",QZGJNFBMYYEFGM-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
83667,6m3m,DB04186,-8.6,"N'-(Pyrrolidino[2,1-B]Isoindolin-4-On-8-Yl)-N-(Pyridin-2-Yl)Urea",KLVYMYQTRZCMLE-CYBMUJFWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83674,6m3m,DB04196,-8.6,Pteroic Acid,JOAQINSXLLMRCV-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
6180,6lzg,DB01685,-8.6,Topiroxostat,UBVZQGOVTLIHLH-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
69536,6lxt,DB09371,-8.6,Norethynodrel,ICTXHFFSOAJUMG-SLHNCBLASA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
130000,6w4h,DB11614,-8.6,Rupatadine,WUZYKBABMWJHDL-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
135798,6w9c,DB05039,-8.6,Indacaterol,QZZUEBNBZAPZLX-QFIPXVFZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
76204,6m2n,DB06930,-8.6,"N-[amino(imino)methyl]-2-(2,5-diphenyl-1H-pyrrol-1-yl)acetamide",WVLDNAVUCUAGDP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
83699,6m3m,DB04226,-8.6,Dihydro-Acarbose,CUAQESWNTOXZJZ-RTNAABQMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
89056,6m3m,DB15377,-8.6,ATB-346,YCNMAPLPQYQJFC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
61701,6crv,DB12459,-8.6,Belotecan,LNHWXBUNXOXMRL-VWLOTQADSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76308,6m2n,DB07054,-8.6,(2R)-1-(DIMETHYLAMINO)-3-{4-[(6-{[2-FLUORO-5-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-4-YL)AMINO]PHENOXY}PROPAN-2-OL,OSCWQKTUILTARV-MRXNPFEDSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
83983,6m3m,DB04610,-8.6,"7,8-dihydro-6-hydroxymethyl-7-methyl-7-[2-phenylethyl]-pterin",XMFJTCGUDFSWSW-INIZCTEOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
69350,6lxt,DB09042,-8.6,Tedizolid phosphate,QCGUSIANLFXSGE-GFCCVEGCSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
83468,6m3m,DB03921,-8.6,4-(3-Pyridin-2-Yl-1h-Pyrazol-4-Yl)Quinoline,IBCXZJCWDGCXQT-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84033,6m3m,DB04678,-8.6,H TYPE II TRISACCHARIDE,PHTAQVMXYWFMHF-QVPNGJTFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83504,6m3m,DB03970,-8.6,"(7R)-7-(6,7-Dihydro-5H-cyclopenta[d]imidazo[2,1-b][1,3]thiazol-2-yl)-2,7-dihydro-1,4-thiazepine-3,6-dicarboxylic acid",CHNMLWCTGYMVFH-GFCCVEGCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
135854,6w9c,DB05408,-8.6,Emricasan,SCVHJVCATBPIHN-SJCJKPOMSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
88940,6m3m,DB15143,-8.6,PF-06650833,JKDGKIBAOAFRPJ-ZBINZKHDSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
76386,6m2n,DB07144,-8.6,"5-[(3R)-3-(5-methoxy-2',6'-dimethylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",XZXVRKHUCSXVBM-AWEZNQCLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76383,6m2n,DB07141,-8.6,"5-[(3R)-3-(5-methoxy-4'-methylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",QVXYJVHNRPNRJL-HNNXBMFYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76382,6m2n,DB07140,-8.6,"5-[(3R)-3-(5-methoxybiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",JPENSYBRTSIYGO-AWEZNQCLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
88950,6m3m,DB15163,-8.6,Selatogrel,FYXHWMQPCJOJCH-GMAHTHKFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84013,6m3m,DB04649,-8.6,TETRAHEDRAL INTERMEDIATE OF BLASTICIDIN S,MVFPGTZTOAHVBP-HXYLPHSESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
69347,6lxt,DB09038,-8.6,Empagliflozin,OBWASQILIWPZMG-QZMOQZSNSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
140654,6w9c,DB13051,-8.6,CH-5132799,JEGHXKRHKHPBJD-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
130115,6w4h,DB11793,-8.6,Niraparib,PCHKPVIQAHNQLW-CQSZACIVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
76138,6m2n,DB06858,-8.6,N-cyclooctylglycyl-N-(4-carbamimidoylbenzyl)-L-prolinamide,MMLOIDMSBRJZAE-FQEVSTJZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
69762,6lxt,DB11663,-8.6,Pictilisib,LHNIIDJUOCFXAP-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
69752,6lxt,DB11645,-8.6,PF-4191834,DVNQWYLVSNPCJZ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
76153,6m2n,DB06875,-8.6,3-(3-FLUORO-4-HYDROXYPHENYL)-7-HYDROXY-1-NAPHTHONITRILE,NSSOSHDCWCMNDM-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
148145,6w9q,DB13005,-8.6,Rebastinib,WVXNSAVVKYZVOE-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
84007,6m3m,DB04642,-8.6,"7-{2,6-DICHLORO-4-[3-(2-CHLORO-BENZOYL)-UREIDO]-PHENOXY}-HEPTANOIC ACID",XQTOWNDCHQJXOQ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
139027,6w9c,DB12732,-8.6,Firategrast,YLFZHHDVRSYTKT-NRFANRHFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
24692,6cs2,DB02473,-8.6,"6-[N-(1-Isopropyl-3,4-Dihydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine",XRHANBWAKSYPEN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
76320,6m2n,DB07067,-8.6,"(2S,3S)-3-{3-[4-(METHYLSULFONYL)PHENYL]-1,2,4-OXADIAZOL-5-YL}-1-OXO-1-PYRROLIDIN-1-YLBUTAN-2-AMINE",SQCDMTZMCHZYGO-FZMZJTMJSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
140661,6w9c,DB13060,-8.6,CEP-37440,BCSHRERPHLTPEE-NRFANRHFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
135724,6w9c,DB04853,-8.6,Binodenoson,XJFMHMFFBSOEPR-DNZQAUTHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
148169,6w9q,DB13042,-8.6,Fenoverine,UBAJTZKNDCEGKL-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
88781,6m3m,DB14775,-8.6,Cavosonstat,BXSZILNGNMDGSL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88780,6m3m,DB14774,-8.6,Balipodect,KVHRYLNQDWXAGI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
69993,6lxt,DB12001,-8.6,Abemaciclib,UZWDCWONPYILKI-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
75886,6m2n,DB06306,-8.6,Onalespib,IFRGXKKQHBVPCQ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138791,6w9c,DB12272,-8.6,Vidupiprant,PFWVGKROPKKEDW-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
77072,6m2n,DB07945,-8.6,"5-(3-carbamoylbenzyl)-5,6,7,8,9,10-hexahydrocyclohepta[b]indole-4-carboxylic acid",GKBQRPKZHUFGOB-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75707,6m2n,DB05498,-8.6,KW-7158,NAFSYPCVPLWHFY-HNNXBMFYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
82502,6m3m,DB02623,-8.6,Aminophosphonic Acid-Guanylate Ester,ZGPDMUBRWRJAQQ-UUOKFMHZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
75724,6m2n,DB05575,-8.6,Motesanib,RAHBGWKEPAQNFF-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77024,6m2n,DB07889,-8.6,"(2S)-1-(Dimethylamino)-3-(4-{[4-(2-methylimidazo[1,2-a]pyridin-3-yl)-2-pyrimidinyl]amino}phenoxy)-2-propanol",VCPXSBULBDYRLT-SFHVURJKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
88519,6m3m,DB13944,-8.6,Testosterone enanthate,VOCBWIIFXDYGNZ-IXKNJLPQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
130524,6w4h,DB12388,-8.6,Evocalcet,RZNUIYPHQFXBAN-XLIONFOSSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
139317,6w9c,DB13312,-8.6,Delapril,WOUOLAUOZXOLJQ-MBSDFSHPSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
77001,6m2n,DB07861,-8.6,(2R)-N-hydroxy-3-naphthalen-2-yl-2-[(naphthalen-2-ylsulfonyl)amino]propanamide,MMOUXLMPQFMDRD-JOCHJYFZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
84466,6m3m,DB06235,-8.6,Vadimezan,XGOYIMQSIKSOBS-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
75688,6m2n,DB05416,-8.6,Cardarine,YDBLKRPLXZNVNB-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
88530,6m3m,DB13957,-8.6,J147,HYMZAYGFKNNHDN-SSDVNMTOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
135179,6w9c,DB04092,-8.6,Apstatin,YVUUZAPYLPWFHE-HXFGRODQSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
88554,6m3m,DB14013,-8.6,SR-9009,MMJJNHOIVCGAAP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
76975,6m2n,DB07831,-8.6,"2-{[(6-OXO-1,6-DIHYDROPYRIDIN-3-YL)METHYL]AMINO}-N-[4-PROPYL-3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE",SHSORWZDEKFFLP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
147631,6w9q,DB12228,-8.6,Telcagepant,CGDZXLJGHVKVIE-DNVCBOLYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
82546,6m3m,DB02684,-8.6,5'-O-(N-(L-Cysteinyl)-Sulfamoyl)Adenosine,FTSDEWPMACCNGN-YTMOPEAISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
135201,6w9c,DB04121,-8.6,Guanosine-3'-Monophosphate-5'-Diphosphate,HEYSFDAMRDTCJM-UUOKFMHZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
75753,6m2n,DB05772,-8.6,Rabeximod,PDNNUMNEXITLCZ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
130493,6w4h,DB12339,-8.6,Radezolid,BTTNOGHPGJANSW-IBGZPJMESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
140553,6w9c,DB12441,-8.6,Tavilermide,DVJXNXPFYJIACK-ULQDDVLXSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
84422,6m3m,DB06148,-8.6,Mianserin,UEQUQVLFIPOEMF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
75761,6m2n,DB05812,-8.6,Abiraterone,GZOSMCIZMLWJML-VJLLXTKPSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76985,6m2n,DB07843,-8.6,5-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1-BENZOTHIOPHENE-2-SULFONAMIDE,LTJNKFUIOOJXNJ-WFASDCNBSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
136157,6w9c,DB06680,-8.6,Asoprisnil,GJMNAFGEUJBOCE-MEQIQULJSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136160,6w9c,DB06684,-8.6,Vilazodone,SGEGOXDYSFKCPT-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
70255,6lxt,DB12379,-8.6,Indirubin,CRDNMYFJWFXOCH-BUHFOSPRSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
88361,6m3m,DB13692,-8.6,Tretoquinol,RGVPOXRFEPSFGH-AWEZNQCLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
62002,6crv,DB12931,-8.6,Fenobam,DWPQODZAOSWNHB-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130583,6w4h,DB12467,-8.6,TU-100,KAYRGFYBCCETPE-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
140746,6w9c,DB15229,-8.6,CNV-2197944,BLFJGFDZMABYMY-ZDUSSCGKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
114679,6vxx,DB14640,-8.6,Isoflupredone acetate,ZOCUOMKMBMEYQV-GSLJADNHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138745,6w9c,DB12210,-8.6,AZD-6280,NVWCZRPXYVDQEE-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
77177,6m2n,DB08063,-8.6,"1-BENZYL-3-(4-METHOXYPHENYLAMINO)-4-PHENYLPYRROLE-2,5-DIONE",HLZMYWLMBBLASX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
88396,6m3m,DB13739,-8.6,Penamecillin,NLOOMWLTUVBWAW-HLLBOEOZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
134929,6w9c,DB03751,-8.6,2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose,YSYKRGRSMLTJNL-URARBOGNSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
130568,6w4h,DB12443,-8.6,Sonedenoson,WUCQGGOGHZRELS-LSCFUAHRSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
140534,6w9c,DB12021,-8.6,Dinaciclib,PIMQWRZWLQKKBJ-SFHVURJKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
70282,6lxt,DB12414,-8.6,Usistapide,WSYALRNYQFNNGP-WJOKGBTCSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
139407,6w9c,DB13425,-8.6,Flutrimazole,QHMWCHQXCUNUAK-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
77165,6m2n,DB08051,-8.6,"(2R)-4-(2-BENZOYL-1,2-DIAZEPAN-1-YL)-4-OXO-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE",XXRHRPGYYNOBHO-QGZVFWFLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
84521,6m3m,DB06395,-8.6,Abafungin,TYBHXIFFPVFXQW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
68262,6lxt,DB07716,-8.6,"(4Z)-2,8:7,12:11,15:14,18:17,22-PENTAANHYDRO-4,5,6,9,10,13,19,20,21-NONADEOXY-D-ARABINO-D-ALLO-D-ALLO-DOCOSA-4,9,20-TRIENITOL",VDRIXSJOPKVWKM-HXGIDPQASA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
5940,6lzg,HMDB0112261,-8.6,"2',3'-Anhydrolutein",HBHHQQIZEXNSHZ-AJGOZXJMSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
77152,6m2n,DB08034,-8.6,"(E)-3,4-DIHYDROXY-N'-[(2-METHOXYNAPHTHALEN-1-YL)METHYLENE]BENZOHYDRAZIDE",TVOPERZEGKBKAY-RGVLZGJSSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
68283,6lxt,DB07741,-8.6,"4-(1R,3AS,4R,8AS,8BR)-[1-DIFLUOROMETHYL-2-(4-FLUOROBENZYL)-3-OXODECAHYDROPYRROLO[3,4-A]PYRROLIZIN-4-YL]BENZAMIDINE",VPNYXOTTXAXSIH-SXYSDOLCSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
75683,6m2n,DB05399,-8.6,Succinobucol,RKSMVPNZHBRNNS-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
147546,6w9q,DB12101,-8.6,CC-220,IXZOHGPZAQLIBH-NRFANRHFSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
70264,6lxt,DB12391,-8.6,Sagopilone,BFZKMNSQCNVFGM-UCEYFQQTSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
82428,6m3m,DB02524,-8.6,"2',3'-O-{4-[Hydroxy(oxido)-??5-azanylidene]-2,6-dinitro-2,5-cyclohexadiene-1,1-diyl}adenosine 5'-(tetrahydrogen triphosphate)",XFMMHXLUHKBKQE-UHEGPQQHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
68305,6lxt,DB07765,-8.6,"METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL](METHYL)AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE",UKCFUFHREWUXJJ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
147549,6w9q,DB12108,-8.6,Taselisib,BEUQXVWXFDOSAQ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
70185,6lxt,DB12280,-8.6,AZD-5423,FCNQMDSJHADDFT-WNSKOXEYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
62004,6crv,DB12935,-8.6,Remogliflozin etabonate,UAOCLDQAQNNEAX-ABMICEGHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
135220,6w9c,DB04144,-8.6,"Cis-[4,5-Bis-(4-Chlorophenyl)-2-(2-Isopropoxy-4-Methoxyphenyl)-4,5-Dihyd Roimidazol-1-Yl]-Piperazin-1-Yl-Methanone",ZXIPEZDMQNYFOO-WUFINQPMSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
70166,6lxt,DB12253,-8.6,GDC-0810,BURHGPHDEVGCEZ-KJGLQBJMSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
130376,6w4h,DB12180,-8.6,Apitolisib,YOVVNQKCSKSHKT-HNNXBMFYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
76841,6m2n,DB07678,-8.6,"(9ALPHA,13BETA,17BETA)-2-[(1Z)-BUT-1-EN-1-YL]ESTRA-1,3,5(10)-TRIENE-3,17-DIOL",ANAMDWGJXBYJEB-OPWFCKQNSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
139260,6w9c,DB13230,-8.6,Gestonorone,GTFUITFQDGVJSK-XGXHKTLJSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
135390,6w9c,DB04405,-8.6,"2-[2-(1,3-Dioxo-1,3-Dihydro-2h-Isoindol-2-Yl)Ethyl]-4-(4'-Ethoxy-1,1'-Biphenyl-4-Yl)-4-Oxobutanoic Acid",AQYSXARQCHHHLK-NRFANRHFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
75824,6m2n,DB06169,-8.6,Indibulin,SOLIIYNRSAWTSQ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
29924,6cs2,DB11818,-8.6,Retosiban,PLVGDGRBPMVYPB-FDUHJNRSSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
139253,6w9c,DB13223,-8.6,Fluocortin,PUWHHWCHAVXSIG-NCLPIGKXSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
130311,6w4h,DB12082,-8.6,Vesnarinone,ZVNYJIZDIRKMBF-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
138848,6w9c,DB12350,-8.6,Rostafuroxin,AEAPORIZZWBIEX-DTBDINHYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140580,6w9c,DB12479,-8.6,Zabofloxacin,ZNPOCLHDJCAZAH-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
18215,6cs2,HMDB0000631,-8.6,Deoxycholic acid glycine conjugate,WVULKSPCQVQLCU-ZMBDPXIHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
68594,6lxt,DB08097,-8.6,"2-(2,6-DIFLUOROPHENOXY)-N-(2-FLUOROPHENYL)-9-ISOPROPYL-9H-PURIN-8-AMINE",OGWSGDLIXOEZJG-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
68725,6lxt,DB08248,-8.6,3-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)-BENZENESULFONAMIDE,BKDUVKJYBJDZQW-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
76796,6m2n,DB07624,-8.6,"1-{[(3R)-3-methyl-4-({4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]phenyl}sulfonyl)piperazin-1-yl]methyl}cyclopropanecarboxamide",YJFULAYRAKPBCY-DYVFJYSZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76792,6m2n,DB07620,-8.6,"2-[(2,4-DICHLORO-5-METHYLPHENYL)SULFONYL]-1,3-DINITRO-5-(TRIFLUOROMETHYL)BENZENE",INAZPZCJNPPHGV-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
68802,6lxt,DB08349,-8.6,"N-cyclopropyl-3-{[1-(2,4-difluorophenyl)-7-methyl-6-oxo-6,7-dihydro-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}-4-methylbenzamide",WMEYCLAVMZKZCS-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
70015,6lxt,DB12036,-8.6,Naquotinib,QKDCLUARMDUUKN-XMMPIXPASA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
138867,6w9c,DB12379,-8.6,Indirubin,CRDNMYFJWFXOCH-BUHFOSPRSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140583,6w9c,DB12483,-8.6,Copanlisib,PZBCKZWLPGJMAO-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
68807,6lxt,DB08354,-8.6,"2-(4-CHLOROBENZYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE",QCVULERVJOYHCP-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
114862,6vxx,DB15292,-8.6,Foliglurax,ZTEDNASHAWNBKQ-NCELDCMTSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136015,6w9c,DB06306,-8.6,Onalespib,IFRGXKKQHBVPCQ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
68814,6lxt,DB08362,-8.6,"N-(3-(8-CYANO-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZIN-2-YLAMINO)PHENYL)ACETAMIDE",QVKXQLGRDOMAGC-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
147864,6w9q,DB12561,-8.6,WNT-974,XXYGTCZJJLTAGH-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
139235,6w9c,DB13185,-8.6,Oxabolone cipionate,KHKDIUPVDIEHAH-KXLSUQFWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
68593,6lxt,DB08096,-8.6,"8-(2-CHLOROPHENYLAMINO)-2-(2,6-DIFLUOROPHENYLAMINO)-9-ETHYL-9H-PURINE-1,7-DIIUM",ZWKOUFZHPNIQSH-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
70088,6lxt,DB12137,-8.6,GSK-256066,JFHROPTYMMSOLG-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
130381,6w4h,DB12186,-8.6,SRT-2104,LAMQVIQMVKWXOC-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
147659,6w9q,DB12267,-8.6,Brigatinib,AILRADAXUVEEIR-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
138809,6w9c,DB12295,-8.6,Evodenoson,SQJXTUJMBYVDBB-RQXXJAGISA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
70162,6lxt,DB12247,-8.6,AZD-4547,VRQMAABPASPXMW-HDICACEKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
61921,6crv,DB12805,-8.6,Ataciguat,PQHLRGARXNPFCF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76927,6m2n,DB07779,-8.6,N-({(2S)-1-[(3R)-3-AMINO-4-(2-FLUOROPHENYL)BUTANOYL]PYRROLIDIN-2-YL}METHYL)BENZAMIDE,ANQHSFFUNMTTRS-MOPGFXCFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
70140,6lxt,DB12221,-8.6,Canrenone,UJVLDDZCTMKXJK-WNHSNXHDSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
130466,6w4h,DB12302,-8.6,CP-724714,LLVZBTWPGQVVLW-SNAWJCMRSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
84381,6m3m,DB05864,-8.6,PPI-2458,QBDVVYNLLXGUGN-XGTBZJOHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
24565,6cs2,DB02331,-8.6,"(2s)-2-[(5-Benzofuran-2-Yl-Thiophen-2-Ylmethyl)-(2,4-Dichloro-Benzoyl)-Amino]-3-Phenyl-Propionic Acid",YBULOUKTPCHXAL-DEOSSOPVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
75796,6m2n,DB06077,-8.6,Lumateperone,HOIIHACBCFLJET-SFTDATJTSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
166588,7bv1,DB15435,-8.6,BMS-986158,KGERZPVQIRYWRK-GDLZYMKVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
76896,6m2n,DB07743,-8.6,"S-[5-(TRIFLUOROMETHYL)-4H-1,2,4-TRIAZOL-3-YL] 5-(PHENYLETHYNYL)FURAN-2-CARBOTHIOATE",VNGWUVBXUIDQTK-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
136085,6w9c,DB06510,-8.6,Muraglitazar,IRLWJILLXJGJTD-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
82725,6m3m,DB02919,-8.6,"2,4-Diamino-6-[N-(3',4',5'-Trimethoxybenzyl)-N-Methylamino]Pyrido[2,3-D]Pyrimidine",PUOZHLHNKHRTOW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
82730,6m3m,DB02925,-8.6,Piretanide,UJEWTUDSLQGTOA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
138830,6w9c,DB12320,-8.6,Palovarotene,YTFHCXIPDIHOIA-DHZHZOJOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
75807,6m2n,DB06137,-8.6,KX-01,HUNGUWOZPQBXGX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
140737,6w9c,DB15209,-8.6,MK-0736,ORQZQBUNAMJFCY-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
75819,6m2n,DB06157,-8.6,Istaroxime,MPYLDWFDPHRTEG-PAAYLBSLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
139266,6w9c,DB13240,-8.6,Cymarin,XQCGNURMLWFQJR-ZNDDOCHDSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
68568,6lxt,DB08068,-8.6,N-[4-CHLORO-3-(PYRIDIN-3-YLOXYMETHYL)-PHENYL]-3-FLUORO-,YQJVDUKATDECHF-ICSRJNTNSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
135360,6w9c,DB04362,-8.6,Adenosine Diphosphate 5-(Beta-Ethyl)-4-Methyl-Thiazole-2-Carboxylic Acid,VGXBGQACJQRWLV-LKGUXBDMSA-K,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
68579,6lxt,DB08079,-8.6,AMG-208,HEAIZQNMNCHNFD-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
76848,6m2n,DB07686,-8.6,"4-{[5-(CYCLOHEXYLAMINO)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE",VPOGRVWIIVMWRI-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
68588,6lxt,DB08091,-8.6,3-FLUORO-5-MORPHOLIN-4-YL-N-[3-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-5-YL]BENZAMIDE,HIUFYIOMUILESI-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
61936,6crv,DB12832,-8.6,Prednimustine,HFVNWDWLWUCIHC-GUPDPFMOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88110,6m3m,DB13355,-8.6,Visnadine,GVBNSPFBYXGREE-CXWAGAITSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
78148,6m2n,DB09378,-8.6,Fluprednisolone,MYYIMZRZXIQBGI-HVIRSNARSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
82060,6m3m,DB02049,-8.6,2-{4-[4-(4-Chloro-Phenoxy)-Benzenesulfonyl]-Tetrahydro-Pyran-4-Yl}-N-Hydroxy-Acetamide,QOPFTBAEAJQKSY-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
64724,6lxt,DB01893,-8.6,N6-Benzyl Adenosine-5'-Diphosphate,MRHGMAGSDAQUFH-LSCFUAHRSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
133110,6w9c,DB01216,-8.6,Finasteride,DBEPLOCGEIEOCV-WSBQPABSSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
62949,6crv,DB14787,-8.6,BMS-830216,YDTUJCNTIMWHPJ-NRFANRHFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78979,6m2n,DB12542,-8.6,GSK-356278,AWDJJMXJUOHGLC-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78982,6m2n,DB12547,-8.6,LY-2886721,NIDRNVHMMDAAIK-YPMLDQLKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
73511,6m2n,DB02128,-8.6,[1-(3-Hydroxy-2-Oxo-1-Phenethyl-Propylcarbamoyl)2-Phenyl-Ethyl]-Carbamic Acid Pyridin-4-Ylmethyl Ester,QCUBCTPTNWPFBC-ZEQRLZLVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78942,6m2n,DB12480,-8.6,Betulinic Acid,QGJZLNKBHJESQX-FZFNOLFKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
132107,6w4h,DB15399,-8.6,BMS-754807,LQVXSNNAFNGRAH-QHCPKHFHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
132118,6w4h,DB15416,-8.6,PX-102,XBUXXJUEBFDQHD-NHCUHLMSSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
64482,6lxt,DB01573,-8.6,Benzylmorphine,RDJGWRFTDZZXSM-RNWLQCGYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
71934,6m2n,DB00146,-8.6,Calcifediol,JWUBBDSIWDLEOM-DTOXIADCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
139985,6w9c,DB14677,-8.6,Gestonorone caproate,XURCMZMFZXXQDJ-UKNJCJGYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
85919,6m3m,DB08213,-8.6,"1-METHYL-5-(2-PHENOXYMETHYL-PYRROLIDINE-1-SULFONYL)-1H-INDOLE-2,3-DIONE",PFAYCUAUBOGVDX-AWEZNQCLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
133075,6w9c,DB01179,-8.6,Podofilox,YJGVMLPVUAXIQN-XVVDYKMHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
85875,6m3m,DB08159,-8.6,"4-(5,11-DIOXO-5H-INDENO[1,2-C]ISOQUINOLIN-6(11H)-YL)BUTANOATE",AHIJTWCJGCWHMT-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85840,6m3m,DB08122,-8.6,"N-METHYL-4-{[(2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]AMINO}BENZENESULFONAMIDE",IKASAFLVQIJQOK-UVTDQMKNSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
133138,6w9c,DB01254,-8.6,Dasatinib,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
71838,6lxt,DB15385,-8.6,Acebilustat,GERJIEKMNDGSCS-DQEYMECFSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
139951,6w9c,DB14641,-8.6,Estriol tripropionate,ONMZMZJEZHMWQL-REUUDLSRSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137809,6w9c,DB08743,-8.6,"2-({8-[(3R)-3-AMINOPIPERIDIN-1-YL]-1,3-DIMETHYL-2,6-DIOXO-1,2,3,6-TETRAHYDRO-7H-PURIN-7-YL}METHYL)BENZONITRILE",XJNKUWDMCBZMTG-OAHLLOKOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
132039,6w4h,DB15257,-8.6,Milademetan,RYAYYVTWKAOAJF-QISPRATLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
78905,6m2n,DB12428,-8.6,PAC-14028,UKGJZDSUJSPAJL-YPUOHESYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
71815,6lxt,DB15333,-8.6,AZD-1386,FPGNKXCEPARJDI-ZDUSSCGKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
132046,6w4h,DB15273,-8.6,VS-4718,IGUBBWJDMLCRIK-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
142372,6w9q,DB02112,-8.6,Zk-806450,DZLGSWPXZYDHBD-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
136829,6w9c,DB07583,-8.6,"(4R,2S)-5'-(4-(4-CHLOROBENZYLOXY)PYRROLIDIN-2-YLMETHANESULFONYL)ISOQUINOLINE",RLNNFNGBXLTQOB-RBUKOAKNSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
80737,6m3m,DB00370,-8.6,Mirtazapine,RONZAEMNMFQXRA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
132049,6w4h,DB15281,-8.6,Ravoxertinib,RZUOCXOYPYGSKL-GOSISDBHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
80732,6m3m,DB00365,-8.6,Grepafloxacin,AIJTTZAVMXIJGM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85802,6m3m,DB08080,-8.6,LATRUNCULIN B,NSHPHXHGRHSMIK-JRIKCGFMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80724,6m3m,DB00353,-8.6,Methylergometrine,UNBRKDKAWYKMIV-QWQRMKEZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
132056,6w4h,DB15292,-8.6,Foliglurax,ZTEDNASHAWNBKQ-NCELDCMTSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
132058,6w4h,DB15294,-8.6,SB-1578,NNXDIGHYPZHXTR-ONEGZZNKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
115237,6w4b,DB00619,-8.6,Imatinib,KTUFNOKKBVMGRW-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
133179,6w9c,DB01347,-8.6,Saprisartan,DUEWVPTZCSAMNB-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
87058,6m3m,DB11772,-8.6,Pilaralisib,QINPEPAQOBZPOF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
79065,6m2n,DB12675,-8.6,PF-04995274,WLLOFQROROXOMO-GOSISDBHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137609,6w9c,DB08504,-8.6,"6-(4-{(1S,2S)-2-AMINO-1-[(DIMETHYLAMINO)CARBONYL]-3-[(3S)-3-FLUOROPYRROLIDIN-1-YL]-3-OXOPROPYL}PHENYL)-1H-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-4-IUM",ZNHVIJAGMFQGMS-IHPCNDPISA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137608,6w9c,DB08503,-8.6,"(3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(4-methylphenyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol",HRCKGDOSPBFICB-MZHQWRCYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
72050,6m2n,DB00276,-8.6,Amsacrine,XCPGHVQEEXUHNC-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
136925,6w9c,DB07698,-8.6,"3-(3-aminophenyl)-N-(3-chlorophenyl)pyrazolo[1,5-a]pyrimidin-5-amine",JDNMRPIWJIDDAY-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
64267,6lxt,DB01260,-8.6,Desonide,WBGKWQHBNHJJPZ-LECWWXJVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
132266,6w9c,DB00224,-8.6,Indinavir,CBVCZFGXHXORBI-PXQQMZJSSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137622,6w9c,DB08521,-8.6,4-[5-(4-FLUORO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-3H-IMIDAZOL-4-YL]-PYRIDINE,CDMGBJANTYXAIV-HHHXNRCGSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
64264,6lxt,DB01254,-8.6,Dasatinib,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
132281,6w9c,DB00240,-8.6,Alclometasone,FJXOGVLKCZQRDN-PHCHRAKRSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
73242,6m2n,DB01767,-8.6,Hemi-Babim,KKJYVDXDZURHMA-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137598,6w9c,DB08493,-8.6,"5-METHYL-3-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.013,18]NONADECA-12(19),13,15,17-TETRAEN-10-YLCARBAMOYL)-HEXANOIC ACID",AKWKBACKRMYPRV-NQIIRXRSSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
63016,6crv,DB14934,-8.6,GDC-0927,KJAAPZIFCQQQKX-NDEPHWFRSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86017,6m3m,DB08340,-8.6,"N,N'-DIPHENYLPYRAZOLO[1,5-A][1,3,5]TRIAZINE-2,4-DIAMINE",LLYYAUZAGCZEKV-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
137592,6w9c,DB08487,-8.6,3-({4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-2-OXOPIPERAZIN-1-YL}METHYL)BENZENECARBOXIMIDAMIDE,PRMSFVUWLBPPLY-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
87002,6m3m,DB11686,-8.6,Iferanserin,UXIPFQUBOVWAQW-UEBLJOKOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
132263,6w9c,DB00220,-8.6,Nelfinavir,QAGYKUNXZHXKMR-HKWSIXNMSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136916,6w9c,DB07688,-8.6,"4-{[5-(CYCLOHEXYLOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE",RPJIMTALCNCQLV-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
64288,6lxt,DB01320,-8.6,Fosphenytoin,XWLUWCNOOVRFPX-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
79071,6m2n,DB12686,-8.6,PHA-793887,HUXYBQXJVXOMKX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137646,6w9c,DB08547,-8.6,PROGESTERONE-11-ALPHA-OL-HEMISUCCINATE,JBBNFGYRYNBDIH-DBGGZKJISA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
87041,6m3m,DB11745,-8.6,Otenabant,UNAZAADNBYXMIV-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
79078,6m2n,DB12696,-8.6,BMS-582949,GDTQLZHHDRRBEB-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
85939,6m3m,DB08239,-8.6,"(2S)-4-(2,5-DIFLUOROPHENYL)-N-METHYL-2-PHENYL-N-PIPERIDIN-4-YL-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDE",NKLVBHMAIMEVEH-QFIPXVFZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
64301,6lxt,DB01338,-8.6,Pipecuronium,OWWLUIWOFHMHOQ-XGHATYIMSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
62985,6crv,DB14875,-8.6,AZD-4017,NCDZABJPWMBMIQ-INIZCTEOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87033,6m3m,DB11736,-8.6,PF-00489791,ZUHZNKJIJDAJFD-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
140260,6w9c,DB15460,-8.6,AGG-523,JWQMTWCFNZSLNR-DEOSSOPVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
64295,6lxt,DB01329,-8.6,Cefoperazone,GCFBRXLSHGKWDP-XCGNWRKASA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
64294,6lxt,DB01328,-8.6,Cefonicid,DYAIAHUQIPBDIP-AXAPSJFSSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
72040,6m2n,DB00266,-8.6,Dicoumarol,DOBMPNYZJYQDGZ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137631,6w9c,DB08531,-8.6,"5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",CVYWYUAQFJMLEO-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
79101,6m2n,DB12731,-8.6,Daporinad,KPBNHDGDUADAGP-VAWYXSNFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
23994,6cs2,DB01640,-8.6,"(5r)-6-(4-{[2-(3-Iodobenzyl)-3-Oxocyclohex-1-En-1-Yl]Amino}Phenyl)-5-Methyl-4,5-Dihydropyridazin-3(2h)-One",QNURTFDBHAQRSI-OAHLLOKOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
85927,6m3m,DB08224,-8.6,"(1S,7S,8S,8AR)-1,2,3,7,8,8A-HEXAHYDRO-7-METHYL-8-[2-[(2R,4R)-TETRAHYDRO-4-HY DROXY-6-OXO-2H-PYRAN-2-YL]ETHYL]-1-NAPHTHALENOL",WWSNTLOVYSRDEL-TVKPWXLESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
72076,6m2n,DB00307,-8.6,Bexarotene,NAVMQTYZDKMPEU-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
65043,6lxt,DB02323,-8.6,EM-1745,CKSDYJASHNGOOS-KTXOUVACSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
73680,6m2n,DB02358,-8.6,LY374571,SZHRIPFGZWWRKW-VIFPVBQESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
85603,6m3m,DB07851,-8.6,"(3R,4S)-1-(3,4-DIMETHOXYPHENYL)-3-(3-METHYLPHENYL)PIPERIDIN-4-AMINE",DQJXBZGPJVSWFI-ROUUACIJSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
78763,6m2n,DB12235,-8.6,Estetrol,AJIPIJNNOJSSQC-NYLIRDPKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
71684,6lxt,DB15078,-8.6,Rogaratinib,HNLRRJSKGXOYNO-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
62866,6crv,DB14636,-8.6,Triciribine phosphate,URLYINUFLXOMHP-HTVVRFAVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78766,6m2n,DB12238,-8.6,MK-0777,QKIWQBLNTSQOLY-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
136755,6w9c,DB07493,-8.6,"(2Z)-5'-BROMO-2,3'-BIINDOLE-2',3(1H,1'H)-DIONE AMMONIATE",IEQQJQHHJMQETK-YPKPFQOOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137926,6w9c,DB08906,-8.6,Fluticasone furoate,XTULMSXFIHGYFS-VLSRWLAYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
65467,6lxt,DB02873,-8.6,"1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperazin-1-Yl-3,4-Dihydroquinazolin-2(1h)-One",YAWZIQKDHQIHOS-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
78769,6m2n,DB12242,-8.6,AZD-7762,IAYGCINLNONXHY-LBPRGKRZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
65430,6lxt,DB02827,-8.6,"7-(1,1-Dioxo-1h-Benzo[D]Isothiazol-3-Yloxymethyl)-2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Pyran-3-Carboxylic Acid",MDYIGSPVMWSFEZ-JTQLQIEISA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
65380,6lxt,DB02759,-8.6,4-Methylumbelliferyl Chitobiose,UPSFMJHZUCSEHU-JYGUBCOQSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
73863,6m2n,DB02587,-8.6,Colforsin,OHCQJHSOBUTRHG-KGGHGJDLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137922,6w9c,DB08899,-8.6,Enzalutamide,WXCXUHSOUPDCQV-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
145966,6w9q,DB07969,-8.6,3-[3-(4-methylpiperazin-1-yl)-7-(trifluoromethyl)quinoxalin-5-yl]phenol,QNCYYRHIUFGGJX-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
80932,6m3m,DB00607,-8.6,Nafcillin,GPXLMGHLHQJAGZ-JTDSTZFVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
131954,6w4h,DB15092,-8.6,LY-2624803,UEFWDVMEDFCHGW-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
62856,6crv,DB14626,-8.6,Pregnenolone acetate,CRRKVZVYZQXICQ-RJJCNJEVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
71669,6lxt,DB15048,-8.6,Licogliflozin,XFJAMQQAAMJFGB-ZQGJOIPISA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
81023,6m3m,DB00716,-8.6,Nedocromil,RQTOOFIXOKYGAN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81021,6m3m,DB00714,-8.6,Apomorphine,VMWNQDUVQKEIOC-CYBMUJFWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85549,6m3m,DB07791,-8.6,4-{[4-(1-CYCLOPROPYL-2-METHYL-1H-IMIDAZOL-5-YL)PYRIMIDIN-2-YL]AMINO}-N-METHYLBENZENESULFONAMIDE,MZWCVBFANHIPTJ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81000,6m3m,DB00691,-8.6,Moexipril,UWWDHYUMIORJTA-HSQYWUDLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
71663,6lxt,DB15036,-8.6,Sitravatinib,WLAVZAAODLTUSW-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
133344,6w9c,DB01564,-8.6,Calusterone,IVFYLRMMHVYGJH-PVPPCFLZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
78726,6m2n,DB12183,-8.6,Sapitinib,DFJSJLGUIXFDJP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
87254,6m3m,DB12059,-8.6,JNJ-40411813,HYOGJHCDLQSAHX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
65852,6lxt,DB03383,-8.6,5-Chloro-1h-Indole-2-Carboxylic Acid [1-(4-Fluorobenzyl)-2-(4-Hydroxypiperidin-1yl)-2-Oxoethyl]Amide,YDCGVASFVACWKF-NRFANRHFSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
131940,6w4h,DB15062,-8.6,Inarigivir,LYMICVBGNUEHGE-FUQPUAIBSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
80993,6m3m,DB00683,-8.6,Midazolam,DDLIGBOFAVUZHB-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80992,6m3m,DB00682,-8.6,Warfarin,PJVWKTKQMONHTI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87245,6m3m,DB12046,-8.6,Atopaxar,QWKAUGRRIXBIPO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
133320,6w9c,DB01540,-8.6,17alpha-methyl-4-hydroxynandrolone,CLNUZOCYKSHICX-FAHHUNKHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
85592,6m3m,DB07838,-8.6,(Z)-3-BENZYL-5-(2-HYDROXY-3-NITROBENZYLIDENE)-2-THIOXOTHIAZOLIDIN-4-ONE,ZTWBCEZQPRYIGY-ZROIWOOFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
78778,6m2n,DB12254,-8.6,ABT-751,URCVCIZFVQDVPM-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137816,6w9c,DB08750,-8.6,"1-[4-(AMINOMETHYL)BENZOYL]-5'-FLUORO-1'H-SPIRO[PIPERIDINE-4,2'-QUINAZOLIN]-4'-AMINE",SFPCNWQWKOUNRT-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
85674,6m3m,DB07935,-8.6,"5-[(5-fluoro-3-methyl-1H-indazol-4-yl)oxy]benzene-1,3-dicarbonitrile",JYAHFMKZJRVTDT-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
137912,6w9c,DB08881,-8.6,Vemurafenib,GPXBXXGIAQBQNI-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
78847,6m2n,DB12350,-8.6,Rostafuroxin,AEAPORIZZWBIEX-DTBDINHYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
136803,6w9c,DB07549,-8.6,"2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUORO-3-METHYL-6-PYRIDINYL)METHYL]ACETAMIDE",WOYBPRBUPLYTPY-UHFFFAOYSA-P,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
80818,6m3m,DB00468,-8.6,Quinine,LOUPRKONTZGTKE-WZBLMQSHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
140367,6w9c,DB04705,-8.6,"(3BETA)-CHOLEST-5-ENE-3,25-DIOL",INBGSXNNRGWLJU-ZHHJOTBYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
133221,6w9c,DB01426,-8.6,Ajmaline,CJDRUOGAGYHKKD-HEFSZTOGSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
80803,6m3m,DB00448,-8.6,Lansoprazole,MJIHNNLFOKEZEW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
133243,6w9c,DB01452,-8.6,Diamorphine,GVGLGOZIDCSQPN-PVHGPHFFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
132031,6w4h,DB15238,-8.6,Olinciguat,YWQFJNWMWZMXRW-HXUWFJFHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
132034,6w4h,DB15245,-8.6,Olorofim,SUFPWYYDCOKDLL-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
114650,6vxx,DB13950,-8.6,WIN 55212-2,HQVHOQAKMCMIIM-HXUWFJFHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78875,6m2n,DB12391,-8.6,Sagopilone,BFZKMNSQCNVFGM-UCEYFQQTSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80790,6m3m,DB00434,-8.6,Cyproheptadine,JJCFRYNCJDLXIK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
65049,6lxt,DB02331,-8.6,"(2s)-2-[(5-Benzofuran-2-Yl-Thiophen-2-Ylmethyl)-(2,4-Dichloro-Benzoyl)-Amino]-3-Phenyl-Propionic Acid",YBULOUKTPCHXAL-DEOSSOPVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
133194,6w9c,DB01380,-8.6,Cortisone acetate,ITRJWOMZKQRYTA-RFZYENFJSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136814,6w9c,DB07563,-8.6,"1-{7-cyclohexyl-6-[4-(4-methylpiperazin-1-yl)benzyl]-7H-pyrrolo[2,3-d]pyrimidin-2-yl}methanamine",GCJSOJRPNOWSEH-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
80844,6m3m,DB00497,-8.6,Oxycodone,BRUQQQPBMZOVGD-XFKAJCMBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
137874,6w9c,DB08816,-8.6,Ticagrelor,OEKWJQXRCDYSHL-FNOIDJSQSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
78831,6m2n,DB12322,-8.6,GW-870086,WUBKGTSFJSEIEM-NSHBDUGJSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
87204,6m3m,DB11985,-8.6,Dapaconazole,FUAHXHWSMYFWGE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
78792,6m2n,DB12275,-8.6,Seviteronel,ZBRAJOQFSNYJMF-SFHVURJKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
87202,6m3m,DB11982,-8.6,GDC-0623,RFWVETIZUQEJEF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
133266,6w9c,DB01476,-8.6,Haloxazolam,XDKCGKQHVBOOHC-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
78800,6m2n,DB12285,-8.6,Verubecestat,YHYKUSGACIYRML-KRWDZBQOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
71741,6lxt,DB15192,-8.6,ABT-288,GNIRITULTPTAQW-KNQAVFIVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
145854,6w9q,DB07837,-8.6,"[4-(5-naphthalen-2-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)phenyl]acetic acid",SWXKLXXVFMYMDP-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
133259,6w9c,DB01469,-8.6,Acetorphine,LFYBMMHFJIAKFE-PMEKXCSPSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
131993,6w4h,DB15168,-8.6,Cilofexor,KZSKGLFYQAYZCO-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
80862,6m3m,DB00524,-8.6,Metolazone,AQCHWTWZEMGIFD-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
114786,6vxx,DB14859,-8.6,Fosifloxuridine nafalbenamide,BIOWRMNRHMERIO-ZVAHOJSLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85708,6m3m,DB07974,-8.6,1-{2-[(4-CHLOROPHENYL)AMINO]-2-OXOETHYL}-N-(1-ISOPROPYLPIPERIDIN-4-YL)-1H-INDOLE-2-CARBOXAMIDE,BDLMBQRBNPDCSS-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87190,6m3m,DB11962,-8.6,GSK-1059615,QDITZBLZQQZVEE-YBEGLDIGSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
139929,6w9c,DB14583,-8.6,Segesterone acetate,CKFBRGLGTWAVLG-GOMYTPFNSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
78830,6m2n,DB12321,-8.6,Ifetroban,BBPRUNPUJIUXSE-DXKRWKNPSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137913,6w9c,DB08882,-8.6,Linagliptin,LTXREWYXXSTFRX-QGZVFWFLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
132286,6w9c,DB00246,-8.6,Ziprasidone,MVWVFYHBGMAFLY-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
63019,6crv,DB14938,-8.6,Flurbiprofen axetil,ALIVXCSEERJYHU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
132288,6w9c,DB00248,-8.6,Cabergoline,KORNTPPJEAJQIU-KJXAQDMKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137179,6w9c,DB07991,-8.6,N-[(1R)-3-(4-HYDROXYPHENYL)-1-METHYLPROPYL]-2-(2-PHENYL-1H-INDOL-3-YL)ACETAMIDE,APLJSSOXDWUNGV-GOSISDBHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
80222,6m2n,DB14898,-8.6,Retagliptin,WIIAMRXFUJLYEF-SNVBAGLBSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79878,6m2n,DB13865,-8.6,Dehydroemetine,XXLZPUYGHQWHRN-RPBOFIJWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
86288,6m3m,DB08665,-8.6,"6,11-DIHYDRO-11-ETHYL-6-METHYL-9-NITRO-5H-PYRIDO[2,3-B][1,5]BENZODIAZEPIN-5-ONE",YCFJZPGDTZVVSM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86608,6m3m,DB09097,-8.6,Quinagolide,GDFGTRDCCWFXTG-ZIFCJYIRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86303,6m3m,DB08686,-8.6,"5,6,7,8,9,10-HEXAHYDRO-4-HYDROXY-3-(1-PHENYLPROPYL)CYCLOOCTA[B]PYRAN-2-ONE",UXCLJNSXDNCIIT-HNNXBMFYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
63156,6crv,DB15241,-8.6,Methylsamidorphan,ATCVVCBJNHXIEX-ZAHKBLQYSA-O,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86310,6m3m,DB08697,-8.6,"4-(2-aminoethoxy)-N-(3-chloro-5-piperidin-1-ylphenyl)-3,5-dimethylbenzamide",JDYIYIRPQKMWMM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
72668,6m2n,DB01013,-8.6,Clobetasol propionate,CBGUOGMQLZIXBE-XGQKBEPLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
140144,6w9c,DB15062,-8.6,Inarigivir,LYMICVBGNUEHGE-FUQPUAIBSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
132529,6w9c,DB00543,-8.6,Amoxapine,QWGDMFLQWFTERH-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
132540,6w9c,DB00554,-8.6,Piroxicam,QYSPLQLAKJAUJT-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137314,6w9c,DB08143,-8.6,"5-CHLORO-THIOPHENE-2-CARBOXYLIC ACID ((3S,4S)-4-FLUORO- 1-{[2-FLUORO-4-(2-OXO-2H-PYRIDIN-1-YL)-PHENYLCARBAMOYL]-METHYL}-PYRROLIDIN-3-YL)-AMIDE",SXIYSYYSKHUTQQ-RDJZCZTQSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
80190,6m2n,DB14840,-8.6,Ripretinib,CEFJVGZHQAGLHS-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
72682,6m2n,DB01030,-8.6,Topotecan,UCFGDBYHRUNTLO-QHCPKHFHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
16556,6cs2,HMDB0002789,-8.6,Zeaxanthin,JKQXZKUSFCKOGQ-PWPFSTEPSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
144502,6w9q,DB05039,-8.6,Indacaterol,QZZUEBNBZAPZLX-QFIPXVFZSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
132749,6w9c,DB00808,-8.6,Indapamide,NDDAHWYSQHTHNT-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
72325,6m2n,DB00611,-8.6,Butorphanol,IFKLAQQSCNILHL-PWRODBHTSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
72812,6m2n,DB01179,-8.6,Podofilox,YJGVMLPVUAXIQN-XVVDYKMHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
140191,6w9c,DB15319,-8.6,VM4-037,QGYZPMXIVNIGKA-GMAHTHKFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137137,6w9c,DB07943,-8.6,2-{4-[5-(4-chlorophenyl)-4-pyrimidin-4-yl-1H-pyrazol-3-yl]piperidin-1-yl}-2-oxoethanol,CATQHDWESBRRQA-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
86645,6m3m,DB09182,-8.6,Benzylfentanyl,POQDXIFVWVZVML-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
114917,6vxx,DB15406,-8.6,GLPG-0974,MPMKMQHJHDHPBE-RUZDIDTESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
137156,6w9c,DB07966,-8.6,[4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]quinazolin-2-yl}amino)phenyl]acetonitrile,NVMCVWOODOWOLT-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
86644,6m3m,DB09181,-8.6,Trefentanil,RJSCINHYBGMIFT-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86640,6m3m,DB09177,-8.6,p-Fluorofentanyl,KXUBAVLIJFTASZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
132771,6w9c,DB00831,-8.6,Trifluoperazine,ZEWQUBUPAILYHI-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
86638,6m3m,DB09174,-8.6,Lofentanil,IMYHGORQCPYVBZ-NLFFAJNJSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
140122,6w9c,DB15024,-8.6,Apararenone,AZNHWXAFPBYFGH-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140190,6w9c,DB15317,-8.6,Posiphen,PBHFNBQPZCRWQP-AZUAARDMSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
79820,6m2n,DB13788,-8.6,Chlorbenzoxamine,VEVSKUJZSMGTMM-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
86230,6m3m,DB08596,-8.6,5'-deoxy-5'-piperidin-1-ylthymidine,GMOUOGHZJCSNOZ-YNEHKIRRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86577,6m3m,DB09054,-8.6,Idelalisib,IFSDAJWBUCMOAH-HNNXBMFYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86661,6m3m,DB09198,-8.6,Lobeglitazone,CHHXEZSCHQVSRE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
132678,6w9c,DB00719,-8.6,Azatadine,SEBMTIQKRHYNIT-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137313,6w9c,DB08142,-8.6,AT-7519,OVPNQJVDAFNBDN-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
132645,6w9c,DB00683,-8.6,Midazolam,DDLIGBOFAVUZHB-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
72429,6m2n,DB00737,-8.6,Meclizine,OCJYIGYOJCODJL-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80142,6m2n,DB14718,-8.6,Pyrazolam,BGRWSFIQQPVEML-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
132641,6w9c,DB00678,-8.6,Losartan,PSIFNNKUMBGKDQ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
86488,6m3m,DB08934,-8.6,Sofosbuvir,TTZHDVOVKQGIBA-IQWMDFIBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
140170,6w9c,DB15114,-8.6,Vamorolone,ZYTXTXAMMDTYDQ-DGEXFFLYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
86509,6m3m,DB08962,-8.6,Glibornuride,RMTYNAPTNBJHQI-LLDVTBCESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86477,6m3m,DB08915,-8.6,Aleglitazar,DAYKLWSKQJBGCS-NRFANRHFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
137264,6w9c,DB08087,-8.6,"4-[(7R,7AS)-7-HYDROXY-1,3-DIOXOTETRAHYDRO-1H-PYRROLO[1,2-C]IMIDAZOL-2(3H)-YL]-1-NAPHTHONITRILE",NHBIWLQQJPSMNP-CABCVRRESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
72508,6m2n,DB00831,-8.6,Trifluoperazine,ZEWQUBUPAILYHI-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
132595,6w9c,DB00621,-8.6,Oxandrolone,QSLJIVKCVHQPLV-PEMPUTJUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140163,6w9c,DB15102,-8.6,Pemigatinib,HCDMJFOHIXMBOV-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
16464,6cs2,HMDB0002268,-8.6,Alpha-Cryptoxanthin,ORAKUVXRZWMARG-DWADUKLPSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
72492,6m2n,DB00814,-8.6,Meloxicam,ZRVUJXDFFKFLMG-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80090,6m2n,DB14636,-8.6,Triciribine phosphate,URLYINUFLXOMHP-HTVVRFAVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
63198,6crv,DB15325,-8.6,ONO-8539,ALLLQQUASFFEKP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86415,6m3m,DB08810,-8.6,Cinitapride,ZDLBNXXKDMLZMF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
21997,6cs2,HMDB0052663,-8.6,"TG(18:2(9Z,12Z)/20:2n6/22:5(7Z,10Z,13Z,16Z,19Z))",BETJPUOQASBYOQ-AHGFPKGFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
132551,6w9c,DB00568,-8.6,Cinnarizine,DERZBLKQOCDDDZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
72631,6m2n,DB00972,-8.6,Azelastine,MBUVEWMHONZEQD-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
140146,6w9c,DB15065,-8.6,PF-06291874,IBDYYOQKQCCSDP-QFIPXVFZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
86569,6m3m,DB09038,-8.6,Empagliflozin,OBWASQILIWPZMG-QZMOQZSNSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86562,6m3m,DB09020,-8.6,Bisacodyl,KHOITXIGCFIULA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86559,6m3m,DB09017,-8.6,Brotizolam,UMSGKTJDUHERQW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
72589,6m2n,DB00921,-8.6,Buprenorphine,RMRJXGBAOAMLHD-IHFGGWKQSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
72588,6m2n,DB00920,-8.6,Ketotifen,ZCVMWBYGMWKGHF-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
63268,6crv,DB01557,-8.6,alpha-Methylfentanyl,NGTVDHYUFBKWID-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
63189,6crv,DB15305,-8.6,Risdiplam,ASKZRYGFUPSJPN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
63196,6crv,DB15323,-8.6,Trelagliptin,IWYJYHUNXVAVAA-OAHLLOKOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
137232,6w9c,DB08051,-8.6,"(2R)-4-(2-BENZOYL-1,2-DIAZEPAN-1-YL)-4-OXO-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE",XXRHRPGYYNOBHO-QGZVFWFLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140680,6w9c,DB13088,-8.6,AZD-0424,MVWATCATLSSVBH-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
63256,6crv,DB15446,-8.6,Vidofludimus,XPRDUGXOWVXZLL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86372,6m3m,DB08762,-8.6,O-(((1R)-((N-PHENYLMETHOXYCARBONYL-L-ALANYL)AMINO)ETHYL)HYDROXYPHOSPHONO)-L-BENZYLACETIC ACID,UPJNMOBJDSFRTI-FCEWJHQRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
79934,6m2n,DB13991,-8.6,Pipequaline,AMEWZCMTSIONOX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
72818,6m2n,DB01185,-8.6,Fluoxymesterone,YLRFCQOZQXIBAB-RBZZARIASA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80283,6m2n,DB15055,-8.6,ABT-639,AGPIHNZOZNKRGT-CYBMUJFWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
72850,6m2n,DB01219,-8.6,Dantrolene,OZOMQRBLCMDCEG-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
132941,6w9c,DB01025,-8.6,Amlexanox,SGRYPYWGNKJSDL-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
73101,6m2n,DB01586,-8.6,Ursodeoxycholic acid,RUDATBOHQWOJDD-UZVSRGJWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
86083,6m3m,DB08422,-8.6,[PHENYLALANINYL-PROLINYL]-[2-(PYRIDIN-4-YLAMINO)-ETHYL]-AMINE,GEIDRYBJURDUSW-MOPGFXCFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
137522,6w9c,DB08400,-8.6,4-(3-{[5-(trifluoromethyl)pyridin-2-yl]oxy}benzyl)piperidine-1-carboxylic acid,KUEKMTNOUPAOBS-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
86925,6m3m,DB11511,-8.6,Difloxacin,NOCJXYPHIIZEHN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
63051,6crv,DB15038,-8.6,Litoxetine,MJJDYOLPMGIWND-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72180,6m2n,DB00436,-8.6,Bendroflumethiazide,HDWIHXWEUNVBIY-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
132931,6w9c,DB01013,-8.6,Clobetasol propionate,CBGUOGMQLZIXBE-XGQKBEPLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137493,6w9c,DB08365,-8.6,"8-bromo-4-(2-chlorophenyl)-N-(2-hydroxyethyl)-6-methyl-1,3-dioxo-1,2,3,6-tetrahydropyrrolo[3,4-e]indole-7-carboxamide",XUAHLMVOYLUYSB-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
145027,6w9q,DB06875,-8.6,3-(3-FLUORO-4-HYDROXYPHENYL)-7-HYDROXY-1-NAPHTHONITRILE,NSSOSHDCWCMNDM-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
86906,6m3m,DB11463,-8.6,Sulfanitran,GWBPFRGXNGPPMF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86900,6m3m,DB11455,-8.6,Robenacoxib,ZEXGDYFACFXQPF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
29916,6cs2,DB11805,-8.6,Saracatinib,OUKYUETWWIPKQR-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
144896,6w9q,DB06666,-8.6,Lixivaptan,PPHTXRNHTVLQED-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
79301,6m2n,DB13051,-8.6,CH-5132799,JEGHXKRHKHPBJD-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
72179,6m2n,DB00434,-8.6,Cyproheptadine,JJCFRYNCJDLXIK-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
145155,6w9q,DB07026,-8.6,"(1S,5S,7R)-N-7-(BIPHENYL-4-YLMETHYL)-N-3-HYDROXY-6,8-DIOXA-3-AZABICYCLO[3.2.1]OCTANE-3,7-DICARBOXAMIDE",PPLDARNGJSQINK-OKZBNKHCSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
132978,6w9c,DB01067,-8.6,Glipizide,ZJJXGWJIGJFDTL-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137570,6w9c,DB08460,-8.6,"3-{5-[(6-amino-1H-pyrazolo[3,4-b]pyridin-3-yl)methoxy]-2-chlorophenoxy}-5-chlorobenzonitrile",KXDIHAQCVNNLIB-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136974,6w9c,DB07756,-8.6,"1-[3-({[(4-AMINO-5-FLUORO-2-METHYLQUINOLIN-3-YL)METHYL]THIO}METHYL)PHENYL]-2,2,2-TRIFLUOROETHANE-1,1-DIOL",GPBGHVRNVGXPNM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136982,6w9c,DB07764,-8.6,FLUORESCIN,MURGITYSBWUQTI-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
86973,6m3m,DB11644,-8.6,Tafamidis,TXEIIPDJKFWEEC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80426,6m2n,DB15333,-8.6,AZD-1386,FPGNKXCEPARJDI-ZDUSSCGKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
166593,7bv1,DB15444,-8.6,Elexacaftor,MVRHVFSOIWFBTE-INIZCTEOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
132328,6w9c,DB00294,-8.6,Etonogestrel,GCKFUYQCUCGESZ-BPIQYHPVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
72158,6m2n,DB00408,-8.6,Loxapine,XJGVXQDUIWGIRW-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80398,6m2n,DB15282,-8.6,Fluorofuranylnorprogesterone F-18,VJKRBRUNEOHPBS-JQKUZGBFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79224,6m2n,DB12929,-8.6,JNJ-39220675,IQOWHZHNGJXGHG-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137017,6w9c,DB07804,-8.6,"5-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1H-1,2,4-TRIAZOLE-3-SULFONAMIDE",FKCQUVAGEOSYRU-QWRGUYRKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
145201,6w9q,DB07078,-8.6,"(3Z)-6-(4-HYDROXY-3-METHOXYPHENYL)-3-(1H-PYRROL-2-YLMETHYLENE)-1,3-DIHYDRO-2H-INDOL-2-ONE",AYSXURJZVXBSRV-WJDWOHSUSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
86944,6m3m,DB11560,-8.6,Lesinurad,FGQFOYHRJSUHMR-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
79248,6m2n,DB12966,-8.6,Falnidamol,FTFRZXFNZVCRSK-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137541,6w9c,DB08426,-8.6,"THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [2-OXO-1-(1H-PYRROLO[2,3-C]PYRIDIN-2-YLMETHYL)-PYRROLIDIN-3-YL]-AMIDE",PLXOQMHGHDZMSX-AWEZNQCLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
80367,6m2n,DB15219,-8.6,Tomivosertib,HKTBYUWLRDZAJK-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80364,6m2n,DB15209,-8.6,MK-0736,ORQZQBUNAMJFCY-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137473,6w9c,DB08341,-8.6,"4-{[4-{[(1R,2R)-2-(dimethylamino)cyclopentyl]amino}-5-(trifluoromethyl)pyrimidin-2-yl]amino}-N-methylbenzenesulfonamide",CAUFYHKGKDJMQG-HZPDHXFCSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
80362,6m2n,DB15207,-8.6,Esaxerenone,NOSNHVJANRODGR-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
143077,6w9q,DB03044,-8.6,1-(5-Tert-Butyl-2-P-Tolyl-2h-Pyrazol-3-Yl)-3-[4-(2-Morpholin-4-Yl-Ethoxy)-Naphthalen-1-Yl]-Urea,MVCOAUNKQVWQHZ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
72266,6m2n,DB00543,-8.6,Amoxapine,QWGDMFLQWFTERH-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
16617,6cs2,HMDB0003178,-8.6,Heme,KABFMIBPWCXCRK-RGGAHWMASA-L,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
132442,6w9c,DB00434,-8.6,Cyproheptadine,JJCFRYNCJDLXIK-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
80302,6m2n,DB15092,-8.6,LY-2624803,UEFWDVMEDFCHGW-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
86720,6m3m,DB09279,-8.6,Fimasartan,AMEROGPZOLAFBN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
144736,6w9q,DB06248,-8.6,Amelubant,SBVYURPQULDJTI-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
80290,6m2n,DB15065,-8.6,PF-06291874,IBDYYOQKQCCSDP-QFIPXVFZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
140084,6w9c,DB14906,-8.6,Adafosbuvir,NIJYGVDQZBBONK-SEUXLIJBSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
86182,6m3m,DB08537,-8.6,"3-bromo-6-phenyl-N-(pyrimidin-5-ylmethyl)imidazo[1,2-a]pyridin-8-amine",LZLKFNBMXXLTLX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
140194,6w9c,DB15325,-8.6,ONO-8539,ALLLQQUASFFEKP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
79630,6m2n,DB13534,-8.6,Gedocarnil,SLYDYLLJUXFULK-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
132797,6w9c,DB00860,-8.6,Prednisolone,OIGNJSKKLXVSLS-VWUMJDOOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
63139,6crv,DB15208,-8.6,NOP-1A,MZBCQWLYUQJXKA-KRWDZBQOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86186,6m3m,DB08542,-8.6,"3,4-dihydroxy-9,10-secoandrosta-1(10),2,4-triene-9,17-dione",YUHVBHDSVLKFNI-NJSLBKSFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
132828,6w9c,DB00897,-8.6,Triazolam,JOFWLTCLBGQGBO-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
131925,6w4h,DB15035,-8.6,Zanubrutinib,RNOAOAWBMHREKO-QFIPXVFZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
114771,6vxx,DB14822,-8.6,SB-649868,ZJXIUGNEAIHSBI-IBGZPJMESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80320,6m2n,DB15124,-8.6,PF-05241328,RVTSXVZXEGFIPW-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
63066,6crv,DB15065,-8.6,PF-06291874,IBDYYOQKQCCSDP-QFIPXVFZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140222,6w9c,DB15391,-8.6,Elenbecestat,AACUJFVOHGRMTR-DPXNYUHVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
80352,6m2n,DB15192,-8.6,ABT-288,GNIRITULTPTAQW-KNQAVFIVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
72949,6m2n,DB01413,-8.6,Cefepime,HVFLCNVBZFFHBT-ZKDACBOMSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79353,6m2n,DB13122,-8.6,Trabodenoson,AQLVRTWKJDTWQQ-SDBHATRESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79357,6m2n,DB13132,-8.6,Artemisinin,BLUAFEHZUWYNDE-NNWCWBAJSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
114918,6vxx,DB15407,-8.6,Acalisib,DOCINCLJNAXZQF-LBPRGKRZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
63781,6lxt,DB00694,-8.6,Daunorubicin,STQGQHZAVUOBTE-VGBVRHCVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
86125,6m3m,DB08471,-8.6,"1-(thiophen-2-ylacetyl)-4-(3-thiophen-2-yl-1,2,4-oxadiazol-5-yl)piperidine",SJEVDMFUHCVNPM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
137055,6w9c,DB07847,-8.6,6-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-(4-MORPHOLINYL)-2-OXO ETHYL]-2-OXO-3-PYRROLIDINYL}-2-NAPHTHALENESULFONAMIDE,ICLOZQFWTRAYPX-LIRRHRJNSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
132862,6w9c,DB00933,-8.6,Mesoridazine,SLVMESMUVMCQIY-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
144835,6w9q,DB06521,-8.6,Ertiprotafib,FONCZICQWCUXEB-RUZDIDTESA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
63091,6crv,DB15117,-8.6,Transfluthrin,DDVNRFNDOPPVQJ-HQJQHLMTSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72935,6m2n,DB01392,-8.6,Yohimbine,BLGXFZZNTVWLAY-SCYLSFHTSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
63096,6crv,DB15124,-8.6,PF-05241328,RVTSXVZXEGFIPW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80319,6m2n,DB15123,-8.6,Dorzagliatin,HMUMWSORCUWQJO-QAPCUYQASA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
81026,6m3m,DB00719,-8.6,Azatadine,SEBMTIQKRHYNIT-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
137977,6w9c,DB08976,-8.6,Floctafenine,APQPGQGAWABJLN-GFCCVEGCSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
78693,6m2n,DB12129,-8.6,Tideglusib,PMJIHLSCWIDGMD-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
70728,6lxt,DB13104,-8.6,X-396,ONPGOSVDVDPBCY-CQSZACIVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
70747,6lxt,DB13135,-8.6,AGN-201904,PPCGSVWOZKNPCX-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
77908,6m2n,DB08973,-8.6,Fluclorolone acetonide,NJNWEGFJCGYWQT-VSXGLTOVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
62371,6crv,DB13487,-8.6,Iodine (131I) norcholesterol,QJHZPCLORSPENH-DRTKWHMQSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77911,6m2n,DB08976,-8.6,Floctafenine,APQPGQGAWABJLN-GFCCVEGCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77926,6m2n,DB08993,-8.6,Enviomycin,HPWIIERXAFODPP-GHBBWTPBSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
130983,6w4h,DB13094,-8.6,Pruvanserin,AQRLDDAFYYAIJP-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
114877,6vxx,DB15319,-8.6,VM4-037,QGYZPMXIVNIGKA-GMAHTHKFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
134059,6w9c,DB02510,-8.6,'5'-O-(N-(L-Prolyl)-Sulfamoyl)Adenosine,LKVJEMXWEODCAY-JVEUSOJLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
77937,6m2n,DB09006,-8.6,Clinofibrate,BMOVQUBVGICXQN-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
67383,6lxt,DB06605,-8.6,Apixaban,QNZCBYKSOIHPEH-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
138522,6w9c,DB11789,-8.6,Hyodeoxycholic Acid,DGABKXLVXPYZII-SIBKNCMHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
67375,6lxt,DB06589,-8.6,Pazopanib,CUIHSIWYWATEQL-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
81610,6m3m,DB01469,-8.6,Acetorphine,LFYBMMHFJIAKFE-PMEKXCSPSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
146887,6w9q,DB09143,-8.6,Sonidegib,VZZJRYRQSPEMTK-CALCHBBNSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
140865,6w9q,DB00210,-8.6,Adapalene,LZCDAPDGXCYOEH-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
140488,6w9c,DB11950,-8.6,Teneligliptin,WGRQANOPCQRCME-PMACEKPBSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138541,6w9c,DB11816,-8.6,Omecamtiv Mecarbil,RFUBTTPMWSKEIW-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
87792,6m3m,DB12869,-8.6,Eliprodil,GGUSQTSTQSHJAH-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
130917,6w4h,DB12996,-8.6,Acteoside,FBSKJMQYURKNSU-ZLSOWSIRSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
62315,6crv,DB13411,-8.6,Lofepramine,SAPNXPWPAUFAJU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84951,6m3m,DB07091,-8.6,(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclohexyloxy)ethanoyl)pyrrolidine-2-carboxamide,IWPMQJKXKKKSEY-SFHVURJKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
147083,6w9q,DB11262,-8.6,Bisoctrizole,FQUNFJULCYSSOP-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
75015,6m2n,DB04137,-8.6,Guanosine-5'-Triphosphate,XKMLYUALXHKNFT-UUOKFMHZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
67454,6lxt,DB06733,-8.6,Bafilomycin A1,XDHNQDDQEHDUTM-JQWOJBOSSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
67453,6lxt,DB06732,-8.6,beta-Naphthoflavone,OUGIDAPQYNCXRA-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
74981,6m2n,DB04092,-8.6,Apstatin,YVUUZAPYLPWFHE-HXFGRODQSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
87771,6m3m,DB12832,-8.6,Prednimustine,HFVNWDWLWUCIHC-GUPDPFMOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81669,6m3m,DB01538,-8.6,Acetyldihydrocodeine,LGGDXXJAGWBUSL-BKRJIHRRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
130947,6w4h,DB13040,-8.6,Gandotinib,SQSZANZGUXWJEA-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
84986,6m3m,DB07131,-8.6,(S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclohexylpropanoyl)pyrrolidine-2-carboxamide,DOTBZTLJSXFKCP-IBGZPJMESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84990,6m3m,DB07136,-8.6,(2S)-2-[3-(AMINOMETHYL)PHENYL]-3-{(R)-HYDROXY[(1R)-2-METHYL-1-{[(3-PHENYLPROPYL)SULFONYL]AMINO}PROPYL]PHOSPHORYL}PROPANOIC ACID,WFFOOKSVFDUPDH-FCHUYYIVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
77870,6m2n,DB08922,-8.6,Perospirone,FBVFZWUMDDXLLG-HDICACEKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138511,6w9c,DB11773,-8.6,BMS-903452,OGIAVRWXUPYGGC-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
130908,6w4h,DB12978,-8.6,Pexidartinib,JGWRKYUXBBNENE-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
78006,6m2n,DB09123,-8.6,Dienogest,AZFLJNIPTRTECV-FUMNGEBKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
85035,6m3m,DB07187,-8.6,6-[(5-CHLORO-3-METHYL-1-BENZOFURAN-2-YL)SULFONYL]PYRIDAZIN-3(2H)-ONE,FXFPQPNUMWQRAO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
67213,6lxt,DB06169,-8.6,Indibulin,SOLIIYNRSAWTSQ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
131222,6w4h,DB13451,-8.6,Tioclomarol,WRGOVNKNTPWHLZ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
136513,6w9c,DB07203,-8.6,6-CYCLOHEXYLMETHOXY-2-(3'-CHLOROANILINO) PURINE,OUEGMEMDEAOAEG-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
74700,6m2n,DB03725,-8.6,Phosphomethylphosphonic Acid-Guanylate Ester,PHBDHXOBFUBCJD-KQYNXXCUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78243,6m2n,DB11371,-8.6,Alfaxalone,DUHUCHOQIDJXAT-OLVMNOGESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138442,6w9c,DB11671,-8.6,AZD-4877,SMFXSYMLJDHGIE-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136510,6w9c,DB07199,-8.6,"(2S,4S,5R)-1-(4-TERT-BUTYLBENZOYL)-2-ISOBUTYL-5-(1,3-THIAZOL-2-YL)PYRROLIDINE-2,4-DICARBOXYLIC ACID",SWYJAQWTBADJTB-RHGYRFJNSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
74665,6m2n,DB03678,-8.6,"(6,7-Difluoro-Quinazolin-4-Yl)-(1-Methyl-2,2-Diphenyl-Ethyl)-Amine",WVGZKPGUHOZIJQ-HNNXBMFYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
87625,6m3m,DB12594,-8.6,AZD-9056,HSQAARMBHJCUOK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136521,6w9c,DB07212,-8.6,N-(7-CARBAMIMIDOYL-NAPHTHALEN-1-YL)-3-HYDROXY-2-METHYL-BENZAMIDE,NNGZRCYXFBHMRM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
78283,6m2n,DB11443,-8.6,Orbifloxacin,QIPQASLPWJVQMH-DTORHVGOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
136522,6w9c,DB07215,-8.6,"2-METHYL-2-(4-{[({4-METHYL-2-[4-(TRIFLUOROMETHYL)PHENYL]-1,3-THIAZOL-5-YL}CARBONYL)AMINO]METHYL}PHENOXY)PROPANOIC ACID",ILUPZUOBHCUBKB-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
85082,6m3m,DB07246,-8.6,"(2R)-2-AMINO-3,3,3-TRIFLUORO-N-HYDROXY-2-{[(4-PHENOXYPHENYL)SULFONYL]METHYL}PROPANAMIDE",MKRPIBSCGZAUCH-OAHLLOKOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
114933,6vxx,DB15437,-8.6,Rocacetrapib,GBHPDJQHZADVAA-SOKVYYICSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
146716,6w9q,DB08875,-8.6,Cabozantinib,ONIQOQHATWINJY-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
71184,6lxt,DB13756,-8.6,Peruvoside,PMTSPAGBAFCORP-HBUONDEYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
78147,6m2n,DB09371,-8.6,Norethynodrel,ICTXHFFSOAJUMG-SLHNCBLASA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
87654,6m3m,DB12645,-8.6,Givinostat,YALNUENQHAQXEA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
166590,7bv1,DB15437,-8.6,Rocacetrapib,GBHPDJQHZADVAA-SOKVYYICSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
70973,6lxt,DB13471,-8.6,Nalfurafine,XGZZHZMWIXFATA-UEZBDDGYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
74857,6m2n,DB03921,-8.6,4-(3-Pyridin-2-Yl-1h-Pyrazol-4-Yl)Quinoline,IBCXZJCWDGCXQT-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
146835,6w9q,DB09042,-8.6,Tedizolid phosphate,QCGUSIANLFXSGE-GFCCVEGCSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
134022,6w9c,DB02466,-8.6,"4-[3-Oxo-3-(5,5,8,8-Tetramethyl-5,6,7,8-Tetrahydro-Naphthalen-2-Yl)-Propenyl]-Benzoic Acid",ZXQHMEUGMCXKLO-KPKJPENVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
141268,6w9q,DB00696,-8.6,Ergotamine,XCGSFFUVFURLIX-VFGNJEKYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
71072,6lxt,DB13607,-8.6,Picloxydine,YNCLPFSAZFGQCD-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
138490,6w9c,DB11741,-8.6,Famitinib,GKEYKDOLBLYGRB-LGMDPLHJSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139736,6w9c,DB13867,-8.6,Fluticasone,MGNNYOODZCAHBA-GQKYHHCASA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
78109,6m2n,DB09279,-8.6,Fimasartan,AMEROGPZOLAFBN-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138465,6w9c,DB11701,-8.6,Amenamevir,MNHNIVNAFBSLLX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
74745,6m2n,DB03777,-8.6,Rbt205 Inhibitor,QMGUOJYZJKLOLH-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
62443,6crv,DB13586,-8.6,Metandienone,XWALNWXLMVGSFR-HLXURNFRSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
67272,6lxt,DB06295,-8.6,Pramiconazole,AEKNYBWUEYNWMJ-QWOOXDRHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
24296,6cs2,DB02008,-8.6,1-(2-Fluorobenzyl)-3-Butyl-8-(N-Acetyl-4-Aminobenzyl)-Xanthine,JHSHXKJSPVHPCJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
138496,6w9c,DB11750,-8.6,Clobetasol,FCSHDIVRCWTZOX-DVTGEIKXSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
70685,6lxt,DB13042,-8.6,Fenoverine,UBAJTZKNDCEGKL-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
84945,6m3m,DB07085,-8.6,2-{[N-(2-ACETYL-5-CHLORO-4-FLUOROPHENYL)GLYCYL]AMINO}BENZOIC ACID,LBMZLHCAPBBOFS-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
138560,6w9c,DB11841,-8.6,Entinostat,INVTYAOGFAGBOE-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
81947,6m3m,DB01895,-8.6,Aspartyl-Adenosine-5'-Monophosphate,QPBSGQWTJLPZNF-VWJPMABRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
75371,6m2n,DB04609,-8.6,INHIBITOR Q8467 OF DUPONT MERCK,HFLCERPZYCWLSZ-VKONIRKNSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
87985,6m3m,DB13175,-8.6,Rheinanthrone,OZFQHULMMDWMIV-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
77569,6m2n,DB08535,-8.6,"3-bromo-5-phenyl-N-(pyridin-3-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",SMIZFGZXFDGISG-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
62146,6crv,DB13166,-8.6,Zofenopril,IAIDUHCBNLFXEF-MNEFBYGVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
67772,6lxt,DB07141,-8.6,"5-[(3R)-3-(5-methoxy-4'-methylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",QVXYJVHNRPNRJL-HNNXBMFYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
67781,6lxt,DB07152,-8.6,N-[4-(5-fluoro-6-methylpyridin-2-yl)-5-quinoxalin-6-yl-1H-imidazol-2-yl]acetamide,TYPILNNEZPSNTI-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
62149,6crv,DB13174,-8.6,Rhein,FCDLCPWAQCPTKC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87964,6m3m,DB13122,-8.6,Trabodenoson,AQLVRTWKJDTWQQ-SDBHATRESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
75355,6m2n,DB04590,-8.6,(2R)-({4-[AMINO(IMINO)METHYL]PHENYL}AMINO){5-ETHOXY-2-FLUORO-3-[(3R)-TETRAHYDROFURAN-3-YLOXY]PHENYL}ACETICACID,PGYOHIAQCFZQDK-AUUYWEPGSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
87958,6m3m,DB13115,-8.6,Saroglitazar,MRWFZSLZNUJVQW-DEOSSOPVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
77582,6m2n,DB08549,-8.6,"(3R)-METHYLCARBAMOYL-7-SULFOAMINO-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLIC ACID BENZYL ESTER",MFDBNNQUDZFSES-KRWDZBQOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
15558,6lzg,DB00224,-8.6,Indinavir,CBVCZFGXHXORBI-PXQQMZJSSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
134433,6w9c,DB03072,-8.6,"2-{3-[4-(4-Fluorophenyl)-3,6-Dihydro-1(2h)-Pyridinyl]Propyl}-8-Methyl-4(3h)-Quinazolinone",LOFDUAJQRUYHBR-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
87969,6m3m,DB13135,-8.6,AGN-201904,PPCGSVWOZKNPCX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87998,6m3m,DB13212,-8.6,Phenolsulfonphthalein,BELBBZDIHDAJOR-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
139534,6w9c,DB13602,-8.6,Promegestone,QFFCYTLOTYIJMR-XMGTWHOFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
29821,6cs2,DB11681,-8.6,Tofimilast,DHCOPPHTVOXDKU-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
70482,6lxt,DB12719,-8.6,Turofexorate isopropyl,INASOKQDNHHMRE-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
77496,6m2n,DB08449,-8.6,"2-(3-((4,5,7-trifluorobenzo[d]thiazol-2-yl)methyl)-1H-pyrrolo[2,3-b]pyridin-1-yl)acetic acid",IEVFQDJUDLCOQY-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
82007,6m3m,DB01977,-8.6,6-(N-Phenylcarbamyl)-2-Naphthalenecarboxamidine,AECPTICWHONWNW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
75435,6m2n,DB04696,-8.6,"4-CHLORO-3',3''-DIBROMOPHENOL-1,8-NAPHTHALEIN",GFGZCXHXQCQRFP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77529,6m2n,DB08490,-8.6,CTS-1027,ROSNVSQTEGHUKU-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
81999,6m3m,DB01967,-8.6,"N-{3-[(7ar,12as,12bs)-7-Oxo-1,3,4,6,7,7a,12a,12b-Octahydroindolo[2,3-a]Quinolizin-12(2h)-Yl]Propyl}Propane-2-Sulfonamide",LICJTIDRHJECTD-SFHVURJKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
134574,6w9c,DB03251,-8.6,RWJ-51084,NQABUEUFRXDDFI-AWEZNQCLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
62123,6crv,DB13115,-8.6,Saroglitazar,MRWFZSLZNUJVQW-DEOSSOPVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81998,6m3m,DB01965,-8.6,"2'-Deoxyuridine 5'-Alpha,Beta-Imido-Triphosphate",XZLLMTSKYYYJLH-SHYZEUOFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
62130,6crv,DB13125,-8.6,Lusutrombopag,NOZIJMHMKORZBA-KJCUYJGMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
70520,6lxt,DB12781,-8.6,Balaglitazone,IETKPTYAGKZLKY-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
67866,6lxt,DB07252,-8.6,"3-({4-[(5-chloro-1,3-benzodioxol-4-yl)amino]pyrimidin-2-yl}amino)benzenesulfonamide",TZHCXOMEOHEZDX-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
88028,6m3m,DB13248,-8.6,Phthalylsulfathiazole,PBMSWVPMRUJMPE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88022,6m3m,DB13242,-8.6,Bucladesine,CJGYSWNGNKCJSB-YVLZZHOMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88019,6m3m,DB13237,-8.6,Clofoctol,HQVZOORKDNCGCK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
130734,6w4h,DB12706,-8.6,Seletalisib,LNLJHGXOFYUARS-OAQYLSRUSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
62161,6crv,DB13208,-8.6,Prednylidene,WSVOMANDJDYYEY-CWNVBEKCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87940,6m3m,DB13090,-8.6,Zidebactam,YCZPXRQPDCXTIO-BBBLOLIVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84844,6m3m,DB06970,-8.6,"2-CHLORO-N-(3-CYANO-5,6-DIHYDRO-4H-CYCLOPENTA[B]THIOPHEN-2-YL)-5-DIETHYLSULFAMOYL-BENZAMIDE",MZCDQILVXXIMEV-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
138595,6w9c,DB11894,-8.6,Efatutazone,JCYNMRJCUYVDBC-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138593,6w9c,DB11892,-8.6,Prulifloxacin,PWNMXPDKBYZCOO-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
70633,6lxt,DB12960,-8.6,INCB-9471,ZMCJFJZOSKEMOM-DNKZPPIMSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
130818,6w4h,DB12843,-8.6,Oleandrin,JLPDBLFIVFSOCC-XYXFTTADSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
75169,6m2n,DB04338,-8.6,SB220025,VSPFURGQAYMVAN-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
130824,6w4h,DB12854,-8.6,BMS-908662,MMNNTJYFHUDSKL-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
70656,6lxt,DB12999,-8.6,MK-6186,FZBAOOQVQXATRL-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
77767,6m2n,DB08770,-8.6,"4-{2-[(7-amino-2-furan-2-yl[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-yl)amino]ethyl}phenol",PWTBZOIUWZOPFT-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
84896,6m3m,DB07030,-8.6,(5-CHLORO-2-{[(3-NITROBENZYL)AMINO]CARBONYL}PHENOXY)ACETIC ACID,VABIMMIJVWNHFI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
114663,6vxx,DB14624,-8.6,Nandrolone hydrogen sulfate,SKZMVWBZTQNCKW-IZPLOLCNSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81740,6m3m,DB01621,-8.6,Pipotiazine,JOMHSQGEWSNUKU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
75088,6m2n,DB04226,-8.6,Dihydro-Acarbose,CUAQESWNTOXZJZ-RTNAABQMSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
81725,6m3m,DB01604,-8.6,Pivampicillin,ZEMIJUDPLILVNQ-ZXFNITATSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
130863,6w4h,DB12910,-8.6,Emicerfont,JFHJGXQFESYQGY-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
136403,6w9c,DB07078,-8.6,"(3Z)-6-(4-HYDROXY-3-METHOXYPHENYL)-3-(1H-PYRROL-2-YLMETHYLENE)-1,3-DIHYDRO-2H-INDOL-2-ONE",AYSXURJZVXBSRV-WJDWOHSUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
81789,6m3m,DB01685,-8.6,Topiroxostat,UBVZQGOVTLIHLH-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
139755,6w9c,DB13931,-8.6,Netarsudil,OURRXQUGYQRVML-AREMUKBSSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
134298,6w9c,DB02889,-8.6,"4-O-(4,6-Dideoxy-4-{[4,5,6-Trihydroxy-3-(Hydroxymethyl)Cyclohex-2-En-1-Yl]Amino}-Beta-D-Lyxo-Hexopyranosyl)-Alpha-D-Erythro-Hexopyranose",SNMISNLUIRCRQE-SFSRYZOZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
87894,6m3m,DB13022,-8.6,LY-2874455,GKJCVYLDJWTWQU-CXLRFSCWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
130746,6w4h,DB12720,-8.6,Nivocasan,VYFGDLGHHBUDTQ-ZLGUVYLKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
75232,6m2n,DB04432,-8.6,ZK-805623,ZXIHYCYAQUQHSG-UHFFFAOYSA-O,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
62184,6crv,DB13237,-8.6,Clofoctol,HQVZOORKDNCGCK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
67673,6lxt,DB07029,-8.6,"4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMIDAZOL-1-YL)PHENOXY]-6-METHYLPYRIMIDINE",QQBNDYARFVOEGW-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
114560,6vxx,DB13791,-8.6,Penfluridol,MDLAAYDRRZXJIF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
134333,6w9c,DB02932,-8.6,(R)-Bicalutamide,LKJPYSCBVHEWIU-KRWDZBQOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
77702,6m2n,DB08701,-8.6,"2-(3-BROMOPHENYL)-6-[(2-HYDROXYETHYL)AMINO]-1H-BENZO[DE]ISOQUINOLINE-1,3(2H)-DIONE",JZCUVYNOSDWORZ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
81800,6m3m,DB01698,-8.6,Rutin,IKGXIBQEEMLURG-NVPNHPEKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
75208,6m2n,DB04395,-8.6,Phosphoaminophosphonic Acid-Adenylate Ester,PVKSNHVPLWYQGJ-FCIPNVEPSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
81799,6m3m,DB01697,-8.6,beta-cellotriose,FYGDTMLNYKFZSV-CSHPIKHBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
75184,6m2n,DB04362,-8.6,Adenosine Diphosphate 5-(Beta-Ethyl)-4-Methyl-Thiazole-2-Carboxylic Acid,VGXBGQACJQRWLV-LKGUXBDMSA-K,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
62210,6crv,DB13275,-8.6,Clorindione,NJDUWAXIURWWLN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87905,6m3m,DB13039,-8.6,Aminaphthone,YLMPBJUYFTWHKJ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
130785,6w4h,DB12784,-8.6,NS-018,UQTPDWDAYHAZNT-AWEZNQCLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
138600,6w9c,DB11901,-8.6,Apalutamide,HJBWBFZLDZWPHF-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
62211,6crv,DB13276,-8.6,Idanpramine,HVYGXNYMNHSBGD-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77486,6m2n,DB08439,-8.6,Parecoxib,TZRHLKRLEZJVIJ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
87611,6m3m,DB12573,-8.6,LY-2452473,IHIWYQYVBNODSV-KRWDZBQOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
78314,6m2n,DB11511,-8.6,Difloxacin,NOCJXYPHIIZEHN-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
15930,6lzg,DB01940,-8.6,Balanol Analog 2,SQLYTJZXRRDERK-ISKFKSNPSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
138145,6w9c,DB09231,-8.6,Benidipine,QZVNQOLPLYWLHQ-ZEQKJWHPSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
141828,6w9q,DB01419,-8.6,Antrafenine,NWGGKKGAFZIVBJ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
66377,6lxt,DB04099,-8.6,Deamido-Nad+,SENPVEZBRZQVST-HISDBWNOSA-O,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
78566,6m2n,DB11943,-8.6,Delafloxacin,DYDCPNMLZGFQTM-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138117,6w9c,DB09199,-8.6,Netoglitazone,PKWDZWYVIHVNKS-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
133520,6w9c,DB01792,-8.6,Adenylyl-3'-5'-Phospho-Uridine-3'-Monophosphate,FZCSEXOMUJFOHQ-KPKSGTNCSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
66376,6lxt,DB04098,-8.6,Balanol,XYUFCXJZFZPEJD-PGRDOPGGSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
85403,6m3m,DB07620,-8.6,"2-[(2,4-DICHLORO-5-METHYLPHENYL)SULFONYL]-1,3-DINITRO-5-(TRIFLUOROMETHYL)BENZENE",INAZPZCJNPPHGV-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
131842,6w4h,DB14840,-8.6,Ripretinib,CEFJVGZHQAGLHS-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
81171,6m3m,DB00890,-8.6,Dienestrol,NFDFQCUYFHCNBW-SCGPFSFSSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
146187,6w9q,DB08221,-8.6,N-{4-METHYL-3-[(3-PYRIMIDIN-4-YLPYRIDIN-2-YL)AMINO]PHENYL}-3-(TRIFLUOROMETHYL)BENZAMIDE,NESXBRNDMQUVNG-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
81167,6m3m,DB00885,-8.6,Pemirolast,HIANJWSAHKJQTH-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
139858,6w9c,DB14128,-8.6,Nadide,BAWFJGJZGIEFAR-NNYOXOHSSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
62721,6crv,DB14017,-8.6,H3B-8800,YOIQWBAHJZGRFW-WVRLKXNASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87392,6m3m,DB12262,-8.6,CRS-3123,NNTYBKTXMKBRFA-CQSZACIVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
140410,6w9c,DB06077,-8.6,Lumateperone,HOIIHACBCFLJET-SFTDATJTSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
87394,6m3m,DB12264,-8.6,Atevirdine,UCPOMLWZWRTIAA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
133581,6w9c,DB01873,-8.6,Epothilone D,XOZIUKBZLSUILX-GIQCAXHBSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
74324,6m2n,DB03205,-8.6,Pyrroloquinoline Quinone,MMXZSJMASHPLLR-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138187,6w9c,DB09295,-8.6,Talniflumate,ANMLJLFWUCQGKZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
78524,6m2n,DB11883,-8.6,SB-705498,JYILLRHXRVTRSH-GFCCVEGCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
85339,6m3m,DB07540,-8.6,"4-{5-[(1Z)-1-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)ETHYL]-2-FURYL}BENZENESULFONAMIDE",AKFVRSQELXTCFW-JYRVWZFOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87411,6m3m,DB12285,-8.6,Verubecestat,YHYKUSGACIYRML-KRWDZBQOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
66565,6lxt,DB04348,-8.6,Taurocholic Acid,WBWWGRHZICKQGZ-HZAMXZRMSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
136623,6w9c,DB07337,-8.6,"4-[4-AMINO-6-(5-CHLORO-1H-INDOL-4-YLMETHYL)-[1,3,5]TRIAZIN-2-YLAMINO]-BENZONITRILE",SOKOHDQTKSROQZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
81222,6m3m,DB00947,-8.6,Fulvestrant,VWUXBMIQPBEWFH-WCCTWKNTSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
140419,6w9c,DB06816,-8.6,Pyrvinium,QMHSXPLYMTVAMK-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
81198,6m3m,DB00919,-8.6,Spectinomycin,UNFWWIHTNXNPBV-WXKVUWSESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
138175,6w9c,DB09279,-8.6,Fimasartan,AMEROGPZOLAFBN-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
81191,6m3m,DB00912,-8.6,Repaglinide,FAEKWTJYAYMJKF-QHCPKHFHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
66450,6lxt,DB04194,-8.6,Chitotriose,WZZVUHWLNMNWLW-VFCSDQTKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
131828,6w4h,DB14792,-8.6,AZD-5991,KBQCEQAXHPIRTF-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
85412,6m3m,DB07629,-8.6,"N-((1R,2S)-2-(5-CHLORO-1H-INDOLE-2-CARBOXAMIDO)CYCLOHEXYL)-5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE-2-CARBOXAMIDE",ARPFWVKYXJZULB-DLBZAZTESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
138214,6w9c,DB09378,-8.6,Fluprednisolone,MYYIMZRZXIQBGI-HVIRSNARSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
81159,6m3m,DB00876,-8.6,Eprosartan,OROAFUQRIXKEMV-LDADJPATSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
62746,6crv,DB14065,-8.6,Lomerizine,JQSAYKKFZOSZGJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85481,6m3m,DB07713,-8.6,"(1S)-1-{[(4'-methoxy-1,1'-biphenyl-4-yl)sulfonyl]amino}-2-methylpropylphosphonic acid",BZVYQWLRCHLAGK-KRWDZBQOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
133365,6w9c,DB01591,-8.6,Solifenacin,FBOUYBDGKBSUES-VXKWHMMOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
78652,6m2n,DB12072,-8.6,Orantinib,NHFDRBXTEDBWCZ-ZROIWOOFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
114612,6vxx,DB13856,-8.6,Fluclorolone,VTWKPILBIUBMDS-OTJLYDAYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114613,6vxx,DB13857,-8.6,Demegestone,JWAHBTQSSMYISL-MHTWAQMVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85510,6m3m,DB07747,-8.6,"(3R)-N-(4-CHLOROPHENYL)-3-(HYDROXYMETHYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONAMIDE",YTBGBMPLINFTBQ-OAHLLOKOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
71637,6lxt,DB14944,-8.6,Tarloxotinib,MUJMYVFVAWFUJL-SNAWJCMRSA-O,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
74018,6m2n,DB02799,-8.6,N-[2-(1-Maleimidyl)Ethyl]-7-Diethylaminocoumarin-3-Carboxamide,OJBZDUMTXGGVSP-KTKRTIGZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
142168,6w9q,DB01836,-8.6,"[4-(6-Chloro-Naphthalene-2-Sulfonyl)-Piperazin-1-Yl]-(3,4,5,6-Tetrahydro-2h-[1,4']Bipyridinyl-4-Yl)-Methanone",ZLAKCKVFSRSENR-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
81051,6m3m,DB00751,-8.6,Epinastine,WHWZLSFABNNENI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
71648,6lxt,DB15006,-8.6,Flufenoxuron,RYLHNOVXKPXDIP-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
133361,6w9c,DB01586,-8.6,Ursodeoxycholic acid,RUDATBOHQWOJDD-UZVSRGJWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136711,6w9c,DB07441,-8.6,"3-{[(9-CYANO-9,10-DIHYDRO-10-METHYLACRIDIN-9-YL)CARBONYL]AMINO}PROPANOIC ACID",FRBAOMHMZCGBOJ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
71652,6lxt,DB15013,-8.6,TAK-243,KJDAGXLMHXUAGV-DGWLBADLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
74013,6m2n,DB02790,-8.6,Phenyl-Uridine-5'-Diphosphate,ZHUWBKDWWGKIEN-FMKGYKFTSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138031,6w9c,DB09053,-8.6,Ibrutinib,XYFPWWZEPKGCCK-GOSISDBHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
78635,6m2n,DB12048,-8.6,Savolitinib,XYDNMOZJKOGZLS-NSHDSACASA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
81102,6m3m,DB00813,-8.6,Fentanyl,PJMPHNIQZUBGLI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
131864,6w4h,DB14879,-8.6,Cefiderocol,DBPPRLRVDVJOCL-FQRUVTKNSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131866,6w4h,DB14882,-8.6,CEP-9722,CTLOSZHDGZLOQE-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
74198,6m2n,DB03038,-8.6,LY341770,MXAFDBCLWLMXSI-ZDUSSCGKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
74181,6m2n,DB03010,-8.6,Patupilone,QXRSDHAAWVKZLJ-PVYNADRNSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
66334,6lxt,DB04044,-8.6,4-{2-[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid,NAQUAVBNIYTIIS-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
136670,6w9c,DB07394,-8.6,AUROVERTIN B,QXCOFYWOWZJFEA-YJMRODJJSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
85425,6m3m,DB07644,-8.6,"5-[(1S)-1-(3-chlorophenyl)ethoxy]quinazoline-2,4-diamine",IDHINEMSCUFEIP-VIFPVBQESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
71612,6lxt,DB14899,-8.6,Tavapadon,AKQXQLUNFKDZBN-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
74122,6m2n,DB02929,-8.6,K201,KCWGETCFOVJEPI-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
133466,6w9c,DB01720,-8.6,(2z)-2-(Benzoylamino)-3-[4-(2-Bromophenoxy)Phenyl]-2-Propenoic Acid,WLPJLQNKCJWAFL-RGEXLXHISA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
81132,6m3m,DB00846,-8.6,Flurandrenolide,POPFMWWJOGLOIF-XWCQMRHXSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87337,6m3m,DB12183,-8.6,Sapitinib,DFJSJLGUIXFDJP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
133426,6w9c,DB01668,-8.6,Nanaomycin D,XUWPJKDMEZSVTP-UOSCCXBLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
66140,6lxt,DB03788,-8.6,GC-24,JYHIGYLGYNCMGI-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
62774,6crv,DB14122,-8.6,Dihydroxymethoxychalcone,NYSZJNUIVUBQMM-BQYQJAHWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62739,6crv,DB14054,-8.6,Asiatic acid,JXSVIVRDWWRQRT-UYDOISQJSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81239,6m3m,DB00967,-8.6,Desloratadine,JAUOIFJMECXRGI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
131792,6w4h,DB14716,-8.6,Clonazolam,XJRGLCAWBRZUFC-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
138224,6w9c,DB09488,-8.6,Acrivastine,PWACSDKDOHSSQD-IUTFFREVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
29907,6cs2,DB11794,-8.6,Berzosertib,JZCWLJDSIRUGIN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
78363,6m2n,DB11645,-8.6,PF-4191834,DVNQWYLVSNPCJZ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
140444,6w9c,DB06849,-8.6,"1-[1'-(3-phenylacryloyl)spiro[1-benzofuran-3,4'-piperidin]-5-yl]methanamine",RQWYWHUKHYFIPB-VQHVLOKHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
78378,6m2n,DB11670,-8.6,SP-8203,SJZBPVOSFYUHFV-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78386,6m2n,DB11679,-8.6,Fruquintinib,BALLNEJQLSTPIO-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78392,6m2n,DB11687,-8.6,E-6201,MWUFVYLAWAXDHQ-HMNLTAHHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
87555,6m3m,DB12483,-8.6,Copanlisib,PZBCKZWLPGJMAO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
131623,6w4h,DB14066,-8.6,Tetrandrine,WVTKBKWTSCPRNU-KYJUHHDHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
78396,6m2n,DB11692,-8.6,Pavinetant,QYTBBBAHNIWFOD-NRFANRHFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
131624,6w4h,DB14067,-8.6,Dofequidar,KLWUUPVJTLHYIM-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
136553,6w9c,DB07252,-8.6,"3-({4-[(5-chloro-1,3-benzodioxol-4-yl)amino]pyrimidin-2-yl}amino)benzenesulfonamide",TZHCXOMEOHEZDX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
81385,6m3m,DB01136,-8.6,Carvedilol,OGHNVEJMJSYVRP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
67073,6lxt,DB05408,-8.6,Emricasan,SCVHJVCATBPIHN-SJCJKPOMSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
7881,6lzg,DB04495,-8.6,RU81843,GGPXNASQNUOIPB-NSOVKSMOSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
138391,6w9c,DB11551,-8.6,Trenbolone,MEHHPFQKXOUFFV-OWSLCNJRSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
85144,6m3m,DB07312,-8.6,"2,5-DICHLORO-N-(5-CHLORO-1,3-BENZOXAZOL-2-YL)BENZENESULFONAMIDE",JCXZHFCBNFFHRC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
138418,6w9c,DB11629,-8.6,Laropiprant,NXFFJDQHYLNEJK-CYBMUJFWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140447,6w9c,DB06853,-8.6,N-cycloheptylglycyl-N-(4-carbamimidoylbenzyl)-L-prolinamide,BYTJPDBCLWUEBU-IBGZPJMESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
133919,6w9c,DB02331,-8.6,"(2s)-2-[(5-Benzofuran-2-Yl-Thiophen-2-Ylmethyl)-(2,4-Dichloro-Benzoyl)-Amino]-3-Phenyl-Propionic Acid",YBULOUKTPCHXAL-DEOSSOPVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
131429,6w4h,DB13728,-8.6,Halometasone,GGXMRPUKBWXVHE-MIHLVHIWSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131453,6w4h,DB13764,-8.6,Monoxerutin,MBHXKZDTQCSVPM-BDAFLREQSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131491,6w4h,DB13814,-8.6,Talampicillin,SOROUYSPFADXSN-SUWVAFIASA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
87583,6m3m,DB12532,-8.6,Oxetacaine,FTLDJPRFCGDUFH-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87579,6m3m,DB12524,-8.6,BI-671800,XEOSTBFUCNZKGS-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81411,6m3m,DB01166,-8.6,Cilostazol,RRGUKTPIGVIEKM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
67171,6lxt,DB05944,-8.6,Varlitinib,UWXSAYUXVSFDBQ-CYBMUJFWSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
139762,6w9c,DB13941,-8.6,Piperaquine,UCRHFBCYFMIWHC-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
85105,6m3m,DB07271,-8.6,"4-[(3R)-3-Amino-4-(2,4,5-trifluorophenyl)butanoyl]-3-(2,2,2-trifluoroethyl)-1,4-diazepan-2-one",RMDAPSXWBVPVOG-IAPIXIRKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85110,6m3m,DB07277,-8.6,2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}ETHANESULFONAMIDE,IAUZEBLXCOCAFL-JSGCOSHPSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81397,6m3m,DB01149,-8.6,Nefazodone,VRBKIVRKKCLPHA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
131559,6w4h,DB13943,-8.6,Testosterone cypionate,HPFVBGJFAYZEBE-ZLQWOROUSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
78342,6m2n,DB11592,-8.6,Nitrocefin,LHNIIDJCEODSHA-OQRUQETBSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
87562,6m3m,DB12499,-8.6,Clascoterone,GPNHMOZDMYNCPO-PDUMRIMRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
74526,6m2n,DB03476,-8.6,Trans-6-(2-Phenylcyclopropyl)-Naphthalene-2-Carboxamidine,NQRIWXVAIWPBEM-OALUTQOASA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
81382,6m3m,DB01132,-8.6,Pioglitazone,HYAFETHFCAUJAY-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
67064,6lxt,DB05327,-8.6,Ranirestat,QCVNMNYRNIMDKV-QGZVFWFLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
78415,6m2n,DB11725,-8.6,Latrepirdine,JNODQFNWMXFMEV-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
133665,6w9c,DB01990,-8.6,Cholesterol sulfate,BHYOQNUELFTYRT-DPAQBDIFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
66862,6lxt,DB04750,-8.6,OREGON GREEN 488 CARBOXYLATE,BRJCLSQFZSHLRL-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
78475,6m2n,DB11811,-8.6,Arhalofenate,BJBCSGQLZQGGIQ-QGZVFWFLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
66844,6lxt,DB04724,-8.6,"(S)-2-((S)-3-ISOBUTYL-2,5-DIOXO-4-QUINOLIN-3-YLMETHYL-[1,4]DIAZEPAN-1YL)-N-METHYL-3-NAPHTALEN-2-YL-PROPIONAMIDE",COVPLULNDBDXTN-KYJUHHDHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
133629,6w9c,DB01946,-8.6,"3-[1-(3-Aminopropyl)-1h-Indol-3-Yl]-4-(1-Methyl-1h-Indol-3-Yl)-1h-Pyrrole-2,5-Dione",UQHKJRCFSLMWIA-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
146317,6w9q,DB08386,-8.6,2-{[4-(4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline,VRWJZGHUCOFGPZ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
15882,6lzg,DB01721,-8.6,Analogue of Indinavir Drug,MJIRDPUZGGHJMX-OIVSQUILSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
71530,6lxt,DB14717,-8.6,Nitrazolam,OYRPNABWTHDOFK-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
146295,6w9q,DB08358,-8.6,"2-(2-QUINOLIN-3-YLPYRIDIN-4-YL)-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE",OWFLADWRSCINST-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
85279,6m3m,DB07470,-8.6,"(3aS)-3a-hydroxy-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one",DOMYOVZXZIZTRD-QGZVFWFLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87444,6m3m,DB12325,-8.6,Idasanutlin,TVTXCJFHQKSQQM-LJQIRTBHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85291,6m3m,DB07485,-8.6,"4,4'-cyclohexane-1,1-diyldiphenol",SDDLEVPIDBLVHC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
66774,6lxt,DB04628,-8.6,Allosamidin,MDWNFWDBQGOKNZ-XYUDZHFQSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
114751,6vxx,DB14770,-8.6,Lanraplenib,XCIGZBVOUQVIPI-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138261,6w9c,DB11184,-8.6,Oftasceine,DEGAKNSWVGKMLS-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
81325,6m3m,DB01066,-8.6,Cefditoren,KMIPKYQIOVAHOP-YLGJWRNMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81416,6m3m,DB01172,-8.6,Kanamycin,SBUJHOSQTJFQJX-NOAMYHISSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
139807,6w9c,DB14029,-8.6,Furafylline,HMZQULPVMKITSP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138336,6w9c,DB11424,-8.6,Lufenuron,PWPJGUXAGUPAHP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
85168,6m3m,DB07338,-8.6,Acifluorfen,NUFNQYOELLVIPL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
131716,6w4h,DB14555,-8.6,Ursadiol,RTLXJEJRLWILSU-GWNGJUQLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
62600,6crv,DB13793,-8.6,Vinburnine,WYJAPUKIYAZSEM-MOPGFXCFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136555,6w9c,DB07254,-8.6,"N-[3-[[4-[(5-CHLORO-1,3-BENZODIOXOL-4-YL)AMINO]PYRIMIDIN-2-YL]AMINO]PHENYL]METHANESULFONAMIDE",KQGTYXRWSIBDOZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
85180,6m3m,DB07352,-8.6,Apigenin,KZNIFHPLKGYRTM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
67044,6lxt,DB05220,-8.6,Alisertib,ZLHFILGSQDJULK-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
71461,6lxt,DB14581,-8.6,CPI-1205,HPODOLXTMDHLLC-QGZVFWFLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
78442,6m2n,DB11765,-8.6,PF-04991532,GKMLFBRLRVQVJO-ZDUSSCGKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138345,6w9c,DB11442,-8.6,Oleandomycin,RZPAKFUAFGMUPI-QESOVKLGSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
17166,6cs2,HMDB0006766,-8.6,Estriol-16-Glucuronide,FQYGGFDZJFIDPU-JRSYHJKYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
81327,6m3m,DB01068,-8.6,Clonazepam,DGBIGWXXNGSACT-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
74443,6m2n,DB03355,-8.6,5'-O-(N-(L-Threonyl)-Sulfamoyl)Adenosine,UPVAPSGKXAAHBG-CKTDUXNWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
62617,6crv,DB13816,-8.6,Aspoxicillin,BHELIUBJHYAEDK-OAIUPTLZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85234,6m3m,DB07418,-8.6,bis(4-nitrophenyl) hydrogen phosphate,MHSVUSZEHNVFKW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
66965,6lxt,DB04882,-8.6,Edotecarin,QMVPQBFHUJZJCS-NTKFZFFISA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
146343,6w9q,DB08418,-8.6,"(4aS,4bR,10bS,12aS)-12a-methyl-1,3-dioxo-2-(pyridin-3-ylmethyl)-1,2,3,4,4a,4b,5,6,10b,11,12,12a-dodecahydronaphtho[2,1-f]isoquinolin-8-yl sulfamate",LSJKARAMQNGZDF-YOEKFXIASA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
135805,6w9c,DB05087,-8.6,Ganaxolone,PGTVWKLGGCQMBR-FLBATMFCSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
92578,6m71,DB04591,-8.6,"N-{2,2-DIFLUORO-2-[(2R)-PIPERIDIN-2-YL]ETHYL}-2-[2-(1H-1,2,4-TRIAZOL-1-YL)BENZYL][1,3]OXAZOLO[4,5-C]PYRIDIN-4-AMINE",VYJOAYZRCNHDNG-GOSISDBHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
28800,6cs2,DB08418,-8.6,"(4aS,4bR,10bS,12aS)-12a-methyl-1,3-dioxo-2-(pyridin-3-ylmethyl)-1,2,3,4,4a,4b,5,6,10b,11,12,12a-dodecahydronaphtho[2,1-f]isoquinolin-8-yl sulfamate",LSJKARAMQNGZDF-YOEKFXIASA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
31184,6cs2,DB01029,-8.6,Irbesartan,YOSHYTLCDANDAN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
94926,6m71,DB08703,-8.6,"12-(2-hydroxyethyl)-2-(1-methylethoxy)-13,14-dihydronaphtho[2,1-a]pyrrolo[3,4-c]carbazol-5(12H)-one",FGKKIHITEICGMN-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
120886,6w4b,DB09074,-8.6,Olaparib,FDLYAMZZIXQODN-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
162474,7bv1,DB02319,-8.6,"5,6-Dihydroxy-Nadp",LRAVAOPKUBJONV-IVCJQJMGSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
55425,6crv,DB00990,-8.6,Exemestane,BFYIZQONLCFLEV-DAELLWKTSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31219,6cs2,DB13552,-8.6,Trifluperidol,GPMXUUPHFNMNDH-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
112188,6vxx,DB06529,-8.6,Ocinaplon,OQJFBUOFGHPMSR-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165878,7bv1,DB13164,-8.6,Olmutinib,FDMQDKQUTRLUBU-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
113198,6vxx,DB08657,-8.6,2-(4-(2-((3-(5-(PYRIDIN-2-YLTHIO)THIAZOL-2-YL)UREIDO)METHYL)-1H-IMIDAZOL-4-YL)PHENOXY)ACETIC ACID,SSXCWVOQWRUMGN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
54772,6crv,DB00214,-8.6,Torasemide,NGBFQHCMQULJNZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31262,6cs2,DB13607,-8.6,Picloxydine,YNCLPFSAZFGQCD-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
112190,6vxx,DB06532,-8.6,Pafuramidine,UKOQVLAXCBRRGH-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27175,6cs2,DB06629,-8.6,Zibotentan,FJHHZXWJVIEFGJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
127731,6w4h,DB06755,-8.6,Beta carotene,OENHQHLEOONYIE-JLTXGRSLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
9223,6lzg,DB07307,-8.6,N-cyclopropyl-4-methyl-3-[1-(2-methylphenyl)phthalazin-6-yl]benzamide,GQXMJOSCBRZMKE-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
94971,6m71,DB08749,-8.6,3-(2-AMINO-6-BENZOYLQUINAZOLIN-3(4H)-YL)-N-CYCLOHEXYL-N-METHYLPROPANAMIDE,KTRFBFMYAJOXLG-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
162401,7bv1,DB02008,-8.6,1-(2-Fluorobenzyl)-3-Butyl-8-(N-Acetyl-4-Aminobenzyl)-Xanthine,JHSHXKJSPVHPCJ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
112191,6vxx,DB06533,-8.6,Ragaglitazar,WMUIIGVAWPWQAW-XMMPIXPASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
95029,6m71,DB08815,-8.6,Lurasidone,PQXKDMSYBGKCJA-CVTJIBDQSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
14105,6lzg,T3D3722,-8.6,Verrucarin J,GXCGYHWSYNQVHU-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
13234,6lzg,DB14943,-8.6,LGH-447,VRQXRVAKPDCRCI-ZNMIVQPWSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
161024,7bv1,DB12414,-8.6,Usistapide,WSYALRNYQFNNGP-WJOKGBTCSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
57797,6crv,DB04142,-8.6,"3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid Dimethylamide",FEYGJZKVMASWJB-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
7379,6lzg,DB03712,-8.6,RU85053,CEKLBQMULVLLTD-VMPREFPWSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
109239,6vxx,DB12939,-8.6,Nikkomycin Z,WWJFFVUVFNBJTN-VHDFTHOZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27152,6cs2,DB06589,-8.6,Pazopanib,CUIHSIWYWATEQL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
10247,6lzg,DB08426,-8.6,"THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [2-OXO-1-(1H-PYRROLO[2,3-C]PYRIDIN-2-YLMETHYL)-PYRROLIDIN-3-YL]-AMIDE",PLXOQMHGHDZMSX-AWEZNQCLSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
164515,7bv1,DB08096,-8.6,"8-(2-CHLOROPHENYLAMINO)-2-(2,6-DIFLUOROPHENYLAMINO)-9-ETHYL-9H-PURINE-1,7-DIIUM",ZWKOUFZHPNIQSH-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
159966,7bv1,DB07133,-8.6,D-phenylalanyl-N-(3-methylbenzyl)-L-prolinamide,CHKWABXWPATIIG-UXHICEINSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
57744,6crv,DB04073,-8.6,N-{3-[4-(3-aminopropyl)piperazin-1-yl]propyl}-3-(beta-D-galactopyranosyloxy)-5-nitrobenzamide,UEIGEWJJVQHIAX-DLBZZEGUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
128211,6w4h,DB07340,-8.6,"N-6-cyclohexyl-N-2-(4-morpholin-4-ylphenyl)-9H-purine-2,6-diamine",ZFLJHSQHILSNCM-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
13227,6lzg,DB14934,-8.6,GDC-0927,KJAAPZIFCQQQKX-NDEPHWFRSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
57741,6crv,DB04070,-8.6,6-Deoxyerythronolide B,HQZOLNNEQAKEHT-IBBGRPSASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
13217,6lzg,DB14916,-8.6,Selonsertib,YIDDLAAKOYYGJG-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
114263,6vxx,DB13212,-8.6,Phenolsulfonphthalein,BELBBZDIHDAJOR-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109185,6vxx,DB12494,-8.6,SGI-1776,MHXGEROHKGDZGO-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
164495,7bv1,DB08073,-8.6,(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE,YWTBGJGMTBHQTM-IBGZPJMESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
112177,6vxx,DB06499,-8.6,Furaprofen,ODZUWQAFWMLWCF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
94714,6m71,DB08445,-8.6,"(3R,4S)-1-[6-(6-METHOXYPYRIDIN-3-YL)PYRIMIDIN-4-YL]-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE",IFKWHPAWYJARQJ-DYVFJYSZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
113266,6vxx,DB08737,-8.6,"(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-9-OL",FSYFYSFYUHBIHE-GLJUWKHASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106034,6vxs,DB14859,-8.6,Fosifloxuridine nafalbenamide,BIOWRMNRHMERIO-ZVAHOJSLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
106025,6vxs,DB14844,-8.6,ONC-201,VLULRUCCHYVXOH-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
113261,6vxx,DB08732,-8.6,NALPHA-[(BENZYLOXY)CARBONYL]-N-[(1R)-4-HYDROXY-1-METHYL-2-OXOBUTYL]-L-PHENYLALANINAMIDE,UUOOAGBWJUGBMV-APWZRJJASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
164510,7bv1,DB08091,-8.6,3-FLUORO-5-MORPHOLIN-4-YL-N-[3-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-5-YL]BENZAMIDE,HIUFYIOMUILESI-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
102922,6vxs,DB07966,-8.6,[4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]quinazolin-2-yl}amino)phenyl]acetonitrile,NVMCVWOODOWOLT-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
14157,6lzg,T3D3779,-8.6,Paspalicine,HSFKQYJRJBEWKH-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
109195,6vxx,DB12511,-8.6,Imiglitazar,ULVDFHLHKNJICZ-QCWLDUFUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60508,6crv,DB08732,-8.6,NALPHA-[(BENZYLOXY)CARBONYL]-N-[(1R)-4-HYDROXY-1-METHYL-2-OXOBUTYL]-L-PHENYLALANINAMIDE,UUOOAGBWJUGBMV-APWZRJJASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
164511,7bv1,DB08092,-8.6,3-fluoro-N-1H-indol-5-yl-5-morpholin-4-ylbenzamide,VMLSXFMXUNVCSK-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
99071,6vxs,DB01763,-8.6,7-thionicotinamide-adenine-dinucleotide phosphate,OJNFDOAQUXJWED-NNYOXOHSSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
109198,6vxx,DB12515,-8.6,9-aminocamptothecin,FUXVKZWTXQUGMW-FQEVSTJZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109202,6vxx,DB12522,-8.6,Toreforant,FCRFVPZAXGJLPW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113237,6vxx,DB08707,-8.6,"4-[3-(4-chlorophenyl)-2,1-benzisoxazol-5-yl]pyrimidin-2-amine",AQVFETGXIRKVAQ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
162488,7bv1,DB02336,-8.6,RU83876,WCMLXBUNHNAMNH-UIOOFZCWSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
109204,6vxx,DB12524,-8.6,BI-671800,XEOSTBFUCNZKGS-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
10267,6lzg,DB08446,-8.6,"3-[6-bromo-2-fluoro-3-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)phenoxy]-5-chlorobenzonitrile",OHQMEDBYNUAVNE-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
94772,6m71,DB08513,-8.6,[4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENYL]ACETIC ACID,PAIQRYUOBBCBSE-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
55442,6crv,DB01009,-8.6,Ketoprofen,DKYWVDODHFEZIM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
54767,6crv,DB00206,-8.6,Reserpine,QEVHRUUCFGRFIF-MDEJGZGSSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28171,6cs2,DB07753,-8.6,"3',5'-DIFLUOROBIPHENYL-4-CARBOXYLIC ACID",VCEFNMHMLWBFNV-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
122211,6w4b,DB13055,-8.6,Oteseconazole,IDUYJRXRDSPPRC-NRFANRHFSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
60530,6crv,DB08754,-8.6,"(2E)-3-(3,4-DIHYDROXYPHENYL)-N-[2-(4-HYDROXYPHENYL)ETHYL]ACRYLAMIDE",VSHUQLRHTJOKTA-XBXARRHUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57740,6crv,DB04069,-8.6,"5,6-Dihydro-Benzo[H]Cinnolin-3-Ylamine",QKVREUJWFZJEJK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
124043,6w4h,DB00693,-8.6,Fluorescein,GNBHRKFJIUUOQI-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
121017,6w4b,DB09280,-8.6,Lumacaftor,UFSKUSARDNFIRC-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
13244,6lzg,DB14995,-8.6,NP-G2-044,XLLRLAABUFOJPC-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
109268,6vxx,DB12985,-8.6,Quisinostat,PAWIYAYFNXQGAP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
10188,6lzg,DB08358,-8.6,"2-(2-QUINOLIN-3-YLPYRIDIN-4-YL)-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE",OWFLADWRSCINST-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
109384,6vxx,DB13499,-8.6,Cefsulodin,SYLKGLMBLAAGSC-QLVMHMETSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
95269,6m71,DB09195,-8.6,Lorpiprazole,BNRMWKUVWLKDQJ-YJBOKZPZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60410,6crv,DB08613,-8.6,"2,2,2-TRIFLUORO-1-{5-[(3-PHENYL-5,6-DIHYDROIMIDAZO[1,2-A]PYRAZIN-7(8H)-YL)CARBONYL]THIOPHEN-2-YL}ETHANE-1,1-DIOL",OFBFUNBBOQCNFX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
13288,6lzg,DB15085,-8.6,Fulacimstat,JDARDSVOVYVQST-MRXNPFEDSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
29289,6cs2,DB08974,-8.6,Flubendazole,CPEUVMUXAHMANV-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
161063,7bv1,DB12823,-8.6,Tecarfarin,QFLNTQDOVCLQKW-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
112248,6vxx,DB06883,-8.6,1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-phenylurea,DHNYNLNKNQJSHF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29003,6cs2,DB08639,-8.6,Dapivirine,ILAYIAGXTHKHNT-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
159912,7bv1,DB07072,-8.6,"(1S,2R,5S)-5-[3-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7(8H)-YL]-2-(2,4,5-TRIFLUOROPHENYL)CYCLOHEXANAMINE",CNKRZILQBKJWDS-WMFXKJRFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
164580,7bv1,DB08164,-8.6,"(3R,4R)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN-3-AMINE",GOBIXGZJSMAOFV-QRWLVFNGSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
105141,6vxs,DB13060,-8.6,CEP-37440,BCSHRERPHLTPEE-NRFANRHFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
105136,6vxs,DB13053,-8.6,CP-195543,NZQDWKCNBOELAI-KSFYIVLOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
28536,6cs2,DB08125,-8.6,"4-{[(2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]AMINO}-N-(1,3-THIAZOL-2-YL)BENZENESULFONAMIDE",BOMPRXSVSIPRDT-PTNGSMBKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
270,6lzg,HMDB0003993,-8.6,Alpha-Carotene,ANVAOWXLWRTKGA-JLTXGRSLSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
98619,6vxs,DB01149,-8.6,Nefazodone,VRBKIVRKKCLPHA-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
95350,6m71,DB09319,-8.6,Carindacillin,JIRBAUWICKGBFE-MNRDOXJOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
115549,6w4b,DB00984,-8.6,Nandrolone phenpropionate,UBWXUGDQUBIEIZ-QNTYDACNSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
54807,6crv,DB00252,-8.6,Phenytoin,CXOFVDLJLONNDW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
98600,6vxs,DB01128,-8.6,Bicalutamide,LKJPYSCBVHEWIU-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
60383,6crv,DB08580,-8.6,4-bromo-2-{[(2R)-2-(2-chlorobenzyl)pyrrolidin-1-yl]carbonyl}aniline,JEGGWFHNKPRKTO-CQSZACIVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
103112,6vxs,DB08174,-8.6,"5-CHLORO-N-((1R,2S)-2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO) CYCLOPENTYL)THIOPHENE-2-CARBOXAMIDE",QCPYHSAHOYXXQK-DLBZAZTESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
11774,6lzg,DB12414,-8.6,Usistapide,WSYALRNYQFNNGP-WJOKGBTCSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
158421,7bv1,DB01167,-8.6,Itraconazole,VHVPQPYKVGDNFY-ZPGVKDDISA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
105113,6vxs,DB13019,-8.6,Henatinib,MCTXSDCWFQAGFS-UEXNTNOUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
54810,6crv,DB00257,-8.6,Clotrimazole,VNFPBHJOKIVQEB-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110373,6vxx,DB01524,-8.6,Androstenediol,QADHLRWLCPCEKT-LOVVWNRFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
98515,6vxs,DB01030,-8.6,Topotecan,UCFGDBYHRUNTLO-QHCPKHFHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
103161,6vxs,DB08239,-8.6,"(2S)-4-(2,5-DIFLUOROPHENYL)-N-METHYL-2-PHENYL-N-PIPERIDIN-4-YL-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDE",NKLVBHMAIMEVEH-QFIPXVFZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
113041,6vxx,DB08303,-8.6,"(3S)-3-cyclopentyl-6-methyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide",CUMKMTBOHBENJI-SFHVURJKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58046,6crv,DB04480,-8.6,"3-(4-Fluorophenyl)-2-(6-Methylpyridin-2-Yl)-5,6-Dihydro-4h-Pyrrolo[1,2-B]Pyrazole",NBDZLUOYAAVYHF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106054,6vxs,DB14896,-8.6,Selitrectinib,OEBIHOVSAMBXIB-SJKOYZFVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
28220,6cs2,DB00715,-8.6,Paroxetine,AHOUBRCZNHFOSL-YOEHRIQHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
28997,6cs2,DB08631,-8.6,"N-(4-CHLOROPHENYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONAMIDE",UVSIFVBCHJEYJP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
55397,6crv,DB00956,-8.6,Hydrocodone,LLPOLZWFYMWNKH-CMKMFDCUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
95057,6m71,DB08861,-8.6,DPDPE,MCMMCRYPQBNCPH-WMIMKTLMSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60503,6crv,DB08727,-8.6,"3-Methyl-5-(7-{4-[(4R)-4-methyl-4,5-dihydro-1,3-oxazol-2-yl]phenoxy}heptyl)-1,2-oxazole",NEAZMARKCJKUMF-QGZVFWFLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59577,6crv,DB07629,-8.6,"N-((1R,2S)-2-(5-CHLORO-1H-INDOLE-2-CARBOXAMIDO)CYCLOHEXYL)-5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE-2-CARBOXAMIDE",ARPFWVKYXJZULB-DLBZAZTESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
11685,6lzg,DB12297,-8.6,GLPG-0187,CXHCNOMGODVIKB-VWLOTQADSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
159957,7bv1,DB07124,-8.6,"(2S)-1-(6H-INDOL-3-YL)-3-{[5-(7H-PYRAZOLO[3,4-C]PYRIDIN-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE",CCIACUJJBPSOHE-KRWDZBQOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
26613,6cs2,DB04790,-8.6,"2,5-bis-O-{3-[amino(imino)methyl]phenyl}-1,4:3,6-dianhydro-D-glucitol",IBIUTOFGXGGVKQ-XMTFNYHQSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
102998,6vxs,DB08051,-8.6,"(2R)-4-(2-BENZOYL-1,2-DIAZEPAN-1-YL)-4-OXO-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE",XXRHRPGYYNOBHO-QGZVFWFLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
109292,6vxx,DB13023,-8.6,IPI-493,XYFFWTYOFPSZRM-TWNAANEASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110406,6vxx,DB01557,-8.6,alpha-Methylfentanyl,NGTVDHYUFBKWID-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
158178,7bv1,DB00693,-8.6,Fluorescein,GNBHRKFJIUUOQI-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
26616,6cs2,DB04792,-8.6,"2,5-O,O-BIS-{4',4''-AMIDINOPHENYL}-1,4:3,6-DIANHYDRO-D-SORBITOL",CDEVHSIVANGYRI-XMTFNYHQSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
13264,6lzg,DB15039,-8.6,ITI-214,BBIPVJCGIASXJB-PKTZIBPZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
11695,6lzg,DB12307,-8.6,Foretinib,CXQHYVUVSFXTMY-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
10191,6lzg,DB08361,-8.6,"2-{[(1R,2S)-2-aminocyclohexyl]amino}-4-[(3-methylphenyl)amino]pyrimidine-5-carboxamide",NZNTWOVDIXCHHS-LSDHHAIUSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
60479,6crv,DB08702,-8.6,"2,5-DIPHENYLFURAN-3,4-DICARBOXYLIC ACID",QPKYPOMZPFDBEZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
103023,6vxs,DB08079,-8.6,AMG-208,HEAIZQNMNCHNFD-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
98724,6vxs,DB01289,-8.6,Glisoxepide,ZKUDBRCEOBOWLF-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
158245,7bv1,DB00773,-8.6,Etoposide,VJJPUSNTGOMMGY-MRVIYFEKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
128197,6w4h,DB07325,-8.6,N-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)METHYL]-3-{[(E)-(2-OXODIHYDROFURAN-3(2H)-YLIDENE)METHYL]AMINO}BENZENESULFONAMIDE,VCOKUBHAJVTVNG-FMIVXFBMSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
98710,6vxs,DB01259,-8.6,Lapatinib,BCFGMOOMADDAQU-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
28211,6cs2,DB07792,-8.6,"(S)-2-CHLORO-N-(1-(2-(2-HYDROXYETHYLAMINO)-2-OXOETHYL)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL)-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE",VUKPNWLGSLOHIF-AWEZNQCLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
58715,6crv,DB06465,-8.6,FK-960,XTOKQKWTUYYVAO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60456,6crv,DB08672,-8.6,4-[(3R)-3-{[2-(4-FLUOROPHENYL)-2-OXOETHYL]AMINO}BUTYL]BENZAMIDE,OIWWNWQZJJKBTR-CYBMUJFWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31397,6cs2,DB13767,-8.6,Vorozole,XLMPPFTZALNBFS-INIZCTEOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
98708,6vxs,DB01254,-8.6,Dasatinib,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
31415,6cs2,DB13788,-8.6,Chlorbenzoxamine,VEVSKUJZSMGTMM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
109330,6vxx,DB13080,-8.6,Roluperidone,RNRYULFRLCBRQS-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127776,6w4h,DB06837,-8.6,"(2R)-N-4-hydroxy-2-(3-hydroxybenzyl)-N-1-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]butanediamide",VXDKQRWTOJFQKH-BJZITVGISA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
60447,6crv,DB08659,-8.6,2-(hydrazinocarbonyl)-3-phenyl-1H-indole-5-sulfonamide,PPDLAUCFAOODER-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
116831,6w4b,DB02668,-8.6,"Je-2147, Ag1776, Kni-764",CUFQBQOBLVLKRF-RZDMPUFOSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
113038,6vxx,DB08300,-8.6,"1-methyl-3-naphthalen-2-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine",UOKGZPYGRJDACN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
94682,6m71,DB08406,-8.6,"[N-(2,4-DIAMINOPTERIDIN-6-YL)-METHYL]-DIBENZ[B,F]AZEPINE",NXCCIJQEAKMFGW-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
165539,7bv1,DB12427,-8.6,Orvepitant,XWNBGDJPEXZSQM-VZOBGQTKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
30814,6cs2,DB13019,-8.6,Henatinib,MCTXSDCWFQAGFS-UEXNTNOUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
102671,6vxs,DB07675,-8.6,(2S)-2-ETHOXY-3-{4-[2-(10H-PHENOXAZIN-10-YL)ETHOXY]PHENYL}PROPANOIC ACID,WMUIIGVAWPWQAW-DEOSSOPVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
106402,6vxx,DB00171,-8.6,ATP,ZKHQWZAMYRWXGA-KQYNXXCUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60829,6crv,DB09201,-8.6,Ciglitazone,YZFWTZACSRHJQD-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30102,6cs2,DB12055,-8.6,MK-0767,ORZMUVMQJPGFOM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
94016,6m71,DB07622,-8.6,"1-(3-(2,4-DIMETHYLTHIAZOL-5-YL)-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)-3-(4-METHYLPIPERAZIN-1-YL)UREA",KRKQVGZXTNLQSV-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94024,6m71,DB07630,-8.6,"N-((1R,2R)-2-(5-CHLORO-1H-INDOLE-2-CARBOXAMIDO)CYCLOHEXYL)-5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE-2-CARBOXAMIDE",ARPFWVKYXJZULB-IAGOWNOFSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
163058,7bv1,DB03714,-8.6,4-Carbamoyl-4-{[6-(Difluoro-Phosphono-Methyl)-Naphthalene-2-Carbonyl]-Amino}-Butyric Acid,OWWCIKSGGKYNHT-ZDUSSCGKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
106332,6vxs,DB03453,-8.6,Methyl (2S)-2-[[2-[(3R)-1-carbamimidoylpiperidin-3-yl]acetyl]amino]-3-[4-(2-phenylethynyl)phenyl]propanoate,MRNGXYMKYHNMLV-PKTZIBPZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
94053,6m71,DB07666,-8.6,"(3R,4S)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE",OAWGQHXWGXOUKV-BEFAXECRSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
127551,6w4h,DB06347,-8.6,Cenisertib,KSOVGRCOLZZTPF-QMKUDKLTSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
40346,6lu7,DB12983,-8.6,Phthalocyanine,IEQIEDJGQAUEQZ-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
94065,6m71,DB07680,-8.6,[(1S)-1-(5-CHLORO-1-BENZOTHIEN-3-YL)-2-(2-NAPHTHYLAMINO)-2-OXOETHYL]PHOSPHONIC ACID,HUJXISJLAPAFBO-IBGZPJMESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59479,6crv,DB07512,-8.6,7-[(3-CHLOROBENZYL)OXY]-2-OXO-2H-CHROMENE-4-CARBALDEHYDE,ZOCADHRNWNJARU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
99397,6vxs,DB02205,-8.6,"6-(1,1-Dimethylallyl)-2-(1-Hydroxy-1-Methylethyl)-2,3-Dihydro-7h-Furo[3,2-G]Chromen-7-One",JCDLLLXYAICSQV-INIZCTEOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
106288,6vxs,DB15399,-8.6,BMS-754807,LQVXSNNAFNGRAH-QHCPKHFHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
120351,6w4b,DB08387,-8.6,2-{[4-(1-methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline,AZEXWHKOMMASPA-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
57284,6crv,DB03449,-8.6,N-(4-(2-((3-Chlorophenylmethyl)Amino)Ethyl)Phenyl)-2-Thiophecarboxamidine,ZZVGLDBDD1AB-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106282,6vxs,DB15385,-8.6,Acebilustat,GERJIEKMNDGSCS-DQEYMECFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
60783,6crv,DB09124,-8.6,Medrogestone,HCFSGRMEEXUOSS-JXEXPEPMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60780,6crv,DB09119,-8.6,Eslicarbazepine acetate,QIALRBLEEWJACW-INIZCTEOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112102,6vxx,DB06281,-8.6,Torcetrapib,CMSGWTNRGKRWGS-NQIIRXRSSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27339,6cs2,DB06876,-8.6,"N-{5-[4-(4-METHYLPIPERAZIN-1-YL)PHENYL]-1H-PYRROLO[2,3-B]PYRIDIN-3-YL}NICOTINAMIDE",YJWJKKXGAPWLGT-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
58813,6crv,DB06696,-8.6,Arbekacin,MKKYBZZTJQGVCD-XTCKQBCOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
157206,6wiq,DB14785,-8.6,Fenebrutinib,WNEODWDFDXWOLU-QHCPKHFHSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
112109,6vxx,DB06306,-8.6,Onalespib,IFRGXKKQHBVPCQ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
102706,6vxs,DB07716,-8.6,"(4Z)-2,8:7,12:11,15:14,18:17,22-PENTAANHYDRO-4,5,6,9,10,13,19,20,21-NONADEOXY-D-ARABINO-D-ALLO-D-ALLO-DOCOSA-4,9,20-TRIENITOL",VDRIXSJOPKVWKM-HXGIDPQASA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
113462,6vxx,DB09215,-8.6,Droxicam,OEHFRZLKGRKFAS-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113448,6vxx,DB09200,-8.6,Rivoglitazone,XMSXOLDPMGMWTH-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112097,6vxx,DB06268,-8.6,Sitaxentan,PHWXUGHIIBDVKD-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106411,6vxx,DB00180,-8.6,Flunisolide,XSFJVAJPIHIPKU-XWCQMRHXSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
129363,6w4h,DB08710,-8.6,"(5Z)-5-[(5-ETHYL-2-FURYL)METHYLENE]-2-{[(S)-(4-FLUOROPHENYL)(1H-TETRAZOL-5-YL)METHYL]AMINO}-1,3-THIAZOL-4(5H)-ONE",BKZOQCGDCHOGOQ-MZLJFPOFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
127537,6w4h,DB06302,-8.6,Glesatinib,YRCHYHRCBXNYNU-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
99809,6vxs,DB02738,-8.6,Adenosine-5'-Pentaphosphate,WYJWVZZCMBUPSP-KQYNXXCUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
106502,6vxx,DB00421,-8.6,Spironolactone,LXMSZDCAJNLERA-ZHYRCANASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
164419,7bv1,DB07809,-8.6,4-({[4-(3-METHYLBENZOYL)PYRIDIN-2-YL]AMINO}METHYL)BENZENECARBOXIMIDAMIDE,MBJYEMUMDMGQQC-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93741,6m71,DB07297,-8.6,"5,6-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-D]PYRIMIDIN-4-AMINE",PTILEOLOGGMFCS-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
26134,6cs2,DB04204,-8.6,[(4-{4-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Butyl}-Phenyl)-Difluoro-Methyl]-Phosphonic Acid,SRHSAABKYJDBDV-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
57115,6crv,DB03221,-8.6,AL7099A,RMOXCYSVWCHXII-GFCCVEGCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57116,6crv,DB03222,-8.6,dATP,SUYVUBYJARFZHO-RRKCRQDMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28637,6cs2,DB08233,-8.6,6-CYCLOHEXYLMETHYLOXY-2-(4'-HYDROXYANILINO)PURINE,RFSDQDHHBKYQOD-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
40338,6lu7,DB04868,-8.6,Nilotinib,HHZIURLSWUIHRB-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
9296,6lzg,DB07382,-8.6,"N-2-1H-benzimidazol-5-yl-N-4-(3-cyclopropyl-1H-pyrazol-5-yl)pyrimidine-2,4-diamine",WJNBSTLIALIIEW-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
160900,7bv1,DB11890,-8.6,Cilengitide,AMLYAMJWYAIXIA-VWNVYAMZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60894,6crv,DB09290,-8.6,Ramosetron,NTHPAPBPFQJABD-LLVKDONJSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
123852,6w4h,DB00457,-8.6,Prazosin,IENZQIKPVFGBNW-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
113565,6vxx,DB11522,-8.6,Isoflupredone,WAIJIHDWAKJCBX-BULBTXNYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60760,6crv,DB09080,-8.6,Olodaterol,COUYJEVMBVSIHV-SFHVURJKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
128269,6w4h,DB07409,-8.6,"(1-HYDROXY-1-PHOSPHONO-2-[1,1';4',1'']TERPHENYL-3-YL-ETHYL)-PHOSPHONIC ACID",MPBUFKZCEBTBSK-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
93835,6m71,DB07405,-8.6,"1-(6-CYANO-3-PYRIDYLCARBONYL)-5',8'-DIFLUOROSPIRO[PIPERIDINE-4,2'(1'H)-QUINAZOLINE]-4'-AMINE",GIZYIOOBBUHOBS-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
164436,7bv1,DB07827,-8.6,"4-{[1-METHYL-2,4-DIOXO-6-(3-PHENYLPROP-1-YN-1-YL)-1,4-DIHYDROQUINAZOLIN-3(2H)-YL]METHYL}BENZOIC ACID",FLTYDFYSVZBKOB-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
113564,6vxx,DB11521,-8.6,Imidocarb,SCEVFJUWLLRELN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110630,6vxx,DB02033,-8.6,"N-(3-Cyclopropyl(5,6,7,8,9,10-Hexahydro-2-Oxo-2h-Cycloocta[B]Pyran-3-Yl)Methyl)Phenylbenzensulfonamide",GDRNWAKVNIROCG-DEOSSOPVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
93849,6m71,DB07422,-8.6,(2S)-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]-3-(pentafluorophenoxy)propanamide,MMNRWNREMUMYQG-INIZCTEOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
163161,7bv1,DB03837,-8.6,Morpholine-4-Carboxylic Acid (1-(3-Benzenesulfonyl-1-Phenethylallylcarbamoyl)-3-Methylbutyl)-Amide,YUMYYTORLYHUFW-ZUDLOMHPSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
30799,6cs2,DB12998,-8.6,PF-00217830,QGNOXTFZOLDODX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
163151,7bv1,DB03823,-8.6,Epigallocatechin,XMOCLSLCDHWDHP-IUODEOHRSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
109008,6vxx,DB11900,-8.6,OC-459,FATGTHLOZSXOBC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27370,6cs2,DB06908,-8.6,"(2S)-3-(1-{[2-(2-CHLOROPHENYL)-5-METHYL-1,3-OXAZOL-4-YL]METHYL}-1H-INDOL-5-YL)-2-ETHOXYPROPANOIC ACID",PAWOPJKHTZCKMT-QFIPXVFZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
112080,6vxx,DB06237,-8.6,Avanafil,WEAJZXNPAWBCOA-INIZCTEOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127535,6w4h,DB06295,-8.6,Pramiconazole,AEKNYBWUEYNWMJ-QWOOXDRHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
8605,6lzg,DB06494,-8.6,Sufugolix,UCQSBGOFELXYIN-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
109011,6vxx,DB11903,-8.6,GW842166,TWQYWUXBZHPIIV-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
93828,6m71,DB07397,-8.6,"(5S)-5-(2-amino-2-oxoethyl)-4-oxo-N-[(3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl)methyl]-3,4,5,6,7,8-hexahydro[1]benzothieno[2,3-d]pyrimidine-2-carboxamide",ITADELAVAWJACR-NSHDSACASA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
165507,7bv1,DB12207,-8.6,Verdinexor,OPAKEJZFFCECPN-XQRVVYSFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
102727,6vxs,DB07741,-8.6,"4-(1R,3AS,4R,8AS,8BR)-[1-DIFLUOROMETHYL-2-(4-FLUOROBENZYL)-3-OXODECAHYDROPYRROLO[3,4-A]PYRROLIZIN-4-YL]BENZAMIDINE",VPNYXOTTXAXSIH-SXYSDOLCSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
57292,6crv,DB03460,-8.6,Violaxanthin,SZCBXWMUOPQSOX-WVJDLNGLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
125211,6w4h,DB02197,-8.6,"4-[(4-Imidazo[1,2-a]Pyridin-3-Ylpyrimidin-2-Yl)Amino]Benzenesulfonamide",NKORVPQBJCGYEC-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
94453,6m71,DB08124,-8.6,"3-{[(2,2-DIOXIDO-1,3-DIHYDRO-2-BENZOTHIEN-5-YL)AMINO]METHYLENE}-5-(1,3-OXAZOL-5-YL)-1,3-DIHYDRO-2H-INDOL-2-ONE",FTQYGMLRLRXBPT-IDUWFGFVSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
57499,6crv,DB03753,-8.6,Flurbiprofen Methyl Ester,CPJBKHZROFMSQM-NSHDSACASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55494,6crv,DB01068,-8.6,Clonazepam,DGBIGWXXNGSACT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109132,6vxx,DB12417,-8.6,Anagliptin,LDXYBEHACFJIEL-HNNXBMFYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28566,6cs2,DB08154,-8.6,3-chloro-5-[2-chloro-5-(1H-indazol-3-ylmethoxy)phenoxy]benzonitrile,WHCLIFOVZDANCU-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
94481,6m71,DB08154,-8.6,3-chloro-5-[2-chloro-5-(1H-indazol-3-ylmethoxy)phenoxy]benzonitrile,WHCLIFOVZDANCU-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59523,6crv,DB07563,-8.6,"1-{7-cyclohexyl-6-[4-(4-methylpiperazin-1-yl)benzyl]-7H-pyrrolo[2,3-d]pyrimidin-2-yl}methanamine",GCJSOJRPNOWSEH-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
102845,6vxs,DB07872,-8.6,5-chloro-N-[(3R)-1-(2-{[2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl]amino}-2-oxoethyl)pyrrolidin-3-yl]thiophene-2-carboxamide,IYGIXVNAMZPBDK-CQSZACIVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
59524,6crv,DB07564,-8.6,"6-amino-2-[(2-morpholin-4-ylethyl)amino]-3,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",JUHXOBNFTFUPKQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112167,6vxx,DB06472,-8.6,Fradafiban,IKZACQMAVUIGPY-HOTGVXAUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57527,6crv,DB03785,-8.6,"(3r,5r)-7-((1r,2r,6s,8r,8as)-2,6-Dimethyl-8-{[(2r)-2-Methylbutanoyl]Oxy}-1,2,6,7,8,8a-Hexahydronaphthalen-1-Yl)-3,5-Dihydroxyheptanoic Acid",QLJODMDSTUBWDW-BXMDZJJMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30110,6cs2,DB12064,-8.6,BMS-777607,VNBRGSXVFBYQNN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
99123,6vxs,DB01831,-8.6,Tryptophanyl-5'amp,IFQVDHDRFCKAAW-SQIXAUHQSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
159990,7bv1,DB07162,-8.6,4-(3-amino-1H-indazol-5-yl)-N-tert-butylbenzenesulfonamide,KFJCXIOVAGJCKB-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
113326,6vxx,DB08997,-8.6,Dexetimide,LQQIVYSCPWCSSD-HSZRJFAPSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109152,6vxx,DB12443,-8.6,Sonedenoson,WUCQGGOGHZRELS-LSCFUAHRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109161,6vxx,DB12459,-8.6,Belotecan,LNHWXBUNXOXMRL-VWLOTQADSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
94635,6m71,DB08349,-8.6,"N-cyclopropyl-3-{[1-(2,4-difluorophenyl)-7-methyl-6-oxo-6,7-dihydro-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}-4-methylbenzamide",WMEYCLAVMZKZCS-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
11558,6lzg,DB12128,-8.6,Ulimorelin,WGYPAJVJMXQXTR-ABNZCKJZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
125150,6w4h,DB02112,-8.6,Zk-806450,DZLGSWPXZYDHBD-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
27239,6cs2,DB06732,-8.6,beta-Naphthoflavone,OUGIDAPQYNCXRA-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
27238,6cs2,DB06731,-8.6,Seproxetine,WIQRCHMSJFFONW-HNNXBMFYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
162650,7bv1,DB02741,-8.6,CD564,RWYREGSYPCNZTL-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
31048,6cs2,DB13347,-8.6,Diphenadione,JYGLAHSAISAEAL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
127660,6w4h,DB06630,-8.6,Anacetrapib,MZZLGJHLQGUVPN-HAWMADMCSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
10288,6lzg,DB08470,-8.6,"3-(4-fluorophenyl)-5-phenyl-4H-1,2,4-triazole",KMGPJKOKSYGMJD-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
122250,6w4b,DB13109,-8.6,PKI-179,WXUUCRLKXQMWRY-OYRHEFFESA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
113275,6vxx,DB08746,-8.6,1-[[(1E)-2-(4-CHLOROPHENYL)ETHENYL]SULFONYL]-4-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]PIPERAZINE,ZOSSOFIFNGGDKG-GIJQJNRQSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127662,6w4h,DB06634,-8.6,Casopitant,XGGTZCKQRWXCHW-WMTVXVAQSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
127658,6w4h,DB06626,-8.6,Axitinib,RITAVMQDGBJQJZ-FMIVXFBMSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
57601,6crv,DB03880,-8.6,Batimastat,XFILPEOLDIKJHX-QYZOEREBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55514,6crv,DB01092,-8.6,Ouabain,LPMXVESGRSUGHW-HBYQJFLCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113358,6vxx,DB09047,-8.6,Finafloxacin,FYMHQCNFKNMJAV-HOTGVXAUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
26785,6cs2,DB05220,-8.6,Alisertib,ZLHFILGSQDJULK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
13171,6lzg,DB14840,-8.6,Ripretinib,CEFJVGZHQAGLHS-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
114480,6vxx,DB13682,-8.6,Cefpirome,DKOQGJHPHLTOJR-WHRDSVKCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58801,6crv,DB06673,-8.6,Almorexant,DKMACHNQISHMDN-RPLLCQBOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106240,6vxs,DB15295,-8.6,Tenalisib,HDXDQPRPFRKGKZ-INIZCTEOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
57314,6crv,DB03490,-8.6,"3-Pyridin-4-Yl-2,4-Dihydro-Indeno[1,2-.C.]Pyrazole",NHOACLCXCKJMAK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106237,6vxs,DB15292,-8.6,Foliglurax,ZTEDNASHAWNBKQ-NCELDCMTSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
40354,6lu7,DB15399,-8.6,BMS-754807,LQVXSNNAFNGRAH-QHCPKHFHSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
113425,6vxx,DB09177,-8.6,p-Fluorofentanyl,KXUBAVLIJFTASZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
14252,6lzg,T3D3887,-8.6,Milbemectin (mixture),VOZIAWLUULBIPN-LRBNAKOISA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
57322,6crv,DB03501,-8.6,Galactose-uridine-5'-diphosphate,HSCJRCZFDFQWRP-ABVWGUQPSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127587,6w4h,DB06455,-8.6,Meclinertant,DYLJVOXRWLXDIG-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
112126,6vxx,DB06362,-8.6,Becatecarin,JSKFWUPVIZYJMR-UDOAKELVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
102788,6vxs,DB07809,-8.6,4-({[4-(3-METHYLBENZOYL)PYRIDIN-2-YL]AMINO}METHYL)BENZENECARBOXIMIDAMIDE,MBJYEMUMDMGQQC-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
109125,6vxx,DB12408,-8.6,PF-03635659,WGOJWDWKHJHXSV-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
8663,6lzg,DB06630,-8.6,Anacetrapib,MZZLGJHLQGUVPN-HAWMADMCSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
162952,7bv1,DB03336,-8.6,BIA,KVIVJQWOYSWCCZ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
162945,7bv1,DB03325,-8.6,Tyrosyladenylate,MJZAZMKENKZBAJ-QTOWJTHWSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110510,6vxx,DB01864,-8.6,5'-Guanosine-Diphosphate-Monothiophosphate,XOFLBQFBSOEHOG-UUOKFMHZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
162850,7bv1,DB03207,-8.6,"2-(Biphenyl-4-Sulfonyl)-1,2,3,4-Tetrahydro-Isoquinoline-3-Carboxylic Acid",BNVMUDXGABBWGP-OAQYLSRUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94374,6m71,DB08034,-8.6,"(E)-3,4-DIHYDROXY-N'-[(2-METHOXYNAPHTHALEN-1-YL)METHYLENE]BENZOHYDRAZIDE",TVOPERZEGKBKAY-RGVLZGJSSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
30910,6cs2,DB13158,-8.6,Clobetasone,XXIFVOHLGBURIG-OZCCCYNHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
94376,6m71,DB08036,-8.6,"6,7,12,13-tetrahydro-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazol-5-one",MEXUTNIFSHFQRG-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
106176,6vxs,DB15170,-8.6,Evobrutinib,QUIWHXQETADMGN-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
57417,6crv,DB03647,-8.6,3-[Isopropyl(4-Methylbenzoyl)Amino]-5-Phenylthiophene-2-Carboxylic Acid,LRHXIDOGMBZJFN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
13197,6lzg,DB14879,-8.6,Cefiderocol,DBPPRLRVDVJOCL-FQRUVTKNSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
94401,6m71,DB08068,-8.6,N-[4-CHLORO-3-(PYRIDIN-3-YLOXYMETHYL)-PHENYL]-3-FLUORO-,YQJVDUKATDECHF-ICSRJNTNSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
157607,6wiq,DB12185,-8.6,Exatecan,ZVYVPGLRVWUPMP-FYSMJZIKSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
128228,6w4h,DB07359,-8.6,"3-[(4-fluorophenyl)sulfanyl]-N-(4-methyl-1,3-thiazol-2-yl)-6-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]pyridine-2-carboxamide",SJTQKYKXCYVFHX-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
162750,7bv1,DB02873,-8.6,"1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperazin-1-Yl-3,4-Dihydroquinazolin-2(1h)-One",YAWZIQKDHQIHOS-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
49094,2fxp,DB04016,-8.6,2-[3-({Methyl[1-(2-Naphthoyl)Piperidin-4-Yl]Amino}Carbonyl)-2-Naphthyl]-1-(1-Naphthyl)-2-Oxoethylphosphonic Acid,XUJQPDQURBZEGJ-KXQOOQHDSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
58678,6crv,DB06358,-8.6,Iclaprim,HWJPWWYTGBZDEG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
128755,6w4h,DB07982,-8.6,2-{4-[4-({4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]pyrimidin-2-yl}amino)phenyl]piperazin-1-yl}-2-oxoethanol,PVTKDXZNSUHUMO-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
13317,6lzg,DB15133,-8.6,Tepotinib,AHYMHWXQRWRBKT-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
112698,6vxx,DB07743,-8.6,"S-[5-(TRIFLUOROMETHYL)-4H-1,2,4-TRIAZOL-3-YL] 5-(PHENYLETHYNYL)FURAN-2-CARBOTHIOATE",VNGWUVBXUIDQTK-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
13481,6lzg,DB15444,-8.6,Elexacaftor,MVRHVFSOIWFBTE-INIZCTEOSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
96512,6m71,DB13029,-8.6,MK-0873,JJWKQXNHYDJXKF-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
112401,6vxx,DB07059,-8.6,"N-{2-[6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2,2-DIMETHYL-3-OXO-2,3-DIHYDRO-4H-1,4-BENZOXAZIN-4-YL]ETHYL}ACETAMIDE",GBXSOZDYCSBLQX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165747,7bv1,DB12746,-8.6,AKN-028,JLRIJKVMMZEKDF-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96526,6m71,DB13055,-8.6,Oteseconazole,IDUYJRXRDSPPRC-NRFANRHFSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110041,6vxx,DB00737,-8.6,Meclizine,OCJYIGYOJCODJL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
96550,6m71,DB13089,-8.6,Enoxolone,MPDGHEJMBKOTSU-YKLVYJNSSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
12256,6lzg,DB13104,-8.6,X-396,ONPGOSVDVDPBCY-CQSZACIVSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
165743,7bv1,DB12742,-8.6,Amuvatinib,FOFDIMHVKGYHRU-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
54967,6crv,DB00445,-8.6,Epirubicin,AOJJSUZBOXZQNB-VTZDEGQISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112405,6vxx,DB07064,-8.6,"(4R)-4-(3-HYDROXYPHENYL)-N,N,7,8-TETRAMETHYL-3,4-DIHYDROISOQUINOLINE-2(1H)-CARBOXAMIDE",HPVCRUIDFODATB-LJQANCHMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59842,6crv,DB07938,-8.6,"5-[[(2R)-2-cyclopropyl-7,8-dimethoxy-chroman-5-yl]methyl]pyrimidine-2,4-diamine",HWJPWWYTGBZDEG-CQSZACIVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
164760,7bv1,DB08572,-8.6,4-{[4-AMINO-6-(CYCLOHEXYLMETHOXY)-5-NITROSOPYRIMIDIN-2-YL]AMINO}BENZAMIDE,YBKLJTXDSBEVRV-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
109795,6vxx,DB00266,-8.6,Dicoumarol,DOBMPNYZJYQDGZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29131,6cs2,DB08770,-8.6,"4-{2-[(7-amino-2-furan-2-yl[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-yl)amino]ethyl}phenol",PWTBZOIUWZOPFT-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
112640,6vxx,DB07489,-8.6,"4-Amino-2-[(3-chlorophenyl)amino]-5-(4-fluorobenzoyl)-1,3-thiazol-3-ium",WWGPTHOMFHDEEC-UHFFFAOYSA-O,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
128041,6w4h,DB07147,-8.6,"methyl (1R,2S)-2-(hydroxycarbamoyl)-1-{4-[(2-methylquinolin-4-yl)methoxy]benzyl}cyclopropanecarboxylate",HJWMYFBKJRVWJY-YKSBVNFPSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
103883,6vxs,DB09198,-8.6,Lobeglitazone,CHHXEZSCHQVSRE-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
58411,6crv,DB05087,-8.6,Ganaxolone,PGTVWKLGGCQMBR-FLBATMFCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
97583,6m71,DB15206,-8.6,Uprifosbuvir,SFPFZQKYPOWCSI-KHFYHRBSSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
58549,6crv,DB05884,-8.6,HCV-086,VBRUONUESYTIDA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55075,6crv,DB00580,-8.6,Valdecoxib,LNPDTQAFDNKSHK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
7336,6lzg,DB03642,-8.6,Benzofuran-2-Carboxylic Acid {(S)-3-Methyl-1-[3-Oxo-1-(Pyridin-2-Ylsulfonyl)Azepan-4-Ylcarbamoyl]Butyl}Amide,VBPPNJCVXGAZDD-PMACEKPBSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
96875,6m71,DB13563,-8.6,Norgestrienone,GVDMJXQHPUYPHP-FYQPLNBISA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
103916,6vxs,DB09235,-8.6,Efonidipine,NSVFSAJIGAJDMR-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
96905,6m71,DB13607,-8.6,Picloxydine,YNCLPFSAZFGQCD-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
104398,6vxs,DB11942,-8.6,Selinexor,DEVSOMFAQLZNKR-RJRFIUFISA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104391,6vxs,DB11934,-8.6,Epelsiban,UWHCWRQFNKUYCG-QUZACWSFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
96478,6m71,DB12978,-8.6,Pexidartinib,JGWRKYUXBBNENE-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
109757,6vxx,DB00223,-8.6,Diflorasone,WXURHACBFYSXBI-XHIJKXOTSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112717,6vxx,DB07764,-8.6,FLUORESCIN,MURGITYSBWUQTI-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
103809,6vxs,DB09070,-8.6,Tibolone,WZDGZWOAQTVYBX-XOINTXKNSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
28463,6cs2,DB08052,-8.6,"1-cyclopentyl-3-(1H-pyrrolo[2,3-b]pyridin-5-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine",NVRXTLZYXZNATH-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
110135,6vxx,DB01016,-8.6,Glyburide,ZNNLBTZKUZBEKO-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60105,6crv,DB08240,-8.6,N-(4-CHLOROPHENYL)-3-(PHOSPHONOOXY)NAPHTHALENE-2-CARBOXAMIDE,RQAQWBFHPMSXKR-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
124498,6w4h,DB01215,-8.6,Estazolam,CDCHDCWJMGXXRH-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
104524,6vxs,DB12127,-8.6,Sultamicillin,OPYGFNJSCUDTBT-PMLPCWDUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
161533,7bv1,DB15029,-8.6,AZD-8186,LMJFJIDLEAWOQJ-CQSZACIVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96315,6m71,DB12719,-8.6,Turofexorate isopropyl,INASOKQDNHHMRE-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
13459,6lzg,DB15403,-8.6,Ziritaxestat,REQQVBGILUTQNN-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
112744,6vxx,DB07795,-8.6,Fisetin,XHEFDIBZLJXQHF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
128013,6w4h,DB07117,-8.6,"5-(4-PHENOXYPHENYL)-5-(4-PYRIMIDIN-2-YLPIPERAZIN-1-YL)PYRIMIDINE-2,4,6(2H,3H)-TRIONE",FMKQJGOROFNCGM-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
104505,6vxs,DB12101,-8.6,CC-220,IXZOHGPZAQLIBH-NRFANRHFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
121539,6w4b,DB12044,-8.6,MK-0893,DNTVJEMGHBIUMW-IBGZPJMESA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
96355,6m71,DB12784,-8.6,NS-018,UQTPDWDAYHAZNT-AWEZNQCLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96360,6m71,DB12794,-8.6,p-Quaterphenyl,GPRIERYVMZVKTC-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
109824,6vxx,DB00298,-8.6,Dapiprazole,RFWZESUMWJKKRN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104500,6vxs,DB12096,-8.6,PF-05175157,BDXXSFOJPYSYOC-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
165788,7bv1,DB13016,-8.6,LY-2300559,DWQVYDLTPMGYNE-DEOSSOPVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
12287,6lzg,DB13164,-8.6,Olmutinib,FDMQDKQUTRLUBU-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
96388,6m71,DB12843,-8.6,Oleandrin,JLPDBLFIVFSOCC-XYXFTTADSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110107,6vxx,DB00984,-8.6,Nandrolone phenpropionate,UBWXUGDQUBIEIZ-QNTYDACNSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59836,6crv,DB07932,-8.6,"dimethyl (1R,4S)-5,6-bis(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hepta-2,5-diene-2,3-dicarboxylate",CRLQCBACIMUGDZ-BGYRXZFFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55135,6crv,DB00654,-8.6,Latanoprost,GGXICVAJURFBLW-CEYXHVGTSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
32026,6cs2,DB15224,-8.6,Lisavanbulin,NIPZLALJRAHABJ-IBGZPJMESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
97617,6m71,DB15275,-8.6,GDC-0077,SGEUNORSOZVTOL-CABZTGNLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
104468,6vxs,DB12048,-8.6,Savolitinib,XYDNMOZJKOGZLS-NSHDSACASA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
112728,6vxx,DB07778,-8.6,FAMOXADONE,PCCSBWNGDMYFCW-QFIPXVFZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55134,6crv,DB00652,-8.6,Pentazocine,VOKSWYLNZZRQPF-GDIGMMSISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
124465,6w4h,DB01180,-8.6,Rescinnamine,SZLZWPPUNLXJEA-LAFLMMDJSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
124419,6w4h,DB01128,-8.6,Bicalutamide,LKJPYSCBVHEWIU-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
96436,6m71,DB12914,-8.6,MGL-3196,FDBYIYFVSAHJLY-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59824,6crv,DB07920,-8.6,N-oxo-2-[(4-phenylphenyl)sulfonylamino]ethanamide,OGRPZMQLAVBWPV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165717,7bv1,DB12706,-8.6,Seletalisib,LNLJHGXOFYUARS-OAQYLSRUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
104386,6vxs,DB11922,-8.6,Danirixin,NGYNBSHYFOFVLS-LBPRGKRZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
109839,6vxx,DB00317,-8.6,Gefitinib,XGALLCVXEZPNRQ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
97336,6m71,DB14662,-8.6,Flunisolide acetate,WEGNFRKBIKYVLC-XTLNBZDDSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
104152,6vxs,DB11521,-8.6,Imidocarb,SCEVFJUWLLRELN-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
159608,7bv1,DB04903,-8.6,Pagoclone,HIUPRQPBWVEQJJ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
109924,6vxx,DB00596,-8.6,Ulobetasol,LEHFPXVYPMWYQD-XHIJKXOTSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110013,6vxx,DB00704,-8.6,Naltrexone,DQCKKXVULJGBQN-XFWGSAIBSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59928,6crv,DB08034,-8.6,"(E)-3,4-DIHYDROXY-N'-[(2-METHOXYNAPHTHALEN-1-YL)METHYLENE]BENZOHYDRAZIDE",TVOPERZEGKBKAY-RGVLZGJSSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104280,6vxs,DB11772,-8.6,Pilaralisib,QINPEPAQOBZPOF-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
58469,6crv,DB05431,-8.6,MLN-977,YANONWCPCKIWEC-CABCVRRESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109990,6vxx,DB00678,-8.6,Losartan,PSIFNNKUMBGKDQ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104273,6vxs,DB11763,-8.6,Momelotinib,ZVHNDZWQTBEVRY-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
31974,6cs2,DB15132,-8.6,AZD-8165,YUHNXUAATAMVKD-PZJWPPBQSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
115845,6w4b,DB01395,-8.6,Drospirenone,METQSPRSQINEEU-HXCATZOESA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
109985,6vxx,DB00673,-8.6,Aprepitant,ATALOFNDEOCMKK-OITMNORJSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104243,6vxs,DB11712,-8.6,Tezacaftor,MJUVRTYWUMPBTR-MRXNPFEDSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
26819,6cs2,DB05414,-8.6,Pipendoxifene,JICOGKJOQXTAIP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
159501,7bv1,DB04495,-8.6,RU81843,GGPXNASQNUOIPB-NSOVKSMOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
12170,6lzg,DB12985,-8.6,Quisinostat,PAWIYAYFNXQGAP-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
97407,6m71,DB14821,-8.6,Macozinone,BJDZBXGJNBMCAV-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
58503,6crv,DB05590,-8.6,Bedoradrine,OANCEOSLKSTLTA-REWPJTCUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
124333,6w4h,DB01029,-8.6,Irbesartan,YOSHYTLCDANDAN-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
28413,6cs2,DB08003,-8.6,ISOTHIAZOLIDINONE ANALOG,UILYPHAKDBTKQV-UFYCRDLUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
97429,6m71,DB14870,-8.6,PF-5190457,ZIUDADZJCKGWKR-AREMUKBSSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
128107,6w4h,DB07226,-8.6,"N-[4-(2-CHLOROPHENYL)-1,3-DIOXO-1,2,3,6-TETRAHYDROPYRROLO[3,4-C]CARBAZOL-9-YL]FORMAMIDE",JWZVNUNTFNELHL-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
161451,7bv1,DB14068,-8.6,Dexniguldipine,SVJMLYUFVDMUHP-MGBGTMOVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97463,6m71,DB14935,-8.6,Serabelisib,BLGWHBSBBJNKJO-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
112461,6vxx,DB07283,-8.6,"9-benzyl-2,3,4,9-tetrahydro-1H-carbazole-8-carboxylic acid",VDOXYKGIKBUISK-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
159566,7bv1,DB04578,-8.6,"(S)-2-[(R)-3-amino-4-(2-fluorophenyl)butyryl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide",OEVYDSSAPNIURZ-AEFFLSMTSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97443,6m71,DB14896,-8.6,Selitrectinib,OEBIHOVSAMBXIB-SJKOYZFVSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
12192,6lzg,DB13019,-8.6,Henatinib,MCTXSDCWFQAGFS-UEXNTNOUSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
59906,6crv,DB08011,-8.6,"(3E)-5-fluoro-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-1H-indole-2,3-dione 3-oxime",DXIHOIDYHQSQKJ-HMMYKYKNSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
97400,6m71,DB14795,-8.6,AZD-3759,MXDSJQHFFDGFDK-CYBMUJFWSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
103647,6vxs,DB08827,-8.6,Lomitapide,MBBCVAKAJPKAKM-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
7579,6lzg,DB00471,-8.6,Montelukast,UCHDWCPVSPXUMX-TZIWLTJVSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
97324,6m71,DB14649,-8.6,Dexamethasone acetate,AKUJBENLRBOFTD-RPRRAYFGSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
13502,6lzg,DB00210,-8.6,Adapalene,LZCDAPDGXCYOEH-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
109840,6vxx,DB00318,-8.6,Codeine,OROGSEYTTFOCAN-DNJOTXNNSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
128982,6w4h,DB08241,-8.6,4-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)--BENZAMIDE,RUUOIINPNMNPIU-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
96964,6m71,DB13682,-8.6,Cefpirome,DKOQGJHPHLTOJR-WHRDSVKCSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
26843,6cs2,DB05511,-8.6,Piclidenoson,HUJXGQILHAUCCV-MOROJQBDSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
109845,6vxx,DB00323,-8.6,Tolcapone,MIQPIUSUKVNLNT-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
97563,6m71,DB15168,-8.6,Cilofexor,KZSKGLFYQAYZCO-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97561,6m71,DB15163,-8.6,Selatogrel,FYXHWMQPCJOJCH-GMAHTHKFSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
26760,6cs2,DB05075,-8.6,TG-100801,JMGXJHWTVBGOKG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
97034,6m71,DB13778,-8.6,Cefazedone,VTLCNEGVSVJLDN-MLGOLLRUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
9971,6lzg,DB08111,-8.6,"4-[(6-phenyl[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl]phenol",ZGJYGQLGSXWEMY-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
97096,6m71,DB13856,-8.6,Fluclorolone,VTWKPILBIUBMDS-OTJLYDAYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
112424,6vxx,DB07087,-8.6,"4-[(1S,2S,5S,9R)-5-(HYDROXYMETHYL)-8,9-DIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL",YMSZEVAWRFDVQX-GHVWTTSJSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
9000,6lzg,DB07065,-8.6,"5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)-3-thiocyanatopyrazolo[1,5-a]pyrimidin-7-amine",AHPKUZJCNHGFQA-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
97328,6m71,DB14653,-8.6,Clocortolone caproate,MMTRTBFDFNRBQO-ANHDKODLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
109856,6vxx,DB00340,-8.6,Metixene,MJFJKKXQDNNUJF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58528,6crv,DB05767,-8.6,Andrographolide,BOJKULTULYSRAS-OTESTREVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
159637,7bv1,DB04983,-8.6,Denufosol,FPNPSEMJLALQSA-MIYUEGBISA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
121775,6w4b,DB12381,-8.6,Merestinib,QHADVLVFMKEIIP-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
104330,6vxs,DB11841,-8.6,Entinostat,INVTYAOGFAGBOE-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
55038,6crv,DB00535,-8.6,Cefdinir,RTXOFQZKPXMALH-GHXIOONMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
159623,7bv1,DB04946,-8.6,Iloperidone,XMXHEBAFVSFQEX-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
112431,6vxx,DB07095,-8.6,(S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclopentylpropanoyl)pyrrolidine-2-carboxamide,BNCHHUFGEOJCNH-SFHVURJKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104121,6vxs,DB11450,-8.6,Pimobendan,GLBJJMFZWDBELO-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
31959,6cs2,DB15108,-8.6,Tipranavir C-14,SUJUHGSWHZTSEU-MWQIXQBFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
121800,6w4b,DB12414,-8.6,Usistapide,WSYALRNYQFNNGP-WJOKGBTCSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
58517,6crv,DB05676,-8.6,Apremilast,IMOZEMNVLZVGJZ-QGZVFWFLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112532,6vxx,DB07359,-8.6,"3-[(4-fluorophenyl)sulfanyl]-N-(4-methyl-1,3-thiazol-2-yl)-6-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]pyridine-2-carboxamide",SJTQKYKXCYVFHX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
26820,6cs2,DB05416,-8.6,Cardarine,YDBLKRPLXZNVNB-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
159397,7bv1,DB04092,-8.6,Apstatin,YVUUZAPYLPWFHE-HXFGRODQSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59976,6crv,DB08092,-8.6,3-fluoro-N-1H-indol-5-yl-5-morpholin-4-ylbenzamide,VMLSXFMXUNVCSK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112760,6vxx,DB07812,-8.6,"N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyrrolo[2,3-b]pyridin-4-yl)thiophene-2-carboxamide",TWYNGDRSMHRPSY-MRXNPFEDSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104532,6vxs,DB12137,-8.6,GSK-256066,JFHROPTYMMSOLG-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
110157,6vxx,DB01041,-8.6,Thalidomide,UEJJHQNACJXSKW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
103258,6vxs,DB08362,-8.6,"N-(3-(8-CYANO-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZIN-2-YLAMINO)PHENYL)ACETAMIDE",QVKXQLGRDOMAGC-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
95729,6m71,DB11855,-8.6,Revefenacin,FYDWDCIFZSGNBU-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
103272,6vxs,DB08382,-8.6,Gosogliptin,QWEWGXUTRTXFRF-KBPBESRZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
95732,6m71,DB11863,-8.6,Alvelestat,QNQZWEGMKJBHEM-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
25990,6cs2,DB04038,-8.6,Ergosterol,DNVPQKQSNYMLRS-APGDWVJJSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
112908,6vxx,DB08137,-8.6,(4E)-N-(4-fluorophenyl)-4-[(phenylcarbonyl)imino]-4H-pyrazole-3-carboxamide,ZMWYSLJBNJUCRK-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127903,6w4h,DB06992,-8.6,"(3,3-dimethylpiperidin-1-yl)(6-(3-fluoro-4-methylphenyl)pyridin-2-yl)methanone",SIDDLTBLAQYZIZ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
103277,6vxs,DB08387,-8.6,2-{[4-(1-methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline,AZEXWHKOMMASPA-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
111567,6vxx,DB04047,-8.6,[Pterin-6-Yl Methanyl]-Phosphonophosphate,AMDUVUKDRBIVAH-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112897,6vxx,DB08125,-8.6,"4-{[(2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]AMINO}-N-(1,3-THIAZOL-2-YL)BENZENESULFONAMIDE",BOMPRXSVSIPRDT-PTNGSMBKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
158668,7bv1,DB02059,-8.6,Adenosine-5-Diphosphoribose,SRNWOUGRCWSEMX-ZQSHOCFMSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
58187,6crv,DB04659,-8.6,"(1S,2S,3R,4S,5S)-2,3,4-TRIHYDROXY-5-(HYDROXYMETHYL)CYCLOHEXYL (1E)-2-PHENYL-N-(SULFOOXY)ETHANIMIDOTHIOATE",LZDZCEOFJWRJIA-GGASBGQWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112895,6vxx,DB08123,-8.6,"N-METHYL-{4-[2-(7-OXO-6,7-DIHYDRO-8H-[1,3]THIAZOLO[5,4-E]INDOL-8-YLIDENE)HYDRAZINO]PHENYL}METHANESULFONAMIDE",GEWPSTLKJDIUHW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
95787,6m71,DB11942,-8.6,Selinexor,DEVSOMFAQLZNKR-RJRFIUFISA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
55256,6crv,DB00799,-8.6,Tazarotene,OGQICQVSFDPSEI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
103307,6vxs,DB08424,-8.6,"[5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL](3-{[(2R)-2,3-DIHYDROXYPROPYL]OXY}PHENYL)METHANONE",IJDQETGUEUJVTB-HNNXBMFYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
103308,6vxs,DB08426,-8.6,"THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [2-OXO-1-(1H-PYRROLO[2,3-C]PYRIDIN-2-YLMETHYL)-PYRROLIDIN-3-YL]-AMIDE",PLXOQMHGHDZMSX-AWEZNQCLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
103310,6vxs,DB08429,-8.6,N-({(2S)-1-[(3R)-3-amino-4-(3-chlorophenyl)butanoyl]pyrrolidin-2-yl}methyl)-3-(methylsulfonyl)benzamide,QRGBOABBMKYMLG-UXHICEINSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
54868,6crv,DB00323,-8.6,Tolcapone,MIQPIUSUKVNLNT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
158742,7bv1,DB02155,-8.6,Balanol Analog 8,XVLMXAUKCDSMMW-YXLARRHKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
55218,6crv,DB00751,-8.6,Epinastine,WHWZLSFABNNENI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
128782,6w4h,DB08011,-8.6,"(3E)-5-fluoro-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-1H-indole-2,3-dione 3-oxime",DXIHOIDYHQSQKJ-HMMYKYKNSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
114214,6vxx,DB13102,-8.6,AZD-8418,MCPBSUCAISQZQK-JTQLQIEISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
11889,6lzg,DB12571,-8.6,Rimacalib,MYTIJGWONQOOLC-HNNXBMFYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
104834,6vxs,DB12574,-8.6,LY-295501,VAMFSFIPDOODFH-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
128786,6w4h,DB08015,-8.6,"(3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-phenyl-1H-indole-2,3-dione 3-oxime",SZYREAUDQRVVLV-DAFNUICNSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
58222,6crv,DB04712,-8.6,ANILINOMETHYL GLUCO-PHENYLIMIDAZOLE,ADKWVGPRAQKVKB-YIYPIFLZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31757,6cs2,DB14676,-8.6,Fagrocorat,QJJBNCHSWFGXML-KEKPKEOLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
58225,6crv,DB04715,-8.6,IMIDAZOPYRIDAZIN 1,IVUBNTNWKIPCPS-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
8869,6lzg,DB06925,-8.6,3-(2-AMINOQUINAZOLIN-6-YL)-4-METHYL-N-[3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE,YEIASMOUYNOXGA-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
29229,6cs2,DB08896,-8.6,Regorafenib,FNHKPVJBJVTLMP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
26670,6cs2,DB04849,-8.6,Cediranib,XXJWYDDUDKYVKI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
129184,6w4h,DB08493,-8.6,"5-METHYL-3-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.013,18]NONADECA-12(19),13,15,17-TETRAEN-10-YLCARBAMOYL)-HEXANOIC ACID",AKWKBACKRMYPRV-NQIIRXRSSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
27013,6cs2,DB06246,-8.6,Exisulind,MVGSNCBCUWPVDA-MFOYZWKCSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
165844,7bv1,DB13097,-8.6,1alpha-Hydroxyvitamin D5,NWFOBODUYTUMNC-VPSCEVSQSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95595,6m71,DB11663,-8.6,Pictilisib,LHNIIDJUOCFXAP-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
109457,6vxx,DB13602,-8.6,Promegestone,QFFCYTLOTYIJMR-XMGTWHOFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60340,6crv,DB08530,-8.6,"7-BENZYL-1,3-DIMETHYL-8-PIPERAZIN-1-YL-3,7-DIHYDRO-PURINE-2,6-DIONE",QFSMMXJBEBXTJP-UHFFFAOYSA-O,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58067,6crv,DB04509,-8.6,N-Methylnaloxonium,PCSQOABIHJXZMR-YNUHATHGSA-O,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112999,6vxx,DB08246,-8.6,"(2S)-4-(2,5-DIFLUOROPHENYL)-N,N-DIMETHYL-2-PHENYL-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDE",WFFMEXQHWXEKBV-SFHVURJKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
105047,6vxs,DB12914,-8.6,MGL-3196,FDBYIYFVSAHJLY-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
164639,7bv1,DB08239,-8.6,"(2S)-4-(2,5-DIFLUOROPHENYL)-N-METHYL-2-PHENYL-N-PIPERIDIN-4-YL-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDE",NKLVBHMAIMEVEH-QFIPXVFZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
98382,6vxs,DB00878,-8.6,Chlorhexidine,GHXZTYHSJHQHIJ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
127867,6w4h,DB06944,-8.6,N-(3-cyclopropyl-1H-pyrazol-5-yl)-2-(2-naphthyl)acetamide,RIGZCVNCFXYBEG-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
27038,6cs2,DB06295,-8.6,Pramiconazole,AEKNYBWUEYNWMJ-QWOOXDRHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
58131,6crv,DB04590,-8.6,(2R)-({4-[AMINO(IMINO)METHYL]PHENYL}AMINO){5-ETHOXY-2-FLUORO-3-[(3R)-TETRAHYDROFURAN-3-YLOXY]PHENYL}ACETICACID,PGYOHIAQCFZQDK-AUUYWEPGSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112269,6vxx,DB06907,-8.6,"2-(2,6-DICHLOROPHENYL)-1,3-BENZOXAZOLE-6-CARBOXYLIC ACID",XVNRKPCHMYOPPL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58668,6crv,DB06321,-8.6,R-348,IGLNXKVGKIFNBQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104914,6vxs,DB12705,-8.6,Cenerimod,KJKKMMMRWISKRF-FQEVSTJZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
95662,6m71,DB11763,-8.6,Momelotinib,ZVHNDZWQTBEVRY-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
28266,6cs2,DB07848,-8.6,5-Chloro-N-{(3S)-1-[(2S)-1-(4-morpholinyl)-1-oxo-2-propanyl]-2-oxo-3-pyrrolidinyl}-1H-indole-2-sulfonamide,BHNMMFGOJRIAEZ-LRDDRELGSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
162032,7bv1,DB01329,-8.6,Cefoperazone,GCFBRXLSHGKWDP-XCGNWRKASA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
159839,7bv1,DB06673,-8.6,Almorexant,DKMACHNQISHMDN-RPLLCQBOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
164666,7bv1,DB08274,-8.6,"6,7,8,9-TETRAHYDRO-4-HYDROXY-3-(1-PHENYLPROPYL)CYCLOHEPTA[B]PYRAN-2-ONE",YKJXQZGJGDTEOC-AWEZNQCLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
104961,6vxs,DB12776,-8.6,E-6005,BBTFKAOFCSOZMB-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
127879,6w4h,DB06963,-8.6,"3-[3-(3-methyl-6-{[(1S)-1-phenylethyl]amino}-1H-pyrazolo[4,3-c]pyridin-1-yl)phenyl]propanamide",ZFGCLYUGFRNYFE-INIZCTEOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
27019,6cs2,DB06257,-8.6,HE-2200,OEVZKEVBDIDVOI-YSZCXEEOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
58158,6crv,DB04624,-8.6,DERIVATIVE OF AKLANONIC ACID METHYL ESTER (AAME),SIHNJMGWRHPFAZ-XHDPSFHLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104942,6vxs,DB12743,-8.6,Z-160,VCPMZDWBEWTGNW-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
161092,7bv1,DB12874,-8.6,Quizartinib,CVWXJKQAOSCOAB-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95703,6m71,DB11819,-8.6,ASP-4058,NJNXCJPSMWKXHO-VIFPVBQESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
104933,6vxs,DB12729,-8.6,ASP-3026,MGGBYMDAPCCKCT-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
129188,6w4h,DB08497,-8.6,"(1S)-2-oxo-1-phenyl-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate",NKBDSMREMMRFSI-INIZCTEOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
104926,6vxs,DB12719,-8.6,Turofexorate isopropyl,INASOKQDNHHMRE-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
55278,6crv,DB00823,-8.6,Ethynodiol diacetate,ONKUMRGIYFNPJW-KIEAKMPYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30758,6cs2,DB12937,-8.6,Quercetin-3'-O-phosphate,UWJBYNLLMAPJMM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
28500,6cs2,DB08092,-8.6,3-fluoro-N-1H-indol-5-yl-5-morpholin-4-ylbenzamide,VMLSXFMXUNVCSK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
59701,6crv,DB07776,-8.6,Flavone,VHBFFQKBGNRLFZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165805,7bv1,DB13040,-8.6,Gandotinib,SQSZANZGUXWJEA-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
103432,6vxs,DB08572,-8.6,4-{[4-AMINO-6-(CYCLOHEXYLMETHOXY)-5-NITROSOPYRIMIDIN-2-YL]AMINO}BENZAMIDE,YBKLJTXDSBEVRV-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
8899,6lzg,DB06962,-8.6,"(5-(aminomethyl)-2H-spiro[benzofuran-3,4'-piperidine]-1'-yl)(5-(phenylethynyl)furan-2-yl)methanone",YKTUSHSSKIWDRY-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
58306,6crv,DB04825,-8.6,Prenylamine,IFFPICMESYHZPQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
9128,6lzg,DB07204,-8.6,"(1S)-1-(1H-INDOL-3-YLMETHYL)-2-(2-PYRIDIN-4-YL-[1,7]NAPHTYRIDIN-5-YLOXY)-EHYLAMINE",DQIXTEDFNFZMCM-SFHVURJKSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
96089,6m71,DB12380,-8.6,GDC-0152,WZRFLSDVFPIXOV-LRQRDZAKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
6378,6lzg,DB02009,-8.6,"L-756,423",AOMZDQMIOCTPQP-QHQMVRJISA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
159722,7bv1,DB05470,-8.6,VX-702,FYSRKRZDBHOFAY-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
112784,6vxx,DB07839,-8.6,"N-2-1,3-BENZOXAZOL-2-YL-3-CYCLOHEXYL-N-{2-[(4-METHOXYPHENYL)AMINO]ETHYL}-L-ALANINAMIDE",VFNWTXUFNNOQHD-QFIPXVFZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
96097,6m71,DB12391,-8.6,Sagopilone,BFZKMNSQCNVFGM-UCEYFQQTSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
54896,6crv,DB00358,-8.6,Mefloquine,XEEQGYMUWCZPDN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58318,6crv,DB04838,-8.6,Cyclandelate,WZHCOOQXZCIUNC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
129098,6w4h,DB08389,-8.6,"6,7-DIMETHOXY-4-[(3R)-3-(2-NAPHTHYLOXY)PYRROLIDIN-1-YL]QUINAZOLINE",UPTQSRGSSJRBKJ-LJQANCHMSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
54904,6crv,DB00370,-8.6,Mirtazapine,RONZAEMNMFQXRA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
124558,6w4h,DB01329,-8.6,Cefoperazone,GCFBRXLSHGKWDP-XCGNWRKASA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
60151,6crv,DB08302,-8.6,3-[5-(2-nitropent-1-en-1-yl)furan-2-yl]benzoic acid,IRHZCQDCMUWUKV-RAXLEYEMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58616,6crv,DB06202,-8.6,Lasofoxifene,GXESHMAMLJKROZ-IAPPQJPRSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59768,6crv,DB07851,-8.6,"(3R,4S)-1-(3,4-DIMETHOXYPHENYL)-3-(3-METHYLPHENYL)PIPERIDIN-4-AMINE",DQJXBZGPJVSWFI-ROUUACIJSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112765,6vxx,DB07817,-8.6,"1-{3-[(4-pyridin-2-ylpiperazin-1-yl)sulfonyl]phenyl}-3-(1,3-thiazol-2-yl)urea",NJPVZSIGDRLLTD-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114207,6vxx,DB13094,-8.6,Pruvanserin,AQRLDDAFYYAIJP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165034,7bv1,DB09143,-8.6,Sonidegib,VZZJRYRQSPEMTK-CALCHBBNSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97679,6m71,DB15403,-8.6,Ziritaxestat,REQQVBGILUTQNN-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
161649,7bv1,DB00220,-8.6,Nelfinavir,QAGYKUNXZHXKMR-HKWSIXNMSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
109681,6vxx,DB15124,-8.6,PF-05241328,RVTSXVZXEGFIPW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59775,6crv,DB07859,-8.6,4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL)PHENYL]PIPERIDINE,LZMOSYUFVYJEPY-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
121967,6w4b,DB12669,-8.6,4SC-203,MAFACRSJGNJHCF-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
112360,6vxx,DB07015,-8.6,"(3R,4R)-4-(pyrrolidin-1-ylcarbonyl)-1-(quinoxalin-2-ylcarbonyl)pyrrolidin-3-amine",XDSKICAQKGYYJF-OLZOCXBDSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
25696,6cs2,DB03696,-8.6,Lanosterol,CAHGCLMLTWQZNJ-BQNIITSRSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
109684,6vxx,DB15132,-8.6,AZD-8165,YUHNXUAATAMVKD-PZJWPPBQSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109688,6vxx,DB15138,-8.6,AZD-9496,DFBDRVGWBHBJNR-BBNFHIFMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
121521,6w4b,DB12012,-8.6,PF-04457845,BATCTBJIJJEPHM-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
31770,6cs2,DB14716,-8.6,Clonazolam,XJRGLCAWBRZUFC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
96064,6m71,DB12341,-8.6,LY-2456302,ZHPMYDSXGRRERG-DEOSSOPVSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96055,6m71,DB12325,-8.6,Idasanutlin,TVTXCJFHQKSQQM-LJQIRTBHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
104799,6vxs,DB12522,-8.6,Toreforant,FCRFVPZAXGJLPW-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
129151,6w4h,DB08454,-8.6,N-(5-METHYL-1H-PYRAZOL-3-YL)-2-PHENYLQUINAZOLIN-4-AMINE,JYCUVOXSZBECAY-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
60221,6crv,DB08388,-8.6,"5-(2-ETHOXYETHYL)-5-[4-(4-FLUOROPHENOXY)PHENOXY]PYRIMIDINE-2,4,6(1H,3H,5H)-TRIONE",XRSYNYGEEYTXJV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
13379,6lzg,DB15245,-8.6,Olorofim,SUFPWYYDCOKDLL-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
104793,6vxs,DB12512,-8.6,Verucerfont,VKHVAUKFLBBZFJ-SFHVURJKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104792,6vxs,DB12511,-8.6,Imiglitazar,ULVDFHLHKNJICZ-QCWLDUFUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
97947,6vxs,DB00354,-8.6,Buclizine,MOYGZHXDRJNJEP-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
161111,7bv1,DB12899,-8.6,TT-301,ZPJGUEPHFXPAQF-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
26952,6cs2,DB06137,-8.6,KX-01,HUNGUWOZPQBXGX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
159793,7bv1,DB06578,-8.6,Tonabersat,XLIIRNOPGJTBJD-ROUUACIJSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
112843,6vxx,DB07909,-8.6,"(1S,2S,5S)2-(4-GLUTARIDYLBENZYL)-5-PHENYL-1-CYCLOHEXANOL",OBWILOKKNDYPLX-HBMCJLEFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
9137,6lzg,DB07215,-8.6,"2-METHYL-2-(4-{[({4-METHYL-2-[4-(TRIFLUOROMETHYL)PHENYL]-1,3-THIAZOL-5-YL}CARBONYL)AMINO]METHYL}PHENOXY)PROPANOIC ACID",ILUPZUOBHCUBKB-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
95973,6m71,DB12221,-8.6,Canrenone,UJVLDDZCTMKXJK-WNHSNXHDSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
114464,6vxx,DB13665,-8.6,Fluanisone,IRYFCWPNDIUQOW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112352,6vxx,DB07005,-8.6,D-phenylalanyl-N-{4-[amino(iminio)methyl]benzyl}-L-prolinamide,VZFTWWJAUZOJDH-MOPGFXCFSA-O,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112821,6vxx,DB07879,-8.6,"N-hydroxy-5-[(3-phenyl-5,6-dihydroimidazo[1,2-a]pyrazin-7(8H)-yl)carbonyl]thiophene-2-carboxamide",SMSIXMLQOONOQQ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58649,6crv,DB06267,-8.6,Udenafil,IYFNEFQTYQPVOC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165814,7bv1,DB13055,-8.6,Oteseconazole,IDUYJRXRDSPPRC-NRFANRHFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
109644,6vxx,DB15055,-8.6,ABT-639,AGPIHNZOZNKRGT-CYBMUJFWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58274,6crv,DB04785,-8.6,Streptolydigin,KVTPRMV1KLIG-NCAOFHFGSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112818,6vxx,DB07876,-8.6,(S)-2-METHYL-1-[(4-METHYL-5-ISOQUINOLINE)SULFONYL]-HOMOPIPERAZINE,AWDORCFLUJZUQS-ZDUSSCGKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
161139,7bv1,DB12939,-8.6,Nikkomycin Z,WWJFFVUVFNBJTN-VHDFTHOZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
7562,6lzg,DB04011,-8.6,"2'-(4-Dimethylaminophenyl)-5-(4-Methyl-1-Piperazinyl)-2,5'-Bi-Benzimidazole",VMCOQLKKSNQANE-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
97779,6vxs,DB00158,-8.6,Folic acid,OVBPIULPVIDEAO-LBPRGKRZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
159770,7bv1,DB06510,-8.6,Muraglitazar,IRLWJILLXJGJTD-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
104704,6vxs,DB12385,-8.6,10-hydroxycamptothecin,HAWSQZCWOQZXHI-FQEVSTJZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
121447,6w4b,DB11904,-8.6,Flumatinib,BJCJYEYYYGBROF-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
110229,6vxx,DB01125,-8.6,Anisindione,XRCFXMGQEVUZFC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59747,6crv,DB07826,-8.6,2-[4-chloro-2-(phenylcarbonyl)phenoxy]-N-phenylacetamide,DTGVSZSMDOMAEB-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104693,6vxs,DB12369,-8.6,Sotrastaurin,OAVGBZOFDPFGPJ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
30030,6cs2,DB11957,-8.6,Idalopirdine,YBAWYTYNMZWMMJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
93711,6m71,DB07265,-8.6,"3-(9-HYDROXY-1,3-DIOXO-4-PHENYL-2,3-DIHYDROPYRROLO[3,4-C]CARBAZOL-6(1H)-YL)PROPANOIC ACID",JDARUOOLJCFUOY-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
27332,6cs2,DB06869,-8.6,1-[2-AMINO-2-CYCLOHEXYL-ACETYL]-PYRROLIDINE-3-CARBOXYLIC ACID 5-CHLORO-2-(2-ETHYLCARBAMOYL-ETHOXY)-BENZYLAMIDE,BMHVHOJXEQTIEA-SIKLNZKXSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
93701,6m71,DB07254,-8.6,"N-[3-[[4-[(5-CHLORO-1,3-BENZODIOXOL-4-YL)AMINO]PYRIMIDIN-2-YL]AMINO]PHENYL]METHANESULFONAMIDE",KQGTYXRWSIBDOZ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
111847,6vxx,DB04778,-8.6,SC45647,LPSXGZAUAOMRNU-FZKQIMNGSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
91381,6m71,DB02976,-8.6,Uridine-5'-monophosphate 2-deoxy-2-fluoro-galactopyranosyl-monophosphate ester,NGTCPFGWXMBZEP-KBQKSTHMSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
10591,6lzg,DB00820,-8.6,Tadalafil,WOXKDUGGOYFFRN-IIBYNOLFSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
102070,6vxs,DB06976,-8.6,"1-(5-OXO-2,3,5,9B-TETRAHYDRO-1H-PYRROLO[2,1-A]ISOINDOL-9-YL)-3-(5-PYRROLIDIN-2-YL-1H-PYRAZOL-3-YL)-UREA",IWOOJEZSDPRYAZ-WFASDCNBSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
165284,7bv1,DB11704,-8.6,Adomeglivant,FASLTMSUPQDLIB-MHZLTWQESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
150358,6wiq,DB01251,-8.6,Gliquidone,LLJFMFZYVVLQKT-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
163817,7bv1,DB06370,-8.6,Indisulam,SETFNECMODOHTO-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
126052,6w4h,DB03300,-8.6,Pterin Cytosine Dinucleotide,WKSPNQYEWZEMMI-FEFZDOOUSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
91446,6m71,DB03072,-8.6,"2-{3-[4-(4-Fluorophenyl)-3,6-Dihydro-1(2h)-Pyridinyl]Propyl}-8-Methyl-4(3h)-Quinazolinone",LOFDUAJQRUYHBR-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
56462,6crv,DB02363,-8.6,2'-Monophosphoadenosine-5'-Diphosphate,YPTPYQSAVGGMFN-KQYNXXCUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111041,6vxx,DB02915,-8.6,"4-(2,4-Dimethyl-1,3-thiazol-5-yl)-N-[4-(trifluoromethyl)phenyl]-2-pyrimidinamine",MEZFDQUDLQCVNX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107532,6vxx,DB03725,-8.6,Phosphomethylphosphonic Acid-Guanylate Ester,PHBDHXOBFUBCJD-KQYNXXCUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
91600,6m71,DB03268,-8.6,RU82197,WKTQBTSOHBKBRW-VMPREFPWSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
91263,6m71,DB02827,-8.6,"7-(1,1-Dioxo-1h-Benzo[D]Isothiazol-3-Yloxymethyl)-2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Pyran-3-Carboxylic Acid",MDYIGSPVMWSFEZ-JTQLQIEISA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
91622,6m71,DB03300,-8.6,Pterin Cytosine Dinucleotide,WKSPNQYEWZEMMI-FEFZDOOUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
107503,6vxx,DB03687,-8.6,4-Diphosphocytidyl-2-C-Methyl-D-Erythritol,YFAUKWZNPVBCFF-XHIBXCGHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
128313,6w4h,DB07460,-8.6,2-({5-CHLORO-2-[(2-METHOXY-4-MORPHOLIN-4-YLPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)-N-METHYLBENZAMIDE,UYJNQQDJUOUFQJ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
107502,6vxx,DB03685,-8.6,Uridine monophosphate,DJJCXFVJDGTHFX-XVFCMESISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
91737,6m71,DB03460,-8.6,Violaxanthin,SZCBXWMUOPQSOX-WVJDLNGLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
101291,6vxs,DB04727,-8.6,"N-(4-{4-AMINO-6-[4-(METHYLOXY)PHENYL]FURO[2,3-D]PYRIMIDIN-5-YL}PHENYL)-N'-[2-FLUORO-5-(TRIFLUOROMETHYL)PHENYL]UREA",FGZIONRFHVNRJB-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
165414,7bv1,DB12068,-8.6,T-900607,FSXLOWIFSZNIMV-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
27635,6cs2,DB00655,-8.6,Estrone,DNXHEGUUPJUMQT-CBZIJGRNSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
56513,6crv,DB02421,-8.6,Uridine-5'-Diphosphate-Mannose,HSCJRCZFDFQWRP-NYYOCOOHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
91810,6m71,DB03571,-8.6,"3-(5-Amino-7-Hydroxy-[1,2,3]Triazolo[4,5-D]Pyrimidin-2-Yl)-N-(3,5-Dichlorobenzyl)-Benzamide",JMQTXEWNXSPEKX-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
128482,6w4h,DB07665,-8.6,"N-[2-(carbamimidamidooxy)ethyl]-2-{6-cyano-3-[(2,2-difluoro-2-pyridin-2-ylethyl)amino]-2-fluorophenyl}acetamide",STHCHQXQLDMISY-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
102140,6vxs,DB07053,-8.6,2-{5-[3-(7-PROPYL-3-TRIFLUOROMETHYLBENZO[D]ISOXAZOL-6-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID,TWVYNPULGKGJOS-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102141,6vxs,DB07054,-8.6,(2R)-1-(DIMETHYLAMINO)-3-{4-[(6-{[2-FLUORO-5-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-4-YL)AMINO]PHENOXY}PROPAN-2-OL,OSCWQKTUILTARV-MRXNPFEDSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
114379,6vxx,DB13360,-8.6,Tolciclate,CANCCLAKQQHLNK-LSDHHAIUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
12936,6lzg,DB14067,-8.6,Dofequidar,KLWUUPVJTLHYIM-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
91855,6m71,DB03638,-8.6,Cytidyl-2'-5'-Phospho-Guanosine,QZDUXDLOEVJGDG-VMIOUTBZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160412,7bv1,DB08354,-8.6,"2-(4-CHLOROBENZYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE",QCVULERVJOYHCP-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
27663,6cs2,DB07216,-8.6,"(11S)-8-CHLORO-11-[1-(METHYLSULFONYL)PIPERIDIN-4-YL]-6-PIPERAZIN-1-YL-11H-BENZO[5,6]CYCLOHEPTA[1,2-B]PYRIDINE",ZMGCFGGMTCMSDP-QHCPKHFHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
108495,6vxx,DB08055,-8.6,"N-(2-chlorophenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine",NNBICZMPIJMWGC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127050,6w4h,DB04644,-8.6,"4-{4-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-2,3-DIMETHYL-PHENOXY}-BUTYRIC ACID",FCEMCUPAYRPTLS-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
107839,6vxx,DB04685,-8.6,"1-{(2S,5S)-4-FLUORO-5-[(TRITYLOXY)METHYL]TETRAHYDROFURAN-2-YL}PYRIMIDINE-2,4(1H,3H)-DIONE",GJNIPWYJQUGERM-BFLUCZKCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107829,6vxx,DB04669,-8.6,TRIAZOLOPYRIMIDINE,YWBFPKPWMSWWEA-UHFFFAOYSA-O,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27701,6cs2,DB07256,-8.6,"3-({4-[(5-CHLORO-1,3-BENZODIOXOL-4-YL)AMINO]PYRIMIDIN-2-YL}AMINO)BENZAMIDE",ZVQZIVCQLFGXFZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
107810,6vxx,DB04644,-8.6,"4-{4-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-2,3-DIMETHYL-PHENOXY}-BUTYRIC ACID",FCEMCUPAYRPTLS-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28729,6cs2,DB08340,-8.6,"N,N'-DIPHENYLPYRAZOLO[1,5-A][1,3,5]TRIAZINE-2,4-DIAMINE",LLYYAUZAGCZEKV-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
128446,6w4h,DB07622,-8.6,"1-(3-(2,4-DIMETHYLTHIAZOL-5-YL)-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)-3-(4-METHYLPIPERAZIN-1-YL)UREA",KRKQVGZXTNLQSV-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
116244,6w4b,DB01897,-8.6,2-(2f-Benzothiazolyl)-5-Styryl-3-(4f-Phthalhydrazidyl)Tetrazolium Chloride,BEIGFKLRGRRJJA-JLHYYAGUSA-O,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
108530,6vxx,DB08096,-8.6,"8-(2-CHLOROPHENYLAMINO)-2-(2,6-DIFLUOROPHENYLAMINO)-9-ETHYL-9H-PURINE-1,7-DIIUM",ZWKOUFZHPNIQSH-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
91055,6m71,DB02545,-8.6,Fexaramine,VLQTUNDJHLEFEQ-KGENOOAVSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
166402,7bv1,DB14828,-8.6,ABX-464,OZOGDCZJYVSUBR-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
55787,6crv,DB01481,-8.6,1-Testosterone,OKJCFMUGMSVJBG-ABEVXSGRSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61400,6crv,DB12029,-8.6,Chlorogenic Acid,CWVRJTMFETXNAD-JUHZACGLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
101971,6vxs,DB06858,-8.6,N-cyclooctylglycyl-N-(4-carbamimidoylbenzyl)-L-prolinamide,MMLOIDMSBRJZAE-FQEVSTJZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
30425,6cs2,DB12465,-8.6,Ketanserin,FPCCSQOGAWCVBH-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
91081,6m71,DB02581,-8.6,"5-[2,3-Dichloro-4-(5-{1-[2-(2-Guanidino-4-Methyl-Pentanoylamino)-Acetyl]-Piperidin-4-Yl}-1-Methyl-1h-Pyrazol-3-Yl)-Phenoxymethyl]-Furan-2-Carboxylic Acid",VNZHOIDQBPFEJU-OAQYLSRUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
27688,6cs2,DB07244,-8.6,"5-{4-[(3,5-DIFLUOROBENZYL)AMINO]PHENYL}-6-ETHYLPYRIMIDINE-2,4-DIAMINE",SRRWXMSVQYQCRX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
30075,6cs2,DB12015,-8.6,Alpelisib,STUWGJZDJHPWGZ-LBPRGKRZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
101401,6vxs,DB04872,-8.6,Osanetant,DZOJBGLFWINFBF-UMSFTDKQSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
160703,7bv1,DB09319,-8.6,Carindacillin,JIRBAUWICKGBFE-MNRDOXJOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59032,6crv,DB06997,-8.6,"2-(4-fluorophenyl)-N-{[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]carbamoyl}acetamide",BMPOCDJEXAXXEZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
102005,6vxs,DB06897,-8.6,"3-[3-chloro-5-(5-{[(1S)-1-phenylethyl]amino}isoxazolo[5,4-c]pyridin-3-yl)phenyl]propan-1-ol",MMGKIHLBFPJYJL-HNNXBMFYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
91163,6m71,DB02691,-8.6,Glycocholic acid,RFDAIACWWDREDC-FRVQLJSFSA-M,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
149815,6wiq,DB00619,-8.6,Imatinib,KTUFNOKKBVMGRW-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
56420,6crv,DB02307,-8.6,N-(1-Carboxy-3-Phenylpropyl)Phenylalanyl-Alpha-Asparagine,FOJUHLDAXGNCIP-FHWLQOOXSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
102040,6vxs,DB06933,-8.6,N-(tert-butyl)-4-[5-(pyridin-2-ylamino)quinolin-3-yl]benzenesulfonamide,GJTCKUKIFXWJKG-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
128352,6w4h,DB07508,-8.6,4-(5-BENZENESULFONYLAMINO-1-METHYL-1H-BENZOIMIDAZOL-2-YLMETHYL)-BENZAMIDINE,MEUAVGJWGDPTLF-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
30420,6cs2,DB12459,-8.6,Belotecan,LNHWXBUNXOXMRL-VWLOTQADSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
90837,6m71,DB02269,-8.6,[4-({[5-Benzyloxy-1-(3-Carbamimidoyl-Benzyl)-1h-Indole-2-Carbonyl]-Amino}-Methyl)-Phenyl]-Trimethyl-Ammonium,UFKJQTGPBFWMGT-UHFFFAOYSA-O,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
102159,6vxs,DB07076,-8.6,6-[(Z)-AMINO(IMINO)METHYL]-N-[3-(CYCLOPENTYLOXY)PHENYL]-2-NAPHTHAMIDE,FWTQOPWAMQXIMI-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
163795,7bv1,DB06302,-8.6,Glesatinib,YRCHYHRCBXNYNU-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
113812,6vxx,DB12120,-8.6,Avoralstat,TUWMKPVJGGWGNL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
100950,6vxs,DB04270,-8.6,(S)-3-(4-(2-Carbazol-9-Yl-Ethoxy)-Phenyl)-2-Ethoxy-Propionic Acid,WUZIMDSVRIBNNI-DEOSSOPVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
59264,6crv,DB07263,-8.6,"[{2-bromo-4-[(2R)-3-oxo-2,3-diphenylpropyl]phenyl}(difluoro)methyl]phosphonic acid",WDTMVBQZDFMOIK-GOSISDBHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107217,6vxx,DB02717,-8.6,Cellotetraose,LUEWUZLMQUOBSB-HGDSAIHNSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
160329,7bv1,DB08015,-8.6,"(3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-phenyl-1H-indole-2,3-dione 3-oxime",SZYREAUDQRVVLV-DAFNUICNSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
128510,6w4h,DB07698,-8.6,"3-(3-aminophenyl)-N-(3-chlorophenyl)pyrazolo[1,5-a]pyrimidin-5-amine",JDNMRPIWJIDDAY-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
59281,6crv,DB07283,-8.6,"9-benzyl-2,3,4,9-tetrahydro-1H-carbazole-8-carboxylic acid",VDOXYKGIKBUISK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
92574,6m71,DB04583,-8.6,"5-Carbamoyl-1,1':4',1''-terphenyl-3-carboxylic acid",LAZPCGBRHLARSI-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
29720,6cs2,DB11464,-8.6,Sulfaquinoxaline,NHZLNPMOSADWGC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
92591,6m71,DB04607,-8.6,"PHENYLAMINOIMIDAZO(1,2-ALPHA)PYRIDINE",UQAWGIKJINAKIZ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
61278,6crv,DB11847,-8.6,Cadazolid,XWFCFMXQTBGXQW-GOSISDBHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61276,6crv,DB11845,-8.6,Lucitanib,CUDVHEFYRIWYQD-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
153411,6wiq,DB06435,-8.6,Tarazepide,CZPILLBHPRAPCB-AREMUKBSSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
100964,6vxs,DB04285,-8.6,"{4-[(2s,4e)-2-(1,3-Benzothiazol-2-Yl)-2-(1h-1,2,3-Benzotriazol-1-Yl)-5-Phenylpent-4-Enyl]Phenyl}(Difluoro)Methylphosphonic Acid",GBLDYRVJENYQNH-AGLOJYHOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
108697,6vxx,DB08816,-8.6,Ticagrelor,OEKWJQXRCDYSHL-FNOIDJSQSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56646,6crv,DB02595,-8.6,Bulgecin A,RPNZWZDLNYCCIG-HMMVDTEZSA-O,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
102312,6vxs,DB07254,-8.6,"N-[3-[[4-[(5-CHLORO-1,3-BENZODIOXOL-4-YL)AMINO]PYRIMIDIN-2-YL]AMINO]PHENYL]METHANESULFONAMIDE",KQGTYXRWSIBDOZ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
113794,6vxx,DB12096,-8.6,PF-05175157,BDXXSFOJPYSYOC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107145,6vxx,DB02623,-8.6,Aminophosphonic Acid-Guanylate Ester,ZGPDMUBRWRJAQQ-UUOKFMHZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
166343,7bv1,DB14676,-8.6,Fagrocorat,QJJBNCHSWFGXML-KEKPKEOLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
100753,6vxs,DB04006,-8.6,"[2-Amino-6-(2,6-Difluoro-Benzoyl)-Imidazo[1,2-a]Pyridin-3-Yl]-Phenyl-Methanone",WUGJIPFLBOATGL-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
153626,6wiq,DB06925,-8.6,3-(2-AMINOQUINAZOLIN-6-YL)-4-METHYL-N-[3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE,YEIASMOUYNOXGA-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
61251,6crv,DB11811,-8.6,Arhalofenate,BJBCSGQLZQGGIQ-QGZVFWFLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127302,6w4h,DB05171,-8.6,E-2012,PUOAETJYKQITMO-LANLRWRYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
100718,6vxs,DB03957,-8.6,SP2456,SSSXBBASYYVGCI-HSZRJFAPSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
127316,6w4h,DB05263,-8.6,Caprospinol,VMOZFSWFUBLCNN-AAPULDEBSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
26467,6cs2,DB04607,-8.6,"PHENYLAMINOIMIDAZO(1,2-ALPHA)PYRIDINE",UQAWGIKJINAKIZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
30568,6cs2,DB12666,-8.6,Emapunil,NBMBIEOUVBHEBM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
107155,6vxx,DB02639,-8.6,4-methylumbelliferyl ??-D-glucoside,YUDPTGPSBJVHCN-JZYAIQKZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163797,7bv1,DB06307,-8.6,Apoptone,CKAXZOYFIHQCBN-JRRMKBMNSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
30536,6cs2,DB12622,-8.6,Lupeol,MQYXUWHLBZFQQO-QGTGJCAVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
32808,6cs2,T3D3721,-8.6,Verrucarin B,WUZWNHCQLPXCLS-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
107454,6vxx,DB03619,-8.6,Deoxycholic Acid,KXGVEGMKQFWNSR-LLQZFEROSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
151463,6wiq,DB02741,-8.6,CD564,RWYREGSYPCNZTL-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
91911,6m71,DB03712,-8.6,RU85053,CEKLBQMULVLLTD-VMPREFPWSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
107448,6vxx,DB03608,-8.6,Diminazene,XNYZHCFCZNMTFY-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30454,6cs2,DB12507,-8.6,Atecegatran metoxil,XSNMGLZVFNDDPW-ZWKOTPCHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
113876,6vxx,DB12219,-8.6,GSK-424887,DRXBWLBZWAJIEF-IBGZPJMESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113872,6vxx,DB12211,-8.6,PSI-697,DIEPFYNZGUUVHD-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61329,6crv,DB11922,-8.6,Danirixin,NGYNBSHYFOFVLS-LBPRGKRZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111908,6vxx,DB04853,-8.6,Binodenoson,XJFMHMFFBSOEPR-DNZQAUTHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
102194,6vxs,DB07117,-8.6,"5-(4-PHENOXYPHENYL)-5-(4-PYRIMIDIN-2-YLPIPERAZIN-1-YL)PYRIMIDINE-2,4,6(2H,3H)-TRIONE",FMKQJGOROFNCGM-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
129383,6w4h,DB08731,-8.6,"2-[(1R)-2-carboxy-1-(naphthalen-1-ylmethyl)ethyl]-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylic acid",GPOKTQCDBPECSS-MRXNPFEDSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
92044,6m71,DB03878,-8.6,N-[4-Methyl-3-[[4-(3-Pyridinyl)-2-Pyrimidinyl]Amino]Phenyl]-3-Pyridinecarboxamide,YWQVBESSYLICRX-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
34178,6cs2,T3D1043,-8.6,Emamectin B1a,CXEGAUYXQAKHKJ-NSBHKLITSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
59258,6crv,DB07257,-8.6,"4-(2-chlorophenyl)-8-(2-hydroxyethyl)-6-methylpyrrolo[3,4-e]indole-1,3(2H,6H)-dione",WHMQZCPGFZBLBG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110948,6vxx,DB02639,-8.6,4-methylumbelliferyl alpha-D-glucoside,YUDPTGPSBJVHCN-JZYAIQKZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110943,6vxx,DB02610,-8.6,"N-(2,3,4,5,6-Pentaflouro-Benzyl)-4-Sulfamoyl-Benzamide",LRKSHOLYETXPGY-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113853,6vxx,DB12183,-8.6,Sapitinib,DFJSJLGUIXFDJP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108634,6vxx,DB08487,-8.6,3-({4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-2-OXOPIPERAZIN-1-YL}METHYL)BENZENECARBOXIMIDAMIDE,PRMSFVUWLBPPLY-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
101128,6vxs,DB04514,-8.6,Phosphoric Acid-2'-[2'-Deoxy-Uridine]Ester-5'-Guanosine Ester,DFYLLEBFVZTKHD-VMIOUTBZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
59247,6crv,DB07246,-8.6,"(2R)-2-AMINO-3,3,3-TRIFLUORO-N-HYDROXY-2-{[(4-PHENOXYPHENYL)SULFONYL]METHYL}PROPANAMIDE",MKRPIBSCGZAUCH-OAHLLOKOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
102219,6vxs,DB07144,-8.6,"5-[(3R)-3-(5-methoxy-2',6'-dimethylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",XZXVRKHUCSXVBM-AWEZNQCLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
92187,6m71,DB04071,-8.6,Cpad,LFERELMXERXKKQ-KMXXXSRASA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
164223,7bv1,DB07397,-8.6,"(5S)-5-(2-amino-2-oxoethyl)-4-oxo-N-[(3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl)methyl]-3,4,5,6,7,8-hexahydro[1]benzothieno[2,3-d]pyrimidine-2-carboxamide",ITADELAVAWJACR-NSHDSACASA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
56610,6crv,DB02545,-8.6,Fexaramine,VLQTUNDJHLEFEQ-KGENOOAVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30523,6cs2,DB12598,-8.6,Nafamostat,MQQNFDZXWVTQEH-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
127228,6w4h,DB04882,-8.6,Edotecarin,QMVPQBFHUJZJCS-NTKFZFFISA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
113816,6vxx,DB12124,-8.6,Namitecan,IBTISPLPBBHVSU-UVOOVGFISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
160347,7bv1,DB08034,-8.6,"(E)-3,4-DIHYDROXY-N'-[(2-METHOXYNAPHTHALEN-1-YL)METHYLENE]BENZOHYDRAZIDE",TVOPERZEGKBKAY-RGVLZGJSSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
102213,6vxs,DB07138,-8.6,Neflamapimod,VEPKQEUBKLEPRA-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
123586,6w4h,DB00146,-8.6,Calcifediol,JWUBBDSIWDLEOM-DTOXIADCSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
149328,6w9q,DB15399,-8.6,BMS-754807,LQVXSNNAFNGRAH-QHCPKHFHSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
113964,6vxx,DB12332,-8.6,Rucaparib,HMABYWSNWIZPAG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
33053,6cs2,T3D4015,-8.6,Protopine,GPTFURBXHJWNHR-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
114139,6vxx,DB12792,-8.6,Boscalid,WYEMLYFITZORAB-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
126708,6w4h,DB04186,-8.6,"N'-(Pyrrolidino[2,1-B]Isoindolin-4-On-8-Yl)-N-(Pyridin-2-Yl)Urea",KLVYMYQTRZCMLE-CYBMUJFWSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
108170,6vxx,DB07183,-8.6,N-(4-phenoxyphenyl)-2-[(pyridin-4-ylmethyl)amino]nicotinamide,CPVRYQAOUPSUDO-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
166467,7bv1,DB15192,-8.6,ABT-288,GNIRITULTPTAQW-KNQAVFIVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
28788,6cs2,DB08402,-8.6,"2-[(2,4-DICHLOROBENZOYL)AMINO]-5-(PYRIMIDIN-2-YLOXY)BENZOIC ACID",VNDRRWBKNSHALL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
111532,6vxx,DB03996,-8.6,"3-[(5s)-1-Acetyl-3-(2-Chlorophenyl)-4,5-Dihydro-1h-Pyrazol-5-Yl]Phenol",QBZAPFWYAPXRGQ-KRWDZBQOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
117511,6w4b,DB03591,-8.6,RU82209,LVZDQVATAQEMCX-NSOVKSMOSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
149104,6w9q,DB14916,-8.6,Selonsertib,YIDDLAAKOYYGJG-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
33020,6cs2,T3D3952,-8.6,Lymecycline,AHEVKYYGXVEWNO-UEPZRUIBSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
61607,6crv,DB12322,-8.6,GW-870086,WUBKGTSFJSEIEM-NSHBDUGJSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108140,6vxx,DB07148,-8.6,"(6S)-1-chloro-3-[(4-fluorobenzyl)oxy]-6-(pyrrolidin-1-ylcarbonyl)pyrrolo[1,2-a]pyrazin-4(6H)-one",HPAFVLDARQIHPU-HNNXBMFYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111696,6vxx,DB04395,-8.6,Phosphoaminophosphonic Acid-Adenylate Ester,PVKSNHVPLWYQGJ-FCIPNVEPSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
123332,6w4b,DB15328,-8.6,Ubrogepant,DDOOFTLHJSMHLN-ZQHRPCGSSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
111525,6vxx,DB03987,-8.6,"2,4-Diamino-6-[N-(3',5'-Dimethoxybenzyl)-N-Methylamino]Pyrido[2,3-D]Pyrimidine",XWCCXDBXMCTZPW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108307,6vxx,DB07607,-8.6,4-[5-(3-IODO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-1H-IMIDAZOL-4-YL]-PYRIDINE,RXDZANYWRNIAOR-HHHXNRCGSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
9451,6lzg,DB07550,-8.6,"2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(1-OXIDO-2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUOROPHENYL)METHYL]ACETAMIDE",ZIGSBBKEPNQXRG-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
27788,6cs2,DB07340,-8.6,"N-6-cyclohexyl-N-2-(4-morpholin-4-ylphenyl)-9H-purine-2,6-diamine",ZFLJHSQHILSNCM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
126509,6w4h,DB03921,-8.6,4-(3-Pyridin-2-Yl-1h-Pyrazol-4-Yl)Quinoline,IBCXZJCWDGCXQT-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
164103,7bv1,DB07261,-8.6,"THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [1-(1-AMINO-ISOQUINOLIN-7-YLMETHYL)-2-OXO-PYRROLDIN-3-YL]-AMIDE",NVKDOURNRJCKJE-INIZCTEOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
33382,6cs2,T3D4573,-8.6,Brotizolam,UMSGKTJDUHERQW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
101594,6vxs,DB05812,-8.6,Abiraterone,GZOSMCIZMLWJML-VJLLXTKPSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
61587,6crv,DB12299,-8.6,Bavisant,BGBVSGSIXIIREO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
101786,6vxs,DB06497,-8.6,Aplaviroc,GWNOTCOIYUNTQP-FQLXRVMXSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
108340,6vxx,DB07643,-8.6,"5-{[1-(2,3-dichlorobenzyl)piperidin-4-yl]methoxy}quinazoline-2,4-diamine",XVLUVRFYGVJKGJ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
116325,6w4b,DB02009,-8.6,"L-756,423",AOMZDQMIOCTPQP-QHQMVRJISA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
89635,6m71,DB00717,-8.6,Norethisterone,VIKNJXKGJWUCNN-XGXHKTLJSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
89645,6m71,DB00728,-8.6,Rocuronium,YXRDKMPIGHSVRX-OOJCLDBCSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
101609,6vxs,DB05913,-8.6,OSI-930,FGTCROZDHDSNIO-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
165348,7bv1,DB11966,-8.6,BMS-986094,YFXGICNMLCGLHJ-RSKRLRQZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
89148,6m71,DB00137,-8.6,Lutein,KBPHJBAIARWVSC-RGZFRNHPSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59096,6crv,DB07067,-8.6,"(2S,3S)-3-{3-[4-(METHYLSULFONYL)PHENYL]-1,2,4-OXADIAZOL-5-YL}-1-OXO-1-PYRROLIDIN-1-YLBUTAN-2-AMINE",SQCDMTZMCHZYGO-FZMZJTMJSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30154,6cs2,DB12122,-8.6,Figopitant,HUTHJVYJUPXHDF-DEOSSOPVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
108240,6vxx,DB07267,-8.6,2-(6-methylpyridin-2-yl)-N-pyridin-4-ylquinazolin-4-amine,JONFDFIXMPXTRH-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
148695,6w9q,DB13791,-8.6,Penfluridol,MDLAAYDRRZXJIF-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
59115,6crv,DB07090,-8.6,(3S)-N-(3-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE,NJNMAZNXKKBTPS-ZDUSSCGKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
10792,6lzg,DB09074,-8.6,Olaparib,FDLYAMZZIXQODN-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
10775,6lzg,DB09048,-8.6,Netupitant,WAXQNWCZJDTGBU-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
160497,7bv1,DB08459,-8.6,"3-chloro-5-[2-chloro-5-(1H-pyrazolo[3,4-b]pyridin-3-ylmethoxy)phenoxy]benzonitrile",SVMHTBVIPYVDIL-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
129928,6w4h,DB11430,-8.6,Monensin,GAOZTHIDHYLHMS-KEOBGNEYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
108218,6vxx,DB07242,-8.6,"(4R)-7,8-dichloro-1',9-dimethyl-1-oxo-1,2,4,9-tetrahydrospiro[beta-carboline-3,4'-piperidine]-4-carbonitrile",XGUIMGJMQKZRGM-LLVKDONJSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28804,6cs2,DB08423,-8.6,[5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL][3-(PIPERIDIN-4-YLOXY)PHENYL]METHANONE,QKZZJXRGCHXIAI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
101676,6vxs,DB06207,-8.6,Silodosin,PNCPYILNMDWPEY-QGZVFWFLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
56021,6crv,DB01771,-8.6,CRA_10991,QXAURVOBXQBPAP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114235,6vxx,DB13136,-8.6,Fluindione,NASXCEITKQITLD-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
12844,6lzg,DB13874,-8.6,Enasidenib,DYLUUSLLRIQKOE-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
59114,6crv,DB07089,-8.6,N-[amino(imino)methyl]-2-[2-(2-chlorophenyl)-4-(4-propoxyphenyl)-3-thienyl]acetamide,VZSMTBLDWPKVRW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
33098,6cs2,T3D4084,-8.6,Veratramine,MALFODICFSIXPO-KFKQDBFTSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
10768,6lzg,DB09030,-8.6,Vorapaxar,ZBGXUVOIWDMMJE-QHNZEKIYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
128432,6w4h,DB07607,-8.6,4-[5-(3-IODO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-1H-IMIDAZOL-4-YL]-PYRIDINE,RXDZANYWRNIAOR-HHHXNRCGSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
111558,6vxx,DB04030,-8.6,"1,3,4,9-Tetrahydro-2-(Hydroxybenzoyl)-9-[(4-Hydroxyphenyl)Methyl]-6-Methoxy-2h-Pyrido[3,4-B]Indole",ADXYEWMDAGIULV-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
101657,6vxs,DB06169,-8.6,Indibulin,SOLIIYNRSAWTSQ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101728,6vxs,DB06334,-8.6,Tucidinostat,SZMJVTADHFNAIS-BJMVGYQFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
164038,7bv1,DB06999,-8.6,"N-{3-[(5-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)carbonyl]-2,4-difluorophenyl}propane-1-sulfonamide",YZDJQTHVDDOVHR-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
114146,6vxx,DB12804,-8.6,Daniquidone,SRIOCKJKFXAKHK-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
89105,6m3m,DB02524,-8.6,"2',3'-O-{4-[Hydroxy(oxido)-lambda5-azanylidene]-2,6-dinitro-2,5-cyclohexadiene-1,1-diyl}adenosine 5'-(tetrahydrogen triphosphate)",XFMMHXLUHKBKQE-UHEGPQQHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
29706,6cs2,DB00875,-8.6,Flupentixol,NJMYODHXAKYRHW-DVZOWYKESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
148947,6w9q,DB14584,-8.6,Segesterone,SFLXYFZGKSGFKA-XUDSTZEESA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
108262,6vxx,DB07548,-8.6,"2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUORO-6-PYRIDINYL)METHYL]ACETAMIDE",JXHWVKOKYDAROD-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111641,6vxx,DB04315,-8.6,Guanosine-5'-Diphosphate,QGWNDRXFNXRZMB-UUOKFMHZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
164072,7bv1,DB07226,-8.6,"N-[4-(2-CHLOROPHENYL)-1,3-DIOXO-1,2,3,6-TETRAHYDROPYRROLO[3,4-C]CARBAZOL-9-YL]FORMAMIDE",JWZVNUNTFNELHL-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
129733,6w4h,DB09233,-8.6,Cronidipine,CNIJVNPIIHWRRP-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
89733,6m71,DB00834,-8.6,Mifepristone,VKHAHZOOUSRJNA-GCNJZUOMSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
108350,6vxx,DB07653,-8.6,"N-(5,6-DIPHENYLFURO[2,3-D]PYRIMIDIN-4-YL)GLYCINE",VXTCEUDVOCLEJG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
166438,7bv1,DB15132,-8.6,AZD-8165,YUHNXUAATAMVKD-PZJWPPBQSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
61498,6crv,DB12174,-8.6,CUDC-101,PLIVFNIUGLLCEK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114013,6vxx,DB12590,-8.6,Indiplon,CBIAWPMZSFFRGN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
128361,6w4h,DB07519,-8.6,"(6R)-2-amino-6-[2-(3'-methoxybiphenyl-3-yl)ethyl]-3,6-dimethyl-5,6-dihydropyrimidin-4(3H)-one",VDFBMQAUECXNKR-OAQYLSRUSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
101497,6vxs,DB05263,-8.6,Caprospinol,VMOZFSWFUBLCNN-AAPULDEBSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
90512,6m71,DB01831,-8.6,Tryptophanyl-5'amp,IFQVDHDRFCKAAW-SQIXAUHQSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
108435,6vxx,DB07988,-8.6,"2-[3-(5-MERCAPTO-[1,3,4]THIADIAZOL-2YL)-UREIDO]-N-METHYL-3-PENTAFLUOROPHENYL-PROPIONAMIDE",HZAXNPDJVFUGDS-BYPYZUCNSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111327,6vxx,DB03507,-8.6,"6-[3-(4-Morpholinyl)Propyl]-2-(3-Nitrophenyl)-5-Thioxo-5,6,-Dihydro-7h-Thienol[2',3':4,5]Pyrrolo[1,2-C]Imidazol-7-One",UXGUZFZBZPPZGL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
160633,7bv1,DB08878,-8.6,Aminopterin,TVZGACDUOSZQKY-LBPRGKRZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
101477,6vxs,DB05129,-8.6,Elsamitrucin,MGQRRMONVLMKJL-KWJIQSIXSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
107925,6vxx,DB05626,-8.6,Retaspimycin,OAKGNIRUXAZDQF-TXHRRWQRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114401,6vxx,DB13393,-8.6,Emetine,AUVVAXYIELKVAI-CKBKHPSWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
160450,7bv1,DB08400,-8.6,4-(3-{[5-(trifluoromethyl)pyridin-2-yl]oxy}benzyl)piperidine-1-carboxylic acid,KUEKMTNOUPAOBS-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
90169,6m71,DB01411,-8.6,Pranlukast,NBQKINXMPLXUET-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
90580,6m71,DB01933,-8.6,7-Hydroxystaurosporine,PBCZSGKMGDDXIJ-HQCWYSJUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
111310,6vxx,DB03486,-8.6,Phosphomethylphosphonic Acid Guanosyl Ester,OCJWYBKRHNXUME-KQYNXXCUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55854,6crv,DB01557,-8.6,??-Methylfentanyl,NGTVDHYUFBKWID-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111297,6vxx,DB03467,-8.6,Naringenin,FTVWIRXFELQLPI-ZDUSSCGKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28738,6cs2,DB08350,-8.6,"5-[3-(2-METHOXYPHENYL)-1H-PYRROLO[2,3-B]PYRIDIN-5-YL]-N,N-DIMETHYLPYRIDINE-3-CARBOXAMIDE",GYQRHHQPEMOLKH-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
61469,6crv,DB12129,-8.6,Tideglusib,PMJIHLSCWIDGMD-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163888,7bv1,DB06817,-8.6,Raltegravir,CZFFBEXEKNGXKS-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
55845,6crv,DB01548,-8.6,Diprenorphine,OIJXLIIMXHRJJH-KNLIIKEYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
166410,7bv1,DB15078,-8.6,Rogaratinib,HNLRRJSKGXOYNO-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
127040,6w4h,DB04632,-8.6,4-(2-HYDROXYBENZYLAMINO)-N-(3-(4-FLUOROPHENOXY)PHENYL)PIPERIDINE-1-SULFONAMIDE,JHHBGNIRSUTQAS-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
107876,6vxx,DB05408,-8.6,Emricasan,SCVHJVCATBPIHN-SJCJKPOMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
164158,7bv1,DB07321,-8.6,"2,5-DICHLORO-N-[5-METHOXY-7-(6-METHOXYPYRIDIN-3-YL)-1,3-BENZOXAZOL-2-YL]BENZENESULFONAMIDE",KOKQLKWXOFRTHE-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
111811,6vxx,DB04726,-8.6,"7,8,10-TRIMETHYLBENZO[G]PTERIDINE-2,4(3H,10H)-DIONE",KPDQZGKJTJRBGU-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
32853,6cs2,T3D3768,-8.6,Luteoskyrin,FAZDYVMEXQHRLI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
90586,6m71,DB01940,-8.6,Balanol Analog 2,SQLYTJZXRRDERK-ISKFKSNPSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
90160,6m71,DB01395,-8.6,Drospirenone,METQSPRSQINEEU-HXCATZOESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
118371,6w4b,DB04739,-8.6,4-[(4-METHYL-1-PIPERAZINYL)METHYL]-N-[3-[[4-(3-PYRIDINYL)-2-PYRIMIDINYL]AMINO]PHENYL]-BENZAMIDE,JHMBUEWQJDGKGS-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
111403,6vxx,DB03823,-8.6,Epigallocatechin,XMOCLSLCDHWDHP-IUODEOHRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108355,6vxx,DB07663,-8.6,"2-[(1R)-1-CARBOXY-2-(4-HYDROXYPHENYL)ETHYL]-1,3-DIOXOISOINDOLINE-5-CARBOXYLIC ACID",QISJEFYTLZTWIQ-CQSZACIVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165347,7bv1,DB11965,-8.6,SJG-136,RWZVMMQNDHPRQD-SFTDATJTSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
30263,6cs2,DB12267,-8.6,Brigatinib,AILRADAXUVEEIR-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
114412,6vxx,DB13407,-8.6,Nifenazone,BRZANEXCSZCZCI-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
101570,6vxs,DB05653,-8.6,IRX-5183,PNAWUIKCVQSLFG-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
28837,6cs2,DB08459,-8.6,"3-chloro-5-[2-chloro-5-(1H-pyrazolo[3,4-b]pyridin-3-ylmethoxy)phenoxy]benzonitrile",SVMHTBVIPYVDIL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
108094,6vxx,DB06837,-8.6,"(2R)-N-4-hydroxy-2-(3-hydroxybenzyl)-N-1-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]butanediamide",VXDKQRWTOJFQKH-BJZITVGISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
149147,6w9q,DB15036,-8.6,Sitravatinib,WLAVZAAODLTUSW-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
55924,6crv,DB01641,-8.6,"(5z)-2-[(1s,2r)-1-Amino-2-Hydroxypropyl]-5-[(4-Amino-1h-Indol-3-Yl)Methylene]-3-(2-Hydroxyethyl)-3,5-Dihydro-4h-Imidazol-4-One",JUWJATLABHTRDF-JURWUIOISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28768,6cs2,DB08383,-8.6,"4,5-bis(4-methoxyphenyl)-2-thiophen-2-yl-1H-imidazole",XBMULXNXJLWLLD-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
126783,6w4h,DB04285,-8.6,"{4-[(2s,4e)-2-(1,3-Benzothiazol-2-Yl)-2-(1h-1,2,3-Benzotriazol-1-Yl)-5-Phenylpent-4-Enyl]Phenyl}(Difluoro)Methylphosphonic Acid",GBLDYRVJENYQNH-AGLOJYHOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
101801,6vxs,DB06533,-8.6,Ragaglitazar,WMUIIGVAWPWQAW-XMMPIXPASA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
56158,6crv,DB01958,-8.6,"5-[4-Tert-Butylphenylsulfanyl]-2,4-Quinazolinediamine",MNYDVPDMLAJJPB-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108370,6vxx,DB07680,-8.6,[(1S)-1-(5-CHLORO-1-BENZOTHIEN-3-YL)-2-(2-NAPHTHYLAMINO)-2-OXOETHYL]PHOSPHONIC ACID,HUJXISJLAPAFBO-IBGZPJMESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
101808,6vxs,DB06555,-8.6,Siramesine,XWAONOGAGZNUSF-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
12871,6lzg,DB13947,-8.6,Testosterone enantate benzilic acid hydrazone,PTVXYACXDYZNID-JKXGKYMWSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
61549,6crv,DB12247,-8.6,AZD-4547,VRQMAABPASPXMW-HDICACEKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61545,6crv,DB12242,-8.6,AZD-7762,IAYGCINLNONXHY-LBPRGKRZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61544,6crv,DB12241,-8.6,TAK-733,RCLQNICOARASSR-SECBINFHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56191,6crv,DB02004,-8.6,"5-(Aminomethyl)-6-(2,4-Dichlorophenyl)-2-(3,5-Dimethoxyphenyl)Pyrimidin-4-Amine",RCJFINNFYUNFGH-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163970,7bv1,DB06916,-8.6,"N-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-1-[2-(1H-IMIDAZOL-1-YL)-6-METHYLPYRIMIDIN-4-YL]-D-PROLINAMIDE",LBCGUKCXRVUULK-QGZVFWFLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
56196,6crv,DB02010,-8.6,Staurosporine,HKSZLNNOFSGOKW-FYTWVXJKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
90069,6m71,DB01216,-8.6,Finasteride,DBEPLOCGEIEOCV-WSBQPABSSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
111758,6vxx,DB04480,-8.6,"3-(4-Fluorophenyl)-2-(6-Methylpyridin-2-Yl)-5,6-Dihydro-4h-Pyrrolo[1,2-B]Pyrazole",NBDZLUOYAAVYHF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108400,6vxx,DB07717,-8.6,"(5S,8R,9S,10S,13R,14S,17S)-13-{2-[(3,5-DIFLUOROBENZYL)OXY]ETHYL}-17-HYDROXY-10-METHYLHEXADECAHYDRO-3H-CYCLOPENTA[A]PHENANTHREN-3-ONE",AJODXHGZHBERGJ-JLYQOUBASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111413,6vxx,DB03837,-8.6,Morpholine-4-Carboxylic Acid (1-(3-Benzenesulfonyl-1-Phenethylallylcarbamoyl)-3-Methylbutyl)-Amide,YUMYYTORLYHUFW-ZUDLOMHPSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27741,6cs2,DB07296,-8.6,(5Z)-3-(4-CHLOROPHENYL)-4-HYDROXY-5-(1-NAPHTHYLMETHYLENE)FURAN-2(5H)-ONE,PLGHLEBIWUQEPR-PDGQHHTCSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
108422,6vxx,DB07973,-8.6,N-(1-ISOPROPYLPIPERIDIN-4-YL)-1-(3-METHOXYBENZYL)-1H-INDOLE-2-CARBOXAMIDE,GIPCBGDQVGKMPO-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
160467,7bv1,DB08423,-8.6,[5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL][3-(PIPERIDIN-4-YLOXY)PHENYL]METHANONE,QKZZJXRGCHXIAI-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
107085,6vxx,DB02266,-8.6,Flufenamic Acid,LPEPZBJOKDYZAD-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
128525,6w4h,DB07716,-8.6,"(4Z)-2,8:7,12:11,15:14,18:17,22-PENTAANHYDRO-4,5,6,9,10,13,19,20,21-NONADEOXY-D-ARABINO-D-ALLO-D-ALLO-DOCOSA-4,9,20-TRIENITOL",VDRIXSJOPKVWKM-HXGIDPQASA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
28417,6cs2,DB08005,-8.6,4-{[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino}-N-ethylpiperidine-1-carboxamide,ARMFMDYRYOKSOW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
113721,6vxx,DB11811,-8.6,Arhalofenate,BJBCSGQLZQGGIQ-QGZVFWFLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58921,6crv,DB06866,-8.6,6-CARBAMIMIDOYL-2-[2-HYDROXY-5-(3-METHOXY-PHENYL)-INDAN-1-YL]-HEXANOIC ACID,NMOUMGFCBOWPAB-RZUBCFFCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59324,6crv,DB07328,-8.6,"METHYL 4-{[({[(2R,5S)-5-{[(2S)-2-(AMINOMETHYL)PYRROLIDIN-1-YL]CARBONYL}PYRROLIDIN-2-YL]METHYL}AMINO)CARBONYL]AMINO}BENZOATE",USDCNOQKDUFKRD-IKGGRYGDSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106844,6vxx,DB01380,-8.6,Cortisone acetate,ITRJWOMZKQRYTA-RFZYENFJSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
93044,6m71,DB06163,-8.6,Plevitrexed,IEJSCSAMMLUINT-NRFANRHFSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
28014,6cs2,DB07584,-8.6,"N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine",OKGCSZUKOGMZAL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
100343,6vxs,DB03453,-8.6,Methyl (2S)-2-[[2-[(3R)-1-carbamimidoylpiperidin-3-yl]acetyl]amino]-3-[4-(2-phenylethynyl)phenyl]propanoate,MRNGXYMKYHNMLV-PKTZIBPZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
110776,6vxx,DB02398,-8.6,6-[N-(4-(Aminomethyl)Phenyl)Carbamyl]-2-Naphthalenecarboxamidine,NLBDETRVUYOIHQ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
8558,6lzg,DB06393,-8.6,Xaliproden,WJJYZXPHLSLMGE-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
57014,6crv,DB03086,-8.6,"N'-(2s,3r)-3-Amino-4-Cyclohexyl-2-Hydroxy-Butano-N-(4-Methylphenyl)Hydrazide",IQMLIGOOOFEBAH-CVEARBPZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30616,6cs2,DB12731,-8.6,Daporinad,KPBNHDGDUADAGP-VAWYXSNFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
61159,6crv,DB11675,-8.6,Mosapride,YPELFRMCRYSPKZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
93508,6m71,DB07031,-8.6,"3-Fluoro-4-{[(2R)-2-hydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthalenyl)acetyl]amino}benzoic acid",AANFHDFOMFRLLR-LJQANCHMSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
129421,6w4h,DB08772,-8.6,"3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL-2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID",BCSVCWVQNOXFGL-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
106837,6vxx,DB01357,-8.6,Mestranol,IMSSROKUHAOUJS-MJCUULBUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56764,6crv,DB02755,-8.6,1-3 Sugar Ring of Pentamannosyl 6-Phosphate,HDQMHAJOIVYOIP-NAVBLJQLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56768,6crv,DB02759,-8.6,4-Methylumbelliferyl Chitobiose,UPSFMJHZUCSEHU-JYGUBCOQSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61162,6crv,DB11679,-8.6,Fruquintinib,BALLNEJQLSTPIO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106848,6vxx,DB01392,-8.6,Yohimbine,BLGXFZZNTVWLAY-SCYLSFHTSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28039,6cs2,DB07613,-8.6,3-phenyl-5-(1H-pyrazol-3-yl)isoxazole,SRSSTOPJERVMRZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
160285,7bv1,DB07967,-8.6,9-CYCLOPENTYL-6-[2-(3-IMIDAZOL-1-YL-PROPOXY)-PHENYLAMINO]-9H-PURINE-2-CARBONITRILE,JJNKDTWKWYLERH-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
61181,6crv,DB11704,-8.6,Adomeglivant,FASLTMSUPQDLIB-MHZLTWQESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108848,6vxx,DB11115,-8.6,Ensulizole,UVCJGUGAGLDPAA-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110725,6vxx,DB02155,-8.6,Balanol Analog 8,XVLMXAUKCDSMMW-YXLARRHKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165280,7bv1,DB11698,-8.6,Ipragliflozin,AHFWIQIYAXSLBA-RQXATKFSSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
163536,7bv1,DB04760,-8.6,"PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-(4-FLUORO-3-METHYL-BENZYLAMIDE)",PYFRREJCFXFNRR-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
61133,6crv,DB11636,-8.6,Nomegestrol,KZUIYQJTUIACIG-YBZCJVABSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61084,6crv,DB11490,-8.6,Nalorphine,UIQMVEYFGZJHCZ-SSTWWWIQSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55633,6crv,DB01228,-8.6,Encainide,PJWPNDMDCLXCOM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163417,7bv1,DB04392,-8.6,"Bishydroxy[2h-1-Benzopyran-2-One,1,2-Benzopyrone]",HIZKPJUTKKJDGA-BETUJISGSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
163630,7bv1,DB04879,-8.6,Vatalanib,YCOYDOIWSSHVCK-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
163545,7bv1,DB04771,-8.6,1-GUANIDINO-4-(N-NITRO-BENZOYLAMINO-L-LEUCYL-L-PROLYLAMINO)BUTANE,FIZYZWLGMGGGBJ-OALUTQOASA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
28928,6cs2,DB00796,-8.6,Candesartan cilexetil,GHOSNRCGJFBJIB-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
59318,6crv,DB07322,-8.6,"2-[(PHENYLSULFONYL)AMINO]-5,6,7,8-TETRAHYDRONAPHTHALENE-1-CARBOXYLIC ACID",RRXVUYHFDBLTEL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
100466,6vxs,DB03638,-8.6,Cytidyl-2'-5'-Phospho-Guanosine,QZDUXDLOEVJGDG-VMIOUTBZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
28001,6cs2,DB07568,-8.6,"(2S)-2-[(2,1,3-BENZOTHIADIAZOL-4-YLSULFONYL)AMINO]-2-PHENYL-N-PYRIDIN-4-YLACETAMIDE",ADRNPUSZBRQDBG-KRWDZBQOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
113688,6vxx,DB11765,-8.6,PF-04991532,GKMLFBRLRVQVJO-ZDUSSCGKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
160288,7bv1,DB07970,-8.6,5-[(2-methyl-5-{[3-(trifluoromethyl)phenyl]carbamoyl}phenyl)amino]pyridine-3-carboxamide,SAAYRHKJHDIDPH-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
11238,6lzg,DB11694,-8.6,Ilorasertib,WPHKIQPVPYJNAX-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
106878,6vxx,DB01691,-8.6,Indole Naphthyridinone,VAZMNDXVXVUKFY-JXMROGBWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
10501,6lzg,DB08708,-8.6,"N-cyclohexyl-3-[3-(trifluoromethyl)phenyl][1,2,4]triazolo[4,3-b]pyridazin-6-amine",XYYDXQCAYXOGQT-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
28038,6cs2,DB07612,-8.6,6-(3-AMINOPHENYL)-N-(TERT-BUTYL)-2-(TRIFLUOROMETHYL)QUINAZOLIN-4-AMINE,XQKJVNGGVLHNLA-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
125698,6w4h,DB02833,-8.6,[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(3-Nitro-Phenyl)-Amine,DYTKVFHLKPDNRW-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
30698,6cs2,DB12857,-8.6,NVP-LEQ-506,POERAARDVFVDLO-QGZVFWFLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
106640,6vxx,DB00844,-8.6,Nalbuphine,NETZHAKZCGBWSS-CEDHKZHLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55688,6crv,DB01337,-8.6,Pancuronium,GVEAYVLWDAFXET-XGHATYIMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61052,6crv,DB11430,-8.6,Monensin,GAOZTHIDHYLHMS-KEOBGNEYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113673,6vxx,DB11741,-8.6,Famitinib,GKEYKDOLBLYGRB-LGMDPLHJSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
93121,6m71,DB06347,-8.6,Cenisertib,KSOVGRCOLZZTPF-QMKUDKLTSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
28025,6cs2,DB07595,-8.6,"(5Z)-5-(3-BROMOCYCLOHEXA-2,5-DIEN-1-YLIDENE)-N-(PYRIDIN-4-YLMETHYL)-1,5-DIHYDROPYRAZOLO[1,5-A]PYRIMIDIN-7-AMINE",WSIQKQLAGWVKSL-UHFFFAOYSA-O,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
112034,6vxx,DB06148,-8.6,Mianserin,UEQUQVLFIPOEMF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106791,6vxx,DB01260,-8.6,Desonide,WBGKWQHBNHJJPZ-LECWWXJVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
8544,6lzg,DB06334,-8.6,Tucidinostat,SZMJVTADHFNAIS-BJMVGYQFSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
127459,6w4h,DB06137,-8.6,KX-01,HUNGUWOZPQBXGX-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
112030,6vxx,DB06137,-8.6,KX-01,HUNGUWOZPQBXGX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
25145,6cs2,DB03010,-8.6,Patupilone,QXRSDHAAWVKZLJ-PVYNADRNSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
56826,6crv,DB02836,-8.6,Guanosine 5'-Diphosphate 2':3'-Cyclic Monophosphate,NGYWTCOGOZELRS-UUOKFMHZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
93446,6m71,DB06955,-8.6,"3,4-bis(7-chloro-1H-indol-3-yl)-1H-pyrrole-2,5-dicarboxylic acid",OAMCCJASDLMTOO-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
102508,6vxs,DB07479,-8.6,"(1S)-1,2,3,4-TETRAHYDRO-BENZO[C]PHENANTHRENE-2,3,4-TRIOL",WCUHTHVUZQCBTI-KBAYOESNSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
58914,6crv,DB06858,-8.6,N-cyclooctylglycyl-N-(4-carbamimidoylbenzyl)-L-prolinamide,MMLOIDMSBRJZAE-FQEVSTJZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106794,6vxx,DB01264,-8.6,Darunavir,CJBJHOAVZSMMDJ-HEXNFIEUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30649,6cs2,DB12781,-8.6,Balaglitazone,IETKPTYAGKZLKY-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
113718,6vxx,DB11805,-8.6,Saracatinib,OUKYUETWWIPKQR-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
11241,6lzg,DB11697,-8.6,Pacritinib,HWXVIOGONBBTBY-ONEGZZNKSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
27438,6cs2,DB06983,-8.6,"(5-phenyl-7-(pyridin-3-ylmethylamino)pyrazolo[1,5-a]pyrimidin-3-yl)methanol",RBLKWWBHDUBPFN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
58920,6crv,DB06865,-8.6,6-CARBAMIMIDOYL-2-[2-HYDROXY-6-(4-HYDROXY-PHENYL)-INDAN-1-YL]-HEXANOIC ACID,ZSRRBAKATXAISL-LMNJBCLMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108794,6vxx,DB08970,-8.6,Fluprednidene,YVHXHNGGPURVOS-SBTDHBFYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163610,7bv1,DB04852,-8.6,Implitapide,AMNXBQPRODZJQR-DITALETJSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
163602,7bv1,DB04841,-8.6,Flunarizine,SMANXXCATUTDDT-QPJJXVBHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
106634,6vxx,DB00836,-8.6,Loperamide,RDOIQAHITMMDAJ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
93394,6m71,DB06897,-8.6,"3-[3-chloro-5-(5-{[(1S)-1-phenylethyl]amino}isoxazolo[5,4-c]pyridin-3-yl)phenyl]propan-1-ol",MMGKIHLBFPJYJL-HNNXBMFYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
58893,6crv,DB06829,-8.6,4-BROMO-3-(CARBOXYMETHOXY)-5-[3-(CYCLOHEXYLAMINO)PHENYL]THIOPHENE-2-CARBOXYLIC ACID,RXDVFLTWXCTCEX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
36840,1r42,DB03466,-8.6,BMS184394,AYAJZQYENGWICE-QHCPKHFHSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
100363,6vxs,DB03480,-8.6,Brequinar Analog,WYKKHJQZENLZID-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
61131,6crv,DB11629,-8.6,Laropiprant,NXFFJDQHYLNEJK-CYBMUJFWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
764,6lzg,HMDB0007098,-8.6,DG(16:0/16:0/0:0),JEJLGIQLPYYGEE-XIFFEERXSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
93105,6m71,DB06295,-8.6,Pramiconazole,AEKNYBWUEYNWMJ-QWOOXDRHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
32709,6cs2,T3D3616,-8.6,Nodularin-R,IXBQSRWSVIBXNC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
93111,6m71,DB06311,-8.6,Darapladib,WDPFJWLDPVQCAJ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
100233,6vxs,DB03300,-8.6,Pterin Cytosine Dinucleotide,WKSPNQYEWZEMMI-FEFZDOOUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
58923,6crv,DB06869,-8.6,1-[2-AMINO-2-CYCLOHEXYL-ACETYL]-PYRROLIDINE-3-CARBOXYLIC ACID 5-CHLORO-2-(2-ETHYLCARBAMOYL-ETHOXY)-BENZYLAMIDE,BMHVHOJXEQTIEA-SIKLNZKXSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61132,6crv,DB11633,-8.6,Isavuconazole,DDFOUSQFMYRUQK-RCDICMHDSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163390,7bv1,DB04350,-8.6,Argadin,FOZYKTUSOWWQGR-KNPYFFGGSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
127340,6w4h,DB05416,-8.6,Cardarine,YDBLKRPLXZNVNB-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
30726,6cs2,DB12895,-8.6,TD-139,YGIDGBAHDZEYMT-MQFIMZJJSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
107032,6vxx,DB02197,-8.6,"4-[(4-Imidazo[1,2-a]Pyridin-3-Ylpyrimidin-2-Yl)Amino]Benzenesulfonamide",NKORVPQBJCGYEC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30580,6cs2,DB12682,-8.6,Mubritinib,ZTFBIUXIQYRUNT-MDWZMJQESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
163521,7bv1,DB04739,-8.6,4-[(4-METHYL-1-PIPERAZINYL)METHYL]-N-[3-[[4-(3-PYRIDINYL)-2-PYRIMIDINYL]AMINO]PHENYL]-BENZAMIDE,JHMBUEWQJDGKGS-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
166500,7bv1,DB15250,-8.6,Vercirnon,JRWROCIMSDXGOZ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
100598,6vxs,DB03802,-8.6,"1-[4-(Octahydro-Pyrido[1,2-a]Pyrazin-2-Yl)-Phenyl]-2-Phenyl-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol",ZGHFWBDHZZKWSI-LITSAYRRSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
27533,6cs2,DB07081,-8.6,"(2R)-4-[(8R)-8-METHYL-2-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[1,5-A]PYRAZIN-7(8H)-YL]-4-OXO-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE",FDEXEPZGMKFCTG-PSASIEDQSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
107017,6vxx,DB02177,-8.6,1-Acetyl-4-(4-{4-[(2-Ethoxyphenyl)Thio]-3-Nitrophenyl}Pyridin-2-Yl)Piperazine,GKGJFUXSTSUKPB-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
92839,6m71,DB04983,-8.6,Denufosol,FPNPSEMJLALQSA-MIYUEGBISA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
58864,6crv,DB06777,-8.6,Chenodeoxycholic acid,RUDATBOHQWOJDD-BSWAIDMHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59309,6crv,DB07312,-8.6,"2,5-DICHLORO-N-(5-CHLORO-1,3-BENZOXAZOL-2-YL)BENZENESULFONAMIDE",JCXZHFCBNFFHRC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
93295,6m71,DB06744,-8.6,ginkgolide-B,SQOJOAFXDQDRGF-MMQTXUMRSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160102,7bv1,DB07514,-8.6,"3-(2-aminoquinazolin-6-yl)-1-(3,3-dimethylindolin-6-yl)-4-methylpyridin-2(1H)-one",LHLGUOHREUTYTO-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
114367,6vxx,DB13347,-8.6,Diphenadione,JYGLAHSAISAEAL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113609,6vxx,DB11645,-8.6,PF-4191834,DVNQWYLVSNPCJZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61212,6crv,DB11755,-8.6,Tetrahydrocannabivarin,ZROLHBHDLIHEMS-HUUCEWRRSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112047,6vxx,DB06169,-8.6,Indibulin,SOLIIYNRSAWTSQ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27469,6cs2,DB07014,-8.6,"2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4-methoxybenzyl)sulfanyl]-1,3,4-oxadiazole",TUTZKAQTSPMEBI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
156133,6wiq,DB12457,-8.6,Rimegepant,KRNAOFGYEFKHPB-ANJVHQHFSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
26474,6cs2,DB04616,-8.6,TACRINE(8)-4-AMINOQUINOLINE,UNVOAAWEEGAXTN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
57062,6crv,DB03154,-8.6,{[7-(Difluoro-Phosphono-Methyl)-Naphthalen-2-Yl]-Difluoro-Methyl}-Phosphonic Acid,VHKBLEYUHBIBNR-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114427,6vxx,DB13425,-8.6,Flutrimazole,QHMWCHQXCUNUAK-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
166497,7bv1,DB15245,-8.6,Olorofim,SUFPWYYDCOKDLL-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
112009,6vxx,DB05220,-8.6,Alisertib,ZLHFILGSQDJULK-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
92803,6m71,DB04888,-8.6,Bifeprunox,CYGODHVAJQTCBG-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
123035,6w4b,DB14676,-8.6,Fagrocorat,QJJBNCHSWFGXML-KEKPKEOLSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
113763,6vxx,DB12049,-8.6,Dasolampanel etibutil,HPBRMCFZIGUGTK-ZMMAXQRCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163651,7bv1,DB05678,-8.6,SLx-4090,AZUIUVJESCFSLJ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
6273,6lzg,DB01836,-8.6,"[4-(6-Chloro-Naphthalene-2-Sulfonyl)-Piperazin-1-Yl]-(3,4,5,6-Tetrahydro-2h-[1,4']Bipyridinyl-4-Yl)-Methanone",ZLAKCKVFSRSENR-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
7864,6lzg,DB04477,-8.6,"N-1,2,3,4-Tetrahydronaphth-1-Yl-2'-[3,5-Dimethoxybenzamido]-2'-Deoxy-Adenosine",FDZQGEIYGFPMOB-ZUURFMEUSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
93294,6m71,DB06743,-8.6,Ginkgolide A,FPUXKXIZEIDQKW-VKMVSBOZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93618,6m71,DB07156,-8.6,"(4Z)-6-bromo-4-({[4-(pyrrolidin-1-ylmethyl)phenyl]amino}methylidene)isoquinoline-1,3(2H,4H)-dione",JFEKAVPMVOLVTH-UNOMPAQXSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
8534,6lzg,DB06302,-8.6,Glesatinib,YRCHYHRCBXNYNU-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
93298,6m71,DB06747,-8.6,ginkgolide-M,KDKROYXEHCYLJQ-FJFAJXJPSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
26169,6cs2,DB04244,-8.6,(2R)-2-(3-Biphenylyl)-N-{(2R)-2-hydroxy-3-[(2-pyridinylsulfonyl)amino]propyl}-4-methylpentanamide,YCDHZDINQZLSRR-DNQXCXABSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
113588,6vxx,DB11592,-8.6,Nitrocefin,LHNIIDJCEODSHA-OQRUQETBSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127376,6w4h,DB05575,-8.6,Motesanib,RAHBGWKEPAQNFF-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
113749,6vxx,DB12027,-8.6,Serdemetan,CEGSUK1LWKJP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
11360,6lzg,DB11863,-8.6,Alvelestat,QNQZWEGMKJBHEM-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
28048,6cs2,DB07622,-8.6,"1-(3-(2,4-DIMETHYLTHIAZOL-5-YL)-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)-3-(4-METHYLPIPERAZIN-1-YL)UREA",KRKQVGZXTNLQSV-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
165452,7bv1,DB12122,-8.6,Figopitant,HUTHJVYJUPXHDF-DEOSSOPVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
127499,6w4h,DB06213,-8.6,Regadenoson,LZPZPHGJDAGEJZ-AKAIJSEGSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
14392,6lzg,T3D4082,-8.6,Cyclopamine,QASFUMOKHFSJGL-LAFRSMQTSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
27407,6cs2,DB06944,-8.6,N-(3-cyclopropyl-1H-pyrazol-5-yl)-2-(2-naphthyl)acetamide,RIGZCVNCFXYBEG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
92705,6m71,DB04764,-8.6,[4-(3-AMINOMETHYL-PHENYL)-PIPERIDIN-1-YL]-(5-PHENETHYL- PYRIDIN-3-YL)-METHANONE,CCLHROFBSWWOQO-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
108969,6vxx,DB11841,-8.6,Entinostat,INVTYAOGFAGBOE-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
37484,1r42,DB04330,-8.6,Bilh 434,KNRVCCXHLSHTFW-HGPRPZRGSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
58924,6crv,DB06870,-8.6,"17-HYDROXY-18A-HOMO-19-NOR-17ALPHA-PREGNA-4,9,11-TRIEN-3-ONE",OXHNQTSIKGHVBH-ANULTFPQSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28696,6cs2,DB08303,-8.6,"(3S)-3-cyclopentyl-6-methyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide",CUMKMTBOHBENJI-SFHVURJKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
99912,6vxs,DB02877,-8.6,Arotinoid acid,FOIVPCKZDPCJJY-JQIJEIRASA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
166336,7bv1,DB14669,-8.6,Betamethasone phosphate,VQODGRNSFPNSQE-DVTGEIKXSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
102389,6vxs,DB07337,-8.6,"4-[4-AMINO-6-(5-CHLORO-1H-INDOL-4-YLMETHYL)-[1,3,5]TRIAZIN-2-YLAMINO]-BENZONITRILE",SOKOHDQTKSROQZ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
30710,6cs2,DB12877,-8.6,Oxatomide,BAINIUMDFURPJM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
59422,6crv,DB07444,-8.6,"6-(3-AMINOPROPYL)-4,9-DIMETHYLPYRROLO[3,4-C]CARBAZOLE-1,3(2H,6H)-DIONE",PKPNSCZPIWCHMW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
125541,6w4h,DB02621,-8.6,Latrunculin A,DDVBPZROPPMBLW-IZGXTMSKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
27423,6cs2,DB06967,-8.6,"6-ETHYL-5-[9-(3-METHOXYPROPYL)-9H-CARBAZOL-2-YL]PYRIMIDINE-2,4-DIAMINE",MLSVRCGEBXIIQO-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
113676,6vxx,DB11745,-8.6,Otenabant,UNAZAADNBYXMIV-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
93239,6m71,DB06652,-8.6,Vicriviroc,CNPVJJQCETWNEU-CYFREDJKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
61238,6crv,DB11792,-8.6,Mirodenafil,MIJFNYMSCFYZNY-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
8067,6lzg,DB04724,-8.5,"(S)-2-((S)-3-ISOBUTYL-2,5-DIOXO-4-QUINOLIN-3-YLMETHYL-[1,4]DIAZEPAN-1YL)-N-METHYL-3-NAPHTALEN-2-YL-PROPIONAMIDE",COVPLULNDBDXTN-KYJUHHDHSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
67788,6lxt,DB07159,-8.5,Tamatinib,NHHQJBCNYHBUSI-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
30016,6cs2,DB11939,-8.5,Henagliflozin,HYTPDMFFHVZBOR-VNXMGFANSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
33616,6cs2,T3D4864,-8.5,Erioglaucine A disodium salt,SGHZXLIDFTYFHQ-UHFFFAOYSA-L,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
79785,6m2n,DB13739,-8.5,Penamecillin,NLOOMWLTUVBWAW-HLLBOEOZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
134527,6w9c,DB03199,-8.5,4-Methoxy-E-Rhodomycin T,XSSVYBYWQBNYOH-QJIXERIWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
33481,6cs2,T3D4738,-8.5,Encainide,PJWPNDMDCLXCOM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
160865,7bv1,DB11832,-8.5,Crenolanib,DYNHJHQFHQTFTP-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
36103,1r42,DB02483,-8.5,Etheno-Nad,JCDBQDNBEQHDHK-BSLNIGMPSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
103813,6vxs,DB09075,-8.5,Edoxaban,HGVDHZBSSITLCT-JLJPHGGASA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
84785,6m3m,DB06899,-8.5,"N-{2-[6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2,2-DIMETHYL-3-OXO-2,3-DIHYDRO-4H-1,4-BENZOTHIAZIN-4-YL]ETHYL}ACETAMIDE",RMEVNJZCKDVVND-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
137826,6w9c,DB08761,-8.5,"(3S,6S)-3,6-bis(4-hydroxybenzyl)piperazine-2,5-dione",NGPCLOGFGKJCBP-HOTGVXAUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
103811,6vxs,DB09073,-8.5,Palbociclib,AHJRHEGDXFFMBM-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
66762,6lxt,DB04612,-8.5,"N-METHYLALANYL-3-METHYLVALYL-4-PHENOXY-N-(1,2,3,4-TETRAHYDRONAPHTHALEN-1-YL)PROLINAMIDE",QKPXPZYQPBWDHS-MCJAPYMPSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
123998,6w4h,DB00637,-8.5,Astemizole,GXDALQBWZGODGZ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
72773,6m2n,DB01134,-8.5,Desoxycorticosterone pivalate,VVOIQBFMTVCINR-WWMZEODYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
65640,6lxt,DB03104,-8.5,RU82129,NKMPOVPTYDXGEC-MNRBYUMSSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
78898,6m2n,DB12419,-8.5,HSD-016,ZWASRJHIEFYJGL-BFUOFWGJSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
110113,6vxx,DB00991,-8.5,Oxaprozin,OFPXSFXSNFPTHF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
73365,6m2n,DB01941,-8.5,"6-[1-(3,5,5,8,8-Pentamethyl-5,6,7,8-Tetrahydronaphthalen-2-Yl)Cyclopropyl]Pyridine-3-Carboxylic Acid",SLXTWXQUEZSSTJ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
110538,6vxx,DB01910,-8.5,Sinefungin,LMXOHSDXUQEUSF-YECHIGJVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58591,6crv,DB06153,-8.5,Pizotifen,FIADGNVRKBPQEU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
67081,6lxt,DB05424,-8.5,Canertinib,OMZCMEYTWSXEPZ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
137812,6w9c,DB08746,-8.5,1-[[(1E)-2-(4-CHLOROPHENYL)ETHENYL]SULFONYL]-4-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]PIPERAZINE,ZOSSOFIFNGGDKG-GIJQJNRQSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139997,6w9c,DB14717,-8.5,Nitrazolam,OYRPNABWTHDOFK-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
111380,6vxx,DB03797,-8.5,3-Aminomethyl-Pyridinium-Adenine-Dinucleotide,HMCRLFVYYFBZEZ-PLEFRAQWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
33539,6cs2,T3D4789,-8.5,Troglitazone,GXPHKUHSUJUWKP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
142278,6w9q,DB01988,-8.5,6((S)-3-Benzylpiperazin-1-Yl)-3-(Naphthalen-2-Yl)-4-(Pyridin-4-Yl)Pyrazine,WFSFNKVFXLIZIY-MHZLTWQESA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
58803,6crv,DB06678,-8.5,Esmirtazapine,RONZAEMNMFQXRA-MRXNPFEDSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
65617,6lxt,DB03076,-8.5,AHA047,CGBDAHCDSVOMCF-FYZVQMPESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
103669,6vxs,DB08864,-8.5,Rilpivirine,YIBOMRUWOWDFLG-ONEGZZNKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
161298,7bv1,DB13520,-8.5,Metergoline,WZHJKEUHNJHDLS-QTGUNEKASA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
54939,6crv,DB00412,-8.5,Rosiglitazone,YASAKCUCGLMORW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110084,6vxx,DB00956,-8.5,Hydrocodone,LLPOLZWFYMWNKH-CMKMFDCUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114671,6vxx,DB14632,-8.5,Prednisolone tebutate,HUMXXHTVHHLNRO-KAJVQRHHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
102764,6vxs,DB07783,-8.5,1-((1R)-1-(HYDROXYMETHYL)-3-{6-[(3-PHENYLPROPANOYL)AMINO]-1H-INDOL-1-YL}PROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE,GUYYFMCFEPDDFL-OAQYLSRUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
84841,6m3m,DB06967,-8.5,"6-ETHYL-5-[9-(3-METHOXYPROPYL)-9H-CARBAZOL-2-YL]PYRIMIDINE-2,4-DIAMINE",MLSVRCGEBXIIQO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
73195,6m2n,DB01705,-8.5,Bis(5-Amidino-Benzimidazolyl)Methane,QZKOOEFIMWKZPK-UHFFFAOYSA-Q,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137808,6w9c,DB08742,-8.5,"1,3-CYCLOHEXANEDIOL, 4-METHYLENE-5-[(2E)-[(1S,3AS,7AS)-OCTAHYDRO-1-(5-HYDROXY-5-METHYL-1,3-HEXADIYNYL)-7A-METHYL-4H-INDEN-4-YLIDENE]ETHYLIDENE]-, (1R,3S,5Z)",CEEUUHVULXTFGS-BQXVGYHGSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
103789,6vxs,DB09030,-8.5,Vorapaxar,ZBGXUVOIWDMMJE-QHNZEKIYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
9863,6lzg,DB07994,-8.5,"N-3-[5-(1H-INDOL-6-YL)-2-(PYRIDIN-2-YLMETHOXY)BENZYL]PYRIDINE-2,3-DIAMINE",KMBPJSHPAXOXBT-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
134500,6w9c,DB03161,-8.5,Thymidine-5'-Diphospho-Beta-D-Xylose,AJUADKZRQSBUAK-KDGZBOQCSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
85307,6m3m,DB07504,-8.5,(2R)-1-{4-[(4-Anilino-5-bromo-2-pyrimidinyl)amino]phenoxy}-3-(dimethylamino)-2-propanol,MEIJADBULOETOV-QGZVFWFLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
67094,6lxt,DB05490,-8.5,AMG-131,NMRWDFUZLLQSBN-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
66759,6lxt,DB04608,-8.5,"9-HYDROXY-4-PHENYL-6H-PYRROLO[3,4-C]CARBAZOLE-1,3-DIONE",IAUZTOZLTFSMIE-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
67776,6lxt,DB07145,-8.5,(2R)-N-HYDROXY-2-[(3S)-3-METHYL-3-{4-[(2-METHYLQUINOLIN-4-YL)METHOXY]PHENYL}-2-OXOPYRROLIDIN-1-YL]PROPANAMIDE,YDMIPBHQKFOFQW-NSYGIPOTSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
85153,6m3m,DB07322,-8.5,"2-[(PHENYLSULFONYL)AMINO]-5,6,7,8-TETRAHYDRONAPHTHALENE-1-CARBOXYLIC ACID",RRXVUYHFDBLTEL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
110557,6vxx,DB01938,-8.5,L-Histidine Beta Naphthylamide,DKDILZBBFKZMRO-OAHLLOKOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
102490,6vxs,DB07456,-8.5,"3-(1H-indol-3-yl)-4-(1-{2-[(2S)-1-methylpyrrolidinyl]ethyl}-1H-indol-3-yl)-1H-pyrrole-2,5-dione",LBFDERUQORUFIN-QGZVFWFLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101858,6vxs,DB06673,-8.5,Almorexant,DKMACHNQISHMDN-RPLLCQBOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
165004,7bv1,DB09079,-8.5,Nintedanib,XZXHXSATPCNXJR-ZIADKAODSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
79043,6m2n,DB12645,-8.5,Givinostat,YALNUENQHAQXEA-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
33391,6cs2,T3D4584,-8.5,Etizolam,VMZUTJCNQWMAGF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
84694,6m3m,DB06766,-8.5,Alcaftadine,MWTBKTRZPHJQLH-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
160538,7bv1,DB08749,-8.5,3-(2-AMINO-6-BENZOYLQUINAZOLIN-3(4H)-YL)-N-CYCLOHEXYL-N-METHYLPROPANAMIDE,KTRFBFMYAJOXLG-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110014,6vxx,DB00705,-8.5,Delavirdine,WHBIGIKBNXZKFE-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
141747,6w9q,DB01251,-8.5,Gliquidone,LLJFMFZYVVLQKT-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
141574,6w9q,DB01051,-8.5,Novobiocin,YJQPYGGHQPGBLI-KGSXXDOSSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
110624,6vxx,DB02023,-8.5,8-Oxo-2'-Deoxy-Guanosine-5'-Monophosphate,AQIVLFLYHYFRKU-VPENINKCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79102,6m2n,DB12732,-8.5,Firategrast,YLFZHHDVRSYTKT-NRFANRHFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
67993,6lxt,DB07395,-8.5,"4-[3-(2-Chloro-4,5-difluoro-benzoyl)ureido]-3-trifluoromethoxybenzoic acid",NWQGDIBCFLDHDO-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
66839,6lxt,DB04716,-8.5,"2-(1,1-DIMETHYLETHYL)9-FLUORO-3,6-DIHYDRO-7H-BENZ[H]-IMIDAZ[4,5-F]ISOQUINOLIN-7-ONE",VNDWQCSOSCCWIP-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
161423,7bv1,DB14017,-8.5,H3B-8800,YOIQWBAHJZGRFW-WVRLKXNASA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
104110,6vxs,DB11431,-8.5,Moxidectin,YZBLFMPOMVTDJY-LSGXYNIPSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
128127,6w4h,DB07250,-8.5,"N'-(5-CHLORO-1,3-BENZODIOXOL-4-YL)-N-(3,4,5- TRIMETHOXYPHENYL)PYRIMIDINE-2,4-DIAMINE",HMKLUOPMOJOUDZ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
65330,6lxt,DB02691,-8.5,Glycocholic acid,RFDAIACWWDREDC-FRVQLJSFSA-M,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
110022,6vxx,DB00714,-8.5,Apomorphine,VMWNQDUVQKEIOC-CYBMUJFWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114333,6vxx,DB13308,-8.5,Oxametacin,AJRNYCDWNITGHF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
133270,6w9c,DB01481,-8.5,1-Testosterone,OKJCFMUGMSVJBG-ABEVXSGRSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
111552,6vxx,DB04022,-8.5,"Guanosine-5',3'-Tetraphosphate",BUFLLCUFNHESEH-UUOKFMHZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
137324,6w9c,DB08153,-8.5,"(5E)-14-CHLORO-15,17-DIHYDROXY-4,7,8,9,10,11-HEXAHYDRO-2-BENZOXACYCLOPENTADECINE-1,12(3H,13H)-DIONE",VZTAZMSAAIUZJV-HWKANZROSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
128126,6w4h,DB07249,-8.5,"N-(5-chloro-1,3-benzodioxol-4-yl)-6-methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-amine",QHIMVPIOWKYPSO-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
140134,6w9c,DB15046,-8.5,LY-2881835,FHRWHNJJQGSCQC-LJAQVGFWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
23075,6cs2,HMDB0055951,-8.5,"TG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/o-18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))",SLNZHQMWTFFEGB-CQZSHLFASA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
137616,6w9c,DB08513,-8.5,[4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENYL]ACETIC ACID,PAIQRYUOBBCBSE-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
66942,6lxt,DB04852,-8.5,Implitapide,AMNXBQPRODZJQR-DITALETJSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
110715,6vxx,DB02140,-8.5,N1-(1-Dimethylcarbamoyl-2-Phenyl-Ethyl)-2-Oxo-N4-(2-Pyridin-2-Yl-Ethyl)-Succinamide,ZPFPZRVOBBMZMP-SFHVURJKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
137620,6w9c,DB08519,-8.5,"N-4-(3-methyl-1H-indazol-6-yl)-N-2-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine",SQQAPOSROFWHIB-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
79106,6m2n,DB12740,-8.5,CC-115,GMYLVKUGJMYTFB-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
111561,6vxx,DB04038,-8.5,Ergosterol,DNVPQKQSNYMLRS-APGDWVJJSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
128265,6w4h,DB07405,-8.5,"1-(6-CYANO-3-PYRIDYLCARBONYL)-5',8'-DIFLUOROSPIRO[PIPERIDINE-4,2'(1'H)-QUINAZOLINE]-4'-AMINE",GIZYIOOBBUHOBS-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
68007,6lxt,DB07410,-8.5,[2-(3-DIBENZOFURAN-4-YL-PHENYL)-1-HYDROXY-1-PHOSPHONO-ETHYL]-PHOSPHONIC ACID,BYVXAUZOTGITQZ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
101724,6vxs,DB06314,-8.5,SGX-523,BCZUAADEACICHN-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
79901,6m2n,DB13936,-8.5,JNJ-28330835,RYBKPGYFXRNMMU-LBPRGKRZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
114785,6vxx,DB14857,-8.5,Avadomide,RSNPAKAFCAAMBH-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
123862,6w4h,DB00471,-8.5,Montelukast,UCHDWCPVSPXUMX-TZIWLTJVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
137876,6w9c,DB08820,-8.5,Ivacaftor,PURKAOJPTOLRMP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
104174,6vxs,DB11591,-8.5,Bilastine,ACCMWZWAEFYUGZ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
164967,7bv1,DB09015,-8.5,Canrenoic acid,PBKZPPIHUVSDNM-WNHSNXHDSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
133687,6w9c,DB02021,-8.5,Fidarestat,WAAPEIZFCHNLKK-UFBFGSQYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
101754,6vxs,DB06420,-8.5,Annamycin,CIDNKDMVSINJCG-GKXONYSUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
110622,6vxx,DB02021,-8.5,Fidarestat,WAAPEIZFCHNLKK-UFBFGSQYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
102549,6vxs,DB07528,-8.5,3-(2-aminoquinazolin-6-yl)-4-methyl-1-[3-(trifluoromethyl)phenyl]pyridin-2(1H)-one,HXUZQEYFKAZBPX-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
110600,6vxx,DB01990,-8.5,Cholesterol sulfate,BHYOQNUELFTYRT-DPAQBDIFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
54969,6crv,DB00447,-8.5,Loracarbef,JAPHQRWPEGVNBT-UTUOFQBUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
73206,6m2n,DB01720,-8.5,(2z)-2-(Benzoylamino)-3-[4-(2-Bromophenoxy)Phenyl]-2-Propenoic Acid,WLPJLQNKCJWAFL-RGEXLXHISA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
84759,6m3m,DB06870,-8.5,"17-HYDROXY-18A-HOMO-19-NOR-17ALPHA-PREGNA-4,9,11-TRIEN-3-ONE",OXHNQTSIKGHVBH-ANULTFPQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
134570,6w9c,DB03247,-8.5,Flavin mononucleotide,FVTCRASFADXXNN-SCRDCRAPSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
8206,6lzg,DB04888,-8.5,Bifeprunox,CYGODHVAJQTCBG-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
84762,6m3m,DB06873,-8.5,"1-((2-HYDROXYETHOXY)METHYL)-5-(3-(BENZYLOXY)BENZYL)PYRIMIDINE-2,4(1H,3H)-DIONE",CSXNPJKDZKLDET-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84756,6m3m,DB06866,-8.5,6-CARBAMIMIDOYL-2-[2-HYDROXY-5-(3-METHOXY-PHENYL)-INDAN-1-YL]-HEXANOIC ACID,NMOUMGFCBOWPAB-RZUBCFFCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
23354,6cs2,HMDB0061015,-8.5,ortho-hydroxyatorvastatin,CZBPKFICAYVHHM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
139936,6w9c,DB14626,-8.5,Pregnenolone acetate,CRRKVZVYZQXICQ-RJJCNJEVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
110806,6vxx,DB02431,-8.5,Cytidine-5'-Triphosphate,PCDQPRRSZKQHHS-XVFCMESISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78858,6m2n,DB12367,-8.5,Selurampanel,MCECSFFXUPEPDB-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
85295,6m3m,DB07489,-8.5,"4-Amino-2-[(3-chlorophenyl)amino]-5-(4-fluorobenzoyl)-1,3-thiazol-3-ium",WWGPTHOMFHDEEC-UHFFFAOYSA-O,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58559,6crv,DB05959,-8.5,ENMD-1198,YQJWOUQGXATDAE-ACNBBOPNSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
128138,6w4h,DB07261,-8.5,"THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [1-(1-AMINO-ISOQUINOLIN-7-YLMETHYL)-2-OXO-PYRROLDIN-3-YL]-AMIDE",NVKDOURNRJCKJE-INIZCTEOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
12262,6lzg,DB13113,-8.5,JNJ-38877605,JRWCBEOAFGHNNU-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
23304,6cs2,HMDB0060028,-8.5,"5-(3',4',5'-trihydroxyphenyl)-gamma-valerolactone-O-methyl-5'-O-glucuronide",KPVLDYMZFUPBJG-VHXBZSDJSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
133771,6w9c,DB02128,-8.5,[1-(3-Hydroxy-2-Oxo-1-Phenethyl-Propylcarbamoyl)2-Phenyl-Ethyl]-Carbamic Acid Pyridin-4-Ylmethyl Ester,QCUBCTPTNWPFBC-ZEQRLZLVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
40344,6lu7,DB11904,-8.5,Flumatinib,BJCJYEYYYGBROF-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
110616,6vxx,DB02014,-8.5,"5-(2-Fluoro-5-{(1E)-3-[3-hydroxy-2-(methoxycarbonyl)phenoxy]-1-propen-1-yl}phenyl)-1,2-oxazole-3-carboxylic acid",QKHWJUMLYAYZFS-ONEGZZNKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84732,6m3m,DB06834,-8.5,"N-(2-hydroxy-1,1-dimethylethyl)-1-methyl-3-(1H-pyrrolo[2,3-b]pyridin-2-yl)-1H-indole-5-carboxamide",XZRYCTLOGNCQDG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
104071,6vxs,DB11363,-8.5,Alectinib,KDGFLJKFZUIJMX-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
123784,6w4h,DB00377,-8.5,Palonosetron,CPZBLNMUGSZIPR-NVXWUHKLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
67011,6lxt,DB05016,-8.5,Ataluren,OOUGLTULBSNHNF-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
79083,6m2n,DB12707,-8.5,AR-42,LAMIXXKAWNLXOC-INIZCTEOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
85676,6m3m,DB07937,-8.5,"2-butoxy-9-(2,6-difluorobenzyl)-N-(2-morpholin-4-ylethyl)-9H-purin-6-amine",UGZWPZWADDDTRN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
101777,6vxs,DB06472,-8.5,Fradafiban,IKZACQMAVUIGPY-HOTGVXAUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
133750,6w9c,DB02102,-8.5,DMP450,KYRSNWPSSXSNEP-ZRTHHSRSSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
103955,6vxs,DB09298,-8.5,Silibinin,SEBFKMXJBCUCAI-HKTJVKLFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
137854,6w9c,DB08794,-8.5,Ethyl biscoumacetate,JCLHQFUTFHUXNN-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
58831,6crv,DB06718,-8.5,Stanozolol,LKAJKIOFIWVMDJ-IYRCEVNGSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
133761,6w9c,DB02115,-8.5,Daidzin,KYQZWONCHDNPDP-QNDFHXLGSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
58543,6crv,DB05838,-8.5,OPC-51803,INGXCNVWWKKWOO-LJQANCHMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59085,6crv,DB07055,-8.5,"2-[2-(1H-tetrazol-5-yl)ethyl]-1H-isoindole-1,3(2H)-dione",DEOJDUHRJBKATO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
160916,7bv1,DB12267,-8.5,Brigatinib,AILRADAXUVEEIR-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
85659,6m3m,DB07920,-8.5,N-oxo-2-[(4-phenylphenyl)sulfonylamino]ethanamide,OGRPZMQLAVBWPV-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
124250,6w4h,DB00932,-8.5,Tipranavir,SUJUHGSWHZTSEU-FYBSXPHGSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
72739,6m2n,DB01095,-8.5,Fluvastatin,FJLGEFLZQAZZCD-JUFISIKESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79656,6m2n,DB13571,-8.5,Pentamycin,AGJUUQSLGVCRQA-SWOUQTJZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
128229,6w4h,DB07360,-8.5,"1-{5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)ethyl]-1,3-thiazol-2-yl}-3-[3-(trifluoromethyl)phenyl]urea",JJHXPDTVQKWKHA-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
28473,6cs2,DB08061,-8.5,4-[3-(4-CHLOROPHENYL)-1H-PYRAZOL-5-YL]PIPERIDINE,GELALLNTKKLQLM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
28521,6cs2,DB08111,-8.5,"4-[(6-phenyl[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl]phenol",ZGJYGQLGSXWEMY-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
58991,6crv,DB06944,-8.5,N-(3-cyclopropyl-1H-pyrazol-5-yl)-2-(2-naphthyl)acetamide,RIGZCVNCFXYBEG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
12682,6lzg,DB13676,-8.5,Mosapramine,PXUIZULXJVRBPC-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
58765,6crv,DB06595,-8.5,Midostaurin,BMGQWWVMWDBQGC-IIFHNQTCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84999,6m3m,DB07146,-8.5,"2,3-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-B]PYRIDIN-4-AMINE",QUIQCYFSBGOBKE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
67415,6lxt,DB06677,-8.5,Clazosentan,LFWCJABOXHSRGC-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
79005,6m2n,DB12579,-8.5,JNJ-37822681,UVUYWJWYRLJHEN-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
26488,6cs2,DB04632,-8.5,4-(2-HYDROXYBENZYLAMINO)-N-(3-(4-FLUOROPHENOXY)PHENYL)PIPERIDINE-1-SULFONAMIDE,JHHBGNIRSUTQAS-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
58689,6crv,DB06403,-8.5,Ambrisentan,OUJTZYPIHDYQMC-LJQANCHMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110356,6vxx,DB01501,-8.5,Difenoxin,UFIVBRCCIRTJTN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
160810,7bv1,DB11759,-8.5,Pevonedistat,MPUQHZXIXSTTDU-QXGSTGNESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
85005,6m3m,DB07154,-8.5,"(3R)-4-[(3R)-3-AMINO-4-(2,4,5-TRIFLUOROPHENYL)BUTANOYL]-3-METHYL-1,4-DIAZEPAN-2-ONE",SWKGZJAAGSVROJ-MWLCHTKSSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
79011,6m2n,DB12590,-8.5,Indiplon,CBIAWPMZSFFRGN-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
58988,6crv,DB06940,-8.5,"N-ethyl-4-{[5-(methoxycarbamoyl)-2-methylphenyl]amino}-5-methylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide",ZZTMFGIGOADCFX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58986,6crv,DB06936,-8.5,N-(4-carbamimidoylbenzyl)-1-(4-methylpentanoyl)-L-prolinamide,AEKJCSNKYXWOAQ-INIZCTEOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
128303,6w4h,DB07450,-8.5,(R)-minalrestat,BMHZAHGTGIZZCT-LJQANCHMSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
123701,6w4h,DB00275,-8.5,Olmesartan,VTRAEEWXHOVJFV-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
58973,6crv,DB06923,-8.5,2-(3-METHYLPHENYL)-1H-INDOLE-5-CARBOXIMIDAMIDE,KJUSXMYSVXZFDJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
123702,6w4h,DB00276,-8.5,Amsacrine,XCPGHVQEEXUHNC-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
79023,6m2n,DB12612,-8.5,Ozanimod,XRVDGNKRPOAQTN-FQEVSTJZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
58761,6crv,DB06588,-8.5,Triphendiol,KQCJZAUNKSGEFM-UNMCSNQZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
141816,6w9q,DB01405,-8.5,Temafloxacin,QKDHBVNJCZBTMR-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
67417,6lxt,DB06680,-8.5,Asoprisnil,GJMNAFGEUJBOCE-MEQIQULJSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
110355,6vxx,DB01500,-8.5,Oxabolone,GXHBCWCMYVTJOW-YGRHGMIBSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72924,6m2n,DB01357,-8.5,Mestranol,IMSSROKUHAOUJS-MJCUULBUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
111015,6vxx,DB02882,-8.5,Cyanocinnoline,CUWRVIIPSSUUDJ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140056,6w9c,DB14857,-8.5,Avadomide,RSNPAKAFCAAMBH-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
128309,6w4h,DB07456,-8.5,"3-(1H-indol-3-yl)-4-(1-{2-[(2S)-1-methylpyrrolidinyl]ethyl}-1H-indol-3-yl)-1H-pyrrole-2,5-dione",LBFDERUQORUFIN-QGZVFWFLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
84978,6m3m,DB07123,-8.5,N-(4-METHYLBENZOYL)-4-BENZYLPIPERIDINE,DVOLWKZEIDCCES-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
73089,6m2n,DB01569,-8.5,Formebolone,AMVODTGMYSRMNP-GNIMZFFESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
133391,6w9c,DB01623,-8.5,Thiothixene,GFBKORZTTCHDGY-UWVJOHFNSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
73394,6m2n,DB01975,-8.5,AMPCPR,ZPZRETFSCSWNDT-DBXCYWGHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
102166,6vxs,DB07084,-8.5,"N-(6,7,9,10,17,18,20,21-octahydrodibenzo[b,k][1,4,7,10,13,16]hexaoxacyclooctadecin-2-yl)acetamide",YHKGWOJTUMJPNW-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
110944,6vxx,DB02611,-8.5,Balanol Analog 1,FZJQHARRQUNVGZ-QZTJIDSGSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
124049,6w4h,DB00699,-8.5,Nicergoline,YSEXMKHXIOCEJA-FVFQAYNVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
103240,6vxs,DB08341,-8.5,"4-{[4-{[(1R,2R)-2-(dimethylamino)cyclopentyl]amino}-5-(trifluoromethyl)pyrimidin-2-yl]amino}-N-methylbenzenesulfonamide",CAUFYHKGKDJMQG-HZPDHXFCSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
110333,6vxx,DB01474,-8.5,"17alpha-methyl-3beta,17beta-dihydroxyandrost-4-ene",BNUOCVTVOYWNJC-DTMQFJJTSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
54744,6crv,DB00179,-8.5,Masoprocol,HCZKYJDFEPMADG-TXEJJXNPSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72942,6m2n,DB01405,-8.5,Temafloxacin,QKDHBVNJCZBTMR-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
73084,6m2n,DB01564,-8.5,Calusterone,IVFYLRMMHVYGJH-PVPPCFLZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
34177,6cs2,T3D1042,-8.5,Avermectin B1b,ZFUKERYTFURFGA-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
133457,6w9c,DB01708,-8.5,Prasterone,FMGSKLZLMKYGDP-USOAJAOKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
85345,6m3m,DB07547,-8.5,5-(4-CYANOPHENYL)-3-{[(2-METHYLPHENYL)SULFONYL]AMINO}THIOPHENE-2-CARBOXYLIC ACID,RYXAHMSZLLIPRO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
161084,7bv1,DB12858,-8.5,LY-377604,RBSGUQYXRDKPAE-QFIPXVFZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110961,6vxx,DB02812,-8.5,"(2s,4r)-1-Acetyl-N-[(1s)-4-[(Aminoiminomethyl)Amino]-1-(2-Benzothiazolylcarbonyl)Butyl]-4-Hydroxy-2-Pyrrolidinecarboxamide",VXDAVYUFYPFGDX-SNPRPXQTSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85356,6m3m,DB07561,-8.5,(2Z)-2-cyano-N-(3'-ethoxybiphenyl-4-yl)-3-hydroxybut-2-enamide,RPILZQUCBKIPAZ-AQTBWJFISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
73060,6m2n,DB01540,-8.5,17alpha-methyl-4-hydroxynandrolone,CLNUZOCYKSHICX-FAHHUNKHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
34865,1r42,DB00872,-8.5,Conivaptan,IKENVDNFQMCRTR-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
103012,6vxs,DB08068,-8.5,N-[4-CHLORO-3-(PYRIDIN-3-YLOXYMETHYL)-PHENYL]-3-FLUORO-,YQJVDUKATDECHF-ICSRJNTNSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
103011,6vxs,DB08064,-8.5,N-(3-TERT-BUTYL-1H-PYRAZOL-5-YL)-N'-{4-CHLORO-3-[(PYRIDIN-3-YLOXY)METHYL]PHENYL}UREA,NTMADESEDXKNFZ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
110410,6vxx,DB01561,-8.5,Androstanedione,RAJWOBJTTGJROA-WZNAKSSCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
133506,6w9c,DB01774,-8.5,Adenosine-5'-Monophosphate Glucopyranosyl-Monophosphate Ester,WFPZSXYXPSUOPY-ROYWQJLOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
85044,6m3m,DB07198,-8.5,5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-CARBONITRILE,GGEKOZPXKBYLNK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
110413,6vxx,DB01564,-8.5,Calusterone,IVFYLRMMHVYGJH-PVPPCFLZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58937,6crv,DB06884,-8.5,4-HYDROXY-N'-(4-ISOPROPYLBENZYL)BENZOHYDRAZIDE,MFDXHRPPSJRQFX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
12636,6lzg,DB00197,-8.5,Troglitazone,GXPHKUHSUJUWKP-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
137675,6w9c,DB08582,-8.5,"N-(4-bromo-2-{[(3R,5S)-3,5-dimethylpiperidin-1-yl]carbonyl}phenyl)-4-morpholin-4-yl-4-oxobutanamide",DELARNBPJXTDBD-IYBDPMFKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
66448,6lxt,DB04190,-8.5,Inhibitor Bea425,AHAVBKNGKPWROK-UMFPTGFGSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
67294,6lxt,DB06367,-8.5,Relacatib,BWYBBMQLUKXECQ-GIVPXCGWSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
73052,6m2n,DB01532,-8.5,??-Methylacetylfentanyl,OKTLVZBUKMRPLL-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
73035,6m2n,DB01513,-8.5,"17Alpha-methyl-3beta,17beta-dihydroxy-5alpha-androstane",QGKQXZFZOIQFBI-UYEYMFBJSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79041,6m2n,DB12643,-8.5,Nelivaptan,NJXZWIIMWNEOGJ-WEWKHQNJSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
128205,6w4h,DB07333,-8.5,"N-(CYCLOPROPYLMETHYL)-4-(METHYLOXY)-3-({5-[3-(3-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-YL}AMINO)BENZENESULFONAMIDE",KRGKAARWVPUWSY-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
67289,6lxt,DB06350,-8.5,Elinogrel,LGSDFTPAICUONK-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
54774,6crv,DB00216,-8.5,Eletriptan,PWVXXGRKLHYWKM-LJQANCHMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
160838,7bv1,DB11796,-8.5,Fostemsavir,SWMDAPWAQQTBOG-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
140039,6w9c,DB14810,-8.5,AZD-1656,FJEJHJINOKKDCW-INIZCTEOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137665,6w9c,DB08572,-8.5,4-{[4-AMINO-6-(CYCLOHEXYLMETHOXY)-5-NITROSOPYRIMIDIN-2-YL]AMINO}BENZAMIDE,YBKLJTXDSBEVRV-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
85055,6m3m,DB07211,-8.5,(2R)-2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}PROPENE-1-SULFONAMIDE,YMJHMJLNQLVUAV-GHYUOPHCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
137475,6w9c,DB08345,-8.5,"4-(2-(1H-IMIDAZOL-4-YL)ETHYLAMINO)-2-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE",IWUUKHQIKFHWIW-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
72981,6m2n,DB01450,-8.5,Dihydroetorphine,BRTSNYPDACNMIP-FAWZKKEFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
110897,6vxx,DB02547,-8.5,Guanosine-5'-Diphosphate-Rhamnose,LQEBEXMHBLQMDB-GDJBGNAASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79029,6m2n,DB12622,-8.5,Lupeol,MQYXUWHLBZFQQO-QGTGJCAVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
73417,6m2n,DB02008,-8.5,1-(2-Fluorobenzyl)-3-Butyl-8-(N-Acetyl-4-Aminobenzyl)-Xanthine,JHSHXKJSPVHPCJ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
58927,6crv,DB06873,-8.5,"1-((2-HYDROXYETHOXY)METHYL)-5-(3-(BENZYLOXY)BENZYL)PYRIMIDINE-2,4(1H,3H)-DIONE",CSXNPJKDZKLDET-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28693,6cs2,DB08300,-8.5,"1-methyl-3-naphthalen-2-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine",UOKGZPYGRJDACN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
67365,6lxt,DB06558,-8.5,Tezosentan,TUYWTLTWNJOZNY-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
110385,6vxx,DB01536,-8.5,Androstenedione,AEMFNILZOJDQLW-QAGGRKNESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
102945,6vxs,DB07991,-8.5,N-[(1R)-3-(4-HYDROXYPHENYL)-1-METHYLPROPYL]-2-(2-PHENYL-1H-INDOL-3-YL)ACETAMIDE,APLJSSOXDWUNGV-GOSISDBHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
54799,6crv,DB00243,-8.5,Ranolazine,XKLMZUWKNUAPSZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110393,6vxx,DB01544,-8.5,Flunitrazepam,PPTYJKAXVCCBDU-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
137658,6w9c,DB08561,-8.5,"BENZYL 6-BENZYL-5,7-DIOXO-6,7-DIHYDRO-5H-[1,3]THIAZOLO[3,2-C]PYRIMIDINE-2-CARBOXYLATE",PLBINCOCFGQAJM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
58711,6crv,DB06455,-8.5,Meclinertant,DYLJVOXRWLXDIG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
102291,6vxs,DB07229,-8.5,"3-{5-[AMINO(IMINIO)METHYL]-1H-INDOL-2-YL}-5-METHOXY-1,1'-BIPHENYL-2-OLATE",MINVOLKUPZPDNX-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
123713,6w4h,DB00288,-8.5,Amcinonide,ILKJAFIWWBXGDU-MOGDOJJUSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
134037,6w9c,DB02485,-8.5,Cytidine-5'-Monophosphate-5-N-Acetylneuraminic Acid,TXCIAUNLDRJGJZ-BILDWYJOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
102305,6vxs,DB07247,-8.5,"[2'-HYDROXY-3'-(1H-PYRROLO[3,2-C]PYRIDIN-2-YL)-BIPHENYL-3-YLMETHYL]-UREA",SRPOHNDQBDHONJ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
160836,7bv1,DB11794,-8.5,Berzosertib,JZCWLJDSIRUGIN-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
72965,6m2n,DB01430,-8.5,Almitrine,OBDOVFRMEYHSQB-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
128279,6w4h,DB07422,-8.5,(2S)-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]-3-(pentafluorophenoxy)propanamide,MMNRWNREMUMYQG-INIZCTEOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
58930,6crv,DB06876,-8.5,"N-{5-[4-(4-METHYLPIPERAZIN-1-YL)PHENYL]-1H-PYRROLO[2,3-B]PYRIDIN-3-YL}NICOTINAMIDE",YJWJKKXGAPWLGT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85073,6m3m,DB07234,-8.5,"3-{[(1R)-1-phenylethyl]amino}-4-(pyridin-4-ylamino)cyclobut-3-ene-1,2-dione",MCBPNFWHHNJTGN-LLVKDONJSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
161039,7bv1,DB12781,-8.5,Balaglitazone,IETKPTYAGKZLKY-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
140061,6w9c,DB14867,-8.5,Parsaclisib,ZQPDJCIXJHUERQ-QWRGUYRKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
34167,6cs2,T3D1030,-8.5,Cycloprothrin,LSFUGNKKPMBOMG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
67464,6lxt,DB06746,-8.5,ginkgolide-J,LMEHVEUFNRJAAV-UKWFQYJJSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
66614,6lxt,DB04421,-8.5,Nicotinamide Adenine Dinucleotide 3-Pentanone Adduct,BZJFKYRGSZWSLT-YLIVDTKOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
66745,6lxt,DB04591,-8.5,"N-{2,2-DIFLUORO-2-[(2R)-PIPERIDIN-2-YL]ETHYL}-2-[2-(1H-1,2,4-TRIAZOL-1-YL)BENZYL][1,3]OXAZOLO[4,5-C]PYRIDIN-4-AMINE",VYJOAYZRCNHDNG-GOSISDBHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
102809,6vxs,DB07832,-8.5,"4-{4-[(5-hydroxy-2-methylphenyl)amino]quinolin-7-yl}-1,3-thiazole-2-carbaldehyde",VKQPTVJDZIILPG-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
79578,6m2n,DB13461,-8.5,Cefcapene,HJJRIJDTIPFROI-NVKITGPLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
128230,6w4h,DB07362,-8.5,"1-(5-{2-[(1-methyl-1H-pyrazolo[4,3-d]pyrimidin-7-yl)amino]ethyl}-1,3-thiazol-2-yl)-3-[3-(trifluoromethyl)phenyl]urea",UOLCZAFAGDOUFX-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
161156,7bv1,DB12966,-8.5,Falnidamol,FTFRZXFNZVCRSK-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
67156,6lxt,DB05838,-8.5,OPC-51803,INGXCNVWWKKWOO-LJQANCHMSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
79260,6m2n,DB12985,-8.5,Quisinostat,PAWIYAYFNXQGAP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
65842,6lxt,DB03367,-8.5,PF-00356231,VMTJQZUZINLEKC-JOCHJYFZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
139968,6w9c,DB14660,-8.5,Trenbolone acetate,CMRJPMODSSEAPL-FYQPLNBISA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
101952,6vxs,DB06831,-8.5,2-((9H-PURIN-6-YLTHIO)METHYL)-5-CHLORO-3-(2-METHOXYPHENYL)QUINAZOLIN-4(3H)-ONE,UMMYTDJYDSTEMB-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
33941,6cs2,T3D0627,-8.5,Tetracene,IFLREYGFSNHWGE-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
67613,6lxt,DB06955,-8.5,"3,4-bis(7-chloro-1H-indol-3-yl)-1H-pyrrole-2,5-dicarboxylic acid",OAMCCJASDLMTOO-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
85322,6m3m,DB07522,-8.5,"N-[(2R,3S)-3-AMINO-2-HYDROXY-4-PHENYLBUTYL]NAPHTHALENE-2-SULFONAMIDE",QSSWSEQPKCCATQ-VQTJNVASSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
67605,6lxt,DB06945,-8.5,N-hydroxy-4-({4-[4-(trifluoromethyl)phenoxy]phenyl}sulfonyl)tetrahydro-2H-pyran-4-carboxamide,FOSWRYKPHVPIDJ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
79556,6m2n,DB13432,-8.5,Lonazolac,XVUQHFRQHBLHQD-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
111153,6vxx,DB03069,-8.5,Cytidine-5'-Diphospho-Beta-D-Xylose,NWSKPSPTJOAICE-OCIMBMBZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
101986,6vxs,DB06875,-8.5,3-(3-FLUORO-4-HYDROXYPHENYL)-7-HYDROXY-1-NAPHTHONITRILE,NSSOSHDCWCMNDM-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
66734,6lxt,DB04575,-8.5,Quinestrol,PWZUUYSISTUNDW-VAFBSOEGSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
161119,7bv1,DB12910,-8.5,Emicerfont,JFHJGXQFESYQGY-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
85546,6m3m,DB07788,-8.5,"(3R,5Z,8S,9S,11E)-8,9,16-TRIHYDROXY-14-METHOXY-3-METHYL-3,4,9,10-TETRAHYDRO-1H-2-BENZOXACYCLOTETRADECINE-1,7(8H)-DIONE",NEQZWEXWOFPKOT-QHSZRYGNSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
110480,6vxx,DB01645,-8.5,Genistein,TZBJGXHYKVUXJN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85111,6m3m,DB07278,-8.5,2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}ETHENESULFONAMIDE,ACEFOQMQINFMRW-DYCFVMESSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
103443,6vxs,DB08584,-8.5,"6-{[6-(1-methyl-1H-pyrazol-4-yl)[1,2,4]triazolo[4,3-b]pyridazin-3-yl]sulfanyl}quinoline",BCZUAADEACICHN-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
161199,7bv1,DB13384,-8.5,Melitracen,GWWLWDURRGNSRS-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
72853,6m2n,DB01224,-8.5,Quetiapine,URKOMYMAXPYINW-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
36077,1r42,DB02449,-8.5,3-(1h-Indol-3-Yl)-2-[4-(4-Phenyl-Piperidin-1-Yl)-Benzenesulfonylamino]-Propionic Acid,ULOTXPTWJAUGGE-MHZLTWQESA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
102790,6vxs,DB07811,-8.5,"N-cyclopropyl-2',6-dimethyl-4'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-3-carboxamide",UBVTVSINEVHYSY-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
110516,6vxx,DB01873,-8.5,Epothilone D,XOZIUKBZLSUILX-GIQCAXHBSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
133324,6w9c,DB01544,-8.5,Flunitrazepam,PPTYJKAXVCCBDU-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
79620,6m2n,DB13520,-8.5,Metergoline,WZHJKEUHNJHDLS-QTGUNEKASA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
58623,6crv,DB06213,-8.5,Regadenoson,LZPZPHGJDAGEJZ-AKAIJSEGSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85123,6m3m,DB07290,-8.5,(2R)-2-{[(4-FLUORO-3-METHYLPHENYL)SULFONYL]AMINO}-N-HYDROXY-2-TETRAHYDRO-2H-PYRAN-4-YLACETAMIDE,LUCFRFDOOYLALP-CYBMUJFWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
79252,6m2n,DB12972,-8.5,Sepranolone,AURFZBICLPNKBZ-FZCSVUEKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137388,6w9c,DB08233,-8.5,6-CYCLOHEXYLMETHYLOXY-2-(4'-HYDROXYANILINO)PURINE,RFSDQDHHBKYQOD-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
59049,6crv,DB07017,-8.5,"(5S)-2-{[(1S)-1-(4-fluorophenyl)ethyl]amino}-5-(1-hydroxy-1-methylethyl)-5-methyl-1,3-thiazol-4(5H)-one",HYVZYASDRIAOPU-BJOHPYRUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79254,6m2n,DB12974,-8.5,Roniciclib,UELYDGOOJPRWGF-SRQXXRKNSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
142201,6w9q,DB01879,-8.5,(S)-2-{Methyl-[2-(Naphthalene-2-Sulfonylamino)-5-(Naphthalene-2-Sulfonyloxy)-Benzoyl]-Amino}-Succinicacid,JOAALZBSMWLOPQ-LJAQVGFWSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
102796,6vxs,DB07817,-8.5,"1-{3-[(4-pyridin-2-ylpiperazin-1-yl)sulfonyl]phenyl}-3-(1,3-thiazol-2-yl)urea",NJPVZSIGDRLLTD-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
33673,6cs2,T3D4916,-8.5,Fast green FCF,MNEJSIQJOSRAAA-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
73105,6m2n,DB01591,-8.5,Solifenacin,FBOUYBDGKBSUES-VXKWHMMOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
85116,6m3m,DB07283,-8.5,"9-benzyl-2,3,4,9-tetrahydro-1H-carbazole-8-carboxylic acid",VDOXYKGIKBUISK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
102471,6vxs,DB07434,-8.5,HONH-BENZYLMALONYL-L-ALANYLGLYCINE-P-NITROANILIDE,TZWQPWGUQCSKDW-GUYCJALGSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
26500,6cs2,DB04645,-8.5,"5-{3-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-2-METHYL-PHENOXY}-PENTANOIC ACID",NJJIFGCFUDDBSP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
73369,6m2n,DB01946,-8.5,"3-[1-(3-Aminopropyl)-1h-Indol-3-Yl]-4-(1-Methyl-1h-Indol-3-Yl)-1h-Pyrrole-2,5-Dione",UQHKJRCFSLMWIA-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79593,6m2n,DB13484,-8.5,Quinbolone,IUVKMZGDUIUOCP-BTNSXGMBSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
26679,6cs2,DB04862,-8.5,Merimepodib,JBPUGFODGPKTDW-SFHVURJKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
79653,6m2n,DB13563,-8.5,Norgestrienone,GVDMJXQHPUYPHP-FYQPLNBISA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
102446,6vxs,DB07405,-8.5,"1-(6-CYANO-3-PYRIDYLCARBONYL)-5',8'-DIFLUOROSPIRO[PIPERIDINE-4,2'(1'H)-QUINAZOLINE]-4'-AMINE",GIZYIOOBBUHOBS-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
79545,6m2n,DB13418,-8.5,Moxestrol,MTMZZIPTQITGCY-OLGWUGKESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
73090,6m2n,DB01570,-8.5,Ohmefentanyl,FRPRNNRJTCONEC-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
161104,7bv1,DB12888,-8.5,Ezutromid,KSGCNXAZROJSNW-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
133933,6w9c,DB02358,-8.5,LY374571,SZHRIPFGZWWRKW-VIFPVBQESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137772,6w9c,DB08705,-8.5,"6-(5-BROMO-2-HYDROXYPHENYL)-2-OXO-4-PHENYL-1,2-DIHYDROPYRIDINE-3-CARBONITRILE",SVSYJTYGPLVUOZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137768,6w9c,DB08701,-8.5,"2-(3-BROMOPHENYL)-6-[(2-HYDROXYETHYL)AMINO]-1H-BENZO[DE]ISOQUINOLINE-1,3(2H)-DIONE",JZCUVYNOSDWORZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
59009,6crv,DB06970,-8.5,"2-CHLORO-N-(3-CYANO-5,6-DIHYDRO-4H-CYCLOPENTA[B]THIOPHEN-2-YL)-5-DIETHYLSULFAMOYL-BENZAMIDE",MZCDQILVXXIMEV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111055,6vxx,DB02932,-8.5,(R)-Bicalutamide,LKJPYSCBVHEWIU-KRWDZBQOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
134168,6w9c,DB02656,-8.5,LY-294002,CZQHHVNHHHRRDU-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
28679,6cs2,DB08285,-8.5,"(2R)-2-{[4-(benzylamino)-8-(1-methylethyl)pyrazolo[1,5-a][1,3,5]triazin-2-yl]amino}butan-1-ol",SQUNOCMDMIQIQK-OAHLLOKOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
110283,6vxx,DB01185,-8.5,Fluoxymesterone,YLRFCQOZQXIBAB-RBZZARIASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110294,6vxx,DB01430,-8.5,Almitrine,OBDOVFRMEYHSQB-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28509,6cs2,DB08100,-8.5,"2,6-dimethyl-4-[(E)-2-phenylethenyl]phenol",PAHKYLUYTGBFNW-CMDGGOBGSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
102087,6vxs,DB06995,-8.5,N-({4-[(2-aminopyridin-4-yl)oxy]-3-fluorophenyl}carbamoyl)-2-(4-fluorophenyl)acetamide,USBSTVPJNQLYEM-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102897,6vxs,DB07936,-8.5,N-(4-{[(3S)-3-(dimethylamino)pyrrolidin-1-yl]carbonyl}phenyl)-5-fluoro-4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]pyrimidin-2-amine,BACSZMCLZIDTIO-IBGZPJMESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
67477,6lxt,DB06777,-8.5,Chenodeoxycholic acid,RUDATBOHQWOJDD-BSWAIDMHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
102094,6vxs,DB07002,-8.5,4-({4-[(4-methoxypyridin-2-yl)amino]piperidin-1-yl}carbonyl)benzonitrile,SZUVGMCKKLJAFX-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
59008,6crv,DB06969,-8.5,"2-amino-4-[2,4-dichloro-5-(2-pyrrolidin-1-ylethoxy)phenyl]-N-ethylthieno[2,3-d]pyrimidine-6-carboxamide",WJUNQSYQHHIVFX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
66635,6lxt,DB04452,-8.5,Aminoquinuride,HOUSDILKOJMENG-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
59006,6crv,DB06967,-8.5,"6-ETHYL-5-[9-(3-METHOXYPROPYL)-9H-CARBAZOL-2-YL]PYRIMIDINE-2,4-DIAMINE",MLSVRCGEBXIIQO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
102104,6vxs,DB07014,-8.5,"2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4-methoxybenzyl)sulfanyl]-1,3,4-oxadiazole",TUTZKAQTSPMEBI-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
103289,6vxs,DB08400,-8.5,4-(3-{[5-(trifluoromethyl)pyridin-2-yl]oxy}benzyl)piperidine-1-carboxylic acid,KUEKMTNOUPAOBS-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
103326,6vxs,DB08446,-8.5,"3-[6-bromo-2-fluoro-3-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)phenoxy]-5-chlorobenzonitrile",OHQMEDBYNUAVNE-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
9750,6lzg,DB07872,-8.5,5-chloro-N-[(3R)-1-(2-{[2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl]amino}-2-oxoethyl)pyrrolidin-3-yl]thiophene-2-carboxamide,IYGIXVNAMZPBDK-CQSZACIVSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
78959,6m2n,DB12511,-8.5,Imiglitazar,ULVDFHLHKNJICZ-QCWLDUFUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
110249,6vxx,DB01147,-8.5,Cloxacillin,LQOLIRLGBULYKD-JKIFEVAISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79525,6m2n,DB13393,-8.5,Emetine,AUVVAXYIELKVAI-CKBKHPSWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
58651,6crv,DB06272,-8.5,Maxacalcitol,DTXXSJZBSTYZKE-ZDQKKZTESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140777,6w9c,DB15292,-8.5,Foliglurax,ZTEDNASHAWNBKQ-NCELDCMTSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
133349,6w9c,DB01569,-8.5,Formebolone,AMVODTGMYSRMNP-GNIMZFFESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
114350,6vxx,DB13327,-8.5,Picotamide,KYWCWBXGRWWINE-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78948,6m2n,DB12492,-8.5,Piritramide,IHEHEFLXQFOQJO-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
35927,1r42,DB02258,-8.5,SR11254,RNZIUDLOJHVHLZ-VYIQYICTSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
30099,6cs2,DB12050,-8.5,LY-3039478,YCBAQKQAINQRFW-UGSOOPFHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
85332,6m3m,DB07533,-8.5,"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]-2-FURYL}-N-METHYLBENZENESULFONAMIDE",FJJJERLTHDXEPT-JYRVWZFOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
29741,6cs2,DB11511,-8.5,Difloxacin,NOCJXYPHIIZEHN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
85333,6m3m,DB07534,-8.5,"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE",BKUMVXIXUVYKDQ-GHXNOFRVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
72903,6m2n,DB01326,-8.5,Cefamandole,OLVCFLKTBJRLHI-AXAPSJFSSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79513,6m2n,DB13371,-8.5,Difenpiramide,PWHROYKAGRUWDQ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
102046,6vxs,DB06942,-8.5,N-(4-carbamimidoylbenzyl)-1-(3-phenylpropanoyl)-L-prolinamide,RNZKCCPFUWHBFY-IBGZPJMESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
111126,6vxx,DB03034,-8.5,D-Levofloxacin,GSDSWSVVBLHKDQ-SNVBAGLBSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
67180,6lxt,DB05990,-8.5,Obeticholic acid,ZXERDUOLZKYMJM-ZWECCWDJSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
78956,6m2n,DB12507,-8.5,Atecegatran metoxil,XSNMGLZVFNDDPW-ZWKOTPCHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
133909,6w9c,DB02319,-8.5,"5,6-Dihydroxy-Nadp",LRAVAOPKUBJONV-IVCJQJMGSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
166490,7bv1,DB15232,-8.5,Telaglenastat,PRAAPINBUWJLGA-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
103328,6vxs,DB08448,-8.5,"(4aS)-5-[(2,4-diaminopteridin-6-yl)methyl]-4a,5-dihydro-2H-dibenzo[b,f]azepin-8-ol",PCBWLKUEKANDCL-INIZCTEOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
110479,6vxx,DB01644,-8.5,"3,6-dihydroxy-xanthene-9-propionic acid",PFQGLFBMMPZYEU-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114658,6vxx,DB14583,-8.5,Segesterone acetate,CKFBRGLGTWAVLG-GOMYTPFNSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61681,6crv,DB12428,-8.5,PAC-14028,UKGJZDSUJSPAJL-YPUOHESYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58501,6crv,DB05585,-8.5,Verubulin,SNHCRNMVYDHVDT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140379,6w9c,DB05830,-8.5,Trestolone,YSGQGNQWBLYHPE-CFUSNLFHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
82493,6m3m,DB02611,-8.5,Balanol Analog 1,FZJQHARRQUNVGZ-QZTJIDSGSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
82481,6m3m,DB02596,-8.5,"Alpha,Beta-Methyleneadenosine-5'-Triphosphate",CAWZRIXWFRFUQB-IOSLPCCCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
108753,6vxx,DB08911,-8.5,Trametinib,LIRYPHYGHXZJBZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27519,6cs2,DB07063,-8.5,"{3-[(4,5,7-TRIFLUORO-1,3-BENZOTHIAZOL-2-YL)METHYL]-1H-INDOL-1-YL}ACETIC ACID",KYHVTMFADJNSGS-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
127384,6w4h,DB05616,-8.5,"4'-Methylene-5,8,10-trideazaaminopterin",NAWXUBYGYWOOIX-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
82455,6m3m,DB02559,-8.5,"6-(Octahydro-1h-Indol-1-Ylmethyl)Decahydroquinazoline-2,4-Diamine",HDQIGGQUKAQTGU-SZTTVXCBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
106812,6vxx,DB01320,-8.5,Fosphenytoin,XWLUWCNOOVRFPX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27521,6cs2,DB07065,-8.5,"5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)-3-thiocyanatopyrazolo[1,5-a]pyrimidin-7-amine",AHPKUZJCNHGFQA-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
70256,6lxt,DB12380,-8.5,GDC-0152,WZRFLSDVFPIXOV-LRQRDZAKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
125762,6w4h,DB02915,-8.5,"4-(2,4-Dimethyl-1,3-thiazol-5-yl)-N-[4-(trifluoromethyl)phenyl]-2-pyrimidinamine",MEZFDQUDLQCVNX-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
80906,6m3m,DB00578,-8.5,Carbenicillin,FPPNZSSZRUTDAP-UWFZAAFLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
125764,6w4h,DB02917,-8.5,N-Hydroxy-4-(Methyl{[5-(2-Pyridinyl)-2-Thienyl]Sulfonyl}Amino)Benzamide,LFGYSFPVLMPUPE-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
106891,6vxx,DB01708,-8.5,Prasterone,FMGSKLZLMKYGDP-USOAJAOKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
71725,6lxt,DB15156,-8.5,ABT-072,XMZSTQYSBYEENY-RMKNXTFCSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
11212,6lzg,DB11663,-8.5,Pictilisib,LHNIIDJUOCFXAP-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
71728,6lxt,DB15163,-8.5,Selatogrel,FYXHWMQPCJOJCH-GMAHTHKFSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
71716,6lxt,DB15138,-8.5,AZD-9496,DFBDRVGWBHBJNR-BBNFHIFMSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
82534,6m3m,DB02666,-8.5,(C8-R)-Hydantocidin 5'-Phosphate,MAXSFYCTFIBEAR-OJMIUMIFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136795,6w9c,DB07540,-8.5,"4-{5-[(1Z)-1-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)ETHYL]-2-FURYL}BENZENESULFONAMIDE",AKFVRSQELXTCFW-JYRVWZFOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
127445,6w4h,DB06011,-8.5,AMG-222,NVSWJKWHLUTHLP-CPJSRVTESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
82641,6m3m,DB02812,-8.5,"(2s,4r)-1-Acetyl-N-[(1s)-4-[(Aminoiminomethyl)Amino]-1-(2-Benzothiazolylcarbonyl)Butyl]-4-Hydroxy-2-Pyrrolidinecarboxamide",VXDAVYUFYPFGDX-SNPRPXQTSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
106738,6vxx,DB01192,-8.5,Oxymorphone,UQCNKQCJZOAFTQ-ISWURRPUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
10479,6lzg,DB08683,-8.5,"REL-(9R,12S)-9,10,11,12-TETRAHYDRO-9,12-EPOXY-1H-DIINDOLO[1,2,3-FG:3',2',1'-KL]PYRROLO[3,4-I][1,6]BENZODIAZOCINE-1,3(2H)-DIONE",OTPNDVKVEAIXTI-IYBDPMFKSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
8026,6lzg,DB04669,-8.5,TRIAZOLOPYRIMIDINE,YWBFPKPWMSWWEA-UHFFFAOYSA-O,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
108798,6vxx,DB08974,-8.5,Flubendazole,CPEUVMUXAHMANV-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106741,6vxx,DB01195,-8.5,Flecainide,DJBNUMBKLMJRSA-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163586,7bv1,DB04824,-8.5,Phenolphthalein,KJFMBFZCATUALV-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
82608,6m3m,DB02766,-8.5,(3r)-3-{[(Benzyloxy)Carbonyl]Amino}-2-Oxo-4-Phenylbutane-1-Diazonium,VLIGBVLLNSWVMI-MRXNPFEDSA-O,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
163559,7bv1,DB04791,-8.5,"2-O-(4'-AMIDINOPHENYL)-5-O-(3''-AMIDINOPHENYL)-1,4:3,6-DIANHYDRO-D-SORBITOL",DKBAWRNTUZFJKV-BSDSXHPESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
136114,6w9c,DB06588,-8.5,Triphendiol,KQCJZAUNKSGEFM-UNMCSNQZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
108780,6vxx,DB08954,-8.5,Ifenprodil,UYNVMODNBIQBMV-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27494,6cs2,DB07039,-8.5,(2S)-N-(4-cyano-3-iodophenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide,RXSZCFAPSDTELY-SFHVURJKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
114728,6vxx,DB14720,-8.5,Brovanexine,DQTRREPKGJIABH-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140372,6w9c,DB05804,-8.5,Prasterone sulfate,CZWCKYRVOZZJNM-USOAJAOKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136130,6w9c,DB06620,-8.5,Aplindore,DYJIKHYBKVODAC-ZDUSSCGKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
56877,6crv,DB02901,-8.5,Stanolone,NVKAWKQGWWIWPM-ABEVXSGRSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80915,6m3m,DB00587,-8.5,Cinalukast,BZMKNPGKXJAIDV-VAWYXSNFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
27526,6cs2,DB07072,-8.5,"(1S,2R,5S)-5-[3-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7(8H)-YL]-2-(2,4,5-TRIFLUOROPHENYL)CYCLOHEXANAMINE",CNKRZILQBKJWDS-WMFXKJRFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
27528,6cs2,DB07074,-8.5,6-CARBAMIMIDOYL-4-(3-HYDROXY-2-METHYL-BENZOYLAMINO)-NAPHTHALENE-2-CARBOXYLIC ACID METHYL ESTER,OUBRALHIKGRAMA-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
70336,6lxt,DB12491,-8.5,Fasiglifam,BZCALJIHZVNMGJ-HSZRJFAPSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
114250,6vxx,DB13175,-8.5,Rheinanthrone,OZFQHULMMDWMIV-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56640,6crv,DB02587,-8.5,Colforsin,OHCQJHSOBUTRHG-KGGHGJDLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80961,6m3m,DB00643,-8.5,Mebendazole,OPXLLQIJSORQAM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
27577,6cs2,DB07125,-8.5,"4-(6-{[(1R)-1-(hydroxymethyl)propyl]amino}imidazo[1,2-b]pyridazin-3-yl)benzoic acid",KKZYGUVAFJCULH-CYBMUJFWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
164251,7bv1,DB07430,-8.5,"(10R)-10-methyl-3-(6-methylpyridin-3-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one",CMWRPDHVGMHLSZ-GFCCVEGCSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
136282,6w9c,DB06932,-8.5,"10,11-dimethoxy-4-methyldibenzo[c,f]-2,7-naphthyridine-3,6-diamine",NVINUNQBDNEMSY-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
82254,6m3m,DB02307,-8.5,N-(1-Carboxy-3-Phenylpropyl)Phenylalanyl-Alpha-Asparagine,FOJUHLDAXGNCIP-FHWLQOOXSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
107212,6vxx,DB02712,-8.5,Sorbinil,LXANPKRCLVQAOG-NSHDSACASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
70380,6lxt,DB12561,-8.5,WNT-974,XXYGTCZJJLTAGH-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
136734,6w9c,DB07469,-8.5,"(3aS)-3a-hydroxy-7-methyl-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one",KAJFGRLMKVNMLH-GOSISDBHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
82175,6m3m,DB02205,-8.5,"6-(1,1-Dimethylallyl)-2-(1-Hydroxy-1-Methylethyl)-2,3-Dihydro-7h-Furo[3,2-G]Chromen-7-One",JCDLLLXYAICSQV-INIZCTEOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80985,6m3m,DB00674,-8.5,Galantamine,ASUTZQLVASHGKV-JDFRZJQESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
108662,6vxx,DB08519,-8.5,"N-4-(3-methyl-1H-indazol-6-yl)-N-2-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine",SQQAPOSROFWHIB-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55730,6crv,DB01418,-8.5,Acenocoumarol,VABCILAOYCMVPS-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140392,6w9c,DB05936,-8.5,CVT-6883,KOYXXLLNCXWUNF-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
80978,6m3m,DB00665,-8.5,Nilutamide,XWXYUMMDTVBTOU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
108704,6vxx,DB08828,-8.5,Vismodegib,BPQMGSKTAYIVFO-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107143,6vxx,DB02621,-8.5,Latrunculin A,DDVBPZROPPMBLW-IZGXTMSKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136250,6w9c,DB06899,-8.5,"N-{2-[6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2,2-DIMETHYL-3-OXO-2,3-DIHYDRO-4H-1,4-BENZOTHIAZIN-4-YL]ETHYL}ACETAMIDE",RMEVNJZCKDVVND-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
106923,6vxx,DB01752,-8.5,S-adenosyl-L-homocysteine,ZJUKTBDSGOFHSH-WFMPWKQPSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163641,7bv1,DB05616,-8.5,"4'-Methylene-5,8,10-trideazaaminopterin",NAWXUBYGYWOOIX-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
108737,6vxx,DB08883,-8.5,Perampanel,PRMWGUBFXWROHD-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163646,7bv1,DB05653,-8.5,IRX-5183,PNAWUIKCVQSLFG-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
56728,6crv,DB02703,-8.5,Fusidic acid,IECPWNUMDGFDKC-MZJAQBGESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
82351,6m3m,DB02427,-8.5,"2,4-Diamino-6-[N-(2',5'-Dimethoxybenzyl)-N-Methylamino]Quinazoline",YBJANOUTWRTBDK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
108726,6vxx,DB08865,-8.5,Crizotinib,KTEIFNKAUNYNJU-GFCCVEGCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
11183,6lzg,DB11611,-8.5,Lifitegrast,JFOZKMSJYSPYLN-QHCPKHFHSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
80938,6m3m,DB00613,-8.5,Amodiaquine,OVCDSSHSILBFBN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
70314,6lxt,DB12459,-8.5,Belotecan,LNHWXBUNXOXMRL-VWLOTQADSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
70318,6lxt,DB12465,-8.5,Ketanserin,FPCCSQOGAWCVBH-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
82299,6m3m,DB02367,-8.5,(1n)-4-N-Butoxyphenylsulfonyl-(2r)-N-Hydroxycarboxamido-(4s)-Methanesulfonylamino-Pyrrolidine,ULDXUWXTVRRUND-SWLSCSKDSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
82296,6m3m,DB02363,-8.5,2'-Monophosphoadenosine-5'-Diphosphate,YPTPYQSAVGGMFN-KQYNXXCUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
125853,6w4h,DB03041,-8.5,UDP-alpha-D-glucuronic acid,HDYANYHVCAPMJV-LXQIFKJMSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
127327,6w4h,DB05327,-8.5,Ranirestat,QCVNMNYRNIMDKV-QGZVFWFLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
56651,6crv,DB02602,-8.5,AL7182,ICIXQGGQPKFQRL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127305,6w4h,DB05197,-8.5,Sofalcone,GFWRVVCDTLRWPK-KPKJPENVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
108816,6vxx,DB09383,-8.5,Meprednisone,PIDANAQULIKBQS-RNUIGHNZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108651,6vxx,DB08504,-8.5,"6-(4-{(1S,2S)-2-AMINO-1-[(DIMETHYLAMINO)CARBONYL]-3-[(3S)-3-FLUOROPYRROLIDIN-1-YL]-3-OXOPROPYL}PHENYL)-1H-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-4-IUM",ZNHVIJAGMFQGMS-IHPCNDPISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
82657,6m3m,DB02833,-8.5,[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(3-Nitro-Phenyl)-Amine,DYTKVFHLKPDNRW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
82670,6m3m,DB02848,-8.5,"{4-[3-(6,7-Diethoxy-Quinazolin-4-Ylamino)-Phenyl]-Thiazol-2-Yl}-Methanol",ZJESXGUODSBHSK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136852,6w9c,DB07612,-8.5,6-(3-AMINOPHENYL)-N-(TERT-BUTYL)-2-(TRIFLUOROMETHYL)QUINAZOLIN-4-AMINE,XQKJVNGGVLHNLA-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
83070,6m3m,DB03376,-8.5,'5'-O-(N-(L-Alanyl)-Sulfamoyl)Adenosine,CWWYMWDIYBJVLP-YTMOPEAISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
163104,7bv1,DB03768,-8.5,"N-[2-Hydroxy-2-(8-Isopropyl-6,9-Dioxo-2-Oxa-7,10-Diaza-Bicyclo[11.2.2]Heptadeca-1(16),13(17),14-Trien-11-Yl)-Ethyl]-N-(3-Methyl-Butyl)-Benzenesulfonamide,Inhibitor 3",WRUVOSYKHXGAQN-GKRYNVPLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
106437,6vxx,DB00213,-8.5,Pantoprazole,IQPSEEYGBUAQFF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
135984,6w9c,DB06235,-8.5,Vadimezan,XGOYIMQSIKSOBS-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
163133,7bv1,DB03802,-8.5,"1-[4-(Octahydro-Pyrido[1,2-a]Pyrazin-2-Yl)-Phenyl]-2-Phenyl-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol",ZGHFWBDHZZKWSI-LITSAYRRSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
71845,6lxt,DB15401,-8.5,Danicopan,PIBARDGJJAGJAJ-NQIIRXRSSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
30083,6cs2,DB12027,-8.5,Serdemetan,CEGSUK1LWKJP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
28068,6cs2,DB07642,-8.5,"5-{[1-(2-fluorobenzyl)piperidin-4-yl]methoxy}quinazoline-2,4-diamine",GYKIQIOWVKCVBP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
114942,6vxx,DB15450,-8.5,PF-05105679,BXNMZRPTQFVRFA-QGZVFWFLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80704,6m3m,DB00328,-8.5,Indometacin,CGIGDMFJXJATDK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136005,6w9c,DB06274,-8.5,Alvimopan,UPNUIXSCZBYVBB-JVFUWBCBSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
108996,6vxx,DB11883,-8.5,SB-705498,JYILLRHXRVTRSH-GFCCVEGCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127527,6w4h,DB06272,-8.5,Maxacalcitol,DTXXSJZBSTYZKE-ZDQKKZTESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
82972,6m3m,DB03247,-8.5,Flavin mononucleotide,FVTCRASFADXXNN-SCRDCRAPSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
163220,7bv1,DB03916,-8.5,4-{2-[4-(2-Aminoethyl)Piperazin-1-Yl]Pyridin-4-Yl}-N-(3-Chloro-4-Methylphenyl)Pyrimidin-2-Amine,RHOOHUMOHVIXEF-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
108997,6vxx,DB11885,-8.5,Anlotinib,KSMZEXLVHXZPEF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
71827,6lxt,DB15356,-8.5,SLV-334,LOFDNSDPZTVIIO-VPUSJEBWSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
80680,6m3m,DB00298,-8.5,Dapiprazole,RFWZESUMWJKKRN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
106385,6vxx,DB00153,-8.5,Ergocalciferol,MECHNRXZTMCUDQ-RKHKHRCZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28100,6cs2,DB07676,-8.5,"3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)-1H,2'H-2,3'-biindol-2'-one",CKLAPOFDFZKCPB-LBPRGKRZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
109062,6vxx,DB11979,-8.5,Elagolix,HEAUOKZIVMZVQL-VWLOTQADSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55545,6crv,DB01128,-8.5,Bicalutamide,LKJPYSCBVHEWIU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136880,6w9c,DB07643,-8.5,"5-{[1-(2,3-dichlorobenzyl)piperidin-4-yl]methoxy}quinazoline-2,4-diamine",XVLUVRFYGVJKGJ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
106286,6vxs,DB15396,-8.5,PF-114,SLIVDYMORZGPLW-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
106293,6vxs,DB15407,-8.5,Acalisib,DOCINCLJNAXZQF-LBPRGKRZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
55555,6crv,DB01139,-8.5,Cefapirin,UQLLWWBDSUHNEB-CZUORRHYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
11407,6lzg,DB11923,-8.5,Decoglurant,DMJHZVARRXJSEG-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
136876,6w9c,DB07638,-8.5,"(3AS,4R,9BR)-2,2-DIFLUORO-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL",QJSMFUTULGSHNQ-ZOBUZTSGSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
83134,6m3m,DB03472,-8.5,Cyclohexyl-Hexyl-Beta-D-Maltoside,WUCWJXGMSXTDAV-QKMCSOCLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83131,6m3m,DB03467,-8.5,Naringenin,FTVWIRXFELQLPI-ZDUSSCGKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
28078,6cs2,DB07651,-8.5,N-ACETYL-L-PHENYLALANYL-4-[DIFLUORO(PHOSPHONO)METHYL]-L-PHENYLALANINAMIDE,KPMMESISHWWXNM-ROUUACIJSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
116522,6w4b,DB02269,-8.5,[4-({[5-Benzyloxy-1-(3-Carbamimidoyl-Benzyl)-1h-Indole-2-Carbonyl]-Amino}-Methyl)-Phenyl]-Trimethyl-Ammonium,UFKJQTGPBFWMGT-UHFFFAOYSA-O,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
27352,6cs2,DB06888,-8.5,"(13R,15S)-13-METHYL-16-OXA-8,9,12,22,24-PENTAAZAHEXACYCLO[15.6.2.16,9.1,12,15.0,2,7.0,21,25]HEPTACOSA-1(24),2,4,6,17(25),18,20-HEPTAENE-23,26-DIONE",KBLPHMRCKHFBJB-OLZOCXBDSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
55567,6crv,DB01153,-8.5,Sertaconazole,JLGKQTAYUIMGRK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
125458,6w4h,DB02510,-8.5,'5'-O-(N-(L-Prolyl)-Sulfamoyl)Adenosine,LKVJEMXWEODCAY-JVEUSOJLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
106306,6vxs,DB15435,-8.5,BMS-986158,KGERZPVQIRYWRK-GDLZYMKVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
70010,6lxt,DB12025,-8.5,Triptolide,DFBIRQPKNDILPW-CIVMWXNOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
80720,6m3m,DB00348,-8.5,Nitisinone,OUBCNLGXQFSTLU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
57101,6crv,DB03205,-8.5,Pyrroloquinoline Quinone,MMXZSJMASHPLLR-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
82792,6m3m,DB03010,-8.5,Patupilone,QXRSDHAAWVKZLJ-PVYNADRNSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
125620,6w4h,DB02723,-8.5,"4-Oxo-2-Phenylmethanesulfonyl-Octahydro-Pyrrolo[1,2-a]Pyrazine-6-Carboxylic Acid [1-(N-Hydroxycarbamimidoyl)-Piperidin-4-Ylmethyl]-Amide",DHTSUHWLPAEEQB-OALUTQOASA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
136067,6w9c,DB06460,-8.5,Enrasentan,GLCKXJLCYIJMRB-UPRLRBBYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
125643,6w4h,DB02759,-8.5,4-Methylumbelliferyl Chitobiose,UPSFMJHZUCSEHU-JYGUBCOQSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
70113,6lxt,DB12180,-8.5,Apitolisib,YOVVNQKCSKSHKT-HNNXBMFYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
163437,7bv1,DB04421,-8.5,Nicotinamide Adenine Dinucleotide 3-Pentanone Adduct,BZJFKYRGSZWSLT-YLIVDTKOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
71784,6lxt,DB15275,-8.5,GDC-0077,SGEUNORSOZVTOL-CABZTGNLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
70102,6lxt,DB12158,-8.5,Filorexant,NPFDWHQSDBWQLH-QZTJIDSGSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
71779,6lxt,DB15265,-8.5,USL-311,XNUNVQKARNSSEO-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
106697,6vxx,DB00908,-8.5,Quinidine,LOUPRKONTZGTKE-LHHVKLHASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163487,7bv1,DB04689,-8.5,2-{5-[3-(6-BENZOYL-1-PROPYLNAPHTHALEN-2-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID,ZXWVCCFKIRBLDP-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
82699,6m3m,DB02887,-8.5,"2',3'-Dehydro-2',3'-Deoxy-Thymidine 5'-Triphosphate",ODSQODTUNULBHF-JGVFFNPUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
106699,6vxx,DB00910,-8.5,Paricalcitol,BPKAHTKRCLCHEA-UBFJEZKGSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
11293,6lzg,DB11772,-8.5,Pilaralisib,QINPEPAQOBZPOF-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
164316,7bv1,DB07692,-8.5,"1-[(2,6-difluorophenyl)sulfonyl]-4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)piperazine",SHWNKRPMUBFWKE-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
106709,6vxx,DB00920,-8.5,Ketotifen,ZCVMWBYGMWKGHF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106690,6vxx,DB00901,-8.5,Bitolterol,FZGVEKPRDOIXJY-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
71789,6lxt,DB15287,-8.5,Elismetrep,CWEFDWIKLABKBX-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
82810,6m3m,DB03039,-8.5,"4-(Aminosulfonyl)-N-[(2,5-Difluorophenyl)Methyl]-Benzamide",KEGUALXMKQVDIO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
57041,6crv,DB03121,-8.5,(1-Benzyl-5-methoxy-2-methyl-1H-indol-3-yl)acetic acid,ZEKCBTQHDTUHRJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27411,6cs2,DB06948,-8.5,2-ANILINO-6-CYCLOHEXYLMETHOXYPURINE,XWWRLKIBRPJQJX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
70024,6lxt,DB12048,-8.5,Savolitinib,XYDNMOZJKOGZLS-NSHDSACASA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
55609,6crv,DB01198,-8.5,Zopiclone,GBBSUAFBMRNDJC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140575,6w9c,DB12474,-8.5,Lynestrenol,YNVGQYHLRCDXFQ-XGXHKTLJSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
70036,6lxt,DB12064,-8.5,BMS-777607,VNBRGSXVFBYQNN-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
125553,6w4h,DB02639,-8.5,4-methylumbelliferyl ??-D-glucoside,YUDPTGPSBJVHCN-JZYAIQKZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
106560,6vxx,DB00490,-8.5,Buspirone,QWCRAEMEVRGPNT-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
82876,6m3m,DB03124,-8.5,5-[4-(1-Carboxymethyl-2-Oxo-Propylcarbamoyl)-Benzylsulfamoyl]-2-Hydroxy-Benzoic Acid,LBAHOXPDTNUYCX-INIZCTEOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
82875,6m3m,DB03121,-8.5,(1-Benzyl-5-methoxy-2-methyl-1H-indol-3-yl)acetic acid,ZEKCBTQHDTUHRJ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136027,6w9c,DB06346,-8.5,Fiboflapon,DFQGDHBGRSTTHX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
108971,6vxx,DB11844,-8.5,Pritelivir,IVZKZONQVYTCKC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106565,6vxx,DB00496,-8.5,Darifenacin,HXGBXQDTNZMWGS-RUZDIDTESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106566,6vxx,DB00497,-8.5,Oxycodone,BRUQQQPBMZOVGD-XFKAJCMBSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55618,6crv,DB01208,-8.5,Sparfloxacin,DZZWHBIBMUVIIW-DTORHVGOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
11332,6lzg,DB11822,-8.5,TMC-647055,UOBYJVFBFSLCTQ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
80783,6m3m,DB00425,-8.5,Zolpidem,ZAFYATHCZYHLPB-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
140366,6w9c,DB04704,-8.5,20-hydroxycholesterol,MCKLJFJEQRYRQT-MGNSQDQZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
80834,6m3m,DB00486,-8.5,Nabilone,GECBBEABIDMGGL-RTBURBONSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
135948,6w9c,DB06157,-8.5,Istaroxime,MPYLDWFDPHRTEG-PAAYLBSLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
11110,6lzg,DB11431,-8.5,Moxidectin,YZBLFMPOMVTDJY-LSGXYNIPSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
107341,6vxx,DB03186,-8.5,U-Pi-a-Pi,JIAJERGOUFOENU-LNAOLWRRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27900,6cs2,DB07459,-8.5,4-PHENOXY-N-(PYRIDIN-2-YLMETHYL)BENZAMIDE,HVLSCZSVTCNAQX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
56202,6crv,DB02019,-8.5,Acetyl Dithranol,IXLRLZOYKJERRA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81634,6m3m,DB01497,-8.5,Etorphine,CAHCBJPUTCKATP-HBDRVVKHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
55887,6crv,DB01599,-8.5,Probucol,FYPMFJGVHOHGLL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81235,6m3m,DB00962,-8.5,Zaleplon,HUNXMJYCHXQEGX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
56173,6crv,DB01977,-8.5,6-(N-Phenylcarbamyl)-2-Naphthalenecarboxamidine,AECPTICWHONWNW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81241,6m3m,DB00969,-8.5,Alosetron,JSWZEAMFRNKZNL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
107997,6vxx,DB06678,-8.5,Esmirtazapine,RONZAEMNMFQXRA-MRXNPFEDSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55906,6crv,DB01621,-8.5,Pipotiazine,JOMHSQGEWSNUKU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
10865,6lzg,DB09195,-8.5,Lorpiprazole,BNRMWKUVWLKDQJ-YJBOKZPZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
81592,6m3m,DB01450,-8.5,Dihydroetorphine,BRTSNYPDACNMIP-FAWZKKEFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
108091,6vxx,DB06834,-8.5,"N-(2-hydroxy-1,1-dimethylethyl)-1-methyl-3-(1H-pyrrolo[2,3-b]pyridin-2-yl)-1H-indole-5-carboxamide",XZRYCTLOGNCQDG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108366,6vxx,DB07676,-8.5,"3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)-1H,2'H-2,3'-biindol-2'-one",CKLAPOFDFZKCPB-LBPRGKRZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108356,6vxx,DB07664,-8.5,"5-AMINO-3-{[4-(AMINOSULFONYL)PHENYL]AMINO}-N-(2,6-DIFLUOROPHENYL)-1H-1,2,4-TRIAZOLE-1-CARBOTHIOAMIDE",ARIOBGGRZJITQX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108101,6vxx,DB06848,-8.5,"1-(1'-{[3-(methylsulfanyl)-2-benzothiophen-1-yl]carbonyl}spiro[1-benzofuran-3,4'-piperidin]-5-yl)methanamine",VCUDZTCDUDDJGG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114737,6vxx,DB14737,-8.5,Cannabinol,VBGLYOIFKLUMQG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81259,6m3m,DB00991,-8.5,Oxaprozin,OFPXSFXSNFPTHF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
140461,6w9c,DB06871,-8.5,17-METHYL-17-ALPHA-DIHYDROEQUILENIN,FQMQOMRDADWGJJ-GBESFXJTSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
164123,7bv1,DB07284,-8.5,"N-3-(3-PYRIDIN-3-YLBENZYL)PYRIDINE-2,3-DIAMINE",NQSBHBFOOVYRNM-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
126884,6w4h,DB04432,-8.5,ZK-805623,ZXIHYCYAQUQHSG-UHFFFAOYSA-O,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
81714,6m3m,DB01588,-8.5,Prazepam,MWQCHHACWWAQLJ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
55862,6crv,DB01565,-8.5,Dihydromorphine,IJVCSMSMFSCRME-KBQPJGBKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
7008,6lzg,DB03072,-8.5,"2-{3-[4-(4-Fluorophenyl)-3,6-Dihydro-1(2h)-Pyridinyl]Propyl}-8-Methyl-4(3h)-Quinazolinone",LOFDUAJQRUYHBR-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
107924,6vxx,DB05616,-8.5,"4'-Methylene-5,8,10-trideazaaminopterin",NAWXUBYGYWOOIX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56269,6crv,DB02104,-8.5,"2,4-Diamino-5-Methyl-6-[(3,4,5-Trimethoxy-N-Methylanilino)Methyl]Pyrido[2,3-D]Pyrimidine",PEGMMEYCSOZKIT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56241,6crv,DB02071,-8.5,WAY-151693,AINJYWXKBKRQSX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163939,7bv1,DB06882,-8.5,1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-naphthalen-1-ylurea,HJWMLCDGRWWLAQ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
81666,6m3m,DB01535,-8.5,Carfentanil,YDSDEBIZUNNPOB-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
107951,6vxx,DB05804,-8.5,Prasterone sulfate,CZWCKYRVOZZJNM-USOAJAOKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
10671,6lzg,DB08912,-8.5,Dabrafenib,BFSMGDJOXZAERB-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
107967,6vxx,DB05903,-8.5,KOS-1584,XAYAKDZVINDZGB-BMVMHAJPSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
126289,6w4h,DB03642,-8.5,Benzofuran-2-Carboxylic Acid {(S)-3-Methyl-1-[3-Oxo-1-(Pyridin-2-Ylsulfonyl)Azepan-4-Ylcarbamoyl]Butyl}Amide,VBPPNJCVXGAZDD-PMACEKPBSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
163943,7bv1,DB06886,-8.5,N-BENZYLOXYCARBONYL-ALA-PRO-3-AMINO-4-PHENYL-BUTAN-2-OL,MACLRJNEKXUAJK-YDLSIGKMSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
70693,6lxt,DB13055,-8.5,Oteseconazole,IDUYJRXRDSPPRC-NRFANRHFSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
70696,6lxt,DB13059,-8.5,PF-03814735,RYYNGWLOYLRZLK-RBUKOAKNSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
108425,6vxx,DB07976,-8.5,3-{[(3-FLUORO-3'-METHOXYBIPHENYL-4-YL)AMINO]CARBONYL}THIOPHENE-2-CARBOXYLIC ACID,GIUMGVUBDBDTDX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107965,6vxx,DB05884,-8.5,HCV-086,VBRUONUESYTIDA-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136584,6w9c,DB07295,-8.5,2-[(7-HYDROXY-NAPHTHALEN-1-YL)-OXALYL-AMINO]-BENZOIC ACID,IGOULVZYQKJJKC-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
27782,6cs2,DB07334,-8.5,"N-[5-(ETHYLSULFONYL)-2-METHOXYPHENYL]-5-[3-(2-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-AMINE",HTIZPBXCJPQDEM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
126498,6w4h,DB03907,-8.5,"N-{3-[5-(6-Amino-Purin-9-Yl)-3,4-Dihydroxy-Tetrahydro-Furan-2-Yl]-Allyl}-2,3-Dihydroxy-5-Nitro-Benzamide",UHHBFOLQOQSPLU-WGRQDFERSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
71496,6lxt,DB14654,-8.5,Bisoxatin acetate,ZCBJDQBSLZREAA-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
56073,6crv,DB01838,-8.5,"6,4'-Dihydroxy-3-Methyl-3',5'-Dibromoflavone",GKDYOXMZSXVKPP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81457,6m3m,DB01215,-8.5,Estazolam,CDCHDCWJMGXXRH-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
164039,7bv1,DB07000,-8.5,"N-{2,4-difluoro-3-[(5-pyridin-3-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)carbonyl]phenyl}ethanesulfonamide",ILXJWLWSYAWJKZ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
71479,6lxt,DB14636,-8.5,Triciribine phosphate,URLYINUFLXOMHP-HTVVRFAVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
55977,6crv,DB01712,-8.5,"(3r)-4-(P-Toluenesulfonyl)-1,4-Thiazane-3-Carboxylicacid-L-Phenylalanine Ethyl Ester",NDDSSAGSYFVBTG-SFTDATJTSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108193,6vxx,DB07210,-8.5,"3-bromo-5-phenyl-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",JECHSYMSTXETFI-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
71503,6lxt,DB14662,-8.5,Flunisolide acetate,WEGNFRKBIKYVLC-XTLNBZDDSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
55978,6crv,DB01713,-8.5,Udp-Alpha-D-Xylopyranose,DQQDLYVHOTZLOR-OCIMBMBZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136532,6w9c,DB07227,-8.5,4-[(5-{[4-(3-CHLOROPHENYL)-3-OXOPIPERAZIN-1-YL]METHYL}-1H-IMIDAZOL-1-YL)METHYL]BENZONITRILE,JNUGFGAVPBYSHF-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
81427,6m3m,DB01183,-8.5,Naloxone,UZHSEJADLWPNLE-GRGSLBFTSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
140448,6w9c,DB06856,-8.5,6-FLUORO-2-[2-HYDROXY-3-(2-METHYL-CYCLOHEXYLOXY)-PHENYL]-1H-INDOLE-5-CARBOXAMIDINE,HUYQYLFFFNSAAX-BUXKBTBVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
10797,6lzg,DB09079,-8.5,Nintedanib,XZXHXSATPCNXJR-ZIADKAODSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
81410,6m3m,DB01165,-8.5,Ofloxacin,GSDSWSVVBLHKDQ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
164058,7bv1,DB07022,-8.5,3-Hydroxypropyl 3-[(7-carbamimidoyl-1-naphthyl)carbamoyl]benzenesulfonate,PXERBGNIBOFZOW-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
164062,7bv1,DB07027,-8.5,D-phenylalanyl-N-(3-fluorobenzyl)-L-prolinamide,JGZSVYZIJHGHMA-MOPGFXCFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
108255,6vxx,DB07540,-8.5,"4-{5-[(1Z)-1-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)ETHYL]-2-FURYL}BENZENESULFONAMIDE",AKFVRSQELXTCFW-JYRVWZFOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81474,6m3m,DB01238,-8.5,Aripiprazole,CEUORZQYGODEFX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
71228,6lxt,DB13814,-8.5,Talampicillin,SOROUYSPFADXSN-SUWVAFIASA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
108178,6vxx,DB07192,-8.5,(3S)-N-(3-BROMOPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE,MVPIURCUINFSAB-LBPRGKRZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136466,6w9c,DB07148,-8.5,"(6S)-1-chloro-3-[(4-fluorobenzyl)oxy]-6-(pyrrolidin-1-ylcarbonyl)pyrrolo[1,2-a]pyrazin-4(6H)-one",HPAFVLDARQIHPU-HNNXBMFYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136576,6w9c,DB07287,-8.5,"2-(2,4-DICHLOROPHENOXY)-5-(PYRIDIN-2-YLMETHYL)PHENOL",AOVDSWPGWPRTSR-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
81547,6m3m,DB01393,-8.5,Bezafibrate,IIBYAHWJQTYFKB-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
71037,6lxt,DB13556,-8.5,Sulfamazone,BGLHAKAJGYLSOX-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
81318,6m3m,DB01059,-8.5,Norfloxacin,OGJPXUAPXNRGGI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
56111,6crv,DB01889,-8.5,"16,17-Androstene-3-Ol",KRVXMNNRSSQZJP-PHFHYRSDSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140459,6w9c,DB06869,-8.5,1-[2-AMINO-2-CYCLOHEXYL-ACETYL]-PYRROLIDINE-3-CARBOXYLIC ACID 5-CHLORO-2-(2-ETHYLCARBAMOYL-ETHOXY)-BENZYLAMIDE,BMHVHOJXEQTIEA-SIKLNZKXSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
108138,6vxx,DB07146,-8.5,"2,3-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-B]PYRIDIN-4-AMINE",QUIQCYFSBGOBKE-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
71505,6lxt,DB14664,-8.5,Difluocortolone pivalate,UWGRWFCLGQWKPR-GSTUPEFVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
108294,6vxx,DB07588,-8.5,"3,4-DI-1H-INDOL-3-YL-1H-PYRROLE-2,5-DICARBOXYLIC ACID",FZDVNXHYGMEEDT-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
164023,7bv1,DB06983,-8.5,"(5-phenyl-7-(pyridin-3-ylmethylamino)pyrazolo[1,5-a]pyrimidin-3-yl)methanol",RBLKWWBHDUBPFN-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
108149,6vxx,DB07159,-8.5,Tamatinib,NHHQJBCNYHBUSI-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27856,6cs2,DB07415,-8.5,4-[(1S)-1-(3-fluoro-4-methoxyphenyl)-2-(2-methoxy-5-nitrophenyl)ethyl]-1H-imidazol-2-amine,RFLOFHKRBGKCOB-AWEZNQCLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
108150,6vxx,DB07161,-8.5,5-phenyl-1H-indazol-3-amine,ZCUSNQPYUNLATP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56093,6crv,DB01865,-8.5,3-(6-Aminopyridin-3-Yl)-N-Methyl-N-[(1-Methyl-1h-Indol-2-Yl)Methyl]Acrylamide,AKFPMLBVLWZSQX-CSKARUKUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56090,6crv,DB01861,-8.5,Uridine diphosphate glucose,HSCJRCZFDFQWRP-JZMIEXBBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56083,6crv,DB01852,-8.5,Kaempherol,IYRMWMYZSQPJKC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163908,7bv1,DB06844,-8.5,"4-[(7-OXO-7H-THIAZOLO[5,4-E]INDOL-8-YLMETHYL)-AMINO]-N-PYRIDIN-2-YL-BENZENESULFONAMIDE",MBXKBJLIESPLIK-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
108638,6vxx,DB08491,-8.5,N-HYDROXY-2-[4-(4-PHENOXY-BENZENESULFONYL)-TETRAHYDRO-PYRAN-4-YL]-ACETAMIDE,ARIRIZBKMKMEBD-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108453,6vxx,DB08008,-8.5,"5-methyl-N-[4-(trifluoromethyl)phenyl][1,2,4]triazolo[1,5-a]pyrimidin-7-amine",LRHHXKBKRNNFRV-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81741,6m3m,DB01622,-8.5,Thioproperazine,VZYCZNZBPPHOFY-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
163793,7bv1,DB06295,-8.5,Pramiconazole,AEKNYBWUEYNWMJ-QWOOXDRHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
108603,6vxx,DB08448,-8.5,"(4aS)-5-[(2,4-diaminopteridin-6-yl)methyl]-4a,5-dihydro-2H-dibenzo[b,f]azepin-8-ol",PCBWLKUEKANDCL-INIZCTEOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163801,7bv1,DB06314,-8.5,SGX-523,BCZUAADEACICHN-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
107487,6vxx,DB03666,-8.5,3'-Azido-3'-Deoxythymidine-5'-Monophosphate,OIFWQOKDSPDILA-XLPZGREQSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
70485,6lxt,DB12724,-8.5,AZD-7295,MAQDQJWCSSCURR-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
125983,6w4h,DB03213,-8.5,Bis(5-Amidino-2-Benzimidazolyl)Methane Ketone,VVVXDHROXQUONB-UHFFFAOYSA-P,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
140397,6w9c,DB05959,-8.5,ENMD-1198,YQJWOUQGXATDAE-ACNBBOPNSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
107443,6vxx,DB03601,-8.5,5-deoxyflavanone,FURUXTVZLHCCNA-AWEZNQCLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
82032,6m3m,DB02014,-8.5,"5-(2-Fluoro-5-{(1E)-3-[3-hydroxy-2-(methoxycarbonyl)phenoxy]-1-propen-1-yl}phenyl)-1,2-oxazole-3-carboxylic acid",QKHWJUMLYAYZFS-ONEGZZNKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
108597,6vxx,DB08442,-8.5,"4-{[(2R)-2-(2-methylphenyl)pyrrolidin-1-yl]carbonyl}benzene-1,3-diol",TWODFUZHWYZBHZ-MRXNPFEDSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136328,6w9c,DB06993,-8.5,"(2S,3S)-4-cyclopropyl-3-{(3R,5R)-3-[2-fluoro-4-(methylsulfonyl)phenyl]-1,2,4-oxadiazolidin-5-yl}-1-[(3S)-3-fluoropyrrolidin-1-yl]-1-oxobutan-2-amine",PTAHVQJZNFGPHN-WFWWEWPISA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
71649,6lxt,DB15009,-8.5,PF-04937319,MASKQITXHVYVFL-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
126013,6w4h,DB03247,-8.5,Flavin mononucleotide,FVTCRASFADXXNN-SCRDCRAPSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
70517,6lxt,DB12776,-8.5,E-6005,BBTFKAOFCSOZMB-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
163805,7bv1,DB06334,-8.5,Tucidinostat,SZMJVTADHFNAIS-BJMVGYQFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
81994,6m3m,DB01960,-8.5,7n-Methyl-8-Hydroguanosine-5'-Diphosphate,QQODJOAVWUWVHJ-KQYNXXCUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
70506,6lxt,DB12756,-8.5,TAK-901,WKDACQVEJIVHMZ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
107522,6vxx,DB03714,-8.5,4-Carbamoyl-4-{[6-(Difluoro-Phosphono-Methyl)-Naphthalene-2-Carbonyl]-Amino}-Butyric Acid,OWWCIKSGGKYNHT-ZDUSSCGKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56534,6crv,DB02450,-8.5,"2-Benzo[1,3]Dioxol-5-Ylmethyl-3-Benzyl-Succinic Acid",ASEJDWRSZYAIOT-GJZGRUSLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55759,6crv,DB01451,-8.5,1-Androstenedione,WJIQCDPCDVWDDE-WZNAKSSCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136725,6w9c,DB07457,-8.5,"3-[1-(3-AMINOPROPYL)-1H-INDOL-3-YL]-4-(1H-INDOL-3-YL)-1H-PYRROLE-2,5-DIONE",APYXQTXFRIDSGE-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
71659,6lxt,DB15031,-8.5,Nemorexant,NBGABHGMJVIVBW-QHCPKHFHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
136302,6w9c,DB06962,-8.5,"(5-(aminomethyl)-2H-spiro[benzofuran-3,4'-piperidine]-1'-yl)(5-(phenylethynyl)furan-2-yl)methanone",YKTUSHSSKIWDRY-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
166499,7bv1,DB15247,-8.5,Vorolanib,KMIOJWCYOHBUJS-HAKPAVFJSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
127217,6w4h,DB04867,-8.5,Lintitript,ILNRQFBVVQUOLP-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
81010,6m3m,DB00701,-8.5,Amprenavir,YMARZQAQMVYCKC-OEMFJLHTSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
27609,6cs2,DB07159,-8.5,Tamatinib,NHHQJBCNYHBUSI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
82075,6m3m,DB02071,-8.5,WAY-151693,AINJYWXKBKRQSX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
127212,6w4h,DB04862,-8.5,Merimepodib,JBPUGFODGPKTDW-SFHVURJKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
107381,6vxx,DB03235,-8.5,N-{3-[4-(3-aminopropyl)piperazin-1-yl]propyl}-3-(alpha-D-galactopyranosyloxy)-5-nitrobenzamide,UEIGEWJJVQHIAX-MKQKURRLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
70440,6lxt,DB12658,-8.5,AFN-1252,QXTWSUQCXCWEHF-JXMROGBWSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
55753,6crv,DB01443,-8.5,19-Nor-5-androstenedione,WELNRNVZXWUOGT-QXUSFIETSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163780,7bv1,DB06263,-8.5,Amrubicin,VJZITPJGSQKZMX-XDPRQOKASA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
108621,6vxx,DB08470,-8.5,"3-(4-fluorophenyl)-5-phenyl-4H-1,2,4-triazole",KMGPJKOKSYGMJD-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
82085,6m3m,DB02082,-8.5,Phosphoaminophosphonic Acid Guanylate Ester,UQABYHGXWYXDTK-UUOKFMHZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
56538,6crv,DB02455,-8.5,Fluoresceinylthioureido,VHJFQSRUDVDTEO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107380,6vxx,DB03234,-8.5,"(4'-{[Allyl(Methyl)Amino]Methyl}-1,1'-Biphenyl-4-Yl)(4-Bromophenyl)Methanone",YATCZCSDJCQNAL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107525,6vxx,DB03718,-8.5,6-Aza-Ump,LRVZOSYMNMNQFR-SHUUEZRQSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108580,6vxx,DB08422,-8.5,[PHENYLALANINYL-PROLINYL]-[2-(PYRIDIN-4-YLAMINO)-ETHYL]-AMINE,GEIDRYBJURDUSW-MOPGFXCFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
70538,6lxt,DB12812,-8.5,Palomid 529,YEAHTLOYHVWAKW-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
136684,6w9c,DB07409,-8.5,"(1-HYDROXY-1-PHOSPHONO-2-[1,1';4',1'']TERPHENYL-3-YL-ETHYL)-PHOSPHONIC ACID",MPBUFKZCEBTBSK-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
70592,6lxt,DB12899,-8.5,TT-301,ZPJGUEPHFXPAQF-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
108547,6vxx,DB08382,-8.5,Gosogliptin,QWEWGXUTRTXFRF-KBPBESRZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136678,6w9c,DB07403,-8.5,"4-[(3-CHLORO-4-{[(2R)-3,3,3-TRIFLUORO-2-HYDROXY-2-METHYLPROPANOYL]AMINO}PHENYL)SULFONYL]-N,N-DIMETHYLBENZAMIDE",DTDZLJHKVNTQGZ-GOSISDBHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
71622,6lxt,DB14918,-8.5,Branaplam,STWTUEAWRAIWJG-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
81126,6m3m,DB00839,-8.5,Tolazamide,OUDSBRTVNLOZBN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81128,6m3m,DB00842,-8.5,Oxazepam,ADIMAYPTOBDMTL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81105,6m3m,DB00817,-8.5,Rosoxacin,XBPZXDSZHPDXQU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136392,6w9c,DB07063,-8.5,"{3-[(4,5,7-TRIFLUORO-1,3-BENZOTHIAZOL-2-YL)METHYL]-1H-INDOL-1-YL}ACETIC ACID",KYHVTMFADJNSGS-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
56329,6crv,DB02189,-8.5,"2',3'-Dideoxyadenosine-5'-Triphosphate",OAKPWEUQDVLTCN-NKWVEPMBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
70630,6lxt,DB12952,-8.5,Methylprednisone,SVYCRJXQZUCUND-PQXSVQADSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
108494,6vxx,DB08054,-8.5,"1-(1-methylethyl)-3-quinolin-6-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine",GEZALMMCQYDFML-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107863,6vxx,DB05294,-8.5,Vandetanib,UHTHHESEBZOYNR-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108488,6vxx,DB08046,-8.5,2-chloro-5-[(1S)-1-hydroxy-3-oxo-2H-isoindol-1-yl]benzenesulfonamide,JIVPVXMEBJLZRO-AWEZNQCLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107875,6vxx,DB05399,-8.5,Succinobucol,RKSMVPNZHBRNNS-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55832,6crv,DB01535,-8.5,Carfentanil,YDSDEBIZUNNPOB-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81817,6m3m,DB01720,-8.5,(2z)-2-(Benzoylamino)-3-[4-(2-Bromophenoxy)Phenyl]-2-Propenoic Acid,WLPJLQNKCJWAFL-RGEXLXHISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136375,6w9c,DB07045,-8.5,"(2R,3R,4S,5R)-2-[6-amino-8-[(3,4-dichlorophenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol",VBJKVZXRYLCYGQ-XNIJJKJLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
70584,6lxt,DB12887,-8.5,Tazemetostat,NSQSAUGJQHDYNO-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
56389,6crv,DB02266,-8.5,Flufenamic Acid,LPEPZBJOKDYZAD-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114245,6vxx,DB13165,-8.5,Ripasudil,QSKQVZWVLOIIEV-NSHDSACASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
18502,6cs2,HMDB0030684,-8.5,Cyanidin 3-glucoside,RKWHWFONKJEUEF-GQUPQBGVSA-O,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
11044,6lzg,DB11274,-8.5,Dihydro-alpha-ergocryptine,PBUNVLRHZGSROC-VTIMJTGVSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
126073,6w4h,DB03325,-8.5,Tyrosyladenylate,MJZAZMKENKZBAJ-QTOWJTHWSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
56438,6crv,DB02333,-8.5,Deoxyuridine-5'-Triphosphate,AHCYMLUZIRLXAA-SHYZEUOFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
126080,6w4h,DB03336,-8.5,BIA,KVIVJQWOYSWCCZ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
140405,6w9c,DB05990,-8.5,Obeticholic acid,ZXERDUOLZKYMJM-ZWECCWDJSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
108555,6vxx,DB08390,-8.5,"(6S)-6-CYCLOPENTYL-6-[2-(3-FLUORO-4-ISOPROPOXYPHENYL)ETHYL]-4-HYDROXY-5,6-DIHYDRO-2H-PYRAN-2-ONE",AKNIHFDXRAOPAI-NRFANRHFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55777,6crv,DB01470,-8.5,alpha-methylthiofentanyl,YPOXDUYRRSUFFG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107666,6vxx,DB04158,-8.5,"6-(Adenosine Tetraphosphate-Methyl)-7,8-Dihydropterin",ZKRKFZJAQKKHKL-SUGPNEFASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81097,6m3m,DB00808,-8.5,Indapamide,NDDAHWYSQHTHNT-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
70575,6lxt,DB12877,-8.5,Oxatomide,BAINIUMDFURPJM-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
136358,6w9c,DB07027,-8.5,D-phenylalanyl-N-(3-fluorobenzyl)-L-prolinamide,JGZSVYZIJHGHMA-MOPGFXCFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
11020,6lzg,DB11176,-8.5,Zeaxanthin,JKQXZKUSFCKOGQ-QAYBQHTQSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
136367,6w9c,DB07036,-8.5,"(3aS,4R,9bR)-2,2-difluoro-4-(4-hydroxyphenyl)-6-(methoxymethyl)-1,2,3,3a,4,9b-hexahydrocyclopenta[c]chromen-8-ol",GPFRMIHXGMVMGF-BZSNNMDCSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
107704,6vxx,DB04204,-8.5,[(4-{4-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Butyl}-Phenyl)-Difluoro-Methyl]-Phosphonic Acid,SRHSAABKYJDBDV-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56409,6crv,DB02292,-8.5,Irosustat,DSLPMJSGSBLWRE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163895,7bv1,DB06827,-8.5,Viomycin,GXFAIFRPOKBQRV-GHXCTMGLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
84643,6m3m,DB06685,-8.5,Laquinimod,GKWPCEFFIHSJOE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80618,6m3m,DB00229,-8.5,Cefotiam,QYQDKDWGWDOFFU-IUODEOHRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
106267,6vxs,DB15346,-8.5,GLPG-1205,IRBAWVGZNJIROV-SFHVURJKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
26919,6cs2,DB05932,-8.5,Denibulin,GAOHLWCIAJNSEE-JTQLQIEISA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
124555,6w4h,DB01326,-8.5,Cefamandole,OLVCFLKTBJRLHI-AXAPSJFSSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
104650,6vxs,DB12306,-8.5,Cipargamin,CKLPLPZSUQEDRT-WPCRTTGESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
84356,6m3m,DB05695,-8.5,NPS-2143,PZUJQWHTIRWCID-HXUWFJFHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
68573,6lxt,DB08073,-8.5,(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE,YWTBGJGMTBHQTM-IBGZPJMESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
11977,6lzg,DB12703,-8.5,Omipalisib,CGBJSGAELGCMKE-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
104666,6vxs,DB12325,-8.5,Idasanutlin,TVTXCJFHQKSQQM-LJQIRTBHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104637,6vxs,DB12289,-8.5,Darexaban,IJNIQYINMSGIPS-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
26926,6cs2,DB05959,-8.5,ENMD-1198,YQJWOUQGXATDAE-ACNBBOPNSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
137226,6w9c,DB08042,-8.5,"N-4-methyl-N-4-(3-methyl-1H-indazol-6-yl)-N-2-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine",FLXGQDHYCWXTAI-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
161723,7bv1,DB00522,-8.5,Bentiromide,SPPTWHFVYKCNNK-FQEVSTJZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
124556,6w4h,DB01327,-8.5,Cefazolin,MLYYVTUWGNIJIB-BXKDBHETSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
58291,6crv,DB04807,-8.5,4-NITROPHENYL-(6-S-ALPHA-D-XYLOPYRANOSYL)-BETA-D-GLUCOPYRANOSIDE,HQYVHBCTLFPWRQ-ZMFOIVQCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
124565,6w4h,DB01339,-8.5,Vecuronium,BGSZAXLLHYERSY-XQIGCQGXSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
104687,6vxs,DB12361,-8.5,Piclozotan,URMTUEWUIGOJBW-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
164710,7bv1,DB08512,-8.5,"6-amino-2-[(1-naphthylmethyl)amino]-3,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",MCEZMMDIEXECTI-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
68580,6lxt,DB08080,-8.5,LATRUNCULIN B,NSHPHXHGRHSMIK-JRIKCGFMSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
30029,6cs2,DB11952,-8.5,Duvelisib,SJVQHLPISAIATJ-ZDUSSCGKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
127975,6w4h,DB07072,-8.5,"(1S,2R,5S)-5-[3-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7(8H)-YL]-2-(2,4,5-TRIFLUOROPHENYL)CYCLOHEXANAMINE",CNKRZILQBKJWDS-WMFXKJRFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
68550,6lxt,DB08044,-8.5,ABT-341,NVVSPGQEXMJZIR-BMIGLBTASA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
104514,6vxs,DB12114,-8.5,Poziotinib,LPFWVDIFUFFKJU-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104525,6vxs,DB12128,-8.5,Ulimorelin,WGYPAJVJMXQXTR-ABNZCKJZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
80162,6m2n,DB14765,-8.5,Rivoceranib,WPEWQEMJFLWMLV-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80165,6m2n,DB14769,-8.5,Pamiparib,DENYZIUJOTUUNY-MRXNPFEDSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
135258,6w9c,DB04194,-8.5,Chitotriose,WZZVUHWLNMNWLW-VFCSDQTKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137237,6w9c,DB08056,-8.5,"N-(2,6-dimethylphenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine",KKYYLKPGILUPOA-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
109702,6vxx,DB15168,-8.5,Cilofexor,KZSKGLFYQAYZCO-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
161684,7bv1,DB00471,-8.5,Montelukast,UCHDWCPVSPXUMX-TZIWLTJVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
104540,6vxs,DB12149,-8.5,S-3304,YWCLDDLVLSQGSZ-JOCHJYFZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
12009,6lzg,DB12742,-8.5,Amuvatinib,FOFDIMHVKGYHRU-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
104570,6vxs,DB12198,-8.5,Fosdagrocorat,BVXLAHSJXXSWFF-KEKPKEOLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
140742,6w9c,DB15221,-8.5,PF-06260414,ZKAVFOXYJCREBQ-SNVBAGLBSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
58345,6crv,DB04873,-8.5,Piboserod,KVCSJPATKXABRQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
12000,6lzg,DB12729,-8.5,ASP-3026,MGGBYMDAPCCKCT-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
80179,6m2n,DB14799,-8.5,PF-06821497,RXCVUHMIWHRLDF-HXUWFJFHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80181,6m2n,DB14802,-8.5,ONO-2952,ZBQMTQGDBFZUBG-NRFANRHFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
7311,6lzg,DB00430,-8.5,Cefpiramide,PWAUCHMQEXVFJR-PMAPCBKXSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
68680,6lxt,DB08191,-8.5,"4-(5-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl)benzoic acid",KSFDVNIKNYXUIP-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
84315,6m3m,DB05482,-8.5,7-ethyl-10-hydroxycamptothecin,FJHBVJOVLFPMQE-QFIPXVFZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
104705,6vxs,DB12388,-8.5,Evocalcet,RZNUIYPHQFXBAN-XLIONFOSSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
11904,6lzg,DB12591,-8.5,BMS-911543,JCINBYQJBYJGDM-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
137188,6w9c,DB08001,-8.5,5-(3-{3-[3-HYDROXY-2-(METHOXYCARBONYL)PHENOXY]PROPENYL}PHENYL)-4-(HYDROXYMETHYL)ISOXAZOLE-3-CARBOXYLIC ACID,DQSRCEFDWMQCCV-GQCTYLIASA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
135532,6w9c,DB04591,-8.5,"N-{2,2-DIFLUORO-2-[(2R)-PIPERIDIN-2-YL]ETHYL}-2-[2-(1H-1,2,4-TRIAZOL-1-YL)BENZYL][1,3]OXAZOLO[4,5-C]PYRIDIN-4-AMINE",VYJOAYZRCNHDNG-GOSISDBHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
104823,6vxs,DB12558,-8.5,AEE-788,OONFNUWBHFSNBT-HXUWFJFHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
55205,6crv,DB00735,-8.5,Naftifine,OZGNYLLQHRPOBR-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80230,6m2n,DB14914,-8.5,Flortaucipir F-18,GETAAWDSFUCLBS-SJPDSGJFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
109619,6vxx,DB14541,-8.5,Hydrocortisone cypionate,DLVOSEUFIRPIRM-KAQKJVHQSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55192,6crv,DB00718,-8.5,Adefovir dipivoxil,WOZSCQDILHKSGG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84237,6m3m,DB05035,-8.5,Eprotirome,VPCSYAVXDAUHLT-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84232,6m3m,DB05015,-8.5,Belinostat,NCNRHFGMJRPRSK-MDZDMXLPSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
104856,6vxs,DB12612,-8.5,Ozanimod,XRVDGNKRPOAQTN-FQEVSTJZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
137176,6w9c,DB07988,-8.5,"2-[3-(5-MERCAPTO-[1,3,4]THIADIAZOL-2YL)-UREIDO]-N-METHYL-3-PENTAFLUOROPHENYL-PROPIONAMIDE",HZAXNPDJVFUGDS-BYPYZUCNSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
55228,6crv,DB00764,-8.5,Mometasone,QLIIKPVHVRXHRI-CXSFZGCWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84221,6m3m,DB04960,-8.5,Tipifarnib,PLHJCIYEEKOWNM-HHHXNRCGSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
104869,6vxs,DB12635,-8.5,Aleplasinin,HSXLMAFNWCSZGP-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104872,6vxs,DB12640,-8.5,CP-609754,JAHDAIPFBPPQHQ-GDLZYMKVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
135550,6w9c,DB04614,-8.5,(R)-tacrine(10)-hupyridone,ROTFGKJJMRTWBD-HHHXNRCGSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
104800,6vxs,DB12523,-8.5,Mizolastine,PVLJETXTTWAYEW-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
68837,6lxt,DB08391,-8.5,"6,7-DIMETHOXY-4-[(3R)-3-(QUINOXALIN-2-YLOXY)PYRROLIDIN-1-YL]QUINAZOLINE",UBIIFKJMNRPNMT-CQSZACIVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
161866,7bv1,DB00912,-8.5,Repaglinide,FAEKWTJYAYMJKF-QHCPKHFHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
55177,6crv,DB00701,-8.5,Amprenavir,YMARZQAQMVYCKC-OEMFJLHTSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104723,6vxs,DB12410,-8.5,Sabarubicin,VQHRZZISQVWPLK-UIRGBLDSSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
124590,6w4h,DB01395,-8.5,Drospirenone,METQSPRSQINEEU-HXCATZOESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
11943,6lzg,DB12651,-8.5,Bardoxolone,TXGZJQLMVSIZEI-UQMAOPSPSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
109646,6vxx,DB15057,-8.5,NUC-1031,NHTKGYOMICWFQZ-KKQYNPQSSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84300,6m3m,DB05421,-8.5,CP-122721,ZIWFCOIGUNPHPM-HKUYNNGSSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
72389,6m2n,DB00691,-8.5,Moexipril,UWWDHYUMIORJTA-HSQYWUDLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
68794,6lxt,DB08339,-8.5,"6-(2,6-DICHLOROPHENYL)-2-{[3-(HYDROXYMETHYL)PHENYL]AMINO}-8-METHYLPYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE",ZIQFYVPVJZEOFS-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
104736,6vxs,DB12426,-8.5,Bitopertin,YUUGYIUSCYNSQR-LBPRGKRZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
68803,6lxt,DB08350,-8.5,"5-[3-(2-METHOXYPHENYL)-1H-PYRROLO[2,3-B]PYRIDIN-5-YL]-N,N-DIMETHYLPYRIDINE-3-CARBOXAMIDE",GYQRHHQPEMOLKH-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
26951,6cs2,DB06134,-8.5,SNS-314,FAYAUAZLLLJJGH-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
161820,7bv1,DB00637,-8.5,Astemizole,GXDALQBWZGODGZ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
55188,6crv,DB00714,-8.5,Apomorphine,VMWNQDUVQKEIOC-CYBMUJFWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58252,6crv,DB04756,-8.5,"2-[(3,5-Dichloro-4-trioxidanylphenyl)amino]benzoic acid",SNAMTVTZDPUVRA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
124594,6w4h,DB01405,-8.5,Temafloxacin,QKDHBVNJCZBTMR-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
166507,7bv1,DB15268,-8.5,Afabicin,HFYMDQMXVPJNTH-VQHVLOKHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
68817,6lxt,DB08366,-8.5,"3-({3-[(1S,4aS,6S,7S,9S,9aR)-1,6-dimethyl-2-oxodecahydro-6,9-epoxy-4a,7-methanobenzo[7]annulen-1-yl]propanoyl}amino)-2,4-dihydroxybenzoic acid",XADCWKSMHQPTGH-OFBLZTNGSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
68489,6lxt,DB07977,-8.5,"3-({[3,5-DIFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)THIOPHENE-2-CARBOXYLIC ACID",CGNHUSCKOHDSMR-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
109596,6vxx,DB14208,-8.5,Ramiprilat,KEDYTOTWMPBSLG-HILJTLORSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84416,6m3m,DB06133,-8.5,Dimethylcurcumin,ZMGUKFHHNQMKJI-CIOHCNBKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58383,6crv,DB04953,-8.5,Ezogabine,PCOBBVZJEWWZFR-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
124349,6w4h,DB01047,-8.5,Fluocinonide,WJOHZNCJWYWUJD-IUGZLZTKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
72545,6m2n,DB00873,-8.5,Loteprednol,YPZVAYHNBBHPTO-MXRBDKCISA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
68168,6lxt,DB07605,-8.5,"2-({4-[(5-CHLORO-1H-INDOL-2-YL)SULFONYL]PIPERAZIN-1-YL}CARBONYL)THIENO[3,2-B]PYRIDINE 4-OXIDE",DHDQMXPAANQKDC-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
55042,6crv,DB00540,-8.5,Nortriptyline,PHVGLTMQBUFIQQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104332,6vxs,DB11844,-8.5,Pritelivir,IVZKZONQVYTCKC-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
84554,6m3m,DB06471,-8.5,Naxifylline,NJYNSYQBNSDGIQ-RDDCQWBRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
26830,6cs2,DB05450,-8.5,Smilagenin,GMBQZIIUCVWOCD-UQHLGXRBSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
104319,6vxs,DB11824,-8.5,Tofogliflozin,VWVKUNOPTJGDOB-BDHVOXNPSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
26835,6cs2,DB05465,-8.5,Tandutinib,UXXQOJXBIDBUAC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
58436,6crv,DB05252,-8.5,Fenoxaprop-ethyl,PQKBPHSEKWERTG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55047,6crv,DB00546,-8.5,Adinazolam,GJSLOMWRLALDCT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104355,6vxs,DB11878,-8.5,Filibuvir,SLVAPEZTBDBAPI-GDLZYMKVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
26839,6cs2,DB05490,-8.5,AMG-131,NMRWDFUZLLQSBN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
28373,6cs2,DB07962,-8.5,"METHYL N-[(2',4'-DIFLUORO-4-HYDROXY-5-IODOBIPHENYL-3-YL)CARBONYL]-BETA-ALANINATE",ZMRRBWRMQPQQAN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
12111,6lzg,DB12899,-8.5,TT-301,ZPJGUEPHFXPAQF-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
72519,6m2n,DB00844,-8.5,Nalbuphine,NETZHAKZCGBWSS-CEDHKZHLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
68191,6lxt,DB07630,-8.5,"N-((1R,2R)-2-(5-CHLORO-1H-INDOLE-2-CARBOXAMIDO)CYCLOHEXYL)-5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE-2-CARBOXAMIDE",ARPFWVKYXJZULB-IAGOWNOFSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
80078,6m2n,DB14624,-8.5,Nandrolone hydrogen sulfate,SKZMVWBZTQNCKW-IZPLOLCNSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
72564,6m2n,DB00896,-8.5,Rimexolone,QTTRZHGPGKRAFB-OOKHYKNYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
104306,6vxs,DB11806,-8.5,VTP-194204,BOOOLEGQBVUTKC-NVQSDHBMSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
79916,6m2n,DB13954,-8.5,Estradiol cypionate,UOACKFBJUYNSLK-XRKIENNPSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
68043,6lxt,DB07453,-8.5,2-PHENYL-4H-BENZO[H]CHROMEN-4-ONE,VFMMPHCGEFXGIP-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
19410,6cs2,HMDB0044200,-8.5,TG(16:0/22:1(13Z)/18:1(11Z)),UBCKVROCLDZVDL-JSPVYFJMSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
26802,6cs2,DB05294,-8.5,Vandetanib,UHTHHESEBZOYNR-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
68077,6lxt,DB07493,-8.5,"(2Z)-5'-BROMO-2,3'-BIINDOLE-2',3(1H,1'H)-DIONE AMMONIATE",IEQQJQHHJMQETK-YPKPFQOOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
161466,7bv1,DB14860,-8.5,Ensartinib,GLYMPHUVMRFTFV-QLFBSQMISA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
55011,6crv,DB00497,-8.5,Oxycodone,BRUQQQPBMZOVGD-XFKAJCMBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
26825,6cs2,DB05424,-8.5,Canertinib,OMZCMEYTWSXEPZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
72628,6m2n,DB00967,-8.5,Desloratadine,JAUOIFJMECXRGI-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
72620,6m2n,DB00957,-8.5,Norgestimate,KIQQMECNKUGGKA-NMYWJIRASA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
134759,6w9c,DB03507,-8.5,"6-[3-(4-Morpholinyl)Propyl]-2-(3-Nitrophenyl)-5-Thioxo-5,6,-Dihydro-7h-Thienol[2',3':4,5]Pyrrolo[1,2-C]Imidazol-7-One",UXGUZFZBZPPZGL-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
128090,6w4h,DB07204,-8.5,"(1S)-1-(1H-INDOL-3-YLMETHYL)-2-(2-PYRIDIN-4-YL-[1,7]NAPHTYRIDIN-5-YLOXY)-EHYLAMINE",DQIXTEDFNFZMCM-SFHVURJKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
12149,6lzg,DB12949,-8.5,PF-03382792,AGMOFKKOVMRGAK-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
104297,6vxs,DB11794,-8.5,Berzosertib,JZCWLJDSIRUGIN-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
134818,6w9c,DB03598,-8.5,"Al-6629, [2h-Thieno[3,2-E]-1,2-Thiazine-6-Sulfonamide,2-(3-Methoxyphenyl)-3-(4-Morpholinyl)-, 1,1-Dioxide]",XSUAVPPTKHUTDX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
58458,6crv,DB05395,-8.5,Amibegron,RDJQCOBTKKAQAH-FPOVZHCZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104283,6vxs,DB11775,-8.5,PF-03758309,AYCPARAPKDAOEN-LJQANCHMSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
68273,6lxt,DB07729,-8.5,3-fluoro-N-[3-(1H-tetrazol-5-yl)phenyl]benzamide,GAKOBKPDJJGRIL-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
80087,6m2n,DB14633,-8.5,Prednisolone hemisuccinate,APGDTXUMTIZLCJ-CGVGKPPMSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
164771,7bv1,DB08584,-8.5,"6-{[6-(1-methyl-1H-pyrazol-4-yl)[1,2,4]triazolo[4,3-b]pyridazin-3-yl]sulfanyl}quinoline",BCZUAADEACICHN-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
161519,7bv1,DB14993,-8.5,Pyrotinib,SADXACCFNXBCFY-IYNHSRRRSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
161520,7bv1,DB14995,-8.5,NP-G2-044,XLLRLAABUFOJPC-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
55113,6crv,DB00624,-8.5,Testosterone,MUMGGOZAMZWBJJ-DYKIIFRCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
135130,6w9c,DB04022,-8.5,"Guanosine-5',3'-Tetraphosphate",BUFLLCUFNHESEH-UUOKFMHZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
135139,6w9c,DB04038,-8.5,Ergosterol,DNVPQKQSNYMLRS-APGDWVJJSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
84454,6m3m,DB06207,-8.5,Silodosin,PNCPYILNMDWPEY-QGZVFWFLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
109731,6vxx,DB15222,-8.5,GS-6620,YAAQYJCOIFNMKX-RSTNYOGXSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104459,6vxs,DB12036,-8.5,Naquotinib,QKDCLUARMDUUKN-XMMPIXPASA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
68457,6lxt,DB07941,-8.5,PH-797804,KCAJXIDMCNPGHZ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
28329,6cs2,DB07917,-8.5,4-(BENZHYDRYLOXY)-1-[3-(1H-TETRAAZOL-5-YL)PROPYL]PIPERIDINE,TZQGXAHOROZEKN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
104470,6vxs,DB12050,-8.5,LY-3039478,YCBAQKQAINQRFW-UGSOOPFHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
135184,6w9c,DB04097,-8.5,Uridine-5'-Diphosphate-4-Deoxy-4-Fluoro-Alpha-D-Galactose,OAPPZHVTNHJVAL-JZMIEXBBSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
104480,6vxs,DB12064,-8.5,BMS-777607,VNBRGSXVFBYQNN-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
164726,7bv1,DB08531,-8.5,"5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",CVYWYUAQFJMLEO-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
72415,6m2n,DB00719,-8.5,Azatadine,SEBMTIQKRHYNIT-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
84426,6m3m,DB06153,-8.5,Pizotifen,FIADGNVRKBPQEU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
166576,7bv1,DB15408,-8.5,Silmitasertib,MUOKSQABCJCOPU-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
104448,6vxs,DB12015,-8.5,Alpelisib,STUWGJZDJHPWGZ-LBPRGKRZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
135123,6w9c,DB04014,-8.5,Alsterpaullone,OLUKILHGKRVDCT-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
109762,6vxx,DB00229,-8.5,Cefotiam,QYQDKDWGWDOFFU-IUODEOHRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109805,6vxx,DB00276,-8.5,Amsacrine,XCPGHVQEEXUHNC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28358,6cs2,DB07945,-8.5,"5-(3-carbamoylbenzyl)-5,6,7,8,9,10-hexahydrocyclohepta[b]indole-4-carboxylic acid",GKBQRPKZHUFGOB-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
68315,6lxt,DB07778,-8.5,FAMOXADONE,PCCSBWNGDMYFCW-QFIPXVFZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
68322,6lxt,DB07786,-8.5,"1-((1R,2S)-1-{2-[2-(4-CHLOROPHENYL)-1,3-BENZOXAZOL-7-YL]ETHYL}-2-HYDROXYPROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE",SMFRBBHLVBWHGB-DJJJIMSYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
137270,6w9c,DB08095,-8.5,"3-(2-CHLOROPHENYL)-1-(2-{[(1S)-2-HYDROXY-1,2-DIMETHYLPROPYL]AMINO}PYRIMIDIN-4-YL)-1-(4-METHOXYPHENYL)UREA",ZWYFTKPEHRQCCW-HNNXBMFYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
84501,6m3m,DB06313,-8.5,BNC105,MYDHDVLPMRNDAZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80106,6m2n,DB14653,-8.5,Clocortolone caproate,MMTRTBFDFNRBQO-ANHDKODLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
104422,6vxs,DB11978,-8.5,Glasdegib,SFNSLLSYNZWZQG-VQIMIIECSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
12069,6lzg,DB12836,-8.5,Grapiprant,HZVLFTCYCLXTGV-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
80111,6m2n,DB14659,-8.5,Melengestrol acetate,UDKABVSQKJNZBH-DWNQPYOZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
164757,7bv1,DB08569,-8.5,"3-PYRIDIN-4-YL-2,4-DIHYDRO-INDENO[1,2-.C.] PYRAZOLE",VLPMRZSKJUTRBQ-IBGZPJMESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
68361,6lxt,DB07827,-8.5,"4-{[1-METHYL-2,4-DIOXO-6-(3-PHENYLPROP-1-YN-1-YL)-1,4-DIHYDROQUINAZOLIN-3(2H)-YL]METHYL}BENZOIC ACID",FLTYDFYSVZBKOB-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
104433,6vxs,DB11995,-8.5,Avatrombopag,OFZJKCQENFPZBH-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
68363,6lxt,DB07830,-8.5,"(4R,5R)-5-AMINO-1-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN-2-ONE",DIRIFWIKLRTNMB-DYVFJYSZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
114682,6vxx,DB14644,-8.5,Methylprednisolone hemisuccinate,IMBXEJJVJRTNOW-XYMSELFBSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84483,6m3m,DB06266,-8.5,Lonidamine,WDRYRZXSPDWGEB-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
114684,6vxx,DB14646,-8.5,Prednisone acetate,MOVRKLZUVNCBIP-RFZYENFJSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
124495,6w4h,DB01212,-8.5,Ceftriaxone,VAAUVRVFOQPIGI-SPQHTLEESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
69926,6lxt,DB11901,-8.5,Apalutamide,HJBWBFZLDZWPHF-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
80245,6m2n,DB14941,-8.5,BMS-817399,GTDPZONCGOCXOD-JPYJTQIMSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
135581,6w9c,DB04652,-8.5,Corticosterone,OMFXVFTZEKFJBZ-HJTSIMOOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136992,6w9c,DB07776,-8.5,Flavone,VHBFFQKBGNRLFZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
80417,6m2n,DB15316,-8.5,Florasulam,QZXATCCPQKOEIH-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
27209,6cs2,DB00157,-8.5,NADH,BOPGDPNILDQYTO-NNYOXOHSSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
80422,6m2n,DB15325,-8.5,ONO-8539,ALLLQQUASFFEKP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
55456,6crv,DB01025,-8.5,Amlexanox,SGRYPYWGNKJSDL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57656,6crv,DB03950,-8.5,(S)-N-(3-Indol-1-Yl-2-Methyl-Propyl)-4-Sulfamoyl-Benzamide,ZFWHOUCRVSOZJE-AWEZNQCLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106044,6vxs,DB14878,-8.5,Liafensine,VCIBGDSRPUOBOG-QFIPXVFZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
136998,6w9c,DB07783,-8.5,1-((1R)-1-(HYDROXYMETHYL)-3-{6-[(3-PHENYLPROPANOYL)AMINO]-1H-INDOL-1-YL}PROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE,GUYYFMCFEPDDFL-OAQYLSRUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
162633,7bv1,DB02524,-8.5,"2',3'-O-{4-[Hydroxy(oxido)-lambda5-azanylidene]-2,6-dinitro-2,5-cyclohexadiene-1,1-diyl}adenosine 5'-(tetrahydrogen triphosphate)",XFMMHXLUHKBKQE-UHEGPQQHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
106074,6vxs,DB14935,-8.5,Serabelisib,BLGWHBSBBJNKJO-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
106079,6vxs,DB14942,-8.5,BMS-986141,KEEBLYWBELVGPQ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
69808,6lxt,DB11732,-8.5,Lasmiditan,XEDHVZKDSYZQBF-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
83516,6m3m,DB03987,-8.5,"2,4-Diamino-6-[N-(3',5'-Dimethoxybenzyl)-N-Methylamino]Pyrido[2,3-D]Pyrimidine",XWCCXDBXMCTZPW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
140646,6w9c,DB13036,-8.5,Ramatroban,LDXDSHIEDAPSSA-OAHLLOKOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
109151,6vxx,DB12442,-8.5,Alvespimycin,KUFRQPKVAWMTJO-LMZWQJSESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
83510,6m3m,DB03980,-8.5,4-(Fluorophenyl)-1-Cyclopropylmethyl-5-(2-Amino-4-Pyrimidinyl)Imidazole,DFEYXQGDDCDXJK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
27230,6cs2,DB06721,-8.5,Gimatecan,UIVFUQKYVFCEKJ-OPTOVBNMSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
162663,7bv1,DB02759,-8.5,4-Methylumbelliferyl Chitobiose,UPSFMJHZUCSEHU-JYGUBCOQSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
27186,6cs2,DB06652,-8.5,Vicriviroc,CNPVJJQCETWNEU-CYFREDJKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
83691,6m3m,DB04215,-8.5,CRA_9076,BVTBOJXEAPSOEB-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
109256,6vxx,DB12966,-8.5,Falnidamol,FTFRZXFNZVCRSK-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
11669,6lzg,DB12280,-8.5,AZD-5423,FCNQMDSJHADDFT-WNSKOXEYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
80383,6m2n,DB15246,-8.5,Salvianolic acid A,YMGFTDKNIWPMGF-UCPJVGPRSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
109237,6vxx,DB12937,-8.5,Quercetin-3'-O-phosphate,UWJBYNLLMAPJMM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
135792,6w9c,DB05016,-8.5,Ataluren,OOUGLTULBSNHNF-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
105769,6vxs,DB13993,-8.5,MRK-409,GOIFCXRIFSYPFG-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
69582,6lxt,DB11176,-8.5,Zeaxanthin,JKQXZKUSFCKOGQ-QAYBQHTQSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
69665,6lxt,DB11430,-8.5,Monensin,GAOZTHIDHYLHMS-KEOBGNEYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
140231,6w9c,DB15406,-8.5,GLPG-0974,MPMKMQHJHDHPBE-RUZDIDTESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140684,6w9c,DB13094,-8.5,Pruvanserin,AQRLDDAFYYAIJP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
162403,7bv1,DB02010,-8.5,Staurosporine,HKSZLNNOFSGOKW-FYTWVXJKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
61683,6crv,DB12430,-8.5,BC-3781,KPVIXBKIJXZQJX-IJUBVZAWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
11646,6lzg,DB12247,-8.5,AZD-4547,VRQMAABPASPXMW-HDICACEKSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
105873,6vxs,DB14217,-8.5,Quinaprilat,FLSLEGPOVLMJMN-YSSFQJQWSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
135810,6w9c,DB05105,-8.5,Pleconaril,KQOXLKOJHVFTRN-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
69659,6lxt,DB11424,-8.5,Lufenuron,PWPJGUXAGUPAHP-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
105784,6vxs,DB14029,-8.5,Furafylline,HMZQULPVMKITSP-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
69819,6lxt,DB11745,-8.5,Otenabant,UNAZAADNBYXMIV-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
28148,6cs2,DB07728,-8.5,"2-[2-(2-FLUOROPHENYL)PYRIDIN-4-YL]-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE",XJJYJNMNYDNXNO-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
106103,6vxs,DB15031,-8.5,Nemorexant,NBGABHGMJVIVBW-QHCPKHFHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
109094,6vxx,DB12367,-8.5,Selurampanel,MCECSFFXUPEPDB-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27300,6cs2,DB06831,-8.5,2-((9H-PURIN-6-YLTHIO)METHYL)-5-CHLORO-3-(2-METHOXYPHENYL)QUINAZOLIN-4(3H)-ONE,UMMYTDJYDSTEMB-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
10345,6lzg,DB08531,-8.5,"5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",CVYWYUAQFJMLEO-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
71946,6m2n,DB00158,-8.5,Folic acid,OVBPIULPVIDEAO-LBPRGKRZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
27312,6cs2,DB06847,-8.5,"5-[(3S)-3-(2-methoxybiphenyl-4-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",YYCPXVRHQUEVAW-CQSZACIVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
55526,6crv,DB01104,-8.5,Sertraline,VGKDLMBJGBXTGI-SJCJKPOMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
11472,6lzg,DB12010,-8.5,Fostamatinib,GKDRMWXFWHEQQT-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
69880,6lxt,DB11830,-8.5,Mocetinostat,HRNLUBSXIHFDHP-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
10352,6lzg,DB08538,-8.5,"N-((2-aminopyrimidin-5-yl)methyl)-5-(2,6-difluorophenyl)-3-ethylpyrazolo[1,5-a]pyrimidin-7-amine",HQPVGVSQPQVZLD-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
55530,6crv,DB01110,-8.5,Miconazole,BYBLEWFAAKGYCD-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
83258,6m3m,DB03656,-8.5,Tribenuron Methyl,VLCQZHSMCYCDJL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83236,6m3m,DB03626,-8.5,"5-Methoxy-1,2-Dimethyl-3-(Phenoxymethyl)Indole-4,7-Dione",JRPJCFILHCLEJI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
57297,6crv,DB03467,-8.5,Naringenin,FTVWIRXFELQLPI-ZDUSSCGKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
71874,6lxt,DB15456,-8.5,Vericiguat,QZFHIXARHDBPBY-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
163029,7bv1,DB03447,-8.5,Uridylyl-2'-5'-Phospho-Adenosine,QARCCHXXGAIRFS-KPKSGTNCSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
140599,6w9c,DB12512,-8.5,Verucerfont,VKHVAUKFLBBZFJ-SFHVURJKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
135921,6w9c,DB05738,-8.5,Vapitadine,VQWGYPVNVICKFC-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
125321,6w4h,DB02341,-8.5,"Mdl 101,146",XQAMVCHQGHAELT-YPAWHYETSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
55520,6crv,DB01098,-8.5,Rosuvastatin,BPRHUIZQVSMCRT-VEUZHWNKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
125312,6w4h,DB02331,-8.5,"(2s)-2-[(5-Benzofuran-2-Yl-Thiophen-2-Ylmethyl)-(2,4-Dichloro-Benzoyl)-Amino]-3-Phenyl-Propionic Acid",YBULOUKTPCHXAL-DEOSSOPVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
136928,6w9c,DB07702,-8.5,17alpha-Estriol,PROQIPRRNZUXQM-PNVOZDDCSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
164480,7bv1,DB08055,-8.5,"N-(2-chlorophenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine",NNBICZMPIJMWGC-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
127639,6w4h,DB06590,-8.5,Ceftaroline fosamil,ZCCUWMICIWSJIX-NQJJCJBVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
166501,7bv1,DB15254,-8.5,RO-5126766 free base,LMMJFBMMJUMSJS-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
11530,6lzg,DB12096,-8.5,PF-05175157,BDXXSFOJPYSYOC-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
55511,6crv,DB01089,-8.5,Deserpidine,CVBMAZKKCSYWQR-WCGOZPBSSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80483,6m2n,DB15449,-8.5,Citarinostat,VLIUIBXPEDFJRF-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
10321,6lzg,DB08504,-8.5,"6-(4-{(1S,2S)-2-AMINO-1-[(DIMETHYLAMINO)CARBONYL]-3-[(3S)-3-FLUOROPYRROLIDIN-1-YL]-3-OXOPROPYL}PHENYL)-1H-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-4-IUM",ZNHVIJAGMFQGMS-IHPCNDPISA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
109118,6vxx,DB12400,-8.5,Voxtalisib,RGHYDLZMTYDBDT-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
69848,6lxt,DB11789,-8.5,Hyodeoxycholic Acid,DGABKXLVXPYZII-SIBKNCMHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
125255,6w4h,DB02255,-8.5,GM6001,NITYDPDXAAFEIT-DYVFJYSZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
80490,6m2n,DB01532,-8.5,alpha-Methylacetylfentanyl,OKTLVZBUKMRPLL-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
69854,6lxt,DB11795,-8.5,GSK-2636771,XTKLTGBKIDQGQL-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
55519,6crv,DB01097,-8.5,Leflunomide,VHOGYURTWQBHIL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
135886,6w9c,DB05532,-8.5,BMS-488043,DBPMWRYLTBNCCE-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
106181,6vxs,DB15187,-8.5,Dubermatinib,YUAALFPUEOYPNX-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
80504,6m2n,DB04596,-8.5,"4-O-{4,6-O-[(1S)-1-Carboxyethylidene]-β-D-mannopyranosyl}-D-glucopyranuronic acid",GZJXZKGVHLWBOW-AISSFXTFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
135787,6w9c,DB04983,-8.5,Denufosol,FPNPSEMJLALQSA-MIYUEGBISA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137171,6w9c,DB07983,-8.5,1-(4-IODOBENZOYL)-5-METHOXY-2-METHYL INDOLE-3-ACETIC ACID,CXBFZYKAVCAPSV-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
162348,7bv1,DB01940,-8.5,Balanol Analog 2,SQLYTJZXRRDERK-ISKFKSNPSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
105729,6vxs,DB13927,-8.5,anle138b,RCQIIBJSUWYYFU-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
109446,6vxx,DB13586,-8.5,Metandienone,XWALNWXLMVGSFR-HLXURNFRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84096,6m3m,DB04768,-8.5,Pyrithiamine Pyrophosphate,ZHKSTKOYQKNDSJ-UHFFFAOYSA-O,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
27054,6cs2,DB00590,-8.5,Doxazosin,RUZYUOTYCVRMRZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
105099,6vxs,DB12998,-8.5,PF-00217830,QGNOXTFZOLDODX-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
105100,6vxs,DB12999,-8.5,MK-6186,FZBAOOQVQXATRL-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
135675,6w9c,DB04794,-8.5,Bifonazole,OCAPBUJLXMYKEJ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
80292,6m2n,DB15071,-8.5,Omidenepag isopropyl,VIQCWEGEHRBLAC-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
105096,6vxs,DB12988,-8.5,LY-518674,PNHFDVSKDSLUFH-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
27056,6cs2,DB06347,-8.5,Cenisertib,KSOVGRCOLZZTPF-QMKUDKLTSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
69231,6lxt,DB08875,-8.5,Cabozantinib,ONIQOQHATWINJY-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
127834,6w4h,DB06908,-8.5,"(2S)-3-(1-{[2-(2-CHLOROPHENYL)-5-METHYL-1,3-OXAZOL-4-YL]METHYL}-1H-INDOL-5-YL)-2-ETHOXYPROPANOIC ACID",PAWOPJKHTZCKMT-QFIPXVFZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
135677,6w9c,DB04796,-8.5,Inecalcitol,HHGRMHMXKPQNGF-WNSNRMDMSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
11775,6lzg,DB12415,-8.5,Galeterone,PAFKTGFSEFKSQG-PAASFTFBSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
140198,6w9c,DB15333,-8.5,AZD-1386,FPGNKXCEPARJDI-ZDUSSCGKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
127833,6w4h,DB06907,-8.5,"2-(2,6-DICHLOROPHENYL)-1,3-BENZOXAZOLE-6-CARBOXYLIC ACID",XVNRKPCHMYOPPL-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
140709,6w9c,DB15156,-8.5,ABT-072,XMZSTQYSBYEENY-RMKNXTFCSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
84084,6m3m,DB04750,-8.5,OREGON GREEN 488 CARBOXYLATE,BRJCLSQFZSHLRL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
69247,6lxt,DB08903,-8.5,Bedaquiline,QUIJNHUBAXPXFS-XLJNKUFUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
84100,6m3m,DB04772,-8.5,1-GUANIDINO-4-(N-PHENYLMETHANESULFONYL-L-LEUCYL-L-PROLYLAMINO)BUTANE,DSVCYWOHJLRGMK-PMACEKPBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58075,6crv,DB04518,-8.5,"3-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamino]-Phenol",JJDRRZFRTKZLFT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58173,6crv,DB04643,-8.5,"4-{3-CHLORO-4-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-PHENOXY}-BUTYRIC ACID",FYQVFMLCZJZZEM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58169,6crv,DB04639,-8.5,Biphenylalanine,JCZLABDVDPYLRZ-AWEZNQCLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
137167,6w9c,DB07977,-8.5,"3-({[3,5-DIFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)THIOPHENE-2-CARBOXYLIC ACID",CGNHUSCKOHDSMR-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
68977,6lxt,DB08557,-8.5,"2-[(2-methoxyethyl)amino]-4-(4-oxo-1,2,3,4-tetrahydro-9H-carbazol-9-yl)benzamide",XQKFKSJUBJPOLY-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
6760,6lzg,DB02651,-8.5,"{[2-(1h-1,2,3-Benzotriazol-1-Yl)-2-(3,4-Difluorophenyl)Propane-1,3-Diyl]Bis[4,1-Phenylene(Difluoromethylene)]}Bis(Phosphonic Acid)",BTAGTGWPDROBMG-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
114695,6vxx,DB14657,-8.5,Paramethasone acetate,HYRKAAMZBDSJFJ-LFDBJOOHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
124819,6w4h,DB01669,-8.5,Virginiamycin M1,DAIKHDNSXMZDCU-FQTGFAPKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
109452,6vxx,DB13596,-8.5,Oxycinchophen,XAPRFLSJBSXESP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
137142,6w9c,DB07949,-8.5,"({[(3E)-2'-OXO-2',7'-DIHYDRO-2,3'-BIINDOL-3(7H)-YLIDENE]AMINO}OXY)ACETIC ACID",BFQRPTKOSYMPOL-LALPNIDTSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
80271,6m2n,DB15033,-8.5,Flortaucipir,GETAAWDSFUCLBS-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
84149,6m3m,DB04833,-8.5,Methaqualone,JEYCTXHKTXCGPB-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
28258,6cs2,DB07839,-8.5,"N-2-1,3-BENZOXAZOL-2-YL-3-CYCLOHEXYL-N-{2-[(4-METHOXYPHENYL)AMINO]ETHYL}-L-ALANINAMIDE",VFNWTXUFNNOQHD-QFIPXVFZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
105002,6vxs,DB12848,-8.5,PF-04217903,PDMUGYOXRHVNMO-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
105005,6vxs,DB12854,-8.5,BMS-908662,MMNNTJYFHUDSKL-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
105019,6vxs,DB12877,-8.5,Oxatomide,BAINIUMDFURPJM-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
55286,6crv,DB00831,-8.5,Trifluoperazine,ZEWQUBUPAILYHI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109493,6vxx,DB13988,-8.5,SB-269970,HWKROQUZSKPIKQ-MRXNPFEDSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
162061,7bv1,DB01392,-8.5,Yohimbine,BLGXFZZNTVWLAY-SCYLSFHTSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
58041,6crv,DB04474,-8.5,1-Anilino-8-Naphthalene Sulfonate,FWEOQOXTVHGIFQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
124892,6w4h,DB01765,-8.5,"(5-Oxo-5,6-Dihydro-Indolo[1,2-a]Quinazolin-7-Yl)-Acetic Acid",INSBKYCYLCEBOD-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
72194,6m2n,DB00450,-8.5,Droperidol,RMEDXOLNCUSCGS-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
162278,7bv1,DB01836,-8.5,"[4-(6-Chloro-Naphthalene-2-Sulfonyl)-Piperazin-1-Yl]-(3,4,5,6-Tetrahydro-2h-[1,4']Bipyridinyl-4-Yl)-Methanone",ZLAKCKVFSRSENR-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
137045,6w9c,DB07834,-8.5,"N-(cyclopropylmethyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-4-carboxamide",FOHZGCHKLPIBBX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
28196,6cs2,DB07779,-8.5,N-({(2S)-1-[(3R)-3-AMINO-4-(2-FLUOROPHENYL)BUTANOYL]PYRROLIDIN-2-YL}METHYL)BENZAMIDE,ANQHSFFUNMTTRS-MOPGFXCFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
135757,6w9c,DB04898,-8.5,Ximelagatran,ZXIBCJHYVWYIKI-PZJWPPBQSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137042,6w9c,DB07831,-8.5,"2-{[(6-OXO-1,6-DIHYDROPYRIDIN-3-YL)METHYL]AMINO}-N-[4-PROPYL-3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE",SHSORWZDEKFFLP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
80359,6m2n,DB15204,-8.5,Fosravuconazole,SYTNEMZCCLUTNX-NPMXOYFQSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
57882,6crv,DB04254,-8.5,"8-Benzo[1,3]Dioxol-,5-Ylmethyl-9-Butyl-2-Fluoro-9h-Purin-6-Ylamine",ARWHTQLGMWHTAZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140223,6w9c,DB15393,-8.5,Telatinib,QFCXANHHBCGMAS-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
27133,6cs2,DB06533,-8.5,Ragaglitazar,WMUIIGVAWPWQAW-XMMPIXPASA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
83863,6m3m,DB04460,-8.5,(C8-S)-Hydantocidin 5'-Phosphate,MAXSFYCTFIBEAR-FUIMDIGMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
125023,6w4h,DB01948,-8.5,"1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperidin-4-Yl-3,4-Dihydroquinolin-2(1h)-One",VXIYTVJEIXMAQF-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
10231,6lzg,DB08406,-8.5,"[N-(2,4-DIAMINOPTERIDIN-6-YL)-METHYL]-DIBENZ[B,F]AZEPINE",NXCCIJQEAKMFGW-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
83842,6m3m,DB04430,-8.5,3-(4-Phenylamino-Phenylamino)-2-(1h-Tetrazol-5-Yl)-Acrylonitrile,FLPLCJJGNZGOAW-QXMHVHEDSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
55396,6crv,DB00955,-8.5,Netilmicin,CIDUJQMULVCIBT-MQDUPKMGSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127757,6w4h,DB06809,-8.5,Plerixafor,YIQPUIGJQJDJOS-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
55392,6crv,DB00950,-8.5,Fexofenadine,RWTNPBWLLIMQHL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28205,6cs2,DB07787,-8.5,"5-FLUORO-1-[4-(4-PHENYL-3,6-DIHYDROPYRIDIN-1(2H)-YL)BUTYL]QUINAZOLINE-2,4(1H,3H)-DIONE",PNPFDRCIGCUCMN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
105515,6vxs,DB13606,-8.5,Phenazocine,ZQHYKVKNPWDQSL-KNXBSLHKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
135749,6w9c,DB04885,-8.5,Cilansetron,NCNFDKWULDWJDS-OAHLLOKOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137087,6w9c,DB07882,-8.5,"4-{4-[2-(1A,7A-DIMETHYL-4-OXY-OCTAHYDRO-1-OXA-4-AZA-CYCLOPROPA[A]NAPHTHALEN-4-YL) -ACETYLAMINO]-PHENYLCARBAMOYL}-BUTYRIC ACID",VFIZFTGABDUGCF-UPVHCHBVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140706,6w9c,DB15149,-8.5,Futibatinib,KEIPNCCJPRMIAX-HNNXBMFYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
58007,6crv,DB04430,-8.5,3-(4-Phenylamino-Phenylamino)-2-(1h-Tetrazol-5-Yl)-Acrylonitrile,FLPLCJJGNZGOAW-QXMHVHEDSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109389,6vxx,DB13506,-8.5,Carfecillin,NZDASSHFKWDBBU-KVMCETHSSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
69346,6lxt,DB09034,-8.5,Suvorexant,JYTNQNCOQXFQPK-MRXNPFEDSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
162115,7bv1,DB01459,-8.5,Bezitramide,FLKWNFFCSSJANB-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
57967,6crv,DB04371,-8.5,AL6528,FBBLOSCXOZYUSS-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
137079,6w9c,DB07872,-8.5,5-chloro-N-[(3R)-1-(2-{[2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl]amino}-2-oxoethyl)pyrrolidin-3-yl]thiophene-2-carboxamide,IYGIXVNAMZPBDK-CQSZACIVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
57958,6crv,DB04357,-8.5,Pteric Acid,JOAQINSXLLMRCV-UHFFFAOYSA-O,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
11729,6lzg,DB12355,-8.5,Netazepide,YDZYKNJZCVIKPP-VWLOTQADSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
105289,6vxs,DB13307,-8.5,Proscillaridin,MYEJFUXQJGHEQK-ALRJYLEOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
11719,6lzg,DB12339,-8.5,Radezolid,BTTNOGHPGJANSW-IBGZPJMESA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
57893,6crv,DB04270,-8.5,(S)-3-(4-(2-Carbazol-9-Yl-Ethoxy)-Phenyl)-2-Ethoxy-Propionic Acid,WUZIMDSVRIBNNI-DEOSSOPVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140701,6w9c,DB15141,-8.5,Deutivacaftor,PURKAOJPTOLRMP-ASMGOKTBSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
105438,6vxs,DB13499,-8.5,Cefsulodin,SYLKGLMBLAAGSC-QLVMHMETSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
80343,6m2n,DB15170,-8.5,Evobrutinib,QUIWHXQETADMGN-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
27116,6cs2,DB06497,-8.5,Aplaviroc,GWNOTCOIYUNTQP-FQLXRVMXSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
137029,6w9c,DB07816,-8.5,N-(P-CYANOPHENYL)-N'-DIPHENYLMETHYL-GUANIDINE-ACETIC ACID,KGHMYJFHUHFOGL-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
104880,6vxs,DB12651,-8.5,Bardoxolone,TXGZJQLMVSIZEI-UQMAOPSPSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
133178,6w9c,DB01342,-8.5,Forasartan,YONOBYIBNBCDSJ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
65222,6lxt,DB02545,-8.5,Fexaramine,VLQTUNDJHLEFEQ-KGENOOAVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
62467,6crv,DB13617,-8.5,Clorexolone,VPMWFZKOWULPGT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
94969,6m71,DB08747,-8.5,"(11R)-10-acetyl-11-(2,4-dichlorophenyl)-6-hydroxy-3,3-dimethyl-2,3,4,5,10,11-hexahydro-1H-dibenzo[b,e][1,4]diazepin-1-one",JJTPPGUNMJMPLY-QFIPXVFZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
15762,6lzg,DB01100,-8.5,Pimozide,YVUQSNJEYSNKRX-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
120954,6w4b,DB09195,-8.5,Lorpiprazole,BNRMWKUVWLKDQJ-YJBOKZPZSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
62480,6crv,DB13635,-8.5,Tiracizine,KJAMZCVTJDTESW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
14104,6lzg,T3D3721,-8.5,Verrucarin B,WUZWNHCQLPXCLS-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
62481,6crv,DB13638,-8.5,Cefbuperazone,SMSRCGPDNDCXFR-CYWZMYCQSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
158117,7bv1,DB00398,-8.5,Sorafenib,MLDQJTXFUGDVEO-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
31296,6cs2,DB13649,-8.5,Proquazone,JTIGKVIOEQASGT-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
95036,6m71,DB08827,-8.5,Lomitapide,MBBCVAKAJPKAKM-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
113149,6vxx,DB08597,-8.5,"6-[4-(2-piperidin-1-ylethoxy)phenyl]-3-pyridin-4-ylpyrazolo[1,5-a]pyrimidine",XHBVYDAKJHETMP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62494,6crv,DB13656,-8.5,Eberconazole,MPTJIDOGFUQSQH-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
14094,6lzg,T3D3711,-8.5,Roridin E,KEEQQEKLEZRLDS-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
77237,6m2n,DB08130,-8.5,"N-(5-{3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]phenyl}-1,3,4-oxadiazol-2-yl)ethane-1,2-diamine",FPDWDLAITHFTTP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
131397,6w4h,DB13685,-8.5,Quingestanol,PCJFRMOEZQQSAX-AIOSZGMZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
77243,6m2n,DB08137,-8.5,(4E)-N-(4-fluorophenyl)-4-[(phenylcarbonyl)imino]-4H-pyrazole-3-carboxamide,ZMWYSLJBNJUCRK-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
95033,6m71,DB08822,-8.5,Azilsartan medoxomil,QJFSABGVXDWMIW-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
15755,6lzg,DB01070,-8.5,Dihydrotachysterol,ILYCWAKSDCYMBB-OPCMSESCSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
138743,6w9c,DB12207,-8.5,Verdinexor,OPAKEJZFFCECPN-XQRVVYSFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
62446,6crv,DB13591,-8.5,Metopimazine,BQDBKDMTIJBJLA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31113,6cs2,DB13422,-8.5,Nicofuranose,FUWFSXZKBMCSKF-ZASNTINBSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
129280,6w4h,DB08607,-8.5,"(5R)-5-(4-{[(2R)-6-HYDROXY-2,5,7,8-TETRAMETHYL-3,4-DIHYDRO-2H-CHROMEN-2-YL]METHOXY}BENZYL)-1,3-THIAZOLIDINE-2,4-DIONE",GXPHKUHSUJUWKP-NTKDMRAZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
77155,6m2n,DB08037,-8.5,"(2S)-4-(2,5-difluorophenyl)-N-[(3R,4S)-3-fluoro-1-methylpiperidin-4-yl]-2-(hydroxymethyl)-N-methyl-2-phenyl-2,5-dihydro-1H-pyrrole-1-carboxamide",MYBGWENAVMIGMM-GIFXNVAJSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
25420,6cs2,DB03337,-8.5,1-(2-Amidinophenyl)-3-(Phenoxyphenyl)Urea,ZHCAYBOLUMAUQX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
60566,6crv,DB08796,-8.5,Pipazethate,DTVJXCOMJLLMAK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29826,6cs2,DB11686,-8.5,Iferanserin,UXIPFQUBOVWAQW-UEBLJOKOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
120863,6w4b,DB09030,-8.5,Vorapaxar,ZBGXUVOIWDMMJE-QHNZEKIYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
29336,6cs2,DB09020,-8.5,Bisacodyl,KHOITXIGCFIULA-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
146802,6w9q,DB08995,-8.5,Diosmin,GZSOSUNBTXMUFQ-YFAPSIMESA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
87676,6m3m,DB12675,-8.5,PF-04995274,WLLOFQROROXOMO-GOSISDBHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
94801,6m71,DB08546,-8.5,"4-[(3AS,4R,7R,8AS,8BR)-2-(1,3-BENZODIOXOL-5-YLMETHYL)-7-HYDROXY-1,3-DIOXODECAHYDROPYRROLO[3,4-A]PYRROLIZIN-4-YL]BENZENECARBOXIMIDAMIDE",CETLUACQMGBMFH-ZALSBGIRSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94832,6m71,DB08584,-8.5,"6-{[6-(1-methyl-1H-pyrazol-4-yl)[1,2,4]triazolo[4,3-b]pyridazin-3-yl]sulfanyl}quinoline",BCZUAADEACICHN-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
29333,6cs2,DB09017,-8.5,Brotizolam,UMSGKTJDUHERQW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
114808,6vxx,DB14899,-8.5,Tavapadon,AKQXQLUNFKDZBN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60529,6crv,DB08753,-8.5,"4-{(1E)-3-OXO-3-[(2-PHENYLETHYL)AMINO]PROP-1-EN-1-YL}-1,2-PHENYLENE DIACETATE",GARHCDOTUULBOQ-PKNBQFBNSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
94891,6m71,DB08657,-8.5,2-(4-(2-((3-(5-(PYRIDIN-2-YLTHIO)THIAZOL-2-YL)UREIDO)METHYL)-1H-IMIDAZOL-4-YL)PHENOXY)ACETIC ACID,SSXCWVOQWRUMGN-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
113228,6vxx,DB08697,-8.5,"4-(2-aminoethoxy)-N-(3-chloro-5-piperidin-1-ylphenyl)-3,5-dimethylbenzamide",JDYIYIRPQKMWMM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31347,6cs2,DB13710,-8.5,Metenolone,ANJQEDFWRSLVBR-VHUDCFPWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
95064,6m71,DB08875,-8.5,Cabozantinib,ONIQOQHATWINJY-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
87592,6m3m,DB12545,-8.5,Indobufen,AYDXAULLCROVIT-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
131474,6w4h,DB13791,-8.5,Penfluridol,MDLAAYDRRZXJIF-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
87527,6m3m,DB12443,-8.5,Sonedenoson,WUCQGGOGHZRELS-LSCFUAHRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
77315,6m2n,DB08223,-8.5,"N-{(1S,2R)-1-BENZYL-3-[(CYCLOPROPYLMETHYL)(2-FURYLSULFONYL)AMINO]-2-HYDROXYPROPYL}-N'-METHYLSUCCINAMIDE",IKOPFHKAECNGQI-VQTJNVASSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
24234,6cs2,DB01938,-8.5,L-Histidine Beta Naphthylamide,DKDILZBBFKZMRO-OAHLLOKOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
75579,6m2n,DB04885,-8.5,Cilansetron,NCNFDKWULDWJDS-OAHLLOKOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77329,6m2n,DB08240,-8.5,N-(4-CHLOROPHENYL)-3-(PHOSPHONOOXY)NAPHTHALENE-2-CARBOXAMIDE,RQAQWBFHPMSXKR-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
95301,6m71,DB09231,-8.5,Benidipine,QZVNQOLPLYWLHQ-ZEQKJWHPSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
62592,6crv,DB13783,-8.5,Acemetacin,FSQKKOOTNAMONP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113082,6vxx,DB08353,-8.5,"2-(CYCLOHEXYLMETHYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE",NCVMTHVSAJMOPI-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
146423,6w9q,DB08512,-8.5,"6-amino-2-[(1-naphthylmethyl)amino]-3,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",MCEZMMDIEXECTI-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
113075,6vxx,DB08346,-8.5,"(5Z)-13-CHLORO-14,16-DIHYDROXY-3,4,7,8,9,10-HEXAHYDRO-1H-2-BENZOXACYCLOTETRADECINE-1,11(12H)-DIONE",YUZYDHRGGDTZLG-DUXPYHPUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113072,6vxx,DB08341,-8.5,"4-{[4-{[(1R,2R)-2-(dimethylamino)cyclopentyl]amino}-5-(trifluoromethyl)pyrimidin-2-yl]amino}-N-methylbenzenesulfonamide",CAUFYHKGKDJMQG-HZPDHXFCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
95415,6m71,DB11176,-8.5,Zeaxanthin,JKQXZKUSFCKOGQ-QAYBQHTQSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95438,6m71,DB11275,-8.5,Epicriptine,SBFXHXZNBNFPHV-PXXBSISHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
131724,6w4h,DB14581,-8.5,CPI-1205,HPODOLXTMDHLLC-QGZVFWFLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
129208,6w4h,DB08521,-8.5,4-[5-(4-FLUORO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-3H-IMIDAZOL-4-YL]-PYRIDINE,CDMGBJANTYXAIV-HHHXNRCGSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131731,6w4h,DB14625,-8.5,Meprednisone acetate,RZAMUHXEOMZXET-ABQXZQTJSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
60367,6crv,DB08560,-8.5,3-FLUORO-N-[1-(4-FLUOROPHENYL)-3-(2-THIENYL)-1H-PYRAZOL-5-YL]BENZENESULFONAMIDE,GULUFDCOGAXLEP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
14050,6lzg,T3D3667,-8.5,Cytochalasin B,GBOGMAARMMDZGR-LFKALUBKSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
165889,7bv1,DB13185,-8.5,Oxabolone cipionate,KHKDIUPVDIEHAH-KXLSUQFWSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
75580,6m2n,DB04886,-8.5,Calanolide A,NIDRYBLTWYFCFV-FMTVUPSXSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
29295,6cs2,DB08980,-8.5,Fendiline,NMKSAYKQLCHXDK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
95070,6m71,DB08883,-8.5,Perampanel,PRMWGUBFXWROHD-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95076,6m71,DB08896,-8.5,Regorafenib,FNHKPVJBJVTLMP-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
31388,6cs2,DB13756,-8.5,Peruvoside,PMTSPAGBAFCORP-HBUONDEYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
75614,6m2n,DB04971,-8.5,Reglitazar,QBQLYIISSRXYKL-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
60481,6crv,DB08704,-8.5,"[[(3R,4R,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-(pentanoylamino)oxan-2-ylidene]amino] N-phenylcarbamate",NUNQIQQEEPOGDJ-JDOAOKHLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
131556,6w4h,DB13939,-8.5,RAD-140,XMBUPPIEVAFYHO-KPZWWZAWSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
113120,6vxx,DB08560,-8.5,3-FLUORO-N-[1-(4-FLUOROPHENYL)-3-(2-THIENYL)-1H-PYRAZOL-5-YL]BENZENESULFONAMIDE,GULUFDCOGAXLEP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
129227,6w4h,DB08542,-8.5,"3,4-dihydroxy-9,10-secoandrosta-1(10),2,4-triene-9,17-dione",YUHVBHDSVLKFNI-NJSLBKSFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
14065,6lzg,T3D3682,-8.5,Dihydrocytochalasin B,ZFGBJIDXDYHNLX-RIYZIHGNSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
131567,6w4h,DB13953,-8.5,Estradiol benzoate,UYIFTLBWAOGQBI-BZDYCCQFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
95185,6m71,DB09048,-8.5,Netupitant,WAXQNWCZJDTGBU-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
62536,6crv,DB13710,-8.5,Metenolone,ANJQEDFWRSLVBR-VHUDCFPWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62542,6crv,DB13717,-8.5,Phenothrin,SBNFWQZLDJGRLK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
95200,6m71,DB09073,-8.5,Palbociclib,AHJRHEGDXFFMBM-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
131603,6w4h,DB14029,-8.5,Furafylline,HMZQULPVMKITSP-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
129220,6w4h,DB08534,-8.5,"5-(2-fluorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",ZAIYYXVHGBMLEC-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
62574,6crv,DB13759,-8.5,Fenpiverinium,QDIYJDPBMZUZEH-UHFFFAOYSA-O,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113102,6vxx,DB08539,-8.5,"3-cyclopropyl-5-phenyl-N-(pyridin-3-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",CCDIUVLNHCGSMH-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62621,6crv,DB13821,-8.5,Ceftezole,DZMVCVMFETWNIU-LDYMZIIASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62409,6crv,DB13540,-8.5,Isepamicin,UDIIBEDMEYAVNG-ZKFPOVNWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29343,6cs2,DB09034,-8.5,Suvorexant,JYTNQNCOQXFQPK-MRXNPFEDSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
130827,6w4h,DB12857,-8.5,NVP-LEQ-506,POERAARDVFVDLO-QGZVFWFLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
139330,6w9c,DB13327,-8.5,Picotamide,KYWCWBXGRWWINE-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
165984,7bv1,DB13327,-8.5,Picotamide,KYWCWBXGRWWINE-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
62242,6crv,DB13317,-8.5,Flunoxaprofen,ARPYQKTVRGFPIS-VIFPVBQESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75727,6m2n,DB05590,-8.5,Bedoradrine,OANCEOSLKSTLTA-REWPJTCUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
113403,6vxx,DB09124,-8.5,Medrogestone,HCFSGRMEEXUOSS-JXEXPEPMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
94323,6m71,DB07978,-8.5,"2-({[2,3,5,6-TETRAFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)CYCLOPENTA-1,3-DIENE-1-CARBOXYLIC ACID",ULMUPVXFUDHRGH-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
113424,6vxx,DB09175,-8.5,Mirfentanil,BJZZDOLVVLWFHN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
94334,6m71,DB07991,-8.5,N-[(1R)-3-(4-HYDROXYPHENYL)-1-METHYLPROPYL]-2-(2-PHENYL-1H-INDOL-3-YL)ACETAMIDE,APLJSSOXDWUNGV-GOSISDBHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94342,6m71,DB08000,-8.5,"2-(CARBOXYMETHYL)-1-OXO-1,2-DIHYDRONAPHTHO[1,2-D]ISOTHIAZOLE-4-CARBOXYLIC ACID 3,3-DIOXIDE",ZTJGXDGAXGWOGR-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
75714,6m2n,DB05524,-8.5,Pelitinib,WVUNYSQLFKLYNI-AATRIKPKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77062,6m2n,DB07934,-8.5,[[CYCLOHEXANESULFONYL-GLYCYL]-3[PYRIDIN-4-YL-AMINOMETHYL]ALANYL]PIPERIDINE,KMUXFASJKPVMGU-HXUWFJFHSA-O,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
62271,6crv,DB13351,-8.5,Piperidolate,KTHVBAZBLKXIHZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87828,6m3m,DB12921,-8.5,Chlorsulfaquinoxaline,CTSNHMQGVWXIEG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
62275,6crv,DB13355,-8.5,Visnadine,GVBNSPFBYXGREE-CXWAGAITSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
94351,6m71,DB08010,-8.5,"(3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-[(E)-2-phenylethenyl]-1H-indole-2,3-dione 3-oxime",DDHASJXGNUWZTM-ZLEWNXFRSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
113400,6vxx,DB09119,-8.5,Eslicarbazepine acetate,QIALRBLEEWJACW-INIZCTEOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113429,6vxx,DB09181,-8.5,Trefentanil,RJSCINHYBGMIFT-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
157399,6wiq,DB15328,-8.5,Ubrogepant,DDOOFTLHJSMHLN-ZQHRPCGSSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
94211,6m71,DB07848,-8.5,5-Chloro-N-{(3S)-1-[(2S)-1-(4-morpholinyl)-1-oxo-2-propanyl]-2-oxo-3-pyrrolidinyl}-1H-indole-2-sulfonamide,BHNMMFGOJRIAEZ-LRDDRELGSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
29412,6cs2,DB09166,-8.5,Etizolam,VMZUTJCNQWMAGF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
130749,6w4h,DB12725,-8.5,TD-8954,MZOITCJKGUIQEI-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
62193,6crv,DB13248,-8.5,Phthalylsulfathiazole,PBMSWVPMRUJMPE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76961,6m2n,DB07815,-8.5,GIBBERELLIN A4,RSQSQJNRHICNNH-NFMPGMCNSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
60801,6crv,DB09172,-8.5,Brifentanil,KKMGCTVJCQYQPV-WBVHZDCISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130762,6w4h,DB12744,-8.5,CGI-1842,ZXBFYBLSJMEBEP-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
94105,6m71,DB07728,-8.5,"2-[2-(2-FLUOROPHENYL)PYRIDIN-4-YL]-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE",XJJYJNMNYDNXNO-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
75751,6m2n,DB05738,-8.5,Vapitadine,VQWGYPVNVICKFC-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
130783,6w4h,DB12781,-8.5,Balaglitazone,IETKPTYAGKZLKY-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
8643,6lzg,DB06595,-8.5,Midostaurin,BMGQWWVMWDBQGC-IIFHNQTCSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
94168,6m71,DB07800,-8.5,N-(2-(((5-CHLORO-2-PYRIDINYL)AMINO)SULFONYL)PHENYL)-4-(2-OXO-1(2H)-PYRIDINYL)BENZAMIDE,MIJGLXFQYBTIFY-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
130790,6w4h,DB12794,-8.5,p-Quaterphenyl,GPRIERYVMZVKTC-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130791,6w4h,DB12796,-8.5,MRX-I,SULYVXZZUMRQAX-NSHDSACASA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
138796,6w9c,DB12279,-8.5,OBP-801,XFLBOEMFLGLWFF-HDXRNPEWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
60748,6crv,DB09063,-8.5,Ceritinib,VERWOWGGCGHDQE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
147195,6w9q,DB11526,-8.5,Masitinib,WJEOLQLKVOPQFV-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
130812,6w4h,DB12832,-8.5,Prednimustine,HFVNWDWLWUCIHC-GUPDPFMOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
94371,6m71,DB08031,-8.5,"N-[(13-CYCLOHEXYL-6,7-DIHYDROINDOLO[1,2-D][1,4]BENZOXAZEPIN-10-YL)CARBONYL]-2-METHYL-L-ALANINE",LNQWELVSNCYKDU-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
120589,6w4b,DB08674,-8.5,"(20S)-19,20,21,22-TETRAHYDRO-19-OXO-5H-18,20-ETHANO-12,14-ETHENO-6,10-METHENO-18H-BENZ[D]IMIDAZO[4,3-K][1,6,9,12]OXATRIAZA-CYCLOOCTADECOSINE-9-CARBONITRILE",USPFJPDEADLGIG-HSZRJFAPSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
113362,6vxx,DB09054,-8.5,Idelalisib,IFSDAJWBUCMOAH-HNNXBMFYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87812,6m3m,DB12896,-8.5,PSI-352938,PVRFQJIRERYGTQ-DSQUMVBZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
114579,6vxx,DB13816,-8.5,Aspoxicillin,BHELIUBJHYAEDK-OAIUPTLZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62356,6crv,DB13463,-8.5,Oxetorone,VZVRZTZPHOHSCK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60630,6crv,DB08896,-8.5,Regorafenib,FNHKPVJBJVTLMP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77109,6m2n,DB07988,-8.5,"2-[3-(5-MERCAPTO-[1,3,4]THIADIAZOL-2YL)-UREIDO]-N-METHYL-3-PENTAFLUOROPHENYL-PROPIONAMIDE",HZAXNPDJVFUGDS-BYPYZUCNSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77114,6m2n,DB07993,-8.5,"N-3-[3-(1H-INDOL-6-YL)BENZYL]PYRIDINE-2,3-DIAMINE",LPQUIIHPUGDHJK-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
87738,6m3m,DB12774,-8.5,AZD-8055,KVLFRAWTRWDEDF-IRXDYDNUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
29347,6cs2,DB09042,-8.5,Tedizolid phosphate,QCGUSIANLFXSGE-GFCCVEGCSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
60621,6crv,DB08880,-8.5,Teriflunomide,UTNUDOFZCWSZMS-YFHOEESVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
94663,6m71,DB08384,-8.5,2-({4-[4-(pyridin-4-ylmethyl)-1H-pyrazol-3-yl]phenoxy}methyl)quinoline,RQDDHVVAAJVVKM-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
113268,6vxx,DB08739,-8.5,"2-{3-[(2S)-4,4-difluoro-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]-3-oxopropyl}-isoindole-1,3(2H)-dione",ZSXNPAWXICXNGZ-HNNXBMFYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60607,6crv,DB08846,-8.5,Ellagic Acid,AFSDNFLWKVMVRB-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
146853,6w9q,DB09074,-8.5,Olaparib,FDLYAMZZIXQODN-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
75669,6m2n,DB05288,-8.5,Anecortave acetate,YUWPMEXLKGOSBF-GACAOOTBSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
94697,6m71,DB08426,-8.5,"THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [2-OXO-1-(1H-PYRROLO[2,3-C]PYRIDIN-2-YLMETHYL)-PYRROLIDIN-3-YL]-AMIDE",PLXOQMHGHDZMSX-AWEZNQCLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94707,6m71,DB08437,-8.5,Puromycin,RXWNCPJZOCPEPQ-NVWDDTSBSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60594,6crv,DB08833,-8.5,Taurochenodeoxycholic acid,BHTRKEVKTKCXOH-BJLOMENOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77142,6m2n,DB08023,-8.5,"N-cyclohexyl-4-imidazo[1,2-a]pyridin-3-yl-N-methylpyrimidin-2-amine",HYNNWLVWJXWXFO-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77105,6m2n,DB07984,-8.5,2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]-n-[(1S)-1-(hydroxymethyl)propyl]acetamide,GKJWXEORYGBJFS-KRWDZBQOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
94721,6m71,DB08454,-8.5,N-(5-METHYL-1H-PYRAZOL-3-YL)-2-PHENYLQUINAZOLIN-4-AMINE,JYCUVOXSZBECAY-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
138767,6w9c,DB12238,-8.5,MK-0777,QKIWQBLNTSQOLY-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
94594,6m71,DB08299,-8.5,"4-[8-(3-nitrophenyl)-1,7-naphthyridin-6-yl]benzoic acid",QTNUWEKKZHSUQO-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94383,6m71,DB08044,-8.5,ABT-341,NVVSPGQEXMJZIR-BMIGLBTASA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
24358,6cs2,DB02081,-8.5,Bis-Benzamidine,BXYGSMRTHHSAHZ-PMACEKPBSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
60690,6crv,DB08981,-8.5,Fenbufen,ZPAKPRAICRBAOD-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29372,6cs2,DB09079,-8.5,Nintedanib,XZXHXSATPCNXJR-ZIADKAODSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
62304,6crv,DB13396,-8.5,Neocitrullamon,PAJBBDCZSMDSFL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
120616,6w4b,DB08708,-8.5,"N-cyclohexyl-3-[3-(trifluoromethyl)phenyl][1,2,4]triazolo[4,3-b]pyridazin-6-amine",XYYDXQCAYXOGQT-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
62307,6crv,DB13399,-8.5,Terguride,JOAHPSVPXZTVEP-YXJHDRRASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29366,6cs2,DB09073,-8.5,Palbociclib,AHJRHEGDXFFMBM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
139370,6w9c,DB13374,-8.5,Vincamine,RXPRRQLKFXBCSJ-GIVPXCGWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
157711,6wiq,DB12323,-8.5,Radotinib,DUPWHXBITIZIKZ-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
139378,6w9c,DB13386,-8.5,Epimestrol,UHQGCIIQUZBJAE-RRQVMCLOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
87778,6m3m,DB12846,-8.5,Reproterol,WVLAAKXASPCBGT-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
29903,6cs2,DB00897,-8.5,Triazolam,JOFWLTCLBGQGBO-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
94548,6m71,DB08237,-8.5,2'-deoxy-N-(naphthalen-1-ylmethyl)guanosine 5'-(dihydrogen phosphate),COMPKRGNHXOXMN-GVDBMIGSSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
30987,6cs2,DB13276,-8.5,Idanpramine,HVYGXNYMNHSBGD-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
113348,6vxx,DB09021,-8.5,Benzoctamine,GNRXCIONJWKSEA-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
94558,6m71,DB08248,-8.5,3-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)-BENZENESULFONAMIDE,BKDUVKJYBJDZQW-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
77102,6m2n,DB07981,-8.5,2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]-n-[(1R)-1-(hydroxymethyl)propyl]acetamide,GKJWXEORYGBJFS-QGZVFWFLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138694,6w9c,DB12129,-8.5,Tideglusib,PMJIHLSCWIDGMD-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
62630,6crv,DB13835,-8.5,Caroverine,MSPRUJDUTKRMLM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62637,6crv,DB13842,-8.5,Etofylline nicotinate,ZWIAODBBEZGVPY-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62882,6crv,DB14653,-8.5,Clocortolone caproate,MMTRTBFDFNRBQO-ANHDKODLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
159084,7bv1,DB03124,-8.5,5-[4-(1-Carboxymethyl-2-Oxo-Propylcarbamoyl)-Benzylsulfamoyl]-2-Hydroxy-Benzoic Acid,LBAHOXPDTNUYCX-INIZCTEOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
112759,6vxx,DB07811,-8.5,"N-cyclopropyl-2',6-dimethyl-4'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-3-carboxamide",UBVTVSINEVHYSY-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77609,6m2n,DB08582,-8.5,"N-(4-bromo-2-{[(3R,5S)-3,5-dimethylpiperidin-1-yl]carbonyl}phenyl)-4-morpholin-4-yl-4-oxobutanamide",DELARNBPJXTDBD-IYBDPMFKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
159108,7bv1,DB03159,-8.5,CRA_8696,GAVRMVQHHVMXFD-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96304,6m71,DB12706,-8.5,Seletalisib,LNLJHGXOFYUARS-OAQYLSRUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
87194,6m3m,DB11966,-8.5,BMS-986094,YFXGICNMLCGLHJ-RSKRLRQZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87208,6m3m,DB11990,-8.5,MK-0812,UNVWTBOGMHPKJM-CWKRKGSWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
77630,6m2n,DB08609,-8.5,"(2R)-N-{4-[Ethyl(phenyl)sulfamoyl]-2-methylphenyl}-3,3,3-trifluoro-2-hydroxy-2-methylpropanamide",SHEIQJGQDUYUBE-GOSISDBHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
159129,7bv1,DB03186,-8.5,U-Pi-a-Pi,JIAJERGOUFOENU-LNAOLWRRSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60059,6crv,DB08179,-8.5,"methyl 4-(2,3-dihydroxy-5-methylphenoxy)-2-hydroxy-6-methylbenzoate",BLXSEOJIXHWXQJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60057,6crv,DB08177,-8.5,(E)-3-(5((5-(4-CHLOROPHENYL)FURAN-2-YL)METHYLENE)-4-OXO-2-THIOXOTHIAZOLIDIN-3-YL)PROPANOIC ACID,YZLFZFALAZYTCI-NTEUORMPSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
96391,6m71,DB12848,-8.5,PF-04217903,PDMUGYOXRHVNMO-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
145852,6w9q,DB07834,-8.5,"N-(cyclopropylmethyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-4-carboxamide",FOHZGCHKLPIBBX-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
96394,6m71,DB12854,-8.5,BMS-908662,MMNNTJYFHUDSKL-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
132003,6w4h,DB15191,-8.5,MAX-40279,AVIOBQFPAGEICQ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
87189,6m3m,DB11961,-8.5,AZD-1236,SFJFBTPHDHUUPU-OAHLLOKOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
96258,6m71,DB12635,-8.5,Aleplasinin,HSXLMAFNWCSZGP-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96232,6m71,DB12588,-8.5,AZD-1480,PDOQBOJDRPLBQU-QMMMGPOBSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60110,6crv,DB08246,-8.5,"(2S)-4-(2,5-DIFLUOROPHENYL)-N,N-DIMETHYL-2-PHENYL-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDE",WFFMEXQHWXEKBV-SFHVURJKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75359,6m2n,DB04596,-8.5,"4-O-{4,6-O-[(1S)-1-Carboxyethylidene]-??-D-mannopyranosyl}-D-glucopyranuronic acid",GZJXZKGVHLWBOW-AISSFXTFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
25678,6cs2,DB03672,-8.5,9-N-Phenylmethylamino-Tacrine,JYJAEHAURXXPSD-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
77573,6m2n,DB08539,-8.5,"3-cyclopropyl-5-phenyl-N-(pyridin-3-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",CCDIUVLNHCGSMH-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
96158,6m71,DB12474,-8.5,Lynestrenol,YNVGQYHLRCDXFQ-XGXHKTLJSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
87238,6m3m,DB12039,-8.5,Epicatechin,PFTAWBLQPZVEMU-UKRRQHHQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
96169,6m71,DB12491,-8.5,Fasiglifam,BZCALJIHZVNMGJ-HSZRJFAPSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60142,6crv,DB08292,-8.5,"(5Z)-12-CHLORO-13,15-DIHYDROXY-4,7,8,9-TETRAHYDRO-2-BENZOXACYCLOTRIDECINE-1,10(3H,11H)-DIONE",AQKZYZQONWDDLS-IWQZZHSRSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62867,6crv,DB14637,-8.5,Fluprednisolone acetate,CYMBAKFTWRNHPS-APRQOCPKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
131962,6w4h,DB15108,-8.5,Tipranavir C-14,SUJUHGSWHZTSEU-MWQIXQBFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
96188,6m71,DB12522,-8.5,Toreforant,FCRFVPZAXGJLPW-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96196,6m71,DB12535,-8.5,AC-430,DCRWIATZWHLIPN-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
75352,6m2n,DB04583,-8.5,"5-Carbamoyl-1,1':4',1''-terphenyl-3-carboxylic acid",LAZPCGBRHLARSI-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
145972,6w9q,DB07975,-8.5,"2-({[3,5-DIFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)CYCLOPENT-1-ENE-1-CARBOXYLIC ACID",VTGXLCZUWFYELR-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
62871,6crv,DB14641,-8.5,Estriol tripropionate,ONMZMZJEZHMWQL-REUUDLSRSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75351,6m2n,DB04582,-8.5,IMAZAQUIN,CABMTIJINOIHOD-QGZVFWFLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
131969,6w4h,DB15121,-8.5,AT-001,YRGPAXAVTDMKDK-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
77591,6m2n,DB08560,-8.5,3-FLUORO-N-[1-(4-FLUOROPHENYL)-3-(2-THIENYL)-1H-PYRAZOL-5-YL]BENZENESULFONAMIDE,GULUFDCOGAXLEP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
129034,6w4h,DB08309,-8.5,3-({2-[(4-{[6-(CYCLOHEXYLMETHOXY)-9H-PURIN-2-YL]AMINO}PHENYL)SULFONYL]ETHYL}AMINO)PROPAN-1-OL,AMFGILNPFBVREA-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
112737,6vxx,DB07788,-8.5,"(3R,5Z,8S,9S,11E)-8,9,16-TRIHYDROXY-14-METHOXY-3-METHYL-3,4,9,10-TETRAHYDRO-1H-2-BENZOXACYCLOTETRADECINE-1,7(8H)-DIONE",NEQZWEXWOFPKOT-QHSZRYGNSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112733,6vxx,DB07783,-8.5,1-((1R)-1-(HYDROXYMETHYL)-3-{6-[(3-PHENYLPROPANOYL)AMINO]-1H-INDOL-1-YL}PROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE,GUYYFMCFEPDDFL-OAQYLSRUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112726,6vxx,DB07775,-8.5,"3',5'-DIBROMO-2',4,4',6'-TETRAHYDROXY AURONE",BRPKBUNFOZFULQ-SGAXSIHGSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77801,6m2n,DB08807,-8.5,Bopindolol,UUOJIACWOAYWEZ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
59988,6crv,DB08104,-8.5,"N-(3,5-dibromo-4-hydroxyphenyl)benzamide",HKODPZBPODONGO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112614,6vxx,DB07457,-8.5,"3-[1-(3-AMINOPROPYL)-1H-INDOL-3-YL]-4-(1H-INDOL-3-YL)-1H-PYRROLE-2,5-DIONE",APYXQTXFRIDSGE-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59983,6crv,DB08099,-8.5,"6-ethyl-5-[(2S)-1-(3-methoxypropyl)-2-phenyl-1,2,3,4-tetrahydroquinolin-7-yl]pyrimidine-2,4-diamine",UOYVKYJWAXJTTE-NRFANRHFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31912,6cs2,DB15028,-8.5,MK-1064,CKTWQGHVNRYNCM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
128981,6w4h,DB08240,-8.5,N-(4-CHLOROPHENYL)-3-(PHOSPHONOOXY)NAPHTHALENE-2-CARBOXAMIDE,RQAQWBFHPMSXKR-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
97044,6m71,DB13791,-8.5,Penfluridol,MDLAAYDRRZXJIF-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
132124,6w4h,DB15431,-8.5,M-2698,HXAUJHZZPCBFPN-QGZVFWFLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
132132,6w4h,DB15446,-8.5,Vidofludimus,XPRDUGXOWVXZLL-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
59955,6crv,DB08068,-8.5,N-[4-CHLORO-3-(PYRIDIN-3-YLOXYMETHYL)-PHENYL]-3-FLUORO-,YQJVDUKATDECHF-ICSRJNTNSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87060,6m3m,DB11774,-8.5,Pazufloxacin,XAGMUUZPGZWTRP-ZETCQYMHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59949,6crv,DB08059,-8.5,Wortmannin,QDLHCMPXEPAAMD-QAIWCSMKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
132147,6w4h,DB02639,-8.5,4-methylumbelliferyl alpha-D-glucoside,YUDPTGPSBJVHCN-JZYAIQKZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
87052,6m3m,DB11764,-8.5,Spebrutinib,KXBDTLQSDKGAEB-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87051,6m3m,DB11763,-8.5,Momelotinib,ZVHNDZWQTBEVRY-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
138549,6w9c,DB11824,-8.5,Tofogliflozin,VWVKUNOPTJGDOB-BDHVOXNPSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
145480,6w9q,DB07397,-8.5,"(5S)-5-(2-amino-2-oxoethyl)-4-oxo-N-[(3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl)methyl]-3,4,5,6,7,8-hexahydro[1]benzothieno[2,3-d]pyrimidine-2-carboxamide",ITADELAVAWJACR-NSHDSACASA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
112623,6vxx,DB07469,-8.5,"(3aS)-3a-hydroxy-7-methyl-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one",KAJFGRLMKVNMLH-GOSISDBHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
129108,6w4h,DB08400,-8.5,4-(3-{[5-(trifluoromethyl)pyridin-2-yl]oxy}benzyl)piperidine-1-carboxylic acid,KUEKMTNOUPAOBS-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
96827,6m71,DB13499,-8.5,Cefsulodin,SYLKGLMBLAAGSC-QLVMHMETSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
8976,6lzg,DB07041,-8.5,"N-[2-(2,4-diaminopyrido[2,3-d]pyrimidin-7-yl)-2-methylpropyl]-4-phenoxybenzamide",FDJWFDQRPKKBFA-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
139570,6w9c,DB13651,-8.5,Lorajmine,LAHDERDHXJFFJU-ZWNKPRIXSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
132019,6w4h,DB15219,-8.5,Tomivosertib,HKTBYUWLRDZAJK-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
138609,6w9c,DB11912,-8.5,Lanopepden,SWHNZGMQMGFQGW-MSOLQXFVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
121617,6w4b,DB12154,-8.5,Itacitinib,KTBSXLIQKWEBRB-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
62921,6crv,DB14725,-8.5,Cefamandole nafate,RRJHESVQVSRQEX-SUYBPPKGSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62925,6crv,DB14734,-8.5,Cannabigerol,QXACEHWTBCFNSA-SFQUDFHCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62938,6crv,DB14765,-8.5,Rivoceranib,WPEWQEMJFLWMLV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
24050,6cs2,DB01708,-8.5,Prasterone,FMGSKLZLMKYGDP-USOAJAOKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
121658,6w4b,DB12221,-8.5,Canrenone,UJVLDDZCTMKXJK-WNHSNXHDSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
60029,6crv,DB08148,-8.5,"1-[4-(4-chlorophenyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine",QOZMRRGNAZNWDN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
145725,6w9q,DB07691,-8.5,"2-({[3-(3,4-dihydroisoquinolin-2(1H)-ylsulfonyl)phenyl]carbonyl}amino)benzoic acid",GYILVHHTCYNIOS-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
138589,6w9c,DB11886,-8.5,Infigratinib,QADPYRIHXKWUSV-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
212,6lzg,HMDB0003415,-8.5,"(3R,3'S,6'R)-b,e-Carotene-3,3'-diol",KBPHJBAIARWVSC-IRHPOQNPSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
112660,6vxx,DB07513,-8.5,7-[(3-CHLOROBENZYL)OXY]-4-[(METHYLAMINO)METHYL]-2H-CHROMEN-2-ONE,JMGUSOLCNQVZCT-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165729,7bv1,DB12720,-8.5,Nivocasan,VYFGDLGHHBUDTQ-ZLGUVYLKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
159291,7bv1,DB03944,-8.5,"5-[1-(3,4-Dimethoxy-Benzoyl)-1,2,3,4-Tetrahydro-Quinolin-6-Yl]-6-Methyl-3,6-Dihydro-[1,3,4]Thiadiazin-2-One",IZLRMTJLQCLMKF-CYBMUJFWSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60006,6crv,DB08123,-8.5,"N-METHYL-{4-[2-(7-OXO-6,7-DIHYDRO-8H-[1,3]THIAZOLO[5,4-E]INDOL-8-YLIDENE)HYDRAZINO]PHENYL}METHANESULFONAMIDE",GEWPSTLKJDIUHW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
159336,7bv1,DB04006,-8.5,"[2-Amino-6-(2,6-Difluoro-Benzoyl)-Imidazo[1,2-a]Pyridin-3-Yl]-Phenyl-Methanone",WUGJIPFLBOATGL-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
129112,6w4h,DB08406,-8.5,"[N-(2,4-DIAMINOPTERIDIN-6-YL)-METHYL]-DIBENZ[B,F]AZEPINE",NXCCIJQEAKMFGW-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
146003,6w9q,DB08010,-8.5,"(3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-[(E)-2-phenylethenyl]-1H-indole-2,3-dione 3-oxime",DDHASJXGNUWZTM-ZLEWNXFRSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
5594,6lzg,HMDB0061196,-8.5,Angiotensin I,ORWYRWWVDCYOMK-HBZPZAIKSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
8092,6lzg,DB04759,-8.5,"PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-(3-METHYL-BENZYLAMIDE)",GTBUZLPQANSGGE-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
75502,6m2n,DB04791,-8.5,"2-O-(4'-AMIDINOPHENYL)-5-O-(3''-AMIDINOPHENYL)-1,4:3,6-DIANHYDRO-D-SORBITOL",DKBAWRNTUZFJKV-BSDSXHPESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
95702,6m71,DB11818,-8.5,Retosiban,PLVGDGRBPMVYPB-FDUHJNRSSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
62707,6crv,DB13988,-8.5,SB-269970,HWKROQUZSKPIKQ-MRXNPFEDSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87403,6m3m,DB12275,-8.5,Seviteronel,ZBRAJOQFSNYJMF-SFHVURJKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
137900,6w9c,DB08860,-8.5,Pitavastatin,VGYFMXBACGZSIL-MCBHFWOFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
112911,6vxx,DB08141,-8.5,"4-{[(2,6-difluorophenyl)carbonyl]amino}-N-[(3S)-piperidin-3-yl]-1H-pyrazole-3-carboxamide",KOMNQBZWMCFDTQ-VIFPVBQESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138667,6w9c,DB12095,-8.5,Telotristat ethyl,MDSQOJYHHZBZKA-GBXCKJPGSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
165838,7bv1,DB13089,-8.5,Enoxolone,MPDGHEJMBKOTSU-YKLVYJNSSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
87389,6m3m,DB12254,-8.5,ABT-751,URCVCIZFVQDVPM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
121411,6w4b,DB11851,-8.5,Bafetinib,ZGBAJMQHJDFTQJ-DEOSSOPVSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
138659,6w9c,DB12081,-8.5,Anecortave,BCFCRXOJOFDUMZ-ONKRVSLGSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
60265,6crv,DB08442,-8.5,"4-{[(2R)-2-(2-methylphenyl)pyrrolidin-1-yl]carbonyl}benzene-1,3-diol",TWODFUZHWYZBHZ-MRXNPFEDSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114465,6vxx,DB13667,-8.5,Cefozopran,QDUIJCOKQCCXQY-WHJQOFBOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112894,6vxx,DB08122,-8.5,"N-METHYL-4-{[(2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]AMINO}BENZENESULFONAMIDE",IKASAFLVQIJQOK-UVTDQMKNSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
95788,6m71,DB11943,-8.5,Delafloxacin,DYDCPNMLZGFQTM-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
87372,6m3m,DB12233,-8.5,Iguratimod,ANMATWQYLIFGOK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
29998,6cs2,DB11912,-8.5,Lanopepden,SWHNZGMQMGFQGW-MSOLQXFVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
87370,6m3m,DB12230,-8.5,Bunazosin,RHLJLALHBZGAFM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87418,6m3m,DB12293,-8.5,Nefopam,RGPDEAGGEXEMMM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
8093,6lzg,DB04760,-8.5,"PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-(4-FLUORO-3-METHYL-BENZYLAMIDE)",PYFRREJCFXFNRR-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
169,6lzg,HMDB0003233,-8.5,Lutein,KBPHJBAIARWVSC-RTIVXWJOSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
62649,6crv,DB13855,-8.5,Nifuroxazide,YCWSUKQGVSGXJO-NTUHNPAUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
25555,6cs2,DB03507,-8.5,"6-[3-(4-Morpholinyl)Propyl]-2-(3-Nitrophenyl)-5-Thioxo-5,6,-Dihydro-7h-Thienol[2',3':4,5]Pyrrolo[1,2-C]Imidazol-7-One",UXGUZFZBZPPZGL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
113014,6vxx,DB08267,-8.5,"6-amino-4-(2-phenylethyl)-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",PBZAIUVFRISTSZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77409,6m2n,DB08345,-8.5,"4-(2-(1H-IMIDAZOL-4-YL)ETHYLAMINO)-2-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE",IWUUKHQIKFHWIW-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
121307,6w4b,DB11697,-8.5,Pacritinib,HWXVIOGONBBTBY-ONEGZZNKSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
146224,6w9q,DB08268,-8.5,"6-AMINO-4-[2-(4-METHYLPHENYL)ETHYL]-1,7-DIHYDRO-8H-IMIDAZO[4,5-G]QUINAZOLIN-8-ONE",SPVJRTJUEVXOMS-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
29249,6cs2,DB08930,-8.5,Dolutegravir,RHWKPHLQXYSBKR-BMIGLBTASA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
31583,6cs2,DB14067,-8.5,Dofequidar,KLWUUPVJTLHYIM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
31626,6cs2,DB14152,-8.5,Ginsenosides,NLHQJXWYMZLQJY-SWIZOJJJSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
77438,6m2n,DB08379,-8.5,6-(4-chloro-2-fluoro-3-phenoxybenzyl)pyridazin-3(2H)-one,NOVPOXGMADEKPP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
95667,6m71,DB11769,-8.5,Funapide,NEBUOXBYNAHKFV-NRFANRHFSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
75503,6m2n,DB04792,-8.5,"2,5-O,O-BIS-{4',4''-AMIDINOPHENYL}-1,4:3,6-DIANHYDRO-D-SORBITOL",CDEVHSIVANGYRI-XMTFNYHQSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77440,6m2n,DB08383,-8.5,"4,5-bis(4-methoxyphenyl)-2-thiophen-2-yl-1H-imidazole",XBMULXNXJLWLLD-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
129191,6w4h,DB08500,-8.5,"(3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(2-naphthyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol",ZCJBDRSKHARECB-PYTCMNEWSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
129190,6w4h,DB08499,-8.5,"N-[3-(2-fluoroethoxy)phenyl]-N'-(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-6-yl)butanediamide",DQXBKUVWJSZHSI-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
121364,6w4b,DB11786,-8.5,Pefcalcitol,SVCSMAZYWOQCBW-NVJMFHFGSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
95688,6m71,DB11796,-8.5,Fostemsavir,SWMDAPWAQQTBOG-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60803,6crv,DB09174,-8.5,Lofentanil,IMYHGORQCPYVBZ-NLFFAJNJSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138650,6w9c,DB12068,-8.5,T-900607,FSXLOWIFSZNIMV-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
112885,6vxx,DB08112,-8.5,N-({6-[(4-CYANO-2-FLUOROBENZYL)OXY]NAPHTHALEN-2-YL}SULFONYL)-D-GLUTAMIC ACID,IRJUSGUHNFMVCK-OAQYLSRUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
95974,6m71,DB12222,-8.5,Lurtotecan,RVFGKBWWUQOIOU-NDEPHWFRSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95995,6m71,DB12247,-8.5,AZD-4547,VRQMAABPASPXMW-HDICACEKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
62779,6crv,DB14129,-8.5,Macelignan,QDDILOVMGWUNGD-UONOGXRCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
96012,6m71,DB12272,-8.5,Vidupiprant,PFWVGKROPKKEDW-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
131912,6w4h,DB15009,-8.5,PF-04937319,MASKQITXHVYVFL-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
62803,6crv,DB14196,-8.5,"N-Cyclohexyl-N'-phenyl-1,4-phenylenediamine",ZRMMVODKVLXCBB-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
96018,6m71,DB12280,-8.5,AZD-5423,FCNQMDSJHADDFT-WNSKOXEYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
75397,6m2n,DB04643,-8.5,"4-{3-CHLORO-4-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-PHENOXY}-BUTYRIC ACID",FYQVFMLCZJZZEM-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
96031,6m71,DB12297,-8.5,GLPG-0187,CXHCNOMGODVIKB-VWLOTQADSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
158972,7bv1,DB02704,-8.5,"(2r,3r,4r,5r)-3,4-Dihydroxy-N,N'-Bis[(1s,2r)-2-Hydroxy-2,3-Dihydro-1h-Inden-1-Yl]-2,5-Bis(2-Phenylethyl)Hexanediamide",GQKBYZPVKVXMJL-LAFNQVRVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
131922,6w4h,DB15031,-8.5,Nemorexant,NBGABHGMJVIVBW-QHCPKHFHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
29189,6cs2,DB08833,-8.5,Taurochenodeoxycholic acid,BHTRKEVKTKCXOH-BJLOMENOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
75396,6m2n,DB04642,-8.5,"7-{2,6-DICHLORO-4-[3-(2-CHLORO-BENZOYL)-UREIDO]-PHENOXY}-HEPTANOIC ACID",XQTOWNDCHQJXOQ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
60170,6crv,DB08322,-8.5,"2-DEOXY-3,4-BIS-O-[3-(4-HYDROXYPHENYL)PROPANOYL]-L-THREO-PENTARIC ACID",VJLMRHSHSNLOGC-NOPZTHQXSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
96063,6m71,DB12339,-8.5,Radezolid,BTTNOGHPGJANSW-IBGZPJMESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
87263,6m3m,DB12072,-8.5,Orantinib,NHFDRBXTEDBWCZ-ZROIWOOFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87261,6m3m,DB12070,-8.5,Letermovir,FWYSMLBETOMXAG-QHCPKHFHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
112828,6vxx,DB07891,-8.5,"4-{[(14beta,17alpha)-3-hydrox1tra-1,3,5(10)-trien-17-yl]oxy}-4-oxobutanoic acid",YJPIDPAGJSWWBE-FNIAAEIWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31703,6cs2,DB14626,-8.5,Pregnenolone acetate,CRRKVZVYZQXICQ-RJJCNJEVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
95964,6m71,DB12207,-8.5,Verdinexor,OPAKEJZFFCECPN-XQRVVYSFSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95923,6m71,DB12141,-8.5,Gilteritinib,GYQYAJJFPNQOOW-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
24153,6cs2,DB01830,-8.5,"{4-[2-Acetylamino-2-(3-Carbamoyl-2-Cyclohexylmethoxy-6,7,8,9-Tetrahydro-5h-Benzocyclohepten-5ylcarbamoyl)-Ethyl]-2-Phosphono-Phenyl}-Phosphonic Acid",SPSGYTWOIGAABK-DQEYMECFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
75450,6m2n,DB04716,-8.5,"2-(1,1-DIMETHYLETHYL)9-FLUORO-3,6-DIHYDRO-7H-BENZ[H]-IMIDAZ[4,5-F]ISOQUINOLIN-7-ONE",VNDWQCSOSCCWIP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
95817,6m71,DB11987,-8.5,GSK-2018682,NFIGDBFIDKDNIG-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
158748,7bv1,DB02164,-8.5,N-Sulfo-Flavin Mononucleotide,ZLPUGFBBLGQWBS-SCRDCRAPSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
87351,6m3m,DB12204,-8.5,Terbogrel,XUTLOCQNGLJNSA-RGVLZGJSSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
95827,6m71,DB12002,-8.5,AZD-4818,HVTUHSABWJPWNK-SFHVURJKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
139518,6w9c,DB13579,-8.5,Mepixanox,PYSOHOOUXFWCFF-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
158771,7bv1,DB02197,-8.5,"4-[(4-Imidazo[1,2-a]Pyridin-3-Ylpyrimidin-2-Yl)Amino]Benzenesulfonamide",NKORVPQBJCGYEC-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60225,6crv,DB08392,-8.5,"2-[5,6-BIS-(4-METHOXY-PHENYL)-FURO[2,3-D]PYRIMIDIN-4-YLAMINO]-ETHANOL",ARBUGBBNEFAECO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77526,6m2n,DB08487,-8.5,3-({4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-2-OXOPIPERAZIN-1-YL}METHYL)BENZENECARBOXIMIDAMIDE,PRMSFVUWLBPPLY-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
158834,7bv1,DB02519,-8.5,Indirubin-5-Sulphonate,IHBOEHLUIBMBMY-YPKPFQOOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
87325,6m3m,DB12161,-8.5,Deutetrabenazine,MKJIEFSOBYUXJB-WEZHFFAMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
158837,7bv1,DB02524,-8.5,"2',3'-O-{4-[Hydroxy(oxido)-??5-azanylidene]-2,6-dinitro-2,5-cyclohexadiene-1,1-diyl}adenosine 5'-(tetrahydrogen triphosphate)",XFMMHXLUHKBKQE-UHEGPQQHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60214,6crv,DB08379,-8.5,6-(4-chloro-2-fluoro-3-phenoxybenzyl)pyridazin-3(2H)-one,NOVPOXGMADEKPP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
95905,6m71,DB12116,-8.5,Epigallocatechin gallate,WMBWREPUVVBILR-WIYYLYMNSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
131888,6w4h,DB14929,-8.5,Elsulfavirine,ULTDEARCBRNRGR-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
95916,6m71,DB12130,-8.5,Lorlatinib,IIXWYSCJSQVBQM-LLVKDONJSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95960,6m71,DB12200,-8.5,Tivantinib,UCEQXRCJXIVODC-PMACEKPBSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
166061,7bv1,DB13640,-8.5,Acetoxolone,FTQDJVZNPJRVPG-XWEVEMRCSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
87935,6m3m,DB13083,-8.5,Talarozole,SNFYYXUGUBUECJ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
60811,6crv,DB09183,-8.5,Dasabuvir,NBRBXGKOEOGLOI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
149576,6wiq,DB00324,-8.5,Fluorometholone,FAOZLTXFLGPHNG-KNAQIMQKSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
76448,6m2n,DB07217,-8.5,"N-(3-cyano-4,5,6,7-tetrahydro-1-benzothien-2-yl)-2-fluorobenzamide",YVYPYORTKAIUGJ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
130256,6w4h,DB12001,-8.5,Abemaciclib,UZWDCWONPYILKI-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
113918,6vxx,DB12273,-8.5,Ecopipam,DMJWENQHWZZWDF-PKOBYXMFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138986,6w9c,DB12670,-8.5,Rolofylline,PJBFVWGQFLYWCB-QUYAXPHCSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
129615,6w4h,DB09048,-8.5,Netupitant,WAXQNWCZJDTGBU-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
147937,6w9q,DB12673,-8.5,ATX-914,ALANRBCCCQEPFZ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
61823,6crv,DB12651,-8.5,Bardoxolone,TXGZJQLMVSIZEI-UQMAOPSPSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
91175,6m71,DB02705,-8.5,"6-[N-(1-Isopropyl-1,2,3,4-Tetrahydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine",DARQQJKHXPXSRO-QFIPXVFZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
149933,6wiq,DB00762,-8.5,Irinotecan,UWKQSNNFCGGAFS-XIFFEERXSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
91190,6m71,DB02723,-8.5,"4-Oxo-2-Phenylmethanesulfonyl-Octahydro-Pyrrolo[1,2-a]Pyrazine-6-Carboxylic Acid [1-(N-Hydroxycarbamimidoyl)-Piperidin-4-Ylmethyl]-Amide",DHTSUHWLPAEEQB-OALUTQOASA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
30436,6cs2,DB12477,-8.5,Perfluoro tert-butylcyclohexane,VLTXBOGHSBHSAC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
130278,6w4h,DB12036,-8.5,Naquotinib,QKDCLUARMDUUKN-XMMPIXPASA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130281,6w4h,DB12041,-8.5,Mapracorat,VJGFOYBQOIPQFY-XMMPIXPASA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
150250,6wiq,DB01126,-8.5,Dutasteride,JWJOTENAMICLJG-QWBYCMEYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
76048,6m2n,DB06710,-8.5,Methyltestosterone,GCKMFJBGXUYNAG-HLXURNFRSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
14734,6lzg,T3D4673,-8.5,Adapalene,LZCDAPDGXCYOEH-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
138990,6w9c,DB12675,-8.5,PF-04995274,WLLOFQROROXOMO-GOSISDBHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
130244,6w4h,DB11984,-8.5,Letaxaban,GEHAEMCVKDPMKO-HXUWFJFHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
118571,6w4b,DB05263,-8.5,Caprospinol,VMOZFSWFUBLCNN-AAPULDEBSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
166409,7bv1,DB15075,-8.5,4-demethyl-4-cholesteryloxycarbonylpenclomedine,ZJUUIXYKTPSIOH-LEZJFEBPSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
24890,6cs2,DB02704,-8.5,"(2r,3r,4r,5r)-3,4-Dihydroxy-N,N'-Bis[(1s,2r)-2-Hydroxy-2,3-Dihydro-1h-Inden-1-Yl]-2,5-Bis(2-Phenylethyl)Hexanediamide",GQKBYZPVKVXMJL-LAFNQVRVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
148006,6w9q,DB12784,-8.5,NS-018,UQTPDWDAYHAZNT-AWEZNQCLSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
149321,6w9q,DB15382,-8.5,SAR-125844,ODIUNTQOXRXOIV-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
90758,6m71,DB02164,-8.5,N-Sulfo-Flavin Mononucleotide,ZLPUGFBBLGQWBS-SCRDCRAPSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
90778,6m71,DB02194,-8.5,"8-Benzyl-2-Hydroxy-2-(4-Hydroxy-Benzyl)-6-(4-Hydroxy-Phenyl)-2h-Imidazo[1,2-a]Pyrazin-3-One",ULLMMKZQNNBLRN-SANMLTNESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
90828,6m71,DB02258,-8.5,SR11254,RNZIUDLOJHVHLZ-VYIQYICTSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
61799,6crv,DB12612,-8.5,Ozanimod,XRVDGNKRPOAQTN-FQEVSTJZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
90888,6m71,DB02338,-8.5,Nadph Dihydro-Nicotinamide-Adenine-Dinucleotidephosphate,ACFIXJIJDZMPPO-NNYOXOHSSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
113960,6vxx,DB12325,-8.5,Idasanutlin,TVTXCJFHQKSQQM-LJQIRTBHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61432,6crv,DB12079,-8.5,Gefarnate,ZPACYDRSPFRDHO-ROBAGEODSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
90997,6m71,DB02473,-8.5,"6-[N-(1-Isopropyl-3,4-Dihydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine",XRHANBWAKSYPEN-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
61419,6crv,DB12059,-8.5,JNJ-40411813,HYOGJHCDLQSAHX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130225,6w4h,DB11951,-8.5,Lemborexant,MUGXRYIUWFITCP-PGRDOPGGSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
30373,6cs2,DB12401,-8.5,Bromperidol,RKLNONIVDFXQRX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
147981,6w9q,DB12742,-8.5,Amuvatinib,FOFDIMHVKGYHRU-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
61819,6crv,DB12645,-8.5,Givinostat,YALNUENQHAQXEA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130287,6w4h,DB12048,-8.5,Savolitinib,XYDNMOZJKOGZLS-NSHDSACASA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
8378,6lzg,DB05678,-8.5,SLx-4090,AZUIUVJESCFSLJ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
76468,6m2n,DB07242,-8.5,"(4R)-7,8-dichloro-1',9-dimethyl-1-oxo-1,2,4,9-tetrahydrospiro[beta-carboline-3,4'-piperidine]-4-carbonitrile",XGUIMGJMQKZRGM-LLVKDONJSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
24616,6cs2,DB02388,-8.5,"Cyclohexyl-{4-[5-(3,4-Dichlorophenyl)-2-Piperidin-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine",UQFRSHRWRKYNDE-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
113893,6vxx,DB12238,-8.5,MK-0777,QKIWQBLNTSQOLY-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
151437,6wiq,DB02704,-8.5,"(2r,3r,4r,5r)-3,4-Dihydroxy-N,N'-Bis[(1s,2r)-2-Hydroxy-2,3-Dihydro-1h-Inden-1-Yl]-2,5-Bis(2-Phenylethyl)Hexanediamide",GQKBYZPVKVXMJL-LAFNQVRVSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
130344,6w4h,DB12128,-8.5,Ulimorelin,WGYPAJVJMXQXTR-ABNZCKJZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
166522,7bv1,DB15295,-8.5,Tenalisib,HDXDQPRPFRKGKZ-INIZCTEOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
130346,6w4h,DB12130,-8.5,Lorlatinib,IIXWYSCJSQVBQM-LLVKDONJSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
30452,6cs2,DB12505,-8.5,E-7820,LWGUASZLXHYWIV-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
61882,6crv,DB12740,-8.5,CC-115,GMYLVKUGJMYTFB-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
91859,6m71,DB03642,-8.5,Benzofuran-2-Carboxylic Acid {(S)-3-Methyl-1-[3-Oxo-1-(Pyridin-2-Ylsulfonyl)Azepan-4-Ylcarbamoyl]Butyl}Amide,VBPPNJCVXGAZDD-PMACEKPBSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
61344,6crv,DB11946,-8.5,AZD-1981,JWYIGNODXSRKGP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
118765,6w4b,DB06240,-8.5,Tariquidar,LGGHDPFKSSRQNS-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
91982,6m71,DB03797,-8.5,3-Aminomethyl-Pyridinium-Adenine-Dinucleotide,HMCRLFVYYFBZEZ-PLEFRAQWSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
76492,6m2n,DB07269,-8.5,(2S)-2-[3-(AMINOMETHYL)PHENYL]-3-[(R)-[(1R)-1-{[(BENZYLOXY)CARBONYL]AMINO}-2-METHYLPROPYL](HYDROXY)PHOSPHORYL]PROPANOIC ACID,SFUOOKBZBVUDBC-VQTJNVASSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
113861,6vxx,DB12193,-8.5,Ajulemic acid,YCHYFHOSGQABSW-RTBURBONSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
152089,6wiq,DB03591,-8.5,RU82209,LVZDQVATAQEMCX-NSOVKSMOSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
61905,6crv,DB12779,-8.5,Higenamine,WZRCQWQRFZITDX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61913,6crv,DB12792,-8.5,Boscalid,WYEMLYFITZORAB-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76010,6m2n,DB06634,-8.5,Casopitant,XGGTZCKQRWXCHW-WMTVXVAQSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61871,6crv,DB12721,-8.5,RO-5028442,QZXVLRCMAHJVIP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
129634,6w4h,DB09078,-8.5,Lenvatinib,WOSKHXYHFSIKNG-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
88731,6m3m,DB14668,-8.5,Dienestrol diacetate,YWLLGDVBTLPARJ-OXAZHYLESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88735,6m3m,DB14672,-8.5,Oxazepam acetate,FYRWUTOZBRWYCS-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
61849,6crv,DB12689,-8.5,Azeliragon,KJNNWYBAOPXVJY-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
95,6lzg,HMDB0002789,-8.5,Zeaxanthin,JKQXZKUSFCKOGQ-PWPFSTEPSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
129608,6w4h,DB09030,-8.5,Vorapaxar,ZBGXUVOIWDMMJE-QHNZEKIYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
113905,6vxx,DB12254,-8.5,ABT-751,URCVCIZFVQDVPM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61378,6crv,DB11999,-8.5,Vosaroxin,XZAFZXJXZHRNAQ-STQMWFEESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
91455,6m71,DB03082,-8.5,6-[(Z)-Amino(Imino)Methyl]-N-[4-(Aminomethyl)Phenyl]-4-(Pyrimidin-2-Ylamino)-2-Naphthamide,CSWQJKHBMACTGB-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
138980,6w9c,DB12663,-8.5,Letrazuril,XQKYUBTUOHHNDV-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
61373,6crv,DB11990,-8.5,MK-0812,UNVWTBOGMHPKJM-CWKRKGSWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76024,6m2n,DB06670,-8.5,Odanacatib,FWIVDMJALNEADT-SFTDATJTSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
130298,6w4h,DB12063,-8.5,CERC-301,RECBFDWSXWAXHY-IAGOWNOFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
91667,6m71,DB03358,-8.5,7n-Methyl-8-Hydroguanosine-5'-Triphosphate,BUJQMJUTTBGELS-KQYNXXCUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
113903,6vxx,DB12252,-8.5,PG-701,OKRSVUYYCJPECG-LFGMFVMYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
150983,6wiq,DB02112,-8.5,Zk-806450,DZLGSWPXZYDHBD-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
91727,6m71,DB03447,-8.5,Uridylyl-2'-5'-Phospho-Adenosine,QARCCHXXGAIRFS-KPKSGTNCSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
91748,6m71,DB03476,-8.5,Trans-6-(2-Phenylcyclopropyl)-Naphthalene-2-Carboxamidine,NQRIWXVAIWPBEM-OALUTQOASA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
147847,6w9q,DB12535,-8.5,AC-430,DCRWIATZWHLIPN-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
114851,6vxx,DB15024,-8.5,Apararenone,AZNHWXAFPBYFGH-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30445,6cs2,DB12491,-8.5,Fasiglifam,BZCALJIHZVNMGJ-HSZRJFAPSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
30354,6cs2,DB12379,-8.5,Indirubin,CRDNMYFJWFXOCH-BUHFOSPRSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
30349,6cs2,DB12371,-8.5,Siponimod,KIHYPELVXPAIDH-HNSNBQBZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
114515,6vxx,DB13728,-8.5,Halometasone,GGXMRPUKBWXVHE-MIHLVHIWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
24715,6cs2,DB02498,-8.5,Carba-Nicotinamide-Adenine-Dinucleotide,DGPLSUKWXXSBCU-VGXGLJSLSA-O,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
148233,6w9q,DB13138,-8.5,Neladenoson bialanate,WESNEIGKOAXSGX-VXKWHMMOSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
89167,6m71,DB00157,-8.5,NADH,BOPGDPNILDQYTO-NNYOXOHSSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
61639,6crv,DB12376,-8.5,Ricolinostat,QGZYDVAGYRLSKP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
149009,6w9q,DB14703,-8.5,Dexamethasone metasulfobenzoate,TWQWRHIQRAZHPR-XNXCGYEVSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
76174,6m2n,DB06899,-8.5,"N-{2-[6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2,2-DIMETHYL-3-OXO-2,3-DIHYDRO-4H-1,4-BENZOTHIAZIN-4-YL]ETHYL}ACETAMIDE",RMEVNJZCKDVVND-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
129758,6w4h,DB09272,-8.5,Eluxadoline,QFNHIDANIVGXPE-FNZWTVRRSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
30194,6cs2,DB12174,-8.5,CUDC-101,PLIVFNIUGLLCEK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
130070,6w4h,DB11730,-8.5,Ribociclib,RHXHGRAEPCAFML-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130078,6w4h,DB11740,-8.5,MK-1775,BKWJAKQVGHWELA-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
76272,6m2n,DB07015,-8.5,"(3R,4R)-4-(pyrrolidin-1-ylcarbonyl)-1-(quinoxalin-2-ylcarbonyl)pyrrolidin-3-amine",XDSKICAQKGYYJF-OLZOCXBDSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
89398,6m71,DB00430,-8.5,Cefpiramide,PWAUCHMQEXVFJR-PMAPCBKXSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
30141,6cs2,DB12108,-8.5,Taselisib,BEUQXVWXFDOSAQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
149120,6w9q,DB14943,-8.5,LGH-447,VRQXRVAKPDCRCI-ZNMIVQPWSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
76277,6m2n,DB07021,-8.5,"(7R,8R)-8-(2,4,5-trifluorophenyl)-6,7,8,9-tetrahydroimidazo[1,2-a:4,5-c']dipyridin-7-amine",SOSYXEPELJIJHZ-RNCFNFMXSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61729,6crv,DB12504,-8.5,JNJ-40346527,BNVPFDRNGHMRJS-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30219,6cs2,DB12211,-8.5,PSI-697,DIEPFYNZGUUVHD-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
139080,6w9c,DB12823,-8.5,Tecarfarin,QFLNTQDOVCLQKW-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
130086,6w4h,DB11751,-8.5,Cabotegravir,WCWSTNLSLKSJPK-LKFCYVNXSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
76238,6m2n,DB06977,-8.5,(2S)-1-{[5-(1H-Indazol-5-yl)-3-pyridinyl]oxy}-3-(7aH-indol-3-yl)-2-propanamine,CAASENZOSQYNPX-HSTJUUNISA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
89028,6m3m,DB15316,-8.5,Florasulam,QZXATCCPQKOEIH-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
76206,6m2n,DB06932,-8.5,"10,11-dimethoxy-4-methyldibenzo[c,f]-2,7-naphthyridine-3,6-diamine",NVINUNQBDNEMSY-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
117110,6w4b,DB03044,-8.5,1-(5-Tert-Butyl-2-P-Tolyl-2h-Pyrazol-3-Yl)-3-[4-(2-Morpholin-4-Yl-Ethoxy)-Naphthalen-1-Yl]-Urea,MVCOAUNKQVWQHZ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
89053,6m3m,DB15360,-8.5,"Carfentanil, C-11",YDSDEBIZUNNPOB-JVVVGQRLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
76224,6m2n,DB06955,-8.5,"3,4-bis(7-chloro-1H-indol-3-yl)-1H-pyrrole-2,5-dicarboxylic acid",OAMCCJASDLMTOO-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
24722,6cs2,DB02505,-8.5,N-(R-Carboxy-Ethyl)-Alpha-(S)-(2-Phenylethyl),JJVQUUYZGJWBPW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
139067,6w9c,DB12802,-8.5,Picropodophyllin,YJGVMLPVUAXIQN-HAEOHBJNSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
114162,6vxx,DB12832,-8.5,Prednimustine,HFVNWDWLWUCIHC-GUPDPFMOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130005,6w4h,DB11622,-8.5,Dehydrocholic acid,OHXPGWPVLFPUSM-KLRNGDHRSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
89040,6m3m,DB15338,-8.5,Rovatirelin,WTXWDXWZGJGIHV-URBCHYCLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
129896,6w4h,DB11372,-8.5,Altrenogest,VWAUPFMBXBWEQY-ANULTFPQSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
148783,6w9q,DB13947,-8.5,Testosterone enantate benzilic acid hydrazone,PTVXYACXDYZNID-JKXGKYMWSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
89080,6m3m,DB15425,-8.5,CYC-065,DLPIYBKBHMZCJI-WBVHZDCISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
129861,6w4h,DB11262,-8.5,Bisoctrizole,FQUNFJULCYSSOP-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
89032,6m3m,DB15324,-8.5,ORM-13070 C-11,VGIYMYGMVXPMKV-GWDMYEQXSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
117254,6w4b,DB03231,-8.5,"3-(5-Amino-7-oxo-3,7-dihydro-2H-[1,2,3]triazolo[4,5-d]pyrimidin-2-yl)-N-(2-{[2-(hydroxymethyl)phenyl]sulfanyl}benzyl)benzamide",IXDQOBDHBWEZOH-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
148788,6w9q,DB13953,-8.5,Estradiol benzoate,UYIFTLBWAOGQBI-BZDYCCQFSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
130015,6w4h,DB11645,-8.5,PF-4191834,DVNQWYLVSNPCJZ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
30171,6cs2,DB12141,-8.5,Gilteritinib,GYQYAJJFPNQOOW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
130403,6w4h,DB12221,-8.5,Canrenone,UJVLDDZCTMKXJK-WNHSNXHDSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
89494,6m71,DB00549,-8.5,Zafirlukast,YEEZWCHGZNKEEK-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
139034,6w9c,DB12743,-8.5,Z-160,VCPMZDWBEWTGNW-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
61520,6crv,DB12210,-8.5,AZD-6280,NVWCZRPXYVDQEE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130152,6w4h,DB11845,-8.5,Lucitanib,CUDVHEFYRIWYQD-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
166441,7bv1,DB15137,-8.5,VK-2809,LGGPZDRLTDGYSQ-JADSYQMUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
76136,6m2n,DB06856,-8.5,6-FLUORO-2-[2-HYDROXY-3-(2-METHYL-CYCLOHEXYLOXY)-PHENYL]-1H-INDOLE-5-CARBOXAMIDINE,HUYQYLFFFNSAAX-BUXKBTBVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
88893,6m3m,DB15052,-8.5,Ansofaxine,QKYBZJLEMOZFFU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
114007,6vxx,DB12579,-8.5,JNJ-37822681,UVUYWJWYRLJHEN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130164,6w4h,DB11865,-8.5,Brivanib alaninate,LTEJRLHKIYCEOX-OCCSQVGLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
90511,6m71,DB01830,-8.5,"{4-[2-Acetylamino-2-(3-Carbamoyl-2-Cyclohexylmethoxy-6,7,8,9-Tetrahydro-5h-Benzocyclohepten-5ylcarbamoyl)-Ethyl]-2-Phosphono-Phenyl}-Phosphonic Acid",SPSGYTWOIGAABK-DQEYMECFSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
114002,6vxx,DB12573,-8.5,LY-2452473,IHIWYQYVBNODSV-KRWDZBQOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130168,6w4h,DB11871,-8.5,PF-00610355,YPHDIMUXXABSSO-YTTGMZPUSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
139101,6w9c,DB12858,-8.5,LY-377604,RBSGUQYXRDKPAE-QFIPXVFZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
76380,6m2n,DB07138,-8.5,Neflamapimod,VEPKQEUBKLEPRA-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
90535,6m71,DB01861,-8.5,Uridine diphosphate glucose,HSCJRCZFDFQWRP-JZMIEXBBSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
61471,6crv,DB12131,-8.5,Vinpocetine,DDNCQMVWWZOMLN-IRLDBZIGSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113998,6vxx,DB12567,-8.5,Camicinal,RZKDEGZIFSJVNA-IBGZPJMESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113995,6vxx,DB12563,-8.5,MK-0686,WZZIQHIQMWJNLU-LLVKDONJSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61470,6crv,DB12130,-8.5,Lorlatinib,IIXWYSCJSQVBQM-LLVKDONJSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
149249,6w9q,DB15233,-8.5,Avapritinib,DWYRIWUZIJHQKQ-SANMLTNESA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
89542,6m71,DB00606,-8.5,Cyclothiazide,BOCUKUHCLICSIY-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
24842,6cs2,DB02647,-8.5,N-(5-Cyclopropyl-1h-Pyrazol-3-Yl)Benzamide,LUCORKWTQSQFFU-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
149199,6w9q,DB15137,-8.5,VK-2809,LGGPZDRLTDGYSQ-JADSYQMUSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
166459,7bv1,DB15173,-8.5,JNJ-42165279,YWGYNGCRVZLMCS-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
89613,6m71,DB00693,-8.5,Fluorescein,GNBHRKFJIUUOQI-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
89620,6m71,DB00700,-8.5,Eplerenone,JUKPWJGBANNWMW-VWBFHTRKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
166457,7bv1,DB15169,-8.5,H3B-6527,MBWRLLRCTIYXDW-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
130116,6w4h,DB11794,-8.5,Berzosertib,JZCWLJDSIRUGIN-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
89834,6m71,DB00948,-8.5,Mezlocillin,YPBATNHYBCGSSN-VWPFQQQWSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
24815,6cs2,DB02615,-8.5,Compound 19,UZOOIPXOYYJULJ-BLIZRMSTSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
118003,6w4b,DB04238,-8.5,N-Alpha-(2-Naphthylsulfonyl)-N-(3-Amidino-L-Phenylalaninyl)-D-Pipecolinic Acid,GNANSBQAIRJZPA-XZOQPEGZSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
149164,6w9q,DB15068,-8.5,Agerafenib,DKNUPRMJNUQNHR-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
29656,6cs2,DB11363,-8.5,Alectinib,KDGFLJKFZUIJMX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
30286,6cs2,DB12289,-8.5,Darexaban,IJNIQYINMSGIPS-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
130124,6w4h,DB11805,-8.5,Saracatinib,OUKYUETWWIPKQR-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
88932,6m3m,DB15126,-8.5,IMG-7289,KQKBMHGOHXOHTD-KKUQBAQOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
90023,6m71,DB01167,-8.5,Itraconazole,VHVPQPYKVGDNFY-ZPGVKDDISA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
130138,6w4h,DB11824,-8.5,Tofogliflozin,VWVKUNOPTJGDOB-BDHVOXNPSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
129712,6w4h,DB09209,-8.5,Pholcodine,GPFAJKDEDBRFOS-FKQDBXSBSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
61543,6crv,DB12239,-8.5,Balicatib,LLCRBOWRJOUJAE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
118365,6w4b,DB04727,-8.5,"N-(4-{4-AMINO-6-[4-(METHYLOXY)PHENYL]FURO[2,3-D]PYRIMIDIN-5-YL}PHENYL)-N'-[2-FLUORO-5-(TRIFLUOROMETHYL)PHENYL]UREA",FGZIONRFHVNRJB-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
77872,6m2n,DB08927,-8.5,Amperozide,NNAIYOXJNVGUOM-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
30479,6cs2,DB12540,-8.5,Lecozotan,NRPQELCNMADTOZ-OAQYLSRUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
113849,6vxx,DB12174,-8.5,CUDC-101,PLIVFNIUGLLCEK-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
8554,6lzg,DB06367,-8.5,Relacatib,BWYBBMQLUKXECQ-GIVPXCGWSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
120000,6w4b,DB07970,-8.5,5-[(2-methyl-5-{[3-(trifluoromethyl)phenyl]carbamoyl}phenyl)amino]pyridine-3-carboxamide,SAAYRHKJHDIDPH-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
93519,6m71,DB07042,-8.5,"7-amino-2-tert-butyl-4-{[2-(1H-imidazol-4-yl)ethyl]amino}pyrido[2,3-d]pyrimidine-6-carboxamide",XESUNWBIAADLPI-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
120005,6w4b,DB07975,-8.5,"2-({[3,5-DIFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)CYCLOPENT-1-ENE-1-CARBOXYLIC ACID",VTGXLCZUWFYELR-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
24452,6cs2,DB02197,-8.5,"4-[(4-Imidazo[1,2-a]Pyridin-3-Ylpyrimidin-2-Yl)Amino]Benzenesulfonamide",NKORVPQBJCGYEC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
75821,6m2n,DB06160,-8.5,Garenoxacin,NJDRXTDGYFKORP-LLVKDONJSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
6299,6lzg,DB01876,-8.5,Bis(5-Amidino-2-Benzimidazolyl)Methanone,VVVXDHROXQUONB-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
7712,6lzg,DB04258,-8.5,Seocalcitol,LVLLALCJVJNGQQ-SEODYNFXSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
93592,6m71,DB07126,-8.5,O6-CYCLOHEXYLMETHOXY-2-(4'-SULPHAMOYLANILINO) PURINE,OWXORKPNCHJYOF-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93593,6m71,DB07127,-8.5,"{4-[2,2-BIS(5-METHYL-1,2,4-OXADIAZOL-3-YL)-3-PHENYLPROPYL]PHENYL}SULFAMIC ACID",SXDBFKLPNPUPRI-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
155992,6wiq,DB12054,-8.5,BQ-123,VYCMAAOURFJIHD-PJNXIOHISA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
93606,6m71,DB07142,-8.5,"5-[(3R)-3-(5-methoxy-3',5'-dimethylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",ATFDKOLABYIYCC-INIZCTEOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
61033,6crv,DB11395,-8.5,Deracoxib,WAZQAZKAZLXFMK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
166282,7bv1,DB14568,-8.5,Ivosidenib,WIJZXSAJMHAVGX-DHLKQENFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
120036,6w4b,DB08010,-8.5,"(3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-[(E)-2-phenylethenyl]-1H-indole-2,3-dione 3-oxime",DDHASJXGNUWZTM-ZLEWNXFRSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
93614,6m71,DB07152,-8.5,N-[4-(5-fluoro-6-methylpyridin-2-yl)-5-quinoxalin-6-yl-1H-imidazol-2-yl]acetamide,TYPILNNEZPSNTI-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
76858,6m2n,DB07698,-8.5,"3-(3-aminophenyl)-N-(3-chlorophenyl)pyrazolo[1,5-a]pyrimidin-5-amine",JDNMRPIWJIDDAY-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
155941,6wiq,DB11977,-8.5,Golvatinib,UQRCJCNVNUFYDX-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
25197,6cs2,DB03076,-8.5,AHA047,CGBDAHCDSVOMCF-FYZVQMPESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
30702,6cs2,DB12867,-8.5,Benperidol,FEBOTPHFXYHVPL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
130619,6w4h,DB12523,-8.5,Mizolastine,PVLJETXTTWAYEW-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
88273,6m3m,DB13579,-8.5,Mepixanox,PYSOHOOUXFWCFF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
113679,6vxx,DB11750,-8.5,Clobetasol,FCSHDIVRCWTZOX-DVTGEIKXSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88256,6m3m,DB13553,-8.5,Carumonam,UIMOJFJSJSIGLV-JNHMLNOCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
93297,6m71,DB06746,-8.5,ginkgolide-J,LMEHVEUFNRJAAV-UKWFQYJJSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
62052,6crv,DB13012,-8.5,AQX-1125,MDEJTPWQNNMAQF-BVMLLJBZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76809,6m2n,DB07638,-8.5,"(3AS,4R,9BR)-2,2-DIFLUORO-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL",QJSMFUTULGSHNQ-ZOBUZTSGSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
155858,6wiq,DB11852,-8.5,Tegobuvir,XBEQSQDCBSKCHJ-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
93385,6m71,DB06886,-8.5,N-BENZYLOXYCARBONYL-ALA-PRO-3-AMINO-4-PHENYL-BUTAN-2-OL,MACLRJNEKXUAJK-YDLSIGKMSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
76813,6m2n,DB07643,-8.5,"5-{[1-(2,3-dichlorobenzyl)piperidin-4-yl]methoxy}quinazoline-2,4-diamine",XVLUVRFYGVJKGJ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
119848,6w4b,DB07794,-8.5,"5-(2-PHENYLPYRAZOLO[1,5-A]PYRIDIN-3-YL)-1H-PYRAZOLO[3,4-C]PYRIDAZIN-3-AMINE",XVECMUKVOMUNLE-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
61060,6crv,DB11446,-8.5,Oxfendazole,BEZZFPOZAYTVHN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
93478,6m71,DB06997,-8.5,"2-(4-fluorophenyl)-N-{[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]carbamoyl}acetamide",BMPOCDJEXAXXEZ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93481,6m71,DB07000,-8.5,"N-{2,4-difluoro-3-[(5-pyridin-3-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)carbonyl]phenyl}ethanesulfonamide",ILXJWLWSYAWJKZ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
88203,6m3m,DB13482,-8.5,Dimefline,ZXFQRFXLFWWKLX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
147342,6w9q,DB11799,-8.5,Bictegravir,SOLUWJRYJLAZCX-LYOVBCGYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
88191,6m3m,DB13463,-8.5,Oxetorone,VZVRZTZPHOHSCK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
113605,6vxx,DB11638,-8.5,Artenimol,BJDCWCLMFKKGEE-HVDUHBCDSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75806,6m2n,DB06134,-8.5,SNS-314,FAYAUAZLLLJJGH-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
147324,6w9q,DB11775,-8.5,PF-03758309,AYCPARAPKDAOEN-LJQANCHMSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
88090,6m3m,DB13333,-8.5,Efloxate,ZVXBAHLOGZCFTP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
93836,6m71,DB07406,-8.5,"(4R)-N-[4-({[2-(DIMETHYLAMINO)ETHYL]AMINO}CARBONYL)-1,3-THIAZOL-2-YL]-4-METHYL-1-OXO-2,3,4,9-TETRAHYDRO-1H-BETA-CARBOLINE-6-CARBOXAMIDE",QWFFPYQWUWLDBV-NSHDSACASA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
76931,6m2n,DB07783,-8.5,1-((1R)-1-(HYDROXYMETHYL)-3-{6-[(3-PHENYLPROPANOYL)AMINO]-1H-INDOL-1-YL}PROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE,GUYYFMCFEPDDFL-OAQYLSRUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
62150,6crv,DB13175,-8.5,Rheinanthrone,OZFQHULMMDWMIV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62151,6crv,DB13177,-8.5,4-methylumbelliferyl beta-D-glucoside,YUDPTGPSBJVHCN-YMILTQATSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76934,6m2n,DB07787,-8.5,"5-FLUORO-1-[4-(4-PHENYL-3,6-DIHYDROPYRIDIN-1(2H)-YL)BUTYL]QUINAZOLINE-2,4(1H,3H)-DIONE",PNPFDRCIGCUCMN-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
87968,6m3m,DB13132,-8.5,Artemisinin,BLUAFEHZUWYNDE-NNWCWBAJSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
130701,6w4h,DB12655,-8.5,Patidegib,HZLFFNCLTRVYJG-WWGOJCOQSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130703,6w4h,DB12658,-8.5,AFN-1252,QXTWSUQCXCWEHF-JXMROGBWSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
87965,6m3m,DB13125,-8.5,Lusutrombopag,NOZIJMHMKORZBA-KJCUYJGMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
76935,6m2n,DB07788,-8.5,"(3R,5Z,8S,9S,11E)-8,9,16-TRIHYDROXY-14-METHOXY-3-METHYL-3,4,9,10-TETRAHYDRO-1H-2-BENZOXACYCLOTETRADECINE-1,7(8H)-DIONE",NEQZWEXWOFPKOT-QHSZRYGNSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
93880,6m71,DB07457,-8.5,"3-[1-(3-AMINOPROPYL)-1H-INDOL-3-YL]-4-(1H-INDOL-3-YL)-1H-PYRROLE-2,5-DIONE",APYXQTXFRIDSGE-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93883,6m71,DB07460,-8.5,2-({5-CHLORO-2-[(2-METHOXY-4-MORPHOLIN-4-YLPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)-N-METHYLBENZAMIDE,UYJNQQDJUOUFQJ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
75773,6m2n,DB05884,-8.5,HCV-086,VBRUONUESYTIDA-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
25264,6cs2,DB03157,-8.5,"N,O-Didansyl-L-Tyrosine",LUBOPDUYHWABFG-NDEPHWFRSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
62155,6crv,DB13185,-8.5,Oxabolone cipionate,KHKDIUPVDIEHAH-KXLSUQFWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
8609,6lzg,DB06510,-8.5,Muraglitazar,IRLWJILLXJGJTD-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
130733,6w4h,DB12705,-8.5,Cenerimod,KJKKMMMRWISKRF-FQEVSTJZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
75778,6m2n,DB05936,-8.5,CVT-6883,KOYXXLLNCXWUNF-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61092,6crv,DB11518,-8.5,Flunixin,NOOCSNJCXJYGPE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
93827,6m71,DB07396,-8.5,"1-{2-[3-(2-Chloro-4,5-difluoro-benzoyl)-ureido]-4-fluoro-phenyl}-piperidine-4-carboxylic acid",KAJJGOCSAXKXBD-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60896,6crv,DB09292,-8.5,Sacubitril,PYNXFZCZUAOOQC-UTKZUKDTSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130668,6w4h,DB12597,-8.5,ABL-001,VOVZXURTCKPRDQ-CQSZACIVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
88077,6m3m,DB13317,-8.5,Flunoxaprofen,ARPYQKTVRGFPIS-VIFPVBQESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
120061,6w4b,DB08036,-8.5,"6,7,12,13-tetrahydro-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazol-5-one",MEXUTNIFSHFQRG-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
30742,6cs2,DB12914,-8.5,MGL-3196,FDBYIYFVSAHJLY-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
14370,6lzg,T3D4050,-8.5,alpha-Chaconine,TYNQWWGVEGFKRU-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
129391,6w4h,DB08739,-8.5,"2-{3-[(2S)-4,4-difluoro-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]-3-oxopropyl}-isoindole-1,3(2H)-dione",ZSXNPAWXICXNGZ-HNNXBMFYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
129390,6w4h,DB08738,-8.5,1-{3-oxo-3-[(2S)-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]propyl}-3-phenylquinoxalin-2(1H)-one,KWCKZIJGKMCYCI-QFIPXVFZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
113578,6vxx,DB11560,-8.5,Lesinurad,FGQFOYHRJSUHMR-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60929,6crv,DB09421,-8.5,Protirelin,XNSAINXGIQZQOO-SRVKXCTJSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30783,6cs2,DB12972,-8.5,Sepranolone,AURFZBICLPNKBZ-FZCSVUEKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
76914,6m2n,DB07763,-8.5,"(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE",OZZFJGCAYWBVBI-INIZCTEOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76915,6m2n,DB07764,-8.5,FLUORESCIN,MURGITYSBWUQTI-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75791,6m2n,DB05990,-8.5,Obeticholic acid,ZXERDUOLZKYMJM-ZWECCWDJSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
93763,6m71,DB07321,-8.5,"2,5-DICHLORO-N-[5-METHOXY-7-(6-METHOXYPYRIDIN-3-YL)-1,3-BENZOXAZOL-2-YL]BENZENESULFONAMIDE",KOKQLKWXOFRTHE-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
62135,6crv,DB13136,-8.5,Fluindione,NASXCEITKQITLD-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114550,6vxx,DB13778,-8.5,Cefazedone,VTLCNEGVSVJLDN-MLGOLLRUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
156259,6wiq,DB12655,-8.5,Patidegib,HZLFFNCLTRVYJG-WWGOJCOQSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
93799,6m71,DB07360,-8.5,"1-{5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)ethyl]-1,3-thiazol-2-yl}-3-[3-(trifluoromethyl)phenyl]urea",JJHXPDTVQKWKHA-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
75863,6m2n,DB06249,-8.5,Arzoxifene,MCGDSOGUHLTADD-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75864,6m2n,DB06250,-8.5,Fluasterone,VHZXNQKVFDBFIK-NBBHSKLNSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
88292,6m3m,DB13605,-8.5,Phenoperidine,IPOPQVVNCFQFRK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
119118,6w4b,DB06938,-8.5,4-[[2-[[4-chloro-3-(trifluoromethyl)phenyl]amino]-3H-benzimidazol-5-yl]oxy]-N-methyl-pyridine-2-carboxamide,ZJLSMLDOCGOURY-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
113780,6vxx,DB12073,-8.5,Albaconazole,UHIXWHUVLCAJQL-MPBGBICISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130502,6w4h,DB12355,-8.5,Netazepide,YDZYKNJZCVIKPP-VWLOTQADSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
30561,6cs2,DB12659,-8.5,SJ-733,VKCPFWKTFZAOTO-LEWJYISDSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
88552,6m3m,DB14008,-8.5,Hispidulin,IHFBPDAQLQOCBX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
29533,6cs2,DB09319,-8.5,Carindacillin,JIRBAUWICKGBFE-MNRDOXJOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
113769,6vxx,DB12058,-8.5,Recoflavone,BCPQOBQIVJZOFL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76639,6m2n,DB07435,-8.5,"1,2,3-TRIHYDROXY-1,2,3,4-TETRAHYDROBENZO[A]PYRENE",GFANZDFKCCJYRF-NSISKUIASA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
88542,6m3m,DB13988,-8.5,SB-269970,HWKROQUZSKPIKQ-MRXNPFEDSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
75936,6m2n,DB06457,-8.5,Tecastemizole,SFOVDSLXFUGAIV-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61245,6crv,DB11800,-8.5,Tivozanib,SPMVMDHWKHCIDT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
147612,6w9q,DB12200,-8.5,Tivantinib,UCEQXRCJXIVODC-PMACEKPBSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
130523,6w4h,DB12385,-8.5,10-hydroxycamptothecin,HAWSQZCWOQZXHI-FQEVSTJZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130527,6w4h,DB12391,-8.5,Sagopilone,BFZKMNSQCNVFGM-UCEYFQQTSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130530,6w4h,DB12394,-8.5,Eleclazine,YNUAEEJQYHYLMS-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
61211,6crv,DB11753,-8.5,Rifamycin,HJYYPODYNSCCOU-ODRIEIDWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
154407,6wiq,DB07837,-8.5,"[4-(5-naphthalen-2-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)phenyl]acetic acid",SWXKLXXVFMYMDP-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
61941,6crv,DB12840,-8.5,Pirnabine,AADNQNOXNWEYHS-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
166340,7bv1,DB14673,-8.5,Flurandrenolide acetate,AUDPKCCPWYXNEV-XTLNBZDDSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
92658,6m71,DB04698,-8.5,"N-(1,4-DIHYDRO-5H-TETRAZOL-5-YLIDENE)-9-OXO-9H-XANTHENE-2-SULFONAMIDE",HJWYZPGYPZNDTN-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
92595,6m71,DB04612,-8.5,"N-METHYLALANYL-3-METHYLVALYL-4-PHENOXY-N-(1,2,3,4-TETRAHYDRONAPHTHALEN-1-YL)PROLINAMIDE",QKPXPZYQPBWDHS-MCJAPYMPSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
92145,6m71,DB04011,-8.5,"2'-(4-Dimethylaminophenyl)-5-(4-Methyl-1-Piperazinyl)-2,5'-Bi-Benzimidazole",VMCOQLKKSNQANE-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
92163,6m71,DB04038,-8.5,Ergosterol,DNVPQKQSNYMLRS-APGDWVJJSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
7755,6lzg,DB04330,-8.5,Bilh 434,KNRVCCXHLSHTFW-HGPRPZRGSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
24569,6cs2,DB02336,-8.5,RU83876,WCMLXBUNHNAMNH-UIOOFZCWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
147689,6w9q,DB12303,-8.5,Motolimod,QSPOQCXMGPDIHI-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
88671,6m3m,DB14544,-8.5,Hydrocortisone valerate,FZCHYNWYXKICIO-FZNHGJLXSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88670,6m3m,DB14543,-8.5,Hydrocortisone probutate,FOGXJPFPZOHSQS-AYVLZSQQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
130448,6w4h,DB12280,-8.5,AZD-5423,FCNQMDSJHADDFT-WNSKOXEYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
119066,6w4b,DB06882,-8.5,1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-naphthalen-1-ylurea,HJWMLCDGRWWLAQ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
88655,6m3m,DB14232,-8.5,Deacetylbisacodyl,LJROKJGQSPMTKB-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
152968,6wiq,DB04764,-8.5,[4-(3-AMINOMETHYL-PHENYL)-PIPERIDIN-1-YL]-(5-PHENETHYL- PYRIDIN-3-YL)-METHANONE,CCLHROFBSWWOQO-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
88649,6m3m,DB14213,-8.5,Perindoprilat,ODAIHABQVKJNIY-PEDHHIEDSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
139156,6w9c,DB12939,-8.5,Nikkomycin Z,WWJFFVUVFNBJTN-VHDFTHOZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
75968,6m2n,DB06533,-8.5,Ragaglitazar,WMUIIGVAWPWQAW-XMMPIXPASA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
147670,6w9q,DB12280,-8.5,AZD-5423,FCNQMDSJHADDFT-WNSKOXEYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
92449,6m71,DB04424,-8.5,RPR128515,XFKVLKLCLYJKNF-MZNJEOGPSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
76603,6m2n,DB07394,-8.5,AUROVERTIN B,QXCOFYWOWZJFEA-YJMRODJJSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76611,6m2n,DB07403,-8.5,"4-[(3-CHLORO-4-{[(2R)-3,3,3-TRIFLUORO-2-HYDROXY-2-METHYLPROPANOYL]AMINO}PHENYL)SULFONYL]-N,N-DIMETHYLBENZAMIDE",DTDZLJHKVNTQGZ-GOSISDBHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
92097,6m71,DB03944,-8.5,"5-[1-(3,4-Dimethoxy-Benzoyl)-1,2,3,4-Tetrahydro-Quinolin-6-Yl]-6-Methyl-3,6-Dihydro-[1,3,4]Thiadiazin-2-One",IZLRMTJLQCLMKF-CYBMUJFWSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
114821,6vxx,DB14929,-8.5,Elsulfavirine,ULTDEARCBRNRGR-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76666,6m2n,DB07468,-8.5,"(3aS)-3a-hydroxy-5-methyl-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one",NJBBBRZNBVLTRZ-GOSISDBHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
30638,6cs2,DB12764,-8.5,ABC-294640,CAOTVXGYTWCKQE-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
119672,6w4b,DB07586,-8.5,"5-(4-METHYL-BENZOYLAMINO)-BIPHENYL-3,4'-DICARBOXYLIC ACID 3-DIMETHYLAMIDE-4'-HYDROXYAMIDE",DOPFUKKMSDUVTQ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
61151,6crv,DB11665,-8.5,BMS-690514,CSGQVNMSRKWUSH-IAGOWNOFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30648,6cs2,DB12780,-8.5,Quinfamide,SBJGFIXQRZOVTO-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
93113,6m71,DB06314,-8.5,SGX-523,BCZUAADEACICHN-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
130591,6w4h,DB12477,-8.5,Perfluoro tert-butylcyclohexane,VLTXBOGHSBHSAC-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
155628,6wiq,DB11399,-8.5,Dirlotapide,TUOSYWCFRFNJBS-BHVANESWSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
130593,6w4h,DB12479,-8.5,Zabofloxacin,ZNPOCLHDJCAZAH-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
93131,6m71,DB06393,-8.5,Xaliproden,WJJYZXPHLSLMGE-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
76763,6m2n,DB07584,-8.5,"N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine",OKGCSZUKOGMZAL-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
130604,6w4h,DB12500,-8.5,Fedratinib,JOOXLOJCABQBSG-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
61129,6crv,DB11622,-8.5,Dehydrocholic acid,OHXPGWPVLFPUSM-KLRNGDHRSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
155762,6wiq,DB11691,-8.5,Naldemedine,AXQACEQYCPKDMV-RZAWKFBISA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
93183,6m71,DB06521,-8.5,Ertiprotafib,FONCZICQWCUXEB-RUZDIDTESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
61109,6crv,DB11560,-8.5,Lesinurad,FGQFOYHRJSUHMR-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75866,6m2n,DB06257,-8.5,HE-2200,OEVZKEVBDIDVOI-YSZCXEEOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
114817,6vxx,DB14917,-8.5,Ceralasertib,DTTJKLNXNZAVSM-JYCIKRDWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130581,6w4h,DB12465,-8.5,Ketanserin,FPCCSQOGAWCVBH-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
29525,6cs2,DB09292,-8.5,Sacubitril,PYNXFZCZUAOOQC-UTKZUKDTSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
76733,6m2n,DB07546,-8.5,[1-(6-{6-[(1-methylethyl)amino]-1H-indazol-1-yl}pyrazin-2-yl)-1H-pyrrol-3-yl]acetic acid,BBYRUZKRFAIQSR-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75897,6m2n,DB06345,-8.5,AR-9281,HUDQLWBKJOMXSZ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76671,6m2n,DB07473,-8.5,"(R)-(+) 5(9BH)-OXO-9B-PHENYL-2,3-DIHYDROTHIAZOLO[2,3-A]ISOINDOL-3-CARBOXYLIC ACID METHYL ESTER",JYIHODAXBBPFQF-MAUKXSAKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61198,6crv,DB11736,-8.5,PF-00489791,ZUHZNKJIJDAJFD-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
5942,6lzg,HMDB0112264,-8.5,9-cis-beta-Carotene,OENHQHLEOONYIE-BVZAMQQESA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
113751,6vxx,DB12029,-8.5,Chlorogenic Acid,CWVRJTMFETXNAD-JUHZACGLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
92927,6m71,DB05490,-8.5,AMG-131,NMRWDFUZLLQSBN-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
76688,6m2n,DB07493,-8.5,"(2Z)-5'-BROMO-2,3'-BIINDOLE-2',3(1H,1'H)-DIONE AMMONIATE",IEQQJQHHJMQETK-YPKPFQOOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
154868,6wiq,DB08384,-8.5,2-({4-[4-(pyridin-4-ylmethyl)-1H-pyrazol-3-yl]phenoxy}methyl)quinoline,RQDDHVVAAJVVKM-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
88456,6m3m,DB13821,-8.5,Ceftezole,DZMVCVMFETWNIU-LDYMZIIASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
76709,6m2n,DB07519,-8.5,"(6R)-2-amino-6-[2-(3'-methoxybiphenyl-3-yl)ethyl]-3,6-dimethyl-5,6-dihydropyrimidin-4(3H)-one",VDFBMQAUECXNKR-OAQYLSRUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
154870,6wiq,DB08386,-8.5,2-{[4-(4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline,VRWJZGHUCOFGPZ-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
92983,6m71,DB05812,-8.5,Abiraterone,GZOSMCIZMLWJML-VJLLXTKPSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
113735,6vxx,DB11828,-8.5,Neratinib,JWNPDZNEKVCWMY-VQHVLOKHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
93004,6m71,DB05944,-8.5,Varlitinib,UWXSAYUXVSFDBQ-CYBMUJFWSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
130563,6w4h,DB12436,-8.5,Vofopitant,XILNRORTJVDYRH-HKUYNNGSSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
129471,6w4h,DB08834,-8.5,Tauroursodeoxycholic acid,BHTRKEVKTKCXOH-LBSADWJPSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
30607,6cs2,DB12720,-8.5,Nivocasan,VYFGDLGHHBUDTQ-ZLGUVYLKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
30612,6cs2,DB12725,-8.5,TD-8954,MZOITCJKGUIQEI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
61990,6crv,DB12914,-8.5,MGL-3196,FDBYIYFVSAHJLY-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
9036,6lzg,DB07107,-8.5,(1S)-2-(1H-INDOL-3-YL)-1-[({5-[(E)-2-PYRIDIN-4-YLVINYL]PYRIDIN-3-YL}OXY)METHYL]ETHYLAMINE,SGHXFHRRWFLILP-XJDXJNMNSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
126595,6w4h,DB04040,-8.5,"N-(2-Morpholin-4-Yl-1-Morpholin-4-Ylmethyl-Ethyl)-3-Nitro-5-(3,4,5-Trihydroxy-6-Hydroxymethyl-Tetrahydro-Pyran-2-Yloxy)-Benzamide",MCMWCTMAKPQTPI-WGNYYXNJSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
32153,6cs2,DB15456,-8.5,Vericiguat,QZFHIXARHDBPBY-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
98330,6vxs,DB00820,-8.5,Tadalafil,WOXKDUGGOYFFRN-IIBYNOLFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
9171,6lzg,DB07255,-8.5,"N'-(5-CHLORO-1,3-BENZODIOXOL-4-YL)-N-(3-MORPHOLIN-4-YLPHENYL)PYRIMIDINE-2,4-DIAMINE",PNEWIQAEGKQNCE-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
138420,6w9c,DB11636,-8.5,Nomegestrol,KZUIYQJTUIACIG-YBZCJVABSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
9169,6lzg,DB07253,-8.5,"N'-(5-chloro-1,3-benzodioxol-4-yl)-N-(3-methylsulfonylphenyl)pyrimidine-2,4-diamine",QTFCKBFCXDAZIU-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
78319,6m2n,DB11521,-8.5,Imidocarb,SCEVFJUWLLRELN-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
123122,6w4b,DB14883,-8.5,Lorecivivint,AQDWDWAYVBQMAM-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
160316,7bv1,DB08001,-8.5,5-(3-{3-[3-HYDROXY-2-(METHOXYCARBONYL)PHENOXY]PROPENYL}PHENYL)-4-(HYDROXYMETHYL)ISOXAZOLE-3-CARBOXYLIC ACID,DQSRCEFDWMQCCV-GQCTYLIASA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
74622,6m2n,DB03619,-8.5,Deoxycholic Acid,KXGVEGMKQFWNSR-LLQZFEROSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
100708,6vxs,DB03944,-8.5,"5-[1-(3,4-Dimethoxy-Benzoyl)-1,2,3,4-Tetrahydro-Quinolin-6-Yl]-6-Methyl-3,6-Dihydro-[1,3,4]Thiadiazin-2-One",IZLRMTJLQCLMKF-CYBMUJFWSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
133007,6w9c,DB01100,-8.5,Pimozide,YVUQSNJEYSNKRX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
59678,6crv,DB07750,-8.5,"(2R)-1-[4-({4-[(2,5-Dichlorophenyl)amino]-2-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol",GNLAGGCSJGJECE-MRXNPFEDSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
100766,6vxs,DB04023,-8.5,"Guanosine 5'-(Trihydrogen Diphosphate), P'-D-Mannopyranosyl Ester",DNBSDUDYNPJVCN-ZXTXFPBHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
98225,6vxs,DB00694,-8.5,Daunorubicin,STQGQHZAVUOBTE-VGBVRHCVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
59682,6crv,DB07755,-8.5,"(2S)-1-[4-({4-[(2,5-Dichlorophenyl)amino]-2-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol",GNLAGGCSJGJECE-INIZCTEOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
98206,6vxs,DB00673,-8.5,Aprepitant,ATALOFNDEOCMKK-OITMNORJSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
138047,6w9c,DB09076,-8.5,Umeclidinium,FVTWTVQXNAJTQP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
74059,6m2n,DB02848,-8.5,"{4-[3-(6,7-Diethoxy-Quinazolin-4-Ylamino)-Phenyl]-Thiazol-2-Yl}-Methanol",ZJESXGUODSBHSK-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
101038,6vxs,DB04392,-8.5,"Bishydroxy[2h-1-Benzopyran-2-One,1,2-Benzopyrone]",HIZKPJUTKKJDGA-BETUJISGSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
74049,6m2n,DB02836,-8.5,Guanosine 5'-Diphosphate 2':3'-Cyclic Monophosphate,NGYWTCOGOZELRS-UUOKFMHZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
121986,6w4b,DB12703,-8.5,Omipalisib,CGBJSGAELGCMKE-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
112323,6vxx,DB06972,-8.5,"7A-[(4-cyanophenyl)methyl]-6-(3,5-dichlorophenyl)-5-oxo-2,3,5,7A-tetrahydro-1H-pyrrolo[1,2-A]pyrrole-7-carbonitrile",TZCXQSNBTXDAJG-QFIPXVFZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85991,6m3m,DB08307,-8.5,"2-{HYDROXY[2-NITRO-4-(TRIFLUOROMETHYL)PHENYL]METHYLENE}CYCLOHEXANE-1,3-DIONE",PMHVFNYNPNKNRO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
64272,6lxt,DB01267,-8.5,Paliperidone,PMXMIIMHBWHSKN-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
78281,6m2n,DB11440,-8.5,Norgestomet,IWSXBCZCPVUWHT-VIFKTUCRSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
101065,6vxs,DB04432,-8.5,ZK-805623,ZXIHYCYAQUQHSG-UHFFFAOYSA-O,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
132981,6w9c,DB01070,-8.5,Dihydrotachysterol,ILYCWAKSDCYMBB-OPCMSESCSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
160370,7bv1,DB08303,-8.5,"(3S)-3-cyclopentyl-6-methyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide",CUMKMTBOHBENJI-SFHVURJKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
98333,6vxs,DB00823,-8.5,Ethynodiol diacetate,ONKUMRGIYFNPJW-KIEAKMPYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
112270,6vxx,DB06908,-8.5,"(2S)-3-(1-{[2-(2-CHLOROPHENYL)-5-METHYL-1,3-OXAZOL-4-YL]METHYL}-1H-INDOL-5-YL)-2-ETHOXYPROPANOIC ACID",PAWOPJKHTZCKMT-QFIPXVFZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138401,6w9c,DB11582,-8.5,Thiocolchicoside,LEQAKWQJCITZNK-AXHKHJLKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
86068,6m3m,DB08401,-8.5,(2E)-2-({(2S)-2-CARBOXY-2-[(PHENOXYACETYL)AMINO]ETHOXY}IMINO)PENTANEDIOIC ACID,LDNKNKRRFZRLIG-HWQJWEFDSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
112254,6vxx,DB06889,-8.5,"3-(1H-tetrazol-5-ylmethyl)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(3H)-one",QSBQXAOOVSQABJ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78366,6m2n,DB11650,-8.5,HT-0712,ABEJDMOBAFLQNJ-NHCUHLMSSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
32108,6cs2,DB15367,-8.5,LY-2623091,YPCLDHGBEKZGEB-RUDKWAFVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
144226,6w9q,DB04583,-8.5,"5-Carbamoyl-1,1':4',1''-terphenyl-3-carboxylic acid",LAZPCGBRHLARSI-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
98548,6vxs,DB01067,-8.5,Glipizide,ZJJXGWJIGJFDTL-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
63197,6crv,DB15324,-8.5,ORM-13070 C-11,VGIYMYGMVXPMKV-GWDMYEQXSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
159879,7bv1,DB06733,-8.5,Bafilomycin A1,XDHNQDDQEHDUTM-JQWOJBOSSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
128750,6w4h,DB07975,-8.5,"2-({[3,5-DIFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)CYCLOPENT-1-ENE-1-CARBOXYLIC ACID",VTGXLCZUWFYELR-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
142713,6w9q,DB02551,-8.5,"6-[N-(4-Ethyl-1,2,3,4-Tetrahydro-6-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine",LVNMYQLXKMSQTG-AWEZNQCLSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
32770,6cs2,T3D3683,-8.5,Dihydrocytochalasin B gamma-lactone,VJQJWFGRYRQFRH-RIYZIHGNSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
64024,6lxt,DB00977,-8.5,Ethinylestradiol,BFPYWIDHMRZLRN-SLHNCBLASA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
74552,6m2n,DB03509,-8.5,2-(4-Chlorophenyl)-5-Quinoxalinecarboxamide,FLYGLPYJEQPCFY-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
74562,6m2n,DB03523,-8.5,Brequinar,PHEZJEYUWHETKO-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
64041,6lxt,DB00997,-8.5,Doxorubicin,AOJJSUZBOXZQNB-TZSSRYMLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
86534,6m3m,DB08990,-8.5,Eprazinone,BSHWLCACYCVCJE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
98464,6vxs,DB00972,-8.5,Azelastine,MBUVEWMHONZEQD-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
74568,6m2n,DB03534,-8.5,3-[(Acetyl-Methyl-Amino)-Methyl]-4-Amino-N-Methyl-N-(1-Methyl-1h-Indol-2-Ylmethyl)-Benzamide,AWTBJNJPBKTHEV-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
100560,6vxs,DB03758,-8.5,Radicicol,WYZWZEOGROVVHK-GTMNPGAYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
123121,6w4b,DB14882,-8.5,CEP-9722,CTLOSZHDGZLOQE-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
138416,6w9c,DB11622,-8.5,Dehydrocholic acid,OHXPGWPVLFPUSM-KLRNGDHRSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
112260,6vxx,DB06897,-8.5,"3-[3-chloro-5-(5-{[(1S)-1-phenylethyl]amino}isoxazolo[5,4-c]pyridin-3-yl)phenyl]propan-1-ol",MMGKIHLBFPJYJL-HNNXBMFYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59650,6crv,DB07717,-8.5,"(5S,8R,9S,10S,13R,14S,17S)-13-{2-[(3,5-DIFLUOROBENZYL)OXY]ETHYL}-17-HYDROXY-10-METHYLHEXADECAHYDRO-3H-CYCLOPENTA[A]PHENANTHREN-3-ONE",AJODXHGZHBERGJ-JLYQOUBASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59308,6crv,DB07311,-8.5,"18-CHLORO-11,12,13,14-TETRAHYDRO-1H,10H-8,4-(AZENO)-9,15,1,3,6-BENZODIOXATRIAZACYCLOHEPTADECIN-2-ONE",JRSWWYITYIOHOP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78341,6m2n,DB11591,-8.5,Bilastine,ACCMWZWAEFYUGZ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
98650,6vxs,DB01184,-8.5,Domperidone,FGXWKSZFVQUSTL-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
25966,6cs2,DB04006,-8.5,"[2-Amino-6-(2,6-Difluoro-Benzoyl)-Imidazo[1,2-a]Pyridin-3-Yl]-Phenyl-Methanone",WUGJIPFLBOATGL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
32056,6cs2,DB15281,-8.5,Ravoxertinib,RZUOCXOYPYGSKL-GOSISDBHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
128461,6w4h,DB07638,-8.5,"(3AS,4R,9BR)-2,2-DIFLUORO-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL",QJSMFUTULGSHNQ-ZOBUZTSGSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
86714,6m3m,DB09262,-8.5,Imidafenacin,SQKXYSGRELMAAU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
133080,6w9c,DB01184,-8.5,Domperidone,FGXWKSZFVQUSTL-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
63123,6crv,DB15186,-8.5,GDC-0084,LGWACEZVCMBSKW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86719,6m3m,DB09274,-8.5,Artesunate,FIHJKUPKCHIPAT-AHIGJZGOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
64416,6lxt,DB01501,-8.5,Difenoxin,UFIVBRCCIRTJTN-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
86725,6m3m,DB09285,-8.5,Morniflumate,LDXSPUSKBDTEKA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
63118,6crv,DB15169,-8.5,H3B-6527,MBWRLLRCTIYXDW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165625,7bv1,DB12558,-8.5,AEE-788,OONFNUWBHFSNBT-HXUWFJFHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
132445,6w9c,DB00438,-8.5,Ceftazidime,ORFOPKXBNMVMKC-DWVKKRMSSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
85894,6m3m,DB08179,-8.5,"methyl 4-(2,3-dihydroxy-5-methylphenoxy)-2-hydroxy-6-methylbenzoate",BLXSEOJIXHWXQJ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
78149,6m2n,DB09383,-8.5,Meprednisone,PIDANAQULIKBQS-RNUIGHNZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
123179,6w4b,DB15034,-8.5,PRI-724,VHOZWHQPEJGPCC-AZXNYEMZSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
132443,6w9c,DB00436,-8.5,Bendroflumethiazide,HDWIHXWEUNVBIY-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
111861,6vxx,DB04796,-8.5,Inecalcitol,HHGRMHMXKPQNGF-WNSNRMDMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59786,6crv,DB07870,-8.5,(2S)-2-(4-{[3-CHLORO-5-(TRIFLUOROMETHYL)PYRIDIN-2-YL]OXY}PHENOXY)PROPANOIC ACID,GOCUAJYOYBLQRH-MRVPVSSYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
73976,6m2n,DB02738,-8.5,Adenosine-5'-Pentaphosphate,WYJWVZZCMBUPSP-KQYNXXCUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
64490,6lxt,DB01586,-8.5,Ursodeoxycholic acid,RUDATBOHQWOJDD-UZVSRGJWSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
28866,6cs2,DB08489,-8.5,"N4-HYDROXY-2-ISOBUTYL-N1-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.013,18]NONADECA-12(19),13,15,17-TETRAEN-10-YL)-SUCCINAMIDE",GCBPAPVOMPJQHK-NQIIRXRSSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
159695,7bv1,DB05327,-8.5,Ranirestat,QCVNMNYRNIMDKV-QGZVFWFLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
133094,6w9c,DB01198,-8.5,Zopiclone,GBBSUAFBMRNDJC-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
26289,6cs2,DB00502,-8.5,Haloperidol,LNEPOXFFQSENCJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
138467,6w9c,DB11703,-8.5,Acalabrutinib,WDENQIQQYWYTPO-IBGZPJMESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
64535,6lxt,DB01640,-8.5,"(5r)-6-(4-{[2-(3-Iodobenzyl)-3-Oxocyclohex-1-En-1-Yl]Amino}Phenyl)-5-Methyl-4,5-Dihydropyridazin-3(2h)-One",QNURTFDBHAQRSI-OAHLLOKOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
132417,6w9c,DB00402,-8.5,Eszopiclone,GBBSUAFBMRNDJC-INIZCTEOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
64336,6lxt,DB01411,-8.5,Pranlukast,NBQKINXMPLXUET-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
59700,6crv,DB07775,-8.5,"3',5'-DIBROMO-2',4,4',6'-TETRAHYDROXY AURONE",BRPKBUNFOZFULQ-SGAXSIHGSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
139892,6w9c,DB14210,-8.5,Moexiprilat,CMPAGYDKASJORH-YSSFQJQWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138455,6w9c,DB11687,-8.5,E-6201,MWUFVYLAWAXDHQ-HMNLTAHHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
63558,6lxt,DB00421,-8.5,Spironolactone,LXMSZDCAJNLERA-ZHYRCANASA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
86637,6m3m,DB09173,-8.5,Butyrfentanyl,QQOMYEQLWQJRKK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59235,6crv,DB07230,-8.5,3-BROMO-6-HYDROXY-2-(4-HYDROXYPHENYL)-1H-INDEN-1-ONE,DHPCBFMFERFZLR-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
97894,6vxs,DB00288,-8.5,Amcinonide,ILKJAFIWWBXGDU-MOGDOJJUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
63147,6crv,DB15224,-8.5,Lisavanbulin,NIPZLALJRAHABJ-IBGZPJMESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86642,6m3m,DB09179,-8.5,R-30490,GARXJOUQUSNOGK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
101178,6vxs,DB04575,-8.5,Quinestrol,PWZUUYSISTUNDW-VAFBSOEGSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101185,6vxs,DB04583,-8.5,"5-Carbamoyl-1,1':4',1''-terphenyl-3-carboxylic acid",LAZPCGBRHLARSI-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
123161,6w4b,DB14989,-8.5,Umbralisib,IUVCFHHAEHNCFT-INIZCTEOSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
138438,6w9c,DB11665,-8.5,BMS-690514,CSGQVNMSRKWUSH-IAGOWNOFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
159781,7bv1,DB06532,-8.5,Pafuramidine,UKOQVLAXCBRRGH-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
32826,6cs2,T3D3740,-8.5,Beauvericin,GYSCAQFHASJXRS-FFCOJMSVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
28878,6cs2,DB08500,-8.5,"(3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(2-naphthyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol",ZCJBDRSKHARECB-PYTCMNEWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
111893,6vxx,DB04834,-8.5,Rapacuronium,HTIKWNNIPGXLGM-YLINKJIISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86664,6m3m,DB09201,-8.5,Ciglitazone,YZFWTZACSRHJQD-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59224,6crv,DB07217,-8.5,"N-(3-cyano-4,5,6,7-tetrahydro-1-benzothien-2-yl)-2-fluorobenzamide",YVYPYORTKAIUGJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
25931,6cs2,DB03962,-8.5,Nicotinamide 8-Bromo-Adenine Dinucleotide Phosphate,MDKMTCCUJSRQGW-NAJQWHGHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
74714,6m2n,DB03742,-8.5,Compound 4-D,TWZNCTCQAGRUGQ-RRPNLBNLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
64332,6lxt,DB01406,-8.5,Danazol,POZRVZJJTULAOH-LHZXLZLDSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
160403,7bv1,DB08345,-8.5,"4-(2-(1H-IMIDAZOL-4-YL)ETHYLAMINO)-2-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE",IWUUKHQIKFHWIW-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
32834,6cs2,T3D3748,-8.5,Paspalinine,BPTIXFRJAOKMRK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
6461,6lzg,DB02152,-8.5,K-252a,KOZFSFOOLUUIGY-SOLYNIJKSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
78664,6m2n,DB12092,-8.5,Naftopidil,HRRBJVNMSRJFHQ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
159740,7bv1,DB05552,-8.5,TG100-115,UJIAQDJKSXQLIT-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
115780,6w4b,DB01251,-8.5,Gliquidone,LLJFMFZYVVLQKT-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
85915,6m3m,DB08208,-8.5,"2-[(4-ETHYNYL-2-FLUOROPHENYL)AMINO]-3,4-DIFLUORO-N-(2-HYDROXYETHOXY)BENZAMIDE",AMNKRBRQQAMACZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
63910,6lxt,DB00846,-8.5,Flurandrenolide,POPFMWWJOGLOIF-XWCQMRHXSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
59313,6crv,DB07316,-8.5,"N-{1-[(1-carbamoylcyclopropyl)methyl]piperidin-4-yl}-N-cyclopropyl-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide",FAVXIEFZKPJZRT-NRFANRHFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
159915,7bv1,DB07076,-8.5,6-[(Z)-AMINO(IMINO)METHYL]-N-[3-(CYCLOPENTYLOXY)PHENYL]-2-NAPHTHAMIDE,FWTQOPWAMQXIMI-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
86283,6m3m,DB08660,-8.5,"1,2,5,8-tetrahydroxyanthracene-9,10-dione",VBHKTXLEJZIDJF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
78480,6m2n,DB11818,-8.5,Retosiban,PLVGDGRBPMVYPB-FDUHJNRSSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
99289,6vxs,DB02059,-8.5,Adenosine-5-Diphosphoribose,SRNWOUGRCWSEMX-ZQSHOCFMSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
63621,6lxt,DB00496,-8.5,Darifenacin,HXGBXQDTNZMWGS-RUZDIDTESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
86290,6m3m,DB08670,-8.5,"METHYL N-[(2S,3R)-3-AMINO-2-HYDROXY-3-(4-ISOPROPYLPHENYL)PROPANOYL]-D-ALANYL-D-LEUCINATE",WIWZNHHLFMPGGO-PIKADFDJSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
99824,6vxs,DB02759,-8.5,4-Methylumbelliferyl Chitobiose,UPSFMJHZUCSEHU-JYGUBCOQSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
86162,6m3m,DB08514,-8.5,"6-amino-2-[(thiophen-2-ylmethyl)amino]-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",IQKMJWDYMFWZRF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59420,6crv,DB07441,-8.5,"3-{[(9-CYANO-9,10-DIHYDRO-10-METHYLACRIDIN-9-YL)CARBONYL]AMINO}PROPANOIC ACID",FRBAOMHMZCGBOJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
123043,6w4b,DB14703,-8.5,Dexamethasone metasulfobenzoate,TWQWRHIQRAZHPR-XNXCGYEVSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
138323,6w9c,DB11395,-8.5,Deracoxib,WAZQAZKAZLXFMK-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138326,6w9c,DB11398,-8.5,Diclazuril,ZSZFUDFOPOMEET-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138174,6w9c,DB09274,-8.5,Artesunate,FIHJKUPKCHIPAT-AHIGJZGOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
132826,6w9c,DB00894,-8.5,Testolactone,BPEWUONYVDABNZ-DZBHQSCQSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
99252,6vxs,DB02010,-8.5,Staurosporine,HKSZLNNOFSGOKW-FYTWVXJKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
86314,6m3m,DB08702,-8.5,"2,5-DIPHENYLFURAN-3,4-DICARBOXYLIC ACID",QPKYPOMZPFDBEZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59503,6crv,DB07539,-8.5,"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZOIC ACID",JLRKRQCTYQGDKJ-GHXNOFRVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78544,6m2n,DB11910,-8.5,MK-0249,DDDZBLNULGDPGA-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
74977,6m2n,DB04086,-8.5,"2',4'-Dinitrophenyl-2deoxy-2-Fluro-B-D-Cellobioside",WFVCNOHOODVBQK-IUBYCILNSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
74428,6m2n,DB03336,-8.5,BIA,KVIVJQWOYSWCCZ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
160122,7bv1,DB07537,-8.5,"N'-(6-aminopyridin-3-yl)-N-(2-cyclopentylethyl)-4-methyl-benzene-1,3-dicarboxamide",CLEGTVIMOPPIBR-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
78463,6m2n,DB11793,-8.5,Niraparib,PCHKPVIQAHNQLW-CQSZACIVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
132696,6w9c,DB00741,-8.5,Hydrocortisone,JYGXADMDTFJGBT-VWUMJDOOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
160002,7bv1,DB07175,-8.5,N-{2-methyl-5-[(6-phenylpyrimidin-4-yl)amino]phenyl}methanesulfonamide,CXQRKICWSCAUGW-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
78462,6m2n,DB11792,-8.5,Mirodenafil,MIJFNYMSCFYZNY-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
29868,6cs2,DB11743,-8.5,Ipatasertib,GRZXWCHAXNAUHY-NSISKUIASA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
86280,6m3m,DB08657,-8.5,2-(4-(2-((3-(5-(PYRIDIN-2-YLTHIO)THIAZOL-2-YL)UREIDO)METHYL)-1H-IMIDAZOL-4-YL)PHENOXY)ACETIC ACID,SSXCWVOQWRUMGN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
78459,6m2n,DB11789,-8.5,Hyodeoxycholic Acid,DGABKXLVXPYZII-SIBKNCMHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
32243,6cs2,DB01215,-8.5,Estazolam,CDCHDCWJMGXXRH-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
99801,6vxs,DB02723,-8.5,"4-Oxo-2-Phenylmethanesulfonyl-Octahydro-Pyrrolo[1,2-a]Pyrazine-6-Carboxylic Acid [1-(N-Hydroxycarbamimidoyl)-Piperidin-4-Ylmethyl]-Amide",DHTSUHWLPAEEQB-OALUTQOASA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
99578,6vxs,DB02432,-8.5,RU90395,RLLAUERCSKPFGD-VMPREFPWSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
74306,6m2n,DB03181,-8.5,"2-[4-(4-Hydroxy-3-Isopropyl-Phenoxy)-3,5-Dimethyl-Phenyl]-2h-[1,2,4]Triazine-3,5-Dione",RXQAVKWRCZYGMV-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
143098,6w9q,DB03072,-8.5,"2-{3-[4-(4-Fluorophenyl)-3,6-Dihydro-1(2h)-Pyridinyl]Propyl}-8-Methyl-4(3h)-Quinazolinone",LOFDUAJQRUYHBR-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
32488,6cs2,T3D1846,-8.5,Fenpropathrin,XQUXKZZNEFRCAW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
86218,6m3m,DB08580,-8.5,4-bromo-2-{[(2R)-2-(2-chlorobenzyl)pyrrolidin-1-yl]carbonyl}aniline,JEGGWFHNKPRKTO-CQSZACIVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
132784,6w9c,DB00846,-8.5,Flurandrenolide,POPFMWWJOGLOIF-XWCQMRHXSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
78508,6m2n,DB11859,-8.5,Brexanolone,AURFZBICLPNKBZ-SYBPFIFISA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
99622,6vxs,DB02491,-8.5,4-[4-(1-Amino-1-Methylethyl)Phenyl]-5-Chloro-N-[4-(2-Morpholin-4-Ylethyl)Phenyl]Pyrimidin-2-Amine,CJSSYVIHFXDFFC-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
99634,6vxs,DB02505,-8.5,N-(R-Carboxy-Ethyl)-Alpha-(S)-(2-Phenylethyl),JJVQUUYZGJWBPW-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
99666,6vxs,DB02545,-8.5,Fexaramine,VLQTUNDJHLEFEQ-KGENOOAVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
59477,6crv,DB07510,-8.5,"3-fluoro-6-(4-fluorophenyl)-2-hydroxy-6-oxohexa-2,4-dienoic acid",CPZFGNOKCMJZFO-BTHQEHEQSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
128640,6w4h,DB07847,-8.5,6-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-(4-MORPHOLINYL)-2-OXO ETHYL]-2-OXO-3-PYRROLIDINYL}-2-NAPHTHALENESULFONAMIDE,ICLOZQFWTRAYPX-LIRRHRJNSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
99668,6vxs,DB02547,-8.5,Guanosine-5'-Diphosphate-Rhamnose,LQEBEXMHBLQMDB-GDJBGNAASA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
59480,6crv,DB07513,-8.5,7-[(3-CHLOROBENZYL)OXY]-4-[(METHYLAMINO)METHYL]-2H-CHROMEN-2-ONE,JMGUSOLCNQVZCT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
143107,6w9q,DB03082,-8.5,6-[(Z)-Amino(Imino)Methyl]-N-[4-(Aminomethyl)Phenyl]-4-(Pyrimidin-2-Ylamino)-2-Naphthamide,CSWQJKHBMACTGB-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
86185,6m3m,DB08540,-8.5,"2-[4-(2H-1,4-BENZOTHIAZINE-3-YL)-PIPERAZINE-1-LY]-1,3-THIAZOLE-4-CARBOXYLIC ACID ETHYLESTER",AQJQFCRTSWIUCY-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
99674,6vxs,DB02554,-8.5,"Sulfoquinovose-Uridine-C1,5'-Diphosphate",FQANCGQCBCUSMI-JZMIEXBBSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
32275,6cs2,DB01254,-8.5,Dasatinib,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
132743,6w9c,DB00801,-8.5,Halazepam,WYCLKVQLVUQKNZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
59494,6crv,DB07530,-8.5,"(1R,3R)-5-[(2E)-3-{(1S,3R)-2,2,3-trimethyl-3-[6,6,6-trifluoro-5-hydroxy-5-(trifluoromethyl)hex-3-yn-1-yl]cyclopentyl}prop-2-en-1-ylidene]cyclohexane-1,3-diol",PCHUQQNKOFNVDU-OSXMSNBXSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
74354,6m2n,DB03239,-8.5,"3',5'-Dinitro-N-Acetyl-L-Thyronine",VZSQTOXQXPKQJX-ZDUSSCGKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78528,6m2n,DB11890,-8.5,Cilengitide,AMLYAMJWYAIXIA-VWNVYAMZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
26097,6cs2,DB00482,-8.5,Celecoxib,RZEKVGVHFLEQIL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
32247,6cs2,DB01218,-8.5,Halofantrine,FOHHNHSLJDZUGQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
59442,6crv,DB07468,-8.5,"(3aS)-3a-hydroxy-5-methyl-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one",NJBBBRZNBVLTRZ-GOSISDBHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86175,6m3m,DB08530,-8.5,"7-BENZYL-1,3-DIMETHYL-8-PIPERAZIN-1-YL-3,7-DIHYDRO-PURINE-2,6-DIONE",QFSMMXJBEBXTJP-UHFFFAOYSA-O,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
128592,6w4h,DB07793,-8.5,"(2S)-N-[(3S)-1-(2-AMINO-2-OXOETHYL)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL]-2-CHLORO-2H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE",ACSGSLPOHKRZCY-GXTWGEPZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
59402,6crv,DB07421,-8.5,"4-{[(1R,2S)-1,2-dihydroxy-2-methyl-3-(4-nitrophenoxy)propyl]amino}-2-(trifluoromethyl)benzonitrile",INVUBEGZQHQAMY-SJORKVTESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86347,6m3m,DB08736,-8.5,"S,R-Warfarin alcohol",ZUJMMGHIYSAEOU-DOMZBBRYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
143563,6w9q,DB03712,-8.5,RU85053,CEKLBQMULVLLTD-VMPREFPWSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
123093,6w4b,DB14822,-8.5,SB-649868,ZJXIUGNEAIHSBI-IBGZPJMESA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
122184,6w4b,DB13014,-8.5,Hypericin,BTXNYTINYBABQR-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
114642,6vxx,DB13939,-8.5,RAD-140,XMBUPPIEVAFYHO-KPZWWZAWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
100361,6vxs,DB03478,-8.5,2'-O-Acetyl Adenosine-5-Diphosphoribose,BFNOPXRXIQJDHO-DLFWLGJNSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
132636,6w9c,DB00673,-8.5,Aprepitant,ATALOFNDEOCMKK-OITMNORJSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
63865,6lxt,DB00796,-8.5,Candesartan cilexetil,GHOSNRCGJFBJIB-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
74159,6m2n,DB02976,-8.5,Uridine-5'-monophosphate 2-deoxy-2-fluoro-galactopyranosyl-monophosphate ester,NGTCPFGWXMBZEP-KBQKSTHMSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
28907,6cs2,DB08531,-8.5,"5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",CVYWYUAQFJMLEO-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
112213,6vxx,DB06597,-8.5,Estradiol sulfamate,YXYXCSOJKUAPJI-ZBRFXRBCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86452,6m3m,DB08873,-8.5,Boceprevir,LHHCSNFAOIFYRV-DOVBMPENSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
142733,6w9q,DB02581,-8.5,"5-[2,3-Dichloro-4-(5-{1-[2-(2-Guanidino-4-Methyl-Pentanoylamino)-Acetyl]-Piperidin-4-Yl}-1-Methyl-1h-Pyrazol-3-Yl)-Phenoxymethyl]-Furan-2-Carboxylic Acid",VNZHOIDQBPFEJU-OAQYLSRUSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
128740,6w4h,DB07965,-8.5,6-(cyclohexylamino)-9-[2-(4-methylpiperazin-1-yl)-ethyl]-9H-purine-2-carbonitrile,OGODDSLNRULSMM-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
143764,6w9q,DB03966,-8.5,Clorobiocin,FJAQNRBDVKIIKK-LFLQOBSNSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
159950,7bv1,DB07117,-8.5,"5-(4-PHENOXYPHENYL)-5-(4-PYRIMIDIN-2-YLPIPERAZIN-1-YL)PYRIMIDINE-2,4,6(2H,3H)-TRIONE",FMKQJGOROFNCGM-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59603,6crv,DB07662,-8.5,N-[4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL]-ACRYLAMIDE,HTUBKQUPEREOGA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
98751,6vxs,DB01349,-8.5,Tasosartan,ADXGNEYLLLSOAR-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
59326,6crv,DB07330,-8.5,trans-4-(7-carbamoyl-1H-benzimidazol-2-yl)-1-propylpiperidinium,KXSIHXHEHABEJX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
63218,6crv,DB15360,-8.5,"Carfentanil, C-11",YDSDEBIZUNNPOB-JVVVGQRLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
63902,6lxt,DB00836,-8.5,Loperamide,RDOIQAHITMMDAJ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
112229,6vxx,DB06626,-8.5,Axitinib,RITAVMQDGBJQJZ-FMIVXFBMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
74535,6m2n,DB03488,-8.5,Uridine-5'-diphosphate-2-deoxy-2-fluoro-alpha-D-galactose,NGTCPFGWXMBZEP-NQQHDEILSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
122177,6w4b,DB13003,-8.5,Cortivazol,RKHQGWMMUURILY-UHRZLXHJSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
63909,6lxt,DB00845,-8.5,Clofazimine,WDQPAMHFFCXSNU-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
78595,6m2n,DB11987,-8.5,GSK-2018682,NFIGDBFIDKDNIG-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
28910,6cs2,DB08534,-8.5,"5-(2-fluorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",ZAIYYXVHGBMLEC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
159959,7bv1,DB07126,-8.5,O6-CYCLOHEXYLMETHOXY-2-(4'-SULPHAMOYLANILINO) PURINE,OWXORKPNCHJYOF-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59565,6crv,DB07616,-8.5,"4-{[4-(4-fluoro-3-methylphenyl)-1,3-thiazol-2-yl]amino}-2-hydroxybenzoic acid",LKZZDHKJFDTYCH-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
132883,6w9c,DB00957,-8.5,Norgestimate,KIQQMECNKUGGKA-NMYWJIRASA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
26157,6cs2,DB04232,-8.5,N-Hydroxy-1-(4-Methoxyphenyl)Sulfonyl-4-Benzyloxycarbonyl-Piperazine-2-Carboxamide,DNGGPLKVDUPXFN-GOSISDBHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
100098,6vxs,DB03124,-8.5,5-[4-(1-Carboxymethyl-2-Oxo-Propylcarbamoyl)-Benzylsulfamoyl]-2-Hydroxy-Benzoic Acid,LBAHOXPDTNUYCX-INIZCTEOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
159976,7bv1,DB07145,-8.5,(2R)-N-HYDROXY-2-[(3S)-3-METHYL-3-{4-[(2-METHYLQUINOLIN-4-YL)METHOXY]PHENYL}-2-OXOPYRROLIDIN-1-YL]PROPANAMIDE,YDMIPBHQKFOFQW-NSYGIPOTSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
86354,6m3m,DB08743,-8.5,"2-({8-[(3R)-3-AMINOPIPERIDIN-1-YL]-1,3-DIMETHYL-2,6-DIOXO-1,2,3,6-TETRAHYDRO-7H-PURIN-7-YL}METHYL)BENZONITRILE",XJNKUWDMCBZMTG-OAHLLOKOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
23704,6cs2,HMDB0112257,-8.5,"(13Z,13'Z,3R,3'R,6'R)-Lutein",KBPHJBAIARWVSC-GUPHUWDZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
159975,7bv1,DB07144,-8.5,"5-[(3R)-3-(5-methoxy-2',6'-dimethylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",XZXVRKHUCSXVBM-AWEZNQCLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
112023,6vxx,DB06106,-8.5,AIT-034,FBVDVFULNXWYRF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
99072,6vxs,DB01764,-8.5,Dalfopristin,SUYRLXYYZQTJHF-VMBLUXKRSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
63266,6crv,DB01470,-8.5,alpha-methylthiofentanyl,YPOXDUYRRSUFFG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78435,6m2n,DB11753,-8.5,Rifamycin,HJYYPODYNSCCOU-ODRIEIDWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
29831,6cs2,DB11692,-8.5,Pavinetant,QYTBBBAHNIWFOD-NRFANRHFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
138126,6w9c,DB09209,-8.5,Pholcodine,GPFAJKDEDBRFOS-FKQDBXSBSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
112367,6vxx,DB07024,-8.5,"2-(3,4-DIHYDROXYPHENYL)-8-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-3-HYDROXY-6-METHYL-4H-CHROMEN-4-ONE",CEXBEGBNDJVZPK-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86135,6m3m,DB08485,-8.5,"(1S,4S,5S)-1,4,5-TRIHYDROXY-3-[3-(PHENYLTHIO)PHENYL]CYCLOHEX-2-ENE-1-CARBOXYLIC ACID",QMNMNSINKIFYBV-LMMKCTJWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86371,6m3m,DB08761,-8.5,"(3S,6S)-3,6-bis(4-hydroxybenzyl)piperazine-2,5-dione",NGPCLOGFGKJCBP-HOTGVXAUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59549,6crv,DB07595,-8.5,"(5Z)-5-(3-BROMOCYCLOHEXA-2,5-DIEN-1-YLIDENE)-N-(PYRIDIN-4-YLMETHYL)-1,5-DIHYDROPYRAZOLO[1,5-A]PYRIMIDIN-7-AMINE",WSIQKQLAGWVKSL-UHFFFAOYSA-O,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86124,6m3m,DB08470,-8.5,"3-(4-fluorophenyl)-5-phenyl-4H-1,2,4-triazole",KMGPJKOKSYGMJD-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
138372,6w9c,DB11491,-8.5,Sarafloxacin,XBHBWNFJWIASRO-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
63252,6crv,DB15440,-8.5,GSK-3117391,AFDPFLDWOXXHQM-NRFANRHFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59556,6crv,DB07607,-8.5,4-[5-(3-IODO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-1H-IMIDAZOL-4-YL]-PYRIDINE,RXDZANYWRNIAOR-HHHXNRCGSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59345,6crv,DB07352,-8.5,Apigenin,KZNIFHPLKGYRTM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
143393,6w9q,DB03466,-8.5,BMS184394,AYAJZQYENGWICE-QHCPKHFHSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
78581,6m2n,DB11964,-8.5,Ilaprazole,HRRXCXABAPSOCP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
160191,7bv1,DB07622,-8.5,"1-(3-(2,4-DIMETHYLTHIAZOL-5-YL)-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)-3-(4-METHYLPIPERAZIN-1-YL)UREA",KRKQVGZXTNLQSV-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
143462,6w9q,DB03571,-8.5,"3-(5-Amino-7-Hydroxy-[1,2,3]Triazolo[4,5-D]Pyrimidin-2-Yl)-N-(3,5-Dichlorobenzyl)-Benzamide",JMQTXEWNXSPEKX-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
74509,6m2n,DB03451,-8.5,"1-alpha, 25-dihydroxyl-20-epi-22-oxa-24, 26 ,27-trihomovitamin D3",KLZOTDOJMRMLDX-YBBVPDDNSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
123083,6w4b,DB14792,-8.5,AZD-5991,KBQCEQAXHPIRTF-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
165633,7bv1,DB12571,-8.5,Rimacalib,MYTIJGWONQOOLC-HNNXBMFYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
64299,6lxt,DB01336,-8.5,Metocurine,JFXBEKISTKFVAB-AJQTZOPKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
78689,6m2n,DB12124,-8.5,Namitecan,IBTISPLPBBHVSU-UVOOVGFISA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
85764,6m3m,DB08035,-8.5,"1-TERT-BUTYL-3-(2,5-DIMETHYLBENZYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE",QUPXEJURIFFVSX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
97367,6m71,DB14725,-8.5,Cefamandole nafate,RRJHESVQVSRQEX-SUYBPPKGSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
32007,6cs2,DB15193,-8.5,BMS-955176,XDMUFNNPLXHNKA-ZTESCHFWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
64731,6lxt,DB01908,-8.5,RU85493,MWEWSHNGVWABKG-SVBPBHIXSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
78025,6m2n,DB09172,-8.5,Brifentanil,KKMGCTVJCQYQPV-WBVHZDCISA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
97572,6m71,DB15190,-8.5,GLPG-0259,YBFGSJUVEOYPIS-OALUTQOASA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
111724,6vxx,DB04437,-8.5,"Cysteine-Methylene-Carbamoyl-1,10-Phenanthroline",ZFGIPRHDRFOMFO-LBPRGKRZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
101537,6vxs,DB05482,-8.5,7-ethyl-10-hydroxycamptothecin,FJHBVJOVLFPMQE-QFIPXVFZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
59151,6crv,DB07131,-8.5,(S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclohexylpropanoyl)pyrrolidine-2-carboxamide,DOTBZTLJSXFKCP-IBGZPJMESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
33010,6cs2,T3D3941,-8.5,Triflusulfuron-methyl,IMEVJVISCHQJRM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
64824,6lxt,DB02033,-8.5,"N-(3-Cyclopropyl(5,6,7,8,9,10-Hexahydro-2-Oxo-2h-Cycloocta[B]Pyran-3-Yl)Methyl)Phenylbenzensulfonamide",GDRNWAKVNIROCG-DEOSSOPVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
97571,6m71,DB15189,-8.5,Birabresib,GNMUEVRJHCWKTO-FQEVSTJZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
114879,6vxx,DB15324,-8.5,ORM-13070 C-11,VGIYMYGMVXPMKV-GWDMYEQXSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85773,6m3m,DB08046,-8.5,2-chloro-5-[(1S)-1-hydroxy-3-oxo-2H-isoindol-1-yl]benzenesulfonamide,JIVPVXMEBJLZRO-AWEZNQCLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
112423,6vxx,DB07086,-8.5,"4-[(1S,2S,5S)-5-(HYDROXYMETHYL)-8-METHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL",XXIFNRNIQJKFLP-XHSDSOJGSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
9054,6lzg,DB07124,-8.5,"(2S)-1-(6H-INDOL-3-YL)-3-{[5-(7H-PYRAZOLO[3,4-C]PYRIDIN-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE",CCIACUJJBPSOHE-KRWDZBQOSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
112489,6vxx,DB07312,-8.5,"2,5-DICHLORO-N-(5-CHLORO-1,3-BENZOXAZOL-2-YL)BENZENESULFONAMIDE",JCXZHFCBNFFHRC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165651,7bv1,DB12597,-8.5,ABL-001,VOVZXURTCKPRDQ-CQSZACIVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97574,6m71,DB15192,-8.5,ABT-288,GNIRITULTPTAQW-KNQAVFIVSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
101461,6vxs,DB05039,-8.5,Indacaterol,QZZUEBNBZAPZLX-QFIPXVFZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
97608,6m71,DB15254,-8.5,RO-5126766 free base,LMMJFBMMJUMSJS-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
28819,6cs2,DB00783,-8.5,Estradiol,VOXZDWNPVJITMN-ZBRFXRBCSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
77887,6m2n,DB08950,-8.5,Indoramin,JXZZEXZZKAWDSP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
101626,6vxs,DB06011,-8.5,AMG-222,NVSWJKWHLUTHLP-CPJSRVTESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
59180,6crv,DB07165,-8.5,N-(5-CHLORO-BENZO[B]THIOPHEN-3-YLMETHYL)-2-[6-CHLORO-OXO-3-(2-PYRIDIN-2-YL-ETHYLAMINO)-2H-PYRAZIN-1-YL]-ACETAMIDE,SOBGXPPOYFFGTK-UGKGYDQZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
32019,6cs2,DB15209,-8.5,MK-0736,ORQZQBUNAMJFCY-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
78052,6m2n,DB09200,-8.5,Rivoglitazone,XMSXOLDPMGMWTH-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
101611,6vxs,DB05936,-8.5,CVT-6883,KOYXXLLNCXWUNF-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
132381,6w9c,DB00358,-8.5,Mefloquine,XEEQGYMUWCZPDN-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
73884,6m2n,DB02615,-8.5,Compound 19,UZOOIPXOYYJULJ-BLIZRMSTSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
87025,6m3m,DB11721,-8.5,Mitoglitazone,IRNJSRAGRIZIHD-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
74959,6m2n,DB04064,-8.5,Nogalaviketone,QHNJNOBWURJIEK-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
159664,7bv1,DB05129,-8.5,Elsamitrucin,MGQRRMONVLMKJL-KWJIQSIXSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97366,6m71,DB14723,-8.5,Larotrectinib,NYNZQNWKBKUAII-KBXCAEBGSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
112410,6vxx,DB07070,-8.5,(2S)-2-{3-[({[2-fluoro-4-(trifluoromethyl)phenyl]carbonyl}amino)methyl]-4-methoxybenzyl}butanoic acid,BDLLIPYDNFENMY-ZDUSSCGKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
101460,6vxs,DB05038,-8.5,Anatibant,XUHBBTKJWIBQMY-MHZLTWQESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
85848,6m3m,DB08130,-8.5,"N-(5-{3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]phenyl}-1,3,4-oxadiazol-2-yl)ethane-1,2-diamine",FPDWDLAITHFTTP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
78748,6m2n,DB12218,-8.5,AZD-5363,JDUBGYFRJFOXQC-KRWDZBQOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
85779,6m3m,DB08054,-8.5,"1-(1-methylethyl)-3-quinolin-6-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine",GEZALMMCQYDFML-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59154,6crv,DB07134,-8.5,"5-(4-CHLORO-5-PHENYL-3-THIENYL)-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDE",LCPRWBWCEGWNKF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
159563,7bv1,DB04575,-8.5,Quinestrol,PWZUUYSISTUNDW-VAFBSOEGSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
86769,6m3m,DB09488,-8.5,Acrivastine,PWACSDKDOHSSQD-IUTFFREVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59895,6crv,DB07999,-8.5,"{4-[(CARBOXYMETHOXY)CARBONYL]-3,3-DIOXIDO-1-OXONAPHTHO[1,2-D]ISOTHIAZOL-2(1H)-YL}ACETIC ACID",IXLBOIRSEDMRPI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
128884,6w4h,DB08125,-8.5,"4-{[(2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]AMINO}-N-(1,3-THIAZOL-2-YL)BENZENESULFONAMIDE",BOMPRXSVSIPRDT-PTNGSMBKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
26316,6cs2,DB04434,-8.5,Naphthyridine Inhibitor,YRBHUKMLAGQYHS-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
59896,6crv,DB08000,-8.5,"2-(CARBOXYMETHYL)-1-OXO-1,2-DIHYDRONAPHTHO[1,2-D]ISOTHIAZOLE-4-CARBOXYLIC ACID 3,3-DIOXIDE",ZTJGXDGAXGWOGR-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
137932,6w9c,DB08915,-8.5,Aleglitazar,DAYKLWSKQJBGCS-NRFANRHFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
77976,6m2n,DB09070,-8.5,Tibolone,WZDGZWOAQTVYBX-XOINTXKNSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
101560,6vxs,DB05590,-8.5,Bedoradrine,OANCEOSLKSTLTA-REWPJTCUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
74940,6m2n,DB04037,-8.5,"N,N-Bis(4-Chlorobenzyl)-1h-1,2,3,4-Tetraazol-5-Amine",UOUXILZUBDIWQU-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138505,6w9c,DB11765,-8.5,PF-04991532,GKMLFBRLRVQVJO-ZDUSSCGKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
132304,6w9c,DB00267,-8.5,Cefmenoxime,HJJDBAOLQAWBMH-YCRCPZNHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
29064,6cs2,DB08706,-8.5,"(2S)-({(5Z)-5-[(5-ETHYL-2-FURYL)METHYLENE]-4-OXO-4,5-DIHYDRO-1,3-THIAZOL-2-YL}AMINO)(4-FLUOROPHENYL)ACETIC ACID",RNEACARJKXYVND-MZLJFPOFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
78740,6m2n,DB12204,-8.5,Terbogrel,XUTLOCQNGLJNSA-RGVLZGJSSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
160454,7bv1,DB08406,-8.5,"[N-(2,4-DIAMINOPTERIDIN-6-YL)-METHYL]-DIBENZ[B,F]AZEPINE",NXCCIJQEAKMFGW-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
138518,6w9c,DB11784,-8.5,NRX-1074,DVBUEXCIEIAXPM-PJUQSVSOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
159588,7bv1,DB04608,-8.5,"9-HYDROXY-4-PHENYL-6H-PYRROLO[3,4-C]CARBAZOLE-1,3-DIONE",IAUZTOZLTFSMIE-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
31998,6cs2,DB15177,-8.5,VX-659,IGEOJNMYRZUKIK-IBGZPJMESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
97440,6m71,DB14889,-8.5,Derazantinib,KPJDVVCDVBFRMU-AREMUKBSSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
28842,6cs2,DB08463,-8.5,(2R)-2-({9-(1-methylethyl)-6-[(4-pyridin-2-ylbenzyl)amino]-9H-purin-2-yl}amino)butan-1-ol,HOCBJBNQIQQQGT-LJQANCHMSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
78004,6m2n,DB09119,-8.5,Eslicarbazepine acetate,QIALRBLEEWJACW-INIZCTEOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
97548,6m71,DB15137,-8.5,VK-2809,LGGPZDRLTDGYSQ-JADSYQMUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
101563,6vxs,DB05608,-8.5,MKC-1,OVSKGTONMLKNPZ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
26308,6cs2,DB04424,-8.5,RPR128515,XFKVLKLCLYJKNF-MZNJEOGPSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
121868,6w4b,DB12513,-8.5,Omaveloxolone,RJCWBNBKOKFWNY-IDPLTSGASA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
77986,6m2n,DB09083,-8.5,Ivabradine,ACRHBAYQBXXRTO-OAQYLSRUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
29875,6cs2,DB11753,-8.5,Rifamycin,HJYYPODYNSCCOU-ODRIEIDWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
7975,6lzg,DB04608,-8.5,"9-HYDROXY-4-PHENYL-6H-PYRROLO[3,4-C]CARBAZOLE-1,3-DIONE",IAUZTOZLTFSMIE-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
65004,6lxt,DB02269,-8.5,[4-({[5-Benzyloxy-1-(3-Carbamimidoyl-Benzyl)-1h-Indole-2-Carbonyl]-Amino}-Methyl)-Phenyl]-Trimethyl-Ammonium,UFKJQTGPBFWMGT-UHFFFAOYSA-O,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
64996,6lxt,DB02259,-8.5,"3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid (4-Sulfamoyl-Phenyl)-Amide",VSYGXLAJQDAWCZ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
59166,6crv,DB07148,-8.5,"(6S)-1-chloro-3-[(4-fluorobenzyl)oxy]-6-(pyrrolidin-1-ylcarbonyl)pyrrolo[1,2-a]pyrazin-4(6H)-one",HPAFVLDARQIHPU-HNNXBMFYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
64896,6lxt,DB02123,-8.5,Glycochenodeoxycholic Acid,GHCZAUBVMUEKKP-GYPHWSFCSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
32001,6cs2,DB15187,-8.5,Dubermatinib,YUAALFPUEOYPNX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
128872,6w4h,DB08112,-8.5,N-({6-[(4-CYANO-2-FLUOROBENZYL)OXY]NAPHTHALEN-2-YL}SULFONYL)-D-GLUTAMIC ACID,IRJUSGUHNFMVCK-OAQYLSRUSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
59909,6crv,DB08014,-8.5,(METHYLPYRIDAZINE PIPERIDINE BUTYLOXYPHENYL)ETHYLACETATE,AQILFLLHLFBLLG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31995,6cs2,DB15169,-8.5,H3B-6527,MBWRLLRCTIYXDW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
145207,6w9q,DB07084,-8.5,"N-(6,7,9,10,17,18,20,21-octahydrodibenzo[b,k][1,4,7,10,13,16]hexaoxacyclooctadecin-2-yl)acetamide",YHKGWOJTUMJPNW-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
101631,6vxs,DB06090,-8.5,Bradanicline,OXKRFEWMSWPKKV-GHTZIAJQSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
133216,6w9c,DB01418,-8.5,Acenocoumarol,VABCILAOYCMVPS-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
85799,6m3m,DB08077,-8.5,"2-[4-({[(3,5-DICHLOROPHENYL)AMINO]CARBONYL}AMINO)PHENOXY]-2-METHYLPROPANOIC ACID",OYJPTSMWFKGZJM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
97616,6m71,DB15273,-8.5,VS-4718,IGUBBWJDMLCRIK-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
32850,6cs2,T3D3765,-8.5,Janthitrem F,SHMYDSYGDWIPKT-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
87036,6m3m,DB11739,-8.5,Vonoprazan,BFDBKMOZYNOTPK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
139735,6w9c,DB13866,-8.5,Etynodiol,JYILPERKVHXLNF-QMNUTNMBSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
112501,6vxx,DB07325,-8.5,N-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)METHYL]-3-{[(E)-(2-OXODIHYDROFURAN-3(2H)-YLIDENE)METHYL]AMINO}BENZENESULFONAMIDE,VCOKUBHAJVTVNG-FMIVXFBMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
132230,6w9c,DB00180,-8.5,Flunisolide,XSFJVAJPIHIPKU-XWCQMRHXSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
26294,6cs2,DB04405,-8.5,"2-[2-(1,3-Dioxo-1,3-Dihydro-2h-Isoindol-2-Yl)Ethyl]-4-(4'-Ethoxy-1,1'-Biphenyl-4-Yl)-4-Oxobutanoic Acid",AQYSXARQCHHHLK-NRFANRHFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
111634,6vxx,DB04306,-8.5,"5-[(4-Methylphenyl)Sulfanyl]-2,4-Quinazolinediamine",UOJFGEAPSYQDIP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59192,6crv,DB07179,-8.5,"3-((3-bromo-5-o-tolylpyrazolo[1,5-a]pyrimidin-7-ylamino)methyl)pyridine 1-oxide",DXUJQXZHHGJMFM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78798,6m2n,DB12283,-8.5,Balapiravir,VKXWOLCNTHXCLF-DXEZIKHYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137910,6w9c,DB08878,-8.5,Aminopterin,TVZGACDUOSZQKY-LBPRGKRZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
128851,6w4h,DB08091,-8.5,3-FLUORO-5-MORPHOLIN-4-YL-N-[3-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-5-YL]BENZAMIDE,HIUFYIOMUILESI-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
85862,6m3m,DB08146,-8.5,"7-(2,5-dihydropyrrol-1-yl)-6-phenyl-pyrido[6,5-d]pyrimidin-2-amine",QFWNOFXQNCLFBC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
128852,6w4h,DB08092,-8.5,3-fluoro-N-1H-indol-5-yl-5-morpholin-4-ylbenzamide,VMLSXFMXUNVCSK-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
28809,6cs2,DB08429,-8.5,N-({(2S)-1-[(3R)-3-amino-4-(3-chlorophenyl)butanoyl]pyrrolidin-2-yl}methyl)-3-(methylsulfonyl)benzamide,QRGBOABBMKYMLG-UXHICEINSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
97620,6m71,DB15282,-8.5,Fluorofuranylnorprogesterone F-18,VJKRBRUNEOHPBS-JQKUZGBFSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97609,6m71,DB15257,-8.5,Milademetan,RYAYYVTWKAOAJF-QISPRATLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
9416,6lzg,DB07514,-8.5,"3-(2-aminoquinazolin-6-yl)-1-(3,3-dimethylindolin-6-yl)-4-methylpyridin-2(1H)-one",LHLGUOHREUTYTO-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
97350,6m71,DB14676,-8.5,Fagrocorat,QJJBNCHSWFGXML-KEKPKEOLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
63079,6crv,DB15096,-8.5,18-methoxycoronaridine,DTJQBBHYRQYDEG-SVBQBFEESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
97613,6m71,DB15266,-8.5,TAK-580,VWMJHAFYPMOMGF-ZCFIWIBFSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
101423,6vxs,DB04908,-8.5,Flibanserin,PPRRDFIXUUSXRA-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
25889,6cs2,DB03916,-8.5,4-{2-[4-(2-Aminoethyl)Piperazin-1-Yl]Pyridin-4-Yl}-N-(3-Chloro-4-Methylphenyl)Pyrimidin-2-Amine,RHOOHUMOHVIXEF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
32029,6cs2,DB15229,-8.5,CNV-2197944,BLFJGFDZMABYMY-ZDUSSCGKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
145452,6w9q,DB07362,-8.5,"1-(5-{2-[(1-methyl-1H-pyrazolo[4,3-d]pyrimidin-7-yl)amino]ethyl}-1,3-thiazol-2-yl)-3-[3-(trifluoromethyl)phenyl]urea",UOLCZAFAGDOUFX-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
59183,6crv,DB07169,-8.5,"5R-(3,4-DICHLOROPHENYLMETHYL)-3-(2-THIOPHENESULFONYLAMINO)-4-OXO-2-THIONOTHIAZOLIDINE",GAOOBYJHWAKZKU-LLVKDONJSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138478,6w9c,DB11725,-8.5,Latrepirdine,JNODQFNWMXFMEV-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
101443,6vxs,DB04960,-8.5,Tipifarnib,PLHJCIYEEKOWNM-HHHXNRCGSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
112386,6vxx,DB07043,-8.5,"7-amino-2-tert-butyl-4-(4-pyrimidin-2-ylpiperazin-1-yl)pyrido[2,3-d]pyrimidine-6-carboxamide",CKLCIJCZOIDJQU-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
32022,6cs2,DB15219,-8.5,Tomivosertib,HKTBYUWLRDZAJK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
111590,6vxx,DB04244,-8.5,(2R)-2-(3-Biphenylyl)-N-{(2R)-2-hydroxy-3-[(2-pyridinylsulfonyl)amino]propyl}-4-methylpentanamide,YCDHZDINQZLSRR-DNQXCXABSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
63070,6crv,DB15075,-8.5,4-demethyl-4-cholesteryloxycarbonylpenclomedine,ZJUUIXYKTPSIOH-LEZJFEBPSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111831,6vxx,DB04757,-8.5,"GUANOSINE-2',3'-O-METHYLIDENEPHOSPHONATE",GKAPYWCOOQBBHV-KXSYMAMXSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78075,6m2n,DB09226,-8.5,RP-5063,PMKMNTBZJOXTJW-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
29711,6cs2,DB11450,-8.4,Pimobendan,GLBJJMFZWDBELO-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
55944,6crv,DB01669,-8.4,Virginiamycin M1,DAIKHDNSXMZDCU-FQTGFAPKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108749,6vxx,DB08906,-8.4,Fluticasone furoate,XTULMSXFIHGYFS-VLSRWLAYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
120008,6w4b,DB07978,-8.4,"2-({[2,3,5,6-TETRAFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)CYCLOPENTA-1,3-DIENE-1-CARBOXYLIC ACID",ULMUPVXFUDHRGH-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
78578,6m2n,DB11961,-8.4,AZD-1236,SFJFBTPHDHUUPU-OAHLLOKOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
112008,6vxx,DB05212,-8.4,HE3286,JJKOQZHWYLMASZ-FJWDNACWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
139212,6w9c,DB13129,-8.4,Trimegestone,JUNDJWOLDSCTFK-MTZCLOFQSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
18921,6cs2,HMDB0000722,-8.4,Lithocholyltaurine,QBYUNVOYXHFVKC-LVMSMGIASA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
136570,6w9c,DB07271,-8.4,"4-[(3R)-3-Amino-4-(2,4,5-trifluorophenyl)butanoyl]-3-(2,2,2-trifluoroethyl)-1,4-diazepan-2-one",RMDAPSXWBVPVOG-IAPIXIRKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
114097,6vxx,DB12721,-8.4,RO-5028442,QZXVLRCMAHJVIP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136792,6w9c,DB07537,-8.4,"N'-(6-aminopyridin-3-yl)-N-(2-cyclopentylethyl)-4-methyl-benzene-1,3-dicarboxamide",CLEGTVIMOPPIBR-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
71516,6lxt,DB14675,-8.4,Temsavir,QRPZBKAMSFHVRW-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
33097,6cs2,T3D4083,-8.4,Jervine,CLEXYFLHGFJONT-DNMILWOZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
164402,7bv1,DB07791,-8.4,4-{[4-(1-CYCLOPROPYL-2-METHYL-1H-IMIDAZOL-5-YL)PYRIMIDIN-2-YL]AMINO}-N-METHYLBENZENESULFONAMIDE,MZWCVBFANHIPTJ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
108752,6vxx,DB08910,-8.4,Pomalidomide,UVSMNLNDYGZFPF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112021,6vxx,DB06090,-8.4,Bradanicline,OXKRFEWMSWPKKV-GHTZIAJQSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136786,6w9c,DB07531,-8.4,"4-{5-[(Z)-(2,4-DIOXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE",JNPRTUHVCHGFHJ-GHXNOFRVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
80876,6m3m,DB00542,-8.4,Benazepril,XPCFTKFZXHTYIP-PMACEKPBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
8548,6lzg,DB06347,-8.4,Cenisertib,KSOVGRCOLZZTPF-QMKUDKLTSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
108754,6vxx,DB08912,-8.4,Dabrafenib,BFSMGDJOXZAERB-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
117913,6w4b,DB04125,-8.4,N-Alpha-(2-Naphthylsulfonyl)-N(3-Amidino-L-Phenylalaninyl)-4-Acetyl-Piperazine,ZUWBXGHMVKDMQO-DEOSSOPVSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
136567,6w9c,DB07268,-8.4,2-({2-[(3-HYDROXYPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)BENZAMIDE,QHPKKGUGRGRSGA-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
111993,6vxx,DB05104,-8.4,Asimadoline,JHLHNYVMZCADTC-LOSJGSFVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
71786,6lxt,DB15281,-8.4,Ravoxertinib,RZUOCXOYPYGSKL-GOSISDBHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
30626,6cs2,DB12744,-8.4,CGI-1842,ZXBFYBLSJMEBEP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
9490,6lzg,DB07595,-8.4,"(5Z)-5-(3-BROMOCYCLOHEXA-2,5-DIEN-1-YLIDENE)-N-(PYRIDIN-4-YLMETHYL)-1,5-DIHYDROPYRAZOLO[1,5-A]PYRIMIDIN-7-AMINE",WSIQKQLAGWVKSL-UHFFFAOYSA-O,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
166329,7bv1,DB14662,-8.4,Flunisolide acetate,WEGNFRKBIKYVLC-XTLNBZDDSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
76291,6m2n,DB07036,-8.4,"(3aS,4R,9bR)-2,2-difluoro-4-(4-hydroxyphenyl)-6-(methoxymethyl)-1,2,3,3a,4,9b-hexahydrocyclopenta[c]chromen-8-ol",GPFRMIHXGMVMGF-BZSNNMDCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
30224,6cs2,DB12219,-8.4,GSK-424887,DRXBWLBZWAJIEF-IBGZPJMESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
73245,6m2n,DB01772,-8.4,"3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl]-4-(5-Fluoro-1-Methyl-1h-Indol-3-Yl)-Pyrrole-2,5-Dione",RPGZQOOZHIEPJW-HNNXBMFYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
108741,6vxx,DB08893,-8.4,Mirabegron,PBAPPPCECJKMCM-IBGZPJMESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
73736,6m2n,DB02421,-8.4,Uridine-5'-Diphosphate-Mannose,HSCJRCZFDFQWRP-NYYOCOOHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
35658,1r42,DB01897,-8.4,2-(2f-Benzothiazolyl)-5-Styryl-3-(4f-Phthalhydrazidyl)Tetrazolium Chloride,BEIGFKLRGRRJJA-JLHYYAGUSA-O,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
139194,6w9c,DB13002,-8.4,HKI-357,NERXPXBELDBEPZ-RMKNXTFCSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
111597,6vxx,DB04258,-8.4,Seocalcitol,LVLLALCJVJNGQQ-SEODYNFXSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28908,6cs2,DB08532,-8.4,"6-(2-fluorophenyl)-N-(pyridin-3-ylmethyl)imidazo[1,2-a]pyrazin-8-amine",WCNPGRRMPFCHEO-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
73925,6m2n,DB02669,-8.4,RB106,ZWDQTNWLXALTOV-QYZOEREBSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
73844,6m2n,DB02559,-8.4,"6-(Octahydro-1h-Indol-1-Ylmethyl)Decahydroquinazoline-2,4-Diamine",HDQIGGQUKAQTGU-SZTTVXCBSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
55938,6crv,DB01661,-8.4,1-(5-phospho-D-ribosyl)-ATP,RKNHJBVBFHDXGR-MRUDJCSFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
120007,6w4b,DB07977,-8.4,"3-({[3,5-DIFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)THIOPHENE-2-CARBOXYLIC ACID",CGNHUSCKOHDSMR-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
76160,6m2n,DB06883,-8.4,1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-phenylurea,DHNYNLNKNQJSHF-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
139942,6w9c,DB14632,-8.4,Prednisolone tebutate,HUMXXHTVHHLNRO-KAJVQRHHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139206,6w9c,DB13118,-8.4,Paquinimod,DIKSYHCCYVYKRO-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
164069,7bv1,DB07034,-8.4,"2,2'-{[9-(HYDROXYIMINO)-9H-FLUORENE-2,7-DIYL]BIS(OXY)}DIACETIC ACID",VOKATEXROYSXDW-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
166335,7bv1,DB14668,-8.4,Dienestrol diacetate,YWLLGDVBTLPARJ-OXAZHYLESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
30161,6cs2,DB12129,-8.4,Tideglusib,PMJIHLSCWIDGMD-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
81302,6m3m,DB01039,-8.4,Fenofibrate,YMTINGFKWWXKFG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
137821,6w9c,DB08755,-8.4,N-[(1S)-2-{[(1R)-2-(benzyloxy)-1-cyano-1-methylethyl]amino}-1-(cyclohexylmethyl)-2-oxoethyl]morpholine-4-carboxamide,MQWUTQCRGGBPBT-WIOPSUGQSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
123305,6w4b,DB15282,-8.4,Fluorofuranylnorprogesterone F-18,VJKRBRUNEOHPBS-JQKUZGBFSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
9528,6lzg,DB00699,-8.4,Nicergoline,YSEXMKHXIOCEJA-FVFQAYNVSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
73243,6m2n,DB01768,-8.4,Methylumbelliferyl Sialic Acid,KKDWIUJBUSOPGC-GKHMPSLRSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
112078,6vxx,DB06235,-8.4,Vadimezan,XGOYIMQSIKSOBS-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28911,6cs2,DB08535,-8.4,"3-bromo-5-phenyl-N-(pyridin-3-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",SMIZFGZXFDGISG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
113748,6vxx,DB12025,-8.4,Triptolide,DFBIRQPKNDILPW-CIVMWXNOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75907,6m2n,DB06370,-8.4,Indisulam,SETFNECMODOHTO-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
126577,6w4h,DB04014,-8.4,Alsterpaullone,OLUKILHGKRVDCT-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
30232,6cs2,DB12228,-8.4,Telcagepant,CGDZXLJGHVKVIE-DNVCBOLYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
113653,6vxx,DB11706,-8.4,Raxatrigine,JESCETIFNOFKEU-SJORKVTESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
33487,6cs2,T3D4743,-8.4,Ethinyl Estradiol,BFPYWIDHMRZLRN-SLHNCBLASA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
73240,6m2n,DB01765,-8.4,"(5-Oxo-5,6-Dihydro-Indolo[1,2-a]Quinazolin-7-Yl)-Acetic Acid",INSBKYCYLCEBOD-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
125604,6w4h,DB02704,-8.4,"(2r,3r,4r,5r)-3,4-Dihydroxy-N,N'-Bis[(1s,2r)-2-Hydroxy-2,3-Dihydro-1h-Inden-1-Yl]-2,5-Bis(2-Phenylethyl)Hexanediamide",GQKBYZPVKVXMJL-LAFNQVRVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
30213,6cs2,DB12203,-8.4,Tozadenant,XNBRWUQWSKXMPW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
111670,6vxx,DB04357,-8.4,Pteric Acid,JOAQINSXLLMRCV-UHFFFAOYSA-O,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
33068,6cs2,T3D4030,-8.4,Dinophysistoxin 1,CLBIEZBAENPDFY-ZHACJKMWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
8193,6lzg,DB04875,-8.4,Pralnacasan,CXAGHAZMQSCAKJ-WAHHBDPQSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
33318,6cs2,T3D4512,-8.4,Fluoxastrobin,UFEODZBUAFNAEU-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
28935,6cs2,DB08560,-8.4,3-FLUORO-N-[1-(4-FLUOROPHENYL)-3-(2-THIENYL)-1H-PYRAZOL-5-YL]BENZENESULFONAMIDE,GULUFDCOGAXLEP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
75876,6m2n,DB06274,-8.4,Alvimopan,UPNUIXSCZBYVBB-JVFUWBCBSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137632,6w9c,DB08532,-8.4,"6-(2-fluorophenyl)-N-(pyridin-3-ylmethyl)imidazo[1,2-a]pyrazin-8-amine",WCNPGRRMPFCHEO-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
76773,6m2n,DB07595,-8.4,"(5Z)-5-(3-BROMOCYCLOHEXA-2,5-DIEN-1-YLIDENE)-N-(PYRIDIN-4-YLMETHYL)-1,5-DIHYDROPYRAZOLO[1,5-A]PYRIMIDIN-7-AMINE",WSIQKQLAGWVKSL-UHFFFAOYSA-O,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
30176,6cs2,DB12148,-8.4,Menatetrenone,DKHGMERMDICWDU-GHDNBGIDSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
164094,7bv1,DB07252,-8.4,"3-({4-[(5-chloro-1,3-benzodioxol-4-yl)amino]pyrimidin-2-yl}amino)benzenesulfonamide",TZHCXOMEOHEZDX-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
28777,6cs2,DB08391,-8.4,"6,7-DIMETHOXY-4-[(3R)-3-(QUINOXALIN-2-YLOXY)PYRROLIDIN-1-YL]QUINAZOLINE",UBIIFKJMNRPNMT-CQSZACIVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
80858,6m3m,DB00519,-8.4,Trandolapril,VXFJYXUZANRPDJ-WTNASJBWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
40340,6lu7,DB14860,-8.4,Ensartinib,GLYMPHUVMRFTFV-QLFBSQMISA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
137634,6w9c,DB08534,-8.4,"5-(2-fluorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",ZAIYYXVHGBMLEC-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140007,6w9c,DB14736,-8.4,Cannabivarin,SVTKBAIRFMXQQF-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
108789,6vxx,DB08965,-8.4,Fusafungine,MIZMDSVSLSIMSC-OGLSAIDSSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55686,6crv,DB01333,-8.4,Cefradine,RDLPVSKMFDYCOR-UEKVPHQBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76817,6m2n,DB07647,-8.4,"(2R)-1-[(5,6-DIPHENYL-7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)AMINO]PROPAN-2-OL",VBASHTSSQNDDAS-CQSZACIVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
30657,6cs2,DB12794,-8.4,p-Quaterphenyl,GPRIERYVMZVKTC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
75877,6m2n,DB06276,-8.4,Tanomastat,JXAGDPXECXQWBC-LJQANCHMSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80819,6m3m,DB00469,-8.4,Tenoxicam,LZNWYQJJBLGYLT-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
114142,6vxx,DB12798,-8.4,Relenopride,KGMMSPVVHZGPHL-NRFANRHFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
164313,7bv1,DB07688,-8.4,"4-{[5-(CYCLOHEXYLOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE",RPJIMTALCNCQLV-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
139241,6w9c,DB13208,-8.4,Prednylidene,WSVOMANDJDYYEY-CWNVBEKCSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
28785,6cs2,DB08400,-8.4,4-(3-{[5-(trifluoromethyl)pyridin-2-yl]oxy}benzyl)piperidine-1-carboxylic acid,KUEKMTNOUPAOBS-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
78777,6m2n,DB12253,-8.4,GDC-0810,BURHGPHDEVGCEZ-KJGLQBJMSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79112,6m2n,DB12746,-8.4,AKN-028,JLRIJKVMMZEKDF-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
113681,6vxx,DB11753,-8.4,Rifamycin,HJYYPODYNSCCOU-ODRIEIDWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114926,6vxx,DB15424,-8.4,Bfpet F-18,QWPLCHDPESWJRN-FNNGWQQSSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80820,6m3m,DB00470,-8.4,Dronabinol,CYQFCXCEBYINGO-IAGOWNOFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
108254,6vxx,DB07539,-8.4,"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZOIC ACID",JLRKRQCTYQGDKJ-GHXNOFRVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111715,6vxx,DB04424,-8.4,RPR128515,XFKVLKLCLYJKNF-MZNJEOGPSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138855,6w9c,DB12361,-8.4,Piclozotan,URMTUEWUIGOJBW-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
119758,6w4b,DB07691,-8.4,"2-({[3-(3,4-dihydroisoquinolin-2(1H)-ylsulfonyl)phenyl]carbonyl}amino)benzoic acid",GYILVHHTCYNIOS-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
123832,6w4h,DB00436,-8.4,Bendroflumethiazide,HDWIHXWEUNVBIY-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
165489,7bv1,DB12180,-8.4,Apitolisib,YOVVNQKCSKSHKT-HNNXBMFYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
32701,6cs2,T3D3607,-8.4,Ochratoxin C,BPZZWRPHVVDAPT-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
113675,6vxx,DB11743,-8.4,Ipatasertib,GRZXWCHAXNAUHY-NSISKUIASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79111,6m2n,DB12745,-8.4,GSK-690693,KGPGFQWBCSZGEL-ZDUSSCGKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
40343,6lu7,DB06938,-8.4,4-[[2-[[4-chloro-3-(trifluoromethyl)phenyl]amino]-3H-benzimidazol-5-yl]oxy]-N-methyl-pyridine-2-carboxamide,ZJLSMLDOCGOURY-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
76184,6m2n,DB06910,-8.4,"[4-R-(4-ALPHA,6-BETA,7-BETA]-HEXAHYDRO-5,6-DI(HYDROXY)-1,3-DI(ALLYL)-4,7-BISPHENYLMETHYL)-2H-1,3-DIAZEPINONE",IWJSQELMWLOYSO-LWSSLDFYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137604,6w9c,DB08499,-8.4,"N-[3-(2-fluoroethoxy)phenyl]-N'-(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-6-yl)butanediamide",DQXBKUVWJSZHSI-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
119884,6w4b,DB07833,-8.4,"N-(3-cyanophenyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)-4-biphenylcarboxamide",PMMLSQFPBFKLHH-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
164075,7bv1,DB07229,-8.4,"3-{5-[AMINO(IMINIO)METHYL]-1H-INDOL-2-YL}-5-METHOXY-1,1'-BIPHENYL-2-OLATE",MINVOLKUPZPDNX-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
33064,6cs2,T3D4026,-8.4,(+)-Calycanthine,XSYCDVWYEVUDKQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
40341,6lu7,DB11691,-8.4,Naldemedine,AXQACEQYCPKDMV-RZAWKFBISA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
108756,6vxx,DB08916,-8.4,Afatinib,ULXXDDBFHOBEHA-CWDCEQMOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
9314,6lzg,DB07403,-8.4,"4-[(3-CHLORO-4-{[(2R)-3,3,3-TRIFLUORO-2-HYDROXY-2-METHYLPROPANOYL]AMINO}PHENYL)SULFONYL]-N,N-DIMETHYLBENZAMIDE",DTDZLJHKVNTQGZ-GOSISDBHSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
30646,6cs2,DB12776,-8.4,E-6005,BBTFKAOFCSOZMB-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
138873,6w9c,DB12388,-8.4,Evocalcet,RZNUIYPHQFXBAN-XLIONFOSSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
164294,7bv1,DB07665,-8.4,"N-[2-(carbamimidamidooxy)ethyl]-2-{6-cyano-3-[(2,2-difluoro-2-pyridin-2-ylethyl)amino]-2-fluorophenyl}acetamide",STHCHQXQLDMISY-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
9316,6lzg,DB07405,-8.4,"1-(6-CYANO-3-PYRIDYLCARBONYL)-5',8'-DIFLUOROSPIRO[PIPERIDINE-4,2'(1'H)-QUINAZOLINE]-4'-AMINE",GIZYIOOBBUHOBS-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
32765,6cs2,T3D3678,-8.4,Cytochalasin D,SDZRWUKZFQQKKV-BBXOWAOSSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
126527,6w4h,DB03944,-8.4,"5-[1-(3,4-Dimethoxy-Benzoyl)-1,2,3,4-Tetrahydro-Quinolin-6-Yl]-6-Methyl-3,6-Dihydro-[1,3,4]Thiadiazin-2-One",IZLRMTJLQCLMKF-CYBMUJFWSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
40342,6lu7,DB07382,-8.4,"N-2-1H-benzimidazol-5-yl-N-4-(3-cyclopropyl-1H-pyrazol-5-yl)pyrimidine-2,4-diamine",WJNBSTLIALIIEW-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
113660,6vxx,DB11721,-8.4,Mitoglitazone,IRNJSRAGRIZIHD-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30627,6cs2,DB12745,-8.4,GSK-690693,KGPGFQWBCSZGEL-ZDUSSCGKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
27862,6cs2,DB07422,-8.4,(2S)-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]-3-(pentafluorophenoxy)propanamide,MMNRWNREMUMYQG-INIZCTEOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
75887,6m2n,DB06307,-8.4,Apoptone,CKAXZOYFIHQCBN-JRRMKBMNSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
30656,6cs2,DB12792,-8.4,Boscalid,WYEMLYFITZORAB-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
108280,6vxx,DB07571,-8.4,"N-2-[(BENZYLOXY)CARBONYL]-N-[(1S,2S)-2-HYDROXY-1-(4-HYDROXYBENZYL)PROPYL]-L-LEUCINAMIDE",ZUWYQZGBCBSHFK-HSQYWUDLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
32706,6cs2,T3D3613,-8.4,Microcystin-LL,GLDUYXHQWLQPRR-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
80817,6m3m,DB00467,-8.4,Enoxacin,IDYZIJYBMGIQMJ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
111718,6vxx,DB04429,-8.4,4'-Hydroxyflavanone,ZLHVIYHWWQYJID-HNNXBMFYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30188,6cs2,DB12165,-8.4,Presatovir,GOFXWTVKPWJNGD-UWJYYQICSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
164348,7bv1,DB07729,-8.4,3-fluoro-N-[3-(1H-tetrazol-5-yl)phenyl]benzamide,GAKOBKPDJJGRIL-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
121,6lzg,HMDB0002950,-8.4,"(3R,3'R,6'R,9'-cis)-beta,epsilon-Carotene-3,3'-diol",KBPHJBAIARWVSC-VKIKRWDYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
113705,6vxx,DB11789,-8.4,Hyodeoxycholic Acid,DGABKXLVXPYZII-SIBKNCMHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30688,6cs2,DB12843,-8.4,Oleandrin,JLPDBLFIVFSOCC-XYXFTTADSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
108278,6vxx,DB07568,-8.4,"(2S)-2-[(2,1,3-BENZOTHIADIAZOL-4-YLSULFONYL)AMINO]-2-PHENYL-N-PYRIDIN-4-YLACETAMIDE",ADRNPUSZBRQDBG-KRWDZBQOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
73885,6m2n,DB02616,-8.4,FR117016,CKJGKHXCUDWFDC-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76166,6m2n,DB06889,-8.4,"3-(1H-tetrazol-5-ylmethyl)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(3H)-one",QSBQXAOOVSQABJ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
81378,6m3m,DB01128,-8.4,Bicalutamide,LKJPYSCBVHEWIU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
76753,6m2n,DB07571,-8.4,"N-2-[(BENZYLOXY)CARBONYL]-N-[(1S,2S)-2-HYDROXY-1-(4-HYDROXYBENZYL)PROPYL]-L-LEUCINAMIDE",ZUWYQZGBCBSHFK-HSQYWUDLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
108277,6vxx,DB07567,-8.4,"(2R,3R,4S)-3-(4-HYDROXYPHENYL)-4-METHYL-2-[4-(2-PYRROLIDIN-1-YLETHOXY)PHENYL]CHROMAN-6-OL",XPVKGTWRXBSJKO-LHXLBICKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76235,6m2n,DB06972,-8.4,"7A-[(4-cyanophenyl)methyl]-6-(3,5-dichlorophenyl)-5-oxo-2,3,5,7A-tetrahydro-1H-pyrrolo[1,2-A]pyrrole-7-carbonitrile",TZCXQSNBTXDAJG-QFIPXVFZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138153,6w9c,DB09239,-8.4,Niguldipine,SVJMLYUFVDMUHP-XIFFEERXSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
10465,6lzg,DB08664,-8.4,({3-[1-(4-HYDROXY-2-OXO-2H-CHROMEN-3-YL)-PROPYL]-PHENYLCARBAMOYL}-METHYL)-CARBAMIC ACID TERT-BUTYL ESTER,QUQQVMVIWCUYFV-KRWDZBQOSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
123338,6w4b,DB15343,-8.4,HM-43239,FZLSDZZNPXXBBB-KDURUIRLSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
71770,6lxt,DB15242,-8.4,MK-0533,STWITCBWQHTJFJ-XMMPIXPASA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
76319,6m2n,DB07066,-8.4,"2-CHLORO-N-[(3R)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL]-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE",LJAHIGGEXIWVJG-LLVKDONJSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75928,6m2n,DB06440,-8.4,Ravuconazole,OPAHEYNNJWPQPX-RCDICMHDSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76475,6m2n,DB07250,-8.4,"N'-(5-CHLORO-1,3-BENZODIOXOL-4-YL)-N-(3,4,5- TRIMETHOXYPHENYL)PYRIMIDINE-2,4-DIAMINE",HMKLUOPMOJOUDZ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
165427,7bv1,DB12085,-8.4,LCL-161,UFPFGVNKHCLJJO-SSKFGXFMSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
164133,7bv1,DB07294,-8.4,"3-fluoro-4-[2-hydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8,-tetrahydro-naphtalen-2-yl)-acetylamino]-benzoic acid",AANFHDFOMFRLLR-IBGZPJMESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
78649,6m2n,DB12068,-8.4,T-900607,FSXLOWIFSZNIMV-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
71647,6lxt,DB15003,-8.4,PF-06700841,BUWBRTXGQRBBHG-MJBXVCDLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
30444,6cs2,DB00950,-8.4,Fexofenadine,RWTNPBWLLIMQHL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
71645,6lxt,DB14995,-8.4,NP-G2-044,XLLRLAABUFOJPC-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
55865,6crv,DB01568,-8.4,Codeine-N-oxide,BDLSDHWCOJPHIE-KFUGMXNISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78995,6m2n,DB12566,-8.4,Decernotinib,ASUGUQWIHMTFJL-QGZVFWFLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
32828,6cs2,T3D3742,-8.4,Fumitremorgin A,ACGHJVZDNQZJOV-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
78994,6m2n,DB12565,-8.4,Abexinostat,MAUCONCHVWBMHK-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78993,6m2n,DB12563,-8.4,MK-0686,WZZIQHIQMWJNLU-LLVKDONJSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
108575,6vxx,DB08414,-8.4,"6-CHLORO-2-(1-FURO[2,3-C]PYRIDIN-5-YL-ETHYLSULFANYL)-PYRIMIDIN-4-YLAMINE",ATCRIOJPQXDFNY-ZETCQYMHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110975,6vxx,DB02830,-8.4,FR236913,KCCUBLLGAMGDJL-HXUWFJFHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111013,6vxx,DB02880,-8.4,N-[1-(4-Bromophenyl)Ethyl]-5-Fluoro Salicylamide,KFTNEILVDDUXGR-SECBINFHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
8320,6lzg,DB05412,-8.4,Talmapimod,ZMELOYOKMZBMRB-DLBZAZTESA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
111197,6vxx,DB03325,-8.4,Tyrosyladenylate,MJZAZMKENKZBAJ-QTOWJTHWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78988,6m2n,DB12555,-8.4,Nelotanserin,COSPVUFTLGQDQL-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76463,6m2n,DB07235,-8.4,"N-[(1S)-2-AMINO-1-(2,4-DICHLOROBENZYL)ETHYL]-5-[2-(METHYLAMINO)PYRIMIDIN-4-YL]THIOPHENE-2-CARBOXAMIDE",HHOVRZGUSBMKKU-ZDUSSCGKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
108582,6vxx,DB08424,-8.4,"[5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL](3-{[(2R)-2,3-DIHYDROXYPROPYL]OXY}PHENYL)METHANONE",IJDQETGUEUJVTB-HNNXBMFYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111915,6vxx,DB04863,-8.4,Lefradafiban,PGCFXITVMNNKON-ROUUACIJSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111919,6vxx,DB04867,-8.4,Lintitript,ILNRQFBVVQUOLP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111230,6vxx,DB03368,-8.4,"5-Methyl-5-(4-Phenoxy-Phenyl)-Pyrimidine-2,4,6-Trione",RTBMLCLTYAPKIF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
7769,6lzg,DB04350,-8.4,Argadin,FOZYKTUSOWWQGR-KNPYFFGGSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
118769,6w4b,DB06248,-8.4,Amelubant,SBVYURPQULDJTI-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
9368,6lzg,DB07460,-8.4,2-({5-CHLORO-2-[(2-METHOXY-4-MORPHOLIN-4-YLPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)-N-METHYLBENZAMIDE,UYJNQQDJUOUFQJ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
79016,6m2n,DB12597,-8.4,ABL-001,VOVZXURTCKPRDQ-CQSZACIVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
74046,6m2n,DB02833,-8.4,[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(3-Nitro-Phenyl)-Amine,DYTKVFHLKPDNRW-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
73456,6m2n,DB02059,-8.4,Adenosine-5-Diphosphoribose,SRNWOUGRCWSEMX-ZQSHOCFMSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
111931,6vxx,DB04883,-8.4,Darusentan,FEJVSJIALLTFRP-LJQANCHMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
310,6lzg,HMDB0004246,-8.4,Bradykinin,QXZGBUJJYSLZLT-FDISYFBBSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
108433,6vxx,DB07986,-8.4,[4-(4-PHENYL-PIPERIDIN-1-YL)-BENZENESULFONYLAMINO]-ACETIC ACID,GNSLACGSDSJAIQ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81091,6m3m,DB00801,-8.4,Halazepam,WYCLKVQLVUQKNZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
76121,6m2n,DB06834,-8.4,"N-(2-hydroxy-1,1-dimethylethyl)-1-methyl-3-(1H-pyrrolo[2,3-b]pyridin-2-yl)-1H-indole-5-carboxamide",XZRYCTLOGNCQDG-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
110940,6vxx,DB02607,-8.4,Adenosine Phosphonoacetic Acid,KJNLSEOJEFDELT-JJNLEZRASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165432,7bv1,DB12096,-8.4,PF-05175157,BDXXSFOJPYSYOC-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
30446,6cs2,DB12492,-8.4,Piritramide,IHEHEFLXQFOQJO-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
108599,6vxx,DB08444,-8.4,"3-[2-bromo-4-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)phenoxy]-5-methylbenzonitrile",YYGZQXRLQMFHDH-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
73961,6m2n,DB02715,-8.4,Compound 18,UZOOIPXOYYJULJ-RHLLTPQKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
123233,6w4b,DB15137,-8.4,VK-2809,LGGPZDRLTDGYSQ-JADSYQMUSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
111925,6vxx,DB04876,-8.4,Vildagliptin,SYOKIDBDQMKNDQ-XWTIBIIYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
32816,6cs2,T3D3729,-8.4,Altertoxin-1,GJIALGLHOBXNAT-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
73653,6m2n,DB02322,-8.4,Heparin Disaccharide I-S,LRPGJWKAYQRIAQ-GYBHJADLSA-J,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
73489,6m2n,DB02101,-8.4,"(S,R)-fidarestat",WAAPEIZFCHNLKK-QPUJVOFHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
81092,6m3m,DB00802,-8.4,Alfentanil,IDBPHNDTYPBSNI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
18848,6cs2,HMDB0036657,-8.4,Epi-alpha-amyrin,FSLPMRQHCOLESF-QJYIJPODSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
111875,6vxx,DB04816,-8.4,Dantron,QBPFLULOKWLNNW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165281,7bv1,DB11701,-8.4,Amenamevir,MNHNIVNAFBSLLX-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
113942,6vxx,DB12303,-8.4,Motolimod,QSPOQCXMGPDIHI-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
118557,6w4b,DB05171,-8.4,E-2012,PUOAETJYKQITMO-LANLRWRYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
138994,6w9c,DB12682,-8.4,Mubritinib,ZTFBIUXIQYRUNT-MDWZMJQESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
111859,6vxx,DB04794,-8.4,Bifonazole,OCAPBUJLXMYKEJ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108529,6vxx,DB08095,-8.4,"3-(2-CHLOROPHENYL)-1-(2-{[(1S)-2-HYDROXY-1,2-DIMETHYLPROPYL]AMINO}PYRIMIDIN-4-YL)-1-(4-METHOXYPHENYL)UREA",ZWYFTKPEHRQCCW-HNNXBMFYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78695,6m2n,DB12131,-8.4,Vinpocetine,DDNCQMVWWZOMLN-IRLDBZIGSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
164174,7bv1,DB07338,-8.4,Acifluorfen,NUFNQYOELLVIPL-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
76405,6m2n,DB07167,-8.4,5-CYANO-FURAN-2-CARBOXYLIC ACID [5-HYDROXYMETHYL-2-(4-METHYL-PIPERIDIN-1-YL)-PHENYL]-AMIDE,NNPCFFIJVKYGHR-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
140408,6w9c,DB06040,-8.4,Filanesib,LLXISKGBWFTGEI-FQEVSTJZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
108517,6vxx,DB08080,-8.4,LATRUNCULIN B,NSHPHXHGRHSMIK-JRIKCGFMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
164163,7bv1,DB07326,-8.4,"6-chloro-N-pyrimidin-5-yl-3-{[3-(trifluoromethyl)phenyl]amino}-1,2-benzisoxazole-7-carboxamide",FEGRQUWSKADGSP-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
126125,6w4h,DB03397,-8.4,Uridine-Diphosphate-N-Acetylglucosamine,LFTYTUAZOPRMMI-CFRASDGPSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
126178,6w4h,DB03476,-8.4,Trans-6-(2-Phenylcyclopropyl)-Naphthalene-2-Carboxamidine,NQRIWXVAIWPBEM-OALUTQOASA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
108499,6vxx,DB08059,-8.4,Wortmannin,QDLHCMPXEPAAMD-QAIWCSMKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
166407,7bv1,DB15071,-8.4,Omidenepag isopropyl,VIQCWEGEHRBLAC-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
76406,6m2n,DB07168,-8.4,[4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-6-(methylamino)pyrimidin-2-yl}amino)phenyl]acetonitrile,MFMSRHREFZCFSN-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
113962,6vxx,DB12327,-8.4,Salvinorin A,OBSYBRPAKCASQB-AGQYDFLVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81146,6m3m,DB00861,-8.4,Diflunisal,HUPFGZXOMWLGNK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
165413,7bv1,DB12066,-8.4,Orteronel,OZPFIJIOIVJZMN-SFHVURJKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
33944,6cs2,T3D0630,-8.4,Triphenylene,SLGBZMMZGDRARJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
71593,6lxt,DB14866,-8.4,Amcasertib,QDWKGEFGLQMDAM-ULJHMMPZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
123655,6w4h,DB00224,-8.4,Indinavir,CBVCZFGXHXORBI-PXQQMZJSSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
34166,6cs2,T3D1029,-8.4,Acrinathrin,YLFSVIMMRPNPFK-WEQBUNFVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
30341,6cs2,DB12361,-8.4,Piclozotan,URMTUEWUIGOJBW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
113981,6vxx,DB12542,-8.4,GSK-356278,AWDJJMXJUOHGLC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
73547,6m2n,DB02181,-8.4,2'-Deoxyguanosine-5'-Triphosphate,HAAZLUGHYHWQIW-KVQBGUIXSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76051,6m2n,DB06713,-8.4,Norelgestromin,ISHXLNHNDMZNMC-XUDSTZEESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
164200,7bv1,DB07369,-8.4,"N-(3-chlorophenyl)-N-methyl-2-oxo-3-[(3,4,5-trimethyl-1H-pyrrol-2-yl)methyl]-2H-indole-5-sulfonamide",YMJLSOJLEXWATP-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
137742,6w9c,DB08664,-8.4,({3-[1-(4-HYDROXY-2-OXO-2H-CHROMEN-3-YL)-PROPYL]-PHENYLCARBAMOYL}-METHYL)-CARBAMIC ACID TERT-BUTYL ESTER,QUQQVMVIWCUYFV-KRWDZBQOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
111020,6vxx,DB02889,-8.4,"4-O-(4,6-Dideoxy-4-{[4,5,6-Trihydroxy-3-(Hydroxymethyl)Cyclohex-2-En-1-Yl]Amino}-Beta-D-Lyxo-Hexopyranosyl)-Alpha-D-Erythro-Hexopyranose",SNMISNLUIRCRQE-SFSRYZOZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
137972,6w9c,DB08971,-8.4,Fluocortolone,GAKMQHDJQHZUTJ-ULHLPKEOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
126202,6w4h,DB03507,-8.4,"6-[3-(4-Morpholinyl)Propyl]-2-(3-Nitrophenyl)-5-Thioxo-5,6,-Dihydro-7h-Thienol[2',3':4,5]Pyrrolo[1,2-C]Imidazol-7-One",UXGUZFZBZPPZGL-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
55838,6crv,DB01541,-8.4,Boldenone,RSIHSRDYCUFFLA-DYKIIFRCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136645,6w9c,DB07362,-8.4,"1-(5-{2-[(1-methyl-1H-pyrazolo[4,3-d]pyrimidin-7-yl)amino]ethyl}-1,3-thiazol-2-yl)-3-[3-(trifluoromethyl)phenyl]urea",UOLCZAFAGDOUFX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
76062,6m2n,DB06730,-8.4,Gestodene,SIGSPDASOTUPFS-XUDSTZEESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
29592,6cs2,DB11115,-8.4,Ensulizole,UVCJGUGAGLDPAA-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
81103,6m3m,DB00814,-8.4,Meloxicam,ZRVUJXDFFKFLMG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
111042,6vxx,DB02916,-8.4,"[(2r,3s,4r,5r)-5-(6-Amino-9h-Purin-9-Yl)-3,4-Dihydroxytetrahydro-2-Furanyl]Methyl Sulfamate",GNZLUJQJDPRUTD-KQYNXXCUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111053,6vxx,DB02929,-8.4,K201,KCWGETCFOVJEPI-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138017,6w9c,DB09020,-8.4,Bisacodyl,KHOITXIGCFIULA-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137976,6w9c,DB08975,-8.4,Florantyrone,QOBAOSCOLAGPKI-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
71607,6lxt,DB14889,-8.4,Derazantinib,KPJDVVCDVBFRMU-AREMUKBSSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
123652,6w4h,DB00220,-8.4,Nelfinavir,QAGYKUNXZHXKMR-HKWSIXNMSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
28872,6cs2,DB08495,-8.4,4-({4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-2-OXOPIPERAZIN-1-YL}METHYL)BENZENECARBOXIMIDAMIDE,VXONTEUOQXFJJS-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
80927,6m3m,DB00601,-8.4,Linezolid,TYZROVQLWOKYKF-ZDUSSCGKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
30460,6cs2,DB12513,-8.4,Omaveloxolone,RJCWBNBKOKFWNY-IDPLTSGASA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
111796,6vxx,DB04706,-8.4,"(3BETA,7BETA)-CHOLEST-5-ENE-3,7-DIOL",OYXZMSRRJOYLLO-KGZHIOMZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76621,6m2n,DB07415,-8.4,4-[(1S)-1-(3-fluoro-4-methoxyphenyl)-2-(2-methoxy-5-nitrophenyl)ethyl]-1H-imidazol-2-amine,RFLOFHKRBGKCOB-AWEZNQCLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
27875,6cs2,DB00680,-8.4,Moricizine,FUBVWMNBEHXPSU-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
71558,6lxt,DB14774,-8.4,Balipodect,KVHRYLNQDWXAGI-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
136748,6w9c,DB07486,-8.4,"3-({4-[(1E)-3-morpholin-4-yl-3-oxoprop-1-en-1-yl]-2,3-bis(trifluoromethyl)phenyl}sulfanyl)aniline",KLSZVPNVFKKIRD-FNORWQNLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
111989,6vxx,DB05087,-8.4,Ganaxolone,PGTVWKLGGCQMBR-FLBATMFCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165450,7bv1,DB12120,-8.4,Avoralstat,TUWMKPVJGGWGNL-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
81250,6m3m,DB00981,-8.4,Physostigmine,PIJVFDBKTWXHHD-HIFRSBDPSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
55908,6crv,DB01623,-8.4,Thiothixene,GFBKORZTTCHDGY-UWVJOHFNSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
71563,6lxt,DB14790,-8.4,BPN-14770,KRRGWHSEDYQKDQ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
30552,6cs2,DB12647,-8.4,Tocotrienol,GJJVAFUKOBZPCB-ZGRPYONQSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
111330,6vxx,DB03510,-8.4,6-O-Phosphoryl Inosine Monophosphate,RXRZOKQPANIEDW-KQYNXXCUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114045,6vxx,DB12645,-8.4,Givinostat,YALNUENQHAQXEA-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78602,6m2n,DB11999,-8.4,Vosaroxin,XZAFZXJXZHRNAQ-STQMWFEESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
136612,6w9c,DB07325,-8.4,N-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)METHYL]-3-{[(E)-(2-OXODIHYDROFURAN-3(2H)-YLIDENE)METHYL]AMINO}BENZENESULFONAMIDE,VCOKUBHAJVTVNG-FMIVXFBMSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136742,6w9c,DB07479,-8.4,"(1S)-1,2,3,4-TETRAHYDRO-BENZO[C]PHENANTHRENE-2,3,4-TRIOL",WCUHTHVUZQCBTI-KBAYOESNSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
113799,6vxx,DB12101,-8.4,CC-220,IXZOHGPZAQLIBH-NRFANRHFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
73941,6m2n,DB02691,-8.4,Glycocholic acid,RFDAIACWWDREDC-FRVQLJSFSA-M,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78731,6m2n,DB12188,-8.4,Zicronapine,BYPMJBXPNZMNQD-PZJWPPBQSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138918,6w9c,DB12563,-8.4,MK-0686,WZZIQHIQMWJNLU-LLVKDONJSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
33572,6cs2,T3D4820,-8.4,Finasteride,DBEPLOCGEIEOCV-WSBQPABSSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
76628,6m2n,DB07423,-8.4,(2S)-3-[4-(acetylamino)phenoxy]-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide,YVXVTLGIDOACBJ-SFHVURJKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
111991,6vxx,DB05100,-8.4,Prinomastat,YKPYIPVDTNNYCN-INIZCTEOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
71680,6lxt,DB15068,-8.4,Agerafenib,DKNUPRMJNUQNHR-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
114067,6vxx,DB12675,-8.4,PF-04995274,WLLOFQROROXOMO-GOSISDBHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76654,6m2n,DB07453,-8.4,2-PHENYL-4H-BENZO[H]CHROMEN-4-ONE,VFMMPHCGEFXGIP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
164287,7bv1,DB07653,-8.4,"N-(5,6-DIPHENYLFURO[2,3-D]PYRIMIDIN-4-YL)GLYCINE",VXTCEUDVOCLEJG-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
108733,6vxx,DB08878,-8.4,Aminopterin,TVZGACDUOSZQKY-LBPRGKRZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
137654,6w9c,DB08557,-8.4,"2-[(2-methoxyethyl)amino]-4-(4-oxo-1,2,3,4-tetrahydro-9H-carbazol-9-yl)benzamide",XQKFKSJUBJPOLY-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
76652,6m2n,DB07451,-8.4,1-(5-BROMO-PYRIDIN-2-YL)-3-[2-(6-FLUORO-2-HYDROXY-3-PROPIONYL-PHENYL)-CYCLOPROPYL]-UREA,VRAJWAGCJIXJHQ-YPMHNXCESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
108723,6vxx,DB08860,-8.4,Pitavastatin,VGYFMXBACGZSIL-MCBHFWOFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114065,6vxx,DB12672,-8.4,Icaritin,TUUXBSASAQJECY-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113764,6vxx,DB12050,-8.4,LY-3039478,YCBAQKQAINQRFW-UGSOOPFHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138920,6w9c,DB12566,-8.4,Decernotinib,ASUGUQWIHMTFJL-QGZVFWFLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
76313,6m2n,DB07059,-8.4,"N-{2-[6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2,2-DIMETHYL-3-OXO-2,3-DIHYDRO-4H-1,4-BENZOXAZIN-4-YL]ETHYL}ACETAMIDE",GBXSOZDYCSBLQX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
119187,6w4b,DB07025,-8.4,3-(5-{[4-(AMINOMETHYL)PIPERIDIN-1-YL]METHYL}-1H-INDOL-2-YL)QUINOLIN-2(1H)-ONE,KBIHHEGEALBUMT-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
76315,6m2n,DB07061,-8.4,"1-(CYCLOHEXYLAMINO)-3-(6-METHYL-3,4-DIHYDRO-1H-CARBAZOL-9(2H)-YL)PROPAN-2-OL",AXYFCRIRLKSCRR-SFHVURJKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
74124,6m2n,DB02932,-8.4,(R)-Bicalutamide,LKJPYSCBVHEWIU-KRWDZBQOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
10523,6lzg,DB08730,-8.4,3-FLUORO-5-MORPHOLIN-4-YL-N-[1-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-6-YL]BENZAMIDE,CPFBZMFUCGHBAP-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
119144,6w4b,DB06976,-8.4,"1-(5-OXO-2,3,5,9B-TETRAHYDRO-1H-PYRROLO[2,1-A]ISOINDOL-9-YL)-3-(5-PYRROLIDIN-2-YL-1H-PYRAZOL-3-YL)-UREA",IWOOJEZSDPRYAZ-WFASDCNBSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
140389,6w9c,DB05903,-8.4,KOS-1584,XAYAKDZVINDZGB-BMVMHAJPSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139173,6w9c,DB12966,-8.4,Falnidamol,FTFRZXFNZVCRSK-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
79055,6m2n,DB12663,-8.4,Letrazuril,XQKYUBTUOHHNDV-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
114060,6vxx,DB12666,-8.4,Emapunil,NBMBIEOUVBHEBM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
21740,6cs2,HMDB0051386,-8.4,"TG(20:3(5Z,8Z,11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:4(8Z,11Z,14Z,17Z))",MKUDSHOEWNCTAU-WWTGNTJDSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
79048,6m2n,DB12654,-8.4,GSK-376501,OIDYMQICWGYEDR-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
111794,6vxx,DB04704,-8.4,20-hydroxycholesterol,MCKLJFJEQRYRQT-MGNSQDQZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76325,6m2n,DB07074,-8.4,6-CARBAMIMIDOYL-4-(3-HYDROXY-2-METHYL-BENZOYLAMINO)-NAPHTHALENE-2-CARBOXYLIC ACID METHYL ESTER,OUBRALHIKGRAMA-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78613,6m2n,DB12011,-8.4,Fevipiprant,GFPPXZDRVCSVNR-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
108423,6vxx,DB07974,-8.4,1-{2-[(4-CHLOROPHENYL)AMINO]-2-OXOETHYL}-N-(1-ISOPROPYLPIPERIDIN-4-YL)-1H-INDOLE-2-CARBOXAMIDE,BDLMBQRBNPDCSS-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75993,6m2n,DB06604,-8.4,Ilepatril,FXKFFTMLFPWYFH-RDGPPVDQSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
71582,6lxt,DB14845,-8.4,Filgotinib,RIJLVEAXPNLDTC-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
139955,6w9c,DB14646,-8.4,Prednisone acetate,MOVRKLZUVNCBIP-RFZYENFJSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
73421,6m2n,DB02014,-8.4,"5-(2-Fluoro-5-{(1E)-3-[3-hydroxy-2-(methoxycarbonyl)phenoxy]-1-propen-1-yl}phenyl)-1,2-oxazole-3-carboxylic acid",QKHWJUMLYAYZFS-ONEGZZNKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
30519,6cs2,DB12594,-8.4,AZD-9056,HSQAARMBHJCUOK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
9357,6lzg,DB07450,-8.4,(R)-minalrestat,BMHZAHGTGIZZCT-LJQANCHMSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
30505,6cs2,DB12574,-8.4,LY-295501,VAMFSFIPDOODFH-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
108650,6vxx,DB08503,-8.4,"(3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(4-methylphenyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol",HRCKGDOSPBFICB-MZHQWRCYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111942,6vxx,DB04903,-8.4,Pagoclone,HIUPRQPBWVEQJJ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
118858,6w4b,DB06486,-8.4,Enzastaurin,AXRCEOKUDYDWLF-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
137690,6w9c,DB08602,-8.4,"3-(2,6-difluorophenyl)-2-(methylthio)quinazolin-4(3H)-one",BFNBJSXMXXQLAW-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
123127,6w4b,DB14895,-8.4,Vibegron,DJXRIQMCROIRCZ-XOEOCAAJSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
123260,6w4b,DB15193,-8.4,BMS-955176,XDMUFNNPLXHNKA-ZTESCHFWSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
9366,6lzg,DB07458,-8.4,"3-(1H-indol-3-yl)-4-{1-[2-(1-methylpyrrolidin-2-yl)ethyl]-1H-indol-3-yl}-1H-pyrrole-2,5-dione",LBFDERUQORUFIN-KRWDZBQOSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
113857,6vxx,DB12187,-8.4,Abacavir hydroxyacetate,ZBBZROWQLKCFQK-KOLCDFICSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
7127,6lzg,DB03268,-8.4,RU82197,WKTQBTSOHBKBRW-VMPREFPWSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
73943,6m2n,DB02694,-8.4,Pantoyl Adenylate,GDPVENOGSVMRJL-FSRKKXLISA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
111795,6vxx,DB04705,-8.4,"(3BETA)-CHOLEST-5-ENE-3,25-DIOL",INBGSXNNRGWLJU-ZHHJOTBYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
137686,6w9c,DB08597,-8.4,"6-[4-(2-piperidin-1-ylethoxy)phenyl]-3-pyridin-4-ylpyrazolo[1,5-a]pyrimidine",XHBVYDAKJHETMP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
76357,6m2n,DB07113,-8.4,"(2S)-6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2-(3,5-DIFLUOROPHENYL)-4-(3-METHOXYPROPYL)-2H-1,4-BENZOXAZIN-3(4H)-ONE",KHZQOXQOUCGGGA-NRFANRHFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
8430,6lzg,DB05983,-8.4,Bardoxolone methyl,WPTTVJLTNAWYAO-KPOXMGGZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
74089,6m2n,DB02889,-8.4,"4-O-(4,6-Dideoxy-4-{[4,5,6-Trihydroxy-3-(Hydroxymethyl)Cyclohex-2-En-1-Yl]Amino}-Beta-D-Lyxo-Hexopyranosyl)-Alpha-D-Erythro-Hexopyranose",SNMISNLUIRCRQE-SFSRYZOZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
108673,6vxx,DB08531,-8.4,"5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",CVYWYUAQFJMLEO-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
119106,6w4b,DB06925,-8.4,3-(2-AMINOQUINAZOLIN-6-YL)-4-METHYL-N-[3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE,YEIASMOUYNOXGA-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
113810,6vxx,DB12116,-8.4,Epigallocatechin gallate,WMBWREPUVVBILR-WIYYLYMNSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
164235,7bv1,DB07410,-8.4,[2-(3-DIBENZOFURAN-4-YL-PHENYL)-1-HYDROXY-1-PHOSPHONO-ETHYL]-PHOSPHONIC ACID,BYVXAUZOTGITQZ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
136735,6w9c,DB07470,-8.4,"(3aS)-3a-hydroxy-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one",DOMYOVZXZIZTRD-QGZVFWFLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
76587,6m2n,DB07375,-8.4,"5-BETA-ANDROSTANE-3,17-DIONE",RAJWOBJTTGJROA-QJISAEMRSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76327,6m2n,DB07078,-8.4,"(3Z)-6-(4-HYDROXY-3-METHOXYPHENYL)-3-(1H-PYRROL-2-YLMETHYLENE)-1,3-DIHYDRO-2H-INDOL-2-ONE",AYSXURJZVXBSRV-WJDWOHSUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
27890,6cs2,DB07450,-8.4,(R)-minalrestat,BMHZAHGTGIZZCT-LJQANCHMSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
71574,6lxt,DB14821,-8.4,Macozinone,BJDZBXGJNBMCAV-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
166442,7bv1,DB15138,-8.4,AZD-9496,DFBDRVGWBHBJNR-BBNFHIFMSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
76329,6m2n,DB07080,-8.4,"N-(2,2,2-TRIFLUOROETHYL)-N-{4-[2,2,2-TRIFLUORO-1-HYDROXY-1-(TRIFLUOROMETHYL)ETHYL]PHENYL}BENZENESULFONAMIDE",SGIWFELWJPNFDH-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
55879,6crv,DB01587,-8.4,Ketazolam,PWAJCNITSBZRBL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55726,6crv,DB01413,-8.4,Cefepime,HVFLCNVBZFFHBT-ZKDACBOMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76571,6m2n,DB07354,-8.4,"2,3-DIMETHOXY-12H-[1,3]DIOXOLO[5,6]INDENO[1,2-C]ISOQUINOLIN-6-IUM",LXDREMZQGAILJU-UHFFFAOYSA-O,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78607,6m2n,DB12005,-8.4,Nirogacestat,VFCRKLWBYMDAED-REWPJTCUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
30296,6cs2,DB12301,-8.4,Doravirine,ZIAOVIPSKUPPQW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
76568,6m2n,DB07351,-8.4,O-(((1R)-((N-(PHENYL-METHOXY-CARBONYL)-ALANYL)-AMINO)METHYL)HYDROXYPHOSPHINYL)3-L-PHENYLLACTATE,ICACWKLCNCPHAM-YJBOKZPZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
108655,6vxx,DB08510,-8.4,5-ALPHA-PREGNANE-3-BETA-OL-HEMISUCCINATE,UVTGFMKBPVLATL-DSOJQRAMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
74110,6m2n,DB02915,-8.4,"4-(2,4-Dimethyl-1,3-thiazol-5-yl)-N-[4-(trifluoromethyl)phenyl]-2-pyrimidinamine",MEZFDQUDLQCVNX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80997,6m3m,DB00688,-8.4,Mycophenolate mofetil,RTGDFNSFWBGLEC-SYZQJQIISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
165446,7bv1,DB12114,-8.4,Poziotinib,LPFWVDIFUFFKJU-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
125593,6w4h,DB02691,-8.4,Glycocholic acid,RFDAIACWWDREDC-FRVQLJSFSA-M,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
109897,6vxx,DB00564,-8.4,Carbamazepine,FFGPTBGBLSHEPO-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112099,6vxx,DB06274,-8.4,Alvimopan,UPNUIXSCZBYVBB-JVFUWBCBSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
124641,6w4h,DB01459,-8.4,Bezitramide,FLKWNFFCSSJANB-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
139524,6w9c,DB13587,-8.4,Mesterolone,UXYRZJKIQKRJCF-TZPFWLJSSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
32028,6cs2,DB15227,-8.4,Tirabrutinib,SEJLPXCPMNSRAM-GOSISDBHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
80226,6m2n,DB14903,-8.4,Rovafovir etalafenamide,OCJRRXHWPBXZSU-BJBBEUPESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
124215,6w4h,DB00894,-8.4,Testolactone,BPEWUONYVDABNZ-DZBHQSCQSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
110100,6vxx,DB00977,-8.4,Ethinylestradiol,BFPYWIDHMRZLRN-SLHNCBLASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
8863,6lzg,DB06920,-8.4,Eribaxaban,QQBKAVAGLMGMHI-WIYYLYMNSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
138647,6w9c,DB12063,-8.4,CERC-301,RECBFDWSXWAXHY-IAGOWNOFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
121423,6w4b,DB11871,-8.4,PF-00610355,YPHDIMUXXABSSO-YTTGMZPUSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
55208,6crv,DB00738,-8.4,Pentamidine,XDRYMKDFEDOLFX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
7568,6lzg,DB04020,-8.4,"4-(2-{[4-{[3-(4-Chlorophenyl)Propyl]Sulfanyl}-6-(1-Piperazinyl)-1,3,5-Triazin-2-Yl]Amino}Ethyl)Phenol",AIBKIFHSQQYXLG-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
72797,6m2n,DB01162,-8.4,Terazosin,VCKUSRYTPJJLNI-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
31771,6cs2,DB14717,-8.4,Nitrazolam,OYRPNABWTHDOFK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
29226,6cs2,DB08893,-8.4,Mirabegron,PBAPPPCECJKMCM-IBGZPJMESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
137175,6w9c,DB07987,-8.4,"[2-(5-MERCAPTO-[1,3,4]THIADIAZOL-2-YLCARBAMOYL)-1-PHENYL-ETHYL]-CARBAMIC ACID BENZYL ESTER",AWAKNMKLVLWIIQ-OAHLLOKOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
79686,6m2n,DB13610,-8.4,Flumedroxone,CDZJOBWKHSYNMO-SCUQKFFVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
110146,6vxx,DB01029,-8.4,Irbesartan,YOSHYTLCDANDAN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112366,6vxx,DB07022,-8.4,3-Hydroxypropyl 3-[(7-carbamimidoyl-1-naphthyl)carbamoyl]benzenesulfonate,PXERBGNIBOFZOW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165630,7bv1,DB12566,-8.4,Decernotinib,ASUGUQWIHMTFJL-QGZVFWFLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
79678,6m2n,DB13602,-8.4,Promegestone,QFFCYTLOTYIJMR-XMGTWHOFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
165840,7bv1,DB13093,-8.4,TAK-593,DZFZXPPHBWCXPQ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
28467,6cs2,DB08056,-8.4,"N-(2,6-dimethylphenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine",KKYYLKPGILUPOA-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
165841,7bv1,DB13094,-8.4,Pruvanserin,AQRLDDAFYYAIJP-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
112918,6vxx,DB08148,-8.4,"1-[4-(4-chlorophenyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine",QOZMRRGNAZNWDN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
137163,6w9c,DB07973,-8.4,N-(1-ISOPROPYLPIPERIDIN-4-YL)-1-(3-METHOXYBENZYL)-1H-INDOLE-2-CARBOXAMIDE,GIPCBGDQVGKMPO-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
124172,6w4h,DB00845,-8.4,Clofazimine,WDQPAMHFFCXSNU-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
139509,6w9c,DB13563,-8.4,Norgestrienone,GVDMJXQHPUYPHP-FYQPLNBISA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139485,6w9c,DB13533,-8.4,Methylestrenolone,ZXSWTMLNIIZPET-ZOFHRBRSSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
78080,6m2n,DB09232,-8.4,Cilnidipine,KJEBULYHNRNJTE-DHZHZOJOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137344,6w9c,DB08173,-8.4,5-CHLORO-N-(2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO)ETHYL)THIOPHENE-2-CARBOXAMIDE,UCKHUNHXYMAFQM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
72727,6m2n,DB01082,-8.4,Streptomycin,UCSJYZPVAKXKNQ-HZYVHMACSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
29186,6cs2,DB08828,-8.4,Vismodegib,BPQMGSKTAYIVFO-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
121454,6w4b,DB11913,-8.4,LY-2090314,HRJWTAWVFDCTGO-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
121449,6w4b,DB11907,-8.4,Rociletinib,HUFOZJXAKZVRNJ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
112415,6vxx,DB07078,-8.4,"(3Z)-6-(4-HYDROXY-3-METHOXYPHENYL)-3-(1H-PYRROL-2-YLMETHYLENE)-1,3-DIHYDRO-2H-INDOL-2-ONE",AYSXURJZVXBSRV-WJDWOHSUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80197,6m2n,DB14854,-8.4,TC-6987,UAKZGMMGIMKFMV-RBUKOAKNSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
121946,6w4b,DB12640,-8.4,CP-609754,JAHDAIPFBPPQHQ-GDLZYMKVSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
112408,6vxx,DB07067,-8.4,"(2S,3S)-3-{3-[4-(METHYLSULFONYL)PHENYL]-1,2,4-OXADIAZOL-5-YL}-1-OXO-1-PYRROLIDIN-1-YLBUTAN-2-AMINE",SQCDMTZMCHZYGO-FZMZJTMJSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112404,6vxx,DB07063,-8.4,"{3-[(4,5,7-TRIFLUORO-1,3-BENZOTHIAZOL-2-YL)METHYL]-1H-INDOL-1-YL}ACETIC ACID",KYHVTMFADJNSGS-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
10084,6lzg,DB08233,-8.4,6-CYCLOHEXYLMETHYLOXY-2-(4'-HYDROXYANILINO)PURINE,RFSDQDHHBKYQOD-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
164982,7bv1,DB09042,-8.4,Tedizolid phosphate,QCGUSIANLFXSGE-GFCCVEGCSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
112396,6vxx,DB07054,-8.4,(2R)-1-(DIMETHYLAMINO)-3-{4-[(6-{[2-FLUORO-5-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-4-YL)AMINO]PHENOXY}PROPAN-2-OL,OSCWQKTUILTARV-MRXNPFEDSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31777,6cs2,DB14726,-8.4,Dabigatran,YBSJFWOBGCMAKL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
114766,6vxx,DB14802,-8.4,ONO-2952,ZBQMTQGDBFZUBG-NRFANRHFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31798,6cs2,DB14769,-8.4,Pamiparib,DENYZIUJOTUUNY-MRXNPFEDSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
110062,6vxx,DB00764,-8.4,Mometasone,QLIIKPVHVRXHRI-CXSFZGCWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109643,6vxx,DB15052,-8.4,Ansofaxine,QKYBZJLEMOZFFU-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79794,6m2n,DB13755,-8.4,Iocarmic acid,SMQYOVYWPWASGU-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137206,6w9c,DB08020,-8.4,"(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-6-(METHOXYMETHYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL",RHQLNMNKTIOREN-AOIWGVFYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
31795,6cs2,DB14765,-8.4,Rivoceranib,WPEWQEMJFLWMLV-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
28300,6cs2,DB07882,-8.4,"4-{4-[2-(1A,7A-DIMETHYL-4-OXY-OCTAHYDRO-1-OXA-4-AZA-CYCLOPROPA[A]NAPHTHALEN-4-YL) -ACETYLAMINO]-PHENYLCARBAMOYL}-BUTYRIC ACID",VFIZFTGABDUGCF-UPVHCHBVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
29857,6cs2,DB11732,-8.4,Lasmiditan,XEDHVZKDSYZQBF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
75417,6m2n,DB04669,-8.4,TRIAZOLOPYRIMIDINE,YWBFPKPWMSWWEA-UHFFFAOYSA-O,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
55190,6crv,DB00716,-8.4,Nedocromil,RQTOOFIXOKYGAN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72767,6m2n,DB01128,-8.4,Bicalutamide,LKJPYSCBVHEWIU-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137191,6w9c,DB08005,-8.4,4-{[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino}-N-ethylpiperidine-1-carboxamide,ARMFMDYRYOKSOW-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
165817,7bv1,DB13059,-8.4,PF-03814735,RYYNGWLOYLRZLK-RBUKOAKNSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
28468,6cs2,DB08057,-8.4,"N-(2-chloro-6-methylphenyl)-8-[(3S)-3-methylpiperazin-1-yl]imidazo[1,5-a]quinoxalin-4-amine",VWJPPYCULHDHBB-HNNXBMFYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
80257,6m2n,DB14998,-8.4,Olorinab,ACSQLTBPYZSGBA-GMXVVIOVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
121368,6w4b,DB11791,-8.4,Capmatinib,LIOLIMKSCNQPLV-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
75528,6m2n,DB04823,-8.4,Oxyphenisatin,SJDACOMXKWHBOW-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
113047,6vxx,DB08309,-8.4,3-({2-[(4-{[6-(CYCLOHEXYLMETHOXY)-9H-PURIN-2-YL]AMINO}PHENYL)SULFONYL]ETHYL}AMINO)PROPAN-1-OL,AMFGILNPFBVREA-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79575,6m2n,DB13458,-8.4,Thebacon,RRJQTGHQFYTZOW-ILWKUFEGSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
31512,6cs2,DB13943,-8.4,Testosterone cypionate,HPFVBGJFAYZEBE-ZLQWOROUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
113071,6vxx,DB08340,-8.4,"N,N'-DIPHENYLPYRAZOLO[1,5-A][1,3,5]TRIAZINE-2,4-DIAMINE",LLYYAUZAGCZEKV-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110232,6vxx,DB01128,-8.4,Bicalutamide,LKJPYSCBVHEWIU-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75551,6m2n,DB04849,-8.4,Cediranib,XXJWYDDUDKYVKI-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
112340,6vxx,DB06993,-8.4,"(2S,3S)-4-cyclopropyl-3-{(3R,5R)-3-[2-fluoro-4-(methylsulfonyl)phenyl]-1,2,4-oxadiazolidin-5-yl}-1-[(3S)-3-fluoropyrrolidin-1-yl]-1-oxobutan-2-amine",PTAHVQJZNFGPHN-WFWWEWPISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29277,6cs2,DB08962,-8.4,Glibornuride,RMTYNAPTNBJHQI-LLDVTBCESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
78244,6m2n,DB11372,-8.4,Altrenogest,VWAUPFMBXBWEQY-ANULTFPQSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78257,6m2n,DB11395,-8.4,Deracoxib,WAZQAZKAZLXFMK-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78260,6m2n,DB11398,-8.4,Diclazuril,ZSZFUDFOPOMEET-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
9837,6lzg,DB07969,-8.4,3-[3-(4-methylpiperazin-1-yl)-7-(trifluoromethyl)quinoxalin-5-yl]phenol,QNCYYRHIUFGGJX-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
7273,6lzg,DB03523,-8.4,Brequinar,PHEZJEYUWHETKO-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
78263,6m2n,DB11409,-8.4,Febantel,HMCCXLBXIJMERM-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77350,6m2n,DB08268,-8.4,"6-AMINO-4-[2-(4-METHYLPHENYL)ETHYL]-1,7-DIHYDRO-8H-IMIDAZO[4,5-G]QUINAZOLIN-8-ONE",SPVJRTJUEVXOMS-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137400,6w9c,DB08246,-8.4,"(2S)-4-(2,5-DIFLUOROPHENYL)-N,N-DIMETHYL-2-PHENYL-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDE",WFFMEXQHWXEKBV-SFHVURJKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
113079,6vxx,DB08350,-8.4,"5-[3-(2-METHOXYPHENYL)-1H-PYRROLO[2,3-B]PYRIDIN-5-YL]-N,N-DIMETHYLPYRIDINE-3-CARBOXAMIDE",GYQRHHQPEMOLKH-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30087,6cs2,DB12036,-8.4,Naquotinib,QKDCLUARMDUUKN-XMMPIXPASA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
28249,6cs2,DB07830,-8.4,"(4R,5R)-5-AMINO-1-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN-2-ONE",DIRIFWIKLRTNMB-DYVFJYSZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
31479,6cs2,DB13865,-8.4,Dehydroemetine,XXLZPUYGHQWHRN-RPBOFIJWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
78275,6m2n,DB11429,-8.4,Mibolerone,PTQMMNYJKCSPET-OMHQDGTGSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
164564,7bv1,DB08148,-8.4,"1-[4-(4-chlorophenyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine",QOZMRRGNAZNWDN-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
72277,6m2n,DB00554,-8.4,Piroxicam,QYSPLQLAKJAUJT-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
121228,6w4b,DB11526,-8.4,Masitinib,WJEOLQLKVOPQFV-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
75573,6m2n,DB04879,-8.4,Vatalanib,YCOYDOIWSSHVCK-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
110243,6vxx,DB01140,-8.4,Cefadroxil,BOEGTKLJZSQCCD-UEKVPHQBSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75515,6m2n,DB04807,-8.4,4-NITROPHENYL-(6-S-ALPHA-D-XYLOPYRANOSYL)-BETA-D-GLUCOPYRANOSIDE,HQYVHBCTLFPWRQ-ZMFOIVQCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
164633,7bv1,DB08233,-8.4,6-CYCLOHEXYLMETHYLOXY-2-(4'-HYDROXYANILINO)PURINE,RFSDQDHHBKYQOD-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
75508,6m2n,DB04797,-8.4,Triazolopyridine,OVCXRBARSPBVMC-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
72334,6m2n,DB00623,-8.4,Fluphenazine,PLDUPXSUYLZYBN-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
112922,6vxx,DB08152,-8.4,{(2S)-1-[N-(tert-butoxycarbonyl)glycyl]pyrrolidin-2-yl}methyl (3-chlorophenyl)acetate,ONXGIEJBNQLITK-INIZCTEOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112923,6vxx,DB08153,-8.4,"(5E)-14-CHLORO-15,17-DIHYDROXY-4,7,8,9,10,11-HEXAHYDRO-2-BENZOXACYCLOPENTADECINE-1,12(3H,13H)-DIONE",VZTAZMSAAIUZJV-HWKANZROSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138681,6w9c,DB12113,-8.4,CE-224535,FUCKCIVGBCBZNP-MRXNPFEDSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
32043,6cs2,DB15254,-8.4,RO-5126766 free base,LMMJFBMMJUMSJS-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
164687,7bv1,DB08487,-8.4,3-({4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-2-OXOPIPERAZIN-1-YL}METHYL)BENZENECARBOXIMIDAMIDE,PRMSFVUWLBPPLY-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
72847,6m2n,DB01216,-8.4,Finasteride,DBEPLOCGEIEOCV-WSBQPABSSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
124836,6w4h,DB01691,-8.4,Indole Naphthyridinone,VAZMNDXVXVUKFY-JXMROGBWSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
110200,6vxx,DB01091,-8.4,Butenafine,ABJKWBDEJIDSJZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138457,6w9c,DB11689,-8.4,Selumetinib,CYOHGALHFOKKQC-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
74720,6m2n,DB03751,-8.4,2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose,YSYKRGRSMLTJNL-URARBOGNSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
140192,6w9c,DB15323,-8.4,Trelagliptin,IWYJYHUNXVAVAA-OAHLLOKOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
124149,6w4h,DB00820,-8.4,Tadalafil,WOXKDUGGOYFFRN-IIBYNOLFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
72321,6m2n,DB00607,-8.4,Nafcillin,GPXLMGHLHQJAGZ-JTDSTZFVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
121327,6w4b,DB11734,-8.4,Fedovapagon,RUOLFWZIFNQQGH-DEOSSOPVSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
78207,6m2n,DB11259,-8.4,Diosmetin,MBNGWHIJMBWFHU-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
112353,6vxx,DB07006,-8.4,"9-HYDROXY-6-(3-HYDROXYPROPYL)-4-(2-METHOXYPHENYL)PYRROLO[3,4-C]CARBAZOLE-1,3(2H,6H)-DIONE",AOGOZJCRIFBTTN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
137129,6w9c,DB07934,-8.4,[[CYCLOHEXANESULFONYL-GLYCYL]-3[PYRIDIN-4-YL-AMINOMETHYL]ALANYL]PIPERIDINE,KMUXFASJKPVMGU-HXUWFJFHSA-O,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
110218,6vxx,DB01112,-8.4,Cefuroxime,JFPVXVDWJQMJEE-IZRZKJBUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29251,6cs2,DB08931,-8.4,Riociguat,WXXSNCNJFUAIDG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
31581,6cs2,DB14065,-8.4,Lomerizine,JQSAYKKFZOSZGJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
112994,6vxx,DB08240,-8.4,N-(4-CHLOROPHENYL)-3-(PHOSPHONOOXY)NAPHTHALENE-2-CARBOXAMIDE,RQAQWBFHPMSXKR-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72320,6m2n,DB00606,-8.4,Cyclothiazide,BOCUKUHCLICSIY-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
124853,6w4h,DB01713,-8.4,Udp-Alpha-D-Xylopyranose,DQQDLYVHOTZLOR-OCIMBMBZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
110222,6vxx,DB01116,-8.4,Trimethaphan,CHQOEHPMXSHGCL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31574,6cs2,DB14054,-8.4,Asiatic acid,JXSVIVRDWWRQRT-UYDOISQJSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
54893,6crv,DB00355,-8.4,Aztreonam,WZPBZJONDBGPKJ-VEHQQRBSSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
164715,7bv1,DB08519,-8.4,"N-4-(3-methyl-1H-indazol-6-yl)-N-2-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine",SQQAPOSROFWHIB-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
77555,6m2n,DB08520,-8.4,"(21S)-1AZA-4,4-DIMETHYL-6,19-DIOXA-2,3,7,20-TETRAOXOBICYCLO[19.4.0] PENTACOSANE",VUCSBBBCFXBFFY-IBGZPJMESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
109670,6vxx,DB15106,-8.4,Surufatinib,TTZSNFLLYPYKIL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110039,6vxx,DB00735,-8.4,Naftifine,OZGNYLLQHRPOBR-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
220,6lzg,HMDB0003448,-8.4,"3-Hydroxy-b,e-caroten-3'-one",OABQIJAIRYEICK-DKLMTRRASA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
112622,6vxx,DB07468,-8.4,"(3aS)-3a-hydroxy-5-methyl-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one",NJBBBRZNBVLTRZ-GOSISDBHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75109,6m2n,DB04258,-8.4,Seocalcitol,LVLLALCJVJNGQQ-SEODYNFXSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80086,6m2n,DB14632,-8.4,Prednisolone tebutate,HUMXXHTVHHLNRO-KAJVQRHHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75113,6m2n,DB04263,-8.4,Geneticin,BRZYSWJRSDMWLG-DJWUNRQOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75117,6m2n,DB04270,-8.4,(S)-3-(4-(2-Carbazol-9-Yl-Ethoxy)-Phenyl)-2-Ethoxy-Propionic Acid,WUZIMDSVRIBNNI-DEOSSOPVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
31971,6cs2,DB15126,-8.4,IMG-7289,KQKBMHGOHXOHTD-KKUQBAQOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
165728,7bv1,DB12719,-8.4,Turofexorate isopropyl,INASOKQDNHHMRE-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
112625,6vxx,DB07471,-8.4,"5-[5,6-BIS(METHYLOXY)-1H-BENZIMIDAZOL-1-YL]-3-{[1-(2-CHLOROPHENYL)ETHYL]OXY}-2-THIOPHENECARBOXAMIDE",UHCHLTQBLNUYRT-GFCCVEGCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79951,6m2n,DB14029,-8.4,Furafylline,HMZQULPVMKITSP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77905,6m2n,DB08970,-8.4,Fluprednidene,YVHXHNGGPURVOS-SBTDHBFYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137271,6w9c,DB08096,-8.4,"8-(2-CHLOROPHENYLAMINO)-2-(2,6-DIFLUOROPHENYLAMINO)-9-ETHYL-9H-PURINE-1,7-DIIUM",ZWKOUFZHPNIQSH-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
77818,6m2n,DB08833,-8.4,Taurochenodeoxycholic acid,BHTRKEVKTKCXOH-BJLOMENOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
31900,6cs2,DB14998,-8.4,Olorinab,ACSQLTBPYZSGBA-GMXVVIOVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
112644,6vxx,DB07493,-8.4,"(2Z)-5'-BROMO-2,3'-BIINDOLE-2',3(1H,1'H)-DIONE AMMONIATE",IEQQJQHHJMQETK-YPKPFQOOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109802,6vxx,DB00273,-8.4,Topiramate,KJADKKWYZYXHBB-XBWDGYHZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77910,6m2n,DB08975,-8.4,Florantyrone,QOBAOSCOLAGPKI-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80107,6m2n,DB14654,-8.4,Bisoxatin acetate,ZCBJDQBSLZREAA-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
165674,7bv1,DB12640,-8.4,CP-609754,JAHDAIPFBPPQHQ-GDLZYMKVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
77750,6m2n,DB08750,-8.4,"1-[4-(AMINOMETHYL)BENZOYL]-5'-FLUORO-1'H-SPIRO[PIPERIDINE-4,2'-QUINAZOLIN]-4'-AMINE",SFPCNWQWKOUNRT-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
109939,6vxx,DB00613,-8.4,Amodiaquine,OVCDSSHSILBFBN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72632,6m2n,DB00973,-8.4,Ezetimibe,OLNTVTPDXPETLC-XPWALMASSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138532,6w9c,DB11800,-8.4,Tivozanib,SPMVMDHWKHCIDT-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137269,6w9c,DB08094,-8.4,"(4-AMINO-2-{[1-(METHYLSULFONYL)PIPERIDIN-4-YL]AMINO}PYRIMIDIN-5-YL)(2,3-DIFLUORO-6-METHOXYPHENYL)METHANONE",JRNJNYBQQYBCLE-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
79938,6m2n,DB13997,-8.4,Baloxavir marboxil,RZVPBGBYGMDSBG-GGAORHGYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
31890,6cs2,DB14944,-8.4,Tarloxotinib,MUJMYVFVAWFUJL-SNAWJCMRSA-O,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
139598,6w9c,DB13682,-8.4,Cefpirome,DKOQGJHPHLTOJR-WHRDSVKCSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138571,6w9c,DB11859,-8.4,Brexanolone,AURFZBICLPNKBZ-SYBPFIFISA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
77831,6m2n,DB08846,-8.4,Ellagic Acid,AFSDNFLWKVMVRB-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
124361,6w4h,DB01061,-8.4,Azlocillin,JTWOMNBEOCYFNV-NFFDBFGFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
79977,6m2n,DB14075,-8.4,Imidurea,ZCTXEAQXZGPWFG-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137305,6w9c,DB08133,-8.4,N-(4-sulfamoylphenyl)-1H-indazole-3-carboxamide,MNHPHKFLWAPNOV-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
112513,6vxx,DB07338,-8.4,Acifluorfen,NUFNQYOELLVIPL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79989,6m2n,DB14097,-8.4,13-cis-12-(3'-Carboxyphenyl)retinoic acid,XKKDQOHDTASHCE-PAZAWXFKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
28391,6cs2,DB07981,-8.4,2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]-n-[(1R)-1-(hydroxymethyl)propyl]acetamide,GKJWXEORYGBJFS-QGZVFWFLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
109899,6vxx,DB00567,-8.4,Cephalexin,ZAIPMKNFIOOWCQ-UEKVPHQBSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72565,6m2n,DB00897,-8.4,Triazolam,JOFWLTCLBGQGBO-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
109889,6vxx,DB00554,-8.4,Piroxicam,QYSPLQLAKJAUJT-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112541,6vxx,DB07373,-8.4,"ANDROSTA-1,4-DIENE-3,17-DIONE",LUJVUUWNAPIQQI-QAGGRKNESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31970,6cs2,DB15124,-8.4,PF-05241328,RVTSXVZXEGFIPW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
109929,6vxx,DB00603,-8.4,Medroxyprogesterone acetate,PSGAAPLEWMOORI-PEINSRQWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112543,6vxx,DB07375,-8.4,"5-BETA-ANDROSTANE-3,17-DIONE",RAJWOBJTTGJROA-QJISAEMRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165695,7bv1,DB12669,-8.4,4SC-203,MAFACRSJGNJHCF-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
164908,7bv1,DB08950,-8.4,Indoramin,JXZZEXZZKAWDSP-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
77856,6m2n,DB08899,-8.4,Enzalutamide,WXCXUHSOUPDCQV-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
164872,7bv1,DB08710,-8.4,"(5Z)-5-[(5-ETHYL-2-FURYL)METHYLENE]-2-{[(S)-(4-FLUOROPHENYL)(1H-TETRAZOL-5-YL)METHYL]AMINO}-1,3-THIAZOL-4(5H)-ONE",BKZOQCGDCHOGOQ-MZLJFPOFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
112567,6vxx,DB07403,-8.4,"4-[(3-CHLORO-4-{[(2R)-3,3,3-TRIFLUORO-2-HYDROXY-2-METHYLPROPANOYL]AMINO}PHENYL)SULFONYL]-N,N-DIMETHYLBENZAMIDE",DTDZLJHKVNTQGZ-GOSISDBHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80059,6m2n,DB14543,-8.4,Hydrocortisone probutate,FOGXJPFPZOHSQS-AYVLZSQQSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
31931,6cs2,DB15057,-8.4,NUC-1031,NHTKGYOMICWFQZ-KKQYNPQSSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
31925,6cs2,DB15048,-8.4,Licogliflozin,XFJAMQQAAMJFGB-ZQGJOIPISA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
77844,6m2n,DB08878,-8.4,Aminopterin,TVZGACDUOSZQKY-LBPRGKRZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
121745,6w4b,DB12336,-8.4,GDC-0917,HSHPBORBOJIXSQ-HARLFGEKSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
138536,6w9c,DB11806,-8.4,VTP-194204,BOOOLEGQBVUTKC-NVQSDHBMSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
116860,6w4b,DB02705,-8.4,"6-[N-(1-Isopropyl-1,2,3,4-Tetrahydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine",DARQQJKHXPXSRO-QFIPXVFZSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
75068,6m2n,DB04201,-8.4,Histidyl-Adenosine Monophosphate,XTFBSLZFYLGYAT-OPYVMVOTSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75070,6m2n,DB04204,-8.4,[(4-{4-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Butyl}-Phenyl)-Difluoro-Methyl]-Phosphonic Acid,SRHSAABKYJDBDV-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
55012,6crv,DB00498,-8.4,Phenindione,NFBAXHOPROOJAW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
139583,6w9c,DB13667,-8.4,Cefozopran,QDUIJCOKQCCXQY-WHJQOFBOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
72899,6m2n,DB01320,-8.4,Fosphenytoin,XWLUWCNOOVRFPX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
31985,6cs2,DB15149,-8.4,Futibatinib,KEIPNCCJPRMIAX-HNNXBMFYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
121644,6w4b,DB12198,-8.4,Fosdagrocorat,BVXLAHSJXXSWFF-KEKPKEOLSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
138501,6w9c,DB11759,-8.4,Pevonedistat,MPUQHZXIXSTTDU-QXGSTGNESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
72413,6m2n,DB00717,-8.4,Norethisterone,VIKNJXKGJWUCNN-XGXHKTLJSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
9911,6lzg,DB08044,-8.4,ABT-341,NVVSPGQEXMJZIR-BMIGLBTASA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
77595,6m2n,DB08568,-8.4,(2S)-1-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}-3-PHENYLPROPAN-2-AMINE,BPNUQXPIQBZCMR-IBGZPJMESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
10050,6lzg,DB08191,-8.4,"4-(5-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl)benzoic acid",KSFDVNIKNYXUIP-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
80170,6m2n,DB14775,-8.4,Cavosonstat,BXSZILNGNMDGSL-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137233,6w9c,DB08052,-8.4,"1-cyclopentyl-3-(1H-pyrrolo[2,3-b]pyridin-5-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine",NVRXTLZYXZNATH-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
77592,6m2n,DB08561,-8.4,"BENZYL 6-BENZYL-5,7-DIOXO-6,7-DIHYDRO-5H-[1,3]THIAZOLO[3,2-C]PYRIMIDINE-2-CARBOXYLATE",PLBINCOCFGQAJM-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
72714,6m2n,DB01066,-8.4,Cefditoren,KMIPKYQIOVAHOP-YLGJWRNMSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75348,6m2n,DB04578,-8.4,"(S)-2-[(R)-3-amino-4-(2-fluorophenyl)butyryl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide",OEVYDSSAPNIURZ-AEFFLSMTSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
54986,6crv,DB00469,-8.4,Tenoxicam,LZNWYQJJBLGYLT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77981,6m2n,DB09076,-8.4,Umeclidinium,FVTWTVQXNAJTQP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138503,6w9c,DB11763,-8.4,Momelotinib,ZVHNDZWQTBEVRY-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
80177,6m2n,DB14793,-8.4,RO-5045337,QBGKPEROWUKSBK-QPPIDDCLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
112429,6vxx,DB07093,-8.4,"{3-[(5-CHLORO-1,3-BENZOTHIAZOL-2-YL)METHYL]-2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL}ACETIC ACID",RQWICELTTDJODO-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
74922,6m2n,DB04010,-8.4,2-(3'-Methoxyphenyl) Benzimidazole-4-Carboxamide,NVVWVYYHTKCIAE-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
112761,6vxx,DB07813,-8.4,GLYCYLALANYL-N-2-NAPHTHYL-L-PROLINEAMIDE,KCELZXZDIUJGNM-GUYCJALGSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165790,7bv1,DB13019,-8.4,Henatinib,MCTXSDCWFQAGFS-UEXNTNOUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
31822,6cs2,DB14828,-8.4,ABX-464,OZOGDCZJYVSUBR-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
165652,7bv1,DB12598,-8.4,Nafamostat,MQQNFDZXWVTQEH-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
164977,7bv1,DB09030,-8.4,Vorapaxar,ZBGXUVOIWDMMJE-QHNZEKIYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
55162,6crv,DB00686,-8.4,Pentosan Polysulfate,FCCNSUIJIOOXEZ-SJYYZXOBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110025,6vxx,DB00717,-8.4,Norethisterone,VIKNJXKGJWUCNN-XGXHKTLJSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112788,6vxx,DB07844,-8.4,6-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1-BENZOTHIOPHENE-2-SULFONAMIDE,PHLKBODTBJLXRD-WFASDCNBSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28435,6cs2,DB08022,-8.4,"(2S)-1,3-benzothiazol-2-yl{2-[(2-pyridin-3-ylethyl)amino]pyrimidin-4-yl}ethanenitrile",RCYPVQCPYKNSTG-OAHLLOKOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
75375,6m2n,DB04615,-8.4,(S)-tacrine(10)-hupyridone,ROTFGKJJMRTWBD-MHZLTWQESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79852,6m2n,DB13828,-8.4,Cyfluthrin,QQODLKZGRKWIFG-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
109704,6vxx,DB15170,-8.4,Evobrutinib,QUIWHXQETADMGN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75344,6m2n,DB04574,-8.4,Estrone sulfate,JKKFKPJIXZFSSB-CBZIJGRNSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
31833,6cs2,DB14850,-8.4,Deleobuvir,BMAIGAHXAJEULY-UKTHLTGXSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
77946,6m2n,DB09015,-8.4,Canrenoic acid,PBKZPPIHUVSDNM-WNHSNXHDSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
164740,7bv1,DB08546,-8.4,"4-[(3AS,4R,7R,8AS,8BR)-2-(1,3-BENZODIOXOL-5-YLMETHYL)-7-HYDROXY-1,3-DIOXODECAHYDROPYRROLO[3,4-A]PYRROLIZIN-4-YL]BENZENECARBOXIMIDAMIDE",CETLUACQMGBMFH-ZALSBGIRSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
138525,6w9c,DB11792,-8.4,Mirodenafil,MIJFNYMSCFYZNY-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
112709,6vxx,DB07756,-8.4,"1-[3-({[(4-AMINO-5-FLUORO-2-METHYLQUINOLIN-3-YL)METHYL]THIO}METHYL)PHENYL]-2,2,2-TRIFLUOROETHANE-1,1-DIOL",GPBGHVRNVGXPNM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77708,6m2n,DB08707,-8.4,"4-[3-(4-chlorophenyl)-2,1-benzisoxazol-5-yl]pyrimidin-2-amine",AQVFETGXIRKVAQ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
164930,7bv1,DB08974,-8.4,Flubendazole,CPEUVMUXAHMANV-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
112722,6vxx,DB07770,-8.4,5-(4-FLUOROPHENYL)-3-{[(4-METHYLPHENYL)SULFONYL]AMINO}THIOPHENE-2-CARBOXYLIC ACID,DJPFUQBNQLKCAB-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109971,6vxx,DB00656,-8.4,Trazodone,PHLBKPHSAVXXEF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77676,6m2n,DB08664,-8.4,({3-[1-(4-HYDROXY-2-OXO-2H-CHROMEN-3-YL)-PROPYL]-PHENYLCARBAMOYL}-METHYL)-CARBAMIC ACID TERT-BUTYL ESTER,QUQQVMVIWCUYFV-KRWDZBQOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77671,6m2n,DB08659,-8.4,2-(hydrazinocarbonyl)-3-phenyl-1H-indole-5-sulfonamide,PPDLAUCFAOODER-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
72450,6m2n,DB00764,-8.4,Mometasone,QLIIKPVHVRXHRI-CXSFZGCWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
109977,6vxx,DB00663,-8.4,Flumethasone,WXURHACBFYSXBI-GQKYHHCASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
124322,6w4h,DB01016,-8.4,Glyburide,ZNNLBTZKUZBEKO-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
138621,6w9c,DB11934,-8.4,Epelsiban,UWHCWRQFNKUYCG-QUZACWSFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
165658,7bv1,DB12612,-8.4,Ozanimod,XRVDGNKRPOAQTN-FQEVSTJZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
109730,6vxx,DB15221,-8.4,PF-06260414,ZKAVFOXYJCREBQ-SNVBAGLBSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75234,6m2n,DB04434,-8.4,Naphthyridine Inhibitor,YRBHUKMLAGQYHS-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77649,6m2n,DB08634,-8.4,6-BENZYL-1-BENZYLOXYMETHYL-5-ISOPROPYL URACIL,KSAAUHMSLCPIEX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
109721,6vxx,DB15205,-8.4,Capromorelin,KVLLHLWBPNCVNR-SKCUWOTOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112445,6vxx,DB07113,-8.4,"(2S)-6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2-(3,5-DIFLUOROPHENYL)-4-(3-METHOXYPROPYL)-2H-1,4-BENZOXAZIN-3(4H)-ONE",KHZQOXQOUCGGGA-NRFANRHFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72423,6m2n,DB00728,-8.4,Rocuronium,YXRDKMPIGHSVRX-OOJCLDBCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
31845,6cs2,DB14870,-8.4,PF-5190457,ZIUDADZJCKGWKR-AREMUKBSSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
9921,6lzg,DB08057,-8.4,"N-(2-chloro-6-methylphenyl)-8-[(3S)-3-methylpiperazin-1-yl]imidazo[1,5-a]quinoxalin-4-amine",VWJPPYCULHDHBB-HNNXBMFYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
124294,6w4h,DB00984,-8.4,Nandrolone phenpropionate,UBWXUGDQUBIEIZ-QNTYDACNSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
112754,6vxx,DB07806,-8.4,"(2R,4S)-2-[(R)-BENZYLCARBAMOYL-PHENYLACETYL-METHYL]-5,5-DIMETHYL-THIAZOLIDINE-4-CARBOXYLIC ACID",UDMBRVGTYILYDX-SVFBPWRDSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75343,6m2n,DB04573,-8.4,Estriol,PROQIPRRNZUXQM-ZXXIGWHRSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
139684,6w9c,DB13797,-8.4,Iodocholesterol (131I),FIOAEFCJGZJUPW-ODFYUTSGSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
28353,6cs2,DB07940,-8.4,"9-(3-IODOBENZYLAMINO)-1,2,3,4-TETRAHYDROACRIDINE",ZUCWQTWGZGIYPV-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
30704,6cs2,DB12869,-8.4,Eliprodil,GGUSQTSTQSHJAH-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
139449,6w9c,DB13484,-8.4,Quinbolone,IUVKMZGDUIUOCP-BTNSXGMBSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137082,6w9c,DB07875,-8.4,"5-Chloro-thiophene-2-carboxylic acid ((3S,4S)-1-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-methyl}-4-hydroxy-pyrrolidin-3-yl)-amide",ARAVOODWJJJNBY-IRXDYDNUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
109067,6vxx,DB11987,-8.4,GSK-2018682,NFIGDBFIDKDNIG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138346,6w9c,DB11443,-8.4,Orbifloxacin,QIPQASLPWJVQMH-DTORHVGOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
110465,6vxx,DB01628,-8.4,Etoricoxib,MNJVRJDLRVPLFE-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30868,6cs2,DB13089,-8.4,Enoxolone,MPDGHEJMBKOTSU-YKLVYJNSSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
30867,6cs2,DB13088,-8.4,AZD-0424,MVWATCATLSSVBH-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
80607,6m3m,DB00216,-8.4,Eletriptan,PWVXXGRKLHYWKM-LJQANCHMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136888,6w9c,DB07651,-8.4,N-ACETYL-L-PHENYLALANYL-4-[DIFLUORO(PHOSPHONO)METHYL]-L-PHENYLALANINAMIDE,KPMMESISHWWXNM-ROUUACIJSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
112163,6vxx,DB06468,-8.4,Cariporide,IWXNYAIICFKCTM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
120363,6w4b,DB08400,-8.4,4-(3-{[5-(trifluoromethyl)pyridin-2-yl]oxy}benzyl)piperidine-1-carboxylic acid,KUEKMTNOUPAOBS-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
76995,6m2n,DB07855,-8.4,(S)-1-PHENYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE,CWHMAWBXRCDOEB-HNNXBMFYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
71873,6lxt,DB15450,-8.4,PF-05105679,BXNMZRPTQFVRFA-QGZVFWFLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
113446,6vxx,DB09198,-8.4,Lobeglitazone,CHHXEZSCHQVSRE-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
137518,6w9c,DB08395,-8.4,2-(ETHOXYMETHYL)-4-(4-FLUOROPHENYL)-3-[2-(2-HYDROXYPHENOXY)PYRIMIDIN-4-YL]ISOXAZOL-5(2H)-ONE,ZSOXFJURLPCSOO-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
74429,6m2n,DB03337,-8.4,1-(2-Amidinophenyl)-3-(Phenoxyphenyl)Urea,ZHCAYBOLUMAUQX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
139303,6w9c,DB13292,-8.4,Pimethixene,NZLVRVYNQYGMAB-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
79261,6m2n,DB12986,-8.4,VS-5584,QYBGBLQCOOISAR-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
30857,6cs2,DB13072,-8.4,GDC-0349,RGJOJUGRHPQXGF-INIZCTEOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
165998,7bv1,DB13551,-8.4,Cinchophen,YTRMTPPVNRALON-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
8640,6lzg,DB06589,-8.4,Pazopanib,CUIHSIWYWATEQL-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
113476,6vxx,DB09232,-8.4,Cilnidipine,KJEBULYHNRNJTE-DHZHZOJOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109052,6vxx,DB11963,-8.4,Dacomitinib,LVXJQMNHJWSHET-AATRIKPKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
8633,6lzg,DB06578,-8.4,Tonabersat,XLIIRNOPGJTBJD-ROUUACIJSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
76962,6m2n,DB07816,-8.4,N-(P-CYANOPHENYL)-N'-DIPHENYLMETHYL-GUANIDINE-ACETIC ACID,KGHMYJFHUHFOGL-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
164439,7bv1,DB07831,-8.4,"2-{[(6-OXO-1,6-DIHYDROPYRIDIN-3-YL)METHYL]AMINO}-N-[4-PROPYL-3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE",SHSORWZDEKFFLP-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
125421,6w4h,DB02466,-8.4,"4-[3-Oxo-3-(5,5,8,8-Tetramethyl-5,6,7,8-Tetrahydro-Naphthalen-2-Yl)-Propenyl]-Benzoic Acid",ZXQHMEUGMCXKLO-KPKJPENVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
122396,6w4b,DB13345,-8.4,Dihydroergocristine,DEQITUUQPICUMR-HJPBWRTMSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
28102,6cs2,DB07678,-8.4,"(9ALPHA,13BETA,17BETA)-2-[(1Z)-BUT-1-EN-1-YL]ESTRA-1,3,5(10)-TRIENE-3,17-DIOL",ANAMDWGJXBYJEB-OPWFCKQNSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
76960,6m2n,DB07814,-8.4,Gibberellic acid,IXORZMNAPKEEDV-OBDJNFEBSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
109069,6vxx,DB11990,-8.4,MK-0812,UNVWTBOGMHPKJM-CWKRKGSWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28111,6cs2,DB07688,-8.4,"4-{[5-(CYCLOHEXYLOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE",RPJIMTALCNCQLV-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
122210,6w4b,DB13053,-8.4,CP-195543,NZQDWKCNBOELAI-KSFYIVLOSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
138379,6w9c,DB11518,-8.4,Flunixin,NOOCSNJCXJYGPE-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
77070,6m2n,DB07943,-8.4,2-{4-[5-(4-chlorophenyl)-4-pyrimidin-4-yl-1H-pyrazol-3-yl]piperidin-1-yl}-2-oxoethanol,CATQHDWESBRRQA-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80491,6m2n,DB01557,-8.4,alpha-Methylfentanyl,NGTVDHYUFBKWID-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
136912,6w9c,DB07683,-8.4,"N-(dibenzo[b,d]thiophen-3-ylsulfonyl)-L-valine",RZWYSEXQXOXWKA-INIZCTEOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
79297,6m2n,DB13044,-8.4,Gossypol,QBKSWRVVCFFDOT-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
140255,6w9c,DB15449,-8.4,Citarinostat,VLIUIBXPEDFJRF-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
109111,6vxx,DB12391,-8.4,Sagopilone,BFZKMNSQCNVFGM-UCEYFQQTSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
120535,6w4b,DB08607,-8.4,"(5R)-5-(4-{[(2R)-6-HYDROXY-2,5,7,8-TETRAMETHYL-3,4-DIHYDRO-2H-CHROMEN-2-YL]METHOXY}BENZYL)-1,3-THIAZOLIDINE-2,4-DIONE",GXPHKUHSUJUWKP-NTKDMRAZSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
112186,6vxx,DB06525,-8.4,Ganstigmine,ZOBDWFRKFSPCRB-UNMCSNQZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
71998,6m2n,DB00218,-8.4,Moxifloxacin,FABPRXSRWADJSP-MEDUHNTESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
29856,6cs2,DB11730,-8.4,Ribociclib,RHXHGRAEPCAFML-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
114195,6vxx,DB12885,-8.4,CF-102,IPSYPUKKXMNCNQ-PFHKOEEOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
125302,6w4h,DB02319,-8.4,"5,6-Dihydroxy-Nadp",LRAVAOPKUBJONV-IVCJQJMGSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
139774,6w9c,DB13956,-8.4,Estradiol valerate,RSEPBGGWRJCQGY-RBRWEJTLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136906,6w9c,DB07676,-8.4,"3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)-1H,2'H-2,3'-biindol-2'-one",CKLAPOFDFZKCPB-LBPRGKRZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139776,6w9c,DB13958,-8.4,Trestolone acetate,IVCRCPJOLWECJU-XQVQQVTHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
77060,6m2n,DB07932,-8.4,"dimethyl (1R,4S)-5,6-bis(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hepta-2,5-diene-2,3-dicarboxylate",CRLQCBACIMUGDZ-BGYRXZFFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
7530,6lzg,DB03944,-8.4,"5-[1-(3,4-Dimethoxy-Benzoyl)-1,2,3,4-Tetrahydro-Quinolin-6-Yl]-6-Methyl-3,6-Dihydro-[1,3,4]Thiadiazin-2-One",IZLRMTJLQCLMKF-CYBMUJFWSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
79283,6m2n,DB13022,-8.4,LY-2874455,GKJCVYLDJWTWQU-CXLRFSCWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
109090,6vxx,DB12361,-8.4,Piclozotan,URMTUEWUIGOJBW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
164460,7bv1,DB07856,-8.4,6-{4-[4-(4-CHLOROPHENYL)PIPERIDIN-4-YL]PHENYL}-9H-PURINE,HPWBHQIUIBFTQC-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
73077,6m2n,DB01557,-8.4,??-Methylfentanyl,NGTVDHYUFBKWID-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77026,6m2n,DB07891,-8.4,"4-{[(14beta,17alpha)-3-hydrox1tra-1,3,5(10)-trien-17-yl]oxy}-4-oxobutanoic acid",YJPIDPAGJSWWBE-FNIAAEIWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
113418,6vxx,DB09169,-8.4,3-Allylfentanyl,BZXKQFFMDLTPJL-LADGPHEKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140284,6w9c,DB02755,-8.4,1-3 Sugar Ring of Pentamannosyl 6-Phosphate,HDQMHAJOIVYOIP-NAVBLJQLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
79294,6m2n,DB13039,-8.4,Aminaphthone,YLMPBJUYFTWHKJ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
8629,6lzg,DB06558,-8.4,Tezosentan,TUYWTLTWNJOZNY-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
125441,6w4h,DB02491,-8.4,4-[4-(1-Amino-1-Methylethyl)Phenyl]-5-Chloro-N-[4-(2-Morpholin-4-Ylethyl)Phenyl]Pyrimidin-2-Amine,CJSSYVIHFXDFFC-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
30830,6cs2,DB13036,-8.4,Ramatroban,LDXDSHIEDAPSSA-OAHLLOKOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
122806,6w4b,DB13931,-8.4,Netarsudil,OURRXQUGYQRVML-AREMUKBSSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
140352,6w9c,DB04215,-8.4,CRA_9076,BVTBOJXEAPSOEB-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138234,6w9c,DB09534,-8.4,Ecamsule,HEAHZSUCFKFERC-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
9714,6lzg,DB07834,-8.4,"N-(cyclopropylmethyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-4-carboxamide",FOHZGCHKLPIBBX-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
112105,6vxx,DB06292,-8.4,Dapagliflozin,JVHXJTBJCFBINQ-ADAARDCZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108991,6vxx,DB11875,-8.4,"3,3'-diindolylmethane",VFTRKSBEFQDZKX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
164405,7bv1,DB07794,-8.4,"5-(2-PHENYLPYRAZOLO[1,5-A]PYRIDIN-3-YL)-1H-PYRAZOLO[3,4-C]PYRIDAZIN-3-AMINE",XVECMUKVOMUNLE-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
108984,6vxx,DB11865,-8.4,Brivanib alaninate,LTEJRLHKIYCEOX-OCCSQVGLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
137557,6w9c,DB08444,-8.4,"3-[2-bromo-4-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)phenoxy]-5-methylbenzonitrile",YYGZQXRLQMFHDH-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
30749,6cs2,DB12926,-8.4,Cafedrine,UJSKUDDDPKGBJY-WFASDCNBSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
110564,6vxx,DB01946,-8.4,"3-[1-(3-Aminopropyl)-1h-Indol-3-Yl]-4-(1-Methyl-1h-Indol-3-Yl)-1h-Pyrrole-2,5-Dione",UQHKJRCFSLMWIA-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79179,6m2n,DB12867,-8.4,Benperidol,FEBOTPHFXYHVPL-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
32268,6cs2,DB00220,-8.4,Nelfinavir,QAGYKUNXZHXKMR-HKWSIXNMSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
110591,6vxx,DB01977,-8.4,6-(N-Phenylcarbamyl)-2-Naphthalenecarboxamidine,AECPTICWHONWNW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76884,6m2n,DB07729,-8.4,3-fluoro-N-[3-(1H-tetrazol-5-yl)phenyl]benzamide,GAKOBKPDJJGRIL-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
164404,7bv1,DB07793,-8.4,"(2S)-N-[(3S)-1-(2-AMINO-2-OXOETHYL)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL]-2-CHLORO-2H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE",ACSGSLPOHKRZCY-GXTWGEPZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
125547,6w4h,DB02629,-8.4,Inhibitor Bea403,LYHLPPXMBKMSSZ-JQFCFGFHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
29448,6cs2,DB09199,-8.4,Netoglitazone,PKWDZWYVIHVNKS-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
140020,6w9c,DB14768,-8.4,PF-06459988,ODMXWZROLKITMS-RISCZKNCSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
165503,7bv1,DB12200,-8.4,Tivantinib,UCEQXRCJXIVODC-PMACEKPBSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110612,6vxx,DB02008,-8.4,1-(2-Fluorobenzyl)-3-Butyl-8-(N-Acetyl-4-Aminobenzyl)-Xanthine,JHSHXKJSPVHPCJ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
125576,6w4h,DB02668,-8.4,"Je-2147, Ag1776, Kni-764",CUFQBQOBLVLKRF-RZDMPUFOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
138197,6w9c,DB09330,-8.4,Osimertinib,DUYJMQONPNNFPI-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
78512,6m2n,DB11865,-8.4,Brivanib alaninate,LTEJRLHKIYCEOX-OCCSQVGLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
113628,6vxx,DB11674,-8.4,Equol,ADFCQWZHKCXPAJ-GFCCVEGCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
73239,6m2n,DB01764,-8.4,Dalfopristin,SUYRLXYYZQTJHF-VMBLUXKRSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
123901,6w4h,DB00522,-8.4,Bentiromide,SPPTWHFVYKCNNK-FQEVSTJZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
139273,6w9c,DB13248,-8.4,Phthalylsulfathiazole,PBMSWVPMRUJMPE-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
71832,6lxt,DB15362,-8.4,LSZ-102,SJXNPGGVGZXKKI-NYYWCZLTSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
55594,6crv,DB01183,-8.4,Naloxone,UZHSEJADLWPNLE-GRGSLBFTSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
71861,6lxt,DB15431,-8.4,M-2698,HXAUJHZZPCBFPN-QGZVFWFLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
74385,6m2n,DB03277,-8.4,alpha-maltotriose,FYGDTMLNYKFZSV-PXXRMHSHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
114205,6vxx,DB13090,-8.4,Zidebactam,YCZPXRQPDCXTIO-BBBLOLIVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
7518,6lzg,DB03925,-8.4,Freselestat,HMPQTEPEMQZWQH-QZTJIDSGSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
53068,2fxp,DB12424,-8.4,MK-3207,AZAANWYREOQRFB-SETSBSEESA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
76950,6m2n,DB07804,-8.4,"5-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1H-1,2,4-TRIAZOLE-3-SULFONAMIDE",FKCQUVAGEOSYRU-QWRGUYRKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
139812,6w9c,DB14035,-8.4,Englitazone,MVDXXGIBARMXSA-PYUWXLGESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
120233,6w4b,DB08237,-8.4,2'-deoxy-N-(naphthalen-1-ylmethyl)guanosine 5'-(dihydrogen phosphate),COMPKRGNHXOXMN-GVDBMIGSSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
8612,6lzg,DB06518,-8.4,R-1487,KKKRKRMVJRHDMG-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
73114,6m2n,DB01604,-8.4,Pivampicillin,ZEMIJUDPLILVNQ-ZXFNITATSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
52521,2fxp,DB11625,-8.4,Perflenapent,NJCBUSHGCBERSK-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
138310,6w9c,DB11372,-8.4,Altrenogest,VWAUPFMBXBWEQY-ANULTFPQSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
73118,6m2n,DB01608,-8.4,Periciazine,LUALIOATIOESLM-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
73130,6m2n,DB01622,-8.4,Thioproperazine,VZYCZNZBPPHOFY-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79227,6m2n,DB12933,-8.4,RO-4987655,FIMYFEGKMOCQKT-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
74365,6m2n,DB03251,-8.4,RWJ-51084,NQABUEUFRXDDFI-AWEZNQCLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
110529,6vxx,DB01889,-8.4,"16,17-Androstene-3-Ol",KRVXMNNRSSQZJP-PHFHYRSDSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28588,6cs2,DB08174,-8.4,"5-CHLORO-N-((1R,2S)-2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO) CYCLOPENTYL)THIOPHENE-2-CARBOXAMIDE",QCPYHSAHOYXXQK-DLBZAZTESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
28069,6cs2,DB07643,-8.4,"5-{[1-(2,3-dichlorobenzyl)piperidin-4-yl]methoxy}quinazoline-2,4-diamine",XVLUVRFYGVJKGJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
136840,6w9c,DB07595,-8.4,"(5Z)-5-(3-BROMOCYCLOHEXA-2,5-DIEN-1-YLIDENE)-N-(PYRIDIN-4-YLMETHYL)-1,5-DIHYDROPYRAZOLO[1,5-A]PYRIMIDIN-7-AMINE",WSIQKQLAGWVKSL-UHFFFAOYSA-O,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137551,6w9c,DB08437,-8.4,Puromycin,RXWNCPJZOCPEPQ-NVWDDTSBSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
125501,6w4h,DB02567,-8.4,PD173955,VAARYSWULJUGST-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
137552,6w9c,DB08439,-8.4,Parecoxib,TZRHLKRLEZJVIJ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138306,6w9c,DB11366,-8.4,Roquinimex,SGOOQMRIPALTEL-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
113567,6vxx,DB11529,-8.4,Melengestrol,OKHAOBQKCCIRLO-IBVJIVQJSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76920,6m2n,DB07770,-8.4,5-(4-FLUOROPHENYL)-3-{[(4-METHYLPHENYL)SULFONYL]AMINO}THIOPHENE-2-CARBOXYLIC ACID,DJPFUQBNQLKCAB-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80712,6m3m,DB00340,-8.4,Metixene,MJFJKKXQDNNUJF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
112202,6vxx,DB06578,-8.4,Tonabersat,XLIIRNOPGJTBJD-ROUUACIJSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
54776,6crv,DB00218,-8.4,Moxifloxacin,FABPRXSRWADJSP-MEDUHNTESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29901,6cs2,DB11789,-8.4,Hyodeoxycholic Acid,DGABKXLVXPYZII-SIBKNCMHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
77091,6m2n,DB07968,-8.4,N-(2-CHLORO-4-FLUOROBENZOYL)-N'-(5-HYDROXY-2-METHOXYPHENYL)UREA,RFOBTYLRURSVJE-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75620,6m2n,DB05013,-8.4,Ingenol mebutate,VDJHFHXMUKFKET-UXMMOKKRSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
124993,6w4h,DB01906,-8.4,"3-(5-Amino-7-Hydroxy-[1,2,3]Triazolo[4,5-D]Pyrimidin-2-Yl)-Benzoic Acid",KNLLRZNGRRRPEW-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
77253,6m2n,DB08148,-8.4,"1-[4-(4-chlorophenyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine",QOZMRRGNAZNWDN-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
72912,6m2n,DB01338,-8.4,Pipecuronium,OWWLUIWOFHMHOQ-XGHATYIMSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138735,6w9c,DB12193,-8.4,Ajulemic acid,YCHYFHOSGQABSW-RTBURBONSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
79427,6m2n,DB13266,-8.4,Cefatrizine,UOCJDOLVGGIYIQ-PBFPGSCMSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
55394,6crv,DB00952,-8.4,Naratriptan,AMKVXSZCKVJAGH-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
54866,6crv,DB00321,-8.4,Amitriptyline,KRMDCWKBEZIMAB-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
121028,6w4b,DB09295,-8.4,Talniflumate,ANMLJLFWUCQGKZ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
110312,6vxx,DB01452,-8.4,Diamorphine,GVGLGOZIDCSQPN-PVHGPHFFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138736,6w9c,DB12194,-8.4,Atamestane,PEPMWUSGRKINHX-TXTPUJOMSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
74609,6m2n,DB03598,-8.4,"Al-6629, [2h-Thieno[3,2-E]-1,2-Thiazine-6-Sulfonamide,2-(3-Methoxyphenyl)-3-(4-Morpholinyl)-, 1,1-Dioxide]",XSUAVPPTKHUTDX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
139436,6w9c,DB13463,-8.4,Oxetorone,VZVRZTZPHOHSCK-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
77239,6m2n,DB08133,-8.4,N-(4-sulfamoylphenyl)-1H-indazole-3-carboxamide,MNHPHKFLWAPNOV-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
54856,6crv,DB00310,-8.4,Chlorthalidone,JIVPVXMEBJLZRO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
137432,6w9c,DB08292,-8.4,"(5Z)-12-CHLORO-13,15-DIHYDROXY-4,7,8,9-TETRAHYDRO-2-BENZOXACYCLOTRIDECINE-1,10(3H,11H)-DIONE",AQKZYZQONWDDLS-IWQZZHSRSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
113143,6vxx,DB08590,-8.4,1-(3-HYDROXYPROPYL)-2-[(3-NITROBENZOYL)AMINO]-1H-BENZIMIDAZOL-5-YL PIVALATE,CEAYRKIZESVQSN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
139431,6w9c,DB13458,-8.4,Thebacon,RRJQTGHQFYTZOW-ILWKUFEGSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
112281,6vxx,DB06919,-8.4,D-phenylalanyl-N-(3-chlorobenzyl)-L-prolinamide,CJHLRGCXPGIPCB-MOPGFXCFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113158,6vxx,DB08608,-8.4,"4-({(2R,5S)-2,5-DIMETHYL-4-[(2R)-3,3,3-TRIFLUORO-2-HYDROXY-2-METHYLPROPANOYL]PIPERAZIN-1-YL}CARBONYL)BENZONITRILE",IWFSHKKFDSWNLZ-BWACUDIHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
9170,6lzg,DB07254,-8.4,"N-[3-[[4-[(5-CHLORO-1,3-BENZODIOXOL-4-YL)AMINO]PYRIMIDIN-2-YL]AMINO]PHENYL]METHANESULFONAMIDE",KQGTYXRWSIBDOZ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
113159,6vxx,DB08609,-8.4,"(2R)-N-{4-[Ethyl(phenyl)sulfamoyl]-2-methylphenyl}-3,3,3-trifluoro-2-hydroxy-2-methylpropanamide",SHEIQJGQDUYUBE-GOSISDBHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
10250,6lzg,DB08429,-8.4,N-({(2S)-1-[(3R)-3-amino-4-(3-chlorophenyl)butanoyl]pyrrolidin-2-yl}methyl)-3-(methylsulfonyl)benzamide,QRGBOABBMKYMLG-UXHICEINSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
137022,6w9c,DB07809,-8.4,4-({[4-(3-METHYLBENZOYL)PYRIDIN-2-YL]AMINO}METHYL)BENZENECARBOXIMIDAMIDE,MBJYEMUMDMGQQC-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
77204,6m2n,DB08096,-8.4,"8-(2-CHLOROPHENYLAMINO)-2-(2,6-DIFLUOROPHENYLAMINO)-9-ETHYL-9H-PURINE-1,7-DIIUM",ZWKOUFZHPNIQSH-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
72933,6m2n,DB01384,-8.4,Paramethasone,MKPDWECBUAZOHP-AFYJWTTESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
7244,6lzg,DB03480,-8.4,Brequinar Analog,WYKKHJQZENLZID-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
75616,6m2n,DB04982,-8.4,Talampanel,JACAAXNEHGBPOQ-LLVKDONJSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
112300,6vxx,DB06940,-8.4,"N-ethyl-4-{[5-(methoxycarbamoyl)-2-methylphenyl]amino}-5-methylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide",ZZTMFGIGOADCFX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
139439,6w9c,DB13470,-8.4,Cefodizime,XDZKBRJLTGRPSS-BGZQYGJUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
112334,6vxx,DB06986,-8.4,"2-CHLORO-N-[(1R,2R)-1-HYDROXY-2,3-DIHYDRO-1H-INDEN-2-YL]-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE",LRHOLHTVXXSIMG-BXUZGUMPSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112331,6vxx,DB06983,-8.4,"(5-phenyl-7-(pyridin-3-ylmethylamino)pyrazolo[1,5-a]pyrimidin-3-yl)methanol",RBLKWWBHDUBPFN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79514,6m2n,DB13374,-8.4,Vincamine,RXPRRQLKFXBCSJ-GIVPXCGWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
28497,6cs2,DB08087,-8.4,"4-[(7R,7AS)-7-HYDROXY-1,3-DIOXOTETRAHYDRO-1H-PYRROLO[1,2-C]IMIDAZOL-2(3H)-YL]-1-NAPHTHONITRILE",NHBIWLQQJPSMNP-CABCVRRESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
79474,6m2n,DB13327,-8.4,Picotamide,KYWCWBXGRWWINE-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
72227,6m2n,DB00490,-8.4,Buspirone,QWCRAEMEVRGPNT-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
10192,6lzg,DB08362,-8.4,"N-(3-(8-CYANO-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZIN-2-YLAMINO)PHENYL)ACETAMIDE",QVKXQLGRDOMAGC-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
113109,6vxx,DB08547,-8.4,PROGESTERONE-11-ALPHA-OL-HEMISUCCINATE,JBBNFGYRYNBDIH-DBGGZKJISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
124912,6w4h,DB01792,-8.4,Adenylyl-3'-5'-Phospho-Uridine-3'-Monophosphate,FZCSEXOMUJFOHQ-KPKSGTNCSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
75588,6m2n,DB04903,-8.4,Pagoclone,HIUPRQPBWVEQJJ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80333,6m2n,DB15149,-8.4,Futibatinib,KEIPNCCJPRMIAX-HNNXBMFYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137068,6w9c,DB07861,-8.4,(2R)-N-hydroxy-3-naphthalen-2-yl-2-[(naphthalen-2-ylsulfonyl)amino]propanamide,MMOUXLMPQFMDRD-JOCHJYFZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
80335,6m2n,DB15152,-8.4,TMC-649128,XJBILYMRFVHPJB-XJQUKVTJSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137066,6w9c,DB07859,-8.4,4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL)PHENYL]PIPERIDINE,LZMOSYUFVYJEPY-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
32057,6cs2,DB15282,-8.4,Fluorofuranylnorprogesterone F-18,VJKRBRUNEOHPBS-JQKUZGBFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
137056,6w9c,DB07848,-8.4,5-Chloro-N-{(3S)-1-[(2S)-1-(4-morpholinyl)-1-oxo-2-propanyl]-2-oxo-3-pyrrolidinyl}-1H-indole-2-sulfonamide,BHNMMFGOJRIAEZ-LRDDRELGSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139754,6w9c,DB13930,-8.4,Ulixertinib,KSERXGMCDHOLSS-LJQANCHMSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
121116,6w4b,DB11262,-8.4,Bisoctrizole,FQUNFJULCYSSOP-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
109310,6vxx,DB13052,-8.4,Upamostat,HUASEDVYRABWCV-NDEPHWFRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
124976,6w4h,DB01876,-8.4,Bis(5-Amidino-2-Benzimidazolyl)Methanone,VVVXDHROXQUONB-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
137053,6w9c,DB07844,-8.4,6-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1-BENZOTHIOPHENE-2-SULFONAMIDE,PHLKBODTBJLXRD-WFASDCNBSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137052,6w9c,DB07843,-8.4,5-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1-BENZOTHIOPHENE-2-SULFONAMIDE,LTJNKFUIOOJXNJ-WFASDCNBSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
55366,6crv,DB00920,-8.4,Ketotifen,ZCVMWBYGMWKGHF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112312,6vxx,DB06955,-8.4,"3,4-bis(7-chloro-1H-indol-3-yl)-1H-pyrrole-2,5-dicarboxylic acid",OAMCCJASDLMTOO-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113119,6vxx,DB08559,-8.4,"N-[(2S,4S,6R)-2-(dihydroxymethyl)-4-hydroxy-3,3-dimethyl-7-oxo-4lambda-4-thia-1-azabicyclo[3.2.0]hept-6-yl]-2-phenylacetamide",WMPGEOZLAYOFHH-MBNYWOFBSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78309,6m2n,DB11491,-8.4,Sarafloxacin,XBHBWNFJWIASRO-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
113121,6vxx,DB08561,-8.4,"BENZYL 6-BENZYL-5,7-DIOXO-6,7-DIHYDRO-5H-[1,3]THIAZOLO[3,2-C]PYRIMIDINE-2-CARBOXYLATE",PLBINCOCFGQAJM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109225,6vxx,DB12921,-8.4,Chlorsulfaquinoxaline,CTSNHMQGVWXIEG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31436,6cs2,DB13814,-8.4,Talampicillin,SOROUYSPFADXSN-SUWVAFIASA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
80392,6m2n,DB15268,-8.4,Afabicin,HFYMDQMXVPJNTH-VQHVLOKHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
54850,6crv,DB00303,-8.4,Ertapenem,JUZNIMUFDBIJCM-ANEDZVCMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79334,6m2n,DB13097,-8.4,1alpha-Hydroxyvitamin D5,NWFOBODUYTUMNC-VPSCEVSQSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78387,6m2n,DB11681,-8.4,Tofimilast,DHCOPPHTVOXDKU-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
120764,6w4b,DB08901,-8.4,Ponatinib,PHXJVRSECIGDHY-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
112228,6vxx,DB06625,-8.4,Vipadenant,HQSBCDPYXDGTCL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
7232,6lzg,DB03460,-8.4,Violaxanthin,SZCBXWMUOPQSOX-WVJDLNGLSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
113315,6vxx,DB08791,-8.4,"1-[(2-NITROPHENYL)SULFONYL]-1H-PYRROLO[3,2-B]PYRIDINE-6-CARBOXAMIDE",USLOIFPDNUDIEG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113322,6vxx,DB08993,-8.4,Enviomycin,HPWIIERXAFODPP-GHBBWTPBSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112227,6vxx,DB06624,-8.4,Taranabant,QLYKJCMUNUWAGO-GAJHUEQPSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110402,6vxx,DB01553,-8.4,Cloxazolam,ZIXNZOBDFKSQTC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
125153,6w4h,DB02115,-8.4,Daidzin,KYQZWONCHDNPDP-QNDFHXLGSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
109155,6vxx,DB12447,-8.4,Nadifloxacin,JYJTVFIEFKZWCJ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30131,6cs2,DB12095,-8.4,Telotristat ethyl,MDSQOJYHHZBZKA-GBXCKJPGSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
136981,6w9c,DB07763,-8.4,"(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE",OZZFJGCAYWBVBI-INIZCTEOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
165546,7bv1,DB12436,-8.4,Vofopitant,XILNRORTJVDYRH-HKUYNNGSSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
138770,6w9c,DB12242,-8.4,AZD-7762,IAYGCINLNONXHY-LBPRGKRZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
72065,6m2n,DB00294,-8.4,Etonogestrel,GCKFUYQCUCGESZ-BPIQYHPVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
125159,6w4h,DB02123,-8.4,Glycochenodeoxycholic Acid,GHCZAUBVMUEKKP-GYPHWSFCSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
28550,6cs2,DB08138,-8.4,"{[(2,6-difluorophenyl)carbonyl]amino}-N-(4-fluorophenyl)-1H-pyrazole-3-carboxamide",BDRDBXXWQDFXEC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
9214,6lzg,DB07297,-8.4,"5,6-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-D]PYRIMIDIN-4-AMINE",PTILEOLOGGMFCS-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
29359,6cs2,DB09063,-8.4,Ceritinib,VERWOWGGCGHDQE-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
113353,6vxx,DB09034,-8.4,Suvorexant,JYTNQNCOQXFQPK-MRXNPFEDSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55486,6crv,DB01060,-8.4,Amoxicillin,LSQZJLSUYDQPKJ-NJBDSQKTSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77094,6m2n,DB07971,-8.4,"5-AMINO-2-{4-[(4-AMINOPHENYL)SULFANYL]PHENYL}-1H-ISOINDOLE-1,3(2H)-DIONE",FQQVTDIBUYSVHM-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137485,6w9c,DB08355,-8.4,"1-methyl-8-(phenylamino)-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxylic acid",ZOBRPBVIEUWYJR-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136924,6w9c,DB07697,-8.4,"1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-4-[(4-methoxyphenyl)sulfonyl]piperazine",HMGDKYUJSFVHIY-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
30967,6cs2,DB13248,-8.4,Phthalylsulfathiazole,PBMSWVPMRUJMPE-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
9210,6lzg,DB07294,-8.4,"3-fluoro-4-[2-hydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8,-tetrahydro-naphtalen-2-yl)-acetylamino]-benzoic acid",AANFHDFOMFRLLR-IBGZPJMESA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
137471,6w9c,DB08339,-8.4,"6-(2,6-DICHLOROPHENYL)-2-{[3-(HYDROXYMETHYL)PHENYL]AMINO}-8-METHYLPYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE",ZIQFYVPVJZEOFS-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
31087,6cs2,DB13393,-8.4,Emetine,AUVVAXYIELKVAI-CKBKHPSWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
72956,6m2n,DB01421,-8.4,Paromomycin,UOZODPSAJZTQNH-LSWIJEOBSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
113201,6vxx,DB08660,-8.4,"1,2,5,8-tetrahydroxyanthracene-9,10-dione",VBHKTXLEJZIDJF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138414,6w9c,DB11619,-8.4,Gestrinone,BJJXHLWLUDYTGC-ANULTFPQSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
113205,6vxx,DB08664,-8.4,({3-[1-(4-HYDROXY-2-OXO-2H-CHROMEN-3-YL)-PROPYL]-PHENYLCARBAMOYL}-METHYL)-CARBAMIC ACID TERT-BUTYL ESTER,QUQQVMVIWCUYFV-KRWDZBQOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
54843,6crv,DB00294,-8.4,Etonogestrel,GCKFUYQCUCGESZ-BPIQYHPVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
137006,6w9c,DB07792,-8.4,"(S)-2-CHLORO-N-(1-(2-(2-HYDROXYETHYLAMINO)-2-OXOETHYL)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL)-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE",VUKPNWLGSLOHIF-AWEZNQCLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
9183,6lzg,DB07268,-8.4,2-({2-[(3-HYDROXYPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)BENZAMIDE,QHPKKGUGRGRSGA-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
75642,6m2n,DB05116,-8.4,Thymectacin,CFBLUORPOFELCE-BACVZHSASA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77169,6m2n,DB08055,-8.4,"N-(2-chlorophenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine",NNBICZMPIJMWGC-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
31162,6cs2,DB01026,-8.4,Ketoconazole,XMAYWYJOQHXEEK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
55426,6crv,DB00991,-8.4,Oxaprozin,OFPXSFXSNFPTHF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113235,6vxx,DB08705,-8.4,"6-(5-BROMO-2-HYDROXYPHENYL)-2-OXO-4-PHENYL-1,2-DIHYDROPYRIDINE-3-CARBONITRILE",SVSYJTYGPLVUOZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
122079,6w4b,DB12854,-8.4,BMS-908662,MMNNTJYFHUDSKL-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
137002,6w9c,DB07788,-8.4,"(3R,5Z,8S,9S,11E)-8,9,16-TRIHYDROXY-14-METHOXY-3-METHYL-3,4,9,10-TETRAHYDRO-1H-2-BENZOXACYCLOTETRADECINE-1,7(8H)-DIONE",NEQZWEXWOFPKOT-QHSZRYGNSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137001,6w9c,DB07787,-8.4,"5-FLUORO-1-[4-(4-PHENYL-3,6-DIHYDROPYRIDIN-1(2H)-YL)BUTYL]QUINAZOLINE-2,4(1H,3H)-DIONE",PNPFDRCIGCUCMN-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
113239,6vxx,DB08709,-8.4,"2,3-diphenyl-1H-indole-7-carboxylic acid",OLUDUXWVPIEHDA-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78359,6m2n,DB11638,-8.4,Artenimol,BJDCWCLMFKKGEE-HVDUHBCDSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77157,6m2n,DB08039,-8.4,"(3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE",LOGJQOUIVKBFGH-YBEGLDIGSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79354,6m2n,DB13125,-8.4,Lusutrombopag,NOZIJMHMKORZBA-KJCUYJGMSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138404,6w9c,DB11591,-8.4,Bilastine,ACCMWZWAEFYUGZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
54803,6crv,DB00248,-8.4,Cabergoline,KORNTPPJEAJQIU-KJXAQDMKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28538,6cs2,DB08126,-8.4,"3-{[4-([AMINO(IMINO)METHYL]AMINOSULFONYL)ANILINO]METHYLENE}-2-OXO-2,3-DIHYDRO-1H-INDOLE",DMCRNUMVSATRTP-LCYFTJDESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
125126,6w4h,DB02082,-8.4,Phosphoaminophosphonic Acid Guanylate Ester,UQABYHGXWYXDTK-UUOKFMHZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
122109,6w4b,DB12897,-8.4,MK-7622,JUVQLZBJFOGEEO-GOTSBHOMSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
72123,6m2n,DB00367,-8.4,Levonorgestrel,WWYNJERNGUHSAO-XUDSTZEESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
139401,6w9c,DB13418,-8.4,Moxestrol,MTMZZIPTQITGCY-OLGWUGKESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
78383,6m2n,DB11675,-8.4,Mosapride,YPELFRMCRYSPKZ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
72115,6m2n,DB00355,-8.4,Aztreonam,WZPBZJONDBGPKJ-VEHQQRBSSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
31291,6cs2,DB13643,-8.4,Loprazolam,UTEFBSAVJNEPTR-RGEXLXHISA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
112919,6vxx,DB08149,-8.4,"1-[4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine",KCWPSUKJCKZEAO-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
93194,6m71,DB06543,-8.4,Astaxanthin,MQZIGYBFDRPAKN-UWFIBFSHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
133236,6w9c,DB01443,-8.4,19-Nor-5-androstenedione,WELNRNVZXWUOGT-QXUSFIETSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
26439,6cs2,DB04575,-8.4,Quinestrol,PWZUUYSISTUNDW-VAFBSOEGSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
102208,6vxs,DB07131,-8.4,(S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclohexylpropanoyl)pyrrolidine-2-carboxamide,DOTBZTLJSXFKCP-IBGZPJMESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
133461,6w9c,DB01713,-8.4,Udp-Alpha-D-Xylopyranose,DQQDLYVHOTZLOR-OCIMBMBZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
66274,6lxt,DB03957,-8.4,SP2456,SSSXBBASYYVGCI-HSZRJFAPSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
102215,6vxs,DB07140,-8.4,"5-[(3R)-3-(5-methoxybiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",JPENSYBRTSIYGO-AWEZNQCLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
66322,6lxt,DB04023,-8.4,"Guanosine 5'-(Trihydrogen Diphosphate), P'-D-Mannopyranosyl Ester",DNBSDUDYNPJVCN-ZXTXFPBHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
102216,6vxs,DB07141,-8.4,"5-[(3R)-3-(5-methoxy-4'-methylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",QVXYJVHNRPNRJL-HNNXBMFYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102220,6vxs,DB07145,-8.4,(2R)-N-HYDROXY-2-[(3S)-3-METHYL-3-{4-[(2-METHYLQUINOLIN-4-YL)METHOXY]PHENYL}-2-OXOPYRROLIDIN-1-YL]PROPANAMIDE,YDMIPBHQKFOFQW-NSYGIPOTSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
158070,7bv1,DB00342,-8.4,Terfenadine,GUGOEEXESWIERI-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160812,7bv1,DB11763,-8.4,Momelotinib,ZVHNDZWQTBEVRY-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94898,6m71,DB08664,-8.4,({3-[1-(4-HYDROXY-2-OXO-2H-CHROMEN-3-YL)-PROPYL]-PHENYLCARBAMOYL}-METHYL)-CARBAMIC ACID TERT-BUTYL ESTER,QUQQVMVIWCUYFV-KRWDZBQOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
128290,6w4h,DB07434,-8.4,HONH-BENZYLMALONYL-L-ALANYLGLYCINE-P-NITROANILIDE,TZWQPWGUQCSKDW-GUYCJALGSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
85409,6m3m,DB07626,-8.4,"4-(2-aminoethoxy)-N-(3-chloro-2-ethoxy-5-piperidin-1-ylphenyl)-3,5-dimethylbenzamide",CKBBGCJYKCLKHE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
62438,6crv,DB13579,-8.4,Mepixanox,PYSOHOOUXFWCFF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
102303,6vxs,DB07245,-8.4,6-[2-(3'-METHOXYBIPHENYL-3-YL)ETHYL]PYRIDIN-2-AMINE,AEVBKBAFFJKFJZ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
133502,6w9c,DB01767,-8.4,Hemi-Babim,KKJYVDXDZURHMA-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
133503,6w9c,DB01768,-8.4,Methylumbelliferyl Sialic Acid,KKDWIUJBUSOPGC-GKHMPSLRSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
87664,6m3m,DB12661,-8.4,Urapidil,ICMGLRUYEQNHPF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
129251,6w4h,DB08572,-8.4,4-{[4-AMINO-6-(CYCLOHEXYLMETHOXY)-5-NITROSOPYRIMIDIN-2-YL]AMINO}BENZAMIDE,YBKLJTXDSBEVRV-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
102311,6vxs,DB07253,-8.4,"N'-(5-chloro-1,3-benzodioxol-4-yl)-N-(3-methylsulfonylphenyl)pyrimidine-2,4-diamine",QTFCKBFCXDAZIU-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
133442,6w9c,DB01689,-8.4,Inhibitor Idd 384,CJKKMQCZOLCXAM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
102155,6vxs,DB07070,-8.4,(2S)-2-{3-[({[2-fluoro-4-(trifluoromethyl)phenyl]carbonyl}amino)methyl]-4-methoxybenzyl}butanoic acid,BDLLIPYDNFENMY-ZDUSSCGKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
129248,6w4h,DB08569,-8.4,"3-PYRIDIN-4-YL-2,4-DIHYDRO-INDENO[1,2-.C.] PYRAZOLE",VLPMRZSKJUTRBQ-IBGZPJMESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
66022,6lxt,DB03638,-8.4,Cytidyl-2'-5'-Phospho-Guanosine,QZDUXDLOEVJGDG-VMIOUTBZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
94960,6m71,DB08738,-8.4,1-{3-oxo-3-[(2S)-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]propyl}-3-phenylquinoxalin-2(1H)-one,KWCKZIJGKMCYCI-QFIPXVFZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
66049,6lxt,DB03671,-8.4,"4-(3,12,14-Trihydroxy-10,13-Dimethyl-Hexadecahydro-Cyclopenta[a]Phenanthren-17-Yl)-5h-Furan-2-One",SHIBSTMRCDJXLN-KCZCNTNESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
85513,6m3m,DB07750,-8.4,"(2R)-1-[4-({4-[(2,5-Dichlorophenyl)amino]-2-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol",GNLAGGCSJGJECE-MRXNPFEDSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85509,6m3m,DB07746,-8.4,3-ETHYL-6-{[(4-FLUOROPHENYL)SULFONYL]AMINO}-2-METHYLBENZOIC ACID,MGUQWAOYPINSIT-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
102086,6vxs,DB06994,-8.4,"(2S,3S)-3-{3-[2-chloro-4-(methylsulfonyl)phenyl]-1,2,4-oxadiazol-5-yl}-1-cyclopentylidene-4-cyclopropyl-1-fluorobutan-2-amine",XCCSSVMRGIQMGF-LPHOPBHVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
94953,6m71,DB08731,-8.4,"2-[(1R)-2-carboxy-1-(naphthalen-1-ylmethyl)ethyl]-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylic acid",GPOKTQCDBPECSS-MRXNPFEDSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
66235,6lxt,DB03907,-8.4,"N-{3-[5-(6-Amino-Purin-9-Yl)-3,4-Dihydroxy-Tetrahydro-Furan-2-Yl]-Allyl}-2,3-Dihydroxy-5-Nitro-Benzamide",UHHBFOLQOQSPLU-WGRQDFERSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
102092,6vxs,DB07000,-8.4,"N-{2,4-difluoro-3-[(5-pyridin-3-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)carbonyl]phenyl}ethanesulfonamide",ILXJWLWSYAWJKZ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
85483,6m3m,DB07715,-8.4,Emodin,RHMXXJGYXNZAPX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
66134,6lxt,DB03777,-8.4,Rbt205 Inhibitor,QMGUOJYZJKLOLH-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
102117,6vxs,DB07029,-8.4,"4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMIDAZOL-1-YL)PHENOXY]-6-METHYLPYRIMIDINE",QQBNDYARFVOEGW-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
128311,6w4h,DB07458,-8.4,"3-(1H-indol-3-yl)-4-{1-[2-(1-methylpyrrolidin-2-yl)ethyl]-1H-indol-3-yl}-1H-pyrrole-2,5-dione",LBFDERUQORUFIN-KRWDZBQOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
85474,6m3m,DB07704,-8.4,"6-AMINO-4-[2-(4-METHOXYPHENYL)ETHYL]-1,7-DIHYDRO-8H-IMIDAZO[4,5-G]QUINAZOLIN-8-ONE",UKRVQKUVWNDGMN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
133389,6w9c,DB01621,-8.4,Pipotiazine,JOMHSQGEWSNUKU-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
62448,6crv,DB13593,-8.4,Zolimidine,VSLIUWLPFRVCDL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
66223,6lxt,DB03893,-8.4,Thionicotinamide-Adenine-Dinucleotide,UQYPZLRUJKCREN-NNYOXOHSSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
66109,6lxt,DB03751,-8.4,2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose,YSYKRGRSMLTJNL-URARBOGNSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
133511,6w9c,DB01780,-8.4,Fusicoccin,KXTYBXCEQOANSX-WYKQKOHHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
26464,6cs2,DB00528,-8.4,Lercanidipine,ZDXUKAKRHYTAKV-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
15739,6lzg,DB01016,-8.4,Glyburide,ZNNLBTZKUZBEKO-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
133624,6w9c,DB01940,-8.4,Balanol Analog 2,SQLYTJZXRRDERK-ISKFKSNPSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
62404,6crv,DB13532,-8.4,Cyclopenthiazide,BKYKPTRYDKTTJY-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58883,6crv,DB06816,-8.4,Pyrvinium,QMHSXPLYMTVAMK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
26515,6cs2,DB04662,-8.4,OLOMOUCINE II,NDUVSANREQEDRE-CQSZACIVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
66833,6lxt,DB04708,-8.4,"(S)-TETRAHYDROFURAN-3-YL (2S,3S)-4-((S)-4-((1R,3R)-3-(2-AMINO-2-OXOETHYL)-2,3-DIHYDRO-1H-INDEN-1-YL)-2-BENZYL-3-OXO-2,3-DIHYDRO-1H-PYRROL-2-YL)-3-HYDROXY-1-PHENYLBUTAN-2-YLCARBAMATE",SYNSHNDQFWMLJW-YZGRCXSVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
102564,6vxs,DB07544,-8.4,N'-(5-CHLOROBENZOFURAN-2-CARBONYL)-2-(TRIFLUOROMETHYL)BENZENESULFONOHYDRAZIDE,ZLQBZYKAQQWOTK-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
94691,6m71,DB08418,-8.4,"(4aS,4bR,10bS,12aS)-12a-methyl-1,3-dioxo-2-(pyridin-3-ylmethyl)-1,2,3,4,4a,4b,5,6,10b,11,12,12a-dodecahydronaphtho[2,1-f]isoquinolin-8-yl sulfamate",LSJKARAMQNGZDF-YOEKFXIASA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60611,6crv,DB08861,-8.4,DPDPE,MCMMCRYPQBNCPH-WMIMKTLMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
131026,6w4h,DB13175,-8.4,Rheinanthrone,OZFQHULMMDWMIV-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
85267,6m3m,DB07455,-8.4,"N,N'-[biphenyl-4,4'-diyldi(2R)propane-2,1-diyl]dimethanesulfonamide",ZESUARCHWPARIF-HOTGVXAUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
66941,6lxt,DB04850,-8.4,Posizolid,HBUJYEUPIIJJOS-PBHICJAKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
157948,6wiq,DB14946,-8.4,PCO-371,LDZJFVOUPUFOHX-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
66954,6lxt,DB04867,-8.4,Lintitript,ILNRQFBVVQUOLP-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
160885,7bv1,DB11867,-8.4,JNJ-39393406,IURMHZBQEYNQOH-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
85253,6m3m,DB07439,-8.4,"1-((2-HYDROXYETHOXY)METHYL)-5-(3-(BENZYLOXY)BENZYL)-6-HYDROXYPYRIMIDINE-2,4(1H,3H)-DIONE",CAWXCABXSPTFRN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
160896,7bv1,DB11883,-8.4,SB-705498,JYILLRHXRVTRSH-GFCCVEGCSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
133681,6w9c,DB02014,-8.4,"5-(2-Fluoro-5-{(1E)-3-[3-hydroxy-2-(methoxycarbonyl)phenoxy]-1-propen-1-yl}phenyl)-1,2-oxazole-3-carboxylic acid",QKHWJUMLYAYZFS-ONEGZZNKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
85247,6m3m,DB07432,-8.4,"[[(3R,4R,5S,6R)-3-(butanoylamino)-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-ylidene]amino] N-phenylcarbamate",ITVRELFVFCOUMV-ZVZWZHPPSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
66887,6lxt,DB04785,-8.4,Streptolydigin,KVTPRMV1KLIG-NCAOFHFGSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
157988,6wiq,DB15437,-8.4,Rocacetrapib,GBHPDJQHZADVAA-SOKVYYICSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
87699,6m3m,DB12713,-8.4,Sotagliflozin,QKDRXGFQVGOQKS-CRSSMBPESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
160871,7bv1,DB11844,-8.4,Pritelivir,IVZKZONQVYTCKC-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
85379,6m3m,DB07589,-8.4,"N-[1-(AMINOMETHYL)CYCLOPROPYL]-3-(BENZYLSULFONYL)-N-2-[(1S)-2,2,2-TRIFLUORO-1-(4-HYDROXYPHENYL)ETHYL]-L-ALANINAMIDE",DWWVPKCSDHDILN-OALUTQOASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
128282,6w4h,DB07426,-8.4,"[1-HYDROXY-2-(1,1':3',1''-TERPHENYL-3-YLOXY)ETHANE-1,1-DIYL]BIS(PHOSPHONIC ACID)",NWIARQRYIRVYCM-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
58936,6crv,DB06883,-8.4,1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-phenylurea,DHNYNLNKNQJSHF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
158053,7bv1,DB00319,-8.4,Piperacillin,IVBHGBMCVLDMKU-GXNBUGAJSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
66491,6lxt,DB04244,-8.4,(2R)-2-(3-Biphenylyl)-N-{(2R)-2-hydroxy-3-[(2-pyridinylsulfonyl)amino]propyl}-4-methylpentanamide,YCDHZDINQZLSRR-DNQXCXABSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
85357,6m3m,DB07562,-8.4,"N-[4-(2,4-DIMETHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YL]-N',N'-DIMETHYL-BENZENE-1,4-DIAMINE",FGGSNQOBRJVAKL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
23385,6cs2,HMDB0061743,-8.4,Perfluoroundecanoic acid,SIDINRCMMRKXGQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
29940,6cs2,DB11833,-8.4,Basimglurant,UPZWINBEAHDTLA-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
94821,6m71,DB08572,-8.4,4-{[4-AMINO-6-(CYCLOHEXYLMETHOXY)-5-NITROSOPYRIMIDIN-2-YL]AMINO}BENZAMIDE,YBKLJTXDSBEVRV-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
87680,6m3m,DB12682,-8.4,Mubritinib,ZTFBIUXIQYRUNT-MDWZMJQESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
60565,6crv,DB08795,-8.4,Azidocillin,ODFHGIPNGIAMDK-NJBDSQKTSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58909,6crv,DB06850,-8.4,(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclohexylamino)ethanoyl)pyrrolidine-2-carboxamide,RYKFVFFOIYLADT-SFHVURJKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
17104,6cs2,HMDB0006327,-8.4,Alpha-Tocotrienol,RZFHLOLGZPDCHJ-XZXLULOTSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
146837,6w9q,DB09048,-8.4,Netupitant,WAXQNWCZJDTGBU-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
94750,6m71,DB08489,-8.4,"N4-HYDROXY-2-ISOBUTYL-N1-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.013,18]NONADECA-12(19),13,15,17-TETRAEN-10-YL)-SUCCINAMIDE",GCBPAPVOMPJQHK-NQIIRXRSSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
102492,6vxs,DB07458,-8.4,"3-(1H-indol-3-yl)-4-{1-[2-(1-methylpyrrolidin-2-yl)ethyl]-1H-indol-3-yl}-1H-pyrrole-2,5-dione",LBFDERUQORUFIN-KRWDZBQOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
85308,6m3m,DB07505,-8.4,"N-({(3R,4R)-4-[(benzyloxy)methyl]pyrrolidin-3-yl}methyl)-N-(2-methylpropyl)benzenesulfonamide",DGURGFSAQIBQCO-FGZHOGPDSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85304,6m3m,DB07500,-8.4,(2E)-1-[2-hydroxy-4-methoxy-5-(3-methylbut-2-en-1-yl)phenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one,ZUGCRBMNFSAUOC-YRNVUSSQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
102514,6vxs,DB07486,-8.4,"3-({4-[(1E)-3-morpholin-4-yl-3-oxoprop-1-en-1-yl]-2,3-bis(trifluoromethyl)phenyl}sulfanyl)aniline",KLSZVPNVFKKIRD-FNORWQNLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
158106,7bv1,DB00384,-8.4,Triamterene,FNYLWPVRPXGIIP-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
85523,6m3m,DB07761,-8.4,"(2R)-1-[4-({6-[(2,6-Difluorophenyl)amino]-4-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol",ZVSBKYYVBCKDBO-OAHLLOKOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
102059,6vxs,DB06962,-8.4,"(5-(aminomethyl)-2H-spiro[benzofuran-3,4'-piperidine]-1'-yl)(5-(phenylethynyl)furan-2-yl)methanone",YKTUSHSSKIWDRY-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
131235,6w4h,DB13470,-8.4,Cefodizime,XDZKBRJLTGRPSS-BGZQYGJUSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
85715,6m3m,DB07983,-8.4,1-(4-IODOBENZOYL)-5-METHOXY-2-METHYL INDOLE-3-ACETIC ACID,CXBFZYKAVCAPSV-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
60454,6crv,DB08669,-8.4,"METHYL N-[(2S,3R)-3-AMINO-2-HYDROXY-3-(4-METHYLPHENYL)PROPANOYL]-D-ALANYL-D-LEUCINATE",BMHZOSJVDHAFEE-SVGFKBNWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
16890,6cs2,HMDB0005000,-8.4,Loratadine,JCCNYMKQOSZNPW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
128414,6w4h,DB07583,-8.4,"(4R,2S)-5'-(4-(4-CHLOROBENZYLOXY)PYRROLIDIN-2-YLMETHANESULFONYL)ISOQUINOLINE",RLNNFNGBXLTQOB-RBUKOAKNSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
65248,6lxt,DB02581,-8.4,"5-[2,3-Dichloro-4-(5-{1-[2-(2-Guanidino-4-Methyl-Pentanoylamino)-Acetyl]-Piperidin-4-Yl}-1-Methyl-1h-Pyrazol-3-Yl)-Phenoxymethyl]-Furan-2-Carboxylic Acid",VNZHOIDQBPFEJU-OAQYLSRUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
101710,6vxs,DB06276,-8.4,Tanomastat,JXAGDPXECXQWBC-LJQANCHMSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
160520,7bv1,DB08731,-8.4,"2-[(1R)-2-carboxy-1-(naphthalen-1-ylmethyl)ethyl]-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylic acid",GPOKTQCDBPECSS-MRXNPFEDSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95179,6m71,DB09034,-8.4,Suvorexant,JYTNQNCOQXFQPK-MRXNPFEDSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
85717,6m3m,DB07985,-8.4,+/-METHYL 4-(AMINOIMINOMETHYL)-BETA-[3- INH (AMINOIMINO)PHENYL]BENZENE PENTANOATE,PVALLOSAENRPQO-INIZCTEOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
133261,6w9c,DB01471,-8.4,Bolasterone,IVFYLRMMHVYGJH-VLOLGRDOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
15808,6lzg,DB01329,-8.4,Cefoperazone,GCFBRXLSHGKWDP-XCGNWRKASA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
65307,6lxt,DB02659,-8.4,Cholic Acid,BHQCQFFYRZLCQQ-OELDTZBJSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
131553,6w4h,DB13936,-8.4,JNJ-28330835,RYBKPGYFXRNMMU-LBPRGKRZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
160558,7bv1,DB08772,-8.4,"3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL-2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID",BCSVCWVQNOXFGL-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
65341,6lxt,DB02704,-8.4,"(2r,3r,4r,5r)-3,4-Dihydroxy-N,N'-Bis[(1s,2r)-2-Hydroxy-2,3-Dihydro-1h-Inden-1-Yl]-2,5-Bis(2-Phenylethyl)Hexanediamide",GQKBYZPVKVXMJL-LAFNQVRVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
101757,6vxs,DB06429,-8.4,Talnetant,BIAVGWDGIJKWRM-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
133278,6w9c,DB01489,-8.4,Camazepam,PXBVEXGRHZFEOF-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
101767,6vxs,DB06454,-8.4,Sarizotan,HKFMQJUJWSFOLY-OAQYLSRUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
158200,7bv1,DB00717,-8.4,Norethisterone,VIKNJXKGJWUCNN-XGXHKTLJSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
101673,6vxs,DB06202,-8.4,Lasofoxifene,GXESHMAMLJKROZ-IAPPQJPRSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
59117,6crv,DB07093,-8.4,"{3-[(5-CHLORO-1,3-BENZOTHIAZOL-2-YL)METHYL]-2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL}ACETIC ACID",RQWICELTTDJODO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85720,6m3m,DB07988,-8.4,"2-[3-(5-MERCAPTO-[1,3,4]THIADIAZOL-2YL)-UREIDO]-N-METHYL-3-PENTAFLUOROPHENYL-PROPIONAMIDE",HZAXNPDJVFUGDS-BYPYZUCNSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87516,6m3m,DB12428,-8.4,PAC-14028,UKGJZDSUJSPAJL-YPUOHESYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
160480,7bv1,DB08439,-8.4,Parecoxib,TZRHLKRLEZJVIJ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
101599,6vxs,DB05835,-8.4,NS-3728,OQRAKHDEGGGWQO-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
59145,6crv,DB07125,-8.4,"4-(6-{[(1R)-1-(hydroxymethyl)propyl]amino}imidazo[1,2-b]pyridazin-3-yl)benzoic acid",KKZYGUVAFJCULH-CYBMUJFWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62588,6crv,DB13778,-8.4,Cefazedone,VTLCNEGVSVJLDN-MLGOLLRUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85754,6m3m,DB08024,-8.4,1-[2-(S)-AMINO-3-BIPHENYL-4-YL-PROPIONYL]-PYRROLIDINE-2-(S)-CARBONITRILE,MUUVLSCVDXKQQV-OALUTQOASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
101622,6vxs,DB05983,-8.4,Bardoxolone methyl,WPTTVJLTNAWYAO-KPOXMGGZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
95255,6m71,DB09181,-8.4,Trefentanil,RJSCINHYBGMIFT-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160489,7bv1,DB08448,-8.4,"(4aS)-5-[(2,4-diaminopteridin-6-yl)methyl]-4a,5-dihydro-2H-dibenzo[b,f]azepin-8-ol",PCBWLKUEKANDCL-INIZCTEOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
65058,6lxt,DB02341,-8.4,"Mdl 101,146",XQAMVCHQGHAELT-YPAWHYETSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
65067,6lxt,DB02354,-8.4,4-{[1-Methyl-5-(2-Methyl-Benzoimidazol-1-Ylmethyl)-1h-Benzoimidazol-2-Ylmethyl]-Amino}-Benzamidine,IRKPNOLLMNHSOU-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
65134,6lxt,DB02432,-8.4,RU90395,RLLAUERCSKPFGD-VMPREFPWSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
133225,6w9c,DB01430,-8.4,Almitrine,OBDOVFRMEYHSQB-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
158307,7bv1,DB00845,-8.4,Clofazimine,WDQPAMHFFCXSNU-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95243,6m71,DB09168,-8.4,4-Phenylfentanyl,BXCJXJLHYMWMQU-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
101639,6vxs,DB06134,-8.4,SNS-314,FAYAUAZLLLJJGH-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
131609,6w4h,DB14037,-8.4,Madecassic acid,PRAUVHZJPXOEIF-AOLYGAPISA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
87543,6m3m,DB12468,-8.4,Pf-04531083,ZRJGMDIPCQOGNI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
126611,6w4h,DB04064,-8.4,Nogalaviketone,QHNJNOBWURJIEK-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
59088,6crv,DB07058,-8.4,"5-[1-(4-methoxyphenyl)-1H-benzimidazol-6-yl]-1,3,4-oxadiazole-2(3H)-thione",QBVJMUOTMRYUKR-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
17157,6cs2,HMDB0006733,-8.4,"CE(22:6(4Z,7Z,10Z,13Z,16Z,19Z))",VOEVEGPMRIYYKC-IWVSHIRDSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
85671,6m3m,DB07932,-8.4,"dimethyl (1R,4S)-5,6-bis(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hepta-2,5-diene-2,3-dicarboxylate",CRLQCBACIMUGDZ-BGYRXZFFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
14075,6lzg,T3D3693,-8.4,Xanthomegnin,WICHONPZVIYWIJ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
85582,6m3m,DB07826,-8.4,2-[4-chloro-2-(phenylcarbonyl)phenoxy]-N-phenylacetamide,DTGVSZSMDOMAEB-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
25458,6cs2,DB03383,-8.4,5-Chloro-1h-Indole-2-Carboxylic Acid [1-(4-Fluorobenzyl)-2-(4-Hydroxypiperidin-1yl)-2-Oxoethyl]Amide,YDCGVASFVACWKF-NRFANRHFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
85573,6m3m,DB07816,-8.4,N-(P-CYANOPHENYL)-N'-DIPHENYLMETHYL-GUANIDINE-ACETIC ACID,KGHMYJFHUHFOGL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59053,6crv,DB07021,-8.4,"(7R,8R)-8-(2,4,5-trifluorophenyl)-6,7,8,9-tetrahydroimidazo[1,2-a:4,5-c']dipyridin-7-amine",SOSYXEPELJIJHZ-RNCFNFMXSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
101933,6vxs,DB06800,-8.4,Methylnaltrexone,JVLBPIPGETUEET-WIXLDOGYSA-O,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
65817,6lxt,DB03336,-8.4,BIA,KVIVJQWOYSWCCZ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
65829,6lxt,DB03351,-8.4,Sri-9439,KMSATRJZEXNGDP-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
101953,6vxs,DB06833,-8.4,1-CYCLOHEXYL-N-{[1-(4-METHYLPHENYL)-1H-INDOL-3-YL]METHYL}METHANAMINE,MMIJMYOYKAKQPN-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
87608,6m3m,DB12569,-8.4,Tonapofylline,ZWTVVWUOTJRXKM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
131296,6w4h,DB13552,-8.4,Trifluperidol,GPMXUUPHFNMNDH-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
62489,6crv,DB13649,-8.4,Proquazone,JTIGKVIOEQASGT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
101969,6vxs,DB06856,-8.4,6-FLUORO-2-[2-HYDROXY-3-(2-METHYL-CYCLOHEXYLOXY)-PHENYL]-1H-INDOLE-5-CARBOXAMIDINE,HUYQYLFFFNSAAX-BUXKBTBVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
65894,6lxt,DB03447,-8.4,Uridylyl-2'-5'-Phospho-Adenosine,QARCCHXXGAIRFS-KPKSGTNCSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
101992,6vxs,DB06882,-8.4,1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-naphthalen-1-ylurea,HJWMLCDGRWWLAQ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
65929,6lxt,DB03495,-8.4,"4,6-Dideoxy-4-{[4,5,6-Trihydroxy-3-(Hydroxymethyl)Cyclohex-2-En-1-Yl]Amino}-Alpha-D-Lyxo-Hexopyranosyl-(1->4)-Alpha-D-Threo-Hexopyranosyl-(1->6)-Alpha-L-Threo-Hexopyranose",FZLCJZILHGFQLM-PISLJJGOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
102023,6vxs,DB06916,-8.4,"N-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-1-[2-(1H-IMIDAZOL-1-YL)-6-METHYLPYRIMIDIN-4-YL]-D-PROLINAMIDE",LBCGUKCXRVUULK-QGZVFWFLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
160743,7bv1,DB09534,-8.4,Ecamsule,HEAHZSUCFKFERC-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
85526,6m3m,DB07764,-8.4,FLUORESCIN,MURGITYSBWUQTI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59046,6crv,DB07013,-8.4,TERT-BUTYL 4-({[4-(BUT-2-YN-1-YLAMINO)PHENYL]SULFONYL}METHYL)-4-[(HYDROXYAMINO)CARBONYL]PIPERIDINE-1-CARBOXYLATE,RXFCFGLSOUOCEA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
133316,6w9c,DB01536,-8.4,Androstenedione,AEMFNILZOJDQLW-QAGGRKNESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
62501,6crv,DB13664,-8.4,Formocortal,QNXUUBBKHBYRFW-QWAPGEGQSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
101854,6vxs,DB06660,-8.4,Saredutant,PGKXDIMONUAMFR-AREMUKBSSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
59079,6crv,DB07049,-8.4,(2R)-1-[(4-tert-butylphenyl)sulfonyl]-2-methyl-4-(4-nitrophenyl)piperazine,SOFGQQQVQZQJFS-MRXNPFEDSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
160620,7bv1,DB08846,-8.4,Ellagic Acid,AFSDNFLWKVMVRB-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
158167,7bv1,DB00457,-8.4,Prazosin,IENZQIKPVFGBNW-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
85628,6m3m,DB07877,-8.4,"8-(6-BROMO-BENZO[1,3]DIOXOL-5-YLSULFANYL)-9-(3-ISOPROPYLAMINO-PROPYL)-ADENINE",MWGWLDJLENCVRQ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59073,6crv,DB07042,-8.4,"7-amino-2-tert-butyl-4-{[2-(1H-imidazol-4-yl)ethyl]amino}pyrido[2,3-d]pyrimidine-6-carboxamide",XESUNWBIAADLPI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
128385,6w4h,DB07546,-8.4,[1-(6-{6-[(1-methylethyl)amino]-1H-indazol-1-yl}pyrazin-2-yl)-1H-pyrrol-3-yl]acetic acid,BBYRUZKRFAIQSR-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
101823,6vxs,DB06597,-8.4,Estradiol sulfamate,YXYXCSOJKUAPJI-ZBRFXRBCSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
128383,6w4h,DB07544,-8.4,N'-(5-CHLOROBENZOFURAN-2-CARBONYL)-2-(TRIFLUOROMETHYL)BENZENESULFONOHYDRAZIDE,ZLQBZYKAQQWOTK-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
128380,6w4h,DB07540,-8.4,"4-{5-[(1Z)-1-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)ETHYL]-2-FURYL}BENZENESULFONAMIDE",AKFVRSQELXTCFW-JYRVWZFOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
128377,6w4h,DB07537,-8.4,"N'-(6-aminopyridin-3-yl)-N-(2-cyclopentylethyl)-4-methyl-benzene-1,3-dicarboxamide",CLEGTVIMOPPIBR-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
146584,6w9q,DB08709,-8.4,"2,3-diphenyl-1H-indole-7-carboxylic acid",OLUDUXWVPIEHDA-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
62514,6crv,DB13678,-8.4,Dihexyverine,MNSQDVCVWNXBFQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
101843,6vxs,DB06634,-8.4,Casopitant,XGGTZCKQRWXCHW-WMTVXVAQSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
133295,6w9c,DB01513,-8.4,"17Alpha-methyl-3beta,17beta-dihydroxy-5alpha-androstane",QGKQXZFZOIQFBI-UYEYMFBJSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
146604,6w9q,DB08730,-8.4,3-FLUORO-5-MORPHOLIN-4-YL-N-[1-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-6-YL]BENZAMIDE,CPFBZMFUCGHBAP-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
95060,6m71,DB08867,-8.4,Ulipristal,HKDLNTKNLJPAIY-WKWWZUSTSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
15784,6lzg,DB01199,-8.4,Tubocurarine,JFJZZMVDLULRGK-URLMMPGGSA-O,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
131357,6w4h,DB13638,-8.4,Cefbuperazone,SMSRCGPDNDCXFR-CYWZMYCQSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
59061,6crv,DB07030,-8.4,(5-CHLORO-2-{[(3-NITROBENZYL)AMINO]CARBONYL}PHENOXY)ACETIC ACID,VABIMMIJVWNHFI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
101792,6vxs,DB06518,-8.4,R-1487,KKKRKRMVJRHDMG-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
12860,6lzg,DB13931,-8.4,Netarsudil,OURRXQUGYQRVML-AREMUKBSSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
166565,7bv1,DB15391,-8.4,Elenbecestat,AACUJFVOHGRMTR-DPXNYUHVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
133706,6w9c,DB02046,-8.4,N-[(Furan-2-Yl)Carbonyl]-(S)-Leucyl-(R)-[1-Amino-2(1h-Indol-3-Yl)Ethyl]-Phosphonic Acid,WHPKSASOSKNDPY-PKOBYXMFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
26671,6cs2,DB04850,-8.4,Posizolid,HBUJYEUPIIJJOS-PBHICJAKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
60774,6crv,DB09101,-8.4,Elvitegravir,JUZYLCPPVHEVSV-LJQANCHMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
157170,6wiq,DB14703,-8.4,Dexamethasone metasulfobenzoate,TWQWRHIQRAZHPR-XNXCGYEVSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
67542,6lxt,DB06875,-8.4,3-(3-FLUORO-4-HYDROXYPHENYL)-7-HYDROXY-1-NAPHTHONITRILE,NSSOSHDCWCMNDM-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
94079,6m71,DB07697,-8.4,"1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-4-[(4-methoxyphenyl)sulfonyl]piperazine",HMGDKYUJSFVHIY-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
103337,6vxs,DB08460,-8.4,"3-{5-[(6-amino-1H-pyrazolo[3,4-b]pyridin-3-yl)methoxy]-2-chlorophenoxy}-5-chlorobenzonitrile",KXDIHAQCVNNLIB-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
26678,6cs2,DB04861,-8.4,Nebivolol,KOHIRBRYDXPAMZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
96908,6m71,DB13610,-8.4,Flumedroxone,CDZJOBWKHSYNMO-SCUQKFFVSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
134214,6w9c,DB02715,-8.4,Compound 18,UZOOIPXOYYJULJ-RHLLTPQKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
134226,6w9c,DB02732,-8.4,Nicotinamide Adenine Dinucleotide Acetone Adduct,SGHBFOOIAAJJMI-YDKVLQLQSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
147224,6w9q,DB11618,-8.4,Zorubicin,FBTUMDXHSRTGRV-BJISBDEGSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
84906,6m3m,DB07040,-8.4,"2-amino-7-fluoro-5-oxo-5H-chromeno[2,3-b]pyridine-3-carboxamide",GCHMLYYPYFXLQB-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84902,6m3m,DB07036,-8.4,"(3aS,4R,9bR)-2,2-difluoro-4-(4-hydroxyphenyl)-6-(methoxymethyl)-1,2,3,3a,4,9b-hexahydrocyclopenta[c]chromen-8-ol",GPFRMIHXGMVMGF-BZSNNMDCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
130763,6w4h,DB12745,-8.4,GSK-690693,KGPGFQWBCSZGEL-ZDUSSCGKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
62200,6crv,DB13258,-8.4,Etofamide,QTRALMGDQMIVFF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
147231,6w9q,DB11636,-8.4,Nomegestrol,KZUIYQJTUIACIG-YBZCJVABSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
161152,7bv1,DB12960,-8.4,INCB-9471,ZMCJFJZOSKEMOM-DNKZPPIMSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
67626,6lxt,DB06976,-8.4,"1-(5-OXO-2,3,5,9B-TETRAHYDRO-1H-PYRROLO[2,1-A]ISOINDOL-9-YL)-3-(5-PYRROLIDIN-2-YL-1H-PYRAZOL-3-YL)-UREA",IWOOJEZSDPRYAZ-WFASDCNBSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
62209,6crv,DB13274,-8.4,Micronomicin,DNYGXMICFMACRA-XHEDQWPISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
103425,6vxs,DB08561,-8.4,"BENZYL 6-BENZYL-5,7-DIOXO-6,7-DIHYDRO-5H-[1,3]THIAZOLO[3,2-C]PYRIMIDINE-2-CARBOXYLATE",PLBINCOCFGQAJM-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
94155,6m71,DB07786,-8.4,"1-((1R,2S)-1-{2-[2-(4-CHLOROPHENYL)-1,3-BENZOXAZOL-7-YL]ETHYL}-2-HYDROXYPROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE",SMFRBBHLVBWHGB-DJJJIMSYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
157230,6wiq,DB14850,-8.4,Deleobuvir,BMAIGAHXAJEULY-UKTHLTGXSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
161083,7bv1,DB12857,-8.4,NVP-LEQ-506,POERAARDVFVDLO-QGZVFWFLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
67443,6lxt,DB06717,-8.4,Fosaprepitant,BARDROPHSZEBKC-OITMNORJSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
84989,6m3m,DB07134,-8.4,"5-(4-CHLORO-5-PHENYL-3-THIENYL)-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDE",LCPRWBWCEGWNKF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
103207,6vxs,DB08301,-8.4,N-({[4-(AMINOSULFONYL)PHENYL]AMINO}CARBONYL)-4-METHYLBENZENESULFONAMIDE,HDCXQTPVTAIPNZ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
58673,6crv,DB06345,-8.4,AR-9281,HUDQLWBKJOMXSZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
67445,6lxt,DB06721,-8.4,Gimatecan,UIVFUQKYVFCEKJ-OPTOVBNMSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
103248,6vxs,DB08351,-8.4,N-cyclopropyl-4-methyl-3-{2-[(2-morpholin-4-ylethyl)amino]quinazolin-6-yl}benzamide,MNEXDVSJIUQQRH-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
103249,6vxs,DB08352,-8.4,"6-[4-(2-fluorophenyl)-1,3-oxazol-5-yl]-N-(1-methylethyl)-1,3-benzothiazol-2-amine",FQYJTHIYAQQJAB-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
134181,6w9c,DB02673,-8.4,"(4ar,6s,8ar)-11-[8-(1,3-Dioxo-1,3-Dihydro-2h-Isoindol-2-Yl)Octyl]-6-Hydroxy-3-Methoxy-5,6,9,10-Tetrahydro-4ah-[1]Benzofuro[3a,3,2-Ef][2]Benzazepin-11-Ium",VLGAHTYYCHWLNI-BHRZLAGCSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
67462,6lxt,DB06744,-8.4,ginkgolide-B,SQOJOAFXDQDRGF-MMQTXUMRSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
26659,6cs2,DB00549,-8.4,Zafirlukast,YEEZWCHGZNKEEK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
130797,6w4h,DB12805,-8.4,Ataciguat,PQHLRGARXNPFCF-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
84957,6m3m,DB07101,-8.4,PD-0325901,SUDAHWBOROXANE-SECBINFHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
103281,6vxs,DB08391,-8.4,"6,7-DIMETHOXY-4-[(3R)-3-(QUINOXALIN-2-YLOXY)PYRROLIDIN-1-YL]QUINAZOLINE",UBIIFKJMNRPNMT-CQSZACIVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
84948,6m3m,DB07088,-8.4,(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclopentyloxy)ethanoyl)pyrrolidine-2-carboxamide,ZWXWAYUCJVQHOR-KRWDZBQOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
103293,6vxs,DB08406,-8.4,"[N-(2,4-DIAMINOPTERIDIN-6-YL)-METHYL]-DIBENZ[B,F]AZEPINE",NXCCIJQEAKMFGW-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
87900,6m3m,DB13028,-8.4,Biapenem,MRMBZHPJVKCOMA-YJFSRANCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
134152,6w9c,DB02636,-8.4,"9-Hydroxy-8-Methoxy-6-Nitro-Phenanthrol[3,4-D][1,3]Dioxole-5-Carboxylic Acid",UCLGCTLOEZZSLA-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
134138,6w9c,DB02616,-8.4,FR117016,CKJGKHXCUDWFDC-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
134293,6w9c,DB02882,-8.4,Cyanocinnoline,CUWRVIIPSSUUDJ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
84877,6m3m,DB07007,-8.4,"(3R)-3-[(1,2,3,4-tetrahydroisoquinolin-7-yloxy)methyl]-2,3-dihydrothieno[2,3-f][1,4]oxazepin-5-amine",UDFXWCLBONUMNA-CYBMUJFWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87925,6m3m,DB13066,-8.4,Liarozole,UGFHIPBXIWJXNA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
93876,6m71,DB07453,-8.4,2-PHENYL-4H-BENZO[H]CHROMEN-4-ONE,VFMMPHCGEFXGIP-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
58585,6crv,DB06144,-8.4,Sertindole,GZKLJWGUPQBVJQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
156425,6wiq,DB13078,-8.4,KOSN-1724,JAYGOFBXDFAXBW-CYEKYUJNSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
103731,6vxs,DB08962,-8.4,Glibornuride,RMTYNAPTNBJHQI-LLDVTBCESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
93840,6m71,DB07410,-8.4,[2-(3-DIBENZOFURAN-4-YL-PHENYL)-1-HYDROXY-1-PHOSPHONO-ETHYL]-PHOSPHONIC ACID,BYVXAUZOTGITQZ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
161384,7bv1,DB13941,-8.4,Piperaquine,UCRHFBCYFMIWHC-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
103798,6vxs,DB09053,-8.4,Ibrutinib,XYFPWWZEPKGCCK-GOSISDBHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
156381,6wiq,DB13014,-8.4,Hypericin,BTXNYTINYBABQR-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
87957,6m3m,DB13114,-8.4,Amitriptylinoxide,ZPMKQFOGINQDAM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
134530,6w9c,DB03202,-8.4,"2-[5-Methanesulfonylamino-2-(4-Aminophenyl)-6-Oxo-1,6-Dihydro-1-Pyrimidinyl]-N-(3,3,3-Trifluoro-1-Isopropyl-2-Oxopropyl)Acetamide",JWSWTHSJMGVOKE-HNNXBMFYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
93815,6m71,DB07382,-8.4,"N-2-1H-benzimidazol-5-yl-N-4-(3-cyclopropyl-1H-pyrazol-5-yl)pyrimidine-2,4-diamine",WJNBSTLIALIIEW-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60890,6crv,DB09285,-8.4,Morniflumate,LDXSPUSKBDTEKA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
26748,6cs2,DB05016,-8.4,Ataluren,OOUGLTULBSNHNF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
93768,6m71,DB07326,-8.4,"6-chloro-N-pyrimidin-5-yl-3-{[3-(trifluoromethyl)phenyl]amino}-1,2-benzisoxazole-7-carboxamide",FEGRQUWSKADGSP-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
103885,6vxs,DB09200,-8.4,Rivoglitazone,XMSXOLDPMGMWTH-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
114672,6vxx,DB14633,-8.4,Prednisolone hemisuccinate,APGDTXUMTIZLCJ-CGVGKPPMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
12236,6lzg,DB13078,-8.4,KOSN-1724,JAYGOFBXDFAXBW-CYEKYUJNSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
67907,6lxt,DB07296,-8.4,(5Z)-3-(4-CHLOROPHENYL)-4-HYDROXY-5-(1-NAPHTHYLMETHYLENE)FURAN-2(5H)-ONE,PLGHLEBIWUQEPR-PDGQHHTCSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
156376,6wiq,DB13005,-8.4,Rebastinib,WVXNSAVVKYZVOE-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
114665,6vxx,DB14626,-8.4,Pregnenolone acetate,CRRKVZVYZQXICQ-RJJCNJEVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
103685,6vxs,DB08893,-8.4,Mirabegron,PBAPPPCECJKMCM-IBGZPJMESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
103668,6vxs,DB08861,-8.4,DPDPE,MCMMCRYPQBNCPH-WMIMKTLMSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
134319,6w9c,DB02915,-8.4,"4-(2,4-Dimethyl-1,3-thiazol-5-yl)-N-[4-(trifluoromethyl)phenyl]-2-pyrimidinamine",MEZFDQUDLQCVNX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
103509,6vxs,DB08664,-8.4,({3-[1-(4-HYDROXY-2-OXO-2H-CHROMEN-3-YL)-PROPYL]-PHENYLCARBAMOYL}-METHYL)-CARBAMIC ACID TERT-BUTYL ESTER,QUQQVMVIWCUYFV-KRWDZBQOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
24396,6cs2,DB02123,-8.4,Glycochenodeoxycholic Acid,GHCZAUBVMUEKKP-GYPHWSFCSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
161258,7bv1,DB13463,-8.4,Oxetorone,VZVRZTZPHOHSCK-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
67648,6lxt,DB07000,-8.4,"N-{2,4-difluoro-3-[(5-pyridin-3-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)carbonyl]phenyl}ethanesulfonamide",ILXJWLWSYAWJKZ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
84860,6m3m,DB06990,-8.4,"4-[(1E,7E)-8-(2,6-DIOXO-1,2,3,6-TETRAHYDROPYRIMIDIN-4-YL)-3,6-DIOXA-2,7-DIAZAOCTA-1,7-DIEN-1-YL]BENZOIC ACID",XHDKIDMFBWLHAX-GONBZBRSSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84857,6m3m,DB06986,-8.4,"2-CHLORO-N-[(1R,2R)-1-HYDROXY-2,3-DIHYDRO-1H-INDEN-2-YL]-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE",LRHOLHTVXXSIMG-BXUZGUMPSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
26707,6cs2,DB04892,-8.4,Phenserine,PBHFNBQPZCRWQP-QUCCMNQESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
134368,6w9c,DB02976,-8.4,Uridine-5'-monophosphate 2-deoxy-2-fluoro-galactopyranosyl-monophosphate ester,NGTCPFGWXMBZEP-KBQKSTHMSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
103571,6vxs,DB08738,-8.4,1-{3-oxo-3-[(2S)-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]propyl}-3-phenylquinoxalin-2(1H)-one,KWCKZIJGKMCYCI-QFIPXVFZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
67668,6lxt,DB07024,-8.4,"2-(3,4-DIHYDROXYPHENYL)-8-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-3-HYDROXY-6-METHYL-4H-CHROMEN-4-ONE",CEXBEGBNDJVZPK-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
67670,6lxt,DB07026,-8.4,"(1S,5S,7R)-N-7-(BIPHENYL-4-YLMETHYL)-N-3-HYDROXY-6,8-DIOXA-3-AZABICYCLO[3.2.1]OCTANE-3,7-DICARBOXAMIDE",PPLDARNGJSQINK-OKZBNKHCSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
67675,6lxt,DB07031,-8.4,"3-Fluoro-4-{[(2R)-2-hydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthalenyl)acetyl]amino}benzoic acid",AANFHDFOMFRLLR-LJQANCHMSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
67685,6lxt,DB07041,-8.4,"N-[2-(2,4-diaminopyrido[2,3-d]pyrimidin-7-yl)-2-methylpropyl]-4-phenoxybenzamide",FDJWFDQRPKKBFA-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
26713,6cs2,DB00554,-8.4,Piroxicam,QYSPLQLAKJAUJT-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
103600,6vxs,DB08770,-8.4,"4-{2-[(7-amino-2-furan-2-yl[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-yl)amino]ethyl}phenol",PWTBZOIUWZOPFT-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
161305,7bv1,DB13531,-8.4,Nicofetamide,DWODOIKZDGJOPQ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
130721,6w4h,DB12682,-8.4,Mubritinib,ZTFBIUXIQYRUNT-MDWZMJQESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
103651,6vxs,DB08833,-8.4,Taurochenodeoxycholic acid,BHTRKEVKTKCXOH-BJLOMENOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
128191,6w4h,DB07318,-8.4,"N-[2-(4-AMINO-5,8-DIFLUORO-1,2-DIHYDROQUINAZOLIN-2-YL)ETHYL]-3-FURAMIDE",BOAUWUUBSXECNL-LLVKDONJSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
85006,6m3m,DB07155,-8.4,(3S)-1-CYCLOHEXYL-5-OXO-N-PHENYLPYRROLIDINE-3-CARBOXAMIDE,BVUSHGJZBZMDML-ZDUSSCGKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
103092,6vxs,DB08154,-8.4,3-chloro-5-[2-chloro-5-(1H-indazol-3-ylmethoxy)phenoxy]benzonitrile,WHCLIFOVZDANCU-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
103085,6vxs,DB08147,-8.4,"4-[3-(dibenzylamino)phenyl]-2,4-dioxobutanoic acid",RMWVENXKUQXLPW-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
94468,6m71,DB08141,-8.4,"4-{[(2,6-difluorophenyl)carbonyl]amino}-N-[(3S)-piperidin-3-yl]-1H-pyrazole-3-carboxamide",KOMNQBZWMCFDTQ-VIFPVBQESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94455,6m71,DB08126,-8.4,"3-{[4-([AMINO(IMINO)METHYL]AMINOSULFONYL)ANILINO]METHYLENE}-2-OXO-2,3-DIHYDRO-1H-INDOLE",DMCRNUMVSATRTP-LCYFTJDESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
87782,6m3m,DB12853,-8.4,DA-6886,AULLTYAISZREAX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
26563,6cs2,DB04724,-8.4,"(S)-2-((S)-3-ISOBUTYL-2,5-DIOXO-4-QUINOLIN-3-YLMETHYL-[1,4]DIAZEPAN-1YL)-N-METHYL-3-NAPHTALEN-2-YL-PROPIONAMIDE",COVPLULNDBDXTN-KYJUHHDHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
102760,6vxs,DB07779,-8.4,N-({(2S)-1-[(3R)-3-AMINO-4-(2-FLUOROPHENYL)BUTANOYL]PYRROLIDIN-2-YL}METHYL)BENZAMIDE,ANQHSFFUNMTTRS-MOPGFXCFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
62312,6crv,DB13407,-8.4,Nifenazone,BRZANEXCSZCZCI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
157616,6wiq,DB12198,-8.4,Fosdagrocorat,BVXLAHSJXXSWFF-KEKPKEOLSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
94424,6m71,DB08094,-8.4,"(4-AMINO-2-{[1-(METHYLSULFONYL)PIPERIDIN-4-YL]AMINO}PYRIMIDIN-5-YL)(2,3-DIFLUORO-6-METHOXYPHENYL)METHANONE",JRNJNYBQQYBCLE-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
85161,6m3m,DB07330,-8.4,trans-4-(7-carbamoyl-1H-benzimidazol-2-yl)-1-propylpiperidinium,KXSIHXHEHABEJX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
160939,7bv1,DB12295,-8.4,Evodenoson,SQJXTUJMBYVDBB-RQXXJAGISA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
128245,6w4h,DB07382,-8.4,"N-2-1H-benzimidazol-5-yl-N-4-(3-cyclopropyl-1H-pyrazol-5-yl)pyrimidine-2,4-diamine",WJNBSTLIALIIEW-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
160949,7bv1,DB12307,-8.4,Foretinib,CXQHYVUVSFXTMY-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
114654,6vxx,DB14570,-8.4,Hydroxyprogesterone,DBPWSSGDRRHUNT-CEGNMAFCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60707,6crv,DB08998,-8.4,Demexiptiline,SEDQWOMFMIJKCU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85121,6m3m,DB07288,-8.4,N-(4-chlorophenyl)-2-[(pyridin-4-ylmethyl)amino]benzamide,GGPZCOONYBPZEW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87819,6m3m,DB12904,-8.4,ZSTK-474,HGVNLRPZOWWDKD-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85120,6m3m,DB07287,-8.4,"2-(2,4-DICHLOROPHENOXY)-5-(PYRIDIN-2-YLMETHYL)PHENOL",AOVDSWPGWPRTSR-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
147162,6w9q,DB11450,-8.4,Pimobendan,GLBJJMFZWDBELO-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
67098,6lxt,DB05511,-8.4,Piclidenoson,HUJXGQILHAUCCV-MOROJQBDSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
130937,6w4h,DB13024,-8.4,MK-8245,UJEAABFSXKCSGI-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
23303,6cs2,HMDB0060027,-8.4,"5-(3',4',5'-trihydroxyphenyl)-gamma-valerolactone-O-methyl-4'-O-glucuronide",OQZAGOJJVQJMIE-ZTPQVCSDSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
94538,6m71,DB08224,-8.4,"(1S,7S,8S,8AR)-1,2,3,7,8,8A-HEXAHYDRO-7-METHYL-8-[2-[(2R,4R)-TETRAHYDRO-4-HY DROXY-6-OXO-2H-PYRAN-2-YL]ETHYL]-1-NAPHTHALENOL",WWSNTLOVYSRDEL-TVKPWXLESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
85235,6m3m,DB07419,-8.4,S-23,SSFVOEAXHZGTRJ-KRWDZBQOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87740,6m3m,DB12779,-8.4,Higenamine,WZRCQWQRFZITDX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
25393,6cs2,DB00404,-8.4,Alprazolam,VREFGVBLTWBCJP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
58832,6crv,DB06721,-8.4,Gimatecan,UIVFUQKYVFCEKJ-OPTOVBNMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
128264,6w4h,DB07404,-8.4,"(1-HYDROXY-1-PHOSPHONO-2-[1,1';3',1'']TERPHENYL-3-YL-ETHYL)-PHOSPHONIC ACID",YXQQNSYZOQHKHD-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
62354,6crv,DB13461,-8.4,Cefcapene,HJJRIJDTIPFROI-NVKITGPLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60631,6crv,DB08897,-8.4,Aclidinium,ASMXXROZKSBQIH-VITNCHFBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
133763,6w9c,DB02118,-8.4,CP-271485,CIUMOGWIMXNXSQ-GOSISDBHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
58827,6crv,DB06713,-8.4,Norelgestromin,ISHXLNHNDMZNMC-XUDSTZEESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85195,6m3m,DB07371,-8.4,3-(10-methyl-9-anthryl)propanoic acid,CKQINRXZVYBCSC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
102680,6vxs,DB07685,-8.4,"4-{[5-(CYCLOHEXYLMETHOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE",NMAZGYDYIYLSLJ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102683,6vxs,DB07689,-8.4,"METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE",NYNAFINLHQEHKU-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
128263,6w4h,DB07403,-8.4,"4-[(3-CHLORO-4-{[(2R)-3,3,3-TRIFLUORO-2-HYDROXY-2-METHYLPROPANOYL]AMINO}PHENYL)SULFONYL]-N,N-DIMETHYLBENZAMIDE",DTDZLJHKVNTQGZ-GOSISDBHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
87755,6m3m,DB12804,-8.4,Daniquidone,SRIOCKJKFXAKHK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
60642,6crv,DB08915,-8.4,Aleglitazar,DAYKLWSKQJBGCS-NRFANRHFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58825,6crv,DB06711,-8.4,Naphazoline,CNIIGCLFLJGOGP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
157783,6wiq,DB12817,-8.4,Zoliflodacin,ZSWMIFNWDQEXDT-ZESJGQACSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
67053,6lxt,DB05263,-8.4,Caprospinol,VMOZFSWFUBLCNN-AAPULDEBSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
85177,6m3m,DB07348,-8.4,Brefeldin A,KQNZDYYTLMIZCT-KQPMLPITSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
102808,6vxs,DB07831,-8.4,"2-{[(6-OXO-1,6-DIHYDROPYRIDIN-3-YL)METHYL]AMINO}-N-[4-PROPYL-3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE",SHSORWZDEKFFLP-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
133693,6w9c,DB02030,-8.4,Alpha-Ribazole-5'-Phosphate,ZMRGXEJKZPRBPJ-SYQHCUMBSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
141443,6w9q,DB00901,-8.4,Bitolterol,FZGVEKPRDOIXJY-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
141394,6w9q,DB00845,-8.4,Clofazimine,WDQPAMHFFCXSNU-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
134009,6w9c,DB02449,-8.4,3-(1h-Indol-3-Yl)-2-[4-(4-Phenyl-Piperidin-1-Yl)-Benzenesulfonylamino]-Propionic Acid,ULOTXPTWJAUGGE-MHZLTWQESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
60736,6crv,DB09040,-8.4,Efinaconazole,NFEZZTICAUWDHU-RDTXWAMCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58730,6crv,DB06499,-8.4,Furaprofen,ODZUWQAFWMLWCF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85045,6m3m,DB07199,-8.4,"(2S,4S,5R)-1-(4-TERT-BUTYLBENZOYL)-2-ISOBUTYL-5-(1,3-THIAZOL-2-YL)PYRROLIDINE-2,4-DICARBOXYLIC ACID",SWYJAQWTBADJTB-RHGYRFJNSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
103004,6vxs,DB08057,-8.4,"N-(2-chloro-6-methylphenyl)-8-[(3S)-3-methylpiperazin-1-yl]imidazo[1,5-a]quinoxalin-4-amine",VWJPPYCULHDHBB-HNNXBMFYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
103005,6vxs,DB08058,-8.4,"4-[3-(1,4-diazepan-1-ylcarbonyl)-4-fluorobenzyl]phthalazin-1(2H)-one",HGEPGGJUGUMFHT-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
130822,6w4h,DB12850,-8.4,Etalocib,YFIZRWPXUYFCSN-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
26618,6cs2,DB04794,-8.4,Bifonazole,OCAPBUJLXMYKEJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
94297,6m71,DB07949,-8.4,"({[(3E)-2'-OXO-2',7'-DIHYDRO-2,3'-BIINDOL-3(7H)-YLIDENE]AMINO}OXY)ACETIC ACID",BFQRPTKOSYMPOL-LALPNIDTSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
103021,6vxs,DB08077,-8.4,"2-[4-({[(3,5-DICHLOROPHENYL)AMINO]CARBONYL}AMINO)PHENOXY]-2-METHYLPROPANOIC ACID",OYJPTSMWFKGZJM-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
29838,6cs2,DB11698,-8.4,Ipragliflozin,AHFWIQIYAXSLBA-RQXATKFSSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
103053,6vxs,DB08112,-8.4,N-({6-[(4-CYANO-2-FLUOROBENZYL)OXY]NAPHTHALEN-2-YL}SULFONYL)-D-GLUTAMIC ACID,IRJUSGUHNFMVCK-OAQYLSRUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
141053,6w9q,DB00434,-8.4,Cyproheptadine,JJCFRYNCJDLXIK-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
67348,6lxt,DB06518,-8.4,R-1487,KKKRKRMVJRHDMG-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
85018,6m3m,DB07169,-8.4,"5R-(3,4-DICHLOROPHENYLMETHYL)-3-(2-THIOPHENESULFONYLAMINO)-4-OXO-2-THIONOTHIAZOLIDINE",GAOOBYJHWAKZKU-LLVKDONJSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
103065,6vxs,DB08125,-8.4,"4-{[(2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]AMINO}-N-(1,3-THIAZOL-2-YL)BENZENESULFONAMIDE",BOMPRXSVSIPRDT-PTNGSMBKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
103066,6vxs,DB08126,-8.4,"3-{[4-([AMINO(IMINO)METHYL]AMINOSULFONYL)ANILINO]METHYLENE}-2-OXO-2,3-DIHYDRO-1H-INDOLE",DMCRNUMVSATRTP-LCYFTJDESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
85011,6m3m,DB07161,-8.4,5-phenyl-1H-indazol-3-amine,ZCUSNQPYUNLATP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
60738,6crv,DB09047,-8.4,Finafloxacin,FYMHQCNFKNMJAV-HOTGVXAUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
94311,6m71,DB07966,-8.4,[4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]quinazolin-2-yl}amino)phenyl]acetonitrile,NVMCVWOODOWOLT-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
67288,6lxt,DB06347,-8.4,Cenisertib,KSOVGRCOLZZTPF-QMKUDKLTSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
58748,6crv,DB06543,-8.4,Astaxanthin,MQZIGYBFDRPAKN-UWFIBFSHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
102820,6vxs,DB07845,-8.4,"2-fluoro-6-{[2-({2-methoxy-4-[(methylsulfonyl)methyl]phenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide",VGYXXQRDIVRILX-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
87833,6m3m,DB12927,-8.4,Theodrenaline,WMCMJIGLYZDKRN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87836,6m3m,DB12930,-8.4,Opipramol,YNZFUWZUGRBMHL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
160990,7bv1,DB12368,-8.4,AZD-3839,MRXBCEQZNKUUIP-DEOSSOPVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
102859,6vxs,DB07891,-8.4,"4-{[(14beta,17alpha)-3-hydrox1tra-1,3,5(10)-trien-17-yl]oxy}-4-oxobutanoic acid",YJPIDPAGJSWWBE-FNIAAEIWSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
67210,6lxt,DB06160,-8.4,Garenoxacin,NJDRXTDGYFKORP-LLVKDONJSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
87841,6m3m,DB12938,-8.4,Isoxaflutole,OYIKARCXOQLFHF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
62255,6crv,DB13333,-8.4,Efloxate,ZVXBAHLOGZCFTP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
133938,6w9c,DB02363,-8.4,2'-Monophosphoadenosine-5'-Diphosphate,YPTPYQSAVGGMFN-KQYNXXCUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
161009,7bv1,DB12394,-8.4,Eleclazine,YNUAEEJQYHYLMS-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94322,6m71,DB07977,-8.4,"3-({[3,5-DIFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)THIOPHENE-2-CARBOXYLIC ACID",CGNHUSCKOHDSMR-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
102925,6vxs,DB07969,-8.4,3-[3-(4-methylpiperazin-1-yl)-7-(trifluoromethyl)quinoxalin-5-yl]phenol,QNCYYRHIUFGGJX-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
85078,6m3m,DB07240,-8.4,3-[(9H-fluoren-9-ylideneamino)oxy]propanoic acid,LASWLEUVWJDDBA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
102932,6vxs,DB07976,-8.4,3-{[(3-FLUORO-3'-METHOXYBIPHENYL-4-YL)AMINO]CARBONYL}THIOPHENE-2-CARBOXYLIC ACID,GIUMGVUBDBDTDX-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102933,6vxs,DB07977,-8.4,"3-({[3,5-DIFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)THIOPHENE-2-CARBOXYLIC ACID",CGNHUSCKOHDSMR-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102947,6vxs,DB07993,-8.4,"N-3-[3-(1H-INDOL-6-YL)BENZYL]PYRIDINE-2,3-DIAMINE",LPQUIIHPUGDHJK-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
58756,6crv,DB06579,-8.4,Adipiplon,UAMAIHOEGLEXSV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
161021,7bv1,DB12410,-8.4,Sabarubicin,VQHRZZISQVWPLK-UIRGBLDSSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
102955,6vxs,DB08003,-8.4,ISOTHIAZOLIDINONE ANALOG,UILYPHAKDBTKQV-UFYCRDLUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
160972,7bv1,DB12339,-8.4,Radezolid,BTTNOGHPGJANSW-IBGZPJMESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
12867,6lzg,DB13941,-8.4,Piperaquine,UCRHFBCYFMIWHC-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
85778,6m3m,DB08053,-8.4,"1-cyclobutyl-3-(3,4-dimethoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine",ITOYZJGFTNTKKR-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
101564,6vxs,DB05611,-8.4,Apilimod,HSKAZIJJKRAJAV-KOEQRZSOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
129066,6w4h,DB08350,-8.4,"5-[3-(2-METHOXYPHENYL)-1H-PYRROLO[2,3-B]PYRIDIN-5-YL]-N,N-DIMETHYLPYRIDINE-3-CARBOXAMIDE",GYQRHHQPEMOLKH-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
63138,6crv,DB15207,-8.4,Esaxerenone,NOSNHVJANRODGR-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
96316,6m71,DB12720,-8.4,Nivocasan,VYFGDLGHHBUDTQ-ZLGUVYLKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
62888,6crv,DB14660,-8.4,Trenbolone acetate,CMRJPMODSSEAPL-FYQPLNBISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
132486,6w9c,DB00486,-8.4,Nabilone,GECBBEABIDMGGL-RTBURBONSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
13403,6lzg,DB15292,-8.4,Foliglurax,ZTEDNASHAWNBKQ-NCELDCMTSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
129069,6w4h,DB08353,-8.4,"2-(CYCLOHEXYLMETHYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE",NCVMTHVSAJMOPI-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
132495,6w9c,DB00496,-8.4,Darifenacin,HXGBXQDTNZMWGS-RUZDIDTESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
60088,6crv,DB08220,-8.4,"(8alpha,10alpha,13alpha,17beta)-17-[(4-hydroxyphenyl)carbonyl]androsta-3,5-diene-3-carboxylic acid",RPNNXCYIESWDSC-JRZBRKEGSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86656,6m3m,DB09193,-8.4,"CP-39,332",HLOCJJORRHQDKS-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
13392,6lzg,DB15273,-8.4,VS-4718,IGUBBWJDMLCRIK-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
159796,7bv1,DB06581,-8.4,Bevirimat,YJEJKUQEXFSVCJ-WRFMNRASSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
159052,7bv1,DB03082,-8.4,6-[(Z)-Amino(Imino)Methyl]-N-[4-(Aminomethyl)Phenyl]-4-(Pyrimidin-2-Ylamino)-2-Naphthamide,CSWQJKHBMACTGB-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
131972,6w4h,DB15124,-8.4,PF-05241328,RVTSXVZXEGFIPW-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
60113,6crv,DB08250,-8.4,"(5S)-5-(3-AMINOPROPYL)-3-(2,5-DIFLUOROPHENYL)-N-ETHYL-5-PHENYL-4,5-DIHYDRO-1H-PYRAZOLE-1-CARBOXAMIDE",OQMVLDZJPRSNOG-NRFANRHFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
144501,6w9q,DB05038,-8.4,Anatibant,XUHBBTKJWIBQMY-MHZLTWQESA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
24097,6cs2,DB01763,-8.4,7-thionicotinamide-adenine-dinucleotide phosphate,OJNFDOAQUXJWED-NNYOXOHSSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
60135,6crv,DB08284,-8.4,"O-[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethyl] (4-iodophenyl)thiocarbamate",CYYIBMGIJWXZEP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
159786,7bv1,DB06543,-8.4,Astaxanthin,MQZIGYBFDRPAKN-UWFIBFSHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
25979,6cs2,DB00470,-8.4,Dronabinol,CYQFCXCEBYINGO-IAGOWNOFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
132461,6w9c,DB00455,-8.4,Loratadine,JCCNYMKQOSZNPW-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
159711,7bv1,DB05423,-8.4,ORG-34517,DFELGYQKEOCHOA-BZAFBGKRSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97615,6m71,DB15269,-8.4,ALK-4290,DWKNOLCXIFYNFV-HSZRJFAPSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
129033,6w4h,DB08308,-8.4,"SUCCINIC ACID MONO-(13-METHYL-3-OXO-2,3,6,7,8,9,10,11,12,13,14,15,16,17-TETRADECAHYDRO-1H-CYCLOPENTA[A]PHENANTHREN-17-YL) ESTER",IRQUJNVGEAJGSD-KIEDKLRZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
132004,6w4h,DB15192,-8.4,ABT-288,GNIRITULTPTAQW-KNQAVFIVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
63092,6crv,DB15120,-8.4,GSK-239512,YFRBKEVUUCQYOW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
144825,6w9q,DB06486,-8.4,Enzastaurin,AXRCEOKUDYDWLF-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
13458,6lzg,DB15401,-8.4,Danicopan,PIBARDGJJAGJAJ-NQIIRXRSSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
87179,6m3m,DB11946,-8.4,AZD-1981,JWYIGNODXSRKGP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
128843,6w4h,DB08080,-8.4,LATRUNCULIN B,NSHPHXHGRHSMIK-JRIKCGFMSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
128817,6w4h,DB08051,-8.4,"(2R)-4-(2-BENZOYL-1,2-DIAZEPAN-1-YL)-4-OXO-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE",XXRHRPGYYNOBHO-QGZVFWFLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
87181,6m3m,DB11948,-8.4,Lapachone,QZPQTZZNNJUOLS-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59796,6crv,DB07882,-8.4,"4-{4-[2-(1A,7A-DIMETHYL-4-OXY-OCTAHYDRO-1-OXA-4-AZA-CYCLOPROPA[A]NAPHTHALEN-4-YL) -ACETYLAMINO]-PHENYLCARBAMOYL}-BUTYRIC ACID",VFIZFTGABDUGCF-UPVHCHBVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
128830,6w4h,DB08064,-8.4,N-(3-TERT-BUTYL-1H-PYRAZOL-5-YL)-N'-{4-CHLORO-3-[(PYRIDIN-3-YLOXY)METHYL]PHENYL}UREA,NTMADESEDXKNFZ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131996,6w4h,DB15173,-8.4,JNJ-42165279,YWGYNGCRVZLMCS-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
128823,6w4h,DB08057,-8.4,"N-(2-chloro-6-methylphenyl)-8-[(3S)-3-methylpiperazin-1-yl]imidazo[1,5-a]quinoxalin-4-amine",VWJPPYCULHDHBB-HNNXBMFYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
86735,6m3m,DB09304,-8.4,Setiptiline,GVPIXRLYKVFFMK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86731,6m3m,DB09292,-8.4,Sacubitril,PYNXFZCZUAOOQC-UTKZUKDTSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
63111,6crv,DB15152,-8.4,TMC-649128,XJBILYMRFVHPJB-XJQUKVTJSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
97683,6m71,DB15408,-8.4,Silmitasertib,MUOKSQABCJCOPU-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59811,6crv,DB07901,-8.4,5-CHLORO-6-METHYL-N-(2-PHENYLETHYL)-2-PYRIDIN-2-YLPYRIMIDIN-4-AMINE,HIUOABSWQSUEGK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
98179,6vxs,DB00637,-8.4,Astemizole,GXDALQBWZGODGZ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
129090,6w4h,DB08379,-8.4,6-(4-chloro-2-fluoro-3-phenoxybenzyl)pyridazin-3(2H)-one,NOVPOXGMADEKPP-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
63161,6crv,DB15250,-8.4,Vercirnon,JRWROCIMSDXGOZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60165,6crv,DB08317,-8.4,"5-methyl-6-phenylquinazoline-2,4-diamine",HUCOXWPHDFINIW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60168,6crv,DB08320,-8.4,"DIETHYL (1R,2S,3R,4S)-5,6-BIS(4-HYDROXYPHENYL)-7-OXABICYCLO[2.2.1]HEPT-5-ENE-2,3-DICARBOXYLATE",NHKDFDHHMHBFLG-COPRSSIGSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
132583,6w9c,DB00606,-8.4,Cyclothiazide,BOCUKUHCLICSIY-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
98662,6vxs,DB01196,-8.4,Estramustine,FRPJXPJMRWBBIH-RBRWEJTLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
60178,6crv,DB08331,-8.4,"N-1H-imidazol-2-yl-N'-[4-(1H-imidazol-2-ylamino)phenyl]benzene-1,4-diamine",JHMXUERQMCJRHG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
98673,6vxs,DB01208,-8.4,Sparfloxacin,DZZWHBIBMUVIIW-DTORHVGOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
128746,6w4h,DB07971,-8.4,"5-AMINO-2-{4-[(4-AMINOPHENYL)SULFANYL]PHENYL}-1H-ISOINDOLE-1,3(2H)-DIONE",FQQVTDIBUYSVHM-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
144157,6w9q,DB04495,-8.4,RU81843,GGPXNASQNUOIPB-NSOVKSMOSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
96072,6m71,DB12355,-8.4,Netazepide,YDZYKNJZCVIKPP-VWLOTQADSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
131923,6w4h,DB15033,-8.4,Flortaucipir,GETAAWDSFUCLBS-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
146035,6w9q,DB08044,-8.4,ABT-341,NVVSPGQEXMJZIR-BMIGLBTASA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
98739,6vxs,DB01329,-8.4,Cefoperazone,GCFBRXLSHGKWDP-XCGNWRKASA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
159920,7bv1,DB07082,-8.4,"1,1,1,3,3,3-HEXAFLUORO-2-{4-[(2,2,2-TRIFLUOROETHYL)AMINO]PHENYL}PROPAN-2-OL",VHDRSZOHKKZOQF-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96039,6m71,DB12306,-8.4,Cipargamin,CKLPLPZSUQEDRT-WPCRTTGESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
128720,6w4h,DB07941,-8.4,PH-797804,KCAJXIDMCNPGHZ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
59589,6crv,DB07643,-8.4,"5-{[1-(2,3-dichlorobenzyl)piperidin-4-yl]methoxy}quinazoline-2,4-diamine",XVLUVRFYGVJKGJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
146064,6w9q,DB08079,-8.4,AMG-208,HEAIZQNMNCHNFD-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
59578,6crv,DB07630,-8.4,"N-((1R,2R)-2-(5-CHLORO-1H-INDOLE-2-CARBOXAMIDO)CYCLOHEXYL)-5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE-2-CARBOXAMIDE",ARPFWVKYXJZULB-IAGOWNOFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
159916,7bv1,DB07078,-8.4,"(3Z)-6-(4-HYDROXY-3-METHOXYPHENYL)-3-(1H-PYRROL-2-YLMETHYLENE)-1,3-DIHYDRO-2H-INDOL-2-ONE",AYSXURJZVXBSRV-WJDWOHSUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
86499,6m3m,DB08951,-8.4,Indoprofen,RJMIEHBSYVWVIN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
159888,7bv1,DB07045,-8.4,"(2R,3R,4S,5R)-2-[6-amino-8-[(3,4-dichlorophenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol",VBJKVZXRYLCYGQ-XNIJJKJLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
86508,6m3m,DB08961,-8.4,Azosemide,HMEDEBAJARCKCT-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
13345,6lzg,DB15191,-8.4,MAX-40279,AVIOBQFPAGEICQ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
59675,6crv,DB07747,-8.4,"(3R)-N-(4-CHLOROPHENYL)-3-(HYDROXYMETHYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONAMIDE",YTBGBMPLINFTBQ-OAHLLOKOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
131946,6w4h,DB15075,-8.4,4-demethyl-4-cholesteryloxycarbonylpenclomedine,ZJUUIXYKTPSIOH-LEZJFEBPSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
13338,6lzg,DB15173,-8.4,JNJ-42165279,YWGYNGCRVZLMCS-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
25993,6cs2,DB04042,-8.4,"2-[4-(Hydroxy-Methoxy-Methyl)-Benzyl]-7-(4-Hydroxymethyl-Benzyl)-1,1-Dioxo-3,6-Bis-Phenoxymethyl-1lambda6-[1,2,7]Thiadiazepane-4,5-Diol",XLJNZONSWKENRP-VABIIVNOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
63164,6crv,DB15261,-8.4,Butafenacil,JEDYYFXHPAIBGR-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
96091,6m71,DB12382,-8.4,R-306465,MUTBJZVSRNUIHA-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
144447,6w9q,DB04879,-8.4,Vatalanib,YCOYDOIWSSHVCK-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
98351,6vxs,DB00843,-8.4,Donepezil,ADEBPBSSDYVVLD-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
59657,6crv,DB07724,-8.4,Indeglitazar,YMPALHOKRBVHOJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59648,6crv,DB07715,-8.4,Emodin,RHMXXJGYXNZAPX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
98396,6vxs,DB00894,-8.4,Testolactone,BPEWUONYVDABNZ-DZBHQSCQSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
98411,6vxs,DB00910,-8.4,Paricalcitol,BPKAHTKRCLCHEA-UBFJEZKGSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
131937,6w4h,DB15057,-8.4,NUC-1031,NHTKGYOMICWFQZ-KKQYNPQSSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
63193,6crv,DB15316,-8.4,Florasulam,QZXATCCPQKOEIH-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
13313,6lzg,DB15126,-8.4,IMG-7289,KQKBMHGOHXOHTD-KKUQBAQOSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
59636,6crv,DB07701,-8.4,"1-BENZYL-4-[(5,6-DIMETHOXY-1-INDANON-2-YL)METHYL]PIPERIDINE",ADEBPBSSDYVVLD-HXUWFJFHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59626,6crv,DB07689,-8.4,"METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE",NYNAFINLHQEHKU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
146028,6w9q,DB08036,-8.4,"6,7,12,13-tetrahydro-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazol-5-one",MEXUTNIFSHFQRG-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
63072,6crv,DB15079,-8.4,Troriluzole,YBZSGIWIPOUSHY-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62915,6crv,DB14715,-8.4,Cinazepam,NQTRBZXDWMDXAQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
132386,6w9c,DB00367,-8.4,Levonorgestrel,WWYNJERNGUHSAO-XUDSTZEESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
13480,6lzg,DB15442,-8.4,Trilaciclib,PDGKHKMBHVFCMG-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
96609,6m71,DB13212,-8.4,Phenolsulfonphthalein,BELBBZDIHDAJOR-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97286,6m71,DB14555,-8.4,Ursadiol,RTLXJEJRLWILSU-GWNGJUQLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97289,6m71,DB14568,-8.4,Ivosidenib,WIJZXSAJMHAVGX-DHLKQENFSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
87047,6m3m,DB11755,-8.4,Tetrahydrocannabivarin,ZROLHBHDLIHEMS-HUUCEWRRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
132188,6w9c,DB00136,-8.4,Calcitriol,GMRQFYUYWCNGIN-NKMMMXOESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
159403,7bv1,DB04098,-8.4,Balanol,XYUFCXJZFZPEJD-PGRDOPGGSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
128964,6w4h,DB08220,-8.4,"(8alpha,10alpha,13alpha,17beta)-17-[(4-hydroxyphenyl)carbonyl]androsta-3,5-diene-3-carboxylic acid",RPNNXCYIESWDSC-JRZBRKEGSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
132209,6w9c,DB00158,-8.4,Folic acid,OVBPIULPVIDEAO-LBPRGKRZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
97263,6m71,DB14218,-8.4,Telotristat,NCLGDOBQAWBXRA-PGRDOPGGSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
62943,6crv,DB14772,-8.4,DCFBC F-18,IDTMSHGCAZPVLC-STUNTBJNSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29948,6cs2,DB00901,-8.4,Bitolterol,FZGVEKPRDOIXJY-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
97364,6m71,DB14718,-8.4,Pyrazolam,BGRWSFIQQPVEML-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
62992,6crv,DB14885,-8.4,PF-05180999,CLGCHUKGBICQTE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
128988,6w4h,DB08248,-8.4,3-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)-BENZENESULFONAMIDE,BKDUVKJYBJDZQW-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
87018,6m3m,DB11706,-8.4,Raxatrigine,JESCETIFNOFKEU-SJORKVTESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
25815,6cs2,DB00450,-8.4,Droperidol,RMEDXOLNCUSCGS-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
159438,7bv1,DB04144,-8.4,"Cis-[4,5-Bis-(4-Chlorophenyl)-2-(2-Isopropoxy-4-Methoxyphenyl)-4,5-Dihyd Roimidazol-1-Yl]-Piperazin-1-Yl-Methanone",ZXIPEZDMQNYFOO-WUFINQPMSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
145415,6w9q,DB07321,-8.4,"2,5-DICHLORO-N-[5-METHOXY-7-(6-METHOXYPYRIDIN-3-YL)-1,3-BENZOXAZOL-2-YL]BENZENESULFONAMIDE",KOKQLKWXOFRTHE-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
97349,6m71,DB14675,-8.4,Temsavir,QRPZBKAMSFHVRW-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97232,6m71,DB14152,-8.4,Ginsenosides,NLHQJXWYMZLQJY-SWIZOJJJSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
62971,6crv,DB14849,-8.4,Nebicapone,MRFOLGFFTUGAEB-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
159295,7bv1,DB03950,-8.4,(S)-N-(3-Indol-1-Yl-2-Methyl-Propyl)-4-Sulfamoyl-Benzamide,ZFWHOUCRVSOZJE-AWEZNQCLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
87109,6m3m,DB11843,-8.4,PF-04958242,TTYKUKSFWHEBLI-DLBZAZTESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
96934,6m71,DB13648,-8.4,Alcuronium,MUQUYTSLDVKIOF-CHJKCJHBSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96870,6m71,DB13556,-8.4,Sulfamazone,BGLHAKAJGYLSOX-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
132078,6w4h,DB15333,-8.4,AZD-1386,FPGNKXCEPARJDI-ZDUSSCGKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
145668,6w9q,DB07622,-8.4,"1-(3-(2,4-DIMETHYLTHIAZOL-5-YL)-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)-3-(4-METHYLPIPERAZIN-1-YL)UREA",KRKQVGZXTNLQSV-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
96949,6m71,DB13667,-8.4,Cefozopran,QDUIJCOKQCCXQY-WHJQOFBOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
62953,6crv,DB14793,-8.4,RO-5045337,QBGKPEROWUKSBK-QPPIDDCLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
166566,7bv1,DB15393,-8.4,Telatinib,QFCXANHHBCGMAS-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96967,6m71,DB13685,-8.4,Quingestanol,PCJFRMOEZQQSAX-AIOSZGMZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96842,6m71,DB13520,-8.4,Metergoline,WZHJKEUHNJHDLS-QTGUNEKASA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
87081,6m3m,DB11801,-8.4,Rapastinel,GIBQQARAXHVEGD-BSOLPCOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
97024,6m71,DB13766,-8.4,Lidoflazine,ZBIAKUMOEKILTF-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97119,6m71,DB13929,-8.4,Relcovaptan,CEBYCSRFKCEUSW-NAYZPBBASA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
132066,6w4h,DB15307,-8.4,Atabecestat,VLLFGVHGKLDDLW-SFHVURJKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
87073,6m3m,DB11792,-8.4,Mirodenafil,MIJFNYMSCFYZNY-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
97128,6m71,DB13941,-8.4,Piperaquine,UCRHFBCYFMIWHC-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
132059,6w4h,DB15295,-8.4,Tenalisib,HDXDQPRPFRKGKZ-INIZCTEOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
97134,6m71,DB13950,-8.4,WIN 55212-2,HQVHOQAKMCMIIM-HXUWFJFHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96771,6m71,DB13422,-8.4,Nicofuranose,FUWFSXZKBMCSKF-ZASNTINBSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60024,6crv,DB08143,-8.4,"5-CHLORO-THIOPHENE-2-CARBOXYLIC ACID ((3S,4S)-4-FLUORO- 1-{[2-FLUORO-4-(2-OXO-2H-PYRIDIN-1-YL)-PHENYLCARBAMOYL]-METHYL}-PYRROLIDIN-3-YL)-AMIDE",SXIYSYYSKHUTQQ-RDJZCZTQSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
115301,6w4b,DB00696,-8.4,Ergotamine,XCGSFFUVFURLIX-VFGNJEKYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
59921,6crv,DB08027,-8.4,1-(3-chloro-4-methylphenyl)-3-{2-[({5-[(dimethylamino)methyl]-2-furyl}methyl)thio]ethyl}urea,WEYNBWVKOYCCQT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
97408,6m71,DB14822,-8.4,SB-649868,ZJXIUGNEAIHSBI-IBGZPJMESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
145150,6w9q,DB07020,-8.4,"N-{3-[5-(1H-1,2,4-triazol-3-yl)-1H-indazol-3-yl]phenyl}furan-2-carboxamide",LMDMJDCLPIVGQD-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
159634,7bv1,DB04971,-8.4,Reglitazar,QBQLYIISSRXYKL-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97545,6m71,DB15132,-8.4,AZD-8165,YUHNXUAATAMVKD-PZJWPPBQSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97553,6m71,DB15145,-8.4,Ziresovir,GAAICKUTDBZCMT-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
25859,6cs2,DB00455,-8.4,Loratadine,JCCNYMKQOSZNPW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
86924,6m3m,DB11507,-8.4,Cloprostenol,VJGGHXVGBSZVMZ-QIZQQNKQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
145045,6w9q,DB06896,-8.4,"1-(4-fluorophenyl)-N-[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]-2-oxo-1,2-dihydropyridine-3-carboxamide",OBSFXHDOLBYWRJ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
159210,7bv1,DB03583,-8.4,"(2e,3s)-3-Hydroxy-5'-[(4-Hydroxypiperidin-1-Yl)Sulfonyl]-3-Methyl-1,3-Dihydro-2,3'-Biindol-2'(1'h)-One",AYOAIABDFUJDKQ-SQJPUDIVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59878,6crv,DB07981,-8.4,2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]-n-[(1R)-1-(hydroxymethyl)propyl]acetamide,GKJWXEORYGBJFS-QGZVFWFLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59867,6crv,DB07968,-8.4,N-(2-CHLORO-4-FLUOROBENZOYL)-N'-(5-HYDROXY-2-METHOXYPHENYL)UREA,RFOBTYLRURSVJE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
132025,6w4h,DB15229,-8.4,CNV-2197944,BLFJGFDZMABYMY-ZDUSSCGKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
63063,6crv,DB15059,-8.4,Aprocitentan,DKULOVKANLVDEA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59843,6crv,DB07940,-8.4,"9-(3-IODOBENZYLAMINO)-1,2,3,4-TETRAHYDROACRIDINE",ZUCWQTWGZGIYPV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
97603,6m71,DB15242,-8.4,MK-0533,STWITCBWQHTJFJ-XMMPIXPASA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
128854,6w4h,DB08094,-8.4,"(4-AMINO-2-{[1-(METHYLSULFONYL)PIPERIDIN-4-YL]AMINO}PYRIMIDIN-5-YL)(2,3-DIFLUORO-6-METHOXYPHENYL)METHANONE",JRNJNYBQQYBCLE-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
96429,6m71,DB12903,-8.4,DEBIO-1347,BEMNJULZEQTDJY-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96418,6m71,DB12888,-8.4,Ezutromid,KSGCNXAZROJSNW-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
145810,6w9q,DB07789,-8.4,"1-[5-methyl-2-(trifluoromethyl)furan-3-yl]-3-[(2Z)-5-(2-{[6-(1H-1,2,4-triazol-3-ylamino)pyrimidin-4-yl]amino}ethyl)-1,3-thiazol-2(3H)-ylidene]urea",KNTGXMNWVXZIMW-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
96463,6m71,DB12952,-8.4,Methylprednisone,SVYCRJXQZUCUND-PQXSVQADSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59881,6crv,DB07984,-8.4,2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]-n-[(1S)-1-(hydroxymethyl)propyl]acetamide,GKJWXEORYGBJFS-KRWDZBQOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
159221,7bv1,DB03596,-8.4,N-[2-(1h-Indol-5-Yl)-Butyl]-4-Sulfamoyl-Benzamide,FSRPBGBMEKDSIJ-CYBMUJFWSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97500,6m71,DB15046,-8.4,LY-2881835,FHRWHNJJQGSCQC-LJAQVGFWSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
128896,6w4h,DB08138,-8.4,"{[(2,6-difluorophenyl)carbonyl]amino}-N-(4-fluorophenyl)-1H-pyrazole-3-carboxamide",BDRDBXXWQDFXEC-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
97426,6m71,DB14866,-8.4,Amcasertib,QDWKGEFGLQMDAM-ULJHMMPZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
128895,6w4h,DB08137,-8.4,(4E)-N-(4-fluorophenyl)-4-[(phenylcarbonyl)imino]-4H-pyrazole-3-carboxamide,ZMWYSLJBNJUCRK-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
60025,6crv,DB08144,-8.4,"6-(2,6-dibromophenyl)pyrido[2,3-d]pyrimidine-2,7-diamine",HGIPWJYTPOHUGK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
145346,6w9q,DB07247,-8.4,"[2'-HYDROXY-3'-(1H-PYRROLO[3,2-C]PYRIDIN-2-YL)-BIPHENYL-3-YLMETHYL]-UREA",SRPOHNDQBDHONJ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
60026,6crv,DB08145,-8.4,"6-(2,6-DIMETHOXYPHENYL)PYRIDO[2,3-D]PYRIMIDINE-2,7-DIAMINE",LRPHIAJXODIASX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
159541,7bv1,DB04549,-8.4,"4-(Aminosulfonyl)-N-[(2,3,4-Trifluorophenyl)Methyl]-Benzamide",AANTYZRUJFNZFI-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
86982,6m3m,DB11658,-8.4,QAV-680,YOPFAMROKXHVCQ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
132291,6w9c,DB00251,-8.4,Terconazole,BLSQLHNBWJLIBQ-OZXSUGGESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
86975,6m3m,DB11648,-8.4,Afuresertib,AFJRDFWMXUECEW-LBPRGKRZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
97468,6m71,DB14942,-8.4,BMS-986141,KEEBLYWBELVGPQ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96525,6m71,DB13053,-8.4,CP-195543,NZQDWKCNBOELAI-KSFYIVLOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
132303,6w9c,DB00266,-8.4,Dicoumarol,DOBMPNYZJYQDGZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
145733,6w9q,DB07700,-8.4,"3-CARBOXAMIDO-1,3,5(10)-ESTRATRIEN-17(R)-SPIRO-2'(5',5'-DIMETHYL-6'OXO)TETRAHYDROPYRAN",YVAJWBACBRSVPR-NDUHRLLKSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
132312,6w9c,DB00275,-8.4,Olmesartan,VTRAEEWXHOVJFV-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
97481,6m71,DB15006,-8.4,Flufenoxuron,RYLHNOVXKPXDIP-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
159227,7bv1,DB03605,-8.4,"(2s)-2-[(2,4-Dichloro-Benzoyl)-(3-Trifluoromethyl-Benzyl)-Amino]-3-Phenyl-Propionic Acid",LAJJKGIZTCCOHY-NRFANRHFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
159604,7bv1,DB04891,-8.4,Becocalcidiol,QSLUXQQUPXBIHH-YHSKWIAJSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
13529,6lzg,DB01177,-8.4,Idarubicin,XDXDZDZNSLXDNA-TZNDIEGXSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
145367,6w9q,DB07270,-8.4,"N-[7-(3-AMINOPHENYL)-5-METHOXY-1,3-BENZOXAZOL-2-YL]-2,5-DICHLOROBENZENESULFONAMIDE",GAYYMURZGLJDCT-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
158901,7bv1,DB02610,-8.4,"N-(2,3,4,5,6-Pentaflouro-Benzyl)-4-Sulfamoyl-Benzamide",LRKSHOLYETXPGY-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
25647,6cs2,DB03638,-8.4,Cytidyl-2'-5'-Phospho-Guanosine,QZDUXDLOEVJGDG-VMIOUTBZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
98994,6vxs,DB01661,-8.4,1-(5-phospho-D-ribosyl)-ATP,RKNHJBVBFHDXGR-MRUDJCSFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
100771,6vxs,DB04030,-8.4,"1,3,4,9-Tetrahydro-2-(Hydroxybenzoyl)-9-[(4-Hydroxyphenyl)Methyl]-6-Methoxy-2h-Pyrido[3,4-B]Indole",ADXYEWMDAGIULV-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
133016,6w9c,DB01112,-8.4,Cefuroxime,JFPVXVDWJQMJEE-IZRZKJBUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
60319,6crv,DB08504,-8.4,"6-(4-{(1S,2S)-2-AMINO-1-[(DIMETHYLAMINO)CARBONYL]-3-[(3S)-3-FLUOROPYRROLIDIN-1-YL]-3-OXOPROPYL}PHENYL)-1H-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-4-IUM",ZNHVIJAGMFQGMS-IHPCNDPISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
160334,7bv1,DB08020,-8.4,"(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-6-(METHOXYMETHYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL",RHQLNMNKTIOREN-AOIWGVFYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
64232,6lxt,DB01212,-8.4,Ceftriaxone,VAAUVRVFOQPIGI-SPQHTLEESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
87446,6m3m,DB12327,-8.4,Salvinorin A,OBSYBRPAKCASQB-AGQYDFLVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86000,6m3m,DB08317,-8.4,"5-methyl-6-phenylquinazoline-2,4-diamine",HUCOXWPHDFINIW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
128501,6w4h,DB07688,-8.4,"4-{[5-(CYCLOHEXYLOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE",RPJIMTALCNCQLV-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
95640,6m71,DB11730,-8.4,Ribociclib,RHXHGRAEPCAFML-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
101050,6vxs,DB04408,-8.4,Ncs-Chromophore,QZGIWPZCWHMVQL-UIYAJPBUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
64280,6lxt,DB01289,-8.4,Glisoxepide,ZKUDBRCEOBOWLF-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
131773,6w4h,DB14669,-8.4,Betamethasone phosphate,VQODGRNSFPNSQE-DVTGEIKXSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
85971,6m3m,DB08285,-8.4,"(2R)-2-{[4-(benzylamino)-8-(1-methylethyl)pyrazolo[1,5-a][1,3,5]triazin-2-yl]amino}butan-1-ol",SQUNOCMDMIQIQK-OAHLLOKOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
129195,6w4h,DB08504,-8.4,"6-(4-{(1S,2S)-2-AMINO-1-[(DIMETHYLAMINO)CARBONYL]-3-[(3S)-3-FLUOROPYRROLIDIN-1-YL]-3-OXOPROPYL}PHENYL)-1H-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-4-IUM",ZNHVIJAGMFQGMS-IHPCNDPISA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
129202,6w4h,DB08513,-8.4,[4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENYL]ACETIC ACID,PAIQRYUOBBCBSE-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
85946,6m3m,DB08247,-8.4,6-(CYCLOHEXYLMETHOXY)-8-ISOPROPYL-9H-PURIN-2-AMINE,JABXNQUXGJTKRO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
64304,6lxt,DB01342,-8.4,Forasartan,YONOBYIBNBCDSJ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
85944,6m3m,DB08245,-8.4,1-(2-DEOXY-5-O-PHOSPHONO-BETA-D-ERYTHRO-PENTOFURANOSYL)-5-NITRO-1H-INDOLE,FQCJFJRLZCIFHB-YNEHKIRRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
114421,6vxx,DB13418,-8.4,Moxestrol,MTMZZIPTQITGCY-OLGWUGKESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87441,6m3m,DB12321,-8.4,Ifetroban,BBPRUNPUJIUXSE-DXKRWKNPSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
95641,6m71,DB11732,-8.4,Lasmiditan,XEDHVZKDSYZQBF-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60318,6crv,DB08503,-8.4,"(3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(4-methylphenyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol",HRCKGDOSPBFICB-MZHQWRCYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
160160,7bv1,DB07584,-8.4,"N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine",OKGCSZUKOGMZAL-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
142852,6w9q,DB02741,-8.4,CD564,RWYREGSYPCNZTL-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
86119,6m3m,DB08464,-8.4,"METHYL 3-CHLORO-2-{3-[(2,5-DIHYDROXY-4-METHOXYPHENYL)AMINO]-3-OXOPROPYL}-4,6-DIHYDROXYBENZOATE",GUVWEHNRWHNDRF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59355,6crv,DB07363,-8.4,"THIOPHENE-2,5-DISULFONIC ACID 2-AMIDE-5-(4-METHYL-BENZYLAMIDE)",GUNRMHMEAWSZQE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
132869,6w9c,DB00941,-8.4,Hexafluronium,HDZAQYPYABGTCL-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
95694,6m71,DB11805,-8.4,Saracatinib,OUKYUETWWIPKQR-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
128559,6w4h,DB07756,-8.4,"1-[3-({[(4-AMINO-5-FLUORO-2-METHYLQUINOLIN-3-YL)METHYL]THIO}METHYL)PHENYL]-2,2,2-TRIFLUOROETHANE-1,1-DIOL",GPBGHVRNVGXPNM-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
87422,6m3m,DB12299,-8.4,Bavisant,BGBVSGSIXIIREO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
132887,6w9c,DB00962,-8.4,Zaleplon,HUNXMJYCHXQEGX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
95679,6m71,DB11786,-8.4,Pefcalcitol,SVCSMAZYWOQCBW-NVJMFHFGSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
86100,6m3m,DB08442,-8.4,"4-{[(2R)-2-(2-methylphenyl)pyrrolidin-1-yl]carbonyl}benzene-1,3-diol",TWODFUZHWYZBHZ-MRXNPFEDSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
13037,6lzg,DB14568,-8.4,Ivosidenib,WIJZXSAJMHAVGX-DHLKQENFSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
100522,6vxs,DB03712,-8.4,RU85053,CEKLBQMULVLLTD-VMPREFPWSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
63925,6lxt,DB00862,-8.4,Vardenafil,SECKRCOLJRRGGV-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
63953,6lxt,DB00896,-8.4,Rimexolone,QTTRZHGPGKRAFB-OOKHYKNYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
29945,6cs2,DB11844,-8.4,Pritelivir,IVZKZONQVYTCKC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
64059,6lxt,DB01016,-8.4,Glyburide,ZNNLBTZKUZBEKO-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
100621,6vxs,DB03830,-8.4,Phosphorylated Dihydropteroate,DNKVHXNVVYQUDC-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
86046,6m3m,DB08373,-8.4,"4,4'-BIS([H]METHYLSULFONYL)-2,2',5,5'-TETRACHLOROBIPHENYL",RDBKPLOYRMCFIY-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85943,6m3m,DB08244,-8.4,"(1S)-1-CYCLOPROPYL-2-[(2S)-4-(2,5-DIFLUOROPHENYL)-2-PHENYL-2,5-DIHYDRO-1H-PYRROL-1-YL]-2-OXOETHANAMINE",VCOUEHUEFUDZIS-PMACEKPBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
60281,6crv,DB08461,-8.4,"3-[(4-AMINO-1-TERT-BUTYL-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL)METHYL]PHENOL",QMAIQPBRCNEJAT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
64305,6lxt,DB01347,-8.4,Saprisartan,DUEWVPTZCSAMNB-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
62641,6crv,DB13846,-8.4,Pyrrobutamine,WDYYVNNRTDZKAZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
101454,6vxs,DB05015,-8.4,Belinostat,NCNRHFGMJRPRSK-MDZDMXLPSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
64710,6lxt,DB01873,-8.4,Epothilone D,XOZIUKBZLSUILX-GIQCAXHBSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
158405,7bv1,DB01148,-8.4,Flavoxate,SPIUTQOUKAMGCX-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
158393,7bv1,DB01134,-8.4,Desoxycorticosterone pivalate,VVOIQBFMTVCINR-WWMZEODYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
146373,6w9q,DB08454,-8.4,N-(5-METHYL-1H-PYRAZOL-3-YL)-2-PHENYLQUINAZOLIN-4-AMINE,JYCUVOXSZBECAY-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
12896,6lzg,DB13991,-8.4,Pipequaline,AMEWZCMTSIONOX-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
85831,6m3m,DB08112,-8.4,N-({6-[(4-CYANO-2-FLUOROBENZYL)OXY]NAPHTHALEN-2-YL}SULFONYL)-D-GLUTAMIC ACID,IRJUSGUHNFMVCK-OAQYLSRUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
64754,6lxt,DB01941,-8.4,"6-[1-(3,5,5,8,8-Pentamethyl-5,6,7,8-Tetrahydronaphthalen-2-Yl)Cyclopropyl]Pyridine-3-Carboxylic Acid",SLXTWXQUEZSSTJ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
64678,6lxt,DB01830,-8.4,"{4-[2-Acetylamino-2-(3-Carbamoyl-2-Cyclohexylmethoxy-6,7,8,9-Tetrahydro-5h-Benzocyclohepten-5ylcarbamoyl)-Ethyl]-2-Phosphono-Phenyl}-Phosphonic Acid",SPSGYTWOIGAABK-DQEYMECFSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
101483,6vxs,DB05171,-8.4,E-2012,PUOAETJYKQITMO-LANLRWRYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
133144,6w9c,DB01264,-8.4,Darunavir,CJBJHOAVZSMMDJ-HEXNFIEUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
64890,6lxt,DB02115,-8.4,Daidzin,KYQZWONCHDNPDP-QNDFHXLGSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
60406,6crv,DB08609,-8.4,"(2R)-N-{4-[Ethyl(phenyl)sulfamoyl]-2-methylphenyl}-3,3,3-trifluoro-2-hydroxy-2-methylpropanamide",SHEIQJGQDUYUBE-GOSISDBHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
142430,6w9q,DB02194,-8.4,"8-Benzyl-2-Hydroxy-2-(4-Hydroxy-Benzyl)-6-(4-Hydroxy-Phenyl)-2h-Imidazo[1,2-a]Pyrazin-3-One",ULLMMKZQNNBLRN-SANMLTNESA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
101524,6vxs,DB05423,-8.4,ORG-34517,DFELGYQKEOCHOA-BZAFBGKRSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
62591,6crv,DB13782,-8.4,Imipramine oxide,QZIQORUGXBPDSU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
160469,7bv1,DB08426,-8.4,"THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [2-OXO-1-(1H-PYRROLO[2,3-C]PYRIDIN-2-YLMETHYL)-PYRROLIDIN-3-YL]-AMIDE",PLXOQMHGHDZMSX-AWEZNQCLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
131641,6w4h,DB14097,-8.4,13-cis-12-(3'-Carboxyphenyl)retinoic acid,XKKDQOHDTASHCE-PAZAWXFKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
146429,6w9q,DB08520,-8.4,"(21S)-1AZA-4,4-DIMETHYL-6,19-DIOXA-2,3,7,20-TETRAOXOBICYCLO[19.4.0] PENTACOSANE",VUCSBBBCFXBFFY-IBGZPJMESA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
64649,6lxt,DB01792,-8.4,Adenylyl-3'-5'-Phospho-Uridine-3'-Monophosphate,FZCSEXOMUJFOHQ-KPKSGTNCSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
62612,6crv,DB13808,-8.4,Mebhydrolin,FQQIIPAOSKSOJM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
160440,7bv1,DB08389,-8.4,"6,7-DIMETHOXY-4-[(3R)-3-(2-NAPHTHYLOXY)PYRROLIDIN-1-YL]QUINAZOLINE",UPTQSRGSSJRBKJ-LJQANCHMSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
62639,6crv,DB13844,-8.4,Pipenzolate,WPUKUEMZZRVAKZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
101269,6vxs,DB04698,-8.4,"N-(1,4-DIHYDRO-5H-TETRAZOL-5-YLIDENE)-9-OXO-9H-XANTHENE-2-SULFONAMIDE",HJWYZPGYPZNDTN-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
128481,6w4h,DB07664,-8.4,"5-AMINO-3-{[4-(AMINOSULFONYL)PHENYL]AMINO}-N-(2,6-DIFLUOROPHENYL)-1H-1,2,4-TRIAZOLE-1-CARBOTHIOAMIDE",ARIOBGGRZJITQX-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
59215,6crv,DB07205,-8.4,N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,GZJXCRHEMLAMRA-SDBHATRESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
129203,6w4h,DB08514,-8.4,"6-amino-2-[(thiophen-2-ylmethyl)amino]-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",IQKMJWDYMFWZRF-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
101313,6vxs,DB04761,-8.4,"PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-[(PYRIDIN-3-YLMETHYL)-AMIDE]",NHPBWKYFMTXWAA-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
85903,6m3m,DB08192,-8.4,2-(4-CARCOXY-5-ISOPROPYLTHIAZOLYL)BENZOPIPERIDINE,HCUGCUQZFBURHR-LBPRGKRZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
158437,7bv1,DB01184,-8.4,Domperidone,FGXWKSZFVQUSTL-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
14005,6lzg,T3D3616,-8.4,Nodularin-R,IXBQSRWSVIBXNC-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
85892,6m3m,DB08177,-8.4,(E)-3-(5((5-(4-CHLOROPHENYL)FURAN-2-YL)METHYLENE)-4-OXO-2-THIOXOTHIAZOLIDIN-3-YL)PROPANOIC ACID,YZLFZFALAZYTCI-NTEUORMPSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
101334,6vxs,DB04790,-8.4,"2,5-bis-O-{3-[amino(imino)methyl]phenyl}-1,4:3,6-dianhydro-D-glucitol",IBIUTOFGXGGVKQ-XMTFNYHQSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101337,6vxs,DB04793,-8.4,"1,4:3,6-Dianhydro-2-O-(3-carbamimidoylphenyl)-5-O-(4-carbamimidoylphenyl)-D-glucitol",DKBAWRNTUZFJKV-XMTFNYHQSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
64425,6lxt,DB01514,-8.4,Furazabol,RGLLOUBXMOGLDQ-IVEVATEUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
95544,6m71,DB11529,-8.4,Melengestrol,OKHAOBQKCCIRLO-IBVJIVQJSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
101378,6vxs,DB04841,-8.4,Flunarizine,SMANXXCATUTDDT-QPJJXVBHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
64555,6lxt,DB01668,-8.4,Nanaomycin D,XUWPJKDMEZSVTP-UOSCCXBLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
146351,6w9q,DB08429,-8.4,N-({(2S)-1-[(3R)-3-amino-4-(3-chlorophenyl)butanoyl]pyrrolidin-2-yl}methyl)-3-(methylsulfonyl)benzamide,QRGBOABBMKYMLG-UXHICEINSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
64562,6lxt,DB01678,-8.4,RU84687,SAFPHFWYRLLBFO-NSOVKSMOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
12916,6lzg,DB01067,-8.4,Glipizide,ZJJXGWJIGJFDTL-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
142630,6w9q,DB02449,-8.4,3-(1h-Indol-3-Yl)-2-[4-(4-Phenyl-Piperidin-1-Yl)-Benzenesulfonylamino]-Propionic Acid,ULOTXPTWJAUGGE-MHZLTWQESA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
58532,6crv,DB05791,-8.4,Perflubron,WTWWXOGTJWMJHI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
63780,6lxt,DB00693,-8.4,Fluorescein,GNBHRKFJIUUOQI-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
160149,7bv1,DB07570,-8.4,3-CYCLOHEXYL-1-(2-MORPHOLIN-4-YL-2-OXOETHYL)-2-PHENYL-1H-INDOLE-6-CARBOXYLIC ACID,ZKEZEXYKYHYIMQ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
25626,6cs2,DB03605,-8.4,"(2s)-2-[(2,4-Dichloro-Benzoyl)-(3-Trifluoromethyl-Benzyl)-Amino]-3-Phenyl-Propionic Acid",LAJJKGIZTCCOHY-NRFANRHFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
13205,6lzg,DB14895,-8.4,Vibegron,DJXRIQMCROIRCZ-XOEOCAAJSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
143163,6w9q,DB03159,-8.4,CRA_8696,GAVRMVQHHVMXFD-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
23768,6cs2,DB01405,-8.4,Temafloxacin,QKDHBVNJCZBTMR-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
99204,6vxs,DB01948,-8.4,"1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperidin-4-Yl-3,4-Dihydroquinolin-2(1h)-One",VXIYTVJEIXMAQF-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
160016,7bv1,DB07190,-8.4,3-cyclohexyl-D-alanyl-N-(3-chlorobenzyl)-L-prolinamide,JGFCNVHEEMBVJG-MOPGFXCFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
158768,7bv1,DB02194,-8.4,"8-Benzyl-2-Hydroxy-2-(4-Hydroxy-Benzyl)-6-(4-Hydroxy-Phenyl)-2h-Imidazo[1,2-a]Pyrazin-3-One",ULLMMKZQNNBLRN-SANMLTNESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
99251,6vxs,DB02009,-8.4,"L-756,423",AOMZDQMIOCTPQP-QHQMVRJISA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
159983,7bv1,DB07154,-8.4,"(3R)-4-[(3R)-3-AMINO-4-(2,4,5-TRIFLUOROPHENYL)BUTANOYL]-3-METHYL-1,4-DIAZEPAN-2-ONE",SWKGZJAAGSVROJ-MWLCHTKSSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
86312,6m3m,DB08699,-8.4,"1-tert-butyl-3-(3-methylbenzyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine",FYCOTGCSHZKHPR-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86308,6m3m,DB08694,-8.4,"9-amino-5-(2-aminopyrimidin-4-yl)pyrido[3',2':4,5]pyrrolo[1,2-c]pyrimidin-4-ol",RTHKPHCVZVYDFN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
99254,6vxs,DB02014,-8.4,"5-(2-Fluoro-5-{(1E)-3-[3-hydroxy-2-(methoxycarbonyl)phenoxy]-1-propen-1-yl}phenyl)-1,2-oxazole-3-carboxylic acid",QKHWJUMLYAYZFS-ONEGZZNKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
60245,6crv,DB08418,-8.4,"(4aS,4bR,10bS,12aS)-12a-methyl-1,3-dioxo-2-(pyridin-3-ylmethyl)-1,2,3,4,4a,4b,5,6,10b,11,12,12a-dodecahydronaphtho[2,1-f]isoquinolin-8-yl sulfamate",LSJKARAMQNGZDF-YOEKFXIASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59502,6crv,DB07538,-8.4,"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}-2-(TRIFLUOROMETHYL)BENZENESULFONAMIDE",RGVVHQNJKUNSFQ-WDZFZDKYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29827,6cs2,DB11687,-8.4,E-6201,MWUFVYLAWAXDHQ-HMNLTAHHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
86284,6m3m,DB08661,-8.4,"1-(2,5-dideoxy-5-pyrrolidin-1-yl-beta-L-erythro-pentofuranosyl)-5-methylpyrimidine-2,4(1H,3H)-dione",XUSBTLVYPZUOAW-WOPDTQHZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87355,6m3m,DB12210,-8.4,AZD-6280,NVWCZRPXYVDQEE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
131862,6w4h,DB14876,-8.4,TAS-116,NVVPMZUGELHVMH-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
13186,6lzg,DB14860,-8.4,Ensartinib,GLYMPHUVMRFTFV-QLFBSQMISA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
86346,6m3m,DB08735,-8.4,"R,S-Warfarin alcohol",ZUJMMGHIYSAEOU-SWLSCSKDSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
99168,6vxs,DB01893,-8.4,N6-Benzyl Adenosine-5'-Diphosphate,MRHGMAGSDAQUFH-LSCFUAHRSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
59537,6crv,DB07582,-8.4,"N-[(2R,3S)-1-((2S)-2-{[(CYCLOPENTYLAMINO)CARBONYL]AMINO}-3-METHYLBUTANOYL)-2-(1-FORMYL-1-CYCLOBUTYL)PYRROLIDINYL]CYCLOPROPANECARBOXAMIDE",GCDRFILPPBOJLM-UFYCRDLUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86420,6m3m,DB08819,-8.4,Tafluprost,WSNODXPBBALQOF-VEJSHDCNSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59562,6crv,DB07613,-8.4,3-phenyl-5-(1H-pyrazol-3-yl)isoxazole,SRSSTOPJERVMRZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86412,6m3m,DB08807,-8.4,Bopindolol,UUOJIACWOAYWEZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
131907,6w4h,DB14993,-8.4,Pyrotinib,SADXACCFNXBCFY-IYNHSRRRSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
86400,6m3m,DB08795,-8.4,Azidocillin,ODFHGIPNGIAMDK-NJBDSQKTSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
99017,6vxs,DB01691,-8.4,Indole Naphthyridinone,VAZMNDXVXVUKFY-JXMROGBWSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
23793,6cs2,DB01430,-8.4,Almitrine,OBDOVFRMEYHSQB-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
131900,6w4h,DB14944,-8.4,Tarloxotinib,MUJMYVFVAWFUJL-SNAWJCMRSA-O,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
132664,6w9c,DB00704,-8.4,Naltrexone,DQCKKXVULJGBQN-XFWGSAIBSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
86373,6m3m,DB08763,-8.4,[N-(BENZYLOXYCARBONYL)AMINO](4-AMIDINOPHENYL)METHANE-PHOSPHONATE,FSNDLCSOLUMYRH-OAHLLOKOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
128671,6w4h,DB07879,-8.4,"N-hydroxy-5-[(3-phenyl-5,6-dihydroimidazo[1,2-a]pyrazin-7(8H)-yl)carbonyl]thiophene-2-carboxamide",SMSIXMLQOONOQQ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
63262,6crv,DB15457,-8.4,Snubh-nm-333 F-18,QLWFXLJVGCECSV-HUYCHCPVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86364,6m3m,DB08753,-8.4,"4-{(1E)-3-OXO-3-[(2-PHENYLETHYL)AMINO]PROP-1-EN-1-YL}-1,2-PHENYLENE DIACETATE",GARHCDOTUULBOQ-PKNBQFBNSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
158853,7bv1,DB02545,-8.4,Fexaramine,VLQTUNDJHLEFEQ-KGENOOAVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
131882,6w4h,DB14914,-8.4,Flortaucipir F-18,GETAAWDSFUCLBS-SJPDSGJFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
159972,7bv1,DB07141,-8.4,"5-[(3R)-3-(5-methoxy-4'-methylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",QVXYJVHNRPNRJL-HNNXBMFYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
132673,6w9c,DB00714,-8.4,Apomorphine,VMWNQDUVQKEIOC-CYBMUJFWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
99093,6vxs,DB01792,-8.4,Adenylyl-3'-5'-Phospho-Uridine-3'-Monophosphate,FZCSEXOMUJFOHQ-KPKSGTNCSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
143252,6w9q,DB03268,-8.4,RU82197,WKTQBTSOHBKBRW-VMPREFPWSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
99340,6vxs,DB02123,-8.4,Glycochenodeoxycholic Acid,GHCZAUBVMUEKKP-GYPHWSFCSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
128586,6w4h,DB07787,-8.4,"5-FLUORO-1-[4-(4-PHENYL-3,6-DIHYDROPYRIDIN-1(2H)-YL)BUTYL]QUINAZOLINE-2,4(1H,3H)-DIONE",PNPFDRCIGCUCMN-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
63392,6lxt,DB00224,-8.4,Indinavir,CBVCZFGXHXORBI-PXQQMZJSSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
95814,6m71,DB11984,-8.4,Letaxaban,GEHAEMCVKDPMKO-HXUWFJFHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
131830,6w4h,DB14795,-8.4,AZD-3759,MXDSJQHFFDGFDK-CYBMUJFWSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
95751,6m71,DB11891,-8.4,CUDC-907,JOWXJLIFIIOYMS-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
25597,6cs2,DB00427,-8.4,Triprolidine,CBEQULMOCCWAQT-WOJGMQOQSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
59428,6crv,DB07451,-8.4,1-(5-BROMO-PYRIDIN-2-YL)-3-[2-(6-FLUORO-2-HYDROXY-3-PROPIONYL-PHENYL)-CYCLOPROPYL]-UREA,VRAJWAGCJIXJHQ-YPMHNXCESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
99851,6vxs,DB02799,-8.4,N-[2-(1-Maleimidyl)Ethyl]-7-Diethylaminocoumarin-3-Carboxamide,OJBZDUMTXGGVSP-KTKRTIGZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
158664,7bv1,DB01764,-8.4,Dalfopristin,SUYRLXYYZQTJHF-VMBLUXKRSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
16620,6cs2,HMDB0003193,-8.4,Testosterone glucuronide,NIKZPECGCSUSBV-HMAFJQTKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
158663,7bv1,DB01763,-8.4,7-thionicotinamide-adenine-dinucleotide phosphate,OJNFDOAQUXJWED-NNYOXOHSSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59446,6crv,DB07472,-8.4,"(R)-(+)9B-(3-METHYL)PHENYL-2,3-DIHYDROTHIAZOLO[2,3-A]ISOINDOL-5(9BH)-ONE",FQVDJZWFSZSGGA-QGZVFWFLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
131821,6w4h,DB14774,-8.4,Balipodect,KVHRYLNQDWXAGI-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
87402,6m3m,DB12273,-8.4,Ecopipam,DMJWENQHWZZWDF-PKOBYXMFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59401,6crv,DB07420,-8.4,(1R)-4-(3-phenoxyphenyl)-1-phosphonobutane-1-sulfonic acid,RCGCZPXSRLLKCK-MRXNPFEDSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
16631,6cs2,HMDB0003236,-8.4,Solanidine,JVKYZPBMZPJNAJ-OQFNDJACSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
63762,6lxt,DB00673,-8.4,Aprepitant,ATALOFNDEOCMKK-OITMNORJSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
100110,6vxs,DB03141,-8.4,"3-{[(5R,6R)-5-Benzyl-6-hydroxy-2,4-bis(4-hydroxybenzyl)-3-oxo-1,2,4-triazepan-1-yl]sulfonyl}benzonitril",UYUWNNRWESUYOB-FIRIVFDPSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
100118,6vxs,DB03154,-8.4,{[7-(Difluoro-Phosphono-Methyl)-Naphthalen-2-Yl]-Difluoro-Methyl}-Phosphonic Acid,VHKBLEYUHBIBNR-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
59390,6crv,DB07406,-8.4,"(4R)-N-[4-({[2-(DIMETHYLAMINO)ETHYL]AMINO}CARBONYL)-1,3-THIAZOL-2-YL]-4-METHYL-1-OXO-2,3,4,9-TETRAHYDRO-1H-BETA-CARBOLINE-6-CARBOXAMIDE",QWFFPYQWUWLDBV-NSHDSACASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
160130,7bv1,DB07546,-8.4,[1-(6-{6-[(1-methylethyl)amino]-1H-indazol-1-yl}pyrazin-2-yl)-1H-pyrrol-3-yl]acetic acid,BBYRUZKRFAIQSR-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
128591,6w4h,DB07792,-8.4,"(S)-2-CHLORO-N-(1-(2-(2-HYDROXYETHYLAMINO)-2-OXOETHYL)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL)-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE",VUKPNWLGSLOHIF-AWEZNQCLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
95752,6m71,DB11892,-8.4,Prulifloxacin,PWNMXPDKBYZCOO-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
99675,6vxs,DB02555,-8.4,SP4160,VCXMTWSYQSVWRK-AREMUKBSSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
87386,6m3m,DB12251,-8.4,Moxaverine,MYCMTMIGRXJNSO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
95812,6m71,DB11979,-8.4,Elagolix,HEAUOKZIVMZVQL-VWLOTQADSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
129159,6w4h,DB08463,-8.4,(2R)-2-({9-(1-methylethyl)-6-[(4-pyridin-2-ylbenzyl)amino]-9H-purin-2-yl}amino)butan-1-ol,HOCBJBNQIQQQGT-LJQANCHMSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
114599,6vxx,DB13842,-8.4,Etofylline nicotinate,ZWIAODBBEZGVPY-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60250,6crv,DB08424,-8.4,"[5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL](3-{[(2R)-2,3-DIHYDROXYPROPYL]OXY}PHENYL)METHANONE",IJDQETGUEUJVTB-HNNXBMFYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
160040,7bv1,DB07220,-8.4,"N-[5-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-1H-INDAZOL-3-YL]-2-(4-PIPERIDIN-1-YLPHENYL)ACETAMIDE",ZXYIRNXOAJYLCU-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
13167,6lzg,DB14822,-8.4,SB-649868,ZJXIUGNEAIHSBI-IBGZPJMESA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
95793,6m71,DB11949,-8.4,Vestipitant,SBBYBXSFWOLDDG-JLTOFOAXSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
63480,6lxt,DB00324,-8.4,Fluorometholone,FAOZLTXFLGPHNG-KNAQIMQKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
132755,6w9c,DB00814,-8.4,Meloxicam,ZRVUJXDFFKFLMG-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
87375,6m3m,DB12236,-8.4,Bexagliflozin,BTCRKOKVYTVOLU-SJSRKZJXSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59469,6crv,DB07500,-8.4,(2E)-1-[2-hydroxy-4-methoxy-5-(3-methylbut-2-en-1-yl)phenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one,ZUGCRBMNFSAUOC-YRNVUSSQSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
6519,6lzg,DB02258,-8.4,SR11254,RNZIUDLOJHVHLZ-VYIQYICTSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
160056,7bv1,DB07458,-8.4,"3-(1H-indol-3-yl)-4-{1-[2-(1-methylpyrrolidin-2-yl)ethyl]-1H-indol-3-yl}-1H-pyrrole-2,5-dione",LBFDERUQORUFIN-KRWDZBQOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
23736,6cs2,DB01339,-8.4,Vecuronium,BGSZAXLLHYERSY-XQIGCQGXSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
128615,6w4h,DB07817,-8.4,"1-{3-[(4-pyridin-2-ylpiperazin-1-yl)sulfonyl]phenyl}-3-(1,3-thiazol-2-yl)urea",NJPVZSIGDRLLTD-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
63568,6lxt,DB00434,-8.4,Cyproheptadine,JJCFRYNCJDLXIK-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
158685,7bv1,DB02081,-8.4,Bis-Benzamidine,BXYGSMRTHHSAHZ-PMACEKPBSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
62716,6crv,DB14002,-8.4,D-alpha-Tocopherol acetate,ZAKOWWREFLAJOT-CEFNRUSXSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
99647,6vxs,DB02519,-8.4,Indirubin-5-Sulphonate,IHBOEHLUIBMBMY-YPKPFQOOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
63419,6lxt,DB00253,-8.4,Medrysone,GZENKSODFLBBHQ-ILSZZQPISA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
12218,6lzg,DB13053,-8.4,CP-195543,NZQDWKCNBOELAI-KSFYIVLOSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
103372,6vxs,DB08500,-8.4,"(3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(2-naphthyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol",ZCJBDRSKHARECB-PYTCMNEWSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
130675,6w4h,DB12612,-8.4,Ozanimod,XRVDGNKRPOAQTN-FQEVSTJZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
82961,6m3m,DB03235,-8.4,N-{3-[4-(3-aminopropyl)piperazin-1-yl]propyl}-3-(alpha-D-galactopyranosyloxy)-5-nitrobenzamide,UEIGEWJJVQHIAX-MKQKURRLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
106497,6vxx,DB00415,-8.4,Ampicillin,AVKUERGKIZMTKX-NJBDSQKTSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
82950,6m3m,DB03222,-8.4,dATP,SUYVUBYJARFZHO-RRKCRQDMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
129616,6w4h,DB09050,-8.4,Ceftolozane,JHFNIHVVXRKLEF-DCZLAGFPSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
136016,6w9c,DB06307,-8.4,Apoptone,CKAXZOYFIHQCBN-JRRMKBMNSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136017,6w9c,DB06309,-8.4,Refametinib,RDSACQWTXKSHJT-NSHDSACASA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
88811,6m3m,DB14857,-8.4,Avadomide,RSNPAKAFCAAMBH-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
106520,6vxx,DB00443,-8.4,Betamethasone,UREBDLICKHMUKA-DVTGEIKXSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
82976,6m3m,DB03251,-8.4,RWJ-51084,NQABUEUFRXDDFI-AWEZNQCLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
149572,6wiq,DB00320,-8.4,Dihydroergotamine,LUZRJRNZXALNLM-JGRZULCMSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
106555,6vxx,DB00485,-8.4,Dicloxacillin,YFAGHNZHGGCZAX-JKIFEVAISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
82893,6m3m,DB03148,-8.4,Phosphomethylphosphonic Acid Adenosyl Ester,OLCWZBFDIYXLAA-IOSLPCCCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
61417,6crv,DB12057,-8.4,ORM-12741,OCUKPFWNSAAHRP-QZTJIDSGSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
82873,6m3m,DB03116,-8.4,5-(1-Carboxy-1-Phosphonooxy-Ethoxyl)-Shikimate-3-Phosphate,QUQKBSPZUVNKIF-JQCUSGDOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
147969,6w9q,DB12724,-8.4,AZD-7295,MAQDQJWCSSCURR-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
61817,6crv,DB12643,-8.4,Nelivaptan,NJXZWIIMWNEOGJ-WEWKHQNJSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106599,6vxx,DB00799,-8.4,Tazarotene,OGQICQVSFDPSEI-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88827,6m3m,DB14885,-8.4,PF-05180999,CLGCHUKGBICQTE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
127476,6w4h,DB06169,-8.4,Indibulin,SOLIIYNRSAWTSQ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
61418,6crv,DB12058,-8.4,Recoflavone,BCPQOBQIVJZOFL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106481,6vxx,DB00396,-8.4,Progesterone,RJKFOVLPORLFTN-LEKSSAKUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136007,6w9c,DB06280,-8.4,Senicapoc,SCTZUZTYRMOMKT-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
106311,6vxs,DB15444,-8.4,Elexacaftor,MVRHVFSOIWFBTE-INIZCTEOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
135966,6w9c,DB06199,-8.4,Atrasentan,MOTJMGVDPWRKOC-QPVYNBJUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
130291,6w4h,DB12054,-8.4,BQ-123,VYCMAAOURFJIHD-PJNXIOHISA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
61385,6crv,DB12007,-8.4,Isoflavone,GOMNOOKGLZYEJT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106378,6vxx,DB00146,-8.4,Calcifediol,JWUBBDSIWDLEOM-DTOXIADCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57220,6crv,DB03355,-8.4,5'-O-(N-(L-Threonyl)-Sulfamoyl)Adenosine,UPVAPSGKXAAHBG-CKTDUXNWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
91403,6m71,DB03010,-8.4,Patupilone,QXRSDHAAWVKZLJ-PVYNADRNSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
61387,6crv,DB12009,-8.4,GW-406381,NXMZBNYLCVTRGB-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57142,6crv,DB03251,-8.4,RWJ-51084,NQABUEUFRXDDFI-AWEZNQCLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88784,6m3m,DB14787,-8.4,BMS-830216,YDTUJCNTIMWHPJ-NRFANRHFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
149982,6wiq,DB00820,-8.4,Tadalafil,WOXKDUGGOYFFRN-IIBYNOLFSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
27381,6cs2,DB06918,-8.4,2-(2-METHYLPHENYL)-1H-INDOLE-6-CARBOXIMIDAMIDE,ZRYXDGAKQGRHFG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
24940,6cs2,DB02766,-8.4,(3r)-3-{[(Benzyloxy)Carbonyl]Amino}-2-Oxo-4-Phenylbutane-1-Diazonium,VLIGBVLLNSWVMI-MRXNPFEDSA-O,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
11384,6lzg,DB11894,-8.4,Efatutazone,JCYNMRJCUYVDBC-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
69978,6lxt,DB11978,-8.4,Glasdegib,SFNSLLSYNZWZQG-VQIMIIECSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
61828,6crv,DB12659,-8.4,SJ-733,VKCPFWKTFZAOTO-LEWJYISDSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61826,6crv,DB12657,-8.4,JNJ-42396302,BPLVDYJDAVYLRQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
82991,6m3m,DB03272,-8.4,4-Bromo-3-(5'-Carboxy-4'-Chloro-2'-Fluorophenyl)-1-Methyl-5-Trifluoromethyl-Pyrazol,YNMHKERYELPEEF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
163128,7bv1,DB03797,-8.4,3-Aminomethyl-Pyridinium-Adenine-Dinucleotide,HMCRLFVYYFBZEZ-PLEFRAQWSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
106600,6vxx,DB00800,-8.4,Fenoldopam,TVURRHSHRRELCG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
70086,6lxt,DB12134,-8.4,Gepotidacin,PZFAZQUREQIODZ-LJQANCHMSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
130226,6w4h,DB11952,-8.4,Duvelisib,SJVQHLPISAIATJ-ZDUSSCGKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
70165,6lxt,DB12252,-8.4,PG-701,OKRSVUYYCJPECG-LFGMFVMYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
149317,6w9q,DB15367,-8.4,LY-2623091,YPCLDHGBEKZGEB-RUDKWAFVSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
70193,6lxt,DB12289,-8.4,Darexaban,IJNIQYINMSGIPS-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
88868,6m3m,DB14998,-8.4,Olorinab,ACSQLTBPYZSGBA-GMXVVIOVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
106759,6vxx,DB01215,-8.4,Estazolam,CDCHDCWJMGXXRH-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
70198,6lxt,DB12297,-8.4,GLPG-0187,CXHCNOMGODVIKB-VWLOTQADSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
163564,7bv1,DB04796,-8.4,Inecalcitol,HHGRMHMXKPQNGF-WNSNRMDMSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
29974,6cs2,DB11883,-8.4,SB-705498,JYILLRHXRVTRSH-GFCCVEGCSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
140554,6w9c,DB12442,-8.4,Alvespimycin,KUFRQPKVAWMTJO-LMZWQJSESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
127428,6w4h,DB05913,-8.4,OSI-930,FGTCROZDHDSNIO-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
24884,6cs2,DB02698,-8.4,"N-(M-Trifluoromethylphenyl) Phenoxazine-4,6-Dicarboxylic Acid",NQOOJFXBGLOGTC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
163616,7bv1,DB04861,-8.4,Nebivolol,KOHIRBRYDXPAMZ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
127413,6w4h,DB05812,-8.4,Abiraterone,GZOSMCIZMLWJML-VJLLXTKPSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
127409,6w4h,DB05796,-8.4,Daglutril,XMQODGUTLZXUGZ-RPBOFIJWSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
61775,6crv,DB12572,-8.4,Pexacerfont,LBWQSAZEYIZZCE-SNVBAGLBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130178,6w4h,DB11886,-8.4,Infigratinib,QADPYRIHXKWUSV-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
82480,6m3m,DB02595,-8.4,Bulgecin A,RPNZWZDLNYCCIG-HMMVDTEZSA-O,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
82478,6m3m,DB02593,-8.4,"7,8-Dihydroxy-1-Methoxy-3-Methyl-10-Oxo-4,10-Dihydro-1h,3h-Pyrano[4,3-B]Chromene-9-Carboxylic Acid",RSFJMLCZHPZXCW-AANKLQPISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136131,6w9c,DB06622,-8.4,7-beta-Hydroxyepiandrosterone,VFPMCLQMAUVEHD-UCPSWNCLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
88864,6m3m,DB14987,-8.4,Difamilast,VFBILHPIHUPBPZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
82631,6m3m,DB02802,-8.4,5-Aminocarbonyl-3-Nitrophenyl-Alpha-D-Galactopyranose,BYSXBFJVGIOFBO-LNSPPBFMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
129632,6w4h,DB09075,-8.4,Edoxaban,HGVDHZBSSITLCT-JLJPHGGASA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
106612,6vxx,DB00813,-8.4,Fentanyl,PJMPHNIQZUBGLI-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136046,6w9c,DB06410,-8.4,Doxercalciferol,HKXBNHCUPKIYDM-CGMHZMFXSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
163420,7bv1,DB04395,-8.4,Phosphoaminophosphonic Acid-Adenylate Ester,PVKSNHVPLWYQGJ-FCIPNVEPSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
127461,6w4h,DB06144,-8.4,Sertindole,GZKLJWGUPQBVJQ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
82789,6m3m,DB03005,-8.4,"3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-5-Yl]Hexyl]-Phenanthridinium",ISUOMOOYAOQQPZ-UHFFFAOYSA-O,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136065,6w9c,DB06457,-8.4,Tecastemizole,SFOVDSLXFUGAIV-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
82755,6m3m,DB02957,-8.4,Orotidine-5'-Monophosphate,KYOBSHFOBAOFBF-XVFCMESISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136073,6w9c,DB06472,-8.4,Fradafiban,IKZACQMAVUIGPY-HOTGVXAUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
88837,6m3m,DB14903,-8.4,Rovafovir etalafenamide,OCJRRXHWPBXZSU-BJBBEUPESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
90900,6m71,DB02354,-8.4,4-{[1-Methyl-5-(2-Methyl-Benzoimidazol-1-Ylmethyl)-1h-Benzoimidazol-2-Ylmethyl]-Amino}-Benzamidine,IRKPNOLLMNHSOU-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
56991,6crv,DB03060,-8.4,Sri-9662,WNDJHUNKXPAREB-PLNGDYQASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
149322,6w9q,DB15385,-8.4,Acebilustat,GERJIEKMNDGSCS-DQEYMECFSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
56982,6crv,DB03046,-8.4,7-Methoxy-8-[1-(Methylsulfonyl)-1h-Pyrazol-4-Yl]Naphthalene-2-Carboximidamide,KQUXAFOLFXHVQN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
82700,6m3m,DB02889,-8.4,"4-O-(4,6-Dideoxy-4-{[4,5,6-Trihydroxy-3-(Hydroxymethyl)Cyclohex-2-En-1-Yl]Amino}-Beta-D-Lyxo-Hexopyranosyl)-Alpha-D-Erythro-Hexopyranose",SNMISNLUIRCRQE-SFSRYZOZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
163493,7bv1,DB04698,-8.4,"N-(1,4-DIHYDRO-5H-TETRAZOL-5-YLIDENE)-9-OXO-9H-XANTHENE-2-SULFONAMIDE",HJWYZPGYPZNDTN-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
136092,6w9c,DB06525,-8.4,Ganstigmine,ZOBDWFRKFSPCRB-UNMCSNQZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
61783,6crv,DB12582,-8.4,Piperine,MXXWOMGUGJBKIW-YPCIICBESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
82664,6m3m,DB02842,-8.4,9-amino-n-[3-(dimethylamino)propyl]acridine-4-carboxamide,VNWAULKXOPRJEL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88860,6m3m,DB14945,-8.4,Florbenazine F-18,GNKGXQHHUUEYQV-WTHAECTESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
127550,6w4h,DB06346,-8.4,Fiboflapon,DFQGDHBGRSTTHX-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
149306,6w9q,DB15345,-8.4,GSK-945237,SRICOHRDRMZREQ-MRXNPFEDSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
147863,6w9q,DB12558,-8.4,AEE-788,OONFNUWBHFSNBT-HXUWFJFHSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
61859,6crv,DB12707,-8.4,AR-42,LAMIXXKAWNLXOC-INIZCTEOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
11557,6lzg,DB12127,-8.4,Sultamicillin,OPYGFNJSCUDTBT-PMLPCWDUSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
140650,6w9c,DB13044,-8.4,Gossypol,QBKSWRVVCFFDOT-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
57585,6crv,DB03860,-8.4,"N-Butyl-11-[(7r,8r,9s,13s,14s,17s)-3,17-Dihydroxy-13-Methyl-7,8,9,11,12,13,14,15,16,17-Decahydro-6h-Cyclopenta[a]Phenanthren-7-Yl]-N-Methylundecanamide",BVVFOLSZMQVDKV-KXQIQQEYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106091,6vxs,DB15003,-8.4,PF-06700841,BUWBRTXGQRBBHG-MJBXVCDLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
83512,6m3m,DB03982,-8.4,"Compound 5, 2-(Naphthalen-1-Yl-Oxalyl-Amino)-Benzoicacid",WQWCUHJIERBOSM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
152616,6wiq,DB04285,-8.4,"{4-[(2s,4e)-2-(1,3-Benzothiazol-2-Yl)-2-(1h-1,2,3-Benzotriazol-1-Yl)-5-Phenylpent-4-Enyl]Phenyl}(Difluoro)Methylphosphonic Acid",GBLDYRVJENYQNH-AGLOJYHOSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
130439,6w4h,DB12269,-8.4,PF-06273340,BPIWZDNVMQQBQX-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
69823,6lxt,DB11751,-8.4,Cabotegravir,WCWSTNLSLKSJPK-LKFCYVNXSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
130449,6w4h,DB12282,-8.4,Defactinib,FWLMVFUGMHIOAA-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
135871,6w9c,DB05465,-8.4,Tandutinib,UXXQOJXBIDBUAC-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
127648,6w4h,DB06609,-8.4,Odiparcil,JRHNIQQUVJOPQC-AQNFWKISSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
106112,6vxs,DB15047,-8.4,BMS-919373,XGKULQQVQWCASY-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
152370,6wiq,DB03957,-8.4,SP2456,SSSXBBASYYVGCI-HSZRJFAPSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
11529,6lzg,DB12095,-8.4,Telotristat ethyl,MDSQOJYHHZBZKA-GBXCKJPGSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
106139,6vxs,DB15099,-8.4,GW-468816,XDKRVNKVAKCFGW-WXWBBQJKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
11525,6lzg,DB12085,-8.4,LCL-161,UFPFGVNKHCLJJO-SSKFGXFMSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
106142,6vxs,DB15106,-8.4,Surufatinib,TTZSNFLLYPYKIL-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
135884,6w9c,DB05524,-8.4,Pelitinib,WVUNYSQLFKLYNI-AATRIKPKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
106104,6vxs,DB15033,-8.4,Flortaucipir,GETAAWDSFUCLBS-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
106150,6vxs,DB15121,-8.4,AT-001,YRGPAXAVTDMKDK-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
83549,6m3m,DB04030,-8.4,"1,3,4,9-Tetrahydro-2-(Hydroxybenzoyl)-9-[(4-Hydroxyphenyl)Methyl]-6-Methoxy-2h-Pyrido[3,4-B]Indole",ADXYEWMDAGIULV-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
106081,6vxs,DB14944,-8.4,Tarloxotinib,MUJMYVFVAWFUJL-SNAWJCMRSA-O,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
105905,6vxs,DB14581,-8.4,CPI-1205,HPODOLXTMDHLLC-QGZVFWFLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
105914,6vxs,DB14627,-8.4,Oxyphenisatin acetate,PHPUXYRXPHEJDF-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
153281,6wiq,DB06077,-8.4,Lumateperone,HOIIHACBCFLJET-SFTDATJTSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
88614,6m3m,DB14129,-8.4,Macelignan,QDDILOVMGWUNGD-UONOGXRCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
127724,6w4h,DB06743,-8.4,Ginkgolide A,FPUXKXIZEIDQKW-VKMVSBOZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
129522,6w4h,DB08922,-8.4,Perospirone,FBVFZWUMDDXLLG-HDICACEKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
153233,6wiq,DB05713,-8.4,LY-517717,VYNKVNDKAOGAAQ-RUZDIDTESA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
129534,6w4h,DB08942,-8.4,Isoxicam,YYUAYBYLJSNDCX-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
92234,6m71,DB04131,-8.4,"10-(4-Dimethylamino-5-Hydroxy-6-Methyl-Tetrahydro-Pyran-2-Yloxy)-8-Ethyl-1,8,11-Trihydroxy-7,8,9,10-Tetrahydro-Naphthacene-5,12-Dione",BLGDWFJQIHBUJY-NWJGULHDSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
11600,6lzg,DB12186,-8.4,SRT-2104,LAMQVIQMVKWXOC-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
106023,6vxs,DB14840,-8.4,Ripretinib,CEFJVGZHQAGLHS-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
25029,6cs2,DB00137,-8.4,Lutein,KBPHJBAIARWVSC-RGZFRNHPSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
130460,6w4h,DB12295,-8.4,Evodenoson,SQJXTUJMBYVDBB-RQXXJAGISA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
135827,6w9c,DB05234,-8.4,LGD2941,HWLLYFXDDGGHOE-BCSUUIJWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
106049,6vxs,DB14885,-8.4,PF-05180999,CLGCHUKGBICQTE-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
88659,6m3m,DB14476,-8.4,DL-alpha-Tocopherol,GVJHHUAWPYXKBD-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
106063,6vxs,DB14914,-8.4,Flortaucipir F-18,GETAAWDSFUCLBS-SJPDSGJFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
152768,6wiq,DB04495,-8.4,RU81843,GGPXNASQNUOIPB-NSOVKSMOSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
106018,6vxs,DB14821,-8.4,Macozinone,BJDZBXGJNBMCAV-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
106154,6vxs,DB15126,-8.4,IMG-7289,KQKBMHGOHXOHTD-KKUQBAQOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
130407,6w4h,DB12225,-8.4,Beclabuvir,ZTTKEBYSXUCBSE-QDFUAKMASA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
106167,6vxs,DB15151,-8.4,RO-6870810,PKQXLRYFPSZKDU-QFIPXVFZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
162969,7bv1,DB03358,-8.4,7n-Methyl-8-Hydroguanosine-5'-Triphosphate,BUJQMJUTTBGELS-KQYNXXCUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
24589,6cs2,DB02360,-8.4,Bis-Napthyl Beta-Ketophosphonic Acid,OFHMUASCSJJNNA-JOCHJYFZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
106247,6vxs,DB15307,-8.4,Atabecestat,VLLFGVHGKLDDLW-SFHVURJKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
61881,6crv,DB12739,-8.4,Bindarit,MTHORRSSURHQPZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
135937,6w9c,DB06140,-8.4,SUVN-502,GWCYPEHWIZXYFZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
83222,6m3m,DB03601,-8.4,5-deoxyflavanone,FURUXTVZLHCCNA-AWEZNQCLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83217,6m3m,DB03593,-8.4,N7-Methyl-Guanosine-5'-Monophosphate,AOKQNZVJJXPUQA-KQYNXXCUSA-O,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
127562,6w4h,DB06395,-8.4,Abafungin,TYBHXIFFPVFXQW-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
151863,6wiq,DB03268,-8.4,RU82197,WKTQBTSOHBKBRW-VMPREFPWSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
24985,6cs2,DB00358,-8.4,Mefloquine,XEEQGYMUWCZPDN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
151167,6wiq,DB02360,-8.4,Bis-Napthyl Beta-Ketophosphonic Acid,OFHMUASCSJJNNA-JOCHJYFZSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
106277,6vxs,DB15367,-8.4,LY-2623091,YPCLDHGBEKZGEB-RUDKWAFVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
61870,6crv,DB12720,-8.4,Nivocasan,VYFGDLGHHBUDTQ-ZLGUVYLKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130300,6w4h,DB12066,-8.4,Orteronel,OZPFIJIOIVJZMN-SFHVURJKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
127557,6w4h,DB06367,-8.4,Relacatib,BWYBBMQLUKXECQ-GIVPXCGWSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
27347,6cs2,DB06884,-8.4,4-HYDROXY-N'-(4-ISOPROPYLBENZYL)BENZOHYDRAZIDE,MFDXHRPPSJRQFX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
91672,6m71,DB03363,-8.4,3-Acetylpyridine Adenine Dinucleotide,KPVQNXLUPNWQHM-RBEMOOQDSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
91650,6m71,DB03336,-8.4,BIA,KVIVJQWOYSWCCZ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
106276,6vxs,DB15362,-8.4,LSZ-102,SJXNPGGVGZXKKI-NYYWCZLTSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
83266,6m3m,DB03666,-8.4,3'-Azido-3'-Deoxythymidine-5'-Monophosphate,OIFWQOKDSPDILA-XLPZGREQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
61333,6crv,DB11933,-8.4,Riboprine,USVMJSALORZVDV-SDBHATRESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
151895,6wiq,DB03311,-8.4,"3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid [4-(Thiazol-2-Ylsulfamoyl)-Phenyl]-Amide",SXKBTDJJEQQEGE-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
69858,6lxt,DB11800,-8.4,Tivozanib,SPMVMDHWKHCIDT-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
88692,6m3m,DB14627,-8.4,Oxyphenisatin acetate,PHPUXYRXPHEJDF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
92056,6m71,DB03893,-8.4,Thionicotinamide-Adenine-Dinucleotide,UQYPZLRUJKCREN-NNYOXOHSSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
135894,6w9c,DB05575,-8.4,Motesanib,RAHBGWKEPAQNFF-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
83346,6m3m,DB03767,-8.4,Morpholine-4-Carboxylic Acid [1s-(2-Benzyloxy-1r-Cyano-Ethylcarbamoyl)-3-Methyl-Butyl]Amide,LXEDKIMJQBOMSU-MOPGFXCFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
69878,6lxt,DB11828,-8.4,Neratinib,JWNPDZNEKVCWMY-VQHVLOKHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
162863,7bv1,DB03222,-8.4,dATP,SUYVUBYJARFZHO-RRKCRQDMSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
57393,6crv,DB03608,-8.4,Diminazene,XNYZHCFCZNMTFY-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57388,6crv,DB03601,-8.4,5-deoxyflavanone,FURUXTVZLHCCNA-AWEZNQCLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106200,6vxs,DB15219,-8.4,Tomivosertib,HKTBYUWLRDZAJK-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
127608,6w4h,DB06510,-8.4,Muraglitazar,IRLWJILLXJGJTD-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
57344,6crv,DB03532,-8.4,Phosphomethylphosphonic Acid Guanylate Ester,GXTIEXDFEKYVGY-KQYNXXCUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
162964,7bv1,DB03351,-8.4,Sri-9439,KMSATRJZEXNGDP-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
151909,6wiq,DB03331,-8.4,"N-Naphthalen-1-Ylmethyl-2'-[3,5-Dimethoxybenzamido]-2'-Deoxy-Adenosine",OARVXDFNTLYMCJ-JVUUKAHWSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
11477,6lzg,DB12020,-8.4,Tecovirimat,CSKDFZIMJXRJGH-VWLPUNTISA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
140607,6w9c,DB12524,-8.4,BI-671800,XEOSTBFUCNZKGS-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
147777,6w9q,DB12426,-8.4,Bitopertin,YUUGYIUSCYNSQR-LBPRGKRZSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
69905,6lxt,DB11871,-8.4,PF-00610355,YPHDIMUXXABSSO-YTTGMZPUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
69911,6lxt,DB11878,-8.4,Filibuvir,SLVAPEZTBDBAPI-GDLZYMKVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
57262,6crv,DB03413,-8.4,Deoxyuridine-5'-Diphosphate,QHWZTVCCBMIIKE-SHYZEUOFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
83680,6m3m,DB04202,-8.4,Isoformononetin,LNIQZRIHAMVRJA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
70250,6lxt,DB12371,-8.4,Siponimod,KIHYPELVXPAIDH-HNSNBQBZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
106876,6vxx,DB01689,-8.4,Inhibitor Idd 384,CJKKMQCZOLCXAM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136416,6w9c,DB07091,-8.4,(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclohexyloxy)ethanoyl)pyrrolidine-2-carboxamide,IWPMQJKXKKKSEY-SFHVURJKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
665,6lzg,HMDB0006559,-8.4,Heptaglutamyl folic acid,KNLHIYYNBQALAI-IMYKNWLQSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
108008,6vxx,DB06697,-8.4,Artemether,SXYIRMFQILZOAM-HVNFFKDJSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
70716,6lxt,DB13088,-8.4,AZD-0424,MVWATCATLSSVBH-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
108020,6vxx,DB06712,-8.4,Nilvadipine,FAIIFDPAEUKBEP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
70720,6lxt,DB13094,-8.4,Pruvanserin,AQRLDDAFYYAIJP-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
130066,6w4h,DB11721,-8.4,Mitoglitazone,IRNJSRAGRIZIHD-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
56210,6crv,DB02030,-8.4,Alpha-Ribazole-5'-Phosphate,ZMRGXEJKZPRBPJ-SYQHCUMBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107991,6vxx,DB06660,-8.4,Saredutant,PGKXDIMONUAMFR-AREMUKBSSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130062,6w4h,DB11712,-8.4,Tezacaftor,MJUVRTYWUMPBTR-MRXNPFEDSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
163974,7bv1,DB06920,-8.4,Eribaxaban,QQBKAVAGLMGMHI-WIYYLYMNSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
61716,6crv,DB12478,-8.4,Piribedil,OQDPVLVUJFGPGQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81620,6m3m,DB01480,-8.4,Cyprenorphine,VSKIOMHXEUHYSI-KNLIIKEYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
70776,6lxt,DB13212,-8.4,Phenolsulfonphthalein,BELBBZDIHDAJOR-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
27758,6cs2,DB07311,-8.4,"18-CHLORO-11,12,13,14-TETRAHYDRO-1H,10H-8,4-(AZENO)-9,15,1,3,6-BENZODIOXATRIAZACYCLOHEPTADECIN-2-ONE",JRSWWYITYIOHOP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
108070,6vxx,DB06800,-8.4,Methylnaltrexone,JVLBPIPGETUEET-WIXLDOGYSA-O,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
126828,6w4h,DB04348,-8.4,Taurocholic Acid,WBWWGRHZICKQGZ-HZAMXZRMSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
24709,6cs2,DB02491,-8.4,4-[4-(1-Amino-1-Methylethyl)Phenyl]-5-Chloro-N-[4-(2-Morpholin-4-Ylethyl)Phenyl]Pyrimidin-2-Amine,CJSSYVIHFXDFFC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
10885,6lzg,DB09215,-8.4,Droxicam,OEHFRZLKGRKFAS-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
136447,6w9c,DB07127,-8.4,"{4-[2,2-BIS(5-METHYL-1,2,4-OXADIAZOL-3-YL)-3-PHENYLPROPYL]PHENYL}SULFAMIC ACID",SXDBFKLPNPUPRI-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
107983,6vxx,DB05990,-8.4,Obeticholic acid,ZXERDUOLZKYMJM-ZWECCWDJSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107975,6vxx,DB05959,-8.4,ENMD-1198,YQJWOUQGXATDAE-ACNBBOPNSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61594,6crv,DB12307,-8.4,Foretinib,CXQHYVUVSFXTMY-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140496,6w9c,DB11963,-8.4,Dacomitinib,LVXJQMNHJWSHET-AATRIKPKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
81762,6m3m,DB01645,-8.4,Genistein,TZBJGXHYKVUXJN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
61602,6crv,DB12316,-8.4,9CUAB30,PPGNMFUMZSAZCW-VOYUZAMQSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61605,6crv,DB12320,-8.4,Palovarotene,YTFHCXIPDIHOIA-DHZHZOJOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81757,6m3m,DB01640,-8.4,"(5r)-6-(4-{[2-(3-Iodobenzyl)-3-Oxocyclohex-1-En-1-Yl]Amino}Phenyl)-5-Methyl-4,5-Dihydropyridazin-3(2h)-One",QNURTFDBHAQRSI-OAHLLOKOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
107882,6vxx,DB05422,-8.4,OPC-14523,TZZGTNZBLPCBIS-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107884,6vxx,DB05424,-8.4,Canertinib,OMZCMEYTWSXEPZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56224,6crv,DB02047,-8.4,"2-(1,1'-Biphenyl-4-Yl)Propanoic Acid",JALUUBQFLPUJMY-NSHDSACASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127008,6w4h,DB04591,-8.4,"N-{2,2-DIFLUORO-2-[(2R)-PIPERIDIN-2-YL]ETHYL}-2-[2-(1H-1,2,4-TRIAZOL-1-YL)BENZYL][1,3]OXAZOLO[4,5-C]PYRIDIN-4-AMINE",VYJOAYZRCNHDNG-GOSISDBHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
61606,6crv,DB12321,-8.4,Ifetroban,BBPRUNPUJIUXSE-DXKRWKNPSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
70673,6lxt,DB13023,-8.4,IPI-493,XYFFWTYOFPSZRM-TWNAANEASA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
163899,7bv1,DB06831,-8.4,2-((9H-PURIN-6-YLTHIO)METHYL)-5-CHLORO-3-(2-METHOXYPHENYL)QUINAZOLIN-4(3H)-ONE,UMMYTDJYDSTEMB-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
81715,6m3m,DB01589,-8.4,Quazepam,IKMPWMZBZSAONZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
107919,6vxx,DB05590,-8.4,Bedoradrine,OANCEOSLKSTLTA-REWPJTCUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81693,6m3m,DB01562,-8.4,1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine,BVURVTVDNWSNFN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
140489,6w9c,DB11951,-8.4,Lemborexant,MUGXRYIUWFITCP-PGRDOPGGSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
56232,6crv,DB02058,-8.4,SU4984,AZGZGRJOCKSSHA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
70659,6lxt,DB13003,-8.4,Cortivazol,RKHQGWMMUURILY-UHRZLXHJSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
27766,6cs2,DB07318,-8.4,"N-[2-(4-AMINO-5,8-DIFLUORO-1,2-DIHYDROQUINAZOLIN-2-YL)ETHYL]-3-FURAMIDE",BOAUWUUBSXECNL-LLVKDONJSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
61703,6crv,DB12463,-8.4,Semagacestat,PKXWXXPNHIWQHW-RCBQFDQVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
70799,6lxt,DB13240,-8.4,Cymarin,XQCGNURMLWFQJR-ZNDDOCHDSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
89038,6m3m,DB15334,-8.4,Biochanin A,WUADCCWRTIWANL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
164032,7bv1,DB06993,-8.4,"(2S,3S)-4-cyclopropyl-3-{(3R,5R)-3-[2-fluoro-4-(methylsulfonyl)phenyl]-1,2,4-oxadiazolidin-5-yl}-1-[(3S)-3-fluoropyrrolidin-1-yl]-1-oxobutan-2-amine",PTAHVQJZNFGPHN-WFWWEWPISA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
129921,6w4h,DB11423,-8.4,Lasalocid,BBMULGJBVDDDNI-OWKLGTHSSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
136514,6w9c,DB07204,-8.4,"(1S)-1-(1H-INDOL-3-YLMETHYL)-2-(2-PYRIDIN-4-YL-[1,7]NAPHTYRIDIN-5-YLOXY)-EHYLAMINE",DQIXTEDFNFZMCM-SFHVURJKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
89071,6m3m,DB15407,-8.4,Acalisib,DOCINCLJNAXZQF-LBPRGKRZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
108183,6vxx,DB07198,-8.4,5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-CARBONITRILE,GGEKOZPXKBYLNK-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136524,6w9c,DB07217,-8.4,"N-(3-cyano-4,5,6,7-tetrahydro-1-benzothien-2-yl)-2-fluorobenzamide",YVYPYORTKAIUGJ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
129922,6w4h,DB11424,-8.4,Lufenuron,PWPJGUXAGUPAHP-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
89031,6m3m,DB15323,-8.4,Trelagliptin,IWYJYHUNXVAVAA-OAHLLOKOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
71286,6lxt,DB13929,-8.4,Relcovaptan,CEBYCSRFKCEUSW-NAYZPBBASA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
27814,6cs2,DB07369,-8.4,"N-(3-chlorophenyl)-N-methyl-2-oxo-3-[(3,4,5-trimethyl-1H-pyrrol-2-yl)methyl]-2H-indole-5-sulfonamide",YMJLSOJLEXWATP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
71299,6lxt,DB13947,-8.4,Testosterone enantate benzilic acid hydrazone,PTVXYACXDYZNID-JKXGKYMWSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
140450,6w9c,DB06858,-8.4,N-cyclooctylglycyl-N-(4-carbamimidoylbenzyl)-L-prolinamide,MMLOIDMSBRJZAE-FQEVSTJZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
148471,6w9q,DB13490,-8.4,Hidrosmin,XYFLWVOTXWXNAM-WTNNCJBMSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
129943,6w4h,DB11457,-8.4,Rotenone,JUVIOZPCNVVQFO-HBGVWJBISA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
136546,6w9c,DB07245,-8.4,6-[2-(3'-METHOXYBIPHENYL-3-YL)ETHYL]PYRIDIN-2-AMINE,AEVBKBAFFJKFJZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136547,6w9c,DB07246,-8.4,"(2R)-2-AMINO-3,3,3-TRIFLUORO-N-HYDROXY-2-{[(4-PHENOXYPHENYL)SULFONYL]METHYL}PROPANAMIDE",MKRPIBSCGZAUCH-OAHLLOKOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
81398,6m3m,DB01150,-8.4,Cefprozil,WDLWHQDACQUCJR-PBFPGSCMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
148362,6w9q,DB13345,-8.4,Dihydroergocristine,DEQITUUQPICUMR-HJPBWRTMSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
164018,7bv1,DB06977,-8.4,(2S)-1-{[5-(1H-Indazol-5-yl)-3-pyridinyl]oxy}-3-(7aH-indol-3-yl)-2-propanamine,CAASENZOSQYNPX-HSTJUUNISA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
136500,6w9c,DB07187,-8.4,6-[(5-CHLORO-3-METHYL-1-BENZOFURAN-2-YL)SULFONYL]PYRIDAZIN-3(2H)-ONE,FXFPQPNUMWQRAO-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136499,6w9c,DB07186,-8.4,"4-(4-METHYLPIPERAZIN-1-YL)-N-[5-(2-THIENYLACETYL)-1,5-DIHYDROPYRROLO[3,4-C]PYRAZOL-3-YL]BENZAMIDE",TYYNSDQVFIOSFH-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
108098,6vxx,DB06844,-8.4,"4-[(7-OXO-7H-THIAZOLO[5,4-E]INDOL-8-YLMETHYL)-AMINO]-N-PYRIDIN-2-YL-BENZENESULFONAMIDE",MBXKBJLIESPLIK-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
89127,6m3m,DB13983,-8.4,"5,7,2'-trihydroxy-6,8-dimethoxyflavone",JWOKGWICZPPYPX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
70914,6lxt,DB13393,-8.4,Emetine,AUVVAXYIELKVAI-CKBKHPSWSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
81562,6m3m,DB01415,-8.4,Ceftibuten,UNJFKXSSGBWRBZ-BJCIPQKHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
148828,6w9q,DB14034,-8.4,Darglitazone,QQKNSPHAFATFNQ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
163987,7bv1,DB06933,-8.4,N-(tert-butyl)-4-[5-(pyridin-2-ylamino)quinolin-3-yl]benzenesulfonamide,GJTCKUKIFXWJKG-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
136465,6w9c,DB07147,-8.4,"methyl (1R,2S)-2-(hydroxycarbamoyl)-1-{4-[(2-methylquinolin-4-yl)methoxy]benzyl}cyclopropanecarboxylate",HJWMYFBKJRVWJY-YKSBVNFPSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
70987,6lxt,DB13490,-8.4,Hidrosmin,XYFLWVOTXWXNAM-WTNNCJBMSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
136472,6w9c,DB07156,-8.4,"(4Z)-6-bromo-4-({[4-(pyrrolidin-1-ylmethyl)phenyl]amino}methylidene)isoquinoline-1,3(2H,4H)-dione",JFEKAVPMVOLVTH-UNOMPAQXSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
27784,6cs2,DB07337,-8.4,"4-[4-AMINO-6-(5-CHLORO-1H-INDOL-4-YLMETHYL)-[1,3,5]TRIAZIN-2-YLAMINO]-BENZONITRILE",SOKOHDQTKSROQZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
61656,6crv,DB12398,-8.4,Naproxen etemesil,JGBUBSOKFSVXKS-LBPRGKRZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
71013,6lxt,DB13528,-8.4,Chlormadinone,VUHJZBBCZGVNDZ-TTYLFXKOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
81528,6m3m,DB01348,-8.4,Spirapril,HRWCVUIFMSZDJS-SZMVWBNQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136489,6w9c,DB07175,-8.4,N-{2-methyl-5-[(6-phenylpyrimidin-4-yl)amino]phenyl}methanesulfonamide,CXQRKICWSCAUGW-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
164015,7bv1,DB06972,-8.4,"7A-[(4-cyanophenyl)methyl]-6-(3,5-dichlorophenyl)-5-oxo-2,3,5,7A-tetrahydro-1H-pyrrolo[1,2-A]pyrrole-7-carbonitrile",TZCXQSNBTXDAJG-QFIPXVFZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
56113,6crv,DB01895,-8.4,Aspartyl-Adenosine-5'-Monophosphate,QPBSGQWTJLPZNF-VWJPMABRSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
129776,6w4h,DB09304,-8.4,Setiptiline,GVPIXRLYKVFFMK-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
71090,6lxt,DB13631,-8.4,Methoserpidine,ULBNWNUHGJLQHO-VKMIBBQISA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
148277,6w9q,DB13230,-8.4,Gestonorone,GTFUITFQDGVJSK-XGXHKTLJSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
27706,6cs2,DB07261,-8.4,"THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [1-(1-AMINO-ISOQUINOLIN-7-YLMETHYL)-2-OXO-PYRROLDIN-3-YL]-AMIDE",NVKDOURNRJCKJE-INIZCTEOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
130167,6w4h,DB11870,-8.4,RG-4733,OJPLJFIFUQPSJR-INIZCTEOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
149127,6w9q,DB14989,-8.4,Umbralisib,IUVCFHHAEHNCFT-INIZCTEOSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
107816,6vxx,DB04651,-8.4,BIOTINOL-5-AMP,KBOGUFFJCBPJEH-SQGSUPJISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27575,6cs2,DB07123,-8.4,N-(4-METHYLBENZOYL)-4-BENZYLPIPERIDINE,DVOLWKZEIDCCES-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
27580,6cs2,DB07128,-8.4,"N7-BUTYL-N2-(5-CHLORO-2-METHYLPHENYL)-5-METHYL[1,2,4]TRIAZOLO[1,5-A]PYRIMIDINE-2,7-DIAMINE",ZTYBIJUAAWLJNU-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
127253,6w4h,DB04942,-8.4,Tamibarotene,MUTNCGKQJGXKEM-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
18421,6cs2,HMDB0029222,-8.4,Urolithin A-3-O-glucuronide,KXBXNRJGUDTJQS-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
82188,6m3m,DB02221,-8.4,"4-(Aminosulfonyl)-N-[(2,4,6-Trifluorophenyl)Methyl]-Benzamide",DVTYOTODFLDHRL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
127240,6w4h,DB04903,-8.4,Pagoclone,HIUPRQPBWVEQJJ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
107266,6vxx,DB02789,-8.4,Pregnenolone,ORNBQBCIOKFOEO-QGVNFLHTSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136292,6w9c,DB06945,-8.4,N-hydroxy-4-({4-[4-(trifluoromethyl)phenoxy]phenyl}sulfonyl)tetrahydro-2H-pyran-4-carboxamide,FOSWRYKPHVPIDJ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140527,6w9c,DB12009,-8.4,GW-406381,NXMZBNYLCVTRGB-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136295,6w9c,DB06948,-8.4,2-ANILINO-6-CYCLOHEXYLMETHOXYPURINE,XWWRLKIBRPJQJX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
107296,6vxx,DB03124,-8.4,5-[4-(1-Carboxymethyl-2-Oxo-Propylcarbamoyl)-Benzylsulfamoyl]-2-Hydroxy-Benzoic Acid,LBAHOXPDTNUYCX-INIZCTEOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107302,6vxx,DB03133,-8.4,"2-(Beta-D-Glucopyranosyl)-5-Methyl-1,2,3-Benzimidazole",XIJZORUYQZBFJK-UJPOAAIJSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
82163,6m3m,DB02189,-8.4,"2',3'-Dideoxyadenosine-5'-Triphosphate",OAKPWEUQDVLTCN-NKWVEPMBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
114249,6vxx,DB13174,-8.4,Rhein,FCDLCPWAQCPTKC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136299,6w9c,DB06954,-8.4,"2-(cycloheptylmethyl)-1,1-dioxido-1-benzothiophen-6-yl sulfamate",BIASYWBGUYOWJR-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
163727,7bv1,DB06155,-8.4,Rimonabant,JZCPYUJPEARBJL-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
82145,6m3m,DB02162,-8.4,5'-O-(N-Ethyl-Sulfamoyl)Adenosine,ONCSLXAPOGUODU-WOUKDFQISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
61756,6crv,DB12543,-8.4,Samidorphan,RYIDHLJADOKWFM-MAODMQOUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
90095,6m71,DB01251,-8.4,Gliquidone,LLJFMFZYVVLQKT-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
61754,6crv,DB12540,-8.4,Lecozotan,NRPQELCNMADTOZ-OAQYLSRUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
82258,6m3m,DB02315,-8.4,Cyclic GMP,ZOOGRGPOEVQQDX-UUOKFMHZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
56659,6crv,DB02611,-8.4,Balanol Analog 1,FZJQHARRQUNVGZ-QZTJIDSGSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106882,6vxx,DB01697,-8.4,beta-cellotriose,FYGDTMLNYKFZSV-CSHPIKHBSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
70260,6lxt,DB12385,-8.4,10-hydroxycamptothecin,HAWSQZCWOQZXHI-FQEVSTJZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
127372,6w4h,DB05552,-8.4,TG100-115,UJIAQDJKSXQLIT-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
106895,6vxx,DB01713,-8.4,Udp-Alpha-D-Xylopyranose,DQQDLYVHOTZLOR-OCIMBMBZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140536,6w9c,DB12024,-8.4,PF-04418948,LWJGMYMNSNVCEM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
11205,6lzg,DB11651,-8.4,Dactolisib,JOGKUKXHTYWRGZ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
56731,6crv,DB02706,-8.4,Mercaptocarboxylate Inhibitor,DUKDFMPUZRDWLT-CQSZACIVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
149297,6w9q,DB15327,-8.4,Abivertinib,UOFYSRZSLXWIQB-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
127296,6w4h,DB05129,-8.4,Elsamitrucin,MGQRRMONVLMKJL-KWJIQSIXSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
70287,6lxt,DB12419,-8.4,HSD-016,ZWASRJHIEFYJGL-BFUOFWGJSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
82368,6m3m,DB02450,-8.4,"2-Benzo[1,3]Dioxol-5-Ylmethyl-3-Benzyl-Succinic Acid",ASEJDWRSZYAIOT-GJZGRUSLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
61497,6crv,DB12173,-8.4,Diphencyprone,HCIBTBXNLVOFER-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61517,6crv,DB12206,-8.4,N-6022,YVPGZQLRPAGKLA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
129703,6w4h,DB09199,-8.4,Netoglitazone,PKWDZWYVIHVNKS-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
56686,6crv,DB02647,-8.4,N-(5-Cyclopropyl-1h-Pyrazol-3-Yl)Benzamide,LUCORKWTQSQFFU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
8176,6lzg,DB04853,-8.4,Binodenoson,XJFMHMFFBSOEPR-DNZQAUTHSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
107050,6vxx,DB02221,-8.4,"4-(Aminosulfonyl)-N-[(2,4,6-Trifluorophenyl)Methyl]-Benzamide",DVTYOTODFLDHRL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61522,6crv,DB12214,-8.4,Luseogliflozin,WHSOLWOTCHFFBK-ZQGJOIPISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
82372,6m3m,DB02455,-8.4,Fluoresceinylthioureido,VHJFQSRUDVDTEO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
163757,7bv1,DB06213,-8.4,Regadenoson,LZPZPHGJDAGEJZ-AKAIJSEGSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
89966,6m71,DB01100,-8.4,Pimozide,YVUQSNJEYSNKRX-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
27615,6cs2,DB07165,-8.4,N-(5-CHLORO-BENZO[B]THIOPHEN-3-YLMETHYL)-2-[6-CHLORO-OXO-3-(2-PYRIDIN-2-YL-ETHYLAMINO)-2H-PYRAZIN-1-YL]-ACETAMIDE,SOBGXPPOYFFGTK-UGKGYDQZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
89680,6m71,DB00773,-8.4,Etoposide,VJJPUSNTGOMMGY-MRVIYFEKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
81921,6m3m,DB01858,-8.4,[1-(4-Fluorobenzyl)Cyclobutyl]Methyl (1s)-1-[Oxo(1h-Pyrazol-5-Ylamino)Acetyl]Pentylcarbamate,QTPYRNAKLBXKNP-SFHVURJKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
61582,6crv,DB12291,-8.4,Tacedinaline,VAZAPHZUAVEOMC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107727,6vxx,DB04540,-8.4,Cholesterol,HVYWMOMLDIMFJA-DPAQBDIFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136379,6w9c,DB07049,-8.4,(2R)-1-[(4-tert-butylphenyl)sulfonyl]-2-methyl-4-(4-nitrophenyl)piperazine,SOFGQQQVQZQJFS-MRXNPFEDSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
163840,7bv1,DB06444,-8.4,Dexanabinol,SSQJFGMEZBFMNV-PMACEKPBSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
56378,6crv,DB02253,-8.4,"(1r)-4-[(1e,3e,5e,7z,9e,11z,13e,15e)-17-Hydroxy-3,7,12,16-Tetramethylheptadeca-1,3,5,7,9,11,13,15-Octaen-1-Yl]-3,5,5-Trimethylcyclohex-3-En-1-Ol",FNAJVVMDXCOSFY-VFGOXHQXSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
6990,6lzg,DB03044,-8.4,1-(5-Tert-Butyl-2-P-Tolyl-2h-Pyrazol-3-Yl)-3-[4-(2-Morpholin-4-Yl-Ethoxy)-Naphthalen-1-Yl]-Urea,MVCOAUNKQVWQHZ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
107656,6vxx,DB04144,-8.4,"Cis-[4,5-Bis-(4-Chlorophenyl)-2-(2-Isopropoxy-4-Methoxyphenyl)-4,5-Dihyd Roimidazol-1-Yl]-Piperazin-1-Yl-Methanone",ZXIPEZDMQNYFOO-WUFINQPMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136388,6w9c,DB07058,-8.4,"5-[1-(4-methoxyphenyl)-1H-benzimidazol-6-yl]-1,3,4-oxadiazole-2(3H)-thione",QBVJMUOTMRYUKR-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
56335,6crv,DB02196,-8.4,Uridine-Diphosphate-N-Acetylgalactosamine,LFTYTUAZOPRMMI-NESSUJCYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27693,6cs2,DB07249,-8.4,"N-(5-chloro-1,3-benzodioxol-4-yl)-6-methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-amine",QHIMVPIOWKYPSO-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
149129,6w9q,DB14995,-8.4,NP-G2-044,XLLRLAABUFOJPC-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
61589,6crv,DB12301,-8.4,Doravirine,ZIAOVIPSKUPPQW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
70613,6lxt,DB12929,-8.4,JNJ-39220675,IQOWHZHNGJXGHG-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
148180,6w9q,DB13059,-8.4,PF-03814735,RYYNGWLOYLRZLK-RBUKOAKNSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
107795,6vxx,DB04626,-8.4,Apramycin,XZNUGFQTQHRASN-XQENGBIVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
70618,6lxt,DB12937,-8.4,Quercetin-3'-O-phosphate,UWJBYNLLMAPJMM-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
136389,6w9c,DB07059,-8.4,"N-{2-[6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2,2-DIMETHYL-3-OXO-2,3-DIHYDRO-4H-1,4-BENZOXAZIN-4-YL]ETHYL}ACETAMIDE",GBXSOZDYCSBLQX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
107649,6vxx,DB04137,-8.4,Guanosine-5'-Triphosphate,XKMLYUALXHKNFT-UUOKFMHZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81927,6m3m,DB01865,-8.4,3-(6-Aminopyridin-3-Yl)-N-Methyl-N-[(1-Methyl-1h-Indol-2-Yl)Methyl]Acrylamide,AKFPMLBVLWZSQX-CSKARUKUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81930,6m3m,DB01871,-8.4,[1-(1-Benzyl-3-Hydroxy-2-Oxo-Propylcarbamoyl)-2-Phenyl-Ethyl]-Carbamic Acid Benzyl Ester,OACUXIVGLLCILS-ZEQRLZLVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
127204,6w4h,DB04850,-8.4,Posizolid,HBUJYEUPIIJJOS-PBHICJAKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
89955,6m71,DB01089,-8.4,Deserpidine,CVBMAZKKCSYWQR-WCGOZPBSSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
70444,6lxt,DB12663,-8.4,Letrazuril,XQKYUBTUOHHNDV-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
149151,6w9q,DB15046,-8.4,LY-2881835,FHRWHNJJQGSCQC-LJAQVGFWSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
70449,6lxt,DB12669,-8.4,4SC-203,MAFACRSJGNJHCF-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
56521,6crv,DB02431,-8.4,Cytidine-5'-Triphosphate,PCDQPRRSZKQHHS-XVFCMESISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
82036,6m3m,DB02019,-8.4,Acetyl Dithranol,IXLRLZOYKJERRA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
70489,6lxt,DB12729,-8.4,ASP-3026,MGGBYMDAPCCKCT-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
130118,6w4h,DB11796,-8.4,Fostemsavir,SWMDAPWAQQTBOG-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
70510,6lxt,DB12764,-8.4,ABC-294640,CAOTVXGYTWCKQE-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
27636,6cs2,DB07186,-8.4,"4-(4-METHYLPIPERAZIN-1-YL)-N-[5-(2-THIENYLACETYL)-1,5-DIHYDROPYRROLO[3,4-C]PYRAZOL-3-YL]BENZAMIDE",TYYNSDQVFIOSFH-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
89937,6m71,DB01067,-8.4,Glipizide,ZJJXGWJIGJFDTL-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
107509,6vxx,DB03696,-8.4,Lanosterol,CAHGCLMLTWQZNJ-BQNIITSRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
89853,6m71,DB00972,-8.4,Azelastine,MBUVEWMHONZEQD-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
89809,6m71,DB00919,-8.4,Spectinomycin,UNFWWIHTNXNPBV-WXKVUWSESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
81952,6m3m,DB01906,-8.4,"3-(5-Amino-7-Hydroxy-[1,2,3]Triazolo[4,5-D]Pyrimidin-2-Yl)-Benzoic Acid",KNLLRZNGRRRPEW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
107621,6vxx,DB04098,-8.4,Balanol,XYUFCXJZFZPEJD-PGRDOPGGSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27659,6cs2,DB07210,-8.4,"3-bromo-5-phenyl-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",JECHSYMSTXETFI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
56430,6crv,DB02322,-8.4,Heparin Disaccharide I-S,LRPGJWKAYQRIAQ-GYBHJADLSA-J,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107817,6vxx,DB04652,-8.4,Corticosterone,OMFXVFTZEKFJBZ-HJTSIMOOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57739,6crv,DB04068,-8.4,Fudp,WLQBZMZTRNPUDL-SHYZEUOFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57413,6crv,DB03641,-8.4,"2'-deoxyuridine 5'-alpha,beta-imido-diphosphate",COFNIXBQVWFHTR-SHYZEUOFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
135809,6w9c,DB05104,-8.4,Asimadoline,JHLHNYVMZCADTC-LOSJGSFVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
135267,6w9c,DB04232,-8.4,N-Hydroxy-1-(4-Methoxyphenyl)Sulfonyl-4-Benzyloxycarbonyl-Piperazine-2-Carboxamide,DNGGPLKVDUPXFN-GOSISDBHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
58353,6crv,DB04883,-8.4,Darusentan,FEJVSJIALLTFRP-LJQANCHMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62030,6crv,DB12974,-8.4,Roniciclib,UELYDGOOJPRWGF-SRQXXRKNSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84388,6m3m,DB05932,-8.4,Denibulin,GAOHLWCIAJNSEE-JTQLQIEISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
61125,6crv,DB11616,-8.4,Pirarubicin,KMSKQZKKOZQFFG-YXRRJAAWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
161554,7bv1,DB15065,-8.4,PF-06291874,IBDYYOQKQCCSDP-QFIPXVFZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
161575,7bv1,DB00137,-8.4,Lutein,KBPHJBAIARWVSC-RGZFRNHPSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
135285,6w9c,DB04258,-8.4,Seocalcitol,LVLLALCJVJNGQQ-SEODYNFXSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
161590,7bv1,DB00153,-8.4,Ergocalciferol,MECHNRXZTMCUDQ-RKHKHRCZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
11996,6lzg,DB12724,-8.4,AZD-7295,MAQDQJWCSSCURR-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
68546,6lxt,DB08039,-8.4,"(3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE",LOGJQOUIVKBFGH-YBEGLDIGSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
127974,6w4h,DB07070,-8.4,(2S)-2-{3-[({[2-fluoro-4-(trifluoromethyl)phenyl]carbonyl}amino)methyl]-4-methoxybenzyl}butanoic acid,BDLLIPYDNFENMY-ZDUSSCGKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
93143,6m71,DB06420,-8.4,Annamycin,CIDNKDMVSINJCG-GKXONYSUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
58314,6crv,DB04833,-8.4,Methaqualone,JEYCTXHKTXCGPB-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88327,6m3m,DB13653,-8.4,Lorcainide,XHOJAWVAWFHGHL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84398,6m3m,DB05973,-8.4,Inosine 5'-sulfate,IGYLPKLXFDOQGM-KQYNXXCUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88303,6m3m,DB13618,-8.4,Ipriflavone,SFBODOKJTYAUCM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
93189,6m71,DB06532,-8.4,Pafuramidine,UKOQVLAXCBRRGH-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
135230,6w9c,DB04158,-8.4,"6-(Adenosine Tetraphosphate-Methyl)-7,8-Dihydropterin",ZKRKFZJAQKKHKL-SUGPNEFASA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
26863,6cs2,DB05590,-8.4,Bedoradrine,OANCEOSLKSTLTA-REWPJTCUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
17638,6cs2,HMDB0000032,-8.4,7-Dehydrocholesterol,UCTLRSWJYQTBFZ-DDPQNLDTSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
84465,6m3m,DB06234,-8.4,Maribavir,KJFBVJALEQWJBS-XUXIUFHCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
29968,6cs2,DB11875,-8.4,"3,3'-diindolylmethane",VFTRKSBEFQDZKX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
93286,6m71,DB06732,-8.4,beta-Naphthoflavone,OUGIDAPQYNCXRA-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
24487,6cs2,DB00303,-8.4,Ertapenem,JUZNIMUFDBIJCM-ANEDZVCMSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
68385,6lxt,DB07856,-8.4,6-{4-[4-(4-CHLOROPHENYL)PIPERIDIN-4-YL]PHENYL}-9H-PURINE,HPWBHQIUIBFTQC-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
127960,6w4h,DB07054,-8.4,(2R)-1-(DIMETHYLAMINO)-3-{4-[(6-{[2-FLUORO-5-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-4-YL)AMINO]PHENOXY}PROPAN-2-OL,OSCWQKTUILTARV-MRXNPFEDSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
84443,6m3m,DB06190,-8.4,Solabegron,LLDXOPKUNJTIRF-QFIPXVFZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88284,6m3m,DB13596,-8.4,Oxycinchophen,XAPRFLSJBSXESP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
128022,6w4h,DB07126,-8.4,O6-CYCLOHEXYLMETHOXY-2-(4'-SULPHAMOYLANILINO) PURINE,OWXORKPNCHJYOF-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
135198,6w9c,DB04115,-8.4,Berberine,YBHILYKTIRIUTE-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
58391,6crv,DB04975,-8.4,Banoxantrone,YZBAXVICWUUHGG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88287,6m3m,DB13600,-8.4,Deltamethrin,OWZREIFADZCYQD-NSHGMRRFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
68485,6lxt,DB07973,-8.4,N-(1-ISOPROPYLPIPERIDIN-4-YL)-1-(3-METHOXYBENZYL)-1H-INDOLE-2-CARBOXAMIDE,GIPCBGDQVGKMPO-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
84406,6m3m,DB06061,-8.4,AZD-8330,RWEVIPRMPFNTLO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
161523,7bv1,DB15006,-8.4,Flufenoxuron,RYLHNOVXKPXDIP-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
26940,6cs2,DB06077,-8.4,Lumateperone,HOIIHACBCFLJET-SFTDATJTSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
104689,6vxs,DB12364,-8.4,Betrixaban,XHOLNRLADUSQLD-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104716,6vxs,DB12401,-8.4,Bromperidol,RKLNONIVDFXQRX-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
26991,6cs2,DB06202,-8.4,Lasofoxifene,GXESHMAMLJKROZ-IAPPQJPRSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
161986,7bv1,DB01051,-8.4,Novobiocin,YJQPYGGHQPGBLI-KGSXXDOSSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
88398,6m3m,DB13741,-8.4,Ioglycamic acid,FZDZULUFHNDEDJ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
135558,6w9c,DB04624,-8.4,DERIVATIVE OF AKLANONIC ACID METHYL ESTER (AAME),SIHNJMGWRHPFAZ-XHDPSFHLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
88409,6m3m,DB13759,-8.4,Fenpiverinium,QDIYJDPBMZUZEH-UHFFFAOYSA-O,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
68928,6lxt,DB08500,-8.4,"(3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(2-naphthyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol",ZCJBDRSKHARECB-PYTCMNEWSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
115853,6w4b,DB01410,-8.4,Ciclesonide,LUKZNWIVRBCLON-GXOBDPJESA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
93068,6m71,DB06212,-8.4,Tolvaptan,GYHCTFXIZSNGJT-XMMPIXPASA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
130577,6w4h,DB12459,-8.4,Belotecan,LNHWXBUNXOXMRL-VWLOTQADSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
104911,6vxs,DB12696,-8.4,BMS-582949,GDTQLZHHDRRBEB-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
93043,6m71,DB06160,-8.4,Garenoxacin,NJDRXTDGYFKORP-LLVKDONJSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
61164,6crv,DB11682,-8.4,Daprodustat,RUEYEZADQJCKGV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88442,6m3m,DB13803,-8.4,Xipamide,MTZBBNMLMNBNJL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
162021,7bv1,DB01091,-8.4,Butenafine,ABJKWBDEJIDSJZ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
104927,6vxs,DB12720,-8.4,Nivocasan,VYFGDLGHHBUDTQ-ZLGUVYLKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
147506,6w9q,DB12044,-8.4,MK-0893,DNTVJEMGHBIUMW-IBGZPJMESA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
88414,6m3m,DB13767,-8.4,Vorozole,XLMPPFTZALNBFS-INIZCTEOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
104440,6vxs,DB12005,-8.4,Nirogacestat,VFCRKLWBYMDAED-REWPJTCUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
58219,6crv,DB04707,-8.4,Hydroxyfasudil,ZAVGJDAFCZAWSZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61155,6crv,DB11671,-8.4,AZD-4877,SMFXSYMLJDHGIE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130469,6w4h,DB12306,-8.4,Cipargamin,CKLPLPZSUQEDRT-WPCRTTGESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
68720,6lxt,DB08242,-8.4,"N,4-dimethyl-3-[(1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl)amino]benzamide",OYTBZXSFNNAVKU-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
127943,6w4h,DB07036,-8.4,"(3aS,4R,9bR)-2,2-difluoro-4-(4-hydroxyphenyl)-6-(methoxymethyl)-1,2,3,3a,4,9b-hexahydrocyclopenta[c]chromen-8-ol",GPFRMIHXGMVMGF-BZSNNMDCSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
140735,6w9c,DB15207,-8.4,Esaxerenone,NOSNHVJANRODGR-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
58269,6crv,DB04778,-8.4,SC45647,LPSXGZAUAOMRNU-FZKQIMNGSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104731,6vxs,DB12419,-8.4,HSD-016,ZWASRJHIEFYJGL-BFUOFWGJSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
88358,6m3m,DB13687,-8.4,Niaprazine,RSKQGBFMNPDPLR-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
93069,6m71,DB06213,-8.4,Regadenoson,LZPZPHGJDAGEJZ-AKAIJSEGSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
11926,6lzg,DB12627,-8.4,GSK-1292263,AYJRTVVIBJSSKN-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
93092,6m71,DB06263,-8.4,Amrubicin,VJZITPJGSQKZMX-XDPRQOKASA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
135511,6w9c,DB04563,-8.4,CRA_9678,VIZNZQTZRMTYPZ-UHFFFAOYSA-M,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
58235,6crv,DB04729,-8.4,Gentamicin C1a,VEGXETMJINRLTH-BOZYPMBZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104789,6vxs,DB12507,-8.4,Atecegatran metoxil,XSNMGLZVFNDDPW-ZWKOTPCHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104811,6vxs,DB12540,-8.4,Lecozotan,NRPQELCNMADTOZ-OAQYLSRUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
84260,6m3m,DB05154,-8.4,Pretomanid,ZLHZLMOSPGACSZ-NSHDSACASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
129470,6w4h,DB08833,-8.4,Taurochenodeoxycholic acid,BHTRKEVKTKCXOH-BJLOMENOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
84283,6m3m,DB05295,-8.4,Eldecalcitol,FZEXGDDBXLBRTD-AYIMTCTASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
104935,6vxs,DB12732,-8.4,Firategrast,YLFZHHDVRSYTKT-NRFANRHFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
93296,6m71,DB06745,-8.4,ginkgolide-C,AMOGMTLMADGEOQ-DTDWCABLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
88246,6m3m,DB13542,-8.4,Bevonium,UHUMRJKDOOEQIG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
24444,6cs2,DB02187,-8.4,Equilin,WKRLQDKEXYKHJB-HFTRVMKXSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
104213,6vxs,DB11672,-8.4,Curcumin,VFLDPWHFBUODDF-FCXRPNKRSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104229,6vxs,DB11692,-8.4,Pavinetant,QYTBBBAHNIWFOD-NRFANRHFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
147325,6w9q,DB11778,-8.4,Danusertib,XKFTZKGMDDZMJI-HSZRJFAPSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
156039,6wiq,DB12121,-8.4,Entospletinib,XSMSNFMDVXXHGJ-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
68070,6lxt,DB07486,-8.4,"3-({4-[(1E)-3-morpholin-4-yl-3-oxoprop-1-en-1-yl]-2,3-bis(trifluoromethyl)phenyl}sulfanyl)aniline",KLSZVPNVFKKIRD-FNORWQNLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
84615,6m3m,DB06624,-8.4,Taranabant,QLYKJCMUNUWAGO-GAJHUEQPSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84609,6m3m,DB06616,-8.4,Bosutinib,UBPYILGKFZZVDX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
134754,6w9c,DB03501,-8.4,Galactose-uridine-5'-diphosphate,HSCJRCZFDFQWRP-ABVWGUQPSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
114327,6vxx,DB13300,-8.4,Epicillin,RPBAFSBGYDKNRG-NJBDSQKTSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140750,6w9c,DB15235,-8.4,Di-2-pyridylketone 4-cyclohexyl-4-methyl-3-thiosemicarbazone,GNLZNQJBZNOUBM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
88139,6m3m,DB13396,-8.4,Neocitrullamon,PAJBBDCZSMDSFL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
104296,6vxs,DB11793,-8.4,Niraparib,PCHKPVIQAHNQLW-CQSZACIVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
155983,6wiq,DB12042,-8.4,Ibodutant,YQYSVMKCMIUCHY-WJOKGBTCSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
68121,6lxt,DB07545,-8.4,N-{3-[(4-{[3-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-2-YL)AMINO]PHENYL}CYCLOPROPANECARBOXAMIDE,RDTDWGQDFJPTPD-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
61017,6crv,DB11367,-8.4,Cefroxadine,RDMOROXKXONCAL-UEKVPHQBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
68019,6lxt,DB07426,-8.4,"[1-HYDROXY-2-(1,1':3',1''-TERPHENYL-3-YLOXY)ETHANE-1,1-DIYL]BIS(PHOSPHONIC ACID)",NWIARQRYIRVYCM-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
88106,6m3m,DB13351,-8.4,Piperidolate,KTHVBAZBLKXIHZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
93635,6m71,DB07175,-8.4,N-{2-methyl-5-[(6-phenylpyrimidin-4-yl)amino]phenyl}methanesulfonamide,CXQRKICWSCAUGW-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
88026,6m3m,DB13246,-8.4,Quinupramine,JCBQCKFFSPGEDY-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
166519,7bv1,DB15292,-8.4,Foliglurax,ZTEDNASHAWNBKQ-NCELDCMTSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
104140,6vxs,DB11487,-8.4,Dexamethasone isonicotinate,BQTXJHAJMDGOFI-NJLPOHDGSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
67991,6lxt,DB07393,-8.4,"2-(2-PHENYL-3-PYRIDIN-2-YL-4,5,6,7-TETRAHYDRO-2H-ISOPHOSPHINDOL-1-YL)PYRIDINE",GSKNNHAAFLPYHG-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
62126,6crv,DB13118,-8.4,Paquinimod,DIKSYHCCYVYKRO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
67994,6lxt,DB07396,-8.4,"1-{2-[3-(2-Chloro-4,5-difluoro-benzoyl)-ureido]-4-fluoro-phenyl}-piperidine-4-carboxylic acid",KAJJGOCSAXKXBD-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
12203,6lzg,DB13029,-8.4,MK-0873,JJWKQXNHYDJXKF-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
68122,6lxt,DB07546,-8.4,[1-(6-{6-[(1-methylethyl)amino]-1H-indazol-1-yl}pyrazin-2-yl)-1H-pyrrol-3-yl]acetic acid,BBYRUZKRFAIQSR-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
60972,6crv,DB11185,-8.4,Sulisobenzone,CXVGEDCSTKKODG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
68003,6lxt,DB07406,-8.4,"(4R)-N-[4-({[2-(DIMETHYLAMINO)ETHYL]AMINO}CARBONYL)-1,3-THIAZOL-2-YL]-4-METHYL-1-OXO-2,3,4,9-TETRAHYDRO-1H-BETA-CARBOLINE-6-CARBOXAMIDE",QWFFPYQWUWLDBV-NSHDSACASA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
129394,6w4h,DB08742,-8.4,"1,3-CYCLOHEXANEDIOL, 4-METHYLENE-5-[(2E)-[(1S,3AS,7AS)-OCTAHYDRO-1-(5-HYDROXY-5-METHYL-1,3-HEXADIYNYL)-7A-METHYL-4H-INDEN-4-YLIDENE]ETHYLIDENE]-, (1R,3S,5Z)",CEEUUHVULXTFGS-BQXVGYHGSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
68006,6lxt,DB07409,-8.4,"(1-HYDROXY-1-PHOSPHONO-2-[1,1';4',1'']TERPHENYL-3-YL-ETHYL)-PHOSPHONIC ACID",MPBUFKZCEBTBSK-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
12196,6lzg,DB13022,-8.4,LY-2874455,GKJCVYLDJWTWQU-CXLRFSCWSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
156078,6wiq,DB12381,-8.4,Merestinib,QHADVLVFMKEIIP-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
26784,6cs2,DB05212,-8.4,HE3286,JJKOQZHWYLMASZ-FJWDNACWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
104196,6vxs,DB11645,-8.4,PF-4191834,DVNQWYLVSNPCJZ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
62114,6crv,DB13102,-8.4,AZD-8418,MCPBSUCAISQZQK-JTQLQIEISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
68141,6lxt,DB07570,-8.4,3-CYCLOHEXYL-1-(2-MORPHOLIN-4-YL-2-OXOETHYL)-2-PHENYL-1H-INDOLE-6-CARBOXYLIC ACID,ZKEZEXYKYHYIMQ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
155947,6wiq,DB11986,-8.4,Entrectinib,HAYYBYPASCDWEQ-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
15473,6lzg,T3D1042,-8.4,Avermectin B1b,ZFUKERYTFURFGA-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
134986,6w9c,DB03830,-8.4,Phosphorylated Dihydropteroate,DNKVHXNVVYQUDC-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
12092,6lzg,DB12875,-8.4,Mavatrep,ORDHXXHTBUZRCN-NTEUORMPSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
12091,6lzg,DB12874,-8.4,Quizartinib,CVWXJKQAOSCOAB-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
58415,6crv,DB05104,-8.4,Asimadoline,JHLHNYVMZCADTC-LOSJGSFVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
93418,6m71,DB06922,-8.4,"2-[(1R)-1-carboxy-2-naphthalen-1-ylethyl]-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylic acid",CZNPWASYMRBJCX-GOSISDBHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
68308,6lxt,DB07769,-8.4,S-3-(4-FLUOROPHENOXY)-2-HYDROXY-2-METHYL-N-[4-NITRO-3-(TRIFLUOROMETHYL)PHENYL]PROPANAMIDE,KJMFOTCDISOHDX-INIZCTEOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
93412,6m71,DB06916,-8.4,"N-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-1-[2-(1H-IMIDAZOL-1-YL)-6-METHYLPYRIMIDIN-4-YL]-D-PROLINAMIDE",LBCGUKCXRVUULK-QGZVFWFLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
58420,6crv,DB05129,-8.4,Elsamitrucin,MGQRRMONVLMKJL-KWJIQSIXSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104409,6vxs,DB11958,-8.4,Brivanib,WCWUXEGQKLTGDX-LLVKDONJSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
93301,6m71,DB06755,-8.4,Beta carotene,OENHQHLEOONYIE-JLTXGRSLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
58410,6crv,DB05076,-8.4,Fenretinide,AKJHMTWEGVYYSE-FXILSDISSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
161512,7bv1,DB14944,-8.4,Tarloxotinib,MUJMYVFVAWFUJL-SNAWJCMRSA-O,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
84499,6m3m,DB06309,-8.4,Refametinib,RDSACQWTXKSHJT-NSHDSACASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
135057,6w9c,DB03925,-8.4,Freselestat,HMPQTEPEMQZWQH-QZTJIDSGSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
104423,6vxs,DB11979,-8.4,Elagolix,HEAUOKZIVMZVQL-VWLOTQADSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
30028,6cs2,DB11951,-8.4,Lemborexant,MUGXRYIUWFITCP-PGRDOPGGSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
62056,6crv,DB13019,-8.4,Henatinib,MCTXSDCWFQAGFS-UEXNTNOUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104428,6vxs,DB11987,-8.4,GSK-2018682,NFIGDBFIDKDNIG-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
93438,6m71,DB06945,-8.4,N-hydroxy-4-({4-[4-(trifluoromethyl)phenoxy]phenyl}sulfonyl)tetrahydro-2H-pyran-4-carboxamide,FOSWRYKPHVPIDJ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93460,6m71,DB06977,-8.4,(2S)-1-{[5-(1H-Indazol-5-yl)-3-pyridinyl]oxy}-3-(7aH-indol-3-yl)-2-propanamine,CAASENZOSQYNPX-HSTJUUNISA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
166572,7bv1,DB15403,-8.4,Ziritaxestat,REQQVBGILUTQNN-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
134849,6w9c,DB03647,-8.4,3-[Isopropyl(4-Methylbenzoyl)Amino]-5-Phenylthiophene-2-Carboxylic Acid,LRHXIDOGMBZJFN-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
84566,6m3m,DB06506,-8.4,Repinotan,YGYBFMRFXNDIPO-QGZVFWFLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
130657,6w4h,DB12579,-8.4,JNJ-37822681,UVUYWJWYRLJHEN-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
134870,6w9c,DB03672,-8.4,9-N-Phenylmethylamino-Tacrine,JYJAEHAURXXPSD-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
104323,6vxs,DB11829,-8.4,Ruboxistaurin,ZCBUQCWBWNUWSU-SFHVURJKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
114323,6vxx,DB13292,-8.4,Pimethixene,NZLVRVYNQYGMAB-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
128056,6w4h,DB07165,-8.4,N-(5-CHLORO-BENZO[B]THIOPHEN-3-YLMETHYL)-2-[6-CHLORO-OXO-3-(2-PYRIDIN-2-YL-ETHYLAMINO)-2H-PYRAZIN-1-YL]-ACETAMIDE,SOBGXPPOYFFGTK-UGKGYDQZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
88186,6m3m,DB13458,-8.4,Thebacon,RRJQTGHQFYTZOW-ILWKUFEGSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84545,6m3m,DB06454,-8.4,Sarizotan,HKFMQJUJWSFOLY-OAQYLSRUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
68213,6lxt,DB07654,-8.4,"(5,6-DIPHENYL-FURO[2,3-D]PYRIMIDIN-4-YLAMINO)-ACETIC",VDJWWYRYKMXMKA-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
12115,6lzg,DB12903,-8.4,DEBIO-1347,BEMNJULZEQTDJY-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
104361,6vxs,DB11890,-8.4,Cilengitide,AMLYAMJWYAIXIA-VWNVYAMZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
128068,6w4h,DB07179,-8.4,"3-((3-bromo-5-o-tolylpyrazolo[1,5-a]pyrimidin-7-ylamino)methyl)pyridine 1-oxide",DXUJQXZHHGJMFM-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
104370,6vxs,DB11901,-8.4,Apalutamide,HJBWBFZLDZWPHF-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
155900,6wiq,DB11913,-8.4,LY-2090314,HRJWTAWVFDCTGO-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
88189,6m3m,DB13461,-8.4,Cefcapene,HJJRIJDTIPFROI-NVKITGPLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
104939,6vxs,DB12740,-8.4,CC-115,GMYLVKUGJMYTFB-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
24500,6cs2,DB02253,-8.4,"(1r)-4-[(1e,3e,5e,7z,9e,11z,13e,15e)-17-Hydroxy-3,7,12,16-Tetramethylheptadeca-1,3,5,7,9,11,13,15-Octaen-1-Yl]-3,5,5-Trimethylcyclohex-3-En-1-Ol",FNAJVVMDXCOSFY-VFGOXHQXSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
96878,6m71,DB13571,-8.4,Pentamycin,AGJUUQSLGVCRQA-SWOUQTJZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
88513,6m3m,DB13937,-8.4,LGD-3303,OMXGOGXEWUCLFI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88508,6m3m,DB13929,-8.4,Relcovaptan,CEBYCSRFKCEUSW-NAYZPBBASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83866,6m3m,DB04463,-8.4,"3-(4-Amino-1-Tert-Butyl-1h-Pyrazolo[3,4-D]Pyrimidin-3-Yl)Phenol",CPLGZXQPPYRNRC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
162305,7bv1,DB01873,-8.4,Epothilone D,XOZIUKBZLSUILX-GIQCAXHBSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
105599,6vxs,DB13717,-8.4,Phenothrin,SBNFWQZLDJGRLK-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
162318,7bv1,DB01889,-8.4,"16,17-Androstene-3-Ol",KRVXMNNRSSQZJP-PHFHYRSDSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
92849,6m71,DB05038,-8.4,Anatibant,XUHBBTKJWIBQMY-MHZLTWQESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
27079,6cs2,DB06414,-8.4,Etravirine,PYGWGZALEOIKDF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
129500,6w4h,DB08883,-8.4,Perampanel,PRMWGUBFXWROHD-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
127767,6w4h,DB06827,-8.4,Viomycin,GXFAIFRPOKBQRV-GHXCTMGLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
105155,6vxs,DB13080,-8.4,Roluperidone,RNRYULFRLCBRQS-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
129496,6w4h,DB08878,-8.4,Aminopterin,TVZGACDUOSZQKY-LBPRGKRZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
162342,7bv1,DB01933,-8.4,7-Hydroxystaurosporine,PBCZSGKMGDDXIJ-HQCWYSJUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
105152,6vxs,DB13074,-8.4,Macimorelin,UJVDJAPJQWZRFR-DHIUTWEWSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
57839,6crv,DB04196,-8.4,Pteroic Acid,JOAQINSXLLMRCV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88540,6m3m,DB13983,-8.4,"5,7,2'-trihydroxy-6,8-dimethoxyflavone",JWOKGWICZPPYPX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
92662,6m71,DB04704,-8.4,20-hydroxycholesterol,MCKLJFJEQRYRQT-MGNSQDQZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
153440,6wiq,DB06638,-8.4,Quarfloxin,WOQIDNWTQOYDLF-CGAIIQECSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
69262,6lxt,DB08930,-8.4,Dolutegravir,RHWKPHLQXYSBKR-BMIGLBTASA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
69495,6lxt,DB09272,-8.4,Eluxadoline,QFNHIDANIVGXPE-FNZWTVRRSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
127815,6w4h,DB06886,-8.4,N-BENZYLOXYCARBONYL-ALA-PRO-3-AMINO-4-PHENYL-BUTAN-2-OL,MACLRJNEKXUAJK-YDLSIGKMSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
11771,6lzg,DB12410,-8.4,Sabarubicin,VQHRZZISQVWPLK-UIRGBLDSSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
11773,6lzg,DB12412,-8.4,Gemigliptin,ZWPRRQZNBDYKLH-VIFPVBQESA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
92908,6m71,DB05412,-8.4,Talmapimod,ZMELOYOKMZBMRB-DLBZAZTESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
105098,6vxs,DB12996,-8.4,Acteoside,FBSKJMQYURKNSU-ZLSOWSIRSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
5943,6lzg,HMDB0112265,-8.4,13-cis-beta-Carotene,OENHQHLEOONYIE-MZMZTKINSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
69497,6lxt,DB09274,-8.4,Artesunate,FIHJKUPKCHIPAT-AHIGJZGOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
84022,6m3m,DB04659,-8.4,"(1S,2S,3R,4S,5S)-2,3,4-TRIHYDROXY-5-(HYDROXYMETHYL)CYCLOHEXYL (1E)-2-PHENYL-N-(SULFOOXY)ETHANIMIDOTHIOATE",LZDZCEOFJWRJIA-GGASBGQWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
114273,6vxx,DB13223,-8.4,Fluocortin,PUWHHWCHAVXSIG-NCLPIGKXSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
11739,6lzg,DB12369,-8.4,Sotrastaurin,OAVGBZOFDPFGPJ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
130503,6w4h,DB12357,-8.4,BMS-863233,JJWLXRKVUJDJKG-VIFPVBQESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
105479,6vxs,DB13554,-8.4,Moperone,AGAHNABIDCTLHW-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
130511,6w4h,DB12368,-8.4,AZD-3839,MRXBCEQZNKUUIP-DEOSSOPVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
147616,6w9q,DB12207,-8.4,Verdinexor,OPAKEJZFFCECPN-XQRVVYSFSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
69355,6lxt,DB09054,-8.4,Idelalisib,IFSDAJWBUCMOAH-HNNXBMFYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
25065,6cs2,DB02914,-8.4,"(6e)-6-[(2e,4e,6e)-3,7-Dimethylnona-2,4,6,8-Tetraenylidene]-1,5,5-Trimethylcyclohexene",FWNRILWHNGFAIN-OYUWDNMLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
130508,6w4h,DB12364,-8.4,Betrixaban,XHOLNRLADUSQLD-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
127773,6w4h,DB06834,-8.4,"N-(2-hydroxy-1,1-dimethylethyl)-1-methyl-3-(1H-pyrrolo[2,3-b]pyridin-2-yl)-1H-indole-5-carboxamide",XZRYCTLOGNCQDG-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
88548,6m3m,DB13994,-8.4,AZD-7325,KYDURMHFWXCKMW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
11697,6lzg,DB12309,-8.4,GI-181771X,CABBMMXFOOZVMS-PMERELPUSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
83883,6m3m,DB04482,-8.4,Cmp-2-Keto-3-Deoxy-Octulosonic Acid,YWWJKULNWGRYAS-UOVSKDHASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
30041,6cs2,DB11968,-8.4,MK-7145,OCKGFTQIICXDQW-ZEQRLZLVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
69354,6lxt,DB09053,-8.4,Ibrutinib,XYFPWWZEPKGCCK-GOSISDBHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
83966,6m3m,DB04590,-8.4,(2R)-({4-[AMINO(IMINO)METHYL]PHENYL}AMINO){5-ETHOXY-2-FLUORO-3-[(3R)-TETRAHYDROFURAN-3-YLOXY]PHENYL}ACETICACID,PGYOHIAQCFZQDK-AUUYWEPGSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
92767,6m71,DB04841,-8.4,Flunarizine,SMANXXCATUTDDT-QPJJXVBHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
135730,6w9c,DB04862,-8.4,Merimepodib,JBPUGFODGPKTDW-SFHVURJKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
61234,6crv,DB11787,-8.4,Ralimetinib,XPPBBJCBDOEXDN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
83975,6m3m,DB04601,-8.4,"4-[(4-O-SULFAMOYLBENZYL)(4-CYANOPHENYL)AMINO]-4H-[1,2,4]-TRIAZOLE",WEXGHQDVDVWOIU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
105431,6vxs,DB13490,-8.4,Hidrosmin,XYFLWVOTXWXNAM-WTNNCJBMSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
135727,6w9c,DB04859,-8.4,Zanapezil,PMBLXLOXUGVTGB-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
61229,6crv,DB11781,-8.4,Tosedostat,FWFGIHPGRQZWIW-SQNIBIBYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61225,6crv,DB11774,-8.4,Pazufloxacin,XAGMUUZPGZWTRP-ZETCQYMHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
105307,6vxs,DB13327,-8.4,Picotamide,KYWCWBXGRWWINE-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
92699,6m71,DB04757,-8.4,"GUANOSINE-2',3'-O-METHYLIDENEPHOSPHONATE",GKAPYWCOOQBBHV-KXSYMAMXSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
61956,6crv,DB12868,-8.4,Intoplicine,QROONAIPJKQFMC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
162200,7bv1,DB01554,-8.4,Bolandiol,CMXKUJNZWYTFJN-XFUVECHXSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
57992,6crv,DB04407,-8.4,4-[4-(4-Methyl-2-Methylamino-Thiazol-5-Yl)-Pyrimidin-2-Ylamino]-Phenol,OTMLAWRVLMYMDF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
135760,6w9c,DB04908,-8.4,Flibanserin,PPRRDFIXUUSXRA-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
135719,6w9c,DB04845,-8.4,Ixabepilone,FABUFPQFXZVHFB-PVYNADRNSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
92920,6m71,DB05454,-8.4,Paliroden,CNEWKIDCGDXBDE-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
153449,6wiq,DB06666,-8.4,Lixivaptan,PPHTXRNHTVLQED-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
147647,6w9q,DB12247,-8.4,AZD-4547,VRQMAABPASPXMW-HDICACEKSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
105029,6vxs,DB12888,-8.4,Ezutromid,KSGCNXAZROJSNW-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
130489,6w4h,DB12332,-8.4,Rucaparib,HMABYWSNWIZPAG-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
166582,7bv1,DB15418,-8.4,AZD-9977,MBKYLPOPYYLTNW-ZDUSSCGKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
58127,6crv,DB04582,-8.4,IMAZAQUIN,CABMTIJINOIHOD-QGZVFWFLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88581,6m3m,DB14065,-8.4,Lomerizine,JQSAYKKFZOSZGJ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88467,6m3m,DB13837,-8.4,Doxefazepam,VOJLELRQLPENHL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83749,6m3m,DB04295,-8.4,N-Benzoyl-N'-Beta-D-Glucopyranosyl Urea,JSBCZGSPFATCOV-BZNQNGANSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84158,6m3m,DB04843,-8.4,Mepenzolate,GKNPSSNBBWDAGH-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
57822,6crv,DB04172,-8.4,"[2,4,6-Triisopropyl-Phenylsulfonyl-L-[3-Amidino-Phenylalanine]]-Piperazine-N'-Beta-Alanine",WATXEHGLYJKXOF-NDEPHWFRSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
83798,6m3m,DB04366,-8.4,3'-Deoxy 3'-Amino Adenosine-5'-Diphosphate,VKODIDNZKBYXJO-QYYRPYCUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58099,6crv,DB04549,-8.4,"4-(Aminosulfonyl)-N-[(2,3,4-Trifluorophenyl)Methyl]-Benzamide",AANTYZRUJFNZFI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57795,6crv,DB04140,-8.4,1-Benzyl-3-(4-Methoxy-Benzenesulfonyl)-6-Oxo-Hexahydro-Pyrimidine-4-Carboxylic Acid Hydroxyamide,SUSMVCKSLVPRCL-QGZVFWFLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58093,6crv,DB04542,-8.4,3'-Azido-3'-Deoxythymidine-5'-Diphosphate,QOYVAFWJURKBJG-XLPZGREQSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
83757,6m3m,DB04306,-8.4,"5-[(4-Methylphenyl)Sulfanyl]-2,4-Quinazolinediamine",UOJFGEAPSYQDIP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
92953,6m71,DB05611,-8.4,Apilimod,HSKAZIJJKRAJAV-KOEQRZSOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
88466,6m3m,DB13836,-8.4,Metampicillin,FZECHKJQHUVANE-MCYUEQNJSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84110,6m3m,DB04787,-8.4,Tanaproget,PYVFWTPEBMRKSR-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
11791,6lzg,DB12432,-8.4,CC-401,XDJCLCLBSGGNKS-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
84145,6m3m,DB04829,-8.4,Lysergic acid diethylamide,VAYOSLLFUXYJDT-RDTXWAMCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83717,6m3m,DB04254,-8.4,"8-Benzo[1,3]Dioxol-,5-Ylmethyl-9-Butyl-2-Fluoro-9h-Purin-6-Ylamine",ARWHTQLGMWHTAZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
27030,6cs2,DB06274,-8.4,Alvimopan,UPNUIXSCZBYVBB-JVFUWBCBSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
75587,6m2n,DB04898,-8.3,Ximelagatran,ZXIBCJHYVWYIKI-PZJWPPBQSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75840,6m2n,DB06202,-8.3,Lasofoxifene,GXESHMAMLJKROZ-IAPPQJPRSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
60762,6crv,DB09083,-8.3,Ivabradine,ACRHBAYQBXXRTO-OAQYLSRUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60001,6crv,DB08118,-8.3,"2-(methylamino)-N-(4-methyl-1,3-thiazol-2-yl)-5-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]benzamide",XRJAKERBMMBUGR-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30163,6cs2,DB12131,-8.3,Vinpocetine,DDNCQMVWWZOMLN-IRLDBZIGSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
60841,6crv,DB09214,-8.3,Dexketoprofen,DKYWVDODHFEZIM-NSHDSACASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61591,6crv,DB12303,-8.3,Motolimod,QSPOQCXMGPDIHI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30166,6cs2,DB12135,-8.3,Elubrixin,YQYFEGTYCUQBEI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
75272,6m2n,DB04482,-8.3,Cmp-2-Keto-3-Deoxy-Octulosonic Acid,YWWJKULNWGRYAS-UOVSKDHASA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
30793,6cs2,DB12986,-8.3,VS-5584,QYBGBLQCOOISAR-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
61592,6crv,DB12305,-8.3,Dasotraline,SRPXSILJHWNFMK-MEDUHNTESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
25037,6cs2,DB02882,-8.3,Cyanocinnoline,CUWRVIIPSSUUDJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
147626,6w9q,DB12222,-8.3,Lurtotecan,RVFGKBWWUQOIOU-NDEPHWFRSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
145848,6w9q,DB07830,-8.3,"(4R,5R)-5-AMINO-1-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN-2-ONE",DIRIFWIKLRTNMB-DYVFJYSZSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
165868,7bv1,DB13135,-8.3,AGN-201904,PPCGSVWOZKNPCX-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
159150,7bv1,DB03490,-8.3,"3-Pyridin-4-Yl-2,4-Dihydro-Indeno[1,2-.C.]Pyrazole",NHOACLCXCKJMAK-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60879,6crv,DB09262,-8.3,Imidafenacin,SQKXYSGRELMAAU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62077,6crv,DB13051,-8.3,CH-5132799,JEGHXKRHKHPBJD-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104,6lzg,HMDB0002865,-8.3,Oxytocin,XNOPRXBHLZRZKH-MQYCRUOZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
61246,6crv,DB11801,-8.3,Rapastinel,GIBQQARAXHVEGD-BSOLPCOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
24571,6cs2,DB02338,-8.3,Nadph Dihydro-Nicotinamide-Adenine-Dinucleotidephosphate,ACFIXJIJDZMPPO-NNYOXOHSSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
60063,6crv,DB08185,-8.3,2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,LCHGAOHLDYRACA-SDBHATRESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62223,6crv,DB13292,-8.3,Pimethixene,NZLVRVYNQYGMAB-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62502,6crv,DB13665,-8.3,Fluanisone,IRYFCWPNDIUQOW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
139090,6w9c,DB12840,-8.3,Pirnabine,AADNQNOXNWEYHS-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
25318,6cs2,DB03220,-8.3,FR233623,OODDZQQDDOVCFD-SCLBCKFNSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
60109,6crv,DB08245,-8.3,1-(2-DEOXY-5-O-PHOSPHONO-BETA-D-ERYTHRO-PENTOFURANOSYL)-5-NITRO-1H-INDOLE,FQCJFJRLZCIFHB-YNEHKIRRSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62132,6crv,DB13129,-8.3,Trimegestone,JUNDJWOLDSCTFK-MTZCLOFQSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30537,6cs2,DB12623,-8.3,Taprenepag,MFFBXYNKZHTCEY-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
62880,6crv,DB14651,-8.3,Perphenazine enanthate,PWEGQJCIAMJJHC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
145942,6w9q,DB07941,-8.3,PH-797804,KCAJXIDMCNPGHZ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
31420,6cs2,DB13793,-8.3,Vinburnine,WYJAPUKIYAZSEM-MOPGFXCFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
148609,6w9q,DB13676,-8.3,Mosapramine,PXUIZULXJVRBPC-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
158163,7bv1,DB00452,-8.3,Framycetin,PGBHMTALBVVCIT-VCIWKGPPSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
62884,6crv,DB14655,-8.3,Drostanolone propionate,NOTIQUSPUUHHEH-UXOVVSIBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
147221,6w9q,DB11611,-8.3,Lifitegrast,JFOZKMSJYSPYLN-QHCPKHFHSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
147274,6w9q,DB11697,-8.3,Pacritinib,HWXVIOGONBBTBY-ONEGZZNKSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
61311,6crv,DB11899,-8.3,MK-8776,GMIZZEXBPRLVIV-SECBINFHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
139560,6w9c,DB13635,-8.3,Tiracizine,KJAMZCVTJDTESW-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
156302,6wiq,DB12892,-8.3,MGB-BP-3,OEKXCVYZBVOWBR-BQYQJAHWSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
24238,6cs2,DB01941,-8.3,"6-[1-(3,5,5,8,8-Pentamethyl-5,6,7,8-Tetrahydronaphthalen-2-Yl)Cyclopropyl]Pyridine-3-Carboxylic Acid",SLXTWXQUEZSSTJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
62575,6crv,DB13760,-8.3,Niperotidine,HXRSXEDVVARPHP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
148445,6w9q,DB13454,-8.3,Nicomorphine,HNDXBGYRMHRUFN-CIVUWBIHSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
75741,6m2n,DB05676,-8.3,Apremilast,IMOZEMNVLZVGJZ-QGZVFWFLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
30494,6cs2,DB12562,-8.3,Setipiprant,IHAXLPDVOWLUOS-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
153274,6wiq,DB05983,-8.3,Bardoxolone methyl,WPTTVJLTNAWYAO-KPOXMGGZSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
62070,6crv,DB13039,-8.3,Aminaphthone,YLMPBJUYFTWHKJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
159125,7bv1,DB03181,-8.3,"2-[4-(4-Hydroxy-3-Isopropyl-Phenoxy)-3,5-Dimethyl-Phenyl]-2h-[1,2,4]Triazine-3,5-Dione",RXQAVKWRCZYGMV-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
30692,6cs2,DB12850,-8.3,Etalocib,YFIZRWPXUYFCSN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
60080,6crv,DB08208,-8.3,"2-[(4-ETHYNYL-2-FLUOROPHENYL)AMINO]-3,4-DIFLUORO-N-(2-HYDROXYETHOXY)BENZAMIDE",AMNKRBRQQAMACZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30756,6cs2,DB12933,-8.3,RO-4987655,FIMYFEGKMOCQKT-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
62104,6crv,DB13089,-8.3,Enoxolone,MPDGHEJMBKOTSU-YKLVYJNSSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
153118,6wiq,DB05075,-8.3,TG-100801,JMGXJHWTVBGOKG-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
25260,6cs2,DB03154,-8.3,{[7-(Difluoro-Phosphono-Methyl)-Naphthalen-2-Yl]-Difluoro-Methyl}-Phosphonic Acid,VHKBLEYUHBIBNR-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
25738,6cs2,DB03744,-8.3,"Cp403700, (S)-1-{2-[(5-Chloro-1h-Indole-2-Carbonyl)-Amino]-3-Phenyl-Propionyl}-Azetidine-3-Carboxylate",RONLONYAIBUEKT-IBGZPJMESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
156729,6wiq,DB13610,-8.3,Flumedroxone,CDZJOBWKHSYNMO-SCUQKFFVSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
62087,6crv,DB13063,-8.3,Parthenolide,KTEXNACQROZXEV-SLXBATTESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62524,6crv,DB13689,-8.3,Tacalcitol,BJYLYJCXYAMOFT-RSFVBTMBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30836,6cs2,DB13048,-8.3,PAC-1,YQNRVGJCPCNMKT-LFVJCYFKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
61040,6crv,DB11410,-8.3,Fenbendazole,HDDSHPAODJUKPD-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76172,6m2n,DB06897,-8.3,"3-[3-chloro-5-(5-{[(1S)-1-phenylethyl]amino}isoxazolo[5,4-c]pyridin-3-yl)phenyl]propan-1-ol",MMGKIHLBFPJYJL-HNNXBMFYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
149045,6w9q,DB14785,-8.3,Fenebrutinib,WNEODWDFDXWOLU-QHCPKHFHSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
149042,6w9q,DB14774,-8.3,Balipodect,KVHRYLNQDWXAGI-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
156749,6wiq,DB13640,-8.3,Acetoxolone,FTQDJVZNPJRVPG-XWEVEMRCSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
75767,6m2n,DB05838,-8.3,OPC-51803,INGXCNVWWKKWOO-LJQANCHMSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
62090,6crv,DB13066,-8.3,Liarozole,UGFHIPBXIWJXNA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
25443,6cs2,DB03363,-8.3,3-Acetylpyridine Adenine Dinucleotide,KPVQNXLUPNWQHM-RBEMOOQDSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
62468,6crv,DB13618,-8.3,Ipriflavone,SFBODOKJTYAUCM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31357,6cs2,DB13720,-8.3,Diphemanil,LCTZPQRFOZKZNK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
62173,6crv,DB13223,-8.3,Fluocortin,PUWHHWCHAVXSIG-NCLPIGKXSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
159268,7bv1,DB03666,-8.3,3'-Azido-3'-Deoxythymidine-5'-Monophosphate,OIFWQOKDSPDILA-XLPZGREQSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60518,6crv,DB08742,-8.3,"1,3-CYCLOHEXANEDIOL, 4-METHYLENE-5-[(2E)-[(1S,3AS,7AS)-OCTAHYDRO-1-(5-HYDROXY-5-METHYL-1,3-HEXADIYNYL)-7A-METHYL-4H-INDEN-4-YLIDENE]ETHYLIDENE]-, (1R,3S,5Z)",CEEUUHVULXTFGS-BQXVGYHGSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62168,6crv,DB13217,-8.3,Fentiazac,JIEKMACRVQTPRC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
149001,6w9q,DB14676,-8.3,Fagrocorat,QJJBNCHSWFGXML-KEKPKEOLSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
75817,6m2n,DB06155,-8.3,Rimonabant,JZCPYUJPEARBJL-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
31887,6cs2,DB14941,-8.3,BMS-817399,GTDPZONCGOCXOD-JPYJTQIMSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
30529,6cs2,DB12612,-8.3,Ozanimod,XRVDGNKRPOAQTN-FQEVSTJZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
61643,6crv,DB12380,-8.3,GDC-0152,WZRFLSDVFPIXOV-LRQRDZAKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60482,6crv,DB08705,-8.3,"6-(5-BROMO-2-HYDROXYPHENYL)-2-OXO-4-PHENYL-1,2-DIHYDROPYRIDINE-3-CARBONITRILE",SVSYJTYGPLVUOZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60825,6crv,DB09197,-8.3,Mepiprazole,DOTIMEKVTCOGED-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62094,6crv,DB13072,-8.3,GDC-0349,RGJOJUGRHPQXGF-INIZCTEOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
152949,6wiq,DB04739,-8.3,4-[(4-METHYL-1-PIPERAZINYL)METHYL]-N-[3-[[4-(3-PYRIDINYL)-2-PYRIMIDINYL]AMINO]PHENYL]-BENZAMIDE,JHMBUEWQJDGKGS-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
31294,6cs2,DB13648,-8.3,Alcuronium,MUQUYTSLDVKIOF-CHJKCJHBSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
75621,6m2n,DB05015,-8.3,Belinostat,NCNRHFGMJRPRSK-MDZDMXLPSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
147232,6w9q,DB11637,-8.3,Delamanid,XDAOLTSRNUSPPH-XMMPIXPASA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
165762,7bv1,DB12972,-8.3,Sepranolone,AURFZBICLPNKBZ-FZCSVUEKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
61942,6crv,DB12843,-8.3,Oleandrin,JLPDBLFIVFSOCC-XYXFTTADSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62910,6crv,DB14682,-8.3,Dextrorphan,JAQUASYNZVUNQP-PVAVHDDUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61021,6crv,DB11376,-8.3,Azaperone,XTKDAFGWCDAMPY-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62571,6crv,DB13756,-8.3,Peruvoside,PMTSPAGBAFCORP-HBUONDEYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75752,6m2n,DB05767,-8.3,Andrographolide,BOJKULTULYSRAS-OTESTREVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
25759,6cs2,DB00445,-8.3,Epirubicin,AOJJSUZBOXZQNB-VTZDEGQISA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
145814,6w9q,DB07793,-8.3,"(2S)-N-[(3S)-1-(2-AMINO-2-OXOETHYL)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL]-2-CHLORO-2H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE",ACSGSLPOHKRZCY-GXTWGEPZSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
166100,7bv1,DB13685,-8.3,Quingestanol,PCJFRMOEZQQSAX-AIOSZGMZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60018,6crv,DB08136,-8.3,4-(acetylamino)-N-(4-fluorophenyl)-1H-pyrazole-3-carboxamide,CWQKPKYIMQTGJK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62522,6crv,DB13686,-8.3,Clometocillin,JKXQBIZCQJLVOS-GSNLGQFWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29691,6cs2,DB11424,-8.3,Lufenuron,PWPJGUXAGUPAHP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
60455,6crv,DB08670,-8.3,"METHYL N-[(2S,3R)-3-AMINO-2-HYDROXY-3-(4-ISOPROPYLPHENYL)PROPANOYL]-D-ALANYL-D-LEUCINATE",WIWZNHHLFMPGGO-PIKADFDJSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60491,6crv,DB08714,-8.3,"2,6-DIMETHYL-1-(3-[3-METHYL-5-ISOXAZOLYL]-PROPANYL)-4-[4-METHYL-2H-TETRAZOL-2-YL]-PHENOL",DRCNRTRGWUYJBH-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60510,6crv,DB08734,-8.3,"6,6-DIMETHYL-1-[3-(2,4,5-TRICHLOROPHENOXY)PROPOXY]-1,6-DIHYDRO-1,3,5-TRIAZINE-2,4-DIAMINE",MJZJYWCQPMNPRM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
147338,6w9q,DB11794,-8.3,Berzosertib,JZCWLJDSIRUGIN-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
149087,6w9q,DB14882,-8.3,CEP-9722,CTLOSZHDGZLOQE-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
31853,6cs2,DB14882,-8.3,CEP-9722,CTLOSZHDGZLOQE-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
166466,7bv1,DB15191,-8.3,MAX-40279,AVIOBQFPAGEICQ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
30521,6cs2,DB12597,-8.3,ABL-001,VOVZXURTCKPRDQ-CQSZACIVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
62085,6crv,DB13061,-8.3,MLN8054,HHFBDROWDBDFBR-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
139430,6w9c,DB13457,-8.3,Oxaflozane,FVYUQFQCEOZYHZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
25736,6cs2,DB03742,-8.3,Compound 4-D,TWZNCTCQAGRUGQ-RRPNLBNLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
165766,7bv1,DB12978,-8.3,Pexidartinib,JGWRKYUXBBNENE-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60476,6crv,DB08698,-8.3,"1-[(3S)-5-PHENYL-3-THIOPHEN-2-YL-3H-1,4-BENZODIAZEPIN-2-YL]AZETIDIN-3-OL",BKSGACYTXOQQNI-OAQYLSRUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
166011,7bv1,DB13571,-8.3,Pentamycin,AGJUUQSLGVCRQA-SWOUQTJZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
75769,6m2n,DB05861,-8.3,Tasquinimod,ONDYALNGTUAJDX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
139154,6w9c,DB12937,-8.3,Quercetin-3'-O-phosphate,UWJBYNLLMAPJMM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
61047,6crv,DB11425,-8.3,Luprostiol,KFUDFIMHDRJVLV-OZCLATTGSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61049,6crv,DB11427,-8.3,Maropitant,OMPCVMLFFSQFIX-CONSDPRKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
25009,6cs2,DB02848,-8.3,"{4-[3-(6,7-Diethoxy-Quinazolin-4-Ylamino)-Phenyl]-Thiazol-2-Yl}-Methanol",ZJESXGUODSBHSK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
139207,6w9c,DB13119,-8.3,GSK-364735,QWLNINWUBHHOLU-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
149138,6w9q,DB15023,-8.3,BMS-791826,DZBKAUMYTFPJIS-QHCPKHFHSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
76086,6m2n,DB06771,-8.3,Besifloxacin,QFFGVLORLPOAEC-SNVBAGLBSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61997,6crv,DB12926,-8.3,Cafedrine,UJSKUDDDPKGBJY-WFASDCNBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
148000,6w9q,DB12774,-8.3,AZD-8055,KVLFRAWTRWDEDF-IRXDYDNUSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
62344,6crv,DB13448,-8.3,Mazaticol,AMHPTVWBZSYFSS-OAGGEKHMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62423,6crv,DB13555,-8.3,Prajmaline,UAUHEPXILIZYCU-ALHOSYKFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60356,6crv,DB08547,-8.3,PROGESTERONE-11-ALPHA-OL-HEMISUCCINATE,JBBNFGYRYNBDIH-DBGGZKJISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
158039,7bv1,DB00303,-8.3,Ertapenem,JUZNIMUFDBIJCM-ANEDZVCMSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
75480,6m2n,DB04761,-8.3,"PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-[(PYRIDIN-3-YLMETHYL)-AMIDE]",NHPBWKYFMTXWAA-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61428,6crv,DB12072,-8.3,Orantinib,NHFDRBXTEDBWCZ-ZROIWOOFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30632,6cs2,DB00972,-8.3,Azelastine,MBUVEWMHONZEQD-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
146921,6w9q,DB09195,-8.3,Lorpiprazole,BNRMWKUVWLKDQJ-YJBOKZPZSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
61158,6crv,DB11674,-8.3,Equol,ADFCQWZHKCXPAJ-GFCCVEGCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62411,6crv,DB13542,-8.3,Bevonium,UHUMRJKDOOEQIG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61186,6crv,DB11712,-8.3,Tezacaftor,MJUVRTYWUMPBTR-MRXNPFEDSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62415,6crv,DB13546,-8.3,Nizofenone,WZGBZLHGOVJDET-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
139503,6w9c,DB13555,-8.3,Prajmaline,UAUHEPXILIZYCU-ALHOSYKFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
147491,6w9q,DB12020,-8.3,Tecovirimat,CSKDFZIMJXRJGH-VWLPUNTISA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
62330,6crv,DB13430,-8.3,Mebutizide,KJLLKLRVCJAFRY-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60670,6crv,DB08957,-8.3,Hexoprenaline,OXLZNBCNGJWPRV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165832,7bv1,DB13080,-8.3,Roluperidone,RNRYULFRLCBRQS-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
24506,6cs2,DB02259,-8.3,"3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid (4-Sulfamoyl-Phenyl)-Amide",VSYGXLAJQDAWCZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
166564,7bv1,DB15385,-8.3,Acebilustat,GERJIEKMNDGSCS-DQEYMECFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
139111,6w9c,DB12877,-8.3,Oxatomide,BAINIUMDFURPJM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
166435,7bv1,DB15124,-8.3,PF-05241328,RVTSXVZXEGFIPW-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
31520,6cs2,DB13952,-8.3,Estradiol acetate,FHXBMXJMKMWVRG-SLHNCBLASA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
158057,7bv1,DB00323,-8.3,Tolcapone,MIQPIUSUKVNLNT-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
29519,6cs2,DB09286,-8.3,Pipamperone,AXKPFOAXAHJUAG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
62734,6crv,DB14038,-8.3,beta-Sitosterol,KZJWDPNRJALLNS-VJSFXXLFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30343,6cs2,DB12364,-8.3,Betrixaban,XHOLNRLADUSQLD-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
166432,7bv1,DB15121,-8.3,AT-001,YRGPAXAVTDMKDK-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60651,6crv,DB08932,-8.3,Macitentan,JGCMEBMXRHSZKX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61147,6crv,DB11658,-8.3,QAV-680,YOPFAMROKXHVCQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60648,6crv,DB08927,-8.3,Amperozide,NNAIYOXJNVGUOM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60277,6crv,DB08457,-8.3,"4-(3,5-DIMETHYLPHENOXY)-5-(FURAN-2-YLMETHYLSULFANYLMETHYL)-3-IODO-6-METHYLPYRIDIN-2(1H)-ONE",YZLKVEDFWLGNQP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62659,6crv,DB13872,-8.3,Lormetazepam,FJIKWRGCXUCUIG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
158632,7bv1,DB01721,-8.3,Analogue of Indinavir Drug,MJIRDPUZGGHJMX-OIVSQUILSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60627,6crv,DB08892,-8.3,Arbaclofen Placarbil,JXTAALBWJQJLGN-KSSFIOAISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
155234,6wiq,DB08815,-8.3,Lurasidone,PQXKDMSYBGKCJA-CVTJIBDQSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
31659,6cs2,DB14217,-8.3,Quinaprilat,FLSLEGPOVLMJMN-YSSFQJQWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
30428,6cs2,DB12468,-8.3,Pf-04531083,ZRJGMDIPCQOGNI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
62678,6crv,DB13937,-8.3,LGD-3303,OMXGOGXEWUCLFI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75674,6m2n,DB05316,-8.3,Pimavanserin,RKEWSXXUOLRFBX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
24187,6cs2,DB01871,-8.3,[1-(1-Benzyl-3-Hydroxy-2-Oxo-Propylcarbamoyl)-2-Phenyl-Ethyl]-Carbamic Acid Benzyl Ester,OACUXIVGLLCILS-ZEQRLZLVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
61179,6crv,DB11702,-8.3,Antineoplaston A10,OQGRFQCUGLKSAV-JTQLQIEISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60323,6crv,DB08510,-8.3,5-ALPHA-PREGNANE-3-BETA-OL-HEMISUCCINATE,UVTGFMKBPVLATL-DSOJQRAMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29518,6cs2,DB09285,-8.3,Morniflumate,LDXSPUSKBDTEKA-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
62383,6crv,DB13502,-8.3,Budipine,QIHLUZAFSSMXHQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
139395,6w9c,DB13411,-8.3,Lofepramine,SAPNXPWPAUFAJU-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
75505,6m2n,DB04794,-8.3,Bifonazole,OCAPBUJLXMYKEJ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61831,6crv,DB12663,-8.3,Letrazuril,XQKYUBTUOHHNDV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61980,6crv,DB12900,-8.3,Irdabisant,XUKROCVZGZNGSI-CQSZACIVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
157979,6wiq,DB15416,-8.3,PX-102,XBUXXJUEBFDQHD-NHCUHLMSSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
60317,6crv,DB08502,-8.3,Capravirine,YQXCVAGCMNFUMQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62309,6crv,DB13403,-8.3,Oxypertine,XCWPUUGSGHNIDZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
24184,6cs2,DB01865,-8.3,3-(6-Aminopyridin-3-Yl)-N-Methyl-N-[(1-Methyl-1h-Indol-2-Yl)Methyl]Acrylamide,AKFPMLBVLWZSQX-CSKARUKUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
62369,6crv,DB13484,-8.3,Quinbolone,IUVKMZGDUIUOCP-BTNSXGMBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
158620,7bv1,DB01705,-8.3,Bis(5-Amidino-Benzimidazolyl)Methane,QZKOOEFIMWKZPK-UHFFFAOYSA-Q,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
157929,6wiq,DB14916,-8.3,Selonsertib,YIDDLAAKOYYGJG-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
76074,6m2n,DB06745,-8.3,ginkgolide-C,AMOGMTLMADGEOQ-DTDWCABLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
146203,6w9q,DB08240,-8.3,N-(4-CHLOROPHENYL)-3-(PHOSPHONOOXY)NAPHTHALENE-2-CARBOXAMIDE,RQAQWBFHPMSXKR-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
31565,6cs2,DB14034,-8.3,Darglitazone,QQKNSPHAFATFNQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
61847,6crv,DB12686,-8.3,PHA-793887,HUXYBQXJVXOMKX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75682,6m2n,DB05395,-8.3,Amibegron,RDJQCOBTKKAQAH-FPOVZHCZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
30381,6cs2,DB12410,-8.3,Sabarubicin,VQHRZZISQVWPLK-UIRGBLDSSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
61820,6crv,DB12647,-8.3,Tocotrienol,GJJVAFUKOBZPCB-ZGRPYONQSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
147955,6w9q,DB12706,-8.3,Seletalisib,LNLJHGXOFYUARS-OAQYLSRUSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
30415,6cs2,DB12448,-8.3,Lifibrol,LNXBEIZREVRNTF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
62687,6crv,DB13948,-8.3,"N-(2-hydroxybenzyl)-2,5-dimethoxy-4-cyanophenylethylamine",VWEDZTZAXHMZIL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
155241,6wiq,DB08827,-8.3,Lomitapide,MBBCVAKAJPKAKM-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
30424,6cs2,DB12464,-8.3,Bevenopran,ZGCYVRNZWGUXNQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
165897,7bv1,DB13212,-8.3,Phenolsulfonphthalein,BELBBZDIHDAJOR-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
30594,6cs2,DB12706,-8.3,Seletalisib,LNLJHGXOFYUARS-OAQYLSRUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
75449,6m2n,DB04715,-8.3,IMIDAZOPYRIDAZIN 1,IVUBNTNWKIPCPS-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
158752,7bv1,DB02170,-8.3,"1,8-Di-Hydroxy-4-Nitro-Xanthen-9-One",ZOHCDJRFYXKEQW-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
62631,6crv,DB13836,-8.3,Metampicillin,FZECHKJQHUVANE-MCYUEQNJSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29254,6cs2,DB08934,-8.3,Sofosbuvir,TTZHDVOVKQGIBA-IQWMDFIBSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
29179,6cs2,DB08822,-8.3,Azilsartan medoxomil,QJFSABGVXDWMIW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
157405,6wiq,DB15343,-8.3,HM-43239,FZLSDZZNPXXBBB-KDURUIRLSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
25507,6cs2,DB03449,-8.3,N-(4-(2-((3-Chlorophenylmethyl)Amino)Ethyl)Phenyl)-2-Thiophecarboxamidine,ZZVGLDBDD1AB-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
62037,6crv,DB12986,-8.3,VS-5584,QYBGBLQCOOISAR-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60163,6crv,DB08315,-8.3,"2-AMINO-N,N-BIS(PHENYLMETHYL)-1,3-OXAZOLE-5-CARBOXAMIDE",KIJXWOGFYAWTNC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30676,6cs2,DB12823,-8.3,Tecarfarin,QFLNTQDOVCLQKW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
25331,6cs2,DB03234,-8.3,"(4'-{[Allyl(Methyl)Amino]Methyl}-1,1'-Biphenyl-4-Yl)(4-Bromophenyl)Methanone",YATCZCSDJCQNAL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
24823,6cs2,DB00342,-8.3,Terfenadine,GUGOEEXESWIERI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
147767,6w9q,DB12414,-8.3,Usistapide,WSYALRNYQFNNGP-WJOKGBTCSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
166524,7bv1,DB15297,-8.3,Petesicatib,KXAAIORSMACJSI-AEFFLSMTSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60727,6crv,DB09020,-8.3,Bisacodyl,KHOITXIGCFIULA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62445,6crv,DB13588,-8.3,Naftidrofuryl,KBAFPSLPKGSANY-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30287,6cs2,DB12290,-8.3,Puerarin,HKEAFJYKMMKDOR-VPRICQMDSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
149248,6w9q,DB15232,-8.3,Telaglenastat,PRAAPINBUWJLGA-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
24230,6cs2,DB01933,-8.3,7-Hydroxystaurosporine,PBCZSGKMGDDXIJ-HQCWYSJUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
61094,6crv,DB11520,-8.3,Hygromycin B,GRRNUXAQVGOGFE-HUCHGKBZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
147715,6w9q,DB12339,-8.3,Radezolid,BTTNOGHPGJANSW-IBGZPJMESA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
147403,6w9q,DB11891,-8.3,CUDC-907,JOWXJLIFIIOYMS-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
152122,6wiq,DB03642,-8.3,Benzofuran-2-Carboxylic Acid {(S)-3-Methyl-1-[3-Oxo-1-(Pyridin-2-Ylsulfonyl)Azepan-4-Ylcarbamoyl]Butyl}Amide,VBPPNJCVXGAZDD-PMACEKPBSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
25695,6cs2,DB03695,-8.3,Piritrexim,VJXSSYDSOJBUAV-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
149145,6w9q,DB15034,-8.3,PRI-724,VHOZWHQPEJGPCC-AZXNYEMZSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
166510,7bv1,DB15275,-8.3,GDC-0077,SGEUNORSOZVTOL-CABZTGNLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
145975,6w9q,DB07978,-8.3,"2-({[2,3,5,6-TETRAFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)CYCLOPENTA-1,3-DIENE-1-CARBOXYLIC ACID",ULMUPVXFUDHRGH-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
62861,6crv,DB14631,-8.3,Prednisolone phosphate,JDOZJEUDSLGTLU-VWUMJDOOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62227,6crv,DB13300,-8.3,Epicillin,RPBAFSBGYDKNRG-NJBDSQKTSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60899,6crv,DB09299,-8.3,Tenofovir alafenamide,LDEKQSIMHVQZJK-CAQYMETFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
24816,6cs2,DB02616,-8.3,FR117016,CKJGKHXCUDWFDC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
166452,7bv1,DB15157,-8.3,Voruciclib,MRPGRAKIAJJGMM-OCCSQVGLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
139142,6w9c,DB12921,-8.3,Chlorsulfaquinoxaline,CTSNHMQGVWXIEG-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
29172,6cs2,DB08810,-8.3,Cinitapride,ZDLBNXXKDMLZMF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
159020,7bv1,DB03041,-8.3,UDP-alpha-D-glucuronic acid,HDYANYHVCAPMJV-LXQIFKJMSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60155,6crv,DB08306,-8.3,3-[(3-Nitrophenyl)sulfamoyl]-2-thiophenecarboxylic acid,CITCNTPVKZFUAJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
147387,6w9q,DB11867,-8.3,JNJ-39393406,IURMHZBQEYNQOH-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
60739,6crv,DB09048,-8.3,Netupitant,WAXQNWCZJDTGBU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76001,6m2n,DB06620,-8.3,Aplindore,DYJIKHYBKVODAC-ZDUSSCGKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61894,6crv,DB12758,-8.3,Atreleuton,MMSNEKOTSJRTRI-LLVKDONJSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
146053,6w9q,DB08068,-8.3,N-[4-CHLORO-3-(PYRIDIN-3-YLOXYMETHYL)-PHENYL]-3-FLUORO-,YQJVDUKATDECHF-ICSRJNTNSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
61482,6crv,DB12148,-8.3,Menatetrenone,DKHGMERMDICWDU-GHDNBGIDSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61476,6crv,DB12138,-8.3,PF-03715455,VGEXRDWWPSGZDH-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62751,6crv,DB14071,-8.3,Desmethylsertraline,SRPXSILJHWNFMK-ZBEGNZNMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30936,6cs2,DB13215,-8.3,Sulfobromophthalein,OHTXTCNTQJFRIG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
60233,6crv,DB08401,-8.3,(2E)-2-({(2S)-2-CARBOXY-2-[(PHENOXYACETYL)AMINO]ETHOXY}IMINO)PENTANEDIOIC ACID,LDNKNKRRFZRLIG-HWQJWEFDSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
157474,6wiq,DB06589,-8.3,Pazopanib,CUIHSIWYWATEQL-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
62297,6crv,DB13384,-8.3,Melitracen,GWWLWDURRGNSRS-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
157589,6wiq,DB12154,-8.3,Itacitinib,KTBSXLIQKWEBRB-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
75878,6m2n,DB06280,-8.3,Senicapoc,SCTZUZTYRMOMKT-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76107,6m2n,DB06816,-8.3,Pyrvinium,QMHSXPLYMTVAMK-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
30327,6cs2,DB12339,-8.3,Radezolid,BTTNOGHPGJANSW-IBGZPJMESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
61769,6crv,DB12563,-8.3,MK-0686,WZZIQHIQMWJNLU-LLVKDONJSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
25150,6cs2,DB00378,-8.3,Dydrogesterone,JGMOKGBVKVMRFX-HQZYFCCVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
60235,6crv,DB08403,-8.3,METHYLAMINO-PHENYLALANYL-LEUCYL-HYDROXAMIC ACID,MOPRTFSMCQNUCT-CABCVRRESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75918,6m2n,DB06412,-8.3,Oxymetholone,ICMWWNHDUZJFDW-DHODBPELSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
147439,6w9q,DB11942,-8.3,Selinexor,DEVSOMFAQLZNKR-RJRFIUFISA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
147421,6w9q,DB11913,-8.3,LY-2090314,HRJWTAWVFDCTGO-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
30318,6cs2,DB12325,-8.3,Idasanutlin,TVTXCJFHQKSQQM-LJQIRTBHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
60366,6crv,DB08559,-8.3,"N-[(2S,4S,6R)-2-(dihydroxymethyl)-4-hydroxy-3,3-dimethyl-7-oxo-4lambda-4-thia-1-azabicyclo[3.2.0]hept-6-yl]-2-phenylacetamide",WMPGEOZLAYOFHH-MBNYWOFBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29477,6cs2,DB09230,-8.3,Azelnidipine,ZKFQEACEUNWPMT-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
75561,6m2n,DB04863,-8.3,Lefradafiban,PGCFXITVMNNKON-ROUUACIJSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61526,6crv,DB12220,-8.3,ORG-25935,UEBBYLJZCHTLEG-UTKZUKDTSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60723,6crv,DB09016,-8.3,Butriptyline,ALELTFCQZDXAMQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30893,6cs2,DB13119,-8.3,GSK-364735,QWLNINWUBHHOLU-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
61763,6crv,DB12554,-8.3,Mebeverine,VYVKHNNGDFVQGA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
147584,6w9q,DB12154,-8.3,Itacitinib,KTBSXLIQKWEBRB-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
158433,7bv1,DB01180,-8.3,Rescinnamine,SZLZWPPUNLXJEA-LAFLMMDJSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
61515,6crv,DB12203,-8.3,Tozadenant,XNBRWUQWSKXMPW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60203,6crv,DB08365,-8.3,"8-bromo-4-(2-chlorophenyl)-N-(2-hydroxyethyl)-6-methyl-1,3-dioxo-1,2,3,6-tetrahydropyrrolo[3,4-e]indole-7-carboxamide",XUAHLMVOYLUYSB-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
149276,6w9q,DB15291,-8.3,BMS-986142,ZRYMMWAJAFUANM-INIZCTEOSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
60207,6crv,DB08369,-8.3,1-(biphenyl-4-ylmethyl)-1H-imidazole,DLYMRVCQTVOYEW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31778,6cs2,DB14729,-8.3,Rebeccamycin,QEHOIJJIZXRMAN-QZQSLCQPSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
61207,6crv,DB11748,-8.3,Benfotiamine,BTNNPSLJPBRMLZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
147832,6w9q,DB12511,-8.3,Imiglitazar,ULVDFHLHKNJICZ-QCWLDUFUSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
62283,6crv,DB13364,-8.3,Feprazone,RBBWCVQDXDFISW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31465,6cs2,DB13846,-8.3,Pyrrobutamine,WDYYVNNRTDZKAZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
27837,6cs2,DB07395,-8.3,"4-[3-(2-Chloro-4,5-difluoro-benzoyl)ureido]-3-trifluoromethoxybenzoic acid",NWQGDIBCFLDHDO-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
59984,6crv,DB08100,-8.3,"2,6-dimethyl-4-[(E)-2-phenylethenyl]phenol",PAHKYLUYTGBFNW-CMDGGOBGSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55232,6crv,DB00768,-8.3,Olopatadine,JBIMVDZLSHOPLA-LSCVHKIXSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
68943,6lxt,DB08519,-8.3,"N-4-(3-methyl-1H-indazol-6-yl)-N-2-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine",SQQAPOSROFWHIB-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
164690,7bv1,DB08490,-8.3,CTS-1027,ROSNVSQTEGHUKU-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
55238,6crv,DB00775,-8.3,Tirofiban,COKMIXFXJJXBQG-NRFANRHFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55243,6crv,DB00782,-8.3,Propantheline,VVWYOYDLCMFIEM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140725,6w9c,DB15192,-8.3,ABT-288,GNIRITULTPTAQW-KNQAVFIVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
164689,7bv1,DB08489,-8.3,"N4-HYDROXY-2-ISOBUTYL-N1-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.013,18]NONADECA-12(19),13,15,17-TETRAEN-10-YL)-SUCCINAMIDE",GCBPAPVOMPJQHK-NQIIRXRSSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
162013,7bv1,DB01082,-8.3,Streptomycin,UCSJYZPVAKXKNQ-HZYVHMACSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
55257,6crv,DB00800,-8.3,Fenoldopam,TVURRHSHRRELCG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
69091,6lxt,DB08701,-8.3,"2-(3-BROMOPHENYL)-6-[(2-HYDROXYETHYL)AMINO]-1H-BENZO[DE]ISOQUINOLINE-1,3(2H)-DIONE",JZCUVYNOSDWORZ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
72332,6m2n,DB00621,-8.3,Oxandrolone,QSLJIVKCVHQPLV-PEMPUTJUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
58152,6crv,DB04616,-8.3,TACRINE(8)-4-AMINOQUINOLINE,UNVOAAWEEGAXTN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
162030,7bv1,DB01100,-8.3,Pimozide,YVUQSNJEYSNKRX-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
58140,6crv,DB04601,-8.3,"4-[(4-O-SULFAMOYLBENZYL)(4-CYANOPHENYL)AMINO]-4H-[1,2,4]-TRIAZOLE",WEXGHQDVDVWOIU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
69132,6lxt,DB08743,-8.3,"2-({8-[(3R)-3-AMINOPIPERIDIN-1-YL]-1,3-DIMETHYL-2,6-DIOXO-1,2,3,6-TETRAHYDRO-7H-PURIN-7-YL}METHYL)BENZONITRILE",XJNKUWDMCBZMTG-OAHLLOKOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
69134,6lxt,DB08745,-8.3,4-[[(1E)-2-(4-CHLOROPHENYL)ETHENYL]SULFONYL]-1-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]PIPERAZINONE,QLHUDNKWOSQSMK-CXUHLZMHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
69207,6lxt,DB08833,-8.3,Taurochenodeoxycholic acid,BHTRKEVKTKCXOH-BJLOMENOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
68915,6lxt,DB08487,-8.3,3-({4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-2-OXOPIPERAZIN-1-YL}METHYL)BENZENECARBOXIMIDAMIDE,PRMSFVUWLBPPLY-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
72288,6m2n,DB00568,-8.3,Cinnarizine,DERZBLKQOCDDDZ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
58198,6crv,DB04678,-8.3,H TYPE II TRISACCHARIDE,PHTAQVMXYWFMHF-QVPNGJTFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
161944,7bv1,DB01003,-8.3,Cromoglicic acid,IMZMKUWMOSJXDT-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
161552,7bv1,DB15062,-8.3,Inarigivir,LYMICVBGNUEHGE-FUQPUAIBSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
58323,6crv,DB04843,-8.3,Mepenzolate,GKNPSSNBBWDAGH-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
68589,6lxt,DB08092,-8.3,3-fluoro-N-1H-indol-5-yl-5-morpholin-4-ylbenzamide,VMLSXFMXUNVCSK-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
58301,6crv,DB04820,-8.3,Nialamide,NOIIUHRQUVNIDD-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
68619,6lxt,DB08123,-8.3,"N-METHYL-{4-[2-(7-OXO-6,7-DIHYDRO-8H-[1,3]THIAZOLO[5,4-E]INDOL-8-YLIDENE)HYDRAZINO]PHENYL}METHANESULFONAMIDE",GEWPSTLKJDIUHW-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
161781,7bv1,DB00590,-8.3,Doxazosin,RUZYUOTYCVRMRZ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
164708,7bv1,DB08510,-8.3,5-ALPHA-PREGNANE-3-BETA-OL-HEMISUCCINATE,UVTGFMKBPVLATL-DSOJQRAMSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
164704,7bv1,DB08504,-8.3,"6-(4-{(1S,2S)-2-AMINO-1-[(DIMETHYLAMINO)CARBONYL]-3-[(3S)-3-FLUOROPYRROLIDIN-1-YL]-3-OXOPROPYL}PHENYL)-1H-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-4-IUM",ZNHVIJAGMFQGMS-IHPCNDPISA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
68766,6lxt,DB08304,-8.3,"(3R)-3-cyclopentyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2-benzothiazine 1,1-dioxide",QZBQVXXESPXFPZ-QGZVFWFLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
58253,6crv,DB04757,-8.3,"GUANOSINE-2',3'-O-METHYLIDENEPHOSPHONATE",GKAPYWCOOQBBHV-KXSYMAMXSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58251,6crv,DB04754,-8.3,"GUANOSINE-2',3'-O-ETHYLIDENEPHOSPHONATE",HYAPEMYRVFIHDJ-QWEIRQIHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
68816,6lxt,DB08365,-8.3,"8-bromo-4-(2-chlorophenyl)-N-(2-hydroxyethyl)-6-methyl-1,3-dioxo-1,2,3,6-tetrahydropyrrolo[3,4-e]indole-7-carboxamide",XUAHLMVOYLUYSB-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
164700,7bv1,DB08500,-8.3,"(3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(2-naphthyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol",ZCJBDRSKHARECB-PYTCMNEWSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
161917,7bv1,DB00972,-8.3,Azelastine,MBUVEWMHONZEQD-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
28294,6cs2,DB07875,-8.3,"5-Chloro-thiophene-2-carboxylic acid ((3S,4S)-1-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-methyl}-4-hydroxy-pyrrolidin-3-yl)-amide",ARAVOODWJJJNBY-IRXDYDNUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
30032,6cs2,DB11960,-8.3,Carboxyamidotriazole,WNRZHQBJSXRYJK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
68862,6lxt,DB08423,-8.3,[5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL][3-(PIPERIDIN-4-YLOXY)PHENYL]METHANONE,QKZZJXRGCHXIAI-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
161956,7bv1,DB01016,-8.3,Glyburide,ZNNLBTZKUZBEKO-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
161548,7bv1,DB15056,-8.3,Bifenthrin,OMFRMAHOUUJSGP-IRHGGOMRSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
162044,7bv1,DB01349,-8.3,Tasosartan,ADXGNEYLLLSOAR-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
69254,6lxt,DB08912,-8.3,Dabrafenib,BFSMGDJOXZAERB-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
27131,6cs2,DB06532,-8.3,Pafuramidine,UKOQVLAXCBRRGH-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
55389,6crv,DB00947,-8.3,Fulvestrant,VWUXBMIQPBEWFH-WCCTWKNTSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
69470,6lxt,DB09233,-8.3,Cronidipine,CNIJVNPIIHWRRP-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
69472,6lxt,DB09235,-8.3,Efonidipine,NSVFSAJIGAJDMR-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
55403,6crv,DB00963,-8.3,Bromfenac,ZBPLOVFIXSTCRZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27163,6cs2,DB06609,-8.3,Odiparcil,JRHNIQQUVJOPQC-AQNFWKISSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
69520,6lxt,DB09330,-8.3,Osimertinib,DUYJMQONPNNFPI-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
55414,6crv,DB00978,-8.3,Lomefloxacin,ZEKZLJVOYLTDKK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
69584,6lxt,DB11184,-8.3,Oftasceine,DEGAKNSWVGKMLS-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
72163,6m2n,DB00414,-8.3,Acetohexamide,VGZSUPCWNCWDAN-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
27187,6cs2,DB00605,-8.3,Sulindac,MLKXDPUZXIRXEP-MFOYZWKCSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
27191,6cs2,DB06660,-8.3,Saredutant,PGKXDIMONUAMFR-AREMUKBSSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
162484,7bv1,DB02331,-8.3,"(2s)-2-[(5-Benzofuran-2-Yl-Thiophen-2-Ylmethyl)-(2,4-Dichloro-Benzoyl)-Amino]-3-Phenyl-Propionic Acid",YBULOUKTPCHXAL-DEOSSOPVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
69671,6lxt,DB11442,-8.3,Oleandomycin,RZPAKFUAFGMUPI-QESOVKLGSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
162504,7bv1,DB02358,-8.3,LY374571,SZHRIPFGZWWRKW-VIFPVBQESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
55445,6crv,DB01012,-8.3,Cinacalcet,VDHAWDNDOKGFTD-MRXNPFEDSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
69710,6lxt,DB11526,-8.3,Masitinib,WJEOLQLKVOPQFV-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
57873,6crv,DB04239,-8.3,2-Amino-6-Aminomethyl-8-Phenylsulfanylmethyl-3h-Quinazolin-4-One,CBFXRTSHUMEYKQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58048,6crv,DB04482,-8.3,Cmp-2-Keto-3-Deoxy-Octulosonic Acid,YWWJKULNWGRYAS-UOVSKDHASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57874,6crv,DB04240,-8.3,"(1S)-1-C-{(2R)-6-[(2R)-2-Butanyl]-5,10-dihydroxy-4-oxo-1,2,3,4-tetrahydro-2-anthracenyl}-5-deoxy-1-O-methyl-D-xylulose",XGORHSPGULYMCV-HHYQQTLHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
69396,6lxt,DB09124,-8.3,Medrogestone,HCFSGRMEEXUOSS-JXEXPEPMSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
27068,6cs2,DB06395,-8.3,Abafungin,TYBHXIFFPVFXQW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
162069,7bv1,DB01406,-8.3,Danazol,POZRVZJJTULAOH-LHZXLZLDSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
27074,6cs2,DB06409,-8.3,Morphine glucuronide,GNJCUHZOSOYIEC-GAROZEBRSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
55326,6crv,DB00876,-8.3,Eprosartan,OROAFUQRIXKEMV-LDADJPATSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
164557,7bv1,DB08141,-8.3,"4-{[(2,6-difluorophenyl)carbonyl]amino}-N-[(3S)-piperidin-3-yl]-1H-pyrazole-3-carboxamide",KOMNQBZWMCFDTQ-VIFPVBQESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
55335,6crv,DB00886,-8.3,Omapatrilat,LVRLSYPNFFBYCZ-VGWMRTNUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55338,6crv,DB00890,-8.3,Dienestrol,NFDFQCUYFHCNBW-SCGPFSFSSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
164544,7bv1,DB08126,-8.3,"3-{[4-([AMINO(IMINO)METHYL]AMINOSULFONYL)ANILINO]METHYLENE}-2-OXO-2,3-DIHYDRO-1H-INDOLE",DMCRNUMVSATRTP-LCYFTJDESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
27100,6cs2,DB06460,-8.3,Enrasentan,GLCKXJLCYIJMRB-UPRLRBBYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
27103,6cs2,DB06469,-8.3,Lestaurtinib,UIARLYUEJFELEN-DMVVYWCZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
162236,7bv1,DB01782,-8.3,"2,6-Dihydroanthra/1,9-Cd/Pyrazol-6-One",ACPOUJIDANTYHO-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
55356,6crv,DB00910,-8.3,Paricalcitol,BPKAHTKRCLCHEA-UBFJEZKGSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28212,6cs2,DB07793,-8.3,"(2S)-N-[(3S)-1-(2-AMINO-2-OXOETHYL)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL]-2-CHLORO-2H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE",ACSGSLPOHKRZCY-GXTWGEPZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
69361,6lxt,DB09063,-8.3,Ceritinib,VERWOWGGCGHDQE-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
27118,6cs2,DB06506,-8.3,Repinotan,YGYBFMRFXNDIPO-QGZVFWFLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
69369,6lxt,DB09075,-8.3,Edoxaban,HGVDHZBSSITLCT-JLJPHGGASA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
69384,6lxt,DB09095,-8.3,Difluocortolone,OGPWIDANBSLJPC-RFPWEZLHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
55377,6crv,DB00933,-8.3,Mesoridazine,SLVMESMUVMCQIY-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
161544,7bv1,DB15048,-8.3,Licogliflozin,XFJAMQQAAMJFGB-ZQGJOIPISA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
68504,6lxt,DB07994,-8.3,"N-3-[5-(1H-INDOL-6-YL)-2-(PYRIDIN-2-YLMETHOXY)BENZYL]PYRIDINE-2,3-DIAMINE",KMBPJSHPAXOXBT-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
161535,7bv1,DB15033,-8.3,Flortaucipir,GETAAWDSFUCLBS-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
67879,6lxt,DB07267,-8.3,2-(6-methylpyridin-2-yl)-N-pyridin-4-ylquinazolin-4-amine,JONFDFIXMPXTRH-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
58522,6crv,DB05706,-8.3,13-deoxydoxorubicin,RGVRUQHYQSORBY-JIGXQNLBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
67965,6lxt,DB07359,-8.3,"3-[(4-fluorophenyl)sulfanyl]-N-(4-methyl-1,3-thiazol-2-yl)-6-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]pyridine-2-carboxamide",SJTQKYKXCYVFHX-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
67972,6lxt,DB07369,-8.3,"N-(3-chlorophenyl)-N-methyl-2-oxo-3-[(3,4,5-trimethyl-1H-pyrrol-2-yl)methyl]-2H-indole-5-sulfonamide",YMJLSOJLEXWATP-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
67982,6lxt,DB07382,-8.3,"N-2-1H-benzimidazol-5-yl-N-4-(3-cyclopropyl-1H-pyrazol-5-yl)pyrimidine-2,4-diamine",WJNBSTLIALIIEW-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
72706,6m2n,DB01058,-8.3,Praziquantel,FSVJFNAIGNNGKK-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
161429,7bv1,DB14029,-8.3,Furafylline,HMZQULPVMKITSP-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
58513,6crv,DB05653,-8.3,IRX-5183,PNAWUIKCVQSLFG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28424,6cs2,DB08012,-8.3,(METHYLPYRIDAZINE PIPERIDINE ETHYLOXYPHENYL)ETHYLACETATE,KCHIOGFOPPOUJC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
54995,6crv,DB00479,-8.3,Amikacin,LKCWBDHBTVXHDL-RMDFUYIESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
54996,6crv,DB00480,-8.3,Lenalidomide,GOTYRUGSSMKFNF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
161435,7bv1,DB14037,-8.3,Madecassic acid,PRAUVHZJPXOEIF-AOLYGAPISA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
68017,6lxt,DB07423,-8.3,(2S)-3-[4-(acetylamino)phenoxy]-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide,YVXVTLGIDOACBJ-SFHVURJKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
72648,6m2n,DB00991,-8.3,Oxaprozin,OFPXSFXSNFPTHF-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
164934,7bv1,DB08980,-8.3,Fendiline,NMKSAYKQLCHXDK-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
161449,7bv1,DB14066,-8.3,Tetrandrine,WVTKBKWTSCPRNU-KYJUHHDHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
72642,6m2n,DB00984,-8.3,Nandrolone phenpropionate,UBWXUGDQUBIEIZ-QNTYDACNSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
58553,6crv,DB05932,-8.3,Denibulin,GAOHLWCIAJNSEE-JTQLQIEISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55007,6crv,DB00493,-8.3,Cefotaxime,GPRBEKHLDVQUJE-QSWIMTSFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
161394,7bv1,DB13954,-8.3,Estradiol cypionate,UOACKFBJUYNSLK-XRKIENNPSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
67845,6lxt,DB07227,-8.3,4-[(5-{[4-(3-CHLOROPHENYL)-3-OXOPIPERAZIN-1-YL]METHYL}-1H-IMIDAZOL-1-YL)METHYL]BENZONITRILE,JNUGFGAVPBYSHF-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
165028,7bv1,DB09124,-8.3,Medrogestone,HCFSGRMEEXUOSS-JXEXPEPMSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
161288,7bv1,DB13506,-8.3,Carfecillin,NZDASSHFKWDBBU-KVMCETHSSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
26716,6cs2,DB04915,-8.3,Idronoxil,ZZUBHVMHNVYXRR-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
58601,6crv,DB06174,-8.3,Noscapine,AKNNEGZIBPJZJG-MSOLQXFVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
67709,6lxt,DB07067,-8.3,"(2S,3S)-3-{3-[4-(METHYLSULFONYL)PHENYL]-1,2,4-OXADIAZOL-5-YL}-1-OXO-1-PYRROLIDIN-1-YLBUTAN-2-AMINE",SQCDMTZMCHZYGO-FZMZJTMJSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
67715,6lxt,DB07076,-8.3,6-[(Z)-AMINO(IMINO)METHYL]-N-[3-(CYCLOPENTYLOXY)PHENYL]-2-NAPHTHAMIDE,FWTQOPWAMQXIMI-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
28462,6cs2,DB08051,-8.3,"(2R)-4-(2-BENZOYL-1,2-DIAZEPAN-1-YL)-4-OXO-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE",XXRHRPGYYNOBHO-QGZVFWFLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
58590,6crv,DB06152,-8.3,Nylidrin,PTGXAUBQBSGPKF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
67769,6lxt,DB07138,-8.3,Neflamapimod,VEPKQEUBKLEPRA-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
54942,6crv,DB00415,-8.3,Ampicillin,AVKUERGKIZMTKX-NJBDSQKTSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28448,6cs2,DB08035,-8.3,"1-TERT-BUTYL-3-(2,5-DIMETHYLBENZYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE",QUPXEJURIFFVSX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
161313,7bv1,DB13542,-8.3,Bevonium,UHUMRJKDOOEQIG-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
26733,6cs2,DB04957,-8.3,Azimilide,MREBEPTUUMTTIA-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
161378,7bv1,DB13934,-8.3,Ligandrol,OPSIVAKKLQRWKC-VXGBXAGGSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
164987,7bv1,DB09054,-8.3,Idelalisib,IFSDAJWBUCMOAH-HNNXBMFYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
161388,7bv1,DB13947,-8.3,Testosterone enantate benzilic acid hydrazone,PTVXYACXDYZNID-JKXGKYMWSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
164986,7bv1,DB09053,-8.3,Ibrutinib,XYFPWWZEPKGCCK-GOSISDBHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
58562,6crv,DB05969,-8.3,SNS-032,OUSFTKFNBAZUKL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
26795,6cs2,DB05263,-8.3,Caprospinol,VMOZFSWFUBLCNN-AAPULDEBSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
68047,6lxt,DB07457,-8.3,"3-[1-(3-AMINOPROPYL)-1H-INDOL-3-YL]-4-(1H-INDOL-3-YL)-1H-PYRROLE-2,5-DIONE",APYXQTXFRIDSGE-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
161455,7bv1,DB14841,-8.3,Centanafadine,HKHCSWPSUSWGLI-CABCVRRESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
55074,6crv,DB00579,-8.3,Mazindol,ZPXSCAKFGYXMGA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28359,6cs2,DB07946,-8.3,"N-[2-({[amino(imino)methyl]amino}oxy)ethyl]-2-{6-chloro-3-[(2,2-difluoro-2-phenylethyl)amino]-2-fluorophenyl}acetamide",DZEJHPMTDNDECN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
161507,7bv1,DB14938,-8.3,Flurbiprofen axetil,ALIVXCSEERJYHU-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
68320,6lxt,DB07783,-8.3,1-((1R)-1-(HYDROXYMETHYL)-3-{6-[(3-PHENYLPROPANOYL)AMINO]-1H-INDOL-1-YL}PROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE,GUYYFMCFEPDDFL-OAQYLSRUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
68335,6lxt,DB07800,-8.3,N-(2-(((5-CHLORO-2-PYRIDINYL)AMINO)SULFONYL)PHENYL)-4-(2-OXO-1(2H)-PYRIDINYL)BENZAMIDE,MIJGLXFQYBTIFY-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
68344,6lxt,DB07809,-8.3,4-({[4-(3-METHYLBENZOYL)PYRIDIN-2-YL]AMINO}METHYL)BENZENECARBOXIMIDAMIDE,MBJYEMUMDMGQQC-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
58407,6crv,DB05053,-8.3,MB-07803,CTKZZUXRWBCFEI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55098,6crv,DB00606,-8.3,Cyclothiazide,BOCUKUHCLICSIY-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
68384,6lxt,DB07855,-8.3,(S)-1-PHENYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE,CWHMAWBXRCDOEB-HNNXBMFYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
164729,7bv1,DB08534,-8.3,"5-(2-fluorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",ZAIYYXVHGBMLEC-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
58396,6crv,DB05013,-8.3,Ingenol mebutate,VDJHFHXMUKFKET-UXMMOKKRSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
68403,6lxt,DB07874,-8.3,"(6S)-2-amino-6-(3'-methoxybiphenyl-3-yl)-3,6-dimethyl-5,6-dihydropyrimidin-4(3H)-one",LQOCXPOKEPYGTJ-IBGZPJMESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
68408,6lxt,DB07879,-8.3,"N-hydroxy-5-[(3-phenyl-5,6-dihydroimidazo[1,2-a]pyrazin-7(8H)-yl)carbonyl]thiophene-2-carboxamide",SMSIXMLQOONOQQ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
58392,6crv,DB04982,-8.3,Talampanel,JACAAXNEHGBPOQ-LLVKDONJSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
161525,7bv1,DB15011,-8.3,Avacopan,PUKBOVABABRILL-YZNIXAGQSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
55145,6crv,DB00665,-8.3,Nilutamide,XWXYUMMDTVBTOU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
164717,7bv1,DB08521,-8.3,4-[5-(4-FLUORO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-3H-IMIDAZOL-4-YL]-PYRIDINE,CDMGBJANTYXAIV-HHHXNRCGSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
164837,7bv1,DB08664,-8.3,({3-[1-(4-HYDROXY-2-OXO-2H-CHROMEN-3-YL)-PROPYL]-PHENYLCARBAMOYL}-METHYL)-CARBAMIC ACID TERT-BUTYL ESTER,QUQQVMVIWCUYFV-KRWDZBQOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
72514,6m2n,DB00838,-8.3,Clocortolone,YMTMADLUXIRMGX-RFPWEZLHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
140745,6w9c,DB15227,-8.3,Tirabrutinib,SEJLPXCPMNSRAM-GOSISDBHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
58426,6crv,DB05171,-8.3,E-2012,PUOAETJYKQITMO-LANLRWRYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
161457,7bv1,DB14845,-8.3,Filgotinib,RIJLVEAXPNLDTC-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
161478,7bv1,DB14882,-8.3,CEP-9722,CTLOSZHDGZLOQE-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
55017,6crv,DB00504,-8.3,Levallorphan,OZYUPQUCAUTOBP-QXAKKESOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
68120,6lxt,DB07544,-8.3,N'-(5-CHLOROBENZOFURAN-2-CARBONYL)-2-(TRIFLUOROMETHYL)BENZENESULFONOHYDRAZIDE,ZLQBZYKAQQWOTK-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
55028,6crv,DB00523,-8.3,Alitretinoin,SHGAZHPCJJPHSC-ZVCIMWCZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58462,6crv,DB05412,-8.3,Talmapimod,ZMELOYOKMZBMRB-DLBZAZTESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55034,6crv,DB00530,-8.3,Erlotinib,AAKJLRGGTJKAMG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
68148,6lxt,DB07578,-8.3,"3-[4-(2-METHYL-IMIDAZO[4,5-C]PYRIDIN-1-YL)BENZYL]-3H-BENZOTHIAZOL-2-ONE",WUOLYUKMMRCXGH-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
27202,6cs2,DB06684,-8.3,Vilazodone,SGEGOXDYSFKCPT-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
26821,6cs2,DB05421,-8.3,CP-122721,ZIWFCOIGUNPHPM-HKUYNNGSSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
140151,6w9c,DB15078,-8.3,Rogaratinib,HNLRRJSKGXOYNO-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
68156,6lxt,DB07588,-8.3,"3,4-DI-1H-INDOL-3-YL-1H-PYRROLE-2,5-DICARBOXYLIC ACID",FZDVNXHYGMEEDT-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
26826,6cs2,DB05431,-8.3,MLN-977,YANONWCPCKIWEC-CABCVRRESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
164870,7bv1,DB08708,-8.3,"N-cyclohexyl-3-[3-(trifluoromethyl)phenyl][1,2,4]triazolo[4,3-b]pyridazin-6-amine",XYYDXQCAYXOGQT-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
161494,7bv1,DB14914,-8.3,Flortaucipir F-18,GETAAWDSFUCLBS-SJPDSGJFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
28374,6cs2,DB07963,-8.3,"N-[(2',4'-DIFLUORO-4-HYDROXY-5-IODOBIPHENYL-3-YL)CARBONYL]-BETA-ALANINE",YZQVXOZCPWWABX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
21994,6cs2,HMDB0052656,-8.3,"TG(18:2(9Z,12Z)/20:2n6/22:2(13Z,16Z))",JJVQIAHLUNUXIN-UDMNNMADSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
68241,6lxt,DB07692,-8.3,"1-[(2,6-difluorophenyl)sulfonyl]-4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)piperazine",SHWNKRPMUBFWKE-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
55037,6crv,DB00533,-8.3,Rofecoxib,RZJQGNCSTQAWON-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
162560,7bv1,DB02421,-8.3,Uridine-5'-Diphosphate-Mannose,HSCJRCZFDFQWRP-NYYOCOOHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
27219,6cs2,DB06708,-8.3,Lumefantrine,DYLGFOYVTXJFJP-MYYYXRDXSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
162625,7bv1,DB02505,-8.3,N-(R-Carboxy-Ethyl)-Alpha-(S)-(2-Phenylethyl),JJVQUUYZGJWBPW-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
55728,6crv,DB01415,-8.3,Ceftibuten,UNJFKXSSGBWRBZ-BJCIPQKHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27597,6cs2,DB07146,-8.3,"2,3-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-B]PYRIDIN-4-AMINE",QUIQCYFSBGOBKE-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
164231,7bv1,DB07406,-8.3,"(4R)-N-[4-({[2-(DIMETHYLAMINO)ETHYL]AMINO}CARBONYL)-1,3-THIAZOL-2-YL]-4-METHYL-1-OXO-2,3,4,9-TETRAHYDRO-1H-BETA-CARBOLINE-6-CARBOXAMIDE",QWFFPYQWUWLDBV-NSHDSACASA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
70431,6lxt,DB12644,-8.3,AZD-2066,SXWHYTICXCLKDG-GFCCVEGCSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
163729,7bv1,DB06157,-8.3,Istaroxime,MPYLDWFDPHRTEG-PAAYLBSLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
30052,6cs2,DB11987,-8.3,GSK-2018682,NFIGDBFIDKDNIG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
71658,6lxt,DB15029,-8.3,AZD-8186,LMJFJIDLEAWOQJ-CQSZACIVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
27973,6cs2,DB07539,-8.3,"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZOIC ACID",JLRKRQCTYQGDKJ-GHXNOFRVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
27970,6cs2,DB07536,-8.3,"N-{(1S,2R)-2-hydroxy-1-[(hydroxyamino)carbonyl]propyl}-4-{[4-(morpholin-4-ylmethyl)phenyl]ethynyl}benzamide",FQYBTYFKOHPWQT-VGSWGCGISA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
70498,6lxt,DB12743,-8.3,Z-160,VCPMZDWBEWTGNW-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
27637,6cs2,DB07187,-8.3,6-[(5-CHLORO-3-METHYL-1-BENZOFURAN-2-YL)SULFONYL]PYRIDAZIN-3(2H)-ONE,FXFPQPNUMWQRAO-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
70522,6lxt,DB12784,-8.3,NS-018,UQTPDWDAYHAZNT-AWEZNQCLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
70527,6lxt,DB12794,-8.3,p-Quaterphenyl,GPRIERYVMZVKTC-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
140508,6w9c,DB11984,-8.3,Letaxaban,GEHAEMCVKDPMKO-HXUWFJFHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
30073,6cs2,DB12011,-8.3,Fevipiprant,GFPPXZDRVCSVNR-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
70558,6lxt,DB12848,-8.3,PF-04217903,PDMUGYOXRHVNMO-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
55773,6crv,DB01466,-8.3,Ethylmorphine,OGDVEMNWJVYAJL-LEPYJNQMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
70387,6lxt,DB12571,-8.3,Rimacalib,MYTIJGWONQOOLC-HNNXBMFYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
70564,6lxt,DB12857,-8.3,NVP-LEQ-506,POERAARDVFVDLO-QGZVFWFLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
70349,6lxt,DB12512,-8.3,Verucerfont,VKHVAUKFLBBZFJ-SFHVURJKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
70305,6lxt,DB12443,-8.3,Sonedenoson,WUCQGGOGHZRELS-LSCFUAHRSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
27500,6cs2,DB07045,-8.3,"(2R,3R,4S,5R)-2-[6-amino-8-[(3,4-dichlorophenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol",VBJKVZXRYLCYGQ-XNIJJKJLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
163622,7bv1,DB04867,-8.3,Lintitript,ILNRQFBVVQUOLP-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
71735,6lxt,DB15183,-8.3,Fosmanogepix,JQONJQKKVAHONF-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
140383,6w9c,DB05861,-8.3,Tasquinimod,ONDYALNGTUAJDX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
70224,6lxt,DB12327,-8.3,Salvinorin A,OBSYBRPAKCASQB-AGQYDFLVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
27518,6cs2,DB07061,-8.3,"1-(CYCLOHEXYLAMINO)-3-(6-METHYL-3,4-DIHYDRO-1H-CARBAZOL-9(2H)-YL)PROPAN-2-OL",AXYFCRIRLKSCRR-SFHVURJKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
70239,6lxt,DB12355,-8.3,Netazepide,YDZYKNJZCVIKPP-VWLOTQADSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
71730,6lxt,DB15168,-8.3,Cilofexor,KZSKGLFYQAYZCO-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
71720,6lxt,DB15145,-8.3,Ziresovir,GAAICKUTDBZCMT-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
27525,6cs2,DB07070,-8.3,(2S)-2-{3-[({[2-fluoro-4-(trifluoromethyl)phenyl]carbonyl}amino)methyl]-4-methoxybenzyl}butanoic acid,BDLLIPYDNFENMY-ZDUSSCGKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
140387,6w9c,DB05884,-8.3,HCV-086,VBRUONUESYTIDA-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
71705,6lxt,DB15120,-8.3,GSK-239512,YFRBKEVUUCQYOW-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
71700,6lxt,DB15109,-8.3,Ingenol disoxate,GLIUZQUNUNICGS-XUBYYPQFSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
163677,7bv1,DB05838,-8.3,OPC-51803,INGXCNVWWKKWOO-LJQANCHMSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
70292,6lxt,DB12426,-8.3,Bitopertin,YUUGYIUSCYNSQR-LBPRGKRZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
164266,7bv1,DB07630,-8.3,"N-((1R,2R)-2-(5-CHLORO-1H-INDOLE-2-CARBOXAMIDO)CYCLOHEXYL)-5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE-2-CARBOXAMIDE",ARPFWVKYXJZULB-IAGOWNOFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
140529,6w9c,DB12011,-8.3,Fevipiprant,GFPPXZDRVCSVNR-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
163686,7bv1,DB05913,-8.3,OSI-930,FGTCROZDHDSNIO-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
71635,6lxt,DB14942,-8.3,BMS-986141,KEEBLYWBELVGPQ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
56425,6crv,DB02316,-8.3,"1-(5-Carboxypentyl)-5-[(2,6-Dichlorobenzyl)Oxy]-1 H-Indole-2-Carboxylic Acid",JTGPYFFQVOIJKR-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56334,6crv,DB02195,-8.3,"3-(4-Fluorophenyl)-1-Hydroxy-2-(Pyridin-4-Yl)-1h-Pyrrolo[3,2-B]Pyridine",ZSMYZLKEZDYVPI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56150,6crv,DB01950,-8.3,"N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thiazol-2-Yl)Urea",YAEMHJKFIIIULI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55928,6crv,DB01645,-8.3,Genistein,TZBJGXHYKVUXJN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
70994,6lxt,DB13499,-8.3,Cefsulodin,SYLKGLMBLAAGSC-QLVMHMETSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
140460,6w9c,DB06870,-8.3,"17-HYDROXY-18A-HOMO-19-NOR-17ALPHA-PREGNA-4,9,11-TRIEN-3-ONE",OXHNQTSIKGHVBH-ANULTFPQSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140456,6w9c,DB06865,-8.3,6-CARBAMIMIDOYL-2-[2-HYDROXY-6-(4-HYDROXY-PHENYL)-INDAN-1-YL]-HEXANOIC ACID,ZSRRBAKATXAISL-LMNJBCLMSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
27796,6cs2,DB07350,-8.3,(2E)-N-hydroxy-3-[1-methyl-4-(phenylacetyl)-1H-pyrrol-2-yl]prop-2-enamide,UFQOXIMRSMFQRI-BQYQJAHWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
71114,6lxt,DB13664,-8.3,Formocortal,QNXUUBBKHBYRFW-QWAPGEGQSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
71166,6lxt,DB13728,-8.3,Halometasone,GGXMRPUKBWXVHE-MIHLVHIWSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
71251,6lxt,DB13843,-8.3,Cloprednol,YTJIBEDMAQUYSZ-FDNPDPBUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
71263,6lxt,DB13856,-8.3,Fluclorolone,VTWKPILBIUBMDS-OTJLYDAYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
71494,6lxt,DB14652,-8.3,Clocortolone acetate,ARPLCFGLEYFDCN-CDACMRRYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
71282,6lxt,DB13919,-8.3,Candesartan,HTQMVQVXFRQIKW-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
71467,6lxt,DB14624,-8.3,Nandrolone hydrogen sulfate,SKZMVWBZTQNCKW-IZPLOLCNSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
71295,6lxt,DB13941,-8.3,Piperaquine,UCRHFBCYFMIWHC-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
56051,6crv,DB01812,-8.3,Adenosine-3'-5'-Diphosphate,WHTCPDAXWFLDIH-KQYNXXCUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56038,6crv,DB01793,-8.3,SB-409513,ONVZFCHLOZUXRP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
71304,6lxt,DB13953,-8.3,Estradiol benzoate,UYIFTLBWAOGQBI-BZDYCCQFSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
56153,6crv,DB01953,-8.3,Inhibitor of P38 Kinase,UUEYCHLWAOBOHG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163976,7bv1,DB06922,-8.3,"2-[(1R)-1-carboxy-2-naphthalen-1-ylethyl]-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylic acid",CZNPWASYMRBJCX-GOSISDBHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
56171,6crv,DB01975,-8.3,AMPCPR,ZPZRETFSCSWNDT-DBXCYWGHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27876,6cs2,DB07434,-8.3,HONH-BENZYLMALONYL-L-ALANYLGLYCINE-P-NITROANILIDE,TZWQPWGUQCSKDW-GUYCJALGSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
27696,6cs2,DB07252,-8.3,"3-({4-[(5-chloro-1,3-benzodioxol-4-yl)amino]pyrimidin-2-yl}amino)benzenesulfonamide",TZHCXOMEOHEZDX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
27697,6cs2,DB07253,-8.3,"N'-(5-chloro-1,3-benzodioxol-4-yl)-N-(3-methylsulfonylphenyl)pyrimidine-2,4-diamine",QTFCKBFCXDAZIU-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
70628,6lxt,DB12949,-8.3,PF-03382792,AGMOFKKOVMRGAK-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
163883,7bv1,DB06803,-8.3,Niclosamide,RJMUSRYZPJIFPJ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
164161,7bv1,DB07324,-8.3,"3-({2-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)ETHYNYL]BENZYL}AMINO)-1,3-OXAZOL-2(3H)-ONE",ZUJWSOPIDUWELP-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
56306,6crv,DB02154,-8.3,"2,3-Bis-Benzo[1,3]Dioxol-5-Ylmethyl-Succinic Acid",FFYBYVPVYLMLAR-KBPBESRZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27932,6cs2,DB07496,-8.3,"1,3-DIPHENYLUREA",GWEHVDNNLFDJLR-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
27926,6cs2,DB07489,-8.3,"4-Amino-2-[(3-chlorophenyl)amino]-5-(4-fluorobenzoyl)-1,3-thiazol-3-ium",WWGPTHOMFHDEEC-UHFFFAOYSA-O,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
55689,6crv,DB01338,-8.3,Pipecuronium,OWWLUIWOFHMHOQ-XGHATYIMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55848,6crv,DB01551,-8.3,Dihydrocodeine,RBOXVHNMENFORY-DNJOTXNNSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56266,6crv,DB02101,-8.3,"(S,R)-fidarestat",WAAPEIZFCHNLKK-QPUJVOFHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163934,7bv1,DB06876,-8.3,"N-{5-[4-(4-METHYLPIPERAZIN-1-YL)PHENYL]-1H-PYRROLO[2,3-B]PYRIDIN-3-YL}NICOTINAMIDE",YJWJKKXGAPWLGT-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
29920,6cs2,DB11814,-8.3,PF-03882845,XNULRSOGWPFPBL-REWPJTCUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
55882,6crv,DB01591,-8.3,Solifenacin,FBOUYBDGKBSUES-VXKWHMMOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56209,6crv,DB02029,-8.3,N-Cyclohexyl-N'-(4-Iodophenyl)Urea,AQTBUVAFYDVTFD-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140476,6w9c,DB08775,-8.3,Nalpha-[(Benzyloxy)carbonyl]-N-[(2S)-4-fluoro-3-oxo-2-butanyl]-L-tyrosinamide,RYABQRLJLIHDIP-KSSFIOAISA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
55895,6crv,DB01608,-8.3,Periciazine,LUALIOATIOESLM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55904,6crv,DB01619,-8.3,Phenindamine,ISFHAYSTHMVOJR-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56297,6crv,DB02140,-8.3,N1-(1-Dimethylcarbamoyl-2-Phenyl-Ethyl)-2-Oxo-N4-(2-Pyridin-2-Yl-Ethyl)-Succinamide,ZPFPZRVOBBMZMP-SFHVURJKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72863,6m2n,DB01238,-8.3,Aripiprazole,CEUORZQYGODEFX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
28010,6cs2,DB07578,-8.3,"3-[4-(2-METHYL-IMIDAZO[4,5-C]PYRIDIN-1-YL)BENZYL]-3H-BENZOTHIAZOL-2-ONE",WUOLYUKMMRCXGH-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
70203,6lxt,DB12302,-8.3,CP-724714,LLVZBTWPGQVVLW-SNAWJCMRSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
28120,6cs2,DB00705,-8.3,Delavirdine,WHBIGIKBNXZKFE-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
140272,6w9c,DB02338,-8.3,Nadph Dihydro-Nicotinamide-Adenine-Dinucleotidephosphate,ACFIXJIJDZMPPO-NNYOXOHSSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140277,6w9c,DB02639,-8.3,4-methylumbelliferyl alpha-D-glucoside,YUDPTGPSBJVHCN-JZYAIQKZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140621,6w9c,DB12547,-8.3,LY-2886721,NIDRNVHMMDAAIK-YPMLDQLKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140619,6w9c,DB12543,-8.3,Samidorphan,RYIDHLJADOKWFM-MAODMQOUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
69904,6lxt,DB11870,-8.3,RG-4733,OJPLJFIFUQPSJR-INIZCTEOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
71941,6m2n,DB00153,-8.3,Ergocalciferol,MECHNRXZTMCUDQ-RKHKHRCZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
55531,6crv,DB01112,-8.3,Cefuroxime,JFPVXVDWJQMJEE-IZRZKJBUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
71929,6m2n,DB00140,-8.3,Riboflavin,AUNGANRZJHBGPY-SCRDCRAPSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
71925,6m2n,DB00136,-8.3,Calcitriol,GMRQFYUYWCNGIN-NKMMMXOESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
71893,6lxt,DB04596,-8.3,"4-O-{4,6-O-[(1S)-1-Carboxyethylidene]-β-D-mannopyranosyl}-D-glucopyranuronic acid",GZJXZKGVHLWBOW-AISSFXTFSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
164451,7bv1,DB07845,-8.3,"2-fluoro-6-{[2-({2-methoxy-4-[(methylsulfonyl)methyl]phenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide",VGYXXQRDIVRILX-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
140595,6w9c,DB12507,-8.3,Atecegatran metoxil,XSNMGLZVFNDDPW-ZWKOTPCHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
163040,7bv1,DB03460,-8.3,Violaxanthin,SZCBXWMUOPQSOX-WVJDLNGLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
57286,6crv,DB03451,-8.3,"1-alpha, 25-dihydroxyl-20-epi-22-oxa-24, 26 ,27-trihomovitamin D3",KLZOTDOJMRMLDX-YBBVPDDNSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55549,6crv,DB01132,-8.3,Pioglitazone,HYAFETHFCAUJAY-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
69941,6lxt,DB11921,-8.3,Deflazacort,FBHSPRKOSMHSIF-GRMWVWQJSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
28121,6cs2,DB07698,-8.3,"3-(3-aminophenyl)-N-(3-chlorophenyl)pyrazolo[1,5-a]pyrimidin-5-amine",JDNMRPIWJIDDAY-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
28084,6cs2,DB07662,-8.3,N-[4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL]-ACRYLAMIDE,HTUBKQUPEREOGA-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
69870,6lxt,DB11819,-8.3,ASP-4058,NJNXCJPSMWKXHO-VIFPVBQESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
57454,6crv,DB03696,-8.3,Lanosterol,CAHGCLMLTWQZNJ-BQNIITSRSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72133,6m2n,DB00378,-8.3,Dydrogesterone,JGMOKGBVKVMRFX-HQZYFCCVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
162630,7bv1,DB02510,-8.3,'5'-O-(N-(L-Prolyl)-Sulfamoyl)Adenosine,LKVJEMXWEODCAY-JVEUSOJLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
69746,6lxt,DB11636,-8.3,Nomegestrol,KZUIYQJTUIACIG-YBZCJVABSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
164490,7bv1,DB08068,-8.3,N-[4-CHLORO-3-(PYRIDIN-3-YLOXYMETHYL)-PHENYL]-3-FLUORO-,YQJVDUKATDECHF-ICSRJNTNSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
164489,7bv1,DB08064,-8.3,N-(3-TERT-BUTYL-1H-PYRAZOL-5-YL)-N'-{4-CHLORO-3-[(PYRIDIN-3-YLOXY)METHYL]PHENYL}UREA,NTMADESEDXKNFZ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
72109,6m2n,DB00348,-8.3,Nitisinone,OUBCNLGXQFSTLU-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
27240,6cs2,DB06733,-8.3,Bafilomycin A1,XDHNQDDQEHDUTM-JQWOJBOSSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
72084,6m2n,DB00317,-8.3,Gefitinib,XGALLCVXEZPNRQ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
164483,7bv1,DB08058,-8.3,"4-[3-(1,4-diazepan-1-ylcarbonyl)-4-fluorobenzyl]phthalazin-1(2H)-one",HGEPGGJUGUMFHT-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
57565,6crv,DB03830,-8.3,Phosphorylated Dihydropteroate,DNKVHXNVVYQUDC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28137,6cs2,DB07716,-8.3,"(4Z)-2,8:7,12:11,15:14,18:17,22-PENTAANHYDRO-4,5,6,9,10,13,19,20,21-NONADEOXY-D-ARABINO-D-ALLO-D-ALLO-DOCOSA-4,9,20-TRIENITOL",VDRIXSJOPKVWKM-HXGIDPQASA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
57512,6crv,DB03767,-8.3,Morpholine-4-Carboxylic Acid [1s-(2-Benzyloxy-1r-Cyano-Ethylcarbamoyl)-3-Methyl-Butyl]Amide,LXEDKIMJQBOMSU-MOPGFXCFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29931,6cs2,DB11824,-8.3,Tofogliflozin,VWVKUNOPTJGDOB-BDHVOXNPSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
162718,7bv1,DB02833,-8.3,[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(3-Nitro-Phenyl)-Amine,DYTKVFHLKPDNRW-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
28128,6cs2,DB07706,-8.3,2-Hydrox1tradiol,DILDHNKDVHLEQB-XSSYPUMDSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
57471,6crv,DB03719,-8.3,N-Ethyl-5'-Carboxamido Adenosine,JADDQZYHOWSFJD-BMYQGPEFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
162751,7bv1,DB02877,-8.3,Arotinoid acid,FOIVPCKZDPCJJY-JQIJEIRASA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
57448,6crv,DB03687,-8.3,4-Diphosphocytidyl-2-C-Methyl-D-Erythritol,YFAUKWZNPVBCFF-XHIBXCGHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
69942,6lxt,DB11922,-8.3,Danirixin,NGYNBSHYFOFVLS-LBPRGKRZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
28080,6cs2,DB07653,-8.3,"N-(5,6-DIPHENYLFURO[2,3-D]PYRIMIDIN-4-YL)GLYCINE",VXTCEUDVOCLEJG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
27351,6cs2,DB00623,-8.3,Fluphenazine,PLDUPXSUYLZYBN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
71796,6lxt,DB15295,-8.3,Tenalisib,HDXDQPRPFRKGKZ-INIZCTEOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
70082,6lxt,DB12129,-8.3,Tideglusib,PMJIHLSCWIDGMD-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
71793,6lxt,DB15292,-8.3,Foliglurax,ZTEDNASHAWNBKQ-NCELDCMTSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
163408,7bv1,DB04378,-8.3,"3-Amino-N-{4-[2-(2,6-Dimethyl-Phenoxy)-Acetylamino]-3-Hydroxy-1-Isobutyl-5-Phenyl-Pentyl}-Benzamide",APJAEXGNDLFGPD-AWCRTANDSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
27446,6cs2,DB06991,-8.3,"N-[2-methyl-5-(methylcarbamoyl)phenyl]-2-{[(1R)-1-methylpropyl]amino}-1,3-thiazole-5-carboxamide",OYOUIHFZUAKCEF-LLVKDONJSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
71781,6lxt,DB15268,-8.3,Afabicin,HFYMDQMXVPJNTH-VQHVLOKHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
71780,6lxt,DB15266,-8.3,TAK-580,VWMJHAFYPMOMGF-ZCFIWIBFSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
22612,6cs2,HMDB0001562,-8.3,Folinic acid,VVIAGPKUTFNRDU-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
55671,6crv,DB01295,-8.3,Bevantolol,HXLAFSUPPDYFEO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140565,6w9c,DB12461,-8.3,GLPG-0492,VAJGULUVTFDTAS-GOSISDBHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
163498,7bv1,DB04705,-8.3,"(3BETA)-CHOLEST-5-ENE-3,25-DIOL",INBGSXNNRGWLJU-ZHHJOTBYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
56972,6crv,DB03034,-8.3,D-Levofloxacin,GSDSWSVVBLHKDQ-SNVBAGLBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27465,6cs2,DB07008,-8.3,"4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMIDAZOL-1-YL)PHENOXY]PYRIMIDINE",XPXGYINSBORUMM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
71772,6lxt,DB15246,-8.3,Salvianolic acid A,YMGFTDKNIWPMGF-UCPJVGPRSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
27477,6cs2,DB07022,-8.3,3-Hydroxypropyl 3-[(7-carbamimidoyl-1-naphthyl)carbamoyl]benzenesulfonate,PXERBGNIBOFZOW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
56865,6crv,DB02887,-8.3,"2',3'-Dehydro-2',3'-Deoxy-Thymidine 5'-Triphosphate",ODSQODTUNULBHF-JGVFFNPUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
70194,6lxt,DB12290,-8.3,Puerarin,HKEAFJYKMMKDOR-VPRICQMDSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
70080,6lxt,DB12127,-8.3,Sultamicillin,OPYGFNJSCUDTBT-PMLPCWDUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
55625,6crv,DB01216,-8.3,Finasteride,DBEPLOCGEIEOCV-WSBQPABSSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140363,6w9c,DB04596,-8.3,"4-O-{4,6-O-[(1S)-1-Carboxyethylidene]-β-D-mannopyranosyl}-D-glucopyranuronic acid",GZJXZKGVHLWBOW-AISSFXTFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
163404,7bv1,DB04373,-8.3,"4-Amino-N-{4-[2-(2,6-Dimethyl-Phenoxy)-Acetylamino]-3-Hydroxy-1-Isobutyl-5-Phenyl-Pentyl}-Benzamide",WQUBEIMCFHCJCO-AWCRTANDSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
57233,6crv,DB03370,-8.3,FR239087,HCJYSIGJDKNVRU-TVQRCGJNSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55569,6crv,DB01155,-8.3,Gemifloxacin,ZRCVYEYHRGVLOC-HYARGMPZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
69966,6lxt,DB11960,-8.3,Carboxyamidotriazole,WNRZHQBJSXRYJK-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
69969,6lxt,DB11963,-8.3,Dacomitinib,LVXJQMNHJWSHET-AATRIKPKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
69972,6lxt,DB11966,-8.3,BMS-986094,YFXGICNMLCGLHJ-RSKRLRQZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
69974,6lxt,DB11968,-8.3,MK-7145,OCKGFTQIICXDQW-ZEQRLZLVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
140587,6w9c,DB12492,-8.3,Piritramide,IHEHEFLXQFOQJO-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
71840,6lxt,DB15393,-8.3,Telatinib,QFCXANHHBCGMAS-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
140550,6w9c,DB12436,-8.3,Vofopitant,XILNRORTJVDYRH-HKUYNNGSSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
164427,7bv1,DB07817,-8.3,"1-{3-[(4-pyridin-2-ylpiperazin-1-yl)sulfonyl]phenyl}-3-(1,3-thiazol-2-yl)urea",NJPVZSIGDRLLTD-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
69981,6lxt,DB11984,-8.3,Letaxaban,GEHAEMCVKDPMKO-HXUWFJFHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
140353,6w9c,DB04216,-8.3,Quercetin,REFJWTPEDVJJIY-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
163233,7bv1,DB03932,-8.3,LFA703,WPVRNXUYVXQXPY-YFAYRSKXSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
163282,7bv1,DB04204,-8.3,[(4-{4-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Butyl}-Phenyl)-Difluoro-Methyl]-Phosphonic Acid,SRHSAABKYJDBDV-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
70037,6lxt,DB12066,-8.3,Orteronel,OZPFIJIOIVJZMN-SFHVURJKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
163355,7bv1,DB04301,-8.3,Bis(5-Amidino-2-Benzimidazolyl)Methane Ketone Hydrate,ZLAHDRAQCSQPOC-UHFFFAOYSA-P,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
70061,6lxt,DB12101,-8.3,CC-220,IXZOHGPZAQLIBH-NRFANRHFSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
70074,6lxt,DB12120,-8.3,Avoralstat,TUWMKPVJGGWGNL-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
57148,6crv,DB03258,-8.3,2'-Deoxycytidine 5'-triphosphate,RGWHQCVHVJXOKC-SHYZEUOFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
26705,6cs2,DB04890,-8.3,Bepotastine,YWGDOWXRIALTES-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
54908,6crv,DB00374,-8.3,Treprostinil,PAJMKGZZBBTTOY-ZFORQUDYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
161203,7bv1,DB13393,-8.3,Emetine,AUVVAXYIELKVAI-CKBKHPSWSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
63441,6lxt,DB00278,-8.3,Argatroban,KXNPVXPOPUZYGB-IOVMHBDKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
74361,6m2n,DB03247,-8.3,Flavin mononucleotide,FVTCRASFADXXNN-SCRDCRAPSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
63454,6lxt,DB00294,-8.3,Etonogestrel,GCKFUYQCUCGESZ-BPIQYHPVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
63465,6lxt,DB00307,-8.3,Bexarotene,NAVMQTYZDKMPEU-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
63475,6lxt,DB00319,-8.3,Piperacillin,IVBHGBMCVLDMKU-GXNBUGAJSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
139816,6w9c,DB14045,-8.3,Cholesteryl chloride,OTVRYZXVVMZHHW-DPAQBDIFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
160048,7bv1,DB07450,-8.3,(R)-minalrestat,BMHZAHGTGIZZCT-LJQANCHMSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59472,6crv,DB07504,-8.3,(2R)-1-{4-[(4-Anilino-5-bromo-2-pyrimidinyl)amino]phenoxy}-3-(dimethylamino)-2-propanol,MEIJADBULOETOV-QGZVFWFLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
160058,7bv1,DB07460,-8.3,2-({5-CHLORO-2-[(2-METHOXY-4-MORPHOLIN-4-YLPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)-N-METHYLBENZAMIDE,UYJNQQDJUOUFQJ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
26117,6cs2,DB04186,-8.3,"N'-(Pyrrolidino[2,1-B]Isoindolin-4-On-8-Yl)-N-(Pyridin-2-Yl)Urea",KLVYMYQTRZCMLE-CYBMUJFWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
59456,6crv,DB07485,-8.3,"4,4'-cyclohexane-1,1-diyldiphenol",SDDLEVPIDBLVHC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28936,6cs2,DB08561,-8.3,"BENZYL 6-BENZYL-5,7-DIOXO-6,7-DIHYDRO-5H-[1,3]THIAZOLO[3,2-C]PYRIMIDINE-2-CARBOXYLATE",PLBINCOCFGQAJM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
59447,6crv,DB07473,-8.3,"(R)-(+) 5(9BH)-OXO-9B-PHENYL-2,3-DIHYDROTHIAZOLO[2,3-A]ISOINDOL-3-CARBOXYLIC ACID METHYL ESTER",JYIHODAXBBPFQF-MAUKXSAKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
32699,6cs2,T3D3605,-8.3,Ochratoxin A,RWQKHEORZBHNRI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
32700,6cs2,T3D3606,-8.3,Ochratoxin B,DAEYIVCTQUFNTM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
139826,6w9c,DB14065,-8.3,Lomerizine,JQSAYKKFZOSZGJ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
63587,6lxt,DB00455,-8.3,Loratadine,JCCNYMKQOSZNPW-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
59497,6crv,DB07533,-8.3,"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]-2-FURYL}-N-METHYLBENZENESULFONAMIDE",FJJJERLTHDXEPT-JYRVWZFOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59424,6crv,DB07447,-8.3,5beta-dihydrotestosterone,NVKAWKQGWWIWPM-MISPCMORSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59500,6crv,DB07536,-8.3,"N-{(1S,2R)-2-hydroxy-1-[(hydroxyamino)carbonyl]propyl}-4-{[4-(morpholin-4-ylmethyl)phenyl]ethynyl}benzamide",FQYBTYFKOHPWQT-VGSWGCGISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
160026,7bv1,DB07203,-8.3,6-CYCLOHEXYLMETHOXY-2-(3'-CHLOROANILINO) PURINE,OUEGMEMDEAOAEG-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
32135,6cs2,DB15425,-8.3,CYC-065,DLPIYBKBHMZCJI-WBVHZDCISA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
139770,6w9c,DB13952,-8.3,Estradiol acetate,FHXBMXJMKMWVRG-SLHNCBLASA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
143400,6w9q,DB03476,-8.3,Trans-6-(2-Phenylcyclopropyl)-Naphthalene-2-Carboxamidine,NQRIWXVAIWPBEM-OALUTQOASA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
63253,6crv,DB15442,-8.3,Trilaciclib,PDGKHKMBHVFCMG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
143389,6w9q,DB03460,-8.3,Violaxanthin,SZCBXWMUOPQSOX-WVJDLNGLSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
32138,6cs2,DB01128,-8.3,Bicalutamide,LKJPYSCBVHEWIU-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
74504,6m2n,DB03446,-8.3,N-Benzyl-3-(alpha-D-galactopyranosyloxy)benzamide,FSMWGHKWKYCPKE-QTVCLEQKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
74454,6m2n,DB03368,-8.3,"5-Methyl-5-(4-Phenoxy-Phenyl)-Pyrimidine-2,4,6-Trione",RTBMLCLTYAPKIF-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
28983,6cs2,DB08613,-8.3,"2,2,2-TRIFLUORO-1-{5-[(3-PHENYL-5,6-DIHYDROIMIDAZO[1,2-A]PYRAZIN-7(8H)-YL)CARBONYL]THIOPHEN-2-YL}ETHANE-1,1-DIOL",OFBFUNBBOQCNFX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
32145,6cs2,DB15444,-8.3,Elexacaftor,MVRHVFSOIWFBTE-INIZCTEOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
32147,6cs2,DB15446,-8.3,Vidofludimus,XPRDUGXOWVXZLL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
165517,7bv1,DB12222,-8.3,Lurtotecan,RVFGKBWWUQOIOU-NDEPHWFRSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
32151,6cs2,DB15449,-8.3,Citarinostat,VLIUIBXPEDFJRF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
32154,6cs2,DB15457,-8.3,Snubh-nm-333 F-18,QLWFXLJVGCECSV-HUYCHCPVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
32160,6cs2,DB01132,-8.3,Pioglitazone,HYAFETHFCAUJAY-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
32175,6cs2,DB01148,-8.3,Flavoxate,SPIUTQOUKAMGCX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
165510,7bv1,DB12211,-8.3,PSI-697,DIEPFYNZGUUVHD-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
63391,6lxt,DB00223,-8.3,Diflorasone,WXURHACBFYSXBI-XHIJKXOTSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
23719,6cs2,DB00224,-8.3,Indinavir,CBVCZFGXHXORBI-PXQQMZJSSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
160121,7bv1,DB07536,-8.3,"N-{(1S,2R)-2-hydroxy-1-[(hydroxyamino)carbonyl]propyl}-4-{[4-(morpholin-4-ylmethyl)phenyl]ethynyl}benzamide",FQYBTYFKOHPWQT-VGSWGCGISA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
63701,6lxt,DB00596,-8.3,Ulobetasol,LEHFPXVYPMWYQD-XHIJKXOTSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
26243,6cs2,DB04336,-8.3,1-(4-Amidinophenyl)-3-(4-Chlorophenyl)Urea,HQWKMDKTTCPCMQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
26254,6cs2,DB04350,-8.3,Argadin,FOZYKTUSOWWQGR-KNPYFFGGSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
59238,6crv,DB07234,-8.3,"3-{[(1R)-1-phenylethyl]amino}-4-(pyridin-4-ylamino)cyclobut-3-ene-1,2-dione",MCBPNFWHHNJTGN-LLVKDONJSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59234,6crv,DB07229,-8.3,"3-{5-[AMINO(IMINIO)METHYL]-1H-INDOL-2-YL}-5-METHOXY-1,1'-BIPHENYL-2-OLATE",MINVOLKUPZPDNX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59229,6crv,DB07222,-8.3,(3S)-N-(5-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE,RJWMDETWDDESBP-ZDUSSCGKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
64302,6lxt,DB01339,-8.3,Vecuronium,BGSZAXLLHYERSY-XQIGCQGXSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
165424,7bv1,DB12082,-8.3,Vesnarinone,ZVNYJIZDIRKMBF-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
64324,6lxt,DB01392,-8.3,Yohimbine,BLGXFZZNTVWLAY-SCYLSFHTSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
160399,7bv1,DB08339,-8.3,"6-(2,6-DICHLOROPHENYL)-2-{[3-(HYDROXYMETHYL)PHENYL]AMINO}-8-METHYLPYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE",ZIQFYVPVJZEOFS-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59212,6crv,DB07201,-8.3,(2S)-3-[(9H-fluoren-9-ylideneamino)oxy]-2-methylpropanoic acid,ZHFDVDMCVXUGGF-NSHDSACASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28871,6cs2,DB08494,-8.3,"S-{2-[(2-chloro-4-sulfamoylphenyl)amino]-2-oxoethyl} 6-methyl-3,4-dihydroquinoline-1(2H)-carbothioate",AWAKIULNKVOBKE-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
64411,6lxt,DB01496,-8.3,Barbituric acid derivative,DNZPLHRZXUJATK-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
73987,6m2n,DB02755,-8.3,1-3 Sugar Ring of Pentamannosyl 6-Phosphate,HDQMHAJOIVYOIP-NAVBLJQLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
59206,6crv,DB07195,-8.3,"4-[(1S,2S,5S)-5-(HYDROXYMETHYL)-6,8,9-TRIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL",DTZWKYVREFMAJA-QXWBOSQLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
64529,6lxt,DB01633,-8.3,Deoxy-2-fluoro-beta-D-cellotrioside,BZNXZJAUEMJQJB-QSCMNUSVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
28865,6cs2,DB08488,-8.3,"4-{[(E)-2-(5-CHLOROTHIEN-2-YL)VINYL]SULFONYL}-1-(1H-PYRROLO[3,2-C]PYRIDIN-2-YLMETHYL)PIPERAZIN-2-ONE",PLWVUIRWJVKSSD-XBXARRHUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
28863,6cs2,DB08487,-8.3,3-({4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-2-OXOPIPERAZIN-1-YL}METHYL)BENZENECARBOXIMIDAMIDE,PRMSFVUWLBPPLY-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
74068,6m2n,DB02859,-8.3,Soraphen A,WPMGNXPRKGXGBO-OFQQMTDKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
64202,6lxt,DB01180,-8.3,Rescinnamine,SZLZWPPUNLXJEA-LAFLMMDJSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
28894,6cs2,DB08519,-8.3,"N-4-(3-methyl-1H-indazol-6-yl)-N-2-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine",SQQAPOSROFWHIB-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
32796,6cs2,T3D3709,-8.3,Roridin A,NSFWWJIQIKBZMJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
28925,6cs2,DB08549,-8.3,"(3R)-METHYLCARBAMOYL-7-SULFOAMINO-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLIC ACID BENZYL ESTER",MFDBNNQUDZFSES-KRWDZBQOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
139830,6w9c,DB14069,-8.3,ONT-093,RSJCLODJSVZNQA-BQYQJAHWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
63754,6lxt,DB00663,-8.3,Flumethasone,WXURHACBFYSXBI-GQKYHHCASA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
165458,7bv1,DB12129,-8.3,Tideglusib,PMJIHLSCWIDGMD-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
139843,6w9c,DB14093,-8.3,"(1,2,6,7-3H)Testosterone",MUMGGOZAMZWBJJ-JQSYSRDDSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
63804,6lxt,DB00719,-8.3,Azatadine,SEBMTIQKRHYNIT-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
59337,6crv,DB07343,-8.3,"4-[4-AMINO-6-(2,6-DICHLORO-PHENOXY)-[1,3,5]TRIAZIN-2-YLAMINO]-BENZONITRILE",NFNNMVVXXITVGD-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
32768,6cs2,T3D3681,-8.3,Cytochalasin J,DMUBZPWTFAPROZ-KRQHZRJMSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
32133,6cs2,DB15418,-8.3,AZD-9977,MBKYLPOPYYLTNW-ZDUSSCGKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
160209,7bv1,DB07874,-8.3,"(6S)-2-amino-6-(3'-methoxybiphenyl-3-yl)-3,6-dimethyl-5,6-dihydropyrimidin-4(3H)-one",LQOCXPOKEPYGTJ-IBGZPJMESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160270,7bv1,DB07949,-8.3,"({[(3E)-2'-OXO-2',7'-DIHYDRO-2,3'-BIINDOL-3(7H)-YLIDENE]AMINO}OXY)ACETIC ACID",BFQRPTKOSYMPOL-LALPNIDTSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
74123,6m2n,DB02930,-8.3,Adenosine 5'-[??-thio]triphosphate,NLTUCYMLOPLUHL-KQYNXXCUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
59312,6crv,DB07315,-8.3,"5-chloro-N-{4-[(1R)-1,2-dihydroxyethyl]phenyl}-1H-indole-2-carboxamide",SHCHFGSUYJUEBR-INIZCTEOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59310,6crv,DB07313,-8.3,5-METHYL-2-[(PHENYLSULFONYL)AMINO]BENZOIC ACID,HXQLTRSIZRSFTR-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59307,6crv,DB07310,-8.3,"(5S)-2-{[(1S)-1-(2-fluorophenyl)ethyl]amino}-5-methyl-5-(trifluoromethyl)-1,3-thiazol-4(5H)-one",KNHNFKZUNFPPQE-MADCSZMMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
64104,6lxt,DB01067,-8.3,Glipizide,ZJJXGWJIGJFDTL-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
26214,6cs2,DB04301,-8.3,Bis(5-Amidino-2-Benzimidazolyl)Methane Ketone Hydrate,ZLAHDRAQCSQPOC-UHFFFAOYSA-P,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
59288,6crv,DB07290,-8.3,(2R)-2-{[(4-FLUORO-3-METHYLPHENYL)SULFONYL]AMINO}-N-HYDROXY-2-TETRAHYDRO-2H-PYRAN-4-YLACETAMIDE,LUCFRFDOOYLALP-CYBMUJFWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
160210,7bv1,DB07875,-8.3,"5-Chloro-thiophene-2-carboxylic acid ((3S,4S)-1-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-methyl}-4-hydroxy-pyrrolidin-3-yl)-amide",ARAVOODWJJJNBY-IRXDYDNUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
64625,6lxt,DB01761,-8.3,4-[5-[2-(1-Phenyl-Ethylamino)-Pyrimidin-4-Yl]-1-Methyl-4-(3-Trifluoromethylphenyl)-1h-Imidazol-2-Yl]-Piperidine,QICPQLFMWYQJGX-SFHVURJKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
74527,6m2n,DB03477,-8.3,1-Phenylsulfonamide-3-Trifluoromethyl-5-Parabromophenylpyrazole,OYZKFVIVPRQRQQ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
26042,6cs2,DB04099,-8.3,Deamido-Nad+,SENPVEZBRZQVST-HISDBWNOSA-O,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
159630,7bv1,DB04960,-8.3,Tipifarnib,PLHJCIYEEKOWNM-HHHXNRCGSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
145085,6w9q,DB06938,-8.3,4-[[2-[[4-chloro-3-(trifluoromethyl)phenyl]amino]-3H-benzimidazol-5-yl]oxy]-N-methyl-pyridine-2-carboxamide,ZJLSMLDOCGOURY-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
165645,7bv1,DB12588,-8.3,AZD-1480,PDOQBOJDRPLBQU-QMMMGPOBSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
159648,7bv1,DB05039,-8.3,Indacaterol,QZZUEBNBZAPZLX-QFIPXVFZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
144953,6w9q,DB06755,-8.3,Beta carotene,OENHQHLEOONYIE-JLTXGRSLSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
59863,6crv,DB07964,-8.3,"(3S)-4-{[4-(BUT-2-YNYLOXY)PHENYL]SULFONYL}-N-HYDROXY-2,2-DIMETHYLTHIOMORPHOLINE-3-CARBOXAMIDE",CVZIHNYAZLXRRS-HNNXBMFYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
32013,6cs2,DB15204,-8.3,Fosravuconazole,SYTNEMZCCLUTNX-NPMXOYFQSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
144887,6w9q,DB06638,-8.3,Quarfloxin,WOQIDNWTQOYDLF-CGAIIQECSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
25880,6cs2,DB00457,-8.3,Prazosin,IENZQIKPVFGBNW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
23935,6cs2,DB01573,-8.3,Benzylmorphine,RDJGWRFTDZZXSM-RNWLQCGYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
144868,6w9q,DB06605,-8.3,Apixaban,QNZCBYKSOIHPEH-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
25881,6cs2,DB03903,-8.3,Tmr,KGFLZYXDJDOIEE-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
29873,6cs2,DB11750,-8.3,Clobetasol,FCSHDIVRCWTZOX-DVTGEIKXSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
25883,6cs2,DB03907,-8.3,"N-{3-[5-(6-Amino-Purin-9-Yl)-3,4-Dihydroxy-Tetrahydro-Furan-2-Yl]-Allyl}-2,3-Dihydroxy-5-Nitro-Benzamide",UHHBFOLQOQSPLU-WGRQDFERSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
59839,6crv,DB07935,-8.3,"5-[(5-fluoro-3-methyl-1H-indazol-4-yl)oxy]benzene-1,3-dicarbonitrile",JYAHFMKZJRVTDT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
144832,6w9q,DB06515,-8.3,Resiniferatoxin,DSDNAKHZNJAGHN-MXTYGGKSSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
139739,6w9c,DB13872,-8.3,Lormetazepam,FJIKWRGCXUCUIG-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
145200,6w9q,DB07076,-8.3,6-[(Z)-AMINO(IMINO)METHYL]-N-[3-(CYCLOPENTYLOXY)PHENYL]-2-NAPHTHAMIDE,FWTQOPWAMQXIMI-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
74788,6m2n,DB03830,-8.3,Phosphorylated Dihydropteroate,DNKVHXNVVYQUDC-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
145292,6w9q,DB07181,-8.3,"4'-[(1R)-1-amino-2-(2,5-difluorophenyl)ethyl]biphenyl-3-carboxamide",JYKFWUXBFJJDTP-HXUWFJFHSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
159574,7bv1,DB04591,-8.3,"N-{2,2-DIFLUORO-2-[(2R)-PIPERIDIN-2-YL]ETHYL}-2-[2-(1H-1,2,4-TRIAZOL-1-YL)BENZYL][1,3]OXAZOLO[4,5-C]PYRIDIN-4-AMINE",VYJOAYZRCNHDNG-GOSISDBHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
165716,7bv1,DB12705,-8.3,Cenerimod,KJKKMMMRWISKRF-FQEVSTJZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
145639,6w9q,DB07586,-8.3,"5-(4-METHYL-BENZOYLAMINO)-BIPHENYL-3,4'-DICARBOXYLIC ACID 3-DIMETHYLAMIDE-4'-HYDROXYAMIDE",DOPFUKKMSDUVTQ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
59977,6crv,DB08093,-8.3,3-(1-NAPHTHYLMETHOXY)PYRIDIN-2-AMINE,SZANYTFSQVBOBA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29107,6cs2,DB08745,-8.3,4-[[(1E)-2-(4-CHLOROPHENYL)ETHENYL]SULFONYL]-1-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]PIPERAZINONE,QLHUDNKWOSQSMK-CXUHLZMHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
139604,6w9c,DB13689,-8.3,Tacalcitol,BJYLYJCXYAMOFT-RSFVBTMBSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
24017,6cs2,DB01669,-8.3,Virginiamycin M1,DAIKHDNSXMZDCU-FQTGFAPKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
30006,6cs2,DB11922,-8.3,Danirixin,NGYNBSHYFOFVLS-LBPRGKRZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
145508,6w9q,DB07430,-8.3,"(10R)-10-methyl-3-(6-methylpyridin-3-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one",CMWRPDHVGMHLSZ-GFCCVEGCSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
159375,7bv1,DB04064,-8.3,Nogalaviketone,QHNJNOBWURJIEK-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
145457,6w9q,DB07369,-8.3,"N-(3-chlorophenyl)-N-methyl-2-oxo-3-[(3,4,5-trimethyl-1H-pyrrol-2-yl)methyl]-2H-indole-5-sulfonamide",YMJLSOJLEXWATP-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
159411,7bv1,DB04107,-8.3,[(1-{2[(4-Carbamimidoyl-Phenylamino)-Methyl]-1-Methyl-1h-Benzoimidazol-5-Yl}-Cyclopropyl)-Pyridin-2-Yl-Methyleneaminooxy]-Acetic Acid Ethyl Ester,RNOYCNIZOAIUSV-LSWMGQQCSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
23996,6cs2,DB00251,-8.3,Terconazole,BLSQLHNBWJLIBQ-OZXSUGGESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
165677,7bv1,DB12644,-8.3,AZD-2066,SXWHYTICXCLKDG-GFCCVEGCSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
31979,6cs2,DB15141,-8.3,Deutivacaftor,PURKAOJPTOLRMP-ASMGOKTBSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
29074,6cs2,DB08714,-8.3,"2,6-DIMETHYL-1-(3-[3-METHYL-5-ISOXAZOLYL]-PROPANYL)-4-[4-METHYL-2H-TETRAZOL-2-YL]-PHENOL",DRCNRTRGWUYJBH-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
159533,7bv1,DB04540,-8.3,Cholesterol,HVYWMOMLDIMFJA-DPAQBDIFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
74941,6m2n,DB04038,-8.3,Ergosterol,DNVPQKQSNYMLRS-APGDWVJJSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
29063,6cs2,DB08705,-8.3,"6-(5-BROMO-2-HYDROXYPHENYL)-2-OXO-4-PHENYL-1,2-DIHYDROPYRIDINE-3-CARBONITRILE",SVSYJTYGPLVUOZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
165636,7bv1,DB12574,-8.3,LY-295501,VAMFSFIPDOODFH-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
29905,6cs2,DB11792,-8.3,Mirodenafil,MIJFNYMSCFYZNY-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
74751,6m2n,DB03788,-8.3,GC-24,JYHIGYLGYNCMGI-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
25980,6cs2,DB04022,-8.3,"Guanosine-5',3'-Tetraphosphate",BUFLLCUFNHESEH-UUOKFMHZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
165616,7bv1,DB12545,-8.3,Indobufen,AYDXAULLCROVIT-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59674,6crv,DB07746,-8.3,3-ETHYL-6-{[(4-FLUOROPHENYL)SULFONYL]AMINO}-2-METHYLBENZOIC ACID,MGUQWAOYPINSIT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165595,7bv1,DB12512,-8.3,Verucerfont,VKHVAUKFLBBZFJ-SFHVURJKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
74608,6m2n,DB03596,-8.3,N-[2-(1h-Indol-5-Yl)-Butyl]-4-Sulfamoyl-Benzamide,FSRPBGBMEKDSIJ-CYBMUJFWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
63163,6crv,DB15257,-8.3,Milademetan,RYAYYVTWKAOAJF-QISPRATLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
25994,6cs2,DB04044,-8.3,4-{2-[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid,NAQUAVBNIYTIIS-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
144332,6w9q,DB04727,-8.3,"N-(4-{4-AMINO-6-[4-(METHYLOXY)PHENYL]FURO[2,3-D]PYRIMIDIN-5-YL}PHENYL)-N'-[2-FLUORO-5-(TRIFLUOROMETHYL)PHENYL]UREA",FGZIONRFHVNRJB-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
144305,6w9q,DB04690,-8.3,Camptothecin,VSJKWCGYPAHWDS-FQEVSTJZSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
159885,7bv1,DB07041,-8.3,"N-[2-(2,4-diaminopyrido[2,3-d]pyrimidin-7-yl)-2-methylpropyl]-4-phenoxybenzamide",FDJWFDQRPKKBFA-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
74545,6m2n,DB03501,-8.3,Galactose-uridine-5'-diphosphate,HSCJRCZFDFQWRP-ABVWGUQPSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
63203,6crv,DB15334,-8.3,Biochanin A,WUADCCWRTIWANL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59621,6crv,DB07683,-8.3,"N-(dibenzo[b,d]thiophen-3-ylsulfonyl)-L-valine",RZWYSEXQXOXWKA-INIZCTEOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
63204,6crv,DB15335,-8.3,Formononetin,HKQYGTCOTHHOMP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
159914,7bv1,DB07074,-8.3,6-CARBAMIMIDOYL-4-(3-HYDROXY-2-METHYL-BENZOYLAMINO)-NAPHTHALENE-2-CARBOXYLIC ACID METHYL ESTER,OUBRALHIKGRAMA-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
144120,6w9q,DB04452,-8.3,Aminoquinuride,HOUSDILKOJMENG-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
23820,6cs2,DB01459,-8.3,Bezitramide,FLKWNFFCSSJANB-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
23865,6cs2,DB01503,-8.3,1-Androstenediol,RZFGPAMUAXASRE-YSZCXEEOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
165618,7bv1,DB12548,-8.3,Sparsentan,WRFHGDPIDHPWIQ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59687,6crv,DB07760,-8.3,"3-[(1E,7E)-8-(2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)-3,6-dioxa-2,7-diazaocta-1,7-dien-1-yl]benzoic acid",TUYDQQMKXSQIQG-GONBZBRSSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
32059,6cs2,DB15287,-8.3,Elismetrep,CWEFDWIKLABKBX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
63109,6crv,DB15149,-8.3,Futibatinib,KEIPNCCJPRMIAX-HNNXBMFYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59785,6crv,DB07869,-8.3,6-CHLORO-4-(CYCLOHEXYLSULFINYL)-3-PROPYLQUINOLIN-2(1H)-ONE,QRBUGQMJMFAHKS-HSZRJFAPSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165628,7bv1,DB12563,-8.3,MK-0686,WZZIQHIQMWJNLU-LLVKDONJSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
74724,6m2n,DB03755,-8.3,"Adenosine-5'-[Beta, Gamma-Methylene]Tetraphosphate",ARRGHMSEJJFDME-IOSLPCCCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
63128,6crv,DB15192,-8.3,ABT-288,GNIRITULTPTAQW-KNQAVFIVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
144616,6w9q,DB05678,-8.3,SLx-4090,AZUIUVJESCFSLJ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
32051,6cs2,DB15268,-8.3,Afabicin,HFYMDQMXVPJNTH-VQHVLOKHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
159766,7bv1,DB06494,-8.3,Sufugolix,UCQSBGOFELXYIN-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
63233,6crv,DB15403,-8.3,Ziritaxestat,REQQVBGILUTQNN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
74709,6m2n,DB03737,-8.3,"4-((3r,4s,5r)-4-Amino-3,5-Dihydroxy-Hex-1-Ynyl)-5-Fluoro-3-[1-(3-Methoxy-1h-Pyrrol-2-Yl)-Meth-(Z)-Ylidene]-1,3-Dihydro-Indol-2-One",RAKYKJWUUUKCCW-MPLBGYFPSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
74698,6m2n,DB03723,-8.3,2'-Deoxy-Thymidine-Beta-L-Rhamnose,ZOSQFDVXNQFKBY-CGAXJHMRSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
74690,6m2n,DB03714,-8.3,4-Carbamoyl-4-{[6-(Difluoro-Phosphono-Methyl)-Naphthalene-2-Carbonyl]-Amino}-Butyric Acid,OWWCIKSGGKYNHT-ZDUSSCGKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
159777,7bv1,DB06525,-8.3,Ganstigmine,ZOBDWFRKFSPCRB-UNMCSNQZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
139753,6w9c,DB13929,-8.3,Relcovaptan,CEBYCSRFKCEUSW-NAYZPBBASA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
59710,6crv,DB07787,-8.3,"5-FLUORO-1-[4-(4-PHENYL-3,6-DIHYDROPYRIDIN-1(2H)-YL)BUTYL]QUINAZOLINE-2,4(1H,3H)-DIONE",PNPFDRCIGCUCMN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
144507,6w9q,DB05075,-8.3,TG-100801,JMGXJHWTVBGOKG-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
59705,6crv,DB07781,-8.3,N-[[3-FLUORO-4-ETHOXY-PYRID-2-YL]ETHYL]-N'-[5-NITRILOMETHYL-PYRIDYL]-THIOUREA,PQSCCWFMTRVFDA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
159815,7bv1,DB06620,-8.3,Aplindore,DYJIKHYBKVODAC-ZDUSSCGKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
159772,7bv1,DB06515,-8.3,Resiniferatoxin,DSDNAKHZNJAGHN-MXTYGGKSSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59991,6crv,DB08107,-8.3,N-{[6-(PENTYLOXY)NAPHTHALEN-2-YL]SULFONYL}-D-GLUTAMIC ACID,LIGACKDHLKEZFH-GOSISDBHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
64628,6lxt,DB01764,-8.3,Dalfopristin,SUYRLXYYZQTJHF-VMBLUXKRSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
73962,6m2n,DB02716,-8.3,7-Methyl-Guanosine-5'-Triphosphate,DKVRNHPCAOHRSI-KQYNXXCUSA-O,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
40347,6lu7,DB12012,-8.3,PF-04457845,BATCTBJIJJEPHM-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
23306,6cs2,HMDB0060030,-8.3,"5-(3',5'-Dihydroxyphenyl)-gamma-valerolactone-O-glucuronide-O-methyl",SNIRJYJBIJKJEM-LQOUNWOVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
26547,6cs2,DB04706,-8.3,"(3BETA,7BETA)-CHOLEST-5-ENE-3,7-DIOL",OYXZMSRRJOYLLO-KGZHIOMZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
58808,6crv,DB06685,-8.3,Laquinimod,GKWPCEFFIHSJOE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
26557,6cs2,DB04716,-8.3,"2-(1,1-DIMETHYLETHYL)9-FLUORO-3,6-DIHYDRO-7H-BENZ[H]-IMIDAZ[4,5-F]ISOQUINOLIN-7-ONE",VNDWQCSOSCCWIP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
58800,6crv,DB06670,-8.3,Odanacatib,FWIVDMJALNEADT-SFTDATJTSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28603,6cs2,DB08192,-8.3,2-(4-CARCOXY-5-ISOPROPYLTHIAZOLYL)BENZOPIPERIDINE,HCUGCUQZFBURHR-LBPRGKRZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
165237,7bv1,DB11637,-8.3,Delamanid,XDAOLTSRNUSPPH-XMMPIXPASA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
40362,6lu7,DB05075,-8.3,TG-100801,JMGXJHWTVBGOKG-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40369,6lu7,DB15308,-8.3,Ridinilazole,UHQFBTAJFNVZIV-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
73166,6m2n,DB01668,-8.3,Nanaomycin D,XUWPJKDMEZSVTP-UOSCCXBLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
40370,6lu7,DB12886,-8.3,GSK-1521498,WIEDUMBCZQRGSY-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
141505,6w9q,DB00972,-8.3,Azelastine,MBUVEWMHONZEQD-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
67093,6lxt,DB05482,-8.3,7-ethyl-10-hydroxycamptothecin,FJHBVJOVLFPMQE-QFIPXVFZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
67110,6lxt,DB05553,-8.3,Regrelor,NXHAXEBZOXCDKD-XIXRRVGJSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
67119,6lxt,DB05608,-8.3,MKC-1,OVSKGTONMLKNPZ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
160948,7bv1,DB12306,-8.3,Cipargamin,CKLPLPZSUQEDRT-WPCRTTGESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
26546,6cs2,DB04705,-8.3,"(3BETA)-CHOLEST-5-ENE-3,25-DIOL",INBGSXNNRGWLJU-ZHHJOTBYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
67120,6lxt,DB05611,-8.3,Apilimod,HSKAZIJJKRAJAV-KOEQRZSOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
40345,6lu7,DB08064,-8.3,N-(3-TERT-BUTYL-1H-PYRAZOL-5-YL)-N'-{4-CHLORO-3-[(PYRIDIN-3-YLOXY)METHYL]PHENYL}UREA,NTMADESEDXKNFZ-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
73231,6m2n,DB01755,-8.3,N-[Isoleucinyl]-N'-[Adenosyl]-Diaminosufone,XVTRBLLRODNOJV-VBJYJYTRSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
28643,6cs2,DB08239,-8.3,"(2S)-4-(2,5-DIFLUOROPHENYL)-N-METHYL-2-PHENYL-N-PIPERIDIN-4-YL-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDE",NKLVBHMAIMEVEH-QFIPXVFZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
160879,7bv1,DB11855,-8.3,Revefenacin,FYDWDCIFZSGNBU-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
140002,6w9c,DB14726,-8.3,Dabigatran,YBSJFWOBGCMAKL-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
58866,6crv,DB06781,-8.3,Difluprednate,WYQPLTPSGFELIB-JTQPXKBDSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165271,7bv1,DB11687,-8.3,E-6201,MWUFVYLAWAXDHQ-HMNLTAHHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
58859,6crv,DB06766,-8.3,Alcaftadine,MWTBKTRZPHJQLH-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
73313,6m2n,DB01861,-8.3,Uridine diphosphate glucose,HSCJRCZFDFQWRP-JZMIEXBBSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
141707,6w9q,DB01200,-8.3,Bromocriptine,OZVBMTJYIDMWIL-AYFBDAFISA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
73272,6m2n,DB01810,-8.3,"[1-(1-Methyl-4,5-Dioxo-Pent-2-Enylcarbamoyl)-2-Phenyl-Ethyl]-Carbamic Acid Benzyl Ester",NOXVWFAAXREWMI-GURWAVDKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
160902,7bv1,DB11892,-8.3,Prulifloxacin,PWNMXPDKBYZCOO-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
26531,6cs2,DB04685,-8.3,"1-{(2S,5S)-4-FLUORO-5-[(TRITYLOXY)METHYL]TETRAHYDROFURAN-2-YL}PYRIMIDINE-2,4(1H,3H)-DIONE",GJNIPWYJQUGERM-BFLUCZKCSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
73244,6m2n,DB01771,-8.3,CRA_10991,QXAURVOBXQBPAP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
66969,6lxt,DB04886,-8.3,Calanolide A,NIDRYBLTWYFCFV-FMTVUPSXSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
160904,7bv1,DB12247,-8.3,AZD-4547,VRQMAABPASPXMW-HDICACEKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
67009,6lxt,DB05013,-8.3,Ingenol mebutate,VDJHFHXMUKFKET-UXMMOKKRSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
67039,6lxt,DB05171,-8.3,E-2012,PUOAETJYKQITMO-LANLRWRYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
28623,6cs2,DB00762,-8.3,Irinotecan,UWKQSNNFCGGAFS-XIFFEERXSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
160921,7bv1,DB12272,-8.3,Vidupiprant,PFWVGKROPKKEDW-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
73106,6m2n,DB01594,-8.3,Cinolazepam,XAXMYHMKTCNRRZ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
67128,6lxt,DB05667,-8.3,Levoketoconazole,XMAYWYJOQHXEEK-ZEQKJWHPSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
67135,6lxt,DB05706,-8.3,13-deoxydoxorubicin,RGVRUQHYQSORBY-JIGXQNLBSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
161103,7bv1,DB12887,-8.3,Tazemetostat,NSQSAUGJQHDYNO-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
28506,6cs2,DB08097,-8.3,"2-(2,6-DIFLUOROPHENOXY)-N-(2-FLUOROPHENYL)-9-ISOPROPYL-9H-PURIN-8-AMINE",OGWSGDLIXOEZJG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
67494,6lxt,DB06809,-8.3,Plerixafor,YIQPUIGJQJDJOS-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
67504,6lxt,DB06827,-8.3,Viomycin,GXFAIFRPOKBQRV-GHXCTMGLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
161108,7bv1,DB12895,-8.3,TD-139,YGIDGBAHDZEYMT-MQFIMZJJSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
67525,6lxt,DB06856,-8.3,6-FLUORO-2-[2-HYDROXY-3-(2-METHYL-CYCLOHEXYLOXY)-PHENYL]-1H-INDOLE-5-CARBOXAMIDINE,HUYQYLFFFNSAAX-BUXKBTBVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
54879,6crv,DB00340,-8.3,Metixene,MJFJKKXQDNNUJF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72904,6m2n,DB01327,-8.3,Cefazolin,MLYYVTUWGNIJIB-BXKDBHETSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
67543,6lxt,DB06876,-8.3,"N-{5-[4-(4-METHYLPIPERAZIN-1-YL)PHENYL]-1H-PYRROLO[2,3-B]PYRIDIN-3-YL}NICOTINAMIDE",YJWJKKXGAPWLGT-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
54887,6crv,DB00348,-8.3,Nitisinone,OUBCNLGXQFSTLU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72884,6m2n,DB01268,-8.3,Sunitinib,WINHZLLDWRZWRT-ATVHPVEESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
67596,6lxt,DB06933,-8.3,N-(tert-butyl)-4-[5-(pyridin-2-ylamino)quinolin-3-yl]benzenesulfonamide,GJTCKUKIFXWJKG-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
161137,7bv1,DB12937,-8.3,Quercetin-3'-O-phosphate,UWJBYNLLMAPJMM-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
67615,6lxt,DB06962,-8.3,"(5-(aminomethyl)-2H-spiro[benzofuran-3,4'-piperidine]-1'-yl)(5-(phenylethynyl)furan-2-yl)methanone",YKTUSHSSKIWDRY-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
28487,6cs2,DB08077,-8.3,"2-[4-({[(3,5-DICHLOROPHENYL)AMINO]CARBONYL}AMINO)PHENOXY]-2-METHYLPROPANOIC ACID",OYJPTSMWFKGZJM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
67616,6lxt,DB06963,-8.3,"3-[3-(3-methyl-6-{[(1S)-1-phenylethyl]amino}-1H-pyrazolo[4,3-c]pyridin-1-yl)phenyl]propanamide",ZFGCLYUGFRNYFE-INIZCTEOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
67647,6lxt,DB06999,-8.3,"N-{3-[(5-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)carbonyl]-2,4-difluorophenyl}propane-1-sulfonamide",YZDJQTHVDDOVHR-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
58662,6crv,DB06306,-8.3,Onalespib,IFRGXKKQHBVPCQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165148,7bv1,DB11424,-8.3,Lufenuron,PWPJGUXAGUPAHP-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
58684,6crv,DB06374,-8.3,Elacestrant,SIFNOOUKXBRGGB-AREMUKBSSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58686,6crv,DB06395,-8.3,Abafungin,TYBHXIFFPVFXQW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
54740,6crv,DB00175,-8.3,Pravastatin,TUZYXOIXSAXUGO-PZAWKZKUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
160981,7bv1,DB12355,-8.3,Netazepide,YDZYKNJZCVIKPP-VWLOTQADSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
67185,6lxt,DB06077,-8.3,Lumateperone,HOIIHACBCFLJET-SFTDATJTSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
73092,6m2n,DB01572,-8.3,Methyl-1-testosterone,JRNSSSJKIGAFCT-YDSAWKJFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
67196,6lxt,DB06137,-8.3,KX-01,HUNGUWOZPQBXGX-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
161003,7bv1,DB12388,-8.3,Evocalcet,RZNUIYPHQFXBAN-XLIONFOSSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
58769,6crv,DB06604,-8.3,Ilepatril,FXKFFTMLFPWYFH-RDGPPVDQSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
73064,6m2n,DB01544,-8.3,Flunitrazepam,PPTYJKAXVCCBDU-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
160878,7bv1,DB11853,-8.3,Relugolix,AOMXMOCNKJTRQP-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
73050,6m2n,DB01530,-8.3,"5alpha-androstane-3alpha,17beta-diol",CBMYJHIOYJEBSB-KHOSGYARSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
73018,6m2n,DB01489,-8.3,Camazepam,PXBVEXGRHZFEOF-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
73010,6m2n,DB01481,-8.3,1-Testosterone,OKJCFMUGMSVJBG-ABEVXSGRSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
67298,6lxt,DB06393,-8.3,Xaliproden,WJJYZXPHLSLMGE-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
28549,6cs2,DB08137,-8.3,(4E)-N-(4-fluorophenyl)-4-[(phenylcarbonyl)imino]-4H-pyrazole-3-carboxamide,ZMWYSLJBNJUCRK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
72984,6m2n,DB01453,-8.3,Beta-hydroxyfentanyl,JEFVHLMGRUJLET-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
141220,6w9q,DB00637,-8.3,Astemizole,GXDALQBWZGODGZ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
54795,6crv,DB00239,-8.3,Oxiconazole,QRJJEGAJXVEBNE-HKOYGPOVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
67349,6lxt,DB06519,-8.3,Edaglitazone,HAAXAFNSRADSMK-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
26610,6cs2,DB04785,-8.3,Streptolydigin,KVTPRMV1KLIG-NCAOFHFGSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
165412,7bv1,DB12064,-8.3,BMS-777607,VNBRGSXVFBYQNN-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
139998,6w9c,DB14718,-8.3,Pyrazolam,BGRWSFIQQPVEML-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
66824,6lxt,DB04696,-8.3,"4-CHLORO-3',3''-DIBROMOPHENOL-1,8-NAPHTHALEIN",GFGZCXHXQCQRFP-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
65230,6lxt,DB02554,-8.3,"Sulfoquinovose-Uridine-C1,5'-Diphosphate",FQANCGQCBCUSMI-JZMIEXBBSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
160519,7bv1,DB08730,-8.3,3-FLUORO-5-MORPHOLIN-4-YL-N-[1-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-6-YL]BENZAMIDE,CPFBZMFUCGHBAP-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
33106,6cs2,T3D4128,-8.3,Brevetoxin B,LYTCVQQGCSNFJU-FGRVLNGBSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
139930,6w9c,DB14584,-8.3,Segesterone,SFLXYFZGKSGFKA-XUDSTZEESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
28791,6cs2,DB08407,-8.3,PLATENSIMYCIN,CSOMAHTTWTVBFL-OFBLZTNGSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
65284,6lxt,DB02629,-8.3,Inhibitor Bea403,LYHLPPXMBKMSSZ-JQFCFGFHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
59095,6crv,DB07066,-8.3,"2-CHLORO-N-[(3R)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL]-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE",LJAHIGGEXIWVJG-LLVKDONJSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
73807,6m2n,DB02511,-8.3,2-Hydroxy-5-({1-[(2-Naphthyloxy)Methyl]-3-Oxoprop-1-Enyl}Amino)Tyrosine,PZWMZAFFUAWVDN-CQXYXCHQSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
160600,7bv1,DB08822,-8.3,Azilsartan medoxomil,QJFSABGVXDWMIW-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
65362,6lxt,DB02732,-8.3,Nicotinamide Adenine Dinucleotide Acetone Adduct,SGHBFOOIAAJJMI-YDKVLQLQSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
59077,6crv,DB07047,-8.3,"2',4'-DICHLORO-4-HYDROXY-1,1'-BIPHENYL-3-CARBOXYLIC ACID",SKAFZYDMDHPPJM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
73761,6m2n,DB02455,-8.3,Fluoresceinylthioureido,VHJFQSRUDVDTEO-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
28754,6cs2,DB08366,-8.3,"3-({3-[(1S,4aS,6S,7S,9S,9aR)-1,6-dimethyl-2-oxodecahydro-6,9-epoxy-4a,7-methanobenzo[7]annulen-1-yl]propanoyl}amino)-2,4-dihydroxybenzoic acid",XADCWKSMHQPTGH-OFBLZTNGSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
65466,6lxt,DB02872,-8.3,"Cis-[4,5-Bis-(4-Bromophenyl)-2-(2-Ethoxy-4-Methoxyphenyl)-4,5-Dihydroimidazol-1-Yl]-[4-(2-Hydroxyethyl)Piperazin-1-Yl]Methanone",PVRYEWOXWGDQHA-URLMMPGGSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
59070,6crv,DB07039,-8.3,(2S)-N-(4-cyano-3-iodophenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide,RXSZCFAPSDTELY-SFHVURJKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
73695,6m2n,DB02375,-8.3,Myricetin,IKMDFBPHZNJCSN-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
139946,6w9c,DB14636,-8.3,Triciribine phosphate,URLYINUFLXOMHP-HTVVRFAVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
65228,6lxt,DB02551,-8.3,"6-[N-(4-Ethyl-1,2,3,4-Tetrahydro-6-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine",LVNMYQLXKMSQTG-AWEZNQCLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
139947,6w9c,DB14637,-8.3,Fluprednisolone acetate,CYMBAKFTWRNHPS-APRQOCPKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
165369,7bv1,DB12001,-8.3,Abemaciclib,UZWDCWONPYILKI-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
65184,6lxt,DB02498,-8.3,Carba-Nicotinamide-Adenine-Dinucleotide,DGPLSUKWXXSBCU-VGXGLJSLSA-O,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
160446,7bv1,DB08395,-8.3,2-(ETHOXYMETHYL)-4-(4-FLUOROPHENYL)-3-[2-(2-HYDROXYPHENOXY)PYRIMIDIN-4-YL]ISOXAZOL-5(2H)-ONE,ZSOXFJURLPCSOO-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
142538,6w9q,DB02336,-8.3,RU83876,WCMLXBUNHNAMNH-UIOOFZCWSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
32877,6cs2,T3D3800,-8.3,Boscalid,WYEMLYFITZORAB-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
32936,6cs2,T3D3864,-8.3,Indoxacarb,VBCVPMMZEGZULK-NRFANRHFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
64948,6lxt,DB02197,-8.3,"4-[(4-Imidazo[1,2-a]Pyridin-3-Ylpyrimidin-2-Yl)Amino]Benzenesulfonamide",NKORVPQBJCGYEC-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
32971,6cs2,T3D3902,-8.3,Primisulfuron-methyl,ZTYVMAQSHCZXLF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
64982,6lxt,DB02241,-8.3,"8-Benzyl-2-Hydroperoxy-2-(4-Hydroxy-Benzyl)-6-(4-Hydroxy-Phenyl)-2h-Imidazo[1,2-a]Pyrazin-3-One",HOSWCJDTHOAORT-SANMLTNESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
59152,6crv,DB07132,-8.3,1-{2-OXO-3-[(1R)-1-(1H-PYRROL-2-YL)ETHYL]-2H-INDOL-5-YL}UREA,KJDBLWKTHMHALD-QMMMGPOBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28829,6cs2,DB08449,-8.3,"2-(3-((4,5,7-trifluorobenzo[d]thiazol-2-yl)methyl)-1H-pyrrolo[2,3-b]pyridin-1-yl)acetic acid",IEVFQDJUDLCOQY-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
28828,6cs2,DB08448,-8.3,"(4aS)-5-[(2,4-diaminopteridin-6-yl)methyl]-4a,5-dihydro-2H-dibenzo[b,f]azepin-8-ol",PCBWLKUEKANDCL-INIZCTEOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
59142,6crv,DB07122,-8.3,1-[4-(2-oxo-2-phenylethyl)phenyl]guanidine,MERNPSIIBFTCAI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59141,6crv,DB07121,-8.3,"4-({4-[(4-AMINOBUT-2-YNYL)OXY]PHENYL}SULFONYL)-N-HYDROXY-2,2-DIMETHYLTHIOMORPHOLINE-3-CARBOXAMIDE",AANXPIMDONQTQF-HNNXBMFYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
65125,6lxt,DB02421,-8.3,Uridine-5'-Diphosphate-Mannose,HSCJRCZFDFQWRP-NYYOCOOHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
65158,6lxt,DB02466,-8.3,"4-[3-Oxo-3-(5,5,8,8-Tetramethyl-5,6,7,8-Tetrahydro-Naphthalen-2-Yl)-Propenyl]-Benzoic Acid",ZXQHMEUGMCXKLO-KPKJPENVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
29909,6cs2,DB11796,-8.3,Fostemsavir,SWMDAPWAQQTBOG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
59122,6crv,DB07101,-8.3,PD-0325901,SUDAHWBOROXANE-SECBINFHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
33067,6cs2,T3D4029,-8.3,Okadaic acid,QNDVLZJODHBUFM-MDZDMXLPSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
59119,6crv,DB07095,-8.3,(S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclopentylpropanoyl)pyrrolidine-2-carboxamide,BNCHHUFGEOJCNH-SFHVURJKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165327,7bv1,DB11939,-8.3,Henagliflozin,HYTPDMFFHVZBOR-VNXMGFANSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59063,6crv,DB07032,-8.3,2-(4-HYDROXY-PHENYL)BENZOFURAN-5-OL,SNNNDCMXZYWCCI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
65621,6lxt,DB03081,-8.3,Crc200 (Chiron-Behring),ZOXOKTJHZSUHRJ-XZOQPEGZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
58985,6crv,DB06935,-8.3,"2',6'-DIFLUOROBIPHENYL-4-CARBOXYLIC ACID",CWWIIKLXUPZDOG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
160817,7bv1,DB11769,-8.3,Funapide,NEBUOXBYNAHKFV-NRFANRHFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
66348,6lxt,DB04064,-8.3,Nogalaviketone,QHNJNOBWURJIEK-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
66366,6lxt,DB04086,-8.3,"2',4'-Dinitrophenyl-2deoxy-2-Fluro-B-D-Cellobioside",WFVCNOHOODVBQK-IUBYCILNSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
160841,7bv1,DB11800,-8.3,Tivozanib,SPMVMDHWKHCIDT-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
66411,6lxt,DB04144,-8.3,"Cis-[4,5-Bis-(4-Chlorophenyl)-2-(2-Isopropoxy-4-Methoxyphenyl)-4,5-Dihyd Roimidazol-1-Yl]-Piperazin-1-Yl-Methanone",ZXIPEZDMQNYFOO-WUFINQPMSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
66452,6lxt,DB04196,-8.3,Pteroic Acid,JOAQINSXLLMRCV-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
35239,1r42,DB01349,-8.3,Tasosartan,ADXGNEYLLLSOAR-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
58922,6crv,DB06868,-8.3,N-(3-chlorobenzyl)-1-(4-methylpentanoyl)-L-prolinamide,PQUULPKGCNPPBX-INIZCTEOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
66571,6lxt,DB04357,-8.3,Pteric Acid,JOAQINSXLLMRCV-UHFFFAOYSA-O,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
66594,6lxt,DB04392,-8.3,"Bishydroxy[2h-1-Benzopyran-2-One,1,2-Benzopyrone]",HIZKPJUTKKJDGA-BETUJISGSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
58912,6crv,DB06856,-8.3,6-FLUORO-2-[2-HYDROXY-3-(2-METHYL-CYCLOHEXYLOXY)-PHENYL]-1H-INDOLE-5-CARBOXAMIDINE,HUYQYLFFFNSAAX-BUXKBTBVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
66672,6lxt,DB04495,-8.3,RU81843,GGPXNASQNUOIPB-NSOVKSMOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
66748,6lxt,DB04596,-8.3,"4-O-{4,6-O-[(1S)-1-Carboxyethylidene]-??-D-mannopyranosyl}-D-glucopyranuronic acid",GZJXZKGVHLWBOW-AISSFXTFSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
73367,6m2n,DB01944,-8.3,(S)-blebbistatin,LZAXPYOBKSJSEX-GOSISDBHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
1209,6lzg,HMDB0000036,-8.3,Taurocholic acid,WBWWGRHZICKQGZ-HZAMXZRMSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
36918,1r42,DB03583,-8.3,"(2e,3s)-3-Hydroxy-5'-[(4-Hydroxypiperidin-1-Yl)Sulfonyl]-3-Methyl-1,3-Dihydro-2,3'-Biindol-2'(1'h)-One",AYOAIABDFUJDKQ-SQJPUDIVSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
66254,6lxt,DB03932,-8.3,LFA703,WPVRNXUYVXQXPY-YFAYRSKXSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
58994,6crv,DB06947,-8.3,1-[(2R)-2-aminobutanoyl]-N-(4-carbamimidoylbenzyl)-L-prolinamide,YHAMQFKGUUSJMU-KGLIPLIRSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
34176,6cs2,T3D1041,-8.3,Avermectin B1a,RRZXIRBKKLTSOM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
66078,6lxt,DB03712,-8.3,RU85053,CEKLBQMULVLLTD-VMPREFPWSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
33574,6cs2,T3D4824,-8.3,CP-122721,ZIWFCOIGUNPHPM-HKUYNNGSSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
28745,6cs2,DB08355,-8.3,"1-methyl-8-(phenylamino)-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxylic acid",ZOBRPBVIEUWYJR-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
65677,6lxt,DB03157,-8.3,"N,O-Didansyl-L-Tyrosine",LUBOPDUYHWABFG-NDEPHWFRSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
65767,6lxt,DB03268,-8.3,RU82197,WKTQBTSOHBKBRW-VMPREFPWSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
65789,6lxt,DB03300,-8.3,Pterin Cytosine Dinucleotide,WKSPNQYEWZEMMI-FEFZDOOUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
160679,7bv1,DB09268,-8.3,Picosulfuric acid,UJIDKYTZIQTXPM-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
73638,6m2n,DB02300,-8.3,Calcipotriol,LWQQLNNNIPYSNX-UROSTWAQSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
28730,6cs2,DB08341,-8.3,"4-{[4-{[(1R,2R)-2-(dimethylamino)cyclopentyl]amino}-5-(trifluoromethyl)pyrimidin-2-yl]amino}-N-methylbenzenesulfonamide",CAUFYHKGKDJMQG-HZPDHXFCSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
37211,1r42,DB03966,-8.3,Clorobiocin,FJAQNRBDVKIIKK-LFLQOBSNSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
33716,6cs2,T3D4963,-8.3,Lithocholic acid,SMEROWZSTRWXGI-HRFHTWGISA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
28725,6cs2,DB08331,-8.3,"N-1H-imidazol-2-yl-N'-[4-(1H-imidazol-2-ylamino)phenyl]benzene-1,4-diamine",JHMXUERQMCJRHG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
26406,6cs2,DB04540,-8.3,Cholesterol,HVYWMOMLDIMFJA-DPAQBDIFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
165302,7bv1,DB11901,-8.3,Apalutamide,HJBWBFZLDZWPHF-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
65905,6lxt,DB03461,-8.3,2'-Monophosphoadenosine 5'-Diphosphoribose,XJLXINKUBYWONI-NNYOXOHSSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
33951,6cs2,T3D0636,-8.3,Picene,GBROPGWFBFCKAG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
33958,6cs2,T3D0677,-8.3,Hydroxocobalamin,YOZNUFWCRFCGIH-WZHZPDAFSA-K,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
66011,6lxt,DB03619,-8.3,Deoxycholic Acid,KXGVEGMKQFWNSR-LLQZFEROSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
66026,6lxt,DB03642,-8.3,Benzofuran-2-Carboxylic Acid {(S)-3-Methyl-1-[3-Oxo-1-(Pyridin-2-Ylsulfonyl)Azepan-4-Ylcarbamoyl]Butyl}Amide,VBPPNJCVXGAZDD-PMACEKPBSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
139964,6w9c,DB14655,-8.3,Drostanolone propionate,NOTIQUSPUUHHEH-UXOVVSIBSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
162411,7bv1,DB02021,-8.3,Fidarestat,WAAPEIZFCHNLKK-UFBFGSQYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
114842,6vxx,DB14998,-8.3,Olorinab,ACSQLTBPYZSGBA-GMXVVIOVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136503,6w9c,DB07190,-8.3,3-cyclohexyl-D-alanyl-N-(3-chlorobenzyl)-L-prolinamide,JGFCNVHEEMBVJG-MOPGFXCFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
134196,6w9c,DB02694,-8.3,Pantoyl Adenylate,GDPVENOGSVMRJL-FSRKKXLISA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
109694,6vxx,DB15149,-8.3,Futibatinib,KEIPNCCJPRMIAX-HNNXBMFYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
101184,6vxs,DB04582,-8.3,IMAZAQUIN,CABMTIJINOIHOD-QGZVFWFLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101204,6vxs,DB04609,-8.3,INHIBITOR Q8467 OF DUPONT MERCK,HFLCERPZYCWLSZ-VKONIRKNSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101207,6vxs,DB04614,-8.3,(R)-tacrine(10)-hupyridone,ROTFGKJJMRTWBD-HHHXNRCGSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
80435,6m2n,DB15347,-8.3,Branebrutinib,VJPPLCNBDLZIFG-ZDUSSCGKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
136985,6w9c,DB07768,-8.3,Epitestosterone,MUMGGOZAMZWBJJ-KZYORJDKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
101268,6vxs,DB04696,-8.3,"4-CHLORO-3',3''-DIBROMOPHENOL-1,8-NAPHTHALEIN",GFGZCXHXQCQRFP-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101283,6vxs,DB04716,-8.3,"2-(1,1-DIMETHYLETHYL)9-FLUORO-3,6-DIHYDRO-7H-BENZ[H]-IMIDAZ[4,5-F]ISOQUINOLIN-7-ONE",VNDWQCSOSCCWIP-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
134178,6w9c,DB02669,-8.3,RB106,ZWDQTNWLXALTOV-QYZOEREBSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
101335,6vxs,DB04791,-8.3,"2-O-(4'-AMIDINOPHENYL)-5-O-(3''-AMIDINOPHENYL)-1,4:3,6-DIANHYDRO-D-SORBITOL",DKBAWRNTUZFJKV-BSDSXHPESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
136994,6w9c,DB07779,-8.3,N-({(2S)-1-[(3R)-3-AMINO-4-(2-FLUOROPHENYL)BUTANOYL]PYRROLIDIN-2-YL}METHYL)BENZAMIDE,ANQHSFFUNMTTRS-MOPGFXCFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
134154,6w9c,DB02639,-8.3,4-methylumbelliferyl ??-D-glucoside,YUDPTGPSBJVHCN-JZYAIQKZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
80400,6m2n,DB15287,-8.3,Elismetrep,CWEFDWIKLABKBX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137005,6w9c,DB07791,-8.3,4-{[4-(1-CYCLOPROPYL-2-METHYL-1H-IMIDAZOL-5-YL)PYRIMIDIN-2-YL]AMINO}-N-METHYLBENZENESULFONAMIDE,MZWCVBFANHIPTJ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137009,6w9c,DB07795,-8.3,Fisetin,XHEFDIBZLJXQHF-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137019,6w9c,DB07806,-8.3,"(2R,4S)-2-[(R)-BENZYLCARBAMOYL-PHENYLACETYL-METHYL]-5,5-DIMETHYL-THIAZOLIDINE-4-CARBOXYLIC ACID",UDMBRVGTYILYDX-SVFBPWRDSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
123283,6w4b,DB15233,-8.3,Avapritinib,DWYRIWUZIJHQKQ-SANMLTNESA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
109656,6vxx,DB15078,-8.3,Rogaratinib,HNLRRJSKGXOYNO-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
128500,6w4h,DB07686,-8.3,"4-{[5-(CYCLOHEXYLAMINO)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE",VPOGRVWIIVMWRI-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
101064,6vxs,DB04430,-8.3,3-(4-Phenylamino-Phenylamino)-2-(1h-Tetrazol-5-Yl)-Acrylonitrile,FLPLCJJGNZGOAW-QXMHVHEDSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
84923,6m3m,DB07058,-8.3,"5-[1-(4-methoxyphenyl)-1H-benzimidazol-6-yl]-1,3,4-oxadiazole-2(3H)-thione",QBVJMUOTMRYUKR-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84921,6m3m,DB07056,-8.3,"2-(6-{[(3-chloro-2-methylphenyl)sulfonyl]amino}pyridin-2-yl)-N,N-diethylacetamide",JNWQLOFSMUGRNY-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80606,6m3m,DB00215,-8.3,Citalopram,WSEQXVZVJXJVFP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80604,6m3m,DB00213,-8.3,Pantoprazole,IQPSEEYGBUAQFF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136895,6w9c,DB07663,-8.3,"2-[(1R)-1-CARBOXY-2-(4-HYDROXYPHENYL)ETHYL]-1,3-DIOXOISOINDOLINE-5-CARBOXYLIC ACID",QISJEFYTLZTWIQ-CQSZACIVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136896,6w9c,DB07664,-8.3,"5-AMINO-3-{[4-(AMINOSULFONYL)PHENYL]AMINO}-N-(2,6-DIFLUOROPHENYL)-1H-1,2,4-TRIAZOLE-1-CARBOTHIOAMIDE",ARIOBGGRZJITQX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
88800,6m3m,DB14835,-8.3,SUVN-G3031,LNXDUSQEXVQFGP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80573,6m3m,DB00175,-8.3,Pravastatin,TUZYXOIXSAXUGO-PZAWKZKUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
119061,6w4b,DB06876,-8.3,"N-{5-[4-(4-METHYLPIPERAZIN-1-YL)PHENYL]-1H-PYRROLO[2,3-B]PYRIDIN-3-YL}NICOTINAMIDE",YJWJKKXGAPWLGT-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
80569,6m3m,DB00171,-8.3,ATP,ZKHQWZAMYRWXGA-KQYNXXCUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
134255,6w9c,DB02833,-8.3,[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(3-Nitro-Phenyl)-Amine,DYTKVFHLKPDNRW-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
134147,6w9c,DB02628,-8.3,"1-[3,3-Dimethyl-2-(2-Methylamino-Propionylamino)-Butyryl]-Pyrrolidine-2-Carboxylic Acid(1,2,3,4-Tetrahydro-Naphthalen-1-Yl)-Amide",JUJIMRZGUBTJRV-NASSWSRMSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
100685,6vxs,DB03916,-8.3,4-{2-[4-(2-Aminoethyl)Piperazin-1-Yl]Pyridin-4-Yl}-N-(3-Chloro-4-Methylphenyl)Pyrimidin-2-Amine,RHOOHUMOHVIXEF-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
100712,6vxs,DB03950,-8.3,(S)-N-(3-Indol-1-Yl-2-Methyl-Propyl)-4-Sulfamoyl-Benzamide,ZFWHOUCRVSOZJE-AWEZNQCLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
84908,6m3m,DB07042,-8.3,"7-amino-2-tert-butyl-4-{[2-(1H-imidazol-4-yl)ethyl]amino}pyrido[2,3-d]pyrimidine-6-carboxamide",XESUNWBIAADLPI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
100758,6vxs,DB04014,-8.3,Alsterpaullone,OLUKILHGKRVDCT-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
88786,6m3m,DB14791,-8.3,GDC-0425,XEZLBMHDUXSICI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
100792,6vxs,DB04064,-8.3,Nogalaviketone,QHNJNOBWURJIEK-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
80497,6m2n,DB02930,-8.3,Adenosine 5'-[gamma-thio]triphosphate,NLTUCYMLOPLUHL-KQYNXXCUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
109728,6vxx,DB15219,-8.3,Tomivosertib,HKTBYUWLRDZAJK-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88763,6m3m,DB14737,-8.3,Cannabinol,VBGLYOIFKLUMQG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
118882,6w4b,DB06555,-8.3,Siramesine,XWAONOGAGZNUSF-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
118971,6w4b,DB06732,-8.3,beta-Naphthoflavone,OUGIDAPQYNCXRA-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
80365,6m2n,DB15212,-8.3,Pemafibrate,ZHKNLJLMDFQVHJ-RUZDIDTESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137041,6w9c,DB07830,-8.3,"(4R,5R)-5-AMINO-1-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN-2-ONE",DIRIFWIKLRTNMB-DYVFJYSZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
128453,6w4h,DB07629,-8.3,"N-((1R,2S)-2-(5-CHLORO-1H-INDOLE-2-CARBOXAMIDO)CYCLOHEXYL)-5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE-2-CARBOXAMIDE",ARPFWVKYXJZULB-DLBZAZTESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
80253,6m2n,DB14987,-8.3,Difamilast,VFBILHPIHUPBPZ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
101679,6vxs,DB06212,-8.3,Tolvaptan,GYHCTFXIZSNGJT-XMMPIXPASA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
130421,6w4h,DB12242,-8.3,AZD-7762,IAYGCINLNONXHY-LBPRGKRZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
85008,6m3m,DB07157,-8.3,"(5R,6S,8S)-8-[3-(AMINOMETHYL)PHENYL]-6-HYDROXY-5-ISOPROPYL-3-OXO-1-PHENYL-2,7-DIOXA-4-AZA-6-PHOSPHANONAN-9-OIC ACID 6-OXIDE",RTFGEFWZCFCODU-RBUKOAKNSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
130452,6w4h,DB12285,-8.3,Verubecestat,YHYKUSGACIYRML-KRWDZBQOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
134054,6w9c,DB02505,-8.3,N-(R-Carboxy-Ethyl)-Alpha-(S)-(2-Phenylethyl),JJVQUUYZGJWBPW-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
109561,6vxx,DB14125,-8.3,Benazeprilat,MADRIHWFJGRSBP-ROUUACIJSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130467,6w4h,DB12303,-8.3,Motolimod,QSPOQCXMGPDIHI-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
88612,6m3m,DB14127,-8.3,Sacubitrilat,DOBNVUFHFMVMDB-BEFAXECRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
101655,6vxs,DB06163,-8.3,Plevitrexed,IEJSCSAMMLUINT-NRFANRHFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
88609,6m3m,DB14122,-8.3,Dihydroxymethoxychalcone,NYSZJNUIVUBQMM-BQYQJAHWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
9428,6lzg,DB07528,-8.3,3-(2-aminoquinazolin-6-yl)-4-methyl-1-[3-(trifluoromethyl)phenyl]pyridin-2(1H)-one,HXUZQEYFKAZBPX-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
137236,6w9c,DB08055,-8.3,"N-(2-chlorophenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine",NNBICZMPIJMWGC-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
85027,6m3m,DB07179,-8.3,"3-((3-bromo-5-o-tolylpyrazolo[1,5-a]pyrimidin-7-ylamino)methyl)pyridine 1-oxide",DXUJQXZHHGJMFM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88555,6m3m,DB14014,-8.3,SR-9011,PPUYOYQTTWJTIU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
123259,6w4b,DB15192,-8.3,ABT-288,GNIRITULTPTAQW-KNQAVFIVSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
8826,6lzg,DB06882,-8.3,1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-naphthalen-1-ylurea,HJWMLCDGRWWLAQ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
85036,6m3m,DB07188,-8.3,"(3S)-1-CYCLOHEXYL-N-(3,5-DICHLOROPHENYL)-5-OXOPYRROLIDINE-3-CARBOXAMIDE",YUFADRZDHJKVOT-NSHDSACASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
101989,6vxs,DB06879,-8.3,"5-(4'-AMINO-1'-ETHYL-5',8'-DIFLUORO-1'H-SPIRO[PIPERIDINE-4,2'-QUINAZOLINE]-1-YLCARBONYL)PICOLINONITRILE",QCFIRACCCDFXIP-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
17290,6cs2,HMDB0007165,-8.3,DG(18:0/20:0/0:0),JPKVDETWOQEHQO-KDXMTYKHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
80200,6m2n,DB14857,-8.3,Avadomide,RSNPAKAFCAAMBH-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
100470,6vxs,DB03642,-8.3,Benzofuran-2-Carboxylic Acid {(S)-3-Methyl-1-[3-Oxo-1-(Pyridin-2-Ylsulfonyl)Azepan-4-Ylcarbamoyl]Butyl}Amide,VBPPNJCVXGAZDD-PMACEKPBSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
137133,6w9c,DB07938,-8.3,"5-[[(2R)-2-cyclopropyl-7,8-dimethoxy-chroman-5-yl]methyl]pyrimidine-2,4-diamine",HWJPWWYTGBZDEG-CQSZACIVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
15247,6lzg,T3D0636,-8.3,Picene,GBROPGWFBFCKAG-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
124583,6w4h,DB01380,-8.3,Cortisone acetate,ITRJWOMZKQRYTA-RFZYENFJSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
101450,6vxs,DB04983,-8.3,Denufosol,FPNPSEMJLALQSA-MIYUEGBISA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
84963,6m3m,DB07107,-8.3,(1S)-2-(1H-INDOL-3-YL)-1-[({5-[(E)-2-PYRIDIN-4-YLVINYL]PYRIDIN-3-YL}OXY)METHYL]ETHYLAMINE,SGHXFHRRWFLILP-XJDXJNMNSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88718,6m3m,DB14654,-8.3,Bisoxatin acetate,ZCBJDQBSLZREAA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
101479,6vxs,DB05137,-8.3,Lobeline,MXYUKLILVYORSK-HBMCJLEFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
88714,6m3m,DB14650,-8.3,Menadiol diphosphate,JTNHOVZOOVVGHI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
10094,6lzg,DB08242,-8.3,"N,4-dimethyl-3-[(1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl)amino]benzamide",OYTBZXSFNNAVKU-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
101517,6vxs,DB05408,-8.3,Emricasan,SCVHJVCATBPIHN-SJCJKPOMSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
124595,6w4h,DB01406,-8.3,Danazol,POZRVZJJTULAOH-LHZXLZLDSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
101642,6vxs,DB06144,-8.3,Sertindole,GZKLJWGUPQBVJQ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
80311,6m2n,DB15109,-8.3,Ingenol disoxate,GLIUZQUNUNICGS-XUBYYPQFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
134102,6w9c,DB02567,-8.3,PD173955,VAARYSWULJUGST-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
124599,6w4h,DB01411,-8.3,Pranlukast,NBQKINXMPLXUET-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130389,6w4h,DB12198,-8.3,Fosdagrocorat,BVXLAHSJXXSWFF-KEKPKEOLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
137124,6w9c,DB07929,-8.3,"N-(TERT-BUTYL)-3,5-DIMETHYL-N'-[(5-METHYL-2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)CARBONYL]BENZOHYDRAZIDE",JGJACZABNQGPMT-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
130392,6w4h,DB12204,-8.3,Terbogrel,XUTLOCQNGLJNSA-RGVLZGJSSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130394,6w4h,DB12207,-8.3,Verdinexor,OPAKEJZFFCECPN-XQRVVYSFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
101615,6vxs,DB05944,-8.3,Varlitinib,UWXSAYUXVSFDBQ-CYBMUJFWSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
137128,6w9c,DB07933,-8.3,Erteberel,XIESSJVMWNJCGZ-VKJFTORMSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
101624,6vxs,DB05990,-8.3,Obeticholic acid,ZXERDUOLZKYMJM-ZWECCWDJSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
84987,6m3m,DB07132,-8.3,1-{2-OXO-3-[(1R)-1-(1H-PYRROL-2-YL)ETHYL]-2H-INDOL-5-YL}UREA,KJDBLWKTHMHALD-QMMMGPOBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
8827,6lzg,DB06883,-8.3,1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-phenylurea,DHNYNLNKNQJSHF-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
100462,6vxs,DB03632,-8.3,Argifin,UHBHXSDKGLPPGO-HTDHLNIYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
80616,6m3m,DB00227,-8.3,Lovastatin,PCZOHLXUXFIOCF-BXMDZJJMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
130054,6w4h,DB11701,-8.3,Amenamevir,MNHNIVNAFBSLLX-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
80945,6m3m,DB00623,-8.3,Fluphenazine,PLDUPXSUYLZYBN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
130080,6w4h,DB11742,-8.3,Ebastine,MJJALKDDGIKVBE-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
88988,6m3m,DB15235,-8.3,Di-2-pyridylketone 4-cyclohexyl-4-methyl-3-thiosemicarbazone,GNLZNQJBZNOUBM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136776,6w9c,DB07519,-8.3,"(6R)-2-amino-6-[2-(3'-methoxybiphenyl-3-yl)ethyl]-3,6-dimethyl-5,6-dihydropyrimidin-4(3H)-one",VDFBMQAUECXNKR-OAQYLSRUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
134533,6w9c,DB03205,-8.3,Pyrroloquinoline Quinone,MMXZSJMASHPLLR-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
84775,6m3m,DB06887,-8.3,"[(3S)-3-(Methylcarbamoyl)-2-{[(2-methyl-2-propanyl)oxy]carbonyl}-1,2,3,4-tetrahydro-7-isoquinolinyl]sulfamic acid",PPSSYXOFPICMQD-ZDUSSCGKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
13176,6lzg,DB14845,-8.3,Filgotinib,RIJLVEAXPNLDTC-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
84777,6m3m,DB06889,-8.3,"3-(1H-tetrazol-5-ylmethyl)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(3H)-one",QSBQXAOOVSQABJ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
99360,6vxs,DB02152,-8.3,K-252a,KOZFSFOOLUUIGY-SOLYNIJKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
99362,6vxs,DB02154,-8.3,"2,3-Bis-Benzo[1,3]Dioxol-5-Ylmethyl-Succinic Acid",FFYBYVPVYLMLAR-KBPBESRZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
123331,6w4b,DB15327,-8.3,Abivertinib,UOFYSRZSLXWIQB-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
80910,6m3m,DB00582,-8.3,Voriconazole,BCEHBSKCWLPMDN-MGPLVRAMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
13164,6lzg,DB14810,-8.3,AZD-1656,FJEJHJINOKKDCW-INIZCTEOSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
80907,6m3m,DB00579,-8.3,Mazindol,ZPXSCAKFGYXMGA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
134515,6w9c,DB03181,-8.3,"2-[4-(4-Hydroxy-3-Isopropyl-Phenoxy)-3,5-Dimethyl-Phenyl]-2h-[1,2,4]Triazine-3,5-Dione",RXQAVKWRCZYGMV-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136793,6w9c,DB07538,-8.3,"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}-2-(TRIFLUOROMETHYL)BENZENESULFONAMIDE",RGVVHQNJKUNSFQ-WDZFZDKYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
111680,6vxx,DB04373,-8.3,"4-Amino-N-{4-[2-(2,6-Dimethyl-Phenoxy)-Acetylamino]-3-Hydroxy-1-Isobutyl-5-Phenyl-Pentyl}-Benzamide",WQUBEIMCFHCJCO-AWCRTANDSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113757,6vxx,DB12042,-8.3,Ibodutant,YQYSVMKCMIUCHY-WJOKGBTCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
99191,6vxs,DB01933,-8.3,7-Hydroxystaurosporine,PBCZSGKMGDDXIJ-HQCWYSJUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
80967,6m3m,DB00652,-8.3,Pentazocine,VOKSWYLNZZRQPF-GDIGMMSISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
128653,6w4h,DB07861,-8.3,(2R)-N-hydroxy-3-naphthalen-2-yl-2-[(naphthalen-2-ylsulfonyl)amino]propanamide,MMOUXLMPQFMDRD-JOCHJYFZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
113746,6vxx,DB12022,-8.3,Evatanepag,WOHRHWDYFNWPNG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
89052,6m3m,DB15359,-8.3,Xanthohumol,ORXQGKIUCDPEAJ-YRNVUSSQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
128742,6w4h,DB07967,-8.3,9-CYCLOPENTYL-6-[2-(3-IMIDAZOL-1-YL-PROPOXY)-PHENYLAMINO]-9H-PURINE-2-CARBONITRILE,JJNKDTWKWYLERH-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
129993,6w4h,DB11591,-8.3,Bilastine,ACCMWZWAEFYUGZ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
81109,6m3m,DB00821,-8.3,Carprofen,PUXBGTOOZJQSKH-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
109848,6vxx,DB00328,-8.3,Indometacin,CGIGDMFJXJATDK-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
98999,6vxs,DB01668,-8.3,Nanaomycin D,XUWPJKDMEZSVTP-UOSCCXBLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
109847,6vxx,DB00327,-8.3,Hydromorphone,WVLOADHCBXTIJK-YNHQPCIGSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109846,6vxx,DB00324,-8.3,Fluorometholone,FAOZLTXFLGPHNG-KNAQIMQKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136694,6w9c,DB07422,-8.3,(2S)-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]-3-(pentafluorophenoxy)propanamide,MMNRWNREMUMYQG-INIZCTEOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
130130,6w4h,DB11816,-8.3,Omecamtiv Mecarbil,RFUBTTPMWSKEIW-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
81064,6m3m,DB00767,-8.3,Benzquinamide,JSZILQVIPPROJI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81058,6m3m,DB00760,-8.3,Meropenem,DMJNNHOOLUXYBV-PQTSNVLCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
13220,6lzg,DB14918,-8.3,Branaplam,STWTUEAWRAIWJG-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
99078,6vxs,DB01772,-8.3,"3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl]-4-(5-Fluoro-1-Methyl-1h-Indol-3-Yl)-Pyrrole-2,5-Dione",RPGZQOOZHIEPJW-HNNXBMFYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
136713,6w9c,DB07444,-8.3,"6-(3-AMINOPROPYL)-4,9-DIMETHYLPYRROLO[3,4-C]CARBAZOLE-1,3(2H,6H)-DIONE",PKPNSCZPIWCHMW-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
99079,6vxs,DB01774,-8.3,Adenosine-5'-Monophosphate Glucopyranosyl-Monophosphate Ester,WFPZSXYXPSUOPY-ROYWQJLOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
13211,6lzg,DB14902,-8.3,JHU-75528 C-11,MCNQUWLLXZZZAC-BJUDXGSMSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
124370,6w4h,DB01070,-8.3,Dihydrotachysterol,ILYCWAKSDCYMBB-OPCMSESCSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
128666,6w4h,DB07874,-8.3,"(6S)-2-amino-6-(3'-methoxybiphenyl-3-yl)-3,6-dimethyl-5,6-dihydropyrimidin-4(3H)-one",LQOCXPOKEPYGTJ-IBGZPJMESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
136723,6w9c,DB07455,-8.3,"N,N'-[biphenyl-4,4'-diyldi(2R)propane-2,1-diyl]dimethanesulfonamide",ZESUARCHWPARIF-HOTGVXAUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
89039,6m3m,DB15335,-8.3,Formononetin,HKQYGTCOTHHOMP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
113762,6vxx,DB12048,-8.3,Savolitinib,XYDNMOZJKOGZLS-NSHDSACASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
99513,6vxs,DB02358,-8.3,LY374571,SZHRIPFGZWWRKW-VIFPVBQESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
99515,6vxs,DB02360,-8.3,Bis-Napthyl Beta-Ketophosphonic Acid,OFHMUASCSJJNNA-JOCHJYFZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
134382,6w9c,DB02998,-8.3,Metribolone,CCCIJQPRIXGQOE-XWSJACJDSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136820,6w9c,DB07571,-8.3,"N-2-[(BENZYLOXY)CARBONYL]-N-[(1S,2S)-2-HYDROXY-1-(4-HYDROXYBENZYL)PROPYL]-L-LEUCINAMIDE",ZUWYQZGBCBSHFK-HSQYWUDLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
113775,6vxx,DB12066,-8.3,Orteronel,OZPFIJIOIVJZMN-SFHVURJKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113777,6vxx,DB12070,-8.3,Letermovir,FWYSMLBETOMXAG-QHCPKHFHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130239,6w4h,DB11971,-8.3,Vilaprisan,JUFWQQVHQFDUOD-ANRPBIDPSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
100296,6vxs,DB03383,-8.3,5-Chloro-1h-Indole-2-Carboxylic Acid [1-(4-Fluorobenzyl)-2-(4-Hydroxypiperidin-1yl)-2-Oxoethyl]Amide,YDCGVASFVACWKF-NRFANRHFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
130241,6w4h,DB11978,-8.3,Glasdegib,SFNSLLSYNZWZQG-VQIMIIECSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
124425,6w4h,DB01134,-8.3,Desoxycorticosterone pivalate,VVOIQBFMTVCINR-WWMZEODYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130247,6w4h,DB11987,-8.3,GSK-2018682,NFIGDBFIDKDNIG-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
80763,6m3m,DB00400,-8.3,Griseofulvin,DDUHZTYCFQRHIY-RBHXEPJQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
100338,6vxs,DB03447,-8.3,Uridylyl-2'-5'-Phospho-Adenosine,QARCCHXXGAIRFS-KPKSGTNCSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
100359,6vxs,DB03476,-8.3,Trans-6-(2-Phenylcyclopropyl)-Naphthalene-2-Carboxamidine,NQRIWXVAIWPBEM-OALUTQOASA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
80685,6m3m,DB00305,-8.3,Mitomycin,NWIBSHFKIJFRCO-WUDYKRTCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84886,6m3m,DB07019,-8.3,"N-[(5R,14R)-5-AMINO-5,14-DIMETHYL-4-OXO-3-OXA-18-AZATRICYCLO[15.3.1.1-7,11-]DOCOSA-1(21),7(22),8,10,17,19-HEXAEN-19-YL]-N-METHYLMETHANESULFONAMIDE",QWDOKZPZLWNULU-MZNJEOGPSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
113791,6vxx,DB12092,-8.3,Naftopidil,HRRBJVNMSRJFHQ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113792,6vxx,DB12093,-8.3,Tetrahydropalmatine,AEQDJSLRWYMAQI-KRWDZBQOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136879,6w9c,DB07642,-8.3,"5-{[1-(2-fluorobenzyl)piperidin-4-yl]methoxy}quinazoline-2,4-diamine",GYKIQIOWVKCVBP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
100395,6vxs,DB03523,-8.3,Brequinar,PHEZJEYUWHETKO-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
119114,6w4b,DB06933,-8.3,N-(tert-butyl)-4-[5-(pyridin-2-ylamino)quinolin-3-yl]benzenesulfonamide,GJTCKUKIFXWJKG-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
128548,6w4h,DB07743,-8.3,"S-[5-(TRIFLUOROMETHYL)-4H-1,2,4-TRIAZOL-3-YL] 5-(PHENYLETHYNYL)FURAN-2-CARBOTHIOATE",VNGWUVBXUIDQTK-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
113788,6vxx,DB12084,-8.3,ADP-597,WPDCHTSXOPUOII-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
100441,6vxs,DB03596,-8.3,N-[2-(1h-Indol-5-Yl)-Butyl]-4-Sulfamoyl-Benzamide,FSRPBGBMEKDSIJ-CYBMUJFWSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
134390,6w9c,DB03010,-8.3,Patupilone,QXRSDHAAWVKZLJ-PVYNADRNSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
100124,6vxs,DB03161,-8.3,Thymidine-5'-Diphospho-Beta-D-Xylose,AJUADKZRQSBUAK-KDGZBOQCSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
88919,6m3m,DB15105,-8.3,PF-06751979,ZLZUHACSRMOLLV-RAALSFIWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
128611,6w4h,DB07813,-8.3,GLYCYLALANYL-N-2-NAPHTHYL-L-PROLINEAMIDE,KCELZXZDIUJGNM-GUYCJALGSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
18950,6cs2,HMDB0041768,-8.3,Phloretin 2'-O-glucuronide,YFJJAJIWPWXWJJ-ZFORQUDYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
99692,6vxs,DB02581,-8.3,"5-[2,3-Dichloro-4-(5-{1-[2-(2-Guanidino-4-Methyl-Pentanoylamino)-Acetyl]-Piperidin-4-Yl}-1-Methyl-1h-Pyrazol-3-Yl)-Phenoxymethyl]-Furan-2-Carboxylic Acid",VNZHOIDQBPFEJU-OAQYLSRUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
99714,6vxs,DB02610,-8.3,"N-(2,3,4,5,6-Pentaflouro-Benzyl)-4-Sulfamoyl-Benzamide",LRKSHOLYETXPGY-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
111704,6vxx,DB04407,-8.3,4-[4-(4-Methyl-2-Methylamino-Thiazol-5-Yl)-Pyrimidin-2-Ylamino]-Phenol,OTMLAWRVLMYMDF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130174,6w4h,DB11878,-8.3,Filibuvir,SLVAPEZTBDBAPI-GDLZYMKVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
136799,6w9c,DB07545,-8.3,N-{3-[(4-{[3-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-2-YL)AMINO]PHENYL}CYCLOPROPANECARBOXAMIDE,RDTDWGQDFJPTPD-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
80863,6m3m,DB00525,-8.3,Tolnaftate,FUSNMLFNXJSCDI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80775,6m3m,DB00415,-8.3,Ampicillin,AVKUERGKIZMTKX-NJBDSQKTSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
109784,6vxx,DB00252,-8.3,Phenytoin,CXOFVDLJLONNDW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
128602,6w4h,DB07804,-8.3,"5-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1H-1,2,4-TRIAZOLE-3-SULFONAMIDE",FKCQUVAGEOSYRU-QWRGUYRKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
84812,6m3m,DB06927,-8.3,[5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-YL]ACETONITRILE,ZKJVCUXZMYKTLT-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
121257,6w4b,DB11618,-8.3,Zorubicin,FBTUMDXHSRTGRV-BJISBDEGSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
88875,6m3m,DB15021,-8.3,Leriglitazone,OXVFDZYQLGRLCD-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
99921,6vxs,DB02887,-8.3,"2',3'-Dehydro-2',3'-Deoxy-Thymidine 5'-Triphosphate",ODSQODTUNULBHF-JGVFFNPUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
123313,6w4b,DB15294,-8.3,SB-1578,NNXDIGHYPZHXTR-ONEGZZNKSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
111741,6vxx,DB04461,-8.3,Coproporphyrinogen III,NIUVHXTXUXOFEB-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136810,6w9c,DB07559,-8.3,"(2Z)-2-cyano-N-(2,2'-dichlorobiphenyl-4-yl)-3-hydroxybut-2-enamide",DDSLONVJHZPSBB-UVTDQMKNSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
130217,6w4h,DB11942,-8.3,Selinexor,DEVSOMFAQLZNKR-RJRFIUFISA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
136802,6w9c,DB07548,-8.3,"2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUORO-6-PYRIDINYL)METHYL]ACETAMIDE",JXHWVKOKYDAROD-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
85047,6m3m,DB07201,-8.3,(2S)-3-[(9H-fluoren-9-ylideneamino)oxy]-2-methylpropanoic acid,ZHFDVDMCVXUGGF-NSHDSACASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
128354,6w4h,DB07511,-8.3,"4-(4-methyl-1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)benzonitrile",MVYDBJXCIFMINH-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
80123,6m2n,DB14671,-8.3,Temazepam acetate,PTWWAHZQIATUFG-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
112889,6vxx,DB08116,-8.3,"(3R)-4-{[(3,4-dihydroxyphenyl)acetyl]oxy}-N-(2-formylindolizin-3-yl)-3-sulfino-D-valine",DEOZLEGRVHDNKC-UGKGYDQZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88034,6m3m,DB13256,-8.3,Clothiapine,KAAZGXDPUNNEFN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
118390,6w4b,DB04764,-8.3,[4-(3-AMINOMETHYL-PHENYL)-PIPERIDIN-1-YL]-(5-PHENETHYL- PYRIDIN-3-YL)-METHANONE,CCLHROFBSWWOQO-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
88030,6m3m,DB13252,-8.3,Tropatepine,JOQKFRLFXDPXHX-HDICACEKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
103279,6vxs,DB08389,-8.3,"6,7-DIMETHOXY-4-[(3R)-3-(2-NAPHTHYLOXY)PYRROLIDIN-1-YL]QUINAZOLINE",UPTQSRGSSJRBKJ-LJQANCHMSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
133716,6w9c,DB02059,-8.3,Adenosine-5-Diphosphoribose,SRNWOUGRCWSEMX-ZQSHOCFMSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
87989,6m3m,DB13182,-8.3,Daidzein,ZQSIJRDFPHDXIC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
103336,6vxs,DB08459,-8.3,"3-chloro-5-[2-chloro-5-(1H-pyrazolo[3,4-b]pyridin-3-ylmethoxy)phenoxy]benzonitrile",SVMHTBVIPYVDIL-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
103340,6vxs,DB08463,-8.3,(2R)-2-({9-(1-methylethyl)-6-[(4-pyridin-2-ylbenzyl)amino]-9H-purin-2-yl}amino)butan-1-ol,HOCBJBNQIQQQGT-LJQANCHMSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
87981,6m3m,DB13166,-8.3,Zofenopril,IAIDUHCBNLFXEF-MNEFBYGVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
109307,6vxx,DB13048,-8.3,PAC-1,YQNRVGJCPCNMKT-LFVJCYFKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130695,6w4h,DB12645,-8.3,Givinostat,YALNUENQHAQXEA-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
112881,6vxx,DB08108,-8.3,N-({6-[(4-CYANOBENZYL)OXY]NAPHTHALEN-2-YL}SULFONYL)-D-GLUTAMIC ACID,PUHRQSFXADUGJW-OAQYLSRUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79298,6m2n,DB13046,-8.3,Tocladesine,CLLFEJLEDNXZNR-UUOKFMHZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
87970,6m3m,DB13136,-8.3,Fluindione,NASXCEITKQITLD-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
130745,6w4h,DB12719,-8.3,Turofexorate isopropyl,INASOKQDNHHMRE-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
103502,6vxs,DB08657,-8.3,2-(4-(2-((3-(5-(PYRIDIN-2-YLTHIO)THIAZOL-2-YL)UREIDO)METHYL)-1H-IMIDAZOL-4-YL)PHENOXY)ACETIC ACID,SSXCWVOQWRUMGN-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
10210,6lzg,DB08384,-8.3,2-({4-[4-(pyridin-4-ylmethyl)-1H-pyrazol-3-yl]phenoxy}methyl)quinoline,RQDDHVVAAJVVKM-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
137511,6w9c,DB08388,-8.3,"5-(2-ETHOXYETHYL)-5-[4-(4-FLUOROPHENOXY)PHENOXY]PYRIMIDINE-2,4,6(1H,3H,5H)-TRIONE",XRSYNYGEEYTXJV-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
88046,6m3m,DB13276,-8.3,Idanpramine,HVYGXNYMNHSBGD-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
103182,6vxs,DB08267,-8.3,"6-amino-4-(2-phenylethyl)-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",PBZAIUVFRISTSZ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
133749,6w9c,DB02101,-8.3,"(S,R)-fidarestat",WAAPEIZFCHNLKK-QPUJVOFHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
128184,6w4h,DB07311,-8.3,"18-CHLORO-11,12,13,14-TETRAHYDRO-1H,10H-8,4-(AZENO)-9,15,1,3,6-BENZODIOXATRIAZACYCLOHEPTADECIN-2-ONE",JRSWWYITYIOHOP-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
113988,6vxx,DB12553,-8.3,Fluocinolone,UUOUOERPONYGOS-CLCRDYEYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79435,6m2n,DB13276,-8.3,Idanpramine,HVYGXNYMNHSBGD-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
85163,6m3m,DB07332,-8.3,"ALPHA-(2,6-DICHLOROPHENYL)-ALPHA-(2-ACETYL-5-METHYLANILINO)ACETAMIDE",CJPLEFFCVDQQFZ-INIZCTEOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88165,6m3m,DB13430,-8.3,Mebutizide,KJLLKLRVCJAFRY-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
109359,6vxx,DB13463,-8.3,Oxetorone,VZVRZTZPHOHSCK-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79415,6m2n,DB13246,-8.3,Quinupramine,JCBQCKFFSPGEDY-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
102992,6vxs,DB08042,-8.3,"N-4-methyl-N-4-(3-methyl-1H-indazol-6-yl)-N-2-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine",FLXGQDHYCWXTAI-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
118464,6w4b,DB04859,-8.3,Zanapezil,PMBLXLOXUGVTGB-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
88094,6m3m,DB13337,-8.3,Pheneticillin,NONJJLVGHLVQQM-JHXYUMNGSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
109305,6vxx,DB13044,-8.3,Gossypol,QBKSWRVVCFFDOT-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
123154,6w4b,DB14943,-8.3,LGH-447,VRQXRVAKPDCRCI-ZNMIVQPWSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
85190,6m3m,DB07363,-8.3,"THIOPHENE-2,5-DISULFONIC ACID 2-AMIDE-5-(4-METHYL-BENZYLAMIDE)",GUNRMHMEAWSZQE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
118414,6w4b,DB04796,-8.3,Inecalcitol,HHGRMHMXKPQNGF-WNSNRMDMSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
103097,6vxs,DB08159,-8.3,"4-(5,11-DIOXO-5H-INDENO[1,2-C]ISOQUINOLIN-6(11H)-YL)BUTANOATE",AHIJTWCJGCWHMT-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
113997,6vxx,DB12566,-8.3,Decernotinib,ASUGUQWIHMTFJL-QGZVFWFLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
137472,6w9c,DB08340,-8.3,"N,N'-DIPHENYLPYRAZOLO[1,5-A][1,3,5]TRIAZINE-2,4-DIAMINE",LLYYAUZAGCZEKV-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
114001,6vxx,DB12572,-8.3,Pexacerfont,LBWQSAZEYIZZCE-SNVBAGLBSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
123140,6w4b,DB14918,-8.3,Branaplam,STWTUEAWRAIWJG-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
88062,6m3m,DB13300,-8.3,Epicillin,RPBAFSBGYDKNRG-NJBDSQKTSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88058,6m3m,DB13292,-8.3,Pimethixene,NZLVRVYNQYGMAB-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
103033,6vxs,DB08092,-8.3,3-fluoro-N-1H-indol-5-yl-5-morpholin-4-ylbenzamide,VMLSXFMXUNVCSK-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
114043,6vxx,DB12643,-8.3,Nelivaptan,NJXZWIIMWNEOGJ-WEWKHQNJSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87924,6m3m,DB13065,-8.3,LY-2811376,MJQMRGWYPNIERM-HNNXBMFYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
124987,6w4h,DB01893,-8.3,N6-Benzyl Adenosine-5'-Diphosphate,MRHGMAGSDAQUFH-LSCFUAHRSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
112871,6vxx,DB07942,-8.3,2-fluoro-4-[4-(4-fluorophenyl)-1H-pyrazol-3-yl]pyridine,YJCHZVXSPFPKMX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
137596,6w9c,DB08491,-8.3,N-HYDROXY-2-[4-(4-PHENOXY-BENZENESULFONYL)-TETRAHYDRO-PYRAN-4-YL]-ACETAMIDE,ARIRIZBKMKMEBD-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
79147,6m2n,DB12808,-8.3,Trifarotene,MFBCDACCJCDGBA-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
130838,6w4h,DB12877,-8.3,Oxatomide,BAINIUMDFURPJM-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
15630,6lzg,DB00590,-8.3,Doxazosin,RUZYUOTYCVRMRZ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
85314,6m3m,DB07512,-8.3,7-[(3-CHLOROBENZYL)OXY]-2-OXO-2H-CHROMENE-4-CARBALDEHYDE,ZOCADHRNWNJARU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
103905,6vxs,DB09223,-8.3,Blonanserin,XVGOZDAJGBALKS-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
114071,6vxx,DB12682,-8.3,Mubritinib,ZTFBIUXIQYRUNT-MDWZMJQESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130848,6w4h,DB12888,-8.3,Ezutromid,KSGCNXAZROJSNW-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
85296,6m3m,DB07490,-8.3,"2-[1-(4-CHLORO-PHENYL)-ETHYL]-4,6-DINITRO-PHENOL",MOZUMFSUQQHSCO-MRVPVSSYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
103919,6vxs,DB09238,-8.3,Manidipine,ANEBWFXPVPTEET-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
103954,6vxs,DB09295,-8.3,Talniflumate,ANMLJLFWUCQGKZ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
12231,6lzg,DB13070,-8.3,Surinabant,HMXDWDSNPRNUKI-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
137607,6w9c,DB08502,-8.3,Capravirine,YQXCVAGCMNFUMQ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
111978,6vxx,DB05022,-8.3,Amonafide,UPALIKSFLSVKIS-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
12222,6lzg,DB13059,-8.3,PF-03814735,RYYNGWLOYLRZLK-RBUKOAKNSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
114080,6vxx,DB12696,-8.3,BMS-582949,GDTQLZHHDRRBEB-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104102,6vxs,DB11423,-8.3,Lasalocid,BBMULGJBVDDDNI-OWKLGTHSSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104109,6vxs,DB11430,-8.3,Monensin,GAOZTHIDHYLHMS-KEOBGNEYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
112869,6vxx,DB07940,-8.3,"9-(3-IODOBENZYLAMINO)-1,2,3,4-TETRAHYDROACRIDINE",ZUCWQTWGZGIYPV-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
103952,6vxs,DB09291,-8.3,Rolapitant,FIVSJYGQAIEMOC-ZGNKEGEESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
130653,6w4h,DB12574,-8.3,LY-295501,VAMFSFIPDOODFH-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
103790,6vxs,DB09034,-8.3,Suvorexant,JYTNQNCOQXFQPK-MRXNPFEDSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
137562,6w9c,DB08449,-8.3,"2-(3-((4,5,7-trifluorobenzo[d]thiazol-2-yl)methyl)-1H-pyrrolo[2,3-b]pyridin-1-yl)acetic acid",IEVFQDJUDLCOQY-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
133654,6w9c,DB01975,-8.3,AMPCPR,ZPZRETFSCSWNDT-DBXCYWGHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
103542,6vxs,DB08708,-8.3,"N-cyclohexyl-3-[3-(trifluoromethyl)phenyl][1,2,4]triazolo[4,3-b]pyridazin-6-amine",XYYDXQCAYXOGQT-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
124988,6w4h,DB01895,-8.3,Aspartyl-Adenosine-5'-Monophosphate,QPBSGQWTJLPZNF-VWJPMABRSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
137534,6w9c,DB08416,-8.3,"(9BETA,13ALPHA,14BETA,17ALPHA)-2-METHOX1TRA-1,3,5(10)-TRIENE-3,17-DIYL DISULFAMATE",AQSNIXKAKUZPSI-SSTWWWIQSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
79246,6m2n,DB12962,-8.3,CP-547632,HXHAJRMTJXHJJZ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
87921,6m3m,DB13062,-8.3,ME-344,QVCAATSEPLQVBX-FPOVZHCZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
130761,6w4h,DB12743,-8.3,Z-160,VCPMZDWBEWTGNW-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130773,6w4h,DB12764,-8.3,ABC-294640,CAOTVXGYTWCKQE-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
87892,6m3m,DB13020,-8.3,Apratastat,MAVDNGWEBZTACC-HNNXBMFYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
130799,6w4h,DB12808,-8.3,Trifarotene,MFBCDACCJCDGBA-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
133625,6w9c,DB01941,-8.3,"6-[1-(3,5,5,8,8-Pentamethyl-5,6,7,8-Tetrahydronaphthalen-2-Yl)Cyclopropyl]Pyridine-3-Carboxylic Acid",SLXTWXQUEZSSTJ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
118040,6w4b,DB04289,-8.3,Genz-10850,YYMZSGIXLQPFAC-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
137554,6w9c,DB08441,-8.3,"6-BROMO-13-THIA-2,4,8,12,19-PENTAAZATRICYCLO[12.3.1.1-3,7-]NONADECA-1(18),3(19),4,6,14,16-HEXAENE 13,13-DIOXIDE",AWSQADBSXFTFKL-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
103703,6vxs,DB08922,-8.3,Perospirone,FBVFZWUMDDXLLG-HDICACEKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
109302,6vxx,DB13039,-8.3,Aminaphthone,YLMPBJUYFTWHKJ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
103720,6vxs,DB08950,-8.3,Indoramin,JXZZEXZZKAWDSP-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
123126,6w4b,DB14894,-8.3,Galicaftor,QVDYQHXNAQHIKH-TZIWHRDSSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
12278,6lzg,DB13138,-8.3,Neladenoson bialanate,WESNEIGKOAXSGX-VXKWHMMOSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
103743,6vxs,DB08975,-8.3,Florantyrone,QOBAOSCOLAGPKI-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
137559,6w9c,DB08446,-8.3,"3-[6-bromo-2-fluoro-3-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)phenoxy]-5-chlorobenzonitrile",OHQMEDBYNUAVNE-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
128142,6w4h,DB07267,-8.3,2-(6-methylpyridin-2-yl)-N-pyridin-4-ylquinazolin-4-amine,JONFDFIXMPXTRH-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
79461,6m2n,DB13312,-8.3,Delapril,WOUOLAUOZXOLJQ-MBSDFSHPSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
133811,6w9c,DB02187,-8.3,Equilin,WKRLQDKEXYKHJB-HFTRVMKXSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137401,6w9c,DB08247,-8.3,6-(CYCLOHEXYLMETHOXY)-8-ISOPROPYL-9H-PURIN-2-AMINE,JABXNQUXGJTKRO-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
88372,6m3m,DB13711,-8.3,Tritoqualine,IRGJVQIJENCTQF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
79970,6m2n,DB14065,-8.3,Lomerizine,JQSAYKKFZOSZGJ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79965,6m2n,DB14059,-8.3,SC-236,NSQNZEUFHPTJME-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
128280,6w4h,DB07423,-8.3,(2S)-3-[4-(acetylamino)phenoxy]-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide,YVXVTLGIDOACBJ-SFHVURJKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
88357,6m3m,DB13686,-8.3,Clometocillin,JKXQBIZCQJLVOS-GSNLGQFWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
79956,6m2n,DB14035,-8.3,Englitazone,MVDXXGIBARMXSA-PYUWXLGESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
9411,6lzg,DB07508,-8.3,4-(5-BENZENESULFONYLAMINO-1-METHYL-1H-BENZOIMIDAZOL-2-YLMETHYL)-BENZAMIDINE,MEUAVGJWGDPTLF-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
137312,6w9c,DB08141,-8.3,"4-{[(2,6-difluorophenyl)carbonyl]amino}-N-[(3S)-piperidin-3-yl]-1H-pyrazole-3-carboxamide",KOMNQBZWMCFDTQ-VIFPVBQESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
88346,6m3m,DB13675,-8.3,Metahexamide,XXYTXQGCRQLRHA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
128286,6w4h,DB07430,-8.3,"(10R)-10-methyl-3-(6-methylpyridin-3-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one",CMWRPDHVGMHLSZ-GFCCVEGCSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
85087,6m3m,DB07251,-8.3,"N'-(3-CHLORO-4-METHOXY-PHENYL)-N-(3,4,5-TRIMETHOXYPHENYL)-1,3,5-TRIAZINE-2,4-DIAMINE",ZVWFECUPYCFYBL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
109460,6vxx,DB13605,-8.3,Phenoperidine,IPOPQVVNCFQFRK-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
102461,6vxs,DB07423,-8.3,(2S)-3-[4-(acetylamino)phenoxy]-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide,YVXVTLGIDOACBJ-SFHVURJKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102484,6vxs,DB07450,-8.3,(R)-minalrestat,BMHZAHGTGIZZCT-LJQANCHMSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
137321,6w9c,DB08150,-8.3,"4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-aminium",RZIDZIGAXXNODG-UHFFFAOYSA-O,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
79896,6m2n,DB13927,-8.3,anle138b,RCQIIBJSUWYYFU-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
102502,6vxs,DB07471,-8.3,"5-[5,6-BIS(METHYLOXY)-1H-BENZIMIDAZOL-1-YL]-3-{[1-(2-CHLOROPHENYL)ETHYL]OXY}-2-THIOPHENECARBOXAMIDE",UHCHLTQBLNUYRT-GFCCVEGCSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
88329,6m3m,DB13656,-8.3,Eberconazole,MPTJIDOGFUQSQH-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
102566,6vxs,DB07546,-8.3,[1-(6-{6-[(1-methylethyl)amino]-1H-indazol-1-yl}pyrazin-2-yl)-1H-pyrrol-3-yl]acetic acid,BBYRUZKRFAIQSR-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
79879,6m2n,DB13866,-8.3,Etynodiol,JYILPERKVHXLNF-QMNUTNMBSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79914,6m2n,DB13952,-8.3,Estradiol acetate,FHXBMXJMKMWVRG-SLHNCBLASA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79875,6m2n,DB13857,-8.3,Demegestone,JWAHBTQSSMYISL-MHTWAQMVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137309,6w9c,DB08137,-8.3,(4E)-N-(4-fluorophenyl)-4-[(phenylcarbonyl)imino]-4H-pyrazole-3-carboxamide,ZMWYSLJBNJUCRK-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
79999,6m2n,DB14125,-8.3,Benazeprilat,MADRIHWFJGRSBP-ROUUACIJSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
102068,6vxs,DB06972,-8.3,"7A-[(4-cyanophenyl)methyl]-6-(3,5-dichlorophenyl)-5-oxo-2,3,5,7A-tetrahydro-1H-pyrrolo[1,2-A]pyrrole-7-carbonitrile",TZCXQSNBTXDAJG-QFIPXVFZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
80108,6m2n,DB14655,-8.3,Drostanolone propionate,NOTIQUSPUUHHEH-UXOVVSIBSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
134010,6w9c,DB02450,-8.3,"2-Benzo[1,3]Dioxol-5-Ylmethyl-3-Benzyl-Succinic Acid",ASEJDWRSZYAIOT-GJZGRUSLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
102078,6vxs,DB06985,-8.3,2-[({4-[2-(trifluoromethyl)phenyl]piperidin-1-yl}carbonyl)amino]benzoic acid,MEAQCLPMSVEOQF-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102085,6vxs,DB06993,-8.3,"(2S,3S)-4-cyclopropyl-3-{(3R,5R)-3-[2-fluoro-4-(methylsulfonyl)phenyl]-1,2,4-oxadiazolidin-5-yl}-1-[(3S)-3-fluoropyrrolidin-1-yl]-1-oxobutan-2-amine",PTAHVQJZNFGPHN-WFWWEWPISA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
113915,6vxx,DB12270,-8.3,Losmapimod,KKYABQBFGDZVNQ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
102152,6vxs,DB07066,-8.3,"2-CHLORO-N-[(3R)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL]-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE",LJAHIGGEXIWVJG-LLVKDONJSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
85054,6m3m,DB07210,-8.3,"3-bromo-5-phenyl-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",JECHSYMSTXETFI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
112940,6vxx,DB08170,-8.3,"(1R)-N,6-DIHYDROXY-7-METHOXY-2-[(4-METHOXYPHENYL)SULFONYL]-1,2,3,4-TETRAHYDROISOQUINOLINE-1-CARBOXAMIDE",AYFCYVLVRYQGME-QGZVFWFLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88377,6m3m,DB13717,-8.3,Phenothrin,SBNFWQZLDJGRLK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
130562,6w4h,DB12434,-8.3,Steviolbioside,OMHUCGDTACNQEX-OSHKXICASA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
102223,6vxs,DB07148,-8.3,"(6S)-1-chloro-3-[(4-fluorobenzyl)oxy]-6-(pyrrolidin-1-ylcarbonyl)pyrrolo[1,2-a]pyrazin-4(6H)-one",HPAFVLDARQIHPU-HNNXBMFYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
88472,6m3m,DB13842,-8.3,Etofylline nicotinate,ZWIAODBBEZGVPY-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
118663,6w4b,DB05791,-8.3,Perflubron,WTWWXOGTJWMJHI-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
102257,6vxs,DB07187,-8.3,6-[(5-CHLORO-3-METHYL-1-BENZOFURAN-2-YL)SULFONYL]PYRIDAZIN-3(2H)-ONE,FXFPQPNUMWQRAO-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
88444,6m3m,DB13805,-8.3,Reposal,MKELYWOVSPVORM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
133989,6w9c,DB02421,-8.3,Uridine-5'-Diphosphate-Mannose,HSCJRCZFDFQWRP-NYYOCOOHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
111828,6vxx,DB04753,-8.3,"9-DEAZAINOSINE-2',3'-O-ETHYLIDENEPHOSPHONATE",ZOEDLCUBOBTIHG-USQSKNHBSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
102321,6vxs,DB07263,-8.3,"[{2-bromo-4-[(2R)-3-oxo-2,3-diphenylpropyl]phenyl}(difluoro)methyl]phosphonic acid",WDTMVBQZDFMOIK-GOSISDBHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
137303,6w9c,DB08130,-8.3,"N-(5-{3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]phenyl}-1,3,4-oxadiazol-2-yl)ethane-1,2-diamine",FPDWDLAITHFTTP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
102217,6vxs,DB07142,-8.3,"5-[(3R)-3-(5-methoxy-3',5'-dimethylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",ATFDKOLABYIYCC-INIZCTEOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
123351,6w4b,DB15367,-8.3,LY-2623091,YPCLDHGBEKZGEB-RUDKWAFVSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
118593,6w4b,DB05412,-8.3,Talmapimod,ZMELOYOKMZBMRB-DLBZAZTESA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
17244,6cs2,HMDB0007115,-8.3,DG(16:0/22:0/0:0),JAJNYVORAKCQCM-KDXMTYKHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
79668,6m2n,DB13587,-8.3,Mesterolone,UXYRZJKIQKRJCF-TZPFWLJSSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79667,6m2n,DB13586,-8.3,Metandienone,XWALNWXLMVGSFR-HLXURNFRSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
88225,6m3m,DB13511,-8.3,Clebopride,BVPWJMCABCPUQY-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
79662,6m2n,DB13579,-8.3,Mepixanox,PYSOHOOUXFWCFF-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
102905,6vxs,DB07945,-8.3,"5-(3-carbamoylbenzyl)-5,6,7,8,9,10-hexahydrocyclohepta[b]indole-4-carboxylic acid",GKBQRPKZHUFGOB-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102923,6vxs,DB07967,-8.3,9-CYCLOPENTYL-6-[2-(3-IMIDAZOL-1-YL-PROPOXY)-PHENYLAMINO]-9H-PURINE-2-CARBONITRILE,JJNKDTWKWYLERH-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
88217,6m3m,DB13501,-8.3,Bendazac,BYFMCKSPFYVMOU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
79635,6m2n,DB13542,-8.3,Bevonium,UHUMRJKDOOEQIG-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
124894,6w4h,DB01767,-8.3,Hemi-Babim,KKJYVDXDZURHMA-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
113969,6vxx,DB12341,-8.3,LY-2456302,ZHPMYDSXGRRERG-DEOSSOPVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85150,6m3m,DB07318,-8.3,"N-[2-(4-AMINO-5,8-DIFLUORO-1,2-DIHYDROQUINAZOLIN-2-YL)ETHYL]-3-FURAMIDE",BOAUWUUBSXECNL-LLVKDONJSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
113980,6vxx,DB12540,-8.3,Lecozotan,NRPQELCNMADTOZ-OAQYLSRUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
124895,6w4h,DB01768,-8.3,Methylumbelliferyl Sialic Acid,KKDWIUJBUSOPGC-GKHMPSLRSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
102948,6vxs,DB07994,-8.3,"N-3-[5-(1H-INDOL-6-YL)-2-(PYRIDIN-2-YLMETHOXY)BENZYL]PYRIDINE-2,3-DIAMINE",KMBPJSHPAXOXBT-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
79551,6m2n,DB13425,-8.3,Flutrimazole,QHMWCHQXCUNUAK-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
109372,6vxx,DB13484,-8.3,Quinbolone,IUVKMZGDUIUOCP-BTNSXGMBSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
102954,6vxs,DB08001,-8.3,5-(3-{3-[3-HYDROXY-2-(METHOXYCARBONYL)PHENOXY]PROPENYL}PHENYL)-4-(HYDROXYMETHYL)ISOXAZOLE-3-CARBOXYLIC ACID,DQSRCEFDWMQCCV-GQCTYLIASA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
113985,6vxx,DB12548,-8.3,Sparsentan,WRFHGDPIDHPWIQ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130648,6w4h,DB12567,-8.3,Camicinal,RZKDEGZIFSJVNA-IBGZPJMESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
109370,6vxx,DB13481,-8.3,Tenidap,LXIKEPCNDFVJKC-QXMHVHEDSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
102927,6vxs,DB07971,-8.3,"5-AMINO-2-{4-[(4-AMINOPHENYL)SULFANYL]PHENYL}-1H-ISOINDOLE-1,3(2H)-DIONE",FQQVTDIBUYSVHM-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
79862,6m2n,DB13843,-8.3,Cloprednol,YTJIBEDMAQUYSZ-FDNPDPBUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
102900,6vxs,DB07940,-8.3,"9-(3-IODOBENZYLAMINO)-1,2,3,4-TETRAHYDROACRIDINE",ZUCWQTWGZGIYPV-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
137363,6w9c,DB08198,-8.3,"[(4R)-4-(3-HYDROXYPHENYL)-1,6-DIMETHYL-2-THIOXO-1,2,3,4-TETRAHYDROPYRIMIDIN-5-YL](PHENYL)METHANONE",JGBBILLMZPWNFU-QGZVFWFLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
102578,6vxs,DB07561,-8.3,(2Z)-2-cyano-N-(3'-ethoxybiphenyl-4-yl)-3-hydroxybut-2-enamide,RPILZQUCBKIPAZ-AQTBWJFISA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
113940,6vxx,DB12301,-8.3,Doravirine,ZIAOVIPSKUPPQW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79816,6m2n,DB13783,-8.3,Acemetacin,FSQKKOOTNAMONP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
102592,6vxs,DB07578,-8.3,"3-[4-(2-METHYL-IMIDAZO[4,5-C]PYRIDIN-1-YL)BENZYL]-3H-BENZOTHIAZOL-2-ONE",WUOLYUKMMRCXGH-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
8355,6lzg,DB05553,-8.3,Regrelor,NXHAXEBZOXCDKD-XIXRRVGJSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
102654,6vxs,DB07651,-8.3,N-ACETYL-L-PHENYLALANYL-4-[DIFLUORO(PHOSPHONO)METHYL]-L-PHENYLALANINAMIDE,KPMMESISHWWXNM-ROUUACIJSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
88265,6m3m,DB13564,-8.3,Zipeprol,VSTNNAYSCJQCQI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85103,6m3m,DB07269,-8.3,(2S)-2-[3-(AMINOMETHYL)PHENYL]-3-[(R)-[(1R)-1-{[(BENZYLOXY)CARBONYL]AMINO}-2-METHYLPROPYL](HYDROXY)PHOSPHORYL]PROPANOIC ACID,SFUOOKBZBVUDBC-VQTJNVASSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
112915,6vxx,DB08145,-8.3,"6-(2,6-DIMETHOXYPHENYL)PYRIDO[2,3-D]PYRIMIDINE-2,7-DIAMINE",LRPHIAJXODIASX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
102874,6vxs,DB07909,-8.3,"(1S,2S,5S)2-(4-GLUTARIDYLBENZYL)-5-PHENYL-1-CYCLOHEXANOL",OBWILOKKNDYPLX-HBMCJLEFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
79777,6m2n,DB13728,-8.3,Halometasone,GGXMRPUKBWXVHE-MIHLVHIWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
102691,6vxs,DB07698,-8.3,"3-(3-aminophenyl)-N-(3-chlorophenyl)pyrazolo[1,5-a]pyrimidin-5-amine",JDNMRPIWJIDDAY-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102693,6vxs,DB07701,-8.3,"1-BENZYL-4-[(5,6-DIMETHOXY-1-INDANON-2-YL)METHYL]PIPERIDINE",ADEBPBSSDYVVLD-HXUWFJFHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102716,6vxs,DB07728,-8.3,"2-[2-(2-FLUOROPHENYL)PYRIDIN-4-YL]-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE",XJJYJNMNYDNXNO-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102751,6vxs,DB07768,-8.3,Epitestosterone,MUMGGOZAMZWBJJ-KZYORJDKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102752,6vxs,DB07769,-8.3,S-3-(4-FLUOROPHENOXY)-2-HYDROXY-2-METHYL-N-[4-NITRO-3-(TRIFLUOROMETHYL)PHENYL]PROPANAMIDE,KJMFOTCDISOHDX-INIZCTEOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102783,6vxs,DB07804,-8.3,"5-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1H-1,2,4-TRIAZOLE-3-SULFONAMIDE",FKCQUVAGEOSYRU-QWRGUYRKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
137358,6w9c,DB08192,-8.3,2-(4-CARCOXY-5-ISOPROPYLTHIAZOLYL)BENZOPIPERIDINE,HCUGCUQZFBURHR-LBPRGKRZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
85119,6m3m,DB07286,-8.3,BMS-564929,KEJORAMIZFOODM-PWSUYJOCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
102848,6vxs,DB07875,-8.3,"5-Chloro-thiophene-2-carboxylic acid ((3S,4S)-1-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-methyl}-4-hydroxy-pyrrolidin-3-yl)-amide",ARAVOODWJJJNBY-IRXDYDNUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
88261,6m3m,DB13558,-8.3,Morclofone,KVCJCEKJKGLBOK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
109865,6vxx,DB00349,-8.3,Clobazam,CXOXHMZGEKVPMT-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109866,6vxx,DB00351,-8.3,Megestrol acetate,RQZAXGRLVPAYTJ-GQFGMJRRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
98617,6vxs,DB01147,-8.3,Cloxacillin,LQOLIRLGBULYKD-JKIFEVAISA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
95056,6m71,DB08860,-8.3,Pitavastatin,VGYFMXBACGZSIL-MCBHFWOFSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
82882,6m3m,DB03133,-8.3,"2-(Beta-D-Glucopyranosyl)-5-Methyl-1,2,3-Benzimidazole",XIJZORUYQZBFJK-UJPOAAIJSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
95080,6m71,DB08903,-8.3,Bedaquiline,QUIJNHUBAXPXFS-XLJNKUFUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
120761,6w4b,DB08896,-8.3,Regorafenib,FNHKPVJBJVTLMP-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
135535,6w9c,DB04596,-8.3,"4-O-{4,6-O-[(1S)-1-Carboxyethylidene]-??-D-mannopyranosyl}-D-glucopyranuronic acid",GZJXZKGVHLWBOW-AISSFXTFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
14071,6lzg,T3D3689,-8.3,Ergocornine,UJYGDMFEEDNVBF-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
129228,6w4h,DB08543,-8.3,1-[2-HYDROXY-3-(4-CYCLOHEXYL-PHENOXY)-PROPYL]-4-(2-PYRIDYL)-PIPERAZINE,BZJHCQBNFUNZPJ-QFIPXVFZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
14062,6lzg,T3D3679,-8.3,Cytochalasin E,NYLMKKSTMIJWJC-GYZZCKOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
95187,6m71,DB09053,-8.3,Ibrutinib,XYFPWWZEPKGCCK-GOSISDBHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
135527,6w9c,DB04582,-8.3,IMAZAQUIN,CABMTIJINOIHOD-QGZVFWFLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
18248,6cs2,HMDB0000637,-8.3,Chenodeoxycholic acid glycine conjugate,GHCZAUBVMUEKKP-AHBZRTSYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
17763,6cs2,HMDB0010351,-8.3,11-beta-Hydroxyandrosterone-3-glucuronide,BRPLOVMHAFXVOQ-HUMIJZDLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
84271,6m3m,DB05252,-8.3,Fenoxaprop-ethyl,PQKBPHSEKWERTG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
129578,6w4h,DB08993,-8.3,Enviomycin,HPWIIERXAFODPP-GHBBWTPBSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
82714,6m3m,DB02905,-8.3,"Phosphoric Acid Mono-[3,4-Dihydroxy-5-(5-Hydroxy-Benzoimidazol-1-Yl)Tetrahydro-Furan-2-Ylmethyl] Ester",BVZASCINAVSQNO-PULFBKJNSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
135519,6w9c,DB04573,-8.3,Estriol,PROQIPRRNZUXQM-ZXXIGWHRSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
91967,6m71,DB03777,-8.3,Rbt205 Inhibitor,QMGUOJYZJKLOLH-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
91922,6m71,DB03725,-8.3,Phosphomethylphosphonic Acid-Guanylate Ester,PHBDHXOBFUBCJD-KQYNXXCUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
82660,6m3m,DB02836,-8.3,Guanosine 5'-Diphosphate 2':3'-Cyclic Monophosphate,NGYWTCOGOZELRS-UUOKFMHZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
14093,6lzg,T3D3710,-8.3,Roridin D,XZWOQFZHIMDODQ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
111128,6vxx,DB03037,-8.3,Oxidized Acetyl Dithranol,IKFRFGXQHSBCQM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113279,6vxx,DB08750,-8.3,"1-[4-(AMINOMETHYL)BENZOYL]-5'-FLUORO-1'H-SPIRO[PIPERIDINE-4,2'-QUINAZOLIN]-4'-AMINE",SFPCNWQWKOUNRT-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136021,6w9c,DB06321,-8.3,R-348,IGLNXKVGKIFNBQ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
110895,6vxx,DB02545,-8.3,Fexaramine,VLQTUNDJHLEFEQ-KGENOOAVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
92620,6m71,DB04644,-8.3,"4-{4-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-2,3-DIMETHYL-PHENOXY}-BUTYRIC ACID",FCEMCUPAYRPTLS-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
124025,6w4h,DB00673,-8.3,Aprepitant,ATALOFNDEOCMKK-OITMNORJSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
84209,6m3m,DB04930,-8.3,Permethrin,RLLPVAHGXHCWKJ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
129272,6w4h,DB08597,-8.3,"6-[4-(2-piperidin-1-ylethoxy)phenyl]-3-pyridin-4-ylpyrazolo[1,5-a]pyrimidine",XHBVYDAKJHETMP-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
92610,6m71,DB04632,-8.3,4-(2-HYDROXYBENZYLAMINO)-N-(3-(4-FLUOROPHENOXY)PHENYL)PIPERIDINE-1-SULFONAMIDE,JHHBGNIRSUTQAS-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
92592,6m71,DB04608,-8.3,"9-HYDROXY-4-PHENYL-6H-PYRROLO[3,4-C]CARBAZOLE-1,3-DIONE",IAUZTOZLTFSMIE-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
135995,6w9c,DB06257,-8.3,HE-2200,OEVZKEVBDIDVOI-YSZCXEEOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136002,6w9c,DB06267,-8.3,Udenafil,IYFNEFQTYQPVOC-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
110414,6vxx,DB01565,-8.3,Dihydromorphine,IJVCSMSMFSCRME-KBQPJGBKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
94836,6m71,DB08590,-8.3,1-(3-HYDROXYPROPYL)-2-[(3-NITROBENZOYL)AMINO]-1H-BENZIMIDAZOL-5-YL PIVALATE,CEAYRKIZESVQSN-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
82982,6m3m,DB03258,-8.3,2'-Deoxycytidine 5'-triphosphate,RGWHQCVHVJXOKC-SHYZEUOFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
14109,6lzg,T3D3726,-8.3,Aflatrem,YVDJBQQJIDPRKP-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
82975,6m3m,DB03250,-8.3,"2-(Beta-D-Glucopyranosyl)-5-Methyl-1,3,4-Benzothiazole",WGJFWQVWYRZPEP-KABOQKQYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
110434,6vxx,DB01591,-8.3,Solifenacin,FBOUYBDGKBSUES-VXKWHMMOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111019,6vxx,DB02887,-8.3,"2',3'-Dehydro-2',3'-Deoxy-Thymidine 5'-Triphosphate",ODSQODTUNULBHF-JGVFFNPUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
123680,6w4h,DB00251,-8.3,Terconazole,BLSQLHNBWJLIBQ-OZXSUGGESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
113515,6vxx,DB09291,-8.3,Rolapitant,FIVSJYGQAIEMOC-ZGNKEGEESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
95032,6m71,DB08820,-8.3,Ivacaftor,PURKAOJPTOLRMP-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
84227,6m3m,DB04982,-8.3,Talampanel,JACAAXNEHGBPOQ-LLVKDONJSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
82996,6m3m,DB03277,-8.3,alpha-maltotriose,FYGDTMLNYKFZSV-PXXRMHSHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84288,6m3m,DB05351,-8.3,Dexlansoprazole,MJIHNNLFOKEZEW-RUZDIDTESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
82647,6m3m,DB02819,-8.3,"Mono-[3,4-Dihydroxy-5-(5-Methyl-Benzoimidazol-1-Yl)-Tetrahydor-Furan-2-Ylmethyl] Ester",HGUDFQQPANTQEU-LPWJVIDDSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
135467,6w9c,DB04509,-8.3,N-Methylnaloxonium,PCSQOABIHJXZMR-YNUHATHGSA-O,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
110343,6vxx,DB01485,-8.3,4-Hydroxytestosterone,BQOIJSIMMIDHMO-FBPKJDBXSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111267,6vxx,DB03421,-8.3,"2-Phenethyl-2,3-Dihydro-Phthalazine-1,4-Dione",JSSVIGGKHIJEHO-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
8593,6lzg,DB06469,-8.3,Lestaurtinib,UIARLYUEJFELEN-DMVVYWCZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
14712,6lzg,T3D4647,-8.3,Loprazolam,UTEFBSAVJNEPTR-RGEXLXHISA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
91395,6m71,DB02998,-8.3,Metribolone,CCCIJQPRIXGQOE-XWSJACJDSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95774,6m71,DB11921,-8.3,Deflazacort,FBHSPRKOSMHSIF-GRMWVWQJSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95776,6m71,DB11923,-8.3,Decoglurant,DMJHZVARRXJSEG-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
136186,6w9c,DB06725,-8.3,Lornoxicam,WLHQHAUOOXYABV-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
95805,6m71,DB11966,-8.3,BMS-986094,YFXGICNMLCGLHJ-RSKRLRQZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110363,6vxx,DB01512,-8.3,Hydromorphinol,AABLHGPVOULICI-BRJGLHKUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
135358,6w9c,DB04357,-8.3,Pteric Acid,JOAQINSXLLMRCV-UHFFFAOYSA-O,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
84358,6m3m,DB05708,-8.3,GTS-21,RPYWXZCFYPVCNQ-RVDMUPIBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84360,6m3m,DB05719,-8.3,Elesclomol,BKJIXTWSNXCKJH-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
95837,6m71,DB12015,-8.3,Alpelisib,STUWGJZDJHPWGZ-LBPRGKRZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
91244,6m71,DB02804,-8.3,A-98881,PMBZSBGCSQGJAQ-GRKNLSHJSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95857,6m71,DB12048,-8.3,Savolitinib,XYDNMOZJKOGZLS-NSHDSACASA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110305,6vxx,DB01443,-8.3,19-Nor-5-androstenedione,WELNRNVZXWUOGT-QXUSFIETSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
95860,6m71,DB12052,-8.3,Icariin,TZJALUIVHRYQQB-XLRXWWTNSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95869,6m71,DB12064,-8.3,BMS-777607,VNBRGSXVFBYQNN-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
91183,6m71,DB02715,-8.3,Compound 18,UZOOIPXOYYJULJ-RHLLTPQKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
136200,6w9c,DB06741,-8.3,Gavestinel,WZBNEZWCNKUOSM-VOTSOKGWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
135960,6w9c,DB06188,-8.3,Ispinesib,QJZRFPJCWMNVAV-HHHXNRCGSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
84330,6m3m,DB05542,-8.3,Naronapride,VGDDOIZXGFJDRC-VJTSUQJLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
82474,6m3m,DB02587,-8.3,Colforsin,OHCQJHSOBUTRHG-KGGHGJDLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
135448,6w9c,DB04482,-8.3,Cmp-2-Keto-3-Deoxy-Octulosonic Acid,YWWJKULNWGRYAS-UOVSKDHASA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
95380,6m71,DB09488,-8.3,Acrivastine,PWACSDKDOHSSQD-IUTFFREVSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
9577,6lzg,DB07689,-8.3,"METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE",NYNAFINLHQEHKU-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
110400,6vxx,DB01551,-8.3,Dihydrocodeine,RBOXVHNMENFORY-DNJOTXNNSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
129207,6w4h,DB08520,-8.3,"(21S)-1AZA-4,4-DIMETHYL-6,19-DIOXA-2,3,7,20-TETRAOXOBICYCLO[19.4.0] PENTACOSANE",VUCSBBBCFXBFFY-IBGZPJMESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
123638,6w4h,DB00203,-8.3,Sildenafil,BNRNXUUZRGQAQC-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
95529,6m71,DB11487,-8.3,Dexamethasone isonicotinate,BQTXJHAJMDGOFI-NJLPOHDGSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95560,6m71,DB11582,-8.3,Thiocolchicoside,LEQAKWQJCITZNK-AXHKHJLKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
91762,6m71,DB03495,-8.3,"4,6-Dideoxy-4-{[4,5,6-Trihydroxy-3-(Hydroxymethyl)Cyclohex-2-En-1-Yl]Amino}-Alpha-D-Lyxo-Hexopyranosyl-(1->4)-Alpha-D-Threo-Hexopyranosyl-(1->6)-Alpha-L-Threo-Hexopyranose",FZLCJZILHGFQLM-PISLJJGOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
113236,6vxx,DB08706,-8.3,"(2S)-({(5Z)-5-[(5-ETHYL-2-FURYL)METHYLENE]-4-OXO-4,5-DIHYDRO-1,3-THIAZOL-2-YL}AMINO)(4-FLUOROPHENYL)ACETIC ACID",RNEACARJKXYVND-MZLJFPOFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
95580,6m71,DB11637,-8.3,Delamanid,XDAOLTSRNUSPPH-XMMPIXPASA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
113560,6vxx,DB11512,-8.3,Dihydrostreptomycin,ASXBYYWOLISCLQ-HZYVHMACSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
95590,6m71,DB11652,-8.3,Tucatinib,SDEAXTCZPQIFQM-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
82574,6m3m,DB02717,-8.3,Cellotetraose,LUEWUZLMQUOBSB-HGDSAIHNSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
135406,6w9c,DB04429,-8.3,4'-Hydroxyflavanone,ZLHVIYHWWQYJID-HNNXBMFYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
135403,6w9c,DB04424,-8.3,RPR128515,XFKVLKLCLYJKNF-MZNJEOGPSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
95660,6m71,DB11759,-8.3,Pevonedistat,MPUQHZXIXSTTDU-QXGSTGNESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
136127,6w9c,DB06616,-8.3,Bosutinib,UBPYILGKFZZVDX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136134,6w9c,DB06625,-8.3,Vipadenant,HQSBCDPYXDGTCL-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
95686,6m71,DB11794,-8.3,Berzosertib,JZCWLJDSIRUGIN-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
113554,6vxx,DB11491,-8.3,Sarafloxacin,XBHBWNFJWIASRO-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
83149,6m3m,DB03491,-8.3,2'-Deoxyguanosine-5'-Diphosphate,CIKGWCTVFSRMJU-KVQBGUIXSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
129293,6w4h,DB08622,-8.3,"4-(4-CHLORO-PHENYL)-1-{3-[2-(4-FLUORO-PHENYL)-[1,3]DITHIOLAN-2-YL]-PROPYL}-PIPERIDIN-4-OL",KVDKNVPAAQKHKD-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
92710,6m71,DB04771,-8.3,1-GUANIDINO-4-(N-NITRO-BENZOYLAMINO-L-LEUCYL-L-PROLYLAMINO)BUTANE,FIZYZWLGMGGGBJ-OALUTQOASA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93781,6m71,DB07340,-8.3,"N-6-cyclohexyl-N-2-(4-morpholin-4-ylphenyl)-9H-purine-2,6-diamine",ZFLJHSQHILSNCM-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
83686,6m3m,DB04209,-8.3,Dequalinium,PCSWXVJAIHCTMO-UHFFFAOYSA-P,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
93798,6m71,DB07359,-8.3,"3-[(4-fluorophenyl)sulfanyl]-N-(4-methyl-1,3-thiazol-2-yl)-6-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]pyridine-2-carboxamide",SJTQKYKXCYVFHX-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93805,6m71,DB07369,-8.3,"N-(3-chlorophenyl)-N-methyl-2-oxo-3-[(3,4,5-trimethyl-1H-pyrrol-2-yl)methyl]-2H-indole-5-sulfonamide",YMJLSOJLEXWATP-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
129467,6w4h,DB08828,-8.3,Vismodegib,BPQMGSKTAYIVFO-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
110829,6vxx,DB02463,-8.3,2-(2-Hydroxy-Phenyl)-1h-Indole-5-Carboxamidine,JPGNPKIYCTXJPG-UHFFFAOYSA-O,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
93873,6m71,DB07450,-8.3,(R)-minalrestat,BMHZAHGTGIZZCT-LJQANCHMSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93903,6m71,DB07486,-8.3,"3-({4-[(1E)-3-morpholin-4-yl-3-oxoprop-1-en-1-yl]-2,3-bis(trifluoromethyl)phenyl}sulfanyl)aniline",KLSZVPNVFKKIRD-FNORWQNLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93948,6m71,DB07538,-8.3,"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}-2-(TRIFLUOROMETHYL)BENZENESULFONAMIDE",RGVVHQNJKUNSFQ-WDZFZDKYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93775,6m71,DB07333,-8.3,"N-(CYCLOPROPYLMETHYL)-4-(METHYLOXY)-3-({5-[3-(3-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-YL}AMINO)BENZENESULFONAMIDE",KRGKAARWVPUWSY-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93953,6m71,DB07544,-8.3,N'-(5-CHLOROBENZOFURAN-2-CARBONYL)-2-(TRIFLUOROMETHYL)BENZENESULFONOHYDRAZIDE,ZLQBZYKAQQWOTK-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93972,6m71,DB07567,-8.3,"(2R,3R,4S)-3-(4-HYDROXYPHENYL)-4-METHYL-2-[4-(2-PYRROLIDIN-1-YLETHOXY)PHENYL]CHROMAN-6-OL",XPVKGTWRXBSJKO-LHXLBICKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
135713,6w9c,DB04839,-8.3,Cyproterone acetate,UWFYSQMTEOIJJG-FDTZYFLXSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
93974,6m71,DB07570,-8.3,3-CYCLOHEXYL-1-(2-MORPHOLIN-4-YL-2-OXOETHYL)-2-PHENYL-1H-INDOLE-6-CARBOXYLIC ACID,ZKEZEXYKYHYIMQ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
83610,6m3m,DB04114,-8.3,"3-Chloro-9-Ethyl-6,7,8,9,10,11-Hexahydro-7,11-Methanocycloocta[B]Quinolin-12-Amine",QTPHSDHUHXUYFE-NWDGAFQWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
110684,6vxx,DB02101,-8.3,"(S,R)-fidarestat",WAAPEIZFCHNLKK-QPUJVOFHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
9685,6lzg,DB07804,-8.3,"5-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1H-1,2,4-TRIAZOLE-3-SULFONAMIDE",FKCQUVAGEOSYRU-QWRGUYRKSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
94003,6m71,DB07608,-8.3,N-(5-{[(2S)-4-amino-2-(3-chlorophenyl)butanoyl]amino}-1H-indazol-3-yl)benzamide,JDGOPNUGILVNJZ-IBGZPJMESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94013,6m71,DB07618,-8.3,"2-(4-(AMINOMETHYL)PIPERIDIN-1-YL)-N-(3_CYCLOHEXYL-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)ACETAMIDE",AITZHKQVQNLKHI-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
8661,6lzg,DB06626,-8.3,Axitinib,RITAVMQDGBJQJZ-FMIVXFBMSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
93125,6m71,DB06362,-8.3,Becatecarin,JSKFWUPVIZYJMR-UDOAKELVSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
8682,6lzg,DB06677,-8.3,Clazosentan,LFWCJABOXHSRGC-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
93767,6m71,DB07325,-8.3,N-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)METHYL]-3-{[(E)-(2-OXODIHYDROFURAN-3(2H)-YLIDENE)METHYL]AMINO}BENZENESULFONAMIDE,VCOKUBHAJVTVNG-FMIVXFBMSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93715,6m71,DB07270,-8.3,"N-[7-(3-AMINOPHENYL)-5-METHOXY-1,3-BENZOXAZOL-2-YL]-2,5-DICHLOROBENZENESULFONAMIDE",GAYYMURZGLJDCT-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93476,6m71,DB06995,-8.3,N-({4-[(2-aminopyridin-4-yl)oxy]-3-fluorophenyl}carbamoyl)-2-(4-fluorophenyl)acetamide,USBSTVPJNQLYEM-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93501,6m71,DB07024,-8.3,"2-(3,4-DIHYDROXYPHENYL)-8-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-3-HYDROXY-6-METHYL-4H-CHROMEN-4-ONE",CEXBEGBNDJVZPK-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
83934,6m3m,DB04549,-8.3,"4-(Aminosulfonyl)-N-[(2,3,4-Trifluorophenyl)Methyl]-Benzamide",AANTYZRUJFNZFI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
93447,6m71,DB06959,-8.3,(2S)-1-(3H-Indol-3-yl)-3-{[5-(6-isoquinolinyl)-3-pyridinyl]oxy}-2-propanamine,BUCZDJYEOAQTHL-KEKNWZKVSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110798,6vxx,DB02421,-8.3,Uridine-5'-Diphosphate-Mannose,HSCJRCZFDFQWRP-NYYOCOOHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110788,6vxx,DB02411,-8.3,"2-(11-{2-[Benzenesulfonyl-(3-Methyl-Butyl)-Amino]-1-Hydroxy-Ethyl}-6,9-Dioxo-2-Oxa-7,10-Diaza-Bicyclo[11.2.2]Heptadeca-1(16),13(17),14-Trien-8-Yl)-Acetamide, Inhibitor 2",HOUHLOFMBSYNBO-KKUQBAQOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
93416,6m71,DB06920,-8.3,Eribaxaban,QQBKAVAGLMGMHI-WIYYLYMNSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
83949,6m3m,DB04566,-8.3,Inosinic Acid,GRSZFWQUAKGDAV-KQYNXXCUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
135735,6w9c,DB04867,-8.3,Lintitript,ILNRQFBVVQUOLP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
93740,6m71,DB07296,-8.3,(5Z)-3-(4-CHLOROPHENYL)-4-HYDROXY-5-(1-NAPHTHYLMETHYLENE)FURAN-2(5H)-ONE,PLGHLEBIWUQEPR-PDGQHHTCSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93376,6m71,DB06876,-8.3,"N-{5-[4-(4-METHYLPIPERAZIN-1-YL)PHENYL]-1H-PYRROLO[2,3-B]PYRIDIN-3-YL}NICOTINAMIDE",YJWJKKXGAPWLGT-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
135790,6w9c,DB05013,-8.3,Ingenol mebutate,VDJHFHXMUKFKET-UXMMOKKRSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
83784,6m3m,DB04345,-8.3,Lumichrome,ZJTJUVIJVLLGSP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
93226,6m71,DB06624,-8.3,Taranabant,QLYKJCMUNUWAGO-GAJHUEQPSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110732,6vxx,DB02342,-8.3,2-Methox1tradiol,CQOQDQWUFQDJMK-SSTWWWIQSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
93694,6m71,DB07247,-8.3,"[2'-HYDROXY-3'-(1H-PYRROLO[3,2-C]PYRIDIN-2-YL)-BIPHENYL-3-YLMETHYL]-UREA",SRPOHNDQBDHONJ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
83747,6m3m,DB04293,-8.3,7-(2-Amino-2-Phenyl-Acetylamino)-3-Chloro-8-Oxo-1-Aza-Bicyclo[4.2.0]Oct-2-Ene-2-Carboxylic Acid,JAPHQRWPEGVNBT-IJLUTSLNSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
123759,6w4h,DB00346,-8.3,Alfuzosin,WNMJYKCGWZFFKR-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
93712,6m71,DB07267,-8.3,2-(6-methylpyridin-2-yl)-N-pyridin-4-ylquinazolin-4-amine,JONFDFIXMPXTRH-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93208,6m71,DB06589,-8.3,Pazopanib,CUIHSIWYWATEQL-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110768,6vxx,DB02388,-8.3,"Cyclohexyl-{4-[5-(3,4-Dichlorophenyl)-2-Piperidin-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine",UQFRSHRWRKYNDE-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
123395,6w4b,DB15460,-8.3,AGG-523,JWQMTWCFNZSLNR-DEOSSOPVSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
94072,6m71,DB07689,-8.3,"METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE",NYNAFINLHQEHKU-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93015,6m71,DB06011,-8.3,AMG-222,NVSWJKWHLUTHLP-CPJSRVTESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
84141,6m3m,DB04825,-8.3,Prenylamine,IFFPICMESYHZPQ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
92823,6m71,DB04942,-8.3,Tamibarotene,MUTNCGKQJGXKEM-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
92810,6m71,DB04903,-8.3,Pagoclone,HIUPRQPBWVEQJJ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
83341,6m3m,DB03761,-8.3,5-Fluoro-2'-Deoxyuridine-5'-Monophosphate,HFEKDTCAMMOLQP-RRKCRQDMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
8688,6lzg,DB06684,-8.3,Vilazodone,SGEGOXDYSFKCPT-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
94427,6m71,DB08097,-8.3,"2-(2,6-DIFLUOROPHENOXY)-N-(2-FLUOROPHENYL)-9-ISOPROPYL-9H-PURIN-8-AMINE",OGWSGDLIXOEZJG-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
92795,6m71,DB04879,-8.3,Vatalanib,YCOYDOIWSSHVCK-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94466,6m71,DB08138,-8.3,"{[(2,6-difluorophenyl)carbonyl]amino}-N-(4-fluorophenyl)-1H-pyrazole-3-carboxamide",BDRDBXXWQDFXEC-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
83296,6m3m,DB03708,-8.3,Adenosine 5'-phosphosulfate,IRLPACMLTUPBCL-KQYNXXCUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
94400,6m71,DB08064,-8.3,N-(3-TERT-BUTYL-1H-PYRAZOL-5-YL)-N'-{4-CHLORO-3-[(PYRIDIN-3-YLOXY)METHYL]PHENYL}UREA,NTMADESEDXKNFZ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
83287,6m3m,DB03695,-8.3,Piritrexim,VJXSSYDSOJBUAV-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
135647,6w9c,DB04757,-8.3,"GUANOSINE-2',3'-O-METHYLIDENEPHOSPHONATE",GKAPYWCOOQBBHV-KXSYMAMXSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
18109,6cs2,HMDB0012958,-8.3,Gamma-Tocotrienol,OTXNTMVVOOBZCV-WAZJVIJMSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
110531,6vxx,DB01895,-8.3,Aspartyl-Adenosine-5'-Monophosphate,QPBSGQWTJLPZNF-VWJPMABRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
94524,6m71,DB08204,-8.3,3-DIPHENOL-6-NITRO-3H-BENZO[DE]ISOCHROMEN-1-ONE,FLWABCQDXUKNQY-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
129321,6w4h,DB08657,-8.3,2-(4-(2-((3-(5-(PYRIDIN-2-YLTHIO)THIAZOL-2-YL)UREIDO)METHYL)-1H-IMIDAZOL-4-YL)PHENOXY)ACETIC ACID,SSXCWVOQWRUMGN-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
94552,6m71,DB08241,-8.3,4-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)--BENZAMIDE,RUUOIINPNMNPIU-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94600,6m71,DB08305,-8.3,"(3R)-3-cyclopentyl-6-methyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2-benzothiazine 1,1-dioxide",KQAGZLQCEURCKJ-QGZVFWFLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
120644,6w4b,DB08737,-8.3,"(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-9-OL",FSYFYSFYUHBIHE-GLJUWKHASA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
94639,6m71,DB08353,-8.3,"2-(CYCLOHEXYLMETHYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE",NCVMTHVSAJMOPI-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
83284,6m3m,DB03691,-8.3,WRR-112,KVZMXOVSHIMGNA-HOTGVXAUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
110589,6vxx,DB01975,-8.3,AMPCPR,ZPZRETFSCSWNDT-DBXCYWGHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
94393,6m71,DB08057,-8.3,"N-(2-chloro-6-methylphenyl)-8-[(3S)-3-methylpiperazin-1-yl]imidazo[1,5-a]quinoxalin-4-amine",VWJPPYCULHDHBB-HNNXBMFYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94392,6m71,DB08056,-8.3,"N-(2,6-dimethylphenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine",KKYYLKPGILUPOA-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
120376,6w4b,DB08418,-8.3,"(4aS,4bR,10bS,12aS)-12a-methyl-1,3-dioxo-2-(pyridin-3-ylmethyl)-1,2,3,4,4a,4b,5,6,10b,11,12,12a-dodecahydronaphtho[2,1-f]isoquinolin-8-yl sulfamate",LSJKARAMQNGZDF-YOEKFXIASA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
94095,6m71,DB07716,-8.3,"(4Z)-2,8:7,12:11,15:14,18:17,22-PENTAANHYDRO-4,5,6,9,10,13,19,20,21-NONADEOXY-D-ARABINO-D-ALLO-D-ALLO-DOCOSA-4,9,20-TRIENITOL",VDRIXSJOPKVWKM-HXGIDPQASA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
92997,6m71,DB05903,-8.3,KOS-1584,XAYAKDZVINDZGB-BMVMHAJPSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94138,6m71,DB07765,-8.3,"METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL](METHYL)AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE",UKCFUFHREWUXJJ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110578,6vxx,DB01960,-8.3,7n-Methyl-8-Hydroguanosine-5'-Diphosphate,QQODJOAVWUWVHJ-KQYNXXCUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
4590,6lzg,HMDB0001438,-8.3,25-Hydroxyvitamin D2,KJKIIUAXZGLUND-BJWBXCNSSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
83513,6m3m,DB03984,-8.3,Morpholine-4-Carboxylic Acid [1-(2-Benzylsulfanyl-1-Formyl-Ethylcarbamoyl)-2-Phenyl-Ethyl]-Amide,MWTQNXVXPLTHJB-YADHBBJMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
94161,6m71,DB07792,-8.3,"(S)-2-CHLORO-N-(1-(2-(2-HYDROXYETHYLAMINO)-2-OXOETHYL)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL)-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE",VUKPNWLGSLOHIF-AWEZNQCLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94162,6m71,DB07793,-8.3,"(2S)-N-[(3S)-1-(2-AMINO-2-OXOETHYL)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL]-2-CHLORO-2H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE",ACSGSLPOHKRZCY-GXTWGEPZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
83404,6m3m,DB03837,-8.3,Morpholine-4-Carboxylic Acid (1-(3-Benzenesulfonyl-1-Phenethylallylcarbamoyl)-3-Methylbutyl)-Amide,YUMYYTORLYHUFW-ZUDLOMHPSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
123728,6w4h,DB00307,-8.3,Bexarotene,NAVMQTYZDKMPEU-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
83490,6m3m,DB03950,-8.3,(S)-N-(3-Indol-1-Yl-2-Methyl-Propyl)-4-Sulfamoyl-Benzamide,ZFWHOUCRVSOZJE-AWEZNQCLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
120637,6w4b,DB08730,-8.3,3-FLUORO-5-MORPHOLIN-4-YL-N-[1-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-6-YL]BENZAMIDE,CPFBZMFUCGHBAP-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
83470,6m3m,DB03925,-8.3,Freselestat,HMPQTEPEMQZWQH-QZTJIDSGSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83469,6m3m,DB03924,-8.3,"5,8-Di-Amino-1,4-Dihydroxy-Anthraquinone",QVEMRPAUHFWHRV-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
94179,6m71,DB07811,-8.3,"N-cyclopropyl-2',6-dimethyl-4'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-3-carboxamide",UBVTVSINEVHYSY-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
92924,6m71,DB05470,-8.3,VX-702,FYSRKRZDBHOFAY-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
84139,6m3m,DB04823,-8.3,Oxyphenisatin,SJDACOMXKWHBOW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
92910,6m71,DB05416,-8.3,Cardarine,YDBLKRPLXZNVNB-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94377,6m71,DB08037,-8.3,"(2S)-4-(2,5-difluorophenyl)-N-[(3R,4S)-3-fluoro-1-methylpiperidin-4-yl]-2-(hydroxymethyl)-N-methyl-2-phenyl-2,5-dihydro-1H-pyrrole-1-carboxamide",MYBGWENAVMIGMM-GIFXNVAJSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110560,6vxx,DB01941,-8.3,"6-[1-(3,5,5,8,8-Pentamethyl-5,6,7,8-Tetrahydronaphthalen-2-Yl)Cyclopropyl]Pyridine-3-Carboxylic Acid",SLXTWXQUEZSSTJ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
12209,6lzg,DB13040,-8.3,Gandotinib,SQSZANZGUXWJEA-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
110262,6vxx,DB01162,-8.3,Terazosin,VCKUSRYTPJJLNI-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
82223,6m3m,DB02266,-8.3,Flufenamic Acid,LPEPZBJOKDYZAD-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
9901,6lzg,DB08034,-8.3,"(E)-3,4-DIHYDROXY-N'-[(2-METHOXYNAPHTHALEN-1-YL)METHYLENE]BENZOHYDRAZIDE",TVOPERZEGKBKAY-RGVLZGJSSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
129735,6w4h,DB09235,-8.3,Efonidipine,NSVFSAJIGAJDMR-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
97594,6m71,DB15227,-8.3,Tirabrutinib,SEJLPXCPMNSRAM-GOSISDBHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
124283,6w4h,DB00972,-8.3,Azelastine,MBUVEWMHONZEQD-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
89614,6m71,DB00694,-8.3,Daunorubicin,STQGQHZAVUOBTE-VGBVRHCVSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
89587,6m71,DB00663,-8.3,Flumethasone,WXURHACBFYSXBI-GQKYHHCASA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
13476,6lzg,DB15435,-8.3,BMS-986158,KGERZPVQIRYWRK-GDLZYMKVSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
97614,6m71,DB15268,-8.3,Afabicin,HFYMDQMXVPJNTH-VQHVLOKHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
113116,6vxx,DB08556,-8.3,"5'-ACETYL-4-{[(2,4-DIMETHYLPHENYL)SULFONYL]AMINO}-2,2'-BITHIOPHENE-5-CARBOXYLIC ACID",CMHHNHDPPWDNAH-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
13468,6lzg,DB15416,-8.3,PX-102,XBUXXJUEBFDQHD-NHCUHLMSSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
81419,6m3m,DB01175,-8.3,Escitalopram,WSEQXVZVJXJVFP-FQEVSTJZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136545,6w9c,DB07244,-8.3,"5-{4-[(3,5-DIFLUOROBENZYL)AMINO]PHENYL}-6-ETHYLPYRIMIDINE-2,4-DIAMINE",SRRWXMSVQYQCRX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
14901,6lzg,T3D4852,-8.3,Carmine red,DGQLVPJVXFOQEV-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
81400,6m3m,DB01153,-8.3,Sertaconazole,JLGKQTAYUIMGRK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
128849,6w4h,DB08087,-8.3,"4-[(7R,7AS)-7-HYDROXY-1,3-DIOXOTETRAHYDRO-1H-PYRROLO[1,2-C]IMIDAZOL-2(3H)-YL]-1-NAPHTHONITRILE",NHBIWLQQJPSMNP-CABCVRRESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
134749,6w9c,DB03495,-8.3,"4,6-Dideoxy-4-{[4,5,6-Trihydroxy-3-(Hydroxymethyl)Cyclohex-2-En-1-Yl]Amino}-Alpha-D-Lyxo-Hexopyranosyl-(1->4)-Alpha-D-Threo-Hexopyranosyl-(1->6)-Alpha-L-Threo-Hexopyranose",FZLCJZILHGFQLM-PISLJJGOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
13452,6lzg,DB15393,-8.3,Telatinib,QFCXANHHBCGMAS-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
13451,6lzg,DB15391,-8.3,Elenbecestat,AACUJFVOHGRMTR-DPXNYUHVSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
134744,6w9c,DB03488,-8.3,Uridine-5'-diphosphate-2-deoxy-2-fluoro-alpha-D-galactose,NGTCPFGWXMBZEP-NQQHDEILSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
97569,6m71,DB15186,-8.3,GDC-0084,LGWACEZVCMBSKW-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
81466,6m3m,DB01228,-8.3,Encainide,PJWPNDMDCLXCOM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
123363,6w4b,DB15401,-8.3,Danicopan,PIBARDGJJAGJAJ-NQIIRXRSSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
97543,6m71,DB15126,-8.3,IMG-7289,KQKBMHGOHXOHTD-KKUQBAQOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
13576,6lzg,DB01254,-8.3,Dasatinib,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
13572,6lzg,DB00220,-8.3,Nelfinavir,QAGYKUNXZHXKMR-HKWSIXNMSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
110066,6vxx,DB00768,-8.3,Olopatadine,JBIMVDZLSHOPLA-LSCVHKIXSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81564,6m3m,DB01418,-8.3,Acenocoumarol,VABCILAOYCMVPS-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
90062,6m71,DB01208,-8.3,Sparfloxacin,DZZWHBIBMUVIIW-DTORHVGOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
134874,6w9c,DB03678,-8.3,"(6,7-Difluoro-Quinazolin-4-Yl)-(1-Methyl-2,2-Diphenyl-Ethyl)-Amine",WVGZKPGUHOZIJQ-HNNXBMFYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136477,6w9c,DB07162,-8.3,4-(3-amino-1H-indazol-5-yl)-N-tert-butylbenzenesulfonamide,KFJCXIOVAGJCKB-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
134856,6w9c,DB03656,-8.3,Tribenuron Methyl,VLCQZHSMCYCDJL-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
97464,6m71,DB14937,-8.3,MK-8666,CODQKEMYZZKQAE-QPVYNBJUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
128831,6w4h,DB08068,-8.3,N-[4-CHLORO-3-(PYRIDIN-3-YLOXYMETHYL)-PHENYL]-3-FLUORO-,YQJVDUKATDECHF-ICSRJNTNSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
136492,6w9c,DB07179,-8.3,"3-((3-bromo-5-o-tolylpyrazolo[1,5-a]pyrimidin-7-ylamino)methyl)pyridine 1-oxide",DXUJQXZHHGJMFM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
97483,6m71,DB15011,-8.3,Avacopan,PUKBOVABABRILL-YZNIXAGQSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97491,6m71,DB15029,-8.3,AZD-8186,LMJFJIDLEAWOQJ-CQSZACIVSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
13532,6lzg,DB01180,-8.3,Rescinnamine,SZLZWPPUNLXJEA-LAFLMMDJSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
97492,6m71,DB15031,-8.3,Nemorexant,NBGABHGMJVIVBW-QHCPKHFHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
123364,6w4b,DB15403,-8.3,Ziritaxestat,REQQVBGILUTQNN-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
97514,6m71,DB15071,-8.3,Omidenepag isopropyl,VIQCWEGEHRBLAC-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
86316,6m3m,DB08704,-8.3,"[[(3R,4R,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-(pentanoylamino)oxan-2-ylidene]amino] N-phenylcarbamate",NUNQIQQEEPOGDJ-JDOAOKHLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
97538,6m71,DB15120,-8.3,GSK-239512,YFRBKEVUUCQYOW-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
81485,6m3m,DB01252,-8.3,Mitiglinide,WPGGHFDDFPHPOB-BBWFWOEESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
97480,6m71,DB15003,-8.3,PF-06700841,BUWBRTXGQRBBHG-MJBXVCDLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97660,6m71,DB15356,-8.3,SLV-334,LOFDNSDPZTVIIO-VPUSJEBWSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
119566,6w4b,DB07458,-8.3,"3-(1H-indol-3-yl)-4-{1-[2-(1-methylpyrrolidin-2-yl)ethyl]-1H-indol-3-yl}-1H-pyrrole-2,5-dione",LBFDERUQORUFIN-KRWDZBQOSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
13440,6lzg,DB15358,-8.3,JNJ-54175446,CWFVVQFVGMFTBD-SECBINFHSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
98121,6vxs,DB00568,-8.3,Cinnarizine,DERZBLKQOCDDDZ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
84684,6m3m,DB06744,-8.3,ginkgolide-B,SQOJOAFXDQDRGF-MMQTXUMRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
109909,6vxx,DB00580,-8.3,Valdecoxib,LNPDTQAFDNKSHK-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
128779,6w4h,DB08008,-8.3,"5-methyl-N-[4-(trifluoromethyl)phenyl][1,2,4]triazolo[1,5-a]pyrimidin-7-amine",LRHHXKBKRNNFRV-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
13341,6lzg,DB15186,-8.3,GDC-0084,LGWACEZVCMBSKW-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
128776,6w4h,DB08005,-8.3,4-{[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino}-N-ethylpiperidine-1-carboxamide,ARMFMDYRYOKSOW-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
134659,6w9c,DB03363,-8.3,3-Acetylpyridine Adenine Dinucleotide,KPVQNXLUPNWQHM-RBEMOOQDSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
98299,6vxs,DB00783,-8.3,Estradiol,VOXZDWNPVJITMN-ZBRFXRBCSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
111598,6vxx,DB04259,-8.3,7n-Methyl-8-Hydroguanosine-5'-Monophosphate,ZMWJGXGSWZFZPJ-KQYNXXCUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
98052,6vxs,DB00481,-8.3,Raloxifene,GZUITABIAKMVPG-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
89087,6m3m,DB15440,-8.3,GSK-3117391,AFDPFLDWOXXHQM-NRFANRHFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
98380,6vxs,DB00875,-8.3,Flupentixol,NJMYODHXAKYRHW-DVZOWYKESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
81203,6m3m,DB00924,-8.3,Cyclobenzaprine,JURKNVYFZMSNLP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84714,6m3m,DB06803,-8.3,Niclosamide,RJMUSRYZPJIFPJ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
98480,6vxs,DB00990,-8.3,Exemestane,BFYIZQONLCFLEV-DAELLWKTSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
81199,6m3m,DB00920,-8.3,Ketotifen,ZCVMWBYGMWKGHF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
129929,6w4h,DB11431,-8.3,Moxidectin,YZBLFMPOMVTDJY-LSGXYNIPSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
81187,6m3m,DB00908,-8.3,Quinidine,LOUPRKONTZGTKE-LHHVKLHASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136644,6w9c,DB07360,-8.3,"1-{5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)ethyl]-1,3-thiazol-2-yl}-3-[3-(trifluoromethyl)phenyl]urea",JJHXPDTVQKWKHA-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
98566,6vxs,DB01089,-8.3,Deserpidine,CVBMAZKKCSYWQR-WCGOZPBSSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
128761,6w4h,DB07988,-8.3,"2-[3-(5-MERCAPTO-[1,3,4]THIADIAZOL-2YL)-UREIDO]-N-METHYL-3-PENTAFLUOROPHENYL-PROPIONAMIDE",HZAXNPDJVFUGDS-BYPYZUCNSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
128943,6w4h,DB08191,-8.3,"4-(5-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl)benzoic acid",KSFDVNIKNYXUIP-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
89180,6m71,DB00171,-8.3,ATP,ZKHQWZAMYRWXGA-KQYNXXCUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
89245,6m71,DB00246,-8.3,Ziprasidone,MVWVFYHBGMAFLY-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
128822,6w4h,DB08056,-8.3,"N-(2,6-dimethylphenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine",KKYYLKPGILUPOA-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
97671,6m71,DB15385,-8.3,Acebilustat,GERJIEKMNDGSCS-DQEYMECFSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
113722,6vxx,DB11814,-8.3,PF-03882845,XNULRSOGWPFPBL-REWPJTCUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
8498,6lzg,DB06229,-8.3,Ocaperidone,ZZQNEJILGNNOEP-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
14912,6lzg,T3D4864,-8.3,Erioglaucine A disodium salt,SGHZXLIDFTYFHQ-UHFFFAOYSA-L,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
124331,6w4h,DB01026,-8.3,Ketoconazole,XMAYWYJOQHXEEK-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
89411,6m71,DB00445,-8.3,Epirubicin,AOJJSUZBOXZQNB-VTZDEGQISA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
9495,6lzg,DB00696,-8.3,Ergotamine,XCGSFFUVFURLIX-VFGNJEKYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
84638,6m3m,DB06678,-8.3,Esmirtazapine,RONZAEMNMFQXRA-MRXNPFEDSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81278,6m3m,DB01012,-8.3,Cinacalcet,VDHAWDNDOKGFTD-MRXNPFEDSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
97710,6m71,DB15460,-8.3,AGG-523,JWQMTWCFNZSLNR-DEOSSOPVSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
111563,6vxx,DB04040,-8.3,"N-(2-Morpholin-4-Yl-1-Morpholin-4-Ylmethyl-Ethyl)-3-Nitro-5-(3,4,5-Trihydroxy-6-Hydroxymethyl-Tetrahydro-Pyran-2-Yloxy)-Benzamide",MCMWCTMAKPQTPI-WGNYYXNJSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
97774,6vxs,DB00153,-8.3,Ergocalciferol,MECHNRXZTMCUDQ-RKHKHRCZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
81312,6m3m,DB01053,-8.3,Benzylpenicillin,JGSARLDLIJGVTE-MBNYWOFBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81303,6m3m,DB01041,-8.3,Thalidomide,UEJJHQNACJXSKW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
89271,6m71,DB00275,-8.3,Olmesartan,VTRAEEWXHOVJFV-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
8772,6lzg,DB06817,-8.3,Raltegravir,CZFFBEXEKNGXKS-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
97885,6vxs,DB00278,-8.3,Argatroban,KXNPVXPOPUZYGB-IOVMHBDKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
13387,6lzg,DB15265,-8.3,USL-311,XNUNVQKARNSSEO-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
97905,6vxs,DB00303,-8.3,Ertapenem,JUZNIMUFDBIJCM-ANEDZVCMSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
97716,6m71,DB02524,-8.3,"2',3'-O-{4-[Hydroxy(oxido)-lambda5-azanylidene]-2,6-dinitro-2,5-cyclohexadiene-1,1-diyl}adenosine 5'-(tetrahydrogen triphosphate)",XFMMHXLUHKBKQE-UHEGPQQHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
128944,6w4h,DB08192,-8.3,2-(4-CARCOXY-5-ISOPROPYLTHIAZOLYL)BENZOPIPERIDINE,HCUGCUQZFBURHR-LBPRGKRZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
81583,6m3m,DB01439,-8.3,3-Methylthiofentanyl,SRARDYUHGVMEQI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136453,6w9c,DB07133,-8.3,D-phenylalanyl-N-(3-methylbenzyl)-L-prolinamide,CHKWABXWPATIIG-UXHICEINSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
113200,6vxx,DB08659,-8.3,2-(hydrazinocarbonyl)-3-phenyl-1H-indole-5-sulfonamide,PPDLAUCFAOODER-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
129075,6w4h,DB08360,-8.3,"2-(4-ETHYLPIPERAZIN-1-YL)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE",BIFHJPUTQBOBGJ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
6391,6lzg,DB02033,-8.3,"N-(3-Cyclopropyl(5,6,7,8,9,10-Hexahydro-2-Oxo-2h-Cycloocta[B]Pyran-3-Yl)Methyl)Phenylbenzensulfonamide",GDRNWAKVNIROCG-DEOSSOPVSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
82044,6m3m,DB02030,-8.3,Alpha-Ribazole-5'-Phosphate,ZMRGXEJKZPRBPJ-SYQHCUMBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
96213,6m71,DB12561,-8.3,WNT-974,XXYGTCZJJLTAGH-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
90872,6m71,DB02319,-8.3,"5,6-Dihydroxy-Nadp",LRAVAOPKUBJONV-IVCJQJMGSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96251,6m71,DB12622,-8.3,Lupeol,MQYXUWHLBZFQQO-QGTGJCAVSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
136322,6w9c,DB06986,-8.3,"2-CHLORO-N-[(1R,2R)-1-HYDROXY-2,3-DIHYDRO-1H-INDEN-2-YL]-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE",LRHOLHTVXXSIMG-BXUZGUMPSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
111374,6vxx,DB03791,-8.3,"(3-{3-[[2-Chloro-3-(Trifluoromethyl)Benzyl](2,2-Diphenylethyl)Amino]Propoxy}Phenyl)Acetic Acid",NAXSRXHZFIBFMI-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
129079,6w4h,DB08365,-8.3,"8-bromo-4-(2-chlorophenyl)-N-(2-hydroxyethyl)-6-methyl-1,3-dioxo-1,2,3,6-tetrahydropyrrolo[3,4-e]indole-7-carboxamide",XUAHLMVOYLUYSB-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
96332,6m71,DB12744,-8.3,CGI-1842,ZXBFYBLSJMEBEP-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
82023,6m3m,DB02001,-8.3,"5-(4-Morpholin-4-Yl-Phenylsulfanyl)-2,4-Quinazolinediamine",CZLWCJRHDBTCGQ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
82002,6m3m,DB01972,-8.3,Guanosine-5'-Monophosphate,RQFCJASXJCIDSX-UUOKFMHZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
129058,6w4h,DB08340,-8.3,"N,N'-DIPHENYLPYRAZOLO[1,5-A][1,3,5]TRIAZINE-2,4-DIAMINE",LLYYAUZAGCZEKV-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
84463,6m3m,DB06230,-8.3,Nalmefene,WJBLNOPPDWQMCH-MBPVOVBZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
123384,6w4b,DB15442,-8.3,Trilaciclib,PDGKHKMBHVFCMG-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
136334,6w9c,DB06999,-8.3,"N-{3-[(5-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)carbonyl]-2,4-difluorophenyl}propane-1-sulfonamide",YZDJQTHVDDOVHR-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
135128,6w9c,DB04020,-8.3,"4-(2-{[4-{[3-(4-Chlorophenyl)Propyl]Sulfanyl}-6-(1-Piperazinyl)-1,3,5-Triazin-2-Yl]Amino}Ethyl)Phenol",AIBKIFHSQQYXLG-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
135120,6w9c,DB04010,-8.3,2-(3'-Methoxyphenyl) Benzimidazole-4-Carboxamide,NVVWVYYHTKCIAE-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
96417,6m71,DB12887,-8.3,Tazemetostat,NSQSAUGJQHDYNO-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
82025,6m3m,DB02004,-8.3,"5-(Aminomethyl)-6-(2,4-Dichlorophenyl)-2-(3,5-Dimethoxyphenyl)Pyrimidin-4-Amine",RCJFINNFYUNFGH-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
96424,6m71,DB12897,-8.3,MK-7622,JUVQLZBJFOGEEO-GOTSBHOMSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
113603,6vxx,DB11636,-8.3,Nomegestrol,KZUIYQJTUIACIG-YBZCJVABSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
96176,6m71,DB12505,-8.3,E-7820,LWGUASZLXHYWIV-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
136273,6w9c,DB06923,-8.3,2-(3-METHYLPHENYL)-1H-INDOLE-5-CARBOXIMIDAMIDE,KJUSXMYSVXZFDJ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
82213,6m3m,DB02254,-8.3,Trifluoro-thiamin phosphate,ZIBIECXVPMYJCV-UHFFFAOYSA-M,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
91111,6m71,DB02621,-8.3,Latrunculin A,DDVBPZROPPMBLW-IZGXTMSKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
82212,6m3m,DB02253,-8.3,"(1r)-4-[(1e,3e,5e,7z,9e,11z,13e,15e)-17-Hydroxy-3,7,12,16-Tetramethylheptadeca-1,3,5,7,9,11,13,15-Octaen-1-Yl]-3,5,5-Trimethylcyclohex-3-En-1-Ol",FNAJVVMDXCOSFY-VFGOXHQXSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
110252,6vxx,DB01150,-8.3,Cefprozil,WDLWHQDACQUCJR-PBFPGSCMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
91107,6m71,DB02616,-8.3,FR117016,CKJGKHXCUDWFDC-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
129140,6w4h,DB08441,-8.3,"6-BROMO-13-THIA-2,4,8,12,19-PENTAAZATRICYCLO[12.3.1.1-3,7-]NONADECA-1(18),3(19),4,6,14,16-HEXAENE 13,13-DIOXIDE",AWSQADBSXFTFKL-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
91057,6m71,DB02547,-8.3,Guanosine-5'-Diphosphate-Rhamnose,LQEBEXMHBLQMDB-GDJBGNAASA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
91039,6m71,DB02524,-8.3,"2',3'-O-{4-[Hydroxy(oxido)-??5-azanylidene]-2,6-dinitro-2,5-cyclohexadiene-1,1-diyl}adenosine 5'-(tetrahydrogen triphosphate)",XFMMHXLUHKBKQE-UHEGPQQHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
84446,6m3m,DB06195,-8.3,Seliciclib,BTIHMVBBUGXLCJ-OAHLLOKOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
129125,6w4h,DB08423,-8.3,[5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL][3-(PIPERIDIN-4-YLOXY)PHENYL]METHANONE,QKZZJXRGCHXIAI-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
8585,6lzg,DB06455,-8.3,Meclinertant,DYLJVOXRWLXDIG-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
129110,6w4h,DB08402,-8.3,"2-[(2,4-DICHLOROBENZOYL)AMINO]-5-(PYRIMIDIN-2-YLOXY)BENZOIC ACID",VNDRRWBKNSHALL-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
91006,6m71,DB02485,-8.3,Cytidine-5'-Monophosphate-5-N-Acetylneuraminic Acid,TXCIAUNLDRJGJZ-BILDWYJOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
135213,6w9c,DB04137,-8.3,Guanosine-5'-Triphosphate,XKMLYUALXHKNFT-UUOKFMHZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
90958,6m71,DB02421,-8.3,Uridine-5'-Diphosphate-Mannose,HSCJRCZFDFQWRP-NYYOCOOHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
14762,6lzg,T3D4715,-8.3,Teniposide,NRUKOCRGYNPUPR-PSZSYXFXSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
82105,6m3m,DB02106,-8.3,"[3,5-Dibromo-4-(4-Hydroxy-3-Phenethylcarbamoyl-Phenoxy)-Phenyl]-Acetic Acid",KIRQJXNQGZAKGR-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
82097,6m3m,DB02098,-8.3,Adenosine-2'-5'-Diphosphate,AEOBEOJCBAYXBA-KQYNXXCUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
90928,6m71,DB02388,-8.3,"Cyclohexyl-{4-[5-(3,4-Dichlorophenyl)-2-Piperidin-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine",UQFRSHRWRKYNDE-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
91028,6m71,DB02510,-8.3,'5'-O-(N-(L-Prolyl)-Sulfamoyl)Adenosine,LKVJEMXWEODCAY-JVEUSOJLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
129148,6w4h,DB08449,-8.3,"2-(3-((4,5,7-trifluorobenzo[d]thiazol-2-yl)methyl)-1H-pyrrolo[2,3-b]pyridin-1-yl)acetic acid",IEVFQDJUDLCOQY-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
81972,6m3m,DB01937,-8.3,Guanosine-2'-Monophosphate,WTIFIAZWCCBCGE-UUOKFMHZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
135110,6w9c,DB03996,-8.3,"3-[(5s)-1-Acetyl-3-(2-Chlorophenyl)-4,5-Dihydro-1h-Pyrazol-5-Yl]Phenol",QBZAPFWYAPXRGQ-KRWDZBQOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
128974,6w4h,DB08233,-8.3,6-CYCLOHEXYLMETHYLOXY-2-(4'-HYDROXYANILINO)PURINE,RFSDQDHHBKYQOD-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
84517,6m3m,DB06368,-8.3,Alamifovir,VDBGPMJFHCJMOL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84519,6m3m,DB06374,-8.3,Elacestrant,SIFNOOUKXBRGGB-AREMUKBSSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81682,6m3m,DB01551,-8.3,Dihydrocodeine,RBOXVHNMENFORY-DNJOTXNNSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
128972,6w4h,DB08230,-8.3,"5,7-DIHYDROXY-2-(3,4,5-TRIHYDROXYPHENYL)-4H-CHROMEN-4-ONE",ARSRJFRKVXALTF-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
8547,6lzg,DB06346,-8.3,Fiboflapon,DFQGDHBGRSTTHX-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
8540,6lzg,DB06314,-8.3,SGX-523,BCZUAADEACICHN-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
81662,6m3m,DB01531,-8.3,Desomorphine,LNNWVNGFPYWNQE-GMIGKAJZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
97303,6m71,DB14627,-8.3,Oxyphenisatin acetate,PHPUXYRXPHEJDF-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
84512,6m3m,DB06354,-8.3,Tezampanel,ZXFRFPSZAKNPQQ-YTWAJWBKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
111499,6vxx,DB03950,-8.3,(S)-N-(3-Indol-1-Yl-2-Methyl-Propyl)-4-Sulfamoyl-Benzamide,ZFWHOUCRVSOZJE-AWEZNQCLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136428,6w9c,DB07107,-8.3,(1S)-2-(1H-INDOL-3-YL)-1-[({5-[(E)-2-PYRIDIN-4-YLVINYL]PYRIDIN-3-YL}OXY)METHYL]ETHYLAMINE,SGHXFHRRWFLILP-XJDXJNMNSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
90134,6m71,DB01338,-8.3,Pipecuronium,OWWLUIWOFHMHOQ-XGHATYIMSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
119853,6w4b,DB07800,-8.3,N-(2-(((5-CHLORO-2-PYRIDINYL)AMINO)SULFONYL)PHENYL)-4-(2-OXO-1(2H)-PYRIDINYL)BENZAMIDE,MIJGLXFQYBTIFY-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
81631,6m3m,DB01491,-8.3,Dipipanone,SVDHSZFEQYXRDC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
9513,6lzg,DB07622,-8.3,"1-(3-(2,4-DIMETHYLTHIAZOL-5-YL)-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)-3-(4-METHYLPIPERAZIN-1-YL)UREA",KRKQVGZXTNLQSV-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
113682,6vxx,DB11755,-8.3,Tetrahydrocannabivarin,ZROLHBHDLIHEMS-HUUCEWRRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84540,6m3m,DB06442,-8.3,Avasimibe,PTQXTEKSNBVPQJ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
90103,6m71,DB01264,-8.3,Darunavir,CJBJHOAVZSMMDJ-HEXNFIEUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97388,6m71,DB14770,-8.3,Lanraplenib,XCIGZBVOUQVIPI-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
134949,6w9c,DB03788,-8.3,GC-24,JYHIGYLGYNCMGI-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
96441,6m71,DB12924,-8.3,Ozenoxacin,XPIJWUTXQAGSLK-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
113633,6vxx,DB11681,-8.3,Tofimilast,DHCOPPHTVOXDKU-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81742,6m3m,DB01623,-8.3,Thiothixene,GFBKORZTTCHDGY-UWVJOHFNSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
96475,6m71,DB12973,-8.3,Serlopitant,FLNYCRJBCNNHRH-OIYLJQICSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96488,6m71,DB12998,-8.3,PF-00217830,QGNOXTFZOLDODX-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
81922,6m3m,DB01859,-8.3,4-Diphosphocytidyl-2-C-Methyl-D-Erythritol 2-Phosphate,HTJXTKBIUVFUAR-XHIBXCGHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
96491,6m71,DB13002,-8.3,HKI-357,NERXPXBELDBEPZ-RMKNXTFCSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
111446,6vxx,DB03882,-8.3,"5-Alpha-Androstane-3-Beta,17beta-Diol",CBMYJHIOYJEBSB-YSZCXEEOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81883,6m3m,DB01810,-8.3,"[1-(1-Methyl-4,5-Dioxo-Pent-2-Enylcarbamoyl)-2-Phenyl-Ethyl]-Carbamic Acid Benzyl Ester",NOXVWFAAXREWMI-GURWAVDKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
129636,6w4h,DB09080,-8.3,Olodaterol,COUYJEVMBVSIHV-SFHVURJKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
96515,6m71,DB13036,-8.3,Ramatroban,LDXDSHIEDAPSSA-OAHLLOKOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
90593,6m71,DB01948,-8.3,"1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperidin-4-Yl-3,4-Dihydroquinolin-2(1h)-One",VXIYTVJEIXMAQF-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
111478,6vxx,DB03924,-8.3,"5,8-Di-Amino-1,4-Dihydroxy-Anthraquinone",QVEMRPAUHFWHRV-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
96518,6m71,DB13042,-8.3,Fenoverine,UBAJTZKNDCEGKL-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
113612,6vxx,DB11650,-8.3,HT-0712,ABEJDMOBAFLQNJ-NHCUHLMSSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81826,6m3m,DB01734,-8.3,3-(Oxalyl-Amino)-Naphthalene-2-Carboxylic Acid,DQBLKSRRWDWNKQ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
129685,6w4h,DB09181,-8.3,Trefentanil,RJSCINHYBGMIFT-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
136396,6w9c,DB07067,-8.3,"(2S,3S)-3-{3-[4-(METHYLSULFONYL)PHENYL]-1,2,4-OXADIAZOL-5-YL}-1-OXO-1-PYRROLIDIN-1-YLBUTAN-2-AMINE",SQCDMTZMCHZYGO-FZMZJTMJSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
90395,6m71,DB01678,-8.3,RU84687,SAFPHFWYRLLBFO-NSOVKSMOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
135091,6w9c,DB03970,-8.3,"(7R)-7-(6,7-Dihydro-5H-cyclopenta[d]imidazo[2,1-b][1,3]thiazol-2-yl)-2,7-dihydro-1,4-thiazepine-3,6-dicarboxylic acid",CHNMLWCTGYMVFH-GFCCVEGCSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
96632,6m71,DB13240,-8.3,Cymarin,XQCGNURMLWFQJR-ZNDDOCHDSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96735,6m71,DB13371,-8.3,Difenpiramide,PWHROYKAGRUWDQ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
81758,6m3m,DB01641,-8.3,"(5z)-2-[(1s,2r)-1-Amino-2-Hydroxypropyl]-5-[(4-Amino-1h-Indol-3-Yl)Methylene]-3-(2-Hydroxyethyl)-3,5-Dihydro-4h-Imidazol-4-One",JUWJATLABHTRDF-JURWUIOISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
96541,6m71,DB13074,-8.3,Macimorelin,UJVDJAPJQWZRFR-DHIUTWEWSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
133579,6w9c,DB01871,-8.3,[1-(1-Benzyl-3-Hydroxy-2-Oxo-Propylcarbamoyl)-2-Phenyl-Ethyl]-Carbamic Acid Benzyl Ester,OACUXIVGLLCILS-ZEQRLZLVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
83876,6m3m,DB04474,-8.3,1-Anilino-8-Naphthalene Sulfonate,FWEOQOXTVHGIFQ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
133576,6w9c,DB01865,-8.3,3-(6-Aminopyridin-3-Yl)-N-Methyl-N-[(1-Methyl-1h-Indol-2-Yl)Methyl]Acrylamide,AKFPMLBVLWZSQX-CSKARUKUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
132071,6w4h,DB15319,-8.3,VM4-037,QGYZPMXIVNIGKA-GMAHTHKFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
77513,6m2n,DB08470,-8.3,"3-(4-fluorophenyl)-5-phenyl-4H-1,2,4-triazole",KMGPJKOKSYGMJD-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
122073,6w4b,DB12843,-8.3,Oleandrin,JLPDBLFIVFSOCC-XYXFTTADSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
87083,6m3m,DB11805,-8.3,Saracatinib,OUKYUETWWIPKQR-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
9168,6lzg,DB07252,-8.3,"3-({4-[(5-chloro-1,3-benzodioxol-4-yl)amino]pyrimidin-2-yl}amino)benzenesulfonamide",TZHCXOMEOHEZDX-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
122058,6w4b,DB12817,-8.3,Zoliflodacin,ZSWMIFNWDQEXDT-ZESJGQACSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
132102,6w4h,DB15391,-8.3,Elenbecestat,AACUJFVOHGRMTR-DPXNYUHVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
87069,6m3m,DB11787,-8.3,Ralimetinib,XPPBBJCBDOEXDN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
133118,6w9c,DB01228,-8.3,Encainide,PJWPNDMDCLXCOM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138660,6w9c,DB12082,-8.3,Vesnarinone,ZVNYJIZDIRKMBF-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
106515,6vxx,DB00438,-8.3,Ceftazidime,ORFOPKXBNMVMKC-DWVKKRMSSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114502,6vxx,DB13714,-8.3,Xibornol,RNRHMQWZFJXKLZ-JCKWVBRZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
16179,6lzg,DB03067,-8.3,"4-{2,4-Bis[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid",VFYAZSTYKPFSFL-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
11362,6lzg,DB11864,-8.3,Preladenant,DTYWJKSSUANMHD-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
77439,6m2n,DB08382,-8.3,Gosogliptin,QWEWGXUTRTXFRF-KBPBESRZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138686,6w9c,DB12120,-8.3,Avoralstat,TUWMKPVJGGWGNL-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
127484,6w4h,DB06190,-8.3,Solabegron,LLDXOPKUNJTIRF-QFIPXVFZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
16789,6cs2,HMDB0004483,-8.3,Estrone glucuronide,FJAZVHYPASAQKM-JBAURARKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
85865,6m3m,DB08149,-8.3,"1-[4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine",KCWPSUKJCKZEAO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
132050,6w4h,DB15282,-8.3,Fluorofuranylnorprogesterone F-18,VJKRBRUNEOHPBS-JQKUZGBFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
133126,6w9c,DB01238,-8.3,Aripiprazole,CEUORZQYGODEFX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
132047,6w4h,DB15275,-8.3,GDC-0077,SGEUNORSOZVTOL-CABZTGNLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
77588,6m2n,DB08557,-8.3,"2-[(2-methoxyethyl)amino]-4-(4-oxo-1,2,3,4-tetrahydro-9H-carbazol-9-yl)benzamide",XQKFKSJUBJPOLY-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
132006,6w4h,DB15197,-8.3,RSV-604,MTPVBMVUENFFLL-HXUWFJFHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
77576,6m2n,DB08543,-8.3,1-[2-HYDROXY-3-(4-CYCLOHEXYL-PHENOXY)-PROPYL]-4-(2-PYRIDYL)-PIPERAZINE,BZJHCQBNFUNZPJ-QFIPXVFZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
106249,6vxs,DB15310,-8.3,Vactosertib,FJCDSQATIJKQKA-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
112704,6vxx,DB07750,-8.3,"(2R)-1-[4-({4-[(2,5-Dichlorophenyl)amino]-2-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol",GNLAGGCSJGJECE-MRXNPFEDSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77566,6m2n,DB08532,-8.3,"6-(2-fluorophenyl)-N-(pyridin-3-ylmethyl)imidazo[1,2-a]pyrazin-8-amine",WCNPGRRMPFCHEO-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77565,6m2n,DB08531,-8.3,"5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",CVYWYUAQFJMLEO-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
114451,6vxx,DB13649,-8.3,Proquazone,JTIGKVIOEQASGT-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127564,6w4h,DB06401,-8.3,Bazedoxifene,UCJGJABZCDBEDK-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
11447,6lzg,DB00910,-8.3,Paricalcitol,BPKAHTKRCLCHEA-UBFJEZKGSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
87154,6m3m,DB11909,-8.3,Varespladib,BHLXTPHDSZUFHR-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
106284,6vxs,DB15393,-8.3,Telatinib,QFCXANHHBCGMAS-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
106294,6vxs,DB15408,-8.3,Silmitasertib,MUOKSQABCJCOPU-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
138638,6w9c,DB12050,-8.3,LY-3039478,YCBAQKQAINQRFW-UGSOOPFHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
108927,6vxx,DB11398,-8.3,Diclazuril,ZSZFUDFOPOMEET-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77532,6m2n,DB08493,-8.3,"5-METHYL-3-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.013,18]NONADECA-12(19),13,15,17-TETRAEN-10-YLCARBAMOYL)-HEXANOIC ACID",AKWKBACKRMYPRV-NQIIRXRSSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
11419,6lzg,DB11942,-8.3,Selinexor,DEVSOMFAQLZNKR-RJRFIUFISA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
11408,6lzg,DB11925,-8.3,Vistusertib,JUSFANSTBFGBAF-IRXDYDNUSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
87134,6m3m,DB11880,-8.3,Acridine Carboxamide,XBGNERSKEKDZDS-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
77387,6m2n,DB08315,-8.3,"2-AMINO-N,N-BIS(PHENYLMETHYL)-1,3-OXAZOLE-5-CARBOXAMIDE",KIJXWOGFYAWTNC-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
106553,6vxx,DB00482,-8.3,Celecoxib,RZEKVGVHFLEQIL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87042,6m3m,DB11748,-8.3,Benfotiamine,BTNNPSLJPBRMLZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
125682,6w4h,DB02812,-8.3,"(2s,4r)-1-Acetyl-N-[(1s)-4-[(Aminoiminomethyl)Amino]-1-(2-Benzothiazolylcarbonyl)Butyl]-4-Hydroxy-2-Pyrrolidinecarboxamide",VXDAVYUFYPFGDX-SNPRPXQTSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
112659,6vxx,DB07512,-8.3,7-[(3-CHLOROBENZYL)OXY]-2-OXO-2H-CHROMENE-4-CARBALDEHYDE,ZOCADHRNWNJARU-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
125699,6w4h,DB02834,-8.3,IDD552,ZCAGEXZTORJQDZ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
86991,6m3m,DB11672,-8.3,Curcumin,VFLDPWHFBUODDF-FCXRPNKRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
138740,6w9c,DB12203,-8.3,Tozadenant,XNBRWUQWSKXMPW-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
86989,6m3m,DB11670,-8.3,SP-8203,SJZBPVOSFYUHFV-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
127434,6w4h,DB05944,-8.3,Varlitinib,UWXSAYUXVSFDBQ-CYBMUJFWSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
108748,6vxx,DB08905,-8.3,Formestane,OSVMTWJCGUFAOD-KZQROQTASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86949,6m3m,DB11582,-8.3,Thiocolchicoside,LEQAKWQJCITZNK-AXHKHJLKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
125833,6w4h,DB03010,-8.3,Patupilone,QXRSDHAAWVKZLJ-PVYNADRNSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
132339,6w9c,DB00307,-8.3,Bexarotene,NAVMQTYZDKMPEU-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
86941,6m3m,DB11555,-8.3,Zolazepam,GDSCFOSHSOWNDL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
127421,6w4h,DB05861,-8.3,Tasquinimod,ONDYALNGTUAJDX-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
138749,6w9c,DB12218,-8.3,AZD-5363,JDUBGYFRJFOXQC-KRWDZBQOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
77139,6m2n,DB08020,-8.3,"(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-6-(METHOXYMETHYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL",RHQLNMNKTIOREN-AOIWGVFYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
133060,6w9c,DB01162,-8.3,Terazosin,VCKUSRYTPJJLNI-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
108676,6vxx,DB08534,-8.3,"5-(2-fluorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",ZAIYYXVHGBMLEC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106827,6vxx,DB01340,-8.3,Cilazapril,HHHKFGXWKKUNCY-FHWLQOOXSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106828,6vxx,DB01342,-8.3,Forasartan,YONOBYIBNBCDSJ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108674,6vxx,DB08532,-8.3,"6-(2-fluorophenyl)-N-(pyridin-3-ylmethyl)imidazo[1,2-a]pyrazin-8-amine",WCNPGRRMPFCHEO-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138727,6w9c,DB12183,-8.3,Sapitinib,DFJSJLGUIXFDJP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
127572,6w4h,DB06414,-8.3,Etravirine,PYGWGZALEOIKDF-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
11283,6lzg,DB11759,-8.3,Pevonedistat,MPUQHZXIXSTTDU-QXGSTGNESA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
106712,6vxx,DB00923,-8.3,Ceforanide,SLAYUXIURFNXPG-CRAIPNDOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87027,6m3m,DB11726,-8.3,Encenicline,SSRDSYXGYPJKRR-ZDUSSCGKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
11329,6lzg,DB11819,-8.3,ASP-4058,NJNXCJPSMWKXHO-VIFPVBQESA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
106613,6vxx,DB00814,-8.3,Meloxicam,ZRVUJXDFFKFLMG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77351,6m2n,DB08270,-8.3,"N-(2-AMINOETHYL)-N-2-{(1S)-1-[4'-(AMINOSULFONYL)BIPHENYL-4-YL]-2,2,2-TRIFLUOROETHYL}-L-LEUCINAMIDE",QPXXBNKMAHUXBB-PMACEKPBSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
108820,6vxx,DB09421,-8.3,Protirelin,XNSAINXGIQZQOO-SRVKXCTJSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114532,6vxx,DB13755,-8.3,Iocarmic acid,SMQYOVYWPWASGU-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106635,6vxx,DB00838,-8.3,Clocortolone,YMTMADLUXIRMGX-RFPWEZLHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77332,6m2n,DB08244,-8.3,"(1S)-1-CYCLOPROPYL-2-[(2S)-4-(2,5-DIFLUOROPHENYL)-2-PHENYL-2,5-DIHYDRO-1H-PYRROL-1-YL]-2-OXOETHANAMINE",VCOUEHUEFUDZIS-PMACEKPBSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
127454,6w4h,DB06117,-8.3,"1alpha,24S-Dihydroxyvitamin D2",ODZFJAXAEXQSKL-WRJREGAQSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
106668,6vxx,DB00875,-8.3,Flupentixol,NJMYODHXAKYRHW-DVZOWYKESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77320,6m2n,DB08230,-8.3,"5,7-DIHYDROXY-2-(3,4,5-TRIHYDROXYPHENYL)-4H-CHROMEN-4-ONE",ARSRJFRKVXALTF-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
87010,6m3m,DB11696,-8.3,Racecadotril,ODUOJXZPIYUATO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
133088,6w9c,DB01192,-8.3,Oxymorphone,UQCNKQCJZOAFTQ-ISWURRPUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138719,6w9c,DB12167,-8.3,LY-3023414,ACCFLVVUVBJNGT-AWEZNQCLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
77304,6m2n,DB08208,-8.3,"2-[(4-ETHYNYL-2-FLUOROPHENYL)AMINO]-3,4-DIFLUORO-N-(2-HYDROXYETHOXY)BENZAMIDE",AMNKRBRQQAMACZ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138720,6w9c,DB12170,-8.3,Veledimex,LZWZPGLVHLSWQX-XMMPIXPASA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
122003,6w4b,DB12724,-8.3,AZD-7295,MAQDQJWCSSCURR-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
85898,6m3m,DB08185,-8.3,2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,LCHGAOHLDYRACA-SDBHATRESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
11291,6lzg,DB11769,-8.3,Funapide,NEBUOXBYNAHKFV-NRFANRHFSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
11285,6lzg,DB11763,-8.3,Momelotinib,ZVHNDZWQTBEVRY-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
11463,6lzg,DB12001,-8.3,Abemaciclib,UZWDCWONPYILKI-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
77596,6m2n,DB08569,-8.3,"3-PYRIDIN-4-YL-2,4-DIHYDRO-INDENO[1,2-.C.] PYRAZOLE",VLPMRZSKJUTRBQ-IBGZPJMESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77604,6m2n,DB08577,-8.3,3-[(3-(2-CARBOXYETHYL)-4-METHYLPYRROL-2-YL)METHYLENE]-2-INDOLINONE,JNDVEAXZWJIOKB-JYRVWZFOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78022,6m2n,DB09169,-8.3,3-Allylfentanyl,BZXKQFFMDLTPJL-LADGPHEKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
131903,6w4h,DB14982,-8.3,Miransertib,HNFMVVHMKGFCMB-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
87300,6m3m,DB12124,-8.3,Namitecan,IBTISPLPBBHVSU-UVOOVGFISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
105928,6vxs,DB14641,-8.3,Estriol tripropionate,ONMZMZJEZHMWQL-REUUDLSRSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
77998,6m2n,DB09101,-8.3,Elvitegravir,JUZYLCPPVHEVSV-LJQANCHMSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
125466,6w4h,DB02519,-8.3,Indirubin-5-Sulphonate,IHBOEHLUIBMBMY-YPKPFQOOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
11624,6lzg,DB12222,-8.3,Lurtotecan,RVFGKBWWUQOIOU-NDEPHWFRSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
8179,6lzg,DB04859,-8.3,Zanapezil,PMBLXLOXUGVTGB-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
105977,6vxs,DB14723,-8.3,Larotrectinib,NYNZQNWKBKUAII-KBXCAEBGSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
133247,6w9c,DB01456,-8.3,5-androstenedione,SQGZFRITSMYKRH-QAGGRKNESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
131913,6w4h,DB15011,-8.3,Avacopan,PUKBOVABABRILL-YZNIXAGQSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131920,6w4h,DB15028,-8.3,MK-1064,CKTWQGHVNRYNCM-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
11608,6lzg,DB12198,-8.3,Fosdagrocorat,BVXLAHSJXXSWFF-KEKPKEOLSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
114251,6vxx,DB13177,-8.3,4-methylumbelliferyl beta-D-glucoside,YUDPTGPSBJVHCN-YMILTQATSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
6809,6lzg,DB02723,-8.3,"4-Oxo-2-Phenylmethanesulfonyl-Octahydro-Pyrrolo[1,2-a]Pyrazine-6-Carboxylic Acid [1-(N-Hydroxycarbamimidoyl)-Piperidin-4-Ylmethyl]-Amide",DHTSUHWLPAEEQB-OALUTQOASA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
133242,6w9c,DB01451,-8.3,1-Androstenedione,WJIQCDPCDVWDDE-WZNAKSSCSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
16015,6lzg,DB02331,-8.3,"(2s)-2-[(5-Benzofuran-2-Yl-Thiophen-2-Ylmethyl)-(2,4-Dichloro-Benzoyl)-Amino]-3-Phenyl-Propionic Acid",YBULOUKTPCHXAL-DEOSSOPVSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
138551,6w9c,DB11827,-8.3,Ertugliflozin,MCIACXAZCBVDEE-CUUWFGFTSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
133228,6w9c,DB01434,-8.3,19-norandrostenedione,JRIZOGLBRPZBLQ-QXUSFIETSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
87320,6m3m,DB12153,-8.3,Citicoline,RZZPDXZPRHQOCG-OJAKKHQRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
11586,6lzg,DB12165,-8.3,Presatovir,GOFXWTVKPWJNGD-UWJYYQICSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
105890,6vxs,DB14541,-8.3,Hydrocortisone cypionate,DLVOSEUFIRPIRM-KAQKJVHQSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
109029,6vxx,DB11933,-8.3,Riboprine,USVMJSALORZVDV-SDBHATRESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138454,6w9c,DB11686,-8.3,Iferanserin,UXIPFQUBOVWAQW-UEBLJOKOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
105747,6vxs,DB13952,-8.3,Estradiol acetate,FHXBMXJMKMWVRG-SLHNCBLASA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
78158,6m2n,DB09488,-8.3,Acrivastine,PWACSDKDOHSSQD-IUTFFREVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
122286,6w4b,DB13185,-8.3,Oxabolone cipionate,KHKDIUPVDIEHAH-KXLSUQFWSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
78124,6m2n,DB09304,-8.3,Setiptiline,GVPIXRLYKVFFMK-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
122275,6w4b,DB13164,-8.3,Olmutinib,FDMQDKQUTRLUBU-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
114234,6vxx,DB13135,-8.3,AGN-201904,PPCGSVWOZKNPCX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85646,6m3m,DB07901,-8.3,5-CHLORO-6-METHYL-N-(2-PHENYLETHYL)-2-PYRIDIN-2-YLPYRIMIDIN-4-AMINE,HIUOABSWQSUEGK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
131880,6w4h,DB14906,-8.3,Adafosbuvir,NIJYGVDQZBBONK-SEUXLIJBSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
109038,6vxx,DB11943,-8.3,Delafloxacin,DYDCPNMLZGFQTM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109034,6vxx,DB11939,-8.3,Henagliflozin,HYTPDMFFHVZBOR-VNXMGFANSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
105778,6vxs,DB14017,-8.3,H3B-8800,YOIQWBAHJZGRFW-WVRLKXNASA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
125436,6w4h,DB02485,-8.3,Cytidine-5'-Monophosphate-5-N-Acetylneuraminic Acid,TXCIAUNLDRJGJZ-BILDWYJOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
11653,6lzg,DB12260,-8.3,Radiprodil,GKGRZLGAQZPEHO-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
78076,6m2n,DB09227,-8.3,Barnidipine,VXMOONUMYLCFJD-DHLKQENFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138492,6w9c,DB11743,-8.3,Ipatasertib,GRZXWCHAXNAUHY-NSISKUIASA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
105789,6vxs,DB14035,-8.3,Englitazone,MVDXXGIBARMXSA-PYUWXLGESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
10392,6lzg,DB08584,-8.3,"6-{[6-(1-methyl-1H-pyrazol-4-yl)[1,2,4]triazolo[4,3-b]pyridazin-3-yl]sulfanyl}quinoline",BCZUAADEACICHN-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
138495,6w9c,DB11749,-8.3,(R)-Praziquantel,FSVJFNAIGNNGKK-KRWDZBQOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
8930,6lzg,DB06995,-8.3,N-({4-[(2-aminopyridin-4-yl)oxy]-3-fluorophenyl}carbamoyl)-2-(4-fluorophenyl)acetamide,USBSTVPJNQLYEM-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
127383,6w4h,DB05611,-8.3,Apilimod,HSKAZIJJKRAJAV-KOEQRZSOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
85731,6m3m,DB08000,-8.3,"2-(CARBOXYMETHYL)-1-OXO-1,2-DIHYDRONAPHTHO[1,2-D]ISOTHIAZOLE-4-CARBOXYLIC ACID 3,3-DIOXIDE",ZTJGXDGAXGWOGR-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
125506,6w4h,DB02573,-8.3,"2'-Deoxycytidine-2'-Deoxyadenosine-3',5'-Monophosphate",LYWWDKIADIGKTH-IDMWBNCISA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
112716,6vxx,DB07763,-8.3,"(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE",OZZFJGCAYWBVBI-INIZCTEOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138587,6w9c,DB11883,-8.3,SB-705498,JYILLRHXRVTRSH-GFCCVEGCSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
127615,6w4h,DB06525,-8.3,Ganstigmine,ZOBDWFRKFSPCRB-UNMCSNQZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
106195,6vxs,DB15207,-8.3,Esaxerenone,NOSNHVJANRODGR-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
114355,6vxx,DB13333,-8.3,Efloxate,ZVXBAHLOGZCFTP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127611,6w4h,DB06518,-8.3,R-1487,KKKRKRMVJRHDMG-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131986,6w4h,DB15151,-8.3,RO-6870810,PKQXLRYFPSZKDU-QFIPXVFZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
106205,6vxs,DB15227,-8.3,Tirabrutinib,SEJLPXCPMNSRAM-GOSISDBHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
112210,6vxx,DB06590,-8.3,Ceftaroline fosamil,ZCCUWMICIWSJIX-NQJJCJBVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77697,6m2n,DB08694,-8.3,"9-amino-5-(2-aminopyrimidin-4-yl)pyrido[3',2':4,5]pyrrolo[1,2-c]pyrimidin-4-ol",RTHKPHCVZVYDFN-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
11486,6lzg,DB12036,-8.3,Naquotinib,QKDCLUARMDUUKN-XMMPIXPASA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
108950,6vxx,DB11443,-8.3,Orbifloxacin,QIPQASLPWJVQMH-DTORHVGOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112216,6vxx,DB06604,-8.3,Ilepatril,FXKFFTMLFPWYFH-RDGPPVDQSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106214,6vxs,DB15242,-8.3,MK-0533,STWITCBWQHTJFJ-XMMPIXPASA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
77641,6m2n,DB08622,-8.3,"4-(4-CHLORO-PHENYL)-1-{3-[2-(4-FLUORO-PHENYL)-[1,3]DITHIOLAN-2-YL]-PROPYL}-PIPERIDIN-4-OL",KVDKNVPAAQKHKD-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77639,6m2n,DB08619,-8.3,Testosterone succinate,CJQNBXFUHQZFOE-VYAQIDIUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77614,6m2n,DB08590,-8.3,1-(3-HYDROXYPROPYL)-2-[(3-NITROBENZOYL)AMINO]-1H-BENZIMIDAZOL-5-YL PIVALATE,CEAYRKIZESVQSN-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
106228,6vxs,DB15275,-8.3,GDC-0077,SGEUNORSOZVTOL-CABZTGNLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
133154,6w9c,DB01289,-8.3,Glisoxepide,ZKUDBRCEOBOWLF-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
114311,6vxx,DB13276,-8.3,Idanpramine,HVYGXNYMNHSBGD-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106064,6vxs,DB14916,-8.3,Selonsertib,YIDDLAAKOYYGJG-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
106178,6vxs,DB15177,-8.3,VX-659,IGEOJNMYRZUKIK-IBGZPJMESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
11509,6lzg,DB12064,-8.3,BMS-777607,VNBRGSXVFBYQNN-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
114284,6vxx,DB13237,-8.3,Clofoctol,HQVZOORKDNCGCK-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106073,6vxs,DB14934,-8.3,GDC-0927,KJAAPZIFCQQQKX-NDEPHWFRSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
112178,6vxx,DB06506,-8.3,Repinotan,YGYBFMRFXNDIPO-QGZVFWFLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87248,6m3m,DB12050,-8.3,LY-3039478,YCBAQKQAINQRFW-UGSOOPFHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
138557,6w9c,DB11833,-8.3,Basimglurant,UPZWINBEAHDTLA-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
87235,6m3m,DB12029,-8.3,Chlorogenic Acid,CWVRJTMFETXNAD-JUHZACGLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85739,6m3m,DB08009,-8.3,"5-[(E)-(5-CHLORO-2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]-N-[2-(DIETHYLAMINO)ETHYL]-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXAMIDE",XPLJEFSRINKZLC-ATVHPVEESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
138562,6w9c,DB11844,-8.3,Pritelivir,IVZKZONQVYTCKC-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
87233,6m3m,DB12027,-8.3,Serdemetan,CEGSUK1LWKJP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
131960,6w4h,DB15105,-8.3,PF-06751979,ZLZUHACSRMOLLV-RAALSFIWSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
106116,6vxs,DB15055,-8.3,ABT-639,AGPIHNZOZNKRGT-CYBMUJFWSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
131968,6w4h,DB15120,-8.3,GSK-239512,YFRBKEVUUCQYOW-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
87221,6m3m,DB12008,-8.3,Prexasertib,DOTGPNHGTYJDEP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
106141,6vxs,DB15105,-8.3,PF-06751979,ZLZUHACSRMOLLV-RAALSFIWSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
131975,6w4h,DB15132,-8.3,AZD-8165,YUHNXUAATAMVKD-PZJWPPBQSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
106160,6vxs,DB15138,-8.3,AZD-9496,DFBDRVGWBHBJNR-BBNFHIFMSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
133196,6w9c,DB01384,-8.3,Paramethasone,MKPDWECBUAZOHP-AFYJWTTESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
106161,6vxs,DB15141,-8.3,Deutivacaftor,PURKAOJPTOLRMP-ASMGOKTBSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
106164,6vxs,DB15145,-8.3,Ziresovir,GAAICKUTDBZCMT-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
133177,6w9c,DB01340,-8.3,Cilazapril,HHHKFGXWKKUNCY-FHWLQOOXSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
105737,6vxs,DB13939,-8.3,RAD-140,XMBUPPIEVAFYHO-KPZWWZAWSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
106872,6vxx,DB01685,-8.3,Topiroxostat,UBVZQGOVTLIHLH-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85945,6m3m,DB08246,-8.3,"(2S)-4-(2,5-DIFLUOROPHENYL)-N,N-DIMETHYL-2-PHENYL-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDE",WFFMEXQHWXEKBV-SFHVURJKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
114788,6vxx,DB14862,-8.3,PF-06815345,QTBYVAZRKWOIDU-FUHWJXTLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138936,6w9c,DB12590,-8.3,Indiplon,CBIAWPMZSFFRGN-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
16427,6lzg,DB04190,-8.3,Inhibitor Bea425,AHAVBKNGKPWROK-UMFPTGFGSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
132835,6w9c,DB00904,-8.3,Ondansetron,FELGMEQIXOGIFQ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
86525,6m3m,DB08981,-8.3,Fenbufen,ZPAKPRAICRBAOD-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86518,6m3m,DB08972,-8.3,Flumequine,DPSPPJIUMHPXMA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
108465,6vxx,DB08020,-8.3,"(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-6-(METHOXYMETHYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL",RHQLNMNKTIOREN-AOIWGVFYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
132580,6w9c,DB00603,-8.3,Medroxyprogesterone acetate,PSGAAPLEWMOORI-PEINSRQWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
76561,6m2n,DB07343,-8.3,"4-[4-AMINO-6-(2,6-DICHLORO-PHENOXY)-[1,3,5]TRIAZIN-2-YLAMINO]-BENZONITRILE",NFNNMVVXXITVGD-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
108072,6vxx,DB06802,-8.3,Nepafenac,QEFAQIPZVLVERP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108089,6vxx,DB06831,-8.3,2-((9H-PURIN-6-YLTHIO)METHYL)-5-CHLORO-3-(2-METHOXYPHENYL)QUINAZOLIN-4(3H)-ONE,UMMYTDJYDSTEMB-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138948,6w9c,DB12612,-8.3,Ozanimod,XRVDGNKRPOAQTN-FQEVSTJZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
108457,6vxx,DB08012,-8.3,(METHYLPYRIDAZINE PIPERIDINE ETHYLOXYPHENYL)ETHYLACETATE,KCHIOGFOPPOUJC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108105,6vxx,DB06853,-8.3,N-cycloheptylglycyl-N-(4-carbamimidoylbenzyl)-L-prolinamide,BYTJPDBCLWUEBU-IBGZPJMESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114880,6vxx,DB15325,-8.3,ONO-8539,ALLLQQUASFFEKP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76482,6m2n,DB07257,-8.3,"4-(2-chlorophenyl)-8-(2-hydroxyethyl)-6-methylpyrrolo[3,4-e]indole-1,3(2H,6H)-dione",WHMQZCPGFZBLBG-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
86168,6m3m,DB08522,-8.3,4-(4-FLUOROPHENYL)-1-CYCLOROPROPYLMETHYL-5-(4-PYRIDYL)-IMIDAZOLE,ROKOFZNQCIIJMI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
126733,6w4h,DB04216,-8.3,Quercetin,REFJWTPEDVJJIY-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
108077,6vxx,DB06816,-8.3,Pyrvinium,QMHSXPLYMTVAMK-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108032,6vxx,DB06730,-8.3,Gestodene,SIGSPDASOTUPFS-XUDSTZEESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108025,6vxx,DB06718,-8.3,Stanozolol,LKAJKIOFIWVMDJ-IYRCEVNGSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107961,6vxx,DB05861,-8.3,Tasquinimod,ONDYALNGTUAJDX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127083,6w4h,DB04690,-8.3,Camptothecin,VSJKWCGYPAHWDS-FQEVSTJZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
132905,6w9c,DB00984,-8.3,Nandrolone phenpropionate,UBWXUGDQUBIEIZ-QNTYDACNSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138890,6w9c,DB12408,-8.3,PF-03635659,WGOJWDWKHJHXSV-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
86111,6m3m,DB08455,-8.3,Ro 12-7310,CAAFTBWHFUPDGX-OFCLTBKTSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
10638,6lzg,DB08861,-8.3,DPDPE,MCMMCRYPQBNCPH-WMIMKTLMSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
138893,6w9c,DB12412,-8.3,Gemigliptin,ZWPRRQZNBDYKLH-VIFPVBQESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
132517,6w9c,DB00528,-8.3,Lercanidipine,ZDXUKAKRHYTAKV-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
86603,6m3m,DB09090,-8.3,Pinaverium,DDHUTBKXLWCZCO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
127003,6w4h,DB04582,-8.3,IMAZAQUIN,CABMTIJINOIHOD-QGZVFWFLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
126997,6w4h,DB04575,-8.3,Quinestrol,PWZUUYSISTUNDW-VAFBSOEGSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
132545,6w9c,DB00559,-8.3,Bosentan,GJPICJJJRGTNOD-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
126182,6w4h,DB03480,-8.3,Brequinar Analog,WYKKHJQZENLZID-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
108479,6vxx,DB08035,-8.3,"1-TERT-BUTYL-3-(2,5-DIMETHYLBENZYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE",QUPXEJURIFFVSX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
7995,6lzg,DB04632,-8.3,4-(2-HYDROXYBENZYLAMINO)-N-(3-(4-FLUOROPHENOXY)PHENYL)PIPERIDINE-1-SULFONAMIDE,JHHBGNIRSUTQAS-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
86131,6m3m,DB08478,-8.3,N-[2-chloro-5-(trifluoromethyl)phenyl]imidodicarbonimidic diamide,IGFTZEOFHWPCDL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
132854,6w9c,DB00923,-8.3,Ceforanide,SLAYUXIURFNXPG-CRAIPNDOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
132558,6w9c,DB00578,-8.3,Carbenicillin,FPPNZSSZRUTDAP-UWFZAAFLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
132843,6w9c,DB00912,-8.3,Repaglinide,FAEKWTJYAYMJKF-QHCPKHFHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138925,6w9c,DB12573,-8.3,LY-2452473,IHIWYQYVBNODSV-KRWDZBQOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
76464,6m2n,DB07237,-8.3,{4-[(2R)-pyrrolidin-2-ylmethoxy]phenyl}(4-thiophen-3-ylphenyl)methanone,VUWFJUJWAWMRQN-HXUWFJFHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
9015,6lzg,DB07084,-8.3,"N-(6,7,9,10,17,18,20,21-octahydrodibenzo[b,k][1,4,7,10,13,16]hexaoxacyclooctadecin-2-yl)acetamide",YHKGWOJTUMJPNW-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
108151,6vxx,DB07162,-8.3,4-(3-amino-1H-indazol-5-yl)-N-tert-butylbenzenesulfonamide,KFJCXIOVAGJCKB-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108162,6vxx,DB07174,-8.3,"6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-4-(3-METHOXYPROPYL)-2,2-DIMETHYL-2H-1,4-BENZOXAZIN-3(4H)-ONE",WPAPODFGOZXFLG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76343,6m2n,DB07095,-8.3,(S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclopentylpropanoyl)pyrrolidine-2-carboxamide,BNCHHUFGEOJCNH-SFHVURJKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
108263,6vxx,DB07549,-8.3,"2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUORO-3-METHYL-6-PYRIDINYL)METHYL]ACETAMIDE",WOYBPRBUPLYTPY-UHFFFAOYSA-P,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86363,6m3m,DB08752,-8.3,N-[(1S)-2-[(4-cyano-1-methylpiperidin-4-yl)amino]-1-(cyclohexylmethyl)-2-oxoethyl]morpholine-4-carboxamide,IRSOCWQJNYLTDD-SFHVURJKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
114823,6vxx,DB14932,-8.3,Coleneuramide,CHMRTBYTCBDIRG-JQZMMWJVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76322,6m2n,DB07070,-8.3,(2S)-2-{3-[({[2-fluoro-4-(trifluoromethyl)phenyl]carbonyl}amino)methyl]-4-methoxybenzyl}butanoic acid,BDLLIPYDNFENMY-ZDUSSCGKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
108269,6vxx,DB07557,-8.3,"(5BETA)-PREGNANE-3,20-DIONE",XMRPGKVKISIQBV-XWOJZHJZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108300,6vxx,DB07595,-8.3,"(5Z)-5-(3-BROMOCYCLOHEXA-2,5-DIEN-1-YLIDENE)-N-(PYRIDIN-4-YLMETHYL)-1,5-DIHYDROPYRAZOLO[1,5-A]PYRIMIDIN-7-AMINE",WSIQKQLAGWVKSL-UHFFFAOYSA-O,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108312,6vxx,DB07612,-8.3,6-(3-AMINOPHENYL)-N-(TERT-BUTYL)-2-(TRIFLUOROMETHYL)QUINAZOLIN-4-AMINE,XQKJVNGGVLHNLA-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112559,6vxx,DB07394,-8.3,AUROVERTIN B,QXCOFYWOWZJFEA-YJMRODJJSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86266,6m3m,DB08642,-8.3,"(2R,6S)-6-{[methyl(3,4,5-trimethoxyphenyl)amino]methyl}-1,2,5,6,7,8-hexahydroquinazoline-2,4-diamine",JJWPLCQODKLEHY-JEOXALJRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
139054,6w9c,DB12779,-8.3,Higenamine,WZRCQWQRFZITDX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
126496,6w4h,DB03903,-8.3,Tmr,KGFLZYXDJDOIEE-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
86352,6m3m,DB08741,-8.3,"5-[[(2R)-2-cyclopropyl-7,8-dimethoxy-2H-chromen-5-yl]methyl]pyrimidine-2,4-diamine",HWJPWWYTGBZDEG-AWEZNQCLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
108344,6vxx,DB07647,-8.3,"(2R)-1-[(5,6-DIPHENYL-7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)AMINO]PROPAN-2-OL",VBASHTSSQNDDAS-CQSZACIVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76246,6m2n,DB06986,-8.3,"2-CHLORO-N-[(1R,2R)-1-HYDROXY-2,3-DIHYDRO-1H-INDEN-2-YL]-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE",LRHOLHTVXXSIMG-BXUZGUMPSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
126440,6w4h,DB03830,-8.3,Phosphorylated Dihydropteroate,DNKVHXNVVYQUDC-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
126412,6w4h,DB03797,-8.3,3-Aminomethyl-Pyridinium-Adenine-Dinucleotide,HMCRLFVYYFBZEZ-PLEFRAQWSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
132692,6w9c,DB00737,-8.3,Meclizine,OCJYIGYOJCODJL-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
76222,6m2n,DB06953,-8.3,2-CHLORO-5-(3-CHLORO-PHENYL)-6-[(4-CYANO-PHENYL)-(3-METHYL-3H-IMIDAZOL-4-YL)- METHOXYMETHYL]-NICOTINONITRILE,JVWHVGIRXILXMU-XMMPIXPASA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
126572,6w4h,DB04006,-8.3,"[2-Amino-6-(2,6-Difluoro-Benzoyl)-Imidazo[1,2-a]Pyridin-3-Yl]-Phenyl-Methanone",WUGJIPFLBOATGL-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
76669,6m2n,DB07471,-8.3,"5-[5,6-BIS(METHYLOXY)-1H-BENZIMIDAZOL-1-YL]-3-{[1-(2-CHLOROPHENYL)ETHYL]OXY}-2-THIOPHENECARBOXAMIDE",UHCHLTQBLNUYRT-GFCCVEGCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
86366,6m3m,DB08755,-8.3,N-[(1S)-2-{[(1R)-2-(benzyloxy)-1-cyano-1-methylethyl]amino}-1-(cyclohexylmethyl)-2-oxoethyl]morpholine-4-carboxamide,MQWUTQCRGGBPBT-WIOPSUGQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86368,6m3m,DB08758,-8.3,"IMIDAZO[2,1-A]ISOQUINOLINE-2-CARBOHYDRAZIDE",WSNWYZBDIKCPIG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
108167,6vxx,DB07180,-8.3,"5-[(Z)-(5-Chloro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-N,2,4-trimethyl-1H-pyrrole-3-carboxamide",FIRPCWHHIWFKCD-GHXNOFRVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108438,6vxx,DB07991,-8.3,N-[(1R)-3-(4-HYDROXYPHENYL)-1-METHYLPROPYL]-2-(2-PHENYL-1H-INDOL-3-YL)ACETAMIDE,APLJSSOXDWUNGV-GOSISDBHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108187,6vxx,DB07203,-8.3,6-CYCLOHEXYLMETHOXY-2-(3'-CHLOROANILINO) PURINE,OUEGMEMDEAOAEG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86191,6m3m,DB08547,-8.3,PROGESTERONE-11-ALPHA-OL-HEMISUCCINATE,JBBNFGYRYNBDIH-DBGGZKJISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
114809,6vxx,DB14900,-8.3,ISO-1 F-18,QVRVXSZKCXFBTE-KPVNRNJOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86201,6m3m,DB08559,-8.3,"N-[(2S,4S,6R)-2-(dihydroxymethyl)-4-hydroxy-3,3-dimethyl-7-oxo-4lambda-4-thia-1-azabicyclo[3.2.0]hept-6-yl]-2-phenylacetamide",WMPGEOZLAYOFHH-MBNYWOFBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
108194,6vxx,DB07211,-8.3,(2R)-2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}PROPENE-1-SULFONAMIDE,YMJHMJLNQLVUAV-GHYUOPHCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86454,6m3m,DB08877,-8.3,Ruxolitinib,HFNKQEVNSGCOJV-OAHLLOKOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
108197,6vxx,DB07216,-8.3,"(11S)-8-CHLORO-11-[1-(METHYLSULFONYL)PIPERIDIN-4-YL]-6-PIPERAZIN-1-YL-11H-BENZO[5,6]CYCLOHEPTA[1,2-B]PYRIDINE",ZMGCFGGMTCMSDP-QHCPKHFHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76404,6m2n,DB07165,-8.3,N-(5-CHLORO-BENZO[B]THIOPHEN-3-YLMETHYL)-2-[6-CHLORO-OXO-3-(2-PYRIDIN-2-YL-ETHYLAMINO)-2H-PYRAZIN-1-YL]-ACETAMIDE,SOBGXPPOYFFGTK-UGKGYDQZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
86432,6m3m,DB08836,-8.3,Temocapril,FIQOFIRCTOWDOW-BJLQDIEVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
112490,6vxx,DB07313,-8.3,5-METHYL-2-[(PHENYLSULFONYL)AMINO]BENZOIC ACID,HXQLTRSIZRSFTR-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
139008,6w9c,DB12707,-8.3,AR-42,LAMIXXKAWNLXOC-INIZCTEOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
108225,6vxx,DB07250,-8.3,"N'-(5-CHLORO-1,3-BENZODIOXOL-4-YL)-N-(3,4,5- TRIMETHOXYPHENYL)PYRIMIDINE-2,4-DIAMINE",HMKLUOPMOJOUDZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76377,6m2n,DB07133,-8.3,D-phenylalanyl-N-(3-methylbenzyl)-L-prolinamide,CHKWABXWPATIIG-UXHICEINSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
132652,6w9c,DB00691,-8.3,Moexipril,UWWDHYUMIORJTA-HSQYWUDLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
112492,6vxx,DB07315,-8.3,"5-chloro-N-{4-[(1R)-1,2-dihydroxyethyl]phenyl}-1H-indole-2-carboxamide",SHCHFGSUYJUEBR-INIZCTEOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
139015,6w9c,DB12715,-8.3,MSX-122,PXZXYRKDDXKDTK-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
76369,6m2n,DB07125,-8.3,"4-(6-{[(1R)-1-(hydroxymethyl)propyl]amino}imidazo[1,2-b]pyridazin-3-yl)benzoic acid",KKZYGUVAFJCULH-CYBMUJFWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
112498,6vxx,DB07322,-8.3,"2-[(PHENYLSULFONYL)AMINO]-5,6,7,8-TETRAHYDRONAPHTHALENE-1-CARBOXYLIC ACID",RRXVUYHFDBLTEL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76675,6m2n,DB07479,-8.3,"(1S)-1,2,3,4-TETRAHYDRO-BENZO[C]PHENANTHRENE-2,3,4-TRIOL",WCUHTHVUZQCBTI-KBAYOESNSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
112440,6vxx,DB07107,-8.3,(1S)-2-(1H-INDOL-3-YL)-1-[({5-[(E)-2-PYRIDIN-4-YLVINYL]PYRIDIN-3-YL}OXY)METHYL]ETHYLAMINE,SGHXFHRRWFLILP-XJDXJNMNSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114763,6vxx,DB14795,-8.3,AZD-3759,MXDSJQHFFDGFDK-CYBMUJFWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112621,6vxx,DB07467,-8.3,"4-chloro-N-[(2S)-2-methyl-2,3-dihydro-1H-indol-1-yl]-3-sulfamoylbenzamide",NDDAHWYSQHTHNT-JTQLQIEISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76982,6m2n,DB07839,-8.3,"N-2-1,3-BENZOXAZOL-2-YL-3-CYCLOHEXYL-N-{2-[(4-METHOXYPHENYL)AMINO]ETHYL}-L-ALANINAMIDE",VFNWTXUFNNOQHD-QFIPXVFZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
86919,6m3m,DB11490,-8.3,Nalorphine,UIQMVEYFGZJHCZ-SSTWWWIQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86907,6m3m,DB11464,-8.3,Sulfaquinoxaline,NHZLNPMOSADWGC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
138799,6w9c,DB12283,-8.3,Balapiravir,VKXWOLCNTHXCLF-DXEZIKHYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
132373,6w9c,DB00349,-8.3,Clobazam,CXOXHMZGEKVPMT-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138801,6w9c,DB12285,-8.3,Verubecestat,YHYKUSGACIYRML-KRWDZBQOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
107148,6vxx,DB02628,-8.3,"1-[3,3-Dimethyl-2-(2-Methylamino-Propionylamino)-Butyryl]-Pyrrolidine-2-Carboxylic Acid(1,2,3,4-Tetrahydro-Naphthalen-1-Yl)-Amide",JUJIMRZGUBTJRV-NASSWSRMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76958,6m2n,DB07812,-8.3,"N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyrrolo[2,3-b]pyridin-4-yl)thiophene-2-carboxamide",TWYNGDRSMHRPSY-MRXNPFEDSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
132377,6w9c,DB00354,-8.3,Buclizine,MOYGZHXDRJNJEP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138814,6w9c,DB12301,-8.3,Doravirine,ZIAOVIPSKUPPQW-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
76938,6m2n,DB07791,-8.3,4-{[4-(1-CYCLOPROPYL-2-METHYL-1H-IMIDAZOL-5-YL)PYRIMIDIN-2-YL]AMINO}-N-METHYLBENZENESULFONAMIDE,MZWCVBFANHIPTJ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
121949,6w4b,DB12644,-8.3,AZD-2066,SXWHYTICXCLKDG-GFCCVEGCSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
76937,6m2n,DB07790,-8.3,N-(2-METHOXYETHYL)-4-({4-[2-METHYL-1-(1-METHYLETHYL)-1H-IMIDAZOL-5-YL]PYRIMIDIN-2-YL}AMINO)BENZENESULFONAMIDE,LDXLQEXLXZCYSR-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76924,6m2n,DB07775,-8.3,"3',5'-DIBROMO-2',4,4',6'-TETRAHYDROXY AURONE",BRPKBUNFOZFULQ-SGAXSIHGSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
86874,6m3m,DB11409,-8.3,Febantel,HMCCXLBXIJMERM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
132384,6w9c,DB00365,-8.3,Grepafloxacin,AIJTTZAVMXIJGM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
114676,6vxx,DB14637,-8.3,Fluprednisolone acetate,CYMBAKFTWRNHPS-APRQOCPKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107241,6vxx,DB02755,-8.3,1-3 Sugar Ring of Pentamannosyl 6-Phosphate,HDQMHAJOIVYOIP-NAVBLJQLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127339,6w4h,DB05414,-8.3,Pipendoxifene,JICOGKJOQXTAIP-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
138820,6w9c,DB12308,-8.3,Eltanolone,AURFZBICLPNKBZ-YZRLXODZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
85993,6m3m,DB08309,-8.3,3-({2-[(4-{[6-(CYCLOHEXYLMETHOXY)-9H-PURIN-2-YL]AMINO}PHENYL)SULFONYL]ETHYL}AMINO)PROPAN-1-OL,AMFGILNPFBVREA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
112365,6vxx,DB07021,-8.3,"(7R,8R)-8-(2,4,5-trifluorophenyl)-6,7,8,9-tetrahydroimidazo[1,2-a:4,5-c']dipyridin-7-amine",SOSYXEPELJIJHZ-RNCFNFMXSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127368,6w4h,DB05532,-8.3,BMS-488043,DBPMWRYLTBNCCE-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
108661,6vxx,DB08517,-8.3,"(2S)-5-hydroxy-2-(4-hydroxyphenyl)-7-methoxy-2,3-dihydro-4H-chromen-4-one",DJOJDHGQRNZXQQ-AWEZNQCLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106917,6vxx,DB01745,-8.3,N-Alpha-(2-Naphthylsulfonyl)-N(3-Amidino-L-Phenylalaninyl)Isopipecolinic Acid Methyl Ester,JJLGQWCKMHPBEB-DEOSSOPVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
9127,6lzg,DB07203,-8.3,6-CYCLOHEXYLMETHOXY-2-(3'-CHLOROANILINO) PURINE,OUEGMEMDEAOAEG-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
112354,6vxx,DB07007,-8.3,"(3R)-3-[(1,2,3,4-tetrahydroisoquinolin-7-yloxy)methyl]-2,3-dihydrothieno[2,3-f][1,4]oxazepin-5-amine",UDFXWCLBONUMNA-CYBMUJFWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112356,6vxx,DB07011,-8.3,"(3S)-1-(1,3-BENZODIOXOL-5-YLMETHYL)-3-[4-(1H-IMIDAZOL-1-YL)PHENOXY]PIPERIDINE",HHOPJGKEAIIIDF-FQEVSTJZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
133050,6w9c,DB01150,-8.3,Cefprozil,WDLWHQDACQUCJR-PBFPGSCMSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
108658,6vxx,DB08513,-8.3,[4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENYL]ACETIC ACID,PAIQRYUOBBCBSE-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
115179,6w4b,DB00549,-8.3,Zafirlukast,YEEZWCHGZNKEEK-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
106946,6vxx,DB01782,-8.3,"2,6-Dihydroanthra/1,9-Cd/Pyrazol-6-One",ACPOUJIDANTYHO-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77067,6m2n,DB07940,-8.3,"9-(3-IODOBENZYLAMINO)-1,2,3,4-TETRAHYDROACRIDINE",ZUCWQTWGZGIYPV-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77065,6m2n,DB07937,-8.3,"2-butoxy-9-(2,6-difluorobenzyl)-N-(2-morpholin-4-ylethyl)-9H-purin-6-amine",UGZWPZWADDDTRN-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77046,6m2n,DB07917,-8.3,4-(BENZHYDRYLOXY)-1-[3-(1H-TETRAAZOL-5-YL)PROPYL]PIPERIDINE,TZQGXAHOROZEKN-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
125887,6w4h,DB03084,-8.3,"Cyclopropyl-{4-[5-(3,4-Dichlorophenyl)-2-[(1-Methyl)-Piperidin]-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine",XCTKFTOEAKJMII-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
125941,6w4h,DB03159,-8.3,CRA_8696,GAVRMVQHHVMXFD-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
115117,6w4b,DB00471,-8.3,Montelukast,UCHDWCPVSPXUMX-TZIWLTJVSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
77035,6m2n,DB07901,-8.3,5-CHLORO-6-METHYL-N-(2-PHENYLETHYL)-2-PYRIDIN-2-YLPYRIMIDIN-4-AMINE,HIUOABSWQSUEGK-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
108641,6vxx,DB08494,-8.3,"S-{2-[(2-chloro-4-sulfamoylphenyl)amino]-2-oxoethyl} 6-methyl-3,4-dihydroquinoline-1(2H)-carbothioate",AWAKIULNKVOBKE-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77019,6m2n,DB07879,-8.3,"N-hydroxy-5-[(3-phenyl-5,6-dihydroimidazo[1,2-a]pyrazin-7(8H)-yl)carbonyl]thiophene-2-carboxamide",SMSIXMLQOONOQQ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
20617,6cs2,HMDB0047982,-8.3,"TG(14:1(9Z)/20:1(11Z)/20:3(5Z,8Z,11Z))",DHQUEWMLMFUPTL-YSSJDGIJSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
77121,6m2n,DB08001,-8.3,5-(3-{3-[3-HYDROXY-2-(METHOXYCARBONYL)PHENOXY]PROPENYL}PHENYL)-4-(HYDROXYMETHYL)ISOXAZOLE-3-CARBOXYLIC ACID,DQSRCEFDWMQCCV-GQCTYLIASA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
127225,6w4h,DB04879,-8.3,Vatalanib,YCOYDOIWSSHVCK-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
132396,6w9c,DB00378,-8.3,Dydrogesterone,JGMOKGBVKVMRFX-HQZYFCCVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
107559,6vxx,DB03758,-8.3,Radicicol,WYZWZEOGROVVHK-GTMNPGAYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114725,6vxx,DB14716,-8.3,Clonazolam,XJRGLCAWBRZUFC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107586,6vxx,DB04054,-8.3,"9-Butyl-8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine",PASRTKOWXJDFFV-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76762,6m2n,DB07583,-8.3,"(4R,2S)-5'-(4-(4-CHLOROBENZYLOXY)PYRROLIDIN-2-YLMETHANESULFONYL)ISOQUINOLINE",RLNNFNGBXLTQOB-RBUKOAKNSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
112425,6vxx,DB07088,-8.3,(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclopentyloxy)ethanoyl)pyrrolidine-2-carboxamide,ZWXWAYUCJVQHOR-KRWDZBQOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86691,6m3m,DB09232,-8.3,Cilnidipine,KJEBULYHNRNJTE-DHZHZOJOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86064,6m3m,DB08397,-8.3,6-(DIFLUORO-PHOSPHONO-METHYL)-NAPHTHALENE-2-CARBOXYLIC ACID,NKGNOWNPXBURRW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
127125,6w4h,DB04750,-8.3,OREGON GREEN 488 CARBOXYLATE,BRJCLSQFZSHLRL-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
127107,6w4h,DB04724,-8.3,"(S)-2-((S)-3-ISOBUTYL-2,5-DIOXO-4-QUINOLIN-3-YLMETHYL-[1,4]DIAZEPAN-1YL)-N-METHYL-3-NAPHTALEN-2-YL-PROPIONAMIDE",COVPLULNDBDXTN-KYJUHHDHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
132969,6w9c,DB01058,-8.3,Praziquantel,FSVJFNAIGNNGKK-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
107695,6vxx,DB04194,-8.3,Chitotriose,WZZVUHWLNMNWLW-VFCSDQTKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86676,6m3m,DB09214,-8.3,Dexketoprofen,DKYWVDODHFEZIM-NSHDSACASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86660,6m3m,DB09197,-8.3,Mepiprazole,DOTIMEKVTCOGED-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
76728,6m2n,DB07540,-8.3,"4-{5-[(1Z)-1-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)ETHYL]-2-FURYL}BENZENESULFONAMIDE",AKFVRSQELXTCFW-JYRVWZFOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
114754,6vxx,DB14774,-8.3,Balipodect,KVHRYLNQDWXAGI-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108540,6vxx,DB08106,-8.3,N-[(6-butoxynaphthalen-2-yl)sulfonyl]-D-glutamic acid,UAGYXJBYAFGRFR-QGZVFWFLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107735,6vxx,DB04549,-8.3,"4-(Aminosulfonyl)-N-[(2,3,4-Trifluorophenyl)Methyl]-Benzamide",AANTYZRUJFNZFI-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
132496,6w9c,DB00497,-8.3,Oxycodone,BRUQQQPBMZOVGD-XFKAJCMBSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
132910,6w9c,DB00990,-8.3,Exemestane,BFYIZQONLCFLEV-DAELLWKTSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138864,6w9c,DB12376,-8.3,Ricolinostat,QGZYDVAGYRLSKP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
11109,6lzg,DB11430,-8.3,Monensin,GAOZTHIDHYLHMS-KEOBGNEYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
76785,6m2n,DB07612,-8.3,6-(3-AMINOPHENYL)-N-(TERT-BUTYL)-2-(TRIFLUOROMETHYL)QUINAZOLIN-4-AMINE,XQKJVNGGVLHNLA-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
114711,6vxx,DB14674,-8.3,Estramustine phosphate,ADFOJJHRTBFFOF-RBRWEJTLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107352,6vxx,DB03202,-8.3,"2-[5-Methanesulfonylamino-2-(4-Aminophenyl)-6-Oxo-1,6-Dihydro-1-Pyrimidinyl]-N-(3,3,3-Trifluoro-1-Isopropyl-2-Oxopropyl)Acetamide",JWSWTHSJMGVOKE-HNNXBMFYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112370,6vxx,DB07027,-8.3,D-phenylalanyl-N-(3-fluorobenzyl)-L-prolinamide,JGZSVYZIJHGHMA-MOPGFXCFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
132989,6w9c,DB01081,-8.3,Diphenoxylate,HYPPXZBJBPSRLK-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
112377,6vxx,DB07034,-8.3,"2,2'-{[9-(HYDROXYIMINO)-9H-FLUORENE-2,7-DIYL]BIS(OXY)}DIACETIC ACID",VOKATEXROYSXDW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112397,6vxx,DB07055,-8.3,"2-[2-(1H-tetrazol-5-yl)ethyl]-1H-isoindole-1,3(2H)-dione",DEOJDUHRJBKATO-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86053,6m3m,DB08385,-8.3,4-(quinolin-3-ylmethyl)piperidine-1-carboxylic acid,QUAGUFNCKDDJFZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
138836,6w9c,DB12327,-8.3,Salvinorin A,OBSYBRPAKCASQB-AGQYDFLVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
76839,6m2n,DB07676,-8.3,"3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)-1H,2'H-2,3'-biindol-2'-one",CKLAPOFDFZKCPB-LBPRGKRZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
86767,6m3m,DB09477,-8.3,Enalaprilat,LZFZMUMEGBBDTC-QEJZJMRPSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
76838,6m2n,DB07675,-8.3,(2S)-2-ETHOXY-3-{4-[2-(10H-PHENOXAZIN-10-YL)ETHOXY]PHENYL}PROPANOIC ACID,WMUIIGVAWPWQAW-DEOSSOPVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
127203,6w4h,DB04849,-8.3,Cediranib,XXJWYDDUDKYVKI-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
132418,6w9c,DB00404,-8.3,Alprazolam,VREFGVBLTWBCJP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
107479,6vxx,DB03656,-8.3,Tribenuron Methyl,VLCQZHSMCYCDJL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86056,6m3m,DB08388,-8.3,"5-(2-ETHOXYETHYL)-5-[4-(4-FLUOROPHENOXY)PHENOXY]PYRIMIDINE-2,4,6(1H,3H,5H)-TRIONE",XRSYNYGEEYTXJV-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86736,6m3m,DB09305,-8.3,Aptazapine,MNHDDERDSNZCCK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86729,6m3m,DB09290,-8.3,Ramosetron,NTHPAPBPFQJABD-LLVKDONJSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
76812,6m2n,DB07642,-8.3,"5-{[1-(2-fluorobenzyl)piperidin-4-yl]methoxy}quinazoline-2,4-diamine",GYKIQIOWVKCVBP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138852,6w9c,DB12357,-8.3,BMS-863233,JJWLXRKVUJDJKG-VIFPVBQESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
127153,6w4h,DB04790,-8.3,"2,5-bis-O-{3-[amino(imino)methyl]phenyl}-1,4:3,6-dianhydro-D-glucitol",IBIUTOFGXGGVKQ-XMTFNYHQSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
76789,6m2n,DB07616,-8.3,"4-{[4-(4-fluoro-3-methylphenyl)-1,3-thiazol-2-yl]amino}-2-hydroxybenzoic acid",LKZZDHKJFDTYCH-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138450,6w9c,DB11681,-8.3,Tofimilast,DHCOPPHTVOXDKU-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
77612,6m2n,DB08588,-8.3,2-({2-[(3R)-3-AMINOPIPERIDIN-1-YL]-4-OXOQUINAZOLIN-3(4H)-YL}METHYL)BENZONITRILE,OYNURZXTLNNKAP-QGZVFWFLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
104782,6vxs,DB12494,-8.3,SGI-1776,MHXGEROHKGDZGO-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104813,6vxs,DB12543,-8.3,Samidorphan,RYIDHLJADOKWFM-MAODMQOUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104339,6vxs,DB11853,-8.3,Relugolix,AOMXMOCNKJTRQP-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
85364,6m3m,DB07571,-8.3,"N-2-[(BENZYLOXY)CARBONYL]-N-[(1S,2S)-2-HYDROXY-1-(4-HYDROXYBENZYL)PROPYL]-L-LEUCINAMIDE",ZUWYQZGBCBSHFK-HSQYWUDLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
133318,6w9c,DB01538,-8.3,Acetyldihydrocodeine,LGGDXXJAGWBUSL-BKRJIHRRSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
130990,6w4h,DB13102,-8.3,AZD-8418,MCPBSUCAISQZQK-JTQLQIEISA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
78936,6m2n,DB12474,-8.3,Lynestrenol,YNVGQYHLRCDXFQ-XGXHKTLJSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
131003,6w4h,DB13119,-8.3,GSK-364735,QWLNINWUBHHOLU-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
114169,6vxx,DB12846,-8.3,Reproterol,WVLAAKXASPCBGT-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85517,6m3m,DB07755,-8.3,"(2S)-1-[4-({4-[(2,5-Dichlorophenyl)amino]-2-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol",GNLAGGCSJGJECE-INIZCTEOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
128053,6w4h,DB07162,-8.3,4-(3-amino-1H-indazol-5-yl)-N-tert-butylbenzenesulfonamide,KFJCXIOVAGJCKB-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
133521,6w9c,DB01793,-8.3,SB-409513,ONVZFCHLOZUXRP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
85377,6m3m,DB07587,-8.3,"N-(1-CYANOCYCLOPROPYL)-3-({[(2S)-5-OXOPYRROLIDIN-2-YL]METHYL}SULFONYL)-N-2-[(1S)-2,2,2-TRIFLUORO-1-(4-FLUOROPHENYL)ETHYL]-L-ALANINAMIDE",JLPXDVXMMYRTKN-ZOBUZTSGSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85449,6m3m,DB07675,-8.3,(2S)-2-ETHOXY-3-{4-[2-(10H-PHENOXAZIN-10-YL)ETHOXY]PHENYL}PROPANOIC ACID,WMUIIGVAWPWQAW-DEOSSOPVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
78473,6m2n,DB11806,-8.3,VTP-194204,BOOOLEGQBVUTKC-NVQSDHBMSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78837,6m2n,DB12332,-8.3,Rucaparib,HMABYWSNWIZPAG-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78631,6m2n,DB12043,-8.3,Sepetaprost,BKVUSNOUTQMSBE-XCMGCKIWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137870,6w9c,DB08810,-8.3,Cinitapride,ZDLBNXXKDMLZMF-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137798,6w9c,DB08732,-8.3,NALPHA-[(BENZYLOXY)CARBONYL]-N-[(1R)-4-HYDROXY-1-METHYL-2-OXOBUTYL]-L-PHENYLALANINAMIDE,UUOOAGBWJUGBMV-APWZRJJASA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
127824,6w4h,DB06897,-8.3,"3-[3-chloro-5-(5-{[(1S)-1-phenylethyl]amino}isoxazolo[5,4-c]pyridin-3-yl)phenyl]propan-1-ol",MMGKIHLBFPJYJL-HNNXBMFYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
78479,6m2n,DB11817,-8.3,Baricitinib,XUZMWHLSFXCVMG-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
105117,6vxs,DB13023,-8.3,IPI-493,XYFFWTYOFPSZRM-TWNAANEASA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
127844,6w4h,DB06918,-8.3,2-(2-METHYLPHENYL)-1H-INDOLE-6-CARBOXIMIDAMIDE,ZRYXDGAKQGRHFG-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
78495,6m2n,DB11836,-8.3,Sapanisertib,GYLDXIAOMVERTK-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78642,6m2n,DB12058,-8.3,Recoflavone,BCPQOBQIVJZOFL-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
105140,6vxs,DB13059,-8.3,PF-03814735,RYYNGWLOYLRZLK-RBUKOAKNSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
112003,6vxx,DB05154,-8.3,Pretomanid,ZLHZLMOSPGACSZ-NSHDSACASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87462,6m3m,DB12357,-8.3,BMS-863233,JJWLXRKVUJDJKG-VIFPVBQESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
130974,6w4h,DB13080,-8.3,Roluperidone,RNRYULFRLCBRQS-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
78819,6m2n,DB12308,-8.3,Eltanolone,AURFZBICLPNKBZ-YZRLXODZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78433,6m2n,DB11750,-8.3,Clobetasol,FCSHDIVRCWTZOX-DVTGEIKXSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
125196,6w4h,DB02177,-8.3,1-Acetyl-4-(4-{4-[(2-Ethoxyphenyl)Thio]-3-Nitrophenyl}Pyridin-2-Yl)Piperazine,GKGJFUXSTSUKPB-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
111999,6vxx,DB05134,-8.3,Tanespimycin,AYUNIORJHRXIBJ-TXHRRWQRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109079,6vxx,DB12005,-8.3,Nirogacestat,VFCRKLWBYMDAED-REWPJTCUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85514,6m3m,DB07751,-8.3,"(2S)-1-[4-({6-[(2,6-Difluorophenyl)amino]-4-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol",ZVSBKYYVBCKDBO-HNNXBMFYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
10346,6lzg,DB08532,-8.3,"6-(2-fluorophenyl)-N-(pyridin-3-ylmethyl)imidazo[1,2-a]pyrazin-8-amine",WCNPGRRMPFCHEO-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
137758,6w9c,DB08686,-8.3,"5,6,7,8,9,10-HEXAHYDRO-4-HYDROXY-3-(1-PHENYLPROPYL)CYCLOOCTA[B]PYRAN-2-ONE",UXCLJNSXDNCIIT-HNNXBMFYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
78441,6m2n,DB11764,-8.3,Spebrutinib,KXBDTLQSDKGAEB-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
19925,6cs2,HMDB0045493,-8.3,"TG(20:0/14:0/22:2(13Z,16Z))",SYGFOSKNZKVBDP-KNAYTQRDSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
131740,6w4h,DB14634,-8.3,Fluprednidene acetate,DEFOZIFYUBUHHU-IYQKUMFPSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131447,6w4h,DB13756,-8.3,Peruvoside,PMTSPAGBAFCORP-HBUONDEYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
138344,6w9c,DB11440,-8.3,Norgestomet,IWSXBCZCPVUWHT-VIFKTUCRSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
112119,6vxx,DB06335,-8.3,Saxagliptin,QGJUIPDUBHWZPV-SGTAVMJGSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104534,6vxs,DB12141,-8.3,Gilteritinib,GYQYAJJFPNQOOW-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
87655,6m3m,DB12647,-8.3,Tocotrienol,GJJVAFUKOBZPCB-ZGRPYONQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
125231,6w4h,DB02224,-8.3,Taxifolin,CXQWRCVTCMQVQX-LSDHHAIUSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
117127,6w4b,DB03067,-8.3,"4-{2,4-Bis[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid",VFYAZSTYKPFSFL-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
78650,6m2n,DB12070,-8.3,Letermovir,FWYSMLBETOMXAG-QHCPKHFHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
11753,6lzg,DB12389,-8.3,Zamicastat,ZSSLCFLHEFXANG-GOSISDBHSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
131765,6w4h,DB14661,-8.3,Loperamide oxide,KXVSBTJVTUVNPM-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
125259,6w4h,DB02259,-8.3,"3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid (4-Sulfamoyl-Phenyl)-Amide",VSYGXLAJQDAWCZ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
78648,6m2n,DB12066,-8.3,Orteronel,OZPFIJIOIVJZMN-SFHVURJKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78826,6m2n,DB12316,-8.3,9CUAB30,PPGNMFUMZSAZCW-VOYUZAMQSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
11738,6lzg,DB12368,-8.3,AZD-3839,MRXBCEQZNKUUIP-DEOSSOPVSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
85533,6m3m,DB07772,-8.3,"(1R)-1-{[(4'-methoxy-1,1'-biphenyl-4-yl)sulfonyl]amino}-2-methylpropylphosphonic acid",BZVYQWLRCHLAGK-QGZVFWFLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
11786,6lzg,DB12427,-8.3,Orvepitant,XWNBGDJPEXZSQM-VZOBGQTKSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
104483,6vxs,DB12070,-8.3,Letermovir,FWYSMLBETOMXAG-QHCPKHFHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
78558,6m2n,DB11934,-8.3,Epelsiban,UWHCWRQFNKUYCG-QUZACWSFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
112826,6vxx,DB07889,-8.3,"(2S)-1-(Dimethylamino)-3-(4-{[4-(2-methylimidazo[1,2-a]pyridin-3-yl)-2-pyrimidinyl]amino}phenoxy)-2-propanol",VCPXSBULBDYRLT-SFHVURJKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87507,6m3m,DB12417,-8.3,Anagliptin,LDXYBEHACFJIEL-HNNXBMFYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
78576,6m2n,DB11958,-8.3,Brivanib,WCWUXEGQKLTGDX-LLVKDONJSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78577,6m2n,DB11960,-8.3,Carboxyamidotriazole,WNRZHQBJSXRYJK-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78863,6m2n,DB12376,-8.3,Ricolinostat,QGZYDVAGYRLSKP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
127871,6w4h,DB06948,-8.3,2-ANILINO-6-CYCLOHEXYLMETHOXYPURINE,XWWRLKIBRPJQJX-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
127897,6w4h,DB06985,-8.3,2-[({4-[2-(trifluoromethyl)phenyl]piperidin-1-yl}carbonyl)amino]benzoic acid,MEAQCLPMSVEOQF-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
104473,6vxs,DB12055,-8.3,MK-0767,ORZMUVMQJPGFOM-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
109209,6vxx,DB12533,-8.3,Cevipabulin,ZUZPCOQWSYNWLU-VIFPVBQESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104472,6vxs,DB12054,-8.3,BQ-123,VYCMAAOURFJIHD-PJNXIOHISA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
11854,6lzg,DB12522,-8.3,Toreforant,FCRFVPZAXGJLPW-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
131693,6w4h,DB14218,-8.3,Telotristat,NCLGDOBQAWBXRA-PGRDOPGGSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
85435,6m3m,DB07654,-8.3,"(5,6-DIPHENYL-FURO[2,3-D]PYRIMIDIN-4-YLAMINO)-ACETIC",VDJWWYRYKMXMKA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
131049,6w4h,DB13223,-8.3,Fluocortin,PUWHHWCHAVXSIG-NCLPIGKXSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
104988,6vxs,DB12823,-8.3,Tecarfarin,QFLNTQDOVCLQKW-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
78877,6m2n,DB12393,-8.3,Fanapanel,WZMQMKNCWDCCMT-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
104978,6vxs,DB12805,-8.3,Ataciguat,PQHLRGARXNPFCF-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
87549,6m3m,DB12476,-8.3,CPG-52852,YZOQZEXYFLXNKA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
133348,6w9c,DB01568,-8.3,Codeine-N-oxide,BDLSDHWCOJPHIE-KFUGMXNISA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
104934,6vxs,DB12731,-8.3,Daporinad,KPBNHDGDUADAGP-VAWYXSNFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
78872,6m2n,DB12388,-8.3,Evocalcet,RZNUIYPHQFXBAN-XLIONFOSSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78895,6m2n,DB12416,-8.3,VTP-27999,NXWASIVXQMMPLM-ZXMXYHOLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
112098,6vxx,DB06272,-8.3,Maxacalcitol,DTXXSJZBSTYZKE-ZDQKKZTESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
131027,6w4h,DB13177,-8.3,4-methylumbelliferyl beta-D-glucoside,YUDPTGPSBJVHCN-YMILTQATSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
85554,6m3m,DB07796,-8.3,"(3ASR,4RS,8ASR,8BRS)-4-(2-(4-FLUOROBENZYL)-1,3-DIOXODEACAHYDROPYRROLO[3,4-A] PYRROLIZIN-4-YL)BENZAMIDINE",GJYCQHGTXMVIBG-MUGJNUQGSA-O,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
133328,6w9c,DB01548,-8.3,Diprenorphine,OIJXLIIMXHRJJH-KNLIIKEYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
78499,6m2n,DB11844,-8.3,Pritelivir,IVZKZONQVYTCKC-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138268,6w9c,DB11219,-8.3,Enzacamene,HEOCBCNFKCOKBX-SDNWHVSQSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
78620,6m2n,DB12024,-8.3,PF-04418948,LWJGMYMNSNVCEM-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
112031,6vxx,DB06140,-8.3,SUVN-502,GWCYPEHWIZXYFZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104844,6vxs,DB12590,-8.3,Indiplon,CBIAWPMZSFFRGN-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
109187,6vxx,DB12499,-8.3,Clascoterone,GPNHMOZDMYNCPO-PDUMRIMRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
105057,6vxs,DB12929,-8.3,JNJ-39220675,IQOWHZHNGJXGHG-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
11886,6lzg,DB12567,-8.3,Camicinal,RZKDEGZIFSJVNA-IBGZPJMESA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
105052,6vxs,DB12924,-8.3,Ozenoxacin,XPIJWUTXQAGSLK-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
131010,6w4h,DB13135,-8.3,AGN-201904,PPCGSVWOZKNPCX-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
127846,6w4h,DB06920,-8.3,Eribaxaban,QQBKAVAGLMGMHI-WIYYLYMNSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
104407,6vxs,DB11952,-8.3,Duvelisib,SJVQHLPISAIATJ-ZDUSSCGKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
105036,6vxs,DB12899,-8.3,TT-301,ZPJGUEPHFXPAQF-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
78611,6m2n,DB12009,-8.3,GW-406381,NXMZBNYLCVTRGB-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
104870,6vxs,DB12637,-8.3,Onapristone,IEXUMDBQLIVNHZ-YOUGDJEHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
137838,6w9c,DB08775,-8.3,N??-[(Benzyloxy)carbonyl]-N-[(2S)-4-fluoro-3-oxo-2-butanyl]-L-tyrosinamide,RYABQRLJLIHDIP-KSSFIOAISA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
131020,6w4h,DB13164,-8.3,Olmutinib,FDMQDKQUTRLUBU-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
137837,6w9c,DB08774,-8.3,"1-[(2S)-4-(5-phenyl-1H-pyrazolo[3,4-b]pyridin-4-yl)morpholin-2-yl]methanamine",YBRZCAKSBYWZTC-ZDUSSCGKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
127864,6w4h,DB06940,-8.3,"N-ethyl-4-{[5-(methoxycarbamoyl)-2-methylphenyl]amino}-5-methylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide",ZZTMFGIGOADCFX-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
105026,6vxs,DB12885,-8.3,CF-102,IPSYPUKKXMNCNQ-PFHKOEEOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
131568,6w4h,DB13954,-8.3,Estradiol cypionate,UOACKFBJUYNSLK-XRKIENNPSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
105017,6vxs,DB12874,-8.3,Quizartinib,CVWXJKQAOSCOAB-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
78548,6m2n,DB11915,-8.3,Valbenazine,GEJDGVNQKABXKG-CFKGEZKQSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
8898,6lzg,DB06959,-8.3,(2S)-1-(3H-Indol-3-yl)-3-{[5-(6-isoquinolinyl)-3-pyridinyl]oxy}-2-propanamine,BUCZDJYEOAQTHL-KEKNWZKVSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
87449,6m3m,DB12336,-8.3,GDC-0917,HSHPBORBOJIXSQ-HARLFGEKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
104807,6vxs,DB12535,-8.3,AC-430,DCRWIATZWHLIPN-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
10241,6lzg,DB08418,-8.3,"(4aS,4bR,10bS,12aS)-12a-methyl-1,3-dioxo-2-(pyridin-3-ylmethyl)-1,2,3,4,4a,4b,5,6,10b,11,12,12a-dodecahydronaphtho[2,1-f]isoquinolin-8-yl sulfamate",LSJKARAMQNGZDF-YOEKFXIASA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
137695,6w9c,DB08608,-8.3,"4-({(2R,5S)-2,5-DIMETHYL-4-[(2R)-3,3,3-TRIFLUORO-2-HYDROXY-2-METHYLPROPANOYL]PIPERAZIN-1-YL}CARBONYL)BENZONITRILE",IWFSHKKFDSWNLZ-BWACUDIHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
125358,6w4h,DB02388,-8.3,"Cyclohexyl-{4-[5-(3,4-Dichlorophenyl)-2-Piperidin-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine",UQFRSHRWRKYNDE-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
11954,6lzg,DB12666,-8.3,Emapunil,NBMBIEOUVBHEBM-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
122479,6w4b,DB13454,-8.3,Nicomorphine,HNDXBGYRMHRUFN-CIVUWBIHSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
104271,6vxs,DB11759,-8.3,Pevonedistat,MPUQHZXIXSTTDU-QXGSTGNESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
127950,6w4h,DB07043,-8.3,"7-amino-2-tert-butyl-4-(4-pyrimidin-2-ylpiperazin-1-yl)pyrido[2,3-d]pyrimidine-6-carboxamide",CKLCIJCZOIDJQU-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
112867,6vxx,DB07937,-8.3,"2-butoxy-9-(2,6-difluorobenzyl)-N-(2-morpholin-4-ylethyl)-9H-purin-6-amine",UGZWPZWADDDTRN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87388,6m3m,DB12253,-8.3,GDC-0810,BURHGPHDEVGCEZ-KJGLQBJMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
78375,6m2n,DB11665,-8.3,BMS-690514,CSGQVNMSRKWUSH-IAGOWNOFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137696,6w9c,DB08609,-8.3,"(2R)-N-{4-[Ethyl(phenyl)sulfamoyl]-2-methylphenyl}-3,3,3-trifluoro-2-hydroxy-2-methylpropanamide",SHEIQJGQDUYUBE-GOSISDBHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
78781,6m2n,DB12262,-8.3,CRS-3123,NNTYBKTXMKBRFA-CQSZACIVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
11711,6lzg,DB12325,-8.3,Idasanutlin,TVTXCJFHQKSQQM-LJQIRTBHSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
112133,6vxx,DB06395,-8.3,Abafungin,TYBHXIFFPVFXQW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78783,6m2n,DB12264,-8.3,Atevirdine,UCPOMLWZWRTIAA-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
133560,6w9c,DB01842,-8.3,3'-Phosphate-Adenosine-5'-Diphosphate,GBBWIZKLHXYJOA-KQYNXXCUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
114136,6vxx,DB12787,-8.3,Norethandrolone,ZDHCJEIGTNNEMY-XGXHKTLJSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
128120,6w4h,DB07242,-8.3,"(4R)-7,8-dichloro-1',9-dimethyl-1-oxo-1,2,4,9-tetrahydrospiro[beta-carboline-3,4'-piperidine]-4-carbonitrile",XGUIMGJMQKZRGM-LLVKDONJSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
116682,6w4b,DB02473,-8.3,"6-[N-(1-Isopropyl-3,4-Dihydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine",XRHANBWAKSYPEN-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
11957,6lzg,DB12670,-8.3,Rolofylline,PJBFVWGQFLYWCB-QUYAXPHCSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
138405,6w9c,DB11592,-8.3,Nitrocefin,LHNIIDJCEODSHA-OQRUQETBSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
128110,6w4h,DB07229,-8.3,"3-{5-[AMINO(IMINIO)METHYL]-1H-INDOL-2-YL}-5-METHOXY-1,1'-BIPHENYL-2-OLATE",MINVOLKUPZPDNX-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
78308,6m2n,DB11490,-8.3,Nalorphine,UIQMVEYFGZJHCZ-SSTWWWIQSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
104675,6vxs,DB12341,-8.3,LY-2456302,ZHPMYDSXGRRERG-DEOSSOPVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
79038,6m2n,DB12638,-8.3,PU-H71,SUPVGFZUWFMATN-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78315,6m2n,DB11512,-8.3,Dihydrostreptomycin,ASXBYYWOLISCLQ-HZYVHMACSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
105403,6vxs,DB13451,-8.3,Tioclomarol,WRGOVNKNTPWHLZ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
105539,6vxs,DB13640,-8.3,Acetoxolone,FTQDJVZNPJRVPG-XWEVEMRCSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
78432,6m2n,DB11749,-8.3,(R)-Praziquantel,FSVJFNAIGNNGKK-KRWDZBQOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
8242,6lzg,DB04971,-8.3,Reglitazar,QBQLYIISSRXYKL-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
8891,6lzg,DB06948,-8.3,2-ANILINO-6-CYCLOHEXYLMETHOXYPURINE,XWWRLKIBRPJQJX-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
104251,6vxs,DB11730,-8.3,Ribociclib,RHXHGRAEPCAFML-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
117792,6w4b,DB03957,-8.3,SP2456,SSSXBBASYYVGCI-HSZRJFAPSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
117720,6w4b,DB03865,-8.3,6-Chloro-2-(2-Hydroxy-Biphenyl-3-Yl)-1h-Indole-5-Carboxamidine,FEKRWNWZMOSVBX-UHFFFAOYSA-O,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
131846,6w4h,DB14846,-8.3,Bimiralisib,ADGGYDAFIHSYFI-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131851,6w4h,DB14856,-8.3,PF-05089771,ZYSCOUXLBXGGIM-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
87410,6m3m,DB12284,-8.3,LY-2608204,QIIVJLHCZUTGSD-CUBQBAPOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
78356,6m2n,DB11633,-8.3,Isavuconazole,DDFOUSQFMYRUQK-RCDICMHDSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
109065,6vxx,DB11985,-8.3,Dapaconazole,FUAHXHWSMYFWGE-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78351,6m2n,DB11619,-8.3,Gestrinone,BJJXHLWLUDYTGC-ANULTFPQSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
112796,6vxx,DB07854,-8.3,N-METHYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE,VRGSDHJXBVCQEL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78388,6m2n,DB11682,-8.3,Daprodustat,RUEYEZADQJCKGV-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
105578,6vxs,DB13685,-8.3,Quingestanol,PCJFRMOEZQQSAX-AIOSZGMZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
112850,6vxx,DB07920,-8.3,N-oxo-2-[(4-phenylphenyl)sulfonylamino]ethanamide,OGRPZMQLAVBWPV-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
137925,6w9c,DB08905,-8.3,Formestane,OSVMTWJCGUFAOD-KZQROQTASA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137969,6w9c,DB08968,-8.3,Fominoben,KSNNEUZOAFRTDS-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
128122,6w4h,DB07245,-8.3,6-[2-(3'-METHOXYBIPHENYL-3-YL)ETHYL]PYRIDIN-2-AMINE,AEVBKBAFFJKFJZ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
127968,6w4h,DB07063,-8.3,"{3-[(4,5,7-TRIFLUORO-1,3-BENZOTHIAZOL-2-YL)METHYL]-1H-INDOL-1-YL}ACETIC ACID",KYHVTMFADJNSGS-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
125347,6w4h,DB02375,-8.3,Myricetin,IKMDFBPHZNJCSN-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
109071,6vxx,DB11994,-8.3,Diacerein,TYNLGDBUJLVSMA-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
137661,6w9c,DB08568,-8.3,(2S)-1-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}-3-PHENYLPROPAN-2-AMINE,BPNUQXPIQBZCMR-IBGZPJMESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
87405,6m3m,DB12278,-8.3,Propiverine,QPCVHQBVMYCJOM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
125188,6w4h,DB02164,-8.3,N-Sulfo-Flavin Mononucleotide,ZLPUGFBBLGQWBS-SCRDCRAPSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
133421,6w9c,DB01661,-8.3,1-(5-phospho-D-ribosyl)-ATP,RKNHJBVBFHDXGR-MRUDJCSFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
78417,6m2n,DB11729,-8.3,GSK-2330672,CZGVOBIGEBDYTP-VSGBNLITSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
104301,6vxs,DB11799,-8.3,Bictegravir,SOLUWJRYJLAZCX-LYOVBCGYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
130956,6w4h,DB13055,-8.3,Oteseconazole,IDUYJRXRDSPPRC-NRFANRHFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
10353,6lzg,DB08539,-8.3,"3-cyclopropyl-5-phenyl-N-(pyridin-3-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",CCDIUVLNHCGSMH-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
112791,6vxx,DB07848,-8.3,5-Chloro-N-{(3S)-1-[(2S)-1-(4-morpholinyl)-1-oxo-2-propanyl]-2-oxo-3-pyrrolidinyl}-1H-indole-2-sulfonamide,BHNMMFGOJRIAEZ-LRDDRELGSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
137737,6w9c,DB08659,-8.3,2-(hydrazinocarbonyl)-3-phenyl-1H-indole-5-sulfonamide,PPDLAUCFAOODER-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
87610,6m3m,DB12572,-8.3,Pexacerfont,LBWQSAZEYIZZCE-SNVBAGLBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
137975,6w9c,DB08974,-8.3,Flubendazole,CPEUVMUXAHMANV-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137718,6w9c,DB08639,-8.3,Dapivirine,ILAYIAGXTHKHNT-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
87378,6m3m,DB12239,-8.3,Balicatib,LLCRBOWRJOUJAE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
127982,6w4h,DB07081,-8.3,"(2R)-4-[(8R)-8-METHYL-2-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[1,5-A]PYRAZIN-7(8H)-YL]-4-OXO-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE",FDEXEPZGMKFCTG-PSASIEDQSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
78328,6m2n,DB11551,-8.3,Trenbolone,MEHHPFQKXOUFFV-OWSLCNJRSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
104741,6vxs,DB12432,-8.3,CC-401,XDJCLCLBSGGNKS-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
78997,6m2n,DB12569,-8.3,Tonapofylline,ZWTVVWUOTJRXKM-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
112125,6vxx,DB06358,-8.3,Iclaprim,HWJPWWYTGBZDEG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
128097,6w4h,DB07212,-8.3,N-(7-CARBAMIMIDOYL-NAPHTHALEN-1-YL)-3-HYDROXY-2-METHYL-BENZAMIDE,NNGZRCYXFBHMRM-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
138419,6w9c,DB11633,-8.3,Isavuconazole,DDFOUSQFMYRUQK-RCDICMHDSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
87620,6m3m,DB12587,-8.3,Razupenem,XFGOMLIRJYURLQ-GOKYHWASSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
104668,6vxs,DB12327,-8.3,Salvinorin A,OBSYBRPAKCASQB-AGQYDFLVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
125125,6w4h,DB02081,-8.3,Bis-Benzamidine,BXYGSMRTHHSAHZ-PMACEKPBSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
122551,6w4b,DB13552,-8.3,Trifluperidol,GPMXUUPHFNMNDH-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
78402,6m2n,DB11701,-8.3,Amenamevir,MNHNIVNAFBSLLX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
133286,6w9c,DB01500,-8.3,Oxabolone,GXHBCWCMYVTJOW-YGRHGMIBSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
125182,6w4h,DB02155,-8.3,Balanol Analog 8,XVLMXAUKCDSMMW-YXLARRHKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
11722,6lzg,DB12345,-8.3,MBX-2982,NFTMKHWBOINJGM-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
12178,6lzg,DB12999,-8.3,MK-6186,FZBAOOQVQXATRL-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
137948,6w9c,DB08942,-8.3,Isoxicam,YYUAYBYLJSNDCX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
104610,6vxs,DB12253,-8.3,GDC-0810,BURHGPHDEVGCEZ-KJGLQBJMSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
116487,6w4b,DB02226,-8.3,"3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-4-Yl]Hexyl]-Phenanthridinium",NAARZDJZGYBXKL-UHFFFAOYSA-O,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
131844,6w4h,DB14844,-8.3,ONC-201,VLULRUCCHYVXOH-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
91240,6m71,DB02799,-8.2,N-[2-(1-Maleimidyl)Ethyl]-7-Diethylaminocoumarin-3-Carboxamide,OJBZDUMTXGGVSP-KTKRTIGZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
88068,6m3m,DB13308,-8.2,Oxametacin,AJRNYCDWNITGHF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
151832,6wiq,DB03231,-8.2,"3-(5-Amino-7-oxo-3,7-dihydro-2H-[1,2,3]triazolo[4,5-d]pyrimidin-2-yl)-N-(2-{[2-(hydroxymethyl)phenyl]sulfanyl}benzyl)benzamide",IXDQOBDHBWEZOH-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
150652,6wiq,DB01669,-8.2,Virginiamycin M1,DAIKHDNSXMZDCU-FQTGFAPKSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
91213,6m71,DB02759,-8.2,4-Methylumbelliferyl Chitobiose,UPSFMJHZUCSEHU-JYGUBCOQSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
88202,6m3m,DB13481,-8.2,Tenidap,LXIKEPCNDFVJKC-QXMHVHEDSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
24934,6cs2,DB02759,-8.2,4-Methylumbelliferyl Chitobiose,UPSFMJHZUCSEHU-JYGUBCOQSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
92081,6m71,DB03925,-8.2,Freselestat,HMPQTEPEMQZWQH-QZTJIDSGSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
91173,6m71,DB02703,-8.2,Fusidic acid,IECPWNUMDGFDKC-MZJAQBGESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
63077,6crv,DB15091,-8.2,Upadacitinib,WYQFJHHDOKWSHR-MNOVXSKESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
63148,6crv,DB15227,-8.2,Tirabrutinib,SEJLPXCPMNSRAM-GOSISDBHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87683,6m3m,DB12687,-8.2,Vesatolimod,VFOKSTCIRGDTBR-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
62426,6crv,DB13558,-8.2,Morclofone,KVCJCEKJKGLBOK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
129561,6w4h,DB08974,-8.2,Flubendazole,CPEUVMUXAHMANV-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
152004,6wiq,DB03466,-8.2,BMS184394,AYAJZQYENGWICE-QHCPKHFHSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
92039,6m71,DB03869,-8.2,5'-O-(N-(L-Seryl)-Sulfamoyl)Adenosine,HQXFJGONGJPTLZ-YTMOPEAISA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
131079,6w4h,DB13266,-8.2,Cefatrizine,UOCJDOLVGGIYIQ-PBFPGSCMSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
132409,6w9c,DB00394,-8.2,Beclomethasone dipropionate,KUVIULQEHSCUHY-XYWKZLDCSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
91195,6m71,DB02732,-8.2,Nicotinamide Adenine Dinucleotide Acetone Adduct,SGHBFOOIAAJJMI-YDKVLQLQSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
112428,6vxx,DB07091,-8.2,(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclohexyloxy)ethanoyl)pyrrolidine-2-carboxamide,IWPMQJKXKKKSEY-SFHVURJKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
144606,6w9q,DB05616,-8.2,"4'-Methylene-5,8,10-trideazaaminopterin",NAWXUBYGYWOOIX-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
112048,6vxx,DB06174,-8.2,Noscapine,AKNNEGZIBPJZJG-MSOLQXFVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111166,6vxx,DB03084,-8.2,"Cyclopropyl-{4-[5-(3,4-Dichlorophenyl)-2-[(1-Methyl)-Piperidin]-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine",XCTKFTOEAKJMII-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
150112,6wiq,DB00966,-8.2,Telmisartan,RMMXLENWKUUMAY-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
23917,6cs2,DB01557,-8.2,??-Methylfentanyl,NGTVDHYUFBKWID-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
150229,6wiq,DB01100,-8.2,Pimozide,YVUQSNJEYSNKRX-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
87642,6m3m,DB12625,-8.2,Evogliptin,LCDDAGSJHKEABN-MLGOLLRUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
61360,6crv,DB11967,-8.2,Binimetinib,ACWZRVQXLIRSDF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
32707,6cs2,T3D3614,-8.2,Microcystin-LW,CJIASZBWXIFQMU-JCEGHRTGSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
123593,6w4h,DB00153,-8.2,Ergocalciferol,MECHNRXZTMCUDQ-RKHKHRCZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
112038,6vxx,DB06153,-8.2,Pizotifen,FIADGNVRKBPQEU-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
91665,6m71,DB03355,-8.2,5'-O-(N-(L-Threonyl)-Sulfamoyl)Adenosine,UPVAPSGKXAAHBG-CKTDUXNWSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
32006,6cs2,DB15192,-8.2,ABT-288,GNIRITULTPTAQW-KNQAVFIVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
150774,6wiq,DB01830,-8.2,"{4-[2-Acetylamino-2-(3-Carbamoyl-2-Cyclohexylmethoxy-6,7,8,9-Tetrahydro-5h-Benzocyclohepten-5ylcarbamoyl)-Ethyl]-2-Phosphono-Phenyl}-Phosphonic Acid",SPSGYTWOIGAABK-DQEYMECFSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
91548,6m71,DB03207,-8.2,"2-(Biphenyl-4-Sulfonyl)-1,2,3,4-Tetrahydro-Isoquinoline-3-Carboxylic Acid",BNVMUDXGABBWGP-OAQYLSRUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
130663,6w4h,DB12590,-8.2,Indiplon,CBIAWPMZSFFRGN-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
88142,6m3m,DB13399,-8.2,Terguride,JOAHPSVPXZTVEP-YXJHDRRASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
15472,6lzg,T3D1041,-8.2,Avermectin B1a,RRZXIRBKKLTSOM-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
91271,6m71,DB02836,-8.2,Guanosine 5'-Diphosphate 2':3'-Cyclic Monophosphate,NGYWTCOGOZELRS-UUOKFMHZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
62089,6crv,DB13065,-8.2,LY-2811376,MJQMRGWYPNIERM-HNNXBMFYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
91528,6m71,DB03181,-8.2,"2-[4-(4-Hydroxy-3-Isopropyl-Phenoxy)-3,5-Dimethyl-Phenyl]-2h-[1,2,4]Triazine-3,5-Dione",RXQAVKWRCZYGMV-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
9086,6lzg,DB07159,-8.2,Tamatinib,NHHQJBCNYHBUSI-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
111285,6vxx,DB03451,-8.2,"1-alpha, 25-dihydroxyl-20-epi-22-oxa-24, 26 ,27-trihomovitamin D3",KLZOTDOJMRMLDX-YBBVPDDNSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
150658,6wiq,DB01678,-8.2,RU84687,SAFPHFWYRLLBFO-NSOVKSMOSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
86755,6m3m,DB09355,-8.2,Sulfabenzamide,PBCZLFBEBARBBI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
150362,6wiq,DB01259,-8.2,Lapatinib,BCFGMOOMADDAQU-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
121943,6w4b,DB12635,-8.2,Aleplasinin,HSXLMAFNWCSZGP-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
9309,6lzg,DB07397,-8.2,"(5S)-5-(2-amino-2-oxoethyl)-4-oxo-N-[(3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl)methyl]-3,4,5,6,7,8-hexahydro[1]benzothieno[2,3-d]pyrimidine-2-carboxamide",ITADELAVAWJACR-NSHDSACASA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
91695,6m71,DB03397,-8.2,Uridine-Diphosphate-N-Acetylglucosamine,LFTYTUAZOPRMMI-CFRASDGPSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
144759,6w9q,DB06302,-8.2,Glesatinib,YRCHYHRCBXNYNU-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
147294,6w9q,DB11734,-8.2,Fedovapagon,RUOLFWZIFNQQGH-DEOSSOPVSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
91902,6m71,DB03701,-8.2,Vanoxerine,NAUWTFJOPJWYOT-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
86800,6m3m,DB11157,-8.2,Anthralin,NUZWLKWWNNJHPT-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
147300,6w9q,DB11740,-8.2,MK-1775,BKWJAKQVGHWELA-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
87677,6m3m,DB12679,-8.2,WP 1066,VFUAJMPDXIRPKO-LQELWAHVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
62430,6crv,DB13564,-8.2,Zipeprol,VSTNNAYSCJQCQI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
126367,6w4h,DB03744,-8.2,"Cp403700, (S)-1-{2-[(5-Chloro-1h-Indole-2-Carbonyl)-Amino]-3-Phenyl-Propionyl}-Azetidine-3-Carboxylate",RONLONYAIBUEKT-IBGZPJMESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
165463,7bv1,DB12135,-8.2,Elubrixin,YQYFEGTYCUQBEI-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
9107,6lzg,DB07181,-8.2,"4'-[(1R)-1-amino-2-(2,5-difluorophenyl)ethyl]biphenyl-3-carboxamide",JYKFWUXBFJJDTP-HXUWFJFHSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
86715,6m3m,DB09268,-8.2,Picosulfuric acid,UJIDKYTZIQTXPM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
29059,6cs2,DB08702,-8.2,"2,5-DIPHENYLFURAN-3,4-DICARBOXYLIC ACID",QPKYPOMZPFDBEZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
32809,6cs2,T3D3722,-8.2,Verrucarin J,GXCGYHWSYNQVHU-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
28887,6cs2,DB08510,-8.2,5-ALPHA-PREGNANE-3-BETA-OL-HEMISUCCINATE,UVTGFMKBPVLATL-DSOJQRAMSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
151398,6wiq,DB02651,-8.2,"{[2-(1h-1,2,3-Benzotriazol-1-Yl)-2-(3,4-Difluorophenyl)Propane-1,3-Diyl]Bis[4,1-Phenylene(Difluoromethylene)]}Bis(Phosphonic Acid)",BTAGTGWPDROBMG-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
91772,6m71,DB03507,-8.2,"6-[3-(4-Morpholinyl)Propyl]-2-(3-Nitrophenyl)-5-Thioxo-5,6,-Dihydro-7h-Thienol[2',3':4,5]Pyrrolo[1,2-C]Imidazol-7-One",UXGUZFZBZPPZGL-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
144725,6w9q,DB06229,-8.2,Ocaperidone,ZZQNEJILGNNOEP-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
132457,6w9c,DB00450,-8.2,Droperidol,RMEDXOLNCUSCGS-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
91755,6m71,DB03486,-8.2,Phosphomethylphosphonic Acid Guanosyl Ester,OCJWYBKRHNXUME-KQYNXXCUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
144757,6w9q,DB06295,-8.2,Pramiconazole,AEKNYBWUEYNWMJ-QWOOXDRHSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
123472,6w4b,DB00197,-8.2,Troglitazone,GXPHKUHSUJUWKP-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
147314,6w9q,DB11763,-8.2,Momelotinib,ZVHNDZWQTBEVRY-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
91732,6m71,DB03453,-8.2,Methyl (2S)-2-[[2-[(3R)-1-carbamimidoylpiperidin-3-yl]acetyl]amino]-3-[4-(2-phenylethynyl)phenyl]propanoate,MRNGXYMKYHNMLV-PKTZIBPZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
129582,6w4h,DB08997,-8.2,Dexetimide,LQQIVYSCPWCSSD-HSZRJFAPSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
129558,6w4h,DB08971,-8.2,Fluocortolone,GAKMQHDJQHZUTJ-ULHLPKEOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
110953,6vxx,DB02804,-8.2,A-98881,PMBZSBGCSQGJAQ-GRKNLSHJSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
92160,6m71,DB04030,-8.2,"1,3,4,9-Tetrahydro-2-(Hydroxybenzoyl)-9-[(4-Hydroxyphenyl)Methyl]-6-Methoxy-2h-Pyrido[3,4-B]Indole",ADXYEWMDAGIULV-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93107,6m71,DB06302,-8.2,Glesatinib,YRCHYHRCBXNYNU-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
155440,6wiq,DB09143,-8.2,Sonidegib,VZZJRYRQSPEMTK-CALCHBBNSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
63238,6crv,DB15410,-8.2,(S)-Propafenone,JWHAUXFOSRPERK-SFHVURJKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61154,6crv,DB11670,-8.2,SP-8203,SJZBPVOSFYUHFV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
93072,6m71,DB06228,-8.2,Rivaroxaban,KGFYHTZWPPHNLQ-AWEZNQCLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
143610,6w9q,DB03768,-8.2,"N-[2-Hydroxy-2-(8-Isopropyl-6,9-Dioxo-2-Oxa-7,10-Diaza-Bicyclo[11.2.2]Heptadeca-1(16),13(17),14-Trien-11-Yl)-Ethyl]-N-(3-Methyl-Butyl)-Benzenesulfonamide,Inhibitor 3",WRUVOSYKHXGAQN-GKRYNVPLSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
86449,6m3m,DB08867,-8.2,Ulipristal,HKDLNTKNLJPAIY-WKWWZUSTSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
93048,6m71,DB06176,-8.2,Romidepsin,OHRURASPPZQGQM-GCCNXGTGSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93042,6m71,DB06159,-8.2,Rubitecan,VHXNKPBCCMUMSW-FQEVSTJZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
9339,6lzg,DB07430,-8.2,"(10R)-10-methyl-3-(6-methylpyridin-3-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one",CMWRPDHVGMHLSZ-GFCCVEGCSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
146925,6w9q,DB09199,-8.2,Netoglitazone,PKWDZWYVIHVNKS-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
132621,6w9c,DB00655,-8.2,Estrone,DNXHEGUUPJUMQT-CBZIJGRNSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
87887,6m3m,DB13012,-8.2,AQX-1125,MDEJTPWQNNMAQF-BVMLLJBZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
35615,1r42,DB01836,-8.2,"[4-(6-Chloro-Naphthalene-2-Sulfonyl)-Piperazin-1-Yl]-(3,4,5,6-Tetrahydro-2h-[1,4']Bipyridinyl-4-Yl)-Methanone",ZLAKCKVFSRSENR-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
129489,6w4h,DB08865,-8.2,Crizotinib,KTEIFNKAUNYNJU-GFCCVEGCSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130970,6w4h,DB13072,-8.2,GDC-0349,RGJOJUGRHPQXGF-INIZCTEOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
144005,6w9q,DB04285,-8.2,"{4-[(2s,4e)-2-(1,3-Benzothiazol-2-Yl)-2-(1h-1,2,3-Benzotriazol-1-Yl)-5-Phenylpent-4-Enyl]Phenyl}(Difluoro)Methylphosphonic Acid",GBLDYRVJENYQNH-AGLOJYHOSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
132597,6w9c,DB00623,-8.2,Fluphenazine,PLDUPXSUYLZYBN-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
112468,6vxx,DB07290,-8.2,(2R)-2-{[(4-FLUORO-3-METHYLPHENYL)SULFONYL]AMINO}-N-HYDROXY-2-TETRAHYDRO-2H-PYRAN-4-YLACETAMIDE,LUCFRFDOOYLALP-CYBMUJFWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
132598,6w9c,DB00624,-8.2,Testosterone,MUMGGOZAMZWBJJ-DYKIIFRCSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
154740,6wiq,DB08221,-8.2,N-{4-METHYL-3-[(3-PYRIMIDIN-4-YLPYRIDIN-2-YL)AMINO]PHENYL}-3-(TRIFLUOROMETHYL)BENZAMIDE,NESXBRNDMQUVNG-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
62361,6crv,DB13472,-8.2,Cyclofenil,GVOUFPWUYJWQSK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
92929,6m71,DB05498,-8.2,KW-7158,NAFSYPCVPLWHFY-HNNXBMFYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
121830,6w4b,DB12457,-8.2,Rimegepant,KRNAOFGYEFKHPB-ANJVHQHFSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
35357,1r42,DB01514,-8.2,Furazabol,RGLLOUBXMOGLDQ-IVEVATEUSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
63217,6crv,DB15359,-8.2,Xanthohumol,ORXQGKIUCDPEAJ-YRNVUSSQSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
92959,6m71,DB05653,-8.2,IRX-5183,PNAWUIKCVQSLFG-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
86469,6m3m,DB08903,-8.2,Bedaquiline,QUIJNHUBAXPXFS-XLJNKUFUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
130764,6w4h,DB12746,-8.2,AKN-028,JLRIJKVMMZEKDF-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
87895,6m3m,DB13023,-8.2,IPI-493,XYFFWTYOFPSZRM-TWNAANEASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
62222,6crv,DB13291,-8.2,Cloridarol,KBFBRIPYVVGWRS-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
92942,6m71,DB05552,-8.2,TG100-115,UJIAQDJKSXQLIT-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
86474,6m3m,DB08910,-8.2,Pomalidomide,UVSMNLNDYGZFPF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
111984,6vxx,DB05048,-8.2,Cannabinor,GSTZHANFXAKPSE-MXTREEOPSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
15675,6lzg,DB00773,-8.2,Etoposide,VJJPUSNTGOMMGY-MRVIYFEKSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
130866,6w4h,DB12914,-8.2,MGL-3196,FDBYIYFVSAHJLY-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
36699,1r42,DB03268,-8.2,RU82197,WKTQBTSOHBKBRW-VMPREFPWSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
130884,6w4h,DB12941,-8.2,ODM-201,BLIJXOOIHRSQRB-PXYINDEMSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
165686,7bv1,DB12658,-8.2,AFN-1252,QXTWSUQCXCWEHF-JXMROGBWSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
132675,6w9c,DB00716,-8.2,Nedocromil,RQTOOFIXOKYGAN-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
87815,6m3m,DB12900,-8.2,Irdabisant,XUKROCVZGZNGSI-CQSZACIVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
25184,6cs2,DB03062,-8.2,(1-Methyl-1h-Imidazol-2-Yl)-(3-Methyl-4-{3-[(Pyridin-3-Ylmethyl)-Amino]-Propoxy}-Benzofuran-2-Yl)-Methanone,VZBQJKIOAOUYJL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
93429,6m71,DB06933,-8.2,N-(tert-butyl)-4-[5-(pyridin-2-ylamino)quinolin-3-yl]benzenesulfonamide,GJTCKUKIFXWJKG-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
24354,6cs2,DB00288,-8.2,Amcinonide,ILKJAFIWWBXGDU-MOGDOJJUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
112506,6vxx,DB07330,-8.2,trans-4-(7-carbamoyl-1H-benzimidazol-2-yl)-1-propylpiperidinium,KXSIHXHEHABEJX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87827,6m3m,DB12919,-8.2,T-62,OTZVBZFYMFTYKH-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
130900,6w4h,DB12966,-8.2,Falnidamol,FTFRZXFNZVCRSK-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130912,6w4h,DB12985,-8.2,Quisinostat,PAWIYAYFNXQGAP-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
143258,6w9q,DB03276,-8.2,"4-[(10s,14s,18s)-18-(2-Amino-2-Oxoethyl)-14-(1-Naphthylmethyl)-8,17,20-Trioxo-7,16,19-Triazaspiro[5.14]Icos-11-En-10-Yl]Benzylphosphonic Acid",RHYFMOCFCFUTNH-GZNVFMSSSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
87791,6m3m,DB12868,-8.2,Intoplicine,QROONAIPJKQFMC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
121811,6w4b,DB12427,-8.2,Orvepitant,XWNBGDJPEXZSQM-VZOBGQTKSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
130913,6w4h,DB12986,-8.2,VS-5584,QYBGBLQCOOISAR-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130801,6w4h,DB12812,-8.2,Palomid 529,YEAHTLOYHVWAKW-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
86409,6m3m,DB08804,-8.2,Nandrolone decanoate,JKWKMORAXJQQSR-MOPIKTETSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
93127,6m71,DB06367,-8.2,Relacatib,BWYBBMQLUKXECQ-GIVPXCGWSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
86383,6m3m,DB08775,-8.2,N??-[(Benzyloxy)carbonyl]-N-[(2S)-4-fluoro-3-oxo-2-butanyl]-L-tyrosinamide,RYABQRLJLIHDIP-KSSFIOAISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
111970,6vxx,DB04982,-8.2,Talampanel,JACAAXNEHGBPOQ-LLVKDONJSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
93146,6m71,DB06429,-8.2,Talnetant,BIAVGWDGIJKWRM-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
63244,6crv,DB15424,-8.2,Bfpet F-18,QWPLCHDPESWJRN-FNNGWQQSSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
93154,6m71,DB06446,-8.2,Dotarizine,LRMJAFKKJLRDLE-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
31966,6cs2,DB15120,-8.2,GSK-239512,YFRBKEVUUCQYOW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
129460,6w4h,DB08816,-8.2,Ticagrelor,OEKWJQXRCDYSHL-FNOIDJSQSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130921,6w4h,DB13002,-8.2,HKI-357,NERXPXBELDBEPZ-RMKNXTFCSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
35975,1r42,DB02323,-8.2,EM-1745,CKSDYJASHNGOOS-KTXOUVACSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
155717,6wiq,DB11618,-8.2,Zorubicin,FBTUMDXHSRTGRV-BJISBDEGSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
155735,6wiq,DB11652,-8.2,Tucatinib,SDEAXTCZPQIFQM-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
87832,6m3m,DB12926,-8.2,Cafedrine,UJSKUDDDPKGBJY-WFASDCNBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86619,6m3m,DB09128,-8.2,Brexpiprazole,ZKIAIYBUSXZPLP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
62199,6crv,DB13256,-8.2,Clothiapine,KAAZGXDPUNNEFN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62363,6crv,DB13475,-8.2,Furazidin,DECBQELQORZLLP-UAIOPKHMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
92626,6m71,DB04651,-8.2,BIOTINOL-5-AMP,KBOGUFFJCBPJEH-SQGSUPJISA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
153418,6wiq,DB06448,-8.2,Lonafarnib,DHMTURDWPRKSOA-RUZDIDTESA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
112007,6vxx,DB05197,-8.2,Sofalcone,GFWRVVCDTLRWPK-KPKJPENVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
153390,6wiq,DB06367,-8.2,Relacatib,BWYBBMQLUKXECQ-GIVPXCGWSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
130719,6w4h,DB12680,-8.2,Intepirdine,JJZFWROHYSMCMU-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
165665,7bv1,DB12623,-8.2,Taprenepag,MFFBXYNKZHTCEY-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
111000,6vxx,DB02861,-8.2,"4-(Aminosulfonyl)-N-[(3,4,5-Trifluorophenyl)Methyl]-Benzamide",DEHMSTGBNAXEGX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
146852,6w9q,DB09073,-8.2,Palbociclib,AHJRHEGDXFFMBM-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
132547,6w9c,DB00562,-8.2,Benzthiazide,NDTSRXAMMQDVSW-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
111937,6vxx,DB04890,-8.2,Bepotastine,YWGDOWXRIALTES-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86582,6m3m,DB09062,-8.2,Cefminox,JSDXOWVAHXDYCU-VXSYNFHWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
92517,6m71,DB04514,-8.2,Phosphoric Acid-2'-[2'-Deoxy-Uridine]Ester-5'-Guanosine Ester,DFYLLEBFVZTKHD-VMIOUTBZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
153275,6wiq,DB05984,-8.2,RAF-265,YABJJWZLRMPFSI-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
112012,6vxx,DB05239,-8.2,Cobimetinib,BSMCAPRUBJMWDF-KRWDZBQOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87980,6m3m,DB13165,-8.2,Ripasudil,QSKQVZWVLOIIEV-NSHDSACASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
165663,7bv1,DB12621,-8.2,ST-101,QZWYXEBIQWJXAR-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
34073,6cs2,T3D0932,-8.2,"Biscarbofuran N,N'-disulfide",RNNGCAGZVZIHNF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
28891,6cs2,DB08514,-8.2,"6-amino-2-[(thiophen-2-ylmethyl)amino]-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",IQKMJWDYMFWZRF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
92237,6m71,DB04137,-8.2,Guanosine-5'-Triphosphate,XKMLYUALXHKNFT-UUOKFMHZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
61302,6crv,DB11886,-8.2,Infigratinib,QADPYRIHXKWUSV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87694,6m3m,DB12707,-8.2,AR-42,LAMIXXKAWNLXOC-INIZCTEOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
9363,6lzg,DB07456,-8.2,"3-(1H-indol-3-yl)-4-(1-{2-[(2S)-1-methylpyrrolidinyl]ethyl}-1H-indol-3-yl)-1H-pyrrole-2,5-dione",LBFDERUQORUFIN-QGZVFWFLSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
152648,6wiq,DB04330,-8.2,Bilh 434,KNRVCCXHLSHTFW-HGPRPZRGSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
9626,6lzg,DB07743,-8.2,"S-[5-(TRIFLUOROMETHYL)-4H-1,2,4-TRIAZOL-3-YL] 5-(PHENYLETHYNYL)FURAN-2-CARBOTHIOATE",VNGWUVBXUIDQTK-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
87703,6m3m,DB12717,-8.2,Mibampator,ULRDYYKSPCRXAJ-KRWDZBQOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
9070,6lzg,DB07142,-8.2,"5-[(3R)-3-(5-methoxy-3',5'-dimethylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",ATFDKOLABYIYCC-INIZCTEOSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
165286,7bv1,DB11706,-8.2,Raxatrigine,JESCETIFNOFKEU-SJORKVTESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
32799,6cs2,T3D3712,-8.2,Satratoxin H,MUACSCLQRGEGOE-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
92283,6m71,DB04194,-8.2,Chitotriose,WZZVUHWLNMNWLW-VFCSDQTKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
144455,6w9q,DB04888,-8.2,Bifeprunox,CYGODHVAJQTCBG-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
34010,6cs2,T3D0821,-8.2,Heratomin,DSDJMMMGDPDPIX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
132510,6w9c,DB00519,-8.2,Trandolapril,VXFJYXUZANRPDJ-WTNASJBWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
61201,6crv,DB11739,-8.2,Vonoprazan,BFDBKMOZYNOTPK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110946,6vxx,DB02615,-8.2,Compound 19,UZOOIPXOYYJULJ-BLIZRMSTSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62164,6crv,DB13213,-8.2,Butaperazine,DVLBYTMYSMAKHP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
154588,6wiq,DB08044,-8.2,ABT-341,NVVSPGQEXMJZIR-BMIGLBTASA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
29075,6cs2,DB08715,-8.2,"2,6-DIMETHYL-1-(3-[3-METHYL-5-ISOXAZOLYL]-PROPANYL)-4-[2-METHYL-4-ISOXAZOLYL]-PHENOL",SLPKYEWAKMNCPT-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
154520,6wiq,DB07970,-8.2,5-[(2-methyl-5-{[3-(trifluoromethyl)phenyl]carbamoyl}phenyl)amino]pyridine-3-carboxamide,SAAYRHKJHDIDPH-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
92825,6m71,DB04946,-8.2,Iloperidone,XMXHEBAFVSFQEX-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
62367,6crv,DB13481,-8.2,Tenidap,LXIKEPCNDFVJKC-QXMHVHEDSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86494,6m3m,DB08943,-8.2,Isoconazole,MPIPASJGOJYODL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
112466,6vxx,DB07288,-8.2,N-(4-chlorophenyl)-2-[(pyridin-4-ylmethyl)amino]benzamide,GGPZCOONYBPZEW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
9647,6lzg,DB07765,-8.2,"METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL](METHYL)AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE",UKCFUFHREWUXJJ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
87716,6m3m,DB12739,-8.2,Bindarit,MTHORRSSURHQPZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
147241,6w9q,DB11651,-8.2,Dactolisib,JOGKUKXHTYWRGZ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
61230,6crv,DB11783,-8.2,Imidapril,KLZWOWYOHUKJIG-BPUTZDHNSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87929,6m3m,DB13072,-8.2,GDC-0349,RGJOJUGRHPQXGF-INIZCTEOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
63187,6crv,DB15300,-8.2,Hydroquinidine,LJOQGZACKSYWCH-LHHVKLHASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62177,6crv,DB13227,-8.2,Tribenoside,ULLNJSBQMBKOJH-VIVFLBMVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
92787,6m71,DB04867,-8.2,Lintitript,ILNRQFBVVQUOLP-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
144324,6w9q,DB04716,-8.2,"2-(1,1-DIMETHYLETHYL)9-FLUORO-3,6-DIHYDRO-7H-BENZ[H]-IMIDAZ[4,5-F]ISOQUINOLIN-7-ONE",VNDWQCSOSCCWIP-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
92776,6m71,DB04853,-8.2,Binodenoson,XJFMHMFFBSOEPR-DNZQAUTHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
92701,6m71,DB04760,-8.2,"PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-(4-FLUORO-3-METHYL-BENZYLAMIDE)",PYFRREJCFXFNRR-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
144435,6w9q,DB04863,-8.2,Lefradafiban,PGCFXITVMNNKON-ROUUACIJSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
92702,6m71,DB04761,-8.2,"PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-[(PYRIDIN-3-YLMETHYL)-AMIDE]",NHPBWKYFMTXWAA-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
112454,6vxx,DB07122,-8.2,1-[4-(2-oxo-2-phenylethyl)phenyl]guanidine,MERNPSIIBFTCAI-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112456,6vxx,DB07124,-8.2,"(2S)-1-(6H-INDOL-3-YL)-3-{[5-(7H-PYRAZOLO[3,4-C]PYRIDIN-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE",CCIACUJJBPSOHE-KRWDZBQOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130747,6w4h,DB12721,-8.2,RO-5028442,QZXVLRCMAHJVIP-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
92695,6m71,DB04750,-8.2,OREGON GREEN 488 CARBOXYLATE,BRJCLSQFZSHLRL-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
130748,6w4h,DB12724,-8.2,AZD-7295,MAQDQJWCSSCURR-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
153853,6wiq,DB07189,-8.2,"(1S,3R,6S)-4-oxo-6-{4-[(2-phenylquinolin-4-yl)methoxy]phenyl}-5-azaspiro[2.4]heptane-1-carboxylic acid",BFZXMIUWGSTUAL-ZSOKXDGFSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
153878,6wiq,DB07220,-8.2,"N-[5-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-1H-INDAZOL-3-YL]-2-(4-PIPERIDIN-1-YLPHENYL)ACETAMIDE",ZXYIRNXOAJYLCU-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
154010,6wiq,DB07369,-8.2,"N-(3-chlorophenyl)-N-methyl-2-oxo-3-[(3,4,5-trimethyl-1H-pyrrol-2-yl)methyl]-2H-indole-5-sulfonamide",YMJLSOJLEXWATP-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
92723,6m71,DB04790,-8.2,"2,5-bis-O-{3-[amino(imino)methyl]phenyl}-1,4:3,6-dianhydro-D-glucitol",IBIUTOFGXGGVKQ-XMTFNYHQSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
92751,6m71,DB04824,-8.2,Phenolphthalein,KJFMBFZCATUALV-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
123721,6w4h,DB00298,-8.2,Dapiprazole,RFWZESUMWJKKRN-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
25069,6cs2,DB02918,-8.2,Zardaverine,HJMQDJPMQIHLPB-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
63073,6crv,DB15080,-8.2,ELX-02,KJBRSTPUILEBDR-YBNFDXCTSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
15958,6lzg,DB02089,-8.2,CP-526423,MWWXABBBAPKJDX-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
132389,6w9c,DB00370,-8.2,Mirtazapine,RONZAEMNMFQXRA-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
129989,6w4h,DB11577,-8.2,Indigotindisulfonic Acid,CFZXDJWFRVEWSR-BUHFOSPRSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
87177,6m3m,DB11943,-8.2,Delafloxacin,DYDCPNMLZGFQTM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
62899,6crv,DB14671,-8.2,Temazepam acetate,PTWWAHZQIATUFG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
5981,6lzg,DB01395,-8.2,Drospirenone,METQSPRSQINEEU-HXCATZOESA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
33069,6cs2,T3D4032,-8.2,Cyclochlorotine,PMBVHCCVEPYDSN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
89047,6m3m,DB15348,-8.2,Ampreloxetine,TZIALEBTHQWNAO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
61920,6crv,DB12804,-8.2,Daniquidone,SRIOCKJKFXAKHK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
131762,6w4h,DB14657,-8.2,Paramethasone acetate,HYRKAAMZBDSJFJ-LFDBJOOHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
88650,6m3m,DB14214,-8.2,Rose bengal lactone,IICCLYANAQEHCI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
131994,6w4h,DB15169,-8.2,H3B-6527,MBWRLLRCTIYXDW-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
24717,6cs2,DB00328,-8.2,Indometacin,CGIGDMFJXJATDK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
147683,6w9q,DB12297,-8.2,GLPG-0187,CXHCNOMGODVIKB-VWLOTQADSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
130444,6w4h,DB12275,-8.2,Seviteronel,ZBRAJOQFSNYJMF-SFHVURJKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
32903,6cs2,T3D3828,-8.2,Difenoconazole,BQYJATMQXGBDHF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
16069,6lzg,DB02547,-8.2,Guanosine-5'-Diphosphate-Rhamnose,LQEBEXMHBLQMDB-GDJBGNAASA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
131766,6w4h,DB14662,-8.2,Flunisolide acetate,WEGNFRKBIKYVLC-XTLNBZDDSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
145915,6w9q,DB07909,-8.2,"(1S,2S,5S)2-(4-GLUTARIDYLBENZYL)-5-PHENYL-1-CYCLOHEXANOL",OBWILOKKNDYPLX-HBMCJLEFSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
88700,6m3m,DB14635,-8.2,Curcumin sulfate,NEJVQQBBTRFOHB-FCXRPNKRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
62660,6crv,DB13873,-8.2,Fenofibric acid,MQOBSOSZFYZQOK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
131768,6w4h,DB14664,-8.2,Difluocortolone pivalate,UWGRWFCLGQWKPR-GSTUPEFVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
147711,6w9q,DB12332,-8.2,Rucaparib,HMABYWSNWIZPAG-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
145963,6w9q,DB07966,-8.2,[4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]quinazolin-2-yl}amino)phenyl]acetonitrile,NVMCVWOODOWOLT-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
130056,6w4h,DB11703,-8.2,Acalabrutinib,WDENQIQQYWYTPO-IBGZPJMESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
147661,6w9q,DB12269,-8.2,PF-06273340,BPIWZDNVMQQBQX-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
112203,6vxx,DB06579,-8.2,Adipiplon,UAMAIHOEGLEXSV-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130038,6w4h,DB11679,-8.2,Fruquintinib,BALLNEJQLSTPIO-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130397,6w4h,DB12211,-8.2,PSI-697,DIEPFYNZGUUVHD-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
61702,6crv,DB12461,-8.2,GLPG-0492,VAJGULUVTFDTAS-GOSISDBHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111626,6vxx,DB04295,-8.2,N-Benzoyl-N'-Beta-D-Glucopyranosyl Urea,JSBCZGSPFATCOV-BZNQNGANSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
15255,6lzg,T3D0679,-8.2,Methylcobalamin,JEWJRMKHSMTXPP-WZHZPDAFSA-L,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
87201,6m3m,DB11979,-8.2,Elagolix,HEAUOKZIVMZVQL-VWLOTQADSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
130053,6w4h,DB11698,-8.2,Ipragliflozin,AHFWIQIYAXSLBA-RQXATKFSSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
32125,6cs2,DB15407,-8.2,Acalisib,DOCINCLJNAXZQF-LBPRGKRZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
87169,6m3m,DB11934,-8.2,Epelsiban,UWHCWRQFNKUYCG-QUZACWSFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
148559,6w9q,DB13610,-8.2,Flumedroxone,CDZJOBWKHSYNMO-SCUQKFFVSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
145807,6w9q,DB07786,-8.2,"1-((1R,2S)-1-{2-[2-(4-CHLOROPHENYL)-1,3-BENZOXAZOL-7-YL]ETHYL}-2-HYDROXYPROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE",SMFRBBHLVBWHGB-DJJJIMSYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
111589,6vxx,DB04243,-8.2,5-Methyluridine 5'-Monophosphate,IGWHDMPTQKSDTL-JXOAFFINSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
129767,6w4h,DB09286,-8.2,Pipamperone,AXKPFOAXAHJUAG-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
129761,6w4h,DB09279,-8.2,Fimasartan,AMEROGPZOLAFBN-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
111576,6vxx,DB04226,-8.2,Dihydro-Acarbose,CUAQESWNTOXZJZ-RTNAABQMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
89118,6m3m,DB08775,-8.2,Nalpha-[(Benzyloxy)carbonyl]-N-[(2S)-4-fluoro-3-oxo-2-butanyl]-L-tyrosinamide,RYABQRLJLIHDIP-KSSFIOAISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
24547,6cs2,DB02310,-8.2,"3,5,6,8-Tetramethyl-N-Methyl Phenanthrolinium",FQTUZNACZKILMC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
147602,6w9q,DB12185,-8.2,Exatecan,ZVYVPGLRVWUPMP-FYSMJZIKSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
122092,6w4b,DB12875,-8.2,Mavatrep,ORDHXXHTBUZRCN-NTEUORMPSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
123231,6w4b,DB15133,-8.2,Tepotinib,AHYMHWXQRWRBKT-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
24767,6cs2,DB02555,-8.2,SP4160,VCXMTWSYQSVWRK-AREMUKBSSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
112249,6vxx,DB06884,-8.2,4-HYDROXY-N'-(4-ISOPROPYLBENZYL)BENZOHYDRAZIDE,MFDXHRPPSJRQFX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28857,6cs2,DB08478,-8.2,N-[2-chloro-5-(trifluoromethyl)phenyl]imidodicarbonimidic diamide,IGFTZEOFHWPCDL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
131737,6w4h,DB14631,-8.2,Prednisolone phosphate,JDOZJEUDSLGTLU-VWUMJDOOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
132021,6w4h,DB15221,-8.2,PF-06260414,ZKAVFOXYJCREBQ-SNVBAGLBSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130102,6w4h,DB11775,-8.2,PF-03758309,AYCPARAPKDAOEN-LJQANCHMSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
87159,6m3m,DB11915,-8.2,Valbenazine,GEJDGVNQKABXKG-CFKGEZKQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
61946,6crv,DB12850,-8.2,Etalocib,YFIZRWPXUYFCSN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62632,6crv,DB13837,-8.2,Doxefazepam,VOJLELRQLPENHL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
24729,6cs2,DB02511,-8.2,2-Hydroxy-5-({1-[(2-Naphthyloxy)Methyl]-3-Oxoprop-1-Enyl}Amino)Tyrosine,PZWMZAFFUAWVDN-CQXYXCHQSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
32864,6cs2,T3D3782,-8.2,Verruculogen,LRXYHMMJJCTUMY-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
129961,6w4h,DB11491,-8.2,Sarafloxacin,XBHBWNFJWIASRO-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
145820,6w9q,DB07800,-8.2,N-(2-(((5-CHLORO-2-PYRIDINYL)AMINO)SULFONYL)PHENYL)-4-(2-OXO-1(2H)-PYRIDINYL)BENZAMIDE,MIJGLXFQYBTIFY-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
130881,6w4h,DB12937,-8.2,Quercetin-3'-O-phosphate,UWJBYNLLMAPJMM-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
87160,6m3m,DB11917,-8.2,Vatiquinone,LNOVHERIIMJMDG-XZXLULOTSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
130485,6w4h,DB12325,-8.2,Idasanutlin,TVTXCJFHQKSQQM-LJQIRTBHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
61943,6crv,DB12846,-8.2,Reproterol,WVLAAKXASPCBGT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
24736,6cs2,DB02519,-8.2,Indirubin-5-Sulphonate,IHBOEHLUIBMBMY-YPKPFQOOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
129859,6w4h,DB11259,-8.2,Diosmetin,MBNGWHIJMBWFHU-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
129810,6w4h,DB09488,-8.2,Acrivastine,PWACSDKDOHSSQD-IUTFFREVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
148789,6w9q,DB13954,-8.2,Estradiol cypionate,UOACKFBJUYNSLK-XRKIENNPSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
24211,6cs2,DB01906,-8.2,"3-(5-Amino-7-Hydroxy-[1,2,3]Triazolo[4,5-D]Pyrimidin-2-Yl)-Benzoic Acid",KNLLRZNGRRRPEW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
111605,6vxx,DB04270,-8.2,(S)-3-(4-(2-Carbazol-9-Yl-Ethoxy)-Phenyl)-2-Ethoxy-Propionic Acid,WUZIMDSVRIBNNI-DEOSSOPVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
131966,6w4h,DB15114,-8.2,Vamorolone,ZYTXTXAMMDTYDQ-DGEXFFLYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
24102,6cs2,DB01768,-8.2,Methylumbelliferyl Sialic Acid,KKDWIUJBUSOPGC-GKHMPSLRSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
33021,6cs2,T3D3953,-8.2,Oxytetracycline,IWVCMVBTMGNXQD-PXOLEDIWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
111753,6vxx,DB04474,-8.2,1-Anilino-8-Naphthalene Sulfonate,FWEOQOXTVHGIFQ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130316,6w4h,DB12092,-8.2,Naftopidil,HRRBJVNMSRJFHQ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130318,6w4h,DB12095,-8.2,Telotristat ethyl,MDSQOJYHHZBZKA-GBXCKJPGSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
62719,6crv,DB14013,-8.2,SR-9009,MMJJNHOIVCGAAP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
32989,6cs2,T3D3919,-8.2,Quizalofop-ethyl,OSUHJPCHFDQAIT-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
87333,6m3m,DB12174,-8.2,CUDC-101,PLIVFNIUGLLCEK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
130307,6w4h,DB12078,-8.2,Enobosarm,JNGVJMBLXIUVRD-SFHVURJKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
28834,6cs2,DB08455,-8.2,Ro 12-7310,CAAFTBWHFUPDGX-OFCLTBKTSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
28977,6cs2,DB08607,-8.2,"(5R)-5-(4-{[(2R)-6-HYDROXY-2,5,7,8-TETRAMETHYL-3,4-DIHYDRO-2H-CHROMEN-2-YL]METHOXY}BENZYL)-1,3-THIAZOLIDINE-2,4-DIONE",GXPHKUHSUJUWKP-NTKDMRAZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
130235,6w4h,DB11966,-8.2,BMS-986094,YFXGICNMLCGLHJ-RSKRLRQZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
123307,6w4b,DB15287,-8.2,Elismetrep,CWEFDWIKLABKBX-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
61816,6crv,DB12641,-8.2,Tedatioxetine,CVASBKDYSQKLSO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
32995,6cs2,T3D3925,-8.2,Tebufenozide,QYPNKSZPJQQLRK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
61814,6crv,DB12638,-8.2,PU-H71,SUPVGFZUWFMATN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87322,6m3m,DB12155,-8.2,Napabucasin,DPHUWDIXHNQOSY-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
146204,6w9q,DB08241,-8.2,4-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)--BENZAMIDE,RUUOIINPNMNPIU-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
146118,6w9q,DB08138,-8.2,"{[(2,6-difluorophenyl)carbonyl]amino}-N-(4-fluorophenyl)-1H-pyrazole-3-carboxamide",BDRDBXXWQDFXEC-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
9243,6lzg,DB07325,-8.2,N-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)METHYL]-3-{[(E)-(2-OXODIHYDROFURAN-3(2H)-YLIDENE)METHYL]AMINO}BENZENESULFONAMIDE,VCOKUBHAJVTVNG-FMIVXFBMSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
88775,6m3m,DB14768,-8.2,PF-06459988,ODMXWZROLKITMS-RISCZKNCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88778,6m3m,DB14772,-8.2,DCFBC F-18,IDTMSHGCAZPVLC-STUNTBJNSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
131870,6w4h,DB14889,-8.2,Derazantinib,KPJDVVCDVBFRMU-AREMUKBSSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
28840,6cs2,DB08462,-8.2,N-(4-PHENYLAMINO-QUINAZOLIN-6-YL)-ACRYLAMIDE,JGWHILNNHLDARR-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
24618,6cs2,DB00317,-8.2,Gefitinib,XGALLCVXEZPNRQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
61857,6crv,DB12705,-8.2,Cenerimod,KJKKMMMRWISKRF-FQEVSTJZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130272,6w4h,DB12024,-8.2,PF-04418948,LWJGMYMNSNVCEM-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
147880,6w9q,DB12582,-8.2,Piperine,MXXWOMGUGJBKIW-YPCIICBESA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
88788,6m3m,DB14793,-8.2,RO-5045337,QBGKPEROWUKSBK-QPPIDDCLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88745,6m3m,DB14682,-8.2,Dextrorphan,JAQUASYNZVUNQP-PVAVHDDUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88795,6m3m,DB14820,-8.2,Profoxydim,KRQUFUKTQHISJB-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
111779,6vxx,DB04509,-8.2,N-Methylnaloxonium,PCSQOABIHJXZMR-YNUHATHGSA-O,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
131877,6w4h,DB14902,-8.2,JHU-75528 C-11,MCNQUWLLXZZZAC-BJUDXGSMSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
122363,6w4b,DB13307,-8.2,Proscillaridin,MYEJFUXQJGHEQK-ALRJYLEOSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
130294,6w4h,DB12058,-8.2,Recoflavone,BCPQOBQIVJZOFL-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
61621,6crv,DB12347,-8.2,CG-400549,YCLREGRRHGLOAK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87296,6m3m,DB12120,-8.2,Avoralstat,TUWMKPVJGGWGNL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
62801,6crv,DB14191,-8.2,Diphenylguanidine,OWRCNXZUPFZXOS-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
148024,6w9q,DB12817,-8.2,Zoliflodacin,ZSWMIFNWDQEXDT-ZESJGQACSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
32143,6cs2,DB15440,-8.2,GSK-3117391,AFDPFLDWOXXHQM-NRFANRHFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
88903,6m3m,DB15071,-8.2,Omidenepag isopropyl,VIQCWEGEHRBLAC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88915,6m3m,DB15097,-8.2,Gefapixant,HLWURFKMDLAKOD-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
130359,6w4h,DB12149,-8.2,S-3304,YWCLDDLVLSQGSZ-JOCHJYFZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
87262,6m3m,DB12071,-8.2,Vabicaserin,NPTIPEQJIDTVKR-STQMWFEESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87427,6m3m,DB12305,-8.2,Dasotraline,SRPXSILJHWNFMK-MEDUHNTESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87439,6m3m,DB12319,-8.2,Benzbromarone,WHQCHUCQKNIQEC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88712,6m3m,DB14648,-8.2,Acetyl simvastatin,OHVWRJDVJRNCPE-BIKFJBPRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
122792,6w4b,DB13874,-8.2,Enasidenib,DYLUUSLLRIQKOE-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
87440,6m3m,DB12320,-8.2,Palovarotene,YTFHCXIPDIHOIA-DHZHZOJOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
111787,6vxx,DB04518,-8.2,"3-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamino]-Phenol",JJDRRZFRTKZLFT-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
148129,6w9q,DB12978,-8.2,Pexidartinib,JGWRKYUXBBNENE-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
88958,6m3m,DB15186,-8.2,GDC-0084,LGWACEZVCMBSKW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87257,6m3m,DB12063,-8.2,CERC-301,RECBFDWSXWAXHY-IAGOWNOFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
130223,6w4h,DB11949,-8.2,Vestipitant,SBBYBXSFWOLDDG-JLTOFOAXSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
62831,6crv,DB14539,-8.2,Hydrocortisone acetate,ALEXXDVDDISNDU-JZYPGELDSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61879,6crv,DB12733,-8.2,Dipraglurant,LZXMUJCJAWVHPZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88839,6m3m,DB14906,-8.2,Adafosbuvir,NIJYGVDQZBBONK-SEUXLIJBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
112161,6vxx,DB06460,-8.2,Enrasentan,GLCKXJLCYIJMRB-UPRLRBBYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88849,6m3m,DB14932,-8.2,Coleneuramide,CHMRTBYTCBDIRG-JQZMMWJVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
130207,6w4h,DB11925,-8.2,Vistusertib,JUSFANSTBFGBAF-IRXDYDNUSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130345,6w4h,DB12129,-8.2,Tideglusib,PMJIHLSCWIDGMD-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130206,6w4h,DB11923,-8.2,Decoglurant,DMJHZVARRXJSEG-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
88715,6m3m,DB14651,-8.2,Perphenazine enanthate,PWEGQJCIAMJJHC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87412,6m3m,DB12286,-8.2,Simendan,WHXMKTBCFHIYNQ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
130188,6w4h,DB11900,-8.2,OC-459,FATGTHLOZSXOBC-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
62811,6crv,DB14209,-8.2,Trandolaprilat,AHYHTSYNOHNUSH-HXFGRODQSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
147802,6w9q,DB12465,-8.2,Ketanserin,FPCCSQOGAWCVBH-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
16005,6lzg,DB02269,-8.2,[4-({[5-Benzyloxy-1-(3-Carbamimidoyl-Benzyl)-1h-Indole-2-Carbonyl]-Amino}-Methyl)-Phenyl]-Trimethyl-Ammonium,UFKJQTGPBFWMGT-UHFFFAOYSA-O,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
62824,6crv,DB14476,-8.2,DL-alpha-Tocopherol,GVJHHUAWPYXKBD-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130177,6w4h,DB11885,-8.2,Anlotinib,KSMZEXLVHXZPEF-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130191,6w4h,DB11903,-8.2,GW842166,TWQYWUXBZHPIIV-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
149695,6wiq,DB00471,-8.2,Montelukast,UCHDWCPVSPXUMX-TZIWLTJVSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
62927,6crv,DB14736,-8.2,Cannabivarin,SVTKBAIRFMXQQF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61613,6crv,DB12332,-8.2,Rucaparib,HMABYWSNWIZPAG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
131410,6w4h,DB13708,-8.2,Fenquizone,DBDTUXMDTSTPQZ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
147404,6w9q,DB11892,-8.2,Prulifloxacin,PWNMXPDKBYZCOO-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
123291,6w4b,DB15247,-8.2,Vorolanib,KMIOJWCYOHBUJS-HAKPAVFJSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
63033,6crv,DB14998,-8.2,Olorinab,ACSQLTBPYZSGBA-GMXVVIOVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
147406,6w9q,DB11894,-8.2,Efatutazone,JCYNMRJCUYVDBC-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
87589,6m3m,DB12540,-8.2,Lecozotan,NRPQELCNMADTOZ-OAQYLSRUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
130614,6w4h,DB12515,-8.2,9-aminocamptothecin,FUXVKZWTXQUGMW-FQEVSTJZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
90557,6m71,DB01893,-8.2,N6-Benzyl Adenosine-5'-Diphosphate,MRHGMAGSDAQUFH-LSCFUAHRSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
90534,6m71,DB01860,-8.2,Cordycepin Triphosphate,NLIHPCYXRYQPSD-BAJZRUMYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
145199,6w9q,DB07074,-8.2,6-CARBAMIMIDOYL-4-(3-HYDROXY-2-METHYL-BENZOYLAMINO)-NAPHTHALENE-2-CARBOXYLIC ACID METHYL ESTER,OUBRALHIKGRAMA-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
90461,6m71,DB01764,-8.2,Dalfopristin,SUYRLXYYZQTJHF-VMBLUXKRSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
88283,6m3m,DB13593,-8.2,Zolimidine,VSLIUWLPFRVCDL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
14815,6lzg,T3D4771,-8.2,Celecoxib,RZEKVGVHFLEQIL-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
90406,6m71,DB01691,-8.2,Indole Naphthyridinone,VAZMNDXVXVUKFY-JXMROGBWSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
88293,6m3m,DB13606,-8.2,Phenazocine,ZQHYKVKNPWDQSL-KNXBSLHKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
24866,6cs2,DB00346,-8.2,Alfuzosin,WNMJYKCGWZFFKR-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
90383,6m71,DB01661,-8.2,1-(5-phospho-D-ribosyl)-ATP,RKNHJBVBFHDXGR-MRUDJCSFSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
121971,6w4b,DB12673,-8.2,ATX-914,ALANRBCCCQEPFZ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
28770,6cs2,DB08385,-8.2,4-(quinolin-3-ylmethyl)piperidine-1-carboxylic acid,QUAGUFNCKDDJFZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
129702,6w4h,DB09198,-8.2,Lobeglitazone,CHHXEZSCHQVSRE-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
145257,6w9q,DB07141,-8.2,"5-[(3R)-3-(5-methoxy-4'-methylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",QVXYJVHNRPNRJL-HNNXBMFYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
61507,6crv,DB12188,-8.2,Zicronapine,BYPMJBXPNZMNQD-PZJWPPBQSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
145244,6w9q,DB07126,-8.2,O6-CYCLOHEXYLMETHOXY-2-(4'-SULPHAMOYLANILINO) PURINE,OWXORKPNCHJYOF-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
32838,6cs2,T3D3752,-8.2,Arisugacin A,PNHIMPBISRQKHV-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
131531,6w4h,DB13866,-8.2,Etynodiol,JYILPERKVHXLNF-QMNUTNMBSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
28766,6cs2,DB08379,-8.2,6-(4-chloro-2-fluoro-3-phenoxybenzyl)pyridazin-3(2H)-one,NOVPOXGMADEKPP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
149279,6w9q,DB15294,-8.2,SB-1578,NNXDIGHYPZHXTR-ONEGZZNKSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
24859,6cs2,DB02668,-8.2,"Je-2147, Ag1776, Kni-764",CUFQBQOBLVLKRF-RZDMPUFOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
129687,6w4h,DB09183,-8.2,Dasabuvir,NBRBXGKOEOGLOI-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
111842,6vxx,DB04771,-8.2,1-GUANIDINO-4-(N-NITRO-BENZOYLAMINO-L-LEUCYL-L-PROLYLAMINO)BUTANE,FIZYZWLGMGGGBJ-OALUTQOASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62031,6crv,DB12977,-8.2,Simenepag isopropyl,MSIIJNOQQWRTFC-GGAORHGYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
132336,6w9c,DB00304,-8.2,Desogestrel,RPLCPCMSCLEKRS-BPIQYHPVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
63042,6crv,DB15024,-8.2,Apararenone,AZNHWXAFPBYFGH-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
90733,6m71,DB02128,-8.2,[1-(3-Hydroxy-2-Oxo-1-Phenethyl-Propylcarbamoyl)2-Phenyl-Ethyl]-Carbamic Acid Pyridin-4-Ylmethyl Ester,QCUBCTPTNWPFBC-ZEQRLZLVSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
111879,6vxx,DB04820,-8.2,Nialamide,NOIIUHRQUVNIDD-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
149350,6w9q,DB15442,-8.2,Trilaciclib,PDGKHKMBHVFCMG-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
29039,6cs2,DB00808,-8.2,Indapamide,NDDAHWYSQHTHNT-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
93449,6m71,DB06963,-8.2,"3-[3-(3-methyl-6-{[(1S)-1-phenylethyl]amino}-1H-pyrazolo[4,3-c]pyridin-1-yl)phenyl]propanamide",ZFGCLYUGFRNYFE-INIZCTEOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
86895,6m3m,DB11446,-8.2,Oxfendazole,BEZZFPOZAYTVHN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
111345,6vxx,DB03534,-8.2,3-[(Acetyl-Methyl-Amino)-Methyl]-4-Amino-N-Methyl-N-(1-Methyl-1h-Indol-2-Ylmethyl)-Benzamide,AWTBJNJPBKTHEV-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61427,6crv,DB12071,-8.2,Vabicaserin,NPTIPEQJIDTVKR-STQMWFEESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
147371,6w9q,DB11841,-8.2,Entinostat,INVTYAOGFAGBOE-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
91011,6m71,DB02491,-8.2,4-[4-(1-Amino-1-Methylethyl)Phenyl]-5-Chloro-N-[4-(2-Morpholin-4-Ylethyl)Phenyl]Pyrimidin-2-Amine,CJSSYVIHFXDFFC-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
28932,6cs2,DB08557,-8.2,"2-[(2-methoxyethyl)amino]-4-(4-oxo-1,2,3,4-tetrahydro-9H-carbazol-9-yl)benzamide",XQKFKSJUBJPOLY-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
32831,6cs2,T3D3745,-8.2,Territrem B,PBXNNDFKPQPJBB-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
87618,6m3m,DB12582,-8.2,Piperine,MXXWOMGUGJBKIW-YPCIICBESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
62073,6crv,DB13044,-8.2,Gossypol,QBKSWRVVCFFDOT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
91063,6m71,DB02554,-8.2,"Sulfoquinovose-Uridine-C1,5'-Diphosphate",FQANCGQCBCUSMI-JZMIEXBBSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
146643,6w9q,DB08772,-8.2,"3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL-2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID",BCSVCWVQNOXFGL-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
86889,6m3m,DB11433,-8.2,Nequinate,NNOPDLNHPOLRRE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86980,6m3m,DB11654,-8.2,T-2000,RRFBTKHQZRCRSS-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
62495,6crv,DB13657,-8.2,Benorilate,FEJKLNWAOXSSNR-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
9390,6lzg,DB07486,-8.2,"3-({4-[(1E)-3-morpholin-4-yl-3-oxoprop-1-en-1-yl]-2,3-bis(trifluoromethyl)phenyl}sulfanyl)aniline",KLSZVPNVFKKIRD-FNORWQNLSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
86929,6m3m,DB11520,-8.2,Hygromycin B,GRRNUXAQVGOGFE-HUCHGKBZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
111433,6vxx,DB03865,-8.2,6-Chloro-2-(2-Hydroxy-Biphenyl-3-Yl)-1h-Indole-5-Carboxamidine,FEKRWNWZMOSVBX-UHFFFAOYSA-O,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86927,6m3m,DB11518,-8.2,Flunixin,NOOCSNJCXJYGPE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
111381,6vxx,DB03798,-8.2,2'-Deoxycytidine-5'-Monophosphate,NCMVOABPESMRCP-SHYZEUOFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62049,6crv,DB13008,-8.2,"2,2-bis(4-hydroxy-3-tert-butylphenyl)propane",ZDRSNHRWLQQICP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
132367,6w9c,DB00343,-8.2,Diltiazem,HSUGRBWQSSZJOP-RTWAWAEBSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
62497,6crv,DB13660,-8.2,Propicillin,HOCWPKXKMNXINF-XQERAMJGSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
90815,6m71,DB02241,-8.2,"8-Benzyl-2-Hydroperoxy-2-(4-Hydroxy-Benzyl)-6-(4-Hydroxy-Phenyl)-2h-Imidazo[1,2-a]Pyrazin-3-One",HOSWCJDTHOAORT-SANMLTNESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
131377,6w4h,DB13664,-8.2,Formocortal,QNXUUBBKHBYRFW-QWAPGEGQSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
111882,6vxx,DB04823,-8.2,Oxyphenisatin,SJDACOMXKWHBOW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
131353,6w4h,DB13631,-8.2,Methoserpidine,ULBNWNUHGJLQHO-VKMIBBQISA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
145034,6w9q,DB06883,-8.2,1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-phenylurea,DHNYNLNKNQJSHF-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
111366,6vxx,DB03572,-8.2,FR230513,URGFTPMACWKJKU-OAHLLOKOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111883,6vxx,DB04824,-8.2,Phenolphthalein,KJFMBFZCATUALV-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
24900,6cs2,DB02715,-8.2,Compound 18,UZOOIPXOYYJULJ-RHLLTPQKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
149256,6w9q,DB15246,-8.2,Salvianolic acid A,YMGFTDKNIWPMGF-UCPJVGPRSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
87584,6m3m,DB12533,-8.2,Cevipabulin,ZUZPCOQWSYNWLU-VIFPVBQESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88330,6m3m,DB13657,-8.2,Benorilate,FEJKLNWAOXSSNR-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
5941,6lzg,HMDB0112262,-8.2,gamma-Carotene,HRQKOYFGHJYEFS-BXOLYSJBSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
145579,6w9q,DB07514,-8.2,"3-(2-aminoquinazolin-6-yl)-1-(3,3-dimethylindolin-6-yl)-4-methylpyridin-2(1H)-one",LHLGUOHREUTYTO-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
88447,6m3m,DB13808,-8.2,Mebhydrolin,FQQIIPAOSKSOJM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87064,6m3m,DB11781,-8.2,Tosedostat,FWFGIHPGRQZWIW-SQNIBIBYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
131703,6w4h,DB14512,-8.2,Mometasone furoate,WOFMFGQZHJDGCX-ZULDAHANSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
145528,6w9q,DB07453,-8.2,2-PHENYL-4H-BENZO[H]CHROMEN-4-ONE,VFMMPHCGEFXGIP-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
145598,6w9q,DB07536,-8.2,"N-{(1S,2R)-2-hydroxy-1-[(hydroxyamino)carbonyl]propyl}-4-{[4-(morpholin-4-ylmethyl)phenyl]ethynyl}benzamide",FQYBTYFKOHPWQT-VGSWGCGISA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
123360,6w4b,DB15396,-8.2,PF-114,SLIVDYMORZGPLW-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
87053,6m3m,DB11765,-8.2,PF-04991532,GKMLFBRLRVQVJO-ZDUSSCGKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
89735,6m71,DB00836,-8.2,Loperamide,RDOIQAHITMMDAJ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
111542,6vxx,DB04010,-8.2,2-(3'-Methoxyphenyl) Benzimidazole-4-Carboxamide,NVVWVYYHTKCIAE-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
89769,6m71,DB00875,-8.2,Flupentixol,NJMYODHXAKYRHW-DVZOWYKESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
62976,6crv,DB14857,-8.2,Avadomide,RSNPAKAFCAAMBH-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
33265,6cs2,T3D4438,-8.2,Coproporphyrinogen III,NIUVHXTXUXOFEB-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
61992,6crv,DB12919,-8.2,T-62,OTZVBZFYMFTYKH-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88381,6m3m,DB13721,-8.2,Cypermethrin,KAATUXNTWXVJKI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88474,6m3m,DB13844,-8.2,Pipenzolate,WPUKUEMZZRVAKZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
122070,6w4b,DB12836,-8.2,Grapiprant,HZVLFTCYCLXTGV-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
132042,6w4h,DB15265,-8.2,USL-311,XNUNVQKARNSSEO-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
149114,6w9q,DB14935,-8.2,Serabelisib,BLGWHBSBBJNKJO-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
89391,6m71,DB00421,-8.2,Spironolactone,LXMSZDCAJNLERA-ZHYRCANASA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
122819,6w4b,DB13950,-8.2,WIN 55212-2,HQVHOQAKMCMIIM-HXUWFJFHSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
122822,6w4b,DB13953,-8.2,Estradiol benzoate,UYIFTLBWAOGQBI-BZDYCCQFSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
87130,6m3m,DB11875,-8.2,"3,3'-diindolylmethane",VFTRKSBEFQDZKX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
145655,6w9q,DB07608,-8.2,N-(5-{[(2S)-4-amino-2-(3-chlorophenyl)butanoyl]amino}-1H-indazol-3-yl)benzamide,JDGOPNUGILVNJZ-IBGZPJMESA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
147571,6w9q,DB12134,-8.2,Gepotidacin,PZFAZQUREQIODZ-LJQANCHMSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
62613,6crv,DB13810,-8.2,Dimemorfan,KBEZZLAAKIIPFK-NJAFHUGGSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
32852,6cs2,T3D3767,-8.2,Lolitrem B,HGBZMCXKHKZYBF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
132086,6w4h,DB15346,-8.2,GLPG-1205,IRBAWVGZNJIROV-SFHVURJKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
62951,6crv,DB14791,-8.2,GDC-0425,XEZLBMHDUXSICI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
89530,6m71,DB00591,-8.2,Fluocinolone acetonide,FEBLZLNTKCEFIT-VSXGLTOVSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
87495,6m3m,DB12402,-8.2,Pumosetrag,AFUWQWYPPZFWCO-LBPRGKRZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
89454,6m71,DB00496,-8.2,Darifenacin,HXGBXQDTNZMWGS-RUZDIDTESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
149066,6w9q,DB14845,-8.2,Filgotinib,RIJLVEAXPNLDTC-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
132204,6w9c,DB00153,-8.2,Ergocalciferol,MECHNRXZTMCUDQ-RKHKHRCZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
132227,6w9c,DB00177,-8.2,Valsartan,ACWBQPMHZXGDFX-QFIPXVFZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
145392,6w9q,DB07296,-8.2,(5Z)-3-(4-CHLOROPHENYL)-4-HYDROXY-5-(1-NAPHTHYLMETHYLENE)FURAN-2(5H)-ONE,PLGHLEBIWUQEPR-PDGQHHTCSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
88345,6m3m,DB13674,-8.2,Cridanimod,UOMKBIIXHQIERR-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
90074,6m71,DB01222,-8.2,Budesonide,VOVIALXJUBGFJZ-KWVAZRHASA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
9410,6lzg,DB07507,-8.2,"2-(4-hydroxybiphenyl-3-yl)-4-methyl-1H-isoindole-1,3(2H)-dione",ROMNEYAQUBNRLR-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
90099,6m71,DB01259,-8.2,Lapatinib,BCFGMOOMADDAQU-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
28774,6cs2,DB08389,-8.2,"6,7-DIMETHOXY-4-[(3R)-3-(2-NAPHTHYLOXY)PYRROLIDIN-1-YL]QUINAZOLINE",UPTQSRGSSJRBKJ-LJQANCHMSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
149225,6w9q,DB15192,-8.2,ABT-288,GNIRITULTPTAQW-KNQAVFIVSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
62527,6crv,DB13693,-8.2,Sulbenicillin,JETQIUPBHQNHNZ-NJBDSQKTSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
131548,6w4h,DB13927,-8.2,anle138b,RCQIIBJSUWYYFU-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
145319,6w9q,DB07212,-8.2,N-(7-CARBAMIMIDOYL-NAPHTHALEN-1-YL)-3-HYDROXY-2-METHYL-BENZAMIDE,NNGZRCYXFBHMRM-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
90135,6m71,DB01339,-8.2,Vecuronium,BGSZAXLLHYERSY-XQIGCQGXSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
88332,6m3m,DB13660,-8.2,Propicillin,HOCWPKXKMNXINF-XQERAMJGSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
149255,6w9q,DB15245,-8.2,Olorofim,SUFPWYYDCOKDLL-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
112333,6vxx,DB06985,-8.2,2-[({4-[2-(trifluoromethyl)phenyl]piperidin-1-yl}carbonyl)amino]benzoic acid,MEAQCLPMSVEOQF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62020,6crv,DB12960,-8.2,INCB-9471,ZMCJFJZOSKEMOM-DNKZPPIMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62980,6crv,DB14866,-8.2,Amcasertib,QDWKGEFGLQMDAM-ULJHMMPZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
146563,6w9q,DB08683,-8.2,"REL-(9R,12S)-9,10,11,12-TETRAHYDRO-9,12-EPOXY-1H-DIINDOLO[1,2,3-FG:3',2',1'-KL]PYRROLO[3,4-I][1,6]BENZODIAZOCINE-1,3(2H)-DIONE",OTPNDVKVEAIXTI-IYBDPMFKSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
87551,6m3m,DB12478,-8.2,Piribedil,OQDPVLVUJFGPGQ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
89874,6m71,DB00997,-8.2,Doxorubicin,AOJJSUZBOXZQNB-TZSSRYMLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
87517,6m3m,DB12429,-8.2,CI-1040,GFMMXOIFOQCCGU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
145420,6w9q,DB07326,-8.2,"6-chloro-N-pyrimidin-5-yl-3-{[3-(trifluoromethyl)phenyl]amino}-1,2-benzisoxazole-7-carboxamide",FEGRQUWSKADGSP-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
129718,6w4h,DB09215,-8.2,Droxicam,OEHFRZLKGRKFAS-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
90032,6m71,DB01177,-8.2,Idarubicin,XDXDZDZNSLXDNA-TZNDIEGXSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
90039,6m71,DB01184,-8.2,Domperidone,FGXWKSZFVQUSTL-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
149222,6w9q,DB15189,-8.2,Birabresib,GNMUEVRJHCWKTO-FQEVSTJZSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
112301,6vxx,DB06942,-8.2,N-(4-carbamimidoylbenzyl)-1-(3-phenylpropanoyl)-L-prolinamide,RNZKCCPFUWHBFY-IBGZPJMESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
123372,6w4b,DB15414,-8.2,CM-4307,MLDQJTXFUGDVEO-FIBGUPNXSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
130584,6w4h,DB12468,-8.2,Pf-04531083,ZRJGMDIPCQOGNI-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
132261,6w9c,DB00218,-8.2,Moxifloxacin,FABPRXSRWADJSP-MEDUHNTESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
90072,6m71,DB01219,-8.2,Dantrolene,OZOMQRBLCMDCEG-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
147468,6w9q,DB11986,-8.2,Entrectinib,HAYYBYPASCDWEQ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
131588,6w4h,DB13993,-8.2,MRK-409,GOIFCXRIFSYPFG-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
88362,6m3m,DB13693,-8.2,Sulbenicillin,JETQIUPBHQNHNZ-NJBDSQKTSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88218,6m3m,DB13502,-8.2,Budipine,QIHLUZAFSSMXHQ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136789,6w9c,DB07534,-8.2,"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE",BKUMVXIXUVYKDQ-GHXNOFRVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
93487,6m71,DB07006,-8.2,"9-HYDROXY-6-(3-HYDROXYPROPYL)-4-(2-METHOXYPHENYL)PYRROLO[3,4-C]CARBAZOLE-1,3(2H,6H)-DIONE",AOGOZJCRIFBTTN-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
104759,6vxs,DB12461,-8.2,GLPG-0492,VAJGULUVTFDTAS-GOSISDBHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
26970,6cs2,DB06166,-8.2,Fosdevirine,CGBYTKOSZYQOPV-CCEZBSFNSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
104764,6vxs,DB12467,-8.2,TU-100,KAYRGFYBCCETPE-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
164471,7bv1,DB08043,-8.2,1-[4-(PYRIDIN-4-YLOXY)PHENYL]-3-[3-(TRIFLUOROMETHYL)PHENYL]UREA,DDDLGNOZDKDSEG-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
127924,6w4h,DB07015,-8.2,"(3R,4R)-4-(pyrrolidin-1-ylcarbonyl)-1-(quinoxalin-2-ylcarbonyl)pyrrolidin-3-amine",XDSKICAQKGYYJF-OLZOCXBDSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
127923,6w4h,DB07014,-8.2,"2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4-methoxybenzyl)sulfanyl]-1,3,4-oxadiazole",TUTZKAQTSPMEBI-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
104822,6vxs,DB12557,-8.2,FK-614,UYGZODVVDUIDDQ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104825,6vxs,DB12562,-8.2,Setipiprant,IHAXLPDVOWLUOS-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
125208,6w4h,DB02194,-8.2,"8-Benzyl-2-Hydroxy-2-(4-Hydroxy-Benzyl)-6-(4-Hydroxy-Phenyl)-2h-Imidazo[1,2-a]Pyrazin-3-One",ULLMMKZQNNBLRN-SANMLTNESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
104849,6vxs,DB12597,-8.2,ABL-001,VOVZXURTCKPRDQ-CQSZACIVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
161992,7bv1,DB01058,-8.2,Praziquantel,FSVJFNAIGNNGKK-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
127918,6w4h,DB07007,-8.2,"(3R)-3-[(1,2,3,4-tetrahydroisoquinolin-7-yloxy)methyl]-2,3-dihydrothieno[2,3-f][1,4]oxazepin-5-amine",UDFXWCLBONUMNA-CYBMUJFWSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
127911,6w4h,DB07000,-8.2,"N-{2,4-difluoro-3-[(5-pyridin-3-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)carbonyl]phenyl}ethanesulfonamide",ILXJWLWSYAWJKZ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
104876,6vxs,DB12645,-8.2,Givinostat,YALNUENQHAQXEA-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104903,6vxs,DB12685,-8.2,K-134,ULGNGSQNNMKROG-WOJBJXKFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
11857,6lzg,DB12524,-8.2,BI-671800,XEOSTBFUCNZKGS-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
28129,6cs2,DB07707,-8.2,"(9BETA,11ALPHA,13ALPHA,14BETA,17ALPHA)-11-(METHOXYMETHYL)ESTRA-1(10),2,4-TRIENE-3,17-DIOL",LEOPSILMAOYZBO-IUTAEKPZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
11839,6lzg,DB12500,-8.2,Fedratinib,JOOXLOJCABQBSG-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
127876,6w4h,DB06955,-8.2,"3,4-bis(7-chloro-1H-indol-3-yl)-1H-pyrrole-2,5-dicarboxylic acid",OAMCCJASDLMTOO-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
104989,6vxs,DB12825,-8.2,Lefamulin,KPVIXBKIJXZQJX-FCEONZPQSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
162037,7bv1,DB01337,-8.2,Pancuronium,GVEAYVLWDAFXET-XGHATYIMSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
105008,6vxs,DB12857,-8.2,NVP-LEQ-506,POERAARDVFVDLO-QGZVFWFLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
127868,6w4h,DB06945,-8.2,N-hydroxy-4-({4-[4-(trifluoromethyl)phenoxy]phenyl}sulfonyl)tetrahydro-2H-pyran-4-carboxamide,FOSWRYKPHVPIDJ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
105012,6vxs,DB12867,-8.2,Benperidol,FEBOTPHFXYHVPL-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
58103,6crv,DB04554,-8.2,8-Bromoadenosine-5'-Diphosphate,KVVVTFSHHQCHNZ-UUOKFMHZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127931,6w4h,DB07024,-8.2,"2-(3,4-DIHYDROXYPHENYL)-8-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-3-HYDROXY-6-METHYL-4H-CHROMEN-4-ONE",CEXBEGBNDJVZPK-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
104740,6vxs,DB12430,-8.2,BC-3781,KPVIXBKIJXZQJX-IJUBVZAWSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
127951,6w4h,DB07045,-8.2,"(2R,3R,4S,5R)-2-[6-amino-8-[(3,4-dichlorophenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol",VBJKVZXRYLCYGQ-XNIJJKJLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
11968,6lzg,DB12686,-8.2,PHA-793887,HUXYBQXJVXOMKX-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
104445,6vxs,DB12010,-8.2,Fostamatinib,GKDRMWXFWHEQQT-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
28169,6cs2,DB07750,-8.2,"(2R)-1-[4-({4-[(2,5-Dichlorophenyl)amino]-2-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol",GNLAGGCSJGJECE-MRXNPFEDSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
55430,6crv,DB00997,-8.2,Doxorubicin,AOJJSUZBOXZQNB-TZSSRYMLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55433,6crv,DB01000,-8.2,Cyclacillin,HGBLNBBNRORJKI-WCABBAIRSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104464,6vxs,DB12043,-8.2,Sepetaprost,BKVUSNOUTQMSBE-XCMGCKIWSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
161524,7bv1,DB15009,-8.2,PF-04937319,MASKQITXHVYVFL-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
104492,6vxs,DB12082,-8.2,Vesnarinone,ZVNYJIZDIRKMBF-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
161534,7bv1,DB15031,-8.2,Nemorexant,NBGABHGMJVIVBW-QHCPKHFHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
104527,6vxs,DB12130,-8.2,Lorlatinib,IIXWYSCJSQVBQM-LLVKDONJSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
161542,7bv1,DB15046,-8.2,LY-2881835,FHRWHNJJQGSCQC-LJAQVGFWSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
128009,6w4h,DB07113,-8.2,"(2S)-6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2-(3,5-DIFLUOROPHENYL)-4-(3-METHOXYPROPYL)-2H-1,4-BENZOXAZIN-3(4H)-ONE",KHZQOXQOUCGGGA-NRFANRHFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
58361,6crv,DB04892,-8.2,Phenserine,PBHFNBQPZCRWQP-QUCCMNQESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58101,6crv,DB04552,-8.2,Niflumic acid,JZFPYUNJRRFVQU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58360,6crv,DB04891,-8.2,Becocalcidiol,QSLUXQQUPXBIHH-YHSKWIAJSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
12019,6lzg,DB12756,-8.2,TAK-901,WKDACQVEJIVHMZ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
104555,6vxs,DB12174,-8.2,CUDC-101,PLIVFNIUGLLCEK-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104557,6vxs,DB12180,-8.2,Apitolisib,YOVVNQKCSKSHKT-HNNXBMFYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104568,6vxs,DB12194,-8.2,Atamestane,PEPMWUSGRKINHX-TXTPUJOMSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104578,6vxs,DB12211,-8.2,PSI-697,DIEPFYNZGUUVHD-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
26911,6cs2,DB05861,-8.2,Tasquinimod,ONDYALNGTUAJDX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
58335,6crv,DB04861,-8.2,Nebivolol,KOHIRBRYDXPAMZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109184,6vxx,DB12492,-8.2,Piritramide,IHEHEFLXQFOQJO-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58315,6crv,DB04834,-8.2,Rapacuronium,HTIKWNNIPGXLGM-YLINKJIISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109172,6vxx,DB12474,-8.2,Lynestrenol,YNVGQYHLRCDXFQ-XGXHKTLJSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
161746,7bv1,DB00549,-8.2,Zafirlukast,YEEZWCHGZNKEEK-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
58302,6crv,DB04821,-8.2,Nomifensine,XXPANQJNYNUNES-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
10274,6lzg,DB08454,-8.2,N-(5-METHYL-1H-PYRAZOL-3-YL)-2-PHENYLQUINAZOLIN-4-AMINE,JYCUVOXSZBECAY-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
104438,6vxs,DB12002,-8.2,AZD-4818,HVTUHSABWJPWNK-SFHVURJKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
105041,6vxs,DB12904,-8.2,ZSTK-474,HGVNLRPZOWWDKD-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
109122,6vxx,DB12405,-8.2,Triciribine,HOGVTUZUJGHKPL-HTVVRFAVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27127,6cs2,DB06525,-8.2,Ganstigmine,ZOBDWFRKFSPCRB-UNMCSNQZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
27129,6cs2,DB06529,-8.2,Ocinaplon,OQJFBUOFGHPMSR-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
162299,7bv1,DB01864,-8.2,5'-Guanosine-Diphosphate-Monothiophosphate,XOFLBQFBSOEHOG-UUOKFMHZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
10377,6lzg,DB08569,-8.2,"3-PYRIDIN-4-YL-2,4-DIHYDRO-INDENO[1,2-.C.] PYRAZOLE",VLPMRZSKJUTRBQ-IBGZPJMESA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
57844,6crv,DB04201,-8.2,Histidyl-Adenosine Monophosphate,XTFBSLZFYLGYAT-OPYVMVOTSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109049,6vxx,DB11960,-8.2,Carboxyamidotriazole,WNRZHQBJSXRYJK-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109047,6vxx,DB11957,-8.2,Idalopirdine,YBAWYTYNMZWMMJ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
105750,6vxs,DB13955,-8.2,Estradiol dienanthate,OVAHZPTYWMWNKO-CAHAWPIUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
162375,7bv1,DB01972,-8.2,Guanosine-5'-Monophosphate,RQFCJASXJCIDSX-UUOKFMHZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
105752,6vxs,DB13957,-8.2,J147,HYMZAYGFKNNHDN-SSDVNMTOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
11660,6lzg,DB12269,-8.2,PF-06273340,BPIWZDNVMQQBQX-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
11658,6lzg,DB12267,-8.2,Brigatinib,AILRADAXUVEEIR-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
105866,6vxs,DB14207,-8.2,Fosinoprilat,WOIWWYDXDVSWAZ-RTWAWAEBSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
11642,6lzg,DB12242,-8.2,AZD-7762,IAYGCINLNONXHY-LBPRGKRZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
28076,6cs2,DB07649,-8.2,"(3R,4S)-1-[(4-amino-5H-pyrrolo[3,2-d]pyrimidin-7-yl)methyl]-4-[(benzylsulfanyl)methyl]pyrrolidin-3-ol",DIGGNILBPCEZIV-CVEARBPZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
105897,6vxs,DB14555,-8.2,Ursadiol,RTLXJEJRLWILSU-GWNGJUQLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
125459,6w4h,DB02511,-8.2,2-Hydroxy-5-({1-[(2-Naphthyloxy)Methyl]-3-Oxoprop-1-Enyl}Amino)Tyrosine,PZWMZAFFUAWVDN-CQXYXCHQSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
57731,6crv,DB04059,-8.2,8-(Pyrimidin-2-Ylamino)Naphthalene-2-Carboximidamide,GRQLDCHTDNYVQI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55577,6crv,DB01165,-8.2,Ofloxacin,GSDSWSVVBLHKDQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
105962,6vxs,DB14677,-8.2,Gestonorone caproate,XURCMZMFZXXQDJ-UKNJCJGYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
105979,6vxs,DB14726,-8.2,Dabigatran,YBSJFWOBGCMAKL-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
105995,6vxs,DB14765,-8.2,Rivoceranib,WPEWQEMJFLWMLV-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
162538,7bv1,DB02398,-8.2,6-[N-(4-(Aminomethyl)Phenyl)Carbamyl]-2-Naphthalenecarboxamidine,NLBDETRVUYOIHQ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
162540,7bv1,DB02400,-8.2,"5-Methoxy-1,2-Dimethyl-3-(4-Nitrophenoxymethyl)Indole-4,7-Dione",IBLWSLZYYZHSRG-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
105998,6vxs,DB14769,-8.2,Pamiparib,DENYZIUJOTUUNY-MRXNPFEDSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
11693,6lzg,DB12306,-8.2,Cipargamin,CKLPLPZSUQEDRT-WPCRTTGESA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
162284,7bv1,DB01842,-8.2,3'-Phosphate-Adenosine-5'-Diphosphate,GBBWIZKLHXYJOA-KQYNXXCUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
105538,6vxs,DB13638,-8.2,Cefbuperazone,SMSRCGPDNDCXFR-CYWZMYCQSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
125366,6w4h,DB02398,-8.2,6-[N-(4-(Aminomethyl)Phenyl)Carbamyl]-2-Naphthalenecarboxamidine,NLBDETRVUYOIHQ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
109117,6vxx,DB12399,-8.2,Polmacoxib,IJWPAFMIFNSIGD-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109112,6vxx,DB12392,-8.2,Resminostat,FECGNJPYVFEKOD-VMPITWQZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
105128,6vxs,DB13040,-8.2,Gandotinib,SQSZANZGUXWJEA-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
10328,6lzg,DB08512,-8.2,"6-amino-2-[(1-naphthylmethyl)amino]-3,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",MCEZMMDIEXECTI-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
127808,6w4h,DB06879,-8.2,"5-(4'-AMINO-1'-ETHYL-5',8'-DIFLUORO-1'H-SPIRO[PIPERIDINE-4,2'-QUINAZOLINE]-1-YLCARBONYL)PICOLINONITRILE",QCFIRACCCDFXIP-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
10330,6lzg,DB08514,-8.2,"6-amino-2-[(thiophen-2-ylmethyl)amino]-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",IQKMJWDYMFWZRF-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
11758,6lzg,DB12394,-8.2,Eleclazine,YNUAEEJQYHYLMS-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
125318,6w4h,DB02338,-8.2,Nadph Dihydro-Nicotinamide-Adenine-Dinucleotidephosphate,ACFIXJIJDZMPPO-NNYOXOHSSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
55524,6crv,DB01102,-8.2,Arbutamine,IIRWWTKISYTTBL-SFHVURJKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
11745,6lzg,DB12379,-8.2,Indirubin,CRDNMYFJWFXOCH-BUHFOSPRSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
105171,6vxs,DB13102,-8.2,AZD-8418,MCPBSUCAISQZQK-JTQLQIEISA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
127784,6w4h,DB06849,-8.2,"1-[1'-(3-phenylacryloyl)spiro[1-benzofuran-3,4'-piperidin]-5-yl]methanamine",RQWYWHUKHYFIPB-VQHVLOKHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
58077,6crv,DB04520,-8.2,"(3s,8ar)-3-(4-Hydroxybenzyl)Hexahydropyrrolo[1,2-a]Pyrazine-1,4-Dione",LSGOTAXPWMCUCK-RYUDHWBXSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
162155,7bv1,DB01503,-8.2,1-Androstenediol,RZFGPAMUAXASRE-YSZCXEEOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
105346,6vxs,DB13371,-8.2,Difenpiramide,PWHROYKAGRUWDQ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
57945,6crv,DB04338,-8.2,SB220025,VSPFURGQAYMVAN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
105355,6vxs,DB13386,-8.2,Epimestrol,UHQGCIIQUZBJAE-RRQVMCLOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
162226,7bv1,DB01767,-8.2,Hemi-Babim,KKJYVDXDZURHMA-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
27106,6cs2,DB06472,-8.2,Fradafiban,IKZACQMAVUIGPY-HOTGVXAUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
57901,6crv,DB04278,-8.2,2-[2-(2-Cyclohexyl-2-Guanidino-Acetylamino)-Acetylamino]-N-(3-Mercapto-Propyl)-Propionamide,YLLNYDDZOMCFDE-SMDDNHRTSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57897,6crv,DB04274,-8.2,"5,4'-Dideoxyflavanone",SWAJPHCXKPCPQZ-AWEZNQCLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
162273,7bv1,DB01830,-8.2,"{4-[2-Acetylamino-2-(3-Carbamoyl-2-Cyclohexylmethoxy-6,7,8,9-Tetrahydro-5h-Benzocyclohepten-5ylcarbamoyl)-Ethyl]-2-Phosphono-Phenyl}-Phosphonic Acid",SPSGYTWOIGAABK-DQEYMECFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
127771,6w4h,DB06831,-8.2,2-((9H-PURIN-6-YLTHIO)METHYL)-5-CHLORO-3-(2-METHOXYPHENYL)QUINAZOLIN-4(3H)-ONE,UMMYTDJYDSTEMB-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
55540,6crv,DB01123,-8.2,Proflavine,WDVSHHCDHLJJJR-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
105509,6vxs,DB13600,-8.2,Deltamethrin,OWZREIFADZCYQD-NSHGMRRFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
28099,6cs2,DB07675,-8.2,(2S)-2-ETHOXY-3-{4-[2-(10H-PHENOXAZIN-10-YL)ETHOXY]PHENYL}PROPANOIC ACID,WMUIIGVAWPWQAW-DEOSSOPVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
27095,6cs2,DB06455,-8.2,Meclinertant,DYLJVOXRWLXDIG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
12075,6lzg,DB12848,-8.2,PF-04217903,PDMUGYOXRHVNMO-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
12078,6lzg,DB12854,-8.2,BMS-908662,MMNNTJYFHUDSKL-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
104412,6vxs,DB11962,-8.2,GSK-1059615,QDITZBLZQQZVEE-YBEGLDIGSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
161087,7bv1,DB12867,-8.2,Benperidol,FEBOTPHFXYHVPL-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
103214,6vxs,DB08308,-8.2,"SUCCINIC ACID MONO-(13-METHYL-3-OXO-2,3,6,7,8,9,10,11,12,13,14,15,16,17-TETRADECAHYDRO-1H-CYCLOPENTA[A]PHENANTHREN-17-YL) ESTER",IRQUJNVGEAJGSD-KIEDKLRZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
109318,6vxx,DB13062,-8.2,ME-344,QVCAATSEPLQVBX-FPOVZHCZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
128176,6w4h,DB07303,-8.2,"N-3-[3-(5-METHOXYPYRIDIN-3-YL)BENZYL]PYRIDINE-2,3-DIAMINE",PGAWZMRRCVSRIM-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
161101,7bv1,DB12885,-8.2,CF-102,IPSYPUKKXMNCNQ-PFHKOEEOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
124942,6w4h,DB01831,-8.2,Tryptophanyl-5'amp,IFQVDHDRFCKAAW-SQIXAUHQSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
103319,6vxs,DB08439,-8.2,Parecoxib,TZRHLKRLEZJVIJ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
109309,6vxx,DB13051,-8.2,CH-5132799,JEGHXKRHKHPBJD-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
103329,6vxs,DB08449,-8.2,"2-(3-((4,5,7-trifluorobenzo[d]thiazol-2-yl)methyl)-1H-pyrrolo[2,3-b]pyridin-1-yl)acetic acid",IEVFQDJUDLCOQY-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
103355,6vxs,DB08481,-8.2,"4-METHYL-N-{(5E)-5-[(5-METHYL-2-FURYL)METHYLENE]-4-OXO-4,5-DIHYDRO-1,3-THIAZOL-2-YL}BENZENESULFONAMIDE",MXAPQGDBWFYKKX-ZROIWOOFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
103361,6vxs,DB08489,-8.2,"N4-HYDROXY-2-ISOBUTYL-N1-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.013,18]NONADECA-12(19),13,15,17-TETRAEN-10-YL)-SUCCINAMIDE",GCBPAPVOMPJQHK-NQIIRXRSSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
103367,6vxs,DB08495,-8.2,4-({4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-2-OXOPIPERAZIN-1-YL}METHYL)BENZENECARBOXIMIDAMIDE,VXONTEUOQXFJJS-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
103380,6vxs,DB08510,-8.2,5-ALPHA-PREGNANE-3-BETA-OL-HEMISUCCINATE,UVTGFMKBPVLATL-DSOJQRAMSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
164541,7bv1,DB08123,-8.2,"N-METHYL-{4-[2-(7-OXO-6,7-DIHYDRO-8H-[1,3]THIAZOLO[5,4-E]INDOL-8-YLIDENE)HYDRAZINO]PHENYL}METHANESULFONAMIDE",GEWPSTLKJDIUHW-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
103388,6vxs,DB08520,-8.2,"(21S)-1AZA-4,4-DIMETHYL-6,19-DIOXA-2,3,7,20-TETRAOXOBICYCLO[19.4.0] PENTACOSANE",VUCSBBBCFXBFFY-IBGZPJMESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
164540,7bv1,DB08122,-8.2,"N-METHYL-4-{[(2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]AMINO}BENZENESULFONAMIDE",IKASAFLVQIJQOK-UVTDQMKNSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
103409,6vxs,DB08543,-8.2,1-[2-HYDROXY-3-(4-CYCLOHEXYL-PHENOXY)-PROPYL]-4-(2-PYRIDYL)-PIPERAZINE,BZJHCQBNFUNZPJ-QFIPXVFZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
26688,6cs2,DB04872,-8.2,Osanetant,DZOJBGLFWINFBF-UMSFTDKQSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
103415,6vxs,DB08549,-8.2,"(3R)-METHYLCARBAMOYL-7-SULFOAMINO-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLIC ACID BENZYL ESTER",MFDBNNQUDZFSES-KRWDZBQOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
103467,6vxs,DB08613,-8.2,"2,2,2-TRIFLUORO-1-{5-[(3-PHENYL-5,6-DIHYDROIMIDAZO[1,2-A]PYRAZIN-7(8H)-YL)CARBONYL]THIOPHEN-2-YL}ETHANE-1,1-DIOL",OFBFUNBBOQCNFX-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
103530,6vxs,DB08694,-8.2,"9-amino-5-(2-aminopyrimidin-4-yl)pyrido[3',2':4,5]pyrrolo[1,2-c]pyrimidin-4-ol",RTHKPHCVZVYDFN-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
161248,7bv1,DB13451,-8.2,Tioclomarol,WRGOVNKNTPWHLZ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
161262,7bv1,DB13471,-8.2,Nalfurafine,XGZZHZMWIXFATA-UEZBDDGYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
58617,6crv,DB06203,-8.2,Alogliptin,ZSBOMTDTBDDKMP-OAHLLOKOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
103541,6vxs,DB08707,-8.2,"4-[3-(4-chlorophenyl)-2,1-benzisoxazol-5-yl]pyrimidin-2-amine",AQVFETGXIRKVAQ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
161086,7bv1,DB12863,-8.2,Sivelestat,BTGNGJJLZOIYID-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
55354,6crv,DB00908,-8.2,Quinidine,LOUPRKONTZGTKE-LHHVKLHASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
161078,7bv1,DB12850,-8.2,Etalocib,YFIZRWPXUYFCSN-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
103137,6vxs,DB08208,-8.2,"2-[(4-ETHYNYL-2-FLUOROPHENYL)AMINO]-3,4-DIFLUORO-N-(2-HYDROXYETHOXY)BENZAMIDE",AMNKRBRQQAMACZ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
26583,6cs2,DB00542,-8.2,Benazepril,XPCFTKFZXHTYIP-PMACEKPBSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
102908,6vxs,DB07949,-8.2,"({[(3E)-2'-OXO-2',7'-DIHYDRO-2,3'-BIINDOL-3(7H)-YLIDENE]AMINO}OXY)ACETIC ACID",BFQRPTKOSYMPOL-LALPNIDTSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
109378,6vxx,DB13491,-8.2,Fluperolone,SLVCCRYLKTYUQP-DVTGEIKXSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
10179,6lzg,DB08349,-8.2,"N-cyclopropyl-3-{[1-(2,4-difluorophenyl)-7-methyl-6-oxo-6,7-dihydro-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}-4-methylbenzamide",WMEYCLAVMZKZCS-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
55330,6crv,DB00881,-8.2,Quinapril,JSDRRTOADPPCHY-HSQYWUDLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
161020,7bv1,DB12408,-8.2,PF-03635659,WGOJWDWKHJHXSV-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
102940,6vxs,DB07986,-8.2,[4-(4-PHENYL-PIPERIDIN-1-YL)-BENZENESULFONYLAMINO]-ACETIC ACID,GNSLACGSDSJAIQ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
128208,6w4h,DB07337,-8.2,"4-[4-AMINO-6-(5-CHLORO-1H-INDOL-4-YLMETHYL)-[1,3,5]TRIAZIN-2-YLAMINO]-BENZONITRILE",SOKOHDQTKSROQZ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
28225,6cs2,DB07806,-8.2,"(2R,4S)-2-[(R)-BENZYLCARBAMOYL-PHENYLACETYL-METHYL]-5,5-DIMETHYL-THIAZOLIDINE-4-CARBOXYLIC ACID",UDMBRVGTYILYDX-SVFBPWRDSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
58744,6crv,DB06533,-8.2,Ragaglitazar,WMUIIGVAWPWQAW-XMMPIXPASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58743,6crv,DB06532,-8.2,Pafuramidine,UKOQVLAXCBRRGH-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
164550,7bv1,DB08133,-8.2,N-(4-sulfamoylphenyl)-1H-indazole-3-carboxamide,MNHPHKFLWAPNOV-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
103543,6vxs,DB08709,-8.2,"2,3-diphenyl-1H-indole-7-carboxylic acid",OLUDUXWVPIEHDA-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
58739,6crv,DB06525,-8.2,Ganstigmine,ZOBDWFRKFSPCRB-UNMCSNQZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
10186,6lzg,DB08355,-8.2,"1-methyl-8-(phenylamino)-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxylic acid",ZOBRPBVIEUWYJR-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
161035,7bv1,DB12774,-8.2,AZD-8055,KVLFRAWTRWDEDF-IRXDYDNUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
103003,6vxs,DB08056,-8.2,"N-(2,6-dimethylphenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine",KKYYLKPGILUPOA-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
103017,6vxs,DB08073,-8.2,(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE,YWTBGJGMTBHQTM-IBGZPJMESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
10190,6lzg,DB08360,-8.2,"2-(4-ETHYLPIPERAZIN-1-YL)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE",BIFHJPUTQBOBGJ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
58712,6crv,DB06457,-8.2,Tecastemizole,SFOVDSLXFUGAIV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
103038,6vxs,DB08097,-8.2,"2-(2,6-DIFLUOROPHENOXY)-N-(2-FLUOROPHENYL)-9-ISOPROPYL-9H-PURIN-8-AMINE",OGWSGDLIXOEZJG-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
103049,6vxs,DB08108,-8.2,N-({6-[(4-CYANOBENZYL)OXY]NAPHTHALEN-2-YL}SULFONYL)-D-GLUTAMIC ACID,PUHRQSFXADUGJW-OAQYLSRUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
164543,7bv1,DB08125,-8.2,"4-{[(2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]AMINO}-N-(1,3-THIAZOL-2-YL)BENZENESULFONAMIDE",BOMPRXSVSIPRDT-PTNGSMBKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
103124,6vxs,DB08191,-8.2,"4-(5-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl)benzoic acid",KSFDVNIKNYXUIP-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
58694,6crv,DB06412,-8.2,Oxymetholone,ICMWWNHDUZJFDW-DHODBPELSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
161077,7bv1,DB12848,-8.2,PF-04217903,PDMUGYOXRHVNMO-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
102990,6vxs,DB08039,-8.2,"(3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE",LOGJQOUIVKBFGH-YBEGLDIGSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
103544,6vxs,DB08710,-8.2,"(5Z)-5-[(5-ETHYL-2-FURYL)METHYLENE]-2-{[(S)-(4-FLUOROPHENYL)(1H-TETRAZOL-5-YL)METHYL]AMINO}-1,3-THIAZOL-4(5H)-ONE",BKZOQCGDCHOGOQ-MZLJFPOFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
161289,7bv1,DB13507,-8.2,Poldine,CQRKVVAGMJJJSR-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
103588,6vxs,DB08755,-8.2,N-[(1S)-2-{[(1R)-2-(benzyloxy)-1-cyano-1-methylethyl]amino}-1-(cyclohexylmethyl)-2-oxoethyl]morpholine-4-carboxamide,MQWUTQCRGGBPBT-WIOPSUGQSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
58484,6crv,DB05501,-8.2,AMD-070,WVLHHLRVNDMIAR-IBGZPJMESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
12176,6lzg,DB12996,-8.2,Acteoside,FBSKJMQYURKNSU-ZLSOWSIRSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
109260,6vxx,DB12972,-8.2,Sepranolone,AURFZBICLPNKBZ-FZCSVUEKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
12158,6lzg,DB12966,-8.2,Falnidamol,FTFRZXFNZVCRSK-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
161468,7bv1,DB14866,-8.2,Amcasertib,QDWKGEFGLQMDAM-ULJHMMPZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
12154,6lzg,DB12960,-8.2,INCB-9471,ZMCJFJZOSKEMOM-DNKZPPIMSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
58465,6crv,DB05421,-8.2,CP-122721,ZIWFCOIGUNPHPM-HKUYNNGSSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104290,6vxs,DB11786,-8.2,Pefcalcitol,SVCSMAZYWOQCBW-NVJMFHFGSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104298,6vxs,DB11795,-8.2,GSK-2636771,XTKLTGBKIDQGQL-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
161482,7bv1,DB14889,-8.2,Derazantinib,KPJDVVCDVBFRMU-AREMUKBSSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
26816,6cs2,DB05408,-8.2,Emricasan,SCVHJVCATBPIHN-SJCJKPOMSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
26818,6cs2,DB05412,-8.2,Talmapimod,ZMELOYOKMZBMRB-DLBZAZTESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
104225,6vxs,DB11687,-8.2,E-6201,MWUFVYLAWAXDHQ-HMNLTAHHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
164514,7bv1,DB08095,-8.2,"3-(2-CHLOROPHENYL)-1-(2-{[(1S)-2-HYDROXY-1,2-DIMETHYLPROPYL]AMINO}PYRIMIDIN-4-YL)-1-(4-METHOXYPHENYL)UREA",ZWYFTKPEHRQCCW-HNNXBMFYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
58449,6crv,DB05298,-8.2,Tetomilast,XDBHURGONHZNJF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
12132,6lzg,DB00984,-8.2,Nandrolone phenpropionate,UBWXUGDQUBIEIZ-QNTYDACNSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
104333,6vxs,DB11845,-8.2,Lucitanib,CUDVHEFYRIWYQD-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104344,6vxs,DB11864,-8.2,Preladenant,DTYWJKSSUANMHD-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104359,6vxs,DB11886,-8.2,Infigratinib,QADPYRIHXKWUSV-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
28173,6cs2,DB07755,-8.2,"(2S)-1-[4-({4-[(2,5-Dichlorophenyl)amino]-2-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol",GNLAGGCSJGJECE-INIZCTEOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
128065,6w4h,DB07175,-8.2,N-{2-methyl-5-[(6-phenylpyrimidin-4-yl)amino]phenyl}methanesulfonamide,CXQRKICWSCAUGW-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
104377,6vxs,DB11910,-8.2,MK-0249,DDDZBLNULGDPGA-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
128048,6w4h,DB07156,-8.2,"(4Z)-6-bromo-4-({[4-(pyrrolidin-1-ylmethyl)phenyl]amino}methylidene)isoquinoline-1,3(2H,4H)-dione",JFEKAVPMVOLVTH-UNOMPAQXSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
104388,6vxs,DB11925,-8.2,Vistusertib,JUSFANSTBFGBAF-IRXDYDNUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104405,6vxs,DB11950,-8.2,Teneligliptin,WGRQANOPCQRCME-PMACEKPBSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104410,6vxs,DB11960,-8.2,Carboxyamidotriazole,WNRZHQBJSXRYJK-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
128089,6w4h,DB07203,-8.2,6-CYCLOHEXYLMETHOXY-2-(3'-CHLOROANILINO) PURINE,OUEGMEMDEAOAEG-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
127716,6w4h,DB06732,-8.2,beta-Naphthoflavone,OUGIDAPQYNCXRA-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
58490,6crv,DB05524,-8.2,Pelitinib,WVUNYSQLFKLYNI-AATRIKPKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
125069,6w4h,DB02008,-8.2,1-(2-Fluorobenzyl)-3-Butyl-8-(N-Acetyl-4-Aminobenzyl)-Xanthine,JHSHXKJSPVHPCJ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
103593,6vxs,DB08761,-8.2,"(3S,6S)-3,6-bis(4-hydroxybenzyl)piperazine-2,5-dione",NGPCLOGFGKJCBP-HOTGVXAUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
161302,7bv1,DB13528,-8.2,Chlormadinone,VUHJZBBCZGVNDZ-TTYLFXKOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
103643,6vxs,DB08820,-8.2,Ivacaftor,PURKAOJPTOLRMP-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
103648,6vxs,DB08828,-8.2,Vismodegib,BPQMGSKTAYIVFO-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
103664,6vxs,DB08846,-8.2,Ellagic Acid,AFSDNFLWKVMVRB-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
103698,6vxs,DB08912,-8.2,Dabrafenib,BFSMGDJOXZAERB-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
103742,6vxs,DB08974,-8.2,Flubendazole,CPEUVMUXAHMANV-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
103763,6vxs,DB08997,-8.2,Dexetimide,LQQIVYSCPWCSSD-HSZRJFAPSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
103796,6vxs,DB09048,-8.2,Netupitant,WAXQNWCZJDTGBU-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
26741,6cs2,DB04982,-8.2,Talampanel,JACAAXNEHGBPOQ-LLVKDONJSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
103815,6vxs,DB09078,-8.2,Lenvatinib,WOSKHXYHFSIKNG-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
103841,6vxs,DB09128,-8.2,Brexpiprazole,ZKIAIYBUSXZPLP-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
128116,6w4h,DB07237,-8.2,{4-[(2R)-pyrrolidin-2-ylmethoxy]phenyl}(4-thiophen-3-ylphenyl)methanone,VUWFJUJWAWMRQN-HXUWFJFHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
103846,6vxs,DB09143,-8.2,Sonidegib,VZZJRYRQSPEMTK-CALCHBBNSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
103866,6vxs,DB09181,-8.2,Trefentanil,RJSCINHYBGMIFT-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
125017,6w4h,DB01941,-8.2,"6-[1-(3,5,5,8,8-Pentamethyl-5,6,7,8-Tetrahydronaphthalen-2-Yl)Cyclopropyl]Pyridine-3-Carboxylic Acid",SLXTWXQUEZSSTJ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
109281,6vxx,DB13008,-8.2,"2,2-bis(4-hydroxy-3-tert-butylphenyl)propane",ZDRSNHRWLQQICP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
103961,6vxs,DB09319,-8.2,Carindacillin,JIRBAUWICKGBFE-MNRDOXJOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
12224,6lzg,DB13061,-8.2,MLN8054,HHFBDROWDBDFBR-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
26769,6cs2,DB00559,-8.2,Bosentan,GJPICJJJRGTNOD-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
109271,6vxx,DB12988,-8.2,LY-518674,PNHFDVSKDSLUFH-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109269,6vxx,DB12986,-8.2,VS-5584,QYBGBLQCOOISAR-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104155,6vxs,DB11529,-8.2,Melengestrol,OKHAOBQKCCIRLO-IBVJIVQJSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
58514,6crv,DB05659,-8.2,Faropenem medoxomil,JQBKWZPHJOEQAO-DVPVEWDBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104161,6vxs,DB11551,-8.2,Trenbolone,MEHHPFQKXOUFFV-OWSLCNJRSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
12198,6lzg,DB13024,-8.2,MK-8245,UJEAABFSXKCSGI-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
12254,6lzg,DB13101,-8.2,4SC-202,PRXXYMVLYKJITB-IZZDOVSWSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
102901,6vxs,DB07941,-8.2,PH-797804,KCAJXIDMCNPGHZ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
125487,6w4h,DB02547,-8.2,Guanosine-5'-Diphosphate-Rhamnose,LQEBEXMHBLQMDB-GDJBGNAASA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
11598,6lzg,DB12185,-8.2,Exatecan,ZVYVPGLRVWUPMP-FYSMJZIKSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
164195,7bv1,DB07362,-8.2,"1-(5-{2-[(1-methyl-1H-pyrazolo[4,3-d]pyrimidin-7-yl)amino]ethyl}-1,3-thiazol-2-yl)-3-[3-(trifluoromethyl)phenyl]urea",UOLCZAFAGDOUFX-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
163815,7bv1,DB06367,-8.2,Relacatib,BWYBBMQLUKXECQ-GIVPXCGWSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
127132,6w4h,DB04761,-8.2,"PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-[(PYRIDIN-3-YLMETHYL)-AMIDE]",NHPBWKYFMTXWAA-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
107622,6vxx,DB04099,-8.2,Deamido-Nad+,SENPVEZBRZQVST-HISDBWNOSA-O,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107629,6vxx,DB04107,-8.2,[(1-{2[(4-Carbamimidoyl-Phenylamino)-Methyl]-1-Methyl-1h-Benzoimidazol-5-Yl}-Cyclopropyl)-Pyridin-2-Yl-Methyleneaminooxy]-Acetic Acid Ethyl Ester,RNOYCNIZOAIUSV-LSWMGQQCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107634,6vxx,DB04115,-8.2,Berberine,YBHILYKTIRIUTE-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27956,6cs2,DB07522,-8.2,"N-[(2R,3S)-3-AMINO-2-HYDROXY-4-PHENYLBUTYL]NAPHTHALENE-2-SULFONAMIDE",QSSWSEQPKCCATQ-VQTJNVASSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
107690,6vxx,DB04186,-8.2,"N'-(Pyrrolidino[2,1-B]Isoindolin-4-On-8-Yl)-N-(Pyridin-2-Yl)Urea",KLVYMYQTRZCMLE-CYBMUJFWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163831,7bv1,DB06420,-8.2,Annamycin,CIDNKDMVSINJCG-GKXONYSUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
127096,6w4h,DB04708,-8.2,"(S)-TETRAHYDROFURAN-3-YL (2S,3S)-4-((S)-4-((1R,3R)-3-(2-AMINO-2-OXOETHYL)-2,3-DIHYDRO-1H-INDEN-1-YL)-2-BENZYL-3-OXO-2,3-DIHYDRO-1H-PYRROL-2-YL)-3-HYDROXY-1-PHENYLBUTAN-2-YLCARBAMATE",SYNSHNDQFWMLJW-YZGRCXSVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
164194,7bv1,DB07360,-8.2,"1-{5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)ethyl]-1,3-thiazol-2-yl}-3-[3-(trifluoromethyl)phenyl]urea",JJHXPDTVQKWKHA-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
10606,6lzg,DB08815,-8.2,Lurasidone,PQXKDMSYBGKCJA-CVTJIBDQSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
127087,6w4h,DB04696,-8.2,"4-CHLORO-3',3''-DIBROMOPHENOL-1,8-NAPHTHALEIN",GFGZCXHXQCQRFP-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
126115,6w4h,DB03383,-8.2,5-Chloro-1h-Indole-2-Carboxylic Acid [1-(4-Fluorobenzyl)-2-(4-Hydroxypiperidin-1yl)-2-Oxoethyl]Amide,YDCGVASFVACWKF-NRFANRHFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
107763,6vxx,DB04582,-8.2,IMAZAQUIN,CABMTIJINOIHOD-QGZVFWFLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56354,6crv,DB02221,-8.2,"4-(Aminosulfonyl)-N-[(2,4,6-Trifluorophenyl)Methyl]-Benzamide",DVTYOTODFLDHRL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56353,6crv,DB02220,-8.2,AL7089A,RMOXCYSVWCHXII-LBPRGKRZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108514,6vxx,DB08077,-8.2,"2-[4-({[(3,5-DICHLOROPHENYL)AMINO]CARBONYL}AMINO)PHENOXY]-2-METHYLPROPANOIC ACID",OYJPTSMWFKGZJM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
126167,6w4h,DB03460,-8.2,Violaxanthin,SZCBXWMUOPQSOX-WVJDLNGLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
127069,6w4h,DB04669,-8.2,TRIAZOLOPYRIMIDINE,YWBFPKPWMSWWEA-UHFFFAOYSA-O,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
55811,6crv,DB01512,-8.2,Hydromorphinol,AABLHGPVOULICI-BRJGLHKUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127051,6w4h,DB04645,-8.2,"5-{3-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-2-METHYL-PHENOXY}-PENTANOIC ACID",NJJIFGCFUDDBSP-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
107865,6vxx,DB05298,-8.2,Tetomilast,XDBHURGONHZNJF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127049,6w4h,DB04643,-8.2,"4-{3-CHLORO-4-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-PHENOXY}-BUTYRIC ACID",FYQVFMLCZJZZEM-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
27713,6cs2,DB07269,-8.2,(2S)-2-[3-(AMINOMETHYL)PHENYL]-3-[(R)-[(1R)-1-{[(BENZYLOXY)CARBONYL]AMINO}-2-METHYLPROPYL](HYDROXY)PHOSPHORYL]PROPANOIC ACID,SFUOOKBZBVUDBC-VQTJNVASSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
107562,6vxx,DB03761,-8.2,5-Fluoro-2'-Deoxyuridine-5'-Monophosphate,HFEKDTCAMMOLQP-RRKCRQDMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107546,6vxx,DB03742,-8.2,Compound 4-D,TWZNCTCQAGRUGQ-RRPNLBNLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27642,6cs2,DB07193,-8.2,"(2R,3R)-7-(methylsulfonyl)-3-(2,4,5-trifluorophenyl)-1,2,3,4-tetrahydropyrido[1,2-a]benzimidazol-2-amine",HJJAYSSCWGUPKO-ABAIWWIYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
56491,6crv,DB02398,-8.2,6-[N-(4-(Aminomethyl)Phenyl)Carbamyl]-2-Naphthalenecarboxamidine,NLBDETRVUYOIHQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108635,6vxx,DB08488,-8.2,"4-{[(E)-2-(5-CHLOROTHIEN-2-YL)VINYL]SULFONYL}-1-(1H-PYRROLO[3,2-C]PYRIDIN-2-YLMETHYL)PIPERAZIN-2-ONE",PLWVUIRWJVKSSD-XBXARRHUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107169,6vxx,DB02656,-8.2,LY-294002,CZQHHVNHHHRRDU-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27576,6cs2,DB07124,-8.2,"(2S)-1-(6H-INDOL-3-YL)-3-{[5-(7H-PYRAZOLO[3,4-C]PYRIDIN-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE",CCIACUJJBPSOHE-KRWDZBQOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
107178,6vxx,DB02668,-8.2,"Je-2147, Ag1776, Kni-764",CUFQBQOBLVLKRF-RZDMPUFOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56628,6crv,DB02569,-8.2,"2',3'-Dehydro-2',3'-Deoxy-Thymidine 5'-Diphosphate",LXCAIISEDMYORY-JGVFFNPUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108632,6vxx,DB08485,-8.2,"(1S,4S,5S)-1,4,5-TRIHYDROXY-3-[3-(PHENYLTHIO)PHENYL]CYCLOHEX-2-ENE-1-CARBOXYLIC ACID",QMNMNSINKIFYBV-LMMKCTJWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56621,6crv,DB02559,-8.2,"6-(Octahydro-1h-Indol-1-Ylmethyl)Decahydroquinazoline-2,4-Diamine",HDQIGGQUKAQTGU-SZTTVXCBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56614,6crv,DB02549,-8.2,3'-O-Acetylthymidine-5'-Diphosphate,UWSIAAWKEICIJY-IVZWLZJFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27595,6cs2,DB07144,-8.2,"5-[(3R)-3-(5-methoxy-2',6'-dimethylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",XZXVRKHUCSXVBM-AWEZNQCLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
107331,6vxx,DB03173,-8.2,CRA_10433,CFSQPEBVGUSQII-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56596,6crv,DB02527,-8.2,Cyclic adenosine monophosphate,IVOMOUWHDPKRLL-KQYNXXCUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127213,6w4h,DB04863,-8.2,Lefradafiban,PGCFXITVMNNKON-ROUUACIJSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
108481,6vxx,DB08037,-8.2,"(2S)-4-(2,5-difluorophenyl)-N-[(3R,4S)-3-fluoro-1-methylpiperidin-4-yl]-2-(hydroxymethyl)-N-methyl-2-phenyl-2,5-dihydro-1H-pyrrole-1-carboxamide",MYBGWENAVMIGMM-GIFXNVAJSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163744,7bv1,DB06194,-8.2,Elocalcitol,LRLWXBHFPGSUOX-GJQYOBCGSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
27611,6cs2,DB07162,-8.2,4-(3-amino-1H-indazol-5-yl)-N-tert-butylbenzenesulfonamide,KFJCXIOVAGJCKB-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
107377,6vxx,DB03230,-8.2,Adenosine-5'-Propylphosphate,XAMXMSZRQHPMRX-QYVSTXNMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107385,6vxx,DB03239,-8.2,"3',5'-Dinitro-N-Acetyl-L-Thyronine",VZSQTOXQXPKQJX-ZDUSSCGKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
125989,6w4h,DB03220,-8.2,FR233623,OODDZQQDDOVCFD-SCLBCKFNSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
127205,6w4h,DB04852,-8.2,Implitapide,AMNXBQPRODZJQR-DITALETJSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
107416,6vxx,DB03277,-8.2,alpha-maltotriose,FYGDTMLNYKFZSV-PXXRMHSHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163786,7bv1,DB06274,-8.2,Alvimopan,UPNUIXSCZBYVBB-JVFUWBCBSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
108585,6vxx,DB08429,-8.2,N-({(2S)-1-[(3R)-3-amino-4-(3-chlorophenyl)butanoyl]pyrrolidin-2-yl}methyl)-3-(methylsulfonyl)benzamide,QRGBOABBMKYMLG-UXHICEINSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
126017,6w4h,DB03251,-8.2,RWJ-51084,NQABUEUFRXDDFI-AWEZNQCLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
11068,6lzg,DB11363,-8.2,Alectinib,KDGFLJKFZUIJMX-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
56493,6crv,DB02400,-8.2,"5-Methoxy-1,2-Dimethyl-3-(4-Nitrophenoxymethyl)Indole-4,7-Dione",IBLWSLZYYZHSRG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107512,6vxx,DB03701,-8.2,Vanoxerine,NAUWTFJOPJWYOT-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56577,6crv,DB02504,-8.2,[3-(1-Benzyl-3-Carbamoylmethyl-2-Methyl-1h-Indol-5-Yloxy)-Propyl-]-Phosphonic Acid,AQEYCNKFBRLUOT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107120,6vxx,DB02315,-8.2,Cyclic GMP,ZOOGRGPOEVQQDX-UUOKFMHZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27718,6cs2,DB07274,-8.2,"N-cyclopropyl-6-[(6,7-dimethoxyquinolin-4-yl)oxy]naphthalene-1-carboxamide",ZATGFXTWDKIEKC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
107933,6vxx,DB05676,-8.2,Apremilast,IMOZEMNVLZVGJZ-QGZVFWFLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56048,6crv,DB01809,-8.2,"1-Ter-Butyl-3-P-Tolyl-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine",ZVPDNRVYHLRXLX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
164048,7bv1,DB07011,-8.2,"(3S)-1-(1,3-BENZODIOXOL-5-YLMETHYL)-3-[4-(1H-IMIDAZOL-1-YL)PHENOXY]PIPERIDINE",HHOPJGKEAIIIDF-FQEVSTJZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
126647,6w4h,DB04107,-8.2,[(1-{2[(4-Carbamimidoyl-Phenylamino)-Methyl]-1-Methyl-1h-Benzoimidazol-5-Yl}-Cyclopropyl)-Pyridin-2-Yl-Methyleneaminooxy]-Acetic Acid Ethyl Ester,RNOYCNIZOAIUSV-LSWMGQQCSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
108203,6vxx,DB07222,-8.2,(3S)-N-(5-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE,RJWMDETWDDESBP-ZDUSSCGKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108209,6vxx,DB07230,-8.2,3-BROMO-6-HYDROXY-2-(4-HYDROXYPHENYL)-1H-INDEN-1-ONE,DHPCBFMFERFZLR-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
126317,6w4h,DB03678,-8.2,"(6,7-Difluoro-Quinazolin-4-Yl)-(1-Methyl-2,2-Diphenyl-Ethyl)-Amine",WVGZKPGUHOZIJQ-HNNXBMFYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
164066,7bv1,DB07031,-8.2,"3-Fluoro-4-{[(2R)-2-hydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthalenyl)acetyl]amino}benzoic acid",AANFHDFOMFRLLR-LJQANCHMSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
126590,6w4h,DB04030,-8.2,"1,3,4,9-Tetrahydro-2-(Hydroxybenzoyl)-9-[(4-Hydroxyphenyl)Methyl]-6-Methoxy-2h-Pyrido[3,4-B]Indole",ADXYEWMDAGIULV-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
10777,6lzg,DB09053,-8.2,Ibrutinib,XYFPWWZEPKGCCK-GOSISDBHSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
108241,6vxx,DB07268,-8.2,2-({2-[(3-HYDROXYPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)BENZAMIDE,QHPKKGUGRGRSGA-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
126585,6w4h,DB04023,-8.2,"Guanosine 5'-(Trihydrogen Diphosphate), P'-D-Mannopyranosyl Ester",DNBSDUDYNPJVCN-ZXTXFPBHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
108402,6vxx,DB07719,-8.2,"[(3R)-3-(Methylcarbamoyl)-2-{[(2-methyl-2-propanyl)oxy]carbonyl}-1,2,3,4-tetrahydro-7-isoquinolinyl]sulfamic acid",PPSSYXOFPICMQD-CYBMUJFWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108250,6vxx,DB07278,-8.2,2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}ETHENESULFONAMIDE,ACEFOQMQINFMRW-DYCFVMESSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
164087,7bv1,DB07245,-8.2,6-[2-(3'-METHOXYBIPHENYL-3-YL)ETHYL]PYRIDIN-2-AMINE,AEVBKBAFFJKFJZ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
108264,6vxx,DB07550,-8.2,"2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(1-OXIDO-2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUOROPHENYL)METHYL]ACETAMIDE",ZIGSBBKEPNQXRG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55965,6crv,DB01697,-8.2,beta-cellotriose,FYGDTMLNYKFZSV-CSHPIKHBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108275,6vxx,DB07564,-8.2,"6-amino-2-[(2-morpholin-4-ylethyl)amino]-3,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",JUHXOBNFTFUPKQ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55955,6crv,DB01685,-8.2,Topiroxostat,UBVZQGOVTLIHLH-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108325,6vxx,DB07626,-8.2,"4-(2-aminoethoxy)-N-(3-chloro-2-ethoxy-5-piperidin-1-ylphenyl)-3,5-dimethylbenzamide",CKBBGCJYKCLKHE-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55936,6crv,DB01658,-8.2,1'-Deazo-Thiamin Diphosphate,JHNXLHRDUXBCJW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108393,6vxx,DB07707,-8.2,"(9BETA,11ALPHA,13ALPHA,14BETA,17ALPHA)-11-(METHOXYMETHYL)ESTRA-1(10),2,4-TRIENE-3,17-DIOL",LEOPSILMAOYZBO-IUTAEKPZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55927,6crv,DB01644,-8.2,"3,6-dihydroxy-xanthene-9-propionic acid",PFQGLFBMMPZYEU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108392,6vxx,DB07706,-8.2,2-Hydrox1tradiol,DILDHNKDVHLEQB-XSSYPUMDSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55917,6crv,DB01633,-8.2,Deoxy-2-fluoro-beta-D-cellotrioside,BZNXZJAUEMJQJB-QSCMNUSVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27877,6cs2,DB07435,-8.2,"1,2,3-TRIHYDROXY-1,2,3,4-TETRAHYDROBENZO[A]PYRENE",GFANZDFKCCJYRF-NSISKUIASA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
10679,6lzg,DB08930,-8.2,Dolutegravir,RHWKPHLQXYSBKR-BMIGLBTASA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
108431,6vxx,DB07984,-8.2,2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]-n-[(1S)-1-(hydroxymethyl)propyl]acetamide,GKJWXEORYGBJFS-KRWDZBQOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
164044,7bv1,DB07005,-8.2,D-phenylalanyl-N-{4-[amino(iminio)methyl]benzyl}-L-prolinamide,VZFTWWJAUZOJDH-MOPGFXCFSA-O,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
108188,6vxx,DB07204,-8.2,"(1S)-1-(1H-INDOL-3-YLMETHYL)-2-(2-PYRIDIN-4-YL-[1,7]NAPHTYRIDIN-5-YLOXY)-EHYLAMINE",DQIXTEDFNFZMCM-SFHVURJKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56263,6crv,DB02098,-8.2,Adenosine-2'-5'-Diphosphate,AEOBEOJCBAYXBA-KQYNXXCUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107943,6vxx,DB05738,-8.2,Vapitadine,VQWGYPVNVICKFC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
126914,6w4h,DB04471,-8.2,"2-Phenyl-1-[4-(2-Piperidin-1-Yl-Ethoxy)-Phenyl]-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol",FMWVCTJKLAVRPB-MUUNZHRXSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
27733,6cs2,DB07288,-8.2,N-(4-chlorophenyl)-2-[(pyridin-4-ylmethyl)amino]benzamide,GGPZCOONYBPZEW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
126192,6w4h,DB03495,-8.2,"4,6-Dideoxy-4-{[4,5,6-Trihydroxy-3-(Hydroxymethyl)Cyclohex-2-En-1-Yl]Amino}-Alpha-D-Lyxo-Hexopyranosyl-(1->4)-Alpha-D-Threo-Hexopyranosyl-(1->6)-Alpha-L-Threo-Hexopyranose",FZLCJZILHGFQLM-PISLJJGOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
108470,6vxx,DB08026,-8.2,"2-{4-[(4-imidazo[1,2-a]pyridin-3-ylpyrimidin-2-yl)amino]piperidin-1-yl}-N-methylacetamide",AJLILYAPRHIFAS-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108016,6vxx,DB06708,-8.2,Lumefantrine,DYLGFOYVTXJFJP-MYYYXRDXSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27923,6cs2,DB07486,-8.2,"3-({4-[(1E)-3-morpholin-4-yl-3-oxoprop-1-en-1-yl]-2,3-bis(trifluoromethyl)phenyl}sulfanyl)aniline",KLSZVPNVFKKIRD-FNORWQNLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
108468,6vxx,DB08023,-8.2,"N-cyclohexyl-4-imidazo[1,2-a]pyridin-3-yl-N-methylpyrimidin-2-amine",HYNNWLVWJXWXFO-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163972,7bv1,DB06918,-8.2,2-(2-METHYLPHENYL)-1H-INDOLE-6-CARBOXIMIDAMIDE,ZRYXDGAKQGRHFG-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
126834,6w4h,DB04357,-8.2,Pteric Acid,JOAQINSXLLMRCV-UHFFFAOYSA-O,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
56188,6crv,DB01998,-8.2,"2-[3,4-Dihydroxy-2-Hydroxymethyl-5-(2-Hydroxy-Nonyl)-Tetrahydro-Furan-2-Yloxy]-6-Hydroxymethyl-Tetra Hydro-Pyran-3,4,5-Triol",IMFJFQAURAFEAH-ZLSOQEJISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55826,6crv,DB01529,-8.2,Dextromoramide,INUNXTSAACVKJS-OAQYLSRUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108053,6vxx,DB06766,-8.2,Alcaftadine,MWTBKTRZPHJQLH-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27770,6cs2,DB07323,-8.2,"2-[({2-[(1Z)-3-(DIMETHYLAMINO)PROP-1-ENYL]-4-FLUOROPHENYL}SULFONYL)AMINO]-5,6,7,8-TETRAHYDRONAPHTHALENE-1-CARBOXYLIC ACID",CTZLIARLNXSXGL-ALCCZGGFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
27771,6cs2,DB07324,-8.2,"3-({2-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)ETHYNYL]BENZYL}AMINO)-1,3-OXAZOL-2(3H)-ONE",ZUJWSOPIDUWELP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
108110,6vxx,DB06860,-8.2,"2-(2-chloropyridin-4-yl)-4-methyl-1H-isoindole-1,3(2H)-dione",YDJMWNHJNJVVMM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56141,6crv,DB01940,-8.2,Balanol Analog 2,SQLYTJZXRRDERK-ISKFKSNPSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
126214,6w4h,DB03523,-8.2,Brequinar,PHEZJEYUWHETKO-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
108125,6vxx,DB07131,-8.2,(S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclohexylpropanoyl)pyrrolidine-2-carboxamide,DOTBZTLJSXFKCP-IBGZPJMESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
164006,7bv1,DB06962,-8.2,"(5-(aminomethyl)-2H-spiro[benzofuran-3,4'-piperidine]-1'-yl)(5-(phenylethynyl)furan-2-yl)methanone",YKTUSHSSKIWDRY-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
108127,6vxx,DB07133,-8.2,D-phenylalanyl-N-(3-methylbenzyl)-L-prolinamide,CHKWABXWPATIIG-UXHICEINSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56118,6crv,DB01906,-8.2,"3-(5-Amino-7-Hydroxy-[1,2,3]Triazolo[4,5-D]Pyrimidin-2-Yl)-Benzoic Acid",KNLLRZNGRRRPEW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
126743,6w4h,DB04232,-8.2,N-Hydroxy-1-(4-Methoxyphenyl)Sulfonyl-4-Benzyloxycarbonyl-Piperazine-2-Carboxamide,DNGGPLKVDUPXFN-GOSISDBHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
56098,6crv,DB01873,-8.2,Epothilone D,XOZIUKBZLSUILX-GIQCAXHBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108166,6vxx,DB07179,-8.2,"3-((3-bromo-5-o-tolylpyrazolo[1,5-a]pyrimidin-7-ylamino)methyl)pyridine 1-oxide",DXUJQXZHHGJMFM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108059,6vxx,DB06780,-8.2,Desoxycorticosterone acetate,VPGRYOFKCNULNK-ACXQXYJUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56661,6crv,DB02615,-8.2,Compound 19,UZOOIPXOYYJULJ-BLIZRMSTSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127323,6w4h,DB05294,-8.2,Vandetanib,UHTHHESEBZOYNR-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
56676,6crv,DB02636,-8.2,"9-Hydroxy-8-Methoxy-6-Nitro-Phenanthrol[3,4-D][1,3]Dioxole-5-Carboxylic Acid",UCLGCTLOEZZSLA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
162953,7bv1,DB03337,-8.2,1-(2-Amidinophenyl)-3-(Phenoxyphenyl)Urea,ZHCAYBOLUMAUQX-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
57345,6crv,DB03534,-8.2,3-[(Acetyl-Methyl-Amino)-Methyl]-4-Amino-N-Methyl-N-(1-Methyl-1h-Indol-2-Ylmethyl)-Benzamide,AWTBJNJPBKTHEV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57343,6crv,DB03530,-8.2,Acylated Ceftazidime,VEHPZKIFULQYFS-BZXVCXBKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127593,6w4h,DB06469,-8.2,Lestaurtinib,UIARLYUEJFELEN-DMVVYWCZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
162967,7bv1,DB03355,-8.2,5'-O-(N-(L-Threonyl)-Sulfamoyl)Adenosine,UPVAPSGKXAAHBG-CKTDUXNWSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
108939,6vxx,DB11426,-8.2,Marbofloxacin,BPFYOAJNDMUVBL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
162978,7bv1,DB03368,-8.2,"5-Methyl-5-(4-Phenoxy-Phenyl)-Pyrimidine-2,4,6-Trione",RTBMLCLTYAPKIF-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
162987,7bv1,DB03383,-8.2,5-Chloro-1h-Indole-2-Carboxylic Acid [1-(4-Fluorobenzyl)-2-(4-Hydroxypiperidin-1yl)-2-Oxoethyl]Amide,YDCGVASFVACWKF-NRFANRHFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
27328,6cs2,DB06865,-8.2,6-CARBAMIMIDOYL-2-[2-HYDROXY-6-(4-HYDROXY-PHENYL)-INDAN-1-YL]-HEXANOIC ACID,ZSRRBAKATXAISL-LMNJBCLMSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
127568,6w4h,DB06409,-8.2,Morphine glucuronide,GNJCUHZOSOYIEC-GAROZEBRSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
11451,6lzg,DB11986,-8.2,Entrectinib,HAYYBYPASCDWEQ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
11438,6lzg,DB11965,-8.2,SJG-136,RWZVMMQNDHPRQD-SFTDATJTSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
27342,6cs2,DB06879,-8.2,"5-(4'-AMINO-1'-ETHYL-5',8'-DIFLUORO-1'H-SPIRO[PIPERIDINE-4,2'-QUINAZOLINE]-1-YLCARBONYL)PICOLINONITRILE",QCFIRACCCDFXIP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
11435,6lzg,DB11963,-8.2,Dacomitinib,LVXJQMNHJWSHET-AATRIKPKSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
106313,6vxs,DB15446,-8.2,Vidofludimus,XPRDUGXOWVXZLL-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
57236,6crv,DB03376,-8.2,'5'-O-(N-(L-Alanyl)-Sulfamoyl)Adenosine,CWWYMWDIYBJVLP-YTMOPEAISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106395,6vxx,DB00163,-8.2,Vitamin E,GVJHHUAWPYXKBD-IEOSBIPESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
823,6lzg,HMDB0007159,-8.2,DG(18:0/18:1(11Z)/0:0),YJORXFQCYXMMHL-KDKAWYBRSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
125613,6w4h,DB02715,-8.2,Compound 18,UZOOIPXOYYJULJ-RHLLTPQKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
106400,6vxx,DB00169,-8.2,Cholecalciferol,QYSXJUFSXHHAJI-YRZJJWOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
164391,7bv1,DB07779,-8.2,N-({(2S)-1-[(3R)-3-AMINO-4-(2-FLUOROPHENYL)BUTANOYL]PYRROLIDIN-2-YL}METHYL)BENZAMIDE,ANQHSFFUNMTTRS-MOPGFXCFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
57215,6crv,DB03348,-8.2,Huperzine B,YYWGABLTRMRUIT-HWWQOWPSSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127538,6w4h,DB06306,-8.2,Onalespib,IFRGXKKQHBVPCQ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
108904,6vxx,DB11362,-8.2,Selexipag,QXWZQTURMXZVHJ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
11391,6lzg,DB11903,-8.2,GW842166,TWQYWUXBZHPIIV-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
27305,6cs2,DB06837,-8.2,"(2R)-N-4-hydroxy-2-(3-hydroxybenzyl)-N-1-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]butanediamide",VXDKQRWTOJFQKH-BJZITVGISA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
106206,6vxs,DB15229,-8.2,CNV-2197944,BLFJGFDZMABYMY-ZDUSSCGKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
7163,6lzg,DB03325,-8.2,Tyrosyladenylate,MJZAZMKENKZBAJ-QTOWJTHWSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
27295,6cs2,DB06827,-8.2,Viomycin,GXFAIFRPOKBQRV-GHXCTMGLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
106026,6vxs,DB14845,-8.2,Filgotinib,RIJLVEAXPNLDTC-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
127707,6w4h,DB06718,-8.2,Stanozolol,LKAJKIOFIWVMDJ-IYRCEVNGSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
106030,6vxs,DB14854,-8.2,TC-6987,UAKZGMMGIMKFMV-RBUKOAKNSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
162631,7bv1,DB02511,-8.2,2-Hydroxy-5-({1-[(2-Naphthyloxy)Methyl]-3-Oxoprop-1-Enyl}Amino)Tyrosine,PZWMZAFFUAWVDN-CQXYXCHQSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
55593,6crv,DB01182,-8.2,Propafenone,JWHAUXFOSRPERK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127669,6w4h,DB06652,-8.2,Vicriviroc,CNPVJJQCETWNEU-CYFREDJKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
106084,6vxs,DB14982,-8.2,Miransertib,HNFMVVHMKGFCMB-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
127659,6w4h,DB06629,-8.2,Zibotentan,FJHHZXWJVIEFGJ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
106088,6vxs,DB14993,-8.2,Pyrotinib,SADXACCFNXBCFY-IYNHSRRRSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
106090,6vxs,DB14998,-8.2,Olorinab,ACSQLTBPYZSGBA-GMXVVIOVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
11552,6lzg,DB12122,-8.2,Figopitant,HUTHJVYJUPXHDF-DEOSSOPVSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
127656,6w4h,DB06624,-8.2,Taranabant,QLYKJCMUNUWAGO-GAJHUEQPSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
108874,6vxx,DB11259,-8.2,Diosmetin,MBNGWHIJMBWFHU-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
162694,7bv1,DB02804,-8.2,A-98881,PMBZSBGCSQGJAQ-GRKNLSHJSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
106102,6vxs,DB15029,-8.2,AZD-8186,LMJFJIDLEAWOQJ-CQSZACIVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
125536,6w4h,DB02615,-8.2,Compound 19,UZOOIPXOYYJULJ-BLIZRMSTSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
106140,6vxs,DB15102,-8.2,Pemigatinib,HCDMJFOHIXMBOV-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
106144,6vxs,DB15109,-8.2,Ingenol disoxate,GLIUZQUNUNICGS-XUBYYPQFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
57462,6crv,DB03708,-8.2,Adenosine 5'-phosphosulfate,IRLPACMLTUPBCL-KQYNXXCUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108980,6vxx,DB11859,-8.2,Brexanolone,AURFZBICLPNKBZ-SYBPFIFISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106170,6vxs,DB15157,-8.2,Voruciclib,MRPGRAKIAJJGMM-OCCSQVGLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
162782,7bv1,DB02915,-8.2,"4-(2,4-Dimethyl-1,3-thiazol-5-yl)-N-[4-(trifluoromethyl)phenyl]-2-pyrimidinamine",MEZFDQUDLQCVNX-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
127620,6w4h,DB06533,-8.2,Ragaglitazar,WMUIIGVAWPWQAW-XMMPIXPASA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
57402,6crv,DB03626,-8.2,"5-Methoxy-1,2-Dimethyl-3-(Phenoxymethyl)Indole-4,7-Dione",JRPJCFILHCLEJI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
11500,6lzg,DB12054,-8.2,BQ-123,VYCMAAOURFJIHD-PJNXIOHISA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
57391,6crv,DB03605,-8.2,"(2s)-2-[(2,4-Dichloro-Benzoyl)-(3-Trifluoromethyl-Benzyl)-Amino]-3-Phenyl-Propionic Acid",LAJJKGIZTCCOHY-NRFANRHFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106101,6vxs,DB15028,-8.2,MK-1064,CKTWQGHVNRYNCM-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
57168,6crv,DB03288,-8.2,5-Chloro-1h-Indole-2-Carboxylic Acid{[Cyclopentyl-(2-Hydroxy-Ethyl)-Carbamoyl]-Methyl}-Amide,VXABTOCIIZSEPD-QGZVFWFLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106446,6vxx,DB00353,-8.2,Methylergometrine,UNBRKDKAWYKMIV-QWQRMKEZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106448,6vxx,DB00355,-8.2,Aztreonam,WZPBZJONDBGPKJ-VEHQQRBSSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106742,6vxx,DB01196,-8.2,Estramustine,FRPJXPJMRWBBIH-RBRWEJTLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127441,6w4h,DB05983,-8.2,Bardoxolone methyl,WPTTVJLTNAWYAO-KPOXMGGZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
56878,6crv,DB02902,-8.2,3'-Phosphate-Adenosine-5'-Phosphate Sulfate,GACDQMDRPRGCTN-KQYNXXCUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127430,6w4h,DB05936,-8.2,CVT-6883,KOYXXLLNCXWUNF-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
56851,6crv,DB02869,-8.2,3-amino-5-phenylpentane,ZPXIQFOUPUVVPU-INIZCTEOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108747,6vxx,DB08903,-8.2,Bedaquiline,QUIJNHUBAXPXFS-XLJNKUFUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27498,6cs2,DB07042,-8.2,"7-amino-2-tert-butyl-4-{[2-(1H-imidazol-4-yl)ethyl]amino}pyrido[2,3-d]pyrimidine-6-carboxamide",XESUNWBIAADLPI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
106797,6vxx,DB01268,-8.2,Sunitinib,WINHZLLDWRZWRT-ATVHPVEESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56813,6crv,DB02819,-8.2,"Mono-[3,4-Dihydroxy-5-(5-Methyl-Benzoimidazol-1-Yl)-Tetrahydor-Furan-2-Ylmethyl] Ester",HGUDFQQPANTQEU-LPWJVIDDSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
164256,7bv1,DB07435,-8.2,"1,2,3-TRIHYDROXY-1,2,3,4-TETRAHYDROBENZO[A]PYRENE",GFANZDFKCCJYRF-NSISKUIASA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
163617,7bv1,DB04862,-8.2,Merimepodib,JBPUGFODGPKTDW-SFHVURJKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
10535,6lzg,DB08742,-8.2,"1,3-CYCLOHEXANEDIOL, 4-METHYLENE-5-[(2E)-[(1S,3AS,7AS)-OCTAHYDRO-1-(5-HYDROXY-5-METHYL-1,3-HEXADIYNYL)-7A-METHYL-4H-INDEN-4-YLIDENE]ETHYLIDENE]-, (1R,3S,5Z)",CEEUUHVULXTFGS-BQXVGYHGSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
28008,6cs2,DB00694,-8.2,Daunorubicin,STQGQHZAVUOBTE-VGBVRHCVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
106874,6vxx,DB01687,-8.2,beta-Mannobiose,GUBGYTABKSRVRQ-PZPXDAEZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56739,6crv,DB02716,-8.2,7-Methyl-Guanosine-5'-Triphosphate,DKVRNHPCAOHRSI-KQYNXXCUSA-O,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127356,6w4h,DB05482,-8.2,7-ethyl-10-hydroxycamptothecin,FJHBVJOVLFPMQE-QFIPXVFZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
27535,6cs2,DB07083,-8.2,beta-phenyl-D-phenylalanyl-N-propyl-L-prolinamide,HZKKJPDVZGOOPU-PZJWPPBQSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
106937,6vxx,DB01768,-8.2,Methylumbelliferyl Sialic Acid,KKDWIUJBUSOPGC-GKHMPSLRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27539,6cs2,DB00643,-8.2,Mebendazole,OPXLLQIJSORQAM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
6925,6lzg,DB02915,-8.2,"4-(2,4-Dimethyl-1,3-thiazol-5-yl)-N-[4-(trifluoromethyl)phenyl]-2-pyrimidinamine",MEZFDQUDLQCVNX-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
164234,7bv1,DB07409,-8.2,"(1-HYDROXY-1-PHOSPHONO-2-[1,1';4',1'']TERPHENYL-3-YL-ETHYL)-PHOSPHONIC ACID",MPBUFKZCEBTBSK-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
56707,6crv,DB02675,-8.2,(4-Hydroxymaltosephenyl)Glycine,PHPOPZGUOBMSPZ-QHJSCRBTSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56700,6crv,DB02666,-8.2,(C8-R)-Hydantocidin 5'-Phosphate,MAXSFYCTFIBEAR-OJMIUMIFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107009,6vxx,DB02164,-8.2,N-Sulfo-Flavin Mononucleotide,ZLPUGFBBLGQWBS-SCRDCRAPSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107013,6vxx,DB02170,-8.2,"1,8-Di-Hydroxy-4-Nitro-Xanthen-9-One",ZOHCDJRFYXKEQW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27559,6cs2,DB07108,-8.2,"4'-FLUORO-1,1'-BIPHENYL-4-CARBOXYLIC ACID",LXWNTLBMNCXRQN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
10540,6lzg,DB08746,-8.2,1-[[(1E)-2-(4-CHLOROPHENYL)ETHENYL]SULFONYL]-4-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]PIPERAZINE,ZOSSOFIFNGGDKG-GIJQJNRQSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
55590,6crv,DB01179,-8.2,Podofilox,YJGVMLPVUAXIQN-XVVDYKMHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108786,6vxx,DB08961,-8.2,Azosemide,HMEDEBAJARCKCT-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106701,6vxx,DB00912,-8.2,Repaglinide,FAEKWTJYAYMJKF-QHCPKHFHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106451,6vxx,DB00358,-8.2,Mefloquine,XEEQGYMUWCZPDN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
11380,6lzg,DB11890,-8.2,Cilengitide,AMLYAMJWYAIXIA-VWNVYAMZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
164380,7bv1,DB07765,-8.2,"METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL](METHYL)AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE",UKCFUFHREWUXJJ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
163212,7bv1,DB03903,-8.2,Tmr,KGFLZYXDJDOIEE-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
57138,6crv,DB03247,-8.2,Flavin mononucleotide,FVTCRASFADXXNN-SCRDCRAPSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106487,6vxx,DB00402,-8.2,Eszopiclone,GBBSUAFBMRNDJC-INIZCTEOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108862,6vxx,DB11184,-8.2,Oftasceine,DEGAKNSWVGKMLS-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163264,7bv1,DB04180,-8.2,"4-(Aminosulfonyl)-N-[(2,4-Difluorophenyl)Methyl]-Benzamide",NTDFJEKGSGSXME-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
127502,6w4h,DB06228,-8.2,Rivaroxaban,KGFYHTZWPPHNLQ-AWEZNQCLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
163268,7bv1,DB04186,-8.2,"N'-(Pyrrolidino[2,1-B]Isoindolin-4-On-8-Yl)-N-(Pyridin-2-Yl)Urea",KLVYMYQTRZCMLE-CYBMUJFWSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
106535,6vxx,DB00459,-8.2,Acitretin,IHUNBGSDBOWDMA-AQFIFDHZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106540,6vxx,DB00468,-8.2,Quinine,LOUPRKONTZGTKE-WZBLMQSHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56905,6crv,DB02936,-8.2,4-(1-Benzyl-3-Carbamoylmethyl-2-Methyl-1h-Indol-5-Yloxy)-Butyric Acid,STENXUCYNKOBHJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163321,7bv1,DB04258,-8.2,Seocalcitol,LVLLALCJVJNGQQ-SEODYNFXSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
127473,6w4h,DB06160,-8.2,Garenoxacin,NJDRXTDGYFKORP-LLVKDONJSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
108856,6vxx,DB11157,-8.2,Anthralin,NUZWLKWWNNJHPT-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55677,6crv,DB01322,-8.2,Kava,OMNGEVNATYFZGG-BQYQJAHWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57048,6crv,DB03133,-8.2,"2-(Beta-D-Glucopyranosyl)-5-Methyl-1,2,3-Benzimidazole",XIJZORUYQZBFJK-UJPOAAIJSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27430,6cs2,DB06972,-8.2,"7A-[(4-cyanophenyl)methyl]-6-(3,5-dichlorophenyl)-5-oxo-2,3,5,7A-tetrahydro-1H-pyrrolo[1,2-A]pyrrole-7-carbonitrile",TZCXQSNBTXDAJG-QFIPXVFZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
108825,6vxx,DB09488,-8.2,Acrivastine,PWACSDKDOHSSQD-IUTFFREVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127460,6w4h,DB06140,-8.2,SUVN-502,GWCYPEHWIZXYFZ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
106653,6vxx,DB00858,-8.2,Drostanolone,IKXILDNPCZPPRV-RFMGOVQKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106686,6vxx,DB00897,-8.2,Triazolam,JOFWLTCLBGQGBO-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
11298,6lzg,DB11778,-8.2,Danusertib,XKFTZKGMDDZMJI-HSZRJFAPSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
11296,6lzg,DB11775,-8.2,PF-03758309,AYCPARAPKDAOEN-LJQANCHMSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
108787,6vxx,DB08962,-8.2,Glibornuride,RMTYNAPTNBJHQI-LLDVTBCESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27416,6cs2,DB06955,-8.2,"3,4-bis(7-chloro-1H-indol-3-yl)-1H-pyrrole-2,5-dicarboxylic acid",OAMCCJASDLMTOO-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
161002,7bv1,DB12385,-8.2,10-hydroxycamptothecin,HAWSQZCWOQZXHI-FQEVSTJZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160993,7bv1,DB12375,-8.2,Oglemilast,OKFDRAHPFKMAJH-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160992,7bv1,DB12371,-8.2,Siponimod,KIHYPELVXPAIDH-HNSNBQBZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110313,6vxx,DB01453,-8.2,Beta-hydroxyfentanyl,JEFVHLMGRUJLET-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28505,6cs2,DB08096,-8.2,"8-(2-CHLOROPHENYLAMINO)-2-(2,6-DIFLUOROPHENYLAMINO)-9-ETHYL-9H-PURINE-1,7-DIIUM",ZWKOUFZHPNIQSH-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
158819,7bv1,DB02259,-8.2,"3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid (4-Sulfamoyl-Phenyl)-Amide",VSYGXLAJQDAWCZ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95871,6m71,DB12068,-8.2,T-900607,FSXLOWIFSZNIMV-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95939,6m71,DB12165,-8.2,Presatovir,GOFXWTVKPWJNGD-UWJYYQICSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60199,6crv,DB08360,-8.2,"2-(4-ETHYLPIPERAZIN-1-YL)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE",BIFHJPUTQBOBGJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
158911,7bv1,DB02623,-8.2,Aminophosphonic Acid-Guanylate Ester,ZGPDMUBRWRJAQQ-UUOKFMHZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96017,6m71,DB12279,-8.2,OBP-801,XFLBOEMFLGLWFF-HDXRNPEWSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96021,6m71,DB12284,-8.2,LY-2608204,QIIVJLHCZUTGSD-CUBQBAPOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110254,6vxx,DB01153,-8.2,Sertaconazole,JLGKQTAYUIMGRK-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
96040,6m71,DB12307,-8.2,Foretinib,CXQHYVUVSFXTMY-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
129137,6w4h,DB08437,-8.2,Puromycin,RXWNCPJZOCPEPQ-NVWDDTSBSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
96051,6m71,DB12320,-8.2,Palovarotene,YTFHCXIPDIHOIA-DHZHZOJOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
129127,6w4h,DB08426,-8.2,"THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [2-OXO-1-(1H-PYRROLO[2,3-C]PYRIDIN-2-YLMETHYL)-PYRROLIDIN-3-YL]-AMIDE",PLXOQMHGHDZMSX-AWEZNQCLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
60159,6crv,DB08310,-8.2,"N-[(2R)-2-{[(2S)-2-(1,3-benzoxazol-2-yl)pyrrolidin-1-yl]carbonyl}hexyl]-N-hydroxyformamide",QDDZLTVSNABZIK-ZBFHGGJFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
96094,6m71,DB12388,-8.2,Evocalcet,RZNUIYPHQFXBAN-XLIONFOSSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
129100,6w4h,DB08391,-8.2,"6,7-DIMETHOXY-4-[(3R)-3-(QUINOXALIN-2-YLOXY)PYRROLIDIN-1-YL]QUINAZOLINE",UBIIFKJMNRPNMT-CQSZACIVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
96120,6m71,DB12419,-8.2,HSD-016,ZWASRJHIEFYJGL-BFUOFWGJSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
124144,6w4h,DB00814,-8.2,Meloxicam,ZRVUJXDFFKFLMG-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
129091,6w4h,DB08382,-8.2,Gosogliptin,QWEWGXUTRTXFRF-KBPBESRZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
110216,6vxx,DB01108,-8.2,Trilostane,KVJXBPDAXMEYOA-CXANFOAXSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
159041,7bv1,DB03069,-8.2,Cytidine-5'-Diphospho-Beta-D-Xylose,NWSKPSPTJOAICE-OCIMBMBZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96174,6m71,DB12500,-8.2,Fedratinib,JOOXLOJCABQBSG-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60136,6crv,DB08285,-8.2,"(2R)-2-{[4-(benzylamino)-8-(1-methylethyl)pyrazolo[1,5-a][1,3,5]triazin-2-yl]amino}butan-1-ol",SQUNOCMDMIQIQK-OAHLLOKOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
96182,6m71,DB12512,-8.2,Verucerfont,VKHVAUKFLBBZFJ-SFHVURJKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110315,6vxx,DB01455,-8.2,19-Nor-5-androstenediol,VVUQRXPUVKXAIO-XFUVECHXSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
95834,6m71,DB12010,-8.2,Fostamatinib,GKDRMWXFWHEQQT-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
158759,7bv1,DB02181,-8.2,2'-Deoxyguanosine-5'-Triphosphate,HAAZLUGHYHWQIW-KVQBGUIXSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
158756,7bv1,DB02177,-8.2,1-Acetyl-4-(4-{4-[(2-Ethoxyphenyl)Thio]-3-Nitrophenyl}Pyridin-2-Yl)Piperazine,GKGJFUXSTSUKPB-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95564,6m71,DB11592,-8.2,Nitrocefin,LHNIIDJCEODSHA-OQRUQETBSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
28542,6cs2,DB08130,-8.2,"N-(5-{3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]phenyl}-1,3,4-oxadiazol-2-yl)ethane-1,2-diamine",FPDWDLAITHFTTP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
165194,7bv1,DB11518,-8.2,Flunixin,NOOCSNJCXJYGPE-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60346,6crv,DB08536,-8.2,"3-bromo-5-phenyl-N-(pyrimidin-5-ylmethyl)pyrazolo[1,5-a]pyridin-7-amine",IBUPHWYGVDAASU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110381,6vxx,DB01532,-8.2,alpha-Methylacetylfentanyl,OKTLVZBUKMRPLL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
129199,6w4h,DB08510,-8.2,5-ALPHA-PREGNANE-3-BETA-OL-HEMISUCCINATE,UVTGFMKBPVLATL-DSOJQRAMSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
165192,7bv1,DB11511,-8.2,Difloxacin,NOCJXYPHIIZEHN-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
158495,7bv1,DB01254,-8.2,Dasatinib,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95639,6m71,DB11729,-8.2,GSK-2330672,CZGVOBIGEBDYTP-VSGBNLITSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95652,6m71,DB11745,-8.2,Otenabant,UNAZAADNBYXMIV-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
158498,7bv1,DB01260,-8.2,Desonide,WBGKWQHBNHJJPZ-LECWWXJVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110370,6vxx,DB01521,-8.2,Clostebol,KCZCIYZKSLLNNH-FBPKJDBXSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60131,6crv,DB08274,-8.2,"6,7,8,9-TETRAHYDRO-4-HYDROXY-3-(1-PHENYLPROPYL)CYCLOHEPTA[B]PYRAN-2-ONE",YKJXQZGJGDTEOC-AWEZNQCLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110365,6vxx,DB01514,-8.2,Furazabol,RGLLOUBXMOGLDQ-IVEVATEUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
95693,6m71,DB11804,-8.2,AZD-5672,SCXSQUUTGCWHFU-WJOKGBTCSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95710,6m71,DB11827,-8.2,Ertugliflozin,MCIACXAZCBVDEE-CUUWFGFTSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60283,6crv,DB08463,-8.2,(2R)-2-({9-(1-methylethyl)-6-[(4-pyridin-2-ylbenzyl)amino]-9H-purin-2-yl}amino)butan-1-ol,HOCBJBNQIQQQGT-LJQANCHMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
129180,6w4h,DB08489,-8.2,"N4-HYDROXY-2-ISOBUTYL-N1-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.013,18]NONADECA-12(19),13,15,17-TETRAEN-10-YL)-SUCCINAMIDE",GCBPAPVOMPJQHK-NQIIRXRSSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
95737,6m71,DB11870,-8.2,RG-4733,OJPLJFIFUQPSJR-INIZCTEOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95759,6m71,DB11901,-8.2,Apalutamide,HJBWBFZLDZWPHF-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110338,6vxx,DB01480,-8.2,Cyprenorphine,VSKIOMHXEUHYSI-KNLIIKEYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
95766,6m71,DB11910,-8.2,MK-0249,DDDZBLNULGDPGA-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
158713,7bv1,DB02115,-8.2,Daidzin,KYQZWONCHDNPDP-QNDFHXLGSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95767,6m71,DB11911,-8.2,Galunisertib,IVRXNBXKWIJUQB-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95822,6m71,DB11995,-8.2,Avatrombopag,OFZJKCQENFPZBH-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95830,6m71,DB12006,-8.2,BMS-906024,AYOUDDAETNMCBW-GSHUGGBRSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
165167,7bv1,DB11455,-8.2,Robenacoxib,ZEXGDYFACFXQPF-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
14004,6lzg,T3D3615,-8.2,Microcystin-LY,SIGQAYSWORHPPH-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
96208,6m71,DB12553,-8.2,Fluocinolone,UUOUOERPONYGOS-CLCRDYEYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96279,6m71,DB12665,-8.2,Isoquercetin,OVSQVDMCBVZWGM-QSOFNFLRSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
159354,7bv1,DB04030,-8.2,"1,3,4,9-Tetrahydro-2-(Hydroxybenzoyl)-9-[(4-Hydroxyphenyl)Methyl]-6-Methoxy-2h-Pyrido[3,4-B]Indole",ADXYEWMDAGIULV-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
25787,6cs2,DB03797,-8.2,3-Aminomethyl-Pyridinium-Adenine-Dinucleotide,HMCRLFVYYFBZEZ-PLEFRAQWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
28451,6cs2,DB08037,-8.2,"(2S)-4-(2,5-difluorophenyl)-N-[(3R,4S)-3-fluoro-1-methylpiperidin-4-yl]-2-(hydroxymethyl)-N-methyl-2-phenyl-2,5-dihydro-1H-pyrrole-1-carboxamide",MYBGWENAVMIGMM-GIFXNVAJSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
59964,6crv,DB08077,-8.2,"2-[4-({[(3,5-DICHLOROPHENYL)AMINO]CARBONYL}AMINO)PHENOXY]-2-METHYLPROPANOIC ACID",OYJPTSMWFKGZJM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
97280,6m71,DB14542,-8.2,Hydrocortisone phosphate,BGSOJVFOEQLVMH-VWUMJDOOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97316,6m71,DB14640,-8.2,Isoflupredone acetate,ZOCUOMKMBMEYQV-GSLJADNHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59939,6crv,DB08049,-8.2,"7,8-dihydroxy-4-phenyl-2H-chromen-2-one",JRVIIPJSVKTPBK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
97335,6m71,DB14661,-8.2,Loperamide oxide,KXVSBTJVTUVNPM-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
159419,7bv1,DB04121,-8.2,Guanosine-3'-Monophosphate-5'-Diphosphate,HEYSFDAMRDTCJM-UUOKFMHZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59934,6crv,DB08041,-8.2,3-BENZYLOXYCARBONYLAMINO-2-HYDROXY-4-PHENYL-BUTYRIC ACID,JXJYTERRLRAUSF-JKSUJKDBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
97353,6m71,DB14679,-8.2,Quingestanol acetate,FLGJKPPXEKYCBY-AKCFYGDASA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
159428,7bv1,DB04131,-8.2,"10-(4-Dimethylamino-5-Hydroxy-6-Methyl-Tetrahydro-Pyran-2-Yloxy)-8-Ethyl-1,8,11-Trihydroxy-7,8,9,10-Tetrahydro-Naphthacene-5,12-Dione",BLGDWFJQIHBUJY-NWJGULHDSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
124221,6w4h,DB00901,-8.2,Bitolterol,FZGVEKPRDOIXJY-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
13590,6lzg,DB01289,-8.2,Glisoxepide,ZKUDBRCEOBOWLF-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
97382,6m71,DB14761,-8.2,Remdesivir,RWWYLEGWBNMMLJ-YSOARWBDSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
13582,6lzg,DB01267,-8.2,Paliperidone,PMXMIIMHBWHSKN-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
97392,6m71,DB14775,-8.2,Cavosonstat,BXSZILNGNMDGSL-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97396,6m71,DB14790,-8.2,BPN-14770,KRRGWHSEDYQKDQ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97415,6m71,DB14845,-8.2,Filgotinib,RIJLVEAXPNLDTC-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97436,6m71,DB14882,-8.2,CEP-9722,CTLOSZHDGZLOQE-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
128891,6w4h,DB08133,-8.2,N-(4-sulfamoylphenyl)-1H-indazole-3-carboxamide,MNHPHKFLWAPNOV-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
54961,6crv,DB00439,-8.2,Cerivastatin,SEERZIQQUAZTOL-ANMDKAQQSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
128882,6w4h,DB08123,-8.2,"N-METHYL-{4-[2-(7-OXO-6,7-DIHYDRO-8H-[1,3]THIAZOLO[5,4-E]INDOL-8-YLIDENE)HYDRAZINO]PHENYL}METHANESULFONAMIDE",GEWPSTLKJDIUHW-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
128881,6w4h,DB08122,-8.2,"N-METHYL-4-{[(2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]AMINO}BENZENESULFONAMIDE",IKASAFLVQIJQOK-UVTDQMKNSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
59899,6crv,DB08004,-8.2,"(2S)-2-{[3-(3-aminophenyl)imidazo[1,2-b]pyridazin-6-yl]amino}-3-methylbutan-1-ol",PUMVONFFLKPPIM-CQSZACIVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
159349,7bv1,DB04023,-8.2,"Guanosine 5'-(Trihydrogen Diphosphate), P'-D-Mannopyranosyl Ester",DNBSDUDYNPJVCN-ZXTXFPBHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
54943,6crv,DB00417,-8.2,Phenoxymethylpenicillin,BPLBGHOLXOTWMN-MBNYWOFBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59979,6crv,DB08095,-8.2,"3-(2-CHLOROPHENYL)-1-(2-{[(1S)-2-HYDROXY-1,2-DIMETHYLPROPYL]AMINO}PYRIMIDIN-4-YL)-1-(4-METHOXYPHENYL)UREA",ZWYFTKPEHRQCCW-HNNXBMFYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
97042,6m71,DB13788,-8.2,Chlorbenzoxamine,VEVSKUJZSMGTMM-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
165050,7bv1,DB09177,-8.2,p-Fluorofentanyl,KXUBAVLIJFTASZ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
54930,6crv,DB00400,-8.2,Griseofulvin,DDUHZTYCFQRHIY-RBHXEPJQSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60083,6crv,DB08212,-8.2,1-[2-(3-ACETYL-2-HYDROXY-6-METHOXY-PHENYL)-CYCLOPROPYL]-3-(5-CYANO-PYRIDIN-2-YL)-THIOUREA,FSRLCMRWYUJTNT-UONOGXRCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
96369,6m71,DB12808,-8.2,Trifarotene,MFBCDACCJCDGBA-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
159141,7bv1,DB03478,-8.2,2'-O-Acetyl Adenosine-5-Diphosphoribose,BFNOPXRXIQJDHO-DLFWLGJNSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96371,6m71,DB12812,-8.2,Palomid 529,YEAHTLOYHVWAKW-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
159146,7bv1,DB03486,-8.2,Phosphomethylphosphonic Acid Guanosyl Ester,OCJWYBKRHNXUME-KQYNXXCUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
13736,6lzg,T3D0174,-8.2,"Indeno(1,2,3-cd)pyrene",SXQBHARYMNFBPS-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
110166,6vxx,DB01053,-8.2,Benzylpenicillin,JGSARLDLIJGVTE-MBNYWOFBSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
96466,6m71,DB12960,-8.2,INCB-9471,ZMCJFJZOSKEMOM-DNKZPPIMSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
28466,6cs2,DB08055,-8.2,"N-(2-chlorophenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine",NNBICZMPIJMWGC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
129025,6w4h,DB08300,-8.2,"1-methyl-3-naphthalen-2-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine",UOKGZPYGRJDACN-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
96214,6m71,DB12562,-8.2,Setipiprant,IHAXLPDVOWLUOS-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
28465,6cs2,DB08054,-8.2,"1-(1-methylethyl)-3-quinolin-6-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine",GEZALMMCQYDFML-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
54932,6crv,DB00402,-8.2,Eszopiclone,GBBSUAFBMRNDJC-INIZCTEOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110143,6vxx,DB01025,-8.2,Amlexanox,SGRYPYWGNKJSDL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
129002,6w4h,DB08268,-8.2,"6-AMINO-4-[2-(4-METHYLPHENYL)ETHYL]-1,7-DIHYDRO-8H-IMIDAZO[4,5-G]QUINAZOLIN-8-ONE",SPVJRTJUEVXOMS-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
60022,6crv,DB08141,-8.2,"4-{[(2,6-difluorophenyl)carbonyl]amino}-N-[(3S)-piperidin-3-yl]-1H-pyrazole-3-carboxamide",KOMNQBZWMCFDTQ-VIFPVBQESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
96559,6m71,DB13101,-8.2,4SC-202,PRXXYMVLYKJITB-IZZDOVSWSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
165005,7bv1,DB09080,-8.2,Olodaterol,COUYJEVMBVSIHV-SFHVURJKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
124188,6w4h,DB00862,-8.2,Vardenafil,SECKRCOLJRRGGV-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
96805,6m71,DB13470,-8.2,Cefodizime,XDZKBRJLTGRPSS-BGZQYGJUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96806,6m71,DB13471,-8.2,Nalfurafine,XGZZHZMWIXFATA-UEZBDDGYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96923,6m71,DB13631,-8.2,Methoserpidine,ULBNWNUHGJLQHO-VKMIBBQISA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96927,6m71,DB13638,-8.2,Cefbuperazone,SMSRCGPDNDCXFR-CYWZMYCQSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
165003,7bv1,DB09078,-8.2,Lenvatinib,WOSKHXYHFSIKNG-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
129019,6w4h,DB08293,-8.2,"(5E)-12-CHLORO-13,15-DIHYDROXY-4,7,8,9-TETRAHYDRO-2-BENZOXACYCLOTRIDECINE-1,10(3H,11H)-DIONE",AQKZYZQONWDDLS-HNQUOIGGSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
60370,6crv,DB08564,-8.2,(2E)-N-{4-[(3-bromophenyl)amino]quinazolin-6-yl}-4-(dimethylamino)but-2-enamide,ZCIXBBSRVLSRJQ-QPJJXVBHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
95390,6m71,DB09534,-8.2,Ecamsule,HEAHZSUCFKFERC-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95371,6m71,DB09383,-8.2,Meprednisone,PIDANAQULIKBQS-RNUIGHNZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
9708,6lzg,DB07827,-8.2,"4-{[1-METHYL-2,4-DIOXO-6-(3-PHENYLPROP-1-YN-1-YL)-1,4-DIHYDROQUINAZOLIN-3(2H)-YL]METHYL}BENZOIC ACID",FLTYDFYSVZBKOB-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
28616,6cs2,DB08208,-8.2,"2-[(4-ETHYNYL-2-FLUOROPHENYL)AMINO]-3,4-DIFLUORO-N-(2-HYDROXYETHOXY)BENZAMIDE",AMNKRBRQQAMACZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
94158,6m71,DB07789,-8.2,"1-[5-methyl-2-(trifluoromethyl)furan-3-yl]-3-[(2Z)-5-(2-{[6-(1H-1,2,4-triazol-3-ylamino)pyrimidin-4-yl]amino}ethyl)-1,3-thiazol-2(3H)-ylidene]urea",KNTGXMNWVXZIMW-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110562,6vxx,DB01944,-8.2,(S)-blebbistatin,LZAXPYOBKSJSEX-GOSISDBHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
129360,6w4h,DB08707,-8.2,"4-[3-(4-chlorophenyl)-2,1-benzisoxazol-5-yl]pyrimidin-2-amine",AQVFETGXIRKVAQ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
94177,6m71,DB07809,-8.2,4-({[4-(3-METHYLBENZOYL)PYRIDIN-2-YL]AMINO}METHYL)BENZENECARBOXIMIDAMIDE,MBJYEMUMDMGQQC-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
129354,6w4h,DB08701,-8.2,"2-(3-BROMOPHENYL)-6-[(2-HYDROXYETHYL)AMINO]-1H-BENZO[DE]ISOQUINOLINE-1,3(2H)-DIONE",JZCUVYNOSDWORZ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
94223,6m71,DB07861,-8.2,(2R)-N-hydroxy-3-naphthalen-2-yl-2-[(naphthalen-2-ylsulfonyl)amino]propanamide,MMOUXLMPQFMDRD-JOCHJYFZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94237,6m71,DB07875,-8.2,"5-Chloro-thiophene-2-carboxylic acid ((3S,4S)-1-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-methyl}-4-hydroxy-pyrrolidin-3-yl)-amide",ARAVOODWJJJNBY-IRXDYDNUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94294,6m71,DB07945,-8.2,"5-(3-carbamoylbenzyl)-5,6,7,8,9,10-hexahydrocyclohepta[b]indole-4-carboxylic acid",GKBQRPKZHUFGOB-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94312,6m71,DB07967,-8.2,9-CYCLOPENTYL-6-[2-(3-IMIDAZOL-1-YL-PROPOXY)-PHENYLAMINO]-9H-PURINE-2-CARBONITRILE,JJNKDTWKWYLERH-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94325,6m71,DB07982,-8.2,2-{4-[4-({4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]pyrimidin-2-yl}amino)phenyl]piperazin-1-yl}-2-oxoethanol,PVTKDXZNSUHUMO-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110535,6vxx,DB01903,-8.2,5-Bromo-2'-Deoxyuridine-5'-Monophosphate,LHLHVDBXXZVYJT-RRKCRQDMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
25348,6cs2,DB03251,-8.2,RWJ-51084,NQABUEUFRXDDFI-AWEZNQCLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
40365,6lu7,DB12424,-8.2,MK-3207,AZAANWYREOQRFB-SETSBSEESA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
28596,6cs2,DB08184,-8.2,2-(2-METHYLPHENYL)-1H-INDOLE-5-CARBOXIMIDAMIDE,YOZKTHGEOJHIDP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
94422,6m71,DB08092,-8.2,3-fluoro-N-1H-indol-5-yl-5-morpholin-4-ylbenzamide,VMLSXFMXUNVCSK-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
40366,6lu7,DB11852,-8.2,Tegobuvir,XBEQSQDCBSKCHJ-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
157621,6wiq,DB12207,-8.2,Verdinexor,OPAKEJZFFCECPN-XQRVVYSFSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
40367,6lu7,DB08827,-8.2,Lomitapide,MBBCVAKAJPKAKM-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40368,6lu7,DB03005,-8.2,"3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-5-Yl]Hexyl]-Phenanthridinium",ISUOMOOYAOQQPZ-UHFFFAOYSA-O,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
60673,6crv,DB08961,-8.2,Azosemide,HMEDEBAJARCKCT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
94441,6m71,DB08111,-8.2,"4-[(6-phenyl[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl]phenol",ZGJYGQLGSXWEMY-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60666,6crv,DB08953,-8.2,Indalpine,SADQVAVFGNTEOD-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
94513,6m71,DB08191,-8.2,"4-(5-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl)benzoic acid",KSFDVNIKNYXUIP-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110586,6vxx,DB01972,-8.2,Guanosine-5'-Monophosphate,RQFCJASXJCIDSX-UUOKFMHZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110620,6vxx,DB02019,-8.2,Acetyl Dithranol,IXLRLZOYKJERRA-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60798,6crv,DB09169,-8.2,3-Allylfentanyl,BZXKQFFMDLTPJL-LADGPHEKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110674,6vxx,DB02089,-8.2,CP-526423,MWWXABBBAPKJDX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
93506,6m71,DB07029,-8.2,"4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMIDAZOL-1-YL)PHENOXY]-6-METHYLPYRIMIDINE",QQBNDYARFVOEGW-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
36745,1r42,DB03331,-8.2,"N-Naphthalen-1-Ylmethyl-2'-[3,5-Dimethoxybenzamido]-2'-Deoxy-Adenosine",OARVXDFNTLYMCJ-JVUUKAHWSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
110778,6vxx,DB02400,-8.2,"5-Methoxy-1,2-Dimethyl-3-(4-Nitrophenoxymethyl)Indole-4,7-Dione",IBLWSLZYYZHSRG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
93555,6m71,DB07084,-8.2,"N-(6,7,9,10,17,18,20,21-octahydrodibenzo[b,k][1,4,7,10,13,16]hexaoxacyclooctadecin-2-yl)acetamide",YHKGWOJTUMJPNW-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93605,6m71,DB07141,-8.2,"5-[(3R)-3-(5-methoxy-4'-methylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",QVXYJVHNRPNRJL-HNNXBMFYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93608,6m71,DB07144,-8.2,"5-[(3R)-3-(5-methoxy-2',6'-dimethylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",XZXVRKHUCSXVBM-AWEZNQCLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93640,6m71,DB07181,-8.2,"4'-[(1R)-1-amino-2-(2,5-difluorophenyl)ethyl]biphenyl-3-carboxamide",JYKFWUXBFJJDTP-HXUWFJFHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
28650,6cs2,DB08246,-8.2,"(2S)-4-(2,5-DIFLUOROPHENYL)-N,N-DIMETHYL-2-PHENYL-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDE",WFFMEXQHWXEKBV-SFHVURJKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
165275,7bv1,DB11692,-8.2,Pavinetant,QYTBBBAHNIWFOD-NRFANRHFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93697,6m71,DB07250,-8.2,"N'-(5-CHLORO-1,3-BENZODIOXOL-4-YL)-N-(3,4,5- TRIMETHOXYPHENYL)PYRIMIDINE-2,4-DIAMINE",HMKLUOPMOJOUDZ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
28644,6cs2,DB08240,-8.2,N-(4-CHLOROPHENYL)-3-(PHOSPHONOOXY)NAPHTHALENE-2-CARBOXAMIDE,RQAQWBFHPMSXKR-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
110724,6vxx,DB02154,-8.2,"2,3-Bis-Benzo[1,3]Dioxol-5-Ylmethyl-Succinic Acid",FFYBYVPVYLMLAR-KBPBESRZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
94599,6m71,DB08304,-8.2,"(3R)-3-cyclopentyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2-benzothiazine 1,1-dioxide",QZBQVXXESPXFPZ-QGZVFWFLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60920,6crv,DB09355,-8.2,Sulfabenzamide,PBCZLFBEBARBBI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
93750,6m71,DB07307,-8.2,N-cyclopropyl-4-methyl-3-[1-(2-methylphenyl)phthalazin-6-yl]benzamide,GQXMJOSCBRZMKE-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93826,6m71,DB07395,-8.2,"4-[3-(2-Chloro-4,5-difluoro-benzoyl)ureido]-3-trifluoromethoxybenzoic acid",NWQGDIBCFLDHDO-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93852,6m71,DB07426,-8.2,"[1-HYDROXY-2-(1,1':3',1''-TERPHENYL-3-YLOXY)ETHANE-1,1-DIYL]BIS(PHOSPHONIC ACID)",NWIARQRYIRVYCM-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60863,6crv,DB09239,-8.2,Niguldipine,SVJMLYUFVDMUHP-XIFFEERXSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
93861,6m71,DB07435,-8.2,"1,2,3-TRIHYDROXY-1,2,3,4-TETRAHYDROBENZO[A]PYRENE",GFANZDFKCCJYRF-NSISKUIASA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
156615,6wiq,DB13454,-8.2,Nicomorphine,HNDXBGYRMHRUFN-CIVUWBIHSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
93958,6m71,DB07549,-8.2,"2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUORO-3-METHYL-6-PYRIDINYL)METHYL]ACETAMIDE",WOYBPRBUPLYTPY-UHFFFAOYSA-P,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60834,6crv,DB09206,-8.2,Trimazosin,YNZXWQJZEDLQEG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
156991,6wiq,DB14037,-8.2,Madecassic acid,PRAUVHZJPXOEIF-AOLYGAPISA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
123846,6w4h,DB00450,-8.2,Droperidol,RMEDXOLNCUSCGS-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
157044,6wiq,DB14152,-8.2,Ginsenosides,NLHQJXWYMZLQJY-SWIZOJJJSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
94045,6m71,DB07653,-8.2,"N-(5,6-DIPHENYLFURO[2,3-D]PYRIMIDIN-4-YL)GLYCINE",VXTCEUDVOCLEJG-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
129381,6w4h,DB08729,-8.2,"5-ethoxy-4-(1-methyl-7-oxo-3-propyl-6,7-dihydro-1H-pyrazolo[4,3-d]pyrimidin-5-yl)thiophene-2-sulfonamide",FENWRHVHBZQJGW-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
124002,6w4h,DB00643,-8.2,Mebendazole,OPXLLQIJSORQAM-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
9733,6lzg,DB07856,-8.2,6-{4-[4-(4-CHLOROPHENYL)PIPERIDIN-4-YL]PHENYL}-9H-PURINE,HPWBHQIUIBFTQC-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
60636,6crv,DB08906,-8.2,Fluticasone furoate,XTULMSXFIHGYFS-VLSRWLAYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28559,6cs2,DB08147,-8.2,"4-[3-(dibenzylamino)phenyl]-2,4-dioxobutanoic acid",RMWVENXKUQXLPW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
60509,6crv,DB08733,-8.2,"(2R,3R)-N^1^-[(1S)-2,2-DIMETHYL-1-(METHYLCARBAMOYL)PROPYL]-N^4^-HYDROXY-2-(2-METHYLPROPYL)-3-{[(1,3-THIAZOL-2-YLCARBONYL)AMINO]METHYL}BUTANEDIAMIDE",GAHIXYNNFMCKFQ-HZSPNIEDSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
25457,6cs2,DB00412,-8.2,Rosiglitazone,YASAKCUCGLMORW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
14095,6lzg,T3D3712,-8.2,Satratoxin H,MUACSCLQRGEGOE-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
95066,6m71,DB08878,-8.2,Aminopterin,TVZGACDUOSZQKY-LBPRGKRZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110430,6vxx,DB01586,-8.2,Ursodeoxycholic acid,RUDATBOHQWOJDD-UZVSRGJWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
95087,6m71,DB08912,-8.2,Dabrafenib,BFSMGDJOXZAERB-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95095,6m71,DB08930,-8.2,Dolutegravir,RHWKPHLQXYSBKR-BMIGLBTASA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95096,6m71,DB08931,-8.2,Riociguat,WXXSNCNJFUAIDG-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95122,6m71,DB08965,-8.2,Fusafungine,MIZMDSVSLSIMSC-OGLSAIDSSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95152,6m71,DB08997,-8.2,Dexetimide,LQQIVYSCPWCSSD-HSZRJFAPSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110418,6vxx,DB01569,-8.2,Formebolone,AMVODTGMYSRMNP-GNIMZFFESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165215,7bv1,DB11577,-8.2,Indigotindisulfonic Acid,CFZXDJWFRVEWSR-BUHFOSPRSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
158265,7bv1,DB00799,-8.2,Tazarotene,OGQICQVSFDPSEI-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95202,6m71,DB09075,-8.2,Edoxaban,HGVDHZBSSITLCT-JLJPHGGASA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95204,6m71,DB09078,-8.2,Lenvatinib,WOSKHXYHFSIKNG-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60435,6crv,DB08646,-8.2,TRW3-(2-AMINO-3-HYDROXY-PROPYL)-6-(N'-CYCLOHEXYL-HYDRAZINO)OCTAHYDRO-INDOL-7-OL,PSUOZWHAKZSNOB-LBPRGKRZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60422,6crv,DB08631,-8.2,"N-(4-CHLOROPHENYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONAMIDE",UVSIFVBCHJEYJP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
14045,6lzg,T3D3662,-8.2,Roquefortine,SPWSUFUPTSJWNG-SXGWCWSVSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
25505,6cs2,DB03447,-8.2,Uridylyl-2'-5'-Phospho-Adenosine,QARCCHXXGAIRFS-KPKSGTNCSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
165200,7bv1,DB11529,-8.2,Melengestrol,OKHAOBQKCCIRLO-IBVJIVQJSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110416,6vxx,DB01567,-8.2,Fludiazepam,ROYOYTLGDLIGBX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
95308,6m71,DB09238,-8.2,Manidipine,ANEBWFXPVPTEET-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95309,6m71,DB09239,-8.2,Niguldipine,SVJMLYUFVDMUHP-XIFFEERXSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
165197,7bv1,DB11521,-8.2,Imidocarb,SCEVFJUWLLRELN-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95328,6m71,DB09272,-8.2,Eluxadoline,QFNHIDANIVGXPE-FNZWTVRRSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60448,6crv,DB08660,-8.2,"1,2,5,8-tetrahydroxyanthracene-9,10-dione",VBHKTXLEJZIDJF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
97477,6m71,DB14993,-8.2,Pyrotinib,SADXACCFNXBCFY-IYNHSRRRSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
158147,7bv1,DB00436,-8.2,Bendroflumethiazide,HDWIHXWEUNVBIY-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60517,6crv,DB08741,-8.2,"5-[[(2R)-2-cyclopropyl-7,8-dimethoxy-2H-chromen-5-yl]methyl]pyrimidine-2,4-diamine",HWJPWWYTGBZDEG-AWEZNQCLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
52534,2fxp,DB11651,-8.2,Dactolisib,JOGKUKXHTYWRGZ-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
157905,6wiq,DB14870,-8.2,PF-5190457,ZIUDADZJCKGWKR-AREMUKBSSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
157909,6wiq,DB14878,-8.2,Liafensine,VCIBGDSRPUOBOG-QFIPXVFZSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
157913,6wiq,DB14883,-8.2,Lorecivivint,AQDWDWAYVBQMAM-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
53058,2fxp,DB12411,-8.2,R-428,KXMZDGSRSGHMMK-VWLOTQADSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
110507,6vxx,DB01860,-8.2,Cordycepin Triphosphate,NLIHPCYXRYQPSD-BAJZRUMYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
157917,6wiq,DB14894,-8.2,Galicaftor,QVDYQHXNAQHIKH-TZIWHRDSSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
60619,6crv,DB08877,-8.2,Ruxolitinib,HFNKQEVNSGCOJV-OAHLLOKOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
124017,6w4h,DB00663,-8.2,Flumethasone,WXURHACBFYSXBI-GQKYHHCASA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
94678,6m71,DB08400,-8.2,4-(3-{[5-(trifluoromethyl)pyridin-2-yl]oxy}benzyl)piperidine-1-carboxylic acid,KUEKMTNOUPAOBS-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94708,6m71,DB08439,-8.2,Parecoxib,TZRHLKRLEZJVIJ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110499,6vxx,DB01674,-8.2,[2-(1-Amino-2-Hydroxy-Propyl)-4-(4-Fluoro-1h-Indol-3-Ylmethyl)-5-Hydroxy-Imidazol-1-Yl]-Acetic Acid,AYMRQIHECFEMIQ-AYVTZFPOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
158146,7bv1,DB00434,-8.2,Cyproheptadine,JJCFRYNCJDLXIK-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
124022,6w4h,DB00670,-8.2,Pirenzepine,RMHMFHUVIITRHF-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
54736,6crv,DB00171,-8.2,ATP,ZKHQWZAMYRWXGA-KQYNXXCUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
158028,7bv1,DB00288,-8.2,Amcinonide,ILKJAFIWWBXGDU-MOGDOJJUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60580,6crv,DB08810,-8.2,Cinitapride,ZDLBNXXKDMLZMF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
14152,6lzg,T3D3774,-8.2,Secalonic Acid D,NFZJAYYORNVZNI-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
14149,6lzg,T3D3768,-8.2,Luteoskyrin,FAZDYVMEXQHRLI-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
129264,6w4h,DB08588,-8.2,2-({2-[(3R)-3-AMINOPIPERIDIN-1-YL]-4-OXOQUINAZOLIN-3(4H)-YL}METHYL)BENZONITRILE,OYNURZXTLNNKAP-QGZVFWFLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
110476,6vxx,DB01641,-8.2,"(5z)-2-[(1s,2r)-1-Amino-2-Hydroxypropyl]-5-[(4-Amino-1h-Indol-3-Yl)Methylene]-3-(2-Hydroxyethyl)-3,5-Dihydro-4h-Imidazol-4-One",JUWJATLABHTRDF-JURWUIOISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
94778,6m71,DB08521,-8.2,4-[5-(4-FLUORO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-3H-IMIDAZOL-4-YL]-PYRIDINE,CDMGBJANTYXAIV-HHHXNRCGSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
76212,6m2n,DB06940,-8.2,"N-ethyl-4-{[5-(methoxycarbamoyl)-2-methylphenyl]amino}-5-methylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide",ZZTMFGIGOADCFX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
110435,6vxx,DB01594,-8.2,Cinolazepam,XAXMYHMKTCNRRZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
95030,6m71,DB08816,-8.2,Ticagrelor,OEKWJQXRCDYSHL-FNOIDJSQSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
25448,6cs2,DB03368,-8.2,"5-Methyl-5-(4-Phenoxy-Phenyl)-Pyrimidine-2,4,6-Trione",RTBMLCLTYAPKIF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
94748,6m71,DB08487,-8.2,3-({4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-2-OXOPIPERAZIN-1-YL}METHYL)BENZENECARBOXIMIDAMIDE,PRMSFVUWLBPPLY-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97496,6m71,DB15036,-8.2,Sitravatinib,WLAVZAAODLTUSW-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
128857,6w4h,DB08097,-8.2,"2-(2,6-DIFLUOROPHENOXY)-N-(2-FLUOROPHENYL)-9-ISOPROPYL-9H-PURIN-8-AMINE",OGWSGDLIXOEZJG-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
97550,6m71,DB15141,-8.2,Deutivacaftor,PURKAOJPTOLRMP-ASMGOKTBSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160485,7bv1,DB08444,-8.2,"3-[2-bromo-4-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)phenoxy]-5-methylbenzonitrile",YYGZQXRLQMFHDH-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
12857,6lzg,DB13927,-8.2,anle138b,RCQIIBJSUWYYFU-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
101600,6vxs,DB05838,-8.2,OPC-51803,INGXCNVWWKKWOO-LJQANCHMSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101608,6vxs,DB05903,-8.2,KOS-1584,XAYAKDZVINDZGB-BMVMHAJPSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
59139,6crv,DB07119,-8.2,1-CHLORO-6-(4-HYDROXYPHENYL)-2-NAPHTHOL,YHEHVRSGKUYDON-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
101629,6vxs,DB06077,-8.2,Lumateperone,HOIIHACBCFLJET-SFTDATJTSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
28293,6cs2,DB07874,-8.2,"(6S)-2-amino-6-(3'-methoxybiphenyl-3-yl)-3,6-dimethyl-5,6-dihydropyrimidin-4(3H)-one",LQOCXPOKEPYGTJ-IBGZPJMESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
164699,7bv1,DB08499,-8.2,"N-[3-(2-fluoroethoxy)phenyl]-N'-(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-6-yl)butanediamide",DQXBKUVWJSZHSI-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
109623,6vxx,DB14545,-8.2,Hydrocortisone succinate,VWQWXZAWFPZJDA-CGVGKPPMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59111,6crv,DB07086,-8.2,"4-[(1S,2S,5S)-5-(HYDROXYMETHYL)-8-METHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL",XXIFNRNIQJKFLP-XHSDSOJGSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
101725,6vxs,DB06321,-8.2,R-348,IGLNXKVGKIFNBQ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
128411,6w4h,DB07578,-8.2,"3-[4-(2-METHYL-IMIDAZO[4,5-C]PYRIDIN-1-YL)BENZYL]-3H-BENZOTHIAZOL-2-ONE",WUOLYUKMMRCXGH-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
101738,6vxs,DB06367,-8.2,Relacatib,BWYBBMQLUKXECQ-GIVPXCGWSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
59103,6crv,DB07078,-8.2,"(3Z)-6-(4-HYDROXY-3-METHOXYPHENYL)-3-(1H-PYRROL-2-YLMETHYLENE)-1,3-DIHYDRO-2H-INDOL-2-ONE",AYSXURJZVXBSRV-WJDWOHSUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55209,6crv,DB00739,-8.2,Hetacillin,DXVUYOAEDJXBPY-NFFDBFGFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59094,6crv,DB07065,-8.2,"5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)-3-thiocyanatopyrazolo[1,5-a]pyrimidin-7-amine",AHPKUZJCNHGFQA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
124741,6w4h,DB01569,-8.2,Formebolone,AMVODTGMYSRMNP-GNIMZFFESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
128388,6w4h,DB07549,-8.2,"2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUORO-3-METHYL-6-PYRIDINYL)METHYL]ACETAMIDE",WOYBPRBUPLYTPY-UHFFFAOYSA-P,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
109545,6vxx,DB14086,-8.2,Cianidanol,PFTAWBLQPZVEMU-DZGCQCFKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
128387,6w4h,DB07548,-8.2,"2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUORO-6-PYRIDINYL)METHYL]ACETAMIDE",JXHWVKOKYDAROD-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
109539,6vxx,DB14075,-8.2,Imidurea,ZCTXEAQXZGPWFG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109534,6vxx,DB14067,-8.2,Dofequidar,KLWUUPVJTLHYIM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109512,6vxx,DB14028,-8.2,Nordazepam,AKPLHCDWDRPJGD-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
160630,7bv1,DB08873,-8.2,Boceprevir,LHHCSNFAOIFYRV-DOVBMPENSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
128373,6w4h,DB07533,-8.2,"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]-2-FURYL}-N-METHYLBENZENESULFONAMIDE",FJJJERLTHDXEPT-JYRVWZFOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
101581,6vxs,DB05713,-8.2,LY-517717,VYNKVNDKAOGAAQ-RUZDIDTESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101555,6vxs,DB05562,-8.2,Naluzotan,SPWZXWDPAWDKQE-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101535,6vxs,DB05470,-8.2,VX-702,FYSRKRZDBHOFAY-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101521,6vxs,DB05416,-8.2,Cardarine,YDBLKRPLXZNVNB-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
160318,7bv1,DB08004,-8.2,"(2S)-2-{[3-(3-aminophenyl)imidazo[1,2-b]pyridazin-6-yl]amino}-3-methylbutan-1-ol",PUMVONFFLKPPIM-CQSZACIVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
100828,6vxs,DB04107,-8.2,[(1-{2[(4-Carbamimidoyl-Phenylamino)-Methyl]-1-Methyl-1h-Benzoimidazol-5-Yl}-Cyclopropyl)-Pyridin-2-Yl-Methyleneaminooxy]-Acetic Acid Ethyl Ester,RNOYCNIZOAIUSV-LSWMGQQCSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
100845,6vxs,DB04131,-8.2,"10-(4-Dimethylamino-5-Hydroxy-6-Methyl-Tetrahydro-Pyran-2-Yloxy)-8-Ethyl-1,8,11-Trihydroxy-7,8,9,10-Tetrahydro-Naphthacene-5,12-Dione",BLGDWFJQIHBUJY-NWJGULHDSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
109724,6vxx,DB15208,-8.2,NOP-1A,MZBCQWLYUQJXKA-KRWDZBQOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59259,6crv,DB07258,-8.2,(R)-pyridin-4-yl[4-(2-pyrrolidin-1-ylethoxy)phenyl]methanol,QQRJWLDQBNAQCC-GOSISDBHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
160344,7bv1,DB08031,-8.2,"N-[(13-CYCLOHEXYL-6,7-DIHYDROINDOLO[1,2-D][1,4]BENZOXAZEPIN-10-YL)CARBONYL]-2-METHYL-L-ALANINE",LNQWELVSNCYKDU-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
55149,6crv,DB00671,-8.2,Cefixime,OKBVVJOGVLARMR-QSWIMTSFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
101025,6vxs,DB04373,-8.2,"4-Amino-N-{4-[2-(2,6-Dimethyl-Phenoxy)-Acetylamino]-3-Hydroxy-1-Isobutyl-5-Phenyl-Pentyl}-Benzamide",WQUBEIMCFHCJCO-AWCRTANDSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
59249,6crv,DB07248,-8.2,"7-PYRIDIN-2-YL-N-(3,4,5-TRIMETHOXYPHENYL)-7H-PYRROLO[2,3-D]PYRIMIDIN-2-AMINE",YENZSPIOXMNEFF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
26252,6cs2,DB04348,-8.2,Taurocholic Acid,WBWWGRHZICKQGZ-HZAMXZRMSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
101095,6vxs,DB04471,-8.2,"2-Phenyl-1-[4-(2-Piperidin-1-Yl-Ethoxy)-Phenyl]-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol",FMWVCTJKLAVRPB-MUUNZHRXSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
160383,7bv1,DB08317,-8.2,"5-methyl-6-phenylquinazoline-2,4-diamine",HUCOXWPHDFINIW-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
10137,6lzg,DB08299,-8.2,"4-[8-(3-nitrophenyl)-1,7-naphthyridin-6-yl]benzoic acid",QTNUWEKKZHSUQO-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
164716,7bv1,DB08520,-8.2,"(21S)-1AZA-4,4-DIMETHYL-6,19-DIOXA-2,3,7,20-TETRAOXOBICYCLO[19.4.0] PENTACOSANE",VUCSBBBCFXBFFY-IBGZPJMESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
128473,6w4h,DB07651,-8.2,N-ACETYL-L-PHENYLALANYL-4-[DIFLUORO(PHOSPHONO)METHYL]-L-PHENYLALANINAMIDE,KPMMESISHWWXNM-ROUUACIJSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
109662,6vxx,DB15091,-8.2,Upadacitinib,WYQFJHHDOKWSHR-MNOVXSKESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
160413,7bv1,DB08355,-8.2,"1-methyl-8-(phenylamino)-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxylic acid",ZOBRPBVIEUWYJR-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
101398,6vxs,DB04867,-8.2,Lintitript,ILNRQFBVVQUOLP-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
28304,6cs2,DB07889,-8.2,"(2S)-1-(Dimethylamino)-3-(4-{[4-(2-methylimidazo[1,2-a]pyridin-3-yl)-2-pyrimidinyl]amino}phenoxy)-2-propanol",VCPXSBULBDYRLT-SFHVURJKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
124585,6w4h,DB01384,-8.2,Paramethasone,MKPDWECBUAZOHP-AFYJWTTESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
160442,7bv1,DB08391,-8.2,"6,7-DIMETHOXY-4-[(3R)-3-(QUINOXALIN-2-YLOXY)PYRROLIDIN-1-YL]QUINAZOLINE",UBIIFKJMNRPNMT-CQSZACIVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
10092,6lzg,DB08241,-8.2,4-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)--BENZAMIDE,RUUOIINPNMNPIU-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
160447,7bv1,DB08397,-8.2,6-(DIFLUORO-PHOSPHONO-METHYL)-NAPHTHALENE-2-CARBOXYLIC ACID,NKGNOWNPXBURRW-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
55189,6crv,DB00715,-8.2,Paroxetine,AHOUBRCZNHFOSL-YOEHRIQHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59171,6crv,DB07155,-8.2,(3S)-1-CYCLOHEXYL-5-OXO-N-PHENYLPYRROLIDINE-3-CARBOXAMIDE,BVUSHGJZBZMDML-ZDUSSCGKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
101520,6vxs,DB05414,-8.2,Pipendoxifene,JICOGKJOQXTAIP-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
109668,6vxx,DB15102,-8.2,Pemigatinib,HCDMJFOHIXMBOV-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
101864,6vxs,DB06684,-8.2,Vilazodone,SGEGOXDYSFKCPT-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
160655,7bv1,DB09232,-8.2,Cilnidipine,KJEBULYHNRNJTE-DHZHZOJOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
101889,6vxs,DB06721,-8.2,Gimatecan,UIVFUQKYVFCEKJ-OPTOVBNMSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
109475,6vxx,DB13951,-8.2,Stanolone acetate,ILCTUFVQFCIIDS-NGFSFWIMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
160850,7bv1,DB11816,-8.2,Omecamtiv Mecarbil,RFUBTTPMWSKEIW-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
102394,6vxs,DB07343,-8.2,"4-[4-AMINO-6-(2,6-DICHLORO-PHENOXY)-[1,3,5]TRIAZIN-2-YLAMINO]-BENZONITRILE",NFNNMVVXXITVGD-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102404,6vxs,DB07354,-8.2,"2,3-DIMETHOXY-12H-[1,3]DIOXOLO[5,6]INDENO[1,2-C]ISOQUINOLIN-6-IUM",LXDREMZQGAILJU-UHFFFAOYSA-O,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
128278,6w4h,DB07421,-8.2,"4-{[(1R,2S)-1,2-dihydroxy-2-methyl-3-(4-nitrophenoxy)propyl]amino}-2-(trifluoromethyl)benzonitrile",INVUBEGZQHQAMY-SJORKVTESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
58916,6crv,DB06860,-8.2,"2-(2-chloropyridin-4-yl)-4-methyl-1H-isoindole-1,3(2H)-dione",YDJMWNHJNJVVMM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58907,6crv,DB06848,-8.2,"1-(1'-{[3-(methylsulfanyl)-2-benzothiophen-1-yl]carbonyl}spiro[1-benzofuran-3,4'-piperidin]-5-yl)methanamine",VCUDZTCDUDDJGG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
26503,6cs2,DB04649,-8.2,TETRAHEDRAL INTERMEDIATE OF BLASTICIDIN S,MVFPGTZTOAHVBP-HXYLPHSESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
109417,6vxx,DB13545,-8.2,Isobromindione,QFLZIWVSQDZLNW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
102552,6vxs,DB07531,-8.2,"4-{5-[(Z)-(2,4-DIOXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE",JNPRTUHVCHGFHJ-GHXNOFRVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102567,6vxs,DB07547,-8.2,5-(4-CYANOPHENYL)-3-{[(2-METHYLPHENYL)SULFONYL]AMINO}THIOPHENE-2-CARBOXYLIC ACID,RYXAHMSZLLIPRO-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
160883,7bv1,DB11864,-8.2,Preladenant,DTYWJKSSUANMHD-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160848,7bv1,DB11814,-8.2,PF-03882845,XNULRSOGWPFPBL-REWPJTCUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
102569,6vxs,DB07549,-8.2,"2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUORO-3-METHYL-6-PYRIDINYL)METHYL]ACETAMIDE",WOYBPRBUPLYTPY-UHFFFAOYSA-P,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
109409,6vxx,DB13534,-8.2,Gedocarnil,SLYDYLLJUXFULK-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
164602,7bv1,DB08191,-8.2,"4-(5-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl)benzoic acid",KSFDVNIKNYXUIP-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
102662,6vxs,DB07664,-8.2,"5-AMINO-3-{[4-(AMINOSULFONYL)PHENYL]AMINO}-N-(2,6-DIFLUOROPHENYL)-1H-1,2,4-TRIAZOLE-1-CARBOTHIOAMIDE",ARIOBGGRZJITQX-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
109408,6vxx,DB13533,-8.2,Methylestrenolone,ZXSWTMLNIIZPET-ZOFHRBRSSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
102674,6vxs,DB07678,-8.2,"(9ALPHA,13BETA,17BETA)-2-[(1Z)-BUT-1-EN-1-YL]ESTRA-1,3,5(10)-TRIENE-3,17-DIOL",ANAMDWGJXBYJEB-OPWFCKQNSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102676,6vxs,DB07680,-8.2,[(1S)-1-(5-CHLORO-1-BENZOTHIEN-3-YL)-2-(2-NAPHTHYLAMINO)-2-OXOETHYL]PHOSPHONIC ACID,HUJXISJLAPAFBO-IBGZPJMESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
58826,6crv,DB06712,-8.2,Nilvadipine,FAIIFDPAEUKBEP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
102690,6vxs,DB07697,-8.2,"1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-4-[(4-methoxyphenyl)sulfonyl]piperazine",HMGDKYUJSFVHIY-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
26545,6cs2,DB04704,-8.2,20-hydroxycholesterol,MCKLJFJEQRYRQT-MGNSQDQZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
102739,6vxs,DB07755,-8.2,"(2S)-1-[4-({4-[(2,5-Dichlorophenyl)amino]-2-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol",GNLAGGCSJGJECE-INIZCTEOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
109390,6vxx,DB13507,-8.2,Poldine,CQRKVVAGMJJJSR-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
102815,6vxs,DB07839,-8.2,"N-2-1,3-BENZOXAZOL-2-YL-3-CYCLOHEXYL-N-{2-[(4-METHOXYPHENYL)AMINO]ETHYL}-L-ALANINAMIDE",VFNWTXUFNNOQHD-QFIPXVFZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102576,6vxs,DB07559,-8.2,"(2Z)-2-cyano-N-(2,2'-dichlorobiphenyl-4-yl)-3-hydroxybut-2-enamide",DDSLONVJHZPSBB-UVTDQMKNSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
128509,6w4h,DB07697,-8.2,"1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-4-[(4-methoxyphenyl)sulfonyl]piperazine",HMGDKYUJSFVHIY-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
102366,6vxs,DB07312,-8.2,"2,5-DICHLORO-N-(5-CHLORO-1,3-BENZOXAZOL-2-YL)BENZENESULFONAMIDE",JCXZHFCBNFFHRC-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
109476,6vxx,DB13952,-8.2,Estradiol acetate,FHXBMXJMKMWVRG-SLHNCBLASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
160662,7bv1,DB09239,-8.2,Niguldipine,SVJMLYUFVDMUHP-XIFFEERXSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
101897,6vxs,DB06732,-8.2,beta-Naphthoflavone,OUGIDAPQYNCXRA-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101957,6vxs,DB06837,-8.2,"(2R)-N-4-hydroxy-2-(3-hydroxybenzyl)-N-1-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]butanediamide",VXDKQRWTOJFQKH-BJZITVGISA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101968,6vxs,DB06853,-8.2,N-cycloheptylglycyl-N-(4-carbamimidoylbenzyl)-L-prolinamide,BYTJPDBCLWUEBU-IBGZPJMESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101993,6vxs,DB06883,-8.2,1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-phenylurea,DHNYNLNKNQJSHF-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
55270,6crv,DB00814,-8.2,Meloxicam,ZRVUJXDFFKFLMG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59031,6crv,DB06996,-8.2,D-leucyl-N-(4-carbamimidoylbenzyl)-L-prolinamide,XFNMDMGNNKIXBT-CVEARBPZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55272,6crv,DB00817,-8.2,Rosoxacin,XBPZXDSZHPDXQU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
102048,6vxs,DB06944,-8.2,N-(3-cyclopropyl-1H-pyrazol-5-yl)-2-(2-naphthyl)acetamide,RIGZCVNCFXYBEG-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102057,6vxs,DB06955,-8.2,"3,4-bis(7-chloro-1H-indol-3-yl)-1H-pyrrole-2,5-dicarboxylic acid",OAMCCJASDLMTOO-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
128340,6w4h,DB07493,-8.2,"(2Z)-5'-BROMO-2,3'-BIINDOLE-2',3(1H,1'H)-DIONE AMMONIATE",IEQQJQHHJMQETK-YPKPFQOOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
102100,6vxs,DB07008,-8.2,"4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMIDAZOL-1-YL)PHENOXY]PYRIMIDINE",XPXGYINSBORUMM-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
160844,7bv1,DB11805,-8.2,Saracatinib,OUKYUETWWIPKQR-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
102173,6vxs,DB07091,-8.2,(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclohexyloxy)ethanoyl)pyrrolidine-2-carboxamide,IWPMQJKXKKKSEY-SFHVURJKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
160804,7bv1,DB11749,-8.2,(R)-Praziquantel,FSVJFNAIGNNGKK-KRWDZBQOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
102210,6vxs,DB07133,-8.2,D-phenylalanyl-N-(3-methylbenzyl)-L-prolinamide,CHKWABXWPATIIG-UXHICEINSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102229,6vxs,DB07156,-8.2,"(4Z)-6-bromo-4-({[4-(pyrrolidin-1-ylmethyl)phenyl]amino}methylidene)isoquinoline-1,3(2H,4H)-dione",JFEKAVPMVOLVTH-UNOMPAQXSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102246,6vxs,DB07175,-8.2,N-{2-methyl-5-[(6-phenylpyrimidin-4-yl)amino]phenyl}methanesulfonamide,CXQRKICWSCAUGW-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102249,6vxs,DB07179,-8.2,"3-((3-bromo-5-o-tolylpyrazolo[1,5-a]pyrimidin-7-ylamino)methyl)pyridine 1-oxide",DXUJQXZHHGJMFM-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102260,6vxs,DB07190,-8.2,3-cyclohexyl-D-alanyl-N-(3-chlorobenzyl)-L-prolinamide,JGFCNVHEEMBVJG-MOPGFXCFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
12657,6lzg,DB13648,-8.2,Alcuronium,MUQUYTSLDVKIOF-CHJKCJHBSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
102294,6vxs,DB07233,-8.2,N-{[4-(but-2-yn-1-yloxy)phenyl]sulfonyl}-5-methyl-D-tryptophan,SFVPXERGVLDWIS-OAQYLSRUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102310,6vxs,DB07252,-8.2,"3-({4-[(5-chloro-1,3-benzodioxol-4-yl)amino]pyrimidin-2-yl}amino)benzenesulfonamide",TZHCXOMEOHEZDX-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102323,6vxs,DB07267,-8.2,2-(6-methylpyridin-2-yl)-N-pyridin-4-ylquinazolin-4-amine,JONFDFIXMPXTRH-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
160837,7bv1,DB11795,-8.2,GSK-2636771,XTKLTGBKIDQGQL-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
102326,6vxs,DB07270,-8.2,"N-[7-(3-AMINOPHENYL)-5-METHOXY-1,3-BENZOXAZOL-2-YL]-2,5-DICHLOROBENZENESULFONAMIDE",GAYYMURZGLJDCT-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
160802,7bv1,DB11745,-8.2,Otenabant,UNAZAADNBYXMIV-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93475,6m71,DB06994,-8.2,"(2S,3S)-3-{3-[2-chloro-4-(methylsulfonyl)phenyl]-1,2,4-oxadiazol-5-yl}-1-cyclopentylidene-4-cyclopropyl-1-fluorobutan-2-amine",XCCSSVMRGIQMGF-LPHOPBHVSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
100819,6vxs,DB04097,-8.2,Uridine-5'-Diphosphate-4-Deoxy-4-Fluoro-Alpha-D-Galactose,OAPPZHVTNHJVAL-JZMIEXBBSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
100774,6vxs,DB04038,-8.2,Ergosterol,DNVPQKQSNYMLRS-APGDWVJJSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
98140,6vxs,DB00590,-8.2,Doxazosin,RUZYUOTYCVRMRZ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
55025,6crv,DB00519,-8.2,Trandolapril,VXFJYXUZANRPDJ-WTNASJBWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28397,6cs2,DB07986,-8.2,[4-(4-PHENYL-PIPERIDIN-1-YL)-BENZENESULFONYLAMINO]-ACETIC ACID,GNSLACGSDSJAIQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
59681,6crv,DB07754,-8.2,N-({(1R)-1-carboxy-2-[(4-fluorobenzyl)sulfanyl]ethyl}carbamoyl)-L-glutamic acid,IDTMSHGCAZPVLC-RYUDHWBXSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
98234,6vxs,DB00704,-8.2,Naltrexone,DQCKKXVULJGBQN-XFWGSAIBSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
159825,7bv1,DB06635,-8.2,Otamixaban,PFGVNLZDWRZPJW-OPAMFIHVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
9950,6lzg,DB08091,-8.2,3-FLUORO-5-MORPHOLIN-4-YL-N-[3-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-5-YL]BENZAMIDE,HIUFYIOMUILESI-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
109896,6vxx,DB00562,-8.2,Benzthiazide,NDTSRXAMMQDVSW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
26004,6cs2,DB04059,-8.2,8-(Pyrimidin-2-Ylamino)Naphthalene-2-Carboximidamide,GRQLDCHTDNYVQI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
59646,6crv,DB07713,-8.2,"(1S)-1-{[(4'-methoxy-1,1'-biphenyl-4-yl)sulfonyl]amino}-2-methylpropylphosphonic acid",BZVYQWLRCHLAGK-KRWDZBQOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
13319,6lzg,DB15137,-8.2,VK-2809,LGGPZDRLTDGYSQ-JADSYQMUSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
128759,6w4h,DB07986,-8.2,[4-(4-PHENYL-PIPERIDIN-1-YL)-BENZENESULFONYLAMINO]-ACETIC ACID,GNSLACGSDSJAIQ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
164882,7bv1,DB08907,-8.2,Canagliflozin,XTNGUQKDFGDXSJ-ZXGKGEBGSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
98485,6vxs,DB00997,-8.2,Doxorubicin,AOJJSUZBOXZQNB-TZSSRYMLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
159869,7bv1,DB06718,-8.2,Stanozolol,LKAJKIOFIWVMDJ-IYRCEVNGSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
28388,6cs2,DB07976,-8.2,3-{[(3-FLUORO-3'-METHOXYBIPHENYL-4-YL)AMINO]CARBONYL}THIOPHENE-2-CARBOXYLIC ACID,GIUMGVUBDBDTDX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
59629,6crv,DB07693,-8.2,"N-(3,5-dibromo-4-hydroxyphenyl)-2,6-dimethylbenzamide",IFECSMFQARKPSU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109882,6vxx,DB00547,-8.2,Desoximetasone,VWVSBHGCDBMOOT-IIEHVVJPSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
164871,7bv1,DB08709,-8.2,"2,3-diphenyl-1H-indole-7-carboxylic acid",OLUDUXWVPIEHDA-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
128743,6w4h,DB07968,-8.2,N-(2-CHLORO-4-FLUOROBENZOYL)-N'-(5-HYDROXY-2-METHOXYPHENYL)UREA,RFOBTYLRURSVJE-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
159922,7bv1,DB07084,-8.2,"N-(6,7,9,10,17,18,20,21-octahydrodibenzo[b,k][1,4,7,10,13,16]hexaoxacyclooctadecin-2-yl)acetamide",YHKGWOJTUMJPNW-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
98869,6vxs,DB01514,-8.2,Furazabol,RGLLOUBXMOGLDQ-IVEVATEUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
59568,6crv,DB07620,-8.2,"2-[(2,4-DICHLORO-5-METHYLPHENYL)SULFONYL]-1,3-DINITRO-5-(TRIFLUOROMETHYL)BENZENE",INAZPZCJNPPHGV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
128713,6w4h,DB07933,-8.2,Erteberel,XIESSJVMWNJCGZ-VKJFTORMSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
59550,6crv,DB07596,-8.2,"(17beta)-17-(cyanomethyl)-2-methox1tra-1(10),2,4-trien-3-yl sulfamate",NTSPHKOMJMBWOU-NNKXXINSSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
98110,6vxs,DB00554,-8.2,Piroxicam,QYSPLQLAKJAUJT-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
59694,6crv,DB07768,-8.2,Epitestosterone,MUMGGOZAMZWBJJ-KZYORJDKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109932,6vxx,DB00606,-8.2,Cyclothiazide,BOCUKUHCLICSIY-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
97883,6vxs,DB00276,-8.2,Amsacrine,XCPGHVQEEXUHNC-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
54970,6crv,DB00448,-8.2,Lansoprazole,MJIHNNLFOKEZEW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
97564,6m71,DB15169,-8.2,H3B-6527,MBWRLLRCTIYXDW-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
128856,6w4h,DB08096,-8.2,"8-(2-CHLOROPHENYLAMINO)-2-(2,6-DIFLUOROPHENYLAMINO)-9-ETHYL-9H-PURINE-1,7-DIIUM",ZWKOUFZHPNIQSH-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
97568,6m71,DB15183,-8.2,Fosmanogepix,JQONJQKKVAHONF-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
25870,6cs2,DB03893,-8.2,Thionicotinamide-Adenine-Dinucleotide,UQYPZLRUJKCREN-NNYOXOHSSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
97593,6m71,DB15224,-8.2,Lisavanbulin,NIPZLALJRAHABJ-IBGZPJMESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97601,6m71,DB15238,-8.2,Olinciguat,YWQFJNWMWZMXRW-HXUWFJFHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97605,6m71,DB15246,-8.2,Salvianolic acid A,YMGFTDKNIWPMGF-UCPJVGPRSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97619,6m71,DB15281,-8.2,Ravoxertinib,RZUOCXOYPYGSKL-GOSISDBHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
13467,6lzg,DB15414,-8.2,CM-4307,MLDQJTXFUGDVEO-FIBGUPNXSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
97636,6m71,DB15307,-8.2,Atabecestat,VLLFGVHGKLDDLW-SFHVURJKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59797,6crv,DB07883,-8.2,(2-AMINO-3-PHENYL-BICYCLO[2.2.1]HEPT-2-YL)-PHENYL-METHANONE,XJQDTOANLAPEIM-JRBPQWBISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109833,6vxx,DB00310,-8.2,Chlorthalidone,JIVPVXMEBJLZRO-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
97665,6m71,DB15362,-8.2,LSZ-102,SJXNPGGVGZXKKI-NYYWCZLTSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
109991,6vxx,DB00679,-8.2,Thioridazine,KLBQZWRITKRQQV-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109970,6vxx,DB00655,-8.2,Estrone,DNXHEGUUPJUMQT-CBZIJGRNSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
97697,6m71,DB15437,-8.2,Rocacetrapib,GBHPDJQHZADVAA-SOKVYYICSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97706,6m71,DB15450,-8.2,PF-05105679,BXNMZRPTQFVRFA-QGZVFWFLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59752,6crv,DB07832,-8.2,"4-{4-[(5-hydroxy-2-methylphenyl)amino]quinolin-7-yl}-1,3-thiazole-2-carbaldehyde",VKQPTVJDZIILPG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
159747,7bv1,DB05590,-8.2,Bedoradrine,OANCEOSLKSTLTA-REWPJTCUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97721,6m71,DB03453,-8.2,Methyl (2S)-2-[[2-[(3R)-1-carbamimidoylpiperidin-3-yl]acetyl]amino]-3-[4-(2-phenylethynyl)phenyl]propanoate,MRNGXYMKYHNMLV-PKTZIBPZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97759,6vxs,DB00137,-8.2,Lutein,KBPHJBAIARWVSC-RGZFRNHPSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
433,6lzg,HMDB0005014,-8.2,Celecoxib,RZEKVGVHFLEQIL-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
159779,7bv1,DB06529,-8.2,Ocinaplon,OQJFBUOFGHPMSR-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97833,6vxs,DB00220,-8.2,Nelfinavir,QAGYKUNXZHXKMR-HKWSIXNMSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
97836,6vxs,DB00224,-8.2,Indinavir,CBVCZFGXHXORBI-PXQQMZJSSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
59774,6crv,DB07858,-8.2,(2S)-2-(4-chlorophenyl)-2-[4-(1H-pyrazol-4-yl)phenyl]ethanamine,HWVGILTYGZFGLR-KRWDZBQOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
128648,6w4h,DB07856,-8.2,6-{4-[4-(4-CHLOROPHENYL)PIPERIDIN-4-YL]PHENYL}-9H-PURINE,HPWBHQIUIBFTQC-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
59518,6crv,DB07557,-8.2,"(5BETA)-PREGNANE-3,20-DIONE",XMRPGKVKISIQBV-XWOJZHJZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
6507,6lzg,DB00303,-8.2,Ertapenem,JUZNIMUFDBIJCM-ANEDZVCMSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
59405,6crv,DB07425,-8.2,Sobetirome,QNAZTOHXCZPOSA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
100061,6vxs,DB03076,-8.2,AHA047,CGBDAHCDSVOMCF-FYZVQMPESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
55097,6crv,DB00605,-8.2,Sulindac,MLKXDPUZXIRXEP-MFOYZWKCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
128590,6w4h,DB07791,-8.2,4-{[4-(1-CYCLOPROPYL-2-METHYL-1H-IMIDAZOL-5-YL)PYRIMIDIN-2-YL]AMINO}-N-METHYLBENZENESULFONAMIDE,MZWCVBFANHIPTJ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
100139,6vxs,DB03181,-8.2,"2-[4-(4-Hydroxy-3-Isopropyl-Phenoxy)-3,5-Dimethyl-Phenyl]-2h-[1,2,4]Triazine-3,5-Dione",RXQAVKWRCZYGMV-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
109764,6vxx,DB00231,-8.2,Temazepam,SEQDDYPDSLOBDC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55105,6crv,DB00613,-8.2,Amodiaquine,OVCDSSHSILBFBN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
164741,7bv1,DB08547,-8.2,PROGESTERONE-11-ALPHA-OL-HEMISUCCINATE,JBBNFGYRYNBDIH-DBGGZKJISA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
6540,6lzg,DB02295,-8.2,"N-[3-(Dimethylamino)Propyl]-2-({[4-({[4-(Formylamino)-1-Methyl-1h-Pyrrol-2-Yl]Carbonyl}Amino)-1-Methyl-1h-Pyrrol-2-Yl]Carbonyl}Amino)-5-Isopropyl-1,3-Thiazole-4-Carboxamide",VDYCDKRATGWFDA-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
160176,7bv1,DB07605,-8.2,"2-({4-[(5-CHLORO-1H-INDOL-2-YL)SULFONYL]PIPERAZIN-1-YL}CARBONYL)THIENO[3,2-B]PYRIDINE 4-OXIDE",DHDQMXPAANQKDC-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
128576,6w4h,DB07775,-8.2,"3',5'-DIBROMO-2',4,4',6'-TETRAHYDROXY AURONE",BRPKBUNFOZFULQ-SGAXSIHGSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
124396,6w4h,DB01100,-8.2,Pimozide,YVUQSNJEYSNKRX-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
99992,6vxs,DB02976,-8.2,Uridine-5'-monophosphate 2-deoxy-2-fluoro-galactopyranosyl-monophosphate ester,NGTCPFGWXMBZEP-KBQKSTHMSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
160186,7bv1,DB07616,-8.2,"4-{[4-(4-fluoro-3-methylphenyl)-1,3-thiazol-2-yl]amino}-2-hydroxybenzoic acid",LKZZDHKJFDTYCH-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
100337,6vxs,DB03446,-8.2,N-Benzyl-3-(alpha-D-galactopyranosyloxy)benzamide,FSMWGHKWKYCPKE-QTVCLEQKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
26186,6cs2,DB04270,-8.2,(S)-3-(4-(2-Carbazol-9-Yl-Ethoxy)-Phenyl)-2-Ethoxy-Propionic Acid,WUZIMDSVRIBNNI-DEOSSOPVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
59331,6crv,DB07335,-8.2,"3-[4-AMINO-1-(1-METHYLETHYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL]PHENOL",MWYBBCLGEHZSCP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
160284,7bv1,DB07966,-8.2,[4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]quinazolin-2-yl}amino)phenyl]acetonitrile,NVMCVWOODOWOLT-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59323,6crv,DB07327,-8.2,"(2-ACETYL-5-METHYLANILINO)(2,6-DIBROMOPHENYL)ACETAMIDE",FELUFXCUIYHAPB-INIZCTEOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59316,6crv,DB07319,-8.2,"6-(3-BROMO-2-NAPHTHYL)-1,3,5-TRIAZINE-2,4-DIAMINE",RXSSKAZHCZWJPP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
100523,6vxs,DB03714,-8.2,4-Carbamoyl-4-{[6-(Difluoro-Phosphono-Methyl)-Naphthalene-2-Carbonyl]-Amino}-Butyric Acid,OWWCIKSGGKYNHT-ZDUSSCGKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
100548,6vxs,DB03744,-8.2,"Cp403700, (S)-1-{2-[(5-Chloro-1h-Indole-2-Carbonyl)-Amino]-3-Phenyl-Propionyl}-Azetidine-3-Carboxylate",RONLONYAIBUEKT-IBGZPJMESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
10015,6lzg,DB08154,-8.2,3-chloro-5-[2-chloro-5-(1H-indazol-3-ylmethoxy)phenoxy]benzonitrile,WHCLIFOVZDANCU-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
28332,6cs2,DB07920,-8.2,N-oxo-2-[(4-phenylphenyl)sulfonylamino]ethanamide,OGRPZMQLAVBWPV-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
26218,6cs2,DB04306,-8.2,"5-[(4-Methylphenyl)Sulfanyl]-2,4-Quinazolinediamine",UOJFGEAPSYQDIP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
100723,6vxs,DB03966,-8.2,Clorobiocin,FJAQNRBDVKIIKK-LFLQOBSNSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
59351,6crv,DB07358,-8.2,"2-amino-N-(4-methyl-1,3-thiazol-2-yl)-5-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]benzamide",JEBOJMQHVUEKBE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59284,6crv,DB07286,-8.2,BMS-564929,KEJORAMIZFOODM-PWSUYJOCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
99955,6vxs,DB02929,-8.2,K201,KCWGETCFOVJEPI-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
99943,6vxs,DB02915,-8.2,"4-(2,4-Dimethyl-1,3-thiazol-5-yl)-N-[4-(trifluoromethyl)phenyl]-2-pyrimidinamine",MEZFDQUDLQCVNX-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
13199,6lzg,DB14882,-8.2,CEP-9722,CTLOSZHDGZLOQE-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
99227,6vxs,DB01975,-8.2,AMPCPR,ZPZRETFSCSWNDT-DBXCYWGHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
99229,6vxs,DB01977,-8.2,6-(N-Phenylcarbamyl)-2-Naphthalenecarboxamidine,AECPTICWHONWNW-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
59504,6crv,DB07540,-8.2,"4-{5-[(1Z)-1-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)ETHYL]-2-FURYL}BENZENESULFONAMIDE",AKFVRSQELXTCFW-JYRVWZFOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
13188,6lzg,DB14866,-8.2,Amcasertib,QDWKGEFGLQMDAM-ULJHMMPZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
164775,7bv1,DB08590,-8.2,1-(3-HYDROXYPROPYL)-2-[(3-NITROBENZOYL)AMINO]-1H-BENZIMIDAZOL-5-YL PIVALATE,CEAYRKIZESVQSN-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
99282,6vxs,DB02049,-8.2,2-{4-[4-(4-Chloro-Phenoxy)-Benzenesulfonyl]-Tetrahydro-Pyran-4-Yl}-N-Hydroxy-Acetamide,QOPFTBAEAJQKSY-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
13175,6lzg,DB14844,-8.2,ONC-201,VLULRUCCHYVXOH-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
99369,6vxs,DB02164,-8.2,N-Sulfo-Flavin Mononucleotide,ZLPUGFBBLGQWBS-SCRDCRAPSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
109813,6vxx,DB00284,-8.2,Acarbose,CEMXHAPUFJOOSV-XGWNLRGSSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
128638,6w4h,DB07844,-8.2,6-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1-BENZOTHIOPHENE-2-SULFONAMIDE,PHLKBODTBJLXRD-WFASDCNBSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
99492,6vxs,DB02329,-8.2,Carbenoxolone,OBZHEBDUNPOCJG-WBXJDKIVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
124390,6w4h,DB01094,-8.2,Hesperetin,AIONOLUJZLIMTK-AWEZNQCLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
128631,6w4h,DB07835,-8.2,"N-3-cyclopropyl-N-4-'-(cyclopropylmethyl)-6-methylbiphenyl-3,4'-dicarboxamide",BOPSUAHGQHFKGG-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
128630,6w4h,DB07834,-8.2,"N-(cyclopropylmethyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-4-carboxamide",FOHZGCHKLPIBBX-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
55084,6crv,DB00589,-8.2,Lisuride,BKRGVLQUQGGVSM-KBXCAEBGSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
160067,7bv1,DB07472,-8.2,"(R)-(+)9B-(3-METHYL)PHENYL-2,3-DIHYDROTHIAZOLO[2,3-A]ISOINDOL-5(9BH)-ONE",FQVDJZWFSZSGGA-QGZVFWFLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
128607,6w4h,DB07809,-8.2,4-({[4-(3-METHYLBENZOYL)PYRIDIN-2-YL]AMINO}METHYL)BENZENECARBOXIMIDAMIDE,MBJYEMUMDMGQQC-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
59449,6crv,DB07477,-8.2,Felbinac,QRZAKQDHEVVFRX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
128604,6w4h,DB07806,-8.2,"(2R,4S)-2-[(R)-BENZYLCARBAMOYL-PHENYLACETYL-METHYL]-5,5-DIMETHYL-THIAZOLIDINE-4-CARBOXYLIC ACID",UDMBRVGTYILYDX-SVFBPWRDSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
13123,6lzg,DB14726,-8.2,Dabigatran,YBSJFWOBGCMAKL-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
109785,6vxx,DB00253,-8.2,Medrysone,GZENKSODFLBBHQ-ILSZZQPISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
128595,6w4h,DB07796,-8.2,"(3ASR,4RS,8ASR,8BRS)-4-(2-(4-FLUOROBENZYL)-1,3-DIOXODEACAHYDROPYRROLO[3,4-A] PYRROLIZIN-4-YL)BENZAMIDINE",GJYCQHGTXMVIBG-MUGJNUQGSA-O,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
160106,7bv1,DB07519,-8.2,"(6R)-2-amino-6-[2-(3'-methoxybiphenyl-3-yl)ethyl]-3,6-dimethyl-5,6-dihydropyrimidin-4(3H)-one",VDFBMQAUECXNKR-OAQYLSRUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
99846,6vxs,DB02790,-8.2,Phenyl-Uridine-5'-Diphosphate,ZHUWBKDWWGKIEN-FMKGYKFTSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
164756,7bv1,DB08568,-8.2,(2S)-1-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}-3-PHENYLPROPAN-2-AMINE,BPNUQXPIQBZCMR-IBGZPJMESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
13154,6lzg,DB14790,-8.2,BPN-14770,KRRGWHSEDYQKDQ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
23760,6cs2,DB01392,-8.2,Yohimbine,BLGXFZZNTVWLAY-SCYLSFHTSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
147304,6w9q,DB11745,-8.2,Otenabant,UNAZAADNBYXMIV-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
72238,6m2n,DB00502,-8.2,Haloperidol,LNEPOXFFQSENCJ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78276,6m2n,DB11430,-8.2,Monensin,GAOZTHIDHYLHMS-KEOBGNEYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
134216,6w9c,DB02717,-8.2,Cellotetraose,LUEWUZLMQUOBSB-HGDSAIHNSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
80143,6m2n,DB14720,-8.2,Brovanexine,DQTRREPKGJIABH-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
82845,6m3m,DB03083,-8.2,IC261,JBJYTZXCZDNOJW-JLHYYAGUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
165847,7bv1,DB13101,-8.2,4SC-202,PRXXYMVLYKJITB-IZZDOVSWSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
116513,6w4b,DB02258,-8.2,SR11254,RNZIUDLOJHVHLZ-VYIQYICTSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
2485,6lzg,HMDB0041760,-8.2,Naringenin 5-O-glucuronide,ZTQGTBHHQGGBSV-ATVZYYHQSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
113527,6vxx,DB09330,-8.2,Osimertinib,DUYJMQONPNNFPI-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
67561,6lxt,DB06897,-8.2,"3-[3-chloro-5-(5-{[(1S)-1-phenylethyl]amino}isoxazolo[5,4-c]pyridin-3-yl)phenyl]propan-1-ol",MMGKIHLBFPJYJL-HNNXBMFYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
67571,6lxt,DB06908,-8.2,"(2S)-3-(1-{[2-(2-CHLOROPHENYL)-5-METHYL-1,3-OXAZOL-4-YL]METHYL}-1H-INDOL-5-YL)-2-ETHOXYPROPANOIC ACID",PAWOPJKHTZCKMT-QFIPXVFZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
139757,6w9c,DB13936,-8.2,JNJ-28330835,RYBKPGYFXRNMMU-LBPRGKRZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
74623,6m2n,DB03622,-8.2,"2-Hydroxy-5-[4-(2-Hydroxy-Ethyl)-Piperidin-1-Yl]-5-Phenyl-1h-Pyrimidine-4,6-Dione",IPBPOBHSNJFRFT-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
134245,6w9c,DB02819,-8.2,"Mono-[3,4-Dihydroxy-5-(5-Methyl-Benzoimidazol-1-Yl)-Tetrahydor-Furan-2-Ylmethyl] Ester",HGUDFQQPANTQEU-LPWJVIDDSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
134253,6w9c,DB02830,-8.2,FR236913,KCCUBLLGAMGDJL-HXUWFJFHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
29269,6cs2,DB08954,-8.2,Ifenprodil,UYNVMODNBIQBMV-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
78322,6m2n,DB11529,-8.2,Melengestrol,OKHAOBQKCCIRLO-IBVJIVQJSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
114213,6vxx,DB13101,-8.2,4SC-202,PRXXYMVLYKJITB-IZZDOVSWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138381,6w9c,DB11520,-8.2,Hygromycin B,GRRNUXAQVGOGFE-HUCHGKBZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
116746,6w4b,DB02551,-8.2,"6-[N-(4-Ethyl-1,2,3,4-Tetrahydro-6-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine",LVNMYQLXKMSQTG-AWEZNQCLSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
31514,6cs2,DB13946,-8.2,Testosterone undecanoate,UDSFVOAUHKGBEK-CNQKSJKFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
139769,6w9c,DB13951,-8.2,Stanolone acetate,ILCTUFVQFCIIDS-NGFSFWIMSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
30100,6cs2,DB12052,-8.2,Icariin,TZJALUIVHRYQQB-XLRXWWTNSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
78394,6m2n,DB11689,-8.2,Selumetinib,CYOHGALHFOKKQC-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
113551,6vxx,DB11485,-8.2,Ceftiofur,ZBHXIWJRIFEVQY-IHMPYVIRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
134309,6w9c,DB02901,-8.2,Stanolone,NVKAWKQGWWIWPM-ABEVXSGRSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
78372,6m2n,DB11662,-8.2,Rabusertib,SYYBDNPGDKKJDU-ZDUSSCGKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
67624,6lxt,DB06972,-8.2,"7A-[(4-cyanophenyl)methyl]-6-(3,5-dichlorophenyl)-5-oxo-2,3,5,7A-tetrahydro-1H-pyrrolo[1,2-A]pyrrole-7-carbonitrile",TZCXQSNBTXDAJG-QFIPXVFZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
70039,6lxt,DB12070,-8.2,Letermovir,FWYSMLBETOMXAG-QHCPKHFHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
134286,6w9c,DB02872,-8.2,"Cis-[4,5-Bis-(4-Bromophenyl)-2-(2-Ethoxy-4-Methoxyphenyl)-4,5-Dihydroimidazol-1-Yl]-[4-(2-Hydroxyethyl)Piperazin-1-Yl]Methanone",PVRYEWOXWGDQHA-URLMMPGGSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
70055,6lxt,DB12095,-8.2,Telotristat ethyl,MDSQOJYHHZBZKA-GBXCKJPGSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
74566,6m2n,DB03530,-8.2,Acylated Ceftazidime,VEHPZKIFULQYFS-BZXVCXBKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
113045,6vxx,DB08307,-8.2,"2-{HYDROXY[2-NITRO-4-(TRIFLUOROMETHYL)PHENYL]METHYLENE}CYCLOHEXANE-1,3-DIONE",PMHVFNYNPNKNRO-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
67520,6lxt,DB06848,-8.2,"1-(1'-{[3-(methylsulfanyl)-2-benzothiophen-1-yl]carbonyl}spiro[1-benzofuran-3,4'-piperidin]-5-yl)methanamine",VCUDZTCDUDDJGG-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
137245,6w9c,DB08064,-8.2,N-(3-TERT-BUTYL-1H-PYRAZOL-5-YL)-N'-{4-CHLORO-3-[(PYRIDIN-3-YLOXY)METHYL]PHENYL}UREA,NTMADESEDXKNFZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
120220,6w4b,DB08221,-8.2,N-{4-METHYL-3-[(3-PYRIMIDIN-4-YLPYRIDIN-2-YL)AMINO]PHENYL}-3-(TRIFLUOROMETHYL)BENZAMIDE,NESXBRNDMQUVNG-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
74817,6m2n,DB03869,-8.2,5'-O-(N-(L-Seryl)-Sulfamoyl)Adenosine,HQXFJGONGJPTLZ-YTMOPEAISA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
134056,6w9c,DB02507,-8.2,4-Hydroxy-3-[(1s)-3-Oxo-1-Phenylbutyl]-2h-Chromen-2-One,PJVWKTKQMONHTI-HNNXBMFYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137210,6w9c,DB08024,-8.2,1-[2-(S)-AMINO-3-BIPHENYL-4-YL-PROPIONYL]-PYRROLIDINE-2-(S)-CARBONITRILE,MUUVLSCVDXKQQV-OALUTQOASA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
74826,6m2n,DB03882,-8.2,"5-Alpha-Androstane-3-Beta,17beta-Diol",CBMYJHIOYJEBSB-YSZCXEEOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
67364,6lxt,DB06555,-8.2,Siramesine,XWAONOGAGZNUSF-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
82720,6m3m,DB02914,-8.2,"(6e)-6-[(2e,4e,6e)-3,7-Dimethylnona-2,4,6,8-Tetraenylidene]-1,5,5-Trimethylcyclohexene",FWNRILWHNGFAIN-OYUWDNMLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
67393,6lxt,DB06624,-8.2,Taranabant,QLYKJCMUNUWAGO-GAJHUEQPSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
72384,6m2n,DB00686,-8.2,Pentosan Polysulfate,FCCNSUIJIOOXEZ-SJYYZXOBSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
140961,6w9q,DB00320,-8.2,Dihydroergotamine,LUZRJRNZXALNLM-JGRZULCMSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
30069,6cs2,DB12008,-8.2,Prexasertib,DOTGPNHGTYJDEP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
82676,6m3m,DB02855,-8.2,N-(3-Propylcarbamoyloxirane-2-Carbonyl)-Isoleucyl-Proline,UDNIFTKCMDIXFC-ABHRYQDASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
134048,6w9c,DB02498,-8.2,Carba-Nicotinamide-Adenine-Dinucleotide,DGPLSUKWXXSBCU-VGXGLJSLSA-O,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
70129,6lxt,DB12204,-8.2,Terbogrel,XUTLOCQNGLJNSA-RGVLZGJSSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
30067,6cs2,DB12006,-8.2,BMS-906024,AYOUDDAETNMCBW-GSHUGGBRSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
118758,6w4b,DB06229,-8.2,Ocaperidone,ZZQNEJILGNNOEP-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
134337,6w9c,DB02936,-8.2,4-(1-Benzyl-3-Carbamoylmethyl-2-Methyl-1h-Indol-5-Yloxy)-Butyric Acid,STENXUCYNKOBHJ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
112997,6vxx,DB08244,-8.2,"(1S)-1-CYCLOPROPYL-2-[(2S)-4-(2,5-DIFLUOROPHENYL)-2-PHENYL-2,5-DIHYDRO-1H-PYRROL-1-YL]-2-OXOETHANAMINE",VCOUEHUEFUDZIS-PMACEKPBSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
74813,6m2n,DB03865,-8.2,6-Chloro-2-(2-Hydroxy-Biphenyl-3-Yl)-1h-Indole-5-Carboxamidine,FEKRWNWZMOSVBX-UHFFFAOYSA-O,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
84974,6m3m,DB07119,-8.2,1-CHLORO-6-(4-HYDROXYPHENYL)-2-NAPHTHOL,YHEHVRSGKUYDON-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
72401,6m2n,DB00704,-8.2,Naltrexone,DQCKKXVULJGBQN-XFWGSAIBSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
67461,6lxt,DB06743,-8.2,Ginkgolide A,FPUXKXIZEIDQKW-VKMVSBOZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
78249,6m2n,DB11385,-8.2,Cefalonium,FMZXNVLFJHCSAF-DNVCBOLYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
70083,6lxt,DB12130,-8.2,Lorlatinib,IIXWYSCJSQVBQM-LLVKDONJSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
29423,6cs2,DB09177,-8.2,p-Fluorofentanyl,KXUBAVLIJFTASZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
31566,6cs2,DB14035,-8.2,Englitazone,MVDXXGIBARMXSA-PYUWXLGESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
170,6lzg,HMDB0003236,-8.2,Solanidine,JVKYZPBMZPJNAJ-OQFNDJACSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
138464,6w9c,DB11698,-8.2,Ipragliflozin,AHFWIQIYAXSLBA-RQXATKFSSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
121302,6w4b,DB11691,-8.2,Naldemedine,AXQACEQYCPKDMV-RZAWKFBISA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
67410,6lxt,DB06660,-8.2,Saredutant,PGKXDIMONUAMFR-AREMUKBSSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
67406,6lxt,DB06652,-8.2,Vicriviroc,CNPVJJQCETWNEU-CYFREDJKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
80203,6m2n,DB14862,-8.2,PF-06815345,QTBYVAZRKWOIDU-FUHWJXTLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
70094,6lxt,DB12147,-8.2,Erdafitinib,OLAHOMJCDNXHFI-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
78195,6m2n,DB11184,-8.2,Oftasceine,DEGAKNSWVGKMLS-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
85031,6m3m,DB07183,-8.2,N-(4-phenoxyphenyl)-2-[(pyridin-4-ylmethyl)amino]nicotinamide,CPVRYQAOUPSUDO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
74515,6m2n,DB03460,-8.2,Violaxanthin,SZCBXWMUOPQSOX-WVJDLNGLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
113520,6vxx,DB09304,-8.2,Setiptiline,GVPIXRLYKVFFMK-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113919,6vxx,DB12275,-8.2,Seviteronel,ZBRAJOQFSNYJMF-SFHVURJKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138185,6w9c,DB09291,-8.2,Rolapitant,FIVSJYGQAIEMOC-ZGNKEGEESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138184,6w9c,DB09290,-8.2,Ramosetron,NTHPAPBPFQJABD-LLVKDONJSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138183,6w9c,DB09289,-8.2,Tianeptine,JICJBGPOMZQUBB-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
74285,6m2n,DB03154,-8.2,{[7-(Difluoro-Phosphono-Methyl)-Naphthalen-2-Yl]-Difluoro-Methyl}-Phosphonic Acid,VHKBLEYUHBIBNR-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
134548,6w9c,DB03222,-8.2,dATP,SUYVUBYJARFZHO-RRKCRQDMSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
30138,6cs2,DB12101,-8.2,CC-220,IXZOHGPZAQLIBH-NRFANRHFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
78562,6m2n,DB11939,-8.2,Henagliflozin,HYTPDMFFHVZBOR-VNXMGFANSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
67868,6lxt,DB07254,-8.2,"N-[3-[[4-[(5-CHLORO-1,3-BENZODIOXOL-4-YL)AMINO]PYRIMIDIN-2-YL]AMINO]PHENYL]METHANESULFONAMIDE",KQGTYXRWSIBDOZ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
84763,6m3m,DB06874,-8.2,"(6-[4-(AMINOMETHYL)-2,6-DIMETHYLPHENOXY]-2-{[4-(AMINOMETHYL)PHENYL]AMINO}-5-BROMOPYRIMIDIN-4-YL)METHANOL",LSIZSSASMKSUIU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
72532,6m2n,DB00858,-8.2,Drostanolone,IKXILDNPCZPPRV-RFMGOVQKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138142,6w9c,DB09227,-8.2,Barnidipine,VXMOONUMYLCFJD-DHLKQENFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
84751,6m3m,DB06860,-8.2,"2-(2-chloropyridin-4-yl)-4-methyl-1H-isoindole-1,3(2H)-dione",YDJMWNHJNJVVMM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
121184,6w4b,DB11431,-8.2,Moxidectin,YZBLFMPOMVTDJY-LSGXYNIPSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
67878,6lxt,DB07265,-8.2,"3-(9-HYDROXY-1,3-DIOXO-4-PHENYL-2,3-DIHYDROPYRROLO[3,4-C]CARBAZOL-6(1H)-YL)PROPANOIC ACID",JDARUOOLJCFUOY-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
31459,6cs2,DB13841,-8.2,Clopenthixol,WFPIAZLQTJBIFN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
72534,6m2n,DB00860,-8.2,Prednisolone,OIGNJSKKLXVSLS-VWUMJDOOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
74197,6m2n,DB03037,-8.2,Oxidized Acetyl Dithranol,IKFRFGXQHSBCQM-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137298,6w9c,DB08125,-8.2,"4-{[(2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]AMINO}-N-(1,3-THIAZOL-2-YL)BENZENESULFONAMIDE",BOMPRXSVSIPRDT-PTNGSMBKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
67948,6lxt,DB07340,-8.2,"N-6-cyclohexyl-N-2-(4-morpholin-4-ylphenyl)-9H-purine-2,6-diamine",ZFLJHSQHILSNCM-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
121145,6w4b,DB11363,-8.2,Alectinib,KDGFLJKFZUIJMX-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
78586,6m2n,DB11969,-8.2,Uprosertib,AXTAPYRUEKNRBA-JTQLQIEISA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80051,6m2n,DB14512,-8.2,Mometasone furoate,WOFMFGQZHJDGCX-ZULDAHANSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
69968,6lxt,DB11962,-8.2,GSK-1059615,QDITZBLZQQZVEE-YBEGLDIGSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
74214,6m2n,DB03060,-8.2,Sri-9662,WNDJHUNKXPAREB-PLNGDYQASA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
113089,6vxx,DB08361,-8.2,"2-{[(1R,2S)-2-aminocyclohexyl]amino}-4-[(3-methylphenyl)amino]pyrimidine-5-carboxamide",NZNTWOVDIXCHHS-LSDHHAIUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78579,6m2n,DB11962,-8.2,GSK-1059615,QDITZBLZQQZVEE-YBEGLDIGSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
140157,6w9c,DB15091,-8.2,Upadacitinib,WYQFJHHDOKWSHR-MNOVXSKESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
84746,6m3m,DB06853,-8.2,N-cycloheptylglycyl-N-(4-carbamimidoylbenzyl)-L-prolinamide,BYTJPDBCLWUEBU-IBGZPJMESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
67905,6lxt,DB07294,-8.2,"3-fluoro-4-[2-hydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8,-tetrahydro-naphtalen-2-yl)-acetylamino]-benzoic acid",AANFHDFOMFRLLR-IBGZPJMESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
67886,6lxt,DB07274,-8.2,"N-cyclopropyl-6-[(6,7-dimethoxyquinolin-4-yl)oxy]naphthalene-1-carboxamide",ZATGFXTWDKIEKC-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
121177,6w4b,DB11424,-8.2,Lufenuron,PWPJGUXAGUPAHP-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
135976,6w9c,DB06213,-8.2,Regadenoson,LZPZPHGJDAGEJZ-AKAIJSEGSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
67847,6lxt,DB07229,-8.2,"3-{5-[AMINO(IMINIO)METHYL]-1H-INDOL-2-YL}-5-METHOXY-1,1'-BIPHENYL-2-OLATE",MINVOLKUPZPDNX-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
139820,6w9c,DB14055,-8.2,(S)-Warfarin,PJVWKTKQMONHTI-HNNXBMFYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
80095,6m2n,DB14641,-8.2,Estriol tripropionate,ONMZMZJEZHMWQL-REUUDLSRSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
67771,6lxt,DB07140,-8.2,"5-[(3R)-3-(5-methoxybiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",JPENSYBRTSIYGO-AWEZNQCLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
84808,6m3m,DB06923,-8.2,2-(3-METHYLPHENYL)-1H-INDOLE-5-CARBOXIMIDAMIDE,KJUSXMYSVXZFDJ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
67760,6lxt,DB07127,-8.2,"{4-[2,2-BIS(5-METHYL-1,2,4-OXADIAZOL-3-YL)-3-PHENYLPROPYL]PHENYL}SULFAMIC ACID",SXDBFKLPNPUPRI-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
72500,6m2n,DB00823,-8.2,Ethynodiol diacetate,ONKUMRGIYFNPJW-KIEAKMPYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
74468,6m2n,DB03388,-8.2,"3-[(2,4-Dichlorobenzoyl)(Isopropyl)Amino]-5-Phenylthiophene-2-Carboxylic Acid",UKNZREOUDLFUFF-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138341,6w9c,DB11429,-8.2,Mibolerone,PTQMMNYJKCSPET-OMHQDGTGSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
80112,6m2n,DB14660,-8.2,Trenbolone acetate,CMRJPMODSSEAPL-FYQPLNBISA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
69997,6lxt,DB12006,-8.2,BMS-906024,AYOUDDAETNMCBW-GSHUGGBRSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
134406,6w9c,DB03037,-8.2,Oxidized Acetyl Dithranol,IKFRFGXQHSBCQM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
82957,6m3m,DB03230,-8.2,Adenosine-5'-Propylphosphate,XAMXMSZRQHPMRX-QYVSTXNMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
70006,6lxt,DB12020,-8.2,Tecovirimat,CSKDFZIMJXRJGH-VWLPUNTISA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
80124,6m2n,DB14672,-8.2,Oxazepam acetate,FYRWUTOZBRWYCS-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
120235,6w4b,DB08239,-8.2,"(2S)-4-(2,5-DIFLUOROPHENYL)-N-METHYL-2-PHENYL-N-PIPERIDIN-4-YL-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDE",NKLVBHMAIMEVEH-QFIPXVFZSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
113067,6vxx,DB08331,-8.2,"N-1H-imidazol-2-yl-N'-[4-(1H-imidazol-2-ylamino)phenyl]benzene-1,4-diamine",JHMXUERQMCJRHG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136026,6w9c,DB06345,-8.2,AR-9281,HUDQLWBKJOMXSZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
67773,6lxt,DB07142,-8.2,"5-[(3R)-3-(5-methoxy-3',5'-dimethylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",ATFDKOLABYIYCC-INIZCTEOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
138338,6w9c,DB11426,-8.2,Marbofloxacin,BPFYOAJNDMUVBL-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
113504,6vxx,DB09274,-8.2,Artesunate,FIHJKUPKCHIPAT-AHIGJZGOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
83062,6m3m,DB03365,-8.2,"4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline",BNDYIYYKEIXHNK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
78497,6m2n,DB11841,-8.2,Entinostat,INVTYAOGFAGBOE-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
114181,6vxx,DB12867,-8.2,Benperidol,FEBOTPHFXYHVPL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72518,6m2n,DB00843,-8.2,Donepezil,ADEBPBSSDYVVLD-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
118673,6w4b,DB05835,-8.2,NS-3728,OQRAKHDEGGGWQO-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
30111,6cs2,DB12066,-8.2,Orteronel,OZPFIJIOIVJZMN-SFHVURJKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
135992,6w9c,DB06249,-8.2,Arzoxifene,MCGDSOGUHLTADD-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
166041,7bv1,DB13610,-8.2,Flumedroxone,CDZJOBWKHSYNMO-SCUQKFFVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
80080,6m2n,DB14626,-8.2,Pregnenolone acetate,CRRKVZVYZQXICQ-RJJCNJEVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
136003,6w9c,DB06268,-8.2,Sitaxentan,PHWXUGHIIBDVKD-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
116859,6w4b,DB02704,-8.2,"(2r,3r,4r,5r)-3,4-Dihydroxy-N,N'-Bis[(1s,2r)-2-Hydroxy-2,3-Dihydro-1h-Inden-1-Yl]-2,5-Bis(2-Phenylethyl)Hexanediamide",GQKBYZPVKVXMJL-LAFNQVRVSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
29733,6cs2,DB11487,-8.2,Dexamethasone isonicotinate,BQTXJHAJMDGOFI-NJLPOHDGSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
138335,6w9c,DB11423,-8.2,Lasalocid,BBMULGJBVDDDNI-OWKLGTHSSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
74377,6m2n,DB03267,-8.2,1-Allyl-3-Butyl-8-(N-Acetyl-4-Aminobenzyl)-Xanthine,XFOWZKUTPKXWIE-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
8606,6lzg,DB06497,-8.2,Aplaviroc,GWNOTCOIYUNTQP-FQLXRVMXSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
30062,6cs2,DB12000,-8.2,Apabetalone,NETXMUIMUZJUTB-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
78021,6m2n,DB09168,-8.2,4-Phenylfentanyl,BXCJXJLHYMWMQU-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
85273,6m3m,DB07461,-8.2,"3-AMINO-3-BENZYL-9-CARBOXAMIDE[4.3.0]BICYCLO-1,6-DIAZANONAN-2-ONE",JVDDTUQPPBUQDD-DZGCQCFKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85271,6m3m,DB07459,-8.2,4-PHENOXY-N-(PYRIDIN-2-YLMETHYL)BENZAMIDE,HVLSCZSVTCNAQX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
120106,6w4b,DB08091,-8.2,3-FLUORO-5-MORPHOLIN-4-YL-N-[3-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-5-YL]BENZAMIDE,HIUFYIOMUILESI-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
85269,6m3m,DB07457,-8.2,"3-[1-(3-AMINOPROPYL)-1H-INDOL-3-YL]-4-(1H-INDOL-3-YL)-1H-PYRROLE-2,5-DIONE",APYXQTXFRIDSGE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
133648,6w9c,DB01967,-8.2,"N-{3-[(7ar,12as,12bs)-7-Oxo-1,3,4,6,7,7a,12a,12b-Octahydroindolo[2,3-a]Quinolizin-12(2h)-Yl]Propyl}Propane-2-Sulfonamide",LICJTIDRHJECTD-SFHVURJKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139546,6w9c,DB13616,-8.2,Melagatran,DKWNMCUOEDMMIN-PKOBYXMFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
66904,6lxt,DB04807,-8.2,4-NITROPHENYL-(6-S-ALPHA-D-XYLOPYRANOSYL)-BETA-D-GLUCOPYRANOSIDE,HQYVHBCTLFPWRQ-ZMFOIVQCSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
136177,6w9c,DB06710,-8.2,Methyltestosterone,GCKMFJBGXUYNAG-HLXURNFRSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
77590,6m2n,DB08559,-8.2,"N-[(2S,4S,6R)-2-(dihydroxymethyl)-4-hydroxy-3,3-dimethyl-7-oxo-4lambda-4-thia-1-azabicyclo[3.2.0]hept-6-yl]-2-phenylacetamide",WMPGEOZLAYOFHH-MBNYWOFBSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
120176,6w4b,DB08164,-8.2,"(3R,4R)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN-3-AMINE",GOBIXGZJSMAOFV-QRWLVFNGSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
72155,6m2n,DB00404,-8.2,Alprazolam,VREFGVBLTWBCJP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
82448,6m3m,DB02549,-8.2,3'-O-Acetylthymidine-5'-Diphosphate,UWSIAAWKEICIJY-IVZWLZJFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
29218,6cs2,DB08878,-8.2,Aminopterin,TVZGACDUOSZQKY-LBPRGKRZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
70251,6lxt,DB12375,-8.2,Oglemilast,OKFDRAHPFKMAJH-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
85257,6m3m,DB07444,-8.2,"6-(3-AMINOPROPYL)-4,9-DIMETHYLPYRROLO[3,4-C]CARBAZOLE-1,3(2H,6H)-DIONE",PKPNSCZPIWCHMW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136156,6w9c,DB06678,-8.2,Esmirtazapine,RONZAEMNMFQXRA-MRXNPFEDSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
75327,6m2n,DB04554,-8.2,8-Bromoadenosine-5'-Diphosphate,KVVVTFSHHQCHNZ-UUOKFMHZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77699,6m2n,DB08697,-8.2,"4-(2-aminoethoxy)-N-(3-chloro-5-piperidin-1-ylphenyl)-3,5-dimethylbenzamide",JDYIYIRPQKMWMM-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
66979,6lxt,DB04908,-8.2,Flibanserin,PPRRDFIXUUSXRA-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
137026,6w9c,DB07813,-8.2,GLYCYLALANYL-N-2-NAPHTHYL-L-PROLINEAMIDE,KCELZXZDIUJGNM-GUYCJALGSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
77677,6m2n,DB08665,-8.2,"6,11-DIHYDRO-11-ETHYL-6-METHYL-9-NITRO-5H-PYRIDO[2,3-B][1,5]BENZODIAZEPIN-5-ONE",YCFJZPGDTZVVSM-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
139569,6w9c,DB13649,-8.2,Proquazone,JTIGKVIOEQASGT-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
75253,6m2n,DB04461,-8.2,Coproporphyrinogen III,NIUVHXTXUXOFEB-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
136180,6w9c,DB06713,-8.2,Norelgestromin,ISHXLNHNDMZNMC-XUDSTZEESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139561,6w9c,DB13638,-8.2,Cefbuperazone,SMSRCGPDNDCXFR-CYWZMYCQSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
85236,6m3m,DB07420,-8.2,(1R)-4-(3-phenoxyphenyl)-1-phosphonobutane-1-sulfonic acid,RCGCZPXSRLLKCK-MRXNPFEDSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85240,6m3m,DB07425,-8.2,Sobetirome,QNAZTOHXCZPOSA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
165837,7bv1,DB13088,-8.2,AZD-0424,MVWATCATLSSVBH-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
85255,6m3m,DB07441,-8.2,"3-{[(9-CYANO-9,10-DIHYDRO-10-METHYLACRIDIN-9-YL)CARBONYL]AMINO}PROPANOIC ACID",FRBAOMHMZCGBOJ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
112877,6vxx,DB07949,-8.2,"({[(3E)-2'-OXO-2',7'-DIHYDRO-2,3'-BIINDOL-3(7H)-YLIDENE]AMINO}OXY)ACETIC ACID",BFQRPTKOSYMPOL-LALPNIDTSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
137025,6w9c,DB07812,-8.2,"N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyrrolo[2,3-b]pyridin-4-yl)thiophene-2-carboxamide",TWYNGDRSMHRPSY-MRXNPFEDSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140543,6w9c,DB12039,-8.2,Epicatechin,PFTAWBLQPZVEMU-UKRRQHHQSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
112872,6vxx,DB07943,-8.2,2-{4-[5-(4-chlorophenyl)-4-pyrimidin-4-yl-1H-pyrazol-3-yl]piperidin-1-yl}-2-oxoethanol,CATQHDWESBRRQA-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29211,6cs2,DB08867,-8.2,Ulipristal,HKDLNTKNLJPAIY-WKWWZUSTSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
85294,6m3m,DB07488,-8.2,"{(2Z)-4-AMINO-2-[(4-METHOXYPHENYL)IMINO]-2,3-DIHYDRO-1,3-THIAZOL-5-YL}(4-METHOXYPHENYL)METHANONE",XQKUGFIWKSKCDL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
72118,6m2n,DB00358,-8.2,Mefloquine,XEEQGYMUWCZPDN-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77527,6m2n,DB08488,-8.2,"4-{[(E)-2-(5-CHLOROTHIEN-2-YL)VINYL]SULFONYL}-1-(1H-PYRROLO[3,2-C]PYRIDIN-2-YLMETHYL)PIPERAZIN-2-ONE",PLWVUIRWJVKSSD-XBXARRHUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
114485,6vxx,DB13687,-8.2,Niaprazine,RSKQGBFMNPDPLR-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136966,6w9c,DB07747,-8.2,"(3R)-N-(4-CHLOROPHENYL)-3-(HYDROXYMETHYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONAMIDE",YTBGBMPLINFTBQ-OAHLLOKOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136215,6w9c,DB06771,-8.2,Besifloxacin,QFFGVLORLPOAEC-SNVBAGLBSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
75440,6m2n,DB04704,-8.2,20-hydroxycholesterol,MCKLJFJEQRYRQT-MGNSQDQZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
82353,6m3m,DB02429,-8.2,4-(Aminosulfonyl)-N-[(4-Fluorophenyl)Methyl]-Benzamide,IXDVPACDZDRCTN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
133556,6w9c,DB01838,-8.2,"6,4'-Dihydroxy-3-Methyl-3',5'-Dibromoflavone",GKDYOXMZSXVKPP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
120079,6w4b,DB08058,-8.2,"4-[3-(1,4-diazepan-1-ylcarbonyl)-4-fluorobenzyl]phthalazin-1(2H)-one",HGEPGGJUGUMFHT-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
17084,6cs2,HMDB0006203,-8.2,5-alpha-Dihydrotestosterone glucuronide,CLQMBSSRTBUNDV-CPKOJWPQSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
66530,6lxt,DB04298,-8.2,"3-(4-Amino-2-Tert-Butyl-5-Methyl-Phenylsulfanyl)-6-Cyclopentyl-4-Hydroxy-6-[2-(4-Hydroxy-Phenyl)-Ethyl]-5,6-Dihydro-Pyran-2-One",ZEBFKFGJWHOOST-LJAQVGFWSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
77506,6m2n,DB08462,-8.2,N-(4-PHENYLAMINO-QUINAZOLIN-6-YL)-ACRYLAMIDE,JGWHILNNHLDARR-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
114496,6vxx,DB13708,-8.2,Fenquizone,DBDTUXMDTSTPQZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31784,6cs2,DB14737,-8.2,Cannabinol,VBGLYOIFKLUMQG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
82329,6m3m,DB02402,-8.2,"5-(4-Methoxyphenoxy)-2,4-Quinazolinediamine",CPZJZAIZIMCJRC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
70245,6lxt,DB12364,-8.2,Betrixaban,XHOLNRLADUSQLD-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
82354,6m3m,DB02430,-8.2,Trehalose-6-Phosphate,LABSPYBHMPDTEL-LIZSDCNHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
66661,6lxt,DB04482,-8.2,Cmp-2-Keto-3-Deoxy-Octulosonic Acid,YWWJKULNWGRYAS-UOVSKDHASA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
77551,6m2n,DB08514,-8.2,"6-amino-2-[(thiophen-2-ylmethyl)amino]-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",IQKMJWDYMFWZRF-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
66770,6lxt,DB04623,-8.2,"2-ETHOXYETHYL (2S,3S)-4-((S)-2-BENZYL-3-OXO-4-((3AR,8R,8AS)-2-OXO-3,3A,8,8A-TETRAHYDRO-2H-INDENO[1,2-D]OXAZOL-8-YL)-2,3-DIHYDRO-1H-PYRROL-2-YL)-3-HYDROXY-1-PHENYLBUTAN-2-YLCARBAMATE",CGBRFCVAMLJVEA-ZGURCIGKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
140535,6w9c,DB12022,-8.2,Evatanepag,WOHRHWDYFNWPNG-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
114472,6vxx,DB13674,-8.2,Cridanimod,UOMKBIIXHQIERR-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138637,6w9c,DB12049,-8.2,Dasolampanel etibutil,HPBRMCFZIGUGTK-ZMMAXQRCSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
113587,6vxx,DB11591,-8.2,Bilastine,ACCMWZWAEFYUGZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136212,6w9c,DB06766,-8.2,Alcaftadine,MWTBKTRZPHJQLH-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
85315,6m3m,DB07513,-8.2,7-[(3-CHLOROBENZYL)OXY]-4-[(METHYLAMINO)METHYL]-2H-CHROMEN-2-ONE,JMGUSOLCNQVZCT-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80427,6m2n,DB15334,-8.2,Biochanin A,WUADCCWRTIWANL-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
85326,6m3m,DB07527,-8.2,"N-[(2R,3S)-3-AMINO-2-HYDROXY-4-PHENYLBUTYL]-4-METHOXY-2,3,6-TRIMETHYLBENZENESULFONAMIDE",HORGTFOBJRCVMO-ZWKOTPCHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
18369,6cs2,HMDB0029094,-8.2,Tryptophyl-Tryptophan,NQIHMZLGCZNZBN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
29795,6cs2,DB11645,-8.2,PF-4191834,DVNQWYLVSNPCJZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
66684,6lxt,DB04514,-8.2,Phosphoric Acid-2'-[2'-Deoxy-Uridine]Ester-5'-Guanosine Ester,DFYLLEBFVZTKHD-VMIOUTBZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
166515,7bv1,DB15287,-8.2,Elismetrep,CWEFDWIKLABKBX-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
85321,6m3m,DB07520,-8.2,"N-[1-(AMINOMETHYL)CYCLOPROPYL]-3-(MORPHOLIN-4-YLSULFONYL)-N-2-[(1S)-2,2,2-TRIFLUORO-1-(4-FLUOROPHENYL)ETHYL]-L-ALANINAMIDE",BJIKKEHGGYGGIX-HOTGVXAUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
18344,6cs2,HMDB0029006,-8.2,Phenylalanyl-Tryptophan,JMCOUWKXLXDERB-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
137043,6w9c,DB07832,-8.2,"4-{4-[(5-hydroxy-2-methylphenyl)amino]quinolin-7-yl}-1,3-thiazole-2-carbaldehyde",VKQPTVJDZIILPG-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
8859,6lzg,DB06916,-8.2,"N-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-1-[2-(1H-IMIDAZOL-1-YL)-6-METHYLPYRIMIDIN-4-YL]-D-PROLINAMIDE",LBCGUKCXRVUULK-QGZVFWFLSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
138542,6w9c,DB11817,-8.2,Baricitinib,XUZMWHLSFXCVMG-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
77859,6m2n,DB08905,-8.2,Formestane,OSVMTWJCGUFAOD-KZQROQTASA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
85070,6m3m,DB07230,-8.2,3-BROMO-6-HYDROXY-2-(4-HYDROXYPHENYL)-1H-INDEN-1-ONE,DHPCBFMFERFZLR-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
67223,6lxt,DB06194,-8.2,Elocalcitol,LRLWXBHFPGSUOX-GJQYOBCGSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
140189,6w9c,DB15316,-8.2,Florasulam,QZXATCCPQKOEIH-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
121352,6w4b,DB11769,-8.2,Funapide,NEBUOXBYNAHKFV-NRFANRHFSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
121330,6w4b,DB11737,-8.2,Icotinib,QQLKULDARVNMAL-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
67215,6lxt,DB06176,-8.2,Romidepsin,OHRURASPPZQGQM-GCCNXGTGSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
133967,6w9c,DB02398,-8.2,6-[N-(4-(Aminomethyl)Phenyl)Carbamyl]-2-Naphthalenecarboxamidine,NLBDETRVUYOIHQ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
67197,6lxt,DB06140,-8.2,SUVN-502,GWCYPEHWIZXYFZ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
70179,6lxt,DB12272,-8.2,Vidupiprant,PFWVGKROPKKEDW-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
75006,6m2n,DB04125,-8.2,N-Alpha-(2-Naphthylsulfonyl)-N(3-Amidino-L-Phenylalaninyl)-4-Acetyl-Piperazine,ZUWBXGHMVKDMQO-DEOSSOPVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77858,6m2n,DB08903,-8.2,Bedaquiline,QUIJNHUBAXPXFS-XLJNKUFUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
67187,6lxt,DB06090,-8.2,Bradanicline,OXKRFEWMSWPKKV-GHTZIAJQSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
136112,6w9c,DB06582,-8.2,Dextofisopam,RUJBDQSFYCKFAA-HNNXBMFYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
75020,6m2n,DB04142,-8.2,"3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid Dimethylamide",FEYGJZKVMASWJB-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
70172,6lxt,DB12264,-8.2,Atevirdine,UCPOMLWZWRTIAA-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
72349,6m2n,DB00641,-8.2,Simvastatin,RYMZZMVNJRMUDD-HGQWONQESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
136096,6w9c,DB06532,-8.2,Pafuramidine,UKOQVLAXCBRRGH-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
77984,6m2n,DB09080,-8.2,Olodaterol,COUYJEVMBVSIHV-SFHVURJKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137194,6w9c,DB08008,-8.2,"5-methyl-N-[4-(trifluoromethyl)phenyl][1,2,4]triazolo[1,5-a]pyrimidin-7-amine",LRHHXKBKRNNFRV-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138504,6w9c,DB11764,-8.2,Spebrutinib,KXBDTLQSDKGAEB-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139680,6w9c,DB13793,-8.2,Vinburnine,WYJAPUKIYAZSEM-MOPGFXCFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
82628,6m3m,DB02798,-8.2,Alpha-Methylene Adenosine Monophosphate,PXSSQXBLDTZHLF-IOSLPCCCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
30798,6cs2,DB12996,-8.2,Acteoside,FBSKJMQYURKNSU-ZLSOWSIRSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
20247,6cs2,HMDB0046342,-8.2,"TG(22:0/18:0/18:3(6Z,9Z,12Z))",NGDYFTHZYYRYJI-VNYALLQPSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
140186,6w9c,DB15307,-8.2,Atabecestat,VLLFGVHGKLDDLW-SFHVURJKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136109,6w9c,DB06579,-8.2,Adipiplon,UAMAIHOEGLEXSV-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
82611,6m3m,DB02770,-8.2,7-Alpha-D-Ribofuranosyl-2-Aminopurine-5'-Phosphate,UDRQVOJQMHZSIM-PULFBKJNSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
67275,6lxt,DB06306,-8.2,Onalespib,IFRGXKKQHBVPCQ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
114255,6vxx,DB13185,-8.2,Oxabolone cipionate,KHKDIUPVDIEHAH-KXLSUQFWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72358,6m2n,DB00655,-8.2,Estrone,DNXHEGUUPJUMQT-CBZIJGRNSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
70151,6lxt,DB12234,-8.2,BMS-214662,OLCWFLWEHWLBTO-HSZRJFAPSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
30150,6cs2,DB12116,-8.2,Epigallocatechin gallate,WMBWREPUVVBILR-WIYYLYMNSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
80287,6m2n,DB15059,-8.2,Aprocitentan,DKULOVKANLVDEA-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
139614,6w9c,DB13708,-8.2,Fenquizone,DBDTUXMDTSTPQZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
112902,6vxx,DB08130,-8.2,"N-(5-{3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]phenyl}-1,3,4-oxadiazol-2-yl)ethane-1,2-diamine",FPDWDLAITHFTTP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77805,6m2n,DB08811,-8.2,Tofisopam,RUJBDQSFYCKFAA-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
70220,6lxt,DB12322,-8.2,GW-870086,WUBKGTSFJSEIEM-NSHBDUGJSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
137062,6w9c,DB07855,-8.2,(S)-1-PHENYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE,CWHMAWBXRCDOEB-HNNXBMFYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137049,6w9c,DB07839,-8.2,"N-2-1,3-BENZOXAZOL-2-YL-3-CYCLOHEXYL-N-{2-[(4-METHOXYPHENYL)AMINO]ETHYL}-L-ALANINAMIDE",VFNWTXUFNNOQHD-QFIPXVFZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
85179,6m3m,DB07351,-8.2,O-(((1R)-((N-(PHENYL-METHOXY-CARBONYL)-ALANYL)-AMINO)METHYL)HYDROXYPHOSPHINYL)3-L-PHENYLLACTATE,ICACWKLCNCPHAM-YJBOKZPZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
67075,6lxt,DB05412,-8.2,Talmapimod,ZMELOYOKMZBMRB-DLBZAZTESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
133790,6w9c,DB02155,-8.2,Balanol Analog 8,XVLMXAUKCDSMMW-YXLARRHKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
75171,6m2n,DB04342,-8.2,7-((Carboxy(4-Hydroxyphenyl)Acetyl)Amino)-7-Methoxy-(3-((1-Methyl-1h-Tetrazol-5-Yl)Thio)Methyl)-8-Oxo-5-Oxa-1-Azabicyclo[4.2.0]Oct-2-Ene-2-Carboxylic Acid,JWCSIUVGFCSJCK-LIUKBUMOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
82471,6m3m,DB02583,-8.2,"N6-(2,5-Dimethoxy-Benzyl)-N6-Methyl-Pyrido[2,3-D]Pyrimidine-2,4,6-Triamine",HZTFNSCZLJLPEO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
70230,6lxt,DB12339,-8.2,Radezolid,BTTNOGHPGJANSW-IBGZPJMESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
138601,6w9c,DB11902,-8.2,Gisadenafil,YPFZMBHKIVDSNR-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
29228,6cs2,DB00826,-8.2,Natamycin,NCXMLFZGDNKEPB-FFPOYIOWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
77706,6m2n,DB08705,-8.2,"6-(5-BROMO-2-HYDROXYPHENYL)-2-OXO-4-PHENYL-1,2-DIHYDROPYRIDINE-3-CARBONITRILE",SVSYJTYGPLVUOZ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
67050,6lxt,DB05253,-8.2,Telapristone acetate,JVBGZFRPTRKSBB-MJBQOYBXSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
133898,6w9c,DB02300,-8.2,Calcipotriol,LWQQLNNNIPYSNX-UROSTWAQSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136125,6w9c,DB06609,-8.2,Odiparcil,JRHNIQQUVJOPQC-AQNFWKISSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137081,6w9c,DB07874,-8.2,"(6S)-2-amino-6-(3'-methoxybiphenyl-3-yl)-3,6-dimethyl-5,6-dihydropyrimidin-4(3H)-one",LQOCXPOKEPYGTJ-IBGZPJMESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
23274,6cs2,HMDB0059991,-8.2,5-(3'-Hydroxyphenyl)-gamma-valerolactone-3'-O-glucuronide,GZLRAFFGSYXMES-UAISQINXSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
166379,7bv1,DB14768,-8.2,PF-06459988,ODMXWZROLKITMS-RISCZKNCSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
75056,6m2n,DB04186,-8.2,"N'-(Pyrrolidino[2,1-B]Isoindolin-4-On-8-Yl)-N-(Pyridin-2-Yl)Urea",KLVYMYQTRZCMLE-CYBMUJFWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
85117,6m3m,DB07284,-8.2,"N-3-(3-PYRIDIN-3-YLBENZYL)PYRIDINE-2,3-DIAMINE",NQSBHBFOOVYRNM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
121398,6w4b,DB11830,-8.2,Mocetinostat,HRNLUBSXIHFDHP-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
118848,6w4b,DB06469,-8.2,Lestaurtinib,UIARLYUEJFELEN-DMVVYWCZSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
30779,6cs2,DB12966,-8.2,Falnidamol,FTFRZXFNZVCRSK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
85122,6m3m,DB07289,-8.2,5-[3-(BENZYLAMINO)PHENYL]-4-BROMO-3-(CARBOXYMETHOXY)THIOPHENE-2-CARBOXYLIC ACID,XEQPGVUGYAUMSA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
72269,6m2n,DB00546,-8.2,Adinazolam,GJSLOMWRLALDCT-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
67096,6lxt,DB05498,-8.2,KW-7158,NAFSYPCVPLWHFY-HNNXBMFYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
70204,6lxt,DB12303,-8.2,Motolimod,QSPOQCXMGPDIHI-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
75091,6m2n,DB04232,-8.2,N-Hydroxy-1-(4-Methoxyphenyl)Sulfonyl-4-Benzyloxycarbonyl-Piperazine-2-Carboxamide,DNGGPLKVDUPXFN-GOSISDBHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
29373,6cs2,DB09080,-8.2,Olodaterol,COUYJEVMBVSIHV-SFHVURJKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
113573,6vxx,DB11551,-8.2,Trenbolone,MEHHPFQKXOUFFV-OWSLCNJRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85128,6m3m,DB07295,-8.2,2-[(7-HYDROXY-NAPHTHALEN-1-YL)-OXALYL-AMINO]-BENZOIC ACID,IGOULVZYQKJJKC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83129,6m3m,DB03464,-8.2,Formycin-5'-Monophosphate,PBAHXXBYQACZMA-KSYZLYKTSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
138090,6w9c,DB09171,-8.2,??-Methylfentanyl,UXIGUKSHASXDNI-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
166488,7bv1,DB15229,-8.2,CNV-2197944,BLFJGFDZMABYMY-ZDUSSCGKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
73388,6m2n,DB01967,-8.2,"N-{3-[(7ar,12as,12bs)-7-Oxo-1,3,4,6,7,7a,12a,12b-Octahydroindolo[2,3-a]Quinolizin-12(2h)-Yl]Propyl}Propane-2-Sulfonamide",LICJTIDRHJECTD-SFHVURJKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
83708,6m3m,DB04239,-8.2,2-Amino-6-Aminomethyl-8-Phenylsulfanylmethyl-3h-Quinazolin-4-One,CBFXRTSHUMEYKQ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
135807,6w9c,DB05100,-8.2,Prinomastat,YKPYIPVDTNNYCN-INIZCTEOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140675,6w9c,DB13080,-8.2,Roluperidone,RNRYULFRLCBRQS-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
30227,6cs2,DB12222,-8.2,Lurtotecan,RVFGKBWWUQOIOU-NDEPHWFRSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
31062,6cs2,DB01016,-8.2,Glyburide,ZNNLBTZKUZBEKO-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
79069,6m2n,DB12682,-8.2,Mubritinib,ZTFBIUXIQYRUNT-MDWZMJQESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79070,6m2n,DB12685,-8.2,K-134,ULGNGSQNNMKROG-WOJBJXKFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
83721,6m3m,DB04259,-8.2,7n-Methyl-8-Hydroguanosine-5'-Monophosphate,ZMWJGXGSWZFZPJ-KQYNXXCUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
8275,6lzg,DB05129,-8.2,Elsamitrucin,MGQRRMONVLMKJL-KWJIQSIXSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
72840,6m2n,DB01208,-8.2,Sparfloxacin,DZZWHBIBMUVIIW-DTORHVGOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
68902,6lxt,DB08470,-8.2,"3-(4-fluorophenyl)-5-phenyl-4H-1,2,4-triazole",KMGPJKOKSYGMJD-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
79105,6m2n,DB12739,-8.2,Bindarit,MTHORRSSURHQPZ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
83732,6m3m,DB04274,-8.2,"5,4'-Dideoxyflavanone",SWAJPHCXKPCPQZ-AWEZNQCLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
30246,6cs2,DB12242,-8.2,AZD-7762,IAYGCINLNONXHY-LBPRGKRZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
30900,6cs2,DB13132,-8.2,Artemisinin,BLUAFEHZUWYNDE-NNWCWBAJSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
73310,6m2n,DB01858,-8.2,[1-(4-Fluorobenzyl)Cyclobutyl]Methyl (1s)-1-[Oxo(1h-Pyrazol-5-Ylamino)Acetyl]Pentylcarbamate,QTPYRNAKLBXKNP-SFHVURJKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
83793,6m3m,DB04357,-8.2,Pteric Acid,JOAQINSXLLMRCV-UHFFFAOYSA-O,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
79580,6m2n,DB13463,-8.2,Oxetorone,VZVRZTZPHOHSCK-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79608,6m2n,DB13504,-8.2,Cefetamet,MQLRYUCJDNBWMV-GHXIOONMSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137601,6w9c,DB08496,-8.2,(R)-warfarin,PJVWKTKQMONHTI-HNNXBMFYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
68945,6lxt,DB08521,-8.2,4-[5-(4-FLUORO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-3H-IMIDAZOL-4-YL]-PYRIDINE,CDMGBJANTYXAIV-HHHXNRCGSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
30901,6cs2,DB13135,-8.2,AGN-201904,PPCGSVWOZKNPCX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
79058,6m2n,DB12666,-8.2,Emapunil,NBMBIEOUVBHEBM-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79629,6m2n,DB13533,-8.2,Methylestrenolone,ZXSWTMLNIIZPET-ZOFHRBRSSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
135562,6w9c,DB04630,-8.2,Aldosterone,PQSUYGKTWSAVDQ-ZVIOFETBSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140012,6w9c,DB14753,-8.2,Hydroxystilbamidine,TUESWZZJYCLFNL-DAFODLJHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
68926,6lxt,DB08498,-8.2,"(1S)-1-(3-chlorophenyl)-2-oxo-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate",OVSAMUIBGQSLDC-INIZCTEOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
68925,6lxt,DB08497,-8.2,"(1S)-2-oxo-1-phenyl-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate",NKBDSMREMMRFSI-INIZCTEOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
30351,6cs2,DB12376,-8.2,Ricolinostat,QGZYDVAGYRLSKP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
83764,6m3m,DB04315,-8.2,Guanosine-5'-Diphosphate,QGWNDRXFNXRZMB-UUOKFMHZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
72855,6m2n,DB01228,-8.2,Encainide,PJWPNDMDCLXCOM-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
68850,6lxt,DB08407,-8.2,PLATENSIMYCIN,CSOMAHTTWTVBFL-OFBLZTNGSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
117797,6w4b,DB03966,-8.2,Clorobiocin,FJAQNRBDVKIIKK-LFLQOBSNSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
84256,6m3m,DB05134,-8.2,Tanespimycin,AYUNIORJHRXIBJ-TXHRRWQRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
8715,6lzg,DB06721,-8.2,Gimatecan,UIVFUQKYVFCEKJ-OPTOVBNMSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
69680,6lxt,DB11457,-8.2,Rotenone,JUVIOZPCNVVQFO-HBGVWJBISA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
113391,6vxx,DB09095,-8.2,Difluocortolone,OGPWIDANBSLJPC-RFPWEZLHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30214,6cs2,DB12204,-8.2,Terbogrel,XUTLOCQNGLJNSA-RGVLZGJSSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
69703,6lxt,DB11511,-8.2,Difloxacin,NOCJXYPHIIZEHN-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
73551,6m2n,DB02187,-8.2,Equilin,WKRLQDKEXYKHJB-HFTRVMKXSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
135410,6w9c,DB04434,-8.2,Naphthyridine Inhibitor,YRBHUKMLAGQYHS-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
78980,6m2n,DB12543,-8.2,Samidorphan,RYIDHLJADOKWFM-MAODMQOUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
73564,6m2n,DB02205,-8.2,"6-(1,1-Dimethylallyl)-2-(1-Hydroxy-1-Methylethyl)-2,3-Dihydro-7h-Furo[3,2-G]Chromen-7-One",JCDLLLXYAICSQV-INIZCTEOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
68653,6lxt,DB08159,-8.2,"4-(5,11-DIOXO-5H-INDENO[1,2-C]ISOQUINOLIN-6(11H)-YL)BUTANOATE",AHIJTWCJGCWHMT-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
78941,6m2n,DB12479,-8.2,Zabofloxacin,ZNPOCLHDJCAZAH-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
83649,6m3m,DB04164,-8.2,"1,4-Deoxy-4-((5-Hydroxymethyl-2,3,4-Trihydroxycyclohex-5-Enyl)Amino)Fructose",ZGWNRGISVMYHTF-KKXLKBQTSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84337,6m3m,DB05586,-8.2,Facinicline,TXCYUSKWBHUVEP-CYBMUJFWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
73579,6m2n,DB02224,-8.2,Taxifolin,CXQWRCVTCMQVQX-LSDHHAIUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137765,6w9c,DB08697,-8.2,"4-(2-aminoethoxy)-N-(3-chloro-5-piperidin-1-ylphenyl)-3,5-dimethylbenzamide",JDYIYIRPQKMWMM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
117966,6w4b,DB04190,-8.2,Inhibitor Bea425,AHAVBKNGKPWROK-UMFPTGFGSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
84304,6m3m,DB05431,-8.2,MLN-977,YANONWCPCKIWEC-CABCVRRESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
73490,6m2n,DB02102,-8.2,DMP450,KYRSNWPSSXSNEP-ZRTHHSRSSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
139995,6w9c,DB14715,-8.2,Cinazepam,NQTRBZXDWMDXAQ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
30222,6cs2,DB12218,-8.2,AZD-5363,JDUBGYFRJFOXQC-KRWDZBQOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
135520,6w9c,DB04574,-8.2,Estrone sulfate,JKKFKPJIXZFSSB-CBZIJGRNSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
84273,6m3m,DB05255,-8.2,Ronacaleret,FQJISUPNMFRIFZ-HXUWFJFHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
79705,6m2n,DB13638,-8.2,Cefbuperazone,SMSRCGPDNDCXFR-CYWZMYCQSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
135811,6w9c,DB05107,-8.2,16-Bromoepiandrosterone,CWVMWSZEMZOUPC-JUAXIXHSSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
83660,6m3m,DB04176,-8.2,"Phosporic Acid Mono-[3,4-Dihydroxy-5-(5-Methoxy-Benzoimidazol-1-Yl)-Tetrahydro-Furan-2-Ylmethyl] Ester",VYUPJUKSTVHSQI-LPWJVIDDSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
137656,6w9c,DB08559,-8.2,"N-[(2S,4S,6R)-2-(dihydroxymethyl)-4-hydroxy-3,3-dimethyl-7-oxo-4lambda-4-thia-1-azabicyclo[3.2.0]hept-6-yl]-2-phenylacetamide",WMPGEOZLAYOFHH-MBNYWOFBSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
84284,6m3m,DB05298,-8.2,Tetomilast,XDBHURGONHZNJF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
120781,6w4b,DB08931,-8.2,Riociguat,WXXSNCNJFUAIDG-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
68806,6lxt,DB08353,-8.2,"2-(CYCLOHEXYLMETHYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE",NCVMTHVSAJMOPI-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
83663,6m3m,DB04180,-8.2,"4-(Aminosulfonyl)-N-[(2,4-Difluorophenyl)Methyl]-Benzamide",NTDFJEKGSGSXME-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
31090,6cs2,DB13396,-8.2,Neocitrullamon,PAJBBDCZSMDSFL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
135446,6w9c,DB04480,-8.2,"3-(4-Fluorophenyl)-2-(6-Methylpyridin-2-Yl)-5,6-Dihydro-4h-Pyrrolo[1,2-B]Pyrazole",NBDZLUOYAAVYHF-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
29680,6cs2,DB11398,-8.2,Diclazuril,ZSZFUDFOPOMEET-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
137398,6w9c,DB08244,-8.2,"(1S)-1-CYCLOPROPYL-2-[(2S)-4-(2,5-DIFLUOROPHENYL)-2-PHENYL-2,5-DIHYDRO-1H-PYRROL-1-YL]-2-OXOETHANAMINE",VCOUEHUEFUDZIS-PMACEKPBSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
8335,6lzg,DB05465,-8.2,Tandutinib,UXXQOJXBIDBUAC-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
113983,6vxx,DB12545,-8.2,Indobufen,AYDXAULLCROVIT-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
135684,6w9c,DB04806,-8.2,(5-BROMO-4-CHLORO-3-INDOLYL)-A-D-MANNOSE,OPIFSICVWOWJMJ-HAAGFXOZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
135678,6w9c,DB04797,-8.2,Triazolopyridine,OVCXRBARSPBVMC-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
29632,6cs2,DB11275,-8.2,Epicriptine,SBFXHXZNBNFPHV-PXXBSISHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
83946,6m3m,DB04563,-8.2,CRA_9678,VIZNZQTZRMTYPZ-UHFFFAOYSA-M,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83939,6m3m,DB04555,-8.2,Cytidine-5'-Diphosphate,ZWIADYZPOWUWEW-XVFCMESISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
140699,6w9c,DB15137,-8.2,VK-2809,LGGPZDRLTDGYSQ-JADSYQMUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
29368,6cs2,DB09075,-8.2,Edoxaban,HGVDHZBSSITLCT-JLJPHGGASA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
84098,6m3m,DB04770,-8.2,"O6-(R)-ROSCOVITINE, R-2-(6-BENZYLOXY-9-ISOPROPYL-9H-PURIN-2-YLAMINO)-BUTAN-1-OL",HGADNQLEUZSUEJ-OAHLLOKOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
114032,6vxx,DB12623,-8.2,Taprenepag,MFFBXYNKZHTCEY-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79293,6m2n,DB13036,-8.2,Ramatroban,LDXDSHIEDAPSSA-OAHLLOKOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
83936,6m3m,DB04552,-8.2,Niflumic acid,JZFPYUNJRRFVQU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
135658,6w9c,DB04771,-8.2,1-GUANIDINO-4-(N-NITRO-BENZOYLAMINO-L-LEUCYL-L-PROLYLAMINO)BUTANE,FIZYZWLGMGGGBJ-OALUTQOASA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
30962,6cs2,DB01006,-8.2,Letrozole,HPJKCIUCZWXJDR-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
72934,6m2n,DB01388,-8.2,Mibefradil,HBNPJJILLOYFJU-VMPREFPWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
73056,6m2n,DB01536,-8.2,Androstenedione,AEMFNILZOJDQLW-QAGGRKNESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
30298,6cs2,DB12303,-8.2,Motolimod,QSPOQCXMGPDIHI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
69249,6lxt,DB08906,-8.2,Fluticasone furoate,XTULMSXFIHGYFS-VLSRWLAYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
29634,6cs2,DB11279,-8.2,Brilliant green cation,HXCILVUBKWANLN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
137476,6w9c,DB08346,-8.2,"(5Z)-13-CHLORO-14,16-DIHYDROXY-3,4,7,8,9,10-HEXAHYDRO-1H-2-BENZOXACYCLOTETRADECINE-1,11(12H)-DIONE",YUZYDHRGGDTZLG-DUXPYHPUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
72968,6m2n,DB01434,-8.2,19-norandrostenedione,JRIZOGLBRPZBLQ-QXUSFIETSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
69299,6lxt,DB08975,-8.2,Florantyrone,QOBAOSCOLAGPKI-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
79338,6m2n,DB13102,-8.2,AZD-8418,MCPBSUCAISQZQK-JTQLQIEISA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
84034,6m3m,DB04679,-8.2,H TYPE I TRISACCHARIDE,MGSDFCKWGHNUSM-QVPNGJTFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
79322,6m2n,DB13080,-8.2,Roluperidone,RNRYULFRLCBRQS-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137505,6w9c,DB08382,-8.2,Gosogliptin,QWEWGXUTRTXFRF-KBPBESRZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
135722,6w9c,DB04850,-8.2,Posizolid,HBUJYEUPIIJJOS-PBHICJAKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140043,6w9c,DB14828,-8.2,ABX-464,OZOGDCZJYVSUBR-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
73004,6m2n,DB01474,-8.2,"17alpha-methyl-3beta,17beta-dihydroxyandrost-4-ene",BNUOCVTVOYWNJC-DTMQFJJTSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
135731,6w9c,DB04863,-8.2,Lefradafiban,PGCFXITVMNNKON-ROUUACIJSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
113996,6vxx,DB12565,-8.2,Abexinostat,MAUCONCHVWBMHK-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
3858,6lzg,HMDB0049221,-8.2,TG(18:1(11Z)/14:1(9Z)/20:1(11Z)),SEJBPZVTMDKZMT-WWAUBUJQSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
137490,6w9c,DB08361,-8.2,"2-{[(1R,2S)-2-aminocyclohexyl]amino}-4-[(3-methylphenyl)amino]pyrimidine-5-carboxamide",NZNTWOVDIXCHHS-LSDHHAIUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137482,6w9c,DB08352,-8.2,"6-[4-(2-fluorophenyl)-1,3-oxazol-5-yl]-N-(1-methylethyl)-1,3-benzothiazol-2-amine",FQYJTHIYAQQJAB-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
84340,6m3m,DB05596,-8.2,PRX-03140,SCHKZZSVELPJKU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
73081,6m2n,DB01561,-8.2,Androstanedione,RAJWOBJTTGJROA-WZNAKSSCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
113990,6vxx,DB12555,-8.2,Nelotanserin,COSPVUFTLGQDQL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140717,6w9c,DB15173,-8.2,JNJ-42165279,YWGYNGCRVZLMCS-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
69065,6lxt,DB08664,-8.2,({3-[1-(4-HYDROXY-2-OXO-2H-CHROMEN-3-YL)-PROPYL]-PHENYLCARBAMOYL}-METHYL)-CARBAMIC ACID TERT-BUTYL ESTER,QUQQVMVIWCUYFV-KRWDZBQOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
118038,6w4b,DB04285,-8.2,"{4-[(2s,4e)-2-(1,3-Benzothiazol-2-Yl)-2-(1h-1,2,3-Benzotriazol-1-Yl)-5-Phenylpent-4-Enyl]Phenyl}(Difluoro)Methylphosphonic Acid",GBLDYRVJENYQNH-AGLOJYHOSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
79479,6m2n,DB13333,-8.2,Efloxate,ZVXBAHLOGZCFTP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
140029,6w9c,DB14787,-8.2,BMS-830216,YDTUJCNTIMWHPJ-NRFANRHFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
135619,6w9c,DB04715,-8.2,IMIDAZOPYRIDAZIN 1,IVUBNTNWKIPCPS-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
79436,6m2n,DB13277,-8.2,Benziodarone,CZCHIEJNWPNBDE-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
29658,6cs2,DB11366,-8.2,Roquinimex,SGOOQMRIPALTEL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
68980,6lxt,DB08560,-8.2,3-FLUORO-N-[1-(4-FLUOROPHENYL)-3-(2-THIENYL)-1H-PYRAZOL-5-YL]BENZENESULFONAMIDE,GULUFDCOGAXLEP-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
135608,6w9c,DB04693,-8.2,"(13S)-13-METHYLDODECAHYDRO-1H-CYCLOPENTA[A]PHENANTHRENE-3,17(2H,4H)-DIONE",CRDKSBHJIGNEOH-IMRIKWHGSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
79529,6m2n,DB13397,-8.2,Prenoxdiazine,PXZDWASDNFWKSD-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79197,6m2n,DB12890,-8.2,Dihydrexidine,BGOQGUHWXBGXJW-YOEHRIQHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79178,6m2n,DB12863,-8.2,Sivelestat,BTGNGJJLZOIYID-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137573,6w9c,DB08463,-8.2,(2R)-2-({9-(1-methylethyl)-6-[(4-pyridin-2-ylbenzyl)amino]-9H-purin-2-yl}amino)butan-1-ol,HOCBJBNQIQQQGT-LJQANCHMSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
79522,6m2n,DB13386,-8.2,Epimestrol,UHQGCIIQUZBJAE-RRQVMCLOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
83847,6m3m,DB04437,-8.2,"Cysteine-Methylene-Carbamoyl-1,10-Phenanthroline",ZFGIPRHDRFOMFO-LBPRGKRZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
69475,6lxt,DB09238,-8.2,Manidipine,ANEBWFXPVPTEET-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
118124,6w4b,DB04408,-8.2,Ncs-Chromophore,QZGIWPZCWHMVQL-UIYAJPBUSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
137514,6w9c,DB08391,-8.2,"6,7-DIMETHOXY-4-[(3R)-3-(QUINOXALIN-2-YLOXY)PYRROLIDIN-1-YL]QUINAZOLINE",UBIIFKJMNRPNMT-CQSZACIVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137524,6w9c,DB08402,-8.2,"2-[(2,4-DICHLOROBENZOYL)AMINO]-5-(PYRIMIDIN-2-YLOXY)BENZOIC ACID",VNDRRWBKNSHALL-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
84140,6m3m,DB04824,-8.2,Phenolphthalein,KJFMBFZCATUALV-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
114046,6vxx,DB12647,-8.2,Tocotrienol,GJJVAFUKOBZPCB-ZGRPYONQSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79244,6m2n,DB12960,-8.2,INCB-9471,ZMCJFJZOSKEMOM-DNKZPPIMSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
113354,6vxx,DB09038,-8.2,Empagliflozin,OBWASQILIWPZMG-QZMOQZSNSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140035,6w9c,DB14799,-8.2,PF-06821497,RXCVUHMIWHRLDF-HXUWFJFHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
83841,6m3m,DB04429,-8.2,4'-Hydroxyflavanone,ZLHVIYHWWQYJID-HNNXBMFYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
79228,6m2n,DB12935,-8.2,Remogliflozin etabonate,UAOCLDQAQNNEAX-ABMICEGHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
72914,6m2n,DB01340,-8.2,Cilazapril,HHHKFGXWKKUNCY-FHWLQOOXSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
30903,6cs2,DB13138,-8.2,Neladenoson bialanate,WESNEIGKOAXSGX-VXKWHMMOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
73132,6m2n,DB01624,-8.2,Zuclopenthixol,WFPIAZLQTJBIFN-DVZOWYKESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79219,6m2n,DB12924,-8.2,Ozenoxacin,XPIJWUTXQAGSLK-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137415,6w9c,DB08267,-8.2,"6-amino-4-(2-phenylethyl)-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",PBZAIUVFRISTSZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
30974,6cs2,DB13256,-8.2,Clothiapine,KAAZGXDPUNNEFN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
139512,6w9c,DB13571,-8.2,Pentamycin,AGJUUQSLGVCRQA-SWOUQTJZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
135812,6w9c,DB05116,-8.2,Thymectacin,CFBLUORPOFELCE-BACVZHSASA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
78932,6m2n,DB12468,-8.2,Pf-04531083,ZRJGMDIPCQOGNI-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
72624,6m2n,DB00962,-8.2,Zaleplon,HUNXMJYCHXQEGX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
84602,6m3m,DB06600,-8.2,Nemonoxacin,AVPQPGFLVZTJOR-RYUDHWBXSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
140145,6w9c,DB15063,-8.2,Inarigivir soproxil,CJCYTUJOSMYXLE-JDLSZIHUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
78722,6m2n,DB12174,-8.2,CUDC-101,PLIVFNIUGLLCEK-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
69900,6lxt,DB11864,-8.2,Preladenant,DTYWJKSSUANMHD-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
113466,6vxx,DB09219,-8.2,Bisoxatin,BPKUDUSVDVLOPY-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
134776,6w9c,DB03532,-8.2,Phosphomethylphosphonic Acid Guanylate Ester,GXTIEXDFEKYVGY-KQYNXXCUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
83305,6m3m,DB03719,-8.2,N-Ethyl-5'-Carboxamido Adenosine,JADDQZYHOWSFJD-BMYQGPEFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
69882,6lxt,DB11832,-8.2,Crenolanib,DYNHJHQFHQTFTP-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
30397,6cs2,DB12427,-8.2,Orvepitant,XWNBGDJPEXZSQM-VZOBGQTKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
134817,6w9c,DB03596,-8.2,N-[2-(1h-Indol-5-Yl)-Butyl]-4-Sulfamoyl-Benzamide,FSRPBGBMEKDSIJ-CYBMUJFWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
68124,6lxt,DB07548,-8.2,"2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUORO-6-PYRIDINYL)METHYL]ACETAMIDE",JXHWVKOKYDAROD-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
72636,6m2n,DB00978,-8.2,Lomefloxacin,ZEKZLJVOYLTDKK-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
113465,6vxx,DB09218,-8.2,Clonixin,CLOMYZFHNHFSIQ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30167,6cs2,DB12137,-8.2,GSK-256066,JFHROPTYMMSOLG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
69877,6lxt,DB11827,-8.2,Ertugliflozin,MCIACXAZCBVDEE-CUUWFGFTSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
68139,6lxt,DB07567,-8.2,"(2R,3R,4S)-3-(4-HYDROXYPHENYL)-4-METHYL-2-[4-(2-PYRROLIDIN-1-YLETHOXY)PHENYL]CHROMAN-6-OL",XPVKGTWRXBSJKO-LHXLBICKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
30858,6cs2,DB13074,-8.2,Macimorelin,UJVDJAPJQWZRFR-DHIUTWEWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
134918,6w9c,DB03737,-8.2,"4-((3r,4s,5r)-4-Amino-3,5-Dihydroxy-Hex-1-Ynyl)-5-Fluoro-3-[1-(3-Methoxy-1h-Pyrrol-2-Yl)-Meth-(Z)-Ylidene]-1,3-Dihydro-Indol-2-One",RAKYKJWUUUKCCW-MPLBGYFPSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
68212,6lxt,DB07653,-8.2,"N-(5,6-DIPHENYLFURO[2,3-D]PYRIMIDIN-4-YL)GLYCINE",VXTCEUDVOCLEJG-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
137318,6w9c,DB08147,-8.2,"4-[3-(dibenzylamino)phenyl]-2,4-dioxobutanoic acid",RMWVENXKUQXLPW-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
134899,6w9c,DB03714,-8.2,4-Carbamoyl-4-{[6-(Difluoro-Phosphono-Methyl)-Naphthalene-2-Carbonyl]-Amino}-Butyric Acid,OWWCIKSGGKYNHT-ZDUSSCGKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
83406,6m3m,DB03841,-8.2,Y-700,AETHRPHBGJAIBT-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
68088,6lxt,DB07507,-8.2,"2-(4-hydroxybiphenyl-3-yl)-4-methyl-1H-isoindole-1,3(2H)-dione",ROMNEYAQUBNRLR-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
29309,6cs2,DB08993,-8.2,Enviomycin,HPWIIERXAFODPP-GHBBWTPBSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
113138,6vxx,DB08582,-8.2,"N-(4-bromo-2-{[(3R,5S)-3,5-dimethylpiperidin-1-yl]carbonyl}phenyl)-4-morpholin-4-yl-4-oxobutanamide",DELARNBPJXTDBD-IYBDPMFKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
73918,6m2n,DB02659,-8.2,Cholic Acid,BHQCQFFYRZLCQQ-OELDTZBJSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
18083,6cs2,HMDB0012281,-8.2,Portulacaxanthin II,MBFJCQLVRQZZOV-KRDOMJLVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
69861,6lxt,DB11805,-8.2,Saracatinib,OUKYUETWWIPKQR-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
137316,6w9c,DB08145,-8.2,"6-(2,6-DIMETHOXYPHENYL)PYRIDO[2,3-D]PYRIMIDINE-2,7-DIAMINE",LRPHIAJXODIASX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
79920,6m2n,DB13958,-8.2,Trestolone acetate,IVCRCPJOLWECJU-XQVQQVTHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
83398,6m3m,DB03829,-8.2,Pseudouridine-5'-Monophosphate,MOBMOJGXNHLLIR-GBNDHIKLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
138001,6w9c,DB09003,-8.2,Clocapramine,QAZKXHSIKKNOHH-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
83272,6m3m,DB03672,-8.2,9-N-Phenylmethylamino-Tacrine,JYJAEHAURXXPSD-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
72619,6m2n,DB00956,-8.2,Hydrocodone,LLPOLZWFYMWNKH-CMKMFDCUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
68016,6lxt,DB07422,-8.2,(2S)-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]-3-(pentafluorophenoxy)propanamide,MMNRWNREMUMYQG-INIZCTEOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
83204,6m3m,DB03577,-8.2,Alpha-Benzyl-Aminobenzyl-Phosphonic Acid,SLMGIUOAZCYKPE-CQSZACIVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
69928,6lxt,DB11903,-8.2,GW842166,TWQYWUXBZHPIIV-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
166479,7bv1,DB15209,-8.2,MK-0736,ORQZQBUNAMJFCY-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
120348,6w4b,DB08384,-8.2,2-({4-[4-(pyridin-4-ylmethyl)-1H-pyrazol-3-yl]phenoxy}methyl)quinoline,RQDDHVVAAJVVKM-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
138078,6w9c,DB09136,-8.2,Isosulfan blue,YFKDCGWIINMRQY-UHFFFAOYSA-O,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
29296,6cs2,DB08981,-8.2,Fenbufen,ZPAKPRAICRBAOD-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
72569,6m2n,DB00901,-8.2,Bitolterol,FZGVEKPRDOIXJY-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
140753,6w9c,DB15241,-8.2,Methylsamidorphan,ATCVVCBJNHXIEX-ZAHKBLQYSA-O,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
68001,6lxt,DB07404,-8.2,"(1-HYDROXY-1-PHOSPHONO-2-[1,1';3',1'']TERPHENYL-3-YL-ETHYL)-PHOSPHONIC ACID",YXQQNSYZOQHKHD-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
135954,6w9c,DB06174,-8.2,Noscapine,AKNNEGZIBPJZJG-MSOLQXFVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
80036,6m2n,DB14210,-8.2,Moexiprilat,CMPAGYDKASJORH-YSSFQJQWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138085,6w9c,DB09166,-8.2,Etizolam,VMZUTJCNQWMAGF-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
134663,6w9c,DB03368,-8.2,"5-Methyl-5-(4-Phenoxy-Phenyl)-Pyrimidine-2,4,6-Trione",RTBMLCLTYAPKIF-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
83164,6m3m,DB03510,-8.2,6-O-Phosphoryl Inosine Monophosphate,RXRZOKQPANIEDW-KQYNXXCUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
134943,6w9c,DB03777,-8.2,Rbt205 Inhibitor,QMGUOJYZJKLOLH-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
74079,6m2n,DB02877,-8.2,Arotinoid acid,FOIVPCKZDPCJJY-JQIJEIRASA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
74069,6m2n,DB02861,-8.2,"4-(Aminosulfonyl)-N-[(3,4,5-Trifluorophenyl)Methyl]-Benzamide",DEHMSTGBNAXEGX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
30405,6cs2,DB12436,-8.2,Vofopitant,XILNRORTJVDYRH-HKUYNNGSSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
121121,6w4b,DB11273,-8.2,Dihydroergocornine,SEALOBQTUQIVGU-QNIJNHAOSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
73997,6m2n,DB02766,-8.2,(3r)-3-{[(Benzyloxy)Carbonyl]Amino}-2-Oxo-4-Phenylbutane-1-Diazonium,VLIGBVLLNSWVMI-MRXNPFEDSA-O,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
135923,6w9c,DB05772,-8.2,Rabeximod,PDNNUMNEXITLCZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
114163,6vxx,DB12833,-8.2,Tandospirone,CEIJFEGBUDEYSX-FZDBZEDMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
134736,6w9c,DB03477,-8.2,1-Phenylsulfonamide-3-Trifluoromethyl-5-Parabromophenylpyrazole,OYZKFVIVPRQRQQ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
84653,6m3m,DB06702,-8.2,Fesoterodine,DCCSDBARQIPTGU-HSZRJFAPSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
69913,6lxt,DB11883,-8.2,SB-705498,JYILLRHXRVTRSH-GFCCVEGCSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
134729,6w9c,DB03467,-8.2,Naringenin,FTVWIRXFELQLPI-ZDUSSCGKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
78636,6m2n,DB12049,-8.2,Dasolampanel etibutil,HPBRMCFZIGUGTK-ZMMAXQRCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
140148,6w9c,DB15071,-8.2,Omidenepag isopropyl,VIQCWEGEHRBLAC-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
113475,6vxx,DB09231,-8.2,Benidipine,QZVNQOLPLYWLHQ-ZEQKJWHPSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
69919,6lxt,DB11892,-8.2,Prulifloxacin,PWNMXPDKBYZCOO-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
135940,6w9c,DB06148,-8.2,Mianserin,UEQUQVLFIPOEMF-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
165999,7bv1,DB13552,-8.2,Trifluperidol,GPMXUUPHFNMNDH-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
117336,6w4b,DB03337,-8.2,1-(2-Amidinophenyl)-3-(Phenoxyphenyl)Urea,ZHCAYBOLUMAUQX-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
18075,6cs2,HMDB0012221,-8.2,Dopaxanthin,YSNPSKZBOQYUHH-AFUNOPLTSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
134981,6w9c,DB03823,-8.2,Epigallocatechin,XMOCLSLCDHWDHP-IUODEOHRSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137343,6w9c,DB08172,-8.2,(2Z)-N-(3-chloro-2'-methoxybiphenyl-4-yl)-2-cyano-3-hydroxybut-2-enamide,YUDQXOMZBLEWBH-KAMYIIQDSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
68503,6lxt,DB07993,-8.2,"N-3-[3-(1H-INDOL-6-YL)BENZYL]PYRIDINE-2,3-DIAMINE",LPQUIIHPUGDHJK-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
135218,6w9c,DB04142,-8.2,"3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid Dimethylamide",FEYGJZKVMASWJB-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
84415,6m3m,DB06127,-8.2,Bisegliptin,AKFNKZFJBFQFAA-DIOPXHOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
137818,6w9c,DB08752,-8.2,N-[(1S)-2-[(4-cyano-1-methylpiperidin-4-yl)amino]-1-(cyclohexylmethyl)-2-oxoethyl]morpholine-4-carboxamide,IRSOCWQJNYLTDD-SFHVURJKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
68487,6lxt,DB07975,-8.2,"2-({[3,5-DIFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)CYCLOPENT-1-ENE-1-CARBOXYLIC ACID",VTGXLCZUWFYELR-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
137815,6w9c,DB08749,-8.2,3-(2-AMINO-6-BENZOYLQUINAZOLIN-3(4H)-YL)-N-CYCLOHEXYL-N-METHYLPROPANAMIDE,KTRFBFMYAJOXLG-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
135841,6w9c,DB05294,-8.2,Vandetanib,UHTHHESEBZOYNR-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
68481,6lxt,DB07969,-8.2,3-[3-(4-methylpiperazin-1-yl)-7-(trifluoromethyl)quinoxalin-5-yl]phenol,QNCYYRHIUFGGJX-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
69781,6lxt,DB11687,-8.2,E-6201,MWUFVYLAWAXDHQ-HMNLTAHHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
83551,6m3m,DB04037,-8.2,"N,N-Bis(4-Chlorobenzyl)-1h-1,2,3,4-Tetraazol-5-Amine",UOUXILZUBDIWQU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
135175,6w9c,DB04086,-8.2,"2',4'-Dinitrophenyl-2deoxy-2-Fluro-B-D-Cellobioside",WFVCNOHOODVBQK-IUBYCILNSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
113417,6vxx,DB09168,-8.2,4-Phenylfentanyl,BXCJXJLHYMWMQU-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
68459,6lxt,DB07943,-8.2,2-{4-[5-(4-chlorophenyl)-4-pyrimidin-4-yl-1H-pyrazol-3-yl]piperidin-1-yl}-2-oxoethanol,CATQHDWESBRRQA-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
29694,6cs2,DB11427,-8.2,Maropitant,OMPCVMLFFSQFIX-CONSDPRKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
166405,7bv1,DB14840,-8.2,Ripretinib,CEFJVGZHQAGLHS-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
135253,6w9c,DB04186,-8.2,"N'-(Pyrrolidino[2,1-B]Isoindolin-4-On-8-Yl)-N-(Pyridin-2-Yl)Urea",KLVYMYQTRZCMLE-CYBMUJFWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
135839,6w9c,DB05288,-8.2,Anecortave acetate,YUWPMEXLKGOSBF-GACAOOTBSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
68562,6lxt,DB08059,-8.2,Wortmannin,QDLHCMPXEPAAMD-QAIWCSMKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
78927,6m2n,DB12463,-8.2,Semagacestat,PKXWXXPNHIWQHW-RCBQFDQVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
118517,6w4b,DB04960,-8.2,Tipifarnib,PLHJCIYEEKOWNM-HHHXNRCGSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
117584,6w4b,DB03696,-8.2,Lanosterol,CAHGCLMLTWQZNJ-BQNIITSRSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
117572,6w4b,DB03678,-8.2,"(6,7-Difluoro-Quinazolin-4-Yl)-(1-Methyl-2,2-Diphenyl-Ethyl)-Amine",WVGZKPGUHOZIJQ-HNNXBMFYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
69742,6lxt,DB11622,-8.2,Dehydrocholic acid,OHXPGWPVLFPUSM-KLRNGDHRSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
135260,6w9c,DB04196,-8.2,Pteroic Acid,JOAQINSXLLMRCV-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
73648,6m2n,DB02316,-8.2,"1-(5-Carboxypentyl)-5-[(2,6-Dichlorobenzyl)Oxy]-1 H-Indole-2-Carboxylic Acid",JTGPYFFQVOIJKR-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137803,6w9c,DB08737,-8.2,"(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-9-OL",FSYFYSFYUHBIHE-GLJUWKHASA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
72760,6m2n,DB01120,-8.2,Gliclazide,BOVGTQGAOIONJV-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
135831,6w9c,DB05253,-8.2,Telapristone acetate,JVBGZFRPTRKSBB-MJBQOYBXSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
165884,7bv1,DB13175,-8.2,Rheinanthrone,OZFQHULMMDWMIV-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
30375,6cs2,DB12404,-8.2,Remimazolam,CYHWMBVXXDIZNZ-KRWDZBQOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
68517,6lxt,DB08009,-8.2,"5-[(E)-(5-CHLORO-2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]-N-[2-(DIETHYLAMINO)ETHYL]-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXAMIDE",XPLJEFSRINKZLC-ATVHPVEESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
79748,6m2n,DB13689,-8.2,Tacalcitol,BJYLYJCXYAMOFT-RSFVBTMBSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
69731,6lxt,DB11592,-8.2,Nitrocefin,LHNIIDJCEODSHA-OQRUQETBSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
113420,6vxx,DB09171,-8.2,β-Methylfentanyl,UXIGUKSHASXDNI-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84448,6m3m,DB06199,-8.2,Atrasentan,MOTJMGVDPWRKOC-QPVYNBJUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
117426,6w4b,DB03466,-8.2,BMS184394,AYAJZQYENGWICE-QHCPKHFHSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
83464,6m3m,DB03917,-8.2,N-Ethyl Retinamide,WKYDOCGICAMTKE-NBIQJRODSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
68346,6lxt,DB07811,-8.2,"N-cyclopropyl-2',6-dimethyl-4'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-3-carboxamide",UBVTVSINEVHYSY-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
68341,6lxt,DB07806,-8.2,"(2R,4S)-2-[(R)-BENZYLCARBAMOYL-PHENYLACETYL-METHYL]-5,5-DIMETHYL-THIAZOLIDINE-4-CARBOXYLIC ACID",UDMBRVGTYILYDX-SVFBPWRDSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
118598,6w4b,DB05423,-8.2,ORG-34517,DFELGYQKEOCHOA-BZAFBGKRSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
73870,6m2n,DB02596,-8.2,"Alpha,Beta-Methyleneadenosine-5'-Triphosphate",CAWZRIXWFRFUQB-IOSLPCCCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
69836,6lxt,DB11772,-8.2,Pilaralisib,QINPEPAQOBZPOF-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
69840,6lxt,DB11778,-8.2,Danusertib,XKFTZKGMDDZMJI-HSZRJFAPSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
113160,6vxx,DB08610,-8.2,N-(2-AMINOETHYL)-2-{3-CHLORO-4-[(4-ISOPROPYLBENZYL)OXY]PHENYL} ACETAMIDE,DFXJYVQAAFOZDP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
83438,6m3m,DB03883,-8.2,Carboxyethyllumazine,PTYCEIBBGGLADD-PJKMHFRUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
135024,6w9c,DB03882,-8.2,"5-Alpha-Androstane-3-Beta,17beta-Diol",CBMYJHIOYJEBSB-YSZCXEEOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
166396,7bv1,DB14802,-8.2,ONO-2952,ZBQMTQGDBFZUBG-NRFANRHFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
68272,6lxt,DB07728,-8.2,"2-[2-(2-FLUOROPHENYL)PYRIDIN-4-YL]-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE",XJJYJNMNYDNXNO-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
137322,6w9c,DB08151,-8.2,"(5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-phenyl-1,6-dioxa-2-azaspiro[4.5]dec-2-ene-8,9,10-triol",YLTDNVVQKRHCJP-RKQHYHRCSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
113161,6vxx,DB08611,-8.2,"2-[(2',3',4'-TRIFLUOROBIPHENYL-2-YL)OXY]ETHANOL",AGXPXFPIOHNDAN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30193,6cs2,DB12173,-8.2,Diphencyprone,HCIBTBXNLVOFER-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
3704,6lzg,HMDB0001056,-8.2,Dihydrofolic acid,OZRNSSUDZOLUSN-LBPRGKRZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
69824,6lxt,DB11753,-8.2,Rifamycin,HJYYPODYNSCCOU-ODRIEIDWSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
68404,6lxt,DB07875,-8.2,"5-Chloro-thiophene-2-carboxylic acid ((3S,4S)-1-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-methyl}-4-hydroxy-pyrrolidin-3-yl)-amide",ARAVOODWJJJNBY-IRXDYDNUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
69794,6lxt,DB11704,-8.2,Adomeglivant,FASLTMSUPQDLIB-MHZLTWQESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
84451,6m3m,DB06202,-8.2,Lasofoxifene,GXESHMAMLJKROZ-IAPPQJPRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
113435,6vxx,DB09187,-8.2,Lortalamine,MJRPHRMGEKCADU-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
69801,6lxt,DB11718,-8.2,Encorafenib,CMJCXYNUCSMDBY-ZDUSSCGKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
83533,6m3m,DB04010,-8.2,2-(3'-Methoxyphenyl) Benzimidazole-4-Carboxamide,NVVWVYYHTKCIAE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
79869,6m2n,DB13851,-8.2,Artemotil,NLYNIRQVMRLPIQ-XQLAAWPRSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79806,6m2n,DB13772,-8.2,Rufloxacin,NJCJBUHJQLFDSW-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
29699,6cs2,DB11431,-8.2,Moxidectin,YZBLFMPOMVTDJY-LSGXYNIPSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
117433,6w4b,DB03476,-8.2,Trans-6-(2-Phenylcyclopropyl)-Naphthalene-2-Carboxamidine,NQRIWXVAIWPBEM-OALUTQOASA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
31288,6cs2,DB13640,-8.2,Acetoxolone,FTQDJVZNPJRVPG-XWEVEMRCSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
30864,6cs2,DB13083,-8.2,Talarozole,SNFYYXUGUBUECJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
137881,6w9c,DB08828,-8.2,Vismodegib,BPQMGSKTAYIVFO-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
30862,6cs2,DB00997,-8.2,Doxorubicin,AOJJSUZBOXZQNB-TZSSRYMLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
73784,6m2n,DB02485,-8.2,Cytidine-5'-Monophosphate-5-N-Acetylneuraminic Acid,TXCIAUNLDRJGJZ-BILDWYJOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
85359,6m3m,DB07564,-8.2,"6-amino-2-[(2-morpholin-4-ylethyl)amino]-3,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",JUHXOBNFTFUPKQ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
72982,6m2n,DB01451,-8.2,1-Androstenedione,WJIQCDPCDVWDDE-WZNAKSSCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
136963,6w9c,DB07743,-8.2,"S-[5-(TRIFLUOROMETHYL)-4H-1,2,4-TRIAZOL-3-YL] 5-(PHENYLETHYNYL)FURAN-2-CARBOTHIOATE",VNGWUVBXUIDQTK-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
65115,6lxt,DB02411,-8.2,"2-(11-{2-[Benzenesulfonyl-(3-Methyl-Butyl)-Amino]-1-Hydroxy-Ethyl}-6,9-Dioxo-2-Oxa-7,10-Diaza-Bicyclo[11.2.2]Heptadeca-1(16),13(17),14-Trien-8-Yl)-Acetamide, Inhibitor 2",HOUHLOFMBSYNBO-KKUQBAQOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
85738,6m3m,DB08008,-8.2,"5-methyl-N-[4-(trifluoromethyl)phenyl][1,2,4]triazolo[1,5-a]pyrimidin-7-amine",LRHHXKBKRNNFRV-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
140494,6w9c,DB11961,-8.2,AZD-1236,SFJFBTPHDHUUPU-OAHLLOKOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
76505,6m2n,DB07283,-8.2,"9-benzyl-2,3,4,9-tetrahydro-1H-carbazole-8-carboxylic acid",VDOXYKGIKBUISK-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
120032,6w4b,DB08006,-8.2,"N-anthracen-2-yl-5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7-amine",OXYDLVAOXASTMW-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
75775,6m2n,DB05903,-8.2,KOS-1584,XAYAKDZVINDZGB-BMVMHAJPSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
85734,6m3m,DB08004,-8.2,"(2S)-2-{[3-(3-aminophenyl)imidazo[1,2-b]pyridazin-6-yl]amino}-3-methylbutan-1-ol",PUMVONFFLKPPIM-CQSZACIVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
76943,6m2n,DB07796,-8.2,"(3ASR,4RS,8ASR,8BRS)-4-(2-(4-FLUOROBENZYL)-1,3-DIOXODEACAHYDROPYRROLO[3,4-A] PYRROLIZIN-4-YL)BENZAMIDINE",GJYCQHGTXMVIBG-MUGJNUQGSA-O,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80813,6m3m,DB00459,-8.2,Acitretin,IHUNBGSDBOWDMA-AQFIFDHZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
76952,6m2n,DB07806,-8.2,"(2R,4S)-2-[(R)-BENZYLCARBAMOYL-PHENYLACETYL-METHYL]-5,5-DIMETHYL-THIAZOLIDINE-4-CARBOXYLIC ACID",UDMBRVGTYILYDX-SVFBPWRDSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
142292,6w9q,DB02009,-8.2,"L-756,423",AOMZDQMIOCTPQP-QHQMVRJISA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
76005,6m2n,DB06625,-8.2,Vipadenant,HQSBCDPYXDGTCL-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
63967,6lxt,DB00910,-8.2,Paricalcitol,BPKAHTKRCLCHEA-UBFJEZKGSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
76959,6m2n,DB07813,-8.2,GLYCYLALANYL-N-2-NAPHTHYL-L-PROLINEAMIDE,KCELZXZDIUJGNM-GUYCJALGSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
16889,6cs2,HMDB0004999,-8.2,Loperamide,RDOIQAHITMMDAJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
71783,6lxt,DB15273,-8.2,VS-4718,IGUBBWJDMLCRIK-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
132955,6w9c,DB01041,-8.2,Thalidomide,UEJJHQNACJXSKW-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
114884,6vxx,DB15333,-8.2,AZD-1386,FPGNKXCEPARJDI-ZDUSSCGKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
166279,7bv1,DB14555,-8.2,Ursadiol,RTLXJEJRLWILSU-GWNGJUQLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
70637,6lxt,DB12966,-8.2,Falnidamol,FTFRZXFNZVCRSK-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
81389,6m3m,DB01140,-8.2,Cefadroxil,BOEGTKLJZSQCCD-UEKVPHQBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81388,6m3m,DB01139,-8.2,Cefapirin,UQLLWWBDSUHNEB-CZUORRHYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
76476,6m2n,DB07251,-8.2,"N'-(3-CHLORO-4-METHOXY-PHENYL)-N-(3,4,5-TRIMETHOXYPHENYL)-1,3,5-TRIAZINE-2,4-DIAMINE",ZVWFECUPYCFYBL-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
133264,6w9c,DB01474,-8.2,"17alpha-methyl-3beta,17beta-dihydroxyandrost-4-ene",BNUOCVTVOYWNJC-DTMQFJJTSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
133241,6w9c,DB01450,-8.2,Dihydroetorphine,BRTSNYPDACNMIP-FAWZKKEFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
85697,6m3m,DB07963,-8.2,"N-[(2',4'-DIFLUORO-4-HYDROXY-5-IODOBIPHENYL-3-YL)CARBONYL]-BETA-ALANINE",YZQVXOZCPWWABX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
113740,6vxx,DB12011,-8.2,Fevipiprant,GFPPXZDRVCSVNR-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165779,7bv1,DB13002,-8.2,HKI-357,NERXPXBELDBEPZ-RMKNXTFCSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
112705,6vxx,DB07751,-8.2,"(2S)-1-[4-({6-[(2,6-Difluorophenyl)amino]-4-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol",ZVSBKYYVBCKDBO-HNNXBMFYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85809,6m3m,DB08089,-8.2,LGD-2226,ULBPQWIGZUGPHU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
29529,6cs2,DB09304,-8.2,Setiptiline,GVPIXRLYKVFFMK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
115057,6w4b,DB00398,-8.2,Sorafenib,MLDQJTXFUGDVEO-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
31860,6cs2,DB14896,-8.2,Selitrectinib,OEBIHOVSAMBXIB-SJKOYZFVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
81690,6m3m,DB01559,-8.2,Clotiazepam,CHBRHODLKOZEPZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85794,6m3m,DB08072,-8.2,"4-(2-AMINOETHOXY)-3,5-DICHLORO-N-[3-(1-METHYLETHOXY)PHENYL]BENZAMIDE",AYKUIRSGEMLIFT-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
133162,6w9c,DB01320,-8.2,Fosphenytoin,XWLUWCNOOVRFPX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
8466,6lzg,DB06163,-8.2,Plevitrexed,IEJSCSAMMLUINT-NRFANRHFSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
80867,6m3m,DB00530,-8.2,Erlotinib,AAKJLRGGTJKAMG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
71362,6lxt,DB14068,-8.2,Dexniguldipine,SVJMLYUFVDMUHP-MGBGTMOVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
65071,6lxt,DB02360,-8.2,Bis-Napthyl Beta-Ketophosphonic Acid,OFHMUASCSJJNNA-JOCHJYFZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
75794,6m2n,DB06040,-8.2,Filanesib,LLXISKGBWFTGEI-FQEVSTJZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
64017,6lxt,DB00967,-8.2,Desloratadine,JAUOIFJMECXRGI-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
85784,6m3m,DB08059,-8.2,Wortmannin,QDLHCMPXEPAAMD-QAIWCSMKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85769,6m3m,DB08041,-8.2,3-BENZYLOXYCARBONYLAMINO-2-HYDROXY-4-PHENYL-BUTYRIC ACID,JXJYTERRLRAUSF-JKSUJKDBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
71768,6lxt,DB15238,-8.2,Olinciguat,YWQFJNWMWZMXRW-HXUWFJFHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
136801,6w9c,DB07547,-8.2,5-(4-CYANOPHENYL)-3-{[(2-METHYLPHENYL)SULFONYL]AMINO}THIOPHENE-2-CARBOXYLIC ACID,RYXAHMSZLLIPRO-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
76906,6m2n,DB07755,-8.2,"(2S)-1-[4-({4-[(2,5-Dichlorophenyl)amino]-2-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol",GNLAGGCSJGJECE-INIZCTEOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76919,6m2n,DB07769,-8.2,S-3-(4-FLUOROPHENOXY)-2-HYDROXY-2-METHYL-N-[4-NITRO-3-(TRIFLUOROMETHYL)PHENYL]PROPANAMIDE,KJMFOTCDISOHDX-INIZCTEOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
71617,6lxt,DB14906,-8.2,Adafosbuvir,NIJYGVDQZBBONK-SEUXLIJBSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
114686,6vxx,DB14648,-8.2,Acetyl simvastatin,OHVWRJDVJRNCPE-BIKFJBPRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81718,6m3m,DB01595,-8.2,Nitrazepam,KJONHKAYOJNZEC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
139279,6w9c,DB13256,-8.2,Clothiapine,KAAZGXDPUNNEFN-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
76903,6m2n,DB07751,-8.2,"(2S)-1-[4-({6-[(2,6-Difluorophenyl)amino]-4-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol",ZVSBKYYVBCKDBO-HNNXBMFYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
119639,6w4b,DB07545,-8.2,N-{3-[(4-{[3-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-2-YL)AMINO]PHENYL}CYCLOPROPANECARBOXAMIDE,RDTDWGQDFJPTPD-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
136398,6w9c,DB07070,-8.2,(2S)-2-{3-[({[2-fluoro-4-(trifluoromethyl)phenyl]carbonyl}amino)methyl]-4-methoxybenzyl}butanoic acid,BDLLIPYDNFENMY-ZDUSSCGKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
133268,6w9c,DB01479,-8.2,BA-2664,QGKQXZFZOIQFBI-XSWYFRFISA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
86116,6m3m,DB08461,-8.2,"3-[(4-AMINO-1-TERT-BUTYL-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL)METHYL]PHENOL",QMAIQPBRCNEJAT-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86117,6m3m,DB08462,-8.2,N-(4-PHENYLAMINO-QUINAZOLIN-6-YL)-ACRYLAMIDE,JGWHILNNHLDARR-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
29109,6cs2,DB08747,-8.2,"(11R)-10-acetyl-11-(2,4-dichlorophenyl)-6-hydroxy-3,3-dimethyl-2,3,4,5,10,11-hexahydro-1H-dibenzo[b,e][1,4]diazepin-1-one",JJTPPGUNMJMPLY-QFIPXVFZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
140412,6w9c,DB06800,-8.2,Methylnaltrexone,JVLBPIPGETUEET-WIXLDOGYSA-O,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
70585,6lxt,DB12888,-8.2,Ezutromid,KSGCNXAZROJSNW-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
86122,6m3m,DB08467,-8.2,"6-(2,3,4,5,6,7-HEXAHYDRO-2,4,4-TRIMETHYL-1-METYLENEINDEN-2-YL)-3-METHYLHEXA-2,4-DIENOIC ACID",HEVXQLBAMFMFKU-IAZPEVBMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86123,6m3m,DB08469,-8.2,"tert-butyl 4-(3-thiophen-2-yl-1,2,4-oxadiazol-5-yl)piperidine-1-carboxylate",METBQPRXNZHZMB-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
70574,6lxt,DB12875,-8.2,Mavatrep,ORDHXXHTBUZRCN-NTEUORMPSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
80765,6m3m,DB00402,-8.2,Eszopiclone,GBBSUAFBMRNDJC-INIZCTEOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
121767,6w4b,DB12369,-8.2,Sotrastaurin,OAVGBZOFDPFGPJ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
81923,6m3m,DB01860,-8.2,Cordycepin Triphosphate,NLIHPCYXRYQPSD-BAJZRUMYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81863,6m3m,DB01782,-8.2,"2,6-Dihydroanthra/1,9-Cd/Pyrazol-6-One",ACPOUJIDANTYHO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136354,6w9c,DB07022,-8.2,3-Hydroxypropyl 3-[(7-carbamimidoyl-1-naphthyl)carbamoyl]benzenesulfonate,PXERBGNIBOFZOW-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138764,6w9c,DB12235,-8.2,Estetrol,AJIPIJNNOJSSQC-NYLIRDPKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
70552,6lxt,DB12836,-8.2,Grapiprant,HZVLFTCYCLXTGV-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
23707,6cs2,HMDB0112262,-8.2,gamma-Carotene,HRQKOYFGHJYEFS-BXOLYSJBSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
65590,6lxt,DB03041,-8.2,UDP-alpha-D-glucuronic acid,HDYANYHVCAPMJV-LXQIFKJMSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
133301,6w9c,DB01521,-8.2,Clostebol,KCZCIYZKSLLNNH-FBPKJDBXSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
165800,7bv1,DB13029,-8.2,MK-0873,JJWKQXNHYDJXKF-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
29946,6cs2,DB11845,-8.2,Lucitanib,CUDVHEFYRIWYQD-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
75677,6m2n,DB05351,-8.2,Dexlansoprazole,MJIHNNLFOKEZEW-RUZDIDTESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76456,6m2n,DB07227,-8.2,4-[(5-{[4-(3-CHLOROPHENYL)-3-OXOPIPERAZIN-1-YL]METHYL}-1H-IMIDAZOL-1-YL)METHYL]BENZONITRILE,JNUGFGAVPBYSHF-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
140360,6w9c,DB04226,-8.2,Dihydro-Acarbose,CUAQESWNTOXZJZ-RTNAABQMSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
142953,6w9q,DB02877,-8.2,Arotinoid acid,FOIVPCKZDPCJJY-JQIJEIRASA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
132851,6w9c,DB00920,-8.2,Ketotifen,ZCVMWBYGMWKGHF-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
76473,6m2n,DB07248,-8.2,"7-PYRIDIN-2-YL-N-(3,4,5-TRIMETHOXYPHENYL)-7H-PYRROLO[2,3-D]PYRIMIDIN-2-AMINE",YENZSPIOXMNEFF-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
30567,6cs2,DB12665,-8.2,Isoquercetin,OVSQVDMCBVZWGM-QSOFNFLRSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
81836,6m3m,DB01748,-8.2,N-Benzyl-4-Sulfamoyl-Benzamide,CZKNSZUJCJHTTM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136652,6w9c,DB07373,-8.2,"ANDROSTA-1,4-DIENE-3,17-DIONE",LUJVUUWNAPIQQI-QAGGRKNESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138793,6w9c,DB12275,-8.2,Seviteronel,ZBRAJOQFSNYJMF-SFHVURJKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136813,6w9c,DB07562,-8.2,"N-[4-(2,4-DIMETHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YL]-N',N'-DIMETHYL-BENZENE-1,4-DIAMINE",FGGSNQOBRJVAKL-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
113770,6vxx,DB12059,-8.2,JNJ-40411813,HYOGJHCDLQSAHX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
8497,6lzg,DB06228,-8.2,Rivaroxaban,KGFYHTZWPPHNLQ-AWEZNQCLSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
63903,6lxt,DB00838,-8.2,Clocortolone,YMTMADLUXIRMGX-RFPWEZLHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
7976,6lzg,DB04609,-8.2,INHIBITOR Q8467 OF DUPONT MERCK,HFLCERPZYCWLSZ-VKONIRKNSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
165702,7bv1,DB12680,-8.2,Intepirdine,JJZFWROHYSMCMU-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
121593,6w4b,DB12121,-8.2,Entospletinib,XSMSNFMDVXXHGJ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
65352,6lxt,DB02717,-8.2,Cellotetraose,LUEWUZLMQUOBSB-HGDSAIHNSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
76470,6m2n,DB07245,-8.2,6-[2-(3'-METHOXYBIPHENYL-3-YL)ETHYL]PYRIDIN-2-AMINE,AEVBKBAFFJKFJZ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
136384,6w9c,DB07054,-8.2,(2R)-1-(DIMETHYLAMINO)-3-{4-[(6-{[2-FLUORO-5-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-4-YL)AMINO]PHENOXY}PROPAN-2-OL,OSCWQKTUILTARV-MRXNPFEDSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
29876,6cs2,DB11755,-8.2,Tetrahydrocannabivarin,ZROLHBHDLIHEMS-HUUCEWRRSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
29112,6cs2,DB08750,-8.2,"1-[4-(AMINOMETHYL)BENZOYL]-5'-FLUORO-1'H-SPIRO[PIPERIDINE-4,2'-QUINAZOLIN]-4'-AMINE",SFPCNWQWKOUNRT-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
133282,6w9c,DB01496,-8.2,Barbituric acid derivative,DNZPLHRZXUJATK-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
77017,6m2n,DB07877,-8.2,"8-(6-BROMO-BENZO[1,3]DIOXOL-5-YLSULFANYL)-9-(3-ISOPROPYLAMINO-PROPYL)-ADENINE",MWGWLDJLENCVRQ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75726,6m2n,DB05586,-8.2,Facinicline,TXCYUSKWBHUVEP-CYBMUJFWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76035,6m2n,DB06693,-8.2,Mevastatin,AJLFOPYRIVGYMJ-INTXDZFKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
121766,6w4b,DB12368,-8.2,AZD-3839,MRXBCEQZNKUUIP-DEOSSOPVSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
139337,6w9c,DB13335,-8.2,Pinazepam,MFZOSKPPVCIFMT-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
81824,6m3m,DB01732,-8.2,"(4r,5s,6s,7r)-1,3-Dibenzyl-4,7-Bis(Phenoxymethyl)-5,6-Dihydroxy-1,3 Diazepan-2-One",SQBOSZXDOHQFAA-ZRTHHSRSSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
77061,6m2n,DB07933,-8.2,Erteberel,XIESSJVMWNJCGZ-VKJFTORMSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76038,6m2n,DB06697,-8.2,Artemether,SXYIRMFQILZOAM-HVNFFKDJSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
136391,6w9c,DB07061,-8.2,"1-(CYCLOHEXYLAMINO)-3-(6-METHYL-3,4-DIHYDRO-1H-CARBAZOL-9(2H)-YL)PROPAN-2-OL",AXYFCRIRLKSCRR-SFHVURJKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
112745,6vxx,DB07796,-8.2,"(3ASR,4RS,8ASR,8BRS)-4-(2-(4-FLUOROBENZYL)-1,3-DIOXODEACAHYDROPYRROLO[3,4-A] PYRROLIZIN-4-YL)BENZAMIDINE",GJYCQHGTXMVIBG-MUGJNUQGSA-O,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76872,6m2n,DB07715,-8.2,Emodin,RHMXXJGYXNZAPX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
29908,6cs2,DB11795,-8.2,GSK-2636771,XTKLTGBKIDQGQL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
85814,6m3m,DB08095,-8.2,"3-(2-CHLOROPHENYL)-1-(2-{[(1S)-2-HYDROXY-1,2-DIMETHYLPROPYL]AMINO}PYRIMIDIN-4-YL)-1-(4-METHOXYPHENYL)UREA",ZWYFTKPEHRQCCW-HNNXBMFYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
30659,6cs2,DB12798,-8.2,Relenopride,KGMMSPVVHZGPHL-NRFANRHFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
76609,6m2n,DB07401,-8.2,METHYL (2Z)-2-(2-{[6-(2-CYANOPHENOXY)PYRIMIDIN-4-YL]OXY}PHENYL)-3-METHOXYACRYLATE,WFDXOXNFNRHQEC-GHRIWEEISA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76697,6m2n,DB07505,-8.2,"N-({(3R,4R)-4-[(benzyloxy)methyl]pyrrolidin-3-yl}methyl)-N-(2-methylpropyl)benzenesulfonamide",DGURGFSAQIBQCO-FGZHOGPDSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
71116,6lxt,DB13667,-8.2,Cefozopran,QDUIJCOKQCCXQY-WHJQOFBOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
64236,6lxt,DB01216,-8.2,Finasteride,DBEPLOCGEIEOCV-WSBQPABSSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
71683,6lxt,DB15075,-8.2,4-demethyl-4-cholesteryloxycarbonylpenclomedine,ZJUUIXYKTPSIOH-LEZJFEBPSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
136496,6w9c,DB07183,-8.2,N-(4-phenoxyphenyl)-2-[(pyridin-4-ylmethyl)amino]nicotinamide,CPVRYQAOUPSUDO-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
112616,6vxx,DB07459,-8.2,4-PHENOXY-N-(PYRIDIN-2-YLMETHYL)BENZAMIDE,HVLSCZSVTCNAQX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85883,6m3m,DB08167,-8.2,Methylthioninium,RBTBFTRPCNLSDE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
142643,6w9q,DB02466,-8.2,"4-[3-Oxo-3-(5,5,8,8-Tetramethyl-5,6,7,8-Tetrahydro-Naphthalen-2-Yl)-Propenyl]-Benzoic Acid",ZXQHMEUGMCXKLO-KPKJPENVSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
81525,6m3m,DB01340,-8.2,Cilazapril,HHHKFGXWKKUNCY-FHWLQOOXSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136705,6w9c,DB07434,-8.2,HONH-BENZYLMALONYL-L-ALANYLGLYCINE-P-NITROANILIDE,TZWQPWGUQCSKDW-GUYCJALGSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
76724,6m2n,DB07536,-8.2,"N-{(1S,2R)-2-hydroxy-1-[(hydroxyamino)carbonyl]propyl}-4-{[4-(morpholin-4-ylmethyl)phenyl]ethynyl}benzamide",FQYBTYFKOHPWQT-VGSWGCGISA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
136488,6w9c,DB07174,-8.2,"6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-4-(3-METHOXYPROPYL)-2,2-DIMETHYL-2H-1,4-BENZOXAZIN-3(4H)-ONE",WPAPODFGOZXFLG-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
8989,6lzg,DB07054,-8.2,(2R)-1-(DIMETHYLAMINO)-3-{4-[(6-{[2-FLUORO-5-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-4-YL)AMINO]PHENOXY}PROPAN-2-OL,OSCWQKTUILTARV-MRXNPFEDSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
133091,6w9c,DB01195,-8.2,Flecainide,DJBNUMBKLMJRSA-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
114779,6vxx,DB14846,-8.2,Bimiralisib,ADGGYDAFIHSYFI-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81090,6m3m,DB00800,-8.2,Fenoldopam,TVURRHSHRRELCG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
140406,6w9c,DB05992,-8.2,Plinabulin,UNRCMCRRFYFGFX-TYPNBTCFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
71033,6lxt,DB13552,-8.2,Trifluperidol,GPMXUUPHFNMNDH-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
121697,6w4b,DB12272,-8.2,Vidupiprant,PFWVGKROPKKEDW-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
85870,6m3m,DB08154,-8.2,3-chloro-5-[2-chloro-5-(1H-indazol-3-ylmethoxy)phenoxy]benzonitrile,WHCLIFOVZDANCU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
138874,6w9c,DB12389,-8.2,Zamicastat,ZSSLCFLHEFXANG-GOSISDBHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
133020,6w9c,DB01116,-8.2,Trimethaphan,CHQOEHPMXSHGCL-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
64491,6lxt,DB01587,-8.2,Ketazolam,PWAJCNITSBZRBL-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
76734,6m2n,DB07547,-8.2,5-(4-CYANOPHENYL)-3-{[(2-METHYLPHENYL)SULFONYL]AMINO}THIOPHENE-2-CARBOXYLIC ACID,RYXAHMSZLLIPRO-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76668,6m2n,DB07470,-8.2,"(3aS)-3a-hydroxy-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one",DOMYOVZXZIZTRD-QGZVFWFLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
119294,6w4b,DB07145,-8.2,(2R)-N-HYDROXY-2-[(3S)-3-METHYL-3-{4-[(2-METHYLQUINOLIN-4-YL)METHOXY]PHENYL}-2-OXOPYRROLIDIN-1-YL]PROPANAMIDE,YDMIPBHQKFOFQW-NSYGIPOTSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
29917,6cs2,DB11806,-8.2,VTP-194204,BOOOLEGQBVUTKC-NVQSDHBMSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
113701,6vxx,DB11784,-8.2,NRX-1074,DVBUEXCIEIAXPM-PJUQSVSOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85960,6m3m,DB08267,-8.2,"6-amino-4-(2-phenylethyl)-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",PBZAIUVFRISTSZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
133052,6w9c,DB01153,-8.2,Sertaconazole,JLGKQTAYUIMGRK-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
75944,6m2n,DB06472,-8.2,Fradafiban,IKZACQMAVUIGPY-HOTGVXAUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
64313,6lxt,DB01357,-8.2,Mestranol,IMSSROKUHAOUJS-MJCUULBUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
112634,6vxx,DB07483,-8.2,"1,1'-BIPHENYL-2-SULFINIC ACID",LZCLZDCSBDVAOV-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29915,6cs2,DB11804,-8.2,AZD-5672,SCXSQUUTGCWHFU-WJOKGBTCSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
138906,6w9c,DB12428,-8.2,PAC-14028,UKGJZDSUJSPAJL-YPUOHESYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138908,6w9c,DB12430,-8.2,BC-3781,KPVIXBKIJXZQJX-IJUBVZAWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
113703,6vxx,DB11786,-8.2,Pefcalcitol,SVCSMAZYWOQCBW-NVJMFHFGSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80998,6m3m,DB00689,-8.2,Cephaloglycin,FUBBGQLTSCSAON-PBFPGSCMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
64331,6lxt,DB01405,-8.2,Temafloxacin,QKDHBVNJCZBTMR-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
64273,6lxt,DB01268,-8.2,Sunitinib,WINHZLLDWRZWRT-ATVHPVEESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
119325,6w4b,DB07181,-8.2,"4'-[(1R)-1-amino-2-(2,5-difluorophenyl)ethyl]biphenyl-3-carboxamide",JYKFWUXBFJJDTP-HXUWFJFHSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
136719,6w9c,DB07451,-8.2,1-(5-BROMO-PYRIDIN-2-YL)-3-[2-(6-FLUORO-2-HYDROXY-3-PROPIONYL-PHENYL)-CYCLOPROPYL]-UREA,VRAJWAGCJIXJHQ-YPMHNXCESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
133038,6w9c,DB01137,-8.2,Levofloxacin,GSDSWSVVBLHKDQ-JTQLQIEISA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
133079,6w9c,DB01183,-8.2,Naloxone,UZHSEJADLWPNLE-GRGSLBFTSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138914,6w9c,DB12557,-8.2,FK-614,UYGZODVVDUIDDQ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
86013,6m3m,DB08331,-8.2,"N-1H-imidazol-2-yl-N'-[4-(1H-imidazol-2-ylamino)phenyl]benzene-1,4-diamine",JHMXUERQMCJRHG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
139185,6w9c,DB12985,-8.2,Quisinostat,PAWIYAYFNXQGAP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
76658,6m2n,DB07457,-8.2,"3-[1-(3-AMINOPROPYL)-1H-INDOL-3-YL]-4-(1H-INDOL-3-YL)-1H-PYRROLE-2,5-DIONE",APYXQTXFRIDSGE-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76667,6m2n,DB07469,-8.2,"(3aS)-3a-hydroxy-7-methyl-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one",KAJFGRLMKVNMLH-GOSISDBHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
112658,6vxx,DB07511,-8.2,"4-(4-methyl-1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)benzonitrile",MVYDBJXCIFMINH-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81495,6m3m,DB01268,-8.2,Sunitinib,WINHZLLDWRZWRT-ATVHPVEESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
142619,6w9q,DB02432,-8.2,RU90395,RLLAUERCSKPFGD-VMPREFPWSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
85867,6m3m,DB08151,-8.2,"(5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-phenyl-1,6-dioxa-2-azaspiro[4.5]dec-2-ene-8,9,10-triol",YLTDNVVQKRHCJP-RKQHYHRCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
76736,6m2n,DB07549,-8.2,"2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUORO-3-METHYL-6-PYRIDINYL)METHYL]ACETAMIDE",WOYBPRBUPLYTPY-UHFFFAOYSA-P,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
114708,6vxx,DB14671,-8.2,Temazepam acetate,PTWWAHZQIATUFG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136236,6w9c,DB06883,-8.2,1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-phenylurea,DHNYNLNKNQJSHF-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
31877,6cs2,DB14929,-8.2,Elsulfavirine,ULTDEARCBRNRGR-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
140478,6w9c,DB09171,-8.2,β-Methylfentanyl,UXIGUKSHASXDNI-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
119701,6w4b,DB07622,-8.2,"1-(3-(2,4-DIMETHYLTHIAZOL-5-YL)-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)-3-(4-METHYLPIPERAZIN-1-YL)UREA",KRKQVGZXTNLQSV-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
76557,6m2n,DB07338,-8.2,Acifluorfen,NUFNQYOELLVIPL-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
71625,6lxt,DB14929,-8.2,Elsulfavirine,ULTDEARCBRNRGR-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
29120,6cs2,DB08758,-8.2,"IMIDAZO[2,1-A]ISOQUINOLINE-2-CARBOHYDRAZIDE",WSNWYZBDIKCPIG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
80898,6m3m,DB00567,-8.2,Cephalexin,ZAIPMKNFIOOWCQ-UEKVPHQBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80896,6m3m,DB00564,-8.2,Carbamazepine,FFGPTBGBLSHEPO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
76548,6m2n,DB07328,-8.2,"METHYL 4-{[({[(2R,5S)-5-{[(2S)-2-(AMINOMETHYL)PYRROLIDIN-1-YL]CARBONYL}PYRROLIDIN-2-YL]METHYL}AMINO)CARBONYL]AMINO}BENZOATE",USDCNOQKDUFKRD-IKGGRYGDSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
81645,6m3m,DB01512,-8.2,Hydromorphinol,AABLHGPVOULICI-BRJGLHKUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
114994,6w4b,DB00320,-8.2,Dihydroergotamine,LUZRJRNZXALNLM-JGRZULCMSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
18946,6cs2,HMDB0041759,-8.2,Naringenin 4'-O-glucuronide,DFIUUCDSSKATFP-DNPGXZAYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
18947,6cs2,HMDB0041760,-8.2,Naringenin 5-O-glucuronide,ZTQGTBHHQGGBSV-ATVZYYHQSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
75825,6m2n,DB06174,-8.2,Noscapine,AKNNEGZIBPJZJG-MSOLQXFVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
85825,6m3m,DB08106,-8.2,N-[(6-butoxynaphthalen-2-yl)sulfonyl]-D-glutamic acid,UAGYXJBYAFGRFR-QGZVFWFLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
132979,6w9c,DB01068,-8.2,Clonazepam,DGBIGWXXNGSACT-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
165756,7bv1,DB12764,-8.2,ABC-294640,CAOTVXGYTWCKQE-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
136419,6w9c,DB07095,-8.2,(S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclopentylpropanoyl)pyrrolidine-2-carboxamide,BNCHHUFGEOJCNH-SFHVURJKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
64807,6lxt,DB02009,-8.2,"L-756,423",AOMZDQMIOCTPQP-QHQMVRJISA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
76863,6m2n,DB07704,-8.2,"6-AMINO-4-[2-(4-METHOXYPHENYL)ETHYL]-1,7-DIHYDRO-8H-IMIDAZO[4,5-G]QUINAZOLIN-8-ONE",UKRVQKUVWNDGMN-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
133142,6w9c,DB01261,-8.2,Sitagliptin,MFFMDFFZMYYVKS-SECBINFHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
75815,6m2n,DB06153,-8.2,Pizotifen,FIADGNVRKBPQEU-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138939,6w9c,DB12594,-8.2,AZD-9056,HSQAARMBHJCUOK-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
71345,6lxt,DB14035,-8.2,Englitazone,MVDXXGIBARMXSA-PYUWXLGESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
64133,6lxt,DB01100,-8.2,Pimozide,YVUQSNJEYSNKRX-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
64713,6lxt,DB01876,-8.2,Bis(5-Amidino-2-Benzimidazolyl)Methanone,VVVXDHROXQUONB-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
121680,6w4b,DB12247,-8.2,AZD-4547,VRQMAABPASPXMW-HDICACEKSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
70988,6lxt,DB13491,-8.2,Fluperolone,SLVCCRYLKTYUQP-DVTGEIKXSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
136785,6w9c,DB07530,-8.2,"(1R,3R)-5-[(2E)-3-{(1S,3R)-2,2,3-trimethyl-3-[6,6,6-trifluoro-5-hydroxy-5-(trifluoromethyl)hex-3-yn-1-yl]cyclopentyl}prop-2-en-1-ylidene]cyclohexane-1,3-diol",PCHUQQNKOFNVDU-OSXMSNBXSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
81560,6m3m,DB01413,-8.2,Cefepime,HVFLCNVBZFFHBT-ZKDACBOMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
76585,6m2n,DB07373,-8.2,"ANDROSTA-1,4-DIENE-3,17-DIONE",LUJVUUWNAPIQQI-QAGGRKNESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76752,6m2n,DB07570,-8.2,3-CYCLOHEXYL-1-(2-MORPHOLIN-4-YL-2-OXOETHYL)-2-PHENYL-1H-INDOLE-6-CARBOXYLIC ACID,ZKEZEXYKYHYIMQ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76761,6m2n,DB07582,-8.2,"N-[(2R,3S)-1-((2S)-2-{[(CYCLOPENTYLAMINO)CARBONYL]AMINO}-3-METHYLBUTANOYL)-2-(1-FORMYL-1-CYCLOBUTYL)PYRROLIDINYL]CYCLOPROPANECARBOXAMIDE",GCDRFILPPBOJLM-UFYCRDLUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
114838,6vxx,DB14987,-8.2,Difamilast,VFBILHPIHUPBPZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138930,6w9c,DB12579,-8.2,JNJ-37822681,UVUYWJWYRLJHEN-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
70959,6lxt,DB13451,-8.2,Tioclomarol,WRGOVNKNTPWHLZ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
70934,6lxt,DB13418,-8.2,Moxestrol,MTMZZIPTQITGCY-OLGWUGKESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
70917,6lxt,DB13396,-8.2,Neocitrullamon,PAJBBDCZSMDSFL-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
119716,6w4b,DB07638,-8.2,"(3AS,4R,9BR)-2,2-DIFLUORO-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL",QJSMFUTULGSHNQ-ZOBUZTSGSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
139231,6w9c,DB13177,-8.2,4-methylumbelliferyl beta-D-glucoside,YUDPTGPSBJVHCN-YMILTQATSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
113687,6vxx,DB11764,-8.2,Spebrutinib,KXBDTLQSDKGAEB-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
70786,6lxt,DB13223,-8.2,Fluocortin,PUWHHWCHAVXSIG-NCLPIGKXSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
136541,6w9c,DB07238,-8.2,Nesbuvir,WTDWVLJJJOTABN-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
76798,6m2n,DB07626,-8.2,"4-(2-aminoethoxy)-N-(3-chloro-2-ethoxy-5-piperidin-1-ylphenyl)-3,5-dimethylbenzamide",CKBBGCJYKCLKHE-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
166595,7bv1,DB15446,-8.2,Vidofludimus,XPRDUGXOWVXZLL-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
71627,6lxt,DB14932,-8.2,Coleneuramide,CHMRTBYTCBDIRG-JQZMMWJVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
133115,6w9c,DB01222,-8.2,Budesonide,VOVIALXJUBGFJZ-KWVAZRHASA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
76827,6m2n,DB07662,-8.2,N-[4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL]-ACRYLAMIDE,HTUBKQUPEREOGA-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
119738,6w4b,DB07666,-8.2,"(3R,4S)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE",OAWGQHXWGXOUKV-BEFAXECRSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
30581,6cs2,DB12685,-8.2,K-134,ULGNGSQNNMKROG-WOJBJXKFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
80908,6m3m,DB00580,-8.2,Valdecoxib,LNPDTQAFDNKSHK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136340,6w9c,DB07005,-8.2,D-phenylalanyl-N-{4-[amino(iminio)methyl]benzyl}-L-prolinamide,VZFTWWJAUZOJDH-MOPGFXCFSA-O,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
71592,6lxt,DB14862,-8.2,PF-06815345,QTBYVAZRKWOIDU-FUHWJXTLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
136715,6w9c,DB07447,-8.2,5beta-dihydrotestosterone,NVKAWKQGWWIWPM-MISPCMORSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
114636,6vxx,DB13930,-8.2,Ulixertinib,KSERXGMCDHOLSS-LJQANCHMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
70441,6lxt,DB12659,-8.2,SJ-733,VKCPFWKTFZAOTO-LEWJYISDSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
166558,7bv1,DB15362,-8.2,LSZ-102,SJXNPGGVGZXKKI-NYYWCZLTSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
113597,6vxx,DB11619,-8.2,Gestrinone,BJJXHLWLUDYTGC-ANULTFPQSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113734,6vxx,DB11827,-8.2,Ertugliflozin,MCIACXAZCBVDEE-CUUWFGFTSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136308,6w9c,DB06969,-8.2,"2-amino-4-[2,4-dichloro-5-(2-pyrrolidin-1-ylethoxy)phenyl]-N-ethylthieno[2,3-d]pyrimidine-6-carboxamide",WJUNQSYQHHIVFX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
65930,6lxt,DB03496,-8.2,Alvocidib,BIIVYFLTOXDAOV-YVEFUNNKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
133363,6w9c,DB01588,-8.2,Prazepam,MWQCHHACWWAQLJ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
76297,6m2n,DB07042,-8.2,"7-amino-2-tert-butyl-4-{[2-(1H-imidazol-4-yl)ethyl]amino}pyrido[2,3-d]pyrimidine-6-carboxamide",XESUNWBIAADLPI-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
71994,6m2n,DB00214,-8.2,Torasemide,NGBFQHCMQULJNZ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
66018,6lxt,DB03632,-8.2,Argifin,UHBHXSDKGLPPGO-HTDHLNIYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
75584,6m2n,DB04891,-8.2,Becocalcidiol,QSLUXQQUPXBIHH-YHSKWIAJSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
115410,6w4b,DB00826,-8.2,Natamycin,NCXMLFZGDNKEPB-FFPOYIOWSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
139461,6w9c,DB13499,-8.2,Cefsulodin,SYLKGLMBLAAGSC-QLVMHMETSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
132751,6w9c,DB00810,-8.2,Biperiden,YSXKPIUOCJLQIE-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138696,6w9c,DB12131,-8.2,Vinpocetine,DDNCQMVWWZOMLN-IRLDBZIGSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
114830,6vxx,DB14941,-8.2,BMS-817399,GTDPZONCGOCXOD-JPYJTQIMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85506,6m3m,DB07742,-8.2,"N-(2,3-DIFLUORO-BENZYL)-4-SULFAMOYL-BENZAMIDE",QASSMVGOSBNFQY-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
133374,6w9c,DB01604,-8.2,Pivampicillin,ZEMIJUDPLILVNQ-ZXFNITATSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
76282,6m2n,DB07027,-8.2,D-phenylalanyl-N-(3-fluorobenzyl)-L-prolinamide,JGZSVYZIJHGHMA-MOPGFXCFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76271,6m2n,DB07014,-8.2,"2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4-methoxybenzyl)sulfanyl]-1,3,4-oxadiazole",TUTZKAQTSPMEBI-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75557,6m2n,DB04859,-8.2,Zanapezil,PMBLXLOXUGVTGB-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
31812,6cs2,DB14795,-8.2,AZD-3759,MXDSJQHFFDGFDK-CYBMUJFWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
85516,6m3m,DB07754,-8.2,N-({(1R)-1-carboxy-2-[(4-fluorobenzyl)sulfanyl]ethyl}carbamoyl)-L-glutamic acid,IDTMSHGCAZPVLC-RYUDHWBXSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
72005,6m2n,DB00227,-8.2,Lovastatin,PCZOHLXUXFIOCF-BXMDZJJMSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
115355,6w4b,DB00762,-8.2,Irinotecan,UWKQSNNFCGGAFS-XIFFEERXSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
82084,6m3m,DB02081,-8.2,Bis-Benzamidine,BXYGSMRTHHSAHZ-PMACEKPBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136891,6w9c,DB07654,-8.2,"(5,6-DIPHENYL-FURO[2,3-D]PYRIMIDIN-4-YLAMINO)-ACETIC",VDJWWYRYKMXMKA-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
71510,6lxt,DB14669,-8.2,Betamethasone phosphate,VQODGRNSFPNSQE-DVTGEIKXSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
70471,6lxt,DB12706,-8.2,Seletalisib,LNLJHGXOFYUARS-OAQYLSRUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
76115,6m2n,DB06827,-8.2,Viomycin,GXFAIFRPOKBQRV-GHXCTMGLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
132778,6w9c,DB00839,-8.2,Tolazamide,OUDSBRTVNLOZBN-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
71514,6lxt,DB14673,-8.2,Flurandrenolide acetate,AUDPKCCPWYXNEV-XTLNBZDDSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
140515,6w9c,DB11994,-8.2,Diacerein,TYNLGDBUJLVSMA-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
63565,6lxt,DB00430,-8.2,Cefpiramide,PWAUCHMQEXVFJR-PMAPCBKXSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
119362,6w4b,DB07226,-8.2,"N-[4-(2-CHLOROPHENYL)-1,3-DIOXO-1,2,3,6-TETRAHYDROPYRROLO[3,4-C]CARBAZOL-9-YL]FORMAMIDE",JWZVNUNTFNELHL-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
77278,6m2n,DB08173,-8.2,5-CHLORO-N-(2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO)ETHYL)THIOPHENE-2-CARBOXAMIDE,UCKHUNHXYMAFQM-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
140427,6w9c,DB06827,-8.2,Viomycin,GXFAIFRPOKBQRV-GHXCTMGLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
113814,6vxx,DB12122,-8.2,Figopitant,HUTHJVYJUPXHDF-DEOSSOPVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86206,6m3m,DB08568,-8.2,(2S)-1-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}-3-PHENYLPROPAN-2-AMINE,BPNUQXPIQBZCMR-IBGZPJMESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80575,6m3m,DB00177,-8.2,Valsartan,ACWBQPMHZXGDFX-QFIPXVFZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
71522,6lxt,DB14681,-8.2,Cortisone,MFYSYFVPBJMHGN-ZPOLXVRWSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
165803,7bv1,DB13036,-8.2,Ramatroban,LDXDSHIEDAPSSA-OAHLLOKOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
86223,6m3m,DB08588,-8.2,2-({2-[(3R)-3-AMINOPIPERIDIN-1-YL]-4-OXOQUINAZOLIN-3(4H)-YL}METHYL)BENZONITRILE,OYNURZXTLNNKAP-QGZVFWFLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
29449,6cs2,DB09200,-8.2,Rivoglitazone,XMSXOLDPMGMWTH-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
85543,6m3m,DB07785,-8.2,"1-{(1R,2S)-2-HYDROXY-1-[2-(2-NAPHTHYLOXY)ETHYL]PROPYL}-1H-IMIDAZONE-4-CARBOXAMIDE",UYAJDVNLQJVRHD-SCLBCKFNSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
30603,6cs2,DB12715,-8.2,MSX-122,PXZXYRKDDXKDTK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
86229,6m3m,DB08595,-8.2,"4-[(1S,2R,5S)-4,4,8-TRIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL",BBZPJHFECDCNGT-BPUTZDHNSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
63503,6lxt,DB00354,-8.2,Buclizine,MOYGZHXDRJNJEP-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
82073,6m3m,DB02069,-8.2,N-(2-Flouro-Benzyl)-4-Sulfamoyl-Benzamide,ULYMHSXFSKOHGH-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
29975,6cs2,DB11885,-8.2,Anlotinib,KSMZEXLVHXZPEF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
70400,6lxt,DB12590,-8.2,Indiplon,CBIAWPMZSFFRGN-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
121461,6w4b,DB11923,-8.2,Decoglurant,DMJHZVARRXJSEG-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
70342,6lxt,DB12504,-8.2,JNJ-40346527,BNVPFDRNGHMRJS-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
76258,6m2n,DB06999,-8.2,"N-{3-[(5-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)carbonyl]-2,4-difluorophenyl}propane-1-sulfonamide",YZDJQTHVDDOVHR-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
142020,6w9q,DB01640,-8.2,"(5r)-6-(4-{[2-(3-Iodobenzyl)-3-Oxocyclohex-1-En-1-Yl]Amino}Phenyl)-5-Methyl-4,5-Dihydropyridazin-3(2h)-One",QNURTFDBHAQRSI-OAHLLOKOSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
82233,6m3m,DB02277,-8.2,1-(5-Tert-Butyl-2-Methyl-2h-Pyrazol-3-Yl)-3-(4-Chloro-Phenyl)-Urea,FWIJKWMXNHRSRO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
139062,6w9c,DB12792,-8.2,Boscalid,WYEMLYFITZORAB-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
133483,6w9c,DB01745,-8.2,N-Alpha-(2-Naphthylsulfonyl)-N(3-Amidino-L-Phenylalaninyl)Isopipecolinic Acid Methyl Ester,JJLGQWCKMHPBEB-DEOSSOPVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139064,6w9c,DB12796,-8.2,MRX-I,SULYVXZZUMRQAX-NSHDSACASA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
141967,6w9q,DB01573,-8.2,Benzylmorphine,RDJGWRFTDZZXSM-RNWLQCGYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
72069,6m2n,DB00298,-8.2,Dapiprazole,RFWZESUMWJKKRN-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
85399,6m3m,DB07615,-8.2,Tranilast,NZHGWWWHIYHZNX-CSKARUKUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
77449,6m2n,DB08392,-8.2,"2-[5,6-BIS-(4-METHOXY-PHENYL)-FURO[2,3-D]PYRIMIDIN-4-YLAMINO]-ETHANOL",ARBUGBBNEFAECO-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
8492,6lzg,DB06212,-8.2,Tolvaptan,GYHCTFXIZSNGJT-XMMPIXPASA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
76233,6m2n,DB06970,-8.2,"2-CHLORO-N-(3-CYANO-5,6-DIHYDRO-4H-CYCLOPENTA[B]THIOPHEN-2-YL)-5-DIETHYLSULFAMOYL-BENZAMIDE",MZCDQILVXXIMEV-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
165818,7bv1,DB13060,-8.2,CEP-37440,BCSHRERPHLTPEE-NRFANRHFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
136259,6w9c,DB06909,-8.2,"1-ethyl-N-(phenylmethyl)-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridine-5-carboxamide",QZGJNFBMYYEFGM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
29987,6cs2,DB11900,-8.2,OC-459,FATGTHLOZSXOBC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
114499,6vxx,DB13711,-8.2,Tritoqualine,IRGJVQIJENCTQF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30498,6cs2,DB12567,-8.2,Camicinal,RZKDEGZIFSJVNA-IBGZPJMESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
76223,6m2n,DB06954,-8.2,"2-(cycloheptylmethyl)-1,1-dioxido-1-benzothiophen-6-yl sulfamate",BIASYWBGUYOWJR-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
136941,6w9c,DB07717,-8.2,"(5S,8R,9S,10S,13R,14S,17S)-13-{2-[(3,5-DIFLUOROBENZYL)OXY]ETHYL}-17-HYDROXY-10-METHYLHEXADECAHYDRO-3H-CYCLOPENTA[A]PHENANTHREN-3-ONE",AJODXHGZHBERGJ-JLYQOUBASA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
77488,6m2n,DB08441,-8.2,"6-BROMO-13-THIA-2,4,8,12,19-PENTAAZATRICYCLO[12.3.1.1-3,7-]NONADECA-1(18),3(19),4,6,14,16-HEXAENE 13,13-DIOXIDE",AWSQADBSXFTFKL-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138643,6w9c,DB12058,-8.2,Recoflavone,BCPQOBQIVJZOFL-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139065,6w9c,DB12798,-8.2,Relenopride,KGMMSPVVHZGPHL-NRFANRHFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
119546,6w4b,DB07435,-8.2,"1,2,3-TRIHYDROXY-1,2,3,4-TETRAHYDROBENZO[A]PYRENE",GFANZDFKCCJYRF-NSISKUIASA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
77447,6m2n,DB08390,-8.2,"(6S)-6-CYCLOPENTYL-6-[2-(3-FLUORO-4-ISOPROPOXYPHENYL)ETHYL]-4-HYDROXY-5,6-DIHYDRO-2H-PYRAN-2-ONE",AKNIHFDXRAOPAI-NRFANRHFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77442,6m2n,DB08385,-8.2,4-(quinolin-3-ylmethyl)piperidine-1-carboxylic acid,QUAGUFNCKDDJFZ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
16566,6cs2,HMDB0002869,-8.2,Campesterol,SGNBVLSWZMBQTH-PODYLUTMSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
63462,6lxt,DB00304,-8.2,Desogestrel,RPLCPCMSCLEKRS-BPIQYHPVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
18429,6cs2,HMDB0029249,-8.2,Luteolinidin,GDNIGMNXEKGFIP-UHFFFAOYSA-O,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
136579,6w9c,DB07290,-8.2,(2R)-2-{[(4-FLUORO-3-METHYLPHENYL)SULFONYL]AMINO}-N-HYDROXY-2-TETRAHYDRO-2H-PYRAN-4-YLACETAMIDE,LUCFRFDOOYLALP-CYBMUJFWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
7624,6lzg,DB04107,-8.2,[(1-{2[(4-Carbamimidoyl-Phenylamino)-Methyl]-1-Methyl-1h-Benzoimidazol-5-Yl}-Cyclopropyl)-Pyridin-2-Yl-Methyleneaminooxy]-Acetic Acid Ethyl Ester,RNOYCNIZOAIUSV-LSWMGQQCSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
120067,6w4b,DB08043,-8.2,1-[4-(PYRIDIN-4-YLOXY)PHENYL]-3-[3-(TRIFLUOROMETHYL)PHENYL]UREA,DDDLGNOZDKDSEG-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
136600,6w9c,DB07312,-8.2,"2,5-DICHLORO-N-(5-CHLORO-1,3-BENZOXAZOL-2-YL)BENZENESULFONAMIDE",JCXZHFCBNFFHRC-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
72025,6m2n,DB00248,-8.2,Cabergoline,KORNTPPJEAJQIU-KJXAQDMKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77374,6m2n,DB08301,-8.2,N-({[4-(AMINOSULFONYL)PHENYL]AMINO}CARBONYL)-4-METHYLBENZENESULFONAMIDE,HDCXQTPVTAIPNZ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
86257,6m3m,DB08631,-8.2,"N-(4-CHLOROPHENYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONAMIDE",UVSIFVBCHJEYJP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
133407,6w9c,DB01641,-8.2,"(5z)-2-[(1s,2r)-1-Amino-2-Hydroxypropyl]-5-[(4-Amino-1h-Indol-3-Yl)Methylene]-3-(2-Hydroxyethyl)-3,5-Dihydro-4h-Imidazol-4-One",JUWJATLABHTRDF-JURWUIOISA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
114505,6vxx,DB13718,-8.2,Hydroquinine,LJOQGZACKSYWCH-WZBLMQSHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
70375,6lxt,DB12553,-8.2,Fluocinolone,UUOUOERPONYGOS-CLCRDYEYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
86267,6m3m,DB08643,-8.2,2-(2-{2-[(BIPHENYL-4-YLMETHYL)-AMINO]-3-MERCAPTO-PENTANOYLAMINO}-ACETYLAMINO)-3-METHYL-BUTYRIC ACID METHYL ESTER,QFAWBPLETHINFK-UNMCSNQZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
63438,6lxt,DB00275,-8.2,Olmesartan,VTRAEEWXHOVJFV-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
136914,6w9c,DB07685,-8.2,"4-{[5-(CYCLOHEXYLMETHOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE",NMAZGYDYIYLSLJ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
80480,6m2n,DB15446,-8.2,Vidofludimus,XPRDUGXOWVXZLL-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
66264,6lxt,DB03944,-8.2,"5-[1-(3,4-Dimethoxy-Benzoyl)-1,2,3,4-Tetrahydro-Quinolin-6-Yl]-6-Methyl-3,6-Dihydro-[1,3,4]Thiadiazin-2-One",IZLRMTJLQCLMKF-CYBMUJFWSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
80469,6m2n,DB15425,-8.2,CYC-065,DLPIYBKBHMZCJI-WBVHZDCISA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
86270,6m3m,DB08646,-8.2,TRW3-(2-AMINO-3-HYDROXY-PROPYL)-6-(N'-CYCLOHEXYL-HYDRAZINO)OCTAHYDRO-INDOL-7-OL,PSUOZWHAKZSNOB-LBPRGKRZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136269,6w9c,DB06919,-8.2,D-phenylalanyl-N-(3-chlorobenzyl)-L-prolinamide,CJHLRGCXPGIPCB-MOPGFXCFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139086,6w9c,DB12833,-8.2,Tandospirone,CEIJFEGBUDEYSX-FZDBZEDMSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
66277,6lxt,DB03962,-8.2,Nicotinamide 8-Bromo-Adenine Dinucleotide Phosphate,MDKMTCCUJSRQGW-NAJQWHGHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
81227,6m3m,DB00952,-8.2,Naratriptan,AMKVXSZCKVJAGH-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
70484,6lxt,DB12721,-8.2,RO-5028442,QZXVLRCMAHJVIP-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
29178,6cs2,DB08820,-8.2,Ivacaftor,PURKAOJPTOLRMP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
85548,6m3m,DB07790,-8.2,N-(2-METHOXYETHYL)-4-({4-[2-METHYL-1-(1-METHYLETHYL)-1H-IMIDAZOL-5-YL]PYRIMIDIN-2-YL}AMINO)BENZENESULFONAMIDE,LDXLQEXLXZCYSR-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81350,6m3m,DB01095,-8.2,Fluvastatin,FJLGEFLZQAZZCD-JUFISIKESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
166303,7bv1,DB14634,-8.2,Fluprednidene acetate,DEFOZIFYUBUHHU-IYQKUMFPSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
81201,6m3m,DB00922,-8.2,Levosimendan,WHXMKTBCFHIYNQ-SECBINFHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81992,6m3m,DB01958,-8.2,"5-[4-Tert-Butylphenylsulfanyl]-2,4-Quinazolinediamine",MNYDVPDMLAJJPB-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
76088,6m2n,DB06777,-8.2,Chenodeoxycholic acid,RUDATBOHQWOJDD-BSWAIDMHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
133334,6w9c,DB01554,-8.2,Bolandiol,CMXKUJNZWYTFJN-XFUVECHXSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
132810,6w9c,DB00875,-8.2,Flupentixol,NJMYODHXAKYRHW-DVZOWYKESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136558,6w9c,DB07257,-8.2,"4-(2-chlorophenyl)-8-(2-hydroxyethyl)-6-methylpyrrolo[3,4-e]indole-1,3(2H,6H)-dione",WHMQZCPGFZBLBG-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139113,6w9c,DB12879,-8.2,Omigapil,QLMMOGWZCFQAPU-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
112778,6vxx,DB07832,-8.2,"4-{4-[(5-hydroxy-2-methylphenyl)amino]quinolin-7-yl}-1,3-thiazole-2-carbaldehyde",VKQPTVJDZIILPG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
133341,6w9c,DB01561,-8.2,Androstanedione,RAJWOBJTTGJROA-WZNAKSSCSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
80669,6m3m,DB00284,-8.2,Acarbose,CEMXHAPUFJOOSV-XGWNLRGSSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
63659,6lxt,DB00547,-8.2,Desoximetasone,VWVSBHGCDBMOOT-IIEHVVJPSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
77216,6m2n,DB08108,-8.2,N-({6-[(4-CYANOBENZYL)OXY]NAPHTHALEN-2-YL}SULFONYL)-D-GLUTAMIC ACID,PUHRQSFXADUGJW-OAQYLSRUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75645,6m2n,DB05134,-8.2,Tanespimycin,AYUNIORJHRXIBJ-TXHRRWQRSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
136635,6w9c,DB07351,-8.2,O-(((1R)-((N-(PHENYL-METHOXY-CARBONYL)-ALANYL)-AMINO)METHYL)HYDROXYPHOSPHINYL)3-L-PHENYLLACTATE,ICACWKLCNCPHAM-YJBOKZPZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
133310,6w9c,DB01530,-8.2,"5alpha-androstane-3alpha,17beta-diol",CBMYJHIOYJEBSB-KHOSGYARSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140310,6w9c,DB02790,-8.2,Phenyl-Uridine-5'-Diphosphate,ZHUWBKDWWGKIEN-FMKGYKFTSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
75640,6m2n,DB05105,-8.2,Pleconaril,KQOXLKOJHVFTRN-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
142245,6w9q,DB01948,-8.2,"1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperidin-4-Yl-3,4-Dihydroquinolin-2(1h)-One",VXIYTVJEIXMAQF-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
133333,6w9c,DB01553,-8.2,Cloxazolam,ZIXNZOBDFKSQTC-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
132827,6w9c,DB00896,-8.2,Rimexolone,QTTRZHGPGKRAFB-OOKHYKNYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136833,6w9c,DB07587,-8.2,"N-(1-CYANOCYCLOPROPYL)-3-({[(2S)-5-OXOPYRROLIDIN-2-YL]METHYL}SULFONYL)-N-2-[(1S)-2,2,2-TRIFLUORO-1-(4-FLUOROPHENYL)ETHYL]-L-ALANINAMIDE",JLPXDVXMMYRTKN-ZOBUZTSGSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
76453,6m2n,DB07222,-8.2,(3S)-N-(5-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE,RJWMDETWDDESBP-ZDUSSCGKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76071,6m2n,DB06741,-8.2,Gavestinel,WZBNEZWCNKUOSM-VOTSOKGWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
65720,6lxt,DB03213,-8.2,Bis(5-Amidino-2-Benzimidazolyl)Methane Ketone,VVVXDHROXQUONB-UHFFFAOYSA-P,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
76427,6m2n,DB07190,-8.2,3-cyclohexyl-D-alanyl-N-(3-chlorobenzyl)-L-prolinamide,JGFCNVHEEMBVJG-MOPGFXCFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138992,6w9c,DB12680,-8.2,Intepirdine,JJZFWROHYSMCMU-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
113784,6vxx,DB12080,-8.2,Ritobegron,VMMYRRFPMAGXNP-BTYIYWSLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
71829,6lxt,DB15358,-8.2,JNJ-54175446,CWFVVQFVGMFTBD-SECBINFHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
82034,6m3m,DB02017,-8.2,Imidazole-Derived Cellobiose,CSXOUJBOYXGFCL-OFKZETBZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136327,6w9c,DB06992,-8.2,"(3,3-dimethylpiperidin-1-yl)(6-(3-fluoro-4-methylphenyl)pyridin-2-yl)methanone",SIDDLTBLAQYZIZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
132841,6w9c,DB00910,-8.2,Paricalcitol,BPKAHTKRCLCHEA-UBFJEZKGSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136841,6w9c,DB07596,-8.2,"(17beta)-17-(cyanomethyl)-2-methox1tra-1(10),2,4-trien-3-yl sulfamate",NTSPHKOMJMBWOU-NNKXXINSSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
142216,6w9q,DB01908,-8.2,RU85493,MWEWSHNGVWABKG-SVBPBHIXSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
76420,6m2n,DB07183,-8.2,N-(4-phenoxyphenyl)-2-[(pyridin-4-ylmethyl)amino]nicotinamide,CPVRYQAOUPSUDO-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
7737,6lzg,DB04301,-8.2,Bis(5-Amidino-2-Benzimidazolyl)Methane Ketone Hydrate,ZLAHDRAQCSQPOC-UHFFFAOYSA-P,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
71581,6lxt,DB14844,-8.2,ONC-201,VLULRUCCHYVXOH-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
71491,6lxt,DB14649,-8.2,Dexamethasone acetate,AKUJBENLRBOFTD-RPRRAYFGSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
133323,6w9c,DB01543,-8.2,18-methyl-19-nortestosterone,FBYZQDCRLYHHHP-ZOFHRBRSSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
114876,6vxx,DB15317,-8.2,Posiphen,PBHFNBQPZCRWQP-AZUAARDMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114583,6vxx,DB13821,-8.2,Ceftezole,DZMVCVMFETWNIU-LDYMZIIASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
132808,6w9c,DB00873,-8.2,Loteprednol,YPZVAYHNBBHPTO-MXRBDKCISA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
76054,6m2n,DB06717,-8.2,Fosaprepitant,BARDROPHSZEBKC-OITMNORJSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
86181,6m3m,DB08536,-8.2,"3-bromo-5-phenyl-N-(pyrimidin-5-ylmethyl)pyrazolo[1,5-a]pyridin-7-amine",IBUPHWYGVDAASU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
114628,6vxx,DB13916,-8.2,Toyocamycin,XOKJUSAYZUAMGJ-WOUKDFQISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77246,6m2n,DB08141,-8.2,"4-{[(2,6-difluorophenyl)carbonyl]amino}-N-[(3S)-piperidin-3-yl]-1H-pyrazole-3-carboxamide",KOMNQBZWMCFDTQ-VIFPVBQESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75657,6m2n,DB05234,-8.2,LGD2941,HWLLYFXDDGGHOE-BCSUUIJWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
8576,6lzg,DB06435,-8.2,Tarazepide,CZPILLBHPRAPCB-AREMUKBSSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
112783,6vxx,DB07838,-8.2,(Z)-3-BENZYL-5-(2-HYDROXY-3-NITROBENZYLIDENE)-2-THIOXOTHIAZOLIDIN-4-ONE,ZTWBCEZQPRYIGY-ZROIWOOFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81980,6m3m,DB01946,-8.2,"3-[1-(3-Aminopropyl)-1h-Indol-3-Yl]-4-(1-Methyl-1h-Indol-3-Yl)-1h-Pyrrole-2,5-Dione",UQHKJRCFSLMWIA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
76100,6m2n,DB06800,-8.2,Methylnaltrexone,JVLBPIPGETUEET-WIXLDOGYSA-O,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
20868,6cs2,HMDB0001091,-8.2,3-Hydroxyquinine,BSRUJCFCZKMFMB-ZNYHDOEXSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
133342,6w9c,DB01562,-8.2,1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine,BVURVTVDNWSNFN-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
16608,6cs2,HMDB0003141,-8.2,Retinoyl b-glucuronide,MTGFYEHKPMOVNE-NEFMKCFNSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
80718,6m3m,DB00346,-8.2,Alfuzosin,WNMJYKCGWZFFKR-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
75653,6m2n,DB05197,-8.2,Sofalcone,GFWRVVCDTLRWPK-KPKJPENVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76394,6m2n,DB07154,-8.2,"(3R)-4-[(3R)-3-AMINO-4-(2,4,5-TRIFLUOROPHENYL)BUTANOYL]-3-METHYL-1,4-DIAZEPAN-2-ONE",SWKGZJAAGSVROJ-MWLCHTKSSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
98468,6vxs,DB00977,-8.1,Ethinylestradiol,BFPYWIDHMRZLRN-SLHNCBLASA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
164590,7bv1,DB08174,-8.1,"5-CHLORO-N-((1R,2S)-2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO) CYCLOPENTYL)THIOPHENE-2-CARBOXAMIDE",QCPYHSAHOYXXQK-DLBZAZTESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
79351,6m2n,DB13119,-8.1,GSK-364735,QWLNINWUBHHOLU-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
58841,6crv,DB06733,-8.1,Bafilomycin A1,XDHNQDDQEHDUTM-JQWOJBOSSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
161053,7bv1,DB12805,-8.1,Ataciguat,PQHLRGARXNPFCF-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
109930,6vxx,DB00604,-8.1,Cisapride,DCSUBABJRXZOMT-IRLDBZIGSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
102906,6vxs,DB07946,-8.1,"N-[2-({[amino(imino)methyl]amino}oxy)ethyl]-2-{6-chloro-3-[(2,2-difluoro-2-phenylethyl)amino]-2-fluorophenyl}acetamide",DZEJHPMTDNDECN-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
13368,6lzg,DB15227,-8.1,Tirabrutinib,SEJLPXCPMNSRAM-GOSISDBHSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
72976,6m2n,DB01443,-8.1,19-Nor-5-androstenedione,WELNRNVZXWUOGT-QXUSFIETSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
72828,6m2n,DB01195,-8.1,Flecainide,DJBNUMBKLMJRSA-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
81094,6m3m,DB00805,-8.1,Minaprine,LDMWSLGGVTVJPG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
79329,6m2n,DB13090,-8.1,Zidebactam,YCZPXRQPDCXTIO-BBBLOLIVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
12481,6lzg,DB13422,-8.1,Nicofuranose,FUWFSXZKBMCSKF-ZASNTINBSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
29511,6cs2,DB09279,-8.1,Fimasartan,AMEROGPZOLAFBN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
109854,6vxx,DB00338,-8.1,Omeprazole,SUBDBMMJDZJVOS-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
103037,6vxs,DB08096,-8.1,"8-(2-CHLOROPHENYLAMINO)-2-(2,6-DIFLUOROPHENYLAMINO)-9-ETHYL-9H-PURINE-1,7-DIIUM",ZWKOUFZHPNIQSH-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
71631,6lxt,DB14937,-8.1,MK-8666,CODQKEMYZZKQAE-QPVYNBJUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
161048,7bv1,DB12798,-8.1,Relenopride,KGMMSPVVHZGPHL-NRFANRHFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
79650,6m2n,DB13558,-8.1,Morclofone,KVCJCEKJKGLBOK-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79692,6m2n,DB13618,-8.1,Ipriflavone,SFBODOKJTYAUCM-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
72711,6m2n,DB01063,-8.1,Acetophenazine,WNTYBHLDCKXEOT-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137446,6w9c,DB08307,-8.1,"2-{HYDROXY[2-NITRO-4-(TRIFLUOROMETHYL)PHENYL]METHYLENE}CYCLOHEXANE-1,3-DIONE",PMHVFNYNPNKNRO-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
28242,6cs2,DB00717,-8.1,Norethisterone,VIKNJXKGJWUCNN-XGXHKTLJSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
81038,6m3m,DB00735,-8.1,Naftifine,OZGNYLLQHRPOBR-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
109412,6vxx,DB13540,-8.1,Isepamicin,UDIIBEDMEYAVNG-ZKFPOVNWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
103153,6vxs,DB08230,-8.1,"5,7-DIHYDROXY-2-(3,4,5-TRIHYDROXYPHENYL)-4H-CHROMEN-4-ONE",ARSRJFRKVXALTF-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
72716,6m2n,DB01068,-8.1,Clonazepam,DGBIGWXXNGSACT-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137369,6w9c,DB08207,-8.1,"2-(3,5-DIMETHYLPHENYL)-1,3-BENZOXAZOLE",BIHLSRJPJFOESJ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
30338,6cs2,DB12357,-8.1,BMS-863233,JJWLXRKVUJDJKG-VIFPVBQESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
25972,6cs2,DB04014,-8.1,Alsterpaullone,OLUKILHGKRVDCT-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
103135,6vxs,DB08204,-8.1,3-DIPHENOL-6-NITRO-3H-BENZO[DE]ISOCHROMEN-1-ONE,FLWABCQDXUKNQY-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
79803,6m2n,DB13767,-8.1,Vorozole,XLMPPFTZALNBFS-INIZCTEOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
136709,6w9c,DB07439,-8.1,"1-((2-HYDROXYETHOXY)METHYL)-5-(3-(BENZYLOXY)BENZYL)-6-HYDROXYPYRIMIDINE-2,4(1H,3H)-DIONE",CAWXCABXSPTFRN-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
102595,6vxs,DB07583,-8.1,"(4R,2S)-5'-(4-(4-CHLOROBENZYLOXY)PYRROLIDIN-2-YLMETHANESULFONYL)ISOQUINOLINE",RLNNFNGBXLTQOB-RBUKOAKNSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
164607,7bv1,DB08197,-8.1,"(5E,7S)-2-amino-7-(4-fluoro-2-pyridin-3-ylphenyl)-4-methyl-7,8-dihydroquinazolin-5(6H)-one oxime",KYIXUSLGFINPTC-WVFAEZDRSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
99022,6vxs,DB01698,-8.1,Rutin,IKGXIBQEEMLURG-NVPNHPEKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
79646,6m2n,DB13554,-8.1,Moperone,AGAHNABIDCTLHW-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
164888,7bv1,DB08916,-8.1,Afatinib,ULXXDDBFHOBEHA-CWDCEQMOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
102600,6vxs,DB07588,-8.1,"3,4-DI-1H-INDOL-3-YL-1H-PYRROLE-2,5-DICARBOXYLIC ACID",FZDVNXHYGMEEDT-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
81070,6m3m,DB00774,-8.1,Hydroflumethiazide,DMDGGSIALPNSEE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
140101,6w9c,DB14941,-8.1,BMS-817399,GTDPZONCGOCXOD-JPYJTQIMSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
128195,6w4h,DB07323,-8.1,"2-[({2-[(1Z)-3-(DIMETHYLAMINO)PROP-1-ENYL]-4-FLUOROPHENYL}SULFONYL)AMINO]-5,6,7,8-TETRAHYDRONAPHTHALENE-1-CARBOXYLIC ACID",CTZLIARLNXSXGL-ALCCZGGFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
81200,6m3m,DB00921,-8.1,Buprenorphine,RMRJXGBAOAMLHD-IHFGGWKQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
99015,6vxs,DB01689,-8.1,Inhibitor Idd 384,CJKKMQCZOLCXAM-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
59563,6crv,DB07614,-8.1,"PHENYL-5-(1H-PYRAZOL-3-YL)-1,3-THIAZOLE",NRAHRUHGPGBWSI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
99000,6vxs,DB01669,-8.1,Virginiamycin M1,DAIKHDNSXMZDCU-FQTGFAPKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102879,6vxs,DB07917,-8.1,4-(BENZHYDRYLOXY)-1-[3-(1H-TETRAAZOL-5-YL)PROPYL]PIPERIDINE,TZQGXAHOROZEKN-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
166400,7bv1,DB14821,-8.1,Macozinone,BJDZBXGJNBMCAV-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
128785,6w4h,DB08014,-8.1,(METHYLPYRIDAZINE PIPERIDINE BUTYLOXYPHENYL)ETHYLACETATE,AQILFLLHLFBLLG-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
26009,6cs2,DB00146,-8.1,Calcifediol,JWUBBDSIWDLEOM-DTOXIADCSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
103072,6vxs,DB08133,-8.1,N-(4-sulfamoylphenyl)-1H-indazole-3-carboxamide,MNHPHKFLWAPNOV-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
137386,6w9c,DB08230,-8.1,"5,7-DIHYDROXY-2-(3,4,5-TRIHYDROXYPHENYL)-4H-CHROMEN-4-ONE",ARSRJFRKVXALTF-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
26582,6cs2,DB04750,-8.1,OREGON GREEN 488 CARBOXYLATE,BRJCLSQFZSHLRL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
98503,6vxs,DB01016,-8.1,Glyburide,ZNNLBTZKUZBEKO-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
58706,6crv,DB06444,-8.1,Dexanabinol,SSQJFGMEZBFMNV-PMACEKPBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
137370,6w9c,DB08208,-8.1,"2-[(4-ETHYNYL-2-FLUOROPHENYL)AMINO]-3,4-DIFLUORO-N-(2-HYDROXYETHOXY)BENZAMIDE",AMNKRBRQQAMACZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
164789,7bv1,DB08607,-8.1,"(5R)-5-(4-{[(2R)-6-HYDROXY-2,5,7,8-TETRAMETHYL-3,4-DIHYDRO-2H-CHROMEN-2-YL]METHOXY}BENZYL)-1,3-THIAZOLIDINE-2,4-DIONE",GXPHKUHSUJUWKP-NTKDMRAZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
102622,6vxs,DB07616,-8.1,"4-{[4-(4-fluoro-3-methylphenyl)-1,3-thiazol-2-yl]amino}-2-hydroxybenzoic acid",LKZZDHKJFDTYCH-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
81275,6m3m,DB01009,-8.1,Ketoprofen,DKYWVDODHFEZIM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
71588,6lxt,DB14856,-8.1,PF-05089771,ZYSCOUXLBXGGIM-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
79824,6m2n,DB13793,-8.1,Vinburnine,WYJAPUKIYAZSEM-MOPGFXCFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79883,6m2n,DB13872,-8.1,Lormetazepam,FJIKWRGCXUCUIG-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
118562,6w4b,DB05220,-8.1,Alisertib,ZLHFILGSQDJULK-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
81164,6m3m,DB00882,-8.1,Clomifene,GKIRPKYJQBWNGO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
164567,7bv1,DB08151,-8.1,"(5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-phenyl-1,6-dioxa-2-azaspiro[4.5]dec-2-ene-8,9,10-triol",YLTDNVVQKRHCJP-RKQHYHRCSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
72799,6m2n,DB01165,-8.1,Ofloxacin,GSDSWSVVBLHKDQ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
161029,7bv1,DB12419,-8.1,HSD-016,ZWASRJHIEFYJGL-BFUOFWGJSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
72908,6m2n,DB01332,-8.1,Ceftizoxime,NNULBSISHYWZJU-LLKWHZGFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
98353,6vxs,DB00845,-8.1,Clofazimine,WDQPAMHFFCXSNU-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
109868,6vxx,DB00530,-8.1,Erlotinib,AAKJLRGGTJKAMG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109864,6vxx,DB00348,-8.1,Nitisinone,OUBCNLGXQFSTLU-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58804,6crv,DB06680,-8.1,Asoprisnil,GJMNAFGEUJBOCE-MEQIQULJSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
102812,6vxs,DB07835,-8.1,"N-3-cyclopropyl-N-4-'-(cyclopropylmethyl)-6-methylbiphenyl-3,4'-dicarboxamide",BOPSUAHGQHFKGG-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
136654,6w9c,DB07375,-8.1,"5-BETA-ANDROSTANE-3,17-DIONE",RAJWOBJTTGJROA-QJISAEMRSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
55313,6crv,DB00861,-8.1,Diflunisal,HUPFGZXOMWLGNK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
102735,6vxs,DB07750,-8.1,"(2R)-1-[4-({4-[(2,5-Dichlorophenyl)amino]-2-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol",GNLAGGCSJGJECE-MRXNPFEDSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
59652,6crv,DB07719,-8.1,"[(3R)-3-(Methylcarbamoyl)-2-{[(2-methyl-2-propanyl)oxy]carbonyl}-1,2,3,4-tetrahydro-7-isoquinolinyl]sulfamic acid",PPSSYXOFPICMQD-CYBMUJFWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30364,6cs2,DB12391,-8.1,Sagopilone,BFZKMNSQCNVFGM-UCEYFQQTSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
160927,7bv1,DB12280,-8.1,AZD-5423,FCNQMDSJHADDFT-WNSKOXEYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
159824,7bv1,DB06634,-8.1,Casopitant,XGGTZCKQRWXCHW-WMTVXVAQSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
79405,6m2n,DB13232,-8.1,Suxibuzone,ONWXNHPOAGOMTG-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
72917,6m2n,DB01348,-8.1,Spirapril,HRWCVUIFMSZDJS-SZMVWBNQSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79417,6m2n,DB13248,-8.1,Phthalylsulfathiazole,PBMSWVPMRUJMPE-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
71570,6lxt,DB14802,-8.1,ONO-2952,ZBQMTQGDBFZUBG-NRFANRHFSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
102745,6vxs,DB07761,-8.1,"(2R)-1-[4-({6-[(2,6-Difluorophenyl)amino]-4-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol",ZVSBKYYVBCKDBO-OAHLLOKOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
98696,6vxs,DB01238,-8.1,Aripiprazole,CEUORZQYGODEFX-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
81139,6m3m,DB00854,-8.1,Levorphanol,JAQUASYNZVUNQP-USXIJHARSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
13330,6lzg,DB15157,-8.1,Voruciclib,MRPGRAKIAJJGMM-OCCSQVGLSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
118497,6w4b,DB04908,-8.1,Flibanserin,PPRRDFIXUUSXRA-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
98325,6vxs,DB00814,-8.1,Meloxicam,ZRVUJXDFFKFLMG-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
12528,6lzg,DB13484,-8.1,Quinbolone,IUVKMZGDUIUOCP-BTNSXGMBSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
71572,6lxt,DB14810,-8.1,AZD-1656,FJEJHJINOKKDCW-INIZCTEOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
13284,6lzg,DB15075,-8.1,4-demethyl-4-cholesteryloxycarbonylpenclomedine,ZJUUIXYKTPSIOH-LEZJFEBPSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
118488,6w4b,DB04888,-8.1,Bifeprunox,CYGODHVAJQTCBG-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
102794,6vxs,DB07815,-8.1,GIBBERELLIN A4,RSQSQJNRHICNNH-NFMPGMCNSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
55029,6crv,DB00524,-8.1,Metolazone,AQCHWTWZEMGIFD-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72791,6m2n,DB01155,-8.1,Gemifloxacin,ZRCVYEYHRGVLOC-HYARGMPZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
59614,6crv,DB07675,-8.1,(2S)-2-ETHOXY-3-{4-[2-(10H-PHENOXAZIN-10-YL)ETHOXY]PHENYL}PROPANOIC ACID,WMUIIGVAWPWQAW-DEOSSOPVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72786,6m2n,DB01149,-8.1,Nefazodone,VRBKIVRKKCLPHA-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
98646,6vxs,DB01180,-8.1,Rescinnamine,SZLZWPPUNLXJEA-LAFLMMDJSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
160935,7bv1,DB12289,-8.1,Darexaban,IJNIQYINMSGIPS-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
128744,6w4h,DB07969,-8.1,3-[3-(4-methylpiperazin-1-yl)-7-(trifluoromethyl)quinoxalin-5-yl]phenol,QNCYYRHIUFGGJX-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
159918,7bv1,DB07080,-8.1,"N-(2,2,2-TRIFLUOROETHYL)-N-{4-[2,2,2-TRIFLUORO-1-HYDROXY-1-(TRIFLUOROMETHYL)ETHYL]PHENYL}BENZENESULFONAMIDE",SGIWFELWJPNFDH-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
98262,6vxs,DB00737,-8.1,Meclizine,OCJYIGYOJCODJL-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
55306,6crv,DB00854,-8.1,Levorphanol,JAQUASYNZVUNQP-USXIJHARSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
8339,6lzg,DB05490,-8.1,AMG-131,NMRWDFUZLLQSBN-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
137433,6w9c,DB08293,-8.1,"(5E)-12-CHLORO-13,15-DIHYDROXY-4,7,8,9-TETRAHYDRO-2-BENZOXACYCLOTRIDECINE-1,10(3H,11H)-DIONE",AQKZYZQONWDDLS-HNQUOIGGSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
160919,7bv1,DB12270,-8.1,Losmapimod,KKYABQBFGDZVNQ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
98859,6vxs,DB01500,-8.1,Oxabolone,GXHBCWCMYVTJOW-YGRHGMIBSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
98860,6vxs,DB01501,-8.1,Difenoxin,UFIVBRCCIRTJTN-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
30380,6cs2,DB12408,-8.1,PF-03635659,WGOJWDWKHJHXSV-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
136604,6w9c,DB07316,-8.1,"N-{1-[(1-carbamoylcyclopropyl)methyl]piperidin-4-yl}-N-cyclopropyl-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide",FAVXIEFZKPJZRT-NRFANRHFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
98889,6vxs,DB01536,-8.1,Androstenedione,AEMFNILZOJDQLW-QAGGRKNESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102792,6vxs,DB07813,-8.1,GLYCYLALANYL-N-2-NAPHTHYL-L-PROLINEAMIDE,KCELZXZDIUJGNM-GUYCJALGSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
79370,6m2n,DB13166,-8.1,Zofenopril,IAIDUHCBNLFXEF-MNEFBYGVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
12443,6lzg,DB13371,-8.1,Difenpiramide,PWHROYKAGRUWDQ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
164891,7bv1,DB08922,-8.1,Perospirone,FBVFZWUMDDXLLG-HDICACEKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
79798,6m2n,DB13759,-8.1,Fenpiverinium,QDIYJDPBMZUZEH-UHFFFAOYSA-O,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
166423,7bv1,DB15105,-8.1,PF-06751979,ZLZUHACSRMOLLV-RAALSFIWSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
128716,6w4h,DB07936,-8.1,N-(4-{[(3S)-3-(dimethylamino)pyrrolidin-1-yl]carbonyl}phenyl)-5-fluoro-4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]pyrimidin-2-amine,BACSZMCLZIDTIO-IBGZPJMESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
13246,6lzg,DB15003,-8.1,PF-06700841,BUWBRTXGQRBBHG-MJBXVCDLSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
59647,6crv,DB07714,-8.1,"6-(3-METHYL-1,4-DIOXO-1,4-DIHYDRONAPHTHALEN-2-YL)HEXANOIC ACID",ICGRXHWXPCXIKM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113974,6vxx,DB12350,-8.1,Rostafuroxin,AEAPORIZZWBIEX-DTBDINHYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58722,6crv,DB06478,-8.1,Porfiromycin,HRHKSTOGXBBQCB-VFWICMBZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
71559,6lxt,DB14775,-8.1,Cavosonstat,BXSZILNGNMDGSL-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
164869,7bv1,DB08707,-8.1,"4-[3-(4-chlorophenyl)-2,1-benzisoxazol-5-yl]pyrimidin-2-amine",AQVFETGXIRKVAQ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
102852,6vxs,DB07879,-8.1,"N-hydroxy-5-[(3-phenyl-5,6-dihydroimidazo[1,2-a]pyrazin-7(8H)-yl)carbonyl]thiophene-2-carboxamide",SMSIXMLQOONOQQ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
98788,6vxs,DB01420,-8.1,Testosterone propionate,PDMMFKSKQVNJMI-BLQWBTBKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102685,6vxs,DB07692,-8.1,"1-[(2,6-difluorophenyl)sulfonyl]-4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)piperazine",SHWNKRPMUBFWKE-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
59601,6crv,DB07655,-8.1,"3-AMINO-3-BENZYL-[4.3.0]BICYCLO-1,6-DIAZANONAN-2-ONE",MPJYGQHMIFDQIN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
102694,6vxs,DB07702,-8.1,17alpha-Estriol,PROQIPRRNZUXQM-PNVOZDDCSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
166328,7bv1,DB14661,-8.1,Loperamide oxide,KXVSBTJVTUVNPM-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
72776,6m2n,DB01138,-8.1,Sulfinpyrazone,MBGGBVCUIVRRBF-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
102996,6vxs,DB08049,-8.1,"7,8-dihydroxy-4-phenyl-2H-chromen-2-one",JRVIIPJSVKTPBK-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
136609,6w9c,DB07322,-8.1,"2-[(PHENYLSULFONYL)AMINO]-5,6,7,8-TETRAHYDRONAPHTHALENE-1-CARBOXYLIC ACID",RRXVUYHFDBLTEL-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
161036,7bv1,DB12776,-8.1,E-6005,BBTFKAOFCSOZMB-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
159939,7bv1,DB07105,-8.1,2-[2-(4-CHLORO-PHENYLSULFANYL)-ACETYLAMINO]-3-(4-GUANIDINO-PHENYL)-PROPIONAMIDE,IEEYGOJDTRVYGR-HNNXBMFYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
79385,6m2n,DB13208,-8.1,Prednylidene,WSVOMANDJDYYEY-CWNVBEKCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
13324,6lzg,DB15145,-8.1,Ziresovir,GAAICKUTDBZCMT-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
118521,6w4b,DB04971,-8.1,Reglitazar,QBQLYIISSRXYKL-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
26617,6cs2,DB04793,-8.1,"1,4:3,6-Dianhydro-2-O-(3-carbamimidoylphenyl)-5-O-(4-carbamimidoylphenyl)-D-glucitol",DKBAWRNTUZFJKV-XMTFNYHQSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
9956,6lzg,DB08097,-8.1,"2-(2,6-DIFLUOROPHENOXY)-N-(2-FLUOROPHENYL)-9-ISOPROPYL-9H-PURIN-8-AMINE",OGWSGDLIXOEZJG-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
98230,6vxs,DB00699,-8.1,Nicergoline,YSEXMKHXIOCEJA-FVFQAYNVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
79536,6m2n,DB13407,-8.1,Nifenazone,BRZANEXCSZCZCI-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
160926,7bv1,DB12279,-8.1,OBP-801,XFLBOEMFLGLWFF-HDXRNPEWSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
10175,6lzg,DB08345,-8.1,"4-(2-(1H-IMIDAZOL-4-YL)ETHYLAMINO)-2-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE",IWUUKHQIKFHWIW-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
102821,6vxs,DB07847,-8.1,6-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-(4-MORPHOLINYL)-2-OXO ETHYL]-2-OXO-3-PYRROLIDINYL}-2-NAPHTHALENESULFONAMIDE,ICLOZQFWTRAYPX-LIRRHRJNSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
103010,6vxs,DB08063,-8.1,"1-BENZYL-3-(4-METHOXYPHENYLAMINO)-4-PHENYLPYRROLE-2,5-DIONE",HLZMYWLMBBLASX-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
81168,6m3m,DB00886,-8.1,Omapatrilat,LVRLSYPNFFBYCZ-VGWMRTNUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
71722,6lxt,DB15149,-8.1,Futibatinib,KEIPNCCJPRMIAX-HNNXBMFYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
58878,6crv,DB06802,-8.1,Nepafenac,QEFAQIPZVLVERP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
100378,6vxs,DB03501,-8.1,Galactose-uridine-5'-diphosphate,HSCJRCZFDFQWRP-ABVWGUQPSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
137130,6w9c,DB07935,-8.1,"5-[(5-fluoro-3-methyl-1H-indazol-4-yl)oxy]benzene-1,3-dicarbonitrile",JYAHFMKZJRVTDT-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
59136,6crv,DB07116,-8.1,1-(2-DEOXY-5-O-PHOSPHONO-BETA-D-ERYTHRO-PENTOFURANOSYL)-4-METHYL-1H-INDOLE,UXXYPWCUINVUHL-BFHYXJOUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
160490,7bv1,DB08449,-8.1,"2-(3-((4,5,7-trifluorobenzo[d]thiazol-2-yl)methyl)-1H-pyrrolo[2,3-b]pyridin-1-yl)acetic acid",IEVFQDJUDLCOQY-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
124617,6w4h,DB01430,-8.1,Almitrine,OBDOVFRMEYHSQB-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
137132,6w9c,DB07937,-8.1,"2-butoxy-9-(2,6-difluorobenzyl)-N-(2-morpholin-4-ylethyl)-9H-purin-6-amine",UGZWPZWADDDTRN-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
59140,6crv,DB07120,-8.1,"N4-(N,N-DIPHENYLCARBAMOYL)-AMINOGUANIDINE",QLXOHIUDKNRVBZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
137155,6w9c,DB07965,-8.1,6-(cyclohexylamino)-9-[2-(4-methylpiperazin-1-yl)-ethyl]-9H-purine-2-carbonitrile,OGODDSLNRULSMM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
80677,6m3m,DB00295,-8.1,Morphine,BQJCRHHNABKAKU-KBQPJGBKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
55116,6crv,DB00628,-8.1,Clorazepic acid,XDDJGVMJFWAHJX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
100373,6vxs,DB03495,-8.1,"4,6-Dideoxy-4-{[4,5,6-Trihydroxy-3-(Hydroxymethyl)Cyclohex-2-En-1-Yl]Amino}-Alpha-D-Lyxo-Hexopyranosyl-(1->4)-Alpha-D-Threo-Hexopyranosyl-(1->6)-Alpha-L-Threo-Hexopyranose",FZLCJZILHGFQLM-PISLJJGOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
100368,6vxs,DB03488,-8.1,Uridine-5'-diphosphate-2-deoxy-2-fluoro-alpha-D-galactose,NGTCPFGWXMBZEP-NQQHDEILSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
71839,6lxt,DB15391,-8.1,Elenbecestat,AACUJFVOHGRMTR-DPXNYUHVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
101664,6vxs,DB06188,-8.1,Ispinesib,QJZRFPJCWMNVAV-HHHXNRCGSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
100374,6vxs,DB03496,-8.1,Alvocidib,BIIVYFLTOXDAOV-YVEFUNNKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
80699,6m3m,DB00321,-8.1,Amitriptyline,KRMDCWKBEZIMAB-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80282,6m2n,DB15052,-8.1,Ansofaxine,QKYBZJLEMOZFFU-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
160487,7bv1,DB08446,-8.1,"3-[6-bromo-2-fluoro-3-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)phenoxy]-5-chlorobenzonitrile",OHQMEDBYNUAVNE-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
100513,6vxs,DB03701,-8.1,Vanoxerine,NAUWTFJOPJWYOT-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
160455,7bv1,DB08407,-8.1,PLATENSIMYCIN,CSOMAHTTWTVBFL-OFBLZTNGSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
12877,6lzg,DB13954,-8.1,Estradiol cypionate,UOACKFBJUYNSLK-XRKIENNPSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
119072,6w4b,DB06888,-8.1,"(13R,15S)-13-METHYL-16-OXA-8,9,12,22,24-PENTAAZAHEXACYCLO[15.6.2.16,9.1,12,15.0,2,7.0,21,25]HEPTACOSA-1(24),2,4,6,17(25),18,20-HEPTAENE-23,26-DIONE",KBLPHMRCKHFBJB-OLZOCXBDSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
101542,6vxs,DB05511,-8.1,Piclidenoson,HUJXGQILHAUCCV-MOROJQBDSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
59157,6crv,DB07139,-8.1,3-[5-(3-nitrophenyl)thiophen-2-yl]propanoic acid,IHKCOKRMJRDWAL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
100389,6vxs,DB03515,-8.1,Equilenin,PDRGHUMCVRDZLQ-WMZOPIPTSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
140199,6w9c,DB15334,-8.1,Biochanin A,WUADCCWRTIWANL-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137091,6w9c,DB07889,-8.1,"(2S)-1-(Dimethylamino)-3-(4-{[4-(2-methylimidazo[1,2-a]pyridin-3-yl)-2-pyrimidinyl]amino}phenoxy)-2-propanol",VCPXSBULBDYRLT-SFHVURJKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
101590,6vxs,DB05796,-8.1,Daglutril,XMQODGUTLZXUGZ-RPBOFIJWSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101592,6vxs,DB05804,-8.1,Prasterone sulfate,CZWCKYRVOZZJNM-USOAJAOKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
8440,6lzg,DB06090,-8.1,Bradanicline,OXKRFEWMSWPKKV-GHTZIAJQSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
71871,6lxt,DB15448,-8.1,Acumapimod,VGUSQKZDZHAAEE-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
113858,6vxx,DB12188,-8.1,Zicronapine,BYPMJBXPNZMNQD-PZJWPPBQSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
101579,6vxs,DB05706,-8.1,13-deoxydoxorubicin,RGVRUQHYQSORBY-JIGXQNLBSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101530,6vxs,DB05450,-8.1,Smilagenin,GMBQZIIUCVWOCD-UQHLGXRBSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
128425,6w4h,DB07595,-8.1,"(5Z)-5-(3-BROMOCYCLOHEXA-2,5-DIEN-1-YLIDENE)-N-(PYRIDIN-4-YLMETHYL)-1,5-DIHYDROPYRAZOLO[1,5-A]PYRIMIDIN-7-AMINE",WSIQKQLAGWVKSL-UHFFFAOYSA-O,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
101709,6vxs,DB06274,-8.1,Alvimopan,UPNUIXSCZBYVBB-JVFUWBCBSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
100182,6vxs,DB03234,-8.1,"(4'-{[Allyl(Methyl)Amino]Methyl}-1,1'-Biphenyl-4-Yl)(4-Bromophenyl)Methanone",YATCZCSDJCQNAL-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
12794,6lzg,DB13814,-8.1,Talampicillin,SOROUYSPFADXSN-SUWVAFIASA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
71811,6lxt,DB15325,-8.1,ONO-8539,ALLLQQUASFFEKP-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
80209,6m2n,DB14875,-8.1,AZD-4017,NCDZABJPWMBMIQ-INIZCTEOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137211,6w9c,DB08026,-8.1,"2-{4-[(4-imidazo[1,2-a]pyridin-3-ylpyrimidin-2-yl)amino]piperidin-1-yl}-N-methylacetamide",AJLILYAPRHIFAS-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140176,6w9c,DB15124,-8.1,PF-05241328,RVTSXVZXEGFIPW-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
128389,6w4h,DB07550,-8.1,"2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(1-OXIDO-2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUOROPHENYL)METHYL]ACETAMIDE",ZIGSBBKEPNQXRG-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
59078,6crv,DB07048,-8.1,"N-[(2R)-5-(aminosulfonyl)-2,3-dihydro-1H-inden-2-yl]-2-propylpentanamide",XBYJCVDSFWJBSM-OAHLLOKOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
26384,6cs2,DB04514,-8.1,Phosphoric Acid-2'-[2'-Deoxy-Uridine]Ester-5'-Guanosine Ester,DFYLLEBFVZTKHD-VMIOUTBZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
164748,7bv1,DB08556,-8.1,"5'-ACETYL-4-{[(2,4-DIMETHYLPHENYL)SULFONYL]AMINO}-2,2'-BITHIOPHENE-5-CARBOXYLIC ACID",CMHHNHDPPWDNAH-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
109532,6vxx,DB14065,-8.1,Lomerizine,JQSAYKKFZOSZGJ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
160132,7bv1,DB07548,-8.1,"2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUORO-6-PYRIDINYL)METHYL]ACETAMIDE",JXHWVKOKYDAROD-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
124798,6w4h,DB01640,-8.1,"(5r)-6-(4-{[2-(3-Iodobenzyl)-3-Oxocyclohex-1-En-1-Yl]Amino}Phenyl)-5-Methyl-4,5-Dihydropyridazin-3(2h)-One",QNURTFDBHAQRSI-OAHLLOKOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
124813,6w4h,DB01661,-8.1,1-(5-phospho-D-ribosyl)-ATP,RKNHJBVBFHDXGR-MRUDJCSFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
160148,7bv1,DB07568,-8.1,"(2S)-2-[(2,1,3-BENZOTHIADIAZOL-4-YLSULFONYL)AMINO]-2-PHENYL-N-PYRIDIN-4-YLACETAMIDE",ADRNPUSZBRQDBG-KRWDZBQOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
101697,6vxs,DB06250,-8.1,Fluasterone,VHZXNQKVFDBFIK-NBBHSKLNSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
128400,6w4h,DB07564,-8.1,"6-amino-2-[(2-morpholin-4-ylethyl)amino]-3,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",JUHXOBNFTFUPKQ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
101753,6vxs,DB06414,-8.1,Etravirine,PYGWGZALEOIKDF-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
80713,6m3m,DB00341,-8.1,Cetirizine,ZKLPARSLTMPFCP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59110,6crv,DB07085,-8.1,2-{[N-(2-ACETYL-5-CHLORO-4-FLUOROPHENYL)GLYCYL]AMINO}BENZOIC ACID,LBMZLHCAPBBOFS-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109617,6vxx,DB14539,-8.1,Hydrocortisone acetate,ALEXXDVDDISNDU-JZYPGELDSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29577,6cs2,DB09534,-8.1,Ecamsule,HEAHZSUCFKFERC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
100273,6vxs,DB03351,-8.1,Sri-9439,KMSATRJZEXNGDP-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
80716,6m3m,DB00344,-8.1,Protriptyline,BWPIARFWQZKAIA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
128585,6w4h,DB07786,-8.1,"1-((1R,2S)-1-{2-[2-(4-CHLOROPHENYL)-1,3-BENZOXAZOL-7-YL]ETHYL}-2-HYDROXYPROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE",SMFRBBHLVBWHGB-DJJJIMSYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
59360,6crv,DB07371,-8.1,3-(10-methyl-9-anthryl)propanoic acid,CKQINRXZVYBCSC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109760,6vxx,DB00227,-8.1,Lovastatin,PCZOHLXUXFIOCF-BXMDZJJMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
160536,7bv1,DB08747,-8.1,"(11R)-10-acetyl-11-(2,4-dichlorophenyl)-6-hydroxy-3,3-dimethyl-2,3,4,5,10,11-hexahydro-1H-dibenzo[b,e][1,4]diazepin-1-one",JJTPPGUNMJMPLY-QFIPXVFZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
101743,6vxs,DB06395,-8.1,Abafungin,TYBHXIFFPVFXQW-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
124737,6w4h,DB01565,-8.1,Dihydromorphine,IJVCSMSMFSCRME-KBQPJGBKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
28342,6cs2,DB07929,-8.1,"N-(TERT-BUTYL)-3,5-DIMETHYL-N'-[(5-METHYL-2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)CARBONYL]BENZOHYDRAZIDE",JGJACZABNQGPMT-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
137209,6w9c,DB08023,-8.1,"N-cyclohexyl-4-imidazo[1,2-a]pyridin-3-yl-N-methylpyrimidin-2-amine",HYNNWLVWJXWXFO-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137174,6w9c,DB07986,-8.1,[4-(4-PHENYL-PIPERIDIN-1-YL)-BENZENESULFONYLAMINO]-ACETIC ACID,GNSLACGSDSJAIQ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
100143,6vxs,DB03186,-8.1,U-Pi-a-Pi,JIAJERGOUFOENU-LNAOLWRRSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101523,6vxs,DB05422,-8.1,OPC-14523,TZZGTNZBLPCBIS-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
137085,6w9c,DB07878,-8.1,"N-[(1S)-1-{1-[(1R,3E)-1-ACETYLPENT-3-EN-1-YL]-1H-1,2,3-TRIAZOL-4-YL}-1,2-DIMETHYLPROPYL]BENZAMIDE",OEHUTYXPQSSKAK-RVLLMHTFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136929,6w9c,DB07703,-8.1,"(3R,4S,5S,7R,9E,11R,12R)-12-ETHYL-4-HYDROXY-3,5,7,11-TETRAMETHYLOXACYCLODODEC-9-ENE-2,8-DIONE",NZUJVBSYQXETNF-PQWITYJESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
10073,6lzg,DB08220,-8.1,"(8alpha,10alpha,13alpha,17beta)-17-[(4-hydroxyphenyl)carbonyl]androsta-3,5-diene-3-carboxylic acid",RPNNXCYIESWDSC-JRZBRKEGSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
124492,6w4h,DB01208,-8.1,Sparfloxacin,DZZWHBIBMUVIIW-DTORHVGOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
59263,6crv,DB07262,-8.1,1-{[N-(1-IMINO-GUANIDINO-METHYL)]SULFANYLMETHYL}-3-TRIFLUOROMETHYL-BENZENE,DWJNPCRXBNWCJC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
101290,6vxs,DB04726,-8.1,"7,8,10-TRIMETHYLBENZO[G]PTERIDINE-2,4(3H,10H)-DIONE",KPDQZGKJTJRBGU-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
128475,6w4h,DB07653,-8.1,"N-(5,6-DIPHENYLFURO[2,3-D]PYRIMIDIN-4-YL)GLYCINE",VXTCEUDVOCLEJG-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
100976,6vxs,DB04301,-8.1,Bis(5-Amidino-2-Benzimidazolyl)Methane Ketone Hydrate,ZLAHDRAQCSQPOC-UHFFFAOYSA-P,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
164714,7bv1,DB08517,-8.1,"(2S)-5-hydroxy-2-(4-hydroxyphenyl)-7-methoxy-2,3-dihydro-4H-chromen-4-one",DJOJDHGQRNZXQQ-AWEZNQCLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
128465,6w4h,DB07643,-8.1,"5-{[1-(2,3-dichlorobenzyl)piperidin-4-yl]methoxy}quinazoline-2,4-diamine",XVLUVRFYGVJKGJ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
101332,6vxs,DB04787,-8.1,Tanaproget,PYVFWTPEBMRKSR-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
59208,6crv,DB07197,-8.1,4-BROMO-3-(CARBOXYMETHOXY)-5-(4-HYDROXYPHENYL)THIOPHENE-2-CARBOXYLIC ACID,QZWUMLLRAVGBHC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
10026,6lzg,DB08164,-8.1,"(3R,4R)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN-3-AMINE",GOBIXGZJSMAOFV-QRWLVFNGSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
80495,6m2n,DB02639,-8.1,4-methylumbelliferyl alpha-D-glucoside,YUDPTGPSBJVHCN-JZYAIQKZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
136991,6w9c,DB07775,-8.1,"3',5'-DIBROMO-2',4,4',6'-TETRAHYDROXY AURONE",BRPKBUNFOZFULQ-SGAXSIHGSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136987,6w9c,DB07770,-8.1,5-(4-FLUOROPHENYL)-3-{[(4-METHYLPHENYL)SULFONYL]AMINO}THIOPHENE-2-CARBOXYLIC ACID,DJPFUQBNQLKCAB-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
30512,6cs2,DB12582,-8.1,Piperine,MXXWOMGUGJBKIW-YPCIICBESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
101274,6vxs,DB04705,-8.1,"(3BETA)-CHOLEST-5-ENE-3,25-DIOL",INBGSXNNRGWLJU-ZHHJOTBYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
59222,6crv,DB07215,-8.1,"2-METHYL-2-(4-{[({4-METHYL-2-[4-(TRIFLUOROMETHYL)PHENYL]-1,3-THIAZOL-5-YL}CARBONYL)AMINO]METHYL}PHENOXY)PROPANOIC ACID",ILUPZUOBHCUBKB-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
101177,6vxs,DB04574,-8.1,Estrone sulfate,JKKFKPJIXZFSSB-CBZIJGRNSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
140241,6w9c,DB15425,-8.1,CYC-065,DLPIYBKBHMZCJI-WBVHZDCISA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
160367,7bv1,DB08300,-8.1,"1-methyl-3-naphthalen-2-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine",UOKGZPYGRJDACN-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
101181,6vxs,DB04578,-8.1,"(S)-2-[(R)-3-amino-4-(2-fluorophenyl)butyryl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide",OEVYDSSAPNIURZ-AEFFLSMTSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
136933,6w9c,DB07707,-8.1,"(9BETA,11ALPHA,13ALPHA,14BETA,17ALPHA)-11-(METHOXYMETHYL)ESTRA-1(10),2,4-TRIENE-3,17-DIOL",LEOPSILMAOYZBO-IUTAEKPZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
72073,6m2n,DB00304,-8.1,Desogestrel,RPLCPCMSCLEKRS-BPIQYHPVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
101009,6vxs,DB04348,-8.1,Taurocholic Acid,WBWWGRHZICKQGZ-HZAMXZRMSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
59252,6crv,DB07251,-8.1,"N'-(3-CHLORO-4-METHOXY-PHENYL)-N-(3,4,5-TRIMETHOXYPHENYL)-1,3,5-TRIAZINE-2,4-DIAMINE",ZVWFECUPYCFYBL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72113,6m2n,DB00353,-8.1,Methylergometrine,UNBRKDKAWYKMIV-QWQRMKEZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
136970,6w9c,DB07751,-8.1,"(2S)-1-[4-({6-[(2,6-Difluorophenyl)amino]-4-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol",ZVSBKYYVBCKDBO-HNNXBMFYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
101214,6vxs,DB04623,-8.1,"2-ETHOXYETHYL (2S,3S)-4-((S)-2-BENZYL-3-OXO-4-((3AR,8R,8AS)-2-OXO-3,3A,8,8A-TETRAHYDRO-2H-INDENO[1,2-D]OXAZOL-8-YL)-2,3-DIHYDRO-1H-PYRROL-2-YL)-3-HYDROXY-1-PHENYLBUTAN-2-YLCARBAMATE",CGBRFCVAMLJVEA-ZGURCIGKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
160354,7bv1,DB08285,-8.1,"(2R)-2-{[4-(benzylamino)-8-(1-methylethyl)pyrazolo[1,5-a][1,3,5]triazin-2-yl]amino}butan-1-ol",SQUNOCMDMIQIQK-OAHLLOKOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160350,7bv1,DB08037,-8.1,"(2S)-4-(2,5-difluorophenyl)-N-[(3R,4S)-3-fluoro-1-methylpiperidin-4-yl]-2-(hydroxymethyl)-N-methyl-2-phenyl-2,5-dihydro-1H-pyrrole-1-carboxamide",MYBGWENAVMIGMM-GIFXNVAJSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
118865,6w4b,DB06515,-8.1,Resiniferatoxin,DSDNAKHZNJAGHN-MXTYGGKSSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
109687,6vxx,DB15137,-8.1,VK-2809,LGGPZDRLTDGYSQ-JADSYQMUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113854,6vxx,DB12184,-8.1,Gepirone,QOIGKGMMAGJZNZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109741,6vxx,DB15241,-8.1,Methylsamidorphan,ATCVVCBJNHXIEX-ZAHKBLQYSA-O,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
124462,6w4h,DB01177,-8.1,Idarubicin,XDXDZDZNSLXDNA-TZNDIEGXSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
100626,6vxs,DB03837,-8.1,Morpholine-4-Carboxylic Acid (1-(3-Benzenesulfonyl-1-Phenethylallylcarbamoyl)-3-Methylbutyl)-Amide,YUMYYTORLYHUFW-ZUDLOMHPSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
166367,7bv1,DB14737,-8.1,Cannabinol,VBGLYOIFKLUMQG-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
166377,7bv1,DB14765,-8.1,Rivoceranib,WPEWQEMJFLWMLV-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59176,6crv,DB07161,-8.1,5-phenyl-1H-indazol-3-amine,ZCUSNQPYUNLATP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
137078,6w9c,DB07871,-8.1,6-CHLORO-4-(CYCLOHEXYLOXY)-3-ISOPROPYLQUINOLIN-2(1H)-ONE,OQCFORGSZJSAEL-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
80329,6m2n,DB15143,-8.1,PF-06650833,JKDGKIBAOAFRPJ-ZBINZKHDSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
136905,6w9c,DB07675,-8.1,(2S)-2-ETHOXY-3-{4-[2-(10H-PHENOXAZIN-10-YL)ETHOXY]PHENYL}PROPANOIC ACID,WMUIIGVAWPWQAW-DEOSSOPVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
26306,6cs2,DB04421,-8.1,Nicotinamide Adenine Dinucleotide 3-Pentanone Adduct,BZJFKYRGSZWSLT-YLIVDTKOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
164733,7bv1,DB08538,-8.1,"N-((2-aminopyrimidin-5-yl)methyl)-5-(2,6-difluorophenyl)-3-ethylpyrazolo[1,5-a]pyrimidin-7-amine",HQPVGVSQPQVZLD-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
72229,6m2n,DB00493,-8.1,Cefotaxime,GPRBEKHLDVQUJE-QSWIMTSFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
101515,6vxs,DB05395,-8.1,Amibegron,RDJQCOBTKKAQAH-FPOVZHCZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
80605,6m3m,DB00214,-8.1,Torasemide,NGBFQHCMQULJNZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
101519,6vxs,DB05412,-8.1,Talmapimod,ZMELOYOKMZBMRB-DLBZAZTESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
13034,6lzg,DB14555,-8.1,Ursadiol,RTLXJEJRLWILSU-GWNGJUQLSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
80327,6m2n,DB15138,-8.1,AZD-9496,DFBDRVGWBHBJNR-BBNFHIFMSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
26284,6cs2,DB04392,-8.1,"Bishydroxy[2h-1-Benzopyran-2-One,1,2-Benzopyrone]",HIZKPJUTKKJDGA-BETUJISGSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
109653,6vxx,DB15071,-8.1,Omidenepag isopropyl,VIQCWEGEHRBLAC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
160302,7bv1,DB07986,-8.1,[4-(4-PHENYL-PIPERIDIN-1-YL)-BENZENESULFONYLAMINO]-ACETIC ACID,GNSLACGSDSJAIQ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
80507,6m2n,DB08775,-8.1,Nalpha-[(Benzyloxy)carbonyl]-N-[(2S)-4-fluoro-3-oxo-2-butanyl]-L-tyrosinamide,RYABQRLJLIHDIP-KSSFIOAISA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
72007,6m2n,DB00229,-8.1,Cefotiam,QYQDKDWGWDOFFU-IUODEOHRSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
101361,6vxs,DB04823,-8.1,Oxyphenisatin,SJDACOMXKWHBOW-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
166359,7bv1,DB14723,-8.1,Larotrectinib,NYNZQNWKBKUAII-KBXCAEBGSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160418,7bv1,DB08361,-8.1,"2-{[(1R,2S)-2-aminocyclohexyl]amino}-4-[(3-methylphenyl)amino]pyrimidine-5-carboxamide",NZNTWOVDIXCHHS-LSDHHAIUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
128515,6w4h,DB07704,-8.1,"6-AMINO-4-[2-(4-METHOXYPHENYL)ETHYL]-1,7-DIHYDRO-8H-IMIDAZO[4,5-G]QUINAZOLIN-8-ONE",UKRVQKUVWNDGMN-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
137046,6w9c,DB07835,-8.1,"N-3-cyclopropyl-N-4-'-(cyclopropylmethyl)-6-methylbiphenyl-3,4'-dicarboxamide",BOPSUAHGQHFKGG-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
101372,6vxs,DB04834,-8.1,Rapacuronium,HTIKWNNIPGXLGM-YLINKJIISA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
8426,6lzg,DB05969,-8.1,SNS-032,OUSFTKFNBAZUKL-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
160432,7bv1,DB08379,-8.1,6-(4-chloro-2-fluoro-3-phenoxybenzyl)pyridazin-3(2H)-one,NOVPOXGMADEKPP-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
80540,6m3m,DB00140,-8.1,Riboflavin,AUNGANRZJHBGPY-SCRDCRAPSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80369,6m2n,DB15221,-8.1,PF-06260414,ZKAVFOXYJCREBQ-SNVBAGLBSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
128448,6w4h,DB07624,-8.1,"1-{[(3R)-3-methyl-4-({4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]phenyl}sulfonyl)piperazin-1-yl]methyl}cyclopropanecarboxamide",YJFULAYRAKPBCY-DYVFJYSZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
100679,6vxs,DB03907,-8.1,"N-{3-[5-(6-Amino-Purin-9-Yl)-3,4-Dihydroxy-Tetrahydro-Furan-2-Yl]-Allyl}-2,3-Dihydroxy-5-Nitro-Benzamide",UHHBFOLQOQSPLU-WGRQDFERSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
30517,6cs2,DB12591,-8.1,BMS-911543,JCINBYQJBYJGDM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
101837,6vxs,DB06624,-8.1,Taranabant,QLYKJCMUNUWAGO-GAJHUEQPSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
55259,6crv,DB00802,-8.1,Alfentanil,IDBPHNDTYPBSNI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113891,6vxx,DB12236,-8.1,Bexagliflozin,BTCRKOKVYTVOLU-SJSRKZJXSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
6510,6lzg,DB02241,-8.1,"8-Benzyl-2-Hydroperoxy-2-(4-Hydroxy-Benzyl)-6-(4-Hydroxy-Phenyl)-2h-Imidazo[1,2-a]Pyrazin-3-One",HOSWCJDTHOAORT-SANMLTNESA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
58949,6crv,DB06898,-8.1,"4-(2-amino-1-methyl-1H-imidazo[4,5-b]pyridin-6-yl)phenol",UGJXOCBVCWTJFP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
71706,6lxt,DB15121,-8.1,AT-001,YRGPAXAVTDMKDK-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
102344,6vxs,DB07289,-8.1,5-[3-(BENZYLAMINO)PHENYL]-4-BROMO-3-(CARBOXYMETHOXY)THIOPHENE-2-CARBOXYLIC ACID,XEQPGVUGYAUMSA-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102352,6vxs,DB07297,-8.1,"5,6-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-D]PYRIMIDIN-4-AMINE",PTILEOLOGGMFCS-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
136777,6w9c,DB07520,-8.1,"N-[1-(AMINOMETHYL)CYCLOPROPYL]-3-(MORPHOLIN-4-YLSULFONYL)-N-2-[(1S)-2,2,2-TRIFLUORO-1-(4-FLUOROPHENYL)ETHYL]-L-ALANINAMIDE",BJIKKEHGGYGGIX-HOTGVXAUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
160035,7bv1,DB07215,-8.1,"2-METHYL-2-(4-{[({4-METHYL-2-[4-(TRIFLUOROMETHYL)PHENYL]-1,3-THIAZOL-5-YL}CARBONYL)AMINO]METHYL}PHENOXY)PROPANOIC ACID",ILUPZUOBHCUBKB-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
109820,6vxx,DB00294,-8.1,Etonogestrel,GCKFUYQCUCGESZ-BPIQYHPVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
102369,6vxs,DB07315,-8.1,"5-chloro-N-{4-[(1R)-1,2-dihydroxyethyl]phenyl}-1H-indole-2-carboxamide",SHCHFGSUYJUEBR-INIZCTEOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
71698,6lxt,DB15106,-8.1,Surufatinib,TTZSNFLLYPYKIL-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
102378,6vxs,DB07325,-8.1,N-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)METHYL]-3-{[(E)-(2-OXODIHYDROFURAN-3(2H)-YLIDENE)METHYL]AMINO}BENZENESULFONAMIDE,VCOKUBHAJVTVNG-FMIVXFBMSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
71696,6lxt,DB15102,-8.1,Pemigatinib,HCDMJFOHIXMBOV-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
72630,6m2n,DB00969,-8.1,Alosetron,JSWZEAMFRNKZNL-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
102392,6vxs,DB07340,-8.1,"N-6-cyclohexyl-N-2-(4-morpholin-4-ylphenyl)-9H-purine-2,6-diamine",ZFLJHSQHILSNCM-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
79958,6m2n,DB14038,-8.1,beta-Sitosterol,KZJWDPNRJALLNS-VJSFXXLFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
160852,7bv1,DB11818,-8.1,Retosiban,PLVGDGRBPMVYPB-FDUHJNRSSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
58950,6crv,DB06899,-8.1,"N-{2-[6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2,2-DIMETHYL-3-OXO-2,3-DIHYDRO-4H-1,4-BENZOTHIAZIN-4-YL]ETHYL}ACETAMIDE",RMEVNJZCKDVVND-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30410,6cs2,DB12443,-8.1,Sonedenoson,WUCQGGOGHZRELS-LSCFUAHRSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
18928,6cs2,HMDB0041623,-8.1,N6-Carbamoyl-L-threonyladenosine,GYCVHQYQICRFAX-CKTDUXNWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
102279,6vxs,DB07215,-8.1,"2-METHYL-2-(4-{[({4-METHYL-2-[4-(TRIFLUOROMETHYL)PHENYL]-1,3-THIAZOL-5-YL}CARBONYL)AMINO]METHYL}PHENOXY)PROPANOIC ACID",ILUPZUOBHCUBKB-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
80039,6m2n,DB14214,-8.1,Rose bengal lactone,IICCLYANAQEHCI-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
28262,6cs2,DB07844,-8.1,6-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1-BENZOTHIOPHENE-2-SULFONAMIDE,PHLKBODTBJLXRD-WFASDCNBSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
55077,6crv,DB00582,-8.1,Voriconazole,BCEHBSKCWLPMDN-MGPLVRAMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113927,6vxx,DB12285,-8.1,Verubecestat,YHYKUSGACIYRML-KRWDZBQOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
124847,6w4h,DB01705,-8.1,Bis(5-Amidino-Benzimidazolyl)Methane,QZKOOEFIMWKZPK-UHFFFAOYSA-Q,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
28261,6cs2,DB07843,-8.1,5-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1-BENZOTHIOPHENE-2-SULFONAMIDE,LTJNKFUIOOJXNJ-WFASDCNBSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
113928,6vxx,DB12286,-8.1,Simendan,WHXMKTBCFHIYNQ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
99389,6vxs,DB02194,-8.1,"8-Benzyl-2-Hydroxy-2-(4-Hydroxy-Benzyl)-6-(4-Hydroxy-Phenyl)-2h-Imidazo[1,2-a]Pyrazin-3-One",ULLMMKZQNNBLRN-SANMLTNESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
79987,6m2n,DB14093,-8.1,"(1,2,6,7-3H)Testosterone",MUMGGOZAMZWBJJ-JQSYSRDDSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
136791,6w9c,DB07536,-8.1,"N-{(1S,2R)-2-hydroxy-1-[(hydroxyamino)carbonyl]propyl}-4-{[4-(morpholin-4-ylmethyl)phenyl]ethynyl}benzamide",FQYBTYFKOHPWQT-VGSWGCGISA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
102324,6vxs,DB07268,-8.1,2-({2-[(3-HYDROXYPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)BENZAMIDE,QHPKKGUGRGRSGA-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
109815,6vxx,DB00287,-8.1,Travoprost,MKPLKVHSHYCHOC-AHTXBMBWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58961,6crv,DB06911,-8.1,D-leucyl-N-(3-chlorobenzyl)-L-prolinamide,FHVBVJXZKNCSLP-CVEARBPZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
160820,7bv1,DB11773,-8.1,BMS-903452,OGIAVRWXUPYGGC-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
12626,6lzg,DB13607,-8.1,Picloxydine,YNCLPFSAZFGQCD-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
30583,6cs2,DB12687,-8.1,Vesatolimod,VFOKSTCIRGDTBR-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
102489,6vxs,DB07455,-8.1,"N,N'-[biphenyl-4,4'-diyldi(2R)propane-2,1-diyl]dimethanesulfonamide",ZESUARCHWPARIF-HOTGVXAUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
109425,6vxx,DB13554,-8.1,Moperone,AGAHNABIDCTLHW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28251,6cs2,DB07832,-8.1,"4-{4-[(5-hydroxy-2-methylphenyl)amino]quinolin-7-yl}-1,3-thiazole-2-carbaldehyde",VKQPTVJDZIILPG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
22249,6cs2,HMDB0053429,-8.1,"TG(20:2n6/20:3(5Z,8Z,11Z)/20:5(5Z,8Z,11Z,14Z,17Z))",PNNSMRQLANHRDX-XBLZGWIDSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
102521,6vxs,DB07493,-8.1,"(2Z)-5'-BROMO-2,3'-BIINDOLE-2',3(1H,1'H)-DIONE AMMONIATE",IEQQJQHHJMQETK-YPKPFQOOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
109422,6vxx,DB13551,-8.1,Cinchophen,YTRMTPPVNRALON-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140138,6w9c,DB15052,-8.1,Ansofaxine,QKYBZJLEMOZFFU-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
102532,6vxs,DB07507,-8.1,"2-(4-hydroxybiphenyl-3-yl)-4-methyl-1H-isoindole-1,3(2H)-dione",ROMNEYAQUBNRLR-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
159977,7bv1,DB07146,-8.1,"2,3-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-B]PYRIDIN-4-AMINE",QUIQCYFSBGOBKE-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
102551,6vxs,DB07530,-8.1,"(1R,3R)-5-[(2E)-3-{(1S,3R)-2,2,3-trimethyl-3-[6,6,6-trifluoro-5-hydroxy-5-(trifluoromethyl)hex-3-yn-1-yl]cyclopentyl}prop-2-en-1-ylidene]cyclohexane-1,3-diol",PCHUQQNKOFNVDU-OSXMSNBXSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
12585,6lzg,DB13554,-8.1,Moperone,AGAHNABIDCTLHW-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
164781,7bv1,DB08597,-8.1,"6-[4-(2-piperidin-1-ylethoxy)phenyl]-3-pyridin-4-ylpyrazolo[1,5-a]pyrimidine",XHBVYDAKJHETMP-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
99122,6vxs,DB01830,-8.1,"{4-[2-Acetylamino-2-(3-Carbamoyl-2-Cyclohexylmethoxy-6,7,8,9-Tetrahydro-5h-Benzocyclohepten-5ylcarbamoyl)-Ethyl]-2-Phosphono-Phenyl}-Phosphonic Acid",SPSGYTWOIGAABK-DQEYMECFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
26069,6cs2,DB04131,-8.1,"10-(4-Dimethylamino-5-Hydroxy-6-Methyl-Tetrahydro-Pyran-2-Yloxy)-8-Ethyl-1,8,11-Trihydroxy-7,8,9,10-Tetrahydro-Naphthacene-5,12-Dione",BLGDWFJQIHBUJY-NWJGULHDSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
159979,7bv1,DB07148,-8.1,"(6S)-1-chloro-3-[(4-fluorobenzyl)oxy]-6-(pyrrolidin-1-ylcarbonyl)pyrrolo[1,2-a]pyrazin-4(6H)-one",HPAFVLDARQIHPU-HNNXBMFYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
79944,6m2n,DB14014,-8.1,SR-9011,PPUYOYQTTWJTIU-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
102487,6vxs,DB07453,-8.1,2-PHENYL-4H-BENZO[H]CHROMEN-4-ONE,VFMMPHCGEFXGIP-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
30396,6cs2,DB12426,-8.1,Bitopertin,YUUGYIUSCYNSQR-LBPRGKRZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
136751,6w9c,DB07489,-8.1,"4-Amino-2-[(3-chlorophenyl)amino]-5-(4-fluorobenzoyl)-1,3-thiazol-3-ium",WWGPTHOMFHDEEC-UHFFFAOYSA-O,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
99200,6vxs,DB01944,-8.1,(S)-blebbistatin,LZAXPYOBKSJSEX-GOSISDBHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
71674,6lxt,DB15057,-8.1,NUC-1031,NHTKGYOMICWFQZ-KKQYNPQSSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
109471,6vxx,DB13618,-8.1,Ipriflavone,SFBODOKJTYAUCM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109465,6vxx,DB13610,-8.1,Flumedroxone,CDZJOBWKHSYNMO-SCUQKFFVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
71672,6lxt,DB15055,-8.1,ABT-639,AGPIHNZOZNKRGT-CYBMUJFWSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
166393,7bv1,DB14795,-8.1,AZD-3759,MXDSJQHFFDGFDK-CYBMUJFWSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
80947,6m3m,DB00625,-8.1,Efavirenz,XPOQHMRABVBWPR-ZDUSSCGKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
109447,6vxx,DB13587,-8.1,Mesterolone,UXYRZJKIQKRJCF-TZPFWLJSSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
128276,6w4h,DB07419,-8.1,S-23,SSFVOEAXHZGTRJ-KRWDZBQOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
102444,6vxs,DB07403,-8.1,"4-[(3-CHLORO-4-{[(2R)-3,3,3-TRIFLUORO-2-HYDROXY-2-METHYLPROPANOYL]AMINO}PHENYL)SULFONYL]-N,N-DIMETHYLBENZAMIDE",DTDZLJHKVNTQGZ-GOSISDBHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
159988,7bv1,DB07159,-8.1,Tamatinib,NHHQJBCNYHBUSI-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
136732,6w9c,DB07467,-8.1,"4-chloro-N-[(2S)-2-methyl-2,3-dihydro-1H-indol-1-yl]-3-sulfamoylbenzamide",NDDAHWYSQHTHNT-JTQLQIEISA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
102447,6vxs,DB07406,-8.1,"(4R)-N-[4-({[2-(DIMETHYLAMINO)ETHYL]AMINO}CARBONYL)-1,3-THIAZOL-2-YL]-4-METHYL-1-OXO-2,3,4,9-TETRAHYDRO-1H-BETA-CARBOLINE-6-CARBOXAMIDE",QWFFPYQWUWLDBV-NSHDSACASA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
13203,6lzg,DB14889,-8.1,Derazantinib,KPJDVVCDVBFRMU-AREMUKBSSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
58979,6crv,DB06929,-8.1,1-butanoyl-N-(4-carbamimidoylbenzyl)-L-prolinamide,RYAZZWWVNUWKNB-AWEZNQCLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30578,6cs2,DB12680,-8.1,Intepirdine,JJZFWROHYSMCMU-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
160814,7bv1,DB11765,-8.1,PF-04991532,GKMLFBRLRVQVJO-ZDUSSCGKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
109480,6vxx,DB13956,-8.1,Estradiol valerate,RSEPBGGWRJCQGY-RBRWEJTLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80139,6m2n,DB14715,-8.1,Cinazepam,NQTRBZXDWMDXAQ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80133,6m2n,DB14681,-8.1,Cortisone,MFYSYFVPBJMHGN-ZPOLXVRWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80802,6m3m,DB00447,-8.1,Loracarbef,JAPHQRWPEGVNBT-UTUOFQBUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
100030,6vxs,DB03037,-8.1,Oxidized Acetyl Dithranol,IKFRFGXQHSBCQM-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
59412,6crv,DB07432,-8.1,"[[(3R,4R,5S,6R)-3-(butanoylamino)-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-ylidene]amino] N-phenylcarbamate",ITVRELFVFCOUMV-ZVZWZHPPSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
101965,6vxs,DB06849,-8.1,"1-[1'-(3-phenylacryloyl)spiro[1-benzofuran-3,4'-piperidin]-5-yl]methanamine",RQWYWHUKHYFIPB-VQHVLOKHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
59037,6crv,DB07002,-8.1,4-({4-[(4-methoxypyridin-2-yl)amino]piperidin-1-yl}carbonyl)benzonitrile,SZUVGMCKKLJAFX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80126,6m2n,DB14674,-8.1,Estramustine phosphate,ADFOJJHRTBFFOF-RBRWEJTLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80809,6m3m,DB00455,-8.1,Loratadine,JCCNYMKQOSZNPW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
119234,6w4b,DB07078,-8.1,"(3Z)-6-(4-HYDROXY-3-METHOXYPHENYL)-3-(1H-PYRROL-2-YLMETHYLENE)-1,3-DIHYDRO-2H-INDOL-2-ONE",AYSXURJZVXBSRV-WJDWOHSUSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
136804,6w9c,DB07550,-8.1,"2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(1-OXIDO-2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUOROPHENYL)METHYL]ACETAMIDE",ZIGSBBKEPNQXRG-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
99917,6vxs,DB02882,-8.1,Cyanocinnoline,CUWRVIIPSSUUDJ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
128355,6w4h,DB07512,-8.1,7-[(3-CHLOROBENZYL)OXY]-2-OXO-2H-CHROMENE-4-CARBALDEHYDE,ZOCADHRNWNJARU-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
136809,6w9c,DB07557,-8.1,"(5BETA)-PREGNANE-3,20-DIONE",XMRPGKVKISIQBV-XWOJZHJZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
72461,6m2n,DB00776,-8.1,Oxcarbazepine,CTRLABGOLIVAIY-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
101962,6vxs,DB06845,-8.1,(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclopentylamino)ethanoyl)pyrrolidine-2-carboxamide,WXYKSWZWRHMJTE-KRWDZBQOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
100065,6vxs,DB03081,-8.1,Crc200 (Chiron-Behring),ZOXOKTJHZSUHRJ-XZOQPEGZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
119142,6w4b,DB06972,-8.1,"7A-[(4-cyanophenyl)methyl]-6-(3,5-dichlorophenyl)-5-oxo-2,3,5,7A-tetrahydro-1H-pyrrolo[1,2-A]pyrrole-7-carbonitrile",TZCXQSNBTXDAJG-QFIPXVFZSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
113895,6vxx,DB12241,-8.1,TAK-733,RCLQNICOARASSR-SECBINFHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
101857,6vxs,DB06670,-8.1,Odanacatib,FWIVDMJALNEADT-SFTDATJTSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101859,6vxs,DB06677,-8.1,Clazosentan,LFWCJABOXHSRGC-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
109503,6vxx,DB14008,-8.1,Hispidulin,IHFBPDAQLQOCBX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113896,6vxx,DB12242,-8.1,AZD-7762,IAYGCINLNONXHY-LBPRGKRZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113908,6vxx,DB12262,-8.1,CRS-3123,NNTYBKTXMKBRFA-CQSZACIVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113904,6vxx,DB12253,-8.1,GDC-0810,BURHGPHDEVGCEZ-KJGLQBJMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
160128,7bv1,DB07544,-8.1,N'-(5-CHLOROBENZOFURAN-2-CARBONYL)-2-(TRIFLUOROMETHYL)BENZENESULFONOHYDRAZIDE,ZLQBZYKAQQWOTK-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
100100,6vxs,DB03126,-8.1,Mant-Adp,QPKUEBLEGWBRHC-BFHYXJOUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101919,6vxs,DB06771,-8.1,Besifloxacin,QFFGVLORLPOAEC-SNVBAGLBSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
136817,6w9c,DB07567,-8.1,"(2R,3R,4S)-3-(4-HYDROXYPHENYL)-4-METHYL-2-[4-(2-PYRROLIDIN-1-YLETHOXY)PHENYL]CHROMAN-6-OL",XPVKGTWRXBSJKO-LHXLBICKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
128356,6w4h,DB07513,-8.1,7-[(3-CHLOROBENZYL)OXY]-4-[(METHYLAMINO)METHYL]-2H-CHROMEN-2-ONE,JMGUSOLCNQVZCT-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
59400,6crv,DB07419,-8.1,S-23,SSFVOEAXHZGTRJ-KRWDZBQOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
100122,6vxs,DB03159,-8.1,CRA_8696,GAVRMVQHHVMXFD-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
72466,6m2n,DB00783,-8.1,Estradiol,VOXZDWNPVJITMN-ZBRFXRBCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
160735,7bv1,DB09495,-8.1,Avobenzone,XNEFYCZVKIDDMS-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59026,6crv,DB06991,-8.1,"N-[2-methyl-5-(methylcarbamoyl)phenyl]-2-{[(1R)-1-methylpropyl]amino}-1,3-thiazole-5-carboxamide",OYOUIHFZUAKCEF-LLVKDONJSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80074,6m2n,DB14584,-8.1,Segesterone,SFLXYFZGKSGFKA-XUDSTZEESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
99722,6vxs,DB02621,-8.1,Latrunculin A,DDVBPZROPPMBLW-IZGXTMSKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
80073,6m2n,DB14583,-8.1,Segesterone acetate,CKFBRGLGTWAVLG-GOMYTPFNSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
109787,6vxx,DB00257,-8.1,Clotrimazole,VNFPBHJOKIVQEB-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28357,6cs2,DB07944,-8.1,N-{3-METHYL-5-[2-(PYRIDIN-4-YLAMINO)-ETHOXY]-PHENYL}-BENZENESULFONAMIDE,MPTWCWHNLVMCRW-UHFFFAOYSA-O,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
102222,6vxs,DB07147,-8.1,"methyl (1R,2S)-2-(hydroxycarbamoyl)-1-{4-[(2-methylquinolin-4-yl)methoxy]benzyl}cyclopropanecarboxylate",HJWMYFBKJRVWJY-YKSBVNFPSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102185,6vxs,DB07107,-8.1,(1S)-2-(1H-INDOL-3-YL)-1-[({5-[(E)-2-PYRIDIN-4-YLVINYL]PYRIDIN-3-YL}OXY)METHYL]ETHYLAMINE,SGHXFHRRWFLILP-XJDXJNMNSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
26444,6cs2,DB04578,-8.1,"(S)-2-[(R)-3-amino-4-(2-fluorophenyl)butyryl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide",OEVYDSSAPNIURZ-AEFFLSMTSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
71753,6lxt,DB15209,-8.1,MK-0736,ORQZQBUNAMJFCY-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
102234,6vxs,DB07162,-8.1,4-(3-amino-1H-indazol-5-yl)-N-tert-butylbenzenesulfonamide,KFJCXIOVAGJCKB-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
30575,6cs2,DB12675,-8.1,PF-04995274,WLLOFQROROXOMO-GOSISDBHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
80870,6m3m,DB00533,-8.1,Rofecoxib,RZJQGNCSTQAWON-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
99611,6vxs,DB02479,-8.1,(R)-N-(3-Indol-1-Yl-2-Methyl-Propyl)-4-Sulfamoyl-Benzamide,ZFWHOUCRVSOZJE-CQSZACIVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
124385,6w4h,DB01089,-8.1,Deserpidine,CVBMAZKKCSYWQR-WCGOZPBSSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
71756,6lxt,DB15219,-8.1,Tomivosertib,HKTBYUWLRDZAJK-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
102176,6vxs,DB07095,-8.1,(S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclopentylpropanoyl)pyrrolidine-2-carboxamide,BNCHHUFGEOJCNH-SFHVURJKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
99761,6vxs,DB02673,-8.1,"(4ar,6s,8ar)-11-[8-(1,3-Dioxo-1,3-Dihydro-2h-Isoindol-2-Yl)Octyl]-6-Hydroxy-3-Methoxy-5,6,9,10-Tetrahydro-4ah-[1]Benzofuro[3a,3,2-Ef][2]Benzazepin-11-Ium",VLGAHTYYCHWLNI-BHRZLAGCSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102149,6vxs,DB07063,-8.1,"{3-[(4,5,7-TRIFLUORO-1,3-BENZOTHIAZOL-2-YL)METHYL]-1H-INDOL-1-YL}ACETIC ACID",KYHVTMFADJNSGS-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102055,6vxs,DB06953,-8.1,2-CHLORO-5-(3-CHLORO-PHENYL)-6-[(4-CYANO-PHENYL)-(3-METHYL-3H-IMIDAZOL-4-YL)- METHOXYMETHYL]-NICOTINONITRILE,JVWHVGIRXILXMU-XMMPIXPASA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
71777,6lxt,DB15261,-8.1,Butafenacil,JEDYYFXHPAIBGR-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
72491,6m2n,DB00813,-8.1,Fentanyl,PJMPHNIQZUBGLI-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80816,6m3m,DB00465,-8.1,Ketorolac,OZWKMVRBQXNZKK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59432,6crv,DB07455,-8.1,"N,N'-[biphenyl-4,4'-diyldi(2R)propane-2,1-diyl]dimethanesulfonamide",ZESUARCHWPARIF-HOTGVXAUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109479,6vxx,DB13955,-8.1,Estradiol dienanthate,OVAHZPTYWMWNKO-CAHAWPIUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
128594,6w4h,DB07795,-8.1,Fisetin,XHEFDIBZLJXQHF-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
109779,6vxx,DB00247,-8.1,Methysergide,KPJZHOPZRAFDTN-NQUBZZJWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80829,6m3m,DB00480,-8.1,Lenalidomide,GOTYRUGSSMKFNF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
102101,6vxs,DB07011,-8.1,"(3S)-1-(1,3-BENZODIOXOL-5-YLMETHYL)-3-[4-(1H-IMIDAZOL-1-YL)PHENOXY]PIPERIDINE",HHOPJGKEAIIIDF-FQEVSTJZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
28265,6cs2,DB07847,-8.1,6-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-(4-MORPHOLINYL)-2-OXO ETHYL]-2-OXO-3-PYRROLIDINYL}-2-NAPHTHALENESULFONAMIDE,ICLOZQFWTRAYPX-LIRRHRJNSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
71774,6lxt,DB15250,-8.1,Vercirnon,JRWROCIMSDXGOZ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
102110,6vxs,DB07021,-8.1,"(7R,8R)-8-(2,4,5-trifluorophenyl)-6,7,8,9-tetrahydroimidazo[1,2-a:4,5-c']dipyridin-7-amine",SOSYXEPELJIJHZ-RNCFNFMXSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
99780,6vxs,DB02698,-8.1,"N-(M-Trifluoromethylphenyl) Phenoxazine-4,6-Dicarboxylic Acid",NQOOJFXBGLOGTC-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102136,6vxs,DB07049,-8.1,(2R)-1-[(4-tert-butylphenyl)sulfonyl]-2-methyl-4-(4-nitrophenyl)piperazine,SOFGQQQVQZQJFS-MRXNPFEDSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102558,6vxs,DB07537,-8.1,"N'-(6-aminopyridin-3-yl)-N-(2-cyclopentylethyl)-4-methyl-benzene-1,3-dicarboxamide",CLEGTVIMOPPIBR-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
136461,6w9c,DB07143,-8.1,D-phenylalanyl-N-benzyl-L-prolinamide,MEPJWLFTTFHOQO-MOPGFXCFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
161656,7bv1,DB00229,-8.1,Cefotiam,QYQDKDWGWDOFFU-IUODEOHRSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
72983,6m2n,DB01452,-8.1,Diamorphine,GVGLGOZIDCSQPN-PVHGPHFFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
127448,6w4h,DB06077,-8.1,Lumateperone,HOIIHACBCFLJET-SFTDATJTSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
106711,6vxx,DB00922,-8.1,Levosimendan,WHXMKTBCFHIYNQ-SECBINFHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106715,6vxx,DB00926,-8.1,Etretinate,HQMNCQVAMBCHCO-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77274,6m2n,DB08169,-8.1,(2Z)-N-biphenyl-4-yl-2-cyano-3-cyclopropyl-3-hydroxyprop-2-enamide,CAGGGMPTWTUYHZ-ZCXUNETKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
163530,7bv1,DB04750,-8.1,OREGON GREEN 488 CARBOXYLATE,BRJCLSQFZSHLRL-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
29960,6cs2,DB11864,-8.1,Preladenant,DTYWJKSSUANMHD-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
138732,6w9c,DB12188,-8.1,Zicronapine,BYPMJBXPNZMNQD-PZJWPPBQSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
114544,6vxx,DB13772,-8.1,Rufloxacin,NJCJBUHJQLFDSW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77254,6m2n,DB08149,-8.1,"1-[4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine",KCWPSUKJCKZEAO-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
108766,6vxx,DB08934,-8.1,Sofosbuvir,TTZHDVOVKQGIBA-IQWMDFIBSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77252,6m2n,DB08147,-8.1,"4-[3-(dibenzylamino)phenyl]-2,4-dioxobutanoic acid",RMWVENXKUQXLPW-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
114572,6vxx,DB13806,-8.1,Linopirdine,YEJCDKJIEMIWRQ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29955,6cs2,DB11855,-8.1,Revefenacin,FYDWDCIFZSGNBU-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
77220,6m2n,DB08112,-8.1,N-({6-[(4-CYANO-2-FLUOROBENZYL)OXY]NAPHTHALEN-2-YL}SULFONYL)-D-GLUTAMIC ACID,IRJUSGUHNFMVCK-OAQYLSRUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
10496,6lzg,DB08703,-8.1,"12-(2-hydroxyethyl)-2-(1-methylethoxy)-13,14-dihydronaphtho[2,1-a]pyrrolo[3,4-c]carbazol-5(12H)-one",FGKKIHITEICGMN-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
163558,7bv1,DB04790,-8.1,"2,5-bis-O-{3-[amino(imino)methyl]phenyl}-1,4:3,6-dianhydro-D-glucitol",IBIUTOFGXGGVKQ-XMTFNYHQSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
108759,6vxx,DB08922,-8.1,Perospirone,FBVFZWUMDDXLLG-HDICACEKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56866,6crv,DB02889,-8.1,"4-O-(4,6-Dideoxy-4-{[4,5,6-Trihydroxy-3-(Hydroxymethyl)Cyclohex-2-En-1-Yl]Amino}-Beta-D-Lyxo-Hexopyranosyl)-Alpha-D-Erythro-Hexopyranose",SNMISNLUIRCRQE-SFSRYZOZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
10500,6lzg,DB08707,-8.1,"4-[3-(4-chlorophenyl)-2,1-benzisoxazol-5-yl]pyrimidin-2-amine",AQVFETGXIRKVAQ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
55693,6crv,DB01347,-8.1,Saprisartan,DUEWVPTZCSAMNB-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
125731,6w4h,DB02877,-8.1,Arotinoid acid,FOIVPCKZDPCJJY-JQIJEIRASA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
56973,6crv,DB03035,-8.1,"1,8-Di-Hydroxy-4-Nitro-Anthraquinone",RIYCICFDXLNQPV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106761,6vxx,DB01217,-8.1,Anastrozole,YBBLVLTVTVSKRW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77287,6m2n,DB08185,-8.1,2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,LCHGAOHLDYRACA-SDBHATRESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
106702,6vxx,DB00913,-8.1,Anileridine,LKYQLAWMNBFNJT-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
139484,6w9c,DB13532,-8.1,Cyclopenthiazide,BKYKPTRYDKTTJY-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
11342,6lzg,DB11832,-8.1,Crenolanib,DYNHJHQFHQTFTP-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
29978,6cs2,DB11890,-8.1,Cilengitide,AMLYAMJWYAIXIA-VWNVYAMZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
57052,6crv,DB03137,-8.1,"8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9-Pent-9h-Purin-6-Ylamine",RMOYVWKKOKERSW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106567,6vxx,DB00498,-8.1,Phenindione,NFBAXHOPROOJAW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127472,6w4h,DB06159,-8.1,Rubitecan,VHXNKPBCCMUMSW-FQEVSTJZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
106588,6vxx,DB00784,-8.1,Mefenamic acid,HYYBABOKPJLUIN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
139483,6w9c,DB13531,-8.1,Nicofetamide,DWODOIKZDGJOPQ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
106609,6vxx,DB00810,-8.1,Biperiden,YSXKPIUOCJLQIE-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57027,6crv,DB03103,-8.1,Thymidine-5'- Diphosphate,UJLXYODCHAELLY-XLPZGREQSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57019,6crv,DB03093,-8.1,"8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine",MWHAHELTVGJGFJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77349,6m2n,DB08267,-8.1,"6-amino-4-(2-phenylethyl)-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",PBZAIUVFRISTSZ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
106657,6vxx,DB00862,-8.1,Vardenafil,SECKRCOLJRRGGV-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138699,6w9c,DB12135,-8.1,Elubrixin,YQYFEGTYCUQBEI-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
115404,6w4b,DB00820,-8.1,Tadalafil,WOXKDUGGOYFFRN-IIBYNOLFSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
108802,6vxx,DB08980,-8.1,Fendiline,NMKSAYKQLCHXDK-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106678,6vxx,DB00886,-8.1,Omapatrilat,LVRLSYPNFFBYCZ-VGWMRTNUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106684,6vxx,DB00894,-8.1,Testolactone,BPEWUONYVDABNZ-DZBHQSCQSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27449,6cs2,DB06994,-8.1,"(2S,3S)-3-{3-[2-chloro-4-(methylsulfonyl)phenyl]-1,2,4-oxadiazol-5-yl}-1-cyclopentylidene-4-cyclopropyl-1-fluorobutan-2-amine",XCCSSVMRGIQMGF-LPHOPBHVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
138708,6w9c,DB12149,-8.1,S-3304,YWCLDDLVLSQGSZ-JOCHJYFZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
29961,6cs2,DB11865,-8.1,Brivanib alaninate,LTEJRLHKIYCEOX-OCCSQVGLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
163507,7bv1,DB04716,-8.1,"2-(1,1-DIMETHYLETHYL)9-FLUORO-3,6-DIHYDRO-7H-BENZ[H]-IMIDAZ[4,5-F]ISOQUINOLIN-7-ONE",VNDWQCSOSCCWIP-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
163365,7bv1,DB04315,-8.1,Guanosine-5'-Diphosphate,QGWNDRXFNXRZMB-UUOKFMHZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
27486,6cs2,DB07031,-8.1,"3-Fluoro-4-{[(2R)-2-hydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthalenyl)acetyl]amino}benzoic acid",AANFHDFOMFRLLR-LJQANCHMSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
56856,6crv,DB02877,-8.1,Arotinoid acid,FOIVPCKZDPCJJY-JQIJEIRASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127359,6w4h,DB05498,-8.1,KW-7158,NAFSYPCVPLWHFY-HNNXBMFYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
138784,6w9c,DB12264,-8.1,Atevirdine,UCPOMLWZWRTIAA-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
56735,6crv,DB02712,-8.1,Sorbinil,LXANPKRCLVQAOG-NSHDSACASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138787,6w9c,DB12268,-8.1,Carmegliptin,GUYMHFIHHOEFOA-ZCPGHIKRSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138789,6w9c,DB12270,-8.1,Losmapimod,KKYABQBFGDZVNQ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
56733,6crv,DB02709,-8.1,Resveratrol,LUKBXSAWLPMMSZ-OWOJBTEDSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
139369,6w9c,DB13371,-8.1,Difenpiramide,PWHROYKAGRUWDQ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139355,6w9c,DB13355,-8.1,Visnadine,GVBNSPFBYXGREE-CXWAGAITSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
163648,7bv1,DB05667,-8.1,Levoketoconazole,XMAYWYJOQHXEEK-ZEQKJWHPSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
77063,6m2n,DB07935,-8.1,"5-[(5-fluoro-3-methyl-1H-indazol-4-yl)oxy]benzene-1,3-dicarbonitrile",JYAHFMKZJRVTDT-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
27985,6cs2,DB07550,-8.1,"2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(1-OXIDO-2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUOROPHENYL)METHYL]ACETAMIDE",ZIGSBBKEPNQXRG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
139335,6w9c,DB13333,-8.1,Efloxate,ZVXBAHLOGZCFTP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
163662,7bv1,DB05772,-8.1,Rabeximod,PDNNUMNEXITLCZ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
138792,6w9c,DB12273,-8.1,Ecopipam,DMJWENQHWZZWDF-PKOBYXMFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
108640,6vxx,DB08493,-8.1,"5-METHYL-3-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.013,18]NONADECA-12(19),13,15,17-TETRAEN-10-YLCARBAMOYL)-HEXANOIC ACID",AKWKBACKRMYPRV-NQIIRXRSSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76999,6m2n,DB07859,-8.1,4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL)PHENYL]PIPERIDINE,LZMOSYUFVYJEPY-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
107031,6vxx,DB02196,-8.1,Uridine-Diphosphate-N-Acetylgalactosamine,LFTYTUAZOPRMMI-NESSUJCYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127334,6w4h,DB05395,-8.1,Amibegron,RDJQCOBTKKAQAH-FPOVZHCZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
107074,6vxx,DB02253,-8.1,"(1r)-4-[(1e,3e,5e,7z,9e,11z,13e,15e)-17-Hydroxy-3,7,12,16-Tetramethylheptadeca-1,3,5,7,9,11,13,15-Octaen-1-Yl]-3,5,5-Trimethylcyclohex-3-En-1-Ol",FNAJVVMDXCOSFY-VFGOXHQXSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
139291,6w9c,DB13276,-8.1,Idanpramine,HVYGXNYMNHSBGD-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
125943,6w4h,DB03161,-8.1,Thymidine-5'-Diphospho-Beta-D-Xylose,AJUADKZRQSBUAK-KDGZBOQCSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
75690,6m2n,DB05422,-8.1,OPC-14523,TZZGTNZBLPCBIS-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
164293,7bv1,DB07664,-8.1,"5-AMINO-3-{[4-(AMINOSULFONYL)PHENYL]AMINO}-N-(2,6-DIFLUOROPHENYL)-1H-1,2,4-TRIAZOLE-1-CARBOTHIOAMIDE",ARIOBGGRZJITQX-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
56740,6crv,DB02717,-8.1,Cellotetraose,LUEWUZLMQUOBSB-HGDSAIHNSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114645,6vxx,DB13943,-8.1,Testosterone cypionate,HPFVBGJFAYZEBE-ZLQWOROUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163562,7bv1,DB04794,-8.1,Bifonazole,OCAPBUJLXMYKEJ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
106772,6vxx,DB01234,-8.1,Dexamethasone,UREBDLICKHMUKA-CXSFZGCWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56836,6crv,DB02848,-8.1,"{4-[3-(6,7-Diethoxy-Quinazolin-4-Ylamino)-Phenyl]-Thiazol-2-Yl}-Methanol",ZJESXGUODSBHSK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106776,6vxx,DB01238,-8.1,Aripiprazole,CEUORZQYGODEFX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77207,6m2n,DB08099,-8.1,"6-ethyl-5-[(2S)-1-(3-methoxypropyl)-2-phenyl-1,2,3,4-tetrahydroquinolin-7-yl]pyrimidine-2,4-diamine",UOYVKYJWAXJTTE-NRFANRHFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
127425,6w4h,DB05884,-8.1,HCV-086,VBRUONUESYTIDA-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
163585,7bv1,DB04823,-8.1,Oxyphenisatin,SJDACOMXKWHBOW-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
114582,6vxx,DB13820,-8.1,Oxomemazine,QTQPVLDZQVPLGV-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77168,6m2n,DB08054,-8.1,"1-(1-methylethyl)-3-quinolin-6-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine",GEZALMMCQYDFML-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
125811,6w4h,DB02976,-8.1,Uridine-5'-monophosphate 2-deoxy-2-fluoro-galactopyranosyl-monophosphate ester,NGTCPFGWXMBZEP-KBQKSTHMSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
11247,6lzg,DB11704,-8.1,Adomeglivant,FASLTMSUPQDLIB-MHZLTWQESA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
56797,6crv,DB02802,-8.1,5-Aminocarbonyl-3-Nitrophenyl-Alpha-D-Galactopyranose,BYSXBFJVGIOFBO-LNSPPBFMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106818,6vxx,DB01328,-8.1,Cefonicid,DYAIAHUQIPBDIP-AXAPSJFSSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127419,6w4h,DB05838,-8.1,OPC-51803,INGXCNVWWKKWOO-LJQANCHMSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
106846,6vxx,DB01384,-8.1,Paramethasone,MKPDWECBUAZOHP-AFYJWTTESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77127,6m2n,DB08008,-8.1,"5-methyl-N-[4-(trifluoromethyl)phenyl][1,2,4]triazolo[1,5-a]pyrimidin-7-amine",LRHHXKBKRNNFRV-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
127391,6w4h,DB05667,-8.1,Levoketoconazole,XMAYWYJOQHXEEK-ZEQKJWHPSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
139384,6w9c,DB13396,-8.1,Neocitrullamon,PAJBBDCZSMDSFL-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
127379,6w4h,DB05590,-8.1,Bedoradrine,OANCEOSLKSTLTA-REWPJTCUSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
77119,6m2n,DB07999,-8.1,"{4-[(CARBOXYMETHOXY)CARBONYL]-3,3-DIOXIDO-1-OXONAPHTHO[1,2-D]ISOTHIAZOL-2(1H)-YL}ACETIC ACID",IXLBOIRSEDMRPI-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77107,6m2n,DB07986,-8.1,[4-(4-PHENYL-PIPERIDIN-1-YL)-BENZENESULFONYLAMINO]-ACETIC ACID,GNSLACGSDSJAIQ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
163640,7bv1,DB05611,-8.1,Apilimod,HSKAZIJJKRAJAV-KOEQRZSOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
11346,6lzg,DB11841,-8.1,Entinostat,INVTYAOGFAGBOE-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
77380,6m2n,DB08307,-8.1,"2-{HYDROXY[2-NITRO-4-(TRIFLUOROMETHYL)PHENYL]METHYLENE}CYCLOHEXANE-1,3-DIONE",PMHVFNYNPNKNRO-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
27414,6cs2,DB06953,-8.1,2-CHLORO-5-(3-CHLORO-PHENYL)-6-[(4-CYANO-PHENYL)-(3-METHYL-3H-IMIDAZOL-4-YL)- METHOXYMETHYL]-NICOTINONITRILE,JVWHVGIRXILXMU-XMMPIXPASA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
139572,6w9c,DB13653,-8.1,Lorcainide,XHOJAWVAWFHGHL-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
75231,6m2n,DB04430,-8.1,3-(4-Phenylamino-Phenylamino)-2-(1h-Tetrazol-5-Yl)-Acrylonitrile,FLPLCJJGNZGOAW-QXMHVHEDSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77652,6m2n,DB08639,-8.1,Dapivirine,ILAYIAGXTHKHNT-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
114432,6vxx,DB13432,-8.1,Lonazolac,XVUQHFRQHBLHQD-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27313,6cs2,DB06848,-8.1,"1-(1'-{[3-(methylsulfanyl)-2-benzothiophen-1-yl]carbonyl}spiro[1-benzofuran-3,4'-piperidin]-5-yl)methanamine",VCUDZTCDUDDJGG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
75315,6m2n,DB04540,-8.1,Cholesterol,HVYWMOMLDIMFJA-DPAQBDIFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
106230,6vxs,DB15281,-8.1,Ravoxertinib,RZUOCXOYPYGSKL-GOSISDBHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
11466,6lzg,DB12005,-8.1,Nirogacestat,VFCRKLWBYMDAED-REWPJTCUSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
75346,6m2n,DB04576,-8.1,Fleroxacin,XBJBPGROQZJDOJ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
27320,6cs2,DB06856,-8.1,6-FLUORO-2-[2-HYDROXY-3-(2-METHYL-CYCLOHEXYLOXY)-PHENYL]-1H-INDOLE-5-CARBOXAMIDINE,HUYQYLFFFNSAAX-BUXKBTBVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
27321,6cs2,DB06857,-8.1,N-(4-CARBAMIMIDOYL-3-CHORO-PHENYL)-2-HYDROXY-3-IODO-5-METHYL-BENZAMIDE,QKGFTDAISIBIBV-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
127584,6w4h,DB06446,-8.1,Dotarizine,LRMJAFKKJLRDLE-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
57310,6crv,DB03486,-8.1,Phosphomethylphosphonic Acid Guanosyl Ester,OCJWYBKRHNXUME-KQYNXXCUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127573,6w4h,DB06420,-8.1,Annamycin,CIDNKDMVSINJCG-GKXONYSUSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
77587,6m2n,DB08556,-8.1,"5'-ACETYL-4-{[(2,4-DIMETHYLPHENYL)SULFONYL]AMINO}-2,2'-BITHIOPHENE-5-CARBOXYLIC ACID",CMHHNHDPPWDNAH-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138634,6w9c,DB12045,-8.1,Mericitabine,MLESJYFEMSJZLZ-MAAOGQSESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
75372,6m2n,DB04610,-8.1,"7,8-dihydro-6-hydroxymethyl-7-methyl-7-[2-phenylethyl]-pterin",XMFJTCGUDFSWSW-INIZCTEOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77564,6m2n,DB08530,-8.1,"7-BENZYL-1,3-DIMETHYL-8-PIPERAZIN-1-YL-3,7-DIHYDRO-PURINE-2,6-DIONE",QFSMMXJBEBXTJP-UHFFFAOYSA-O,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
163035,7bv1,DB03453,-8.1,Methyl (2S)-2-[[2-[(3R)-1-carbamimidoylpiperidin-3-yl]acetyl]amino]-3-[4-(2-phenylethynyl)phenyl]propanoate,MRNGXYMKYHNMLV-PKTZIBPZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
27334,6cs2,DB06871,-8.1,17-METHYL-17-ALPHA-DIHYDROEQUILENIN,FQMQOMRDADWGJJ-GBESFXJTSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
75382,6m2n,DB04624,-8.1,DERIVATIVE OF AKLANONIC ACID METHYL ESTER (AAME),SIHNJMGWRHPFAZ-XHDPSFHLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
162888,7bv1,DB03250,-8.1,"2-(Beta-D-Glucopyranosyl)-5-Methyl-1,3,4-Benzothiazole",WGJFWQVWYRZPEP-KABOQKQYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
27336,6cs2,DB06873,-8.1,"1-((2-HYDROXYETHOXY)METHYL)-5-(3-(BENZYLOXY)BENZYL)PYRIMIDINE-2,4(1H,3H)-DIONE",CSXNPJKDZKLDET-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
114386,6vxx,DB13368,-8.1,Motretinide,IYIYMCASGKQOCZ-DJRRULDNSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
139574,6w9c,DB13656,-8.1,Eberconazole,MPTJIDOGFUQSQH-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
125537,6w4h,DB02616,-8.1,FR117016,CKJGKHXCUDWFDC-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
10426,6lzg,DB08622,-8.1,"4-(4-CHLORO-PHENYL)-1-{3-[2-(4-FLUORO-PHENYL)-[1,3]DITHIOLAN-2-YL]-PROPYL}-PIPERIDIN-4-OL",KVDKNVPAAQKHKD-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
114299,6vxx,DB13256,-8.1,Clothiapine,KAAZGXDPUNNEFN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127634,6w4h,DB06581,-8.1,Bevirimat,YJEJKUQEXFSVCJ-WRFMNRASSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
138579,6w9c,DB11871,-8.1,PF-00610355,YPHDIMUXXABSSO-YTTGMZPUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
162755,7bv1,DB02881,-8.1,4-(4-Hydroxy-3-Isopropylphenylthio)-2-Isopropylphenol,NEMLLZAROZVCCE-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
138582,6w9c,DB11875,-8.1,"3,3'-diindolylmethane",VFTRKSBEFQDZKX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
162756,7bv1,DB02882,-8.1,Cyanocinnoline,CUWRVIIPSSUUDJ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
114300,6vxx,DB13258,-8.1,Etofamide,QTRALMGDQMIVFF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77789,6m2n,DB08795,-8.1,Azidocillin,ODFHGIPNGIAMDK-NJBDSQKTSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
139602,6w9c,DB13686,-8.1,Clometocillin,JKXQBIZCQJLVOS-GSNLGQFWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
114310,6vxx,DB13275,-8.1,Clorindione,NJDUWAXIURWWLN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77772,6m2n,DB08775,-8.1,N??-[(Benzyloxy)carbonyl]-N-[(2S)-4-fluoro-3-oxo-2-butanyl]-L-tyrosinamide,RYABQRLJLIHDIP-KSSFIOAISA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
57424,6crv,DB03656,-8.1,Tribenuron Methyl,VLCQZHSMCYCDJL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57419,6crv,DB03650,-8.1,(3e)-3-[(4-Hydroxyphenyl)Imino]-1h-Indol-2(3h)-One,ZJASRZFZRYISET-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108967,6vxx,DB11836,-8.1,Sapanisertib,GYLDXIAOMVERTK-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77771,6m2n,DB08774,-8.1,"1-[(2S)-4-(5-phenyl-1H-pyrazolo[3,4-b]pyridin-4-yl)morpholin-2-yl]methanamine",YBRZCAKSBYWZTC-ZDUSSCGKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
162855,7bv1,DB03213,-8.1,Bis(5-Amidino-2-Benzimidazolyl)Methane Ketone,VVVXDHROXQUONB-UHFFFAOYSA-P,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
75182,6m2n,DB04357,-8.1,Pteric Acid,JOAQINSXLLMRCV-UHFFFAOYSA-O,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
106184,6vxs,DB15191,-8.1,MAX-40279,AVIOBQFPAGEICQ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
77729,6m2n,DB08729,-8.1,"5-ethoxy-4-(1-methyl-7-oxo-3-propyl-6,7-dihydro-1H-pyrazolo[4,3-d]pyrimidin-5-yl)thiophene-2-sulfonamide",FENWRHVHBZQJGW-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
106197,6vxs,DB15209,-8.1,MK-0736,ORQZQBUNAMJFCY-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
27337,6cs2,DB06874,-8.1,"(6-[4-(AMINOMETHYL)-2,6-DIMETHYLPHENOXY]-2-{[4-(AMINOMETHYL)PHENYL]AMINO}-5-BROMOPYRIMIDIN-4-YL)METHANOL",LSIZSSASMKSUIU-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
11443,6lzg,DB11971,-8.1,Vilaprisan,JUFWQQVHQFDUOD-ANRPBIDPSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
55631,6crv,DB01224,-8.1,Quetiapine,URKOMYMAXPYINW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
164390,7bv1,DB07778,-8.1,FAMOXADONE,PCCSBWNGDMYFCW-QFIPXVFZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
164384,7bv1,DB07770,-8.1,5-(4-FLUOROPHENYL)-3-{[(4-METHYLPHENYL)SULFONYL]AMINO}THIOPHENE-2-CARBOXYLIC ACID,DJPFUQBNQLKCAB-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
163194,7bv1,DB03882,-8.1,"5-Alpha-Androstane-3-Beta,17beta-Diol",CBMYJHIOYJEBSB-YSZCXEEOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
75465,6m2n,DB04740,-8.1,MOXALACTAM (HYDROLYZED),ZTOQXKUYWZBJLG-XNAIMREJSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75474,6m2n,DB04753,-8.1,"9-DEAZAINOSINE-2',3'-O-ETHYLIDENEPHOSPHONATE",ZOEDLCUBOBTIHG-USQSKNHBSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
11376,6lzg,DB11883,-8.1,SB-705498,JYILLRHXRVTRSH-GFCCVEGCSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
8114,6lzg,DB04785,-8.1,Streptolydigin,KVTPRMV1KLIG-NCAOFHFGSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
164337,7bv1,DB07716,-8.1,"(4Z)-2,8:7,12:11,15:14,18:17,22-PENTAANHYDRO-4,5,6,9,10,13,19,20,21-NONADEOXY-D-ARABINO-D-ALLO-D-ALLO-DOCOSA-4,9,20-TRIENITOL",VDRIXSJOPKVWKM-HXGIDPQASA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
106488,6vxx,DB00404,-8.1,Alprazolam,VREFGVBLTWBCJP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108861,6vxx,DB11182,-8.1,Rose bengal free acid,VDNLFJGJEQUWRB-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77450,6m2n,DB08393,-8.1,"2-[(5,6-DIPHENYLFURO[2,3-D]PYRIMIDIN-4-YL)AMINO]ETHANOL",UQHINZSKNAAVOZ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
127509,6w4h,DB06237,-8.1,Avanafil,WEAJZXNPAWBCOA-INIZCTEOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
20438,6cs2,HMDB0047024,-8.1,"TG(24:0/14:0/20:4(8Z,11Z,14Z,17Z))",VGJLRVHUGWORNM-UXNDQROASA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
11357,6lzg,DB11855,-8.1,Revefenacin,FYDWDCIFZSGNBU-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
57095,6crv,DB03199,-8.1,4-Methoxy-E-Rhodomycin T,XSSVYBYWQBNYOH-QJIXERIWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106533,6vxx,DB00457,-8.1,Prazosin,IENZQIKPVFGBNW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77416,6m2n,DB08352,-8.1,"6-[4-(2-fluorophenyl)-1,3-oxazol-5-yl]-N-(1-methylethyl)-1,3-benzothiazol-2-amine",FQYJTHIYAQQJAB-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
163280,7bv1,DB04201,-8.1,Histidyl-Adenosine Monophosphate,XTFBSLZFYLGYAT-OPYVMVOTSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
75507,6m2n,DB04796,-8.1,Inecalcitol,HHGRMHMXKPQNGF-WNSNRMDMSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
106539,6vxx,DB00467,-8.1,Enoxacin,IDYZIJYBMGIQMJ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77392,6m2n,DB08320,-8.1,"DIETHYL (1R,2S,3R,4S)-5,6-BIS(4-HYDROXYPHENYL)-7-OXABICYCLO[2.2.1]HEPT-5-ENE-2,3-DICARBOXYLATE",NHKDFDHHMHBFLG-COPRSSIGSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
27383,6cs2,DB06920,-8.1,Eribaxaban,QQBKAVAGLMGMHI-WIYYLYMNSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
29990,6cs2,DB11903,-8.1,GW842166,TWQYWUXBZHPIIV-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
106442,6vxx,DB00218,-8.1,Moxifloxacin,FABPRXSRWADJSP-MEDUHNTESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57162,6crv,DB03277,-8.1,alpha-maltotriose,FYGDTMLNYKFZSV-PXXRMHSHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106283,6vxs,DB15391,-8.1,Elenbecestat,AACUJFVOHGRMTR-DPXNYUHVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
108931,6vxx,DB11410,-8.1,Fenbendazole,HDDSHPAODJUKPD-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77542,6m2n,DB08503,-8.1,"(3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(4-methylphenyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol",HRCKGDOSPBFICB-MZHQWRCYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
108930,6vxx,DB11409,-8.1,Febantel,HMCCXLBXIJMERM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29794,6cs2,DB11644,-8.1,Tafamidis,TXEIIPDJKFWEEC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
57249,6crv,DB03396,-8.1,"(E)-(2r,3r,4s,5r)-3,4,5-Trihydroxy-2-Methoxy-8,8-Dimethyl-Non-6-Enoic Acid ((3s,6r)-6-Hydroxy-2-Oxo-Azepan-3-Yl)-Amide",FVBBTOIQETYGOA-SDNORSGYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106318,6vxs,DB15456,-8.1,Vericiguat,QZFHIXARHDBPBY-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
163045,7bv1,DB03696,-8.1,Lanosterol,CAHGCLMLTWQZNJ-BQNIITSRSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
75422,6m2n,DB04678,-8.1,H TYPE II TRISACCHARIDE,PHTAQVMXYWFMHF-QVPNGJTFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
108907,6vxx,DB11366,-8.1,Roquinimex,SGOOQMRIPALTEL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
139290,6w9c,DB13275,-8.1,Clorindione,NJDUWAXIURWWLN-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
127544,6w4h,DB06321,-8.1,R-348,IGLNXKVGKIFNBQ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
75430,6m2n,DB04689,-8.1,2-{5-[3-(6-BENZOYL-1-PROPYLNAPHTHALEN-2-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID,ZXWVCCFKIRBLDP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
115513,6w4b,DB00941,-8.1,Hexafluronium,HDZAQYPYABGTCL-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
77524,6m2n,DB08485,-8.1,"(1S,4S,5S)-1,4,5-TRIHYDROXY-3-[3-(PHENYLTHIO)PHENYL]CYCLOHEX-2-ENE-1-CARBOXYLIC ACID",QMNMNSINKIFYBV-LMMKCTJWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
163092,7bv1,DB03755,-8.1,"Adenosine-5'-[Beta, Gamma-Methylene]Tetraphosphate",ARRGHMSEJJFDME-IOSLPCCCSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
77522,6m2n,DB08481,-8.1,"4-METHYL-N-{(5E)-5-[(5-METHYL-2-FURYL)METHYLENE]-4-OXO-4,5-DIHYDRO-1,3-THIAZOL-2-YL}BENZENESULFONAMIDE",MXAPQGDBWFYKKX-ZROIWOOFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
139523,6w9c,DB13586,-8.1,Metandienone,XWALNWXLMVGSFR-HLXURNFRSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
106430,6vxx,DB00203,-8.1,Sildenafil,BNRNXUUZRGQAQC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106439,6vxx,DB00215,-8.1,Citalopram,WSEQXVZVJXJVFP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163122,7bv1,DB03791,-8.1,"(3-{3-[[2-Chloro-3-(Trifluoromethyl)Benzyl](2,2-Diphenylethyl)Amino]Propoxy}Phenyl)Acetic Acid",NAXSRXHZFIBFMI-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
27376,6cs2,DB06913,-8.1,"(2R,3R)-3-{[3,5-BIS(TRIFLUOROMETHYL)PHENYL]AMINO}-2-CYANO-3-THIOXOPROPANAMIDE",ZTUMRSFHUOBXAC-LHIURRSHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
163066,7bv1,DB03723,-8.1,2'-Deoxy-Thymidine-Beta-L-Rhamnose,ZOSQFDVXNQFKBY-CGAXJHMRSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
163688,7bv1,DB05936,-8.1,CVT-6883,KOYXXLLNCXWUNF-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
107105,6vxx,DB02292,-8.1,Irosustat,DSLPMJSGSBLWRE-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138800,6w9c,DB12284,-8.1,LY-2608204,QIIVJLHCZUTGSD-CUBQBAPOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
108058,6vxx,DB06777,-8.1,Chenodeoxycholic acid,RUDATBOHQWOJDD-BSWAIDMHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76002,6m2n,DB06622,-8.1,7-beta-Hydroxyepiandrosterone,VFPMCLQMAUVEHD-UCPSWNCLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
55840,6crv,DB01543,-8.1,18-methyl-19-nortestosterone,FBYZQDCRLYHHHP-ZOFHRBRSSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
10871,6lzg,DB09200,-8.1,Rivoglitazone,XMSXOLDPMGMWTH-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
27762,6cs2,DB07315,-8.1,"5-chloro-N-{4-[(1R)-1,2-dihydroxyethyl]phenyl}-1H-indole-2-carboxamide",SHCHFGSUYJUEBR-INIZCTEOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
139145,6w9c,DB12925,-8.1,Crolibulin,JXONINOYTKKXQQ-CQSZACIVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
56160,6crv,DB01960,-8.1,7n-Methyl-8-Hydroguanosine-5'-Diphosphate,QQODJOAVWUWVHJ-KQYNXXCUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
126823,6w4h,DB04342,-8.1,7-((Carboxy(4-Hydroxyphenyl)Acetyl)Amino)-7-Methoxy-(3-((1-Methyl-1h-Tetrazol-5-Yl)Thio)Methyl)-8-Oxo-5-Oxa-1-Azabicyclo[4.2.0]Oct-2-Ene-2-Carboxylic Acid,JWCSIUVGFCSJCK-LIUKBUMOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
108464,6vxx,DB08019,-8.1,"N-{(3R,4S)-4-[(6-amino-4-methylpyridin-2-yl)methyl]pyrrolidin-3-yl}-N'-(3-chlorobenzyl)ethane-1,2-diamine",VWCMAGONQJHIJZ-LPHOPBHVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114886,6vxx,DB15335,-8.1,Formononetin,HKQYGTCOTHHOMP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76500,6m2n,DB07278,-8.1,2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}ETHENESULFONAMIDE,ACEFOQMQINFMRW-DYCFVMESSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
108103,6vxx,DB06850,-8.1,(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclohexylamino)ethanoyl)pyrrolidine-2-carboxamide,RYKFVFFOIYLADT-SFHVURJKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56151,6crv,DB01951,-8.1,Gpi-1046,OQAHHWOPVDDWHD-INIZCTEOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114885,6vxx,DB15334,-8.1,Biochanin A,WUADCCWRTIWANL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108106,6vxx,DB06856,-8.1,6-FLUORO-2-[2-HYDROXY-3-(2-METHYL-CYCLOHEXYLOXY)-PHENYL]-1H-INDOLE-5-CARBOXAMIDINE,HUYQYLFFFNSAAX-BUXKBTBVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108119,6vxx,DB07125,-8.1,"4-(6-{[(1R)-1-(hydroxymethyl)propyl]amino}imidazo[1,2-b]pyridazin-3-yl)benzoic acid",KKZYGUVAFJCULH-CYBMUJFWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
126750,6w4h,DB04240,-8.1,"(1S)-1-C-{(2R)-6-[(2R)-2-Butanyl]-5,10-dihydroxy-4-oxo-1,2,3,4-tetrahydro-2-anthracenyl}-5-deoxy-1-O-methyl-D-xylulose",XGORHSPGULYMCV-HHYQQTLHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
29874,6cs2,DB11751,-8.1,Cabotegravir,WCWSTNLSLKSJPK-LKFCYVNXSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
108126,6vxx,DB07132,-8.1,1-{2-OXO-3-[(1R)-1-(1H-PYRROL-2-YL)ETHYL]-2H-INDOL-5-YL}UREA,KJDBLWKTHMHALD-QMMMGPOBSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56127,6crv,DB01922,-8.1,"Maltosyl-Alpha (1,4)-D-Gluconhydroximo-1,5-Lactam",AHRWQUNEPBVNOT-IVJVVCOPSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108135,6vxx,DB07143,-8.1,D-phenylalanyl-N-benzyl-L-prolinamide,MEPJWLFTTFHOQO-MOPGFXCFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138943,6w9c,DB12601,-8.1,Sonolisib,QIUASFSNWYMDFS-NILGECQDSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
126219,6w4h,DB03532,-8.1,Phosphomethylphosphonic Acid Guanylate Ester,GXTIEXDFEKYVGY-KQYNXXCUSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
75995,6m2n,DB06608,-8.1,Tafenoquine,LBHLFPGPEGDCJG-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
126836,6w4h,DB04362,-8.1,Adenosine Diphosphate 5-(Beta-Ethyl)-4-Methyl-Thiazole-2-Carboxylic Acid,VGXBGQACJQRWLV-LKGUXBDMSA-K,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
107916,6vxx,DB05575,-8.1,Motesanib,RAHBGWKEPAQNFF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138919,6w9c,DB12565,-8.1,Abexinostat,MAUCONCHVWBMHK-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
163933,7bv1,DB06875,-8.1,3-(3-FLUORO-4-HYDROXYPHENYL)-7-HYDROXY-1-NAPHTHONITRILE,NSSOSHDCWCMNDM-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
126951,6w4h,DB04518,-8.1,"3-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamino]-Phenol",JJDRRZFRTKZLFT-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
138921,6w9c,DB12567,-8.1,Camicinal,RZKDEGZIFSJVNA-IBGZPJMESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
56251,6crv,DB02082,-8.1,Phosphoaminophosphonic Acid Guanylate Ester,UQABYHGXWYXDTK-UUOKFMHZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27728,6cs2,DB07284,-8.1,"N-3-(3-PYRIDIN-3-YLBENZYL)PYRIDINE-2,3-DIAMINE",NQSBHBFOOVYRNM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
107944,6vxx,DB05767,-8.1,Andrographolide,BOJKULTULYSRAS-OTESTREVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107945,6vxx,DB05772,-8.1,Rabeximod,PDNNUMNEXITLCZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107949,6vxx,DB05796,-8.1,Daglutril,XMQODGUTLZXUGZ-RPBOFIJWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75967,6m2n,DB06532,-8.1,Pafuramidine,UKOQVLAXCBRRGH-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
126187,6w4h,DB03488,-8.1,Uridine-5'-diphosphate-2-deoxy-2-fluoro-alpha-D-galactose,NGTCPFGWXMBZEP-NQQHDEILSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
139152,6w9c,DB12933,-8.1,RO-4987655,FIMYFEGKMOCQKT-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
107979,6vxx,DB05973,-8.1,Inosine 5'-sulfate,IGYLPKLXFDOQGM-KQYNXXCUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108001,6vxx,DB06684,-8.1,Vilazodone,SGEGOXDYSFKCPT-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114900,6vxx,DB15360,-8.1,"Carfentanil, C-11",YDSDEBIZUNNPOB-JVVVGQRLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27925,6cs2,DB07488,-8.1,"{(2Z)-4-AMINO-2-[(4-METHOXYPHENYL)IMINO]-2,3-DIHYDRO-1,3-THIAZOL-5-YL}(4-METHOXYPHENYL)METHANONE",XQKUGFIWKSKCDL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
114899,6vxx,DB15359,-8.1,Xanthohumol,ORXQGKIUCDPEAJ-YRNVUSSQSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75983,6m2n,DB06582,-8.1,Dextofisopam,RUJBDQSFYCKFAA-HNNXBMFYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138934,6w9c,DB12587,-8.1,Razupenem,XFGOMLIRJYURLQ-GOKYHWASSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
56198,6crv,DB02014,-8.1,"5-(2-Fluoro-5-{(1E)-3-[3-hydroxy-2-(methoxycarbonyl)phenoxy]-1-propen-1-yl}phenyl)-1,2-oxazole-3-carboxylic acid",QKHWJUMLYAYZFS-ONEGZZNKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108041,6vxx,DB06741,-8.1,Gavestinel,WZBNEZWCNKUOSM-VOTSOKGWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108447,6vxx,DB08001,-8.1,5-(3-{3-[3-HYDROXY-2-(METHOXYCARBONYL)PHENOXY]PROPENYL}PHENYL)-4-(HYDROXYMETHYL)ISOXAZOLE-3-CARBOXYLIC ACID,DQSRCEFDWMQCCV-GQCTYLIASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108145,6vxx,DB07155,-8.1,(3S)-1-CYCLOHEXYL-5-OXO-N-PHENYLPYRROLIDINE-3-CARBOXAMIDE,BVUSHGJZBZMDML-ZDUSSCGKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
126720,6w4h,DB04201,-8.1,Histidyl-Adenosine Monophosphate,XTFBSLZFYLGYAT-OPYVMVOTSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
10769,6lzg,DB09034,-8.1,Suvorexant,JYTNQNCOQXFQPK-MRXNPFEDSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
76130,6m2n,DB06847,-8.1,"5-[(3S)-3-(2-methoxybiphenyl-4-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",YYCPXVRHQUEVAW-CQSZACIVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76352,6m2n,DB07107,-8.1,(1S)-2-(1H-INDOL-3-YL)-1-[({5-[(E)-2-PYRIDIN-4-YLVINYL]PYRIDIN-3-YL}OXY)METHYL]ETHYLAMINE,SGHXFHRRWFLILP-XJDXJNMNSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76132,6m2n,DB06849,-8.1,"1-[1'-(3-phenylacryloyl)spiro[1-benzofuran-3,4'-piperidin]-5-yl]methanamine",RQWYWHUKHYFIPB-VQHVLOKHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
27848,6cs2,DB07406,-8.1,"(4R)-N-[4-({[2-(DIMETHYLAMINO)ETHYL]AMINO}CARBONYL)-1,3-THIAZOL-2-YL]-4-METHYL-1-OXO-2,3,4,9-TETRAHYDRO-1H-BETA-CARBOLINE-6-CARBOXAMIDE",QWFFPYQWUWLDBV-NSHDSACASA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
108261,6vxx,DB07547,-8.1,5-(4-CYANOPHENYL)-3-{[(2-METHYLPHENYL)SULFONYL]AMINO}THIOPHENE-2-CARBOXYLIC ACID,RYXAHMSZLLIPRO-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76149,6m2n,DB06871,-8.1,17-METHYL-17-ALPHA-DIHYDROEQUILENIN,FQMQOMRDADWGJJ-GBESFXJTSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
164092,7bv1,DB07250,-8.1,"N'-(5-CHLORO-1,3-BENZODIOXOL-4-YL)-N-(3,4,5- TRIMETHOXYPHENYL)PYRIMIDINE-2,4-DIAMINE",HMKLUOPMOJOUDZ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
114820,6vxx,DB14924,-8.1,PF-06651600,CBRJPFGIXUFMTM-WDEREUQCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108301,6vxx,DB07596,-8.1,"(17beta)-17-(cyanomethyl)-2-methox1tra-1(10),2,4-trien-3-yl sulfamate",NTSPHKOMJMBWOU-NNKXXINSSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
10738,6lzg,DB08995,-8.1,Diosmin,GZSOSUNBTXMUFQ-YFAPSIMESA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
126517,6w4h,DB03932,-8.1,LFA703,WPVRNXUYVXQXPY-YFAYRSKXSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
76270,6m2n,DB07013,-8.1,TERT-BUTYL 4-({[4-(BUT-2-YN-1-YLAMINO)PHENYL]SULFONYL}METHYL)-4-[(HYDROXYAMINO)CARBONYL]PIPERIDINE-1-CARBOXYLATE,RXFCFGLSOUOCEA-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
114849,6vxx,DB15021,-8.1,Leriglitazone,OXVFDZYQLGRLCD-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
139056,6w9c,DB12781,-8.1,Balaglitazone,IETKPTYAGKZLKY-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
10717,6lzg,DB08974,-8.1,Flubendazole,CPEUVMUXAHMANV-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
76193,6m2n,DB06919,-8.1,D-phenylalanyl-N-(3-chlorobenzyl)-L-prolinamide,CJHLRGCXPGIPCB-MOPGFXCFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76230,6m2n,DB06967,-8.1,"6-ETHYL-5-[9-(3-METHOXYPROPYL)-9H-CARBAZOL-2-YL]PYRIMIDINE-2,4-DIAMINE",MLSVRCGEBXIIQO-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
108388,6vxx,DB07702,-8.1,17alpha-Estriol,PROQIPRRNZUXQM-PNVOZDDCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
126366,6w4h,DB03742,-8.1,Compound 4-D,TWZNCTCQAGRUGQ-RRPNLBNLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
27880,6cs2,DB07439,-8.1,"1-((2-HYDROXYETHOXY)METHYL)-5-(3-(BENZYLOXY)BENZYL)-6-HYDROXYPYRIMIDINE-2,4(1H,3H)-DIONE",CAWXCABXSPTFRN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
139095,6w9c,DB12850,-8.1,Etalocib,YFIZRWPXUYFCSN-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
76120,6m2n,DB06833,-8.1,1-CYCLOHEXYL-N-{[1-(4-METHYLPHENYL)-1H-INDOL-3-YL]METHYL}METHANAMINE,MMIJMYOYKAKQPN-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76375,6m2n,DB07131,-8.1,(S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclohexylpropanoyl)pyrrolidine-2-carboxamide,DOTBZTLJSXFKCP-IBGZPJMESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
139104,6w9c,DB12867,-8.1,Benperidol,FEBOTPHFXYHVPL-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
27797,6cs2,DB07351,-8.1,O-(((1R)-((N-(PHENYL-METHOXY-CARBONYL)-ALANYL)-AMINO)METHYL)HYDROXYPHOSPHINYL)3-L-PHENYLLACTATE,ICACWKLCNCPHAM-YJBOKZPZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
108446,6vxx,DB08000,-8.1,"2-(CARBOXYMETHYL)-1-OXO-1,2-DIHYDRONAPHTHO[1,2-D]ISOTHIAZOLE-4-CARBOXYLIC ACID 3,3-DIOXIDE",ZTJGXDGAXGWOGR-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
126715,6w4h,DB04196,-8.1,Pteroic Acid,JOAQINSXLLMRCV-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
56092,6crv,DB01864,-8.1,5'-Guanosine-Diphosphate-Monothiophosphate,XOFLBQFBSOEHOG-UUOKFMHZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
10666,6lzg,DB08907,-8.1,Canagliflozin,XTNGUQKDFGDXSJ-ZXGKGEBGSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
139122,6w9c,DB12890,-8.1,Dihydrexidine,BGOQGUHWXBGXJW-YOEHRIQHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
76057,6m2n,DB06725,-8.1,Lornoxicam,WLHQHAUOOXYABV-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
164034,7bv1,DB06995,-8.1,N-({4-[(2-aminopyridin-4-yl)oxy]-3-fluorophenyl}carbamoyl)-2-(4-fluorophenyl)acetamide,USBSTVPJNQLYEM-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
76450,6m2n,DB07219,-8.1,"BENZYL N-({(2S,3S)-3-[(PROPYLAMINO)CARBONYL]OXIRAN-2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINATE",OMQNYWZURFTFHE-MQBSTWLZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138996,6w9c,DB12686,-8.1,PHA-793887,HUXYBQXJVXOMKX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
164145,7bv1,DB07307,-8.1,N-cyclopropyl-4-methyl-3-[1-(2-methylphenyl)phthalazin-6-yl]benzamide,GQXMJOSCBRZMKE-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
114875,6vxx,DB15316,-8.1,Florasulam,QZXATCCPQKOEIH-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56036,6crv,DB01791,-8.1,Piclamilast,RRRUXBQSQLKHEL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29880,6cs2,DB11763,-8.1,Momelotinib,ZVHNDZWQTBEVRY-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
76089,6m2n,DB06780,-8.1,Desoxycorticosterone acetate,VPGRYOFKCNULNK-ACXQXYJUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
164112,7bv1,DB07272,-8.1,"N-(4-AMINO-5-CYANO-6-ETHOXYPYRIDIN-2-YL)-2-(4-BROMO-2,5-DIMETHOXYPHENYL)ACETAMIDE",GKODDLYLEKSDJL-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
164110,7bv1,DB07270,-8.1,"N-[7-(3-AMINOPHENYL)-5-METHOXY-1,3-BENZOXAZOL-2-YL]-2,5-DICHLOROBENZENESULFONAMIDE",GAYYMURZGLJDCT-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
126638,6w4h,DB04097,-8.1,Uridine-5'-Diphosphate-4-Deoxy-4-Fluoro-Alpha-D-Galactose,OAPPZHVTNHJVAL-JZMIEXBBSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
126329,6w4h,DB03696,-8.1,Lanosterol,CAHGCLMLTWQZNJ-BQNIITSRSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
114813,6vxx,DB14906,-8.1,Adafosbuvir,NIJYGVDQZBBONK-SEUXLIJBSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27835,6cs2,DB07393,-8.1,"2-(2-PHENYL-3-PYRIDIN-2-YL-4,5,6,7-TETRAHYDRO-2H-ISOPHOSPHINDOL-1-YL)PYRIDINE",GSKNNHAAFLPYHG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
126629,6w4h,DB04086,-8.1,"2',4'-Dinitrophenyl-2deoxy-2-Fluro-B-D-Cellobioside",WFVCNOHOODVBQK-IUBYCILNSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
10680,6lzg,DB08931,-8.1,Riociguat,WXXSNCNJFUAIDG-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
162719,7bv1,DB02834,-8.1,IDD552,ZCAGEXZTORJQDZ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
138910,6w9c,DB12433,-8.1,SCH-900271,ARJKMWXLIHZLQZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
107899,6vxx,DB05498,-8.1,KW-7158,NAFSYPCVPLWHFY-HNNXBMFYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
125952,6w4h,DB03173,-8.1,CRA_10433,CFSQPEBVGUSQII-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
75802,6m2n,DB06117,-8.1,"1alpha,24S-Dihydroxyvitamin D2",ODZFJAXAEXQSKL-WRJREGAQSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
125958,6w4h,DB03181,-8.1,"2-[4-(4-Hydroxy-3-Isopropyl-Phenoxy)-3,5-Dimethyl-Phenyl]-2h-[1,2,4]Triazine-3,5-Dione",RXQAVKWRCZYGMV-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
76865,6m2n,DB07706,-8.1,2-Hydrox1tradiol,DILDHNKDVHLEQB-XSSYPUMDSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
29934,6cs2,DB11828,-8.1,Neratinib,JWNPDZNEKVCWMY-VQHVLOKHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
163772,7bv1,DB06248,-8.1,Amelubant,SBVYURPQULDJTI-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
76861,6m2n,DB07702,-8.1,17alpha-Estriol,PROQIPRRNZUXQM-PNVOZDDCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76860,6m2n,DB07701,-8.1,"1-BENZYL-4-[(5,6-DIMETHOXY-1-INDANON-2-YL)METHYL]PIPERIDINE",ADEBPBSSDYVVLD-HXUWFJFHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
163783,7bv1,DB06267,-8.1,Udenafil,IYFNEFQTYQPVOC-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
75823,6m2n,DB06166,-8.1,Fosdevirine,CGBYTKOSZYQOPV-CCEZBSFNSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
56536,6crv,DB02452,-8.1,Thymidine-5'-Triphosphate,NHVNXKFIZYSCEB-XLPZGREQSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107440,6vxx,DB03596,-8.1,N-[2-(1h-Indol-5-Yl)-Butyl]-4-Sulfamoyl-Benzamide,FSRPBGBMEKDSIJ-CYBMUJFWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76828,6m2n,DB07663,-8.1,"2-[(1R)-1-CARBOXY-2-(4-HYDROXYPHENYL)ETHYL]-1,3-DIOXOISOINDOLINE-5-CARBOXYLIC ACID",QISJEFYTLZTWIQ-CQSZACIVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
127191,6w4h,DB04834,-8.1,Rapacuronium,HTIKWNNIPGXLGM-YLINKJIISA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
108566,6vxx,DB08402,-8.1,"2-[(2,4-DICHLOROBENZOYL)AMINO]-5-(PYRIMIDIN-2-YLOXY)BENZOIC ACID",VNDRRWBKNSHALL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108560,6vxx,DB08395,-8.1,2-(ETHOXYMETHYL)-4-(4-FLUOROPHENYL)-3-[2-(2-HYDROXYPHENOXY)PYRIMIDIN-4-YL]ISOXAZOL-5(2H)-ONE,ZSOXFJURLPCSOO-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56520,6crv,DB02430,-8.1,Trehalose-6-Phosphate,LABSPYBHMPDTEL-LIZSDCNHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
164202,7bv1,DB07373,-8.1,"ANDROSTA-1,4-DIENE-3,17-DIONE",LUJVUUWNAPIQQI-QAGGRKNESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
27632,6cs2,DB07183,-8.1,N-(4-phenoxyphenyl)-2-[(pyridin-4-ylmethyl)amino]nicotinamide,CPVRYQAOUPSUDO-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
107489,6vxx,DB03668,-8.1,1-(5'-Phospho-Beta-D-Ribofuranosyl)Barbituric Acid,AODYJUNLDJOADV-YXZULKJRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75837,6m2n,DB06199,-8.1,Atrasentan,MOTJMGVDPWRKOC-QPVYNBJUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
107355,6vxx,DB03205,-8.1,Pyrroloquinoline Quinone,MMXZSJMASHPLLR-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127167,6w4h,DB04807,-8.1,4-NITROPHENYL-(6-S-ALPHA-D-XYLOPYRANOSYL)-BETA-D-GLUCOPYRANOSIDE,HQYVHBCTLFPWRQ-ZMFOIVQCSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
11103,6lzg,DB11424,-8.1,Lufenuron,PWPJGUXAGUPAHP-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
75795,6m2n,DB06061,-8.1,AZD-8330,RWEVIPRMPFNTLO-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
107107,6vxx,DB02295,-8.1,"N-[3-(Dimethylamino)Propyl]-2-({[4-({[4-(Formylamino)-1-Methyl-1h-Pyrrol-2-Yl]Carbonyl}Amino)-1-Methyl-1h-Pyrrol-2-Yl]Carbonyl}Amino)-5-Isopropyl-1,3-Thiazole-4-Carboxamide",VDYCDKRATGWFDA-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107117,6vxx,DB02310,-8.1,"3,5,6,8-Tetramethyl-N-Methyl Phenanthrolinium",FQTUZNACZKILMC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55742,6crv,DB01430,-8.1,Almitrine,OBDOVFRMEYHSQB-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27570,6cs2,DB07119,-8.1,1-CHLORO-6-(4-HYDROXYPHENYL)-2-NAPHTHOL,YHEHVRSGKUYDON-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
75759,6m2n,DB05804,-8.1,Prasterone sulfate,CZWCKYRVOZZJNM-USOAJAOKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
127286,6w4h,DB05076,-8.1,Fenretinide,AKJHMTWEGVYYSE-FXILSDISSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
107172,6vxx,DB02659,-8.1,Cholic Acid,BHQCQFFYRZLCQQ-OELDTZBJSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107179,6vxx,DB02669,-8.1,RB106,ZWDQTNWLXALTOV-QYZOEREBSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27579,6cs2,DB07127,-8.1,"{4-[2,2-BIS(5-METHYL-1,2,4-OXADIAZOL-3-YL)-3-PHENYLPROPYL]PHENYL}SULFAMIC ACID",SXDBFKLPNPUPRI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
11142,6lzg,DB11487,-8.1,Dexamethasone isonicotinate,BQTXJHAJMDGOFI-NJLPOHDGSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
163703,7bv1,DB06011,-8.1,AMG-222,NVSWJKWHLUTHLP-CPJSRVTESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
75781,6m2n,DB05943,-8.1,Resatorvid,LEEIJTHMHDMWLJ-CQSZACIVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
108633,6vxx,DB08486,-8.1,Efaproxiral,BNFRJXLZYUTIII-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163712,7bv1,DB06117,-8.1,"1alpha,24S-Dihydroxyvitamin D2",ODZFJAXAEXQSKL-WRJREGAQSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
107215,6vxx,DB02715,-8.1,Compound 18,UZOOIPXOYYJULJ-RHLLTPQKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108614,6vxx,DB08462,-8.1,N-(4-PHENYLAMINO-QUINAZOLIN-6-YL)-ACRYLAMIDE,JGWHILNNHLDARR-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108608,6vxx,DB08455,-8.1,Ro 12-7310,CAAFTBWHFUPDGX-OFCLTBKTSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163718,7bv1,DB06140,-8.1,SUVN-502,GWCYPEHWIZXYFZ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
107281,6vxx,DB03103,-8.1,Thymidine-5'- Diphosphate,UJLXYODCHAELLY-XLPZGREQSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
11121,6lzg,DB11450,-8.1,Pimobendan,GLBJJMFZWDBELO-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
27598,6cs2,DB07147,-8.1,"methyl (1R,2S)-2-(hydroxycarbamoyl)-1-{4-[(2-methylquinolin-4-yl)methoxy]benzyl}cyclopropanecarboxylate",HJWMYFBKJRVWJY-YKSBVNFPSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
76902,6m2n,DB07750,-8.1,"(2R)-1-[4-({4-[(2,5-Dichlorophenyl)amino]-2-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol",GNLAGGCSJGJECE-MRXNPFEDSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
127157,6w4h,DB04794,-8.1,Bifonazole,OCAPBUJLXMYKEJ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
166583,7bv1,DB15424,-8.1,Bfpet F-18,QWPLCHDPESWJRN-FNNGWQQSSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
76818,6m2n,DB07648,-8.1,"(2R)-3-{[(4Z)-5,6-DIPHENYL-6,7-DIHYDRO-4H-PYRROLO[2,3-D]PYRIMIDIN-4-YLIDENE]AMINO}PROPANE-1,2-DIOL",TWEONIHFGKSPLC-MRXNPFEDSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
164171,7bv1,DB07334,-8.1,"N-[5-(ETHYLSULFONYL)-2-METHOXYPHENYL]-5-[3-(2-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-AMINE",HTIZPBXCJPQDEM-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
76719,6m2n,DB07531,-8.1,"4-{5-[(Z)-(2,4-DIOXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE",JNPRTUHVCHGFHJ-GHXNOFRVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
8011,6lzg,DB04651,-8.1,BIOTINOL-5-AMP,KBOGUFFJCBPJEH-SQGSUPJISA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
138882,6w9c,DB12399,-8.1,Polmacoxib,IJWPAFMIFNSIGD-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
76685,6m2n,DB07490,-8.1,"2-[1-(4-CHLORO-PHENYL)-ETHYL]-4,6-DINITRO-PHENOL",MOZUMFSUQQHSCO-MRVPVSSYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
56351,6crv,DB02218,-8.1,"N-[4-hydroxymethyl-cyclohexan-6-yl-1,2,3-triol]-4,6-dideoxy-4-aminoglucopyranoside",RBZIIHWPZWOIDU-ZCGMLSCUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163845,7bv1,DB06455,-8.1,Meclinertant,DYLJVOXRWLXDIG-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
163851,7bv1,DB06741,-8.1,Gavestinel,WZBNEZWCNKUOSM-VOTSOKGWSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
163852,7bv1,DB06743,-8.1,Ginkgolide A,FPUXKXIZEIDQKW-VKMVSBOZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
163853,7bv1,DB06744,-8.1,ginkgolide-B,SQOJOAFXDQDRGF-MMQTXUMRSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
76656,6m2n,DB07455,-8.1,"N,N'-[biphenyl-4,4'-diyldi(2R)propane-2,1-diyl]dimethanesulfonamide",ZESUARCHWPARIF-HOTGVXAUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
107794,6vxx,DB04624,-8.1,DERIVATIVE OF AKLANONIC ACID METHYL ESTER (AAME),SIHNJMGWRHPFAZ-XHDPSFHLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138900,6w9c,DB12420,-8.1,Diazepinomicin,SALVHVNECODMJP-GNUCVDFRSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
10640,6lzg,DB08865,-8.1,Crizotinib,KTEIFNKAUNYNJU-GFCCVEGCSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
27936,6cs2,DB07500,-8.1,(2E)-1-[2-hydroxy-4-methoxy-5-(3-methylbut-2-en-1-yl)phenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one,ZUGCRBMNFSAUOC-YRNVUSSQSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
114769,6vxx,DB14820,-8.1,Profoxydim,KRQUFUKTQHISJB-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56313,6crv,DB02164,-8.1,N-Sulfo-Flavin Mononucleotide,ZLPUGFBBLGQWBS-SCRDCRAPSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107862,6vxx,DB05289,-8.1,Tarenflurbil,SYTBZMRGLBWNTM-SNVBAGLBSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76646,6m2n,DB07444,-8.1,"6-(3-AMINOPROPYL)-4,9-DIMETHYLPYRROLO[3,4-C]CARBAZOLE-1,3(2H,6H)-DIONE",PKPNSCZPIWCHMW-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
107874,6vxx,DB05395,-8.1,Amibegron,RDJQCOBTKKAQAH-FPOVZHCZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114776,6vxx,DB14841,-8.1,Centanafadine,HKHCSWPSUSWGLI-CABCVRRESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55797,6crv,DB01491,-8.1,Dipipanone,SVDHSZFEQYXRDC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108524,6vxx,DB08089,-8.1,LGD-2226,ULBPQWIGZUGPHU-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76721,6m2n,DB07533,-8.1,"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]-2-FURYL}-N-METHYLBENZENESULFONAMIDE",FJJJERLTHDXEPT-JYRVWZFOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
108539,6vxx,DB08105,-8.1,N-[(6-butoxynaphthalen-2-yl)sulfonyl]-L-glutamic acid,UAGYXJBYAFGRFR-KRWDZBQOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
166587,7bv1,DB15431,-8.1,M-2698,HXAUJHZZPCBFPN-QGZVFWFLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
108550,6vxx,DB08385,-8.1,4-(quinolin-3-ylmethyl)piperidine-1-carboxylic acid,QUAGUFNCKDDJFZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56465,6crv,DB02367,-8.1,(1n)-4-N-Butoxyphenylsulfonyl-(2r)-N-Hydroxycarboxamido-(4s)-Methanesulfonylamino-Pyrrolidine,ULDXUWXTVRRUND-SWLSCSKDSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
139229,6w9c,DB13174,-8.1,Rhein,FCDLCPWAQCPTKC-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
75872,6m2n,DB06266,-8.1,Lonidamine,WDRYRZXSPDWGEB-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76777,6m2n,DB07602,-8.1,S-{3-[(4-ANILINOQUINAZOLIN-6-YL)AMINO]-3-OXOPROPYL}-L-CYSTEINE,NLVZTRZPMRTVRC-INIZCTEOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76774,6m2n,DB07596,-8.1,"(17beta)-17-(cyanomethyl)-2-methox1tra-1(10),2,4-trien-3-yl sulfamate",NTSPHKOMJMBWOU-NNKXXINSSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76766,6m2n,DB07587,-8.1,"N-(1-CYANOCYCLOPROPYL)-3-({[(2S)-5-OXOPYRROLIDIN-2-YL]METHYL}SULFONYL)-N-2-[(1S)-2,2,2-TRIFLUORO-1-(4-FLUOROPHENYL)ETHYL]-L-ALANINAMIDE",JLPXDVXMMYRTKN-ZOBUZTSGSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
107615,6vxx,DB04092,-8.1,Apstatin,YVUUZAPYLPWFHE-HXFGRODQSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107619,6vxx,DB04096,-8.1,"5-Amino-5-Deoxy-Cellobiono-1,5-Lactam",WXSNJJDPPISYEF-ZNLUKOTNSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163904,7bv1,DB06837,-8.1,"(2R)-N-4-hydroxy-2-(3-hydroxybenzyl)-N-1-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]butanediamide",VXDKQRWTOJFQKH-BJZITVGISA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
75882,6m2n,DB06292,-8.1,Dapagliflozin,JVHXJTBJCFBINQ-ADAARDCZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
20746,6cs2,HMDB0001056,-8.1,Dihydrofolic acid,OZRNSSUDZOLUSN-LBPRGKRZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
27661,6cs2,DB07212,-8.1,N-(7-CARBAMIMIDOYL-NAPHTHALEN-1-YL)-3-HYDROXY-2-METHYL-BENZAMIDE,NNGZRCYXFBHMRM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
76742,6m2n,DB07557,-8.1,"(5BETA)-PREGNANE-3,20-DIONE",XMRPGKVKISIQBV-XWOJZHJZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
114741,6vxx,DB14753,-8.1,Hydroxystilbamidine,TUESWZZJYCLFNL-DAFODLJHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108541,6vxx,DB08107,-8.1,N-{[6-(PENTYLOXY)NAPHTHALEN-2-YL]SULFONYL}-D-GLUTAMIC ACID,LIGACKDHLKEZFH-GOSISDBHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75896,6m2n,DB06335,-8.1,Saxagliptin,QGJUIPDUBHWZPV-SGTAVMJGSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76726,6m2n,DB07538,-8.1,"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}-2-(TRIFLUOROMETHYL)BENZENESULFONAMIDE",RGVVHQNJKUNSFQ-WDZFZDKYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
164193,7bv1,DB07359,-8.1,"3-[(4-fluorophenyl)sulfanyl]-N-(4-methyl-1,3-thiazol-2-yl)-6-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]pyridine-2-carboxamide",SJTQKYKXCYVFHX-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
27672,6cs2,DB07226,-8.1,"N-[4-(2-CHLOROPHENYL)-1,3-DIOXO-1,2,3,6-TETRAHYDROPYRROLO[3,4-C]CARBAZOL-9-YL]FORMAMIDE",JWZVNUNTFNELHL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
107715,6vxx,DB04216,-8.1,Quercetin,REFJWTPEDVJJIY-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127129,6w4h,DB04757,-8.1,"GUANOSINE-2',3'-O-METHYLIDENEPHOSPHONATE",GKAPYWCOOQBBHV-KXSYMAMXSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
128188,6w4h,DB07315,-8.1,"5-chloro-N-{4-[(1R)-1,2-dihydroxyethyl]phenyl}-1H-indole-2-carboxamide",SHCHFGSUYJUEBR-INIZCTEOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
138574,6w9c,DB11864,-8.1,Preladenant,DTYWJKSSUANMHD-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
106125,6vxs,DB15071,-8.1,Omidenepag isopropyl,VIQCWEGEHRBLAC-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
137807,6w9c,DB08741,-8.1,"5-[[(2R)-2-cyclopropyl-7,8-dimethoxy-2H-chromen-5-yl]methyl]pyrimidine-2,4-diamine",HWJPWWYTGBZDEG-AWEZNQCLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
117536,6w4b,DB03632,-8.1,Argifin,UHBHXSDKGLPPGO-HTDHLNIYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
128040,6w4h,DB07146,-8.1,"2,3-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-B]PYRIDIN-4-AMINE",QUIQCYFSBGOBKE-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
73669,6m2n,DB02341,-8.1,"Mdl 101,146",XQAMVCHQGHAELT-YPAWHYETSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
114120,6vxx,DB12758,-8.1,Atreleuton,MMSNEKOTSJRTRI-LLVKDONJSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
161515,7bv1,DB14982,-8.1,Miransertib,HNFMVVHMKGFCMB-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
30198,6cs2,DB12183,-8.1,Sapitinib,DFJSJLGUIXFDJP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
128031,6w4h,DB07136,-8.1,(2S)-2-[3-(AMINOMETHYL)PHENYL]-3-{(R)-HYDROXY[(1R)-2-METHYL-1-{[(3-PHENYLPROPYL)SULFONYL]AMINO}PROPYL]PHOSPHORYL}PROPANOIC ACID,WFFOOKSVFDUPDH-FCHUYYIVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
139943,6w9c,DB14633,-8.1,Prednisolone hemisuccinate,APGDTXUMTIZLCJ-CGVGKPPMSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
55436,6crv,DB01003,-8.1,Cromoglicic acid,IMZMKUWMOSJXDT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
128023,6w4h,DB07127,-8.1,"{4-[2,2-BIS(5-METHYL-1,2,4-OXADIAZOL-3-YL)-3-PHENYLPROPYL]PHENYL}SULFAMIC ACID",SXDBFKLPNPUPRI-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
117495,6w4b,DB03571,-8.1,"3-(5-Amino-7-Hydroxy-[1,2,3]Triazolo[4,5-D]Pyrimidin-2-Yl)-N-(3,5-Dichlorobenzyl)-Benzamide",JMQTXEWNXSPEKX-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
8250,6lzg,DB05016,-8.1,Ataluren,OOUGLTULBSNHNF-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
104481,6vxs,DB12066,-8.1,Orteronel,OZPFIJIOIVJZMN-SFHVURJKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
26876,6cs2,DB05667,-8.1,Levoketoconazole,XMAYWYJOQHXEEK-ZEQKJWHPSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
73744,6m2n,DB02431,-8.1,Cytidine-5'-Triphosphate,PCDQPRRSZKQHHS-XVFCMESISA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
30189,6cs2,DB12167,-8.1,LY-3023414,ACCFLVVUVBJNGT-AWEZNQCLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
104494,6vxs,DB12084,-8.1,ADP-597,WPDCHTSXOPUOII-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
10266,6lzg,DB08445,-8.1,"(3R,4S)-1-[6-(6-METHOXYPYRIDIN-3-YL)PYRIMIDIN-4-YL]-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE",IFKWHPAWYJARQJ-DYVFJYSZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
104515,6vxs,DB12115,-8.1,AZD-9164,FNYFFCOCVNTJCD-NNMXADRKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104516,6vxs,DB12116,-8.1,Epigallocatechin gallate,WMBWREPUVVBILR-WIYYLYMNSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
109212,6vxx,DB12900,-8.1,Irdabisant,XUKROCVZGZNGSI-CQSZACIVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
125107,6w4h,DB02058,-8.1,SU4984,AZGZGRJOCKSSHA-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
104414,6vxs,DB11964,-8.1,Ilaprazole,HRRXCXABAPSOCP-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
78916,6m2n,DB12443,-8.1,Sonedenoson,WUCQGGOGHZRELS-LSCFUAHRSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
26824,6cs2,DB05423,-8.1,ORG-34517,DFELGYQKEOCHOA-BZAFBGKRSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
128085,6w4h,DB07198,-8.1,5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-CARBONITRILE,GGEKOZPXKBYLNK-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
12134,6lzg,DB12929,-8.1,JNJ-39220675,IQOWHZHNGJXGHG-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
26828,6cs2,DB05444,-8.1,Iroxanadine,QWVRTSZDKPRPDF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
73577,6m2n,DB02221,-8.1,"4-(Aminosulfonyl)-N-[(2,4,6-Trifluorophenyl)Methyl]-Benzamide",DVTYOTODFLDHRL-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
128076,6w4h,DB07187,-8.1,6-[(5-CHLORO-3-METHYL-1-BENZOFURAN-2-YL)SULFONYL]PYRIDAZIN-3(2H)-ONE,FXFPQPNUMWQRAO-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
164512,7bv1,DB08093,-8.1,3-(1-NAPHTHYLMETHOXY)PYRIDIN-2-AMINE,SZANYTFSQVBOBA-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
117672,6w4b,DB03802,-8.1,"1-[4-(Octahydro-Pyrido[1,2-a]Pyrazin-2-Yl)-Phenyl]-2-Phenyl-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol",ZGHFWBDHZZKWSI-LITSAYRRSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
58440,6crv,DB05263,-8.1,Caprospinol,VMOZFSWFUBLCNN-AAPULDEBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104346,6vxs,DB11867,-8.1,JNJ-39393406,IURMHZBQEYNQOH-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
26836,6cs2,DB05470,-8.1,VX-702,FYSRKRZDBHOFAY-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
161495,7bv1,DB14916,-8.1,Selonsertib,YIDDLAAKOYYGJG-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
128069,6w4h,DB07180,-8.1,"5-[(Z)-(5-Chloro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-N,2,4-trimethyl-1H-pyrrole-3-carboxamide",FIRPCWHHIWFKCD-GHXNOFRVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
12110,6lzg,DB12897,-8.1,MK-7622,JUVQLZBJFOGEEO-GOTSBHOMSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
6696,6lzg,DB02545,-8.1,Fexaramine,VLQTUNDJHLEFEQ-KGENOOAVSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
128058,6w4h,DB07168,-8.1,[4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-6-(methylamino)pyrimidin-2-yl}amino)phenyl]acetonitrile,MFMSRHREFZCFSN-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
6699,6lzg,DB02551,-8.1,"6-[N-(4-Ethyl-1,2,3,4-Tetrahydro-6-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine",LVNMYQLXKMSQTG-AWEZNQCLSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
73634,6m2n,DB02295,-8.1,"N-[3-(Dimethylamino)Propyl]-2-({[4-({[4-(Formylamino)-1-Methyl-1h-Pyrrol-2-Yl]Carbonyl}Amino)-1-Methyl-1h-Pyrrol-2-Yl]Carbonyl}Amino)-5-Isopropyl-1,3-Thiazole-4-Carboxamide",VDYCDKRATGWFDA-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
73647,6m2n,DB02315,-8.1,Cyclic GMP,ZOOGRGPOEVQQDX-UUOKFMHZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
125085,6w4h,DB02030,-8.1,Alpha-Ribazole-5'-Phosphate,ZMRGXEJKZPRBPJ-SYQHCUMBSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
137802,6w9c,DB08736,-8.1,"S,R-Warfarin alcohol",ZUJMMGHIYSAEOU-DOMZBBRYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
104413,6vxs,DB11963,-8.1,Dacomitinib,LVXJQMNHJWSHET-AATRIKPKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
55418,6crv,DB00982,-8.1,Isotretinoin,SHGAZHPCJJPHSC-XFYACQKRSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58369,6crv,DB04915,-8.1,Idronoxil,ZZUBHVMHNVYXRR-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
137852,6w9c,DB08791,-8.1,"1-[(2-NITROPHENYL)SULFONYL]-1H-PYRROLO[3,2-B]PYRIDINE-6-CARBOXAMIDE",USLOIFPDNUDIEG-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
127972,6w4h,DB07067,-8.1,"(2S,3S)-3-{3-[4-(METHYLSULFONYL)PHENYL]-1,2,4-OXADIAZOL-5-YL}-1-OXO-1-PYRROLIDIN-1-YLBUTAN-2-AMINE",SQCDMTZMCHZYGO-FZMZJTMJSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
127971,6w4h,DB07066,-8.1,"2-CHLORO-N-[(3R)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL]-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE",LJAHIGGEXIWVJG-LLVKDONJSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
73891,6m2n,DB02623,-8.1,Aminophosphonic Acid-Guanylate Ester,ZGPDMUBRWRJAQQ-UUOKFMHZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
109177,6vxx,DB12479,-8.1,Zabofloxacin,ZNPOCLHDJCAZAH-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
11973,6lzg,DB00966,-8.1,Telmisartan,RMMXLENWKUUMAY-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
55468,6crv,DB01038,-8.1,Carphenazine,XZSMZRXAEFNJCU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
73899,6m2n,DB02636,-8.1,"9-Hydroxy-8-Methoxy-6-Nitro-Phenanthrol[3,4-D][1,3]Dioxole-5-Carboxylic Acid",UCLGCTLOEZZSLA-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
73901,6m2n,DB02639,-8.1,4-methylumbelliferyl ??-D-glucoside,YUDPTGPSBJVHCN-JZYAIQKZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
58310,6crv,DB04829,-8.1,Lysergic acid diethylamide,VAYOSLLFUXYJDT-RDTXWAMCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
137929,6w9c,DB08910,-8.1,Pomalidomide,UVSMNLNDYGZFPF-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
109168,6vxx,DB12468,-8.1,Pf-04531083,ZRJGMDIPCQOGNI-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
26933,6cs2,DB05983,-8.1,Bardoxolone methyl,WPTTVJLTNAWYAO-KPOXMGGZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
104670,6vxs,DB12332,-8.1,Rucaparib,HMABYWSNWIZPAG-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
139913,6w9c,DB14541,-8.1,Hydrocortisone cypionate,DLVOSEUFIRPIRM-KAQKJVHQSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
26937,6cs2,DB06011,-8.1,AMG-222,NVSWJKWHLUTHLP-CPJSRVTESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
104671,6vxs,DB12336,-8.1,GDC-0917,HSHPBORBOJIXSQ-HARLFGEKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
139911,6w9c,DB14539,-8.1,Hydrocortisone acetate,ALEXXDVDDISNDU-JZYPGELDSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
55473,6crv,DB01044,-8.1,Gatifloxacin,XUBOMFCQGDBHNK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78741,6m2n,DB12206,-8.1,N-6022,YVPGZQLRPAGKLA-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
73935,6m2n,DB02684,-8.1,5'-O-(N-(L-Cysteinyl)-Sulfamoyl)Adenosine,FTSDEWPMACCNGN-YTMOPEAISA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
109150,6vxx,DB12441,-8.1,Tavilermide,DVJXNXPFYJIACK-ULQDDVLXSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104647,6vxs,DB12302,-8.1,CP-724714,LLVZBTWPGQVVLW-SNAWJCMRSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
78854,6m2n,DB12361,-8.1,Piclozotan,URMTUEWUIGOJBW-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
114144,6vxx,DB12802,-8.1,Picropodophyllin,YJGVMLPVUAXIQN-HAEOHBJNSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
161693,7bv1,DB00481,-8.1,Raloxifene,GZUITABIAKMVPG-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
58365,6crv,DB04905,-8.1,Tesmilifene,NFIXBCVWIPOYCD-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78833,6m2n,DB12325,-8.1,Idasanutlin,TVTXCJFHQKSQQM-LJQIRTBHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
125108,6w4h,DB02059,-8.1,Adenosine-5-Diphosphoribose,SRNWOUGRCWSEMX-ZQSHOCFMSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
30184,6cs2,DB12158,-8.1,Filorexant,NPFDWHQSDBWQLH-QZTJIDSGSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
139927,6w9c,DB14575,-8.1,Eslicarbazepine,BMPDWHIDQYTSHX-AWEZNQCLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137897,6w9c,DB08846,-8.1,Ellagic Acid,AFSDNFLWKVMVRB-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
55447,6crv,DB01015,-8.1,Sulfamethoxazole,JLKIGFTWXXRPMT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58347,6crv,DB04876,-8.1,Vildagliptin,SYOKIDBDQMKNDQ-XWTIBIIYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
137907,6w9c,DB08873,-8.1,Boceprevir,LHHCSNFAOIFYRV-DOVBMPENSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
28160,6cs2,DB07741,-8.1,"4-(1R,3AS,4R,8AS,8BR)-[1-DIFLUOROMETHYL-2-(4-FLUOROBENZYL)-3-OXODECAHYDROPYRROLO[3,4-A]PYRROLIZIN-4-YL]BENZAMIDINE",VPNYXOTTXAXSIH-SXYSDOLCSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
29704,6cs2,DB11442,-8.1,Oleandomycin,RZPAKFUAFGMUPI-QESOVKLGSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
161607,7bv1,DB00171,-8.1,ATP,ZKHQWZAMYRWXGA-KQYNXXCUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
104584,6vxs,DB12221,-8.1,Canrenone,UJVLDDZCTMKXJK-WNHSNXHDSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
161631,7bv1,DB00197,-8.1,Troglitazone,GXPHKUHSUJUWKP-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
104591,6vxs,DB12229,-8.1,Cerlapirdine,NXQGEDVQXVTCDA-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
73881,6m2n,DB02610,-8.1,"N-(2,3,4,5,6-Pentaflouro-Benzyl)-4-Sulfamoyl-Benzamide",LRKSHOLYETXPGY-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78768,6m2n,DB12241,-8.1,TAK-733,RCLQNICOARASSR-SECBINFHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
98022,6vxs,DB00445,-8.1,Epirubicin,AOJJSUZBOXZQNB-VTZDEGQISA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
161672,7bv1,DB00246,-8.1,Ziprasidone,MVWVFYHBGMAFLY-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
127977,6w4h,DB07074,-8.1,6-CARBAMIMIDOYL-4-(3-HYDROXY-2-METHYL-BENZOYLAMINO)-NAPHTHALENE-2-CARBOXYLIC ACID METHYL ESTER,OUBRALHIKGRAMA-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
7829,6lzg,DB04434,-8.1,Naphthyridine Inhibitor,YRBHUKMLAGQYHS-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
104641,6vxs,DB12295,-8.1,Evodenoson,SQJXTUJMBYVDBB-RQXXJAGISA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
125073,6w4h,DB02014,-8.1,"5-(2-Fluoro-5-{(1E)-3-[3-hydroxy-2-(methoxycarbonyl)phenoxy]-1-propen-1-yl}phenyl)-1,2-oxazole-3-carboxylic acid",QKHWJUMLYAYZFS-ONEGZZNKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
161484,7bv1,DB14895,-8.1,Vibegron,DJXRIQMCROIRCZ-XOEOCAAJSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
137738,6w9c,DB08660,-8.1,"1,2,5,8-tetrahydroxyanthracene-9,10-dione",VBHKTXLEJZIDJF-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
103387,6vxs,DB08519,-8.1,"N-4-(3-methyl-1H-indazol-6-yl)-N-2-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine",SQQAPOSROFWHIB-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
161140,7bv1,DB12941,-8.1,ODM-201,BLIJXOOIHRSQRB-PXYINDEMSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
103462,6vxs,DB08608,-8.1,"4-({(2R,5S)-2,5-DIMETHYL-4-[(2R)-3,3,3-TRIFLUORO-2-HYDROXY-2-METHYLPROPANOYL]PIPERAZIN-1-YL}CARBONYL)BENZONITRILE",IWFSHKKFDSWNLZ-BWACUDIHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
114039,6vxx,DB12637,-8.1,Onapristone,IEXUMDBQLIVNHZ-YOUGDJEHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
103474,6vxs,DB08622,-8.1,"4-(4-CHLORO-PHENYL)-1-{3-[2-(4-FLUORO-PHENYL)-[1,3]DITHIOLAN-2-YL]-PROPYL}-PIPERIDIN-4-OL",KVDKNVPAAQKHKD-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
103485,6vxs,DB08639,-8.1,Dapivirine,ILAYIAGXTHKHNT-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
79284,6m2n,DB13023,-8.1,IPI-493,XYFFWTYOFPSZRM-TWNAANEASA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
73067,6m2n,DB01547,-8.1,Drotebanol,LCAHPIFLPICNRW-OPGCRTJHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
103539,6vxs,DB08705,-8.1,"6-(5-BROMO-2-HYDROXYPHENYL)-2-OXO-4-PHENYL-1,2-DIHYDROPYRIDINE-3-CARBONITRILE",SVSYJTYGPLVUOZ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
79278,6m2n,DB13016,-8.1,LY-2300559,DWQVYDLTPMGYNE-DEOSSOPVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
55368,6crv,DB00922,-8.1,Levosimendan,WHXMKTBCFHIYNQ-SECBINFHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
137516,6w9c,DB08393,-8.1,"2-[(5,6-DIPHENYLFURO[2,3-D]PYRIMIDIN-4-YL)AMINO]ETHANOL",UQHINZSKNAAVOZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
103575,6vxs,DB08742,-8.1,"1,3-CYCLOHEXANEDIOL, 4-METHYLENE-5-[(2E)-[(1S,3AS,7AS)-OCTAHYDRO-1-(5-HYDROXY-5-METHYL-1,3-HEXADIYNYL)-7A-METHYL-4H-INDEN-4-YLIDENE]ETHYLIDENE]-, (1R,3S,5Z)",CEEUUHVULXTFGS-BQXVGYHGSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
79230,6m2n,DB12938,-8.1,Isoxaflutole,OYIKARCXOQLFHF-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
103580,6vxs,DB08747,-8.1,"(11R)-10-acetyl-11-(2,4-dichlorophenyl)-6-hydroxy-3,3-dimethyl-2,3,4,5,10,11-hexahydro-1H-dibenzo[b,e][1,4]diazepin-1-one",JJTPPGUNMJMPLY-QFIPXVFZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
73129,6m2n,DB01621,-8.1,Pipotiazine,JOMHSQGEWSNUKU-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79225,6m2n,DB12930,-8.1,Opipramol,YNZFUWZUGRBMHL-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
103641,6vxs,DB08816,-8.1,Ticagrelor,OEKWJQXRCDYSHL-FNOIDJSQSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
161307,7bv1,DB13533,-8.1,Methylestrenolone,ZXSWTMLNIIZPET-ZOFHRBRSSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
103677,6vxs,DB08878,-8.1,Aminopterin,TVZGACDUOSZQKY-LBPRGKRZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
103692,6vxs,DB08905,-8.1,Formestane,OSVMTWJCGUFAOD-KZQROQTASA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
161132,7bv1,DB12929,-8.1,JNJ-39220675,IQOWHZHNGJXGHG-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
103697,6vxs,DB08911,-8.1,Trametinib,LIRYPHYGHXZJBZ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
73046,6m2n,DB01526,-8.1,4-Androstenediol,BTTWKVFKBPAFDK-LOVVWNRFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
103376,6vxs,DB08504,-8.1,"6-(4-{(1S,2S)-2-AMINO-1-[(DIMETHYLAMINO)CARBONYL]-3-[(3S)-3-FLUOROPYRROLIDIN-1-YL]-3-OXOPROPYL}PHENYL)-1H-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-4-IUM",ZNHVIJAGMFQGMS-IHPCNDPISA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
103167,6vxs,DB08246,-8.1,"(2S)-4-(2,5-DIFLUOROPHENYL)-N,N-DIMETHYL-2-PHENYL-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDE",WFFMEXQHWXEKBV-SFHVURJKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
28215,6cs2,DB07796,-8.1,"(3ASR,4RS,8ASR,8BRS)-4-(2-(4-FLUOROBENZYL)-1,3-DIOXODEACAHYDROPYRROLO[3,4-A] PYRROLIZIN-4-YL)BENZAMIDINE",GJYCQHGTXMVIBG-MUGJNUQGSA-O,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
72986,6m2n,DB01455,-8.1,19-Nor-5-androstenediol,VVUQRXPUVKXAIO-XFUVECHXSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
103209,6vxs,DB08303,-8.1,"(3S)-3-cyclopentyl-6-methyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide",CUMKMTBOHBENJI-SFHVURJKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
114003,6vxx,DB12574,-8.1,LY-295501,VAMFSFIPDOODFH-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
103247,6vxs,DB08350,-8.1,"5-[3-(2-METHOXYPHENYL)-1H-PYRROLO[2,3-B]PYRIDIN-5-YL]-N,N-DIMETHYLPYRIDINE-3-CARBOXAMIDE",GYQRHHQPEMOLKH-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
103250,6vxs,DB08353,-8.1,"2-(CYCLOHEXYLMETHYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE",NCVMTHVSAJMOPI-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
103251,6vxs,DB08354,-8.1,"2-(4-CHLOROBENZYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE",QCVULERVJOYHCP-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
73008,6m2n,DB01479,-8.1,BA-2664,QGKQXZFZOIQFBI-XSWYFRFISA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
128171,6w4h,DB07297,-8.1,"5,6-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-D]PYRIMIDIN-4-AMINE",PTILEOLOGGMFCS-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
124962,6w4h,DB01858,-8.1,[1-(4-Fluorobenzyl)Cyclobutyl]Methyl (1s)-1-[Oxo(1h-Pyrazol-5-Ylamino)Acetyl]Pentylcarbamate,QTPYRNAKLBXKNP-SFHVURJKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
73022,6m2n,DB01496,-8.1,Barbituric acid derivative,DNZPLHRZXUJATK-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
58657,6crv,DB06288,-8.1,Amisulpride,NTJOBXMMWNYJFB-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
73023,6m2n,DB01497,-8.1,Etorphine,CAHCBJPUTCKATP-HBDRVVKHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
103332,6vxs,DB08454,-8.1,N-(5-METHYL-1H-PYRAZOL-3-YL)-2-PHENYLQUINAZOLIN-4-AMINE,JYCUVOXSZBECAY-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
73026,6m2n,DB01500,-8.1,Oxabolone,GXHBCWCMYVTJOW-YGRHGMIBSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
73029,6m2n,DB01503,-8.1,1-Androstenediol,RZFGPAMUAXASRE-YSZCXEEOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
58653,6crv,DB06276,-8.1,Tanomastat,JXAGDPXECXQWBC-LJQANCHMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
103358,6vxs,DB08486,-8.1,Efaproxiral,BNFRJXLZYUTIII-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
118386,6w4b,DB04760,-8.1,"PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-(4-FLUORO-3-METHYL-BENZYLAMIDE)",PYFRREJCFXFNRR-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
79299,6m2n,DB13048,-8.1,PAC-1,YQNRVGJCPCNMKT-LFVJCYFKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
73044,6m2n,DB01524,-8.1,Androstenediol,QADHLRWLCPCEKT-LOVVWNRFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
118016,6w4b,DB04258,-8.1,Seocalcitol,LVLLALCJVJNGQQ-SEODYNFXSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
137555,6w9c,DB08442,-8.1,"4-{[(2R)-2-(2-methylphenyl)pyrrolidin-1-yl]carbonyl}benzene-1,3-diol",TWODFUZHWYZBHZ-MRXNPFEDSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
58581,6crv,DB06133,-8.1,Dimethylcurcumin,ZMGUKFHHNQMKJI-CIOHCNBKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
161436,7bv1,DB14038,-8.1,beta-Sitosterol,KZJWDPNRJALLNS-VJSFXXLFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
104189,6vxs,DB11633,-8.1,Isavuconazole,DDFOUSQFMYRUQK-RCDICMHDSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104199,6vxs,DB11650,-8.1,HT-0712,ABEJDMOBAFLQNJ-NHCUHLMSSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
26787,6cs2,DB05234,-8.1,LGD2941,HWLLYFXDDGGHOE-BCSUUIJWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
128117,6w4h,DB07238,-8.1,Nesbuvir,WTDWVLJJJOTABN-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
73383,6m2n,DB01960,-8.1,7n-Methyl-8-Hydroguanosine-5'-Diphosphate,QQODJOAVWUWVHJ-KQYNXXCUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
104203,6vxs,DB11656,-8.1,Rebamipide,ALLWOAVDORUJLA-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
117830,6w4b,DB04011,-8.1,"2'-(4-Dimethylaminophenyl)-5-(4-Methyl-1-Piperazinyl)-2,5'-Bi-Benzimidazole",VMCOQLKKSNQANE-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
28182,6cs2,DB07763,-8.1,"(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE",OZZFJGCAYWBVBI-INIZCTEOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
12177,6lzg,DB12998,-8.1,PF-00217830,QGNOXTFZOLDODX-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
58479,6crv,DB05475,-8.1,Golotimod,CATMPQFFVNKDEY-YPMHNXCESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104234,6vxs,DB11698,-8.1,Ipragliflozin,AHFWIQIYAXSLBA-RQXATKFSSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
8271,6lzg,DB00559,-8.1,Bosentan,GJPICJJJRGTNOD-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
73455,6m2n,DB02058,-8.1,SU4984,AZGZGRJOCKSSHA-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
10245,6lzg,DB08423,-8.1,[5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL][3-(PIPERIDIN-4-YLOXY)PHENYL]METHANONE,QKZZJXRGCHXIAI-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
79009,6m2n,DB12587,-8.1,Razupenem,XFGOMLIRJYURLQ-GOKYHWASSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
114107,6vxx,DB12739,-8.1,Bindarit,MTHORRSSURHQPZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
137701,6w9c,DB08614,-8.1,"3-[[(METHYLAMINO)SULFONYL]AMINO]-2-OXO-6-PHENYL-N-[3,3,3-TRIFLUORO-1-(1-METHYLETHYL)-2-OXOPHENYL]-1(2H)-PYRIDINE ACETAMIDE",MYFMPKCOIMRDDD-KRWDZBQOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
73515,6m2n,DB02132,-8.1,Zenarestat,SXONDGSPUVNZLO-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
139979,6w9c,DB14671,-8.1,Temazepam acetate,PTWWAHZQIATUFG-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
78989,6m2n,DB12557,-8.1,FK-614,UYGZODVVDUIDDQ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
117845,6w4b,DB04030,-8.1,"1,3,4,9-Tetrahydro-2-(Hydroxybenzoyl)-9-[(4-Hydroxyphenyl)Methyl]-6-Methoxy-2h-Pyrido[3,4-B]Indole",ADXYEWMDAGIULV-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
137636,6w9c,DB08536,-8.1,"3-bromo-5-phenyl-N-(pyrimidin-5-ylmethyl)pyrazolo[1,5-a]pyridin-7-amine",IBUPHWYGVDAASU-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
30233,6cs2,DB12229,-8.1,Cerlapirdine,NXQGEDVQXVTCDA-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
137635,6w9c,DB08535,-8.1,"3-bromo-5-phenyl-N-(pyridin-3-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",SMIZFGZXFDGISG-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
103795,6vxs,DB09047,-8.1,Finafloxacin,FYMHQCNFKNMJAV-HOTGVXAUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
125014,6w4h,DB01938,-8.1,L-Histidine Beta Naphthylamide,DKDILZBBFKZMRO-OAHLLOKOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
137588,6w9c,DB08481,-8.1,"4-METHYL-N-{(5E)-5-[(5-METHYL-2-FURYL)METHYLENE]-4-OXO-4,5-DIHYDRO-1,3-THIAZOL-2-YL}BENZENESULFONAMIDE",MXAPQGDBWFYKKX-ZROIWOOFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
103805,6vxs,DB09063,-8.1,Ceritinib,VERWOWGGCGHDQE-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
137599,6w9c,DB08494,-8.1,"S-{2-[(2-chloro-4-sulfamoylphenyl)amino]-2-oxoethyl} 6-methyl-3,4-dihydroquinoline-1(2H)-carbothioate",AWAKIULNKVOBKE-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
103861,6vxs,DB09175,-8.1,Mirfentanil,BJZZDOLVVLWFHN-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
109286,6vxx,DB13016,-8.1,LY-2300559,DWQVYDLTPMGYNE-DEOSSOPVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30266,6cs2,DB00932,-8.1,Tipranavir,SUJUHGSWHZTSEU-FYBSXPHGSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
140018,6w9c,DB14765,-8.1,Rivoceranib,WPEWQEMJFLWMLV-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
103911,6vxs,DB09230,-8.1,Azelnidipine,ZKFQEACEUNWPMT-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
78734,6m2n,DB12193,-8.1,Ajulemic acid,YCHYFHOSGQABSW-RTBURBONSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
73271,6m2n,DB01809,-8.1,"1-Ter-Butyl-3-P-Tolyl-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine",ZVPDNRVYHLRXLX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
140016,6w9c,DB14761,-8.1,Remdesivir,RWWYLEGWBNMMLJ-YSOARWBDSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
12233,6lzg,DB13072,-8.1,GDC-0349,RGJOJUGRHPQXGF-INIZCTEOSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
140008,6w9c,DB14737,-8.1,Cannabinol,VBGLYOIFKLUMQG-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
73296,6m2n,DB01838,-8.1,"6,4'-Dihydroxy-3-Methyl-3',5'-Dibromoflavone",GKDYOXMZSXVKPP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
58530,6crv,DB05779,-8.1,Oglufanide,LLEUXCDZPQOJMY-AAEUAGOBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104093,6vxs,DB11398,-8.1,Diclazuril,ZSZFUDFOPOMEET-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
128128,6w4h,DB07251,-8.1,"N'-(3-CHLORO-4-METHOXY-PHENYL)-N-(3,4,5-TRIMETHOXYPHENYL)-1,3,5-TRIAZINE-2,4-DIAMINE",ZVWFECUPYCFYBL-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
161415,7bv1,DB13994,-8.1,AZD-7325,KYDURMHFWXCKMW-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
30240,6cs2,DB12236,-8.1,Bexagliflozin,BTCRKOKVYTVOLU-SJSRKZJXSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
30238,6cs2,DB12234,-8.1,BMS-214662,OLCWFLWEHWLBTO-HSZRJFAPSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
125046,6w4h,DB01975,-8.1,AMPCPR,ZPZRETFSCSWNDT-DBXCYWGHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
58275,6crv,DB04787,-8.1,Tanaproget,PYVFWTPEBMRKSR-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109147,6vxx,DB12436,-8.1,Vofopitant,XILNRORTJVDYRH-HKUYNNGSSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104729,6vxs,DB12417,-8.1,Anagliptin,LDXYBEHACFJIEL-HNNXBMFYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
78237,6m2n,DB11362,-8.1,Selexipag,QXWZQTURMXZVHJ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
127744,6w4h,DB06786,-8.1,Halcinonide,MUQNGPZZQDCDFT-JNQJZLCISA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
57825,6crv,DB04176,-8.1,"Phosporic Acid Mono-[3,4-Dihydroxy-5-(5-Methoxy-Benzoimidazol-1-Yl)-Tetrahydro-Furan-2-Ylmethyl] Ester",VYUPJUKSTVHSQI-LPWJVIDDSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78123,6m2n,DB09299,-8.1,Tenofovir alafenamide,LDEKQSIMHVQZJK-CAQYMETFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
11663,6lzg,DB12272,-8.1,Vidupiprant,PFWVGKROPKKEDW-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
138475,6w9c,DB11718,-8.1,Encorafenib,CMJCXYNUCSMDBY-ZDUSSCGKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
114241,6vxx,DB13155,-8.1,Esculin,XHCADAYNFIFUHF-TVKJYDDYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
162378,7bv1,DB01975,-8.1,AMPCPR,ZPZRETFSCSWNDT-DBXCYWGHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
109042,6vxx,DB11948,-8.1,Lapachone,QZPQTZZNNJUOLS-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57776,6crv,DB04114,-8.1,"3-Chloro-9-Ethyl-6,7,8,9,10,11-Hexahydro-7,11-Methanocycloocta[B]Quinolin-12-Amine",QTPHSDHUHXUYFE-NWDGAFQWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78084,6m2n,DB09236,-8.1,Lacidipine,GKQPCPXONLDCMU-CCEZHUSRSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
105771,6vxs,DB13997,-8.1,Baloxavir marboxil,RZVPBGBYGMDSBG-GGAORHGYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
8182,6lzg,DB04862,-8.1,Merimepodib,JBPUGFODGPKTDW-SFHVURJKSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
74836,6m2n,DB03895,-8.1,Malachite Green,VFCNQNZNPKRXIT-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
74847,6m2n,DB03909,-8.1,"Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate",UFZTZBNSLXELAL-IOSLPCCCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78034,6m2n,DB09182,-8.1,Benzylfentanyl,POQDXIFVWVZVML-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
30071,6cs2,DB12009,-8.1,GW-406381,NXMZBNYLCVTRGB-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
127726,6w4h,DB06745,-8.1,ginkgolide-C,AMOGMTLMADGEOQ-DTDWCABLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
27180,6cs2,DB06635,-8.1,Otamixaban,PFGVNLZDWRZPJW-OPAMFIHVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
109025,6vxx,DB11922,-8.1,Danirixin,NGYNBSHYFOFVLS-LBPRGKRZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78027,6m2n,DB09174,-8.1,Lofentanil,IMYHGORQCPYVBZ-NLFFAJNJSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
7195,6lzg,DB03383,-8.1,5-Chloro-1h-Indole-2-Carboxylic Acid [1-(4-Fluorobenzyl)-2-(4-Hydroxypiperidin-1yl)-2-Oxoethyl]Amide,YDCGVASFVACWKF-NRFANRHFSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
11638,6lzg,DB12238,-8.1,MK-0777,QKIWQBLNTSQOLY-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
30078,6cs2,DB12021,-8.1,Dinaciclib,PIMQWRZWLQKKBJ-SFHVURJKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
105730,6vxs,DB13929,-8.1,Relcovaptan,CEBYCSRFKCEUSW-NAYZPBBASA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
166496,7bv1,DB15242,-8.1,MK-0533,STWITCBWQHTJFJ-XMMPIXPASA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
10365,6lzg,DB08553,-8.1,"(1E)-5-(1-piperidin-4-yl-3-pyridin-4-yl-1H-pyrazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime",KWEFZSZCLBHIEQ-YYADALCUSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
116585,6w4b,DB02354,-8.1,4-{[1-Methyl-5-(2-Methyl-Benzoimidazol-1-Ylmethyl)-1h-Benzoimidazol-2-Ylmethyl]-Amino}-Benzamidine,IRKPNOLLMNHSOU-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
78317,6m2n,DB11519,-8.1,Fluprostenol,WWSWYXNVCBLWNZ-QIZQQNKQSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
55542,6crv,DB01125,-8.1,Anisindione,XRCFXMGQEVUZFC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
74647,6m2n,DB03656,-8.1,Tribenuron Methyl,VLCQZHSMCYCDJL-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78289,6m2n,DB11455,-8.1,Robenacoxib,ZEXGDYFACFXQPF-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78278,6m2n,DB11433,-8.1,Nequinate,NNOPDLNHPOLRRE-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
105575,6vxs,DB13682,-8.1,Cefpirome,DKOQGJHPHLTOJR-WHRDSVKCSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
138435,6w9c,DB11662,-8.1,Rabusertib,SYYBDNPGDKKJDU-ZDUSSCGKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
30080,6cs2,DB12024,-8.1,PF-04418948,LWJGMYMNSNVCEM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
57868,6crv,DB04234,-8.1,N2-({[(4-Bromophenyl)Methyl]Oxy}Carbonyl)-N1-[(1s)-1-Formylpentyl]-L-Leucinamide,UEDKSAKLZBMNMA-ROUUACIJSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
105611,6vxs,DB13729,-8.1,Camostat,XASIMHXSUQUHLV-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
125388,6w4h,DB02421,-8.1,Uridine-5'-Diphosphate-Mannose,HSCJRCZFDFQWRP-NYYOCOOHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
105628,6vxs,DB13756,-8.1,Peruvoside,PMTSPAGBAFCORP-HBUONDEYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
57851,6crv,DB04209,-8.1,Dequalinium,PCSWXVJAIHCTMO-UHFFFAOYSA-P,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138449,6w9c,DB11679,-8.1,Fruquintinib,BALLNEJQLSTPIO-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
105657,6vxs,DB13793,-8.1,Vinburnine,WYJAPUKIYAZSEM-MOPGFXCFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
105708,6vxs,DB13857,-8.1,Demegestone,JWAHBTQSSMYISL-MHTWAQMVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
57845,6crv,DB04202,-8.1,Isoformononetin,LNIQZRIHAMVRJA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
105726,6vxs,DB13919,-8.1,Candesartan,HTQMVQVXFRQIKW-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
27148,6cs2,DB06581,-8.1,Bevirimat,YJEJKUQEXFSVCJ-WRFMNRASSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
74879,6m2n,DB03950,-8.1,(S)-N-(3-Indol-1-Yl-2-Methyl-Propyl)-4-Sulfamoyl-Benzamide,ZFWHOUCRVSOZJE-AWEZNQCLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
8181,6lzg,DB04861,-8.1,Nebivolol,KOHIRBRYDXPAMZ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
105906,6vxs,DB14583,-8.1,Segesterone acetate,CKFBRGLGTWAVLG-GOMYTPFNSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
57613,6crv,DB03895,-8.1,Malachite Green,VFCNQNZNPKRXIT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114280,6vxx,DB13230,-8.1,Gestonorone,GTFUITFQDGVJSK-XGXHKTLJSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75003,6m2n,DB04121,-8.1,Guanosine-3'-Monophosphate-5'-Diphosphate,HEYSFDAMRDTCJM-UUOKFMHZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75018,6m2n,DB04140,-8.1,1-Benzyl-3-(4-Methoxy-Benzenesulfonyl)-6-Oxo-Hexahydro-Pyrimidine-4-Carboxylic Acid Hydroxyamide,SUSMVCKSLVPRCL-QGZVFWFLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
115896,6w4b,DB01459,-8.1,Bezitramide,FLKWNFFCSSJANB-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
77855,6m2n,DB08897,-8.1,Aclidinium,ASMXXROZKSBQIH-VITNCHFBSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
11560,6lzg,DB12130,-8.1,Lorlatinib,IIXWYSCJSQVBQM-LLVKDONJSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
106093,6vxs,DB15009,-8.1,PF-04937319,MASKQITXHVYVFL-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
127657,6w4h,DB06625,-8.1,Vipadenant,HQSBCDPYXDGTCL-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
30035,6cs2,DB11963,-8.1,Dacomitinib,LVXJQMNHJWSHET-AATRIKPKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
27247,6cs2,DB06741,-8.1,Gavestinel,WZBNEZWCNKUOSM-VOTSOKGWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
162684,7bv1,DB02789,-8.1,Pregnenolone,ORNBQBCIOKFOEO-QGVNFLHTSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
77836,6m2n,DB08864,-8.1,Rilpivirine,YIBOMRUWOWDFLG-ONEGZZNKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
162713,7bv1,DB02827,-8.1,"7-(1,1-Dioxo-1h-Benzo[D]Isothiazol-3-Yloxymethyl)-2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Pyran-3-Carboxylic Acid",MDYIGSPVMWSFEZ-JTQLQIEISA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
77835,6m2n,DB08861,-8.1,DPDPE,MCMMCRYPQBNCPH-WMIMKTLMSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
11539,6lzg,DB12108,-8.1,Taselisib,BEUQXVWXFDOSAQ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
57516,6crv,DB03771,-8.1,Allyl-{4-[3-(4-Bromo-Phenyl)-Benzofuran-6-Yloxy]-but-2-Enyl}-Methyl-Amine,KCNKJCHARANTIP-SNAWJCMRSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75071,6m2n,DB04205,-8.1,"Thymidine-3',5'-Diphosphate",CSNCBOPUCJOHLS-XLPZGREQSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
106121,6vxs,DB15062,-8.1,Inarigivir,LYMICVBGNUEHGE-FUQPUAIBSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
57507,6crv,DB03761,-8.1,5-Fluoro-2'-Deoxyuridine-5'-Monophosphate,HFEKDTCAMMOLQP-RRKCRQDMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29777,6cs2,DB11611,-8.1,Lifitegrast,JFOZKMSJYSPYLN-QHCPKHFHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
127673,6w4h,DB06660,-8.1,Saredutant,PGKXDIMONUAMFR-AREMUKBSSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
6817,6lzg,DB02741,-8.1,CD564,RWYREGSYPCNZTL-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
30042,6cs2,DB11969,-8.1,Uprosertib,AXTAPYRUEKNRBA-JTQLQIEISA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
10412,6lzg,DB08607,-8.1,"(5R)-5-(4-{[(2R)-6-HYDROXY-2,5,7,8-TETRAMETHYL-3,4-DIHYDRO-2H-CHROMEN-2-YL]METHOXY}BENZYL)-1,3-THIAZOLIDINE-2,4-DIONE",GXPHKUHSUJUWKP-NTKDMRAZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
139692,6w9c,DB13808,-8.1,Mebhydrolin,FQQIIPAOSKSOJM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
105959,6vxs,DB14674,-8.1,Estramustine phosphate,ADFOJJHRTBFFOF-RBRWEJTLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
139662,6w9c,DB13772,-8.1,Rufloxacin,NJCJBUHJQLFDSW-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
162506,7bv1,DB02360,-8.1,Bis-Napthyl Beta-Ketophosphonic Acid,OFHMUASCSJJNNA-JOCHJYFZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
27203,6cs2,DB06685,-8.1,Laquinimod,GKWPCEFFIHSJOE-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
77960,6m2n,DB09040,-8.1,Efinaconazole,NFEZZTICAUWDHU-RDTXWAMCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77951,6m2n,DB09020,-8.1,Bisacodyl,KHOITXIGCFIULA-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
162550,7bv1,DB02411,-8.1,"2-(11-{2-[Benzenesulfonyl-(3-Methyl-Butyl)-Amino]-1-Hydroxy-Ethyl}-6,9-Dioxo-2-Oxa-7,10-Diaza-Bicyclo[11.2.2]Heptadeca-1(16),13(17),14-Trien-8-Yl)-Acetamide, Inhibitor 2",HOUHLOFMBSYNBO-KKUQBAQOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
139659,6w9c,DB13767,-8.1,Vorozole,XLMPPFTZALNBFS-INIZCTEOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
30049,6cs2,DB11984,-8.1,Letaxaban,GEHAEMCVKDPMKO-HXUWFJFHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
74599,6m2n,DB03585,-8.1,Oxyphenbutazone,HFHZKZSRXITVMK-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
74954,6m2n,DB04059,-8.1,8-(Pyrimidin-2-Ylamino)Naphthalene-2-Carboximidamide,GRQLDCHTDNYVQI-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77875,6m2n,DB08932,-8.1,Macitentan,JGCMEBMXRHSZKX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
57676,6crv,DB03980,-8.1,4-(Fluorophenyl)-1-Cyclopropylmethyl-5-(2-Amino-4-Pyrimidinyl)Imidazole,DFEYXQGDDCDXJK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
125493,6w4h,DB02554,-8.1,"Sulfoquinovose-Uridine-C1,5'-Diphosphate",FQANCGQCBCUSMI-JZMIEXBBSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
74967,6m2n,DB04073,-8.1,N-{3-[4-(3-aminopropyl)piperazin-1-yl]propyl}-3-(beta-D-galactopyranosyloxy)-5-nitrobenzamide,UEIGEWJJVQHIAX-DLBZZEGUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
114261,6vxx,DB13208,-8.1,Prednylidene,WSVOMANDJDYYEY-CWNVBEKCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
162593,7bv1,DB02466,-8.1,"4-[3-Oxo-3-(5,5,8,8-Tetramethyl-5,6,7,8-Tetrahydro-Naphthalen-2-Yl)-Propenyl]-Benzoic Acid",ZXQHMEUGMCXKLO-KPKJPENVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
11596,6lzg,DB12183,-8.1,Sapitinib,DFJSJLGUIXFDJP-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
139622,6w9c,DB13717,-8.1,Phenothrin,SBNFWQZLDJGRLK-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
28065,6cs2,DB07638,-8.1,"(3AS,4R,9BR)-2,2-DIFLUORO-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL",QJSMFUTULGSHNQ-ZOBUZTSGSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
162619,7bv1,DB02498,-8.1,Carba-Nicotinamide-Adenine-Dinucleotide,DGPLSUKWXXSBCU-VGXGLJSLSA-O,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
57682,6crv,DB03987,-8.1,"2,4-Diamino-6-[N-(3',5'-Dimethoxybenzyl)-N-Methylamino]Pyrido[2,3-D]Pyrimidine",XWCCXDBXMCTZPW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106127,6vxs,DB15075,-8.1,4-demethyl-4-cholesteryloxycarbonylpenclomedine,ZJUUIXYKTPSIOH-LEZJFEBPSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
105382,6vxs,DB13422,-8.1,Nicofuranose,FUWFSXZKBMCSKF-ZASNTINBSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
74537,6m2n,DB03490,-8.1,"3-Pyridin-4-Yl-2,4-Dihydro-Indeno[1,2-.C.]Pyrazole",NHOACLCXCKJMAK-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
109135,6vxx,DB12420,-8.1,Diazepinomicin,SALVHVNECODMJP-GNUCVDFRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114179,6vxx,DB12861,-8.1,Rimeporide,GROMEQPXDKRRIE-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
11885,6lzg,DB12566,-8.1,Decernotinib,ASUGUQWIHMTFJL-QGZVFWFLSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
161964,7bv1,DB01025,-8.1,Amlexanox,SGRYPYWGNKJSDL-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
138070,6w9c,DB09119,-8.1,Eslicarbazepine acetate,QIALRBLEEWJACW-INIZCTEOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
11880,6lzg,DB12558,-8.1,AEE-788,OONFNUWBHFSNBT-HXUWFJFHSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
164470,7bv1,DB08042,-8.1,"N-4-methyl-N-4-(3-methyl-1H-indazol-6-yl)-N-2-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine",FLXGQDHYCWXTAI-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
74103,6m2n,DB02905,-8.1,"Phosphoric Acid Mono-[3,4-Dihydroxy-5-(5-Hydroxy-Benzoimidazol-1-Yl)Tetrahydro-Furan-2-Ylmethyl] Ester",BVZASCINAVSQNO-PULFBKJNSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138072,6w9c,DB09123,-8.1,Dienogest,AZFLJNIPTRTECV-FUMNGEBKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
162001,7bv1,DB01067,-8.1,Glipizide,ZJJXGWJIGJFDTL-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
78599,6m2n,DB11994,-8.1,Diacerein,TYNLGDBUJLVSMA-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
162007,7bv1,DB01074,-8.1,Perhexiline,CYXKNKQEMFBLER-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
164461,7bv1,DB07857,-8.1,(2R)-2-(4-chlorophenyl)-2-[4-(1H-pyrazol-4-yl)phenyl]ethanamine,HWVGILTYGZFGLR-QGZVFWFLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
127905,6w4h,DB06994,-8.1,"(2S,3S)-3-{3-[2-chloro-4-(methylsulfonyl)phenyl]-1,2,4-oxadiazol-5-yl}-1-cyclopentylidene-4-cyclopropyl-1-fluorobutan-2-amine",XCCSSVMRGIQMGF-LPHOPBHVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
104902,6vxs,DB12682,-8.1,Mubritinib,ZTFBIUXIQYRUNT-MDWZMJQESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
58172,6crv,DB04642,-8.1,"7-{2,6-DICHLORO-4-[3-(2-CHLORO-BENZOYL)-UREIDO]-PHENOXY}-HEPTANOIC ACID",XQTOWNDCHQJXOQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78593,6m2n,DB11985,-8.1,Dapaconazole,FUAHXHWSMYFWGE-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78589,6m2n,DB11978,-8.1,Glasdegib,SFNSLLSYNZWZQG-VQIMIIECSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
55513,6crv,DB01091,-8.1,Butenafine,ABJKWBDEJIDSJZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138091,6w9c,DB09172,-8.1,Brifentanil,KKMGCTVJCQYQPV-WBVHZDCISA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
104943,6vxs,DB12744,-8.1,CGI-1842,ZXBFYBLSJMEBEP-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104827,6vxs,DB12565,-8.1,Abexinostat,MAUCONCHVWBMHK-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104945,6vxs,DB12746,-8.1,AKN-028,JLRIJKVMMZEKDF-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
116986,6w4b,DB02877,-8.1,Arotinoid acid,FOIVPCKZDPCJJY-JQIJEIRASA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
26982,6cs2,DB06194,-8.1,Elocalcitol,LRLWXBHFPGSUOX-GJQYOBCGSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
104738,6vxs,DB12428,-8.1,PAC-14028,UKGJZDSUJSPAJL-YPUOHESYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
73947,6m2n,DB02698,-8.1,"N-(M-Trifluoromethylphenyl) Phenoxazine-4,6-Dicarboxylic Acid",NQOOJFXBGLOGTC-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
58267,6crv,DB04776,-8.1,(2R)-2-({6-[benzyl(methyl)amino]-9-isopropyl-9H-purin-2-yl}amino)butan-1-ol,YPYWONAECUVKHY-MRXNPFEDSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
73951,6m2n,DB02703,-8.1,Fusidic acid,IECPWNUMDGFDKC-MZJAQBGESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
161782,7bv1,DB00591,-8.1,Fluocinolone acetonide,FEBLZLNTKCEFIT-VSXGLTOVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
26957,6cs2,DB06148,-8.1,Mianserin,UEQUQVLFIPOEMF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
104753,6vxs,DB12448,-8.1,Lifibrol,LNXBEIZREVRNTF-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
58258,6crv,DB04763,-8.1,"1-N-(4-SULFAMOYLPHENYL-ETHYL)-2,4,6-TRIMETHYLPYRIDINIUM",UXBCHTZINZNVRG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28146,6cs2,DB07724,-8.1,Indeglitazar,YMPALHOKRBVHOJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
137953,6w9c,DB08950,-8.1,Indoramin,JXZZEXZZKAWDSP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
104758,6vxs,DB12459,-8.1,Belotecan,LNHWXBUNXOXMRL-VWLOTQADSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
139899,6w9c,DB14221,-8.1,Beclomethasone 17-monopropionate,OHYGPBKGZGRQKT-XGQKBEPLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
58250,6crv,DB04753,-8.1,"9-DEAZAINOSINE-2',3'-O-ETHYLIDENEPHOSPHONATE",ZOEDLCUBOBTIHG-USQSKNHBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55489,6crv,DB01063,-8.1,Acetophenazine,WNTYBHLDCKXEOT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138014,6w9c,DB09017,-8.1,Brotizolam,UMSGKTJDUHERQW-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
55492,6crv,DB01066,-8.1,Cefditoren,KMIPKYQIOVAHOP-YLGJWRNMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
161855,7bv1,DB00682,-8.1,Warfarin,PJVWKTKQMONHTI-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
74000,6m2n,DB02770,-8.1,7-Alpha-D-Ribofuranosyl-2-Aminopurine-5'-Phosphate,UDRQVOJQMHZSIM-PULFBKJNSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
104801,6vxs,DB12524,-8.1,BI-671800,XEOSTBFUCNZKGS-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
117131,6w4b,DB03072,-8.1,"2-{3-[4-(4-Fluorophenyl)-3,6-Dihydro-1(2h)-Pyridinyl]Propyl}-8-Methyl-4(3h)-Quinazolinone",LOFDUAJQRUYHBR-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
104812,6vxs,DB12542,-8.1,GSK-356278,AWDJJMXJUOHGLC-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104821,6vxs,DB12555,-8.1,Nelotanserin,COSPVUFTLGQDQL-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
11833,6lzg,DB00950,-8.1,Fexofenadine,RWTNPBWLLIMQHL-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
104966,6vxs,DB12784,-8.1,NS-018,UQTPDWDAYHAZNT-AWEZNQCLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104970,6vxs,DB12792,-8.1,Boscalid,WYEMLYFITZORAB-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
125306,6w4h,DB02323,-8.1,EM-1745,CKSDYJASHNGOOS-KTXOUVACSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
127792,6w4h,DB06860,-8.1,"2-(2-chloropyridin-4-yl)-4-methyl-1H-isoindole-1,3(2H)-dione",YDJMWNHJNJVVMM-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
116820,6w4b,DB02651,-8.1,"{[2-(1h-1,2,3-Benzotriazol-1-Yl)-2-(3,4-Difluorophenyl)Propane-1,3-Diyl]Bis[4,1-Phenylene(Difluoromethylene)]}Bis(Phosphonic Acid)",BTAGTGWPDROBMG-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
74459,6m2n,DB03376,-8.1,'5'-O-(N-(L-Alanyl)-Sulfamoyl)Adenosine,CWWYMWDIYBJVLP-YTMOPEAISA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
57994,6crv,DB04409,-8.1,Naphthalene Trisulfonate,ZPBSAMLXSQCSOX-UHFFFAOYSA-K,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
139775,6w9c,DB13957,-8.1,J147,HYMZAYGFKNNHDN-SSDVNMTOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
30109,6cs2,DB12063,-8.1,CERC-301,RECBFDWSXWAXHY-IAGOWNOFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
105188,6vxs,DB13126,-8.1,BMS-986115,SRJNRAQUSAVENA-GSHUGGBRSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
162134,7bv1,DB01479,-8.1,BA-2664,QGKQXZFZOIQFBI-XSWYFRFISA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
162153,7bv1,DB01501,-8.1,Difenoxin,UFIVBRCCIRTJTN-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
162176,7bv1,DB01530,-8.1,"5alpha-androstane-3alpha,17beta-diol",CBMYJHIOYJEBSB-KHOSGYARSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
10351,6lzg,DB08537,-8.1,"3-bromo-6-phenyl-N-(pyrimidin-5-ylmethyl)imidazo[1,2-a]pyridin-8-amine",LZLKFNBMXXLTLX-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
162178,7bv1,DB01532,-8.1,alpha-Methylacetylfentanyl,OKTLVZBUKMRPLL-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
138359,6w9c,DB11464,-8.1,Sulfaquinoxaline,NHZLNPMOSADWGC-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
28110,6cs2,DB07686,-8.1,"4-{[5-(CYCLOHEXYLAMINO)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE",VPOGRVWIIVMWRI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
162203,7bv1,DB01557,-8.1,alpha-Methylfentanyl,NGTVDHYUFBKWID-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
109075,6vxx,DB12000,-8.1,Apabetalone,NETXMUIMUZJUTB-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
116749,6w4b,DB02555,-8.1,SP4160,VCXMTWSYQSVWRK-AREMUKBSSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
27096,6cs2,DB06457,-8.1,Tecastemizole,SFOVDSLXFUGAIV-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
162216,7bv1,DB01570,-8.1,Ohmefentanyl,FRPRNNRJTCONEC-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
78391,6m2n,DB11686,-8.1,Iferanserin,UXIPFQUBOVWAQW-UEBLJOKOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
30113,6cs2,DB12070,-8.1,Letermovir,FWYSMLBETOMXAG-QHCPKHFHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
58036,6crv,DB04468,-8.1,Afimoxifene,TXUZVZSFRXZGTL-QPLCGJKRSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27063,6cs2,DB06368,-8.1,Alamifovir,VDBGPMJFHCJMOL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
74396,6m2n,DB03296,-8.1,3'-beta-Sialyl-beta-lactose,CILYIEBUXJIHCO-LPTWSRJFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138097,6w9c,DB09179,-8.1,R-30490,GARXJOUQUSNOGK-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
30148,6cs2,DB12114,-8.1,Poziotinib,LPFWVDIFUFFKJU-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
104999,6vxs,DB12843,-8.1,Oleandrin,JLPDBLFIVFSOCC-XYXFTTADSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
105000,6vxs,DB12846,-8.1,Reproterol,WVLAAKXASPCBGT-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
11817,6lzg,DB12468,-8.1,Pf-04531083,ZRJGMDIPCQOGNI-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
10317,6lzg,DB08500,-8.1,"(3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(2-naphthyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol",ZCJBDRSKHARECB-PYTCMNEWSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
138144,6w9c,DB09230,-8.1,Azelnidipine,ZKFQEACEUNWPMT-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
114180,6vxx,DB12863,-8.1,Sivelestat,BTGNGJJLZOIYID-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138186,6w9c,DB09292,-8.1,Sacubitril,PYNXFZCZUAOOQC-UTKZUKDTSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138189,6w9c,DB09299,-8.1,Tenofovir alafenamide,LDEKQSIMHVQZJK-CAQYMETFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
10363,6lzg,DB08549,-8.1,"(3R)-METHYLCARBAMOYL-7-SULFOAMINO-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLIC ACID BENZYL ESTER",MFDBNNQUDZFSES-KRWDZBQOSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
105044,6vxs,DB12910,-8.1,Emicerfont,JFHJGXQFESYQGY-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
125245,6w4h,DB02241,-8.1,"8-Benzyl-2-Hydroperoxy-2-(4-Hydroxy-Benzyl)-6-(4-Hydroxy-Phenyl)-2h-Imidazo[1,2-a]Pyrazin-3-One",HOSWCJDTHOAORT-SANMLTNESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
74321,6m2n,DB03202,-8.1,"2-[5-Methanesulfonylamino-2-(4-Aminophenyl)-6-Oxo-1,6-Dihydro-1-Pyrimidinyl]-N-(3,3,3-Trifluoro-1-Isopropyl-2-Oxopropyl)Acetamide",JWSWTHSJMGVOKE-HNNXBMFYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
58074,6crv,DB04517,-8.1,Dipyrromethane Cofactor,LCAXMKQKEYTFDM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
162042,7bv1,DB01347,-8.1,Saprisartan,DUEWVPTZCSAMNB-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
74337,6m2n,DB03220,-8.1,FR233623,OODDZQQDDOVCFD-SCLBCKFNSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
74350,6m2n,DB03235,-8.1,N-{3-[4-(3-aminopropyl)piperazin-1-yl]propyl}-3-(alpha-D-galactopyranosyloxy)-5-nitrobenzamide,UEIGEWJJVQHIAX-MKQKURRLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138273,6w9c,DB11259,-8.1,Diosmetin,MBNGWHIJMBWFHU-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
78488,6m2n,DB11827,-8.1,Ertugliflozin,MCIACXAZCBVDEE-CUUWFGFTSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
28123,6cs2,DB07701,-8.1,"1-BENZYL-4-[(5,6-DIMETHOXY-1-INDANON-2-YL)METHYL]PIPERIDINE",ADEBPBSSDYVVLD-HXUWFJFHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
30129,6cs2,DB12092,-8.1,Naftopidil,HRRBJVNMSRJFHQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
30137,6cs2,DB12100,-8.1,Abediterol,SFYAXIFVXBKRPK-QFIPXVFZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
55014,6crv,DB00500,-8.1,Tolmetin,UPSPUYADGBWSHF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55907,6crv,DB01622,-8.1,Thioproperazine,VZYCZNZBPPHOFY-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
134958,6w9c,DB03797,-8.1,3-Aminomethyl-Pyridinium-Adenine-Dinucleotide,HMCRLFVYYFBZEZ-PLEFRAQWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
165354,7bv1,DB11978,-8.1,Glasdegib,SFNSLLSYNZWZQG-VQIMIIECSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
89758,6m71,DB00862,-8.1,Vardenafil,SECKRCOLJRRGGV-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
28784,6cs2,DB08399,-8.1,PICEATANNOL,CDRPUGZCRXZLFL-OWOJBTEDSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
112713,6vxx,DB07760,-8.1,"3-[(1E,7E)-8-(2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)-3,6-dioxa-2,7-diazaocta-1,7-dien-1-yl]benzoic acid",TUYDQQMKXSQIQG-GONBZBRSSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
33311,6cs2,T3D4504,-8.1,Famoxadone,PCCSBWNGDMYFCW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
61557,6crv,DB12262,-8.1,CRS-3123,NNTYBKTXMKBRFA-CQSZACIVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
89945,6m71,DB01076,-8.1,Atorvastatin,XUKUURHRXDUEBC-KAYWLYCHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
68136,6lxt,DB07563,-8.1,"1-{7-cyclohexyl-6-[4-(4-methylpiperazin-1-yl)benzyl]-7H-pyrrolo[2,3-d]pyrimidin-2-yl}methanamine",GCJSOJRPNOWSEH-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
68115,6lxt,DB07538,-8.1,"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}-2-(TRIFLUOROMETHYL)BENZENESULFONAMIDE",RGVVHQNJKUNSFQ-WDZFZDKYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
33344,6cs2,T3D4536,-8.1,Spirodiclofen,OYNVHVAEOLJJPV-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
64962,6lxt,DB02217,-8.1,Dpb-T,WTZFKHNHHRPQOU-WSMBLCCSSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
112219,6vxx,DB06609,-8.1,Odiparcil,JRHNIQQUVJOPQC-AQNFWKISSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
145851,6w9q,DB07833,-8.1,"N-(3-cyanophenyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)-4-biphenylcarboxamide",PMMLSQFPBFKLHH-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
134832,6w9c,DB03622,-8.1,"2-Hydroxy-5-[4-(2-Hydroxy-Ethyl)-Piperidin-1-Yl]-5-Phenyl-1h-Pyrimidine-4,6-Dione",IPBPOBHSNJFRFT-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
149194,6w9q,DB15126,-8.1,IMG-7289,KQKBMHGOHXOHTD-KKUQBAQOSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
84565,6m3m,DB06499,-8.1,Furaprofen,ODZUWQAFWMLWCF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
64918,6lxt,DB02154,-8.1,"2,3-Bis-Benzo[1,3]Dioxol-5-Ylmethyl-Succinic Acid",FFYBYVPVYLMLAR-KBPBESRZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
31327,6cs2,DB13682,-8.1,Cefpirome,DKOQGJHPHLTOJR-WHRDSVKCSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
90006,6m71,DB01147,-8.1,Cloxacillin,LQOLIRLGBULYKD-JKIFEVAISA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
84548,6m3m,DB06458,-8.1,Remacemide,YSGASDXSLKIKOD-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
142347,6w9q,DB02081,-8.1,Bis-Benzamidine,BXYGSMRTHHSAHZ-PMACEKPBSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
61574,6crv,DB12283,-8.1,Balapiravir,VKXWOLCNTHXCLF-DXEZIKHYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
24787,6cs2,DB02583,-8.1,"N6-(2,5-Dimethoxy-Benzyl)-N6-Methyl-Pyrido[2,3-D]Pyrimidine-2,4,6-Triamine",HZTFNSCZLJLPEO-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
149121,6w9q,DB14944,-8.1,Tarloxotinib,MUJMYVFVAWFUJL-SNAWJCMRSA-O,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
89416,6m71,DB00450,-8.1,Droperidol,RMEDXOLNCUSCGS-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
123356,6w4b,DB15385,-8.1,Acebilustat,GERJIEKMNDGSCS-DQEYMECFSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
68050,6lxt,DB07460,-8.1,2-({5-CHLORO-2-[(2-METHOXY-4-MORPHOLIN-4-YLPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)-N-METHYLBENZAMIDE,UYJNQQDJUOUFQJ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
89471,6m71,DB00522,-8.1,Bentiromide,SPPTWHFVYKCNNK-FQEVSTJZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
89529,6m71,DB00590,-8.1,Doxazosin,RUZYUOTYCVRMRZ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
145946,6w9q,DB07945,-8.1,"5-(3-carbamoylbenzyl)-5,6,7,8,9,10-hexahydrocyclohepta[b]indole-4-carboxylic acid",GKBQRPKZHUFGOB-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
62887,6crv,DB14659,-8.1,Melengestrol acetate,UDKABVSQKJNZBH-DWNQPYOZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
123358,6w4b,DB15393,-8.1,Telatinib,QFCXANHHBCGMAS-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
131980,6w4h,DB15141,-8.1,Deutivacaftor,PURKAOJPTOLRMP-ASMGOKTBSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
89607,6m71,DB00687,-8.1,Fludrocortisone,AAXVEMMRQDVLJB-BULBTXNYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
134761,6w9c,DB03509,-8.1,2-(4-Chlorophenyl)-5-Quinoxalinecarboxamide,FLYGLPYJEQPCFY-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
61579,6crv,DB12288,-8.1,Piromelatine,PNTNBIHOAPJYDB-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61577,6crv,DB12286,-8.1,Simendan,WHXMKTBCFHIYNQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113117,6vxx,DB08557,-8.1,"2-[(2-methoxyethyl)amino]-4-(4-oxo-1,2,3,4-tetrahydro-9H-carbazol-9-yl)benzamide",XQKFKSJUBJPOLY-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113123,6vxx,DB08564,-8.1,(2E)-N-{4-[(3-bromophenyl)amino]quinazolin-6-yl}-4-(dimethylamino)but-2-enamide,ZCIXBBSRVLSRJQ-QPJJXVBHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85786,6m3m,DB08061,-8.1,4-[3-(4-CHLOROPHENYL)-1H-PYRAZOL-5-YL]PIPERIDINE,GELALLNTKKLQLM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
68058,6lxt,DB07471,-8.1,"5-[5,6-BIS(METHYLOXY)-1H-BENZIMIDAZOL-1-YL]-3-{[1-(2-CHLOROPHENYL)ETHYL]OXY}-2-THIOPHENECARBOXAMIDE",UHCHLTQBLNUYRT-GFCCVEGCSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
32124,6cs2,DB15406,-8.1,GLPG-0974,MPMKMQHJHDHPBE-RUZDIDTESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
90100,6m71,DB01260,-8.1,Desonide,WBGKWQHBNHJJPZ-LECWWXJVSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
28773,6cs2,DB08388,-8.1,"5-(2-ETHOXYETHYL)-5-[4-(4-FLUOROPHENOXY)PHENOXY]PYRIMIDINE-2,4,6(1H,3H,5H)-TRIONE",XRSYNYGEEYTXJV-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
90435,6m71,DB01732,-8.1,"(4r,5s,6s,7r)-1,3-Dibenzyl-4,7-Bis(Phenoxymethyl)-5,6-Dihydroxy-1,3 Diazepan-2-One",SQBOSZXDOHQFAA-ZRTHHSRSSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
61481,6crv,DB12147,-8.1,Erdafitinib,OLAHOMJCDNXHFI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113175,6vxx,DB08631,-8.1,"N-(4-CHLOROPHENYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONAMIDE",UVSIFVBCHJEYJP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
24878,6cs2,DB02691,-8.1,Glycocholic acid,RFDAIACWWDREDC-FRVQLJSFSA-M,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
90467,6m71,DB01772,-8.1,"3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl]-4-(5-Fluoro-1-Methyl-1h-Indol-3-Yl)-Pyrrole-2,5-Dione",RPGZQOOZHIEPJW-HNNXBMFYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
68352,6lxt,DB07817,-8.1,"1-{3-[(4-pyridin-2-ylpiperazin-1-yl)sulfonyl]phenyl}-3-(1,3-thiazol-2-yl)urea",NJPVZSIGDRLLTD-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
129660,6w4h,DB09128,-8.1,Brexpiprazole,ZKIAIYBUSXZPLP-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
33452,6cs2,T3D4695,-8.1,Etoposide,VJJPUSNTGOMMGY-MRVIYFEKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
90428,6m71,DB01720,-8.1,(2z)-2-(Benzoylamino)-3-[4-(2-Bromophenoxy)Phenyl]-2-Propenoic Acid,WLPJLQNKCJWAFL-RGEXLXHISA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
135099,6w9c,DB03982,-8.1,"Compound 5, 2-(Naphthalen-1-Yl-Oxalyl-Amino)-Benzoicacid",WQWCUHJIERBOSM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
64806,6lxt,DB02008,-8.1,1-(2-Fluorobenzyl)-3-Butyl-8-(N-Acetyl-4-Aminobenzyl)-Xanthine,JHSHXKJSPVHPCJ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
61468,6crv,DB12128,-8.1,Ulimorelin,WGYPAJVJMXQXTR-ABNZCKJZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
68364,6lxt,DB07831,-8.1,"2-{[(6-OXO-1,6-DIHYDROPYRIDIN-3-YL)METHYL]AMINO}-N-[4-PROPYL-3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE",SHSORWZDEKFFLP-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
31272,6cs2,DB00197,-8.1,Troglitazone,GXPHKUHSUJUWKP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
90723,6m71,DB02115,-8.1,Daidzin,KYQZWONCHDNPDP-QNDFHXLGSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
165870,7bv1,DB13138,-8.1,Neladenoson bialanate,WESNEIGKOAXSGX-VXKWHMMOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
68377,6lxt,DB07847,-8.1,6-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-(4-MORPHOLINYL)-2-OXO ETHYL]-2-OXO-3-PYRROLIDINYL}-2-NAPHTHALENESULFONAMIDE,ICLOZQFWTRAYPX-LIRRHRJNSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
68378,6lxt,DB07848,-8.1,5-Chloro-N-{(3S)-1-[(2S)-1-(4-morpholinyl)-1-oxo-2-propanyl]-2-oxo-3-pyrrolidinyl}-1H-indole-2-sulfonamide,BHNMMFGOJRIAEZ-LRDDRELGSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
28760,6cs2,DB08371,-8.1,PARA-(BENZOYL)-PHENYLALANINE,TVIDEEHSOPHZBR-AWEZNQCLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
111473,6vxx,DB03917,-8.1,N-Ethyl Retinamide,WKYDOCGICAMTKE-NBIQJRODSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
129673,6w4h,DB09168,-8.1,4-Phenylfentanyl,BXCJXJLHYMWMQU-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
68348,6lxt,DB07813,-8.1,GLYCYLALANYL-N-2-NAPHTHYL-L-PROLINEAMIDE,KCELZXZDIUJGNM-GUYCJALGSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
134923,6w9c,DB03742,-8.1,Compound 4-D,TWZNCTCQAGRUGQ-RRPNLBNLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
90133,6m71,DB01337,-8.1,Pancuronium,GVEAYVLWDAFXET-XGHATYIMSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
24071,6cs2,DB01734,-8.1,3-(Oxalyl-Amino)-Naphthalene-2-Carboxylic Acid,DQBLKSRRWDWNKQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
68246,6lxt,DB07697,-8.1,"1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-4-[(4-methoxyphenyl)sulfonyl]piperazine",HMGDKYUJSFVHIY-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
128794,6w4h,DB08023,-8.1,"N-cyclohexyl-4-imidazo[1,2-a]pyridin-3-yl-N-methylpyrimidin-2-amine",HYNNWLVWJXWXFO-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
16098,6lzg,DB02704,-8.1,"(2r,3r,4r,5r)-3,4-Dihydroxy-N,N'-Bis[(1s,2r)-2-Hydroxy-2,3-Dihydro-1h-Inden-1-Yl]-2,5-Bis(2-Phenylethyl)Hexanediamide",GQKBYZPVKVXMJL-LAFNQVRVSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
90164,6m71,DB01405,-8.1,Temafloxacin,QKDHBVNJCZBTMR-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
90165,6m71,DB01406,-8.1,Danazol,POZRVZJJTULAOH-LHZXLZLDSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
165343,7bv1,DB11961,-8.1,AZD-1236,SFJFBTPHDHUUPU-OAHLLOKOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
149267,6w9q,DB15273,-8.1,VS-4718,IGUBBWJDMLCRIK-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
111479,6vxx,DB03925,-8.1,Freselestat,HMPQTEPEMQZWQH-QZTJIDSGSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31310,6cs2,DB13665,-8.1,Fluanisone,IRYFCWPNDIUQOW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
84507,6m3m,DB06335,-8.1,Saxagliptin,QGJUIPDUBHWZPV-SGTAVMJGSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85824,6m3m,DB08105,-8.1,N-[(6-butoxynaphthalen-2-yl)sulfonyl]-L-glutamic acid,UAGYXJBYAFGRFR-KRWDZBQOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
113168,6vxx,DB08619,-8.1,Testosterone succinate,CJQNBXFUHQZFOE-VYAQIDIUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
90388,6m71,DB01668,-8.1,Nanaomycin D,XUWPJKDMEZSVTP-UOSCCXBLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
135058,6w9c,DB03926,-8.1,"5-Alpha-Androstane-3-Beta,17-Alpha-Diol",CBMYJHIOYJEBSB-MFXFBURESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
84488,6m3m,DB06276,-8.1,Tanomastat,JXAGDPXECXQWBC-LJQANCHMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
149289,6w9q,DB15310,-8.1,Vactosertib,FJCDSQATIJKQKA-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
123355,6w4b,DB15382,-8.1,SAR-125844,ODIUNTQOXRXOIV-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
149119,6w9q,DB14942,-8.1,BMS-986141,KEEBLYWBELVGPQ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
33174,6cs2,T3D4232,-8.1,Cylindrospermopsin,LHJPHMKIGRLKDR-VDPNAHCISA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
84639,6m3m,DB06680,-8.1,Asoprisnil,GJMNAFGEUJBOCE-MEQIQULJSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
165848,7bv1,DB13102,-8.1,AZD-8418,MCPBSUCAISQZQK-JTQLQIEISA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
111661,6vxx,DB04345,-8.1,Lumichrome,ZJTJUVIJVLLGSP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
65150,6lxt,DB02455,-8.1,Fluoresceinylthioureido,VHJFQSRUDVDTEO-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
131942,6w4h,DB15065,-8.1,PF-06291874,IBDYYOQKQCCSDP-QFIPXVFZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
148205,6w9q,DB13095,-8.1,JTK-853,JQLOVYLALGSISI-HXUWFJFHSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
111657,6vxx,DB04338,-8.1,SB220025,VSPFURGQAYMVAN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
33060,6cs2,T3D4022,-8.1,Sanguinarine,INVGWHRKADIJHF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
67858,6lxt,DB07244,-8.1,"5-{4-[(3,5-DIFLUOROBENZYL)AMINO]PHENYL}-6-ETHYLPYRIMIDINE-2,4-DIAMINE",SRRWXMSVQYQCRX-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
130094,6w4h,DB11765,-8.1,PF-04991532,GKMLFBRLRVQVJO-ZDUSSCGKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
6163,6lzg,DB01661,-8.1,1-(5-phospho-D-ribosyl)-ATP,RKNHJBVBFHDXGR-MRUDJCSFSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
165540,7bv1,DB12428,-8.1,PAC-14028,UKGJZDSUJSPAJL-YPUOHESYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
89012,6m3m,DB15288,-8.1,Etamicastat,CWWWTTYMUOYSQA-LLVKDONJSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
61704,6crv,DB12464,-8.1,Bevenopran,ZGCYVRNZWGUXNQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
134558,6w9c,DB03234,-8.1,"(4'-{[Allyl(Methyl)Amino]Methyl}-1,1'-Biphenyl-4-Yl)(4-Bromophenyl)Methanone",YATCZCSDJCQNAL-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
89022,6m3m,DB15300,-8.1,Hydroquinidine,LJOQGZACKSYWCH-LHHVKLHASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
31474,6cs2,DB13855,-8.1,Nifuroxazide,YCWSUKQGVSGXJO-NTUHNPAUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
131958,6w4h,DB15099,-8.1,GW-468816,XDKRVNKVAKCFGW-WXWBBQJKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
148586,6w9q,DB13649,-8.1,Proquazone,JTIGKVIOEQASGT-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
84772,6m3m,DB06884,-8.1,4-HYDROXY-N'-(4-ISOPROPYLBENZYL)BENZOHYDRAZIDE,MFDXHRPPSJRQFX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
133226,6w9c,DB01431,-8.1,Allylestrenol,ATXHVCQZZJYMCF-XUDSTZEESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
28820,6cs2,DB08440,-8.1,"N-1,10-phenanthrolin-5-ylacetamide",AAJXINSCZMZERD-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
130099,6w4h,DB11772,-8.1,Pilaralisib,QINPEPAQOBZPOF-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
85713,6m3m,DB07981,-8.1,2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]-n-[(1R)-1-(hydroxymethyl)propyl]acetamide,GKJWXEORYGBJFS-QGZVFWFLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
130149,6w4h,DB11841,-8.1,Entinostat,INVTYAOGFAGBOE-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
112727,6vxx,DB07776,-8.1,Flavone,VHBFFQKBGNRLFZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
134494,6w9c,DB03154,-8.1,{[7-(Difluoro-Phosphono-Methyl)-Naphthalen-2-Yl]-Difluoro-Methyl}-Phosphonic Acid,VHKBLEYUHBIBNR-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
130145,6w4h,DB11832,-8.1,Crenolanib,DYNHJHQFHQTFTP-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
84803,6m3m,DB06918,-8.1,2-(2-METHYLPHENYL)-1H-INDOLE-6-CARBOXIMIDAMIDE,ZRYXDGAKQGRHFG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
130142,6w4h,DB11829,-8.1,Ruboxistaurin,ZCBUQCWBWNUWSU-SFHVURJKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130140,6w4h,DB11827,-8.1,Ertugliflozin,MCIACXAZCBVDEE-CUUWFGFTSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
111682,6vxx,DB04376,-8.1,13-Acetylphorbol,SDSVJYOOAPRSDA-RPCQODIISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88938,6m3m,DB15138,-8.1,AZD-9496,DFBDRVGWBHBJNR-BBNFHIFMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88946,6m3m,DB15152,-8.1,TMC-649128,XJBILYMRFVHPJB-XJQUKVTJSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
131936,6w4h,DB15056,-8.1,Bifenthrin,OMFRMAHOUUJSGP-IRHGGOMRSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
111675,6vxx,DB04366,-8.1,3'-Deoxy 3'-Amino Adenosine-5'-Diphosphate,VKODIDNZKBYXJO-QYYRPYCUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
148126,6w9q,DB12973,-8.1,Serlopitant,FLNYCRJBCNNHRH-OIYLJQICSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
67790,6lxt,DB07162,-8.1,4-(3-amino-1H-indazol-5-yl)-N-tert-butylbenzenesulfonamide,KFJCXIOVAGJCKB-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
67802,6lxt,DB07175,-8.1,N-{2-methyl-5-[(6-phenylpyrimidin-4-yl)amino]phenyl}methanesulfonamide,CXQRKICWSCAUGW-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
8785,6lzg,DB06834,-8.1,"N-(2-hydroxy-1,1-dimethylethyl)-1-methyl-3-(1H-pyrrolo[2,3-b]pyridin-2-yl)-1H-indole-5-carboxamide",XZRYCTLOGNCQDG-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
29282,6cs2,DB00831,-8.1,Trifluoperazine,ZEWQUBUPAILYHI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
148163,6w9q,DB13029,-8.1,MK-0873,JJWKQXNHYDJXKF-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
129966,6w4h,DB11511,-8.1,Difloxacin,NOCJXYPHIIZEHN-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
24061,6cs2,DB01720,-8.1,(2z)-2-(Benzoylamino)-3-[4-(2-Bromophenoxy)Phenyl]-2-Propenoic Acid,WLPJLQNKCJWAFL-RGEXLXHISA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
33073,6cs2,T3D4042,-8.1,alpha-Solanine,ZGVSETXHNHBTRK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
67921,6lxt,DB07311,-8.1,"18-CHLORO-11,12,13,14-TETRAHYDRO-1H,10H-8,4-(AZENO)-9,15,1,3,6-BENZODIOXATRIAZACYCLOHEPTADECIN-2-ONE",JRSWWYITYIOHOP-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
89204,6m71,DB00197,-8.1,Troglitazone,GXPHKUHSUJUWKP-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
149020,6w9q,DB14729,-8.1,Rebeccamycin,QEHOIJJIZXRMAN-QZQSLCQPSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
149036,6w9q,DB14766,-8.1,Etrasimod,MVGWUTBTXDYMND-QGZVFWFLSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
134677,6w9c,DB03388,-8.1,"3-[(2,4-Dichlorobenzoyl)(Isopropyl)Amino]-5-Phenylthiophene-2-Carboxylic Acid",UKNZREOUDLFUFF-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
113104,6vxx,DB08542,-8.1,"3,4-dihydroxy-9,10-secoandrosta-1(10),2,4-triene-9,17-dione",YUHVBHDSVLKFNI-NJSLBKSFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87222,6m3m,DB12009,-8.1,GW-406381,NXMZBNYLCVTRGB-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
165363,7bv1,DB11992,-8.1,Omarigliptin,MKMPWKUAHLTIBJ-ISTRZQFTSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
24098,6cs2,DB01764,-8.1,Dalfopristin,SUYRLXYYZQTJHF-VMBLUXKRSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
89189,6m71,DB00180,-8.1,Flunisolide,XSFJVAJPIHIPKU-XWCQMRHXSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
89246,6m71,DB00247,-8.1,Methysergide,KPJZHOPZRAFDTN-NQUBZZJWSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
89294,6m71,DB00303,-8.1,Ertapenem,JUZNIMUFDBIJCM-ANEDZVCMSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
89313,6m71,DB00324,-8.1,Fluorometholone,FAOZLTXFLGPHNG-KNAQIMQKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
85747,6m3m,DB08017,-8.1,3-METHOXY-6-[4-(3-METHYLPHENYL)-1-PIPERAZINYL]PYRIDAZINE,DDOAUTHWSCUHQA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
149093,6w9q,DB14895,-8.1,Vibegron,DJXRIQMCROIRCZ-XOEOCAAJSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
68027,6lxt,DB07434,-8.1,HONH-BENZYLMALONYL-L-ALANYLGLYCINE-P-NITROANILIDE,TZWQPWGUQCSKDW-GUYCJALGSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
87217,6m3m,DB12004,-8.1,Briciclib,LXENKEWVEVKKGV-BQYQJAHWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
31855,6cs2,DB14885,-8.1,PF-05180999,CLGCHUKGBICQTE-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
165777,7bv1,DB12999,-8.1,MK-6186,FZBAOOQVQXATRL-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
165357,7bv1,DB11984,-8.1,Letaxaban,GEHAEMCVKDPMKO-HXUWFJFHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
84681,6m3m,DB06739,-8.1,Seratrodast,ZBVKEHDGYSLCCC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
89168,6m71,DB00158,-8.1,Folic acid,OVBPIULPVIDEAO-LBPRGKRZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
89119,6m3m,DB09170,-8.1,β-Hydroxythiofentanyl,GLAAETOTOUGGSB-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84718,6m3m,DB06816,-8.1,Pyrvinium,QMHSXPLYMTVAMK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
129862,6w4h,DB11263,-8.1,Polydatin,HSTZMXCBWJGKHG-CUYWLFDKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
148785,6w9q,DB13950,-8.1,WIN 55212-2,HQVHOQAKMCMIIM-HXUWFJFHSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
67966,6lxt,DB07360,-8.1,"1-{5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)ethyl]-1,3-thiazol-2-yl}-3-[3-(trifluoromethyl)phenyl]urea",JJHXPDTVQKWKHA-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
67967,6lxt,DB07362,-8.1,"1-(5-{2-[(1-methyl-1H-pyrazolo[4,3-d]pyrimidin-7-yl)amino]ethyl}-1,3-thiazol-2-yl)-3-[3-(trifluoromethyl)phenyl]urea",UOLCZAFAGDOUFX-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
145986,6w9q,DB07991,-8.1,N-[(1R)-3-(4-HYDROXYPHENYL)-1-METHYLPROPYL]-2-(2-PHENYL-1H-INDOL-3-YL)ACETAMIDE,APLJSSOXDWUNGV-GOSISDBHSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
148818,6w9q,DB14017,-8.1,H3B-8800,YOIQWBAHJZGRFW-WVRLKXNASA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
113096,6vxx,DB08369,-8.1,1-(biphenyl-4-ylmethyl)-1H-imidazole,DLYMRVCQTVOYEW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
129800,6w4h,DB09378,-8.1,Fluprednisolone,MYYIMZRZXIQBGI-HVIRSNARSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
89094,6m3m,DB15449,-8.1,Citarinostat,VLIUIBXPEDFJRF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84688,6m3m,DB06751,-8.1,Drotaverine,OMFNSKIUKYOYRG-MOSHPQCFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
131959,6w4h,DB15102,-8.1,Pemigatinib,HCDMJFOHIXMBOV-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
29889,6cs2,DB11773,-8.1,BMS-903452,OGIAVRWXUPYGGC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
65095,6lxt,DB02388,-8.1,"Cyclohexyl-{4-[5-(3,4-Dichlorophenyl)-2-Piperidin-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine",UQFRSHRWRKYNDE-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
68000,6lxt,DB07403,-8.1,"4-[(3-CHLORO-4-{[(2R)-3,3,3-TRIFLUORO-2-HYDROXY-2-METHYLPROPANOYL]AMINO}PHENYL)SULFONYL]-N,N-DIMETHYLBENZAMIDE",DTDZLJHKVNTQGZ-GOSISDBHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
61649,6crv,DB12389,-8.1,Zamicastat,ZSSLCFLHEFXANG-GOSISDBHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28803,6cs2,DB08422,-8.1,[PHENYLALANINYL-PROLINYL]-[2-(PYRIDIN-4-YLAMINO)-ETHYL]-AMINE,GEIDRYBJURDUSW-MOPGFXCFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
85743,6m3m,DB08013,-8.1,(METHYLPYRIDAZINE PIPERIDINE PROPYLOXYPHENYL)ETHYLACETATE,UEIUDEUUVLYRFV-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
148914,6w9q,DB14218,-8.1,Telotristat,NCLGDOBQAWBXRA-PGRDOPGGSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
148618,6w9q,DB13685,-8.1,Quingestanol,PCJFRMOEZQQSAX-AIOSZGMZSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
111418,6vxx,DB03844,-8.1,"N-(2,6-Diflouro-Benzyl)-4-Sulfamoyl-Benzamide",ZFNCKGXGCCDDFN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
135138,6w9c,DB04037,-8.1,"N,N-Bis(4-Chlorobenzyl)-1h-1,2,3,4-Tetraazol-5-Amine",UOUXILZUBDIWQU-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
61455,6crv,DB12112,-8.1,Zuretinol acetate,QGNJRVVDBSJHIZ-AQDFTDIISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
68936,6lxt,DB08510,-8.1,5-ALPHA-PREGNANE-3-BETA-OL-HEMISUCCINATE,UVTGFMKBPVLATL-DSOJQRAMSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
8961,6lzg,DB07027,-8.1,D-phenylalanyl-N-(3-fluorobenzyl)-L-prolinamide,JGZSVYZIJHGHMA-MOPGFXCFSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
68939,6lxt,DB08513,-8.1,[4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENYL]ACETIC ACID,PAIQRYUOBBCBSE-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
64627,6lxt,DB01763,-8.1,7-thionicotinamide-adenine-dinucleotide phosphate,OJNFDOAQUXJWED-NNYOXOHSSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
84198,6m3m,DB04898,-8.1,Ximelagatran,ZXIBCJHYVWYIKI-PZJWPPBQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
132111,6w4h,DB15406,-8.1,GLPG-0974,MPMKMQHJHDHPBE-RUZDIDTESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
135573,6w9c,DB04643,-8.1,"4-{3-CHLORO-4-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-PHENOXY}-BUTYRIC ACID",FYQVFMLCZJZZEM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
92639,6m71,DB04669,-8.1,TRIAZOLOPYRIMIDINE,YWBFPKPWMSWWEA-UHFFFAOYSA-O,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
153368,6wiq,DB06295,-8.1,Pramiconazole,AEKNYBWUEYNWMJ-QWOOXDRHSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
133103,6w9c,DB01208,-8.1,Sparfloxacin,DZZWHBIBMUVIIW-DTORHVGOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
6269,6lzg,DB01830,-8.1,"{4-[2-Acetylamino-2-(3-Carbamoyl-2-Cyclohexylmethoxy-6,7,8,9-Tetrahydro-5h-Benzocyclohepten-5ylcarbamoyl)-Ethyl]-2-Phosphono-Phenyl}-Phosphonic Acid",SPSGYTWOIGAABK-DQEYMECFSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
113301,6vxx,DB08775,-8.1,Nalpha-[(Benzyloxy)carbonyl]-N-[(2S)-4-fluoro-3-oxo-2-butanyl]-L-tyrosinamide,RYABQRLJLIHDIP-KSSFIOAISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87067,6m3m,DB11785,-8.1,Anisodamine,WTQYWNWRJNXDEG-RBZJEDDUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
120645,6w4b,DB08738,-8.1,1-{3-oxo-3-[(2S)-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]propyl}-3-phenylquinoxalin-2(1H)-one,KWCKZIJGKMCYCI-QFIPXVFZSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
129515,6w4h,DB08910,-8.1,Pomalidomide,UVSMNLNDYGZFPF-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
29353,6cs2,DB09054,-8.1,Idelalisib,IFSDAJWBUCMOAH-HNNXBMFYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
31015,6cs2,DB13312,-8.1,Delapril,WOUOLAUOZXOLJQ-MBSDFSHPSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
64584,6lxt,DB01705,-8.1,Bis(5-Amidino-Benzimidazolyl)Methane,QZKOOEFIMWKZPK-UHFFFAOYSA-Q,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
68954,6lxt,DB08531,-8.1,"5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",CVYWYUAQFJMLEO-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
64629,6lxt,DB01765,-8.1,"(5-Oxo-5,6-Dihydro-Indolo[1,2-a]Quinazolin-7-Yl)-Acetic Acid",INSBKYCYLCEBOD-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
113289,6vxx,DB08761,-8.1,"(3S,6S)-3,6-bis(4-hydroxybenzyl)piperazine-2,5-dione",NGPCLOGFGKJCBP-HOTGVXAUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
14607,6lzg,T3D4504,-8.1,Famoxadone,PCCSBWNGDMYFCW-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
92251,6m71,DB04154,-8.1,"N-Methyl-N-[3-(6-Phenyl[1,2,4]Triazolo[4,3-B]Pyridazin-3-Yl)Phenyl]Acetamide",ALBWBHNFOJJMCV-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
68885,6lxt,DB08449,-8.1,"2-(3-((4,5,7-trifluorobenzo[d]thiazol-2-yl)methyl)-1H-pyrrolo[2,3-b]pyridin-1-yl)acetic acid",IEVFQDJUDLCOQY-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
133109,6w9c,DB01215,-8.1,Estazolam,CDCHDCWJMGXXRH-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
24030,6cs2,DB01685,-8.1,Topiroxostat,UBVZQGOVTLIHLH-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
68892,6lxt,DB08459,-8.1,"3-chloro-5-[2-chloro-5-(1H-pyrazolo[3,4-b]pyridin-3-ylmethoxy)phenoxy]benzonitrile",SVMHTBVIPYVDIL-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
31884,6cs2,DB14937,-8.1,MK-8666,CODQKEMYZZKQAE-QPVYNBJUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
8960,6lzg,DB07026,-8.1,"(1S,5S,7R)-N-7-(BIPHENYL-4-YLMETHYL)-N-3-HYDROXY-6,8-DIOXA-3-AZABICYCLO[3.2.1]OCTANE-3,7-DICARBOXAMIDE",PPLDARNGJSQINK-OKZBNKHCSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
68896,6lxt,DB08463,-8.1,(2R)-2-({9-(1-methylethyl)-6-[(4-pyridin-2-ylbenzyl)amino]-9H-purin-2-yl}amino)butan-1-ol,HOCBJBNQIQQQGT-LJQANCHMSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
123676,6w4h,DB00247,-8.1,Methysergide,KPJZHOPZRAFDTN-NQUBZZJWSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
153060,6wiq,DB04881,-8.1,Elacridar,OSFCMRGOZNQUSW-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
123682,6w4h,DB00253,-8.1,Medrysone,GZENKSODFLBBHQ-ILSZZQPISA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
153182,6wiq,DB05450,-8.1,Smilagenin,GMBQZIIUCVWOCD-UQHLGXRBSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
68913,6lxt,DB08485,-8.1,"(1S,4S,5S)-1,4,5-TRIHYDROXY-3-[3-(PHENYLTHIO)PHENYL]CYCLOHEX-2-ENE-1-CARBOXYLIC ACID",QMNMNSINKIFYBV-LMMKCTJWSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
111104,6vxx,DB02998,-8.1,Metribolone,CCCIJQPRIXGQOE-XWSJACJDSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
92365,6m71,DB04301,-8.1,Bis(5-Amidino-2-Benzimidazolyl)Methane Ketone Hydrate,ZLAHDRAQCSQPOC-UHFFFAOYSA-P,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
165589,7bv1,DB12505,-8.1,E-7820,LWGUASZLXHYWIV-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
165920,7bv1,DB13240,-8.1,Cymarin,XQCGNURMLWFQJR-ZNDDOCHDSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
64632,6lxt,DB01768,-8.1,Methylumbelliferyl Sialic Acid,KKDWIUJBUSOPGC-GKHMPSLRSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
92489,6m71,DB04477,-8.1,"N-1,2,3,4-Tetrahydronaphth-1-Yl-2'-[3,5-Dimethoxybenzamido]-2'-Deoxy-Adenosine",FDZQGEIYGFPMOB-ZUURFMEUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110890,6vxx,DB02538,-8.1,"N-[4-(2-Methylimidazo[1,2-a]Pyridin-3-Yl)-2-Pyrimidinyl]Acetamide",ZCRPPLDDHBLUES-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
135551,6w9c,DB04615,-8.1,(S)-tacrine(10)-hupyridone,ROTFGKJJMRTWBD-MHZLTWQESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
145573,6w9q,DB07507,-8.1,"2-(4-hydroxybiphenyl-3-yl)-4-methyl-1H-isoindole-1,3(2H)-dione",ROMNEYAQUBNRLR-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
113347,6vxx,DB09020,-8.1,Bisacodyl,KHOITXIGCFIULA-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
9160,6lzg,DB07244,-8.1,"5-{4-[(3,5-DIFLUOROBENZYL)AMINO]PHENYL}-6-ETHYLPYRIMIDINE-2,4-DIAMINE",SRRWXMSVQYQCRX-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
35131,1r42,DB01177,-8.1,Idarubicin,XDXDZDZNSLXDNA-TZNDIEGXSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
69139,6lxt,DB08750,-8.1,"1-[4-(AMINOMETHYL)BENZOYL]-5'-FLUORO-1'H-SPIRO[PIPERIDINE-4,2'-QUINAZOLIN]-4'-AMINE",SFPCNWQWKOUNRT-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
35194,1r42,DB01251,-8.1,Gliquidone,LLJFMFZYVVLQKT-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
85885,6m3m,DB08169,-8.1,(2Z)-N-biphenyl-4-yl-2-cyano-3-cyclopropyl-3-hydroxyprop-2-enamide,CAGGGMPTWTUYHZ-ZCXUNETKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
154626,6wiq,DB08091,-8.1,3-FLUORO-5-MORPHOLIN-4-YL-N-[3-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-5-YL]BENZAMIDE,HIUFYIOMUILESI-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
64473,6lxt,DB01564,-8.1,Calusterone,IVFYLRMMHVYGJH-PVPPCFLZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
69177,6lxt,DB08794,-8.1,Ethyl biscoumacetate,JCLHQFUTFHUXNN-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
92836,6m71,DB04971,-8.1,Reglitazar,QBQLYIISSRXYKL-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110846,6vxx,DB02485,-8.1,Cytidine-5'-Monophosphate-5-N-Acetylneuraminic Acid,TXCIAUNLDRJGJZ-BILDWYJOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
64457,6lxt,DB01548,-8.1,Diprenorphine,OIJXLIIMXHRJJH-KNLIIKEYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
61192,6crv,DB11726,-8.1,Encenicline,SSRDSYXGYPJKRR-ZDUSSCGKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
69199,6lxt,DB08820,-8.1,Ivacaftor,PURKAOJPTOLRMP-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
30960,6cs2,DB13242,-8.1,Bucladesine,CJGYSWNGNKCJSB-YVLZZHOMSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
145393,6w9q,DB07297,-8.1,"5,6-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-D]PYRIMIDIN-4-AMINE",PTILEOLOGGMFCS-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
92952,6m71,DB05608,-8.1,MKC-1,OVSKGTONMLKNPZ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
84099,6m3m,DB04771,-8.1,1-GUANIDINO-4-(N-NITRO-BENZOYLAMINO-L-LEUCYL-L-PROLYLAMINO)BUTANE,FIZYZWLGMGGGBJ-OALUTQOASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
14530,6lzg,T3D4350,-8.1,Bilirubin,BPYKTIZUTYGOLE-KDUUSRDASA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
69197,6lxt,DB08816,-8.1,Ticagrelor,OEKWJQXRCDYSHL-FNOIDJSQSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
69135,6lxt,DB08746,-8.1,1-[[(1E)-2-(4-CHLOROPHENYL)ETHENYL]SULFONYL]-4-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]PIPERAZINE,ZOSSOFIFNGGDKG-GIJQJNRQSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
34948,1r42,DB00966,-8.1,Telmisartan,RMMXLENWKUUMAY-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
129508,6w4h,DB08899,-8.1,Enzalutamide,WXCXUHSOUPDCQV-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
25068,6cs2,DB02917,-8.1,N-Hydroxy-4-(Methyl{[5-(2-Pyridinyl)-2-Thienyl]Sulfonyl}Amino)Benzamide,LFGYSFPVLMPUPE-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
68988,6lxt,DB08572,-8.1,4-{[4-AMINO-6-(CYCLOHEXYLMETHOXY)-5-NITROSOPYRIMIDIN-2-YL]AMINO}BENZAMIDE,YBKLJTXDSBEVRV-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
16790,6cs2,HMDB0004484,-8.1,Etiocholanolone glucuronide,VFUIRAVTUVCQTF-SDHZCXLISA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
165591,7bv1,DB12507,-8.1,Atecegatran metoxil,XSNMGLZVFNDDPW-ZWKOTPCHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
32080,6cs2,DB15319,-8.1,VM4-037,QGYZPMXIVNIGKA-GMAHTHKFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
8965,6lzg,DB07031,-8.1,"3-Fluoro-4-{[(2R)-2-hydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthalenyl)acetyl]amino}benzoic acid",AANFHDFOMFRLLR-LJQANCHMSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
135635,6w9c,DB04740,-8.1,MOXALACTAM (HYDROLYZED),ZTOQXKUYWZBJLG-XNAIMREJSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
132197,6w9c,DB00146,-8.1,Calcifediol,JWUBBDSIWDLEOM-DTOXIADCSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
16203,6lzg,DB03159,-8.1,CRA_8696,GAVRMVQHHVMXFD-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
135644,6w9c,DB04753,-8.1,"9-DEAZAINOSINE-2',3'-O-ETHYLIDENEPHOSPHONATE",ZOEDLCUBOBTIHG-USQSKNHBSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
69098,6lxt,DB08708,-8.1,"N-cyclohexyl-3-[3-(trifluoromethyl)phenyl][1,2,4]triazolo[4,3-b]pyridazin-6-amine",XYYDXQCAYXOGQT-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
69099,6lxt,DB08709,-8.1,"2,3-diphenyl-1H-indole-7-carboxylic acid",OLUDUXWVPIEHDA-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
129512,6w4h,DB08906,-8.1,Fluticasone furoate,XTULMSXFIHGYFS-VLSRWLAYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
135650,6w9c,DB04761,-8.1,"PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-[(PYRIDIN-3-YLMETHYL)-AMIDE]",NHPBWKYFMTXWAA-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
154192,6wiq,DB07586,-8.1,"5-(4-METHYL-BENZOYLAMINO)-BIPHENYL-3,4'-DICARBOXYLIC ACID 3-DIMETHYLAMIDE-4'-HYDROXYAMIDE",DOPFUKKMSDUVTQ-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
16210,6lzg,DB03213,-8.1,Bis(5-Amidino-2-Benzimidazolyl)Methane Ketone,VVVXDHROXQUONB-UHFFFAOYSA-P,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
87531,6m3m,DB12448,-8.1,Lifibrol,LNXBEIZREVRNTF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
110861,6vxx,DB02502,-8.1,8-Hydroxy-2'-Deoxyguanosine,HCAJQHYUCKICQH-VPENINKCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112292,6vxx,DB06930,-8.1,"N-[amino(imino)methyl]-2-(2,5-diphenyl-1H-pyrrol-1-yl)acetamide",WVLDNAVUCUAGDP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
92700,6m71,DB04759,-8.1,"PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-(3-METHYL-BENZYLAMIDE)",GTBUZLPQANSGGE-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
130151,6w4h,DB11844,-8.1,Pritelivir,IVZKZONQVYTCKC-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
84231,6m3m,DB05013,-8.1,Ingenol mebutate,VDJHFHXMUKFKET-UXMMOKKRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
120772,6w4b,DB08912,-8.1,Dabrafenib,BFSMGDJOXZAERB-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
33583,6cs2,T3D4832,-8.1,17a-Estradiol,VOXZDWNPVJITMN-SFFUCWETSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
135345,6w9c,DB04338,-8.1,SB220025,VSPFURGQAYMVAN-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
68544,6lxt,DB08037,-8.1,"(2S)-4-(2,5-difluorophenyl)-N-[(3R,4S)-3-fluoro-1-methylpiperidin-4-yl]-2-(hydroxymethyl)-N-methyl-2-phenyl-2,5-dihydro-1H-pyrrole-1-carboxamide",MYBGWENAVMIGMM-GIFXNVAJSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
165582,7bv1,DB12491,-8.1,Fasiglifam,BZCALJIHZVNMGJ-HSZRJFAPSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
84367,6m3m,DB05791,-8.1,Perflubron,WTWWXOGTJWMJHI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
68548,6lxt,DB08042,-8.1,"N-4-methyl-N-4-(3-methyl-1H-indazol-6-yl)-N-2-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine",FLXGQDHYCWXTAI-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
113229,6vxx,DB08698,-8.1,"1-[(3S)-5-PHENYL-3-THIOPHEN-2-YL-3H-1,4-BENZODIAZEPIN-2-YL]AZETIDIN-3-OL",BKSGACYTXOQQNI-OAQYLSRUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
145737,6w9q,DB07704,-8.1,"6-AMINO-4-[2-(4-METHOXYPHENYL)ETHYL]-1,7-DIHYDRO-8H-IMIDAZO[4,5-G]QUINAZOLIN-8-ONE",UKRVQKUVWNDGMN-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
135278,6w9c,DB04244,-8.1,(2R)-2-(3-Biphenylyl)-N-{(2R)-2-hydroxy-3-[(2-pyridinylsulfonyl)amino]propyl}-4-methylpentanamide,YCDHZDINQZLSRR-DNQXCXABSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
113230,6vxx,DB08699,-8.1,"1-tert-butyl-3-(3-methylbenzyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine",FYCOTGCSHZKHPR-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84352,6m3m,DB05676,-8.1,Apremilast,IMOZEMNVLZVGJZ-QGZVFWFLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
122091,6w4b,DB12874,-8.1,Quizartinib,CVWXJKQAOSCOAB-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
8949,6lzg,DB07014,-8.1,"2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4-methoxybenzyl)sulfanyl]-1,3,4-oxadiazole",TUTZKAQTSPMEBI-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
85827,6m3m,DB08108,-8.1,N-({6-[(4-CYANOBENZYL)OXY]NAPHTHALEN-2-YL}SULFONYL)-D-GLUTAMIC ACID,PUHRQSFXADUGJW-OAQYLSRUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
142552,6w9q,DB02354,-8.1,4-{[1-Methyl-5-(2-Methyl-Benzoimidazol-1-Ylmethyl)-1h-Benzoimidazol-2-Ylmethyl]-Amino}-Benzamidine,IRKPNOLLMNHSOU-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
87129,6m3m,DB11873,-8.1,Verinurad,YYBOLPLTQDKXPM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
165584,7bv1,DB12494,-8.1,SGI-1776,MHXGEROHKGDZGO-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
113232,6vxx,DB08702,-8.1,"2,5-DIPHENYLFURAN-3,4-DICARBOXYLIC ACID",QPKYPOMZPFDBEZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113231,6vxx,DB08701,-8.1,"2-(3-BROMOPHENYL)-6-[(2-HYDROXYETHYL)AMINO]-1H-BENZO[DE]ISOQUINOLINE-1,3(2H)-DIONE",JZCUVYNOSDWORZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
120872,6w4b,DB09053,-8.1,Ibrutinib,XYFPWWZEPKGCCK-GOSISDBHSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
61409,6crv,DB12045,-8.1,Mericitabine,MLESJYFEMSJZLZ-MAAOGQSESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
149757,6wiq,DB00549,-8.1,Zafirlukast,YEEZWCHGZNKEEK-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
149330,6w9q,DB15403,-8.1,Ziritaxestat,REQQVBGILUTQNN-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
149334,6w9q,DB15408,-8.1,Silmitasertib,MUOKSQABCJCOPU-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
90891,6m71,DB02341,-8.1,"Mdl 101,146",XQAMVCHQGHAELT-YPAWHYETSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
28750,6cs2,DB08361,-8.1,"2-{[(1R,2S)-2-aminocyclohexyl]amino}-4-[(3-methylphenyl)amino]pyrimidine-5-carboxamide",NZNTWOVDIXCHHS-LSDHHAIUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
165323,7bv1,DB11934,-8.1,Epelsiban,UWHCWRQFNKUYCG-QUZACWSFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
90938,6m71,DB02400,-8.1,"5-Methoxy-1,2-Dimethyl-3-(4-Nitrophenoxymethyl)Indole-4,7-Dione",IBLWSLZYYZHSRG-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
61435,6crv,DB12082,-8.1,Vesnarinone,ZVNYJIZDIRKMBF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
123392,6w4b,DB15456,-8.1,Vericiguat,QZFHIXARHDBPBY-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
87152,6m3m,DB11905,-8.1,Sutezolid,FNDDDNOJWPQCBZ-ZDUSSCGKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
149353,6w9q,DB15446,-8.1,Vidofludimus,XPRDUGXOWVXZLL-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
149372,6w9q,DB03453,-8.1,Methyl (2S)-2-[[2-[(3R)-1-carbamimidoylpiperidin-3-yl]acetyl]amino]-3-[4-(2-phenylethynyl)phenyl]propanoate,MRNGXYMKYHNMLV-PKTZIBPZSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
64753,6lxt,DB01940,-8.1,Balanol Analog 2,SQLYTJZXRRDERK-ISKFKSNPSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
149476,6wiq,DB00210,-8.1,Adapalene,LZCDAPDGXCYOEH-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
149546,6wiq,DB00288,-8.1,Amcinonide,ILKJAFIWWBXGDU-MOGDOJJUSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
91036,6m71,DB02519,-8.1,Indirubin-5-Sulphonate,IHBOEHLUIBMBMY-YPKPFQOOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
31200,6cs2,DB13531,-8.1,Nicofetamide,DWODOIKZDGJOPQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
84397,6m3m,DB05969,-8.1,SNS-032,OUSFTKFNBAZUKL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84392,6m3m,DB05943,-8.1,Resatorvid,LEEIJTHMHDMWLJ-CQSZACIVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
91113,6m71,DB02623,-8.1,Aminophosphonic Acid-Guanylate Ester,ZGPDMUBRWRJAQQ-UUOKFMHZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
17716,6cs2,HMDB0000483,-8.1,"5b-Cholestane-3a,7a,12a,23S,25-pentol",OXSBBBPDYVCAKC-CTSLUMRNSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
92199,6m71,DB04086,-8.1,"2',4'-Dinitrophenyl-2deoxy-2-Fluro-B-D-Cellobioside",WFVCNOHOODVBQK-IUBYCILNSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
145724,6w9q,DB07689,-8.1,"METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE",NYNAFINLHQEHKU-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
150423,6wiq,DB01395,-8.1,Drospirenone,METQSPRSQINEEU-HXCATZOESA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
8959,6lzg,DB07025,-8.1,3-(5-{[4-(AMINOMETHYL)PIPERIDIN-1-YL]METHYL}-1H-INDOL-2-YL)QUINOLIN-2(1H)-ONE,KBIHHEGEALBUMT-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
61340,6crv,DB11941,-8.1,Tasisulam,WWONFUQGBVOKOF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
91937,6m71,DB03744,-8.1,"Cp403700, (S)-1-{2-[(5-Chloro-1h-Indole-2-Carbonyl)-Amino]-3-Phenyl-Propionyl}-Azetidine-3-Carboxylate",RONLONYAIBUEKT-IBGZPJMESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
111163,6vxx,DB03081,-8.1,Crc200 (Chiron-Behring),ZOXOKTJHZSUHRJ-XZOQPEGZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
132090,6w4h,DB15356,-8.1,SLV-334,LOFDNSDPZTVIIO-VPUSJEBWSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
91958,6m71,DB03768,-8.1,"N-[2-Hydroxy-2-(8-Isopropyl-6,9-Dioxo-2-Oxa-7,10-Diaza-Bicyclo[11.2.2]Heptadeca-1(16),13(17),14-Trien-11-Yl)-Ethyl]-N-(3-Methyl-Butyl)-Benzenesulfonamide,Inhibitor 3",WRUVOSYKHXGAQN-GKRYNVPLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
135503,6w9c,DB04554,-8.1,8-Bromoadenosine-5'-Diphosphate,KVVVTFSHHQCHNZ-UUOKFMHZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
84268,6m3m,DB05234,-8.1,LGD2941,HWLLYFXDDGGHOE-BCSUUIJWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
112271,6vxx,DB06909,-8.1,"1-ethyl-N-(phenylmethyl)-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridine-5-carboxamide",QZGJNFBMYYEFGM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
152082,6wiq,DB03583,-8.1,"(2e,3s)-3-Hydroxy-5'-[(4-Hydroxypiperidin-1-Yl)Sulfonyl]-3-Methyl-1,3-Dihydro-2,3'-Biindol-2'(1'h)-One",AYOAIABDFUJDKQ-SQJPUDIVSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
92079,6m71,DB03921,-8.1,4-(3-Pyridin-2-Yl-1h-Pyrazol-4-Yl)Quinoline,IBCXZJCWDGCXQT-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
9587,6lzg,DB07700,-8.1,"3-CARBOXAMIDO-1,3,5(10)-ESTRATRIEN-17(R)-SPIRO-2'(5',5'-DIMETHYL-6'OXO)TETRAHYDROPYRAN",YVAJWBACBRSVPR-NDUHRLLKSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
152174,6wiq,DB03712,-8.1,RU85053,CEKLBQMULVLLTD-VMPREFPWSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
61314,6crv,DB11902,-8.1,Gisadenafil,YPFZMBHKIVDSNR-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87090,6m3m,DB11817,-8.1,Baricitinib,XUZMWHLSFXCVMG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
129540,6w4h,DB08951,-8.1,Indoprofen,RJMIEHBSYVWVIN-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
152408,6wiq,DB04011,-8.1,"2'-(4-Dimethylaminophenyl)-5-(4-Methyl-1-Piperazinyl)-2,5'-Bi-Benzimidazole",VMCOQLKKSNQANE-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
123654,6w4h,DB00223,-8.1,Diflorasone,WXURHACBFYSXBI-XHIJKXOTSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
165294,7bv1,DB11725,-8.1,Latrepirdine,JNODQFNWMXFMEV-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
9575,6lzg,DB07686,-8.1,"4-{[5-(CYCLOHEXYLAMINO)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE",VPOGRVWIIVMWRI-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
132073,6w4h,DB15324,-8.1,ORM-13070 C-11,VGIYMYGMVXPMKV-GWDMYEQXSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
68762,6lxt,DB08300,-8.1,"1-methyl-3-naphthalen-2-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine",UOKGZPYGRJDACN-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
91444,6m71,DB03069,-8.1,Cytidine-5'-Diphospho-Beta-D-Xylose,NWSKPSPTJOAICE-OCIMBMBZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
135384,6w9c,DB04395,-8.1,Phosphoaminophosphonic Acid-Adenylate Ester,PVKSNHVPLWYQGJ-FCIPNVEPSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
91532,6m71,DB03186,-8.1,U-Pi-a-Pi,JIAJERGOUFOENU-LNAOLWRRSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
150669,6wiq,DB01691,-8.1,Indole Naphthyridinone,VAZMNDXVXVUKFY-JXMROGBWSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
135394,6w9c,DB04409,-8.1,Naphthalene Trisulfonate,ZPBSAMLXSQCSOX-UHFFFAOYSA-K,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
150779,6wiq,DB01836,-8.1,"[4-(6-Chloro-Naphthalene-2-Sulfonyl)-Piperazin-1-Yl]-(3,4,5,6-Tetrahydro-2h-[1,4']Bipyridinyl-4-Yl)-Methanone",ZLAKCKVFSRSENR-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
28731,6cs2,DB08344,-8.1,4-chloro-N-(3-methoxypropyl)-N-[(3S)-1-(2-phenylethyl)piperidin-3-yl]benzamide,OOUGHDJEJNMXSV-QHCPKHFHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
68664,6lxt,DB08170,-8.1,"(1R)-N,6-DIHYDROXY-7-METHOXY-2-[(4-METHOXYPHENYL)SULFONYL]-1,2,3,4-TETRAHYDROISOQUINOLINE-1-CARBOXAMIDE",AYFCYVLVRYQGME-QGZVFWFLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
84319,6m3m,DB05501,-8.1,AMD-070,WVLHHLRVNDMIAR-IBGZPJMESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
9573,6lzg,DB07685,-8.1,"4-{[5-(CYCLOHEXYLMETHOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE",NMAZGYDYIYLSLJ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
68685,6lxt,DB08197,-8.1,"(5E,7S)-2-amino-7-(4-fluoro-2-pyridin-3-ylphenyl)-4-methyl-7,8-dihydroquinazolin-5(6H)-one oxime",KYIXUSLGFINPTC-WVFAEZDRSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
151091,6wiq,DB02258,-8.1,SR11254,RNZIUDLOJHVHLZ-VYIQYICTSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
91676,6m71,DB03368,-8.1,"5-Methyl-5-(4-Phenoxy-Phenyl)-Pyrimidine-2,4,6-Trione",RTBMLCLTYAPKIF-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
31121,6cs2,DB13432,-8.1,Lonazolac,XVUQHFRQHBLHQD-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
9182,6lzg,DB07267,-8.1,2-(6-methylpyridin-2-yl)-N-pyridin-4-ylquinazolin-4-amine,JONFDFIXMPXTRH-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
113244,6vxx,DB08714,-8.1,"2,6-DIMETHYL-1-(3-[3-METHYL-5-ISOXAZOLYL]-PROPANYL)-4-[4-METHYL-2H-TETRAZOL-2-YL]-PHENOL",DRCNRTRGWUYJBH-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
68717,6lxt,DB08239,-8.1,"(2S)-4-(2,5-DIFLUOROPHENYL)-N-METHYL-2-PHENYL-N-PIPERIDIN-4-YL-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDE",NKLVBHMAIMEVEH-QFIPXVFZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
91757,6m71,DB03488,-8.1,Uridine-5'-diphosphate-2-deoxy-2-fluoro-alpha-D-galactose,NGTCPFGWXMBZEP-NQQHDEILSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
91763,6m71,DB03496,-8.1,Alvocidib,BIIVYFLTOXDAOV-YVEFUNNKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
111280,6vxx,DB03446,-8.1,N-Benzyl-3-(alpha-D-galactopyranosyloxy)benzamide,FSMWGHKWKYCPKE-QTVCLEQKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85897,6m3m,DB08184,-8.1,2-(2-METHYLPHENYL)-1H-INDOLE-5-CARBOXIMIDAMIDE,YOZKTHGEOJHIDP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
146029,6w9q,DB08037,-8.1,"(2S)-4-(2,5-difluorophenyl)-N-[(3R,4S)-3-fluoro-1-methylpiperidin-4-yl]-2-(hydroxymethyl)-N-methyl-2-phenyl-2,5-dihydro-1H-pyrrole-1-carboxamide",MYBGWENAVMIGMM-GIFXNVAJSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
130176,6w4h,DB11883,-8.1,SB-705498,JYILLRHXRVTRSH-GFCCVEGCSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
133595,6w9c,DB01893,-8.1,N6-Benzyl Adenosine-5'-Diphosphate,MRHGMAGSDAQUFH-LSCFUAHRSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
111975,6vxx,DB05015,-8.1,Belinostat,NCNRHFGMJRPRSK-MDZDMXLPSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
146315,6w9q,DB08384,-8.1,2-({4-[4-(pyridin-4-ylmethyl)-1H-pyrazol-3-yl]phenoxy}methyl)quinoline,RQDDHVVAAJVVKM-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
62656,6crv,DB13867,-8.1,Fluticasone,MGNNYOODZCAHBA-GQKYHHCASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130828,6w4h,DB12858,-8.1,LY-377604,RBSGUQYXRDKPAE-QFIPXVFZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
65707,6lxt,DB03199,-8.1,4-Methoxy-E-Rhodomycin T,XSSVYBYWQBNYOH-QJIXERIWSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
130807,6w4h,DB12823,-8.1,Tecarfarin,QFLNTQDOVCLQKW-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
112873,6vxx,DB07944,-8.1,N-{3-METHYL-5-[2-(PYRIDIN-4-YLAMINO)-ETHOXY]-PHENYL}-BENZENESULFONAMIDE,MPTWCWHNLVMCRW-UHFFFAOYSA-O,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62259,6crv,DB13337,-8.1,Pheneticillin,NONJJLVGHLVQQM-JHXYUMNGSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
142238,6w9q,DB01940,-8.1,Balanol Analog 2,SQLYTJZXRRDERK-ISKFKSNPSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
65695,6lxt,DB03181,-8.1,"2-[4-(4-Hydroxy-3-Isopropyl-Phenoxy)-3,5-Dimethyl-Phenyl]-2h-[1,2,4]Triazine-3,5-Dione",RXQAVKWRCZYGMV-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
87912,6m3m,DB13051,-8.1,CH-5132799,JEGHXKRHKHPBJD-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
133646,6w9c,DB01964,-8.1,AL5424,ZWTSOJQGEWPWGO-NSHDSACASA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
29216,6cs2,DB08877,-8.1,Ruxolitinib,HFNKQEVNSGCOJV-OAHLLOKOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
131777,6w4h,DB14673,-8.1,Flurandrenolide acetate,AUDPKCCPWYXNEV-XTLNBZDDSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
87922,6m3m,DB13063,-8.1,Parthenolide,KTEXNACQROZXEV-SLXBATTESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
31725,6cs2,DB14646,-8.1,Prednisone acetate,MOVRKLZUVNCBIP-RFZYENFJSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
32779,6cs2,T3D3693,-8.1,Xanthomegnin,WICHONPZVIYWIJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
62212,6crv,DB13277,-8.1,Benziodarone,CZCHIEJNWPNBDE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
66918,6lxt,DB04824,-8.1,Phenolphthalein,KJFMBFZCATUALV-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
133594,6w9c,DB01889,-8.1,"16,17-Androstene-3-Ol",KRVXMNNRSSQZJP-PHFHYRSDSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
62269,6crv,DB13349,-8.1,Talastine,LCAAMXMULMCKLJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130945,6w4h,DB13036,-8.1,Ramatroban,LDXDSHIEDAPSSA-OAHLLOKOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
112862,6vxx,DB07932,-8.1,"dimethyl (1R,4S)-5,6-bis(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hepta-2,5-diene-2,3-dicarboxylate",CRLQCBACIMUGDZ-BGYRXZFFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
123114,6w4b,DB14870,-8.1,PF-5190457,ZIUDADZJCKGWKR-AREMUKBSSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
130930,6w4h,DB13016,-8.1,LY-2300559,DWQVYDLTPMGYNE-DEOSSOPVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
31775,6cs2,DB14723,-8.1,Larotrectinib,NYNZQNWKBKUAII-KBXCAEBGSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
122800,6w4b,DB13919,-8.1,Candesartan,HTQMVQVXFRQIKW-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
141812,6w9q,DB01395,-8.1,Drospirenone,METQSPRSQINEEU-HXCATZOESA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
85338,6m3m,DB07539,-8.1,"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZOIC ACID",JLRKRQCTYQGDKJ-GHXNOFRVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
147151,6w9q,DB11431,-8.1,Moxidectin,YZBLFMPOMVTDJY-LSGXYNIPSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
65763,6lxt,DB03262,-8.1,"Al-6619, [2h-Thieno[3,2-E]-1,2-Thiazine-6-Sulfonamide,2-(3-Hydroxyphenyl)-3-(4-Morpholinyl)-, 1,1-Dioxide]",PZLYYZPXSSNGJS-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
130891,6w4h,DB12949,-8.1,PF-03382792,AGMOFKKOVMRGAK-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
65715,6lxt,DB03207,-8.1,"2-(Biphenyl-4-Sulfonyl)-1,2,3,4-Tetrahydro-Isoquinoline-3-Carboxylic Acid",BNVMUDXGABBWGP-OAQYLSRUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
130883,6w4h,DB12939,-8.1,Nikkomycin Z,WWJFFVUVFNBJTN-VHDFTHOZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130879,6w4h,DB12933,-8.1,RO-4987655,FIMYFEGKMOCQKT-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
147112,6w9q,DB11363,-8.1,Alectinib,KDGFLJKFZUIJMX-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
62287,6crv,DB13369,-8.1,Benzilone,ZKCWITXZGWUJAV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
24364,6cs2,DB02089,-8.1,CP-526423,MWWXABBBAPKJDX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
17109,6cs2,HMDB0000241,-8.1,Protoporphyrin IX,KSFOVUSSGSKXFI-UJJXFSCMSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
130893,6w4h,DB12952,-8.1,Methylprednisone,SVYCRJXQZUCUND-PQXSVQADSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
66928,6lxt,DB04834,-8.1,Rapacuronium,HTIKWNNIPGXLGM-YLINKJIISA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
111941,6vxx,DB04898,-8.1,Ximelagatran,ZXIBCJHYVWYIKI-PZJWPPBQSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
66938,6lxt,DB04845,-8.1,Ixabepilone,FABUFPQFXZVHFB-PVYNADRNSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
31697,6cs2,DB14584,-8.1,Segesterone,SFLXYFZGKSGFKA-XUDSTZEESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
123153,6w4b,DB14942,-8.1,BMS-986141,KEEBLYWBELVGPQ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
67034,6lxt,DB05134,-8.1,Tanespimycin,AYUNIORJHRXIBJ-TXHRRWQRSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
88083,6m3m,DB13324,-8.1,Tetrazepam,IQWYAQCHYZHJOS-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85213,6m3m,DB07393,-8.1,"2-(2-PHENYL-3-PYRIDIN-2-YL-4,5,6,7-TETRAHYDRO-2H-ISOPHOSPHINDOL-1-YL)PYRIDINE",GSKNNHAAFLPYHG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
24436,6cs2,DB02177,-8.1,1-Acetyl-4-(4-{4-[(2-Ethoxyphenyl)Thio]-3-Nitrophenyl}Pyridin-2-Yl)Piperazine,GKGJFUXSTSUKPB-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
147308,6w9q,DB11751,-8.1,Cabotegravir,WCWSTNLSLKSJPK-LKFCYVNXSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
62684,6crv,DB13944,-8.1,Testosterone enanthate,VOCBWIIFXDYGNZ-IXKNJLPQSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
67017,6lxt,DB05039,-8.1,Indacaterol,QZZUEBNBZAPZLX-QFIPXVFZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
121417,6w4b,DB11863,-8.1,Alvelestat,QNQZWEGMKJBHEM-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
133797,6w9c,DB02166,-8.1,Propidium,ZDWVWKDAWBGPDN-UHFFFAOYSA-O,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
111923,6vxx,DB04873,-8.1,Piboserod,KVCSJPATKXABRQ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165431,7bv1,DB12095,-8.1,Telotristat ethyl,MDSQOJYHHZBZKA-GBXCKJPGSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
88118,6m3m,DB13364,-8.1,Feprazone,RBBWCVQDXDFISW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88121,6m3m,DB13368,-8.1,Motretinide,IYIYMCASGKQOCZ-DJRRULDNSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
123163,6w4b,DB14995,-8.1,NP-G2-044,XLLRLAABUFOJPC-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
65613,6lxt,DB03072,-8.1,"2-{3-[4-(4-Fluorophenyl)-3,6-Dihydro-1(2h)-Pyridinyl]Propyl}-8-Methyl-4(3h)-Quinazolinone",LOFDUAJQRUYHBR-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
88138,6m3m,DB13395,-8.1,Eprozinol,QSRHLIUOSXVKTG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
133303,6w9c,DB01523,-8.1,Clonitazene,GPZLDQAEBHTMPG-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
67016,6lxt,DB05038,-8.1,Anatibant,XUHBBTKJWIBQMY-MHZLTWQESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
87414,6m3m,DB12288,-8.1,Piromelatine,PNTNBIHOAPJYDB-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
133746,6w9c,DB02098,-8.1,Adenosine-2'-5'-Diphosphate,AEOBEOJCBAYXBA-KQYNXXCUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
32797,6cs2,T3D3710,-8.1,Roridin D,XZWOQFZHIMDODQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
31719,6cs2,DB14639,-8.1,Boldenone undecylenate,AHMMSNQYOPMLSX-CNQKSJKFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
130736,6w4h,DB12708,-8.1,Sulprostone,UQZVCDCIMBLVNR-TWYODKAFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
66949,6lxt,DB04862,-8.1,Merimepodib,JBPUGFODGPKTDW-SFHVURJKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
87961,6m3m,DB13118,-8.1,Paquinimod,DIKSYHCCYVYKRO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
65678,6lxt,DB03159,-8.1,CRA_8696,GAVRMVQHHVMXFD-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
141675,6w9q,DB01167,-8.1,Itraconazole,VHVPQPYKVGDNFY-ZPGVKDDISA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
122643,6w4b,DB13676,-8.1,Mosapramine,PXUIZULXJVRBPC-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
87999,6m3m,DB13213,-8.1,Butaperazine,DVLBYTMYSMAKHP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
133306,6w9c,DB01526,-8.1,4-Androstenediol,BTTWKVFKBPAFDK-LOVVWNRFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
122613,6w4b,DB13640,-8.1,Acetoxolone,FTQDJVZNPJRVPG-XWEVEMRCSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
133724,6w9c,DB02071,-8.1,WAY-151693,AINJYWXKBKRQSX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
62133,6crv,DB13132,-8.1,Artemisinin,BLUAFEHZUWYNDE-NNWCWBAJSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
121515,6w4b,DB12006,-8.1,BMS-906024,AYOUDDAETNMCBW-GSHUGGBRSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
88016,6m3m,DB13232,-8.1,Suxibuzone,ONWXNHPOAGOMTG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
31704,6cs2,DB14627,-8.1,Oxyphenisatin acetate,PHPUXYRXPHEJDF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
32204,6cs2,DB01177,-8.1,Idarubicin,XDXDZDZNSLXDNA-TZNDIEGXSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
62129,6crv,DB13122,-8.1,Trabodenoson,AQLVRTWKJDTWQQ-SDBHATRESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
141544,6w9q,DB01016,-8.1,Glyburide,ZNNLBTZKUZBEKO-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
62333,6crv,DB13433,-8.1,Simfibrate,JLRNKCZRCMIVKA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87753,6m3m,DB12802,-8.1,Picropodophyllin,YJGVMLPVUAXIQN-HAEOHBJNSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
66532,6lxt,DB04301,-8.1,Bis(5-Amidino-2-Benzimidazolyl)Methane Ketone Hydrate,ZLAHDRAQCSQPOC-UHFFFAOYSA-P,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
62353,6crv,DB13460,-8.1,Ronifibrate,AYJVGKWCGIYEAK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
66103,6lxt,DB03742,-8.1,Compound 4-D,TWZNCTCQAGRUGQ-RRPNLBNLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
66104,6lxt,DB03744,-8.1,"Cp403700, (S)-1-{2-[(5-Chloro-1h-Indole-2-Carbonyl)-Amino]-3-Phenyl-Propionyl}-Azetidine-3-Carboxylate",RONLONYAIBUEKT-IBGZPJMESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
131338,6w4h,DB13610,-8.1,Flumedroxone,CDZJOBWKHSYNMO-SCUQKFFVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
165806,7bv1,DB13042,-8.1,Fenoverine,UBAJTZKNDCEGKL-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
131635,6w4h,DB14086,-8.1,Cianidanol,PFTAWBLQPZVEMU-DZGCQCFKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
112063,6vxx,DB06202,-8.1,Lasofoxifene,GXESHMAMLJKROZ-IAPPQJPRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165809,7bv1,DB13048,-8.1,PAC-1,YQNRVGJCPCNMKT-LFVJCYFKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
66149,6lxt,DB03797,-8.1,3-Aminomethyl-Pyridinium-Adenine-Dinucleotide,HMCRLFVYYFBZEZ-PLEFRAQWSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
85515,6m3m,DB07753,-8.1,"3',5'-DIFLUOROBIPHENYL-4-CARBOXYLIC ACID",VCEFNMHMLWBFNV-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
112096,6vxx,DB06267,-8.1,Udenafil,IYFNEFQTYQPVOC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85473,6m3m,DB07703,-8.1,"(3R,4S,5S,7R,9E,11R,12R)-12-ETHYL-4-HYDROXY-3,5,7,11-TETRAMETHYLOXACYCLODODEC-9-ENE-2,8-DIONE",NZUJVBSYQXETNF-PQWITYJESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
123070,6w4b,DB14766,-8.1,Etrasimod,MVGWUTBTXDYMND-QGZVFWFLSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
131713,6w4h,DB14545,-8.1,Hydrocortisone succinate,VWQWXZAWFPZJDA-CGVGKPPMSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131236,6w4h,DB13471,-8.1,Nalfurafine,XGZZHZMWIXFATA-UEZBDDGYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
65839,6lxt,DB03363,-8.1,3-Acetylpyridine Adenine Dinucleotide,KPVQNXLUPNWQHM-RBEMOOQDSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
112101,6vxx,DB06280,-8.1,Senicapoc,SCTZUZTYRMOMKT-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
146747,6w9q,DB08930,-8.1,Dolutegravir,RHWKPHLQXYSBKR-BMIGLBTASA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
87649,6m3m,DB12638,-8.1,PU-H71,SUPVGFZUWFMATN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87624,6m3m,DB12593,-8.1,Apaziquone,MXPOCMVWFLDDLZ-NSCUHMNNSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
112068,6vxx,DB06211,-8.1,Doripenem,AVAACINZEOAHHE-VFZPANTDSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
65898,6lxt,DB03451,-8.1,"1-alpha, 25-dihydroxyl-20-epi-22-oxa-24, 26 ,27-trihomovitamin D3",KLZOTDOJMRMLDX-YBBVPDDNSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
62582,6crv,DB13772,-8.1,Rufloxacin,NJCJBUHJQLFDSW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
122862,6w4b,DB14034,-8.1,Darglitazone,QQKNSPHAFATFNQ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
62572,6crv,DB13757,-8.1,Epanolol,YARKMNAWFIMDKV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
131593,6w4h,DB14008,-8.1,Hispidulin,IHFBPDAQLQOCBX-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
112087,6vxx,DB06250,-8.1,Fluasterone,VHZXNQKVFDBFIK-NBBHSKLNSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112077,6vxx,DB06234,-8.1,Maribavir,KJFBVJALEQWJBS-XUXIUFHCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
65919,6lxt,DB03480,-8.1,Brequinar Analog,WYKKHJQZENLZID-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
62543,6crv,DB13718,-8.1,Hydroquinine,LJOQGZACKSYWCH-WZBLMQSHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
131586,6w4h,DB13991,-8.1,Pipequaline,AMEWZCMTSIONOX-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
65924,6lxt,DB03488,-8.1,Uridine-5'-diphosphate-2-deoxy-2-fluoro-alpha-D-galactose,NGTCPFGWXMBZEP-NQQHDEILSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
32490,6cs2,T3D1848,-8.1,Flumethrin,YXWCBRDRVXHABN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
121494,6w4b,DB11971,-8.1,Vilaprisan,JUFWQQVHQFDUOD-ANRPBIDPSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
87525,6m3m,DB12441,-8.1,Tavilermide,DVJXNXPFYJIACK-ULQDDVLXSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
32493,6cs2,T3D1851,-8.1,Tefluthrin,ZFHGXWPMULPQSE-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
24255,6cs2,DB01958,-8.1,"5-[4-Tert-Butylphenylsulfanyl]-2,4-Quinazolinediamine",MNYDVPDMLAJJPB-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
112075,6vxx,DB06230,-8.1,Nalmefene,WJBLNOPPDWQMCH-MBPVOVBZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
65939,6lxt,DB03507,-8.1,"6-[3-(4-Morpholinyl)Propyl]-2-(3-Nitrophenyl)-5-Thioxo-5,6,-Dihydro-7h-Thienol[2',3':4,5]Pyrrolo[1,2-C]Imidazol-7-One",UXGUZFZBZPPZGL-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
122971,6w4b,DB14555,-8.1,Ursadiol,RTLXJEJRLWILSU-GWNGJUQLSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
87518,6m3m,DB12430,-8.1,BC-3781,KPVIXBKIJXZQJX-IJUBVZAWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
131464,6w4h,DB13778,-8.1,Cefazedone,VTLCNEGVSVJLDN-MLGOLLRUSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
87487,6m3m,DB12392,-8.1,Resminostat,FECGNJPYVFEKOD-VMPITWQZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
121524,6w4b,DB12020,-8.1,Tecovirimat,CSKDFZIMJXRJGH-VWLPUNTISA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
65832,6lxt,DB03355,-8.1,5'-O-(N-(L-Threonyl)-Sulfamoyl)Adenosine,UPVAPSGKXAAHBG-CKTDUXNWSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
24292,6cs2,DB02004,-8.1,"5-(Aminomethyl)-6-(2,4-Dichlorophenyl)-2-(3,5-Dimethoxyphenyl)Pyrimidin-4-Amine",RCJFINNFYUNFGH-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
62384,6crv,DB13504,-8.1,Cefetamet,MQLRYUCJDNBWMV-GHXIOONMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
66421,6lxt,DB04158,-8.1,"6-(Adenosine Tetraphosphate-Methyl)-7,8-Dihydropterin",ZKRKFZJAQKKHKL-SUGPNEFASA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
62382,6crv,DB13501,-8.1,Bendazac,BYFMCKSPFYVMOU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
66439,6lxt,DB04177,-8.1,"4-(3,14-Dihydroxy-10,13-Dimethyl-Hexadecahydro-Cyclopenta[a]Phenanthren-17-Yl)-5h-Furan-2-One",XZTUSOXSLKTKJQ-CESUGQOBSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
8878,6lzg,DB06933,-8.1,N-(tert-butyl)-4-[5-(pyridin-2-ylamino)quinolin-3-yl]benzenesulfonamide,GJTCKUKIFXWJKG-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
146909,6w9q,DB09183,-8.1,Dasabuvir,NBRBXGKOEOGLOI-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
87722,6m3m,DB12745,-8.1,GSK-690693,KGPGFQWBCSZGEL-ZDUSSCGKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
131742,6w4h,DB14636,-8.1,Triciribine phosphate,URLYINUFLXOMHP-HTVVRFAVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
121439,6w4b,DB11894,-8.1,Efatutazone,JCYNMRJCUYVDBC-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
87727,6m3m,DB12752,-8.1,Bucindolol,FBMYKMYQHCBIGU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
122817,6w4b,DB13947,-8.1,Testosterone enantate benzilic acid hydrazone,PTVXYACXDYZNID-JKXGKYMWSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
31788,6cs2,DB14753,-8.1,Hydroxystilbamidine,TUESWZZJYCLFNL-DAFODLJHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
112115,6vxx,DB06321,-8.1,R-348,IGLNXKVGKIFNBQ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111995,6vxx,DB05107,-8.1,16-Bromoepiandrosterone,CWVMWSZEMZOUPC-JUAXIXHSSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
32272,6cs2,DB01247,-8.1,Isocarboxazid,XKFPYPQQHFEXRZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
141821,6w9q,DB01411,-8.1,Pranlukast,NBQKINXMPLXUET-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
141820,6w9q,DB01410,-8.1,Ciclesonide,LUKZNWIVRBCLON-GXOBDPJESA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
165509,7bv1,DB12210,-8.1,AZD-6280,NVWCZRPXYVDQEE-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
133541,6w9c,DB01820,-8.1,"Compound 12, N-Acetyl-4-[(Carboxycarbonyl)(2-Carboxyphenyl)Amino]-N-Pentyl-1-Napthylalaniamide",UESXELNYBIOROE-QHCPKHFHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
62393,6crv,DB13514,-8.1,Pranoprofen,TVQZAMVBTVNYLA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
133504,6w9c,DB01771,-8.1,CRA_10991,QXAURVOBXQBPAP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
112110,6vxx,DB06307,-8.1,Apoptone,CKAXZOYFIHQCBN-JRRMKBMNSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
66236,6lxt,DB03909,-8.1,"Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate",UFZTZBNSLXELAL-IOSLPCCCSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
28922,6cs2,DB08546,-8.1,"4-[(3AS,4R,7R,8AS,8BR)-2-(1,3-BENZODIOXOL-5-YLMETHYL)-7-HYDROXY-1,3-DIOXODECAHYDROPYRROLO[3,4-A]PYRROLIZIN-4-YL]BENZENECARBOXIMIDAMIDE",CETLUACQMGBMFH-ZALSBGIRSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
29190,6cs2,DB08834,-8.1,Tauroursodeoxycholic acid,BHTRKEVKTKCXOH-LBSADWJPSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
62616,6crv,DB13815,-8.1,Xenysalate,HLDCSYXMVXILQC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28919,6cs2,DB08543,-8.1,1-[2-HYDROXY-3-(4-CYCLOHEXYL-PHENOXY)-PROPYL]-4-(2-PYRIDYL)-PIPERAZINE,BZJHCQBNFUNZPJ-QFIPXVFZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
9317,6lzg,DB07406,-8.1,"(4R)-N-[4-({[2-(DIMETHYLAMINO)ETHYL]AMINO}CARBONYL)-1,3-THIAZOL-2-YL]-4-METHYL-1-OXO-2,3,4,9-TETRAHYDRO-1H-BETA-CARBOLINE-6-CARBOXAMIDE",QWFFPYQWUWLDBV-NSHDSACASA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
87663,6m3m,DB12659,-8.1,SJ-733,VKCPFWKTFZAOTO-LEWJYISDSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
8887,6lzg,DB06944,-8.1,N-(3-cyclopropyl-1H-pyrazol-5-yl)-2-(2-naphthyl)acetamide,RIGZCVNCFXYBEG-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
142114,6w9q,DB01765,-8.1,"(5-Oxo-5,6-Dihydro-Indolo[1,2-a]Quinazolin-7-Yl)-Acetic Acid",INSBKYCYLCEBOD-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
66309,6lxt,DB04006,-8.1,"[2-Amino-6-(2,6-Difluoro-Benzoyl)-Imidazo[1,2-a]Pyridin-3-Yl]-Phenyl-Methanone",WUGJIPFLBOATGL-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
142081,6w9q,DB01721,-8.1,Analogue of Indinavir Drug,MJIRDPUZGGHJMX-OIVSQUILSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
62625,6crv,DB13825,-8.1,Fedrilate,RDEOYUSTRWNWLX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62627,6crv,DB13827,-8.1,Indanazoline,KUCWWEPJRBANHL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87478,6m3m,DB12380,-8.1,GDC-0152,WZRFLSDVFPIXOV-LRQRDZAKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
131037,6w4h,DB13208,-8.1,Prednylidene,WSVOMANDJDYYEY-CWNVBEKCSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131031,6w4h,DB13185,-8.1,Oxabolone cipionate,KHKDIUPVDIEHAH-KXLSUQFWSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
133321,6w9c,DB01541,-8.1,Boldenone,RSIHSRDYCUFFLA-DYKIIFRCSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
85408,6m3m,DB07625,-8.1,"4-(2-aminoethoxy)-N-(2,5-diethoxyphenyl)-3,5-dimethylbenzamide",PHTPPZCTHZHCQD-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85397,6m3m,DB07613,-8.1,3-phenyl-5-(1H-pyrazol-3-yl)isoxazole,SRSSTOPJERVMRZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
112042,6vxx,DB06157,-8.1,Istaroxime,MPYLDWFDPHRTEG-PAAYLBSLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
123166,6w4b,DB15006,-8.1,Flufenoxuron,RYLHNOVXKPXDIP-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
88168,6m3m,DB13433,-8.1,Simfibrate,JLRNKCZRCMIVKA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85159,6m3m,DB07328,-8.1,"METHYL 4-{[({[(2R,5S)-5-{[(2S)-2-(AMINOMETHYL)PYRROLIDIN-1-YL]CARBONYL}PYRROLIDIN-2-YL]METHYL}AMINO)CARBONYL]AMINO}BENZOATE",USDCNOQKDUFKRD-IKGGRYGDSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84976,6m3m,DB07121,-8.1,"4-({4-[(4-AMINOBUT-2-YNYL)OXY]PHENYL}SULFONYL)-N-HYDROXY-2,2-DIMETHYLTHIOMORPHOLINE-3-CARBOXAMIDE",AANXPIMDONQTQF-HNNXBMFYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
147779,6w9q,DB12428,-8.1,PAC-14028,UKGJZDSUJSPAJL-YPUOHESYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
130350,6w4h,DB12135,-8.1,Elubrixin,YQYFEGTYCUQBEI-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
84971,6m3m,DB07116,-8.1,1-(2-DEOXY-5-O-PHOSPHONO-BETA-D-ERYTHRO-PENTOFURANOSYL)-4-METHYL-1H-INDOLE,UXXYPWCUINVUHL-BFHYXJOUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84970,6m3m,DB07115,-8.1,"N-(4-chlorobenzyl)-N-methylbenzene-1,4-disulfonamide",IPPUTOHDQOYDIL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84952,6m3m,DB07093,-8.1,"{3-[(5-CHLORO-1,3-BENZOTHIAZOL-2-YL)METHYL]-2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL}ACETIC ACID",RQWICELTTDJODO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
130333,6w4h,DB12114,-8.1,Poziotinib,LPFWVDIFUFFKJU-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
84943,6m3m,DB07083,-8.1,beta-phenyl-D-phenylalanyl-N-propyl-L-prolinamide,HZKKJPDVZGOOPU-PZJWPPBQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85629,6m3m,DB07878,-8.1,"N-[(1S)-1-{1-[(1R,3E)-1-ACETYLPENT-3-EN-1-YL]-1H-1,2,3-TRIAZOL-4-YL}-1,2-DIMETHYLPROPYL]BENZAMIDE",OEHUTYXPQSSKAK-RVLLMHTFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
32949,6cs2,T3D3880,-8.1,Methoxyfenozide,QCAWEPFNJXQPAN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
140800,6w9q,DB00137,-8.1,Lutein,KBPHJBAIARWVSC-RGZFRNHPSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
31848,6cs2,DB14876,-8.1,TAS-116,NVVPMZUGELHVMH-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
88762,6m3m,DB14736,-8.1,Cannabivarin,SVTKBAIRFMXQQF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
146082,6w9q,DB08100,-8.1,"2,6-dimethyl-4-[(E)-2-phenylethenyl]phenol",PAHKYLUYTGBFNW-CMDGGOBGSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
84911,6m3m,DB07046,-8.1,"2-[(2-chloro-4-iodophenyl)amino]-N-{[(2R)-2,3-dihydroxypropyl]oxy}-3,4-difluorobenzamide",FCADPEDUULETPK-SECBINFHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
9438,6lzg,DB07538,-8.1,"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}-2-(TRIFLUOROMETHYL)BENZENESULFONAMIDE",RGVVHQNJKUNSFQ-WDZFZDKYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
147879,6w9q,DB12580,-8.1,Tradipitant,CAVRKWRKTNINFF-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
32980,6cs2,T3D3912,-8.1,Prosulfuron,LTUNNEGNEKBSEH-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
133281,6w9c,DB01493,-8.1,Ethylestrenol,AOXRBFRFYPMWLR-XGXHKTLJSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
31545,6cs2,DB13994,-8.1,AZD-7325,KYDURMHFWXCKMW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
31546,6cs2,DB13997,-8.1,Baloxavir marboxil,RZVPBGBYGMDSBG-GGAORHGYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
15235,6lzg,T3D0624,-8.1,Coronene,VPUGDVKSAQVFFS-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
67368,6lxt,DB06578,-8.1,Tonabersat,XLIIRNOPGJTBJD-ROUUACIJSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
67369,6lxt,DB06579,-8.1,Adipiplon,UAMAIHOEGLEXSV-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
140950,6w9q,DB00307,-8.1,Bexarotene,NAVMQTYZDKMPEU-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
67395,6lxt,DB06626,-8.1,Axitinib,RITAVMQDGBJQJZ-FMIVXFBMSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
130429,6w4h,DB12253,-8.1,GDC-0810,BURHGPHDEVGCEZ-KJGLQBJMSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
31568,6cs2,DB14038,-8.1,beta-Sitosterol,KZJWDPNRJALLNS-VJSFXXLFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
112998,6vxx,DB08245,-8.1,1-(2-DEOXY-5-O-PHOSPHONO-BETA-D-ERYTHRO-PENTOFURANOSYL)-5-NITRO-1H-INDOLE,FQCJFJRLZCIFHB-YNEHKIRRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62738,6crv,DB14050,-8.1,Cannabidivarin,REOZWEGFPHTFEI-JKSUJKDBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140830,6w9q,DB00169,-8.1,Cholecalciferol,QYSXJUFSXHHAJI-YRZJJWOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
87357,6m3m,DB12214,-8.1,Luseogliflozin,WHSOLWOTCHFFBK-ZQGJOIPISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
130396,6w4h,DB12210,-8.1,AZD-6280,NVWCZRPXYVDQEE-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
146107,6w9q,DB08126,-8.1,"3-{[4-([AMINO(IMINO)METHYL]AMINOSULFONYL)ANILINO]METHYLENE}-2-OXO-2,3-DIHYDRO-1H-INDOLE",DMCRNUMVSATRTP-LCYFTJDESA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
147745,6w9q,DB12385,-8.1,10-hydroxycamptothecin,HAWSQZCWOQZXHI-FQEVSTJZSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
61899,6crv,DB12766,-8.1,Cicletanine,CVKNDPRBJVBDSS-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
134072,6w9c,DB02527,-8.1,Cyclic adenosine monophosphate,IVOMOUWHDPKRLL-KQYNXXCUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
15242,6lzg,T3D0632,-8.1,Anthanthrene,YFIJJNAKSZUOLT-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
15239,6lzg,T3D0629,-8.1,Pentacene,SLIUAWYAILUBJU-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
113020,6vxx,DB08274,-8.1,"6,7,8,9-TETRAHYDRO-4-HYDROXY-3-(1-PHENYLPROPYL)CYCLOHEPTA[B]PYRAN-2-ONE",YKJXQZGJGDTEOC-AWEZNQCLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130378,6w4h,DB12183,-8.1,Sapitinib,DFJSJLGUIXFDJP-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
67579,6lxt,DB06916,-8.1,"N-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-1-[2-(1H-IMIDAZOL-1-YL)-6-METHYLPYRIMIDIN-4-YL]-D-PROLINAMIDE",LBCGUKCXRVUULK-QGZVFWFLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
85621,6m3m,DB07870,-8.1,(2S)-2-(4-{[3-CHLORO-5-(TRIFLUOROMETHYL)PYRIDIN-2-YL]OXY}PHENOXY)PROPANOIC ACID,GOCUAJYOYBLQRH-MRVPVSSYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
67583,6lxt,DB06920,-8.1,Eribaxaban,QQBKAVAGLMGMHI-WIYYLYMNSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
84909,6m3m,DB07043,-8.1,"7-amino-2-tert-butyl-4-(4-pyrimidin-2-ylpiperazin-1-yl)pyrido[2,3-d]pyrimidine-6-carboxamide",CKLCIJCZOIDJQU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
2027,6lzg,HMDB0030180,-8.1,Crustecdysone,NKDFYOWSKOHCCO-YPVLXUMRSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
133244,6w9c,DB01453,-8.1,Beta-hydroxyfentanyl,JEFVHLMGRUJLET-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
61795,6crv,DB12604,-8.1,Sisomicin,URWAJWIAIPFPJE-YFMIWBNJSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112169,6vxx,DB06478,-8.1,Porfiromycin,HRHKSTOGXBBQCB-VFWICMBZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
147992,6w9q,DB12760,-8.1,GW-493838,ZQYJPMPXQLNTPQ-QCUYGVNKSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
65238,6lxt,DB02567,-8.1,PD173955,VAARYSWULJUGST-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
61790,6crv,DB12594,-8.1,AZD-9056,HSQAARMBHJCUOK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130214,6w4h,DB11939,-8.1,Henagliflozin,HYTPDMFFHVZBOR-VNXMGFANSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
165385,7bv1,DB12024,-8.1,PF-04418948,LWJGMYMNSNVCEM-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
84845,6m3m,DB06971,-8.1,"N-{2-[(4'-CYANO-1,1'-BIPHENYL-4-YL)OXY]ETHYL}-N'-HYDROXY-N-METHYLUREA",GVMUNGGWXRKCEU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
61786,6crv,DB12588,-8.1,AZD-1480,PDOQBOJDRPLBQU-QMMMGPOBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
134405,6w9c,DB03035,-8.1,"1,8-Di-Hydroxy-4-Nitro-Anthraquinone",RIYCICFDXLNQPV-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
134431,6w9c,DB03069,-8.1,Cytidine-5'-Diphospho-Beta-D-Xylose,NWSKPSPTJOAICE-OCIMBMBZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
84824,6m3m,DB06942,-8.1,N-(4-carbamimidoylbenzyl)-1-(3-phenylpropanoyl)-L-prolinamide,RNZKCCPFUWHBFY-IBGZPJMESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
131921,6w4h,DB15029,-8.1,AZD-8186,LMJFJIDLEAWOQJ-CQSZACIVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
67716,6lxt,DB07078,-8.1,"(3Z)-6-(4-HYDROXY-3-METHOXYPHENYL)-3-(1H-PYRROL-2-YLMETHYLENE)-1,3-DIHYDRO-2H-INDOL-2-ONE",AYSXURJZVXBSRV-WJDWOHSUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
146046,6w9q,DB08058,-8.1,"4-[3-(1,4-diazepan-1-ylcarbonyl)-4-fluorobenzyl]phthalazin-1(2H)-one",HGEPGGJUGUMFHT-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
87282,6m3m,DB12100,-8.1,Abediterol,SFYAXIFVXBKRPK-QFIPXVFZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
142291,6w9q,DB02008,-8.1,1-(2-Fluorobenzyl)-3-Butyl-8-(N-Acetyl-4-Aminobenzyl)-Xanthine,JHSHXKJSPVHPCJ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
65273,6lxt,DB02615,-8.1,Compound 19,UZOOIPXOYYJULJ-BLIZRMSTSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
67669,6lxt,DB07025,-8.1,3-(5-{[4-(AMINOMETHYL)PIPERIDIN-1-YL]METHYL}-1H-INDOL-2-YL)QUINOLIN-2(1H)-ONE,KBIHHEGEALBUMT-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
88835,6m3m,DB14900,-8.1,ISO-1 F-18,QVRVXSZKCXFBTE-KPVNRNJOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
130273,6w4h,DB12025,-8.1,Triptolide,DFBIRQPKNDILPW-CIVMWXNOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130270,6w4h,DB12021,-8.1,Dinaciclib,PIMQWRZWLQKKBJ-SFHVURJKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
147933,6w9q,DB12669,-8.1,4SC-203,MAFACRSJGNJHCF-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
87319,6m3m,DB12150,-8.1,Pelubiprofen,AUZUGWXLBGZUPP-GXDHUFHOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
165394,7bv1,DB12041,-8.1,Mapracorat,VJGFOYBQOIPQFY-XMMPIXPASA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
134273,6w9c,DB02854,-8.1,Aetiocholanolone,QGXBDMJGAMFCBF-BNSUEQOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
133269,6w9c,DB01480,-8.1,Cyprenorphine,VSKIOMHXEUHYSI-KNLIIKEYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
88806,6m3m,DB14849,-8.1,Nebicapone,MRFOLGFFTUGAEB-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
65313,6lxt,DB02668,-8.1,"Je-2147, Ag1776, Kni-764",CUFQBQOBLVLKRF-RZDMPUFOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
32984,6cs2,T3D3916,-8.1,Pyriproxyfen,NHDHVHZZCFYRSB-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
130255,6w4h,DB12000,-8.1,Apabetalone,NETXMUIMUZJUTB-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130251,6w4h,DB11994,-8.1,Diacerein,TYNLGDBUJLVSMA-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
67645,6lxt,DB06997,-8.1,"2-(4-fluorophenyl)-N-{[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]carbamoyl}acetamide",BMPOCDJEXAXXEZ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
134331,6w9c,DB02929,-8.1,K201,KCWGETCFOVJEPI-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
67654,6lxt,DB07006,-8.1,"9-HYDROXY-6-(3-HYDROXYPROPYL)-4-(2-METHOXYPHENYL)PYRROLO[3,4-C]CARBAZOLE-1,3(2H,6H)-DIONE",AOGOZJCRIFBTTN-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
31515,6cs2,DB13947,-8.1,Testosterone enantate benzilic acid hydrazone,PTVXYACXDYZNID-JKXGKYMWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
67661,6lxt,DB07015,-8.1,"(3R,4R)-4-(pyrrolidin-1-ylcarbonyl)-1-(quinoxalin-2-ylcarbonyl)pyrrolidin-3-amine",XDSKICAQKGYYJF-OLZOCXBDSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
130228,6w4h,DB11958,-8.1,Brivanib,WCWUXEGQKLTGDX-LLVKDONJSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130224,6w4h,DB11950,-8.1,Teneligliptin,WGRQANOPCQRCME-PMACEKPBSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
61846,6crv,DB12685,-8.1,K-134,ULGNGSQNNMKROG-WOJBJXKFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
9449,6lzg,DB07548,-8.1,"2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUORO-6-PYRIDINYL)METHYL]ACETAMIDE",JXHWVKOKYDAROD-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
65499,6lxt,DB02915,-8.1,"4-(2,4-Dimethyl-1,3-thiazol-5-yl)-N-[4-(trifluoromethyl)phenyl]-2-pyrimidinamine",MEZFDQUDLQCVNX-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
88588,6m3m,DB14075,-8.1,Imidurea,ZCTXEAQXZGPWFG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85106,6m3m,DB07272,-8.1,"N-(4-AMINO-5-CYANO-6-ETHOXYPYRIDIN-2-YL)-2-(4-BROMO-2,5-DIMETHOXYPHENYL)ACETAMIDE",GKODDLYLEKSDJL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
112130,6vxx,DB06370,-8.1,Indisulam,SETFNECMODOHTO-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31664,6cs2,DB14232,-8.1,Deacetylbisacodyl,LJROKJGQSPMTKB-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
31660,6cs2,DB14218,-8.1,Telotristat,NCLGDOBQAWBXRA-PGRDOPGGSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
87400,6m3m,DB12271,-8.1,ORE-1001,NTCCRGGIJNDEAB-IRXDYDNUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
112921,6vxx,DB08151,-8.1,"(5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-phenyl-1,6-dioxa-2-azaspiro[4.5]dec-2-ene-8,9,10-triol",YLTDNVVQKRHCJP-RKQHYHRCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
131835,6w4h,DB14810,-8.1,AZD-1656,FJEJHJINOKKDCW-INIZCTEOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
146200,6w9q,DB08237,-8.1,2'-deoxy-N-(naphthalen-1-ylmethyl)guanosine 5'-(dihydrogen phosphate),COMPKRGNHXOXMN-GVDBMIGSSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
111869,6vxx,DB04807,-8.1,4-NITROPHENYL-(6-S-ALPHA-D-XYLOPYRANOSYL)-BETA-D-GLUCOPYRANOSIDE,HQYVHBCTLFPWRQ-ZMFOIVQCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
32840,6cs2,T3D3754,-8.1,Emestrin,VASYTSFNISZKEL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
147428,6w9q,DB11923,-8.1,Decoglurant,DMJHZVARRXJSEG-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
67191,6lxt,DB06117,-8.1,"1alpha,24S-Dihydroxyvitamin D2",ODZFJAXAEXQSKL-WRJREGAQSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
67195,6lxt,DB06134,-8.1,SNS-314,FAYAUAZLLLJJGH-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
62023,6crv,DB12964,-8.1,Lerisetron,PWWDCRQZITYKDV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
133923,6w9c,DB02342,-8.1,2-Methox1tradiol,CQOQDQWUFQDJMK-SSTWWWIQSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
67208,6lxt,DB06157,-8.1,Istaroxime,MPYLDWFDPHRTEG-PAAYLBSLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
147459,6w9q,DB11968,-8.1,MK-7145,OCKGFTQIICXDQW-ZEQRLZLVSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
62015,6crv,DB12949,-8.1,PF-03382792,AGMOFKKOVMRGAK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
131839,6w4h,DB14828,-8.1,ABX-464,OZOGDCZJYVSUBR-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
133839,6w9c,DB02224,-8.1,Taxifolin,CXQWRCVTCMQVQX-LSDHHAIUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
85109,6m3m,DB07276,-8.1,"5-CYANO-N-(2,5-DIMETHOXYBENZYL)-6-ETHOXYPYRIDINE-2-CARBOXAMIDE",VEGKZYFYGCWXMN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
131817,6w4h,DB14769,-8.1,Pamiparib,DENYZIUJOTUUNY-MRXNPFEDSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
15471,6lzg,T3D1039,-8.1,Fluvalinate,INISTDXBRIBGOC-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
147337,6w9q,DB11793,-8.1,Niraparib,PCHKPVIQAHNQLW-CQSZACIVSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
131816,6w4h,DB14768,-8.1,PF-06459988,ODMXWZROLKITMS-RISCZKNCSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
29233,6cs2,DB08903,-8.1,Bedaquiline,QUIJNHUBAXPXFS-XLJNKUFUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
31686,6cs2,DB14555,-8.1,Ursadiol,RTLXJEJRLWILSU-GWNGJUQLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
31682,6cs2,DB14545,-8.1,Hydrocortisone succinate,VWQWXZAWFPZJDA-CGVGKPPMSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
147350,6w9q,DB11814,-8.1,PF-03882845,XNULRSOGWPFPBL-REWPJTCUSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
85145,6m3m,DB07313,-8.1,5-METHYL-2-[(PHENYLSULFONYL)AMINO]BENZOIC ACID,HXQLTRSIZRSFTR-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85141,6m3m,DB07309,-8.1,5-BROMO-2-{[(4-CHLOROPHENYL)SULFONYL]AMINO}BENZOIC ACID,JDVLYAYDIMUAAC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
133818,6w9c,DB02196,-8.1,Uridine-Diphosphate-N-Acetylgalactosamine,LFTYTUAZOPRMMI-NESSUJCYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
133824,6w9c,DB02205,-8.1,"6-(1,1-Dimethylallyl)-2-(1-Hydroxy-1-Methylethyl)-2,3-Dihydro-7h-Furo[3,2-G]Chromen-7-One",JCDLLLXYAICSQV-INIZCTEOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
130640,6w4h,DB12555,-8.1,Nelotanserin,COSPVUFTLGQDQL-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
62064,6crv,DB13027,-8.1,Tucaresol,XEDONBRPTABQFB-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62691,6crv,DB13953,-8.1,Estradiol benzoate,UYIFTLBWAOGQBI-BZDYCCQFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
147373,6w9q,DB11844,-8.1,Pritelivir,IVZKZONQVYTCKC-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
141501,6w9q,DB00966,-8.1,Telmisartan,RMMXLENWKUUMAY-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
28876,6cs2,DB08498,-8.1,"(1S)-1-(3-chlorophenyl)-2-oxo-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate",OVSAMUIBGQSLDC-INIZCTEOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
88238,6m3m,DB13531,-8.1,Nicofetamide,DWODOIKZDGJOPQ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88250,6m3m,DB13546,-8.1,Nizofenone,WZGBZLHGOVJDET-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
62717,6crv,DB14008,-8.1,Hispidulin,IHFBPDAQLQOCBX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
67361,6lxt,DB06543,-8.1,Astaxanthin,MQZIGYBFDRPAKN-UWFIBFSHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
67209,6lxt,DB06159,-8.1,Rubitecan,VHXNKPBCCMUMSW-FQEVSTJZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
147466,6w9q,DB11984,-8.1,Letaxaban,GEHAEMCVKDPMKO-HXUWFJFHSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
112946,6vxx,DB08177,-8.1,(E)-3-(5((5-(4-CHLOROPHENYL)FURAN-2-YL)METHYLENE)-4-OXO-2-THIOXOTHIAZOLIDIN-3-YL)PROPANOIC ACID,YZLFZFALAZYTCI-NTEUORMPSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
65570,6lxt,DB03010,-8.1,Patupilone,QXRSDHAAWVKZLJ-PVYNADRNSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
32156,6cs2,DB15460,-8.1,AGG-523,JWQMTWCFNZSLNR-DEOSSOPVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
130555,6w4h,DB12426,-8.1,Bitopertin,YUUGYIUSCYNSQR-LBPRGKRZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
111800,6vxx,DB04712,-8.1,ANILINOMETHYL GLUCO-PHENYLIMIDAZOLE,ADKWVGPRAQKVKB-YIYPIFLZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
146122,6w9q,DB08143,-8.1,"5-CHLORO-THIOPHENE-2-CARBOXYLIC ACID ((3S,4S)-4-FLUORO- 1-{[2-FLUORO-4-(2-OXO-2H-PYRIDIN-1-YL)-PHENYLCARBAMOYL]-METHYL}-PYRROLIDIN-3-YL)-AMIDE",SXIYSYYSKHUTQQ-RDJZCZTQSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
85041,6m3m,DB07195,-8.1,"4-[(1S,2S,5S)-5-(HYDROXYMETHYL)-6,8,9-TRIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL",DTZWKYVREFMAJA-QXWBOSQLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
147611,6w9q,DB12198,-8.1,Fosdagrocorat,BVXLAHSJXXSWFF-KEKPKEOLSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
67307,6lxt,DB06412,-8.1,Oxymetholone,ICMWWNHDUZJFDW-DHODBPELSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
130544,6w4h,DB12412,-8.1,Gemigliptin,ZWPRRQZNBDYKLH-VIFPVBQESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
88528,6m3m,DB13955,-8.1,Estradiol dienanthate,OVAHZPTYWMWNKO-CAHAWPIUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
165405,7bv1,DB12055,-8.1,MK-0767,ORZMUVMQJPGFOM-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
141106,6w9q,DB00496,-8.1,Darifenacin,HXGBXQDTNZMWGS-RUZDIDTESA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
31582,6cs2,DB14066,-8.1,Tetrandrine,WVTKBKWTSCPRNU-KYJUHHDHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
85023,6m3m,DB07174,-8.1,"6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-4-(3-METHOXYPROPYL)-2,2-DIMETHYL-2H-1,4-BENZOXAZIN-3(4H)-ONE",WPAPODFGOZXFLG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
112969,6vxx,DB08208,-8.1,"2-[(4-ETHYNYL-2-FLUOROPHENYL)AMINO]-3,4-DIFLUORO-N-(2-HYDROXYETHOXY)BENZAMIDE",AMNKRBRQQAMACZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88571,6m3m,DB14045,-8.1,Cholesteryl chloride,OTVRYZXVVMZHHW-DPAQBDIFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
8821,6lzg,DB06876,-8.1,"N-{5-[4-(4-METHYLPIPERAZIN-1-YL)PHENYL]-1H-PYRROLO[2,3-B]PYRIDIN-3-YL}NICOTINAMIDE",YJWJKKXGAPWLGT-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
130514,6w4h,DB12375,-8.1,Oglemilast,OKFDRAHPFKMAJH-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
31586,6cs2,DB14069,-8.1,ONT-093,RSJCLODJSVZNQA-BQYQJAHWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
85050,6m3m,DB07205,-8.1,N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,GZJXCRHEMLAMRA-SDBHATRESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
28859,6cs2,DB08481,-8.1,"4-METHYL-N-{(5E)-5-[(5-METHYL-2-FURYL)METHYLENE]-4-OXO-4,5-DIHYDRO-1,3-THIAZOL-2-YL}BENZENESULFONAMIDE",MXAPQGDBWFYKKX-ZROIWOOFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
67220,6lxt,DB06188,-8.1,Ispinesib,QJZRFPJCWMNVAV-HHHXNRCGSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
111834,6vxx,DB04761,-8.1,"PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-[(PYRIDIN-3-YLMETHYL)-AMIDE]",NHPBWKYFMTXWAA-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61998,6crv,DB12927,-8.1,Theodrenaline,WMCMJIGLYZDKRN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88375,6m3m,DB13714,-8.1,Xibornol,RNRHMQWZFJXKLZ-JCKWVBRZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
61996,6crv,DB12925,-8.1,Crolibulin,JXONINOYTKKXQQ-CQSZACIVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
133969,6w9c,DB02400,-8.1,"5-Methoxy-1,2-Dimethyl-3-(4-Nitrophenoxymethyl)Indole-4,7-Dione",IBLWSLZYYZHSRG-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
141350,6w9q,DB00796,-8.1,Candesartan cilexetil,GHOSNRCGJFBJIB-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
85067,6m3m,DB07227,-8.1,4-[(5-{[4-(3-CHLOROPHENYL)-3-OXOPIPERAZIN-1-YL]METHYL}-1H-IMIDAZOL-1-YL)METHYL]BENZONITRILE,JNUGFGAVPBYSHF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
112939,6vxx,DB08169,-8.1,(2Z)-N-biphenyl-4-yl-2-cyano-3-cyclopropyl-3-hydroxyprop-2-enamide,CAGGGMPTWTUYHZ-ZCXUNETKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61989,6crv,DB12912,-8.1,Nolatrexed,XHWRWCSCBDLOLM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
65585,6lxt,DB03035,-8.1,"1,8-Di-Hydroxy-4-Nitro-Anthraquinone",RIYCICFDXLNQPV-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
67274,6lxt,DB06302,-8.1,Glesatinib,YRCHYHRCBXNYNU-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
141272,6w9q,DB00700,-8.1,Eplerenone,JUKPWJGBANNWMW-VWBFHTRKSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
88458,6m3m,DB13823,-8.1,Pipemidic acid,JOHZPMXAZQZXHR-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
133289,6w9c,DB01503,-8.1,1-Androstenediol,RZFGPAMUAXASRE-YSZCXEEOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
133992,6w9c,DB02424,-8.1,Geldanamycin,QTQAWLPCGQOSGP-KSRBKZBZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
85061,6m3m,DB07219,-8.1,"BENZYL N-({(2S,3S)-3-[(PROPYLAMINO)CARBONYL]OXIRAN-2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINATE",OMQNYWZURFTFHE-MQBSTWLZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
147556,6w9q,DB12115,-8.1,AZD-9164,FNYFFCOCVNTJCD-NNMXADRKSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
85058,6m3m,DB07216,-8.1,"(11S)-8-CHLORO-11-[1-(METHYLSULFONYL)PIPERIDIN-4-YL]-6-PIPERAZIN-1-YL-11H-BENZO[5,6]CYCLOHEPTA[1,2-B]PYRIDINE",ZMGCFGGMTCMSDP-QHCPKHFHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85077,6m3m,DB07239,-8.1,7-(aminomethyl)-6-(2-chlorophenyl)-1-methyl-1H-benzimidazole-5-carbonitrile,YJLVMTVZVJSNHG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
64412,6lxt,DB01497,-8.1,Etorphine,CAHCBJPUTCKATP-HBDRVVKHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
145451,6w9q,DB07360,-8.1,"1-{5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)ethyl]-1,3-thiazol-2-yl}-3-[3-(trifluoromethyl)phenyl]urea",JJHXPDTVQKWKHA-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
35557,1r42,DB01761,-8.1,4-[5-[2-(1-Phenyl-Ethylamino)-Pyrimidin-4-Yl]-1-Methyl-4-(3-Trifluoromethylphenyl)-1h-Imidazol-2-Yl]-Piperidine,QICPQLFMWYQJGX-SFHVURJKSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
136288,6w9c,DB06940,-8.1,"N-ethyl-4-{[5-(methoxycarbamoyl)-2-methylphenyl]amino}-5-methylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide",ZZTMFGIGOADCFX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
60177,6crv,DB08330,-8.1,METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE,VEJCBCPEURAYAS-MEAXDALNSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110244,6vxx,DB01142,-8.1,Doxepin,ODQWQRRAPPTVAG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
120062,6w4b,DB08037,-8.1,"(2S)-4-(2,5-difluorophenyl)-N-[(3R,4S)-3-fluoro-1-methylpiperidin-4-yl]-2-(hydroxymethyl)-N-methyl-2-phenyl-2,5-dihydro-1H-pyrrole-1-carboxamide",MYBGWENAVMIGMM-GIFXNVAJSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
96078,6m71,DB12364,-8.1,Betrixaban,XHOLNRLADUSQLD-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
70421,6lxt,DB12627,-8.1,GSK-1292263,AYJRTVVIBJSSKN-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
132569,6w9c,DB00589,-8.1,Lisuride,BKRGVLQUQGGVSM-KBXCAEBGSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
82148,6m3m,DB02166,-8.1,Propidium,ZDWVWKDAWBGPDN-UHFFFAOYSA-O,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
60184,6crv,DB08344,-8.1,4-chloro-N-(3-methoxypropyl)-N-[(3S)-1-(2-phenylethyl)piperidin-3-yl]benzamide,OOUGHDJEJNMXSV-QHCPKHFHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86528,6m3m,DB08984,-8.1,Etofenamate,XILVEPYQJIOVNB-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
70426,6lxt,DB12637,-8.1,Onapristone,IEXUMDBQLIVNHZ-YOUGDJEHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
9833,6lzg,DB07965,-8.1,6-(cyclohexylamino)-9-[2-(4-methylpiperazin-1-yl)-ethyl]-9H-purine-2-carbonitrile,OGODDSLNRULSMM-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
140523,6w9c,DB12005,-8.1,Nirogacestat,VFCRKLWBYMDAED-REWPJTCUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136301,6w9c,DB06959,-8.1,(2S)-1-(3H-Indol-3-yl)-3-{[5-(6-isoquinolinyl)-3-pyridinyl]oxy}-2-propanamine,BUCZDJYEOAQTHL-KEKNWZKVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
9839,6lzg,DB00734,-8.1,Risperidone,RAPZEAPATHNIPO-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
82113,6m3m,DB02116,-8.1,Olomoucine,GTVPOLSIJWJJNY-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
165081,7bv1,DB09209,-8.1,Pholcodine,GPFAJKDEDBRFOS-FKQDBXSBSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
70453,6lxt,DB12673,-8.1,ATX-914,ALANRBCCCQEPFZ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
110240,6vxx,DB01137,-8.1,Levofloxacin,GSDSWSVVBLHKDQ-JTQLQIEISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
70379,6lxt,DB12558,-8.1,AEE-788,OONFNUWBHFSNBT-HXUWFJFHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
82191,6m3m,DB02226,-8.1,"3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-4-Yl]Hexyl]-Phenanthridinium",NAARZDJZGYBXKL-UHFFFAOYSA-O,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
54880,6crv,DB00341,-8.1,Cetirizine,ZKLPARSLTMPFCP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110281,6vxx,DB01183,-8.1,Naloxone,UZHSEJADLWPNLE-GRGSLBFTSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60213,6crv,DB08378,-8.1,"4-[4-(2,5-DIOXO-PYRROLIDIN-1-YL)-PHENYLAMINO]-4-HYDROXY-BUTYRIC ACID",SUETUOGYOWOLNJ-NSHDSACASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
95894,6m71,DB12101,-8.1,CC-220,IXZOHGPZAQLIBH-NRFANRHFSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
132567,6w9c,DB00587,-8.1,Cinalukast,BZMKNPGKXJAIDV-VAWYXSNFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
143072,6w9q,DB03038,-8.1,LY341770,MXAFDBCLWLMXSI-ZDUSSCGKSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
95913,6m71,DB12127,-8.1,Sultamicillin,OPYGFNJSCUDTBT-PMLPCWDUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
63774,6lxt,DB00687,-8.1,Fludrocortisone,AAXVEMMRQDVLJB-BULBTXNYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
110273,6vxx,DB01175,-8.1,Escitalopram,WSEQXVZVJXJVFP-FQEVSTJZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
124081,6w4h,DB00737,-8.1,Meclizine,OCJYIGYOJCODJL-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
95999,6m71,DB12253,-8.1,GDC-0810,BURHGPHDEVGCEZ-KJGLQBJMSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
158909,7bv1,DB02621,-8.1,Latrunculin A,DDVBPZROPPMBLW-IZGXTMSKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
136268,6w9c,DB06918,-8.1,2-(2-METHYLPHENYL)-1H-INDOLE-6-CARBOXIMIDAMIDE,ZRYXDGAKQGRHFG-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
132568,6w9c,DB00588,-8.1,Fluticasone propionate,WMWTYOKRWGGJOA-CENSZEJFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
70355,6lxt,DB12522,-8.1,Toreforant,FCRFVPZAXGJLPW-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
9005,6lzg,DB07072,-8.1,"(1S,2R,5S)-5-[3-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7(8H)-YL]-2-(2,4,5-TRIFLUOROPHENYL)CYCLOHEXANAMINE",CNKRZILQBKJWDS-WMFXKJRFSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
70367,6lxt,DB12540,-8.1,Lecozotan,NRPQELCNMADTOZ-OAQYLSRUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
70371,6lxt,DB12547,-8.1,LY-2886721,NIDRNVHMMDAAIK-YPMLDQLKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
144313,6w9q,DB04703,-8.1,Hesperidin,QUQPHWDTPGMPEX-QJBIFVCTSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
144309,6w9q,DB04696,-8.1,"4-CHLORO-3',3''-DIBROMOPHENOL-1,8-NAPHTHALEIN",GFGZCXHXQCQRFP-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
144255,6w9q,DB04623,-8.1,"2-ETHOXYETHYL (2S,3S)-4-((S)-2-BENZYL-3-OXO-4-((3AR,8R,8AS)-2-OXO-3,3A,8,8A-TETRAHYDRO-2H-INDENO[1,2-D]OXAZOL-8-YL)-2,3-DIHYDRO-1H-PYRROL-2-YL)-3-HYDROXY-1-PHENYLBUTAN-2-YLCARBAMATE",CGBRFCVAMLJVEA-ZGURCIGKSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
112455,6vxx,DB07123,-8.1,N-(4-METHYLBENZOYL)-4-BENZYLPIPERIDINE,DVOLWKZEIDCCES-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
63733,6lxt,DB00635,-8.1,Prednisone,XOFYZVNMUHMLCC-ZPOLXVRWSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
9847,6lzg,DB07978,-8.1,"2-({[2,3,5,6-TETRAFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)CYCLOPENTA-1,3-DIENE-1-CARBOXYLIC ACID",ULMUPVXFUDHRGH-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
129059,6w4h,DB08341,-8.1,"4-{[4-{[(1R,2R)-2-(dimethylamino)cyclopentyl]amino}-5-(trifluoromethyl)pyrimidin-2-yl]amino}-N-methylbenzenesulfonamide",CAUFYHKGKDJMQG-HZPDHXFCSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
70516,6lxt,DB12774,-8.1,AZD-8055,KVLFRAWTRWDEDF-IRXDYDNUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
96343,6m71,DB12764,-8.1,ABC-294640,CAOTVXGYTWCKQE-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
165672,7bv1,DB12637,-8.1,Onapristone,IEXUMDBQLIVNHZ-YOUGDJEHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
121891,6w4b,DB12550,-8.1,Taladegib,SZBGQDXLNMELTB-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
70528,6lxt,DB12796,-8.1,MRX-I,SULYVXZZUMRQAX-NSHDSACASA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
165019,7bv1,DB09101,-8.1,Elvitegravir,JUZYLCPPVHEVSV-LJQANCHMSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
140507,6w9c,DB11982,-8.1,GDC-0623,RFWVETIZUQEJEF-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
159119,7bv1,DB03173,-8.1,CRA_10433,CFSQPEBVGUSQII-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
70545,6lxt,DB12825,-8.1,Lefamulin,KPVIXBKIJXZQJX-FCEONZPQSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
70565,6lxt,DB12858,-8.1,LY-377604,RBSGUQYXRDKPAE-QFIPXVFZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
81911,6m3m,DB01842,-8.1,3'-Phosphate-Adenosine-5'-Diphosphate,GBBWIZKLHXYJOA-KQYNXXCUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81870,6m3m,DB01791,-8.1,Piclamilast,RRRUXBQSQLKHEL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
140502,6w9c,DB11969,-8.1,Uprosertib,AXTAPYRUEKNRBA-JTQLQIEISA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
113610,6vxx,DB11648,-8.1,Afuresertib,AFJRDFWMXUECEW-LBPRGKRZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
96530,6m71,DB13060,-8.1,CEP-37440,BCSHRERPHLTPEE-NRFANRHFSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
129001,6w4h,DB08267,-8.1,"6-amino-4-(2-phenylethyl)-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",PBZAIUVFRISTSZ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
86466,6m3m,DB08897,-8.1,Aclidinium,ASMXXROZKSBQIH-VITNCHFBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136348,6w9c,DB07015,-8.1,"(3R,4R)-4-(pyrrolidin-1-ylcarbonyl)-1-(quinoxalin-2-ylcarbonyl)pyrrolidin-3-amine",XDSKICAQKGYYJF-OLZOCXBDSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
166183,7bv1,DB13797,-8.1,Iodocholesterol (131I),FIOAEFCJGZJUPW-ODFYUTSGSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
129061,6w4h,DB08345,-8.1,"4-(2-(1H-IMIDAZOL-4-YL)ETHYLAMINO)-2-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE",IWUUKHQIKFHWIW-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
63608,6lxt,DB00481,-8.1,Raloxifene,GZUITABIAKMVPG-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
82051,6m3m,DB02038,-8.1,"D-[3-hydroxy-2-methyl-5-phosphonooxymethyl-pyridin-4-ylmethyl]-N,O-cycloserylamide",NNRZSZJOQKAGTO-SECBINFHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
60114,6crv,DB08253,-8.1,NAM NAPTHYLAMINOALANINE,DGFMSNJYBBNHCX-LBPRGKRZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136319,6w9c,DB06983,-8.1,"(5-phenyl-7-(pyridin-3-ylmethylamino)pyrazolo[1,5-a]pyrimidin-3-yl)methanol",RBLKWWBHDUBPFN-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
132832,6w9c,DB00901,-8.1,Bitolterol,FZGVEKPRDOIXJY-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
60111,6crv,DB08247,-8.1,6-(CYCLOHEXYLMETHOXY)-8-ISOPROPYL-9H-PURIN-2-AMINE,JABXNQUXGJTKRO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86514,6m3m,DB08968,-8.1,Fominoben,KSNNEUZOAFRTDS-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86513,6m3m,DB08967,-8.1,Dimetotiazine,VWNWVCJGUMZDIU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
82037,6m3m,DB02020,-8.1,Alrestatin,GCUCIFQCGJIRNT-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
96273,6m71,DB12658,-8.1,AFN-1252,QXTWSUQCXCWEHF-JXMROGBWSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96286,6m71,DB12673,-8.1,ATX-914,ALANRBCCCQEPFZ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
70497,6lxt,DB12742,-8.1,Amuvatinib,FOFDIMHVKGYHRU-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
31928,6cs2,DB15052,-8.1,Ansofaxine,QKYBZJLEMOZFFU-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
54924,6crv,DB00394,-8.1,Beclomethasone dipropionate,KUVIULQEHSCUHY-XYWKZLDCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
124165,6w4h,DB00836,-8.1,Loperamide,RDOIQAHITMMDAJ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
129068,6w4h,DB08352,-8.1,"6-[4-(2-fluorophenyl)-1,3-oxazol-5-yl]-N-(1-methylethyl)-1,3-benzothiazol-2-amine",FQYJTHIYAQQJAB-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
96303,6m71,DB12705,-8.1,Cenerimod,KJKKMMMRWISKRF-FQEVSTJZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
112467,6vxx,DB07289,-8.1,5-[3-(BENZYLAMINO)PHENYL]-4-BROMO-3-(CARBOXYMETHOXY)THIOPHENE-2-CARBOXYLIC ACID,XEQPGVUGYAUMSA-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
124171,6w4h,DB00844,-8.1,Nalbuphine,NETZHAKZCGBWSS-CEDHKZHLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
9012,6lzg,DB07081,-8.1,"(2R)-4-[(8R)-8-METHYL-2-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[1,5-A]PYRAZIN-7(8H)-YL]-4-OXO-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE",FDEXEPZGMKFCTG-PSASIEDQSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
9844,6lzg,DB07975,-8.1,"2-({[3,5-DIFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)CYCLOPENT-1-ENE-1-CARBOXYLIC ACID",VTGXLCZUWFYELR-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
70620,6lxt,DB12939,-8.1,Nikkomycin Z,WWJFFVUVFNBJTN-VHDFTHOZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
132559,6w9c,DB00579,-8.1,Mazindol,ZPXSCAKFGYXMGA-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
63172,6crv,DB15279,-8.1,CB-103,WHIWGRCYMQLLAO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
144622,6w9q,DB05713,-8.1,LY-517717,VYNKVNDKAOGAAQ-RUZDIDTESA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
82587,6m3m,DB02738,-8.1,Adenosine-5'-Pentaphosphate,WYJWVZZCMBUPSP-KQYNXXCUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
63958,6lxt,DB00901,-8.1,Bitolterol,FZGVEKPRDOIXJY-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
112427,6vxx,DB07090,-8.1,(3S)-N-(3-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE,NJNMAZNXKKBTPS-ZDUSSCGKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86683,6m3m,DB09223,-8.1,Blonanserin,XVGOZDAJGBALKS-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
95618,6m71,DB11692,-8.1,Pavinetant,QYTBBBAHNIWFOD-NRFANRHFSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60337,6crv,DB08526,-8.1,CARBOBENZYLOXY-(L)-LEUCINYL-(L)LEUCINYL METHOXYMETHYLKETONE,LHCNZPLAATYYPI-SLFFLAALSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112598,6vxx,DB07439,-8.1,"1-((2-HYDROXYETHOXY)METHYL)-5-(3-(BENZYLOXY)BENZYL)-6-HYDROXYPYRIMIDINE-2,4(1H,3H)-DIONE",CAWXCABXSPTFRN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
155109,6wiq,DB08674,-8.1,"(20S)-19,20,21,22-TETRAHYDRO-19-OXO-5H-18,20-ETHANO-12,14-ETHENO-6,10-METHENO-18H-BENZ[D]IMIDAZO[4,3-K][1,6,9,12]OXATRIAZA-CYCLOOCTADECOSINE-9-CARBONITRILE",USPFJPDEADLGIG-HSZRJFAPSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
9782,6lzg,DB07909,-8.1,"(1S,2S,5S)2-(4-GLUTARIDYLBENZYL)-5-PHENYL-1-CYCLOHEXANOL",OBWILOKKNDYPLX-HBMCJLEFSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
60329,6crv,DB08517,-8.1,"(2S)-5-hydroxy-2-(4-hydroxyphenyl)-7-methoxy-2,3-dihydro-4H-chromen-4-one",DJOJDHGQRNZXQQ-AWEZNQCLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112589,6vxx,DB07429,-8.1,2-({[4-bromo-3-(diethylsulfamoyl)phenyl]carbonyl}amino)benzoic acid,VNOMZKMKBNFCMC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28532,6cs2,DB08121,-8.1,(2S)-2-(biphenyl-4-yloxy)-3-phenylpropanoic acid,TZTPJJNNACUQQR-FQEVSTJZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
86651,6m3m,DB09188,-8.1,Amedalin,HBGWAZBZXJBYQD-IBGZPJMESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
129194,6w4h,DB08503,-8.1,"(3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(4-methylphenyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol",HRCKGDOSPBFICB-MZHQWRCYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
70207,6lxt,DB12307,-8.1,Foretinib,CXQHYVUVSFXTMY-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
86647,6m3m,DB09184,-8.1,Edivoxetine,CPBHSHYQQLFAPW-ZWKOTPCHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
158499,7bv1,DB01261,-8.1,Sitagliptin,MFFMDFFZMYYVKS-SECBINFHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95626,6m71,DB11703,-8.1,Acalabrutinib,WDENQIQQYWYTPO-IBGZPJMESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
70186,6lxt,DB12282,-8.1,Defactinib,FWLMVFUGMHIOAA-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
60347,6crv,DB08537,-8.1,"3-bromo-6-phenyl-N-(pyrimidin-5-ylmethyl)imidazo[1,2-a]pyridin-8-amine",LZLKFNBMXXLTLX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
82597,6m3m,DB02754,-8.1,"9-Butyl-8-(3,4,5-Trimethoxybenzyl)-9h-Purin-6-Amine",TUOSCZDRWRYPRS-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
25529,6cs2,DB03477,-8.1,1-Phenylsulfonamide-3-Trifluoromethyl-5-Parabromophenylpyrazole,OYZKFVIVPRQRQQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
95505,6m71,DB11443,-8.1,Orbifloxacin,QIPQASLPWJVQMH-DTORHVGOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
29056,6cs2,DB08698,-8.1,"1-[(3S)-5-PHENYL-3-THIOPHEN-2-YL-3H-1,4-BENZODIAZEPIN-2-YL]AZETIDIN-3-OL",BKSGACYTXOQQNI-OAQYLSRUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
110396,6vxx,DB01547,-8.1,Drotebanol,LCAHPIFLPICNRW-OPGCRTJHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
95542,6m71,DB11522,-8.1,Isoflupredone,WAIJIHDWAKJCBX-BULBTXNYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
82598,6m3m,DB02755,-8.1,1-3 Sugar Ring of Pentamannosyl 6-Phosphate,HDQMHAJOIVYOIP-NAVBLJQLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
166106,7bv1,DB13693,-8.1,Sulbenicillin,JETQIUPBHQNHNZ-NJBDSQKTSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
158453,7bv1,DB01200,-8.1,Bromocriptine,OZVBMTJYIDMWIL-AYFBDAFISA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
144700,6w9q,DB06176,-8.1,Romidepsin,OHRURASPPZQGQM-GCCNXGTGSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
158463,7bv1,DB01212,-8.1,Ceftriaxone,VAAUVRVFOQPIGI-SPQHTLEESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
30796,6cs2,DB12988,-8.1,LY-518674,PNHFDVSKDSLUFH-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
95570,6m71,DB11614,-8.1,Rupatadine,WUZYKBABMWJHDL-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
121939,6w4b,DB12627,-8.1,GSK-1292263,AYJRTVVIBJSSKN-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
23890,6cs2,DB01532,-8.1,??-Methylacetylfentanyl,OKTLVZBUKMRPLL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
70184,6lxt,DB12279,-8.1,OBP-801,XFLBOEMFLGLWFF-HDXRNPEWSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
25545,6cs2,DB03496,-8.1,Alvocidib,BIIVYFLTOXDAOV-YVEFUNNKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
144647,6w9q,DB05884,-8.1,HCV-086,VBRUONUESYTIDA-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
60350,6crv,DB08540,-8.1,"2-[4-(2H-1,4-BENZOTHIAZINE-3-YL)-PIPERAZINE-1-LY]-1,3-THIAZOLE-4-CARBOXYLIC ACID ETHYLESTER",AQJQFCRTSWIUCY-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110389,6vxx,DB01540,-8.1,17alpha-methyl-4-hydroxynandrolone,CLNUZOCYKSHICX-FAHHUNKHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
70218,6lxt,DB12320,-8.1,Palovarotene,YTFHCXIPDIHOIA-DHZHZOJOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
144357,6w9q,DB04764,-8.1,[4-(3-AMINOMETHYL-PHENYL)-PIPERIDIN-1-YL]-(5-PHENETHYL- PYRIDIN-3-YL)-METHANONE,CCLHROFBSWWOQO-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
25574,6cs2,DB03534,-8.1,3-[(Acetyl-Methyl-Amino)-Methyl]-4-Amino-N-Methyl-N-(1-Methyl-1h-Indol-2-Ylmethyl)-Benzamide,AWTBJNJPBKTHEV-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
158523,7bv1,DB01326,-8.1,Cefamandole,OLVCFLKTBJRLHI-AXAPSJFSSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
158741,7bv1,DB02154,-8.1,"2,3-Bis-Benzo[1,3]Dioxol-5-Ylmethyl-Succinic Acid",FFYBYVPVYLMLAR-KBPBESRZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110325,6vxx,DB01466,-8.1,Ethylmorphine,OGDVEMNWJVYAJL-LEPYJNQMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110316,6vxx,DB01456,-8.1,5-androstenedione,SQGZFRITSMYKRH-QAGGRKNESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60244,6crv,DB08416,-8.1,"(9BETA,13ALPHA,14BETA,17ALPHA)-2-METHOX1TRA-1,3,5(10)-TRIENE-3,17-DIYL DISULFAMATE",AQSNIXKAKUZPSI-SSTWWWIQSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
82378,6m3m,DB02463,-8.1,2-(2-Hydroxy-Phenyl)-1h-Indole-5-Carboxamidine,JPGNPKIYCTXJPG-UHFFFAOYSA-O,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
82370,6m3m,DB02452,-8.1,Thymidine-5'-Triphosphate,NHVNXKFIZYSCEB-XLPZGREQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
28510,6cs2,DB08101,-8.1,"2,6-dibromo-4-[(E)-2-phenylethenyl]phenol",WMVYUPRIADVLTH-VOTSOKGWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
86615,6m3m,DB09119,-8.1,Eslicarbazepine acetate,QIALRBLEEWJACW-INIZCTEOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
70278,6lxt,DB12408,-8.1,PF-03635659,WGOJWDWKHJHXSV-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
95846,6m71,DB12029,-8.1,Chlorogenic Acid,CWVRJTMFETXNAD-JUHZACGLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
63812,6lxt,DB00728,-8.1,Rocuronium,YXRDKMPIGHSVRX-OOJCLDBCSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
82350,6m3m,DB02424,-8.1,Geldanamycin,QTQAWLPCGQOSGP-KSRBKZBZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
63786,6lxt,DB00699,-8.1,Nicergoline,YSEXMKHXIOCEJA-FVFQAYNVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
158805,7bv1,DB02241,-8.1,"8-Benzyl-2-Hydroperoxy-2-(4-Hydroxy-Benzyl)-6-(4-Hydroxy-Phenyl)-2h-Imidazo[1,2-a]Pyrazin-3-One",HOSWCJDTHOAORT-SANMLTNESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
82313,6m3m,DB02383,-8.1,Tolrestat,LUBHDINQXIHVLS-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
144434,6w9q,DB04862,-8.1,Merimepodib,JBPUGFODGPKTDW-SFHVURJKSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
86570,6m3m,DB09039,-8.1,Eliglustat,FJZZPCZKBUKGGU-AUSIDOKSSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136257,6w9c,DB06907,-8.1,"2-(2,6-DICHLOROPHENYL)-1,3-BENZOXAZOLE-6-CARBOXYLIC ACID",XVNRKPCHMYOPPL-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
112448,6vxx,DB07116,-8.1,1-(2-DEOXY-5-O-PHOSPHONO-BETA-D-ERYTHRO-PENTOFURANOSYL)-4-METHYL-1H-INDOLE,UXXYPWCUINVUHL-BFHYXJOUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60260,6crv,DB08436,-8.1,"8-BENZO[1,3]DIOXOL-,5-YLMETHYL-9-BUTYL-9H-",JCDXXNIRWRRGBX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
25607,6cs2,DB03583,-8.1,"(2e,3s)-3-Hydroxy-5'-[(4-Hydroxypiperidin-1-Yl)Sulfonyl]-3-Methyl-1,3-Dihydro-2,3'-Biindol-2'(1'h)-One",AYOAIABDFUJDKQ-SQJPUDIVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
110330,6vxx,DB01471,-8.1,Bolasterone,IVFYLRMMHVYGJH-VLOLGRDOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
158530,7bv1,DB01591,-8.1,Solifenacin,FBOUYBDGKBSUES-VXKWHMMOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
82528,6m3m,DB02658,-8.1,"2,4-Dinitrophenyl 2-Deoxy-2-Fluoro-Beta-D-Allopyranoside",UFSBFVZQJZMIOU-LZQZFOIKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
110364,6vxx,DB01513,-8.1,"17Alpha-methyl-3beta,17beta-dihydroxy-5alpha-androstane",QGKQXZFZOIQFBI-UYEYMFBJSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
70226,6lxt,DB12332,-8.1,Rucaparib,HMABYWSNWIZPAG-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
129186,6w4h,DB08495,-8.1,4-({4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-2-OXOPIPERAZIN-1-YL}METHYL)BENZENECARBOXIMIDAMIDE,VXONTEUOQXFJJS-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
158608,7bv1,DB01690,-8.1,Bis(Adenosine)-5'-Triphosphate,QCICUPZZLIQAPA-XPWFQUROSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
54836,6crv,DB00284,-8.1,Acarbose,CEMXHAPUFJOOSV-XGWNLRGSSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
158609,7bv1,DB01691,-8.1,Indole Naphthyridinone,VAZMNDXVXVUKFY-JXMROGBWSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
144531,6w9q,DB05234,-8.1,LGD2941,HWLLYFXDDGGHOE-BCSUUIJWSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
132911,6w9c,DB00991,-8.1,Oxaprozin,OFPXSFXSNFPTHF-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
112438,6vxx,DB07105,-8.1,2-[2-(4-CHLORO-PHENYLSULFANYL)-ACETYLAMINO]-3-(4-GUANIDINO-PHENYL)-PROPIONAMIDE,IEEYGOJDTRVYGR-HNNXBMFYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
82462,6m3m,DB02569,-8.1,"2',3'-Dehydro-2',3'-Deoxy-Thymidine 5'-Diphosphate",LXCAIISEDMYORY-JGVFFNPUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
129178,6w4h,DB08487,-8.1,3-({4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-2-OXOPIPERAZIN-1-YL}METHYL)BENZENECARBOXIMIDAMIDE,PRMSFVUWLBPPLY-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
95735,6m71,DB11867,-8.1,JNJ-39393406,IURMHZBQEYNQOH-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95748,6m71,DB11886,-8.1,Infigratinib,QADPYRIHXKWUSV-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110337,6vxx,DB01479,-8.1,BA-2664,QGKQXZFZOIQFBI-XSWYFRFISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86634,6m3m,DB09170,-8.1,??-Hydroxythiofentanyl,GLAAETOTOUGGSB-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
63875,6lxt,DB00808,-8.1,Indapamide,NDDAHWYSQHTHNT-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
165154,7bv1,DB11430,-8.1,Monensin,GAOZTHIDHYLHMS-KEOBGNEYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
54819,6crv,DB00267,-8.1,Cefmenoxime,HJJDBAOLQAWBMH-YCRCPZNHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
96577,6m71,DB13126,-8.1,BMS-986115,SRJNRAQUSAVENA-GSHUGGBRSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
23814,6cs2,DB01453,-8.1,Beta-hydroxyfentanyl,JEFVHLMGRUJLET-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
60015,6crv,DB08133,-8.1,N-(4-sulfamoylphenyl)-1H-indazole-3-carboxamide,MNHPHKFLWAPNOV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
97644,6m71,DB15325,-8.1,ONO-8539,ALLLQQUASFFEKP-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
119612,6w4b,DB07514,-8.1,"3-(2-aminoquinazolin-6-yl)-1-(3,3-dimethylindolin-6-yl)-4-methylpyridin-2(1H)-one",LHLGUOHREUTYTO-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
71428,6lxt,DB14214,-8.1,Rose bengal lactone,IICCLYANAQEHCI-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
13445,6lzg,DB15367,-8.1,LY-2623091,YPCLDHGBEKZGEB-RUDKWAFVSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
97656,6m71,DB15346,-8.1,GLPG-1205,IRBAWVGZNJIROV-SFHVURJKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59793,6crv,DB07877,-8.1,"8-(6-BROMO-BENZO[1,3]DIOXOL-5-YLSULFANYL)-9-(3-ISOPROPYLAMINO-PROPYL)-ADENINE",MWGWLDJLENCVRQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109999,6vxx,DB00689,-8.1,Cephaloglycin,FUBBGQLTSCSAON-PBFPGSCMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109997,6vxx,DB00687,-8.1,Fludrocortisone,AAXVEMMRQDVLJB-BULBTXNYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81390,6m3m,DB01142,-8.1,Doxepin,ODQWQRRAPPTVAG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
71430,6lxt,DB14218,-8.1,Telotristat,NCLGDOBQAWBXRA-PGRDOPGGSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
7731,6lzg,DB04289,-8.1,Genz-10850,YYMZSGIXLQPFAC-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
81365,6m3m,DB01113,-8.1,Papaverine,XQYZDYMELSJDRZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
71468,6lxt,DB14625,-8.1,Meprednisone acetate,RZAMUHXEOMZXET-ABQXZQTJSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
164947,7bv1,DB08993,-8.1,Enviomycin,HPWIIERXAFODPP-GHBBWTPBSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
143284,6w9q,DB03311,-8.1,"3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid [4-(Thiazol-2-Ylsulfamoyl)-Phenyl]-Amide",SXKBTDJJEQQEGE-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
71469,6lxt,DB14626,-8.1,Pregnenolone acetate,CRRKVZVYZQXICQ-RJJCNJEVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
71470,6lxt,DB14627,-8.1,Oxyphenisatin acetate,PHPUXYRXPHEJDF-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
132674,6w9c,DB00715,-8.1,Paroxetine,AHOUBRCZNHFOSL-YOEHRIQHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
109992,6vxx,DB00680,-8.1,Moricizine,FUBVWMNBEHXPSU-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86365,6m3m,DB08754,-8.1,"(2E)-3-(3,4-DIHYDROXYPHENYL)-N-[2-(4-HYDROXYPHENYL)ETHYL]ACRYLAMIDE",VSHUQLRHTJOKTA-XBXARRHUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86249,6m3m,DB08618,-8.1,3-(HYDROXY-PHENYL-PHOSPHINOYLOXY)-8-METHYL-8-AZA-BICYCLO[3.2.1]OCTANE-2-CARBOXYLIC ACID METHYL ESTER,WJTKWTJTOSZMKO-PMOUVXMZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
28426,6cs2,DB08014,-8.1,(METHYLPYRIDAZINE PIPERIDINE BUTYLOXYPHENYL)ETHYLACETATE,AQILFLLHLFBLLG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
81448,6m3m,DB01205,-8.1,Flumazenil,OFBIFZUFASYYRE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136526,6w9c,DB07219,-8.1,"BENZYL N-({(2S,3S)-3-[(PROPYLAMINO)CARBONYL]OXIRAN-2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINATE",OMQNYWZURFTFHE-MQBSTWLZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
113704,6vxx,DB11787,-8.1,Ralimetinib,XPPBBJCBDOEXDN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110020,6vxx,DB00712,-8.1,Flurbiprofen,SYTBZMRGLBWNTM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
9910,6lzg,DB08043,-8.1,1-[4-(PYRIDIN-4-YLOXY)PHENYL]-3-[3-(TRIFLUOROMETHYL)PHENYL]UREA,DDDLGNOZDKDSEG-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
13488,6lzg,DB15450,-8.1,PF-05105679,BXNMZRPTQFVRFA-QGZVFWFLSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
81439,6m3m,DB01195,-8.1,Flecainide,DJBNUMBKLMJRSA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
159666,7bv1,DB05137,-8.1,Lobeline,MXYUKLILVYORSK-HBMCJLEFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
81436,6m3m,DB01192,-8.1,Oxymorphone,UQCNKQCJZOAFTQ-ISWURRPUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
97602,6m71,DB15241,-8.1,Methylsamidorphan,ATCVVCBJNHXIEX-ZAHKBLQYSA-O,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
71305,6lxt,DB13954,-8.1,Estradiol cypionate,UOACKFBJUYNSLK-XRKIENNPSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
71309,6lxt,DB13958,-8.1,Trestolone acetate,IVCRCPJOLWECJU-XQVQQVTHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
119708,6w4b,DB07629,-8.1,"N-((1R,2S)-2-(5-CHLORO-1H-INDOLE-2-CARBOXAMIDO)CYCLOHEXYL)-5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE-2-CARBOXAMIDE",ARPFWVKYXJZULB-DLBZAZTESA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
71323,6lxt,DB13991,-8.1,Pipequaline,AMEWZCMTSIONOX-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
143327,6w9q,DB03367,-8.1,PF-00356231,VMTJQZUZINLEKC-JOCHJYFZSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
159673,7bv1,DB05197,-8.1,Sofalcone,GFWRVVCDTLRWPK-KPKJPENVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
121782,6w4b,DB12391,-8.1,Sagopilone,BFZKMNSQCNVFGM-UCEYFQQTSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
97629,6m71,DB15295,-8.1,Tenalisib,HDXDQPRPFRKGKZ-INIZCTEOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
25890,6cs2,DB03917,-8.1,N-Ethyl Retinamide,WKYDOCGICAMTKE-NBIQJRODSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
86343,6m3m,DB08732,-8.1,NALPHA-[(BENZYLOXY)CARBONYL]-N-[(1R)-4-HYDROXY-1-METHYL-2-OXOBUTYL]-L-PHENYLALANINAMIDE,UUOOAGBWJUGBMV-APWZRJJASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
143384,6w9q,DB03453,-8.1,Methyl (2S)-2-[[2-[(3R)-1-carbamimidoylpiperidin-3-yl]acetyl]amino]-3-[4-(2-phenylethynyl)phenyl]propanoate,MRNGXYMKYHNMLV-PKTZIBPZSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
97694,6m71,DB15431,-8.1,M-2698,HXAUJHZZPCBFPN-QGZVFWFLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
159725,7bv1,DB05490,-8.1,AMG-131,NMRWDFUZLLQSBN-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97893,6vxs,DB00287,-8.1,Travoprost,MKPLKVHSHYCHOC-AHTXBMBWSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
25950,6cs2,DB03987,-8.1,"2,4-Diamino-6-[N-(3',5'-Dimethoxybenzyl)-N-Methylamino]Pyrido[2,3-D]Pyrimidine",XWCCXDBXMCTZPW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
13388,6lzg,DB15266,-8.1,TAK-580,VWMJHAFYPMOMGF-ZCFIWIBFSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
59713,6crv,DB07790,-8.1,N-(2-METHOXYETHYL)-4-({4-[2-METHYL-1-(1-METHYLETHYL)-1H-IMIDAZOL-5-YL]PYRIMIDIN-2-YL}AMINO)BENZENESULFONAMIDE,LDXLQEXLXZCYSR-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30618,6cs2,DB12733,-8.1,Dipraglurant,LZXMUJCJAWVHPZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
63412,6lxt,DB00246,-8.1,Ziprasidone,MVWVFYHBGMAFLY-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
128801,6w4h,DB08031,-8.1,"N-[(13-CYCLOHEXYL-6,7-DIHYDROINDOLO[1,2-D][1,4]BENZOXAZEPIN-10-YL)CARBONYL]-2-METHYL-L-ALANINE",LNQWELVSNCYKDU-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
28407,6cs2,DB07995,-8.1,N-[2-(4-BROMOCINNAMYLAMINO)ETHYL]-5-ISOQUINOLINE SULFONAMIDE,ZKZXNDJNWUTGDK-NSCUHMNNSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
136577,6w9c,DB07288,-8.1,N-(4-chlorophenyl)-2-[(pyridin-4-ylmethyl)amino]benzamide,GGPZCOONYBPZEW-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
25957,6cs2,DB03996,-8.1,"3-[(5s)-1-Acetyl-3-(2-Chlorophenyl)-4,5-Dihydro-1h-Pyrazol-5-Yl]Phenol",QBZAPFWYAPXRGQ-KRWDZBQOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
97966,6vxs,DB00378,-8.1,Dydrogesterone,JGMOKGBVKVMRFX-HQZYFCCVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
132703,6w9c,DB00751,-8.1,Epinastine,WHWZLSFABNNENI-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
13377,6lzg,DB15242,-8.1,MK-0533,STWITCBWQHTJFJ-XMMPIXPASA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
13375,6lzg,DB15238,-8.1,Olinciguat,YWQFJNWMWZMXRW-HXUWFJFHSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
159801,7bv1,DB06590,-8.1,Ceftaroline fosamil,ZCCUWMICIWSJIX-NQJJCJBVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
164909,7bv1,DB08951,-8.1,Indoprofen,RJMIEHBSYVWVIN-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
63371,6lxt,DB00197,-8.1,Troglitazone,GXPHKUHSUJUWKP-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
63378,6lxt,DB00206,-8.1,Reserpine,QEVHRUUCFGRFIF-MDEJGZGSSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
86278,6m3m,DB08655,-8.1,"9-ACETYL-2,3,4,9-TETRAHYDRO-1H-CARBAZOL-1-ONE",MIGJEXKBUJPKJF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
140442,6w9c,DB06847,-8.1,"5-[(3S)-3-(2-methoxybiphenyl-4-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",YYCPXVRHQUEVAW-CQSZACIVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
9940,6lzg,DB08079,-8.1,AMG-208,HEAIZQNMNCHNFD-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
97857,6vxs,DB00247,-8.1,Methysergide,KPJZHOPZRAFDTN-NQUBZZJWSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
121805,6w4b,DB12419,-8.1,HSD-016,ZWASRJHIEFYJGL-BFUOFWGJSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
112554,6vxx,DB07389,-8.1,N-[2-(6-AMINO-4-METHYLPYRIDIN-2-YL)ETHYL]-4-CYANOBENZAMIDE,QINCZVSBLITNRD-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109944,6vxx,DB00621,-8.1,Oxandrolone,QSLJIVKCVHQPLV-PEMPUTJUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
164912,7bv1,DB08954,-8.1,Ifenprodil,UYNVMODNBIQBMV-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
166309,7bv1,DB14640,-8.1,Isoflupredone acetate,ZOCUOMKMBMEYQV-GSLJADNHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
63315,6lxt,DB00137,-8.1,Lutein,KBPHJBAIARWVSC-RGZFRNHPSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
109943,6vxx,DB00620,-8.1,Triamcinolone,GFNANZIMVAIWHM-OBYCQNJPSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81346,6m3m,DB01091,-8.1,Butenafine,ABJKWBDEJIDSJZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59746,6crv,DB07825,-8.1,(3S)-1-(4-acetylphenyl)-5-oxopyrrolidine-3-carboxylic acid,SQGYWRZISBCKMW-JTQLQIEISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
159768,7bv1,DB06499,-8.1,Furaprofen,ODZUWQAFWMLWCF-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
31955,6cs2,DB15099,-8.1,GW-468816,XDKRVNKVAKCFGW-WXWBBQJKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
81322,6m3m,DB01063,-8.1,Acetophenazine,WNTYBHLDCKXEOT-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
97767,6vxs,DB00146,-8.1,Calcifediol,JWUBBDSIWDLEOM-DTOXIADCSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
13405,6lzg,DB15294,-8.1,SB-1578,NNXDIGHYPZHXTR-ONEGZZNKSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
63330,6lxt,DB00153,-8.1,Ergocalciferol,MECHNRXZTMCUDQ-RKHKHRCZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
97822,6vxs,DB00206,-8.1,Reserpine,QEVHRUUCFGRFIF-MDEJGZGSSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
159775,7bv1,DB06521,-8.1,Ertiprotafib,FONCZICQWCUXEB-RUZDIDTESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97829,6vxs,DB00216,-8.1,Eletriptan,PWVXXGRKLHYWKM-LJQANCHMSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
71520,6lxt,DB14679,-8.1,Quingestanol acetate,FLGJKPPXEKYCBY-AKCFYGDASA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
63285,6crv,DB08775,-8.1,Nalpha-[(Benzyloxy)carbonyl]-N-[(2S)-4-fluoro-3-oxo-2-butanyl]-L-tyrosinamide,RYABQRLJLIHDIP-KSSFIOAISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
54983,6crv,DB00465,-8.1,Ketorolac,OZWKMVRBQXNZKK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28432,6cs2,DB08019,-8.1,"N-{(3R,4S)-4-[(6-amino-4-methylpyridin-2-yl)methyl]pyrrolidin-3-yl}-N'-(3-chlorobenzyl)ethane-1,2-diamine",VWCMAGONQJHIJZ-LPHOPBHVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
128855,6w4h,DB08095,-8.1,"3-(2-CHLOROPHENYL)-1-(2-{[(1S)-2-HYDROXY-1,2-DIMETHYLPROPYL]AMINO}PYRIMIDIN-4-YL)-1-(4-METHOXYPHENYL)UREA",ZWYFTKPEHRQCCW-HNNXBMFYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
59971,6crv,DB08084,-8.1,IDD594,JCZUIWYXULSXSW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165002,7bv1,DB09076,-8.1,Umeclidinium,FVTWTVQXNAJTQP-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
81696,6m3m,DB01565,-8.1,Dihydromorphine,IJVCSMSMFSCRME-KBQPJGBKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
132613,6w9c,DB00643,-8.1,Mebendazole,OPXLLQIJSORQAM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
63576,6lxt,DB00443,-8.1,Betamethasone,UREBDLICKHMUKA-DVTGEIKXSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
97159,6m71,DB13994,-8.1,AZD-7325,KYDURMHFWXCKMW-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
136410,6w9c,DB07085,-8.1,2-{[N-(2-ACETYL-5-CHLORO-4-FLUOROPHENYL)GLYCYL]AMINO}BENZOIC ACID,LBMZLHCAPBBOFS-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
97185,6m71,DB14054,-8.1,Asiatic acid,JXSVIVRDWWRQRT-UYDOISQJSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
113637,6vxx,DB11686,-8.1,Iferanserin,UXIPFQUBOVWAQW-UEBLJOKOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
54950,6crv,DB00425,-8.1,Zolpidem,ZAFYATHCZYHLPB-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
143759,6w9q,DB03957,-8.1,SP2456,SSSXBBASYYVGCI-HSZRJFAPSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
110095,6vxx,DB00969,-8.1,Alosetron,JSWZEAMFRNKZNL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
97307,6m71,DB14631,-8.1,Prednisolone phosphate,JDOZJEUDSLGTLU-VWUMJDOOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97310,6m71,DB14634,-8.1,Fluprednidene acetate,DEFOZIFYUBUHHU-IYQKUMFPSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
143718,6w9q,DB03903,-8.1,Tmr,KGFLZYXDJDOIEE-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
59943,6crv,DB08053,-8.1,"1-cyclobutyl-3-(3,4-dimethoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine",ITOYZJGFTNTKKR-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
97327,6m71,DB14652,-8.1,Clocortolone acetate,ARPLCFGLEYFDCN-CDACMRRYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
121836,6w4b,DB12465,-8.1,Ketanserin,FPCCSQOGAWCVBH-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
119895,6w4b,DB07847,-8.1,6-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-(4-MORPHOLINYL)-2-OXO ETHYL]-2-OXO-3-PYRROLIDINYL}-2-NAPHTHALENESULFONAMIDE,ICLOZQFWTRAYPX-LIRRHRJNSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
81713,6m3m,DB01587,-8.1,Ketazolam,PWAJCNITSBZRBL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
70674,6lxt,DB13024,-8.1,MK-8245,UJEAABFSXKCSGI-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
97126,6m71,DB13939,-8.1,RAD-140,XMBUPPIEVAFYHO-KPZWWZAWSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60011,6crv,DB08128,-8.1,"(1S,4R,9S)-5-(trifluoromethyl)-1,2,3,4-tetrahydro-1,4-methanonaphthalen-9-amine",HHIJEPNAHYLKPE-DLLGPJQISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
9870,6lzg,DB08003,-8.1,ISOTHIAZOLIDINONE ANALOG,UILYPHAKDBTKQV-UFYCRDLUSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
1537,6lzg,HMDB0011628,-8.1,Glycyrrhetinic acid,MPDGHEJMBKOTSU-WFJWTYAKSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
96594,6m71,DB13169,-8.1,Nandrolone,NPAGDVCDWIYMMC-IZPLOLCNSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
121856,6w4b,DB12494,-8.1,SGI-1776,MHXGEROHKGDZGO-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
81771,6m3m,DB01659,-8.1,"3-(1,10-Phenanthrol-2-Yl)-L-Alanine",LODBCIBKOKOGNL-LBPRGKRZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
9872,6lzg,DB08005,-8.1,4-{[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino}-N-ethylpiperidine-1-carboxamide,ARMFMDYRYOKSOW-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
70645,6lxt,DB12978,-8.1,Pexidartinib,JGWRKYUXBBNENE-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
120041,6w4b,DB08015,-8.1,"(3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-phenyl-1H-indole-2,3-dione 3-oxime",SZYREAUDQRVVLV-DAFNUICNSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
96821,6m71,DB13491,-8.1,Fluperolone,SLVCCRYLKTYUQP-DVTGEIKXSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96846,6m71,DB13528,-8.1,Chlormadinone,VUHJZBBCZGVNDZ-TTYLFXKOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110112,6vxx,DB00990,-8.1,Exemestane,BFYIZQONLCFLEV-DAELLWKTSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112486,6vxx,DB07309,-8.1,5-BROMO-2-{[(4-CHLOROPHENYL)SULFONYL]AMINO}BENZOIC ACID,JDVLYAYDIMUAAC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
159341,7bv1,DB04014,-8.1,Alsterpaullone,OLUKILHGKRVDCT-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
113621,6vxx,DB11665,-8.1,BMS-690514,CSGQVNMSRKWUSH-IAGOWNOFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28455,6cs2,DB08042,-8.1,"N-4-methyl-N-4-(3-methyl-1H-indazol-6-yl)-N-2-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine",FLXGQDHYCWXTAI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
70667,6lxt,DB13016,-8.1,LY-2300559,DWQVYDLTPMGYNE-DEOSSOPVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
128980,6w4h,DB08239,-8.1,"(2S)-4-(2,5-DIFLUOROPHENYL)-N-METHYL-2-PHENYL-N-PIPERIDIN-4-YL-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDE",NKLVBHMAIMEVEH-QFIPXVFZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
81723,6m3m,DB01602,-8.1,Bacampicillin,PFOLLRNADZZWEX-FFGRCDKISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
23733,6cs2,DB01336,-8.1,Metocurine,JFXBEKISTKFVAB-AJQTZOPKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
159402,7bv1,DB04097,-8.1,Uridine-5'-Diphosphate-4-Deoxy-4-Fluoro-Alpha-D-Galactose,OAPPZHVTNHJVAL-JZMIEXBBSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
166283,7bv1,DB14569,-8.1,Tedizolid,XFALPSLJIHVRKE-GFCCVEGCSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97329,6m71,DB14654,-8.1,Bisoxatin acetate,ZCBJDQBSLZREAA-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97502,6m71,DB15048,-8.1,Licogliflozin,XFJAMQQAAMJFGB-ZQGJOIPISA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59882,6crv,DB07985,-8.1,+/-METHYL 4-(AMINOIMINOMETHYL)-BETA-[3- INH (AMINOIMINO)PHENYL]BENZENE PENTANOATE,PVALLOSAENRPQO-INIZCTEOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
71131,6lxt,DB13682,-8.1,Cefpirome,DKOQGJHPHLTOJR-WHRDSVKCSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
59880,6crv,DB07983,-8.1,1-(4-IODOBENZOYL)-5-METHOXY-2-METHYL INDOLE-3-ACETIC ACID,CXBFZYKAVCAPSV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
97517,6m71,DB15078,-8.1,Rogaratinib,HNLRRJSKGXOYNO-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
9898,6lzg,DB08031,-8.1,"N-[(13-CYCLOHEXYL-6,7-DIHYDROINDOLO[1,2-D][1,4]BENZOXAZEPIN-10-YL)CARBONYL]-2-METHYL-L-ALANINE",LNQWELVSNCYKDU-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
136509,6w9c,DB07198,-8.1,5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-CARBONITRILE,GGEKOZPXKBYLNK-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
97539,6m71,DB15121,-8.1,AT-001,YRGPAXAVTDMKDK-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
86395,6m3m,DB08789,-8.1,"2-AMINO-4-(2,4-DICHLOROPHENYL)-N-ETHYLTHIENO[2,3-D]PYRIMIDINE-6-CARBOXAMIDE",YPEOXUOUTBMBCX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
71192,6lxt,DB13767,-8.1,Vorozole,XLMPPFTZALNBFS-INIZCTEOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
71211,6lxt,DB13791,-8.1,Penfluridol,MDLAAYDRRZXJIF-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
97555,6m71,DB15149,-8.1,Futibatinib,KEIPNCCJPRMIAX-HNNXBMFYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
86235,6m3m,DB08602,-8.1,"3-(2,6-difluorophenyl)-2-(methylthio)quinazolin-4(3H)-one",BFNBJSXMXXQLAW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136519,6w9c,DB07210,-8.1,"3-bromo-5-phenyl-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",JECHSYMSTXETFI-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
71268,6lxt,DB13866,-8.1,Etynodiol,JYILPERKVHXLNF-QMNUTNMBSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
63500,6lxt,DB00351,-8.1,Megestrol acetate,RQZAXGRLVPAYTJ-GQFGMJRRSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
71274,6lxt,DB13874,-8.1,Enasidenib,DYLUUSLLRIQKOE-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
9905,6lzg,DB08037,-8.1,"(2S)-4-(2,5-difluorophenyl)-N-[(3R,4S)-3-fluoro-1-methylpiperidin-4-yl]-2-(hydroxymethyl)-N-methyl-2-phenyl-2,5-dihydro-1H-pyrrole-1-carboxamide",MYBGWENAVMIGMM-GIFXNVAJSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
16504,6cs2,HMDB0002395,-8.1,Ursolic acid,WCGUUGGRBIKTOS-GPOJBZKASA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
110040,6vxx,DB00736,-8.1,Esomeprazole,SUBDBMMJDZJVOS-DEOSSOPVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
95498,6m71,DB11430,-8.1,Monensin,GAOZTHIDHYLHMS-KEOBGNEYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
81519,6m3m,DB01332,-8.1,Ceftizoxime,NNULBSISHYWZJU-LLKWHZGFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
110043,6vxx,DB00739,-8.1,Hetacillin,DXVUYOAEDJXBPY-NFFDBFGFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
121776,6w4b,DB12382,-8.1,R-306465,MUTBJZVSRNUIHA-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
81644,6m3m,DB01511,-8.1,Delorazepam,CHIFCDOIPRCHCF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
140471,6w9c,DB07283,-8.1,"9-benzyl-2,3,4,9-tetrahydro-1H-carbazole-8-carboxylic acid",VDOXYKGIKBUISK-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
86207,6m3m,DB08569,-8.1,"3-PYRIDIN-4-YL-2,4-DIHYDRO-INDENO[1,2-.C.] PYRAZOLE",VLPMRZSKJUTRBQ-IBGZPJMESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
70757,6lxt,DB13164,-8.1,Olmutinib,FDMQDKQUTRLUBU-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
30673,6cs2,DB00977,-8.1,Ethinylestradiol,BFPYWIDHMRZLRN-SLHNCBLASA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
81607,6m3m,DB01466,-8.1,Ethylmorphine,OGDVEMNWJVYAJL-LEPYJNQMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
70824,6lxt,DB13276,-8.1,Idanpramine,HVYGXNYMNHSBGD-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
81576,6m3m,DB01430,-8.1,Almitrine,OBDOVFRMEYHSQB-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
132717,6w9c,DB00768,-8.1,Olopatadine,JBIMVDZLSHOPLA-LSCVHKIXSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
124230,6w4h,DB00910,-8.1,Paricalcitol,BPKAHTKRCLCHEA-UBFJEZKGSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
63547,6lxt,DB00408,-8.1,Loxapine,XJGVXQDUIWGIRW-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
81553,6m3m,DB01405,-8.1,Temafloxacin,QKDHBVNJCZBTMR-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
8518,6lzg,DB06263,-8.1,Amrubicin,VJZITPJGSQKZMX-XDPRQOKASA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
97447,6m71,DB14902,-8.1,JHU-75528 C-11,MCNQUWLLXZZZAC-BJUDXGSMSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
136482,6w9c,DB07168,-8.1,[4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-6-(methylamino)pyrimidin-2-yl}amino)phenyl]acetonitrile,MFMSRHREFZCFSN-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
97473,6m71,DB14982,-8.1,Miransertib,HNFMVVHMKGFCMB-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
132650,6w9c,DB00689,-8.1,Cephaloglycin,FUBBGQLTSCSAON-PBFPGSCMSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
30664,6cs2,DB12804,-8.1,Daniquidone,SRIOCKJKFXAKHK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
86401,6m3m,DB08796,-8.1,Pipazethate,DTVJXCOMJLLMAK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
95465,6m71,DB11371,-8.1,Alfaxalone,DUHUCHOQIDJXAT-OLVMNOGESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110384,6vxx,DB01535,-8.1,Carfentanil,YDSDEBIZUNNPOB-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60377,6crv,DB08574,-8.1,"(5R)-2-SULFANYL-5-[4-(TRIFLUOROMETHYL)BENZYL]-1,3-THIAZOL-4-ONE",HBYVUUWMCCSRBI-MRVPVSSYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
145023,6w9q,DB06871,-8.1,17-METHYL-17-ALPHA-DIHYDROEQUILENIN,FQMQOMRDADWGJJ-GBESFXJTSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
83648,6m3m,DB04163,-8.1,"5-Phenylsulfanyl-2,4-Quinazolinediamine",BUFDQCGCADQQQY-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
60849,6crv,DB09224,-8.1,Melperone,DKMFBWQBDIGMHM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
93957,6m71,DB07548,-8.1,"2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUORO-6-PYRIDINYL)METHYL]ACETAMIDE",JXHWVKOKYDAROD-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
156923,6wiq,DB13867,-8.1,Fluticasone,MGNNYOODZCAHBA-GQKYHHCASA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
7401,6lzg,DB03744,-8.1,"Cp403700, (S)-1-{2-[(5-Chloro-1h-Indole-2-Carbonyl)-Amino]-3-Phenyl-Propionyl}-Azetidine-3-Carboxylate",RONLONYAIBUEKT-IBGZPJMESA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
18009,6cs2,HMDB0011658,-8.1,"2,8-Dihydroxyquinoline-beta-D-glucuronide",YQBCNQXCTHWJOK-DKBOKBLXSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
145010,6w9q,DB06856,-8.1,6-FLUORO-2-[2-HYDROXY-3-(2-METHYL-CYCLOHEXYLOXY)-PHENYL]-1H-INDOLE-5-CARBOXAMIDINE,HUYQYLFFFNSAAX-BUXKBTBVSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
60853,6crv,DB09229,-8.1,Aranidipine,NCUCGYYHUFIYNU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60839,6crv,DB09212,-8.1,Loxoprofen,YMBXTVYHTMGZDW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
64248,6lxt,DB01234,-8.1,Dexamethasone,UREBDLICKHMUKA-CXSFZGCWSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
83614,6m3m,DB04121,-8.1,Guanosine-3'-Monophosphate-5'-Diphosphate,HEYSFDAMRDTCJM-UUOKFMHZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
135828,6w9c,DB05239,-8.1,Cobimetinib,BSMCAPRUBJMWDF-KRWDZBQOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
94002,6m71,DB07607,-8.1,4-[5-(3-IODO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-1H-IMIDAZOL-4-YL]-PYRIDINE,RXDZANYWRNIAOR-HHHXNRCGSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
83596,6m3m,DB04096,-8.1,"5-Amino-5-Deoxy-Cellobiono-1,5-Lactam",WXSNJJDPPISYEF-ZNLUKOTNSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
165255,7bv1,DB11666,-8.1,Buparlisib,CWHUFRVAEUJCEF-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60821,6crv,DB09193,-8.1,"CP-39,332",HLOCJJORRHQDKS-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60815,6crv,DB09187,-8.1,Lortalamine,MJRPHRMGEKCADU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
144995,6w9q,DB06834,-8.1,"N-(2-hydroxy-1,1-dimethylethyl)-1-methyl-3-(1H-pyrrolo[2,3-b]pyridin-2-yl)-1H-indole-5-carboxamide",XZRYCTLOGNCQDG-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
93940,6m71,DB07530,-8.1,"(1R,3R)-5-[(2E)-3-{(1S,3R)-2,2,3-trimethyl-3-[6,6,6-trifluoro-5-hydroxy-5-(trifluoromethyl)hex-3-yn-1-yl]cyclopentyl}prop-2-en-1-ylidene]cyclohexane-1,3-diol",PCHUQQNKOFNVDU-OSXMSNBXSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
69709,6lxt,DB11522,-8.1,Isoflupredone,WAIJIHDWAKJCBX-BULBTXNYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
156593,6wiq,DB13345,-8.1,Dihydroergocristine,DEQITUUQPICUMR-HJPBWRTMSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
9673,6lzg,DB07792,-8.1,"(S)-2-CHLORO-N-(1-(2-(2-HYDROXYETHYLAMINO)-2-OXOETHYL)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL)-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE",VUKPNWLGSLOHIF-AWEZNQCLSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
132347,6w9c,DB00317,-8.1,Gefitinib,XGALLCVXEZPNRQ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
9674,6lzg,DB07793,-8.1,"(2S)-N-[(3S)-1-(2-AMINO-2-OXOETHYL)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL]-2-CHLORO-2H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE",ACSGSLPOHKRZCY-GXTWGEPZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
9675,6lzg,DB07794,-8.1,"5-(2-PHENYLPYRAZOLO[1,5-A]PYRIDIN-3-YL)-1H-PYRAZOLO[3,4-C]PYRIDAZIN-3-AMINE",XVECMUKVOMUNLE-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
83714,6m3m,DB04248,-8.1,beta-(1->4)-galactotriose,FYGDTMLNYKFZSV-XJJKTWKOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
132355,6w9c,DB00327,-8.1,Hydromorphone,WVLOADHCBXTIJK-YNHQPCIGSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
156261,6wiq,DB12658,-8.1,AFN-1252,QXTWSUQCXCWEHF-JXMROGBWSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
133048,6w9c,DB01148,-8.1,Flavoxate,SPIUTQOUKAMGCX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
64293,6lxt,DB01327,-8.1,Cefazolin,MLYYVTUWGNIJIB-BXKDBHETSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
30892,6cs2,DB13118,-8.1,Paquinimod,DIKSYHCCYVYKRO-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
85986,6m3m,DB08302,-8.1,3-[5-(2-nitropent-1-en-1-yl)furan-2-yl]benzoic acid,IRHZCQDCMUWUKV-RAXLEYEMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
93834,6m71,DB07404,-8.1,"(1-HYDROXY-1-PHOSPHONO-2-[1,1';3',1'']TERPHENYL-3-YL-ETHYL)-PHOSPHONIC ACID",YXQQNSYZOQHKHD-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
133041,6w9c,DB01140,-8.1,Cefadroxil,BOEGTKLJZSQCCD-UEKVPHQBSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
93860,6m71,DB07434,-8.1,HONH-BENZYLMALONYL-L-ALANYLGLYCINE-P-NITROANILIDE,TZWQPWGUQCSKDW-GUYCJALGSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60860,6crv,DB09236,-8.1,Lacidipine,GKQPCPXONLDCMU-CCEZHUSRSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
145081,6w9q,DB06933,-8.1,N-(tert-butyl)-4-[5-(pyridin-2-ylamino)quinolin-3-yl]benzenesulfonamide,GJTCKUKIFXWJKG-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
69708,6lxt,DB11521,-8.1,Imidocarb,SCEVFJUWLLRELN-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
86008,6m3m,DB08325,-8.1,2-(2-HYDROXYETHYLAMINO)-6-(3-CHLOROANILINO)-9-ISOPROPYLPURINE,XZEFMZCNXDQXOZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
132372,6w9c,DB00348,-8.1,Nitisinone,OUBCNLGXQFSTLU-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
60810,6crv,DB09182,-8.1,Benzylfentanyl,POQDXIFVWVZVML-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
69599,6lxt,DB11263,-8.1,Polydatin,HSTZMXCBWJGKHG-CUYWLFDKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
165968,7bv1,DB13309,-8.1,Benproperine,JTUQXGZRVLWBCR-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94023,6m71,DB07629,-8.1,"N-((1R,2S)-2-(5-CHLORO-1H-INDOLE-2-CARBOXAMIDO)CYCLOHEXYL)-5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE-2-CARBOXAMIDE",ARPFWVKYXJZULB-DLBZAZTESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
69847,6lxt,DB11787,-8.1,Ralimetinib,XPPBBJCBDOEXDN-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
157407,6wiq,DB15345,-8.1,GSK-945237,SRICOHRDRMZREQ-MRXNPFEDSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
113449,6vxx,DB09201,-8.1,Ciglitazone,YZFWTZACSRHJQD-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165242,7bv1,DB11645,-8.1,PF-4191834,DVNQWYLVSNPCJZ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
144860,6w9q,DB06589,-8.1,Pazopanib,CUIHSIWYWATEQL-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
60728,6crv,DB09021,-8.1,Benzoctamine,GNRXCIONJWKSEA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86852,6m3m,DB11367,-8.1,Cefroxadine,RDMOROXKXONCAL-UEKVPHQBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
133002,6w9c,DB01095,-8.1,Fluvastatin,FJLGEFLZQAZZCD-JUFISIKESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
94218,6m71,DB07856,-8.1,6-{4-[4-(4-CHLOROPHENYL)PIPERIDIN-4-YL]PHENYL}-9H-PURINE,HPWBHQIUIBFTQC-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
9723,6lzg,DB07845,-8.1,"2-fluoro-6-{[2-({2-methoxy-4-[(methylsulfonyl)methyl]phenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide",VGYXXQRDIVRILX-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
144850,6w9q,DB06558,-8.1,Tezosentan,TUYWTLTWNJOZNY-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
64189,6lxt,DB01166,-8.1,Cilostazol,RRGUKTPIGVIEKM-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
94381,6m71,DB08042,-8.1,"N-4-methyl-N-4-(3-methyl-1H-indazol-6-yl)-N-2-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine",FLXGQDHYCWXTAI-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
40363,6lu7,DB07124,-8.1,"(2S)-1-(6H-INDOL-3-YL)-3-{[5-(7H-PYRAZOLO[3,4-C]PYRIDIN-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE",CCIACUJJBPSOHE-KRWDZBQOSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
86842,6m3m,DB11335,-8.1,Ascorbyl glucoside,MLSJBGYKDYSOAE-DCWMUDTNSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
31908,6cs2,DB15021,-8.1,Leriglitazone,OXVFDZYQLGRLCD-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
60693,6crv,DB08984,-8.1,Etofenamate,XILVEPYQJIOVNB-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
83383,6m3m,DB03812,-8.1,"3-{2,6,8-trioxo-9-[(2S,3R,4R)-2,3,4,5-tetrahydroxypentyl]-1,2,3,6,8,9-hexahydro-7H-purin-7-Yl}propyl dihydrogen phosphate",KPHFGOGGKPGLTM-LKEWCRSYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
40361,6lu7,DB08878,-8.1,Aminopterin,TVZGACDUOSZQKY-LBPRGKRZSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
29123,6cs2,DB08761,-8.1,"(3S,6S)-3,6-bis(4-hydroxybenzyl)piperazine-2,5-dione",NGPCLOGFGKJCBP-HOTGVXAUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
95462,6m71,DB11366,-8.1,Roquinimex,SGOOQMRIPALTEL-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
64206,6lxt,DB01184,-8.1,Domperidone,FGXWKSZFVQUSTL-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
94051,6m71,DB07664,-8.1,"5-AMINO-3-{[4-(AMINOSULFONYL)PHENYL]AMINO}-N-(2,6-DIFLUOROPHENYL)-1H-1,2,4-TRIAZOLE-1-CARBOTHIOAMIDE",ARIOBGGRZJITQX-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
132376,6w9c,DB00353,-8.1,Methylergometrine,UNBRKDKAWYKMIV-QWQRMKEZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
69785,6lxt,DB11692,-8.1,Pavinetant,QYTBBBAHNIWFOD-NRFANRHFSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
123871,6w4h,DB00481,-8.1,Raloxifene,GZUITABIAKMVPG-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
140651,6w9c,DB13046,-8.1,Tocladesine,CLLFEJLEDNXZNR-UUOKFMHZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
110583,6vxx,DB01967,-8.1,"N-{3-[(7ar,12as,12bs)-7-Oxo-1,3,4,6,7,7a,12a,12b-Octahydroindolo[2,3-a]Quinolizin-12(2h)-Yl]Propyl}Propane-2-Sulfonamide",LICJTIDRHJECTD-SFHVURJKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
94146,6m71,DB07775,-8.1,"3',5'-DIBROMO-2',4,4',6'-TETRAHYDROXY AURONE",BRPKBUNFOZFULQ-SGAXSIHGSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
29393,6cs2,DB00843,-8.1,Donepezil,ADEBPBSSDYVVLD-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
94156,6m71,DB07787,-8.1,"5-FLUORO-1-[4-(4-PHENYL-3,6-DIHYDROPYRIDIN-1(2H)-YL)BUTYL]QUINAZOLINE-2,4(1H,3H)-DIONE",PNPFDRCIGCUCMN-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
140647,6w9c,DB13039,-8.1,Aminaphthone,YLMPBJUYFTWHKJ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
123911,6w4h,DB00533,-8.1,Rofecoxib,RZJQGNCSTQAWON-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
69818,6lxt,DB11743,-8.1,Ipatasertib,GRZXWCHAXNAUHY-NSISKUIASA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
135858,6w9c,DB05416,-8.1,Cardarine,YDBLKRPLXZNVNB-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
32039,6cs2,DB15245,-8.1,Olorofim,SUFPWYYDCOKDLL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
123934,6w4h,DB00559,-8.1,Bosentan,GJPICJJJRGTNOD-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
157377,6wiq,DB15291,-8.1,BMS-986142,ZRYMMWAJAFUANM-INIZCTEOSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
86893,6m3m,DB11442,-8.1,Oleandomycin,RZPAKFUAFGMUPI-QESOVKLGSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
40355,6lu7,DB06666,-8.1,Lixivaptan,PPHTXRNHTVLQED-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
94200,6m71,DB07834,-8.1,"N-(cyclopropylmethyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-4-carboxamide",FOHZGCHKLPIBBX-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60807,6crv,DB09179,-8.1,R-30490,GARXJOUQUSNOGK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112361,6vxx,DB07017,-8.1,"(5S)-2-{[(1S)-1-(4-fluorophenyl)ethyl]amino}-5-(1-hydroxy-1-methylethyl)-5-methyl-1,3-thiazol-4(5H)-one",HYVZYASDRIAOPU-BJOHPYRUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60969,6crv,DB11176,-8.1,Zeaxanthin,JKQXZKUSFCKOGQ-QAYBQHTQSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
93692,6m71,DB07245,-8.1,6-[2-(3'-METHOXYBIPHENYL-3-YL)ETHYL]PYRIDIN-2-AMINE,AEVBKBAFFJKFJZ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
61135,6crv,DB11638,-8.1,Artenimol,BJDCWCLMFKKGEE-HVDUHBCDSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
155688,6wiq,DB11526,-8.1,Masitinib,WJEOLQLKVOPQFV-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
93139,6m71,DB06410,-8.1,Doxercalciferol,HKXBNHCUPKIYDM-CGMHZMFXSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93140,6m71,DB06412,-8.1,Oxymetholone,ICMWWNHDUZJFDW-DHODBPELSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
64354,6lxt,DB01430,-8.1,Almitrine,OBDOVFRMEYHSQB-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
69315,6lxt,DB08993,-8.1,Enviomycin,HPWIIERXAFODPP-GHBBWTPBSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
84029,6m3m,DB04672,-8.1,"Cyclic 3',5'-thymidine monophosphate",XLPGURCDSRIXFL-JGVFFNPUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
28668,6cs2,DB08268,-8.1,"6-AMINO-4-[2-(4-METHYLPHENYL)ETHYL]-1,7-DIHYDRO-8H-IMIDAZO[4,5-G]QUINAZOLIN-8-ONE",SPVJRTJUEVXOMS-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
64370,6lxt,DB01450,-8.1,Dihydroetorphine,BRTSNYPDACNMIP-FAWZKKEFSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
93181,6m71,DB06518,-8.1,R-1487,KKKRKRMVJRHDMG-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93182,6m71,DB06519,-8.1,Edaglitazone,HAAXAFNSRADSMK-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
155828,6wiq,DB11791,-8.1,Capmatinib,LIOLIMKSCNQPLV-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
35999,1r42,DB02354,-8.1,4-{[1-Methyl-5-(2-Methyl-Benzoimidazol-1-Ylmethyl)-1h-Benzoimidazol-2-Ylmethyl]-Amino}-Benzamidine,IRKPNOLLMNHSOU-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
93187,6m71,DB06529,-8.1,Ocinaplon,OQJFBUOFGHPMSR-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110823,6vxx,DB02455,-8.1,Fluoresceinylthioureido,VHJFQSRUDVDTEO-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
123743,6w4h,DB00324,-8.1,Fluorometholone,FAOZLTXFLGPHNG-KNAQIMQKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
83985,6m3m,DB04614,-8.1,(R)-tacrine(10)-hupyridone,ROTFGKJJMRTWBD-HHHXNRCGSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
145297,6w9q,DB07186,-8.1,"4-(4-METHYLPIPERAZIN-1-YL)-N-[5-(2-THIENYLACETYL)-1,5-DIHYDROPYRROLO[3,4-C]PYRAZOL-3-YL]BENZAMIDE",TYYNSDQVFIOSFH-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
135717,6w9c,DB04843,-8.1,Mepenzolate,GKNPSSNBBWDAGH-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
155674,6wiq,DB11487,-8.1,Dexamethasone isonicotinate,BQTXJHAJMDGOFI-NJLPOHDGSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
69294,6lxt,DB08970,-8.1,Fluprednidene,YVHXHNGGPURVOS-SBTDHBFYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
69263,6lxt,DB08931,-8.1,Riociguat,WXXSNCNJFUAIDG-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
84076,6m3m,DB04740,-8.1,MOXALACTAM (HYDROLYZED),ZTOQXKUYWZBJLG-XNAIMREJSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
155383,6wiq,DB09030,-8.1,Vorapaxar,ZBGXUVOIWDMMJE-QHNZEKIYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
112307,6vxx,DB06948,-8.1,2-ANILINO-6-CYCLOHEXYLMETHOXYPURINE,XWWRLKIBRPJQJX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
132284,6w9c,DB00243,-8.1,Ranolazine,XKLMZUWKNUAPSZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
69237,6lxt,DB08883,-8.1,Perampanel,PRMWGUBFXWROHD-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
61163,6crv,DB11681,-8.1,Tofimilast,DHCOPPHTVOXDKU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
93046,6m71,DB06169,-8.1,Indibulin,SOLIIYNRSAWTSQ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
112321,6vxx,DB06970,-8.1,"2-CHLORO-N-(3-CYANO-5,6-DIHYDRO-4H-CYCLOPENTA[B]THIOPHEN-2-YL)-5-DIETHYLSULFAMOYL-BENZAMIDE",MZCDQILVXXIMEV-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29370,6cs2,DB09078,-8.1,Lenvatinib,WOSKHXYHFSIKNG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
93084,6m71,DB06248,-8.1,Amelubant,SBVYURPQULDJTI-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93085,6m71,DB06249,-8.1,Arzoxifene,MCGDSOGUHLTADD-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
123736,6w4h,DB00317,-8.1,Gefitinib,XGALLCVXEZPNRQ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
25135,6cs2,DB02998,-8.1,Metribolone,CCCIJQPRIXGQOE-XWSJACJDSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
135704,6w9c,DB04829,-8.1,Lysergic acid diethylamide,VAYOSLLFUXYJDT-RDTXWAMCSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
121982,6w4b,DB12693,-8.1,Ritanserin,JUQLTPCYUFPYKE-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
135708,6w9c,DB04833,-8.1,Methaqualone,JEYCTXHKTXCGPB-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
64398,6lxt,DB01480,-8.1,Cyprenorphine,VSKIOMHXEUHYSI-KNLIIKEYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
93108,6m71,DB06306,-8.1,Onalespib,IFRGXKKQHBVPCQ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93114,6m71,DB06321,-8.1,R-348,IGLNXKVGKIFNBQ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93233,6m71,DB06635,-8.1,Otamixaban,PFGVNLZDWRZPJW-OPAMFIHVSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
61095,6crv,DB11521,-8.1,Imidocarb,SCEVFJUWLLRELN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112339,6vxx,DB06992,-8.1,"(3,3-dimethylpiperidin-1-yl)(6-(3-fluoro-4-methylphenyl)pyridin-2-yl)methanone",SIDDLTBLAQYZIZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
129412,6w4h,DB08761,-8.1,"(3S,6S)-3,6-bis(4-hydroxybenzyl)piperazine-2,5-dione",NGPCLOGFGKJCBP-HOTGVXAUSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
69468,6lxt,DB09231,-8.1,Benidipine,QZVNQOLPLYWLHQ-ZEQKJWHPSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
83819,6m3m,DB04395,-8.1,Phosphoaminophosphonic Acid-Adenylate Ester,PVKSNHVPLWYQGJ-FCIPNVEPSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
37010,1r42,DB03712,-8.1,RU85053,CEKLBQMULVLLTD-VMPREFPWSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
83805,6m3m,DB04376,-8.1,13-Acetylphorbol,SDSVJYOOAPRSDA-RPCQODIISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
61036,6crv,DB11398,-8.1,Diclazuril,ZSZFUDFOPOMEET-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
83803,6m3m,DB04373,-8.1,"4-Amino-N-{4-[2-(2,6-Dimethyl-Phenoxy)-Acetylamino]-3-Hydroxy-1-Isobutyl-5-Phenyl-Pentyl}-Benzamide",WQUBEIMCFHCJCO-AWCRTANDSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
93610,6m71,DB07146,-8.1,"2,3-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-B]PYRIDIN-4-AMINE",QUIQCYFSBGOBKE-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93611,6m71,DB07147,-8.1,"methyl (1R,2S)-2-(hydroxycarbamoyl)-1-{4-[(2-methylquinolin-4-yl)methoxy]benzyl}cyclopropanecarboxylate",HJWMYFBKJRVWJY-YKSBVNFPSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
156070,6wiq,DB12369,-8.1,Sotrastaurin,OAVGBZOFDPFGPJ-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
93621,6m71,DB07159,-8.1,Tamatinib,NHHQJBCNYHBUSI-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
83799,6m3m,DB04367,-8.1,Debromohymenialdisine,JYRJOQGKGMHTOO-VURMDHGXSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
61013,6crv,DB11362,-8.1,Selexipag,QXWZQTURMXZVHJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112624,6vxx,DB07470,-8.1,"(3aS)-3a-hydroxy-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one",DOMYOVZXZIZTRD-QGZVFWFLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
69513,6lxt,DB09304,-8.1,Setiptiline,GVPIXRLYKVFFMK-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
60988,6crv,DB11269,-8.1,Diethylamino hydroxybenzoyl hexyl benzoate,FDATWRLUYRHCJE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
9667,6lzg,DB07787,-8.1,"5-FLUORO-1-[4-(4-PHENYL-3,6-DIHYDROPYRIDIN-1(2H)-YL)BUTYL]QUINAZOLINE-2,4(1H,3H)-DIONE",PNPFDRCIGCUCMN-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
69537,6lxt,DB09378,-8.1,Fluprednisolone,MYYIMZRZXIQBGI-HVIRSNARSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
93677,6m71,DB07226,-8.1,"N-[4-(2-CHLOROPHENYL)-1,3-DIOXO-1,2,3,6-TETRAHYDROPYRROLO[3,4-C]CARBAZOL-9-YL]FORMAMIDE",JWZVNUNTFNELHL-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93679,6m71,DB07228,-8.1,1-(5-CHLORO-2-METHOXYPHENYL)-3-{6-[2-(DIMETHYLAMINO)-1-METHYLETHOXY]PYRAZIN-2-YL}UREA,GIAYFZLMPSVQDV-NSHDSACASA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
85966,6m3m,DB08274,-8.1,"6,7,8,9-TETRAHYDRO-4-HYDROXY-3-(1-PHENYLPROPYL)CYCLOHEPTA[B]PYRAN-2-ONE",YKJXQZGJGDTEOC-AWEZNQCLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
140636,6w9c,DB13022,-8.1,LY-2874455,GKJCVYLDJWTWQU-CXLRFSCWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
61048,6crv,DB11426,-8.1,Marbofloxacin,BPFYOAJNDMUVBL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
93497,6m71,DB07019,-8.1,"N-[(5R,14R)-5-AMINO-5,14-DIMETHYL-4-OXO-3-OXA-18-AZATRICYCLO[15.3.1.1-7,11-]DOCOSA-1(21),7(22),8,10,17,19-HEXAEN-19-YL]-N-METHYLMETHANESULFONAMIDE",QWDOKZPZLWNULU-MZNJEOGPSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93248,6m71,DB06677,-8.1,Clazosentan,LFWCJABOXHSRGC-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93277,6m71,DB06718,-8.1,Stanozolol,LKAJKIOFIWVMDJ-IYRCEVNGSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93287,6m71,DB06733,-8.1,Bafilomycin A1,XDHNQDDQEHDUTM-JQWOJBOSSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93341,6m71,DB06831,-8.1,2-((9H-PURIN-6-YLTHIO)METHYL)-5-CHLORO-3-(2-METHOXYPHENYL)QUINAZOLIN-4(3H)-ONE,UMMYTDJYDSTEMB-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93346,6m71,DB06837,-8.1,"(2R)-N-4-hydroxy-2-(3-hydroxybenzyl)-N-1-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]butanediamide",VXDKQRWTOJFQKH-BJZITVGISA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
85936,6m3m,DB08236,-8.1,"(2S)-2-(3-bromophenyl)-3-(5-chloro-2-hydroxyphenyl)-1,3-thiazolidin-4-one",KEGQNJITMFBVAC-HNNXBMFYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
36541,1r42,DB03067,-8.1,"4-{2,4-Bis[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid",VFYAZSTYKPFSFL-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
36572,1r42,DB03104,-8.1,RU82129,NKMPOVPTYDXGEC-MNRBYUMSSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
112639,6vxx,DB07488,-8.1,"{(2Z)-4-AMINO-2-[(4-METHOXYPHENYL)IMINO]-2,3-DIHYDRO-1,3-THIAZOL-5-YL}(4-METHOXYPHENYL)METHANONE",XQKUGFIWKSKCDL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61071,6crv,DB11463,-8.1,Sulfanitran,GWBPFRGXNGPPMF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
133062,6w9c,DB01165,-8.1,Ofloxacin,GSDSWSVVBLHKDQ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
133054,6w9c,DB01155,-8.1,Gemifloxacin,ZRCVYEYHRGVLOC-HYARGMPZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
83928,6m3m,DB04542,-8.1,3'-Azido-3'-Deoxythymidine-5'-Diphosphate,QOYVAFWJURKBJG-XLPZGREQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
36731,1r42,DB03311,-8.1,"3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid [4-(Thiazol-2-Ylsulfamoyl)-Phenyl]-Amide",SXKBTDJJEQQEGE-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
83909,6m3m,DB04517,-8.1,Dipyrromethane Cofactor,LCAXMKQKEYTFDM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
165956,7bv1,DB13291,-8.1,Cloridarol,KBFBRIPYVVGWRS-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
61055,6crv,DB11436,-8.1,Nifurpirinol,JQKHJQJVKRFMCO-SNAWJCMRSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61054,6crv,DB11433,-8.1,Nequinate,NNOPDLNHPOLRRE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140691,6w9c,DB13102,-8.1,AZD-8418,MCPBSUCAISQZQK-JTQLQIEISA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
69459,6lxt,DB09219,-8.1,Bisoxatin,BPKUDUSVDVLOPY-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
83356,6m3m,DB03777,-8.1,Rbt205 Inhibitor,QMGUOJYZJKLOLH-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83447,6m3m,DB03895,-8.1,Malachite Green,VFCNQNZNPKRXIT-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
129244,6w4h,DB08561,-8.1,"BENZYL 6-BENZYL-5,7-DIOXO-6,7-DIHYDRO-5H-[1,3]THIAZOLO[3,2-C]PYRIMIDINE-2-CARBOXYLATE",PLBINCOCFGQAJM-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
60547,6crv,DB08774,-8.1,"1-[(2S)-4-(5-phenyl-1H-pyrazolo[3,4-b]pyridin-4-yl)morpholin-2-yl]methanamine",YBRZCAKSBYWZTC-ZDUSSCGKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
158051,7bv1,DB00317,-8.1,Gefitinib,XGALLCVXEZPNRQ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
86034,6m3m,DB08360,-8.1,"2-(4-ETHYLPIPERAZIN-1-YL)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE",BIFHJPUTQBOBGJ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
94834,6m71,DB08588,-8.1,2-({2-[(3R)-3-AMINOPIPERIDIN-1-YL]-4-OXOQUINAZOLIN-3(4H)-YL}METHYL)BENZONITRILE,OYNURZXTLNNKAP-QGZVFWFLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60533,6crv,DB08758,-8.1,"IMIDAZO[2,1-A]ISOQUINOLINE-2-CARBOHYDRAZIDE",WSNWYZBDIKCPIG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
82760,6m3m,DB02963,-8.1,"(5-Chloropyrazolo[1,5-a]Pyrimidin-7-Yl)-(4-Methanesulfonylphenyl)Amine",LVNXHNRYPADEAD-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
60548,6crv,DB08775,-8.1,N??-[(Benzyloxy)carbonyl]-N-[(2S)-4-fluoro-3-oxo-2-butanyl]-L-tyrosinamide,RYABQRLJLIHDIP-KSSFIOAISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
82794,6m3m,DB03013,-8.1,Di(N-Acetyl-D-Glucosamine),CDOJPCSDOXYJJF-KSKNGZLJSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
60450,6crv,DB08662,-8.1,3-[1-(4-BROMO-PHENYL)-2-METHYL-PROPYL]-4-HYDROXY-CHROMEN-2-ONE,KGDWLSFLMSFPSU-INIZCTEOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136004,6w9c,DB06272,-8.1,Maxacalcitol,DTXXSJZBSTYZKE-ZDQKKZTESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
14128,6lzg,T3D3746,-8.1,Territrem A,LCJHAHVVYAVVPA-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
165206,7bv1,DB11551,-8.1,Trenbolone,MEHHPFQKXOUFFV-OWSLCNJRSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
64107,6lxt,DB01070,-8.1,Dihydrotachysterol,ILYCWAKSDCYMBB-OPCMSESCSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
70090,6lxt,DB12141,-8.1,Gilteritinib,GYQYAJJFPNQOOW-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
94842,6m71,DB08597,-8.1,"6-[4-(2-piperidin-1-ylethoxy)phenyl]-3-pyridin-4-ylpyrazolo[1,5-a]pyrimidine",XHBVYDAKJHETMP-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110489,6vxx,DB01659,-8.1,"3-(1,10-Phenanthrol-2-Yl)-L-Alanine",LODBCIBKOKOGNL-LBPRGKRZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60560,6crv,DB08789,-8.1,"2-AMINO-4-(2,4-DICHLOROPHENYL)-N-ETHYLTHIENO[2,3-D]PYRIMIDINE-6-CARBOXAMIDE",YPEOXUOUTBMBCX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
94761,6m71,DB08500,-8.1,"(3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(2-naphthyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol",ZCJBDRSKHARECB-PYTCMNEWSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95288,6m71,DB09215,-8.1,Droxicam,OEHFRZLKGRKFAS-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95273,6m71,DB09199,-8.1,Netoglitazone,PKWDZWYVIHVNKS-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
158308,7bv1,DB00846,-8.1,Flurandrenolide,POPFMWWJOGLOIF-XWCQMRHXSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94752,6m71,DB08491,-8.1,N-HYDROXY-2-[4-(4-PHENOXY-BENZENESULFONYL)-TETRAHYDRO-PYRAN-4-YL]-ACETAMIDE,ARIRIZBKMKMEBD-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
144774,6w9q,DB06350,-8.1,Elinogrel,LGSDFTPAICUONK-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
64140,6lxt,DB01108,-8.1,Trilostane,KVJXBPDAXMEYOA-CXANFOAXSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
112375,6vxx,DB07032,-8.1,2-(4-HYDROXY-PHENYL)BENZOFURAN-5-OL,SNNNDCMXZYWCCI-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30803,6cs2,DB13003,-8.1,Cortivazol,RKHQGWMMUURILY-UHRZLXHJSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
158287,7bv1,DB00823,-8.1,Ethynodiol diacetate,ONKUMRGIYFNPJW-KIEAKMPYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
82739,6m3m,DB02936,-8.1,4-(1-Benzyl-3-Carbamoylmethyl-2-Methyl-1h-Indol-5-Yloxy)-Butyric Acid,STENXUCYNKOBHJ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83088,6m3m,DB03403,-8.1,Cytidine-5'-Monophosphate,IERHLVCPSMICTF-XVFCMESISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
94758,6m71,DB08497,-8.1,"(1S)-2-oxo-1-phenyl-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate",NKBDSMREMMRFSI-INIZCTEOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60436,6crv,DB08647,-8.1,TRAZEOLIDE,YUTXECPABXNXPU-DJJJIMSYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
95228,6m71,DB09123,-8.1,Dienogest,AZFLJNIPTRTECV-FUMNGEBKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
113499,6vxx,DB09262,-8.1,Imidafenacin,SQKXYSGRELMAAU-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
132977,6w9c,DB01066,-8.1,Cefditoren,KMIPKYQIOVAHOP-YLGJWRNMSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
112417,6vxx,DB07080,-8.1,"N-(2,2,2-TRIFLUOROETHYL)-N-{4-[2,2,2-TRIFLUORO-1-HYDROXY-1-(TRIFLUOROMETHYL)ETHYL]PHENYL}BENZENESULFONAMIDE",SGIWFELWJPNFDH-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110442,6vxx,DB01603,-8.1,Meticillin,RJQXTJLFIWVMTO-TYNCELHUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
129225,6w4h,DB08539,-8.1,"3-cyclopropyl-5-phenyl-N-(pyridin-3-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",CCDIUVLNHCGSMH-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
95059,6m71,DB08865,-8.1,Crizotinib,KTEIFNKAUNYNJU-GFCCVEGCSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
82861,6m3m,DB03103,-8.1,Thymidine-5'- Diphosphate,UJLXYODCHAELLY-XLPZGREQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
64070,6lxt,DB01029,-8.1,Irbesartan,YOSHYTLCDANDAN-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
95130,6m71,DB08973,-8.1,Fluclorolone acetonide,NJNWEGFJCGYWQT-VSXGLTOVSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
140566,6w9c,DB12463,-8.1,Semagacestat,PKXWXXPNHIWQHW-RCBQFDQVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
82848,6m3m,DB03086,-8.1,"N'-(2s,3r)-3-Amino-4-Cyclohexyl-2-Hydroxy-Butano-N-(4-Methylphenyl)Hydrazide",IQMLIGOOOFEBAH-CVEARBPZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
60505,6crv,DB08729,-8.1,"5-ethoxy-4-(1-methyl-7-oxo-3-propyl-6,7-dihydro-1H-pyrazolo[4,3-d]pyrimidin-5-yl)thiophene-2-sulfonamide",FENWRHVHBZQJGW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
95068,6m71,DB08881,-8.1,Vemurafenib,GPXBXXGIAQBQNI-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60490,6crv,DB08713,-8.1,"2,6-DIMETHYL-1-(3-[3-METHYL-5-ISOXAZOLYL]-PROPANYL)-4-[2N-METHYL-2H-TETRAZOL-5-YL]-PHENOL",RVZKQTQAFHEOKT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
129240,6w4h,DB08557,-8.1,"2-[(2-methoxyethyl)amino]-4-(4-oxo-1,2,3,4-tetrahydro-9H-carbazol-9-yl)benzamide",XQKFKSJUBJPOLY-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
113547,6vxx,DB11478,-8.1,Zeranol,DWTTZBARDOXEAM-GXTWGEPZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
14072,6lzg,T3D3690,-8.1,Ergocryptine,YDOTUXAWKBPQJW-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
64068,6lxt,DB01026,-8.1,Ketoconazole,XMAYWYJOQHXEEK-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
82842,6m3m,DB03079,-8.1,Alpha-Ribazole-5'-Phosphate Derivative,YPYFPLLZCVEYCS-KKOKHZNYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
165213,7bv1,DB11562,-8.1,Bicuculline,IYGYMKDQCDOMRE-ZWKOTPCHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
8614,6lzg,DB06521,-8.1,Ertiprotafib,FONCZICQWCUXEB-RUZDIDTESA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
95053,6m71,DB08846,-8.1,Ellagic Acid,AFSDNFLWKVMVRB-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
158161,7bv1,DB00450,-8.1,Droperidol,RMEDXOLNCUSCGS-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94967,6m71,DB08745,-8.1,4-[[(1E)-2-(4-CHLOROPHENYL)ETHENYL]SULFONYL]-1-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]PIPERAZINONE,QLHUDNKWOSQSMK-CXUHLZMHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
4516,6lzg,HMDB0001420,-8.1,"25,26-dihydroxyvitamin D",WWGCQHXFACVYPT-JKVVTCAUSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
54750,6crv,DB00186,-8.1,Lorazepam,DIWRORZWFLOCLC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
70002,6lxt,DB12011,-8.1,Fevipiprant,GFPPXZDRVCSVNR-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
95186,6m71,DB09050,-8.1,Ceftolozane,JHFNIHVVXRKLEF-DCZLAGFPSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
70004,6lxt,DB12015,-8.1,Alpelisib,STUWGJZDJHPWGZ-LBPRGKRZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
120243,6w4b,DB08248,-8.1,3-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)-BENZENESULFONAMIDE,BKDUVKJYBJDZQW-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
60457,6crv,DB08673,-8.1,"4-[(5-ISOPROPYL-1,3-THIAZOL-2-YL)AMINO]BENZENESULFONAMIDE",LPQUJAANWFHCJV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86734,6m3m,DB09299,-8.1,Tenofovir alafenamide,LDEKQSIMHVQZJK-CAQYMETFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
112383,6vxx,DB07040,-8.1,"2-amino-7-fluoro-5-oxo-5H-chromeno[2,3-b]pyridine-3-carboxamide",GCHMLYYPYFXLQB-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
166056,7bv1,DB13631,-8.1,Methoserpidine,ULBNWNUHGJLQHO-VKMIBBQISA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
64037,6lxt,DB00991,-8.1,Oxaprozin,OFPXSFXSNFPTHF-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
112608,6vxx,DB07451,-8.1,1-(5-BROMO-PYRIDIN-2-YL)-3-[2-(6-FLUORO-2-HYDROXY-3-PROPIONYL-PHENYL)-CYCLOPROPYL]-UREA,VRAJWAGCJIXJHQ-YPMHNXCESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60471,6crv,DB08690,-8.1,UBIQUINONE-2,SQQWBSBBCSFQGC-JLHYYAGUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
82914,6m3m,DB03176,-8.1,KB-141,OZYQIQVPUZANTM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
70089,6lxt,DB12138,-8.1,PF-03715455,VGEXRDWWPSGZDH-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
69962,6lxt,DB11951,-8.1,Lemborexant,MUGXRYIUWFITCP-PGRDOPGGSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
110429,6vxx,DB01582,-8.1,Sulfamethazine,ASWVTGNCAZCNNR-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
120328,6w4b,DB08358,-8.1,"2-(2-QUINOLIN-3-YLPYRIDIN-4-YL)-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE",OWFLADWRSCINST-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
60629,6crv,DB08895,-8.1,Tofacitinib,UJLAWZDWDVHWOW-YPMHNXCESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
94636,6m71,DB08350,-8.1,"5-[3-(2-METHOXYPHENYL)-1H-PYRROLO[2,3-B]PYRIDIN-5-YL]-N,N-DIMETHYLPYRIDINE-3-CARBOXAMIDE",GYQRHHQPEMOLKH-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60395,6crv,DB08596,-8.1,5'-deoxy-5'-piperidin-1-ylthymidine,GMOUOGHZJCSNOZ-YNEHKIRRSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30802,6cs2,DB13002,-8.1,HKI-357,NERXPXBELDBEPZ-RMKNXTFCSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
83253,6m3m,DB03650,-8.1,(3e)-3-[(4-Hydroxyphenyl)Imino]-1h-Indol-2(3h)-One,ZJASRZFZRYISET-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
60394,6crv,DB08595,-8.1,"4-[(1S,2R,5S)-4,4,8-TRIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL",BBZPJHFECDCNGT-BPUTZDHNSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
54787,6crv,DB00231,-8.1,Temazepam,SEQDDYPDSLOBDC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
70152,6lxt,DB12235,-8.1,Estetrol,AJIPIJNNOJSSQC-NYLIRDPKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
52428,2fxp,DB11399,-8.1,Dirlotapide,TUOSYWCFRFNJBS-BHVANESWSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
29428,6cs2,DB09181,-8.1,Trefentanil,RJSCINHYBGMIFT-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
50100,2fxp,DB06448,-8.1,Lonafarnib,DHMTURDWPRKSOA-RUZDIDTESA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
32035,6cs2,DB15238,-8.1,Olinciguat,YWQFJNWMWZMXRW-HXUWFJFHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
28544,6cs2,DB08133,-8.1,N-(4-sulfamoylphenyl)-1H-indazole-3-carboxamide,MNHPHKFLWAPNOV-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
63084,6crv,DB15105,-8.1,PF-06751979,ZLZUHACSRMOLLV-RAALSFIWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
132411,6w9c,DB00396,-8.1,Progesterone,RJKFOVLPORLFTN-LEKSSAKUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
64009,6lxt,DB00957,-8.1,Norgestimate,KIQQMECNKUGGKA-NMYWJIRASA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
40371,6lu7,DB08386,-8.1,2-{[4-(4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline,VRWJZGHUCOFGPZ-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
140631,6w9c,DB13016,-8.1,LY-2300559,DWQVYDLTPMGYNE-DEOSSOPVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
69875,6lxt,DB11824,-8.1,Tofogliflozin,VWVKUNOPTJGDOB-BDHVOXNPSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
60380,6crv,DB08577,-8.1,3-[(3-(2-CARBOXYETHYL)-4-METHYLPYRROL-2-YL)METHYLENE]-2-INDOLINONE,JNDVEAXZWJIOKB-JYRVWZFOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
157699,6wiq,DB12309,-8.1,GI-181771X,CABBMMXFOOZVMS-PMERELPUSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
18095,6cs2,HMDB0012454,-8.1,"3beta,7alpha-Dihydroxy-5-cholestenoate",GYJSAWZGYQXRBS-GRJZKGIBSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
69896,6lxt,DB11855,-8.1,Revefenacin,FYDWDCIFZSGNBU-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
64010,6lxt,DB00959,-8.1,Methylprednisolone,VHRSUDSXCMQTMA-PJHHCJLFSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
133001,6w9c,DB01094,-8.1,Hesperetin,AIONOLUJZLIMTK-AWEZNQCLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
8636,6lzg,DB06581,-8.1,Bevirimat,YJEJKUQEXFSVCJ-WRFMNRASSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
157728,6wiq,DB12724,-8.1,AZD-7295,MAQDQJWCSSCURR-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
60657,6crv,DB08941,-8.1,Isoxsuprine,BMUKKTUHUDJSNZ-HBUWYVDXSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
63980,6lxt,DB00923,-8.1,Ceforanide,SLAYUXIURFNXPG-CRAIPNDOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
83281,6m3m,DB03685,-8.1,Uridine monophosphate,DJJCXFVJDGTHFX-XVFCMESISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83279,6m3m,DB03682,-8.1,"Dibenzofuran-4,6-Dicarboxylic Acid",HBBGSNOHAGNQRQ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
60659,6crv,DB08943,-8.1,Isoconazole,MPIPASJGOJYODL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110411,6vxx,DB01562,-8.1,1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine,BVURVTVDNWSNFN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
135946,6w9c,DB06155,-8.1,Rimonabant,JZCPYUJPEARBJL-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
157966,6wiq,DB15396,-8.1,PF-114,SLIVDYMORZGPLW-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
9083,6lzg,DB07156,-8.1,"(4Z)-6-bromo-4-({[4-(pyrrolidin-1-ylmethyl)phenyl]amino}methylidene)isoquinoline-1,3(2H,4H)-dione",JFEKAVPMVOLVTH-UNOMPAQXSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
132971,6w9c,DB01060,-8.1,Amoxicillin,LSQZJLSUYDQPKJ-NJBDSQKTSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
86806,6m3m,DB11184,-8.1,Oftasceine,DEGAKNSWVGKMLS-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
135961,6w9c,DB06190,-8.1,Solabegron,LLDXOPKUNJTIRF-QFIPXVFZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
60407,6crv,DB08610,-8.1,N-(2-AMINOETHYL)-2-{3-CHLORO-4-[(4-ISOPROPYLBENZYL)OXY]PHENYL} ACETAMIDE,DFXJYVQAAFOZDP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
94715,6m71,DB08446,-8.1,"3-[6-bromo-2-fluoro-3-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)phenoxy]-5-chlorobenzonitrile",OHQMEDBYNUAVNE-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
54686,6crv,DB00118,-8.1,Ademetionine,MEFKEPWMEQBLKI-AIRLBKTGSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
120332,6w4b,DB08362,-8.1,"N-(3-(8-CYANO-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZIN-2-YLAMINO)PHENYL)ACETAMIDE",QVKXQLGRDOMAGC-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
83186,6m3m,DB03549,-8.1,Biotinyl P-Nitroaniline,PORZMUYPQKOFQY-YDHLFZDLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
140591,6w9c,DB12500,-8.1,Fedratinib,JOOXLOJCABQBSG-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
158001,6wiq,DB15460,-8.1,AGG-523,JWQMTWCFNZSLNR-DEOSSOPVSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
83125,6m3m,DB03458,-8.1,"N(4)-Adenosyl-N(4)-methyl-2,4-diaminobutanoic acid",JISVTSUBJCPLSV-TWBCTODHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
53308,2fxp,DB12799,-8.1,Laniquidar,TULGGJGJQXESOO-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
53276,2fxp,DB12743,-8.1,Z-160,VCPMZDWBEWTGNW-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
94695,6m71,DB08423,-8.1,[5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL][3-(PIPERIDIN-4-YLOXY)PHENYL]METHANONE,QKZZJXRGCHXIAI-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
69933,6lxt,DB11910,-8.1,MK-0249,DDDZBLNULGDPGA-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
165228,7bv1,DB11616,-8.1,Pirarubicin,KMSKQZKKOZQFFG-YXRRJAAWSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
158336,7bv1,DB00878,-8.1,Chlorhexidine,GHXZTYHSJHQHIJ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
121976,6w4b,DB12682,-8.0,Mubritinib,ZTFBIUXIQYRUNT-MDWZMJQESA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
164219,7bv1,DB07393,-8.0,"2-(2-PHENYL-3-PYRIDIN-2-YL-4,5,6,7-TETRAHYDRO-2H-ISOPHOSPHINDOL-1-YL)PYRIDINE",GSKNNHAAFLPYHG-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
32079,6cs2,DB15317,-8.0,Posiphen,PBHFNBQPZCRWQP-AZUAARDMSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
55810,6crv,DB01511,-8.0,Delorazepam,CHIFCDOIPRCHCF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
121785,6w4b,DB12394,-8.0,Eleclazine,YNUAEEJQYHYLMS-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
108387,6vxx,DB07701,-8.0,"1-BENZYL-4-[(5,6-DIMETHOXY-1-INDANON-2-YL)METHYL]PIPERIDINE",ADEBPBSSDYVVLD-HXUWFJFHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108501,6vxx,DB08061,-8.0,4-[3-(4-CHLOROPHENYL)-1H-PYRAZOL-5-YL]PIPERIDINE,GELALLNTKKLQLM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31913,6cs2,DB15029,-8.0,AZD-8186,LMJFJIDLEAWOQJ-CQSZACIVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
112306,6vxx,DB06947,-8.0,1-[(2R)-2-aminobutanoyl]-N-(4-carbamimidoylbenzyl)-L-prolinamide,YHAMQFKGUUSJMU-KGLIPLIRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
121499,6w4b,DB11984,-8.0,Letaxaban,GEHAEMCVKDPMKO-HXUWFJFHSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
112330,6vxx,DB06982,-8.0,(2S)-8-[(tert-butoxycarbonyl)amino]-2-(1H-indol-3-yl)octanoic acid,AWVCKFLATUTBCX-INIZCTEOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
121716,6w4b,DB12297,-8.0,GLPG-0187,CXHCNOMGODVIKB-VWLOTQADSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
108458,6vxx,DB08013,-8.0,(METHYLPYRIDAZINE PIPERIDINE PROPYLOXYPHENYL)ETHYLACETATE,UEIUDEUUVLYRFV-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112540,6vxx,DB07371,-8.0,3-(10-methyl-9-anthryl)propanoic acid,CKQINRXZVYBCSC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55884,6crv,DB01595,-8.0,Nitrazepam,KJONHKAYOJNZEC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
121748,6w4b,DB12339,-8.0,Radezolid,BTTNOGHPGJANSW-IBGZPJMESA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
114675,6vxx,DB14636,-8.0,Triciribine phosphate,URLYINUFLXOMHP-HTVVRFAVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
126197,6w4h,DB03501,-8.0,Galactose-uridine-5'-diphosphate,HSCJRCZFDFQWRP-ABVWGUQPSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
165601,7bv1,DB12522,-8.0,Toreforant,FCRFVPZAXGJLPW-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
126111,6w4h,DB03376,-8.0,'5'-O-(N-(L-Alanyl)-Sulfamoyl)Adenosine,CWWYMWDIYBJVLP-YTMOPEAISA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
112667,6vxx,DB07522,-8.0,"N-[(2R,3S)-3-AMINO-2-HYDROXY-4-PHENYLBUTYL]NAPHTHALENE-2-SULFONAMIDE",QSSWSEQPKCCATQ-VQTJNVASSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55841,6crv,DB01544,-8.0,Flunitrazepam,PPTYJKAXVCCBDU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
122026,6w4b,DB12760,-8.0,GW-493838,ZQYJPMPXQLNTPQ-QCUYGVNKSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
122827,6w4b,DB13958,-8.0,Trestolone acetate,IVCRCPJOLWECJU-XQVQQVTHSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
165692,7bv1,DB12665,-8.0,Isoquercetin,OVSQVDMCBVZWGM-QSOFNFLRSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
121662,6w4b,DB12225,-8.0,Beclabuvir,ZTTKEBYSXUCBSE-QDFUAKMASA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
165713,7bv1,DB12696,-8.0,BMS-582949,GDTQLZHHDRRBEB-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
112089,6vxx,DB06257,-8.0,HE-2200,OEVZKEVBDIDVOI-YSZCXEEOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108616,6vxx,DB08464,-8.0,"METHYL 3-CHLORO-2-{3-[(2,5-DIHYDROXY-4-METHOXYPHENYL)AMINO]-3-OXOPROPYL}-4,6-DIHYDROXYBENZOATE",GUVWEHNRWHNDRF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
121594,6w4b,DB12122,-8.0,Figopitant,HUTHJVYJUPXHDF-DEOSSOPVSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
29919,6cs2,DB11811,-8.0,Arhalofenate,BJBCSGQLZQGGIQ-QGZVFWFLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
122244,6w4b,DB13101,-8.0,4SC-202,PRXXYMVLYKJITB-IZZDOVSWSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
126157,6w4h,DB03447,-8.0,Uridylyl-2'-5'-Phospho-Adenosine,QARCCHXXGAIRFS-KPKSGTNCSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
108421,6vxx,DB07972,-8.0,1-(3-METHYLPHENYL)-1H-BENZIMIDAZOL-5-AMINE,VFSVFGIODYZMOF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55855,6crv,DB01558,-8.0,Bromazepam,VMIYHDSEFNYJSL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112612,6vxx,DB07455,-8.0,"N,N'-[biphenyl-4,4'-diyldi(2R)propane-2,1-diyl]dimethanesulfonamide",ZESUARCHWPARIF-HOTGVXAUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165640,7bv1,DB12579,-8.0,JNJ-37822681,UVUYWJWYRLJHEN-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
112373,6vxx,DB07030,-8.0,(5-CHLORO-2-{[(3-NITROBENZYL)AMINO]CARBONYL}PHENOXY)ACETIC ACID,VABIMMIJVWNHFI-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114639,6vxx,DB13936,-8.0,JNJ-28330835,RYBKPGYFXRNMMU-LBPRGKRZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55867,6crv,DB01570,-8.0,Ohmefentanyl,FRPRNNRJTCONEC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165583,7bv1,DB12492,-8.0,Piritramide,IHEHEFLXQFOQJO-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
164108,7bv1,DB07268,-8.0,2-({2-[(3-HYDROXYPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)BENZAMIDE,QHPKKGUGRGRSGA-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
112762,6vxx,DB07814,-8.0,Gibberellic acid,IXORZMNAPKEEDV-OBDJNFEBSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114651,6vxx,DB13983,-8.0,"5,7,2'-trihydroxy-6,8-dimethoxyflavone",JWOKGWICZPPYPX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114618,6vxx,DB13867,-8.0,Fluticasone,MGNNYOODZCAHBA-GQKYHHCASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
121734,6w4b,DB12318,-8.0,BMS-599626,LUJZZYWHBDHDQX-QFIPXVFZSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
112708,6vxx,DB07755,-8.0,"(2S)-1-[4-({4-[(2,5-Dichlorophenyl)amino]-2-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol",GNLAGGCSJGJECE-INIZCTEOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108677,6vxx,DB08535,-8.0,"3-bromo-5-phenyl-N-(pyridin-3-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",SMIZFGZXFDGISG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108469,6vxx,DB08024,-8.0,1-[2-(S)-AMINO-3-BIPHENYL-4-YL-PROPIONYL]-PYRROLIDINE-2-(S)-CARBONITRILE,MUUVLSCVDXKQQV-OALUTQOASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108553,6vxx,DB08388,-8.0,"5-(2-ETHOXYETHYL)-5-[4-(4-FLUOROPHENOXY)PHENOXY]PYRIMIDINE-2,4,6(1H,3H,5H)-TRIONE",XRSYNYGEEYTXJV-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165795,7bv1,DB13024,-8.0,MK-8245,UJEAABFSXKCSGI-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
112256,6vxx,DB06891,-8.0,"5-{[(4-AMINO-3-CHLORO-5-FLUOROPHENYL)SULFONYL]AMINO}-1,3,4-THIADIAZOLE-2-SULFONAMIDE",HOLJYLOVIHBQHO-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165549,7bv1,DB12441,-8.0,Tavilermide,DVJXNXPFYJIACK-ULQDDVLXSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
125880,6w4h,DB03076,-8.0,AHA047,CGBDAHCDSVOMCF-FYZVQMPESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
121768,6w4b,DB12371,-8.0,Siponimod,KIHYPELVXPAIDH-HNSNBQBZSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
126299,6w4h,DB03656,-8.0,Tribenuron Methyl,VLCQZHSMCYCDJL-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
32173,6cs2,DB01146,-8.0,Diphenylpyraline,OWQUZNMMYNAXSL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
122110,6w4b,DB12899,-8.0,TT-301,ZPJGUEPHFXPAQF-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
165574,7bv1,DB12477,-8.0,Perfluoro tert-butylcyclohexane,VLTXBOGHSBHSAC-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
108417,6vxx,DB07968,-8.0,N-(2-CHLORO-4-FLUOROBENZOYL)-N'-(5-HYDROXY-2-METHOXYPHENYL)UREA,RFOBTYLRURSVJE-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108473,6vxx,DB08029,-8.0,N-2-(biphenyl-4-ylsulfonyl)-N-hydroxy-N-2-(2-hydroxyethyl)glycinamide,QQDWEVONJRXVDB-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112577,6vxx,DB07415,-8.0,4-[(1S)-1-(3-fluoro-4-methoxyphenyl)-2-(2-methoxy-5-nitrophenyl)ethyl]-1H-imidazol-2-amine,RFLOFHKRBGKCOB-AWEZNQCLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
122531,6w4b,DB13528,-8.0,Chlormadinone,VUHJZBBCZGVNDZ-TTYLFXKOSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
108592,6vxx,DB08436,-8.0,"8-BENZO[1,3]DIOXOL-,5-YLMETHYL-9-BUTYL-9H-",JCDXXNIRWRRGBX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31873,6cs2,DB14917,-8.0,Ceralasertib,DTTJKLNXNZAVSM-JYCIKRDWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
112465,6vxx,DB07287,-8.0,"2-(2,4-DICHLOROPHENOXY)-5-(PYRIDIN-2-YLMETHYL)PHENOL",AOVDSWPGWPRTSR-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112480,6vxx,DB07303,-8.0,"N-3-[3-(5-METHOXYPYRIDIN-3-YL)BENZYL]PYRIDINE-2,3-DIAMINE",PGAWZMRRCVSRIM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
122174,6w4b,DB12999,-8.0,MK-6186,FZBAOOQVQXATRL-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
112143,6vxx,DB06414,-8.0,Etravirine,PYGWGZALEOIKDF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112221,6vxx,DB06616,-8.0,Bosutinib,UBPYILGKFZZVDX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114677,6vxx,DB14638,-8.0,Diloxanide furoate,BDYYDXJSHYEDGB-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
126241,6w4h,DB03572,-8.0,FR230513,URGFTPMACWKJKU-OAHLLOKOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
112462,6vxx,DB07284,-8.0,"N-3-(3-PYRIDIN-3-YLBENZYL)PYRIDINE-2,3-DIAMINE",NQSBHBFOOVYRNM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
121533,6w4b,DB12036,-8.0,Naquotinib,QKDCLUARMDUUKN-XMMPIXPASA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
31828,6cs2,DB01095,-8.0,Fluvastatin,FJLGEFLZQAZZCD-JUFISIKESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
121546,6w4b,DB12054,-8.0,BQ-123,VYCMAAOURFJIHD-PJNXIOHISA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
122228,6w4b,DB13078,-8.0,KOSN-1724,JAYGOFBXDFAXBW-CYEKYUJNSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
165698,7bv1,DB12672,-8.0,Icaritin,TUUXBSASAQJECY-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
126097,6w4h,DB03358,-8.0,7n-Methyl-8-Hydroguanosine-5'-Triphosphate,BUJQMJUTTBGELS-KQYNXXCUSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
112273,6vxx,DB06911,-8.0,D-leucyl-N-(3-chlorobenzyl)-L-prolinamide,FHVBVJXZKNCSLP-CVEARBPZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
121511,6w4b,DB12001,-8.0,Abemaciclib,UZWDCWONPYILKI-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
114790,6vxx,DB14867,-8.0,Parsaclisib,ZQPDJCIXJHUERQ-QWRGUYRKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108394,6vxx,DB07708,-8.0,3-CHLORO-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL,ZNHQDSBJVFFIAK-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
115333,6w4b,DB00734,-8.0,Risperidone,RAPZEAPATHNIPO-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
122239,6w4b,DB13095,-8.0,JTK-853,JQLOVYLALGSISI-HXUWFJFHSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
112159,6vxx,DB06457,-8.0,Tecastemizole,SFOVDSLXFUGAIV-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108546,6vxx,DB08379,-8.0,6-(4-chloro-2-fluoro-3-phenoxybenzyl)pyridazin-3(2H)-one,NOVPOXGMADEKPP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114941,6vxx,DB15449,-8.0,Citarinostat,VLIUIBXPEDFJRF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114656,6vxx,DB14575,-8.0,Eslicarbazepine,BMPDWHIDQYTSHX-AWEZNQCLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114696,6vxx,DB14659,-8.0,Melengestrol acetate,UDKABVSQKJNZBH-DWNQPYOZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
164138,7bv1,DB07300,-8.0,"2-(1H-imidazol-1-yl)-9-methoxy-8-(2-methoxyethoxy)benzo[c][2,7]naphthyridin-4-amine",QSSGYSRUMIOURP-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
121924,6w4b,DB12598,-8.0,Nafamostat,MQQNFDZXWVTQEH-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
121645,6w4b,DB12200,-8.0,Tivantinib,UCEQXRCJXIVODC-PMACEKPBSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
165513,7bv1,DB12218,-8.0,AZD-5363,JDUBGYFRJFOXQC-KRWDZBQOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
29941,6cs2,DB11836,-8.0,Sapanisertib,GYLDXIAOMVERTK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
114607,6vxx,DB13851,-8.0,Artemotil,NLYNIRQVMRLPIQ-XQLAAWPRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
121528,6w4b,DB12025,-8.0,Triptolide,DFBIRQPKNDILPW-CIVMWXNOSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
164263,7bv1,DB07444,-8.0,"6-(3-AMINOPROPYL)-4,9-DIMETHYLPYRROLO[3,4-C]CARBAZOLE-1,3(2H,6H)-DIONE",PKPNSCZPIWCHMW-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
126350,6w4h,DB03723,-8.0,2'-Deoxy-Thymidine-Beta-L-Rhamnose,ZOSQFDVXNQFKBY-CGAXJHMRSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
55732,6crv,DB01420,-8.0,Testosterone propionate,PDMMFKSKQVNJMI-BLQWBTBKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
122203,6w4b,DB13042,-8.0,Fenoverine,UBAJTZKNDCEGKL-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
32042,6cs2,DB15250,-8.0,Vercirnon,JRWROCIMSDXGOZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
125774,6w4h,DB02929,-8.0,K201,KCWGETCFOVJEPI-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
164153,7bv1,DB07315,-8.0,"5-chloro-N-{4-[(1R)-1,2-dihydroxyethyl]phenyl}-1H-indole-2-carboxamide",SHCHFGSUYJUEBR-INIZCTEOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
121954,6w4b,DB12651,-8.0,Bardoxolone,TXGZJQLMVSIZEI-UQMAOPSPSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
55883,6crv,DB01594,-8.0,Cinolazepam,XAXMYHMKTCNRRZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31834,6cs2,DB14854,-8.0,TC-6987,UAKZGMMGIMKFMV-RBUKOAKNSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
114868,6vxx,DB15299,-8.0,AMG-232,DRLCSJFKKILATL-YWCVFVGNSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55687,6crv,DB01336,-8.0,Metocurine,JFXBEKISTKFVAB-AJQTZOPKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109931,6vxx,DB00605,-8.0,Sulindac,MLKXDPUZXIRXEP-MFOYZWKCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
122865,6w4b,DB14038,-8.0,beta-Sitosterol,KZJWDPNRJALLNS-VJSFXXLFSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
30427,6cs2,DB12467,-8.0,TU-100,KAYRGFYBCCETPE-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
54743,6crv,DB00178,-8.0,Ramipril,HDACQVRGBOVJII-JBDAPHQKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
118668,6w4b,DB05812,-8.0,Abiraterone,GZOSMCIZMLWJML-VJLLXTKPSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
164645,7bv1,DB08246,-8.0,"(2S)-4-(2,5-DIFLUOROPHENYL)-N,N-DIMETHYL-2-PHENYL-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDE",WFFMEXQHWXEKBV-SFHVURJKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
30838,6cs2,DB13051,-8.0,CH-5132799,JEGHXKRHKHPBJD-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
164644,7bv1,DB08245,-8.0,1-(2-DEOXY-5-O-PHOSPHONO-BETA-D-ERYTHRO-PENTOFURANOSYL)-5-NITRO-1H-INDOLE,FQCJFJRLZCIFHB-YNEHKIRRSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110504,6vxx,DB01681,-8.0,Benzene Hexacarboxylic Acid,YDSWCNNOKPMOTP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
53321,2fxp,DB12821,-8.0,Perflubutane,KAVGMUDTWQVPDF-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
165236,7bv1,DB11636,-8.0,Nomegestrol,KZUIYQJTUIACIG-YBZCJVABSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
47504,2fxp,DB01897,-8.0,2-(2f-Benzothiazolyl)-5-Styryl-3-(4f-Phthalhydrazidyl)Tetrazolium Chloride,BEIGFKLRGRRJJA-JLHYYAGUSA-O,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
113913,6vxx,DB12268,-8.0,Carmegliptin,GUYMHFIHHOEFOA-ZCPGHIKRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
123996,6w4h,DB00635,-8.0,Prednisone,XOFYZVNMUHMLCC-ZPOLXVRWSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
113930,6vxx,DB12288,-8.0,Piromelatine,PNTNBIHOAPJYDB-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
123960,6w4h,DB00591,-8.0,Fluocinolone acetonide,FEBLZLNTKCEFIT-VSXGLTOVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
164631,7bv1,DB08230,-8.0,"5,7-DIHYDROXY-2-(3,4,5-TRIHYDROXYPHENYL)-4H-CHROMEN-4-ONE",ARSRJFRKVXALTF-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
40364,6lu7,DB07817,-8.0,"1-{3-[(4-pyridin-2-ylpiperazin-1-yl)sulfonyl]phenyl}-3-(1,3-thiazol-2-yl)urea",NJPVZSIGDRLLTD-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
113454,6vxx,DB09206,-8.0,Trimazosin,YNZXWQJZEDLQEG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110536,6vxx,DB01906,-8.0,"3-(5-Amino-7-Hydroxy-[1,2,3]Triazolo[4,5-D]Pyrimidin-2-Yl)-Benzoic Acid",KNLLRZNGRRRPEW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
40360,6lu7,DB00696,-8.0,Ergotamine,XCGSFFUVFURLIX-VFGNJEKYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40359,6lu7,DB02449,-8.0,3-(1h-Indol-3-Yl)-2-[4-(4-Phenyl-Piperidin-1-Yl)-Benzenesulfonylamino]-Propionic Acid,ULOTXPTWJAUGGE-MHZLTWQESA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40358,6lu7,DB03957,-8.0,SP2456,SSSXBBASYYVGCI-HSZRJFAPSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
164613,7bv1,DB08204,-8.0,3-DIPHENOL-6-NITRO-3H-BENZO[DE]ISOCHROMEN-1-ONE,FLWABCQDXUKNQY-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
46711,2fxp,DB00872,-8.0,Conivaptan,IKENVDNFQMCRTR-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
40357,6lu7,DB04698,-8.0,"N-(1,4-DIHYDRO-5H-TETRAZOL-5-YLIDENE)-9-OXO-9H-XANTHENE-2-SULFONAMIDE",HJWYZPGYPZNDTN-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
30432,6cs2,DB12474,-8.0,Lynestrenol,YNVGQYHLRCDXFQ-XGXHKTLJSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
30827,6cs2,DB13032,-8.0,Enecadin,SZSHJTJCJOWMHM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
124598,6w4h,DB01410,-8.0,Ciclesonide,LUKZNWIVRBCLON-GXOBDPJESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
30468,6cs2,DB12524,-8.0,BI-671800,XEOSTBFUCNZKGS-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
118807,6w4b,DB06350,-8.0,Elinogrel,LGSDFTPAICUONK-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
110392,6vxx,DB01543,-8.0,18-methyl-19-nortestosterone,FBYZQDCRLYHHHP-ZOFHRBRSSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
118802,6w4b,DB06334,-8.0,Tucidinostat,SZMJVTADHFNAIS-BJMVGYQFSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
124686,6w4h,DB01512,-8.0,Hydromorphinol,AABLHGPVOULICI-BRJGLHKUSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
124708,6w4h,DB01536,-8.0,Androstenedione,AEMFNILZOJDQLW-QAGGRKNESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
113867,6vxx,DB12204,-8.0,Terbogrel,XUTLOCQNGLJNSA-RGVLZGJSSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109620,6vxx,DB14542,-8.0,Hydrocortisone phosphate,BGSOJVFOEQLVMH-VWUMJDOOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113868,6vxx,DB12206,-8.0,N-6022,YVPGZQLRPAGKLA-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113910,6vxx,DB12264,-8.0,Atevirdine,UCPOMLWZWRTIAA-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
118792,6w4b,DB06302,-8.0,Glesatinib,YRCHYHRCBXNYNU-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
120219,6w4b,DB08220,-8.0,"(8alpha,10alpha,13alpha,17beta)-17-[(4-hydroxyphenyl)carbonyl]androsta-3,5-diene-3-carboxylic acid",RPNNXCYIESWDSC-JRZBRKEGSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
164694,7bv1,DB08494,-8.0,"S-{2-[(2-chloro-4-sulfamoylphenyl)amino]-2-oxoethyl} 6-methyl-3,4-dihydroquinoline-1(2H)-carbothioate",AWAKIULNKVOBKE-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
109602,6vxx,DB14217,-8.0,Quinaprilat,FLSLEGPOVLMJMN-YSSFQJQWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109520,6vxx,DB14038,-8.0,beta-Sitosterol,KZJWDPNRJALLNS-VJSFXXLFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
166102,7bv1,DB13687,-8.0,Niaprazine,RSKQGBFMNPDPLR-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110419,6vxx,DB01570,-8.0,Ohmefentanyl,FRPRNNRJTCONEC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110420,6vxx,DB01571,-8.0,3-Methylfentanyl,MLQRZXNZHAOCHQ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
118753,6w4b,DB06212,-8.0,Tolvaptan,GYHCTFXIZSNGJT-XMMPIXPASA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
118703,6w4b,DB06077,-8.0,Lumateperone,HOIIHACBCFLJET-SFTDATJTSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
109491,6vxx,DB13983,-8.0,"5,7,2'-trihydroxy-6,8-dimethoxyflavone",JWOKGWICZPPYPX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109616,6vxx,DB14538,-8.0,Hydrocortisone aceponate,MFBMYAOAMQLLPK-FZNHGJLXSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
123958,6w4h,DB00589,-8.0,Lisuride,BKRGVLQUQGGVSM-KBXCAEBGSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
123929,6w4h,DB00554,-8.0,Piroxicam,QYSPLQLAKJAUJT-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
110651,6vxx,DB02059,-8.0,Adenosine-5-Diphosphoribose,SRNWOUGRCWSEMX-ZQSHOCFMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
36294,1r42,DB02732,-8.0,Nicotinamide Adenine Dinucleotide Acetone Adduct,SGHBFOOIAAJJMI-YDKVLQLQSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
35928,1r42,DB02259,-8.0,"3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid (4-Sulfamoyl-Phenyl)-Amide",VSYGXLAJQDAWCZ-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
120596,6w4b,DB08683,-8.0,"REL-(9R,12S)-9,10,11,12-TETRAHYDRO-9,12-EPOXY-1H-DIINDOLO[1,2,3-FG:3',2',1'-KL]PYRROLO[3,4-I][1,6]BENZODIAZOCINE-1,3(2H)-DIONE",OTPNDVKVEAIXTI-IYBDPMFKSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
124913,6w4h,DB01793,-8.0,SB-409513,ONVZFCHLOZUXRP-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
30957,6cs2,DB13237,-8.0,Clofoctol,HQVZOORKDNCGCK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
124933,6w4h,DB01820,-8.0,"Compound 12, N-Acetyl-4-[(Carboxycarbonyl)(2-Carboxyphenyl)Amino]-N-Pentyl-1-Napthylalaniamide",UESXELNYBIOROE-QHCPKHFHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
35848,1r42,DB02152,-8.0,K-252a,KOZFSFOOLUUIGY-SOLYNIJKSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
114012,6vxx,DB12588,-8.0,AZD-1480,PDOQBOJDRPLBQU-QMMMGPOBSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
35725,1r42,DB01988,-8.0,6((S)-3-Benzylpiperazin-1-Yl)-3-(Naphthalen-2-Yl)-4-(Pyridin-4-Yl)Pyrazine,WFSFNKVFXLIZIY-MHZLTWQESA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
35648,1r42,DB01879,-8.0,(S)-2-{Methyl-[2-(Naphthalene-2-Sulfonylamino)-5-(Naphthalene-2-Sulfonyloxy)-Benzoyl]-Amino}-Succinicacid,JOAALZBSMWLOPQ-LJAQVGFWSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
109332,6vxx,DB13083,-8.0,Talarozole,SNFYYXUGUBUECJ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
35645,1r42,DB01876,-8.0,Bis(5-Amidino-2-Benzimidazolyl)Methanone,VVVXDHROXQUONB-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
165937,7bv1,DB13266,-8.0,Cefatrizine,UOCJDOLVGGIYIQ-PBFPGSCMSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
118380,6w4b,DB04750,-8.0,OREGON GREEN 488 CARBOXYLATE,BRJCLSQFZSHLRL-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
35488,1r42,DB01669,-8.0,Virginiamycin M1,DAIKHDNSXMZDCU-FQTGFAPKSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
118337,6w4b,DB04689,-8.0,2-{5-[3-(6-BENZOYL-1-PROPYLNAPHTHALEN-2-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID,ZXWVCCFKIRBLDP-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
35275,1r42,DB01419,-8.0,Antrafenine,NWGGKKGAFZIVBJ-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
118277,6w4b,DB04608,-8.0,"9-HYDROXY-4-PHENYL-6H-PYRROLO[3,4-C]CARBAZOLE-1,3-DIONE",IAUZTOZLTFSMIE-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
30965,6cs2,DB13246,-8.0,Quinupramine,JCBQCKFFSPGEDY-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
35153,1r42,DB01199,-8.0,Tubocurarine,JFJZZMVDLULRGK-URLMMPGGSA-O,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
166443,7bv1,DB15141,-8.0,Deutivacaftor,PURKAOJPTOLRMP-ASMGOKTBSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
35072,1r42,DB01108,-8.0,Trilostane,KVJXBPDAXMEYOA-CXANFOAXSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
30313,6cs2,DB12319,-8.0,Benzbromarone,WHQCHUCQKNIQEC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
123765,6w4h,DB00353,-8.0,Methylergometrine,UNBRKDKAWYKMIV-QWQRMKEZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
113372,6vxx,DB09070,-8.0,Tibolone,WZDGZWOAQTVYBX-XOINTXKNSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55351,6crv,DB00905,-8.0,Bimatoprost,AQOKCDNYWBIDND-FTOWTWDKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
120445,6w4b,DB08499,-8.0,"N-[3-(2-fluoroethoxy)phenyl]-N'-(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-6-yl)butanediamide",DQXBKUVWJSZHSI-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
40339,6lu7,DB11399,-8.0,Dirlotapide,TUOSYWCFRFNJBS-BHVANESWSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
113394,6vxx,DB09101,-8.0,Elvitegravir,JUZYLCPPVHEVSV-LJQANCHMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
164569,7bv1,DB08153,-8.0,"(5E)-14-CHLORO-15,17-DIHYDROXY-4,7,8,9,10,11-HEXAHYDRO-2-BENZOXACYCLOPENTADECINE-1,12(3H,13H)-DIONE",VZTAZMSAAIUZJV-HWKANZROSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
30362,6cs2,DB12389,-8.0,Zamicastat,ZSSLCFLHEFXANG-GOSISDBHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
40336,6lu7,DB07794,-8.0,"5-(2-PHENYLPYRAZOLO[1,5-A]PYRIDIN-3-YL)-1H-PYRAZOLO[3,4-C]PYRIDAZIN-3-AMINE",XVECMUKVOMUNLE-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
109396,6vxx,DB13514,-8.0,Pranoprofen,TVQZAMVBTVNYLA-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
164565,7bv1,DB08149,-8.0,"1-[4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine",KCWPSUKJCKZEAO-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
40319,6lu7,DB11618,-8.0,Zorubicin,FBTUMDXHSRTGRV-BJISBDEGSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40318,6lu7,DB11942,-8.0,Selinexor,DEVSOMFAQLZNKR-RJRFIUFISA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40317,6lu7,DB12207,-8.0,Verdinexor,OPAKEJZFFCECPN-XQRVVYSFSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40316,6lu7,DB12579,-8.0,JNJ-37822681,UVUYWJWYRLJHEN-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
123839,6w4h,DB00443,-8.0,Betamethasone,UREBDLICKHMUKA-DVTGEIKXSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
120456,6w4b,DB08512,-8.0,"6-amino-2-[(1-naphthylmethyl)amino]-3,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",MCEZMMDIEXECTI-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
113380,6vxx,DB09080,-8.0,Olodaterol,COUYJEVMBVSIHV-SFHVURJKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
40315,6lu7,DB13093,-8.0,TAK-593,DZFZXPPHBWCXPQ-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
37464,1r42,DB04301,-8.0,Bis(5-Amidino-2-Benzimidazolyl)Methane Ketone Hydrate,ZLAHDRAQCSQPOC-UHFFFAOYSA-P,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
30899,6cs2,DB13129,-8.0,Trimegestone,JUNDJWOLDSCTFK-MTZCLOFQSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
37167,1r42,DB03907,-8.0,"N-{3-[5-(6-Amino-Purin-9-Yl)-3,4-Dihydroxy-Tetrahydro-Furan-2-Yl]-Allyl}-2,3-Dihydroxy-5-Nitro-Benzamide",UHHBFOLQOQSPLU-WGRQDFERSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
120491,6w4b,DB08553,-8.0,"(1E)-5-(1-piperidin-4-yl-3-pyridin-4-yl-1H-pyrazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime",KWEFZSZCLBHIEQ-YYADALCUSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
36652,1r42,DB03213,-8.0,Bis(5-Amidino-2-Benzimidazolyl)Methane Ketone,VVVXDHROXQUONB-UHFFFAOYSA-P,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
36645,1r42,DB03205,-8.0,Pyrroloquinoline Quinone,MMXZSJMASHPLLR-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
55350,6crv,DB00904,-8.0,Ondansetron,FELGMEQIXOGIFQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113563,6vxx,DB11520,-8.0,Hygromycin B,GRRNUXAQVGOGFE-HUCHGKBZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
118259,6w4b,DB04583,-8.0,"5-Carbamoyl-1,1':4',1''-terphenyl-3-carboxylic acid",LAZPCGBRHLARSI-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
110380,6vxx,DB01531,-8.0,Desomorphine,LNNWVNGFPYWNQE-GMIGKAJZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165193,7bv1,DB11512,-8.0,Dihydrostreptomycin,ASXBYYWOLISCLQ-HZYVHMACSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
166331,7bv1,DB14664,-8.0,Difluocortolone pivalate,UWGRWFCLGQWKPR-GSTUPEFVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
113699,6vxx,DB11781,-8.0,Tosedostat,FWFGIHPGRQZWIW-SQNIBIBYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
124366,6w4h,DB01066,-8.0,Cefditoren,KMIPKYQIOVAHOP-YLGJWRNMSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
166284,7bv1,DB14570,-8.0,Hydroxyprogesterone,DBPWSSGDRRHUNT-CEGNMAFCSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
164978,7bv1,DB09034,-8.0,Suvorexant,JYTNQNCOQXFQPK-MRXNPFEDSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
30584,6cs2,DB12689,-8.0,Azeliragon,KJNNWYBAOPXVJY-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
119709,6w4b,DB07630,-8.0,"N-((1R,2R)-2-(5-CHLORO-1H-INDOLE-2-CARBOXAMIDO)CYCLOHEXYL)-5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE-2-CARBOXAMIDE",ARPFWVKYXJZULB-IAGOWNOFSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
124243,6w4h,DB00923,-8.0,Ceforanide,SLAYUXIURFNXPG-CRAIPNDOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
110079,6vxx,DB00950,-8.0,Fexofenadine,RWTNPBWLLIMQHL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
164989,7bv1,DB09056,-8.0,Amorolfine,MQHLMHIZUIDKOO-AYHJJNSGSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
54981,6crv,DB00461,-8.0,Nabumetone,BLXXJMDCKKHMKV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55083,6crv,DB00588,-8.0,Fluticasone propionate,WMWTYOKRWGGJOA-CENSZEJFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
119291,6w4b,DB07142,-8.0,"5-[(3R)-3-(5-methoxy-3',5'-dimethylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",ATFDKOLABYIYCC-INIZCTEOSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
113668,6vxx,DB11736,-8.0,PF-00489791,ZUHZNKJIJDAJFD-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
124388,6w4h,DB01092,-8.0,Ouabain,LPMXVESGRSUGHW-HBYQJFLCSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
164999,7bv1,DB09073,-8.0,Palbociclib,AHJRHEGDXFFMBM-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
113655,6vxx,DB11711,-8.0,Navarixin,IXBYSXNOKFHHDR-QGZVFWFLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110101,6vxx,DB00978,-8.0,Lomefloxacin,ZEKZLJVOYLTDKK-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55094,6crv,DB00601,-8.0,Linezolid,TYZROVQLWOKYKF-ZDUSSCGKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109773,6vxx,DB00240,-8.0,Alclometasone,FJXOGVLKCZQRDN-PHCHRAKRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109772,6vxx,DB00239,-8.0,Oxiconazole,QRJJEGAJXVEBNE-HKOYGPOVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
124173,6w4h,DB00846,-8.0,Flurandrenolide,POPFMWWJOGLOIF-XWCQMRHXSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
113756,6vxx,DB12041,-8.0,Mapracorat,VJGFOYBQOIPQFY-XMMPIXPASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
166256,7bv1,DB14218,-8.0,Telotristat,NCLGDOBQAWBXRA-PGRDOPGGSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
124358,6w4h,DB01058,-8.0,Praziquantel,FSVJFNAIGNNGKK-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
109858,6vxx,DB00342,-8.0,Terfenadine,GUGOEEXESWIERI-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30617,6cs2,DB12732,-8.0,Firategrast,YLFZHHDVRSYTKT-NRFANRHFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
164895,7bv1,DB08931,-8.0,Riociguat,WXXSNCNJFUAIDG-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
119561,6w4b,DB07453,-8.0,2-PHENYL-4H-BENZO[H]CHROMEN-4-ONE,VFMMPHCGEFXGIP-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
55023,6crv,DB00514,-8.0,Dextromethorphan,MKXZASYAUGDDCJ-NJAFHUGGSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
119558,6w4b,DB07450,-8.0,(R)-minalrestat,BMHZAHGTGIZZCT-LJQANCHMSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
124334,6w4h,DB01030,-8.0,Topotecan,UCFGDBYHRUNTLO-QHCPKHFHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
109937,6vxx,DB00611,-8.0,Butorphanol,IFKLAQQSCNILHL-PWRODBHTSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30598,6cs2,DB00967,-8.0,Desloratadine,JAUOIFJMECXRGI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
30622,6cs2,DB12740,-8.0,CC-115,GMYLVKUGJMYTFB-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
109895,6vxx,DB00561,-8.0,Doxapram,XFDJYSQDBULQSI-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
119358,6w4b,DB07220,-8.0,"N-[5-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-1H-INDAZOL-3-YL]-2-(4-PIPERIDIN-1-YLPHENYL)ACETAMIDE",ZXYIRNXOAJYLCU-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
109946,6vxx,DB00623,-8.0,Fluphenazine,PLDUPXSUYLZYBN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30593,6cs2,DB12705,-8.0,Cenerimod,KJKKMMMRWISKRF-FQEVSTJZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
164929,7bv1,DB08973,-8.0,Fluclorolone acetonide,NJNWEGFJCGYWQT-VSXGLTOVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
109956,6vxx,DB00635,-8.0,Prednisone,XOFYZVNMUHMLCC-ZPOLXVRWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109968,6vxx,DB00652,-8.0,Pentazocine,VOKSWYLNZZRQPF-GDIGMMSISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
166317,7bv1,DB14649,-8.0,Dexamethasone acetate,AKUJBENLRBOFTD-RPRRAYFGSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
164877,7bv1,DB08899,-8.0,Enzalutamide,WXCXUHSOUPDCQV-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
109878,6vxx,DB00543,-8.0,Amoxapine,QWGDMFLQWFTERH-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
54989,6crv,DB00472,-8.0,Fluoxetine,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
166322,7bv1,DB14654,-8.0,Bisoxatin acetate,ZCBJDQBSLZREAA-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
124287,6w4h,DB00977,-8.0,Ethinylestradiol,BFPYWIDHMRZLRN-SLHNCBLASA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
113725,6vxx,DB11817,-8.0,Baricitinib,XUZMWHLSFXCVMG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110161,6vxx,DB01046,-8.0,Lubiprostone,WGFOBBZOWHGYQH-MXHNKVEKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
166254,7bv1,DB14214,-8.0,Rose bengal lactone,IICCLYANAQEHCI-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
54931,6crv,DB00401,-8.0,Nisoldipine,VKQFCGNPDRICFG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30496,6cs2,DB12565,-8.0,Abexinostat,MAUCONCHVWBMHK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
110290,6vxx,DB01426,-8.0,Ajmaline,CJDRUOGAGYHKKD-HEFSZTOGSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110297,6vxx,DB01434,-8.0,19-norandrostenedione,JRIZOGLBRPZBLQ-QXUSFIETSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55157,6crv,DB00679,-8.0,Thioridazine,KLBQZWRITKRQQV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110299,6vxx,DB01436,-8.0,Alfacalcidol,OFHCOWSQAMBJIW-AVJTYSNKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30495,6cs2,DB12563,-8.0,MK-0686,WZZIQHIQMWJNLU-LLVKDONJSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
165138,7bv1,DB11398,-8.0,Diclazuril,ZSZFUDFOPOMEET-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
109675,6vxx,DB15114,-8.0,Vamorolone,ZYTXTXAMMDTYDQ-DGEXFFLYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110311,6vxx,DB01451,-8.0,1-Androstenedione,WJIQCDPCDVWDDE-WZNAKSSCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
166179,7bv1,DB13793,-8.0,Vinburnine,WYJAPUKIYAZSEM-MOPGFXCFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
124062,6w4h,DB00714,-8.0,Apomorphine,VMWNQDUVQKEIOC-CYBMUJFWSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
110321,6vxx,DB01462,-8.0,Etonitazene,PXDBZSCGSQSKST-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110335,6vxx,DB01476,-8.0,Haloxazolam,XDKCGKQHVBOOHC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
124576,6w4h,DB01357,-8.0,Mestranol,IMSSROKUHAOUJS-MJCUULBUSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
109657,6vxx,DB15079,-8.0,Troriluzole,YBZSGIWIPOUSHY-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110358,6vxx,DB01503,-8.0,1-Androstenediol,RZFGPAMUAXASRE-YSZCXEEOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
54832,6crv,DB00280,-8.0,Disopyramide,UVTNFZQICZKOEM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110375,6vxx,DB01526,-8.0,4-Androstenediol,BTTWKVFKBPAFDK-LOVVWNRFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165187,7bv1,DB11491,-8.0,Sarafloxacin,XBHBWNFJWIASRO-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
113845,6vxx,DB12167,-8.0,LY-3023414,ACCFLVVUVBJNGT-AWEZNQCLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113846,6vxx,DB12170,-8.0,Veledimex,LZWZPGLVHLSWQX-XMMPIXPASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
166175,7bv1,DB13788,-8.0,Chlorbenzoxamine,VEVSKUJZSMGTMM-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
109667,6vxx,DB15099,-8.0,GW-468816,XDKRVNKVAKCFGW-WXWBBQJKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
124511,6w4h,DB01234,-8.0,Dexamethasone,UREBDLICKHMUKA-CXSFZGCWSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
166361,7bv1,DB14726,-8.0,Dabigatran,YBSJFWOBGCMAKL-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
124075,6w4h,DB00728,-8.0,Rocuronium,YXRDKMPIGHSVRX-OOJCLDBCSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
113779,6vxx,DB12072,-8.0,Orantinib,NHFDRBXTEDBWCZ-ZROIWOOFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30556,6cs2,DB12651,-8.0,Bardoxolone,TXGZJQLMVSIZEI-UQMAOPSPSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
164737,7bv1,DB08543,-8.0,1-[2-HYDROXY-3-(4-CYCLOHEXYL-PHENOXY)-PROPYL]-4-(2-PYRIDYL)-PIPERAZINE,BZJHCQBNFUNZPJ-QFIPXVFZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
113782,6vxx,DB12078,-8.0,Enobosarm,JNGVJMBLXIUVRD-SFHVURJKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110179,6vxx,DB01066,-8.0,Cefditoren,KMIPKYQIOVAHOP-YLGJWRNMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113789,6vxx,DB12085,-8.0,LCL-161,UFPFGVNKHCLJJO-SSKFGXFMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165042,7bv1,DB09168,-8.0,4-Phenylfentanyl,BXCJXJLHYMWMQU-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
54923,6crv,DB00393,-8.0,Nimodipine,UIAGMCDKSXEBJQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
54916,6crv,DB00383,-8.0,Oxyphencyclimine,DUDKAZCAISNGQN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165056,7bv1,DB09183,-8.0,Dasabuvir,NBRBXGKOEOGLOI-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110203,6vxx,DB01094,-8.0,Hesperetin,AIONOLUJZLIMTK-AWEZNQCLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
164734,7bv1,DB08539,-8.0,"3-cyclopropyl-5-phenyl-N-(pyridin-3-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",CCDIUVLNHCGSMH-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
120056,6w4b,DB08031,-8.0,"N-[(13-CYCLOHEXYL-6,7-DIHYDROINDOLO[1,2-D][1,4]BENZOXAZEPIN-10-YL)CARBONYL]-2-METHYL-L-ALANINE",LNQWELVSNCYKDU-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
55125,6crv,DB00639,-8.0,Butoconazole,SWLMUYACZKCSHZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
118915,6w4b,DB06630,-8.0,Anacetrapib,MZZLGJHLQGUVPN-HAWMADMCSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
110241,6vxx,DB01138,-8.0,Sulfinpyrazone,MBGGBVCUIVRRBF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110251,6vxx,DB01149,-8.0,Nefazodone,VRBKIVRKKCLPHA-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
118901,6w4b,DB06605,-8.0,Apixaban,QNZCBYKSOIHPEH-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
109727,6vxx,DB15214,-8.0,BMS-986104,BPMMYKAHRIEVDH-VOQZNFBZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109722,6vxx,DB15206,-8.0,Uprifosbuvir,SFPFZQKYPOWCSI-KHFYHRBSSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
124502,6w4h,DB01219,-8.0,Dantrolene,OZOMQRBLCMDCEG-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
109709,6vxx,DB15187,-8.0,Dubermatinib,YUAALFPUEOYPNX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
118879,6w4b,DB06543,-8.0,Astaxanthin,MQZIGYBFDRPAKN-UWFIBFSHSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
120198,6w4b,DB08191,-8.0,"4-(5-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl)benzoic acid",KSFDVNIKNYXUIP-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
112086,6vxx,DB06249,-8.0,Arzoxifene,MCGDSOGUHLTADD-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
35054,1r42,DB01089,-8.0,Deserpidine,CVBMAZKKCSYWQR-WCGOZPBSSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
165276,7bv1,DB11694,-8.0,Ilorasertib,WPHKIQPVPYJNAX-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
111793,6vxx,DB04596,-8.0,"4-O-{4,6-O-[(1S)-1-Carboxyethylidene]-β-D-mannopyranosyl}-D-glucopyranuronic acid",GZJXZKGVHLWBOW-AISSFXTFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55576,6crv,DB01163,-8.0,Amdinocillin,BWWVAEOLVKTZFQ-NTZNESFSSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30057,6cs2,DB11995,-8.0,Avatrombopag,OFZJKCQENFPZBH-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
114248,6vxx,DB13169,-8.0,Nandrolone,NPAGDVCDWIYMMC-IZPLOLCNSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
125480,6w4h,DB02538,-8.0,"N-[4-(2-Methylimidazo[1,2-a]Pyridin-3-Yl)-2-Pyrimidinyl]Acetamide",ZCRPPLDDHBLUES-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
55583,6crv,DB01172,-8.0,Kanamycin,SBUJHOSQTJFQJX-NOAMYHISSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
123219,6w4b,DB15110,-8.0,Onvansertib,QHLVBNKYJGBCQJ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
123186,6w4b,DB15047,-8.0,BMS-919373,XGKULQQVQWCASY-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
125485,6w4h,DB02545,-8.0,Fexaramine,VLQTUNDJHLEFEQ-KGENOOAVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
123185,6w4b,DB15046,-8.0,LY-2881835,FHRWHNJJQGSCQC-LJAQVGFWSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
31576,6cs2,DB14059,-8.0,SC-236,NSQNZEUFHPTJME-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
114264,6vxx,DB13213,-8.0,Butaperazine,DVLBYTMYSMAKHP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111843,6vxx,DB04772,-8.0,1-GUANIDINO-4-(N-PHENYLMETHANESULFONYL-L-LEUCYL-L-PROLYLAMINO)BUTANE,DSVCYWOHJLRGMK-PMACEKPBSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
123180,6w4b,DB15035,-8.0,Zanubrutinib,RNOAOAWBMHREKO-QFIPXVFZSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
111864,6vxx,DB04800,-8.0,1-METHYL-3-PHENYL-1H-PYRAZOL-5-YLSULFAMIC ACID,OTZLVSGSRPNRFT-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112917,6vxx,DB08147,-8.0,"4-[3-(dibenzylamino)phenyl]-2,4-dioxobutanoic acid",RMWVENXKUQXLPW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
125533,6w4h,DB02610,-8.0,"N-(2,3,4,5,6-Pentaflouro-Benzyl)-4-Sulfamoyl-Benzamide",LRKSHOLYETXPGY-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
114291,6vxx,DB13246,-8.0,Quinupramine,JCBQCKFFSPGEDY-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
125534,6w4h,DB02611,-8.0,Balanol Analog 1,FZJQHARRQUNVGZ-QZTJIDSGSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
111897,6vxx,DB04839,-8.0,Cyproterone acetate,UWFYSQMTEOIJJG-FDTZYFLXSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111905,6vxx,DB04849,-8.0,Cediranib,XXJWYDDUDKYVKI-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31689,6cs2,DB14568,-8.0,Ivosidenib,WIJZXSAJMHAVGX-DHLKQENFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
108995,6vxx,DB11880,-8.0,Acridine Carboxamide,XBGNERSKEKDZDS-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
125570,6w4h,DB02659,-8.0,Cholic Acid,BHQCQFFYRZLCQQ-OELDTZBJSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
32887,6cs2,T3D3811,-8.0,Clofentezine,UXADOQPNKNTIHB-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
125419,6w4h,DB02463,-8.0,2-(2-Hydroxy-Phenyl)-1h-Indole-5-Carboxamidine,JPGNPKIYCTXJPG-UHFFFAOYSA-O,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
116766,6w4b,DB02581,-8.0,"5-[2,3-Dichloro-4-(5-{1-[2-(2-Guanidino-4-Methyl-Pentanoylamino)-Acetyl]-Piperidin-4-Yl}-1-Methyl-1h-Pyrazol-3-Yl)-Phenoxymethyl]-Furan-2-Carboxylic Acid",VNZHOIDQBPFEJU-OAQYLSRUSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
113054,6vxx,DB08317,-8.0,"5-methyl-6-phenylquinazoline-2,4-diamine",HUCOXWPHDFINIW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
164452,7bv1,DB07847,-8.0,6-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-(4-MORPHOLINYL)-2-OXO ETHYL]-2-OXO-3-PYRROLIDINYL}-2-NAPHTHALENESULFONAMIDE,ICLOZQFWTRAYPX-LIRRHRJNSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
111743,6vxx,DB04463,-8.0,"3-(4-Amino-1-Tert-Butyl-1h-Pyrazolo[3,4-D]Pyrimidin-3-Yl)Phenol",CPLGZXQPPYRNRC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
125334,6w4h,DB02360,-8.0,Bis-Napthyl Beta-Ketophosphonic Acid,OFHMUASCSJJNNA-JOCHJYFZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
30097,6cs2,DB12048,-8.0,Savolitinib,XYDNMOZJKOGZLS-NSHDSACASA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
116676,6w4b,DB02466,-8.0,"4-[3-Oxo-3-(5,5,8,8-Tetramethyl-5,6,7,8-Tetrahydro-Naphthalen-2-Yl)-Propenyl]-Benzoic Acid",ZXQHMEUGMCXKLO-KPKJPENVSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
116589,6w4b,DB02360,-8.0,Bis-Napthyl Beta-Ketophosphonic Acid,OFHMUASCSJJNNA-JOCHJYFZSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
121265,6w4b,DB11637,-8.0,Delamanid,XDAOLTSRNUSPPH-XMMPIXPASA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
113040,6vxx,DB08302,-8.0,3-[5-(2-nitropent-1-en-1-yl)furan-2-yl]benzoic acid,IRHZCQDCMUWUKV-RAXLEYEMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
121317,6w4b,DB11712,-8.0,Tezacaftor,MJUVRTYWUMPBTR-MRXNPFEDSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
121275,6w4b,DB11652,-8.0,Tucatinib,SDEAXTCZPQIFQM-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
55544,6crv,DB01127,-8.0,Econazole,LEZWWPYKPKIXLL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
125368,6w4h,DB02400,-8.0,"5-Methoxy-1,2-Dimethyl-3-(4-Nitrophenoxymethyl)Indole-4,7-Dione",IBLWSLZYYZHSRG-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
113031,6vxx,DB08292,-8.0,"(5Z)-12-CHLORO-13,15-DIHYDROXY-4,7,8,9-TETRAHYDRO-2-BENZOXACYCLOTRIDECINE-1,10(3H,11H)-DIONE",AQKZYZQONWDDLS-IWQZZHSRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55552,6crv,DB01136,-8.0,Carvedilol,OGHNVEJMJSYVRP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109050,6vxx,DB11961,-8.0,AZD-1236,SFJFBTPHDHUUPU-OAHLLOKOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109046,6vxx,DB11952,-8.0,Duvelisib,SJVQHLPISAIATJ-ZDUSSCGKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114227,6vxx,DB13119,-8.0,GSK-364735,QWLNINWUBHHOLU-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109044,6vxx,DB11950,-8.0,Teneligliptin,WGRQANOPCQRCME-PMACEKPBSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
32935,6cs2,T3D3863,-8.0,Imazaquin,CABMTIJINOIHOD-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
55557,6crv,DB01142,-8.0,Doxepin,ODQWQRRAPPTVAG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113032,6vxx,DB08293,-8.0,"(5E)-12-CHLORO-13,15-DIHYDROXY-4,7,8,9-TETRAHYDRO-2-BENZOXACYCLOTRIDECINE-1,10(3H,11H)-DIONE",AQKZYZQONWDDLS-HNQUOIGGSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
121409,6w4b,DB11847,-8.0,Cadazolid,XWFCFMXQTBGXQW-GOSISDBHSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
55619,6crv,DB01209,-8.0,Dezocine,VTMVHDZWSFQSQP-VBNZEHGJSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108960,6vxx,DB11461,-8.0,Sulfachlorpyridazine,XOXHILFPRYWFOD-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112848,6vxx,DB07917,-8.0,4-(BENZHYDRYLOXY)-1-[3-(1H-TETRAAZOL-5-YL)PROPYL]PIPERIDINE,TZQGXAHOROZEKN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112006,6vxx,DB05187,-8.0,Elafibranor,AFLFKFHDSCQHOL-IZZDOVSWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114501,6vxx,DB13713,-8.0,Quifenadine,PZMAHNDJABQWGS-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55668,6crv,DB01288,-8.0,Fenoterol,LSLYOANBFKQKPT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165456,7bv1,DB12127,-8.0,Sultamicillin,OPYGFNJSCUDTBT-PMLPCWDUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
112819,6vxx,DB07877,-8.0,"8-(6-BROMO-BENZO[1,3]DIOXOL-5-YLSULFANYL)-9-(3-ISOPROPYLAMINO-PROPYL)-ADENINE",MWGWLDJLENCVRQ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112029,6vxx,DB06134,-8.0,SNS-314,FAYAUAZLLLJJGH-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
164321,7bv1,DB07697,-8.0,"1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-4-[(4-methoxyphenyl)sulfonyl]piperazine",HMGDKYUJSFVHIY-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
125670,6w4h,DB02799,-8.0,N-[2-(1-Maleimidyl)Ethyl]-7-Diethylaminocoumarin-3-Carboxamide,OJBZDUMTXGGVSP-KTKRTIGZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
123079,6w4b,DB14785,-8.0,Fenebrutinib,WNEODWDFDXWOLU-QHCPKHFHSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
112000,6vxx,DB05137,-8.0,Lobeline,MXYUKLILVYORSK-HBMCJLEFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
166553,7bv1,DB15356,-8.0,SLV-334,LOFDNSDPZTVIIO-VPUSJEBWSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
31802,6cs2,DB14774,-8.0,Balipodect,KVHRYLNQDWXAGI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
29976,6cs2,DB11886,-8.0,Infigratinib,QADPYRIHXKWUSV-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
112060,6vxx,DB06199,-8.0,Atrasentan,MOTJMGVDPWRKOC-QPVYNBJUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114514,6vxx,DB13727,-8.0,Azapetine,NYGHGTMKALXFIA-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
32494,6cs2,T3D1852,-8.0,Tralomethrin,YWSCPYYRJXKUDB-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
166555,7bv1,DB15358,-8.0,JNJ-54175446,CWFVVQFVGMFTBD-SECBINFHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
122981,6w4b,DB14584,-8.0,Segesterone,SFLXYFZGKSGFKA-XUDSTZEESA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
108796,6vxx,DB08972,-8.0,Flumequine,DPSPPJIUMHPXMA-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55685,6crv,DB01332,-8.0,Ceftizoxime,NNULBSISHYWZJU-LLKWHZGFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108795,6vxx,DB08971,-8.0,Fluocortolone,GAKMQHDJQHZUTJ-ULHLPKEOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165473,7bv1,DB12150,-8.0,Pelubiprofen,AUZUGWXLBGZUPP-GXDHUFHOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
108863,6vxx,DB11185,-8.0,Sulisobenzone,CXVGEDCSTKKODG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114486,6vxx,DB13689,-8.0,Tacalcitol,BJYLYJCXYAMOFT-RSFVBTMBSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31773,6cs2,DB14718,-8.0,Pyrazolam,BGRWSFIQQPVEML-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
114316,6vxx,DB13283,-8.0,Sulfaisodimidine,YZMCKZRAOLZXAZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114322,6vxx,DB13291,-8.0,Cloridarol,KBFBRIPYVVGWRS-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108956,6vxx,DB11455,-8.0,Robenacoxib,ZEXGDYFACFXQPF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111933,6vxx,DB04885,-8.0,Cilansetron,NCNFDKWULDWJDS-OAHLLOKOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55627,6crv,DB01218,-8.0,Halofantrine,FOHHNHSLJDZUGQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
32807,6cs2,T3D3720,-8.0,Verrucarin A,NLUGUZJQJYVUHS-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
114407,6vxx,DB13399,-8.0,Terguride,JOAHPSVPXZTVEP-YXJHDRRASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
164403,7bv1,DB07792,-8.0,"(S)-2-CHLORO-N-(1-(2-(2-HYDROXYETHYLAMINO)-2-OXOETHYL)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL)-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE",VUKPNWLGSLOHIF-AWEZNQCLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
108940,6vxx,DB11427,-8.0,Maropitant,OMPCVMLFFSQFIX-CONSDPRKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31710,6cs2,DB14632,-8.0,Prednisolone tebutate,HUMXXHTVHHLNRO-KAJVQRHHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
32798,6cs2,T3D3711,-8.0,Roridin E,KEEQQEKLEZRLDS-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
115817,6w4b,DB01336,-8.0,Metocurine,JFXBEKISTKFVAB-AJQTZOPKSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
115790,6w4b,DB01267,-8.0,Paliperidone,PMXMIIMHBWHSKN-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
115739,6w4b,DB01199,-8.0,Tubocurarine,JFJZZMVDLULRGK-URLMMPGGSA-O,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
121437,6w4b,DB11892,-8.0,Prulifloxacin,PWNMXPDKBYZCOO-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
31744,6cs2,DB14664,-8.0,Difluocortolone pivalate,UWGRWFCLGQWKPR-GSTUPEFVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
31760,6cs2,DB14679,-8.0,Quingestanol acetate,FLGJKPPXEKYCBY-AKCFYGDASA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
125603,6w4h,DB02703,-8.0,Fusidic acid,IECPWNUMDGFDKC-MZJAQBGESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
114457,6vxx,DB13657,-8.0,Benorilate,FEJKLNWAOXSSNR-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165828,7bv1,DB13072,-8.0,GDC-0349,RGJOJUGRHPQXGF-INIZCTEOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
108916,6vxx,DB11385,-8.0,Cefalonium,FMZXNVLFJHCSAF-DNVCBOLYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31769,6cs2,DB14715,-8.0,Cinazepam,NQTRBZXDWMDXAQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
112864,6vxx,DB07934,-8.0,[[CYCLOHEXANESULFONYL-GLYCYL]-3[PYRIDIN-4-YL-AMINOMETHYL]ALANYL]PIPERIDINE,KMUXFASJKPVMGU-HXUWFJFHSA-O,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
164456,7bv1,DB07851,-8.0,"(3R,4S)-1-(3,4-DIMETHOXYPHENYL)-3-(3-METHYLPHENYL)PIPERIDIN-4-AMINE",DQJXBZGPJVSWFI-ROUUACIJSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
30978,6cs2,DB13266,-8.0,Cefatrizine,UOCJDOLVGGIYIQ-PBFPGSCMSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
121264,6w4b,DB11636,-8.0,Nomegestrol,KZUIYQJTUIACIG-YBZCJVABSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
31505,6cs2,DB13936,-8.0,JNJ-28330835,RYBKPGYFXRNMMU-LBPRGKRZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
125066,6w4h,DB02004,-8.0,"5-(Aminomethyl)-6-(2,4-Dichlorophenyl)-2-(3,5-Dimethoxyphenyl)Pyrimidin-4-Amine",RCJFINNFYUNFGH-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
164537,7bv1,DB08119,-8.0,"1,1,1-TRIFLUORO-3-((N-ACETYL)-L-LEUCYLAMIDO)-4-PHENYL-BUTAN-2-ONE(N-ACETYL-L-LEUCYL-L-PHENYLALANYL TRIFLUOROMETHYL KETONE)",MZNXJCZDQRNGRC-GJZGRUSLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
113265,6vxx,DB08736,-8.0,"S,R-Warfarin alcohol",ZUJMMGHIYSAEOU-DOMZBBRYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
123648,6w4h,DB00216,-8.0,Eletriptan,PWVXXGRKLHYWKM-LJQANCHMSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
123641,6w4h,DB00206,-8.0,Reserpine,QEVHRUUCFGRFIF-MDEJGZGSSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
30218,6cs2,DB12210,-8.0,AZD-6280,NVWCZRPXYVDQEE-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
120835,6w4b,DB08995,-8.0,Diosmin,GZSOSUNBTXMUFQ-YFAPSIMESA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
125071,6w4h,DB02010,-8.0,Staurosporine,HKSZLNNOFSGOKW-FYTWVXJKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
111244,6vxx,DB03388,-8.0,"3-[(2,4-Dichlorobenzoyl)(Isopropyl)Amino]-5-Phenylthiophene-2-Carboxylic Acid",UKNZREOUDLFUFF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31136,6cs2,DB13451,-8.0,Tioclomarol,WRGOVNKNTPWHLZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
165291,7bv1,DB11718,-8.0,Encorafenib,CMJCXYNUCSMDBY-ZDUSSCGKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
165885,7bv1,DB13177,-8.0,4-methylumbelliferyl beta-D-glucoside,YUDPTGPSBJVHCN-YMILTQATSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
111290,6vxx,DB03456,-8.0,N2-[(benzyloxy)carbonyl]-n1-[(3S)-1-cyanopyrrolidin-3-yl]-l-leucinamide,IMTUSTXBVIALBC-SJORKVTESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
123493,6w4b,DB00224,-8.0,Indinavir,CBVCZFGXHXORBI-PXQQMZJSSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
123492,6w4b,DB00223,-8.0,Diflorasone,WXURHACBFYSXBI-XHIJKXOTSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
117622,6w4b,DB03744,-8.0,"Cp403700, (S)-1-{2-[(5-Chloro-1h-Indole-2-Carbonyl)-Amino]-3-Phenyl-Propionyl}-Azetidine-3-Carboxylate",RONLONYAIBUEKT-IBGZPJMESA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
109227,6vxx,DB12924,-8.0,Ozenoxacin,XPIJWUTXQAGSLK-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165310,7bv1,DB11911,-8.0,Galunisertib,IVRXNBXKWIJUQB-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
165311,7bv1,DB11912,-8.0,Lanopepden,SWHNZGMQMGFQGW-MSOLQXFVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
165318,7bv1,DB11922,-8.0,Danirixin,NGYNBSHYFOFVLS-LBPRGKRZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
123416,6w4b,DB00137,-8.0,Lutein,KBPHJBAIARWVSC-RGZFRNHPSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
113203,6vxx,DB08662,-8.0,3-[1-(4-BROMO-PHENYL)-2-METHYL-PROPYL]-4-HYDROXY-CHROMEN-2-ONE,KGDWLSFLMSFPSU-INIZCTEOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
120868,6w4b,DB09042,-8.0,Tedizolid phosphate,QCGUSIANLFXSGE-GFCCVEGCSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
111352,6vxx,DB03549,-8.0,Biotinyl P-Nitroaniline,PORZMUYPQKOFQY-YDHLFZDLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55399,6crv,DB00959,-8.0,Methylprednisolone,VHRSUDSXCMQTMA-PJHHCJLFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111120,6vxx,DB03022,-8.0,"3-{2,6,8-trioxo-9-[(2R,3S,4R)-2,3,4,5-tetrahydroxypentyl]-1,2,3,6,8,9-hexahydro-7H-purin-7-Yl}propyl dihydrogen phosphate",KPHFGOGGKPGLTM-BHNWBGBOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55370,6crv,DB00924,-8.0,Cyclobenzaprine,JURKNVYFZMSNLP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
123725,6w4h,DB00304,-8.0,Desogestrel,RPLCPCMSCLEKRS-BPIQYHPVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
164539,7bv1,DB08121,-8.0,(2S)-2-(biphenyl-4-yloxy)-3-phenylpropanoic acid,TZTPJJNNACUQQR-FQEVSTJZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
34651,1r42,DB00619,-8.0,Imatinib,KTUFNOKKBVMGRW-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
31000,6cs2,DB13292,-8.0,Pimethixene,NZLVRVYNQYGMAB-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
110881,6vxx,DB02527,-8.0,Cyclic adenosine monophosphate,IVOMOUWHDPKRLL-KQYNXXCUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165927,7bv1,DB13248,-8.0,Phthalylsulfathiazole,PBMSWVPMRUJMPE-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
55378,6crv,DB00934,-8.0,Maprotiline,QSLMDECMDJKHMQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114059,6vxx,DB12665,-8.0,Isoquercetin,OVSQVDMCBVZWGM-QSOFNFLRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30270,6cs2,DB12273,-8.0,Ecopipam,DMJWENQHWZZWDF-PKOBYXMFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
117848,6w4b,DB04038,-8.0,Ergosterol,DNVPQKQSNYMLRS-APGDWVJJSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
109301,6vxx,DB13036,-8.0,Ramatroban,LDXDSHIEDAPSSA-OAHLLOKOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114063,6vxx,DB12670,-8.0,Rolofylline,PJBFVWGQFLYWCB-QUYAXPHCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
123693,6w4h,DB00267,-8.0,Cefmenoxime,HJJDBAOLQAWBMH-YCRCPZNHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
166456,7bv1,DB15168,-8.0,Cilofexor,KZSKGLFYQAYZCO-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110999,6vxx,DB02859,-8.0,Soraphen A,WPMGNXPRKGXGBO-OFQQMTDKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30258,6cs2,DB12260,-8.0,Radiprodil,GKGRZLGAQZPEHO-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
123684,6w4h,DB00257,-8.0,Clotrimazole,VNFPBHJOKIVQEB-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
125048,6w4h,DB01977,-8.0,6-(N-Phenylcarbamyl)-2-Naphthalenecarboxamidine,AECPTICWHONWNW-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
114075,6vxx,DB12689,-8.0,Azeliragon,KJNNWYBAOPXVJY-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111080,6vxx,DB02963,-8.0,"(5-Chloropyrazolo[1,5-a]Pyrimidin-7-Yl)-(4-Methanesulfonylphenyl)Amine",LVNXHNRYPADEAD-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113286,6vxx,DB08758,-8.0,"IMIDAZO[2,1-A]ISOQUINOLINE-2-CARBOHYDRAZIDE",WSNWYZBDIKCPIG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
123704,6w4h,DB00278,-8.0,Argatroban,KXNPVXPOPUZYGB-IOVMHBDKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
31221,6cs2,DB13554,-8.0,Moperone,AGAHNABIDCTLHW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
31251,6cs2,DB13596,-8.0,Oxycinchophen,XAPRFLSJBSXESP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
120920,6w4b,DB09143,-8.0,Sonidegib,VZZJRYRQSPEMTK-CALCHBBNSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
30156,6cs2,DB12124,-8.0,Namitecan,IBTISPLPBBHVSU-UVOOVGFISA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
31416,6cs2,DB13790,-8.0,Fipexide,BFUJHVVEMMWLHC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
125210,6w4h,DB02196,-8.0,Uridine-Diphosphate-N-Acetylgalactosamine,LFTYTUAZOPRMMI-NESSUJCYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
125225,6w4h,DB02217,-8.0,Dpb-T,WTZFKHNHHRPQOU-WSMBLCCSSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
33087,6cs2,T3D4067,-8.0,Convallatoxin,HULMNSIAKWANQO-JQKSAQOKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
123352,6w4b,DB15377,-8.0,ATB-346,YCNMAPLPQYQJFC-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
111585,6vxx,DB04239,-8.0,2-Amino-6-Aminomethyl-8-Phenylsulfanylmethyl-3h-Quinazolin-4-One,CBFXRTSHUMEYKQ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55510,6crv,DB01088,-8.0,Iloprost,HIFJCPQKFCZDDL-ACWOEMLNSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111586,6vxx,DB04240,-8.0,"(1S)-1-C-{(2R)-6-[(2R)-2-Butanyl]-5,10-dihydroxy-4-oxo-1,2,3,4-tetrahydro-2-anthracenyl}-5-deoxy-1-O-methyl-D-xylulose",XGORHSPGULYMCV-HHYQQTLHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31431,6cs2,DB13806,-8.0,Linopirdine,YEJCDKJIEMIWRQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
121123,6w4b,DB11275,-8.0,Epicriptine,SBFXHXZNBNFPHV-PXXBSISHSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
31438,6cs2,DB13816,-8.0,Aspoxicillin,BHELIUBJHYAEDK-OAIUPTLZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
111629,6vxx,DB04298,-8.0,"3-(4-Amino-2-Tert-Butyl-5-Methyl-Phenylsulfanyl)-6-Cyclopentyl-4-Hydroxy-6-[2-(4-Hydroxy-Phenyl)-Ethyl]-5,6-Dihydro-Pyran-2-One",ZEBFKFGJWHOOST-LJAQVGFWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111659,6vxx,DB04342,-8.0,7-((Carboxy(4-Hydroxyphenyl)Acetyl)Amino)-7-Methoxy-(3-((1-Methyl-1h-Tetrazol-5-Yl)Thio)Methyl)-8-Oxo-5-Oxa-1-Azabicyclo[4.2.0]Oct-2-Ene-2-Carboxylic Acid,JWCSIUVGFCSJCK-LIUKBUMOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
121229,6w4b,DB11529,-8.0,Melengestrol,OKHAOBQKCCIRLO-IBVJIVQJSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
123323,6w4b,DB15310,-8.0,Vactosertib,FJCDSQATIJKQKA-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
30132,6cs2,DB12096,-8.0,PF-05175157,BDXXSFOJPYSYOC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
114183,6vxx,DB12869,-8.0,Eliprodil,GGUSQTSTQSHJAH-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
121254,6w4b,DB11611,-8.0,Lifitegrast,JFOZKMSJYSPYLN-QHCPKHFHSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
113074,6vxx,DB08345,-8.0,"4-(2-(1H-IMIDAZOL-4-YL)ETHYLAMINO)-2-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE",IWUUKHQIKFHWIW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30112,6cs2,DB12068,-8.0,T-900607,FSXLOWIFSZNIMV-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
109087,6vxx,DB12357,-8.0,BMS-863233,JJWLXRKVUJDJKG-VIFPVBQESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
123340,6w4b,DB15345,-8.0,GSK-945237,SRICOHRDRMZREQ-MRXNPFEDSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
111560,6vxx,DB04037,-8.0,"N,N-Bis(4-Chlorobenzyl)-1h-1,2,3,4-Tetraazol-5-Amine",UOUXILZUBDIWQU-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30159,6cs2,DB12127,-8.0,Sultamicillin,OPYGFNJSCUDTBT-PMLPCWDUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
117158,6w4b,DB03104,-8.0,RU82129,NKMPOVPTYDXGEC-MNRBYUMSSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
33502,6cs2,T3D4757,-8.0,Fulvestrant,VWUXBMIQPBEWFH-LQKBAPIOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
165331,7bv1,DB11943,-8.0,Delafloxacin,DYDCPNMLZGFQTM-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
109192,6vxx,DB12507,-8.0,Atecegatran metoxil,XSNMGLZVFNDDPW-ZWKOTPCHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
33420,6cs2,T3D4650,-8.0,Nimetazepam,GWUSZQUVEVMBPI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
165339,7bv1,DB11952,-8.0,Duvelisib,SJVQHLPISAIATJ-ZDUSSCGKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
31314,6cs2,DB13670,-8.0,Oxantel,VRYKTHBAWRESFI-VOTSOKGWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
111480,6vxx,DB03926,-8.0,"5-Alpha-Androstane-3-Beta,17-Alpha-Diol",CBMYJHIOYJEBSB-MFXFBURESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
120988,6w4b,DB09233,-8.0,Cronidipine,CNIJVNPIIHWRRP-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
113147,6vxx,DB08595,-8.0,"4-[(1S,2R,5S)-4,4,8-TRIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL",BBZPJHFECDCNGT-BPUTZDHNSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111501,6vxx,DB03952,-8.0,9-(6-deoxy-beta-D-allofuranosyl)-6-methylpurine,XJZDIUOABWMPLZ-FHQKJXBVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
33360,6cs2,T3D4552,-8.0,Eszopiclone,GBBSUAFBMRNDJC-INIZCTEOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
113137,6vxx,DB08581,-8.0,"4-[(4-bromo-2-{[(3R,5S)-3,5-dimethylpiperidin-1-yl]carbonyl}phenyl)amino]-4-oxobutanoic acid",JSVSGWHGYIDZFX-TXEJJXNPSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
117291,6w4b,DB03276,-8.0,"4-[(10s,14s,18s)-18-(2-Amino-2-Oxoethyl)-14-(1-Naphthylmethyl)-8,17,20-Trioxo-7,16,19-Triazaspiro[5.14]Icos-11-En-10-Yl]Benzylphosphonic Acid",RHYFMOCFCFUTNH-GZNVFMSSSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
31345,6cs2,DB13708,-8.0,Fenquizone,DBDTUXMDTSTPQZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
33354,6cs2,T3D4546,-8.0,Trifloxystrobin,ONCZDRURRATYFI-TVJDWZFNSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
109162,6vxx,DB12461,-8.0,GLPG-0492,VAJGULUVTFDTAS-GOSISDBHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113136,6vxx,DB08580,-8.0,4-bromo-2-{[(2R)-2-(2-chlorobenzyl)pyrrolidin-1-yl]carbonyl}aniline,JEGGWFHNKPRKTO-CQSZACIVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
121056,6w4b,DB09383,-8.0,Meprednisone,PIDANAQULIKBQS-RNUIGHNZSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
33179,6cs2,T3D4242,-8.0,Dehydroepiandrosterone sulfate,CZWCKYRVOZZJNM-USOAJAOKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
117233,6w4b,DB03207,-8.0,"2-(Biphenyl-4-Sulfonyl)-1,2,3,4-Tetrahydro-Isoquinoline-3-Carboxylic Acid",BNVMUDXGABBWGP-OAQYLSRUSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
109145,6vxx,DB12433,-8.0,SCH-900271,ARJKMWXLIHZLQZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
33178,6cs2,T3D4240,-8.0,Androstenedione,AEMFNILZOJDQLW-QAGGRKNESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
164476,7bv1,DB08051,-8.0,"(2R)-4-(2-BENZOYL-1,2-DIAZEPAN-1-YL)-4-OXO-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE",XXRHRPGYYNOBHO-QGZVFWFLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
33018,6cs2,T3D3950,-8.0,Doxycycline,JBIWCJUYHHGXTC-AKNGSSGZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
165687,7bv1,DB12659,-8.0,SJ-733,VKCPFWKTFZAOTO-LEWJYISDSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
139069,6w9c,DB12804,-8.0,Daniquidone,SRIOCKJKFXAKHK-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
55909,6crv,DB01624,-8.0,Zuclopenthixol,WFPIAZLQTJBIFN-DVZOWYKESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
141516,6w9q,DB00984,-8.0,Nandrolone phenpropionate,UBWXUGDQUBIEIZ-QNTYDACNSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
67024,6lxt,DB05087,-8.0,Ganaxolone,PGTVWKLGGCQMBR-FLBATMFCSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
85220,6m3m,DB07401,-8.0,METHYL (2Z)-2-(2-{[6-(2-CYANOPHENOXY)PYRIMIDIN-4-YL]OXY}PHENYL)-3-METHOXYACRYLATE,WFDXOXNFNRHQEC-GHRIWEEISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
67005,6lxt,DB04982,-8.0,Talampanel,JACAAXNEHGBPOQ-LLVKDONJSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
66974,6lxt,DB04892,-8.0,Phenserine,PBHFNBQPZCRWQP-QUCCMNQESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
66968,6lxt,DB04885,-8.0,Cilansetron,NCNFDKWULDWJDS-OAHLLOKOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
133685,6w9c,DB02019,-8.0,Acetyl Dithranol,IXLRLZOYKJERRA-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
85256,6m3m,DB07443,-8.0,(2Z)-N-biphenyl-4-yl-2-cyano-3-hydroxybut-2-enamide,MUVPBAIVOHJDOC-VBKFSLOCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
66950,6lxt,DB04863,-8.0,Lefradafiban,PGCFXITVMNNKON-ROUUACIJSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
66948,6lxt,DB04861,-8.0,Nebivolol,KOHIRBRYDXPAMZ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
85263,6m3m,DB07451,-8.0,1-(5-BROMO-PYRIDIN-2-YL)-3-[2-(6-FLUORO-2-HYDROXY-3-PROPIONYL-PHENYL)-CYCLOPROPYL]-UREA,VRAJWAGCJIXJHQ-YPMHNXCESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
66917,6lxt,DB04823,-8.0,Oxyphenisatin,SJDACOMXKWHBOW-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
66872,6lxt,DB04764,-8.0,[4-(3-AMINOMETHYL-PHENYL)-PIPERIDIN-1-YL]-(5-PHENETHYL- PYRIDIN-3-YL)-METHANONE,CCLHROFBSWWOQO-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
85274,6m3m,DB07462,-8.0,"(3,4-DIHYDROXY-2-NITROPHENYL)(PHENYL)METHANONE",ICLKAUQIPVFHOI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
141757,6w9q,DB01267,-8.0,Paliperidone,PMXMIIMHBWHSKN-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
85281,6m3m,DB07472,-8.0,"(R)-(+)9B-(3-METHYL)PHENYL-2,3-DIHYDROTHIAZOLO[2,3-A]ISOINDOL-5(9BH)-ONE",FQVDJZWFSZSGGA-QGZVFWFLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
66821,6lxt,DB04693,-8.0,"(13S)-13-METHYLDODECAHYDRO-1H-CYCLOPENTA[A]PHENANTHRENE-3,17(2H,4H)-DIONE",CRDKSBHJIGNEOH-IMRIKWHGSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
133622,6w9c,DB01938,-8.0,L-Histidine Beta Naphthylamide,DKDILZBBFKZMRO-OAHLLOKOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
66791,6lxt,DB04649,-8.0,TETRAHEDRAL INTERMEDIATE OF BLASTICIDIN S,MVFPGTZTOAHVBP-HXYLPHSESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
85305,6m3m,DB07501,-8.0,(2S)-1-{4-[(4-Anilino-5-bromo-2-pyrimidinyl)amino]phenoxy}-3-(dimethylamino)-2-propanol,MEIJADBULOETOV-KRWDZBQOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
66716,6lxt,DB04554,-8.0,8-Bromoadenosine-5'-Diphosphate,KVVVTFSHHQCHNZ-UUOKFMHZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
66642,6lxt,DB04461,-8.0,Coproporphyrinogen III,NIUVHXTXUXOFEB-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
133573,6w9c,DB01861,-8.0,Uridine diphosphate glucose,HSCJRCZFDFQWRP-JZMIEXBBSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
66616,6lxt,DB04424,-8.0,RPR128515,XFKVLKLCLYJKNF-MZNJEOGPSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
66597,6lxt,DB04395,-8.0,Phosphoaminophosphonic Acid-Adenylate Ester,PVKSNHVPLWYQGJ-FCIPNVEPSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
85341,6m3m,DB07543,-8.0,(2S)-1-(9H-Carbazol-4-yloxy)-3-(isopropylamino)propan-2-ol,BQXQGZPYHWWCEB-ZDUSSCGKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
66573,6lxt,DB04362,-8.0,Adenosine Diphosphate 5-(Beta-Ethyl)-4-Methyl-Thiazole-2-Carboxylic Acid,VGXBGQACJQRWLV-LKGUXBDMSA-K,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
85178,6m3m,DB07350,-8.0,(2E)-N-hydroxy-3-[1-methyl-4-(phenylacetyl)-1H-pyrrol-2-yl]prop-2-enamide,UFQOXIMRSMFQRI-BQYQJAHWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
133566,6w9c,DB01852,-8.0,Kaempherol,IYRMWMYZSQPJKC-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
133800,6w9c,DB02170,-8.0,"1,8-Di-Hydroxy-4-Nitro-Xanthen-9-One",ZOHCDJRFYXKEQW-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
133806,6w9c,DB02179,-8.0,O-Trifluoromethylphenyl Anthranilic Acid,ONKHJNFXJDEMNQ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140815,6w9q,DB00153,-8.0,Ergocalciferol,MECHNRXZTMCUDQ-RKHKHRCZSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
67400,6lxt,DB06635,-8.0,Otamixaban,PFGVNLZDWRZPJW-OPAMFIHVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
85001,6m3m,DB07148,-8.0,"(6S)-1-chloro-3-[(4-fluorobenzyl)oxy]-6-(pyrrolidin-1-ylcarbonyl)pyrrolo[1,2-a]pyrazin-4(6H)-one",HPAFVLDARQIHPU-HNNXBMFYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
134060,6w9c,DB02511,-8.0,2-Hydroxy-5-({1-[(2-Naphthyloxy)Methyl]-3-Oxoprop-1-Enyl}Amino)Tyrosine,PZWMZAFFUAWVDN-CQXYXCHQSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
67394,6lxt,DB06625,-8.0,Vipadenant,HQSBCDPYXDGTCL-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
85013,6m3m,DB07163,-8.0,5-[(2-AMINOETHYL)AMINO]-6-FLUORO-3-(1H-PYRROL-2-YL)BENZO[CD]INDOL-2(1H)-ONE,CQCXWWWNUFQYJS-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
67357,6lxt,DB06533,-8.0,Ragaglitazar,WMUIIGVAWPWQAW-XMMPIXPASA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
67356,6lxt,DB06532,-8.0,Pafuramidine,UKOQVLAXCBRRGH-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
85016,6m3m,DB07167,-8.0,5-CYANO-FURAN-2-CARBOXYLIC ACID [5-HYDROXYMETHYL-2-(4-METHYL-PIPERIDIN-1-YL)-PHENYL]-AMIDE,NNPCFFIJVKYGHR-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
141084,6w9q,DB00471,-8.0,Montelukast,UCHDWCPVSPXUMX-TZIWLTJVSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
85033,6m3m,DB07185,-8.0,2-{[(4-CHLOROPHENOXY)ACETYL]AMINO}BENZOIC ACID,LXSDGQYDSDIUPN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
67313,6lxt,DB06429,-8.0,Talnetant,BIAVGWDGIJKWRM-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
67309,6lxt,DB06414,-8.0,Etravirine,PYGWGZALEOIKDF-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
67301,6lxt,DB06401,-8.0,Bazedoxifene,UCJGJABZCDBEDK-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
133993,6w9c,DB02427,-8.0,"2,4-Diamino-6-[N-(2',5'-Dimethoxybenzyl)-N-Methylamino]Quinazoline",YBJANOUTWRTBDK-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
67268,6lxt,DB06281,-8.0,Torcetrapib,CMSGWTNRGKRWGS-NQIIRXRSSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
67236,6lxt,DB06213,-8.0,Regadenoson,LZPZPHGJDAGEJZ-AKAIJSEGSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
67217,6lxt,DB06178,-8.0,Talotrexin,NYQPLPNEESYGNO-IBGZPJMESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
141360,6w9q,DB00808,-8.0,Indapamide,NDDAHWYSQHTHNT-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
141392,6w9q,DB00843,-8.0,Donepezil,ADEBPBSSDYVVLD-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
133892,6w9c,DB02292,-8.0,Irosustat,DSLPMJSGSBLWRE-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
133861,6w9c,DB02253,-8.0,"(1r)-4-[(1e,3e,5e,7z,9e,11z,13e,15e)-17-Hydroxy-3,7,12,16-Tetramethylheptadeca-1,3,5,7,9,11,13,15-Octaen-1-Yl]-3,5,5-Trimethylcyclohex-3-En-1-Ol",FNAJVVMDXCOSFY-VFGOXHQXSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
67167,6lxt,DB05936,-8.0,CVT-6883,KOYXXLLNCXWUNF-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
133836,6w9c,DB02220,-8.0,AL7089A,RMOXCYSVWCHXII-LBPRGKRZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
85151,6m3m,DB07319,-8.0,"6-(3-BROMO-2-NAPHTHYL)-1,3,5-TRIAZINE-2,4-DIAMINE",RXSSKAZHCZWJPP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
133817,6w9c,DB02195,-8.0,"3-(4-Fluorophenyl)-1-Hydroxy-2-(Pyridin-4-Yl)-1h-Pyrrolo[3,2-B]Pyridine",ZSMYZLKEZDYVPI-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
85158,6m3m,DB07327,-8.0,"(2-ACETYL-5-METHYLANILINO)(2,6-DIBROMOPHENYL)ACETAMIDE",FELUFXCUIYHAPB-INIZCTEOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85166,6m3m,DB07335,-8.0,"3-[4-AMINO-1-(1-METHYLETHYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL]PHENOL",MWYBBCLGEHZSCP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85354,6m3m,DB07559,-8.0,"(2Z)-2-cyano-N-(2,2'-dichlorobiphenyl-4-yl)-3-hydroxybut-2-enamide",DDSLONVJHZPSBB-UVTDQMKNSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
66498,6lxt,DB04258,-8.0,Seocalcitol,LVLLALCJVJNGQQ-SEODYNFXSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
85360,6m3m,DB07565,-8.0,Chloramphenicol succinate,LIRCDOVJWUGTMW-ZWNOBZJWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
133283,6w9c,DB01497,-8.0,Etorphine,CAHCBJPUTCKATP-HBDRVVKHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
65407,6lxt,DB02799,-8.0,N-[2-(1-Maleimidyl)Ethyl]-7-Diethylaminocoumarin-3-Carboxamide,OJBZDUMTXGGVSP-KTKRTIGZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
65365,6lxt,DB02738,-8.0,Adenosine-5'-Pentaphosphate,WYJWVZZCMBUPSP-KQYNXXCUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
85666,6m3m,DB07927,-8.0,3-[(4-Carboxy-2-hydroxyphenyl)sulfamoyl]-2-thiophenecarboxylic acid,RDPXXOOKKRIKFN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85670,6m3m,DB07931,-8.0,Hexestrol,PBBGSZCBWVPOOL-HDICACEKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
133274,6w9c,DB01485,-8.0,4-Hydroxytestosterone,BQOIJSIMMIDHMO-FBPKJDBXSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
85680,6m3m,DB07942,-8.0,2-fluoro-4-[4-(4-fluorophenyl)-1H-pyrazol-3-yl]pyridine,YJCHZVXSPFPKMX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
65190,6lxt,DB02505,-8.0,N-(R-Carboxy-Ethyl)-Alpha-(S)-(2-Phenylethyl),JJVQUUYZGJWBPW-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
65178,6lxt,DB02491,-8.0,4-[4-(1-Amino-1-Methylethyl)Phenyl]-5-Chloro-N-[4-(2-Morpholin-4-Ylethyl)Phenyl]Pyrimidin-2-Amine,CJSSYVIHFXDFFC-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
133219,6w9c,DB01421,-8.0,Paromomycin,UOZODPSAJZTQNH-LSWIJEOBSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
85758,6m3m,DB08029,-8.0,N-2-(biphenyl-4-ylsulfonyl)-N-hydroxy-N-2-(2-hydroxyethyl)glycinamide,QQDWEVONJRXVDB-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
142309,6w9q,DB02033,-8.0,"N-(3-Cyclopropyl(5,6,7,8,9,10-Hexahydro-2-Oxo-2h-Cycloocta[B]Pyran-3-Yl)Methyl)Phenylbenzensulfonamide",GDRNWAKVNIROCG-DEOSSOPVSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
65027,6lxt,DB02300,-8.0,Calcipotriol,LWQQLNNNIPYSNX-UROSTWAQSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
133166,6w9c,DB01326,-8.0,Cefamandole,OLVCFLKTBJRLHI-AXAPSJFSSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
85798,6m3m,DB08076,-8.0,"4-[1-(2,6-dichlorobenzyl)-2-methyl-1H-imidazol-4-yl]pyrimidin-2-amine",CKSSZTMRRVJNNG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
133161,6w9c,DB01319,-8.0,Fosamprenavir,MLBVMOWEQCZNCC-OEMFJLHTSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
133147,6w9c,DB01268,-8.0,Sunitinib,WINHZLLDWRZWRT-ATVHPVEESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
142481,6w9q,DB02259,-8.0,"3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid (4-Sulfamoyl-Phenyl)-Amide",VSYGXLAJQDAWCZ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
142489,6w9q,DB02269,-8.0,[4-({[5-Benzyloxy-1-(3-Carbamimidoyl-Benzyl)-1h-Indole-2-Carbonyl]-Amino}-Methyl)-Phenyl]-Trimethyl-Ammonium,UFKJQTGPBFWMGT-UHFFFAOYSA-O,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
85826,6m3m,DB08107,-8.0,N-{[6-(PENTYLOXY)NAPHTHALEN-2-YL]SULFONYL}-D-GLUTAMIC ACID,LIGACKDHLKEZFH-GOSISDBHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
142528,6w9q,DB02323,-8.0,EM-1745,CKSDYJASHNGOOS-KTXOUVACSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
85837,6m3m,DB08119,-8.0,"1,1,1-TRIFLUORO-3-((N-ACETYL)-L-LEUCYLAMIDO)-4-PHENYL-BUTAN-2-ONE(N-ACETYL-L-LEUCYL-L-PHENYLALANYL TRIFLUOROMETHYL KETONE)",MZNXJCZDQRNGRC-GJZGRUSLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
64702,6lxt,DB01861,-8.0,Uridine diphosphate glucose,HSCJRCZFDFQWRP-JZMIEXBBSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
133113,6w9c,DB01219,-8.0,Dantrolene,OZOMQRBLCMDCEG-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
64641,6lxt,DB01782,-8.0,"2,6-Dihydroanthra/1,9-Cd/Pyrazol-6-One",ACPOUJIDANTYHO-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
64634,6lxt,DB01772,-8.0,"3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl]-4-(5-Fluoro-1-Methyl-1h-Indol-3-Yl)-Pyrrole-2,5-Dione",RPGZQOOZHIEPJW-HNNXBMFYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
85861,6m3m,DB08145,-8.0,"6-(2,6-DIMETHOXYPHENYL)PYRIDO[2,3-D]PYRIMIDINE-2,7-DIAMINE",LRPHIAJXODIASX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85622,6m3m,DB07871,-8.0,6-CHLORO-4-(CYCLOHEXYLOXY)-3-ISOPROPYLQUINOLIN-2(1H)-ONE,OQCFORGSZJSAEL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
65501,6lxt,DB02917,-8.0,N-Hydroxy-4-(Methyl{[5-(2-Pyridinyl)-2-Thienyl]Sulfonyl}Amino)Benzamide,LFGYSFPVLMPUPE-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
85614,6m3m,DB07863,-8.0,2-chloro-5-nitro-N-phenylbenzamide,DNTSIBUQMRRYIU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
133294,6w9c,DB01512,-8.0,Hydromorphinol,AABLHGPVOULICI-BRJGLHKUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
66477,6lxt,DB04226,-8.0,Dihydro-Acarbose,CUAQESWNTOXZJZ-RTNAABQMSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
133532,6w9c,DB01810,-8.0,"[1-(1-Methyl-4,5-Dioxo-Pent-2-Enylcarbamoyl)-2-Phenyl-Ethyl]-Carbamic Acid Benzyl Ester",NOXVWFAAXREWMI-GURWAVDKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
85387,6m3m,DB07598,-8.0,"2,3,6A,7,8,9-HEXAHYDRO-11H-[1,4]DIOXINO[2,3-G]PYRROLO[2,1-B][1,3]BENZOXAZIN-11-ONE",RQEPVMAYUINZRE-GFCCVEGCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85388,6m3m,DB07602,-8.0,S-{3-[(4-ANILINOQUINAZOLIN-6-YL)AMINO]-3-OXOPROPYL}-L-CYSTEINE,NLVZTRZPMRTVRC-INIZCTEOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
133491,6w9c,DB01755,-8.0,N-[Isoleucinyl]-N'-[Adenosyl]-Diaminosufone,XVTRBLLRODNOJV-VBJYJYTRSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
66314,6lxt,DB04014,-8.0,Alsterpaullone,OLUKILHGKRVDCT-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
85438,6m3m,DB07662,-8.0,N-[4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL]-ACRYLAMIDE,HTUBKQUPEREOGA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
66241,6lxt,DB03916,-8.0,4-{2-[4-(2-Aminoethyl)Piperazin-1-Yl]Pyridin-4-Yl}-N-(3-Chloro-4-Methylphenyl)Pyrimidin-2-Amine,RHOOHUMOHVIXEF-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
133390,6w9c,DB01622,-8.0,Thioproperazine,VZYCZNZBPPHOFY-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
133387,6w9c,DB01619,-8.0,Phenindamine,ISFHAYSTHMVOJR-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
66177,6lxt,DB03830,-8.0,Phosphorylated Dihydropteroate,DNKVHXNVVYQUDC-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
66143,6lxt,DB03791,-8.0,"(3-{3-[[2-Chloro-3-(Trifluoromethyl)Benzyl](2,2-Diphenylethyl)Amino]Propoxy}Phenyl)Acetic Acid",NAXSRXHZFIBFMI-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
85475,6m3m,DB07705,-8.0,"1-[(2S)-2-[(4-CHLOROBENZYL)OXY]-2-(2,4-DICHLOROPHENYL)ETHYL]-1H-IMIDAZOLE",LEZWWPYKPKIXLL-GOSISDBHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
134097,6w9c,DB02559,-8.0,"6-(Octahydro-1h-Indol-1-Ylmethyl)Decahydroquinazoline-2,4-Diamine",HDQIGGQUKAQTGU-SZTTVXCBSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
85482,6m3m,DB07714,-8.0,"6-(3-METHYL-1,4-DIOXO-1,4-DIHYDRONAPHTHALEN-2-YL)HEXANOIC ACID",ICGRXHWXPCXIKM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
133378,6w9c,DB01608,-8.0,Periciazine,LUALIOATIOESLM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
66066,6lxt,DB03696,-8.0,Lanosterol,CAHGCLMLTWQZNJ-BQNIITSRSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
65934,6lxt,DB03501,-8.0,Galactose-uridine-5'-diphosphate,HSCJRCZFDFQWRP-ABVWGUQPSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
133350,6w9c,DB01570,-8.0,Ohmefentanyl,FRPRNNRJTCONEC-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
65917,6lxt,DB03478,-8.0,2'-O-Acetyl Adenosine-5-Diphosphoribose,BFNOPXRXIQJDHO-DLFWLGJNSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
133347,6w9c,DB01567,-8.0,Fludiazepam,ROYOYTLGDLIGBX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
65893,6lxt,DB03446,-8.0,N-Benzyl-3-(alpha-D-galactopyranosyloxy)benzamide,FSMWGHKWKYCPKE-QTVCLEQKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
133345,6w9c,DB01565,-8.0,Dihydromorphine,IJVCSMSMFSCRME-KBQPJGBKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
133312,6w9c,DB01532,-8.0,??-Methylacetylfentanyl,OKTLVZBUKMRPLL-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
65680,6lxt,DB03161,-8.0,Thymidine-5'-Diphospho-Beta-D-Xylose,AJUADKZRQSBUAK-KDGZBOQCSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
133304,6w9c,DB01524,-8.0,Androstenediol,QADHLRWLCPCEKT-LOVVWNRFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
65611,6lxt,DB03069,-8.0,Cytidine-5'-Diphospho-Beta-D-Xylose,NWSKPSPTJOAICE-OCIMBMBZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
142270,6w9q,DB01977,-8.0,6-(N-Phenylcarbamyl)-2-Naphthalenecarboxamidine,AECPTICWHONWNW-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
66116,6lxt,DB03758,-8.0,Radicicol,WYZWZEOGROVVHK-GTMNPGAYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
64602,6lxt,DB01732,-8.0,"(4r,5s,6s,7r)-1,3-Dibenzyl-4,7-Bis(Phenoxymethyl)-5,6-Dihydroxy-1,3 Diazepan-2-One",SQBOSZXDOHQFAA-ZRTHHSRSSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
67420,6lxt,DB06684,-8.0,Vilazodone,SGEGOXDYSFKCPT-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
134137,6w9c,DB02615,-8.0,Compound 19,UZOOIPXOYYJULJ-BLIZRMSTSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
84194,6m3m,DB04890,-8.0,Bepotastine,YWGDOWXRIALTES-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
68962,6lxt,DB08539,-8.0,"3-cyclopropyl-5-phenyl-N-(pyridin-3-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",CCDIUVLNHCGSMH-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
68961,6lxt,DB08538,-8.0,"N-((2-aminopyrimidin-5-yl)methyl)-5-(2,6-difluorophenyl)-3-ethylpyrazolo[1,5-a]pyrimidin-7-amine",HQPVGVSQPQVZLD-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
68921,6lxt,DB08493,-8.0,"5-METHYL-3-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.013,18]NONADECA-12(19),13,15,17-TETRAEN-10-YLCARBAMOYL)-HEXANOIC ACID",AKWKBACKRMYPRV-NQIIRXRSSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
68917,6lxt,DB08489,-8.0,"N4-HYDROXY-2-ISOBUTYL-N1-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.013,18]NONADECA-12(19),13,15,17-TETRAEN-10-YL)-SUCCINAMIDE",GCBPAPVOMPJQHK-NQIIRXRSSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
84219,6m3m,DB04954,-8.0,Tecadenoson,OESBDSFYJMDRJY-BAYCTPFLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
140734,6w9c,DB15206,-8.0,Uprifosbuvir,SFPFZQKYPOWCSI-KHFYHRBSSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
68880,6lxt,DB08444,-8.0,"3-[2-bromo-4-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)phenoxy]-5-methylbenzonitrile",YYGZQXRLQMFHDH-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
68864,6lxt,DB08426,-8.0,"THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [2-OXO-1-(1H-PYRROLO[2,3-C]PYRIDIN-2-YLMETHYL)-PYRROLIDIN-3-YL]-AMIDE",PLXOQMHGHDZMSX-AWEZNQCLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
84250,6m3m,DB05104,-8.0,Asimadoline,JHLHNYVMZCADTC-LOSJGSFVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
68857,6lxt,DB08416,-8.0,"(9BETA,13ALPHA,14BETA,17ALPHA)-2-METHOX1TRA-1,3,5(10)-TRIENE-3,17-DIYL DISULFAMATE",AQSNIXKAKUZPSI-SSTWWWIQSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
135499,6w9c,DB04549,-8.0,"4-(Aminosulfonyl)-N-[(2,3,4-Trifluorophenyl)Methyl]-Benzamide",AANTYZRUJFNZFI-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
84294,6m3m,DB05399,-8.0,Succinobucol,RKSMVPNZHBRNNS-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
68765,6lxt,DB08303,-8.0,"(3S)-3-cyclopentyl-6-methyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide",CUMKMTBOHBENJI-SFHVURJKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
84311,6m3m,DB05462,-8.0,Chlorotoxin I-131,YUFAHBUWIVNVNJ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
68715,6lxt,DB08237,-8.0,2'-deoxy-N-(naphthalen-1-ylmethyl)guanosine 5'-(dihydrogen phosphate),COMPKRGNHXOXMN-GVDBMIGSSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
84314,6m3m,DB05475,-8.0,Golotimod,CATMPQFFVNKDEY-YPMHNXCESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84322,6m3m,DB05514,-8.0,Cobiprostone,SDDSJMXGJNWMJY-BRHAQHMBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
68608,6lxt,DB08111,-8.0,"4-[(6-phenyl[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl]phenol",ZGJYGQLGSXWEMY-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
84333,6m3m,DB05562,-8.0,Naluzotan,SPWZXWDPAWDKQE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
68586,6lxt,DB08087,-8.0,"4-[(7R,7AS)-7-HYDROXY-1,3-DIOXOTETRAHYDRO-1H-PYRROLO[1,2-C]IMIDAZOL-2(3H)-YL]-1-NAPHTHONITRILE",NHBIWLQQJPSMNP-CABCVRRESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
135367,6w9c,DB04371,-8.0,AL6528,FBBLOSCXOZYUSS-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
68555,6lxt,DB08052,-8.0,"1-cyclopentyl-3-(1H-pyrrolo[2,3-b]pyridin-5-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine",NVRXTLZYXZNATH-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
84361,6m3m,DB05737,-8.0,Varespladib methyl,VJYDOJXJUCJUHL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84365,6m3m,DB05779,-8.0,Oglufanide,LLEUXCDZPQOJMY-AAEUAGOBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
68533,6lxt,DB08026,-8.0,"2-{4-[(4-imidazo[1,2-a]pyridin-3-ylpyrimidin-2-yl)amino]piperidin-1-yl}-N-methylacetamide",AJLILYAPRHIFAS-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
135274,6w9c,DB04240,-8.0,"(1S)-1-C-{(2R)-6-[(2R)-2-Butanyl]-5,10-dihydroxy-4-oxo-1,2,3,4-tetrahydro-2-anthracenyl}-5-deoxy-1-O-methyl-D-xylulose",XGORHSPGULYMCV-HHYQQTLHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
68969,6lxt,DB08547,-8.0,PROGESTERONE-11-ALPHA-OL-HEMISUCCINATE,JBBNFGYRYNBDIH-DBGGZKJISA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
68513,6lxt,DB08005,-8.0,4-{[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino}-N-ethylpiperidine-1-carboxamide,ARMFMDYRYOKSOW-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
135599,6w9c,DB04679,-8.0,H TYPE I TRISACCHARIDE,MGSDFCKWGHNUSM-QVPNGJTFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
69061,6lxt,DB08660,-8.0,"1,2,5,8-tetrahydroxyanthracene-9,10-dione",VBHKTXLEJZIDJF-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
140664,6w9c,DB13063,-8.0,Parthenolide,KTEXNACQROZXEV-SLXBATTESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
83672,6m3m,DB04194,-8.0,Chitotriose,WZZVUHWLNMNWLW-VFCSDQTKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
69652,6lxt,DB11409,-8.0,Febantel,HMCCXLBXIJMERM-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
69649,6lxt,DB11398,-8.0,Diclazuril,ZSZFUDFOPOMEET-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
135800,6w9c,DB05048,-8.0,Cannabinor,GSTZHANFXAKPSE-MXTREEOPSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
69597,6lxt,DB11260,-8.0,Diacetyl benzoyl lathyrol,JPYYWXPAHJBKJX-VWSFRBHVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
135791,6w9c,DB05015,-8.0,Belinostat,NCNRHFGMJRPRSK-MDZDMXLPSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
135785,6w9c,DB04975,-8.0,Banoxantrone,YZBAXVICWUUHGG-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
69461,6lxt,DB09223,-8.0,Blonanserin,XVGOZDAJGBALKS-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
69422,6lxt,DB09181,-8.0,Trefentanil,RJSCINHYBGMIFT-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
135733,6w9c,DB04865,-8.0,Omacetaxine mepesuccinate,HYFHYPWGAURHIV-JFIAXGOJSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
84024,6m3m,DB04662,-8.0,OLOMOUCINE II,NDUVSANREQEDRE-CQSZACIVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
69300,6lxt,DB08976,-8.0,Floctafenine,APQPGQGAWABJLN-GFCCVEGCSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
69295,6lxt,DB08971,-8.0,Fluocortolone,GAKMQHDJQHZUTJ-ULHLPKEOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
135687,6w9c,DB04812,-8.0,Benoxaprofen,MITFXPHMIHQXPI-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
135685,6w9c,DB04807,-8.0,4-NITROPHENYL-(6-S-ALPHA-D-XYLOPYRANOSYL)-BETA-D-GLUCOPYRANOSIDE,HQYVHBCTLFPWRQ-ZMFOIVQCSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
84056,6m3m,DB04711,-8.0,Iodipamide,FFINMCNLQNTKLU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84079,6m3m,DB04743,-8.0,Nimesulide,HYWYRSMBCFDLJT-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
69226,6lxt,DB08865,-8.0,Crizotinib,KTEIFNKAUNYNJU-GFCCVEGCSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
135663,6w9c,DB04778,-8.0,SC45647,LPSXGZAUAOMRNU-FZKQIMNGSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
84121,6m3m,DB04800,-8.0,1-METHYL-3-PHENYL-1H-PYRAZOL-5-YLSULFAMIC ACID,OTZLVSGSRPNRFT-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
69158,6lxt,DB08772,-8.0,"3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL-2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID",BCSVCWVQNOXFGL-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
84153,6m3m,DB04838,-8.0,Cyclandelate,WZHCOOQXZCIUNC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
69131,6lxt,DB08742,-8.0,"1,3-CYCLOHEXANEDIOL, 4-METHYLENE-5-[(2E)-[(1S,3AS,7AS)-OCTAHYDRO-1-(5-HYDROXY-5-METHYL-1,3-HEXADIYNYL)-7A-METHYL-4H-INDEN-4-YLIDENE]ETHYLIDENE]-, (1R,3S,5Z)",CEEUUHVULXTFGS-BQXVGYHGSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
69128,6lxt,DB08739,-8.0,"2-{3-[(2S)-4,4-difluoro-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]-3-oxopropyl}-isoindole-1,3(2H)-dione",ZSXNPAWXICXNGZ-HNNXBMFYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
135652,6w9c,DB04763,-8.0,"1-N-(4-SULFAMOYLPHENYL-ETHYL)-2,4,6-TRIMETHYLPYRIDINIUM",UXBCHTZINZNVRG-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
84174,6m3m,DB04865,-8.0,Omacetaxine mepesuccinate,HYFHYPWGAURHIV-JFIAXGOJSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
69001,6lxt,DB08588,-8.0,2-({2-[(3R)-3-AMINOPIPERIDIN-1-YL]-4-OXOQUINAZOLIN-3(4H)-YL}METHYL)BENZONITRILE,OYNURZXTLNNKAP-QGZVFWFLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
68492,6lxt,DB07982,-8.0,2-{4-[4-({4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]pyrimidin-2-yl}amino)phenyl]piperazin-1-yl}-2-oxoethanol,PVTKDXZNSUHUMO-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
84428,6m3m,DB06155,-8.0,Rimonabant,JZCPYUJPEARBJL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
68415,6lxt,DB07891,-8.0,"4-{[(14beta,17alpha)-3-hydrox1tra-1,3,5(10)-trien-17-yl]oxy}-4-oxobutanoic acid",YJPIDPAGJSWWBE-FNIAAEIWSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
84733,6m3m,DB06835,-8.0,(2S)-2-[3-(AMINOMETHYL)PHENYL]-3-{(S)-HYDROXY[(1R)-2-METHYL-1-{[(2-PHENYLETHYL)SULFONYL]AMINO}PROPYL]PHOSPHORYL}PROPANOIC ACID,CTQDLSDUHUFBQW-LEWJYISDSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
134586,6w9c,DB03267,-8.0,1-Allyl-3-Butyl-8-(N-Acetyl-4-Aminobenzyl)-Xanthine,XFOWZKUTPKXWIE-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
67882,6lxt,DB07270,-8.0,"N-[7-(3-AMINOPHENYL)-5-METHOXY-1,3-BENZOXAZOL-2-YL]-2,5-DICHLOROBENZENESULFONAMIDE",GAYYMURZGLJDCT-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
84748,6m3m,DB06857,-8.0,N-(4-CARBAMIMIDOYL-3-CHORO-PHENYL)-2-HYDROXY-3-IODO-5-METHYL-BENZAMIDE,QKGFTDAISIBIBV-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
67877,6lxt,DB07263,-8.0,"[{2-bromo-4-[(2R)-3-oxo-2,3-diphenylpropyl]phenyl}(difluoro)methyl]phosphonic acid",WDTMVBQZDFMOIK-GOSISDBHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
84757,6m3m,DB06868,-8.0,N-(3-chlorobenzyl)-1-(4-methylpentanoyl)-L-prolinamide,PQUULPKGCNPPBX-INIZCTEOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
67857,6lxt,DB07242,-8.0,"(4R)-7,8-dichloro-1',9-dimethyl-1-oxo-1,2,4,9-tetrahydrospiro[beta-carboline-3,4'-piperidine]-4-carbonitrile",XGUIMGJMQKZRGM-LLVKDONJSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
84784,6m3m,DB06898,-8.0,"4-(2-amino-1-methyl-1H-imidazo[4,5-b]pyridin-6-yl)phenol",UGJXOCBVCWTJFP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84789,6m3m,DB06903,-8.0,"(1S,3aS,5aR,8aS)-1,7,7-trimethyl-1,2,3,3a,5a,6,7,8-octahydrocyclopenta[c]pentalene-4-carboxylic acid",DCFDRCCHOOORSB-JOXOIDLHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
67807,6lxt,DB07181,-8.0,"4'-[(1R)-1-amino-2-(2,5-difluorophenyl)ethyl]biphenyl-3-carboxamide",JYKFWUXBFJJDTP-HXUWFJFHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
67785,6lxt,DB07156,-8.0,"(4Z)-6-bromo-4-({[4-(pyrrolidin-1-ylmethyl)phenyl]amino}methylidene)isoquinoline-1,3(2H,4H)-dione",JFEKAVPMVOLVTH-UNOMPAQXSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
84796,6m3m,DB06911,-8.0,D-leucyl-N-(3-chlorobenzyl)-L-prolinamide,FHVBVJXZKNCSLP-CVEARBPZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
134474,6w9c,DB03124,-8.0,5-[4-(1-Carboxymethyl-2-Oxo-Propylcarbamoyl)-Benzylsulfamoyl]-2-Hydroxy-Benzoic Acid,LBAHOXPDTNUYCX-INIZCTEOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
84821,6m3m,DB06936,-8.0,N-(4-carbamimidoylbenzyl)-1-(4-methylpentanoyl)-L-prolinamide,AEKJCSNKYXWOAQ-INIZCTEOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
67719,6lxt,DB07081,-8.0,"(2R)-4-[(8R)-8-METHYL-2-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[1,5-A]PYRAZIN-7(8H)-YL]-4-OXO-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE",FDEXEPZGMKFCTG-PSASIEDQSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
67714,6lxt,DB07074,-8.0,6-CARBAMIMIDOYL-4-(3-HYDROXY-2-METHYL-BENZOYLAMINO)-NAPHTHALENE-2-CARBOXYLIC ACID METHYL ESTER,OUBRALHIKGRAMA-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
134404,6w9c,DB03034,-8.0,D-Levofloxacin,GSDSWSVVBLHKDQ-SNVBAGLBSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
134332,6w9c,DB02930,-8.0,Adenosine 5'-[??-thio]triphosphate,NLTUCYMLOPLUHL-KQYNXXCUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
67656,6lxt,DB07008,-8.0,"4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMIDAZOL-1-YL)PHENOXY]PYRIMIDINE",XPXGYINSBORUMM-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
84884,6m3m,DB07017,-8.0,"(5S)-2-{[(1S)-1-(4-fluorophenyl)ethyl]amino}-5-(1-hydroxy-1-methylethyl)-5-methyl-1,3-thiazol-4(5H)-one",HYVZYASDRIAOPU-BJOHPYRUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
134256,6w9c,DB02834,-8.0,IDD552,ZCAGEXZTORJQDZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
67612,6lxt,DB06954,-8.0,"2-(cycloheptylmethyl)-1,1-dioxido-1-benzothiophen-6-yl sulfamate",BIASYWBGUYOWJR-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
67552,6lxt,DB06886,-8.0,N-BENZYLOXYCARBONYL-ALA-PRO-3-AMINO-4-PHENYL-BUTAN-2-OL,MACLRJNEKXUAJK-YDLSIGKMSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
84915,6m3m,DB07050,-8.0,"5-[(phenylsulfonyl)amino]-1,3,4-thiadiazole-2-sulfonamide",PWDGTQXZLNDOKS-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
134215,6w9c,DB02716,-8.0,7-Methyl-Guanosine-5'-Triphosphate,DKVRNHPCAOHRSI-KQYNXXCUSA-O,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
134188,6w9c,DB02684,-8.0,5'-O-(N-(L-Cysteinyl)-Sulfamoyl)Adenosine,FTSDEWPMACCNGN-YTMOPEAISA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
67513,6lxt,DB06837,-8.0,"(2R)-N-4-hydroxy-2-(3-hydroxybenzyl)-N-1-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]butanediamide",VXDKQRWTOJFQKH-BJZITVGISA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
134638,6w9c,DB03337,-8.0,1-(2-Amidinophenyl)-3-(Phenoxyphenyl)Urea,ZHCAYBOLUMAUQX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
84704,6m3m,DB06787,-8.0,Hexocyclium,ZRYHPQCHHOKSMD-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
134647,6w9c,DB03348,-8.0,Huperzine B,YYWGABLTRMRUIT-HWWQOWPSSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
134700,6w9c,DB03421,-8.0,"2-Phenethyl-2,3-Dihydro-Phthalazine-1,4-Dione",JSSVIGGKHIJEHO-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
68409,6lxt,DB07882,-8.0,"4-{4-[2-(1A,7A-DIMETHYL-4-OXY-OCTAHYDRO-1-OXA-4-AZA-CYCLOPROPA[A]NAPHTHALEN-4-YL) -ACETYLAMINO]-PHENYLCARBAMOYL}-BUTYRIC ACID",VFIZFTGABDUGCF-UPVHCHBVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
68390,6lxt,DB07861,-8.0,(2R)-N-hydroxy-3-naphthalen-2-yl-2-[(naphthalen-2-ylsulfonyl)amino]propanamide,MMOUXLMPQFMDRD-JOCHJYFZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
68367,6lxt,DB07834,-8.0,"N-(cyclopropylmethyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-4-carboxamide",FOHZGCHKLPIBBX-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
68365,6lxt,DB07832,-8.0,"4-{4-[(5-hydroxy-2-methylphenyl)amino]quinolin-7-yl}-1,3-thiazole-2-carbaldehyde",VKQPTVJDZIILPG-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
135100,6w9c,DB03984,-8.0,Morpholine-4-Carboxylic Acid [1-(2-Benzylsulfanyl-1-Formyl-Ethylcarbamoyl)-2-Phenyl-Ethyl]-Amide,MWTQNXVXPLTHJB-YADHBBJMSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
68349,6lxt,DB07814,-8.0,Gibberellic acid,IXORZMNAPKEEDV-OBDJNFEBSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
68328,6lxt,DB07792,-8.0,"(S)-2-CHLORO-N-(1-(2-(2-HYDROXYETHYLAMINO)-2-OXOETHYL)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL)-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE",VUKPNWLGSLOHIF-AWEZNQCLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
68324,6lxt,DB07788,-8.0,"(3R,5Z,8S,9S,11E)-8,9,16-TRIHYDROXY-14-METHOXY-3-METHYL-3,4,9,10-TETRAHYDRO-1H-2-BENZOXACYCLOTETRADECINE-1,7(8H)-DIONE",NEQZWEXWOFPKOT-QHSZRYGNSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
135032,6w9c,DB03893,-8.0,Thionicotinamide-Adenine-Dinucleotide,UQYPZLRUJKCREN-NNYOXOHSSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
135022,6w9c,DB03880,-8.0,Batimastat,XFILPEOLDIKJHX-QYZOEREBSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
84513,6m3m,DB06358,-8.0,Iclaprim,HWJPWWYTGBZDEG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
68261,6lxt,DB07715,-8.0,Emodin,RHMXXJGYXNZAPX-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
84531,6m3m,DB06414,-8.0,Etravirine,PYGWGZALEOIKDF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84983,6m3m,DB07128,-8.0,"N7-BUTYL-N2-(5-CHLORO-2-METHYLPHENYL)-5-METHYL[1,2,4]TRIAZOLO[1,5-A]PYRIMIDINE-2,7-DIAMINE",ZTYBIJUAAWLJNU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84557,6m3m,DB06478,-8.0,Porfiromycin,HRHKSTOGXBBQCB-VFWICMBZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
68174,6lxt,DB07612,-8.0,6-(3-AMINOPHENYL)-N-(TERT-BUTYL)-2-(TRIFLUOROMETHYL)QUINAZOLIN-4-AMINE,XQKJVNGGVLHNLA-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
68170,6lxt,DB07608,-8.0,N-(5-{[(2S)-4-amino-2-(3-chlorophenyl)butanoyl]amino}-1H-indazol-3-yl)benzamide,JDGOPNUGILVNJZ-IBGZPJMESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
84581,6m3m,DB06536,-8.0,Tesaglitazar,CXGTZJYQWSUFET-IBGZPJMESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
68131,6lxt,DB07557,-8.0,"(5BETA)-PREGNANE-3,20-DIONE",XMRPGKVKISIQBV-XWOJZHJZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
84588,6m3m,DB06573,-8.0,Rebimastat,GTXSRFUZSLTDFX-HRCADAONSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
68108,6lxt,DB07531,-8.0,"4-{5-[(Z)-(2,4-DIOXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE",JNPRTUHVCHGFHJ-GHXNOFRVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
84596,6m3m,DB06588,-8.0,Triphendiol,KQCJZAUNKSGEFM-UNMCSNQZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84603,6m3m,DB06603,-8.0,Panobinostat,FPOHNWQLNRZRFC-ZHACJKMWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84625,6m3m,DB06640,-8.0,Fispemifene,NKZTZAQIKKGTDB-QPLCGJKRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84640,6m3m,DB06682,-8.0,Naproxcinod,AKFJWRDCWYYTIG-ZDUSSCGKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84649,6m3m,DB06697,-8.0,Artemether,SXYIRMFQILZOAM-HVNFFKDJSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
134716,6w9c,DB03449,-8.0,N-(4-(2-((3-Chlorophenylmethyl)Amino)Ethyl)Phenyl)-2-Thiophecarboxamidine,ZZVGLDBDD1AB-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
84668,6m3m,DB06725,-8.0,Lornoxicam,WLHQHAUOOXYABV-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84560,6m3m,DB06481,-8.0,Manitimus,IRELROQHIPLASX-SEYXRHQNSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
64595,6lxt,DB01720,-8.0,(2z)-2-(Benzoylamino)-3-[4-(2-Bromophenoxy)Phenyl]-2-Propenoic Acid,WLPJLQNKCJWAFL-RGEXLXHISA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
64577,6lxt,DB01697,-8.0,beta-cellotriose,FYGDTMLNYKFZSV-CSHPIKHBSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
85868,6m3m,DB08152,-8.0,{(2S)-1-[N-(tert-butoxycarbonyl)glycyl]pyrrolidin-2-yl}methyl (3-chlorophenyl)acetate,ONXGIEJBNQLITK-INIZCTEOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87315,6m3m,DB12146,-8.0,Rigosertib,OWBFCJROIKNMGD-BQYQJAHWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87336,6m3m,DB12181,-8.0,Dalcetrapib,YZQLWPMZQVHJED-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87338,6m3m,DB12184,-8.0,Gepirone,QOIGKGMMAGJZNZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
146105,6w9q,DB08124,-8.0,"3-{[(2,2-DIOXIDO-1,3-DIHYDRO-2-BENZOTHIEN-5-YL)AMINO]METHYLENE}-5-(1,3-OXAZOL-5-YL)-1,3-DIHYDRO-2H-INDOL-2-ONE",FTQYGMLRLRXBPT-IDUWFGFVSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
87352,6m3m,DB12206,-8.0,N-6022,YVPGZQLRPAGKLA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
131856,6w4h,DB14866,-8.0,Amcasertib,QDWKGEFGLQMDAM-ULJHMMPZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
146153,6w9q,DB08174,-8.0,"5-CHLORO-N-((1R,2S)-2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO) CYCLOPENTYL)THIOPHENE-2-CARBOXAMIDE",QCPYHSAHOYXXQK-DLBZAZTESA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
146196,6w9q,DB08233,-8.0,6-CYCLOHEXYLMETHYLOXY-2-(4'-HYDROXYANILINO)PURINE,RFSDQDHHBKYQOD-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
62726,6crv,DB14028,-8.0,Nordazepam,AKPLHCDWDRPJGD-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62724,6crv,DB14025,-8.0,Clinafloxacin,QGPKADBNRMWEQR-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87379,6m3m,DB12241,-8.0,TAK-733,RCLQNICOARASSR-SECBINFHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
62705,6crv,DB13983,-8.0,"5,7,2'-trihydroxy-6,8-dimethoxyflavone",JWOKGWICZPPYPX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87406,6m3m,DB12279,-8.0,OBP-801,XFLBOEMFLGLWFF-HDXRNPEWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
131814,6w4h,DB14765,-8.0,Rivoceranib,WPEWQEMJFLWMLV-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131785,6w4h,DB14681,-8.0,Cortisone,MFYSYFVPBJMHGN-ZPOLXVRWSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131783,6w4h,DB14679,-8.0,Quingestanol acetate,FLGJKPPXEKYCBY-AKCFYGDASA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
87437,6m3m,DB12316,-8.0,9CUAB30,PPGNMFUMZSAZCW-VOYUZAMQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
146205,6w9q,DB08242,-8.0,"N,4-dimethyl-3-[(1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl)amino]benzamide",OYTBZXSFNNAVKU-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
146223,6w9q,DB08267,-8.0,"6-amino-4-(2-phenylethyl)-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",PBZAIUVFRISTSZ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
146299,6w9q,DB08362,-8.0,"N-(3-(8-CYANO-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZIN-2-YLAMINO)PHENYL)ACETAMIDE",QVKXQLGRDOMAGC-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
131758,6w4h,DB14653,-8.0,Clocortolone caproate,MMTRTBFDFNRBQO-ANHDKODLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131754,6w4h,DB14649,-8.0,Dexamethasone acetate,AKUJBENLRBOFTD-RPRRAYFGSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131751,6w4h,DB14646,-8.0,Prednisone acetate,MOVRKLZUVNCBIP-RFZYENFJSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131749,6w4h,DB14644,-8.0,Methylprednisolone hemisuccinate,IMBXEJJVJRTNOW-XYMSELFBSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131743,6w4h,DB14637,-8.0,Fluprednisolone acetate,CYMBAKFTWRNHPS-APRQOCPKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
87475,6m3m,DB12377,-8.0,Relebactam,SMOBCLHAZXOKDQ-ZJUUUORDSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
131733,6w4h,DB14627,-8.0,Oxyphenisatin acetate,PHPUXYRXPHEJDF-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
87299,6m3m,DB12123,-8.0,Cinepazide,RCUDFXMNPQNBDU-VOTSOKGWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87484,6m3m,DB12389,-8.0,Zamicastat,ZSSLCFLHEFXANG-GOSISDBHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
62807,6crv,DB14201,-8.0,"2,2'-Dibenzothiazyl disulfide",AFZSMODLJJCVPP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
131932,6w4h,DB15048,-8.0,Licogliflozin,XFJAMQQAAMJFGB-ZQGJOIPISA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
145663,6w9q,DB07616,-8.0,"4-{[4-(4-fluoro-3-methylphenyl)-1,3-thiazol-2-yl]amino}-2-hydroxybenzoic acid",LKZZDHKJFDTYCH-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
145665,6w9q,DB07618,-8.0,"2-(4-(AMINOMETHYL)PIPERIDIN-1-YL)-N-(3_CYCLOHEXYL-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)ACETAMIDE",AITZHKQVQNLKHI-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
145687,6w9q,DB07643,-8.0,"5-{[1-(2,3-dichlorobenzyl)piperidin-4-yl]methoxy}quinazoline-2,4-diamine",XVLUVRFYGVJKGJ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
132061,6w4h,DB15297,-8.0,Petesicatib,KXAAIORSMACJSI-AEFFLSMTSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
87128,6m3m,DB11872,-8.0,ZD-6126,UGBMEXLBFDAOGL-INIZCTEOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87146,6m3m,DB11899,-8.0,MK-8776,GMIZZEXBPRLVIV-SECBINFHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87149,6m3m,DB11902,-8.0,Gisadenafil,YPFZMBHKIVDSNR-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
132033,6w4h,DB15242,-8.0,MK-0533,STWITCBWQHTJFJ-XMMPIXPASA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
62926,6crv,DB14735,-8.0,Cannabichromene,UVOLYTDXHDXWJU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62924,6crv,DB14732,-8.0,Queuine,WYROLENTHWJFLR-ACLDMZEESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
145757,6w9q,DB07728,-8.0,"2-[2-(2-FLUOROPHENYL)PYRIDIN-4-YL]-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE",XJJYJNMNYDNXNO-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
145758,6w9q,DB07729,-8.0,3-fluoro-N-[3-(1H-tetrazol-5-yl)phenyl]benzamide,GAKOBKPDJJGRIL-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
132016,6w4h,DB15209,-8.0,MK-0736,ORQZQBUNAMJFCY-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
132014,6w4h,DB15207,-8.0,Esaxerenone,NOSNHVJANRODGR-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
145815,6w9q,DB07794,-8.0,"5-(2-PHENYLPYRAZOLO[1,5-A]PYRIDIN-3-YL)-1H-PYRAZOLO[3,4-C]PYRIDAZIN-3-AMINE",XVECMUKVOMUNLE-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
87170,6m3m,DB11935,-8.0,Flomoxef,UHRBTBZOWWGKMK-DOMZBBRYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
132000,6w4h,DB15187,-8.0,Dubermatinib,YUAALFPUEOYPNX-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131999,6w4h,DB15186,-8.0,GDC-0084,LGWACEZVCMBSKW-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
87186,6m3m,DB11957,-8.0,Idalopirdine,YBAWYTYNMZWMMJ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
62896,6crv,DB14668,-8.0,Dienestrol diacetate,YWLLGDVBTLPARJ-OXAZHYLESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62890,6crv,DB14662,-8.0,Flunisolide acetate,WEGNFRKBIKYVLC-XTLNBZDDSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
131985,6w4h,DB15149,-8.0,Futibatinib,KEIPNCCJPRMIAX-HNNXBMFYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131979,6w4h,DB15138,-8.0,AZD-9496,DFBDRVGWBHBJNR-BBNFHIFMSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
87213,6m3m,DB11999,-8.0,Vosaroxin,XZAFZXJXZHRNAQ-STQMWFEESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
131947,6w4h,DB15078,-8.0,Rogaratinib,HNLRRJSKGXOYNO-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
145996,6w9q,DB08003,-8.0,ISOTHIAZOLIDINONE ANALOG,UILYPHAKDBTKQV-UFYCRDLUSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
131941,6w4h,DB15063,-8.0,Inarigivir soproxil,CJCYTUJOSMYXLE-JDLSZIHUSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131918,6w4h,DB15024,-8.0,Apararenone,AZNHWXAFPBYFGH-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
87492,6m3m,DB12399,-8.0,Polmacoxib,IJWPAFMIFNSIGD-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
131723,6w4h,DB14575,-8.0,Eslicarbazepine,BMPDWHIDQYTSHX-AWEZNQCLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131709,6w4h,DB14541,-8.0,Hydrocortisone cypionate,DLVOSEUFIRPIRM-KAQKJVHQSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131025,6w4h,DB13174,-8.0,Rhein,FCDLCPWAQCPTKC-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
87712,6m3m,DB12731,-8.0,Daporinad,KPBNHDGDUADAGP-VAWYXSNFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
62370,6crv,DB13485,-8.0,Sulfametomidine,QKLSCPPJEVXONT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62368,6crv,DB13482,-8.0,Dimefline,ZXFQRFXLFWWKLX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130981,6w4h,DB13090,-8.0,Zidebactam,YCZPXRQPDCXTIO-BBBLOLIVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
62359,6crv,DB13470,-8.0,Cefodizime,XDZKBRJLTGRPSS-BGZQYGJUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62357,6crv,DB13465,-8.0,Ciclobendazole,OXLKOMYHDYVIDM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
146940,6w9q,DB09215,-8.0,Droxicam,OEHFRZLKGRKFAS-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
130953,6w4h,DB13051,-8.0,CH-5132799,JEGHXKRHKHPBJD-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
147067,6w9q,DB11176,-8.0,Zeaxanthin,JKQXZKUSFCKOGQ-QAYBQHTQSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
87820,6m3m,DB12906,-8.0,LY-2334737,MEOYFIHNRBNEPI-UXIGCNINSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
147188,6w9q,DB11511,-8.0,Difloxacin,NOCJXYPHIIZEHN-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
87858,6m3m,DB12964,-8.0,Lerisetron,PWWDCRQZITYKDV-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
130798,6w4h,DB12806,-8.0,GSK-1004723,YANGEESWIGIKOP-UUWRZZSWSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
87927,6m3m,DB13070,-8.0,Surinabant,HMXDWDSNPRNUKI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87931,6m3m,DB13077,-8.0,LCB01-0371,QLUWQAFDTNAYPN-LLVKDONJSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
147247,6w9q,DB11663,-8.0,Pictilisib,LHNIIDJUOCFXAP-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
87976,6m3m,DB13155,-8.0,Esculin,XHCADAYNFIFUHF-TVKJYDDYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
62145,6crv,DB13165,-8.0,Ripasudil,QSKQVZWVLOIIEV-NSHDSACASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
147269,6w9q,DB11691,-8.0,Naldemedine,AXQACEQYCPKDMV-RZAWKFBISA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
88012,6m3m,DB13227,-8.0,Tribenoside,ULLNJSBQMBKOJH-VIVFLBMVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
147270,6w9q,DB11692,-8.0,Pavinetant,QYTBBBAHNIWFOD-NRFANRHFSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
88045,6m3m,DB13275,-8.0,Clorindione,NJDUWAXIURWWLN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
147276,6w9q,DB11701,-8.0,Amenamevir,MNHNIVNAFBSLLX-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
147289,6w9q,DB11725,-8.0,Latrepirdine,JNODQFNWMXFMEV-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
88069,6m3m,DB13309,-8.0,Benproperine,JTUQXGZRVLWBCR-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
147312,6w9q,DB11759,-8.0,Pevonedistat,MPUQHZXIXSTTDU-QXGSTGNESA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
146836,6w9q,DB09047,-8.0,Finafloxacin,FYMHQCNFKNMJAV-HOTGVXAUSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
131071,6w4h,DB13252,-8.0,Tropatepine,JOQKFRLFXDPXHX-HDICACEKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131087,6w4h,DB13276,-8.0,Idanpramine,HVYGXNYMNHSBGD-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131113,6w4h,DB13312,-8.0,Delapril,WOUOLAUOZXOLJQ-MBSDFSHPSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
146447,6w9q,DB08539,-8.0,"3-cyclopropyl-5-phenyl-N-(pyridin-3-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",CCDIUVLNHCGSMH-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
87526,6m3m,DB12442,-8.0,Alvespimycin,KUFRQPKVAWMTJO-LMZWQJSESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87529,6m3m,DB12445,-8.0,Nitroaspirin,IOJUJUOXKXMJNF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
131615,6w4h,DB14054,-8.0,Asiatic acid,JXSVIVRDWWRQRT-UYDOISQJSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131608,6w4h,DB14035,-8.0,Englitazone,MVDXXGIBARMXSA-PYUWXLGESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
146484,6w9q,DB08584,-8.0,"6-{[6-(1-methyl-1H-pyrazol-4-yl)[1,2,4]triazolo[4,3-b]pyridazin-3-yl]sulfanyl}quinoline",BCZUAADEACICHN-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
146489,6w9q,DB08591,-8.0,"5-(4-METHOXYBIPHENYL-3-YL)-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDE",IGXKSKWHHHYBFM-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
87554,6m3m,DB12482,-8.0,Acotiamide,TWHZNAUBXFZMCA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
62526,6crv,DB13692,-8.0,Tretoquinol,RGVPOXRFEPSFGH-AWEZNQCLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
131550,6w4h,DB13930,-8.0,Ulixertinib,KSERXGMCDHOLSS-LJQANCHMSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
146582,6w9q,DB08707,-8.0,"4-[3-(4-chlorophenyl)-2,1-benzisoxazol-5-yl]pyrimidin-2-amine",AQVFETGXIRKVAQ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
62520,6crv,DB13684,-8.0,Omoconazole,JMFOSJNGKJCTMJ-ZHZULCJRSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
146612,6w9q,DB08738,-8.0,1-{3-oxo-3-[(2S)-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]propyl}-3-phenylquinoxalin-2(1H)-one,KWCKZIJGKMCYCI-QFIPXVFZSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
62955,6crv,DB14799,-8.0,PF-06821497,RXCVUHMIWHRLDF-HXUWFJFHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62509,6crv,DB13673,-8.0,Bekanamycin,SKKLOUVUUNMCJE-FQSMHNGLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
131308,6w4h,DB13571,-8.0,Pentamycin,AGJUUQSLGVCRQA-SWOUQTJZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
146629,6w9q,DB08755,-8.0,N-[(1S)-2-{[(1R)-2-(benzyloxy)-1-cyano-1-methylethyl]amino}-1-(cyclohexylmethyl)-2-oxoethyl]morpholine-4-carboxamide,MQWUTQCRGGBPBT-WIOPSUGQSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
131258,6w4h,DB13501,-8.0,Bendazac,BYFMCKSPFYVMOU-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131251,6w4h,DB13491,-8.0,Fluperolone,SLVCCRYLKTYUQP-DVTGEIKXSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131245,6w4h,DB13484,-8.0,Quinbolone,IUVKMZGDUIUOCP-BTNSXGMBSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
146728,6w9q,DB08896,-8.0,Regorafenib,FNHKPVJBJVTLMP-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
146783,6w9q,DB08974,-8.0,Flubendazole,CPEUVMUXAHMANV-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
87651,6m3m,DB12641,-8.0,Tedatioxetine,CVASBKDYSQKLSO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
131188,6w4h,DB13407,-8.0,Nifenazone,BRZANEXCSZCZCI-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131183,6w4h,DB13399,-8.0,Terguride,JOAHPSVPXZTVEP-YXJHDRRASA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131165,6w4h,DB13371,-8.0,Difenpiramide,PWHROYKAGRUWDQ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
87659,6m3m,DB12654,-8.0,GSK-376501,OIDYMQICWGYEDR-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
131126,6w4h,DB13327,-8.0,Picotamide,KYWCWBXGRWWINE-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
62492,6crv,DB13653,-8.0,Lorcainide,XHOJAWVAWFHGHL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62958,6crv,DB14808,-8.0,Lumicitabine,MJVKYGMNSQJLIN-KYZVSKTDSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
145662,6w9q,DB07615,-8.0,Tranilast,NZHGWWWHIYHZNX-CSKARUKUSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
145659,6w9q,DB07612,-8.0,6-(3-AMINOPHENYL)-N-(TERT-BUTYL)-2-(TRIFLUOROMETHYL)QUINAZOLIN-4-AMINE,XQKJVNGGVLHNLA-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
86180,6m3m,DB08535,-8.0,"3-bromo-5-phenyl-N-(pyridin-3-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",SMIZFGZXFDGISG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86205,6m3m,DB08564,-8.0,(2E)-N-{4-[(3-bromophenyl)amino]quinazolin-6-yl}-4-(dimethylamino)but-2-enamide,ZCIXBBSRVLSRJQ-QPJJXVBHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86246,6m3m,DB08614,-8.0,"3-[[(METHYLAMINO)SULFONYL]AMINO]-2-OXO-6-PHENYL-N-[3,3,3-TRIFLUORO-1-(1-METHYLETHYL)-2-OXOPHENYL]-1(2H)-PYRIDINE ACETAMIDE",MYFMPKCOIMRDDD-KRWDZBQOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86252,6m3m,DB08622,-8.0,"4-(4-CHLORO-PHENYL)-1-{3-[2-(4-FLUORO-PHENYL)-[1,3]DITHIOLAN-2-YL]-PROPYL}-PIPERIDIN-4-OL",KVDKNVPAAQKHKD-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
132729,6w9c,DB00783,-8.0,Estradiol,VOXZDWNPVJITMN-ZBRFXRBCSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
63417,6lxt,DB00251,-8.0,Terconazole,BLSQLHNBWJLIBQ-OZXSUGGESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
132716,6w9c,DB00767,-8.0,Benzquinamide,JSZILQVIPPROJI-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
86325,6m3m,DB08713,-8.0,"2,6-DIMETHYL-1-(3-[3-METHYL-5-ISOXAZOLYL]-PROPANYL)-4-[2N-METHYL-2H-TETRAZOL-5-YL]-PHENOL",RVZKQTQAFHEOKT-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
63294,6crv,DB13983,-8.0,"5,7,2'-trihydroxy-6,8-dimethoxyflavone",JWOKGWICZPPYPX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86327,6m3m,DB08715,-8.0,"2,6-DIMETHYL-1-(3-[3-METHYL-5-ISOXAZOLYL]-PROPANYL)-4-[2-METHYL-4-ISOXAZOLYL]-PHENOL",SLPKYEWAKMNCPT-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86340,6m3m,DB08729,-8.0,"5-ethoxy-4-(1-methyl-7-oxo-3-propyl-6,7-dihydro-1H-pyrazolo[4,3-d]pyrimidin-5-yl)thiophene-2-sulfonamide",FENWRHVHBZQJGW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
143223,6w9q,DB03234,-8.0,"(4'-{[Allyl(Methyl)Amino]Methyl}-1,1'-Biphenyl-4-Yl)(4-Bromophenyl)Methanone",YATCZCSDJCQNAL-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
63274,6crv,DB02930,-8.0,Adenosine 5'-[gamma-thio]triphosphate,NLTUCYMLOPLUHL-KQYNXXCUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
132665,6w9c,DB00705,-8.0,Delavirdine,WHBIGIKBNXZKFE-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
143298,6w9q,DB03331,-8.0,"N-Naphthalen-1-Ylmethyl-2'-[3,5-Dimethoxybenzamido]-2'-Deoxy-Adenosine",OARVXDFNTLYMCJ-JVUUKAHWSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
143303,6w9q,DB03337,-8.0,1-(2-Amidinophenyl)-3-(Phenoxyphenyl)Urea,ZHCAYBOLUMAUQX-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
86394,6m3m,DB08788,-8.0,"3,6-DIAMINO-5-CYANO-4-(4-ETHOXYPHENYL)THIENO[2,3-B]PYRIDINE-2-CARBOXAMIDE",UOPQHPBCVYHSFF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
132647,6w9c,DB00686,-8.0,Pentosan Polysulfate,FCCNSUIJIOOXEZ-SJYYZXOBSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
132644,6w9c,DB00682,-8.0,Warfarin,PJVWKTKQMONHTI-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
132622,6w9c,DB00656,-8.0,Trazodone,PHLBKPHSAVXXEF-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
86459,6m3m,DB08883,-8.0,Perampanel,PRMWGUBFXWROHD-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86463,6m3m,DB08893,-8.0,Mirabegron,PBAPPPCECJKMCM-IBGZPJMESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
143799,6w9q,DB04014,-8.0,Alsterpaullone,OLUKILHGKRVDCT-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
143839,6w9q,DB04071,-8.0,Cpad,LFERELMXERXKKQ-KMXXXSRASA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
132601,6w9c,DB00628,-8.0,Clorazepic acid,XDDJGVMJFWAHJX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
144091,6w9q,DB04408,-8.0,Ncs-Chromophore,QZGIWPZCWHMVQL-UIYAJPBUSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
132596,6w9c,DB00622,-8.0,Nicardipine,ZBBHBTPTTSWHBA-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
63655,6lxt,DB00543,-8.0,Amoxapine,QWGDMFLQWFTERH-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
132820,6w9c,DB00886,-8.0,Omapatrilat,LVRLSYPNFFBYCZ-VGWMRTNUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
86152,6m3m,DB08502,-8.0,Capravirine,YQXCVAGCMNFUMQ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
63720,6lxt,DB00620,-8.0,Triamcinolone,GFNANZIMVAIWHM-OBYCQNJPSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
85874,6m3m,DB08158,-8.0,"2,4-DINITROPHENYL 2-DEOXY-2-FLUORO-BETA-D-MANNOPYRANOSIDE",UFSBFVZQJZMIOU-IYKVGLELSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
64388,6lxt,DB01469,-8.0,Acetorphine,LFYBMMHFJIAKFE-PMEKXCSPSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
64378,6lxt,DB01459,-8.0,Bezitramide,FLKWNFFCSSJANB-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
85908,6m3m,DB08198,-8.0,"[(4R)-4-(3-HYDROXYPHENYL)-1,6-DIMETHYL-2-THIOXO-1,2,3,4-TETRAHYDROPYRIMIDIN-5-YL](PHENYL)METHANONE",JGBBILLMZPWNFU-QGZVFWFLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
133063,6w9c,DB01166,-8.0,Cilostazol,RRGUKTPIGVIEKM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
64322,6lxt,DB01384,-8.0,Paramethasone,MKPDWECBUAZOHP-AFYJWTTESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
85975,6m3m,DB08289,-8.0,N-(PARA-GLUTARAMIDOPHENYL-ETHYL)-PIPERIDINIUM-N-OXIDE,RKJXWOJUCCBWSC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86003,6m3m,DB08320,-8.0,"DIETHYL (1R,2S,3R,4S)-5,6-BIS(4-HYDROXYPHENYL)-7-OXABICYCLO[2.2.1]HEPT-5-ENE-2,3-DICARBOXYLATE",NHKDFDHHMHBFLG-COPRSSIGSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
64241,6lxt,DB01222,-8.0,Budesonide,VOVIALXJUBGFJZ-KWVAZRHASA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
133023,6w9c,DB01120,-8.0,Gliclazide,BOVGTQGAOIONJV-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
86019,6m3m,DB08344,-8.0,4-chloro-N-(3-methoxypropyl)-N-[(3S)-1-(2-phenylethyl)piperidin-3-yl]benzamide,OOUGHDJEJNMXSV-QHCPKHFHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86023,6m3m,DB08348,-8.0,"N-2-,N-2-DIMETHYL-N-1-(6-OXO-5,6-DIHYDROPHENANTHRIDIN-2-YL)GLYCINAMIDE",UYJZZVDLGDDTCL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
64188,6lxt,DB01165,-8.0,Ofloxacin,GSDSWSVVBLHKDQ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
86491,6m3m,DB08940,-8.0,Kebuzone,LGYTZKPVOAIUKX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
142656,6w9q,DB02483,-8.0,Etheno-Nad,JCDBQDNBEQHDHK-BSLNIGMPSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
86042,6m3m,DB08369,-8.0,1-(biphenyl-4-ylmethyl)-1H-imidazole,DLYMRVCQTVOYEW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
64050,6lxt,DB01006,-8.0,Letrozole,HPJKCIUCZWXJDR-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
63978,6lxt,DB00921,-8.0,Buprenorphine,RMRJXGBAOAMLHD-IHFGGWKQSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
86070,6m3m,DB08403,-8.0,METHYLAMINO-PHENYLALANYL-LEUCYL-HYDROXAMIC ACID,MOPRTFSMCQNUCT-CABCVRRESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86078,6m3m,DB08414,-8.0,"6-CHLORO-2-(1-FURO[2,3-C]PYRIDIN-5-YL-ETHYLSULFANYL)-PYRIMIDIN-4-YLAMINE",ATCRIOJPQXDFNY-ZETCQYMHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
63908,6lxt,DB00844,-8.0,Nalbuphine,NETZHAKZCGBWSS-CEDHKZHLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
86095,6m3m,DB08436,-8.0,"8-BENZO[1,3]DIOXOL-,5-YLMETHYL-9-BUTYL-9H-",JCDXXNIRWRRGBX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
142763,6w9q,DB02621,-8.0,Latrunculin A,DDVBPZROPPMBLW-IZGXTMSKSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
86112,6m3m,DB08457,-8.0,"4-(3,5-DIMETHYLPHENOXY)-5-(FURAN-2-YLMETHYLSULFANYLMETHYL)-3-IODO-6-METHYLPYRIDIN-2(1H)-ONE",YZLKVEDFWLGNQP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
132882,6w9c,DB00956,-8.0,Hydrocodone,LLPOLZWFYMWNKH-CMKMFDCUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
86120,6m3m,DB08465,-8.0,"2-(3-AMINO-2,5,6-TRIMETHOXYPHENYL)ETHYL 5-CHLORO-2,4-DIHYDROXYBENZOATE",DFYGLJKFZQGYPA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
142952,6w9q,DB02873,-8.0,"1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperazin-1-Yl-3,4-Dihydroquinazolin-2(1h)-One",YAWZIQKDHQIHOS-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
63759,6lxt,DB00670,-8.0,Pirenzepine,RMHMFHUVIITRHF-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
132986,6w9c,DB01076,-8.0,Atorvastatin,XUKUURHRXDUEBC-KAYWLYCHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
135823,6w9c,DB05197,-8.0,Sofalcone,GFWRVVCDTLRWPK-KPKJPENVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
144244,6w9q,DB04608,-8.0,"9-HYDROXY-4-PHENYL-6H-PYRROLO[3,4-C]CARBAZOLE-1,3-DIONE",IAUZTOZLTFSMIE-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
144318,6w9q,DB04708,-8.0,"(S)-TETRAHYDROFURAN-3-YL (2S,3S)-4-((S)-4-((1R,3R)-3-(2-AMINO-2-OXOETHYL)-2,3-DIHYDRO-1H-INDEN-1-YL)-2-BENZYL-3-OXO-2,3-DIHYDRO-1H-PYRROL-2-YL)-3-HYDROXY-1-PHENYLBUTAN-2-YLCARBAMATE",SYNSHNDQFWMLJW-YZGRCXSVSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
132374,6w9c,DB00351,-8.0,Megestrol acetate,RQZAXGRLVPAYTJ-GQFGMJRRSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
86920,6m3m,DB11491,-8.0,Sarafloxacin,XBHBWNFJWIASRO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
145064,6w9q,DB06916,-8.0,"N-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-1-[2-(1H-IMIDAZOL-1-YL)-6-METHYLPYRIMIDIN-4-YL]-D-PROLINAMIDE",LBCGUKCXRVUULK-QGZVFWFLSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
145101,6w9q,DB06963,-8.0,"3-[3-(3-methyl-6-{[(1S)-1-phenylethyl]amino}-1H-pyrazolo[4,3-c]pyridin-1-yl)phenyl]propanamide",ZFGCLYUGFRNYFE-INIZCTEOSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
86934,6m3m,DB11537,-8.0,Pirlimycin,HBJOXQRURQPDEX-MHXMMLMNSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
63036,6crv,DB15009,-8.0,PF-04937319,MASKQITXHVYVFL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86936,6m3m,DB11541,-8.0,Ractopamine,YJQZYXCXBBCEAQ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
145170,6w9q,DB07041,-8.0,"N-[2-(2,4-diaminopyrido[2,3-d]pyrimidin-7-yl)-2-methylpropyl]-4-phenoxybenzamide",FDJWFDQRPKKBFA-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
145258,6w9q,DB07142,-8.0,"5-[(3R)-3-(5-methoxy-3',5'-dimethylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",ATFDKOLABYIYCC-INIZCTEOSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
132332,6w9c,DB00298,-8.0,Dapiprazole,RFWZESUMWJKKRN-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
63014,6crv,DB14932,-8.0,Coleneuramide,CHMRTBYTCBDIRG-JQZMMWJVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
145303,6w9q,DB07193,-8.0,"(2R,3R)-7-(methylsulfonyl)-3-(2,4,5-trifluorophenyl)-1,2,3,4-tetrahydropyrido[1,2-a]benzimidazol-2-amine",HJJAYSSCWGUPKO-ABAIWWIYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
63011,6crv,DB14924,-8.0,PF-06651600,CBRJPFGIXUFMTM-WDEREUQCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
145325,6w9q,DB07220,-8.0,"N-[5-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-1H-INDAZOL-3-YL]-2-(4-PIPERIDIN-1-YLPHENYL)ACETAMIDE",ZXYIRNXOAJYLCU-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
145329,6w9q,DB07226,-8.0,"N-[4-(2-CHLOROPHENYL)-1,3-DIOXO-1,2,3,6-TETRAHYDROPYRROLO[3,4-C]CARBAZOL-9-YL]FORMAMIDE",JWZVNUNTFNELHL-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
132280,6w9c,DB00239,-8.0,Oxiconazole,QRJJEGAJXVEBNE-HKOYGPOVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
132268,6w9c,DB00227,-8.0,Lovastatin,PCZOHLXUXFIOCF-BXMDZJJMSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
145390,6w9q,DB07294,-8.0,"3-fluoro-4-[2-hydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8,-tetrahydro-naphtalen-2-yl)-acetylamino]-benzoic acid",AANFHDFOMFRLLR-IBGZPJMESA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
132259,6w9c,DB00216,-8.0,Eletriptan,PWVXXGRKLHYWKM-LJQANCHMSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
145418,6w9q,DB07324,-8.0,"3-({2-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)ETHYNYL]BENZYL}AMINO)-1,3-OXAZOL-2(3H)-ONE",ZUJWSOPIDUWELP-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
87020,6m3m,DB11711,-8.0,Navarixin,IXBYSXNOKFHHDR-QGZVFWFLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87023,6m3m,DB11718,-8.0,Encorafenib,CMJCXYNUCSMDBY-ZDUSSCGKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
145445,6w9q,DB07354,-8.0,"2,3-DIMETHOXY-12H-[1,3]DIOXOLO[5,6]INDENO[1,2-C]ISOQUINOLIN-6-IUM",LXDREMZQGAILJU-UHFFFAOYSA-O,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
132221,6w9c,DB00171,-8.0,ATP,ZKHQWZAMYRWXGA-KQYNXXCUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
87046,6m3m,DB11753,-8.0,Rifamycin,HJYYPODYNSCCOU-ODRIEIDWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
145513,6w9q,DB07435,-8.0,"1,2,3-TRIHYDROXY-1,2,3,4-TETRAHYDROBENZO[A]PYRENE",GFANZDFKCCJYRF-NSISKUIASA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
132097,6w4h,DB15377,-8.0,ATB-346,YCNMAPLPQYQJFC-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
63062,6crv,DB15058,-8.0,Flutemetamol,VVECGOCJFKTUAX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
132378,6w9c,DB00355,-8.0,Aztreonam,WZPBZJONDBGPKJ-VEHQQRBSSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
86815,6m3m,DB11226,-8.0,Ethylhexyl methoxycrylene,WAJCJDLRJVDSSD-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
144846,6w9q,DB06543,-8.0,Astaxanthin,MQZIGYBFDRPAKN-UWFIBFSHSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
144329,6w9q,DB04724,-8.0,"(S)-2-((S)-3-ISOBUTYL-2,5-DIOXO-4-QUINOLIN-3-YLMETHYL-[1,4]DIAZEPAN-1YL)-N-METHYL-3-NAPHTALEN-2-YL-PROPIONAMIDE",COVPLULNDBDXTN-KYJUHHDHSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
86563,6m3m,DB09021,-8.0,Benzoctamine,GNRXCIONJWKSEA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
144427,6w9q,DB04852,-8.0,Implitapide,AMNXBQPRODZJQR-DITALETJSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
132548,6w9c,DB00564,-8.0,Carbamazepine,FFGPTBGBLSHEPO-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
132523,6w9c,DB00535,-8.0,Cefdinir,RTXOFQZKPXMALH-GHXIOONMSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
86597,6m3m,DB09083,-8.0,Ivabradine,ACRHBAYQBXXRTO-OAQYLSRUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
144484,6w9q,DB04960,-8.0,Tipifarnib,PLHJCIYEEKOWNM-HHHXNRCGSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
132514,6w9c,DB00524,-8.0,Metolazone,AQCHWTWZEMGIFD-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
132502,6w9c,DB00504,-8.0,Levallorphan,OZYUPQUCAUTOBP-QXAKKESOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
144518,6w9q,DB05129,-8.0,Elsamitrucin,MGQRRMONVLMKJL-KWJIQSIXSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
144529,6w9q,DB05220,-8.0,Alisertib,ZLHFILGSQDJULK-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
132481,6w9c,DB00480,-8.0,Lenalidomide,GOTYRUGSSMKFNF-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
132472,6w9c,DB00470,-8.0,Dronabinol,CYQFCXCEBYINGO-IAGOWNOFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
144304,6w9q,DB04689,-8.0,2-{5-[3-(6-BENZOYL-1-PROPYLNAPHTHALEN-2-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID,ZXWVCCFKIRBLDP-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
132463,6w9c,DB00457,-8.0,Prazosin,IENZQIKPVFGBNW-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
144702,6w9q,DB06178,-8.0,Talotrexin,NYQPLPNEESYGNO-IBGZPJMESA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
86726,6m3m,DB09286,-8.0,Pipamperone,AXKPFOAXAHJUAG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86728,6m3m,DB09289,-8.0,Tianeptine,JICJBGPOMZQUBB-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
144765,6w9q,DB06314,-8.0,SGX-523,BCZUAADEACICHN-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
86764,6m3m,DB09421,-8.0,Protirelin,XNSAINXGIQZQOO-SRVKXCTJSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
144798,6w9q,DB06429,-8.0,Talnetant,BIAVGWDGIJKWRM-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
132415,6w9c,DB00400,-8.0,Griseofulvin,DDUHZTYCFQRHIY-RBHXEPJQSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
144807,6w9q,DB06448,-8.0,Lonafarnib,DHMTURDWPRKSOA-RUZDIDTESA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
86788,6m3m,DB11096,-8.0,Meradimate,SOXAGEOHPCXXIO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86792,6m3m,DB11115,-8.0,Ensulizole,UVCJGUGAGLDPAA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86795,6m3m,DB11125,-8.0,Benzethonium,SIYLLGKDQZGJHK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86807,6m3m,DB11185,-8.0,Sulisobenzone,CXVGEDCSTKKODG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86813,6m3m,DB11219,-8.0,Enzacamene,HEOCBCNFKCOKBX-SDNWHVSQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
144696,6w9q,DB06163,-8.0,Plevitrexed,IEJSCSAMMLUINT-NRFANRHFSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
69743,6lxt,DB11625,-8.0,Perflenapent,NJCBUSHGCBERSK-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
140655,6w9c,DB13052,-8.0,Upamostat,HUASEDVYRABWCV-NDEPHWFRSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
83565,6m3m,DB04059,-8.0,8-(Pyrimidin-2-Ylamino)Naphthalene-2-Carboximidamide,GRQLDCHTDNYVQI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
74349,6m2n,DB03234,-8.0,"(4'-{[Allyl(Methyl)Amino]Methyl}-1,1'-Biphenyl-4-Yl)(4-Bromophenyl)Methanone",YATCZCSDJCQNAL-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138190,6w9c,DB09304,-8.0,Setiptiline,GVPIXRLYKVFFMK-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139821,6w9c,DB14059,-8.0,SC-236,NSQNZEUFHPTJME-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138180,6w9c,DB09285,-8.0,Morniflumate,LDXSPUSKBDTEKA-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139839,6w9c,DB14086,-8.0,Cianidanol,PFTAWBLQPZVEMU-DZGCQCFKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
74205,6m2n,DB03046,-8.0,7-Methoxy-8-[1-(Methylsulfonyl)-1h-Pyrazol-4-Yl]Naphthalene-2-Carboximidamide,KQUXAFOLFXHVQN-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
139890,6w9c,DB14208,-8.0,Ramiprilat,KEDYTOTWMPBSLG-HILJTLORSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
74173,6m2n,DB02998,-8.0,Metribolone,CCCIJQPRIXGQOE-XWSJACJDSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
74100,6m2n,DB02901,-8.0,Stanolone,NVKAWKQGWWIWPM-ABEVXSGRSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138063,6w9c,DB09097,-8.0,Quinagolide,GDFGTRDCCWFXTG-ZIFCJYIRSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
74064,6m2n,DB02854,-8.0,Aetiocholanolone,QGXBDMJGAMFCBF-BNSUEQOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138042,6w9c,DB09070,-8.0,Tibolone,WZDGZWOAQTVYBX-XOINTXKNSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138038,6w9c,DB09063,-8.0,Ceritinib,VERWOWGGCGHDQE-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
78633,6m2n,DB12045,-8.0,Mericitabine,MLESJYFEMSJZLZ-MAAOGQSESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78655,6m2n,DB12078,-8.0,Enobosarm,JNGVJMBLXIUVRD-SFHVURJKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138024,6w9c,DB09038,-8.0,Empagliflozin,OBWASQILIWPZMG-QZMOQZSNSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
74012,6m2n,DB02789,-8.0,Pregnenolone,ORNBQBCIOKFOEO-QGVNFLHTSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138012,6w9c,DB09015,-8.0,Canrenoic acid,PBKZPPIHUVSDNM-WNHSNXHDSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139910,6w9c,DB14538,-8.0,Hydrocortisone aceponate,MFBMYAOAMQLLPK-FZNHGJLXSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137946,6w9c,DB08940,-8.0,Kebuzone,LGYTZKPVOAIUKX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
78744,6m2n,DB12210,-8.0,AZD-6280,NVWCZRPXYVDQEE-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
73889,6m2n,DB02621,-8.0,Latrunculin A,DDVBPZROPPMBLW-IZGXTMSKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78758,6m2n,DB12229,-8.0,Cerlapirdine,NXQGEDVQXVTCDA-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78767,6m2n,DB12239,-8.0,Balicatib,LLCRBOWRJOUJAE-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
73878,6m2n,DB02607,-8.0,Adenosine Phosphonoacetic Acid,KJNLSEOJEFDELT-JJNLEZRASA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
73869,6m2n,DB02595,-8.0,Bulgecin A,RPNZWZDLNYCCIG-HMMVDTEZSA-O,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78775,6m2n,DB12251,-8.0,Moxaverine,MYCMTMIGRXJNSO-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138315,6w9c,DB11385,-8.0,Cefalonium,FMZXNVLFJHCSAF-DNVCBOLYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
78786,6m2n,DB12268,-8.0,Carmegliptin,GUYMHFIHHOEFOA-ZCPGHIKRSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138321,6w9c,DB11393,-8.0,Danofloxacin,QMLVECGLEOSESV-RYUDHWBXSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139797,6w9c,DB14008,-8.0,Hispidulin,IHFBPDAQLQOCBX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
78026,6m2n,DB09173,-8.0,Butyrfentanyl,QQOMYEQLWQJRKK-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
74860,6m2n,DB03926,-8.0,"5-Alpha-Androstane-3-Beta,17-Alpha-Diol",CBMYJHIOYJEBSB-MFXFBURESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
139719,6w9c,DB13844,-8.0,Pipenzolate,WPUKUEMZZRVAKZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138485,6w9c,DB11736,-8.0,PF-00489791,ZUHZNKJIJDAJFD-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138479,6w9c,DB11726,-8.0,Encenicline,SSRDSYXGYPJKRR-ZDUSSCGKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
78104,6m2n,DB09268,-8.0,Picosulfuric acid,UJIDKYTZIQTXPM-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138470,6w9c,DB11706,-8.0,Raxatrigine,JESCETIFNOFKEU-SJORKVTESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
78240,6m2n,DB11366,-8.0,Roquinimex,SGOOQMRIPALTEL-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78255,6m2n,DB11393,-8.0,Danofloxacin,QMLVECGLEOSESV-RYUDHWBXSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
74685,6m2n,DB03708,-8.0,Adenosine 5'-phosphosulfate,IRLPACMLTUPBCL-KQYNXXCUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
74676,6m2n,DB03695,-8.0,Piritrexim,VJXSSYDSOJBUAV-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
74611,6m2n,DB03601,-8.0,5-deoxyflavanone,FURUXTVZLHCCNA-AWEZNQCLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78318,6m2n,DB11520,-8.0,Hygromycin B,GRRNUXAQVGOGFE-HUCHGKBZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
139764,6w9c,DB13944,-8.0,Testosterone enanthate,VOCBWIIFXDYGNZ-IXKNJLPQSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
74567,6m2n,DB03532,-8.0,Phosphomethylphosphonic Acid Guanylate Ester,GXTIEXDFEKYVGY-KQYNXXCUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78355,6m2n,DB11629,-8.0,Laropiprant,NXFFJDQHYLNEJK-CYBMUJFWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
74556,6m2n,DB03515,-8.0,Equilenin,PDRGHUMCVRDZLQ-WMZOPIPTSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78364,6m2n,DB11648,-8.0,Afuresertib,AFJRDFWMXUECEW-LBPRGKRZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78407,6m2n,DB11706,-8.0,Raxatrigine,JESCETIFNOFKEU-SJORKVTESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
74518,6m2n,DB03464,-8.0,Formycin-5'-Monophosphate,PBAHXXBYQACZMA-KSYZLYKTSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78412,6m2n,DB11718,-8.0,Encorafenib,CMJCXYNUCSMDBY-ZDUSSCGKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
74491,6m2n,DB03421,-8.0,"2-Phenethyl-2,3-Dihydro-Phthalazine-1,4-Dione",JSSVIGGKHIJEHO-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
74488,6m2n,DB03417,-8.0,1-(4-Tert-Butylcarbamoyl-Piperazine-1-Carbonyl)-3-(3-Guanidino-Propyl)-4-Oxo-Azetidine-2-Carboxylic Acid,BVNQCAHTTOIOEK-STQMWFEESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78437,6m2n,DB11757,-8.0,Istradefylline,IQVRBWUUXZMOPW-PKNBQFBNSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78458,6m2n,DB11787,-8.0,Ralimetinib,XPPBBJCBDOEXDN-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138339,6w9c,DB11427,-8.0,Maropitant,OMPCVMLFFSQFIX-CONSDPRKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
78470,6m2n,DB11801,-8.0,Rapastinel,GIBQQARAXHVEGD-BSOLPCOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
139804,6w9c,DB14025,-8.0,Clinafloxacin,QGPKADBNRMWEQR-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
78828,6m2n,DB12319,-8.0,Benzbromarone,WHQCHUCQKNIQEC-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137871,6w9c,DB08811,-8.0,Tofisopam,RUJBDQSFYCKFAA-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137855,6w9c,DB08795,-8.0,Azidocillin,ODFHGIPNGIAMDK-NJBDSQKTSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
79134,6m2n,DB12787,-8.0,Norethandrolone,ZDHCJEIGTNNEMY-XGXHKTLJSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
73261,6m2n,DB01793,-8.0,SB-409513,ONVZFCHLOZUXRP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79142,6m2n,DB12802,-8.0,Picropodophyllin,YJGVMLPVUAXIQN-HAEOHBJNSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79144,6m2n,DB12804,-8.0,Daniquidone,SRIOCKJKFXAKHK-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137595,6w9c,DB08490,-8.0,CTS-1027,ROSNVSQTEGHUKU-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
79165,6m2n,DB12840,-8.0,Pirnabine,AADNQNOXNWEYHS-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137572,6w9c,DB08462,-8.0,N-(4-PHENYLAMINO-QUINAZOLIN-6-YL)-ACRYLAMIDE,JGWHILNNHLDARR-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
73197,6m2n,DB01708,-8.0,Prasterone,FMGSKLZLMKYGDP-USOAJAOKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
73184,6m2n,DB01691,-8.0,Indole Naphthyridinone,VAZMNDXVXVUKFY-JXMROGBWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
73182,6m2n,DB01689,-8.0,Inhibitor Idd 384,CJKKMQCZOLCXAM-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79201,6m2n,DB12896,-8.0,PSI-352938,PVRFQJIRERYGTQ-DSQUMVBZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79217,6m2n,DB12921,-8.0,Chlorsulfaquinoxaline,CTSNHMQGVWXIEG-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
73151,6m2n,DB01645,-8.0,Genistein,TZBJGXHYKVUXJN-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
73112,6m2n,DB01602,-8.0,Bacampicillin,PFOLLRNADZZWEX-FFGRCDKISA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79264,6m2n,DB12989,-8.0,Neosaxitoxin,PPEKGEBBBBNZKS-HGRQIUPRSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79271,6m2n,DB13004,-8.0,Mavoglurant,ZFPZEYHRWGMJCV-ZHALLVOQSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
73087,6m2n,DB01567,-8.0,Fludiazepam,ROYOYTLGDLIGBX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
73074,6m2n,DB01554,-8.0,Bolandiol,CMXKUJNZWYTFJN-XFUVECHXSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
73065,6m2n,DB01545,-8.0,Ethyl loflazepate,CUCHJCMWNFEYOM-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
73063,6m2n,DB01543,-8.0,18-methyl-19-nortestosterone,FBYZQDCRLYHHHP-ZOFHRBRSSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
73061,6m2n,DB01541,-8.0,Boldenone,RSIHSRDYCUFFLA-DYKIIFRCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
73058,6m2n,DB01538,-8.0,Acetyldihydrocodeine,LGGDXXJAGWBUSL-BKRJIHRRSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137506,6w9c,DB08383,-8.0,"4,5-bis(4-methoxyphenyl)-2-thiophen-2-yl-1H-imidazole",XBMULXNXJLWLLD-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140038,6w9c,DB14808,-8.0,Lumicitabine,MJVKYGMNSQJLIN-KYZVSKTDSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
73034,6m2n,DB01512,-8.0,Hydromorphinol,AABLHGPVOULICI-BRJGLHKUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
73014,6m2n,DB01485,-8.0,4-Hydroxytestosterone,BQOIJSIMMIDHMO-FBPKJDBXSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
73006,6m2n,DB01476,-8.0,Haloxazolam,XDKCGKQHVBOOHC-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79129,6m2n,DB12779,-8.0,Higenamine,WZRCQWQRFZITDX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137617,6w9c,DB08514,-8.0,"6-amino-2-[(thiophen-2-ylmethyl)amino]-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",IQKMJWDYMFWZRF-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
73316,6m2n,DB01865,-8.0,3-(6-Aminopyridin-3-Yl)-N-Methyl-N-[(1-Methyl-1h-Indol-2-Yl)Methyl]Acrylamide,AKFPMLBVLWZSQX-CSKARUKUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
73319,6m2n,DB01871,-8.0,[1-(1-Benzyl-3-Hydroxy-2-Oxo-Propylcarbamoyl)-2-Phenyl-Ethyl]-Carbamic Acid Benzyl Ester,OACUXIVGLLCILS-ZEQRLZLVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
73757,6m2n,DB02450,-8.0,"2-Benzo[1,3]Dioxol-5-Ylmethyl-3-Benzyl-Succinic Acid",ASEJDWRSZYAIOT-GJZGRUSLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137833,6w9c,DB08770,-8.0,"4-{2-[(7-amino-2-furan-2-yl[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-yl)amino]ethyl}phenol",PWTBZOIUWZOPFT-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
73739,6m2n,DB02424,-8.0,Geldanamycin,QTQAWLPCGQOSGP-KSRBKZBZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137828,6w9c,DB08763,-8.0,[N-(BENZYLOXYCARBONYL)AMINO](4-AMIDINOPHENYL)METHANE-PHOSPHONATE,FSNDLCSOLUMYRH-OAHLLOKOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137820,6w9c,DB08754,-8.0,"(2E)-3-(3,4-DIHYDROXYPHENYL)-N-[2-(4-HYDROXYPHENYL)ETHYL]ACRYLAMIDE",VSHUQLRHTJOKTA-XBXARRHUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137819,6w9c,DB08753,-8.0,"4-{(1E)-3-OXO-3-[(2-PHENYLETHYL)AMINO]PROP-1-EN-1-YL}-1,2-PHENYLENE DIACETATE",GARHCDOTUULBOQ-PKNBQFBNSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
73670,6m2n,DB02342,-8.0,2-Methox1tradiol,CQOQDQWUFQDJMK-SSTWWWIQSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
139953,6w9c,DB14644,-8.0,Methylprednisolone hemisuccinate,IMBXEJJVJRTNOW-XYMSELFBSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
73632,6m2n,DB02292,-8.0,Irosustat,DSLPMJSGSBLWRE-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
139962,6w9c,DB14653,-8.0,Clocortolone caproate,MMTRTBFDFNRBQO-ANHDKODLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
73589,6m2n,DB02237,-8.0,Maltotetraose,UYQJCPNSAVWAFU-KVXMBEGHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78938,6m2n,DB12476,-8.0,CPG-52852,YZOQZEXYFLXNKA-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
73537,6m2n,DB02166,-8.0,Propidium,ZDWVWKDAWBGPDN-UHFFFAOYSA-O,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78024,6m2n,DB09171,-8.0,??-Methylfentanyl,UXIGUKSHASXDNI-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79006,6m2n,DB12580,-8.0,Tradipitant,CAVRKWRKTNINFF-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79019,6m2n,DB12604,-8.0,Sisomicin,URWAJWIAIPFPJE-YFMIWBNJSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137681,6w9c,DB08591,-8.0,"5-(4-METHOXYBIPHENYL-3-YL)-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDE",IGXKSKWHHHYBFM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
73427,6m2n,DB02021,-8.0,Fidarestat,WAAPEIZFCHNLKK-UFBFGSQYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137662,6w9c,DB08569,-8.0,"3-PYRIDIN-4-YL-2,4-DIHYDRO-INDENO[1,2-.C.] PYRAZOLE",VLPMRZSKJUTRBQ-IBGZPJMESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
79053,6m2n,DB12661,-8.0,Urapidil,ICMGLRUYEQNHPF-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
73396,6m2n,DB01977,-8.0,6-(N-Phenylcarbamyl)-2-Naphthalenecarboxamidine,AECPTICWHONWNW-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79061,6m2n,DB12670,-8.0,Rolofylline,PJBFVWGQFLYWCB-QUYAXPHCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79063,6m2n,DB12672,-8.0,Icaritin,TUUXBSASAQJECY-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79072,6m2n,DB12687,-8.0,Vesatolimod,VFOKSTCIRGDTBR-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137653,6w9c,DB08556,-8.0,"5'-ACETYL-4-{[(2,4-DIMETHYLPHENYL)SULFONYL]AMINO}-2,2'-BITHIOPHENE-5-CARBOXYLIC ACID",CMHHNHDPPWDNAH-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137641,6w9c,DB08542,-8.0,"3,4-dihydroxy-9,10-secoandrosta-1(10),2,4-triene-9,17-dione",YUHVBHDSVLKFNI-NJSLBKSFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140001,6w9c,DB14725,-8.0,Cefamandole nafate,RRJHESVQVSRQEX-SUYBPPKGSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137630,6w9c,DB08530,-8.0,"7-BENZYL-1,3-DIMETHYL-8-PIPERAZIN-1-YL-3,7-DIHYDRO-PURINE-2,6-DIONE",QFSMMXJBEBXTJP-UHFFFAOYSA-O,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
79010,6m2n,DB12588,-8.0,AZD-1480,PDOQBOJDRPLBQU-QMMMGPOBSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
139712,6w9c,DB13837,-8.0,Doxefazepam,VOJLELRQLPENHL-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
78007,6m2n,DB09124,-8.0,Medrogestone,HCFSGRMEEXUOSS-JXEXPEPMSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138499,6w9c,DB11755,-8.0,Tetrahydrocannabivarin,ZROLHBHDLIHEMS-HUUCEWRRSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139221,6w9c,DB13155,-8.0,Esculin,XHCADAYNFIFUHF-TVKJYDDYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
75888,6m2n,DB06309,-8.0,Refametinib,RDSACQWTXKSHJT-NSHDSACASA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75875,6m2n,DB06272,-8.0,Maxacalcitol,DTXXSJZBSTYZKE-ZDQKKZTESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75874,6m2n,DB06268,-8.0,Sitaxentan,PHWXUGHIIBDVKD-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75860,6m2n,DB06246,-8.0,Exisulind,MVGSNCBCUWPVDA-MFOYZWKCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76800,6m2n,DB07628,-8.0,"6-(2-fluorobenzyl)-2,4-dimethyl-4,6-dihydro-5H-thieno[2',3':4,5]pyrrolo[2,3-d]pyridazin-5-one",IEWYEWDDQWYJLU-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76825,6m2n,DB07655,-8.0,"3-AMINO-3-BENZYL-[4.3.0]BICYCLO-1,6-DIAZANONAN-2-ONE",MPJYGQHMIFDQIN-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75834,6m2n,DB06194,-8.0,Elocalcitol,LRLWXBHFPGSUOX-GJQYOBCGSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
139257,6w9c,DB13227,-8.0,Tribenoside,ULLNJSBQMBKOJH-VIVFLBMVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139267,6w9c,DB13242,-8.0,Bucladesine,CJGYSWNGNKCJSB-YVLZZHOMSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
76876,6m2n,DB07719,-8.0,"[(3R)-3-(Methylcarbamoyl)-2-{[(2-methyl-2-propanyl)oxy]carbonyl}-1,2,3,4-tetrahydro-7-isoquinolinyl]sulfamic acid",PPSSYXOFPICMQD-CYBMUJFWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76895,6m2n,DB07742,-8.0,"N-(2,3-DIFLUORO-BENZYL)-4-SULFAMOYL-BENZAMIDE",QASSMVGOSBNFQY-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76922,6m2n,DB07772,-8.0,"(1R)-1-{[(4'-methoxy-1,1'-biphenyl-4-yl)sulfonyl]amino}-2-methylpropylphosphonic acid",BZVYQWLRCHLAGK-QGZVFWFLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75786,6m2n,DB05969,-8.0,SNS-032,OUSFTKFNBAZUKL-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75783,6m2n,DB05959,-8.0,ENMD-1198,YQJWOUQGXATDAE-ACNBBOPNSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75765,6m2n,DB05830,-8.0,Trestolone,YSGQGNQWBLYHPE-CFUSNLFHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77018,6m2n,DB07878,-8.0,"N-[(1S)-1-{1-[(1R,3E)-1-ACETYLPENT-3-EN-1-YL]-1H-1,2,3-TRIAZOL-4-YL}-1,2-DIMETHYLPROPYL]BENZAMIDE",OEHUTYXPQSSKAK-RVLLMHTFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75722,6m2n,DB05562,-8.0,Naluzotan,SPWZXWDPAWDKQE-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75719,6m2n,DB05542,-8.0,Naronapride,VGDDOIZXGFJDRC-VJTSUQJLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77073,6m2n,DB07946,-8.0,"N-[2-({[amino(imino)methyl]amino}oxy)ethyl]-2-{6-chloro-3-[(2,2-difluoro-2-phenylethyl)amino]-2-fluorophenyl}acetamide",DZEJHPMTDNDECN-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
139363,6w9c,DB13364,-8.0,Feprazone,RBBWCVQDXDFISW-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
77099,6m2n,DB07976,-8.0,3-{[(3-FLUORO-3'-METHOXYBIPHENYL-4-YL)AMINO]CARBONYL}THIOPHENE-2-CARBOXYLIC ACID,GIUMGVUBDBDTDX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77120,6m2n,DB08000,-8.0,"2-(CARBOXYMETHYL)-1-OXO-1,2-DIHYDRONAPHTHO[1,2-D]ISOTHIAZOLE-4-CARBOXYLIC ACID 3,3-DIOXIDE",ZTJGXDGAXGWOGR-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138760,6w9c,DB12230,-8.0,Bunazosin,RHLJLALHBZGAFM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
77131,6m2n,DB08012,-8.0,(METHYLPYRIDAZINE PIPERIDINE ETHYLOXYPHENYL)ETHYLACETATE,KCHIOGFOPPOUJC-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
139392,6w9c,DB13407,-8.0,Nifenazone,BRZANEXCSZCZCI-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138759,6w9c,DB12229,-8.0,Cerlapirdine,NXQGEDVQXVTCDA-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
75902,6m2n,DB06358,-8.0,Iclaprim,HWJPWWYTGBZDEG-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76710,6m2n,DB07520,-8.0,"N-[1-(AMINOMETHYL)CYCLOPROPYL]-3-(MORPHOLIN-4-YLSULFONYL)-N-2-[(1S)-2,2,2-TRIFLUORO-1-(4-FLUOROPHENYL)ETHYL]-L-ALANINAMIDE",BJIKKEHGGYGGIX-HOTGVXAUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76702,6m2n,DB07511,-8.0,"4-(4-methyl-1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)benzonitrile",MVYDBJXCIFMINH-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76648,6m2n,DB07447,-8.0,5beta-dihydrotestosterone,NVKAWKQGWWIWPM-MISPCMORSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76266,6m2n,DB07007,-8.0,"(3R)-3-[(1,2,3,4-tetrahydroisoquinolin-7-yloxy)methyl]-2,3-dihydrothieno[2,3-f][1,4]oxazepin-5-amine",UDFXWCLBONUMNA-CYBMUJFWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76295,6m2n,DB07040,-8.0,"2-amino-7-fluoro-5-oxo-5H-chromeno[2,3-b]pyridine-3-carboxamide",GCHMLYYPYFXLQB-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76337,6m2n,DB07088,-8.0,(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclopentyloxy)ethanoyl)pyrrolidine-2-carboxamide,ZWXWAYUCJVQHOR-KRWDZBQOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76338,6m2n,DB07089,-8.0,N-[amino(imino)methyl]-2-[2-(2-chlorophenyl)-4-(4-propoxyphenyl)-3-thienyl]acetamide,VZSMTBLDWPKVRW-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76339,6m2n,DB07090,-8.0,(3S)-N-(3-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE,NJNMAZNXKKBTPS-ZDUSSCGKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76379,6m2n,DB07136,-8.0,(2S)-2-[3-(AMINOMETHYL)PHENYL]-3-{(R)-HYDROXY[(1R)-2-METHYL-1-{[(3-PHENYLPROPYL)SULFONYL]AMINO}PROPYL]PHOSPHORYL}PROPANOIC ACID,WFFOOKSVFDUPDH-FCHUYYIVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76083,6m2n,DB06766,-8.0,Alcaftadine,MWTBKTRZPHJQLH-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76412,6m2n,DB07174,-8.0,"6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-4-(3-METHOXYPROPYL)-2,2-DIMETHYL-2H-1,4-BENZOXAZIN-3(4H)-ONE",WPAPODFGOZXFLG-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76068,6m2n,DB06737,-8.0,Zaltoprofen,MUXFZBHBYYYLTH-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138983,6w9c,DB12666,-8.0,Emapunil,NBMBIEOUVBHEBM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
76465,6m2n,DB07238,-8.0,Nesbuvir,WTDWVLJJJOTABN-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76027,6m2n,DB06678,-8.0,Esmirtazapine,RONZAEMNMFQXRA-MRXNPFEDSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
139129,6w9c,DB12900,-8.0,Irdabisant,XUKROCVZGZNGSI-CQSZACIVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
77167,6m2n,DB08053,-8.0,"1-cyclobutyl-3-(3,4-dimethoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine",ITOYZJGFTNTKKR-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76017,6m2n,DB06652,-8.0,Vicriviroc,CNPVJJQCETWNEU-CYFREDJKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76494,6m2n,DB07271,-8.0,"4-[(3R)-3-Amino-4-(2,4,5-trifluorophenyl)butanoyl]-3-(2,2,2-trifluoroethyl)-1,4-diazepan-2-one",RMDAPSXWBVPVOG-IAPIXIRKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76506,6m2n,DB07284,-8.0,"N-3-(3-PYRIDIN-3-YLBENZYL)PYRIDINE-2,3-DIAMINE",NQSBHBFOOVYRNM-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76517,6m2n,DB07295,-8.0,2-[(7-HYDROXY-NAPHTHALEN-1-YL)-OXALYL-AMINO]-BENZOIC ACID,IGOULVZYQKJJKC-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75991,6m2n,DB06600,-8.0,Nemonoxacin,AVPQPGFLVZTJOR-RYUDHWBXSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
139147,6w9c,DB12927,-8.0,Theodrenaline,WMCMJIGLYZDKRN-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139150,6w9c,DB12930,-8.0,Opipramol,YNZFUWZUGRBMHL-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
75980,6m2n,DB06579,-8.0,Adipiplon,UAMAIHOEGLEXSV-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138932,6w9c,DB12582,-8.0,Piperine,MXXWOMGUGJBKIW-YPCIICBESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
75965,6m2n,DB06529,-8.0,Ocinaplon,OQJFBUOFGHPMSR-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
139157,6w9c,DB12941,-8.0,ODM-201,BLIJXOOIHRSQRB-PXYINDEMSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
76642,6m2n,DB07439,-8.0,"1-((2-HYDROXYETHOXY)METHYL)-5-(3-(BENZYLOXY)BENZYL)-6-HYDROXYPYRIMIDINE-2,4(1H,3H)-DIONE",CAWXCABXSPTFRN-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75943,6m2n,DB06471,-8.0,Naxifylline,NJYNSYQBNSDGIQ-RDDCQWBRSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76644,6m2n,DB07441,-8.0,"3-{[(9-CYANO-9,10-DIHYDRO-10-METHYLACRIDIN-9-YL)CARBONYL]AMINO}PROPANOIC ACID",FRBAOMHMZCGBOJ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138953,6w9c,DB12621,-8.0,ST-101,QZWYXEBIQWJXAR-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
72987,6m2n,DB01456,-8.0,5-androstenedione,SQGZFRITSMYKRH-QAGGRKNESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75646,6m2n,DB05137,-8.0,Lobeline,MXYUKLILVYORSK-HBMCJLEFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75639,6m2n,DB05104,-8.0,Asimadoline,JHLHNYVMZCADTC-LOSJGSFVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75376,6m2n,DB04616,-8.0,TACRINE(8)-4-AMINOQUINOLINE,UNVOAAWEEGAXTN-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
139547,6w9c,DB13617,-8.0,Clorexolone,VPMWFZKOWULPGT-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
77570,6m2n,DB08536,-8.0,"3-bromo-5-phenyl-N-(pyrimidin-5-ylmethyl)pyrazolo[1,5-a]pyridin-7-amine",IBUPHWYGVDAASU-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75317,6m2n,DB04542,-8.0,3'-Azido-3'-Deoxythymidine-5'-Diphosphate,QOYVAFWJURKBJG-XLPZGREQSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75291,6m2n,DB04509,-8.0,N-Methylnaloxonium,PCSQOABIHJXZMR-YNUHATHGSA-O,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
139564,6w9c,DB13642,-8.0,Pridinol,RQXCLMGKHJWMOA-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138607,6w9c,DB11910,-8.0,MK-0249,DDDZBLNULGDPGA-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138602,6w9c,DB11903,-8.0,GW842166,TWQYWUXBZHPIIV-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
75191,6m2n,DB04371,-8.0,AL6528,FBBLOSCXOZYUSS-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77732,6m2n,DB08732,-8.0,NALPHA-[(BENZYLOXY)CARBONYL]-N-[(1R)-4-HYDROXY-1-METHYL-2-OXOBUTYL]-L-PHENYLALANINAMIDE,UUOOAGBWJUGBMV-APWZRJJASA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77760,6m2n,DB08761,-8.0,"(3S,6S)-3,6-bis(4-hydroxybenzyl)piperazine-2,5-dione",NGPCLOGFGKJCBP-HOTGVXAUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77784,6m2n,DB08789,-8.0,"2-AMINO-4-(2,4-DICHLOROPHENYL)-N-ETHYLTHIENO[2,3-D]PYRIMIDINE-6-CARBOXAMIDE",YPEOXUOUTBMBCX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77804,6m2n,DB08810,-8.0,Cinitapride,ZDLBNXXKDMLZMF-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75098,6m2n,DB04240,-8.0,"(1S)-1-C-{(2R)-6-[(2R)-2-Butanyl]-5,10-dihydroxy-4-oxo-1,2,3,4-tetrahydro-2-anthracenyl}-5-deoxy-1-O-methyl-D-xylulose",XGORHSPGULYMCV-HHYQQTLHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75075,6m2n,DB04209,-8.0,Dequalinium,PCSWXVJAIHCTMO-UHFFFAOYSA-P,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75067,6m2n,DB04200,-8.0,Matairesinol,MATGKVZWFZHCLI-LSDHHAIUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77843,6m2n,DB08877,-8.0,Ruxolitinib,HFNKQEVNSGCOJV-OAHLLOKOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75022,6m2n,DB04144,-8.0,"Cis-[4,5-Bis-(4-Chlorophenyl)-2-(2-Isopropoxy-4-Methoxyphenyl)-4,5-Dihyd Roimidazol-1-Yl]-Piperazin-1-Yl-Methanone",ZXIPEZDMQNYFOO-WUFINQPMSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
139617,6w9c,DB13711,-8.0,Tritoqualine,IRGJVQIJENCTQF-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
75001,6m2n,DB04116,-8.0,Allolactose,DLRVVLDZNNYCBX-VDGMBKLFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75000,6m2n,DB04115,-8.0,Berberine,YBHILYKTIRIUTE-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
139620,6w9c,DB13714,-8.0,Xibornol,RNRHMQWZFJXKLZ-JCKWVBRZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138538,6w9c,DB11811,-8.0,Arhalofenate,BJBCSGQLZQGGIQ-QGZVFWFLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
77897,6m2n,DB08961,-8.0,Azosemide,HMEDEBAJARCKCT-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
74953,6m2n,DB04055,-8.0,"2,3-Dicarboxy-4-(2-Chloro-Phenyl)-1-Ethyl-5-Isopropoxycarbonyl-6-Methyl-Pyridinium",HMSIYRVIPQHZBI-UHFFFAOYSA-O,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
74947,6m2n,DB04047,-8.0,[Pterin-6-Yl Methanyl]-Phosphonophosphate,AMDUVUKDRBIVAH-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
74930,6m2n,DB04020,-8.0,"4-(2-{[4-{[3-(4-Chlorophenyl)Propyl]Sulfanyl}-6-(1-Piperazinyl)-1,3,5-Triazin-2-Yl]Amino}Ethyl)Phenol",AIBKIFHSQQYXLG-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138635,6w9c,DB12046,-8.0,Atopaxar,QWKAUGRRIXBIPO-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139532,6w9c,DB13600,-8.0,Deltamethrin,OWZREIFADZCYQD-NSHGMRRFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
75399,6m2n,DB04645,-8.0,"5-{3-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-2-METHYL-PHENOXY}-PENTANOIC ACID",NJJIFGCFUDDBSP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75402,6m2n,DB04649,-8.0,TETRAHEDRAL INTERMEDIATE OF BLASTICIDIN S,MVFPGTZTOAHVBP-HXYLPHSESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77228,6m2n,DB08121,-8.0,(2S)-2-(biphenyl-4-yloxy)-3-phenylpropanoic acid,TZTPJJNNACUQQR-FQEVSTJZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77229,6m2n,DB08122,-8.0,"N-METHYL-4-{[(2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]AMINO}BENZENESULFONAMIDE",IKASAFLVQIJQOK-UVTDQMKNSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77255,6m2n,DB08150,-8.0,"4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-aminium",RZIDZIGAXXNODG-UHFFFAOYSA-O,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77271,6m2n,DB08166,-8.0,"(4R)-7-chloro-9-methyl-1-oxo-1,2,4,9-tetrahydrospiro[beta-carboline-3,4'-piperidine]-4-carbonitrile",LPFQFJAOMCGYCP-GFCCVEGCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138723,6w9c,DB12174,-8.0,CUDC-101,PLIVFNIUGLLCEK-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
77295,6m2n,DB08195,-8.0,(1R)-2-[(CYANOMETHYL)AMINO]-1-({[2-(DIFLUOROMETHOXY)BENZYL]SULFONYL}METHYL)-2-OXOETHYL MORPHOLINE-4-CARBOXYLATE,YKWHKILAGONYKL-HNNXBMFYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77316,6m2n,DB08224,-8.0,"(1S,7S,8S,8AR)-1,2,3,7,8,8A-HEXAHYDRO-7-METHYL-8-[2-[(2R,4R)-TETRAHYDRO-4-HY DROXY-6-OXO-2H-PYRAN-2-YL]ETHYL]-1-NAPHTHALENOL",WWSNTLOVYSRDEL-TVKPWXLESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138706,6w9c,DB12147,-8.0,Erdafitinib,OLAHOMJCDNXHFI-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
75571,6m2n,DB04876,-8.0,Vildagliptin,SYOKIDBDQMKNDQ-XWTIBIIYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75569,6m2n,DB04873,-8.0,Piboserod,KVCSJPATKXABRQ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77335,6m2n,DB08247,-8.0,6-(CYCLOHEXYLMETHOXY)-8-ISOPROPYL-9H-PURIN-2-AMINE,JABXNQUXGJTKRO-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77355,6m2n,DB08274,-8.0,"6,7,8,9-TETRAHYDRO-4-HYDROXY-3-(1-PHENYLPROPYL)CYCLOHEPTA[B]PYRAN-2-ONE",YKJXQZGJGDTEOC-AWEZNQCLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77360,6m2n,DB08285,-8.0,"(2R)-2-{[4-(benzylamino)-8-(1-methylethyl)pyrazolo[1,5-a][1,3,5]triazin-2-yl]amino}butan-1-ol",SQUNOCMDMIQIQK-OAHLLOKOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77170,6m2n,DB08056,-8.0,"N-(2,6-dimethylphenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine",KKYYLKPGILUPOA-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77367,6m2n,DB08293,-8.0,"(5E)-12-CHLORO-13,15-DIHYDROXY-4,7,8,9-TETRAHYDRO-2-BENZOXACYCLOTRIDECINE-1,10(3H,11H)-DIONE",AQKZYZQONWDDLS-HNQUOIGGSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77373,6m2n,DB08300,-8.0,"1-methyl-3-naphthalen-2-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine",UOKGZPYGRJDACN-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77381,6m2n,DB08308,-8.0,"SUCCINIC ACID MONO-(13-METHYL-3-OXO-2,3,6,7,8,9,10,11,12,13,14,15,16,17-TETRADECAHYDRO-1H-CYCLOPENTA[A]PHENANTHREN-17-YL) ESTER",IRQUJNVGEAJGSD-KIEDKLRZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75489,6m2n,DB04772,-8.0,1-GUANIDINO-4-(N-PHENYLMETHANESULFONYL-L-LEUCYL-L-PROLYLAMINO)BUTANE,DSVCYWOHJLRGMK-PMACEKPBSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138665,6w9c,DB12092,-8.0,Naftopidil,HRRBJVNMSRJFHQ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139495,6w9c,DB13546,-8.0,Nizofenone,WZGBZLHGOVJDET-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
75475,6m2n,DB04754,-8.0,"GUANOSINE-2',3'-O-ETHYLIDENEPHOSPHONATE",HYAPEMYRVFIHDJ-QWEIRQIHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77472,6m2n,DB08422,-8.0,[PHENYLALANINYL-PROLINYL]-[2-(PYRIDIN-4-YLAMINO)-ETHYL]-AMINE,GEIDRYBJURDUSW-MOPGFXCFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138656,6w9c,DB12078,-8.0,Enobosarm,JNGVJMBLXIUVRD-SFHVURJKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
77501,6m2n,DB08457,-8.0,"4-(3,5-DIMETHYLPHENOXY)-5-(FURAN-2-YLMETHYLSULFANYLMETHYL)-3-IODO-6-METHYLPYRIDIN-2(1H)-ONE",YZLKVEDFWLGNQP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75442,6m2n,DB04706,-8.0,"(3BETA,7BETA)-CHOLEST-5-ENE-3,7-DIOL",OYXZMSRRJOYLLO-KGZHIOMZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75432,6m2n,DB04693,-8.0,"(13S)-13-METHYLDODECAHYDRO-1H-CYCLOPENTA[A]PHENANTHRENE-3,17(2H,4H)-DIONE",CRDKSBHJIGNEOH-IMRIKWHGSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77525,6m2n,DB08486,-8.0,Efaproxiral,BNFRJXLZYUTIII-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77528,6m2n,DB08489,-8.0,"N4-HYDROXY-2-ISOBUTYL-N1-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.013,18]NONADECA-12(19),13,15,17-TETRAEN-10-YL)-SUCCINAMIDE",GCBPAPVOMPJQHK-NQIIRXRSSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75549,6m2n,DB04845,-8.0,Ixabepilone,FABUFPQFXZVHFB-PVYNADRNSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
88092,6m3m,DB13335,-8.0,Pinazepam,MFZOSKPPVCIFMT-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
72970,6m2n,DB01436,-8.0,Alfacalcidol,OFHCOWSQAMBJIW-AVJTYSNKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
72952,6m2n,DB01416,-8.0,Cefpodoxime,WYUSVOMTXWRGEK-HBWVYFAYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
81520,6m3m,DB01333,-8.0,Cefradine,RDLPVSKMFDYCOR-UEKVPHQBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136493,6w9c,DB07180,-8.0,"5-[(Z)-(5-Chloro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-N,2,4-trimethyl-1H-pyrrole-3-carboxamide",FIRPCWHHIWFKCD-GHXNOFRVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136481,6w9c,DB07167,-8.0,5-CYANO-FURAN-2-CARBOXYLIC ACID [5-HYDROXYMETHYL-2-(4-METHYL-PIPERIDIN-1-YL)-PHENYL]-AMIDE,NNPCFFIJVKYGHR-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140463,6w9c,DB06873,-8.0,"1-((2-HYDROXYETHOXY)METHYL)-5-(3-(BENZYLOXY)BENZYL)PYRIMIDINE-2,4(1H,3H)-DIONE",CSXNPJKDZKLDET-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
70800,6lxt,DB13242,-8.0,Bucladesine,CJGYSWNGNKCJSB-YVLZZHOMSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
136445,6w9c,DB07125,-8.0,"4-(6-{[(1R)-1-(hydroxymethyl)propyl]amino}imidazo[1,2-b]pyridazin-3-yl)benzoic acid",KKZYGUVAFJCULH-CYBMUJFWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
81622,6m3m,DB01482,-8.0,Fenethylline,NMCHYWGKBADVMK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136443,6w9c,DB07123,-8.0,N-(4-METHYLBENZOYL)-4-BENZYLPIPERIDINE,DVOLWKZEIDCCES-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136429,6w9c,DB07108,-8.0,"4'-FLUORO-1,1'-BIPHENYL-4-CARBOXYLIC ACID",LXWNTLBMNCXRQN-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136426,6w9c,DB07105,-8.0,2-[2-(4-CHLORO-PHENYLSULFANYL)-ACETYLAMINO]-3-(4-GUANIDINO-PHENYL)-PROPIONAMIDE,IEEYGOJDTRVYGR-HNNXBMFYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
70711,6lxt,DB13080,-8.0,Roluperidone,RNRYULFRLCBRQS-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
70699,6lxt,DB13062,-8.0,ME-344,QVCAATSEPLQVBX-FPOVZHCZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
136415,6w9c,DB07090,-8.0,(3S)-N-(3-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE,NJNMAZNXKKBTPS-ZDUSSCGKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136414,6w9c,DB07089,-8.0,N-[amino(imino)methyl]-2-[2-(2-chlorophenyl)-4-(4-propoxyphenyl)-3-thienyl]acetamide,VZSMTBLDWPKVRW-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136408,6w9c,DB07083,-8.0,beta-phenyl-D-phenylalanyl-N-propyl-L-prolinamide,HZKKJPDVZGOOPU-PZJWPPBQSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136405,6w9c,DB07080,-8.0,"N-(2,2,2-TRIFLUOROETHYL)-N-{4-[2,2,2-TRIFLUORO-1-HYDROXY-1-(TRIFLUOROMETHYL)ETHYL]PHENYL}BENZENESULFONAMIDE",SGIWFELWJPNFDH-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
70672,6lxt,DB13022,-8.0,LY-2874455,GKJCVYLDJWTWQU-CXLRFSCWSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
140495,6w9c,DB11962,-8.0,GSK-1059615,QDITZBLZQQZVEE-YBEGLDIGSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
81729,6m3m,DB01608,-8.0,Periciazine,LUALIOATIOESLM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81769,6m3m,DB01656,-8.0,Roflumilast,MNDBXUUTURYVHR-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81770,6m3m,DB01658,-8.0,1'-Deazo-Thiamin Diphosphate,JHNXLHRDUXBCJW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81802,6m3m,DB01700,-8.0,AICA ribonucleotide,NOTGFIUVDGNKRI-UUOKFMHZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
70597,6lxt,DB12904,-8.0,ZSTK-474,HGVNLRPZOWWDKD-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
136383,6w9c,DB07053,-8.0,2-{5-[3-(7-PROPYL-3-TRIFLUOROMETHYLBENZO[D]ISOXAZOL-6-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID,TWVYNPULGKGJOS-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
70536,6lxt,DB12808,-8.0,Trifarotene,MFBCDACCJCDGBA-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
81984,6m3m,DB01950,-8.0,"N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thiazol-2-Yl)Urea",YAEMHJKFIIIULI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
70499,6lxt,DB12744,-8.0,CGI-1842,ZXBFYBLSJMEBEP-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
81507,6m3m,DB01298,-8.0,Sulfacytine,SIBQAECNSSQUOD-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
140519,6w9c,DB12000,-8.0,Apabetalone,NETXMUIMUZJUTB-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136501,6w9c,DB07188,-8.0,"(3S)-1-CYCLOHEXYL-N-(3,5-DICHLOROPHENYL)-5-OXOPYRROLIDINE-3-CARBOXAMIDE",YUFADRZDHJKVOT-NSHDSACASA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
71267,6lxt,DB13865,-8.0,Dehydroemetine,XXLZPUYGHQWHRN-RPBOFIJWSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
140418,6w9c,DB06814,-8.0,Protokylol,LUMAEVHDZXIGEP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136638,6w9c,DB07354,-8.0,"2,3-DIMETHOXY-12H-[1,3]DIOXOLO[5,6]INDENO[1,2-C]ISOQUINOLIN-6-IUM",LXDREMZQGAILJU-UHFFFAOYSA-O,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
81210,6m3m,DB00933,-8.0,Mesoridazine,SLVMESMUVMCQIY-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81229,6m3m,DB00955,-8.0,Netilmicin,CIDUJQMULVCIBT-MQDUPKMGSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136617,6w9c,DB07330,-8.0,trans-4-(7-carbamoyl-1H-benzimidazol-2-yl)-1-propylpiperidinium,KXSIHXHEHABEJX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
71562,6lxt,DB14787,-8.0,BMS-830216,YDTUJCNTIMWHPJ-NRFANRHFSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
81254,6m3m,DB00986,-8.0,Glycopyrronium,ANGKOCUUWGHLCE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81272,6m3m,DB01006,-8.0,Letrozole,HPJKCIUCZWXJDR-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
71554,6lxt,DB14769,-8.0,Pamiparib,DENYZIUJOTUUNY-MRXNPFEDSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
71549,6lxt,DB14761,-8.0,Remdesivir,RWWYLEGWBNMMLJ-YSOARWBDSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
71535,6lxt,DB14726,-8.0,Dabigatran,YBSJFWOBGCMAKL-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
136578,6w9c,DB07289,-8.0,5-[3-(BENZYLAMINO)PHENYL]-4-BROMO-3-(CARBOXYMETHOXY)THIOPHENE-2-CARBOXYLIC ACID,XEQPGVUGYAUMSA-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
71483,6lxt,DB14640,-8.0,Isoflupredone acetate,ZOCUOMKMBMEYQV-GSLJADNHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
71480,6lxt,DB14637,-8.0,Fluprednisolone acetate,CYMBAKFTWRNHPS-APRQOCPKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
81359,6m3m,DB01104,-8.0,Sertraline,VGKDLMBJGBXTGI-SJCJKPOMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
71474,6lxt,DB14631,-8.0,Prednisolone phosphate,JDOZJEUDSLGTLU-VWUMJDOOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
81364,6m3m,DB01112,-8.0,Cefuroxime,JFPVXVDWJQMJEE-IZRZKJBUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
71463,6lxt,DB14584,-8.0,Segesterone,SFLXYFZGKSGFKA-XUDSTZEESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
71462,6lxt,DB14583,-8.0,Segesterone acetate,CKFBRGLGTWAVLG-GOMYTPFNSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
71457,6lxt,DB14569,-8.0,Tedizolid,XFALPSLJIHVRKE-GFCCVEGCSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
71440,6lxt,DB14512,-8.0,Mometasone furoate,WOFMFGQZHJDGCX-ZULDAHANSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
71399,6lxt,DB14152,-8.0,Ginsenosides,NLHQJXWYMZLQJY-SWIZOJJJSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
136550,6w9c,DB07249,-8.0,"N-(5-chloro-1,3-benzodioxol-4-yl)-6-methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-amine",QHIMVPIOWKYPSO-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136549,6w9c,DB07248,-8.0,"7-PYRIDIN-2-YL-N-(3,4,5-TRIMETHOXYPHENYL)-7H-PYRROLO[2,3-D]PYRIMIDIN-2-AMINE",YENZSPIOXMNEFF-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
71317,6lxt,DB13981,-8.0,Nomegestrol acetate,IIVBFTNIGYRNQY-YQLZSBIMSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
136529,6w9c,DB07222,-8.0,(3S)-N-(5-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE,RJWMDETWDDESBP-ZDUSSCGKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
71269,6lxt,DB13867,-8.0,Fluticasone,MGNNYOODZCAHBA-GQKYHHCASA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
81483,6m3m,DB01247,-8.0,Isocarboxazid,XKFPYPQQHFEXRZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
70454,6lxt,DB12675,-8.0,PF-04995274,WLLOFQROROXOMO-GOSISDBHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
82078,6m3m,DB02075,-8.0,"(1s)-1(9-Deazahypoxanthin-9yl)1,4-Dideoxy-1,4-Imino-D-Ribitol-5-Phosphate",VJTAXXUIRYOXBT-KUBHLMPHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136309,6w9c,DB06970,-8.0,"2-CHLORO-N-(3-CYANO-5,6-DIHYDRO-4H-CYCLOPENTA[B]THIOPHEN-2-YL)-5-DIETHYLSULFAMOYL-BENZAMIDE",MZCDQILVXXIMEV-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
70026,6lxt,DB12050,-8.0,LY-3039478,YCBAQKQAINQRFW-UGSOOPFHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
82930,6m3m,DB03200,-8.0,7-Alpha-D-Ribofuranosyl-Purine-5'-Phosphate,NICKPTPNIMHUHB-DQUBFYRCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
82932,6m3m,DB03202,-8.0,"2-[5-Methanesulfonylamino-2-(4-Aminophenyl)-6-Oxo-1,6-Dihydro-1-Pyrimidinyl]-N-(3,3,3-Trifluoro-1-Isopropyl-2-Oxopropyl)Acetamide",JWSWTHSJMGVOKE-HNNXBMFYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136018,6w9c,DB06311,-8.0,Darapladib,WDPFJWLDPVQCAJ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
82954,6m3m,DB03227,-8.0,Nicotinamide Mononucleotide,DAYLJWODMCOQEW-WYOJIJJFSA-O,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
135993,6w9c,DB06250,-8.0,Fluasterone,VHZXNQKVFDBFIK-NBBHSKLNSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
83067,6m3m,DB03370,-8.0,FR239087,HCJYSIGJDKNVRU-TVQRCGJNSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
135970,6w9c,DB06203,-8.0,Alogliptin,ZSBOMTDTBDDKMP-OAHLLOKOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
83096,6m3m,DB03413,-8.0,Deoxyuridine-5'-Diphosphate,QHWZTVCCBMIIKE-SHYZEUOFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83101,6m3m,DB03420,-8.0,"2,4-Deoxy-4-Guanidino-5-N-Acetyl-Neuraminic Acid",DAAUVSVERFXBSX-IHICSVBISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
69951,6lxt,DB11939,-8.0,Henagliflozin,HYTPDMFFHVZBOR-VNXMGFANSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
83178,6m3m,DB03532,-8.0,Phosphomethylphosphonic Acid Guanylate Ester,GXTIEXDFEKYVGY-KQYNXXCUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83234,6m3m,DB03622,-8.0,"2-Hydroxy-5-[4-(2-Hydroxy-Ethyl)-Piperidin-1-Yl]-5-Phenyl-1h-Pyrimidine-4,6-Dione",IPBPOBHSNJFRFT-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
69915,6lxt,DB11886,-8.0,Infigratinib,QADPYRIHXKWUSV-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
69901,6lxt,DB11865,-8.0,Brivanib alaninate,LTEJRLHKIYCEOX-OCCSQVGLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
83304,6m3m,DB03718,-8.0,6-Aza-Ump,LRVZOSYMNMNQFR-SHUUEZRQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83335,6m3m,DB03755,-8.0,"Adenosine-5'-[Beta, Gamma-Methylene]Tetraphosphate",ARRGHMSEJJFDME-IOSLPCCCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83409,6m3m,DB03844,-8.0,"N-(2,6-Diflouro-Benzyl)-4-Sulfamoyl-Benzamide",ZFNCKGXGCCDDFN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
69852,6lxt,DB11793,-8.0,Niraparib,PCHKPVIQAHNQLW-CQSZACIVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
83413,6m3m,DB03851,-8.0,Carbazole Butanoic Acid,HQAKVYGASUTQHH-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
69822,6lxt,DB11750,-8.0,Clobetasol,FCSHDIVRCWTZOX-DVTGEIKXSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
69816,6lxt,DB11741,-8.0,Famitinib,GKEYKDOLBLYGRB-LGMDPLHJSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
83541,6m3m,DB04020,-8.0,"4-(2-{[4-{[3-(4-Chlorophenyl)Propyl]Sulfanyl}-6-(1-Piperazinyl)-1,3,5-Triazin-2-Yl]Amino}Ethyl)Phenol",AIBKIFHSQQYXLG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
69799,6lxt,DB11712,-8.0,Tezacaftor,MJUVRTYWUMPBTR-MRXNPFEDSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
69793,6lxt,DB11703,-8.0,Acalabrutinib,WDENQIQQYWYTPO-IBGZPJMESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
83543,6m3m,DB04022,-8.0,"Guanosine-5',3'-Tetraphosphate",BUFLLCUFNHESEH-UUOKFMHZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
69786,6lxt,DB11694,-8.0,Ilorasertib,WPHKIQPVPYJNAX-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
136025,6w9c,DB06335,-8.0,Saxagliptin,QGJUIPDUBHWZPV-SGTAVMJGSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
82894,6m3m,DB03150,-8.0,"2',3'-Dideoxythymidine-5'-Monophosphate",WVNRRNJFRREKAR-JGVFFNPUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
70070,6lxt,DB12114,-8.0,Poziotinib,LPFWVDIFUFFKJU-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
136031,6w9c,DB06358,-8.0,Iclaprim,HWJPWWYTGBZDEG-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
82157,6m3m,DB02179,-8.0,O-Trifluoromethylphenyl Anthranilic Acid,ONKHJNFXJDEMNQ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
82165,6m3m,DB02191,-8.0,"(7as,12ar,12bs)-1,2,3,4,7a,12,12a,12b-Octahydroindolo[2,3-a]Quinolizin-7(6h)-One",PGKUSHWBQJPFOP-LBPRGKRZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
82180,6m3m,DB02213,-8.0,Metanitrophenyl-Alpha-D-Galactoside,VCCMGHVCRFMITI-IIRVCBMXSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136219,6w9c,DB06781,-8.0,Difluprednate,WYQPLTPSGFELIB-JTQPXKBDSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
70296,6lxt,DB12430,-8.0,BC-3781,KPVIXBKIJXZQJX-IJUBVZAWSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
70281,6lxt,DB12412,-8.0,Gemigliptin,ZWPRRQZNBDYKLH-VIFPVBQESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
82439,6m3m,DB02538,-8.0,"N-[4-(2-Methylimidazo[1,2-a]Pyridin-3-Yl)-2-Pyrimidinyl]Acetamide",ZCRPPLDDHBLUES-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136167,6w9c,DB06697,-8.0,Artemether,SXYIRMFQILZOAM-HVNFFKDJSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136164,6w9c,DB06693,-8.0,Mevastatin,AJLFOPYRIVGYMJ-INTXDZFKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
70208,6lxt,DB12308,-8.0,Eltanolone,AURFZBICLPNKBZ-YZRLXODZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
136122,6w9c,DB06604,-8.0,Ilepatril,FXKFFTMLFPWYFH-RDGPPVDQSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
82569,6m3m,DB02712,-8.0,Sorbinil,LXANPKRCLVQAOG-NSHDSACASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
70202,6lxt,DB12301,-8.0,Doravirine,ZIAOVIPSKUPPQW-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
81192,6m3m,DB00913,-8.0,Anileridine,LKYQLAWMNBFNJT-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136119,6w9c,DB06597,-8.0,Estradiol sulfamate,YXYXCSOJKUAPJI-ZBRFXRBCSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
70188,6lxt,DB12284,-8.0,LY-2608204,QIIVJLHCZUTGSD-CUBQBAPOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
70181,6lxt,DB12275,-8.0,Seviteronel,ZBRAJOQFSNYJMF-SFHVURJKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
70177,6lxt,DB12270,-8.0,Losmapimod,KKYABQBFGDZVNQ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
82605,6m3m,DB02762,-8.0,RU79072,NQLPTOOPFMPCHQ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
70155,6lxt,DB12238,-8.0,MK-0777,QKIWQBLNTSQOLY-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
136094,6w9c,DB06529,-8.0,Ocinaplon,OQJFBUOFGHPMSR-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
70134,6lxt,DB12211,-8.0,PSI-697,DIEPFYNZGUUVHD-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
82681,6m3m,DB02862,-8.0,Gluco-Phenylimidazole,DLVNFMROYKHANV-FVCCEPFGSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
82712,6m3m,DB02902,-8.0,3'-Phosphate-Adenosine-5'-Phosphate Sulfate,GACDQMDRPRGCTN-KQYNXXCUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136042,6w9c,DB06403,-8.0,Ambrisentan,OUJTZYPIHDYQMC-LJQANCHMSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
82825,6m3m,DB03060,-8.0,Sri-9662,WNDJHUNKXPAREB-PLNGDYQASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136036,6w9c,DB06370,-8.0,Indisulam,SETFNECMODOHTO-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
82843,6m3m,DB03081,-8.0,Crc200 (Chiron-Behring),ZOXOKTJHZSUHRJ-XZOQPEGZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
70189,6lxt,DB12285,-8.0,Verubecestat,YHYKUSGACIYRML-KRWDZBQOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
81184,6m3m,DB00905,-8.0,Bimatoprost,AQOKCDNYWBIDND-FTOWTWDKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81136,6m3m,DB00850,-8.0,Perphenazine,RGCVKNLCSQQDEP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136677,6w9c,DB07402,-8.0,Azapropazone,WOIIIUDZSOLAIW-NSHDSACASA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
79907,6m2n,DB13943,-8.0,Testosterone cypionate,HPFVBGJFAYZEBE-ZLQWOROUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
72661,6m2n,DB01006,-8.0,Letrozole,HPJKCIUCZWXJDR-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79929,6m2n,DB13983,-8.0,"5,7,2'-trihydroxy-6,8-dimethoxyflavone",JWOKGWICZPPYPX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
72621,6m2n,DB00959,-8.0,Methylprednisolone,VHRSUDSXCMQTMA-PJHHCJLFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
72610,6m2n,DB00946,-8.0,Phenprocoumon,DQDAYGNAKTZFIW-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79983,6m2n,DB14086,-8.0,Cianidanol,PFTAWBLQPZVEMU-DZGCQCFKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80003,6m2n,DB14129,-8.0,Macelignan,QDDILOVMGWUNGD-UONOGXRCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
72557,6m2n,DB00886,-8.0,Omapatrilat,LVRLSYPNFFBYCZ-VGWMRTNUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80055,6m2n,DB14539,-8.0,Hydrocortisone acetate,ALEXXDVDDISNDU-JZYPGELDSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137290,6w9c,DB08116,-8.0,"(3R)-4-{[(3,4-dihydroxyphenyl)acetyl]oxy}-N-(2-formylindolizin-3-yl)-3-sulfino-D-valine",DEOZLEGRVHDNKC-UGKGYDQZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
80069,6m2n,DB14570,-8.0,Hydroxyprogesterone,DBPWSSGDRRHUNT-CEGNMAFCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80076,6m2n,DB14596,-8.0,Loteprednol etabonate,DMKSVUSAATWOCU-HROMYWEYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
140159,6w9c,DB15096,-8.0,18-methoxycoronaridine,DTJQBBHYRQYDEG-SVBQBFEESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137274,6w9c,DB08099,-8.0,"6-ethyl-5-[(2S)-1-(3-methoxypropyl)-2-phenyl-1,2,3,4-tetrahydroquinolin-7-yl]pyrimidine-2,4-diamine",UOYVKYJWAXJTTE-NRFANRHFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
80093,6m2n,DB14639,-8.0,Boldenone undecylenate,AHMMSNQYOPMLSX-CNQKSJKFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
72486,6m2n,DB00808,-8.0,Indapamide,NDDAHWYSQHTHNT-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
72465,6m2n,DB00782,-8.0,Propantheline,VVWYOYDLCMFIEM-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
72440,6m2n,DB00751,-8.0,Epinastine,WHWZLSFABNNENI-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
72428,6m2n,DB00736,-8.0,Esomeprazole,SUBDBMMJDZJVOS-DEOSSOPVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
140172,6w9c,DB15120,-8.0,GSK-239512,YFRBKEVUUCQYOW-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
80145,6m2n,DB14725,-8.0,Cefamandole nafate,RRJHESVQVSRQEX-SUYBPPKGSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137235,6w9c,DB08054,-8.0,"1-(1-methylethyl)-3-quinolin-6-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine",GEZALMMCQYDFML-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
80187,6m2n,DB14828,-8.0,ABX-464,OZOGDCZJYVSUBR-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137220,6w9c,DB08035,-8.0,"1-TERT-BUTYL-3-(2,5-DIMETHYLBENZYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE",QUPXEJURIFFVSX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
72381,6m2n,DB00682,-8.0,Warfarin,PJVWKTKQMONHTI-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
72378,6m2n,DB00678,-8.0,Losartan,PSIFNNKUMBGKDQ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137172,6w9c,DB07984,-8.0,2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]-n-[(1S)-1-(hydroxymethyl)propyl]acetamide,GKJWXEORYGBJFS-KRWDZBQOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
72690,6m2n,DB01038,-8.0,Carphenazine,XZSMZRXAEFNJCU-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
72695,6m2n,DB01044,-8.0,Gatifloxacin,XUBOMFCQGDBHNK-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79873,6m2n,DB13855,-8.0,Nifuroxazide,YCWSUKQGVSGXJO-NTUHNPAUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
72723,6m2n,DB01076,-8.0,Atorvastatin,XUKUURHRXDUEBC-KAYWLYCHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137468,6w9c,DB08331,-8.0,"N-1H-imidazol-2-yl-N'-[4-(1H-imidazol-2-ylamino)phenyl]benzene-1,4-diamine",JHMXUERQMCJRHG-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137448,6w9c,DB08309,-8.0,3-({2-[(4-{[6-(CYCLOHEXYLMETHOXY)-9H-PURIN-2-YL]AMINO}PHENYL)SULFONYL]ETHYL}AMINO)PROPAN-1-OL,AMFGILNPFBVREA-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
79346,6m2n,DB13114,-8.0,Amitriptylinoxide,ZPMKQFOGINQDAM-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79369,6m2n,DB13165,-8.0,Ripasudil,QSKQVZWVLOIIEV-NSHDSACASA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137439,6w9c,DB08300,-8.0,"1-methyl-3-naphthalen-2-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine",UOKGZPYGRJDACN-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
79392,6m2n,DB13217,-8.0,Fentiazac,JIEKMACRVQTPRC-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79447,6m2n,DB13292,-8.0,Pimethixene,NZLVRVYNQYGMAB-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79533,6m2n,DB13403,-8.0,Oxypertine,XCWPUUGSGHNIDZ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79539,6m2n,DB13411,-8.0,Lofepramine,SAPNXPWPAUFAJU-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79568,6m2n,DB13448,-8.0,Mazaticol,AMHPTVWBZSYFSS-OAGGEKHMSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79585,6m2n,DB13472,-8.0,Cyclofenil,GVOUFPWUYJWQSK-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
72874,6m2n,DB01252,-8.0,Mitiglinide,WPGGHFDDFPHPOB-BBWFWOEESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79624,6m2n,DB13528,-8.0,Chlormadinone,VUHJZBBCZGVNDZ-TTYLFXKOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
72359,6m2n,DB00656,-8.0,Trazodone,PHLBKPHSAVXXEF-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79645,6m2n,DB13553,-8.0,Carumonam,UIMOJFJSJSIGLV-JNHMLNOCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
72829,6m2n,DB01196,-8.0,Estramustine,FRPJXPJMRWBBIH-RBRWEJTLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
72805,6m2n,DB01172,-8.0,Kanamycin,SBUJHOSQTJFQJX-NOAMYHISSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79711,6m2n,DB13645,-8.0,Ethacizine,PQXGNJKJMFUPPM-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79719,6m2n,DB13657,-8.0,Benorilate,FEJKLNWAOXSSNR-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79735,6m2n,DB13675,-8.0,Metahexamide,XXYTXQGCRQLRHA-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
72775,6m2n,DB01137,-8.0,Levofloxacin,GSDSWSVVBLHKDQ-JTQLQIEISA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137352,6w9c,DB08184,-8.0,2-(2-METHYLPHENYL)-1H-INDOLE-5-CARBOXIMIDAMIDE,YOZKTHGEOJHIDP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
72757,6m2n,DB01116,-8.0,Trimethaphan,CHQOEHPMXSHGCL-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
72753,6m2n,DB01112,-8.0,Cefuroxime,JFPVXVDWJQMJEE-IZRZKJBUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
72752,6m2n,DB01110,-8.0,Miconazole,BYBLEWFAAKGYCD-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137341,6w9c,DB08170,-8.0,"(1R)-N,6-DIHYDROXY-7-METHOXY-2-[(4-METHOXYPHENYL)SULFONYL]-1,2,3,4-TETRAHYDROISOQUINOLINE-1-CARBOXAMIDE",AYFCYVLVRYQGME-QGZVFWFLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
72738,6m2n,DB01094,-8.0,Hesperetin,AIONOLUJZLIMTK-AWEZNQCLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79821,6m2n,DB13790,-8.0,Fipexide,BFUJHVVEMMWLHC-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
72849,6m2n,DB01218,-8.0,Halofantrine,FOHHNHSLJDZUGQ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
72953,6m2n,DB01418,-8.0,Acenocoumarol,VABCILAOYCMVPS-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137158,6w9c,DB07968,-8.0,N-(2-CHLORO-4-FLUOROBENZOYL)-N'-(5-HYDROXY-2-METHOXYPHENYL)UREA,RFOBTYLRURSVJE-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137127,6w9c,DB07932,-8.0,"dimethyl (1R,4S)-5,6-bis(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hepta-2,5-diene-2,3-dicarboxylate",CRLQCBACIMUGDZ-BGYRXZFFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
80696,6m3m,DB00318,-8.0,Codeine,OROGSEYTTFOCAN-DNJOTXNNSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136835,6w9c,DB07589,-8.0,"N-[1-(AMINOMETHYL)CYCLOPROPYL]-3-(BENZYLSULFONYL)-N-2-[(1S)-2,2,2-TRIFLUORO-1-(4-HYDROXYPHENYL)ETHYL]-L-ALANINAMIDE",DWWVPKCSDHDILN-OALUTQOASA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
80701,6m3m,DB00323,-8.0,Tolcapone,MIQPIUSUKVNLNT-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
71834,6lxt,DB15377,-8.0,ATB-346,YCNMAPLPQYQJFC-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
80721,6m3m,DB00349,-8.0,Clobazam,CXOXHMZGEKVPMT-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80749,6m3m,DB00383,-8.0,Oxyphencyclimine,DUDKAZCAISNGQN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80769,6m3m,DB00408,-8.0,Loxapine,XJGVXQDUIWGIRW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80776,6m3m,DB00417,-8.0,Phenoxymethylpenicillin,BPLBGHOLXOTWMN-MBNYWOFBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136815,6w9c,DB07564,-8.0,"6-amino-2-[(2-morpholin-4-ylethyl)amino]-3,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",JUHXOBNFTFUPKQ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
80810,6m3m,DB00456,-8.0,Cefalotin,XIURVHNZVLADCM-IUODEOHRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
71762,6lxt,DB15229,-8.0,CNV-2197944,BLFJGFDZMABYMY-ZDUSSCGKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
71759,6lxt,DB15222,-8.0,GS-6620,YAAQYJCOIFNMKX-RSTNYOGXSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
71743,6lxt,DB15197,-8.0,RSV-604,MTPVBMVUENFFLL-HXUWFJFHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
80871,6m3m,DB00535,-8.0,Cefdinir,RTXOFQZKPXMALH-GHXIOONMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80875,6m3m,DB00540,-8.0,Nortriptyline,PHVGLTMQBUFIQQ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80877,6m3m,DB00543,-8.0,Amoxapine,QWGDMFLQWFTERH-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136794,6w9c,DB07539,-8.0,"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZOIC ACID",JLRKRQCTYQGDKJ-GHXNOFRVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
71732,6lxt,DB15170,-8.0,Evobrutinib,QUIWHXQETADMGN-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
71713,6lxt,DB15133,-8.0,Tepotinib,AHYMHWXQRWRBKT-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
136752,6w9c,DB07490,-8.0,"2-[1-(4-CHLORO-PHENYL)-ETHYL]-4,6-DINITRO-PHENOL",MOZUMFSUQQHSCO-MRVPVSSYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
71678,6lxt,DB15063,-8.0,Inarigivir soproxil,CJCYTUJOSMYXLE-JDLSZIHUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
136727,6w9c,DB07459,-8.0,4-PHENOXY-N-(PYRIDIN-2-YLMETHYL)BENZAMIDE,HVLSCZSVTCNAQX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140395,6w9c,DB05943,-8.0,Resatorvid,LEEIJTHMHDMWLJ-CQSZACIVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
81022,6m3m,DB00715,-8.0,Paroxetine,AHOUBRCZNHFOSL-YOEHRIQHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81042,6m3m,DB00739,-8.0,Hetacillin,DXVUYOAEDJXBPY-NFFDBFGFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136688,6w9c,DB07415,-8.0,4-[(1S)-1-(3-fluoro-4-methoxyphenyl)-2-(2-methoxy-5-nitrophenyl)ethyl]-1H-imidazol-2-amine,RFLOFHKRBGKCOB-AWEZNQCLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
81117,6m3m,DB00829,-8.0,Diazepam,AAOVKJBEBIDNHE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
140323,6w9c,DB02930,-8.0,Adenosine 5'-[gamma-thio]triphosphate,NLTUCYMLOPLUHL-KQYNXXCUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136863,6w9c,DB07624,-8.0,"1-{[(3R)-3-methyl-4-({4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]phenyl}sulfonyl)piperazin-1-yl]methyl}cyclopropanecarboxamide",YJFULAYRAKPBCY-DYVFJYSZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136865,6w9c,DB07626,-8.0,"4-(2-aminoethoxy)-N-(3-chloro-2-ethoxy-5-piperidin-1-ylphenyl)-3,5-dimethylbenzamide",CKBBGCJYKCLKHE-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136867,6w9c,DB07628,-8.0,"6-(2-fluorobenzyl)-2,4-dimethyl-4,6-dihydro-5H-thieno[2',3':4,5]pyrrolo[2,3-d]pyridazin-5-one",IEWYEWDDQWYJLU-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
72299,6m2n,DB00582,-8.0,Voriconazole,BCEHBSKCWLPMDN-MGPLVRAMSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
72297,6m2n,DB00580,-8.0,Valdecoxib,LNPDTQAFDNKSHK-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137102,6w9c,DB07901,-8.0,5-CHLORO-6-METHYL-N-(2-PHENYLETHYL)-2-PYRIDIN-2-YLPYRIMIDIN-4-AMINE,HIUOABSWQSUEGK-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140201,6w9c,DB15338,-8.0,Rovatirelin,WTXWDXWZGJGIHV-URBCHYCLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
72260,6m2n,DB00535,-8.0,Cefdinir,RTXOFQZKPXMALH-GHXIOONMSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
72250,6m2n,DB00523,-8.0,Alitretinoin,SHGAZHPCJJPHSC-ZVCIMWCZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137083,6w9c,DB07876,-8.0,(S)-2-METHYL-1-[(4-METHYL-5-ISOQUINOLINE)SULFONYL]-HOMOPIPERAZINE,AWDORCFLUJZUQS-ZDUSSCGKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137064,6w9c,DB07857,-8.0,(2R)-2-(4-chlorophenyl)-2-[4-(1H-pyrazol-4-yl)phenyl]ethanamine,HWVGILTYGZFGLR-QGZVFWFLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140208,6w9c,DB15348,-8.0,Ampreloxetine,TZIALEBTHQWNAO-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
72126,6m2n,DB00370,-8.0,Mirtazapine,RONZAEMNMFQXRA-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80445,6m2n,DB15377,-8.0,ATB-346,YCNMAPLPQYQJFC-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
136948,6w9c,DB07724,-8.0,Indeglitazar,YMPALHOKRBVHOJ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136932,6w9c,DB07706,-8.0,2-Hydrox1tradiol,DILDHNKDVHLEQB-XSSYPUMDSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137131,6w9c,DB07936,-8.0,N-(4-{[(3S)-3-(dimethylamino)pyrrolidin-1-yl]carbonyl}phenyl)-5-fluoro-4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]pyrimidin-2-amine,BACSZMCLZIDTIO-IBGZPJMESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
80459,6m2n,DB15406,-8.0,GLPG-0974,MPMKMQHJHDHPBE-RUZDIDTESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
136930,6w9c,DB07704,-8.0,"6-AMINO-4-[2-(4-METHOXYPHENYL)ETHYL]-1,7-DIHYDRO-8H-IMIDAZO[4,5-G]QUINAZOLIN-8-ONE",UKRVQKUVWNDGMN-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
80476,6m2n,DB15440,-8.0,GSK-3117391,AFDPFLDWOXXHQM-NRFANRHFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
72024,6m2n,DB00247,-8.0,Methysergide,KPJZHOPZRAFDTN-NQUBZZJWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80509,6m2n,DB09171,-8.0,β-Methylfentanyl,UXIGUKSHASXDNI-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
140265,6w9c,DB01532,-8.0,alpha-Methylacetylfentanyl,OKTLVZBUKMRPLL-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
80516,6m2n,DB13983,-8.0,"5,7,2'-trihydroxy-6,8-dimethoxyflavone",JWOKGWICZPPYPX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80519,6m3m,DB00118,-8.0,Ademetionine,MEFKEPWMEQBLKI-AIRLBKTGSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80531,6m3m,DB00131,-8.0,Adenosine phosphate,UDMBCSSLTHHNCD-KQYNXXCUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
71972,6m2n,DB00186,-8.0,Lorazepam,DIWRORZWFLOCLC-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80577,6m3m,DB00179,-8.0,Masoprocol,HCZKYJDFEPMADG-TXEJJXNPSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136892,6w9c,DB07655,-8.0,"3-AMINO-3-BENZYL-[4.3.0]BICYCLO-1,6-DIAZANONAN-2-ONE",MPJYGQHMIFDQIN-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136884,6w9c,DB07647,-8.0,"(2R)-1-[(5,6-DIPHENYL-7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)AMINO]PROPAN-2-OL",VBASHTSSQNDDAS-CQSZACIVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
80628,6m3m,DB00239,-8.0,Oxiconazole,QRJJEGAJXVEBNE-HKOYGPOVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
72066,6m2n,DB00295,-8.0,Morphine,BQJCRHHNABKAKU-KBQPJGBKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
126372,6w4h,DB03751,-8.0,2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose,YSYKRGRSMLTJNL-URARBOGNSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
62102,6crv,DB13087,-8.0,Miridesap,HZLAWYIBLZNRFZ-VXGBXAGGSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88113,6m3m,DB13358,-8.0,Cibenzoline,IPOBOOXFSRWSHL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58746,6crv,DB06536,-8.0,Tesaglitazar,CXGTZJYQWSUFET-IBGZPJMESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
102977,6vxs,DB08026,-8.0,"2-{4-[(4-imidazo[1,2-a]pyridin-3-ylpyrimidin-2-yl)amino]piperidin-1-yl}-N-methylacetamide",AJLILYAPRHIFAS-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102985,6vxs,DB08034,-8.0,"(E)-3,4-DIHYDROXY-N'-[(2-METHOXYNAPHTHALEN-1-YL)METHYLENE]BENZOHYDRAZIDE",TVOPERZEGKBKAY-RGVLZGJSSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102993,6vxs,DB08043,-8.0,1-[4-(PYRIDIN-4-YLOXY)PHENYL]-3-[3-(TRIFLUOROMETHYL)PHENYL]UREA,DDDLGNOZDKDSEG-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
161042,7bv1,DB12787,-8.0,Norethandrolone,ZDHCJEIGTNNEMY-XGXHKTLJSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
103035,6vxs,DB08094,-8.0,"(4-AMINO-2-{[1-(METHYLSULFONYL)PIPERIDIN-4-YL]AMINO}PYRIMIDIN-5-YL)(2,3-DIFLUORO-6-METHOXYPHENYL)METHANONE",JRNJNYBQQYBCLE-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
161047,7bv1,DB12796,-8.0,MRX-I,SULYVXZZUMRQAX-NSHDSACASA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
128196,6w4h,DB07324,-8.0,"3-({2-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)ETHYNYL]BENZYL}AMINO)-1,3-OXAZOL-2(3H)-ONE",ZUJWSOPIDUWELP-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
58703,6crv,DB06436,-8.0,Semaxanib,WUWDLXZGHZSWQZ-WQLSENKSSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
103163,6vxs,DB08241,-8.0,4-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)--BENZAMIDE,RUUOIINPNMNPIU-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
103169,6vxs,DB08248,-8.0,3-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)-BENZENESULFONAMIDE,BKDUVKJYBJDZQW-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
103183,6vxs,DB08268,-8.0,"6-AMINO-4-[2-(4-METHYLPHENYL)ETHYL]-1,7-DIHYDRO-8H-IMIDAZO[4,5-G]QUINAZOLIN-8-ONE",SPVJRTJUEVXOMS-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
161089,7bv1,DB12869,-8.0,Eliprodil,GGUSQTSTQSHJAH-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
103252,6vxs,DB08355,-8.0,"1-methyl-8-(phenylamino)-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxylic acid",ZOBRPBVIEUWYJR-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
103288,6vxs,DB08399,-8.0,PICEATANNOL,CDRPUGZCRXZLFL-OWOJBTEDSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
103318,6vxs,DB08437,-8.0,Puromycin,RXWNCPJZOCPEPQ-NVWDDTSBSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
103324,6vxs,DB08444,-8.0,"3-[2-bromo-4-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)phenoxy]-5-methylbenzonitrile",YYGZQXRLQMFHDH-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
103362,6vxs,DB08490,-8.0,CTS-1027,ROSNVSQTEGHUKU-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
128163,6w4h,DB07289,-8.0,5-[3-(BENZYLAMINO)PHENYL]-4-BROMO-3-(CARBOXYMETHOXY)THIOPHENE-2-CARBOXYLIC ACID,XEQPGVUGYAUMSA-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
103405,6vxs,DB08538,-8.0,"N-((2-aminopyrimidin-5-yl)methyl)-5-(2,6-difluorophenyl)-3-ethylpyrazolo[1,5-a]pyrimidin-7-amine",HQPVGVSQPQVZLD-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
103535,6vxs,DB08701,-8.0,"2-(3-BROMOPHENYL)-6-[(2-HYDROXYETHYL)AMINO]-1H-BENZO[DE]ISOQUINOLINE-1,3(2H)-DIONE",JZCUVYNOSDWORZ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
161261,7bv1,DB13470,-8.0,Cefodizime,XDZKBRJLTGRPSS-BGZQYGJUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
58619,6crv,DB06207,-8.0,Silodosin,PNCPYILNMDWPEY-QGZVFWFLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
103540,6vxs,DB08706,-8.0,"(2S)-({(5Z)-5-[(5-ETHYL-2-FURYL)METHYLENE]-4-OXO-4,5-DIHYDRO-1,3-THIAZOL-2-YL}AMINO)(4-FLUOROPHENYL)ACETIC ACID",RNEACARJKXYVND-MZLJFPOFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
58615,6crv,DB06201,-8.0,Rufinamide,POGQSBRIGCQNEG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
103621,6vxs,DB08794,-8.0,Ethyl biscoumacetate,JCLHQFUTFHUXNN-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
103689,6vxs,DB08899,-8.0,Enzalutamide,WXCXUHSOUPDCQV-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102963,6vxs,DB08011,-8.0,"(3E)-5-fluoro-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-1H-indole-2,3-dione 3-oxime",DXIHOIDYHQSQKJ-HMMYKYKNSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
103710,6vxs,DB08934,-8.0,Sofosbuvir,TTZHDVOVKQGIBA-IQWMDFIBSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102953,6vxs,DB08000,-8.0,"2-(CARBOXYMETHYL)-1-OXO-1,2-DIHYDRONAPHTHO[1,2-D]ISOTHIAZOLE-4-CARBOXYLIC ACID 3,3-DIOXIDE",ZTJGXDGAXGWOGR-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
161017,7bv1,DB12405,-8.0,Triciribine,HOGVTUZUJGHKPL-HTVVRFAVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
102436,6vxs,DB07394,-8.0,AUROVERTIN B,QXCOFYWOWZJFEA-YJMRODJJSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
58915,6crv,DB06859,-8.0,N-ALLYL-5-AMIDINOAMINOOXY-PROPYLOXY-3-CHLORO-N-CYCLOPENTYLBENZAMIDE,XWIUMAPBZWNFNV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
102437,6vxs,DB07395,-8.0,"4-[3-(2-Chloro-4,5-difluoro-benzoyl)ureido]-3-trifluoromethoxybenzoic acid",NWQGDIBCFLDHDO-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
128273,6w4h,DB07415,-8.0,4-[(1S)-1-(3-fluoro-4-methoxyphenyl)-2-(2-methoxy-5-nitrophenyl)ethyl]-1H-imidazol-2-amine,RFLOFHKRBGKCOB-AWEZNQCLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
102500,6vxs,DB07469,-8.0,"(3aS)-3a-hydroxy-7-methyl-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one",KAJFGRLMKVNMLH-GOSISDBHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
160869,7bv1,DB11841,-8.0,Entinostat,INVTYAOGFAGBOE-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
102527,6vxs,DB07501,-8.0,(2S)-1-{4-[(4-Anilino-5-bromo-2-pyrimidinyl)amino]phenoxy}-3-(dimethylamino)-2-propanol,MEIJADBULOETOV-KRWDZBQOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102542,6vxs,DB07519,-8.0,"(6R)-2-amino-6-[2-(3'-methoxybiphenyl-3-yl)ethyl]-3,6-dimethyl-5,6-dihydropyrimidin-4(3H)-one",VDFBMQAUECXNKR-OAQYLSRUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
58882,6crv,DB06814,-8.0,Protokylol,LUMAEVHDZXIGEP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
102568,6vxs,DB07548,-8.0,"2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUORO-6-PYRIDINYL)METHYL]ACETAMIDE",JXHWVKOKYDAROD-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102580,6vxs,DB07563,-8.0,"1-{7-cyclohexyl-6-[4-(4-methylpiperazin-1-yl)benzyl]-7H-pyrrolo[2,3-d]pyrimidin-2-yl}methanamine",GCJSOJRPNOWSEH-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102585,6vxs,DB07570,-8.0,3-CYCLOHEXYL-1-(2-MORPHOLIN-4-YL-2-OXOETHYL)-2-PHENYL-1H-INDOLE-6-CARBOXYLIC ACID,ZKEZEXYKYHYIMQ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102618,6vxs,DB07612,-8.0,6-(3-AMINOPHENYL)-N-(TERT-BUTYL)-2-(TRIFLUOROMETHYL)QUINAZOLIN-4-AMINE,XQKJVNGGVLHNLA-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102627,6vxs,DB07622,-8.0,"1-(3-(2,4-DIMETHYLTHIAZOL-5-YL)-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)-3-(4-METHYLPIPERAZIN-1-YL)UREA",KRKQVGZXTNLQSV-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102652,6vxs,DB07649,-8.0,"(3R,4S)-1-[(4-amino-5H-pyrrolo[3,2-d]pyrimidin-7-yl)methyl]-4-[(benzylsulfanyl)methyl]pyrrolidin-3-ol",DIGGNILBPCEZIV-CVEARBPZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102672,6vxs,DB07676,-8.0,"3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)-1H,2'H-2,3'-biindol-2'-one",CKLAPOFDFZKCPB-LBPRGKRZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
58822,6crv,DB06708,-8.0,Lumefantrine,DYLGFOYVTXJFJP-MYYYXRDXSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
102698,6vxs,DB07706,-8.0,2-Hydrox1tradiol,DILDHNKDVHLEQB-XSSYPUMDSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
160931,7bv1,DB12285,-8.0,Verubecestat,YHYKUSGACIYRML-KRWDZBQOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
102736,6vxs,DB07751,-8.0,"(2S)-1-[4-({6-[(2,6-Difluorophenyl)amino]-4-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol",ZVSBKYYVBCKDBO-HNNXBMFYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102753,6vxs,DB07770,-8.0,5-(4-FLUOROPHENYL)-3-{[(4-METHYLPHENYL)SULFONYL]AMINO}THIOPHENE-2-CARBOXYLIC ACID,DJPFUQBNQLKCAB-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102774,6vxs,DB07794,-8.0,"5-(2-PHENYLPYRAZOLO[1,5-A]PYRIDIN-3-YL)-1H-PYRAZOLO[3,4-C]PYRIDAZIN-3-AMINE",XVECMUKVOMUNLE-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
128237,6w4h,DB07373,-8.0,"ANDROSTA-1,4-DIENE-3,17-DIONE",LUJVUUWNAPIQQI-QAGGRKNESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
102819,6vxs,DB07844,-8.0,6-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1-BENZOTHIOPHENE-2-SULFONAMIDE,PHLKBODTBJLXRD-WFASDCNBSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
161006,7bv1,DB12391,-8.0,Sagopilone,BFZKMNSQCNVFGM-UCEYFQQTSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
102924,6vxs,DB07968,-8.0,N-(2-CHLORO-4-FLUOROBENZOYL)-N'-(5-HYDROXY-2-METHOXYPHENYL)UREA,RFOBTYLRURSVJE-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
161014,7bv1,DB12401,-8.0,Bromperidol,RKLNONIVDFXQRX-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
128221,6w4h,DB07352,-8.0,Apigenin,KZNIFHPLKGYRTM-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
103715,6vxs,DB08942,-8.0,Isoxicam,YYUAYBYLJSNDCX-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
128141,6w4h,DB07265,-8.0,"3-(9-HYDROXY-1,3-DIOXO-4-PHENYL-2,3-DIHYDROPYRROLO[3,4-C]CARBAZOL-6(1H)-YL)PROPANOIC ACID",JDARUOOLJCFUOY-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
103799,6vxs,DB09054,-8.0,Idelalisib,IFSDAJWBUCMOAH-HNNXBMFYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
161546,7bv1,DB15052,-8.0,Ansofaxine,QKYBZJLEMOZFFU-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
104551,6vxs,DB12167,-8.0,LY-3023414,ACCFLVVUVBJNGT-AWEZNQCLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
127979,6w4h,DB07078,-8.0,"(3Z)-6-(4-HYDROXY-3-METHOXYPHENYL)-3-(1H-PYRROL-2-YLMETHYLENE)-1,3-DIHYDRO-2H-INDOL-2-ONE",AYSXURJZVXBSRV-WJDWOHSUSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
104614,6vxs,DB12262,-8.0,CRS-3123,NNTYBKTXMKBRFA-CQSZACIVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104624,6vxs,DB12273,-8.0,Ecopipam,DMJWENQHWZZWDF-PKOBYXMFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104646,6vxs,DB12301,-8.0,Doravirine,ZIAOVIPSKUPPQW-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
161694,7bv1,DB00482,-8.0,Celecoxib,RZEKVGVHFLEQIL-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
127967,6w4h,DB07061,-8.0,"1-(CYCLOHEXYLAMINO)-3-(6-METHYL-3,4-DIHYDRO-1H-CARBAZOL-9(2H)-YL)PROPAN-2-OL",AXYFCRIRLKSCRR-SFHVURJKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
58316,6crv,DB04836,-8.0,Amineptine,ONNOFKFOZAJDHT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127961,6w4h,DB07055,-8.0,"2-[2-(1H-tetrazol-5-yl)ethyl]-1H-isoindole-1,3(2H)-dione",DEOJDUHRJBKATO-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
161712,7bv1,DB00502,-8.0,Haloperidol,LNEPOXFFQSENCJ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
161751,7bv1,DB00554,-8.0,Piroxicam,QYSPLQLAKJAUJT-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
127955,6w4h,DB07049,-8.0,(2R)-1-[(4-tert-butylphenyl)sulfonyl]-2-methyl-4-(4-nitrophenyl)piperazine,SOFGQQQVQZQJFS-MRXNPFEDSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
104699,6vxs,DB12379,-8.0,Indirubin,CRDNMYFJWFXOCH-BUHFOSPRSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
127937,6w4h,DB07030,-8.0,(5-CHLORO-2-{[(3-NITROBENZYL)AMINO]CARBONYL}PHENOXY)ACETIC ACID,VABIMMIJVWNHFI-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
58261,6crv,DB04768,-8.0,Pyrithiamine Pyrophosphate,ZHKSTKOYQKNDSJ-UHFFFAOYSA-O,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
161812,7bv1,DB00628,-8.0,Clorazepic acid,XDDJGVMJFWAHJX-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
127930,6w4h,DB07022,-8.0,3-Hydroxypropyl 3-[(7-carbamimidoyl-1-naphthyl)carbamoyl]benzenesulfonate,PXERBGNIBOFZOW-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
161824,7bv1,DB00643,-8.0,Mebendazole,OPXLLQIJSORQAM-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
104760,6vxs,DB12463,-8.0,Semagacestat,PKXWXXPNHIWQHW-RCBQFDQVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
161841,7bv1,DB00665,-8.0,Nilutamide,XWXYUMMDTVBTOU-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
161844,7bv1,DB00670,-8.0,Pirenzepine,RMHMFHUVIITRHF-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
104772,6vxs,DB12477,-8.0,Perfluoro tert-butylcyclohexane,VLTXBOGHSBHSAC-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104777,6vxs,DB12483,-8.0,Copanlisib,PZBCKZWLPGJMAO-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104829,6vxs,DB12567,-8.0,Camicinal,RZKDEGZIFSJVNA-IBGZPJMESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104839,6vxs,DB12580,-8.0,Tradipitant,CAVRKWRKTNINFF-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
58211,6crv,DB04696,-8.0,"4-CHLORO-3',3''-DIBROMOPHENOL-1,8-NAPHTHALEIN",GFGZCXHXQCQRFP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104531,6vxs,DB12135,-8.0,Elubrixin,YQYFEGTYCUQBEI-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
58371,6crv,DB04920,-8.0,Clevidipine,KPBZROQVTHLCDU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104497,6vxs,DB12092,-8.0,Naftopidil,HRRBJVNMSRJFHQ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
161522,7bv1,DB15003,-8.0,PF-06700841,BUWBRTXGQRBBHG-MJBXVCDLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
103863,6vxs,DB09178,-8.0,Phenaridine,ODPKHHGQKIYCTJ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
103868,6vxs,DB09183,-8.0,Dasabuvir,NBRBXGKOEOGLOI-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
103912,6vxs,DB09231,-8.0,Benidipine,QZVNQOLPLYWLHQ-ZEQKJWHPSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
103941,6vxs,DB09274,-8.0,Artesunate,FIHJKUPKCHIPAT-AHIGJZGOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
103964,6vxs,DB09330,-8.0,Osimertinib,DUYJMQONPNNFPI-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104114,6vxs,DB11440,-8.0,Norgestomet,IWSXBCZCPVUWHT-VIFKTUCRSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104124,6vxs,DB11457,-8.0,Rotenone,JUVIOZPCNVVQFO-HBGVWJBISA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104175,6vxs,DB11592,-8.0,Nitrocefin,LHNIIDJCEODSHA-OQRUQETBSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
128125,6w4h,DB07248,-8.0,"7-PYRIDIN-2-YL-N-(3,4,5-TRIMETHOXYPHENYL)-7H-PYRROLO[2,3-D]PYRIMIDIN-2-AMINE",YENZSPIOXMNEFF-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
58505,6crv,DB05596,-8.0,PRX-03140,SCHKZZSVELPJKU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
128121,6w4h,DB07244,-8.0,"5-{4-[(3,5-DIFLUOROBENZYL)AMINO]PHENYL}-6-ETHYLPYRIMIDINE-2,4-DIAMINE",SRRWXMSVQYQCRX-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
58498,6crv,DB05562,-8.0,Naluzotan,SPWZXWDPAWDKQE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
128105,6w4h,DB07222,-8.0,(3S)-N-(5-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE,RJWMDETWDDESBP-ZDUSSCGKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
102420,6vxs,DB07375,-8.0,"5-BETA-ANDROSTANE-3,17-DIONE",RAJWOBJTTGJROA-QJISAEMRSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
128100,6w4h,DB07217,-8.0,"N-(3-cyano-4,5,6,7-tetrahydro-1-benzothien-2-yl)-2-fluorobenzamide",YVYPYORTKAIUGJ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
104299,6vxs,DB11796,-8.0,Fostemsavir,SWMDAPWAQQTBOG-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104305,6vxs,DB11805,-8.0,Saracatinib,OUKYUETWWIPKQR-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104309,6vxs,DB11814,-8.0,PF-03882845,XNULRSOGWPFPBL-REWPJTCUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104312,6vxs,DB11817,-8.0,Baricitinib,XUZMWHLSFXCVMG-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
58445,6crv,DB05288,-8.0,Anecortave acetate,YUWPMEXLKGOSBF-GACAOOTBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
161496,7bv1,DB14917,-8.0,Ceralasertib,DTTJKLNXNZAVSM-JYCIKRDWSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
161502,7bv1,DB14932,-8.0,Coleneuramide,CHMRTBYTCBDIRG-JQZMMWJVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
104406,6vxs,DB11951,-8.0,Lemborexant,MUGXRYIUWFITCP-PGRDOPGGSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
128042,6w4h,DB07148,-8.0,"(6S)-1-chloro-3-[(4-fluorobenzyl)oxy]-6-(pyrrolidin-1-ylcarbonyl)pyrrolo[1,2-a]pyrazin-4(6H)-one",HPAFVLDARQIHPU-HNNXBMFYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
104451,6vxs,DB12021,-8.0,Dinaciclib,PIMQWRZWLQKKBJ-SFHVURJKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
128032,6w4h,DB07138,-8.0,Neflamapimod,VEPKQEUBKLEPRA-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
104454,6vxs,DB12025,-8.0,Triptolide,DFBIRQPKNDILPW-CIVMWXNOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104460,6vxs,DB12039,-8.0,Epicatechin,PFTAWBLQPZVEMU-UKRRQHHQSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104281,6vxs,DB11773,-8.0,BMS-903452,OGIAVRWXUPYGGC-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
161967,7bv1,DB01029,-8.0,Irbesartan,YOSHYTLCDANDAN-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
102374,6vxs,DB07321,-8.0,"2,5-DICHLORO-N-[5-METHOXY-7-(6-METHOXYPYRIDIN-3-YL)-1,3-BENZOXAZOL-2-YL]BENZENESULFONAMIDE",KOKQLKWXOFRTHE-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102327,6vxs,DB07271,-8.0,"4-[(3R)-3-Amino-4-(2,4,5-trifluorophenyl)butanoyl]-3-(2,2,2-trifluoroethyl)-1,4-diazepan-2-one",RMDAPSXWBVPVOG-IAPIXIRKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
160116,7bv1,DB07531,-8.0,"4-{5-[(Z)-(2,4-DIOXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE",JNPRTUHVCHGFHJ-GHXNOFRVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160123,7bv1,DB07538,-8.0,"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}-2-(TRIFLUOROMETHYL)BENZENESULFONAMIDE",RGVVHQNJKUNSFQ-WDZFZDKYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160125,7bv1,DB07540,-8.0,"4-{5-[(1Z)-1-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)ETHYL]-2-FURYL}BENZENESULFONAMIDE",AKFVRSQELXTCFW-JYRVWZFOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
100066,6vxs,DB03082,-8.0,6-[(Z)-Amino(Imino)Methyl]-N-[4-(Aminomethyl)Phenyl]-4-(Pyrimidin-2-Ylamino)-2-Naphthamide,CSWQJKHBMACTGB-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
160133,7bv1,DB07549,-8.0,"2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUORO-3-METHYL-6-PYRIDINYL)METHYL]ACETAMIDE",WOYBPRBUPLYTPY-UHFFFAOYSA-P,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
100151,6vxs,DB03199,-8.0,4-Methoxy-E-Rhodomycin T,XSSVYBYWQBNYOH-QJIXERIWSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
100164,6vxs,DB03213,-8.0,Bis(5-Amidino-2-Benzimidazolyl)Methane Ketone,VVVXDHROXQUONB-UHFFFAOYSA-P,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
160159,7bv1,DB07583,-8.0,"(4R,2S)-5'-(4-(4-CHLOROBENZYLOXY)PYRROLIDIN-2-YLMETHANESULFONYL)ISOQUINOLINE",RLNNFNGBXLTQOB-RBUKOAKNSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160170,7bv1,DB07595,-8.0,"(5Z)-5-(3-BROMOCYCLOHEXA-2,5-DIEN-1-YLIDENE)-N-(PYRIDIN-4-YLMETHYL)-1,5-DIHYDROPYRAZOLO[1,5-A]PYRIMIDIN-7-AMINE",WSIQKQLAGWVKSL-UHFFFAOYSA-O,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
100262,6vxs,DB03337,-8.0,1-(2-Amidinophenyl)-3-(Phenoxyphenyl)Urea,ZHCAYBOLUMAUQX-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
100287,6vxs,DB03368,-8.0,"5-Methyl-5-(4-Phenoxy-Phenyl)-Pyrimidine-2,4,6-Trione",RTBMLCLTYAPKIF-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
59343,6crv,DB07350,-8.0,(2E)-N-hydroxy-3-[1-methyl-4-(phenylacetyl)-1H-pyrrol-2-yl]prop-2-enamide,UFQOXIMRSMFQRI-BQYQJAHWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59342,6crv,DB07348,-8.0,Brefeldin A,KQNZDYYTLMIZCT-KQPMLPITSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
160283,7bv1,DB07965,-8.0,6-(cyclohexylamino)-9-[2-(4-methylpiperazin-1-yl)-ethyl]-9H-purine-2-carbonitrile,OGODDSLNRULSMM-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
100531,6vxs,DB03723,-8.0,2'-Deoxy-Thymidine-Beta-L-Rhamnose,ZOSQFDVXNQFKBY-CGAXJHMRSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
100553,6vxs,DB03751,-8.0,2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose,YSYKRGRSMLTJNL-URARBOGNSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
100584,6vxs,DB03788,-8.0,GC-24,JYHIGYLGYNCMGI-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
128524,6w4h,DB07715,-8.0,Emodin,RHMXXJGYXNZAPX-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
100698,6vxs,DB03932,-8.0,LFA703,WPVRNXUYVXQXPY-YFAYRSKXSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
59278,6crv,DB07280,-8.0,5-[4-(DIMETHYLAMINO)PHENYL]-6-[(6-MORPHOLIN-4-YLPYRIDIN-3-YL)ETHYNYL]PYRIMIDIN-4-AMINE,AINVOEOJEKKMKB-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
100814,6vxs,DB04092,-8.0,Apstatin,YVUUZAPYLPWFHE-HXFGRODQSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
160319,7bv1,DB08005,-8.0,4-{[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino}-N-ethylpiperidine-1-carboxamide,ARMFMDYRYOKSOW-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
100839,6vxs,DB04125,-8.0,N-Alpha-(2-Naphthylsulfonyl)-N(3-Amidino-L-Phenylalaninyl)-4-Acetyl-Piperazine,ZUWBXGHMVKDMQO-DEOSSOPVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
128507,6w4h,DB07695,-8.0,"N-(3,5-dibromo-4-hydroxyphenyl)-4-hydroxy-3,5-dimethylbenzamide",HHFKUQZPNITQLU-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
100883,6vxs,DB04177,-8.0,"4-(3,14-Dihydroxy-10,13-Dimethyl-Hexadecahydro-Cyclopenta[a]Phenanthren-17-Yl)-5h-Furan-2-One",XZTUSOXSLKTKJQ-CESUGQOBSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
160337,7bv1,DB08023,-8.0,"N-cyclohexyl-4-imidazo[1,2-a]pyridin-3-yl-N-methylpyrimidin-2-amine",HYNNWLVWJXWXFO-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
128504,6w4h,DB07692,-8.0,"1-[(2,6-difluorophenyl)sulfonyl]-4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)piperazine",SHWNKRPMUBFWKE-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
99880,6vxs,DB02834,-8.0,IDD552,ZCAGEXZTORJQDZ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
100914,6vxs,DB04216,-8.0,Quercetin,REFJWTPEDVJJIY-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
99874,6vxs,DB02827,-8.0,"7-(1,1-Dioxo-1h-Benzo[D]Isothiazol-3-Yloxymethyl)-2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Pyran-3-Carboxylic Acid",MDYIGSPVMWSFEZ-JTQLQIEISA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
99774,6vxs,DB02691,-8.0,Glycocholic acid,RFDAIACWWDREDC-FRVQLJSFSA-M,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
98712,6vxs,DB01261,-8.0,Sitagliptin,MFFMDFFZMYYVKS-SECBINFHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
159919,7bv1,DB07081,-8.0,"(2R)-4-[(8R)-8-METHYL-2-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[1,5-A]PYRAZIN-7(8H)-YL]-4-OXO-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE",FDEXEPZGMKFCTG-PSASIEDQSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
98749,6vxs,DB01347,-8.0,Saprisartan,DUEWVPTZCSAMNB-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
98855,6vxs,DB01496,-8.0,Barbituric acid derivative,DNZPLHRZXUJATK-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
98907,6vxs,DB01554,-8.0,Bolandiol,CMXKUJNZWYTFJN-XFUVECHXSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
98926,6vxs,DB01573,-8.0,Benzylmorphine,RDJGWRFTDZZXSM-RNWLQCGYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
98964,6vxs,DB01623,-8.0,Thiothixene,GFBKORZTTCHDGY-UWVJOHFNSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
128700,6w4h,DB07920,-8.0,N-oxo-2-[(4-phenylphenyl)sulfonylamino]ethanamide,OGRPZMQLAVBWPV-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
128687,6w4h,DB07901,-8.0,5-CHLORO-6-METHYL-N-(2-PHENYLETHYL)-2-PYRIDIN-2-YLPYRIMIDIN-4-AMINE,HIUOABSWQSUEGK-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
128676,6w4h,DB07889,-8.0,"(2S)-1-(Dimethylamino)-3-(4-{[4-(2-methylimidazo[1,2-a]pyridin-3-yl)-2-pyrimidinyl]amino}phenoxy)-2-propanol",VCPXSBULBDYRLT-SFHVURJKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
99028,6vxs,DB01705,-8.0,Bis(5-Amidino-Benzimidazolyl)Methane,QZKOOEFIMWKZPK-UHFFFAOYSA-Q,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
99046,6vxs,DB01732,-8.0,"(4r,5s,6s,7r)-1,3-Dibenzyl-4,7-Bis(Phenoxymethyl)-5,6-Dihydroxy-1,3 Diazepan-2-One",SQBOSZXDOHQFAA-ZRTHHSRSSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
99146,6vxs,DB01861,-8.0,Uridine diphosphate glucose,HSCJRCZFDFQWRP-JZMIEXBBSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
59532,6crv,DB07574,-8.0,"2-MERCAPTO-N-[1,2,3,10-TETRAMETHOXY-9-OXO-5,6,7,9-TETRAHYDRO-BENZO[A]HEPTALEN-7-YL]ACETAMIDE",TYDIWMTWTXFWSY-HNNXBMFYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
99157,6vxs,DB01876,-8.0,Bis(5-Amidino-2-Benzimidazolyl)Methanone,VVVXDHROXQUONB-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
99258,6vxs,DB02019,-8.0,Acetyl Dithranol,IXLRLZOYKJERRA-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
99306,6vxs,DB02081,-8.0,Bis-Benzamidine,BXYGSMRTHHSAHZ-PMACEKPBSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
59491,6crv,DB07527,-8.0,"N-[(2R,3S)-3-AMINO-2-HYDROXY-4-PHENYLBUTYL]-4-METHOXY-2,3,6-TRIMETHYLBENZENESULFONAMIDE",HORGTFOBJRCVMO-ZWKOTPCHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
99392,6vxs,DB02197,-8.0,"4-[(4-Imidazo[1,2-a]Pyridin-3-Ylpyrimidin-2-Yl)Amino]Benzenesulfonamide",NKORVPQBJCGYEC-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
99410,6vxs,DB02221,-8.0,"4-(Aminosulfonyl)-N-[(2,4,6-Trifluorophenyl)Methyl]-Benzamide",DVTYOTODFLDHRL-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
128633,6w4h,DB07838,-8.0,(Z)-3-BENZYL-5-(2-HYDROXY-3-NITROBENZYLIDENE)-2-THIOXOTHIAZOLIDIN-4-ONE,ZTWBCEZQPRYIGY-ZROIWOOFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
99503,6vxs,DB02342,-8.0,2-Methox1tradiol,CQOQDQWUFQDJMK-SSTWWWIQSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
160078,7bv1,DB07486,-8.0,"3-({4-[(1E)-3-morpholin-4-yl-3-oxoprop-1-en-1-yl]-2,3-bis(trifluoromethyl)phenyl}sulfanyl)aniline",KLSZVPNVFKKIRD-FNORWQNLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59452,6crv,DB07480,-8.0,4-PHOSPHONOOXY-PHENYL-METHYL-[4-PHOSPHONOOXY]BENZEN,LGSCVLKUKMBYNC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
99718,6vxs,DB02616,-8.0,FR117016,CKJGKHXCUDWFDC-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
160081,7bv1,DB07489,-8.0,"4-Amino-2-[(3-chlorophenyl)amino]-5-(4-fluorobenzoyl)-1,3-thiazol-3-ium",WWGPTHOMFHDEEC-UHFFFAOYSA-O,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59438,6crv,DB07461,-8.0,"3-AMINO-3-BENZYL-9-CARBOXAMIDE[4.3.0]BICYCLO-1,6-DIAZANONAN-2-ONE",JVDDTUQPPBUQDD-DZGCQCFKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
99795,6vxs,DB02716,-8.0,7-Methyl-Guanosine-5'-Triphosphate,DKVRNHPCAOHRSI-KQYNXXCUSA-O,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
160339,7bv1,DB08026,-8.0,"2-{4-[(4-imidazo[1,2-a]pyridin-3-ylpyrimidin-2-yl)amino]piperidin-1-yl}-N-methylacetamide",AJLILYAPRHIFAS-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
101017,6vxs,DB04362,-8.0,Adenosine Diphosphate 5-(Beta-Ethyl)-4-Methyl-Thiazole-2-Carboxylic Acid,VGXBGQACJQRWLV-LKGUXBDMSA-K,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101041,6vxs,DB04395,-8.0,Phosphoaminophosphonic Acid-Adenylate Ester,PVKSNHVPLWYQGJ-FCIPNVEPSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
128404,6w4h,DB07570,-8.0,3-CYCLOHEXYL-1-(2-MORPHOLIN-4-YL-2-OXOETHYL)-2-PHENYL-1H-INDOLE-6-CARBOXYLIC ACID,ZKEZEXYKYHYIMQ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
101749,6vxs,DB06409,-8.0,Morphine glucuronide,GNJCUHZOSOYIEC-GAROZEBRSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101750,6vxs,DB06410,-8.0,Doxercalciferol,HKXBNHCUPKIYDM-CGMHZMFXSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
128403,6w4h,DB07568,-8.0,"(2S)-2-[(2,1,3-BENZOTHIADIAZOL-4-YLSULFONYL)AMINO]-2-PHENYL-N-PYRIDIN-4-YLACETAMIDE",ADRNPUSZBRQDBG-KRWDZBQOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
160597,7bv1,DB08816,-8.0,Ticagrelor,OEKWJQXRCDYSHL-FNOIDJSQSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
101761,6vxs,DB06440,-8.0,Ravuconazole,OPAHEYNNJWPQPX-RCDICMHDSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101789,6vxs,DB06510,-8.0,Muraglitazar,IRLWJILLXJGJTD-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101796,6vxs,DB06525,-8.0,Ganstigmine,ZOBDWFRKFSPCRB-UNMCSNQZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101798,6vxs,DB06529,-8.0,Ocinaplon,OQJFBUOFGHPMSR-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101805,6vxs,DB06543,-8.0,Astaxanthin,MQZIGYBFDRPAKN-UWFIBFSHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101812,6vxs,DB06578,-8.0,Tonabersat,XLIIRNOPGJTBJD-ROUUACIJSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101815,6vxs,DB06581,-8.0,Bevirimat,YJEJKUQEXFSVCJ-WRFMNRASSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101831,6vxs,DB06616,-8.0,Bosutinib,UBPYILGKFZZVDX-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
160627,7bv1,DB08867,-8.0,Ulipristal,HKDLNTKNLJPAIY-WKWWZUSTSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
128376,6w4h,DB07536,-8.0,"N-{(1S,2R)-2-hydroxy-1-[(hydroxyamino)carbonyl]propyl}-4-{[4-(morpholin-4-ylmethyl)phenyl]ethynyl}benzamide",FQYBTYFKOHPWQT-VGSWGCGISA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
160636,7bv1,DB08882,-8.0,Linagliptin,LTXREWYXXSTFRX-QGZVFWFLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160647,7bv1,DB09223,-8.0,Blonanserin,XVGOZDAJGBALKS-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160689,7bv1,DB09285,-8.0,Morniflumate,LDXSPUSKBDTEKA-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
101966,6vxs,DB06850,-8.0,(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclohexylamino)ethanoyl)pyrrolidine-2-carboxamide,RYKFVFFOIYLADT-SFHVURJKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101996,6vxs,DB06886,-8.0,N-BENZYLOXYCARBONYL-ALA-PRO-3-AMINO-4-PHENYL-BUTAN-2-OL,MACLRJNEKXUAJK-YDLSIGKMSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
160706,7bv1,DB09330,-8.0,Osimertinib,DUYJMQONPNNFPI-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160768,7bv1,DB11176,-8.0,Zeaxanthin,JKQXZKUSFCKOGQ-QAYBQHTQSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
128327,6w4h,DB07479,-8.0,"(1S)-1,2,3,4-TETRAHYDRO-BENZO[C]PHENANTHRENE-2,3,4-TRIOL",WCUHTHVUZQCBTI-KBAYOESNSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
102225,6vxs,DB07152,-8.0,N-[4-(5-fluoro-6-methylpyridin-2-yl)-5-quinoxalin-6-yl-1H-imidazol-2-yl]acetamide,TYPILNNEZPSNTI-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102288,6vxs,DB07226,-8.0,"N-[4-(2-CHLOROPHENYL)-1,3-DIOXO-1,2,3,6-TETRAHYDROPYRROLO[3,4-C]CARBAZOL-9-YL]FORMAMIDE",JWZVNUNTFNELHL-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
160829,7bv1,DB11786,-8.0,Pefcalcitol,SVCSMAZYWOQCBW-NVJMFHFGSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
102302,6vxs,DB07244,-8.0,"5-{4-[(3,5-DIFLUOROBENZYL)AMINO]PHENYL}-6-ETHYLPYRIMIDINE-2,4-DIAMINE",SRRWXMSVQYQCRX-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
160535,7bv1,DB08746,-8.0,1-[[(1E)-2-(4-CHLOROPHENYL)ETHENYL]SULFONYL]-4-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]PIPERAZINE,ZOSSOFIFNGGDKG-GIJQJNRQSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59108,6crv,DB07083,-8.0,beta-phenyl-D-phenylalanyl-N-propyl-L-prolinamide,HZKKJPDVZGOOPU-PZJWPPBQSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59112,6crv,DB07087,-8.0,"4-[(1S,2S,5S,9R)-5-(HYDROXYMETHYL)-8,9-DIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL",YMSZEVAWRFDVQX-GHVWTTSJSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
101711,6vxs,DB06280,-8.0,Senicapoc,SCTZUZTYRMOMKT-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101156,6vxs,DB04549,-8.0,"4-(Aminosulfonyl)-N-[(2,3,4-Trifluorophenyl)Methyl]-Benzamide",AANTYZRUJFNZFI-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101176,6vxs,DB04573,-8.0,Estriol,PROQIPRRNZUXQM-ZXXIGWHRSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101203,6vxs,DB04608,-8.0,"9-HYDROXY-4-PHENYL-6H-PYRROLO[3,4-C]CARBAZOLE-1,3-DIONE",IAUZTOZLTFSMIE-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
59230,6crv,DB07223,-8.0,"METHYL N-({(2S,3S)-3-[(PROPYLAMINO)CARBONYL]OXIRAN-2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINATE",XGWSRLSPWIEMLQ-YTFOTSKYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
160396,7bv1,DB08331,-8.0,"N-1H-imidazol-2-yl-N'-[4-(1H-imidazol-2-ylamino)phenyl]benzene-1,4-diamine",JHMXUERQMCJRHG-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160400,7bv1,DB08340,-8.0,"N,N'-DIPHENYLPYRAZOLO[1,5-A][1,3,5]TRIAZINE-2,4-DIAMINE",LLYYAUZAGCZEKV-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
128480,6w4h,DB07663,-8.0,"2-[(1R)-1-CARBOXY-2-(4-HYDROXYPHENYL)ETHYL]-1,3-DIOXOISOINDOLINE-5-CARBOXYLIC ACID",QISJEFYTLZTWIQ-CQSZACIVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
101306,6vxs,DB04750,-8.0,OREGON GREEN 488 CARBOXYLATE,BRJCLSQFZSHLRL-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101350,6vxs,DB04812,-8.0,Benoxaprofen,MITFXPHMIHQXPI-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
59204,6crv,DB07192,-8.0,(3S)-N-(3-BROMOPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE,MVPIURCUINFSAB-LBPRGKRZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59198,6crv,DB07185,-8.0,2-{[(4-CHLOROPHENOXY)ACETYL]AMINO}BENZOIC ACID,LXSDGQYDSDIUPN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
101379,6vxs,DB04842,-8.0,Fluspirilene,QOYHHIBFXOOADH-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101387,6vxs,DB04853,-8.0,Binodenoson,XJFMHMFFBSOEPR-DNZQAUTHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
58944,6crv,DB06891,-8.0,"5-{[(4-AMINO-3-CHLORO-5-FLUOROPHENYL)SULFONYL]AMINO}-1,3,4-THIADIAZOLE-2-SULFONAMIDE",HOLJYLOVIHBQHO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
101413,6vxs,DB04886,-8.0,Calanolide A,NIDRYBLTWYFCFV-FMTVUPSXSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101449,6vxs,DB04982,-8.0,Talampanel,JACAAXNEHGBPOQ-LLVKDONJSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
59179,6crv,DB07164,-8.0,"N-cyclopropyl-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amine",CAGHIASAHLPQMS-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
101455,6vxs,DB05016,-8.0,Ataluren,OOUGLTULBSNHNF-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101473,6vxs,DB05105,-8.0,Pleconaril,KQOXLKOJHVFTRN-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101482,6vxs,DB05154,-8.0,Pretomanid,ZLHZLMOSPGACSZ-NSHDSACASA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
160452,7bv1,DB08402,-8.0,"2-[(2,4-DICHLOROBENZOYL)AMINO]-5-(PYRIMIDIN-2-YLOXY)BENZOIC ACID",VNDRRWBKNSHALL-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
128437,6w4h,DB07612,-8.0,6-(3-AMINOPHENYL)-N-(TERT-BUTYL)-2-(TRIFLUOROMETHYL)QUINAZOLIN-4-AMINE,XQKJVNGGVLHNLA-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
160471,7bv1,DB08429,-8.0,N-({(2S)-1-[(3R)-3-amino-4-(3-chlorophenyl)butanoyl]pyrrolidin-2-yl}methyl)-3-(methylsulfonyl)benzamide,QRGBOABBMKYMLG-UXHICEINSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
101635,6vxs,DB06117,-8.0,"1alpha,24S-Dihydroxyvitamin D2",ODZFJAXAEXQSKL-WRJREGAQSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
59125,6crv,DB07104,-8.0,4-amino-N-[4-(benzyloxy)phenyl]butanamide,QTWBKNVNGVYTNZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
101656,6vxs,DB06166,-8.0,Fosdevirine,CGBYTKOSZYQOPV-CCEZBSFNSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
59121,6crv,DB07099,-8.0,N-[4-(benzyloxy)phenyl]glycinamide,YJPUATSIKWOSST-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
101659,6vxs,DB06176,-8.0,Romidepsin,OHRURASPPZQGQM-GCCNXGTGSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101431,6vxs,DB04930,-8.0,Permethrin,RLLPVAHGXHCWKJ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104863,6vxs,DB12623,-8.0,Taprenepag,MFFBXYNKZHTCEY-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104883,6vxs,DB12657,-8.0,JNJ-42396302,BPLVDYJDAVYLRQ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
162009,7bv1,DB01076,-8.0,Atorvastatin,XUKUURHRXDUEBC-KAYWLYCHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
56627,6crv,DB02568,-8.0,Peldesine,DOHVAKFYAHLCJP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56626,6crv,DB02567,-8.0,PD173955,VAARYSWULJUGST-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163717,7bv1,DB06137,-8.0,KX-01,HUNGUWOZPQBXGX-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
127237,6w4h,DB04892,-8.0,Phenserine,PBHFNBQPZCRWQP-QUCCMNQESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
163734,7bv1,DB06169,-8.0,Indibulin,SOLIIYNRSAWTSQ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
107374,6vxx,DB03227,-8.0,Nicotinamide Mononucleotide,DAYLJWODMCOQEW-WYOJIJJFSA-O,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107405,6vxx,DB03262,-8.0,"Al-6619, [2h-Thieno[3,2-E]-1,2-Thiazine-6-Sulfonamide,2-(3-Hydroxyphenyl)-3-(4-Morpholinyl)-, 1,1-Dioxide]",PZLYYZPXSSNGJS-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56555,6crv,DB02479,-8.0,(R)-N-(3-Indol-1-Yl-2-Methyl-Propyl)-4-Sulfamoyl-Benzamide,ZFWHOUCRVSOZJE-CQSZACIVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107446,6vxx,DB03605,-8.0,"(2s)-2-[(2,4-Dichloro-Benzoyl)-(3-Trifluoromethyl-Benzyl)-Amino]-3-Phenyl-Propionic Acid",LAJJKGIZTCCOHY-NRFANRHFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127197,6w4h,DB04841,-8.0,Flunarizine,SMANXXCATUTDDT-QPJJXVBHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
127180,6w4h,DB04823,-8.0,Oxyphenisatin,SJDACOMXKWHBOW-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
107472,6vxx,DB03647,-8.0,3-[Isopropyl(4-Methylbenzoyl)Amino]-5-Phenylthiophene-2-Carboxylic Acid,LRHXIDOGMBZJFN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107474,6vxx,DB03650,-8.0,(3e)-3-[(4-Hydroxyphenyl)Imino]-1h-Indol-2(3h)-One,ZJASRZFZRYISET-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163802,7bv1,DB06321,-8.0,R-348,IGLNXKVGKIFNBQ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
56479,6crv,DB02383,-8.0,Tolrestat,LUBHDINQXIHVLS-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163809,7bv1,DB06347,-8.0,Cenisertib,KSOVGRCOLZZTPF-QMKUDKLTSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
163811,7bv1,DB06354,-8.0,Tezampanel,ZXFRFPSZAKNPQQ-YTWAJWBKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
107571,6vxx,DB03771,-8.0,Allyl-{4-[3-(4-Bromo-Phenyl)-Benzofuran-6-Yloxy]-but-2-Enyl}-Methyl-Amine,KCNKJCHARANTIP-SNAWJCMRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107686,6vxx,DB04180,-8.0,"4-(Aminosulfonyl)-N-[(2,4-Difluorophenyl)Methyl]-Benzamide",NTDFJEKGSGSXME-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56421,6crv,DB02310,-8.0,"3,5,6,8-Tetramethyl-N-Methyl Phenanthrolinium",FQTUZNACZKILMC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107701,6vxx,DB04200,-8.0,Matairesinol,MATGKVZWFZHCLI-LSDHHAIUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107714,6vxx,DB04215,-8.0,CRA_9076,BVTBOJXEAPSOEB-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56398,6crv,DB02276,-8.0,(S)-2-(Phosphonoxy)Caproyl-L-Leucyl-P-Nitroanilide,HARXAJAHMRMERT-HOTGVXAUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163834,7bv1,DB06429,-8.0,Talnetant,BIAVGWDGIJKWRM-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
107730,6vxx,DB04543,-8.0,"2,6-Diamino-8-(1h-Imidazol-2-Ylsulfanylmethyl)-3h-Quinazoline-4-One",CEWKWXPCQGWWBM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163842,7bv1,DB06446,-8.0,Dotarizine,LRMJAFKKJLRDLE-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
107737,6vxx,DB04552,-8.0,Niflumic acid,JZFPYUNJRRFVQU-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127261,6w4h,DB04957,-8.0,Azimilide,MREBEPTUUMTTIA-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
107739,6vxx,DB04554,-8.0,8-Bromoadenosine-5'-Diphosphate,KVVVTFSHHQCHNZ-UUOKFMHZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127269,6w4h,DB04983,-8.0,Denufosol,FPNPSEMJLALQSA-MIYUEGBISA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
107126,6vxx,DB02322,-8.0,Heparin Disaccharide I-S,LRPGJWKAYQRIAQ-GYBHJADLSA-J,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106754,6vxx,DB01209,-8.0,Dezocine,VTMVHDZWSFQSQP-VBNZEHGJSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163561,7bv1,DB04793,-8.0,"1,4:3,6-Dianhydro-2-O-(3-carbamimidoylphenyl)-5-O-(4-carbamimidoylphenyl)-D-glucitol",DKBAWRNTUZFJKV-XMTFNYHQSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
106760,6vxx,DB01216,-8.0,Finasteride,DBEPLOCGEIEOCV-WSBQPABSSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106765,6vxx,DB01222,-8.0,Budesonide,VOVIALXJUBGFJZ-KWVAZRHASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106768,6vxx,DB01228,-8.0,Encainide,PJWPNDMDCLXCOM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127429,6w4h,DB05932,-8.0,Denibulin,GAOHLWCIAJNSEE-JTQLQIEISA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
106816,6vxx,DB01326,-8.0,Cefamandole,OLVCFLKTBJRLHI-AXAPSJFSSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163587,7bv1,DB04825,-8.0,Prenylamine,IFFPICMESYHZPQ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
106817,6vxx,DB01327,-8.0,Cefazolin,MLYYVTUWGNIJIB-BXKDBHETSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163603,7bv1,DB04842,-8.0,Fluspirilene,QOYHHIBFXOOADH-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
56800,6crv,DB02805,-8.0,Uracil arabinose-3'-phosphate,FOGRQMPFHUHIGU-PXBUCIJWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56777,6crv,DB02770,-8.0,7-Alpha-D-Ribofuranosyl-2-Aminopurine-5'-Phosphate,UDRQVOJQMHZSIM-PULFBKJNSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127411,6w4h,DB05804,-8.0,Prasterone sulfate,CZWCKYRVOZZJNM-USOAJAOKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
127405,6w4h,DB05772,-8.0,Rabeximod,PDNNUMNEXITLCZ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
106852,6vxx,DB01399,-8.0,Salsalate,WVYADZUPLLSGPU-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163625,7bv1,DB04872,-8.0,Osanetant,DZOJBGLFWINFBF-UMSFTDKQSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
106909,6vxx,DB01734,-8.0,3-(Oxalyl-Amino)-Naphthalene-2-Carboxylic Acid,DQBLKSRRWDWNKQ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163633,7bv1,DB04882,-8.0,Edotecarin,QMVPQBFHUJZJCS-NTKFZFFISA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
106945,6vxx,DB01780,-8.0,Fusicoccin,KXTYBXCEQOANSX-WYKQKOHHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106965,6vxx,DB01809,-8.0,"1-Ter-Butyl-3-P-Tolyl-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine",ZVPDNRVYHLRXLX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56720,6crv,DB02694,-8.0,Pantoyl Adenylate,GDPVENOGSVMRJL-FSRKKXLISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127344,6w4h,DB05424,-8.0,Canertinib,OMZCMEYTWSXEPZ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
56712,6crv,DB02684,-8.0,5'-O-(N-(L-Cysteinyl)-Sulfamoyl)Adenosine,FTSDEWPMACCNGN-YTMOPEAISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107004,6vxx,DB01858,-8.0,[1-(4-Fluorobenzyl)Cyclobutyl]Methyl (1s)-1-[Oxo(1h-Pyrazol-5-Ylamino)Acetyl]Pentylcarbamate,QTPYRNAKLBXKNP-SFHVURJKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127342,6w4h,DB05422,-8.0,OPC-14523,TZZGTNZBLPCBIS-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
163683,7bv1,DB05884,-8.0,HCV-086,VBRUONUESYTIDA-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
107076,6vxx,DB02255,-8.0,GM6001,NITYDPDXAAFEIT-DYVFJYSZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56644,6crv,DB02593,-8.0,"7,8-Dihydroxy-1-Methoxy-3-Methyl-10-Oxo-4,10-Dihydro-1h,3h-Pyrano[4,3-B]Chromene-9-Carboxylic Acid",RSFJMLCZHPZXCW-AANKLQPISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107750,6vxx,DB04566,-8.0,Inosinic Acid,GRSZFWQUAKGDAV-KQYNXXCUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107758,6vxx,DB04576,-8.0,Fleroxacin,XBJBPGROQZJDOJ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107771,6vxx,DB04596,-8.0,"4-O-{4,6-O-[(1S)-1-Carboxyethylidene]-??-D-mannopyranosyl}-D-glucopyranuronic acid",GZJXZKGVHLWBOW-AISSFXTFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
126740,6w4h,DB04226,-8.0,Dihydro-Acarbose,CUAQESWNTOXZJZ-RTNAABQMSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
126732,6w4h,DB04215,-8.0,CRA_9076,BVTBOJXEAPSOEB-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
108147,6vxx,DB07157,-8.0,"(5R,6S,8S)-8-[3-(AMINOMETHYL)PHENYL]-6-HYDROXY-5-ISOPROPYL-3-OXO-1-PHENYL-2,7-DIOXA-4-AZA-6-PHOSPHANONAN-9-OIC ACID 6-OXIDE",RTFGEFWZCFCODU-RBUKOAKNSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
164033,7bv1,DB06994,-8.0,"(2S,3S)-3-{3-[2-chloro-4-(methylsulfonyl)phenyl]-1,2,4-oxadiazol-5-yl}-1-cyclopentylidene-4-cyclopropyl-1-fluorobutan-2-amine",XCCSSVMRGIQMGF-LPHOPBHVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
126711,6w4h,DB04190,-8.0,Inhibitor Bea425,AHAVBKNGKPWROK-UMFPTGFGSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
56081,6crv,DB01850,-8.0,"(2s,3s,8s,9s)-3-Amino-9-Methoxy-2,6,8-Trimethyl-10-Phenyldeca-4,6-Dienoic Acid",HJVCHYDYCYBBQX-AWKNMOFVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108190,6vxx,DB07206,-8.0,6-[2-(1H-INDOL-6-YL)ETHYL]PYRIDIN-2-AMINE,OSHSZKRWKLQZBV-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
164045,7bv1,DB07006,-8.0,"9-HYDROXY-6-(3-HYDROXYPROPYL)-4-(2-METHOXYPHENYL)PYRROLO[3,4-C]CARBAZOLE-1,3(2H,6H)-DIONE",AOGOZJCRIFBTTN-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
126664,6w4h,DB04131,-8.0,"10-(4-Dimethylamino-5-Hydroxy-6-Methyl-Tetrahydro-Pyran-2-Yloxy)-8-Ethyl-1,8,11-Trihydroxy-7,8,9,10-Tetrahydro-Naphthacene-5,12-Dione",BLGDWFJQIHBUJY-NWJGULHDSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
108200,6vxx,DB07219,-8.0,"BENZYL N-({(2S,3S)-3-[(PROPYLAMINO)CARBONYL]OXIRAN-2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINATE",OMQNYWZURFTFHE-MQBSTWLZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
164052,7bv1,DB07015,-8.0,"(3R,4R)-4-(pyrrolidin-1-ylcarbonyl)-1-(quinoxalin-2-ylcarbonyl)pyrrolidin-3-amine",XDSKICAQKGYYJF-OLZOCXBDSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
56022,6crv,DB01772,-8.0,"3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl]-4-(5-Fluoro-1-Methyl-1h-Indol-3-Yl)-Pyrrole-2,5-Dione",RPGZQOOZHIEPJW-HNNXBMFYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108213,6vxx,DB07235,-8.0,"N-[(1S)-2-AMINO-1-(2,4-DICHLOROBENZYL)ETHYL]-5-[2-(METHYLAMINO)PYRIMIDIN-4-YL]THIOPHENE-2-CARBOXAMIDE",HHOVRZGUSBMKKU-ZDUSSCGKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108219,6vxx,DB07244,-8.0,"5-{4-[(3,5-DIFLUOROBENZYL)AMINO]PHENYL}-6-ETHYLPYRIMIDINE-2,4-DIAMINE",SRRWXMSVQYQCRX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56018,6crv,DB01766,-8.0,Beta-(2-Naphthyl)-Alanine,JPZXHKDZASGCLU-LBPRGKRZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108224,6vxx,DB07249,-8.0,"N-(5-chloro-1,3-benzodioxol-4-yl)-6-methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-amine",QHIMVPIOWKYPSO-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108226,6vxx,DB07251,-8.0,"N'-(3-CHLORO-4-METHOXY-PHENYL)-N-(3,4,5-TRIMETHOXYPHENYL)-1,3,5-TRIAZINE-2,4-DIAMINE",ZVWFECUPYCFYBL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
126619,6w4h,DB04073,-8.0,N-{3-[4-(3-aminopropyl)piperazin-1-yl]propyl}-3-(beta-D-galactopyranosyloxy)-5-nitrobenzamide,UEIGEWJJVQHIAX-DLBZZEGUSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
108249,6vxx,DB07277,-8.0,2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}ETHANESULFONAMIDE,IAUZEBLXCOCAFL-JSGCOSHPSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
164086,7bv1,DB07244,-8.0,"5-{4-[(3,5-DIFLUOROBENZYL)AMINO]PHENYL}-6-ETHYLPYRIMIDINE-2,4-DIAMINE",SRRWXMSVQYQCRX-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
108260,6vxx,DB07546,-8.0,[1-(6-{6-[(1-methylethyl)amino]-1H-indazol-1-yl}pyrazin-2-yl)-1H-pyrrol-3-yl]acetic acid,BBYRUZKRFAIQSR-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108272,6vxx,DB07561,-8.0,(2Z)-2-cyano-N-(3'-ethoxybiphenyl-4-yl)-3-hydroxybut-2-enamide,RPILZQUCBKIPAZ-AQTBWJFISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108319,6vxx,DB07620,-8.0,"2-[(2,4-DICHLORO-5-METHYLPHENYL)SULFONYL]-1,3-DINITRO-5-(TRIFLUOROMETHYL)BENZENE",INAZPZCJNPPHGV-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55935,6crv,DB01656,-8.0,Roflumilast,MNDBXUUTURYVHR-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108372,6vxx,DB07683,-8.0,"N-(dibenzo[b,d]thiophen-3-ylsulfonyl)-L-valine",RZWYSEXQXOXWKA-INIZCTEOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
126376,6w4h,DB03755,-8.0,"Adenosine-5'-[Beta, Gamma-Methylene]Tetraphosphate",ARRGHMSEJJFDME-IOSLPCCCSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
55910,6crv,DB01625,-8.0,Isopropamide,JTPUMZTWMWIVPA-UHFFFAOYSA-O,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
164003,7bv1,DB06954,-8.0,"2-(cycloheptylmethyl)-1,1-dioxido-1-benzothiophen-6-yl sulfamate",BIASYWBGUYOWJR-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
108121,6vxx,DB07127,-8.0,"{4-[2,2-BIS(5-METHYL-1,2,4-OXADIAZOL-3-YL)-3-PHENYLPROPYL]PHENYL}SULFAMIC ACID",SXDBFKLPNPUPRI-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163999,7bv1,DB06948,-8.0,2-ANILINO-6-CYCLOHEXYLMETHOXYPURINE,XWWRLKIBRPJQJX-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
108102,6vxx,DB06849,-8.0,"1-[1'-(3-phenylacryloyl)spiro[1-benzofuran-3,4'-piperidin]-5-yl]methanamine",RQWYWHUKHYFIPB-VQHVLOKHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107778,6vxx,DB04603,-8.0,2'-DEOXY-5-FORMYLCYTIDINE-5'-MONOPHOSPHATE,HDFNXAHZEYLDBJ-XLPZGREQSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127079,6w4h,DB04685,-8.0,"1-{(2S,5S)-4-FLUORO-5-[(TRITYLOXY)METHYL]TETRAHYDROFURAN-2-YL}PYRIMIDINE-2,4(1H,3H)-DIONE",GJNIPWYJQUGERM-BFLUCZKCSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
163859,7bv1,DB06755,-8.0,Beta carotene,OENHQHLEOONYIE-JLTXGRSLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
107786,6vxx,DB04614,-8.0,(R)-tacrine(10)-hupyridone,ROTFGKJJMRTWBD-HHHXNRCGSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107809,6vxx,DB04643,-8.0,"4-{3-CHLORO-4-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-PHENOXY}-BUTYRIC ACID",FYQVFMLCZJZZEM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107814,6vxx,DB04649,-8.0,TETRAHEDRAL INTERMEDIATE OF BLASTICIDIN S,MVFPGTZTOAHVBP-HXYLPHSESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107819,6vxx,DB04655,-8.0,Metoprine,VQJHOPSWBGJHQS-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127065,6w4h,DB04662,-8.0,OLOMOUCINE II,NDUVSANREQEDRE-CQSZACIVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
127000,6w4h,DB04578,-8.0,"(S)-2-[(R)-3-amino-4-(2-fluorophenyl)butyryl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide",OEVYDSSAPNIURZ-AEFFLSMTSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
107906,6vxx,DB05524,-8.0,Pelitinib,WVUNYSQLFKLYNI-AATRIKPKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163900,7bv1,DB06833,-8.0,1-CYCLOHEXYL-N-{[1-(4-METHYLPHENYL)-1H-INDOL-3-YL]METHYL}METHANAMINE,MMIJMYOYKAKQPN-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
107911,6vxx,DB05542,-8.0,Naronapride,VGDDOIZXGFJDRC-VJTSUQJLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
126996,6w4h,DB04574,-8.0,Estrone sulfate,JKKFKPJIXZFSSB-CBZIJGRNSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
106753,6vxx,DB01208,-8.0,Sparfloxacin,DZZWHBIBMUVIIW-DTORHVGOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
126969,6w4h,DB04542,-8.0,3'-Azido-3'-Deoxythymidine-5'-Diphosphate,QOYVAFWJURKBJG-XLPZGREQSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
107978,6vxx,DB05969,-8.0,SNS-032,OUSFTKFNBAZUKL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
126886,6w4h,DB04434,-8.0,Naphthyridine Inhibitor,YRBHUKMLAGQYHS-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
108002,6vxx,DB06685,-8.0,Laquinimod,GKWPCEFFIHSJOE-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108021,6vxx,DB06713,-8.0,Norelgestromin,ISHXLNHNDMZNMC-XUDSTZEESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56204,6crv,DB02021,-8.0,Fidarestat,WAAPEIZFCHNLKK-UFBFGSQYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108033,6vxx,DB06731,-8.0,Seproxetine,WIQRCHMSJFFONW-HNNXBMFYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163952,7bv1,DB06897,-8.0,"3-[3-chloro-5-(5-{[(1S)-1-phenylethyl]amino}isoxazolo[5,4-c]pyridin-3-yl)phenyl]propan-1-ol",MMGKIHLBFPJYJL-HNNXBMFYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
108038,6vxx,DB06737,-8.0,Zaltoprofen,MUXFZBHBYYYLTH-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108056,6vxx,DB06771,-8.0,Besifloxacin,QFFGVLORLPOAEC-SNVBAGLBSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108076,6vxx,DB06814,-8.0,Protokylol,LUMAEVHDZXIGEP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56163,6crv,DB01964,-8.0,AL5424,ZWTSOJQGEWPWGO-NSHDSACASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108080,6vxx,DB06820,-8.0,Sulconazole,AFNXATANNDIXLG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108099,6vxx,DB06845,-8.0,(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclopentylamino)ethanoyl)pyrrolidine-2-carboxamide,WXYKSWZWRHMJTE-KRWDZBQOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107969,6vxx,DB05932,-8.0,Denibulin,GAOHLWCIAJNSEE-JTQLQIEISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106752,6vxx,DB01207,-8.0,Ridogrel,GLLPUTYLZIKEGF-HAVVHWLPSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56890,6crv,DB02918,-8.0,Zardaverine,HJMQDJPMQIHLPB-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56900,6crv,DB02930,-8.0,Adenosine 5'-[??-thio]triphosphate,NLTUCYMLOPLUHL-KQYNXXCUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
105516,6vxs,DB13607,-8.0,Picloxydine,YNCLPFSAZFGQCD-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
105519,6vxs,DB13610,-8.0,Flumedroxone,CDZJOBWKHSYNMO-SCUQKFFVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
105534,6vxs,DB13631,-8.0,Methoserpidine,ULBNWNUHGJLQHO-VKMIBBQISA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
105591,6vxs,DB13708,-8.0,Fenquizone,DBDTUXMDTSTPQZ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
105593,6vxs,DB13710,-8.0,Metenolone,ANJQEDFWRSLVBR-VHUDCFPWSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
162308,7bv1,DB01876,-8.0,Bis(5-Amidino-2-Benzimidazolyl)Methanone,VVVXDHROXQUONB-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
57847,6crv,DB04205,-8.0,"Thymidine-3',5'-Diphosphate",CSNCBOPUCJOHLS-XLPZGREQSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
162319,7bv1,DB01893,-8.0,N6-Benzyl Adenosine-5'-Diphosphate,MRHGMAGSDAQUFH-LSCFUAHRSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
57837,6crv,DB04194,-8.0,Chitotriose,WZZVUHWLNMNWLW-VFCSDQTKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127755,6w4h,DB06803,-8.0,Niclosamide,RJMUSRYZPJIFPJ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
162351,7bv1,DB01944,-8.0,(S)-blebbistatin,LZAXPYOBKSJSEX-GOSISDBHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
127742,6w4h,DB06781,-8.0,Difluprednate,WYQPLTPSGFELIB-JTQPXKBDSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
162367,7bv1,DB01960,-8.0,7n-Methyl-8-Hydroguanosine-5'-Diphosphate,QQODJOAVWUWVHJ-KQYNXXCUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
105751,6vxs,DB13956,-8.0,Estradiol valerate,RSEPBGGWRJCQGY-RBRWEJTLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
105753,6vxs,DB13958,-8.0,Trestolone acetate,IVCRCPJOLWECJU-XQVQQVTHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
105762,6vxs,DB13983,-8.0,"5,7,2'-trihydroxy-6,8-dimethoxyflavone",JWOKGWICZPPYPX-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
57780,6crv,DB04121,-8.0,Guanosine-3'-Monophosphate-5'-Diphosphate,HEYSFDAMRDTCJM-UUOKFMHZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
162379,7bv1,DB01976,-8.0,Aminoanthracene,YUENFNPLGJCNRB-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
105767,6vxs,DB13991,-8.0,Pipequaline,AMEWZCMTSIONOX-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
162389,7bv1,DB01990,-8.0,Cholesterol sulfate,BHYOQNUELFTYRT-DPAQBDIFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
105803,6vxs,DB14065,-8.0,Lomerizine,JQSAYKKFZOSZGJ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
105806,6vxs,DB14068,-8.0,Dexniguldipine,SVJMLYUFVDMUHP-MGBGTMOVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
105869,6vxs,DB14210,-8.0,Moexiprilat,CMPAGYDKASJORH-YSSFQJQWSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
105894,6vxs,DB14545,-8.0,Hydrocortisone succinate,VWQWXZAWFPZJDA-CGVGKPPMSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
105907,6vxs,DB14584,-8.0,Segesterone,SFLXYFZGKSGFKA-XUDSTZEESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
57730,6crv,DB04055,-8.0,"2,3-Dicarboxy-4-(2-Chloro-Phenyl)-1-Ethyl-5-Isopropoxycarbonyl-6-Methyl-Pyridinium",HMSIYRVIPQHZBI-UHFFFAOYSA-O,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
105922,6vxs,DB14635,-8.0,Curcumin sulfate,NEJVQQBBTRFOHB-FCXRPNKRSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
105503,6vxs,DB13591,-8.0,Metopimazine,BQDBKDMTIJBJLA-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
57886,6crv,DB04259,-8.0,7n-Methyl-8-Hydroguanosine-5'-Monophosphate,ZMWJGXGSWZFZPJ-KQYNXXCUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
105443,6vxs,DB13506,-8.0,Carfecillin,NZDASSHFKWDBBU-KVMCETHSSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
105366,6vxs,DB13403,-8.0,Oxypertine,XCWPUUGSGHNIDZ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
162019,7bv1,DB01089,-8.0,Deserpidine,CVBMAZKKCSYWQR-WCGOZPBSSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
104925,6vxs,DB12717,-8.0,Mibampator,ULRDYYKSPCRXAJ-KRWDZBQOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
58159,6crv,DB04626,-8.0,Apramycin,XZNUGFQTQHRASN-XQENGBIVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
162038,7bv1,DB01338,-8.0,Pipecuronium,OWWLUIWOFHMHOQ-XGHATYIMSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
162039,7bv1,DB01339,-8.0,Vecuronium,BGSZAXLLHYERSY-XQIGCQGXSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
162041,7bv1,DB01342,-8.0,Forasartan,YONOBYIBNBCDSJ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
105064,6vxs,DB12939,-8.0,Nikkomycin Z,WWJFFVUVFNBJTN-VHDFTHOZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
105103,6vxs,DB13003,-8.0,Cortivazol,RKHQGWMMUURILY-UHRZLXHJSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
105126,6vxs,DB13036,-8.0,Ramatroban,LDXDSHIEDAPSSA-OAHLLOKOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
105132,6vxs,DB13048,-8.0,PAC-1,YQNRVGJCPCNMKT-LFVJCYFKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
58028,6crv,DB04460,-8.0,(C8-S)-Hydantocidin 5'-Phosphate,MAXSFYCTFIBEAR-FUIMDIGMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
162068,7bv1,DB01405,-8.0,Temafloxacin,QKDHBVNJCZBTMR-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
127804,6w4h,DB06874,-8.0,"(6-[4-(AMINOMETHYL)-2,6-DIMETHYLPHENOXY]-2-{[4-(AMINOMETHYL)PHENYL]AMINO}-5-BROMOPYRIMIDIN-4-YL)METHANOL",LSIZSSASMKSUIU-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
105938,6vxs,DB14652,-8.0,Clocortolone acetate,ARPLCFGLEYFDCN-CDACMRRYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
58012,6crv,DB04437,-8.0,"Cysteine-Methylene-Carbamoyl-1,10-Phenanthroline",ZFGIPRHDRFOMFO-LBPRGKRZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127787,6w4h,DB06853,-8.0,N-cycloheptylglycyl-N-(4-carbamimidoylbenzyl)-L-prolinamide,BYTJPDBCLWUEBU-IBGZPJMESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
162073,7bv1,DB01411,-8.0,Pranlukast,NBQKINXMPLXUET-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
162092,7bv1,DB01431,-8.0,Allylestrenol,ATXHVCQZZJYMCF-XUDSTZEESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
105186,6vxs,DB13122,-8.0,Trabodenoson,AQLVRTWKJDTWQQ-SDBHATRESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
57970,6crv,DB04376,-8.0,13-Acetylphorbol,SDSVJYOOAPRSDA-RPCQODIISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
105190,6vxs,DB13132,-8.0,Artemisinin,BLUAFEHZUWYNDE-NNWCWBAJSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
105206,6vxs,DB13174,-8.0,Rhein,FCDLCPWAQCPTKC-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
105230,6vxs,DB13223,-8.0,Fluocortin,PUWHHWCHAVXSIG-NCLPIGKXSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
162208,7bv1,DB01562,-8.0,1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine,BVURVTVDNWSNFN-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
105250,6vxs,DB13248,-8.0,Phthalylsulfathiazole,PBMSWVPMRUJMPE-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
105292,6vxs,DB13310,-8.0,Ormeloxifene,XZEUAXYWNKYKPL-WDYNHAJCSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
105299,6vxs,DB13317,-8.0,Flunoxaprofen,ARPYQKTVRGFPIS-VIFPVBQESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
105362,6vxs,DB13397,-8.0,Prenoxdiazine,PXZDWASDNFWKSD-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
127790,6w4h,DB06858,-8.0,N-cyclooctylglycyl-N-(4-carbamimidoylbenzyl)-L-prolinamide,MMLOIDMSBRJZAE-FQEVSTJZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
98707,6vxs,DB01252,-8.0,Mitiglinide,WPGGHFDDFPHPOB-BBWFWOEESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
105945,6vxs,DB14660,-8.0,Trenbolone acetate,CMRJPMODSSEAPL-FYQPLNBISA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
106010,6vxs,DB14793,-8.0,RO-5045337,QBGKPEROWUKSBK-QPPIDDCLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
57222,6crv,DB03358,-8.0,7n-Methyl-8-Hydroguanosine-5'-Triphosphate,BUJQMJUTTBGELS-KQYNXXCUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57216,6crv,DB03349,-8.0,8-Bromo-Adenosine-5'-Monophosphate,DNPIJKNXFSPNNY-UUOKFMHZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127531,6w4h,DB06281,-8.0,Torcetrapib,CMSGWTNRGKRWGS-NQIIRXRSSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
57177,6crv,DB03300,-8.0,Pterin Cytosine Dinucleotide,WKSPNQYEWZEMMI-FEFZDOOUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57173,6crv,DB03296,-8.0,3'-beta-Sialyl-beta-lactose,CILYIEBUXJIHCO-LPTWSRJFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163185,7bv1,DB03869,-8.0,5'-O-(N-(L-Seryl)-Sulfamoyl)Adenosine,HQXFJGONGJPTLZ-YTMOPEAISA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
127528,6w4h,DB06274,-8.0,Alvimopan,UPNUIXSCZBYVBB-JVFUWBCBSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
106466,6vxx,DB00378,-8.0,Dydrogesterone,JGMOKGBVKVMRFX-HQZYFCCVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163221,7bv1,DB03917,-8.0,N-Ethyl Retinamide,WKYDOCGICAMTKE-NBIQJRODSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
57123,6crv,DB03230,-8.0,Adenosine-5'-Propylphosphate,XAMXMSZRQHPMRX-QYVSTXNMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106496,6vxx,DB00414,-8.0,Acetohexamide,VGZSUPCWNCWDAN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163226,7bv1,DB03924,-8.0,"5,8-Di-Amino-1,4-Dihydroxy-Anthraquinone",QVEMRPAUHFWHRV-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
127477,6w4h,DB06174,-8.0,Noscapine,AKNNEGZIBPJZJG-MSOLQXFVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
106552,6vxx,DB00481,-8.0,Raloxifene,GZUITABIAKMVPG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57059,6crv,DB03148,-8.0,Phosphomethylphosphonic Acid Adenosyl Ester,OLCWZBFDIYXLAA-IOSLPCCCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106562,6vxx,DB00493,-8.0,Cefotaxime,GPRBEKHLDVQUJE-QSWIMTSFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106604,6vxx,DB00805,-8.0,Minaprine,LDMWSLGGVTVJPG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127463,6w4h,DB06148,-8.0,Mianserin,UEQUQVLFIPOEMF-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
106629,6vxx,DB00831,-8.0,Trifluoperazine,ZEWQUBUPAILYHI-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106677,6vxx,DB00885,-8.0,Pemirolast,HIANJWSAHKJQTH-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56993,6crv,DB03062,-8.0,(1-Methyl-1h-Imidazol-2-Yl)-(3-Methyl-4-{3-[(Pyridin-3-Ylmethyl)-Amino]-Propoxy}-Benzofuran-2-Yl)-Methanone,VZBQJKIOAOUYJL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106693,6vxx,DB00904,-8.0,Ondansetron,FELGMEQIXOGIFQ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163488,7bv1,DB04690,-8.0,Camptothecin,VSJKWCGYPAHWDS-FQEVSTJZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
163492,7bv1,DB04696,-8.0,"4-CHLORO-3',3''-DIBROMOPHENOL-1,8-NAPHTHALEIN",GFGZCXHXQCQRFP-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
56960,6crv,DB03013,-8.0,Di(N-Acetyl-D-Glucosamine),CDOJPCSDOXYJJF-KSKNGZLJSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106721,6vxx,DB00934,-8.0,Maprotiline,QSLMDECMDJKHMQ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106732,6vxx,DB00947,-8.0,Fulvestrant,VWUXBMIQPBEWFH-WCCTWKNTSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57232,6crv,DB03369,-8.0,9-Aminophenanthrene,KIHQWOBUUIPWAN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106349,6vxs,DB13983,-8.0,"5,7,2'-trihydroxy-6,8-dimethoxyflavone",JWOKGWICZPPYPX-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
106309,6vxs,DB15440,-8.0,GSK-3117391,AFDPFLDWOXXHQM-NRFANRHFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
127555,6w4h,DB06362,-8.0,Becatecarin,JSKFWUPVIZYJMR-UDOAKELVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
162563,7bv1,DB02424,-8.0,Geldanamycin,QTQAWLPCGQOSGP-KSRBKZBZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
106014,6vxs,DB14802,-8.0,ONO-2952,ZBQMTQGDBFZUBG-NRFANRHFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
162566,7bv1,DB02429,-8.0,4-(Aminosulfonyl)-N-[(4-Fluorophenyl)Methyl]-Benzamide,IXDVPACDZDRCTN-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
127706,6w4h,DB06717,-8.0,Fosaprepitant,BARDROPHSZEBKC-OITMNORJSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
57624,6crv,DB03909,-8.0,"Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate",UFZTZBNSLXELAL-IOSLPCCCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127679,6w4h,DB06678,-8.0,Esmirtazapine,RONZAEMNMFQXRA-MRXNPFEDSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
57609,6crv,DB03890,-8.0,N-[2-(1-Formyl-2-Methyl-Propyl)-1-(4-Piperidin-1-Yl-but-2-Enoyl)-Pyrrolidin-3-Yl]-Methanesulfonamide,BSBJWRKWANAVRQ-POTLKAILSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57607,6crv,DB03887,-8.0,Alpha-Adenosine Monophosphate,NVOIXARBSSLBAS-CRKDRTNXSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57568,6crv,DB03835,-8.0,"N-[(5S,7R,8S,9S,10R)-8,9,10-Trihydroxy-7-(hydroxymethyl)-2,4-dioxo-6-oxa-1,3-diazaspiro[4.5]dec-3-yl]acetamide",MAHIOGAAEAWGLR-UTAYWCBXSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106115,6vxs,DB15052,-8.0,Ansofaxine,QKYBZJLEMOZFFU-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
162716,7bv1,DB02830,-8.0,FR236913,KCCUBLLGAMGDJL-HXUWFJFHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
57486,6crv,DB03737,-8.0,"4-((3r,4s,5r)-4-Amino-3,5-Dihydroxy-Hex-1-Ynyl)-5-Fluoro-3-[1-(3-Methoxy-1h-Pyrrol-2-Yl)-Meth-(Z)-Ylidene]-1,3-Dihydro-Indol-2-One",RAKYKJWUUUKCCW-MPLBGYFPSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57477,6crv,DB03725,-8.0,Phosphomethylphosphonic Acid-Guanylate Ester,PHBDHXOBFUBCJD-KQYNXXCUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
105974,6vxs,DB14717,-8.0,Nitrazolam,OYRPNABWTHDOFK-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
57453,6crv,DB03695,-8.0,Piritrexim,VJXSSYDSOJBUAV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106175,6vxs,DB15169,-8.0,H3B-6527,MBWRLLRCTIYXDW-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
162796,7bv1,DB02932,-8.0,(R)-Bicalutamide,LKJPYSCBVHEWIU-KRWDZBQOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
162806,7bv1,DB02946,-8.0,Carpropamide,RXDMAYSSBPYBFW-RULNRJAQSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
162878,7bv1,DB03239,-8.0,"3',5'-Dinitro-N-Acetyl-L-Thyronine",VZSQTOXQXPKQJX-ZDUSSCGKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
57376,6crv,DB03585,-8.0,Oxyphenbutazone,HFHZKZSRXITVMK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57367,6crv,DB03573,-8.0,WRR-99,KVZMXOVSHIMGNA-CVEARBPZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127604,6w4h,DB06494,-8.0,Sufugolix,UCQSBGOFELXYIN-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
127596,6w4h,DB06472,-8.0,Fradafiban,IKZACQMAVUIGPY-HOTGVXAUSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
106223,6vxs,DB15265,-8.0,USL-311,XNUNVQKARNSSEO-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
106233,6vxs,DB15287,-8.0,Elismetrep,CWEFDWIKLABKBX-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
106278,6vxs,DB15377,-8.0,ATB-346,YCNMAPLPQYQJFC-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
127559,6w4h,DB06370,-8.0,Indisulam,SETFNECMODOHTO-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
163044,7bv1,DB03695,-8.0,Piritrexim,VJXSSYDSOJBUAV-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
57450,6crv,DB03691,-8.0,WRR-112,KVZMXOVSHIMGNA-HOTGVXAUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
98630,6vxs,DB01162,-8.0,Terazosin,VCKUSRYTPJJLNI-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
159908,7bv1,DB07066,-8.0,"2-CHLORO-N-[(3R)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL]-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE",LJAHIGGEXIWVJG-LLVKDONJSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
128749,6w4h,DB07974,-8.0,1-{2-[(4-CHLOROPHENYL)AMINO]-2-OXOETHYL}-N-(1-ISOPROPYLPIPERIDIN-4-YL)-1H-INDOLE-2-CARBOXAMIDE,BDLMBQRBNPDCSS-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
151453,6wiq,DB02723,-8.0,"4-Oxo-2-Phenylmethanesulfonyl-Octahydro-Pyrrolo[1,2-a]Pyrazine-6-Carboxylic Acid [1-(N-Hydroxycarbamimidoyl)-Piperidin-4-Ylmethyl]-Amide",DHTSUHWLPAEEQB-OALUTQOASA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
91907,6m71,DB03708,-8.0,Adenosine 5'-phosphosulfate,IRLPACMLTUPBCL-KQYNXXCUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
151736,6wiq,DB03104,-8.0,RU82129,NKMPOVPTYDXGEC-MNRBYUMSSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
91949,6m71,DB03758,-8.0,Radicicol,WYZWZEOGROVVHK-GTMNPGAYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
151869,6wiq,DB03276,-8.0,"4-[(10s,14s,18s)-18-(2-Amino-2-Oxoethyl)-14-(1-Naphthylmethyl)-8,17,20-Trioxo-7,16,19-Triazaspiro[5.14]Icos-11-En-10-Yl]Benzylphosphonic Acid",RHYFMOCFCFUTNH-GZNVFMSSSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
92075,6m71,DB03917,-8.0,N-Ethyl Retinamide,WKYDOCGICAMTKE-NBIQJRODSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
129560,6w4h,DB08973,-8.0,Fluclorolone acetonide,NJNWEGFJCGYWQT-VSXGLTOVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
92154,6m71,DB04022,-8.0,"Guanosine-5',3'-Tetraphosphate",BUFLLCUFNHESEH-UUOKFMHZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
92272,6m71,DB04177,-8.0,"4-(3,14-Dihydroxy-10,13-Dimethyl-Hexadecahydro-Cyclopenta[a]Phenanthren-17-Yl)-5h-Furan-2-One",XZTUSOXSLKTKJQ-CESUGQOBSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
152964,6wiq,DB04760,-8.0,"PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-(4-FLUORO-3-METHYL-BENZYLAMIDE)",PYFRREJCFXFNRR-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
129539,6w4h,DB08950,-8.0,Indoramin,JXZZEXZZKAWDSP-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
61293,6crv,DB11872,-8.0,ZD-6126,UGBMEXLBFDAOGL-INIZCTEOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
92290,6m71,DB04201,-8.0,Histidyl-Adenosine Monophosphate,XTFBSLZFYLGYAT-OPYVMVOTSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
92310,6m71,DB04226,-8.0,Dihydro-Acarbose,CUAQESWNTOXZJZ-RTNAABQMSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
92313,6m71,DB04232,-8.0,N-Hydroxy-1-(4-Methoxyphenyl)Sulfonyl-4-Benzyloxycarbonyl-Piperazine-2-Carboxamide,DNGGPLKVDUPXFN-GOSISDBHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
153183,6wiq,DB05454,-8.0,Paliroden,CNEWKIDCGDXBDE-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
92324,6m71,DB04244,-8.0,(2R)-2-(3-Biphenylyl)-N-{(2R)-2-hydroxy-3-[(2-pyridinylsulfonyl)amino]propyl}-4-methylpentanamide,YCDHZDINQZLSRR-DNQXCXABSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
92398,6m71,DB04348,-8.0,Taurocholic Acid,WBWWGRHZICKQGZ-HZAMXZRMSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
92418,6m71,DB04378,-8.0,"3-Amino-N-{4-[2-(2,6-Dimethyl-Phenoxy)-Acetylamino]-3-Hydroxy-1-Isobutyl-5-Phenyl-Pentyl}-Benzamide",APJAEXGNDLFGPD-AWCRTANDSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
92454,6m71,DB04432,-8.0,ZK-805623,ZXIHYCYAQUQHSG-UHFFFAOYSA-O,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
129518,6w4h,DB08915,-8.0,Aleglitazar,DAYKLWSKQJBGCS-NRFANRHFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
153343,6wiq,DB06240,-8.0,Tariquidar,LGGHDPFKSSRQNS-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
153394,6wiq,DB06393,-8.0,Xaliproden,WJJYZXPHLSLMGE-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
153437,6wiq,DB06634,-8.0,Casopitant,XGGTZCKQRWXCHW-WMTVXVAQSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
61259,6crv,DB11821,-8.0,Danegaptide,BIZKIHUJGMSVFD-MNOVXSKESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
92664,6m71,DB04706,-8.0,"(3BETA,7BETA)-CHOLEST-5-ENE-3,7-DIOL",OYXZMSRRJOYLLO-KGZHIOMZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
153621,6wiq,DB06920,-8.0,Eribaxaban,QQBKAVAGLMGMHI-WIYYLYMNSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
91899,6m71,DB03696,-8.0,Lanosterol,CAHGCLMLTWQZNJ-BQNIITSRSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
153653,6wiq,DB06962,-8.0,"(5-(aminomethyl)-2H-spiro[benzofuran-3,4'-piperidine]-1'-yl)(5-(phenylethynyl)furan-2-yl)methanone",YKTUSHSSKIWDRY-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
91882,6m71,DB03671,-8.0,"4-(3,12,14-Trihydroxy-10,13-Dimethyl-Hexadecahydro-Cyclopenta[a]Phenanthren-17-Yl)-5h-Furan-2-One",SHIBSTMRCDJXLN-KCZCNTNESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
150827,6wiq,DB01908,-8.0,RU85493,MWEWSHNGVWABKG-SVBPBHIXSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
90742,6m71,DB02140,-8.0,N1-(1-Dimethylcarbamoyl-2-Phenyl-Ethyl)-2-Oxo-N4-(2-Pyridin-2-Yl-Ethyl)-Succinamide,ZPFPZRVOBBMZMP-SFHVURJKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
90780,6m71,DB02196,-8.0,Uridine-Diphosphate-N-Acetylgalactosamine,LFTYTUAZOPRMMI-NESSUJCYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
149323,6w9q,DB15391,-8.0,Elenbecestat,AACUJFVOHGRMTR-DPXNYUHVSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
149324,6w9q,DB15393,-8.0,Telatinib,QFCXANHHBCGMAS-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
90781,6m71,DB02197,-8.0,"4-[(4-Imidazo[1,2-a]Pyridin-3-Ylpyrimidin-2-Yl)Amino]Benzenesulfonamide",NKORVPQBJCGYEC-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
90795,6m71,DB02217,-8.0,Dpb-T,WTZFKHNHHRPQOU-WSMBLCCSSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
61450,6crv,DB12106,-8.0,PF-06305591,APWZIFIAVVFPNT-PELKAZGASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
90936,6m71,DB02398,-8.0,6-[N-(4-(Aminomethyl)Phenyl)Carbamyl]-2-Naphthalenecarboxamidine,NLBDETRVUYOIHQ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
149348,6w9q,DB15437,-8.0,Rocacetrapib,GBHPDJQHZADVAA-SOKVYYICSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
90948,6m71,DB02411,-8.0,"2-(11-{2-[Benzenesulfonyl-(3-Methyl-Butyl)-Amino]-1-Hydroxy-Ethyl}-6,9-Dioxo-2-Oxa-7,10-Diaza-Bicyclo[11.2.2]Heptadeca-1(16),13(17),14-Trien-8-Yl)-Acetamide, Inhibitor 2",HOUHLOFMBSYNBO-KKUQBAQOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
129628,6w4h,DB09070,-8.0,Tibolone,WZDGZWOAQTVYBX-XOINTXKNSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
90991,6m71,DB02466,-8.0,"4-[3-Oxo-3-(5,5,8,8-Tetramethyl-5,6,7,8-Tetrahydro-Naphthalen-2-Yl)-Propenyl]-Benzoic Acid",ZXQHMEUGMCXKLO-KPKJPENVSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
149850,6wiq,DB00663,-8.0,Flumethasone,WXURHACBFYSXBI-GQKYHHCASA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
149876,6wiq,DB00693,-8.0,Fluorescein,GNBHRKFJIUUOQI-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
129610,6w4h,DB09038,-8.0,Empagliflozin,OBWASQILIWPZMG-QZMOQZSNSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
91252,6m71,DB02812,-8.0,"(2s,4r)-1-Acetyl-N-[(1s)-4-[(Aminoiminomethyl)Amino]-1-(2-Benzothiazolylcarbonyl)Butyl]-4-Hydroxy-2-Pyrrolidinecarboxamide",VXDAVYUFYPFGDX-SNPRPXQTSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
150127,6wiq,DB00984,-8.0,Nandrolone phenpropionate,UBWXUGDQUBIEIZ-QNTYDACNSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
91268,6m71,DB02833,-8.0,[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(3-Nitro-Phenyl)-Amine,DYTKVFHLKPDNRW-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
150286,6wiq,DB01167,-8.0,Itraconazole,VHVPQPYKVGDNFY-ZPGVKDDISA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
91301,6m71,DB02877,-8.0,Arotinoid acid,FOIVPCKZDPCJJY-JQIJEIRASA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
91306,6m71,DB02882,-8.0,Cyanocinnoline,CUWRVIIPSSUUDJ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
91334,6m71,DB02917,-8.0,N-Hydroxy-4-(Methyl{[5-(2-Pyridinyl)-2-Thienyl]Sulfonyl}Amino)Benzamide,LFGYSFPVLMPUPE-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
91438,6m71,DB03062,-8.0,(1-Methyl-1h-Imidazol-2-Yl)-(3-Methyl-4-{3-[(Pyridin-3-Ylmethyl)-Amino]-Propoxy}-Benzofuran-2-Yl)-Methanone,VZBQJKIOAOUYJL-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
61383,6crv,DB12005,-8.0,Nirogacestat,VFCRKLWBYMDAED-REWPJTCUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
91489,6m71,DB03126,-8.0,Mant-Adp,QPKUEBLEGWBRHC-BFHYXJOUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
61367,6crv,DB11982,-8.0,GDC-0623,RFWVETIZUQEJEF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
91651,6m71,DB03337,-8.0,1-(2-Amidinophenyl)-3-(Phenoxyphenyl)Urea,ZHCAYBOLUMAUQX-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
91675,6m71,DB03367,-8.0,PF-00356231,VMTJQZUZINLEKC-JOCHJYFZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
153703,6wiq,DB07020,-8.0,"N-{3-[5-(1H-1,2,4-triazol-3-yl)-1H-indazol-3-yl]phenyl}furan-2-carboxamide",LMDMJDCLPIVGQD-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
153708,6wiq,DB07026,-8.0,"(1S,5S,7R)-N-7-(BIPHENYL-4-YLMETHYL)-N-3-HYDROXY-6,8-DIOXA-3-AZABICYCLO[3.2.1]OCTANE-3,7-DICARBOXAMIDE",PPLDARNGJSQINK-OKZBNKHCSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
153980,6wiq,DB07333,-8.0,"N-(CYCLOPROPYLMETHYL)-4-(METHYLOXY)-3-({5-[3-(3-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-YL}AMINO)BENZENESULFONAMIDE",KRGKAARWVPUWSY-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
155844,6wiq,DB11830,-8.0,Mocetinostat,HRNLUBSXIHFDHP-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
93314,6m71,DB06786,-8.0,Halcinonide,MUQNGPZZQDCDFT-JNQJZLCISA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
155860,6wiq,DB11855,-8.0,Revefenacin,FYDWDCIFZSGNBU-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
155886,6wiq,DB11896,-8.0,Gedatolisib,DWZAEMINVBZMHQ-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
93434,6m71,DB06940,-8.0,"N-ethyl-4-{[5-(methoxycarbamoyl)-2-methylphenyl]amino}-5-methylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide",ZZTMFGIGOADCFX-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93445,6m71,DB06954,-8.0,"2-(cycloheptylmethyl)-1,1-dioxido-1-benzothiophen-6-yl sulfamate",BIASYWBGUYOWJR-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
155895,6wiq,DB11907,-8.0,Rociletinib,HUFOZJXAKZVRNJ-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
93448,6m71,DB06962,-8.0,"(5-(aminomethyl)-2H-spiro[benzofuran-3,4'-piperidine]-1'-yl)(5-(phenylethynyl)furan-2-yl)methanone",YKTUSHSSKIWDRY-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93518,6m71,DB07041,-8.0,"N-[2-(2,4-diaminopyrido[2,3-d]pyrimidin-7-yl)-2-methylpropyl]-4-phenoxybenzamide",FDJWFDQRPKKBFA-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93525,6m71,DB07049,-8.0,(2R)-1-[(4-tert-butylphenyl)sulfonyl]-2-methyl-4-(4-nitrophenyl)piperazine,SOFGQQQVQZQJFS-MRXNPFEDSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
155967,6wiq,DB12012,-8.0,PF-04457845,BATCTBJIJJEPHM-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
93541,6m71,DB07066,-8.0,"2-CHLORO-N-[(3R)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL]-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE",LJAHIGGEXIWVJG-LLVKDONJSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93604,6m71,DB07140,-8.0,"5-[(3R)-3-(5-methoxybiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",JPENSYBRTSIYGO-AWEZNQCLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93642,6m71,DB07183,-8.0,N-(4-phenoxyphenyl)-2-[(pyridin-4-ylmethyl)amino]nicotinamide,CPVRYQAOUPSUDO-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93659,6m71,DB07203,-8.0,6-CYCLOHEXYLMETHOXY-2-(3'-CHLOROANILINO) PURINE,OUEGMEMDEAOAEG-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
156114,6wiq,DB12427,-8.0,Orvepitant,XWNBGDJPEXZSQM-VZOBGQTKSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
156115,6wiq,DB12428,-8.0,PAC-14028,UKGJZDSUJSPAJL-YPUOHESYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
93668,6m71,DB07215,-8.0,"2-METHYL-2-(4-{[({4-METHYL-2-[4-(TRIFLUOROMETHYL)PHENYL]-1,3-THIAZOL-5-YL}CARBONYL)AMINO]METHYL}PHENOXY)PROPANOIC ACID",ILUPZUOBHCUBKB-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
156152,6wiq,DB12480,-8.0,Betulinic Acid,QGJZLNKBHJESQX-FZFNOLFKSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
93713,6m71,DB07268,-8.0,2-({2-[(3-HYDROXYPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)BENZAMIDE,QHPKKGUGRGRSGA-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60936,6crv,DB09495,-8.0,Avobenzone,XNEFYCZVKIDDMS-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
93719,6m71,DB07274,-8.0,"N-cyclopropyl-6-[(6,7-dimethoxyquinolin-4-yl)oxy]naphthalene-1-carboxamide",ZATGFXTWDKIEKC-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
156184,6wiq,DB12535,-8.0,AC-430,DCRWIATZWHLIPN-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
60924,6crv,DB09378,-8.0,Fluprednisolone,MYYIMZRZXIQBGI-HVIRSNARSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
156200,6wiq,DB12558,-8.0,AEE-788,OONFNUWBHFSNBT-HXUWFJFHSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
156249,6wiq,DB12640,-8.0,CP-609754,JAHDAIPFBPPQHQ-GDLZYMKVSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
156284,6wiq,DB12690,-8.0,LY-2584702,FYXRSVDHGLUMHB-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
61098,6crv,DB11529,-8.0,Melengestrol,OKHAOBQKCCIRLO-IBVJIVQJSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61106,6crv,DB11555,-8.0,Zolazepam,GDSCFOSHSOWNDL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
93201,6m71,DB06578,-8.0,Tonabersat,XLIIRNOPGJTBJD-ROUUACIJSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
155831,6wiq,DB11794,-8.0,Berzosertib,JZCWLJDSIRUGIN-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
92771,6m71,DB04845,-8.0,Ixabepilone,FABUFPQFXZVHFB-PVYNADRNSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
154159,6wiq,DB07545,-8.0,N-{3-[(4-{[3-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-2-YL)AMINO]PHENYL}CYCLOPROPANECARBOXAMIDE,RDTDWGQDFJPTPD-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
92783,6m71,DB04863,-8.0,Lefradafiban,PGCFXITVMNNKON-ROUUACIJSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
129511,6w4h,DB08905,-8.0,Formestane,OSVMTWJCGUFAOD-KZQROQTASA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
154221,6wiq,DB07622,-8.0,"1-(3-(2,4-DIMETHYLTHIAZOL-5-YL)-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)-3-(4-METHYLPIPERAZIN-1-YL)UREA",KRKQVGZXTNLQSV-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
154279,6wiq,DB07692,-8.0,"1-[(2,6-difluorophenyl)sulfonyl]-4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)piperazine",SHWNKRPMUBFWKE-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
154286,6wiq,DB07700,-8.0,"3-CARBOXAMIDO-1,3,5(10)-ESTRATRIEN-17(R)-SPIRO-2'(5',5'-DIMETHYL-6'OXO)TETRAHYDROPYRAN",YVAJWBACBRSVPR-NDUHRLLKSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
92812,6m71,DB04908,-8.0,Flibanserin,PPRRDFIXUUSXRA-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
92843,6m71,DB05015,-8.0,Belinostat,NCNRHFGMJRPRSK-MDZDMXLPSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
92852,6m71,DB05048,-8.0,Cannabinor,GSTZHANFXAKPSE-MXTREEOPSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
92906,6m71,DB05408,-8.0,Emricasan,SCVHJVCATBPIHN-SJCJKPOMSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
154618,6wiq,DB08080,-8.0,LATRUNCULIN B,NSHPHXHGRHSMIK-JRIKCGFMSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
154696,6wiq,DB08164,-8.0,"(3R,4R)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN-3-AMINE",GOBIXGZJSMAOFV-QRWLVFNGSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
61464,6crv,DB12123,-8.0,Cinepazide,RCUDFXMNPQNBDU-VOTSOKGWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
92913,6m71,DB05423,-8.0,ORG-34517,DFELGYQKEOCHOA-BZAFBGKRSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
92961,6m71,DB05667,-8.0,Levoketoconazole,XMAYWYJOQHXEEK-ZEQKJWHPSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
155176,6wiq,DB08749,-8.0,3-(2-AMINO-6-BENZOYLQUINAZOLIN-3(4H)-YL)-N-CYCLOHEXYL-N-METHYLPROPANAMIDE,KTRFBFMYAJOXLG-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
92968,6m71,DB05706,-8.0,13-deoxydoxorubicin,RGVRUQHYQSORBY-JIGXQNLBSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
92991,6m71,DB05861,-8.0,Tasquinimod,ONDYALNGTUAJDX-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
61170,6crv,DB11689,-8.0,Selumetinib,CYOHGALHFOKKQC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
93062,6m71,DB06202,-8.0,Lasofoxifene,GXESHMAMLJKROZ-IAPPQJPRSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
155406,6wiq,DB09074,-8.0,Olaparib,FDLYAMZZIXQODN-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
93096,6m71,DB06268,-8.0,Sitaxentan,PHWXUGHIIBDVKD-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
155644,6wiq,DB11431,-8.0,Moxidectin,YZBLFMPOMVTDJY-LSGXYNIPSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
93128,6m71,DB06368,-8.0,Alamifovir,VDBGPMJFHCJMOL-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
129462,6w4h,DB08820,-8.0,Ivacaftor,PURKAOJPTOLRMP-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
129441,6w4h,DB08795,-8.0,Azidocillin,ODFHGIPNGIAMDK-NJBDSQKTSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
93178,6m71,DB06510,-8.0,Muraglitazar,IRLWJILLXJGJTD-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
92931,6m71,DB05511,-8.0,Piclidenoson,HUJXGQILHAUCCV-MOROJQBDSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
90605,6m71,DB01960,-8.0,7n-Methyl-8-Hydroguanosine-5'-Diphosphate,QQODJOAVWUWVHJ-KQYNXXCUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
129647,6w4h,DB09095,-8.0,Difluocortolone,OGPWIDANBSLJPC-RFPWEZLHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
149313,6w9q,DB15358,-8.0,JNJ-54175446,CWFVVQFVGMFTBD-SECBINFHSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
88577,6m3m,DB14060,-8.0,NS-398,KTDZCOWXCWUPEO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
130481,6w4h,DB12320,-8.0,Palovarotene,YTFHCXIPDIHOIA-DHZHZOJOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
147662,6w9q,DB12270,-8.0,Losmapimod,KKYABQBFGDZVNQ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
130440,6w4h,DB12270,-8.0,Losmapimod,KKYABQBFGDZVNQ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
147743,6w9q,DB12382,-8.0,R-306465,MUTBJZVSRNUIHA-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
88703,6m3m,DB14638,-8.0,Diloxanide furoate,BDYYDXJSHYEDGB-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
147839,6w9q,DB12522,-8.0,Toreforant,FCRFVPZAXGJLPW-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
130332,6w4h,DB12113,-8.0,CE-224535,FUCKCIVGBCBZNP-MRXNPFEDSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
61864,6crv,DB12713,-8.0,Sotagliflozin,QKDRXGFQVGOQKS-CRSSMBPESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88767,6m3m,DB14753,-8.0,Hydroxystilbamidine,TUESWZZJYCLFNL-DAFODLJHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
147871,6w9q,DB12571,-8.0,Rimacalib,MYTIJGWONQOOLC-HNNXBMFYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
130288,6w4h,DB12049,-8.0,Dasolampanel etibutil,HPBRMCFZIGUGTK-ZMMAXQRCSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130286,6w4h,DB12046,-8.0,Atopaxar,QWKAUGRRIXBIPO-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
147948,6w9q,DB12693,-8.0,Ritanserin,JUQLTPCYUFPYKE-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
88805,6m3m,DB14846,-8.0,Bimiralisib,ADGGYDAFIHSYFI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
147949,6w9q,DB12694,-8.0,CE-326597,UBNMGTSDHSQBEL-PMERELPUSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
130263,6w4h,DB12009,-8.0,GW-406381,NXMZBNYLCVTRGB-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130252,6w4h,DB11995,-8.0,Avatrombopag,OFZJKCQENFPZBH-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130232,6w4h,DB11963,-8.0,Dacomitinib,LVXJQMNHJWSHET-AATRIKPKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130229,6w4h,DB11960,-8.0,Carboxyamidotriazole,WNRZHQBJSXRYJK-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
61801,6crv,DB12615,-8.0,Plazomicin,IYDYFVUFSPQPPV-PEXOCOHZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130218,6w4h,DB11943,-8.0,Delafloxacin,DYDCPNMLZGFQTM-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130204,6w4h,DB11921,-8.0,Deflazacort,FBHSPRKOSMHSIF-GRMWVWQJSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130196,6w4h,DB11910,-8.0,MK-0249,DDDZBLNULGDPGA-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
148022,6w9q,DB12812,-8.0,Palomid 529,YEAHTLOYHVWAKW-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
148048,6w9q,DB12857,-8.0,NVP-LEQ-506,POERAARDVFVDLO-QGZVFWFLSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
88898,6m3m,DB15059,-8.0,Aprocitentan,DKULOVKANLVDEA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88561,6m3m,DB14028,-8.0,Nordazepam,AKPLHCDWDRPJGD-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
61951,6crv,DB12857,-8.0,NVP-LEQ-506,POERAARDVFVDLO-QGZVFWFLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88543,6m3m,DB13989,-8.0,Epitizide,RINBGYCKMGDWPY-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
147598,6w9q,DB12180,-8.0,Apitolisib,YOVVNQKCSKSHKT-HNNXBMFYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
88129,6m3m,DB13380,-8.0,Difemerine,GUONSMXZEYTWML-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
130658,6w4h,DB12580,-8.0,Tradipitant,CAVRKWRKTNINFF-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
88179,6m3m,DB13448,-8.0,Mazaticol,AMHPTVWBZSYFSS-OAGGEKHMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
130647,6w4h,DB12566,-8.0,Decernotinib,ASUGUQWIHMTFJL-QGZVFWFLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130644,6w4h,DB12562,-8.0,Setipiprant,IHAXLPDVOWLUOS-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
88228,6m3m,DB13514,-8.0,Pranoprofen,TVQZAMVBTVNYLA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
130638,6w4h,DB12553,-8.0,Fluocinolone,UUOUOERPONYGOS-CLCRDYEYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130635,6w4h,DB12548,-8.0,Sparsentan,WRFHGDPIDHPWIQ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
88251,6m3m,DB13548,-8.0,Dibrompropamidine,GMJFVGRUYJHMCO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
130634,6w4h,DB12547,-8.0,LY-2886721,NIDRNVHMMDAAIK-YPMLDQLKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130630,6w4h,DB12540,-8.0,Lecozotan,NRPQELCNMADTOZ-OAQYLSRUSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
147390,6w9q,DB11871,-8.0,PF-00610355,YPHDIMUXXABSSO-YTTGMZPUSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
147416,6w9q,DB11907,-8.0,Rociletinib,HUFOZJXAKZVRNJ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
148069,6w9q,DB12888,-8.0,Ezutromid,KSGCNXAZROJSNW-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
130612,6w4h,DB12512,-8.0,Verucerfont,VKHVAUKFLBBZFJ-SFHVURJKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
88315,6m3m,DB13635,-8.0,Tiracizine,KJAMZCVTJDTESW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
147429,6w9q,DB11925,-8.0,Vistusertib,JUSFANSTBFGBAF-IRXDYDNUSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
88337,6m3m,DB13665,-8.0,Fluanisone,IRYFCWPNDIUQOW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88355,6m3m,DB13684,-8.0,Omoconazole,JMFOSJNGKJCTMJ-ZHZULCJRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
62001,6crv,DB12930,-8.0,Opipramol,YNZFUWZUGRBMHL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
147482,6w9q,DB12006,-8.0,BMS-906024,AYOUDDAETNMCBW-GSHUGGBRSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
130580,6w4h,DB12464,-8.0,Bevenopran,ZGCYVRNZWGUXNQ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
88460,6m3m,DB13825,-8.0,Fedrilate,RDEOYUSTRWNWLX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
61977,6crv,DB12896,-8.0,PSI-352938,PVRFQJIRERYGTQ-DSQUMVBZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130557,6w4h,DB12428,-8.0,PAC-14028,UKGJZDSUJSPAJL-YPUOHESYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
88495,6m3m,DB13873,-8.0,Fenofibric acid,MQOBSOSZFYZQOK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88501,6m3m,DB13916,-8.0,Toyocamycin,XOKJUSAYZUAMGJ-WOUKDFQISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
61964,6crv,DB12879,-8.0,Omigapil,QLMMOGWZCFQAPU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88302,6m3m,DB13617,-8.0,Clorexolone,VPMWFZKOWULPGT-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
93779,6m71,DB07338,-8.0,Acifluorfen,NUFNQYOELLVIPL-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
88947,6m3m,DB15156,-8.0,ABT-072,XMZSTQYSBYEENY-RMKNXTFCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88959,6m3m,DB15187,-8.0,Dubermatinib,YUAALFPUEOYPNX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
149134,6w9q,DB15011,-8.0,Avacopan,PUKBOVABABRILL-YZNIXAGQSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
149136,6w9q,DB15013,-8.0,TAK-243,KJDAGXLMHXUAGV-DGWLBADLSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
149141,6w9q,DB15028,-8.0,MK-1064,CKTWQGHVNRYNCM-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
89743,6m71,DB00846,-8.0,Flurandrenolide,POPFMWWJOGLOIF-XWCQMRHXSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
129731,6w4h,DB09231,-8.0,Benidipine,QZVNQOLPLYWLHQ-ZEQKJWHPSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
89820,6m71,DB00932,-8.0,Tipranavir,SUJUHGSWHZTSEU-FYBSXPHGSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
89843,6m71,DB00959,-8.0,Methylprednisolone,VHRSUDSXCMQTMA-PJHHCJLFSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
89870,6m71,DB00991,-8.0,Oxaprozin,OFPXSFXSNFPTHF-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
61554,6crv,DB12254,-8.0,ABT-751,URCVCIZFVQDVPM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
89948,6m71,DB01081,-8.0,Diphenoxylate,HYPPXZBJBPSRLK-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
90013,6m71,DB01155,-8.0,Gemifloxacin,ZRCVYEYHRGVLOC-HYARGMPZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
129710,6w4h,DB09206,-8.0,Trimazosin,YNZXWQJZEDLQEG-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
90065,6m71,DB01212,-8.0,Ceftriaxone,VAAUVRVFOQPIGI-SPQHTLEESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
90097,6m71,DB01254,-8.0,Dasatinib,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
90101,6m71,DB01261,-8.0,Sitagliptin,MFFMDFFZMYYVKS-SECBINFHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
129704,6w4h,DB09200,-8.0,Rivoglitazone,XMSXOLDPMGMWTH-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
90121,6m71,DB01320,-8.0,Fosphenytoin,XWLUWCNOOVRFPX-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
90157,6m71,DB01392,-8.0,Yohimbine,BLGXFZZNTVWLAY-SCYLSFHTSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
149257,6w9q,DB15247,-8.0,Vorolanib,KMIOJWCYOHBUJS-HAKPAVFJSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
149260,6w9q,DB15257,-8.0,Milademetan,RYAYYVTWKAOAJF-QISPRATLSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
149264,6w9q,DB15266,-8.0,TAK-580,VWMJHAFYPMOMGF-ZCFIWIBFSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
90187,6m71,DB01430,-8.0,Almitrine,OBDOVFRMEYHSQB-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
61503,6crv,DB12184,-8.0,Gepirone,QOIGKGMMAGJZNZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61501,6crv,DB12181,-8.0,Dalcetrapib,YZQLWPMZQVHJED-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61499,6crv,DB12179,-8.0,Secoisolariciresinol,PUETUDUXMCLALY-HOTGVXAUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
90258,6m71,DB01514,-8.0,Furazabol,RGLLOUBXMOGLDQ-IVEVATEUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
90423,6m71,DB01713,-8.0,Udp-Alpha-D-Xylopyranose,DQQDLYVHOTZLOR-OCIMBMBZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
89553,6m71,DB00620,-8.0,Triamcinolone,GFNANZIMVAIWHM-OBYCQNJPSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
61588,6crv,DB12300,-8.0,P-nitrobiphenyl,BAJQRLZAPXASRD-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
89441,6m71,DB00481,-8.0,Raloxifene,GZUITABIAKMVPG-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
89409,6m71,DB00443,-8.0,Betamethasone,UREBDLICKHMUKA-DVTGEIKXSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
148168,6w9q,DB13040,-8.0,Gandotinib,SQSZANZGUXWJEA-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
130087,6w4h,DB11753,-8.0,Rifamycin,HJYYPODYNSCCOU-ODRIEIDWSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130084,6w4h,DB11749,-8.0,(R)-Praziquantel,FSVJFNAIGNNGKK-KRWDZBQOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130081,6w4h,DB11743,-8.0,Ipatasertib,GRZXWCHAXNAUHY-NSISKUIASA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
148203,6w9q,DB13093,-8.0,TAK-593,DZFZXPPHBWCXPQ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
130061,6w4h,DB11711,-8.0,Navarixin,IXBYSXNOKFHHDR-QGZVFWFLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
148210,6w9q,DB13101,-8.0,4SC-202,PRXXYMVLYKJITB-IZZDOVSWSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
130043,6w4h,DB11686,-8.0,Iferanserin,UXIPFQUBOVWAQW-UEBLJOKOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130028,6w4h,DB11666,-8.0,Buparlisib,CWHUFRVAEUJCEF-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130018,6w4h,DB11650,-8.0,HT-0712,ABEJDMOBAFLQNJ-NHCUHLMSSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
61694,6crv,DB12445,-8.0,Nitroaspirin,IOJUJUOXKXMJNF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
148556,6w9q,DB13607,-8.0,Picloxydine,YNCLPFSAZFGQCD-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
89063,6m3m,DB15394,-8.0,gamma-Tocopherol,QUEDXNHFTDJVIY-DQCZWYHMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
148080,6w9q,DB12903,-8.0,DEBIO-1347,BEMNJULZEQTDJY-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
148712,6w9q,DB13814,-8.0,Talampicillin,SOROUYSPFADXSN-SUWVAFIASA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
61658,6crv,DB12400,-8.0,Voxtalisib,RGHYDLZMTYDBDT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
129773,6w4h,DB09295,-8.0,Talniflumate,ANMLJLFWUCQGKZ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
148829,6w9q,DB14035,-8.0,Englitazone,MVDXXGIBARMXSA-PYUWXLGESA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
148847,6w9q,DB14069,-8.0,ONT-093,RSJCLODJSVZNQA-BQYQJAHWSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
148945,6w9q,DB14581,-8.0,CPI-1205,HPODOLXTMDHLLC-QGZVFWFLSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
148970,6w9q,DB14644,-8.0,Methylprednisolone hemisuccinate,IMBXEJJVJRTNOW-XYMSELFBSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
89208,6m71,DB00203,-8.0,Sildenafil,BNRNXUUZRGQAQC-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
61627,6crv,DB12357,-8.0,BMS-863233,JJWLXRKVUJDJKG-VIFPVBQESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
149047,6w9q,DB14790,-8.0,BPN-14770,KRRGWHSEDYQKDQ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
129756,6w4h,DB09268,-8.0,Picosulfuric acid,UJIDKYTZIQTXPM-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
89376,6m71,DB00402,-8.0,Eszopiclone,GBBSUAFBMRNDJC-INIZCTEOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
89401,6m71,DB00434,-8.0,Cyproheptadine,JJCFRYNCJDLXIK-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
61604,6crv,DB12319,-8.0,Benzbromarone,WHQCHUCQKNIQEC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
129801,6w4h,DB09383,-8.0,Meprednisone,PIDANAQULIKBQS-RNUIGHNZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130664,6w4h,DB12591,-8.0,BMS-911543,JCINBYQJBYJGDM-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
156306,6wiq,DB12897,-8.0,MK-7622,JUVQLZBJFOGEEO-GOTSBHOMSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
93868,6m71,DB07444,-8.0,"6-(3-AMINOPROPYL)-4,9-DIMETHYLPYRROLO[3,4-C]CARBAZOLE-1,3(2H,6H)-DIONE",PKPNSCZPIWCHMW-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
159104,7bv1,DB03154,-8.0,{[7-(Difluoro-Phosphono-Methyl)-Naphthalen-2-Yl]-Difluoro-Methyl}-Phosphonic Acid,VHKBLEYUHBIBNR-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96300,6m71,DB12696,-8.0,BMS-582949,GDTQLZHHDRRBEB-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60100,6crv,DB08235,-8.0,N-[2-(2-methyl-1H-indol-3-yl)ethyl]thiophene-2-carboxamide,ACAKNPKRLPMONU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60095,6crv,DB08229,-8.0,[N-(3-DIBENZYLCARBAMOYL-OXIRANECARBONYL)-HYDRAZINO]-ACETIC ACID,JGMMFVVACJREFE-KRWDZBQOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60091,6crv,DB08223,-8.0,"N-{(1S,2R)-1-BENZYL-3-[(CYCLOPROPYLMETHYL)(2-FURYLSULFONYL)AMINO]-2-HYDROXYPROPYL}-N'-METHYLSUCCINAMIDE",IKOPFHKAECNGQI-VQTJNVASSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
96364,6m71,DB12802,-8.0,Picropodophyllin,YJGVMLPVUAXIQN-HAEOHBJNSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
129044,6w4h,DB08320,-8.0,"DIETHYL (1R,2S,3R,4S)-5,6-BIS(4-HYDROXYPHENYL)-7-OXABICYCLO[2.2.1]HEPT-5-ENE-2,3-DICARBOXYLATE",NHKDFDHHMHBFLG-COPRSSIGSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
96415,6m71,DB12885,-8.0,CF-102,IPSYPUKKXMNCNQ-PFHKOEEOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
159151,7bv1,DB03491,-8.0,2'-Deoxyguanosine-5'-Diphosphate,CIKGWCTVFSRMJU-KVQBGUIXSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
159224,7bv1,DB03601,-8.0,5-deoxyflavanone,FURUXTVZLHCCNA-AWEZNQCLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96516,6m71,DB13039,-8.0,Aminaphthone,YLMPBJUYFTWHKJ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
159250,7bv1,DB03642,-8.0,Benzofuran-2-Carboxylic Acid {(S)-3-Methyl-1-[3-Oxo-1-(Pyridin-2-Ylsulfonyl)Azepan-4-Ylcarbamoyl]Butyl}Amide,VBPPNJCVXGAZDD-PMACEKPBSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96544,6m71,DB13080,-8.0,Roluperidone,RNRYULFRLCBRQS-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
159273,7bv1,DB03671,-8.0,"4-(3,12,14-Trihydroxy-10,13-Dimethyl-Hexadecahydro-Cyclopenta[a]Phenanthren-17-Yl)-5h-Furan-2-One",SHIBSTMRCDJXLN-KCZCNTNESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96580,6m71,DB13135,-8.0,AGN-201904,PPCGSVWOZKNPCX-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96590,6m71,DB13164,-8.0,Olmutinib,FDMQDKQUTRLUBU-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96597,6m71,DB13177,-8.0,4-methylumbelliferyl beta-D-glucoside,YUDPTGPSBJVHCN-YMILTQATSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96802,6m71,DB13463,-8.0,Oxetorone,VZVRZTZPHOHSCK-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96904,6m71,DB13606,-8.0,Phenazocine,ZQHYKVKNPWDQSL-KNXBSLHKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96947,6m71,DB13664,-8.0,Formocortal,QNXUUBBKHBYRFW-QWAPGEGQSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96999,6m71,DB13728,-8.0,Halometasone,GGXMRPUKBWXVHE-MIHLVHIWSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
159348,7bv1,DB04022,-8.0,"Guanosine-5',3'-Tetraphosphate",BUFLLCUFNHESEH-UUOKFMHZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97084,6m71,DB13843,-8.0,Cloprednol,YTJIBEDMAQUYSZ-FDNPDPBUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97137,6m71,DB13953,-8.0,Estradiol benzoate,UYIFTLBWAOGQBI-BZDYCCQFSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97156,6m71,DB13991,-8.0,Pipequaline,AMEWZCMTSIONOX-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97158,6m71,DB13993,-8.0,MRK-409,GOIFCXRIFSYPFG-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97279,6m71,DB14541,-8.0,Hydrocortisone cypionate,DLVOSEUFIRPIRM-KAQKJVHQSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
159101,7bv1,DB03148,-8.0,Phosphomethylphosphonic Acid Adenosyl Ester,OLCWZBFDIYXLAA-IOSLPCCCSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97291,6m71,DB14570,-8.0,Hydroxyprogesterone,DBPWSSGDRRHUNT-CEGNMAFCSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
159090,7bv1,DB03133,-8.0,"2-(Beta-D-Glucopyranosyl)-5-Methyl-1,2,3-Benzimidazole",XIJZORUYQZBFJK-UJPOAAIJSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96228,6m71,DB12580,-8.0,Tradipitant,CAVRKWRKTNINFF-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95858,6m71,DB12049,-8.0,Dasolampanel etibutil,HPBRMCFZIGUGTK-ZMMAXQRCSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60223,6crv,DB08390,-8.0,"(6S)-6-CYCLOPENTYL-6-[2-(3-FLUORO-4-ISOPROPOXYPHENYL)ETHYL]-4-HYDROXY-5,6-DIHYDRO-2H-PYRAN-2-ONE",AKNIHFDXRAOPAI-NRFANRHFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
95862,6m71,DB12055,-8.0,MK-0767,ORZMUVMQJPGFOM-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95872,6m71,DB12070,-8.0,Letermovir,FWYSMLBETOMXAG-QHCPKHFHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95881,6m71,DB12082,-8.0,Vesnarinone,ZVNYJIZDIRKMBF-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95888,6m71,DB12095,-8.0,Telotristat ethyl,MDSQOJYHHZBZKA-GBXCKJPGSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95889,6m71,DB12096,-8.0,PF-05175157,BDXXSFOJPYSYOC-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95967,6m71,DB12211,-8.0,PSI-697,DIEPFYNZGUUVHD-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95980,6m71,DB12229,-8.0,Cerlapirdine,NXQGEDVQXVTCDA-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95998,6m71,DB12252,-8.0,PG-701,OKRSVUYYCJPECG-LFGMFVMYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
158902,7bv1,DB02611,-8.0,Balanol Analog 1,FZJQHARRQUNVGZ-QZTJIDSGSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96036,6m71,DB12302,-8.0,CP-724714,LLVZBTWPGQVVLW-SNAWJCMRSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
158963,7bv1,DB02694,-8.0,Pantoyl Adenylate,GDPVENOGSVMRJL-FSRKKXLISA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96037,6m71,DB12303,-8.0,Motolimod,QSPOQCXMGPDIHI-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96053,6m71,DB12322,-8.0,GW-870086,WUBKGTSFJSEIEM-NSHBDUGJSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96059,6m71,DB12332,-8.0,Rucaparib,HMABYWSNWIZPAG-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96093,6m71,DB12385,-8.0,10-hydroxycamptothecin,HAWSQZCWOQZXHI-FQEVSTJZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
159007,7bv1,DB03020,-8.0,5-Beta-D-Ribofuranosylnicotinamide Adenine Dinucleotide,UINNILASBHZOTM-KMXXXSRASA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96114,6m71,DB12412,-8.0,Gemigliptin,ZWPRRQZNBDYKLH-VIFPVBQESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96125,6m71,DB12426,-8.0,Bitopertin,YUUGYIUSCYNSQR-LBPRGKRZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96127,6m71,DB12428,-8.0,PAC-14028,UKGJZDSUJSPAJL-YPUOHESYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96171,6m71,DB12494,-8.0,SGI-1776,MHXGEROHKGDZGO-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60140,6crv,DB08289,-8.0,N-(PARA-GLUTARAMIDOPHENYL-ETHYL)-PIPERIDINIUM-N-OXIDE,RKJXWOJUCCBWSC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
96184,6m71,DB12515,-8.0,9-aminocamptothecin,FUXVKZWTXQUGMW-FQEVSTJZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60127,6crv,DB08270,-8.0,"N-(2-AMINOETHYL)-N-2-{(1S)-1-[4'-(AMINOSULFONYL)BIPHENYL-4-YL]-2,2,2-TRIFLUOROETHYL}-L-LEUCINAMIDE",QPXXBNKMAHUXBB-PMACEKPBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
96202,6m71,DB12543,-8.0,Samidorphan,RYIDHLJADOKWFM-MAODMQOUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96221,6m71,DB12572,-8.0,Pexacerfont,LBWQSAZEYIZZCE-SNVBAGLBSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96238,6m71,DB12597,-8.0,ABL-001,VOVZXURTCKPRDQ-CQSZACIVSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97347,6m71,DB14673,-8.0,Flurandrenolide acetate,AUDPKCCPWYXNEV-XTLNBZDDSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97362,6m71,DB14716,-8.0,Clonazolam,XJRGLCAWBRZUFC-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59929,6crv,DB08035,-8.0,"1-TERT-BUTYL-3-(2,5-DIMETHYLBENZYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE",QUPXEJURIFFVSX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
97707,6m71,DB15456,-8.0,Vericiguat,QZFHIXARHDBPBY-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
159767,7bv1,DB06497,-8.0,Aplaviroc,GWNOTCOIYUNTQP-FQLXRVMXSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59738,6crv,DB07816,-8.0,N-(P-CYANOPHENYL)-N'-DIPHENYLMETHYL-GUANIDINE-ACETIC ACID,KGHMYJFHUHFOGL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
159774,7bv1,DB06519,-8.0,Edaglitazone,HAAXAFNSRADSMK-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97873,6vxs,DB00266,-8.0,Dicoumarol,DOBMPNYZJYQDGZ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
128796,6w4h,DB08026,-8.0,"2-{4-[(4-imidazo[1,2-a]pyridin-3-ylpyrimidin-2-yl)amino]piperidin-1-yl}-N-methylacetamide",AJLILYAPRHIFAS-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
97988,6vxs,DB00404,-8.0,Alprazolam,VREFGVBLTWBCJP-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
98009,6vxs,DB00430,-8.0,Cefpiramide,PWAUCHMQEXVFJR-PMAPCBKXSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
59698,6crv,DB07772,-8.0,"(1R)-1-{[(4'-methoxy-1,1'-biphenyl-4-yl)sulfonyl]amino}-2-methylpropylphosphonic acid",BZVYQWLRCHLAGK-QGZVFWFLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
128791,6w4h,DB08020,-8.0,"(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-6-(METHOXYMETHYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL",RHQLNMNKTIOREN-AOIWGVFYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
98031,6vxs,DB00455,-8.0,Loratadine,JCCNYMKQOSZNPW-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
159808,7bv1,DB06605,-8.0,Apixaban,QNZCBYKSOIHPEH-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
98071,6vxs,DB00502,-8.0,Haloperidol,LNEPOXFFQSENCJ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
98152,6vxs,DB00605,-8.0,Sulindac,MLKXDPUZXIRXEP-MFOYZWKCSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
98167,6vxs,DB00623,-8.0,Fluphenazine,PLDUPXSUYLZYBN-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
159821,7bv1,DB06629,-8.0,Zibotentan,FJHHZXWJVIEFGJ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
98224,6vxs,DB00693,-8.0,Fluorescein,GNBHRKFJIUUOQI-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
98231,6vxs,DB00700,-8.0,Eplerenone,JUKPWJGBANNWMW-VWBFHTRKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
159829,7bv1,DB06645,-8.0,Anamorelin,VQPFSIRUEPQQPP-MXBOTTGLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59662,6crv,DB07732,-8.0,2-[(2-NAPHTHYLSULFONYL)AMINO]ETHYL DIHYDROGEN PHOSPHATE,FCROUVVWZFPGFM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
98336,6vxs,DB00826,-8.0,Natamycin,NCXMLFZGDNKEPB-FFPOYIOWSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
59645,6crv,DB07712,-8.0,3-ETHYL-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL,XBMVVMYGKMGLJX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59640,6crv,DB07705,-8.0,"1-[(2S)-2-[(4-CHLOROBENZYL)OXY]-2-(2,4-DICHLOROPHENYL)ETHYL]-1H-IMIDAZOLE",LEZWWPYKPKIXLL-GOSISDBHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
159845,7bv1,DB06684,-8.0,Vilazodone,SGEGOXDYSFKCPT-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
98514,6vxs,DB01029,-8.0,Irbesartan,YOSHYTLCDANDAN-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
98530,6vxs,DB01047,-8.0,Fluocinonide,WJOHZNCJWYWUJD-IUGZLZTKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
98577,6vxs,DB01100,-8.0,Pimozide,YVUQSNJEYSNKRX-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
59755,6crv,DB07835,-8.0,"N-3-cyclopropyl-N-4-'-(cyclopropylmethyl)-6-methylbiphenyl-3,4'-dicarboxamide",BOPSUAHGQHFKGG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
128812,6w4h,DB08043,-8.0,1-[4-(PYRIDIN-4-YLOXY)PHENYL]-3-[3-(TRIFLUOROMETHYL)PHENYL]UREA,DDDLGNOZDKDSEG-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
159724,7bv1,DB05482,-8.0,7-ethyl-10-hydroxycamptothecin,FJHBVJOVLFPMQE-QFIPXVFZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
128814,6w4h,DB08046,-8.0,2-chloro-5-[(1S)-1-hydroxy-3-oxo-2H-isoindol-1-yl]benzenesulfonamide,JIVPVXMEBJLZRO-AWEZNQCLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
59914,6crv,DB08019,-8.0,"N-{(3R,4S)-4-[(6-amino-4-methylpyridin-2-yl)methyl]pyrrolidin-3-yl}-N'-(3-chlorobenzyl)ethane-1,2-diamine",VWCMAGONQJHIJZ-LPHOPBHVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59912,6crv,DB08017,-8.0,3-METHOXY-6-[4-(3-METHYLPHENYL)-1-PIPERAZINYL]PYRIDAZINE,DDOAUTHWSCUHQA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
97434,6m71,DB14879,-8.0,Cefiderocol,DBPPRLRVDVJOCL-FQRUVTKNSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97444,6m71,DB14898,-8.0,Retagliptin,WIIAMRXFUJLYEF-SNVBAGLBSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59892,6crv,DB07995,-8.0,N-[2-(4-BROMOCINNAMYLAMINO)ETHYL]-5-ISOQUINOLINE SULFONAMIDE,ZKZXNDJNWUTGDK-NSCUHMNNSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
97488,6m71,DB15024,-8.0,Apararenone,AZNHWXAFPBYFGH-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
128880,6w4h,DB08121,-8.0,(2S)-2-(biphenyl-4-yloxy)-3-phenylpropanoic acid,TZTPJJNNACUQQR-FQEVSTJZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
97532,6m71,DB15108,-8.0,Tipranavir C-14,SUJUHGSWHZTSEU-MWQIXQBFSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97559,6m71,DB15157,-8.0,Voruciclib,MRPGRAKIAJJGMM-OCCSQVGLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97573,6m71,DB15191,-8.0,MAX-40279,AVIOBQFPAGEICQ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
159660,7bv1,DB05105,-8.0,Pleconaril,KQOXLKOJHVFTRN-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59865,6crv,DB07966,-8.0,[4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]quinazolin-2-yl}amino)phenyl]acetonitrile,NVMCVWOODOWOLT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
97589,6m71,DB15219,-8.0,Tomivosertib,HKTBYUWLRDZAJK-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95851,6m71,DB12041,-8.0,Mapracorat,VJGFOYBQOIPQFY-XMMPIXPASA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59858,6crv,DB07958,-8.0,(2-CARBAMOYLMETHYL-5-PROPYL-OCTAHYDRO-INDOL-7-YL)ACETIC ACID,OMLOGGCSARAIGZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
159662,7bv1,DB05116,-8.0,Thymectacin,CFBLUORPOFELCE-BACVZHSASA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59847,6crv,DB07944,-8.0,N-{3-METHYL-5-[2-(PYRIDIN-4-YLAMINO)-ETHOXY]-PHENYL}-BENZENESULFONAMIDE,MPTWCWHNLVMCRW-UHFFFAOYSA-O,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59835,6crv,DB07931,-8.0,Hexestrol,PBBGSZCBWVPOOL-HDICACEKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
97631,6m71,DB15297,-8.0,Petesicatib,KXAAIORSMACJSI-AEFFLSMTSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
159681,7bv1,DB05253,-8.0,Telapristone acetate,JVBGZFRPTRKSBB-MJBQOYBXSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59792,6crv,DB07876,-8.0,(S)-2-METHYL-1-[(4-METHYL-5-ISOQUINOLINE)SULFONYL]-HOMOPIPERAZINE,AWDORCFLUJZUQS-ZDUSSCGKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
159693,7bv1,DB05298,-8.0,Tetomilast,XDBHURGONHZNJF-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97662,6m71,DB15358,-8.0,JNJ-54175446,CWFVVQFVGMFTBD-SECBINFHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59773,6crv,DB07857,-8.0,(2R)-2-(4-chlorophenyl)-2-[4-(1H-pyrazol-4-yl)phenyl]ethanamine,HWVGILTYGZFGLR-QGZVFWFLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
159707,7bv1,DB05414,-8.0,Pipendoxifene,JICOGKJOQXTAIP-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
128821,6w4h,DB08055,-8.0,"N-(2-chlorophenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine",NNBICZMPIJMWGC-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
97682,6m71,DB15407,-8.0,Acalisib,DOCINCLJNAXZQF-LBPRGKRZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
128818,6w4h,DB08052,-8.0,"1-cyclopentyl-3-(1H-pyrrolo[2,3-b]pyridin-5-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine",NVRXTLZYXZNATH-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
59850,6crv,DB07947,-8.0,ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY)ETHYLAMINO)ETHYL)AMIDE,AUHWQSZMVMMRLM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60230,6crv,DB08398,-8.0,"2-Amino-1-methyl-6-phenylimidazo(4,5-b)pyridine",UQVKZNNCIHJZLS-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
95843,6m71,DB12025,-8.0,Triptolide,DFBIRQPKNDILPW-CIVMWXNOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95839,6m71,DB12020,-8.0,Tecovirimat,CSKDFZIMJXRJGH-VWLPUNTISA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60710,6crv,DB09002,-8.0,Cloperastine,FLNXBVJLPJNOSI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60703,6crv,DB08994,-8.0,Ditazole,UUCMDZWCRNZCOY-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
157544,6wiq,DB09298,-8.0,Silibinin,SEBFKMXJBCUCAI-HKTJVKLFSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
94395,6m71,DB08059,-8.0,Wortmannin,QDLHCMPXEPAAMD-QAIWCSMKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94421,6m71,DB08091,-8.0,3-FLUORO-5-MORPHOLIN-4-YL-N-[3-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-5-YL]BENZAMIDE,HIUFYIOMUILESI-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94426,6m71,DB08096,-8.0,"8-(2-CHLOROPHENYLAMINO)-2-(2,6-DIFLUOROPHENYLAMINO)-9-ETHYL-9H-PURINE-1,7-DIIUM",ZWKOUFZHPNIQSH-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
157631,6wiq,DB12222,-8.0,Lurtotecan,RVFGKBWWUQOIOU-NDEPHWFRSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
60679,6crv,DB08968,-8.0,Fominoben,KSNNEUZOAFRTDS-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
94470,6m71,DB08143,-8.0,"5-CHLORO-THIOPHENE-2-CARBOXYLIC ACID ((3S,4S)-4-FLUORO- 1-{[2-FLUORO-4-(2-OXO-2H-PYRIDIN-1-YL)-PHENYLCARBAMOYL]-METHYL}-PYRROLIDIN-3-YL)-AMIDE",SXIYSYYSKHUTQQ-RDJZCZTQSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94518,6m71,DB08197,-8.0,"(5E,7S)-2-amino-7-(4-fluoro-2-pyridin-3-ylphenyl)-4-methyl-7,8-dihydroquinazolin-5(6H)-one oxime",KYIXUSLGFINPTC-WVFAEZDRSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
129320,6w4h,DB08656,-8.0,5-amino-2-methyl-N-[(1R)-1-naphthalen-1-ylethyl]benzamide,UVERBUNNCOKGNZ-CQSZACIVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
157773,6wiq,DB12799,-8.0,Laniquidar,TULGGJGJQXESOO-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
60647,6crv,DB08926,-8.0,Acediasulfone,FKKUMFTYSTZUJG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
94556,6m71,DB08246,-8.0,"(2S)-4-(2,5-DIFLUOROPHENYL)-N,N-DIMETHYL-2-PHENYL-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDE",WFFMEXQHWXEKBV-SFHVURJKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
157795,6wiq,DB12836,-8.0,Grapiprant,HZVLFTCYCLXTGV-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
157816,6wiq,DB12874,-8.0,Quizartinib,CVWXJKQAOSCOAB-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
60639,6crv,DB08910,-8.0,Pomalidomide,UVSMNLNDYGZFPF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
157826,6wiq,DB12886,-8.0,GSK-1521498,WIEDUMBCZQRGSY-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
94604,6m71,DB08309,-8.0,3-({2-[(4-{[6-(CYCLOHEXYLMETHOXY)-9H-PURIN-2-YL]AMINO}PHENYL)SULFONYL]ETHYL}AMINO)PROPAN-1-OL,AMFGILNPFBVREA-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94631,6m71,DB08345,-8.0,"4-(2-(1H-IMIDAZOL-4-YL)ETHYLAMINO)-2-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE",IWUUKHQIKFHWIW-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94637,6m71,DB08351,-8.0,N-cyclopropyl-4-methyl-3-{2-[(2-morpholin-4-ylethyl)amino]quinazolin-6-yl}benzamide,MNEXDVSJIUQQRH-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94641,6m71,DB08355,-8.0,"1-methyl-8-(phenylamino)-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxylic acid",ZOBRPBVIEUWYJR-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
157945,6wiq,DB14943,-8.0,LGH-447,VRQXRVAKPDCRCI-ZNMIVQPWSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
157946,6wiq,DB14944,-8.0,Tarloxotinib,MUJMYVFVAWFUJL-SNAWJCMRSA-O,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
94649,6m71,DB08365,-8.0,"8-bromo-4-(2-chlorophenyl)-N-(2-hydroxyethyl)-6-methyl-1,3-dioxo-1,2,3,6-tetrahydropyrrolo[3,4-e]indole-7-carboxamide",XUAHLMVOYLUYSB-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94657,6m71,DB08373,-8.0,"4,4'-BIS([H]METHYLSULFONYL)-2,2',5,5'-TETRACHLOROBIPHENYL",RDBKPLOYRMCFIY-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
129286,6w4h,DB08613,-8.0,"2,2,2-TRIFLUORO-1-{5-[(3-PHENYL-5,6-DIHYDROIMIDAZO[1,2-A]PYRAZIN-7(8H)-YL)CARBONYL]THIOPHEN-2-YL}ETHANE-1,1-DIOL",OFBFUNBBOQCNFX-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
94356,6m71,DB08015,-8.0,"(3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-phenyl-1H-indole-2,3-dione 3-oxime",SZYREAUDQRVVLV-DAFNUICNSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60713,6crv,DB09006,-8.0,Clinofibrate,BMOVQUBVGICXQN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
94343,6m71,DB08001,-8.0,5-(3-{3-[3-HYDROXY-2-(METHOXYCARBONYL)PHENOXY]PROPENYL}PHENYL)-4-(HYDROXYMETHYL)ISOXAZOLE-3-CARBOXYLIC ACID,DQSRCEFDWMQCCV-GQCTYLIASA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94341,6m71,DB07999,-8.0,"{4-[(CARBOXYMETHOXY)CARBONYL]-3,3-DIOXIDO-1-OXONAPHTHO[1,2-D]ISOTHIAZOL-2(1H)-YL}ACETIC ACID",IXLBOIRSEDMRPI-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
156449,6wiq,DB13113,-8.0,JNJ-38877605,JRWCBEOAFGHNNU-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
156949,6wiq,DB13953,-8.0,Estradiol benzoate,UYIFTLBWAOGQBI-BZDYCCQFSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
93973,6m71,DB07568,-8.0,"(2S)-2-[(2,1,3-BENZOTHIADIAZOL-4-YLSULFONYL)AMINO]-2-PHENYL-N-PYRIDIN-4-YLACETAMIDE",ADRNPUSZBRQDBG-KRWDZBQOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93989,6m71,DB07588,-8.0,"3,4-DI-1H-INDOL-3-YL-1H-PYRROLE-2,5-DICARBOXYLIC ACID",FZDVNXHYGMEEDT-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
156997,6wiq,DB14054,-8.0,Asiatic acid,JXSVIVRDWWRQRT-UYDOISQJSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
157006,6wiq,DB14067,-8.0,Dofequidar,KLWUUPVJTLHYIM-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
60822,6crv,DB09194,-8.0,Etoperidone,IZBNNCFOBMGTQX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
94064,6m71,DB07679,-8.0,"(9S,12S)-9-(1-methylethyl)-7,10-dioxo-2-oxa-8,11-diazabicyclo[12.2.2]octadeca-1(16),14,17-triene-12-carboxylic acid",RRAAROKJUVKWAF-RDJZCZTQSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
157136,6wiq,DB14649,-8.0,Dexamethasone acetate,AKUJBENLRBOFTD-RPRRAYFGSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
157162,6wiq,DB14676,-8.0,Fagrocorat,QJJBNCHSWFGXML-KEKPKEOLSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
94074,6m71,DB07692,-8.0,"1-[(2,6-difluorophenyl)sulfonyl]-4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)piperazine",SHWNKRPMUBFWKE-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60794,6crv,DB09151,-8.0,Flutemetamol (18F),VVECGOCJFKTUAX-HUYCHCPVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60792,6crv,DB09148,-8.0,Florbetaben (18F),NCWZOASIUQVOFA-FWZJPQCDSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
94668,6m71,DB08389,-8.0,"6,7-DIMETHOXY-4-[(3R)-3-(2-NAPHTHYLOXY)PYRROLIDIN-1-YL]QUINAZOLINE",UPTQSRGSSJRBKJ-LJQANCHMSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94116,6m71,DB07741,-8.0,"4-(1R,3AS,4R,8AS,8BR)-[1-DIFLUOROMETHYL-2-(4-FLUOROBENZYL)-3-OXODECAHYDROPYRROLO[3,4-A]PYRROLIZIN-4-YL]BENZAMIDINE",VPNYXOTTXAXSIH-SXYSDOLCSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94149,6m71,DB07779,-8.0,N-({(2S)-1-[(3R)-3-AMINO-4-(2-FLUOROPHENYL)BUTANOYL]PYRROLIDIN-2-YL}METHYL)BENZAMIDE,ANQHSFFUNMTTRS-MOPGFXCFSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60772,6crv,DB09096,-8.0,Benzoyl peroxide,OMPJBNCRMGITSC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
94160,6m71,DB07791,-8.0,4-{[4-(1-CYCLOPROPYL-2-METHYL-1H-IMIDAZOL-5-YL)PYRIMIDIN-2-YL]AMINO}-N-METHYLBENZENESULFONAMIDE,MZWCVBFANHIPTJ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
157250,6wiq,DB15039,-8.0,ITI-214,BBIPVJCGIASXJB-PKTZIBPZSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
157327,6wiq,DB15193,-8.0,BMS-955176,XDMUFNNPLXHNKA-ZTESCHFWSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
94172,6m71,DB07804,-8.0,"5-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1H-1,2,4-TRIAZOLE-3-SULFONAMIDE",FKCQUVAGEOSYRU-QWRGUYRKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
157328,6wiq,DB15197,-8.0,RSV-604,MTPVBMVUENFFLL-HXUWFJFHSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
129359,6w4h,DB08706,-8.0,"(2S)-({(5Z)-5-[(5-ETHYL-2-FURYL)METHYLENE]-4-OXO-4,5-DIHYDRO-1,3-THIAZOL-2-YL}AMINO)(4-FLUOROPHENYL)ACETIC ACID",RNEACARJKXYVND-MZLJFPOFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
94196,6m71,DB07830,-8.0,"(4R,5R)-5-AMINO-1-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN-2-ONE",DIRIFWIKLRTNMB-DYVFJYSZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94207,6m71,DB07843,-8.0,5-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1-BENZOTHIOPHENE-2-SULFONAMIDE,LTJNKFUIOOJXNJ-WFASDCNBSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94314,6m71,DB07969,-8.0,3-[3-(4-methylpiperazin-1-yl)-7-(trifluoromethyl)quinoxalin-5-yl]phenol,QNCYYRHIUFGGJX-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94320,6m71,DB07975,-8.0,"2-({[3,5-DIFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)CYCLOPENT-1-ENE-1-CARBOXYLIC ACID",VTGXLCZUWFYELR-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94321,6m71,DB07976,-8.0,3-{[(3-FLUORO-3'-METHOXYBIPHENYL-4-YL)AMINO]CARBONYL}THIOPHENE-2-CARBOXYLIC ACID,GIUMGVUBDBDTDX-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94136,6m71,DB07763,-8.0,"(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE",OZZFJGCAYWBVBI-INIZCTEOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93839,6m71,DB07409,-8.0,"(1-HYDROXY-1-PHOSPHONO-2-[1,1';4',1'']TERPHENYL-3-YL-ETHYL)-PHOSPHONIC ACID",MPBUFKZCEBTBSK-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94680,6m71,DB08402,-8.0,"2-[(2,4-DICHLOROBENZOYL)AMINO]-5-(PYRIMIDIN-2-YLOXY)BENZOIC ACID",VNDRRWBKNSHALL-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94717,6m71,DB08448,-8.0,"(4aS)-5-[(2,4-diaminopteridin-6-yl)methyl]-4a,5-dihydro-2H-dibenzo[b,f]azepin-8-ol",PCBWLKUEKANDCL-INIZCTEOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95592,6m71,DB11656,-8.0,Rebamipide,ALLWOAVDORUJLA-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95614,6m71,DB11687,-8.0,E-6201,MWUFVYLAWAXDHQ-HMNLTAHHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60333,6crv,DB08522,-8.0,4-(4-FLUOROPHENYL)-1-CYCLOROPROPYLMETHYL-5-(4-PYRIDYL)-IMIDAZOLE,ROKOFZNQCIIJMI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
95623,6m71,DB11698,-8.0,Ipragliflozin,AHFWIQIYAXSLBA-RQXATKFSSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95624,6m71,DB11701,-8.0,Amenamevir,MNHNIVNAFBSLLX-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
158497,7bv1,DB01259,-8.0,Lapatinib,BCFGMOOMADDAQU-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95632,6m71,DB11712,-8.0,Tezacaftor,MJUVRTYWUMPBTR-MRXNPFEDSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95670,6m71,DB11773,-8.0,BMS-903452,OGIAVRWXUPYGGC-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95672,6m71,DB11775,-8.0,PF-03758309,AYCPARAPKDAOEN-LJQANCHMSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95685,6m71,DB11793,-8.0,Niraparib,PCHKPVIQAHNQLW-CQSZACIVSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
158526,7bv1,DB01586,-8.0,Ursodeoxycholic acid,RUDATBOHQWOJDD-UZVSRGJWSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95687,6m71,DB11795,-8.0,GSK-2636771,XTKLTGBKIDQGQL-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95691,6m71,DB11800,-8.0,Tivozanib,SPMVMDHWKHCIDT-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
158586,7bv1,DB01661,-8.0,1-(5-phospho-D-ribosyl)-ATP,RKNHJBVBFHDXGR-MRUDJCSFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60296,6crv,DB08478,-8.0,N-[2-chloro-5-(trifluoromethyl)phenyl]imidodicarbonimidic diamide,IGFTZEOFHWPCDL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60284,6crv,DB08464,-8.0,"METHYL 3-CHLORO-2-{3-[(2,5-DIHYDROXY-4-METHOXYPHENYL)AMINO]-3-OXOPROPYL}-4,6-DIHYDROXYBENZOATE",GUVWEHNRWHNDRF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
95719,6m71,DB11841,-8.0,Entinostat,INVTYAOGFAGBOE-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95722,6m71,DB11845,-8.0,Lucitanib,CUDVHEFYRIWYQD-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95761,6m71,DB11903,-8.0,GW842166,TWQYWUXBZHPIIV-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
158674,7bv1,DB02069,-8.0,N-(2-Flouro-Benzyl)-4-Sulfamoyl-Benzamide,ULYMHSXFSKOHGH-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
129165,6w4h,DB08470,-8.0,"3-(4-fluorophenyl)-5-phenyl-4H-1,2,4-triazole",KMGPJKOKSYGMJD-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
158719,7bv1,DB02123,-8.0,Glycochenodeoxycholic Acid,GHCZAUBVMUEKKP-GYPHWSFCSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
129160,6w4h,DB08464,-8.0,"METHYL 3-CHLORO-2-{3-[(2,5-DIHYDROXY-4-METHOXYPHENYL)AMINO]-3-OXOPROPYL}-4,6-DIHYDROXYBENZOATE",GUVWEHNRWHNDRF-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
95796,6m71,DB11952,-8.0,Duvelisib,SJVQHLPISAIATJ-ZDUSSCGKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95803,6m71,DB11964,-8.0,Ilaprazole,HRRXCXABAPSOCP-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95820,6m71,DB11992,-8.0,Omarigliptin,MKMPWKUAHLTIBJ-ISTRZQFTSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95835,6m71,DB12011,-8.0,Fevipiprant,GFPPXZDRVCSVNR-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60345,6crv,DB08535,-8.0,"3-bromo-5-phenyl-N-(pyridin-3-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",SMIZFGZXFDGISG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
95577,6m71,DB11629,-8.0,Laropiprant,NXFFJDQHYLNEJK-CYBMUJFWSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
158483,7bv1,DB01238,-8.0,Aripiprazole,CEUORZQYGODEFX-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
158470,7bv1,DB01219,-8.0,Dantrolene,OZOMQRBLCMDCEG-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
158017,7bv1,DB00276,-8.0,Amsacrine,XCPGHVQEEXUHNC-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60577,6crv,DB08807,-8.0,Bopindolol,UUOJIACWOAYWEZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60559,6crv,DB08788,-8.0,"3,6-DIAMINO-5-CYANO-4-(4-ETHOXYPHENYL)THIENO[2,3-B]PYRIDINE-2-CARBOXAMIDE",UOPQHPBCVYHSFF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
94776,6m71,DB08519,-8.0,"N-4-(3-methyl-1H-indazol-6-yl)-N-2-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine",SQQAPOSROFWHIB-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94795,6m71,DB08539,-8.0,"3-cyclopropyl-5-phenyl-N-(pyridin-3-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",CCDIUVLNHCGSMH-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94931,6m71,DB08708,-8.0,"N-cyclohexyl-3-[3-(trifluoromethyl)phenyl][1,2,4]triazolo[4,3-b]pyridazin-6-amine",XYYDXQCAYXOGQT-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94972,6m71,DB08750,-8.0,"1-[4-(AMINOMETHYL)BENZOYL]-5'-FLUORO-1'H-SPIRO[PIPERIDINE-4,2'-QUINAZOLIN]-4'-AMINE",SFPCNWQWKOUNRT-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94989,6m71,DB08770,-8.0,"4-{2-[(7-amino-2-furan-2-yl[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-yl)amino]ethyl}phenol",PWTBZOIUWZOPFT-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95008,6m71,DB08791,-8.0,"1-[(2-NITROPHENYL)SULFONYL]-1H-PYRROLO[3,2-B]PYRIDINE-6-CARBOXAMIDE",USLOIFPDNUDIEG-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95040,6m71,DB08833,-8.0,Taurochenodeoxycholic acid,BHTRKEVKTKCXOH-BJLOMENOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95041,6m71,DB08834,-8.0,Tauroursodeoxycholic acid,BHTRKEVKTKCXOH-LBSADWJPSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60496,6crv,DB08720,-8.0,"5-(5-(4-(4,5-dihydro-2-oxazoly)phenoxy)pentyl)-3-methyl osoxazole",IWZDYGHUSXWPPM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
95078,6m71,DB08899,-8.0,Enzalutamide,WXCXUHSOUPDCQV-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94710,6m71,DB08441,-8.0,"6-BROMO-13-THIA-2,4,8,12,19-PENTAAZATRICYCLO[12.3.1.1-3,7-]NONADECA-1(18),3(19),4,6,14,16-HEXAENE 13,13-DIOXIDE",AWSQADBSXFTFKL-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
158184,7bv1,DB00699,-8.0,Nicergoline,YSEXMKHXIOCEJA-FVFQAYNVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60468,6crv,DB08686,-8.0,"5,6,7,8,9,10-HEXAHYDRO-4-HYDROXY-3-(1-PHENYLPROPYL)CYCLOOCTA[B]PYRAN-2-ONE",UXCLJNSXDNCIIT-HNNXBMFYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60453,6crv,DB08665,-8.0,"6,11-DIHYDRO-11-ETHYL-6-METHYL-9-NITRO-5H-PYRIDO[2,3-B][1,5]BENZODIAZEPIN-5-ONE",YCFJZPGDTZVVSM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60451,6crv,DB08663,-8.0,4-HYDROXY-7-METHOXY-3-(1-PHENYL-PROPYL)-CHROMEN-2-ONE,CCPGCKQLIHGSCJ-AWEZNQCLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
95292,6m71,DB09219,-8.0,Bisoxatin,BPKUDUSVDVLOPY-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95303,6m71,DB09233,-8.0,Cronidipine,CNIJVNPIIHWRRP-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60405,6crv,DB08608,-8.0,"4-({(2R,5S)-2,5-DIMETHYL-4-[(2R)-3,3,3-TRIFLUORO-2-HYDROXY-2-METHYLPROPANOYL]PIPERAZIN-1-YL}CARBONYL)BENZONITRILE",IWFSHKKFDSWNLZ-BWACUDIHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60400,6crv,DB08602,-8.0,"3-(2,6-difluorophenyl)-2-(methylthio)quinazolin-4(3H)-one",BFNBJSXMXXQLAW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
95326,6m71,DB09268,-8.0,Picosulfuric acid,UJIDKYTZIQTXPM-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
129218,6w4h,DB08532,-8.0,"6-(2-fluorophenyl)-N-(pyridin-3-ylmethyl)imidazo[1,2-a]pyrazin-8-amine",WCNPGRRMPFCHEO-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
60385,6crv,DB08582,-8.0,"N-(4-bromo-2-{[(3R,5S)-3,5-dimethylpiperidin-1-yl]carbonyl}phenyl)-4-morpholin-4-yl-4-oxobutanamide",DELARNBPJXTDBD-IYBDPMFKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
129217,6w4h,DB08531,-8.0,"5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",CVYWYUAQFJMLEO-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
95531,6m71,DB11491,-8.0,Sarafloxacin,XBHBWNFJWIASRO-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
158467,7bv1,DB01216,-8.0,Finasteride,DBEPLOCGEIEOCV-WSBQPABSSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
129231,6w4h,DB08546,-8.0,"4-[(3AS,4R,7R,8AS,8BR)-2-(1,3-BENZODIOXOL-5-YLMETHYL)-7-HYDROXY-1,3-DIOXODECAHYDROPYRROLO[3,4-A]PYRROLIZIN-4-YL]BENZENECARBOXIMIDAMIDE",CETLUACQMGBMFH-ZALSBGIRSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
94874,6m71,DB08639,-8.0,Dapivirine,ILAYIAGXTHKHNT-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
166603,7bv1,DB15460,-8.0,AGG-523,JWQMTWCFNZSLNR-DEOSSOPVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
2480,6lzg,HMDB0041742,-8.0,"Hesperetin 3',7-O-diglucuronide",DRQALSJOSDMKCR-HXPBIGRZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
26598,6cs2,DB04770,-8.0,"O6-(R)-ROSCOVITINE, R-2-(6-BENZYLOXY-9-ISOPROPYL-9H-PURIN-2-YLAMINO)-BUTAN-1-OL",HGADNQLEUZSUEJ-OAHLLOKOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
9076,6lzg,DB07148,-8.0,"(6S)-1-chloro-3-[(4-fluorobenzyl)oxy]-6-(pyrrolidin-1-ylcarbonyl)pyrrolo[1,2-a]pyrazin-4(6H)-one",HPAFVLDARQIHPU-HNNXBMFYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
11327,6lzg,DB11818,-8.0,Retosiban,PLVGDGRBPMVYPB-FDUHJNRSSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
12557,6lzg,DB13520,-8.0,Metergoline,WZHJKEUHNJHDLS-QTGUNEKASA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
12011,6lzg,DB12744,-8.0,CGI-1842,ZXBFYBLSJMEBEP-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
9843,6lzg,DB07974,-8.0,1-{2-[(4-CHLOROPHENYL)AMINO]-2-OXOETHYL}-N-(1-ISOPROPYLPIPERIDIN-4-YL)-1H-INDOLE-2-CARBOXAMIDE,BDLMBQRBNPDCSS-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
24502,6cs2,DB02255,-8.0,GM6001,NITYDPDXAAFEIT-DYVFJYSZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
9056,6lzg,DB07126,-8.0,O6-CYCLOHEXYLMETHOXY-2-(4'-SULPHAMOYLANILINO) PURINE,OWXORKPNCHJYOF-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
14158,6lzg,T3D3780,-8.0,Paxilline,ACNHBCIZLNNLRS-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
28393,6cs2,DB00735,-8.0,Naftifine,OZGNYLLQHRPOBR-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
9023,6lzg,DB07091,-8.0,(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclohexyloxy)ethanoyl)pyrrolidine-2-carboxamide,IWPMQJKXKKKSEY-SFHVURJKSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
28385,6cs2,DB07973,-8.0,N-(1-ISOPROPYLPIPERIDIN-4-YL)-1-(3-METHOXYBENZYL)-1H-INDOLE-2-CARBOXAMIDE,GIPCBGDQVGKMPO-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
18782,6cs2,HMDB0034902,-8.0,"2,6-Cyclolycopene-1,5-diol",VDFVQEJGOSCZNZ-HNNISBQLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
9008,6lzg,DB07076,-8.0,6-[(Z)-AMINO(IMINO)METHYL]-N-[3-(CYCLOPENTYLOXY)PHENYL]-2-NAPHTHAMIDE,FWTQOPWAMQXIMI-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
28369,6cs2,DB07958,-8.0,(2-CARBAMOYLMETHYL-5-PROPYL-OCTAHYDRO-INDOL-7-YL)ACETIC ACID,OMLOGGCSARAIGZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
14183,6lzg,T3D3811,-8.0,Clofentezine,UXADOQPNKNTIHB-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
10562,6lzg,DB08770,-8.0,"4-{2-[(7-amino-2-furan-2-yl[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-yl)amino]ethyl}phenol",PWTBZOIUWZOPFT-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
27548,6cs2,DB07095,-8.0,(S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclopentylpropanoyl)pyrrolidine-2-carboxamide,BNCHHUFGEOJCNH-SFHVURJKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
27555,6cs2,DB07104,-8.0,4-amino-N-[4-(benzyloxy)phenyl]butanamide,QTWBKNVNGVYTNZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
7650,6lzg,DB04154,-8.0,"N-Methyl-N-[3-(6-Phenyl[1,2,4]Triazolo[4,3-B]Pyridazin-3-Yl)Phenyl]Acetamide",ALBWBHNFOJJMCV-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
17691,6cs2,HMDB0000430,-8.0,"24,25-Dihydroxyvitamin D",FCKJYANJHNLEEP-OIMXRAFZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
28938,6cs2,DB08564,-8.0,(2E)-N-{4-[(3-bromophenyl)amino]quinazolin-6-yl}-4-(dimethylamino)but-2-enamide,ZCIXBBSRVLSRJQ-QPJJXVBHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
8963,6lzg,DB07029,-8.0,"4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMIDAZOL-1-YL)PHENOXY]-6-METHYLPYRIMIDINE",QQBNDYARFVOEGW-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
10564,6lzg,DB08772,-8.0,"3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL-2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID",BCSVCWVQNOXFGL-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
11280,6lzg,DB11753,-8.0,Rifamycin,HJYYPODYNSCCOU-ODRIEIDWSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
27567,6cs2,DB07116,-8.0,1-(2-DEOXY-5-O-PHOSPHONO-BETA-D-ERYTHRO-PENTOFURANOSYL)-4-METHYL-1H-INDOLE,UXXYPWCUINVUHL-BFHYXJOUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
24453,6cs2,DB00298,-8.0,Dapiprazole,RFWZESUMWJKKRN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
13010,6lzg,DB14218,-8.0,Telotristat,NCLGDOBQAWBXRA-PGRDOPGGSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
18780,6cs2,HMDB0000708,-8.0,Glycoursodeoxycholic acid,GHCZAUBVMUEKKP-XROMFQGDSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
26615,6cs2,DB04791,-8.0,"2-O-(4'-AMIDINOPHENYL)-5-O-(3''-AMIDINOPHENYL)-1,4:3,6-DIANHYDRO-D-SORBITOL",DKBAWRNTUZFJKV-BSDSXHPESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
6404,6lzg,DB02059,-8.0,Adenosine-5-Diphosphoribose,SRNWOUGRCWSEMX-ZQSHOCFMSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
28522,6cs2,DB08112,-8.0,N-({6-[(4-CYANO-2-FLUOROBENZYL)OXY]NAPHTHALEN-2-YL}SULFONYL)-D-GLUTAMIC ACID,IRJUSGUHNFMVCK-OAQYLSRUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
9242,6lzg,DB07324,-8.0,"3-({2-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)ETHYNYL]BENZYL}AMINO)-1,3-OXAZOL-2(3H)-ONE",ZUJWSOPIDUWELP-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
23054,6cs2,HMDB0055860,-8.0,"TG(22:5(7Z,10Z,13Z,16Z,19Z)/20:3n6/o-18:0)",QUHURZUDLDDFJM-VDBBUMQZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
11374,6lzg,DB11878,-8.0,Filibuvir,SLVAPEZTBDBAPI-GDLZYMKVSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
9229,6lzg,DB07311,-8.0,"18-CHLORO-11,12,13,14-TETRAHYDRO-1H,10H-8,4-(AZENO)-9,15,1,3,6-BENZODIOXATRIAZACYCLOHEPTADECIN-2-ONE",JRSWWYITYIOHOP-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
26710,6cs2,DB04903,-8.0,Pagoclone,HIUPRQPBWVEQJJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
26709,6cs2,DB04898,-8.0,Ximelagatran,ZXIBCJHYVWYIKI-PZJWPPBQSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
27468,6cs2,DB07013,-8.0,TERT-BUTYL 4-({[4-(BUT-2-YN-1-YLAMINO)PHENYL]SULFONYL}METHYL)-4-[(HYDROXYAMINO)CARBONYL]PIPERIDINE-1-CARBOXYLATE,RXFCFGLSOUOCEA-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
6379,6lzg,DB02010,-8.0,Staurosporine,HKSZLNNOFSGOKW-FYTWVXJKSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
26706,6cs2,DB04891,-8.0,Becocalcidiol,QSLUXQQUPXBIHH-YHSKWIAJSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
24564,6cs2,DB02329,-8.0,Carbenoxolone,OBZHEBDUNPOCJG-WBXJDKIVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
27474,6cs2,DB07019,-8.0,"N-[(5R,14R)-5-AMINO-5,14-DIMETHYL-4-OXO-3-OXA-18-AZATRICYCLO[15.3.1.1-7,11-]DOCOSA-1(21),7(22),8,10,17,19-HEXAEN-19-YL]-N-METHYLMETHANESULFONAMIDE",QWDOKZPZLWNULU-MZNJEOGPSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
13489,6lzg,DB15456,-8.0,Vericiguat,QZFHIXARHDBPBY-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
27476,6cs2,DB07021,-8.0,"(7R,8R)-8-(2,4,5-trifluorophenyl)-6,7,8,9-tetrahydroimidazo[1,2-a:4,5-c']dipyridin-7-amine",SOSYXEPELJIJHZ-RNCFNFMXSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
26673,6cs2,DB04853,-8.0,Binodenoson,XJFMHMFFBSOEPR-DNZQAUTHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
24558,6cs2,DB02323,-8.0,EM-1745,CKSDYJASHNGOOS-KTXOUVACSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
19923,6cs2,HMDB0000874,-8.0,Tauroursodeoxycholic acid,BHTRKEVKTKCXOH-VSHSPWMTSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
9155,6lzg,DB07237,-8.0,{4-[(2R)-pyrrolidin-2-ylmethoxy]phenyl}(4-thiophen-3-ylphenyl)methanone,VUWFJUJWAWMRQN-HXUWFJFHSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
13474,6lzg,DB01128,-8.0,Bicalutamide,LKJPYSCBVHEWIU-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
27481,6cs2,DB07027,-8.0,D-phenylalanyl-N-(3-fluorobenzyl)-L-prolinamide,JGZSVYZIJHGHMA-MOPGFXCFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
13450,6lzg,DB15385,-8.0,Acebilustat,GERJIEKMNDGSCS-DQEYMECFSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
11352,6lzg,DB11847,-8.0,Cadazolid,XWFCFMXQTBGXQW-GOSISDBHSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
6324,6lzg,DB01933,-8.0,7-Hydroxystaurosporine,PBCZSGKMGDDXIJ-HQCWYSJUSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
10531,6lzg,DB08738,-8.0,1-{3-oxo-3-[(2S)-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]propyl}-3-phenylquinoxalin-2(1H)-one,KWCKZIJGKMCYCI-QFIPXVFZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
24530,6cs2,DB00307,-8.0,Bexarotene,NAVMQTYZDKMPEU-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
13434,6lzg,DB15346,-8.0,GLPG-1205,IRBAWVGZNJIROV-SFHVURJKSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
26481,6cs2,DB04624,-8.0,DERIVATIVE OF AKLANONIC ACID METHYL ESTER (AAME),SIHNJMGWRHPFAZ-XHDPSFHLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
28590,6cs2,DB08177,-8.0,(E)-3-(5((5-(4-CHLOROPHENYL)FURAN-2-YL)METHYLENE)-4-OXO-2-THIOXOTHIAZOLIDIN-3-YL)PROPANOIC ACID,YZLFZFALAZYTCI-NTEUORMPSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
24427,6cs2,DB02164,-8.0,N-Sulfo-Flavin Mononucleotide,ZLPUGFBBLGQWBS-SCRDCRAPSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
27586,6cs2,DB07133,-8.0,D-phenylalanyl-N-(3-methylbenzyl)-L-prolinamide,CHKWABXWPATIIG-UXHICEINSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
28703,6cs2,DB08309,-8.0,3-({2-[(4-{[6-(CYCLOHEXYLMETHOXY)-9H-PURIN-2-YL]AMINO}PHENYL)SULFONYL]ETHYL}AMINO)PROPAN-1-OL,AMFGILNPFBVREA-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
14233,6lzg,T3D3865,-8.0,Iodosulfuron-methyl-sodium,JUJFQMPKBJPSFZ-UHFFFAOYSA-M,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
11154,6lzg,DB11521,-8.0,Imidocarb,SCEVFJUWLLRELN-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
2318,6lzg,HMDB0000708,-8.0,Glycoursodeoxycholic acid,GHCZAUBVMUEKKP-XROMFQGDSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
5986,6lzg,DB01410,-8.0,Ciclesonide,LUKZNWIVRBCLON-GXOBDPJESA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
8713,6lzg,DB06717,-8.0,Fosaprepitant,BARDROPHSZEBKC-OITMNORJSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
16593,6cs2,HMDB0003033,-8.0,Canrenone,UJVLDDZCTMKXJK-WNHSNXHDSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
26296,6cs2,DB04407,-8.0,4-[4-(4-Methyl-2-Methylamino-Thiazol-5-Yl)-Pyrimidin-2-Ylamino]-Phenol,OTMLAWRVLMYMDF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
13088,6lzg,DB14661,-8.0,Loperamide oxide,KXVSBTJVTUVNPM-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
24339,6cs2,DB02059,-8.0,Adenosine-5-Diphosphoribose,SRNWOUGRCWSEMX-ZQSHOCFMSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
28193,6cs2,DB07775,-8.0,"3',5'-DIBROMO-2',4,4',6'-TETRAHYDROXY AURONE",BRPKBUNFOZFULQ-SGAXSIHGSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
27694,6cs2,DB07250,-8.0,"N'-(5-CHLORO-1,3-BENZODIOXOL-4-YL)-N-(3,4,5- TRIMETHOXYPHENYL)PYRIMIDINE-2,4-DIAMINE",HMKLUOPMOJOUDZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
28706,6cs2,DB08313,-8.0,nocodazole,KYRVNWMVYQXFEU-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
25619,6cs2,DB00430,-8.0,Cefpiramide,PWAUCHMQEXVFJR-PMAPCBKXSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
23363,6cs2,HMDB0061386,-8.0,Triclosan glucuronide,DNYVWBJVOYZRCX-RNGZQALNSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
25629,6cs2,DB03608,-8.0,Diminazene,XNYZHCFCZNMTFY-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
2483,6lzg,HMDB0041745,-8.0,Hesperetin 7-O-glucuronide,NEAWXAXVQDDFJL-PLEVBHNASA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
2482,6lzg,HMDB0041744,-8.0,"Hesperetin 5,7-O-diglucuronide",DDHZYRQUEFLRIC-HXPBIGRZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
24331,6cs2,DB02049,-8.0,2-{4-[4-(4-Chloro-Phenoxy)-Benzenesulfonyl]-Tetrahydro-Pyran-4-Yl}-N-Hydroxy-Acetamide,QOPFTBAEAJQKSY-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
28166,6cs2,DB07747,-8.0,"(3R)-N-(4-CHLOROPHENYL)-3-(HYDROXYMETHYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONAMIDE",YTBGBMPLINFTBQ-OAHLLOKOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
23759,6cs2,DB01388,-8.0,Mibefradil,HBNPJJILLOYFJU-VMPREFPWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
27705,6cs2,DB07260,-8.0,N-benzyl-4-[(2R)-pyrrolidin-2-ylmethoxy]aniline,HITMFLNAOQIZSN-QGZVFWFLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
27712,6cs2,DB07268,-8.0,2-({2-[(3-HYDROXYPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)BENZAMIDE,QHPKKGUGRGRSGA-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
11124,6lzg,DB11457,-8.0,Rotenone,JUVIOZPCNVVQFO-HBGVWJBISA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
12210,6lzg,DB13042,-8.0,Fenoverine,UBAJTZKNDCEGKL-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
27715,6cs2,DB07271,-8.0,"4-[(3R)-3-Amino-4-(2,4,5-trifluorophenyl)butanoyl]-3-(2,2,2-trifluoroethyl)-1,4-diazepan-2-one",RMDAPSXWBVPVOG-IAPIXIRKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
8009,6lzg,DB04649,-8.0,TETRAHEDRAL INTERMEDIATE OF BLASTICIDIN S,MVFPGTZTOAHVBP-HXYLPHSESA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
28232,6cs2,DB07812,-8.0,"N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyrrolo[2,3-b]pyridin-4-yl)thiophene-2-carboxamide",TWYNGDRSMHRPSY-MRXNPFEDSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
7604,6lzg,DB04071,-8.0,Cpad,LFERELMXERXKKQ-KMXXXSRASA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
8784,6lzg,DB06833,-8.0,1-CYCLOHEXYL-N-{[1-(4-METHYLPHENYL)-1H-INDOL-3-YL]METHYL}METHANAMINE,MMIJMYOYKAKQPN-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
28317,6cs2,DB07901,-8.0,5-CHLORO-6-METHYL-N-(2-PHENYLETHYL)-2-PYRIDIN-2-YLPYRIMIDIN-4-AMINE,HIUOABSWQSUEGK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
17641,6cs2,HMDB0000338,-8.0,2-Hydrox1tradiol,DILDHNKDVHLEQB-XSSYPUMDSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
8912,6lzg,DB06976,-8.0,"1-(5-OXO-2,3,5,9B-TETRAHYDRO-1H-PYRROLO[2,1-A]ISOINDOL-9-YL)-3-(5-PYRROLIDIN-2-YL-1H-PYRAZOL-3-YL)-UREA",IWOOJEZSDPRYAZ-WFASDCNBSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
6193,6lzg,DB01705,-8.0,Bis(5-Amidino-Benzimidazolyl)Methane,QZKOOEFIMWKZPK-UHFFFAOYSA-Q,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
27594,6cs2,DB07143,-8.0,D-phenylalanyl-N-benzyl-L-prolinamide,MEPJWLFTTFHOQO-MOPGFXCFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
21754,6cs2,HMDB0001358,-8.0,Retinal,NCYCYZXNIZJOKI-HWCYFHEPSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
7329,6lzg,DB03632,-8.0,Argifin,UHBHXSDKGLPPGO-HTDHLNIYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
12101,6lzg,DB12885,-8.0,CF-102,IPSYPUKKXMNCNQ-PFHKOEEOSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
23341,6cs2,HMDB0060464,-8.0,Codeine-6-glucuronide,CRWVOYRJXPDBPM-HSCJLHHPSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
11252,6lzg,DB11712,-8.0,Tezacaftor,MJUVRTYWUMPBTR-MRXNPFEDSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
6169,6lzg,DB01669,-8.0,Virginiamycin M1,DAIKHDNSXMZDCU-FQTGFAPKSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
27606,6cs2,DB07156,-8.0,"(4Z)-6-bromo-4-({[4-(pyrrolidin-1-ylmethyl)phenyl]amino}methylidene)isoquinoline-1,3(2H,4H)-dione",JFEKAVPMVOLVTH-UNOMPAQXSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
12103,6lzg,DB12887,-8.0,Tazemetostat,NSQSAUGJQHDYNO-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
25524,6cs2,DB03471,-8.0,6-Phenyl-4(R)-(7-Phenyl-Heptanoylamino)-Hexanoic Acid,SMNHQYPORNSAQH-HSZRJFAPSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
8862,6lzg,DB06919,-8.0,D-phenylalanyl-N-(3-chlorobenzyl)-L-prolinamide,CJHLRGCXPGIPCB-MOPGFXCFSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
24390,6cs2,DB02115,-8.0,Daidzin,KYQZWONCHDNPDP-QNDFHXLGSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
8850,6lzg,DB06908,-8.0,"(2S)-3-(1-{[2-(2-CHLOROPHENYL)-5-METHYL-1,3-OXAZOL-4-YL]METHYL}-1H-INDOL-5-YL)-2-ETHOXYPROPANOIC ACID",PAWOPJKHTZCKMT-QFIPXVFZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
8839,6lzg,DB06897,-8.0,"3-[3-chloro-5-(5-{[(1S)-1-phenylethyl]amino}isoxazolo[5,4-c]pyridin-3-yl)phenyl]propan-1-ol",MMGKIHLBFPJYJL-HNNXBMFYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
8830,6lzg,DB06886,-8.0,N-BENZYLOXYCARBONYL-ALA-PRO-3-AMINO-4-PHENYL-BUTAN-2-OL,MACLRJNEKXUAJK-YDLSIGKMSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
26389,6cs2,DB04518,-8.0,"3-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamino]-Phenol",JJDRRZFRTKZLFT-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
7617,6lzg,DB04098,-8.0,Balanol,XYUFCXJZFZPEJD-PGRDOPGGSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
18943,6cs2,HMDB0041743,-8.0,Hesperetin 3'-O-glucuronide,PJAUEKWZQWLQSU-WDXLFLMVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
8803,6lzg,DB06856,-8.0,6-FLUORO-2-[2-HYDROXY-3-(2-METHYL-CYCLOHEXYLOXY)-PHENYL]-1H-INDOLE-5-CARBOXAMIDINE,HUYQYLFFFNSAAX-BUXKBTBVSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
8802,6lzg,DB06853,-8.0,N-cycloheptylglycyl-N-(4-carbamimidoylbenzyl)-L-prolinamide,BYTJPDBCLWUEBU-IBGZPJMESA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
13336,6lzg,DB15169,-8.0,H3B-6527,MBWRLLRCTIYXDW-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
26348,6cs2,DB04471,-8.0,"2-Phenyl-1-[4-(2-Piperidin-1-Yl-Ethoxy)-Phenyl]-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol",FMWVCTJKLAVRPB-MUUNZHRXSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
27648,6cs2,DB07198,-8.0,5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-CARBONITRILE,GGEKOZPXKBYLNK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
11270,6lzg,DB11740,-8.0,MK-1775,BKWJAKQVGHWELA-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
8050,6lzg,DB04703,-8.0,Hesperidin,QUQPHWDTPGMPEX-QJBIFVCTSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
9252,6lzg,DB07333,-8.0,"N-(CYCLOPROPYLMETHYL)-4-(METHYLOXY)-3-({5-[3-(3-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-YL}AMINO)BENZENESULFONAMIDE",KRGKAARWVPUWSY-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
29537,6cs2,DB09330,-8.0,Osimertinib,DUYJMQONPNNFPI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
10055,6lzg,DB08197,-8.0,"(5E,7S)-2-amino-7-(4-fluoro-2-pyridin-3-ylphenyl)-4-methyl-7,8-dihydroquinazolin-5(6H)-one oxime",KYIXUSLGFINPTC-WVFAEZDRSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
15611,6lzg,DB00502,-8.0,Haloperidol,LNEPOXFFQSENCJ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
11780,6lzg,DB12419,-8.0,HSD-016,ZWASRJHIEFYJGL-BFUOFWGJSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
9657,6lzg,DB07778,-8.0,FAMOXADONE,PCCSBWNGDMYFCW-QFIPXVFZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
29406,6cs2,DB09143,-8.0,Sonidegib,VZZJRYRQSPEMTK-CALCHBBNSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
27045,6cs2,DB06311,-8.0,Darapladib,WDPFJWLDPVQCAJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
11781,6lzg,DB12420,-8.0,Diazepinomicin,SALVHVNECODMJP-GNUCVDFRSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
10099,6lzg,DB08248,-8.0,3-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)-BENZENESULFONAMIDE,BKDUVKJYBJDZQW-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
18419,6cs2,HMDB0029203,-8.0,hesperetin-7-O-glucuronide,PLNORHFXCFFTRD-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
11609,6lzg,DB12200,-8.0,Tivantinib,UCEQXRCJXIVODC-PMACEKPBSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
29418,6cs2,DB09171,-8.0,??-Methylfentanyl,UXIGUKSHASXDNI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
6707,6lzg,DB02567,-8.0,PD173955,VAARYSWULJUGST-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
24813,6cs2,DB02611,-8.0,Balanol Analog 1,FZJQHARRQUNVGZ-QZTJIDSGSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
24759,6cs2,DB02547,-8.0,Guanosine-5'-Diphosphate-Rhamnose,LQEBEXMHBLQMDB-GDJBGNAASA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
27317,6cs2,DB00158,-8.0,Folic acid,OVBPIULPVIDEAO-LBPRGKRZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
13630,6lzg,T3D0015,-8.0,"Dibenzo[a,h]anthracene",LHRCREOYAASXPZ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
3610,6lzg,HMDB0047982,-8.0,"TG(14:1(9Z)/20:1(11Z)/20:3(5Z,8Z,11Z))",DHQUEWMLMFUPTL-YSSJDGIJSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
28846,6cs2,DB08467,-8.0,"6-(2,3,4,5,6,7-HEXAHYDRO-2,4,4-TRIMETHYL-1-METYLENEINDEN-2-YL)-3-METHYLHEXA-2,4-DIENOIC ACID",HEVXQLBAMFMFKU-IAZPEVBMSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
27338,6cs2,DB06875,-8.0,3-(3-FLUORO-4-HYDROXYPHENYL)-7-HYDROXY-1-NAPHTHONITRILE,NSSOSHDCWCMNDM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
29437,6cs2,DB09189,-8.0,Daledalin,YFAIJBZEDDOCAN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
10171,6lzg,DB08339,-8.0,"6-(2,6-DICHLOROPHENYL)-2-{[3-(HYDROXYMETHYL)PHENYL]AMINO}-8-METHYLPYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE",ZIQFYVPVJZEOFS-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
27346,6cs2,DB06883,-8.0,1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-phenylurea,DHNYNLNKNQJSHF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
10172,6lzg,DB08340,-8.0,"N,N'-DIPHENYLPYRAZOLO[1,5-A][1,3,5]TRIAZINE-2,4-DIAMINE",LLYYAUZAGCZEKV-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
11830,6lzg,DB12483,-8.0,Copanlisib,PZBCKZWLPGJMAO-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
9556,6lzg,DB07666,-8.0,"(3R,4S)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE",OAWGQHXWGXOUKV-BEFAXECRSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
3575,6lzg,HMDB0047852,-8.0,"TG(14:1(9Z)/22:0/22:2(13Z,16Z))",XORGQMNRBOZGBM-WVHAEAGOSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
27315,6cs2,DB06850,-8.0,(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclohexylamino)ethanoyl)pyrrolidine-2-carboxamide,RYKFVFFOIYLADT-SFHVURJKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
29399,6cs2,DB09128,-8.0,Brexpiprazole,ZKIAIYBUSXZPLP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
20272,6cs2,HMDB0000921,-8.0,Cholestenone,NYOXRYYXRWJDKP-GYKMGIIDSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
27284,6cs2,DB06809,-8.0,Plerixafor,YIQPUIGJQJDJOS-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
24977,6cs2,DB02812,-8.0,"(2s,4r)-1-Acetyl-N-[(1s)-4-[(Aminoiminomethyl)Amino]-1-(2-Benzothiazolylcarbonyl)Butyl]-4-Hydroxy-2-Pyrrolidinecarboxamide",VXDAVYUFYPFGDX-SNPRPXQTSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
15812,6lzg,DB01349,-8.0,Tasosartan,ADXGNEYLLLSOAR-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
27211,6cs2,DB06697,-8.0,Artemether,SXYIRMFQILZOAM-HVNFFKDJSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
24919,6cs2,DB00136,-8.0,Calcitriol,GMRQFYUYWCNGIN-NKMMMXOESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
12776,6lzg,DB13791,-8.0,Penfluridol,MDLAAYDRRZXJIF-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
24901,6cs2,DB02716,-8.0,7-Methyl-Guanosine-5'-Triphosphate,DKVRNHPCAOHRSI-KQYNXXCUSA-O,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
329,6lzg,HMDB0004484,-8.0,Etiocholanolone glucuronide,VFUIRAVTUVCQTF-SDHZCXLISA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
28782,6cs2,DB08397,-8.0,6-(DIFLUORO-PHOSPHONO-METHYL)-NAPHTHALENE-2-CARBOXYLIC ACID,NKGNOWNPXBURRW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
15870,6lzg,DB01640,-8.0,"(5r)-6-(4-{[2-(3-Iodobenzyl)-3-Oxocyclohex-1-En-1-Yl]Amino}Phenyl)-5-Methyl-4,5-Dihydropyridazin-3(2h)-One",QNURTFDBHAQRSI-OAHLLOKOSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
27231,6cs2,DB06725,-8.0,Lornoxicam,WLHQHAUOOXYABV-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
12858,6lzg,DB13929,-8.0,Relcovaptan,CEBYCSRFKCEUSW-NAYZPBBASA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
6814,6lzg,DB02732,-8.0,Nicotinamide Adenine Dinucleotide Acetone Adduct,SGHBFOOIAAJJMI-YDKVLQLQSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
10907,6lzg,DB09238,-8.0,Manidipine,ANEBWFXPVPTEET-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
25073,6cs2,DB00370,-8.0,Mirtazapine,RONZAEMNMFQXRA-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
11675,6lzg,DB12285,-8.0,Verubecestat,YHYKUSGACIYRML-KRWDZBQOSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
15680,6lzg,DB00796,-8.0,Candesartan cilexetil,GHOSNRCGJFBJIB-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
9724,6lzg,DB00719,-8.0,Azatadine,SEBMTIQKRHYNIT-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
11661,6lzg,DB12270,-8.0,Losmapimod,KKYABQBFGDZVNQ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
6795,6lzg,DB02705,-8.0,"6-[N-(1-Isopropyl-1,2,3,4-Tetrahydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine",DARQQJKHXPXSRO-QFIPXVFZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
28805,6cs2,DB08424,-8.0,"[5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL](3-{[(2R)-2,3-DIHYDROXYPROPYL]OXY}PHENYL)METHANONE",IJDQETGUEUJVTB-HNNXBMFYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
25086,6cs2,DB02936,-8.0,4-(1-Benzyl-3-Carbamoylmethyl-2-Methyl-1h-Indol-5-Yloxy)-Butyric Acid,STENXUCYNKOBHJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
7012,6lzg,DB03076,-8.0,AHA047,CGBDAHCDSVOMCF-FYZVQMPESA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
24833,6cs2,DB02639,-8.0,4-methylumbelliferyl ??-D-glucoside,YUDPTGPSBJVHCN-JZYAIQKZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
9692,6lzg,DB07811,-8.0,"N-cyclopropyl-2',6-dimethyl-4'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-3-carboxamide",UBVTVSINEVHYSY-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
11740,6lzg,DB12371,-8.0,Siponimod,KIHYPELVXPAIDH-HNSNBQBZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
29344,6cs2,DB09038,-8.0,Empagliflozin,OBWASQILIWPZMG-QZMOQZSNSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
9985,6lzg,DB08125,-8.0,"4-{[(2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]AMINO}-N-(1,3-THIAZOL-2-YL)BENZENESULFONAMIDE",BOMPRXSVSIPRDT-PTNGSMBKSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
7090,6lzg,DB03207,-8.0,"2-(Biphenyl-4-Sulfonyl)-1,2,3,4-Tetrahydro-Isoquinoline-3-Carboxylic Acid",BNVMUDXGABBWGP-OAQYLSRUSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
14748,6lzg,T3D4695,-8.0,Etoposide,VJJPUSNTGOMMGY-MRVIYFEKSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
10183,6lzg,DB08353,-8.0,"2-(CYCLOHEXYLMETHYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE",NCVMTHVSAJMOPI-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
27371,6cs2,DB06909,-8.0,"1-ethyl-N-(phenylmethyl)-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridine-5-carboxamide",QZGJNFBMYYEFGM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
26814,6cs2,DB05395,-8.0,Amibegron,RDJQCOBTKKAQAH-FPOVZHCZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
6482,6lzg,DB02197,-8.0,"4-[(4-Imidazo[1,2-a]Pyridin-3-Ylpyrimidin-2-Yl)Amino]Benzenesulfonamide",NKORVPQBJCGYEC-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
6480,6lzg,DB02194,-8.0,"8-Benzyl-2-Hydroxy-2-(4-Hydroxy-Benzyl)-6-(4-Hydroxy-Phenyl)-2h-Imidazo[1,2-a]Pyrazin-3-One",ULLMMKZQNNBLRN-SANMLTNESA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
7180,6lzg,DB03351,-8.0,Sri-9439,KMSATRJZEXNGDP-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
28562,6cs2,DB08150,-8.0,"4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-aminium",RZIDZIGAXXNODG-UHFFFAOYSA-O,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
28560,6cs2,DB08148,-8.0,"1-[4-(4-chlorophenyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine",QOZMRRGNAZNWDN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
28666,6cs2,DB08267,-8.0,"6-amino-4-(2-phenylethyl)-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",PBZAIUVFRISTSZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
3187,6lzg,HMDB0000874,-8.0,Tauroursodeoxycholic acid,BHTRKEVKTKCXOH-VSHSPWMTSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
23273,6cs2,HMDB0059990,-8.0,"5-(3',4'-Dihydroxyphenyl)-gamma-valerolactone-4'-O-methyl-3'-O-glucuronide",VZGJAVFCUBLIJF-ZOQSEFCISA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
26791,6cs2,DB00562,-8.0,Benzthiazide,NDTSRXAMMQDVSW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
11398,6lzg,DB11912,-8.0,Lanopepden,SWHNZGMQMGFQGW-MSOLQXFVSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
26788,6cs2,DB05239,-8.0,Cobimetinib,BSMCAPRUBJMWDF-KRWDZBQOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
14059,6lzg,T3D3676,-8.0,Cytochalasin A,APAAWKRGRLFEPA-LFKALUBKSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
11396,6lzg,DB11910,-8.0,MK-0249,DDDZBLNULGDPGA-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
27458,6cs2,DB07002,-8.0,4-({4-[(4-methoxypyridin-2-yl)amino]piperidin-1-yl}carbonyl)benzonitrile,SZUVGMCKKLJAFX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
26775,6cs2,DB05137,-8.0,Lobeline,MXYUKLILVYORSK-HBMCJLEFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
11389,6lzg,DB11901,-8.0,Apalutamide,HJBWBFZLDZWPHF-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
28629,6cs2,DB08224,-8.0,"(1S,7S,8S,8AR)-1,2,3,7,8,8A-HEXAHYDRO-7-METHYL-8-[2-[(2R,4R)-TETRAHYDRO-4-HY DROXY-6-OXO-2H-PYRAN-2-YL]ETHYL]-1-NAPHTHALENOL",WWSNTLOVYSRDEL-TVKPWXLESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
28614,6cs2,DB08204,-8.0,3-DIPHENOL-6-NITRO-3H-BENZO[DE]ISOCHROMEN-1-ONE,FLWABCQDXUKNQY-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
27463,6cs2,DB07006,-8.0,"9-HYDROXY-6-(3-HYDROXYPROPYL)-4-(2-METHOXYPHENYL)PYRROLO[3,4-C]CARBAZOLE-1,3(2H,6H)-DIONE",AOGOZJCRIFBTTN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
27466,6cs2,DB07011,-8.0,"(3S)-1-(1,3-BENZODIOXOL-5-YLMETHYL)-3-[4-(1H-IMIDAZOL-1-YL)PHENOXY]PIPERIDINE",HHOPJGKEAIIIDF-FQEVSTJZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
26762,6cs2,DB05087,-8.0,Ganaxolone,PGTVWKLGGCQMBR-FLBATMFCSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
12624,6lzg,DB13606,-8.0,Phenazocine,ZQHYKVKNPWDQSL-KNXBSLHKSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
11945,6lzg,DB12655,-8.0,Patidegib,HZLFFNCLTRVYJG-WWGOJCOQSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
9261,6lzg,DB07343,-8.0,"4-[4-AMINO-6-(2,6-DICHLORO-PHENOXY)-[1,3,5]TRIAZIN-2-YLAMINO]-BENZONITRILE",NFNNMVVXXITVGD-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
9259,6lzg,DB07340,-8.0,"N-6-cyclohexyl-N-2-(4-morpholin-4-ylphenyl)-9H-purine-2,6-diamine",ZFLJHSQHILSNCM-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
26783,6cs2,DB05197,-8.0,Sofalcone,GFWRVVCDTLRWPK-KPKJPENVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
28648,6cs2,DB08244,-8.0,"(1S)-1-CYCLOPROPYL-2-[(2S)-4-(2,5-DIFLUOROPHENYL)-2-PHENYL-2,5-DIHYDRO-1H-PYRROL-1-YL]-2-OXOETHANAMINE",VCOUEHUEFUDZIS-PMACEKPBSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
28916,6cs2,DB08540,-8.0,"2-[4-(2H-1,4-BENZOTHIAZINE-3-YL)-PIPERAZINE-1-LY]-1,3-THIAZOLE-4-CARBOXYLIC ACID ETHYLESTER",AQJQFCRTSWIUCY-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
28913,6cs2,DB08537,-8.0,"3-bromo-6-phenyl-N-(pyrimidin-5-ylmethyl)imidazo[1,2-a]pyridin-8-amine",LZLKFNBMXXLTLX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
18077,6cs2,HMDB0012242,-8.0,Ketoconazole,XMAYWYJOQHXEEK-ZEQKJWHPSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
10218,6lzg,DB08391,-8.0,"6,7-DIMETHOXY-4-[(3R)-3-(QUINOXALIN-2-YLOXY)PYRROLIDIN-1-YL]QUINAZOLINE",UBIIFKJMNRPNMT-CQSZACIVSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
11863,6lzg,DB12535,-8.0,AC-430,DCRWIATZWHLIPN-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
12692,6lzg,DB13685,-8.0,Quingestanol,PCJFRMOEZQQSAX-AIOSZGMZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
4458,6lzg,HMDB0001396,-8.0,5-Methyltetrahydrofolic acid,ZNOVTXRBGFNYRX-ZGTCLIOFSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
27382,6cs2,DB06919,-8.0,D-phenylalanyl-N-(3-chlorobenzyl)-L-prolinamide,CJHLRGCXPGIPCB-MOPGFXCFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
10279,6lzg,DB08460,-8.0,"3-{5-[(6-amino-1H-pyrazolo[3,4-b]pyridin-3-yl)methoxy]-2-chlorophenoxy}-5-chlorobenzonitrile",KXDIHAQCVNNLIB-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
27387,6cs2,DB06923,-8.0,2-(3-METHYLPHENYL)-1H-INDOLE-5-CARBOXIMIDAMIDE,KJUSXMYSVXZFDJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
29464,6cs2,DB09215,-8.0,Droxicam,OEHFRZLKGRKFAS-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
28874,6cs2,DB08497,-8.0,"(1S)-2-oxo-1-phenyl-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate",NKBDSMREMMRFSI-INIZCTEOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
26908,6cs2,DB05838,-8.0,OPC-51803,INGXCNVWWKKWOO-LJQANCHMSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
26893,6cs2,DB05772,-8.0,Rabeximod,PDNNUMNEXITLCZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
11475,6lzg,DB12015,-8.0,Alpelisib,STUWGJZDJHPWGZ-LBPRGKRZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
26885,6cs2,DB05706,-8.0,13-deoxydoxorubicin,RGVRUQHYQSORBY-JIGXQNLBSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
9462,6lzg,DB07563,-8.0,"1-{7-cyclohexyl-6-[4-(4-methylpiperazin-1-yl)benzyl]-7H-pyrrolo[2,3-d]pyrimidin-2-yl}methanamine",GCJSOJRPNOWSEH-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
29319,6cs2,DB09003,-8.0,Clocapramine,QAZKXHSIKKNOHH-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
10333,6lzg,DB08519,-8.0,"N-4-(3-methyl-1H-indazol-6-yl)-N-2-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine",SQQAPOSROFWHIB-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
24654,6cs2,DB02427,-8.0,"2,4-Diamino-6-[N-(2',5'-Dimethoxybenzyl)-N-Methylamino]Quinazoline",YBJANOUTWRTBDK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
28896,6cs2,DB08520,-8.0,"(21S)-1AZA-4,4-DIMETHYL-6,19-DIOXA-2,3,7,20-TETRAOXOBICYCLO[19.4.0] PENTACOSANE",VUCSBBBCFXBFFY-IBGZPJMESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
26874,6cs2,DB05653,-8.0,IRX-5183,PNAWUIKCVQSLFG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
25240,6cs2,DB03126,-8.0,Mant-Adp,QPKUEBLEGWBRHC-BFHYXJOUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
29483,6cs2,DB09235,-8.0,Efonidipine,NSVFSAJIGAJDMR-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
11896,6lzg,DB12579,-8.0,JNJ-37822681,UVUYWJWYRLJHEN-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
24640,6cs2,DB00319,-8.0,Piperacillin,IVBHGBMCVLDMKU-GXNBUGAJSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
11449,6lzg,DB11984,-8.0,Letaxaban,GEHAEMCVKDPMKO-HXUWFJFHSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
29313,6cs2,DB08997,-8.0,Dexetimide,LQQIVYSCPWCSSD-HSZRJFAPSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
7689,6lzg,DB04215,-8.0,CRA_9076,BVTBOJXEAPSOEB-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
24727,6cs2,DB02510,-8.0,'5'-O-(N-(L-Prolyl)-Sulfamoyl)Adenosine,LKVJEMXWEODCAY-JVEUSOJLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
28140,6cs2,DB07719,-8.0,"[(3R)-3-(Methylcarbamoyl)-2-{[(2-methyl-2-propanyl)oxy]carbonyl}-1,2,3,4-tetrahydro-7-isoquinolinyl]sulfamic acid",PPSSYXOFPICMQD-CYBMUJFWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
12012,6lzg,DB12745,-8.0,GSK-690693,KGPGFQWBCSZGEL-ZDUSSCGKSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
27173,6cs2,DB06625,-8.0,Vipadenant,HQSBCDPYXDGTCL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
8237,6lzg,DB04960,-8.0,Tipifarnib,PLHJCIYEEKOWNM-HHHXNRCGSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
8417,6lzg,DB05936,-8.0,CVT-6883,KOYXXLLNCXWUNF-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
29108,6cs2,DB08746,-8.0,1-[[(1E)-2-(4-CHLOROPHENYL)ETHENYL]SULFONYL]-4-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]PIPERAZINE,ZOSSOFIFNGGDKG-GIJQJNRQSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
13145,6lzg,DB14770,-8.0,Lanraplenib,XCIGZBVOUQVIPI-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
24104,6cs2,DB01772,-8.0,"3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl]-4-(5-Fluoro-1-Methyl-1h-Indol-3-Yl)-Pyrrole-2,5-Dione",RPGZQOOZHIEPJW-HNNXBMFYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
43,6lzg,HMDB0002395,-8.0,Ursolic acid,WCGUUGGRBIKTOS-GPOJBZKASA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
22348,6cs2,HMDB0001496,-8.0,7a-Hydroxycholesterol,OYXZMSRRJOYLLO-AWBHSAGMSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
5499,6lzg,HMDB0001903,-8.0,Calcitriol,GMRQFYUYWCNGIN-NKMMMXOESA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
27790,6cs2,DB07343,-8.0,"4-[4-AMINO-6-(2,6-DICHLORO-PHENOXY)-[1,3,5]TRIAZIN-2-YLAMINO]-BENZONITRILE",NFNNMVVXXITVGD-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
8215,6lzg,DB04908,-8.0,Flibanserin,PPRRDFIXUUSXRA-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
7440,6lzg,DB03802,-8.0,"1-[4-(Octahydro-Pyrido[1,2-a]Pyrazin-2-Yl)-Phenyl]-2-Phenyl-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol",ZGHFWBDHZZKWSI-LITSAYRRSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
29869,6cs2,DB11745,-8.0,Otenabant,UNAZAADNBYXMIV-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
8628,6lzg,DB06555,-8.0,Siramesine,XWAONOGAGZNUSF-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
8538,6lzg,DB06311,-8.0,Darapladib,WDPFJWLDPVQCAJ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
29084,6cs2,DB08724,-8.0,5-(5-(4-(5-hydro-4-methyl-2-oxazolyl)phenoxy)pentyl)-3-methyl isoxazole,UXIYKMARWUSIKU-HNNXBMFYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
29165,6cs2,DB08804,-8.0,Nandrolone decanoate,JKWKMORAXJQQSR-MOPIKTETSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
27905,6cs2,DB07467,-8.0,"4-chloro-N-[(2S)-2-methyl-2,3-dihydro-1H-indol-1-yl]-3-sulfamoylbenzamide",NDDAHWYSQHTHNT-JTQLQIEISA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
10791,6lzg,DB09073,-8.0,Palbociclib,AHJRHEGDXFFMBM-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
12381,6lzg,DB13307,-8.0,Proscillaridin,MYEJFUXQJGHEQK-ALRJYLEOSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
16891,6cs2,HMDB0005006,-8.0,Atorvastatin,XUKUURHRXDUEBC-KAYWLYCHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
8343,6lzg,DB05511,-8.0,Piclidenoson,HUJXGQILHAUCCV-MOROJQBDSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
27916,6cs2,DB07479,-8.0,"(1S)-1,2,3,4-TETRAHYDRO-BENZO[C]PHENANTHRENE-2,3,4-TRIOL",WCUHTHVUZQCBTI-KBAYOESNSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
13266,6lzg,DB15046,-8.0,LY-2881835,FHRWHNJJQGSCQC-LJAQVGFWSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
7435,6lzg,DB03797,-8.0,3-Aminomethyl-Pyridinium-Adenine-Dinucleotide,HMCRLFVYYFBZEZ-PLEFRAQWSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
8422,6lzg,DB05944,-8.0,Varlitinib,UWXSAYUXVSFDBQ-CYBMUJFWSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
26209,6cs2,DB04295,-8.0,N-Benzoyl-N'-Beta-D-Glucopyranosyl Urea,JSBCZGSPFATCOV-BZNQNGANSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
23934,6cs2,DB01572,-8.0,Methyl-1-testosterone,JRNSSSJKIGAFCT-YDSAWKJFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
24134,6cs2,DB01810,-8.0,"[1-(1-Methyl-4,5-Dioxo-Pent-2-Enylcarbamoyl)-2-Phenyl-Ethyl]-Carbamic Acid Benzyl Ester",NOXVWFAAXREWMI-GURWAVDKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
28694,6cs2,DB08301,-8.0,N-({[4-(AMINOSULFONYL)PHENYL]AMINO}CARBONYL)-4-METHYLBENZENESULFONAMIDE,HDCXQTPVTAIPNZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
23871,6cs2,DB01513,-8.0,"17Alpha-methyl-3beta,17beta-dihydroxy-5alpha-androstane",QGKQXZFZOIQFBI-UYEYMFBJSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
27761,6cs2,DB07314,-8.0,"1-(5-CHLORO-2,4-DIMETHOXYPHENYL)-3-(5-CYANOPYRAZIN-2-YL)UREA",URQYPXQXSVUVRG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
8124,6lzg,DB04796,-8.0,Inecalcitol,HHGRMHMXKPQNGF-WNSNRMDMSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
27853,6cs2,DB07410,-8.0,[2-(3-DIBENZOFURAN-4-YL-PHENYL)-1-HYDROXY-1-PHOSPHONO-ETHYL]-PHOSPHONIC ACID,BYVXAUZOTGITQZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
29021,6cs2,DB08656,-8.0,5-amino-2-methyl-N-[(1R)-1-naphthalen-1-ylethyl]benzamide,UVERBUNNCOKGNZ-CQSZACIVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
13201,6lzg,DB14885,-8.0,PF-05180999,CLGCHUKGBICQTE-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
28980,6cs2,DB08610,-8.0,N-(2-AMINOETHYL)-2-{3-CHLORO-4-[(4-ISOPROPYLBENZYL)OXY]PHENYL} ACETAMIDE,DFXJYVQAAFOZDP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
8611,6lzg,DB06515,-8.0,Resiniferatoxin,DSDNAKHZNJAGHN-MXTYGGKSSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
8374,6lzg,DB05667,-8.0,Levoketoconazole,XMAYWYJOQHXEEK-ZEQKJWHPSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
29057,6cs2,DB08699,-8.0,"1-tert-butyl-3-(3-methylbenzyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine",FYCOTGCSHZKHPR-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
28991,6cs2,DB08622,-8.0,"4-(4-CHLORO-PHENYL)-1-{3-[2-(4-FLUORO-PHENYL)-[1,3]DITHIOLAN-2-YL]-PROPYL}-PIPERIDIN-4-OL",KVDKNVPAAQKHKD-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
27865,6cs2,DB07423,-8.0,(2S)-3-[4-(acetylamino)phenoxy]-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide,YVXVTLGIDOACBJ-SFHVURJKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
8121,6lzg,DB04793,-8.0,"1,4:3,6-Dianhydro-2-O-(3-carbamimidoylphenyl)-5-O-(4-carbamimidoylphenyl)-D-glucitol",DKBAWRNTUZFJKV-XMTFNYHQSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
14865,6lzg,T3D4818,-8.0,Bicalutamide,LKJPYSCBVHEWIU-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
14394,6lzg,T3D4084,-8.0,Veratramine,MALFODICFSIXPO-KFKQDBFTSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
33,6lzg,HMDB0002364,-8.0,Oleanolic acid,MIJYXULNPSFWEK-GTOFXWBISA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
29067,6cs2,DB08709,-8.0,"2,3-diphenyl-1H-indole-7-carboxylic acid",OLUDUXWVPIEHDA-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
7503,6lzg,DB03903,-8.0,Tmr,KGFLZYXDJDOIEE-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
28057,6cs2,DB07630,-8.0,"N-((1R,2R)-2-(5-CHLORO-1H-INDOLE-2-CARBOXAMIDO)CYCLOHEXYL)-5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE-2-CARBOXAMIDE",ARPFWVKYXJZULB-IAGOWNOFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
29118,6cs2,DB08755,-8.0,N-[(1S)-2-{[(1R)-2-(benzyloxy)-1-cyano-1-methylethyl]amino}-1-(cyclohexylmethyl)-2-oxoethyl]morpholine-4-carboxamide,MQWUTQCRGGBPBT-WIOPSUGQSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
24205,6cs2,DB01893,-8.0,N6-Benzyl Adenosine-5'-Diphosphate,MRHGMAGSDAQUFH-LSCFUAHRSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
29073,6cs2,DB08713,-8.0,"2,6-DIMETHYL-1-(3-[3-METHYL-5-ISOXAZOLYL]-PROPANYL)-4-[2N-METHYL-2H-TETRAZOL-5-YL]-PHENOL",RVZKQTQAFHEOKT-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
25986,6cs2,DB04030,-8.0,"1,3,4,9-Tetrahydro-2-(Hydroxybenzoyl)-9-[(4-Hydroxyphenyl)Methyl]-6-Methoxy-2h-Pyrido[3,4-B]Indole",ADXYEWMDAGIULV-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
13180,6lzg,DB14854,-8.0,TC-6987,UAKZGMMGIMKFMV-RBUKOAKNSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
8618,6lzg,DB06529,-8.0,Ocinaplon,OQJFBUOFGHPMSR-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
28056,6cs2,DB07629,-8.0,"N-((1R,2S)-2-(5-CHLORO-1H-INDOLE-2-CARBOXAMIDO)CYCLOHEXYL)-5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE-2-CARBOXAMIDE",ARPFWVKYXJZULB-DLBZAZTESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
14835,6lzg,T3D4789,-8.0,Troglitazone,GXPHKUHSUJUWKP-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
24112,6cs2,DB01782,-8.0,"2,6-Dihydroanthra/1,9-Cd/Pyrazol-6-One",ACPOUJIDANTYHO-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
7510,6lzg,DB03916,-8.0,4-{2-[4-(2-Aminoethyl)Piperazin-1-Yl]Pyridin-4-Yl}-N-(3-Chloro-4-Methylphenyl)Pyrimidin-2-Amine,RHOOHUMOHVIXEF-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
27909,6cs2,DB07470,-8.0,"(3aS)-3a-hydroxy-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one",DOMYOVZXZIZTRD-QGZVFWFLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
8541,6lzg,DB06321,-8.0,R-348,IGLNXKVGKIFNBQ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
12247,6lzg,DB13094,-8.0,Pruvanserin,AQRLDDAFYYAIJP-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
24283,6cs2,DB01990,-8.0,Cholesterol sulfate,BHYOQNUELFTYRT-DPAQBDIFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
17082,6cs2,HMDB0006117,-8.0,APGPR Enterostatin,ITZMJCSORYKOSI-AJNGGQMLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
27727,6cs2,DB07283,-8.0,"9-benzyl-2,3,4,9-tetrahydro-1H-carbazole-8-carboxylic acid",VDOXYKGIKBUISK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
8510,6lzg,DB06248,-8.0,Amelubant,SBVYURPQULDJTI-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
8665,6lzg,DB06634,-8.0,Casopitant,XGGTZCKQRWXCHW-WMTVXVAQSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
28012,6cs2,DB07582,-8.0,"N-[(2R,3S)-1-((2S)-2-{[(CYCLOPENTYLAMINO)CARBONYL]AMINO}-3-METHYLBUTANOYL)-2-(1-FORMYL-1-CYCLOBUTYL)PYRROLIDINYL]CYCLOPROPANECARBOXAMIDE",GCDRFILPPBOJLM-UFYCRDLUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
10773,6lzg,DB09042,-8.0,Tedizolid phosphate,QCGUSIANLFXSGE-GFCCVEGCSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
26080,6cs2,DB04144,-8.0,"Cis-[4,5-Bis-(4-Chlorophenyl)-2-(2-Isopropoxy-4-Methoxyphenyl)-4,5-Dihyd Roimidazol-1-Yl]-Piperazin-1-Yl-Methanone",ZXIPEZDMQNYFOO-WUFINQPMSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
17125,6cs2,HMDB0006552,-8.0,Aflatoxin B1,OQIQSTLJSLGHID-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
8449,6lzg,DB06137,-8.0,KX-01,HUNGUWOZPQBXGX-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
8197,6lzg,DB04879,-8.0,Vatalanib,YCOYDOIWSSHVCK-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
24298,6cs2,DB02010,-8.0,Staurosporine,HKSZLNNOFSGOKW-FYTWVXJKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
26091,6cs2,DB04158,-8.0,"6-(Adenosine Tetraphosphate-Methyl)-7,8-Dihydropterin",ZKRKFZJAQKKHKL-SUGPNEFASA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
8521,6lzg,DB06267,-8.0,Udenafil,IYFNEFQTYQPVOC-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
25819,6cs2,DB03830,-8.0,Phosphorylated Dihydropteroate,DNKVHXNVVYQUDC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
8504,6lzg,DB06237,-8.0,Avanafil,WEAJZXNPAWBCOA-INIZCTEOSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
28000,6cs2,DB07567,-8.0,"(2R,3R,4S)-3-(4-HYDROXYPHENYL)-4-METHYL-2-[4-(2-PYRROLIDIN-1-YLETHOXY)PHENYL]CHROMAN-6-OL",XPVKGTWRXBSJKO-LHXLBICKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
25710,6cs2,DB03714,-8.0,4-Carbamoyl-4-{[6-(Difluoro-Phosphono-Methyl)-Naphthalene-2-Carbonyl]-Amino}-Butyric Acid,OWWCIKSGGKYNHT-ZDUSSCGKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
157098,6wiq,DB14555,-7.9,Ursadiol,RTLXJEJRLWILSU-GWNGJUQLSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
56971,6crv,DB03030,-7.9,4-(2-Thienyl)-1-(4-Methylbenzyl)-1h-Imidazole,UMOFOLLUKPBVQG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
101015,6vxs,DB04357,-7.9,Pteric Acid,JOAQINSXLLMRCV-UHFFFAOYSA-O,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101336,6vxs,DB04792,-7.9,"2,5-O,O-BIS-{4',4''-AMIDINOPHENYL}-1,4:3,6-DIANHYDRO-D-SORBITOL",CDEVHSIVANGYRI-XMTFNYHQSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
125917,6w4h,DB03124,-7.9,5-[4-(1-Carboxymethyl-2-Oxo-Propylcarbamoyl)-Benzylsulfamoyl]-2-Hydroxy-Benzoic Acid,LBAHOXPDTNUYCX-INIZCTEOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
125923,6w4h,DB03133,-7.9,"2-(Beta-D-Glucopyranosyl)-5-Methyl-1,2,3-Benzimidazole",XIJZORUYQZBFJK-UJPOAAIJSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
24173,6cs2,DB01852,-7.9,Kaempherol,IYRMWMYZSQPJKC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
164358,7bv1,DB07741,-7.9,"4-(1R,3AS,4R,8AS,8BR)-[1-DIFLUOROMETHYL-2-(4-FLUOROBENZYL)-3-OXODECAHYDROPYRROLO[3,4-A]PYRROLIZIN-4-YL]BENZAMIDINE",VPNYXOTTXAXSIH-SXYSDOLCSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
69717,6lxt,DB11551,-7.9,Trenbolone,MEHHPFQKXOUFFV-OWSLCNJRSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
11501,6lzg,DB12055,-7.9,MK-0767,ORZMUVMQJPGFOM-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
88104,6m3m,DB13349,-7.9,Talastine,LCAAMXMULMCKLJ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
138480,6w9c,DB11729,-7.9,GSK-2330672,CZGVOBIGEBDYTP-VSGBNLITSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
101011,6vxs,DB04350,-7.9,Argadin,FOZYKTUSOWWQGR-KNPYFFGGSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
69730,6lxt,DB11591,-7.9,Bilastine,ACCMWZWAEFYUGZ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
88084,6m3m,DB13325,-7.9,Nifurzide,IDUMOVRJNBNOTR-BIZLIJPVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
106194,6vxs,DB15206,-7.9,Uprifosbuvir,SFPFZQKYPOWCSI-KHFYHRBSSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
107861,6vxx,DB05288,-7.9,Anecortave acetate,YUWPMEXLKGOSBF-GACAOOTBSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
32025,6cs2,DB15222,-7.9,GS-6620,YAAQYJCOIFNMKX-RSTNYOGXSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
123167,6w4b,DB15009,-7.9,PF-04937319,MASKQITXHVYVFL-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
57008,6crv,DB03079,-7.9,Alpha-Ribazole-5'-Phosphate Derivative,YPYFPLLZCVEYCS-KKOKHZNYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106198,6vxs,DB15212,-7.9,Pemafibrate,ZHKNLJLMDFQVHJ-RUZDIDTESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
138580,6w9c,DB11872,-7.9,ZD-6126,UGBMEXLBFDAOGL-INIZCTEOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
164360,7bv1,DB07743,-7.9,"S-[5-(TRIFLUOROMETHYL)-4H-1,2,4-TRIAZOL-3-YL] 5-(PHENYLETHYNYL)FURAN-2-CARBOTHIOATE",VNGWUVBXUIDQTK-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
107747,6vxx,DB04563,-7.9,CRA_9678,VIZNZQTZRMTYPZ-UHFFFAOYSA-M,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
164345,7bv1,DB07724,-7.9,Indeglitazar,YMPALHOKRBVHOJ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
138575,6w9c,DB11865,-7.9,Brivanib alaninate,LTEJRLHKIYCEOX-OCCSQVGLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
126002,6w4h,DB03235,-7.9,N-{3-[4-(3-aminopropyl)piperazin-1-yl]propyl}-3-(alpha-D-galactopyranosyloxy)-5-nitrobenzamide,UEIGEWJJVQHIAX-MKQKURRLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
7487,6lzg,DB00455,-7.9,Loratadine,JCCNYMKQOSZNPW-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
138558,6w9c,DB11836,-7.9,Sapanisertib,GYLDXIAOMVERTK-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
28868,6cs2,DB08491,-7.9,N-HYDROXY-2-[4-(4-PHENOXY-BENZENESULFONYL)-TETRAHYDRO-PYRAN-4-YL]-ACETAMIDE,ARIRIZBKMKMEBD-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
69707,6lxt,DB11520,-7.9,Hygromycin B,GRRNUXAQVGOGFE-HUCHGKBZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
12938,6lzg,DB14068,-7.9,Dexniguldipine,SVJMLYUFVDMUHP-MGBGTMOVSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
12935,6lzg,DB14066,-7.9,Tetrandrine,WVTKBKWTSCPRNU-KYJUHHDHSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
99471,6vxs,DB02300,-7.9,Calcipotriol,LWQQLNNNIPYSNX-UROSTWAQSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
88132,6m3m,DB13384,-7.9,Melitracen,GWWLWDURRGNSRS-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
69698,6lxt,DB11491,-7.9,Sarafloxacin,XBHBWNFJWIASRO-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
57184,6crv,DB03307,-7.9,4-[(6-Amino-4-Pyrimidinyl)Amino]Benzenesulfonamide,FVFVVRPJERUECT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
32067,6cs2,DB15295,-7.9,Tenalisib,HDXDQPRPFRKGKZ-INIZCTEOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
69759,6lxt,DB11656,-7.9,Rebamipide,ALLWOAVDORUJLA-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
61685,6crv,DB12433,-7.9,SCH-900271,ARJKMWXLIHZLQZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56976,6crv,DB03039,-7.9,"4-(Aminosulfonyl)-N-[(2,5-Difluorophenyl)Methyl]-Benzamide",KEGUALXMKQVDIO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106152,6vxs,DB15123,-7.9,Dorzagliatin,HMUMWSORCUWQJO-QAPCUYQASA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
126081,6w4h,DB03337,-7.9,1-(2-Amidinophenyl)-3-(Phenoxyphenyl)Urea,ZHCAYBOLUMAUQX-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
68916,6lxt,DB08488,-7.9,"4-{[(E)-2-(5-CHLOROTHIEN-2-YL)VINYL]SULFONYL}-1-(1H-PYRROLO[3,2-C]PYRIDIN-2-YLMETHYL)PIPERAZIN-2-ONE",PLWVUIRWJVKSSD-XBXARRHUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
138427,6w9c,DB11648,-7.9,Afuresertib,AFJRDFWMXUECEW-LBPRGKRZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
61708,6crv,DB12468,-7.9,Pf-04531083,ZRJGMDIPCQOGNI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
68957,6lxt,DB08534,-7.9,"5-(2-fluorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",ZAIYYXVHGBMLEC-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
139105,6w9c,DB12868,-7.9,Intoplicine,QROONAIPJKQFMC-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
69755,6lxt,DB11650,-7.9,HT-0712,ABEJDMOBAFLQNJ-NHCUHLMSSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
81885,6m3m,DB01812,-7.9,Adenosine-3'-5'-Diphosphate,WHTCPDAXWFLDIH-KQYNXXCUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
164312,7bv1,DB07686,-7.9,"4-{[5-(CYCLOHEXYLAMINO)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE",VPOGRVWIIVMWRI-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
88057,6m3m,DB13291,-7.9,Cloridarol,KBFBRIPYVVGWRS-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
126143,6w4h,DB03421,-7.9,"2-Phenethyl-2,3-Dihydro-Phthalazine-1,4-Dione",JSSVIGGKHIJEHO-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
138393,6w9c,DB11555,-7.9,Zolazepam,GDSCFOSHSOWNDL-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
126156,6w4h,DB03446,-7.9,N-Benzyl-3-(alpha-D-galactopyranosyloxy)benzamide,FSMWGHKWKYCPKE-QTVCLEQKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
126106,6w4h,DB03368,-7.9,"5-Methyl-5-(4-Phenoxy-Phenyl)-Pyrimidine-2,4,6-Trione",RTBMLCLTYAPKIF-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
81882,6m3m,DB01809,-7.9,"1-Ter-Butyl-3-P-Tolyl-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine",ZVPDNRVYHLRXLX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
162983,7bv1,DB03376,-7.9,'5'-O-(N-(L-Alanyl)-Sulfamoyl)Adenosine,CWWYMWDIYBJVLP-YTMOPEAISA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
164314,7bv1,DB07689,-7.9,"METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE",NYNAFINLHQEHKU-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
138446,6w9c,DB11675,-7.9,Mosapride,YPELFRMCRYSPKZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
88070,6m3m,DB13310,-7.9,Ormeloxifene,XZEUAXYWNKYKPL-WDYNHAJCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
157144,6wiq,DB14657,-7.9,Paramethasone acetate,HYRKAAMZBDSJFJ-LFDBJOOHSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
138445,6w9c,DB11674,-7.9,Equol,ADFCQWZHKCXPAJ-GFCCVEGCSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138432,6w9c,DB11654,-7.9,T-2000,RRFBTKHQZRCRSS-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
126189,6w4h,DB03490,-7.9,"3-Pyridin-4-Yl-2,4-Dihydro-Indeno[1,2-.C.]Pyrazole",NHOACLCXCKJMAK-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
138586,6w9c,DB11880,-7.9,Acridine Carboxamide,XBGNERSKEKDZDS-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
141729,6w9q,DB01228,-7.9,Encainide,PJWPNDMDCLXCOM-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
32021,6cs2,DB15214,-7.9,BMS-986104,BPMMYKAHRIEVDH-VOQZNFBZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
27447,6cs2,DB06992,-7.9,"(3,3-dimethylpiperidin-1-yl)(6-(3-fluoro-4-methylphenyl)pyridin-2-yl)methanone",SIDDLTBLAQYZIZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
81781,6m3m,DB01674,-7.9,[2-(1-Amino-2-Hydroxy-Propyl)-4-(4-Fluoro-1h-Indol-3-Ylmethyl)-5-Hydroxy-Imidazol-1-Yl]-Acetic Acid,AYMRQIHECFEMIQ-AYVTZFPOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
107854,6vxx,DB05255,-7.9,Ronacaleret,FQJISUPNMFRIFZ-HXUWFJFHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
126172,6w4h,DB03467,-7.9,Naringenin,FTVWIRXFELQLPI-ZDUSSCGKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
138429,6w9c,DB11650,-7.9,HT-0712,ABEJDMOBAFLQNJ-NHCUHLMSSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
99238,6vxs,DB01990,-7.9,Cholesterol sulfate,BHYOQNUELFTYRT-DPAQBDIFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
81787,6m3m,DB01682,-7.9,6'-Methyl-Thiamin Diphosphate,XTYXJYCWAJSHCY-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
162997,7bv1,DB03397,-7.9,Uridine-Diphosphate-N-Acetylglucosamine,LFTYTUAZOPRMMI-CFRASDGPSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
73055,6m2n,DB01535,-7.9,Carfentanil,YDSDEBIZUNNPOB-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
99391,6vxs,DB02196,-7.9,Uridine-Diphosphate-N-Acetylgalactosamine,LFTYTUAZOPRMMI-NESSUJCYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
138588,6w9c,DB11885,-7.9,Anlotinib,KSMZEXLVHXZPEF-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
107755,6vxx,DB04573,-7.9,Estriol,PROQIPRRNZUXQM-ZXXIGWHRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81571,6m3m,DB01425,-7.9,Alizapride,KSEYRUGYKHXGFW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
7154,6lzg,DB03311,-7.9,"3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid [4-(Thiazol-2-Ylsulfamoyl)-Phenyl]-Amide",SXKBTDJJEQQEGE-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
88226,6m3m,DB13512,-7.9,Clefamide,ODCUSWJXZDHLKV-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
73009,6m2n,DB01480,-7.9,Cyprenorphine,VSKIOMHXEUHYSI-KNLIIKEYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
88319,6m3m,DB13642,-7.9,Pridinol,RQXCLMGKHJWMOA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
106255,6vxs,DB15325,-7.9,ONO-8539,ALLLQQUASFFEKP-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
88222,6m3m,DB13507,-7.9,Poldine,CQRKVVAGMJJJSR-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81603,6m3m,DB01462,-7.9,Etonitazene,PXDBZSCGSQSKST-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
138922,6w9c,DB12569,-7.9,Tonapofylline,ZWTVVWUOTJRXKM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
163181,7bv1,DB03865,-7.9,6-Chloro-2-(2-Hydroxy-Biphenyl-3-Yl)-1h-Indole-5-Carboxamidine,FEKRWNWZMOSVBX-UHFFFAOYSA-O,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
27427,6cs2,DB06971,-7.9,"N-{2-[(4'-CYANO-1,1'-BIPHENYL-4-YL)OXY]ETHYL}-N'-HYDROXY-N-METHYLUREA",GVMUNGGWXRKCEU-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
138779,6w9c,DB12254,-7.9,ABT-751,URCVCIZFVQDVPM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
61808,6crv,DB12627,-7.9,GSK-1292263,AYJRTVVIBJSSKN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56029,6crv,DB01782,-7.9,"2,6-Dihydroanthra/1,9-Cd/Pyrazol-6-One",ACPOUJIDANTYHO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81611,6m3m,DB01470,-7.9,alpha-methylthiofentanyl,YPOXDUYRRSUFFG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
72996,6m2n,DB01466,-7.9,Ethylmorphine,OGDVEMNWJVYAJL-LEPYJNQMSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
138795,6w9c,DB12278,-7.9,Propiverine,QPCVHQBVMYCJOM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138896,6w9c,DB12416,-7.9,VTP-27999,NXWASIVXQMMPLM-ZXMXYHOLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
61837,6crv,DB12670,-7.9,Rolofylline,PJBFVWGQFLYWCB-QUYAXPHCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
101206,6vxs,DB04612,-7.9,"N-METHYLALANYL-3-METHYLVALYL-4-PHENOXY-N-(1,2,3,4-TETRAHYDRONAPHTHALEN-1-YL)PROLINAMIDE",QKPXPZYQPBWDHS-MCJAPYMPSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
32767,6cs2,T3D3680,-7.9,Cytochalasin H,NAEWXXDGBKTIMN-BBXOWAOSSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
88260,6m3m,DB13557,-7.9,Thiopropazate,AIUHRQHVWSUTGJ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
125551,6w4h,DB02636,-7.9,"9-Hydroxy-8-Methoxy-6-Nitro-Phenanthrol[3,4-D][1,3]Dioxole-5-Carboxylic Acid",UCLGCTLOEZZSLA-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
11005,6lzg,DB00862,-7.9,Vardenafil,SECKRCOLJRRGGV-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
138838,6w9c,DB12332,-7.9,Rucaparib,HMABYWSNWIZPAG-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138827,6w9c,DB12316,-7.9,9CUAB30,PPGNMFUMZSAZCW-VOYUZAMQSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
125522,6w4h,DB02596,-7.9,"Alpha,Beta-Methyleneadenosine-5'-Triphosphate",CAWZRIXWFRFUQB-IOSLPCCCSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
13168,6lzg,DB14828,-7.9,ABX-464,OZOGDCZJYVSUBR-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
99412,6vxs,DB02224,-7.9,Taxifolin,CXQWRCVTCMQVQX-LSDHHAIUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
29034,6cs2,DB08672,-7.9,4-[(3R)-3-{[2-(4-FLUOROPHENYL)-2-OXOETHYL]AMINO}BUTYL]BENZAMIDE,OIWWNWQZJJKBTR-CYBMUJFWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
32773,6cs2,T3D3687,-7.9,Lysergic acid hydroxyethylamide,WYTJZJPVCDWOOI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
88249,6m3m,DB13545,-7.9,Isobromindione,QFLZIWVSQDZLNW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
24638,6cs2,DB02411,-7.9,"2-(11-{2-[Benzenesulfonyl-(3-Methyl-Butyl)-Amino]-1-Hydroxy-Ethyl}-6,9-Dioxo-2-Oxa-7,10-Diaza-Bicyclo[11.2.2]Heptadeca-1(16),13(17),14-Trien-8-Yl)-Acetamide, Inhibitor 2",HOUHLOFMBSYNBO-KKUQBAQOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
88245,6m3m,DB13541,-7.9,Iprazochrome,XZKVIDLLLOUTSS-ZSOIEALJSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
138878,6w9c,DB12393,-7.9,Fanapanel,WZMQMKNCWDCCMT-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
32049,6cs2,DB00206,-7.9,Reserpine,QEVHRUUCFGRFIF-MDEJGZGSSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
101205,6vxs,DB04610,-7.9,"7,8-dihydro-6-hydroxymethyl-7-methyl-7-[2-phenylethyl]-pterin",XMFJTCGUDFSWSW-INIZCTEOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
57080,6crv,DB03176,-7.9,KB-141,OZYQIQVPUZANTM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
32772,6cs2,T3D3686,-7.9,Methylergonovine,UNBRKDKAWYKMIV-QWQRMKEZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
125849,6w4h,DB03037,-7.9,Oxidized Acetyl Dithranol,IKFRFGXQHSBCQM-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
163156,7bv1,DB03830,-7.9,Phosphorylated Dihydropteroate,DNKVHXNVVYQUDC-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
138768,6w9c,DB12239,-7.9,Balicatib,LLCRBOWRJOUJAE-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138662,6w9c,DB12084,-7.9,ADP-597,WPDCHTSXOPUOII-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
32054,6cs2,DB15275,-7.9,GDC-0077,SGEUNORSOZVTOL-CABZTGNLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
32822,6cs2,T3D3735,-7.9,Dicumarol,DOBMPNYZJYQDGZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
138653,6w9c,DB12072,-7.9,Orantinib,NHFDRBXTEDBWCZ-ZROIWOOFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138631,6w9c,DB11946,-7.9,AZD-1981,JWYIGNODXSRKGP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
107834,6vxx,DB04678,-7.9,H TYPE II TRISACCHARIDE,PHTAQVMXYWFMHF-QVPNGJTFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88399,6m3m,DB13744,-7.9,Piromidic acid,RCIMBBZXSXFZBV-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
24677,6cs2,DB02455,-7.9,Fluoresceinylthioureido,VHJFQSRUDVDTEO-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
106342,6vxs,DB09171,-7.9,β-Methylfentanyl,UXIGUKSHASXDNI-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
106218,6vxs,DB15250,-7.9,Vercirnon,JRWROCIMSDXGOZ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101273,6vxs,DB04704,-7.9,20-hydroxycholesterol,MCKLJFJEQRYRQT-MGNSQDQZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
72966,6m2n,DB01431,-7.9,Allylestrenol,ATXHVCQZZJYMCF-XUDSTZEESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
24684,6cs2,DB02463,-7.9,2-(2-Hydroxy-Phenyl)-1h-Indole-5-Carboxamidine,JPGNPKIYCTXJPG-UHFFFAOYSA-O,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
163077,7bv1,DB03737,-7.9,"4-((3r,4s,5r)-4-Amino-3,5-Dihydroxy-Hex-1-Ynyl)-5-Fluoro-3-[1-(3-Methoxy-1h-Pyrrol-2-Yl)-Meth-(Z)-Ylidene]-1,3-Dihydro-Indol-2-One",RAKYKJWUUUKCCW-MPLBGYFPSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
155576,6wiq,DB11262,-7.9,Bisoctrizole,FQUNFJULCYSSOP-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
61749,6crv,DB12533,-7.9,Cevipabulin,ZUZPCOQWSYNWLU-VIFPVBQESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
101067,6vxs,DB04434,-7.9,Naphthyridine Inhibitor,YRBHUKMLAGQYHS-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101237,6vxs,DB04651,-7.9,BIOTINOL-5-AMP,KBOGUFFJCBPJEH-SQGSUPJISA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
32818,6cs2,T3D3731,-7.9,Rubratoxin A,XOEFANNJIKAWGX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
155581,6wiq,DB11273,-7.9,Dihydroergocornine,SEALOBQTUQIVGU-QNIJNHAOSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
107830,6vxx,DB04672,-7.9,"Cyclic 3',5'-thymidine monophosphate",XLPGURCDSRIXFL-JGVFFNPUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
125496,6w4h,DB02559,-7.9,"6-(Octahydro-1h-Indol-1-Ylmethyl)Decahydroquinazoline-2,4-Diamine",HDQIGGQUKAQTGU-SZTTVXCBSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
81629,6m3m,DB01489,-7.9,Camazepam,PXBVEXGRHZFEOF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88351,6m3m,DB13680,-7.9,Naftazone,TZGBBMBARSFJBG-UKTHLTGXSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
32040,6cs2,DB15246,-7.9,Salvianolic acid A,YMGFTDKNIWPMGF-UCPJVGPRSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
138933,6w9c,DB12585,-7.9,Ondelopran,QWNDOCKIKKQJNN-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
101230,6vxs,DB04643,-7.9,"4-{3-CHLORO-4-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-PHENOXY}-BUTYRIC ACID",FYQVFMLCZJZZEM-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
81654,6m3m,DB01523,-7.9,Clonitazene,GPZLDQAEBHTMPG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
10956,6lzg,DB09330,-7.9,Osimertinib,DUYJMQONPNNFPI-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
125665,6w4h,DB02790,-7.9,Phenyl-Uridine-5'-Diphosphate,ZHUWBKDWWGKIEN-FMKGYKFTSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
101231,6vxs,DB04644,-7.9,"4-{4-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-2,3-DIMETHYL-PHENOXY}-BUTYRIC ACID",FCEMCUPAYRPTLS-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
88193,6m3m,DB13469,-7.9,Phanquinone,VLPADTBFADIFKG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
32812,6cs2,T3D3725,-7.9,Aflatoxicol,WYIWLDSPNDMZIT-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
101124,6vxs,DB04509,-7.9,N-Methylnaloxonium,PCSQOABIHJXZMR-YNUHATHGSA-O,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
138709,6w9c,DB12150,-7.9,Pelubiprofen,AUZUGWXLBGZUPP-GXDHUFHOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
163275,7bv1,DB04196,-7.9,Pteroic Acid,JOAQINSXLLMRCV-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
99312,6vxs,DB02089,-7.9,CP-526423,MWWXABBBAPKJDX-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
163281,7bv1,DB04202,-7.9,Isoformononetin,LNIQZRIHAMVRJA-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
125741,6w4h,DB02889,-7.9,"4-O-(4,6-Dideoxy-4-{[4,5,6-Trihydroxy-3-(Hydroxymethyl)Cyclohex-2-En-1-Yl]Amino}-Beta-D-Lyxo-Hexopyranosyl)-Alpha-D-Erythro-Hexopyranose",SNMISNLUIRCRQE-SFSRYZOZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
81675,6m3m,DB01544,-7.9,Flunitrazepam,PPTYJKAXVCCBDU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
35985,1r42,DB02336,-7.9,RU83876,WCMLXBUNHNAMNH-UIOOFZCWSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
81973,6m3m,DB01938,-7.9,L-Histidine Beta Naphthylamide,DKDILZBBFKZMRO-OAHLLOKOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
28848,6cs2,DB08470,-7.9,"3-(4-fluorophenyl)-5-phenyl-4H-1,2,4-triazole",KMGPJKOKSYGMJD-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
127056,6w4h,DB04651,-7.9,BIOTINOL-5-AMP,KBOGUFFJCBPJEH-SQGSUPJISA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
127057,6w4h,DB04652,-7.9,Corticosterone,OMFXVFTZEKFJBZ-HJTSIMOOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
57590,6crv,DB03865,-7.9,6-Chloro-2-(2-Hydroxy-Biphenyl-3-Yl)-1h-Indole-5-Carboxamidine,FEKRWNWZMOSVBX-UHFFFAOYSA-O,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127092,6w4h,DB04704,-7.9,20-hydroxycholesterol,MCKLJFJEQRYRQT-MGNSQDQZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
157367,6wiq,DB15269,-7.9,ALK-4290,DWKNOLCXIFYNFV-HSZRJFAPSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
27906,6cs2,DB07468,-7.9,"(3aS)-3a-hydroxy-5-methyl-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one",NJBBBRZNBVLTRZ-GOSISDBHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
31969,6cs2,DB15123,-7.9,Dorzagliatin,HMUMWSORCUWQJO-QAPCUYQASA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
33100,6cs2,T3D4087,-7.9,Chelidonine,GHKISGDRQRSCII-ZOCIIQOWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
87747,6m3m,DB12791,-7.9,Laninamivir,QNRRHYPPQFELSF-CNYIRLTGSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
137637,6w9c,DB08537,-7.9,"3-bromo-6-phenyl-N-(pyrimidin-5-ylmethyl)imidazo[1,2-a]pyridin-8-amine",LZLKFNBMXXLTLX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
82403,6m3m,DB02495,-7.9,9-(4-hydroxybutyl)-N2-phenylguanine,JHBXNPBKSPYOFT-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
105693,6vxs,DB13841,-7.9,Clopenthixol,WFPIAZLQTJBIFN-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
6979,6lzg,DB03020,-7.9,5-Beta-D-Ribofuranosylnicotinamide Adenine Dinucleotide,UINNILASBHZOTM-KMXXXSRASA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
61465,6crv,DB12124,-7.9,Namitecan,IBTISPLPBBHVSU-UVOOVGFISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57630,6crv,DB03917,-7.9,N-Ethyl Retinamide,WKYDOCGICAMTKE-NBIQJRODSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
142198,6w9q,DB01876,-7.9,Bis(5-Amidino-2-Benzimidazolyl)Methanone,VVVXDHROXQUONB-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
69955,6lxt,DB11943,-7.9,Delafloxacin,DYDCPNMLZGFQTM-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
35777,1r42,DB02059,-7.9,Adenosine-5-Diphosphoribose,SRNWOUGRCWSEMX-ZQSHOCFMSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
10908,6lzg,DB09239,-7.9,Niguldipine,SVJMLYUFVDMUHP-XIFFEERXSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
79863,6m2n,DB13844,-7.9,Pipenzolate,WPUKUEMZZRVAKZ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
127141,6w4h,DB04772,-7.9,1-GUANIDINO-4-(N-PHENYLMETHANESULFONYL-L-LEUCYL-L-PROLYLAMINO)BUTANE,DSVCYWOHJLRGMK-PMACEKPBSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
55877,6crv,DB01582,-7.9,Sulfamethazine,ASWVTGNCAZCNNR-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127037,6w4h,DB04628,-7.9,Allosamidin,MDWNFWDBQGOKNZ-XYUDZHFQSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
33085,6cs2,T3D4065,-7.9,Mesaconitine,XUHJBXVYNBQQBD-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
137734,6w9c,DB08656,-7.9,5-amino-2-methyl-N-[(1R)-1-naphthalen-1-ylethyl]benzamide,UVERBUNNCOKGNZ-CQSZACIVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
61537,6crv,DB12233,-7.9,Iguratimod,ANMATWQYLIFGOK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
33054,6cs2,T3D4016,-7.9,Vincristine,OGWKCGZFUXNPDA-XQKSVPLYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
126879,6w4h,DB04424,-7.9,RPR128515,XFKVLKLCLYJKNF-MZNJEOGPSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
61535,6crv,DB12230,-7.9,Bunazosin,RHLJLALHBZGAFM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
142163,6w9q,DB01830,-7.9,"{4-[2-Acetylamino-2-(3-Carbamoyl-2-Cyclohexylmethoxy-6,7,8,9-Tetrahydro-5h-Benzocyclohepten-5ylcarbamoyl)-Ethyl]-2-Phosphono-Phenyl}-Phosphonic Acid",SPSGYTWOIGAABK-DQEYMECFSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
55888,6crv,DB01600,-7.9,Tiaprofenic acid,GUHPRPJDBZHYCJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72735,6m2n,DB01091,-7.9,Butenafine,ABJKWBDEJIDSJZ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137801,6w9c,DB08735,-7.9,"R,S-Warfarin alcohol",ZUJMMGHIYSAEOU-SWLSCSKDSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
101549,6vxs,DB05532,-7.9,BMS-488043,DBPMWRYLTBNCCE-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
126975,6w4h,DB04549,-7.9,"4-(Aminosulfonyl)-N-[(2,3,4-Trifluorophenyl)Methyl]-Benzamide",AANTYZRUJFNZFI-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
137579,6w9c,DB08470,-7.9,"3-(4-fluorophenyl)-5-phenyl-4H-1,2,4-triazole",KMGPJKOKSYGMJD-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
24099,6cs2,DB01765,-7.9,"(5-Oxo-5,6-Dihydro-Indolo[1,2-a]Quinazolin-7-Yl)-Acetic Acid",INSBKYCYLCEBOD-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
105773,6vxs,DB14002,-7.9,D-alpha-Tocopherol acetate,ZAKOWWREFLAJOT-CEFNRUSXSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
162608,7bv1,DB02485,-7.9,Cytidine-5'-Monophosphate-5-N-Acetylneuraminic Acid,TXCIAUNLDRJGJZ-BILDWYJOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
137773,6w9c,DB08706,-7.9,"(2S)-({(5Z)-5-[(5-ETHYL-2-FURYL)METHYLENE]-4-OXO-4,5-DIHYDRO-1,3-THIAZOL-2-YL}AMINO)(4-FLUOROPHENYL)ACETIC ACID",RNEACARJKXYVND-MZLJFPOFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
122863,6w4b,DB14035,-7.9,Englitazone,MVDXXGIBARMXSA-PYUWXLGESA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
27895,6cs2,DB07455,-7.9,"N,N'-[biphenyl-4,4'-diyldi(2R)propane-2,1-diyl]dimethanesulfonamide",ZESUARCHWPARIF-HOTGVXAUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
137771,6w9c,DB08704,-7.9,"[[(3R,4R,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-(pentanoylamino)oxan-2-ylidene]amino] N-phenylcarbamate",NUNQIQQEEPOGDJ-JDOAOKHLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
162602,7bv1,DB02479,-7.9,(R)-N-(3-Indol-1-Yl-2-Methyl-Propyl)-4-Sulfamoyl-Benzamide,ZFWHOUCRVSOZJE-CQSZACIVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
137769,6w9c,DB08702,-7.9,"2,5-DIPHENYLFURAN-3,4-DICARBOXYLIC ACID",QPKYPOMZPFDBEZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
73714,6m2n,DB02398,-7.9,6-[N-(4-(Aminomethyl)Phenyl)Carbamyl]-2-Naphthalenecarboxamidine,NLBDETRVUYOIHQ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
18371,6cs2,HMDB0029095,-7.9,Tryptophyl-Tyrosine,TYYLDKGBCJGJGW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
105774,6vxs,DB14008,-7.9,Hispidulin,IHFBPDAQLQOCBX-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
68874,6lxt,DB08437,-7.9,Puromycin,RXWNCPJZOCPEPQ-NVWDDTSBSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
101619,6vxs,DB05969,-7.9,SNS-032,OUSFTKFNBAZUKL-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101625,6vxs,DB05992,-7.9,Plinabulin,UNRCMCRRFYFGFX-TYPNBTCFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
162405,7bv1,DB02014,-7.9,"5-(2-Fluoro-5-{(1E)-3-[3-hydroxy-2-(methoxycarbonyl)phenoxy]-1-propen-1-yl}phenyl)-1,2-oxazole-3-carboxylic acid",QKHWJUMLYAYZFS-ONEGZZNKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
70000,6lxt,DB12009,-7.9,GW-406381,NXMZBNYLCVTRGB-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
82568,6m3m,DB02711,-7.9,"4-{2,6,8-Trioxo-9-[(2S,3R,4R)-2,3,4,5-Tetrahydroxypentyl]-1,2,3,6,8,9-Hexahydro-7h-Purin-7-Yl}Butyl Dihydrogen Phosphate",VBXZSBKAJFXURR-QXFUBDJGSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
127280,6w4h,DB05039,-7.9,Indacaterol,QZZUEBNBZAPZLX-QFIPXVFZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
31951,6cs2,DB15092,-7.9,LY-2624803,UEFWDVMEDFCHGW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
101677,6vxs,DB06209,-7.9,Prasugrel,DTGLZDAWLRGWQN-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
127298,6w4h,DB05137,-7.9,Lobeline,MXYUKLILVYORSK-HBMCJLEFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
57724,6crv,DB04047,-7.9,[Pterin-6-Yl Methanyl]-Phosphonophosphate,AMDUVUKDRBIVAH-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57732,6crv,DB04060,-7.9,"(5-Methyl-6-Oxo-1,6-Dihydro-Pyridin-3-Yl)-1,2-Dideoxy-Ribofuranose-5-Monophosphate",MUWYCJQCZPFLFI-IVZWLZJFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127325,6w4h,DB05298,-7.9,Tetomilast,XDBHURGONHZNJF-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
6936,6lzg,DB02929,-7.9,K201,KCWGETCFOVJEPI-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
105545,6vxs,DB13648,-7.9,Alcuronium,MUQUYTSLDVKIOF-CHJKCJHBSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
137382,6w9c,DB08224,-7.9,"(1S,7S,8S,8AR)-1,2,3,7,8,8A-HEXAHYDRO-7-METHYL-8-[2-[(2R,4R)-TETRAHYDRO-4-HY DROXY-6-OXO-2H-PYRAN-2-YL]ETHYL]-1-NAPHTHALENOL",WWSNTLOVYSRDEL-TVKPWXLESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137374,6w9c,DB08213,-7.9,"1-METHYL-5-(2-PHENOXYMETHYL-PYRROLIDINE-1-SULFONYL)-1H-INDOLE-2,3-DIONE",PFAYCUAUBOGVDX-AWEZNQCLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
33180,6cs2,T3D4245,-7.9,Deoxycorticosterone,ZESRJSPZRDMNHY-YFWFAHHUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
105511,6vxs,DB13602,-7.9,Promegestone,QFFCYTLOTYIJMR-XMGTWHOFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
127378,6w4h,DB05586,-7.9,Facinicline,TXCYUSKWBHUVEP-CYBMUJFWSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
70023,6lxt,DB12046,-7.9,Atopaxar,QWKAUGRRIXBIPO-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
87629,6m3m,DB12601,-7.9,Sonolisib,QIUASFSNWYMDFS-NILGECQDSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
105501,6vxs,DB13587,-7.9,Mesterolone,UXYRZJKIQKRJCF-TZPFWLJSSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
137325,6w9c,DB08154,-7.9,3-chloro-5-[2-chloro-5-(1H-indazol-3-ylmethoxy)phenoxy]benzonitrile,WHCLIFOVZDANCU-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
82559,6m3m,DB02699,-7.9,4-Oxoretinol,PLIUCYCUYQIBDZ-RMWYGNQTSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
82556,6m3m,DB02696,-7.9,"6-Aminohexyl-Uridine-C1,5'-Diphosphate",MLWJBKPFDKRHBM-FMKGYKFTSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
82548,6m3m,DB02686,-7.9,Undecyl-Beta-D-Maltopyranoside,UYEMNFYVTFDKRG-ZNGNCRBCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
137458,6w9c,DB08320,-7.9,"DIETHYL (1R,2S,3R,4S)-5,6-BIS(4-HYDROXYPHENYL)-7-OXABICYCLO[2.2.1]HEPT-5-ENE-2,3-DICARBOXYLATE",NHKDFDHHMHBFLG-COPRSSIGSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
157392,6wiq,DB15317,-7.9,Posiphen,PBHFNBQPZCRWQP-AZUAARDMSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
27223,6cs2,DB06711,-7.9,Naphazoline,CNIIGCLFLJGOGP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
127160,6w4h,DB04797,-7.9,Triazolopyridine,OVCXRBARSPBVMC-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
137566,6w9c,DB08455,-7.9,Ro 12-7310,CAAFTBWHFUPDGX-OFCLTBKTSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
57642,6crv,DB03932,-7.9,LFA703,WPVRNXUYVXQXPY-YFAYRSKXSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61430,6crv,DB12074,-7.9,Censavudine,OSYWBJSVKUFFSU-SKDRFNHKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
99075,6vxs,DB01767,-7.9,Hemi-Babim,KKJYVDXDZURHMA-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
87697,6m3m,DB12710,-7.9,Perazine,WEYVCQFUGFRXOM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
82508,6m3m,DB02632,-7.9,4-nitrophenyl-beta-D-galactoside,IFBHRQDFSNCLOZ-YBXAARCKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87695,6m3m,DB12708,-7.9,Sulprostone,UQZVCDCIMBLVNR-TWYODKAFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
127154,6w4h,DB04791,-7.9,"2-O-(4'-AMIDINOPHENYL)-5-O-(3''-AMIDINOPHENYL)-1,4:3,6-DIANHYDRO-D-SORBITOL",DKBAWRNTUZFJKV-BSDSXHPESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
69984,6lxt,DB11987,-7.9,GSK-2018682,NFIGDBFIDKDNIG-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
137504,6w9c,DB08379,-7.9,6-(4-chloro-2-fluoro-3-phenoxybenzyl)pyridazin-3(2H)-one,NOVPOXGMADEKPP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
69987,6lxt,DB11992,-7.9,Omarigliptin,MKMPWKUAHLTIBJ-ISTRZQFTSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
29094,6cs2,DB00813,-7.9,Fentanyl,PJMPHNIQZUBGLI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
72658,6m2n,DB01003,-7.9,Cromoglicic acid,IMZMKUWMOSJXDT-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
101652,6vxs,DB06157,-7.9,Istaroxime,MPYLDWFDPHRTEG-PAAYLBSLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
31956,6cs2,DB15102,-7.9,Pemigatinib,HCDMJFOHIXMBOV-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
87673,6m3m,DB12671,-7.9,Beloranib,ZEZFKUBILQRZCK-MJSCXXSSSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
127236,6w4h,DB04891,-7.9,Becocalcidiol,QSLUXQQUPXBIHH-YHSKWIAJSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
69994,6lxt,DB12002,-7.9,AZD-4818,HVTUHSABWJPWNK-SFHVURJKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
101654,6vxs,DB06160,-7.9,Garenoxacin,NJDRXTDGYFKORP-LLVKDONJSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
127207,6w4h,DB04854,-7.9,Febuxostat,BQSJTQLCZDPROO-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
162924,7bv1,DB03300,-7.9,Pterin Cytosine Dinucleotide,WKSPNQYEWZEMMI-FEFZDOOUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
101526,6vxs,DB05431,-7.9,MLN-977,YANONWCPCKIWEC-CABCVRRESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
69902,6lxt,DB11867,-7.9,JNJ-39393406,IURMHZBQEYNQOH-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
57315,6crv,DB03491,-7.9,2'-Deoxyguanosine-5'-Diphosphate,CIKGWCTVFSRMJU-KVQBGUIXSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106033,6vxs,DB14857,-7.9,Avadomide,RSNPAKAFCAAMBH-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
126403,6w4h,DB03788,-7.9,GC-24,JYHIGYLGYNCMGI-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
138146,6w9c,DB09232,-7.9,Cilnidipine,KJEBULYHNRNJTE-DHZHZOJOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
72846,6m2n,DB01215,-7.9,Estazolam,CDCHDCWJMGXXRH-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
82091,6m3m,DB02090,-7.9,A Disubstituted Succinyl Caprolactam Hydroxymate Mmp3inhibitor,JLEGVELHGVWFGG-BBWFWOEESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
57330,6crv,DB03510,-7.9,6-O-Phosphoryl Inosine Monophosphate,RXRZOKQPANIEDW-KQYNXXCUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
126465,6w4h,DB03865,-7.9,6-Chloro-2-(2-Hydroxy-Biphenyl-3-Yl)-1h-Indole-5-Carboxamidine,FEKRWNWZMOSVBX-UHFFFAOYSA-O,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
15583,6lzg,DB00319,-7.9,Piperacillin,IVBHGBMCVLDMKU-GXNBUGAJSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
32962,6cs2,T3D3893,-7.9,Norflurazon,NVGOPFQZYCNLDU-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
138102,6w9c,DB09184,-7.9,Edivoxetine,CPBHSHYQQLFAPW-ZWKOTPCHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
157224,6wiq,DB14840,-7.9,Ripretinib,CEFJVGZHQAGLHS-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
142058,6w9q,DB01691,-7.9,Indole Naphthyridinone,VAZMNDXVXVUKFY-JXMROGBWSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
27311,6cs2,DB06845,-7.9,(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclopentylamino)ethanoyl)pyrrolidine-2-carboxamide,WXYKSWZWRHMJTE-KRWDZBQOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
32966,6cs2,T3D3897,-7.9,Paclobutrazol,RMOGWMIKYWRTKW-UONOGXRCSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
7064,6lzg,DB03173,-7.9,CRA_10433,CFSQPEBVGUSQII-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
61610,6crv,DB12326,-7.9,Antroquinonol,LJTSIMVOOOLKOL-FNRDIUJOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
18433,6cs2,HMDB0029377,-7.9,Piperine,MXXWOMGUGJBKIW-YPCIICBESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
106011,6vxs,DB14795,-7.9,AZD-3759,MXDSJQHFFDGFDK-CYBMUJFWSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
57352,6crv,DB03549,-7.9,Biotinyl P-Nitroaniline,PORZMUYPQKOFQY-YDHLFZDLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106006,6vxs,DB14787,-7.9,BMS-830216,YDTUJCNTIMWHPJ-NRFANRHFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
57295,6crv,DB03464,-7.9,Formycin-5'-Monophosphate,PBAHXXBYQACZMA-KSYZLYKTSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107918,6vxx,DB05586,-7.9,Facinicline,TXCYUSKWBHUVEP-CYBMUJFWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
126328,6w4h,DB03695,-7.9,Piritrexim,VJXSSYDSOJBUAV-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
82049,6m3m,DB02036,-7.9,"2-(3,4-Dihydro-3-Oxo-2h-Benzo[B][1,4]Thiazin-2-Yl)-N-Hydroxyacetamide",UKDWCJNGBPZOBU-MRVPVSSYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
138352,6w9c,DB11455,-7.9,Robenacoxib,ZEXGDYFACFXQPF-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
11550,6lzg,DB12120,-7.9,Avoralstat,TUWMKPVJGGWGNL-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
88047,6m3m,DB13277,-7.9,Benziodarone,CZCHIEJNWPNBDE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
62820,6crv,DB14232,-7.9,Deacetylbisacodyl,LJROKJGQSPMTKB-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81961,6m3m,DB01922,-7.9,"Maltosyl-Alpha (1,4)-D-Gluconhydroximo-1,5-Lactam",AHRWQUNEPBVNOT-IVJVVCOPSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
27350,6cs2,DB06887,-7.9,"[(3S)-3-(Methylcarbamoyl)-2-{[(2-methyl-2-propanyl)oxy]carbonyl}-1,2,3,4-tetrahydro-7-isoquinolinyl]sulfamic acid",PPSSYXOFPICMQD-ZDUSSCGKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
99202,6vxs,DB01946,-7.9,"3-[1-(3-Aminopropyl)-1h-Indol-3-Yl]-4-(1-Methyl-1h-Indol-3-Yl)-1h-Pyrrole-2,5-Dione",UQHKJRCFSLMWIA-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
27349,6cs2,DB06886,-7.9,N-BENZYLOXYCARBONYL-ALA-PRO-3-AMINO-4-PHENYL-BUTAN-2-OL,MACLRJNEKXUAJK-YDLSIGKMSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
69765,6lxt,DB11666,-7.9,Buparlisib,CWHUFRVAEUJCEF-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
126260,6w4h,DB03596,-7.9,N-[2-(1h-Indol-5-Yl)-Butyl]-4-Sulfamoyl-Benzamide,FSRPBGBMEKDSIJ-CYBMUJFWSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
164371,7bv1,DB07756,-7.9,"1-[3-({[(4-AMINO-5-FLUORO-2-METHYLQUINOLIN-3-YL)METHYL]THIO}METHYL)PHENYL]-2,2,2-TRIFLUOROETHANE-1,1-DIOL",GPBGHVRNVGXPNM-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
126263,6w4h,DB03601,-7.9,5-deoxyflavanone,FURUXTVZLHCCNA-AWEZNQCLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
27859,6cs2,DB07419,-7.9,S-23,SSFVOEAXHZGTRJ-KRWDZBQOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
29053,6cs2,DB08694,-7.9,"9-amino-5-(2-aminopyrimidin-4-yl)pyrido[3',2':4,5]pyrrolo[1,2-c]pyrimidin-4-ol",RTHKPHCVZVYDFN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
32920,6cs2,T3D3845,-7.9,Flumetsulam,RXCPQSJAVKGONC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
81979,6m3m,DB01945,-7.9,4-Carbamoyl-1-Beta-D-Ribofuranosyl-Imidazolium-5-Olate-5'-Phosphate,KTKAFSMJDTUUAN-UUOKFMHZSA-L,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
106061,6vxs,DB14906,-7.9,Adafosbuvir,NIJYGVDQZBBONK-SEUXLIJBSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
88010,6m3m,DB13225,-7.9,Dibenzepin,QPGGEKPRGVJKQB-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
101412,6vxs,DB04885,-7.9,Cilansetron,NCNFDKWULDWJDS-OAHLLOKOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
15539,6lzg,DB00157,-7.9,NADH,BOPGDPNILDQYTO-NNYOXOHSSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
142047,6w9q,DB01678,-7.9,RU84687,SAFPHFWYRLLBFO-NSOVKSMOSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
106055,6vxs,DB14898,-7.9,Retagliptin,WIIAMRXFUJLYEF-SNVBAGLBSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
99198,6vxs,DB01941,-7.9,"6-[1-(3,5,5,8,8-Pentamethyl-5,6,7,8-Tetrahydronaphthalen-2-Yl)Cyclopropyl]Pyridine-3-Carboxylic Acid",SLXTWXQUEZSSTJ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
33050,6cs2,T3D4005,-7.9,Perfluoroundecanoic acid,SIDINRCMMRKXGQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
105997,6vxs,DB14768,-7.9,PF-06459988,ODMXWZROLKITMS-RISCZKNCSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
105988,6vxs,DB14750,-7.9,Cidoxepin,ODQWQRRAPPTVAG-BOPFTXTBSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
87869,6m3m,DB12980,-7.9,CHS-828,BOIPLTNGIAPDBY-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
24105,6cs2,DB01774,-7.9,Adenosine-5'-Monophosphate Glucopyranosyl-Monophosphate Ester,WFPZSXYXPSUOPY-ROYWQJLOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
27286,6cs2,DB06814,-7.9,Protokylol,LUMAEVHDZXIGEP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
82255,6m3m,DB02310,-7.9,"3,5,6,8-Tetramethyl-N-Methyl Phenanthrolinium",FQTUZNACZKILMC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
105944,6vxs,DB14659,-7.9,Melengestrol acetate,UDKABVSQKJNZBH-DWNQPYOZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
72769,6m2n,DB01130,-7.9,Prednicarbate,FNPXMHRZILFCKX-KAJVQRHHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
55892,6crv,DB01605,-7.9,Pivmecillinam,NPGNOVNWUSPMDP-HLLBOEOZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72766,6m2n,DB01127,-7.9,Econazole,LEZWWPYKPKIXLL-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
105940,6vxs,DB14654,-7.9,Bisoxatin acetate,ZCBJDQBSLZREAA-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
82272,6m3m,DB02333,-7.9,Deoxyuridine-5'-Triphosphate,AHCYMLUZIRLXAA-SHYZEUOFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
137959,6w9c,DB08956,-7.9,Hydroxydione,USPYDUPOCUYHQL-VEVMSBRDSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
87839,6m3m,DB12935,-7.9,Remogliflozin etabonate,UAOCLDQAQNNEAX-ABMICEGHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
105912,6vxs,DB14625,-7.9,Meprednisone acetate,RZAMUHXEOMZXET-ABQXZQTJSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
162692,7bv1,DB02802,-7.9,5-Aminocarbonyl-3-Nitrophenyl-Alpha-D-Galactopyranose,BYSXBFJVGIOFBO-LNSPPBFMSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
157300,6wiq,DB15137,-7.9,VK-2809,LGGPZDRLTDGYSQ-JADSYQMUSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
126773,6w4h,DB04274,-7.9,"5,4'-Dideoxyflavanone",SWAJPHCXKPCPQZ-AWEZNQCLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
137954,6w9c,DB08951,-7.9,Indoprofen,RJMIEHBSYVWVIN-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
82312,6m3m,DB02382,-7.9,Namn,JOUIQRNQJGXQDC-ZYUZMQFOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
126805,6w4h,DB04315,-7.9,Guanosine-5'-Diphosphate,QGWNDRXFNXRZMB-UUOKFMHZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
126843,6w4h,DB04371,-7.9,AL6528,FBBLOSCXOZYUSS-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
57498,6crv,DB03752,-7.9,P-(2'-Iodo-5'-Thenoyl)Hydrotropic Acid,UIZPHGUBGPJBAR-QMMMGPOBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31989,6cs2,DB15157,-7.9,Voruciclib,MRPGRAKIAJJGMM-OCCSQVGLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
72778,6m2n,DB01140,-7.9,Cefadroxil,BOEGTKLJZSQCCD-UEKVPHQBSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
15615,6lzg,DB00522,-7.9,Bentiromide,SPPTWHFVYKCNNK-FQEVSTJZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
82242,6m3m,DB02290,-7.9,"3-{2,6,8-trioxo-9-[(2S,3S,4R)-2,3,4,5-tetrahydroxypentyl]-1,2,3,6,8,9-hexahydro-7H-purin-7-Yl}propyl dihydrogen phosphate",KPHFGOGGKPGLTM-OOZYFLPDSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
101467,6vxs,DB05076,-7.9,Fenretinide,AKJHMTWEGVYYSE-FXILSDISSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
157239,6wiq,DB15023,-7.9,BMS-791826,DZBKAUMYTFPJIS-QHCPKHFHSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
162784,7bv1,DB02917,-7.9,N-Hydroxy-4-(Methyl{[5-(2-Pyridinyl)-2-Thienyl]Sulfonyl}Amino)Benzamide,LFGYSFPVLMPUPE-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
18414,6cs2,HMDB0029184,-7.9,4'-O-Methyl-(-)-epicatechin-7-O-sulphate,JENKBLJXTTYNTJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
142080,6w9q,DB01720,-7.9,(2z)-2-(Benzoylamino)-3-[4-(2-Bromophenoxy)Phenyl]-2-Propenoic Acid,WLPJLQNKCJWAFL-RGEXLXHISA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
72800,6m2n,DB01166,-7.9,Cilostazol,RRGUKTPIGVIEKM-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
157246,6wiq,DB15034,-7.9,PRI-724,VHOZWHQPEJGPCC-AZXNYEMZSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
157247,6wiq,DB15035,-7.9,Zanubrutinib,RNOAOAWBMHREKO-QFIPXVFZSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
79918,6m2n,DB13956,-7.9,Estradiol valerate,RSEPBGGWRJCQGY-RBRWEJTLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
87882,6m3m,DB13004,-7.9,Mavoglurant,ZFPZEYHRWGMJCV-ZHALLVOQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
72816,6m2n,DB01183,-7.9,Naloxone,UZHSEJADLWPNLE-GRGSLBFTSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
82232,6m3m,DB02276,-7.9,(S)-2-(Phosphonoxy)Caproyl-L-Leucyl-P-Nitroanilide,HARXAJAHMRMERT-HOTGVXAUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
155462,6wiq,DB09183,-7.9,Dasabuvir,NBRBXGKOEOGLOI-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
101486,6vxs,DB05197,-7.9,Sofalcone,GFWRVVCDTLRWPK-KPKJPENVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
126606,6w4h,DB04059,-7.9,8-(Pyrimidin-2-Ylamino)Naphthalene-2-Carboximidamide,GRQLDCHTDNYVQI-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
138048,6w9c,DB09078,-7.9,Lenvatinib,WOSKHXYHFSIKNG-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
101490,6vxs,DB05234,-7.9,LGD2941,HWLLYFXDDGGHOE-BCSUUIJWSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
105964,6vxs,DB14679,-7.9,Quingestanol acetate,FLGJKPPXEKYCBY-AKCFYGDASA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
21921,6cs2,HMDB0001396,-7.9,5-Methyltetrahydrofolic acid,ZNOVTXRBGFNYRX-ZGTCLIOFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
68882,6lxt,DB08446,-7.9,"3-[6-bromo-2-fluoro-3-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)phenoxy]-5-chlorobenzonitrile",OHQMEDBYNUAVNE-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
87875,6m3m,DB12989,-7.9,Neosaxitoxin,PPEKGEBBBBNZKS-HGRQIUPRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
138003,6w9c,DB09006,-7.9,Clinofibrate,BMOVQUBVGICXQN-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
99154,6vxs,DB01873,-7.9,Epothilone D,XOZIUKBZLSUILX-GIQCAXHBSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
73071,6m2n,DB01551,-7.9,Dihydrocodeine,RBOXVHNMENFORY-DNJOTXNNSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
28963,6cs2,DB08591,-7.9,"5-(4-METHOXYBIPHENYL-3-YL)-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDE",IGXKSKWHHHYBFM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
139126,6w9c,DB12896,-7.9,PSI-352938,PVRFQJIRERYGTQ-DSQUMVBZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
80420,6m2n,DB15323,-7.9,Trelagliptin,IWYJYHUNXVAVAA-OAHLLOKOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
107441,6vxx,DB03598,-7.9,"Al-6629, [2h-Thieno[3,2-E]-1,2-Thiazine-6-Sulfonamide,2-(3-Methoxyphenyl)-3-(4-Morpholinyl)-, 1,1-Dioxide]",XSUAVPPTKHUTDX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
7369,6lzg,DB03696,-7.9,Lanosterol,CAHGCLMLTWQZNJ-BQNIITSRSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
106975,6vxx,DB01820,-7.9,"Compound 12, N-Acetyl-4-[(Carboxycarbonyl)(2-Carboxyphenyl)Amino]-N-Pentyl-1-Napthylalaniamide",UESXELNYBIOROE-QHCPKHFHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80856,6m3m,DB00514,-7.9,Dextromethorphan,MKXZASYAUGDDCJ-NJAFHUGGSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
56478,6crv,DB02382,-7.9,Namn,JOUIQRNQJGXQDC-ZYUZMQFOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140315,6w9c,DB02799,-7.9,N-[2-(1-Maleimidyl)Ethyl]-7-Diethylaminocoumarin-3-Carboxamide,OJBZDUMTXGGVSP-KTKRTIGZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
106939,6vxx,DB01772,-7.9,"3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl]-4-(5-Fluoro-1-Methyl-1h-Indol-3-Yl)-Pyrrole-2,5-Dione",RPGZQOOZHIEPJW-HNNXBMFYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
100276,6vxs,DB03355,-7.9,5'-O-(N-(L-Threonyl)-Sulfamoyl)Adenosine,UPVAPSGKXAAHBG-CKTDUXNWSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
69248,6lxt,DB08905,-7.9,Formestane,OSVMTWJCGUFAOD-KZQROQTASA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
100278,6vxs,DB03358,-7.9,7n-Methyl-8-Hydroguanosine-5'-Triphosphate,BUJQMJUTTBGELS-KQYNXXCUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
27638,6cs2,DB07188,-7.9,"(3S)-1-CYCLOHEXYL-N-(3,5-DICHLOROPHENYL)-5-OXOPYRROLIDINE-3-CARBOXAMIDE",YUFADRZDHJKVOT-NSHDSACASA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
80377,6m2n,DB15235,-7.9,Di-2-pyridylketone 4-cyclohexyl-4-methyl-3-thiosemicarbazone,GNLZNQJBZNOUBM-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
140264,6w9c,DB01470,-7.9,alpha-methylthiofentanyl,YPOXDUYRRSUFFG-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
124224,6w4h,DB00904,-7.9,Ondansetron,FELGMEQIXOGIFQ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
140214,6w9c,DB15360,-7.9,"Carfentanil, C-11",YDSDEBIZUNNPOB-JVVVGQRLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
56506,6crv,DB02414,-7.9,"(3s,8ar)-3-(1h-Imidazol-5-Ylmethyl)Hexahydropyrrolo[1,2-a]Pyrazine-1,4-Dione",NAKUGCPAQTUSBE-IUCAKERBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
124240,6w4h,DB00920,-7.9,Ketotifen,ZCVMWBYGMWKGHF-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
89252,6m71,DB00253,-7.9,Medrysone,GZENKSODFLBBHQ-ILSZZQPISA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
140193,6w9c,DB15324,-7.9,ORM-13070 C-11,VGIYMYGMVXPMKV-GWDMYEQXSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
27629,6cs2,DB07180,-7.9,"5-[(Z)-(5-Chloro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-N,2,4-trimethyl-1H-pyrrole-3-carboxamide",FIRPCWHHIWFKCD-GHXNOFRVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
89291,6m71,DB00298,-7.9,Dapiprazole,RFWZESUMWJKKRN-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
73557,6m2n,DB02195,-7.9,"3-(4-Fluorophenyl)-1-Hydroxy-2-(Pyridin-4-Yl)-1h-Pyrrolo[3,2-B]Pyridine",ZSMYZLKEZDYVPI-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
106994,6vxx,DB01842,-7.9,3'-Phosphate-Adenosine-5'-Diphosphate,GBBWIZKLHXYJOA-KQYNXXCUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
69236,6lxt,DB08882,-7.9,Linagliptin,LTXREWYXXSTFRX-QGZVFWFLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
107037,6vxx,DB02205,-7.9,"6-(1,1-Dimethylallyl)-2-(1-Hydroxy-1-Methylethyl)-2,3-Dihydro-7h-Furo[3,2-G]Chromen-7-One",JCDLLLXYAICSQV-INIZCTEOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
11177,6lzg,DB11591,-7.9,Bilastine,ACCMWZWAEFYUGZ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
124061,6w4h,DB00713,-7.9,Oxacillin,UWYHMGVUTGAWSP-JKIFEVAISA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
107027,6vxx,DB02191,-7.9,"(7as,12ar,12bs)-1,2,3,4,7a,12,12a,12b-Octahydroindolo[2,3-a]Quinolizin-7(6h)-One",PGKUSHWBQJPFOP-LBPRGKRZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
124067,6w4h,DB00719,-7.9,Azatadine,SEBMTIQKRHYNIT-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
100133,6vxs,DB03173,-7.9,CRA_10433,CFSQPEBVGUSQII-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
107025,6vxx,DB02189,-7.9,"2',3'-Dideoxyadenosine-5'-Triphosphate",OAKPWEUQDVLTCN-NKWVEPMBSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80428,6m2n,DB15335,-7.9,Formononetin,HKQYGTCOTHHOMP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
27653,6cs2,DB07204,-7.9,"(1S)-1-(1H-INDOL-3-YLMETHYL)-2-(2-PYRIDIN-4-YL-[1,7]NAPHTYRIDIN-5-YLOXY)-EHYLAMINE",DQIXTEDFNFZMCM-SFHVURJKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
124085,6w4h,DB00741,-7.9,Hydrocortisone,JYGXADMDTFJGBT-VWUMJDOOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
73576,6m2n,DB02220,-7.9,AL7089A,RMOXCYSVWCHXII-LBPRGKRZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
32343,6cs2,T3D1649,-7.9,Fluorescein isothiocyanate,MHMNJMPURVTYEJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
124113,6w4h,DB00776,-7.9,Oxcarbazepine,CTRLABGOLIVAIY-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
140391,6w9c,DB05932,-7.9,Denibulin,GAOHLWCIAJNSEE-JTQLQIEISA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140369,6w9c,DB04707,-7.9,Hydroxyfasudil,ZAVGJDAFCZAWSZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140343,6w9c,DB04205,-7.9,"Thymidine-3',5'-Diphosphate",CSNCBOPUCJOHLS-XLPZGREQSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140341,6w9c,DB04202,-7.9,Isoformononetin,LNIQZRIHAMVRJA-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
80421,6m2n,DB15324,-7.9,ORM-13070 C-11,VGIYMYGMVXPMKV-GWDMYEQXSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
36365,1r42,DB02830,-7.9,FR236913,KCCUBLLGAMGDJL-HXUWFJFHSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
62249,6crv,DB13325,-7.9,Nifurzide,IDUMOVRJNBNOTR-BIZLIJPVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
36362,1r42,DB02827,-7.9,"7-(1,1-Dioxo-1h-Benzo[D]Isothiazol-3-Yloxymethyl)-2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Pyran-3-Carboxylic Acid",MDYIGSPVMWSFEZ-JTQLQIEISA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
163986,7bv1,DB06932,-7.9,"10,11-dimethoxy-4-methyldibenzo[c,f]-2,7-naphthyridine-3,6-diamine",NVINUNQBDNEMSY-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
155833,6wiq,DB11796,-7.9,Fostemsavir,SWMDAPWAQQTBOG-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
124044,6w4h,DB00694,-7.9,Daunorubicin,STQGQHZAVUOBTE-VGBVRHCVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
106864,6vxx,DB01415,-7.9,Ceftibuten,UNJFKXSSGBWRBZ-BJCIPQKHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107452,6vxx,DB03615,-7.9,Ribostamycin,NSKGQURZWSPSBC-VVPCINPTSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
73336,6m2n,DB01895,-7.9,Aspartyl-Adenosine-5'-Monophosphate,QPBSGQWTJLPZNF-VWJPMABRSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
11249,6lzg,DB11706,-7.9,Raxatrigine,JESCETIFNOFKEU-SJORKVTESA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
107455,6vxx,DB03622,-7.9,"2-Hydroxy-5-[4-(2-Hydroxy-Ethyl)-Piperidin-1-Yl]-5-Phenyl-1h-Pyrimidine-4,6-Dione",IPBPOBHSNJFRFT-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27748,6cs2,DB07303,-7.9,"N-3-[3-(5-METHOXYPYRIDIN-3-YL)BENZYL]PYRIDINE-2,3-DIAMINE",PGAWZMRRCVSRIM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
73334,6m2n,DB01889,-7.9,"16,17-Androstene-3-Ol",KRVXMNNRSSQZJP-PHFHYRSDSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
99732,6vxs,DB02636,-7.9,"9-Hydroxy-8-Methoxy-6-Nitro-Phenanthrol[3,4-D][1,3]Dioxole-5-Carboxylic Acid",UCLGCTLOEZZSLA-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
7332,6lzg,DB03638,-7.9,Cytidyl-2'-5'-Phospho-Guanosine,QZDUXDLOEVJGDG-VMIOUTBZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
62539,6crv,DB13713,-7.9,Quifenadine,PZMAHNDJABQWGS-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
141300,6w9q,DB00734,-7.9,Risperidone,RAPZEAPATHNIPO-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
156201,6wiq,DB12561,-7.9,WNT-974,XXYGTCZJJLTAGH-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
107500,6vxx,DB03682,-7.9,"Dibenzofuran-4,6-Dicarboxylic Acid",HBBGSNOHAGNQRQ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
89595,6m71,DB00673,-7.9,Aprepitant,ATALOFNDEOCMKK-OITMNORJSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
56605,6crv,DB02538,-7.9,"N-[4-(2-Methylimidazo[1,2-a]Pyridin-3-Yl)-2-Pyrimidinyl]Acetamide",ZCRPPLDDHBLUES-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62158,6crv,DB13203,-7.9,Bamifylline,VVUYEFBRTFASAH-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56609,6crv,DB02544,-7.9,"N-(6-{[3-(4-Bromophenyl)-1,2-Benzisothiazol-6-Yl]Oxy}Hexyl)-N-Methylprop-2-En-1-Amine",UCIDPJLYUKNYFZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
89108,6m3m,DB02930,-7.9,Adenosine 5'-[gamma-thio]triphosphate,NLTUCYMLOPLUHL-KQYNXXCUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
73315,6m2n,DB01864,-7.9,5'-Guanosine-Diphosphate-Monothiophosphate,XOFLBQFBSOEHOG-UUOKFMHZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80986,6m3m,DB00675,-7.9,Tamoxifen,NKANXQFJJICGDU-QPLCGJKRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
89100,6m3m,DB01470,-7.9,alpha-methylthiofentanyl,YPOXDUYRRSUFFG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80266,6m2n,DB15024,-7.9,Apararenone,AZNHWXAFPBYFGH-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
99715,6vxs,DB02611,-7.9,Balanol Analog 1,FZJQHARRQUNVGZ-QZTJIDSGSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
80944,6m3m,DB00622,-7.9,Nicardipine,ZBBHBTPTTSWHBA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
139967,6w9c,DB14659,-7.9,Melengestrol acetate,UDKABVSQKJNZBH-DWNQPYOZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139980,6w9c,DB14672,-7.9,Oxazepam acetate,FYRWUTOZBRWYCS-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
73343,6m2n,DB01910,-7.9,Sinefungin,LMXOHSDXUQEUSF-YECHIGJVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
89250,6m71,DB00251,-7.9,Terconazole,BLSQLHNBWJLIBQ-OZXSUGGESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
163924,7bv1,DB06865,-7.9,6-CARBAMIMIDOYL-2-[2-HYDROXY-6-(4-HYDROXY-PHENYL)-INDAN-1-YL]-HEXANOIC ACID,ZSRRBAKATXAISL-LMNJBCLMSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
140164,6w9c,DB15105,-7.9,PF-06751979,ZLZUHACSRMOLLV-RAALSFIWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140153,6w9c,DB15080,-7.9,ELX-02,KJBRSTPUILEBDR-YBNFDXCTSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
106842,6vxx,DB01366,-7.9,Procaterol,FKNXQNWAXFXVNW-BLLLJJGKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163909,7bv1,DB06845,-7.9,(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclopentylamino)ethanoyl)pyrrolidine-2-carboxamide,WXYKSWZWRHMJTE-KRWDZBQOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
140113,6w9c,DB14998,-7.9,Olorinab,ACSQLTBPYZSGBA-GMXVVIOVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
89566,6m71,DB00635,-7.9,Prednisone,XOFYZVNMUHMLCC-ZPOLXVRWSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
140109,6w9c,DB14987,-7.9,Difamilast,VFBILHPIHUPBPZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
123508,6w4b,DB00240,-7.9,Alclometasone,FJXOGVLKCZQRDN-PHCHRAKRSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
163927,7bv1,DB06869,-7.9,1-[2-AMINO-2-CYCLOHEXYL-ACETYL]-PYRROLIDINE-3-CARBOXYLIC ACID 5-CHLORO-2-(2-ETHYLCARBAMOYL-ETHOXY)-BENZYLAMIDE,BMHVHOJXEQTIEA-SIKLNZKXSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
156141,6wiq,DB12467,-7.9,TU-100,KAYRGFYBCCETPE-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
56199,6crv,DB02016,-7.9,R048-8071,CMYCCJYVZIMDFU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
89224,6m71,DB00223,-7.9,Diflorasone,WXURHACBFYSXBI-XHIJKXOTSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
73350,6m2n,DB01922,-7.9,"Maltosyl-Alpha (1,4)-D-Gluconhydroximo-1,5-Lactam",AHRWQUNEPBVNOT-IVJVVCOPSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
56560,6crv,DB02484,-7.9,Cytidine 5'-Diphosphoglycerol,HHPOUCCVONEPRK-CNYIRLTGSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140031,6w9c,DB14791,-7.9,GDC-0425,XEZLBMHDUXSICI-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
24392,6cs2,DB02118,-7.9,CP-271485,CIUMOGWIMXNXSQ-GOSISDBHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
32162,6cs2,DB01134,-7.9,Desoxycorticosterone pivalate,VVOIQBFMTVCINR-WWMZEODYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
156163,6wiq,DB12504,-7.9,JNJ-40346527,BNVPFDRNGHMRJS-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
139982,6w9c,DB14674,-7.9,Estramustine phosphate,ADFOJJHRTBFFOF-RBRWEJTLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
99735,6vxs,DB02640,-7.9,Fumagillin,NGGMYCMLYOUNGM-CSDLUJIJSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
124299,6w4h,DB00990,-7.9,Exemestane,BFYIZQONLCFLEV-DAELLWKTSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
24353,6cs2,DB02077,-7.9,L-N(omega)-Nitroarginine-(4R)-Amino-L-Proline Amide,IUFRDGFKAVLPFZ-CSMHCCOUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
140492,6w9c,DB11958,-7.9,Brivanib,WCWUXEGQKLTGDX-LLVKDONJSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
80807,6m3m,DB00452,-7.9,Framycetin,PGBHMTALBVVCIT-VCIWKGPPSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
73494,6m2n,DB02106,-7.9,"[3,5-Dibromo-4-(4-Hydroxy-3-Phenethylcarbamoyl-Phenoxy)-Phenyl]-Acetic Acid",KIRQJXNQGZAKGR-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
32202,6cs2,DB00214,-7.9,Torasemide,NGBFQHCMQULJNZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
140808,6w9q,DB00146,-7.9,Calcifediol,JWUBBDSIWDLEOM-DTOXIADCSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
73492,6m2n,DB02104,-7.9,"2,4-Diamino-5-Methyl-6-[(3,4,5-Trimethoxy-N-Methylanilino)Methyl]Pyrido[2,3-D]Pyrimidine",PEGMMEYCSOZKIT-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
89510,6m71,DB00568,-7.9,Cinnarizine,DERZBLKQOCDDDZ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
107240,6vxx,DB02754,-7.9,"9-Butyl-8-(3,4,5-Trimethoxybenzyl)-9h-Purin-6-Amine",TUOSCZDRWRYPRS-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56317,6crv,DB02170,-7.9,"1,8-Di-Hydroxy-4-Nitro-Xanthen-9-One",ZOHCDJRFYXKEQW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
131981,6w4h,DB15143,-7.9,PF-06650833,JKDGKIBAOAFRPJ-ZBINZKHDSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
99911,6vxs,DB02873,-7.9,"1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperazin-1-Yl-3,4-Dihydroquinazolin-2(1h)-One",YAWZIQKDHQIHOS-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
32255,6cs2,DB01231,-7.9,Diphenidol,OGAKLTJNUQRZJU-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
56321,6crv,DB02177,-7.9,1-Acetyl-4-(4-{4-[(2-Ethoxyphenyl)Thio]-3-Nitrophenyl}Pyridin-2-Yl)Piperazine,GKGJFUXSTSUKPB-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
155863,6wiq,DB11863,-7.9,Alvelestat,QNQZWEGMKJBHEM-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
123824,6w4h,DB00425,-7.9,Zolpidem,ZAFYATHCZYHLPB-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
56323,6crv,DB02179,-7.9,O-Trifluoromethylphenyl Anthranilic Acid,ONKHJNFXJDEMNQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
99902,6vxs,DB02861,-7.9,"4-(Aminosulfonyl)-N-[(3,4,5-Trifluorophenyl)Methyl]-Benzamide",DEHMSTGBNAXEGX-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
73529,6m2n,DB02154,-7.9,"2,3-Bis-Benzo[1,3]Dioxol-5-Ylmethyl-Succinic Acid",FFYBYVPVYLMLAR-KBPBESRZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
56324,6crv,DB02181,-7.9,2'-Deoxyguanosine-5'-Triphosphate,HAAZLUGHYHWQIW-KVQBGUIXSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
123831,6w4h,DB00434,-7.9,Cyproheptadine,JJCFRYNCJDLXIK-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
2489,6lzg,HMDB0041787,-7.9,Urolithin B 3-O-glucuronide,MHBWCULXQBVPQT-KSPMYQCISA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
24338,6cs2,DB02058,-7.9,SU4984,AZGZGRJOCKSSHA-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
164122,7bv1,DB07283,-7.9,"9-benzyl-2,3,4,9-tetrahydro-1H-carbazole-8-carboxylic acid",VDOXYKGIKBUISK-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
123692,6w4h,DB00266,-7.9,Dicoumarol,DOBMPNYZJYQDGZ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
7406,6lzg,DB00444,-7.9,Teniposide,NRUKOCRGYNPUPR-QBPJDGROSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
155875,6wiq,DB11878,-7.9,Filibuvir,SLVAPEZTBDBAPI-GDLZYMKVSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
62431,6crv,DB13566,-7.9,Sequifenadine,OXDOWGVJMITMJL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62428,6crv,DB13561,-7.9,Clobenzorex,LRXXRIXDSAEIOR-ZDUSSCGKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
123712,6w4h,DB00287,-7.9,Travoprost,MKPLKVHSHYCHOC-AHTXBMBWSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
62421,6crv,DB13553,-7.9,Carumonam,UIMOJFJSJSIGLV-JNHMLNOCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62414,6crv,DB13545,-7.9,Isobromindione,QFLZIWVSQDZLNW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
164157,7bv1,DB07319,-7.9,"6-(3-BROMO-2-NAPHTHYL)-1,3,5-TRIAZINE-2,4-DIAMINE",RXSSKAZHCZWJPP-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
123730,6w4h,DB00310,-7.9,Chlorthalidone,JIVPVXMEBJLZRO-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
123742,6w4h,DB00323,-7.9,Tolcapone,MIQPIUSUKVNLNT-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
32223,6cs2,DB01195,-7.9,Flecainide,DJBNUMBKLMJRSA-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
107346,6vxx,DB03195,-7.9,"Phosphoric Acid Mono-[3-Fluoro-5-(5-Methyl-2,4-Dioxo-3,4-Dihydro-2h-Pyrimidin-1-Yl)-Tetrahyro-Furan-2-Ylmethyl] Ester",GGCAVPJXJISBOA-XLPZGREQSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
32224,6cs2,DB00216,-7.9,Eletriptan,PWVXXGRKLHYWKM-LJQANCHMSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
99877,6vxs,DB02830,-7.9,FR236913,KCCUBLLGAMGDJL-HXUWFJFHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
62391,6crv,DB13512,-7.9,Clefamide,ODCUSWJXZDHLKV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107350,6vxx,DB03200,-7.9,7-Alpha-D-Ribofuranosyl-Purine-5'-Phosphate,NICKPTPNIMHUHB-DQUBFYRCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80627,6m3m,DB00238,-7.9,Nevirapine,NQDJXKOVJZTUJA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
140897,6w9q,DB00246,-7.9,Ziprasidone,MVWVFYHBGMAFLY-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
73503,6m2n,DB02118,-7.9,CP-271485,CIUMOGWIMXNXSQ-GOSISDBHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
62387,6crv,DB13507,-7.9,Poldine,CQRKVVAGMJJJSR-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140874,6w9q,DB00220,-7.9,Nelfinavir,QAGYKUNXZHXKMR-HKWSIXNMSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
89476,6m71,DB00528,-7.9,Lercanidipine,ZDXUKAKRHYTAKV-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
80640,6m3m,DB00252,-7.9,Phenytoin,CXOFVDLJLONNDW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
123775,6w4h,DB00367,-7.9,Levonorgestrel,WWYNJERNGUHSAO-XUDSTZEESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
155918,6wiq,DB11942,-7.9,Selinexor,DEVSOMFAQLZNKR-RJRFIUFISA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
69100,6lxt,DB08710,-7.9,"(5Z)-5-[(5-ETHYL-2-FURYL)METHYLENE]-2-{[(S)-(4-FLUOROPHENYL)(1H-TETRAZOL-5-YL)METHYL]AMINO}-1,3-THIAZOL-4(5H)-ONE",BKZOQCGDCHOGOQ-MZLJFPOFSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
32191,6cs2,DB00213,-7.9,Pantoprazole,IQPSEEYGBUAQFF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
27692,6cs2,DB07248,-7.9,"7-PYRIDIN-2-YL-N-(3,4,5-TRIMETHOXYPHENYL)-7H-PYRROLO[2,3-D]PYRIMIDIN-2-AMINE",YENZSPIOXMNEFF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
69136,6lxt,DB08747,-7.9,"(11R)-10-acetyl-11-(2,4-dichlorophenyl)-6-hydroxy-3,3-dimethyl-2,3,4,5,10,11-hexahydro-1H-dibenzo[b,e][1,4]diazepin-1-one",JJTPPGUNMJMPLY-QFIPXVFZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
80436,6m2n,DB15348,-7.9,Ampreloxetine,TZIALEBTHQWNAO-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
107111,6vxx,DB02300,-7.9,Calcipotriol,LWQQLNNNIPYSNX-UROSTWAQSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27673,6cs2,DB07227,-7.9,4-[(5-{[4-(3-CHLOROPHENYL)-3-OXOPIPERAZIN-1-YL]METHYL}-1H-IMIDAZOL-1-YL)METHYL]BENZONITRILE,JNUGFGAVPBYSHF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
140626,6w9c,DB13008,-7.9,"2,2-bis(4-hydroxy-3-tert-butylphenyl)propane",ZDRSNHRWLQQICP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140620,6w9c,DB12545,-7.9,Indobufen,AYDXAULLCROVIT-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140618,6w9c,DB12542,-7.9,GSK-356278,AWDJJMXJUOHGLC-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
155993,6wiq,DB12055,-7.9,MK-0767,ORZMUVMQJPGFOM-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
123969,6w4h,DB00603,-7.9,Medroxyprogesterone acetate,PSGAAPLEWMOORI-PEINSRQWSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
73433,6m2n,DB02030,-7.9,Alpha-Ribazole-5'-Phosphate,ZMRGXEJKZPRBPJ-SYQHCUMBSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
123973,6w4h,DB00607,-7.9,Nafcillin,GPXLMGHLHQJAGZ-JTDSTZFVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
123936,6w4h,DB00562,-7.9,Benzthiazide,NDTSRXAMMQDVSW-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
140555,6w9c,DB12443,-7.9,Sonedenoson,WUCQGGOGHZRELS-LSCFUAHRSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
27670,6cs2,DB07222,-7.9,(3S)-N-(5-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE,RJWMDETWDDESBP-ZDUSSCGKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
124011,6w4h,DB00656,-7.9,Trazodone,PHLBKPHSAVXXEF-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
107062,6vxx,DB02237,-7.9,Maltotetraose,UYQJCPNSAVWAFU-KVXMBEGHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107047,6vxx,DB02218,-7.9,"N-[4-hydroxymethyl-cyclohexan-6-yl-1,2,3-triol]-4,6-dideoxy-4-aminoglucopyranoside",RBZIIHWPZWOIDU-ZCGMLSCUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62318,6crv,DB13414,-7.9,Fenyramidol,ZEAJXCPGHPJVNP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
124030,6w4h,DB00678,-7.9,Losartan,PSIFNNKUMBGKDQ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
107422,6vxx,DB03288,-7.9,5-Chloro-1h-Indole-2-Carboxylic Acid{[Cyclopentyl-(2-Hydroxy-Ethyl)-Carbamoyl]-Methyl}-Amide,VXABTOCIIZSEPD-QGZVFWFLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140511,6w9c,DB11987,-7.9,GSK-2018682,NFIGDBFIDKDNIG-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140509,6w9c,DB11985,-7.9,Dapaconazole,FUAHXHWSMYFWGE-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
99787,6vxs,DB02706,-7.9,Mercaptocarboxylate Inhibitor,DUKDFMPUZRDWLT-CQSZACIVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
2626,6lzg,HMDB0042499,-7.9,TG(14:0/24:1(15Z)/20:3n6),IGCRUOUEUMSKRE-IVOQZZDCSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
124443,6w4h,DB01155,-7.9,Gemifloxacin,ZRCVYEYHRGVLOC-HYARGMPZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
107134,6vxx,DB02333,-7.9,Deoxyuridine-5'-Triphosphate,AHCYMLUZIRLXAA-SHYZEUOFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80750,6m3m,DB00384,-7.9,Triamterene,FNYLWPVRPXGIIP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
62352,6crv,DB13459,-7.9,Pecilocin,ZYPGADGCNXOUJP-CXVPHVKISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
73473,6m2n,DB02081,-7.9,Bis-Benzamidine,BXYGSMRTHHSAHZ-PMACEKPBSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
69144,6lxt,DB08755,-7.9,N-[(1S)-2-{[(1R)-2-(benzyloxy)-1-cyano-1-methylethyl]amino}-1-(cyclohexylmethyl)-2-oxoethyl]morpholine-4-carboxamide,MQWUTQCRGGBPBT-WIOPSUGQSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
107210,6vxx,DB02709,-7.9,Resveratrol,LUKBXSAWLPMMSZ-OWOJBTEDSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
89424,6m71,DB00459,-7.9,Acitretin,IHUNBGSDBOWDMA-AQFIFDHZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
89422,6m71,DB00457,-7.9,Prazosin,IENZQIKPVFGBNW-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
80442,6m2n,DB15360,-7.9,"Carfentanil, C-11",YDSDEBIZUNNPOB-JVVVGQRLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
107402,6vxx,DB03258,-7.9,2'-Deoxycytidine 5'-triphosphate,RGWHQCVHVJXOKC-SHYZEUOFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
99820,6vxs,DB02755,-7.9,1-3 Sugar Ring of Pentamannosyl 6-Phosphate,HDQMHAJOIVYOIP-NAVBLJQLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
140708,6w9c,DB15152,-7.9,TMC-649128,XJBILYMRFVHPJB-XJQUKVTJSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
62335,6crv,DB13435,-7.9,Endralazine,ALAXZYHFVBSJKZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
69156,6lxt,DB08770,-7.9,"4-{2-[(7-amino-2-furan-2-yl[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-yl)amino]ethyl}phenol",PWTBZOIUWZOPFT-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
89402,6m71,DB00436,-7.9,Bendroflumethiazide,HDWIHXWEUNVBIY-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
140673,6w9c,DB13077,-7.9,LCB01-0371,QLUWQAFDTNAYPN-LLVKDONJSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
32289,6cs2,DB00223,-7.9,Diflorasone,WXURHACBFYSXBI-XHIJKXOTSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
80739,6m3m,DB00372,-7.9,Thiethylperazine,XCTYLCDETUVOIP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
69058,6lxt,DB08657,-7.9,2-(4-(2-((3-(5-(PYRIDIN-2-YLTHIO)THIAZOL-2-YL)UREIDO)METHYL)-1H-IMIDAZOL-4-YL)PHENOXY)ACETIC ACID,SSXCWVOQWRUMGN-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
107153,6vxx,DB02636,-7.9,"9-Hydroxy-8-Methoxy-6-Nitro-Phenanthrol[3,4-D][1,3]Dioxole-5-Carboxylic Acid",UCLGCTLOEZZSLA-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
123918,6w4h,DB00543,-7.9,Amoxapine,QWGDMFLQWFTERH-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
164096,7bv1,DB07254,-7.9,"N-[3-[[4-[(5-CHLORO-1,3-BENZODIOXOL-4-YL)AMINO]PYRIMIDIN-2-YL]AMINO]PHENYL]METHANESULFONAMIDE",KQGTYXRWSIBDOZ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
80742,6m3m,DB00376,-7.9,Trihexyphenidyl,HWHLPVGTWGOCJO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
123922,6w4h,DB00547,-7.9,Desoximetasone,VWVSBHGCDBMOOT-IIEHVVJPSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
89404,6m71,DB00438,-7.9,Ceftazidime,ORFOPKXBNMVMKC-DWVKKRMSSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
124452,6w4h,DB01166,-7.9,Cilostazol,RRGUKTPIGVIEKM-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
36274,1r42,DB02705,-7.9,"6-[N-(1-Isopropyl-1,2,3,4-Tetrahydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine",DARQQJKHXPXSRO-QFIPXVFZSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
705,6lzg,HMDB0006766,-7.9,Estriol-16-Glucuronide,FQYGGFDZJFIDPU-JRSYHJKYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
139385,6w9c,DB13397,-7.9,Prenoxdiazine,PXZDWASDNFWKSD-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
100853,6vxs,DB04142,-7.9,"3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid Dimethylamide",FEYGJZKVMASWJB-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
139359,6w9c,DB13360,-7.9,Tolciclate,CANCCLAKQQHLNK-LSDHHAIUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139339,6w9c,DB13337,-7.9,Pheneticillin,NONJJLVGHLVQQM-JHXYUMNGSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
124948,6w4h,DB01838,-7.9,"6,4'-Dihydroxy-3-Methyl-3',5'-Dibromoflavone",GKDYOXMZSXVKPP-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
124958,6w4h,DB01852,-7.9,Kaempherol,IYRMWMYZSQPJKC-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
124971,6w4h,DB01871,-7.9,[1-(1-Benzyl-3-Hydroxy-2-Oxo-Propylcarbamoyl)-2-Phenyl-Ethyl]-Carbamic Acid Benzyl Ester,OACUXIVGLLCILS-ZEQRLZLVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
68981,6lxt,DB08561,-7.9,"BENZYL 6-BENZYL-5,7-DIOXO-6,7-DIHYDRO-5H-[1,3]THIAZOLO[3,2-C]PYRIMIDINE-2-CARBOXYLATE",PLBINCOCFGQAJM-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
24552,6cs2,DB02316,-7.9,"1-(5-Carboxypentyl)-5-[(2,6-Dichlorobenzyl)Oxy]-1 H-Indole-2-Carboxylic Acid",JTGPYFFQVOIJKR-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
80130,6m2n,DB14678,-7.9,Norethindrone enanthate,APTGJECXMIKIET-WOSSHHRXSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
139328,6w9c,DB13324,-7.9,Tetrazepam,IQWYAQCHYZHJOS-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
100896,6vxs,DB04196,-7.9,Pteroic Acid,JOAQINSXLLMRCV-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
164285,7bv1,DB07651,-7.9,N-ACETYL-L-PHENYLALANYL-4-[DIFLUORO(PHOSPHONO)METHYL]-L-PHENYLALANINAMIDE,KPMMESISHWWXNM-ROUUACIJSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
99539,6vxs,DB02388,-7.9,"Cyclohexyl-{4-[5-(3,4-Dichlorophenyl)-2-Piperidin-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine",UQFRSHRWRKYNDE-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
7252,6lzg,DB00421,-7.9,Spironolactone,LXMSZDCAJNLERA-ZHYRCANASA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
99528,6vxs,DB02375,-7.9,Myricetin,IKMDFBPHZNJCSN-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
56880,6crv,DB02905,-7.9,"Phosphoric Acid Mono-[3,4-Dihydroxy-5-(5-Hydroxy-Benzoimidazol-1-Yl)Tetrahydro-Furan-2-Ylmethyl] Ester",BVZASCINAVSQNO-PULFBKJNSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81356,6m3m,DB01101,-7.9,Capecitabine,GAGWJHPBXLXJQN-UORFTKCHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
11364,6lzg,DB11867,-7.9,JNJ-39393406,IURMHZBQEYNQOH-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
36135,1r42,DB02519,-7.9,Indirubin-5-Sulphonate,IHBOEHLUIBMBMY-YPKPFQOOSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
125021,6w4h,DB01946,-7.9,"3-[1-(3-Aminopropyl)-1h-Indol-3-Yl]-4-(1-Methyl-1h-Indol-3-Yl)-1h-Pyrrole-2,5-Dione",UQHKJRCFSLMWIA-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
99547,6vxs,DB02398,-7.9,6-[N-(4-(Aminomethyl)Phenyl)Carbamyl]-2-Naphthalenecarboxamidine,NLBDETRVUYOIHQ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
24540,6cs2,DB02300,-7.9,Calcipotriol,LWQQLNNNIPYSNX-UROSTWAQSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
106541,6vxx,DB00469,-7.9,Tenoxicam,LZNWYQJJBLGYLT-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80151,6m2n,DB14736,-7.9,Cannabivarin,SVTKBAIRFMXQQF-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
139451,6w9c,DB13487,-7.9,Iodine (131I) norcholesterol,QJHZPCLORSPENH-DRTKWHMQSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
81251,6m3m,DB00982,-7.9,Isotretinoin,SHGAZHPCJJPHSC-XFYACQKRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
18775,6cs2,HMDB0034369,-7.9,"(3beta,5alpha)-3-Hydroxypregn-16-en-20-one",SFXPZLCQRZASKK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
88756,6m3m,DB14725,-7.9,Cefamandole nafate,RRJHESVQVSRQEX-SUYBPPKGSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
73178,6m2n,DB01685,-7.9,Topiroxostat,UBVZQGOVTLIHLH-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
11338,6lzg,DB11829,-7.9,Ruboxistaurin,ZCBUQCWBWNUWSU-SFHVURJKSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
13144,6lzg,DB14769,-7.9,Pamiparib,DENYZIUJOTUUNY-MRXNPFEDSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
100777,6vxs,DB04042,-7.9,"2-[4-(Hydroxy-Methoxy-Methyl)-Benzyl]-7-(4-Hydroxymethyl-Benzyl)-1,1-Dioxo-3,6-Bis-Phenoxymethyl-1lambda6-[1,2,7]Thiadiazepane-4,5-Diol",XLJNZONSWKENRP-VABIIVNOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
27499,6cs2,DB07043,-7.9,"7-amino-2-tert-butyl-4-(4-pyrimidin-2-ylpiperazin-1-yl)pyrido[2,3-d]pyrimidine-6-carboxamide",CKLCIJCZOIDJQU-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
124803,6w4h,DB01645,-7.9,Genistein,TZBJGXHYKVUXJN-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
56888,6crv,DB02916,-7.9,"[(2r,3s,4r,5r)-5-(6-Amino-9h-Purin-9-Yl)-3,4-Dihydroxytetrahydro-2-Furanyl]Methyl Sulfamate",GNZLUJQJDPRUTD-KQYNXXCUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81266,6m3m,DB01000,-7.9,Cyclacillin,HGBLNBBNRORJKI-WCABBAIRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
139434,6w9c,DB13461,-7.9,Cefcapene,HJJRIJDTIPFROI-NVKITGPLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
124822,6w4h,DB01674,-7.9,[2-(1-Amino-2-Hydroxy-Propyl)-4-(4-Fluoro-1h-Indol-3-Ylmethyl)-5-Hydroxy-Imidazol-1-Yl]-Acetic Acid,AYMRQIHECFEMIQ-AYVTZFPOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
73170,6m2n,DB01674,-7.9,[2-(1-Amino-2-Hydroxy-Propyl)-4-(4-Fluoro-1h-Indol-3-Ylmethyl)-5-Hydroxy-Imidazol-1-Yl]-Acetic Acid,AYMRQIHECFEMIQ-AYVTZFPOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
156412,6wiq,DB13060,-7.9,CEP-37440,BCSHRERPHLTPEE-NRFANRHFSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
81286,6m3m,DB01022,-7.9,Phylloquinone,MBWXNTAXLNYFJB-NKFFZRIASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
124830,6w4h,DB01685,-7.9,Topiroxostat,UBVZQGOVTLIHLH-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
88750,6m3m,DB14715,-7.9,Cinazepam,NQTRBZXDWMDXAQ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
69455,6lxt,DB09215,-7.9,Droxicam,OEHFRZLKGRKFAS-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
163535,7bv1,DB04759,-7.9,"PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-(3-METHYL-BENZYLAMIDE)",GTBUZLPQANSGGE-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
163534,7bv1,DB04757,-7.9,"GUANOSINE-2',3'-O-METHYLIDENEPHOSPHONATE",GKAPYWCOOQBBHV-KXSYMAMXSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
106557,6vxx,DB00487,-7.9,Pefloxacin,FHFYDNQZQSQIAI-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80120,6m2n,DB14668,-7.9,Dienestrol diacetate,YWLLGDVBTLPARJ-OXAZHYLESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
69493,6lxt,DB09268,-7.9,Picosulfuric acid,UJIDKYTZIQTXPM-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
106511,6vxx,DB00433,-7.9,Prochlorperazine,WIKYUJGCLQQFNW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80071,6m2n,DB14575,-7.9,Eslicarbazepine,BMPDWHIDQYTSHX-AWEZNQCLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
88494,6m3m,DB13872,-7.9,Lormetazepam,FJIKWRGCXUCUIG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
13149,6lzg,DB14775,-7.9,Cavosonstat,BXSZILNGNMDGSL-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
164303,7bv1,DB07676,-7.9,"3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)-1H,2'H-2,3'-biindol-2'-one",CKLAPOFDFZKCPB-LBPRGKRZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
139179,6w9c,DB12974,-7.9,Roniciclib,UELYDGOOJPRWGF-SRQXXRKNSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
106471,6vxx,DB00383,-7.9,Oxyphencyclimine,DUDKAZCAISNGQN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88465,6m3m,DB13835,-7.9,Caroverine,MSPRUJDUTKRMLM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
56941,6crv,DB02984,-7.9,"4-[3-Methylsulfanylanilino]-6,7-Dimethoxyquinazoline",FUSDVOSGGMBSMK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88459,6m3m,DB13824,-7.9,Enprostil,PTOJVMZPWPAXER-FPXSIRDUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
106459,6vxx,DB00370,-7.9,Mirtazapine,RONZAEMNMFQXRA-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
139188,6w9c,DB12988,-7.9,LY-518674,PNHFDVSKDSLUFH-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
69538,6lxt,DB09383,-7.9,Meprednisone,PIDANAQULIKBQS-RNUIGHNZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
24587,6cs2,DB02358,-7.9,LY374571,SZHRIPFGZWWRKW-VIFPVBQESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
164307,7bv1,DB07680,-7.9,[(1S)-1-(5-CHLORO-1-BENZOTHIEN-3-YL)-2-(2-NAPHTHYLAMINO)-2-OXOETHYL]PHOSPHONIC ACID,HUJXISJLAPAFBO-IBGZPJMESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
62693,6crv,DB13955,-7.9,Estradiol dienanthate,OVAHZPTYWMWNKO-CAHAWPIUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106456,6vxx,DB00367,-7.9,Levonorgestrel,WWYNJERNGUHSAO-XUDSTZEESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
32704,6cs2,T3D3610,-7.9,Cyanoginosin-LA,DIAQQISRBBDJIM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
88448,6m3m,DB13810,-7.9,Dimemorfan,KBEZZLAAKIIPFK-NJAFHUGGSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
56958,6crv,DB03010,-7.9,Patupilone,QXRSDHAAWVKZLJ-PVYNADRNSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56077,6crv,DB01842,-7.9,3'-Phosphate-Adenosine-5'-Diphosphate,GBBWIZKLHXYJOA-KQYNXXCUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62695,6crv,DB13957,-7.9,J147,HYMZAYGFKNNHDN-SSDVNMTOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
125284,6w4h,DB02292,-7.9,Irosustat,DSLPMJSGSBLWRE-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
123205,6w4b,DB15085,-7.9,Fulacimstat,JDARDSVOVYVQST-MRXNPFEDSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
56804,6crv,DB02809,-7.9,"Brodimoprim-4,6-Dicarboxylate",SZAVCZNFKJSWRN-LBPRGKRZSA-M,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106479,6vxx,DB00394,-7.9,Beclomethasone dipropionate,KUVIULQEHSCUHY-XYWKZLDCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
155704,6wiq,DB11577,-7.9,Indigotindisulfonic Acid,CFZXDJWFRVEWSR-BUHFOSPRSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
81375,6m3m,DB01125,-7.9,Anisindione,XRCFXMGQEVUZFC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
56899,6crv,DB02929,-7.9,K201,KCWGETCFOVJEPI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
100924,6vxs,DB04232,-7.9,N-Hydroxy-1-(4-Methoxyphenyl)Sulfonyl-4-Benzyloxycarbonyl-Piperazine-2-Carboxamide,DNGGPLKVDUPXFN-GOSISDBHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
139244,6w9c,DB13213,-7.9,Butaperazine,DVLBYTMYSMAKHP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
56901,6crv,DB02932,-7.9,(R)-Bicalutamide,LKJPYSCBVHEWIU-KRWDZBQOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80104,6m2n,DB14651,-7.9,Perphenazine enanthate,PWEGQJCIAMJJHC-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
139238,6w9c,DB13203,-7.9,Bamifylline,VVUYEFBRTFASAH-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
69498,6lxt,DB09279,-7.9,Fimasartan,AMEROGPZOLAFBN-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
125101,6w4h,DB02049,-7.9,2-{4-[4-(4-Chloro-Phenoxy)-Benzenesulfonyl]-Tetrahydro-Pyran-4-Yl}-N-Hydroxy-Acetamide,QOPFTBAEAJQKSY-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
123253,6w4b,DB15183,-7.9,Fosmanogepix,JQONJQKKVAHONF-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
88511,6m3m,DB13934,-7.9,Ligandrol,OPSIVAKKLQRWKC-VXGBXAGGSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
62672,6crv,DB13927,-7.9,anle138b,RCQIIBJSUWYYFU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
69510,6lxt,DB09295,-7.9,Talniflumate,ANMLJLFWUCQGKZ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
106491,6vxx,DB00408,-7.9,Loxapine,XJGVXQDUIWGIRW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
125141,6w4h,DB02101,-7.9,"(S,R)-fidarestat",WAAPEIZFCHNLKK-QPUJVOFHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
73096,6m2n,DB01578,-7.9,Metrizamide,DTZMSDADRKLCQE-RFMXWLSYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
139209,6w9c,DB13122,-7.9,Trabodenoson,AQLVRTWKJDTWQQ-SDBHATRESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
29012,6cs2,DB08647,-7.9,TRAZEOLIDE,YUTXECPABXNXPU-DJJJIMSYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
123248,6w4b,DB15168,-7.9,Cilofexor,KZSKGLFYQAYZCO-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
141649,6w9q,DB01137,-7.9,Levofloxacin,GSDSWSVVBLHKDQ-JTQLQIEISA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
139202,6w9c,DB13114,-7.9,Amitriptylinoxide,ZPMKQFOGINQDAM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
61906,6crv,DB12780,-7.9,Quinfamide,SBJGFIXQRZOVTO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
139215,6w9c,DB13136,-7.9,Fluindione,NASXCEITKQITLD-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
163333,7bv1,DB04274,-7.9,"5,4'-Dideoxyflavanone",SWAJPHCXKPCPQZ-AWEZNQCLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
68985,6lxt,DB08569,-7.9,"3-PYRIDIN-4-YL-2,4-DIHYDRO-INDENO[1,2-.C.] PYRAZOLE",VLPMRZSKJUTRBQ-IBGZPJMESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
106584,6vxx,DB00524,-7.9,Metolazone,AQCHWTWZEMGIFD-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
89033,6m3m,DB15325,-7.9,ONO-8539,ALLLQQUASFFEKP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80235,6m2n,DB14924,-7.9,PF-06651600,CBRJPFGIXUFMTM-WDEREUQCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80224,6m2n,DB14900,-7.9,ISO-1 F-18,QVRVXSZKCXFBTE-KPVNRNJOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
27556,6cs2,DB07105,-7.9,2-[2-(4-CHLORO-PHENYLSULFANYL)-ACETYLAMINO]-3-(4-GUANIDINO-PHENYL)-PROPIONAMIDE,IEEYGOJDTRVYGR-HNNXBMFYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
81055,6m3m,DB00755,-7.9,Tretinoin,SHGAZHPCJJPHSC-YCNIQYBTSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
106713,6vxx,DB00924,-7.9,Cyclobenzaprine,JURKNVYFZMSNLP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81065,6m3m,DB00768,-7.9,Olopatadine,JBIMVDZLSHOPLA-LSCVHKIXSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
62593,6crv,DB13784,-7.9,Dixyrazine,MSYUMPGNGDNTIQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62603,6crv,DB13796,-7.9,Dibunate,WBEBQCINXJDZCX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
123299,6w4b,DB15268,-7.9,Afabicin,HFYMDQMXVPJNTH-VQHVLOKHSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
139701,6w9c,DB13821,-7.9,Ceftezole,DZMVCVMFETWNIU-LDYMZIIASA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139677,6w9c,DB13790,-7.9,Fipexide,BFUJHVVEMMWLHC-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139672,6w9c,DB13783,-7.9,Acemetacin,FSQKKOOTNAMONP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
81076,6m3m,DB00782,-7.9,Propantheline,VVWYOYDLCMFIEM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
18854,6cs2,HMDB0036927,-7.9,"7,7',8,8'-Tetrahydrolycopene",BIWLELKAFXRPDE-WTXAYMOSSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
69371,6lxt,DB09078,-7.9,Lenvatinib,WOSKHXYHFSIKNG-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
80189,6m2n,DB14835,-7.9,SUVN-G3031,LNXDUSQEXVQFGP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
36234,1r42,DB02651,-7.9,"{[2-(1h-1,2,3-Benzotriazol-1-Yl)-2-(3,4-Difluorophenyl)Propane-1,3-Diyl]Bis[4,1-Phenylene(Difluoromethylene)]}Bis(Phosphonic Acid)",BTAGTGWPDROBMG-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
141423,6w9q,DB00878,-7.9,Chlorhexidine,GHXZTYHSJHQHIJ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
24447,6cs2,DB02191,-7.9,"(7as,12ar,12bs)-1,2,3,4,7a,12,12a,12b-Octahydroindolo[2,3-a]Quinolizin-7(6h)-One",PGKUSHWBQJPFOP-LBPRGKRZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
106685,6vxx,DB00896,-7.9,Rimexolone,QTTRZHGPGKRAFB-OOKHYKNYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
89606,6m71,DB00686,-7.9,Pentosan Polysulfate,FCCNSUIJIOOXEZ-SJYYZXOBSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
69353,6lxt,DB09050,-7.9,Ceftolozane,JHFNIHVVXRKLEF-DCZLAGFPSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
69351,6lxt,DB09047,-7.9,Finafloxacin,FYMHQCNFKNMJAV-HOTGVXAUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
139711,6w9c,DB13836,-7.9,Metampicillin,FZECHKJQHUVANE-MCYUEQNJSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
106777,6vxx,DB01239,-7.9,Chlorprothixene,WSPOMRSOLSGNFJ-AUWJEWJLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
69324,6lxt,DB09003,-7.9,Clocapramine,QAZKXHSIKKNOHH-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
69326,6lxt,DB09006,-7.9,Clinofibrate,BMOVQUBVGICXQN-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
62144,6crv,DB13164,-7.9,Olmutinib,FDMQDKQUTRLUBU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
24237,6cs2,DB00276,-7.9,Amsacrine,XCPGHVQEEXUHNC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
141374,6w9q,DB00823,-7.9,Ethynodiol diacetate,ONKUMRGIYFNPJW-KIEAKMPYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
27585,6cs2,DB07132,-7.9,1-{2-OXO-3-[(1R)-1-(1H-PYRROL-2-YL)ETHYL]-2H-INDOL-5-YL}UREA,KJDBLWKTHMHALD-QMMMGPOBSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
73300,6m2n,DB01842,-7.9,3'-Phosphate-Adenosine-5'-Diphosphate,GBBWIZKLHXYJOA-KQYNXXCUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
139793,6w9c,DB13994,-7.9,AZD-7325,KYDURMHFWXCKMW-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
24417,6cs2,DB02152,-7.9,K-252a,KOZFSFOOLUUIGY-SOLYNIJKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
139654,6w9c,DB13759,-7.9,Fenpiverinium,QDIYJDPBMZUZEH-UHFFFAOYSA-O,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
163774,7bv1,DB06250,-7.9,Fluasterone,VHZXNQKVFDBFIK-NBBHSKLNSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
81019,6m3m,DB00712,-7.9,Flurbiprofen,SYTBZMRGLBWNTM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
7456,6lzg,DB03830,-7.9,Phosphorylated Dihydropteroate,DNKVHXNVVYQUDC-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
163767,7bv1,DB06237,-7.9,Avanafil,WEAJZXNPAWBCOA-INIZCTEOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
124483,6w4h,DB01198,-7.9,Zopiclone,GBBSUAFBMRNDJC-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
27574,6cs2,DB07122,-7.9,1-[4-(2-oxo-2-phenylethyl)phenyl]guanidine,MERNPSIIBFTCAI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
56652,6crv,DB02603,-7.9,1-Amino-6-Cyclohex-3-Enylmethyloxypurine,VPUIDVRYMVIXGO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
124499,6w4h,DB01216,-7.9,Finasteride,DBEPLOCGEIEOCV-WSBQPABSSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
141377,6w9q,DB00826,-7.9,Natamycin,NCXMLFZGDNKEPB-FFPOYIOWSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
14974,6lzg,T3D4921,-7.9,Diflubenzuron,QQQYTWIFVNKMRW-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
139725,6w9c,DB13851,-7.9,Artemotil,NLYNIRQVMRLPIQ-XQLAAWPRSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
56637,6crv,DB02583,-7.9,"N6-(2,5-Dimethoxy-Benzyl)-N6-Methyl-Pyrido[2,3-D]Pyrimidine-2,4,6-Triamine",HZTFNSCZLJLPEO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
99639,6vxs,DB02510,-7.9,'5'-O-(N-(L-Prolyl)-Sulfamoyl)Adenosine,LKVJEMXWEODCAY-JVEUSOJLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
139650,6w9c,DB13755,-7.9,Iocarmic acid,SMQYOVYWPWASGU-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
80184,6m2n,DB14820,-7.9,Profoxydim,KRQUFUKTQHISJB-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
124704,6w4h,DB01532,-7.9,??-Methylacetylfentanyl,OKTLVZBUKMRPLL-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
124712,6w4h,DB01540,-7.9,17alpha-methyl-4-hydroxynandrolone,CLNUZOCYKSHICX-FAHHUNKHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
107588,6vxx,DB04059,-7.9,8-(Pyrimidin-2-Ylamino)Naphthalene-2-Carboximidamide,GRQLDCHTDNYVQI-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
164265,7bv1,DB07629,-7.9,"N-((1R,2S)-2-(5-CHLORO-1H-INDOLE-2-CARBOXAMIDO)CYCLOHEXYL)-5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE-2-CARBOXAMIDE",ARPFWVKYXJZULB-DLBZAZTESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
106627,6vxx,DB00829,-7.9,Diazepam,AAOVKJBEBIDNHE-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
124725,6w4h,DB01553,-7.9,Cloxazolam,ZIXNZOBDFKSQTC-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
139502,6w9c,DB13554,-7.9,Moperone,AGAHNABIDCTLHW-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
164273,7bv1,DB07638,-7.9,"(3AS,4R,9BR)-2,2-DIFLUORO-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL",QJSMFUTULGSHNQ-ZOBUZTSGSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
81205,6m3m,DB00926,-7.9,Etretinate,HQMNCQVAMBCHCO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81211,6m3m,DB00934,-7.9,Maprotiline,QSLMDECMDJKHMQ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
106636,6vxx,DB00839,-7.9,Tolazamide,OUDSBRTVNLOZBN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81215,6m3m,DB00939,-7.9,Meclofenamic acid,SBDNJUWAMKYJOX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
106601,6vxx,DB00801,-7.9,Halazepam,WYCLKVQLVUQKNZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
139486,6w9c,DB13534,-7.9,Gedocarnil,SLYDYLLJUXFULK-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
56120,6crv,DB01910,-7.9,Sinefungin,LMXOHSDXUQEUSF-YECHIGJVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163618,7bv1,DB04863,-7.9,Lefradafiban,PGCFXITVMNNKON-ROUUACIJSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
100745,6vxs,DB03996,-7.9,"3-[(5s)-1-Acetyl-3-(2-Chlorophenyl)-4,5-Dihydro-1h-Pyrazol-5-Yl]Phenol",QBZAPFWYAPXRGQ-KRWDZBQOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
163611,7bv1,DB04853,-7.9,Binodenoson,XJFMHMFFBSOEPR-DNZQAUTHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
81236,6m3m,DB00963,-7.9,Bromfenac,ZBPLOVFIXSTCRZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
163606,7bv1,DB04845,-7.9,Ixabepilone,FABUFPQFXZVHFB-PVYNADRNSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
107596,6vxx,DB04068,-7.9,Fudp,WLQBZMZTRNPUDL-SHYZEUOFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107597,6vxx,DB04069,-7.9,"5,6-Dihydro-Benzo[H]Cinnolin-3-Ylamine",QKVREUJWFZJEJK-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62645,6crv,DB13851,-7.9,Artemotil,NLYNIRQVMRLPIQ-XQLAAWPRSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
36180,1r42,DB02581,-7.9,"5-[2,3-Dichloro-4-(5-{1-[2-(2-Guanidino-4-Methyl-Pentanoylamino)-Acetyl]-Piperidin-4-Yl}-1-Methyl-1h-Pyrazol-3-Yl)-Phenoxymethyl]-Furan-2-Carboxylic Acid",VNZHOIDQBPFEJU-OAQYLSRUSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
81186,6m3m,DB00907,-7.9,Cocaine,ZPUCINDJVBIVPJ-LJISPDSOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
100646,6vxs,DB03865,-7.9,6-Chloro-2-(2-Hydroxy-Biphenyl-3-Yl)-1h-Indole-5-Carboxamidine,FEKRWNWZMOSVBX-UHFFFAOYSA-O,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
100578,6vxs,DB03777,-7.9,Rbt205 Inhibitor,QMGUOJYZJKLOLH-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
139600,6w9c,DB13684,-7.9,Omoconazole,JMFOSJNGKJCTMJ-ZHZULCJRSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
62065,6crv,DB13028,-7.9,Biapenem,MRMBZHPJVKCOMA-YJFSRANCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80182,6m2n,DB14808,-7.9,Lumicitabine,MJVKYGMNSQJLIN-KYZVSKTDSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
88907,6m3m,DB15079,-7.9,Troriluzole,YBZSGIWIPOUSHY-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81119,6m3m,DB00831,-7.9,Trifluoperazine,ZEWQUBUPAILYHI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80180,6m2n,DB14801,-7.9,Lanifibranor,OQDQIFQRNZIEEJ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
163687,7bv1,DB05932,-7.9,Denibulin,GAOHLWCIAJNSEE-JTQLQIEISA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
88886,6m3m,DB15038,-7.9,Litoxetine,MJJDYOLPMGIWND-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
155740,6wiq,DB11663,-7.9,Pictilisib,LHNIIDJUOCFXAP-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
81185,6m3m,DB00906,-7.9,Tiagabine,PBJUNZJWGZTSKL-MRXNPFEDSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
73621,6m2n,DB02276,-7.9,(S)-2-(Phosphonoxy)Caproyl-L-Leucyl-P-Nitroanilide,HARXAJAHMRMERT-HOTGVXAUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
62046,6crv,DB13003,-7.9,Cortivazol,RKHQGWMMUURILY-UHRZLXHJSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88877,6m3m,DB15024,-7.9,Apararenone,AZNHWXAFPBYFGH-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81169,6m3m,DB00887,-7.9,Bumetanide,MAEIEVLCKWDQJH-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
22810,6cs2,HMDB0055048,-7.9,"TG(22:5(4Z,7Z,10Z,13Z,16Z)/20:2n6/20:4(8Z,11Z,14Z,17Z))",UOFWKNNJKYNSGN-XDTNFSKOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
11315,6lzg,DB11799,-7.9,Bictegravir,SOLUWJRYJLAZCX-LYOVBCGYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
88846,6m3m,DB14924,-7.9,PF-06651600,CBRJPFGIXUFMTM-WDEREUQCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
139548,6w9c,DB13618,-7.9,Ipriflavone,SFBODOKJTYAUCM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
69408,6lxt,DB09166,-7.9,Etizolam,VMZUTJCNQWMAGF-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
124675,6w4h,DB01497,-7.9,Etorphine,CAHCBJPUTCKATP-HBDRVVKHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
163655,7bv1,DB05706,-7.9,13-deoxydoxorubicin,RGVRUQHYQSORBY-JIGXQNLBSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
100616,6vxs,DB03823,-7.9,Epigallocatechin,XMOCLSLCDHWDHP-IUODEOHRSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
62689,6crv,DB13951,-7.9,Stanolone acetate,ILCTUFVQFCIIDS-NGFSFWIMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
157664,6wiq,DB12267,-7.9,Brigatinib,AILRADAXUVEEIR-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
82693,6m3m,DB02880,-7.9,N-[1-(4-Bromophenyl)Ethyl]-5-Fluoro Salicylamide,KFTNEILVDDUXGR-SECBINFHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
158945,7bv1,DB02669,-7.9,RB106,ZWDQTNWLXALTOV-QYZOEREBSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
102942,6vxs,DB07988,-7.9,"2-[3-(5-MERCAPTO-[1,3,4]THIADIAZOL-2YL)-UREIDO]-N-METHYL-3-PENTAFLUOROPHENYL-PROPIONAMIDE",HZAXNPDJVFUGDS-BYPYZUCNSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
71703,6lxt,DB15114,-7.9,Vamorolone,ZYTXTXAMMDTYDQ-DGEXFFLYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
86269,6m3m,DB08645,-7.9,"6-CHLORO-3-(DICHLOROMETHYL)-3,4-DIHYDRO-2H-1,2,4-BENZOTHIADIAZINE-7-SULFONAMIDE 1,1-DIOXIDE",LMJSLTNSBFUCMU-MRVPVSSYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86261,6m3m,DB08635,-7.9,N-(TRANS-4'-NITRO-4-STILBENYL)-N-METHYL-5-AMINO-PENTANOIC ACID,QLLZAVDYYAQESE-AATRIKPKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
133596,6w9c,DB01895,-7.9,Aspartyl-Adenosine-5'-Monophosphate,QPBSGQWTJLPZNF-VWJPMABRSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
104262,6vxs,DB11743,-7.9,Ipatasertib,GRZXWCHAXNAUHY-NSISKUIASA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
158967,7bv1,DB02698,-7.9,"N-(M-Trifluoromethylphenyl) Phenoxazine-4,6-Dicarboxylic Acid",NQOOJFXBGLOGTC-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
104260,6vxs,DB11741,-7.9,Famitinib,GKEYKDOLBLYGRB-LGMDPLHJSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
71695,6lxt,DB15099,-7.9,GW-468816,XDKRVNKVAKCFGW-WXWBBQJKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
60291,6crv,DB08472,-7.9,(R)-Fluoxetine,RTHCYVBBDHJXIQ-MRXNPFEDSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60289,6crv,DB08470,-7.9,"3-(4-fluorophenyl)-5-phenyl-4H-1,2,4-triazole",KMGPJKOKSYGMJD-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
12163,6lzg,DB12973,-7.9,Serlopitant,FLNYCRJBCNNHRH-OIYLJQICSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
160534,7bv1,DB08745,-7.9,4-[[(1E)-2-(4-CHLOROPHENYL)ETHENYL]SULFONYL]-1-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]PIPERAZINONE,QLHUDNKWOSQSMK-CXUHLZMHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
16563,6cs2,HMDB0002829,-7.9,Androsterone glucuronide,VFUIRAVTUVCQTF-BSOWLZGZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
133570,6w9c,DB01858,-7.9,[1-(4-Fluorobenzyl)Cyclobutyl]Methyl (1s)-1-[Oxo(1h-Pyrazol-5-Ylamino)Acetyl]Pentylcarbamate,QTPYRNAKLBXKNP-SFHVURJKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
60287,6crv,DB08467,-7.9,"6-(2,3,4,5,6,7-HEXAHYDRO-2,4,4-TRIMETHYL-1-METYLENEINDEN-2-YL)-3-METHYLHEXA-2,4-DIENOIC ACID",HEVXQLBAMFMFKU-IAZPEVBMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
158981,7bv1,DB02715,-7.9,Compound 18,UZOOIPXOYYJULJ-RHLLTPQKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160526,7bv1,DB08737,-7.9,"(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-9-OL",FSYFYSFYUHBIHE-GLJUWKHASA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60286,6crv,DB08466,-7.9,"5-[2-(4-hydroxyphenyl)ethyl]benzene-1,3-diol",HITJFUSPLYBJPE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
133534,6w9c,DB01812,-7.9,Adenosine-3'-5'-Diphosphate,WHTCPDAXWFLDIH-KQYNXXCUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
133505,6w9c,DB01772,-7.9,"3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl]-4-(5-Fluoro-1-Methyl-1h-Indol-3-Yl)-Pyrrole-2,5-Dione",RPGZQOOZHIEPJW-HNNXBMFYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
60276,6crv,DB08455,-7.9,Ro 12-7310,CAAFTBWHFUPDGX-OFCLTBKTSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104252,6vxs,DB11732,-7.9,Lasmiditan,XEDHVZKDSYZQBF-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
130334,6w4h,DB12115,-7.9,AZD-9164,FNYFFCOCVNTJCD-NNMXADRKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
71709,6lxt,DB15124,-7.9,PF-05241328,RVTSXVZXEGFIPW-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
130279,6w4h,DB12039,-7.9,Epicatechin,PFTAWBLQPZVEMU-UKRRQHHQSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
84657,6m3m,DB06708,-7.9,Lumefantrine,DYLGFOYVTXJFJP-MYYYXRDXSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
104267,6vxs,DB11751,-7.9,Cabotegravir,WCWSTNLSLKSJPK-LKFCYVNXSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104345,6vxs,DB11865,-7.9,Brivanib alaninate,LTEJRLHKIYCEOX-OCCSQVGLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
160661,7bv1,DB09238,-7.9,Manidipine,ANEBWFXPVPTEET-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
71736,6lxt,DB15186,-7.9,GDC-0084,LGWACEZVCMBSKW-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
59064,6crv,DB07033,-7.9,5-HYDROXY-3-[(1R)-1-(1H-PYRROL-2-YL)ETHYL]-2H-INDOL-2-ONE,VWQVBIPGKIAUGA-QMMMGPOBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84610,6m3m,DB06618,-7.9,Cutamesine,UVSWWUWQVAQPJR-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
102895,6vxs,DB07934,-7.9,[[CYCLOHEXANESULFONYL-GLYCYL]-3[PYRIDIN-4-YL-AMINOMETHYL]ALANYL]PIPERIDINE,KMUXFASJKPVMGU-HXUWFJFHSA-O,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
59071,6crv,DB07040,-7.9,"2-amino-7-fluoro-5-oxo-5H-chromeno[2,3-b]pyridine-3-carboxamide",GCHMLYYPYFXLQB-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60335,6crv,DB08524,-7.9,2-(3-BENZOYLPHENOXY)ETHYL(HYDROXY)FORMAMIDE,ZHFKBNAHHTUQBH-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86297,6m3m,DB08680,-7.9,N-{3-[(E)-(tert-butoxyimino)methyl]-4-chlorophenyl}-2-methylfuran-3-carbimidothioic acid,PLGIIOKXCKDKEU-VXLYETTFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
133715,6w9c,DB02058,-7.9,SU4984,AZGZGRJOCKSSHA-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
104311,6vxs,DB11816,-7.9,Omecamtiv Mecarbil,RFUBTTPMWSKEIW-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
86291,6m3m,DB08672,-7.9,4-[(3R)-3-{[2-(4-FLUOROPHENYL)-2-OXOETHYL]AMINO}BUTYL]BENZAMIDE,OIWWNWQZJJKBTR-CYBMUJFWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
130335,6w4h,DB12116,-7.9,Epigallocatechin gallate,WMBWREPUVVBILR-WIYYLYMNSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
86289,6m3m,DB08669,-7.9,"METHYL N-[(2S,3R)-3-AMINO-2-HYDROXY-3-(4-METHYLPHENYL)PROPANOYL]-D-ALANYL-D-LEUCINATE",BMHZOSJVDHAFEE-SVGFKBNWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
130231,6w4h,DB11962,-7.9,GSK-1059615,QDITZBLZQQZVEE-YBEGLDIGSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
84635,6m3m,DB06670,-7.9,Odanacatib,FWIVDMJALNEADT-SFTDATJTSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
160608,7bv1,DB08834,-7.9,Tauroursodeoxycholic acid,BHTRKEVKTKCXOH-LBSADWJPSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60327,6crv,DB08514,-7.9,"6-amino-2-[(thiophen-2-ylmethyl)amino]-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",IQKMJWDYMFWZRF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
133689,6w9c,DB02023,-7.9,8-Oxo-2'-Deoxy-Guanosine-5'-Monophosphate,AQIVLFLYHYFRKU-VPENINKCSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
133674,6w9c,DB02004,-7.9,"5-(Aminomethyl)-6-(2,4-Dichlorophenyl)-2-(3,5-Dimethoxyphenyl)Pyrimidin-4-Amine",RCJFINNFYUNFGH-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
86286,6m3m,DB08663,-7.9,4-HYDROXY-7-METHOXY-3-(1-PHENYL-PROPYL)-CHROMEN-2-ONE,CCPGCKQLIHGSCJ-AWEZNQCLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
71723,6lxt,DB15151,-7.9,RO-6870810,PKQXLRYFPSZKDU-QFIPXVFZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
158919,7bv1,DB02636,-7.9,"9-Hydroxy-8-Methoxy-6-Nitro-Phenanthrol[3,4-D][1,3]Dioxole-5-Carboxylic Acid",UCLGCTLOEZZSLA-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60321,6crv,DB08507,-7.9,N-[[2-METHYL-4-HYDROXYCARBAMOYL]BUT-4-YL-N]-BENZYL-P-[PHENYL]-P-[METHYL]PHOSPHINAMID,KGUVBHLPMGERAT-NIYFSFCBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
102921,6vxs,DB07965,-7.9,6-(cyclohexylamino)-9-[2-(4-methylpiperazin-1-yl)-ethyl]-9H-purine-2-carbonitrile,OGODDSLNRULSMM-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
133643,6w9c,DB01960,-7.9,7n-Methyl-8-Hydroguanosine-5'-Diphosphate,QQODJOAVWUWVHJ-KQYNXXCUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
130230,6w4h,DB11961,-7.9,AZD-1236,SFJFBTPHDHUUPU-OAHLLOKOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
133460,6w9c,DB01712,-7.9,"(3r)-4-(P-Toluenesulfonyl)-1,4-Thiazane-3-Carboxylicacid-L-Phenylalanine Ethyl Ester",NDDSSAGSYFVBTG-SFTDATJTSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
130341,6w4h,DB12124,-7.9,Namitecan,IBTISPLPBBHVSU-UVOOVGFISA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
102974,6vxs,DB08022,-7.9,"(2S)-1,3-benzothiazol-2-yl{2-[(2-pyridin-3-ylethyl)amino]pyrimidin-4-yl}ethanenitrile",RCYPVQCPYKNSTG-OAHLLOKOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
133331,6w9c,DB01551,-7.9,Dihydrocodeine,RBOXVHNMENFORY-DNJOTXNNSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
71629,6lxt,DB14934,-7.9,GDC-0927,KJAAPZIFCQQQKX-NDEPHWFRSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
133315,6w9c,DB01535,-7.9,Carfentanil,YDSDEBIZUNNPOB-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
84843,6m3m,DB06969,-7.9,"2-amino-4-[2,4-dichloro-5-(2-pyrrolidin-1-ylethoxy)phenyl]-N-ethylthieno[2,3-d]pyrimidine-6-carboxamide",WJUNQSYQHHIVFX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84847,6m3m,DB06973,-7.9,"4,4'-PROPANE-2,2-DIYLDIPHENOL",IISBACLAFKSPIT-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
133311,6w9c,DB01531,-7.9,Desomorphine,LNNWVNGFPYWNQE-GMIGKAJZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
71621,6lxt,DB14917,-7.9,Ceralasertib,DTTJKLNXNZAVSM-JYCIKRDWSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
59193,6crv,DB07180,-7.9,"5-[(Z)-(5-Chloro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-N,2,4-trimethyl-1H-pyrrole-3-carboxamide",FIRPCWHHIWFKCD-GHXNOFRVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
159153,7bv1,DB03495,-7.9,"4,6-Dideoxy-4-{[4,5,6-Trihydroxy-3-(Hydroxymethyl)Cyclohex-2-En-1-Yl]Amino}-Alpha-D-Lyxo-Hexopyranosyl-(1->4)-Alpha-D-Threo-Hexopyranosyl-(1->6)-Alpha-L-Threo-Hexopyranose",FZLCJZILHGFQLM-PISLJJGOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
84859,6m3m,DB06989,-7.9,{4-[2-BENZYL-3-METHOXY-2-(METHOXYCARBONYL)-3-OXOPROPYL]PHENYL}SULFAMIC ACID,SUACYXRSGYYBGT-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84861,6m3m,DB06991,-7.9,"N-[2-methyl-5-(methylcarbamoyl)phenyl]-2-{[(1R)-1-methylpropyl]amino}-1,3-thiazole-5-carboxamide",OYOUIHFZUAKCEF-LLVKDONJSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
130490,6w4h,DB12336,-7.9,GDC-0917,HSHPBORBOJIXSQ-HARLFGEKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130451,6w4h,DB12284,-7.9,LY-2608204,QIIVJLHCZUTGSD-CUBQBAPOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130506,6w4h,DB12361,-7.9,Piclozotan,URMTUEWUIGOJBW-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
84866,6m3m,DB06996,-7.9,D-leucyl-N-(4-carbamimidoylbenzyl)-L-prolinamide,XFNMDMGNNKIXBT-CVEARBPZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
160404,7bv1,DB08346,-7.9,"(5Z)-13-CHLORO-14,16-DIHYDROXY-3,4,7,8,9,10-HEXAHYDRO-1H-2-BENZOXACYCLOTETRADECINE-1,11(12H)-DIONE",YUZYDHRGGDTZLG-DUXPYHPUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
70880,6lxt,DB13347,-7.9,Diphenadione,JYGLAHSAISAEAL-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
160401,7bv1,DB08341,-7.9,"4-{[4-{[(1R,2R)-2-(dimethylamino)cyclopentyl]amino}-5-(trifluoromethyl)pyrimidin-2-yl]amino}-N-methylbenzenesulfonamide",CAUFYHKGKDJMQG-HZPDHXFCSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
71601,6lxt,DB14879,-7.9,Cefiderocol,DBPPRLRVDVJOCL-FQRUVTKNSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
133260,6w9c,DB01470,-7.9,alpha-methylthiofentanyl,YPOXDUYRRSUFFG-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
133246,6w9c,DB01455,-7.9,19-Nor-5-androstenediol,VVUQRXPUVKXAIO-XFUVECHXSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
130535,6w4h,DB12401,-7.9,Bromperidol,RKLNONIVDFXQRX-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
71594,6lxt,DB14867,-7.9,Parsaclisib,ZQPDJCIXJHUERQ-QWRGUYRKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
86156,6m3m,DB08507,-7.9,N-[[2-METHYL-4-HYDROXYCARBAMOYL]BUT-4-YL-N]-BENZYL-P-[PHENYL]-P-[METHYL]PHOSPHINAMID,KGUVBHLPMGERAT-NIYFSFCBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
133218,6w9c,DB01420,-7.9,Testosterone propionate,PDMMFKSKQVNJMI-BLQWBTBKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
160379,7bv1,DB08313,-7.9,nocodazole,KYRVNWMVYQXFEU-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
104190,6vxs,DB11636,-7.9,Nomegestrol,KZUIYQJTUIACIG-YBZCJVABSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
133794,6w9c,DB02162,-7.9,5'-O-(N-Ethyl-Sulfamoyl)Adenosine,ONCSLXAPOGUODU-WOUKDFQISA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
59188,6crv,DB07174,-7.9,"6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-4-(3-METHOXYPROPYL)-2,2-DIMETHYL-2H-1,4-BENZOXAZIN-3(4H)-ONE",WPAPODFGOZXFLG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130442,6w4h,DB12272,-7.9,Vidupiprant,PFWVGKROPKKEDW-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
133430,6w9c,DB01674,-7.9,[2-(1-Amino-2-Hydroxy-Propyl)-4-(4-Fluoro-1h-Indol-3-Ylmethyl)-5-Hydroxy-Imidazol-1-Yl]-Acetic Acid,AYMRQIHECFEMIQ-AYVTZFPOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
86242,6m3m,DB08610,-7.9,N-(2-AMINOETHYL)-2-{3-CHLORO-4-[(4-ISOPROPYLBENZYL)OXY]PHENYL} ACETAMIDE,DFXJYVQAAFOZDP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
130353,6w4h,DB12141,-7.9,Gilteritinib,GYQYAJJFPNQOOW-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
104247,6vxs,DB11721,-7.9,Mitoglitazone,IRNJSRAGRIZIHD-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
59150,6crv,DB07130,-7.9,4-BROMO-3-(CARBOXYMETHOXY)-5-PHENYLTHIOPHENE-2-CARBOXYLIC ACID,MVDWLRCTJUXCCB-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
22240,6cs2,HMDB0000121,-7.9,Folic acid,OVBPIULPVIDEAO-LBPRGKRZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
104240,6vxs,DB11706,-7.9,Raxatrigine,JESCETIFNOFKEU-SJORKVTESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
133410,6w9c,DB01644,-7.9,"3,6-dihydroxy-xanthene-9-propionic acid",PFQGLFBMMPZYEU-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
84734,6m3m,DB06836,-7.9,"N-(5-{4-Chloro-3-[(2-hydroxyethyl)sulfamoyl]phenyl}-4-methyl-1,3-thiazol-2-yl)acetamide",JFVNFXCESCXMBC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
130365,6w4h,DB12158,-7.9,Filorexant,NPFDWHQSDBWQLH-QZTJIDSGSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
133396,6w9c,DB01628,-7.9,Etoricoxib,MNJVRJDLRVPLFE-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
84742,6m3m,DB06848,-7.9,"1-(1'-{[3-(methylsulfanyl)-2-benzothiophen-1-yl]carbonyl}spiro[1-benzofuran-3,4'-piperidin]-5-yl)methanamine",VCUDZTCDUDDJGG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
159107,7bv1,DB03157,-7.9,"N,O-Didansyl-L-Tyrosine",LUBOPDUYHWABFG-NDEPHWFRSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160498,7bv1,DB08460,-7.9,"3-{5-[(6-amino-1H-pyrazolo[3,4-b]pyridin-3-yl)methoxy]-2-chlorophenoxy}-5-chlorobenzonitrile",KXDIHAQCVNNLIB-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
70846,6lxt,DB13308,-7.9,Oxametacin,AJRNYCDWNITGHF-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
133375,6w9c,DB01605,-7.9,Pivmecillinam,NPGNOVNWUSPMDP-HLLBOEOZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
12181,6lzg,DB13003,-7.9,Cortivazol,RKHQGWMMUURILY-UHRZLXHJSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
133367,6w9c,DB01595,-7.9,Nitrazepam,KJONHKAYOJNZEC-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
26312,6cs2,DB04429,-7.9,4'-Hydroxyflavanone,ZLHVIYHWWQYJID-HNNXBMFYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
12182,6lzg,DB13004,-7.9,Mavoglurant,ZFPZEYHRWGMJCV-ZHALLVOQSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
130413,6w4h,DB12233,-7.9,Iguratimod,ANMATWQYLIFGOK-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130414,6w4h,DB12234,-7.9,BMS-214662,OLCWFLWEHWLBTO-HSZRJFAPSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130420,6w4h,DB12241,-7.9,TAK-733,RCLQNICOARASSR-SECBINFHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
103002,6vxs,DB08055,-7.9,"N-(2-chlorophenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine",NNBICZMPIJMWGC-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104219,6vxs,DB11679,-7.9,Fruquintinib,BALLNEJQLSTPIO-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
86204,6m3m,DB08562,-7.9,4-(4-STYRYL-PHENYLCARBAMOYL)-BUTYRIC ACID,FTXJWRRYLLRFMG-MDZDMXLPSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84744,6m3m,DB06850,-7.9,(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclohexylamino)ethanoyl)pyrrolidine-2-carboxamide,RYKFVFFOIYLADT-SFHVURJKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59051,6crv,DB07019,-7.9,"N-[(5R,14R)-5-AMINO-5,14-DIMETHYL-4-OXO-3-OXA-18-AZATRICYCLO[15.3.1.1-7,11-]DOCOSA-1(21),7(22),8,10,17,19-HEXAEN-19-YL]-N-METHYLMETHANESULFONAMIDE",QWDOKZPZLWNULU-MZNJEOGPSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130146,6w4h,DB11833,-7.9,Basimglurant,UPZWINBEAHDTLA-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
35021,1r42,DB01051,-7.9,Novobiocin,YJQPYGGHQPGBLI-KGSXXDOSSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
25453,6cs2,DB03376,-7.9,'5'-O-(N-(L-Alanyl)-Sulfamoyl)Adenosine,CWWYMWDIYBJVLP-YTMOPEAISA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
12031,6lzg,DB12776,-7.9,E-6005,BBTFKAOFCSOZMB-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
70682,6lxt,DB13036,-7.9,Ramatroban,LDXDSHIEDAPSSA-OAHLLOKOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
129614,6w4h,DB09047,-7.9,Finafloxacin,FYMHQCNFKNMJAV-HOTGVXAUSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
129624,6w4h,DB09063,-7.9,Ceritinib,VERWOWGGCGHDQE-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
84349,6m3m,DB05659,-7.9,Faropenem medoxomil,JQBKWZPHJOEQAO-DVPVEWDBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86416,6m3m,DB08811,-7.9,Tofisopam,RUJBDQSFYCKFAA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
22426,6cs2,HMDB0053912,-7.9,"TG(20:3n6/22:4(7Z,10Z,13Z,16Z)/20:4(8Z,11Z,14Z,17Z))",OIHKRHQEBBJGMC-ZZIBGWPQSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
129656,6w4h,DB09119,-7.9,Eslicarbazepine acetate,QIALRBLEEWJACW-INIZCTEOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
158626,7bv1,DB01713,-7.9,Udp-Alpha-D-Xylopyranose,DQQDLYVHOTZLOR-OCIMBMBZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
71856,6lxt,DB15418,-7.9,AZD-9977,MBKYLPOPYYLTNW-ZDUSSCGKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
26517,6cs2,DB04664,-7.9,Cyclohexyl-pentyl-maltoside,RVTGFZGNOSKUDA-ZNGNCRBCSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
160945,7bv1,DB12302,-7.9,CP-724714,LLVZBTWPGQVVLW-SNAWJCMRSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
58879,6crv,DB06803,-7.9,Niclosamide,RJMUSRYZPJIFPJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
102729,6vxs,DB07743,-7.9,"S-[5-(TRIFLUOROMETHYL)-4H-1,2,4-TRIAZOL-3-YL] 5-(PHENYLETHYNYL)FURAN-2-CARBOTHIOATE",VNGWUVBXUIDQTK-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
60501,6crv,DB08725,-7.9,"(S)-5-(7-(4-(4-Ethyl-4,5-dihydro-2-oxazolyl)phenoxy)heptyl)-3-methylisoxazole",PZDSRPCFNWOUFP-IBGZPJMESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104471,6vxs,DB12052,-7.9,Icariin,TZJALUIVHRYQQB-XLRXWWTNSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
160907,7bv1,DB12252,-7.9,PG-701,OKRSVUYYCJPECG-LFGMFVMYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
84399,6m3m,DB05974,-7.9,Transcrocetinate,PANKHBYNKQNAHN-MQQNZMFNSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
6232,6lzg,DB01764,-7.9,Dalfopristin,SUYRLXYYZQTJHF-VMBLUXKRSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
129722,6w4h,DB09219,-7.9,Bisoxatin,BPKUDUSVDVLOPY-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
129724,6w4h,DB09223,-7.9,Blonanserin,XVGOZDAJGBALKS-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
160894,7bv1,DB11878,-7.9,Filibuvir,SLVAPEZTBDBAPI-GDLZYMKVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
84411,6m3m,DB06106,-7.9,AIT-034,FBVDVFULNXWYRF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
129727,6w4h,DB09226,-7.9,RP-5063,PMKMNTBZJOXTJW-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
129738,6w4h,DB09238,-7.9,Manidipine,ANEBWFXPVPTEET-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
158638,7bv1,DB01732,-7.9,"(4r,5s,6s,7r)-1,3-Dibenzyl-4,7-Bis(Phenoxymethyl)-5,6-Dihydroxy-1,3 Diazepan-2-One",SQBOSZXDOHQFAA-ZRTHHSRSSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
26493,6cs2,DB04639,-7.9,Biphenylalanine,JCZLABDVDPYLRZ-AWEZNQCLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
160947,7bv1,DB12305,-7.9,Dasotraline,SRPXSILJHWNFMK-MEDUHNTESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
84336,6m3m,DB05585,-7.9,Verubulin,SNHCRNMVYDHVDT-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58793,6crv,DB06652,-7.9,Vicriviroc,CNPVJJQCETWNEU-CYFREDJKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
160997,7bv1,DB12379,-7.9,Indirubin,CRDNMYFJWFXOCH-BUHFOSPRSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
17759,6cs2,HMDB0010340,-7.9,Retinyl beta-glucuronide,IYHVRAMISWFIRU-GMBUFXMQSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
60546,6crv,DB08773,-7.9,RALOXIFENE CORE,MDGWZLQPNOETLH-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
102681,6vxs,DB07686,-7.9,"4-{[5-(CYCLOHEXYLAMINO)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE",VPOGRVWIIVMWRI-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
160987,7bv1,DB12364,-7.9,Betrixaban,XHOLNRLADUSQLD-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
86487,6m3m,DB08933,-7.9,Luliconazole,YTAOBBFIOAEMLL-REQDGWNSSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
12017,6lzg,DB00972,-7.9,Azelastine,MBUVEWMHONZEQD-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
84281,6m3m,DB05289,-7.9,Tarenflurbil,SYTBZMRGLBWNTM-SNVBAGLBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
129529,6w4h,DB08934,-7.9,Sofosbuvir,TTZHDVOVKQGIBA-IQWMDFIBSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
17757,6cs2,HMDB0000494,-7.9,Stigmastanol,LGJMUZUPVCAVPU-KZXGMYDKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
134589,6w9c,DB03272,-7.9,4-Bromo-3-(5'-Carboxy-4'-Chloro-2'-Fluorophenyl)-1-Methyl-5-Trifluoromethyl-Pyrazol,YNMHKERYELPEEF-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
104520,6vxs,DB12122,-7.9,Figopitant,HUTHJVYJUPXHDF-DEOSSOPVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
35134,1r42,DB01180,-7.9,Rescinnamine,SZLZWPPUNLXJEA-LAFLMMDJSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
160966,7bv1,DB12327,-7.9,Salvinorin A,OBSYBRPAKCASQB-AGQYDFLVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
12023,6lzg,DB12764,-7.9,ABC-294640,CAOTVXGYTWCKQE-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
86464,6m3m,DB08895,-7.9,Tofacitinib,UJLAWZDWDVHWOW-YPMHNXCESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86462,6m3m,DB08892,-7.9,Arbaclofen Placarbil,JXTAALBWJQJLGN-KSSFIOAISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
28719,6cs2,DB08325,-7.9,2-(2-HYDROXYETHYLAMINO)-6-(3-CHLOROANILINO)-9-ISOPROPYLPURINE,XZEFMZCNXDQXOZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
129562,6w4h,DB08975,-7.9,Florantyrone,QOBAOSCOLAGPKI-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
60532,6crv,DB08757,-7.9,5-(2-chlorophenyl)furan-2-carbohydrazide,XQMRHWSGTVEDFG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104526,6vxs,DB12129,-7.9,Tideglusib,PMJIHLSCWIDGMD-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104522,6vxs,DB12124,-7.9,Namitecan,IBTISPLPBBHVSU-UVOOVGFISA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
26535,6cs2,DB04690,-7.9,Camptothecin,VSJKWCGYPAHWDS-FQEVSTJZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
58839,6crv,DB06731,-7.9,Seproxetine,WIQRCHMSJFFONW-HNNXBMFYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60526,6crv,DB08750,-7.9,"1-[4-(AMINOMETHYL)BENZOYL]-5'-FLUORO-1'H-SPIRO[PIPERIDINE-4,2'-QUINAZOLIN]-4'-AMINE",SFPCNWQWKOUNRT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
17751,6cs2,HMDB0010318,-7.9,Pregnanediol-3-glucuronide,ZFFFJLDTCLJDHL-JQYCEVDMSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
84920,6m3m,DB07055,-7.9,"2-[2-(1H-tetrazol-5-yl)ethyl]-1H-isoindole-1,3(2H)-dione",DEOJDUHRJBKATO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
129760,6w4h,DB09274,-7.9,Artesunate,FIHJKUPKCHIPAT-AHIGJZGOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
58928,6crv,DB06874,-7.9,"(6-[4-(AMINOMETHYL)-2,6-DIMETHYLPHENOXY]-2-{[4-(AMINOMETHYL)PHENYL]AMINO}-5-BROMOPYRIMIDIN-4-YL)METHANOL",LSIZSSASMKSUIU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130001,6w4h,DB11616,-7.9,Pirarubicin,KMSKQZKKOZQFFG-YXRRJAAWSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
160794,7bv1,DB11736,-7.9,PF-00489791,ZUHZNKJIJDAJFD-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160790,7bv1,DB11730,-7.9,Ribociclib,RHXHGRAEPCAFML-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
70755,6lxt,DB13158,-7.9,Clobetasone,XXIFVOHLGBURIG-OZCCCYNHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
160782,7bv1,DB11259,-7.9,Diosmetin,MBNGWHIJMBWFHU-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
134020,6w9c,DB02463,-7.9,2-(2-Hydroxy-Phenyl)-1h-Indole-5-Carboxamidine,JPGNPKIYCTXJPG-UHFFFAOYSA-O,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
134012,6w9c,DB02452,-7.9,Thymidine-5'-Triphosphate,NHVNXKFIZYSCEB-XLPZGREQSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
130048,6w4h,DB11692,-7.9,Pavinetant,QYTBBBAHNIWFOD-NRFANRHFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
102811,6vxs,DB07834,-7.9,"N-(cyclopropylmethyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-4-carboxamide",FOHZGCHKLPIBBX-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
130057,6w4h,DB11704,-7.9,Adomeglivant,FASLTMSUPQDLIB-MHZLTWQESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
102818,6vxs,DB07843,-7.9,5-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1-BENZOTHIOPHENE-2-SULFONAMIDE,LTJNKFUIOOJXNJ-WFASDCNBSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102822,6vxs,DB07848,-7.9,5-Chloro-N-{(3S)-1-[(2S)-1-(4-morpholinyl)-1-oxo-2-propanyl]-2-oxo-3-pyrrolidinyl}-1H-indole-2-sulfonamide,BHNMMFGOJRIAEZ-LRDDRELGSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
134042,6w9c,DB02491,-7.9,4-[4-(1-Amino-1-Methylethyl)Phenyl]-5-Chloro-N-[4-(2-Morpholin-4-Ylethyl)Phenyl]Pyrimidin-2-Amine,CJSSYVIHFXDFFC-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
130059,6w4h,DB11706,-7.9,Raxatrigine,JESCETIFNOFKEU-SJORKVTESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
70764,6lxt,DB13177,-7.9,4-methylumbelliferyl beta-D-glucoside,YUDPTGPSBJVHCN-YMILTQATSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
130067,6w4h,DB11725,-7.9,Latrepirdine,JNODQFNWMXFMEV-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
71758,6lxt,DB15221,-7.9,PF-06260414,ZKAVFOXYJCREBQ-SNVBAGLBSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
60376,6crv,DB08573,-7.9,3-[(4-CHLOROANILINO)SULFONYL]THIOPHENE-2-CARBOXYLIC ACID,YRWKEEDITQJPCZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60369,6crv,DB08562,-7.9,4-(4-STYRYL-PHENYLCARBAMOYL)-BUTYRIC ACID,FTXJWRRYLLRFMG-MDZDMXLPSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
160722,7bv1,DB09371,-7.9,Norethynodrel,ICTXHFFSOAJUMG-SLHNCBLASA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
133912,6w9c,DB02322,-7.9,Heparin Disaccharide I-S,LRPGJWKAYQRIAQ-GYBHJADLSA-J,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
130114,6w4h,DB11792,-7.9,Mirodenafil,MIJFNYMSCFYZNY-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
59042,6crv,DB07007,-7.9,"(3R)-3-[(1,2,3,4-tetrahydroisoquinolin-7-yloxy)methyl]-2,3-dihydrothieno[2,3-f][1,4]oxazepin-5-amine",UDFXWCLBONUMNA-CYBMUJFWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
158869,7bv1,DB02567,-7.9,PD173955,VAARYSWULJUGST-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
84577,6m3m,DB06530,-7.9,Resiquimod,BXNMTOQRYBFHNZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
60353,6crv,DB08544,-7.9,(S)-Fluoxetine,RTHCYVBBDHJXIQ-INIZCTEOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
102829,6vxs,DB07856,-7.9,6-{4-[4-(4-CHLOROPHENYL)PIPERIDIN-4-YL]PHENYL}-9H-PURINE,HPWBHQIUIBFTQC-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
12061,6lzg,DB12823,-7.9,Tecarfarin,QFLNTQDOVCLQKW-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
26435,6cs2,DB04571,-7.9,Trioxsalen,FMHHVULEAZTJMA-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
86344,6m3m,DB08733,-7.9,"(2R,3R)-N^1^-[(1S)-2,2-DIMETHYL-1-(METHYLCARBAMOYL)PROPYL]-N^4^-HYDROXY-2-(2-METHYLPROPYL)-3-{[(1,3-THIAZOL-2-YLCARBONYL)AMINO]METHYL}BUTANEDIAMIDE",GAHIXYNNFMCKFQ-HZSPNIEDSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58942,6crv,DB06889,-7.9,"3-(1H-tetrazol-5-ylmethyl)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(3H)-one",QSBQXAOOVSQABJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
26470,6cs2,DB04610,-7.9,"7,8-dihydro-6-hydroxymethyl-7-methyl-7-[2-phenylethyl]-pterin",XMFJTCGUDFSWSW-INIZCTEOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
134312,6w9c,DB02905,-7.9,"Phosphoric Acid Mono-[3,4-Dihydroxy-5-(5-Hydroxy-Benzoimidazol-1-Yl)Tetrahydro-Furan-2-Ylmethyl] Ester",BVZASCINAVSQNO-PULFBKJNSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
134310,6w9c,DB02902,-7.9,3'-Phosphate-Adenosine-5'-Phosphate Sulfate,GACDQMDRPRGCTN-KQYNXXCUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
60473,6crv,DB08694,-7.9,"9-amino-5-(2-aminopyrimidin-4-yl)pyrido[3',2':4,5]pyrrolo[1,2-c]pyrimidin-4-ol",RTHKPHCVZVYDFN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
160858,7bv1,DB11824,-7.9,Tofogliflozin,VWVKUNOPTJGDOB-BDHVOXNPSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
86382,6m3m,DB08774,-7.9,"1-[(2S)-4-(5-phenyl-1H-pyrazolo[3,4-b]pyridin-4-yl)morpholin-2-yl]methanamine",YBRZCAKSBYWZTC-ZDUSSCGKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
35086,1r42,DB01126,-7.9,Dutasteride,JWJOTENAMICLJG-QWBYCMEYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
26468,6cs2,DB04608,-7.9,"9-HYDROXY-4-PHENYL-6H-PYRROLO[3,4-C]CARBAZOLE-1,3-DIONE",IAUZTOZLTFSMIE-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
102768,6vxs,DB07788,-7.9,"(3R,5Z,8S,9S,11E)-8,9,16-TRIHYDROXY-14-METHOXY-3-METHYL-3,4,9,10-TETRAHYDRO-1H-2-BENZOXACYCLOTETRADECINE-1,7(8H)-DIONE",NEQZWEXWOFPKOT-QHSZRYGNSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
12072,6lzg,DB12843,-7.9,Oleandrin,JLPDBLFIVFSOCC-XYXFTTADSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
129915,6w4h,DB11409,-7.9,Febantel,HMCCXLBXIJMERM-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
134053,6w9c,DB02504,-7.9,[3-(1-Benzyl-3-Carbamoylmethyl-2-Methyl-1h-Indol-5-Yloxy)-Propyl-]-Phosphonic Acid,AQEYCNKFBRLUOT-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
16505,6cs2,HMDB0002409,-7.9,"N-[(3a,5b,7b)-7-hydroxy-24-oxo-3-(sulfooxy)cholan-24-yl]-Glycine",DKXXSIJHWWVNMO-XROMFQGDSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
102775,6vxs,DB07795,-7.9,Fisetin,XHEFDIBZLJXQHF-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
71803,6lxt,DB15307,-7.9,Atabecestat,VLLFGVHGKLDDLW-SFHVURJKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
12085,6lzg,DB12867,-7.9,Benperidol,FEBOTPHFXYHVPL-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
104408,6vxs,DB11957,-7.9,Idalopirdine,YBAWYTYNMZWMMJ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
134134,6w9c,DB02610,-7.9,"N-(2,3,4,5,6-Pentaflouro-Benzyl)-4-Sulfamoyl-Benzamide",LRKSHOLYETXPGY-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
84456,6m3m,DB06211,-7.9,Doripenem,AVAACINZEOAHHE-VFZPANTDSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84459,6m3m,DB06217,-7.9,Vernakalant,VBHQKCBVWWUUKN-KZNAEPCWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
160813,7bv1,DB11764,-7.9,Spebrutinib,KXBDTLQSDKGAEB-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
12087,6lzg,DB12869,-7.9,Eliprodil,GGUSQTSTQSHJAH-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
160807,7bv1,DB11753,-7.9,Rifamycin,HJYYPODYNSCCOU-ODRIEIDWSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
134094,6w9c,DB02554,-7.9,"Sulfoquinovose-Uridine-C1,5'-Diphosphate",FQANCGQCBCUSMI-JZMIEXBBSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
129972,6w4h,DB11522,-7.9,Isoflupredone,WAIJIHDWAKJCBX-BULBTXNYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
102773,6vxs,DB07793,-7.9,"(2S)-N-[(3S)-1-(2-AMINO-2-OXOETHYL)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL]-2-CHLORO-2H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE",ACSGSLPOHKRZCY-GXTWGEPZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
130547,6w4h,DB12416,-7.9,VTP-27999,NXWASIVXQMMPLM-ZXMXYHOLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
59237,6crv,DB07233,-7.9,N-{[4-(but-2-yn-1-yloxy)phenyl]sulfonyl}-5-methyl-D-tryptophan,SFVPXERGVLDWIS-OAQYLSRUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
103052,6vxs,DB08111,-7.9,"4-[(6-phenyl[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl]phenol",ZGJYGQLGSXWEMY-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
71378,6lxt,DB14097,-7.9,13-cis-12-(3'-Carboxyphenyl)retinoic acid,XKKDQOHDTASHCE-PAZAWXFKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
131473,6w4h,DB13790,-7.9,Fipexide,BFUJHVVEMMWLHC-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
132435,6w9c,DB00425,-7.9,Zolpidem,ZAFYATHCZYHLPB-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
85727,6m3m,DB07995,-7.9,N-[2-(4-BROMOCINNAMYLAMINO)ETHYL]-5-ISOQUINOLINE SULFONAMIDE,ZKZXNDJNWUTGDK-NSCUHMNNSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
160013,7bv1,DB07187,-7.9,6-[(5-CHLORO-3-METHYL-1-BENZOFURAN-2-YL)SULFONYL]PYRIDAZIN-3(2H)-ONE,FXFPQPNUMWQRAO-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
132428,6w9c,DB00417,-7.9,Phenoxymethylpenicillin,BPLBGHOLXOTWMN-MBNYWOFBSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
34715,1r42,DB00696,-7.9,Ergotamine,XCGSFFUVFURLIX-VFGNJEKYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
132427,6w9c,DB00415,-7.9,Ampicillin,AVKUERGKIZMTKX-NJBDSQKTSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
59590,6crv,DB07644,-7.9,"5-[(1S)-1-(3-chlorophenyl)ethoxy]quinazoline-2,4-diamine",IDHINEMSCUFEIP-VIFPVBQESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
103721,6vxs,DB08951,-7.9,Indoprofen,RJMIEHBSYVWVIN-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
131504,6w4h,DB13828,-7.9,Cyfluthrin,QQODLKZGRKWIFG-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
26041,6cs2,DB04098,-7.9,Balanol,XYUFCXJZFZPEJD-PGRDOPGGSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
85352,6m3m,DB07556,-7.9,N-HYDROXY-2(R)-[[(4-METHOXYPHENYL)SULFONYL](3-PICOLYL)AMINO]-3-METHYLBUTANAMIDE HYDROCHLORIDE,BSIZUMJRKYHEBR-QGZVFWFLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59598,6crv,DB07652,-7.9,"1-[2-DEOXYRIBOFURANOSYL]-2,4-DIFLUORO-5-METHYL-BENZENE-5'MONOPHOSPHATE",NMMWBGNJJMNAIJ-QJPTWQEYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
103707,6vxs,DB08931,-7.9,Riociguat,WXXSNCNJFUAIDG-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
103370,6vxs,DB08498,-7.9,"(1S)-1-(3-chlorophenyl)-2-oxo-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate",OVSAMUIBGQSLDC-INIZCTEOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
159678,7bv1,DB05239,-7.9,Cobimetinib,BSMCAPRUBJMWDF-KRWDZBQOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
16897,6cs2,HMDB0005017,-7.9,Pantoprazole,IQPSEEYGBUAQFF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
103700,6vxs,DB08916,-7.9,Afatinib,ULXXDDBFHOBEHA-CWDCEQMOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
103699,6vxs,DB08915,-7.9,Aleglitazar,DAYKLWSKQJBGCS-NRFANRHFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
159985,7bv1,DB07156,-7.9,"(4Z)-6-bromo-4-({[4-(pyrrolidin-1-ylmethyl)phenyl]amino}methylidene)isoquinoline-1,3(2H,4H)-dione",JFEKAVPMVOLVTH-UNOMPAQXSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
71149,6lxt,DB13710,-7.9,Metenolone,ANJQEDFWRSLVBR-VHUDCFPWSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
85416,6m3m,DB07633,-7.9,octyl 3-deoxy-2-O-(6-deoxy-alpha-L-galactopyranosyl)-beta-D-xylo-hexopyranoside,FBVFDKBCZLMLQT-PPCMOIRNSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
71340,6lxt,DB14029,-7.9,Furafylline,HMZQULPVMKITSP-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
103389,6vxs,DB08521,-7.9,4-[5-(4-FLUORO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-3H-IMIDAZOL-4-YL]-PYRIDINE,CDMGBJANTYXAIV-HHHXNRCGSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
103406,6vxs,DB08539,-7.9,"3-cyclopropyl-5-phenyl-N-(pyridin-3-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",CCDIUVLNHCGSMH-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
71361,6lxt,DB14067,-7.9,Dofequidar,KLWUUPVJTLHYIM-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
159969,7bv1,DB07138,-7.9,Neflamapimod,VEPKQEUBKLEPRA-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
103363,6vxs,DB08491,-7.9,N-HYDROXY-2-[4-(4-PHENOXY-BENZENESULFONYL)-TETRAHYDRO-PYRAN-4-YL]-ACETAMIDE,ARIRIZBKMKMEBD-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
132455,6w9c,DB00448,-7.9,Lansoprazole,MJIHNNLFOKEZEW-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
159589,7bv1,DB04609,-7.9,INHIBITOR Q8467 OF DUPONT MERCK,HFLCERPZYCWLSZ-VKONIRKNSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
131319,6w4h,DB13586,-7.9,Metandienone,XWALNWXLMVGSFR-HLXURNFRSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
103828,6vxs,DB09095,-7.9,Difluocortolone,OGPWIDANBSLJPC-RFPWEZLHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
85283,6m3m,DB07476,-7.9,N-[4-(AMINOSULFONYL)PHENYL]-2-MERCAPTOBENZAMIDE,MRLVIVXGUGNENL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
25793,6cs2,DB00448,-7.9,Lansoprazole,MJIHNNLFOKEZEW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
71094,6lxt,DB13638,-7.9,Cefbuperazone,SMSRCGPDNDCXFR-CYWZMYCQSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
85287,6m3m,DB07480,-7.9,4-PHOSPHONOOXY-PHENYL-METHYL-[4-PHOSPHONOOXY]BENZEN,LGSCVLKUKMBYNC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59951,6crv,DB08061,-7.9,4-[3-(4-CHLOROPHENYL)-1H-PYRAZOL-5-YL]PIPERIDINE,GELALLNTKKLQLM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
160066,7bv1,DB07471,-7.9,"5-[5,6-BIS(METHYLOXY)-1H-BENZIMIDAZOL-1-YL]-3-{[1-(2-CHLOROPHENYL)ETHYL]OXY}-2-THIOPHENECARBOXAMIDE",UHCHLTQBLNUYRT-GFCCVEGCSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59506,6crv,DB07543,-7.9,(2S)-1-(9H-Carbazol-4-yloxy)-3-(isopropylamino)propan-2-ol,BQXQGZPYHWWCEB-ZDUSSCGKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
159610,7bv1,DB04908,-7.9,Flibanserin,PPRRDFIXUUSXRA-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59522,6crv,DB07562,-7.9,"N-[4-(2,4-DIMETHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YL]-N',N'-DIMETHYL-BENZENE-1,4-DIAMINE",FGGSNQOBRJVAKL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85347,6m3m,DB07549,-7.9,"2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUORO-3-METHYL-6-PYRIDINYL)METHYL]ACETAMIDE",WOYBPRBUPLYTPY-UHFFFAOYSA-P,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
132501,6w9c,DB00502,-7.9,Haloperidol,LNEPOXFFQSENCJ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
131399,6w4h,DB13687,-7.9,Niaprazine,RSKQGBFMNPDPLR-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
159628,7bv1,DB04954,-7.9,Tecadenoson,OESBDSFYJMDRJY-BAYCTPFLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
131412,6w4h,DB13710,-7.9,Metenolone,ANJQEDFWRSLVBR-VHUDCFPWSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
132490,6w9c,DB00490,-7.9,Buspirone,QWCRAEMEVRGPNT-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
132471,6w9c,DB00469,-7.9,Tenoxicam,LZNWYQJJBLGYLT-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
59553,6crv,DB07602,-7.9,S-{3-[(4-ANILINOQUINAZOLIN-6-YL)AMINO]-3-OXOPROPYL}-L-CYSTEINE,NLVZTRZPMRTVRC-INIZCTEOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
103360,6vxs,DB08488,-7.9,"4-{[(E)-2-(5-CHLOROTHIEN-2-YL)VINYL]SULFONYL}-1-(1H-PYRROLO[3,2-C]PYRIDIN-2-YLMETHYL)PIPERAZIN-2-ONE",PLWVUIRWJVKSSD-XBXARRHUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
59564,6crv,DB07615,-7.9,Tranilast,NZHGWWWHIYHZNX-CSKARUKUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
25824,6cs2,DB03837,-7.9,Morpholine-4-Carboxylic Acid (1-(3-Benzenesulfonyl-1-Phenethylallylcarbamoyl)-3-Methylbutyl)-Amide,YUMYYTORLYHUFW-ZUDLOMHPSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
131454,6w4h,DB13766,-7.9,Lidoflazine,ZBIAKUMOEKILTF-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
59913,6crv,DB08018,-7.9,"N-{(3S,4S)-4-[(6-AMINO-4-METHYLPYRIDIN-2-YL)METHYL]PYRROLIDIN-3-YL}-N'-(4-CHLOROBENZYL)ETHANE-1,2-DIAMINE",JDRSQGJWTVRNGM-QFBILLFUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
17091,6cs2,HMDB0006225,-7.9,Ercalcitriol,ZGLHBRQAEXKACO-XJRQOBMKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
103346,6vxs,DB08470,-7.9,"3-(4-fluorophenyl)-5-phenyl-4H-1,2,4-triazole",KMGPJKOKSYGMJD-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
159587,7bv1,DB04607,-7.9,"PHENYLAMINOIMIDAZO(1,2-ALPHA)PYRIDINE",UQAWGIKJINAKIZ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
132348,6w9c,DB00318,-7.9,Codeine,OROGSEYTTFOCAN-DNJOTXNNSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
132341,6w9c,DB00310,-7.9,Chlorthalidone,JIVPVXMEBJLZRO-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
132142,6w4h,DB01532,-7.9,alpha-Methylacetylfentanyl,OKTLVZBUKMRPLL-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
159769,7bv1,DB06506,-7.9,Repinotan,YGYBFMRFXNDIPO-QGZVFWFLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
25969,6cs2,DB00469,-7.9,Tenoxicam,LZNWYQJJBLGYLT-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
25968,6cs2,DB04010,-7.9,2-(3'-Methoxyphenyl) Benzimidazole-4-Carboxamide,NVVWVYYHTKCIAE-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
131812,6w4h,DB14761,-7.9,Remdesivir,RWWYLEGWBNMMLJ-YSOARWBDSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131833,6w4h,DB14802,-7.9,ONO-2952,ZBQMTQGDBFZUBG-NRFANRHFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
103586,6vxs,DB08753,-7.9,"4-{(1E)-3-OXO-3-[(2-PHENYLETHYL)AMINO]PROP-1-EN-1-YL}-1,2-PHENYLENE DIACETATE",GARHCDOTUULBOQ-PKNBQFBNSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
131868,6w4h,DB14885,-7.9,PF-05180999,CLGCHUKGBICQTE-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
103572,6vxs,DB08739,-7.9,"2-{3-[(2S)-4,4-difluoro-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]-3-oxopropyl}-isoindole-1,3(2H)-dione",ZSXNPAWXICXNGZ-HNNXBMFYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
71223,6lxt,DB13806,-7.9,Linopirdine,YEJCDKJIEMIWRQ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
85519,6m3m,DB07757,-7.9,"(9aS)-4-bromo-9a-butyl-7-hydroxy-1,2,9,9a-tetrahydro-3H-fluoren-3-one",FTEBGBCQCYMDPH-KRWDZBQOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59783,6crv,DB07867,-7.9,6-CHLORO-4-(CYCLOHEXYLOXY)-3-PROPYLQUINOLIN-2(1H)-ONE,BNZHKKGOSYAQSW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59684,6crv,DB07757,-7.9,"(9aS)-4-bromo-9a-butyl-7-hydroxy-1,2,9,9a-tetrahydro-3H-fluoren-3-one",FTEBGBCQCYMDPH-KRWDZBQOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
71272,6lxt,DB13872,-7.9,Lormetazepam,FJIKWRGCXUCUIG-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
85522,6m3m,DB07760,-7.9,"3-[(1E,7E)-8-(2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)-3,6-dioxa-2,7-diazaocta-1,7-dien-1-yl]benzoic acid",TUYDQQMKXSQIQG-GONBZBRSSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85608,6m3m,DB07857,-7.9,(2R)-2-(4-chlorophenyl)-2-[4-(1H-pyrazol-4-yl)phenyl]ethanamine,HWVGILTYGZFGLR-QGZVFWFLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59725,6crv,DB07803,-7.9,2-phenyl-1H-imidazole-4-carboxylic acid,XCAXKZJNJCKTQH-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
159842,7bv1,DB06680,-7.9,Asoprisnil,GJMNAFGEUJBOCE-MEQIQULJSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
85536,6m3m,DB07776,-7.9,Flavone,VHBFFQKBGNRLFZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
159804,7bv1,DB06597,-7.9,Estradiol sulfamate,YXYXCSOJKUAPJI-ZBRFXRBCSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59760,6crv,DB07842,-7.9,(2S)-2-(4-ethylphenoxy)-3-phenylpropanoic acid,CJMVTSLLWMPEKQ-INIZCTEOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
25921,6cs2,DB03950,-7.9,(S)-N-(3-Indol-1-Yl-2-Methyl-Propyl)-4-Sulfamoyl-Benzamide,ZFWHOUCRVSOZJE-AWEZNQCLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
59753,6crv,DB07833,-7.9,"N-(3-cyanophenyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)-4-biphenylcarboxamide",PMMLSQFPBFKLHH-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85577,6m3m,DB07820,-7.9,"6-(3',5'-DIMETHYLBENZYL)-1-ETHOXYMETHYL-5-ISOPROPYLURACIL",NVGVZWUORYLPAL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
103538,6vxs,DB08704,-7.9,"[[(3R,4R,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-(pentanoylamino)oxan-2-ylidene]amino] N-phenylcarbamate",NUNQIQQEEPOGDJ-JDOAOKHLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
131989,6w4h,DB15157,-7.9,Voruciclib,MRPGRAKIAJJGMM-OCCSQVGLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
59780,6crv,DB07864,-7.9,4-[(CYCLOPROPYLETHYNYL)OXY]-6-FLUORO-3-ISOPROPYLQUINOLIN-2(1H)-ONE,YVJFHKQYMKKIHK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
103681,6vxs,DB08883,-7.9,Perampanel,PRMWGUBFXWROHD-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
103468,6vxs,DB08614,-7.9,"3-[[(METHYLAMINO)SULFONYL]AMINO]-2-OXO-6-PHENYL-N-[3,3,3-TRIFLUORO-1-(1-METHYLETHYL)-2-OXOPHENYL]-1(2H)-PYRIDINE ACETAMIDE",MYFMPKCOIMRDDD-KRWDZBQOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
71205,6lxt,DB13783,-7.9,Acemetacin,FSQKKOOTNAMONP-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
159964,7bv1,DB07131,-7.9,(S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclohexylpropanoyl)pyrrolidine-2-carboxamide,DOTBZTLJSXFKCP-IBGZPJMESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59631,6crv,DB07695,-7.9,"N-(3,5-dibromo-4-hydroxyphenyl)-4-hydroxy-3,5-dimethylbenzamide",HHFKUQZPNITQLU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
159960,7bv1,DB07127,-7.9,"{4-[2,2-BIS(5-METHYL-1,2,4-OXADIAZOL-3-YL)-3-PHENYLPROPYL]PHENYL}SULFAMIC ACID",SXDBFKLPNPUPRI-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
26019,6cs2,DB04073,-7.9,N-{3-[4-(3-aminopropyl)piperazin-1-yl]propyl}-3-(beta-D-galactopyranosyloxy)-5-nitrobenzamide,UEIGEWJJVQHIAX-DLBZZEGUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
159956,7bv1,DB07123,-7.9,N-(4-METHYLBENZOYL)-4-BENZYLPIPERIDINE,DVOLWKZEIDCCES-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
103411,6vxs,DB08545,-7.9,(1R)-1-PHENYLETHYL 4-(ACETYLAMINO)BENZYLPHOSPHONATE,YPTMOJMDCPUCJT-ZDUSSCGKSA-M,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
132329,6w9c,DB00295,-7.9,Morphine,BQJCRHHNABKAKU-KBQPJGBKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
71325,6lxt,DB13993,-7.9,MRK-409,GOIFCXRIFSYPFG-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
25861,6cs2,DB03882,-7.9,"5-Alpha-Androstane-3-Beta,17beta-Diol",CBMYJHIOYJEBSB-YSZCXEEOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
103420,6vxs,DB08556,-7.9,"5'-ACETYL-4-{[(2,4-DIMETHYLPHENYL)SULFONYL]AMINO}-2,2'-BITHIOPHENE-5-CARBOXYLIC ACID",CMHHNHDPPWDNAH-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
131626,6w4h,DB14069,-7.9,ONT-093,RSJCLODJSVZNQA-BQYQJAHWSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
85696,6m3m,DB07962,-7.9,"METHYL N-[(2',4'-DIFLUORO-4-HYDROXY-5-IODOBIPHENYL-3-YL)CARBONYL]-BETA-ALANINATE",ZMRRBWRMQPQQAN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59830,6crv,DB07926,-7.9,N-[3-(N'-HYDROXYCARBOXAMIDO)-2-(2-METHYLPROPYL)-PROPANOYL]-O-TYROSINE-N-METHYLAMIDE,QYZPDCGWIJYZMN-ZBFHGGJFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
26015,6cs2,DB04069,-7.9,"5,6-Dihydro-Benzo[H]Cinnolin-3-Ylamine",QKVREUJWFZJEJK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
103427,6vxs,DB08564,-7.9,(2E)-N-{4-[(3-bromophenyl)amino]quinazolin-6-yl}-4-(dimethylamino)but-2-enamide,ZCIXBBSRVLSRJQ-QPJJXVBHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
131692,6w4h,DB14217,-7.9,Quinaprilat,FLSLEGPOVLMJMN-YSSFQJQWSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
132272,6w9c,DB00231,-7.9,Temazepam,SEQDDYPDSLOBDC-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
85665,6m3m,DB07926,-7.9,N-[3-(N'-HYDROXYCARBOXAMIDO)-2-(2-METHYLPROPYL)-PROPANOYL]-O-TYROSINE-N-METHYLAMIDE,QYZPDCGWIJYZMN-ZBFHGGJFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
103437,6vxs,DB08577,-7.9,3-[(3-(2-CARBOXYETHYL)-4-METHYLPYRROL-2-YL)METHYLENE]-2-INDOLINONE,JNDVEAXZWJIOKB-JYRVWZFOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
131738,6w4h,DB14632,-7.9,Prednisolone tebutate,HUMXXHTVHHLNRO-KAJVQRHHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
59845,6crv,DB07942,-7.9,2-fluoro-4-[4-(4-fluorophenyl)-1H-pyrazol-3-yl]pyridine,YJCHZVXSPFPKMX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
131746,6w4h,DB14640,-7.9,Isoflupredone acetate,ZOCUOMKMBMEYQV-GSLJADNHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
25992,6cs2,DB04040,-7.9,"N-(2-Morpholin-4-Yl-1-Morpholin-4-Ylmethyl-Ethyl)-3-Nitro-5-(3,4,5-Trihydroxy-6-Hydroxymethyl-Tetrahydro-Pyran-2-Yloxy)-Benzamide",MCMWCTMAKPQTPI-WGNYYXNJSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
59831,6crv,DB07927,-7.9,3-[(4-Carboxy-2-hydroxyphenyl)sulfamoyl]-2-thiophenecarboxylic acid,RDPXXOOKKRIKFN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
131760,6w4h,DB14655,-7.9,Drostanolone propionate,NOTIQUSPUUHHEH-UXOVVSIBSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
159905,7bv1,DB07063,-7.9,"{3-[(4,5,7-TRIFLUORO-1,3-BENZOTHIAZOL-2-YL)METHYL]-1H-INDOL-1-YL}ACETIC ACID",KYHVTMFADJNSGS-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
159712,7bv1,DB05424,-7.9,Canertinib,OMZCMEYTWSXEPZ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
102663,6vxs,DB07665,-7.9,"N-[2-(carbamimidamidooxy)ethyl]-2-{6-cyano-3-[(2,2-difluoro-2-pyridin-2-ylethyl)amino]-2-fluorophenyl}acetamide",STHCHQXQLDMISY-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
85860,6m3m,DB08144,-7.9,"6-(2,6-dibromophenyl)pyrido[2,3-d]pyrimidine-2,7-diamine",HGIPWJYTPOHUGK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
131287,6w4h,DB13542,-7.9,Bevonium,UHUMRJKDOOEQIG-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
133030,6w9c,DB01128,-7.9,Bicalutamide,LKJPYSCBVHEWIU-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
160292,7bv1,DB07974,-7.9,1-{2-[(4-CHLOROPHENYL)AMINO]-2-OXOETHYL}-N-(1-ISOPROPYLPIPERIDIN-4-YL)-1H-INDOLE-2-CARBOXAMIDE,BDLMBQRBNPDCSS-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
86005,6m3m,DB08322,-7.9,"2-DEOXY-3,4-BIS-O-[3-(4-HYDROXYPHENYL)PROPANOYL]-L-THREO-PENTARIC ACID",VJLMRHSHSNLOGC-NOPZTHQXSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
133021,6w9c,DB01118,-7.9,Amiodarone,IYIKLHRQXLHMJQ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
130792,6w4h,DB12798,-7.9,Relenopride,KGMMSPVVHZGPHL-NRFANRHFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
160286,7bv1,DB07968,-7.9,N-(2-CHLORO-4-FLUOROBENZOYL)-N'-(5-HYDROXY-2-METHOXYPHENYL)UREA,RFOBTYLRURSVJE-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59300,6crv,DB07303,-7.9,"N-3-[3-(5-METHOXYPYRIDIN-3-YL)BENZYL]PYRIDINE-2,3-DIAMINE",PGAWZMRRCVSRIM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130831,6w4h,DB12867,-7.9,Benperidol,FEBOTPHFXYHVPL-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
103149,6vxs,DB08224,-7.9,"(1S,7S,8S,8AR)-1,2,3,7,8,8A-HEXAHYDRO-7-METHYL-8-[2-[(2R,4R)-TETRAHYDRO-4-HY DROXY-6-OXO-2H-PYRAN-2-YL]ETHYL]-1-NAPHTHALENOL",WWSNTLOVYSRDEL-TVKPWXLESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
85068,6m3m,DB07228,-7.9,1-(5-CHLORO-2-METHOXYPHENYL)-3-{6-[2-(DIMETHYLAMINO)-1-METHYLETHOXY]PYRAZIN-2-YL}UREA,GIAYFZLMPSVQDV-NSHDSACASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
132974,6w9c,DB01063,-7.9,Acetophenazine,WNTYBHLDCKXEOT-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
71534,6lxt,DB14725,-7.9,Cefamandole nafate,RRJHESVQVSRQEX-SUYBPPKGSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
130754,6w4h,DB12732,-7.9,Firategrast,YLFZHHDVRSYTKT-NRFANRHFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
103152,6vxs,DB08229,-7.9,[N-(3-DIBENZYLCARBAMOYL-OXIRANECARBONYL)-HYDRAZINO]-ACETIC ACID,JGMMFVVACJREFE-KRWDZBQOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
130853,6w4h,DB12896,-7.9,PSI-352938,PVRFQJIRERYGTQ-DSQUMVBZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
85996,6m3m,DB08313,-7.9,nocodazole,KYRVNWMVYQXFEU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
160262,7bv1,DB07940,-7.9,"9-(3-IODOBENZYLAMINO)-1,2,3,4-TETRAHYDROACRIDINE",ZUCWQTWGZGIYPV-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
26211,6cs2,DB04297,-7.9,"7-[4-(Dimethylamino)Phenyl]-N-Hydroxy-4,6-Dimethyl-7-Oxo-2,4-Heptadienamide",RTKIYFITIVXBLE-QEQCGCAPSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
130869,6w4h,DB12921,-7.9,Chlorsulfaquinoxaline,CTSNHMQGVWXIEG-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
16730,6cs2,HMDB0003990,-7.9,"3b,5a,6b-Cholestanetriol",YMMFNKXZULYSOQ-RUXQDQFYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
130876,6w4h,DB12929,-7.9,JNJ-39220675,IQOWHZHNGJXGHG-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
103184,6vxs,DB08270,-7.9,"N-(2-AMINOETHYL)-N-2-{(1S)-1-[4'-(AMINOSULFONYL)BIPHENYL-4-YL]-2,2,2-TRIFLUOROETHYL}-L-LEUCINAMIDE",QPXXBNKMAHUXBB-PMACEKPBSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
85112,6m3m,DB07279,-7.9,N-ETHYL-N-ISOPROPYL-3-METHYL-5-{[(2S)-2-(PYRIDIN-4-YLAMINO)PROPYL]OXY}BENZAMIDE,JMPSZYHYDMQFEO-KRWDZBQOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
130915,6w4h,DB12988,-7.9,LY-518674,PNHFDVSKDSLUFH-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
160236,7bv1,DB07909,-7.9,"(1S,2S,5S)2-(4-GLUTARIDYLBENZYL)-5-PHENYL-1-CYCLOHEXANOL",OBWILOKKNDYPLX-HBMCJLEFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
130936,6w4h,DB13023,-7.9,IPI-493,XYFFWTYOFPSZRM-TWNAANEASA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
132970,6w9c,DB01059,-7.9,Norfloxacin,OGJPXUAPXNRGGI-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
132893,6w9c,DB00969,-7.9,Alosetron,JSWZEAMFRNKZNL-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
130740,6w4h,DB12713,-7.9,Sotagliflozin,QKDRXGFQVGOQKS-CRSSMBPESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
71553,6lxt,DB14768,-7.9,PF-06459988,ODMXWZROLKITMS-RISCZKNCSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
25650,6cs2,DB00434,-7.9,Cyproheptadine,JJCFRYNCJDLXIK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
133170,6w9c,DB01331,-7.9,Cefoxitin,WZOZEZRFJCJXNZ-ZBFHGGJFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
103062,6vxs,DB08122,-7.9,"N-METHYL-4-{[(2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]AMINO}BENZENESULFONAMIDE",IKASAFLVQIJQOK-UVTDQMKNSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
103077,6vxs,DB08138,-7.9,"{[(2,6-difluorophenyl)carbonyl]amino}-N-(4-fluorophenyl)-1H-pyrazole-3-carboxamide",BDRDBXXWQDFXEC-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
130579,6w4h,DB12463,-7.9,Semagacestat,PKXWXXPNHIWQHW-RCBQFDQVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
86098,6m3m,DB08440,-7.9,"N-1,10-phenanthrolin-5-ylacetamide",AAJXINSCZMZERD-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
25661,6cs2,DB00436,-7.9,Bendroflumethiazide,HDWIHXWEUNVBIY-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
1544,6lzg,HMDB0011637,-7.9,Taurohyocholate,XSOLDPYUICCHJX-RBPXSRGGSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
86089,6m3m,DB08430,-7.9,PARA-NITROPHENYL 1-THIO-BETA-D-GLUCOPYRANOSIDE,IXFOBQXJWRLXMD-ZIQFBCGOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59245,6crv,DB07244,-7.9,"5-{4-[(3,5-DIFLUOROBENZYL)AMINO]PHENYL}-6-ETHYLPYRIMIDINE-2,4-DIAMINE",SRRWXMSVQYQCRX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60181,6crv,DB08339,-7.9,"6-(2,6-DICHLOROPHENYL)-2-{[3-(HYDROXYMETHYL)PHENYL]AMINO}-8-METHYLPYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE",ZIQFYVPVJZEOFS-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130631,6w4h,DB12542,-7.9,GSK-356278,AWDJJMXJUOHGLC-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
160297,7bv1,DB07981,-7.9,2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]-n-[(1R)-1-(hydroxymethyl)propyl]acetamide,GKJWXEORYGBJFS-QGZVFWFLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
130633,6w4h,DB12545,-7.9,Indobufen,AYDXAULLCROVIT-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130662,6w4h,DB12588,-7.9,AZD-1480,PDOQBOJDRPLBQU-QMMMGPOBSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
160338,7bv1,DB08024,-7.9,1-[2-(S)-AMINO-3-BIPHENYL-4-YL-PROPIONYL]-PYRROLIDINE-2-(S)-CARBONITRILE,MUUVLSCVDXKQQV-OALUTQOASA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
84985,6m3m,DB07130,-7.9,4-BROMO-3-(CARBOXYMETHOXY)-5-PHENYLTHIOPHENE-2-CARBOXYLIC ACID,MVDWLRCTJUXCCB-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86065,6m3m,DB08398,-7.9,"2-Amino-1-methyl-6-phenylimidazo(4,5-b)pyridine",UQVKZNNCIHJZLS-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
160328,7bv1,DB08014,-7.9,(METHYLPYRIDAZINE PIPERIDINE BUTYLOXYPHENYL)ETHYLACETATE,AQILFLLHLFBLLG-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
159274,7bv1,DB03672,-7.9,9-N-Phenylmethylamino-Tacrine,JYJAEHAURXXPSD-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59275,6crv,DB07277,-7.9,2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}ETHANESULFONAMIDE,IAUZEBLXCOCAFL-JSGCOSHPSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60161,6crv,DB08313,-7.9,nocodazole,KYRVNWMVYQXFEU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130709,6w4h,DB12665,-7.9,Isoquercetin,OVSQVDMCBVZWGM-QSOFNFLRSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130715,6w4h,DB12672,-7.9,Icaritin,TUUXBSASAQJECY-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
103111,6vxs,DB08173,-7.9,5-CHLORO-N-(2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO)ETHYL)THIOPHENE-2-CARBOXAMIDE,UCKHUNHXYMAFQM-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
130730,6w4h,DB12696,-7.9,BMS-582949,GDTQLZHHDRRBEB-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
26244,6cs2,DB04338,-7.9,SB220025,VSPFURGQAYMVAN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
85869,6m3m,DB08153,-7.9,"(5E)-14-CHLORO-15,17-DIHYDROXY-4,7,8,9,10,11-HEXAHYDRO-2-BENZOXACYCLOPENTADECINE-1,12(3H,13H)-DIONE",VZTAZMSAAIUZJV-HWKANZROSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59347,6crv,DB07354,-7.9,"2,3-DIMETHOXY-12H-[1,3]DIOXOLO[5,6]INDENO[1,2-C]ISOQUINOLIN-6-IUM",LXDREMZQGAILJU-UHFFFAOYSA-O,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
103210,6vxs,DB08304,-7.9,"(3R)-3-cyclopentyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2-benzothiazine 1,1-dioxide",QZBQVXXESPXFPZ-QGZVFWFLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
132724,6w9c,DB00776,-7.9,Oxcarbazepine,CTRLABGOLIVAIY-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
131197,6w4h,DB13418,-7.9,Moxestrol,MTMZZIPTQITGCY-OLGWUGKESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131208,6w4h,DB13432,-7.9,Lonazolac,XVUQHFRQHBLHQD-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
71056,6lxt,DB13586,-7.9,Metandienone,XWALNWXLMVGSFR-HLXURNFRSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
159556,7bv1,DB04566,-7.9,Inosinic Acid,GRSZFWQUAKGDAV-KQYNXXCUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
132662,6w9c,DB00701,-7.9,Amprenavir,YMARZQAQMVYCKC-OEMFJLHTSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
71458,6lxt,DB14570,-7.9,Hydroxyprogesterone,DBPWSSGDRRHUNT-CEGNMAFCSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
132642,6w9c,DB00679,-7.9,Thioridazine,KLBQZWRITKRQQV-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
85237,6m3m,DB07421,-7.9,"4-{[(1R,2S)-1,2-dihydroxy-2-methyl-3-(4-nitrophenoxy)propyl]amino}-2-(trifluoromethyl)benzonitrile",INVUBEGZQHQAMY-SJORKVTESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
160119,7bv1,DB07534,-7.9,"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE",BKUMVXIXUVYKDQ-GHXNOFRVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
103857,6vxs,DB09171,-7.9,??-Methylfentanyl,UXIGUKSHASXDNI-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
131247,6w4h,DB13487,-7.9,Iodine (131I) norcholesterol,QJHZPCLORSPENH-DRTKWHMQSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131185,6w4h,DB13403,-7.9,Oxypertine,XCWPUUGSGHNIDZ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
71447,6lxt,DB14542,-7.9,Hydrocortisone phosphate,BGSOJVFOEQLVMH-VWUMJDOOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
71446,6lxt,DB14541,-7.9,Hydrocortisone cypionate,DLVOSEUFIRPIRM-KAQKJVHQSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
159569,7bv1,DB04582,-7.9,IMAZAQUIN,CABMTIJINOIHOD-QGZVFWFLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59465,6crv,DB07496,-7.9,"1,3-DIPHENYLUREA",GWEHVDNNLFDJLR-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
71444,6lxt,DB14539,-7.9,Hydrocortisone acetate,ALEXXDVDDISNDU-JZYPGELDSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
85244,6m3m,DB07429,-7.9,2-({[4-bromo-3-(diethylsulfamoyl)phenyl]carbonyl}amino)benzoic acid,VNOMZKMKBNFCMC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
160101,7bv1,DB07513,-7.9,7-[(3-CHLOROBENZYL)OXY]-4-[(METHYLAMINO)METHYL]-2H-CHROMEN-2-ONE,JMGUSOLCNQVZCT-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59470,6crv,DB07501,-7.9,(2S)-1-{4-[(4-Anilino-5-bromo-2-pyrimidinyl)amino]phenoxy}-3-(dimethylamino)-2-propanol,MEIJADBULOETOV-KRWDZBQOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85879,6m3m,DB08163,-7.9,5'-{[4-(aminooxy)butyl](methyl)amino}-5'-deoxy-8-ethenyladenosine,XUKYGMIDWKBMIW-IWCJZZDYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85258,6m3m,DB07446,-7.9,N-(biphenyl-4-ylsulfonyl)-D-leucine,FBSVJQQVDISETN-QGZVFWFLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59471,6crv,DB07503,-7.9,"(5E)-5-[(2,2-DIFLUORO-1,3-BENZODIOXOL-5-YL)METHYLENE]-1,3-THIAZOLIDINE-2,4-DIONE",SRLVNYDXMUGOFI-YWEYNIOJSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
160090,7bv1,DB07500,-7.9,(2E)-1-[2-hydroxy-4-methoxy-5-(3-methylbut-2-en-1-yl)phenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one,ZUGCRBMNFSAUOC-YRNVUSSQSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
71071,6lxt,DB13606,-7.9,Phenazocine,ZQHYKVKNPWDQSL-KNXBSLHKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
103285,6vxs,DB08395,-7.9,2-(ETHOXYMETHYL)-4-(4-FLUOROPHENYL)-3-[2-(2-HYDROXYPHENOXY)PYRIMIDIN-4-YL]ISOXAZOL-5(2H)-ONE,ZSOXFJURLPCSOO-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
130951,6w4h,DB13048,-7.9,PAC-1,YQNRVGJCPCNMKT-LFVJCYFKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
60013,6crv,DB08130,-7.9,"N-(5-{3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]phenyl}-1,3,4-oxadiazol-2-yl)ethane-1,2-diamine",FPDWDLAITHFTTP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
103886,6vxs,DB09201,-7.9,Ciglitazone,YZFWTZACSRHJQD-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
130971,6w4h,DB13074,-7.9,Macimorelin,UJVDJAPJQWZRFR-DHIUTWEWSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130976,6w4h,DB13083,-7.9,Talarozole,SNFYYXUGUBUECJ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
59365,6crv,DB07377,-7.9,"N'-((2S,3R)-3-AMINO-2-HYDROXY-5-(ISOPROPYLSULFANYL)PENTANOYL)-N-3-CHLOROBENZOYL HYDRAZIDE",BYBVYIPUGPZRSX-OLZOCXBDSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
132874,6w9c,DB00947,-7.9,Fulvestrant,VWUXBMIQPBEWFH-WCCTWKNTSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
85142,6m3m,DB07310,-7.9,"(5S)-2-{[(1S)-1-(2-fluorophenyl)ethyl]amino}-5-methyl-5-(trifluoromethyl)-1,3-thiazol-4(5H)-one",KNHNFKZUNFPPQE-MADCSZMMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
131006,6w4h,DB13125,-7.9,Lusutrombopag,NOZIJMHMKORZBA-KJCUYJGMSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
16742,6cs2,HMDB0004068,-7.9,Melanin,XUMBMVFBXHLACL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
131007,6w4h,DB13126,-7.9,BMS-986115,SRJNRAQUSAVENA-GSHUGGBRSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
71502,6lxt,DB14661,-7.9,Loperamide oxide,KXVSBTJVTUVNPM-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
71500,6lxt,DB14659,-7.9,Melengestrol acetate,UDKABVSQKJNZBH-DWNQPYOZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
71499,6lxt,DB14657,-7.9,Paramethasone acetate,HYRKAAMZBDSJFJ-LFDBJOOHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
71497,6lxt,DB14655,-7.9,Drostanolone propionate,NOTIQUSPUUHHEH-UXOVVSIBSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
59423,6crv,DB07446,-7.9,N-(biphenyl-4-ylsulfonyl)-D-leucine,FBSVJQQVDISETN-QGZVFWFLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
103222,6vxs,DB08317,-7.9,"5-methyl-6-phenylquinazoline-2,4-diamine",HUCOXWPHDFINIW-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
131040,6w4h,DB13213,-7.9,Butaperazine,DVLBYTMYSMAKHP-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
159445,7bv1,DB04154,-7.9,"N-Methyl-N-[3-(6-Phenyl[1,2,4]Triazolo[4,3-B]Pyridazin-3-Yl)Phenyl]Acetamide",ALBWBHNFOJJMCV-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
85186,6m3m,DB07358,-7.9,"2-amino-N-(4-methyl-1,3-thiazol-2-yl)-5-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]benzamide",JEBOJMQHVUEKBE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
71488,6lxt,DB14646,-7.9,Prednisone acetate,MOVRKLZUVNCBIP-RFZYENFJSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
160182,7bv1,DB07612,-7.9,6-(3-AMINOPHENYL)-N-(TERT-BUTYL)-2-(TRIFLUOROMETHYL)QUINAZOLIN-4-AMINE,XQKJVNGGVLHNLA-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
159450,7bv1,DB04432,-7.9,ZK-805623,ZXIHYCYAQUQHSG-UHFFFAOYSA-O,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59384,6crv,DB07400,-7.9,1-ETHOXYCARBONYL-D-PHE-PRO-2(4-AMINOBUTYL)HYDRAZINE,AEHSFPPTWRQOFS-MSOLQXFVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85935,6m3m,DB08235,-7.9,N-[2-(2-methyl-1H-indol-3-yl)ethyl]thiophene-2-carboxamide,ACAKNPKRLPMONU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85926,6m3m,DB08223,-7.9,"N-{(1S,2R)-1-BENZYL-3-[(CYCLOPROPYLMETHYL)(2-FURYLSULFONYL)AMINO]-2-HYDROXYPROPYL}-N'-METHYLSUCCINAMIDE",IKOPFHKAECNGQI-VQTJNVASSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
103238,6vxs,DB08339,-7.9,"6-(2,6-DICHLOROPHENYL)-2-{[3-(HYDROXYMETHYL)PHENYL]AMINO}-8-METHYLPYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE",ZIQFYVPVJZEOFS-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
131109,6w4h,DB13308,-7.9,Oxametacin,AJRNYCDWNITGHF-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
85917,6m3m,DB08211,-7.9,5-bromo-3-(pyrrolidin-1-ylsulfonyl)-1H-indole-2-carboxamide,FEPUPYVRZUWCQB-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59375,6crv,DB07390,-7.9,"2-[3-(5-MERCAPTO-[1,3,4]THIADIAZOL-2-YL)-UREIDO]-N-METHYL-3-PHENYL-PROPIONAMIDE",RKWXKADYTDWZIJ-VIFPVBQESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87621,6m3m,DB12588,-7.9,AZD-1480,PDOQBOJDRPLBQU-QMMMGPOBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86505,6m3m,DB08957,-7.9,Hexoprenaline,OXLZNBCNGJWPRV-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58774,6crv,DB06616,-7.9,Bosutinib,UBPYILGKFZZVDX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
105054,6vxs,DB12926,-7.9,Cafedrine,UJSKUDDDPKGBJY-WFASDCNBSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
128020,6w4h,DB07124,-7.9,"(2S)-1-(6H-INDOL-3-YL)-3-{[5-(7H-PYRAZOLO[3,4-C]PYRIDIN-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE",CCIACUJJBPSOHE-KRWDZBQOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
136537,6w9c,DB07233,-7.9,N-{[4-(but-2-yn-1-yloxy)phenyl]sulfonyl}-5-methyl-D-tryptophan,SFVPXERGVLDWIS-OAQYLSRUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
157891,6wiq,DB13931,-7.9,Netarsudil,OURRXQUGYQRVML-AREMUKBSSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
61115,6crv,DB11584,-7.9,Pipradrol,XSWHNYGMWWVAIE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
128038,6w4h,DB07144,-7.9,"5-[(3R)-3-(5-methoxy-2',6'-dimethylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",XZXVRKHUCSXVBM-AWEZNQCLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
87220,6m3m,DB12007,-7.9,Isoflavone,GOMNOOKGLZYEJT-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
70267,6lxt,DB12394,-7.9,Eleclazine,YNUAEEJQYHYLMS-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
70270,6lxt,DB12399,-7.9,Polmacoxib,IJWPAFMIFNSIGD-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
16064,6lzg,DB02524,-7.9,"2',3'-O-{4-[Hydroxy(oxido)-??5-azanylidene]-2,6-dinitro-2,5-cyclohexadiene-1,1-diyl}adenosine 5'-(tetrahydrogen triphosphate)",XFMMHXLUHKBKQE-UHEGPQQHSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
35522,1r42,DB01713,-7.9,Udp-Alpha-D-Xylopyranose,DQQDLYVHOTZLOR-OCIMBMBZSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
105037,6vxs,DB12900,-7.9,Irdabisant,XUKROCVZGZNGSI-CQSZACIVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
161900,7bv1,DB00950,-7.9,Fexofenadine,RWTNPBWLLIMQHL-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
27024,6cs2,DB06263,-7.9,Amrubicin,VJZITPJGSQKZMX-XDPRQOKASA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
58148,6crv,DB04610,-7.9,"7,8-dihydro-6-hydroxymethyl-7-methyl-7-[2-phenylethyl]-pterin",XMFJTCGUDFSWSW-INIZCTEOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
25165,6cs2,DB03039,-7.9,"4-(Aminosulfonyl)-N-[(2,5-Difluorophenyl)Methyl]-Benzamide",KEGUALXMKQVDIO-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
87168,6m3m,DB11933,-7.9,Riboprine,USVMJSALORZVDV-SDBHATRESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136480,6w9c,DB07165,-7.9,N-(5-CHLORO-BENZO[B]THIOPHEN-3-YLMETHYL)-2-[6-CHLORO-OXO-3-(2-PYRIDIN-2-YL-ETHYLAMINO)-2H-PYRAZIN-1-YL]-ACETAMIDE,SOBGXPPOYFFGTK-UGKGYDQZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
33439,6cs2,T3D4674,-7.9,Amsacrine,XCPGHVQEEXUHNC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
83227,6m3m,DB03608,-7.9,Diminazene,XNYZHCFCZNMTFY-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
102067,6vxs,DB06971,-7.9,"N-{2-[(4'-CYANO-1,1'-BIPHENYL-4-YL)OXY]ETHYL}-N'-HYDROXY-N-METHYLUREA",GVMUNGGWXRKCEU-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
128079,6w4h,DB07190,-7.9,3-cyclohexyl-D-alanyl-N-(3-chlorobenzyl)-L-prolinamide,JGFCNVHEEMBVJG-MOPGFXCFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
105014,6vxs,DB12869,-7.9,Eliprodil,GGUSQTSTQSHJAH-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
128091,6w4h,DB07205,-7.9,N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,GZJXCRHEMLAMRA-SDBHATRESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
136440,6w9c,DB07120,-7.9,"N4-(N,N-DIPHENYLCARBAMOYL)-AMINOGUANIDINE",QLXOHIUDKNRVBZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
128015,6w4h,DB07119,-7.9,1-CHLORO-6-(4-HYDROXYPHENYL)-2-NAPHTHOL,YHEHVRSGKUYDON-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
87244,6m3m,DB12045,-7.9,Mericitabine,MLESJYFEMSJZLZ-MAAOGQSESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58114,6crv,DB04566,-7.9,Inosinic Acid,GRSZFWQUAKGDAV-KQYNXXCUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136540,6w9c,DB07237,-7.9,{4-[(2R)-pyrrolidin-2-ylmethoxy]phenyl}(4-thiophen-3-ylphenyl)methanone,VUWFJUJWAWMRQN-HXUWFJFHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
22021,6cs2,HMDB0001420,-7.9,"25,26-dihydroxyvitamin D",WWGCQHXFACVYPT-JKVVTCAUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
27058,6cs2,DB06354,-7.9,Tezampanel,ZXFRFPSZAKNPQQ-YTWAJWBKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
127920,6w4h,DB07011,-7.9,"(3S)-1-(1,3-BENZODIOXOL-5-YLMETHYL)-3-[4-(1H-IMIDAZOL-1-YL)PHENOXY]PIPERIDINE",HHOPJGKEAIIIDF-FQEVSTJZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
61145,6crv,DB11654,-7.9,T-2000,RRFBTKHQZRCRSS-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136603,6w9c,DB07315,-7.9,"5-chloro-N-{4-[(1R)-1,2-dihydroxyethyl]phenyl}-1H-indole-2-carboxamide",SHCHFGSUYJUEBR-INIZCTEOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
127941,6w4h,DB07034,-7.9,"2,2'-{[9-(HYDROXYIMINO)-9H-FLUORENE-2,7-DIYL]BIS(OXY)}DIACETIC ACID",VOKATEXROYSXDW-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
72412,6m2n,DB00716,-7.9,Nedocromil,RQTOOFIXOKYGAN-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
72410,6m2n,DB00714,-7.9,Apomorphine,VMWNQDUVQKEIOC-CYBMUJFWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61138,6crv,DB11644,-7.9,Tafamidis,TXEIIPDJKFWEEC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136575,6w9c,DB07286,-7.9,BMS-564929,KEJORAMIZFOODM-PWSUYJOCSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
83144,6m3m,DB03486,-7.9,Phosphomethylphosphonic Acid Guanosyl Ester,OCJWYBKRHNXUME-KQYNXXCUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87266,6m3m,DB12078,-7.9,Enobosarm,JNGVJMBLXIUVRD-SFHVURJKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
27007,6cs2,DB06235,-7.9,Vadimezan,XGOYIMQSIKSOBS-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
127946,6w4h,DB07039,-7.9,(2S)-N-(4-cyano-3-iodophenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide,RXSZCFAPSDTELY-SFHVURJKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
105102,6vxs,DB13002,-7.9,HKI-357,NERXPXBELDBEPZ-RMKNXTFCSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
136568,6w9c,DB07269,-7.9,(2S)-2-[3-(AMINOMETHYL)PHENYL]-3-[(R)-[(1R)-1-{[(BENZYLOXY)CARBONYL]AMINO}-2-METHYLPROPYL](HYDROXY)PHOSPHORYL]PROPANOIC ACID,SFUOOKBZBVUDBC-VQTJNVASSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
83158,6m3m,DB03504,-7.9,"9-Butyl-8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-9h-Purin-6-Ylamine",IVPCTHKPOPQMSX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
16020,6lzg,DB02358,-7.9,LY374571,SZHRIPFGZWWRKW-VIFPVBQESA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
72399,6m2n,DB00701,-7.9,Amprenavir,YMARZQAQMVYCKC-OEMFJLHTSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
70233,6lxt,DB12345,-7.9,MBX-2982,NFTMKHWBOINJGM-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
87252,6m3m,DB12057,-7.9,ORM-12741,OCUKPFWNSAAHRP-QZTJIDSGSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136551,6w9c,DB07250,-7.9,"N'-(5-CHLORO-1,3-BENZODIOXOL-4-YL)-N-(3,4,5- TRIMETHOXYPHENYL)PYRIMIDINE-2,4-DIAMINE",HMKLUOPMOJOUDZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
72388,6m2n,DB00690,-7.9,Flurazepam,SAADBVWGJQAEFS-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
72387,6m2n,DB00689,-7.9,Cephaloglycin,FUBBGQLTSCSAON-PBFPGSCMSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
58104,6crv,DB04555,-7.9,Cytidine-5'-Diphosphate,ZWIADYZPOWUWEW-XVFCMESISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136543,6w9c,DB07240,-7.9,3-[(9H-fluoren-9-ylideneamino)oxy]propanoic acid,LASWLEUVWJDDBA-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
161965,7bv1,DB01026,-7.9,Ketoconazole,XMAYWYJOQHXEEK-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
87094,6m3m,DB11821,-7.9,Danegaptide,BIZKIHUJGMSVFD-MNOVXSKESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
161867,7bv1,DB00913,-7.9,Anileridine,LKYQLAWMNBFNJT-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
161864,7bv1,DB00910,-7.9,Paricalcitol,BPKAHTKRCLCHEA-UBFJEZKGSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
70337,6lxt,DB12492,-7.9,Piritramide,IHEHEFLXQFOQJO-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
83377,6m3m,DB03804,-7.9,5-Bromothienyldeoxyuridine,IGUZFFOBAZCVRK-VAOFZXAKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
72296,6m2n,DB00579,-7.9,Mazindol,ZPXSCAKFGYXMGA-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
11850,6lzg,DB12515,-7.9,9-aminocamptothecin,FUXVKZWTXQUGMW-FQEVSTJZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
26968,6cs2,DB06160,-7.9,Garenoxacin,NJDRXTDGYFKORP-LLVKDONJSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
136218,6w9c,DB06780,-7.9,Desoxycorticosterone acetate,VPGRYOFKCNULNK-ACXQXYJUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
83391,6m3m,DB03820,-7.9,"(2s,5r,6r)-6-{[(6r)-6-(Glycylamino)-7-Oxido-7-Oxoheptanoyl]Amino}-3,3-Dimethyl-7-Oxo-4-Thia-1-Azabicyclo[3.2.0]Heptane-2-Carboxylate",LDJWRKFRKCXUDO-RBQWDTSBSA-M,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
26963,6cs2,DB06155,-7.9,Rimonabant,JZCPYUJPEARBJL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
128321,6w4h,DB07471,-7.9,"5-[5,6-BIS(METHYLOXY)-1H-BENZIMIDAZOL-1-YL]-3-{[1-(2-CHLOROPHENYL)ETHYL]OXY}-2-THIOPHENECARBOXAMIDE",UHCHLTQBLNUYRT-GFCCVEGCSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
136197,6w9c,DB06737,-7.9,Zaltoprofen,MUXFZBHBYYYLTH-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
33523,6cs2,T3D4775,-7.9,Fenofibrate,YMTINGFKWWXKFG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
58263,6crv,DB04770,-7.9,"O6-(R)-ROSCOVITINE, R-2-(6-BENZYLOXY-9-ISOPROPYL-9H-PURIN-2-YLAMINO)-BUTAN-1-OL",HGADNQLEUZSUEJ-OAHLLOKOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
102127,6vxs,DB07039,-7.9,(2S)-N-(4-cyano-3-iodophenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide,RXSZCFAPSDTELY-SFHVURJKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
83402,6m3m,DB03835,-7.9,"N-[(5S,7R,8S,9S,10R)-8,9,10-Trihydroxy-7-(hydroxymethyl)-2,4-dioxo-6-oxa-1,3-diazaspiro[4.5]dec-3-yl]acetamide",MAHIOGAAEAWGLR-UTAYWCBXSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136190,6w9c,DB06729,-7.9,Sulfaphenazole,QWCJHSGMANYXCW-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
46254,2fxp,DB00320,-7.9,Dihydroergotamine,LUZRJRNZXALNLM-JGRZULCMSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
128335,6w4h,DB07488,-7.9,"{(2Z)-4-AMINO-2-[(4-METHOXYPHENYL)IMINO]-2,3-DIHYDRO-1,3-THIAZOL-5-YL}(4-METHOXYPHENYL)METHANONE",XQKUGFIWKSKCDL-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
128336,6w4h,DB07489,-7.9,"4-Amino-2-[(3-chlorophenyl)amino]-5-(4-fluorobenzoyl)-1,3-thiazol-3-ium",WWGPTHOMFHDEEC-UHFFFAOYSA-O,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
136161,6w9c,DB06685,-7.9,Laquinimod,GKWPCEFFIHSJOE-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
26947,6cs2,DB06117,-7.9,"1alpha,24S-Dihydroxyvitamin D2",ODZFJAXAEXQSKL-WRJREGAQSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
128348,6w4h,DB07504,-7.9,(2R)-1-{4-[(4-Anilino-5-bromo-2-pyrimidinyl)amino]phenoxy}-3-(dimethylamino)-2-propanol,MEIJADBULOETOV-QGZVFWFLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
102153,6vxs,DB07067,-7.9,"(2S,3S)-3-{3-[4-(METHYLSULFONYL)PHENYL]-1,2,4-OXADIAZOL-5-YL}-1-OXO-1-PYRROLIDIN-1-YLBUTAN-2-AMINE",SQCDMTZMCHZYGO-FZMZJTMJSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
26943,6cs2,DB06090,-7.9,Bradanicline,OXKRFEWMSWPKKV-GHTZIAJQSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
6601,6lzg,DB02388,-7.9,"Cyclohexyl-{4-[5-(3,4-Dichlorophenyl)-2-Piperidin-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine",UQFRSHRWRKYNDE-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
86993,6m3m,DB11674,-7.9,Equol,ADFCQWZHKCXPAJ-GFCCVEGCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
104898,6vxs,DB12675,-7.9,PF-04995274,WLLOFQROROXOMO-GOSISDBHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
70345,6lxt,DB12507,-7.9,Atecegatran metoxil,XSNMGLZVFNDDPW-ZWKOTPCHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
136624,6w9c,DB07338,-7.9,Acifluorfen,NUFNQYOELLVIPL-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
83374,6m3m,DB03800,-7.9,Deoxyuridine monophosphate,JSRLJPSBLDHEIO-SHYZEUOFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
72305,6m2n,DB00588,-7.9,Fluticasone propionate,WMWTYOKRWGGJOA-CENSZEJFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
83260,6m3m,DB03658,-7.9,"2-{1-[2-Amino-2-(4-Hydroxy-Phenyl)-Acetylamino]-2-Oxo-Ethyl}-5,5-Dimethyl-Thiazolidine-4-Carboxylic Acid",SMLJDSWXGVMNTH-NRWUCQMLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
70303,6lxt,DB12441,-7.9,Tavilermide,DVJXNXPFYJIACK-ULQDDVLXSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
58189,6crv,DB04662,-7.9,OLOMOUCINE II,NDUVSANREQEDRE-CQSZACIVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
157953,6wiq,DB14993,-7.9,Pyrotinib,SADXACCFNXBCFY-IYNHSRRRSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
6655,6lzg,DB02473,-7.9,"6-[N-(1-Isopropyl-3,4-Dihydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine",XRHANBWAKSYPEN-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
104973,6vxs,DB12798,-7.9,Relenopride,KGMMSPVVHZGPHL-NRFANRHFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
136373,6w9c,DB07042,-7.9,"7-amino-2-tert-butyl-4-{[2-(1H-imidazol-4-yl)ethyl]amino}pyrido[2,3-d]pyrimidine-6-carboxamide",XESUNWBIAADLPI-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
128192,6w4h,DB07319,-7.9,"6-(3-BROMO-2-NAPHTHYL)-1,3,5-TRIAZINE-2,4-DIAMINE",RXSSKAZHCZWJPP-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
87065,6m3m,DB11783,-7.9,Imidapril,KLZWOWYOHUKJIG-BPUTZDHNSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
161847,7bv1,DB00673,-7.9,Aprepitant,ATALOFNDEOCMKK-OITMNORJSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
16183,6lzg,DB03082,-7.9,6-[(Z)-Amino(Imino)Methyl]-N-[4-(Aminomethyl)Phenyl]-4-(Pyrimidin-2-Ylamino)-2-Naphthamide,CSWQJKHBMACTGB-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
136337,6w9c,DB07002,-7.9,4-({4-[(4-methoxypyridin-2-yl)amino]piperidin-1-yl}carbonyl)benzonitrile,SZUVGMCKKLJAFX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
72304,6m2n,DB00587,-7.9,Cinalukast,BZMKNPGKXJAIDV-VAWYXSNFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
157978,6wiq,DB15414,-7.9,CM-4307,MLDQJTXFUGDVEO-FIBGUPNXSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
6641,6lzg,DB02449,-7.9,3-(1h-Indol-3-Yl)-2-[4-(4-Phenyl-Piperidin-1-Yl)-Benzenesulfonylamino]-Propionic Acid,ULOTXPTWJAUGGE-MHZLTWQESA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
72318,6m2n,DB00604,-7.9,Cisapride,DCSUBABJRXZOMT-IRLDBZIGSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
128209,6w4h,DB07338,-7.9,Acifluorfen,NUFNQYOELLVIPL-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
136306,6w9c,DB06967,-7.9,"6-ETHYL-5-[9-(3-METHOXYPROPYL)-9H-CARBAZOL-2-YL]PYRIMIDINE-2,4-DIAMINE",MLSVRCGEBXIIQO-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
102122,6vxs,DB07034,-7.9,"2,2'-{[9-(HYDROXYIMINO)-9H-FLUORENE-2,7-DIYL]BIS(OXY)}DIACETIC ACID",VOKATEXROYSXDW-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
72316,6m2n,DB00601,-7.9,Linezolid,TYZROVQLWOKYKF-ZDUSSCGKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
136291,6w9c,DB06944,-7.9,N-(3-cyclopropyl-1H-pyrazol-5-yl)-2-(2-naphthyl)acetamide,RIGZCVNCFXYBEG-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
26983,6cs2,DB06195,-7.9,Seliciclib,BTIHMVBBUGXLCJ-OAHLLOKOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
33496,6cs2,T3D4751,-7.9,Dihydrotestosterone,NVKAWKQGWWIWPM-ABEVXSGRSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
136271,6w9c,DB06921,-7.9,(2S)-2-[3-(AMINOMETHYL)PHENYL]-3-[(R)-HYDROXY{(1R)-2-METHYL-1-[(PHENYLSULFONYL)AMINO]PROPYL}PHOSPHORYL]PROPANOIC ACID,FNZHLCNFXRRIIC-RBUKOAKNSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
70330,6lxt,DB12479,-7.9,Zabofloxacin,ZNPOCLHDJCAZAH-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
128275,6w4h,DB07418,-7.9,bis(4-nitrophenyl) hydrogen phosphate,MHSVUSZEHNVFKW-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
72319,6m2n,DB00605,-7.9,Sulindac,MLKXDPUZXIRXEP-MFOYZWKCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
136633,6w9c,DB07348,-7.9,Brefeldin A,KQNZDYYTLMIZCT-KQPMLPITSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
33367,6cs2,T3D4558,-7.9,Azelastine,MBUVEWMHONZEQD-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
105151,6vxs,DB13072,-7.9,GDC-0349,RGJOJUGRHPQXGF-INIZCTEOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
105416,6vxs,DB13470,-7.9,Cefodizime,XDZKBRJLTGRPSS-BGZQYGJUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
27145,6cs2,DB06578,-7.9,Tonabersat,XLIIRNOPGJTBJD-ROUUACIJSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
127522,6w4h,DB06263,-7.9,Amrubicin,VJZITPJGSQKZMX-XDPRQOKASA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
15830,6lzg,DB01459,-7.9,Bezitramide,FLKWNFFCSSJANB-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
24995,6cs2,DB02834,-7.9,IDD552,ZCAGEXZTORJQDZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
157575,6wiq,DB11822,-7.9,TMC-647055,UOBYJVFBFSLCTQ-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
87520,6m3m,DB12433,-7.9,SCH-900271,ARJKMWXLIHZLQZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
6867,6lzg,DB02830,-7.9,FR236913,KCCUBLLGAMGDJL-HXUWFJFHSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
127549,6w4h,DB06345,-7.9,AR-9281,HUDQLWBKJOMXSZ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
101768,6vxs,DB06455,-7.9,Meclinertant,DYLJVOXRWLXDIG-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101771,6vxs,DB06460,-7.9,Enrasentan,GLCKXJLCYIJMRB-UPRLRBBYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
61325,6crv,DB11917,-7.9,Vatiquinone,LNOVHERIIMJMDG-XZXLULOTSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
82734,6m3m,DB02930,-7.9,Adenosine 5'-[??-thio]triphosphate,NLTUCYMLOPLUHL-KQYNXXCUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
137108,6w9c,DB07909,-7.9,"(1S,2S,5S)2-(4-GLUTARIDYLBENZYL)-5-PHENYL-1-CYCLOHEXANOL",OBWILOKKNDYPLX-HBMCJLEFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
35663,1r42,DB01908,-7.9,RU85493,MWEWSHNGVWABKG-SVBPBHIXSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
157624,6wiq,DB12211,-7.9,PSI-697,DIEPFYNZGUUVHD-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
101809,6vxs,DB06558,-7.9,Tezosentan,TUYWTLTWNJOZNY-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
137065,6w9c,DB07858,-7.9,(2S)-2-(4-chlorophenyl)-2-[4-(1H-pyrazol-4-yl)phenyl]ethanamine,HWVGILTYGZFGLR-KRWDZBQOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
157636,6wiq,DB12228,-7.9,Telcagepant,CGDZXLJGHVKVIE-DNVCBOLYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
127619,6w4h,DB06532,-7.9,Pafuramidine,UKOQVLAXCBRRGH-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
105324,6vxs,DB13347,-7.9,Diphenadione,JYGLAHSAISAEAL-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
33267,6cs2,T3D4440,-7.9,Protoporphyrin IX,KSFOVUSSGSKXFI-UJJXFSCMSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
61272,6crv,DB11837,-7.9,Osilodrostat,USUZGMWDZDXMDG-CYBMUJFWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127650,6w4h,DB06616,-7.9,Bosutinib,UBPYILGKFZZVDX-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
57929,6crv,DB04315,-7.9,Guanosine-5'-Diphosphate,QGWNDRXFNXRZMB-UUOKFMHZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
105290,6vxs,DB13308,-7.9,Oxametacin,AJRNYCDWNITGHF-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
137088,6w9c,DB07883,-7.9,(2-AMINO-3-PHENYL-BICYCLO[2.2.1]HEPT-2-YL)-PHENYL-METHANONE,XJQDTOANLAPEIM-JRBPQWBISA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
127663,6w4h,DB06635,-7.9,Otamixaban,PFGVNLZDWRZPJW-OPAMFIHVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
70069,6lxt,DB12113,-7.9,CE-224535,FUCKCIVGBCBZNP-MRXNPFEDSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
105428,6vxs,DB13487,-7.9,Iodine (131I) norcholesterol,QJHZPCLORSPENH-DRTKWHMQSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
27169,6cs2,DB06620,-7.9,Aplindore,DYJIKHYBKVODAC-ZDUSSCGKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
70029,6lxt,DB12055,-7.9,MK-0767,ORZMUVMQJPGFOM-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
137296,6w9c,DB08123,-7.9,"N-METHYL-{4-[2-(7-OXO-6,7-DIHYDRO-8H-[1,3]THIAZOLO[5,4-E]INDOL-8-YLIDENE)HYDRAZINO]PHENYL}METHANESULFONAMIDE",GEWPSTLKJDIUHW-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137295,6w9c,DB08122,-7.9,"N-METHYL-4-{[(2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]AMINO}BENZENESULFONAMIDE",IKASAFLVQIJQOK-UVTDQMKNSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
57778,6crv,DB04116,-7.9,Allolactose,DLRVVLDZNNYCBX-VDGMBKLFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127435,6w4h,DB05959,-7.9,ENMD-1198,YQJWOUQGXATDAE-ACNBBOPNSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
105476,6vxs,DB13551,-7.9,Cinchophen,YTRMTPPVNRALON-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
57790,6crv,DB04133,-7.9,Degraded Cephaloridine,SFVACKBZMIZHCK-ZWNOBZJWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
101730,6vxs,DB06345,-7.9,AR-9281,HUDQLWBKJOMXSZ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
127450,6w4h,DB06090,-7.9,Bradanicline,OXKRFEWMSWPKKV-GHTZIAJQSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
137282,6w9c,DB08108,-7.9,N-({6-[(4-CYANOBENZYL)OXY]NAPHTHALEN-2-YL}SULFONYL)-D-GLUTAMIC ACID,PUHRQSFXADUGJW-OAQYLSRUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
127458,6w4h,DB06134,-7.9,SNS-314,FAYAUAZLLLJJGH-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
61345,6crv,DB11947,-7.9,Pridopidine,YGKUEOZJFIXDGI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
101732,6vxs,DB06347,-7.9,Cenisertib,KSOVGRCOLZZTPF-QMKUDKLTSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
70042,6lxt,DB12073,-7.9,Albaconazole,UHIXWHUVLCAJQL-MPBGBICISA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
82719,6m3m,DB02911,-7.9,"2,4-Diamino-6-Phenyl-5,6,7,8,-Tetrahydropteridine",VEKRIXRQADJFAG-QMMMGPOBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
82722,6m3m,DB02916,-7.9,"[(2r,3s,4r,5r)-5-(6-Amino-9h-Purin-9-Yl)-3,4-Dihydroxytetrahydro-2-Furanyl]Methyl Sulfamate",GNZLUJQJDPRUTD-KQYNXXCUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
137265,6w9c,DB08089,-7.9,LGD-2226,ULBPQWIGZUGPHU-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
162227,7bv1,DB01768,-7.9,Methylumbelliferyl Sialic Acid,KKDWIUJBUSOPGC-GKHMPSLRSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
70047,6lxt,DB12081,-7.9,Anecortave,BCFCRXOJOFDUMZ-ONKRVSLGSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
33217,6cs2,T3D4314,-7.9,Cholesterol,HVYWMOMLDIMFJA-FNOPAARDSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
70050,6lxt,DB12084,-7.9,ADP-597,WPDCHTSXOPUOII-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
70051,6lxt,DB12085,-7.9,LCL-161,UFPFGVNKHCLJJO-SSKFGXFMSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
33222,6cs2,T3D4323,-7.9,Coproporphyrin III,JWFCYWSMNRLXLX-UJJXFSCMSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
101751,6vxs,DB06412,-7.9,Oxymetholone,ICMWWNHDUZJFDW-DHODBPELSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
61346,6crv,DB11948,-7.9,Lapachone,QZPQTZZNNJUOLS-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27157,6cs2,DB06597,-7.9,Estradiol sulfamate,YXYXCSOJKUAPJI-ZBRFXRBCSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
33544,6cs2,T3D4795,-7.9,Kaempferol,IYRMWMYZSQPJKC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
87474,6m3m,DB12376,-7.9,Ricolinostat,QGZYDVAGYRLSKP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
72525,6m2n,DB00850,-7.9,Perphenazine,RGCVKNLCSQQDEP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
127818,6w4h,DB06889,-7.9,"3-(1H-tetrazol-5-ylmethyl)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(3H)-one",QSBQXAOOVSQABJ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
136855,6w9c,DB07615,-7.9,Tranilast,NZHGWWWHIYHZNX-CSKARUKUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
70169,6lxt,DB12260,-7.9,Radiprodil,GKGRZLGAQZPEHO-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
87390,6m3m,DB12259,-7.9,CG-200745,AUGCSOFQTDKPSO-RGVLZGJSSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
57998,6crv,DB04416,-7.9,"R-2-{[4'-Methoxy-(1,1'-Biphenyl)-4-Yl]-Sulfonyl}-Amino-6-Methoxy-Hex-4-Ynoic Acid",QJKGJGURDPRKGW-LJQANCHMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136788,6w9c,DB07533,-7.9,"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]-2-FURYL}-N-METHYLBENZENESULFONAMIDE",FJJJERLTHDXEPT-JYRVWZFOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
58009,6crv,DB04433,-7.9,"N''-{3-[(3s,8ar)-1,4-Dioxooctahydropyrrolo[1,2-a]Pyrazin-3-Yl]Propyl}Guanidine",ZRJHYOXNWCMGMW-YUMQZZPRSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127842,6w4h,DB06916,-7.9,"N-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-1-[2-(1H-IMIDAZOL-1-YL)-6-METHYLPYRIMIDIN-4-YL]-D-PROLINAMIDE",LBCGUKCXRVUULK-QGZVFWFLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
27070,6cs2,DB06401,-7.9,Bazedoxifene,UCJGJABZCDBEDK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
157740,6wiq,DB12742,-7.9,Amuvatinib,FOFDIMHVKGYHRU-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
136769,6w9c,DB07511,-7.9,"4-(4-methyl-1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)benzonitrile",MVYDBJXCIFMINH-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
127856,6w4h,DB06930,-7.9,"N-[amino(imino)methyl]-2-(2,5-diphenyl-1H-pyrrol-1-yl)acetamide",WVLDNAVUCUAGDP-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
162050,7bv1,DB01357,-7.9,Mestranol,IMSSROKUHAOUJS-MJCUULBUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
162024,7bv1,DB01094,-7.9,Hesperetin,AIONOLUJZLIMTK-AWEZNQCLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
136750,6w9c,DB07488,-7.9,"{(2Z)-4-AMINO-2-[(4-METHOXYPHENYL)IMINO]-2,3-DIHYDRO-1,3-THIAZOL-5-YL}(4-METHOXYPHENYL)METHANONE",XQKUGFIWKSKCDL-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
6772,6lzg,DB02673,-7.9,"(4ar,6s,8ar)-11-[8-(1,3-Dioxo-1,3-Dihydro-2h-Isoindol-2-Yl)Octyl]-6-Hydroxy-3-Methoxy-5,6,9,10-Tetrahydro-4ah-[1]Benzofuro[3a,3,2-Ef][2]Benzazepin-11-Ium",VLGAHTYYCHWLNI-BHRZLAGCSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
83087,6m3m,DB03401,-7.9,"1D-myo-inositol 1,4,5-trisphosphate",MMWCIQZXVOZEGG-XJTPDSDZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
72433,6m2n,DB00741,-7.9,Hydrocortisone,JYGXADMDTFJGBT-VWUMJDOOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
105160,6vxs,DB13088,-7.9,AZD-0424,MVWATCATLSSVBH-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
27069,6cs2,DB06397,-7.9,Nicaraven,KTXBOOWDLPUROC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
136737,6w9c,DB07472,-7.9,"(R)-(+)9B-(3-METHYL)PHENYL-2,3-DIHYDROTHIAZOLO[2,3-A]ISOINDOL-5(9BH)-ONE",FQVDJZWFSZSGGA-QGZVFWFLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
12754,6lzg,DB13766,-7.9,Lidoflazine,ZBIAKUMOEKILTF-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
87342,6m3m,DB12188,-7.9,Zicronapine,BYPMJBXPNZMNQD-PZJWPPBQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
127898,6w4h,DB06986,-7.9,"2-CHLORO-N-[(1R,2R)-1-HYDROXY-2,3-DIHYDRO-1H-INDEN-2-YL]-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE",LRHOLHTVXXSIMG-BXUZGUMPSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
87341,6m3m,DB12187,-7.9,Abacavir hydroxyacetate,ZBBZROWQLKCFQK-KOLCDFICSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
127904,6w4h,DB06993,-7.9,"(2S,3S)-4-cyclopropyl-3-{(3R,5R)-3-[2-fluoro-4-(methylsulfonyl)phenyl]-1,2,4-oxadiazolidin-5-yl}-1-[(3S)-3-fluoropyrrolidin-1-yl]-1-oxobutan-2-amine",PTAHVQJZNFGPHN-WFWWEWPISA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
87367,6m3m,DB12226,-7.9,Terameprocol,ORQFDHFZSMXRLM-IYBDPMFKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
82886,6m3m,DB03137,-7.9,"8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9-Pent-9h-Purin-6-Ylamine",RMOYVWKKOKERSW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
127816,6w4h,DB06887,-7.9,"[(3S)-3-(Methylcarbamoyl)-2-{[(2-methyl-2-propanyl)oxy]carbonyl}-1,2,3,4-tetrahydro-7-isoquinolinyl]sulfamic acid",PPSSYXOFPICMQD-ZDUSSCGKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
105191,6vxs,DB13135,-7.9,AGN-201904,PPCGSVWOZKNPCX-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
82897,6m3m,DB03155,-7.9,"1-(2-Deoxy-2-Fluoro-3-O-Phosphono-Beta-L-Ribofuranosyl)Pyrimidine-2,4(1h,3h)-Dione",IFIXUMAFUNKIAA-XVFCMESISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
57934,6crv,DB04324,-7.9,Ovalicin,UOXVFQCRPDLSFN-DGXTUMSLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
137004,6w9c,DB07790,-7.9,N-(2-METHOXYETHYL)-4-({4-[2-METHYL-1-(1-METHYLETHYL)-1H-IMIDAZOL-5-YL]PYRIMIDIN-2-YL}AMINO)BENZENESULFONAMIDE,LDXLQEXLXZCYSR-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
57944,6crv,DB04336,-7.9,1-(4-Amidinophenyl)-3-(4-Chlorophenyl)Urea,HQWKMDKTTCPCMQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72515,6m2n,DB00839,-7.9,Tolazamide,OUDSBRTVNLOZBN-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
57949,6crv,DB04345,-7.9,Lumichrome,ZJTJUVIJVLLGSP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
105252,6vxs,DB13252,-7.9,Tropatepine,JOQKFRLFXDPXHX-HDICACEKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
87456,6m3m,DB12347,-7.9,CG-400549,YCLREGRRHGLOAK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136969,6w9c,DB07750,-7.9,"(2R)-1-[4-({4-[(2,5-Dichlorophenyl)amino]-2-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol",GNLAGGCSJGJECE-MRXNPFEDSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
87445,6m3m,DB12326,-7.9,Antroquinonol,LJTSIMVOOOLKOL-FNRDIUJOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
105223,6vxs,DB13215,-7.9,Sulfobromophthalein,OHTXTCNTQJFRIG-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
61236,6crv,DB11790,-7.9,Radafaxine,RCOBKSKAZMVBHT-TVQRCGJNSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136859,6w9c,DB07620,-7.9,"2-[(2,4-DICHLORO-5-METHYLPHENYL)SULFONYL]-1,3-DINITRO-5-(TRIFLUOROMETHYL)BENZENE",INAZPZCJNPPHGV-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136943,6w9c,DB07719,-7.9,"[(3R)-3-(Methylcarbamoyl)-2-{[(2-methyl-2-propanyl)oxy]carbonyl}-1,2,3,4-tetrahydro-7-isoquinolinyl]sulfamic acid",PPSSYXOFPICMQD-CYBMUJFWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
70147,6lxt,DB12229,-7.9,Cerlapirdine,NXQGEDVQXVTCDA-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
105208,6vxs,DB13177,-7.9,4-methylumbelliferyl beta-D-glucoside,YUDPTGPSBJVHCN-YMILTQATSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
105207,6vxs,DB13175,-7.9,Rheinanthrone,OZFQHULMMDWMIV-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
87417,6m3m,DB12291,-7.9,Tacedinaline,VAZAPHZUAVEOMC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
25081,6cs2,DB02932,-7.9,(R)-Bicalutamide,LKJPYSCBVHEWIU-KRWDZBQOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
127781,6w4h,DB06845,-7.9,(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclopentylamino)ethanoyl)pyrrolidine-2-carboxamide,WXYKSWZWRHMJTE-KRWDZBQOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
157706,6wiq,DB12318,-7.9,BMS-599626,LUJZZYWHBDHDQX-QFIPXVFZSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
136886,6w9c,DB07649,-7.9,"(3R,4S)-1-[(4-amino-5H-pyrrolo[3,2-d]pyrimidin-7-yl)methyl]-4-[(benzylsulfanyl)methyl]pyrrolidin-3-ol",DIGGNILBPCEZIV-CVEARBPZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
61224,6crv,DB11773,-7.9,BMS-903452,OGIAVRWXUPYGGC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61217,6crv,DB11764,-7.9,Spebrutinib,KXBDTLQSDKGAEB-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
83007,6m3m,DB03296,-7.9,3'-beta-Sialyl-beta-lactose,CILYIEBUXJIHCO-LPTWSRJFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
162057,7bv1,DB01380,-7.9,Cortisone acetate,ITRJWOMZKQRYTA-RFZYENFJSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
82974,6m3m,DB03249,-7.9,2'-O-Methyl-3'-Methyl-3'-Deoxy-Arabinofuranosyl-Thymine-5'-Phosphate,MCXXETKRWYMFCI-TURQNECASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
72265,6m2n,DB00542,-7.9,Benazepril,XPCFTKFZXHTYIP-PMACEKPBSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
128370,6w4h,DB07530,-7.9,"(1R,3R)-5-[(2E)-3-{(1S,3R)-2,2,3-trimethyl-3-[6,6,6-trifluoro-5-hydroxy-5-(trifluoromethyl)hex-3-yn-1-yl]cyclopentyl}prop-2-en-1-ylidene]cyclohexane-1,3-diol",PCHUQQNKOFNVDU-OSXMSNBXSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
158080,7bv1,DB00353,-7.9,Methylergometrine,UNBRKDKAWYKMIV-QWQRMKEZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
17921,6cs2,HMDB0000554,-7.9,Dihydroandrosterone,CBMYJHIOYJEBSB-KHOSGYARSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
135246,6w9c,DB04176,-7.9,"Phosporic Acid Mono-[3,4-Dihydroxy-5-(5-Methoxy-Benzoimidazol-1-Yl)-Tetrahydro-Furan-2-Ylmethyl] Ester",VYUPJUKSTVHSQI-LPWJVIDDSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
129054,6w4h,DB08331,-7.9,"N-1H-imidazol-2-yl-N'-[4-(1H-imidazol-2-ylamino)phenyl]benzene-1,4-diamine",JHMXUERQMCJRHG-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
60735,6crv,DB09039,-7.9,Eliglustat,FJZZPCZKBUKGGU-AUSIDOKSSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
135243,6w9c,DB04172,-7.9,"[2,4,6-Triisopropyl-Phenylsulfonyl-L-[3-Amidino-Phenylalanine]]-Piperazine-N'-Beta-Alanine",WATXEHGLYJKXOF-NDEPHWFRSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
129071,6w4h,DB08355,-7.9,"1-methyl-8-(phenylamino)-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxylic acid",ZOBRPBVIEUWYJR-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
58606,6crv,DB06187,-7.9,Valtorcitabine,VFCYZPOEGWLYRM-QCZKYFFMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
158399,7bv1,DB01142,-7.9,Doxepin,ODQWQRRAPPTVAG-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
83984,6m3m,DB04612,-7.9,"N-METHYLALANYL-3-METHYLVALYL-4-PHENOXY-N-(1,2,3,4-TETRAHYDRONAPHTHALEN-1-YL)PROLINAMIDE",QKPXPZYQPBWDHS-MCJAPYMPSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
102478,6vxs,DB07443,-7.9,(2Z)-N-biphenyl-4-yl-2-cyano-3-hydroxybut-2-enamide,MUVPBAIVOHJDOC-VBKFSLOCSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102479,6vxs,DB07444,-7.9,"6-(3-AMINOPROPYL)-4,9-DIMETHYLPYRROLO[3,4-C]CARBAZOLE-1,3(2H,6H)-DIONE",PKPNSCZPIWCHMW-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
86650,6m3m,DB09187,-7.9,Lortalamine,MJRPHRMGEKCADU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
158380,7bv1,DB01120,-7.9,Gliclazide,BOVGTQGAOIONJV-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
135152,6w9c,DB04059,-7.9,8-(Pyrimidin-2-Ylamino)Naphthalene-2-Carboximidamide,GRQLDCHTDNYVQI-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
35227,1r42,DB01329,-7.9,Cefoperazone,GCFBRXLSHGKWDP-XCGNWRKASA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
102491,6vxs,DB07457,-7.9,"3-[1-(3-AMINOPROPYL)-1H-INDOL-3-YL]-4-(1H-INDOL-3-YL)-1H-PYRROLE-2,5-DIONE",APYXQTXFRIDSGE-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
60695,6crv,DB08986,-7.9,Etifoxine,IBYCYJFUEJQSMK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
26689,6cs2,DB04873,-7.9,Piboserod,KVCSJPATKXABRQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
86625,6m3m,DB09144,-7.9,Uridine triacetate,AUFUWRKPQLGTGF-FMKGYKFTSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
102501,6vxs,DB07470,-7.9,"(3aS)-3a-hydroxy-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one",DOMYOVZXZIZTRD-QGZVFWFLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
129174,6w4h,DB08481,-7.9,"4-METHYL-N-{(5E)-5-[(5-METHYL-2-FURYL)METHYLENE]-4-OXO-4,5-DIHYDRO-1,3-THIAZOL-2-YL}BENZENESULFONAMIDE",MXAPQGDBWFYKKX-ZROIWOOFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
70582,6lxt,DB12885,-7.9,CF-102,IPSYPUKKXMNCNQ-PFHKOEEOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
161206,7bv1,DB13396,-7.9,Neocitrullamon,PAJBBDCZSMDSFL-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
161200,7bv1,DB13386,-7.9,Epimestrol,UHQGCIIQUZBJAE-RRQVMCLOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
104659,6vxs,DB12316,-7.9,9CUAB30,PPGNMFUMZSAZCW-VOYUZAMQSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
70586,6lxt,DB12890,-7.9,Dihydrexidine,BGOQGUHWXBGXJW-YOEHRIQHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
102485,6vxs,DB07451,-7.9,1-(5-BROMO-PYRIDIN-2-YL)-3-[2-(6-FLUORO-2-HYDROXY-3-PROPIONYL-PHENYL)-CYCLOPROPYL]-UREA,VRAJWAGCJIXJHQ-YPMHNXCESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
6355,6lzg,DB01975,-7.9,AMPCPR,ZPZRETFSCSWNDT-DBXCYWGHSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
83952,6m3m,DB04571,-7.9,Trioxsalen,FMHHVULEAZTJMA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
72060,6m2n,DB00287,-7.9,Travoprost,MKPLKVHSHYCHOC-AHTXBMBWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
128916,6w4h,DB08159,-7.9,"4-(5,11-DIOXO-5H-INDENO[1,2-C]ISOQUINOLIN-6(11H)-YL)BUTANOATE",AHIJTWCJGCWHMT-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
86701,6m3m,DB09244,-7.9,Pirlindole,IWVRVEIKCBFZNF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
26768,6cs2,DB00153,-7.9,Ergocalciferol,MECHNRXZTMCUDQ-RKHKHRCZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
58526,6crv,DB05737,-7.9,Varespladib methyl,VJYDOJXJUCJUHL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60796,6crv,DB09167,-7.9,Dosulepin,PHTUQLWOUWZIMZ-GZTJUZNOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
128930,6w4h,DB08173,-7.9,5-CHLORO-N-(2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO)ETHYL)THIOPHENE-2-CARBOXAMIDE,UCKHUNHXYMAFQM-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
72101,6m2n,DB00340,-7.9,Metixene,MJFJKKXQDNNUJF-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
102381,6vxs,DB07328,-7.9,"METHYL 4-{[({[(2R,5S)-5-{[(2S)-2-(AMINOMETHYL)PYRROLIDIN-1-YL]CARBONYL}PYRROLIDIN-2-YL]METHYL}AMINO)CARBONYL]AMINO}BENZOATE",USDCNOQKDUFKRD-IKGGRYGDSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
128938,6w4h,DB08184,-7.9,2-(2-METHYLPHENYL)-1H-INDOLE-5-CARBOXIMIDAMIDE,YOZKTHGEOJHIDP-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
128939,6w4h,DB08185,-7.9,2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,LCHGAOHLDYRACA-SDBHATRESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
128948,6w4h,DB08197,-7.9,"(5E,7S)-2-amino-7-(4-fluoro-2-pyridin-3-ylphenyl)-4-methyl-7,8-dihydroquinazolin-5(6H)-one oxime",KYIXUSLGFINPTC-WVFAEZDRSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
86693,6m3m,DB09234,-7.9,Darodipine,QERUYFVNIOLCHV-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
26734,6cs2,DB04960,-7.9,Tipifarnib,PLHJCIYEEKOWNM-HHHXNRCGSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
83848,6m3m,DB04438,-7.9,Brivudine monophosphate,LKWCVKAHHUJPQO-PIXDULNESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
72085,6m2n,DB00318,-7.9,Codeine,OROGSEYTTFOCAN-DNJOTXNNSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
16355,6lzg,DB03865,-7.9,6-Chloro-2-(2-Hydroxy-Biphenyl-3-Yl)-1h-Indole-5-Carboxamidine,FEKRWNWZMOSVBX-UHFFFAOYSA-O,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
11947,6lzg,DB12658,-7.9,AFN-1252,QXTWSUQCXCWEHF-JXMROGBWSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
128984,6w4h,DB08244,-7.9,"(1S)-1-CYCLOPROPYL-2-[(2S)-4-(2,5-DIFLUOROPHENYL)-2-PHENYL-2,5-DIHYDRO-1H-PYRROL-1-YL]-2-OXOETHANAMINE",VCOUEHUEFUDZIS-PMACEKPBSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
102418,6vxs,DB07373,-7.9,"ANDROSTA-1,4-DIENE-3,17-DIONE",LUJVUUWNAPIQQI-QAGGRKNESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
83871,6m3m,DB04468,-7.9,Afimoxifene,TXUZVZSFRXZGTL-QPLCGJKRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
70529,6lxt,DB12798,-7.9,Relenopride,KGMMSPVVHZGPHL-NRFANRHFSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
135392,6w9c,DB04407,-7.9,4-[4-(4-Methyl-2-Methylamino-Thiazol-5-Yl)-Pyrimidin-2-Ylamino]-Phenol,OTMLAWRVLMYMDF-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
60763,6crv,DB09084,-7.9,Benzydamine,CNBGNNVCVSKAQZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
70534,6lxt,DB12805,-7.9,Ataciguat,PQHLRGARXNPFCF-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
158371,7bv1,DB01108,-7.9,Trilostane,KVJXBPDAXMEYOA-CXANFOAXSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
83910,6m3m,DB04518,-7.9,"3-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamino]-Phenol",JJDRRZFRTKZLFT-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83850,6m3m,DB04441,-7.9,2-Fluoroadenosine,HBUBKKRHXORPQB-UUOKFMHZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
11934,6lzg,DB12640,-7.9,CP-609754,JAHDAIPFBPPQHQ-GDLZYMKVSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
70590,6lxt,DB12896,-7.9,PSI-352938,PVRFQJIRERYGTQ-DSQUMVBZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
58664,6crv,DB06309,-7.9,Refametinib,RDSACQWTXKSHJT-NSHDSACASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
71964,6m2n,DB00177,-7.9,Valsartan,ACWBQPMHZXGDFX-QFIPXVFZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
86558,6m3m,DB09016,-7.9,Butriptyline,ALELTFCQZDXAMQ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
70621,6lxt,DB12941,-7.9,ODM-201,BLIJXOOIHRSQRB-PXYINDEMSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
134825,6w9c,DB03608,-7.9,Diminazene,XNYZHCFCZNMTFY-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
84173,6m3m,DB04864,-7.9,Huperzine A,ZRJBHWIHUMBLCN-YQEJDHNASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
71958,6m2n,DB00171,-7.9,ATP,ZKHQWZAMYRWXGA-KQYNXXCUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
134820,6w9c,DB03601,-7.9,5-deoxyflavanone,FURUXTVZLHCCNA-AWEZNQCLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
161116,7bv1,DB12904,-7.9,ZSTK-474,HGVNLRPZOWWDKD-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
104609,6vxs,DB12252,-7.9,PG-701,OKRSVUYYCJPECG-LFGMFVMYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
26623,6cs2,DB04800,-7.9,1-METHYL-3-PHENYL-1H-PYRAZOL-5-YLSULFAMIC ACID,OTZLVSGSRPNRFT-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
58725,6crv,DB06481,-7.9,Manitimus,IRELROQHIPLASX-SEYXRHQNSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84204,6m3m,DB04915,-7.9,Idronoxil,ZZUBHVMHNVYXRR-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
158477,7bv1,DB01231,-7.9,Diphenidol,OGAKLTJNUQRZJU-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
129344,6w4h,DB08686,-7.9,"5,6,7,8,9,10-HEXAHYDRO-4-HYDROXY-3-(1-PHENYLPROPYL)CYCLOOCTA[B]PYRAN-2-ONE",UXCLJNSXDNCIIT-HNNXBMFYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
104599,6vxs,DB12238,-7.9,MK-0777,QKIWQBLNTSQOLY-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
129353,6w4h,DB08699,-7.9,"1-tert-butyl-3-(3-methylbenzyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine",FYCOTGCSHZKHPR-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
86530,6m3m,DB08986,-7.9,Etifoxine,IBYCYJFUEJQSMK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84223,6m3m,DB04967,-7.9,Lucanthone,FBQPGGIHOFZRGH-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
102629,6vxs,DB07624,-7.9,"1-{[(3R)-3-methyl-4-({4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]phenyl}sulfonyl)piperazin-1-yl]methyl}cyclopropanecarboxamide",YJFULAYRAKPBCY-DYVFJYSZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
60585,6crv,DB08819,-7.9,Tafluprost,WSNODXPBBALQOF-VEJSHDCNSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
129389,6w4h,DB08737,-7.9,"(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-9-OL",FSYFYSFYUHBIHE-GLJUWKHASA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
102633,6vxs,DB07628,-7.9,"6-(2-fluorobenzyl)-2,4-dimethyl-4,6-dihydro-5H-thieno[2',3':4,5]pyrrolo[2,3-d]pyridazin-5-one",IEWYEWDDQWYJLU-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
17766,6cs2,HMDB0010359,-7.9,17-Hydroxyandrostane-3-glucuronide,GYNWSIBKBBWJJW-JRTXBCKMSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
129406,6w4h,DB08754,-7.9,"(2E)-3-(3,4-DIHYDROXYPHENYL)-N-[2-(4-HYDROXYPHENYL)ETHYL]ACRYLAMIDE",VSHUQLRHTJOKTA-XBXARRHUSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
16435,6lzg,DB04232,-7.9,N-Hydroxy-1-(4-Methoxyphenyl)Sulfonyl-4-Benzyloxycarbonyl-Piperazine-2-Carboxamide,DNGGPLKVDUPXFN-GOSISDBHSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
58767,6crv,DB06600,-7.9,Nemonoxacin,AVPQPGFLVZTJOR-RYUDHWBXSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
134777,6w9c,DB03534,-7.9,3-[(Acetyl-Methyl-Amino)-Methyl]-4-Amino-N-Methyl-N-(1-Methyl-1h-Indol-2-Ylmethyl)-Benzamide,AWTBJNJPBKTHEV-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
84054,6m3m,DB04707,-7.9,Hydroxyfasudil,ZAVGJDAFCZAWSZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58705,6crv,DB06442,-7.9,Avasimibe,PTQXTEKSNBVPQJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
134858,6w9c,DB03658,-7.9,"2-{1-[2-Amino-2-(4-Hydroxy-Phenyl)-Acetylamino]-2-Oxo-Ethyl}-5,5-Dimethyl-Thiazolidine-4-Carboxylic Acid",SMLJDSWXGVMNTH-NRWUCQMLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
1644,6lzg,HMDB0012895,-7.9,Arginine vasopressin 1-8,SXYIOPJBWYQZRQ-VMPYSSHJSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
84085,6m3m,DB04753,-7.9,"9-DEAZAINOSINE-2',3'-O-ETHYLIDENEPHOSPHONATE",ZOEDLCUBOBTIHG-USQSKNHBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
60678,6crv,DB08967,-7.9,Dimetotiazine,VWNWVCJGUMZDIU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58666,6crv,DB06313,-7.9,BNC105,MYDHDVLPMRNDAZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60668,6crv,DB08955,-7.9,Ibuproxam,BYPIURIATSUHDW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
129221,6w4h,DB08535,-7.9,"3-bromo-5-phenyl-N-(pyridin-3-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",SMIZFGZXFDGISG-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
129222,6w4h,DB08536,-7.9,"3-bromo-5-phenyl-N-(pyrimidin-5-ylmethyl)pyrazolo[1,5-a]pyridin-7-amine",IBUPHWYGVDAASU-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
84093,6m3m,DB04763,-7.9,"1-N-(4-SULFAMOYLPHENYL-ETHYL)-2,4,6-TRIMETHYLPYRIDINIUM",UXBCHTZINZNVRG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
129223,6w4h,DB08537,-7.9,"3-bromo-6-phenyl-N-(pyrimidin-5-ylmethyl)imidazo[1,2-a]pyridin-8-amine",LZLKFNBMXXLTLX-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
25363,6cs2,DB03267,-7.9,1-Allyl-3-Butyl-8-(N-Acetyl-4-Aminobenzyl)-Xanthine,XFOWZKUTPKXWIE-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
129239,6w4h,DB08556,-7.9,"5'-ACETYL-4-{[(2,4-DIMETHYLPHENYL)SULFONYL]AMINO}-2,2'-BITHIOPHENE-5-CARBOXYLIC ACID",CMHHNHDPPWDNAH-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
60656,6crv,DB08940,-7.9,Kebuzone,LGYTZKPVOAIUKX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86564,6m3m,DB09022,-7.9,Benfluorex,CJAVTWRYCDNHSM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84133,6m3m,DB04817,-7.9,Metamizole,LVWZTYCIRDMTEY-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86579,6m3m,DB09056,-7.9,Amorolfine,MQHLMHIZUIDKOO-AYHJJNSGSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
4818,6lzg,HMDB0053904,-7.9,"TG(20:3n6/22:2(13Z,16Z)/o-18:0)",ROYJPPZMPGNTCP-VKWATNDDSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
26645,6cs2,DB04825,-7.9,Prenylamine,IFFPICMESYHZPQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
104628,6vxs,DB12279,-7.9,OBP-801,XFLBOEMFLGLWFF-HDXRNPEWSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
84147,6m3m,DB04831,-7.9,Tienilic acid,AGHANLSBXUWXTB-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86571,6m3m,DB09040,-7.9,Efinaconazole,NFEZZTICAUWDHU-RDTXWAMCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
161149,7bv1,DB12952,-7.9,Methylprednisone,SVYCRJXQZUCUND-PQXSVQADSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
102557,6vxs,DB07536,-7.9,"N-{(1S,2R)-2-hydroxy-1-[(hydroxyamino)carbonyl]propyl}-4-{[4-(morpholin-4-ylmethyl)phenyl]ethynyl}benzamide",FQYBTYFKOHPWQT-VGSWGCGISA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
134903,6w9c,DB03719,-7.9,N-Ethyl-5'-Carboxamido Adenosine,JADDQZYHOWSFJD-BMYQGPEFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
84166,6m3m,DB04854,-7.9,Febuxostat,BQSJTQLCZDPROO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
102559,6vxs,DB07538,-7.9,"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}-2-(TRIFLUOROMETHYL)BENZENESULFONAMIDE",RGVVHQNJKUNSFQ-WDZFZDKYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
134877,6w9c,DB03682,-7.9,"Dibenzofuran-4,6-Dicarboxylic Acid",HBBGSNOHAGNQRQ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
58680,6crv,DB06364,-7.9,XR5944,SFOADSRLCHRTKT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104573,6vxs,DB12204,-7.9,Terbogrel,XUTLOCQNGLJNSA-RGVLZGJSSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
161352,7bv1,DB13856,-7.9,Fluclorolone,VTWKPILBIUBMDS-OTJLYDAYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60816,6crv,DB09188,-7.9,Amedalin,HBGWAZBZXJBYQD-IBGZPJMESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
135897,6w9c,DB05590,-7.9,Bedoradrine,OANCEOSLKSTLTA-REWPJTCUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
135896,6w9c,DB05586,-7.9,Facinicline,TXCYUSKWBHUVEP-CYBMUJFWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
104864,6vxs,DB12625,-7.9,Evogliptin,LCDDAGSJHKEABN-MLGOLLRUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
83573,6m3m,DB04068,-7.9,Fudp,WLQBZMZTRNPUDL-SHYZEUOFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
70389,6lxt,DB12573,-7.9,LY-2452473,IHIWYQYVBNODSV-KRWDZBQOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
26894,6cs2,DB05779,-7.9,Oglufanide,LLEUXCDZPQOJMY-AAEUAGOBSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
135883,6w9c,DB05519,-7.9,Budiodarone,ZXOSVKYCXLTVGS-KRWDZBQOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
135864,6w9c,DB05442,-7.9,Etiprednol dicloacetate,QAIOVDNCIZSSSF-RFAJLIJZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
128546,6w4h,DB07741,-7.9,"4-(1R,3AS,4R,8AS,8BR)-[1-DIFLUOROMETHYL-2-(4-FLUOROBENZYL)-3-OXODECAHYDROPYRROLO[3,4-A]PYRROLIZIN-4-YL]BENZAMIDINE",VPNYXOTTXAXSIH-SXYSDOLCSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
128555,6w4h,DB07751,-7.9,"(2S)-1-[4-({6-[(2,6-Difluorophenyl)amino]-4-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol",ZVSBKYYVBCKDBO-HNNXBMFYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
128558,6w4h,DB07755,-7.9,"(2S)-1-[4-({4-[(2,5-Dichlorophenyl)amino]-2-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol",GNLAGGCSJGJECE-INIZCTEOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
104843,6vxs,DB12588,-7.9,AZD-1480,PDOQBOJDRPLBQU-QMMMGPOBSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
70382,6lxt,DB12563,-7.9,MK-0686,WZZIQHIQMWJNLU-LLVKDONJSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
70394,6lxt,DB12579,-7.9,JNJ-37822681,UVUYWJWYRLJHEN-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
70401,6lxt,DB12591,-7.9,BMS-911543,JCINBYQJBYJGDM-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
33611,6cs2,T3D4860,-7.9,Allura red AC,UQWIHFJXDRNUDP-FMQUCBEESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
158176,7bv1,DB00470,-7.9,Dronabinol,CYQFCXCEBYINGO-IAGOWNOFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
161616,7bv1,DB00180,-7.9,Flunisolide,XSFJVAJPIHIPKU-XWCQMRHXSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
28740,6cs2,DB08352,-7.9,"6-[4-(2-fluorophenyl)-1,3-oxazol-5-yl]-N-(1-methylethyl)-1,3-benzothiazol-2-amine",FQYJTHIYAQQJAB-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
161615,7bv1,DB00179,-7.9,Masoprocol,HCZKYJDFEPMADG-TXEJJXNPSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
70406,6lxt,DB12598,-7.9,Nafamostat,MQQNFDZXWVTQEH-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
70412,6lxt,DB12612,-7.9,Ozanimod,XRVDGNKRPOAQTN-FQEVSTJZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
128578,6w4h,DB07778,-7.9,FAMOXADONE,PCCSBWNGDMYFCW-QFIPXVFZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
135835,6w9c,DB05265,-7.9,Ecabet,IWCWQNVIUXZOMJ-MISYRCLQSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
60901,6crv,DB09305,-7.9,Aptazapine,MNHDDERDSNZCCK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86905,6m3m,DB11462,-7.9,Sulfaethoxypyridazine,FFJIWWBSBCOKLS-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
128564,6w4h,DB07761,-7.9,"(2R)-1-[4-({6-[(2,6-Difluorophenyl)amino]-4-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol",ZVSBKYYVBCKDBO-OAHLLOKOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
102280,6vxs,DB07216,-7.9,"(11S)-8-CHLORO-11-[1-(METHYLSULFONYL)PIPERIDIN-4-YL]-6-PIPERAZIN-1-YL-11H-BENZO[5,6]CYCLOHEPTA[1,2-B]PYRIDINE",ZMGCFGGMTCMSDP-QHCPKHFHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
135915,6w9c,DB05695,-7.9,NPS-2143,PZUJQWHTIRWCID-HXUWFJFHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
128490,6w4h,DB07675,-7.9,(2S)-2-ETHOXY-3-{4-[2-(10H-PHENOXAZIN-10-YL)ETHOXY]PHENYL}PROPANOIC ACID,WMUIIGVAWPWQAW-DEOSSOPVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
128378,6w4h,DB07538,-7.9,"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}-2-(TRIFLUOROMETHYL)BENZENESULFONAMIDE",RGVVHQNJKUNSFQ-WDZFZDKYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
58290,6crv,DB04806,-7.9,(5-BROMO-4-CHLORO-3-INDOLYL)-A-D-MANNOSE,OPIFSICVWOWJMJ-HAAGFXOZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86987,6m3m,DB11666,-7.9,Buparlisib,CWHUFRVAEUJCEF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58293,6crv,DB04812,-7.9,Benoxaprofen,MITFXPHMIHQXPI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58298,6crv,DB04817,-7.9,Metamizole,LVWZTYCIRDMTEY-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136097,6w9c,DB06533,-7.9,Ragaglitazar,WMUIIGVAWPWQAW-XMMPIXPASA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
128402,6w4h,DB07567,-7.9,"(2R,3R,4S)-3-(4-HYDROXYPHENYL)-4-METHYL-2-[4-(2-PYRROLIDIN-1-YLETHOXY)PHENYL]CHROMAN-6-OL",XPVKGTWRXBSJKO-LHXLBICKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
161728,7bv1,DB00528,-7.9,Lercanidipine,ZDXUKAKRHYTAKV-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
102190,6vxs,DB07113,-7.9,"(2S)-6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2-(3,5-DIFLUOROPHENYL)-4-(3-METHOXYPROPYL)-2H-1,4-BENZOXAZIN-3(4H)-ONE",KHZQOXQOUCGGGA-NRFANRHFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
136075,6w9c,DB06478,-7.9,Porfiromycin,HRHKSTOGXBBQCB-VFWICMBZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
128415,6w4h,DB07584,-7.9,"N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine",OKGCSZUKOGMZAL-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
102203,6vxs,DB07126,-7.9,O6-CYCLOHEXYLMETHOXY-2-(4'-SULPHAMOYLANILINO) PURINE,OWXORKPNCHJYOF-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
135922,6w9c,DB05767,-7.9,Andrographolide,BOJKULTULYSRAS-OTESTREVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
60963,6crv,DB11155,-7.9,Triclocarban,ICUTUKXCWQ1Q-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136001,6w9c,DB06266,-7.9,Lonidamine,WDRYRZXSPDWGEB-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
128440,6w4h,DB07615,-7.9,Tranilast,NZHGWWWHIYHZNX-CSKARUKUSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
72245,6m2n,DB00514,-7.9,Dextromethorphan,MKXZASYAUGDDCJ-NJAFHUGGSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
135990,6w9c,DB06247,-7.9,CX516,ANDGGVOPIJEHOF-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
128464,6w4h,DB07642,-7.9,"5-{[1-(2-fluorobenzyl)piperidin-4-yl]methoxy}quinazoline-2,4-diamine",GYKIQIOWVKCVBP-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
102232,6vxs,DB07159,-7.9,Tamatinib,NHHQJBCNYHBUSI-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
11872,6lzg,DB12547,-7.9,LY-2886721,NIDRNVHMMDAAIK-YPMLDQLKSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
135944,6w9c,DB06153,-7.9,Pizotifen,FIADGNVRKBPQEU-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
26915,6cs2,DB05884,-7.9,HCV-086,VBRUONUESYTIDA-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
135935,6w9c,DB06134,-7.9,SNS-314,FAYAUAZLLLJJGH-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
128479,6w4h,DB07662,-7.9,N-[4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL]-ACRYLAMIDE,HTUBKQUPEREOGA-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
58332,6crv,DB04857,-7.9,Brasofensine,NRLIFEGHTNUYFL-QJDHNRDASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136037,6w9c,DB06374,-7.9,Elacestrant,SIFNOOUKXBRGGB-AREMUKBSSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
128898,6w4h,DB08141,-7.9,"4-{[(2,6-difluorophenyl)carbonyl]amino}-N-[(3S)-piperidin-3-yl]-1H-pyrazole-3-carboxamide",KOMNQBZWMCFDTQ-VIFPVBQESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
135779,6w9c,DB04957,-7.9,Azimilide,MREBEPTUUMTTIA-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
60893,6crv,DB09289,-7.9,Tianeptine,JICJBGPOMZQUBB-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
70470,6lxt,DB12705,-7.9,Cenerimod,KJKKMMMRWISKRF-FQEVSTJZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
33682,6cs2,T3D4924,-7.9,Flavone,VHBFFQKBGNRLFZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
161441,7bv1,DB14054,-7.9,Asiatic acid,JXSVIVRDWWRQRT-UYDOISQJSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
135626,6w9c,DB04725,-7.9,Licofelone,UAWXGRJVZSAUSZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
86819,6m3m,DB11260,-7.9,Diacetyl benzoyl lathyrol,JPYYWXPAHJBKJX-VWSFRBHVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83712,6m3m,DB04243,-7.9,5-Methyluridine 5'-Monophosphate,IGWHDMPTQKSDTL-JXOAFFINSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
26805,6cs2,DB05316,-7.9,Pimavanserin,RKEWSXXUOLRFBX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
161419,7bv1,DB14008,-7.9,Hispidulin,IHFBPDAQLQOCBX-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
128783,6w4h,DB08012,-7.9,(METHYLPYRIDAZINE PIPERIDINE ETHYLOXYPHENYL)ETHYLACETATE,KCHIOGFOPPOUJC-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
58476,6crv,DB05462,-7.9,Chlorotoxin I-131,YUFAHBUWIVNVNJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60843,6crv,DB09216,-7.9,Tolfenamic Acid,YEZNLOUZAIOMLT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58480,6crv,DB05482,-7.9,7-ethyl-10-hydroxycamptothecin,FJHBVJOVLFPMQE-QFIPXVFZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
128748,6w4h,DB07973,-7.9,N-(1-ISOPROPYLPIPERIDIN-4-YL)-1-(3-METHOXYBENZYL)-1H-INDOLE-2-CARBOXAMIDE,GIPCBGDQVGKMPO-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
86810,6m3m,DB11201,-7.9,Menthyl salicylate,SJOXEWUZWQYCGL-DVOMOZLQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
161402,7bv1,DB13967,-7.9,Patent Blue,DHAHKSQXIXFZJB-UHFFFAOYSA-O,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
135578,6w9c,DB04649,-7.9,TETRAHEDRAL INTERMEDIATE OF BLASTICIDIN S,MVFPGTZTOAHVBP-HXYLPHSESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
161396,7bv1,DB13956,-7.9,Estradiol valerate,RSEPBGGWRJCQGY-RBRWEJTLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
58488,6crv,DB05518,-7.9,Managlinat dialanetil,BYKBUQDQTLDNLE-KBPBESRZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
135559,6w9c,DB04626,-7.9,Apramycin,XZNUGFQTQHRASN-XQENGBIVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
26793,6cs2,DB05255,-7.9,Ronacaleret,FQJISUPNMFRIFZ-HXUWFJFHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
135531,6w9c,DB04590,-7.9,(2R)-({4-[AMINO(IMINO)METHYL]PHENYL}AMINO){5-ETHOXY-2-FLUORO-3-[(3R)-TETRAHYDROFURAN-3-YLOXY]PHENYL}ACETICACID,PGYOHIAQCFZQDK-AUUYWEPGSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
72121,6m2n,DB00365,-7.9,Grepafloxacin,AIJTTZAVMXIJGM-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
128868,6w4h,DB08108,-7.9,N-({6-[(4-CYANOBENZYL)OXY]NAPHTHALEN-2-YL}SULFONYL)-D-GLUTAMIC ACID,PUHRQSFXADUGJW-OAQYLSRUSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
161376,7bv1,DB13930,-7.9,Ulixertinib,KSERXGMCDHOLSS-LJQANCHMSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
128876,6w4h,DB08116,-7.9,"(3R)-4-{[(3,4-dihydroxyphenyl)acetyl]oxy}-N-(2-formylindolizin-3-yl)-3-sulfino-D-valine",DEOZLEGRVHDNKC-UGKGYDQZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
26778,6cs2,DB05154,-7.9,Pretomanid,ZLHZLMOSPGACSZ-NSHDSACASA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
128829,6w4h,DB08063,-7.9,"1-BENZYL-3-(4-METHOXYPHENYLAMINO)-4-PHENYLPYRROLE-2,5-DIONE",HLZMYWLMBBLASX-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
161549,7bv1,DB15057,-7.9,NUC-1031,NHTKGYOMICWFQZ-KKQYNPQSSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
135636,6w9c,DB04741,-7.9,Myxothiazol,XKTFQMCPGMTBMD-FYHMSGCOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
102322,6vxs,DB07265,-7.9,"3-(9-HYDROXY-1,3-DIOXO-4-PHENYL-2,3-DIHYDROPYRROLO[3,4-C]CARBAZOL-6(1H)-YL)PROPANOIC ACID",JDARUOOLJCFUOY-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102286,6vxs,DB07222,-7.9,(3S)-N-(5-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE,RJWMDETWDDESBP-ZDUSSCGKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
128610,6w4h,DB07812,-7.9,"N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyrrolo[2,3-b]pyridin-4-yl)thiophene-2-carboxamide",TWYNGDRSMHRPSY-MRXNPFEDSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
128613,6w4h,DB07815,-7.9,GIBBERELLIN A4,RSQSQJNRHICNNH-NFMPGMCNSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
161527,7bv1,DB15013,-7.9,TAK-243,KJDAGXLMHXUAGV-DGWLBADLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
104828,6vxs,DB12566,-7.9,Decernotinib,ASUGUQWIHMTFJL-QGZVFWFLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
26862,6cs2,DB05586,-7.9,Facinicline,TXCYUSKWBHUVEP-CYBMUJFWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
128634,6w4h,DB07839,-7.9,"N-2-1,3-BENZOXAZOL-2-YL-3-CYCLOHEXYL-N-{2-[(4-METHOXYPHENYL)AMINO]ETHYL}-L-ALANINAMIDE",VFNWTXUFNNOQHD-QFIPXVFZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
128637,6w4h,DB07843,-7.9,5-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1-BENZOTHIOPHENE-2-SULFONAMIDE,LTJNKFUIOOJXNJ-WFASDCNBSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
70437,6lxt,DB12654,-7.9,GSK-376501,OIDYMQICWGYEDR-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
135763,6w9c,DB04915,-7.9,Idronoxil,ZZUBHVMHNVYXRR-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
86875,6m3m,DB11410,-7.9,Fenbendazole,HDDSHPAODJUKPD-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
72172,6m2n,DB00425,-7.9,Zolpidem,ZAFYATHCZYHLPB-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
11910,6lzg,DB12598,-7.9,Nafamostat,MQQNFDZXWVTQEH-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
135741,6w9c,DB04876,-7.9,Vildagliptin,SYOKIDBDQMKNDQ-XWTIBIIYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
161485,7bv1,DB14896,-7.9,Selitrectinib,OEBIHOVSAMBXIB-SJKOYZFVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
102297,6vxs,DB07237,-7.9,{4-[(2R)-pyrrolidin-2-ylmethoxy]phenyl}(4-thiophen-3-ylphenyl)methanone,VUWFJUJWAWMRQN-HXUWFJFHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102307,6vxs,DB07249,-7.9,"N-(5-chloro-1,3-benzodioxol-4-yl)-6-methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-amine",QHIMVPIOWKYPSO-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
158241,7bv1,DB00768,-7.9,Olopatadine,JBIMVDZLSHOPLA-LSCVHKIXSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
128717,6w4h,DB07937,-7.9,"2-butoxy-9-(2,6-difluorobenzyl)-N-(2-morpholin-4-ylethyl)-9H-purin-6-amine",UGZWPZWADDDTRN-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
60868,6crv,DB09246,-7.9,Benmoxin,BEWNZPMDJIGBED-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
70456,6lxt,DB12680,-7.9,Intepirdine,JJZFWROHYSMCMU-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
128722,6w4h,DB07943,-7.9,2-{4-[5-(4-chlorophenyl)-4-pyrimidin-4-yl-1H-pyrazol-3-yl]piperidin-1-yl}-2-oxoethanol,CATQHDWESBRRQA-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
11908,6lzg,DB12597,-7.9,ABL-001,VOVZXURTCKPRDQ-CQSZACIVSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
86856,6m3m,DB11376,-7.9,Azaperone,XTKDAFGWCDAMPY-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
161458,7bv1,DB14846,-7.9,Bimiralisib,ADGGYDAFIHSYFI-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
12651,6lzg,DB13640,-7.9,Acetoxolone,FTQDJVZNPJRVPG-XWEVEMRCSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
70447,6lxt,DB12666,-7.9,Emapunil,NBMBIEOUVBHEBM-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
164395,7bv1,DB07783,-7.9,1-((1R)-1-(HYDROXYMETHYL)-3-{6-[(3-PHENYLPROPANOYL)AMINO]-1H-INDOL-1-YL}PROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE,GUYYFMCFEPDDFL-OAQYLSRUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
104292,6vxs,DB11789,-7.9,Hyodeoxycholic Acid,DGABKXLVXPYZII-SIBKNCMHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
164397,7bv1,DB07786,-7.9,"1-((1R,2S)-1-{2-[2-(4-CHLOROPHENYL)-1,3-BENZOXAZOL-7-YL]ETHYL}-2-HYDROXYPROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE",SMFRBBHLVBWHGB-DJJJIMSYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
77224,6m2n,DB08116,-7.9,"(3R)-4-{[(3,4-dihydroxyphenyl)acetyl]oxy}-N-(2-formylindolizin-3-yl)-3-sulfino-D-valine",DEOZLEGRVHDNKC-UGKGYDQZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
30777,6cs2,DB12962,-7.9,CP-547632,HXHAJRMTJXHJJZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
95700,6m71,DB11816,-7.9,Omecamtiv Mecarbil,RFUBTTPMWSKEIW-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
67387,6lxt,DB06616,-7.9,Bosutinib,UBPYILGKFZZVDX-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
9586,6lzg,DB07698,-7.9,"3-(3-aminophenyl)-N-(3-chlorophenyl)pyrazolo[1,5-a]pyrimidin-5-amine",JDNMRPIWJIDDAY-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
95730,6m71,DB11859,-7.9,Brexanolone,AURFZBICLPNKBZ-SYBPFIFISA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
30787,6cs2,DB12977,-7.9,Simenepag isopropyl,MSIIJNOQQWRTFC-GGAORHGYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
77251,6m2n,DB08146,-7.9,"7-(2,5-dihydropyrrol-1-yl)-6-phenyl-pyrido[6,5-d]pyrimidin-2-amine",QFWNOFXQNCLFBC-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
65195,6lxt,DB02510,-7.9,'5'-O-(N-(L-Prolyl)-Sulfamoyl)Adenosine,LKVJEMXWEODCAY-JVEUSOJLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
118612,6w4b,DB05490,-7.9,AMG-131,NMRWDFUZLLQSBN-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
165647,7bv1,DB12591,-7.9,BMS-911543,JCINBYQJBYJGDM-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
111130,6vxx,DB03039,-7.9,"4-(Aminosulfonyl)-N-[(2,5-Difluorophenyl)Methyl]-Benzamide",KEGUALXMKQVDIO-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
95733,6m71,DB11864,-7.9,Preladenant,DTYWJKSSUANMHD-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
118639,6w4b,DB05616,-7.9,"4'-Methylene-5,8,10-trideazaaminopterin",NAWXUBYGYWOOIX-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
95746,6m71,DB11883,-7.9,SB-705498,JYILLRHXRVTRSH-GFCCVEGCSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
77263,6m2n,DB08158,-7.9,"2,4-DINITROPHENYL 2-DEOXY-2-FLUORO-BETA-D-MANNOPYRANOSIDE",UFSBFVZQJZMIOU-IYKVGLELSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
29426,6cs2,DB09179,-7.9,R-30490,GARXJOUQUSNOGK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
95768,6m71,DB11912,-7.9,Lanopepden,SWHNZGMQMGFQGW-MSOLQXFVSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
146292,6w9q,DB08354,-7.9,"2-(4-CHLOROBENZYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE",QCVULERVJOYHCP-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
152943,6wiq,DB04727,-7.9,"N-(4-{4-AMINO-6-[4-(METHYLOXY)PHENYL]FURO[2,3-D]PYRIMIDIN-5-YL}PHENYL)-N'-[2-FLUORO-5-(TRIFLUOROMETHYL)PHENYL]UREA",FGZIONRFHVNRJB-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
146289,6w9q,DB08351,-7.9,N-cyclopropyl-4-methyl-3-{2-[(2-morpholin-4-ylethyl)amino]quinazolin-6-yl}benzamide,MNEXDVSJIUQQRH-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
9613,6lzg,DB07729,-7.9,3-fluoro-N-[3-(1H-tetrazol-5-yl)phenyl]benzamide,GAKOBKPDJJGRIL-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
146288,6w9q,DB08350,-7.9,"5-[3-(2-METHOXYPHENYL)-1H-PYRROLO[2,3-B]PYRIDIN-5-YL]-N,N-DIMETHYLPYRIDINE-3-CARBOXAMIDE",GYQRHHQPEMOLKH-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
111224,6vxx,DB03361,-7.9,"2-{(9as)-9a-[(1s)-1-Hydroxyethyl]-2,7-Dimethyl-9a,10-Dihydro-5h-Pyrimido[4,5-D][1,3]Thiazolo[3,2-a]Pyrimidin-8-Yl}Ethyl Trihydrogen Diphosphate",UQFVHIGKDHNMJT-XPTSAGLGSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111231,6vxx,DB03369,-7.9,9-Aminophenanthrene,KIHQWOBUUIPWAN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
92430,6m71,DB04395,-7.9,Phosphoaminophosphonic Acid-Adenylate Ester,PVKSNHVPLWYQGJ-FCIPNVEPSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
67376,6lxt,DB06590,-7.9,Ceftaroline fosamil,ZCCUWMICIWSJIX-NQJJCJBVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
65271,6lxt,DB02611,-7.9,Balanol Analog 1,FZJQHARRQUNVGZ-QZTJIDSGSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
67327,6lxt,DB06460,-7.9,Enrasentan,GLCKXJLCYIJMRB-UPRLRBBYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
118452,6w4b,DB04841,-7.9,Flunarizine,SMANXXCATUTDDT-QPJJXVBHSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
53467,2fxp,DB13050,-7.9,Tirilazad,RBKASMJPSJDQKY-RBFSKHHSSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
92539,6m71,DB04542,-7.9,3'-Azido-3'-Deoxythymidine-5'-Diphosphate,QOYVAFWJURKBJG-XLPZGREQSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
146442,6w9q,DB08534,-7.9,"5-(2-fluorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",ZAIYYXVHGBMLEC-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
23227,6cs2,HMDB0059878,-7.9,alpha-Curcumene,VMYXUZSZMNBRCN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
95634,6m71,DB11718,-7.9,Encorafenib,CMJCXYNUCSMDBY-ZDUSSCGKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
65243,6lxt,DB02573,-7.9,"2'-Deoxycytidine-2'-Deoxyadenosine-3',5'-Monophosphate",LYWWDKIADIGKTH-IDMWBNCISA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
146411,6w9q,DB08498,-7.9,"(1S)-1-(3-chlorophenyl)-2-oxo-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate",OVSAMUIBGQSLDC-INIZCTEOSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
111329,6vxx,DB03509,-7.9,2-(4-Chlorophenyl)-5-Quinoxalinecarboxamide,FLYGLPYJEQPCFY-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77292,6m2n,DB08192,-7.9,2-(4-CARCOXY-5-ISOPROPYLTHIAZOLYL)BENZOPIPERIDINE,HCUGCUQZFBURHR-LBPRGKRZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77173,6m2n,DB08059,-7.9,Wortmannin,QDLHCMPXEPAAMD-QAIWCSMKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
67352,6lxt,DB06525,-7.9,Ganstigmine,ZOBDWFRKFSPCRB-UNMCSNQZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
77188,6m2n,DB08077,-7.9,"2-[4-({[(3,5-DICHLOROPHENYL)AMINO]CARBONYL}AMINO)PHENOXY]-2-METHYLPROPANOIC ACID",OYJPTSMWFKGZJM-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
30760,6cs2,DB12939,-7.9,Nikkomycin Z,WWJFFVUVFNBJTN-VHDFTHOZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
165679,7bv1,DB12647,-7.9,Tocotrienol,GJJVAFUKOBZPCB-ZGRPYONQSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95656,6m71,DB11751,-7.9,Cabotegravir,WCWSTNLSLKSJPK-LKFCYVNXSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
118508,6w4b,DB04942,-7.9,Tamibarotene,MUTNCGKQJGXKEM-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
95673,6m71,DB11778,-7.9,Danusertib,XKFTZKGMDDZMJI-HSZRJFAPSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
146387,6w9q,DB08470,-7.9,"3-(4-fluorophenyl)-5-phenyl-4H-1,2,4-triazole",KMGPJKOKSYGMJD-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
95695,6m71,DB11806,-7.9,VTP-194204,BOOOLEGQBVUTKC-NVQSDHBMSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
9555,6lzg,DB07665,-7.9,"N-[2-(carbamimidamidooxy)ethyl]-2-{6-cyano-3-[(2,2-difluoro-2-pyridin-2-ylethyl)amino]-2-fluorophenyl}acetamide",STHCHQXQLDMISY-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
111291,6vxx,DB03458,-7.9,"N(4)-Adenosyl-N(4)-methyl-2,4-diaminobutanoic acid",JISVTSUBJCPLSV-TWBCTODHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77187,6m2n,DB08076,-7.9,"4-[1-(2,6-dichlorobenzyl)-2-methyl-1H-imidazol-4-yl]pyrimidin-2-amine",CKSSZTMRRVJNNG-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
29420,6cs2,DB09173,-7.9,Butyrfentanyl,QQOMYEQLWQJRKK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
146287,6w9q,DB08349,-7.9,"N-cyclopropyl-3-{[1-(2,4-difluorophenyl)-7-methyl-6-oxo-6,7-dihydro-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}-4-methylbenzamide",WMEYCLAVMZKZCS-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
95784,6m71,DB11939,-7.9,Henagliflozin,HYTPDMFFHVZBOR-VNXMGFANSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95946,6m71,DB12180,-7.9,Apitolisib,YOVVNQKCSKSHKT-HNNXBMFYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
146051,6w9q,DB08063,-7.9,"1-BENZYL-3-(4-METHOXYPHENYLAMINO)-4-PHENYLPYRROLE-2,5-DIONE",HLZMYWLMBBLASX-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
118917,6w4b,DB06634,-7.9,Casopitant,XGGTZCKQRWXCHW-WMTVXVAQSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
146045,6w9q,DB08057,-7.9,"N-(2-chloro-6-methylphenyl)-8-[(3S)-3-methylpiperazin-1-yl]imidazo[1,5-a]quinoxalin-4-amine",VWJPPYCULHDHBB-HNNXBMFYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
165566,7bv1,DB12467,-7.9,TU-100,KAYRGFYBCCETPE-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
77445,6m2n,DB08388,-7.9,"5-(2-ETHOXYETHYL)-5-[4-(4-FLUOROPHENOXY)PHENOXY]PYRIMIDINE-2,4,6(1H,3H,5H)-TRIONE",XRSYNYGEEYTXJV-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
92155,6m71,DB04023,-7.9,"Guanosine 5'-(Trihydrogen Diphosphate), P'-D-Mannopyranosyl Ester",DNBSDUDYNPJVCN-ZXTXFPBHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
20439,6cs2,HMDB0000951,-7.9,Taurochenodesoxycholic acid,BHTRKEVKTKCXOH-BJLOMENOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
92147,6m71,DB04014,-7.9,Alsterpaullone,OLUKILHGKRVDCT-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
165561,7bv1,DB12461,-7.9,GLPG-0492,VAJGULUVTFDTAS-GOSISDBHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110659,6vxx,DB02071,-7.9,WAY-151693,AINJYWXKBKRQSX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
9680,6lzg,DB07800,-7.9,N-(2-(((5-CHLORO-2-PYRIDINYL)AMINO)SULFONYL)PHENYL)-4-(2-OXO-1(2H)-PYRIDINYL)BENZAMIDE,MIJGLXFQYBTIFY-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
110657,6vxx,DB02069,-7.9,N-(2-Flouro-Benzyl)-4-Sulfamoyl-Benzamide,ULYMHSXFSKOHGH-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110654,6vxx,DB02065,-7.9,4-Deoxylactose,DSYGIMVFFQCOQZ-KYYLAPRMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77484,6m2n,DB08436,-7.9,"8-BENZO[1,3]DIOXOL-,5-YLMETHYL-9-BUTYL-9H-",JCDXXNIRWRRGBX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
9690,6lzg,DB07809,-7.9,4-({[4-(3-METHYLBENZOYL)PYRIDIN-2-YL]AMINO}METHYL)BENZENECARBOXIMIDAMIDE,MBJYEMUMDMGQQC-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
153171,6wiq,DB05412,-7.9,Talmapimod,ZMELOYOKMZBMRB-DLBZAZTESA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
96002,6m71,DB12260,-7.9,Radiprodil,GKGRZLGAQZPEHO-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110607,6vxx,DB02001,-7.9,"5-(4-Morpholin-4-Yl-Phenylsulfanyl)-2,4-Quinazolinediamine",CZLWCJRHDBTCGQ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110582,6vxx,DB01965,-7.9,"2'-Deoxyuridine 5'-Alpha,Beta-Imido-Triphosphate",XZLLMTSKYYYJLH-SHYZEUOFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
96013,6m71,DB12273,-7.9,Ecopipam,DMJWENQHWZZWDF-PKOBYXMFSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
145988,6w9q,DB07993,-7.9,"N-3-[3-(1H-INDOL-6-YL)BENZYL]PYRIDINE-2,3-DIAMINE",LPQUIIHPUGDHJK-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
96020,6m71,DB12283,-7.9,Balapiravir,VKXWOLCNTHXCLF-DXEZIKHYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
145974,6w9q,DB07977,-7.9,"3-({[3,5-DIFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)THIOPHENE-2-CARBOXYLIC ACID",CGNHUSCKOHDSMR-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
118938,6w4b,DB06684,-7.9,Vilazodone,SGEGOXDYSFKCPT-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
146494,6w9q,DB08597,-7.9,"6-[4-(2-piperidin-1-ylethoxy)phenyl]-3-pyridin-4-ylpyrazolo[1,5-a]pyrimidine",XHBVYDAKJHETMP-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
118893,6w4b,DB06589,-7.9,Pazopanib,CUIHSIWYWATEQL-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
95920,6m71,DB12135,-7.9,Elubrixin,YQYFEGTYCUQBEI-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110936,6vxx,DB02602,-7.9,AL7182,ICIXQGGQPKFQRL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110925,6vxx,DB02587,-7.9,Colforsin,OHCQJHSOBUTRHG-KGGHGJDLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110924,6vxx,DB02586,-7.9,"4,7-Dimethyl-[1,10]Phenanthroline",JIVLDFFWTQYGSR-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
146250,6w9q,DB08303,-7.9,"(3S)-3-cyclopentyl-6-methyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide",CUMKMTBOHBENJI-SFHVURJKSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
110903,6vxx,DB02554,-7.9,"Sulfoquinovose-Uridine-C1,5'-Diphosphate",FQANCGQCBCUSMI-JZMIEXBBSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77319,6m2n,DB08229,-7.9,[N-(3-DIBENZYLCARBAMOYL-OXIRANECARBONYL)-HYDRAZINO]-ACETIC ACID,JGMMFVVACJREFE-KRWDZBQOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
95819,6m71,DB11990,-7.9,MK-0812,UNVWTBOGMHPKJM-CWKRKGSWSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95821,6m71,DB11994,-7.9,Diacerein,TYNLGDBUJLVSMA-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
65145,6lxt,DB02449,-7.9,3-(1h-Indol-3-Yl)-2-[4-(4-Phenyl-Piperidin-1-Yl)-Benzenesulfonylamino]-Propionic Acid,ULOTXPTWJAUGGE-MHZLTWQESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
30831,6cs2,DB13039,-7.9,Aminaphthone,YLMPBJUYFTWHKJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
65128,6lxt,DB02424,-7.9,Geldanamycin,QTQAWLPCGQOSGP-KSRBKZBZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
77397,6m2n,DB08325,-7.9,2-(2-HYDROXYETHYLAMINO)-6-(3-CHLOROANILINO)-9-ISOPROPYLPURINE,XZEFMZCNXDQXOZ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
118806,6w4b,DB06347,-7.9,Cenisertib,KSOVGRCOLZZTPF-QMKUDKLTSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
118831,6w4b,DB06429,-7.9,Talnetant,BIAVGWDGIJKWRM-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
74754,6m2n,DB03791,-7.9,"(3-{3-[[2-Chloro-3-(Trifluoromethyl)Benzyl](2,2-Diphenylethyl)Amino]Propoxy}Phenyl)Acetic Acid",NAXSRXHZFIBFMI-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
118840,6w4b,DB06448,-7.9,Lonafarnib,DHMTURDWPRKSOA-RUZDIDTESA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
110780,6vxx,DB02402,-7.9,"5-(4-Methoxyphenoxy)-2,4-Quinazolinediamine",CPZJZAIZIMCJRC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
7764,6lzg,DB04345,-7.9,Lumichrome,ZJTJUVIJVLLGSP-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
165597,7bv1,DB12515,-7.9,9-aminocamptothecin,FUXVKZWTXQUGMW-FQEVSTJZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110763,6vxx,DB02382,-7.9,Namn,JOUIQRNQJGXQDC-ZYUZMQFOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
95880,6m71,DB12081,-7.9,Anecortave,BCFCRXOJOFDUMZ-ONKRVSLGSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95886,6m71,DB12092,-7.9,Naftopidil,HRRBJVNMSRJFHQ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
146106,6w9q,DB08125,-7.9,"4-{[(2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]AMINO}-N-(1,3-THIAZOL-2-YL)BENZENESULFONAMIDE",BOMPRXSVSIPRDT-PTNGSMBKSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
92225,6m71,DB04121,-7.9,Guanosine-3'-Monophosphate-5'-Diphosphate,HEYSFDAMRDTCJM-UUOKFMHZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110840,6vxx,DB02479,-7.9,(R)-N-(3-Indol-1-Yl-2-Methyl-Propyl)-4-Sulfamoyl-Benzamide,ZFWHOUCRVSOZJE-CQSZACIVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
67533,6lxt,DB06865,-7.9,6-CARBAMIMIDOYL-2-[2-HYDROXY-6-(4-HYDROXY-PHENYL)-INDAN-1-YL]-HEXANOIC ACID,ZSRRBAKATXAISL-LMNJBCLMSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
77140,6m2n,DB08021,-7.9,5-bromo-N-(3-chloro-2-(4-(prop-2-ynyl)piperazin-1-yl)phenyl)furan-2-carboxamide,MEFJFXHHHNDHEN-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
111407,6vxx,DB03829,-7.9,Pseudouridine-5'-Monophosphate,MOBMOJGXNHLLIR-GBNDHIKLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
14061,6lzg,T3D3678,-7.9,Cytochalasin D,SDZRWUKZFQQKKV-BBXOWAOSSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
67198,6lxt,DB06144,-7.9,Sertindole,GZKLJWGUPQBVJQ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
76866,6m2n,DB07707,-7.9,"(9BETA,11ALPHA,13ALPHA,14BETA,17ALPHA)-11-(METHOXYMETHYL)ESTRA-1(10),2,4-TRIENE-3,17-DIOL",LEOPSILMAOYZBO-IUTAEKPZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
111939,6vxx,DB04892,-7.9,Phenserine,PBHFNBQPZCRWQP-QUCCMNQESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
147002,6w9q,DB09319,-7.9,Carindacillin,JIRBAUWICKGBFE-MNRDOXJOSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
95184,6m71,DB09047,-7.9,Finafloxacin,FYMHQCNFKNMJAV-HOTGVXAUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
151938,6wiq,DB03367,-7.9,PF-00356231,VMTJQZUZINLEKC-JOCHJYFZSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
92724,6m71,DB04791,-7.9,"2-O-(4'-AMIDINOPHENYL)-5-O-(3''-AMIDINOPHENYL)-1,4:3,6-DIANHYDRO-D-SORBITOL",DKBAWRNTUZFJKV-BSDSXHPESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
20679,6cs2,HMDB0001036,-7.9,Angiotensin III,QMMRCKSBBNJCMR-KMZPNFOHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
76898,6m2n,DB07746,-7.9,3-ETHYL-6-{[(4-FLUOROPHENYL)SULFONYL]AMINO}-2-METHYLBENZOIC ACID,MGUQWAOYPINSIT-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
65468,6lxt,DB02877,-7.9,Arotinoid acid,FOIVPCKZDPCJJY-JQIJEIRASA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
111888,6vxx,DB04829,-7.9,Lysergic acid diethylamide,VAYOSLLFUXYJDT-RDTXWAMCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
95203,6m71,DB09076,-7.9,Umeclidinium,FVTWTVQXNAJTQP-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95206,6m71,DB09080,-7.9,Olodaterol,COUYJEVMBVSIHV-SFHVURJKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
30634,6cs2,DB12756,-7.9,TAK-901,WKDACQVEJIVHMZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
95229,6m71,DB09124,-7.9,Medrogestone,HCFSGRMEEXUOSS-JXEXPEPMSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
165807,7bv1,DB13044,-7.9,Gossypol,QBKSWRVVCFFDOT-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
111871,6vxx,DB04812,-7.9,Benoxaprofen,MITFXPHMIHQXPI-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
117700,6w4b,DB03837,-7.9,Morpholine-4-Carboxylic Acid (1-(3-Benzenesulfonyl-1-Phenethylallylcarbamoyl)-3-Methylbutyl)-Amide,YUMYYTORLYHUFW-ZUDLOMHPSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
95230,6m71,DB09128,-7.9,Brexpiprazole,ZKIAIYBUSXZPLP-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
65438,6lxt,DB02836,-7.9,Guanosine 5'-Diphosphate 2':3'-Cyclic Monophosphate,NGYWTCOGOZELRS-UUOKFMHZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
165794,7bv1,DB13023,-7.9,IPI-493,XYFFWTYOFPSZRM-TWNAANEASA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95294,6m71,DB09223,-7.9,Blonanserin,XVGOZDAJGBALKS-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
111948,6vxx,DB04917,-7.9,Renzapride,YFUAYKVMQVBSNG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
92737,6m71,DB04807,-7.9,4-NITROPHENYL-(6-S-ALPHA-D-XYLOPYRANOSYL)-BETA-D-GLUCOPYRANOSIDE,HQYVHBCTLFPWRQ-ZMFOIVQCSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
111961,6vxx,DB04953,-7.9,Ezogabine,PCOBBVZJEWWZFR-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30611,6cs2,DB12724,-7.9,AZD-7295,MAQDQJWCSSCURR-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
95092,6m71,DB08922,-7.9,Perospirone,FBVFZWUMDDXLLG-HDICACEKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
29527,6cs2,DB09298,-7.9,Silibinin,SEBFKMXJBCUCAI-HKTJVKLFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
147211,6w9q,DB11577,-7.9,Indigotindisulfonic Acid,CFZXDJWFRVEWSR-BUHFOSPRSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
95104,6m71,DB08942,-7.9,Isoxicam,YYUAYBYLJSNDCX-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
92774,6m71,DB04850,-7.9,Posizolid,HBUJYEUPIIJJOS-PBHICJAKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
92773,6m71,DB04849,-7.9,Cediranib,XXJWYDDUDKYVKI-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
92768,6m71,DB04842,-7.9,Fluspirilene,QOYHHIBFXOOADH-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95120,6m71,DB08962,-7.9,Glibornuride,RMTYNAPTNBJHQI-LLDVTBCESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
147146,6w9q,DB11426,-7.9,Marbofloxacin,BPFYOAJNDMUVBL-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
147144,6w9q,DB11424,-7.9,Lufenuron,PWPJGUXAGUPAHP-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
112040,6vxx,DB06155,-7.9,Rimonabant,JZCPYUJPEARBJL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
95297,6m71,DB09226,-7.9,RP-5063,PMKMNTBZJOXTJW-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95132,6m71,DB08975,-7.9,Florantyrone,QOBAOSCOLAGPKI-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
29508,6cs2,DB09272,-7.9,Eluxadoline,QFNHIDANIVGXPE-FNZWTVRRSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
151713,6wiq,DB03076,-7.9,AHA047,CGBDAHCDSVOMCF-FYZVQMPESA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
111996,6vxx,DB05116,-7.9,Thymectacin,CFBLUORPOFELCE-BACVZHSASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
117370,6w4b,DB03383,-7.9,5-Chloro-1h-Indole-2-Carboxylic Acid [1-(4-Fluorobenzyl)-2-(4-Hydroxypiperidin-1yl)-2-Oxoethyl]Amide,YDCGVASFVACWKF-NRFANRHFSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
92750,6m71,DB04823,-7.9,Oxyphenisatin,SJDACOMXKWHBOW-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
111969,6vxx,DB04975,-7.9,Banoxantrone,YZBAXVICWUUHGG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
23269,6cs2,HMDB0059986,-7.9,"5-(3',4',5'-Trihydroxyphenyl)-gamma-valerolactone-4'-O-glucuronide",ATYNVCXMADLPJQ-YSVLGHOVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
165861,7bv1,DB13119,-7.9,GSK-364735,QWLNINWUBHHOLU-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
147090,6w9q,DB11275,-7.9,Epicriptine,SBFXHXZNBNFPHV-PXXBSISHSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
147089,6w9q,DB11274,-7.9,Dihydro-alpha-ergocryptine,PBUNVLRHZGSROC-VTIMJTGVSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
147088,6w9q,DB11273,-7.9,Dihydroergocornine,SEALOBQTUQIVGU-QNIJNHAOSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
76814,6m2n,DB07644,-7.9,"5-[(1S)-1-(3-chlorophenyl)ethoxy]quinazoline-2,4-diamine",IDHINEMSCUFEIP-VIFPVBQESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
152073,6wiq,DB03571,-7.9,"3-(5-Amino-7-Hydroxy-[1,2,3]Triazolo[4,5-D]Pyrimidin-2-Yl)-N-(3,5-Dichlorobenzyl)-Benzamide",JMQTXEWNXSPEKX-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
111810,6vxx,DB04725,-7.9,Licofelone,UAWXGRJVZSAUSZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
146854,6w9q,DB09075,-7.9,Edoxaban,HGVDHZBSSITLCT-JLJPHGGASA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
146685,6w9q,DB08822,-7.9,Azilsartan medoxomil,QJFSABGVXDWMIW-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
118190,6w4b,DB04495,-7.9,RU81843,GGPXNASQNUOIPB-NSOVKSMOSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
111609,6vxx,DB04274,-7.9,"5,4'-Dideoxyflavanone",SWAJPHCXKPCPQZ-AWEZNQCLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
74899,6m2n,DB03980,-7.9,4-(Fluorophenyl)-1-Cyclopropylmethyl-5-(2-Amino-4-Pyrimidinyl)Imidazole,DFEYXQGDDCDXJK-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
146681,6w9q,DB08815,-7.9,Lurasidone,PQXKDMSYBGKCJA-CVTJIBDQSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
165725,7bv1,DB12715,-7.9,MSX-122,PXZXYRKDDXKDTK-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
77057,6m2n,DB07929,-7.9,"N-(TERT-BUTYL)-3,5-DIMETHYL-N'-[(5-METHYL-2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)CARBONYL]BENZOHYDRAZIDE",JGJACZABNQGPMT-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
118252,6w4b,DB04575,-7.9,Quinestrol,PWZUUYSISTUNDW-VAFBSOEGSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
95541,6m71,DB11521,-7.9,Imidocarb,SCEVFJUWLLRELN-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
165718,7bv1,DB12707,-7.9,AR-42,LAMIXXKAWNLXOC-INIZCTEOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95563,6m71,DB11591,-7.9,Bilastine,ACCMWZWAEFYUGZ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
118153,6w4b,DB04452,-7.9,Aminoquinuride,HOUSDILKOJMENG-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
13999,6lzg,T3D3609,-7.9,Microcystin-RR,JIGDOBKZMULDHS-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
118346,6w4b,DB04703,-7.9,Hesperidin,QUQPHWDTPGMPEX-QJBIFVCTSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
29458,6cs2,DB09209,-7.9,Pholcodine,GPFAJKDEDBRFOS-FKQDBXSBSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
146556,6w9q,DB08674,-7.9,"(20S)-19,20,21,22-TETRAHYDRO-19-OXO-5H-18,20-ETHANO-12,14-ETHENO-6,10-METHENO-18H-BENZ[D]IMIDAZO[4,3-K][1,6,9,12]OXATRIAZA-CYCLOOCTADECOSINE-9-CARBONITRILE",USPFJPDEADLGIG-HSZRJFAPSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
95575,6m71,DB11622,-7.9,Dehydrocholic acid,OHXPGWPVLFPUSM-KLRNGDHRSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95579,6m71,DB11636,-7.9,Nomegestrol,KZUIYQJTUIACIG-YBZCJVABSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
9521,6lzg,DB07629,-7.9,"N-((1R,2S)-2-(5-CHLORO-1H-INDOLE-2-CARBOXAMIDO)CYCLOHEXYL)-5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE-2-CARBOXAMIDE",ARPFWVKYXJZULB-DLBZAZTESA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
67306,6lxt,DB06410,-7.9,Doxercalciferol,HKXBNHCUPKIYDM-CGMHZMFXSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
92581,6m71,DB04596,-7.9,"4-O-{4,6-O-[(1S)-1-Carboxyethylidene]-??-D-mannopyranosyl}-D-glucopyranuronic acid",GZJXZKGVHLWBOW-AISSFXTFSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
92573,6m71,DB04582,-7.9,IMAZAQUIN,CABMTIJINOIHOD-QGZVFWFLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
146515,6w9q,DB08622,-7.9,"4-(4-CHLORO-PHENYL)-1-{3-[2-(4-FLUORO-PHENYL)-[1,3]DITHIOLAN-2-YL]-PROPYL}-PIPERIDIN-4-OL",KVDKNVPAAQKHKD-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
65280,6lxt,DB02623,-7.9,Aminophosphonic Acid-Guanylate Ester,ZGPDMUBRWRJAQQ-UUOKFMHZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
118342,6w4b,DB04696,-7.9,"4-CHLORO-3',3''-DIBROMOPHENOL-1,8-NAPHTHALEIN",GFGZCXHXQCQRFP-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
92567,6m71,DB04575,-7.9,Quinestrol,PWZUUYSISTUNDW-VAFBSOEGSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
146689,6w9q,DB08828,-7.9,Vismodegib,BPQMGSKTAYIVFO-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
146721,6w9q,DB08882,-7.9,Linagliptin,LTXREWYXXSTFRX-QGZVFWFLSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
20657,6cs2,HMDB0001032,-7.9,Dehydroepiandrosterone sulfate,CZWCKYRVOZZJNM-USOAJAOKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
152114,6wiq,DB03632,-7.9,Argifin,UHBHXSDKGLPPGO-HTDHLNIYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
146784,6w9q,DB08975,-7.9,Florantyrone,QOBAOSCOLAGPKI-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
165773,7bv1,DB12988,-7.9,LY-518674,PNHFDVSKDSLUFH-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
9437,6lzg,DB07537,-7.9,"N'-(6-aminopyridin-3-yl)-N-(2-cyclopentylethyl)-4-methyl-benzene-1,3-dicarboxamide",CLEGTVIMOPPIBR-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
23252,6cs2,HMDB0059971,-7.9,"4-Hydroxy-5-(3',4'-dihydroxyphenyl)-valeric acid-O-glucuronide",FZTBEBWSWJPSHQ-AHLSELSJSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
92663,6m71,DB04705,-7.9,"(3BETA)-CHOLEST-5-ENE-3,25-DIOL",INBGSXNNRGWLJU-ZHHJOTBYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
111737,6vxx,DB04457,-7.9,2'-Deoxyguanosine-5'-Monophosphate,LTFMZDNNPPEQNG-KVQBGUIXSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
95353,6m71,DB09330,-7.9,Osimertinib,DUYJMQONPNNFPI-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95370,6m71,DB09378,-7.9,Fluprednisolone,MYYIMZRZXIQBGI-HVIRSNARSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
92657,6m71,DB04696,-7.9,"4-CHLORO-3',3''-DIBROMOPHENOL-1,8-NAPHTHALEIN",GFGZCXHXQCQRFP-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
111615,6vxx,DB04280,-7.9,"((2r,3s,5r)-3-Hydroxy-5-(4-Hydroxy-2-Oxo-3,4-Dihydropyrimidin-1(2h)-Yl)-Tetrahydrofuran-2-Yl)Methyldihydrogen Phosphate",ILSIYJVILUIVPM-LXGUWJNJSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30669,6cs2,DB12812,-7.9,Palomid 529,YEAHTLOYHVWAKW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
165758,7bv1,DB12766,-7.9,Cicletanine,CVKNDPRBJVBDSS-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
76997,6m2n,DB07857,-7.9,(2R)-2-(4-chlorophenyl)-2-[4-(1H-pyrazol-4-yl)phenyl]ethanamine,HWVGILTYGZFGLR-QGZVFWFLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76998,6m2n,DB07858,-7.9,(2S)-2-(4-chlorophenyl)-2-[4-(1H-pyrazol-4-yl)phenyl]ethanamine,HWVGILTYGZFGLR-KRWDZBQOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
111676,6vxx,DB04367,-7.9,Debromohymenialdisine,JYRJOQGKGMHTOO-VURMDHGXSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
9467,6lzg,DB07568,-7.9,"(2S)-2-[(2,1,3-BENZOTHIADIAZOL-4-YLSULFONYL)AMINO]-2-PHENYL-N-PYRIDIN-4-YLACETAMIDE",ADRNPUSZBRQDBG-KRWDZBQOSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
67262,6lxt,DB06267,-7.9,Udenafil,IYFNEFQTYQPVOC-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
67263,6lxt,DB06268,-7.9,Sitaxentan,PHWXUGHIIBDVKD-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
74905,6m2n,DB03987,-7.9,"2,4-Diamino-6-[N-(3',5'-Dimethoxybenzyl)-N-Methylamino]Pyrido[2,3-D]Pyrimidine",XWCCXDBXMCTZPW-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
29471,6cs2,DB09223,-7.9,Blonanserin,XVGOZDAJGBALKS-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
165737,7bv1,DB12732,-7.9,Firategrast,YLFZHHDVRSYTKT-NRFANRHFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
77041,6m2n,DB07909,-7.9,"(1S,2S,5S)2-(4-GLUTARIDYLBENZYL)-5-PHENYL-1-CYCLOHEXANOL",OBWILOKKNDYPLX-HBMCJLEFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
111684,6vxx,DB04378,-7.9,"3-Amino-N-{4-[2-(2,6-Dimethyl-Phenoxy)-Acetylamino]-3-Hydroxy-1-Isobutyl-5-Phenyl-Pentyl}-Benzamide",APJAEXGNDLFGPD-AWCRTANDSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
119031,6w4b,DB06837,-7.9,"(2R)-N-4-hydroxy-2-(3-hydroxybenzyl)-N-1-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]butanediamide",VXDKQRWTOJFQKH-BJZITVGISA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
67536,6lxt,DB06869,-7.9,1-[2-AMINO-2-CYCLOHEXYL-ACETYL]-PYRROLIDINE-3-CARBOXYLIC ACID 5-CHLORO-2-(2-ETHYLCARBAMOYL-ETHOXY)-BENZYLAMIDE,BMHVHOJXEQTIEA-SIKLNZKXSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
165531,7bv1,DB12238,-7.9,MK-0777,QKIWQBLNTSQOLY-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96815,6m71,DB13484,-7.9,Quinbolone,IUVKMZGDUIUOCP-BTNSXGMBSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
10036,6lzg,DB08173,-7.9,5-CHLORO-N-(2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO)ETHYL)THIOPHENE-2-CARBOXAMIDE,UCKHUNHXYMAFQM-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
10037,6lzg,DB08174,-7.9,"5-CHLORO-N-((1R,2S)-2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO) CYCLOPENTYL)THIOPHENE-2-CARBOXAMIDE",QCPYHSAHOYXXQK-DLBZAZTESA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
145704,6w9q,DB07665,-7.9,"N-[2-(carbamimidamidooxy)ethyl]-2-{6-cyano-3-[(2,2-difluoro-2-pyridin-2-ylethyl)amino]-2-fluorophenyl}acetamide",STHCHQXQLDMISY-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
96868,6m71,DB13554,-7.9,Moperone,AGAHNABIDCTLHW-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
77893,6m2n,DB08956,-7.9,Hydroxydione,USPYDUPOCUYHQL-VEVMSBRDSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
67766,6lxt,DB07133,-7.9,D-phenylalanyl-N-(3-methylbenzyl)-L-prolinamide,CHKWABXWPATIIG-UXHICEINSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
165289,7bv1,DB11712,-7.9,Tezacaftor,MJUVRTYWUMPBTR-MRXNPFEDSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
109665,6vxx,DB15097,-7.9,Gefapixant,HLWURFKMDLAKOD-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109658,6vxx,DB15080,-7.9,ELX-02,KJBRSTPUILEBDR-YBNFDXCTSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
67777,6lxt,DB07146,-7.9,"2,3-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-B]PYRIDIN-4-AMINE",QUIQCYFSBGOBKE-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
109649,6vxx,DB15062,-7.9,Inarigivir,LYMICVBGNUEHGE-FUQPUAIBSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77909,6m2n,DB08974,-7.9,Flubendazole,CPEUVMUXAHMANV-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
31129,6cs2,DB13439,-7.9,Fenpiprane,JXJPYHDHJZJWRI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
109618,6vxx,DB14540,-7.9,Hydrocortisone butyrate,BMCQMVFGOVHVNG-TUFAYURCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109605,6vxx,DB14221,-7.9,Beclomethasone 17-monopropionate,OHYGPBKGZGRQKT-XGQKBEPLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109598,6vxx,DB14210,-7.9,Moexiprilat,CMPAGYDKASJORH-YSSFQJQWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109565,6vxx,DB14129,-7.9,Macelignan,QDDILOVMGWUNGD-UONOGXRCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109560,6vxx,DB14122,-7.9,Dihydroxymethoxychalcone,NYSZJNUIVUBQMM-BQYQJAHWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
64520,6lxt,DB01623,-7.9,Thiothixene,GFBKORZTTCHDGY-UWVJOHFNSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
64503,6lxt,DB01604,-7.9,Pivampicillin,ZEMIJUDPLILVNQ-ZXFNITATSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
145599,6w9q,DB07537,-7.9,"N'-(6-aminopyridin-3-yl)-N-(2-cyclopentylethyl)-4-methyl-benzene-1,3-dicarboxamide",CLEGTVIMOPPIBR-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
67806,6lxt,DB07180,-7.9,"5-[(Z)-(5-Chloro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-N,2,4-trimethyl-1H-pyrrole-3-carboxamide",FIRPCWHHIWFKCD-GHXNOFRVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
109720,6vxx,DB15204,-7.9,Fosravuconazole,SYTNEMZCCLUTNX-NPMXOYFQSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109738,6vxx,DB15235,-7.9,Di-2-pyridylketone 4-cyclohexyl-4-methyl-3-thiosemicarbazone,GNLZNQJBZNOUBM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165304,7bv1,DB11903,-7.9,GW842166,TWQYWUXBZHPIIV-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
109744,6vxx,DB15246,-7.9,Salvianolic acid A,YMGFTDKNIWPMGF-UCPJVGPRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
67708,6lxt,DB07066,-7.9,"2-CHLORO-N-[(3R)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL]-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE",LJAHIGGEXIWVJG-LLVKDONJSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
109911,6vxx,DB00582,-7.9,Voriconazole,BCEHBSKCWLPMDN-MGPLVRAMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
64708,6lxt,DB01871,-7.9,[1-(1-Benzyl-3-Hydroxy-2-Oxo-Propylcarbamoyl)-2-Phenyl-Ethyl]-Carbamic Acid Benzyl Ester,OACUXIVGLLCILS-ZEQRLZLVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
119513,6w4b,DB07397,-7.9,"(5S)-5-(2-amino-2-oxoethyl)-4-oxo-N-[(3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl)methyl]-3,4,5,6,7,8-hexahydro[1]benzothieno[2,3-d]pyrimidine-2-carboxamide",ITADELAVAWJACR-NSHDSACASA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
67712,6lxt,DB07072,-7.9,"(1S,2R,5S)-5-[3-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7(8H)-YL]-2-(2,4,5-TRIFLUOROPHENYL)CYCLOHEXANAMINE",CNKRZILQBKJWDS-WMFXKJRFSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
91767,6m71,DB03501,-7.9,Galactose-uridine-5'-diphosphate,HSCJRCZFDFQWRP-ABVWGUQPSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
91760,6m71,DB03491,-7.9,2'-Deoxyguanosine-5'-Diphosphate,CIKGWCTVFSRMJU-KVQBGUIXSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
91752,6m71,DB03480,-7.9,Brequinar Analog,WYKKHJQZENLZID-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
109871,6vxx,DB00533,-7.9,Rofecoxib,RZJQGNCSTQAWON-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
153586,6wiq,DB06882,-7.9,1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-naphthalen-1-ylurea,HJWMLCDGRWWLAQ-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
96695,6m71,DB13325,-7.9,Nifurzide,IDUMOVRJNBNOTR-BIZLIJPVSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
67812,6lxt,DB07186,-7.9,"4-(4-METHYLPIPERAZIN-1-YL)-N-[5-(2-THIENYLACETYL)-1,5-DIHYDROPYRROLO[3,4-C]PYRAZOL-3-YL]BENZAMIDE",TYYNSDQVFIOSFH-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
9984,6lzg,DB08124,-7.9,"3-{[(2,2-DIOXIDO-1,3-DIHYDRO-2-BENZOTHIEN-5-YL)AMINO]METHYLENE}-5-(1,3-OXAZOL-5-YL)-1,3-DIHYDRO-2H-INDOL-2-ONE",FTQYGMLRLRXBPT-IDUWFGFVSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
165337,7bv1,DB11950,-7.9,Teneligliptin,WGRQANOPCQRCME-PMACEKPBSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
64640,6lxt,DB01780,-7.9,Fusicoccin,KXTYBXCEQOANSX-WYKQKOHHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
119582,6w4b,DB07479,-7.9,"(1S)-1,2,3,4-TETRAHYDRO-BENZO[C]PHENANTHRENE-2,3,4-TRIOL",WCUHTHVUZQCBTI-KBAYOESNSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
67746,6lxt,DB07113,-7.9,"(2S)-6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2-(3,5-DIFLUOROPHENYL)-4-(3-METHOXYPROPYL)-2H-1,4-BENZOXAZIN-3(4H)-ONE",KHZQOXQOUCGGGA-NRFANRHFSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
64631,6lxt,DB01767,-7.9,Hemi-Babim,KKJYVDXDZURHMA-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
96751,6m71,DB13397,-7.9,Prenoxdiazine,PXZDWASDNFWKSD-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
9999,6lzg,DB08138,-7.9,"{[(2,6-difluorophenyl)carbonyl]amino}-N-(4-fluorophenyl)-1H-pyrazole-3-carboxamide",BDRDBXXWQDFXEC-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
96753,6m71,DB13399,-7.9,Terguride,JOAHPSVPXZTVEP-YXJHDRRASA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
29339,6cs2,DB09022,-7.9,Benfluorex,CJAVTWRYCDNHSM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
119625,6w4b,DB07530,-7.9,"(1R,3R)-5-[(2E)-3-{(1S,3R)-2,2,3-trimethyl-3-[6,6,6-trifluoro-5-hydroxy-5-(trifluoromethyl)hex-3-yn-1-yl]cyclopentyl}prop-2-en-1-ylidene]cyclohexane-1,3-diol",PCHUQQNKOFNVDU-OSXMSNBXSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
77866,6m2n,DB08915,-7.9,Aleglitazar,DAYKLWSKQJBGCS-NRFANRHFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
96713,6m71,DB13347,-7.9,Diphenadione,JYGLAHSAISAEAL-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
31148,6cs2,DB13465,-7.9,Ciclobendazole,OXLKOMYHDYVIDM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
91596,6m71,DB03262,-7.9,"Al-6619, [2h-Thieno[3,2-E]-1,2-Thiazine-6-Sulfonamide,2-(3-Hydroxyphenyl)-3-(4-Morpholinyl)-, 1,1-Dioxide]",PZLYYZPXSSNGJS-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
31150,6cs2,DB01025,-7.9,Amlexanox,SGRYPYWGNKJSDL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
97312,6m71,DB14636,-7.9,Triciribine phosphate,URLYINUFLXOMHP-HTVVRFAVSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
78058,6m2n,DB09206,-7.9,Trimazosin,YNZXWQJZEDLQEG-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
145235,6w9q,DB07117,-7.9,"5-(4-PHENOXYPHENYL)-5-(4-PYRIMIDIN-2-YLPIPERAZIN-1-YL)PYRIMIDINE-2,4,6(2H,3H)-TRIONE",FMKQJGOROFNCGM-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
97346,6m71,DB14672,-7.9,Oxazepam acetate,FYRWUTOZBRWYCS-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
67930,6lxt,DB07321,-7.9,"2,5-DICHLORO-N-[5-METHOXY-7-(6-METHOXYPYRIDIN-3-YL)-1,3-BENZOXAZOL-2-YL]BENZENESULFONAMIDE",KOKQLKWXOFRTHE-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
78114,6m2n,DB09285,-7.9,Morniflumate,LDXSPUSKBDTEKA-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
165174,7bv1,DB11464,-7.9,Sulfaquinoxaline,NHZLNPMOSADWGC-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
67942,6lxt,DB07333,-7.9,"N-(CYCLOPROPYLMETHYL)-4-(METHYLOXY)-3-({5-[3-(3-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-YL}AMINO)BENZENESULFONAMIDE",KRGKAARWVPUWSY-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
97387,6m71,DB14769,-7.9,Pamiparib,DENYZIUJOTUUNY-MRXNPFEDSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
145190,6w9q,DB07063,-7.9,"{3-[(4,5,7-TRIFLUORO-1,3-BENZOTHIAZOL-2-YL)METHYL]-1H-INDOL-1-YL}ACETIC ACID",KYHVTMFADJNSGS-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
13580,6lzg,DB01261,-7.9,Sitagliptin,MFFMDFFZMYYVKS-SECBINFHSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
37308,1r42,DB04098,-7.9,Balanol,XYUFCXJZFZPEJD-PGRDOPGGSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
109254,6vxx,DB12962,-7.9,CP-547632,HXHAJRMTJXHJJZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
20184,6cs2,HMDB0000908,-7.9,5alpha-Cholestanol,QYIXCDOBOSTCEI-QCYZZNICSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
78153,6m2n,DB09421,-7.9,Protirelin,XNSAINXGIQZQOO-SRVKXCTJSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
109240,6vxx,DB12941,-7.9,ODM-201,BLIJXOOIHRSQRB-PXYINDEMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
74371,6m2n,DB03258,-7.9,2'-Deoxycytidine 5'-triphosphate,RGWHQCVHVJXOKC-SHYZEUOFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
109238,6vxx,DB12938,-7.9,Isoxaflutole,OYIKARCXOQLFHF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
64235,6lxt,DB01215,-7.9,Estazolam,CDCHDCWJMGXXRH-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
109228,6vxx,DB12925,-7.9,Crolibulin,JXONINOYTKKXQQ-CQSZACIVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
10269,6lzg,DB08448,-7.9,"(4aS)-5-[(2,4-diaminopteridin-6-yl)methyl]-4a,5-dihydro-2H-dibenzo[b,f]azepin-8-ol",PCBWLKUEKANDCL-INIZCTEOSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
165156,7bv1,DB11433,-7.9,Nequinate,NNOPDLNHPOLRRE-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
120085,6w4b,DB08064,-7.9,N-(3-TERT-BUTYL-1H-PYRAZOL-5-YL)-N'-{4-CHLORO-3-[(PYRIDIN-3-YLOXY)METHYL]PHENYL}UREA,NTMADESEDXKNFZ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
120097,6w4b,DB08079,-7.9,AMG-208,HEAIZQNMNCHNFD-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
64239,6lxt,DB01219,-7.9,Dantrolene,OZOMQRBLCMDCEG-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
67707,6lxt,DB07065,-7.9,"5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)-3-thiocyanatopyrazolo[1,5-a]pyrimidin-7-amine",AHPKUZJCNHGFQA-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
109357,6vxx,DB13461,-7.9,Cefcapene,HJJRIJDTIPFROI-NVKITGPLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109362,6vxx,DB13470,-7.9,Cefodizime,XDZKBRJLTGRPSS-BGZQYGJUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
64481,6lxt,DB01572,-7.9,Methyl-1-testosterone,JRNSSSJKIGAFCT-YDSAWKJFSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
67818,6lxt,DB07193,-7.9,"(2R,3R)-7-(methylsulfonyl)-3-(2,4,5-trifluorophenyl)-1,2,3,4-tetrahydropyrido[1,2-a]benzimidazol-2-amine",HJJAYSSCWGUPKO-ABAIWWIYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
97067,6m71,DB13821,-7.9,Ceftezole,DZMVCVMFETWNIU-LDYMZIIASA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
109482,6vxx,DB13958,-7.9,Trestolone acetate,IVCRCPJOLWECJU-XQVQQVTHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
97115,6m71,DB13919,-7.9,Candesartan,HTQMVQVXFRQIKW-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
74448,6m2n,DB03361,-7.9,"2-{(9as)-9a-[(1s)-1-Hydroxyethyl]-2,7-Dimethyl-9a,10-Dihydro-5h-Pyrimido[4,5-D][1,3]Thiazolo[3,2-a]Pyrimidin-8-Yl}Ethyl Trihydrogen Diphosphate",UQFVHIGKDHNMJT-XPTSAGLGSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
97129,6m71,DB13943,-7.9,Testosterone cypionate,HPFVBGJFAYZEBE-ZLQWOROUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
109423,6vxx,DB13552,-7.9,Trifluperidol,GPMXUUPHFNMNDH-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109419,6vxx,DB13548,-7.9,Dibrompropamidine,GMJFVGRUYJHMCO-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
64376,6lxt,DB01456,-7.9,5-androstenedione,SQGZFRITSMYKRH-QAGGRKNESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
165249,7bv1,DB11656,-7.9,Rebamipide,ALLWOAVDORUJLA-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
153814,6wiq,DB07145,-7.9,(2R)-N-HYDROXY-2-[(3S)-3-METHYL-3-{4-[(2-METHYLQUINOLIN-4-YL)METHOXY]PHENYL}-2-OXOPYRROLIDIN-1-YL]PROPANAMIDE,YDMIPBHQKFOFQW-NSYGIPOTSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
74439,6m2n,DB03349,-7.9,8-Bromo-Adenosine-5'-Monophosphate,DNPIJKNXFSPNNY-UUOKFMHZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
64365,6lxt,DB01443,-7.9,19-Nor-5-androstenedione,WELNRNVZXWUOGT-QXUSFIETSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
31177,6cs2,DB13501,-7.9,Bendazac,BYFMCKSPFYVMOU-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
64342,6lxt,DB01418,-7.9,Acenocoumarol,VABCILAOYCMVPS-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
64320,6lxt,DB01380,-7.9,Cortisone acetate,ITRJWOMZKQRYTA-RFZYENFJSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
97273,6m71,DB14512,-7.9,Mometasone furoate,WOFMFGQZHJDGCX-ZULDAHANSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
78029,6m2n,DB09177,-7.9,p-Fluorofentanyl,KXUBAVLIJFTASZ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78030,6m2n,DB09178,-7.9,Phenaridine,ODPKHHGQKIYCTJ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
165227,7bv1,DB11614,-7.9,Rupatadine,WUZYKBABMWJHDL-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97283,6m71,DB14545,-7.9,Hydrocortisone succinate,VWQWXZAWFPZJDA-CGVGKPPMSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
145266,6w9q,DB07152,-7.9,N-[4-(5-fluoro-6-methylpyridin-2-yl)-5-quinoxalin-6-yl-1H-imidazol-2-yl]acetamide,TYPILNNEZPSNTI-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
10184,6lzg,DB08354,-7.9,"2-(4-CHLOROBENZYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE",QCVULERVJOYHCP-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
91546,6m71,DB03205,-7.9,Pyrroloquinoline Quinone,MMXZSJMASHPLLR-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
77761,6m2n,DB08762,-7.9,O-(((1R)-((N-PHENYLMETHOXYCARBONYL-L-ALANYL)AMINO)ETHYL)HYDROXYPHOSPHONO)-L-BENZYLACETIC ACID,UPJNMOBJDSFRTI-FCEWJHQRSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
67706,6lxt,DB07064,-7.9,"(4R)-4-(3-HYDROXYPHENYL)-N,N,7,8-TETRAMETHYL-3,4-DIHYDROISOQUINOLINE-2(1H)-CARBOXAMIDE",HPVCRUIDFODATB-LJQANCHMSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
31063,6cs2,DB13360,-7.9,Tolciclate,CANCCLAKQQHLNK-LSDHHAIUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
110350,6vxx,DB01493,-7.9,Ethylestrenol,AOXRBFRFYPMWLR-XGXHKTLJSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110347,6vxx,DB01489,-7.9,Camazepam,PXBVEXGRHZFEOF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
96153,6m71,DB12467,-7.9,TU-100,KAYRGFYBCCETPE-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
119182,6w4b,DB07019,-7.9,"N-[(5R,14R)-5-AMINO-5,14-DIMETHYL-4-OXO-3-OXA-18-AZATRICYCLO[15.3.1.1-7,11-]DOCOSA-1(21),7(22),8,10,17,19-HEXAEN-19-YL]-N-METHYLMETHANESULFONAMIDE",QWDOKZPZLWNULU-MZNJEOGPSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
92015,6m71,DB03837,-7.9,Morpholine-4-Carboxylic Acid (1-(3-Benzenesulfonyl-1-Phenethylallylcarbamoyl)-3-Methylbutyl)-Amide,YUMYYTORLYHUFW-ZUDLOMHPSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
165483,7bv1,DB12167,-7.9,LY-3023414,ACCFLVVUVBJNGT-AWEZNQCLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
165482,7bv1,DB12165,-7.9,Presatovir,GOFXWTVKPWJNGD-UWJYYQICSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
77624,6m2n,DB08602,-7.9,"3-(2,6-difluorophenyl)-2-(methylthio)quinazolin-4(3H)-one",BFNBJSXMXXQLAW-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
96161,6m71,DB12477,-7.9,Perfluoro tert-butylcyclohexane,VLTXBOGHSBHSAC-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
77629,6m2n,DB08608,-7.9,"4-({(2R,5S)-2,5-DIMETHYL-4-[(2R)-3,3,3-TRIFLUORO-2-HYDROXY-2-METHYLPROPANOYL]PIPERAZIN-1-YL}CARBONYL)BENZONITRILE",IWFSHKKFDSWNLZ-BWACUDIHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
96166,6m71,DB12483,-7.9,Copanlisib,PZBCKZWLPGJMAO-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
119174,6w4b,DB07008,-7.9,"4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMIDAZOL-1-YL)PHENOXY]PYRIMIDINE",XPXGYINSBORUMM-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
119188,6w4b,DB07026,-7.9,"(1S,5S,7R)-N-7-(BIPHENYL-4-YLMETHYL)-N-3-HYDROXY-6,8-DIOXA-3-AZABICYCLO[3.2.1]OCTANE-3,7-DICARBOXAMIDE",PPLDARNGJSQINK-OKZBNKHCSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
153313,6wiq,DB06178,-7.9,Talotrexin,NYQPLPNEESYGNO-IBGZPJMESA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
9806,6lzg,DB07936,-7.9,N-(4-{[(3S)-3-(dimethylamino)pyrrolidin-1-yl]carbonyl}phenyl)-5-fluoro-4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]pyrimidin-2-amine,BACSZMCLZIDTIO-IBGZPJMESA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
165470,7bv1,DB12147,-7.9,Erdafitinib,OLAHOMJCDNXHFI-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
30969,6cs2,DB13252,-7.9,Tropatepine,JOQKFRLFXDPXHX-HDICACEKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
165466,7bv1,DB12141,-7.9,Gilteritinib,GYQYAJJFPNQOOW-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96216,6m71,DB12565,-7.9,Abexinostat,MAUCONCHVWBMHK-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
165459,7bv1,DB12130,-7.9,Lorlatinib,IIXWYSCJSQVBQM-LLVKDONJSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96229,6m71,DB12582,-7.9,Piperine,MXXWOMGUGJBKIW-YPCIICBESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96234,6m71,DB12591,-7.9,BMS-911543,JCINBYQJBYJGDM-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96239,6m71,DB12598,-7.9,Nafamostat,MQQNFDZXWVTQEH-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110236,6vxx,DB01132,-7.9,Pioglitazone,HYAFETHFCAUJAY-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
153305,6wiq,DB06159,-7.9,Rubitecan,VHXNKPBCCMUMSW-FQEVSTJZSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
110234,6vxx,DB01130,-7.9,Prednicarbate,FNPXMHRZILFCKX-KAJVQRHHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
119163,6w4b,DB06997,-7.9,"2-(4-fluorophenyl)-N-{[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]carbamoyl}acetamide",BMPOCDJEXAXXEZ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
77615,6m2n,DB08591,-7.9,"5-(4-METHOXYBIPHENYL-3-YL)-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDE",IGXKSKWHHHYBFM-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
67538,6lxt,DB06871,-7.9,17-METHYL-17-ALPHA-DIHYDROEQUILENIN,FQMQOMRDADWGJJ-GBESFXJTSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
110506,6vxx,DB01859,-7.9,4-Diphosphocytidyl-2-C-Methyl-D-Erythritol 2-Phosphate,HTJXTKBIUVFUAR-XHIBXCGHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
96057,6m71,DB12327,-7.9,Salvinorin A,OBSYBRPAKCASQB-AGQYDFLVSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110469,6vxx,DB01633,-7.9,Deoxy-2-fluoro-beta-D-cellotrioside,BZNXZJAUEMJQJB-QSCMNUSVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
153227,6wiq,DB05678,-7.9,SLx-4090,AZUIUVJESCFSLJ-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
119078,6w4b,DB06896,-7.9,"1-(4-fluorophenyl)-N-[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]-2-oxo-1,2-dihydropyridine-3-carboxamide",OBSFXHDOLBYWRJ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
96084,6m71,DB12375,-7.9,Oglemilast,OKFDRAHPFKMAJH-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
119079,6w4b,DB06897,-7.9,"3-[3-chloro-5-(5-{[(1S)-1-phenylethyl]amino}isoxazolo[5,4-c]pyridin-3-yl)phenyl]propan-1-ol",MMGKIHLBFPJYJL-HNNXBMFYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
96100,6m71,DB12394,-7.9,Eleclazine,YNUAEEJQYHYLMS-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
145894,6w9q,DB07882,-7.9,"4-{4-[2-(1A,7A-DIMETHYL-4-OXY-OCTAHYDRO-1-OXA-4-AZA-CYCLOPROPA[A]NAPHTHALEN-4-YL) -ACETYLAMINO]-PHENYLCARBAMOYL}-BUTYRIC ACID",VFIZFTGABDUGCF-UPVHCHBVSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
74671,6m2n,DB03687,-7.9,4-Diphosphocytidyl-2-C-Methyl-D-Erythritol,YFAUKWZNPVBCFF-XHIBXCGHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
110390,6vxx,DB01541,-7.9,Boldenone,RSIHSRDYCUFFLA-DYKIIFRCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
96111,6m71,DB12408,-7.9,PF-03635659,WGOJWDWKHJHXSV-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
77574,6m2n,DB08540,-7.9,"2-[4-(2H-1,4-BENZOTHIAZINE-3-YL)-PIPERAZINE-1-LY]-1,3-THIAZOLE-4-CARBOXYLIC ACID ETHYLESTER",AQJQFCRTSWIUCY-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
153251,6wiq,DB05835,-7.9,NS-3728,OQRAKHDEGGGWQO-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
77575,6m2n,DB08542,-7.9,"3,4-dihydroxy-9,10-secoandrosta-1(10),2,4-triene-9,17-dione",YUHVBHDSVLKFNI-NJSLBKSFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
74661,6m2n,DB03672,-7.9,9-N-Phenylmethylamino-Tacrine,JYJAEHAURXXPSD-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
9758,6lzg,DB07879,-7.9,"N-hydroxy-5-[(3-phenyl-5,6-dihydroimidazo[1,2-a]pyrazin-7(8H)-yl)carbonyl]thiophene-2-carboxamide",SMSIXMLQOONOQQ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
77594,6m2n,DB08564,-7.9,(2E)-N-{4-[(3-bromophenyl)amino]quinazolin-6-yl}-4-(dimethylamino)but-2-enamide,ZCIXBBSRVLSRJQ-QPJJXVBHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
96117,6m71,DB12416,-7.9,VTP-27999,NXWASIVXQMMPLM-ZXMXYHOLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
145886,6w9q,DB07872,-7.9,5-chloro-N-[(3R)-1-(2-{[2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl]amino}-2-oxoethyl)pyrrolidin-3-yl]thiophene-2-carboxamide,IYGIXVNAMZPBDK-CQSZACIVSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
96132,6m71,DB12434,-7.9,Steviolbioside,OMHUCGDTACNQEX-OSHKXICASA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96141,6m71,DB12447,-7.9,Nadifloxacin,JYJTVFIEFKZWCJ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
119145,6w4b,DB06977,-7.9,(2S)-1-{[5-(1H-Indazol-5-yl)-3-pyridinyl]oxy}-3-(7aH-indol-3-yl)-2-propanamine,CAASENZOSQYNPX-HSTJUUNISA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
92074,6m71,DB03916,-7.9,4-{2-[4-(2-Aminoethyl)Piperazin-1-Yl]Pyridin-4-Yl}-N-(3-Chloro-4-Methylphenyl)Pyrimidin-2-Amine,RHOOHUMOHVIXEF-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
29528,6cs2,DB09299,-7.9,Tenofovir alafenamide,LDEKQSIMHVQZJK-CAQYMETFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
119268,6w4b,DB07117,-7.9,"5-(4-PHENOXYPHENYL)-5-(4-PYRIMIDIN-2-YLPIPERAZIN-1-YL)PYRIMIDINE-2,4,6(2H,3H)-TRIONE",FMKQJGOROFNCGM-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
9835,6lzg,DB07967,-7.9,9-CYCLOPENTYL-6-[2-(3-IMIDAZOL-1-YL-PROPOXY)-PHENYLAMINO]-9H-PURINE-2-CARBONITRILE,JJNKDTWKWYLERH-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
119400,6w4b,DB07270,-7.9,"N-[7-(3-AMINOPHENYL)-5-METHOXY-1,3-BENZOXAZOL-2-YL]-2,5-DICHLOROBENZENESULFONAMIDE",GAYYMURZGLJDCT-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
96451,6m71,DB12937,-7.9,Quercetin-3'-O-phosphate,UWJBYNLLMAPJMM-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
165387,7bv1,DB12027,-7.9,Serdemetan,CEGSUK1LWKJP-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110001,6vxx,DB00691,-7.9,Moexipril,UWWDHYUMIORJTA-HSQYWUDLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165386,7bv1,DB12025,-7.9,Triptolide,DFBIRQPKNDILPW-CIVMWXNOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96470,6m71,DB12966,-7.9,Falnidamol,FTFRZXFNZVCRSK-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
31035,6cs2,DB13333,-7.9,Efloxate,ZVXBAHLOGZCFTP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
67680,6lxt,DB07036,-7.9,"(3aS,4R,9bR)-2,2-difluoro-4-(4-hydroxyphenyl)-6-(methoxymethyl)-1,2,3,3a,4,9b-hexahydrocyclopenta[c]chromen-8-ol",GPFRMIHXGMVMGF-BZSNNMDCSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
64758,6lxt,DB01946,-7.9,"3-[1-(3-Aminopropyl)-1h-Indol-3-Yl]-4-(1-Methyl-1h-Indol-3-Yl)-1h-Pyrrole-2,5-Dione",UQHKJRCFSLMWIA-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
9922,6lzg,DB08058,-7.9,"4-[3-(1,4-diazepan-1-ylcarbonyl)-4-fluorobenzyl]phthalazin-1(2H)-one",HGEPGGJUGUMFHT-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
119435,6w4b,DB07307,-7.9,N-cyclopropyl-4-methyl-3-[1-(2-methylphenyl)phthalazin-6-yl]benzamide,GQXMJOSCBRZMKE-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
110023,6vxx,DB00715,-7.9,Paroxetine,AHOUBRCZNHFOSL-YOEHRIQHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
96506,6m71,DB13023,-7.9,IPI-493,XYFFWTYOFPSZRM-TWNAANEASA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
37454,1r42,DB04289,-7.9,Genz-10850,YYMZSGIXLQPFAC-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
37452,1r42,DB04285,-7.9,"{4-[(2s,4e)-2-(1,3-Benzothiazol-2-Yl)-2-(1h-1,2,3-Benzotriazol-1-Yl)-5-Phenylpent-4-Enyl]Phenyl}(Difluoro)Methylphosphonic Acid",GBLDYRVJENYQNH-AGLOJYHOSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
109958,6vxx,DB00637,-7.9,Astemizole,GXDALQBWZGODGZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
96549,6m71,DB13088,-7.9,AZD-0424,MVWATCATLSSVBH-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
67692,6lxt,DB07049,-7.9,(2R)-1-[(4-tert-butylphenyl)sulfonyl]-2-methyl-4-(4-nitrophenyl)piperazine,SOFGQQQVQZQJFS-MRXNPFEDSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
96553,6m71,DB13094,-7.9,Pruvanserin,AQRLDDAFYYAIJP-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
77737,6m2n,DB08737,-7.9,"(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-9-OL",FSYFYSFYUHBIHE-GLJUWKHASA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
165370,7bv1,DB12002,-7.9,AZD-4818,HVTUHSABWJPWNK-SFHVURJKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
77741,6m2n,DB08741,-7.9,"5-[[(2R)-2-cyclopropyl-7,8-dimethoxy-2H-chromen-5-yl]methyl]pyrimidine-2,4-diamine",HWJPWWYTGBZDEG-AWEZNQCLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
165364,7bv1,DB11994,-7.9,Diacerein,TYNLGDBUJLVSMA-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
77757,6m2n,DB08758,-7.9,"IMIDAZO[2,1-A]ISOQUINOLINE-2-CARBOHYDRAZIDE",WSNWYZBDIKCPIG-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
96507,6m71,DB13024,-7.9,MK-8245,UJEAABFSXKCSGI-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
165437,7bv1,DB12101,-7.9,CC-220,IXZOHGPZAQLIBH-NRFANRHFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
77705,6m2n,DB08704,-7.9,"[[(3R,4R,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-(pentanoylamino)oxan-2-ylidene]amino] N-phenylcarbamate",NUNQIQQEEPOGDJ-JDOAOKHLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
67660,6lxt,DB07014,-7.9,"2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4-methoxybenzyl)sulfanyl]-1,3,4-oxadiazole",TUTZKAQTSPMEBI-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
96270,6m71,DB12654,-7.9,GSK-376501,OIDYMQICWGYEDR-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110219,6vxx,DB01113,-7.9,Papaverine,XQYZDYMELSJDRZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30988,6cs2,DB13277,-7.9,Benziodarone,CZCHIEJNWPNBDE-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
110217,6vxx,DB01110,-7.9,Miconazole,BYBLEWFAAKGYCD-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
67627,6lxt,DB06977,-7.9,(2S)-1-{[5-(1H-Indazol-5-yl)-3-pyridinyl]oxy}-3-(7aH-indol-3-yl)-2-propanamine,CAASENZOSQYNPX-HSTJUUNISA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
110172,6vxx,DB01059,-7.9,Norfloxacin,OGJPXUAPXNRGGI-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
64856,6lxt,DB02075,-7.9,"(1s)-1(9-Deazahypoxanthin-9yl)1,4-Dideoxy-1,4-Imino-D-Ribitol-5-Phosphate",VJTAXXUIRYOXBT-KUBHLMPHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
110133,6vxx,DB01013,-7.9,Clobetasol propionate,CBGUOGMQLZIXBE-XGQKBEPLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77672,6m2n,DB08660,-7.9,"1,2,5,8-tetrahydroxyanthracene-9,10-dione",VBHKTXLEJZIDJF-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
119353,6w4b,DB07215,-7.9,"2-METHYL-2-(4-{[({4-METHYL-2-[4-(TRIFLUOROMETHYL)PHENYL]-1,3-THIAZOL-5-YL}CARBONYL)AMINO]METHYL}PHENOXY)PROPANOIC ACID",ILUPZUOBHCUBKB-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
110105,6vxx,DB00982,-7.9,Isotretinoin,SHGAZHPCJJPHSC-XFYACQKRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110033,6vxx,DB00726,-7.9,Trimipramine,ZSCDBOWYZJWBIY-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
9883,6lzg,DB08015,-7.9,"(3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-phenyl-1H-indole-2,3-dione 3-oxime",SZYREAUDQRVVLV-DAFNUICNSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
110086,6vxx,DB00959,-7.9,Methylprednisolone,VHRSUDSXCMQTMA-PJHHCJLFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110085,6vxx,DB00957,-7.9,Norgestimate,KIQQMECNKUGGKA-NMYWJIRASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110078,6vxx,DB00783,-7.9,Estradiol,VOXZDWNPVJITMN-ZBRFXRBCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
153420,6wiq,DB06455,-7.9,Meclinertant,DYLJVOXRWLXDIG-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
91887,6m71,DB03678,-7.9,"(6,7-Difluoro-Quinazolin-4-Yl)-(1-Methyl-2,2-Diphenyl-Ethyl)-Amine",WVGZKPGUHOZIJQ-HNNXBMFYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96398,6m71,DB12858,-7.9,LY-377604,RBSGUQYXRDKPAE-QFIPXVFZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
31013,6cs2,DB13310,-7.9,Ormeloxifene,XZEUAXYWNKYKPL-WDYNHAJCSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
74589,6m2n,DB03572,-7.9,FR230513,URGFTPMACWKJKU-OAHLLOKOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
165402,7bv1,DB12050,-7.9,LY-3039478,YCBAQKQAINQRFW-UGSOOPFHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
77701,6m2n,DB08699,-7.9,"1-tert-butyl-3-(3-methylbenzyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine",FYCOTGCSHZKHPR-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77703,6m2n,DB08702,-7.9,"2,5-DIPHENYLFURAN-3,4-DICARBOXYLIC ACID",QPKYPOMZPFDBEZ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
96361,6m71,DB12796,-7.9,MRX-I,SULYVXZZUMRQAX-NSHDSACASA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
31247,6cs2,DB13591,-7.9,Metopimazine,BQDBKDMTIJBJLA-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
9285,6lzg,DB07369,-7.9,"N-(3-chlorophenyl)-N-methyl-2-oxo-3-[(3,4,5-trimethyl-1H-pyrrol-2-yl)methyl]-2H-indole-5-sulfonamide",YMJLSOJLEXWATP-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
117105,6w4b,DB03038,-7.9,LY341770,MXAFDBCLWLMXSI-ZDUSSCGKSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
114554,6vxx,DB13783,-7.9,Acemetacin,FSQKKOOTNAMONP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
148579,6w9q,DB13640,-7.9,Acetoxolone,FTQDJVZNPJRVPG-XWEVEMRCSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
94069,6m71,DB07685,-7.9,"4-{[5-(CYCLOHEXYLMETHOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE",NMAZGYDYIYLSLJ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93337,6m71,DB06827,-7.9,Viomycin,GXFAIFRPOKBQRV-GHXCTMGLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93327,6m71,DB06809,-7.9,Plerixafor,YIQPUIGJQJDJOS-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
114587,6vxx,DB13825,-7.9,Fedrilate,RDEOYUSTRWNWLX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75441,6m2n,DB04705,-7.9,"(3BETA)-CHOLEST-5-ENE-3,25-DIOL",INBGSXNNRGWLJU-ZHHJOTBYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
113427,6vxx,DB09179,-7.9,R-30490,GARXJOUQUSNOGK-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30117,6cs2,DB12073,-7.9,Albaconazole,UHIXWHUVLCAJQL-MPBGBICISA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
8094,6lzg,DB04761,-7.9,"PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-[(PYRIDIN-3-YLMETHYL)-AMIDE]",NHPBWKYFMTXWAA-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
113426,6vxx,DB09178,-7.9,Phenaridine,ODPKHHGQKIYCTJ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
148526,6w9q,DB13563,-7.9,Norgestrienone,GVDMJXQHPUYPHP-FYQPLNBISA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
75929,6m2n,DB06442,-7.9,Avasimibe,PTQXTEKSNBVPQJ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
148517,6w9q,DB13552,-7.9,Trifluperidol,GPMXUUPHFNMNDH-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
113419,6vxx,DB09170,-7.9,β-Hydroxythiofentanyl,GLAAETOTOUGGSB-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114600,6vxx,DB13843,-7.9,Cloprednol,YTJIBEDMAQUYSZ-FDNPDPBUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114611,6vxx,DB13855,-7.9,Nifuroxazide,YCWSUKQGVSGXJO-NTUHNPAUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113404,6vxx,DB09128,-7.9,Brexpiprazole,ZKIAIYBUSXZPLP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
8662,6lzg,DB06629,-7.9,Zibotentan,FJHHZXWJVIEFGJ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
114661,6vxx,DB14596,-7.9,Loteprednol etabonate,DMKSVUSAATWOCU-HROMYWEYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75423,6m2n,DB04679,-7.9,H TYPE I TRISACCHARIDE,MGSDFCKWGHNUSM-QVPNGJTFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
66732,6lxt,DB04573,-7.9,Estriol,PROQIPRRNZUXQM-ZXXIGWHRSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
166398,7bv1,DB14810,-7.9,AZD-1656,FJEJHJINOKKDCW-INIZCTEOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
148582,6w9q,DB13643,-7.9,Loprazolam,UTEFBSAVJNEPTR-RGEXLXHISA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
30105,6cs2,DB12058,-7.9,Recoflavone,BCPQOBQIVJZOFL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
8641,6lzg,DB06590,-7.9,Ceftaroline fosamil,ZCCUWMICIWSJIX-NQJJCJBVSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
114530,6vxx,DB13753,-7.9,Cetiedil,MMNICIJVQJJHHF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
93950,6m71,DB07540,-7.9,"4-{5-[(1Z)-1-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)ETHYL]-2-FURYL}BENZENESULFONAMIDE",AKFVRSQELXTCFW-JYRVWZFOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
29761,6cs2,DB11560,-7.9,Lesinurad,FGQFOYHRJSUHMR-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
148779,6w9q,DB13941,-7.9,Piperaquine,UCRHFBCYFMIWHC-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
148774,6w9q,DB13936,-7.9,JNJ-28330835,RYBKPGYFXRNMMU-LBPRGKRZSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
113568,6vxx,DB11537,-7.9,Pirlimycin,HBJOXQRURQPDEX-MHXMMLMNSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114452,6vxx,DB13651,-7.9,Lorajmine,LAHDERDHXJFFJU-ZWNKPRIXSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
93964,6m71,DB07557,-7.9,"(5BETA)-PREGNANE-3,20-DIONE",XMRPGKVKISIQBV-XWOJZHJZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
30072,6cs2,DB12010,-7.9,Fostamatinib,GKDRMWXFWHEQQT-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
113553,6vxx,DB11490,-7.9,Nalorphine,UIQMVEYFGZJHCZ-SSTWWWIQSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
166451,7bv1,DB15156,-7.9,ABT-072,XMZSTQYSBYEENY-RMKNXTFCSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
8122,6lzg,DB04794,-7.9,Bifonazole,OCAPBUJLXMYKEJ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
113349,6vxx,DB09022,-7.9,Benfluorex,CJAVTWRYCDNHSM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
166449,7bv1,DB15151,-7.9,RO-6870810,PKQXLRYFPSZKDU-QFIPXVFZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94007,6m71,DB07612,-7.9,6-(3-AMINOPHENYL)-N-(TERT-BUTYL)-2-(TRIFLUOROMETHYL)QUINAZOLIN-4-AMINE,XQKJVNGGVLHNLA-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
75890,6m2n,DB06313,-7.9,BNC105,MYDHDVLPMRNDAZ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
114489,6vxx,DB13693,-7.9,Sulbenicillin,JETQIUPBHQNHNZ-NJBDSQKTSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113521,6vxx,DB09305,-7.9,Aptazapine,MNHDDERDSNZCCK-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113519,6vxx,DB09299,-7.9,Tenofovir alafenamide,LDEKQSIMHVQZJK-CAQYMETFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114498,6vxx,DB13710,-7.9,Metenolone,ANJQEDFWRSLVBR-VHUDCFPWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113510,6vxx,DB09285,-7.9,Morniflumate,LDXSPUSKBDTEKA-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113488,6vxx,DB09246,-7.9,Benmoxin,BEWNZPMDJIGBED-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
66202,6lxt,DB03865,-7.9,6-Chloro-2-(2-Hydroxy-Biphenyl-3-Yl)-1h-Indole-5-Carboxamidine,FEKRWNWZMOSVBX-UHFFFAOYSA-O,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
30098,6cs2,DB12049,-7.9,Dasolampanel etibutil,HPBRMCFZIGUGTK-ZMMAXQRCSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
75913,6m2n,DB06403,-7.9,Ambrisentan,OUJTZYPIHDYQMC-LJQANCHMSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
8613,6lzg,DB06519,-7.9,Edaglitazone,HAAXAFNSRADSMK-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
93278,6m71,DB06721,-7.9,Gimatecan,UIVFUQKYVFCEKJ-OPTOVBNMSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93276,6m71,DB06717,-7.9,Fosaprepitant,BARDROPHSZEBKC-OITMNORJSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
114680,6vxx,DB14641,-7.9,Estriol tripropionate,ONMZMZJEZHMWQL-REUUDLSRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113300,6vxx,DB08774,-7.9,"1-[(2S)-4-(5-phenyl-1H-pyrazolo[3,4-b]pyridin-4-yl)morpholin-2-yl]methanamine",YBRZCAKSBYWZTC-ZDUSSCGKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
93229,6m71,DB06629,-7.9,Zibotentan,FJHHZXWJVIEFGJ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
7978,6lzg,DB04612,-7.9,"N-METHYLALANYL-3-METHYLVALYL-4-PHENOXY-N-(1,2,3,4-TETRAHYDRONAPHTHALEN-1-YL)PROLINAMIDE",QKPXPZYQPBWDHS-MCJAPYMPSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
7974,6lzg,DB04607,-7.9,"PHENYLAMINOIMIDAZO(1,2-ALPHA)PYRIDINE",UQAWGIKJINAKIZ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
114825,6vxx,DB14934,-7.9,GDC-0927,KJAAPZIFCQQQKX-NDEPHWFRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75364,6m2n,DB04601,-7.9,"4-[(4-O-SULFAMOYLBENZYL)(4-CYANOPHENYL)AMINO]-4H-[1,2,4]-TRIAZOLE",WEXGHQDVDVWOIU-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75363,6m2n,DB04600,-7.9,"4-[(3-BROMO-4-O-SULFAMOYLBENZYL)(4-CYANOPHENYL)AMINO]-4H-[1,2,4]-TRIAZOLE",GHDKYBCUDPSXGJ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
8714,6lzg,DB06718,-7.9,Stanozolol,LKAJKIOFIWVMDJ-IYRCEVNGSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
30204,6cs2,DB12188,-7.9,Zicronapine,BYPMJBXPNZMNQD-PZJWPPBQSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
66787,6lxt,DB04644,-7.9,"4-{4-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-2,3-DIMETHYL-PHENOXY}-BUTYRIC ACID",FCEMCUPAYRPTLS-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
93209,6m71,DB06590,-7.9,Ceftaroline fosamil,ZCCUWMICIWSJIX-NQJJCJBVSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
114764,6vxx,DB14799,-7.9,PF-06821497,RXCVUHMIWHRLDF-HXUWFJFHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114878,6vxx,DB15323,-7.9,Trelagliptin,IWYJYHUNXVAVAA-OAHLLOKOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113206,6vxx,DB08665,-7.9,"6,11-DIHYDRO-11-ETHYL-6-METHYL-9-NITRO-5H-PYRIDO[2,3-B][1,5]BENZODIAZEPIN-5-ONE",YCFJZPGDTZVVSM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
94346,6m71,DB08005,-7.9,4-{[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino}-N-ethylpiperidine-1-carboxamide,ARMFMDYRYOKSOW-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
30215,6cs2,DB12206,-7.9,N-6022,YVPGZQLRPAGKLA-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
113204,6vxx,DB08663,-7.9,4-HYDROXY-7-METHOXY-3-(1-PHENYL-PROPYL)-CHROMEN-2-ONE,CCPGCKQLIHGSCJ-AWEZNQCLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
7899,6lzg,DB04518,-7.9,"3-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamino]-Phenol",JJDRRZFRTKZLFT-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
76133,6m2n,DB06850,-7.9,(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclohexylamino)ethanoyl)pyrrolidine-2-carboxamide,RYKFVFFOIYLADT-SFHVURJKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76135,6m2n,DB06853,-7.9,N-cycloheptylglycyl-N-(4-carbamimidoylbenzyl)-L-prolinamide,BYTJPDBCLWUEBU-IBGZPJMESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
166325,7bv1,DB14657,-7.9,Paramethasone acetate,HYRKAAMZBDSJFJ-LFDBJOOHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
66806,6lxt,DB04669,-7.9,TRIAZOLOPYRIMIDINE,YWBFPKPWMSWWEA-UHFFFAOYSA-O,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
76144,6m2n,DB06865,-7.9,6-CARBAMIMIDOYL-2-[2-HYDROXY-6-(4-HYDROXY-PHENYL)-INDAN-1-YL]-HEXANOIC ACID,ZSRRBAKATXAISL-LMNJBCLMSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
29675,6cs2,DB11393,-7.9,Danofloxacin,QMLVECGLEOSESV-RYUDHWBXSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
76106,6m2n,DB06814,-7.9,Protokylol,LUMAEVHDZXIGEP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75466,6m2n,DB04741,-7.9,Myxothiazol,XKTFQMCPGMTBMD-FYHMSGCOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
30180,6cs2,DB00922,-7.9,Levosimendan,WHXMKTBCFHIYNQ-SECBINFHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
113317,6vxx,DB08794,-7.9,Ethyl biscoumacetate,JCLHQFUTFHUXNN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75413,6m2n,DB04662,-7.9,OLOMOUCINE II,NDUVSANREQEDRE-CQSZACIVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
30149,6cs2,DB12115,-7.9,AZD-9164,FNYFFCOCVNTJCD-NNMXADRKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
166392,7bv1,DB14793,-7.9,RO-5045337,QBGKPEROWUKSBK-QPPIDDCLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
66741,6lxt,DB04583,-7.9,"5-Carbamoyl-1,1':4',1''-terphenyl-3-carboxylic acid",LAZPCGBRHLARSI-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
94183,6m71,DB07815,-7.9,GIBBERELLIN A4,RSQSQJNRHICNNH-NFMPGMCNSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
75996,6m2n,DB06609,-7.9,Odiparcil,JRHNIQQUVJOPQC-AQNFWKISSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
166385,7bv1,DB14775,-7.9,Cavosonstat,BXSZILNGNMDGSL-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
114697,6vxx,DB14660,-7.9,Trenbolone acetate,CMRJPMODSSEAPL-FYQPLNBISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
94198,6m71,DB07832,-7.9,"4-{4-[(5-hydroxy-2-methylphenyl)amino]quinolin-7-yl}-1,3-thiazole-2-carbaldehyde",VKQPTVJDZIILPG-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
114705,6vxx,DB14668,-7.9,Dienestrol diacetate,YWLLGDVBTLPARJ-OXAZHYLESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113333,6vxx,DB09006,-7.9,Clinofibrate,BMOVQUBVGICXQN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
148329,6w9q,DB13307,-7.9,Proscillaridin,MYEJFUXQJGHEQK-ALRJYLEOSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
14260,6lzg,T3D3895,-7.9,Oxasulfuron,IOXAXYHXMLCCJJ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
148386,6w9q,DB13371,-7.9,Difenpiramide,PWHROYKAGRUWDQ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
94219,6m71,DB07857,-7.9,(2R)-2-(4-chlorophenyl)-2-[4-(1H-pyrazol-4-yl)phenyl]ethanamine,HWVGILTYGZFGLR-QGZVFWFLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
114718,6vxx,DB14681,-7.9,Cortisone,MFYSYFVPBJMHGN-ZPOLXVRWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29712,6cs2,DB11455,-7.9,Robenacoxib,ZEXGDYFACFXQPF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
149900,6wiq,DB00719,-7.9,Azatadine,SEBMTIQKRHYNIT-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
114724,6vxx,DB14715,-7.9,Cinazepam,NQTRBZXDWMDXAQ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
148364,6w9q,DB13347,-7.9,Diphenadione,JYGLAHSAISAEAL-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
93247,6m71,DB06673,-7.9,Almorexant,DKMACHNQISHMDN-RPLLCQBOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
114740,6vxx,DB14750,-7.9,Cidoxepin,ODQWQRRAPPTVAG-BOPFTXTBSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114745,6vxx,DB14761,-7.9,Remdesivir,RWWYLEGWBNMMLJ-YSOARWBDSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29707,6cs2,DB11446,-7.9,Oxfendazole,BEZZFPOZAYTVHN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
30162,6cs2,DB12130,-7.9,Lorlatinib,IIXWYSCJSQVBQM-LLVKDONJSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
114927,6vxx,DB15425,-7.9,CYC-065,DLPIYBKBHMZCJI-WBVHZDCISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
93946,6m71,DB07536,-7.9,"N-{(1S,2R)-2-hydroxy-1-[(hydroxyamino)carbonyl]propyl}-4-{[4-(morpholin-4-ylmethyl)phenyl]ethynyl}benzamide",FQYBTYFKOHPWQT-VGSWGCGISA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93944,6m71,DB07534,-7.9,"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE",BKUMVXIXUVYKDQ-GHXNOFRVSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
75672,6m2n,DB05295,-7.9,Eldecalcitol,FZEXGDDBXLBRTD-AYIMTCTASA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75673,6m2n,DB05298,-7.9,Tetomilast,XDBHURGONHZNJF-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
23384,6cs2,HMDB0061742,-7.9,2-(N-Methyl-perfluorooctane sulfanamido) acetic acid,QNDHIRFIMVNHBN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
14364,6lzg,T3D4030,-7.9,Dinophysistoxin 1,CLBIEZBAENPDFY-ZHACJKMWSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
29844,6cs2,DB11706,-7.9,Raxatrigine,JESCETIFNOFKEU-SJORKVTESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
149307,6w9q,DB15346,-7.9,GLPG-1205,IRBAWVGZNJIROV-SFHVURJKSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
149106,6w9q,DB14918,-7.9,Branaplam,STWTUEAWRAIWJG-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
114085,6vxx,DB12707,-7.9,AR-42,LAMIXXKAWNLXOC-INIZCTEOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
166541,7bv1,DB15333,-7.9,AZD-1386,FPGNKXCEPARJDI-ZDUSSCGKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
14360,6lzg,T3D4026,-7.9,(+)-Calycanthine,XSYCDVWYEVUDKQ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
75694,6m2n,DB05442,-7.9,Etiprednol dicloacetate,QAIOVDNCIZSSSF-RFAJLIJZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
149320,6w9q,DB15381,-7.9,Menaquinone,HYPYXGZDOYTYDR-HAJWAVTHSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
149080,6w9q,DB14870,-7.9,PF-5190457,ZIUDADZJCKGWKR-AREMUKBSSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
166534,7bv1,DB15319,-7.9,VM4-037,QGYZPMXIVNIGKA-GMAHTHKFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
113875,6vxx,DB12218,-7.9,AZD-5363,JDUBGYFRJFOXQC-KRWDZBQOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
149338,6w9q,DB15414,-7.9,CM-4307,MLDQJTXFUGDVEO-FIBGUPNXSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
29956,6cs2,DB11859,-7.9,Brexanolone,AURFZBICLPNKBZ-SYBPFIFISA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
8404,6lzg,DB05835,-7.9,NS-3728,OQRAKHDEGGGWQO-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
149346,6w9q,DB15435,-7.9,BMS-986158,KGERZPVQIRYWRK-GDLZYMKVSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
75539,6m2n,DB04834,-7.9,Rapacuronium,HTIKWNNIPGXLGM-YLINKJIISA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
149351,6w9q,DB15444,-7.9,Elexacaftor,MVRHVFSOIWFBTE-INIZCTEOSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
166513,7bv1,DB15282,-7.9,Fluorofuranylnorprogesterone F-18,VJKRBRUNEOHPBS-JQKUZGBFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
75713,6m2n,DB05519,-7.9,Budiodarone,ZXOSVKYCXLTVGS-KRWDZBQOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
93602,6m71,DB07138,-7.9,Neflamapimod,VEPKQEUBKLEPRA-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
14383,6lzg,T3D4067,-7.9,Convallatoxin,HULMNSIAKWANQO-JQKSAQOKSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
113925,6vxx,DB12283,-7.9,Balapiravir,VKXWOLCNTHXCLF-DXEZIKHYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
166560,7bv1,DB15377,-7.9,ATB-346,YCNMAPLPQYQJFC-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
8338,6lzg,DB05482,-7.9,7-ethyl-10-hydroxycamptothecin,FJHBVJOVLFPMQE-QFIPXVFZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
149223,6w9q,DB15190,-7.9,GLPG-0259,YBFGSJUVEOYPIS-OALUTQOASA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
8322,6lzg,DB05416,-7.9,Cardarine,YDBLKRPLXZNVNB-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
75615,6m2n,DB04975,-7.9,Banoxantrone,YZBAXVICWUUHGG-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
29896,6cs2,DB11783,-7.9,Imidapril,KLZWOWYOHUKJIG-BPUTZDHNSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
66480,6lxt,DB04232,-7.9,N-Hydroxy-1-(4-Methoxyphenyl)Sulfonyl-4-Benzyloxycarbonyl-Piperazine-2-Carboxamide,DNGGPLKVDUPXFN-GOSISDBHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
149215,6w9q,DB15169,-7.9,H3B-6527,MBWRLLRCTIYXDW-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
75626,6m2n,DB05035,-7.9,Eprotirome,VPCSYAVXDAUHLT-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
149246,6w9q,DB15229,-7.9,CNV-2197944,BLFJGFDZMABYMY-ZDUSSCGKSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
75636,6m2n,DB05095,-7.9,Cimicoxib,KYXDNECMRLFQMZ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75577,6m2n,DB04883,-7.9,Darusentan,FEJVSJIALLTFRP-LJQANCHMSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
149056,6w9q,DB14810,-7.9,AZD-1656,FJEJHJINOKKDCW-INIZCTEOSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
29872,6cs2,DB11749,-7.9,(R)-Praziquantel,FSVJFNAIGNNGKK-KRWDZBQOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
29866,6cs2,DB11741,-7.9,Famitinib,GKEYKDOLBLYGRB-LGMDPLHJSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
14369,6lzg,T3D4042,-7.9,alpha-Solanine,ZGVSETXHNHBTRK-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
114020,6vxx,DB12601,-7.9,Sonolisib,QIUASFSNWYMDFS-NILGECQDSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
149259,6w9q,DB15254,-7.9,RO-5126766 free base,LMMJFBMMJUMSJS-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
149265,6w9q,DB15268,-7.9,Afabicin,HFYMDQMXVPJNTH-VQHVLOKHSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
149266,6w9q,DB15269,-7.9,ALK-4290,DWKNOLCXIFYNFV-HSZRJFAPSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
93680,6m71,DB07229,-7.9,"3-{5-[AMINO(IMINIO)METHYL]-1H-INDOL-2-YL}-5-METHOXY-1,1'-BIPHENYL-2-OLATE",MINVOLKUPZPDNX-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
113934,6vxx,DB12293,-7.9,Nefopam,RGPDEAGGEXEMMM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
149152,6w9q,DB15047,-7.9,BMS-919373,XGKULQQVQWCASY-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
29852,6cs2,DB11721,-7.9,Mitoglitazone,IRNJSRAGRIZIHD-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
93683,6m71,DB07233,-7.9,N-{[4-(but-2-yn-1-yloxy)phenyl]sulfonyl}-5-methyl-D-tryptophan,SFVPXERGVLDWIS-OAQYLSRUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
114009,6vxx,DB12582,-7.9,Piperine,MXXWOMGUGJBKIW-YPCIICBESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
66395,6lxt,DB04125,-7.9,N-Alpha-(2-Naphthylsulfonyl)-N(3-Amidino-L-Phenylalaninyl)-4-Acetyl-Piperazine,ZUWBXGHMVKDMQO-DEOSSOPVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
75738,6m2n,DB05659,-7.9,Faropenem medoxomil,JQBKWZPHJOEQAO-DVPVEWDBSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
166506,7bv1,DB15266,-7.9,TAK-580,VWMJHAFYPMOMGF-ZCFIWIBFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
114348,6vxx,DB13324,-7.9,Tetrazepam,IQWYAQCHYZHJOS-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
66621,6lxt,DB04432,-7.9,ZK-805623,ZXIHYCYAQUQHSG-UHFFFAOYSA-O,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
93493,6m71,DB07014,-7.9,"2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4-methoxybenzyl)sulfanyl]-1,3,4-oxadiazole",TUTZKAQTSPMEBI-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
148941,6w9q,DB14569,-7.9,Tedizolid,XFALPSLJIHVRKE-GFCCVEGCSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
114369,6vxx,DB13349,-7.9,Talastine,LCAAMXMULMCKLJ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75491,6m2n,DB04776,-7.9,(2R)-2-({6-[benzyl(methyl)amino]-9-isopropyl-9H-purin-2-yl}amino)butan-1-ol,YPYWONAECUVKHY-MRXNPFEDSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
166475,7bv1,DB15205,-7.9,Capromorelin,KVLLHLWBPNCVNR-SKCUWOTOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
114390,6vxx,DB13374,-7.9,Vincamine,RXPRRQLKFXBCSJ-GIVPXCGWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75811,6m2n,DB06148,-7.9,Mianserin,UEQUQVLFIPOEMF-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75487,6m2n,DB04770,-7.9,"O6-(R)-ROSCOVITINE, R-2-(6-BENZYLOXY-9-ISOPROPYL-9H-PURIN-2-YLAMINO)-BUTAN-1-OL",HGADNQLEUZSUEJ-OAHLLOKOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
30037,6cs2,DB11964,-7.9,Ilaprazole,HRRXCXABAPSOCP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
148951,6w9q,DB14624,-7.9,Nandrolone hydrogen sulfate,SKZMVWBZTQNCKW-IZPLOLCNSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
148875,6w9q,DB14128,-7.9,Nadide,BAWFJGJZGIEFAR-NNYOXOHSSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
114398,6vxx,DB13386,-7.9,Epimestrol,UHQGCIIQUZBJAE-RRQVMCLOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113663,6vxx,DB11729,-7.9,GSK-2330672,CZGVOBIGEBDYTP-VSGBNLITSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75477,6m2n,DB04757,-7.9,"GUANOSINE-2',3'-O-METHYLIDENEPHOSPHONATE",GKAPYWCOOQBBHV-KXSYMAMXSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
93941,6m71,DB07531,-7.9,"4-{5-[(Z)-(2,4-DIOXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE",JNPRTUHVCHGFHJ-GHXNOFRVSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
75841,6m2n,DB06203,-7.9,Alogliptin,ZSBOMTDTBDDKMP-OAHLLOKOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
93943,6m71,DB07533,-7.9,"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]-2-FURYL}-N-METHYLBENZENESULFONAMIDE",FJJJERLTHDXEPT-JYRVWZFOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93444,6m71,DB06953,-7.9,2-CHLORO-5-(3-CHLORO-PHENYL)-6-[(4-CYANO-PHENYL)-(3-METHYL-3H-IMIDAZOL-4-YL)- METHOXYMETHYL]-NICOTINONITRILE,JVWHVGIRXILXMU-XMMPIXPASA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
66651,6lxt,DB04471,-7.9,"2-Phenyl-1-[4-(2-Piperidin-1-Yl-Ethoxy)-Phenyl]-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol",FMWVCTJKLAVRPB-MUUNZHRXSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
93441,6m71,DB06948,-7.9,2-ANILINO-6-CYCLOHEXYLMETHOXYPURINE,XWWRLKIBRPJQJX-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
113634,6vxx,DB11682,-7.9,Daprodustat,RUEYEZADQJCKGV-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75844,6m2n,DB06209,-7.9,Prasugrel,DTGLZDAWLRGWQN-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
93924,6m71,DB07511,-7.9,"4-(4-methyl-1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)benzonitrile",MVYDBJXCIFMINH-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
30055,6cs2,DB11992,-7.9,Omarigliptin,MKMPWKUAHLTIBJ-ISTRZQFTSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
75493,6m2n,DB04778,-7.9,SC45647,LPSXGZAUAOMRNU-FZKQIMNGSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
166484,7bv1,DB15221,-7.9,PF-06260414,ZKAVFOXYJCREBQ-SNVBAGLBSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
113823,6vxx,DB12133,-7.9,BLXA4,HEDVTGFTYROYFE-RREUNBNVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
149039,6w9q,DB14770,-7.9,Lanraplenib,XCIGZBVOUQVIPI-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
29982,6cs2,DB11893,-7.9,Avagacestat,XEAOPVUAMONVLA-QGZVFWFLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
66389,6lxt,DB04115,-7.9,Berberine,YBHILYKTIRIUTE-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
93547,6m71,DB07074,-7.9,6-CARBAMIMIDOYL-4-(3-HYDROXY-2-METHYL-BENZOYLAMINO)-NAPHTHALENE-2-CARBOXYLIC ACID METHYL ESTER,OUBRALHIKGRAMA-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93542,6m71,DB07067,-7.9,"(2S,3S)-3-{3-[4-(METHYLSULFONYL)PHENYL]-1,2,4-OXADIAZOL-5-YL}-1-OXO-1-PYRROLIDIN-1-YLBUTAN-2-AMINE",SQCDMTZMCHZYGO-FZMZJTMJSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
66384,6lxt,DB04107,-7.9,[(1-{2[(4-Carbamimidoyl-Phenylamino)-Methyl]-1-Methyl-1h-Benzoimidazol-5-Yl}-Cyclopropyl)-Pyridin-2-Yl-Methyleneaminooxy]-Acetic Acid Ethyl Ester,RNOYCNIZOAIUSV-LSWMGQQCSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
113807,6vxx,DB12113,-7.9,CE-224535,FUCKCIVGBCBZNP-MRXNPFEDSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
93539,6m71,DB07064,-7.9,"(4R)-4-(3-HYDROXYPHENYL)-N,N,7,8-TETRAMETHYL-3,4-DIHYDROISOQUINOLINE-2(1H)-CARBOXAMIDE",HPVCRUIDFODATB-LJQANCHMSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
66375,6lxt,DB04097,-7.9,Uridine-5'-Diphosphate-4-Deoxy-4-Fluoro-Alpha-D-Galactose,OAPPZHVTNHJVAL-JZMIEXBBSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
113785,6vxx,DB12081,-7.9,Anecortave,BCFCRXOJOFDUMZ-ONKRVSLGSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114334,6vxx,DB13309,-7.9,Benproperine,JTUQXGZRVLWBCR-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114246,6vxx,DB13166,-7.9,Zofenopril,IAIDUHCBNLFXEF-MNEFBYGVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
93521,6m71,DB07045,-7.9,"(2R,3R,4S,5R)-2-[6-amino-8-[(3,4-dichlorophenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol",VBJKVZXRYLCYGQ-XNIJJKJLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
113768,6vxx,DB12057,-7.9,ORM-12741,OCUKPFWNSAAHRP-QZTJIDSGSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
93520,6m71,DB07043,-7.9,"7-amino-2-tert-butyl-4-(4-pyrimidin-2-ylpiperazin-1-yl)pyrido[2,3-d]pyrimidine-6-carboxamide",CKLCIJCZOIDJQU-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
75777,6m2n,DB05932,-7.9,Denibulin,GAOHLWCIAJNSEE-JTQLQIEISA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
93825,6m71,DB07394,-7.9,AUROVERTIN B,QXCOFYWOWZJFEA-YJMRODJJSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
29790,6cs2,DB11638,-7.9,Artenimol,BJDCWCLMFKKGEE-HVDUHBCDSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
93843,6m71,DB07415,-7.9,4-[(1S)-1-(3-fluoro-4-methoxyphenyl)-2-(2-methoxy-5-nitrophenyl)ethyl]-1H-imidazol-2-amine,RFLOFHKRBGKCOB-AWEZNQCLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
113728,6vxx,DB11820,-7.9,Nifurtimox,ARFHIAQFJWUCFH-IZZDOVSWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30011,6cs2,DB11934,-7.9,Epelsiban,UWHCWRQFNKUYCG-QUZACWSFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
113708,6vxx,DB11792,-7.9,Mirodenafil,MIJFNYMSCFYZNY-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
66332,6lxt,DB04040,-7.9,"N-(2-Morpholin-4-Yl-1-Morpholin-4-Ylmethyl-Ethyl)-3-Nitro-5-(3,4,5-Trihydroxy-6-Hydroxymethyl-Tetrahydro-Pyran-2-Yloxy)-Benzamide",MCMWCTMAKPQTPI-WGNYYXNJSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
93797,6m71,DB07358,-7.9,"2-amino-N-(4-methyl-1,3-thiazol-2-yl)-5-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]benzamide",JEBOJMQHVUEKBE-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
76147,6m2n,DB06869,-7.9,1-[2-AMINO-2-CYCLOHEXYL-ACETYL]-PYRROLIDINE-3-CARBOXYLIC ACID 5-CHLORO-2-(2-ETHYLCARBAMOYL-ETHOXY)-BENZYLAMIDE,BMHVHOJXEQTIEA-SIKLNZKXSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
94366,6m71,DB08026,-7.9,"2-{4-[(4-imidazo[1,2-a]pyridin-3-ylpyrimidin-2-yl)amino]piperidin-1-yl}-N-methylacetamide",AJLILYAPRHIFAS-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
114934,6vxx,DB15440,-7.9,GSK-3117391,AFDPFLDWOXXHQM-NRFANRHFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112419,6vxx,DB07082,-7.9,"1,1,1,3,3,3-HEXAFLUORO-2-{4-[(2,2,2-TRIFLUOROETHYL)AMINO]PHENYL}PROPAN-2-OL",VHDRSZOHKKZOQF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
94792,6m71,DB08536,-7.9,"3-bromo-5-phenyl-N-(pyrimidin-5-ylmethyl)pyrazolo[1,5-a]pyridin-7-amine",IBUPHWYGVDAASU-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94794,6m71,DB08538,-7.9,"N-((2-aminopyrimidin-5-yl)methyl)-5-(2,6-difluorophenyl)-3-ethylpyrazolo[1,5-a]pyrimidin-7-amine",HQPVGVSQPQVZLD-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
112406,6vxx,DB07065,-7.9,"5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)-3-thiocyanatopyrazolo[1,5-a]pyrimidin-7-amine",AHPKUZJCNHGFQA-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76545,6m2n,DB07325,-7.9,N-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)METHYL]-3-{[(E)-(2-OXODIHYDROFURAN-3(2H)-YLIDENE)METHYL]AMINO}BENZENESULFONAMIDE,VCOKUBHAJVTVNG-FMIVXFBMSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
67046,6lxt,DB05234,-7.9,LGD2941,HWLLYFXDDGGHOE-BCSUUIJWSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
9102,6lzg,DB07175,-7.9,N-{2-methyl-5-[(6-phenylpyrimidin-4-yl)amino]phenyl}methanesulfonamide,CXQRKICWSCAUGW-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
166017,7bv1,DB13579,-7.9,Mepixanox,PYSOHOOUXFWCFF-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94802,6m71,DB08547,-7.9,PROGESTERONE-11-ALPHA-OL-HEMISUCCINATE,JBBNFGYRYNBDIH-DBGGZKJISA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
9112,6lzg,DB07186,-7.9,"4-(4-METHYLPIPERAZIN-1-YL)-N-[5-(2-THIENYLACETYL)-1,5-DIHYDROPYRROLO[3,4-C]PYRAZOL-3-YL]BENZAMIDE",TYYNSDQVFIOSFH-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
67063,6lxt,DB05316,-7.9,Pimavanserin,RKEWSXXUOLRFBX-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
147488,6w9q,DB12012,-7.9,PF-04457845,BATCTBJIJJEPHM-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
76575,6m2n,DB07358,-7.9,"2-amino-N-(4-methyl-1,3-thiazol-2-yl)-5-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]benzamide",JEBOJMQHVUEKBE-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
116201,6w4b,DB01836,-7.9,"[4-(6-Chloro-Naphthalene-2-Sulfonyl)-Piperazin-1-Yl]-(3,4,5,6-Tetrahydro-2h-[1,4']Bipyridinyl-4-Yl)-Methanone",ZLAKCKVFSRSENR-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
75121,6m2n,DB04274,-7.9,"5,4'-Dideoxyflavanone",SWAJPHCXKPCPQZ-AWEZNQCLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76598,6m2n,DB07389,-7.9,N-[2-(6-AMINO-4-METHYLPYRIDIN-2-YL)ETHYL]-4-CYANOBENZAMIDE,QINCZVSBLITNRD-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76599,6m2n,DB07390,-7.9,"2-[3-(5-MERCAPTO-[1,3,4]THIADIAZOL-2-YL)-UREIDO]-N-METHYL-3-PHENYL-PROPIONAMIDE",RKWXKADYTDWZIJ-VIFPVBQESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
30480,6cs2,DB12542,-7.9,GSK-356278,AWDJJMXJUOHGLC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
147456,6w9q,DB11965,-7.9,SJG-136,RWZVMMQNDHPRQD-SFTDATJTSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
94850,6m71,DB08607,-7.9,"(5R)-5-(4-{[(2R)-6-HYDROXY-2,5,7,8-TETRAMETHYL-3,4-DIHYDRO-2H-CHROMEN-2-YL]METHOXY}BENZYL)-1,3-THIAZOLIDINE-2,4-DIONE",GXPHKUHSUJUWKP-NTKDMRAZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
30484,6cs2,DB12548,-7.9,Sparsentan,WRFHGDPIDHPWIQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
116272,6w4b,DB01941,-7.9,"6-[1-(3,5,5,8,8-Pentamethyl-5,6,7,8-Tetrahydronaphthalen-2-Yl)Cyclopropyl]Pyridine-3-Carboxylic Acid",SLXTWXQUEZSSTJ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
151029,6wiq,DB02177,-7.9,1-Acetyl-4-(4-{4-[(2-Ethoxyphenyl)Thio]-3-Nitrophenyl}Pyridin-2-Yl)Piperazine,GKGJFUXSTSUKPB-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
76540,6m2n,DB07319,-7.9,"6-(3-BROMO-2-NAPHTHYL)-1,3,5-TRIAZINE-2,4-DIAMINE",RXSSKAZHCZWJPP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
112434,6vxx,DB07101,-7.9,PD-0325901,SUDAHWBOROXANE-SECBINFHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
147514,6w9q,DB12055,-7.9,MK-0767,ORZMUVMQJPGFOM-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
116000,6w4b,DB01573,-7.9,Benzylmorphine,RDJGWRFTDZZXSM-RNWLQCGYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
75173,6m2n,DB04345,-7.9,Lumichrome,ZJTJUVIJVLLGSP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
112592,6vxx,DB07432,-7.9,"[[(3R,4R,5S,6R)-3-(butanoylamino)-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-ylidene]amino] N-phenylcarbamate",ITVRELFVFCOUMV-ZVZWZHPPSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
92946,6m71,DB05575,-7.9,Motesanib,RAHBGWKEPAQNFF-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
147619,6w9q,DB12211,-7.9,PSI-697,DIEPFYNZGUUVHD-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
9017,6lzg,DB00643,-7.9,Mebendazole,OPXLLQIJSORQAM-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
115861,6w4b,DB01419,-7.9,Antrafenine,NWGGKKGAFZIVBJ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
92923,6m71,DB05465,-7.9,Tandutinib,UXXQOJXBIDBUAC-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
150692,6wiq,DB01721,-7.9,Analogue of Indinavir Drug,MJIRDPUZGGHJMX-OIVSQUILSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
94729,6m71,DB08463,-7.9,(2R)-2-({9-(1-methylethyl)-6-[(4-pyridin-2-ylbenzyl)amino]-9H-purin-2-yl}amino)butan-1-ol,HOCBJBNQIQQQGT-LJQANCHMSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
112522,6vxx,DB07348,-7.9,Brefeldin A,KQNZDYYTLMIZCT-KQPMLPITSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112512,6vxx,DB07337,-7.9,"4-[4-AMINO-6-(5-CHLORO-1H-INDOL-4-YLMETHYL)-[1,3,5]TRIAZIN-2-YLAMINO]-BENZONITRILE",SOKOHDQTKSROQZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
65654,6lxt,DB03124,-7.9,5-[4-(1-Carboxymethyl-2-Oxo-Propylcarbamoyl)-Benzylsulfamoyl]-2-Hydroxy-Benzoic Acid,LBAHOXPDTNUYCX-INIZCTEOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
166067,7bv1,DB13648,-7.9,Alcuronium,MUQUYTSLDVKIOF-CHJKCJHBSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94756,6m71,DB08495,-7.9,4-({4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-2-OXOPIPERAZIN-1-YL}METHYL)BENZENECARBOXIMIDAMIDE,VXONTEUOQXFJJS-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
67035,6lxt,DB05137,-7.9,Lobeline,MXYUKLILVYORSK-HBMCJLEFSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
94759,6m71,DB08498,-7.9,"(1S)-1-(3-chlorophenyl)-2-oxo-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate",OVSAMUIBGQSLDC-INIZCTEOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
112464,6vxx,DB07286,-7.9,BMS-564929,KEJORAMIZFOODM-PWSUYJOCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112458,6vxx,DB07280,-7.9,5-[4-(DIMETHYLAMINO)PHENYL]-6-[(6-MORPHOLIN-4-YLPYRIDIN-3-YL)ETHYNYL]PYRIMIDIN-4-AMINE,AINVOEOJEKKMKB-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
94760,6m71,DB08499,-7.9,"N-[3-(2-fluoroethoxy)phenyl]-N'-(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-6-yl)butanediamide",DQXBKUVWJSZHSI-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
166047,7bv1,DB13618,-7.9,Ipriflavone,SFBODOKJTYAUCM-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
76536,6m2n,DB07315,-7.9,"5-chloro-N-{4-[(1R)-1,2-dihydroxyethyl]phenyl}-1H-indole-2-carboxamide",SHCHFGSUYJUEBR-INIZCTEOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
94788,6m71,DB08532,-7.9,"6-(2-fluorophenyl)-N-(pyridin-3-ylmethyl)imidazo[1,2-a]pyrazin-8-amine",WCNPGRRMPFCHEO-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
9072,6lzg,DB07144,-7.9,"5-[(3R)-3-(5-methoxy-2',6'-dimethylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",XZXVRKHUCSXVBM-AWEZNQCLSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
94790,6m71,DB08534,-7.9,"5-(2-fluorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",ZAIYYXVHGBMLEC-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
67028,6lxt,DB05104,-7.9,Asimadoline,JHLHNYVMZCADTC-LOSJGSFVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
92867,6m71,DB05134,-7.9,Tanespimycin,AYUNIORJHRXIBJ-TXHRRWQRSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
9142,6lzg,DB07220,-7.9,"N-[5-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-1H-INDAZOL-3-YL]-2-(4-PIPERIDIN-1-YLPHENYL)ACETAMIDE",ZXYIRNXOAJYLCU-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
112324,6vxx,DB06973,-7.9,"4,4'-PROPANE-2,2-DIYLDIPHENOL",IISBACLAFKSPIT-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
65584,6lxt,DB03034,-7.9,D-Levofloxacin,GSDSWSVVBLHKDQ-SNVBAGLBSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
67113,6lxt,DB05575,-7.9,Motesanib,RAHBGWKEPAQNFF-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
75052,6m2n,DB04180,-7.9,"4-(Aminosulfonyl)-N-[(2,4-Difluorophenyl)Methyl]-Benzamide",NTDFJEKGSGSXME-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
9212,6lzg,DB07296,-7.9,(5Z)-3-(4-CHLOROPHENYL)-4-HYDROXY-5-(1-NAPHTHYLMETHYLENE)FURAN-2(5H)-ONE,PLGHLEBIWUQEPR-PDGQHHTCSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
112206,6vxx,DB06582,-7.9,Dextofisopam,RUJBDQSFYCKFAA-HNNXBMFYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
116796,6w4b,DB02621,-7.9,Latrunculin A,DDVBPZROPPMBLW-IZGXTMSKSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
147319,6w9q,DB11769,-7.9,Funapide,NEBUOXBYNAHKFV-NRFANRHFSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
9239,6lzg,DB07321,-7.9,"2,5-DICHLORO-N-[5-METHOXY-7-(6-METHOXYPYRIDIN-3-YL)-1,3-BENZOXAZOL-2-YL]BENZENESULFONAMIDE",KOKQLKWXOFRTHE-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
7842,6lzg,DB04452,-7.9,Aminoquinuride,HOUSDILKOJMENG-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
9244,6lzg,DB07326,-7.9,"6-chloro-N-pyrimidin-5-yl-3-{[3-(trifluoromethyl)phenyl]amino}-1,2-benzisoxazole-7-carboxamide",FEGRQUWSKADGSP-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
112155,6vxx,DB06446,-7.9,Dotarizine,LRMJAFKKJLRDLE-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76694,6m2n,DB07501,-7.9,(2S)-1-{4-[(4-Anilino-5-bromo-2-pyrimidinyl)amino]phenoxy}-3-(dimethylamino)-2-propanol,MEIJADBULOETOV-KRWDZBQOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
112151,6vxx,DB06440,-7.9,Ravuconazole,OPAHEYNNJWPQPX-RCDICMHDSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
95010,6m71,DB08794,-7.9,Ethyl biscoumacetate,JCLHQFUTFHUXNN-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
165907,7bv1,DB13223,-7.9,Fluocortin,PUWHHWCHAVXSIG-NCLPIGKXSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
28580,6cs2,DB00755,-7.9,Tretinoin,SHGAZHPCJJPHSC-YCNIQYBTSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
76727,6m2n,DB07539,-7.9,"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZOIC ACID",JLRKRQCTYQGDKJ-GHXNOFRVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76743,6m2n,DB07559,-7.9,"(2Z)-2-cyano-N-(2,2'-dichlorobiphenyl-4-yl)-3-hydroxybut-2-enamide",DDSLONVJHZPSBB-UVTDQMKNSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
30564,6cs2,DB12663,-7.9,Letrazuril,XQKYUBTUOHHNDV-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
65548,6lxt,DB02976,-7.9,Uridine-5'-monophosphate 2-deoxy-2-fluoro-galactopyranosyl-monophosphate ester,NGTCPFGWXMBZEP-KBQKSTHMSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
117085,6w4b,DB03005,-7.9,"3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-5-Yl]Hexyl]-Phenanthridinium",ISUOMOOYAOQQPZ-UHFFFAOYSA-O,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
23284,6cs2,HMDB0060001,-7.9,Indole-3-acetic-acid-O-glucuronide,BPTLUNCVRGWZSW-JHZZJYKESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
76746,6m2n,DB07562,-7.9,"N-[4-(2,4-DIMETHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YL]-N',N'-DIMETHYL-BENZENE-1,4-DIAMINE",FGGSNQOBRJVAKL-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
53090,2fxp,DB12457,-7.9,Rimegepant,KRNAOFGYEFKHPB-ANJVHQHFSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
92802,6m71,DB04886,-7.9,Calanolide A,NIDRYBLTWYFCFV-FMTVUPSXSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
92948,6m71,DB05586,-7.9,Facinicline,TXCYUSKWBHUVEP-CYBMUJFWSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
76684,6m2n,DB07489,-7.9,"4-Amino-2-[(3-chlorophenyl)amino]-5-(4-fluorobenzoyl)-1,3-thiazol-3-ium",WWGPTHOMFHDEEC-UHFFFAOYSA-O,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
67109,6lxt,DB05552,-7.9,TG100-115,UJIAQDJKSXQLIT-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
92862,6m71,DB05105,-7.9,Pleconaril,KQOXLKOJHVFTRN-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
65624,6lxt,DB03084,-7.9,"Cyclopropyl-{4-[5-(3,4-Dichlorophenyl)-2-[(1-Methyl)-Piperidin]-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine",XCTKFTOEAKJMII-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
9146,6lzg,DB07226,-7.9,"N-[4-(2-CHLOROPHENYL)-1,3-DIOXO-1,2,3,6-TETRAHYDROPYRROLO[3,4-C]CARBAZOL-9-YL]FORMAMIDE",JWZVNUNTFNELHL-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
65622,6lxt,DB03082,-7.9,6-[(Z)-Amino(Imino)Methyl]-N-[4-(Aminomethyl)Phenyl]-4-(Pyrimidin-2-Ylamino)-2-Naphthamide,CSWQJKHBMACTGB-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
30501,6cs2,DB12569,-7.9,Tonapofylline,ZWTVVWUOTJRXKM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
112310,6vxx,DB06953,-7.9,2-CHLORO-5-(3-CHLORO-PHENYL)-6-[(4-CYANO-PHENYL)-(3-METHYL-3H-IMIDAZOL-4-YL)- METHOXYMETHYL]-NICOTINONITRILE,JVWHVGIRXILXMU-XMMPIXPASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30503,6cs2,DB12572,-7.9,Pexacerfont,LBWQSAZEYIZZCE-SNVBAGLBSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
112297,6vxx,DB06935,-7.9,"2',6'-DIFLUOROBIPHENYL-4-CARBOXYLIC ACID",CWWIIKLXUPZDOG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
9161,6lzg,DB07245,-7.9,6-[2-(3'-METHOXYBIPHENYL-3-YL)ETHYL]PYRIDIN-2-AMINE,AEVBKBAFFJKFJZ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
151145,6wiq,DB02331,-7.9,"(2s)-2-[(5-Benzofuran-2-Yl-Thiophen-2-Ylmethyl)-(2,4-Dichloro-Benzoyl)-Amino]-3-Phenyl-Propionic Acid",YBULOUKTPCHXAL-DEOSSOPVSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
112285,6vxx,DB06923,-7.9,2-(3-METHYLPHENYL)-1H-INDOLE-5-CARBOXIMIDAMIDE,KJUSXMYSVXZFDJ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75063,6m2n,DB04196,-7.9,Pteroic Acid,JOAQINSXLLMRCV-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
92857,6m71,DB05087,-7.9,Ganaxolone,PGTVWKLGGCQMBR-FLBATMFCSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
151163,6wiq,DB02354,-7.9,4-{[1-Methyl-5-(2-Methyl-Benzoimidazol-1-Ylmethyl)-1h-Benzoimidazol-2-Ylmethyl]-Amino}-Benzamidine,IRKPNOLLMNHSOU-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
30513,6cs2,DB12585,-7.9,Ondelopran,QWNDOCKIKKQJNN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
92850,6m71,DB05039,-7.9,Indacaterol,QZZUEBNBZAPZLX-QFIPXVFZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
151230,6wiq,DB02432,-7.9,RU90395,RLLAUERCSKPFGD-VMPREFPWSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
92844,6m71,DB05016,-7.9,Ataluren,OOUGLTULBSNHNF-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
151260,6wiq,DB02473,-7.9,"6-[N-(1-Isopropyl-3,4-Dihydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine",XRHANBWAKSYPEN-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
75080,6m2n,DB04215,-7.9,CRA_9076,BVTBOJXEAPSOEB-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
116561,6w4b,DB02323,-7.9,EM-1745,CKSDYJASHNGOOS-KTXOUVACSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
112239,6vxx,DB06873,-7.9,"1-((2-HYDROXYETHOXY)METHYL)-5-(3-(BENZYLOXY)BENZYL)PYRIMIDINE-2,4(1H,3H)-DIONE",CSXNPJKDZKLDET-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
67105,6lxt,DB05532,-7.9,BMS-488043,DBPMWRYLTBNCCE-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
147355,6w9q,DB11819,-7.9,ASP-4058,NJNXCJPSMWKXHO-VIFPVBQESA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
116463,6w4b,DB02194,-7.9,"8-Benzyl-2-Hydroxy-2-(4-Hydroxy-Benzyl)-6-(4-Hydroxy-Phenyl)-2h-Imidazo[1,2-a]Pyrazin-3-One",ULLMMKZQNNBLRN-SANMLTNESA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
94696,6m71,DB08424,-7.9,"[5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL](3-{[(2R)-2,3-DIHYDROXYPROPYL]OXY}PHENYL)METHANONE",IJDQETGUEUJVTB-HNNXBMFYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
115708,6w4b,DB01167,-7.9,Itraconazole,VHVPQPYKVGDNFY-ZPGVKDDISA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
92974,6m71,DB05767,-7.9,Andrographolide,BOJKULTULYSRAS-OTESTREVSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
76215,6m2n,DB06944,-7.9,N-(3-cyclopropyl-1H-pyrazol-5-yl)-2-(2-naphthyl)acetamide,RIGZCVNCFXYBEG-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
30288,6cs2,DB12291,-7.9,Tacedinaline,VAZAPHZUAVEOMC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
112980,6vxx,DB08223,-7.9,"N-{(1S,2R)-1-BENZYL-3-[(CYCLOPROPYLMETHYL)(2-FURYLSULFONYL)AMINO]-2-HYDROXYPROPYL}-N'-METHYLSUCCINAMIDE",IKOPFHKAECNGQI-VQTJNVASSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
66868,6lxt,DB04760,-7.9,"PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-(4-FLUORO-3-METHYL-BENZYLAMIDE)",PYFRREJCFXFNRR-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
147931,6w9q,DB12666,-7.9,Emapunil,NBMBIEOUVBHEBM-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
94454,6m71,DB08125,-7.9,"4-{[(2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]AMINO}-N-(1,3-THIAZOL-2-YL)BENZENESULFONAMIDE",BOMPRXSVSIPRDT-PTNGSMBKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
112952,6vxx,DB08185,-7.9,2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,LCHGAOHLDYRACA-SDBHATRESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75298,6m2n,DB04517,-7.9,Dipyrromethane Cofactor,LCAXMKQKEYTFDM-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
147924,6w9q,DB12658,-7.9,AFN-1252,QXTWSUQCXCWEHF-JXMROGBWSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
66877,6lxt,DB04771,-7.9,1-GUANIDINO-4-(N-NITRO-BENZOYLAMINO-L-LEUCYL-L-PROLYLAMINO)BUTANE,FIZYZWLGMGGGBJ-OALUTQOASA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
76261,6m2n,DB07002,-7.9,4-({4-[(4-methoxypyridin-2-yl)amino]piperidin-1-yl}carbonyl)benzonitrile,SZUVGMCKKLJAFX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
112981,6vxx,DB08224,-7.9,"(1S,7S,8S,8AR)-1,2,3,7,8,8A-HEXAHYDRO-7-METHYL-8-[2-[(2R,4R)-TETRAHYDRO-4-HY DROXY-6-OXO-2H-PYRAN-2-YL]ETHYL]-1-NAPHTHALENOL",WWSNTLOVYSRDEL-TVKPWXLESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76264,6m2n,DB07005,-7.9,D-phenylalanyl-N-{4-[amino(iminio)methyl]benzyl}-L-prolinamide,VZFTWWJAUZOJDH-MOPGFXCFSA-O,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
8832,6lzg,DB06888,-7.9,"(13R,15S)-13-METHYL-16-OXA-8,9,12,22,24-PENTAAZAHEXACYCLO[15.6.2.16,9.1,12,15.0,2,7.0,21,25]HEPTACOSA-1(24),2,4,6,17(25),18,20-HEPTAENE-23,26-DIONE",KBLPHMRCKHFBJB-OLZOCXBDSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
76289,6m2n,DB07034,-7.9,"2,2'-{[9-(HYDROXYIMINO)-9H-FLUORENE-2,7-DIYL]BIS(OXY)}DIACETIC ACID",VOKATEXROYSXDW-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
30310,6cs2,DB12316,-7.9,9CUAB30,PPGNMFUMZSAZCW-VOYUZAMQSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
112907,6vxx,DB08136,-7.9,4-(acetylamino)-N-(4-fluorophenyl)-1H-pyrazole-3-carboxamide,CWQKPKYIMQTGJK-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75270,6m2n,DB04480,-7.9,"3-(4-Fluorophenyl)-2-(6-Methylpyridin-2-Yl)-5,6-Dihydro-4h-Pyrrolo[1,2-B]Pyrazole",NBDZLUOYAAVYHF-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
166225,7bv1,DB14152,-7.9,Ginsenosides,NLHQJXWYMZLQJY-SWIZOJJJSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
112890,6vxx,DB08118,-7.9,"2-(methylamino)-N-(4-methyl-1,3-thiazol-2-yl)-5-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]benzamide",XRJAKERBMMBUGR-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
147878,6w9q,DB12579,-7.9,JNJ-37822681,UVUYWJWYRLJHEN-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
150403,6wiq,DB01349,-7.9,Tasosartan,ADXGNEYLLLSOAR-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
112870,6vxx,DB07941,-7.9,PH-797804,KCAJXIDMCNPGHZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
65907,6lxt,DB03464,-7.9,Formycin-5'-Monophosphate,PBAHXXBYQACZMA-KSYZLYKTSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
30303,6cs2,DB12308,-7.9,Eltanolone,AURFZBICLPNKBZ-YZRLXODZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
147869,6w9q,DB12567,-7.9,Camicinal,RZKDEGZIFSJVNA-IBGZPJMESA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
113000,6vxx,DB08247,-7.9,6-(CYCLOHEXYLMETHOXY)-8-ISOPROPYL-9H-PURIN-2-AMINE,JABXNQUXGJTKRO-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
93104,6m71,DB06292,-7.9,Dapagliflozin,JVHXJTBJCFBINQ-ADAARDCZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94379,6m71,DB08039,-7.9,"(3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE",LOGJQOUIVKBFGH-YBEGLDIGSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
113148,6vxx,DB08596,-7.9,5'-deoxy-5'-piperidin-1-ylthymidine,GMOUOGHZJCSNOZ-YNEHKIRRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
93150,6m71,DB06440,-7.9,Ravuconazole,OPAHEYNNJWPQPX-RCDICMHDSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94388,6m71,DB08052,-7.9,"1-cyclopentyl-3-(1H-pyrrolo[2,3-b]pyridin-5-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine",NVRXTLZYXZNATH-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
75328,6m2n,DB04555,-7.9,Cytidine-5'-Diphosphate,ZWIADYZPOWUWEW-XVFCMESISA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
166306,7bv1,DB14637,-7.9,Fluprednisolone acetate,CYMBAKFTWRNHPS-APRQOCPKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
148020,6w9q,DB12808,-7.9,Trifarotene,MFBCDACCJCDGBA-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
113103,6vxx,DB08540,-7.9,"2-[4-(2H-1,4-BENZOTHIAZINE-3-YL)-PIPERAZINE-1-LY]-1,3-THIAZOLE-4-CARBOXYLIC ACID ETHYLESTER",AQJQFCRTSWIUCY-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113099,6vxx,DB08536,-7.9,"3-bromo-5-phenyl-N-(pyrimidin-5-ylmethyl)pyrazolo[1,5-a]pyridin-7-amine",IBUPHWYGVDAASU-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
166304,7bv1,DB14635,-7.9,Curcumin sulfate,NEJVQQBBTRFOHB-FCXRPNKRSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
148004,6w9q,DB12781,-7.9,Balaglitazone,IETKPTYAGKZLKY-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
113002,6vxx,DB08250,-7.9,"(5S)-5-(3-AMINOPROPYL)-3-(2,5-DIFLUOROPHENYL)-N-ETHYL-5-PHENYL-4,5-DIHYDRO-1H-PYRAZOLE-1-CARBOXAMIDE",OQMVLDZJPRSNOG-NRFANRHFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
94410,6m71,DB08077,-7.9,"2-[4-({[(3,5-DICHLOROPHENYL)AMINO]CARBONYL}AMINO)PHENOXY]-2-METHYLPROPANOIC ACID",OYJPTSMWFKGZJM-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
113088,6vxx,DB08360,-7.9,"2-(4-ETHYLPIPERAZIN-1-YL)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE",BIFHJPUTQBOBGJ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
14216,6lzg,T3D3845,-7.9,Flumetsulam,RXCPQSJAVKGONC-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
113062,6vxx,DB08325,-7.9,2-(2-HYDROXYETHYLAMINO)-6-(3-CHLOROANILINO)-9-ISOPROPYLPURINE,XZEFMZCNXDQXOZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
166296,7bv1,DB14627,-7.9,Oxyphenisatin acetate,PHPUXYRXPHEJDF-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
75323,6m2n,DB04549,-7.9,"4-(Aminosulfonyl)-N-[(2,3,4-Trifluorophenyl)Methyl]-Benzamide",AANTYZRUJFNZFI-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
65942,6lxt,DB03510,-7.9,6-O-Phosphoryl Inosine Monophosphate,RXRZOKQPANIEDW-KQYNXXCUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
166294,7bv1,DB14625,-7.9,Meprednisone acetate,RZAMUHXEOMZXET-ABQXZQTJSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
115094,6w4b,DB00443,-7.9,Betamethasone,UREBDLICKHMUKA-DVTGEIKXSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
8797,6lzg,DB06849,-7.9,"1-[1'-(3-phenylacryloyl)spiro[1-benzofuran-3,4'-piperidin]-5-yl]methanamine",RQWYWHUKHYFIPB-VQHVLOKHSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
93117,6m71,DB06334,-7.9,Tucidinostat,SZMJVTADHFNAIS-BJMVGYQFSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
113022,6vxx,DB08282,-7.9,"O-[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethyl] (4-chlorophenyl)thiocarbamate",BWRRXOIACQYNEK-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
65951,6lxt,DB03523,-7.9,Brequinar,PHEZJEYUWHETKO-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
151438,6wiq,DB02705,-7.9,"6-[N-(1-Isopropyl-1,2,3,4-Tetrahydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine",DARQQJKHXPXSRO-QFIPXVFZSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
112866,6vxx,DB07936,-7.9,N-(4-{[(3S)-3-(dimethylamino)pyrrolidin-1-yl]carbonyl}phenyl)-5-fluoro-4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]pyrimidin-2-amine,BACSZMCLZIDTIO-IBGZPJMESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112865,6vxx,DB07935,-7.9,"5-[(5-fluoro-3-methyl-1H-indazol-4-yl)oxy]benzene-1,3-dicarbonitrile",JYAHFMKZJRVTDT-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30371,6cs2,DB12399,-7.9,Polmacoxib,IJWPAFMIFNSIGD-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
112703,6vxx,DB07749,-7.9,2-ACETYLAMINO-4-METHYL-PENTANOIC ACID (1-FORMYL-2-PHENYL-ETHYL)-AMIDE,QRDDFQYJOFVDNR-HOTGVXAUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
115565,6w4b,DB01003,-7.9,Cromoglicic acid,IMZMKUWMOSJXDT-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
76385,6m2n,DB07143,-7.9,D-phenylalanyl-N-benzyl-L-prolinamide,MEPJWLFTTFHOQO-MOPGFXCFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
94588,6m71,DB08292,-7.9,"(5Z)-12-CHLORO-13,15-DIHYDROXY-4,7,8,9-TETRAHYDRO-2-BENZOXACYCLOTRIDECINE-1,10(3H,11H)-DIONE",AQKZYZQONWDDLS-IWQZZHSRSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
112699,6vxx,DB07745,-7.9,2-{[4-(TRIFLUOROMETHOXY)BENZOYL]AMINO}ETHYL DIHYDROGEN PHOSPHATE,YAHFSBJEYPSDPU-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
147724,6w9q,DB12355,-7.9,Netazepide,YDZYKNJZCVIKPP-VWLOTQADSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
147716,6w9q,DB12341,-7.9,LY-2456302,ZHPMYDSXGRRERG-DEOSSOPVSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
66962,6lxt,DB04879,-7.9,Vatalanib,YCOYDOIWSSHVCK-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
112697,6vxx,DB07742,-7.9,"N-(2,3-DIFLUORO-BENZYL)-4-SULFAMOYL-BENZAMIDE",QASSMVGOSBNFQY-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
93000,6m71,DB05936,-7.9,CVT-6883,KOYXXLLNCXWUNF-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
112706,6vxx,DB07753,-7.9,"3',5'-DIFLUOROBIPHENYL-4-CARBOXYLIC ACID",VCEFNMHMLWBFNV-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
147692,6w9q,DB12307,-7.9,Foretinib,CXQHYVUVSFXTMY-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
147691,6w9q,DB12306,-7.9,Cipargamin,CKLPLPZSUQEDRT-WPCRTTGESA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
65828,6lxt,DB03349,-7.9,8-Bromo-Adenosine-5'-Monophosphate,DNPIJKNXFSPNNY-UUOKFMHZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
30387,6cs2,DB12417,-7.9,Anagliptin,LDXYBEHACFJIEL-HNNXBMFYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
115651,6w4b,DB01100,-7.9,Pimozide,YVUQSNJEYSNKRX-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
112649,6vxx,DB07500,-7.9,(2E)-1-[2-hydroxy-4-methoxy-5-(3-methylbut-2-en-1-yl)phenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one,ZUGCRBMNFSAUOC-YRNVUSSQSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
94602,6m71,DB08307,-7.9,"2-{HYDROXY[2-NITRO-4-(TRIFLUOROMETHYL)PHENYL]METHYLENE}CYCLOHEXANE-1,3-DIONE",PMHVFNYNPNKNRO-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
92981,6m71,DB05804,-7.9,Prasterone sulfate,CZWCKYRVOZZJNM-USOAJAOKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
92979,6m71,DB05796,-7.9,Daglutril,XMQODGUTLZXUGZ-RPBOFIJWSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
52700,2fxp,DB11896,-7.9,Gedatolisib,DWZAEMINVBZMHQ-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
147671,6w9q,DB12282,-7.9,Defactinib,FWLMVFUGMHIOAA-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
30398,6cs2,DB12428,-7.9,PAC-14028,UKGJZDSUJSPAJL-YPUOHESYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
115607,6w4b,DB01051,-7.9,Novobiocin,YJQPYGGHQPGBLI-KGSXXDOSSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
66897,6lxt,DB04797,-7.9,Triazolopyridine,OVCXRBARSPBVMC-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
115521,6w4b,DB00950,-7.9,Fexofenadine,RWTNPBWLLIMQHL-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
93014,6m71,DB05992,-7.9,Plinabulin,UNRCMCRRFYFGFX-TYPNBTCFSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
147857,6w9q,DB12550,-7.9,Taladegib,SZBGQDXLNMELTB-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
76317,6m2n,DB07064,-7.9,"(4R)-4-(3-HYDROXYPHENYL)-N,N,7,8-TETRAMETHYL-3,4-DIHYDROISOQUINOLINE-2(1H)-CARBOXAMIDE",HPVCRUIDFODATB-LJQANCHMSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
147827,6w9q,DB12505,-7.9,E-7820,LWGUASZLXHYWIV-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
147820,6w9q,DB12491,-7.9,Fasiglifam,BZCALJIHZVNMGJ-HSZRJFAPSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
94497,6m71,DB08170,-7.9,"(1R)-N,6-DIHYDROXY-7-METHOXY-2-[(4-METHOXYPHENYL)SULFONYL]-1,2,3,4-TETRAHYDROISOQUINOLINE-1-CARBOXAMIDE",AYFCYVLVRYQGME-QGZVFWFLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
147804,6w9q,DB12467,-7.9,TU-100,KAYRGFYBCCETPE-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
76334,6m2n,DB07085,-7.9,2-{[N-(2-ACETYL-5-CHLORO-4-FLUOROPHENYL)GLYCYL]AMINO}BENZOIC ACID,LBMZLHCAPBBOFS-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
112811,6vxx,DB07869,-7.9,6-CHLORO-4-(CYCLOHEXYLSULFINYL)-3-PROPYLQUINOLIN-2(1H)-ONE,QRBUGQMJMFAHKS-HSZRJFAPSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112801,6vxx,DB07859,-7.9,4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL)PHENYL]PIPERIDINE,LZMOSYUFVYJEPY-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112799,6vxx,DB07857,-7.9,(2R)-2-(4-chlorophenyl)-2-[4-(1H-pyrazol-4-yl)phenyl]ethanamine,HWVGILTYGZFGLR-QGZVFWFLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76340,6m2n,DB07091,-7.9,(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclohexyloxy)ethanoyl)pyrrolidine-2-carboxamide,IWPMQJKXKKKSEY-SFHVURJKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
147740,6w9q,DB12379,-7.9,Indirubin,CRDNMYFJWFXOCH-BUHFOSPRSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
93041,6m71,DB06157,-7.9,Istaroxime,MPYLDWFDPHRTEG-PAAYLBSLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
147796,6w9q,DB12457,-7.9,Rimegepant,KRNAOFGYEFKHPB-ANJVHQHFSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
93031,6m71,DB06144,-7.9,Sertindole,GZKLJWGUPQBVJQ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
30350,6cs2,DB12375,-7.9,Oglemilast,OKFDRAHPFKMAJH-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
147782,6w9q,DB12432,-7.9,CC-401,XDJCLCLBSGGNKS-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
93029,6m71,DB06137,-7.9,KX-01,HUNGUWOZPQBXGX-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
147773,6w9q,DB12420,-7.9,Diazepinomicin,SALVHVNECODMJP-GNUCVDFRSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
112758,6vxx,DB07810,-7.9,"3-(4-HYDROXYPHENYL)-1-(2,4,6-TRIHYDROXYPHENYL)PROPAN-1-ONE",VGEREEWJJVICBM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
94550,6m71,DB08239,-7.9,"(2S)-4-(2,5-DIFLUOROPHENYL)-N-METHYL-2-PHENYL-N-PIPERIDIN-4-YL-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDE",NKLVBHMAIMEVEH-QFIPXVFZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
66935,6lxt,DB04842,-7.9,Fluspirilene,QOYHHIBFXOOADH-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
93018,6m71,DB06077,-7.9,Lumateperone,HOIIHACBCFLJET-SFTDATJTSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94553,6m71,DB08242,-7.9,"N,4-dimethyl-3-[(1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl)amino]benzamide",OYTBZXSFNNAVKU-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
8900,6lzg,DB06963,-7.9,"3-[3-(3-methyl-6-{[(1S)-1-phenylethyl]amino}-1H-pyrazolo[4,3-c]pyridin-1-yl)phenyl]propanamide",ZFGCLYUGFRNYFE-INIZCTEOSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
91305,6m71,DB02881,-7.9,4-(4-Hydroxy-3-Isopropylphenylthio)-2-Isopropylphenol,NEMLLZAROZVCCE-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
85581,6m3m,DB07825,-7.9,(3S)-1-(4-acetylphenyl)-5-oxopyrrolidine-3-carboxylic acid,SQGYWRZISBCKMW-JTQLQIEISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
164931,7bv1,DB08975,-7.9,Florantyrone,QOBAOSCOLAGPKI-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
79647,6m2n,DB13555,-7.9,Prajmaline,UAUHEPXILIZYCU-ALHOSYKFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
73837,6m2n,DB02549,-7.9,3'-O-Acetylthymidine-5'-Diphosphate,UWSIAAWKEICIJY-IVZWLZJFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78973,6m2n,DB12533,-7.9,Cevipabulin,ZUZPCOQWSYNWLU-VIFPVBQESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
90983,6m71,DB02455,-7.9,Fluoresceinylthioureido,VHJFQSRUDVDTEO-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
78627,6m2n,DB12039,-7.9,Epicatechin,PFTAWBLQPZVEMU-UKRRQHHQSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79649,6m2n,DB13557,-7.9,Thiopropazate,AIUHRQHVWSUTGJ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
29299,6cs2,DB08984,-7.9,Etofenamate,XILVEPYQJIOVNB-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
31396,6cs2,DB01051,-7.9,Novobiocin,YJQPYGGHQPGBLI-KGSXXDOSSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
68329,6lxt,DB07793,-7.9,"(2S)-N-[(3S)-1-(2-AMINO-2-OXOETHYL)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL]-2-CHLORO-2H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE",ACSGSLPOHKRZCY-GXTWGEPZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
98461,6vxs,DB00967,-7.9,Desloratadine,JAUOIFJMECXRGI-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
98776,6vxs,DB01406,-7.9,Danazol,POZRVZJJTULAOH-LHZXLZLDSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
55167,6crv,DB00691,-7.9,Moexipril,UWWDHYUMIORJTA-HSQYWUDLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
121354,6w4b,DB11772,-7.9,Pilaralisib,QINPEPAQOBZPOF-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
54863,6crv,DB00318,-7.9,Codeine,OROGSEYTTFOCAN-DNJOTXNNSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
122215,6w4b,DB13060,-7.9,CEP-37440,BCSHRERPHLTPEE-NRFANRHFSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
79433,6m2n,DB13274,-7.9,Micronomicin,DNYGXMICFMACRA-XHEDQWPISA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
143812,6w9q,DB04030,-7.9,"1,3,4,9-Tetrahydro-2-(Hydroxybenzoyl)-9-[(4-Hydroxyphenyl)Methyl]-6-Methoxy-2h-Pyrido[3,4-B]Indole",ADXYEWMDAGIULV-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
108156,6vxx,DB07168,-7.9,[4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-6-(methylamino)pyrimidin-2-yl}amino)phenyl]acetonitrile,MFMSRHREFZCFSN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
98129,6vxs,DB00579,-7.9,Mazindol,ZPXSCAKFGYXMGA-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
28306,6cs2,DB07891,-7.9,"4-{[(14beta,17alpha)-3-hydrox1tra-1,3,5(10)-trien-17-yl]oxy}-4-oxobutanoic acid",YJPIDPAGJSWWBE-FNIAAEIWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
63407,6lxt,DB00240,-7.9,Alclometasone,FJXOGVLKCZQRDN-PHCHRAKRSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
144681,6w9q,DB06137,-7.9,KX-01,HUNGUWOZPQBXGX-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
78610,6m2n,DB12008,-7.9,Prexasertib,DOTGPNHGTYJDEP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
28043,6cs2,DB07616,-7.9,"4-{[4-(4-fluoro-3-methylphenyl)-1,3-thiazol-2-yl]amino}-2-hydroxybenzoic acid",LKZZDHKJFDTYCH-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
91004,6m71,DB02483,-7.9,Etheno-Nad,JCDBQDNBEQHDHK-BSLNIGMPSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
90618,6m71,DB01977,-7.9,6-(N-Phenylcarbamyl)-2-Naphthalenecarboxamidine,AECPTICWHONWNW-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
143804,6w9q,DB04020,-7.9,"4-(2-{[4-{[3-(4-Chlorophenyl)Propyl]Sulfanyl}-6-(1-Piperazinyl)-1,3,5-Triazin-2-Yl]Amino}Ethyl)Phenol",AIBKIFHSQQYXLG-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
98146,6vxs,DB00598,-7.9,Labetalol,SGUAFYQXFOLMHL-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
90081,6m71,DB01234,-7.9,Dexamethasone,UREBDLICKHMUKA-CXSFZGCWSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
154126,6wiq,DB07507,-7.9,"2-(4-hydroxybiphenyl-3-yl)-4-methyl-1H-isoindole-1,3(2H)-dione",ROMNEYAQUBNRLR-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
120611,6w4b,DB08703,-7.9,"12-(2-hydroxyethyl)-2-(1-methylethoxy)-13,14-dihydronaphtho[2,1-a]pyrrolo[3,4-c]carbazol-5(12H)-one",FGKKIHITEICGMN-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
98103,6vxs,DB00547,-7.9,Desoximetasone,VWVSBHGCDBMOOT-IIEHVVJPSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
74216,6m2n,DB03062,-7.9,(1-Methyl-1h-Imidazol-2-Yl)-(3-Methyl-4-{3-[(Pyridin-3-Ylmethyl)-Amino]-Propoxy}-Benzofuran-2-Yl)-Methanone,VZBQJKIOAOUYJL-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
164830,7bv1,DB08657,-7.9,2-(4-(2-((3-(5-(PYRIDIN-2-YLTHIO)THIAZOL-2-YL)UREIDO)METHYL)-1H-IMIDAZOL-4-YL)PHENOXY)ACETIC ACID,SSXCWVOQWRUMGN-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
31424,6cs2,DB13797,-7.9,Iodocholesterol (131I),FIOAEFCJGZJUPW-ODFYUTSGSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
98746,6vxs,DB01339,-7.9,Vecuronium,BGSZAXLLHYERSY-XQIGCQGXSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
23761,6cs2,DB01393,-7.9,Bezafibrate,IIBYAHWJQTYFKB-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
122163,6w4b,DB12978,-7.9,Pexidartinib,JGWRKYUXBBNENE-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
90882,6m71,DB02331,-7.9,"(2s)-2-[(5-Benzofuran-2-Yl-Thiophen-2-Ylmethyl)-(2,4-Dichloro-Benzoyl)-Amino]-3-Phenyl-Propionic Acid",YBULOUKTPCHXAL-DEOSSOPVSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
144037,6w9q,DB04330,-7.9,Bilh 434,KNRVCCXHLSHTFW-HGPRPZRGSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
55452,6crv,DB01021,-7.9,Trichlormethiazide,LMJSLTNSBFUCMU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
74195,6m2n,DB03034,-7.9,D-Levofloxacin,GSDSWSVVBLHKDQ-SNVBAGLBSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
97626,6m71,DB15292,-7.9,Foliglurax,ZTEDNASHAWNBKQ-NCELDCMTSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
74199,6m2n,DB03039,-7.9,"4-(Aminosulfonyl)-N-[(2,5-Difluorophenyl)Methyl]-Benzamide",KEGUALXMKQVDIO-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78688,6m2n,DB12123,-7.9,Cinepazide,RCUDFXMNPQNBDU-VOTSOKGWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
108744,6vxx,DB08897,-7.9,Aclidinium,ASMXXROZKSBQIH-VITNCHFBSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79459,6m2n,DB13310,-7.9,Ormeloxifene,XZEUAXYWNKYKPL-WDYNHAJCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
108315,6vxx,DB07615,-7.9,Tranilast,NZHGWWWHIYHZNX-CSKARUKUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
68178,6lxt,DB07616,-7.9,"4-{[4-(4-fluoro-3-methylphenyl)-1,3-thiazol-2-yl]amino}-2-hydroxybenzoic acid",LKZZDHKJFDTYCH-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
143970,6w9q,DB04238,-7.9,N-Alpha-(2-Naphthylsulfonyl)-N-(3-Amidino-L-Phenylalaninyl)-D-Pipecolinic Acid,GNANSBQAIRJZPA-XZOQPEGZSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
120718,6w4b,DB08822,-7.9,Azilsartan medoxomil,QJFSABGVXDWMIW-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
78665,6m2n,DB12093,-7.9,Tetrahydropalmatine,AEQDJSLRWYMAQI-KRWDZBQOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
144605,6w9q,DB05611,-7.9,Apilimod,HSKAZIJJKRAJAV-KOEQRZSOSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
63389,6lxt,DB00220,-7.9,Nelfinavir,QAGYKUNXZHXKMR-HKWSIXNMSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
13478,6lzg,DB15437,-7.9,Rocacetrapib,GBHPDJQHZADVAA-SOKVYYICSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
108548,6vxx,DB08383,-7.9,"4,5-bis(4-methoxyphenyl)-2-thiophen-2-yl-1H-imidazole",XBMULXNXJLWLLD-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
97592,6m71,DB15222,-7.9,GS-6620,YAAQYJCOIFNMKX-RSTNYOGXSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
13312,6lzg,DB15124,-7.9,PF-05241328,RVTSXVZXEGFIPW-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
90137,6m71,DB01342,-7.9,Forasartan,YONOBYIBNBCDSJ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
31406,6cs2,DB13778,-7.9,Cefazedone,VTLCNEGVSVJLDN-MLGOLLRUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
7581,6lzg,DB04042,-7.9,"2-[4-(Hydroxy-Methoxy-Methyl)-Benzyl]-7-(4-Hydroxymethyl-Benzyl)-1,1-Dioxo-3,6-Bis-Phenoxymethyl-1lambda6-[1,2,7]Thiadiazepane-4,5-Diol",XLJNZONSWKENRP-VABIIVNOSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
98768,6vxs,DB01392,-7.9,Yohimbine,BLGXFZZNTVWLAY-SCYLSFHTSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
97566,6m71,DB15173,-7.9,JNJ-42165279,YWGYNGCRVZLMCS-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
98744,6vxs,DB01337,-7.9,Pancuronium,GVEAYVLWDAFXET-XGHATYIMSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
54860,6crv,DB00315,-7.9,Zolmitriptan,ULSDMUVEXKOYBU-ZDUSSCGKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78603,6m2n,DB12000,-7.9,Apabetalone,NETXMUIMUZJUTB-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
145117,6w9q,DB06983,-7.9,"(5-phenyl-7-(pyridin-3-ylmethylamino)pyrazolo[1,5-a]pyrimidin-3-yl)methanol",RBLKWWBHDUBPFN-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
79704,6m2n,DB13635,-7.9,Tiracizine,KJAMZCVTJDTESW-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
28291,6cs2,DB07872,-7.9,5-chloro-N-[(3R)-1-(2-{[2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl]amino}-2-oxoethyl)pyrrolidin-3-yl]thiophene-2-carboxamide,IYGIXVNAMZPBDK-CQSZACIVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
13259,6lzg,DB15033,-7.9,Flortaucipir,GETAAWDSFUCLBS-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
13258,6lzg,DB15031,-7.9,Nemorexant,NBGABHGMJVIVBW-QHCPKHFHSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
121749,6w4b,DB12341,-7.9,LY-2456302,ZHPMYDSXGRRERG-DEOSSOPVSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
28546,6cs2,DB08135,-7.9,N-phenyl-1H-pyrazole-3-carboxamide,WMZYZYFPPQOFKY-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
28194,6cs2,DB07776,-7.9,Flavone,VHBFFQKBGNRLFZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
28195,6cs2,DB07778,-7.9,FAMOXADONE,PCCSBWNGDMYFCW-QFIPXVFZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
98398,6vxs,DB00897,-7.9,Triazolam,JOFWLTCLBGQGBO-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
91071,6m71,DB02567,-7.9,PD173955,VAARYSWULJUGST-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
23914,6cs2,DB01554,-7.9,Bolandiol,CMXKUJNZWYTFJN-XFUVECHXSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
64098,6lxt,DB01061,-7.9,Azlocillin,JTWOMNBEOCYFNV-NFFDBFGFSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
28018,6cs2,DB07588,-7.9,"3,4-DI-1H-INDOL-3-YL-1H-PYRROLE-2,5-DICARBOXYLIC ACID",FZDVNXHYGMEEDT-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
78549,6m2n,DB11917,-7.9,Vatiquinone,LNOVHERIIMJMDG-XZXLULOTSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
98183,6vxs,DB00643,-7.9,Mebendazole,OPXLLQIJSORQAM-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
97542,6m71,DB15124,-7.9,PF-05241328,RVTSXVZXEGFIPW-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
10457,6lzg,DB08657,-7.9,2-(4-(2-((3-(5-(PYRIDIN-2-YLTHIO)THIAZOL-2-YL)UREIDO)METHYL)-1H-IMIDAZOL-4-YL)PHENOXY)ACETIC ACID,SSXCWVOQWRUMGN-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
145130,6w9q,DB06997,-7.9,"2-(4-fluorophenyl)-N-{[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]carbamoyl}acetamide",BMPOCDJEXAXXEZ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
120457,6w4b,DB08513,-7.9,[4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENYL]ACETIC ACID,PAIQRYUOBBCBSE-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
98834,6vxs,DB01471,-7.9,Bolasterone,IVFYLRMMHVYGJH-VLOLGRDOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
54771,6crv,DB00213,-7.9,Pantoprazole,IQPSEEYGBUAQFF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31352,6cs2,DB13714,-7.9,Xibornol,RNRHMQWZFJXKLZ-JCKWVBRZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
108908,6vxx,DB11367,-7.9,Cefroxadine,RDMOROXKXONCAL-UEKVPHQBSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78519,6m2n,DB11875,-7.9,"3,3'-diindolylmethane",VFTRKSBEFQDZKX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
68719,6lxt,DB08241,-7.9,4-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)--BENZAMIDE,RUUOIINPNMNPIU-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
78518,6m2n,DB11873,-7.9,Verinurad,YYBOLPLTQDKXPM-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
108910,6vxx,DB11371,-7.9,Alfaxalone,DUHUCHOQIDJXAT-OLVMNOGESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79375,6m2n,DB13177,-7.9,4-methylumbelliferyl beta-D-glucoside,YUDPTGPSBJVHCN-YMILTQATSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79388,6m2n,DB13213,-7.9,Butaperazine,DVLBYTMYSMAKHP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
108352,6vxx,DB07655,-7.9,"3-AMINO-3-BENZYL-[4.3.0]BICYCLO-1,6-DIAZANONAN-2-ONE",MPJYGQHMIFDQIN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
98158,6vxs,DB00611,-7.9,Butorphanol,IFKLAQQSCNILHL-PWRODBHTSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
121751,6w4b,DB12345,-7.9,MBX-2982,NFTMKHWBOINJGM-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
54845,6crv,DB00296,-7.9,Ropivacaine,ZKMNUMMKYBVTFN-HNNXBMFYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
68116,6lxt,DB07539,-7.9,"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZOIC ACID",JLRKRQCTYQGDKJ-GHXNOFRVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
108815,6vxx,DB09378,-7.9,Fluprednisolone,MYYIMZRZXIQBGI-HVIRSNARSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
164482,7bv1,DB08057,-7.9,"N-(2-chloro-6-methylphenyl)-8-[(3S)-3-methylpiperazin-1-yl]imidazo[1,5-a]quinoxalin-4-amine",VWJPPYCULHDHBB-HNNXBMFYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
23893,6cs2,DB01535,-7.9,Carfentanil,YDSDEBIZUNNPOB-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
108515,6vxx,DB08078,-7.9,{4-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]phenoxy}acetic acid,HBBVCKCCQCQCTJ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
143720,6w9q,DB03907,-7.9,"N-{3-[5-(6-Amino-Purin-9-Yl)-3,4-Dihydroxy-Tetrahydro-Furan-2-Yl]-Allyl}-2,3-Dihydroxy-5-Nitro-Benzamide",UHHBFOLQOQSPLU-WGRQDFERSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
78584,6m2n,DB11967,-7.9,Binimetinib,ACWZRVQXLIRSDF-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
28180,6cs2,DB07761,-7.9,"(2R)-1-[4-({6-[(2,6-Difluorophenyl)amino]-4-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol",ZVSBKYYVBCKDBO-OAHLLOKOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
121400,6w4b,DB11832,-7.9,Crenolanib,DYNHJHQFHQTFTP-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
165001,7bv1,DB09075,-7.9,Edoxaban,HGVDHZBSSITLCT-JLJPHGGASA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
164802,7bv1,DB08622,-7.9,"4-(4-CHLORO-PHENYL)-1-{3-[2-(4-FLUORO-PHENYL)-[1,3]DITHIOLAN-2-YL]-PROPYL}-PIPERIDIN-4-OL",KVDKNVPAAQKHKD-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
68541,6lxt,DB08034,-7.9,"(E)-3,4-DIHYDROXY-N'-[(2-METHOXYNAPHTHALEN-1-YL)METHYLENE]BENZOHYDRAZIDE",TVOPERZEGKBKAY-RGVLZGJSSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
10620,6lzg,DB08834,-7.9,Tauroursodeoxycholic acid,BHTRKEVKTKCXOH-LBSADWJPSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
54822,6crv,DB00270,-7.9,Isradipine,HMJIYCCIJYRONP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
90591,6m71,DB01946,-7.9,"3-[1-(3-Aminopropyl)-1h-Indol-3-Yl]-4-(1-Methyl-1h-Indol-3-Yl)-1h-Pyrrole-2,5-Dione",UQHKJRCFSLMWIA-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
28533,6cs2,DB08122,-7.9,"N-METHYL-4-{[(2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]AMINO}BENZENESULFONAMIDE",IKASAFLVQIJQOK-UVTDQMKNSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
10838,6lzg,DB09168,-7.9,4-Phenylfentanyl,BXCJXJLHYMWMQU-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
108510,6vxx,DB08073,-7.9,(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE,YWTBGJGMTBHQTM-IBGZPJMESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28534,6cs2,DB08123,-7.9,"N-METHYL-{4-[2-(7-OXO-6,7-DIHYDRO-8H-[1,3]THIAZOLO[5,4-E]INDOL-8-YLIDENE)HYDRAZINO]PHENYL}METHANESULFONAMIDE",GEWPSTLKJDIUHW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
55201,6crv,DB00728,-7.9,Rocuronium,YXRDKMPIGHSVRX-OOJCLDBCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
13380,6lzg,DB15246,-7.9,Salvianolic acid A,YMGFTDKNIWPMGF-UCPJVGPRSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
55662,6crv,DB01268,-7.9,Sunitinib,WINHZLLDWRZWRT-ATVHPVEESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
145111,6w9q,DB06976,-7.9,"1-(5-OXO-2,3,5,9B-TETRAHYDRO-1H-PYRROLO[2,1-A]ISOINDOL-9-YL)-3-(5-PYRROLIDIN-2-YL-1H-PYRAZOL-3-YL)-UREA",IWOOJEZSDPRYAZ-WFASDCNBSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
68530,6lxt,DB08022,-7.9,"(2S)-1,3-benzothiazol-2-yl{2-[(2-pyridin-3-ylethyl)amino]pyrimidin-4-yl}ethanenitrile",RCYPVQCPYKNSTG-OAHLLOKOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
78568,6m2n,DB11946,-7.9,AZD-1981,JWYIGNODXSRKGP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
122311,6w4b,DB13230,-7.9,Gestonorone,GTFUITFQDGVJSK-XGXHKTLJSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
28189,6cs2,DB07770,-7.9,5-(4-FLUOROPHENYL)-3-{[(4-METHYLPHENYL)SULFONYL]AMINO}THIOPHENE-2-CARBOXYLIC ACID,DJPFUQBNQLKCAB-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
28537,6cs2,DB00751,-7.9,Epinastine,WHWZLSFABNNENI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
31367,6cs2,DB13729,-7.9,Camostat,XASIMHXSUQUHLV-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
78509,6m2n,DB11861,-7.9,Litronesib,YVAFBXLHPINSIK-QHCPKHFHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78943,6m2n,DB12482,-7.9,Acotiamide,TWHZNAUBXFZMCA-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
64036,6lxt,DB00990,-7.9,Exemestane,BFYIZQONLCFLEV-DAELLWKTSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
23789,6cs2,DB01426,-7.9,Ajmaline,CJDRUOGAGYHKKD-HEFSZTOGSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
55002,6crv,DB00487,-7.9,Pefloxacin,FHFYDNQZQSQIAI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
97854,6vxs,DB00243,-7.9,Ranolazine,XKLMZUWKNUAPSZ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
79507,6m2n,DB13364,-7.9,Feprazone,RBBWCVQDXDFISW-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
74149,6m2n,DB02963,-7.9,"(5-Chloropyrazolo[1,5-a]Pyrimidin-7-Yl)-(4-Methanesulfonylphenyl)Amine",LVNXHNRYPADEAD-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
68238,6lxt,DB07688,-7.9,"4-{[5-(CYCLOHEXYLOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE",RPJIMTALCNCQLV-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
90712,6m71,DB02102,-7.9,DMP450,KYRSNWPSSXSNEP-ZRTHHSRSSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
122053,6w4b,DB12806,-7.9,GSK-1004723,YANGEESWIGIKOP-UUWRZZSWSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
90243,6m71,DB01493,-7.9,Ethylestrenol,AOXRBFRFYPMWLR-XGXHKTLJSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
31469,6cs2,DB13851,-7.9,Artemotil,NLYNIRQVMRLPIQ-XQLAAWPRSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
144391,6w9q,DB04812,-7.9,Benoxaprofen,MITFXPHMIHQXPI-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
144538,6w9q,DB05263,-7.9,Caprospinol,VMOZFSWFUBLCNN-AAPULDEBSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
144543,6w9q,DB05288,-7.9,Anecortave acetate,YUWPMEXLKGOSBF-GACAOOTBSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
31781,6cs2,DB14735,-7.9,Cannabichromene,UVOLYTDXHDXWJU-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
108630,6vxx,DB08481,-7.9,"4-METHYL-N-{(5E)-5-[(5-METHYL-2-FURYL)METHYLENE]-4-OXO-4,5-DIHYDRO-1,3-THIAZOL-2-YL}BENZENESULFONAMIDE",MXAPQGDBWFYKKX-ZROIWOOFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
13406,6lzg,DB15295,-7.9,Tenalisib,HDXDQPRPFRKGKZ-INIZCTEOSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
63820,6lxt,DB00739,-7.9,Hetacillin,DXVUYOAEDJXBPY-NFFDBFGFSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
78795,6m2n,DB12279,-7.9,OBP-801,XFLBOEMFLGLWFF-HDXRNPEWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78794,6m2n,DB12278,-7.9,Propiverine,QPCVHQBVMYCJOM-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
54992,6crv,DB00476,-7.9,Duloxetine,ZEUITGRIYCTCEM-KRWDZBQOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
68236,6lxt,DB07685,-7.9,"4-{[5-(CYCLOHEXYLMETHOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE",NMAZGYDYIYLSLJ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
55068,6crv,DB00573,-7.9,Fenoprofen,RDJGLLICXDHJDY-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
63952,6lxt,DB00894,-7.9,Testolactone,BPEWUONYVDABNZ-DZBHQSCQSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
28136,6cs2,DB07715,-7.9,Emodin,RHMXXJGYXNZAPX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
31783,6cs2,DB01091,-7.9,Butenafine,ABJKWBDEJIDSJZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
55488,6crv,DB01062,-7.9,Oxybutynin,XIQVNETUBQGFHX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108623,6vxx,DB08472,-7.9,(R)-Fluoxetine,RTHCYVBBDHJXIQ-MRXNPFEDSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31462,6cs2,DB01058,-7.9,Praziquantel,FSVJFNAIGNNGKK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
13300,6lzg,DB15106,-7.9,Surufatinib,TTZSNFLLYPYKIL-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
31502,6cs2,DB13930,-7.9,Ulixertinib,KSERXGMCDHOLSS-LJQANCHMSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
28075,6cs2,DB07648,-7.9,"(2R)-3-{[(4Z)-5,6-DIPHENYL-6,7-DIHYDRO-4H-PYRROLO[2,3-D]PYRIMIDIN-4-YLIDENE]AMINO}PROPANE-1,2-DIOL",TWEONIHFGKSPLC-MRXNPFEDSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
68621,6lxt,DB08125,-7.9,"4-{[(2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]AMINO}-N-(1,3-THIAZOL-2-YL)BENZENESULFONAMIDE",BOMPRXSVSIPRDT-PTNGSMBKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
68247,6lxt,DB07698,-7.9,"3-(3-aminophenyl)-N-(3-chlorophenyl)pyrazolo[1,5-a]pyrimidin-5-amine",JDNMRPIWJIDDAY-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
55040,6crv,DB00537,-7.9,Ciprofloxacin,MYSWGUAQZAJSOK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
164881,7bv1,DB08906,-7.9,Fluticasone furoate,XTULMSXFIHGYFS-VLSRWLAYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
13383,6lzg,DB15254,-7.9,RO-5126766 free base,LMMJFBMMJUMSJS-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
164575,7bv1,DB08159,-7.9,"4-(5,11-DIOXO-5H-INDENO[1,2-C]ISOQUINOLIN-6(11H)-YL)BUTANOATE",AHIJTWCJGCWHMT-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
55532,6crv,DB01113,-7.9,Papaverine,XQYZDYMELSJDRZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
10549,6lzg,DB08755,-7.9,N-[(1S)-2-{[(1R)-2-(benzyloxy)-1-cyano-1-methylethyl]amino}-1-(cyclohexylmethyl)-2-oxoethyl]morpholine-4-carboxamide,MQWUTQCRGGBPBT-WIOPSUGQSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
31761,6cs2,DB01089,-7.9,Deserpidine,CVBMAZKKCSYWQR-WCGOZPBSSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
164867,7bv1,DB08705,-7.9,"6-(5-BROMO-2-HYDROXYPHENYL)-2-OXO-4-PHENYL-1,2-DIHYDROPYRIDINE-3-CARBONITRILE",SVSYJTYGPLVUOZ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
144496,6w9q,DB05016,-7.9,Ataluren,OOUGLTULBSNHNF-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
98571,6vxs,DB01094,-7.9,Hesperetin,AIONOLUJZLIMTK-AWEZNQCLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
68596,6lxt,DB08099,-7.9,"6-ethyl-5-[(2S)-1-(3-methoxypropyl)-2-phenyl-1,2,3,4-tetrahydroquinolin-7-yl]pyrimidine-2,4-diamine",UOYVKYJWAXJTTE-NRFANRHFSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
23769,6cs2,DB01406,-7.9,Danazol,POZRVZJJTULAOH-LHZXLZLDSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
98559,6vxs,DB01081,-7.9,Diphenoxylate,HYPPXZBJBPSRLK-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
73894,6m2n,DB02628,-7.9,"1-[3,3-Dimethyl-2-(2-Methylamino-Propionylamino)-Butyryl]-Pyrrolidine-2-Carboxylic Acid(1,2,3,4-Tetrahydro-Naphthalen-1-Yl)-Amide",JUJIMRZGUBTJRV-NASSWSRMSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
98590,6vxs,DB01116,-7.9,Trimethaphan,CHQOEHPMXSHGCL-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
97909,6vxs,DB00307,-7.9,Bexarotene,NAVMQTYZDKMPEU-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
10794,6lzg,DB09076,-7.9,Umeclidinium,FVTWTVQXNAJTQP-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
144477,6w9q,DB04946,-7.9,Iloperidone,XMXHEBAFVSFQEX-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
120958,6w4b,DB09199,-7.9,Netoglitazone,PKWDZWYVIHVNKS-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
154888,6wiq,DB08407,-7.9,PLATENSIMYCIN,CSOMAHTTWTVBFL-OFBLZTNGSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
164864,7bv1,DB08702,-7.9,"2,5-DIPHENYLFURAN-3,4-DICARBOXYLIC ACID",QPKYPOMZPFDBEZ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
144433,6w9q,DB04861,-7.9,Nebivolol,KOHIRBRYDXPAMZ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
97898,6vxs,DB00294,-7.9,Etonogestrel,GCKFUYQCUCGESZ-BPIQYHPVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
13299,6lzg,DB15105,-7.9,PF-06751979,ZLZUHACSRMOLLV-RAALSFIWSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
13391,6lzg,DB15269,-7.9,ALK-4290,DWKNOLCXIFYNFV-HSZRJFAPSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
164894,7bv1,DB08930,-7.9,Dolutegravir,RHWKPHLQXYSBKR-BMIGLBTASA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
144419,6w9q,DB04841,-7.9,Flunarizine,SMANXXCATUTDDT-QPJJXVBHSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
68591,6lxt,DB08094,-7.9,"(4-AMINO-2-{[1-(METHYLSULFONYL)PIPERIDIN-4-YL]AMINO}PYRIMIDIN-5-YL)(2,3-DIFLUORO-6-METHOXYPHENYL)METHANONE",JRNJNYBQQYBCLE-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
23026,6cs2,HMDB0055755,-7.9,"TG(20:5(5Z,8Z,11Z,14Z,17Z)/20:2n6/22:6(4Z,7Z,10Z,13Z,16Z,19Z))",ACAFAPUIJTWQJQ-IZIWYNFFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
122040,6w4b,DB12784,-7.9,NS-018,UQTPDWDAYHAZNT-AWEZNQCLSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
144101,6w9q,DB04424,-7.9,RPR128515,XFKVLKLCLYJKNF-MZNJEOGPSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
68285,6lxt,DB07743,-7.9,"S-[5-(TRIFLUOROMETHYL)-4H-1,2,4-TRIAZOL-3-YL] 5-(PHENYLETHYNYL)FURAN-2-CARBOTHIOATE",VNGWUVBXUIDQTK-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
98012,6vxs,DB00434,-7.9,Cyproheptadine,JJCFRYNCJDLXIK-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
64001,6lxt,DB00948,-7.9,Mezlocillin,YPBATNHYBCGSSN-VWPFQQQWSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
68202,6lxt,DB07643,-7.9,"5-{[1-(2,3-dichlorobenzyl)piperidin-4-yl]methoxy}quinazoline-2,4-diamine",XVLUVRFYGVJKGJ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
13444,6lzg,DB15362,-7.9,LSZ-102,SJXNPGGVGZXKKI-NYYWCZLTSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
108710,6vxx,DB08836,-7.9,Temocapril,FIQOFIRCTOWDOW-BJLQDIEVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
121860,6w4b,DB12504,-7.9,JNJ-40346527,BNVPFDRNGHMRJS-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
68304,6lxt,DB07764,-7.9,FLUORESCIN,MURGITYSBWUQTI-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
68198,6lxt,DB07638,-7.9,"(3AS,4R,9BR)-2,2-DIFLUORO-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL",QJSMFUTULGSHNQ-ZOBUZTSGSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
144310,6w9q,DB04698,-7.9,"N-(1,4-DIHYDRO-5H-TETRAZOL-5-YLIDENE)-9-OXO-9H-XANTHENE-2-SULFONAMIDE",HJWYZPGYPZNDTN-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
122107,6w4b,DB12895,-7.9,TD-139,YGIDGBAHDZEYMT-MQFIMZJJSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
108596,6vxx,DB08441,-7.9,"6-BROMO-13-THIA-2,4,8,12,19-PENTAAZATRICYCLO[12.3.1.1-3,7-]NONADECA-1(18),3(19),4,6,14,16-HEXAENE 13,13-DIOXIDE",AWSQADBSXFTFKL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55114,6crv,DB00625,-7.9,Efavirenz,XPOQHMRABVBWPR-ZDUSSCGKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28475,6cs2,DB08063,-7.9,"1-BENZYL-3-(4-METHOXYPHENYLAMINO)-4-PHENYLPYRROLE-2,5-DIONE",HLZMYWLMBBLASX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
63212,6crv,DB15348,-7.9,Ampreloxetine,TZIALEBTHQWNAO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108186,6vxx,DB07201,-7.9,(2S)-3-[(9H-fluoren-9-ylideneamino)oxy]-2-methylpropanoic acid,ZHFDVDMCVXUGGF-NSHDSACASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
63211,6crv,DB15347,-7.9,Branebrutinib,VJPPLCNBDLZIFG-ZDUSSCGKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
68566,6lxt,DB08063,-7.9,"1-BENZYL-3-(4-METHOXYPHENYLAMINO)-4-PHENYLPYRROLE-2,5-DIONE",HLZMYWLMBBLASX-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
164836,7bv1,DB08663,-7.9,4-HYDROXY-7-METHOXY-3-(1-PHENYL-PROPYL)-CHROMEN-2-ONE,CCPGCKQLIHGSCJ-AWEZNQCLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
154399,6wiq,DB07827,-7.9,"4-{[1-METHYL-2,4-DIOXO-6-(3-PHENYLPROP-1-YN-1-YL)-1,4-DIHYDROQUINAZOLIN-3(2H)-YL]METHYL}BENZOIC ACID",FLTYDFYSVZBKOB-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
68647,6lxt,DB08153,-7.9,"(5E)-14-CHLORO-15,17-DIHYDROXY-4,7,8,9,10,11-HEXAHYDRO-2-BENZOXACYCLOPENTADECINE-1,12(3H,13H)-DIONE",VZTAZMSAAIUZJV-HWKANZROSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
63205,6crv,DB15338,-7.9,Rovatirelin,WTXWDXWZGJGIHV-URBCHYCLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
63375,6lxt,DB00203,-7.9,Sildenafil,BNRNXUUZRGQAQC-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
90869,6m71,DB02315,-7.9,Cyclic GMP,ZOOGRGPOEVQQDX-UUOKFMHZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
108558,6vxx,DB08393,-7.9,"2-[(5,6-DIPHENYLFURO[2,3-D]PYRIMIDIN-4-YL)AMINO]ETHANOL",UQHINZSKNAAVOZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108730,6vxx,DB08873,-7.9,Boceprevir,LHHCSNFAOIFYRV-DOVBMPENSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
23837,6cs2,DB01474,-7.9,"17alpha-methyl-3beta,17beta-dihydroxyandrost-4-ene",BNUOCVTVOYWNJC-DTMQFJJTSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
122148,6w4b,DB12952,-7.9,Methylprednisone,SVYCRJXQZUCUND-PQXSVQADSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
79627,6m2n,DB13531,-7.9,Nicofetamide,DWODOIKZDGJOPQ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
98736,6vxs,DB01326,-7.9,Cefamandole,OLVCFLKTBJRLHI-AXAPSJFSSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
154976,6wiq,DB08512,-7.9,"6-amino-2-[(1-naphthylmethyl)amino]-3,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",MCEZMMDIEXECTI-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
121874,6w4b,DB12523,-7.9,Mizolastine,PVLJETXTTWAYEW-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
13408,6lzg,DB15297,-7.9,Petesicatib,KXAAIORSMACJSI-AEFFLSMTSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
120818,6w4b,DB08976,-7.9,Floctafenine,APQPGQGAWABJLN-GFCCVEGCSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
78727,6m2n,DB12184,-7.9,Gepirone,QOIGKGMMAGJZNZ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
120885,6w4b,DB09073,-7.9,Palbociclib,AHJRHEGDXFFMBM-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
154922,6wiq,DB08448,-7.9,"(4aS)-5-[(2,4-diaminopteridin-6-yl)methyl]-4a,5-dihydro-2H-dibenzo[b,f]azepin-8-ol",PCBWLKUEKANDCL-INIZCTEOSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
97726,6m71,DB04596,-7.9,"4-O-{4,6-O-[(1S)-1-Carboxyethylidene]-β-D-mannopyranosyl}-D-glucopyranuronic acid",GZJXZKGVHLWBOW-AISSFXTFSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97717,6m71,DB02639,-7.9,4-methylumbelliferyl alpha-D-glucoside,YUDPTGPSBJVHCN-JZYAIQKZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
78761,6m2n,DB12233,-7.9,Iguratimod,ANMATWQYLIFGOK-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
164548,7bv1,DB08130,-7.9,"N-(5-{3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]phenyl}-1,3,4-oxadiazol-2-yl)ethane-1,2-diamine",FPDWDLAITHFTTP-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
78759,6m2n,DB12230,-7.9,Bunazosin,RHLJLALHBZGAFM-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
54977,6crv,DB00456,-7.9,Cefalotin,XIURVHNZVLADCM-IUODEOHRSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
54974,6crv,DB00452,-7.9,Framycetin,PGBHMTALBVVCIT-VCIWKGPPSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108620,6vxx,DB08469,-7.9,"tert-butyl 4-(3-thiophen-2-yl-1,2,4-oxadiazol-5-yl)piperidine-1-carboxylate",METBQPRXNZHZMB-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108618,6vxx,DB08466,-7.9,"5-[2-(4-hydroxyphenyl)ethyl]benzene-1,3-diol",HITJFUSPLYBJPE-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
90695,6m71,DB02081,-7.9,Bis-Benzamidine,BXYGSMRTHHSAHZ-PMACEKPBSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
63771,6lxt,DB00683,-7.9,Midazolam,DDLIGBOFAVUZHB-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
98683,6vxs,DB01219,-7.9,Dantrolene,OZOMQRBLCMDCEG-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
97704,6m71,DB15448,-7.9,Acumapimod,VGUSQKZDZHAAEE-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
144316,6w9q,DB04706,-7.9,"(3BETA,7BETA)-CHOLEST-5-ENE-3,7-DIOL",OYXZMSRRJOYLLO-KGZHIOMZSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
68217,6lxt,DB07663,-7.9,"2-[(1R)-1-CARBOXY-2-(4-HYDROXYPHENYL)ETHYL]-1,3-DIOXOISOINDOLINE-5-CARBOXYLIC ACID",QISJEFYTLZTWIQ-CQSZACIVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
78746,6m2n,DB12214,-7.9,Luseogliflozin,WHSOLWOTCHFFBK-ZQGJOIPISA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
97688,6m71,DB15416,-7.9,PX-102,XBUXXJUEBFDQHD-NHCUHLMSSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
108613,6vxx,DB08461,-7.9,"3-[(4-AMINO-1-TERT-BUTYL-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL)METHYL]PHENOL",QMAIQPBRCNEJAT-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78735,6m2n,DB12194,-7.9,Atamestane,PEPMWUSGRKINHX-TXTPUJOMSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
154218,6wiq,DB07618,-7.9,"2-(4-(AMINOMETHYL)PIPERIDIN-1-YL)-N-(3_CYCLOHEXYL-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)ACETAMIDE",AITZHKQVQNLKHI-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
55485,6crv,DB01059,-7.9,Norfloxacin,OGJPXUAPXNRGGI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
63347,6lxt,DB00171,-7.9,ATP,ZKHQWZAMYRWXGA-KQYNXXCUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
13302,6lzg,DB15109,-7.9,Ingenol disoxate,GLIUZQUNUNICGS-XUBYYPQFSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
144562,6w9q,DB05416,-7.9,Cardarine,YDBLKRPLXZNVNB-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
108693,6vxx,DB08810,-7.9,Cinitapride,ZDLBNXXKDMLZMF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
144315,6w9q,DB04705,-7.9,"(3BETA)-CHOLEST-5-ENE-3,25-DIOL",INBGSXNNRGWLJU-ZHHJOTBYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
28453,6cs2,DB08039,-7.9,"(3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE",LOGJQOUIVKBFGH-YBEGLDIGSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
122103,6w4b,DB12888,-7.9,Ezutromid,KSGCNXAZROJSNW-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
55222,6crv,DB00755,-7.9,Tretinoin,SHGAZHPCJJPHSC-YCNIQYBTSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55523,6crv,DB01101,-7.9,Capecitabine,GAGWJHPBXLXJQN-UORFTKCHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55223,6crv,DB00756,-7.9,Hexachlorophene,ACGUYXCXAPNIKK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
144880,6w9q,DB06626,-7.9,Axitinib,RITAVMQDGBJQJZ-FMIVXFBMSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
40312,6lu7,DB04301,-7.9,Bis(5-Amidino-2-Benzimidazolyl)Methane Ketone Hydrate,ZLAHDRAQCSQPOC-UHFFFAOYSA-P,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
55266,6crv,DB00810,-7.9,Biperiden,YSXKPIUOCJLQIE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79817,6m2n,DB13784,-7.9,Dixyrazine,MSYUMPGNGDNTIQ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78357,6m2n,DB11636,-7.9,Nomegestrol,KZUIYQJTUIACIG-YBZCJVABSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
40310,6lu7,DB06558,-7.9,Tezosentan,TUYWTLTWNJOZNY-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40309,6lu7,DB07789,-7.9,"1-[5-methyl-2-(trifluoromethyl)furan-3-yl]-3-[(2Z)-5-(2-{[6-(1H-1,2,4-triazol-3-ylamino)pyrimidin-4-yl]amino}ethyl)-1,3-thiazol-2(3H)-ylidene]urea",KNTGXMNWVXZIMW-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40308,6lu7,DB07804,-7.9,"5-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1H-1,2,4-TRIAZOLE-3-SULFONAMIDE",FKCQUVAGEOSYRU-QWRGUYRKSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
108462,6vxx,DB08017,-7.9,3-METHOXY-6-[4-(3-METHYLPHENYL)-1-PIPERAZINYL]PYRIDAZINE,DDOAUTHWSCUHQA-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
40307,6lu7,DB11730,-7.9,Ribociclib,RHXHGRAEPCAFML-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
121642,6w4b,DB12194,-7.9,Atamestane,PEPMWUSGRKINHX-TXTPUJOMSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
79137,6m2n,DB12792,-7.9,Boscalid,WYEMLYFITZORAB-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
31652,6cs2,DB14207,-7.9,Fosinoprilat,WOIWWYDXDVSWAZ-RTWAWAEBSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
73759,6m2n,DB02452,-7.9,Thymidine-5'-Triphosphate,NHVNXKFIZYSCEB-XLPZGREQSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
7613,6lzg,DB04092,-7.9,Apstatin,YVUUZAPYLPWFHE-HXFGRODQSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
122619,6w4b,DB13648,-7.9,Alcuronium,MUQUYTSLDVKIOF-CHJKCJHBSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
144884,6w9q,DB06634,-7.9,Casopitant,XGGTZCKQRWXCHW-WMTVXVAQSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
10350,6lzg,DB08536,-7.9,"3-bromo-5-phenyl-N-(pyrimidin-5-ylmethyl)pyrazolo[1,5-a]pyridin-7-amine",IBUPHWYGVDAASU-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
144885,6w9q,DB06635,-7.9,Otamixaban,PFGVNLZDWRZPJW-OPAMFIHVSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
120257,6w4b,DB08268,-7.9,"6-AMINO-4-[2-(4-METHYLPHENYL)ETHYL]-1,7-DIHYDRO-8H-IMIDAZO[4,5-G]QUINAZOLIN-8-ONE",SPVJRTJUEVXOMS-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
109081,6vxx,DB12007,-7.9,Isoflavone,GOMNOOKGLZYEJT-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109082,6vxx,DB12008,-7.9,Prexasertib,DOTGPNHGTYJDEP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
68798,6lxt,DB08345,-7.9,"4-(2-(1H-IMIDAZOL-4-YL)ETHYLAMINO)-2-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE",IWUUKHQIKFHWIW-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
120241,6w4b,DB08246,-7.9,"(2S)-4-(2,5-DIFLUOROPHENYL)-N,N-DIMETHYL-2-PHENYL-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDE",WFFMEXQHWXEKBV-SFHVURJKSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
108397,6vxx,DB07713,-7.9,"(1S)-1-{[(4'-methoxy-1,1'-biphenyl-4-yl)sulfonyl]amino}-2-methylpropylphosphonic acid",BZVYQWLRCHLAGK-KRWDZBQOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
40306,6lu7,DB12369,-7.9,Sotrastaurin,OAVGBZOFDPFGPJ-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
155269,6wiq,DB08875,-7.9,Cabozantinib,ONIQOQHATWINJY-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
40305,6lu7,DB04016,-7.9,2-[3-({Methyl[1-(2-Naphthoyl)Piperidin-4-Yl]Amino}Carbonyl)-2-Naphthyl]-1-(1-Naphthyl)-2-Oxoethylphosphonic Acid,XUJQPDQURBZEGJ-KXQOOQHDSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
98914,6vxs,DB01561,-7.9,Androstanedione,RAJWOBJTTGJROA-WZNAKSSCSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
31910,6cs2,DB15024,-7.9,Apararenone,AZNHWXAFPBYFGH-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
91152,6m71,DB02675,-7.9,(4-Hydroxymaltosephenyl)Glycine,PHPOPZGUOBMSPZ-QHJSCRBTSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
120279,6w4b,DB08299,-7.9,"4-[8-(3-nitrophenyl)-1,7-naphthyridin-6-yl]benzoic acid",QTNUWEKKZHSUQO-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
10870,6lzg,DB09199,-7.9,Netoglitazone,PKWDZWYVIHVNKS-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
29887,6cs2,DB11770,-7.9,Talinolol,MXFWWQICDIZSOA-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
23964,6cs2,DB01608,-7.9,Periciazine,LUALIOATIOESLM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
98365,6vxs,DB00858,-7.9,Drostanolone,IKXILDNPCZPPRV-RFMGOVQKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
108064,6vxx,DB06789,-7.9,Hydroxyprogesterone caproate,DOMWKUIIPQCAJU-LJHIYBGHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
54712,6crv,DB00146,-7.9,Calcifediol,JWUBBDSIWDLEOM-DTOXIADCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79791,6m2n,DB13752,-7.9,Tetramethrin,CXBMCYHAMVGWJQ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
121492,6w4b,DB11968,-7.9,MK-7145,OCKGFTQIICXDQW-ZEQRLZLVSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
54707,6crv,DB00140,-7.9,Riboflavin,AUNGANRZJHBGPY-SCRDCRAPSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
40320,6lu7,DB04727,-7.9,"N-(4-{4-AMINO-6-[4-(METHYLOXY)PHENYL]FURO[2,3-D]PYRIMIDIN-5-YL}PHENYL)-N'-[2-FLUORO-5-(TRIFLUOROMETHYL)PHENYL]UREA",FGZIONRFHVNRJB-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
145028,6w9q,DB06876,-7.9,"N-{5-[4-(4-METHYLPIPERAZIN-1-YL)PHENYL]-1H-PYRROLO[2,3-B]PYRIDIN-3-YL}NICOTINAMIDE",YJWJKKXGAPWLGT-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
144834,6w9q,DB06519,-7.9,Edaglitazone,HAAXAFNSRADSMK-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
68054,6lxt,DB07467,-7.9,"4-chloro-N-[(2S)-2-methyl-2,3-dihydro-1H-indol-1-yl]-3-sulfamoylbenzamide",NDDAHWYSQHTHNT-JTQLQIEISA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
143069,6w9q,DB03034,-7.9,D-Levofloxacin,GSDSWSVVBLHKDQ-SNVBAGLBSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
144839,6w9q,DB06529,-7.9,Ocinaplon,OQJFBUOFGHPMSR-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
89973,6m71,DB01108,-7.9,Trilostane,KVJXBPDAXMEYOA-CXANFOAXSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
49052,2fxp,DB03957,-7.9,SP2456,SSSXBBASYYVGCI-HSZRJFAPSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
145141,6w9q,DB07008,-7.9,"4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMIDAZOL-1-YL)PHENOXY]PYRIMIDINE",XPXGYINSBORUMM-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
154552,6wiq,DB08006,-7.9,"N-anthracen-2-yl-5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7-amine",OXYDLVAOXASTMW-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
10403,6lzg,DB08597,-7.9,"6-[4-(2-piperidin-1-ylethoxy)phenyl]-3-pyridin-4-ylpyrazolo[1,5-a]pyrimidine",XHBVYDAKJHETMP-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
13251,6lzg,DB15013,-7.9,TAK-243,KJDAGXLMHXUAGV-DGWLBADLSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
64112,6lxt,DB01076,-7.9,Atorvastatin,XUKUURHRXDUEBC-KAYWLYCHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
40314,6lu7,DB03213,-7.9,Bis(5-Amidino-2-Benzimidazolyl)Methane Ketone,VVVXDHROXQUONB-UHFFFAOYSA-P,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
121664,6w4b,DB12228,-7.9,Telcagepant,CGDZXLJGHVKVIE-DNVCBOLYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
98893,6vxs,DB01540,-7.9,17alpha-methyl-4-hydroxynandrolone,CLNUZOCYKSHICX-FAHHUNKHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
154658,6wiq,DB08124,-7.9,"3-{[(2,2-DIOXIDO-1,3-DIHYDRO-2-BENZOTHIEN-5-YL)AMINO]METHYLENE}-5-(1,3-OXAZOL-5-YL)-1,3-DIHYDRO-2H-INDOL-2-ONE",FTQYGMLRLRXBPT-IDUWFGFVSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
63492,6lxt,DB00342,-7.9,Terfenadine,GUGOEEXESWIERI-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
78371,6m2n,DB11658,-7.9,QAV-680,YOPFAMROKXHVCQ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
121649,6w4b,DB12207,-7.9,Verdinexor,OPAKEJZFFCECPN-XQRVVYSFSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
90353,6m71,DB01623,-7.9,Thiothixene,GFBKORZTTCHDGY-UWVJOHFNSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
145068,6w9q,DB06920,-7.9,Eribaxaban,QQBKAVAGLMGMHI-WIYYLYMNSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
155281,6wiq,DB08896,-7.9,Regorafenib,FNHKPVJBJVTLMP-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
108454,6vxx,DB08009,-7.9,"5-[(E)-(5-CHLORO-2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]-N-[2-(DIETHYLAMINO)ETHYL]-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXAMIDE",XPLJEFSRINKZLC-ATVHPVEESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107994,6vxx,DB06670,-7.9,Odanacatib,FWIVDMJALNEADT-SFTDATJTSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
97490,6m71,DB15028,-7.9,MK-1064,CKTWQGHVNRYNCM-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
13535,6lzg,DB01184,-7.9,Domperidone,FGXWKSZFVQUSTL-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
68827,6lxt,DB08379,-7.9,6-(4-chloro-2-fluoro-3-phenoxybenzyl)pyridazin-3(2H)-one,NOVPOXGMADEKPP-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
154599,6wiq,DB08058,-7.9,"4-[3-(1,4-diazepan-1-ylcarbonyl)-4-fluorobenzyl]phthalazin-1(2H)-one",HGEPGGJUGUMFHT-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
68828,6lxt,DB08382,-7.9,Gosogliptin,QWEWGXUTRTXFRF-KBPBESRZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
74339,6m2n,DB03222,-7.9,dATP,SUYVUBYJARFZHO-RRKCRQDMSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
108443,6vxx,DB07996,-7.9,5-(2-methylpiperazine-1-sulfonyl)isoquinoline,BDVFVCGFMNCYPV-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
144994,6w9q,DB06833,-7.9,1-CYCLOHEXYL-N-{[1-(4-METHYLPHENYL)-1H-INDOL-3-YL]METHYL}METHANAMINE,MMIJMYOYKAKQPN-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
55295,6crv,DB00842,-7.9,Oxazepam,ADIMAYPTOBDMTL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
10676,6lzg,DB08922,-7.9,Perospirone,FBVFZWUMDDXLLG-HDICACEKSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
142438,6w9q,DB02205,-7.9,"6-(1,1-Dimethylallyl)-2-(1-Hydroxy-1-Methylethyl)-2,3-Dihydro-7h-Furo[3,2-G]Chromen-7-One",JCDLLLXYAICSQV-INIZCTEOSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
120140,6w4b,DB08126,-7.9,"3-{[4-([AMINO(IMINO)METHYL]AMINOSULFONYL)ANILINO]METHYLENE}-2-OXO-2,3-DIHYDRO-1H-INDOLE",DMCRNUMVSATRTP-LCYFTJDESA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
97501,6m71,DB15047,-7.9,BMS-919373,XGKULQQVQWCASY-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
63546,6lxt,DB00406,-7.9,Gentian violet cation,LGLFFNDHMLKUMI-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
64180,6lxt,DB01155,-7.9,Gemifloxacin,ZRCVYEYHRGVLOC-HYARGMPZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
97458,6m71,DB14929,-7.9,Elsulfavirine,ULTDEARCBRNRGR-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97454,6m71,DB14917,-7.9,Ceralasertib,DTTJKLNXNZAVSM-JYCIKRDWSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
91286,6m71,DB02854,-7.9,Aetiocholanolone,QGXBDMJGAMFCBF-BNSUEQOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
121582,6w4b,DB12108,-7.9,Taselisib,BEUQXVWXFDOSAQ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
98309,6vxs,DB00796,-7.9,Candesartan cilexetil,GHOSNRCGJFBJIB-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
62900,6crv,DB14672,-7.9,Oxazepam acetate,FYRWUTOZBRWYCS-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
91290,6m71,DB02859,-7.9,Soraphen A,WPMGNXPRKGXGBO-OFQQMTDKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
64201,6lxt,DB01179,-7.9,Podofilox,YJGVMLPVUAXIQN-XVVDYKMHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
64207,6lxt,DB01185,-7.9,Fluoxymesterone,YLRFCQOZQXIBAB-RBZZARIASA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
108428,6vxx,DB07981,-7.9,2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]-n-[(1R)-1-(hydroxymethyl)propyl]acetamide,GKJWXEORYGBJFS-QGZVFWFLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
144938,6w9q,DB06732,-7.9,beta-Naphthoflavone,OUGIDAPQYNCXRA-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
91300,6m71,DB02873,-7.9,"1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperazin-1-Yl-3,4-Dihydroquinazolin-2(1h)-One",YAWZIQKDHQIHOS-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
121573,6w4b,DB12095,-7.9,Telotristat ethyl,MDSQOJYHHZBZKA-GBXCKJPGSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
108445,6vxx,DB07999,-7.9,"{4-[(CARBOXYMETHOXY)CARBONYL]-3,3-DIOXIDO-1-OXONAPHTHO[1,2-D]ISOTHIAZOL-2(1H)-YL}ACETIC ACID",IXLBOIRSEDMRPI-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
144905,6w9q,DB06684,-7.9,Vilazodone,SGEGOXDYSFKCPT-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
90460,6m71,DB01763,-7.9,7-thionicotinamide-adenine-dinucleotide phosphate,OJNFDOAQUXJWED-NNYOXOHSSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97511,6m71,DB15063,-7.9,Inarigivir soproxil,CJCYTUJOSMYXLE-JDLSZIHUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
31282,6cs2,DB13631,-7.9,Methoserpidine,ULBNWNUHGJLQHO-VKMIBBQISA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
164749,7bv1,DB08557,-7.9,"2-[(2-methoxyethyl)amino]-4-(4-oxo-1,2,3,4-tetrahydro-9H-carbazol-9-yl)benzamide",XQKFKSJUBJPOLY-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
155283,6wiq,DB08899,-7.9,Enzalutamide,WXCXUHSOUPDCQV-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
155284,6wiq,DB08901,-7.9,Ponatinib,PHXJVRSECIGDHY-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
121635,6w4b,DB12185,-7.9,Exatecan,ZVYVPGLRVWUPMP-FYSMJZIKSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
154561,6wiq,DB08015,-7.9,"(3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-phenyl-1H-indole-2,3-dione 3-oxime",SZYREAUDQRVVLV-DAFNUICNSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
142798,6w9q,DB02668,-7.9,"Je-2147, Ag1776, Kni-764",CUFQBQOBLVLKRF-RZDMPUFOSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
68808,6lxt,DB08355,-7.9,"1-methyl-8-(phenylamino)-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxylic acid",ZOBRPBVIEUWYJR-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
90468,6m71,DB01774,-7.9,Adenosine-5'-Monophosphate Glucopyranosyl-Monophosphate Ester,WFPZSXYXPSUOPY-ROYWQJLOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
63512,6lxt,DB00367,-7.9,Levonorgestrel,WWYNJERNGUHSAO-XUDSTZEESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
165087,7bv1,DB09215,-7.9,Droxicam,OEHFRZLKGRKFAS-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
78313,6m2n,DB11507,-7.9,Cloprostenol,VJGGHXVGBSZVMZ-QIZQQNKQSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
154617,6wiq,DB08079,-7.9,AMG-208,HEAIZQNMNCHNFD-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
78302,6m2n,DB11478,-7.9,Zeranol,DWTTZBARDOXEAM-GXTWGEPZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
54651,2fxp,DB15450,-7.9,PF-05105679,BXNMZRPTQFVRFA-QGZVFWFLSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
122709,6w4b,DB13766,-7.9,Lidoflazine,ZBIAKUMOEKILTF-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
142707,6w9q,DB02545,-7.9,Fexaramine,VLQTUNDJHLEFEQ-KGENOOAVSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
108005,6vxx,DB06693,-7.9,Mevastatin,AJLFOPYRIVGYMJ-INTXDZFKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
90465,6m71,DB01768,-7.9,Methylumbelliferyl Sialic Acid,KKDWIUJBUSOPGC-GKHMPSLRSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
89903,6m71,DB01029,-7.9,Irbesartan,YOSHYTLCDANDAN-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
78296,6m2n,DB11464,-7.9,Sulfaquinoxaline,NHZLNPMOSADWGC-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
24034,6cs2,DB01689,-7.9,Inhibitor Idd 384,CJKKMQCZOLCXAM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
79180,6m2n,DB12868,-7.9,Intoplicine,QROONAIPJKQFMC-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
164693,7bv1,DB08493,-7.9,"5-METHYL-3-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.013,18]NONADECA-12(19),13,15,17-TETRAEN-10-YLCARBAMOYL)-HEXANOIC ACID",AKWKBACKRMYPRV-NQIIRXRSSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97510,6m71,DB15062,-7.9,Inarigivir,LYMICVBGNUEHGE-FUQPUAIBSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
98962,6vxs,DB01621,-7.9,Pipotiazine,JOMHSQGEWSNUKU-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
97507,6m71,DB15057,-7.9,NUC-1031,NHTKGYOMICWFQZ-KKQYNPQSSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
90462,6m71,DB01765,-7.9,"(5-Oxo-5,6-Dihydro-Indolo[1,2-a]Quinazolin-7-Yl)-Acetic Acid",INSBKYCYLCEBOD-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
98264,6vxs,DB00739,-7.9,Hetacillin,DXVUYOAEDJXBPY-NFFDBFGFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
154528,6wiq,DB07978,-7.9,"2-({[2,3,5,6-TETRAFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)CYCLOPENTA-1,3-DIENE-1-CARBOXYLIC ACID",ULMUPVXFUDHRGH-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
165074,7bv1,DB09201,-7.9,Ciglitazone,YZFWTZACSRHJQD-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
79373,6m2n,DB13174,-7.9,Rhein,FCDLCPWAQCPTKC-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
23725,6cs2,DB01326,-7.9,Cefamandole,OLVCFLKTBJRLHI-AXAPSJFSSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
98242,6vxs,DB00713,-7.9,Oxacillin,UWYHMGVUTGAWSP-JKIFEVAISA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
90008,6m71,DB01149,-7.9,Nefazodone,VRBKIVRKKCLPHA-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
108912,6vxx,DB11376,-7.9,Azaperone,XTKDAFGWCDAMPY-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
68745,6lxt,DB08281,-7.9,"O-[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethyl] (4-bromophenyl)thiocarbamate",BDVAWAILQCYMQE-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
23933,6cs2,DB01571,-7.9,3-Methylfentanyl,MLQRZXNZHAOCHQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
120399,6w4b,DB08445,-7.9,"(3R,4S)-1-[6-(6-METHOXYPYRIDIN-3-YL)PYRIMIDIN-4-YL]-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE",IFKWHPAWYJARQJ-DYVFJYSZSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
78453,6m2n,DB11781,-7.9,Tosedostat,FWFGIHPGRQZWIW-SQNIBIBYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
40328,6lu7,DB13113,-7.9,JNJ-38877605,JRWCBEOAFGHNNU-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
74282,6m2n,DB03148,-7.9,Phosphomethylphosphonic Acid Adenosyl Ester,OLCWZBFDIYXLAA-IOSLPCCCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
23947,6cs2,DB01588,-7.9,Prazepam,MWQCHHACWWAQLJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
54735,6crv,DB00170,-7.9,Menadione,MJVAVZPDRWSRRC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108382,6vxx,DB07695,-7.9,"N-(3,5-dibromo-4-hydroxyphenyl)-4-hydroxy-3,5-dimethylbenzamide",HHFKUQZPNITQLU-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108122,6vxx,DB07128,-7.9,"N7-BUTYL-N2-(5-CHLORO-2-METHYLPHENYL)-5-METHYL[1,2,4]TRIAZOLO[1,5-A]PYRIMIDINE-2,7-DIAMINE",ZTYBIJUAAWLJNU-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
54734,6crv,DB00169,-7.9,Cholecalciferol,QYSXJUFSXHHAJI-YRZJJWOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
68498,6lxt,DB07988,-7.9,"2-[3-(5-MERCAPTO-[1,3,4]THIADIAZOL-2YL)-UREIDO]-N-METHYL-3-PENTAFLUOROPHENYL-PROPIONAMIDE",HZAXNPDJVFUGDS-BYPYZUCNSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
55364,6crv,DB00918,-7.9,Almotriptan,WKEMJKQOLOHJLZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27986,6cs2,DB00692,-7.9,Phentolamine,MRBDMNSDAVCSSF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
108942,6vxx,DB11429,-7.9,Mibolerone,PTQMMNYJKCSPET-OMHQDGTGSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78443,6m2n,DB11766,-7.9,AZD-1305,BLLNYXOLLAVTRF-HDICACEKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79758,6m2n,DB13708,-7.9,Fenquizone,DBDTUXMDTSTPQZ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
40330,6lu7,DB15003,-7.9,PF-06700841,BUWBRTXGQRBBHG-MJBXVCDLSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
164459,7bv1,DB07855,-7.9,(S)-1-PHENYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE,CWHMAWBXRCDOEB-HNNXBMFYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
63609,6lxt,DB00482,-7.9,Celecoxib,RZEKVGVHFLEQIL-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
144773,6w9q,DB06347,-7.9,Cenisertib,KSOVGRCOLZZTPF-QMKUDKLTSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
54755,6crv,DB00192,-7.9,Indecainide,UCEWGESNIULAGX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
143314,6w9q,DB03351,-7.9,Sri-9439,KMSATRJZEXNGDP-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
143324,6w9q,DB03363,-7.9,3-Acetylpyridine Adenine Dinucleotide,KPVQNXLUPNWQHM-RBEMOOQDSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
79073,6m2n,DB12689,-7.9,Azeliragon,KJNNWYBAOPXVJY-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79365,6m2n,DB13155,-7.9,Esculin,XHCADAYNFIFUHF-TVKJYDDYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
55365,6crv,DB00919,-7.9,Spectinomycin,UNFWWIHTNXNPBV-WXKVUWSESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
164790,7bv1,DB08608,-7.9,"4-({(2R,5S)-2,5-DIMETHYL-4-[(2R)-3,3,3-TRIFLUORO-2-HYDROXY-2-METHYLPROPANOYL]PIPERAZIN-1-YL}CARBONYL)BENZONITRILE",IWFSHKKFDSWNLZ-BWACUDIHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
164661,7bv1,DB08268,-7.9,"6-AMINO-4-[2-(4-METHYLPHENYL)ETHYL]-1,7-DIHYDRO-8H-IMIDAZO[4,5-G]QUINAZOLIN-8-ONE",SPVJRTJUEVXOMS-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
90332,6m71,DB01599,-7.9,Probucol,FYPMFJGVHOHGLL-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
108936,6vxx,DB11423,-7.9,Lasalocid,BBMULGJBVDDDNI-OWKLGTHSSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79372,6m2n,DB13169,-7.9,Nandrolone,NPAGDVCDWIYMMC-IZPLOLCNSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
121462,6w4b,DB11925,-7.9,Vistusertib,JUSFANSTBFGBAF-IRXDYDNUSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
55733,6crv,DB01421,-7.9,Paromomycin,UOZODPSAJZTQNH-LSWIJEOBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
68510,6lxt,DB08001,-7.9,5-(3-{3-[3-HYDROXY-2-(METHOXYCARBONYL)PHENOXY]PROPENYL}PHENYL)-4-(HYDROXYMETHYL)ISOXAZOLE-3-CARBOXYLIC ACID,DQSRCEFDWMQCCV-GQCTYLIASA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
89995,6m71,DB01134,-7.9,Desoxycorticosterone pivalate,VVOIQBFMTVCINR-WWMZEODYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
79088,6m2n,DB12713,-7.9,Sotagliflozin,QKDRXGFQVGOQKS-CRSSMBPESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
54729,6crv,DB00163,-7.9,Vitamin E,GVJHHUAWPYXKBD-IEOSBIPESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
98839,6vxs,DB01476,-7.9,Haloxazolam,XDKCGKQHVBOOHC-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
143415,6w9q,DB03496,-7.9,Alvocidib,BIIVYFLTOXDAOV-YVEFUNNKSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
68064,6lxt,DB07479,-7.9,"(1S)-1,2,3,4-TETRAHYDRO-BENZO[C]PHENANTHRENE-2,3,4-TRIOL",WCUHTHVUZQCBTI-KBAYOESNSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
144763,6w9q,DB06311,-7.9,Darapladib,WDPFJWLDPVQCAJ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
91123,6m71,DB02639,-7.9,4-methylumbelliferyl ??-D-glucoside,YUDPTGPSBJVHCN-JZYAIQKZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
68388,6lxt,DB07859,-7.9,4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL)PHENYL]PIPERIDINE,LZMOSYUFVYJEPY-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
122500,6w4b,DB13484,-7.9,Quinbolone,IUVKMZGDUIUOCP-BTNSXGMBSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
108087,6vxx,DB06829,-7.9,4-BROMO-3-(CARBOXYMETHOXY)-5-[3-(CYCLOHEXYLAMINO)PHENYL]THIOPHENE-2-CARBOXYLIC ACID,RXDVFLTWXCTCEX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
36909,1r42,DB03571,-7.9,"3-(5-Amino-7-Hydroxy-[1,2,3]Triazolo[4,5-D]Pyrimidin-2-Yl)-N-(3,5-Dichlorobenzyl)-Benzamide",JMQTXEWNXSPEKX-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
121694,6w4b,DB12269,-7.9,PF-06273340,BPIWZDNVMQQBQX-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
55741,6crv,DB01429,-7.9,Aprindine,NZLBHDRPUJLHCE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79314,6m2n,DB13066,-7.9,Liarozole,UGFHIPBXIWJXNA-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
143535,6w9q,DB03672,-7.9,9-N-Phenylmethylamino-Tacrine,JYJAEHAURXXPSD-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
62343,6crv,DB13445,-7.8,Nepinalone,RVXGRCNWGOHSDE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
94813,6m71,DB08560,-7.8,3-FLUORO-N-[1-(4-FLUOROPHENYL)-3-(2-THIENYL)-1H-PYRAZOL-5-YL]BENZENESULFONAMIDE,GULUFDCOGAXLEP-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
14136,6lzg,T3D3754,-7.8,Emestrin,VASYTSFNISZKEL-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
66878,6lxt,DB04772,-7.8,1-GUANIDINO-4-(N-PHENYLMETHANESULFONYL-L-LEUCYL-L-PROLYLAMINO)BUTANE,DSVCYWOHJLRGMK-PMACEKPBSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
99882,6vxs,DB02836,-7.8,Guanosine 5'-Diphosphate 2':3'-Cyclic Monophosphate,NGYWTCOGOZELRS-UUOKFMHZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
140452,6w9c,DB06860,-7.8,"2-(2-chloropyridin-4-yl)-4-methyl-1H-isoindole-1,3(2H)-dione",YDJMWNHJNJVVMM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
147915,6w9q,DB12644,-7.8,AZD-2066,SXWHYTICXCLKDG-GFCCVEGCSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
158494,7bv1,DB01252,-7.8,Mitiglinide,WPGGHFDDFPHPOB-BBWFWOEESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
98572,6vxs,DB01095,-7.8,Fluvastatin,FJLGEFLZQAZZCD-JUFISIKESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
98407,6vxs,DB00906,-7.8,Tiagabine,PBJUNZJWGZTSKL-MRXNPFEDSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
134423,6w9c,DB03060,-7.8,Sri-9662,WNDJHUNKXPAREB-PLNGDYQASA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
92868,6m71,DB05137,-7.8,Lobeline,MXYUKLILVYORSK-HBMCJLEFSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
68453,6lxt,DB07936,-7.8,N-(4-{[(3S)-3-(dimethylamino)pyrrolidin-1-yl]carbonyl}phenyl)-5-fluoro-4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]pyrimidin-2-amine,BACSZMCLZIDTIO-IBGZPJMESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
133752,6w9c,DB02104,-7.8,"2,4-Diamino-5-Methyl-6-[(3,4,5-Trimethoxy-N-Methylanilino)Methyl]Pyrido[2,3-D]Pyrimidine",PEGMMEYCSOZKIT-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
69089,6lxt,DB08698,-7.8,"1-[(3S)-5-PHENYL-3-THIOPHEN-2-YL-3H-1,4-BENZODIAZEPIN-2-YL]AZETIDIN-3-OL",BKSGACYTXOQQNI-OAQYLSRUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
147679,6w9q,DB12290,-7.8,Puerarin,HKEAFJYKMMKDOR-VPRICQMDSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
147896,6w9q,DB12612,-7.8,Ozanimod,XRVDGNKRPOAQTN-FQEVSTJZSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
140667,6w9c,DB13066,-7.8,Liarozole,UGFHIPBXIWJXNA-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
86326,6m3m,DB08714,-7.8,"2,6-DIMETHYL-1-(3-[3-METHYL-5-ISOXAZOLYL]-PROPANYL)-4-[4-METHYL-2H-TETRAZOL-2-YL]-PHENOL",DRCNRTRGWUYJBH-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
155885,6wiq,DB11894,-7.8,Efatutazone,JCYNMRJCUYVDBC-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
68456,6lxt,DB07940,-7.8,"9-(3-IODOBENZYLAMINO)-1,2,3,4-TETRAHYDROACRIDINE",ZUCWQTWGZGIYPV-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
90249,6m71,DB01501,-7.8,Difenoxin,UFIVBRCCIRTJTN-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
63429,6lxt,DB00266,-7.8,Dicoumarol,DOBMPNYZJYQDGZ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
134440,6w9c,DB03079,-7.8,Alpha-Ribazole-5'-Phosphate Derivative,YPYFPLLZCVEYCS-KKOKHZNYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
65915,6lxt,DB03476,-7.8,Trans-6-(2-Phenylcyclopropyl)-Naphthalene-2-Carboxamidine,NQRIWXVAIWPBEM-OALUTQOASA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
133641,6w9c,DB01958,-7.8,"5-[4-Tert-Butylphenylsulfanyl]-2,4-Quinazolinediamine",MNYDVPDMLAJJPB-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
93120,6m71,DB06346,-7.8,Fiboflapon,DFQGDHBGRSTTHX-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
134546,6w9c,DB03220,-7.8,FR233623,OODDZQQDDOVCFD-SCLBCKFNSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
102853,6vxs,DB07882,-7.8,"4-{4-[2-(1A,7A-DIMETHYL-4-OXY-OCTAHYDRO-1-OXA-4-AZA-CYCLOPROPA[A]NAPHTHALEN-4-YL) -ACETYLAMINO]-PHENYLCARBAMOYL}-BUTYRIC ACID",VFIZFTGABDUGCF-UPVHCHBVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102929,6vxs,DB07973,-7.8,N-(1-ISOPROPYLPIPERIDIN-4-YL)-1-(3-METHOXYBENZYL)-1H-INDOLE-2-CARBOXAMIDE,GIPCBGDQVGKMPO-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
25540,6cs2,DB03490,-7.8,"3-Pyridin-4-Yl-2,4-Dihydro-Indeno[1,2-.C.]Pyrazole",NHOACLCXCKJMAK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
99933,6vxs,DB02901,-7.8,Stanolone,NVKAWKQGWWIWPM-ABEVXSGRSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
133812,6w9c,DB02189,-7.8,"2',3'-Dideoxyadenosine-5'-Triphosphate",OAKPWEUQDVLTCN-NKWVEPMBSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
86445,6m3m,DB08860,-7.8,Pitavastatin,VGYFMXBACGZSIL-MCBHFWOFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
102584,6vxs,DB07568,-7.8,"(2S)-2-[(2,1,3-BENZOTHIADIAZOL-4-YLSULFONYL)AMINO]-2-PHENYL-N-PYRIDIN-4-YLACETAMIDE",ADRNPUSZBRQDBG-KRWDZBQOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
92879,6m71,DB05234,-7.8,LGD2941,HWLLYFXDDGGHOE-BCSUUIJWSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
158656,7bv1,DB01755,-7.8,N-[Isoleucinyl]-N'-[Adenosyl]-Diaminosufone,XVTRBLLRODNOJV-VBJYJYTRSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
86285,6m3m,DB08662,-7.8,3-[1-(4-BROMO-PHENYL)-2-METHYL-PROPYL]-4-HYDROXY-CHROMEN-2-ONE,KGDWLSFLMSFPSU-INIZCTEOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
60498,6crv,DB08722,-7.8,5-(7-(6-chloro-4-(5-hydro-4-methyl-2-oxazolyl)phenoxy)heptyl)-3-methyl isoxazole,WOJFAPUTPSWFLJ-INIZCTEOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
98319,6vxs,DB00808,-7.8,Indapamide,NDDAHWYSQHTHNT-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
158479,7bv1,DB01234,-7.8,Dexamethasone,UREBDLICKHMUKA-CXSFZGCWSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
134473,6w9c,DB03121,-7.8,(1-Benzyl-5-methoxy-2-methyl-1H-indol-3-yl)acetic acid,ZEKCBTQHDTUHRJ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
94690,6m71,DB08416,-7.8,"(9BETA,13ALPHA,14BETA,17ALPHA)-2-METHOX1TRA-1,3,5(10)-TRIENE-3,17-DIYL DISULFAMATE",AQSNIXKAKUZPSI-SSTWWWIQSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94674,6m71,DB08395,-7.8,2-(ETHOXYMETHYL)-4-(4-FLUOROPHENYL)-3-[2-(2-HYDROXYPHENOXY)PYRIMIDIN-4-YL]ISOXAZOL-5(2H)-ONE,ZSOXFJURLPCSOO-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
67077,6lxt,DB05416,-7.8,Cardarine,YDBLKRPLXZNVNB-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
68592,6lxt,DB08095,-7.8,"3-(2-CHLOROPHENYL)-1-(2-{[(1S)-2-HYDROXY-1,2-DIMETHYLPROPYL]AMINO}PYRIMIDIN-4-YL)-1-(4-METHOXYPHENYL)UREA",ZWYFTKPEHRQCCW-HNNXBMFYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
94670,6m71,DB08391,-7.8,"6,7-DIMETHOXY-4-[(3R)-3-(QUINOXALIN-2-YLOXY)PYRROLIDIN-1-YL]QUINAZOLINE",UBIIFKJMNRPNMT-CQSZACIVSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
102717,6vxs,DB07729,-7.8,3-fluoro-N-[3-(1H-tetrazol-5-yl)phenyl]benzamide,GAKOBKPDJJGRIL-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
25561,6cs2,DB03515,-7.8,Equilenin,PDRGHUMCVRDZLQ-WMZOPIPTSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
98556,6vxs,DB01076,-7.8,Atorvastatin,XUKUURHRXDUEBC-KAYWLYCHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
158904,7bv1,DB02615,-7.8,Compound 19,UZOOIPXOYYJULJ-BLIZRMSTSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
154855,6wiq,DB08366,-7.8,"3-({3-[(1S,4aS,6S,7S,9S,9aR)-1,6-dimethyl-2-oxodecahydro-6,9-epoxy-4a,7-methanobenzo[7]annulen-1-yl]propanoyl}amino)-2,4-dihydroxybenzoic acid",XADCWKSMHQPTGH-OFBLZTNGSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
65656,6lxt,DB03126,-7.8,Mant-Adp,QPKUEBLEGWBRHC-BFHYXJOUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
102705,6vxs,DB07715,-7.8,Emodin,RHMXXJGYXNZAPX-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
150344,6wiq,DB01234,-7.8,Dexamethasone,UREBDLICKHMUKA-CXSFZGCWSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
94628,6m71,DB08340,-7.8,"N,N'-DIPHENYLPYRAZOLO[1,5-A][1,3,5]TRIAZINE-2,4-DIAMINE",LLYYAUZAGCZEKV-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
147448,6w9q,DB11952,-7.8,Duvelisib,SJVQHLPISAIATJ-ZDUSSCGKSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
65926,6lxt,DB03490,-7.8,"3-Pyridin-4-Yl-2,4-Dihydro-Indeno[1,2-.C.]Pyrazole",NHOACLCXCKJMAK-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
66866,6lxt,DB04757,-7.8,"GUANOSINE-2',3'-O-METHYLIDENEPHOSPHONATE",GKAPYWCOOQBBHV-KXSYMAMXSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
62350,6crv,DB13457,-7.8,Oxaflozane,FVYUQFQCEOZYHZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
134408,6w9c,DB03039,-7.8,"4-(Aminosulfonyl)-N-[(2,5-Difluorophenyl)Methyl]-Benzamide",KEGUALXMKQVDIO-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
144930,6w9q,DB06721,-7.8,Gimatecan,UIVFUQKYVFCEKJ-OPTOVBNMSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
140457,6w9c,DB06866,-7.8,6-CARBAMIMIDOYL-2-[2-HYDROXY-5-(3-METHOXY-PHENYL)-INDAN-1-YL]-HEXANOIC ACID,NMOUMGFCBOWPAB-RZUBCFFCSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140702,6w9c,DB15143,-7.8,PF-06650833,JKDGKIBAOAFRPJ-ZBINZKHDSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
94450,6m71,DB08121,-7.8,(2S)-2-(biphenyl-4-yloxy)-3-phenylpropanoic acid,TZTPJJNNACUQQR-FQEVSTJZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
89308,6m71,DB00319,-7.8,Piperacillin,IVBHGBMCVLDMKU-GXNBUGAJSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
36849,1r42,DB03478,-7.8,2'-O-Acetyl Adenosine-5-Diphosphoribose,BFNOPXRXIQJDHO-DLFWLGJNSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
70804,6lxt,DB13246,-7.8,Quinupramine,JCBQCKFFSPGEDY-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
98549,6vxs,DB01068,-7.8,Clonazepam,DGBIGWXXNGSACT-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
134834,6w9c,DB03626,-7.8,"5-Methoxy-1,2-Dimethyl-3-(Phenoxymethyl)Indole-4,7-Dione",JRPJCFILHCLEJI-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
68519,6lxt,DB08011,-7.8,"(3E)-5-fluoro-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-1H-indole-2,3-dione 3-oxime",DXIHOIDYHQSQKJ-HMMYKYKNSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
147942,6w9q,DB12682,-7.8,Mubritinib,ZTFBIUXIQYRUNT-MDWZMJQESA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
60338,6crv,DB08528,-7.8,"2-AMINO-6-(3,5-DIMETHYLPHENYL)SULFONYLBENZONITRILE",SWGDXLAZBZDUBR-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
16481,6cs2,HMDB0002326,-7.8,Coumesterol,ZZIALNLLNHEQPJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
94814,6m71,DB08561,-7.8,"BENZYL 6-BENZYL-5,7-DIOXO-6,7-DIHYDRO-5H-[1,3]THIAZOLO[3,2-C]PYRIMIDINE-2-CARBOXYLATE",PLBINCOCFGQAJM-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
66990,6lxt,DB04942,-7.8,Tamibarotene,MUTNCGKQJGXKEM-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
92989,6m71,DB05838,-7.8,OPC-51803,INGXCNVWWKKWOO-LJQANCHMSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
36950,1r42,DB03632,-7.8,Argifin,UHBHXSDKGLPPGO-HTDHLNIYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
133722,6w9c,DB02069,-7.8,N-(2-Flouro-Benzyl)-4-Sulfamoyl-Benzamide,ULYMHSXFSKOHGH-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
93095,6m71,DB06267,-7.8,Udenafil,IYFNEFQTYQPVOC-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
23301,6cs2,HMDB0060022,-7.8,Urolithin A-8-O-glucuronide,KXBXNRJGUDTJQS-FDQIELQPSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
141022,6w9q,DB00396,-7.8,Progesterone,RJKFOVLPORLFTN-LEKSSAKUSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
16494,6cs2,HMDB0002364,-7.8,Oleanolic acid,MIJYXULNPSFWEK-GTOFXWBISA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
67004,6lxt,DB04975,-7.8,Banoxantrone,YZBAXVICWUUHGG-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
94713,6m71,DB08444,-7.8,"3-[2-bromo-4-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)phenoxy]-5-methylbenzonitrile",YYGZQXRLQMFHDH-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
68497,6lxt,DB07987,-7.8,"[2-(5-MERCAPTO-[1,3,4]THIADIAZOL-2-YLCARBAMOYL)-1-PHENYL-ETHYL]-CARBAMIC ACID BENZYL ESTER",AWAKNMKLVLWIIQ-OAHLLOKOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
98539,6vxs,DB01058,-7.8,Praziquantel,FSVJFNAIGNNGKK-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
98424,6vxs,DB00923,-7.8,Ceforanide,SLAYUXIURFNXPG-CRAIPNDOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
147735,6w9q,DB12371,-7.8,Siponimod,KIHYPELVXPAIDH-HNSNBQBZSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
67030,6lxt,DB05107,-7.8,16-Bromoepiandrosterone,CWVMWSZEMZOUPC-JUAXIXHSSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
147734,6w9q,DB12369,-7.8,Sotrastaurin,OAVGBZOFDPFGPJ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
86486,6m3m,DB08932,-7.8,Macitentan,JGCMEBMXRHSZKX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
98347,6vxs,DB00838,-7.8,Clocortolone,YMTMADLUXIRMGX-RFPWEZLHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
134279,6w9c,DB02862,-7.8,Gluco-Phenylimidazole,DLVNFMROYKHANV-FVCCEPFGSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
98481,6vxs,DB00991,-7.8,Oxaprozin,OFPXSFXSNFPTHF-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
23331,6cs2,HMDB0060058,-7.8,CE(16:2),OYOAMRKUJRRRSM-FYALRKDYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
147733,6w9q,DB12368,-7.8,AZD-3839,MRXBCEQZNKUUIP-DEOSSOPVSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
147730,6w9q,DB12364,-7.8,Betrixaban,XHOLNRLADUSQLD-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
68478,6lxt,DB07966,-7.8,[4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]quinazolin-2-yl}amino)phenyl]acetonitrile,NVMCVWOODOWOLT-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
89460,6m71,DB00502,-7.8,Haloperidol,LNEPOXFFQSENCJ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
24328,6cs2,DB02046,-7.8,N-[(Furan-2-Yl)Carbonyl]-(S)-Leucyl-(R)-[1-Amino-2(1h-Indol-3-Yl)Ethyl]-Phosphonic Acid,WHPKSASOSKNDPY-PKOBYXMFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
63461,6lxt,DB00303,-7.8,Ertapenem,JUZNIMUFDBIJCM-ANEDZVCMSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
65726,6lxt,DB03220,-7.8,FR233623,OODDZQQDDOVCFD-SCLBCKFNSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
144595,6w9q,DB05553,-7.8,Regrelor,NXHAXEBZOXCDKD-XIXRRVGJSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
60418,6crv,DB08623,-7.8,"2-[CARBOXY-(2-THIOPHEN-2-YL-ACETYLAMINO)-METHYL]-5-METHYLENE-5,6-DIHYDRO-2H-[1,3]THIAZINE-4-CARBOXYLIC ACID",VBBNCGUNWSPHOY-QWRGUYRKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
100055,6vxs,DB03069,-7.8,Cytidine-5'-Diphospho-Beta-D-Xylose,NWSKPSPTJOAICE-OCIMBMBZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
147561,6w9q,DB12122,-7.8,Figopitant,HUTHJVYJUPXHDF-DEOSSOPVSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
13309,6lzg,DB15121,-7.8,AT-001,YRGPAXAVTDMKDK-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
94755,6m71,DB08494,-7.8,"S-{2-[(2-chloro-4-sulfamoylphenyl)amino]-2-oxoethyl} 6-methyl-3,4-dihydroquinoline-1(2H)-carbothioate",AWAKIULNKVOBKE-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
62390,6crv,DB13511,-7.8,Clebopride,BVPWJMCABCPUQY-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
158556,7bv1,DB01623,-7.8,Thiothixene,GFBKORZTTCHDGY-UWVJOHFNSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
102765,6vxs,DB07785,-7.8,"1-{(1R,2S)-2-HYDROXY-1-[2-(2-NAPHTHYLOXY)ETHYL]PROPYL}-1H-IMIDAZONE-4-CARBOXAMIDE",UYAJDVNLQJVRHD-SCLBCKFNSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
158785,7bv1,DB02217,-7.8,Dpb-T,WTZFKHNHHRPQOU-WSMBLCCSSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
147799,6w9q,DB12461,-7.8,GLPG-0492,VAJGULUVTFDTAS-GOSISDBHSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
12560,6lzg,DB01030,-7.8,Topotecan,UCFGDBYHRUNTLO-QHCPKHFHSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
63394,6lxt,DB00227,-7.8,Lovastatin,PCZOHLXUXFIOCF-BXMDZJJMSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
60449,6crv,DB08661,-7.8,"1-(2,5-dideoxy-5-pyrrolidin-1-yl-beta-L-erythro-pentofuranosyl)-5-methylpyrimidine-2,4(1H,3H)-dione",XUSBTLVYPZUOAW-WOPDTQHZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
25489,6cs2,DB03421,-7.8,"2-Phenethyl-2,3-Dihydro-Phthalazine-1,4-Dione",JSSVIGGKHIJEHO-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
68554,6lxt,DB08051,-7.8,"(2R)-4-(2-BENZOYL-1,2-DIAZEPAN-1-YL)-4-OXO-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE",XXRHRPGYYNOBHO-QGZVFWFLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
36925,1r42,DB03591,-7.8,RU82209,LVZDQVATAQEMCX-NSOVKSMOSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
102791,6vxs,DB07812,-7.8,"N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyrrolo[2,3-b]pyridin-4-yl)thiophene-2-carboxamide",TWYNGDRSMHRPSY-MRXNPFEDSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
68549,6lxt,DB08043,-7.8,1-[4-(PYRIDIN-4-YLOXY)PHENYL]-3-[3-(TRIFLUOROMETHYL)PHENYL]UREA,DDDLGNOZDKDSEG-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
2478,6lzg,HMDB0041729,-7.8,(-)-Epicatechin 7-O-glucuronide,FDWDKTKDGDLDTP-BBGDWMAASA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
158764,7bv1,DB02189,-7.8,"2',3'-Dideoxyadenosine-5'-Triphosphate",OAKPWEUQDVLTCN-NKWVEPMBSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
70744,6lxt,DB13126,-7.8,BMS-986115,SRJNRAQUSAVENA-GSHUGGBRSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
94765,6m71,DB08504,-7.8,"6-(4-{(1S,2S)-2-AMINO-1-[(DIMETHYLAMINO)CARBONYL]-3-[(3S)-3-FLUOROPYRROLIDIN-1-YL]-3-OXOPROPYL}PHENYL)-1H-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-4-IUM",ZNHVIJAGMFQGMS-IHPCNDPISA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
86389,6m3m,DB08781,-7.8,"1-[(2S)-4-(5-BROMO-1H-PYRAZOLO[3,4-B]PYRIDIN-4-YL)MORPHOLIN-2-YL]METHANAMINE",BJUBFXSKTBULRW-ZETCQYMHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
93028,6m71,DB06134,-7.8,SNS-314,FAYAUAZLLLJJGH-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
134258,6w9c,DB02836,-7.8,Guanosine 5'-Diphosphate 2':3'-Cyclic Monophosphate,NGYWTCOGOZELRS-UUOKFMHZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
102661,6vxs,DB07663,-7.8,"2-[(1R)-1-CARBOXY-2-(4-HYDROXYPHENYL)ETHYL]-1,3-DIOXOISOINDOLINE-5-CARBOXYLIC ACID",QISJEFYTLZTWIQ-CQSZACIVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
147522,6w9q,DB12066,-7.8,Orteronel,OZPFIJIOIVJZMN-SFHVURJKSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
36399,1r42,DB02873,-7.8,"1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperazin-1-Yl-3,4-Dihydroquinazolin-2(1h)-One",YAWZIQKDHQIHOS-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
102675,6vxs,DB07679,-7.8,"(9S,12S)-9-(1-methylethyl)-7,10-dioxo-2-oxa-8,11-diazabicyclo[12.2.2]octadeca-1(16),14,17-triene-12-carboxylic acid",RRAAROKJUVKWAF-RDJZCZTQSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
66943,6lxt,DB04853,-7.8,Binodenoson,XJFMHMFFBSOEPR-DNZQAUTHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
94572,6m71,DB08268,-7.8,"6-AMINO-4-[2-(4-METHYLPHENYL)ETHYL]-1,7-DIHYDRO-8H-IMIDAZO[4,5-G]QUINAZOLIN-8-ONE",SPVJRTJUEVXOMS-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
140819,6w9q,DB00157,-7.8,NADH,BOPGDPNILDQYTO-NNYOXOHSSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
134668,6w9c,DB03376,-7.8,'5'-O-(N-(L-Alanyl)-Sulfamoyl)Adenosine,CWWYMWDIYBJVLP-YTMOPEAISA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
150474,6wiq,DB01459,-7.8,Bezitramide,FLKWNFFCSSJANB-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
158770,7bv1,DB02196,-7.8,Uridine-Diphosphate-N-Acetylgalactosamine,LFTYTUAZOPRMMI-NESSUJCYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
70745,6lxt,DB13129,-7.8,Trimegestone,JUNDJWOLDSCTFK-MTZCLOFQSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
140497,6w9c,DB11964,-7.8,Ilaprazole,HRRXCXABAPSOCP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
60414,6crv,DB08618,-7.8,3-(HYDROXY-PHENYL-PHOSPHINOYLOXY)-8-METHYL-8-AZA-BICYCLO[3.2.1]OCTANE-2-CARBOXYLIC ACID METHYL ESTER,WJTKWTJTOSZMKO-PMOUVXMZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
25470,6cs2,DB03397,-7.8,Uridine-Diphosphate-N-Acetylglucosamine,LFTYTUAZOPRMMI-CFRASDGPSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
158667,7bv1,DB02058,-7.8,SU4984,AZGZGRJOCKSSHA-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
133948,6w9c,DB02375,-7.8,Myricetin,IKMDFBPHZNJCSN-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
28653,6cs2,DB08250,-7.8,"(5S)-5-(3-AMINOPROPYL)-3-(2,5-DIFLUOROPHENYL)-N-ETHYL-5-PHENYL-4,5-DIHYDRO-1H-PYRAZOLE-1-CARBOXAMIDE",OQMVLDZJPRSNOG-NRFANRHFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
94465,6m71,DB08137,-7.8,(4E)-N-(4-fluorophenyl)-4-[(phenylcarbonyl)imino]-4H-pyrazole-3-carboxamide,ZMWYSLJBNJUCRK-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
92926,6m71,DB05482,-7.8,7-ethyl-10-hydroxycamptothecin,FJHBVJOVLFPMQE-QFIPXVFZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
140761,6w9c,DB15261,-7.8,Butafenacil,JEDYYFXHPAIBGR-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
147603,6w9q,DB12186,-7.8,SRT-2104,LAMQVIQMVKWXOC-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
133920,6w9c,DB02333,-7.8,Deoxyuridine-5'-Triphosphate,AHCYMLUZIRLXAA-SHYZEUOFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
69097,6lxt,DB08707,-7.8,"4-[3-(4-chlorophenyl)-2,1-benzisoxazol-5-yl]pyrimidin-2-amine",AQVFETGXIRKVAQ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
93086,6m71,DB06250,-7.8,Fluasterone,VHZXNQKVFDBFIK-NBBHSKLNSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
68557,6lxt,DB08054,-7.8,"1-(1-methylethyl)-3-quinolin-6-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine",GEZALMMCQYDFML-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
102841,6vxs,DB07868,-7.8,6-CHLORO-4-(CYCLOHEXYLSULFANYL)-3-PROPYLQUINOLIN-2(1H)-ONE,CLKFNGKDJYMUPK-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
133894,6w9c,DB02295,-7.8,"N-[3-(Dimethylamino)Propyl]-2-({[4-({[4-(Formylamino)-1-Methyl-1h-Pyrrol-2-Yl]Carbonyl}Amino)-1-Methyl-1h-Pyrrol-2-Yl]Carbonyl}Amino)-5-Isopropyl-1,3-Thiazole-4-Carboxamide",VDYCDKRATGWFDA-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
70774,6lxt,DB13208,-7.8,Prednylidene,WSVOMANDJDYYEY-CWNVBEKCSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
70697,6lxt,DB13060,-7.8,CEP-37440,BCSHRERPHLTPEE-NRFANRHFSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
92938,6m71,DB05532,-7.8,BMS-488043,DBPMWRYLTBNCCE-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
89444,6m71,DB00485,-7.8,Dicloxacillin,YFAGHNZHGGCZAX-JKIFEVAISA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
155940,6wiq,DB11971,-7.8,Vilaprisan,JUFWQQVHQFDUOD-ANRPBIDPSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
94804,6m71,DB08549,-7.8,"(3R)-METHYLCARBAMOYL-7-SULFOAMINO-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLIC ACID BENZYL ESTER",MFDBNNQUDZFSES-KRWDZBQOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
67060,6lxt,DB05294,-7.8,Vandetanib,UHTHHESEBZOYNR-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
62397,6crv,DB13523,-7.8,Veralipride,RYJXBGGBZJGVQF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
102599,6vxs,DB07587,-7.8,"N-(1-CYANOCYCLOPROPYL)-3-({[(2S)-5-OXOPYRROLIDIN-2-YL]METHYL}SULFONYL)-N-2-[(1S)-2,2,2-TRIFLUORO-1-(4-FLUOROPHENYL)ETHYL]-L-ALANINAMIDE",JLPXDVXMMYRTKN-ZOBUZTSGSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
133862,6w9c,DB02254,-7.8,Trifluoro-thiamin phosphate,ZIBIECXVPMYJCV-UHFFFAOYSA-M,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
86545,6m3m,DB09002,-7.8,Cloperastine,FLNXBVJLPJNOSI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
66890,6lxt,DB04790,-7.8,"2,5-bis-O-{3-[amino(imino)methyl]phenyl}-1,4:3,6-dianhydro-D-glucitol",IBIUTOFGXGGVKQ-XMTFNYHQSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
66891,6lxt,DB04791,-7.8,"2-O-(4'-AMIDINOPHENYL)-5-O-(3''-AMIDINOPHENYL)-1,4:3,6-DIANHYDRO-D-SORBITOL",DKBAWRNTUZFJKV-BSDSXHPESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
134346,6w9c,DB02950,-7.8,Hymenialdisine,QPCBNXNDVYOBIP-WHFBIAKZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
134727,6w9c,DB03464,-7.8,Formycin-5'-Monophosphate,PBAHXXBYQACZMA-KSYZLYKTSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
86338,6m3m,DB08727,-7.8,"3-Methyl-5-(7-{4-[(4R)-4-methyl-4,5-dihydro-1,3-oxazol-2-yl]phenoxy}heptyl)-1,2-oxazole",NEAZMARKCJKUMF-QGZVFWFLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
150432,6wiq,DB01411,-7.8,Pranlukast,NBQKINXMPLXUET-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
147835,6w9q,DB12515,-7.8,9-aminocamptothecin,FUXVKZWTXQUGMW-FQEVSTJZSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
86523,6m3m,DB08979,-7.8,Fenspiride,FVNFBBAOMBJTST-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
134573,6w9c,DB03250,-7.8,"2-(Beta-D-Glucopyranosyl)-5-Methyl-1,3,4-Benzothiazole",WGJFWQVWYRZPEP-KABOQKQYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140518,6w9c,DB11999,-7.8,Vosaroxin,XZAFZXJXZHRNAQ-STQMWFEESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
89492,6m71,DB00547,-7.8,Desoximetasone,VWVSBHGCDBMOOT-IIEHVVJPSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
86524,6m3m,DB08980,-7.8,Fendiline,NMKSAYKQLCHXDK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
70759,6lxt,DB13166,-7.8,Zofenopril,IAIDUHCBNLFXEF-MNEFBYGVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
134737,6w9c,DB03478,-7.8,2'-O-Acetyl Adenosine-5-Diphosphoribose,BFNOPXRXIQJDHO-DLFWLGJNSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
147834,6w9q,DB12513,-7.8,Omaveloxolone,RJCWBNBKOKFWNY-IDPLTSGASA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
102744,6vxs,DB07760,-7.8,"3-[(1E,7E)-8-(2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)-3,6-dioxa-2,7-diazaocta-1,7-dien-1-yl]benzoic acid",TUYDQQMKXSQIQG-GONBZBRSSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
144579,6w9q,DB05490,-7.8,AMG-131,NMRWDFUZLLQSBN-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
102740,6vxs,DB07756,-7.8,"1-[3-({[(4-AMINO-5-FLUORO-2-METHYLQUINOLIN-3-YL)METHYL]THIO}METHYL)PHENYL]-2,2,2-TRIFLUOROETHANE-1,1-DIOL",GPBGHVRNVGXPNM-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
147568,6w9q,DB12130,-7.8,Lorlatinib,IIXWYSCJSQVBQM-LLVKDONJSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
94797,6m71,DB08542,-7.8,"3,4-dihydroxy-9,10-secoandrosta-1(10),2,4-triene-9,17-dione",YUHVBHDSVLKFNI-NJSLBKSFSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60408,6crv,DB08611,-7.8,"2-[(2',3',4'-TRIFLUOROBIPHENYL-2-YL)OXY]ETHANOL",AGXPXFPIOHNDAN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
134765,6w9c,DB03515,-7.8,Equilenin,PDRGHUMCVRDZLQ-WMZOPIPTSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
36405,1r42,DB02882,-7.8,Cyanocinnoline,CUWRVIIPSSUUDJ-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
147587,6w9q,DB12158,-7.8,Filorexant,NPFDWHQSDBWQLH-QZTJIDSGSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
144682,6w9q,DB06140,-7.8,SUVN-502,GWCYPEHWIZXYFZ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
98511,6vxs,DB01025,-7.8,Amlexanox,SGRYPYWGNKJSDL-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
147500,6w9q,DB12036,-7.8,Naquotinib,QKDCLUARMDUUKN-XMMPIXPASA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
67047,6lxt,DB05239,-7.8,Cobimetinib,BSMCAPRUBJMWDF-KRWDZBQOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
144695,6w9q,DB06160,-7.8,Garenoxacin,NJDRXTDGYFKORP-LLVKDONJSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
35980,1r42,DB02329,-7.8,Carbenoxolone,OBZHEBDUNPOCJG-WBXJDKIVSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
94438,6m71,DB08108,-7.8,N-({6-[(4-CYANOBENZYL)OXY]NAPHTHALEN-2-YL}SULFONYL)-D-GLUTAMIC ACID,PUHRQSFXADUGJW-OAQYLSRUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
85812,6m3m,DB08093,-7.8,3-(1-NAPHTHYLMETHOXY)PYRIDIN-2-AMINE,SZANYTFSQVBOBA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
155165,6wiq,DB08738,-7.8,1-{3-oxo-3-[(2S)-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]propyl}-3-phenylquinoxalin-2(1H)-one,KWCKZIJGKMCYCI-QFIPXVFZSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
5402,6lzg,HMDB0059746,-7.8,"(1R,2S,5R,6S)-6-(3,4-Dihydroxyphenyl)-2-(3,4-methylenedioxyphenyl)-3,7-dioxabicyclo-[3,3,0]octane",CGEORJKFOZSMEZ-NWZDRYQDSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
66330,6lxt,DB04038,-7.8,Ergosterol,DNVPQKQSNYMLRS-APGDWVJJSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
103333,6vxs,DB08455,-7.8,Ro 12-7310,CAAFTBWHFUPDGX-OFCLTBKTSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
143302,6w9q,DB03336,-7.8,BIA,KVIVJQWOYSWCCZ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
103321,6vxs,DB08441,-7.8,"6-BROMO-13-THIA-2,4,8,12,19-PENTAAZATRICYCLO[12.3.1.1-3,7-]NONADECA-1(18),3(19),4,6,14,16-HEXAENE 13,13-DIOXIDE",AWSQADBSXFTFKL-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
93500,6m71,DB07022,-7.8,3-Hydroxypropyl 3-[(7-carbamimidoyl-1-naphthyl)carbamoyl]benzenesulfonate,PXERBGNIBOFZOW-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59932,6crv,DB08038,-7.8,"L-alanyl-N-[(1S,2R)-1-benzyl-2-hydroxypropyl]-L-alaninamide",CPAOOGAUUDSJCS-FMSGJZPZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
132546,6w9c,DB00561,-7.8,Doxapram,XFDJYSQDBULQSI-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
85821,6m3m,DB08102,-7.8,"3,5-dibromobiphenyl-4-ol",SKQRVOXIIAXXEM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
155157,6wiq,DB08730,-7.8,3-FLUORO-5-MORPHOLIN-4-YL-N-[1-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-6-YL]BENZAMIDE,CPFBZMFUCGHBAP-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
99377,6vxs,DB02177,-7.8,1-Acetyl-4-(4-{4-[(2-Ethoxyphenyl)Thio]-3-Nitrophenyl}Pyridin-2-Yl)Piperazine,GKGJFUXSTSUKPB-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
99384,6vxs,DB02187,-7.8,Equilin,WKRLQDKEXYKHJB-HFTRVMKXSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
132562,6w9c,DB00582,-7.8,Voriconazole,BCEHBSKCWLPMDN-MGPLVRAMSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
93489,6m71,DB07008,-7.8,"4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMIDAZOL-1-YL)PHENOXY]PYRIMIDINE",XPXGYINSBORUMM-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
132619,6w9c,DB00652,-7.8,Pentazocine,VOKSWYLNZZRQPF-GDIGMMSISA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
93898,6m71,DB07480,-7.8,4-PHOSPHONOOXY-PHENYL-METHYL-[4-PHOSPHONOOXY]BENZEN,LGSCVLKUKMBYNC-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
155158,6wiq,DB08731,-7.8,"2-[(1R)-2-carboxy-1-(naphthalen-1-ylmethyl)ethyl]-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylic acid",GPOKTQCDBPECSS-MRXNPFEDSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
93511,6m71,DB07034,-7.8,"2,2'-{[9-(HYDROXYIMINO)-9H-FLUORENE-2,7-DIYL]BIS(OXY)}DIACETIC ACID",VOKATEXROYSXDW-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
99307,6vxs,DB02082,-7.8,Phosphoaminophosphonic Acid Guanylate Ester,UQABYHGXWYXDTK-UUOKFMHZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
159627,7bv1,DB04953,-7.8,Ezogabine,PCOBBVZJEWWZFR-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
149017,6w9q,DB14723,-7.8,Larotrectinib,NYNZQNWKBKUAII-KBXCAEBGSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
98874,6vxs,DB01521,-7.8,Clostebol,KCZCIYZKSLLNNH-FBPKJDBXSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
62819,6crv,DB14221,-7.8,Beclomethasone 17-monopropionate,OHYGPBKGZGRQKT-XGQKBEPLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
93538,6m71,DB07063,-7.8,"{3-[(4,5,7-TRIFLUORO-1,3-BENZOTHIAZOL-2-YL)METHYL]-1H-INDOL-1-YL}ACETIC ACID",KYHVTMFADJNSGS-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
13252,6lzg,DB15021,-7.8,Leriglitazone,OXVFDZYQLGRLCD-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
132441,6w9c,DB00433,-7.8,Prochlorperazine,WIKYUJGCLQQFNW-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
149004,6w9q,DB14679,-7.8,Quingestanol acetate,FLGJKPPXEKYCBY-AKCFYGDASA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
93530,6m71,DB07054,-7.8,(2R)-1-(DIMETHYLAMINO)-3-{4-[(6-{[2-FLUORO-5-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-4-YL)AMINO]PHENOXY}PROPAN-2-OL,OSCWQKTUILTARV-MRXNPFEDSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
143200,6w9q,DB03207,-7.8,"2-(Biphenyl-4-Sulfonyl)-1,2,3,4-Tetrahydro-Isoquinoline-3-Carboxylic Acid",BNVMUDXGABBWGP-OAQYLSRUSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
148987,6w9q,DB14662,-7.8,Flunisolide acetate,WEGNFRKBIKYVLC-XTLNBZDDSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
93824,6m71,DB07393,-7.8,"2-(2-PHENYL-3-PYRIDIN-2-YL-4,5,6,7-TETRAHYDRO-2H-ISOPHOSPHINDOL-1-YL)PYRIDINE",GSKNNHAAFLPYHG-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
99245,6vxs,DB02001,-7.8,"5-(4-Morpholin-4-Yl-Phenylsulfanyl)-2,4-Quinazolinediamine",CZLWCJRHDBTCGQ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
143205,6w9q,DB03213,-7.8,Bis(5-Amidino-2-Benzimidazolyl)Methane Ketone,VVVXDHROXQUONB-UHFFFAOYSA-P,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
159641,7bv1,DB05015,-7.8,Belinostat,NCNRHFGMJRPRSK-MDZDMXLPSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
99260,6vxs,DB02021,-7.8,Fidarestat,WAAPEIZFCHNLKK-UFBFGSQYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
93866,6m71,DB07441,-7.8,"3-{[(9-CYANO-9,10-DIHYDRO-10-METHYLACRIDIN-9-YL)CARBONYL]AMINO}PROPANOIC ACID",FRBAOMHMZCGBOJ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
68923,6lxt,DB08495,-7.8,4-({4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-2-OXOPIPERAZIN-1-YL}METHYL)BENZENECARBOXIMIDAMIDE,VXONTEUOQXFJJS-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
132492,6w9c,DB00493,-7.8,Cefotaxime,GPRBEKHLDVQUJE-QSWIMTSFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
99288,6vxs,DB02058,-7.8,SU4984,AZGZGRJOCKSSHA-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
93910,6m71,DB07493,-7.8,"(2Z)-5'-BROMO-2,3'-BIINDOLE-2',3(1H,1'H)-DIONE AMMONIATE",IEQQJQHHJMQETK-YPKPFQOOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59963,6crv,DB08076,-7.8,"4-[1-(2,6-dichlorobenzyl)-2-methyl-1H-imidazol-4-yl]pyrimidin-2-amine",CKSSZTMRRVJNNG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85853,6m3m,DB08136,-7.8,4-(acetylamino)-N-(4-fluorophenyl)-1H-pyrazole-3-carboxamide,CWQKPKYIMQTGJK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
155605,6wiq,DB11363,-7.8,Alectinib,KDGFLJKFZUIJMX-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
14305,6lzg,T3D3940,-7.8,Trifloxysulfuron-sodium,UFEIWEXHHOXPGP-UHFFFAOYSA-M,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
148780,6w9q,DB13943,-7.8,Testosterone cypionate,HPFVBGJFAYZEBE-ZLQWOROUSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
60002,6crv,DB08119,-7.8,"1,1,1-TRIFLUORO-3-((N-ACETYL)-L-LEUCYLAMIDO)-4-PHENYL-BUTAN-2-ONE(N-ACETYL-L-LEUCYL-L-PHENYLALANYL TRIFLUOROMETHYL KETONE)",MZNXJCZDQRNGRC-GJZGRUSLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62703,6crv,DB13978,-7.8,Selisistat,FUZYTVDVLBBXDL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
159535,7bv1,DB04542,-7.8,3'-Azido-3'-Deoxythymidine-5'-Diphosphate,QOYVAFWJURKBJG-XLPZGREQSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
103256,6vxs,DB08360,-7.8,"2-(4-ETHYLPIPERAZIN-1-YL)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE",BIFHJPUTQBOBGJ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
93404,6m71,DB06908,-7.8,"(2S)-3-(1-{[2-(2-CHLOROPHENYL)-5-METHYL-1,3-OXAZOL-4-YL]METHYL}-1H-INDOL-5-YL)-2-ETHOXYPROPANOIC ACID",PAWOPJKHTZCKMT-QFIPXVFZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
159517,7bv1,DB04518,-7.8,"3-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamino]-Phenol",JJDRRZFRTKZLFT-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
85914,6m3m,DB08207,-7.8,"2-(3,5-DIMETHYLPHENYL)-1,3-BENZOXAZOLE",BIHLSRJPJFOESJ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
132744,6w9c,DB00802,-7.8,Alfentanil,IDBPHNDTYPBSNI-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
132754,6w9c,DB00813,-7.8,Fentanyl,PJMPHNIQZUBGLI-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
132757,6w9c,DB00817,-7.8,Rosoxacin,XBPZXDSZHPDXQU-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
148758,6w9q,DB13874,-7.8,Enasidenib,DYLUUSLLRIQKOE-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
98815,6vxs,DB01451,-7.8,1-Androstenedione,WJIQCDPCDVWDDE-WZNAKSSCSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
93383,6m71,DB06884,-7.8,4-HYDROXY-N'-(4-ISOPROPYLBENZYL)BENZOHYDRAZIDE,MFDXHRPPSJRQFX-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
14854,6lzg,T3D4808,-7.8,Fluorescein,GNBHRKFJIUUOQI-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
93995,6m71,DB07595,-7.8,"(5Z)-5-(3-BROMOCYCLOHEXA-2,5-DIEN-1-YLIDENE)-N-(PYRIDIN-4-YLMETHYL)-1,5-DIHYDROPYRAZOLO[1,5-A]PYRIMIDIN-7-AMINE",WSIQKQLAGWVKSL-UHFFFAOYSA-O,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60034,6crv,DB08153,-7.8,"(5E)-14-CHLORO-15,17-DIHYDROXY-4,7,8,9,10,11-HEXAHYDRO-2-BENZOXACYCLOPENTADECINE-1,12(3H,13H)-DIONE",VZTAZMSAAIUZJV-HWKANZROSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
68711,6lxt,DB08233,-7.8,6-CYCLOHEXYLMETHYLOXY-2-(4'-HYDROXYANILINO)PURINE,RFSDQDHHBKYQOD-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
132718,6w9c,DB00769,-7.8,Hydrocortamate,FWFVLWGEFDIZMJ-FOMYWIRZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
68767,6lxt,DB08305,-7.8,"(3R)-3-cyclopentyl-6-methyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2-benzothiazine 1,1-dioxide",KQAGZLQCEURCKJ-QGZVFWFLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
132707,6w9c,DB00755,-7.8,Tretinoin,SHGAZHPCJJPHSC-YCNIQYBTSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
149635,6wiq,DB00398,-7.8,Sorafenib,MLDQJTXFUGDVEO-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
89736,6m71,DB00838,-7.8,Clocortolone,YMTMADLUXIRMGX-RFPWEZLHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
103291,6vxs,DB08402,-7.8,"2-[(2,4-DICHLOROBENZOYL)AMINO]-5-(PYRIMIDIN-2-YLOXY)BENZOIC ACID",VNDRRWBKNSHALL-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
68739,6lxt,DB08268,-7.8,"6-AMINO-4-[2-(4-METHYLPHENYL)ETHYL]-1,7-DIHYDRO-8H-IMIDAZO[4,5-G]QUINAZOLIN-8-ONE",SPVJRTJUEVXOMS-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
159577,7bv1,DB04596,-7.8,"4-O-{4,6-O-[(1S)-1-Carboxyethylidene]-??-D-mannopyranosyl}-D-glucopyranuronic acid",GZJXZKGVHLWBOW-AISSFXTFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
13166,6lzg,DB14821,-7.8,Macozinone,BJDZBXGJNBMCAV-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
159573,7bv1,DB04590,-7.8,(2R)-({4-[AMINO(IMINO)METHYL]PHENYL}AMINO){5-ETHOXY-2-FLUORO-3-[(3R)-TETRAHYDROFURAN-3-YLOXY]PHENYL}ACETICACID,PGYOHIAQCFZQDK-AUUYWEPGSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
143411,6w9q,DB03490,-7.8,"3-Pyridin-4-Yl-2,4-Dihydro-Indeno[1,2-.C.]Pyrazole",NHOACLCXCKJMAK-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
66282,6lxt,DB03970,-7.8,"(7R)-7-(6,7-Dihydro-5H-cyclopenta[d]imidazo[2,1-b][1,3]thiazol-2-yl)-2,7-dihydro-1,4-thiazepine-3,6-dicarboxylic acid",CHNMLWCTGYMVFH-GFCCVEGCSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
62730,6crv,DB14033,-7.8,Acetyl sulfisoxazole,JFNWFXVFBDDWCX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
89714,6m71,DB00814,-7.8,Meloxicam,ZRVUJXDFFKFLMG-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
148824,6w9q,DB14029,-7.8,Furafylline,HMZQULPVMKITSP-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
68723,6lxt,DB08246,-7.8,"(2S)-4-(2,5-DIFLUOROPHENYL)-N,N-DIMETHYL-2-PHENYL-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDE",WFFMEXQHWXEKBV-SFHVURJKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
132637,6w9c,DB00674,-7.8,Galantamine,ASUTZQLVASHGKV-JDFRZJQESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
143539,6w9q,DB03678,-7.8,"(6,7-Difluoro-Quinazolin-4-Yl)-(1-Methyl-2,2-Diphenyl-Ethyl)-Amine",WVGZKPGUHOZIJQ-HNNXBMFYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
99413,6vxs,DB02226,-7.8,"3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-4-Yl]Hexyl]-Phenanthridinium",NAARZDJZGYBXKL-UHFFFAOYSA-O,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
23919,6cs2,DB01558,-7.8,Bromazepam,VMIYHDSEFNYJSL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
99434,6vxs,DB02253,-7.8,"(1r)-4-[(1e,3e,5e,7z,9e,11z,13e,15e)-17-Hydroxy-3,7,12,16-Tetramethylheptadeca-1,3,5,7,9,11,13,15-Octaen-1-Yl]-3,5,5-Trimethylcyclohex-3-En-1-Ol",FNAJVVMDXCOSFY-VFGOXHQXSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
141751,6w9q,DB01259,-7.8,Lapatinib,BCFGMOOMADDAQU-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
143551,6w9q,DB03696,-7.8,Lanosterol,CAHGCLMLTWQZNJ-BQNIITSRSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
14306,6lzg,T3D3941,-7.8,Triflusulfuron-methyl,IMEVJVISCHQJRM-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
63112,6crv,DB15156,-7.8,ABT-072,XMZSTQYSBYEENY-RMKNXTFCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62830,6crv,DB14538,-7.8,Hydrocortisone aceponate,MFBMYAOAMQLLPK-FZNHGJLXSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
98885,6vxs,DB01532,-7.8,??-Methylacetylfentanyl,OKTLVZBUKMRPLL-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
149171,6w9q,DB15085,-7.8,Fulacimstat,JDARDSVOVYVQST-MRXNPFEDSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
132121,6w4h,DB15425,-7.8,CYC-065,DLPIYBKBHMZCJI-WBVHZDCISA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
132125,6w4h,DB15435,-7.8,BMS-986158,KGERZPVQIRYWRK-GDLZYMKVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
132127,6w4h,DB15437,-7.8,Rocacetrapib,GBHPDJQHZADVAA-SOKVYYICSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
13243,6lzg,DB14993,-7.8,Pyrotinib,SADXACCFNXBCFY-IYNHSRRRSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
89900,6m71,DB01025,-7.8,Amlexanox,SGRYPYWGNKJSDL-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
149268,6w9q,DB15275,-7.8,GDC-0077,SGEUNORSOZVTOL-CABZTGNLSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
159773,7bv1,DB06518,-7.8,R-1487,KKKRKRMVJRHDMG-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
62873,6crv,DB14644,-7.8,Methylprednisolone hemisuccinate,IMBXEJJVJRTNOW-XYMSELFBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
132128,6w4h,DB15440,-7.8,GSK-3117391,AFDPFLDWOXXHQM-NRFANRHFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
66457,6lxt,DB04201,-7.8,Histidyl-Adenosine Monophosphate,XTFBSLZFYLGYAT-OPYVMVOTSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
155422,6wiq,DB09095,-7.8,Difluocortolone,OGPWIDANBSLJPC-RFPWEZLHSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
132156,6w4h,DB04596,-7.8,"4-O-{4,6-O-[(1S)-1-Carboxyethylidene]-β-D-mannopyranosyl}-D-glucopyranuronic acid",GZJXZKGVHLWBOW-AISSFXTFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
149146,6w9q,DB15035,-7.8,Zanubrutinib,RNOAOAWBMHREKO-QFIPXVFZSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
98951,6vxs,DB01608,-7.8,Periciazine,LUALIOATIOESLM-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
132183,6w9c,DB00131,-7.8,Adenosine phosphate,UDMBCSSLTHHNCD-KQYNXXCUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
159746,7bv1,DB05586,-7.8,Facinicline,TXCYUSKWBHUVEP-CYBMUJFWSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
149124,6w9q,DB14982,-7.8,Miransertib,HNFMVVHMKGFCMB-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
159758,7bv1,DB06472,-7.8,Fradafiban,IKZACQMAVUIGPY-HOTGVXAUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
25895,6cs2,DB03921,-7.8,4-(3-Pyridin-2-Yl-1h-Pyrazol-4-Yl)Quinoline,IBCXZJCWDGCXQT-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
149254,6w9q,DB15242,-7.8,MK-0533,STWITCBWQHTJFJ-XMMPIXPASA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
132069,6w4h,DB15316,-7.8,Florasulam,QZXATCCPQKOEIH-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
68845,6lxt,DB08400,-7.8,4-(3-{[5-(trifluoromethyl)pyridin-2-yl]oxy}benzyl)piperidine-1-carboxylic acid,KUEKMTNOUPAOBS-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
142295,6w9q,DB02014,-7.8,"5-(2-Fluoro-5-{(1E)-3-[3-hydroxy-2-(methoxycarbonyl)phenoxy]-1-propen-1-yl}phenyl)-1,2-oxazole-3-carboxylic acid",QKHWJUMLYAYZFS-ONEGZZNKSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
142279,6w9q,DB01990,-7.8,Cholesterol sulfate,BHYOQNUELFTYRT-DPAQBDIFSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
149219,6w9q,DB15183,-7.8,Fosmanogepix,JQONJQKKVAHONF-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
68846,6lxt,DB08401,-7.8,(2E)-2-({(2S)-2-CARBOXY-2-[(PHENOXYACETYL)AMINO]ETHOXY}IMINO)PENTANEDIOIC ACID,LDNKNKRRFZRLIG-HWQJWEFDSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
159806,7bv1,DB06603,-7.8,Panobinostat,FPOHNWQLNRZRFC-ZHACJKMWSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
62902,6crv,DB14674,-7.8,Estramustine phosphate,ADFOJJHRTBFFOF-RBRWEJTLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59770,6crv,DB07854,-7.8,N-METHYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE,VRGSDHJXBVCQEL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
103505,6vxs,DB08660,-7.8,"1,2,5,8-tetrahydroxyanthracene-9,10-dione",VBHKTXLEJZIDJF-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
99073,6vxs,DB01765,-7.8,"(5-Oxo-5,6-Dihydro-Indolo[1,2-a]Quinazolin-7-Yl)-Acetic Acid",INSBKYCYLCEBOD-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
99034,6vxs,DB01713,-7.8,Udp-Alpha-D-Xylopyranose,DQQDLYVHOTZLOR-OCIMBMBZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
149204,6w9q,DB15145,-7.8,Ziresovir,GAAICKUTDBZCMT-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
142467,6w9q,DB02241,-7.8,"8-Benzyl-2-Hydroperoxy-2-(4-Hydroxy-Benzyl)-6-(4-Hydroxy-Phenyl)-2h-Imidazo[1,2-a]Pyrazin-3-One",HOSWCJDTHOAORT-SANMLTNESA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
36647,1r42,DB03207,-7.8,"2-(Biphenyl-4-Sulfonyl)-1,2,3,4-Tetrahydro-Isoquinoline-3-Carboxylic Acid",BNVMUDXGABBWGP-OAQYLSRUSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
99077,6vxs,DB01771,-7.8,CRA_10991,QXAURVOBXQBPAP-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
93672,6m71,DB07219,-7.8,"BENZYL N-({(2S,3S)-3-[(PROPYLAMINO)CARBONYL]OXIRAN-2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINATE",OMQNYWZURFTFHE-MQBSTWLZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
34633,1r42,DB00596,-7.8,Ulobetasol,LEHFPXVYPMWYQD-XHIJKXOTSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
85609,6m3m,DB07858,-7.8,(2S)-2-(4-chlorophenyl)-2-[4-(1H-pyrazol-4-yl)phenyl]ethanamine,HWVGILTYGZFGLR-KRWDZBQOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
13216,6lzg,DB14914,-7.8,Flortaucipir F-18,GETAAWDSFUCLBS-SJPDSGJFSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
89846,6m71,DB00962,-7.8,Zaleplon,HUNXMJYCHXQEGX-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
159744,7bv1,DB05575,-7.8,Motesanib,RAHBGWKEPAQNFF-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
155288,6wiq,DB08907,-7.8,Canagliflozin,XTNGUQKDFGDXSJ-ZXGKGEBGSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
132235,6w9c,DB00186,-7.8,Lorazepam,DIWRORZWFLOCLC-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
23381,6cs2,HMDB0061739,-7.8,Perfluorononanoic acid,UZUFPBIDKMEQEQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
132353,6w9c,DB00323,-7.8,Tolcapone,MIQPIUSUKVNLNT-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
62845,6crv,DB14570,-7.8,Hydroxyprogesterone,DBPWSSGDRRHUNT-CEGNMAFCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59894,6crv,DB07997,-7.8,N-[2-(METHYLAMINO)ETHYL]-5-ISOQUINOLINESULFONAMIDE,PJWUXKNZVMEPPH-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
68893,6lxt,DB08460,-7.8,"3-{5-[(6-amino-1H-pyrazolo[3,4-b]pyridin-3-yl)methoxy]-2-chlorophenoxy}-5-chlorobenzonitrile",KXDIHAQCVNNLIB-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
149358,6w9q,DB15456,-7.8,Vericiguat,QZFHIXARHDBPBY-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
93759,6m71,DB07316,-7.8,"N-{1-[(1-carbamoylcyclopropyl)methyl]piperidin-4-yl}-N-cyclopropyl-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide",FAVXIEFZKPJZRT-NRFANRHFSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
23979,6cs2,DB01624,-7.8,Zuclopenthixol,WFPIAZLQTJBIFN-DVZOWYKESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
149059,6w9q,DB14822,-7.8,SB-649868,ZJXIUGNEAIHSBI-IBGZPJMESA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
103384,6vxs,DB08514,-7.8,"6-amino-2-[(thiophen-2-ylmethyl)amino]-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",IQKMJWDYMFWZRF-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
159677,7bv1,DB05234,-7.8,LGD2941,HWLLYFXDDGGHOE-BCSUUIJWSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
159674,7bv1,DB05212,-7.8,HE3286,JJKOQZHWYLMASZ-FJWDNACWSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
149049,6w9q,DB14792,-7.8,AZD-5991,KBQCEQAXHPIRTF-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
159670,7bv1,DB05171,-7.8,E-2012,PUOAETJYKQITMO-LANLRWRYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59904,6crv,DB08009,-7.8,"5-[(E)-(5-CHLORO-2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]-N-[2-(DIETHYLAMINO)ETHYL]-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXAMIDE",XPLJEFSRINKZLC-ATVHPVEESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
159665,7bv1,DB05134,-7.8,Tanespimycin,AYUNIORJHRXIBJ-TXHRRWQRSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93762,6m71,DB07319,-7.8,"6-(3-BROMO-2-NAPHTHYL)-1,3,5-TRIAZINE-2,4-DIAMINE",RXSSKAZHCZWJPP-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
34712,1r42,DB00693,-7.8,Fluorescein,GNBHRKFJIUUOQI-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
93552,6m71,DB07081,-7.8,"(2R)-4-[(8R)-8-METHYL-2-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[1,5-A]PYRAZIN-7(8H)-YL]-4-OXO-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE",FDEXEPZGMKFCTG-PSASIEDQSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
149074,6w9q,DB14859,-7.8,Fosifloxuridine nafalbenamide,BIOWRMNRHMERIO-ZVAHOJSLSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
103369,6vxs,DB08497,-7.8,"(1S)-2-oxo-1-phenyl-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate",NKBDSMREMMRFSI-INIZCTEOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
98910,6vxs,DB01557,-7.8,??-Methylfentanyl,NGTVDHYUFBKWID-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
149075,6w9q,DB14860,-7.8,Ensartinib,GLYMPHUVMRFTFV-QLFBSQMISA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
24100,6cs2,DB01766,-7.8,Beta-(2-Naphthyl)-Alanine,JPZXHKDZASGCLU-LBPRGKRZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
132258,6w9c,DB00215,-7.8,Citalopram,WSEQXVZVJXJVFP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
1788,6lzg,HMDB0015044,-7.8,Quinidine,LOUPRKONTZGTKE-LHHVKLHASA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
103428,6vxs,DB08568,-7.8,(2S)-1-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}-3-PHENYLPROPAN-2-AMINE,BPNUQXPIQBZCMR-IBGZPJMESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
149311,6w9q,DB15356,-7.8,SLV-334,LOFDNSDPZTVIIO-VPUSJEBWSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
103426,6vxs,DB08562,-7.8,4-(4-STYRYL-PHENYLCARBAMOYL)-BUTYRIC ACID,FTXJWRRYLLRFMG-MDZDMXLPSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
59860,6crv,DB07961,-7.8,"1-(4-CYANO-PHENYL)-3-[2-(2,6-DICHLORO-PHENYL)-1-IMINO-ETHYL]-THIOUREA",NWKJBFSBEAMDBE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
25866,6cs2,DB03888,-7.8,N-Allyl-6-{[3-(4-bromophenyl)-1-methyl-1H-indazol-6-yl]oxy}-N-methyl-1-hexanamine,FNZKIJOTNKEJBF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
24008,6cs2,DB01656,-7.8,Roflumilast,MNDBXUUTURYVHR-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
93704,6m71,DB07257,-7.8,"4-(2-chlorophenyl)-8-(2-hydroxyethyl)-6-methylpyrrolo[3,4-e]indole-1,3(2H,6H)-dione",WHMQZCPGFZBLBG-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
149318,6w9q,DB15377,-7.8,ATB-346,YCNMAPLPQYQJFC-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
89813,6m71,DB00923,-7.8,Ceforanide,SLAYUXIURFNXPG-CRAIPNDOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
1907,6lzg,HMDB0029094,-7.8,Tryptophyl-Tryptophan,NQIHMZLGCZNZBN-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
93587,6m71,DB07121,-7.8,"4-({4-[(4-AMINOBUT-2-YNYL)OXY]PHENYL}SULFONYL)-N-HYDROXY-2,2-DIMETHYLTHIOMORPHOLINE-3-CARBOXAMIDE",AANXPIMDONQTQF-HNNXBMFYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
132335,6w9c,DB00303,-7.8,Ertapenem,JUZNIMUFDBIJCM-ANEDZVCMSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
1957,6lzg,HMDB0029203,-7.8,hesperetin-7-O-glucuronide,PLNORHFXCFFTRD-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
98923,6vxs,DB01570,-7.8,Ohmefentanyl,FRPRNNRJTCONEC-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
155265,6wiq,DB08867,-7.8,Ulipristal,HKDLNTKNLJPAIY-WKWWZUSTSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
16899,6cs2,HMDB0005028,-7.8,Escitalopram,WSEQXVZVJXJVFP-FQEVSTJZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
103407,6vxs,DB08540,-7.8,"2-[4-(2H-1,4-BENZOTHIAZINE-3-YL)-PIPERAZINE-1-LY]-1,3-THIAZOLE-4-CARBOXYLIC ACID ETHYLESTER",AQJQFCRTSWIUCY-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
132819,6w9c,DB00885,-7.8,Pemirolast,HIANJWSAHKJQTH-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
93378,6m71,DB06879,-7.8,"5-(4'-AMINO-1'-ETHYL-5',8'-DIFLUORO-1'H-SPIRO[PIPERIDINE-4,2'-QUINAZOLINE]-1-YLCARBONYL)PICOLINONITRILE",QCFIRACCCDFXIP-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
22882,6cs2,HMDB0055293,-7.8,"TG(18:3(9Z,12Z,15Z)/22:2(13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))",PHBPVJUUYJZCOS-BTFSSQDWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
89593,6m71,DB00671,-7.8,Cefixime,OKBVVJOGVLARMR-QSWIMTSFSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94292,6m71,DB07943,-7.8,2-{4-[5-(4-chlorophenyl)-4-pyrimidin-4-yl-1H-pyrazol-3-yl]piperidin-1-yl}-2-oxoethanol,CATQHDWESBRRQA-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
86189,6m3m,DB08545,-7.8,(1R)-1-PHENYLETHYL 4-(ACETYLAMINO)BENZYLPHOSPHONATE,YPTMOJMDCPUCJT-ZDUSSCGKSA-M,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
93220,6m71,DB06616,-7.8,Bosutinib,UBPYILGKFZZVDX-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
148224,6w9q,DB13119,-7.8,GSK-364735,QWLNINWUBHHOLU-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
133325,6w9c,DB01545,-7.8,Ethyl loflazepate,CUCHJCMWNFEYOM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
148204,6w9q,DB13094,-7.8,Pruvanserin,AQRLDDAFYYAIJP-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
62540,6crv,DB13714,-7.8,Xibornol,RNRHMQWZFJXKLZ-JCKWVBRZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
23799,6cs2,DB01436,-7.8,Alfacalcidol,OFHCOWSQAMBJIW-AVJTYSNKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
60241,6crv,DB08412,-7.8,6-{4-[HYDROXY-(4-NITRO-PHENOXY)-PHOSPHORYL]-BUTYRYLAMINO}-HEXANOIC ACID,WYHHVZLGTMCKOR-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
98679,6vxs,DB01215,-7.8,Estazolam,CDCHDCWJMGXXRH-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
133337,6w9c,DB01557,-7.8,??-Methylfentanyl,NGTVDHYUFBKWID-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
148177,6w9q,DB13055,-7.8,Oteseconazole,IDUYJRXRDSPPRC-NRFANRHFSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
89572,6m71,DB00643,-7.8,Mebendazole,OPXLLQIJSORQAM-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94331,6m71,DB07988,-7.8,"2-[3-(5-MERCAPTO-[1,3,4]THIADIAZOL-2YL)-UREIDO]-N-METHYL-3-PENTAFLUOROPHENYL-PROPIONAMIDE",HZAXNPDJVFUGDS-BYPYZUCNSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
133339,6w9c,DB01559,-7.8,Clotiazepam,CHBRHODLKOZEPZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
68626,6lxt,DB08130,-7.8,"N-(5-{3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]phenyl}-1,3,4-oxadiazol-2-yl)ethane-1,2-diamine",FPDWDLAITHFTTP-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
94336,6m71,DB07993,-7.8,"N-3-[3-(1H-INDOL-6-YL)BENZYL]PYRIDINE-2,3-DIAMINE",LPQUIIHPUGDHJK-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94316,6m71,DB07971,-7.8,"5-AMINO-2-{4-[(4-AMINOPHENYL)SULFANYL]PHENYL}-1H-ISOINDOLE-1,3(2H)-DIONE",FQQVTDIBUYSVHM-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94290,6m71,DB07941,-7.8,PH-797804,KCAJXIDMCNPGHZ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94287,6m71,DB07937,-7.8,"2-butoxy-9-(2,6-difluorobenzyl)-N-(2-morpholin-4-ylethyl)-9H-purin-6-amine",UGZWPZWADDDTRN-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
159148,7bv1,DB03488,-7.8,Uridine-5'-diphosphate-2-deoxy-2-fluoro-alpha-D-galactose,NGTCPFGWXMBZEP-NQQHDEILSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
68637,6lxt,DB08143,-7.8,"5-CHLORO-THIOPHENE-2-CARBOXYLIC ACID ((3S,4S)-4-FLUORO- 1-{[2-FLUORO-4-(2-OXO-2H-PYRIDIN-1-YL)-PHENYLCARBAMOYL]-METHYL}-PYRROLIDIN-3-YL)-AMIDE",SXIYSYYSKHUTQQ-RDJZCZTQSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
66079,6lxt,DB03714,-7.8,4-Carbamoyl-4-{[6-(Difluoro-Phosphono-Methyl)-Naphthalene-2-Carbonyl]-Amino}-Butyric Acid,OWWCIKSGGKYNHT-ZDUSSCGKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
25623,6cs2,DB03601,-7.8,5-deoxyflavanone,FURUXTVZLHCCNA-AWEZNQCLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
133293,6w9c,DB01511,-7.8,Delorazepam,CHIFCDOIPRCHCF-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
66765,6lxt,DB04616,-7.8,TACRINE(8)-4-AMINOQUINOLINE,UNVOAAWEEGAXTN-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
93237,6m71,DB06645,-7.8,Anamorelin,VQPFSIRUEPQQPP-MXBOTTGLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
141371,6w9q,DB00820,-7.8,Tadalafil,WOXKDUGGOYFFRN-IIBYNOLFSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
140445,6w9c,DB06850,-7.8,(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclohexylamino)ethanoyl)pyrrolidine-2-carboxamide,RYKFVFFOIYLADT-SFHVURJKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
155793,6wiq,DB11740,-7.8,MK-1775,BKWJAKQVGHWELA-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
159163,7bv1,DB03507,-7.8,"6-[3-(4-Morpholinyl)Propyl]-2-(3-Nitrophenyl)-5-Thioxo-5,6,-Dihydro-7h-Thienol[2',3':4,5]Pyrrolo[1,2-C]Imidazol-7-One",UXGUZFZBZPPZGL-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
159158,7bv1,DB03501,-7.8,Galactose-uridine-5'-diphosphate,HSCJRCZFDFQWRP-ABVWGUQPSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
62568,6crv,DB13753,-7.8,Cetiedil,MMNICIJVQJJHHF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
94279,6m71,DB07929,-7.8,"N-(TERT-BUTYL)-3,5-DIMETHYL-N'-[(5-METHYL-2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)CARBONYL]BENZOHYDRAZIDE",JGJACZABNQGPMT-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
103006,6vxs,DB08059,-7.8,Wortmannin,QDLHCMPXEPAAMD-QAIWCSMKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
94282,6m71,DB07932,-7.8,"dimethyl (1R,4S)-5,6-bis(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hepta-2,5-diene-2,3-dicarboxylate",CRLQCBACIMUGDZ-BGYRXZFFSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
66054,6lxt,DB03678,-7.8,"(6,7-Difluoro-Quinazolin-4-Yl)-(1-Methyl-2,2-Diphenyl-Ethyl)-Amine",WVGZKPGUHOZIJQ-HNNXBMFYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
68633,6lxt,DB08138,-7.8,"{[(2,6-difluorophenyl)carbonyl]amino}-N-(4-fluorophenyl)-1H-pyrazole-3-carboxamide",BDRDBXXWQDFXEC-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
66775,6lxt,DB04630,-7.8,Aldosterone,PQSUYGKTWSAVDQ-ZVIOFETBSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
159152,7bv1,DB03493,-7.8,7-Methylguanosine,OGHAROSJZRTIOK-KQYNXXCUSA-O,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
159096,7bv1,DB03141,-7.8,"3-{[(5R,6R)-5-Benzyl-6-hydroxy-2,4-bis(4-hydroxybenzyl)-3-oxo-1,2,4-triazepan-1-yl]sulfonyl}benzonitril",UYUWNNRWESUYOB-FIRIVFDPSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
86211,6m3m,DB08573,-7.8,3-[(4-CHLOROANILINO)SULFONYL]THIOPHENE-2-CARBOXYLIC ACID,YRWKEEDITQJPCZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
102999,6vxs,DB08052,-7.8,"1-cyclopentyl-3-(1H-pyrrolo[2,3-b]pyridin-5-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine",NVRXTLZYXZNATH-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
99746,6vxs,DB02651,-7.8,"{[2-(1h-1,2,3-Benzotriazol-1-Yl)-2-(3,4-Difluorophenyl)Propane-1,3-Diyl]Bis[4,1-Phenylene(Difluoromethylene)]}Bis(Phosphonic Acid)",BTAGTGWPDROBMG-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
148036,6w9q,DB12836,-7.8,Grapiprant,HZVLFTCYCLXTGV-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
16565,6cs2,HMDB0002865,-7.8,Oxytocin,XNOPRXBHLZRZKH-MQYCRUOZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
144464,6w9q,DB04908,-7.8,Flibanserin,PPRRDFIXUUSXRA-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
158982,7bv1,DB02716,-7.8,7-Methyl-Guanosine-5'-Triphosphate,DKVRNHPCAOHRSI-KQYNXXCUSA-O,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94394,6m71,DB08058,-7.8,"4-[3-(1,4-diazepan-1-ylcarbonyl)-4-fluorobenzyl]phthalazin-1(2H)-one",HGEPGGJUGUMFHT-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
155838,6wiq,DB11804,-7.8,AZD-5672,SCXSQUUTGCWHFU-WJOKGBTCSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
148001,6w9q,DB12776,-7.8,E-6005,BBTFKAOFCSOZMB-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
62487,6crv,DB13645,-7.8,Ethacizine,PQXGNJKJMFUPPM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
94413,6m71,DB08080,-7.8,LATRUNCULIN B,NSHPHXHGRHSMIK-JRIKCGFMSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
141123,6w9q,DB00522,-7.8,Bentiromide,SPPTWHFVYKCNNK-FQEVSTJZSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
147970,6w9q,DB12725,-7.8,TD-8954,MZOITCJKGUIQEI-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
144508,6w9q,DB05076,-7.8,Fenretinide,AKJHMTWEGVYYSE-FXILSDISSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
147966,6w9q,DB12719,-7.8,Turofexorate isopropyl,INASOKQDNHHMRE-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
93129,6m71,DB06370,-7.8,Indisulam,SETFNECMODOHTO-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
99855,6vxs,DB02804,-7.8,A-98881,PMBZSBGCSQGJAQ-GRKNLSHJSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102941,6vxs,DB07987,-7.8,"[2-(5-MERCAPTO-[1,3,4]THIADIAZOL-2-YLCARBAMOYL)-1-PHENYL-ETHYL]-CARBAMIC ACID BENZYL ESTER",AWAKNMKLVLWIIQ-OAHLLOKOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
93126,6m71,DB06364,-7.8,XR5944,SFOADSRLCHRTKT-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
86274,6m3m,DB08651,-7.8,3'-THIO-THYMIDINE-5'-PHOSPHATE,BORVFKJZAOEGOO-GJMOJQLCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
66845,6lxt,DB04725,-7.8,Licofelone,UAWXGRJVZSAUSZ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
63286,6crv,DB09170,-7.8,β-Hydroxythiofentanyl,GLAAETOTOUGGSB-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
133252,6w9c,DB01462,-7.8,Etonitazene,PXDBZSCGSQSKST-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
154896,6wiq,DB08418,-7.8,"(4aS,4bR,10bS,12aS)-12a-methyl-1,3-dioxo-2-(pyridin-3-ylmethyl)-1,2,3,4,4a,4b,5,6,10b,11,12,12a-dodecahydronaphtho[2,1-f]isoquinolin-8-yl sulfamate",LSJKARAMQNGZDF-YOEKFXIASA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
148049,6w9q,DB12858,-7.8,LY-377604,RBSGUQYXRDKPAE-QFIPXVFZSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
148142,6w9q,DB13002,-7.8,HKI-357,NERXPXBELDBEPZ-RMKNXTFCSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
133370,6w9c,DB01599,-7.8,Probucol,FYPMFJGVHOHGLL-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
154919,6wiq,DB08445,-7.8,"(3R,4S)-1-[6-(6-METHOXYPYRIDIN-3-YL)PYRIMIDIN-4-YL]-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE",IFKWHPAWYJARQJ-DYVFJYSZSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
150083,6wiq,DB00932,-7.8,Tipranavir,SUJUHGSWHZTSEU-FYBSXPHGSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
148133,6w9q,DB12985,-7.8,Quisinostat,PAWIYAYFNXQGAP-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
150106,6wiq,DB00959,-7.8,Methylprednisolone,VHRSUDSXCMQTMA-PJHHCJLFSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
34956,1r42,DB00977,-7.8,Ethinylestradiol,BFPYWIDHMRZLRN-SLHNCBLASA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
62528,6crv,DB13694,-7.8,Distigmine,AHZBEVXBKNYXPU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
133400,6w9c,DB01633,-7.8,Deoxy-2-fluoro-beta-D-cellotrioside,BZNXZJAUEMJQJB-QSCMNUSVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
68622,6lxt,DB08126,-7.8,"3-{[4-([AMINO(IMINO)METHYL]AMINOSULFONYL)ANILINO]METHYLENE}-2-OXO-2,3-DIHYDRO-1H-INDOLE",DMCRNUMVSATRTP-LCYFTJDESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
148112,6w9q,DB12949,-7.8,PF-03382792,AGMOFKKOVMRGAK-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
150132,6wiq,DB00990,-7.8,Exemestane,BFYIZQONLCFLEV-DAELLWKTSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
99757,6vxs,DB02668,-7.8,"Je-2147, Ag1776, Kni-764",CUFQBQOBLVLKRF-RZDMPUFOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
133418,6w9c,DB01656,-7.8,Roflumilast,MNDBXUUTURYVHR-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
94363,6m71,DB08022,-7.8,"(2S)-1,3-benzothiazol-2-yl{2-[(2-pyridin-3-ylethyl)amino]pyrimidin-4-yl}ethanenitrile",RCYPVQCPYKNSTG-OAHLLOKOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
141181,6w9q,DB00590,-7.8,Doxazosin,RUZYUOTYCVRMRZ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
148087,6w9q,DB12914,-7.8,MGL-3196,FDBYIYFVSAHJLY-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
148076,6w9q,DB12899,-7.8,TT-301,ZPJGUEPHFXPAQF-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
133438,6w9c,DB01685,-7.8,Topiroxostat,UBVZQGOVTLIHLH-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
150185,6wiq,DB01051,-7.8,Novobiocin,YJQPYGGHQPGBLI-KGSXXDOSSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
144262,6w9q,DB04632,-7.8,4-(2-HYDROXYBENZYLAMINO)-N-(3-(4-FLUOROPHENOXY)PHENYL)PIPERIDINE-1-SULFONAMIDE,JHHBGNIRSUTQAS-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
70892,6lxt,DB13360,-7.8,Tolciclate,CANCCLAKQQHLNK-LSDHHAIUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
148339,6w9q,DB13317,-7.8,Flunoxaprofen,ARPYQKTVRGFPIS-VIFPVBQESA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
70999,6lxt,DB13506,-7.8,Carfecillin,NZDASSHFKWDBBU-KVMCETHSSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
60073,6crv,DB08198,-7.8,"[(4R)-4-(3-HYDROXYPHENYL)-1,6-DIMETHYL-2-THIOXO-1,2,3,4-TETRAHYDROPYRIMIDIN-5-YL](PHENYL)METHANONE",JGBBILLMZPWNFU-QGZVFWFLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60079,6crv,DB08207,-7.8,"2-(3,5-DIMETHYLPHENYL)-1,3-BENZOXAZOLE",BIHLSRJPJFOESJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
159393,7bv1,DB04086,-7.8,"2',4'-Dinitrophenyl-2deoxy-2-Fluro-B-D-Cellobioside",WFVCNOHOODVBQK-IUBYCILNSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
62668,6crv,DB13918,-7.8,Diclofop-methyl,BACHBFVBHLGWSL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
94071,6m71,DB07688,-7.8,"4-{[5-(CYCLOHEXYLOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE",RPJIMTALCNCQLV-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
85990,6m3m,DB08306,-7.8,3-[(3-Nitrophenyl)sulfamoyl]-2-thiophenecarboxylic acid,CITCNTPVKZFUAJ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
62666,6crv,DB13916,-7.8,Toyocamycin,XOKJUSAYZUAMGJ-WOUKDFQISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
149792,6wiq,DB00590,-7.8,Doxazosin,RUZYUOTYCVRMRZ-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
103162,6vxs,DB08240,-7.8,N-(4-CHLOROPHENYL)-3-(PHOSPHONOOXY)NAPHTHALENE-2-CARBOXAMIDE,RQAQWBFHPMSXKR-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
36771,1r42,DB03363,-7.8,3-Acetylpyridine Adenine Dinucleotide,KPVQNXLUPNWQHM-RBEMOOQDSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
103155,6vxs,DB08233,-7.8,6-CYCLOHEXYLMETHYLOXY-2-(4'-HYDROXYANILINO)PURINE,RFSDQDHHBKYQOD-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
143819,6w9q,DB04044,-7.8,4-{2-[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid,NAQUAVBNIYTIIS-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
94106,6m71,DB07729,-7.8,3-fluoro-N-[3-(1H-tetrazol-5-yl)phenyl]benzamide,GAKOBKPDJJGRIL-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
99569,6vxs,DB02421,-7.8,Uridine-5'-Diphosphate-Mannose,HSCJRCZFDFQWRP-NYYOCOOHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
99572,6vxs,DB02424,-7.8,Geldanamycin,QTQAWLPCGQOSGP-KSRBKZBZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
94118,6m71,DB07743,-7.8,"S-[5-(TRIFLUOROMETHYL)-4H-1,2,4-TRIAZOL-3-YL] 5-(PHENYLETHYNYL)FURAN-2-CARBOTHIOATE",VNGWUVBXUIDQTK-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
143886,6w9q,DB04131,-7.8,"10-(4-Dimethylamino-5-Hydroxy-6-Methyl-Tetrahydro-Pyran-2-Yloxy)-8-Ethyl-1,8,11-Trihydroxy-7,8,9,10-Tetrahydro-Naphthacene-5,12-Dione",BLGDWFJQIHBUJY-NWJGULHDSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
23872,6cs2,DB01514,-7.8,Furazabol,RGLLOUBXMOGLDQ-IVEVATEUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
132903,6w9c,DB00982,-7.8,Isotretinoin,SHGAZHPCJJPHSC-XFYACQKRSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
132998,6w9c,DB01091,-7.8,Butenafine,ABJKWBDEJIDSJZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
143796,6w9q,DB04010,-7.8,2-(3'-Methoxyphenyl) Benzimidazole-4-Carboxamide,NVVWVYYHTKCIAE-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
132899,6w9c,DB00978,-7.8,Lomefloxacin,ZEKZLJVOYLTDKK-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
94018,6m71,DB07624,-7.8,"1-{[(3R)-3-methyl-4-({4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]phenyl}sulfonyl)piperazin-1-yl]methyl}cyclopropanecarboxamide",YJFULAYRAKPBCY-DYVFJYSZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
66225,6lxt,DB03895,-7.8,Malachite Green,VFCNQNZNPKRXIT-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
94043,6m71,DB07651,-7.8,N-ACETYL-L-PHENYLALANYL-4-[DIFLUORO(PHOSPHONO)METHYL]-L-PHENYLALANINAMIDE,KPMMESISHWWXNM-ROUUACIJSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94046,6m71,DB07654,-7.8,"(5,6-DIPHENYL-FURO[2,3-D]PYRIMIDIN-4-YLAMINO)-ACETIC",VDJWWYRYKMXMKA-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60044,6crv,DB08163,-7.8,5'-{[4-(aminooxy)butyl](methyl)amino}-5'-deoxy-8-ethenyladenosine,XUKYGMIDWKBMIW-IWCJZZDYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
89666,6m71,DB00755,-7.8,Tretinoin,SHGAZHPCJJPHSC-YCNIQYBTSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
132839,6w9c,DB00908,-7.8,Quinidine,LOUPRKONTZGTKE-LHHVKLHASA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
94050,6m71,DB07663,-7.8,"2-[(1R)-1-CARBOXY-2-(4-HYDROXYPHENYL)ETHYL]-1,3-DIOXOISOINDOLINE-5-CARBOXYLIC ACID",QISJEFYTLZTWIQ-CQSZACIVSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
99493,6vxs,DB02331,-7.8,"(2s)-2-[(5-Benzofuran-2-Yl-Thiophen-2-Ylmethyl)-(2,4-Dichloro-Benzoyl)-Amino]-3-Phenyl-Propionic Acid",YBULOUKTPCHXAL-DEOSSOPVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
24179,6cs2,DB01860,-7.8,Cordycepin Triphosphate,NLIHPCYXRYQPSD-BAJZRUMYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
13153,6lzg,DB14787,-7.8,BMS-830216,YDTUJCNTIMWHPJ-NRFANRHFSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
63114,6crv,DB15161,-7.8,Pittsburgh Compound B,ZQAQXZBSGZUUNL-BJUDXGSMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
103211,6vxs,DB08305,-7.8,"(3R)-3-cyclopentyl-6-methyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2-benzothiazine 1,1-dioxide",KQAGZLQCEURCKJ-QGZVFWFLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
143667,6w9q,DB03837,-7.8,Morpholine-4-Carboxylic Acid (1-(3-Benzenesulfonyl-1-Phenethylallylcarbamoyl)-3-Methylbutyl)-Amide,YUMYYTORLYHUFW-ZUDLOMHPSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
13148,6lzg,DB14774,-7.8,Balipodect,KVHRYLNQDWXAGI-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
94061,6m71,DB07676,-7.8,"3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)-1H,2'H-2,3'-biindol-2'-one",CKLAPOFDFZKCPB-LBPRGKRZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93354,6m71,DB06849,-7.8,"1-[1'-(3-phenylacryloyl)spiro[1-benzofuran-3,4'-piperidin]-5-yl]methanamine",RQWYWHUKHYFIPB-VQHVLOKHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
143739,6w9q,DB03932,-7.8,LFA703,WPVRNXUYVXQXPY-YFAYRSKXSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
90075,6m71,DB01224,-7.8,Quetiapine,URKOMYMAXPYINW-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
103200,6vxs,DB08293,-7.8,"(5E)-12-CHLORO-13,15-DIHYDROXY-4,7,8,9-TETRAHYDRO-2-BENZOXACYCLOTRIDECINE-1,10(3H,11H)-DIONE",AQKZYZQONWDDLS-HNQUOIGGSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
99879,6vxs,DB02833,-7.8,[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(3-Nitro-Phenyl)-Amine,DYTKVFHLKPDNRW-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
94128,6m71,DB07755,-7.8,"(2S)-1-[4-({4-[(2,5-Dichlorophenyl)amino]-2-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol",GNLAGGCSJGJECE-INIZCTEOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
103141,6vxs,DB08213,-7.8,"1-METHYL-5-(2-PHENOXYMETHYL-PYRROLIDINE-1-SULFONYL)-1H-INDOLE-2,3-DIONE",PFAYCUAUBOGVDX-AWEZNQCLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
159260,7bv1,DB03656,-7.8,Tribenuron Methyl,VLCQZHSMCYCDJL-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94153,6m71,DB07783,-7.8,1-((1R)-1-(HYDROXYMETHYL)-3-{6-[(3-PHENYLPROPANOYL)AMINO]-1H-INDOL-1-YL}PROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE,GUYYFMCFEPDDFL-OAQYLSRUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60173,6crv,DB08325,-7.8,2-(2-HYDROXYETHYLAMINO)-6-(3-CHLOROANILINO)-9-ISOPROPYLPURINE,XZEFMZCNXDQXOZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
68998,6lxt,DB08582,-7.8,"N-(4-bromo-2-{[(3R,5S)-3,5-dimethylpiperidin-1-yl]carbonyl}phenyl)-4-morpholin-4-yl-4-oxobutanamide",DELARNBPJXTDBD-IYBDPMFKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
16671,6cs2,HMDB0003409,-7.8,Berberine,YBHILYKTIRIUTE-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
94184,6m71,DB07816,-7.8,N-(P-CYANOPHENYL)-N'-DIPHENYLMETHYL-GUANIDINE-ACETIC ACID,KGHMYJFHUHFOGL-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60188,6crv,DB08348,-7.8,"N-2-,N-2-DIMETHYL-N-1-(6-OXO-5,6-DIHYDROPHENANTHRIDIN-2-YL)GLYCINAMIDE",UYJZZVDLGDDTCL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62606,6crv,DB13801,-7.8,Muzolimine,RLWRMIYXDPXIEX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
144189,6w9q,DB04540,-7.8,Cholesterol,HVYWMOMLDIMFJA-DPAQBDIFSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
36524,1r42,DB03044,-7.8,1-(5-Tert-Butyl-2-P-Tolyl-2h-Pyrazol-3-Yl)-3-[4-(2-Morpholin-4-Yl-Ethoxy)-Naphthalen-1-Yl]-Urea,MVCOAUNKQVWQHZ-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
99682,6vxs,DB02567,-7.8,PD173955,VAARYSWULJUGST-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
69009,6lxt,DB08597,-7.8,"6-[4-(2-piperidin-1-ylethoxy)phenyl]-3-pyridin-4-ylpyrazolo[1,5-a]pyrimidine",XHBVYDAKJHETMP-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
60209,6crv,DB08371,-7.8,PARA-(BENZOYL)-PHENYLALANINE,TVIDEEHSOPHZBR-AWEZNQCLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
133199,6w9c,DB01393,-7.8,Bezafibrate,IIBYAHWJQTYFKB-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
133200,6w9c,DB01394,-7.8,Colchicine,IAKHMKGGTNLKSZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
133212,6w9c,DB01413,-7.8,Cefepime,HVFLCNVBZFFHBT-ZKDACBOMSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
66753,6lxt,DB04601,-7.8,"4-[(4-O-SULFAMOYLBENZYL)(4-CYANOPHENYL)AMINO]-4H-[1,2,4]-TRIAZOLE",WEXGHQDVDVWOIU-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
36519,1r42,DB03038,-7.8,LY341770,MXAFDBCLWLMXSI-ZDUSSCGKSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
60216,6crv,DB08383,-7.8,"4,5-bis(4-methoxyphenyl)-2-thiophen-2-yl-1H-imidazole",XBMULXNXJLWLLD-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
89623,6m71,DB00704,-7.8,Naltrexone,DQCKKXVULJGBQN-XFWGSAIBSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93308,6m71,DB06771,-7.8,Besifloxacin,QFFGVLORLPOAEC-SNVBAGLBSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
133111,6w9c,DB01217,-7.8,Anastrozole,YBBLVLTVTVSKRW-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
14276,6lzg,T3D3912,-7.8,Prosulfuron,LTUNNEGNEKBSEH-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
94129,6m71,DB07756,-7.8,"1-[3-({[(4-AMINO-5-FLUORO-2-METHYLQUINOLIN-3-YL)METHYL]THIO}METHYL)PHENYL]-2,2,2-TRIFLUOROETHANE-1,1-DIOL",GPBGHVRNVGXPNM-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
133027,6w9c,DB01125,-7.8,Anisindione,XRCFXMGQEVUZFC-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
86012,6m3m,DB08330,-7.8,METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE,VEJCBCPEURAYAS-MEAXDALNSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
143933,6w9q,DB04190,-7.8,Inhibitor Bea425,AHAVBKNGKPWROK-UMFPTGFGSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
93293,6m71,DB06741,-7.8,Gavestinel,WZBNEZWCNKUOSM-VOTSOKGWSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
149831,6wiq,DB00637,-7.8,Astemizole,GXDALQBWZGODGZ-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
94134,6m71,DB07761,-7.8,"(2R)-1-[4-({6-[(2,6-Difluorophenyl)amino]-4-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol",ZVSBKYYVBCKDBO-OAHLLOKOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
103129,6vxs,DB08197,-7.8,"(5E,7S)-2-amino-7-(4-fluoro-2-pyridin-3-ylphenyl)-4-methyl-7,8-dihydroquinazolin-5(6H)-one oxime",KYIXUSLGFINPTC-WVFAEZDRSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
133049,6w9c,DB01149,-7.8,Nefazodone,VRBKIVRKKCLPHA-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
159304,7bv1,DB03962,-7.8,Nicotinamide 8-Bromo-Adenine Dinucleotide Phosphate,MDKMTCCUJSRQGW-NAJQWHGHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
86044,6m3m,DB08371,-7.8,PARA-(BENZOYL)-PHENYLALANINE,TVIDEEHSOPHZBR-AWEZNQCLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
133056,6w9c,DB01157,-7.8,Trimetrexate,NOYPYLRCIDNJJB-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
133071,6w9c,DB01175,-7.8,Escitalopram,WSEQXVZVJXJVFP-FQEVSTJZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
94142,6m71,DB07770,-7.8,5-(4-FLUOROPHENYL)-3-{[(4-METHYLPHENYL)SULFONYL]AMINO}THIOPHENE-2-CARBOXYLIC ACID,DJPFUQBNQLKCAB-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
86051,6m3m,DB08383,-7.8,"4,5-bis(4-methoxyphenyl)-2-thiophen-2-yl-1H-imidazole",XBMULXNXJLWLLD-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
68668,6lxt,DB08174,-7.8,"5-CHLORO-N-((1R,2S)-2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO) CYCLOPENTYL)THIOPHENE-2-CARBOXAMIDE",QCPYHSAHOYXXQK-DLBZAZTESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
103110,6vxs,DB08172,-7.8,(2Z)-N-(3-chloro-2'-methoxybiphenyl-4-yl)-2-cyano-3-hydroxybut-2-enamide,YUDQXOMZBLEWBH-KAMYIIQDSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
25671,6cs2,DB03666,-7.8,3'-Azido-3'-Deoxythymidine-5'-Monophosphate,OIFWQOKDSPDILA-XLPZGREQSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
98748,6vxs,DB01342,-7.8,Forasartan,YONOBYIBNBCDSJ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
62640,6crv,DB13845,-7.8,Etafenone,OEGDFSLNGABBKJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
92864,6m71,DB05116,-7.8,Thymectacin,CFBLUORPOFELCE-BACVZHSASA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
90543,6m71,DB01873,-7.8,Epothilone D,XOZIUKBZLSUILX-GIQCAXHBSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
86585,6m3m,DB09068,-7.8,Vortioxetine,YQNWZWMKLDQSAC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
139196,6w9c,DB13004,-7.8,Mavoglurant,ZFPZEYHRWGMJCV-ZHALLVOQSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
40378,6lu7,DB12941,-7.8,ODM-201,BLIJXOOIHRSQRB-PXYINDEMSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
88514,6m3m,DB13938,-7.8,S-40503,YNYAUBNZRZVNLX-KBPBESRZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
12819,6lzg,DB01058,-7.8,Praziquantel,FSVJFNAIGNNGKK-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
139189,6w9c,DB12989,-7.8,Neosaxitoxin,PPEKGEBBBBNZKS-HGRQIUPRSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
88505,6m3m,DB13920,-7.8,Valopicitabine,TVRCRTJYMVTEFS-ICGCPXGVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87632,6m3m,DB12606,-7.8,Netivudine,QLOCVMVCRJOTTM-SDNRWEOFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
64838,6lxt,DB02049,-7.8,2-{4-[4-(4-Chloro-Phenoxy)-Benzenesulfonyl]-Tetrahydro-Pyran-4-Yl}-N-Hydroxy-Acetamide,QOPFTBAEAJQKSY-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
24958,6cs2,DB02790,-7.8,Phenyl-Uridine-5'-Diphosphate,ZHUWBKDWWGKIEN-FMKGYKFTSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
137385,6w9c,DB08229,-7.8,[N-(3-DIBENZYLCARBAMOYL-OXIRANECARBONYL)-HYDRAZINO]-ACETIC ACID,JGMMFVVACJREFE-KRWDZBQOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137391,6w9c,DB08236,-7.8,"(2S)-2-(3-bromophenyl)-3-(5-chloro-2-hydroxyphenyl)-1,3-thiazolidin-4-one",KEGQNJITMFBVAC-HNNXBMFYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
13510,6lzg,DB01149,-7.8,Nefazodone,VRBKIVRKKCLPHA-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
88480,6m3m,DB13851,-7.8,Artemotil,NLYNIRQVMRLPIQ-XQLAAWPRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
137399,6w9c,DB08245,-7.8,1-(2-DEOXY-5-O-PHOSPHONO-BETA-D-ERYTHRO-PENTOFURANOSYL)-5-NITRO-1H-INDOLE,FQCJFJRLZCIFHB-YNEHKIRRSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137417,6w9c,DB08270,-7.8,"N-(2-AMINOETHYL)-N-2-{(1S)-1-[4'-(AMINOSULFONYL)BIPHENYL-4-YL]-2,2,2-TRIFLUOROETHYL}-L-LEUCINAMIDE",QPXXBNKMAHUXBB-PMACEKPBSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137426,6w9c,DB08285,-7.8,"(2R)-2-{[4-(benzylamino)-8-(1-methylethyl)pyrazolo[1,5-a][1,3,5]triazin-2-yl]amino}butan-1-ol",SQUNOCMDMIQIQK-OAHLLOKOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
96367,6m71,DB12805,-7.8,Ataciguat,PQHLRGARXNPFCF-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
100971,6vxs,DB04295,-7.8,N-Benzoyl-N'-Beta-D-Glucopyranosyl Urea,JSBCZGSPFATCOV-BZNQNGANSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
24931,6cs2,DB00353,-7.8,Methylergometrine,UNBRKDKAWYKMIV-QWQRMKEZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
96318,6m71,DB12724,-7.8,AZD-7295,MAQDQJWCSSCURR-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
145808,6w9q,DB07787,-7.8,"5-FLUORO-1-[4-(4-PHENYL-3,6-DIHYDROPYRIDIN-1(2H)-YL)BUTYL]QUINAZOLINE-2,4(1H,3H)-DIONE",PNPFDRCIGCUCMN-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
137320,6w9c,DB08149,-7.8,"1-[4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine",KCWPSUKJCKZEAO-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137317,6w9c,DB08146,-7.8,"7-(2,5-dihydropyrrol-1-yl)-6-phenyl-pyrido[6,5-d]pyrimidin-2-amine",QFWNOFXQNCLFBC-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
70048,6lxt,DB12082,-7.8,Vesnarinone,ZVNYJIZDIRKMBF-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
64929,6lxt,DB02170,-7.8,"1,8-Di-Hydroxy-4-Nitro-Xanthen-9-One",ZOHCDJRFYXKEQW-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
96215,6m71,DB12563,-7.8,MK-0686,WZZIQHIQMWJNLU-LLVKDONJSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
139234,6w9c,DB13182,-7.8,Daidzein,ZQSIJRDFPHDXIC-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139228,6w9c,DB13169,-7.8,Nandrolone,NPAGDVCDWIYMMC-IZPLOLCNSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139225,6w9c,DB13165,-7.8,Ripasudil,QSKQVZWVLOIIEV-NSHDSACASA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
96217,6m71,DB12566,-7.8,Decernotinib,ASUGUQWIHMTFJL-QGZVFWFLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96222,6m71,DB12573,-7.8,LY-2452473,IHIWYQYVBNODSV-KRWDZBQOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
69503,6lxt,DB09285,-7.8,Morniflumate,LDXSPUSKBDTEKA-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
137440,6w9c,DB08301,-7.8,N-({[4-(AMINOSULFONYL)PHENYL]AMINO}CARBONYL)-4-METHYLBENZENESULFONAMIDE,HDCXQTPVTAIPNZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
40416,6lu7,DB15328,-7.8,Ubrogepant,DDOOFTLHJSMHLN-ZQHRPCGSSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
91936,6m71,DB03742,-7.8,Compound 4-D,TWZNCTCQAGRUGQ-RRPNLBNLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96265,6m71,DB12645,-7.8,Givinostat,YALNUENQHAQXEA-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
70038,6lxt,DB12068,-7.8,T-900607,FSXLOWIFSZNIMV-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
87615,6m3m,DB12577,-7.8,Fosbretabulin,WDOGQTQEKVLZIJ-WAYWQWQTSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
137294,6w9c,DB08121,-7.8,(2S)-2-(biphenyl-4-yloxy)-3-phenylpropanoic acid,TZTPJJNNACUQQR-FQEVSTJZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
40415,6lu7,DB15391,-7.8,Elenbecestat,AACUJFVOHGRMTR-DPXNYUHVSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
36116,1r42,DB02498,-7.8,Carba-Nicotinamide-Adenine-Dinucleotide,DGPLSUKWXXSBCU-VGXGLJSLSA-O,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
139210,6w9c,DB13125,-7.8,Lusutrombopag,NOZIJMHMKORZBA-KJCUYJGMSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
88535,6m3m,DB13967,-7.8,Patent Blue,DHAHKSQXIXFZJB-UHFFFAOYSA-O,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
67614,6lxt,DB06959,-7.8,(2S)-1-(3H-Indol-3-yl)-3-{[5-(6-isoquinolinyl)-3-pyridinyl]oxy}-2-propanamine,BUCZDJYEOAQTHL-KEKNWZKVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
96377,6m71,DB12823,-7.8,Tecarfarin,QFLNTQDOVCLQKW-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
61421,6crv,DB12061,-7.8,Pardoprunox,YVPUUUDAZYFFQT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
96397,6m71,DB12857,-7.8,NVP-LEQ-506,POERAARDVFVDLO-QGZVFWFLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
69970,6lxt,DB11964,-7.8,Ilaprazole,HRRXCXABAPSOCP-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
96500,6m71,DB13016,-7.8,LY-2300559,DWQVYDLTPMGYNE-DEOSSOPVSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
101006,6vxs,DB04345,-7.8,Lumichrome,ZJTJUVIJVLLGSP-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
96505,6m71,DB13022,-7.8,LY-2874455,GKJCVYLDJWTWQU-CXLRFSCWSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
101616,6vxs,DB05959,-7.8,ENMD-1198,YQJWOUQGXATDAE-ACNBBOPNSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
137591,6w9c,DB08486,-7.8,Efaproxiral,BNFRJXLZYUTIII-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137593,6w9c,DB08488,-7.8,"4-{[(E)-2-(5-CHLOROTHIEN-2-YL)VINYL]SULFONYL}-1-(1H-PYRROLO[3,2-C]PYRIDIN-2-YLMETHYL)PIPERAZIN-2-ONE",PLWVUIRWJVKSSD-XBXARRHUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
87729,6m3m,DB12758,-7.8,Atreleuton,MMSNEKOTSJRTRI-LLVKDONJSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
67688,6lxt,DB07045,-7.8,"(2R,3R,4S,5R)-2-[6-amino-8-[(3,4-dichlorophenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol",VBJKVZXRYLCYGQ-XNIJJKJLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
87701,6m3m,DB12715,-7.8,MSX-122,PXZXYRKDDXKDTK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
15369,6lzg,T3D0932,-7.8,"Biscarbofuran N,N'-disulfide",RNNGCAGZVZIHNF-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
40337,6lu7,DB11851,-7.8,Bafetinib,ZGBAJMQHJDFTQJ-DEOSSOPVSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
67697,6lxt,DB07054,-7.8,(2R)-1-(DIMETHYLAMINO)-3-{4-[(6-{[2-FLUORO-5-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-4-YL)AMINO]PHENOXY}PROPAN-2-OL,OSCWQKTUILTARV-MRXNPFEDSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
67699,6lxt,DB07056,-7.8,"2-(6-{[(3-chloro-2-methylphenyl)sulfonyl]amino}pyridin-2-yl)-N,N-diethylacetamide",JNWQLOFSMUGRNY-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
139103,6w9c,DB12863,-7.8,Sivelestat,BTGNGJJLZOIYID-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
40335,6lu7,DB02616,-7.8,FR117016,CKJGKHXCUDWFDC-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
137660,6w9c,DB08564,-7.8,(2E)-N-{4-[(3-bromophenyl)amino]quinazolin-6-yl}-4-(dimethylamino)but-2-enamide,ZCIXBBSRVLSRJQ-QPJJXVBHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
40334,6lu7,DB05454,-7.8,Paliroden,CNEWKIDCGDXBDE-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
96556,6m71,DB13097,-7.8,1alpha-Hydroxyvitamin D5,NWFOBODUYTUMNC-VPSCEVSQSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
137673,6w9c,DB08580,-7.8,4-bromo-2-{[(2R)-2-(2-chlorobenzyl)pyrrolidin-1-yl]carbonyl}aniline,JEGGWFHNKPRKTO-CQSZACIVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
64720,6lxt,DB01883,-7.8,N-(Sulfanylacetyl)Tyrosylprolylmethioninamide,LNLWXWOYQHAKTD-ULQDDVLXSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
64933,6lxt,DB02177,-7.8,1-Acetyl-4-(4-{4-[(2-Ethoxyphenyl)Thio]-3-Nitrophenyl}Pyridin-2-Yl)Piperazine,GKGJFUXSTSUKPB-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
101638,6vxs,DB06133,-7.8,Dimethylcurcumin,ZMGUKFHHNQMKJI-CIOHCNBKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
156667,6wiq,DB13528,-7.8,Chlormadinone,VUHJZBBCZGVNDZ-TTYLFXKOSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
87665,6m3m,DB12662,-7.8,Naveglitazar,OKJHGOPITGTTIM-DEOSSOPVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
67653,6lxt,DB07005,-7.8,D-phenylalanyl-N-{4-[amino(iminio)methyl]benzyl}-L-prolinamide,VZFTWWJAUZOJDH-MOPGFXCFSA-O,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
137453,6w9c,DB08315,-7.8,"2-AMINO-N,N-BIS(PHENYLMETHYL)-1,3-OXAZOLE-5-CARBOXAMIDE",KIJXWOGFYAWTNC-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
96401,6m71,DB12867,-7.8,Benperidol,FEBOTPHFXYHVPL-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
64810,6lxt,DB02014,-7.8,"5-(2-Fluoro-5-{(1E)-3-[3-hydroxy-2-(methoxycarbonyl)phenoxy]-1-propen-1-yl}phenyl)-1,2-oxazole-3-carboxylic acid",QKHWJUMLYAYZFS-ONEGZZNKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
139153,6w9c,DB12935,-7.8,Remogliflozin etabonate,UAOCLDQAQNNEAX-ABMICEGHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
157440,6wiq,DB06494,-7.8,Sufugolix,UCQSBGOFELXYIN-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
40356,6lu7,DB13050,-7.8,Tirilazad,RBKASMJPSJDQKY-RBFSKHHSSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
61892,6crv,DB12752,-7.8,Bucindolol,FBMYKMYQHCBIGU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
137538,6w9c,DB08422,-7.8,[PHENYLALANINYL-PROLINYL]-[2-(PYRIDIN-4-YLAMINO)-ETHYL]-AMINE,GEIDRYBJURDUSW-MOPGFXCFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
69988,6lxt,DB11994,-7.8,Diacerein,TYNLGDBUJLVSMA-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
96419,6m71,DB12890,-7.8,Dihydrexidine,BGOQGUHWXBGXJW-YOEHRIQHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96433,6m71,DB12910,-7.8,Emicerfont,JFHJGXQFESYQGY-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
64785,6lxt,DB01977,-7.8,6-(N-Phenylcarbamyl)-2-Naphthalenecarboxamidine,AECPTICWHONWNW-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
67671,6lxt,DB07027,-7.8,D-phenylalanyl-N-(3-fluorobenzyl)-L-prolinamide,JGZSVYZIJHGHMA-MOPGFXCFSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
137508,6w9c,DB08385,-7.8,4-(quinolin-3-ylmethyl)piperidine-1-carboxylic acid,QUAGUFNCKDDJFZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137513,6w9c,DB08390,-7.8,"(6S)-6-CYCLOPENTYL-6-[2-(3-FLUORO-4-ISOPROPOXYPHENYL)ETHYL]-4-HYDROXY-5,6-DIHYDRO-2H-PYRAN-2-ONE",AKNIHFDXRAOPAI-NRFANRHFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137519,6w9c,DB08397,-7.8,6-(DIFLUORO-PHOSPHONO-METHYL)-NAPHTHALENE-2-CARBOXYLIC ACID,NKGNOWNPXBURRW-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139138,6w9c,DB12912,-7.8,Nolatrexed,XHWRWCSCBDLOLM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
64772,6lxt,DB01960,-7.8,7n-Methyl-8-Hydroguanosine-5'-Diphosphate,QQODJOAVWUWVHJ-KQYNXXCUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
154066,6wiq,DB07435,-7.8,"1,2,3-TRIHYDROXY-1,2,3,4-TETRAHYDROBENZO[A]PYRENE",GFANZDFKCCJYRF-NSISKUIASA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
64940,6lxt,DB02187,-7.8,Equilin,WKRLQDKEXYKHJB-HFTRVMKXSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
137214,6w9c,DB08029,-7.8,N-2-(biphenyl-4-ylsulfonyl)-N-hydroxy-N-2-(2-hydroxyethyl)glycinamide,QQDWEVONJRXVDB-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
40417,6lu7,DB15310,-7.8,Vactosertib,FJCDSQATIJKQKA-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
15918,6lzg,DB01893,-7.8,N6-Benzyl Adenosine-5'-Diphosphate,MRHGMAGSDAQUFH-LSCFUAHRSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
145971,6w9q,DB07974,-7.8,1-{2-[(4-CHLOROPHENYL)AMINO]-2-OXOETHYL}-N-(1-ISOPROPYLPIPERIDIN-4-YL)-1H-INDOLE-2-CARBOXAMIDE,BDLMBQRBNPDCSS-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
87409,6m3m,DB12283,-7.8,Balapiravir,VKXWOLCNTHXCLF-DXEZIKHYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
96030,6m71,DB12295,-7.8,Evodenoson,SQJXTUJMBYVDBB-RQXXJAGISA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
100833,6vxs,DB04115,-7.8,Berberine,YBHILYKTIRIUTE-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
87423,6m3m,DB12300,-7.8,P-nitrobiphenyl,BAJQRLZAPXASRD-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
101895,6vxs,DB06730,-7.8,Gestodene,SIGSPDASOTUPFS-XUDSTZEESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
96041,6m71,DB12308,-7.8,Eltanolone,AURFZBICLPNKBZ-YZRLXODZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
156432,6wiq,DB13089,-7.8,Enoxolone,MPDGHEJMBKOTSU-YKLVYJNSSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
145973,6w9q,DB07976,-7.8,3-{[(3-FLUORO-3'-METHOXYBIPHENYL-4-YL)AMINO]CARBONYL}THIOPHENE-2-CARBOXYLIC ACID,GIUMGVUBDBDTDX-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
61232,6crv,DB11785,-7.8,Anisodamine,WTQYWNWRJNXDEG-RBZJEDDUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
25079,6cs2,DB02929,-7.8,K201,KCWGETCFOVJEPI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
145949,6w9q,DB07949,-7.8,"({[(3E)-2'-OXO-2',7'-DIHYDRO-2,3'-BIINDOL-3(7H)-YLIDENE]AMINO}OXY)ACETIC ACID",BFQRPTKOSYMPOL-LALPNIDTSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
139387,6w9c,DB13399,-7.8,Terguride,JOAHPSVPXZTVEP-YXJHDRRASA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
153217,6wiq,DB05616,-7.8,"4'-Methylene-5,8,10-trideazaaminopterin",NAWXUBYGYWOOIX-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
15884,6lzg,DB01732,-7.8,"(4r,5s,6s,7r)-1,3-Dibenzyl-4,7-Bis(Phenoxymethyl)-5,6-Dihydroxy-1,3 Diazepan-2-One",SQBOSZXDOHQFAA-ZRTHHSRSSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
70130,6lxt,DB12206,-7.8,N-6022,YVPGZQLRPAGKLA-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
100851,6vxs,DB04140,-7.8,1-Benzyl-3-(4-Methoxy-Benzenesulfonyl)-6-Oxo-Hexahydro-Pyrimidine-4-Carboxylic Acid Hydroxyamide,SUSMVCKSLVPRCL-QGZVFWFLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
70128,6lxt,DB12203,-7.8,Tozadenant,XNBRWUQWSKXMPW-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
90875,6m71,DB02322,-7.8,Heparin Disaccharide I-S,LRPGJWKAYQRIAQ-GYBHJADLSA-J,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
136937,6w9c,DB07713,-7.8,"(1S)-1-{[(4'-methoxy-1,1'-biphenyl-4-yl)sulfonyl]amino}-2-methylpropylphosphonic acid",BZVYQWLRCHLAGK-KRWDZBQOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
88704,6m3m,DB14639,-7.8,Boldenone undecylenate,AHMMSNQYOPMLSX-CNQKSJKFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
15232,6lzg,T3D0621,-7.8,Benzo[ghi]perylene,GYFAGKUZYNFMBN-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
96027,6m71,DB12290,-7.8,Puerarin,HKEAFJYKMMKDOR-VPRICQMDSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
15950,6lzg,DB02049,-7.8,2-{4-[4-(4-Chloro-Phenoxy)-Benzenesulfonyl]-Tetrahydro-Pyran-4-Yl}-N-Hydroxy-Acetamide,QOPFTBAEAJQKSY-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
92165,6m71,DB04040,-7.8,"N-(2-Morpholin-4-Yl-1-Morpholin-4-Ylmethyl-Ethyl)-3-Nitro-5-(3,4,5-Trihydroxy-6-Hydroxymethyl-Tetrahydro-Pyran-2-Yloxy)-Benzamide",MCMWCTMAKPQTPI-WGNYYXNJSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
67508,6lxt,DB06831,-7.8,2-((9H-PURIN-6-YLTHIO)METHYL)-5-CHLORO-3-(2-METHOXYPHENYL)QUINAZOLIN-4(3H)-ONE,UMMYTDJYDSTEMB-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
67510,6lxt,DB06834,-7.8,"N-(2-hydroxy-1,1-dimethylethyl)-1-methyl-3-(1H-pyrrolo[2,3-b]pyridin-2-yl)-1H-indole-5-carboxamide",XZRYCTLOGNCQDG-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
70180,6lxt,DB12273,-7.8,Ecopipam,DMJWENQHWZZWDF-PKOBYXMFSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
156407,6wiq,DB13053,-7.8,CP-195543,NZQDWKCNBOELAI-KSFYIVLOSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
146026,6w9q,DB08034,-7.8,"(E)-3,4-DIHYDROXY-N'-[(2-METHOXYNAPHTHALEN-1-YL)METHYLENE]BENZOHYDRAZIDE",TVOPERZEGKBKAY-RGVLZGJSSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
136790,6w9c,DB07535,-7.8,2-amino-6-[2-(1H-indol-6-yl)ethyl]pyrimidin-4(3H)-one,VRAZIAJSKFRSIP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
157732,6wiq,DB12729,-7.8,ASP-3026,MGGBYMDAPCCKCT-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
136894,6w9c,DB07662,-7.8,N-[4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL]-ACRYLAMIDE,HTUBKQUPEREOGA-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
97672,6m71,DB15391,-7.8,Elenbecestat,AACUJFVOHGRMTR-DPXNYUHVSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95986,6m71,DB12236,-7.8,Bexagliflozin,BTCRKOKVYTVOLU-SJSRKZJXSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
100797,6vxs,DB04070,-7.8,6-Deoxyerythronolide B,HQZOLNNEQAKEHT-IBBGRPSASA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
70167,6lxt,DB12254,-7.8,ABT-751,URCVCIZFVQDVPM-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
88749,6m3m,DB14714,-7.8,Tenivastatin,XWLXKKNPFMNSFA-HGQWONQESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
96010,6m71,DB12270,-7.8,Losmapimod,KKYABQBFGDZVNQ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
64020,6lxt,DB00972,-7.8,Azelastine,MBUVEWMHONZEQD-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
61222,6crv,DB11770,-7.8,Talinolol,MXFWWQICDIZSOA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
64021,6lxt,DB00973,-7.8,Ezetimibe,OLNTVTPDXPETLC-XPWALMASSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
88726,6m3m,DB14663,-7.8,Ribavirin monophosphate,SDWIOXKHTFOULX-AFCXAGJDSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
95970,6m71,DB12218,-7.8,AZD-5363,JDUBGYFRJFOXQC-KRWDZBQOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96579,6m71,DB13132,-7.8,Artemisinin,BLUAFEHZUWYNDE-NNWCWBAJSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
156436,6wiq,DB13095,-7.8,JTK-853,JQLOVYLALGSISI-HXUWFJFHSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
101871,6vxs,DB06697,-7.8,Artemether,SXYIRMFQILZOAM-HVNFFKDJSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
88586,6m3m,DB14071,-7.8,Desmethylsertraline,SRPXSILJHWNFMK-ZBEGNZNMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
68140,6lxt,DB07568,-7.8,"(2S)-2-[(2,1,3-BENZOTHIADIAZOL-4-YLSULFONYL)AMINO]-2-PHENYL-N-PYRIDIN-4-YLACETAMIDE",ADRNPUSZBRQDBG-KRWDZBQOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
137153,6w9c,DB07963,-7.8,"N-[(2',4'-DIFLUORO-4-HYDROXY-5-IODOBIPHENYL-3-YL)CARBONYL]-BETA-ALANINE",YZQVXOZCPWWABX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
15842,6lzg,DB01514,-7.8,Furazabol,RGLLOUBXMOGLDQ-IVEVATEUSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
90981,6m71,DB02452,-7.8,Thymidine-5'-Triphosphate,NHVNXKFIZYSCEB-XLPZGREQSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
137169,6w9c,DB07981,-7.8,2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]-n-[(1R)-1-(hydroxymethyl)propyl]acetamide,GKJWXEORYGBJFS-QGZVFWFLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
40420,6lu7,DB14676,-7.8,Fagrocorat,QJJBNCHSWFGXML-KEKPKEOLSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
137183,6w9c,DB07995,-7.8,N-[2-(4-BROMOCINNAMYLAMINO)ETHYL]-5-ISOQUINOLINE SULFONAMIDE,ZKZXNDJNWUTGDK-NSCUHMNNSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
100921,6vxs,DB04226,-7.8,Dihydro-Acarbose,CUAQESWNTOXZJZ-RTNAABQMSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
139292,6w9c,DB13277,-7.8,Benziodarone,CZCHIEJNWPNBDE-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
87539,6m3m,DB12464,-7.8,Bevenopran,ZGCYVRNZWGUXNQ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
100931,6vxs,DB04240,-7.8,"(1S)-1-C-{(2R)-6-[(2R)-2-Butanyl]-5,10-dihydroxy-4-oxo-1,2,3,4-tetrahydro-2-anthracenyl}-5-deoxy-1-O-methyl-D-xylulose",XGORHSPGULYMCV-HHYQQTLHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
153302,6wiq,DB06155,-7.8,Rimonabant,JZCPYUJPEARBJL-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
87548,6m3m,DB12475,-7.8,Biphenyl dimethyl dicarboxylate,BKRIRZXWWALTPU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
24992,6cs2,DB02830,-7.8,FR236913,KCCUBLLGAMGDJL-HXUWFJFHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
40419,6lu7,DB14850,-7.8,Deleobuvir,BMAIGAHXAJEULY-UKTHLTGXSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
137208,6w9c,DB08022,-7.8,"(2S)-1,3-benzothiazol-2-yl{2-[(2-pyridin-3-ylethyl)amino]pyrimidin-4-yl}ethanenitrile",RCYPVQCPYKNSTG-OAHLLOKOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
96195,6m71,DB12533,-7.8,Cevipabulin,ZUZPCOQWSYNWLU-VIFPVBQESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96200,6m71,DB12540,-7.8,Lecozotan,NRPQELCNMADTOZ-OAQYLSRUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
40418,6lu7,DB14883,-7.8,Lorecivivint,AQDWDWAYVBQMAM-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
70071,6lxt,DB12115,-7.8,AZD-9164,FNYFFCOCVNTJCD-NNMXADRKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
145941,6w9q,DB07940,-7.8,"9-(3-IODOBENZYLAMINO)-1,2,3,4-TETRAHYDROACRIDINE",ZUCWQTWGZGIYPV-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
137115,6w9c,DB07920,-7.8,N-oxo-2-[(4-phenylphenyl)sulfonylamino]ethanamide,OGRPZMQLAVBWPV-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
96151,6m71,DB12465,-7.8,Ketanserin,FPCCSQOGAWCVBH-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
136986,6w9c,DB07769,-7.8,S-3-(4-FLUOROPHENOXY)-2-HYDROXY-2-METHYL-N-[4-NITRO-3-(TRIFLUOROMETHYL)PHENYL]PROPANAMIDE,KJMFOTCDISOHDX-INIZCTEOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139377,6w9c,DB13384,-7.8,Melitracen,GWWLWDURRGNSRS-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
96088,6m71,DB12379,-7.8,Indirubin,CRDNMYFJWFXOCH-BUHFOSPRSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
68841,6lxt,DB08395,-7.8,2-(ETHOXYMETHYL)-4-(4-FLUOROPHENYL)-3-[2-(2-HYDROXYPHENOXY)PYRIMIDIN-4-YL]ISOXAZOL-5(2H)-ONE,ZSOXFJURLPCSOO-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
100855,6vxs,DB04144,-7.8,"Cis-[4,5-Bis-(4-Chlorophenyl)-2-(2-Isopropoxy-4-Methoxyphenyl)-4,5-Dihyd Roimidazol-1-Yl]-Piperazin-1-Yl-Methanone",ZXIPEZDMQNYFOO-WUFINQPMSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
96105,6m71,DB12401,-7.8,Bromperidol,RKLNONIVDFXQRX-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
88665,6m3m,DB14538,-7.8,Hydrocortisone aceponate,MFBMYAOAMQLLPK-FZNHGJLXSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
70115,6lxt,DB12183,-7.8,Sapitinib,DFJSJLGUIXFDJP-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
101834,6vxs,DB06620,-7.8,Aplindore,DYJIKHYBKVODAC-ZDUSSCGKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
61313,6crv,DB11901,-7.8,Apalutamide,HJBWBFZLDZWPHF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
139332,6w9c,DB13329,-7.8,Guaiazulen,FWKQNCXZGNBPFD-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
70107,6lxt,DB12167,-7.8,LY-3023414,ACCFLVVUVBJNGT-AWEZNQCLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
90904,6m71,DB02360,-7.8,Bis-Napthyl Beta-Ketophosphonic Acid,OFHMUASCSJJNNA-JOCHJYFZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
68169,6lxt,DB07607,-7.8,4-[5-(3-IODO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-1H-IMIDAZOL-4-YL]-PYRIDINE,RXDZANYWRNIAOR-HHHXNRCGSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
96136,6m71,DB12441,-7.8,Tavilermide,DVJXNXPFYJIACK-ULQDDVLXSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
137048,6w9c,DB07838,-7.8,(Z)-3-BENZYL-5-(2-HYDROXY-3-NITROBENZYLIDENE)-2-THIOXOTHIAZOLIDIN-4-ONE,ZTWBCEZQPRYIGY-ZROIWOOFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
101826,6vxs,DB06604,-7.8,Ilepatril,FXKFFTMLFPWYFH-RDGPPVDQSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
67581,6lxt,DB06918,-7.8,2-(2-METHYLPHENYL)-1H-INDOLE-6-CARBOXIMIDAMIDE,ZRYXDGAKQGRHFG-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
61299,6crv,DB11880,-7.8,Acridine Carboxamide,XBGNERSKEKDZDS-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
68162,6lxt,DB07595,-7.8,"(5Z)-5-(3-BROMOCYCLOHEXA-2,5-DIEN-1-YLIDENE)-N-(PYRIDIN-4-YLMETHYL)-1,5-DIHYDROPYRAZOLO[1,5-A]PYRIMIDIN-7-AMINE",WSIQKQLAGWVKSL-UHFFFAOYSA-O,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
92066,6m71,DB03903,-7.8,Tmr,KGFLZYXDJDOIEE-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
153129,6wiq,DB05129,-7.8,Elsamitrucin,MGQRRMONVLMKJL-KWJIQSIXSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
87748,6m3m,DB12792,-7.8,Boscalid,WYEMLYFITZORAB-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
40333,6lu7,DB05586,-7.8,Facinicline,TXCYUSKWBHUVEP-CYBMUJFWSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
101417,6vxs,DB04891,-7.8,Becocalcidiol,QSLUXQQUPXBIHH-YHSKWIAJSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
69790,6lxt,DB11698,-7.8,Ipragliflozin,AHFWIQIYAXSLBA-RQXATKFSSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
145360,6w9q,DB07261,-7.8,"THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [1-(1-AMINO-ISOQUINOLIN-7-YLMETHYL)-2-OXO-PYRROLDIN-3-YL]-AMIDE",NVKDOURNRJCKJE-INIZCTEOSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
61662,6crv,DB12405,-7.8,Triciribine,HOGVTUZUJGHKPL-HTVVRFAVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
69775,6lxt,DB11679,-7.8,Fruquintinib,BALLNEJQLSTPIO-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
101406,6vxs,DB04879,-7.8,Vatalanib,YCOYDOIWSSHVCK-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
88035,6m3m,DB13258,-7.8,Etofamide,QTRALMGDQMIVFF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
138762,6w9c,DB12233,-7.8,Iguratimod,ANMATWQYLIFGOK-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
64357,6lxt,DB01434,-7.8,19-norandrostenedione,JRIZOGLBRPZBLQ-QXUSFIETSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
97199,6m71,DB14075,-7.8,Imidurea,ZCTXEAQXZGPWFG-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
153788,6wiq,DB07117,-7.8,"5-(4-PHENOXYPHENYL)-5-(4-PYRIMIDIN-2-YLPIPERAZIN-1-YL)PYRIMIDINE-2,4,6(2H,3H)-TRIONE",FMKQJGOROFNCGM-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
67871,6lxt,DB07257,-7.8,"4-(2-chlorophenyl)-8-(2-hydroxyethyl)-6-methylpyrrolo[3,4-e]indole-1,3(2H,6H)-dione",WHMQZCPGFZBLBG-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
91511,6m71,DB03159,-7.8,CRA_8696,GAVRMVQHHVMXFD-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
69768,6lxt,DB11671,-7.8,AZD-4877,SMFXSYMLJDHGIE-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
138329,6w9c,DB11409,-7.8,Febantel,HMCCXLBXIJMERM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
61794,6crv,DB12601,-7.8,Sonolisib,QIUASFSNWYMDFS-NILGECQDSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61791,6crv,DB12596,-7.8,Combretastatin,LGZKGOGODCLQHG-CYBMUJFWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
157161,6wiq,DB14675,-7.8,Temsavir,QRPZBKAMSFHVRW-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
12921,6lzg,DB14037,-7.8,Madecassic acid,PRAUVHZJPXOEIF-AOLYGAPISA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
97178,6m71,DB14035,-7.8,Englitazone,MVDXXGIBARMXSA-PYUWXLGESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
101418,6vxs,DB04892,-7.8,Phenserine,PBHFNBQPZCRWQP-QUCCMNQESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
157197,6wiq,DB14766,-7.8,Etrasimod,MVGWUTBTXDYMND-QGZVFWFLSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
87973,6m3m,DB13143,-7.8,Methallenestril,KHLJKRBMZVNZOC-MRXNPFEDSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
40311,6lu7,DB12978,-7.8,Pexidartinib,JGWRKYUXBBNENE-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
12900,6lzg,DB13997,-7.8,Baloxavir marboxil,RZVPBGBYGMDSBG-GGAORHGYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
87936,6m3m,DB13084,-7.8,Pyritinol,SIXLXDIJGIWWFU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87937,6m3m,DB13087,-7.8,Miridesap,HZLAWYIBLZNRFZ-VXGBXAGGSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
64463,6lxt,DB01554,-7.8,Bolandiol,CMXKUJNZWYTFJN-XFUVECHXSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
61634,6crv,DB12367,-7.8,Selurampanel,MCECSFFXUPEPDB-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
64449,6lxt,DB01540,-7.8,17alpha-methyl-4-hydroxynandrolone,CLNUZOCYKSHICX-FAHHUNKHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
61641,6crv,DB12378,-7.8,Apricoxib,JTMITOKKUMVWRT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
145504,6w9q,DB07426,-7.8,"[1-HYDROXY-2-(1,1':3',1''-TERPHENYL-3-YLOXY)ETHANE-1,1-DIYL]BIS(PHOSPHONIC ACID)",NWIARQRYIRVYCM-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
145287,6w9q,DB07175,-7.8,N-{2-methyl-5-[(6-phenylpyrimidin-4-yl)amino]phenyl}methanesulfonamide,CXQRKICWSCAUGW-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
157212,6wiq,DB14795,-7.8,AZD-3759,MXDSJQHFFDGFDK-CYBMUJFWSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
67827,6lxt,DB07204,-7.8,"(1S)-1-(1H-INDOL-3-YLMETHYL)-2-(2-PYRIDIN-4-YL-[1,7]NAPHTYRIDIN-5-YLOXY)-EHYLAMINE",DQIXTEDFNFZMCM-SFHVURJKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
88219,6m3m,DB13504,-7.8,Cefetamet,MQLRYUCJDNBWMV-GHXIOONMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
15555,6lzg,DB00216,-7.8,Eletriptan,PWVXXGRKLHYWKM-LJQANCHMSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
64415,6lxt,DB01500,-7.8,Oxabolone,GXHBCWCMYVTJOW-YGRHGMIBSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
64407,6lxt,DB01489,-7.8,Camazepam,PXBVEXGRHZFEOF-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
145433,6w9q,DB07340,-7.8,"N-6-cyclohexyl-N-2-(4-morpholin-4-ylphenyl)-9H-purine-2,6-diamine",ZFLJHSQHILSNCM-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
91174,6m71,DB02704,-7.8,"(2r,3r,4r,5r)-3,4-Dihydroxy-N,N'-Bis[(1s,2r)-2-Hydroxy-2,3-Dihydro-1h-Inden-1-Yl]-2,5-Bis(2-Phenylethyl)Hexanediamide",GQKBYZPVKVXMJL-LAFNQVRVSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
64390,6lxt,DB01471,-7.8,Bolasterone,IVFYLRMMHVYGJH-VLOLGRDOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
91553,6m71,DB03213,-7.8,Bis(5-Amidino-2-Benzimidazolyl)Methane Ketone,VVVXDHROXQUONB-UHFFFAOYSA-P,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
157210,6wiq,DB14792,-7.8,AZD-5991,KBQCEQAXHPIRTF-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
138710,6w9c,DB12153,-7.8,Citicoline,RZZPDXZPRHQOCG-OJAKKHQRSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
67894,6lxt,DB07283,-7.8,"9-benzyl-2,3,4,9-tetrahydro-1H-carbazole-8-carboxylic acid",VDOXYKGIKBUISK-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
97300,6m71,DB14624,-7.8,Nandrolone hydrogen sulfate,SKZMVWBZTQNCKW-IZPLOLCNSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
37286,1r42,DB04071,-7.8,Cpad,LFERELMXERXKKQ-KMXXXSRASA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
68018,6lxt,DB07425,-7.8,Sobetirome,QNAZTOHXCZPOSA-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
64164,6lxt,DB01137,-7.8,Levofloxacin,GSDSWSVVBLHKDQ-JTQLQIEISA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
91235,6m71,DB02790,-7.8,Phenyl-Uridine-5'-Diphosphate,ZHUWBKDWWGKIEN-FMKGYKFTSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
61714,6crv,DB12476,-7.8,CPG-52852,YZOQZEXYFLXNKA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
97395,6m71,DB14787,-7.8,BMS-830216,YDTUJCNTIMWHPJ-NRFANRHFSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
68010,6lxt,DB07415,-7.8,4-[(1S)-1-(3-fluoro-4-methoxyphenyl)-2-(2-methoxy-5-nitrophenyl)ethyl]-1H-imidazol-2-amine,RFLOFHKRBGKCOB-AWEZNQCLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
97462,6m71,DB14934,-7.8,GDC-0927,KJAAPZIFCQQQKX-NDEPHWFRSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
138498,6w9c,DB11753,-7.8,Rifamycin,HJYYPODYNSCCOU-ODRIEIDWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
61713,6crv,DB12475,-7.8,Biphenyl dimethyl dicarboxylate,BKRIRZXWWALTPU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138606,6w9c,DB11909,-7.8,Varespladib,BHLXTPHDSZUFHR-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
97405,6m71,DB14810,-7.8,AZD-1656,FJEJHJINOKKDCW-INIZCTEOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
24696,6cs2,DB02479,-7.8,(R)-N-(3-Indol-1-Yl-2-Methyl-Propyl)-4-Sulfamoyl-Benzamide,ZFWHOUCRVSOZJE-CQSZACIVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
91332,6m71,DB02915,-7.8,"4-(2,4-Dimethyl-1,3-thiazol-5-yl)-N-[4-(trifluoromethyl)phenyl]-2-pyrimidinamine",MEZFDQUDLQCVNX-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
15474,6lzg,T3D1043,-7.8,Emamectin B1a,CXEGAUYXQAKHKJ-NSBHKLITSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
145160,6w9q,DB07031,-7.8,"3-Fluoro-4-{[(2R)-2-hydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthalenyl)acetyl]amino}benzoic acid",AANFHDFOMFRLLR-LJQANCHMSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
145158,6w9q,DB07029,-7.8,"4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMIDAZOL-1-YL)PHENOXY]-6-METHYLPYRIMIDINE",QQBNDYARFVOEGW-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
97412,6m71,DB14840,-7.8,Ripretinib,CEFJVGZHQAGLHS-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97414,6m71,DB14844,-7.8,ONC-201,VLULRUCCHYVXOH-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97421,6m71,DB14856,-7.8,PF-05089771,ZYSCOUXLBXGGIM-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
88172,6m3m,DB13437,-7.8,Medazepam,YLCXGBZIZBEVPZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
67813,6lxt,DB07187,-7.8,6-[(5-CHLORO-3-METHYL-1-BENZOFURAN-2-YL)SULFONYL]PYRIDAZIN-3(2H)-ONE,FXFPQPNUMWQRAO-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
64162,6lxt,DB01134,-7.8,Desoxycorticosterone pivalate,VVOIQBFMTVCINR-WWMZEODYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
138666,6w9c,DB12093,-7.8,Tetrahydropalmatine,AEQDJSLRWYMAQI-KRWDZBQOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
97301,6m71,DB14625,-7.8,Meprednisone acetate,RZAMUHXEOMZXET-ABQXZQTJSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
88196,6m3m,DB13472,-7.8,Cyclofenil,GVOUFPWUYJWQSK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
138358,6w9c,DB11463,-7.8,Sulfanitran,GWBPFRGXNGPPMF-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
15462,6lzg,T3D1029,-7.8,Acrinathrin,YLFSVIMMRPNPFK-WEQBUNFVSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
91185,6m71,DB02717,-7.8,Cellotetraose,LUEWUZLMQUOBSB-HGDSAIHNSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97308,6m71,DB14632,-7.8,Prednisolone tebutate,HUMXXHTVHHLNRO-KAJVQRHHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
138360,6w9c,DB11466,-7.8,Tepoxalin,XYKWNRUXCOIMFZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
12927,6lzg,DB14054,-7.8,Asiatic acid,JXSVIVRDWWRQRT-UYDOISQJSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
145260,6w9q,DB07144,-7.8,"5-[(3R)-3-(5-methoxy-2',6'-dimethylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",XZXVRKHUCSXVBM-AWEZNQCLSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
145197,6w9q,DB07072,-7.8,"(1S,2R,5S)-5-[3-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7(8H)-YL]-2-(2,4,5-TRIFLUOROPHENYL)CYCLOHEXANAMINE",CNKRZILQBKJWDS-WMFXKJRFSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
138707,6w9c,DB12148,-7.8,Menatetrenone,DKHGMERMDICWDU-GHDNBGIDSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
64292,6lxt,DB01326,-7.8,Cefamandole,OLVCFLKTBJRLHI-AXAPSJFSSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
97321,6m71,DB14646,-7.8,Prednisone acetate,MOVRKLZUVNCBIP-RFZYENFJSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
91423,6m71,DB03041,-7.8,UDP-alpha-D-glucuronic acid,HDYANYHVCAPMJV-LXQIFKJMSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
145237,6w9q,DB07119,-7.8,1-CHLORO-6-(4-HYDROXYPHENYL)-2-NAPHTHOL,YHEHVRSGKUYDON-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
69664,6lxt,DB11429,-7.8,Mibolerone,PTQMMNYJKCSPET-OMHQDGTGSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
97363,6m71,DB14717,-7.8,Nitrazolam,OYRPNABWTHDOFK-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
91417,6m71,DB03034,-7.8,D-Levofloxacin,GSDSWSVVBLHKDQ-SNVBAGLBSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
64268,6lxt,DB01261,-7.8,Sitagliptin,MFFMDFFZMYYVKS-SECBINFHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
145204,6w9q,DB07081,-7.8,"(2R)-4-[(8R)-8-METHYL-2-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[1,5-A]PYRAZIN-7(8H)-YL]-4-OXO-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE",FDEXEPZGMKFCTG-PSASIEDQSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
97506,6m71,DB15056,-7.8,Bifenthrin,OMFRMAHOUUJSGP-IRHGGOMRSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
138096,6w9c,DB09178,-7.8,Phenaridine,ODPKHHGQKIYCTJ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
145593,6w9q,DB07531,-7.8,"4-{5-[(Z)-(2,4-DIOXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE",JNPRTUHVCHGFHJ-GHXNOFRVSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
101463,6vxs,DB05048,-7.8,Cannabinor,GSTZHANFXAKPSE-MXTREEOPSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101540,6vxs,DB05498,-7.8,KW-7158,NAFSYPCVPLWHFY-HNNXBMFYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
138988,6w9c,DB12672,-7.8,Icaritin,TUUXBSASAQJECY-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137849,6w9c,DB08788,-7.8,"3,6-DIAMINO-5-CYANO-4-(4-ETHOXYPHENYL)THIENO[2,3-B]PYRIDINE-2-CARBOXAMIDE",UOPQHPBCVYHSFF-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
35819,1r42,DB02112,-7.8,Zk-806450,DZLGSWPXZYDHBD-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
40329,6lu7,DB11830,-7.8,Mocetinostat,HRNLUBSXIHFDHP-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
35822,1r42,DB02115,-7.8,Daidzin,KYQZWONCHDNPDP-QNDFHXLGSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
96649,6m71,DB13266,-7.8,Cefatrizine,UOCJDOLVGGIYIQ-PBFPGSCMSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
138987,6w9c,DB12671,-7.8,Beloranib,ZEZFKUBILQRZCK-MJSCXXSSSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138973,6w9c,DB12654,-7.8,GSK-376501,OIDYMQICWGYEDR-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138995,6w9c,DB12685,-7.8,K-134,ULGNGSQNNMKROG-WOJBJXKFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138968,6w9c,DB12645,-7.8,Givinostat,YALNUENQHAQXEA-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
12969,6lzg,DB14128,-7.8,Nadide,BAWFJGJZGIEFAR-NNYOXOHSSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
101525,6vxs,DB05424,-7.8,Canertinib,OMZCMEYTWSXEPZ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
137943,6w9c,DB08934,-7.8,Sofosbuvir,TTZHDVOVKQGIBA-IQWMDFIBSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
87824,6m3m,DB12912,-7.8,Nolatrexed,XHWRWCSCBDLOLM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
64635,6lxt,DB01774,-7.8,Adenosine-5'-Monophosphate Glucopyranosyl-Monophosphate Ester,WFPZSXYXPSUOPY-ROYWQJLOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
87831,6m3m,DB12925,-7.8,Crolibulin,JXONINOYTKKXQQ-CQSZACIVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
157305,6wiq,DB15145,-7.8,Ziresovir,GAAICKUTDBZCMT-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
138924,6w9c,DB12572,-7.8,Pexacerfont,LBWQSAZEYIZZCE-SNVBAGLBSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
35836,1r42,DB02132,-7.8,Zenarestat,SXONDGSPUVNZLO-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
137909,6w9c,DB08877,-7.8,Ruxolitinib,HFNKQEVNSGCOJV-OAHLLOKOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
69886,6lxt,DB11841,-7.8,Entinostat,INVTYAOGFAGBOE-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
137827,6w9c,DB08762,-7.8,O-(((1R)-((N-PHENYLMETHOXYCARBONYL-L-ALANYL)AMINO)ETHYL)HYDROXYPHOSPHONO)-L-BENZYLACETIC ACID,UPJNMOBJDSFRTI-FCEWJHQRSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137781,6w9c,DB08714,-7.8,"2,6-DIMETHYL-1-(3-[3-METHYL-5-ISOXAZOLYL]-PROPANYL)-4-[4-METHYL-2H-TETRAZOL-2-YL]-PHENOL",DRCNRTRGWUYJBH-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
67705,6lxt,DB07063,-7.8,"{3-[(4,5,7-TRIFLUORO-1,3-BENZOTHIAZOL-2-YL)METHYL]-1H-INDOL-1-YL}ACETIC ACID",KYHVTMFADJNSGS-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
40332,6lu7,DB06393,-7.8,Xaliproden,WJJYZXPHLSLMGE-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40331,6lu7,DB07833,-7.8,"N-(3-cyanophenyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)-4-biphenylcarboxamide",PMMLSQFPBFKLHH-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
157356,6wiq,DB15245,-7.8,Olorofim,SUFPWYYDCOKDLL-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
91106,6m71,DB02615,-7.8,Compound 19,UZOOIPXOYYJULJ-BLIZRMSTSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
101051,6vxs,DB04409,-7.8,Naphthalene Trisulfonate,ZPBSAMLXSQCSOX-UHFFFAOYSA-K,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
137763,6w9c,DB08694,-7.8,"9-amino-5-(2-aminopyrimidin-4-yl)pyrido[3',2':4,5]pyrrolo[1,2-c]pyrimidin-4-ol",RTHKPHCVZVYDFN-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
157350,6wiq,DB15233,-7.8,Avapritinib,DWYRIWUZIJHQKQ-SANMLTNESA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
137767,6w9c,DB08699,-7.8,"1-tert-butyl-3-(3-methylbenzyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine",FYCOTGCSHZKHPR-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
96645,6m71,DB13256,-7.8,Clothiapine,KAAZGXDPUNNEFN-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
91790,6m71,DB03534,-7.8,3-[(Acetyl-Methyl-Amino)-Methyl]-4-Amino-N-Methyl-N-(1-Methyl-1h-Indol-2-Ylmethyl)-Benzamide,AWTBJNJPBKTHEV-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
153548,6wiq,DB06834,-7.8,"N-(2-hydroxy-1,1-dimethylethyl)-1-methyl-3-(1H-pyrrolo[2,3-b]pyridin-2-yl)-1H-indole-5-carboxamide",XZRYCTLOGNCQDG-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
139022,6w9c,DB12725,-7.8,TD-8954,MZOITCJKGUIQEI-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
61863,6crv,DB12712,-7.8,Pilsicainide,BCQTVJKBTWGHCX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
96587,6m71,DB13155,-7.8,Esculin,XHCADAYNFIFUHF-TVKJYDDYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
137780,6w9c,DB08713,-7.8,"2,6-DIMETHYL-1-(3-[3-METHYL-5-ISOXAZOLYL]-PROPANYL)-4-[2N-METHYL-2H-TETRAZOL-5-YL]-PHENOL",RVZKQTQAFHEOKT-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
96619,6m71,DB13223,-7.8,Fluocortin,PUWHHWCHAVXSIG-NCLPIGKXSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96633,6m71,DB13242,-7.8,Bucladesine,CJGYSWNGNKCJSB-YVLZZHOMSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
69914,6lxt,DB11885,-7.8,Anlotinib,KSMZEXLVHXZPEF-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
96639,6m71,DB13248,-7.8,Phthalylsulfathiazole,PBMSWVPMRUJMPE-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
139030,6w9c,DB12739,-7.8,Bindarit,MTHORRSSURHQPZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137674,6w9c,DB08581,-7.8,"4-[(4-bromo-2-{[(3R,5S)-3,5-dimethylpiperidin-1-yl]carbonyl}phenyl)amino]-4-oxobutanoic acid",JSVSGWHGYIDZFX-TXEJJXNPSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
61551,6crv,DB12251,-7.8,Moxaverine,MYCMTMIGRXJNSO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
145705,6w9q,DB07666,-7.8,"(3R,4S)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE",OAWGQHXWGXOUKV-BEFAXECRSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
40321,6lu7,DB08391,-7.8,"6,7-DIMETHOXY-4-[(3R)-3-(QUINOXALIN-2-YLOXY)PYRROLIDIN-1-YL]QUINAZOLINE",UBIIFKJMNRPNMT-CQSZACIVSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
145686,6w9q,DB07642,-7.8,"5-{[1-(2-fluorobenzyl)piperidin-4-yl]methoxy}quinazoline-2,4-diamine",GYKIQIOWVKCVBP-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
157253,6wiq,DB15047,-7.8,BMS-919373,XGKULQQVQWCASY-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
157248,6wiq,DB15036,-7.8,Sitravatinib,WLAVZAAODLTUSW-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
145654,6w9q,DB07607,-7.8,4-[5-(3-IODO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-1H-IMIDAZOL-4-YL]-PYRIDINE,RXDZANYWRNIAOR-HHHXNRCGSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
145653,6w9q,DB07605,-7.8,"2-({4-[(5-CHLORO-1H-INDOL-2-YL)SULFONYL]PIPERAZIN-1-YL}CARBONYL)THIENO[3,2-B]PYRIDINE 4-OXIDE",DHDQMXPAANQKDC-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
101485,6vxs,DB05187,-7.8,Elafibranor,AFLFKFHDSCQHOL-IZZDOVSWSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
138059,6w9c,DB09091,-7.8,Tixocortol,YWDBSCORAARPPF-VWUMJDOOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
145647,6w9q,DB07595,-7.8,"(5Z)-5-(3-BROMOCYCLOHEXA-2,5-DIEN-1-YLIDENE)-N-(PYRIDIN-4-YLMETHYL)-1,5-DIHYDROPYRAZOLO[1,5-A]PYRIMIDIN-7-AMINE",WSIQKQLAGWVKSL-UHFFFAOYSA-O,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
87879,6m3m,DB13001,-7.8,Tinoridine,PFENFDGYVLAFBR-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
138064,6w9c,DB09101,-7.8,Elvitegravir,JUZYLCPPVHEVSV-LJQANCHMSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
87899,6m3m,DB13027,-7.8,Tucaresol,XEDONBRPTABQFB-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
138080,6w9c,DB09144,-7.8,Uridine triacetate,AUFUWRKPQLGTGF-FMKGYKFTSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
157236,6wiq,DB14860,-7.8,Ensartinib,GLYMPHUVMRFTFV-QLFBSQMISA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
96973,6m71,DB13693,-7.8,Sulbenicillin,JETQIUPBHQNHNZ-NJBDSQKTSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
40313,6lu7,DB01988,-7.8,6((S)-3-Benzylpiperazin-1-Yl)-3-(Naphthalen-2-Yl)-4-(Pyridin-4-Yl)Pyrazine,WFSFNKVFXLIZIY-MHZLTWQESA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
15588,6lzg,DB00342,-7.8,Terfenadine,GUGOEEXESWIERI-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
138092,6w9c,DB09173,-7.8,Butyrfentanyl,QQOMYEQLWQJRKK-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
97013,6m71,DB13752,-7.8,Tetramethrin,CXBMCYHAMVGWJQ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
37380,1r42,DB04190,-7.8,Inhibitor Bea425,AHAVBKNGKPWROK-UMFPTGFGSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
101472,6vxs,DB05104,-7.8,Asimadoline,JHLHNYVMZCADTC-LOSJGSFVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
69884,6lxt,DB11836,-7.8,Sapanisertib,GYLDXIAOMVERTK-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
40323,6lu7,DB12892,-7.8,MGB-BP-3,OEKXCVYZBVOWBR-BQYQJAHWSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40324,6lu7,DB12799,-7.8,Laniquidar,TULGGJGJQXESOO-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
138913,6w9c,DB12555,-7.8,Nelotanserin,COSPVUFTLGQDQL-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
157290,6wiq,DB15120,-7.8,GSK-239512,YFRBKEVUUCQYOW-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
137957,6w9c,DB08954,-7.8,Ifenprodil,UYNVMODNBIQBMV-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
67752,6lxt,DB07119,-7.8,1-CHLORO-6-(4-HYDROXYPHENYL)-2-NAPHTHOL,YHEHVRSGKUYDON-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
157284,6wiq,DB15108,-7.8,Tipranavir C-14,SUJUHGSWHZTSEU-MWQIXQBFSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
153634,6wiq,DB06933,-7.8,N-(tert-butyl)-4-[5-(pyridin-2-ylamino)quinolin-3-yl]benzenesulfonamide,GJTCKUKIFXWJKG-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
69869,6lxt,DB11818,-7.8,Retosiban,PLVGDGRBPMVYPB-FDUHJNRSSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
67759,6lxt,DB07126,-7.8,O6-CYCLOHEXYLMETHOXY-2-(4'-SULPHAMOYLANILINO) PURINE,OWXORKPNCHJYOF-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
138897,6w9c,DB12417,-7.8,Anagliptin,LDXYBEHACFJIEL-HNNXBMFYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
64573,6lxt,DB01691,-7.8,Indole Naphthyridinone,VAZMNDXVXVUKFY-JXMROGBWSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
91121,6m71,DB02636,-7.8,"9-Hydroxy-8-Methoxy-6-Nitro-Phenanthrol[3,4-D][1,3]Dioxole-5-Carboxylic Acid",UCLGCTLOEZZSLA-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
40327,6lu7,DB11907,-7.8,Rociletinib,HUFOZJXAKZVRNJ-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
61562,6crv,DB12268,-7.8,Carmegliptin,GUYMHFIHHOEFOA-ZCPGHIKRSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
15429,6lzg,T3D0994,-7.8,Phenmedipham,IDOWTHOLJBTAFI-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
138859,6w9c,DB12367,-7.8,Selurampanel,MCECSFFXUPEPDB-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
64590,6lxt,DB01713,-7.8,Udp-Alpha-D-Xylopyranose,DQQDLYVHOTZLOR-OCIMBMBZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
40326,6lu7,DB12381,-7.8,Merestinib,QHADVLVFMKEIIP-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
138835,6w9c,DB12326,-7.8,Antroquinonol,LJTSIMVOOOLKOL-FNRDIUJOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138831,6w9c,DB12321,-7.8,Ifetroban,BBPRUNPUJIUXSE-DXKRWKNPSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
40325,6lu7,DB12673,-7.8,ATX-914,ALANRBCCCQEPFZ-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
137979,6w9c,DB08980,-7.8,Fendiline,NMKSAYKQLCHXDK-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
146049,6w9q,DB08061,-7.8,4-[3-(4-CHLOROPHENYL)-1H-PYRAZOL-5-YL]PIPERIDINE,GELALLNTKKLQLM-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
61193,6crv,DB11729,-7.8,GSK-2330672,CZGVOBIGEBDYTP-VSGBNLITSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
67496,6lxt,DB06816,-7.8,Pyrvinium,QMHSXPLYMTVAMK-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
63643,6lxt,DB00528,-7.8,Lercanidipine,ZDXUKAKRHYTAKV-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
69289,6lxt,DB08965,-7.8,Fusafungine,MIZMDSVSLSIMSC-OGLSAIDSSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
147084,6w9q,DB11263,-7.8,Polydatin,HSTZMXCBWJGKHG-CUYWLFDKSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
70477,6lxt,DB12713,-7.8,Sotagliflozin,QKDRXGFQVGOQKS-CRSSMBPESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
135615,6w9c,DB04711,-7.8,Iodipamide,FFINMCNLQNTKLU-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
90565,6m71,DB01910,-7.8,Sinefungin,LMXOHSDXUQEUSF-YECHIGJVSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
135616,6w9c,DB04712,-7.8,ANILINOMETHYL GLUCO-PHENYLIMIDAZOLE,ADKWVGPRAQKVKB-YIYPIFLZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
23267,6cs2,HMDB0059984,-7.8,"5-(3',4',5'-Trihydroxyphenyl)-gamma-valerolactone-3'-O-glucuronide",VQHXMQYHVVQQFP-CXWHQSFFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
16310,6lzg,DB03678,-7.8,"(6,7-Difluoro-Quinazolin-4-Yl)-(1-Methyl-2,2-Diphenyl-Ethyl)-Amine",WVGZKPGUHOZIJQ-HNNXBMFYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
62186,6crv,DB13240,-7.8,Cymarin,XQCGNURMLWFQJR-ZNDDOCHDSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
69298,6lxt,DB08974,-7.8,Flubendazole,CPEUVMUXAHMANV-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
90587,6m71,DB01941,-7.8,"6-[1-(3,5,5,8,8-Pentamethyl-5,6,7,8-Tetrahydronaphthalen-2-Yl)Cyclopropyl]Pyridine-3-Carboxylic Acid",SLXTWXQUEZSSTJ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
67200,6lxt,DB06148,-7.8,Mianserin,UEQUQVLFIPOEMF-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
135627,6w9c,DB04726,-7.8,"7,8,10-TRIMETHYLBENZO[G]PTERIDINE-2,4(3H,10H)-DIONE",KPDQZGKJTJRBGU-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
70467,6lxt,DB12696,-7.8,BMS-582949,GDTQLZHHDRRBEB-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
156194,6wiq,DB12550,-7.8,Taladegib,SZBGQDXLNMELTB-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
158263,7bv1,DB00796,-7.8,Candesartan cilexetil,GHOSNRCGJFBJIB-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95188,6m71,DB09054,-7.8,Idelalisib,IFSDAJWBUCMOAH-HNNXBMFYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
102330,6vxs,DB07274,-7.8,"N-cyclopropyl-6-[(6,7-dimethoxyquinolin-4-yl)oxy]naphthalene-1-carboxamide",ZATGFXTWDKIEKC-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
90563,6m71,DB01906,-7.8,"3-(5-Amino-7-Hydroxy-[1,2,3]Triazolo[4,5-D]Pyrimidin-2-Yl)-Benzoic Acid",KNLLRZNGRRRPEW-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
63638,6lxt,DB00522,-7.8,Bentiromide,SPPTWHFVYKCNNK-FQEVSTJZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
89220,6m71,DB00218,-7.8,Moxifloxacin,FABPRXSRWADJSP-MEDUHNTESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
135598,6w9c,DB04678,-7.8,H TYPE II TRISACCHARIDE,PHTAQVMXYWFMHF-QVPNGJTFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
70501,6lxt,DB12746,-7.8,AKN-028,JLRIJKVMMZEKDF-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
92761,6m71,DB04834,-7.8,Rapacuronium,HTIKWNNIPGXLGM-YLINKJIISA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
147134,6w9q,DB11398,-7.8,Diclazuril,ZSZFUDFOPOMEET-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
70500,6lxt,DB12745,-7.8,GSK-690693,KGPGFQWBCSZGEL-ZDUSSCGKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
36312,1r42,DB02759,-7.8,4-Methylumbelliferyl Chitobiose,UPSFMJHZUCSEHU-JYGUBCOQSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
151705,6wiq,DB03067,-7.8,"4-{2,4-Bis[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid",VFYAZSTYKPFSFL-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
151709,6wiq,DB03072,-7.8,"2-{3-[4-(4-Fluorophenyl)-3,6-Dihydro-1(2h)-Pyridinyl]Propyl}-8-Methyl-4(3h)-Quinazolinone",LOFDUAJQRUYHBR-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
158298,7bv1,DB00834,-7.8,Mifepristone,VKHAHZOOUSRJNA-GCNJZUOMSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95133,6m71,DB08976,-7.8,Floctafenine,APQPGQGAWABJLN-GFCCVEGCSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
156196,6wiq,DB12553,-7.8,Fluocinolone,UUOUOERPONYGOS-CLCRDYEYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
23272,6cs2,HMDB0059989,-7.8,"5-(3',4'-Dihydroxyphenyl)-gamma-valerolactone-4'-O-glucuronide",OTBJYBQGMPICIK-GHPVWUPISA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
70495,6lxt,DB12740,-7.8,CC-115,GMYLVKUGJMYTFB-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
135574,6w9c,DB04644,-7.8,"4-{4-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-2,3-DIMETHYL-PHENOXY}-BUTYRIC ACID",FCEMCUPAYRPTLS-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
95159,6m71,DB09006,-7.8,Clinofibrate,BMOVQUBVGICXQN-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
69282,6lxt,DB08956,-7.8,Hydroxydione,USPYDUPOCUYHQL-VEVMSBRDSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
86805,6m3m,DB11182,-7.8,Rose bengal free acid,VDNLFJGJEQUWRB-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
89222,6m71,DB00220,-7.8,Nelfinavir,QAGYKUNXZHXKMR-HKWSIXNMSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
135580,6w9c,DB04651,-7.8,BIOTINOL-5-AMP,KBOGUFFJCBPJEH-SQGSUPJISA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
98203,6vxs,DB00670,-7.8,Pirenzepine,RMHMFHUVIITRHF-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
70486,6lxt,DB12725,-7.8,TD-8954,MZOITCJKGUIQEI-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
90546,6m71,DB01876,-7.8,Bis(5-Amidino-2-Benzimidazolyl)Methanone,VVVXDHROXQUONB-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60862,6crv,DB09238,-7.8,Manidipine,ANEBWFXPVPTEET-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
139901,6w9c,DB14471,-7.8,2-Ethylhexyl 4-phenylbenzophenone-2'-carboxylate,TWAOKHHZKFMFMD-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
28651,6cs2,DB08247,-7.8,6-(CYCLOHEXYLMETHOXY)-8-ISOPROPYL-9H-PURIN-2-AMINE,JABXNQUXGJTKRO-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
68332,6lxt,DB07796,-7.8,"(3ASR,4RS,8ASR,8BRS)-4-(2-(4-FLUOROBENZYL)-1,3-DIOXODEACAHYDROPYRROLO[3,4-A] PYRROLIZIN-4-YL)BENZAMIDINE",GJYCQHGTXMVIBG-MUGJNUQGSA-O,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
63714,6lxt,DB00611,-7.8,Butorphanol,IFKLAQQSCNILHL-PWRODBHTSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
152145,6wiq,DB03671,-7.8,"4-(3,12,14-Trihydroxy-10,13-Dimethyl-Hexadecahydro-Cyclopenta[a]Phenanthren-17-Yl)-5h-Furan-2-One",SHIBSTMRCDJXLN-KCZCNTNESA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
95343,6m71,DB09295,-7.8,Talniflumate,ANMLJLFWUCQGKZ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
67246,6lxt,DB06237,-7.8,Avanafil,WEAJZXNPAWBCOA-INIZCTEOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
135830,6w9c,DB05252,-7.8,Fenoxaprop-ethyl,PQKBPHSEKWERTG-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
68327,6lxt,DB07791,-7.8,4-{[4-(1-CYCLOPROPYL-2-METHYL-1H-IMIDAZOL-5-YL)PYRIMIDIN-2-YL]AMINO}-N-METHYLBENZENESULFONAMIDE,MZWCVBFANHIPTJ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
68326,6lxt,DB07790,-7.8,N-(2-METHOXYETHYL)-4-({4-[2-METHYL-1-(1-METHYLETHYL)-1H-IMIDAZOL-5-YL]PYRIMIDIN-2-YL}AMINO)BENZENESULFONAMIDE,LDXLQEXLXZCYSR-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
67249,6lxt,DB06246,-7.8,Exisulind,MVGSNCBCUWPVDA-MFOYZWKCSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
92672,6m71,DB04716,-7.8,"2-(1,1-DIMETHYLETHYL)9-FLUORO-3,6-DIHYDRO-7H-BENZ[H]-IMIDAZ[4,5-F]ISOQUINOLIN-7-ONE",VNDWQCSOSCCWIP-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
158185,7bv1,DB00700,-7.8,Eplerenone,JUKPWJGBANNWMW-VWBFHTRKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
139799,6w9c,DB14013,-7.8,SR-9009,MMJJNHOIVCGAAP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
63735,6lxt,DB00637,-7.8,Astemizole,GXDALQBWZGODGZ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
146761,6w9q,DB08950,-7.8,Indoramin,JXZZEXZZKAWDSP-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
70405,6lxt,DB12597,-7.8,ABL-001,VOVZXURTCKPRDQ-CQSZACIVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
16279,6lzg,DB03507,-7.8,"6-[3-(4-Morpholinyl)Propyl]-2-(3-Nitrophenyl)-5-Thioxo-5,6,-Dihydro-7h-Thienol[2',3':4,5]Pyrrolo[1,2-C]Imidazol-7-One",UXGUZFZBZPPZGL-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
139784,6w9c,DB13981,-7.8,Nomegestrol acetate,IIVBFTNIGYRNQY-YQLZSBIMSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
95375,6m71,DB09421,-7.8,Protirelin,XNSAINXGIQZQOO-SRVKXCTJSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
135860,6w9c,DB05422,-7.8,OPC-14523,TZZGTNZBLPCBIS-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
67253,6lxt,DB06250,-7.8,Fluasterone,VHZXNQKVFDBFIK-NBBHSKLNSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
90639,6m71,DB02008,-7.8,1-(2-Fluorobenzyl)-3-Butyl-8-(N-Acetyl-4-Aminobenzyl)-Xanthine,JHSHXKJSPVHPCJ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
158304,7bv1,DB00842,-7.8,Oxazepam,ADIMAYPTOBDMTL-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
90630,6m71,DB01995,-7.8,5-Methylcytidine-5'-Monophosphate,NJQONZSFUKNYOY-JXOAFFINSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
146855,6w9q,DB09076,-7.8,Umeclidinium,FVTWTVQXNAJTQP-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
139900,6w9c,DB14232,-7.8,Deacetylbisacodyl,LJROKJGQSPMTKB-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139896,6w9c,DB14217,-7.8,Quinaprilat,FLSLEGPOVLMJMN-YSSFQJQWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139891,6w9c,DB14209,-7.8,Trandolaprilat,AHYHTSYNOHNUSH-HXFGRODQSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
95217,6m71,DB09095,-7.8,Difluocortolone,OGPWIDANBSLJPC-RFPWEZLHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
12654,6lzg,DB13643,-7.8,Loprazolam,UTEFBSAVJNEPTR-RGEXLXHISA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
135721,6w9c,DB04849,-7.8,Cediranib,XXJWYDDUDKYVKI-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
156202,6wiq,DB12562,-7.8,Setipiprant,IHAXLPDVOWLUOS-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
135739,6w9c,DB04873,-7.8,Piboserod,KVCSJPATKXABRQ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
68350,6lxt,DB07815,-7.8,GIBBERELLIN A4,RSQSQJNRHICNNH-NFMPGMCNSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
70432,6lxt,DB12645,-7.8,Givinostat,YALNUENQHAQXEA-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
135754,6w9c,DB04891,-7.8,Becocalcidiol,QSLUXQQUPXBIHH-YHSKWIAJSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
69319,6lxt,DB08997,-7.8,Dexetimide,LQQIVYSCPWCSSD-HSZRJFAPSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
65433,6lxt,DB02830,-7.8,FR236913,KCCUBLLGAMGDJL-HXUWFJFHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
22506,6cs2,HMDB0054121,-7.8,"TG(20:4(5Z,8Z,11Z,14Z)/18:1(11Z)/o-18:0)",ZSUORVUZOXBKRZ-RCDIBCAKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
86882,6m3m,DB11425,-7.8,Luprostiol,KFUDFIMHDRJVLV-OZCLATTGSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
67229,6lxt,DB06202,-7.8,Lasofoxifene,GXESHMAMLJKROZ-IAPPQJPRSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
158216,7bv1,DB00737,-7.8,Meclizine,OCJYIGYOJCODJL-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
86884,6m3m,DB11427,-7.8,Maropitant,OMPCVMLFFSQFIX-CONSDPRKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
25248,6cs2,DB03137,-7.8,"8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9-Pent-9h-Purin-6-Ylamine",RMOYVWKKOKERSW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
95298,6m71,DB09227,-7.8,Barnidipine,VXMOONUMYLCFJD-DHLKQENFSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
35348,1r42,DB01501,-7.8,Difenoxin,UFIVBRCCIRTJTN-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
158305,7bv1,DB00843,-7.8,Donepezil,ADEBPBSSDYVVLD-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
140094,6w9c,DB14932,-7.8,Coleneuramide,CHMRTBYTCBDIRG-JQZMMWJVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
60812,6crv,DB09184,-7.8,Edivoxetine,CPBHSHYQQLFAPW-ZWKOTPCHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60702,6crv,DB08993,-7.8,Enviomycin,HPWIIERXAFODPP-GHBBWTPBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
156053,6wiq,DB12138,-7.8,PF-03715455,VGEXRDWWPSGZDH-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
70568,6lxt,DB12867,-7.8,Benperidol,FEBOTPHFXYHVPL-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
147345,6w9q,DB11804,-7.8,AZD-5672,SCXSQUUTGCWHFU-WJOKGBTCSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
25344,6cs2,DB03247,-7.8,Flavin mononucleotide,FVTCRASFADXXNN-SCRDCRAPSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
86643,6m3m,DB09180,-7.8,Thienylfentanyl,YMRFZDHYDKZXPA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
135162,6w9c,DB04070,-7.8,6-Deoxyerythronolide B,HQZOLNNEQAKEHT-IBBGRPSASA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
68413,6lxt,DB07889,-7.8,"(2S)-1-(Dimethylamino)-3-(4-{[4-(2-methylimidazo[1,2-a]pyridin-3-yl)-2-pyrimidinyl]amino}phenoxy)-2-propanol",VCPXSBULBDYRLT-SFHVURJKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
140314,6w9c,DB02798,-7.8,Alpha-Methylene Adenosine Monophosphate,PXSSQXBLDTZHLF-IOSLPCCCSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
94932,6m71,DB08709,-7.8,"2,3-diphenyl-1H-indole-7-carboxylic acid",OLUDUXWVPIEHDA-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
147343,6w9q,DB11800,-7.8,Tivozanib,SPMVMDHWKHCIDT-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
14114,6lzg,T3D3731,-7.8,Rubratoxin A,XOEFANNJIKAWGX-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
60719,6crv,DB09012,-7.8,Carbazochrome,XSXCZNVKFKNLPR-SDQBBNPISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60724,6crv,DB09017,-7.8,Brotizolam,UMSGKTJDUHERQW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
135224,6w9c,DB04150,-7.8,Threonine Derivative,TWMKRGDZEJLDDH-LKXWSVAYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
86652,6m3m,DB09189,-7.8,Daledalin,YFAIJBZEDDOCAN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86653,6m3m,DB09190,-7.8,Talopram,LJBBMCNHIUJBDU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
13337,6lzg,DB15170,-7.8,Evobrutinib,QUIWHXQETADMGN-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
94968,6m71,DB08746,-7.8,1-[[(1E)-2-(4-CHLOROPHENYL)ETHENYL]SULFONYL]-4-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]PIPERAZINE,ZOSSOFIFNGGDKG-GIJQJNRQSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
62234,6crv,DB13309,-7.8,Benproperine,JTUQXGZRVLWBCR-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
65586,6lxt,DB03037,-7.8,Oxidized Acetyl Dithranol,IKFRFGXQHSBCQM-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
63569,6lxt,DB00436,-7.8,Bendroflumethiazide,HDWIHXWEUNVBIY-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
135097,6w9c,DB03980,-7.8,4-(Fluorophenyl)-1-Cyclopropylmethyl-5-(2-Amino-4-Pyrimidinyl)Imidazole,DFEYXQGDDCDXJK-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
102498,6vxs,DB07467,-7.8,"4-chloro-N-[(2S)-2-methyl-2,3-dihydro-1H-indol-1-yl]-3-sulfamoylbenzamide",NDDAHWYSQHTHNT-JTQLQIEISA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
140434,6w9c,DB06835,-7.8,(2S)-2-[3-(AMINOMETHYL)PHENYL]-3-{(S)-HYDROXY[(1R)-2-METHYL-1-{[(2-PHENYLETHYL)SULFONYL]AMINO}PROPYL]PHOSPHORYL}PROPANOIC ACID,CTQDLSDUHUFBQW-LEWJYISDSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
25366,6cs2,DB03272,-7.8,4-Bromo-3-(5'-Carboxy-4'-Chloro-2'-Fluorophenyl)-1-Methyl-5-Trifluoromethyl-Pyrazol,YNMHKERYELPEEF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
102517,6vxs,DB07489,-7.8,"4-Amino-2-[(3-chlorophenyl)amino]-5-(4-fluorobenzoyl)-1,3-thiazol-3-ium",WWGPTHOMFHDEEC-UHFFFAOYSA-O,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
92861,6m71,DB05104,-7.8,Asimadoline,JHLHNYVMZCADTC-LOSJGSFVSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
98311,6vxs,DB00799,-7.8,Tazarotene,OGQICQVSFDPSEI-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
90417,6m71,DB01705,-7.8,Bis(5-Amidino-Benzimidazolyl)Methane,QZKOOEFIMWKZPK-UHFFFAOYSA-Q,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
63537,6lxt,DB00396,-7.8,Progesterone,RJKFOVLPORLFTN-LEKSSAKUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
147396,6w9q,DB11878,-7.8,Filibuvir,SLVAPEZTBDBAPI-GDLZYMKVSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
158438,7bv1,DB01185,-7.8,Fluoxymesterone,YLRFCQOZQXIBAB-RBZZARIASA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
62248,6crv,DB13324,-7.8,Tetrazepam,IQWYAQCHYZHJOS-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
144974,6w9q,DB06800,-7.8,Methylnaltrexone,JVLBPIPGETUEET-WIXLDOGYSA-O,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
89293,6m71,DB00301,-7.8,Flucloxacillin,UIOFUWFRIANQPC-JKIFEVAISA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
135034,6w9c,DB03895,-7.8,Malachite Green,VFCNQNZNPKRXIT-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
92856,6m71,DB05076,-7.8,Fenretinide,AKJHMTWEGVYYSE-FXILSDISSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
90453,6m71,DB01755,-7.8,N-[Isoleucinyl]-N'-[Adenosyl]-Diaminosufone,XVTRBLLRODNOJV-VBJYJYTRSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
156050,6wiq,DB12134,-7.8,Gepotidacin,PZFAZQUREQIODZ-LJQANCHMSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
135051,6w9c,DB03917,-7.8,N-Ethyl Retinamide,WKYDOCGICAMTKE-NBIQJRODSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
94930,6m71,DB08707,-7.8,"4-[3-(4-chlorophenyl)-2,1-benzisoxazol-5-yl]pyrimidin-2-amine",AQVFETGXIRKVAQ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
158425,7bv1,DB01172,-7.8,Kanamycin,SBUJHOSQTJFQJX-NOAMYHISSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
14122,6lzg,T3D3740,-7.8,Beauvericin,GYSCAQFHASJXRS-FFCOJMSVSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
24375,6cs2,DB02101,-7.8,"(S,R)-fidarestat",WAAPEIZFCHNLKK-QPUJVOFHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
63738,6lxt,DB00641,-7.8,Simvastatin,RYMZZMVNJRMUDD-HGQWONQESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
62228,6crv,DB13303,-7.8,Febarbamate,QHZQILHUJDRDAI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140266,6w9c,DB01557,-7.8,alpha-Methylfentanyl,NGTVDHYUFBKWID-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
156108,6wiq,DB12419,-7.8,HSD-016,ZWASRJHIEFYJGL-BFUOFWGJSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
89247,6m71,DB00248,-7.8,Cabergoline,KORNTPPJEAJQIU-KJXAQDMKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
102400,6vxs,DB07350,-7.8,(2E)-N-hydroxy-3-[1-methyl-4-(phenylacetyl)-1H-pyrrol-2-yl]prop-2-enamide,UFQOXIMRSMFQRI-BQYQJAHWSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
158334,7bv1,DB00875,-7.8,Flupentixol,NJMYODHXAKYRHW-DVZOWYKESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
102390,6vxs,DB07338,-7.8,Acifluorfen,NUFNQYOELLVIPL-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
62208,6crv,DB13273,-7.8,Sultopride,UNRHXEPDKXPRTM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
67142,6lxt,DB05772,-7.8,Rabeximod,PDNNUMNEXITLCZ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
13058,6lzg,DB14632,-7.8,Prednisolone tebutate,HUMXXHTVHHLNRO-KAJVQRHHSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
62206,6crv,DB13270,-7.8,Dibekacin,JJCQSGDBDPYCEO-XVZSLQNASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
98243,6vxs,DB00714,-7.8,Apomorphine,VMWNQDUVQKEIOC-CYBMUJFWSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
100340,6vxs,DB03449,-7.8,N-(4-(2-((3-Chlorophenylmethyl)Amino)Ethyl)Phenyl)-2-Thiophecarboxamidine,ZZVGLDBDD1AB-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
13347,6lzg,DB15192,-7.8,ABT-288,GNIRITULTPTAQW-KNQAVFIVSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
147193,6w9q,DB11521,-7.8,Imidocarb,SCEVFJUWLLRELN-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
98232,6vxs,DB00701,-7.8,Amprenavir,YMARZQAQMVYCKC-OEMFJLHTSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
60799,6crv,DB09170,-7.8,??-Hydroxythiofentanyl,GLAAETOTOUGGSB-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
135475,6w9c,DB04518,-7.8,"3-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamino]-Phenol",JJDRRZFRTKZLFT-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
135493,6w9c,DB04542,-7.8,3'-Azido-3'-Deoxythymidine-5'-Diphosphate,QOYVAFWJURKBJG-XLPZGREQSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
86737,6m3m,DB09306,-7.8,Metralindole,GVXBHSBKKJRBMS-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
60808,6crv,DB09180,-7.8,Thienylfentanyl,YMRFZDHYDKZXPA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
97423,6m71,DB14859,-7.8,Fosifloxuridine nafalbenamide,BIOWRMNRHMERIO-ZVAHOJSLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
67148,6lxt,DB05804,-7.8,Prasterone sulfate,CZWCKYRVOZZJNM-USOAJAOKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
135286,6w9c,DB04259,-7.8,7n-Methyl-8-Hydroguanosine-5'-Monophosphate,ZMWJGXGSWZFZPJ-KQYNXXCUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
95069,6m71,DB08882,-7.8,Linagliptin,LTXREWYXXSTFRX-QGZVFWFLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
62216,6crv,DB13283,-7.8,Sulfaisodimidine,YZMCKZRAOLZXAZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
135293,6w9c,DB04270,-7.8,(S)-3-(4-(2-Carbazol-9-Yl-Ethoxy)-Phenyl)-2-Ethoxy-Propionic Acid,WUZIMDSVRIBNNI-DEOSSOPVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
147297,6w9q,DB11737,-7.8,Icotinib,QQLKULDARVNMAL-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
86657,6m3m,DB09194,-7.8,Etoperidone,IZBNNCFOBMGTQX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
60746,6crv,DB09061,-7.8,Cannabidiol,QHMBSVQNZZTUGM-ZWKOTPCHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60747,6crv,DB09062,-7.8,Cefminox,JSDXOWVAHXDYCU-VXSYNFHWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140213,6w9c,DB15359,-7.8,Xanthohumol,ORXQGKIUCDPEAJ-YRNVUSSQSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
135314,6w9c,DB04295,-7.8,N-Benzoyl-N'-Beta-D-Glucopyranosyl Urea,JSBCZGSPFATCOV-BZNQNGANSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
135322,6w9c,DB04306,-7.8,"5-[(4-Methylphenyl)Sulfanyl]-2,4-Quinazolinediamine",UOJFGEAPSYQDIP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
135349,6w9c,DB04345,-7.8,Lumichrome,ZJTJUVIJVLLGSP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
102402,6vxs,DB07352,-7.8,Apigenin,KZNIFHPLKGYRTM-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
69256,6lxt,DB08916,-7.8,Afatinib,ULXXDDBFHOBEHA-CWDCEQMOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
95027,6m71,DB08811,-7.8,Tofisopam,RUJBDQSFYCKFAA-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95037,6m71,DB08828,-7.8,Vismodegib,BPQMGSKTAYIVFO-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
70531,6lxt,DB12802,-7.8,Picropodophyllin,YJGVMLPVUAXIQN-HAEOHBJNSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
13342,6lzg,DB15187,-7.8,Dubermatinib,YUAALFPUEOYPNX-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
67130,6lxt,DB05676,-7.8,Apremilast,IMOZEMNVLZVGJZ-QGZVFWFLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
140182,6w9c,DB15299,-7.8,AMG-232,DRLCSJFKKILATL-YWCVFVGNSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
60773,6crv,DB09097,-7.8,Quinagolide,GDFGTRDCCWFXTG-ZIFCJYIRSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
147265,6w9q,DB11686,-7.8,Iferanserin,UXIPFQUBOVWAQW-UEBLJOKOSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
158350,7bv1,DB00894,-7.8,Testolactone,BPEWUONYVDABNZ-DZBHQSCQSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
135364,6w9c,DB04367,-7.8,Debromohymenialdisine,JYRJOQGKGMHTOO-VURMDHGXSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
156239,6wiq,DB12622,-7.8,Lupeol,MQYXUWHLBZFQQO-QGTGJCAVSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
69335,6lxt,DB09015,-7.8,Canrenoic acid,PBKZPPIHUVSDNM-WNHSNXHDSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
16268,6lzg,DB03453,-7.8,Methyl (2S)-2-[[2-[(3R)-1-carbamimidoylpiperidin-3-yl]acetyl]amino]-3-[4-(2-phenylethynyl)phenyl]propanoate,MRNGXYMKYHNMLV-PKTZIBPZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
102097,6vxs,DB07005,-7.8,D-phenylalanyl-N-{4-[amino(iminio)methyl]benzyl}-L-prolinamide,VZFTWWJAUZOJDH-MOPGFXCFSA-O,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102084,6vxs,DB06992,-7.8,"(3,3-dimethylpiperidin-1-yl)(6-(3-fluoro-4-methylphenyl)pyridin-2-yl)methanone",SIDDLTBLAQYZIZ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
136439,6w9c,DB07119,-7.8,1-CHLORO-6-(4-HYDROXYPHENYL)-2-NAPHTHOL,YHEHVRSGKUYDON-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
97904,6vxs,DB00301,-7.8,Flucloxacillin,UIOFUWFRIANQPC-JKIFEVAISA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
68249,6lxt,DB07701,-7.8,"1-BENZYL-4-[(5,6-DIMETHOXY-1-INDANON-2-YL)METHYL]PIPERIDINE",ADEBPBSSDYVVLD-HXUWFJFHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
70297,6lxt,DB12432,-7.8,CC-401,XDJCLCLBSGGNKS-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
136470,6w9c,DB07154,-7.8,"(3R)-4-[(3R)-3-AMINO-4-(2,4,5-TRIFLUOROPHENYL)BUTANOYL]-3-METHYL-1,4-DIAZEPAN-2-ONE",SWKGZJAAGSVROJ-MWLCHTKSSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
157923,6wiq,DB14902,-7.8,JHU-75528 C-11,MCNQUWLLXZZZAC-BJUDXGSMSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
95738,6m71,DB11871,-7.8,PF-00610355,YPHDIMUXXABSSO-YTTGMZPUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
102099,6vxs,DB07007,-7.8,"(3R)-3-[(1,2,3,4-tetrahydroisoquinolin-7-yloxy)methyl]-2,3-dihydrothieno[2,3-f][1,4]oxazepin-5-amine",UDFXWCLBONUMNA-CYBMUJFWSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
92375,6m71,DB04315,-7.8,Guanosine-5'-Diphosphate,QGWNDRXFNXRZMB-UUOKFMHZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
62027,6crv,DB12971,-7.8,Pactimibe,TXIIZHHIOHVWJD-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
146291,6w9q,DB08353,-7.8,"2-(CYCLOHEXYLMETHYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE",NCVMTHVSAJMOPI-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
63907,6lxt,DB00843,-7.8,Donepezil,ADEBPBSSDYVVLD-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
67414,6lxt,DB06673,-7.8,Almorexant,DKMACHNQISHMDN-RPLLCQBOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
95775,6m71,DB11922,-7.8,Danirixin,NGYNBSHYFOFVLS-LBPRGKRZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
87175,6m3m,DB11941,-7.8,Tasisulam,WWONFUQGBVOKOF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
102056,6vxs,DB06954,-7.8,"2-(cycloheptylmethyl)-1,1-dioxido-1-benzothiophen-6-yl sulfamate",BIASYWBGUYOWJR-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
152963,6wiq,DB04759,-7.8,"PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-(3-METHYL-BENZYLAMIDE)",GTBUZLPQANSGGE-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
63921,6lxt,DB00858,-7.8,Drostanolone,IKXILDNPCZPPRV-RFMGOVQKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
92363,6m71,DB04298,-7.8,"3-(4-Amino-2-Tert-Butyl-5-Methyl-Phenylsulfanyl)-6-Cyclopentyl-4-Hydroxy-6-[2-(4-Hydroxy-Phenyl)-Ethyl]-5,6-Dihydro-Pyran-2-One",ZEBFKFGJWHOOST-LJAQVGFWSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
136504,6w9c,DB07192,-7.8,(3S)-N-(3-BROMOPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE,MVPIURCUINFSAB-LBPRGKRZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136417,6w9c,DB07093,-7.8,"{3-[(5-CHLORO-1,3-BENZOTHIAZOL-2-YL)METHYL]-2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL}ACETIC ACID",RQWICELTTDJODO-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
68254,6lxt,DB07706,-7.8,2-Hydrox1tradiol,DILDHNKDVHLEQB-XSSYPUMDSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
156345,6wiq,DB12952,-7.8,Methylprednisone,SVYCRJXQZUCUND-PQXSVQADSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
90759,6m71,DB02166,-7.8,Propidium,ZDWVWKDAWBGPDN-UHFFFAOYSA-O,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
139577,6w9c,DB13660,-7.8,Propicillin,HOCWPKXKMNXINF-XQERAMJGSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
157970,6wiq,DB15403,-7.8,Ziritaxestat,REQQVBGILUTQNN-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
67379,6lxt,DB06597,-7.8,Estradiol sulfamate,YXYXCSOJKUAPJI-ZBRFXRBCSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
139567,6w9c,DB13645,-7.8,Ethacizine,PQXGNJKJMFUPPM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
156360,6wiq,DB12978,-7.8,Pexidartinib,JGWRKYUXBBNENE-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
136349,6w9c,DB07017,-7.8,"(5S)-2-{[(1S)-1-(4-fluorophenyl)ethyl]amino}-5-(1-hydroxy-1-methylethyl)-5-methyl-1,3-thiazol-4(5H)-one",HYVZYASDRIAOPU-BJOHPYRUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
61070,6crv,DB11462,-7.8,Sulfaethoxypyridazine,FFJIWWBSBCOKLS-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
68252,6lxt,DB07704,-7.8,"6-AMINO-4-[2-(4-METHOXYPHENYL)ETHYL]-1,7-DIHYDRO-8H-IMIDAZO[4,5-G]QUINAZOLIN-8-ONE",UKRVQKUVWNDGMN-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
16169,6lzg,DB03010,-7.8,Patupilone,QXRSDHAAWVKZLJ-PVYNADRNSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
102108,6vxs,DB07019,-7.8,"N-[(5R,14R)-5-AMINO-5,14-DIMETHYL-4-OXO-3-OXA-18-AZATRICYCLO[15.3.1.1-7,11-]DOCOSA-1(21),7(22),8,10,17,19-HEXAEN-19-YL]-N-METHYLMETHANESULFONAMIDE",QWDOKZPZLWNULU-MZNJEOGPSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
136413,6w9c,DB07088,-7.8,(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclopentyloxy)ethanoyl)pyrrolidine-2-carboxamide,ZWXWAYUCJVQHOR-KRWDZBQOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
88854,6m3m,DB14938,-7.8,Flurbiprofen axetil,ALIVXCSEERJYHU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
95708,6m71,DB11824,-7.8,Tofogliflozin,VWVKUNOPTJGDOB-BDHVOXNPSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
157954,6wiq,DB14995,-7.8,NP-G2-044,XLLRLAABUFOJPC-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
67396,6lxt,DB06629,-7.8,Zibotentan,FJHHZXWJVIEFGJ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
157952,6wiq,DB14989,-7.8,Umbralisib,IUVCFHHAEHNCFT-INIZCTEOSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
100631,6vxs,DB03844,-7.8,"N-(2,6-Diflouro-Benzyl)-4-Sulfamoyl-Benzamide",ZFNCKGXGCCDDFN-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
97906,6vxs,DB00304,-7.8,Desogestrel,RPLCPCMSCLEKRS-BPIQYHPVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
67391,6lxt,DB06622,-7.8,7-beta-Hydroxyepiandrosterone,VFPMCLQMAUVEHD-UCPSWNCLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
62057,6crv,DB13020,-7.8,Apratastat,MAVDNGWEBZTACC-HNNXBMFYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
68237,6lxt,DB07686,-7.8,"4-{[5-(CYCLOHEXYLAMINO)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE",VPOGRVWIIVMWRI-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
157899,6wiq,DB13943,-7.8,Testosterone cypionate,HPFVBGJFAYZEBE-ZLQWOROUSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
63954,6lxt,DB00897,-7.8,Triazolam,JOFWLTCLBGQGBO-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
68228,6lxt,DB07676,-7.8,"3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)-1H,2'H-2,3'-biindol-2'-one",CKLAPOFDFZKCPB-LBPRGKRZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
88761,6m3m,DB14735,-7.8,Cannabichromene,UVOLYTDXHDXWJU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
95875,6m71,DB12073,-7.8,Albaconazole,UHIXWHUVLCAJQL-MPBGBICISA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
139459,6w9c,DB13496,-7.8,Iprindole,PLIGPBGDXASWPX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
25140,6cs2,DB00377,-7.8,Palonosetron,CPZBLNMUGSZIPR-NVXWUHKLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
153073,6wiq,DB04903,-7.8,Pagoclone,HIUPRQPBWVEQJJ-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
65105,6lxt,DB02400,-7.8,"5-Methoxy-1,2-Dimethyl-3-(4-Nitrophenoxymethyl)Indole-4,7-Dione",IBLWSLZYYZHSRG-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
146093,6w9q,DB08111,-7.8,"4-[(6-phenyl[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl]phenol",ZGJYGQLGSXWEMY-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
67478,6lxt,DB06780,-7.8,Desoxycorticosterone acetate,VPGRYOFKCNULNK-ACXQXYJUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
136636,6w9c,DB07352,-7.8,Apigenin,KZNIFHPLKGYRTM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136712,6w9c,DB07443,-7.8,(2Z)-N-biphenyl-4-yl-2-cyano-3-hydroxybut-2-enamide,MUVPBAIVOHJDOC-VBKFSLOCSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
156400,6wiq,DB13042,-7.8,Fenoverine,UBAJTZKNDCEGKL-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
24522,6cs2,DB02276,-7.8,(S)-2-(Phosphonoxy)Caproyl-L-Leucyl-P-Nitroanilide,HARXAJAHMRMERT-HOTGVXAUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
87334,6m3m,DB12179,-7.8,Secoisolariciresinol,PUETUDUXMCLALY-HOTGVXAUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
95929,6m71,DB12149,-7.8,S-3304,YWCLDDLVLSQGSZ-JOCHJYFZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
146074,6w9q,DB08092,-7.8,3-fluoro-N-1H-indol-5-yl-5-morpholin-4-ylbenzamide,VMLSXFMXUNVCSK-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
136714,6w9c,DB07446,-7.8,N-(biphenyl-4-ylsulfonyl)-D-leucine,FBSVJQQVDISETN-QGZVFWFLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
36175,1r42,DB02573,-7.8,"2'-Deoxycytidine-2'-Deoxyadenosine-3',5'-Monophosphate",LYWWDKIADIGKTH-IDMWBNCISA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
15962,6lzg,DB02123,-7.8,Glycochenodeoxycholic Acid,GHCZAUBVMUEKKP-GYPHWSFCSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
101982,6vxs,DB06871,-7.8,17-METHYL-17-ALPHA-DIHYDROEQUILENIN,FQMQOMRDADWGJJ-GBESFXJTSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
136506,6w9c,DB07195,-7.8,"4-[(1S,2S,5S)-5-(HYDROXYMETHYL)-6,8,9-TRIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL",DTZWKYVREFMAJA-QXWBOSQLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
146143,6w9q,DB08164,-7.8,"(3R,4R)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN-3-AMINE",GOBIXGZJSMAOFV-QRWLVFNGSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
67468,6lxt,DB06755,-7.8,Beta carotene,OENHQHLEOONYIE-JLTXGRSLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
95795,6m71,DB11951,-7.8,Lemborexant,MUGXRYIUWFITCP-PGRDOPGGSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
16045,6lzg,DB02466,-7.8,"4-[3-Oxo-3-(5,5,8,8-Tetramethyl-5,6,7,8-Tetrahydro-Naphthalen-2-Yl)-Propenyl]-Benzoic Acid",ZXQHMEUGMCXKLO-KPKJPENVSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
146252,6w9q,DB08305,-7.8,"(3R)-3-cyclopentyl-6-methyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2-benzothiazine 1,1-dioxide",KQAGZLQCEURCKJ-QGZVFWFLSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
156374,6wiq,DB13003,-7.8,Cortivazol,RKHQGWMMUURILY-UHRZLXHJSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
92323,6m71,DB04243,-7.8,5-Methyluridine 5'-Monophosphate,IGWHDMPTQKSDTL-JXOAFFINSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
139489,6w9c,DB13540,-7.8,Isepamicin,UDIIBEDMEYAVNG-ZKFPOVNWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
67437,6lxt,DB06710,-7.8,Methyltestosterone,GCKMFJBGXUYNAG-HLXURNFRSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
136538,6w9c,DB07234,-7.8,"3-{[(1R)-1-phenylethyl]amino}-4-(pyridin-4-ylamino)cyclobut-3-ene-1,2-dione",MCBPNFWHHNJTGN-LLVKDONJSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
67440,6lxt,DB06713,-7.8,Norelgestromin,ISHXLNHNDMZNMC-XUDSTZEESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
139470,6w9c,DB13511,-7.8,Clebopride,BVPWJMCABCPUQY-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
24512,6cs2,DB02266,-7.8,Flufenamic Acid,LPEPZBJOKDYZAD-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
136552,6w9c,DB07251,-7.8,"N'-(3-CHLORO-4-METHOXY-PHENYL)-N-(3,4,5-TRIMETHOXYPHENYL)-1,3,5-TRIAZINE-2,4-DIAMINE",ZVWFECUPYCFYBL-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
95824,6m71,DB11999,-7.8,Vosaroxin,XZAFZXJXZHRNAQ-STQMWFEESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
102045,6vxs,DB06940,-7.8,"N-ethyl-4-{[5-(methoxycarbamoyl)-2-methylphenyl]amino}-5-methylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide",ZZTMFGIGOADCFX-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
16021,6lzg,DB02360,-7.8,Bis-Napthyl Beta-Ketophosphonic Acid,OFHMUASCSJJNNA-JOCHJYFZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
70231,6lxt,DB12341,-7.8,LY-2456302,ZHPMYDSXGRRERG-DEOSSOPVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
67451,6lxt,DB06730,-7.8,Gestodene,SIGSPDASOTUPFS-XUDSTZEESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
95840,6m71,DB12021,-7.8,Dinaciclib,PIMQWRZWLQKKBJ-SFHVURJKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
88793,6m3m,DB14808,-7.8,Lumicitabine,MJVKYGMNSQJLIN-KYZVSKTDSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87265,6m3m,DB12074,-7.8,Censavudine,OSYWBJSVKUFFSU-SKDRFNHKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
70236,6lxt,DB12350,-7.8,Rostafuroxin,AEAPORIZZWBIEX-DTBDINHYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
89306,6m71,DB00317,-7.8,Gefitinib,XGALLCVXEZPNRQ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
90751,6m71,DB02154,-7.8,"2,3-Bis-Benzo[1,3]Dioxol-5-Ylmethyl-Succinic Acid",FFYBYVPVYLMLAR-KBPBESRZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
102112,6vxs,DB07024,-7.8,"2-(3,4-DIHYDROXYPHENYL)-8-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-3-HYDROXY-6-METHYL-4H-CHROMEN-4-ONE",CEXBEGBNDJVZPK-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
22824,6cs2,HMDB0001852,-7.8,all-trans-Retinoic acid,SHGAZHPCJJPHSC-YCNIQYBTSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
95536,6m71,DB11511,-7.8,Difloxacin,NOCJXYPHIIZEHN-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
92624,6m71,DB04649,-7.8,TETRAHEDRAL INTERMEDIATE OF BLASTICIDIN S,MVFPGTZTOAHVBP-HXYLPHSESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
98056,6vxs,DB00486,-7.8,Nabilone,GECBBEABIDMGGL-RTBURBONSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
14002,6lzg,T3D3613,-7.8,Microcystin-LL,GLDUYXHQWLQPRR-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
136056,6w9c,DB06436,-7.8,Semaxanib,WUWDLXZGHZSWQZ-WQLSENKSSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
67284,6lxt,DB06334,-7.8,Tucidinostat,SZMJVTADHFNAIS-BJMVGYQFSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
65304,6lxt,DB02656,-7.8,LY-294002,CZQHHVNHHHRRDU-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
92619,6m71,DB04643,-7.8,"4-{3-CHLORO-4-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-PHENOXY}-BUTYRIC ACID",FYQVFMLCZJZZEM-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
146620,6w9q,DB08746,-7.8,1-[[(1E)-2-(4-CHLOROPHENYL)ETHENYL]SULFONYL]-4-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]PIPERAZINE,ZOSSOFIFNGGDKG-GIJQJNRQSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
25222,6cs2,DB03104,-7.8,RU82129,NKMPOVPTYDXGEC-MNRBYUMSSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
100498,6vxs,DB03678,-7.8,"(6,7-Difluoro-Quinazolin-4-Yl)-(1-Methyl-2,2-Diphenyl-Ethyl)-Amine",WVGZKPGUHOZIJQ-HNNXBMFYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
139708,6w9c,DB13828,-7.8,Cyfluthrin,QQODLKZGRKWIFG-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
86983,6m3m,DB11662,-7.8,Rabusertib,SYYBDNPGDKKJDU-ZDUSSCGKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
146577,6w9q,DB08702,-7.8,"2,5-DIPHENYLFURAN-3,4-DICARBOXYLIC ACID",QPKYPOMZPFDBEZ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
89016,6m3m,DB15293,-7.8,Epalrestat,CHNUOJQWGUIOLD-NFZZJPOKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136120,6w9c,DB06600,-7.8,Nemonoxacin,AVPQPGFLVZTJOR-RYUDHWBXSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
98027,6vxs,DB00450,-7.8,Droperidol,RMEDXOLNCUSCGS-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
136124,6w9c,DB06608,-7.8,Tafenoquine,LBHLFPGPEGDCJG-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
65283,6lxt,DB02628,-7.8,"1-[3,3-Dimethyl-2-(2-Methylamino-Propionylamino)-Butyryl]-Pyrrolidine-2-Carboxylic Acid(1,2,3,4-Tetrahydro-Naphthalen-1-Yl)-Amide",JUJIMRZGUBTJRV-NASSWSRMSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
90686,6m71,DB02071,-7.8,WAY-151693,AINJYWXKBKRQSX-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
98021,6vxs,DB00444,-7.8,Teniposide,NRUKOCRGYNPUPR-QBPJDGROSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
95528,6m71,DB11485,-7.8,Ceftiofur,ZBHXIWJRIFEVQY-IHMPYVIRSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
98060,6vxs,DB00490,-7.8,Buspirone,QWCRAEMEVRGPNT-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
146735,6w9q,DB08907,-7.8,Canagliflozin,XTNGUQKDFGDXSJ-ZXGKGEBGSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
156242,6wiq,DB12627,-7.8,GSK-1292263,AYJRTVVIBJSSKN-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
156246,6wiq,DB12635,-7.8,Aleplasinin,HSXLMAFNWCSZGP-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
152307,6wiq,DB03878,-7.8,N-[4-Methyl-3-[[4-(3-Pyridinyl)-2-Pyrimidinyl]Amino]Phenyl]-3-Pyridinecarboxamide,YWQVBESSYLICRX-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
63739,6lxt,DB00643,-7.8,Mebendazole,OPXLLQIJSORQAM-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
158156,7bv1,DB00445,-7.8,Epirubicin,AOJJSUZBOXZQNB-VTZDEGQISA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95430,6m71,DB11260,-7.8,Diacetyl benzoyl lathyrol,JPYYWXPAHJBKJX-VWSFRBHVSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
67265,6lxt,DB06274,-7.8,Alvimopan,UPNUIXSCZBYVBB-JVFUWBCBSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
70385,6lxt,DB12567,-7.8,Camicinal,RZKDEGZIFSJVNA-IBGZPJMESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
135973,6w9c,DB06209,-7.8,Prasugrel,DTGLZDAWLRGWQN-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
70384,6lxt,DB12566,-7.8,Decernotinib,ASUGUQWIHMTFJL-QGZVFWFLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
68311,6lxt,DB07772,-7.8,"(1R)-1-{[(4'-methoxy-1,1'-biphenyl-4-yl)sulfonyl]amino}-2-methylpropylphosphonic acid",BZVYQWLRCHLAGK-QGZVFWFLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
98082,6vxs,DB00522,-7.8,Bentiromide,SPPTWHFVYKCNNK-FQEVSTJZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
158128,7bv1,DB00412,-7.8,Rosiglitazone,YASAKCUCGLMORW-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
90671,6m71,DB02049,-7.8,2-{4-[4-(4-Chloro-Phenoxy)-Benzenesulfonyl]-Tetrahydro-Pyran-4-Yl}-N-Hydroxy-Acetamide,QOPFTBAEAJQKSY-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
139740,6w9c,DB13873,-7.8,Fenofibric acid,MQOBSOSZFYZQOK-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
135934,6w9c,DB06133,-7.8,Dimethylcurcumin,ZMGUKFHHNQMKJI-CIOHCNBKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
90678,6m71,DB02059,-7.8,Adenosine-5-Diphosphoribose,SRNWOUGRCWSEMX-ZQSHOCFMSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
152375,6wiq,DB03966,-7.8,Clorobiocin,FJAQNRBDVKIIKK-LFLQOBSNSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
65340,6lxt,DB02703,-7.8,Fusidic acid,IECPWNUMDGFDKC-MZJAQBGESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
98083,6vxs,DB00523,-7.8,Alitretinoin,SHGAZHPCJJPHSC-ZVCIMWCZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
146370,6w9q,DB08449,-7.8,"2-(3-((4,5,7-trifluorobenzo[d]thiazol-2-yl)methyl)-1H-pyrrolo[2,3-b]pyridin-1-yl)acetic acid",IEVFQDJUDLCOQY-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
139687,6w9c,DB13803,-7.8,Xipamide,MTZBBNMLMNBNJL-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136153,6w9c,DB06670,-7.8,Odanacatib,FWIVDMJALNEADT-SFTDATJTSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
92484,6m71,DB04471,-7.8,"2-Phenyl-1-[4-(2-Piperidin-1-Yl-Ethoxy)-Phenyl]-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol",FMWVCTJKLAVRPB-MUUNZHRXSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
139641,6w9c,DB13739,-7.8,Penamecillin,NLOOMWLTUVBWAW-HLLBOEOZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
152752,6wiq,DB04477,-7.8,"N-1,2,3,4-Tetrahydronaphth-1-Yl-2'-[3,5-Dimethoxybenzamido]-2'-Deoxy-Adenosine",FDZQGEIYGFPMOB-ZUURFMEUSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
25204,6cs2,DB03084,-7.8,"Cyclopropyl-{4-[5-(3,4-Dichlorophenyl)-2-[(1-Methyl)-Piperidin]-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine",XCTKFTOEAKJMII-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
100557,6vxs,DB03755,-7.8,"Adenosine-5'-[Beta, Gamma-Methylene]Tetraphosphate",ARRGHMSEJJFDME-IOSLPCCCSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
158019,7bv1,DB00278,-7.8,Argatroban,KXNPVXPOPUZYGB-IOVMHBDKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
70333,6lxt,DB12483,-7.8,Copanlisib,PZBCKZWLPGJMAO-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
139626,6w9c,DB13721,-7.8,Cypermethrin,KAATUXNTWXVJKI-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
97956,6vxs,DB00367,-7.8,Levonorgestrel,WWYNJERNGUHSAO-XUDSTZEESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
25207,6cs2,DB03086,-7.8,"N'-(2s,3r)-3-Amino-4-Cyclohexyl-2-Hydroxy-Butano-N-(4-Methylphenyl)Hydrazide",IQMLIGOOOFEBAH-CVEARBPZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
139606,6w9c,DB13692,-7.8,Tretoquinol,RGVPOXRFEPSFGH-AWEZNQCLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136277,6w9c,DB06927,-7.8,[5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-YL]ACETONITRILE,ZKJVCUXZMYKTLT-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136280,6w9c,DB06930,-7.8,"N-[amino(imino)methyl]-2-(2,5-diphenyl-1H-pyrrol-1-yl)acetamide",WVLDNAVUCUAGDP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
25201,6cs2,DB03081,-7.8,Crc200 (Chiron-Behring),ZOXOKTJHZSUHRJ-XZOQPEGZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
136286,6w9c,DB06936,-7.8,N-(4-carbamimidoylbenzyl)-1-(4-methylpentanoyl)-L-prolinamide,AEKJCSNKYXWOAQ-INIZCTEOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
146400,6w9q,DB08487,-7.8,3-({4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-2-OXOPIPERAZIN-1-YL}METHYL)BENZENECARBOXIMIDAMIDE,PRMSFVUWLBPPLY-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
97954,6vxs,DB00365,-7.8,Grepafloxacin,AIJTTZAVMXIJGM-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
36216,1r42,DB02629,-7.8,Inhibitor Bea403,LYHLPPXMBKMSSZ-JQFCFGFHSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
157990,6wiq,DB15442,-7.8,Trilaciclib,PDGKHKMBHVFCMG-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
61058,6crv,DB11442,-7.8,Oleandomycin,RZPAKFUAFGMUPI-QESOVKLGSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
70328,6lxt,DB12477,-7.8,Perfluoro tert-butylcyclohexane,VLTXBOGHSBHSAC-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
92570,6m71,DB04578,-7.8,"(S)-2-[(R)-3-amino-4-(2-fluorophenyl)butyryl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide",OEVYDSSAPNIURZ-AEFFLSMTSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
102130,6vxs,DB07042,-7.8,"7-amino-2-tert-butyl-4-{[2-(1H-imidazol-4-yl)ethyl]amino}pyrido[2,3-d]pyrimidine-6-carboxamide",XESUNWBIAADLPI-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
88967,6m3m,DB15201,-7.8,Norbixin,ZVKOASAVGLETCT-UOGKPENDSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
62101,6crv,DB13084,-7.8,Pyritinol,SIXLXDIJGIWWFU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
97996,6vxs,DB00414,-7.8,Acetohexamide,VGZSUPCWNCWDAN-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
86999,6m3m,DB11682,-7.8,Daprodustat,RUEYEZADQJCKGV-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
156285,6wiq,DB12693,-7.8,Ritanserin,JUQLTPCYUFPYKE-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
156286,6wiq,DB12694,-7.8,CE-326597,UBNMGTSDHSQBEL-PMERELPUSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
87000,6m3m,DB11683,-7.8,PF-06282999,ICYNYWFGIDGBRD-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
146473,6w9q,DB08572,-7.8,4-{[4-AMINO-6-(CYCLOHEXYLMETHOXY)-5-NITROSOPYRIMIDIN-2-YL]AMINO}BENZAMIDE,YBKLJTXDSBEVRV-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
100533,6vxs,DB03725,-7.8,Phosphomethylphosphonic Acid-Guanylate Ester,PHBDHXOBFUBCJD-KQYNXXCUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
146470,6w9q,DB08569,-7.8,"3-PYRIDIN-4-YL-2,4-DIHYDRO-INDENO[1,2-.C.] PYRAZOLE",VLPMRZSKJUTRBQ-IBGZPJMESA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
136242,6w9c,DB06889,-7.8,"3-(1H-tetrazol-5-ylmethyl)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(3H)-one",QSBQXAOOVSQABJ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
92545,6m71,DB04549,-7.8,"4-(Aminosulfonyl)-N-[(2,3,4-Trifluorophenyl)Methyl]-Benzamide",AANTYZRUJFNZFI-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
146465,6w9q,DB08560,-7.8,3-FLUORO-N-[1-(4-FLUOROPHENYL)-3-(2-THIENYL)-1H-PYRAZOL-5-YL]BENZENESULFONAMIDE,GULUFDCOGAXLEP-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
90711,6m71,DB02101,-7.8,"(S,R)-fidarestat",WAAPEIZFCHNLKK-QPUJVOFHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
146439,6w9q,DB08531,-7.8,"5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",CVYWYUAQFJMLEO-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
136199,6w9c,DB06739,-7.8,Seratrodast,ZBVKEHDGYSLCCC-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
97965,6vxs,DB00377,-7.8,Palonosetron,CPZBLNMUGSZIPR-NVXWUHKLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
146430,6w9q,DB08521,-7.8,4-[5-(4-FLUORO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-3H-IMIDAZOL-4-YL]-PYRIDINE,CDMGBJANTYXAIV-HHHXNRCGSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
70343,6lxt,DB12505,-7.8,E-7820,LWGUASZLXHYWIV-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
156311,6wiq,DB12903,-7.8,DEBIO-1347,BEMNJULZEQTDJY-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
146410,6w9q,DB08497,-7.8,"(1S)-2-oxo-1-phenyl-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate",NKBDSMREMMRFSI-INIZCTEOSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
63822,6lxt,DB00741,-7.8,Hydrocortisone,JYGXADMDTFJGBT-VWUMJDOOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
157659,6wiq,DB12260,-7.8,Radiprodil,GKGRZLGAQZPEHO-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
8331,6lzg,DB05450,-7.8,Smilagenin,GMBQZIIUCVWOCD-UQHLGXRBSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
159820,7bv1,DB06626,-7.8,Axitinib,RITAVMQDGBJQJZ-FMIVXFBMSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
31978,6cs2,DB15138,-7.8,AZD-9496,DFBDRVGWBHBJNR-BBNFHIFMSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
55876,6crv,DB01581,-7.8,Sulfamerazine,QPPBRPIAZZHUNT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27907,6cs2,DB07469,-7.8,"(3aS)-3a-hydroxy-7-methyl-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one",KAJFGRLMKVNMLH-GOSISDBHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
79884,6m2n,DB13873,-7.8,Fenofibric acid,MQOBSOSZFYZQOK-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
107988,6vxx,DB06654,-7.8,Safinamide,NEMGRZFTLSKBAP-LBPRGKRZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29095,6cs2,DB08734,-7.8,"6,6-DIMETHYL-1-[3-(2,4,5-TRICHLOROPHENOXY)PROPOXY]-1,6-DIHYDRO-1,3,5-TRIAZINE-2,4-DIAMINE",MJZJYWCQPMNPRM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
164379,7bv1,DB07764,-7.8,FLUORESCIN,MURGITYSBWUQTI-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
164389,7bv1,DB07776,-7.8,Flavone,VHBFFQKBGNRLFZ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
164399,7bv1,DB07788,-7.8,"(3R,5Z,8S,9S,11E)-8,9,16-TRIHYDROXY-14-METHOXY-3-METHYL-3,4,9,10-TETRAHYDRO-1H-2-BENZOXACYCLOTETRADECINE-1,7(8H)-DIONE",NEQZWEXWOFPKOT-QHSZRYGNSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
31943,6cs2,DB15078,-7.8,Rogaratinib,HNLRRJSKGXOYNO-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
79854,6m2n,DB13835,-7.8,Caroverine,MSPRUJDUTKRMLM-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
55850,6crv,DB01553,-7.8,Cloxazolam,ZIXNZOBDFKSQTC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29098,6cs2,DB08737,-7.8,"(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-9-OL",FSYFYSFYUHBIHE-GLJUWKHASA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
107998,6vxx,DB06680,-7.8,Asoprisnil,GJMNAFGEUJBOCE-MEQIQULJSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79856,6m2n,DB13837,-7.8,Doxefazepam,VOJLELRQLPENHL-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
122879,6w4b,DB14067,-7.8,Dofequidar,KLWUUPVJTLHYIM-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
55890,6crv,DB01603,-7.8,Meticillin,RJQXTJLFIWVMTO-TYNCELHUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
122881,6w4b,DB14069,-7.8,ONT-093,RSJCLODJSVZNQA-BQYQJAHWSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
79964,6m2n,DB14055,-7.8,(S)-Warfarin,PJVWKTKQMONHTI-HNNXBMFYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
73685,6m2n,DB02363,-7.8,2'-Monophosphoadenosine-5'-Diphosphate,YPTPYQSAVGGMFN-KQYNXXCUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79960,6m2n,DB14045,-7.8,Cholesteryl chloride,OTVRYZXVVMZHHW-DPAQBDIFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
123081,6w4b,DB14790,-7.8,BPN-14770,KRRGWHSEDYQKDQ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
56004,6crv,DB01750,-7.8,1-naphthaleneacetic acid,PRPINYUDVPFIRX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
32027,6cs2,DB01116,-7.8,Trimethaphan,CHQOEHPMXSHGCL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
107852,6vxx,DB05252,-7.8,Fenoxaprop-ethyl,PQKBPHSEKWERTG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55992,6crv,DB01734,-7.8,3-(Oxalyl-Amino)-Naphthalene-2-Carboxylic Acid,DQBLKSRRWDWNKQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107881,6vxx,DB05421,-7.8,CP-122721,ZIWFCOIGUNPHPM-HKUYNNGSSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
164363,7bv1,DB07747,-7.8,"(3R)-N-(4-CHLOROPHENYL)-3-(HYDROXYMETHYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONAMIDE",YTBGBMPLINFTBQ-OAHLLOKOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
79937,6m2n,DB13994,-7.8,AZD-7325,KYDURMHFWXCKMW-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
55937,6crv,DB01659,-7.8,"3-(1,10-Phenanthrol-2-Yl)-L-Alanine",LODBCIBKOKOGNL-LBPRGKRZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55926,6crv,DB01643,-7.8,Thymidine monophosphate,GYOZYWVXFNDGLU-XLPZGREQSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107948,6vxx,DB05791,-7.8,Perflubron,WTWWXOGTJWMJHI-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107957,6vxx,DB05830,-7.8,Trestolone,YSGQGNQWBLYHPE-CFUSNLFHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29102,6cs2,DB08741,-7.8,"5-[[(2R)-2-cyclopropyl-7,8-dimethoxy-2H-chromen-5-yl]methyl]pyrimidine-2,4-diamine",HWJPWWYTGBZDEG-AWEZNQCLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
55820,6crv,DB01523,-7.8,Clonitazene,GPZLDQAEBHTMPG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
10895,6lzg,DB09226,-7.8,RP-5063,PMKMNTBZJOXTJW-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
27934,6cs2,DB07498,-7.8,"4-[3-(3-NITROPHENYL)-1,2,4-OXADIAZOL-5-YL]BUTANOIC ACID",LQQYZJRCWBRIMW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
79760,6m2n,DB13710,-7.8,Metenolone,ANJQEDFWRSLVBR-VHUDCFPWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
122420,6w4b,DB13371,-7.8,Difenpiramide,PWHROYKAGRUWDQ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
164462,7bv1,DB07858,-7.8,(2S)-2-(4-chlorophenyl)-2-[4-(1H-pyrazol-4-yl)phenyl]ethanamine,HWVGILTYGZFGLR-KRWDZBQOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
55700,6crv,DB01355,-7.8,Hexobarbital,UYXAWHWODHRRMR-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79747,6m2n,DB13687,-7.8,Niaprazine,RSKQGBFMNPDPLR-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
73803,6m2n,DB02507,-7.8,4-Hydroxy-3-[(1s)-3-Oxo-1-Phenylbutyl]-2h-Chromen-2-One,PJVWKTKQMONHTI-HNNXBMFYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
164468,7bv1,DB08039,-7.8,"(3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE",LOGJQOUIVKBFGH-YBEGLDIGSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
55684,6crv,DB01331,-7.8,Cefoxitin,WZOZEZRFJCJXNZ-ZBFHGGJFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79726,6m2n,DB13665,-7.8,Fluanisone,IRYFCWPNDIUQOW-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
31865,6cs2,DB14902,-7.8,JHU-75528 C-11,MCNQUWLLXZZZAC-BJUDXGSMSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
79721,6m2n,DB13660,-7.8,Propicillin,HOCWPKXKMNXINF-XQERAMJGSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
29150,6cs2,DB08789,-7.8,"2-AMINO-4-(2,4-DICHLOROPHENYL)-N-ETHYLTHIENO[2,3-D]PYRIMIDINE-6-CARBOXAMIDE",YPEOXUOUTBMBCX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
79716,6m2n,DB13653,-7.8,Lorcainide,XHOJAWVAWFHGHL-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
108131,6vxx,DB07139,-7.8,3-[5-(3-nitrophenyl)thiophen-2-yl]propanoic acid,IHKCOKRMJRDWAL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28026,6cs2,DB07596,-7.8,"(17beta)-17-(cyanomethyl)-2-methox1tra-1(10),2,4-trien-3-yl sulfamate",NTSPHKOMJMBWOU-NNKXXINSSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
164453,7bv1,DB07848,-7.8,5-Chloro-N-{(3S)-1-[(2S)-1-(4-morpholinyl)-1-oxo-2-propanyl]-2-oxo-3-pyrrolidinyl}-1H-indole-2-sulfonamide,BHNMMFGOJRIAEZ-LRDDRELGSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
123108,6w4b,DB14859,-7.8,Fosifloxuridine nafalbenamide,BIOWRMNRHMERIO-ZVAHOJSLSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
27996,6cs2,DB07563,-7.8,"1-{7-cyclohexyl-6-[4-(4-methylpiperazin-1-yl)benzyl]-7H-pyrrolo[2,3-d]pyrimidin-2-yl}methanamine",GCJSOJRPNOWSEH-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
73783,6m2n,DB02484,-7.8,Cytidine 5'-Diphosphoglycerol,HHPOUCCVONEPRK-CNYIRLTGSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
27937,6cs2,DB07501,-7.8,(2S)-1-{4-[(4-Anilino-5-bromo-2-pyrimidinyl)amino]phenoxy}-3-(dimethylamino)-2-propanol,MEIJADBULOETOV-KRWDZBQOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
27939,6cs2,DB07504,-7.8,(2R)-1-{4-[(4-Anilino-5-bromo-2-pyrimidinyl)amino]phenoxy}-3-(dimethylamino)-2-propanol,MEIJADBULOETOV-QGZVFWFLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
122652,6w4b,DB13685,-7.8,Quingestanol,PCJFRMOEZQQSAX-AIOSZGMZSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
29115,6cs2,DB08753,-7.8,"4-{(1E)-3-OXO-3-[(2-PHENYLETHYL)AMINO]PROP-1-EN-1-YL}-1,2-PHENYLENE DIACETATE",GARHCDOTUULBOQ-PKNBQFBNSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
55795,6crv,DB01489,-7.8,Camazepam,PXBVEXGRHZFEOF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
122616,6w4b,DB13643,-7.8,Loprazolam,UTEFBSAVJNEPTR-RGEXLXHISA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
27948,6cs2,DB07513,-7.8,7-[(3-CHLOROBENZYL)OXY]-4-[(METHYLAMINO)METHYL]-2H-CHROMEN-2-ONE,JMGUSOLCNQVZCT-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
122590,6w4b,DB13607,-7.8,Picloxydine,YNCLPFSAZFGQCD-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
108047,6vxx,DB06751,-7.8,Drotaverine,OMFNSKIUKYOYRG-MOSHPQCFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55769,6crv,DB01462,-7.8,Etonitazene,PXDBZSCGSQSKST-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27969,6cs2,DB07535,-7.8,2-amino-6-[2-(1H-indol-6-yl)ethyl]pyrimidin-4(3H)-one,VRAZIAJSKFRSIP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
55749,6crv,DB01439,-7.8,3-Methylthiofentanyl,SRARDYUHGVMEQI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
122527,6w4b,DB13520,-7.8,Metergoline,WZHJKEUHNJHDLS-QTGUNEKASA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
73778,6m2n,DB02479,-7.8,(R)-N-(3-Indol-1-Yl-2-Methyl-Propyl)-4-Sulfamoyl-Benzamide,ZFWHOUCRVSOZJE-CQSZACIVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
27979,6cs2,DB07544,-7.8,N'-(5-CHLOROBENZOFURAN-2-CARBONYL)-2-(TRIFLUOROMETHYL)BENZENESULFONOHYDRAZIDE,ZLQBZYKAQQWOTK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
164450,7bv1,DB07844,-7.8,6-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1-BENZOTHIOPHENE-2-SULFONAMIDE,PHLKBODTBJLXRD-WFASDCNBSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
107797,6vxx,DB04628,-7.8,Allosamidin,MDWNFWDBQGOKNZ-XYUDZHFQSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
7493,6lzg,DB03893,-7.8,Thionicotinamide-Adenine-Dinucleotide,UQYPZLRUJKCREN-NNYOXOHSSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
107767,6vxx,DB04590,-7.8,(2R)-({4-[AMINO(IMINO)METHYL]PHENYL}AMINO){5-ETHOXY-2-FLUORO-3-[(3R)-TETRAHYDROFURAN-3-YLOXY]PHENYL}ACETICACID,PGYOHIAQCFZQDK-AUUYWEPGSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
123618,6w4h,DB00179,-7.8,Masoprocol,HCZKYJDFEPMADG-TXEJJXNPSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
107408,6vxx,DB03267,-7.8,1-Allyl-3-Butyl-8-(N-Acetyl-4-Aminobenzyl)-Xanthine,XFOWZKUTPKXWIE-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56215,6crv,DB02036,-7.8,"2-(3,4-Dihydro-3-Oxo-2h-Benzo[B][1,4]Thiazin-2-Yl)-N-Hydroxyacetamide",UKDWCJNGBPZOBU-MRVPVSSYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80411,6m2n,DB15300,-7.8,Hydroquinidine,LJOQGZACKSYWCH-LHHVKLHASA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
56203,6crv,DB02020,-7.8,Alrestatin,GCUCIFQCGJIRNT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
123513,6w4b,DB00246,-7.8,Ziprasidone,MVWVFYHBGMAFLY-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
80297,6m2n,DB15080,-7.8,ELX-02,KJBRSTPUILEBDR-YBNFDXCTSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
28973,6cs2,DB00801,-7.8,Halazepam,WYCLKVQLVUQKNZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
164222,7bv1,DB07396,-7.8,"1-{2-[3-(2-Chloro-4,5-difluoro-benzoyl)-ureido]-4-fluoro-phenyl}-piperidine-4-carboxylic acid",KAJJGOCSAXKXBD-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
123391,6w4b,DB15450,-7.8,PF-05105679,BXNMZRPTQFVRFA-QGZVFWFLSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
164228,7bv1,DB07403,-7.8,"4-[(3-CHLORO-4-{[(2R)-3,3,3-TRIFLUORO-2-HYDROXY-2-METHYLPROPANOYL]AMINO}PHENYL)SULFONYL]-N,N-DIMETHYLBENZAMIDE",DTDZLJHKVNTQGZ-GOSISDBHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
123368,6w4b,DB15408,-7.8,Silmitasertib,MUOKSQABCJCOPU-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
107508,6vxx,DB03695,-7.8,Piritrexim,VJXSSYDSOJBUAV-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28985,6cs2,DB08614,-7.8,"3-[[(METHYLAMINO)SULFONYL]AMINO]-2-OXO-6-PHENYL-N-[3,3,3-TRIFLUORO-1-(1-METHYLETHYL)-2-OXOPHENYL]-1(2H)-PYRIDINE ACETAMIDE",MYFMPKCOIMRDDD-KRWDZBQOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
123345,6w4b,DB15356,-7.8,SLV-334,LOFDNSDPZTVIIO-VPUSJEBWSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
123619,6w4h,DB00180,-7.8,Flunisolide,XSFJVAJPIHIPKU-XWCQMRHXSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
164240,7bv1,DB07418,-7.8,bis(4-nitrophenyl) hydrogen phosphate,MHSVUSZEHNVFKW-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
131988,6w4h,DB15156,-7.8,ABT-072,XMZSTQYSBYEENY-RMKNXTFCSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
11097,6lzg,DB11410,-7.8,Fenbendazole,HDDSHPAODJUKPD-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
11117,6lzg,DB11446,-7.8,Oxfendazole,BEZZFPOZAYTVHN-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
107334,6vxx,DB03176,-7.8,KB-141,OZYQIQVPUZANTM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
123723,6w4h,DB00301,-7.8,Flucloxacillin,UIOFUWFRIANQPC-JKIFEVAISA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
7416,6lzg,DB00445,-7.8,Epirubicin,AOJJSUZBOXZQNB-VTZDEGQISA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
56256,6crv,DB02089,-7.8,CP-526423,MWWXABBBAPKJDX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80590,6m3m,DB00194,-7.8,Vidarabine,OIRDTQYFTABQOQ-UHTZMRCNSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
32212,6cs2,DB01185,-7.8,Fluoxymesterone,YLRFCQOZQXIBAB-RBZZARIASA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
32207,6cs2,DB01180,-7.8,Rescinnamine,SZLZWPPUNLXJEA-LAFLMMDJSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
80588,6m3m,DB00192,-7.8,Indecainide,UCEWGESNIULAGX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
164162,7bv1,DB07325,-7.8,N-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)METHYL]-3-{[(E)-(2-OXODIHYDROFURAN-3(2H)-YLIDENE)METHYL]AMINO}BENZENESULFONAMIDE,VCOKUBHAJVTVNG-FMIVXFBMSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
123681,6w4h,DB00252,-7.8,Phenytoin,CXOFVDLJLONNDW-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
164165,7bv1,DB07328,-7.8,"METHYL 4-{[({[(2R,5S)-5-{[(2S)-2-(AMINOMETHYL)PYRROLIDIN-1-YL]CARBONYL}PYRROLIDIN-2-YL]METHYL}AMINO)CARBONYL]AMINO}BENZOATE",USDCNOQKDUFKRD-IKGGRYGDSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
123673,6w4h,DB00243,-7.8,Ranolazine,XKLMZUWKNUAPSZ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
80561,6m3m,DB00162,-7.8,Vitamin A,FPIPGXGPPPQFEQ-OVSJKPMPSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
107369,6vxx,DB03221,-7.8,AL7099A,RMOXCYSVWCHXII-GFCCVEGCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
48254,2fxp,DB02885,-7.8,4-Imino-5-Methidyl-2-Trifluoromethylpyrimidine,YKFRUALXTUDSBW-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
73819,6m2n,DB02527,-7.8,Cyclic adenosine monophosphate,IVOMOUWHDPKRLL-KQYNXXCUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
28989,6cs2,DB08619,-7.8,Testosterone succinate,CJQNBXFUHQZFOE-VYAQIDIUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
56138,6crv,DB01937,-7.8,Guanosine-2'-Monophosphate,WTIFIAZWCCBCGE-UUOKFMHZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
123217,6w4b,DB15108,-7.8,Tipranavir C-14,SUJUHGSWHZTSEU-MWQIXQBFSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
56089,6crv,DB01860,-7.8,Cordycepin Triphosphate,NLIHPCYXRYQPSD-BAJZRUMYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
123201,6w4b,DB15075,-7.8,4-demethyl-4-cholesteryloxycarbonylpenclomedine,ZJUUIXYKTPSIOH-LEZJFEBPSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
80040,6m2n,DB14217,-7.8,Quinaprilat,FLSLEGPOVLMJMN-YSSFQJQWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
123187,6w4b,DB15048,-7.8,Licogliflozin,XFJAMQQAAMJFGB-ZQGJOIPISA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
80034,6m2n,DB14208,-7.8,Ramiprilat,KEDYTOTWMPBSLG-HILJTLORSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
123178,6w4b,DB15033,-7.8,Flortaucipir,GETAAWDSFUCLBS-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
107703,6vxx,DB04202,-7.8,Isoformononetin,LNIQZRIHAMVRJA-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
123175,6w4b,DB15028,-7.8,MK-1064,CKTWQGHVNRYNCM-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
107705,6vxx,DB04205,-7.8,"Thymidine-3',5'-Diphosphate",CSNCBOPUCJOHLS-XLPZGREQSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80031,6m2n,DB14201,-7.8,"2,2'-Dibenzothiazyl disulfide",AFZSMODLJJCVPP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
107753,6vxx,DB04571,-7.8,Trioxsalen,FMHHVULEAZTJMA-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
123148,6w4b,DB14935,-7.8,Serabelisib,BLGWHBSBBJNKJO-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
123143,6w4b,DB14929,-7.8,Elsulfavirine,ULTDEARCBRNRGR-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
123137,6w4b,DB14914,-7.8,Flortaucipir F-18,GETAAWDSFUCLBS-SJPDSGJFSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
123228,6w4b,DB15126,-7.8,IMG-7289,KQKBMHGOHXOHTD-KKUQBAQOSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
123314,6w4b,DB15295,-7.8,Tenalisib,HDXDQPRPFRKGKZ-INIZCTEOSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
27799,6cs2,DB07352,-7.8,Apigenin,KZNIFHPLKGYRTM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
123235,6w4b,DB15141,-7.8,Deutivacaftor,PURKAOJPTOLRMP-ASMGOKTBSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
164245,7bv1,DB07423,-7.8,(2S)-3-[4-(acetylamino)phenoxy]-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide,YVXVTLGIDOACBJ-SFHVURJKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
123294,6w4b,DB15257,-7.8,Milademetan,RYAYYVTWKAOAJF-QISPRATLSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
107556,6vxx,DB03755,-7.8,"Adenosine-5'-[Beta, Gamma-Methylene]Tetraphosphate",ARRGHMSEJJFDME-IOSLPCCCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80175,6m2n,DB14791,-7.8,GDC-0425,XEZLBMHDUXSICI-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
164262,7bv1,DB07443,-7.8,(2Z)-N-biphenyl-4-yl-2-cyano-3-hydroxybut-2-enamide,MUVPBAIVOHJDOC-VBKFSLOCSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
164276,7bv1,DB07642,-7.8,"5-{[1-(2-fluorobenzyl)piperidin-4-yl]methoxy}quinazoline-2,4-diamine",GYKIQIOWVKCVBP-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
29006,6cs2,DB00805,-7.8,Minaprine,LDMWSLGGVTVJPG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
80152,6m2n,DB14737,-7.8,Cannabinol,VBGLYOIFKLUMQG-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
73631,6m2n,DB02290,-7.8,"3-{2,6,8-trioxo-9-[(2S,3S,4R)-2,3,4,5-tetrahydroxypentyl]-1,2,3,6,8,9-hexahydro-7H-purin-7-Yl}propyl dihydrogen phosphate",KPHFGOGGKPGLTM-OOZYFLPDSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
107601,6vxx,DB04073,-7.8,N-{3-[4-(3-aminopropyl)piperazin-1-yl]propyl}-3-(beta-D-galactopyranosyloxy)-5-nitrobenzamide,UEIGEWJJVQHIAX-DLBZZEGUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80134,6m2n,DB14682,-7.8,Dextrorphan,JAQUASYNZVUNQP-PVAVHDDUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
19338,6cs2,HMDB0044007,-7.8,"TG(16:0/24:0/20:3(5Z,8Z,11Z))",GKUAJCNVJMNRAV-HPCJMVLVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
29011,6cs2,DB08646,-7.8,TRW3-(2-AMINO-3-HYDROXY-PROPYL)-6-(N'-CYCLOHEXYL-HYDRAZINO)OCTAHYDRO-INDOL-7-OL,PSUOZWHAKZSNOB-LBPRGKRZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
107633,6vxx,DB04114,-7.8,"3-Chloro-9-Ethyl-6,7,8,9,10,11-Hexahydro-7,11-Methanocycloocta[B]Quinolin-12-Amine",QTPHSDHUHXUYFE-NWDGAFQWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107635,6vxx,DB04116,-7.8,Allolactose,DLRVVLDZNNYCBX-VDGMBKLFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
570,6lzg,HMDB0005794,-7.8,Quercetin,REFJWTPEDVJJIY-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
107295,6vxx,DB03121,-7.8,(1-Benzyl-5-methoxy-2-methyl-1H-indol-3-yl)acetic acid,ZEKCBTQHDTUHRJ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55667,6crv,DB01283,-7.8,Lumiracoxib,KHPKQFYUPIUARC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
73828,6m2n,DB02538,-7.8,"N-[4-(2-Methylimidazo[1,2-a]Pyridin-3-Yl)-2-Pyrimidinyl]Acetamide",ZCRPPLDDHBLUES-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
55299,6crv,DB00846,-7.8,Flurandrenolide,POPFMWWJOGLOIF-XWCQMRHXSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79204,6m2n,DB12900,-7.8,Irdabisant,XUKROCVZGZNGSI-CQSZACIVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
55284,6crv,DB00829,-7.8,Diazepam,AAOVKJBEBIDNHE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108449,6vxx,DB08004,-7.8,"(2S)-2-{[3-(3-aminophenyl)imidazo[1,2-b]pyridazin-6-yl]amino}-3-methylbutan-1-ol",PUMVONFFLKPPIM-CQSZACIVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
121536,6w4b,DB12041,-7.8,Mapracorat,VJGFOYBQOIPQFY-XMMPIXPASA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
55276,6crv,DB00821,-7.8,Carprofen,PUXBGTOOZJQSKH-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
164712,7bv1,DB08514,-7.8,"6-amino-2-[(thiophen-2-ylmethyl)amino]-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",IQKMJWDYMFWZRF-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
55268,6crv,DB00812,-7.8,Phenylbutazone,VYMDGNCVAMGZFE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79116,6m2n,DB12752,-7.8,Bucindolol,FBMYKMYQHCBIGU-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
121490,6w4b,DB11966,-7.8,BMS-986094,YFXGICNMLCGLHJ-RSKRLRQZSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
121489,6w4b,DB11965,-7.8,SJG-136,RWZVMMQNDHPRQD-SFTDATJTSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
55245,6crv,DB00784,-7.8,Mefenamic acid,HYYBABOKPJLUIN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
121480,6w4b,DB11951,-7.8,Lemborexant,MUGXRYIUWFITCP-PGRDOPGGSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
10648,6lzg,DB08878,-7.8,Aminopterin,TVZGACDUOSZQKY-LBPRGKRZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
121507,6w4b,DB11995,-7.8,Avatrombopag,OFZJKCQENFPZBH-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
79221,6m2n,DB12926,-7.8,Cafedrine,UJSKUDDDPKGBJY-WFASDCNBSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
164698,7bv1,DB08498,-7.8,"(1S)-1-(3-chlorophenyl)-2-oxo-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate",OVSAMUIBGQSLDC-INIZCTEOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
121607,6w4b,DB12138,-7.8,PF-03715455,VGEXRDWWPSGZDH-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
55360,6crv,DB00914,-7.8,Phenformin,ICFJFFQQTFMIBG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28209,6cs2,DB00714,-7.8,Apomorphine,VMWNQDUVQKEIOC-CYBMUJFWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
108389,6vxx,DB07703,-7.8,"(3R,4S,5S,7R,9E,11R,12R)-12-ETHYL-4-HYDROXY-3,5,7,11-TETRAMETHYLOXACYCLODODEC-9-ENE-2,8-DIONE",NZUJVBSYQXETNF-PQWITYJESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55353,6crv,DB00907,-7.8,Cocaine,ZPUCINDJVBIVPJ-LJISPDSOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28219,6cs2,DB07801,-7.8,N-butyl-3-{[6-(9H-purin-6-ylamino)hexanoyl]amino}benzamide,WOYITRCGMUXUDE-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
29242,6cs2,DB08915,-7.8,Aleglitazar,DAYKLWSKQJBGCS-NRFANRHFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
108391,6vxx,DB07705,-7.8,"1-[(2S)-2-[(4-CHLOROBENZYL)OXY]-2-(2,4-DICHLOROPHENYL)ETHYL]-1H-IMIDAZOLE",LEZWWPYKPKIXLL-GOSISDBHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
121659,6w4b,DB12222,-7.8,Lurtotecan,RVFGKBWWUQOIOU-NDEPHWFRSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
31655,6cs2,DB14210,-7.8,Moexiprilat,CMPAGYDKASJORH-YSSFQJQWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
55342,6crv,DB00896,-7.8,Rimexolone,QTTRZHGPGKRAFB-OOKHYKNYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31651,6cs2,DB01076,-7.8,Atorvastatin,XUKUURHRXDUEBC-KAYWLYCHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
79268,6m2n,DB13001,-7.8,Tinoridine,PFENFDGYVLAFBR-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
121614,6w4b,DB12149,-7.8,S-3304,YWCLDDLVLSQGSZ-JOCHJYFZSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
108414,6vxx,DB07965,-7.8,6-(cyclohexylamino)-9-[2-(4-methylpiperazin-1-yl)-ethyl]-9H-purine-2-carbonitrile,OGODDSLNRULSMM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79247,6m2n,DB12964,-7.8,Lerisetron,PWWDCRQZITYKDV-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
108474,6vxx,DB08030,-7.8,3-[(4'-cyanobiphenyl-4-yl)oxy]-N-hydroxypropanamide,XZWFHJUEAVOHHG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
10645,6lzg,DB08875,-7.8,Cabozantinib,ONIQOQHATWINJY-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
121460,6w4b,DB11922,-7.8,Danirixin,NGYNBSHYFOFVLS-LBPRGKRZSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
121459,6w4b,DB11921,-7.8,Deflazacort,FBHSPRKOSMHSIF-GRMWVWQJSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
55129,6crv,DB00645,-7.8,Dyclonine,BZEWSEKUUPWQDQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
121270,6w4b,DB11645,-7.8,PF-4191834,DVNQWYLVSNPCJZ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
55112,6crv,DB00623,-7.8,Fluphenazine,PLDUPXSUYLZYBN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
121242,6w4b,DB11562,-7.8,Bicuculline,IYGYMKDQCDOMRE-ZWKOTPCHSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
28346,6cs2,DB07933,-7.8,Erteberel,XIESSJVMWNJCGZ-VKJFTORMSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
28349,6cs2,DB07936,-7.8,N-(4-{[(3S)-3-(dimethylamino)pyrrolidin-1-yl]carbonyl}phenyl)-5-fluoro-4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]pyrimidin-2-amine,BACSZMCLZIDTIO-IBGZPJMESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
121214,6w4b,DB11487,-7.8,Dexamethasone isonicotinate,BQTXJHAJMDGOFI-NJLPOHDGSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
78886,6m2n,DB12405,-7.8,Triciribine,HOGVTUZUJGHKPL-HTVVRFAVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
31513,6cs2,DB13944,-7.8,Testosterone enanthate,VOCBWIIFXDYGNZ-IXKNJLPQSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
121122,6w4b,DB11274,-7.8,Dihydro-alpha-ergocryptine,PBUNVLRHZGSROC-VTIMJTGVSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
164862,7bv1,DB08699,-7.8,"1-tert-butyl-3-(3-methylbenzyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine",FYCOTGCSHZKHPR-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
121100,6w4b,DB11176,-7.8,Zeaxanthin,JKQXZKUSFCKOGQ-QAYBQHTQSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
55062,6crv,DB00562,-7.8,Benzthiazide,NDTSRXAMMQDVSW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55061,6crv,DB00561,-7.8,Doxapram,XFDJYSQDBULQSI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
121055,6w4b,DB09378,-7.8,Fluprednisolone,MYYIMZRZXIQBGI-HVIRSNARSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
108561,6vxx,DB08397,-7.8,6-(DIFLUORO-PHOSPHONO-METHYL)-NAPHTHALENE-2-CARBOXYLIC ACID,NKGNOWNPXBURRW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79324,6m2n,DB13083,-7.8,Talarozole,SNFYYXUGUBUECJ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
108559,6vxx,DB08394,-7.8,PARA-NITROPHENYLPHOSPHONOBUTANOYL-GLYCINE,WLNKGRQBMNPVSJ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55153,6crv,DB00675,-7.8,Tamoxifen,NKANXQFJJICGDU-QPLCGJKRSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79066,6m2n,DB12679,-7.8,WP 1066,VFUAJMPDXIRPKO-LQELWAHVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
55216,6crv,DB00749,-7.8,Etodolac,NNYBQONXHNTVIJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
121436,6w4b,DB11891,-7.8,CUDC-907,JOWXJLIFIIOYMS-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
10639,6lzg,DB08864,-7.8,Rilpivirine,YIBOMRUWOWDFLG-ONEGZZNKSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
55206,6crv,DB00736,-7.8,Esomeprazole,SUBDBMMJDZJVOS-DEOSSOPVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79028,6m2n,DB12621,-7.8,ST-101,QZWYXEBIQWJXAR-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
108493,6vxx,DB08053,-7.8,"1-cyclobutyl-3-(3,4-dimethoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine",ITOYZJGFTNTKKR-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
121393,6w4b,DB11824,-7.8,Tofogliflozin,VWVKUNOPTJGDOB-BDHVOXNPSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
121375,6w4b,DB11799,-7.8,Bictegravir,SOLUWJRYJLAZCX-LYOVBCGYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
79007,6m2n,DB12582,-7.8,Piperine,MXXWOMGUGJBKIW-YPCIICBESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
31553,6cs2,DB14014,-7.8,SR-9011,PPUYOYQTTWJTIU-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
74088,6m2n,DB02887,-7.8,"2',3'-Dehydro-2',3'-Deoxy-Thymidine 5'-Triphosphate",ODSQODTUNULBHF-JGVFFNPUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
121335,6w4b,DB11742,-7.8,Ebastine,MJJALKDDGIKVBE-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
121333,6w4b,DB11740,-7.8,MK-1775,BKWJAKQVGHWELA-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
121326,6w4b,DB11732,-7.8,Lasmiditan,XEDHVZKDSYZQBF-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
121308,6w4b,DB11698,-7.8,Ipragliflozin,AHFWIQIYAXSLBA-RQXATKFSSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
28206,6cs2,DB07788,-7.8,"(3R,5Z,8S,9S,11E)-8,9,16-TRIHYDROXY-14-METHOXY-3-METHYL-3,4,9,10-TETRAHYDRO-1H-2-BENZOXACYCLOTETRADECINE-1,7(8H)-DIONE",NEQZWEXWOFPKOT-QHSZRYGNSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
121722,6w4b,DB12303,-7.8,Motolimod,QSPOQCXMGPDIHI-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
121724,6w4b,DB12306,-7.8,Cipargamin,CKLPLPZSUQEDRT-WPCRTTGESA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
79628,6m2n,DB13532,-7.8,Cyclopenthiazide,BKYKPTRYDKTTJY-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
108185,6vxx,DB07200,-7.8,"(2S,4S,5R)-2-ISOBUTYL-5-(2-THIENYL)-1-[4-(TRIFLUOROMETHYL)BENZOYL]PYRROLIDINE-2,4-DICARBOXYLIC ACID",ZNCZVHCYBGHCHA-XPIZARPCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
122114,6w4b,DB12903,-7.8,DEBIO-1347,BEMNJULZEQTDJY-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
79611,6m2n,DB13507,-7.8,Poldine,CQRKVVAGMJJJSR-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
108189,6vxx,DB07205,-7.8,N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,GZJXCRHEMLAMRA-SDBHATRESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79607,6m2n,DB13502,-7.8,Budipine,QIHLUZAFSSMXHQ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
122102,6w4b,DB12887,-7.8,Tazemetostat,NSQSAUGJQHDYNO-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
28073,6cs2,DB07647,-7.8,"(2R)-1-[(5,6-DIPHENYL-7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)AMINO]PROPAN-2-OL",VBASHTSSQNDDAS-CQSZACIVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
55575,6crv,DB01162,-7.8,Terazosin,VCKUSRYTPJJLNI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108198,6vxx,DB07217,-7.8,"N-(3-cyano-4,5,6,7-tetrahydro-1-benzothien-2-yl)-2-fluorobenzamide",YVYPYORTKAIUGJ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
73874,6m2n,DB02602,-7.8,AL7182,ICIXQGGQPKFQRL-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
108210,6vxx,DB07232,-7.8,Veliparib,JNAHVYVRKWKWKQ-CYBMUJFWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79558,6m2n,DB13434,-7.8,Fenticonazole,ZCJYUTQZBAIHBS-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
122034,6w4b,DB12774,-7.8,AZD-8055,KVLFRAWTRWDEDF-IRXDYDNUSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
122028,6w4b,DB12764,-7.8,ABC-294640,CAOTVXGYTWCKQE-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
108177,6vxx,DB07190,-7.8,3-cyclohexyl-D-alanyl-N-(3-chlorobenzyl)-L-prolinamide,JGFCNVHEEMBVJG-MOPGFXCFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
122015,6w4b,DB12742,-7.8,Amuvatinib,FOFDIMHVKGYHRU-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
55601,6crv,DB01190,-7.8,Clindamycin,KDLRVYVGXIQJDK-NOWPCOIGSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55607,6crv,DB01196,-7.8,Estramustine,FRPJXPJMRWBBIH-RBRWEJTLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
10836,6lzg,DB00845,-7.8,Clofazimine,WDQPAMHFFCXSNU-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
28029,6cs2,DB07602,-7.8,S-{3-[(4-ANILINOQUINAZOLIN-6-YL)AMINO]-3-OXOPROPYL}-L-CYSTEINE,NLVZTRZPMRTVRC-INIZCTEOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
55650,6crv,DB01247,-7.8,Isocarboxazid,XKFPYPQQHFEXRZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
122273,6w4b,DB13158,-7.8,Clobetasone,XXIFVOHLGBURIG-OZCCCYNHSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
55642,6crv,DB01239,-7.8,Chlorprothixene,WSPOMRSOLSGNFJ-AUWJEWJLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108153,6vxx,DB07164,-7.8,"N-cyclopropyl-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amine",CAGHIASAHLPQMS-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
164488,7bv1,DB08063,-7.8,"1-BENZYL-3-(4-METHOXYPHENYLAMINO)-4-PHENYLPYRROLE-2,5-DIONE",HLZMYWLMBBLASX-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
122214,6w4b,DB13059,-7.8,PF-03814735,RYYNGWLOYLRZLK-RBUKOAKNSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
55620,6crv,DB01210,-7.8,Levobunolol,IXHBTMCLRNMKHZ-LBPRGKRZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29168,6cs2,DB08807,-7.8,Bopindolol,UUOJIACWOAYWEZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
122197,6w4b,DB13029,-7.8,MK-0873,JJWKQXNHYDJXKF-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
29173,6cs2,DB08811,-7.8,Tofisopam,RUJBDQSFYCKFAA-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
122187,6w4b,DB13019,-7.8,Henatinib,MCTXSDCWFQAGFS-UEXNTNOUSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
79643,6m2n,DB13551,-7.8,Cinchophen,YTRMTPPVNRALON-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
122173,6w4b,DB12998,-7.8,PF-00217830,QGNOXTFZOLDODX-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
31811,6cs2,DB14793,-7.8,RO-5045337,QBGKPEROWUKSBK-QPPIDDCLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
55664,6crv,DB01274,-7.8,Arformoterol,BPZSYCZIITTYBL-YJYMSZOUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79554,6m2n,DB13430,-7.8,Mebutizide,KJLLKLRVCJAFRY-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
55551,6crv,DB01134,-7.8,Desoxycorticosterone pivalate,VVOIQBFMTVCINR-WWMZEODYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108303,6vxx,DB07598,-7.8,"2,3,6A,7,8,9-HEXAHYDRO-11H-[1,4]DIOXINO[2,3-G]PYRROLO[2,1-B][1,3]BENZOXAZIN-11-ONE",RQEPVMAYUINZRE-GFCCVEGCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108304,6vxx,DB07602,-7.8,S-{3-[(4-ANILINOQUINAZOLIN-6-YL)AMINO]-3-OXOPROPYL}-L-CYSTEINE,NLVZTRZPMRTVRC-INIZCTEOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79466,6m2n,DB13317,-7.8,Flunoxaprofen,ARPYQKTVRGFPIS-VIFPVBQESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
108323,6vxx,DB07624,-7.8,"1-{[(3R)-3-methyl-4-({4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]phenyl}sulfonyl)piperazin-1-yl]methyl}cyclopropanecarboxamide",YJFULAYRAKPBCY-DYVFJYSZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108348,6vxx,DB07651,-7.8,N-ACETYL-L-PHENYLALANYL-4-[DIFLUORO(PHOSPHONO)METHYL]-L-PHENYLALANINAMIDE,KPMMESISHWWXNM-ROUUACIJSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108351,6vxx,DB07654,-7.8,"(5,6-DIPHENYL-FURO[2,3-D]PYRIMIDIN-4-YLAMINO)-ACETIC",VDJWWYRYKMXMKA-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55419,6crv,DB00983,-7.8,Formoterol,BPZSYCZIITTYBL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108354,6vxx,DB07662,-7.8,N-[4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL]-ACRYLAMIDE,HTUBKQUPEREOGA-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
121774,6w4b,DB12380,-7.8,GDC-0152,WZRFLSDVFPIXOV-LRQRDZAKSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
121769,6w4b,DB12375,-7.8,Oglemilast,OKFDRAHPFKMAJH-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
55402,6crv,DB00962,-7.8,Zaleplon,HUNXMJYCHXQEGX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55398,6crv,DB00957,-7.8,Norgestimate,KIQQMECNKUGGKA-NMYWJIRASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
73954,6m2n,DB02706,-7.8,Mercaptocarboxylate Inhibitor,DUKDFMPUZRDWLT-CQSZACIVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79374,6m2n,DB13175,-7.8,Rheinanthrone,OZFQHULMMDWMIV-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
55382,6crv,DB00939,-7.8,Meclofenamic acid,SBDNJUWAMKYJOX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
121859,6w4b,DB12500,-7.8,Fedratinib,JOOXLOJCABQBSG-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
164566,7bv1,DB08150,-7.8,"4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-aminium",RZIDZIGAXXNODG-UHFFFAOYSA-O,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
164597,7bv1,DB08184,-7.8,2-(2-METHYLPHENYL)-1H-INDOLE-5-CARBOXIMIDAMIDE,YOZKTHGEOJHIDP-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
121897,6w4b,DB12558,-7.8,AEE-788,OONFNUWBHFSNBT-HXUWFJFHSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
108221,6vxx,DB07246,-7.8,"(2R)-2-AMINO-3,3,3-TRIFLUORO-N-HYDROXY-2-{[(4-PHENOXYPHENYL)SULFONYL]METHYL}PROPANAMIDE",MKRPIBSCGZAUCH-OAHLLOKOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
121989,6w4b,DB12706,-7.8,Seletalisib,LNLJHGXOFYUARS-OAQYLSRUSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
29209,6cs2,DB08864,-7.8,Rilpivirine,YIBOMRUWOWDFLG-ONEGZZNKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
121959,6w4b,DB12659,-7.8,SJ-733,VKCPFWKTFZAOTO-LEWJYISDSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
121958,6w4b,DB12658,-7.8,AFN-1252,QXTWSUQCXCWEHF-JXMROGBWSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
121952,6w4b,DB12649,-7.8,Ibipinabant,AXJQVVLKUYCICH-OAQYLSRUSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
73902,6m2n,DB02640,-7.8,Fumagillin,NGGMYCMLYOUNGM-CSDLUJIJSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
10778,6lzg,DB09054,-7.8,Idelalisib,IFSDAJWBUCMOAH-HNNXBMFYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
31749,6cs2,DB14669,-7.8,Betamethasone phosphate,VQODGRNSFPNSQE-DVTGEIKXSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
31748,6cs2,DB14668,-7.8,Dienestrol diacetate,YWLLGDVBTLPARJ-OXAZHYLESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
79510,6m2n,DB13368,-7.8,Motretinide,IYIYMCASGKQOCZ-DJRRULDNSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
108245,6vxx,DB07272,-7.8,"N-(4-AMINO-5-CYANO-6-ETHOXYPYRIDIN-2-YL)-2-(4-BROMO-2,5-DIMETHOXYPHENYL)ACETAMIDE",GKODDLYLEKSDJL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79495,6m2n,DB13351,-7.8,Piperidolate,KTHVBAZBLKXIHZ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
55497,6crv,DB01071,-7.8,Mequitazine,HOKDBMAJZXIPGC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79483,6m2n,DB13337,-7.8,Pheneticillin,NONJJLVGHLVQQM-JHXYUMNGSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
55474,6crv,DB01046,-7.8,Lubiprostone,WGFOBBZOWHGYQH-MXHNKVEKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28383,6cs2,DB07971,-7.8,"5-AMINO-2-{4-[(4-AMINOPHENYL)SULFANYL]PHENYL}-1H-ISOINDOLE-1,3(2H)-DIONE",FQQVTDIBUYSVHM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
107273,6vxx,DB03093,-7.8,"8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine",MWHAHELTVGJGFJ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
164150,7bv1,DB07312,-7.8,"2,5-DICHLORO-N-(5-CHLORO-1,3-BENZOXAZOL-2-YL)BENZENESULFONAMIDE",JCXZHFCBNFFHRC-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
125582,6w4h,DB02675,-7.8,(4-Hydroxymaltosephenyl)Glycine,PHPOPZGUOBMSPZ-QHJSCRBTSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
106269,6vxs,DB15348,-7.8,Ampreloxetine,TZIALEBTHQWNAO-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
106273,6vxs,DB15358,-7.8,JNJ-54175446,CWFVVQFVGMFTBD-SECBINFHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
11442,6lzg,DB11969,-7.8,Uprosertib,AXTAPYRUEKNRBA-JTQLQIEISA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
81533,6m3m,DB01354,-7.8,Heptabarbital,PAZQYDJGLKSCSI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
32758,6cs2,T3D3671,-7.8,Aflatoxin G2,BHCOKYJYXDKTPG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
81550,6m3m,DB01399,-7.8,Salsalate,WVYADZUPLLSGPU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
125512,6w4h,DB02583,-7.8,"N6-(2,5-Dimethoxy-Benzyl)-N6-Methyl-Pyrido[2,3-D]Pyrimidine-2,4,6-Triamine",HZTFNSCZLJLPEO-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
32752,6cs2,T3D3665,-7.8,"(S,E)-Zearalenone",MBMQEIFVQACCCH-XVNBXDOJSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
32749,6cs2,T3D3662,-7.8,Roquefortine,SPWSUFUPTSJWNG-SXGWCWSVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
106300,6vxs,DB15418,-7.8,AZD-9977,MBKYLPOPYYLTNW-ZDUSSCGKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
7188,6lzg,DB03367,-7.8,PF-00356231,VMTJQZUZINLEKC-JOCHJYFZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
106323,6vxs,DB01532,-7.8,alpha-Methylacetylfentanyl,OKTLVZBUKMRPLL-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
106324,6vxs,DB01557,-7.8,alpha-Methylfentanyl,NGTVDHYUFBKWID-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
11429,6lzg,DB11952,-7.8,Duvelisib,SJVQHLPISAIATJ-ZDUSSCGKSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
163202,7bv1,DB03893,-7.8,Thionicotinamide-Adenine-Dinucleotide,UQYPZLRUJKCREN-NNYOXOHSSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
73021,6m2n,DB01493,-7.8,Ethylestrenol,AOXRBFRFYPMWLR-XGXHKTLJSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
106259,6vxs,DB15333,-7.8,AZD-1386,FPGNKXCEPARJDI-ZDUSSCGKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
11479,6lzg,DB12022,-7.8,Evatanepag,WOHRHWDYFNWPNG-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
57120,6crv,DB03227,-7.8,Nicotinamide Mononucleotide,DAYLJWODMCOQEW-WYOJIJJFSA-O,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72972,6m2n,DB01439,-7.8,3-Methylthiofentanyl,SRARDYUHGVMEQI-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
125736,6w4h,DB02882,-7.8,Cyanocinnoline,CUWRVIIPSSUUDJ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
125730,6w4h,DB02873,-7.8,"1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperazin-1-Yl-3,4-Dihydroquinazolin-2(1h)-One",YAWZIQKDHQIHOS-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
125722,6w4h,DB02862,-7.8,Gluco-Phenylimidazole,DLVNFMROYKHANV-FVCCEPFGSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
125720,6w4h,DB02859,-7.8,Soraphen A,WPMGNXPRKGXGBO-OFQQMTDKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
163119,7bv1,DB03788,-7.8,GC-24,JYHIGYLGYNCMGI-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
81650,6m3m,DB01518,-7.8,Benzethidine,UVTBZAWTRVBTMK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
27404,6cs2,DB06942,-7.8,N-(4-carbamimidoylbenzyl)-1-(3-phenylpropanoyl)-L-prolinamide,RNZKCCPFUWHBFY-IBGZPJMESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
125688,6w4h,DB02819,-7.8,"Mono-[3,4-Dihydroxy-5-(5-Methyl-Benzoimidazol-1-Yl)-Tetrahydor-Furan-2-Ylmethyl] Ester",HGUDFQQPANTQEU-LPWJVIDDSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
57092,6crv,DB03195,-7.8,"Phosphoric Acid Mono-[3-Fluoro-5-(5-Methyl-2,4-Dioxo-3,4-Dihydro-2h-Pyrimidin-1-Yl)-Tetrahyro-Furan-2-Ylmethyl] Ester",GGCAVPJXJISBOA-XLPZGREQSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163166,7bv1,DB03844,-7.8,"N-(2,6-Diflouro-Benzyl)-4-Sulfamoyl-Benzamide",ZFNCKGXGCCDDFN-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
72999,6m2n,DB01469,-7.8,Acetorphine,LFYBMMHFJIAKFE-PMEKXCSPSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
57089,6crv,DB03190,-7.8,"N-Octanoyl-B-D-Fructofuranosyl-a-D-Glucopyranoside,Sucrose Monocaproylate",AWSYOWHJNGZJGU-OASARBKBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
125430,6w4h,DB02479,-7.8,(R)-N-(3-Indol-1-Yl-2-Methyl-Propyl)-4-Sulfamoyl-Benzamide,ZFWHOUCRVSOZJE-CQSZACIVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
81500,6m3m,DB01283,-7.8,Lumiracoxib,KHPKQFYUPIUARC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
163293,7bv1,DB04216,-7.8,Quercetin,REFJWTPEDVJJIY-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
57011,6crv,DB03083,-7.8,IC261,JBJYTZXCZDNOJW-JLHYYAGUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81409,6m3m,DB01163,-7.8,Amdinocillin,BWWVAEOLVKTZFQ-NTZNESFSSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
125131,6w4h,DB02089,-7.8,CP-526423,MWWXABBBAPKJDX-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
163441,7bv1,DB04596,-7.8,"4-O-{4,6-O-[(1S)-1-Carboxyethylidene]-β-D-mannopyranosyl}-D-glucopyranuronic acid",GZJXZKGVHLWBOW-AISSFXTFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
73107,6m2n,DB01595,-7.8,Nitrazepam,KJONHKAYOJNZEC-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
81393,6m3m,DB01145,-7.8,Sulfoxone,NEDPPCHNEOMTJV-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
73110,6m2n,DB01599,-7.8,Probucol,FYPMFJGVHOHGLL-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
125087,6w4h,DB02033,-7.8,"N-(3-Cyclopropyl(5,6,7,8,9,10-Hexahydro-2-Oxo-2h-Cycloocta[B]Pyran-3-Yl)Methyl)Phenylbenzensulfonamide",GDRNWAKVNIROCG-DEOSSOPVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
81379,6m3m,DB01129,-7.8,Rabeprazole,YREYEVIYCVEVJK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
73115,6m2n,DB01605,-7.8,Pivmecillinam,NPGNOVNWUSPMDP-HLLBOEOZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
125079,6w4h,DB02021,-7.8,Fidarestat,WAAPEIZFCHNLKK-UFBFGSQYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
56885,6crv,DB02911,-7.8,"2,4-Diamino-6-Phenyl-5,6,7,8,-Tetrahydropteridine",VEKRIXRQADJFAG-QMMMGPOBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27478,6cs2,DB07024,-7.8,"2-(3,4-DIHYDROXYPHENYL)-8-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-3-HYDROXY-6-METHYL-4H-CHROMEN-4-ONE",CEXBEGBNDJVZPK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
81352,6m3m,DB01097,-7.8,Leflunomide,VHOGYURTWQBHIL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
163470,7bv1,DB04662,-7.8,OLOMOUCINE II,NDUVSANREQEDRE-CQSZACIVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
81343,6m3m,DB01088,-7.8,Iloprost,HIFJCPQKFCZDDL-ACWOEMLNSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
106485,6vxx,DB00400,-7.8,Griseofulvin,DDUHZTYCFQRHIY-RBHXEPJQSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
32823,6cs2,T3D3736,-7.8,Cyclopiazonic acid,RLOAZVAJNNPPDI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
73091,6m2n,DB01571,-7.8,3-Methylfentanyl,MLQRZXNZHAOCHQ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
73088,6m2n,DB01568,-7.8,Codeine-N-oxide,BDLSDHWCOJPHIE-KFUGMXNISA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
11406,6lzg,DB11922,-7.8,Danirixin,NGYNBSHYFOFVLS-LBPRGKRZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
27442,6cs2,DB06986,-7.8,"2-CHLORO-N-[(1R,2R)-1-HYDROXY-2,3-DIHYDRO-1H-INDEN-2-YL]-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE",LRHOLHTVXXSIMG-BXUZGUMPSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
125378,6w4h,DB02411,-7.8,"2-(11-{2-[Benzenesulfonyl-(3-Methyl-Butyl)-Amino]-1-Hydroxy-Ethyl}-6,9-Dioxo-2-Oxa-7,10-Diaza-Bicyclo[11.2.2]Heptadeca-1(16),13(17),14-Trien-8-Yl)-Acetamide, Inhibitor 2",HOUHLOFMBSYNBO-KKUQBAQOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
125374,6w4h,DB02407,-7.8,6-O-Cyclohexylmethyl Guanine,MWGXGTJJAOZBNW-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
106416,6vxx,DB00186,-7.8,Lorazepam,DIWRORZWFLOCLC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106425,6vxx,DB00196,-7.8,Fluconazole,RFHAOTPXVQNOHP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
73073,6m2n,DB01553,-7.8,Cloxazolam,ZIXNZOBDFKSQTC-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
27464,6cs2,DB07007,-7.8,"(3R)-3-[(1,2,3,4-tetrahydroisoquinolin-7-yloxy)methyl]-2,3-dihydrothieno[2,3-f][1,4]oxazepin-5-amine",UDFXWCLBONUMNA-CYBMUJFWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
106454,6vxx,DB00365,-7.8,Grepafloxacin,AIJTTZAVMXIJGM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28931,6cs2,DB08556,-7.8,"5'-ACETYL-4-{[(2,4-DIMETHYLPHENYL)SULFONYL]AMINO}-2,2'-BITHIOPHENE-5-CARBOXYLIC ACID",CMHHNHDPPWDNAH-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
125253,6w4h,DB02253,-7.8,"(1r)-4-[(1e,3e,5e,7z,9e,11z,13e,15e)-17-Hydroxy-3,7,12,16-Tetramethylheptadeca-1,3,5,7,9,11,13,15-Octaen-1-Yl]-3,5,5-Trimethylcyclohex-3-En-1-Ol",FNAJVVMDXCOSFY-VFGOXHQXSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
81450,6m3m,DB01207,-7.8,Ridogrel,GLLPUTYLZIKEGF-HAVVHWLPSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
163385,7bv1,DB04345,-7.8,Lumichrome,ZJTJUVIJVLLGSP-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
163396,7bv1,DB04362,-7.8,Adenosine Diphosphate 5-(Beta-Ethyl)-4-Methyl-Thiazole-2-Carboxylic Acid,VGXBGQACJQRWLV-LKGUXBDMSA-K,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
32687,6cs2,T3D2098,-7.8,"1,2,4,6,7-Pentachlorodibenzo-p-dioxin",SEKDDGLKEYEVQK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
81430,6m3m,DB01186,-7.8,Pergolide,YEHCICAEULNIGD-MZMPZRCHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
57126,6crv,DB03234,-7.8,"(4'-{[Allyl(Methyl)Amino]Methyl}-1,1'-Biphenyl-4-Yl)(4-Bromophenyl)Methanone",YATCZCSDJCQNAL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163089,7bv1,DB03752,-7.8,P-(2'-Iodo-5'-Thenoyl)Hydrotropic Acid,UIZPHGUBGPJBAR-QMMMGPOBSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
163083,7bv1,DB03744,-7.8,"Cp403700, (S)-1-{2-[(5-Chloro-1h-Indole-2-Carbonyl)-Amino]-3-Phenyl-Propionyl}-Azetidine-3-Carboxylate",RONLONYAIBUEKT-IBGZPJMESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
72793,6m2n,DB01157,-7.8,Trimetrexate,NOYPYLRCIDNJJB-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
126593,6w4h,DB04038,-7.8,Ergosterol,DNVPQKQSNYMLRS-APGDWVJJSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
162773,7bv1,DB02902,-7.8,3'-Phosphate-Adenosine-5'-Phosphate Sulfate,GACDQMDRPRGCTN-KQYNXXCUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
162780,7bv1,DB02911,-7.8,"2,4-Diamino-6-Phenyl-5,6,7,8,-Tetrahydropteridine",VEKRIXRQADJFAG-QMMMGPOBSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
126574,6w4h,DB04010,-7.8,2-(3'-Methoxyphenyl) Benzimidazole-4-Carboxamide,NVVWVYYHTKCIAE-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
57370,6crv,DB03577,-7.8,Alpha-Benzyl-Aminobenzyl-Phosphonic Acid,SLMGIUOAZCYKPE-CQSZACIVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
32982,6cs2,T3D3914,-7.8,Pyraclostrobin,HZRSNVGNWUDEFX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
32979,6cs2,T3D3911,-7.8,Propoxycarbazone-sodium,JRQGDDUXDKCWRF-UHFFFAOYSA-M,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
126531,6w4h,DB03950,-7.8,(S)-N-(3-Indol-1-Yl-2-Methyl-Propyl)-4-Sulfamoyl-Benzamide,ZFWHOUCRVSOZJE-AWEZNQCLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
32964,6cs2,T3D3895,-7.8,Oxasulfuron,IOXAXYHXMLCCJJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
82128,6m3m,DB02135,-7.8,"4-{2,6,8-Trioxo-9-[(2R,3S,4R)-2,3,4,5-Tetrahydroxypentyl]-1,2,3,6,8,9-Hexahydro-7h-Purin-7-Yl}Butyl Dihydrogen Phosphate",VBXZSBKAJFXURR-MRTMQBJTSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
126469,6w4h,DB03869,-7.8,5'-O-(N-(L-Seryl)-Sulfamoyl)Adenosine,HQXFJGONGJPTLZ-YTMOPEAISA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
72836,6m2n,DB01204,-7.8,Mitoxantrone,KKZJGLLVHKMTCM-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
27314,6cs2,DB06849,-7.8,"1-[1'-(3-phenylacryloyl)spiro[1-benzofuran-3,4'-piperidin]-5-yl]methanamine",RQWYWHUKHYFIPB-VQHVLOKHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
106020,6vxs,DB14828,-7.8,ABX-464,OZOGDCZJYVSUBR-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
126596,6w4h,DB04042,-7.8,"2-[4-(Hydroxy-Methoxy-Methyl)-Benzyl]-7-(4-Hydroxymethyl-Benzyl)-1,1-Dioxo-3,6-Bis-Phenoxymethyl-1lambda6-[1,2,7]Thiadiazepane-4,5-Diol",XLJNZONSWKENRP-VABIIVNOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
126445,6w4h,DB03837,-7.8,Morpholine-4-Carboxylic Acid (1-(3-Benzenesulfonyl-1-Phenethylallylcarbamoyl)-3-Methylbutyl)-Amide,YUMYYTORLYHUFW-ZUDLOMHPSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
72787,6m2n,DB01150,-7.8,Cefprozil,WDLWHQDACQUCJR-PBFPGSCMSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
105973,6vxs,DB14716,-7.8,Clonazolam,XJRGLCAWBRZUFC-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
126825,6w4h,DB04345,-7.8,Lumichrome,ZJTJUVIJVLLGSP-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
82290,6m3m,DB02357,-7.8,Methyl-O3-(Alpha-D-Mannose)-Alpha-D-Mannose,WOKXHOIRHHAHDA-ZEEOCKJESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
105902,6vxs,DB14570,-7.8,Hydroxyprogesterone,DBPWSSGDRRHUNT-CEGNMAFCSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
105911,6vxs,DB14624,-7.8,Nandrolone hydrogen sulfate,SKZMVWBZTQNCKW-IZPLOLCNSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
57445,6crv,DB03682,-7.8,"Dibenzofuran-4,6-Dicarboxylic Acid",HBBGSNOHAGNQRQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
126723,6w4h,DB04205,-7.8,"Thymidine-3',5'-Diphosphate",CSNCBOPUCJOHLS-XLPZGREQSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
57432,6crv,DB03666,-7.8,3'-Azido-3'-Deoxythymidine-5'-Monophosphate,OIFWQOKDSPDILA-XLPZGREQSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57426,6crv,DB03658,-7.8,"2-{1-[2-Amino-2-(4-Hydroxy-Phenyl)-Acetylamino]-2-Oxo-Ethyl}-5,5-Dimethyl-Thiazolidine-4-Carboxylic Acid",SMLJDSWXGVMNTH-NRWUCQMLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
105937,6vxs,DB14651,-7.8,Perphenazine enanthate,PWEGQJCIAMJJHC-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
82264,6m3m,DB02322,-7.8,Heparin Disaccharide I-S,LRPGJWKAYQRIAQ-GYBHJADLSA-J,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
105947,6vxs,DB14662,-7.8,Flunisolide acetate,WEGNFRKBIKYVLC-XTLNBZDDSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
72779,6m2n,DB01142,-7.8,Doxepin,ODQWQRRAPPTVAG-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
33009,6cs2,T3D3940,-7.8,Trifloxysulfuron-sodium,UFEIWEXHHOXPGP-UHFFFAOYSA-M,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
105958,6vxs,DB14673,-7.8,Flurandrenolide acetate,AUDPKCCPWYXNEV-XTLNBZDDSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
105972,6vxs,DB14715,-7.8,Cinazepam,NQTRBZXDWMDXAQ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
57383,6crv,DB03593,-7.8,N7-Methyl-Guanosine-5'-Monophosphate,AOKQNZVJJXPUQA-KQYNXXCUSA-O,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
73140,6m2n,DB01633,-7.8,Deoxy-2-fluoro-beta-D-cellotrioside,BZNXZJAUEMJQJB-QSCMNUSVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
32952,6cs2,T3D3883,-7.8,Metsulfuron-methyl,RSMUVYRMZCOLBH-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
126307,6w4h,DB03666,-7.8,3'-Azido-3'-Deoxythymidine-5'-Monophosphate,OIFWQOKDSPDILA-XLPZGREQSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
106162,6vxs,DB15143,-7.8,PF-06650833,JKDGKIBAOAFRPJ-ZBINZKHDSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
125991,6w4h,DB03222,-7.8,dATP,SUYVUBYJARFZHO-RRKCRQDMSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
11508,6lzg,DB12063,-7.8,CERC-301,RECBFDWSXWAXHY-IAGOWNOFSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
125968,6w4h,DB03196,-7.8,4-Nitrophenyl-Ara,DUYYBTBDYZXISX-UKKRHICBSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
57167,6crv,DB03285,-7.8,"2',4,4'-Trihydroxychalcone",DXDRHHKMWQZJHT-FPYGCLRLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163068,7bv1,DB03725,-7.8,Phosphomethylphosphonic Acid-Guanylate Ester,PHBDHXOBFUBCJD-KQYNXXCUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
28861,6cs2,DB08485,-7.8,"(1S,4S,5S)-1,4,5-TRIHYDROXY-3-[3-(PHENYLTHIO)PHENYL]CYCLOHEX-2-ENE-1-CARBOXYLIC ACID",QMNMNSINKIFYBV-LMMKCTJWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
125884,6w4h,DB03081,-7.8,Crc200 (Chiron-Behring),ZOXOKTJHZSUHRJ-XZOQPEGZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
81728,6m3m,DB01607,-7.8,Ticarcillin,OHKOGUYZJXTSFX-KZFFXBSXSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
125857,6w4h,DB03046,-7.8,7-Methoxy-8-[1-(Methylsulfonyl)-1h-Pyrazol-4-Yl]Naphthalene-2-Carboximidamide,KQUXAFOLFXHVQN-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
81724,6m3m,DB01603,-7.8,Meticillin,RJQXTJLFIWVMTO-TYNCELHUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
106199,6vxs,DB15214,-7.8,BMS-986104,BPMMYKAHRIEVDH-VOQZNFBZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
57141,6crv,DB03250,-7.8,"2-(Beta-D-Glucopyranosyl)-5-Methyl-1,3,4-Benzothiazole",WGJFWQVWYRZPEP-KABOQKQYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163082,7bv1,DB03742,-7.8,Compound 4-D,TWZNCTCQAGRUGQ-RRPNLBNLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
106203,6vxs,DB15222,-7.8,GS-6620,YAAQYJCOIFNMKX-RSTNYOGXSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
32871,6cs2,T3D3792,-7.8,Amitraz,QXAITBQSYVNQDR-ZIOPAAQOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
126435,6w4h,DB03823,-7.8,Epigallocatechin,XMOCLSLCDHWDHP-IUODEOHRSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
81760,6m3m,DB01643,-7.8,Thymidine monophosphate,GYOZYWVXFNDGLU-XLPZGREQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
27369,6cs2,DB06907,-7.8,"2-(2,6-DICHLOROPHENYL)-1,3-BENZOXAZOLE-6-CARBOXYLIC ACID",XVNRKPCHMYOPPL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
162874,7bv1,DB03235,-7.8,N-{3-[4-(3-aminopropyl)piperazin-1-yl]propyl}-3-(alpha-D-galactopyranosyloxy)-5-nitrobenzamide,UEIGEWJJVQHIAX-MKQKURRLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
82019,6m3m,DB01995,-7.8,5-Methylcytidine-5'-Monophosphate,NJQONZSFUKNYOY-JXOAFFINSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
32922,6cs2,T3D3847,-7.8,Flumioxazin,FOUWCSDKDDHKQP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
32915,6cs2,T3D3840,-7.8,Fluazifop-butyl,VAIZTNZGPYBOGF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
106086,6vxs,DB14987,-7.8,Difamilast,VFBILHPIHUPBPZ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
162898,7bv1,DB03262,-7.8,"Al-6619, [2h-Thieno[3,2-E]-1,2-Thiazine-6-Sulfonamide,2-(3-Hydroxyphenyl)-3-(4-Morpholinyl)-, 1,1-Dioxide]",PZLYYZPXSSNGJS-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
32909,6cs2,T3D3834,-7.8,Etoxazole,IXSZQYVWNJNRAL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
11554,6lzg,DB12124,-7.8,Namitecan,IBTISPLPBBHVSU-UVOOVGFISA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
81954,6m3m,DB01910,-7.8,Sinefungin,LMXOHSDXUQEUSF-YECHIGJVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
106096,6vxs,DB15013,-7.8,TAK-243,KJDAGXLMHXUAGV-DGWLBADLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
81936,6m3m,DB01877,-7.8,"N-Hydroxy 1n(4-Methoxyphenyl)Sulfonyl-4-(Z,E-N-Methoxyimino)Pyrrolidine-2r-Carboxamide",OJLWCTMBGWSVFC-JOYOIKCWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
126193,6w4h,DB03496,-7.8,Alvocidib,BIIVYFLTOXDAOV-YVEFUNNKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
57228,6crv,DB03365,-7.8,"4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline",BNDYIYYKEIXHNK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28849,6cs2,DB08471,-7.8,"1-(thiophen-2-ylacetyl)-4-(3-thiophen-2-yl-1,2,4-oxadiazol-5-yl)piperidine",SJEVDMFUHCVNPM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
106123,6vxs,DB15065,-7.8,PF-06291874,IBDYYOQKQCCSDP-QFIPXVFZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
126095,6w4h,DB03355,-7.8,5'-O-(N-(L-Threonyl)-Sulfamoyl)Adenosine,UPVAPSGKXAAHBG-CKTDUXNWSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
123770,6w4h,DB00358,-7.8,Mefloquine,XEEQGYMUWCZPDN-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
56860,6crv,DB02881,-7.8,4-(4-Hydroxy-3-Isopropylphenylthio)-2-Isopropylphenol,NEMLLZAROZVCCE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27487,6cs2,DB07032,-7.8,2-(4-HYDROXY-PHENYL)BENZOFURAN-5-OL,SNNNDCMXZYWCCI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
106912,6vxx,DB01737,-7.8,"Nalpha-(2-Naphthylsulfonylglycyl)-3-Amidino-D,L-Phenylalanine-Isopropylester",YAEIKQDHLCFGAA-KRWDZBQOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
18941,6cs2,HMDB0041733,-7.8,Ferulic acid 4-O-glucuronide,PZPATWACAAOHTJ-HWKANZROSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
106925,6vxx,DB01755,-7.8,N-[Isoleucinyl]-N'-[Adenosyl]-Diaminosufone,XVTRBLLRODNOJV-VBJYJYTRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
124186,6w4h,DB00860,-7.8,Prednisolone,OIGNJSKKLXVSLS-VWUMJDOOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
124184,6w4h,DB00858,-7.8,Drostanolone,IKXILDNPCZPPRV-RFMGOVQKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
11201,6lzg,DB11645,-7.8,PF-4191834,DVNQWYLVSNPCJZ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
80880,6m3m,DB00546,-7.8,Adinazolam,GJSLOMWRLALDCT-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
124166,6w4h,DB00838,-7.8,Clocortolone,YMTMADLUXIRMGX-RFPWEZLHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
163977,7bv1,DB06923,-7.8,2-(3-METHYLPHENYL)-1H-INDOLE-5-CARBOXIMIDAMIDE,KJUSXMYSVXZFDJ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
56464,6crv,DB02365,-7.8,"1,10-Phenanthroline",DGEZNRSVGBDHLK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
124138,6w4h,DB00808,-7.8,Indapamide,NDDAHWYSQHTHNT-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
27646,6cs2,DB00656,-7.8,Trazodone,PHLBKPHSAVXXEF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
163989,7bv1,DB06935,-7.8,"2',6'-DIFLUOROBIPHENYL-4-CARBOXYLIC ACID",CWWIIKLXUPZDOG-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
80852,6m3m,DB00507,-7.8,Nitazoxanide,YQNQNVDNTFHQSW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
124152,6w4h,DB00823,-7.8,Ethynodiol diacetate,ONKUMRGIYFNPJW-KIEAKMPYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
56516,6crv,DB02424,-7.8,Geldanamycin,QTQAWLPCGQOSGP-KSRBKZBZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27631,6cs2,DB07182,-7.8,(2S)-2-(3-{[AMINO(IMINO)METHYL]AMINO}PHENYL)-3-[(S)-HYDROXY(3-PHENYLPROPYL)PHOSPHORYL]PROPANOIC ACID,HFRHWTYCVGKGIE-KRWDZBQOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
124242,6w4h,DB00922,-7.8,Levosimendan,WHXMKTBCFHIYNQ-SECBINFHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
163885,7bv1,DB06809,-7.8,Plerixafor,YIQPUIGJQJDJOS-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
106822,6vxx,DB01333,-7.8,Cefradine,RDLPVSKMFDYCOR-UEKVPHQBSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
124344,6w4h,DB01041,-7.8,Thalidomide,UEJJHQNACJXSKW-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
124330,6w4h,DB01025,-7.8,Amlexanox,SGRYPYWGNKJSDL-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
80895,6m3m,DB00562,-7.8,Benzthiazide,NDTSRXAMMQDVSW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
18934,6cs2,HMDB0041693,-7.8,"5-(3',5'-Dihydroxyphenyl)-gamma-valerolactone 3-O-glucuronide",RUSMDDXSDLDLKU-PHPHFFAHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
80892,6m3m,DB00558,-7.8,Zanamivir,ARAIBEBZBOPLMB-UFGQHTETSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
163912,7bv1,DB06849,-7.8,"1-[1'-(3-phenylacryloyl)spiro[1-benzofuran-3,4'-piperidin]-5-yl]methanamine",RQWYWHUKHYFIPB-VQHVLOKHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
106847,6vxx,DB01388,-7.8,Mibefradil,HBNPJJILLOYFJU-VMPREFPWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163916,7bv1,DB06856,-7.8,6-FLUORO-2-[2-HYDROXY-3-(2-METHYL-CYCLOHEXYLOXY)-PHENYL]-1H-INDOLE-5-CARBOXAMIDINE,HUYQYLFFFNSAAX-BUXKBTBVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
124276,6w4h,DB00962,-7.8,Zaleplon,HUNXMJYCHXQEGX-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
163918,7bv1,DB06858,-7.8,N-cyclooctylglycyl-N-(4-carbamimidoylbenzyl)-L-prolinamide,MMLOIDMSBRJZAE-FQEVSTJZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
124272,6w4h,DB00957,-7.8,Norgestimate,KIQQMECNKUGGKA-NMYWJIRASA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
106849,6vxx,DB01393,-7.8,Bezafibrate,IIBYAHWJQTYFKB-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106862,6vxx,DB01413,-7.8,Cefepime,HVFLCNVBZFFHBT-ZKDACBOMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56454,6crv,DB02353,-7.8,Heparin Disaccharide Iii-S,GSYQGRODWXMUOO-GYBHJADLSA-K,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80845,6m3m,DB00498,-7.8,Phenindione,NFBAXHOPROOJAW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80842,6m3m,DB00495,-7.8,Zidovudine,HBOMLICNUCNMMY-XLPZGREQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
27651,6cs2,DB07201,-7.8,(2S)-3-[(9H-fluoren-9-ylideneamino)oxy]-2-methylpropanoic acid,ZHFDVDMCVXUGGF-NSHDSACASA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
107202,6vxx,DB02699,-7.8,4-Oxoretinol,PLIUCYCUYQIBDZ-RMWYGNQTSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56346,6crv,DB02213,-7.8,Metanitrophenyl-Alpha-D-Galactoside,VCCMGHVCRFMITI-IIRVCBMXSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28953,6cs2,DB08580,-7.8,4-bromo-2-{[(2R)-2-(2-chlorobenzyl)pyrrolidin-1-yl]carbonyl}aniline,JEGGWFHNKPRKTO-CQSZACIVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
56341,6crv,DB02205,-7.8,"6-(1,1-Dimethylallyl)-2-(1-Hydroxy-1-Methylethyl)-2,3-Dihydro-7h-Furo[3,2-G]Chromen-7-One",JCDLLLXYAICSQV-INIZCTEOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27695,6cs2,DB07251,-7.8,"N'-(3-CHLORO-4-METHOXY-PHENYL)-N-(3,4,5-TRIMETHOXYPHENYL)-1,3,5-TRIAZINE-2,4-DIAMINE",ZVWFECUPYCFYBL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
56331,6crv,DB02191,-7.8,"(7as,12ar,12bs)-1,2,3,4,7a,12,12a,12b-Octahydroindolo[2,3-a]Quinolizin-7(6h)-One",PGKUSHWBQJPFOP-LBPRGKRZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
32262,6cs2,DB01238,-7.8,Aripiprazole,CEUORZQYGODEFX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
80665,6m3m,DB00280,-7.8,Disopyramide,UVTNFZQICZKOEM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
107234,6vxx,DB02743,-7.8,beta-D-galactopyranosyl-(1->4)-beta-D-galactopyranose,GUBGYTABKSRVRQ-WWZHPTPQSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80655,6m3m,DB00270,-7.8,Isradipine,HMJIYCCIJYRONP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
107254,6vxx,DB02770,-7.8,7-Alpha-D-Ribofuranosyl-2-Aminopurine-5'-Phosphate,UDRQVOJQMHZSIM-PULFBKJNSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
123778,6w4h,DB00370,-7.8,Mirtazapine,RONZAEMNMFQXRA-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
123773,6w4h,DB00365,-7.8,Grepafloxacin,AIJTTZAVMXIJGM-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
32236,6cs2,DB01207,-7.8,Ridogrel,GLLPUTYLZIKEGF-HAVVHWLPSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
164149,7bv1,DB07311,-7.8,"18-CHLORO-11,12,13,14-TETRAHYDRO-1H,10H-8,4-(AZENO)-9,15,1,3,6-BENZODIOXATRIAZACYCLOHEPTADECIN-2-ONE",JRSWWYITYIOHOP-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
123874,6w4h,DB00485,-7.8,Dicloxacillin,YFAGHNZHGGCZAX-JKIFEVAISA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
11246,6lzg,DB11703,-7.8,Acalabrutinib,WDENQIQQYWYTPO-IBGZPJMESA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
27685,6cs2,DB07240,-7.8,3-[(9H-fluoren-9-ylideneamino)oxy]propanoic acid,LASWLEUVWJDDBA-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
28949,6cs2,DB08577,-7.8,3-[(3-(2-CARBOXYETHYL)-4-METHYLPYRROL-2-YL)METHYLENE]-2-INDOLINONE,JNDVEAXZWJIOKB-JYRVWZFOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
80840,6m3m,DB00493,-7.8,Cefotaxime,GPRBEKHLDVQUJE-QSWIMTSFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
164026,7bv1,DB06986,-7.8,"2-CHLORO-N-[(1R,2R)-1-HYDROXY-2,3-DIHYDRO-1H-INDEN-2-YL]-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE",LRHOLHTVXXSIMG-BXUZGUMPSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
124037,6w4h,DB00687,-7.8,Fludrocortisone,AAXVEMMRQDVLJB-BULBTXNYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
164050,7bv1,DB07013,-7.8,TERT-BUTYL 4-({[4-(BUT-2-YN-1-YLAMINO)PHENYL]SULFONYL}METHYL)-4-[(HYDROXYAMINO)CARBONYL]PIPERIDINE-1-CARBOXYLATE,RXFCFGLSOUOCEA-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
80801,6m3m,DB00446,-7.8,Chloramphenicol,WIIZWVCIJKGZOK-RKDXNWHRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
164055,7bv1,DB07019,-7.8,"N-[(5R,14R)-5-AMINO-5,14-DIMETHYL-4-OXO-3-OXA-18-AZATRICYCLO[15.3.1.1-7,11-]DOCOSA-1(21),7(22),8,10,17,19-HEXAEN-19-YL]-N-METHYLMETHANESULFONAMIDE",QWDOKZPZLWNULU-MZNJEOGPSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
56424,6crv,DB02315,-7.8,Cyclic GMP,ZOOGRGPOEVQQDX-UUOKFMHZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
123983,6w4h,DB00620,-7.8,Triamcinolone,GFNANZIMVAIWHM-OBYCQNJPSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
123964,6w4h,DB00596,-7.8,Ulobetasol,LEHFPXVYPMWYQD-XHIJKXOTSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
80772,6m3m,DB00412,-7.8,Rosiglitazone,YASAKCUCGLMORW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
164091,7bv1,DB07249,-7.8,"N-(5-chloro-1,3-benzodioxol-4-yl)-6-methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-amine",QHIMVPIOWKYPSO-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
80746,6m3m,DB00380,-7.8,Dexrazoxane,BMKDZUISNHGIBY-ZETCQYMHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
56366,6crv,DB02237,-7.8,Maltotetraose,UYQJCPNSAVWAFU-KVXMBEGHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107171,6vxx,DB02658,-7.8,"2,4-Dinitrophenyl 2-Deoxy-2-Fluoro-Beta-D-Allopyranoside",UFSBFVZQJZMIOU-LZQZFOIKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
123890,6w4h,DB00502,-7.8,Haloperidol,LNEPOXFFQSENCJ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
107184,6vxx,DB02675,-7.8,(4-Hydroxymaltosephenyl)Glycine,PHPOPZGUOBMSPZ-QHJSCRBTSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
73341,6m2n,DB01906,-7.8,"3-(5-Amino-7-Hydroxy-[1,2,3]Triazolo[4,5-D]Pyrimidin-2-Yl)-Benzoic Acid",KNLLRZNGRRRPEW-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80949,6m3m,DB00628,-7.8,Clorazepic acid,XDDJGVMJFWAHJX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
163855,7bv1,DB06746,-7.8,ginkgolide-J,LMEHVEUFNRJAAV-UKWFQYJJSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
163608,7bv1,DB04849,-7.8,Cediranib,XXJWYDDUDKYVKI-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
163609,7bv1,DB04850,-7.8,Posizolid,HBUJYEUPIIJJOS-PBHICJAKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
124753,6w4h,DB01586,-7.8,Ursodeoxycholic acid,RUDATBOHQWOJDD-UZVSRGJWSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
73200,6m2n,DB01712,-7.8,"(3r)-4-(P-Toluenesulfonyl)-1,4-Thiazane-3-Carboxylicacid-L-Phenylalanine Ethyl Ester",NDDSSAGSYFVBTG-SFTDATJTSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
124733,6w4h,DB01561,-7.8,Androstanedione,RAJWOBJTTGJROA-WZNAKSSCSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
11316,6lzg,DB11800,-7.8,Tivozanib,SPMVMDHWKHCIDT-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
73223,6m2n,DB01745,-7.8,N-Alpha-(2-Naphthylsulfonyl)-N(3-Amidino-L-Phenylalaninyl)Isopipecolinic Acid Methyl Ester,JJLGQWCKMHPBEB-DEOSSOPVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
124674,6w4h,DB01496,-7.8,Barbituric acid derivative,DNZPLHRZXUJATK-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
106649,6vxx,DB00854,-7.8,Levorphanol,JAQUASYNZVUNQP-USXIJHARSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163665,7bv1,DB05791,-7.8,Perflubron,WTWWXOGTJWMJHI-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
11311,6lzg,DB11794,-7.8,Berzosertib,JZCWLJDSIRUGIN-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
11310,6lzg,DB11793,-7.8,Niraparib,PCHKPVIQAHNQLW-CQSZACIVSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
81121,6m3m,DB00833,-7.8,Cefaclor,QYIYFLOTGYLRGG-GPCCPHFNSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
11309,6lzg,DB11792,-7.8,Mirodenafil,MIJFNYMSCFYZNY-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
163692,7bv1,DB05944,-7.8,Varlitinib,UWXSAYUXVSFDBQ-CYBMUJFWSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
124759,6w4h,DB01595,-7.8,Nitrazepam,KJONHKAYOJNZEC-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
124620,6w4h,DB01434,-7.8,19-norandrostenedione,JRIZOGLBRPZBLQ-QXUSFIETSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
106580,6vxx,DB00519,-7.8,Trandolapril,VXFJYXUZANRPDJ-WTNASJBWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
32594,6cs2,T3D1994,-7.8,"3,4',5-Tribromobiphenyl",PMLLBFUHDNYTAP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
81330,6m3m,DB01071,-7.8,Mequitazine,HOKDBMAJZXIPGC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
73147,6m2n,DB01641,-7.8,"(5z)-2-[(1s,2r)-1-Amino-2-Hydroxypropyl]-5-[(4-Amino-1h-Indol-3-Yl)Methylene]-3-(2-Hydroxyethyl)-3,5-Dihydro-4h-Imidazol-4-One",JUWJATLABHTRDF-JURWUIOISA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
81309,6m3m,DB01048,-7.8,Abacavir,MCGSCOLBFJQGHM-SCZZXKLOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
73158,6m2n,DB01656,-7.8,Roflumilast,MNDBXUUTURYVHR-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
163522,7bv1,DB04740,-7.8,MOXALACTAM (HYDROLYZED),ZTOQXKUYWZBJLG-XNAIMREJSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
11349,6lzg,DB11845,-7.8,Lucitanib,CUDVHEFYRIWYQD-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
124883,6w4h,DB01755,-7.8,N-[Isoleucinyl]-N'-[Adenosyl]-Diaminosufone,XVTRBLLRODNOJV-VBJYJYTRSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
124875,6w4h,DB01745,-7.8,N-Alpha-(2-Naphthylsulfonyl)-N(3-Amidino-L-Phenylalaninyl)Isopipecolinic Acid Methyl Ester,JJLGQWCKMHPBEB-DEOSSOPVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
106544,6vxx,DB00472,-7.8,Fluoxetine,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106551,6vxx,DB00480,-7.8,Lenalidomide,GOTYRUGSSMKFNF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163540,7bv1,DB04764,-7.8,[4-(3-AMINOMETHYL-PHENYL)-PIPERIDIN-1-YL]-(5-PHENETHYL- PYRIDIN-3-YL)-METHANONE,CCLHROFBSWWOQO-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
81285,6m3m,DB01021,-7.8,Trichlormethiazide,LMJSLTNSBFUCMU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
124818,6w4h,DB01668,-7.8,Nanaomycin D,XUWPJKDMEZSVTP-UOSCCXBLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
11343,6lzg,DB11833,-7.8,Basimglurant,UPZWINBEAHDTLA-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
163556,7bv1,DB04787,-7.8,Tanaproget,PYVFWTPEBMRKSR-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
81264,6m3m,DB00998,-7.8,Frovatriptan,XPSQPHWEGNHMSK-SECBINFHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
124926,6w4h,DB01812,-7.8,Adenosine-3'-5'-Diphosphate,WHTCPDAXWFLDIH-KQYNXXCUSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
106666,6vxx,DB00873,-7.8,Loteprednol,YPZVAYHNBBHPTO-MXRBDKCISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
73252,6m2n,DB01782,-7.8,"2,6-Dihydroanthra/1,9-Cd/Pyrazol-6-One",ACPOUJIDANTYHO-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
106766,6vxx,DB01224,-7.8,Quetiapine,URKOMYMAXPYINW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81004,6m3m,DB00695,-7.8,Furosemide,ZZUFCTLCJUWOSV-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
11261,6lzg,DB11730,-7.8,Ribociclib,RHXHGRAEPCAFML-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
163799,7bv1,DB06311,-7.8,Darapladib,WDPFJWLDPVQCAJ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
80995,6m3m,DB00686,-7.8,Pentosan Polysulfate,FCCNSUIJIOOXEZ-SJYYZXOBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
27589,6cs2,DB07138,-7.8,Neflamapimod,VEPKQEUBKLEPRA-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
27599,6cs2,DB07148,-7.8,"(6S)-1-chloro-3-[(4-fluorobenzyl)oxy]-6-(pyrrolidin-1-ylcarbonyl)pyrrolo[1,2-a]pyrazin-4(6H)-one",HPAFVLDARQIHPU-HNNXBMFYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
80982,6m3m,DB00671,-7.8,Cefixime,OKBVVJOGVLARMR-QSWIMTSFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
124436,6w4h,DB01147,-7.8,Cloxacillin,LQOLIRLGBULYKD-JKIFEVAISA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
73321,6m2n,DB01873,-7.8,Epothilone D,XOZIUKBZLSUILX-GIQCAXHBSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
124429,6w4h,DB01139,-7.8,Cefapirin,UQLLWWBDSUHNEB-CZUORRHYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
124409,6w4h,DB01116,-7.8,Trimethaphan,CHQOEHPMXSHGCL-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
124403,6w4h,DB01108,-7.8,Trilostane,KVJXBPDAXMEYOA-CXANFOAXSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
106798,6vxx,DB01273,-7.8,Varenicline,JQSHBVHOMNKWFT-DTORHVGOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163854,7bv1,DB06745,-7.8,ginkgolide-C,AMOGMTLMADGEOQ-DTDWCABLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
81014,6m3m,DB00706,-7.8,Tamsulosin,DRHKJLXJIQTDTD-OAHLLOKOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
73251,6m2n,DB01780,-7.8,Fusicoccin,KXTYBXCEQOANSX-WYKQKOHHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
81015,6m3m,DB00708,-7.8,Sufentanil,GGCSSNBKKAUURC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
27564,6cs2,DB07113,-7.8,"(2S)-6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2-(3,5-DIFLUOROPHENYL)-4-(3-METHOXYPROPYL)-2H-1,4-BENZOXAZIN-3(4H)-ONE",KHZQOXQOUCGGGA-NRFANRHFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
124605,6w4h,DB01418,-7.8,Acenocoumarol,VABCILAOYCMVPS-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
56714,6crv,DB02686,-7.8,Undecyl-Beta-D-Maltopyranoside,UYEMNFYVTFDKRG-ZNGNCRBCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81099,6m3m,DB00810,-7.8,Biperiden,YSXKPIUOCJLQIE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
124587,6w4h,DB01392,-7.8,Yohimbine,BLGXFZZNTVWLAY-SCYLSFHTSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
163716,7bv1,DB06134,-7.8,SNS-314,FAYAUAZLLLJJGH-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
81082,6m3m,DB00790,-7.8,Perindopril,IPVQLZZIHOAWMC-QXKUPLGCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
106694,6vxx,DB00905,-7.8,Bimatoprost,AQOKCDNYWBIDND-FTOWTWDKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163731,7bv1,DB06160,-7.8,Garenoxacin,NJDRXTDGYFKORP-LLVKDONJSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
56694,6crv,DB02658,-7.8,"2,4-Dinitrophenyl 2-Deoxy-2-Fluoro-Beta-D-Allopyranoside",UFSBFVZQJZMIOU-LZQZFOIKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27553,6cs2,DB07102,-7.8,(2S)-2-amino-5-oxo-5-[(4-phenylmethoxyphenyl)amino]pentanoic acid,BYSBXIPCDJNEBG-INIZCTEOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
106708,6vxx,DB00919,-7.8,Spectinomycin,UNFWWIHTNXNPBV-WXKVUWSESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106720,6vxx,DB00933,-7.8,Mesoridazine,SLVMESMUVMCQIY-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
124536,6w4h,DB01268,-7.8,Sunitinib,WINHZLLDWRZWRT-ATVHPVEESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
163742,7bv1,DB06190,-7.8,Solabegron,LLDXOPKUNJTIRF-QFIPXVFZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
32486,6cs2,T3D1844,-7.8,Bioresmethrin,VEMKTZHHVJILDY-UXHICEINSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
56655,6crv,DB02607,-7.8,Adenosine Phosphonoacetic Acid,KJNLSEOJEFDELT-JJNLEZRASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72742,6m2n,DB01098,-7.8,Rosuvastatin,BPRHUIZQVSMCRT-VEUZHWNKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
28392,6cs2,DB07982,-7.8,2-{4-[4-({4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]pyrimidin-2-yl}amino)phenyl]piperazin-1-yl}-2-oxoethanol,PVTKDXZNSUHUMO-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
78851,6m2n,DB12357,-7.8,BMS-863233,JJWLXRKVUJDJKG-VIFPVBQESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
9048,6lzg,DB07119,-7.8,1-CHLORO-6-(4-HYDROXYPHENYL)-2-NAPHTHOL,YHEHVRSGKUYDON-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
112493,6vxx,DB07316,-7.8,"N-{1-[(1-carbamoylcyclopropyl)methyl]piperidin-4-yl}-N-cyclopropyl-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide",FAVXIEFZKPJZRT-NRFANRHFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
52797,2fxp,DB12042,-7.8,Ibodutant,YQYSVMKCMIUCHY-WJOKGBTCSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
112519,6vxx,DB07345,-7.8,4-(2-aminoethyl)-2-cyclohexylphenol,DOCCSEDGBYCYLS-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
115908,6w4b,DB01471,-7.8,Bolasterone,IVFYLRMMHVYGJH-VLOLGRDOSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
76510,6m2n,DB07288,-7.8,N-(4-chlorophenyl)-2-[(pyridin-4-ylmethyl)amino]benzamide,GGPZCOONYBPZEW-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76530,6m2n,DB07309,-7.8,5-BROMO-2-{[(4-CHLOROPHENYL)SULFONYL]AMINO}BENZOIC ACID,JDVLYAYDIMUAAC-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76509,6m2n,DB07287,-7.8,"2-(2,4-DICHLOROPHENOXY)-5-(PYRIDIN-2-YLMETHYL)PHENOL",AOVDSWPGWPRTSR-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
112531,6vxx,DB07358,-7.8,"2-amino-N-(4-methyl-1,3-thiazol-2-yl)-5-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]benzamide",JEBOJMQHVUEKBE-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112564,6vxx,DB07400,-7.8,1-ETHOXYCARBONYL-D-PHE-PRO-2(4-AMINOBUTYL)HYDRAZINE,AEHSFPPTWRQOFS-MSOLQXFVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
115820,6w4b,DB01339,-7.8,Vecuronium,BGSZAXLLHYERSY-XQIGCQGXSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
8997,6lzg,DB07061,-7.8,"1-(CYCLOHEXYLAMINO)-3-(6-METHYL-3,4-DIHYDRO-1H-CARBAZOL-9(2H)-YL)PROPAN-2-OL",AXYFCRIRLKSCRR-SFHVURJKSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
76471,6m2n,DB07246,-7.8,"(2R)-2-AMINO-3,3,3-TRIFLUORO-N-HYDROXY-2-{[(4-PHENOXYPHENYL)SULFONYL]METHYL}PROPANAMIDE",MKRPIBSCGZAUCH-OAHLLOKOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
112600,6vxx,DB07441,-7.8,"3-{[(9-CYANO-9,10-DIHYDRO-10-METHYLACRIDIN-9-YL)CARBONYL]AMINO}PROPANOIC ACID",FRBAOMHMZCGBOJ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30422,6cs2,DB00948,-7.8,Mezlocillin,YPBATNHYBCGSSN-VWPFQQQWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
76533,6m2n,DB07312,-7.8,"2,5-DICHLORO-N-(5-CHLORO-1,3-BENZOXAZOL-2-YL)BENZENESULFONAMIDE",JCXZHFCBNFFHRC-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
9063,6lzg,DB07133,-7.8,D-phenylalanyl-N-(3-methylbenzyl)-L-prolinamide,CHKWABXWPATIIG-UXHICEINSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
112451,6vxx,DB07119,-7.8,1-CHLORO-6-(4-HYDROXYPHENYL)-2-NAPHTHOL,YHEHVRSGKUYDON-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75103,6m2n,DB04248,-7.8,beta-(1->4)-galactotriose,FYGDTMLNYKFZSV-XJJKTWKOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76624,6m2n,DB07419,-7.8,S-23,SSFVOEAXHZGTRJ-KRWDZBQOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
147,6lzg,HMDB0003141,-7.8,Retinoyl b-glucuronide,MTGFYEHKPMOVNE-NEFMKCFNSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
166001,7bv1,DB13554,-7.8,Moperone,AGAHNABIDCTLHW-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
112338,6vxx,DB06991,-7.8,"N-[2-methyl-5-(methylcarbamoyl)phenyl]-2-{[(1R)-1-methylpropyl]amino}-1,3-thiazole-5-carboxamide",OYOUIHFZUAKCEF-LLVKDONJSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76608,6m2n,DB07400,-7.8,1-ETHOXYCARBONYL-D-PHE-PRO-2(4-AMINOBUTYL)HYDRAZINE,AEHSFPPTWRQOFS-MSOLQXFVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
166003,7bv1,DB13556,-7.8,Sulfamazone,BGLHAKAJGYLSOX-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
76584,6m2n,DB07371,-7.8,3-(10-methyl-9-anthryl)propanoic acid,CKQINRXZVYBCSC-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76569,6m2n,DB07352,-7.8,Apigenin,KZNIFHPLKGYRTM-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
112388,6vxx,DB07046,-7.8,"2-[(2-chloro-4-iodophenyl)amino]-N-{[(2R)-2,3-dihydroxypropyl]oxy}-3,4-difluorobenzamide",FCADPEDUULETPK-SECBINFHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112403,6vxx,DB07061,-7.8,"1-(CYCLOHEXYLAMINO)-3-(6-METHYL-3,4-DIHYDRO-1H-CARBAZOL-9(2H)-YL)PROPAN-2-OL",AXYFCRIRLKSCRR-SFHVURJKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75138,6m2n,DB04295,-7.8,N-Benzoyl-N'-Beta-D-Glucopyranosyl Urea,JSBCZGSPFATCOV-BZNQNGANSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
116074,6w4b,DB01669,-7.8,Virginiamycin M1,DAIKHDNSXMZDCU-FQTGFAPKSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
112435,6vxx,DB07102,-7.8,(2S)-2-amino-5-oxo-5-[(4-phenylmethoxyphenyl)amino]pentanoic acid,BYSBXIPCDJNEBG-INIZCTEOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
9069,6lzg,DB07141,-7.8,"5-[(3R)-3-(5-methoxy-4'-methylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",QVXYJVHNRPNRJL-HNNXBMFYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
112604,6vxx,DB07447,-7.8,5beta-dihydrotestosterone,NVKAWKQGWWIWPM-MISPCMORSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30403,6cs2,DB12433,-7.8,SCH-900271,ARJKMWXLIHZLQZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
112629,6vxx,DB07477,-7.8,Felbinac,QRZAKQDHEVVFRX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76439,6m2n,DB07205,-7.8,N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,GZJXCRHEMLAMRA-SDBHATRESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
30353,6cs2,DB12378,-7.8,Apricoxib,JTMITOKKUMVWRT-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
166157,7bv1,DB13766,-7.8,Lidoflazine,ZBIAKUMOEKILTF-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
112764,6vxx,DB07816,-7.8,N-(P-CYANOPHENYL)-N'-DIPHENYLMETHYL-GUANIDINE-ACETIC ACID,KGHMYJFHUHFOGL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76350,6m2n,DB07105,-7.8,2-[2-(4-CHLORO-PHENYLSULFANYL)-ACETYLAMINO]-3-(4-GUANIDINO-PHENYL)-PROPIONAMIDE,IEEYGOJDTRVYGR-HNNXBMFYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
112781,6vxx,DB07835,-7.8,"N-3-cyclopropyl-N-4-'-(cyclopropylmethyl)-6-methylbiphenyl-3,4'-dicarboxamide",BOPSUAHGQHFKGG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
115425,6w4b,DB00843,-7.8,Donepezil,ADEBPBSSDYVVLD-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
115420,6w4b,DB00836,-7.8,Loperamide,RDOIQAHITMMDAJ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
76332,6m2n,DB07083,-7.8,beta-phenyl-D-phenylalanyl-N-propyl-L-prolinamide,HZKKJPDVZGOOPU-PZJWPPBQSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
112812,6vxx,DB07870,-7.8,(2S)-2-(4-{[3-CHLORO-5-(TRIFLUOROMETHYL)PYRIDIN-2-YL]OXY}PHENOXY)PROPANOIC ACID,GOCUAJYOYBLQRH-MRVPVSSYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75255,6m2n,DB04463,-7.8,"3-(4-Amino-1-Tert-Butyl-1h-Pyrazolo[3,4-D]Pyrimidin-3-Yl)Phenol",CPLGZXQPPYRNRC-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
112813,6vxx,DB07871,-7.8,6-CHLORO-4-(CYCLOHEXYLOXY)-3-ISOPROPYLQUINOLIN-2(1H)-ONE,OQCFORGSZJSAEL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
8888,6lzg,DB06945,-7.8,N-hydroxy-4-({4-[4-(trifluoromethyl)phenoxy]phenyl}sulfonyl)tetrahydro-2H-pyran-4-carboxamide,FOSWRYKPHVPIDJ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
112820,6vxx,DB07878,-7.8,"N-[(1S)-1-{1-[(1R,3E)-1-ACETYLPENT-3-EN-1-YL]-1H-1,2,3-TRIAZOL-4-YL}-1,2-DIMETHYLPROPYL]BENZAMIDE",OEHUTYXPQSSKAK-RVLLMHTFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
166191,7bv1,DB13983,-7.8,"5,7,2'-trihydroxy-6,8-dimethoxyflavone",JWOKGWICZPPYPX-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
76312,6m2n,DB07058,-7.8,"5-[1-(4-methoxyphenyl)-1H-benzimidazol-6-yl]-1,3,4-oxadiazole-2(3H)-thione",QBVJMUOTMRYUKR-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
8918,6lzg,DB06983,-7.8,"(5-phenyl-7-(pyridin-3-ylmethylamino)pyrazolo[1,5-a]pyrimidin-3-yl)methanol",RBLKWWBHDUBPFN-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
76626,6m2n,DB07421,-7.8,"4-{[(1R,2S)-1,2-dihydroxy-2-methyl-3-(4-nitrophenoxy)propyl]amino}-2-(trifluoromethyl)benzonitrile",INVUBEGZQHQAMY-SJORKVTESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
8936,6lzg,DB07000,-7.8,"N-{2,4-difluoro-3-[(5-pyridin-3-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)carbonyl]phenyl}ethanesulfonamide",ILXJWLWSYAWJKZ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
112724,6vxx,DB07772,-7.8,"(1R)-1-{[(4'-methoxy-1,1'-biphenyl-4-yl)sulfonyl]amino}-2-methylpropylphosphonic acid",BZVYQWLRCHLAGK-QGZVFWFLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76433,6m2n,DB07198,-7.8,5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-CARBONITRILE,GGEKOZPXKBYLNK-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
112641,6vxx,DB07490,-7.8,"2-[1-(4-CHLORO-PHENYL)-ETHYL]-4,6-DINITRO-PHENOL",MOZUMFSUQQHSCO-MRVPVSSYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76425,6m2n,DB07188,-7.8,"(3S)-1-CYCLOHEXYL-N-(3,5-DICHLOROPHENYL)-5-OXOPYRROLIDINE-3-CARBOXAMIDE",YUFADRZDHJKVOT-NSHDSACASA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
112651,6vxx,DB07503,-7.8,"(5E)-5-[(2,2-DIFLUORO-1,3-BENZODIOXOL-5-YL)METHYLENE]-1,3-THIAZOLIDINE-2,4-DIONE",SRLVNYDXMUGOFI-YWEYNIOJSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
52672,2fxp,DB11852,-7.8,Tegobuvir,XBEQSQDCBSKCHJ-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
8956,6lzg,DB07021,-7.8,"(7R,8R)-8-(2,4,5-trifluorophenyl)-6,7,8,9-tetrahydroimidazo[1,2-a:4,5-c']dipyridin-7-amine",SOSYXEPELJIJHZ-RNCFNFMXSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
75216,6m2n,DB04407,-7.8,4-[4-(4-Methyl-2-Methylamino-Thiazol-5-Yl)-Pyrimidin-2-Ylamino]-Phenol,OTMLAWRVLMYMDF-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76397,6m2n,DB07157,-7.8,"(5R,6S,8S)-8-[3-(AMINOMETHYL)PHENYL]-6-HYDROXY-5-ISOPROPYL-3-OXO-1-PHENYL-2,7-DIOXA-4-AZA-6-PHOSPHANONAN-9-OIC ACID 6-OXIDE",RTFGEFWZCFCODU-RBUKOAKNSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
115577,6w4b,DB01016,-7.8,Glyburide,ZNNLBTZKUZBEKO-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
75218,6m2n,DB04409,-7.8,Naphthalene Trisulfonate,ZPBSAMLXSQCSOX-UHFFFAOYSA-K,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
112701,6vxx,DB07747,-7.8,"(3R)-N-(4-CHLOROPHENYL)-3-(HYDROXYMETHYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONAMIDE",YTBGBMPLINFTBQ-OAHLLOKOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
8946,6lzg,DB07011,-7.8,"(3S)-1-(1,3-BENZODIOXOL-5-YLMETHYL)-3-[4-(1H-IMIDAZOL-1-YL)PHENOXY]PIPERIDINE",HHOPJGKEAIIIDF-FQEVSTJZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
76366,6m2n,DB07122,-7.8,1-[4-(2-oxo-2-phenylethyl)phenyl]guanidine,MERNPSIIBFTCAI-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
112714,6vxx,DB07761,-7.8,"(2R)-1-[4-({6-[(2,6-Difluorophenyl)amino]-4-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol",ZVSBKYYVBCKDBO-OAHLLOKOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30363,6cs2,DB12390,-7.8,MBX-8025,JWHYSEDOYMYMNM-QGZVFWFLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
115505,6w4b,DB00932,-7.8,Tipranavir,SUJUHGSWHZTSEU-FYBSXPHGSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
30497,6cs2,DB12566,-7.8,Decernotinib,ASUGUQWIHMTFJL-QGZVFWFLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
112322,6vxx,DB06971,-7.8,"N-{2-[(4'-CYANO-1,1'-BIPHENYL-4-YL)OXY]ETHYL}-N'-HYDROXY-N-METHYLUREA",GVMUNGGWXRKCEU-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30504,6cs2,DB12573,-7.8,LY-2452473,IHIWYQYVBNODSV-KRWDZBQOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
111803,6vxx,DB04715,-7.8,IMIDAZOPYRIDAZIN 1,IVUBNTNWKIPCPS-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111835,6vxx,DB04762,-7.8,N-PYRIDOXYL-D-GLUTAMIC ACID-5'-MONOPHOSPHATE,JMRKOGDJNHPMHS-SNVBAGLBSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
117782,6w4b,DB03944,-7.8,"5-[1-(3,4-Dimethoxy-Benzoyl)-1,2,3,4-Tetrahydro-Quinolin-6-Yl]-6-Methyl-3,6-Dihydro-[1,3,4]Thiadiazin-2-One",IZLRMTJLQCLMKF-CYBMUJFWSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
117729,6w4b,DB03878,-7.8,N-[4-Methyl-3-[[4-(3-Pyridinyl)-2-Pyrimidinyl]Amino]Phenyl]-3-Pyridinecarboxamide,YWQVBESSYLICRX-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
165793,7bv1,DB13022,-7.8,LY-2874455,GKJCVYLDJWTWQU-CXLRFSCWSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
76911,6m2n,DB07760,-7.8,"3-[(1E,7E)-8-(2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)-3,6-dioxa-2,7-diazaocta-1,7-dien-1-yl]benzoic acid",TUYDQQMKXSQIQG-GONBZBRSSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
29491,6cs2,DB09244,-7.8,Pirlindole,IWVRVEIKCBFZNF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
76899,6m2n,DB07747,-7.8,"(3R)-N-(4-CHLOROPHENYL)-3-(HYDROXYMETHYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONAMIDE",YTBGBMPLINFTBQ-OAHLLOKOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76881,6m2n,DB07724,-7.8,Indeglitazar,YMPALHOKRBVHOJ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
111892,6vxx,DB04833,-7.8,Methaqualone,JEYCTXHKTXCGPB-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111894,6vxx,DB04836,-7.8,Amineptine,ONNOFKFOZAJDHT-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
117504,6w4b,DB03583,-7.8,"(2e,3s)-3-Hydroxy-5'-[(4-Hydroxypiperidin-1-Yl)Sulfonyl]-3-Methyl-1,3-Dihydro-2,3'-Biindol-2'(1'h)-One",AYOAIABDFUJDKQ-SQJPUDIVSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
111913,6vxx,DB04861,-7.8,Nebivolol,KOHIRBRYDXPAMZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111917,6vxx,DB04865,-7.8,Omacetaxine mepesuccinate,HYFHYPWGAURHIV-JFIAXGOJSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
9360,6lzg,DB07453,-7.8,2-PHENYL-4H-BENZO[H]CHROMEN-4-ONE,VFMMPHCGEFXGIP-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
9435,6lzg,DB07535,-7.8,2-amino-6-[2-(1H-indol-6-yl)ethyl]pyrimidin-4(3H)-one,VRAZIAJSKFRSIP-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
111947,6vxx,DB04915,-7.8,Idronoxil,ZZUBHVMHNVYXRR-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
117936,6w4b,DB04154,-7.8,"N-Methyl-N-[3-(6-Phenyl[1,2,4]Triazolo[4,3-B]Pyridazin-3-Yl)Phenyl]Acetamide",ALBWBHNFOJJMCV-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
29481,6cs2,DB09233,-7.8,Cronidipine,CNIJVNPIIHWRRP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
77048,6m2n,DB07920,-7.8,N-oxo-2-[(4-phenylphenyl)sulfonylamino]ethanamide,OGRPZMQLAVBWPV-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
74901,6m2n,DB03982,-7.8,"Compound 5, 2-(Naphthalen-1-Yl-Oxalyl-Amino)-Benzoicacid",WQWCUHJIERBOSM-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
165740,7bv1,DB12739,-7.8,Bindarit,MTHORRSSURHQPZ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
118121,6w4b,DB04405,-7.8,"2-[2-(1,3-Dioxo-1,3-Dihydro-2h-Isoindol-2-Yl)Ethyl]-4-(4'-Ethoxy-1,1'-Biphenyl-4-Yl)-4-Oxobutanoic Acid",AQYSXARQCHHHLK-NRFANRHFSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
30682,6cs2,DB12833,-7.8,Tandospirone,CEIJFEGBUDEYSX-FZDBZEDMSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
118112,6w4b,DB04392,-7.8,"Bishydroxy[2h-1-Benzopyran-2-One,1,2-Benzopyrone]",HIZKPJUTKKJDGA-BETUJISGSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
111679,6vxx,DB04371,-7.8,AL6528,FBBLOSCXOZYUSS-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76981,6m2n,DB07838,-7.8,(Z)-3-BENZYL-5-(2-HYDROXY-3-NITROBENZYLIDENE)-2-THIOXOTHIAZOLIDIN-4-ONE,ZTWBCEZQPRYIGY-ZROIWOOFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
111702,6vxx,DB04405,-7.8,"2-[2-(1,3-Dioxo-1,3-Dihydro-2h-Isoindol-2-Yl)Ethyl]-4-(4'-Ethoxy-1,1'-Biphenyl-4-Yl)-4-Oxobutanoic Acid",AQYSXARQCHHHLK-NRFANRHFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
118048,6w4b,DB04298,-7.8,"3-(4-Amino-2-Tert-Butyl-5-Methyl-Phenylsulfanyl)-6-Cyclopentyl-4-Hydroxy-6-[2-(4-Hydroxy-Phenyl)-Ethyl]-5,6-Dihydro-Pyran-2-One",ZEBFKFGJWHOOST-LJAQVGFWSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
9447,6lzg,DB07546,-7.8,[1-(6-{6-[(1-methylethyl)amino]-1H-indazol-1-yl}pyrazin-2-yl)-1H-pyrrol-3-yl]acetic acid,BBYRUZKRFAIQSR-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
76971,6m2n,DB07826,-7.8,2-[4-chloro-2-(phenylcarbonyl)phenoxy]-N-phenylacetamide,DTGVSZSMDOMAEB-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
165770,7bv1,DB12985,-7.8,Quisinostat,PAWIYAYFNXQGAP-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
7810,6lzg,DB04407,-7.8,4-[4-(4-Methyl-2-Methylamino-Thiazol-5-Yl)-Pyrimidin-2-Ylamino]-Phenol,OTMLAWRVLMYMDF-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
76947,6m2n,DB07801,-7.8,N-butyl-3-{[6-(9H-purin-6-ylamino)hexanoyl]amino}benzamide,WOYITRCGMUXUDE-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
7811,6lzg,DB04408,-7.8,Ncs-Chromophore,QZGIWPZCWHMVQL-UIYAJPBUSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
30324,6cs2,DB12336,-7.8,GDC-0917,HSHPBORBOJIXSQ-HARLFGEKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
165834,7bv1,DB13083,-7.8,Talarozole,SNFYYXUGUBUECJ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
111962,6vxx,DB04954,-7.8,Tecadenoson,OESBDSFYJMDRJY-BAYCTPFLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165902,7bv1,DB13217,-7.8,Fentiazac,JIEKMACRVQTPRC-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
76722,6m2n,DB07534,-7.8,"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE",BKUMVXIXUVYKDQ-GHXNOFRVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
116835,6w4b,DB02673,-7.8,"(4ar,6s,8ar)-11-[8-(1,3-Dioxo-1,3-Dihydro-2h-Isoindol-2-Yl)Octyl]-6-Hydroxy-3-Methoxy-5,6,9,10-Tetrahydro-4ah-[1]Benzofuro[3a,3,2-Ef][2]Benzazepin-11-Ium",VLGAHTYYCHWLNI-BHRZLAGCSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
116696,6w4b,DB02491,-7.8,4-[4-(1-Amino-1-Methylethyl)Phenyl]-5-Chloro-N-[4-(2-Morpholin-4-Ylethyl)Phenyl]Pyrimidin-2-Amine,CJSSYVIHFXDFFC-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
76696,6m2n,DB07504,-7.8,(2R)-1-{4-[(4-Anilino-5-bromo-2-pyrimidinyl)amino]phenoxy}-3-(dimethylamino)-2-propanol,MEIJADBULOETOV-QGZVFWFLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76683,6m2n,DB07488,-7.8,"{(2Z)-4-AMINO-2-[(4-METHOXYPHENYL)IMINO]-2,3-DIHYDRO-1,3-THIAZOL-5-YL}(4-METHOXYPHENYL)METHANONE",XQKUGFIWKSKCDL-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
116621,6w4b,DB02398,-7.8,6-[N-(4-(Aminomethyl)Phenyl)Carbamyl]-2-Naphthalenecarboxamidine,NLBDETRVUYOIHQ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
116566,6w4b,DB02329,-7.8,Carbenoxolone,OBZHEBDUNPOCJG-WBXJDKIVSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
75081,6m2n,DB04216,-7.8,Quercetin,REFJWTPEDVJJIY-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76660,6m2n,DB07459,-7.8,4-PHENOXY-N-(PYRIDIN-2-YLMETHYL)BENZAMIDE,HVLSCZSVTCNAQX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
112265,6vxx,DB06902,-7.8,4-(1-methyl-1-phenylethyl)phenol,QBDSZLJBMIMQRS-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76647,6m2n,DB07446,-7.8,N-(biphenyl-4-ylsulfonyl)-D-leucine,FBSVJQQVDISETN-QGZVFWFLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
112275,6vxx,DB06913,-7.8,"(2R,3R)-3-{[3,5-BIS(TRIFLUOROMETHYL)PHENYL]AMINO}-2-CYANO-3-THIOXOPROPANAMIDE",ZTUMRSFHUOBXAC-LHIURRSHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76636,6m2n,DB07432,-7.8,"[[(3R,4R,5S,6R)-3-(butanoylamino)-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-ylidene]amino] N-phenylcarbamate",ITVRELFVFCOUMV-ZVZWZHPPSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
116434,6w4b,DB02152,-7.8,K-252a,KOZFSFOOLUUIGY-SOLYNIJKSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
112111,6vxx,DB06309,-7.8,Refametinib,RDSACQWTXKSHJT-NSHDSACASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
172,6lzg,HMDB0003249,-7.8,Rutin,IKGXIBQEEMLURG-NVPNHPEKSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
76748,6m2n,DB07564,-7.8,"6-amino-2-[(2-morpholin-4-ylethyl)amino]-3,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",JUHXOBNFTFUPKQ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
30577,6cs2,DB12679,-7.8,WP 1066,VFUAJMPDXIRPKO-LQELWAHVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
117437,6w4b,DB03480,-7.8,Brequinar Analog,WYKKHJQZENLZID-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
30608,6cs2,DB12721,-7.8,RO-5028442,QZXVLRCMAHJVIP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
165865,7bv1,DB13126,-7.8,BMS-986115,SRJNRAQUSAVENA-GSHUGGBRSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
74999,6m2n,DB04114,-7.8,"3-Chloro-9-Ethyl-6,7,8,9,10,11-Hexahydro-7,11-Methanocycloocta[B]Quinolin-12-Amine",QTPHSDHUHXUYFE-NWDGAFQWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
117317,6w4b,DB03311,-7.8,"3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid [4-(Thiazol-2-Ylsulfamoyl)-Phenyl]-Amide",SXKBTDJJEQQEGE-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
117285,6w4b,DB03268,-7.8,RU82197,WKTQBTSOHBKBRW-VMPREFPWSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
30595,6cs2,DB12707,-7.8,AR-42,LAMIXXKAWNLXOC-INIZCTEOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
9320,6lzg,DB07409,-7.8,"(1-HYDROXY-1-PHOSPHONO-2-[1,1';4',1'']TERPHENYL-3-YL-ETHYL)-PHOSPHONIC ACID",MPBUFKZCEBTBSK-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
112035,6vxx,DB06150,-7.8,Sulfadimethoxine,ZZORFUFYDOWNEF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
117196,6w4b,DB03159,-7.8,CRA_8696,GAVRMVQHHVMXFD-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
9308,6lzg,DB07396,-7.8,"1-{2-[3-(2-Chloro-4,5-difluoro-benzoyl)-ureido]-4-fluoro-phenyl}-piperidine-4-carboxylic acid",KAJJGOCSAXKXBD-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
112054,6vxx,DB06188,-7.8,Ispinesib,QJZRFPJCWMNVAV-HHHXNRCGSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112064,6vxx,DB06203,-7.8,Alogliptin,ZSBOMTDTBDDKMP-OAHLLOKOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76768,6m2n,DB07589,-7.8,"N-[1-(AMINOMETHYL)CYCLOPROPYL]-3-(BENZYLSULFONYL)-N-2-[(1S)-2,2,2-TRIFLUORO-1-(4-HYDROXYPHENYL)ETHYL]-L-ALANINAMIDE",DWWVPKCSDHDILN-OALUTQOASA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
30579,6cs2,DB12681,-7.8,Salirasib,WUILNKCFCLNXOK-CFBAGHHKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
30573,6cs2,DB12672,-7.8,Icaritin,TUUXBSASAQJECY-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
118174,6w4b,DB04477,-7.8,"N-1,2,3,4-Tetrahydronaphth-1-Yl-2'-[3,5-Dimethoxybenzamido]-2'-Deoxy-Adenosine",FDZQGEIYGFPMOB-ZUURFMEUSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
8867,6lzg,DB06923,-7.8,2-(3-METHYLPHENYL)-1H-INDOLE-5-CARBOXIMIDAMIDE,KJUSXMYSVXZFDJ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
115280,6w4b,DB00673,-7.8,Aprepitant,ATALOFNDEOCMKK-OITMNORJSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
75835,6m2n,DB06195,-7.8,Seliciclib,BTIHMVBBUGXLCJ-OAHLLOKOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75831,6m2n,DB06188,-7.8,Ispinesib,QJZRFPJCWMNVAV-HHHXNRCGSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
113683,6vxx,DB11757,-7.8,Istradefylline,IQVRBWUUXZMOPW-PKNBQFBNSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114357,6vxx,DB13335,-7.8,Pinazepam,MFZOSKPPVCIFMT-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114342,6vxx,DB13317,-7.8,Flunoxaprofen,ARPYQKTVRGFPIS-VIFPVBQESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113695,6vxx,DB11774,-7.8,Pazufloxacin,XAGMUUZPGZWTRP-ZETCQYMHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30047,6cs2,DB00910,-7.8,Paricalcitol,BPKAHTKRCLCHEA-UBFJEZKGSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
113702,6vxx,DB11785,-7.8,Anisodamine,WTQYWNWRJNXDEG-RBZJEDDUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
8511,6lzg,DB06249,-7.8,Arzoxifene,MCGDSOGUHLTADD-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
113754,6vxx,DB12039,-7.8,Epicatechin,PFTAWBLQPZVEMU-UKRRQHHQSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
8468,6lzg,DB06169,-7.8,Indibulin,SOLIIYNRSAWTSQ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
113772,6vxx,DB12061,-7.8,Pardoprunox,YVPUUUDAZYFFQT-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
8174,6lzg,DB04850,-7.8,Posizolid,HBUJYEUPIIJJOS-PBHICJAKSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
29996,6cs2,DB11910,-7.8,MK-0249,DDDZBLNULGDPGA-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
114328,6vxx,DB13303,-7.8,Febarbamate,QHZQILHUJDRDAI-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30048,6cs2,DB11982,-7.8,GDC-0623,RFWVETIZUQEJEF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
30050,6cs2,DB11985,-7.8,Dapaconazole,FUAHXHWSMYFWGE-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
113626,6vxx,DB11672,-7.8,Curcumin,VFLDPWHFBUODDF-FCXRPNKRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29749,6cs2,DB11529,-7.8,Melengestrol,OKHAOBQKCCIRLO-IBVJIVQJSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
8117,6lzg,DB04790,-7.8,"2,5-bis-O-{3-[amino(imino)methyl]phenyl}-1,4:3,6-dianhydro-D-glucitol",IBIUTOFGXGGVKQ-XMTFNYHQSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
30085,6cs2,DB12029,-7.8,Chlorogenic Acid,CWVRJTMFETXNAD-JUHZACGLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
113523,6vxx,DB09313,-7.8,Ioxaglic acid,TYYBFXNZMFNZJT-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114478,6vxx,DB13680,-7.8,Naftazone,TZGBBMBARSFJBG-UKTHLTGXSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75880,6m2n,DB06282,-7.8,Levocetirizine,ZKLPARSLTMPFCP-OAQYLSRUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75879,6m2n,DB06281,-7.8,Torcetrapib,CMSGWTNRGKRWGS-NQIIRXRSSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
113561,6vxx,DB11518,-7.8,Flunixin,NOOCSNJCXJYGPE-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113575,6vxx,DB11555,-7.8,Zolazepam,GDSCFOSHSOWNDL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75852,6m2n,DB06230,-7.8,Nalmefene,WJBLNOPPDWQMCH-MBPVOVBZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
113583,6vxx,DB11582,-7.8,Thiocolchicoside,LEQAKWQJCITZNK-AXHKHJLKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114442,6vxx,DB13635,-7.8,Tiracizine,KJAMZCVTJDTESW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113608,6vxx,DB11644,-7.8,Tafamidis,TXEIIPDJKFWEEC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113617,6vxx,DB11658,-7.8,QAV-680,YOPFAMROKXHVCQ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
166462,7bv1,DB15186,-7.8,GDC-0084,LGWACEZVCMBSKW-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
29798,6cs2,DB11650,-7.8,HT-0712,ABEJDMOBAFLQNJ-NHCUHLMSSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
75517,6m2n,DB04812,-7.8,Benoxaprofen,MITFXPHMIHQXPI-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
114226,6vxx,DB13118,-7.8,Paquinimod,DIKSYHCCYVYKRO-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75749,6m2n,DB05719,-7.8,Elesclomol,BKJIXTWSNXCKJH-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75562,6m2n,DB04864,-7.8,Huperzine A,ZRJBHWIHUMBLCN-YQEJDHNASA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
114073,6vxx,DB12686,-7.8,PHA-793887,HUXYBQXJVXOMKX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
8365,6lzg,DB05608,-7.8,MKC-1,OVSKGTONMLKNPZ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
113933,6vxx,DB12291,-7.8,Tacedinaline,VAZAPHZUAVEOMC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75665,6m2n,DB05265,-7.8,Ecabet,IWCWQNVIUXZOMJ-MISYRCLQSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
8297,6lzg,DB05263,-7.8,Caprospinol,VMOZFSWFUBLCNN-AAPULDEBSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
113938,6vxx,DB12299,-7.8,Bavisant,BGBVSGSIXIIREO-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113939,6vxx,DB12300,-7.8,P-nitrobiphenyl,BAJQRLZAPXASRD-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
8358,6lzg,DB05575,-7.8,Motesanib,RAHBGWKEPAQNFF-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
75660,6m2n,DB05252,-7.8,Fenoxaprop-ethyl,PQKBPHSEKWERTG-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
114011,6vxx,DB12587,-7.8,Razupenem,XFGOMLIRJYURLQ-GOKYHWASSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75637,6m2n,DB05100,-7.8,Prinomastat,YKPYIPVDTNNYCN-INIZCTEOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75583,6m2n,DB04890,-7.8,Bepotastine,YWGDOWXRIALTES-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
113999,6vxx,DB12569,-7.8,Tonapofylline,ZWTVVWUOTJRXKM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75608,6m2n,DB04954,-7.8,Tecadenoson,OESBDSFYJMDRJY-BAYCTPFLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
166551,7bv1,DB15348,-7.8,Ampreloxetine,TZIALEBTHQWNAO-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
75901,6m2n,DB06354,-7.8,Tezampanel,ZXFRFPSZAKNPQQ-YTWAJWBKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
29933,6cs2,DB11827,-7.8,Ertugliflozin,MCIACXAZCBVDEE-CUUWFGFTSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
114092,6vxx,DB12715,-7.8,MSX-122,PXZXYRKDDXKDTK-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114220,6vxx,DB13111,-7.8,Chromanol,SEBPXHSZHLFWRL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
8200,6lzg,DB04882,-7.8,Edotecarin,QMVPQBFHUJZJCS-NTKFZFFISA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
75745,6m2n,DB05695,-7.8,NPS-2143,PZUJQWHTIRWCID-HXUWFJFHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
114203,6vxx,DB12896,-7.8,PSI-352938,PVRFQJIRERYGTQ-DSQUMVBZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113838,6vxx,DB12155,-7.8,Napabucasin,DPHUWDIXHNQOSY-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75538,6m2n,DB04833,-7.8,Methaqualone,JEYCTXHKTXCGPB-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
29820,6cs2,DB11679,-7.8,Fruquintinib,BALLNEJQLSTPIO-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
8256,6lzg,DB05039,-7.8,Indacaterol,QZZUEBNBZAPZLX-QFIPXVFZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
113871,6vxx,DB12210,-7.8,AZD-6280,NVWCZRPXYVDQEE-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113873,6vxx,DB12214,-7.8,Luseogliflozin,WHSOLWOTCHFFBK-ZQGJOIPISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113886,6vxx,DB12230,-7.8,Bunazosin,RHLJLALHBZGAFM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113888,6vxx,DB12233,-7.8,Iguratimod,ANMATWQYLIFGOK-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113898,6vxx,DB12244,-7.8,CP-601927,RNOBTWYQAWEZHH-JGVFFNPUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113902,6vxx,DB12251,-7.8,Moxaverine,MYCMTMIGRXJNSO-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
8270,6lzg,DB00153,-7.8,Ergocalciferol,MECHNRXZTMCUDQ-RKHKHRCZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
75559,6m2n,DB04861,-7.8,Nebivolol,KOHIRBRYDXPAMZ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
113471,6vxx,DB09226,-7.8,RP-5063,PMKMNTBZJOXTJW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114559,6vxx,DB13790,-7.8,Fipexide,BFUJHVVEMMWLHC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114565,6vxx,DB13796,-7.8,Dibunate,WBEBQCINXJDZCX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30252,6cs2,DB12251,-7.8,Moxaverine,MYCMTMIGRXJNSO-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
76168,6m2n,DB06891,-7.8,"5-{[(4-AMINO-3-CHLORO-5-FLUOROPHENYL)SULFONYL]AMINO}-1,3,4-THIADIAZOLE-2-SULFONAMIDE",HOLJYLOVIHBQHO-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
113105,6vxx,DB08543,-7.8,1-[2-HYDROXY-3-(4-CYCLOHEXYL-PHENOXY)-PROPYL]-4-(2-PYRIDYL)-PIPERAZINE,BZJHCQBNFUNZPJ-QFIPXVFZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
115010,6w4b,DB00342,-7.8,Terfenadine,GUGOEEXESWIERI-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
113144,6vxx,DB08591,-7.8,"5-(4-METHOXYBIPHENYL-3-YL)-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDE",IGXKSKWHHHYBFM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30242,6cs2,DB12238,-7.8,MK-0777,QKIWQBLNTSQOLY-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
114946,6vxx,DB15460,-7.8,AGG-523,JWQMTWCFNZSLNR-DEOSSOPVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113184,6vxx,DB08642,-7.8,"(2R,6S)-6-{[methyl(3,4,5-trimethoxyphenyl)amino]methyl}-1,2,5,6,7,8-hexahydroquinazoline-2,4-diamine",JJWPLCQODKLEHY-JEOXALJRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113185,6vxx,DB08643,-7.8,2-(2-{2-[(BIPHENYL-4-YLMETHYL)-AMINO]-3-MERCAPTO-PENTANOYLAMINO}-ACETYLAMINO)-3-METHYL-BUTYRIC ACID METHYL ESTER,QFAWBPLETHINFK-UNMCSNQZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
7894,6lzg,DB04514,-7.8,Phosphoric Acid-2'-[2'-Deoxy-Uridine]Ester-5'-Guanosine Ester,DFYLLEBFVZTKHD-VMIOUTBZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
113188,6vxx,DB08646,-7.8,TRW3-(2-AMINO-3-HYDROXY-PROPYL)-6-(N'-CYCLOHEXYL-HYDRAZINO)OCTAHYDRO-INDOL-7-OL,PSUOZWHAKZSNOB-LBPRGKRZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113196,6vxx,DB08655,-7.8,"9-ACETYL-2,3,4,9-TETRAHYDRO-1H-CARBAZOL-1-ONE",MIGJEXKBUJPKJF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76129,6m2n,DB06845,-7.8,(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclopentylamino)ethanoyl)pyrrolidine-2-carboxamide,WXYKSWZWRHMJTE-KRWDZBQOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76127,6m2n,DB06843,-7.8,"2',5'-DIDEOXY-ADENOSINE 3'-MONOPHOSPHATE",NFGZMOICZSFFLB-DSYKOEDSSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
29685,6cs2,DB11410,-7.8,Fenbendazole,HDDSHPAODJUKPD-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
30253,6cs2,DB12252,-7.8,PG-701,OKRSVUYYCJPECG-LFGMFVMYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
114903,6vxx,DB15377,-7.8,ATB-346,YCNMAPLPQYQJFC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29667,6cs2,DB11380,-7.8,Cambendazole,QZWHWHNCPFEXLL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
115040,6w4b,DB00378,-7.8,Dydrogesterone,JGMOKGBVKVMRFX-HQZYFCCVSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
76307,6m2n,DB07053,-7.8,2-{5-[3-(7-PROPYL-3-TRIFLUOROMETHYLBENZO[D]ISOXAZOL-6-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID,TWVYNPULGKGJOS-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
112916,6vxx,DB08146,-7.8,"7-(2,5-dihydropyrrol-1-yl)-6-phenyl-pyrido[6,5-d]pyrimidin-2-amine",QFWNOFXQNCLFBC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76285,6m2n,DB07030,-7.8,(5-CHLORO-2-{[(3-NITROBENZYL)AMINO]CARBONYL}PHENOXY)ACETIC ACID,VABIMMIJVWNHFI-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
112942,6vxx,DB08172,-7.8,(2Z)-N-(3-chloro-2'-methoxybiphenyl-4-yl)-2-cyano-3-hydroxybut-2-enamide,YUDQXOMZBLEWBH-KAMYIIQDSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112948,6vxx,DB08179,-7.8,"methyl 4-(2,3-dihydroxy-5-methylphenoxy)-2-hydroxy-6-methylbenzoate",BLXSEOJIXHWXQJ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76250,6m2n,DB06991,-7.8,"N-[2-methyl-5-(methylcarbamoyl)phenyl]-2-{[(1R)-1-methylpropyl]amino}-1,3-thiazole-5-carboxamide",OYOUIHFZUAKCEF-LLVKDONJSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
115219,6w4b,DB00596,-7.8,Ulobetasol,LEHFPXVYPMWYQD-XHIJKXOTSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
75299,6m2n,DB04518,-7.8,"3-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamino]-Phenol",JJDRRZFRTKZLFT-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
8823,6lzg,DB06879,-7.8,"5-(4'-AMINO-1'-ETHYL-5',8'-DIFLUORO-1'H-SPIRO[PIPERIDINE-4,2'-QUINAZOLINE]-1-YLCARBONYL)PICOLINONITRILE",QCFIRACCCDFXIP-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
112989,6vxx,DB08235,-7.8,N-[2-(2-methyl-1H-indol-3-yl)ethyl]thiophene-2-carboxamide,ACAKNPKRLPMONU-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76195,6m2n,DB06921,-7.8,(2S)-2-[3-(AMINOMETHYL)PHENYL]-3-[(R)-HYDROXY{(1R)-2-METHYL-1-[(PHENYLSULFONYL)AMINO]PROPYL}PHOSPHORYL]PROPANOIC ACID,FNZHLCNFXRRIIC-RBUKOAKNSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
21366,6cs2,HMDB0001251,-7.8,Lanosterin,CAHGCLMLTWQZNJ-BQNIITSRSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
113044,6vxx,DB08306,-7.8,3-[(3-Nitrophenyl)sulfamoyl]-2-thiophenecarboxylic acid,CITCNTPVKZFUAJ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30264,6cs2,DB12268,-7.8,Carmegliptin,GUYMHFIHHOEFOA-ZCPGHIKRSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
113073,6vxx,DB08344,-7.8,4-chloro-N-(3-methoxypropyl)-N-[(3S)-1-(2-phenylethyl)piperidin-3-yl]benzamide,OOUGHDJEJNMXSV-QHCPKHFHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30255,6cs2,DB12254,-7.8,ABT-751,URCVCIZFVQDVPM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
20936,6cs2,HMDB0049155,-7.8,TG(18:1(11Z)/18:0/o-18:0),KJOJFBLODPQJLX-ORXJQOAGSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
76110,6m2n,DB06820,-7.8,Sulconazole,AFNXATANNDIXLG-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
113226,6vxx,DB08694,-7.8,"9-amino-5-(2-aminopyrimidin-4-yl)pyrido[3',2':4,5]pyrrolo[1,2-c]pyrimidin-4-ol",RTHKPHCVZVYDFN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30146,6cs2,DB12113,-7.8,CE-224535,FUCKCIVGBCBZNP-MRXNPFEDSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
30145,6cs2,DB12112,-7.8,Zuretinol acetate,QGNJRVVDBSJHIZ-AQDFTDIISA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
75415,6m2n,DB04664,-7.8,Cyclohexyl-pentyl-maltoside,RVTGFZGNOSKUDA-ZNGNCRBCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
114674,6vxx,DB14635,-7.8,Curcumin sulfate,NEJVQQBBTRFOHB-FCXRPNKRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
8681,6lzg,DB06673,-7.8,Almorexant,DKMACHNQISHMDN-RPLLCQBOSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
113393,6vxx,DB09097,-7.8,Quinagolide,GDFGTRDCCWFXTG-ZIFCJYIRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75949,6m2n,DB06481,-7.8,Manitimus,IRELROQHIPLASX-SEYXRHQNSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
8666,6lzg,DB06635,-7.8,Otamixaban,PFGVNLZDWRZPJW-OPAMFIHVSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
30127,6cs2,DB12085,-7.8,LCL-161,UFPFGVNKHCLJJO-SSKFGXFMSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
114598,6vxx,DB13841,-7.8,Clopenthixol,WFPIAZLQTJBIFN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113421,6vxx,DB09172,-7.8,Brifentanil,KKMGCTVJCQYQPV-WBVHZDCISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113422,6vxx,DB09173,-7.8,Butyrfentanyl,QQOMYEQLWQJRKK-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30119,6cs2,DB12078,-7.8,Enobosarm,JNGVJMBLXIUVRD-SFHVURJKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
114575,6vxx,DB13810,-7.8,Dimemorfan,KBEZZLAAKIIPFK-NJAFHUGGSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113441,6vxx,DB09193,-7.8,"CP-39,332",HLOCJJORRHQDKS-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
166390,7bv1,DB14791,-7.8,GDC-0425,XEZLBMHDUXSICI-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
30208,6cs2,DB12194,-7.8,Atamestane,PEPMWUSGRKINHX-TXTPUJOMSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
8047,6lzg,DB04698,-7.8,"N-(1,4-DIHYDRO-5H-TETRAZOL-5-YLIDENE)-9-OXO-9H-XANTHENE-2-SULFONAMIDE",HJWYZPGYPZNDTN-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
114714,6vxx,DB14677,-7.8,Gestonorone caproate,XURCMZMFZXXQDJ-UKNJCJGYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114847,6vxx,DB15012,-7.8,Farampator,XFVRBYKKGGDPAJ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
7951,6lzg,DB04578,-7.8,"(S)-2-[(R)-3-amino-4-(2-fluorophenyl)butyryl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide",OEVYDSSAPNIURZ-AEFFLSMTSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
7955,6lzg,DB04583,-7.8,"5-Carbamoyl-1,1':4',1''-terphenyl-3-carboxylic acid",LAZPCGBRHLARSI-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
102,6lzg,HMDB0002829,-7.8,Androsterone glucuronide,VFUIRAVTUVCQTF-BSOWLZGZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
114802,6vxx,DB14888,-7.8,IQP-0528,UCOAKFIVSAVHLC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29698,6cs2,DB11430,-7.8,Monensin,GAOZTHIDHYLHMS-KEOBGNEYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
113290,6vxx,DB08762,-7.8,O-(((1R)-((N-PHENYLMETHOXYCARBONYL-L-ALANYL)AMINO)ETHYL)HYDROXYPHOSPHONO)-L-BENZYLACETIC ACID,UPJNMOBJDSFRTI-FCEWJHQRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114780,6vxx,DB14849,-7.8,Nebicapone,MRFOLGFFTUGAEB-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30178,6cs2,DB12150,-7.8,Pelubiprofen,AUZUGWXLBGZUPP-GXDHUFHOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
75374,6m2n,DB04614,-7.8,(R)-tacrine(10)-hupyridone,ROTFGKJJMRTWBD-HHHXNRCGSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
114734,6vxx,DB14734,-7.8,Cannabigerol,QXACEHWTBCFNSA-SFQUDFHCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113319,6vxx,DB08990,-7.8,Eprazinone,BSHWLCACYCVCJE-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113323,6vxx,DB08994,-7.8,Ditazole,UUCMDZWCRNZCOY-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113327,6vxx,DB08998,-7.8,Demexiptiline,SEDQWOMFMIJKCU-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30164,6cs2,DB12133,-7.8,BLXA4,HEDVTGFTYROYFE-RREUNBNVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
166384,7bv1,DB14774,-7.8,Balipodect,KVHRYLNQDWXAGI-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
28395,6cs2,DB07984,-7.8,2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]-n-[(1S)-1-(hydroxymethyl)propyl]acetamide,GKJWXEORYGBJFS-KRWDZBQOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
77054,6m2n,DB07926,-7.8,N-[3-(N'-HYDROXYCARBOXAMIDO)-2-(2-METHYLPROPYL)-PROPANOYL]-O-TYROSINE-N-METHYLAMIDE,QYZPDCGWIJYZMN-ZBFHGGJFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
111591,6vxx,DB04248,-7.8,beta-(1->4)-galactotriose,FYGDTMLNYKFZSV-XJJKTWKOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109176,6vxx,DB12478,-7.8,Piribedil,OQDPVLVUJFGPGQ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78184,6m2n,DB11125,-7.8,Benzethonium,SIYLLGKDQZGJHK-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
120068,6w4b,DB08044,-7.8,ABT-341,NVVSPGQEXMJZIR-BMIGLBTASA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
10244,6lzg,DB08422,-7.8,[PHENYLALANINYL-PROLINYL]-[2-(PYRIDIN-4-YLAMINO)-ETHYL]-AMINE,GEIDRYBJURDUSW-MOPGFXCFSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
78127,6m2n,DB09313,-7.8,Ioxaglic acid,TYYBFXNZMFNZJT-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
109265,6vxx,DB12979,-7.8,Nepicastat,YZZVIKDAOTXDEB-JTQLQIEISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78202,6m2n,DB11219,-7.8,Enzacamene,HEOCBCNFKCOKBX-SDNWHVSQSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
109272,6vxx,DB12989,-7.8,Neosaxitoxin,PPEKGEBBBBNZKS-HGRQIUPRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109296,6vxx,DB13027,-7.8,Tucaresol,XEDONBRPTABQFB-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78118,6m2n,DB09290,-7.8,Ramosetron,NTHPAPBPFQJABD-LLVKDONJSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
10215,6lzg,DB08389,-7.8,"6,7-DIMETHOXY-4-[(3R)-3-(2-NAPHTHYLOXY)PYRROLIDIN-1-YL]QUINAZOLINE",UPTQSRGSSJRBKJ-LJQANCHMSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
10208,6lzg,DB08382,-7.8,Gosogliptin,QWEWGXUTRTXFRF-KBPBESRZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
109319,6vxx,DB13063,-7.8,Parthenolide,KTEXNACQROZXEV-SLXBATTESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
119999,6w4b,DB07969,-7.8,3-[3-(4-methylpiperazin-1-yl)-7-(trifluoromethyl)quinoxalin-5-yl]phenol,QNCYYRHIUFGGJX-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
109279,6vxx,DB13004,-7.8,Mavoglurant,ZFPZEYHRWGMJCV-ZHALLVOQSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
120098,6w4b,DB08080,-7.8,LATRUNCULIN B,NSHPHXHGRHSMIK-JRIKCGFMSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
109164,6vxx,DB12464,-7.8,Bevenopran,ZGCYVRNZWGUXNQ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109148,6vxx,DB12438,-7.8,Filociclovir,KMUNHOKTIVSFRA-KXFIGUGUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29318,6cs2,DB09002,-7.8,Cloperastine,FLNXBVJLPJNOSI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
10348,6lzg,DB08534,-7.8,"5-(2-fluorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",ZAIYYXVHGBMLEC-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
165121,7bv1,DB11371,-7.8,Alfaxalone,DUHUCHOQIDJXAT-OLVMNOGESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
31271,6cs2,DB13618,-7.8,Ipriflavone,SFBODOKJTYAUCM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
78282,6m2n,DB11442,-7.8,Oleandomycin,RZPAKFUAFGMUPI-QESOVKLGSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
31269,6cs2,DB13616,-7.8,Melagatran,DKWNMCUOEDMMIN-PKOBYXMFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
109113,6vxx,DB12393,-7.8,Fanapanel,WZMQMKNCWDCCMT-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
120166,6w4b,DB08154,-7.8,3-chloro-5-[2-chloro-5-(1H-indazol-3-ylmethoxy)phenoxy]benzonitrile,WHCLIFOVZDANCU-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
109120,6vxx,DB12402,-7.8,Pumosetrag,AFUWQWYPPZFWCO-LBPRGKRZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109142,6vxx,DB12429,-7.8,CI-1040,GFMMXOIFOQCCGU-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31259,6cs2,DB13605,-7.8,Phenoperidine,IPOPQVVNCFQFRK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
10305,6lzg,DB08489,-7.8,"N4-HYDROXY-2-ISOBUTYL-N1-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.013,18]NONADECA-12(19),13,15,17-TETRAEN-10-YL)-SUCCINAMIDE",GCBPAPVOMPJQHK-NQIIRXRSSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
78245,6m2n,DB11376,-7.8,Azaperone,XTKDAFGWCDAMPY-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
120127,6w4b,DB08112,-7.8,N-({6-[(4-CYANO-2-FLUOROBENZYL)OXY]NAPHTHALEN-2-YL}SULFONYL)-D-GLUTAMIC ACID,IRJUSGUHNFMVCK-OAQYLSRUSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
120126,6w4b,DB08111,-7.8,"4-[(6-phenyl[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl]phenol",ZGJYGQLGSXWEMY-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
109322,6vxx,DB13066,-7.8,Liarozole,UGFHIPBXIWJXNA-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165195,7bv1,DB11519,-7.8,Fluprostenol,WWSWYXNVCBLWNZ-QIZQQNKQSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
109353,6vxx,DB13457,-7.8,Oxaflozane,FVYUQFQCEOZYHZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109354,6vxx,DB13458,-7.8,Thebacon,RRJQTGHQFYTZOW-ILWKUFEGSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
54382,2fxp,DB14883,-7.8,Lorecivivint,AQDWDWAYVBQMAM-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
109490,6vxx,DB13981,-7.8,Nomegestrol acetate,IIVBFTNIGYRNQY-YQLZSBIMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
119801,6w4b,DB07741,-7.8,"4-(1R,3AS,4R,8AS,8BR)-[1-DIFLUOROMETHYL-2-(4-FLUOROBENZYL)-3-OXODECAHYDROPYRROLO[3,4-A]PYRROLIZIN-4-YL]BENZAMIDINE",VPNYXOTTXAXSIH-SXYSDOLCSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
109510,6vxx,DB14025,-7.8,Clinafloxacin,QGPKADBNRMWEQR-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109514,6vxx,DB14030,-7.8,PZM21,MEDBIJOVZJEMBI-YOEHRIQHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
119767,6w4b,DB07701,-7.8,"1-BENZYL-4-[(5,6-DIMETHOXY-1-INDANON-2-YL)METHYL]PIPERIDINE",ADEBPBSSDYVVLD-HXUWFJFHSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
31147,6cs2,DB13463,-7.8,Oxetorone,VZVRZTZPHOHSCK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
109527,6vxx,DB14059,-7.8,SC-236,NSQNZEUFHPTJME-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31143,6cs2,DB13459,-7.8,Pecilocin,ZYPGADGCNXOUJP-CXVPHVKISA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
54339,2fxp,DB14785,-7.8,Fenebrutinib,WNEODWDFDXWOLU-QHCPKHFHSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
54335,2fxp,DB14773,-7.8,Lifirafenib,NGFFVZQXSRKHBM-FKBYEOEOSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
109563,6vxx,DB14127,-7.8,Sacubitrilat,DOBNVUFHFMVMDB-BEFAXECRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
49909,2fxp,DB05678,-7.8,SLx-4090,AZUIUVJESCFSLJ-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
165283,7bv1,DB11703,-7.8,Acalabrutinib,WDENQIQQYWYTPO-IBGZPJMESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
77891,6m2n,DB08954,-7.8,Ifenprodil,UYNVMODNBIQBMV-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
109432,6vxx,DB13563,-7.8,Norgestrienone,GVDMJXQHPUYPHP-FYQPLNBISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78330,6m2n,DB11555,-7.8,Zolazepam,GDSCFOSHSOWNDL-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
119840,6w4b,DB07786,-7.8,"1-((1R,2S)-1-{2-[2-(4-CHLOROPHENYL)-1,3-BENZOXAZOL-7-YL]ETHYL}-2-HYDROXYPROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE",SMFRBBHLVBWHGB-DJJJIMSYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
119846,6w4b,DB07792,-7.8,"(S)-2-CHLORO-N-(1-(2-(2-HYDROXYETHYLAMINO)-2-OXOETHYL)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL)-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE",VUKPNWLGSLOHIF-AWEZNQCLSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
109361,6vxx,DB13469,-7.8,Phanquinone,VLPADTBFADIFKG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109374,6vxx,DB13487,-7.8,Iodine (131I) norcholesterol,QJHZPCLORSPENH-DRTKWHMQSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
10180,6lzg,DB08350,-7.8,"5-[3-(2-METHOXYPHENYL)-1H-PYRROLO[2,3-B]PYRIDIN-5-YL]-N,N-DIMETHYLPYRIDINE-3-CARBOXAMIDE",GYQRHHQPEMOLKH-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
78028,6m2n,DB09175,-7.8,Mirfentanil,BJZZDOLVVLWFHN-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
109385,6vxx,DB13501,-7.8,Bendazac,BYFMCKSPFYVMOU-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78019,6m2n,DB09166,-7.8,Etizolam,VMZUTJCNQWMAGF-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
119886,6w4b,DB07835,-7.8,"N-3-cyclopropyl-N-4-'-(cyclopropylmethyl)-6-methylbiphenyl-3,4'-dicarboxamide",BOPSUAHGQHFKGG-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
109406,6vxx,DB13531,-7.8,Nicofetamide,DWODOIKZDGJOPQ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31176,6cs2,DB13499,-7.8,Cefsulodin,SYLKGLMBLAAGSC-QLVMHMETSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
119879,6w4b,DB07827,-7.8,"4-{[1-METHYL-2,4-DIOXO-6-(3-PHENYLPROP-1-YN-1-YL)-1,4-DIHYDROQUINAZOLIN-3(2H)-YL]METHYL}BENZOIC ACID",FLTYDFYSVZBKOB-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
119869,6w4b,DB07816,-7.8,N-(P-CYANOPHENYL)-N'-DIPHENYLMETHYL-GUANIDINE-ACETIC ACID,KGHMYJFHUHFOGL-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
119868,6w4b,DB07815,-7.8,GIBBERELLIN A4,RSQSQJNRHICNNH-NFMPGMCNSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
78008,6m2n,DB09128,-7.8,Brexpiprazole,ZKIAIYBUSXZPLP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
119864,6w4b,DB07811,-7.8,"N-cyclopropyl-2',6-dimethyl-4'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-3-carboxamide",UBVTVSINEVHYSY-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
109414,6vxx,DB13542,-7.8,Bevonium,UHUMRJKDOOEQIG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109426,6vxx,DB13555,-7.8,Prajmaline,UAUHEPXILIZYCU-ALHOSYKFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109078,6vxx,DB12004,-7.8,Briciclib,LXENKEWVEVKKGV-BQYQJAHWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29316,6cs2,DB00834,-7.8,Mifepristone,VKHAHZOOUSRJNA-GCNJZUOMSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
10357,6lzg,DB08543,-7.8,1-[2-HYDROXY-3-(4-CYCLOHEXYL-PHENOXY)-PROPYL]-4-(2-PYRIDYL)-PIPERAZINE,BZJHCQBNFUNZPJ-QFIPXVFZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
28464,6cs2,DB08053,-7.8,"1-cyclobutyl-3-(3,4-dimethoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine",ITOYZJGFTNTKKR-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
164935,7bv1,DB08981,-7.8,Fenbufen,ZPAKPRAICRBAOD-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
108725,6vxx,DB08864,-7.8,Rilpivirine,YIBOMRUWOWDFLG-ONEGZZNKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
74183,6m2n,DB03013,-7.8,Di(N-Acetyl-D-Glucosamine),CDOJPCSDOXYJJF-KSKNGZLJSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
108732,6vxx,DB08877,-7.8,Ruxolitinib,HFNKQEVNSGCOJV-OAHLLOKOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
120749,6w4b,DB08875,-7.8,Cabozantinib,ONIQOQHATWINJY-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
54899,6crv,DB00365,-7.8,Grepafloxacin,AIJTTZAVMXIJGM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
54888,6crv,DB00349,-7.8,Clobazam,CXOXHMZGEKVPMT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
120717,6w4b,DB08820,-7.8,Ivacaftor,PURKAOJPTOLRMP-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
31411,6cs2,DB13783,-7.8,Acemetacin,FSQKKOOTNAMONP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
78658,6m2n,DB12081,-7.8,Anecortave,BCFCRXOJOFDUMZ-ONKRVSLGSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
108760,6vxx,DB08926,-7.8,Acediasulfone,FKKUMFTYSTZUJG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78646,6m2n,DB12063,-7.8,CERC-301,RECBFDWSXWAXHY-IAGOWNOFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
120714,6w4b,DB08815,-7.8,Lurasidone,PQXKDMSYBGKCJA-CVTJIBDQSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
120676,6w4b,DB08772,-7.8,"3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL-2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID",BCSVCWVQNOXFGL-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
54952,6crv,DB00427,-7.8,Triprolidine,CBEQULMOCCWAQT-WOJGMQOQSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
54877,6crv,DB00338,-7.8,Omeprazole,SUBDBMMJDZJVOS-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
164927,7bv1,DB08971,-7.8,Fluocortolone,GAKMQHDJQHZUTJ-ULHLPKEOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
120870,6w4b,DB09048,-7.8,Netupitant,WAXQNWCZJDTGBU-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
78849,6m2n,DB12354,-7.8,Imrecoxib,AXMZZGKKZDJGAZ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
10539,6lzg,DB08745,-7.8,4-[[(1E)-2-(4-CHLOROPHENYL)ETHENYL]SULFONYL]-1-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]PIPERAZINONE,QLHUDNKWOSQSMK-CXUHLZMHSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
164893,7bv1,DB08927,-7.8,Amperozide,NNAIYOXJNVGUOM-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
120942,6w4b,DB09183,-7.8,Dasabuvir,NBRBXGKOEOGLOI-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
31476,6cs2,DB13857,-7.8,Demegestone,JWAHBTQSSMYISL-MHTWAQMVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
108672,6vxx,DB08530,-7.8,"7-BENZYL-1,3-DIMETHYL-8-PIPERAZIN-1-YL-3,7-DIHYDRO-PURINE-2,6-DIONE",QFSMMXJBEBXTJP-UHFFFAOYSA-O,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78803,6m2n,DB12288,-7.8,Piromelatine,PNTNBIHOAPJYDB-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
28420,6cs2,DB08008,-7.8,"5-methyl-N-[4-(trifluoromethyl)phenyl][1,2,4]triazolo[1,5-a]pyrimidin-7-amine",LRHHXKBKRNNFRV-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
28423,6cs2,DB08011,-7.8,"(3E)-5-fluoro-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-1H-indole-2,3-dione 3-oxime",DXIHOIDYHQSQKJ-HMMYKYKNSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
28430,6cs2,DB08017,-7.8,3-METHOXY-6-[4-(3-METHYLPHENYL)-1-PIPERAZINYL]PYRIDAZINE,DDOAUTHWSCUHQA-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
78779,6m2n,DB12259,-7.8,CG-200745,AUGCSOFQTDKPSO-RGVLZGJSSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
28431,6cs2,DB08018,-7.8,"N-{(3S,4S)-4-[(6-AMINO-4-METHYLPYRIDIN-2-YL)METHYL]PYRROLIDIN-3-YL}-N'-(4-CHLOROBENZYL)ETHANE-1,2-DIAMINE",JDRSQGJWTVRNGM-QFBILLFUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
10532,6lzg,DB08739,-7.8,"2-{3-[(2S)-4,4-difluoro-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]-3-oxopropyl}-isoindole-1,3(2H)-dione",ZSXNPAWXICXNGZ-HNNXBMFYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
54978,6crv,DB00457,-7.8,Prazosin,IENZQIKPVFGBNW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78762,6m2n,DB12234,-7.8,BMS-214662,OLCWFLWEHWLBTO-HSZRJFAPSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
28438,6cs2,DB00739,-7.8,Hetacillin,DXVUYOAEDJXBPY-NFFDBFGFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
10063,6lzg,DB08207,-7.8,"2-(3,5-DIMETHYLPHENYL)-1,3-BENZOXAZOLE",BIHLSRJPJFOESJ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
28501,6cs2,DB08093,-7.8,3-(1-NAPHTHYLMETHOXY)PYRIDIN-2-AMINE,SZANYTFSQVBOBA-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
78624,6m2n,DB12029,-7.8,Chlorogenic Acid,CWVRJTMFETXNAD-JUHZACGLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
165045,7bv1,DB09171,-7.8,β-Methylfentanyl,UXIGUKSHASXDNI-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
78449,6m2n,DB11774,-7.8,Pazufloxacin,XAGMUUZPGZWTRP-ZETCQYMHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
120398,6w4b,DB08444,-7.8,"3-[2-bromo-4-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)phenoxy]-5-methylbenzonitrile",YYGZQXRLQMFHDH-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
108945,6vxx,DB11433,-7.8,Nequinate,NNOPDLNHPOLRRE-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78416,6m2n,DB11726,-7.8,Encenicline,SSRDSYXGYPJKRR-ZDUSSCGKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
108951,6vxx,DB11446,-7.8,Oxfendazole,BEZZFPOZAYTVHN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78409,6m2n,DB11711,-7.8,Navarixin,IXBYSXNOKFHHDR-QGZVFWFLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
108962,6vxx,DB11463,-7.8,Sulfanitran,GWBPFRGXNGPPMF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78399,6m2n,DB11696,-7.8,Racecadotril,ODUOJXZPIYUATO-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
54704,6crv,DB00137,-7.8,Lutein,KBPHJBAIARWVSC-RGZFRNHPSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
54698,6crv,DB00131,-7.8,Adenosine phosphate,UDMBCSSLTHHNCD-KQYNXXCUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
10396,6lzg,DB08590,-7.8,1-(3-HYDROXYPROPYL)-2-[(3-NITROBENZOYL)AMINO]-1H-BENZIMIDAZOL-5-YL PIVALATE,CEAYRKIZESVQSN-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
109063,6vxx,DB11982,-7.8,GDC-0623,RFWVETIZUQEJEF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165073,7bv1,DB09200,-7.8,Rivoglitazone,XMSXOLDPMGMWTH-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
29314,6cs2,DB08998,-7.8,Demexiptiline,SEDQWOMFMIJKCU-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
74271,6m2n,DB03133,-7.8,"2-(Beta-D-Glucopyranosyl)-5-Methyl-1,2,3-Benzimidazole",XIJZORUYQZBFJK-UJPOAAIJSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
28502,6cs2,DB08094,-7.8,"(4-AMINO-2-{[1-(METHYLSULFONYL)PIPERIDIN-4-YL]AMINO}PYRIMIDIN-5-YL)(2,3-DIFLUORO-6-METHOXYPHENYL)METHANONE",JRNJNYBQQYBCLE-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
78494,6m2n,DB11833,-7.8,Basimglurant,UPZWINBEAHDTLA-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78498,6m2n,DB11843,-7.8,PF-04958242,TTYKUKSFWHEBLI-DLBZAZTESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
120649,6w4b,DB08742,-7.8,"1,3-CYCLOHEXANEDIOL, 4-METHYLENE-5-[(2E)-[(1S,3AS,7AS)-OCTAHYDRO-1-(5-HYDROXY-5-METHYL-1,3-HEXADIYNYL)-7A-METHYL-4H-INDEN-4-YLIDENE]ETHYLIDENE]-, (1R,3S,5Z)",CEEUUHVULXTFGS-BQXVGYHGSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
164983,7bv1,DB09047,-7.8,Finafloxacin,FYMHQCNFKNMJAV-HOTGVXAUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
120617,6w4b,DB08709,-7.8,"2,3-diphenyl-1H-indole-7-carboxylic acid",OLUDUXWVPIEHDA-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
108777,6vxx,DB08951,-7.8,Indoprofen,RJMIEHBSYVWVIN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
19969,6cs2,HMDB0045600,-7.8,"TG(20:0/20:0/18:3(9Z,12Z,15Z))",SJKUKFUWJWEPFD-AHYWTYHESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
78591,6m2n,DB11982,-7.8,GDC-0623,RFWVETIZUQEJEF-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
108823,6vxx,DB09477,-7.8,Enalaprilat,LZFZMUMEGBBDTC-QEJZJMRPSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165016,7bv1,DB09095,-7.8,Difluocortolone,OGPWIDANBSLJPC-RFPWEZLHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
108869,6vxx,DB11219,-7.8,Enzacamene,HEOCBCNFKCOKBX-SDNWHVSQSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
54794,6crv,DB00238,-7.8,Nevirapine,NQDJXKOVJZTUJA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
54785,6crv,DB00229,-7.8,Cefotiam,QYQDKDWGWDOFFU-IUODEOHRSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78543,6m2n,DB11909,-7.8,Varespladib,BHLXTPHDSZUFHR-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
165029,7bv1,DB09128,-7.8,Brexpiprazole,ZKIAIYBUSXZPLP-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
78523,6m2n,DB11880,-7.8,Acridine Carboxamide,XBGNERSKEKDZDS-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
74261,6m2n,DB03115,-7.8,"5-Bromo-N-(2,3-Dihydroxypropoxy)-3,4-Difluoro-2-[(2-Fluoro-4-Iodophenyl)Amino]Benzamide",XXSSGBYXSKOLAM-QMMMGPOBSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
54765,6crv,DB00204,-7.8,Dofetilide,IXTMWRCNAAVVAI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
53365,2fxp,DB12892,-7.8,MGB-BP-3,OEKXCVYZBVOWBR-BQYQJAHWSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
77863,6m2n,DB08910,-7.8,Pomalidomide,UVSMNLNDYGZFPF-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
74520,6m2n,DB03467,-7.8,Naringenin,FTVWIRXFELQLPI-ZDUSSCGKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77337,6m2n,DB08250,-7.8,"(5S)-5-(3-AMINOPROPYL)-3-(2,5-DIFLUOROPHENYL)-N-ETHYL-5-PHENYL-4,5-DIHYDRO-1H-PYRAZOLE-1-CARBOXAMIDE",OQMVLDZJPRSNOG-NRFANRHFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
9643,6lzg,DB07761,-7.8,"(2R)-1-[4-({6-[(2,6-Difluorophenyl)amino]-4-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol",ZVSBKYYVBCKDBO-OAHLLOKOSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
110899,6vxx,DB02549,-7.8,3'-O-Acetylthymidine-5'-Diphosphate,UWSIAAWKEICIJY-IVZWLZJFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110906,6vxx,DB02559,-7.8,"6-(Octahydro-1h-Indol-1-Ylmethyl)Decahydroquinazoline-2,4-Diamine",HDQIGGQUKAQTGU-SZTTVXCBSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110922,6vxx,DB02583,-7.8,"N6-(2,5-Dimethoxy-Benzyl)-N6-Methyl-Pyrido[2,3-D]Pyrimidine-2,4,6-Triamine",HZTFNSCZLJLPEO-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110967,6vxx,DB02819,-7.8,"Mono-[3,4-Dihydroxy-5-(5-Methyl-Benzoimidazol-1-Yl)-Tetrahydor-Furan-2-Ylmethyl] Ester",HGUDFQQPANTQEU-LPWJVIDDSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110862,6vxx,DB02504,-7.8,[3-(1-Benzyl-3-Carbamoylmethyl-2-Methyl-1h-Indol-5-Yloxy)-Propyl-]-Phosphonic Acid,AQEYCNKFBRLUOT-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110984,6vxx,DB02842,-7.8,9-amino-n-[3-(dimethylamino)propyl]acridine-4-carboxamide,VNWAULKXOPRJEL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111032,6vxx,DB02902,-7.8,3'-Phosphate-Adenosine-5'-Phosphate Sulfate,GACDQMDRPRGCTN-KQYNXXCUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77275,6m2n,DB08170,-7.8,"(1R)-N,6-DIHYDROXY-7-METHOXY-2-[(4-METHOXYPHENYL)SULFONYL]-1,2,3,4-TETRAHYDROISOQUINOLINE-1-CARBOXAMIDE",AYFCYVLVRYQGME-QGZVFWFLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
111039,6vxx,DB02911,-7.8,"2,4-Diamino-6-Phenyl-5,6,7,8,-Tetrahydropteridine",VEKRIXRQADJFAG-QMMMGPOBSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111040,6vxx,DB02914,-7.8,"(6e)-6-[(2e,4e,6e)-3,7-Dimethylnona-2,4,6,8-Tetraenylidene]-1,5,5-Trimethylcyclohexene",FWNRILWHNGFAIN-OYUWDNMLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111057,6vxx,DB02934,-7.8,9-(6-deoxy-alpha-L-talofuranosyl)-6-methylpurine,XJZDIUOABWMPLZ-DSBXBFMBSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111066,6vxx,DB02947,-7.8,2-Fluoro-2'-Deoxyadenosine,ZWPYUXAXLRFWQC-KVQBGUIXSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165635,7bv1,DB12573,-7.8,LY-2452473,IHIWYQYVBNODSV-KRWDZBQOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110854,6vxx,DB02495,-7.8,9-(4-hydroxybutyl)-N2-phenylguanine,JHBXNPBKSPYOFT-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
118805,6w4b,DB06346,-7.8,Fiboflapon,DFQGDHBGRSTTHX-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
110822,6vxx,DB02454,-7.8,5-(6-Amino-9h-Purin-9-Yl)-4-Hydroxytetrahydrofuran-3-Yl Dihydrogen Phosphate,IJEJRDCFMFEDGL-AFEQZKEHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110581,6vxx,DB01964,-7.8,AL5424,ZWTSOJQGEWPWGO-NSHDSACASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110590,6vxx,DB01976,-7.8,Aminoanthracene,YUENFNPLGJCNRB-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30879,6cs2,DB13102,-7.8,AZD-8418,MCPBSUCAISQZQK-JTQLQIEISA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
30875,6cs2,DB13097,-7.8,1alpha-Hydroxyvitamin D5,NWFOBODUYTUMNC-VPSCEVSQSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
29388,6cs2,DB09101,-7.8,Elvitegravir,JUZYLCPPVHEVSV-LJQANCHMSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
77435,6m2n,DB08373,-7.8,"4,4'-BIS([H]METHYLSULFONYL)-2,2',5,5'-TETRACHLOROBIPHENYL",RDBKPLOYRMCFIY-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
118911,6w4b,DB06624,-7.8,Taranabant,QLYKJCMUNUWAGO-GAJHUEQPSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
77402,6m2n,DB08331,-7.8,"N-1H-imidazol-2-yl-N'-[4-(1H-imidazol-2-ylamino)phenyl]benzene-1,4-diamine",JHMXUERQMCJRHG-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
110706,6vxx,DB02128,-7.8,[1-(3-Hydroxy-2-Oxo-1-Phenethyl-Propylcarbamoyl)2-Phenyl-Ethyl]-Carbamic Acid Pyridin-4-Ylmethyl Ester,QCUBCTPTNWPFBC-ZEQRLZLVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165579,7bv1,DB12483,-7.8,Copanlisib,PZBCKZWLPGJMAO-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
9666,6lzg,DB07786,-7.8,"1-((1R,2S)-1-{2-[2-(4-CHLOROPHENYL)-1,3-BENZOXAZOL-7-YL]ETHYL}-2-HYDROXYPROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE",SMFRBBHLVBWHGB-DJJJIMSYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
110747,6vxx,DB02363,-7.8,2'-Monophosphoadenosine-5'-Diphosphate,YPTPYQSAVGGMFN-KQYNXXCUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
9664,6lzg,DB07783,-7.8,1-((1R)-1-(HYDROXYMETHYL)-3-{6-[(3-PHENYLPROPANOYL)AMINO]-1H-INDOL-1-YL}PROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE,GUYYFMCFEPDDFL-OAQYLSRUSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
110764,6vxx,DB02383,-7.8,Tolrestat,LUBHDINQXIHVLS-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110804,6vxx,DB02429,-7.8,4-(Aminosulfonyl)-N-[(4-Fluorophenyl)Methyl]-Benzamide,IXDVPACDZDRCTN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
118655,6w4b,DB05713,-7.8,LY-517717,VYNKVNDKAOGAAQ-RUZDIDTESA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
118644,6w4b,DB05653,-7.8,IRX-5183,PNAWUIKCVQSLFG-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
111145,6vxx,DB03060,-7.8,Sri-9662,WNDJHUNKXPAREB-PLNGDYQASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30786,6cs2,DB12974,-7.8,Roniciclib,UELYDGOOJPRWGF-SRQXXRKNSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
77148,6m2n,DB08030,-7.8,3-[(4'-cyanobiphenyl-4-yl)oxy]-N-hydroxypropanamide,XZWFHJUEAVOHHG-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
29447,6cs2,DB09198,-7.8,Lobeglitazone,CHHXEZSCHQVSRE-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
111353,6vxx,DB03550,-7.8,Isopenicillin N,MIFYHUACUWQUKT-GTQWGBSQSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30731,6cs2,DB12900,-7.8,Irdabisant,XUKROCVZGZNGSI-CQSZACIVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
118412,6w4b,DB04794,-7.8,Bifonazole,OCAPBUJLXMYKEJ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
77132,6m2n,DB08013,-7.8,(METHYLPYRIDAZINE PIPERIDINE PROPYLOXYPHENYL)ETHYLACETATE,UEIUDEUUVLYRFV-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
9522,6lzg,DB07630,-7.8,"N-((1R,2R)-2-(5-CHLORO-1H-INDOLE-2-CARBOXAMIDO)CYCLOHEXYL)-5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE-2-CARBOXAMIDE",ARPFWVKYXJZULB-IAGOWNOFSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
165704,7bv1,DB12682,-7.8,Mubritinib,ZTFBIUXIQYRUNT-MDWZMJQESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
9510,6lzg,DB07618,-7.8,"2-(4-(AMINOMETHYL)PIPERIDIN-1-YL)-N-(3_CYCLOHEXYL-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)ACETAMIDE",AITZHKQVQNLKHI-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
118343,6w4b,DB04698,-7.8,"N-(1,4-DIHYDRO-5H-TETRAZOL-5-YLIDENE)-9-OXO-9H-XANTHENE-2-SULFONAMIDE",HJWYZPGYPZNDTN-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
118338,6w4b,DB04690,-7.8,Camptothecin,VSJKWCGYPAHWDS-FQEVSTJZSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
118334,6w4b,DB04685,-7.8,"1-{(2S,5S)-4-FLUORO-5-[(TRITYLOXY)METHYL]TETRAHYDROFURAN-2-YL}PYRIMIDINE-2,4(1H,3H)-DIONE",GJNIPWYJQUGERM-BFLUCZKCSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
111521,6vxx,DB03982,-7.8,"Compound 5, 2-(Naphthalen-1-Yl-Oxalyl-Amino)-Benzoicacid",WQWCUHJIERBOSM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
9503,6lzg,DB07612,-7.8,6-(3-AMINOPHENYL)-N-(TERT-BUTYL)-2-(TRIFLUOROMETHYL)QUINAZOLIN-4-AMINE,XQKJVNGGVLHNLA-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
74893,6m2n,DB03970,-7.8,"(7R)-7-(6,7-Dihydro-5H-cyclopenta[d]imidazo[2,1-b][1,3]thiazol-2-yl)-2,7-dihydro-1,4-thiazepine-3,6-dicarboxylic acid",CHNMLWCTGYMVFH-GFCCVEGCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
30747,6cs2,DB12924,-7.8,Ozenoxacin,XPIJWUTXQAGSLK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
77508,6m2n,DB08464,-7.8,"METHYL 3-CHLORO-2-{3-[(2,5-DIHYDROXY-4-METHOXYPHENYL)AMINO]-3-OXOPROPYL}-4,6-DIHYDROXYBENZOATE",GUVWEHNRWHNDRF-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
118477,6w4b,DB04875,-7.8,Pralnacasan,CXAGHAZMQSCAKJ-WAHHBDPQSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
53476,2fxp,DB13061,-7.8,MLN8054,HHFBDROWDBDFBR-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
77250,6m2n,DB08145,-7.8,"6-(2,6-DIMETHOXYPHENYL)PYRIDO[2,3-D]PYRIMIDINE-2,7-DIAMINE",LRPHIAJXODIASX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
118609,6w4b,DB05470,-7.8,VX-702,FYSRKRZDBHOFAY-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
111168,6vxx,DB03086,-7.8,"N'-(2s,3r)-3-Amino-4-Cyclohexyl-2-Hydroxy-Butano-N-(4-Methylphenyl)Hydrazide",IQMLIGOOOFEBAH-CVEARBPZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
9576,6lzg,DB07688,-7.8,"4-{[5-(CYCLOHEXYLOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE",RPJIMTALCNCQLV-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
9569,6lzg,DB07680,-7.8,[(1S)-1-(5-CHLORO-1-BENZOTHIEN-3-YL)-2-(2-NAPHTHYLAMINO)-2-OXOETHYL]PHOSPHONIC ACID,HUJXISJLAPAFBO-IBGZPJMESA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
30771,6cs2,DB12952,-7.8,Methylprednisone,SVYCRJXQZUCUND-PQXSVQADSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
30769,6cs2,DB12949,-7.8,PF-03382792,AGMOFKKOVMRGAK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
111295,6vxx,DB03464,-7.8,Formycin-5'-Monophosphate,PBAHXXBYQACZMA-KSYZLYKTSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111304,6vxx,DB03477,-7.8,1-Phenylsulfonamide-3-Trifluoromethyl-5-Parabromophenylpyrazole,OYZKFVIVPRQRQQ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77197,6m2n,DB08087,-7.8,"4-[(7R,7AS)-7-HYDROXY-1,3-DIOXOTETRAHYDRO-1H-PYRROLO[1,2-C]IMIDAZOL-2(3H)-YL]-1-NAPHTHONITRILE",NHBIWLQQJPSMNP-CABCVRRESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
111315,6vxx,DB03491,-7.8,2'-Deoxyguanosine-5'-Diphosphate,CIKGWCTVFSRMJU-KVQBGUIXSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111324,6vxx,DB03504,-7.8,"9-Butyl-8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-9h-Purin-6-Ylamine",IVPCTHKPOPQMSX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30757,6cs2,DB12935,-7.8,Remogliflozin etabonate,UAOCLDQAQNNEAX-ABMICEGHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
30754,6cs2,DB12930,-7.8,Opipramol,YNZFUWZUGRBMHL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
9541,6lzg,DB07649,-7.8,"(3R,4S)-1-[(4-amino-5H-pyrrolo[3,2-d]pyrimidin-7-yl)methyl]-4-[(benzylsulfanyl)methyl]pyrrolidin-3-ol",DIGGNILBPCEZIV-CVEARBPZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
232,6lzg,HMDB0003550,-7.8,Calcidiol,JWUBBDSIWDLEOM-DTOXIADCSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
110571,6vxx,DB01953,-7.8,Inhibitor of P38 Kinase,UUEYCHLWAOBOHG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110568,6vxx,DB01950,-7.8,"N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thiazol-2-Yl)Urea",YAEMHJKFIIIULI-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77514,6m2n,DB08471,-7.8,"1-(thiophen-2-ylacetyl)-4-(3-thiophen-2-yl-1,2,4-oxadiazol-5-yl)piperidine",SJEVDMFUHCVNPM-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
109950,6vxx,DB00628,-7.8,Clorazepic acid,XDDJGVMJFWAHJX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
119466,6w4b,DB07340,-7.8,"N-6-cyclohexyl-N-2-(4-morpholin-4-ylphenyl)-9H-purine-2,6-diamine",ZFLJHSQHILSNCM-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
77735,6m2n,DB08735,-7.8,"R,S-Warfarin alcohol",ZUJMMGHIYSAEOU-SWLSCSKDSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
109983,6vxx,DB00671,-7.8,Cefixime,OKBVVJOGVLARMR-QSWIMTSFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77733,6m2n,DB08733,-7.8,"(2R,3R)-N^1^-[(1S)-2,2-DIMETHYL-1-(METHYLCARBAMOYL)PROPYL]-N^4^-HYDROXY-2-(2-METHYLPROPYL)-3-{[(1,3-THIAZOL-2-YLCARBONYL)AMINO]METHYL}BUTANEDIAMIDE",GAHIXYNNFMCKFQ-HZSPNIEDSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
165380,7bv1,DB12015,-7.8,Alpelisib,STUWGJZDJHPWGZ-LBPRGKRZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
165389,7bv1,DB12029,-7.8,Chlorogenic Acid,CWVRJTMFETXNAD-JUHZACGLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
165392,7bv1,DB12039,-7.8,Epicatechin,PFTAWBLQPZVEMU-UKRRQHHQSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
77707,6m2n,DB08706,-7.8,"(2S)-({(5Z)-5-[(5-ETHYL-2-FURYL)METHYLENE]-4-OXO-4,5-DIHYDRO-1,3-THIAZOL-2-YL}AMINO)(4-FLUOROPHENYL)ACETIC ACID",RNEACARJKXYVND-MZLJFPOFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
165395,7bv1,DB12042,-7.8,Ibodutant,YQYSVMKCMIUCHY-WJOKGBTCSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
119393,6w4b,DB07261,-7.8,"THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [1-(1-AMINO-ISOQUINOLIN-7-YLMETHYL)-2-OXO-PYRROLDIN-3-YL]-AMIDE",NVKDOURNRJCKJE-INIZCTEOSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
165407,7bv1,DB12058,-7.8,Recoflavone,BCPQOBQIVJZOFL-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110045,6vxx,DB00741,-7.8,Hydrocortisone,JYGXADMDTFJGBT-VWUMJDOOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110056,6vxx,DB00755,-7.8,Tretinoin,SHGAZHPCJJPHSC-YCNIQYBTSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110059,6vxx,DB00760,-7.8,Meropenem,DMJNNHOOLUXYBV-PQTSNVLCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109948,6vxx,DB00625,-7.8,Efavirenz,XPOQHMRABVBWPR-ZDUSSCGKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110067,6vxx,DB00769,-7.8,Hydrocortamate,FWFVLWGEFDIZMJ-FOMYWIRZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31054,6cs2,DB13351,-7.8,Piperidolate,KTHVBAZBLKXIHZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
77753,6m2n,DB08753,-7.8,"4-{(1E)-3-OXO-3-[(2-PHENYLETHYL)AMINO]PROP-1-EN-1-YL}-1,2-PHENYLENE DIACETATE",GARHCDOTUULBOQ-PKNBQFBNSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
9998,6lzg,DB08137,-7.8,(4E)-N-(4-fluorophenyl)-4-[(phenylcarbonyl)imino]-4H-pyrazole-3-carboxamide,ZMWYSLJBNJUCRK-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
119588,6w4b,DB07486,-7.8,"3-({4-[(1E)-3-morpholin-4-yl-3-oxoprop-1-en-1-yl]-2,3-bis(trifluoromethyl)phenyl}sulfanyl)aniline",KLSZVPNVFKKIRD-FNORWQNLSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
109798,6vxx,DB00269,-7.8,Chlorotrianisene,BFPSDSIWYFKGBC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
119564,6w4b,DB07456,-7.8,"3-(1H-indol-3-yl)-4-(1-{2-[(2S)-1-methylpyrrolidinyl]ethyl}-1H-indol-3-yl)-1H-pyrrole-2,5-dione",LBFDERUQORUFIN-QGZVFWFLSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
109843,6vxx,DB00321,-7.8,Amitriptyline,KRMDCWKBEZIMAB-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165345,7bv1,DB11963,-7.8,Dacomitinib,LVXJQMNHJWSHET-AATRIKPKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
119541,6w4b,DB07430,-7.8,"(10R)-10-methyl-3-(6-methylpyridin-3-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one",CMWRPDHVGMHLSZ-GFCCVEGCSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
109881,6vxx,DB00546,-7.8,Adinazolam,GJSLOMWRLALDCT-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109887,6vxx,DB00552,-7.8,Pentostatin,FPVKHBSQESCIEP-JQCXWYLXSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109905,6vxx,DB00576,-7.8,Sulfamethizole,VACCAVUAMIDAGB-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
119512,6w4b,DB07396,-7.8,"1-{2-[3-(2-Chloro-4,5-difluoro-benzoyl)-ureido]-4-fluoro-phenyl}-piperidine-4-carboxylic acid",KAJJGOCSAXKXBD-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
77762,6m2n,DB08763,-7.8,[N-(BENZYLOXYCARBONYL)AMINO](4-AMIDINOPHENYL)METHANE-PHOSPHONATE,FSNDLCSOLUMYRH-OAHLLOKOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
31067,6cs2,DB13364,-7.8,Feprazone,RBBWCVQDXDFISW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
109917,6vxx,DB00588,-7.8,Fluticasone propionate,WMWTYOKRWGGJOA-CENSZEJFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77754,6m2n,DB08754,-7.8,"(2E)-3-(3,4-DIHYDROXYPHENYL)-N-[2-(4-HYDROXYPHENYL)ETHYL]ACRYLAMIDE",VSHUQLRHTJOKTA-XBXARRHUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
109933,6vxx,DB00607,-7.8,Nafcillin,GPXLMGHLHQJAGZ-JTDSTZFVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
119607,6w4b,DB07508,-7.8,4-(5-BENZENESULFONYLAMINO-1-METHYL-1H-BENZOIMIDAZOL-2-YLMETHYL)-BENZAMIDINE,MEUAVGJWGDPTLF-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
50093,2fxp,DB06435,-7.8,Tarazepide,CZPILLBHPRAPCB-AREMUKBSSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
110156,6vxx,DB01039,-7.8,Fenofibrate,YMTINGFKWWXKFG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110428,6vxx,DB01581,-7.8,Sulfamerazine,QPPBRPIAZZHUNT-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110432,6vxx,DB01588,-7.8,Prazepam,MWQCHHACWWAQLJ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30928,6cs2,DB01003,-7.8,Cromoglicic acid,IMZMKUWMOSJXDT-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
110439,6vxx,DB01599,-7.8,Probucol,FYPMFJGVHOHGLL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110441,6vxx,DB01602,-7.8,Bacampicillin,PFOLLRNADZZWEX-FFGRCDKISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
9753,6lzg,DB07875,-7.8,"5-Chloro-thiophene-2-carboxylic acid ((3S,4S)-1-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-methyl}-4-hydroxy-pyrrolidin-3-yl)-amide",ARAVOODWJJJNBY-IRXDYDNUSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
110444,6vxx,DB01605,-7.8,Pivmecillinam,NPGNOVNWUSPMDP-HLLBOEOZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110456,6vxx,DB01619,-7.8,Phenindamine,ISFHAYSTHMVOJR-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30918,6cs2,DB13174,-7.8,Rhein,FCDLCPWAQCPTKC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
77541,6m2n,DB08502,-7.8,Capravirine,YQXCVAGCMNFUMQ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
110514,6vxx,DB01871,-7.8,[1-(1-Benzyl-3-Hydroxy-2-Oxo-Propylcarbamoyl)-2-Phenyl-Ethyl]-Carbamic Acid Benzyl Ester,OACUXIVGLLCILS-ZEQRLZLVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77535,6m2n,DB08496,-7.8,(R)-warfarin,PJVWKTKQMONHTI-HNNXBMFYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
9726,6lzg,DB07848,-7.8,5-Chloro-N-{(3S)-1-[(2S)-1-(4-morpholinyl)-1-oxo-2-propanyl]-2-oxo-3-pyrrolidinyl}-1H-indole-2-sulfonamide,BHNMMFGOJRIAEZ-LRDDRELGSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
9715,6lzg,DB07835,-7.8,"N-3-cyclopropyl-N-4-'-(cyclopropylmethyl)-6-methylbiphenyl-3,4'-dicarboxamide",BOPSUAHGQHFKGG-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
165538,7bv1,DB12426,-7.8,Bitopertin,YUUGYIUSCYNSQR-LBPRGKRZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
9759,6lzg,DB07882,-7.8,"4-{4-[2-(1A,7A-DIMETHYL-4-OXY-OCTAHYDRO-1-OXA-4-AZA-CYCLOPROPA[A]NAPHTHALEN-4-YL) -ACETYLAMINO]-PHENYLCARBAMOYL}-BUTYRIC ACID",VFIZFTGABDUGCF-UPVHCHBVSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
110093,6vxx,DB00967,-7.8,Desloratadine,JAUOIFJMECXRGI-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110407,6vxx,DB01558,-7.8,Bromazepam,VMIYHDSEFNYJSL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
9775,6lzg,DB07901,-7.8,5-CHLORO-6-METHYL-N-(2-PHENYLETHYL)-2-PYRIDIN-2-YLPYRIMIDIN-4-AMINE,HIUOABSWQSUEGK-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
110181,6vxx,DB01068,-7.8,Clonazepam,DGBIGWXXNGSACT-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110238,6vxx,DB01134,-7.8,Desoxycorticosterone pivalate,VVOIQBFMTVCINR-WWMZEODYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
119233,6w4b,DB07076,-7.8,6-[(Z)-AMINO(IMINO)METHYL]-N-[3-(CYCLOPENTYLOXY)PHENYL]-2-NAPHTHAMIDE,FWTQOPWAMQXIMI-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
119232,6w4b,DB07074,-7.8,6-CARBAMIMIDOYL-4-(3-HYDROXY-2-METHYL-BENZOYLAMINO)-NAPHTHALENE-2-CARBOXYLIC ACID METHYL ESTER,OUBRALHIKGRAMA-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
119230,6w4b,DB07072,-7.8,"(1S,2R,5S)-5-[3-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7(8H)-YL]-2-(2,4,5-TRIFLUOROPHENYL)CYCLOHEXANAMINE",CNKRZILQBKJWDS-WMFXKJRFSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
110277,6vxx,DB01179,-7.8,Podofilox,YJGVMLPVUAXIQN-XVVDYKMHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
9816,6lzg,DB07946,-7.8,"N-[2-({[amino(imino)methyl]amino}oxy)ethyl]-2-{6-chloro-3-[(2,2-difluoro-2-phenylethyl)amino]-2-fluorophenyl}acetamide",DZEJHPMTDNDECN-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
77646,6m2n,DB08631,-7.8,"N-(4-CHLOROPHENYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONAMIDE",UVSIFVBCHJEYJP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
119215,6w4b,DB07054,-7.8,(2R)-1-(DIMETHYLAMINO)-3-{4-[(6-{[2-FLUORO-5-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-4-YL)AMINO]PHENOXY}PROPAN-2-OL,OSCWQKTUILTARV-MRXNPFEDSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
165472,7bv1,DB12149,-7.8,S-3304,YWCLDDLVLSQGSZ-JOCHJYFZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
119198,6w4b,DB07036,-7.8,"(3aS,4R,9bR)-2,2-difluoro-4-(4-hydroxyphenyl)-6-(methoxymethyl)-1,2,3,3a,4,9b-hexahydrocyclopenta[c]chromen-8-ol",GPFRMIHXGMVMGF-BZSNNMDCSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
30959,6cs2,DB13240,-7.8,Cymarin,XQCGNURMLWFQJR-ZNDDOCHDSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
165476,7bv1,DB12155,-7.8,Napabucasin,DPHUWDIXHNQOSY-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
119183,6w4b,DB07020,-7.8,"N-{3-[5-(1H-1,2,4-triazol-3-yl)-1H-indazol-3-yl]phenyl}furan-2-carboxamide",LMDMJDCLPIVGQD-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
165486,7bv1,DB12173,-7.8,Diphencyprone,HCIBTBXNLVOFER-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
119133,6w4b,DB06962,-7.8,"(5-(aminomethyl)-2H-spiro[benzofuran-3,4'-piperidine]-1'-yl)(5-(phenylethynyl)furan-2-yl)methanone",YKTUSHSSKIWDRY-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
126868,6w4h,DB04407,-7.8,4-[4-(4-Methyl-2-Methylamino-Thiazol-5-Yl)-Pyrimidin-2-Ylamino]-Phenol,OTMLAWRVLMYMDF-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
80441,6m2n,DB15359,-7.8,Xanthohumol,ORXQGKIUCDPEAJ-YRNVUSSQSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
161196,7bv1,DB13380,-7.8,Difemerine,GUONSMXZEYTWML-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
58034,6crv,DB04466,-7.8,SR12813,YQLJDECYQDRSBI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72427,6m2n,DB00735,-7.8,Naftifine,OZGNYLLQHRPOBR-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
103993,6vxs,DB09495,-7.8,Avobenzone,XNEFYCZVKIDDMS-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104001,6vxs,DB09534,-7.8,Ecamsule,HEAHZSUCFKFERC-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
128899,6w4h,DB08142,-7.8,AT-7519,OVPNQJVDAFNBDN-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
85113,6m3m,DB07280,-7.8,5-[4-(DIMETHYLAMINO)PHENYL]-6-[(6-MORPHOLIN-4-YLPYRIDIN-3-YL)ETHYNYL]PYRIMIDIN-4-AMINE,AINVOEOJEKKMKB-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
130906,6w4h,DB12974,-7.8,Roniciclib,UELYDGOOJPRWGF-SRQXXRKNSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
128894,6w4h,DB08136,-7.8,4-(acetylamino)-N-(4-fluorophenyl)-1H-pyrazole-3-carboxamide,CWQKPKYIMQTGJK-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
127913,6w4h,DB07002,-7.8,4-({4-[(4-methoxypyridin-2-yl)amino]piperidin-1-yl}carbonyl)benzonitrile,SZUVGMCKKLJAFX-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
127916,6w4h,DB07005,-7.8,D-phenylalanyl-N-{4-[amino(iminio)methyl]benzyl}-L-prolinamide,VZFTWWJAUZOJDH-MOPGFXCFSA-O,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
58511,6crv,DB05644,-7.8,KP-1461,SZWIAFVYPPMZML-YNEHKIRRSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
161983,7bv1,DB01047,-7.8,Fluocinonide,WJOHZNCJWYWUJD-IUGZLZTKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
130896,6w4h,DB12960,-7.8,INCB-9471,ZMCJFJZOSKEMOM-DNKZPPIMSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
128889,6w4h,DB08130,-7.8,"N-(5-{3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]phenyl}-1,3,4-oxadiazol-2-yl)ethane-1,2-diamine",FPDWDLAITHFTTP-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
104040,6vxs,DB11259,-7.8,Diosmetin,MBNGWHIJMBWFHU-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
83751,6m3m,DB04297,-7.8,"7-[4-(Dimethylamino)Phenyl]-N-Hydroxy-4,6-Dimethyl-7-Oxo-2,4-Heptadienamide",RTKIYFITIVXBLE-QEQCGCAPSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
11770,6lzg,DB12408,-7.8,PF-03635659,WGOJWDWKHJHXSV-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
130998,6w4h,DB13114,-7.8,Amitriptylinoxide,ZPMKQFOGINQDAM-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
104749,6vxs,DB12443,-7.8,Sonedenoson,WUCQGGOGHZRELS-LSCFUAHRSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
85146,6m3m,DB07314,-7.8,"1-(5-CHLORO-2,4-DIMETHOXYPHENYL)-3-(5-CYANOPYRAZIN-2-YL)UREA",URQYPXQXSVUVRG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
127884,6w4h,DB06969,-7.8,"2-amino-4-[2,4-dichloro-5-(2-pyrrolidin-1-ylethoxy)phenyl]-N-ethylthieno[2,3-d]pyrimidine-6-carboxamide",WJUNQSYQHHIVFX-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
33338,6cs2,T3D4531,-7.8,Pyraflufen-ethyl,APTZNLHMIGJTEW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
128968,6w4h,DB08224,-7.8,"(1S,7S,8S,8AR)-1,2,3,7,8,8A-HEXAHYDRO-7-METHYL-8-[2-[(2R,4R)-TETRAHYDRO-4-HY DROXY-6-OXO-2H-PYRAN-2-YL]ETHYL]-1-NAPHTHALENOL",WWSNTLOVYSRDEL-TVKPWXLESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131069,6w4h,DB13248,-7.8,Phthalylsulfathiazole,PBMSWVPMRUJMPE-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
71485,6lxt,DB14643,-7.8,Methylprednisolone aceponate,DALKLAYLIPSCQL-YPYQNWSCSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
131067,6w4h,DB13246,-7.8,Quinupramine,JCBQCKFFSPGEDY-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
72092,6m2n,DB00327,-7.8,Hydromorphone,WVLOADHCBXTIJK-YNHQPCIGSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
127849,6w4h,DB06923,-7.8,2-(3-METHYLPHENYL)-1H-INDOLE-5-CARBOXIMIDAMIDE,KJUSXMYSVXZFDJ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
128935,6w4h,DB08179,-7.8,"methyl 4-(2,3-dihydroxy-5-methylphenoxy)-2-hydroxy-6-methylbenzoate",BLXSEOJIXHWXQJ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
83827,6m3m,DB04407,-7.8,4-[4-(4-Methyl-2-Methylamino-Thiazol-5-Yl)-Pyrimidin-2-Ylamino]-Phenol,OTMLAWRVLMYMDF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83079,6m3m,DB03388,-7.8,"3-[(2,4-Dichlorobenzoyl)(Isopropyl)Amino]-5-Phenylthiophene-2-Carboxylic Acid",UKNZREOUDLFUFF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
130110,6w4h,DB11787,-7.8,Ralimetinib,XPPBBJCBDOEXDN-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
72099,6m2n,DB00338,-7.8,Omeprazole,SUBDBMMJDZJVOS-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
26766,6cs2,DB05104,-7.8,Asimadoline,JHLHNYVMZCADTC-LOSJGSFVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
162004,7bv1,DB01070,-7.8,Dihydrotachysterol,ILYCWAKSDCYMBB-OPCMSESCSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
128910,6w4h,DB08153,-7.8,"(5E)-14-CHLORO-15,17-DIHYDROXY-4,7,8,9,10,11-HEXAHYDRO-2-BENZOXACYCLOPENTADECINE-1,12(3H,13H)-DIONE",VZTAZMSAAIUZJV-HWKANZROSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
161356,7bv1,DB13865,-7.8,Dehydroemetine,XXLZPUYGHQWHRN-RPBOFIJWSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
83099,6m3m,DB03417,-7.8,1-(4-Tert-Butylcarbamoyl-Piperazine-1-Carbonyl)-3-(3-Guanidino-Propyl)-4-Oxo-Azetidine-2-Carboxylic Acid,BVNQCAHTTOIOEK-STQMWFEESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
33730,6cs2,T3D4981,-7.8,Pioglitazone,HYAFETHFCAUJAY-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
83031,6m3m,DB03323,-7.8,Maltose,GUBGYTABKSRVRQ-PICCSMPSSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
104358,6vxs,DB11885,-7.8,Anlotinib,KSMZEXLVHXZPEF-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
26409,6cs2,DB04542,-7.8,3'-Azido-3'-Deoxythymidine-5'-Diphosphate,QOYVAFWJURKBJG-XLPZGREQSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
6112,6lzg,DB00246,-7.8,Ziprasidone,MVWVFYHBGMAFLY-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
130819,6w4h,DB12846,-7.8,Reproterol,WVLAAKXASPCBGT-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
84614,6m3m,DB06623,-7.8,Flupirtine,JUUFBMODXQKSTD-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
128839,6w4h,DB08076,-7.8,"4-[1-(2,6-dichlorobenzyl)-2-methyl-1H-imidazol-4-yl]pyrimidin-2-amine",CKSSZTMRRVJNNG-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
84626,6m3m,DB06645,-7.8,Anamorelin,VQPFSIRUEPQQPP-MXBOTTGLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
105050,6vxs,DB12921,-7.8,Chlorsulfaquinoxaline,CTSNHMQGVWXIEG-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
59298,6crv,DB07301,-7.8,9H-CARBAZOLE,UJOBWOGCFQCDNV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104322,6vxs,DB11828,-7.8,Neratinib,JWNPDZNEKVCWMY-VQHVLOKHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
161407,7bv1,DB13983,-7.8,"5,7,2'-trihydroxy-6,8-dimethoxyflavone",JWOKGWICZPPYPX-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
33421,6cs2,T3D4651,-7.8,Oxazolam,VCCZBYPHZRWKFY-XIKOKIGWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
59297,6crv,DB07300,-7.8,"2-(1H-imidazol-1-yl)-9-methoxy-8-(2-methoxyethoxy)benzo[c][2,7]naphthyridin-4-amine",QSSGYSRUMIOURP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
128043,6w4h,DB07149,-7.8,"(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluoroethyl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one",LCBAQTCTQXHTJG-ZETCQYMHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
128805,6w4h,DB08035,-7.8,"1-TERT-BUTYL-3-(2,5-DIMETHYLBENZYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE",QUPXEJURIFFVSX-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
104774,6vxs,DB12479,-7.8,Zabofloxacin,ZNPOCLHDJCAZAH-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
161910,7bv1,DB00962,-7.8,Zaleplon,HUNXMJYCHXQEGX-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
72374,6m2n,DB00674,-7.8,Galantamine,ASUTZQLVASHGKV-JDFRZJQESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
27026,6cs2,DB06266,-7.8,Lonidamine,WDRYRZXSPDWGEB-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
130849,6w4h,DB12890,-7.8,Dihydrexidine,BGOQGUHWXBGXJW-YOEHRIQHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130874,6w4h,DB12927,-7.8,Theodrenaline,WMCMJIGLYZDKRN-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
12119,6lzg,DB12910,-7.8,Emicerfont,JFHJGXQFESYQGY-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
160267,7bv1,DB07945,-7.8,"5-(3-carbamoylbenzyl)-5,6,7,8,9,10-hexahydrocyclohepta[b]indole-4-carboxylic acid",GKBQRPKZHUFGOB-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
84582,6m3m,DB06538,-7.8,Robalzotan,MQTUXRKNJYPMCG-CYBMUJFWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
105106,6vxs,DB13008,-7.8,"2,2-bis(4-hydroxy-3-tert-butylphenyl)propane",ZDRSNHRWLQQICP-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
11785,6lzg,DB12426,-7.8,Bitopertin,YUUGYIUSCYNSQR-LBPRGKRZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
127962,6w4h,DB07056,-7.8,"2-(6-{[(3-chloro-2-methylphenyl)sulfonyl]amino}pyridin-2-yl)-N,N-diethylacetamide",JNWQLOFSMUGRNY-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
59306,6crv,DB07309,-7.8,5-BROMO-2-{[(4-CHLOROPHENYL)SULFONYL]AMINO}BENZOIC ACID,JDVLYAYDIMUAAC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58495,6crv,DB05542,-7.8,Naronapride,VGDDOIZXGFJDRC-VJTSUQJLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
83175,6m3m,DB03526,-7.8,AL5927,LRRAIRJIZOLGPR-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
22028,6cs2,HMDB0052724,-7.8,"TG(18:2(9Z,12Z)/22:4(7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))",JQULTLMUUUQRFY-MSGRFAKHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
161392,7bv1,DB13952,-7.8,Estradiol acetate,FHXBMXJMKMWVRG-SLHNCBLASA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160263,7bv1,DB07941,-7.8,PH-797804,KCAJXIDMCNPGHZ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
105081,6vxs,DB12966,-7.8,Falnidamol,FTFRZXFNZVCRSK-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
160681,7bv1,DB09272,-7.8,Eluxadoline,QFNHIDANIVGXPE-FNZWTVRRSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
127991,6w4h,DB07090,-7.8,(3S)-N-(3-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE,NJNMAZNXKKBTPS-ZDUSSCGKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
83180,6m3m,DB03535,-7.8,Z-Pro-Prolinal,ORZXYSPOAVJYRU-HOTGVXAUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
161938,7bv1,DB00997,-7.8,Doxorubicin,AOJJSUZBOXZQNB-TZSSRYMLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
161395,7bv1,DB13955,-7.8,Estradiol dienanthate,OVAHZPTYWMWNKO-CAHAWPIUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160266,7bv1,DB07944,-7.8,N-{3-METHYL-5-[2-(PYRIDIN-4-YLAMINO)-ETHOXY]-PHENYL}-BENZENESULFONAMIDE,MPTWCWHNLVMCRW-UHFFFAOYSA-O,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
22032,6cs2,HMDB0001425,-7.8,Estrone sulfate,JKKFKPJIXZFSSB-CBZIJGRNSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
128971,6w4h,DB08229,-7.8,[N-(3-DIBENZYLCARBAMOYL-OXIRANECARBONYL)-HYDRAZINO]-ACETIC ACID,JGMMFVVACJREFE-KRWDZBQOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
103909,6vxs,DB09227,-7.8,Barnidipine,VXMOONUMYLCFJD-DHLKQENFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
130068,6w4h,DB11726,-7.8,Encenicline,SSRDSYXGYPJKRR-ZDUSSCGKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
85282,6m3m,DB07473,-7.8,"(R)-(+) 5(9BH)-OXO-9B-PHENYL-2,3-DIHYDROTHIAZOLO[2,3-A]ISOINDOL-3-CARBOXYLIC ACID METHYL ESTER",JYIHODAXBBPFQF-MAUKXSAKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59487,6crv,DB07522,-7.8,"N-[(2R,3S)-3-AMINO-2-HYDROXY-4-PHENYLBUTYL]NAPHTHALENE-2-SULFONAMIDE",QSSWSEQPKCCATQ-VQTJNVASSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127678,6w4h,DB06677,-7.8,Clazosentan,LFWCJABOXHSRGC-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
160806,7bv1,DB11751,-7.8,Cabotegravir,WCWSTNLSLKSJPK-LKFCYVNXSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
82910,6m3m,DB03172,-7.8,Tubercidin,HDZZVAMISRMYHH-KCGFPETGSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
105260,6vxs,DB13266,-7.8,Cefatrizine,UOCJDOLVGGIYIQ-PBFPGSCMSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
26727,6cs2,DB04946,-7.8,Iloperidone,XMXHEBAFVSFQEX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
84472,6m3m,DB06247,-7.8,CX516,ANDGGVOPIJEHOF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
162091,7bv1,DB01430,-7.8,Almitrine,OBDOVFRMEYHSQB-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
105248,6vxs,DB13246,-7.8,Quinupramine,JCBQCKFFSPGEDY-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
127714,6w4h,DB06730,-7.8,Gestodene,SIGSPDASOTUPFS-XUDSTZEESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
160801,7bv1,DB11743,-7.8,Ipatasertib,GRZXWCHAXNAUHY-NSISKUIASA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
129974,6w4h,DB11529,-7.8,Melengestrol,OKHAOBQKCCIRLO-IBVJIVQJSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
59478,6crv,DB07511,-7.8,"4-(4-methyl-1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)benzonitrile",MVYDBJXCIFMINH-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72506,6m2n,DB00829,-7.8,Diazepam,AAOVKJBEBIDNHE-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
127717,6w4h,DB06733,-7.8,Bafilomycin A1,XDHNQDDQEHDUTM-JQWOJBOSSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
58580,6crv,DB06127,-7.8,Bisegliptin,AKFNKZFJBFQFAA-DIOPXHOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
129076,6w4h,DB08361,-7.8,"2-{[(1R,2S)-2-aminocyclohexyl]amino}-4-[(3-methylphenyl)amino]pyrimidine-5-carboxamide",NZNTWOVDIXCHHS-LSDHHAIUSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
72058,6m2n,DB00284,-7.8,Acarbose,CEMXHAPUFJOOSV-XGWNLRGSSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
127653,6w4h,DB06620,-7.8,Aplindore,DYJIKHYBKVODAC-ZDUSSCGKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
105294,6vxs,DB13312,-7.8,Delapril,WOUOLAUOZXOLJQ-MBSDFSHPSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
71798,6lxt,DB15297,-7.8,Petesicatib,KXAAIORSMACJSI-AEFFLSMTSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
59510,6crv,DB07547,-7.8,5-(4-CYANOPHENYL)-3-{[(2-METHYLPHENYL)SULFONYL]AMINO}THIOPHENE-2-CARBOXYLIC ACID,RYXAHMSZLLIPRO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
83996,6m3m,DB04628,-7.8,Allosamidin,MDWNFWDBQGOKNZ-XYUDZHFQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
27119,6cs2,DB06510,-7.8,Muraglitazar,IRLWJILLXJGJTD-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
105358,6vxs,DB13393,-7.8,Emetine,AUVVAXYIELKVAI-CKBKHPSWSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
160064,7bv1,DB07469,-7.8,"(3aS)-3a-hydroxy-7-methyl-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one",KAJFGRLMKVNMLH-GOSISDBHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
57899,6crv,DB04276,-7.8,N-[N-[1-Hydroxycarboxyethyl-Carbonyl]Leucylamino-Butyl]-Guanidine,QPQNJAXBPHVASB-QWRGUYRKSA-O,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27110,6cs2,DB00596,-7.8,Ulobetasol,LEHFPXVYPMWYQD-XHIJKXOTSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
58611,6crv,DB06195,-7.8,Seliciclib,BTIHMVBBUGXLCJ-OAHLLOKOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
129947,6w4h,DB11463,-7.8,Sulfanitran,GWBPFRGXNGPPMF-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
82827,6m3m,DB03062,-7.8,(1-Methyl-1h-Imidazol-2-Yl)-(3-Methyl-4-{3-[(Pyridin-3-Ylmethyl)-Amino]-Propoxy}-Benzofuran-2-Yl)-Methanone,VZBQJKIOAOUYJL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
127613,6w4h,DB06521,-7.8,Ertiprotafib,FONCZICQWCUXEB-RUZDIDTESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
127631,6w4h,DB06578,-7.8,Tonabersat,XLIIRNOPGJTBJD-ROUUACIJSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
127642,6w4h,DB06597,-7.8,Estradiol sulfamate,YXYXCSOJKUAPJI-ZBRFXRBCSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131334,6w4h,DB13606,-7.8,Phenazocine,ZQHYKVKNPWDQSL-KNXBSLHKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
26096,6cs2,DB04163,-7.8,"5-Phenylsulfanyl-2,4-Quinazolinediamine",BUFDQCGCADQQQY-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
26721,6cs2,DB04930,-7.8,Permethrin,RLLPVAHGXHCWKJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
34031,6cs2,T3D0871,-7.8,Antimony pentasulfide,OEIXRVAJAKPPBU-ALFHTMLSSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
127727,6w4h,DB06746,-7.8,ginkgolide-J,LMEHVEUFNRJAAV-UKWFQYJJSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
127740,6w4h,DB06777,-7.8,Chenodeoxycholic acid,RUDATBOHQWOJDD-BSWAIDMHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
104379,6vxs,DB11912,-7.8,Lanopepden,SWHNZGMQMGFQGW-MSOLQXFVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
33320,6cs2,T3D4513,-7.8,Forchlorfenuron,GPXLRLUVLMHHIK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
85214,6m3m,DB07394,-7.8,AUROVERTIN B,QXCOFYWOWZJFEA-YJMRODJJSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
57984,6crv,DB04395,-7.8,Phosphoaminophosphonic Acid-Adenylate Ester,PVKSNHVPLWYQGJ-FCIPNVEPSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127801,6w4h,DB06871,-7.8,17-METHYL-17-ALPHA-DIHYDROEQUILENIN,FQMQOMRDADWGJJ-GBESFXJTSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131177,6w4h,DB13393,-7.8,Emetine,AUVVAXYIELKVAI-CKBKHPSWSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
84550,6m3m,DB06465,-7.8,FK-960,XTOKQKWTUYYVAO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
71764,6lxt,DB15232,-7.8,Telaglenastat,PRAAPINBUWJLGA-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
71761,6lxt,DB15227,-7.8,Tirabrutinib,SEJLPXCPMNSRAM-GOSISDBHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
26132,6cs2,DB04201,-7.8,Histidyl-Adenosine Monophosphate,XTFBSLZFYLGYAT-OPYVMVOTSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
58557,6crv,DB05943,-7.8,Resatorvid,LEEIJTHMHDMWLJ-CQSZACIVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
131143,6w4h,DB13347,-7.8,Diphenadione,JYGLAHSAISAEAL-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
72454,6m2n,DB00768,-7.8,Olopatadine,JBIMVDZLSHOPLA-LSCVHKIXSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
105184,6vxs,DB13119,-7.8,GSK-364735,QWLNINWUBHHOLU-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
26146,6cs2,DB04216,-7.8,Quercetin,REFJWTPEDVJJIY-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
161308,7bv1,DB13534,-7.8,Gedocarnil,SLYDYLLJUXFULK-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
130064,6w4h,DB11718,-7.8,Encorafenib,CMJCXYNUCSMDBY-ZDUSSCGKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131099,6w4h,DB13292,-7.8,Pimethixene,NZLVRVYNQYGMAB-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
104714,6vxs,DB12399,-7.8,Polmacoxib,IJWPAFMIFNSIGD-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
83001,6m3m,DB03285,-7.8,"2',4,4'-Trihydroxychalcone",DXDRHHKMWQZJHT-FPYGCLRLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
82998,6m3m,DB03281,-7.8,2'-Deoxymaltose,FDCIWBIYHZDLEG-AEEGTDTOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
127782,6w4h,DB06847,-7.8,"5-[(3S)-3-(2-methoxybiphenyl-4-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",YYCPXVRHQUEVAW-CQSZACIVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
103854,6vxs,DB09168,-7.8,4-Phenylfentanyl,BXCJXJLHYMWMQU-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
72494,6m2n,DB00817,-7.8,Rosoxacin,XBPZXDSZHPDXQU-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
160115,7bv1,DB07530,-7.8,"(1R,3R)-5-[(2E)-3-{(1S,3R)-2,2,3-trimethyl-3-[6,6,6-trifluoro-5-hydroxy-5-(trifluoromethyl)hex-3-yn-1-yl]cyclopentyl}prop-2-en-1-ylidene]cyclohexane-1,3-diol",PCHUQQNKOFNVDU-OSXMSNBXSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
129026,6w4h,DB08301,-7.8,N-({[4-(AMINOSULFONYL)PHENYL]AMINO}CARBONYL)-4-METHYLBENZENESULFONAMIDE,HDCXQTPVTAIPNZ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
84492,6m3m,DB06288,-7.8,Amisulpride,NTJOBXMMWNYJFB-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
33774,6cs2,T3D0452,-7.8,"2,3,4',5-Tetrachlorobiphenyl",CITMYAMXIZQCJD-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
27088,6cs2,DB06440,-7.8,Ravuconazole,OPAHEYNNJWPQPX-RCDICMHDSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
103862,6vxs,DB09177,-7.8,p-Fluorofentanyl,KXUBAVLIJFTASZ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
130210,6w4h,DB11934,-7.8,Epelsiban,UWHCWRQFNKUYCG-QUZACWSFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
18192,6cs2,HMDB0000626,-7.8,Deoxycholic acid,KXGVEGMKQFWNSR-LLQZFEROSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
72481,6m2n,DB00802,-7.8,Alfentanil,IDBPHNDTYPBSNI-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
71769,6lxt,DB15241,-7.8,Methylsamidorphan,ATCVVCBJNHXIEX-ZAHKBLQYSA-O,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
26126,6cs2,DB04196,-7.8,Pteroic Acid,JOAQINSXLLMRCV-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
26739,6cs2,DB04971,-7.8,Reglitazar,QBQLYIISSRXYKL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
131203,6w4h,DB13425,-7.8,Flutrimazole,QHMWCHQXCUNUAK-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
104372,6vxs,DB11903,-7.8,GW842166,TWQYWUXBZHPIIV-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
82992,6m3m,DB03273,-7.8,3'-Oxo-Adenosine,MIAZJCOESMXYNJ-XMRAEQSQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84541,6m3m,DB06444,-7.8,Dexanabinol,SSQJFGMEZBFMNV-PMACEKPBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
130046,6w4h,DB11689,-7.8,Selumetinib,CYOHGALHFOKKQC-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
27123,6cs2,DB06518,-7.8,R-1487,KKKRKRMVJRHDMG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
128054,6w4h,DB07163,-7.8,5-[(2-AMINOETHYL)AMINO]-6-FLUORO-3-(1H-PYRROL-2-YL)BENZO[CD]INDOL-2(1H)-ONE,CQCXWWWNUFQYJS-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
27021,6cs2,DB00587,-7.8,Cinalukast,BZMKNPGKXJAIDV-VAWYXSNFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
26338,6cs2,DB04461,-7.8,Coproporphyrinogen III,NIUVHXTXUXOFEB-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
130518,6w4h,DB12379,-7.8,Indirubin,CRDNMYFJWFXOCH-BUHFOSPRSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
84700,6m3m,DB06780,-7.8,Desoxycorticosterone acetate,VPGRYOFKCNULNK-ACXQXYJUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
34162,6cs2,T3D1025,-7.8,Cismethrin,SSUJIHXQXFBEJN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
161605,7bv1,DB00169,-7.8,Cholecalciferol,QYSXJUFSXHHAJI-YRZJJWOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
84872,6m3m,DB07002,-7.8,4-({4-[(4-methoxypyridin-2-yl)amino]piperidin-1-yl}carbonyl)benzonitrile,SZUVGMCKKLJAFX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
128379,6w4h,DB07539,-7.8,"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZOIC ACID",JLRKRQCTYQGDKJ-GHXNOFRVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
84713,6m3m,DB06802,-7.8,Nepafenac,QEFAQIPZVLVERP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
26939,6cs2,DB06061,-7.8,AZD-8330,RWEVIPRMPFNTLO-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
58297,6crv,DB04816,-7.8,Dantron,QBPFLULOKWLNNW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
5962,6lzg,DB01339,-7.8,Vecuronium,BGSZAXLLHYERSY-XQIGCQGXSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
104186,6vxs,DB11622,-7.8,Dehydrocholic acid,OHXPGWPVLFPUSM-KLRNGDHRSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
71679,6lxt,DB15065,-7.8,PF-06291874,IBDYYOQKQCCSDP-QFIPXVFZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
58384,6crv,DB04954,-7.8,Tecadenoson,OESBDSFYJMDRJY-BAYCTPFLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104887,6vxs,DB12662,-7.8,Naveglitazar,OKJHGOPITGTTIM-DEOSSOPVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
83590,6m3m,DB04089,-7.8,AL5300,HHPUQNGRNUOYCD-VIFPVBQESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
72206,6m2n,DB00467,-7.8,Enoxacin,IDYZIJYBMGIQMJ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
5960,6lzg,DB01337,-7.8,Pancuronium,GVEAYVLWDAFXET-XGHATYIMSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
104206,6vxs,DB11663,-7.8,Pictilisib,LHNIIDJUOCFXAP-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
59135,6crv,DB07115,-7.8,"N-(4-chlorobenzyl)-N-methylbenzene-1,4-disulfonamide",IPPUTOHDQOYDIL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
11891,6lzg,DB12573,-7.8,LY-2452473,IHIWYQYVBNODSV-KRWDZBQOSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
26967,6cs2,DB06159,-7.8,Rubitecan,VHXNKPBCCMUMSW-FQEVSTJZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
72192,6m2n,DB00448,-7.8,Lansoprazole,MJIHNNLFOKEZEW-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
128310,6w4h,DB07457,-7.8,"3-[1-(3-AMINOPROPYL)-1H-INDOL-3-YL]-4-(1H-INDOL-3-YL)-1H-PYRROLE-2,5-DIONE",APYXQTXFRIDSGE-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
128317,6w4h,DB07467,-7.8,"4-chloro-N-[(2S)-2-methyl-2,3-dihydro-1H-indol-1-yl]-3-sulfamoylbenzamide",NDDAHWYSQHTHNT-JTQLQIEISA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
72284,6m2n,DB00562,-7.8,Benzthiazide,NDTSRXAMMQDVSW-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
26954,6cs2,DB06140,-7.8,SUVN-502,GWCYPEHWIZXYFZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
58400,6crv,DB05022,-7.8,Amonafide,UPALIKSFLSVKIS-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130313,6w4h,DB12084,-7.8,ADP-597,WPDCHTSXOPUOII-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
104904,6vxs,DB12686,-7.8,PHA-793887,HUXYBQXJVXOMKX-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
84912,6m3m,DB07047,-7.8,"2',4'-DICHLORO-4-HYDROXY-1,1'-BIPHENYL-3-CARBOXYLIC ACID",SKAFZYDMDHPPJM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83441,6m3m,DB03887,-7.8,Alpha-Adenosine Monophosphate,NVOIXARBSSLBAS-CRKDRTNXSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
104900,6vxs,DB12680,-7.8,Intepirdine,JJZFWROHYSMCMU-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
130534,6w4h,DB12400,-7.8,Voxtalisib,RGHYDLZMTYDBDT-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
33541,6cs2,T3D4791,-7.8,Mestranol,IMSSROKUHAOUJS-MJCUULBUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
161553,7bv1,DB15063,-7.8,Inarigivir soproxil,CJCYTUJOSMYXLE-JDLSZIHUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
130314,6w4h,DB12085,-7.8,LCL-161,UFPFGVNKHCLJJO-SSKFGXFMSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
128587,6w4h,DB07788,-7.8,"(3R,5Z,8S,9S,11E)-8,9,16-TRIHYDROXY-14-METHOXY-3-METHYL-3,4,9,10-TETRAHYDRO-1H-2-BENZOXACYCLOTETRADECINE-1,7(8H)-DIONE",NEQZWEXWOFPKOT-QHSZRYGNSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
59211,6crv,DB07200,-7.8,"(2S,4S,5R)-2-ISOBUTYL-5-(2-THIENYL)-1-[4-(TRIFLUOROMETHYL)BENZOYL]PYRROLIDINE-2,4-DICARBOXYLIC ACID",ZNCZVHCYBGHCHA-XPIZARPCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
128296,6w4h,DB07441,-7.8,"3-{[(9-CYANO-9,10-DIHYDRO-10-METHYLACRIDIN-9-YL)CARBONYL]AMINO}PROPANOIC ACID",FRBAOMHMZCGBOJ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
26936,6cs2,DB05992,-7.8,Plinabulin,UNRCMCRRFYFGFX-TYPNBTCFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
5984,6lzg,DB01406,-7.8,Danazol,POZRVZJJTULAOH-LHZXLZLDSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
161673,7bv1,DB00247,-7.8,Methysergide,KPJZHOPZRAFDTN-NQUBZZJWSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160479,7bv1,DB08437,-7.8,Puromycin,RXWNCPJZOCPEPQ-NVWDDTSBSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
130357,6w4h,DB12147,-7.8,Erdafitinib,OLAHOMJCDNXHFI-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
58324,6crv,DB04844,-7.8,Tetrabenazine,MKJIEFSOBYUXJB-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
161679,7bv1,DB00253,-7.8,Medrysone,GZENKSODFLBBHQ-ILSZZQPISA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
83505,6m3m,DB03973,-7.8,"3-{2,6,8-trioxo-9-[(2R,3R,4R)-2,3,4,5-tetrahydroxypentyl]-1,2,3,6,8,9-hexahydro-7H-purin-7-Yl}propyl dihydrogen phosphate",KPHFGOGGKPGLTM-ZXFLCMHBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59167,6crv,DB07149,-7.8,"(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluoroethyl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one",LCBAQTCTQXHTJG-ZETCQYMHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
71667,6lxt,DB15046,-7.8,LY-2881835,FHRWHNJJQGSCQC-LJAQVGFWSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
128476,6w4h,DB07654,-7.8,"(5,6-DIPHENYL-FURO[2,3-D]PYRIMIDIN-4-YLAMINO)-ACETIC",VDJWWYRYKMXMKA-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
84738,6m3m,DB06843,-7.8,"2',5'-DIDEOXY-ADENOSINE 3'-MONOPHOSPHATE",NFGZMOICZSFFLB-DSYKOEDSSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
6562,6lzg,DB02329,-7.8,Carbenoxolone,OBZHEBDUNPOCJG-WBXJDKIVSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
58338,6crv,DB04864,-7.8,Huperzine A,ZRJBHWIHUMBLCN-YQEJDHNASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
128493,6w4h,DB07678,-7.8,"(9ALPHA,13BETA,17BETA)-2-[(1Z)-BUT-1-EN-1-YL]ESTRA-1,3,5(10)-TRIENE-3,17-DIOL",ANAMDWGJXBYJEB-OPWFCKQNSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
18040,6cs2,HMDB0000577,-7.8,5beta-Coprostanol,QYIXCDOBOSTCEI-NWKZBHTNSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
130386,6w4h,DB12193,-7.8,Ajulemic acid,YCHYFHOSGQABSW-RTBURBONSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
83545,6m3m,DB04024,-7.8,N'-L-Seryl-3'-Amino-(3'-Deoxy)-Adenosine,ITDKSTILAWHDJI-AYEBZEFBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
130370,6w4h,DB12167,-7.8,LY-3023414,ACCFLVVUVBJNGT-AWEZNQCLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
59169,6crv,DB07153,-7.8,"6-methyl-5-[3-methyl-3-(3,4,5-trimethoxyphenyl)but-1-yn-1-yl]pyrimidine-2,4-diamine",FJNFXXGWYVMQNA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59191,6crv,DB07178,-7.8,5-PENTYL-2-PHENOXYPHENOL,OJLYTHOKCYLPMA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104224,6vxs,DB11686,-7.8,Iferanserin,UXIPFQUBOVWAQW-UEBLJOKOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
128452,6w4h,DB07628,-7.8,"6-(2-fluorobenzyl)-2,4-dimethyl-4,6-dihydro-5H-thieno[2',3':4,5]pyrrolo[2,3-d]pyridazin-5-one",IEWYEWDDQWYJLU-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
83492,6m3m,DB03952,-7.8,9-(6-deoxy-beta-D-allofuranosyl)-6-methylpurine,XJZDIUOABWMPLZ-FHQKJXBVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
130458,6w4h,DB12291,-7.8,Tacedinaline,VAZAPHZUAVEOMC-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
1299,6lzg,HMDB0010345,-7.8,Aldosterone 18-glucuronide,OMRIQCUHVVBJKI-ACOLCOCVSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
130453,6w4h,DB12286,-7.8,Simendan,WHXMKTBCFHIYNQ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
58309,6crv,DB04828,-7.8,Zomepirac,ZXVNMYWKKDOREA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
161642,7bv1,DB00213,-7.8,Pantoprazole,IQPSEEYGBUAQFF-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
161643,7bv1,DB00214,-7.8,Torasemide,NGBFQHCMQULJNZ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
128554,6w4h,DB07750,-7.8,"(2R)-1-[4-({4-[(2,5-Dichlorophenyl)amino]-2-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol",GNLAGGCSJGJECE-MRXNPFEDSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
84829,6m3m,DB06947,-7.8,1-[(2R)-2-aminobutanoyl]-N-(4-carbamimidoylbenzyl)-L-prolinamide,YHAMQFKGUUSJMU-KGLIPLIRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
128429,6w4h,DB07602,-7.8,S-{3-[(4-ANILINOQUINAZOLIN-6-YL)AMINO]-3-OXOPROPYL}-L-CYSTEINE,NLVZTRZPMRTVRC-INIZCTEOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
104211,6vxs,DB11670,-7.8,SP-8203,SJZBPVOSFYUHFV-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
26334,6cs2,DB04457,-7.8,2'-Deoxyguanosine-5'-Monophosphate,LTFMZDNNPPEQNG-KVQBGUIXSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
58359,6crv,DB04890,-7.8,Bepotastine,YWGDOWXRIALTES-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104862,6vxs,DB12622,-7.8,Lupeol,MQYXUWHLBZFQQO-QGTGJCAVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
128438,6w4h,DB07613,-7.8,3-phenyl-5-(1H-pyrazol-3-yl)isoxazole,SRSSTOPJERVMRZ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130433,6w4h,DB12262,-7.8,CRS-3123,NNTYBKTXMKBRFA-CQSZACIVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130351,6w4h,DB12137,-7.8,GSK-256066,JFHROPTYMMSOLG-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
160462,7bv1,DB08416,-7.8,"(9BETA,13ALPHA,14BETA,17ALPHA)-2-METHOX1TRA-1,3,5(10)-TRIENE-3,17-DIYL DISULFAMATE",AQSNIXKAKUZPSI-SSTWWWIQSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160376,7bv1,DB08309,-7.8,3-({2-[(4-{[6-(CYCLOHEXYLMETHOXY)-9H-PURIN-2-YL]AMINO}PHENYL)SULFONYL]ETHYL}AMINO)PROPAN-1-OL,AMFGILNPFBVREA-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
71583,6lxt,DB14846,-7.8,Bimiralisib,ADGGYDAFIHSYFI-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
26973,6cs2,DB06176,-7.8,Romidepsin,OHRURASPPZQGQM-GCCNXGTGSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
130238,6w4h,DB11969,-7.8,Uprosertib,AXTAPYRUEKNRBA-JTQLQIEISA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
104994,6vxs,DB12833,-7.8,Tandospirone,CEIJFEGBUDEYSX-FZDBZEDMSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
12219,6lzg,DB13055,-7.8,Oteseconazole,IDUYJRXRDSPPRC-NRFANRHFSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
17994,6cs2,HMDB0000570,-7.8,Coproporphyrin III,JWFCYWSMNRLXLX-UJJXFSCMSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
160311,7bv1,DB07995,-7.8,N-[2-(4-BROMOCINNAMYLAMINO)ETHYL]-5-ISOQUINOLINE SULFONAMIDE,ZKZXNDJNWUTGDK-NSCUHMNNSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59282,6crv,DB07284,-7.8,"N-3-(3-PYRIDIN-3-YLBENZYL)PYRIDINE-2,3-DIAMINE",NQSBHBFOOVYRNM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130259,6w4h,DB12005,-7.8,Nirogacestat,VFCRKLWBYMDAED-REWPJTCUSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
18111,6cs2,HMDB0013034,-7.8,Palmitoylglycine,KVTFEOAKFFQCCX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
128715,6w4h,DB07935,-7.8,"5-[(5-fluoro-3-methyl-1H-indazol-4-yl)oxy]benzene-1,3-dicarbonitrile",JYAHFMKZJRVTDT-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
26357,6cs2,DB04480,-7.8,"3-(4-Fluorophenyl)-2-(6-Methylpyridin-2-Yl)-5,6-Dihydro-4h-Pyrrolo[1,2-B]Pyrazole",NBDZLUOYAAVYHF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
58196,6crv,DB04676,-7.8,Dansyllysine,VQPRNSWQIAHPMS-HNNXBMFYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104108,6vxs,DB11429,-7.8,Mibolerone,PTQMMNYJKCSPET-OMHQDGTGSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104972,6vxs,DB12796,-7.8,MRX-I,SULYVXZZUMRQAX-NSHDSACASA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
26994,6cs2,DB06207,-7.8,Silodosin,PNCPYILNMDWPEY-QGZVFWFLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
128672,6w4h,DB07882,-7.8,"4-{4-[2-(1A,7A-DIMETHYL-4-OXY-OCTAHYDRO-1-OXA-4-AZA-CYCLOPROPA[A]NAPHTHALEN-4-YL) -ACETYLAMINO]-PHENYLCARBAMOYL}-BUTYRIC ACID",VFIZFTGABDUGCF-UPVHCHBVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130282,6w4h,DB12042,-7.8,Ibodutant,YQYSVMKCMIUCHY-WJOKGBTCSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
59120,6crv,DB07096,-7.8,"6-AMINO-BENZO[DE]ISOQUINOLINE-1,3-DIONE",SSMIFVHARFVINF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84646,6m3m,DB06693,-7.8,Mevastatin,AJLFOPYRIVGYMJ-INTXDZFKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
11828,6lzg,DB12480,-7.8,Betulinic Acid,QGJZLNKBHJESQX-FZFNOLFKSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
58184,6crv,DB04656,-7.8,"1,3,4-TRIHYDROXY-5-(3-PHENOXYPROPYL)-CYCLOHEXANE-1-CARBOXYLIC A CID",SCUFESRLGCQXRX-DCDXPUDHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58178,6crv,DB04649,-7.8,TETRAHEDRAL INTERMEDIATE OF BLASTICIDIN S,MVFPGTZTOAHVBP-HXYLPHSESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
128760,6w4h,DB07987,-7.8,"[2-(5-MERCAPTO-[1,3,4]THIADIAZOL-2-YLCARBAMOYL)-1-PHENYL-ETHYL]-CARBAMIC ACID BENZYL ESTER",AWAKNMKLVLWIIQ-OAHLLOKOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
26812,6cs2,DB00564,-7.8,Carbamazepine,FFGPTBGBLSHEPO-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
160637,7bv1,DB08883,-7.8,Perampanel,PRMWGUBFXWROHD-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160607,7bv1,DB08833,-7.8,Taurochenodeoxycholic acid,BHTRKEVKTKCXOH-BJLOMENOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
128088,6w4h,DB07201,-7.8,(2S)-3-[(9H-fluoren-9-ylideneamino)oxy]-2-methylpropanoic acid,ZHFDVDMCVXUGGF-NSHDSACASA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
72356,6m2n,DB00652,-7.8,Pentazocine,VOKSWYLNZZRQPF-GDIGMMSISA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
71551,6lxt,DB14765,-7.8,Rivoceranib,WPEWQEMJFLWMLV-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
130233,6w4h,DB11964,-7.8,Ilaprazole,HRRXCXABAPSOCP-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
128734,6w4h,DB07958,-7.8,(2-CARBAMOYLMETHYL-5-PROPYL-OCTAHYDRO-INDOL-7-YL)ACETIC ACID,OMLOGGCSARAIGZ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
161448,7bv1,DB14065,-7.8,Lomerizine,JQSAYKKFZOSZGJ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160599,7bv1,DB08820,-7.8,Ivacaftor,PURKAOJPTOLRMP-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
71724,6lxt,DB15152,-7.8,TMC-649128,XJBILYMRFVHPJB-XJQUKVTJSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
160590,7bv1,DB08807,-7.8,Bopindolol,UUOJIACWOAYWEZ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
72157,6m2n,DB00406,-7.8,Gentian violet cation,LGLFFNDHMLKUMI-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
130236,6w4h,DB11967,-7.8,Binimetinib,ACWZRVQXLIRSDF-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
160300,7bv1,DB07984,-7.8,2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]-n-[(1S)-1-(hydroxymethyl)propyl]acetamide,GKJWXEORYGBJFS-KRWDZBQOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160303,7bv1,DB07987,-7.8,"[2-(5-MERCAPTO-[1,3,4]THIADIAZOL-2-YLCARBAMOYL)-1-PHENYL-ETHYL]-CARBAMIC ACID BENZYL ESTER",AWAKNMKLVLWIIQ-OAHLLOKOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
85014,6m3m,DB07164,-7.8,"N-cyclopropyl-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amine",CAGHIASAHLPQMS-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
130681,6w4h,DB12622,-7.8,Lupeol,MQYXUWHLBZFQQO-QGTGJCAVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
104116,6vxs,DB11443,-7.8,Orbifloxacin,QIPQASLPWJVQMH-DTORHVGOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
58433,6crv,DB05234,-7.8,LGD2941,HWLLYFXDDGGHOE-BCSUUIJWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
26848,6cs2,DB05519,-7.8,Budiodarone,ZXOSVKYCXLTVGS-KRWDZBQOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
104815,6vxs,DB12547,-7.8,LY-2886721,NIDRNVHMMDAAIK-YPMLDQLKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
128250,6w4h,DB07389,-7.8,N-[2-(6-AMINO-4-METHYLPYRIDIN-2-YL)ETHYL]-4-CYANOBENZAMIDE,QINCZVSBLITNRD-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
26851,6cs2,DB05532,-7.8,BMS-488043,DBPMWRYLTBNCCE-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
59241,6crv,DB07238,-7.8,Nesbuvir,WTDWVLJJJOTABN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58417,6crv,DB05107,-7.8,16-Bromoepiandrosterone,CWVMWSZEMZOUPC-JUAXIXHSSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
128251,6w4h,DB07390,-7.8,"2-[3-(5-MERCAPTO-[1,3,4]THIADIAZOL-2-YL)-UREIDO]-N-METHYL-3-PHENYL-PROPIONAMIDE",RKWXKADYTDWZIJ-VIFPVBQESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
128255,6w4h,DB07394,-7.8,AUROVERTIN B,QXCOFYWOWZJFEA-YJMRODJJSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
11834,6lzg,DB12491,-7.8,Fasiglifam,BZCALJIHZVNMGJ-HSZRJFAPSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
83350,6m3m,DB03771,-7.8,Allyl-{4-[3-(4-Bromo-Phenyl)-Benzofuran-6-Yloxy]-but-2-Enyl}-Methyl-Amine,KCNKJCHARANTIP-SNAWJCMRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
104951,6vxs,DB12758,-7.8,Atreleuton,MMSNEKOTSJRTRI-LLVKDONJSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
58233,6crv,DB04726,-7.8,"7,8,10-TRIMETHYLBENZO[G]PTERIDINE-2,4(3H,10H)-DIONE",KPDQZGKJTJRBGU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
33503,6cs2,T3D4758,-7.8,Quercetin,REFJWTPEDVJJIY-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
83372,6m3m,DB03798,-7.8,2'-Deoxycytidine-5'-Monophosphate,NCMVOABPESMRCP-SHYZEUOFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
104265,6vxs,DB11749,-7.8,(R)-Praziquantel,FSVJFNAIGNNGKK-KRWDZBQOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
6520,6lzg,DB02259,-7.8,"3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid (4-Sulfamoyl-Phenyl)-Amide",VSYGXLAJQDAWCZ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
161528,7bv1,DB15021,-7.8,Leriglitazone,OXVFDZYQLGRLCD-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
161823,7bv1,DB00641,-7.8,Simvastatin,RYMZZMVNJRMUDD-HGQWONQESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
26985,6cs2,DB06199,-7.8,Atrasentan,MOTJMGVDPWRKOC-QPVYNBJUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
72178,6m2n,DB00433,-7.8,Prochlorperazine,WIKYUJGCLQQFNW-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
161832,7bv1,DB00655,-7.8,Estrone,DNXHEGUUPJUMQT-CBZIJGRNSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160336,7bv1,DB08022,-7.8,"(2S)-1,3-benzothiazol-2-yl{2-[(2-pyridin-3-ylethyl)amino]pyrimidin-4-yl}ethanenitrile",RCYPVQCPYKNSTG-OAHLLOKOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
26842,6cs2,DB05501,-7.8,AMD-070,WVLHHLRVNDMIAR-IBGZPJMESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
84975,6m3m,DB07120,-7.8,"N4-(N,N-DIPHENYLCARBAMOYL)-AMINOGUANIDINE",QLXOHIUDKNRVBZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
161486,7bv1,DB14898,-7.8,Retagliptin,WIIAMRXFUJLYEF-SNVBAGLBSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
161489,7bv1,DB14902,-7.8,JHU-75528 C-11,MCNQUWLLXZZZAC-BJUDXGSMSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
84661,6m3m,DB06712,-7.8,Nilvadipine,FAIIFDPAEUKBEP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83312,6m3m,DB03726,-7.8,Purine Riboside-5'-Monophosphate,MCWDCZIDTUQRHK-FDDDBJFASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
33475,6cs2,T3D4732,-7.8,Tacrolimus,QJJXYPPXXYFBGM-LJIGMGMYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
105030,6vxs,DB12890,-7.8,Dihydrexidine,BGOQGUHWXBGXJW-YOEHRIQHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
130594,6w4h,DB12480,-7.8,Betulinic Acid,QGJZLNKBHJESQX-FZFNOLFKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
83332,6m3m,DB03752,-7.8,P-(2'-Iodo-5'-Thenoyl)Hydrotropic Acid,UIZPHGUBGPJBAR-QMMMGPOBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59243,6crv,DB07240,-7.8,3-[(9H-fluoren-9-ylideneamino)oxy]propanoic acid,LASWLEUVWJDDBA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104814,6vxs,DB12545,-7.8,Indobufen,AYDXAULLCROVIT-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104963,6vxs,DB12780,-7.8,Quinfamide,SBJGFIXQRZOVTO-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
84954,6m3m,DB07095,-7.8,(S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclopentylpropanoyl)pyrrolidine-2-carboxamide,BNCHHUFGEOJCNH-SFHVURJKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
128651,6w4h,DB07859,-7.8,4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL)PHENYL]PIPERIDINE,LZMOSYUFVYJEPY-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
72317,6m2n,DB00603,-7.8,Medroxyprogesterone acetate,PSGAAPLEWMOORI-PEINSRQWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
84662,6m3m,DB06713,-7.8,Norelgestromin,ISHXLNHNDMZNMC-XUDSTZEESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84955,6m3m,DB07096,-7.8,"6-AMINO-BENZO[DE]ISOQUINOLINE-1,3-DIONE",SSMIFVHARFVINF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
26700,6cs2,DB04885,-7.8,Cilansetron,NCNFDKWULDWJDS-OAHLLOKOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
84538,6m3m,DB06436,-7.8,Semaxanib,WUWDLXZGHZSWQZ-WQLSENKSSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58954,6crv,DB06903,-7.8,"(1S,3aS,5aR,8aS)-1,7,7-trimethyl-1,2,3,3a,5a,6,7,8-octahydrocyclopenta[c]pentalene-4-carboxylic acid",DCFDRCCHOOORSB-JOXOIDLHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
162398,7bv1,DB02004,-7.8,"5-(Aminomethyl)-6-(2,4-Dichlorophenyl)-2-(3,5-Dimethoxyphenyl)Pyrimidin-4-Amine",RCJFINNFYUNFGH-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160944,7bv1,DB12301,-7.8,Doravirine,ZIAOVIPSKUPPQW-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
84087,6m3m,DB04756,-7.8,"2-[(3,5-Dichloro-4-trioxidanylphenyl)amino]benzoic acid",SNAMTVTZDPUVRA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
57792,6crv,DB04137,-7.8,Guanosine-5'-Triphosphate,XKMLYUALXHKNFT-UUOKFMHZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
160012,7bv1,DB07186,-7.8,"4-(4-METHYLPIPERAZIN-1-YL)-N-[5-(2-THIENYLACETYL)-1,5-DIHYDROPYRROLO[3,4-C]PYRAZOL-3-YL]BENZAMIDE",TYYNSDQVFIOSFH-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
131822,6w4h,DB14775,-7.8,Cavosonstat,BXSZILNGNMDGSL-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
11679,6lzg,DB12289,-7.8,Darexaban,IJNIQYINMSGIPS-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
160005,7bv1,DB07179,-7.8,"3-((3-bromo-5-o-tolylpyrazolo[1,5-a]pyrimidin-7-ylamino)methyl)pyridine 1-oxide",DXUJQXZHHGJMFM-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
105718,6vxs,DB13874,-7.8,Enasidenib,DYLUUSLLRIQKOE-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
103670,6vxs,DB08865,-7.8,Crizotinib,KTEIFNKAUNYNJU-GFCCVEGCSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
127155,6w4h,DB04792,-7.8,"2,5-O,O-BIS-{4',4''-AMIDINOPHENYL}-1,4:3,6-DIANHYDRO-D-SORBITOL",CDEVHSIVANGYRI-XMTFNYHQSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
104621,6vxs,DB12270,-7.8,Losmapimod,KKYABQBFGDZVNQ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104596,6vxs,DB12235,-7.8,Estetrol,AJIPIJNNOJSSQC-NYLIRDPKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
159887,7bv1,DB07043,-7.8,"7-amino-2-tert-butyl-4-(4-pyrimidin-2-ylpiperazin-1-yl)pyrido[2,3-d]pyrimidine-6-carboxamide",CKLCIJCZOIDJQU-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
33201,6cs2,T3D4282,-7.8,17-Hydroxyprogesterone,DBPWSSGDRRHUNT-CEGNMAFCSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
84235,6m3m,DB05022,-7.8,Amonafide,UPALIKSFLSVKIS-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
57777,6crv,DB04115,-7.8,Berberine,YBHILYKTIRIUTE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
129224,6w4h,DB08538,-7.8,"N-((2-aminopyrimidin-5-yl)methyl)-5-(2,6-difluorophenyl)-3-ethylpyrazolo[1,5-a]pyrimidin-7-amine",HQPVGVSQPQVZLD-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
161136,7bv1,DB12935,-7.8,Remogliflozin etabonate,UAOCLDQAQNNEAX-ABMICEGHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
72599,6m2n,DB00933,-7.8,Mesoridazine,SLVMESMUVMCQIY-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
57594,6crv,DB03869,-7.8,5'-O-(N-(L-Seryl)-Sulfamoyl)Adenosine,HQXFJGONGJPTLZ-YTMOPEAISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
26656,6cs2,DB04836,-7.8,Amineptine,ONNOFKFOZAJDHT-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
131796,6w4h,DB14723,-7.8,Larotrectinib,NYNZQNWKBKUAII-KBXCAEBGSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
6333,6lzg,DB01948,-7.8,"1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperidin-4-Yl-3,4-Dihydroquinolin-2(1h)-One",VXIYTVJEIXMAQF-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
11984,6lzg,DB00967,-7.8,Desloratadine,JAUOIFJMECXRGI-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
131825,6w4h,DB14787,-7.8,BMS-830216,YDTUJCNTIMWHPJ-NRFANRHFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
129205,6w4h,DB08517,-7.8,"(2S)-5-hydroxy-2-(4-hydroxyphenyl)-7-methoxy-2,3-dihydro-4H-chromen-4-one",DJOJDHGQRNZXQQ-AWEZNQCLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
84077,6m3m,DB04741,-7.8,Myxothiazol,XKTFQMCPGMTBMD-FYHMSGCOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85464,6m3m,DB07693,-7.8,"N-(3,5-dibromo-4-hydroxyphenyl)-2,6-dimethylbenzamide",IFECSMFQARKPSU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
46716,2fxp,DB00878,-7.8,Chlorhexidine,GHXZTYHSJHQHIJ-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
57814,6crv,DB04164,-7.8,"1,4-Deoxy-4-((5-Hydroxymethyl-2,3,4-Trihydroxycyclohex-5-Enyl)Amino)Fructose",ZGWNRGISVMYHTF-KKXLKBQTSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104619,6vxs,DB12268,-7.8,Carmegliptin,GUYMHFIHHOEFOA-ZCPGHIKRSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104625,6vxs,DB12275,-7.8,Seviteronel,ZBRAJOQFSNYJMF-SFHVURJKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
71877,6lxt,DB15460,-7.8,AGG-523,JWQMTWCFNZSLNR-DEOSSOPVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
127478,6w4h,DB06176,-7.8,Romidepsin,OHRURASPPZQGQM-GCCNXGTGSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
71965,6m2n,DB00178,-7.8,Ramipril,HDACQVRGBOVJII-JBDAPHQKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
159870,7bv1,DB06721,-7.8,Gimatecan,UIVFUQKYVFCEKJ-OPTOVBNMSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
105580,6vxs,DB13687,-7.8,Niaprazine,RSKQGBFMNPDPLR-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
58719,6crv,DB06471,-7.8,Naxifylline,NJYNSYQBNSDGIQ-RDDCQWBRSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104455,6vxs,DB12027,-7.8,Serdemetan,CEGSUK1LWKJP-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
58760,6crv,DB06585,-7.8,Fipamezole,KXSUAWAUCNFBQJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127268,6w4h,DB04982,-7.8,Talampanel,JACAAXNEHGBPOQ-LLVKDONJSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
58880,6crv,DB06807,-7.8,Phenyl aminosalicylate,DNVVZWSVACQWJE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
12001,6lzg,DB12731,-7.8,Daporinad,KPBNHDGDUADAGP-VAWYXSNFSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
160022,7bv1,DB07198,-7.8,5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-CARBONITRILE,GGEKOZPXKBYLNK-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
162228,7bv1,DB01771,-7.8,CRA_10991,QXAURVOBXQBPAP-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
162230,7bv1,DB01774,-7.8,Adenosine-5'-Monophosphate Glucopyranosyl-Monophosphate Ester,WFPZSXYXPSUOPY-ROYWQJLOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
72587,6m2n,DB00919,-7.8,Spectinomycin,UNFWWIHTNXNPBV-WXKVUWSESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
159877,7bv1,DB06731,-7.8,Seproxetine,WIQRCHMSJFFONW-HNNXBMFYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
129589,6w4h,DB09006,-7.8,Clinofibrate,BMOVQUBVGICXQN-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
129182,6w4h,DB08491,-7.8,N-HYDROXY-2-[4-(4-PHENOXY-BENZENESULFONYL)-TETRAHYDRO-PYRAN-4-YL]-ACETAMIDE,ARIRIZBKMKMEBD-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
59574,6crv,DB07626,-7.8,"4-(2-aminoethoxy)-N-(3-chloro-2-ethoxy-5-piperidin-1-ylphenyl)-3,5-dimethylbenzamide",CKBBGCJYKCLKHE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
103739,6vxs,DB08971,-7.8,Fluocortolone,GAKMQHDJQHZUTJ-ULHLPKEOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
131757,6w4h,DB14652,-7.8,Clocortolone acetate,ARPLCFGLEYFDCN-CDACMRRYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
160854,7bv1,DB11820,-7.8,Nifurtimox,ARFHIAQFJWUCFH-IZZDOVSWSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
85375,6m3m,DB07585,-7.8,"5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine",YFFJXGRXFASBDL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
131526,6w4h,DB13856,-7.8,Fluclorolone,VTWKPILBIUBMDS-OTJLYDAYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
162530,7bv1,DB02388,-7.8,"Cyclohexyl-{4-[5-(3,4-Dichlorophenyl)-2-Piperidin-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine",UQFRSHRWRKYNDE-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
129351,6w4h,DB08697,-7.8,"4-(2-aminoethoxy)-N-(3-chloro-5-piperidin-1-ylphenyl)-3,5-dimethylbenzamide",JDYIYIRPQKMWMM-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
72692,6m2n,DB01041,-7.8,Thalidomide,UEJJHQNACJXSKW-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
71326,6lxt,DB13994,-7.8,AZD-7325,KYDURMHFWXCKMW-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
33102,6cs2,T3D4092,-7.8,Dicentrine,YJWBWQWUHVXPNC-AWEZNQCLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
82411,6m3m,DB02504,-7.8,[3-(1-Benzyl-3-Carbamoylmethyl-2-Methyl-1h-Indol-5-Yloxy)-Propyl-]-Phosphonic Acid,AQEYCNKFBRLUOT-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
131622,6w4h,DB14065,-7.8,Lomerizine,JQSAYKKFZOSZGJ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
46794,2fxp,DB00966,-7.8,Telmisartan,RMMXLENWKUUMAY-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
131764,6w4h,DB14660,-7.8,Trenbolone acetate,CMRJPMODSSEAPL-FYQPLNBISA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
58682,6crv,DB06368,-7.8,Alamifovir,VDBGPMJFHCJMOL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
129349,6w4h,DB08694,-7.8,"9-amino-5-(2-aminopyrimidin-4-yl)pyrido[3',2':4,5]pyrrolo[1,2-c]pyrimidin-4-ol",RTHKPHCVZVYDFN-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
160861,7bv1,DB11828,-7.8,Neratinib,JWNPDZNEKVCWMY-VQHVLOKHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
34005,6cs2,T3D0813,-7.8,Amygdalin,XUCIJNAGGSZNQT-SWRVSKMJSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
129267,6w4h,DB08591,-7.8,"5-(4-METHOXYBIPHENYL-3-YL)-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDE",IGXKSKWHHHYBFM-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
129799,6w4h,DB09371,-7.8,Norethynodrel,ICTXHFFSOAJUMG-SLHNCBLASA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
71296,6lxt,DB13943,-7.8,Testosterone cypionate,HPFVBGJFAYZEBE-ZLQWOROUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
85433,6m3m,DB07652,-7.8,"1-[2-DEOXYRIBOFURANOSYL]-2,4-DIFLUORO-5-METHYL-BENZENE-5'MONOPHOSPHATE",NMMWBGNJJMNAIJ-QJPTWQEYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
25981,6cs2,DB04023,-7.8,"Guanosine 5'-(Trihydrogen Diphosphate), P'-D-Mannopyranosyl Ester",DNBSDUDYNPJVCN-ZXTXFPBHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
59630,6crv,DB07694,-7.8,"2,5-dichloro-N-(3,5-dibromo-4-hydroxyphenyl)benzamide",IFLWCZRMFPKYBN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72698,6m2n,DB01048,-7.8,Abacavir,MCGSCOLBFJQGHM-SCZZXKLOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
84364,6m3m,DB05772,-7.8,Rabeximod,PDNNUMNEXITLCZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
103691,6vxs,DB08903,-7.8,Bedaquiline,QUIJNHUBAXPXFS-XLJNKUFUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
103674,6vxs,DB08873,-7.8,Boceprevir,LHHCSNFAOIFYRV-DOVBMPENSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
71823,6lxt,DB15346,-7.8,GLPG-1205,IRBAWVGZNJIROV-SFHVURJKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
104504,6vxs,DB12100,-7.8,Abediterol,SFYAXIFVXBKRPK-QFIPXVFZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
131625,6w4h,DB14068,-7.8,Dexniguldipine,SVJMLYUFVDMUHP-MGBGTMOVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
159904,7bv1,DB07061,-7.8,"1-(CYCLOHEXYLAMINO)-3-(6-METHYL-3,4-DIHYDRO-1H-CARBAZOL-9(2H)-YL)PROPAN-2-OL",AXYFCRIRLKSCRR-SFHVURJKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
17050,6cs2,HMDB0005886,-7.8,19-Noretiocholanolone,UOUIARGWRPHDBX-DHMVHTBWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
17031,6cs2,HMDB0005794,-7.8,Quercetin,REFJWTPEDVJJIY-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
105711,6vxs,DB13865,-7.8,Dehydroemetine,XXLZPUYGHQWHRN-RPBOFIJWSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
82461,6m3m,DB02568,-7.8,Peldesine,DOHVAKFYAHLCJP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
105495,6vxs,DB13579,-7.8,Mepixanox,PYSOHOOUXFWCFF-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
131759,6w4h,DB14654,-7.8,Bisoxatin acetate,ZCBJDQBSLZREAA-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
162519,7bv1,DB02375,-7.8,Myricetin,IKMDFBPHZNJCSN-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
131530,6w4h,DB13865,-7.8,Dehydroemetine,XXLZPUYGHQWHRN-RPBOFIJWSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
17068,6cs2,HMDB0006045,-7.8,Dityrosine,FHOZGLMQYMAREG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
82401,6m3m,DB02493,-7.8,Hydantocidin-5'-Phosphate,HVXIMXHBUJADCC-GTBMBKLPSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
127094,6w4h,DB04706,-7.8,"(3BETA,7BETA)-CHOLEST-5-ENE-3,7-DIOL",OYXZMSRRJOYLLO-KGZHIOMZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
57762,6crv,DB04096,-7.8,"5-Amino-5-Deoxy-Cellobiono-1,5-Lactam",WXSNJJDPPISYEF-ZNLUKOTNSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
162327,7bv1,DB01910,-7.8,Sinefungin,LMXOHSDXUQEUSF-YECHIGJVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
28711,6cs2,DB08317,-7.8,"5-methyl-6-phenylquinazoline-2,4-diamine",HUCOXWPHDFINIW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
34509,1r42,DB00444,-7.8,Teniposide,NRUKOCRGYNPUPR-QBPJDGROSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
71354,6lxt,DB14059,-7.8,SC-236,NSQNZEUFHPTJME-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
131532,6w4h,DB13867,-7.8,Fluticasone,MGNNYOODZCAHBA-GQKYHHCASA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
105505,6vxs,DB13593,-7.8,Zolimidine,VSLIUWLPFRVCDL-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
84226,6m3m,DB04975,-7.8,Banoxantrone,YZBAXVICWUUHGG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
131536,6w4h,DB13873,-7.8,Fenofibric acid,MQOBSOSZFYZQOK-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
160860,7bv1,DB11827,-7.8,Ertugliflozin,MCIACXAZCBVDEE-CUUWFGFTSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
71966,6m2n,DB00179,-7.8,Masoprocol,HCZKYJDFEPMADG-TXEJJXNPSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
84159,6m3m,DB04844,-7.8,Tetrabenazine,MKJIEFSOBYUXJB-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
17032,6cs2,HMDB0005800,-7.8,Luteolin,IQPNAANSBPBGFQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
84218,6m3m,DB04953,-7.8,Ezogabine,PCOBBVZJEWWZFR-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
27194,6cs2,DB06670,-7.8,Odanacatib,FWIVDMJALNEADT-SFTDATJTSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
104430,6vxs,DB11990,-7.8,MK-0812,UNVWTBOGMHPKJM-CWKRKGSWSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
27210,6cs2,DB00607,-7.8,Nafcillin,GPXLMGHLHQJAGZ-JTDSTZFVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
105450,6vxs,DB13514,-7.8,Pranoprofen,TVQZAMVBTVNYLA-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
17088,6cs2,HMDB0006219,-7.8,13-cis-Retinoic acid,SHGAZHPCJJPHSC-XFYACQKRSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
162462,7bv1,DB02300,-7.8,Calcipotriol,LWQQLNNNIPYSNX-UROSTWAQSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
57854,6crv,DB04213,-7.8,N-Cyclohexyl-N'-(Propyl)Phenyl Urea,HBTZVNKXMFGOOJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
11716,6lzg,DB12336,-7.8,GDC-0917,HSHPBORBOJIXSQ-HARLFGEKSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
129498,6w4h,DB08881,-7.8,Vemurafenib,GPXBXXGIAQBQNI-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
82336,6m3m,DB02410,-7.8,"2-Acetyl-3-[(4-Amino-2-Methyl-5-Pyrimidinyl)Methyl]-4-Methyl-5-(4,6,6-Trihydroxy-3,5-Dioxa-4,6-Diphosphahex-1-Yl)Thiazolium Inner Salt P,P'-Dioxide",GYRGKLZCJRVYRV-UHFFFAOYSA-O,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
129557,6w4h,DB08970,-7.8,Fluprednidene,YVHXHNGGPURVOS-SBTDHBFYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
126922,6w4h,DB04480,-7.8,"3-(4-Fluorophenyl)-2-(6-Methylpyridin-2-Yl)-5,6-Dihydro-4h-Pyrrolo[1,2-B]Pyrazole",NBDZLUOYAAVYHF-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
161007,7bv1,DB12392,-7.8,Resminostat,FECGNJPYVFEKOD-VMPITWQZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
17761,6cs2,HMDB0010345,-7.8,Aldosterone 18-glucuronide,OMRIQCUHVVBJKI-ACOLCOCVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
127541,6w4h,DB06311,-7.8,Darapladib,WDPFJWLDPVQCAJ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
85478,6m3m,DB07708,-7.8,3-CHLORO-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL,ZNHQDSBJVFFIAK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58960,6crv,DB06910,-7.8,"[4-R-(4-ALPHA,6-BETA,7-BETA]-HEXAHYDRO-5,6-DI(HYDROXY)-1,3-DI(ALLYL)-4,7-BISPHENYLMETHYL)-2H-1,3-DIAZEPINONE",IWJSQELMWLOYSO-LWSSLDFYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
18379,6cs2,HMDB0029117,-7.8,Tyrosyl-Tyrosine,JAQGKXUEKGKTKX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
84031,6m3m,DB04676,-7.8,Dansyllysine,VQPRNSWQIAHPMS-HNNXBMFYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85306,6m3m,DB07503,-7.8,"(5E)-5-[(2,2-DIFLUORO-1,3-BENZODIOXOL-5-YL)METHYLENE]-1,3-THIAZOLIDINE-2,4-DIONE",SRLVNYDXMUGOFI-YWEYNIOJSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
34593,1r42,DB00549,-7.8,Zafirlukast,YEEZWCHGZNKEEK-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
105653,6vxs,DB13788,-7.8,Chlorbenzoxamine,VEVSKUJZSMGTMM-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
129324,6w4h,DB08660,-7.8,"1,2,5,8-tetrahydroxyanthracene-9,10-dione",VBHKTXLEJZIDJF-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
161217,7bv1,DB13411,-7.8,Lofepramine,SAPNXPWPAUFAJU-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
131707,6w4h,DB14539,-7.8,Hydrocortisone acetate,ALEXXDVDDISNDU-JZYPGELDSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
103779,6vxs,DB09015,-7.8,Canrenoic acid,PBKZPPIHUVSDNM-WNHSNXHDSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
127534,6w4h,DB06292,-7.8,Dapagliflozin,JVHXJTBJCFBINQ-ADAARDCZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131916,6w4h,DB15021,-7.8,Leriglitazone,OXVFDZYQLGRLCD-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
82775,6m3m,DB02984,-7.8,"4-[3-Methylsulfanylanilino]-6,7-Dimethoxyquinazoline",FUSDVOSGGMBSMK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
33136,6cs2,T3D4177,-7.8,Pentosidine,AYEKKSTZQYEZPU-RYUDHWBXSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
162477,7bv1,DB02322,-7.8,Heparin Disaccharide I-S,LRPGJWKAYQRIAQ-GYBHJADLSA-J,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160964,7bv1,DB12325,-7.8,Idasanutlin,TVTXCJFHQKSQQM-LJQIRTBHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
58814,6crv,DB06697,-7.8,Artemether,SXYIRMFQILZOAM-HVNFFKDJSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
105391,6vxs,DB13434,-7.8,Fenticonazole,ZCJYUTQZBAIHBS-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
129138,6w4h,DB08439,-7.8,Parecoxib,TZRHLKRLEZJVIJ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
84005,6m3m,DB04640,-7.8,"Naphthalene-2,6-disulfonic acid",FITZJYAVATZPMJ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
129291,6w4h,DB08619,-7.8,Testosterone succinate,CJQNBXFUHQZFOE-VYAQIDIUSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
162161,7bv1,DB01513,-7.8,"17Alpha-methyl-3beta,17beta-dihydroxy-5alpha-androstane",QGKQXZFZOIQFBI-UYEYMFBJSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
85567,6m3m,DB07810,-7.8,"3-(4-HYDROXYPHENYL)-1-(2,4,6-TRIHYDROXYPHENYL)PROPAN-1-ONE",VGEREEWJJVICBM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58886,6crv,DB06820,-7.8,Sulconazole,AFNXATANNDIXLG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28816,6cs2,DB08436,-7.8,"8-BENZO[1,3]DIOXOL-,5-YLMETHYL-9-BUTYL-9H-",JCDXXNIRWRRGBX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
129519,6w4h,DB08916,-7.8,Afatinib,ULXXDDBFHOBEHA-CWDCEQMOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
104538,6vxs,DB12147,-7.8,Erdafitinib,OLAHOMJCDNXHFI-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
84175,6m3m,DB04866,-7.8,Halofuginone,LVASCWIMLIKXLA-CABCVRRESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
26625,6cs2,DB00546,-7.8,Adinazolam,GJSLOMWRLALDCT-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
57524,6crv,DB03781,-7.8,"2-[4-(2,4-Dichlorophenoxy)Phenoxy]Propanoic Acid",OOLBCHYXZDXLDS-SECBINFHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
160057,7bv1,DB07459,-7.8,4-PHENOXY-N-(PYRIDIN-2-YLMETHYL)BENZAMIDE,HVLSCZSVTCNAQX-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59520,6crv,DB07560,-7.8,N-[(1S)-2-methyl-1-(pyridin-4-ylcarbamoyl)propyl]cyclohexanecarboxamide,VYLDPSVXLWTIAJ-HNNXBMFYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104533,6vxs,DB12138,-7.8,PF-03715455,VGEXRDWWPSGZDH-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
6234,6lzg,DB01767,-7.8,Hemi-Babim,KKJYVDXDZURHMA-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
131741,6w4h,DB14635,-7.8,Curcumin sulfate,NEJVQQBBTRFOHB-FCXRPNKRSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131379,6w4h,DB13667,-7.8,Cefozopran,QDUIJCOKQCCXQY-WHJQOFBOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
129935,6w4h,DB11443,-7.8,Orbifloxacin,QIPQASLPWJVQMH-DTORHVGOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
57856,6crv,DB04215,-7.8,CRA_9076,BVTBOJXEAPSOEB-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
103791,6vxs,DB09038,-7.8,Empagliflozin,OBWASQILIWPZMG-QZMOQZSNSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
105791,6vxs,DB14038,-7.8,beta-Sitosterol,KZJWDPNRJALLNS-VJSFXXLFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
129152,6w4h,DB08455,-7.8,Ro 12-7310,CAAFTBWHFUPDGX-OFCLTBKTSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
59540,6crv,DB07585,-7.8,"5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine",YFFJXGRXFASBDL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59732,6crv,DB07810,-7.8,"3-(4-HYDROXYPHENYL)-1-(2,4,6-TRIHYDROXYPHENYL)PROPAN-1-ONE",VGEREEWJJVICBM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57545,6crv,DB03808,-7.8,Hexamidine,OQLKNTOKMBVBKV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72576,6m2n,DB00908,-7.8,Quinidine,LOUPRKONTZGTKE-LHHVKLHASA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
129176,6w4h,DB08485,-7.8,"(1S,4S,5S)-1,4,5-TRIHYDROXY-3-[3-(PHENYLTHIO)PHENYL]CYCLOHEX-2-ENE-1-CARBOXYLIC ACID",QMNMNSINKIFYBV-LMMKCTJWSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
162210,7bv1,DB01564,-7.8,Calusterone,IVFYLRMMHVYGJH-PVPPCFLZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59727,6crv,DB07805,-7.8,"3-CHLORO-2,2-DIMETHYL-N-[4-(TRIFLUOROMETHYL)PHENYL]PROPANAMIDE",QCQZFHOGRCQNIH-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127231,6w4h,DB04885,-7.8,Cilansetron,NCNFDKWULDWJDS-OAHLLOKOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
105667,6vxs,DB13806,-7.8,Linopirdine,YEJCDKJIEMIWRQ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
162433,7bv1,DB02049,-7.8,2-{4-[4-(4-Chloro-Phenoxy)-Benzenesulfonyl]-Tetrahydro-Pyran-4-Yl}-N-Hydroxy-Acetamide,QOPFTBAEAJQKSY-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59643,6crv,DB07708,-7.8,3-CHLORO-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL,ZNHQDSBJVFFIAK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127011,6w4h,DB04596,-7.8,"4-O-{4,6-O-[(1S)-1-Carboxyethylidene]-??-D-mannopyranosyl}-D-glucopyranuronic acid",GZJXZKGVHLWBOW-AISSFXTFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
160037,7bv1,DB07217,-7.8,"N-(3-cyano-4,5,6,7-tetrahydro-1-benzothien-2-yl)-2-fluorobenzamide",YVYPYORTKAIUGJ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
129177,6w4h,DB08486,-7.8,Efaproxiral,BNFRJXLZYUTIII-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
59559,6crv,DB07610,-7.8,"NAPHTHALENE-1,2-DIOL",NXPPAOGUKPJVDI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84324,6m3m,DB05519,-7.8,Budiodarone,ZXOSVKYCXLTVGS-KRWDZBQOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
82373,6m3m,DB02456,-7.8,Aracytidine 5'-monophosphate,IERHLVCPSMICTF-CCXZUQQUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
127492,6w4h,DB06202,-7.8,Lasofoxifene,GXESHMAMLJKROZ-IAPPQJPRSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
72009,6m2n,DB00231,-7.8,Temazepam,SEQDDYPDSLOBDC-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
105740,6vxs,DB13943,-7.8,Testosterone cypionate,HPFVBGJFAYZEBE-ZLQWOROUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
26056,6cs2,DB04115,-7.8,Berberine,YBHILYKTIRIUTE-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
72580,6m2n,DB00912,-7.8,Repaglinide,FAEKWTJYAYMJKF-QHCPKHFHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
127028,6w4h,DB04616,-7.8,TACRINE(8)-4-AMINOQUINOLINE,UNVOAAWEEGAXTN-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
72678,6m2n,DB01025,-7.8,Amlexanox,SGRYPYWGNKJSDL-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
59573,6crv,DB07625,-7.8,"4-(2-aminoethoxy)-N-(2,5-diethoxyphenyl)-3,5-dimethylbenzamide",PHTPPZCTHZHCQD-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
162430,7bv1,DB02046,-7.8,N-[(Furan-2-Yl)Carbonyl]-(S)-Leucyl-(R)-[1-Amino-2(1h-Indol-3-Yl)Ethyl]-Phosphonic Acid,WHPKSASOSKNDPY-PKOBYXMFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
27149,6cs2,DB06582,-7.8,Dextofisopam,RUJBDQSFYCKFAA-HNNXBMFYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
25946,6cs2,DB03984,-7.8,Morpholine-4-Carboxylic Acid [1-(2-Benzylsulfanyl-1-Formyl-Ethylcarbamoyl)-2-Phenyl-Ethyl]-Amide,MWTQNXVXPLTHJB-YADHBBJMSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
105426,6vxs,DB13484,-7.8,Quinbolone,IUVKMZGDUIUOCP-BTNSXGMBSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
131610,6w4h,DB14038,-7.8,beta-Sitosterol,KZJWDPNRJALLNS-VJSFXXLFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
129463,6w4h,DB08822,-7.8,Azilsartan medoxomil,QJFSABGVXDWMIW-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
127166,6w4h,DB04806,-7.8,(5-BROMO-4-CHLORO-3-INDOLYL)-A-D-MANNOSE,OPIFSICVWOWJMJ-HAAGFXOZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
57678,6crv,DB03982,-7.8,"Compound 5, 2-(Naphthalen-1-Yl-Oxalyl-Amino)-Benzoicacid",WQWCUHJIERBOSM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
159862,7bv1,DB06710,-7.8,Methyltestosterone,GCKMFJBGXUYNAG-HLXURNFRSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
162197,7bv1,DB01551,-7.8,Dihydrocodeine,RBOXVHNMENFORY-DNJOTXNNSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
82513,6m3m,DB02640,-7.8,Fumagillin,NGGMYCMLYOUNGM-CSDLUJIJSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
72572,6m2n,DB00904,-7.8,Ondansetron,FELGMEQIXOGIFQ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
131897,6w4h,DB14941,-7.8,BMS-817399,GTDPZONCGOCXOD-JPYJTQIMSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
71808,6lxt,DB15319,-7.8,VM4-037,QGYZPMXIVNIGKA-GMAHTHKFSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
131892,6w4h,DB14934,-7.8,GDC-0927,KJAAPZIFCQQQKX-NDEPHWFRSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
58903,6crv,DB06843,-7.8,"2',5'-DIDEOXY-ADENOSINE 3'-MONOPHOSPHATE",NFGZMOICZSFFLB-DSYKOEDSSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85466,6m3m,DB07695,-7.8,"N-(3,5-dibromo-4-hydroxyphenyl)-4-hydroxy-3,5-dimethylbenzamide",HHFKUQZPNITQLU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
57546,6crv,DB03809,-7.8,9-Butyl-8-(3-Methoxybenzyl)-9h-Purin-6-Amine,BWLWUGBHOXIUBP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104662,6vxs,DB12320,-7.8,Palovarotene,YTFHCXIPDIHOIA-DHZHZOJOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
58647,6crv,DB06264,-7.8,Tolperisone,FSKFPVLPFLJRQB-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
105654,6vxs,DB13790,-7.8,Fipexide,BFUJHVVEMMWLHC-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
109324,6vxx,DB13070,-7.7,Surinabant,HMXDWDSNPRNUKI-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
118932,6w4b,DB06673,-7.7,Almorexant,DKMACHNQISHMDN-RPLLCQBOSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
97333,6m71,DB14659,-7.7,Melengestrol acetate,UDKABVSQKJNZBH-DWNQPYOZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
65036,6lxt,DB02315,-7.7,Cyclic GMP,ZOOGRGPOEVQQDX-UUOKFMHZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
102952,6vxs,DB07999,-7.7,"{4-[(CARBOXYMETHOXY)CARBONYL]-3,3-DIOXIDO-1-OXONAPHTHO[1,2-D]ISOTHIAZOL-2(1H)-YL}ACETIC ACID",IXLBOIRSEDMRPI-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
97313,6m71,DB14637,-7.7,Fluprednisolone acetate,CYMBAKFTWRNHPS-APRQOCPKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
130271,6w4h,DB12022,-7.7,Evatanepag,WOHRHWDYFNWPNG-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
25583,6cs2,DB03549,-7.7,Biotinyl P-Nitroaniline,PORZMUYPQKOFQY-YDHLFZDLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
97355,6m71,DB14681,-7.7,Cortisone,MFYSYFVPBJMHGN-ZPOLXVRWSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
10195,6lzg,DB08366,-7.7,"3-({3-[(1S,4aS,6S,7S,9S,9aR)-1,6-dimethyl-2-oxodecahydro-6,9-epoxy-4a,7-methanobenzo[7]annulen-1-yl]propanoyl}amino)-2,4-dihydroxybenzoic acid",XADCWKSMHQPTGH-OFBLZTNGSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
110609,6vxx,DB02004,-7.7,"5-(Aminomethyl)-6-(2,4-Dichlorophenyl)-2-(3,5-Dimethoxyphenyl)Pyrimidin-4-Amine",RCJFINNFYUNFGH-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
146034,6w9q,DB08043,-7.7,1-[4-(PYRIDIN-4-YLOXY)PHENYL]-3-[3-(TRIFLUOROMETHYL)PHENYL]UREA,DDDLGNOZDKDSEG-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
134425,6w9c,DB03062,-7.7,(1-Methyl-1h-Imidazol-2-Yl)-(3-Methyl-4-{3-[(Pyridin-3-Ylmethyl)-Amino]-Propoxy}-Benzofuran-2-Yl)-Methanone,VZBQJKIOAOUYJL-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
119979,6w4b,DB07945,-7.7,"5-(3-carbamoylbenzyl)-5,6,7,8,9,10-hexahydrocyclohepta[b]indole-4-carboxylic acid",GKBQRPKZHUFGOB-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
104486,6vxs,DB12073,-7.7,Albaconazole,UHIXWHUVLCAJQL-MPBGBICISA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
120004,6w4b,DB07974,-7.7,1-{2-[(4-CHLOROPHENYL)AMINO]-2-OXOETHYL}-N-(1-ISOPROPYLPIPERIDIN-4-YL)-1H-INDOLE-2-CARBOXAMIDE,BDLMBQRBNPDCSS-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
65069,6lxt,DB02358,-7.7,LY374571,SZHRIPFGZWWRKW-VIFPVBQESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
134414,6w9c,DB03046,-7.7,7-Methoxy-8-[1-(Methylsulfonyl)-1h-Pyrazol-4-Yl]Naphthalene-2-Carboximidamide,KQUXAFOLFXHVQN-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
110577,6vxx,DB01959,-7.7,"3,5-Dimethyl-1-(3-Nitrophenyl)-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester",MSYGAHOHLUJIKV-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
64270,6lxt,DB01264,-7.7,Darunavir,CJBJHOAVZSMMDJ-HEXNFIEUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
110621,6vxx,DB02020,-7.7,Alrestatin,GCUCIFQCGJIRNT-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
118962,6w4b,DB06718,-7.7,Stanozolol,LKAJKIOFIWVMDJ-IYRCEVNGSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
110662,6vxx,DB02075,-7.7,"(1s)-1(9-Deazahypoxanthin-9yl)1,4-Dideoxy-1,4-Imino-D-Ribitol-5-Phosphate",VJTAXXUIRYOXBT-KUBHLMPHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
129659,6w4h,DB09124,-7.7,Medrogestone,HCFSGRMEEXUOSS-JXEXPEPMSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
110664,6vxx,DB02077,-7.7,L-N(omega)-Nitroarginine-(4R)-Amino-L-Proline Amide,IUFRDGFKAVLPFZ-CSMHCCOUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130289,6w4h,DB12050,-7.7,LY-3039478,YCBAQKQAINQRFW-UGSOOPFHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
65042,6lxt,DB02322,-7.7,Heparin Disaccharide I-S,LRPGJWKAYQRIAQ-GYBHJADLSA-J,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
95963,6m71,DB12206,-7.7,N-6022,YVPGZQLRPAGKLA-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
118986,6w4b,DB06755,-7.7,Beta carotene,OENHQHLEOONYIE-JLTXGRSLSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
145697,6w9q,DB07653,-7.7,"N-(5,6-DIPHENYLFURO[2,3-D]PYRIMIDIN-4-YL)GLYCINE",VXTCEUDVOCLEJG-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
104491,6vxs,DB12081,-7.7,Anecortave,BCFCRXOJOFDUMZ-ONKRVSLGSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
129563,6w4h,DB08976,-7.7,Floctafenine,APQPGQGAWABJLN-GFCCVEGCSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
58843,6crv,DB06736,-7.7,Aceclofenac,MNIPYSSQXLZQLJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
95780,6m71,DB11934,-7.7,Epelsiban,UWHCWRQFNKUYCG-QUZACWSFSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
146283,6w9q,DB08345,-7.7,"4-(2-(1H-IMIDAZOL-4-YL)ETHYLAMINO)-2-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE",IWUUKHQIKFHWIW-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
60274,6crv,DB08451,-7.7,N-(QUINOLIN-8-YL)METHANESULFONAMIDE,XYEPUTZVZYUENX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130339,6w4h,DB12122,-7.7,Figopitant,HUTHJVYJUPXHDF-DEOSSOPVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
118735,6w4b,DB06178,-7.7,Talotrexin,NYQPLPNEESYGNO-IBGZPJMESA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
110929,6vxx,DB02593,-7.7,"7,8-Dihydroxy-1-Methoxy-3-Methyl-10-Oxo-4,10-Dihydro-1h,3h-Pyrano[4,3-B]Chromene-9-Carboxylic Acid",RSFJMLCZHPZXCW-AANKLQPISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
146251,6w9q,DB08304,-7.7,"(3R)-3-cyclopentyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2-benzothiazine 1,1-dioxide",QZBQVXXESPXFPZ-QGZVFWFLSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
130337,6w4h,DB12120,-7.7,Avoralstat,TUWMKPVJGGWGNL-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
120115,6w4b,DB08100,-7.7,"2,6-dimethyl-4-[(E)-2-phenylethenyl]phenol",PAHKYLUYTGBFNW-CMDGGOBGSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
9633,6lzg,DB07751,-7.7,"(2S)-1-[4-({6-[(2,6-Difluorophenyl)amino]-4-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol",ZVSBKYYVBCKDBO-HNNXBMFYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
130326,6w4h,DB12106,-7.7,PF-06305591,APWZIFIAVVFPNT-PELKAZGASA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
95801,6m71,DB11962,-7.7,GSK-1059615,QDITZBLZQQZVEE-YBEGLDIGSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110900,6vxx,DB02550,-7.7,"8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-2-Fluoro-9-Pent-4-Ylnyl-9h-Purin-6-Ylamine",KCIOVTSUEXGUFJ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
146210,6w9q,DB08248,-7.7,3-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)-BENZENESULFONAMIDE,BKDUVKJYBJDZQW-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
109154,6vxx,DB12445,-7.7,Nitroaspirin,IOJUJUOXKXMJNF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
97425,6m71,DB14862,-7.7,PF-06815345,QTBYVAZRKWOIDU-FUHWJXTLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
54592,2fxp,DB15328,-7.7,Ubrogepant,DDOOFTLHJSMHLN-ZQHRPCGSSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
110990,6vxx,DB02848,-7.7,"{4-[3-(6,7-Diethoxy-Quinazolin-4-Ylamino)-Phenyl]-Thiazol-2-Yl}-Methanol",ZJESXGUODSBHSK-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
133519,6w9c,DB01791,-7.7,Piclamilast,RRRUXBQSQLKHEL-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
97438,6m71,DB14885,-7.7,PF-05180999,CLGCHUKGBICQTE-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97445,6m71,DB14899,-7.7,Tavapadon,AKQXQLUNFKDZBN-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
134580,6w9c,DB03258,-7.7,2'-Deoxycytidine 5'-triphosphate,RGWHQCVHVJXOKC-SHYZEUOFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
118637,6w4b,DB05608,-7.7,MKC-1,OVSKGTONMLKNPZ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
64163,6lxt,DB01136,-7.7,Carvedilol,OGHNVEJMJSYVRP-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
130369,6w4h,DB12165,-7.7,Presatovir,GOFXWTVKPWJNGD-UWJYYQICSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
109119,6vxx,DB12401,-7.7,Bromperidol,RKLNONIVDFXQRX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
146320,6w9q,DB08389,-7.7,"6,7-DIMETHOXY-4-[(3R)-3-(2-NAPHTHYLOXY)PYRROLIDIN-1-YL]QUINAZOLINE",UPTQSRGSSJRBKJ-LJQANCHMSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
95757,6m71,DB11899,-7.7,MK-8776,GMIZZEXBPRLVIV-SECBINFHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
64165,6lxt,DB01138,-7.7,Sulfinpyrazone,MBGGBVCUIVRRBF-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
133411,6w9c,DB01645,-7.7,Genistein,TZBJGXHYKVUXJN-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
10316,6lzg,DB08499,-7.7,"N-[3-(2-fluoroethoxy)phenyl]-N'-(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-6-yl)butanediamide",DQXBKUVWJSZHSI-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
111044,6vxx,DB02918,-7.7,Zardaverine,HJMQDJPMQIHLPB-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
64167,6lxt,DB01140,-7.7,Cefadroxil,BOEGTKLJZSQCCD-UEKVPHQBSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
133420,6w9c,DB01659,-7.7,"3-(1,10-Phenanthrol-2-Yl)-L-Alanine",LODBCIBKOKOGNL-LBPRGKRZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
104248,6vxs,DB11725,-7.7,Latrepirdine,JNODQFNWMXFMEV-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
111034,6vxx,DB02905,-7.7,"Phosphoric Acid Mono-[3,4-Dihydroxy-5-(5-Hydroxy-Benzoimidazol-1-Yl)Tetrahydro-Furan-2-Ylmethyl] Ester",BVZASCINAVSQNO-PULFBKJNSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60535,6crv,DB08760,-7.7,(2S)-2-(4-chlorophenoxy)-3-phenylpropanoic acid,CPBLTMSKPQDJPW-AWEZNQCLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
134563,6w9c,DB03239,-7.7,"3',5'-Dinitro-N-Acetyl-L-Thyronine",VZSQTOXQXPKQJX-ZDUSSCGKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
64194,6lxt,DB01172,-7.7,Kanamycin,SBUJHOSQTJFQJX-NOAMYHISSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
9612,6lzg,DB07728,-7.7,"2-[2-(2-FLUOROPHENYL)PYRIDIN-4-YL]-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE",XJJYJNMNYDNXNO-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
111008,6vxx,DB02872,-7.7,"Cis-[4,5-Bis-(4-Bromophenyl)-2-(2-Ethoxy-4-Methoxyphenyl)-4,5-Dihydroimidazol-1-Yl]-[4-(2-Hydroxyethyl)Piperazin-1-Yl]Methanone",PVRYEWOXWGDQHA-URLMMPGGSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
118798,6w4b,DB06314,-7.7,SGX-523,BCZUAADEACICHN-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
97422,6m71,DB14857,-7.7,Avadomide,RSNPAKAFCAAMBH-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95825,6m71,DB12000,-7.7,Apabetalone,NETXMUIMUZJUTB-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
104512,6vxs,DB12112,-7.7,Zuretinol acetate,QGNJRVVDBSJHIZ-AQDFTDIISA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
110737,6vxx,DB02350,-7.7,"N-Hydroxy-4-[(4-Methoxylphenyl)Sulfonyl]-2,2-Dimethyl-Hexahydro-1,4-Thiazepine-3(S)-Carboxamide",CYYCSKFJEOSZTF-CYBMUJFWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130304,6w4h,DB12072,-7.7,Orantinib,NHFDRBXTEDBWCZ-ZROIWOOFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
102714,6vxs,DB07724,-7.7,Indeglitazar,YMPALHOKRBVHOJ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
110712,6vxx,DB02135,-7.7,"4-{2,6,8-Trioxo-9-[(2R,3S,4R)-2,3,4,5-Tetrahydroxypentyl]-1,2,3,6,8,9-Hexahydro-7h-Purin-7-Yl}Butyl Dihydrogen Phosphate",VBXZSBKAJFXURR-MRTMQBJTSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130302,6w4h,DB12070,-7.7,Letermovir,FWYSMLBETOMXAG-QHCPKHFHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
9681,6lzg,DB07801,-7.7,N-butyl-3-{[6-(9H-purin-6-ylamino)hexanoyl]amino}benzamide,WOYITRCGMUXUDE-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
104263,6vxs,DB11745,-7.7,Otenabant,UNAZAADNBYXMIV-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
97391,6m71,DB14774,-7.7,Balipodect,KVHRYLNQDWXAGI-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95948,6m71,DB12183,-7.7,Sapitinib,DFJSJLGUIXFDJP-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
146058,6w9q,DB08073,-7.7,(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE,YWTBGJGMTBHQTM-IBGZPJMESA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
145189,6w9q,DB07061,-7.7,"1-(CYCLOHEXYLAMINO)-3-(6-METHYL-3,4-DIHYDRO-1H-CARBAZOL-9(2H)-YL)PROPAN-2-OL",AXYFCRIRLKSCRR-SFHVURJKSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
110679,6vxx,DB02096,-7.7,FR221647,ZUYUIKKHHBEVHL-GFCCVEGCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
102728,6vxs,DB07742,-7.7,"N-(2,3-DIFLUORO-BENZYL)-4-SULFAMOYL-BENZAMIDE",QASSMVGOSBNFQY-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
9687,6lzg,DB07806,-7.7,"(2R,4S)-2-[(R)-BENZYLCARBAMOYL-PHENYLACETYL-METHYL]-5,5-DIMETHYL-THIAZOLIDINE-4-CARBOXYLIC ACID",UDMBRVGTYILYDX-SVFBPWRDSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
110668,6vxx,DB02081,-7.7,Bis-Benzamidine,BXYGSMRTHHSAHZ-PMACEKPBSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
12034,6lzg,DB12781,-7.7,Balaglitazone,IETKPTYAGKZLKY-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
145193,6w9q,DB07066,-7.7,"2-CHLORO-N-[(3R)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL]-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE",LJAHIGGEXIWVJG-LLVKDONJSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
120014,6w4b,DB07986,-7.7,[4-(4-PHENYL-PIPERIDIN-1-YL)-BENZENESULFONYLAMINO]-ACETIC ACID,GNSLACGSDSJAIQ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
97399,6m71,DB14793,-7.7,RO-5045337,QBGKPEROWUKSBK-QPPIDDCLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
58855,6crv,DB06755,-7.7,Beta carotene,OENHQHLEOONYIE-JLTXGRSLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
95907,6m71,DB12120,-7.7,Avoralstat,TUWMKPVJGGWGNL-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
109233,6vxx,DB12930,-7.7,Opipramol,YNZFUWZUGRBMHL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
133531,6w9c,DB01809,-7.7,"1-Ter-Butyl-3-P-Tolyl-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine",ZVPDNRVYHLRXLX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
120107,6w4b,DB08092,-7.7,3-fluoro-N-1H-indol-5-yl-5-morpholin-4-ylbenzamide,VMLSXFMXUNVCSK-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
13567,6lzg,DB01238,-7.7,Aripiprazole,CEUORZQYGODEFX-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
146165,6w9q,DB08191,-7.7,"4-(5-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl)benzoic acid",KSFDVNIKNYXUIP-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
95864,6m71,DB12058,-7.7,Recoflavone,BCPQOBQIVJZOFL-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
134528,6w9c,DB03200,-7.7,7-Alpha-D-Ribofuranosyl-Purine-5'-Phosphate,NICKPTPNIMHUHB-DQUBFYRCSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
146133,6w9q,DB08154,-7.7,3-chloro-5-[2-chloro-5-(1H-indazol-3-ylmethoxy)phenoxy]benzonitrile,WHCLIFOVZDANCU-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
97409,6m71,DB14828,-7.7,ABX-464,OZOGDCZJYVSUBR-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95870,6m71,DB12066,-7.7,Orteronel,OZPFIJIOIVJZMN-SFHVURJKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
7708,6lzg,DB04244,-7.7,(2R)-2-(3-Biphenylyl)-N-{(2R)-2-hydroxy-3-[(2-pyridinylsulfonyl)amino]propyl}-4-methylpentanamide,YCDHZDINQZLSRR-DNQXCXABSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
146117,6w9q,DB08137,-7.7,(4E)-N-(4-fluorophenyl)-4-[(phenylcarbonyl)imino]-4H-pyrazole-3-carboxamide,ZMWYSLJBNJUCRK-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
25577,6cs2,DB00425,-7.7,Zolpidem,ZAFYATHCZYHLPB-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
118860,6w4b,DB06497,-7.7,Aplaviroc,GWNOTCOIYUNTQP-FQLXRVMXSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
134480,6w9c,DB03133,-7.7,"2-(Beta-D-Glucopyranosyl)-5-Methyl-1,2,3-Benzimidazole",XIJZORUYQZBFJK-UJPOAAIJSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
118870,6w4b,DB06525,-7.7,Ganstigmine,ZOBDWFRKFSPCRB-UNMCSNQZSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
95903,6m71,DB12114,-7.7,Poziotinib,LPFWVDIFUFFKJU-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95904,6m71,DB12115,-7.7,AZD-9164,FNYFFCOCVNTJCD-NNMXADRKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
130310,6w4h,DB12081,-7.7,Anecortave,BCFCRXOJOFDUMZ-ONKRVSLGSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130305,6w4h,DB12073,-7.7,Albaconazole,UHIXWHUVLCAJQL-MPBGBICISA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
58853,6crv,DB06751,-7.7,Drotaverine,OMFNSKIUKYOYRG-MOSHPQCFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
10282,6lzg,DB08463,-7.7,(2R)-2-({9-(1-methylethyl)-6-[(4-pyridin-2-ylbenzyl)amino]-9H-purin-2-yl}amino)butan-1-ol,HOCBJBNQIQQQGT-LJQANCHMSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
109338,6vxx,DB13435,-7.7,Endralazine,ALAXZYHFVBSJKZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
129771,6w4h,DB09291,-7.7,Rolapitant,FIVSJYGQAIEMOC-ZGNKEGEESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
104482,6vxs,DB12068,-7.7,T-900607,FSXLOWIFSZNIMV-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
109961,6vxx,DB00641,-7.7,Simvastatin,RYMZZMVNJRMUDD-HGQWONQESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
129912,6w4h,DB11398,-7.7,Diclazuril,ZSZFUDFOPOMEET-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
96532,6m71,DB13062,-7.7,ME-344,QVCAATSEPLQVBX-FPOVZHCZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
129916,6w4h,DB11410,-7.7,Fenbendazole,HDDSHPAODJUKPD-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
133960,6w9c,DB02390,-7.7,5-Bromo-N[2-(Dimethylamino)Ethyl]-9-Aminoacridine-4-Carboxamide,NROQPXQSDDINMC-UHFFFAOYSA-P,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
64732,6lxt,DB01910,-7.7,Sinefungin,LMXOHSDXUQEUSF-YECHIGJVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
64725,6lxt,DB01895,-7.7,Aspartyl-Adenosine-5'-Monophosphate,QPBSGQWTJLPZNF-VWJPMABRSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
146334,6w9q,DB08406,-7.7,"[N-(2,4-DIAMINOPTERIDIN-6-YL)-METHYL]-DIBENZ[B,F]AZEPINE",NXCCIJQEAKMFGW-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
97063,6m71,DB13816,-7.7,Aspoxicillin,BHELIUBJHYAEDK-OAIUPTLZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
119484,6w4b,DB07360,-7.7,"1-{5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)ethyl]-1,3-thiazol-2-yl}-3-[3-(trifluoromethyl)phenyl]urea",JJHXPDTVQKWKHA-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
64478,6lxt,DB01569,-7.7,Formebolone,AMVODTGMYSRMNP-GNIMZFFESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
119485,6w4b,DB07362,-7.7,"1-(5-{2-[(1-methyl-1H-pyrazolo[4,3-d]pyrimidin-7-yl)amino]ethyl}-1,3-thiazol-2-yl)-3-[3-(trifluoromethyl)phenyl]urea",UOLCZAFAGDOUFX-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
109947,6vxx,DB00624,-7.7,Testosterone,MUMGGOZAMZWBJJ-DYKIIFRCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
119780,6w4b,DB07716,-7.7,"(4Z)-2,8:7,12:11,15:14,18:17,22-PENTAANHYDRO-4,5,6,9,10,13,19,20,21-NONADEOXY-D-ARABINO-D-ALLO-D-ALLO-DOCOSA-4,9,20-TRIENITOL",VDRIXSJOPKVWKM-HXGIDPQASA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
59018,6crv,DB06982,-7.7,(2S)-8-[(tert-butoxycarbonyl)amino]-2-(1H-indol-3-yl)octanoic acid,AWVCKFLATUTBCX-INIZCTEOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130035,6w4h,DB11675,-7.7,Mosapride,YPELFRMCRYSPKZ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
9941,6lzg,DB08080,-7.7,LATRUNCULIN B,NSHPHXHGRHSMIK-JRIKCGFMSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
130027,6w4h,DB11665,-7.7,BMS-690514,CSGQVNMSRKWUSH-IAGOWNOFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
119768,6w4b,DB07702,-7.7,17alpha-Estriol,PROQIPRRNZUXQM-PNVOZDDCSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
109916,6vxx,DB00587,-7.7,Cinalukast,BZMKNPGKXJAIDV-VAWYXSNFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
97050,6m71,DB13797,-7.7,Iodocholesterol (131I),FIOAEFCJGZJUPW-ODFYUTSGSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
109979,6vxx,DB00665,-7.7,Nilutamide,XWXYUMMDTVBTOU-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
54363,2fxp,DB14850,-7.7,Deleobuvir,BMAIGAHXAJEULY-UKTHLTGXSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
119425,6w4b,DB07296,-7.7,(5Z)-3-(4-CHLOROPHENYL)-4-HYDROXY-5-(1-NAPHTHYLMETHYLENE)FURAN-2(5H)-ONE,PLGHLEBIWUQEPR-PDGQHHTCSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
134278,6w9c,DB02861,-7.7,"4-(Aminosulfonyl)-N-[(3,4,5-Trifluorophenyl)Methyl]-Benzamide",DEHMSTGBNAXEGX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
133907,6w9c,DB02316,-7.7,"1-(5-Carboxypentyl)-5-[(2,6-Dichlorobenzyl)Oxy]-1 H-Indole-2-Carboxylic Acid",JTGPYFFQVOIJKR-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
64424,6lxt,DB01513,-7.7,"17Alpha-methyl-3beta,17beta-dihydroxy-5alpha-androstane",QGKQXZFZOIQFBI-UYEYMFBJSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
97105,6m71,DB13872,-7.7,Lormetazepam,FJIKWRGCXUCUIG-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
119388,6w4b,DB07256,-7.7,"3-({4-[(5-CHLORO-1,3-BENZODIOXOL-4-YL)AMINO]PYRIMIDIN-2-YL}AMINO)BENZAMIDE",ZVQZIVCQLFGXFZ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
110050,6vxx,DB00749,-7.7,Etodolac,NNYBQONXHNTVIJ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110048,6vxx,DB00745,-7.7,Modafinil,YFGHCGITMMYXAQ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
64814,6lxt,DB02019,-7.7,Acetyl Dithranol,IXLRLZOYKJERRA-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
130093,6w4h,DB11764,-7.7,Spebrutinib,KXBDTLQSDKGAEB-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
26417,6cs2,DB04552,-7.7,Niflumic acid,JZFPYUNJRRFVQU-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
130083,6w4h,DB11748,-7.7,Benfotiamine,BTNNPSLJPBRMLZ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
64494,6lxt,DB01591,-7.7,Solifenacin,FBOUYBDGKBSUES-VXKWHMMOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
130082,6w4h,DB11745,-7.7,Otenabant,UNAZAADNBYXMIV-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
25525,6cs2,DB03472,-7.7,Cyclohexyl-Hexyl-Beta-D-Maltoside,WUCWJXGMSXTDAV-QKMCSOCLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
119401,6w4b,DB07271,-7.7,"4-[(3R)-3-Amino-4-(2,4,5-trifluorophenyl)butanoyl]-3-(2,2,2-trifluoroethyl)-1,4-diazepan-2-one",RMDAPSXWBVPVOG-IAPIXIRKSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
145487,6w9q,DB07405,-7.7,"1-(6-CYANO-3-PYRIDYLCARBONYL)-5',8'-DIFLUOROSPIRO[PIPERIDINE-4,2'(1'H)-QUINAZOLINE]-4'-AMINE",GIZYIOOBBUHOBS-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
96454,6m71,DB12941,-7.7,ODM-201,BLIJXOOIHRSQRB-PXYINDEMSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110016,6vxx,DB00708,-7.7,Sufentanil,GGCSSNBKKAUURC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109998,6vxx,DB00688,-7.7,Mycophenolate mofetil,RTGDFNSFWBGLEC-SYZQJQIISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
9920,6lzg,DB08056,-7.7,"N-(2,6-dimethylphenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine",KKYYLKPGILUPOA-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
97102,6m71,DB13867,-7.7,Fluticasone,MGNNYOODZCAHBA-GQKYHHCASA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97101,6m71,DB13866,-7.7,Etynodiol,JYILPERKVHXLNF-QMNUTNMBSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
64435,6lxt,DB01526,-7.7,4-Androstenediol,BTTWKVFKBPAFDK-LOVVWNRFSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
96430,6m71,DB12904,-7.7,ZSTK-474,HGVNLRPZOWWDKD-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
134031,6w9c,DB02479,-7.7,(R)-N-(3-Indol-1-Yl-2-Methyl-Propyl)-4-Sulfamoyl-Benzamide,ZFWHOUCRVSOZJE-CQSZACIVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
145577,6w9q,DB07512,-7.7,7-[(3-CHLOROBENZYL)OXY]-2-OXO-2H-CHROMENE-4-CARBALDEHYDE,ZOCADHRNWNJARU-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
104385,6vxs,DB11921,-7.7,Deflazacort,FBHSPRKOSMHSIF-GRMWVWQJSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
145621,6w9q,DB07563,-7.7,"1-{7-cyclohexyl-6-[4-(4-methylpiperazin-1-yl)benzyl]-7H-pyrrolo[2,3-d]pyrimidin-2-yl}methanamine",GCJSOJRPNOWSEH-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
60434,6crv,DB08645,-7.7,"6-CHLORO-3-(DICHLOROMETHYL)-3,4-DIHYDRO-2H-1,2,4-BENZOTHIADIAZINE-7-SULFONAMIDE 1,1-DIOXIDE",LMJSLTNSBFUCMU-MRVPVSSYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
96980,6m71,DB13708,-7.7,Fenquizone,DBDTUXMDTSTPQZ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
134131,6w9c,DB02607,-7.7,Adenosine Phosphonoacetic Acid,KJNLSEOJEFDELT-JJNLEZRASA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
49957,2fxp,DB05984,-7.7,RAF-265,YABJJWZLRMPFSI-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
96767,6m71,DB13418,-7.7,Moxestrol,MTMZZIPTQITGCY-OLGWUGKESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
134183,6w9c,DB02675,-7.7,(4-Hydroxymaltosephenyl)Glycine,PHPOPZGUOBMSPZ-QHJSCRBTSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
10002,6lzg,DB08142,-7.7,AT-7519,OVPNQJVDAFNBDN-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
96792,6m71,DB13451,-7.7,Tioclomarol,WRGOVNKNTPWHLZ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
119629,6w4b,DB07534,-7.7,"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE",BKUMVXIXUVYKDQ-GHXNOFRVSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
64633,6lxt,DB01771,-7.7,CRA_10991,QXAURVOBXQBPAP-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
64612,6lxt,DB01745,-7.7,N-Alpha-(2-Naphthylsulfonyl)-N(3-Amidino-L-Phenylalaninyl)Isopipecolinic Acid Methyl Ester,JJLGQWCKMHPBEB-DEOSSOPVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
119632,6w4b,DB07537,-7.7,"N'-(6-aminopyridin-3-yl)-N-(2-cyclopentylethyl)-4-methyl-benzene-1,3-dicarboxamide",CLEGTVIMOPPIBR-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
109717,6vxx,DB15201,-7.7,Norbixin,ZVKOASAVGLETCT-UOGKPENDSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
134144,6w9c,DB02623,-7.7,Aminophosphonic Acid-Guanylate Ester,ZGPDMUBRWRJAQQ-UUOKFMHZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
109676,6vxx,DB15117,-7.7,Transfluthrin,DDVNRFNDOPPVQJ-HQJQHLMTSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109647,6vxx,DB15058,-7.7,Flutemetamol,VVECGOCJFKTUAX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
64567,6lxt,DB01685,-7.7,Topiroxostat,UBVZQGOVTLIHLH-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
129941,6w4h,DB11455,-7.7,Robenacoxib,ZEXGDYFACFXQPF-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
145688,6w9q,DB07644,-7.7,"5-[(1S)-1-(3-chlorophenyl)ethoxy]quinazoline-2,4-diamine",IDHINEMSCUFEIP-VIFPVBQESA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
10082,6lzg,DB00171,-7.7,ATP,ZKHQWZAMYRWXGA-KQYNXXCUSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
10068,6lzg,DB08213,-7.7,"1-METHYL-5-(2-PHENOXYMETHYL-PYRROLIDINE-1-SULFONYL)-1H-INDOLE-2,3-DIONE",PFAYCUAUBOGVDX-AWEZNQCLSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
10090,6lzg,DB08239,-7.7,"(2S)-4-(2,5-DIFLUOROPHENYL)-N-METHYL-2-PHENYL-N-PIPERIDIN-4-YL-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDE",NKLVBHMAIMEVEH-QFIPXVFZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
133904,6w9c,DB02310,-7.7,"3,5,6,8-Tetramethyl-N-Methyl Phenanthrolinium",FQTUZNACZKILMC-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
60433,6crv,DB08644,-7.7,{1-[2-(1-FORMYL-PROPYL)-3-METHANESULFONYLAMINO-PYRROLIDINE-1-CARBONYL]-2-METHYL-PROPYL}-CARBAMIC ACID TERT-BUTYL ESTER,NOWIRVOXJOWTSQ-FXUDXRNXSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
9987,6lzg,DB08126,-7.7,"3-{[4-([AMINO(IMINO)METHYL]AMINOSULFONYL)ANILINO]METHYLENE}-2-OXO-2,3-DIHYDRO-1H-INDOLE",DMCRNUMVSATRTP-LCYFTJDESA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
134268,6w9c,DB02848,-7.7,"{4-[3-(6,7-Diethoxy-Quinazolin-4-Ylamino)-Phenyl]-Thiazol-2-Yl}-Methanol",ZJESXGUODSBHSK-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
119524,6w4b,DB07409,-7.7,"(1-HYDROXY-1-PHOSPHONO-2-[1,1';4',1'']TERPHENYL-3-YL-ETHYL)-PHOSPHONIC ACID",MPBUFKZCEBTBSK-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
96588,6m71,DB13158,-7.7,Clobetasone,XXIFVOHLGBURIG-OZCCCYNHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
119525,6w4b,DB07410,-7.7,[2-(3-DIBENZOFURAN-4-YL-PHENYL)-1-HYDROXY-1-PHOSPHONO-ETHYL]-PHOSPHONIC ACID,BYVXAUZOTGITQZ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
119765,6w4b,DB07698,-7.7,"3-(3-aminophenyl)-N-(3-chlorophenyl)pyrazolo[1,5-a]pyrimidin-5-amine",JDNMRPIWJIDDAY-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
96626,6m71,DB13230,-7.7,Gestonorone,GTFUITFQDGVJSK-XGXHKTLJSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
145583,6w9q,DB07519,-7.7,"(6R)-2-amino-6-[2-(3'-methoxybiphenyl-3-yl)ethyl]-3,6-dimethyl-5,6-dihydropyrimidin-4(3H)-one",VDFBMQAUECXNKR-OAQYLSRUSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
145590,6w9q,DB07528,-7.7,3-(2-aminoquinazolin-6-yl)-4-methyl-1-[3-(trifluoromethyl)phenyl]pyridin-2(1H)-one,HXUZQEYFKAZBPX-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
9955,6lzg,DB08096,-7.7,"8-(2-CHLOROPHENYLAMINO)-2-(2,6-DIFLUOROPHENYLAMINO)-9-ETHYL-9H-PURINE-1,7-DIIUM",ZWKOUFZHPNIQSH-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
102771,6vxs,DB07791,-7.7,4-{[4-(1-CYCLOPROPYL-2-METHYL-1H-IMIDAZOL-5-YL)PYRIMIDIN-2-YL]AMINO}-N-METHYLBENZENESULFONAMIDE,MZWCVBFANHIPTJ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
129949,6w4h,DB11466,-7.7,Tepoxalin,XYKWNRUXCOIMFZ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
10125,6lzg,DB08285,-7.7,"(2R)-2-{[4-(benzylamino)-8-(1-methylethyl)pyrazolo[1,5-a][1,3,5]triazin-2-yl]amino}butan-1-ol",SQUNOCMDMIQIQK-OAHLLOKOSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
102772,6vxs,DB07792,-7.7,"(S)-2-CHLORO-N-(1-(2-(2-HYDROXYETHYLAMINO)-2-OXOETHYL)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL)-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE",VUKPNWLGSLOHIF-AWEZNQCLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
54343,2fxp,DB14792,-7.7,AZD-5991,KBQCEQAXHPIRTF-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
109872,6vxx,DB00535,-7.7,Cefdinir,RTXOFQZKPXMALH-GHXIOONMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104403,6vxs,DB11948,-7.7,Lapachone,QZPQTZZNNJUOLS-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
96679,6m71,DB13308,-7.7,Oxametacin,AJRNYCDWNITGHF-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96681,6m71,DB13310,-7.7,Ormeloxifene,XZEUAXYWNKYKPL-WDYNHAJCSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
109549,6vxx,DB14093,-7.7,"(1,2,6,7-3H)Testosterone",MUMGGOZAMZWBJJ-JQSYSRDDSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58963,6crv,DB06913,-7.7,"(2R,3R)-3-{[3,5-BIS(TRIFLUOROMETHYL)PHENYL]AMINO}-2-CYANO-3-THIOXOPROPANAMIDE",ZTUMRSFHUOBXAC-LHIURRSHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
26451,6cs2,DB04590,-7.7,(2R)-({4-[AMINO(IMINO)METHYL]PHENYL}AMINO){5-ETHOXY-2-FLUORO-3-[(3R)-TETRAHYDROFURAN-3-YLOXY]PHENYL}ACETICACID,PGYOHIAQCFZQDK-AUUYWEPGSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
109828,6vxx,DB00304,-7.7,Desogestrel,RPLCPCMSCLEKRS-BPIQYHPVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
96641,6m71,DB13252,-7.7,Tropatepine,JOQKFRLFXDPXHX-HDICACEKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
9710,6lzg,DB07830,-7.7,"(4R,5R)-5-AMINO-1-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN-2-ONE",DIRIFWIKLRTNMB-DYVFJYSZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
59033,6crv,DB06998,-7.7,"[(5R)-5-(2,3-dibromo-5-ethoxy-4-hydroxybenzyl)-4-oxo-2-thioxo-1,3-thiazolidin-3-yl]acetic acid",ABQHPGHMYXJJIV-MRVPVSSYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
119377,6w4b,DB07245,-7.7,6-[2-(3'-METHOXYBIPHENYL-3-YL)ETHYL]PYRIDIN-2-AMINE,AEVBKBAFFJKFJZ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
110421,6vxx,DB01572,-7.7,Methyl-1-testosterone,JRNSSSJKIGAFCT-YDSAWKJFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
96133,6m71,DB12436,-7.7,Vofopitant,XILNRORTJVDYRH-HKUYNNGSSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59080,6crv,DB07050,-7.7,"5-[(phenylsulfonyl)amino]-1,3,4-thiadiazole-2-sulfonamide",PWDGTQXZLNDOKS-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
145870,6w9q,DB07856,-7.7,6-{4-[4-(4-CHLOROPHENYL)PIPERIDIN-4-YL]PHENYL}-9H-PURINE,HPWBHQIUIBFTQC-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
130202,6w4h,DB11919,-7.7,6-O-benzylguanine,KRWMERLEINMZFT-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
96147,6m71,DB12459,-7.7,Belotecan,LNHWXBUNXOXMRL-VWLOTQADSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
145861,6w9q,DB07845,-7.7,"2-fluoro-6-{[2-({2-methoxy-4-[(methylsulfonyl)methyl]phenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide",VGYXXQRDIVRILX-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
12533,6lzg,DB13490,-7.7,Hidrosmin,XYFLWVOTXWXNAM-WTNNCJBMSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
59076,6crv,DB07046,-7.7,"2-[(2-chloro-4-iodophenyl)amino]-N-{[(2R)-2,3-dihydroxypropyl]oxy}-3,4-difluorobenzamide",FCADPEDUULETPK-SECBINFHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
119686,6w4b,DB07605,-7.7,"2-({4-[(5-CHLORO-1H-INDOL-2-YL)SULFONYL]PIPERAZIN-1-YL}CARBONYL)THIENO[3,2-B]PYRIDINE 4-OXIDE",DHDQMXPAANQKDC-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
145859,6w9q,DB07843,-7.7,5-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1-BENZOTHIOPHENE-2-SULFONAMIDE,LTJNKFUIOOJXNJ-WFASDCNBSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
110379,6vxx,DB01530,-7.7,"5alpha-androstane-3alpha,17beta-diol",CBMYJHIOYJEBSB-KHOSGYARSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
119881,6w4b,DB07830,-7.7,"(4R,5R)-5-AMINO-1-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN-2-ONE",DIRIFWIKLRTNMB-DYVFJYSZSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
64968,6lxt,DB02224,-7.7,Taxifolin,CXQWRCVTCMQVQX-LSDHHAIUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
110339,6vxx,DB01481,-7.7,1-Testosterone,OKJCFMUGMSVJBG-ABEVXSGRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
145344,6w9q,DB07245,-7.7,6-[2-(3'-METHOXYBIPHENYL-3-YL)ETHYL]PYRIDIN-2-AMINE,AEVBKBAFFJKFJZ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
119191,6w4b,DB07029,-7.7,"4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMIDAZOL-1-YL)PHENOXY]-6-METHYLPYRIMIDINE",QQBNDYARFVOEGW-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
96170,6m71,DB12492,-7.7,Piritramide,IHEHEFLXQFOQJO-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97192,6m71,DB14065,-7.7,Lomerizine,JQSAYKKFZOSZGJ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96181,6m71,DB12511,-7.7,Imiglitazar,ULVDFHLHKNJICZ-QCWLDUFUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
13787,6lzg,T3D1849,-7.7,Tau-fluvalinate,INISTDXBRIBGOC-XMMISQBUSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
145320,6w9q,DB07215,-7.7,"2-METHYL-2-(4-{[({4-METHYL-2-[4-(TRIFLUOROMETHYL)PHENYL]-1,3-THIAZOL-5-YL}CARBONYL)AMINO]METHYL}PHENOXY)PROPANOIC ACID",ILUPZUOBHCUBKB-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
12142,6lzg,DB12941,-7.7,ODM-201,BLIJXOOIHRSQRB-PXYINDEMSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
149226,6w9q,DB15193,-7.7,BMS-955176,XDMUFNNPLXHNKA-ZTESCHFWSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
109393,6vxx,DB13511,-7.7,Clebopride,BVPWJMCABCPUQY-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
12043,6lzg,DB12796,-7.7,MRX-I,SULYVXZZUMRQAX-NSHDSACASA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
9711,6lzg,DB07831,-7.7,"2-{[(6-OXO-1,6-DIHYDROPYRIDIN-3-YL)METHYL]AMINO}-N-[4-PROPYL-3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE",SHSORWZDEKFFLP-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
119968,6w4b,DB07933,-7.7,Erteberel,XIESSJVMWNJCGZ-VKJFTORMSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
119948,6w4b,DB07909,-7.7,"(1S,2S,5S)2-(4-GLUTARIDYLBENZYL)-5-PHENYL-1-CYCLOHEXANOL",OBWILOKKNDYPLX-HBMCJLEFSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
59107,6crv,DB07082,-7.7,"1,1,1,3,3,3-HEXAFLUORO-2-{4-[(2,2,2-TRIFLUOROETHYL)AMINO]PHENYL}PROPAN-2-OL",VHDRSZOHKKZOQF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
49800,2fxp,DB05075,-7.7,TG-100801,JMGXJHWTVBGOKG-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
109373,6vxx,DB13485,-7.7,Sulfametomidine,QKLSCPPJEVXONT-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
145273,6w9q,DB07159,-7.7,Tamatinib,NHHQJBCNYHBUSI-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
9732,6lzg,DB07855,-7.7,(S)-1-PHENYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE,CWHMAWBXRCDOEB-HNNXBMFYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
60320,6crv,DB08505,-7.7,methyl 4-bromo-N-[8-(hydroxyamino)-8-oxooctanoyl]-L-phenylalaninate,UPYGSQPRAHMDPD-HNNXBMFYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
133754,6w9c,DB02106,-7.7,"[3,5-Dibromo-4-(4-Hydroxy-3-Phenethylcarbamoyl-Phenoxy)-Phenyl]-Acetic Acid",KIRQJXNQGZAKGR-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
119921,6w4b,DB07874,-7.7,"(6S)-2-amino-6-(3'-methoxybiphenyl-3-yl)-3,6-dimethyl-5,6-dihydropyrimidin-4(3H)-one",LQOCXPOKEPYGTJ-IBGZPJMESA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
96066,6m71,DB12345,-7.7,MBX-2982,NFTMKHWBOINJGM-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
104469,6vxs,DB12049,-7.7,Dasolampanel etibutil,HPBRMCFZIGUGTK-ZMMAXQRCSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
110461,6vxx,DB01624,-7.7,Zuclopenthixol,WFPIAZLQTJBIFN-DVZOWYKESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
133672,6w9c,DB02001,-7.7,"5-(4-Morpholin-4-Yl-Phenylsulfanyl)-2,4-Quinazolinediamine",CZLWCJRHDBTCGQ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
102732,6vxs,DB07747,-7.7,"(3R)-N-(4-CHLOROPHENYL)-3-(HYDROXYMETHYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONAMIDE",YTBGBMPLINFTBQ-OAHLLOKOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
54443,2fxp,DB15039,-7.7,ITI-214,BBIPVJCGIASXJB-PKTZIBPZSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
119101,6w4b,DB06920,-7.7,Eribaxaban,QQBKAVAGLMGMHI-WIYYLYMNSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
145317,6w9q,DB07210,-7.7,"3-bromo-5-phenyl-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",JECHSYMSTXETFI-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
145888,6w9q,DB07874,-7.7,"(6S)-2-amino-6-(3'-methoxybiphenyl-3-yl)-3,6-dimethyl-5,6-dihydropyrimidin-4(3H)-one",LQOCXPOKEPYGTJ-IBGZPJMESA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
64343,6lxt,DB01419,-7.7,Antrafenine,NWGGKKGAFZIVBJ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
119060,6w4b,DB06875,-7.7,3-(3-FLUORO-4-HYDROXYPHENYL)-7-HYDROXY-1-NAPHTHONITRILE,NSSOSHDCWCMNDM-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
119203,6w4b,DB07041,-7.7,"N-[2-(2,4-diaminopyrido[2,3-d]pyrimidin-7-yl)-2-methylpropyl]-4-phenoxybenzamide",FDJWFDQRPKKBFA-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
130141,6w4h,DB11828,-7.7,Neratinib,JWNPDZNEKVCWMY-VQHVLOKHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
145348,6w9q,DB07249,-7.7,"N-(5-chloro-1,3-benzodioxol-4-yl)-6-methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-amine",QHIMVPIOWKYPSO-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
110225,6vxx,DB01120,-7.7,Gliclazide,BOVGTQGAOIONJV-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
145813,6w9q,DB07792,-7.7,"(S)-2-CHLORO-N-(1-(2-(2-HYDROXYETHYLAMINO)-2-OXOETHYL)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL)-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE",VUKPNWLGSLOHIF-AWEZNQCLSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
145428,6w9q,DB07334,-7.7,"N-[5-(ETHYLSULFONYL)-2-METHOXYPHENYL]-5-[3-(2-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-AMINE",HTIZPBXCJPQDEM-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
110207,6vxx,DB01098,-7.7,Rosuvastatin,BPRHUIZQVSMCRT-VEUZHWNKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
96277,6m71,DB12663,-7.7,Letrazuril,XQKYUBTUOHHNDV-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110204,6vxx,DB01095,-7.7,Fluvastatin,FJLGEFLZQAZZCD-JUFISIKESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
96287,6m71,DB12675,-7.7,PF-04995274,WLLOFQROROXOMO-GOSISDBHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96289,6m71,DB12680,-7.7,Intepirdine,JJZFWROHYSMCMU-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
64403,6lxt,DB01485,-7.7,4-Hydroxytestosterone,BQOIJSIMMIDHMO-FBPKJDBXSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
109424,6vxx,DB13553,-7.7,Carumonam,UIMOJFJSJSIGLV-JNHMLNOCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
97138,6m71,DB13954,-7.7,Estradiol cypionate,UOACKFBJUYNSLK-XRKIENNPSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
130111,6w4h,DB11789,-7.7,Hyodeoxycholic Acid,DGABKXLVXPYZII-SIBKNCMHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
145770,6w9q,DB07743,-7.7,"S-[5-(TRIFLUOROMETHYL)-4H-1,2,4-TRIAZOL-3-YL] 5-(PHENYLETHYNYL)FURAN-2-CARBOTHIOATE",VNGWUVBXUIDQTK-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
133872,6w9c,DB02266,-7.7,Flufenamic Acid,LPEPZBJOKDYZAD-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
145755,6w9q,DB07724,-7.7,Indeglitazar,YMPALHOKRBVHOJ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
96333,6m71,DB12745,-7.7,GSK-690693,KGPGFQWBCSZGEL-ZDUSSCGKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96349,6m71,DB12774,-7.7,AZD-8055,KVLFRAWTRWDEDF-IRXDYDNUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
64845,6lxt,DB02059,-7.7,Adenosine-5-Diphosphoribose,SRNWOUGRCWSEMX-ZQSHOCFMSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
129893,6w4h,DB11367,-7.7,Cefroxadine,RDMOROXKXONCAL-UEKVPHQBSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
145734,6w9q,DB07701,-7.7,"1-BENZYL-4-[(5,6-DIMETHOXY-1-INDANON-2-YL)METHYL]PIPERIDINE",ADEBPBSSDYVVLD-HXUWFJFHSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
64844,6lxt,DB02058,-7.7,SU4984,AZGZGRJOCKSSHA-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
102849,6vxs,DB07876,-7.7,(S)-2-METHYL-1-[(4-METHYL-5-ISOQUINOLINE)SULFONYL]-HOMOPIPERAZINE,AWDORCFLUJZUQS-ZDUSSCGKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
96324,6m71,DB12732,-7.7,Firategrast,YLFZHHDVRSYTKT-NRFANRHFSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
145721,6w9q,DB07685,-7.7,"4-{[5-(CYCLOHEXYLMETHOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE",NMAZGYDYIYLSLJ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
145826,6w9q,DB07806,-7.7,"(2R,4S)-2-[(R)-BENZYLCARBAMOYL-PHENYLACETYL-METHYL]-5,5-DIMETHYL-THIAZOLIDINE-4-CARBOXYLIC ACID",UDMBRVGTYILYDX-SVFBPWRDSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
26471,6cs2,DB04612,-7.7,"N-METHYLALANYL-3-METHYLVALYL-4-PHENOXY-N-(1,2,3,4-TETRAHYDRONAPHTHALEN-1-YL)PROLINAMIDE",QKPXPZYQPBWDHS-MCJAPYMPSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
97187,6m71,DB14059,-7.7,SC-236,NSQNZEUFHPTJME-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96205,6m71,DB12548,-7.7,Sparsentan,WRFHGDPIDHPWIQ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
145352,6w9q,DB07253,-7.7,"N'-(5-chloro-1,3-benzodioxol-4-yl)-N-(3-methylsulfonylphenyl)pyrimidine-2,4-diamine",QTFCKBFCXDAZIU-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
9811,6lzg,DB07941,-7.7,PH-797804,KCAJXIDMCNPGHZ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
97180,6m71,DB14038,-7.7,beta-Sitosterol,KZJWDPNRJALLNS-VJSFXXLFSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
9813,6lzg,DB07943,-7.7,2-{4-[5-(4-chlorophenyl)-4-pyrimidin-4-yl-1H-pyrazol-3-yl]piperidin-1-yl}-2-oxoethanol,CATQHDWESBRRQA-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
104354,6vxs,DB11877,-7.7,Basmisanil,VCGRFBXVSFAGGA-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
129778,6w4h,DB09306,-7.7,Metralindole,GVXBHSBKKJRBMS-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
119225,6w4b,DB07065,-7.7,"5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)-3-thiocyanatopyrazolo[1,5-a]pyrimidin-7-amine",AHPKUZJCNHGFQA-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
96219,6m71,DB12569,-7.7,Tonapofylline,ZWTVVWUOTJRXKM-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
64393,6lxt,DB01474,-7.7,"17alpha-methyl-3beta,17beta-dihydroxyandrost-4-ene",BNUOCVTVOYWNJC-DTMQFJJTSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
130127,6w4h,DB11811,-7.7,Arhalofenate,BJBCSGQLZQGGIQ-QGZVFWFLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
110272,6vxx,DB01174,-7.7,Phenobarbital,DDBREPKUVSBGFI-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
102749,6vxs,DB07765,-7.7,"METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL](METHYL)AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE",UKCFUFHREWUXJJ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
145363,6w9q,DB07265,-7.7,"3-(9-HYDROXY-1,3-DIOXO-4-PHENYL-2,3-DIHYDROPYRROLO[3,4-C]CARBAZOL-6(1H)-YL)PROPANOIC ACID",JDARUOOLJCFUOY-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
64371,6lxt,DB01451,-7.7,1-Androstenedione,WJIQCDPCDVWDDE-WZNAKSSCSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
97173,6m71,DB14029,-7.7,Furafylline,HMZQULPVMKITSP-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
104357,6vxs,DB11883,-7.7,SB-705498,JYILLRHXRVTRSH-GFCCVEGCSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
110258,6vxx,DB01157,-7.7,Trimetrexate,NOYPYLRCIDNJJB-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
96252,6m71,DB12623,-7.7,Taprenepag,MFFBXYNKZHTCEY-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
145831,6w9q,DB07811,-7.7,"N-cyclopropyl-2',6-dimethyl-4'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-3-carboxamide",UBVTVSINEVHYSY-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
145829,6w9q,DB07809,-7.7,4-({[4-(3-METHYLBENZOYL)PYRIDIN-2-YL]AMINO}METHYL)BENZENECARBOXIMIDAMIDE,MBJYEMUMDMGQQC-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
96227,6m71,DB12579,-7.7,JNJ-37822681,UVUYWJWYRLJHEN-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
12180,6lzg,DB13002,-7.7,HKI-357,NERXPXBELDBEPZ-RMKNXTFCSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
95198,6m71,DB09070,-7.7,Tibolone,WZDGZWOAQTVYBX-XOINTXKNSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95721,6m71,DB11844,-7.7,Pritelivir,IVZKZONQVYTCKC-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94319,6m71,DB07974,-7.7,1-{2-[(4-CHLOROPHENYL)AMINO]-2-OXOETHYL}-N-(1-ISOPROPYLPIPERIDIN-4-YL)-1H-INDOLE-2-CARBOXAMIDE,BDLMBQRBNPDCSS-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59927,6crv,DB08033,-7.7,"(5R)-N,N-DIETHYL-5-METHYL-2-[(THIOPHEN-2-YLCARBONYL)AMINO]-4,5,6,7-TETRAHYDRO-1-BENZOTHIOPHENE-3-CARBOXAMIDE",UQKSYQYWUHUIEH-GFCCVEGCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
94329,6m71,DB07986,-7.7,[4-(4-PHENYL-PIPERIDIN-1-YL)-BENZENESULFONYLAMINO]-ACETIC ACID,GNSLACGSDSJAIQ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
132487,6w9c,DB00487,-7.7,Pefloxacin,FHFYDNQZQSQIAI-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
114894,6vxx,DB15348,-7.7,Ampreloxetine,TZIALEBTHQWNAO-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
148153,6w9q,DB13019,-7.7,Henatinib,MCTXSDCWFQAGFS-UEXNTNOUSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
148140,6w9q,DB12999,-7.7,MK-6186,FZBAOOQVQXATRL-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
113202,6vxx,DB08661,-7.7,"1-(2,5-dideoxy-5-pyrrolidin-1-yl-beta-L-erythro-pentofuranosyl)-5-methylpyrimidine-2,4(1H,3H)-dione",XUSBTLVYPZUOAW-WOPDTQHZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
131402,6w4h,DB13692,-7.7,Tretoquinol,RGVPOXRFEPSFGH-AWEZNQCLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
148136,6w9q,DB12988,-7.7,LY-518674,PNHFDVSKDSLUFH-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
131392,6w4h,DB13680,-7.7,Naftazone,TZGBBMBARSFJBG-UKTHLTGXSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
65998,6lxt,DB03598,-7.7,"Al-6629, [2h-Thieno[3,2-E]-1,2-Thiazine-6-Sulfonamide,2-(3-Methoxyphenyl)-3-(4-Morpholinyl)-, 1,1-Dioxide]",XSUAVPPTKHUTDX-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
113189,6vxx,DB08647,-7.7,TRAZEOLIDE,YUTXECPABXNXPU-DJJJIMSYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
65995,6lxt,DB03593,-7.7,N7-Methyl-Guanosine-5'-Monophosphate,AOKQNZVJJXPUQA-KQYNXXCUSA-O,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
65993,6lxt,DB03591,-7.7,RU82209,LVZDQVATAQEMCX-NSOVKSMOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
132497,6w9c,DB00498,-7.7,Phenindione,NFBAXHOPROOJAW-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
148105,6w9q,DB12941,-7.7,ODM-201,BLIJXOOIHRSQRB-PXYINDEMSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
148092,6w9q,DB12924,-7.7,Ozenoxacin,XPIJWUTXQAGSLK-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
113181,6vxx,DB08639,-7.7,Dapivirine,ILAYIAGXTHKHNT-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
148073,6w9q,DB12895,-7.7,TD-139,YGIDGBAHDZEYMT-MQFIMZJJSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
148054,6w9q,DB12869,-7.7,Eliprodil,GGUSQTSTQSHJAH-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
113179,6vxx,DB08635,-7.7,N-(TRANS-4'-NITRO-4-STILBENYL)-N-METHYL-5-AMINO-PENTANOIC ACID,QLLZAVDYYAQESE-AATRIKPKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
148042,6w9q,DB12848,-7.7,PF-04217903,PDMUGYOXRHVNMO-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
113172,6vxx,DB08624,-7.7,BENZOTHIAZOLE,MAJHCCQPIDXPAN-QMMMGPOBSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
148039,6w9q,DB12843,-7.7,Oleandrin,JLPDBLFIVFSOCC-XYXFTTADSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
114968,6w4b,DB00288,-7.7,Amcinonide,ILKJAFIWWBXGDU-MOGDOJJUSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
132515,6w9c,DB00525,-7.7,Tolnaftate,FUSNMLFNXJSCDI-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
59517,6crv,DB07556,-7.7,N-HYDROXY-2(R)-[[(4-METHOXYPHENYL)SULFONYL](3-PICOLYL)AMINO]-3-METHYLBUTANAMIDE HYDROCHLORIDE,BSIZUMJRKYHEBR-QGZVFWFLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
131368,6w4h,DB13653,-7.7,Lorcainide,XHOJAWVAWFHGHL-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
5411,6lzg,HMDB0059759,-7.7,1-Hydroxypyrene glucuronide,BUCREAQPYGLZLI-SXFAUFNYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
113234,6vxx,DB08704,-7.7,"[[(3R,4R,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-(pentanoylamino)oxan-2-ylidene]amino] N-phenylcarbamate",NUNQIQQEEPOGDJ-JDOAOKHLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
103768,6vxs,DB09003,-7.7,Clocapramine,QAZKXHSIKKNOHH-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
14248,6lzg,T3D3883,-7.7,Metsulfuron-methyl,RSMUVYRMZCOLBH-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
94181,6m71,DB07813,-7.7,GLYCYLALANYL-N-2-NAPHTHYL-L-PROLINEAMIDE,KCELZXZDIUJGNM-GUYCJALGSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
113342,6vxx,DB09015,-7.7,Canrenoic acid,PBKZPPIHUVSDNM-WNHSNXHDSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113335,6vxx,DB09008,-7.7,Cefaloridine,CZTQZXZIADLWOZ-CRAIPNDOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
26040,6cs2,DB04097,-7.7,Uridine-5'-Diphosphate-4-Deoxy-4-Fluoro-Alpha-D-Galactose,OAPPZHVTNHJVAL-JZMIEXBBSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
94204,6m71,DB07839,-7.7,"N-2-1,3-BENZOXAZOL-2-YL-3-CYCLOHEXYL-N-{2-[(4-METHOXYPHENYL)AMINO]ETHYL}-L-ALANINAMIDE",VFNWTXUFNNOQHD-QFIPXVFZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94210,6m71,DB07847,-7.7,6-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-(4-MORPHOLINYL)-2-OXO ETHYL]-2-OXO-3-PYRROLIDINYL}-2-NAPHTHALENESULFONAMIDE,ICLOZQFWTRAYPX-LIRRHRJNSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
114715,6vxx,DB14678,-7.7,Norethindrone enanthate,APTGJECXMIKIET-WOSSHHRXSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
94217,6m71,DB07855,-7.7,(S)-1-PHENYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE,CWHMAWBXRCDOEB-HNNXBMFYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
103726,6vxs,DB08956,-7.7,Hydroxydione,USPYDUPOCUYHQL-VEVMSBRDSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
114727,6vxx,DB14718,-7.7,Pyrazolam,BGRWSFIQQPVEML-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
94234,6m71,DB07872,-7.7,5-chloro-N-[(3R)-1-(2-{[2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl]amino}-2-oxoethyl)pyrrolidin-3-yl]thiophene-2-carboxamide,IYGIXVNAMZPBDK-CQSZACIVSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
131493,6w4h,DB13816,-7.7,Aspoxicillin,BHELIUBJHYAEDK-OAIUPTLZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
94240,6m71,DB07878,-7.7,"N-[(1S)-1-{1-[(1R,3E)-1-ACETYLPENT-3-EN-1-YL]-1H-1,2,3-TRIAZOL-4-YL}-1,2-DIMETHYLPROPYL]BENZAMIDE",OEHUTYXPQSSKAK-RVLLMHTFSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
114749,6vxx,DB14768,-7.7,PF-06459988,ODMXWZROLKITMS-RISCZKNCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
132525,6w9c,DB00537,-7.7,Ciprofloxacin,MYSWGUAQZAJSOK-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
94242,6m71,DB07882,-7.7,"4-{4-[2-(1A,7A-DIMETHYL-4-OXY-OCTAHYDRO-1-OXA-4-AZA-CYCLOPROPA[A]NAPHTHALEN-4-YL) -ACETYLAMINO]-PHENYLCARBAMOYL}-BUTYRIC ACID",VFIZFTGABDUGCF-UPVHCHBVSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
113312,6vxx,DB08788,-7.7,"3,6-DIAMINO-5-CYANO-4-(4-ETHOXYPHENYL)THIENO[2,3-B]PYRIDINE-2-CARBOXAMIDE",UOPQHPBCVYHSFF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114760,6vxx,DB14791,-7.7,GDC-0425,XEZLBMHDUXSICI-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113299,6vxx,DB08773,-7.7,RALOXIFENE CORE,MDGWZLQPNOETLH-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
94248,6m71,DB07891,-7.7,"4-{[(14beta,17alpha)-3-hydrox1tra-1,3,5(10)-trien-17-yl]oxy}-4-oxobutanoic acid",YJPIDPAGJSWWBE-FNIAAEIWSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94263,6m71,DB07909,-7.7,"(1S,2S,5S)2-(4-GLUTARIDYLBENZYL)-5-PHENYL-1-CYCLOHEXANOL",OBWILOKKNDYPLX-HBMCJLEFSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
103744,6vxs,DB08976,-7.7,Floctafenine,APQPGQGAWABJLN-GFCCVEGCSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
148247,6w9q,DB13175,-7.7,Rheinanthrone,OZFQHULMMDWMIV-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
113283,6vxx,DB08754,-7.7,"(2E)-3-(3,4-DIHYDROXYPHENYL)-N-[2-(4-HYDROXYPHENYL)ETHYL]ACRYLAMIDE",VSHUQLRHTJOKTA-XBXARRHUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
131437,6w4h,DB13739,-7.7,Penamecillin,NLOOMWLTUVBWAW-HLLBOEOZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
148228,6w9q,DB13126,-7.7,BMS-986115,SRJNRAQUSAVENA-GSHUGGBRSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
7947,6lzg,DB04575,-7.7,Quinestrol,PWZUUYSISTUNDW-VAFBSOEGSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
148212,6w9q,DB13104,-7.7,X-396,ONPGOSVDVDPBCY-CQSZACIVSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
148211,6w9q,DB13102,-7.7,AZD-8418,MCPBSUCAISQZQK-JTQLQIEISA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
113253,6vxx,DB08724,-7.7,5-(5-(4-(5-hydro-4-methyl-2-oxazolyl)phenoxy)pentyl)-3-methyl isoxazole,UXIYKMARWUSIKU-HNNXBMFYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
148292,6w9q,DB13252,-7.7,Tropatepine,JOQKFRLFXDPXHX-HDICACEKSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
132420,6w9c,DB00406,-7.7,Gentian violet cation,LGLFFNDHMLKUMI-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
132528,6w9c,DB00542,-7.7,Benazepril,XPCFTKFZXHTYIP-PMACEKPBSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
147994,6w9q,DB12764,-7.7,ABC-294640,CAOTVXGYTWCKQE-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
131282,6w4h,DB13534,-7.7,Gedocarnil,SLYDYLLJUXFULK-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
115305,6w4b,DB00700,-7.7,Eplerenone,JUKPWJGBANNWMW-VWBFHTRKSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
131281,6w4h,DB13533,-7.7,Methylestrenolone,ZXSWTMLNIIZPET-ZOFHRBRSSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
112868,6vxx,DB07938,-7.7,"5-[[(2R)-2-cyclopropyl-7,8-dimethoxy-chroman-5-yl]methyl]pyrimidine-2,4-diamine",HWJPWWYTGBZDEG-CQSZACIVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
131276,6w4h,DB13528,-7.7,Chlormadinone,VUHJZBBCZGVNDZ-TTYLFXKOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
65899,6lxt,DB03453,-7.7,Methyl (2S)-2-[[2-[(3R)-1-carbamimidoylpiperidin-3-yl]acetyl]amino]-3-[4-(2-phenylethynyl)phenyl]propanoate,MRNGXYMKYHNMLV-PKTZIBPZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
147865,6w9q,DB12562,-7.7,Setipiprant,IHAXLPDVOWLUOS-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
131257,6w4h,DB13499,-7.7,Cefsulodin,SYLKGLMBLAAGSC-QLVMHMETSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
112823,6vxx,DB07883,-7.7,(2-AMINO-3-PHENYL-BICYCLO[2.2.1]HEPT-2-YL)-PHENYL-METHANONE,XJQDTOANLAPEIM-JRBPQWBISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59454,6crv,DB07483,-7.7,"1,1'-BIPHENYL-2-SULFINIC ACID",LZCLZDCSBDVAOV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
132651,6w9c,DB00690,-7.7,Flurazepam,SAADBVWGJQAEFS-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
115393,6w4b,DB00808,-7.7,Indapamide,NDDAHWYSQHTHNT-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
147825,6w9q,DB12500,-7.7,Fedratinib,JOOXLOJCABQBSG-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
132653,6w9c,DB00692,-7.7,Phentolamine,MRBDMNSDAVCSSF-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
59453,6crv,DB07481,-7.7,"tert-butyl [(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)methyl]carbamate",RXVQMCMIOHBKNE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
147814,6w9q,DB12479,-7.7,Zabofloxacin,ZNPOCLHDJCAZAH-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
103280,6vxs,DB08390,-7.7,"(6S)-6-CYCLOPENTYL-6-[2-(3-FLUORO-4-ISOPROPOXYPHENYL)ETHYL]-4-HYDROXY-5,6-DIHYDRO-2H-PYRAN-2-ONE",AKNIHFDXRAOPAI-NRFANRHFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
103271,6vxs,DB08379,-7.7,6-(4-chloro-2-fluoro-3-phenoxybenzyl)pyridazin-3(2H)-one,NOVPOXGMADEKPP-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
52562,2fxp,DB11691,-7.7,Naldemedine,AXQACEQYCPKDMV-RZAWKFBISA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
59448,6crv,DB07476,-7.7,N-[4-(AMINOSULFONYL)PHENYL]-2-MERCAPTOBENZAMIDE,MRLVIVXGUGNENL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
147792,6w9q,DB12447,-7.7,Nadifloxacin,JYJTVFIEFKZWCJ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
94525,6m71,DB08207,-7.7,"2-(3,5-DIMETHYLPHENYL)-1,3-BENZOXAZOLE",BIHLSRJPJFOESJ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
131210,6w4h,DB13434,-7.7,Fenticonazole,ZCJYUTQZBAIHBS-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
59439,6crv,DB07462,-7.7,"(3,4-DIHYDROXY-2-NITROPHENYL)(PHENYL)METHANONE",ICLKAUQIPVFHOI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
94544,6m71,DB08233,-7.7,6-CYCLOHEXYLMETHYLOXY-2-(4'-HYDROXYANILINO)PURINE,RFSDQDHHBKYQOD-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
103257,6vxs,DB08361,-7.7,"2-{[(1R,2S)-2-aminocyclohexyl]amino}-4-[(3-methylphenyl)amino]pyrimidine-5-carboxamide",NZNTWOVDIXCHHS-LSDHHAIUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
112749,6vxx,DB07801,-7.7,N-butyl-3-{[6-(9H-purin-6-ylamino)hexanoyl]amino}benzamide,WOYITRCGMUXUDE-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
65857,6lxt,DB03388,-7.7,"3-[(2,4-Dichlorobenzoyl)(Isopropyl)Amino]-5-Phenylthiophene-2-Carboxylic Acid",UKNZREOUDLFUFF-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
112739,6vxx,DB07790,-7.7,N-(2-METHOXYETHYL)-4-({4-[2-METHYL-1-(1-METHYLETHYL)-1H-IMIDAZOL-5-YL]PYRIMIDIN-2-YL}AMINO)BENZENESULFONAMIDE,LDXLQEXLXZCYSR-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
65909,6lxt,DB03467,-7.7,Naringenin,FTVWIRXFELQLPI-ZDUSSCGKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
103840,6vxs,DB09124,-7.7,Medrogestone,HCFSGRMEEXUOSS-JXEXPEPMSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
115265,6w4b,DB00655,-7.7,Estrone,DNXHEGUUPJUMQT-CBZIJGRNSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
103839,6vxs,DB09123,-7.7,Dienogest,AZFLJNIPTRTECV-FUMNGEBKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
59499,6crv,DB07535,-7.7,2-amino-6-[2-(1H-indol-6-yl)ethyl]pyrimidin-4(3H)-one,VRAZIAJSKFRSIP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113091,6vxx,DB08363,-7.7,1-(9-ethyl-9H-carbazol-3-yl)-N-methylmethanamine,LBPNOEAFWYTTEB-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
132550,6w9c,DB00567,-7.7,Cephalexin,ZAIPMKNFIOOWCQ-UEKVPHQBSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
103816,6vxs,DB09079,-7.7,Nintedanib,XZXHXSATPCNXJR-ZIADKAODSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
103819,6vxs,DB09083,-7.7,Ivabradine,ACRHBAYQBXXRTO-OAQYLSRUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
115079,6w4b,DB00425,-7.7,Zolpidem,ZAFYATHCZYHLPB-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
8794,6lzg,DB06845,-7.7,(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclopentylamino)ethanoyl)pyrrolidine-2-carboxamide,WXYKSWZWRHMJTE-KRWDZBQOSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
113052,6vxx,DB08315,-7.7,"2-AMINO-N,N-BIS(PHENYLMETHYL)-1,3-OXAZOLE-5-CARBOXAMIDE",KIJXWOGFYAWTNC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
147954,6w9q,DB12705,-7.7,Cenerimod,KJKKMMMRWISKRF-FQEVSTJZSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
113050,6vxx,DB08313,-7.7,nocodazole,KYRVNWMVYQXFEU-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113048,6vxx,DB08310,-7.7,"N-[(2R)-2-{[(2S)-2-(1,3-benzoxazol-2-yl)pyrrolidin-1-yl]carbonyl}hexyl]-N-hydroxyformamide",QDDZLTVSNABZIK-ZBFHGGJFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
94442,6m71,DB08112,-7.7,N-({6-[(4-CYANO-2-FLUOROBENZYL)OXY]NAPHTHALEN-2-YL}SULFONYL)-D-GLUTAMIC ACID,IRJUSGUHNFMVCK-OAQYLSRUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
113025,6vxx,DB08285,-7.7,"(2R)-2-{[4-(benzylamino)-8-(1-methylethyl)pyrazolo[1,5-a][1,3,5]triazin-2-yl]amino}butan-1-ol",SQUNOCMDMIQIQK-OAHLLOKOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
132599,6w9c,DB00625,-7.7,Efavirenz,XPOQHMRABVBWPR-ZDUSSCGKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
132532,6w9c,DB00546,-7.7,Adinazolam,GJSLOMWRLALDCT-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
113016,6vxx,DB08270,-7.7,"N-(2-AMINOETHYL)-N-2-{(1S)-1-[4'-(AMINOSULFONYL)BIPHENYL-4-YL]-2,2,2-TRIFLUOROETHYL}-L-LEUCINAMIDE",QPXXBNKMAHUXBB-PMACEKPBSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
94451,6m71,DB08122,-7.7,"N-METHYL-4-{[(2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]AMINO}BENZENESULFONAMIDE",IKASAFLVQIJQOK-UVTDQMKNSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
131325,6w4h,DB13596,-7.7,Oxycinchophen,XAPRFLSJBSXESP-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
112984,6vxx,DB08229,-7.7,[N-(3-DIBENZYLCARBAMOYL-OXIRANECARBONYL)-HYDRAZINO]-ACETIC ACID,JGMMFVVACJREFE-KRWDZBQOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112982,6vxx,DB08227,-7.7,"1-(1-HYDROXY-2,2,6,6-TETRAMETHYLPIPERIDIN-4-YL)PYRROLIDINE-2,5-DIONE",ZHMZILPINCAHPK-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
115189,6w4b,DB00559,-7.7,Bosentan,GJPICJJJRGTNOD-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
112971,6vxx,DB08211,-7.7,5-bromo-3-(pyrrolidin-1-ylsulfonyl)-1H-indole-2-carboxamide,FEPUPYVRZUWCQB-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
103301,6vxs,DB08416,-7.7,"(9BETA,13ALPHA,14BETA,17ALPHA)-2-METHOX1TRA-1,3,5(10)-TRIENE-3,17-DIYL DISULFAMATE",AQSNIXKAKUZPSI-SSTWWWIQSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
147922,6w9q,DB12655,-7.7,Patidegib,HZLFFNCLTRVYJG-WWGOJCOQSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
131305,6w4h,DB13563,-7.7,Norgestrienone,GVDMJXQHPUYPHP-FYQPLNBISA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131302,6w4h,DB13558,-7.7,Morclofone,KVCJCEKJKGLBOK-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
147920,6w9q,DB12651,-7.7,Bardoxolone,TXGZJQLMVSIZEI-UQMAOPSPSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
147916,6w9q,DB12645,-7.7,Givinostat,YALNUENQHAQXEA-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
131299,6w4h,DB13555,-7.7,Prajmaline,UAUHEPXILIZYCU-ALHOSYKFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
59482,6crv,DB07516,-7.7,"(2Z,4E)-3-chloro-2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoic acid",IBJDCVXDXGFGIO-FKTQTOOFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
147940,6w9q,DB12680,-7.7,Intepirdine,JJZFWROHYSMCMU-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
103375,6vxs,DB08503,-7.7,"(3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(4-methylphenyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol",HRCKGDOSPBFICB-MZHQWRCYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
103705,6vxs,DB08927,-7.7,Amperozide,NNAIYOXJNVGUOM-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
114601,6vxx,DB13844,-7.7,Pipenzolate,WPUKUEMZZRVAKZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113894,6vxx,DB12239,-7.7,Balicatib,LLCRBOWRJOUJAE-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
14356,6lzg,T3D4022,-7.7,Sanguinarine,INVGWHRKADIJHF-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
149094,6w9q,DB14896,-7.7,Selitrectinib,OEBIHOVSAMBXIB-SJKOYZFVSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
149091,6w9q,DB14889,-7.7,Derazantinib,KPJDVVCDVBFRMU-AREMUKBSSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
14349,6lzg,T3D4015,-7.7,Protopine,GPTFURBXHJWNHR-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
113877,6vxx,DB12220,-7.7,ORG-25935,UEBBYLJZCHTLEG-UTKZUKDTSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
131797,6w4h,DB14725,-7.7,Cefamandole nafate,RRJHESVQVSRQEX-SUYBPPKGSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
66407,6lxt,DB04140,-7.7,1-Benzyl-3-(4-Methoxy-Benzenesulfonyl)-6-Oxo-Hexahydro-Pyrimidine-4-Carboxylic Acid Hydroxyamide,SUSMVCKSLVPRCL-QGZVFWFLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
114125,6vxx,DB12766,-7.7,Cicletanine,CVKNDPRBJVBDSS-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
131794,6w4h,DB14718,-7.7,Pyrazolam,BGRWSFIQQPVEML-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
132134,6w4h,DB15448,-7.7,Acumapimod,VGUSQKZDZHAAEE-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
93754,6m71,DB07311,-7.7,"18-CHLORO-11,12,13,14-TETRAHYDRO-1H,10H-8,4-(AZENO)-9,15,1,3,6-BENZODIOXATRIAZACYCLOHEPTADECIN-2-ONE",JRSWWYITYIOHOP-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93757,6m71,DB07314,-7.7,"1-(5-CHLORO-2,4-DIMETHOXYPHENYL)-3-(5-CYANOPYRAZIN-2-YL)UREA",URQYPXQXSVUVRG-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
114132,6vxx,DB12780,-7.7,Quinfamide,SBJGFIXQRZOVTO-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
8408,6lzg,DB05861,-7.7,Tasquinimod,ONDYALNGTUAJDX-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
114158,6vxx,DB12825,-7.7,Lefamulin,KPVIXBKIJXZQJX-FCEONZPQSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
132136,6w4h,DB15450,-7.7,PF-05105679,BXNMZRPTQFVRFA-QGZVFWFLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
149054,6w9q,DB14802,-7.7,ONO-2952,ZBQMTQGDBFZUBG-NRFANRHFSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
114182,6vxx,DB12868,-7.7,Intoplicine,QROONAIPJKQFMC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113835,6vxx,DB12150,-7.7,Pelubiprofen,AUZUGWXLBGZUPP-GXDHUFHOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
8213,6lzg,DB04903,-7.7,Pagoclone,HIUPRQPBWVEQJJ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
103594,6vxs,DB08762,-7.7,O-(((1R)-((N-PHENYLMETHOXYCARBONYL-L-ALANYL)AMINO)ETHYL)HYDROXYPHOSPHONO)-L-BENZYLACETIC ACID,UPJNMOBJDSFRTI-FCEWJHQRSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
59819,6crv,DB07911,-7.7,"(3E)-2,6-DIOXO-6-PHENYLHEX-3-ENOATE",QPGAZPBFRAAJBD-XBXARRHUSA-M,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
149038,6w9q,DB14769,-7.7,Pamiparib,DENYZIUJOTUUNY-MRXNPFEDSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
131778,6w4h,DB14674,-7.7,Estramustine phosphate,ADFOJJHRTBFFOF-RBRWEJTLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
59686,6crv,DB07759,-7.7,5-[2-(TRIFLUOROMETHYL)PHENYL]-2-FUROIC ACID,IJPNRBZMRINMMR-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
149019,6w9q,DB14726,-7.7,Dabigatran,YBSJFWOBGCMAKL-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
114223,6vxx,DB13115,-7.7,Saroglitazar,MRWFZSLZNUJVQW-DEOSSOPVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113806,6vxx,DB12112,-7.7,Zuretinol acetate,QGNJRVVDBSJHIZ-AQDFTDIISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
103483,6vxs,DB08635,-7.7,N-(TRANS-4'-NITRO-4-STILBENYL)-N-METHYL-5-AMINO-PENTANOIC ACID,QLLZAVDYYAQESE-AATRIKPKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
131847,6w4h,DB14849,-7.7,Nebicapone,MRFOLGFFTUGAEB-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
149103,6w9q,DB14914,-7.7,Flortaucipir F-18,GETAAWDSFUCLBS-SJPDSGJFSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
25904,6cs2,DB00459,-7.7,Acitretin,IHUNBGSDBOWDMA-AQFIFDHZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
8325,6lzg,DB05423,-7.7,ORG-34517,DFELGYQKEOCHOA-BZAFBGKRSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
131963,6w4h,DB15109,-7.7,Ingenol disoxate,GLIUZQUNUNICGS-XUBYYPQFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131991,6w4h,DB15163,-7.7,Selatogrel,FYXHWMQPCJOJCH-GMAHTHKFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
149209,6w9q,DB15156,-7.7,ABT-072,XMZSTQYSBYEENY-RMKNXTFCSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
8318,6lzg,DB05408,-7.7,Emricasan,SCVHJVCATBPIHN-SJCJKPOMSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
93667,6m71,DB07212,-7.7,N-(7-CARBAMIMIDOYL-NAPHTHALEN-1-YL)-3-HYDROXY-2-METHYL-BENZAMIDE,NNGZRCYXFBHMRM-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
114004,6vxx,DB12575,-7.7,Ronopterin,NDSDGUULXHNXGA-RPDRRWSUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
149193,6w9q,DB15124,-7.7,PF-05241328,RVTSXVZXEGFIPW-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
149185,6w9q,DB15110,-7.7,Onvansertib,QHLVBNKYJGBCQJ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
103532,6vxs,DB08697,-7.7,"4-(2-aminoethoxy)-N-(3-chloro-5-piperidin-1-ylphenyl)-3,5-dimethylbenzamide",JDYIYIRPQKMWMM-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
131953,6w4h,DB15091,-7.7,Upadacitinib,WYQFJHHDOKWSHR-MNOVXSKESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
113955,6vxx,DB12319,-7.7,Benzbromarone,WHQCHUCQKNIQEC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113953,6vxx,DB12316,-7.7,9CUAB30,PPGNMFUMZSAZCW-VOYUZAMQSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
149179,6w9q,DB15099,-7.7,GW-468816,XDKRVNKVAKCFGW-WXWBBQJKSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
132171,6w9c,DB00118,-7.7,Ademetionine,MEFKEPWMEQBLKI-AIRLBKTGSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
113943,6vxx,DB12305,-7.7,Dasotraline,SRPXSILJHWNFMK-MEDUHNTESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
131935,6w4h,DB15055,-7.7,ABT-639,AGPIHNZOZNKRGT-CYBMUJFWSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
103513,6vxs,DB08672,-7.7,4-[(3R)-3-{[2-(4-FLUOROPHENYL)-2-OXOETHYL]AMINO}BUTYL]BENZAMIDE,OIWWNWQZJJKBTR-CYBMUJFWSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
149167,6w9q,DB15075,-7.7,4-demethyl-4-cholesteryloxycarbonylpenclomedine,ZJUUIXYKTPSIOH-LEZJFEBPSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
149153,6w9q,DB15048,-7.7,Licogliflozin,XFJAMQQAAMJFGB-ZQGJOIPISA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
149144,6w9q,DB15033,-7.7,Flortaucipir,GETAAWDSFUCLBS-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
8367,6lzg,DB05616,-7.7,"4'-Methylene-5,8,10-trideazaaminopterin",NAWXUBYGYWOOIX-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
66445,6lxt,DB04186,-7.7,"N'-(Pyrrolidino[2,1-B]Isoindolin-4-On-8-Yl)-N-(Pyridin-2-Yl)Urea",KLVYMYQTRZCMLE-CYBMUJFWSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
131878,6w4h,DB14903,-7.7,Rovafovir etalafenamide,OCJRRXHWPBXZSU-BJBBEUPESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
93696,6m71,DB07249,-7.7,"N-(5-chloro-1,3-benzodioxol-4-yl)-6-methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-amine",QHIMVPIOWKYPSO-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
149115,6w9q,DB14937,-7.7,MK-8666,CODQKEMYZZKQAE-QPVYNBJUSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
114074,6vxx,DB12687,-7.7,Vesatolimod,VFOKSTCIRGDTBR-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
14363,6lzg,T3D4029,-7.7,Okadaic acid,QNDVLZJODHBUFM-MDZDMXLPSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
8277,6lzg,DB05137,-7.7,Lobeline,MXYUKLILVYORSK-HBMCJLEFSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
114082,6vxx,DB12704,-7.7,Spiradoline,NYKCGQQJNVPOLU-ONTIZHBOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
5588,6lzg,HMDB0061015,-7.7,ortho-hydroxyatorvastatin,CZBPKFICAYVHHM-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
8452,6lzg,DB06144,-7.7,Sertindole,GZKLJWGUPQBVJQ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
148998,6w9q,DB14673,-7.7,Flurandrenolide acetate,AUDPKCCPWYXNEV-XTLNBZDDSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
8167,6lzg,DB04841,-7.7,Flunarizine,SMANXXCATUTDDT-QPJJXVBHSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
103652,6vxs,DB08834,-7.7,Tauroursodeoxycholic acid,BHTRKEVKTKCXOH-LBSADWJPSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
26011,6cs2,DB04064,-7.7,Nogalaviketone,QHNJNOBWURJIEK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
148772,6w9q,DB13931,-7.7,Netarsudil,OURRXQUGYQRVML-AREMUKBSSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
114456,6vxx,DB13656,-7.7,Eberconazole,MPTJIDOGFUQSQH-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
8125,6lzg,DB04797,-7.7,Triazolopyridine,OVCXRBARSPBVMC-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
66246,6lxt,DB03921,-7.7,4-(3-Pyridin-2-Yl-1h-Pyrazol-4-Yl)Quinoline,IBCXZJCWDGCXQT-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
93985,6m71,DB07584,-7.7,"N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine",OKGCSZUKOGMZAL-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
132306,6w9c,DB00269,-7.7,Chlorotrianisene,BFPSDSIWYFKGBC-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
59871,6crv,DB07972,-7.7,1-(3-METHYLPHENYL)-1H-BENZIMIDAZOL-5-AMINE,VFSVFGIODYZMOF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
94011,6m71,DB07616,-7.7,"4-{[4-(4-fluoro-3-methylphenyl)-1,3-thiazol-2-yl]amino}-2-hydroxybenzoic acid",LKZZDHKJFDTYCH-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
148679,6w9q,DB13772,-7.7,Rufloxacin,NJCJBUHJQLFDSW-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
132337,6w9c,DB00305,-7.7,Mitomycin,NWIBSHFKIJFRCO-WUDYKRTCSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
113486,6vxx,DB09244,-7.7,Pirlindole,IWVRVEIKCBFZNF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114525,6vxx,DB13741,-7.7,Ioglycamic acid,FZDZULUFHNDEDJ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
132295,6w9c,DB00257,-7.7,Clotrimazole,VNFPBHJOKIVQEB-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
148585,6w9q,DB13648,-7.7,Alcuronium,MUQUYTSLDVKIOF-CHJKCJHBSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
148574,6w9q,DB13631,-7.7,Methoserpidine,ULBNWNUHGJLQHO-VKMIBBQISA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
131590,6w4h,DB13997,-7.7,Baloxavir marboxil,RZVPBGBYGMDSBG-GGAORHGYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
114571,6vxx,DB13805,-7.7,Reposal,MKELYWOVSPVORM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
148555,6w9q,DB13606,-7.7,Phenazocine,ZQHYKVKNPWDQSL-KNXBSLHKSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
132364,6w9c,DB00340,-7.7,Metixene,MJFJKKXQDNNUJF-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
113430,6vxx,DB09182,-7.7,Benzylfentanyl,POQDXIFVWVZVML-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
94080,6m71,DB07698,-7.7,"3-(3-aminophenyl)-N-(3-chlorophenyl)pyrazolo[1,5-a]pyrimidin-5-amine",JDNMRPIWJIDDAY-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94083,6m71,DB07702,-7.7,17alpha-Estriol,PROQIPRRNZUXQM-PNVOZDDCSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
131589,6w4h,DB13994,-7.7,AZD-7325,KYDURMHFWXCKMW-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
114593,6vxx,DB13836,-7.7,Metampicillin,FZECHKJQHUVANE-MCYUEQNJSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
131580,6w4h,DB13981,-7.7,Nomegestrol acetate,IIVBFTNIGYRNQY-YQLZSBIMSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
148519,6w9q,DB13554,-7.7,Moperone,AGAHNABIDCTLHW-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
132401,6w9c,DB00383,-7.7,Oxyphencyclimine,DUDKAZCAISNGQN-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
131549,6w4h,DB13929,-7.7,Relcovaptan,CEBYCSRFKCEUSW-NAYZPBBASA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
113461,6vxx,DB09214,-7.7,Dexketoprofen,DKYWVDODHFEZIM-NSHDSACASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
131181,6w4h,DB13397,-7.7,Prenoxdiazine,PXZDWASDNFWKSD-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
8571,6lzg,DB06420,-7.7,Annamycin,CIDNKDMVSINJCG-GKXONYSUSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
113618,6vxx,DB11662,-7.7,Rabusertib,SYYBDNPGDKKJDU-ZDUSSCGKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
148986,6w9q,DB14661,-7.7,Loperamide oxide,KXVSBTJVTUVNPM-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
131753,6w4h,DB14648,-7.7,Acetyl simvastatin,OHVWRJDVJRNCPE-BIKFJBPRSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
113758,6vxx,DB12043,-7.7,Sepetaprost,BKVUSNOUTQMSBE-XCMGCKIWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59669,6crv,DB07739,-7.7,"(3R)-3-(FLUOROMETHYL)-7-(THIOMORPHOLIN-4-YLSULFONYL)-1,2,3,4-TETRAHYDROISOQUINOLINE",SBUKSNPHYWXCDG-CYBMUJFWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114312,6vxx,DB13277,-7.7,Benziodarone,CZCHIEJNWPNBDE-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
93858,6m71,DB07432,-7.7,"[[(3R,4R,5S,6R)-3-(butanoylamino)-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-ylidene]amino] N-phenylcarbamate",ITVRELFVFCOUMV-ZVZWZHPPSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
113716,6vxx,DB11801,-7.7,Rapastinel,GIBQQARAXHVEGD-BSOLPCOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
132213,6w9c,DB00162,-7.7,Vitamin A,FPIPGXGPPPQFEQ-OVSJKPMPSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
132228,6w9c,DB00178,-7.7,Ramipril,HDACQVRGBOVJII-JBDAPHQKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
132229,6w9c,DB00179,-7.7,Masoprocol,HCZKYJDFEPMADG-TXEJJXNPSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
148954,6w9q,DB14627,-7.7,Oxyphenisatin acetate,PHPUXYRXPHEJDF-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
93882,6m71,DB07459,-7.7,4-PHENOXY-N-(PYRIDIN-2-YLMETHYL)BENZAMIDE,HVLSCZSVTCNAQX-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
131739,6w4h,DB14633,-7.7,Prednisolone hemisuccinate,APGDTXUMTIZLCJ-CGVGKPPMSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
114349,6vxx,DB13325,-7.7,Nifurzide,IDUMOVRJNBNOTR-BIZLIJPVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
93955,6m71,DB07546,-7.7,[1-(6-{6-[(1-methylethyl)amino]-1H-indazol-1-yl}pyrazin-2-yl)-1H-pyrrol-3-yl]acetic acid,BBYRUZKRFAIQSR-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
66321,6lxt,DB04022,-7.7,"Guanosine-5',3'-Tetraphosphate",BUFLLCUFNHESEH-UUOKFMHZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
131721,6w4h,DB14570,-7.7,Hydroxyprogesterone,DBPWSSGDRRHUNT-CEGNMAFCSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131719,6w4h,DB14568,-7.7,Ivosidenib,WIJZXSAJMHAVGX-DHLKQENFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
93897,6m71,DB07479,-7.7,"(1S)-1,2,3,4-TETRAHYDRO-BENZO[C]PHENANTHRENE-2,3,4-TRIOL",WCUHTHVUZQCBTI-KBAYOESNSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
114371,6vxx,DB13351,-7.7,Piperidolate,KTHVBAZBLKXIHZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114375,6vxx,DB13355,-7.7,Visnadine,GVBNSPFBYXGREE-CXWAGAITSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113674,6vxx,DB11742,-7.7,Ebastine,MJJALKDDGIKVBE-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
93913,6m71,DB07498,-7.7,"4-[3-(3-NITROPHENYL)-1,2,4-OXADIAZOL-5-YL]BUTANOIC ACID",LQQYZJRCWBRIMW-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
114397,6vxx,DB13384,-7.7,Melitracen,GWWLWDURRGNSRS-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114409,6vxx,DB13403,-7.7,Oxypertine,XCWPUUGSGHNIDZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59853,6crv,DB07952,-7.7,N-[1H-INDOL-3-YL-ACETYL]GLYCINE ACID,YDXXLJMIHMIOIF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
103429,6vxs,DB08569,-7.7,"3-PYRIDIN-4-YL-2,4-DIHYDRO-INDENO[1,2-.C.] PYRAZOLE",VLPMRZSKJUTRBQ-IBGZPJMESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
114415,6vxx,DB13411,-7.7,Lofepramine,SAPNXPWPAUFAJU-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
8559,6lzg,DB06395,-7.7,Abafungin,TYBHXIFFPVFXQW-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
131687,6w4h,DB14209,-7.7,Trandolaprilat,AHYHTSYNOHNUSH-HXFGRODQSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
93887,6m71,DB07467,-7.7,"4-chloro-N-[(2S)-2-methyl-2,3-dihydro-1H-indol-1-yl]-3-sulfamoylbenzamide",NDDAHWYSQHTHNT-JTQLQIEISA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
133395,6w9c,DB01627,-7.7,Lincomycin,OJMMVQQUTAEWLP-KIDUDLJLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
103878,6vxs,DB09193,-7.7,"CP-39,332",HLOCJJORRHQDKS-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
8941,6lzg,DB07005,-7.7,D-phenylalanyl-N-{4-[amino(iminio)methyl]benzyl}-L-prolinamide,VZFTWWJAUZOJDH-MOPGFXCFSA-O,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
130588,6w4h,DB12474,-7.7,Lynestrenol,YNVGQYHLRCDXFQ-XGXHKTLJSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
111853,6vxx,DB04787,-7.7,Tanaproget,PYVFWTPEBMRKSR-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
65435,6lxt,DB02833,-7.7,[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(3-Nitro-Phenyl)-Amine,DYTKVFHLKPDNRW-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
130572,6w4h,DB12448,-7.7,Lifibrol,LNXBEIZREVRNTF-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
95274,6m71,DB09200,-7.7,Rivoglitazone,XMSXOLDPMGMWTH-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
146881,6w9q,DB09124,-7.7,Medrogestone,HCFSGRMEEXUOSS-JXEXPEPMSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
103076,6vxs,DB08137,-7.7,(4E)-N-(4-fluorophenyl)-4-[(phenylcarbonyl)imino]-4H-pyrazole-3-carboxamide,ZMWYSLJBNJUCRK-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
111839,6vxx,DB04768,-7.7,Pyrithiamine Pyrophosphate,ZHKSTKOYQKNDSJ-UHFFFAOYSA-O,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
103063,6vxs,DB08123,-7.7,"N-METHYL-{4-[2-(7-OXO-6,7-DIHYDRO-8H-[1,3]THIAZOLO[5,4-E]INDOL-8-YLIDENE)HYDRAZINO]PHENYL}METHANESULFONAMIDE",GEWPSTLKJDIUHW-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
111830,6vxx,DB04756,-7.7,"2-[(3,5-Dichloro-4-trioxidanylphenyl)amino]benzoic acid",SNAMTVTZDPUVRA-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111829,6vxx,DB04754,-7.7,"GUANOSINE-2',3'-O-ETHYLIDENEPHOSPHONATE",HYAPEMYRVFIHDJ-QWEIRQIHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
133167,6w9c,DB01327,-7.7,Cefazolin,MLYYVTUWGNIJIB-BXKDBHETSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
104142,6vxs,DB11491,-7.7,Sarafloxacin,XBHBWNFJWIASRO-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
65402,6lxt,DB02790,-7.7,Phenyl-Uridine-5'-Diphosphate,ZHUWBKDWWGKIEN-FMKGYKFTSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
95305,6m71,DB09235,-7.7,Efonidipine,NSVFSAJIGAJDMR-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95331,6m71,DB09279,-7.7,Fimasartan,AMEROGPZOLAFBN-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
133172,6w9c,DB01333,-7.7,Cefradine,RDLPVSKMFDYCOR-UEKVPHQBSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
65386,6lxt,DB02766,-7.7,(3r)-3-{[(Benzyloxy)Carbonyl]Amino}-2-Oxo-4-Phenylbutane-1-Diazonium,VLIGBVLLNSWVMI-MRXNPFEDSA-O,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
104146,6vxs,DB11507,-7.7,Cloprostenol,VJGGHXVGBSZVMZ-QIZQQNKQSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
103057,6vxs,DB08116,-7.7,"(3R)-4-{[(3,4-dihydroxyphenyl)acetyl]oxy}-N-(2-formylindolizin-3-yl)-3-sulfino-D-valine",DEOZLEGRVHDNKC-UGKGYDQZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
130566,6w4h,DB12441,-7.7,Tavilermide,DVJXNXPFYJIACK-ULQDDVLXSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
26259,6cs2,DB04357,-7.7,Pteric Acid,JOAQINSXLLMRCV-UHFFFAOYSA-O,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
118009,6w4b,DB04244,-7.7,(2R)-2-(3-Biphenylyl)-N-{(2R)-2-hydroxy-3-[(2-pyridinylsulfonyl)amino]propyl}-4-methylpentanamide,YCDHZDINQZLSRR-DNQXCXABSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
130558,6w4h,DB12429,-7.7,CI-1040,GFMMXOIFOQCCGU-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
104147,6vxs,DB11511,-7.7,Difloxacin,NOCJXYPHIIZEHN-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
26261,6cs2,DB04362,-7.7,Adenosine Diphosphate 5-(Beta-Ethyl)-4-Methyl-Thiazole-2-Carboxylic Acid,VGXBGQACJQRWLV-LKGUXBDMSA-K,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
118070,6w4b,DB04330,-7.7,Bilh 434,KNRVCCXHLSHTFW-HGPRPZRGSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
59233,6crv,DB07228,-7.7,1-(5-CHLORO-2-METHOXYPHENYL)-3-{6-[2-(DIMETHYLAMINO)-1-METHYLETHOXY]PYRAZIN-2-YL}UREA,GIAYFZLMPSVQDV-NSHDSACASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
25635,6cs2,DB03619,-7.7,Deoxycholic Acid,KXGVEGMKQFWNSR-LLQZFEROSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
117643,6w4b,DB03768,-7.7,"N-[2-Hydroxy-2-(8-Isopropyl-6,9-Dioxo-2-Oxa-7,10-Diaza-Bicyclo[11.2.2]Heptadeca-1(16),13(17),14-Trien-11-Yl)-Ethyl]-N-(3-Methyl-Butyl)-Benzenesulfonamide,Inhibitor 3",WRUVOSYKHXGAQN-GKRYNVPLSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
9393,6lzg,DB07489,-7.7,"4-Amino-2-[(3-chlorophenyl)amino]-5-(4-fluorobenzoyl)-1,3-thiazol-3-ium",WWGPTHOMFHDEEC-UHFFFAOYSA-O,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
7821,6lzg,DB04424,-7.7,RPR128515,XFKVLKLCLYJKNF-MZNJEOGPSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
97482,6m71,DB15009,-7.7,PF-04937319,MASKQITXHVYVFL-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
112046,6vxx,DB06166,-7.7,Fosdevirine,CGBYTKOSZYQOPV-CCEZBSFNSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
147181,6w9q,DB11487,-7.7,Dexamethasone isonicotinate,BQTXJHAJMDGOFI-NJLPOHDGSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
9307,6lzg,DB07395,-7.7,"4-[3-(2-Chloro-4,5-difluoro-benzoyl)ureido]-3-trifluoromethoxybenzoic acid",NWQGDIBCFLDHDO-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
147165,6w9q,DB11457,-7.7,Rotenone,JUVIOZPCNVVQFO-HBGVWJBISA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
117195,6w4b,DB03157,-7.7,"N,O-Didansyl-L-Tyrosine",LUBOPDUYHWABFG-NDEPHWFRSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
95131,6m71,DB08974,-7.7,Flubendazole,CPEUVMUXAHMANV-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
130717,6w4h,DB12675,-7.7,PF-04995274,WLLOFQROROXOMO-GOSISDBHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
112028,6vxx,DB06133,-7.7,Dimethylcurcumin,ZMGUKFHHNQMKJI-CIOHCNBKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130707,6w4h,DB12663,-7.7,Letrazuril,XQKYUBTUOHHNDV-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
103108,6vxs,DB08170,-7.7,"(1R)-N,6-DIHYDROXY-7-METHOXY-2-[(4-METHOXYPHENYL)SULFONYL]-1,2,3,4-TETRAHYDROISOQUINOLINE-1-CARBOXAMIDE",AYFCYVLVRYQGME-QGZVFWFLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104106,6vxs,DB11427,-7.7,Maropitant,OMPCVMLFFSQFIX-CONSDPRKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
60160,6crv,DB08312,-7.7,"6-CYCLOHEXYLMETHYLOXY-5-NITROSO-PYRIMIDINE-2,4-DIAMINE",DGWXOLHKVGDQLN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
117335,6w4b,DB03336,-7.7,BIA,KVIVJQWOYSWCCZ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
14064,6lzg,T3D3681,-7.7,Cytochalasin J,DMUBZPWTFAPROZ-KRQHZRJMSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
146739,6w9q,DB08912,-7.7,Dabrafenib,BFSMGDJOXZAERB-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
14063,6lzg,T3D3680,-7.7,Cytochalasin H,NAEWXXDGBKTIMN-BBXOWAOSSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
111980,6vxx,DB05035,-7.7,Eprotirome,VPCSYAVXDAUHLT-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111963,6vxx,DB04957,-7.7,Azimilide,MREBEPTUUMTTIA-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59271,6crv,DB07272,-7.7,"N-(4-AMINO-5-CYANO-6-ETHOXYPYRIDIN-2-YL)-2-(4-BROMO-2,5-DIMETHOXYPHENYL)ACETAMIDE",GKODDLYLEKSDJL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
5228,6lzg,HMDB0055590,-7.7,"TG(20:4(8Z,11Z,14Z,17Z)/18:1(9Z)/o-18:0)",HEIAOQGWRROSQN-CNVGNDOZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
111957,6vxx,DB04946,-7.7,Iloperidone,XMXHEBAFVSFQEX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
133116,6w9c,DB01224,-7.7,Quetiapine,URKOMYMAXPYINW-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
103090,6vxs,DB08152,-7.7,{(2S)-1-[N-(tert-butoxycarbonyl)glycyl]pyrrolidin-2-yl}methyl (3-chlorophenyl)acetate,ONXGIEJBNQLITK-INIZCTEOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
65477,6lxt,DB02887,-7.7,"2',3'-Dehydro-2',3'-Deoxy-Thymidine 5'-Triphosphate",ODSQODTUNULBHF-JGVFFNPUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
130620,6w4h,DB12524,-7.7,BI-671800,XEOSTBFUCNZKGS-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130595,6w4h,DB12482,-7.7,Acotiamide,TWHZNAUBXFZMCA-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
111901,6vxx,DB04843,-7.7,Mepenzolate,GKNPSSNBBWDAGH-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
146996,6w9q,DB09298,-7.7,Silibinin,SEBFKMXJBCUCAI-HKTJVKLFSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
65473,6lxt,DB02882,-7.7,Cyanocinnoline,CUWRVIIPSSUUDJ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
25663,6cs2,DB03656,-7.7,Tribenuron Methyl,VLCQZHSMCYCDJL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
111990,6vxx,DB05095,-7.7,Cimicoxib,KYXDNECMRLFQMZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
117140,6w4b,DB03082,-7.7,6-[(Z)-Amino(Imino)Methyl]-N-[4-(Aminomethyl)Phenyl]-4-(Pyrimidin-2-Ylamino)-2-Naphthamide,CSWQJKHBMACTGB-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
95417,6m71,DB11184,-7.7,Oftasceine,DEGAKNSWVGKMLS-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
133230,6w9c,DB01436,-7.7,Alfacalcidol,OFHCOWSQAMBJIW-AVJTYSNKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
9534,6lzg,DB07643,-7.7,"5-{[1-(2,3-dichlorobenzyl)piperidin-4-yl]methoxy}quinazoline-2,4-diamine",XVLUVRFYGVJKGJ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
111368,6vxx,DB03575,-7.7,Phencyclidine,JTJMJGYZQZDUJJ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
95608,6m71,DB11679,-7.7,Fruquintinib,BALLNEJQLSTPIO-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
118468,6w4b,DB04863,-7.7,Lefradafiban,PGCFXITVMNNKON-ROUUACIJSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
146456,6w9q,DB08549,-7.7,"(3R)-METHYLCARBAMOYL-7-SULFOAMINO-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLIC ACID BENZYL ESTER",MFDBNNQUDZFSES-KRWDZBQOSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
118475,6w4b,DB04872,-7.7,Osanetant,DZOJBGLFWINFBF-UMSFTDKQSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
111333,6vxx,DB03515,-7.7,Equilenin,PDRGHUMCVRDZLQ-WMZOPIPTSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130443,6w4h,DB12273,-7.7,Ecopipam,DMJWENQHWZZWDF-PKOBYXMFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
118480,6w4b,DB04879,-7.7,Vatalanib,YCOYDOIWSSHVCK-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
95644,6m71,DB11736,-7.7,PF-00489791,ZUHZNKJIJDAJFD-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95651,6m71,DB11743,-7.7,Ipatasertib,GRZXWCHAXNAUHY-NSISKUIASA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95654,6m71,DB11749,-7.7,(R)-Praziquantel,FSVJFNAIGNNGKK-KRWDZBQOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
130430,6w4h,DB12254,-7.7,ABT-751,URCVCIZFVQDVPM-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
9543,6lzg,DB07651,-7.7,N-ACETYL-L-PHENYLALANYL-4-[DIFLUORO(PHOSPHONO)METHYL]-L-PHENYLALANINAMIDE,KPMMESISHWWXNM-ROUUACIJSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
95658,6m71,DB11755,-7.7,Tetrahydrocannabivarin,ZROLHBHDLIHEMS-HUUCEWRRSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
65224,6lxt,DB02547,-7.7,Guanosine-5'-Diphosphate-Rhamnose,LQEBEXMHBLQMDB-GDJBGNAASA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
60243,6crv,DB08414,-7.7,"6-CHLORO-2-(1-FURO[2,3-C]PYRIDIN-5-YL-ETHYLSULFANYL)-PYRIMIDIN-4-YLAMINE",ATCRIOJPQXDFNY-ZETCQYMHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
133351,6w9c,DB01571,-7.7,3-Methylfentanyl,MLQRZXNZHAOCHQ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
65217,6lxt,DB02538,-7.7,"N-[4-(2-Methylimidazo[1,2-a]Pyridin-3-Yl)-2-Pyrimidinyl]Acetamide",ZCRPPLDDHBLUES-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
146381,6w9q,DB08463,-7.7,(2R)-2-({9-(1-methylethyl)-6-[(4-pyridin-2-ylbenzyl)amino]-9H-purin-2-yl}amino)butan-1-ol,HOCBJBNQIQQQGT-LJQANCHMSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
26313,6cs2,DB04430,-7.7,3-(4-Phenylamino-Phenylamino)-2-(1h-Tetrazol-5-Yl)-Acrylonitrile,FLPLCJJGNZGOAW-QXMHVHEDSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
130393,6w4h,DB12206,-7.7,N-6022,YVPGZQLRPAGKLA-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
118551,6w4b,DB05129,-7.7,Elsamitrucin,MGQRRMONVLMKJL-KWJIQSIXSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
102995,6vxs,DB08046,-7.7,2-chloro-5-[(1S)-1-hydroxy-3-oxo-2H-isoindol-1-yl]benzenesulfonamide,JIVPVXMEBJLZRO-AWEZNQCLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
146366,6w9q,DB08445,-7.7,"(3R,4S)-1-[6-(6-METHOXYPYRIDIN-3-YL)PYRIMIDIN-4-YL]-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE",IFKWHPAWYJARQJ-DYVFJYSZSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
111214,6vxx,DB03348,-7.7,Huperzine B,YYWGABLTRMRUIT-HWWQOWPSSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
133372,6w9c,DB01602,-7.7,Bacampicillin,PFOLLRNADZZWEX-FFGRCDKISA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
133392,6w9c,DB01624,-7.7,Zuclopenthixol,WFPIAZLQTJBIFN-DVZOWYKESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
95711,6m71,DB11828,-7.7,Neratinib,JWNPDZNEKVCWMY-VQHVLOKHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
111388,6vxx,DB03808,-7.7,Hexamidine,OQLKNTOKMBVBKV-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111389,6vxx,DB03809,-7.7,9-Butyl-8-(3-Methoxybenzyl)-9h-Purin-6-Amine,BWLWUGBHOXIUBP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
23518,6cs2,HMDB0061925,-7.7,Dehydroabietic acid,NFWKVWVWBFBAOV-IPNZSQQUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
111400,6vxx,DB03820,-7.7,"(2s,5r,6r)-6-{[(6r)-6-(Glycylamino)-7-Oxido-7-Oxoheptanoyl]Amino}-3,3-Dimethyl-7-Oxo-4-Thia-1-Azabicyclo[3.2.0]Heptane-2-Carboxylate",LDJWRKFRKCXUDO-RBQWDTSBSA-M,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
103030,6vxs,DB08087,-7.7,"4-[(7R,7AS)-7-HYDROXY-1,3-DIOXOTETRAHYDRO-1H-PYRROLO[1,2-C]IMIDAZOL-2(3H)-YL]-1-NAPHTHONITRILE",NHBIWLQQJPSMNP-CABCVRRESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
111624,6vxx,DB04293,-7.7,7-(2-Amino-2-Phenyl-Acetylamino)-3-Chloro-8-Oxo-1-Aza-Bicyclo[4.2.0]Oct-2-Ene-2-Carboxylic Acid,JAPHQRWPEGVNBT-IJLUTSLNSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
95432,6m71,DB11263,-7.7,Polydatin,HSTZMXCBWJGKHG-CUYWLFDKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59219,6crv,DB07210,-7.7,"3-bromo-5-phenyl-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",JECHSYMSTXETFI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
146720,6w9q,DB08881,-7.7,Vemurafenib,GPXBXXGIAQBQNI-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
133256,6w9c,DB01466,-7.7,Ethylmorphine,OGDVEMNWJVYAJL-LEPYJNQMSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
146688,6w9q,DB08827,-7.7,Lomitapide,MBBCVAKAJPKAKM-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
5959,6lzg,DB01336,-7.7,Metocurine,JFXBEKISTKFVAB-AJQTZOPKSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
25627,6cs2,DB03606,-7.7,(S)-Rolipram,HJORMJIFDVBMOB-GFCCVEGCSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
95524,6m71,DB11478,-7.7,Zeranol,DWTTZBARDOXEAM-GXTWGEPZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
118250,6w4b,DB04573,-7.7,Estriol,PROQIPRRNZUXQM-ZXXIGWHRSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
111584,6vxx,DB04238,-7.7,N-Alpha-(2-Naphthylsulfonyl)-N-(3-Amidino-L-Phenylalaninyl)-D-Pipecolinic Acid,GNANSBQAIRJZPA-XZOQPEGZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
146605,6w9q,DB08731,-7.7,"2-[(1R)-2-carboxy-1-(naphthalen-1-ylmethyl)ethyl]-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylic acid",GPOKTQCDBPECSS-MRXNPFEDSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
118263,6w4b,DB04591,-7.7,"N-{2,2-DIFLUORO-2-[(2R)-PIPERIDIN-2-YL]ETHYL}-2-[2-(1H-1,2,4-TRIAZOL-1-YL)BENZYL][1,3]OXAZOLO[4,5-C]PYRIDIN-4-AMINE",VYJOAYZRCNHDNG-GOSISDBHSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
9463,6lzg,DB00693,-7.7,Fluorescein,GNBHRKFJIUUOQI-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
9499,6lzg,DB07608,-7.7,N-(5-{[(2S)-4-amino-2-(3-chlorophenyl)butanoyl]amino}-1H-indazol-3-yl)benzamide,JDGOPNUGILVNJZ-IBGZPJMESA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
104184,6vxs,DB11619,-7.7,Gestrinone,BJJXHLWLUDYTGC-ANULTFPQSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
111513,6vxx,DB03970,-7.7,"(7R)-7-(6,7-Dihydro-5H-cyclopenta[d]imidazo[2,1-b][1,3]thiazol-2-yl)-2,7-dihydro-1,4-thiazepine-3,6-dicarboxylic acid",CHNMLWCTGYMVFH-GFCCVEGCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
133299,6w9c,DB01518,-7.7,Benzethidine,UVTBZAWTRVBTMK-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
146583,6w9q,DB08708,-7.7,"N-cyclohexyl-3-[3-(trifluoromethyl)phenyl][1,2,4]triazolo[4,3-b]pyridazin-6-amine",XYYDXQCAYXOGQT-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
104192,6vxs,DB11638,-7.7,Artenimol,BJDCWCLMFKKGEE-HVDUHBCDSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
26287,6cs2,DB04395,-7.7,Phosphoaminophosphonic Acid-Adenylate Ester,PVKSNHVPLWYQGJ-FCIPNVEPSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
118362,6w4b,DB04724,-7.7,"(S)-2-((S)-3-ISOBUTYL-2,5-DIOXO-4-QUINOLIN-3-YLMETHYL-[1,4]DIAZEPAN-1YL)-N-METHYL-3-NAPHTALEN-2-YL-PROPIONAMIDE",COVPLULNDBDXTN-KYJUHHDHSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
65290,6lxt,DB02639,-7.7,4-methylumbelliferyl ??-D-glucoside,YUDPTGPSBJVHCN-JZYAIQKZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
65288,6lxt,DB02636,-7.7,"9-Hydroxy-8-Methoxy-6-Nitro-Phenanthrol[3,4-D][1,3]Dioxole-5-Carboxylic Acid",UCLGCTLOEZZSLA-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
59199,6crv,DB07186,-7.7,"4-(4-METHYLPIPERAZIN-1-YL)-N-[5-(2-THIENYLACETYL)-1,5-DIHYDROPYRROLO[3,4-C]PYRAZOL-3-YL]BENZAMIDE",TYYNSDQVFIOSFH-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111460,6vxx,DB03899,-7.7,9-Butyl-8-(4-Methoxybenzyl)-9h-Purin-6-Amine,NVYATAJRTRFKSW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
95593,6m71,DB11658,-7.7,QAV-680,YOPFAMROKXHVCQ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
111456,6vxx,DB03895,-7.7,Malachite Green,VFCNQNZNPKRXIT-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
118415,6w4b,DB04797,-7.7,Triazolopyridine,OVCXRBARSPBVMC-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
9508,6lzg,DB07616,-7.7,"4-{[4-(4-fluoro-3-methylphenyl)-1,3-thiazol-2-yl]amino}-2-hydroxybenzoic acid",LKZZDHKJFDTYCH-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
147196,6w9q,DB11529,-7.7,Melengestrol,OKHAOBQKCCIRLO-IBVJIVQJSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
60143,6crv,DB08293,-7.7,"(5E)-12-CHLORO-13,15-DIHYDROXY-4,7,8,9-TETRAHYDRO-2-BENZOXACYCLOTRIDECINE-1,10(3H,11H)-DIONE",AQKZYZQONWDDLS-HNQUOIGGSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
95097,6m71,DB08932,-7.7,Macitentan,JGCMEBMXRHSZKX-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
115875,6w4b,DB01434,-7.7,19-norandrostenedione,JRIZOGLBRPZBLQ-QXUSFIETSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
94744,6m71,DB08481,-7.7,"4-METHYL-N-{(5E)-5-[(5-METHYL-2-FURYL)METHYLENE]-4-OXO-4,5-DIHYDRO-1,3-THIAZOL-2-YL}BENZENESULFONAMIDE",MXAPQGDBWFYKKX-ZROIWOOFSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
131009,6w4h,DB13132,-7.7,Artemisinin,BLUAFEHZUWYNDE-NNWCWBAJSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
94749,6m71,DB08488,-7.7,"4-{[(E)-2-(5-CHLOROTHIEN-2-YL)VINYL]SULFONYL}-1-(1H-PYRROLO[3,2-C]PYRIDIN-2-YLMETHYL)PIPERAZIN-2-ONE",PLWVUIRWJVKSSD-XBXARRHUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60048,6crv,DB08167,-7.7,Methylthioninium,RBTBFTRPCNLSDE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
132853,6w9c,DB00922,-7.7,Levosimendan,WHXMKTBCFHIYNQ-SECBINFHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
94754,6m71,DB08493,-7.7,"5-METHYL-3-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.013,18]NONADECA-12(19),13,15,17-TETRAEN-10-YLCARBAMOYL)-HEXANOIC ACID",AKWKBACKRMYPRV-NQIIRXRSSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
103215,6vxs,DB08309,-7.7,3-({2-[(4-{[6-(CYCLOHEXYLMETHOXY)-9H-PURIN-2-YL]AMINO}PHENYL)SULFONYL]ETHYL}AMINO)PROPAN-1-OL,AMFGILNPFBVREA-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
131005,6w4h,DB13122,-7.7,Trabodenoson,AQLVRTWKJDTWQQ-SDBHATRESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
112491,6vxx,DB07314,-7.7,"1-(5-CHLORO-2,4-DIMETHOXYPHENYL)-3-(5-CYANOPYRAZIN-2-YL)UREA",URQYPXQXSVUVRG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112477,6vxx,DB07300,-7.7,"2-(1H-imidazol-1-yl)-9-methoxy-8-(2-methoxyethoxy)benzo[c][2,7]naphthyridin-4-amine",QSSGYSRUMIOURP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
147540,6w9q,DB12095,-7.7,Telotristat ethyl,MDSQOJYHHZBZKA-GBXCKJPGSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
132877,6w9c,DB00950,-7.7,Fexofenadine,RWTNPBWLLIMQHL-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
9058,6lzg,DB07128,-7.7,"N7-BUTYL-N2-(5-CHLORO-2-METHYLPHENYL)-5-METHYL[1,2,4]TRIAZOLO[1,5-A]PYRIMIDINE-2,7-DIAMINE",ZTYBIJUAAWLJNU-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
26174,6cs2,DB04254,-7.7,"8-Benzo[1,3]Dioxol-,5-Ylmethyl-9-Butyl-2-Fluoro-9h-Purin-6-Ylamine",ARWHTQLGMWHTAZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
130946,6w4h,DB13039,-7.7,Aminaphthone,YLMPBJUYFTWHKJ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
112437,6vxx,DB07104,-7.7,4-amino-N-[4-(benzyloxy)phenyl]butanamide,QTWBKNVNGVYTNZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
116080,6w4b,DB01678,-7.7,RU84687,SAFPHFWYRLLBFO-NSOVKSMOSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
59328,6crv,DB07332,-7.7,"ALPHA-(2,6-DICHLOROPHENYL)-ALPHA-(2-ACETYL-5-METHYLANILINO)ACETAMIDE",CJPLEFFCVDQQFZ-INIZCTEOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
103197,6vxs,DB08289,-7.7,N-(PARA-GLUTARAMIDOPHENYL-ETHYL)-PIPERIDINIUM-N-OXIDE,RKJXWOJUCCBWSC-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
112385,6vxx,DB07042,-7.7,"7-amino-2-tert-butyl-4-{[2-(1H-imidazol-4-yl)ethyl]amino}pyrido[2,3-d]pyrimidine-6-carboxamide",XESUNWBIAADLPI-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
116143,6w4b,DB01761,-7.7,4-[5-[2-(1-Phenyl-Ethylamino)-Pyrimidin-4-Yl]-1-Methyl-4-(3-Trifluoromethylphenyl)-1h-Imidazol-2-Yl]-Piperidine,QICPQLFMWYQJGX-SFHVURJKSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
147494,6w9q,DB12024,-7.7,PF-04418948,LWJGMYMNSNVCEM-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
112379,6vxx,DB07036,-7.7,"(3aS,4R,9bR)-2,2-difluoro-4-(4-hydroxyphenyl)-6-(methoxymethyl)-1,2,3,3a,4,9b-hexahydrocyclopenta[c]chromen-8-ol",GPFRMIHXGMVMGF-BZSNNMDCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112376,6vxx,DB07033,-7.7,5-HYDROXY-3-[(1R)-1-(1H-PYRROL-2-YL)ETHYL]-2H-INDOL-2-ONE,VWQVBIPGKIAUGA-QMMMGPOBSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
147489,6w9q,DB12015,-7.7,Alpelisib,STUWGJZDJHPWGZ-LBPRGKRZSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
9116,6lzg,DB07190,-7.7,3-cyclohexyl-D-alanyl-N-(3-chlorobenzyl)-L-prolinamide,JGFCNVHEEMBVJG-MOPGFXCFSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
147478,6w9q,DB12001,-7.7,Abemaciclib,UZWDCWONPYILKI-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
116196,6w4b,DB01830,-7.7,"{4-[2-Acetylamino-2-(3-Carbamoyl-2-Cyclohexylmethoxy-6,7,8,9-Tetrahydro-5h-Benzocyclohepten-5ylcarbamoyl)-Ethyl]-2-Phosphono-Phenyl}-Phosphonic Acid",SPSGYTWOIGAABK-DQEYMECFSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
131018,6w4h,DB13158,-7.7,Clobetasone,XXIFVOHLGBURIG-OZCCCYNHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
59374,6crv,DB07389,-7.7,N-[2-(6-AMINO-4-METHYLPYRIDIN-2-YL)ETHYL]-4-CYANOBENZAMIDE,QINCZVSBLITNRD-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
115854,6w4b,DB01411,-7.7,Pranlukast,NBQKINXMPLXUET-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
112555,6vxx,DB07390,-7.7,"2-[3-(5-MERCAPTO-[1,3,4]THIADIAZOL-2-YL)-UREIDO]-N-METHYL-3-PHENYL-PROPIONAMIDE",RKWXKADYTDWZIJ-VIFPVBQESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
12400,6lzg,DB13327,-7.7,Picotamide,KYWCWBXGRWWINE-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
132741,6w9c,DB00799,-7.7,Tazarotene,OGQICQVSFDPSEI-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
115538,6w4b,DB00972,-7.7,Azelastine,MBUVEWMHONZEQD-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
115539,6w4b,DB00973,-7.7,Ezetimibe,OLNTVTPDXPETLC-XPWALMASSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
59421,6crv,DB07443,-7.7,(2Z)-N-biphenyl-4-yl-2-cyano-3-hydroxybut-2-enamide,MUVPBAIVOHJDOC-VBKFSLOCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
131131,6w4h,DB13333,-7.7,Efloxate,ZVXBAHLOGZCFTP-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
132769,6w9c,DB00829,-7.7,Diazepam,AAOVKJBEBIDNHE-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
147712,6w9q,DB12336,-7.7,GDC-0917,HSHPBORBOJIXSQ-HARLFGEKSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
60023,6crv,DB08142,-7.7,AT-7519,OVPNQJVDAFNBDN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
132791,6w9c,DB00854,-7.7,Levorphanol,JAQUASYNZVUNQP-USXIJHARSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
103239,6vxs,DB08340,-7.7,"N,N'-DIPHENYLPYRAZOLO[1,5-A][1,3,5]TRIAZINE-2,4-DIAMINE",LLYYAUZAGCZEKV-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
12244,6lzg,DB13089,-7.7,Enoxolone,MPDGHEJMBKOTSU-YKLVYJNSSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
8978,6lzg,DB07043,-7.7,"7-amino-2-tert-butyl-4-(4-pyrimidin-2-ylpiperazin-1-yl)pyrido[2,3-d]pyrimidine-6-carboxamide",CKLCIJCZOIDJQU-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
132811,6w9c,DB00876,-7.7,Eprosartan,OROAFUQRIXKEMV-LDADJPATSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
59315,6crv,DB07318,-7.7,"N-[2-(4-AMINO-5,8-DIFLUORO-1,2-DIHYDROQUINAZOLIN-2-YL)ETHYL]-3-FURAMIDE",BOAUWUUBSXECNL-LLVKDONJSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
8979,6lzg,DB07045,-7.7,"(2R,3R,4S,5R)-2-[6-amino-8-[(3,4-dichlorophenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol",VBJKVZXRYLCYGQ-XNIJJKJLSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
94629,6m71,DB08341,-7.7,"4-{[4-{[(1R,2R)-2-(dimethylamino)cyclopentyl]amino}-5-(trifluoromethyl)pyrimidin-2-yl]amino}-N-methylbenzenesulfonamide",CAUFYHKGKDJMQG-HZPDHXFCSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
132812,6w9c,DB00878,-7.7,Chlorhexidine,GHXZTYHSJHQHIJ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
112627,6vxx,DB07473,-7.7,"(R)-(+) 5(9BH)-OXO-9B-PHENYL-2,3-DIHYDROTHIAZOLO[2,3-A]ISOINDOL-3-CARBOXYLIC ACID METHYL ESTER",JYIHODAXBBPFQF-MAUKXSAKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112626,6vxx,DB07472,-7.7,"(R)-(+)9B-(3-METHYL)PHENYL-2,3-DIHYDROTHIAZOLO[2,3-A]ISOINDOL-5(9BH)-ONE",FQVDJZWFSZSGGA-QGZVFWFLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
52707,2fxp,DB11904,-7.7,Flumatinib,BJCJYEYYYGBROF-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
132815,6w9c,DB00881,-7.7,Quinapril,JSDRRTOADPPCHY-HSQYWUDLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
60039,6crv,DB08158,-7.7,"2,4-DINITROPHENYL 2-DEOXY-2-FLUORO-BETA-D-MANNOPYRANOSIDE",UFSBFVZQJZMIOU-IYKVGLELSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112594,6vxx,DB07434,-7.7,HONH-BENZYLMALONYL-L-ALANYLGLYCINE-P-NITROANILIDE,TZWQPWGUQCSKDW-GUYCJALGSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
147629,6w9q,DB12225,-7.7,Beclabuvir,ZTTKEBYSXUCBSE-QDFUAKMASA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
112579,6vxx,DB07418,-7.7,bis(4-nitrophenyl) hydrogen phosphate,MHSVUSZEHNVFKW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
14160,6lzg,T3D3782,-7.7,Verruculogen,LRXYHMMJJCTUMY-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
103227,6vxs,DB08322,-7.7,"2-DEOXY-3,4-BIS-O-[3-(4-HYDROXYPHENYL)PROPANOYL]-L-THREO-PENTARIC ACID",VJLMRHSHSNLOGC-NOPZTHQXSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
131063,6w4h,DB13242,-7.7,Bucladesine,CJGYSWNGNKCJSB-YVLZZHOMSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
52755,2fxp,DB11977,-7.7,Golvatinib,UQRCJCNVNUFYDX-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
147678,6w9q,DB12289,-7.7,Darexaban,IJNIQYINMSGIPS-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
94810,6m71,DB08557,-7.7,"2-[(2-methoxyethyl)amino]-4-(4-oxo-1,2,3,4-tetrahydro-9H-carbazol-9-yl)benzamide",XQKFKSJUBJPOLY-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60099,6crv,DB08234,-7.7,"5-[3-(2,5-dimethoxyphenyl)prop-1-yn-1-yl]-6-ethylpyrimidine-2,4-diamine",NNFDQABYXZBKRK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
103170,6vxs,DB08250,-7.7,"(5S)-5-(3-AMINOPROPYL)-3-(2,5-DIFLUOROPHENYL)-N-ETHYL-5-PHENYL-4,5-DIHYDRO-1H-PYRAZOLE-1-CARBOXAMIDE",OQMVLDZJPRSNOG-NRFANRHFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
103140,6vxs,DB08212,-7.7,1-[2-(3-ACETYL-2-HYDROXY-6-METHOXY-PHENYL)-CYCLOPROPYL]-3-(5-CYANO-PYRIDIN-2-YL)-THIOUREA,FSRLCMRWYUJTNT-UONOGXRCSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
52999,2fxp,DB12323,-7.7,Radotinib,DUPWHXBITIZIKZ-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
116652,6w4b,DB02432,-7.7,RU90395,RLLAUERCSKPFGD-VMPREFPWSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
94964,6m71,DB08742,-7.7,"1,3-CYCLOHEXANEDIOL, 4-METHYLENE-5-[(2E)-[(1S,3AS,7AS)-OCTAHYDRO-1-(5-HYDROXY-5-METHYL-1,3-HEXADIYNYL)-7A-METHYL-4H-INDEN-4-YLIDENE]ETHYLIDENE]-, (1R,3S,5Z)",CEEUUHVULXTFGS-BQXVGYHGSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
116663,6w4b,DB02449,-7.7,3-(1h-Indol-3-Yl)-2-[4-(4-Phenyl-Piperidin-1-Yl)-Benzenesulfonylamino]-Propionic Acid,ULOTXPTWJAUGGE-MHZLTWQESA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
147331,6w9q,DB11786,-7.7,Pefcalcitol,SVCSMAZYWOQCBW-NVJMFHFGSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
60122,6crv,DB08262,-7.7,"2,6-dicarboxynaphthalene",RXOHFPCZGPKIRD-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
147321,6w9q,DB11772,-7.7,Pilaralisib,QINPEPAQOBZPOF-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
116740,6w4b,DB02545,-7.7,Fexaramine,VLQTUNDJHLEFEQ-KGENOOAVSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
112166,6vxx,DB06471,-7.7,Naxifylline,NJYNSYQBNSDGIQ-RDDCQWBRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
65572,6lxt,DB03013,-7.7,Di(N-Acetyl-D-Glucosamine),CDOJPCSDOXYJJF-KSKNGZLJSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
130781,6w4h,DB12779,-7.7,Higenamine,WZRCQWQRFZITDX-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
112150,6vxx,DB06436,-7.7,Semaxanib,WUWDLXZGHZSWQZ-WQLSENKSSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
133029,6w9c,DB01127,-7.7,Econazole,LEZWWPYKPKIXLL-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
112223,6vxx,DB06619,-7.7,Amdoxovir,RLAHNGKRJJEIJL-RFZPGFLSSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
147292,6w9q,DB11730,-7.7,Ribociclib,RHXHGRAEPCAFML-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
9253,6lzg,DB07334,-7.7,"N-[5-(ETHYLSULFONYL)-2-METHOXYPHENYL]-5-[3-(2-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-AMINE",HTIZPBXCJPQDEM-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
9269,6lzg,DB00673,-7.7,Aprepitant,ATALOFNDEOCMKK-OITMNORJSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
147278,6w9q,DB11703,-7.7,Acalabrutinib,WDENQIQQYWYTPO-IBGZPJMESA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
117019,6w4b,DB02917,-7.7,N-Hydroxy-4-(Methyl{[5-(2-Pyridinyl)-2-Thienyl]Sulfonyl}Amino)Benzamide,LFGYSFPVLMPUPE-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
9277,6lzg,DB07359,-7.7,"3-[(4-fluorophenyl)sulfanyl]-N-(4-methyl-1,3-thiazol-2-yl)-6-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]pyridine-2-carboxamide",SJTQKYKXCYVFHX-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
60130,6crv,DB08273,-7.7,4-HYDROXY-5-IODO-3-NITROPHENYLACETYL-EPSILON-AMINOCAPROIC ACID ANION,LKGGMBQFWIIXJM-UHFFFAOYSA-M,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
95082,6m71,DB08906,-7.7,Fluticasone furoate,XTULMSXFIHGYFS-VLSRWLAYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
147240,6w9q,DB11650,-7.7,HT-0712,ABEJDMOBAFLQNJ-NHCUHLMSSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
133032,6w9c,DB01130,-7.7,Prednicarbate,FNPXMHRZILFCKX-KAJVQRHHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
147236,6w9q,DB11644,-7.7,Tafamidis,TXEIIPDJKFWEEC-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
112067,6vxx,DB06209,-7.7,Prasugrel,DTGLZDAWLRGWQN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
147225,6w9q,DB11619,-7.7,Gestrinone,BJJXHLWLUDYTGC-ANULTFPQSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
95094,6m71,DB08927,-7.7,Amperozide,NNAIYOXJNVGUOM-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
104082,6vxs,DB11385,-7.7,Cefalonium,FMZXNVLFJHCSAF-DNVCBOLYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
130757,6w4h,DB12739,-7.7,Bindarit,MTHORRSSURHQPZ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
112720,6vxx,DB07768,-7.7,Epitestosterone,MUMGGOZAMZWBJJ-KZYORJDKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
147352,6w9q,DB11816,-7.7,Omecamtiv Mecarbil,RFUBTTPMWSKEIW-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
147360,6w9q,DB11824,-7.7,Tofogliflozin,VWVKUNOPTJGDOB-BDHVOXNPSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
112358,6vxx,DB07013,-7.7,TERT-BUTYL 4-({[4-(BUT-2-YN-1-YLAMINO)PHENYL]SULFONYL}METHYL)-4-[(HYDROXYAMINO)CARBONYL]PIPERIDINE-1-CARBOXYLATE,RXFCFGLSOUOCEA-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
116228,6w4b,DB01873,-7.7,Epothilone D,XOZIUKBZLSUILX-GIQCAXHBSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
14134,6lzg,T3D3752,-7.7,Arisugacin A,PNHIMPBISRQKHV-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
130871,6w4h,DB12924,-7.7,Ozenoxacin,XPIJWUTXQAGSLK-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
116271,6w4b,DB01940,-7.7,Balanol Analog 2,SQLYTJZXRRDERK-ISKFKSNPSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
112336,6vxx,DB06989,-7.7,{4-[2-BENZYL-3-METHOXY-2-(METHOXYCARBONYL)-3-OXOPROPYL]PHENYL}SULFAMIC ACID,SUACYXRSGYYBGT-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
116278,6w4b,DB01948,-7.7,"1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperidin-4-Yl-3,4-Dihydroquinolin-2(1h)-One",VXIYTVJEIXMAQF-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
103165,6vxs,DB08244,-7.7,"(1S)-1-CYCLOPROPYL-2-[(2S)-4-(2,5-DIFLUOROPHENYL)-2-PHENYL-2,5-DIHYDRO-1H-PYRROL-1-YL]-2-OXOETHANAMINE",VCOUEHUEFUDZIS-PMACEKPBSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
14129,6lzg,T3D3747,-7.7,Territrem C,FTTNXWIFPFEOQT-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
132958,6w9c,DB01044,-7.7,Gatifloxacin,XUBOMFCQGDBHNK-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
116303,6w4b,DB01977,-7.7,6-(N-Phenylcarbamyl)-2-Naphthalenecarboxamidine,AECPTICWHONWNW-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
147427,6w9q,DB11922,-7.7,Danirixin,NGYNBSHYFOFVLS-LBPRGKRZSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
147426,6w9q,DB11921,-7.7,Deflazacort,FBHSPRKOSMHSIF-GRMWVWQJSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
130860,6w4h,DB12904,-7.7,ZSTK-474,HGVNLRPZOWWDKD-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
9203,6lzg,DB07287,-7.7,"2-(2,4-DICHLOROPHENOXY)-5-(PYRIDIN-2-YLMETHYL)PHENOL",AOVDSWPGWPRTSR-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
59305,6crv,DB07308,-7.7,5-(2-CHLOROBENZYL)-2-FUROIC ACID,YRUPEIZURHOLHV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
116342,6w4b,DB02033,-7.7,"N-(3-Cyclopropyl(5,6,7,8,9,10-Hexahydro-2-Oxo-2h-Cycloocta[B]Pyran-3-Yl)Methyl)Phenylbenzensulfonamide",GDRNWAKVNIROCG-DEOSSOPVSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
14124,6lzg,T3D3742,-7.7,Fumitremorgin A,ACGHJVZDNQZJOV-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
94919,6m71,DB08694,-7.7,"9-amino-5-(2-aminopyrimidin-4-yl)pyrido[3',2':4,5]pyrrolo[1,2-c]pyrimidin-4-ol",RTHKPHCVZVYDFN-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94922,6m71,DB08698,-7.7,"1-[(3S)-5-PHENYL-3-THIOPHEN-2-YL-3H-1,4-BENZODIAZEPIN-2-YL]AZETIDIN-3-OL",BKSGACYTXOQQNI-OAQYLSRUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
9165,6lzg,DB07249,-7.7,"N-(5-chloro-1,3-benzodioxol-4-yl)-6-methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-amine",QHIMVPIOWKYPSO-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
59302,6crv,DB07305,-7.7,5-(2-CHLORO-4-NITROPHENYL)-2-FUROIC ACID,HDIHNBCCQWMVBW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
132982,6w9c,DB01071,-7.7,Mequitazine,HOKDBMAJZXIPGC-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
94924,6m71,DB08701,-7.7,"2-(3-BROMOPHENYL)-6-[(2-HYDROXYETHYL)AMINO]-1H-BENZO[DE]ISOQUINOLINE-1,3(2H)-DIONE",JZCUVYNOSDWORZ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94928,6m71,DB08705,-7.7,"6-(5-BROMO-2-HYDROXYPHENYL)-2-OXO-4-PHENYL-1,2-DIHYDROPYRIDINE-3-CARBONITRILE",SVSYJTYGPLVUOZ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
112261,6vxx,DB06898,-7.7,"4-(2-amino-1-methyl-1H-imidazo[4,5-b]pyridin-6-yl)phenol",UGJXOCBVCWTJFP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
133011,6w9c,DB01104,-7.7,Sertraline,VGKDLMBJGBXTGI-SJCJKPOMSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
130808,6w4h,DB12825,-7.7,Lefamulin,KPVIXBKIJXZQJX-FCEONZPQSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
116514,6w4b,DB02259,-7.7,"3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid (4-Sulfamoyl-Phenyl)-Amide",VSYGXLAJQDAWCZ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
133019,6w9c,DB01115,-7.7,Nifedipine,HYIMSNHJOBLJNT-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
147411,6w9q,DB11901,-7.7,Apalutamide,HJBWBFZLDZWPHF-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
10329,6lzg,DB08513,-7.7,[4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENYL]ACETIC ACID,PAIQRYUOBBCBSE-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
137887,6w9c,DB08836,-7.7,Temocapril,FIQOFIRCTOWDOW-BJLQDIEVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
102682,6vxs,DB07688,-7.7,"4-{[5-(CYCLOHEXYLOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE",RPJIMTALCNCQLV-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
27614,6cs2,DB07164,-7.7,"N-cyclopropyl-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amine",CAGHIASAHLPQMS-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
58015,6crv,DB04441,-7.7,2-Fluoroadenosine,HBUBKKRHXORPQB-UUOKFMHZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
11741,6lzg,DB12375,-7.7,Oglemilast,OKFDRAHPFKMAJH-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
140051,6w9c,DB14849,-7.7,Nebicapone,MRFOLGFFTUGAEB-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
56569,6crv,DB02495,-7.7,9-(4-hydroxybutyl)-N2-phenylguanine,JHBXNPBKSPYOFT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27612,6cs2,DB07163,-7.7,5-[(2-AMINOETHYL)AMINO]-6-FLUORO-3-(1H-PYRROL-2-YL)BENZO[CD]INDOL-2(1H)-ONE,CQCXWWWNUFQYJS-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
139999,6w9c,DB14720,-7.7,Brovanexine,DQTRREPKGJIABH-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139986,6w9c,DB14678,-7.7,Norethindrone enanthate,APTGJECXMIKIET-WOSSHHRXSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
124368,6w4h,DB01068,-7.7,Clonazepam,DGBIGWXXNGSACT-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
61213,6crv,DB11757,-7.7,Istradefylline,IQVRBWUUXZMOPW-PKNBQFBNSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
100370,6vxs,DB03490,-7.7,"3-Pyridin-4-Yl-2,4-Dihydro-Indeno[1,2-.C.]Pyrazole",NHOACLCXCKJMAK-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
136828,6w9c,DB07582,-7.7,"N-[(2R,3S)-1-((2S)-2-{[(CYCLOPENTYLAMINO)CARBONYL]AMINO}-3-METHYLBUTANOYL)-2-(1-FORMYL-1-CYCLOBUTYL)PYRROLIDINYL]CYCLOPROPANECARBOXAMIDE",GCDRFILPPBOJLM-UFYCRDLUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
27610,6cs2,DB07161,-7.7,5-phenyl-1H-indazol-3-amine,ZCUSNQPYUNLATP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
139952,6w9c,DB14643,-7.7,Methylprednisolone aceponate,DALKLAYLIPSCQL-YPYQNWSCSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
11233,6lzg,DB11687,-7.7,E-6201,MWUFVYLAWAXDHQ-HMNLTAHHSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
124375,6w4h,DB01076,-7.7,Atorvastatin,XUKUURHRXDUEBC-KAYWLYCHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
62181,6crv,DB13232,-7.7,Suxibuzone,ONWXNHPOAGOMTG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61215,6crv,DB11762,-7.7,Marizomib,NGWSFRIPKNWYAO-SHTIJGAHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
101905,6vxs,DB06743,-7.7,Ginkgolide A,FPUXKXIZEIDQKW-VKMVSBOZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
106809,6vxx,DB01298,-7.7,Sulfacytine,SIBQAECNSSQUOD-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127820,6w4h,DB06891,-7.7,"5-{[(4-AMINO-3-CHLORO-5-FLUOROPHENYL)SULFONYL]AMINO}-1,3,4-THIADIAZOLE-2-SULFONAMIDE",HOLJYLOVIHBQHO-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
124416,6w4h,DB01125,-7.7,Anisindione,XRCFXMGQEVUZFC-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
127812,6w4h,DB06883,-7.7,1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-phenylurea,DHNYNLNKNQJSHF-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
139889,6w9c,DB14207,-7.7,Fosinoprilat,WOIWWYDXDVSWAZ-RTWAWAEBSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139883,6w9c,DB14196,-7.7,"N-Cyclohexyl-N'-phenyl-1,4-phenylenediamine",ZRMMVODKVLXCBB-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139857,6w9c,DB14127,-7.7,Sacubitrilat,DOBNVUFHFMVMDB-BEFAXECRSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139855,6w9c,DB14125,-7.7,Benazeprilat,MADRIHWFJGRSBP-ROUUACIJSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
100408,6vxs,DB03549,-7.7,Biotinyl P-Nitroaniline,PORZMUYPQKOFQY-YDHLFZDLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
139831,6w9c,DB14071,-7.7,Desmethylsertraline,SRPXSILJHWNFMK-ZBEGNZNMSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
13043,6lzg,DB14581,-7.7,CPI-1205,HPODOLXTMDHLLC-QGZVFWFLSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
136831,6w9c,DB07585,-7.7,"5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine",YFFJXGRXFASBDL-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
127797,6w4h,DB06866,-7.7,6-CARBAMIMIDOYL-2-[2-HYDROXY-5-(3-METHOXY-PHENYL)-INDAN-1-YL]-HEXANOIC ACID,NMOUMGFCBOWPAB-RZUBCFFCSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
140065,6w9c,DB14875,-7.7,AZD-4017,NCDZABJPWMBMIQ-INIZCTEOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
101912,6vxs,DB06755,-7.7,Beta carotene,OENHQHLEOONYIE-JLTXGRSLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
56484,6crv,DB02390,-7.7,5-Bromo-N[2-(Dimethylamino)Ethyl]-9-Aminoacridine-4-Carboxamide,NROQPXQSDDINMC-UHFFFAOYSA-P,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
11195,6lzg,DB11637,-7.7,Delamanid,XDAOLTSRNUSPPH-XMMPIXPASA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
127902,6w4h,DB06991,-7.7,"N-[2-methyl-5-(methylcarbamoyl)phenyl]-2-{[(1R)-1-methylpropyl]amino}-1,3-thiazole-5-carboxamide",OYOUIHFZUAKCEF-LLVKDONJSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
27061,6cs2,DB06364,-7.7,XR5944,SFOADSRLCHRTKT-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
140297,6w9c,DB02770,-7.7,7-Alpha-D-Ribofuranosyl-2-Aminopurine-5'-Phosphate,UDRQVOJQMHZSIM-PULFBKJNSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
12753,6lzg,DB13764,-7.7,Monoxerutin,MBHXKZDTQCSVPM-BDAFLREQSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
100292,6vxs,DB03376,-7.7,'5'-O-(N-(L-Alanyl)-Sulfamoyl)Adenosine,CWWYMWDIYBJVLP-YTMOPEAISA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
56499,6crv,DB02407,-7.7,6-O-Cyclohexylmethyl Guanine,MWGXGTJJAOZBNW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106919,6vxx,DB01748,-7.7,N-Benzyl-4-Sulfamoyl-Benzamide,CZKNSZUJCJHTTM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140248,6w9c,DB15440,-7.7,GSK-3117391,AFDPFLDWOXXHQM-NRFANRHFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
100301,6vxs,DB03388,-7.7,"3-[(2,4-Dichlorobenzoyl)(Isopropyl)Amino]-5-Phenylthiophene-2-Carboxylic Acid",UKNZREOUDLFUFF-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
61185,6crv,DB11711,-7.7,Navarixin,IXBYSXNOKFHHDR-QGZVFWFLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27066,6cs2,DB06374,-7.7,Elacestrant,SIFNOOUKXBRGGB-AREMUKBSSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
105161,6vxs,DB13089,-7.7,Enoxolone,MPDGHEJMBKOTSU-YKLVYJNSSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
124300,6w4h,DB00991,-7.7,Oxaprozin,OFPXSFXSNFPTHF-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
140183,6w9c,DB15300,-7.7,Hydroquinidine,LJOQGZACKSYWCH-LHHVKLHASA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140175,6w9c,DB15123,-7.7,Dorzagliatin,HMUMWSORCUWQJO-QAPCUYQASA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
101921,6vxs,DB06777,-7.7,Chenodeoxycholic acid,RUDATBOHQWOJDD-BSWAIDMHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
136760,6w9c,DB07500,-7.7,(2E)-1-[2-hydroxy-4-methoxy-5-(3-methylbut-2-en-1-yl)phenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one,ZUGCRBMNFSAUOC-YRNVUSSQSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
127858,6w4h,DB06932,-7.7,"10,11-dimethoxy-4-methyldibenzo[c,f]-2,7-naphthyridine-3,6-diamine",NVINUNQBDNEMSY-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
136761,6w9c,DB07501,-7.7,(2S)-1-{4-[(4-Anilino-5-bromo-2-pyrimidinyl)amino]phenoxy}-3-(dimethylamino)-2-propanol,MEIJADBULOETOV-KRWDZBQOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136764,6w9c,DB07505,-7.7,"N-({(3R,4R)-4-[(benzyloxy)methyl]pyrrolidin-3-yl}methyl)-N-(2-methylpropyl)benzenesulfonamide",DGURGFSAQIBQCO-FGZHOGPDSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
124280,6w4h,DB00967,-7.7,Desloratadine,JAUOIFJMECXRGI-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
140142,6w9c,DB15058,-7.7,Flutemetamol,VVECGOCJFKTUAX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
11752,6lzg,DB12388,-7.7,Evocalcet,RZNUIYPHQFXBAN-XLIONFOSSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
11232,6lzg,DB11686,-7.7,Iferanserin,UXIPFQUBOVWAQW-UEBLJOKOSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
140120,6w9c,DB15021,-7.7,Leriglitazone,OXVFDZYQLGRLCD-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
27616,6cs2,DB07167,-7.7,5-CYANO-FURAN-2-CARBOXYLIC ACID [5-HYDROXYMETHYL-2-(4-METHYL-PIPERIDIN-1-YL)-PHENYL]-AMIDE,NNPCFFIJVKYGHR-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
140099,6w9c,DB14938,-7.7,Flurbiprofen axetil,ALIVXCSEERJYHU-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136771,6w9c,DB07513,-7.7,7-[(3-CHLOROBENZYL)OXY]-4-[(METHYLAMINO)METHYL]-2H-CHROMEN-2-ONE,JMGUSOLCNQVZCT-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
106866,6vxx,DB01418,-7.7,Acenocoumarol,VABCILAOYCMVPS-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127785,6w4h,DB06850,-7.7,(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclohexylamino)ethanoyl)pyrrolidine-2-carboxamide,RYKFVFFOIYLADT-SFHVURJKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
139810,6w9c,DB14033,-7.7,Acetyl sulfisoxazole,JFNWFXVFBDDWCX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
100444,6vxs,DB03601,-7.7,5-deoxyflavanone,FURUXTVZLHCCNA-AWEZNQCLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
124613,6w4h,DB01426,-7.7,Ajmaline,CJDRUOGAGYHKKD-HEFSZTOGSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
56725,6crv,DB02699,-7.7,4-Oxoretinol,PLIUCYCUYQIBDZ-RMWYGNQTSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
105256,6vxs,DB13256,-7.7,Clothiapine,KAAZGXDPUNNEFN-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
136973,6w9c,DB07755,-7.7,"(2S)-1-[4-({4-[(2,5-Dichlorophenyl)amino]-2-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol",GNLAGGCSJGJECE-INIZCTEOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139591,6w9c,DB13675,-7.7,Metahexamide,XXYTXQGCRQLRHA-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
27542,6cs2,DB07088,-7.7,(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclopentyloxy)ethanoyl)pyrrolidine-2-carboxamide,ZWXWAYUCJVQHOR-KRWDZBQOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
124634,6w4h,DB01451,-7.7,1-Androstenedione,WJIQCDPCDVWDDE-WZNAKSSCSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
124636,6w4h,DB01453,-7.7,Beta-hydroxyfentanyl,JEFVHLMGRUJLET-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
27537,6cs2,DB07085,-7.7,2-{[N-(2-ACETYL-5-CHLORO-4-FLUOROPHENYL)GLYCYL]AMINO}BENZOIC ACID,LBMZLHCAPBBOFS-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
105280,6vxs,DB13292,-7.7,Pimethixene,NZLVRVYNQYGMAB-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
124651,6w4h,DB01469,-7.7,Acetorphine,LFYBMMHFJIAKFE-PMEKXCSPSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
101840,6vxs,DB06629,-7.7,Zibotentan,FJHHZXWJVIEFGJ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
106655,6vxx,DB00860,-7.7,Prednisolone,OIGNJSKKLXVSLS-VWUMJDOOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
101835,6vxs,DB06622,-7.7,7-beta-Hydroxyepiandrosterone,VFPMCLQMAUVEHD-UCPSWNCLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
27543,6cs2,DB07089,-7.7,N-[amino(imino)methyl]-2-[2-(2-chlorophenyl)-4-(4-propoxyphenyl)-3-thienyl]acetamide,VZSMTBLDWPKVRW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
11313,6lzg,DB11796,-7.7,Fostemsavir,SWMDAPWAQQTBOG-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
127667,6w4h,DB06645,-7.7,Anamorelin,VQPFSIRUEPQQPP-MXBOTTGLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
124688,6w4h,DB01514,-7.7,Furazabol,RGLLOUBXMOGLDQ-IVEVATEUSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
100650,6vxs,DB03869,-7.7,5'-O-(N-(L-Seryl)-Sulfamoyl)Adenosine,HQXFJGONGJPTLZ-YTMOPEAISA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
139529,6w9c,DB13596,-7.7,Oxycinchophen,XAPRFLSJBSXESP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
11320,6lzg,DB11806,-7.7,VTP-194204,BOOOLEGQBVUTKC-NVQSDHBMSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
11323,6lzg,DB11814,-7.7,PF-03882845,XNULRSOGWPFPBL-REWPJTCUSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
106615,6vxx,DB00817,-7.7,Rosoxacin,XBPZXDSZHPDXQU-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
139499,6w9c,DB13551,-7.7,Cinchophen,YTRMTPPVNRALON-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
105312,6vxs,DB13333,-7.7,Efloxate,ZVXBAHLOGZCFTP-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
56794,6crv,DB02798,-7.7,Alpha-Methylene Adenosine Monophosphate,PXSSQXBLDTZHLF-IOSLPCCCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127617,6w4h,DB06529,-7.7,Ocinaplon,OQJFBUOFGHPMSR-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
106585,6vxx,DB00525,-7.7,Tolnaftate,FUSNMLFNXJSCDI-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
139467,6w9c,DB13507,-7.7,Poldine,CQRKVVAGMJJJSR-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139464,6w9c,DB13504,-7.7,Cefetamet,MQLRYUCJDNBWMV-GHXIOONMSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
106639,6vxx,DB00843,-7.7,Donepezil,ADEBPBSSDYVVLD-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56722,6crv,DB02696,-7.7,"6-Aminohexyl-Uridine-C1,5'-Diphosphate",MLWJBKPFDKRHBM-FMKGYKFTSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136965,6w9c,DB07746,-7.7,3-ETHYL-6-{[(4-FLUOROPHENYL)SULFONYL]AMINO}-2-METHYLBENZOIC ACID,MGUQWAOYPINSIT-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
11305,6lzg,DB11787,-7.7,Ralimetinib,XPPBBJCBDOEXDN-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
136885,6w9c,DB07648,-7.7,"(2R)-3-{[(4Z)-5,6-DIPHENYL-6,7-DIHYDRO-4H-PYRROLO[2,3-D]PYRIMIDIN-4-YLIDENE]AMINO}PROPANE-1,2-DIOL",TWEONIHFGKSPLC-MRXNPFEDSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
124470,6w4h,DB01185,-7.7,Fluoxymesterone,YLRFCQOZQXIBAB-RBZZARIASA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
62138,6crv,DB13143,-7.7,Methallenestril,KHLJKRBMZVNZOC-MRXNPFEDSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
11262,6lzg,DB11732,-7.7,Lasmiditan,XEDHVZKDSYZQBF-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
124477,6w4h,DB01192,-7.7,Oxymorphone,UQCNKQCJZOAFTQ-ISWURRPUSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
105203,6vxs,DB13166,-7.7,Zofenopril,IAIDUHCBNLFXEF-MNEFBYGVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
139758,6w9c,DB13937,-7.7,LGD-3303,OMXGOGXEWUCLFI-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
127772,6w4h,DB06833,-7.7,1-CYCLOHEXYL-N-{[1-(4-METHYLPHENYL)-1H-INDOL-3-YL]METHYL}METHANAMINE,MMIJMYOYKAKQPN-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
106762,6vxx,DB01218,-7.7,Halofantrine,FOHHNHSLJDZUGQ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
13038,6lzg,DB14569,-7.7,Tedizolid,XFALPSLJIHVRKE-GFCCVEGCSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
100473,6vxs,DB03647,-7.7,3-[Isopropyl(4-Methylbenzoyl)Amino]-5-Phenylthiophene-2-Carboxylic Acid,LRHXIDOGMBZJFN-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
106744,6vxx,DB01198,-7.7,Zopiclone,GBBSUAFBMRNDJC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127769,6w4h,DB06829,-7.7,4-BROMO-3-(CARBOXYMETHOXY)-5-[3-(CYCLOHEXYLAMINO)PHENYL]THIOPHENE-2-CARBOXYLIC ACID,RXDVFLTWXCTCEX-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
124515,6w4h,DB01238,-7.7,Aripiprazole,CEUORZQYGODEFX-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
106731,6vxx,DB00946,-7.7,Phenprocoumon,DQDAYGNAKTZFIW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
124530,6w4h,DB01260,-7.7,Desonide,WBGKWQHBNHJJPZ-LECWWXJVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
56674,6crv,DB02632,-7.7,4-nitrophenyl-beta-D-galactoside,IFBHRQDFSNCLOZ-YBXAARCKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
24451,6cs2,DB02196,-7.7,Uridine-Diphosphate-N-Acetylgalactosamine,LFTYTUAZOPRMMI-NESSUJCYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
139668,6w9c,DB13778,-7.7,Cefazedone,VTLCNEGVSVJLDN-MLGOLLRUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
105237,6vxs,DB13230,-7.7,Gestonorone,GTFUITFQDGVJSK-XGXHKTLJSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101884,6vxs,DB06713,-7.7,Norelgestromin,ISHXLNHNDMZNMC-XUDSTZEESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
127741,6w4h,DB06780,-7.7,Desoxycorticosterone acetate,VPGRYOFKCNULNK-ACXQXYJUSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
124568,6w4h,DB01347,-7.7,Saprisartan,DUEWVPTZCSAMNB-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
140317,6w9c,DB02802,-7.7,5-Aminocarbonyl-3-Nitrophenyl-Alpha-D-Galactopyranose,BYSXBFJVGIOFBO-LNSPPBFMSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
124567,6w4h,DB01342,-7.7,Forasartan,YONOBYIBNBCDSJ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
105220,6vxs,DB13212,-7.7,Phenolsulfonphthalein,BELBBZDIHDAJOR-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
11294,6lzg,DB11773,-7.7,BMS-903452,OGIAVRWXUPYGGC-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
139703,6w9c,DB13823,-7.7,Pipemidic acid,JOHZPMXAZQZXHR-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
27090,6cs2,DB06444,-7.7,Dexanabinol,SSQJFGMEZBFMNV-PMACEKPBSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
136927,6w9c,DB07701,-7.7,"1-BENZYL-4-[(5,6-DIMETHOXY-1-INDANON-2-YL)METHYL]PIPERIDINE",ADEBPBSSDYVVLD-HXUWFJFHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136922,6w9c,DB07695,-7.7,"N-(3,5-dibromo-4-hydroxyphenyl)-4-hydroxy-3,5-dimethylbenzamide",HHFKUQZPNITQLU-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
124562,6w4h,DB01336,-7.7,Metocurine,JFXBEKISTKFVAB-AJQTZOPKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
127910,6w4h,DB06999,-7.7,"N-{3-[(5-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)carbonyl]-2,4-difluorophenyl}propane-1-sulfonamide",YZDJQTHVDDOVHR-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
62245,6crv,DB13320,-7.7,Sulfaperin,DZQVFHSCSRACSX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136700,6w9c,DB07429,-7.7,2-({[4-bromo-3-(diethylsulfamoyl)phenyl]carbonyl}amino)benzoic acid,VNOMZKMKBNFCMC-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
128140,6w4h,DB07263,-7.7,"[{2-bromo-4-[(2R)-3-oxo-2,3-diphenylpropyl]phenyl}(difluoro)methyl]phosphonic acid",WDTMVBQZDFMOIK-GOSISDBHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
104998,6vxs,DB12840,-7.7,Pirnabine,AADNQNOXNWEYHS-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
107395,6vxx,DB03250,-7.7,"2-(Beta-D-Glucopyranosyl)-5-Methyl-1,3,4-Benzothiazole",WGJFWQVWYRZPEP-KABOQKQYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107379,6vxx,DB03233,-7.7,"Phosphoric Acid Mono-[3-Amino-5-(5-Methyl-2,4-Dioxo-3,4-Dihydro-2h-Pyrimidin-1-Yl)-Tetrahydro-Furan-2-Ylmethyl] Ester",BQZMHQZNZNBJNF-XLPZGREQSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62463,6crv,DB13611,-7.7,Chlormidazole,WNAQOLSMVPFGTE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62462,6crv,DB13610,-7.7,Flumedroxone,CDZJOBWKHSYNMO-SCUQKFFVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
128112,6w4h,DB07232,-7.7,Veliparib,JNAHVYVRKWKWKQ-CYBMUJFWSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
11814,6lzg,DB12465,-7.7,Ketanserin,FPCCSQOGAWCVBH-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
58170,6crv,DB04640,-7.7,"Naphthalene-2,6-disulfonic acid",FITZJYAVATZPMJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
141062,6w9q,DB00444,-7.7,Teniposide,NRUKOCRGYNPUPR-QBPJDGROSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
56244,6crv,DB02075,-7.7,"(1s)-1(9-Deazahypoxanthin-9yl)1,4-Dideoxy-1,4-Imino-D-Ribitol-5-Phosphate",VJTAXXUIRYOXBT-KUBHLMPHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136442,6w9c,DB07122,-7.7,1-[4-(2-oxo-2-phenylethyl)phenyl]guanidine,MERNPSIIBFTCAI-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
4305,6lzg,HMDB0001339,-7.7,Glutaryl-CoA,SYKWLIJQEHRDNH-KRPIADGTSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
62439,6crv,DB13580,-7.7,Succinylsulfathiazole,SKVLYVHULOWXTD-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
123581,6w4h,DB00140,-7.7,Riboflavin,AUNGANRZJHBGPY-SCRDCRAPSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
102082,6vxs,DB06990,-7.7,"4-[(1E,7E)-8-(2,6-DIOXO-1,2,3,6-TETRAHYDROPYRIMIDIN-4-YL)-3,6-DIOXA-2,7-DIAZAOCTA-1,7-DIEN-1-YL]BENZOIC ACID",XHDKIDMFBWLHAX-GONBZBRSSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102079,6vxs,DB06986,-7.7,"2-CHLORO-N-[(1R,2R)-1-HYDROXY-2,3-DIHYDRO-1H-INDEN-2-YL]-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE",LRHOLHTVXXSIMG-BXUZGUMPSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
141024,6w9q,DB00398,-7.7,Sorafenib,MLDQJTXFUGDVEO-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
25171,6cs2,DB03046,-7.7,7-Methoxy-8-[1-(Methylsulfonyl)-1h-Pyrazol-4-Yl]Naphthalene-2-Carboximidamide,KQUXAFOLFXHVQN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
128077,6w4h,DB07188,-7.7,"(3S)-1-CYCLOHEXYL-N-(3,5-DICHLOROPHENYL)-5-OXOPYRROLIDINE-3-CARBOXAMIDE",YUFADRZDHJKVOT-NSHDSACASA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
136476,6w9c,DB07161,-7.7,5-phenyl-1H-indazol-3-amine,ZCUSNQPYUNLATP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
7417,6lzg,DB03768,-7.7,"N-[2-Hydroxy-2-(8-Isopropyl-6,9-Dioxo-2-Oxa-7,10-Diaza-Bicyclo[11.2.2]Heptadeca-1(16),13(17),14-Trien-11-Yl)-Ethyl]-N-(3-Methyl-Butyl)-Benzenesulfonamide,Inhibitor 3",WRUVOSYKHXGAQN-GKRYNVPLSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
128072,6w4h,DB07183,-7.7,N-(4-phenoxyphenyl)-2-[(pyridin-4-ylmethyl)amino]nicotinamide,CPVRYQAOUPSUDO-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
123718,6w4h,DB00295,-7.7,Morphine,BQJCRHHNABKAKU-KBQPJGBKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
136483,6w9c,DB07169,-7.7,"5R-(3,4-DICHLOROPHENYLMETHYL)-3-(2-THIOPHENESULFONYLAMINO)-4-OXO-2-THIONOTHIAZOLIDINE",GAOOBYJHWAKZKU-LLVKDONJSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
128052,6w4h,DB07161,-7.7,5-phenyl-1H-indazol-3-amine,ZCUSNQPYUNLATP-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
107276,6vxx,DB03097,-7.7,"Pmp-Hydroxyisoxazole, Pyridoxamine-5-Phosphate-Hydroxyisoxazole",PXWFNGNWQUPGPJ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56294,6crv,DB02135,-7.7,"4-{2,6,8-Trioxo-9-[(2R,3S,4R)-2,3,4,5-Tetrahydroxypentyl]-1,2,3,6,8,9-Hexahydro-7h-Purin-7-Yl}Butyl Dihydrogen Phosphate",VBXZSBKAJFXURR-MRTMQBJTSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62379,6crv,DB13496,-7.7,Iprindole,PLIGPBGDXASWPX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140863,6w9q,DB00206,-7.7,Reserpine,QEVHRUUCFGRFIF-MDEJGZGSSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
13106,6lzg,DB14679,-7.7,Quingestanol acetate,FLGJKPPXEKYCBY-AKCFYGDASA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
128146,6w4h,DB07271,-7.7,"4-[(3R)-3-Amino-4-(2,4,5-trifluorophenyl)butanoyl]-3-(2,2,2-trifluoroethyl)-1,4-diazepan-2-one",RMDAPSXWBVPVOG-IAPIXIRKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
107431,6vxx,DB03585,-7.7,Oxyphenbutazone,HFHZKZSRXITVMK-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62506,6crv,DB13670,-7.7,Oxantel,VRYKTHBAWRESFI-VOTSOKGWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
128187,6w4h,DB07314,-7.7,"1-(5-CHLORO-2,4-DIMETHOXYPHENYL)-3-(5-CYANOPYRAZIN-2-YL)UREA",URQYPXQXSVUVRG-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
24226,6cs2,DB00275,-7.7,Olmesartan,VTRAEEWXHOVJFV-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
61069,6crv,DB11461,-7.7,Sulfachlorpyridazine,XOXHILFPRYWFOD-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136365,6w9c,DB07034,-7.7,"2,2'-{[9-(HYDROXYIMINO)-9H-FLUORENE-2,7-DIYL]BIS(OXY)}DIACETIC ACID",VOKATEXROYSXDW-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
107533,6vxx,DB03726,-7.7,Purine Riboside-5'-Monophosphate,MCWDCZIDTUQRHK-FDDDBJFASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107517,6vxx,DB03708,-7.7,Adenosine 5'-phosphosulfate,IRLPACMLTUPBCL-KQYNXXCUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
128185,6w4h,DB07312,-7.7,"2,5-DICHLORO-N-(5-CHLORO-1,3-BENZOXAZOL-2-YL)BENZENESULFONAMIDE",JCXZHFCBNFFHRC-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
141387,6w9q,DB00836,-7.7,Loperamide,RDOIQAHITMMDAJ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
58208,6crv,DB04693,-7.7,"(13S)-13-METHYLDODECAHYDRO-1H-CYCLOPENTA[A]PHENANTHRENE-3,17(2H,4H)-DIONE",CRDKSBHJIGNEOH-IMRIKWHGSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
123362,6w4b,DB15399,-7.7,BMS-754807,LQVXSNNAFNGRAH-QHCPKHFHSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
136371,6w9c,DB07040,-7.7,"2-amino-7-fluoro-5-oxo-5H-chromeno[2,3-b]pyridine-3-carboxamide",GCHMLYYPYFXLQB-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136376,6w9c,DB07046,-7.7,"2-[(2-chloro-4-iodophenyl)amino]-N-{[(2R)-2,3-dihydroxypropyl]oxy}-3,4-difluorobenzamide",FCADPEDUULETPK-SECBINFHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
99703,6vxs,DB02596,-7.7,"Alpha,Beta-Methyleneadenosine-5'-Triphosphate",CAWZRIXWFRFUQB-IOSLPCCCSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
123382,6w4b,DB15437,-7.7,Rocacetrapib,GBHPDJQHZADVAA-SOKVYYICSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
27759,6cs2,DB07312,-7.7,"2,5-DICHLORO-N-(5-CHLORO-1,3-BENZOXAZOL-2-YL)BENZENESULFONAMIDE",JCXZHFCBNFFHRC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
62555,6crv,DB13730,-7.7,Nifurtoinol,UIDWQGRXEVDFCA-XCVCLJGOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61073,6crv,DB11466,-7.7,Tepoxalin,XYKWNRUXCOIMFZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
24266,6cs2,DB01972,-7.7,Guanosine-5'-Monophosphate,RQFCJASXJCIDSX-UUOKFMHZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
62510,6crv,DB13674,-7.7,Cridanimod,UOMKBIIXHQIERR-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
99768,6vxs,DB02684,-7.7,5'-O-(N-(L-Cysteinyl)-Sulfamoyl)Adenosine,FTSDEWPMACCNGN-YTMOPEAISA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
99758,6vxs,DB02669,-7.7,RB106,ZWDQTNWLXALTOV-QYZOEREBSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
123520,6w4b,DB00253,-7.7,Medrysone,GZENKSODFLBBHQ-ILSZZQPISA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
104980,6vxs,DB12808,-7.7,Trifarotene,MFBCDACCJCDGBA-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
27028,6cs2,DB06268,-7.7,Sitaxentan,PHWXUGHIIBDVKD-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
141224,6w9q,DB00643,-7.7,Mebendazole,OPXLLQIJSORQAM-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
62530,6crv,DB13696,-7.7,Bromochlorosalicylanilide,QBSGXIBYUQJHMJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107457,6vxx,DB03626,-7.7,"5-Methoxy-1,2-Dimethyl-3-(Phenoxymethyl)Indole-4,7-Dione",JRPJCFILHCLEJI-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
24251,6cs2,DB01954,-7.7,Rolipram,HJORMJIFDVBMOB-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
107468,6vxx,DB03641,-7.7,"2'-deoxyuridine 5'-alpha,beta-imido-diphosphate",COFNIXBQVWFHTR-SHYZEUOFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
123424,6w4b,DB00146,-7.7,Calcifediol,JWUBBDSIWDLEOM-DTOXIADCSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
56180,6crv,DB01987,-7.7,Cocarboxylase,AYEKOFBPNLCAJY-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
123490,6w4b,DB00220,-7.7,Nelfinavir,QAGYKUNXZHXKMR-HKWSIXNMSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
139463,6w9c,DB13502,-7.7,Budipine,QIHLUZAFSSMXHQ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136498,6w9c,DB07185,-7.7,2-{[(4-CHLOROPHENOXY)ACETYL]AMINO}BENZOIC ACID,LXSDGQYDSDIUPN-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
24329,6cs2,DB02047,-7.7,"2-(1,1'-Biphenyl-4-Yl)Propanoic Acid",JALUUBQFLPUJMY-NSHDSACASA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
140579,6w9c,DB12478,-7.7,Piribedil,OQDPVLVUJFGPGQ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
127976,6w4h,DB07073,-7.7,"5,5-dimethyl-2-morpholin-4-yl-5,6-dihydro-1,3-benzothiazol-7(4H)-one",DZXMARZBAUMWLK-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
140540,6w9c,DB12029,-7.7,Chlorogenic Acid,CWVRJTMFETXNAD-JUHZACGLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
24348,6cs2,DB02071,-7.7,WAY-151693,AINJYWXKBKRQSX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
56408,6crv,DB02290,-7.7,"3-{2,6,8-trioxo-9-[(2S,3S,4R)-2,3,4,5-tetrahydroxypentyl]-1,2,3,6,8,9-hexahydro-7H-purin-7-Yl}propyl dihydrogen phosphate",KPHFGOGGKPGLTM-OOZYFLPDSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127964,6w4h,DB07058,-7.7,"5-[1-(4-methoxyphenyl)-1H-benzimidazol-6-yl]-1,3,4-oxadiazole-2(3H)-thione",QBVJMUOTMRYUKR-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
127944,6w4h,DB07037,-7.7,(2S)-1-AMINO-3-[(5-NITROQUINOLIN-8-YL)AMINO]PROPAN-2-OL,MBZPCTWLFNYBND-QMMMGPOBSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
124038,6w4h,DB00688,-7.7,Mycophenolate mofetil,RTGDFNSFWBGLEC-SYZQJQIISA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
124039,6w4h,DB00689,-7.7,Cephaloglycin,FUBBGQLTSCSAON-PBFPGSCMSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
27654,6cs2,DB07205,-7.7,N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,GZJXCRHEMLAMRA-SDBHATRESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
140468,6w9c,DB07280,-7.7,5-[4-(DIMETHYLAMINO)PHENYL]-6-[(6-MORPHOLIN-4-YLPYRIDIN-3-YL)ETHYNYL]PYRIMIDIN-4-AMINE,AINVOEOJEKKMKB-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
105111,6vxs,DB13016,-7.7,LY-2300559,DWQVYDLTPMGYNE-DEOSSOPVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
136598,6w9c,DB07310,-7.7,"(5S)-2-{[(1S)-1-(2-fluorophenyl)ethyl]amino}-5-methyl-5-(trifluoromethyl)-1,3-thiazol-4(5H)-one",KNHNFKZUNFPPQE-MADCSZMMSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
124079,6w4h,DB00735,-7.7,Naftifine,OZGNYLLQHRPOBR-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
56399,6crv,DB02277,-7.7,1-(5-Tert-Butyl-2-Methyl-2h-Pyrazol-3-Yl)-3-(4-Chloro-Phenyl)-Urea,FWIJKWMXNHRSRO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107024,6vxx,DB02187,-7.7,Equilin,WKRLQDKEXYKHJB-HFTRVMKXSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
7371,6lzg,DB03701,-7.7,Vanoxerine,NAUWTFJOPJWYOT-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
140401,6w9c,DB05973,-7.7,Inosine 5'-sulfate,IGYLPKLXFDOQGM-KQYNXXCUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
11763,6lzg,DB12401,-7.7,Bromperidol,RKLNONIVDFXQRX-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
62270,6crv,DB13350,-7.7,Azanidazole,LHIALLMPKJMSIQ-NSCUHMNNSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
100210,6vxs,DB03267,-7.7,1-Allyl-3-Butyl-8-(N-Acetyl-4-Aminobenzyl)-Xanthine,XFOWZKUTPKXWIE-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
27055,6cs2,DB06346,-7.7,Fiboflapon,DFQGDHBGRSTTHX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
127917,6w4h,DB07006,-7.7,"9-HYDROXY-6-(3-HYDROXYPROPYL)-4-(2-METHOXYPHENYL)PYRROLO[3,4-C]CARBAZOLE-1,3(2H,6H)-DIONE",AOGOZJCRIFBTTN-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
11185,6lzg,DB11616,-7.7,Pirarubicin,KMSKQZKKOZQFFG-YXRRJAAWSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
140340,6w9c,DB04201,-7.7,Histidyl-Adenosine Monophosphate,XTFBSLZFYLGYAT-OPYVMVOTSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
61156,6crv,DB11672,-7.7,Curcumin,VFLDPWHFBUODDF-FCXRPNKRSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
124130,6w4h,DB00799,-7.7,Tazarotene,OGQICQVSFDPSEI-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
107007,6vxx,DB02162,-7.7,5'-O-(N-Ethyl-Sulfamoyl)Adenosine,ONCSLXAPOGUODU-WOUKDFQISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136634,6w9c,DB07350,-7.7,(2E)-N-hydroxy-3-[1-methyl-4-(phenylacetyl)-1H-pyrrol-2-yl]prop-2-enamide,UFQOXIMRSMFQRI-BQYQJAHWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
101978,6vxs,DB06866,-7.7,6-CARBAMIMIDOYL-2-[2-HYDROXY-5-(3-METHOXY-PHENYL)-INDAN-1-YL]-HEXANOIC ACID,NMOUMGFCBOWPAB-RZUBCFFCSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
140439,6w9c,DB06843,-7.7,"2',5'-DIDEOXY-ADENOSINE 3'-MONOPHOSPHATE",NFGZMOICZSFFLB-DSYKOEDSSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
107099,6vxx,DB02281,-7.7,Formycin,KBHMEHLJSZMEMI-KSYZLYKTSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56379,6crv,DB02254,-7.7,Trifluoro-thiamin phosphate,ZIBIECXVPMYJCV-UHFFFAOYSA-M,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140629,6w9c,DB13012,-7.7,AQX-1125,MDEJTPWQNNMAQF-BVMLLJBZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
11799,6lzg,DB12443,-7.7,Sonedenoson,WUCQGGOGHZRELS-LSCFUAHRSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
100029,6vxs,DB03035,-7.7,"1,8-Di-Hydroxy-4-Nitro-Anthraquinone",RIYCICFDXLNQPV-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
136512,6w9c,DB07201,-7.7,(2S)-3-[(9H-fluoren-9-ylideneamino)oxy]-2-methylpropanoic acid,ZHFDVDMCVXUGGF-NSHDSACASA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
56311,6crv,DB02162,-7.7,5'-O-(N-Ethyl-Sulfamoyl)Adenosine,ONCSLXAPOGUODU-WOUKDFQISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
123800,6w4h,DB00396,-7.7,Progesterone,RJKFOVLPORLFTN-LEKSSAKUSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
123810,6w4h,DB00408,-7.7,Loxapine,XJGVXQDUIWGIRW-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
128037,6w4h,DB07143,-7.7,D-phenylalanyl-N-benzyl-L-prolinamide,MEPJWLFTTFHOQO-MOPGFXCFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
123821,6w4h,DB00421,-7.7,Spironolactone,LXMSZDCAJNLERA-ZHYRCANASA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
136515,6w9c,DB07205,-7.7,N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,GZJXCRHEMLAMRA-SDBHATRESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
123834,6w4h,DB00438,-7.7,Ceftazidime,ORFOPKXBNMVMKC-DWVKKRMSSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
102049,6vxs,DB06945,-7.7,N-hydroxy-4-({4-[4-(trifluoromethyl)phenoxy]phenyl}sulfonyl)tetrahydro-2H-pyran-4-carboxamide,FOSWRYKPHVPIDJ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
136535,6w9c,DB07230,-7.7,3-BROMO-6-HYDROXY-2-(4-HYDROXYPHENYL)-1H-INDEN-1-ONE,DHPCBFMFERFZLR-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
123850,6w4h,DB00455,-7.7,Loratadine,JCCNYMKQOSZNPW-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
27690,6cs2,DB07246,-7.7,"(2R)-2-AMINO-3,3,3-TRIFLUORO-N-HYDROXY-2-{[(4-PHENOXYPHENYL)SULFONYL]METHYL}PROPANAMIDE",MKRPIBSCGZAUCH-OAHLLOKOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
128029,6w4h,DB07133,-7.7,D-phenylalanyl-N-(3-methylbenzyl)-L-prolinamide,CHKWABXWPATIIG-UXHICEINSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
107211,6vxx,DB02711,-7.7,"4-{2,6,8-Trioxo-9-[(2S,3R,4R)-2,3,4,5-Tetrahydroxypentyl]-1,2,3,6,8,9-Hexahydro-7h-Purin-7-Yl}Butyl Dihydrogen Phosphate",VBXZSBKAJFXURR-QXFUBDJGSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136536,6w9c,DB07232,-7.7,Veliparib,JNAHVYVRKWKWKQ-CYBMUJFWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140634,6w9c,DB13020,-7.7,Apratastat,MAVDNGWEBZTACC-HNNXBMFYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140652,6w9c,DB13048,-7.7,PAC-1,YQNRVGJCPCNMKT-LFVJCYFKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140666,6w9c,DB13065,-7.7,LY-2811376,MJQMRGWYPNIERM-HNNXBMFYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140677,6w9c,DB13083,-7.7,Talarozole,SNFYYXUGUBUECJ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
56360,6crv,DB02230,-7.7,Immucillin-G,KBIDJCVAURJXFG-PVEDRDFWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
100068,6vxs,DB03084,-7.7,"Cyclopropyl-{4-[5-(3,4-Dichlorophenyl)-2-[(1-Methyl)-Piperidin]-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine",XCTKFTOEAKJMII-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
140856,6w9q,DB00197,-7.7,Troglitazone,GXPHKUHSUJUWKP-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
127992,6w4h,DB07091,-7.7,(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclohexyloxy)ethanoyl)pyrrolidine-2-carboxamide,IWPMQJKXKKKSEY-SFHVURJKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
128002,6w4h,DB07105,-7.7,2-[2-(4-CHLORO-PHENYLSULFANYL)-ACETYLAMINO]-3-(4-GUANIDINO-PHENYL)-PROPIONAMIDE,IEEYGOJDTRVYGR-HNNXBMFYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
105058,6vxs,DB12930,-7.7,Opipramol,YNZFUWZUGRBMHL-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
105055,6vxs,DB12927,-7.7,Theodrenaline,WMCMJIGLYZDKRN-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
128024,6w4h,DB07128,-7.7,"N7-BUTYL-N2-(5-CHLORO-2-METHYLPHENYL)-5-METHYL[1,2,4]TRIAZOLO[1,5-A]PYRIMIDINE-2,7-DIAMINE",ZTYBIJUAAWLJNU-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
123872,6w4h,DB00482,-7.7,Celecoxib,RZEKVGVHFLEQIL-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
58122,6crv,DB04576,-7.7,Fleroxacin,XBJBPGROQZJDOJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27681,6cs2,DB07235,-7.7,"N-[(1S)-2-AMINO-1-(2,4-DICHLOROBENZYL)ETHYL]-5-[2-(METHYLAMINO)PYRIMIDIN-4-YL]THIOPHENE-2-CARBOXAMIDE",HHOVRZGUSBMKKU-ZDUSSCGKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
27778,6cs2,DB07330,-7.7,trans-4-(7-carbamoyl-1H-benzimidazol-2-yl)-1-propylpiperidinium,KXSIHXHEHABEJX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
124766,6w4h,DB01604,-7.7,Pivampicillin,ZEMIJUDPLILVNQ-ZXFNITATSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
27504,6cs2,DB07049,-7.7,(2R)-1-[(4-tert-butylphenyl)sulfonyl]-2-methyl-4-(4-nitrophenyl)piperazine,SOFGQQQVQZQJFS-MRXNPFEDSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
127199,6w4h,DB04843,-7.7,Mepenzolate,GKNPSSNBBWDAGH-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
105634,6vxs,DB13764,-7.7,Monoxerutin,MBHXKZDTQCSVPM-BDAFLREQSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
126029,6w4h,DB03267,-7.7,1-Allyl-3-Butyl-8-(N-Acetyl-4-Aminobenzyl)-Xanthine,XFOWZKUTPKXWIE-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
126043,6w4h,DB03288,-7.7,5-Chloro-1h-Indole-2-Carboxylic Acid{[Cyclopentyl-(2-Hydroxy-Ethyl)-Carbamoyl]-Methyl}-Amide,VXABTOCIIZSEPD-QGZVFWFLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
138441,6w9c,DB11670,-7.7,SP-8203,SJZBPVOSFYUHFV-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138434,6w9c,DB11658,-7.7,QAV-680,YOPFAMROKXHVCQ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
126048,6w4h,DB03296,-7.7,3'-beta-Sialyl-beta-lactose,CILYIEBUXJIHCO-LPTWSRJFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
127156,6w4h,DB04793,-7.7,"1,4:3,6-Dianhydro-2-O-(3-carbamimidoylphenyl)-5-O-(4-carbamimidoylphenyl)-D-glucitol",DKBAWRNTUZFJKV-XMTFNYHQSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
57225,6crv,DB03361,-7.7,"2-{(9as)-9a-[(1s)-1-Hydroxyethyl]-2,7-Dimethyl-9a,10-Dihydro-5h-Pyrimido[4,5-D][1,3]Thiazolo[3,2-a]Pyrimidin-8-Yl}Ethyl Trihydrogen Diphosphate",UQFVHIGKDHNMJT-XPTSAGLGSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
11536,6lzg,DB12101,-7.7,CC-220,IXZOHGPZAQLIBH-NRFANRHFSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
138371,6w9c,DB11490,-7.7,Nalorphine,UIQMVEYFGZJHCZ-SSTWWWIQSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138369,6w9c,DB11485,-7.7,Ceftiofur,ZBHXIWJRIFEVQY-IHMPYVIRSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
11546,6lzg,DB12114,-7.7,Poziotinib,LPFWVDIFUFFKJU-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
126205,6w4h,DB03510,-7.7,6-O-Phosphoryl Inosine Monophosphate,RXRZOKQPANIEDW-KQYNXXCUSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
125976,6w4h,DB03205,-7.7,Pyrroloquinoline Quinone,MMXZSJMASHPLLR-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
126208,6w4h,DB03515,-7.7,Equilenin,PDRGHUMCVRDZLQ-WMZOPIPTSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
138347,6w9c,DB11446,-7.7,Oxfendazole,BEZZFPOZAYTVHN-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
127140,6w4h,DB04771,-7.7,1-GUANIDINO-4-(N-NITRO-BENZOYLAMINO-L-LEUCYL-L-PROLYLAMINO)BUTANE,FIZYZWLGMGGGBJ-OALUTQOASA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
126227,6w4h,DB03549,-7.7,Biotinyl P-Nitroaniline,PORZMUYPQKOFQY-YDHLFZDLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
127139,6w4h,DB04770,-7.7,"O6-(R)-ROSCOVITINE, R-2-(6-BENZYLOXY-9-ISOPROPYL-9H-PURIN-2-YLAMINO)-BUTAN-1-OL",HGADNQLEUZSUEJ-OAHLLOKOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
127138,6w4h,DB04769,-7.7,"5-QUINOXALIN-6-YLMETHYLENE-THIAZOLIDINE-2,4-DIONE",SQWZFLMPDUSYGV-POHAHGRESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
12919,6lzg,DB14034,-7.7,Darglitazone,QQKNSPHAFATFNQ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
24740,6cs2,DB02524,-7.7,"2',3'-O-{4-[Hydroxy(oxido)-??5-azanylidene]-2,6-dinitro-2,5-cyclohexadiene-1,1-diyl}adenosine 5'-(tetrahydrogen triphosphate)",XFMMHXLUHKBKQE-UHEGPQQHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
24894,6cs2,DB02709,-7.7,Resveratrol,LUKBXSAWLPMMSZ-OWOJBTEDSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
57272,6crv,DB03428,-7.7,SU9516,QNUKRWAIZMBVCU-WCIBSUBMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
126274,6w4h,DB03619,-7.7,Deoxycholic Acid,KXGVEGMKQFWNSR-LLQZFEROSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
57278,6crv,DB03437,-7.7,"2-{1-[2-(2-Amino-Thiazol-4-Yl)-2-Methoxyimino-Acetylamino]-2-Oxo-Ethyl}-5,5-Dimethyl-Thiazolidine-4-Carboxylic Acid",YVNKGXXVZIQNIV-RKMXGKDGSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
101409,6vxs,DB04882,-7.7,Edotecarin,QMVPQBFHUJZJCS-NTKFZFFISA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
106059,6vxs,DB14903,-7.7,Rovafovir etalafenamide,OCJRRXHWPBXZSU-BJBBEUPESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
106058,6vxs,DB14902,-7.7,JHU-75528 C-11,MCNQUWLLXZZZAC-BJUDXGSMSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
57635,6crv,DB03924,-7.7,"5,8-Di-Amino-1,4-Dihydroxy-Anthraquinone",QVEMRPAUHFWHRV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
126301,6w4h,DB03658,-7.7,"2-{1-[2-Amino-2-(4-Hydroxy-Phenyl)-Acetylamino]-2-Oxo-Ethyl}-5,5-Dimethyl-Thiazolidine-4-Carboxylic Acid",SMLJDSWXGVMNTH-NRWUCQMLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
101341,6vxs,DB04797,-7.7,Triazolopyridine,OVCXRBARSPBVMC-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
127201,6w4h,DB04845,-7.7,Ixabepilone,FABUFPQFXZVHFB-PVYNADRNSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
24662,6cs2,DB00321,-7.7,Amitriptyline,KRMDCWKBEZIMAB-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
11470,6lzg,DB00912,-7.7,Repaglinide,FAEKWTJYAYMJKF-QHCPKHFHSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
101235,6vxs,DB04649,-7.7,TETRAHEDRAL INTERMEDIATE OF BLASTICIDIN S,MVFPGTZTOAHVBP-HXYLPHSESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
61773,6crv,DB12569,-7.7,Tonapofylline,ZWTVVWUOTJRXKM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57125,6crv,DB03233,-7.7,"Phosphoric Acid Mono-[3-Amino-5-(5-Methyl-2,4-Dioxo-3,4-Dihydro-2h-Pyrimidin-1-Yl)-Tetrahydro-Furan-2-Ylmethyl] Ester",BQZMHQZNZNBJNF-XLPZGREQSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61772,6crv,DB12567,-7.7,Camicinal,RZKDEGZIFSJVNA-IBGZPJMESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138642,6w9c,DB12057,-7.7,ORM-12741,OCUKPFWNSAAHRP-QZTJIDSGSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
127262,6w4h,DB04960,-7.7,Tipifarnib,PLHJCIYEEKOWNM-HHHXNRCGSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
61764,6crv,DB12555,-7.7,Nelotanserin,COSPVUFTLGQDQL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
125825,6w4h,DB02998,-7.7,Metribolone,CCCIJQPRIXGQOE-XWSJACJDSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
137474,6w9c,DB08344,-7.7,4-chloro-N-(3-methoxypropyl)-N-[(3S)-1-(2-phenylethyl)piperidin-3-yl]benzamide,OOUGHDJEJNMXSV-QHCPKHFHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
57140,6crv,DB03249,-7.7,2'-O-Methyl-3'-Methyl-3'-Deoxy-Arabinofuranosyl-Thymine-5'-Phosphate,MCXXETKRWYMFCI-TURQNECASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106202,6vxs,DB15221,-7.7,PF-06260414,ZKAVFOXYJCREBQ-SNVBAGLBSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
127229,6w4h,DB04883,-7.7,Darusentan,FEJVSJIALLTFRP-LJQANCHMSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
125973,6w4h,DB03202,-7.7,"2-[5-Methanesulfonylamino-2-(4-Aminophenyl)-6-Oxo-1,6-Dihydro-1-Pyrimidinyl]-N-(3,3,3-Trifluoro-1-Isopropyl-2-Oxopropyl)Acetamide",JWSWTHSJMGVOKE-HNNXBMFYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
125851,6w4h,DB03039,-7.7,"4-(Aminosulfonyl)-N-[(2,5-Difluorophenyl)Methyl]-Benzamide",KEGUALXMKQVDIO-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
106196,6vxs,DB15208,-7.7,NOP-1A,MZBCQWLYUQJXKA-KRWDZBQOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
138572,6w9c,DB11861,-7.7,Litronesib,YVAFBXLHPINSIK-QHCPKHFHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
101310,6vxs,DB04757,-7.7,"GUANOSINE-2',3'-O-METHYLIDENEPHOSPHONATE",GKAPYWCOOQBBHV-KXSYMAMXSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
125868,6w4h,DB03062,-7.7,(1-Methyl-1h-Imidazol-2-Yl)-(3-Methyl-4-{3-[(Pyridin-3-Ylmethyl)-Amino]-Propoxy}-Benzofuran-2-Yl)-Methanone,VZBQJKIOAOUYJL-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
125874,6w4h,DB03069,-7.7,Cytidine-5'-Diphospho-Beta-D-Xylose,NWSKPSPTJOAICE-OCIMBMBZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
137515,6w9c,DB08392,-7.7,"2-[5,6-BIS-(4-METHOXY-PHENYL)-FURO[2,3-D]PYRIMIDIN-4-YLAMINO]-ETHANOL",ARBUGBBNEFAECO-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
57154,6crv,DB03267,-7.7,1-Allyl-3-Butyl-8-(N-Acetyl-4-Aminobenzyl)-Xanthine,XFOWZKUTPKXWIE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138512,6w9c,DB11774,-7.7,Pazufloxacin,XAGMUUZPGZWTRP-ZETCQYMHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
125894,6w4h,DB03093,-7.7,"8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine",MWHAHELTVGJGFJ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
11496,6lzg,DB12048,-7.7,Savolitinib,XYDNMOZJKOGZLS-NSHDSACASA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
127206,6w4h,DB04853,-7.7,Binodenoson,XJFMHMFFBSOEPR-DNZQAUTHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
125955,6w4h,DB03176,-7.7,KB-141,OZYQIQVPUZANTM-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
138494,6w9c,DB11748,-7.7,Benfotiamine,BTNNPSLJPBRMLZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138491,6w9c,DB11742,-7.7,Ebastine,MJJALKDDGIKVBE-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
105603,6vxs,DB13721,-7.7,Cypermethrin,KAATUXNTWXVJKI-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
137619,6w9c,DB08517,-7.7,"(2S)-5-hydroxy-2-(4-hydroxyphenyl)-7-methoxy-2,3-dihydro-4H-chromen-4-one",DJOJDHGQRNZXQQ-AWEZNQCLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
126312,6w4h,DB03671,-7.7,"4-(3,12,14-Trihydroxy-10,13-Dimethyl-Hexadecahydro-Cyclopenta[a]Phenanthren-17-Yl)-5h-Furan-2-One",SHIBSTMRCDJXLN-KCZCNTNESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
61653,6crv,DB12393,-7.7,Fanapanel,WZMQMKNCWDCCMT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
105761,6vxs,DB13981,-7.7,Nomegestrol acetate,IIVBFTNIGYRNQY-YQLZSBIMSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
105963,6vxs,DB14678,-7.7,Norethindrone enanthate,APTGJECXMIKIET-WOSSHHRXSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
138026,6w9c,DB09040,-7.7,Efinaconazole,NFEZZTICAUWDHU-RDTXWAMCSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
105764,6vxs,DB13988,-7.7,SB-269970,HWKROQUZSKPIKQ-MRXNPFEDSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101491,6vxs,DB05239,-7.7,Cobimetinib,BSMCAPRUBJMWDF-KRWDZBQOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101495,6vxs,DB05255,-7.7,Ronacaleret,FQJISUPNMFRIFZ-HXUWFJFHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
57397,6crv,DB03615,-7.7,Ribostamycin,NSKGQURZWSPSBC-VVPCINPTSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
24810,6cs2,DB02610,-7.7,"N-(2,3,4,5,6-Pentaflouro-Benzyl)-4-Sulfamoyl-Benzamide",LRKSHOLYETXPGY-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
105954,6vxs,DB14669,-7.7,Betamethasone phosphate,VQODGRNSFPNSQE-DVTGEIKXSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
137985,6w9c,DB08986,-7.7,Etifoxine,IBYCYJFUEJQSMK-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137790,6w9c,DB08724,-7.7,5-(5-(4-(5-hydro-4-methyl-2-oxazolyl)phenoxy)pentyl)-3-methyl isoxazole,UXIYKMARWUSIKU-HNNXBMFYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
61555,6crv,DB12259,-7.7,CG-200745,AUGCSOFQTDKPSO-RGVLZGJSSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
137963,6w9c,DB08961,-7.7,Azosemide,HMEDEBAJARCKCT-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
24820,6cs2,DB02621,-7.7,Latrunculin A,DDVBPZROPPMBLW-IZGXTMSKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
61583,6crv,DB12293,-7.7,Nefopam,RGPDEAGGEXEMMM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57540,6crv,DB03800,-7.7,Deoxyuridine monophosphate,JSRLJPSBLDHEIO-SHYZEUOFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
12876,6lzg,DB13953,-7.7,Estradiol benzoate,UYIFTLBWAOGQBI-BZDYCCQFSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
105913,6vxs,DB14626,-7.7,Pregnenolone acetate,CRRKVZVYZQXICQ-RJJCNJEVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
24822,6cs2,DB02623,-7.7,Aminophosphonic Acid-Guanylate Ester,ZGPDMUBRWRJAQQ-UUOKFMHZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
61532,6crv,DB12226,-7.7,Terameprocol,ORQFDHFZSMXRLM-IYBDPMFKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
126761,6w4h,DB04258,-7.7,Seocalcitol,LVLLALCJVJNGQQ-SEODYNFXSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
47040,2fxp,DB01251,-7.7,Gliquidone,LLJFMFZYVVLQKT-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
126790,6w4h,DB04295,-7.7,N-Benzoyl-N'-Beta-D-Glucopyranosyl Urea,JSBCZGSPFATCOV-BZNQNGANSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
57484,6crv,DB03735,-7.7,9-(2-Deoxy-Beta-D-Ribofuranosyl)-6-Methylpurine,SJXRKKYXNZWKDB-DJLDLDEBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
137949,6w9c,DB08943,-7.7,Isoconazole,MPIPASJGOJYODL-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
126844,6w4h,DB04373,-7.7,"4-Amino-N-{4-[2-(2,6-Dimethyl-Phenoxy)-Acetylamino]-3-Hydroxy-1-Isobutyl-5-Phenyl-Pentyl}-Benzamide",WQUBEIMCFHCJCO-AWCRTANDSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
105810,6vxs,DB14075,-7.7,Imidurea,ZCTXEAQXZGPWFG-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
105834,6vxs,DB14127,-7.7,Sacubitrilat,DOBNVUFHFMVMDB-BEFAXECRSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
105816,6vxs,DB14086,-7.7,Cianidanol,PFTAWBLQPZVEMU-DZGCQCFKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
57502,6crv,DB03756,-7.7,Doconexent,MBMBGCFOFBJSGT-KUBAVDMBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27252,6cs2,DB06747,-7.7,ginkgolide-M,KDKROYXEHCYLJQ-FJFAJXJPSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
57557,6crv,DB03820,-7.7,"(2s,5r,6r)-6-{[(6r)-6-(Glycylamino)-7-Oxido-7-Oxoheptanoyl]Amino}-3,3-Dimethyl-7-Oxo-4-Thia-1-Azabicyclo[3.2.0]Heptane-2-Carboxylate",LDJWRKFRKCXUDO-RBQWDTSBSA-M,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138050,6w9c,DB09080,-7.7,Olodaterol,COUYJEVMBVSIHV-SFHVURJKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137743,6w9c,DB08665,-7.7,"6,11-DIHYDRO-11-ETHYL-6-METHYL-9-NITRO-5H-PYRIDO[2,3-B][1,5]BENZODIAZEPIN-5-ONE",YCFJZPGDTZVVSM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
126313,6w4h,DB03672,-7.7,9-N-Phenylmethylamino-Tacrine,JYJAEHAURXXPSD-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
138247,6w9c,DB11115,-7.7,Ensulizole,UVCJGUGAGLDPAA-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138219,6w9c,DB09421,-7.7,Protirelin,XNSAINXGIQZQOO-SRVKXCTJSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
106056,6vxs,DB14899,-7.7,Tavapadon,AKQXQLUNFKDZBN-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
126406,6w4h,DB03791,-7.7,"(3-{3-[[2-Chloro-3-(Trifluoromethyl)Benzyl](2,2-Diphenylethyl)Amino]Propoxy}Phenyl)Acetic Acid",NAXSRXHZFIBFMI-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
126421,6w4h,DB03809,-7.7,9-Butyl-8-(3-Methoxybenzyl)-9h-Purin-6-Amine,BWLWUGBHOXIUBP-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
137640,6w9c,DB08540,-7.7,"2-[4-(2H-1,4-BENZOTHIAZINE-3-YL)-PIPERAZINE-1-LY]-1,3-THIAZOLE-4-CARBOXYLIC ACID ETHYLESTER",AQJQFCRTSWIUCY-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
127109,6w4h,DB04726,-7.7,"7,8,10-TRIMETHYLBENZO[G]PTERIDINE-2,4(3H,10H)-DIONE",KPDQZGKJTJRBGU-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
138124,6w9c,DB09206,-7.7,Trimazosin,YNZXWQJZEDLQEG-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137670,6w9c,DB08577,-7.7,3-[(3-(2-CARBOXYETHYL)-4-METHYLPYRROL-2-YL)METHYLENE]-2-INDOLINONE,JNDVEAXZWJIOKB-JYRVWZFOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
101442,6vxs,DB04957,-7.7,Azimilide,MREBEPTUUMTTIA-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
24770,6cs2,DB02559,-7.7,"6-(Octahydro-1h-Indol-1-Ylmethyl)Decahydroquinazoline-2,4-Diamine",HDQIGGQUKAQTGU-SZTTVXCBSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
106019,6vxs,DB14822,-7.7,SB-649868,ZJXIUGNEAIHSBI-IBGZPJMESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
57339,6crv,DB03523,-7.7,Brequinar,PHEZJEYUWHETKO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57346,6crv,DB03535,-7.7,Z-Pro-Prolinal,ORZXYSPOAVJYRU-HOTGVXAUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106012,6vxs,DB14799,-7.7,PF-06821497,RXCVUHMIWHRLDF-HXUWFJFHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
137705,6w9c,DB08619,-7.7,Testosterone succinate,CJQNBXFUHQZFOE-VYAQIDIUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
7051,6lzg,DB03154,-7.7,{[7-(Difluoro-Phosphono-Methyl)-Naphthalen-2-Yl]-Difluoro-Methyl}-Phosphonic Acid,VHKBLEYUHBIBNR-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
126584,6w4h,DB04022,-7.7,"Guanosine-5',3'-Tetraphosphate",BUFLLCUFNHESEH-UUOKFMHZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
127033,6w4h,DB04623,-7.7,"2-ETHOXYETHYL (2S,3S)-4-((S)-2-BENZYL-3-OXO-4-((3AR,8R,8AS)-2-OXO-3,3A,8,8A-TETRAHYDRO-2H-INDENO[1,2-D]OXAZOL-8-YL)-2,3-DIHYDRO-1H-PYRROL-2-YL)-3-HYDROXY-1-PHENYLBUTAN-2-YLCARBAMATE",CGBRFCVAMLJVEA-ZGURCIGKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
105978,6vxs,DB14725,-7.7,Cefamandole nafate,RRJHESVQVSRQEX-SUYBPPKGSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
127038,6w4h,DB04630,-7.7,Aldosterone,PQSUYGKTWSAVDQ-ZVIOFETBSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
27298,6cs2,DB06829,-7.7,4-BROMO-3-(CARBOXYMETHOXY)-5-[3-(CYCLOHEXYLAMINO)PHENYL]THIOPHENE-2-CARBOXYLIC ACID,RXDVFLTWXCTCEX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
127272,6w4h,DB05013,-7.7,Ingenol mebutate,VDJHFHXMUKFKET-UXMMOKKRSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
105980,6vxs,DB14729,-7.7,Rebeccamycin,QEHOIJJIZXRMAN-QZQSLCQPSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101468,6vxs,DB05087,-7.7,Ganaxolone,PGTVWKLGGCQMBR-FLBATMFCSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
137712,6w9c,DB08631,-7.7,"N-(4-CHLOROPHENYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONAMIDE",UVSIFVBCHJEYJP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
27303,6cs2,DB06835,-7.7,(2S)-2-[3-(AMINOMETHYL)PHENYL]-3-{(S)-HYDROXY[(1R)-2-METHYL-1-{[(2-PHENYLETHYL)SULFONYL]AMINO}PROPYL]PHOSPHORYL}PROPANOIC ACID,CTQDLSDUHUFBQW-LEWJYISDSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
27242,6cs2,DB06736,-7.7,Aceclofenac,MNIPYSSQXLZQLJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
61478,6crv,DB12143,-7.7,Rezatomidine,WQXVKEDUCPMRRI-JTQLQIEISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
105989,6vxs,DB14753,-7.7,Hydroxystilbamidine,TUESWZZJYCLFNL-DAFODLJHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
12865,6lzg,DB13939,-7.7,RAD-140,XMBUPPIEVAFYHO-KPZWWZAWSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
125740,6w4h,DB02887,-7.7,"2',3'-Dehydro-2',3'-Deoxy-Thymidine 5'-Triphosphate",ODSQODTUNULBHF-JGVFFNPUSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
137447,6w9c,DB08308,-7.7,"SUCCINIC ACID MONO-(13-METHYL-3-OXO-2,3,6,7,8,9,10,11,12,13,14,15,16,17-TETRADECAHYDRO-1H-CYCLOPENTA[A]PHENANTHREN-17-YL) ESTER",IRQUJNVGEAJGSD-KIEDKLRZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
127274,6w4h,DB05016,-7.7,Ataluren,OOUGLTULBSNHNF-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
125057,6w4h,DB01990,-7.7,Cholesterol sulfate,BHYOQNUELFTYRT-DPAQBDIFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
125064,6w4h,DB02001,-7.7,"5-(4-Morpholin-4-Yl-Phenylsulfanyl)-2,4-Quinazolinediamine",CZLWCJRHDBTCGQ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
137162,6w9c,DB07972,-7.7,1-(3-METHYLPHENYL)-1H-BENZIMIDAZOL-5-AMINE,VFSVFGIODYZMOF-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
6870,6lzg,DB02834,-7.7,IDD552,ZCAGEXZTORJQDZ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
105413,6vxs,DB13463,-7.7,Oxetorone,VZVRZTZPHOHSCK-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
56903,6crv,DB02934,-7.7,9-(6-deoxy-alpha-L-talofuranosyl)-6-methylpurine,XJZDIUOABWMPLZ-DSBXBFMBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127525,6w4h,DB06267,-7.7,Udenafil,IYFNEFQTYQPVOC-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
139230,6w9c,DB13175,-7.7,Rheinanthrone,OZFQHULMMDWMIV-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
127524,6w4h,DB06266,-7.7,Lonidamine,WDRYRZXSPDWGEB-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
105417,6vxs,DB13471,-7.7,Nalfurafine,XGZZHZMWIXFATA-UEZBDDGYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
100939,6vxs,DB04254,-7.7,"8-Benzo[1,3]Dioxol-,5-Ylmethyl-9-Butyl-2-Fluoro-9h-Purin-6-Ylamine",ARWHTQLGMWHTAZ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
7236,6lzg,DB03466,-7.7,BMS184394,AYAJZQYENGWICE-QHCPKHFHSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
56914,6crv,DB02950,-7.7,Hymenialdisine,QPCBNXNDVYOBIP-WHFBIAKZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106494,6vxx,DB00412,-7.7,Rosiglitazone,YASAKCUCGLMORW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
11367,6lzg,DB11871,-7.7,PF-00610355,YPHDIMUXXABSSO-YTTGMZPUSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
105418,6vxs,DB13472,-7.7,Cyclofenil,GVOUFPWUYJWQSK-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
11377,6lzg,DB11885,-7.7,Anlotinib,KSMZEXLVHXZPEF-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
7229,6lzg,DB03451,-7.7,"1-alpha, 25-dihydroxyl-20-epi-22-oxa-24, 26 ,27-trihomovitamin D3",KLZOTDOJMRMLDX-YBBVPDDNSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
11378,6lzg,DB11886,-7.7,Infigratinib,QADPYRIHXKWUSV-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
27155,6cs2,DB06594,-7.7,Agomelatine,YJYPHIXNFHFHND-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
100942,6vxs,DB04258,-7.7,Seocalcitol,LVLLALCJVJNGQQ-SEODYNFXSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
125181,6w4h,DB02154,-7.7,"2,3-Bis-Benzo[1,3]Dioxol-5-Ylmethyl-Succinic Acid",FFYBYVPVYLMLAR-KBPBESRZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
106472,6vxx,DB00384,-7.7,Triamterene,FNYLWPVRPXGIIP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106470,6vxx,DB00382,-7.7,Tacrine,YLJREFDVOIBQDA-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
139155,6w9c,DB12938,-7.7,Isoxaflutole,OYIKARCXOQLFHF-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
106464,6vxx,DB00376,-7.7,Trihexyphenidyl,HWHLPVGTWGOCJO-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
125229,6w4h,DB02221,-7.7,"4-(Aminosulfonyl)-N-[(2,4,6-Trifluorophenyl)Methyl]-Benzamide",DVTYOTODFLDHRL-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
101740,6vxs,DB06370,-7.7,Indisulam,SETFNECMODOHTO-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
100973,6vxs,DB04297,-7.7,"7-[4-(Dimethylamino)Phenyl]-N-Hydroxy-4,6-Dimethyl-7-Oxo-2,4-Heptadienamide",RTKIYFITIVXBLE-QEQCGCAPSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
100986,6vxs,DB04315,-7.7,Guanosine-5'-Diphosphate,QGWNDRXFNXRZMB-UUOKFMHZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
125144,6w4h,DB02104,-7.7,"2,4-Diamino-5-Methyl-6-[(3,4,5-Trimethoxy-N-Methylanilino)Methyl]Pyrido[2,3-D]Pyrimidine",PEGMMEYCSOZKIT-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
56886,6crv,DB02914,-7.7,"(6e)-6-[(2e,4e,6e)-3,7-Dimethylnona-2,4,6,8-Tetraenylidene]-1,5,5-Trimethylcyclohexene",FWNRILWHNGFAIN-OYUWDNMLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
6869,6lzg,DB02833,-7.7,[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(3-Nitro-Phenyl)-Amine,DYTKVFHLKPDNRW-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
106519,6vxx,DB00442,-7.7,Entecavir,QDGZDCVAUDNJFG-FXQIFTODSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56809,6crv,DB02814,-7.7,3'-Deazo-Thiamin Diphosphate,NWZZJKMZTWGIFE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
137059,6w9c,DB07851,-7.7,"(3R,4S)-1-(3,4-DIMETHOXYPHENYL)-3-(3-METHYLPHENYL)PIPERIDIN-4-AMINE",DQJXBZGPJVSWFI-ROUUACIJSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
106571,6vxx,DB00502,-7.7,Haloperidol,LNEPOXFFQSENCJ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
25028,6cs2,DB02872,-7.7,"Cis-[4,5-Bis-(4-Bromophenyl)-2-(2-Ethoxy-4-Methoxyphenyl)-4,5-Dihydroimidazol-1-Yl]-[4-(2-Hydroxyethyl)Piperazin-1-Yl]Methanone",PVRYEWOXWGDQHA-URLMMPGGSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
139424,6w9c,DB13448,-7.7,Mazaticol,AMHPTVWBZSYFSS-OAGGEKHMSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137074,6w9c,DB07867,-7.7,6-CHLORO-4-(CYCLOHEXYLOXY)-3-PROPYLQUINOLIN-2(1H)-ONE,BNZHKKGOSYAQSW-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
11348,6lzg,DB11844,-7.7,Pritelivir,IVZKZONQVYTCKC-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
25020,6cs2,DB02861,-7.7,"4-(Aminosulfonyl)-N-[(3,4,5-Trifluorophenyl)Methyl]-Benzamide",DEHMSTGBNAXEGX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
57877,6crv,DB04243,-7.7,5-Methyluridine 5'-Monophosphate,IGWHDMPTQKSDTL-JXOAFFINSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
124870,6w4h,DB01737,-7.7,"Nalpha-(2-Naphthylsulfonylglycyl)-3-Amidino-D,L-Phenylalanine-Isopropylester",YAEIKQDHLCFGAA-KRWDZBQOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
139412,6w9c,DB13432,-7.7,Lonazolac,XVUQHFRQHBLHQD-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137077,6w9c,DB07870,-7.7,(2S)-2-(4-{[3-CHLORO-5-(TRIFLUOROMETHYL)PYRIDIN-2-YL]OXY}PHENOXY)PROPANOIC ACID,GOCUAJYOYBLQRH-MRVPVSSYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
13001,6lzg,DB01076,-7.7,Atorvastatin,XUKUURHRXDUEBC-KAYWLYCHSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
25018,6cs2,DB00365,-7.7,Grepafloxacin,AIJTTZAVMXIJGM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
101800,6vxs,DB06532,-7.7,Pafuramidine,UKOQVLAXCBRRGH-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101794,6vxs,DB06521,-7.7,Ertiprotafib,FONCZICQWCUXEB-RUZDIDTESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
124904,6w4h,DB01782,-7.7,"2,6-Dihydroanthra/1,9-Cd/Pyrazol-6-One",ACPOUJIDANTYHO-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
101765,6vxs,DB06446,-7.7,Dotarizine,LRMJAFKKJLRDLE-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
100885,6vxs,DB04180,-7.7,"4-(Aminosulfonyl)-N-[(2,4-Difluorophenyl)Methyl]-Benzamide",NTDFJEKGSGSXME-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
139322,6w9c,DB13317,-7.7,Flunoxaprofen,ARPYQKTVRGFPIS-VIFPVBQESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
11356,6lzg,DB11853,-7.7,Relugolix,AOMXMOCNKJTRQP-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
139349,6w9c,DB13349,-7.7,Talastine,LCAAMXMULMCKLJ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139351,6w9c,DB13351,-7.7,Piperidolate,KTHVBAZBLKXIHZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
125264,6w4h,DB02266,-7.7,Flufenamic Acid,LPEPZBJOKDYZAD-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
61324,6crv,DB11915,-7.7,Valbenazine,GEJDGVNQKABXKG-CFKGEZKQSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
24546,6cs2,DB02307,-7.7,N-(1-Carboxy-3-Phenylpropyl)Phenylalanyl-Alpha-Asparagine,FOJUHLDAXGNCIP-FHWLQOOXSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
6855,6lzg,DB02812,-7.7,"(2s,4r)-1-Acetyl-N-[(1s)-4-[(Aminoiminomethyl)Amino]-1-(2-Benzothiazolylcarbonyl)Butyl]-4-Hydroxy-2-Pyrrolidinecarboxamide",VXDAVYUFYPFGDX-SNPRPXQTSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
27489,6cs2,DB07034,-7.7,"2,2'-{[9-(HYDROXYIMINO)-9H-FLUORENE-2,7-DIYL]BIS(OXY)}DIACETIC ACID",VOKATEXROYSXDW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
101787,6vxs,DB06499,-7.7,Furaprofen,ODZUWQAFWMLWCF-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
127570,6w4h,DB06412,-7.7,Oxymetholone,ICMWWNHDUZJFDW-DHODBPELSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
106538,6vxx,DB00465,-7.7,Ketorolac,OZWKMVRBQXNZKK-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
139367,6w9c,DB13369,-7.7,Benzilone,ZKCWITXZGWUJAV-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
56803,6crv,DB02808,-7.7,Trifluorofurnesyl Diphosphate,PXLMLAFPAPGGKK-GVCYOOEQSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
137229,6w9c,DB08046,-7.7,2-chloro-5-[(1S)-1-hydroxy-3-oxo-2H-isoindol-1-yl]benzenesulfonamide,JIVPVXMEBJLZRO-AWEZNQCLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139106,6w9c,DB12869,-7.7,Eliprodil,GGUSQTSTQSHJAH-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
61379,6crv,DB12000,-7.7,Apabetalone,NETXMUIMUZJUTB-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138829,6w9c,DB12319,-7.7,Benzbromarone,WHQCHUCQKNIQEC-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137361,6w9c,DB08195,-7.7,(1R)-2-[(CYANOMETHYL)AMINO]-1-({[2-(DIFLUOROMETHOXY)BENZYL]SULFONYL}METHYL)-2-OXOETHYL MORPHOLINE-4-CARBOXYLATE,YKWHKILAGONYKL-HNNXBMFYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
127354,6w4h,DB05470,-7.7,VX-702,FYSRKRZDBHOFAY-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
6927,6lzg,DB02917,-7.7,N-Hydroxy-4-(Methyl{[5-(2-Pyridinyl)-2-Thienyl]Sulfonyl}Amino)Benzamide,LFGYSFPVLMPUPE-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
11450,6lzg,DB11985,-7.7,Dapaconazole,FUAHXHWSMYFWGE-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
138817,6w9c,DB12305,-7.7,Dasotraline,SRPXSILJHWNFMK-MEDUHNTESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
27179,6cs2,DB06634,-7.7,Casopitant,XGGTZCKQRWXCHW-WMTVXVAQSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
106260,6vxs,DB15334,-7.7,Biochanin A,WUADCCWRTIWANL-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
138804,6w9c,DB12288,-7.7,Piromelatine,PNTNBIHOAPJYDB-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138802,6w9c,DB12286,-7.7,Simendan,WHXMKTBCFHIYNQ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
125610,6w4h,DB02712,-7.7,Sorbinil,LXANPKRCLVQAOG-NSHDSACASA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
101209,6vxs,DB04616,-7.7,TACRINE(8)-4-AMINOQUINOLINE,UNVOAAWEEGAXTN-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
127343,6w4h,DB05423,-7.7,ORG-34517,DFELGYQKEOCHOA-BZAFBGKRSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
106275,6vxs,DB15360,-7.7,"Carfentanil, C-11",YDSDEBIZUNNPOB-JVVVGQRLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
125649,6w4h,DB02766,-7.7,(3r)-3-{[(Benzyloxy)Carbonyl]Amino}-2-Oxo-4-Phenylbutane-1-Diazonium,VLIGBVLLNSWVMI-MRXNPFEDSA-O,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
127321,6w4h,DB05288,-7.7,Anecortave acetate,YUWPMEXLKGOSBF-GACAOOTBSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
138776,6w9c,DB12251,-7.7,Moxaverine,MYCMTMIGRXJNSO-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
101706,6vxs,DB06267,-7.7,Udenafil,IYFNEFQTYQPVOC-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
138769,6w9c,DB12241,-7.7,TAK-733,RCLQNICOARASSR-SECBINFHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
105551,6vxs,DB13656,-7.7,Eberconazole,MPTJIDOGFUQSQH-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101696,6vxs,DB06249,-7.7,Arzoxifene,MCGDSOGUHLTADD-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
57729,6crv,DB04054,-7.7,"9-Butyl-8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine",PASRTKOWXJDFFV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138747,6w9c,DB12214,-7.7,Luseogliflozin,WHSOLWOTCHFFBK-ZQGJOIPISA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
125711,6w4h,DB02848,-7.7,"{4-[3-(6,7-Diethoxy-Quinazolin-4-Ylamino)-Phenyl]-Thiazol-2-Yl}-Methanol",ZJESXGUODSBHSK-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
101680,6vxs,DB06213,-7.7,Regadenoson,LZPZPHGJDAGEJZ-AKAIJSEGSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
24656,6cs2,DB02429,-7.7,4-(Aminosulfonyl)-N-[(4-Fluorophenyl)Methyl]-Benzamide,IXDVPACDZDRCTN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
27195,6cs2,DB06673,-7.7,Almorexant,DKMACHNQISHMDN-RPLLCQBOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
125721,6w4h,DB02861,-7.7,"4-(Aminosulfonyl)-N-[(3,4,5-Trifluorophenyl)Methyl]-Benzamide",DEHMSTGBNAXEGX-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
57711,6crv,DB04024,-7.7,N'-L-Seryl-3'-Amino-(3'-Deoxy)-Adenosine,ITDKSTILAWHDJI-AYEBZEFBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
137395,6w9c,DB08240,-7.7,N-(4-CHLOROPHENYL)-3-(PHOSPHONOOXY)NAPHTHALENE-2-CARBOXAMIDE,RQAQWBFHPMSXKR-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
11445,6lzg,DB11978,-7.7,Glasdegib,SFNSLLSYNZWZQG-VQIMIIECSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
105523,6vxs,DB13616,-7.7,Melagatran,DKWNMCUOEDMMIN-PKOBYXMFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
125526,6w4h,DB02602,-7.7,AL7182,ICIXQGGQPKFQRL-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
106440,6vxx,DB00216,-7.7,Eletriptan,PWVXXGRKLHYWKM-LJQANCHMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
125333,6w4h,DB02359,-7.7,"9-Butyl-8-(2,5-Dimethoxy-Benzyl)-9h-Purin-6-Ylamine",PPFZLLAIQRZNJE-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
137254,6w9c,DB08076,-7.7,"4-[1-(2,6-dichlorobenzyl)-2-methyl-1H-imidazol-4-yl]pyrimidin-2-amine",CKSSZTMRRVJNNG-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
101029,6vxs,DB04378,-7.7,"3-Amino-N-{4-[2-(2,6-Dimethyl-Phenoxy)-Acetylamino]-3-Hydroxy-1-Isobutyl-5-Phenyl-Pentyl}-Benzamide",APJAEXGNDLFGPD-AWCRTANDSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
105457,6vxs,DB13528,-7.7,Chlormadinone,VUHJZBBCZGVNDZ-TTYLFXKOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
139059,6w9c,DB12787,-7.7,Norethandrolone,ZDHCJEIGTNNEMY-XGXHKTLJSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
61875,6crv,DB12728,-7.7,Fenpropidin,MGNFYQILYYYUBS-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
47494,2fxp,DB01879,-7.7,(S)-2-{Methyl-[2-(Naphthalene-2-Sulfonylamino)-5-(Naphthalene-2-Sulfonyloxy)-Benzoyl]-Amino}-Succinicacid,JOAALZBSMWLOPQ-LJAQVGFWSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
127457,6w4h,DB06133,-7.7,Dimethylcurcumin,ZMGUKFHHNQMKJI-CIOHCNBKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
127444,6w4h,DB05992,-7.7,Plinabulin,UNRCMCRRFYFGFX-TYPNBTCFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
61865,6crv,DB12714,-7.7,Nerispirdine,BTDHTARYCBHHPJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106364,6vxx,DB00131,-7.7,Adenosine phosphate,UDMBCSSLTHHNCD-KQYNXXCUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
101086,6vxs,DB04461,-7.7,Coproporphyrinogen III,NIUVHXTXUXOFEB-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
127443,6w4h,DB05990,-7.7,Obeticholic acid,ZXERDUOLZKYMJM-ZWECCWDJSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
127403,6w4h,DB05738,-7.7,Vapitadine,VQWGYPVNVICKFC-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
7189,6lzg,DB03368,-7.7,"5-Methyl-5-(4-Phenoxy-Phenyl)-Pyrimidine-2,4,6-Trione",RTBMLCLTYAPKIF-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
101105,6vxs,DB04482,-7.7,Cmp-2-Keto-3-Deoxy-Octulosonic Acid,YWWJKULNWGRYAS-UOVSKDHASA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101160,6vxs,DB04554,-7.7,8-Bromoadenosine-5'-Diphosphate,KVVVTFSHHQCHNZ-UUOKFMHZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
127366,6w4h,DB05524,-7.7,Pelitinib,WVUNYSQLFKLYNI-AATRIKPKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
138877,6w9c,DB12392,-7.7,Resminostat,FECGNJPYVFEKOD-VMPITWQZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138884,6w9c,DB12401,-7.7,Bromperidol,RKLNONIVDFXQRX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138887,6w9c,DB12405,-7.7,Triciribine,HOGVTUZUJGHKPL-HTVVRFAVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
57060,6crv,DB03150,-7.7,"2',3'-Dideoxythymidine-5'-Monophosphate",WVNRRNJFRREKAR-JGVFFNPUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
125286,6w4h,DB02295,-7.7,"N-[3-(Dimethylamino)Propyl]-2-({[4-({[4-(Formylamino)-1-Methyl-1h-Pyrrol-2-Yl]Carbonyl}Amino)-1-Methyl-1h-Pyrrol-2-Yl]Carbonyl}Amino)-5-Isopropyl-1,3-Thiazole-4-Carboxamide",VDYCDKRATGWFDA-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
11439,6lzg,DB11966,-7.7,BMS-986094,YFXGICNMLCGLHJ-RSKRLRQZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
105496,6vxs,DB13580,-7.7,Succinylsulfathiazole,SKVLYVHULOWXTD-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
105486,6vxs,DB13563,-7.7,Norgestrienone,GVDMJXQHPUYPHP-FYQPLNBISA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
61841,6crv,DB12675,-7.7,PF-04995274,WLLOFQROROXOMO-GOSISDBHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106305,6vxs,DB15431,-7.7,M-2698,HXAUJHZZPCBFPN-QGZVFWFLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
11426,6lzg,DB11949,-7.7,Vestipitant,SBBYBXSFWOLDDG-JLTOFOAXSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
106316,6vxs,DB15449,-7.7,Citarinostat,VLIUIBXPEDFJRF-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
11428,6lzg,DB11951,-7.7,Lemborexant,MUGXRYIUWFITCP-PGRDOPGGSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
129543,6w4h,DB08954,-7.7,Ifenprodil,UYNVMODNBIQBMV-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
99661,6vxs,DB02538,-7.7,"N-[4-(2-Methylimidazo[1,2-a]Pyridin-3-Yl)-2-Pyrimidinyl]Acetamide",ZCRPPLDDHBLUES-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
141437,6w9q,DB00894,-7.7,Testolactone,BPEWUONYVDABNZ-DZBHQSCQSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
13360,6lzg,DB15209,-7.7,MK-0736,ORQZQBUNAMJFCY-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
129064,6w4h,DB08348,-7.7,"N-2-,N-2-DIMETHYL-N-1-(6-OXO-5,6-DIHYDROPHENANTHRIDIN-2-YL)GLYCINAMIDE",UYJZZVDLGDDTCL-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
121388,6w4b,DB11819,-7.7,ASP-4058,NJNXCJPSMWKXHO-VIFPVBQESA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
129062,6w4h,DB08346,-7.7,"(5Z)-13-CHLORO-14,16-DIHYDROXY-3,4,7,8,9,10-HEXAHYDRO-1H-2-BENZOXACYCLOTETRADECINE-1,11(12H)-DIONE",YUZYDHRGGDTZLG-DUXPYHPUSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
63686,6lxt,DB00580,-7.7,Valdecoxib,LNPDTQAFDNKSHK-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
98149,6vxs,DB00601,-7.7,Linezolid,TYZROVQLWOKYKF-ZDUSSCGKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
121404,6w4b,DB11841,-7.7,Entinostat,INVTYAOGFAGBOE-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
12613,6lzg,DB13593,-7.7,Zolimidine,VSLIUWLPFRVCDL-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
129049,6w4h,DB08325,-7.7,2-(2-HYDROXYETHYLAMINO)-6-(3-CHLOROANILINO)-9-ISOPROPYLPURINE,XZEFMZCNXDQXOZ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
98168,6vxs,DB00624,-7.7,Testosterone,MUMGGOZAMZWBJJ-DYKIIFRCSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
98177,6vxs,DB00635,-7.7,Prednisone,XOFYZVNMUHMLCC-ZPOLXVRWSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
28289,6cs2,DB07870,-7.7,(2S)-2-(4-{[3-CHLORO-5-(TRIFLUOROMETHYL)PYRIDIN-2-YL]OXY}PHENOXY)PROPANOIC ACID,GOCUAJYOYBLQRH-MRVPVSSYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
121428,6w4b,DB11877,-7.7,Basmisanil,VCGRFBXVSFAGGA-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
129041,6w4h,DB08317,-7.7,"5-methyl-6-phenylquinazoline-2,4-diamine",HUCOXWPHDFINIW-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
63694,6lxt,DB00588,-7.7,Fluticasone propionate,WMWTYOKRWGGJOA-CENSZEJFSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
135297,6w9c,DB04274,-7.7,"5,4'-Dideoxyflavanone",SWAJPHCXKPCPQZ-AWEZNQCLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
98213,6vxs,DB00680,-7.7,Moricizine,FUBVWMNBEHXPSU-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
55225,6crv,DB00760,-7.7,Meropenem,DMJNNHOOLUXYBV-PQTSNVLCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
129031,6w4h,DB08306,-7.7,3-[(3-Nitrophenyl)sulfamoyl]-2-thiophenecarboxylic acid,CITCNTPVKZFUAJ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
104708,6vxs,DB12391,-7.7,Sagopilone,BFZKMNSQCNVFGM-UCEYFQQTSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
60750,6crv,DB09068,-7.7,Vortioxetine,YQNWZWMKLDQSAC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
102435,6vxs,DB07393,-7.7,"2-(2-PHENYL-3-PYRIDIN-2-YL-4,5,6,7-TETRAHYDRO-2H-ISOPHOSPHINDOL-1-YL)PYRIDINE",GSKNNHAAFLPYHG-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104709,6vxs,DB12392,-7.7,Resminostat,FECGNJPYVFEKOD-VMPITWQZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
108467,6vxx,DB08022,-7.7,"(2S)-1,3-benzothiazol-2-yl{2-[(2-pyridin-3-ylethyl)amino]pyrimidin-4-yl}ethanenitrile",RCYPVQCPYKNSTG-OAHLLOKOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
135363,6w9c,DB04366,-7.7,3'-Deoxy 3'-Amino Adenosine-5'-Diphosphate,VKODIDNZKBYXJO-QYYRPYCUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
145093,6w9q,DB06948,-7.7,2-ANILINO-6-CYCLOHEXYLMETHOXYPURINE,XWWRLKIBRPJQJX-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
145089,6w9q,DB06944,-7.7,N-(3-cyclopropyl-1H-pyrazol-5-yl)-2-(2-naphthyl)acetamide,RIGZCVNCFXYBEG-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
145087,6w9q,DB06942,-7.7,N-(4-carbamimidoylbenzyl)-1-(3-phenylpropanoyl)-L-prolinamide,RNZKCCPFUWHBFY-IBGZPJMESA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
145071,6w9q,DB06923,-7.7,2-(3-METHYLPHENYL)-1H-INDOLE-5-CARBOXIMIDAMIDE,KJUSXMYSVXZFDJ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
145070,6w9q,DB06922,-7.7,"2-[(1R)-1-carboxy-2-naphthalen-1-ylethyl]-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylic acid",CZNPWASYMRBJCX-GOSISDBHSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
98207,6vxs,DB00674,-7.7,Galantamine,ASUTZQLVASHGKV-JDFRZJQESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
55253,6crv,DB00794,-7.7,Primidone,DQMZLTXERSFNPB-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
121371,6w4b,DB11794,-7.7,Berzosertib,JZCWLJDSIRUGIN-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
58595,6crv,DB06157,-7.7,Istaroxime,MPYLDWFDPHRTEG-PAAYLBSLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60705,6crv,DB08996,-7.7,Dimetacrine,RYQOGSFEJBUZBX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55079,6crv,DB00584,-7.7,Enalapril,GBXSMTUPTTWBMN-XIRDDKMYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
98002,6vxs,DB00421,-7.7,Spironolactone,LXMSZDCAJNLERA-ZHYRCANASA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
108622,6vxx,DB08471,-7.7,"1-(thiophen-2-ylacetyl)-4-(3-thiophen-2-yl-1,2,4-oxadiazol-5-yl)piperidine",SJEVDMFUHCVNPM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
98013,6vxs,DB00436,-7.7,Bendroflumethiazide,HDWIHXWEUNVBIY-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
63798,6lxt,DB00713,-7.7,Oxacillin,UWYHMGVUTGAWSP-JKIFEVAISA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
28355,6cs2,DB07942,-7.7,2-fluoro-4-[4-(4-fluorophenyl)-1H-pyrazol-3-yl]pyridine,YJCHZVXSPFPKMX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
63790,6lxt,DB00704,-7.7,Naltrexone,DQCKKXVULJGBQN-XFWGSAIBSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
58637,6crv,DB06247,-7.7,CX516,ANDGGVOPIJEHOF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
11972,6lzg,DB12693,-7.7,Ritanserin,JUQLTPCYUFPYKE-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
121255,6w4b,DB11614,-7.7,Rupatadine,WUZYKBABMWJHDL-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
121256,6w4b,DB11616,-7.7,Pirarubicin,KMSKQZKKOZQFFG-YXRRJAAWSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
102481,6vxs,DB07447,-7.7,5beta-dihydrotestosterone,NVKAWKQGWWIWPM-MISPCMORSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
63747,6lxt,DB00655,-7.7,Estrone,DNXHEGUUPJUMQT-CBZIJGRNSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
63706,6lxt,DB00603,-7.7,Medroxyprogesterone acetate,PSGAAPLEWMOORI-PEINSRQWSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
108586,6vxx,DB08430,-7.7,PARA-NITROPHENYL 1-THIO-BETA-D-GLUCOPYRANOSIDE,IXFOBQXJWRLXMD-ZIQFBCGOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
129107,6w4h,DB08399,-7.7,PICEATANNOL,CDRPUGZCRXZLFL-OWOJBTEDSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
108557,6vxx,DB08392,-7.7,"2-[5,6-BIS-(4-METHOXY-PHENYL)-FURO[2,3-D]PYRIMIDIN-4-YLAMINO]-ETHANOL",ARBUGBBNEFAECO-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
102475,6vxs,DB07439,-7.7,"1-((2-HYDROXYETHOXY)METHYL)-5-(3-(BENZYLOXY)BENZYL)-6-HYDROXYPYRIMIDINE-2,4(1H,3H)-DIONE",CAWXCABXSPTFRN-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
55152,6crv,DB00674,-7.7,Galantamine,ASUTZQLVASHGKV-JDFRZJQESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
98102,6vxs,DB00546,-7.7,Adinazolam,GJSLOMWRLALDCT-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
13363,6lzg,DB15219,-7.7,Tomivosertib,HKTBYUWLRDZAJK-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
63721,6lxt,DB00621,-7.7,Oxandrolone,QSLJIVKCVHQPLV-PEMPUTJUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
104684,6vxs,DB12357,-7.7,BMS-863233,JJWLXRKVUJDJKG-VIFPVBQESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
98117,6vxs,DB00562,-7.7,Benzthiazide,NDTSRXAMMQDVSW-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
11961,6lzg,DB12675,-7.7,PF-04995274,WLLOFQROROXOMO-GOSISDBHSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
25336,6cs2,DB03239,-7.7,"3',5'-Dinitro-N-Acetyl-L-Thyronine",VZSQTOXQXPKQJX-ZDUSSCGKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
121340,6w4b,DB11750,-7.7,Clobetasol,FCSHDIVRCWTZOX-DVTGEIKXSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
63710,6lxt,DB00607,-7.7,Nafcillin,GPXLMGHLHQJAGZ-JTDSTZFVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
63709,6lxt,DB00606,-7.7,Cyclothiazide,BOCUKUHCLICSIY-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
11966,6lzg,DB12682,-7.7,Mubritinib,ZTFBIUXIQYRUNT-MDWZMJQESA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
145056,6w9q,DB06908,-7.7,"(2S)-3-(1-{[2-(2-CHLOROPHENYL)-5-METHYL-1,3-OXAZOL-4-YL]METHYL}-1H-INDOL-5-YL)-2-ETHOXYPROPANOIC ACID",PAWOPJKHTZCKMT-QFIPXVFZSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
28276,6cs2,DB07858,-7.7,(2S)-2-(4-chlorophenyl)-2-[4-(1H-pyrazol-4-yl)phenyl]ethanamine,HWVGILTYGZFGLR-KRWDZBQOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
26742,6cs2,DB04983,-7.7,Denufosol,FPNPSEMJLALQSA-MIYUEGBISA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
13326,6lzg,DB15149,-7.7,Futibatinib,KEIPNCCJPRMIAX-HNNXBMFYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
121670,6w4b,DB12235,-7.7,Estetrol,AJIPIJNNOJSSQC-NYLIRDPKSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
63482,6lxt,DB00328,-7.7,Indometacin,CGIGDMFJXJATDK-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
144827,6w9q,DB06497,-7.7,Aplaviroc,GWNOTCOIYUNTQP-FQLXRVMXSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
102372,6vxs,DB07318,-7.7,"N-[2-(4-AMINO-5,8-DIFLUORO-1,2-DIHYDROQUINAZOLIN-2-YL)ETHYL]-3-FURAMIDE",BOAUWUUBSXECNL-LLVKDONJSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
144815,6w9q,DB06469,-7.7,Lestaurtinib,UIARLYUEJFELEN-DMVVYWCZSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
144809,6w9q,DB06455,-7.7,Meclinertant,DYLJVOXRWLXDIG-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
102370,6vxs,DB07316,-7.7,"N-{1-[(1-carbamoylcyclopropyl)methyl]piperidin-4-yl}-N-cyclopropyl-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide",FAVXIEFZKPJZRT-NRFANRHFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
121711,6w4b,DB12289,-7.7,Darexaban,IJNIQYINMSGIPS-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
63467,6lxt,DB00310,-7.7,Chlorthalidone,JIVPVXMEBJLZRO-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
104743,6vxs,DB12434,-7.7,Steviolbioside,OMHUCGDTACNQEX-OSHKXICASA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104744,6vxs,DB12436,-7.7,Vofopitant,XILNRORTJVDYRH-HKUYNNGSSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
144772,6w9q,DB06346,-7.7,Fiboflapon,DFQGDHBGRSTTHX-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
2320,6lzg,HMDB0034902,-7.7,"2,6-Cyclolycopene-1,5-diol",VDFVQEJGOSCZNZ-HNNISBQLSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
98352,6vxs,DB00844,-7.7,Nalbuphine,NETZHAKZCGBWSS-CEDHKZHLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
23748,6cs2,DB01357,-7.7,Mestranol,IMSSROKUHAOUJS-MJCUULBUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
55383,6crv,DB00940,-7.7,Methantheline,GZHFODJQISUKAY-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
23749,6cs2,DB01359,-7.7,Penbutolol,KQXKVJAGOJTNJS-HNNXBMFYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
98397,6vxs,DB00896,-7.7,Rimexolone,QTTRZHGPGKRAFB-OOKHYKNYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
108360,6vxx,DB07669,-7.7,"2,3-DIMETHYL-1,4-NAPHTHOQUINONE",LGFDNUSAWCHVJN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
98406,6vxs,DB00905,-7.7,Bimatoprost,AQOKCDNYWBIDND-FTOWTWDKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
60818,6crv,DB09190,-7.7,Talopram,LJBBMCNHIUJBDU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
63430,6lxt,DB00267,-7.7,Cefmenoxime,HJJDBAOLQAWBMH-YCRCPZNHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
102357,6vxs,DB07303,-7.7,"N-3-[3-(5-METHOXYPYRIDIN-3-YL)BENZYL]PYRIDINE-2,3-DIAMINE",PGAWZMRRCVSRIM-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
144698,6w9q,DB06169,-7.7,Indibulin,SOLIIYNRSAWTSQ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
121763,6w4b,DB12364,-7.7,Betrixaban,XHOLNRLADUSQLD-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
135548,6w9c,DB04610,-7.7,"7,8-dihydro-6-hydroxymethyl-7-methyl-7-[2-phenylethyl]-pterin",XMFJTCGUDFSWSW-INIZCTEOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
144683,6w9q,DB06144,-7.7,Sertindole,GZKLJWGUPQBVJQ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
6439,6lzg,DB02106,-7.7,"[3,5-Dibromo-4-(4-Hydroxy-3-Phenethylcarbamoyl-Phenoxy)-Phenyl]-Acetic Acid",KIRQJXNQGZAKGR-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
135572,6w9c,DB04642,-7.7,"7-{2,6-DICHLORO-4-[3-(2-CHLORO-BENZOYL)-UREIDO]-PHENOXY}-HEPTANOIC ACID",XQTOWNDCHQJXOQ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
121727,6w4b,DB12309,-7.7,GI-181771X,CABBMMXFOOZVMS-PMERELPUSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
128904,6w4h,DB08147,-7.7,"4-[3-(dibenzylamino)phenyl]-2,4-dioxobutanoic acid",RMWVENXKUQXLPW-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
58523,6crv,DB05708,-7.7,GTS-21,RPYWXZCFYPVCNQ-RVDMUPIBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
26764,6cs2,DB05100,-7.7,Prinomastat,YKPYIPVDTNNYCN-INIZCTEOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
63571,6lxt,DB00438,-7.7,Ceftazidime,ORFOPKXBNMVMKC-DWVKKRMSSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
58563,6crv,DB05973,-7.7,Inosine 5'-sulfate,IGYLPKLXFDOQGM-KQYNXXCUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28269,6cs2,DB07851,-7.7,"(3R,4S)-1-(3,4-DIMETHOXYPHENYL)-3-(3-METHYLPHENYL)PIPERIDIN-4-AMINE",DQJXBZGPJVSWFI-ROUUACIJSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
121525,6w4b,DB12021,-7.7,Dinaciclib,PIMQWRZWLQKKBJ-SFHVURJKSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
129012,6w4h,DB08285,-7.7,"(2R)-2-{[4-(benzylamino)-8-(1-methylethyl)pyrazolo[1,5-a][1,3,5]triazin-2-yl]amino}butan-1-ol",SQUNOCMDMIQIQK-OAHLLOKOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
129011,6w4h,DB08284,-7.7,"O-[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethyl] (4-iodophenyl)thiocarbamate",CYYIBMGIJWXZEP-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
10660,6lzg,DB08897,-7.7,Aclidinium,ASMXXROZKSBQIH-VITNCHFBSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
10661,6lzg,DB08899,-7.7,Enzalutamide,WXCXUHSOUPDCQV-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
145002,6w9q,DB06844,-7.7,"4-[(7-OXO-7H-THIAZOLO[5,4-E]INDOL-8-YLMETHYL)-AMINO]-N-PYRIDIN-2-YL-BENZENESULFONAMIDE",MBXKBJLIESPLIK-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
128987,6w4h,DB08247,-7.7,6-(CYCLOHEXYLMETHOXY)-8-ISOPROPYL-9H-PURIN-2-AMINE,JABXNQUXGJTKRO-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
121547,6w4b,DB12055,-7.7,MK-0767,ORZMUVMQJPGFOM-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
121555,6w4b,DB12066,-7.7,Orteronel,OZPFIJIOIVJZMN-SFHVURJKSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
55294,6crv,DB00841,-7.7,Dobutamine,JRWZLRBJNMZMFE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
102417,6vxs,DB07371,-7.7,3-(10-methyl-9-anthryl)propanoic acid,CKQINRXZVYBCSC-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
63544,6lxt,DB00404,-7.7,Alprazolam,VREFGVBLTWBCJP-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
121579,6w4b,DB12101,-7.7,CC-220,IXZOHGPZAQLIBH-NRFANRHFSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
63535,6lxt,DB00394,-7.7,Beclomethasone dipropionate,KUVIULQEHSCUHY-XYWKZLDCSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
121636,6w4b,DB12186,-7.7,SRT-2104,LAMQVIQMVKWXOC-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
63510,6lxt,DB00365,-7.7,Grepafloxacin,AIJTTZAVMXIJGM-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
13332,6lzg,DB15163,-7.7,Selatogrel,FYXHWMQPCJOJCH-GMAHTHKFSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
28233,6cs2,DB07813,-7.7,GLYCYLALANYL-N-2-NAPHTHYL-L-PROLINEAMIDE,KCELZXZDIUJGNM-GUYCJALGSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
144895,6w9q,DB06660,-7.7,Saredutant,PGKXDIMONUAMFR-AREMUKBSSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
144900,6w9q,DB06677,-7.7,Clazosentan,LFWCJABOXHSRGC-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
25347,6cs2,DB03250,-7.7,"2-(Beta-D-Glucopyranosyl)-5-Methyl-1,3,4-Benzothiazole",WGJFWQVWYRZPEP-KABOQKQYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
58536,6crv,DB05805,-7.7,NS-2359,PGYDXVBZYKQYCS-VPWBDBDCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55320,6crv,DB00870,-7.7,Suprofen,MDKGKXOCJGEUJW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
63522,6lxt,DB00378,-7.7,Dydrogesterone,JGMOKGBVKVMRFX-HQZYFCCVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
11940,6lzg,DB12649,-7.7,Ibipinabant,AXJQVVLKUYCICH-OAQYLSRUSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
108416,6vxx,DB07967,-7.7,9-CYCLOPENTYL-6-[2-(3-IMIDAZOL-1-YL-PROPOXY)-PHENYLAMINO]-9H-PURINE-2-CARBONITRILE,JJNKDTWKWYLERH-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108432,6vxx,DB07985,-7.7,+/-METHYL 4-(AMINOIMINOMETHYL)-BETA-[3- INH (AMINOIMINO)PHENYL]BENZENE PENTANOATE,PVALLOSAENRPQO-INIZCTEOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55302,6crv,DB00849,-7.7,Methylphenobarbital,ALARQZQTBTVLJV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
121604,6w4b,DB12134,-7.7,Gepotidacin,PZFAZQUREQIODZ-LJQANCHMSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
97981,6vxs,DB00396,-7.7,Progesterone,RJKFOVLPORLFTN-LEKSSAKUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
129154,6w4h,DB08458,-7.7,(4-BROMOPHENYL)[4-({(2E)-4-[CYCLOPROPYL(METHYL)AMINO]BUT-2-ENYL}OXY)PHENYL]METHANONE,JAZMZJDLZUDIDG-NSCUHMNNSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
102493,6vxs,DB07459,-7.7,4-PHENOXY-N-(PYRIDIN-2-YLMETHYL)BENZAMIDE,HVLSCZSVTCNAQX-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
28620,6cs2,DB08213,-7.7,"1-METHYL-5-(2-PHENOXYMETHYL-PYRROLIDINE-1-SULFONYL)-1H-INDOLE-2,3-DIONE",PFAYCUAUBOGVDX-AWEZNQCLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
120462,6w4b,DB08520,-7.7,"(21S)-1AZA-4,4-DIMETHYL-6,19-DIOXA-2,3,7,20-TETRAOXOBICYCLO[19.4.0] PENTACOSANE",VUCSBBBCFXBFFY-IBGZPJMESA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
108898,6vxx,DB11335,-7.7,Ascorbyl glucoside,MLSJBGYKDYSOAE-DCWMUDTNSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
102607,6vxs,DB07596,-7.7,"(17beta)-17-(cyanomethyl)-2-methox1tra-1(10),2,4-trien-3-yl sulfamate",NTSPHKOMJMBWOU-NNKXXINSSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
54798,6crv,DB00242,-7.7,Cladribine,PTOAARAWEBMLNO-KVQBGUIXSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
134798,6w9c,DB03572,-7.7,FR230513,URGFTPMACWKJKU-OAHLLOKOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
54809,6crv,DB00255,-7.7,Diethylstilbestrol,RGLYKWWBQGJZGM-ISLYRVAYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
120517,6w4b,DB08584,-7.7,"6-{[6-(1-methyl-1H-pyrazol-4-yl)[1,2,4]triazolo[4,3-b]pyridazin-3-yl]sulfanyl}quinoline",BCZUAADEACICHN-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
97558,6m71,DB15156,-7.7,ABT-072,XMZSTQYSBYEENY-RMKNXTFCSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
104602,6vxs,DB12242,-7.7,AZD-7762,IAYGCINLNONXHY-LBPRGKRZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102606,6vxs,DB07595,-7.7,"(5Z)-5-(3-BROMOCYCLOHEXA-2,5-DIEN-1-YLIDENE)-N-(PYRIDIN-4-YLMETHYL)-1,5-DIHYDROPYRAZOLO[1,5-A]PYRIMIDIN-7-AMINE",WSIQKQLAGWVKSL-UHFFFAOYSA-O,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
40405,6lu7,DB00619,-7.7,Imatinib,KTUFNOKKBVMGRW-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40407,6lu7,DB06435,-7.7,Tarazepide,CZPILLBHPRAPCB-AREMUKBSSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
108806,6vxx,DB08984,-7.7,Etofenamate,XILVEPYQJIOVNB-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
102613,6vxs,DB07607,-7.7,4-[5-(3-IODO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-1H-IMIDAZOL-4-YL]-PYRIDINE,RXDZANYWRNIAOR-HHHXNRCGSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
40408,6lu7,DB05105,-7.7,Pleconaril,KQOXLKOJHVFTRN-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40410,6lu7,DB01897,-7.7,2-(2f-Benzothiazolyl)-5-Styryl-3-(4f-Phthalhydrazidyl)Tetrazolium Chloride,BEIGFKLRGRRJJA-JLHYYAGUSA-O,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40411,6lu7,DB01051,-7.7,Novobiocin,YJQPYGGHQPGBLI-KGSXXDOSSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40412,6lu7,DB07220,-7.7,"N-[5-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-1H-INDAZOL-3-YL]-2-(4-PIPERIDIN-1-YLPHENYL)ACETAMIDE",ZXYIRNXOAJYLCU-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40413,6lu7,DB00762,-7.7,Irinotecan,UWKQSNNFCGGAFS-XIFFEERXSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40414,6lu7,DB07252,-7.7,"3-({4-[(5-chloro-1,3-benzodioxol-4-yl)amino]pyrimidin-2-yl}amino)benzenesulfonamide",TZHCXOMEOHEZDX-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
102596,6vxs,DB07584,-7.7,"N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine",OKGCSZUKOGMZAL-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
11997,6lzg,DB12725,-7.7,TD-8954,MZOITCJKGUIQEI-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
120653,6w4b,DB08746,-7.7,1-[[(1E)-2-(4-CHLOROPHENYL)ETHENYL]SULFONYL]-4-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]PIPERAZINE,ZOSSOFIFNGGDKG-GIJQJNRQSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
129323,6w4h,DB08659,-7.7,2-(hydrazinocarbonyl)-3-phenyl-1H-indole-5-sulfonamide,PPDLAUCFAOODER-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
129311,6w4h,DB08646,-7.7,TRW3-(2-AMINO-3-HYDROXY-PROPYL)-6-(N'-CYCLOHEXYL-HYDRAZINO)OCTAHYDRO-INDOL-7-OL,PSUOZWHAKZSNOB-LBPRGKRZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
40421,6lu7,DB00878,-7.7,Chlorhexidine,GHXZTYHSJHQHIJ-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
104616,6vxs,DB12264,-7.7,Atevirdine,UCPOMLWZWRTIAA-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
40422,6lu7,DB12432,-7.7,CC-401,XDJCLCLBSGGNKS-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40426,6lu7,DB15197,-7.7,RSV-604,MTPVBMVUENFFLL-HXUWFJFHSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40409,6lu7,DB04154,-7.7,"N-Methyl-N-[3-(6-Phenyl[1,2,4]Triazolo[4,3-B]Pyridazin-3-Yl)Phenyl]Acetamide",ALBWBHNFOJJMCV-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
97531,6m71,DB15106,-7.7,Surufatinib,TTZSNFLLYPYKIL-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60591,6crv,DB08828,-7.7,Vismodegib,BPQMGSKTAYIVFO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
120435,6w4b,DB08489,-7.7,"N4-HYDROXY-2-ISOBUTYL-N1-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.013,18]NONADECA-12(19),13,15,17-TETRAEN-10-YL)-SUCCINAMIDE",GCBPAPVOMPJQHK-NQIIRXRSSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
104550,6vxs,DB12165,-7.7,Presatovir,GOFXWTVKPWJNGD-UWJYYQICSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
120203,6w4b,DB08197,-7.7,"(5E,7S)-2-amino-7-(4-fluoro-2-pyridin-3-ylphenyl)-4-methyl-7,8-dihydroquinazolin-5(6H)-one oxime",KYIXUSLGFINPTC-WVFAEZDRSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
109089,6vxx,DB12359,-7.7,BIIB021,QULDDKSCVCJTPV-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
64127,6lxt,DB01094,-7.7,Hesperetin,AIONOLUJZLIMTK-AWEZNQCLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
97512,6m71,DB15065,-7.7,PF-06291874,IBDYYOQKQCCSDP-QFIPXVFZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
120236,6w4b,DB08240,-7.7,N-(4-CHLOROPHENYL)-3-(PHOSPHONOOXY)NAPHTHALENE-2-CARBOXAMIDE,RQAQWBFHPMSXKR-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
120238,6w4b,DB08242,-7.7,"N,4-dimethyl-3-[(1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl)amino]benzamide",OYTBZXSFNNAVKU-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
134594,6w9c,DB03277,-7.7,alpha-maltotriose,FYGDTMLNYKFZSV-PXXRMHSHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
6270,6lzg,DB01831,-7.7,Tryptophanyl-5'amp,IFQVDHDRFCKAAW-SQIXAUHQSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
12013,6lzg,DB12746,-7.7,AKN-028,JLRIJKVMMZEKDF-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
109074,6vxx,DB11999,-7.7,Vosaroxin,XZAFZXJXZHRNAQ-STQMWFEESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
134657,6w9c,DB03361,-7.7,"2-{(9as)-9a-[(1s)-1-Hydroxyethyl]-2,7-Dimethyl-9a,10-Dihydro-5h-Pyrimido[4,5-D][1,3]Thiazolo[3,2-a]Pyrimidin-8-Yl}Ethyl Trihydrogen Diphosphate",UQFVHIGKDHNMJT-XPTSAGLGSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
129483,6w4h,DB08846,-7.7,Ellagic Acid,AFSDNFLWKVMVRB-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
120284,6w4b,DB08304,-7.7,"(3R)-3-cyclopentyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2-benzothiazine 1,1-dioxide",QZBQVXXESPXFPZ-QGZVFWFLSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
102656,6vxs,DB07653,-7.7,"N-(5,6-DIPHENYLFURO[2,3-D]PYRIMIDIN-4-YL)GLYCINE",VXTCEUDVOCLEJG-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
120320,6w4b,DB08349,-7.7,"N-cyclopropyl-3-{[1-(2,4-difluorophenyl)-7-methyl-6-oxo-6,7-dihydro-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}-4-methylbenzamide",WMEYCLAVMZKZCS-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
60568,6crv,DB08798,-7.7,Sulfamoxole,CYFLXLSBHQBMFT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
134732,6w9c,DB03472,-7.7,Cyclohexyl-Hexyl-Beta-D-Maltoside,WUCWJXGMSXTDAV-QKMCSOCLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
129362,6w4h,DB08709,-7.7,"2,3-diphenyl-1H-indole-7-carboxylic acid",OLUDUXWVPIEHDA-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
129366,6w4h,DB08713,-7.7,"2,6-DIMETHYL-1-(3-[3-METHYL-5-ISOXAZOLYL]-PROPANYL)-4-[2N-METHYL-2H-TETRAZOL-5-YL]-PHENOL",RVZKQTQAFHEOKT-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
25414,6cs2,DB00406,-7.7,Gentian violet cation,LGLFFNDHMLKUMI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
120406,6w4b,DB08454,-7.7,N-(5-METHYL-1H-PYRAZOL-3-YL)-2-PHENYLQUINAZOLIN-4-AMINE,JYCUVOXSZBECAY-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
120368,6w4b,DB08407,-7.7,PLATENSIMYCIN,CSOMAHTTWTVBFL-OFBLZTNGSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
40427,6lu7,DB13104,-7.7,X-396,ONPGOSVDVDPBCY-CQSZACIVSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
108948,6vxx,DB11440,-7.7,Norgestomet,IWSXBCZCPVUWHT-VIFKTUCRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60581,6crv,DB08811,-7.7,Tofisopam,RUJBDQSFYCKFAA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58775,6crv,DB06618,-7.7,Cutamesine,UVSWWUWQVAQPJR-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108961,6vxx,DB11462,-7.7,Sulfaethoxypyridazine,FFJIWWBSBCOKLS-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104575,6vxs,DB12207,-7.7,Verdinexor,OPAKEJZFFCECPN-XQRVVYSFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
108968,6vxx,DB11837,-7.7,Osilodrostat,USUZGMWDZDXMDG-CYBMUJFWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60571,6crv,DB08801,-7.7,Dimetindene,MVMQESMQSYOVGV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
129409,6w4h,DB08758,-7.7,"IMIDAZO[2,1-A]ISOQUINOLINE-2-CARBOHYDRAZIDE",WSNWYZBDIKCPIG-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
98445,6vxs,DB00948,-7.7,Mezlocillin,YPBATNHYBCGSSN-VWPFQQQWSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
40428,6lu7,DB13005,-7.7,Rebastinib,WVXNSAVVKYZVOE-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40429,6lu7,DB06638,-7.7,Quarfloxin,WOQIDNWTQOYDLF-CGAIIQECSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
63987,6lxt,DB00932,-7.7,Tipranavir,SUJUHGSWHZTSEU-FYBSXPHGSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
97702,6m71,DB15446,-7.7,Vidofludimus,XPRDUGXOWVXZLL-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
58677,6crv,DB06354,-7.7,Tezampanel,ZXFRFPSZAKNPQQ-YTWAJWBKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
102529,6vxs,DB07504,-7.7,(2R)-1-{4-[(4-Anilino-5-bromo-2-pyrimidinyl)amino]phenoxy}-3-(dimethylamino)-2-propanol,MEIJADBULOETOV-QGZVFWFLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
97705,6m71,DB15449,-7.7,Citarinostat,VLIUIBXPEDFJRF-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97758,6vxs,DB00136,-7.7,Calcitriol,GMRQFYUYWCNGIN-NKMMMXOESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
135015,6w9c,DB03869,-7.7,5'-O-(N-(L-Seryl)-Sulfamoyl)Adenosine,HQXFJGONGJPTLZ-YTMOPEAISA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
120890,6w4b,DB09079,-7.7,Nintedanib,XZXHXSATPCNXJR-ZIADKAODSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
63936,6lxt,DB00875,-7.7,Flupentixol,NJMYODHXAKYRHW-DVZOWYKESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
129179,6w4h,DB08488,-7.7,"4-{[(E)-2-(5-CHLOROTHIEN-2-YL)VINYL]SULFONYL}-1-(1H-PYRROLO[3,2-C]PYRIDIN-2-YLMETHYL)PIPERAZIN-2-ONE",PLWVUIRWJVKSSD-XBXARRHUSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
28415,6cs2,DB00169,-7.7,Cholecalciferol,QYSXJUFSXHHAJI-YRZJJWOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
13396,6lzg,DB15282,-7.7,Fluorofuranylnorprogesterone F-18,VJKRBRUNEOHPBS-JQKUZGBFSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
135045,6w9c,DB03909,-7.7,"Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate",UFZTZBNSLXELAL-IOSLPCCCSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
108670,6vxx,DB08528,-7.7,"2-AMINO-6-(3,5-DIMETHYLPHENYL)SULFONYLBENZONITRILE",SWGDXLAZBZDUBR-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28439,6cs2,DB08026,-7.7,"2-{4-[(4-imidazo[1,2-a]pyridin-3-ylpyrimidin-2-yl)amino]piperidin-1-yl}-N-methylacetamide",AJLILYAPRHIFAS-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
55008,6crv,DB00494,-7.7,Entacapone,JRURYQJSLYLRLN-BJMVGYQFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
105820,6vxs,DB14093,-7.7,"(1,2,6,7-3H)Testosterone",MUMGGOZAMZWBJJ-JQSYSRDDSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
97902,6vxs,DB00298,-7.7,Dapiprazole,RFWZESUMWJKKRN-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
10543,6lzg,DB08749,-7.7,3-(2-AMINO-6-BENZOYLQUINAZOLIN-3(4H)-YL)-N-CYCLOHEXYL-N-METHYLPROPANAMIDE,KTRFBFMYAJOXLG-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
28399,6cs2,DB07988,-7.7,"2-[3-(5-MERCAPTO-[1,3,4]THIADIAZOL-2YL)-UREIDO]-N-METHYL-3-PENTAFLUOROPHENYL-PROPIONAMIDE",HZAXNPDJVFUGDS-BYPYZUCNSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
28394,6cs2,DB07983,-7.7,1-(4-IODOBENZOYL)-5-METHOXY-2-METHYL INDOLE-3-ACETIC ACID,CXBFZYKAVCAPSV-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
97925,6vxs,DB00327,-7.7,Hydromorphone,WVLOADHCBXTIJK-YNHQPCIGSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
63855,6lxt,DB00783,-7.7,Estradiol,VOXZDWNPVJITMN-ZBRFXRBCSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
97946,6vxs,DB00353,-7.7,Methylergometrine,UNBRKDKAWYKMIV-QWQRMKEZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
108653,6vxx,DB08507,-7.7,N-[[2-METHYL-4-HYDROXYCARBAMOYL]BUT-4-YL-N]-BENZYL-P-[PHENYL]-P-[METHYL]PHOSPHINAMID,KGUVBHLPMGERAT-NIYFSFCBSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
26685,6cs2,DB04867,-7.7,Lintitript,ILNRQFBVVQUOLP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
129158,6w4h,DB08462,-7.7,N-(4-PHENYLAMINO-QUINAZOLIN-6-YL)-ACRYLAMIDE,JGWHILNNHLDARR-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
129157,6w4h,DB08461,-7.7,"3-[(4-AMINO-1-TERT-BUTYL-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL)METHYL]PHENOL",QMAIQPBRCNEJAT-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
63839,6lxt,DB00764,-7.7,Mometasone,QLIIKPVHVRXHRI-CXSFZGCWSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
97959,6vxs,DB00370,-7.7,Mirtazapine,RONZAEMNMFQXRA-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
55013,6crv,DB00499,-7.7,Flutamide,MKXKFYHWDHIYRV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
13426,6lzg,DB15333,-7.7,AZD-1386,FPGNKXCEPARJDI-ZDUSSCGKSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
97681,6m71,DB15406,-7.7,GLPG-0974,MPMKMQHJHDHPBE-RUZDIDTESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
129246,6w4h,DB08564,-7.7,(2E)-N-{4-[(3-bromophenyl)amino]quinazolin-6-yl}-4-(dimethylamino)but-2-enamide,ZCIXBBSRVLSRJQ-QPJJXVBHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
40430,6lu7,DB12690,-7.7,LY-2584702,FYXRSVDHGLUMHB-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40432,6lu7,DB12154,-7.7,Itacitinib,KTBSXLIQKWEBRB-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40433,6lu7,DB11977,-7.7,Golvatinib,UQRCJCNVNUFYDX-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40434,6lu7,DB08901,-7.7,Ponatinib,PHXJVRSECIGDHY-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40435,6lu7,DB08358,-7.7,"2-(2-QUINOLIN-3-YLPYRIDIN-4-YL)-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE",OWFLADWRSCINST-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40436,6lu7,DB08010,-7.7,"(3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-[(E)-2-phenylethenyl]-1H-indole-2,3-dione 3-oxime",DDHASJXGNUWZTM-ZLEWNXFRSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40437,6lu7,DB07297,-7.7,"5,6-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-D]PYRIMIDIN-4-AMINE",PTILEOLOGGMFCS-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40438,6lu7,DB12966,-7.7,Falnidamol,FTFRZXFNZVCRSK-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
108764,6vxx,DB08932,-7.7,Macitentan,JGCMEBMXRHSZKX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
64071,6lxt,DB01030,-7.7,Topotecan,UCFGDBYHRUNTLO-QHCPKHFHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
102581,6vxs,DB07564,-7.7,"6-amino-2-[(2-morpholin-4-ylethyl)amino]-3,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",JUHXOBNFTFUPKQ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
13487,6lzg,DB15449,-7.7,Citarinostat,VLIUIBXPEDFJRF-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
102575,6vxs,DB07557,-7.7,"(5BETA)-PREGNANE-3,20-DIONE",XMRPGKVKISIQBV-XWOJZHJZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
134885,6w9c,DB03695,-7.7,Piritrexim,VJXSSYDSOJBUAV-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
13475,6lzg,DB15431,-7.7,M-2698,HXAUJHZZPCBFPN-QGZVFWFLSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
54909,6crv,DB00376,-7.7,Trihexyphenidyl,HWHLPVGTWGOCJO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
54913,6crv,DB00380,-7.7,Dexrazoxane,BMKDZUISNHGIBY-ZETCQYMHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
134964,6w9c,DB03804,-7.7,5-Bromothienyldeoxyuridine,IGUZFFOBAZCVRK-VAOFZXAKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
120817,6w4b,DB08975,-7.7,Florantyrone,QOBAOSCOLAGPKI-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
64003,6lxt,DB00950,-7.7,Fexofenadine,RWTNPBWLLIMQHL-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
54935,6crv,DB00406,-7.7,Gentian violet cation,LGLFFNDHMLKUMI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
97669,6m71,DB15381,-7.7,Menaquinone,HYPYXGZDOYTYDR-HAJWAVTHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
64013,6lxt,DB00962,-7.7,Zaleplon,HUNXMJYCHXQEGX-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
54882,6crv,DB00343,-7.7,Diltiazem,HSUGRBWQSSZJOP-RTWAWAEBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
129259,6w4h,DB08580,-7.7,4-bromo-2-{[(2R)-2-(2-chlorobenzyl)pyrrolidin-1-yl]carbonyl}aniline,JEGGWFHNKPRKTO-CQSZACIVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
4823,6lzg,HMDB0053912,-7.7,"TG(20:3n6/22:4(7Z,10Z,13Z,16Z)/20:4(8Z,11Z,14Z,17Z))",OIHKRHQEBBJGMC-ZZIBGWPQSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
108727,6vxx,DB08867,-7.7,Ulipristal,HKDLNTKNLJPAIY-WKWWZUSTSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
97648,6m71,DB15333,-7.7,AZD-1386,FPGNKXCEPARJDI-ZDUSSCGKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
54921,6crv,DB00391,-7.7,Sulpiride,BGRJTUBHPOOWDU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
54915,6crv,DB00382,-7.7,Tacrine,YLJREFDVOIBQDA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
97639,6m71,DB15316,-7.7,Florasulam,QZXATCCPQKOEIH-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
64019,6lxt,DB00969,-7.7,Alosetron,JSWZEAMFRNKZNL-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
102111,6vxs,DB07022,-7.7,3-Hydroxypropyl 3-[(7-carbamimidoyl-1-naphthyl)carbamoyl]benzenesulfonate,PXERBGNIBOFZOW-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
63413,6lxt,DB00247,-7.7,Methysergide,KPJZHOPZRAFDTN-NQUBZZJWSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
55421,6crv,DB00986,-7.7,Glycopyrronium,ANGKOCUUWGHLCE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
99011,6vxs,DB01685,-7.7,Topiroxostat,UBVZQGOVTLIHLH-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
99033,6vxs,DB01712,-7.7,"(3r)-4-(P-Toluenesulfonyl)-1,4-Thiazane-3-Carboxylicacid-L-Phenylalanine Ethyl Ester",NDDSSAGSYFVBTG-SFTDATJTSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
24069,6cs2,DB01732,-7.7,"(4r,5s,6s,7r)-1,3-Dibenzyl-4,7-Bis(Phenoxymethyl)-5,6-Dihydroxy-1,3 Diazepan-2-One",SQBOSZXDOHQFAA-ZRTHHSRSSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
7516,6lzg,DB03921,-7.7,4-(3-Pyridin-2-Yl-1h-Pyrazol-4-Yl)Quinoline,IBCXZJCWDGCXQT-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
24075,6cs2,DB01737,-7.7,"Nalpha-(2-Naphthylsulfonylglycyl)-3-Amidino-D,L-Phenylalanine-Isopropylester",YAEIKQDHLCFGAA-KRWDZBQOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
122803,6w4b,DB13927,-7.7,anle138b,RCQIIBJSUWYYFU-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
122808,6w4b,DB13936,-7.7,JNJ-28330835,RYBKPGYFXRNMMU-LBPRGKRZSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
99064,6vxs,DB01755,-7.7,N-[Isoleucinyl]-N'-[Adenosyl]-Diaminosufone,XVTRBLLRODNOJV-VBJYJYTRSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
6582,6lzg,DB02363,-7.7,2'-Monophosphoadenosine-5'-Diphosphate,YPTPYQSAVGGMFN-KQYNXXCUSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
55856,6crv,DB01559,-7.7,Clotiazepam,CHBRHODLKOZEPZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136059,6w9c,DB06444,-7.7,Dexanabinol,SSQJFGMEZBFMNV-PMACEKPBSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
102196,6vxs,DB07119,-7.7,1-CHLORO-6-(4-HYDROXYPHENYL)-2-NAPHTHOL,YHEHVRSGKUYDON-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
27910,6cs2,DB07471,-7.7,"5-[5,6-BIS(METHYLOXY)-1H-BENZIMIDAZOL-1-YL]-3-{[1-(2-CHLOROPHENYL)ETHYL]OXY}-2-THIOPHENECARBOXAMIDE",UHCHLTQBLNUYRT-GFCCVEGCSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
122823,6w4b,DB13954,-7.7,Estradiol cypionate,UOACKFBJUYNSLK-XRKIENNPSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
136035,6w9c,DB06368,-7.7,Alamifovir,VDBGPMJFHCJMOL-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
60975,6crv,DB11201,-7.7,Menthyl salicylate,SJOXEWUZWQYCGL-DVOMOZLQSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55864,6crv,DB01567,-7.7,Fludiazepam,ROYOYTLGDLIGBX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
122835,6w4b,DB13981,-7.7,Nomegestrol acetate,IIVBFTNIGYRNQY-YQLZSBIMSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
136072,6w9c,DB06471,-7.7,Naxifylline,NJYNSYQBNSDGIQ-RDDCQWBRSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
62872,6crv,DB14643,-7.7,Methylprednisolone aceponate,DALKLAYLIPSCQL-YPYQNWSCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104886,6vxs,DB12661,-7.7,Urapidil,ICMGLRUYEQNHPF-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
27891,6cs2,DB07451,-7.7,1-(5-BROMO-PYRIDIN-2-YL)-3-[2-(6-FLUORO-2-HYDROXY-3-PROPIONYL-PHENYL)-CYCLOPROPYL]-UREA,VRAJWAGCJIXJHQ-YPMHNXCESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
122878,6w4b,DB14066,-7.7,Tetrandrine,WVTKBKWTSCPRNU-KYJUHHDHSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
24103,6cs2,DB01771,-7.7,CRA_10991,QXAURVOBXQBPAP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
128399,6w4h,DB07563,-7.7,"1-{7-cyclohexyl-6-[4-(4-methylpiperazin-1-yl)benzyl]-7H-pyrrolo[2,3-d]pyrimidin-2-yl}methanamine",GCJSOJRPNOWSEH-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
136100,6w9c,DB06538,-7.7,Robalzotan,MQTUXRKNJYPMCG-CYBMUJFWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
12688,6lzg,DB13682,-7.7,Cefpirome,DKOQGJHPHLTOJR-WHRDSVKCSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
27885,6cs2,DB07446,-7.7,N-(biphenyl-4-ylsulfonyl)-D-leucine,FBSVJQQVDISETN-QGZVFWFLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
99149,6vxs,DB01865,-7.7,3-(6-Aminopyridin-3-Yl)-N-Methyl-N-[(1-Methyl-1h-Indol-2-Yl)Methyl]Acrylamide,AKFPMLBVLWZSQX-CSKARUKUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
142110,6w9q,DB01761,-7.7,4-[5-[2-(1-Phenyl-Ethylamino)-Pyrimidin-4-Yl]-1-Methyl-4-(3-Trifluoromethylphenyl)-1h-Imidazol-2-Yl]-Piperidine,QICPQLFMWYQJGX-SFHVURJKSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
62879,6crv,DB14650,-7.7,Menadiol diphosphate,JTNHOVZOOVVGHI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62850,6crv,DB14584,-7.7,Segesterone,SFLXYFZGKSGFKA-XUDSTZEESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62931,6crv,DB14750,-7.7,Cidoxepin,ODQWQRRAPPTVAG-BOPFTXTBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
98965,6vxs,DB01624,-7.7,Zuclopenthixol,WFPIAZLQTJBIFN-DVZOWYKESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
63021,6crv,DB14941,-7.7,BMS-817399,GTDPZONCGOCXOD-JPYJTQIMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27960,6cs2,DB07527,-7.7,"N-[(2R,3S)-3-AMINO-2-HYDROXY-4-PHENYLBUTYL]-4-METHOXY-2,3,6-TRIMETHYLBENZENESULFONAMIDE",HORGTFOBJRCVMO-ZWKOTPCHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
23976,6cs2,DB01621,-7.7,Pipotiazine,JOMHSQGEWSNUKU-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
142958,6w9q,DB02882,-7.7,Cyanocinnoline,CUWRVIIPSSUUDJ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
102252,6vxs,DB07182,-7.7,(2S)-2-(3-{[AMINO(IMINO)METHYL]AMINO}PHENYL)-3-[(S)-HYDROXY(3-PHENYLPROPYL)PHOSPHORYL]PROPANOIC ACID,HFRHWTYCVGKGIE-KRWDZBQOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
98894,6vxs,DB01541,-7.7,Boldenone,RSIHSRDYCUFFLA-DYKIIFRCSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
135920,6w9c,DB05737,-7.7,Varespladib methyl,VJYDOJXJUCJUHL-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
98918,6vxs,DB01565,-7.7,Dihydromorphine,IJVCSMSMFSCRME-KBQPJGBKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
60932,6crv,DB09477,-7.7,Enalaprilat,LZFZMUMEGBBDTC-QEJZJMRPSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27946,6cs2,DB07511,-7.7,"4-(4-methyl-1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)benzonitrile",MVYDBJXCIFMINH-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
98924,6vxs,DB01571,-7.7,3-Methylfentanyl,MLQRZXNZHAOCHQ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
142802,6w9q,DB02673,-7.7,"(4ar,6s,8ar)-11-[8-(1,3-Dioxo-1,3-Dihydro-2h-Isoindol-2-Yl)Octyl]-6-Hydroxy-3-Methoxy-5,6,9,10-Tetrahydro-4ah-[1]Benzofuro[3a,3,2-Ef][2]Benzazepin-11-Ium",VLGAHTYYCHWLNI-BHRZLAGCSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
128469,6w4h,DB07647,-7.7,"(2R)-1-[(5,6-DIPHENYL-7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)AMINO]PROPAN-2-OL",VBASHTSSQNDDAS-CQSZACIVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
55814,6crv,DB01515,-7.7,Benzoylecgonine,GVGYEFKIHJTNQZ-RFQIPJPRSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62932,6crv,DB14753,-7.7,Hydroxystilbamidine,TUESWZZJYCLFNL-DAFODLJHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108027,6vxx,DB06725,-7.7,Lornoxicam,WLHQHAUOOXYABV-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
142787,6w9q,DB02651,-7.7,"{[2-(1h-1,2,3-Benzotriazol-1-Yl)-2-(3,4-Difluorophenyl)Propane-1,3-Diyl]Bis[4,1-Phenylene(Difluoromethylene)]}Bis(Phosphonic Acid)",BTAGTGWPDROBMG-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
27931,6cs2,DB07493,-7.7,"(2Z)-5'-BROMO-2,3'-BIINDOLE-2',3(1H,1'H)-DIONE AMMONIATE",IEQQJQHHJMQETK-YPKPFQOOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
142688,6w9q,DB02519,-7.7,Indirubin-5-Sulphonate,IHBOEHLUIBMBMY-YPKPFQOOSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
98940,6vxs,DB01595,-7.7,Nitrazepam,KJONHKAYOJNZEC-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
98945,6vxs,DB01602,-7.7,Bacampicillin,PFOLLRNADZZWEX-FFGRCDKISA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
142588,6w9q,DB02398,-7.7,6-[N-(4-(Aminomethyl)Phenyl)Carbamyl]-2-Naphthalenecarboxamidine,NLBDETRVUYOIHQ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
108018,6vxx,DB06710,-7.7,Methyltestosterone,GCKMFJBGXUYNAG-HLXURNFRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
10902,6lzg,DB09233,-7.7,Cronidipine,CNIJVNPIIHWRRP-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
122759,6w4b,DB13828,-7.7,Cyfluthrin,QQODLKZGRKWIFG-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
27917,6cs2,DB07480,-7.7,4-PHOSPHONOOXY-PHENYL-METHYL-[4-PHOSPHONOOXY]BENZEN,LGSCVLKUKMBYNC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
142540,6w9q,DB02338,-7.7,Nadph Dihydro-Nicotinamide-Adenine-Dinucleotidephosphate,ACFIXJIJDZMPPO-NNYOXOHSSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
142534,6w9q,DB02331,-7.7,"(2s)-2-[(5-Benzofuran-2-Yl-Thiophen-2-Ylmethyl)-(2,4-Dichloro-Benzoyl)-Amino]-3-Phenyl-Propionic Acid",YBULOUKTPCHXAL-DEOSSOPVSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
136019,6w9c,DB06313,-7.7,BNC105,MYDHDVLPMRNDAZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136030,6w9c,DB06354,-7.7,Tezampanel,ZXFRFPSZAKNPQQ-YTWAJWBKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
135964,6w9c,DB06195,-7.7,Seliciclib,BTIHMVBBUGXLCJ-OAHLLOKOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
27884,6cs2,DB07444,-7.7,"6-(3-AMINOPROPYL)-4,9-DIMETHYLPYRROLO[3,4-C]CARBAZOLE-1,3(2H,6H)-DIONE",PKPNSCZPIWCHMW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
107942,6vxx,DB05737,-7.7,Varespladib methyl,VJYDOJXJUCJUHL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
122975,6w4b,DB14569,-7.7,Tedizolid,XFALPSLJIHVRKE-GFCCVEGCSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
136244,6w9c,DB06891,-7.7,"5-{[(4-AMINO-3-CHLORO-5-FLUOROPHENYL)SULFONYL]AMINO}-1,3,4-THIADIAZOLE-2-SULFONAMIDE",HOLJYLOVIHBQHO-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
6614,6lzg,DB02407,-7.7,6-O-Cyclohexylmethyl Guanine,MWGXGTJJAOZBNW-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
102128,6vxs,DB07040,-7.7,"2-amino-7-fluoro-5-oxo-5H-chromeno[2,3-b]pyridine-3-carboxamide",GCHMLYYPYFXLQB-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104929,6vxs,DB12724,-7.7,AZD-7295,MAQDQJWCSSCURR-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
136260,6w9c,DB06910,-7.7,"[4-R-(4-ALPHA,6-BETA,7-BETA]-HEXAHYDRO-5,6-DI(HYDROXY)-1,3-DI(ALLYL)-4,7-BISPHENYLMETHYL)-2H-1,3-DIAZEPINONE",IWJSQELMWLOYSO-LWSSLDFYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
99480,6vxs,DB02315,-7.7,Cyclic GMP,ZOOGRGPOEVQQDX-UUOKFMHZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
99481,6vxs,DB02316,-7.7,"1-(5-Carboxypentyl)-5-[(2,6-Dichlorobenzyl)Oxy]-1 H-Indole-2-Carboxylic Acid",JTGPYFFQVOIJKR-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
141706,6w9q,DB01199,-7.7,Tubocurarine,JFJZZMVDLULRGK-URLMMPGGSA-O,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
104938,6vxs,DB12739,-7.7,Bindarit,MTHORRSSURHQPZ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
107664,6vxx,DB04155,-7.7,2-Fluoro-2-Deoxy-Beta-D-Galactopyranosyl-Beta-D-Glucopyranose,KWMZPXRIEZDXAQ-QRZGKKJRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
141673,6w9q,DB01165,-7.7,Ofloxacin,GSDSWSVVBLHKDQ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
26979,6cs2,DB06188,-7.7,Ispinesib,QJZRFPJCWMNVAV-HHHXNRCGSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
56102,6crv,DB01877,-7.7,"N-Hydroxy 1n(4-Methoxyphenyl)Sulfonyl-4-(Z,E-N-Methoxyimino)Pyrrolidine-2r-Carboxamide",OJLWCTMBGWSVFC-JOYOIKCWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56108,6crv,DB01883,-7.7,N-(Sulfanylacetyl)Tyrosylprolylmethioninamide,LNLWXWOYQHAKTD-ULQDDVLXSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61034,6crv,DB11396,-7.7,Dichlorophen,MDNWOSOZYLHTCG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62670,6crv,DB13920,-7.7,Valopicitabine,TVRCRTJYMVTEFS-ICGCPXGVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107613,6vxx,DB04089,-7.7,AL5300,HHPUQNGRNUOYCD-VIFPVBQESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104960,6vxs,DB12774,-7.7,AZD-8055,KVLFRAWTRWDEDF-IRXDYDNUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
123261,6w4b,DB15197,-7.7,RSV-604,MTPVBMVUENFFLL-HXUWFJFHSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
99549,6vxs,DB02400,-7.7,"5-Methoxy-1,2-Dimethyl-3-(4-Nitrophenoxymethyl)Indole-4,7-Dione",IBLWSLZYYZHSRG-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
26988,6cs2,DB00584,-7.7,Enalapril,GBXSMTUPTTWBMN-XIRDDKMYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
107598,6vxx,DB04070,-7.7,6-Deoxyerythronolide B,HQZOLNNEQAKEHT-IBBGRPSASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
99590,6vxs,DB02450,-7.7,"2-Benzo[1,3]Dioxol-5-Ylmethyl-3-Benzyl-Succinic Acid",ASEJDWRSZYAIOT-GJZGRUSLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
136331,6w9c,DB06996,-7.7,D-leucyl-N-(4-carbamimidoylbenzyl)-L-prolinamide,XFNMDMGNNKIXBT-CVEARBPZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
123289,6w4b,DB15245,-7.7,Olorofim,SUFPWYYDCOKDLL-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
48355,2fxp,DB03020,-7.7,5-Beta-D-Ribofuranosylnicotinamide Adenine Dinucleotide,UINNILASBHZOTM-KMXXXSRASA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
24206,6cs2,DB01895,-7.7,Aspartyl-Adenosine-5'-Monophosphate,QPBSGQWTJLPZNF-VWJPMABRSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
13142,6lzg,DB14766,-7.7,Etrasimod,MVGWUTBTXDYMND-QGZVFWFLSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
13141,6lzg,DB14765,-7.7,Rivoceranib,WPEWQEMJFLWMLV-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
128202,6w4h,DB07330,-7.7,trans-4-(7-carbamoyl-1H-benzimidazol-2-yl)-1-propylpiperidinium,KXSIHXHEHABEJX-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
123257,6w4b,DB15190,-7.7,GLPG-0259,YBFGSJUVEOYPIS-OALUTQOASA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
141765,6w9q,DB01289,-7.7,Glisoxepide,ZKUDBRCEOBOWLF-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
62723,6crv,DB14020,-7.7,Benzoin,ISAOCJYIOMOJEB-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107733,6vxx,DB04546,-7.7,3-Deaza-Adenosine,DBZQFUNLCALWDY-PNHWDRBUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
122985,6w4b,DB14624,-7.7,Nandrolone hydrogen sulfate,SKZMVWBZTQNCKW-IZPLOLCNSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
107930,6vxx,DB05659,-7.7,Faropenem medoxomil,JQBKWZPHJOEQAO-DVPVEWDBSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
142069,6w9q,DB01705,-7.7,Bis(5-Amidino-Benzimidazolyl)Methane,QZKOOEFIMWKZPK-UHFFFAOYSA-Q,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
13208,6lzg,DB14898,-7.7,Retagliptin,WIIAMRXFUJLYEF-SNVBAGLBSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
128374,6w4h,DB07534,-7.7,"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE",BKUMVXIXUVYKDQ-GHXNOFRVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
142057,6w9q,DB01690,-7.7,Bis(Adenosine)-5'-Triphosphate,QCICUPZZLIQAPA-XPWFQUROSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
123014,6w4b,DB14654,-7.7,Bisoxatin acetate,ZCBJDQBSLZREAA-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
13206,6lzg,DB14896,-7.7,Selitrectinib,OEBIHOVSAMBXIB-SJKOYZFVSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
62835,6crv,DB14543,-7.7,Hydrocortisone probutate,FOGXJPFPZOHSQS-AYVLZSQQSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
10946,6lzg,DB09298,-7.7,Silibinin,SEBFKMXJBCUCAI-HKTJVKLFSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
107900,6vxx,DB05501,-7.7,AMD-070,WVLHHLRVNDMIAR-IBGZPJMESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
128371,6w4h,DB07531,-7.7,"4-{5-[(Z)-(2,4-DIOXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE",JNPRTUHVCHGFHJ-GHXNOFRVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
102172,6vxs,DB07090,-7.7,(3S)-N-(3-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE,NJNMAZNXKKBTPS-ZDUSSCGKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
27851,6cs2,DB07409,-7.7,"(1-HYDROXY-1-PHOSPHONO-2-[1,1';4',1'']TERPHENYL-3-YL-ETHYL)-PHOSPHONIC ACID",MPBUFKZCEBTBSK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
104895,6vxs,DB12671,-7.7,Beloranib,ZEZFKUBILQRZCK-MJSCXXSSSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
13194,6lzg,DB14876,-7.7,TAS-116,NVVPMZUGELHVMH-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
107859,6vxx,DB05271,-7.7,Rotigotine,KFQYTPMOWPVWEJ-INIZCTEOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
24160,6cs2,DB01838,-7.7,"6,4'-Dihydroxy-3-Methyl-3',5'-Dibromoflavone",GKDYOXMZSXVKPP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
141785,6w9q,DB01337,-7.7,Pancuronium,GVEAYVLWDAFXET-XGHATYIMSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
123130,6w4b,DB14899,-7.7,Tavapadon,AKQXQLUNFKDZBN-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
61022,6crv,DB11378,-7.7,Buquinolate,LVVXOXRUTDAKFE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
123109,6w4b,DB14860,-7.7,Ensartinib,GLYMPHUVMRFTFV-QLFBSQMISA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
104906,6vxs,DB12689,-7.7,Azeliragon,KJNNWYBAOPXVJY-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
10879,6lzg,DB09209,-7.7,Pholcodine,GPFAJKDEDBRFOS-FKQDBXSBSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
141863,6w9q,DB01459,-7.7,Bezitramide,FLKWNFFCSSJANB-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
136171,6w9c,DB06702,-7.7,Fesoterodine,DCCSDBARQIPTGU-HSZRJFAPSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
128345,6w4h,DB07500,-7.7,(2E)-1-[2-hydroxy-4-methoxy-5-(3-methylbut-2-en-1-yl)phenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one,ZUGCRBMNFSAUOC-YRNVUSSQSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
56006,6crv,DB01752,-7.7,S-adenosyl-L-homocysteine,ZJUKTBDSGOFHSH-WFMPWKQPSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107835,6vxx,DB04679,-7.7,H TYPE I TRISACCHARIDE,MGSDFCKWGHNUSM-QVPNGJTFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
26941,6cs2,DB06083,-7.7,Tapinarof,ZISJNXNHJRQYJO-CMDGGOBGSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
58286,6crv,DB04800,-7.7,1-METHYL-3-PHENYL-1H-PYRAZOL-5-YLSULFAMIC ACID,OTZLVSGSRPNRFT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107823,6vxx,DB04659,-7.7,"(1S,2S,3R,4S,5S)-2,3,4-TRIHYDROXY-5-(HYDROXYMETHYL)CYCLOHEXYL (1E)-2-PHENYL-N-(SULFOOXY)ETHANIMIDOTHIOATE",LZDZCEOFJWRJIA-GGASBGQWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55771,6crv,DB01464,-7.7,Furethidine,NNCOZXNZFLUYGG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
98888,6vxs,DB01535,-7.7,Carfentanil,YDSDEBIZUNNPOB-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
135903,6w9c,DB05626,-7.7,Retaspimycin,OAKGNIRUXAZDQF-TXHRRWQRSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
63323,6lxt,DB00146,-7.7,Calcifediol,JWUBBDSIWDLEOM-DTOXIADCSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
135655,6w9c,DB04768,-7.7,Pyrithiamine Pyrophosphate,ZHKSTKOYQKNDSJ-UHFFFAOYSA-O,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
28103,6cs2,DB07679,-7.7,"(9S,12S)-9-(1-methylethyl)-7,10-dioxo-2-oxa-8,11-diazabicyclo[12.2.2]octadeca-1(16),14,17-triene-12-carboxylic acid",RRAAROKJUVKWAF-RDJZCZTQSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
128725,6w4h,DB07946,-7.7,"N-[2-({[amino(imino)methyl]amino}oxy)ethyl]-2-{6-chloro-3-[(2,2-difluoro-2-phenylethyl)amino]-2-fluorophenyl}acetamide",DZEJHPMTDNDECN-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
144488,6w9q,DB04971,-7.7,Reglitazar,QBQLYIISSRXYKL-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
122004,6w4b,DB12725,-7.7,TD-8954,MZOITCJKGUIQEI-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
128724,6w4h,DB07945,-7.7,"5-(3-carbamoylbenzyl)-5,6,7,8,9,10-hexahydrocyclohepta[b]indole-4-carboxylic acid",GKBQRPKZHUFGOB-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
13293,6lzg,DB15092,-7.7,LY-2624803,UEFWDVMEDFCHGW-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
60866,6crv,DB09244,-7.7,Pirlindole,IWVRVEIKCBFZNF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
26822,6cs2,DB05422,-7.7,OPC-14523,TZZGTNZBLPCBIS-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
128719,6w4h,DB07940,-7.7,"9-(3-IODOBENZYLAMINO)-1,2,3,4-TETRAHYDROACRIDINE",ZUCWQTWGZGIYPV-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
98649,6vxs,DB01183,-7.7,Naloxone,UZHSEJADLWPNLE-GRGSLBFTSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
23780,6cs2,DB01418,-7.7,Acenocoumarol,VABCILAOYCMVPS-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
58444,6crv,DB05284,-7.7,CA4P,LGZKGOGODCLQHG-ZDUSSCGKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
12645,6lzg,DB13631,-7.7,Methoserpidine,ULBNWNUHGJLQHO-VKMIBBQISA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
102306,6vxs,DB07248,-7.7,"7-PYRIDIN-2-YL-N-(3,4,5-TRIMETHOXYPHENYL)-7H-PYRROLO[2,3-D]PYRIMIDIN-2-AMINE",YENZSPIOXMNEFF-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
55566,6crv,DB01151,-7.7,Desipramine,HCYAFALTSJYZDH-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
122062,6w4b,DB12823,-7.7,Tecarfarin,QFLNTQDOVCLQKW-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
122067,6w4b,DB12832,-7.7,Prednimustine,HFVNWDWLWUCIHC-GUPDPFMOSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
63250,6crv,DB15436,-7.7,Glucoraphanin,GMMLNKINDDUDCF-JRWRFYLSSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55571,6crv,DB01157,-7.7,Trimetrexate,NOYPYLRCIDNJJB-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
98680,6vxs,DB01216,-7.7,Finasteride,DBEPLOCGEIEOCV-WSBQPABSSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
122083,6w4b,DB12858,-7.7,LY-377604,RBSGUQYXRDKPAE-QFIPXVFZSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
144352,6w9q,DB04759,-7.7,"PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-(3-METHYL-BENZYLAMIDE)",GTBUZLPQANSGGE-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
98685,6vxs,DB01222,-7.7,Budesonide,VOVIALXJUBGFJZ-KWVAZRHASA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
128669,6w4h,DB07877,-7.7,"8-(6-BROMO-BENZO[1,3]DIOXOL-5-YLSULFANYL)-9-(3-ISOPROPYLAMINO-PROPYL)-ADENINE",MWGWLDJLENCVRQ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
135747,6w9c,DB04883,-7.7,Darusentan,FEJVSJIALLTFRP-LJQANCHMSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
144291,6w9q,DB04669,-7.7,TRIAZOLOPYRIMIDINE,YWBFPKPWMSWWEA-UHFFFAOYSA-O,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
28070,6cs2,DB07644,-7.7,"5-[(1S)-1-(3-chlorophenyl)ethoxy]quinazoline-2,4-diamine",IDHINEMSCUFEIP-VIFPVBQESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
55586,6crv,DB01175,-7.7,Escitalopram,WSEQXVZVJXJVFP-FQEVSTJZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55561,6crv,DB01146,-7.7,Diphenylpyraline,OWQUZNMMYNAXSL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
128727,6w4h,DB07949,-7.7,"({[(3E)-2'-OXO-2',7'-DIHYDRO-2,3'-BIINDOL-3(7H)-YLIDENE]AMINO}OXY)ACETIC ACID",BFQRPTKOSYMPOL-LALPNIDTSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
55518,6crv,DB01096,-7.7,Oxamniquine,XCGYUJZMCCFSRP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
98569,6vxs,DB01092,-7.7,Ouabain,LPMXVESGRSUGHW-HBYQJFLCSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
28172,6cs2,DB07754,-7.7,N-({(1R)-1-carboxy-2-[(4-fluorobenzyl)sulfanyl]ethyl}carbamoyl)-L-glutamic acid,IDTMSHGCAZPVLC-RYUDHWBXSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
144640,6w9q,DB05835,-7.7,NS-3728,OQRAKHDEGGGWQO-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
28170,6cs2,DB07751,-7.7,"(2S)-1-[4-({6-[(2,6-Difluorophenyl)amino]-4-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol",ZVSBKYYVBCKDBO-HNNXBMFYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
6447,6lzg,DB02115,-7.7,Daidzin,KYQZWONCHDNPDP-QNDFHXLGSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
108345,6vxx,DB07648,-7.7,"(2R)-3-{[(4Z)-5,6-DIPHENYL-6,7-DIHYDRO-4H-PYRROLO[2,3-D]PYRIMIDIN-4-YLIDENE]AMINO}PROPANE-1,2-DIOL",TWEONIHFGKSPLC-MRXNPFEDSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55439,6crv,DB01006,-7.7,Letrozole,HPJKCIUCZWXJDR-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55440,6crv,DB01007,-7.7,Tioconazole,QXHHHPZILQDDPS-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108327,6vxx,DB07628,-7.7,"6-(2-fluorobenzyl)-2,4-dimethyl-4,6-dihydro-5H-thieno[2',3':4,5]pyrrolo[2,3-d]pyridazin-5-one",IEWYEWDDQWYJLU-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
128840,6w4h,DB08077,-7.7,"2-[4-({[(3,5-DICHLOROPHENYL)AMINO]CARBONYL}AMINO)PHENOXY]-2-METHYLPROPANOIC ACID",OYJPTSMWFKGZJM-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
55455,6crv,DB01024,-7.7,Mycophenolic acid,HPNSFSBZBAHARI-RUDMXATFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
121854,6w4b,DB12491,-7.7,Fasiglifam,BZCALJIHZVNMGJ-HSZRJFAPSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
128825,6w4h,DB08059,-7.7,Wortmannin,QDLHCMPXEPAAMD-QAIWCSMKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
102339,6vxs,DB07284,-7.7,"N-3-(3-PYRIDIN-3-YLBENZYL)PYRIDINE-2,3-DIAMINE",NQSBHBFOOVYRNM-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
144583,6w9q,DB05511,-7.7,Piclidenoson,HUJXGQILHAUCCV-MOROJQBDSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
128820,6w4h,DB08054,-7.7,"1-(1-methylethyl)-3-quinolin-6-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine",GEZALMMCQYDFML-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
98494,6vxs,DB01006,-7.7,Letrozole,HPJKCIUCZWXJDR-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
121881,6w4b,DB12535,-7.7,AC-430,DCRWIATZWHLIPN-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
121950,6w4b,DB12645,-7.7,Givinostat,YALNUENQHAQXEA-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
58454,6crv,DB05377,-7.7,Chlorfenson,RZXLPPRPEOUENN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104787,6vxs,DB12505,-7.7,E-7820,LWGUASZLXHYWIV-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
128751,6w4h,DB07976,-7.7,3-{[(3-FLUORO-3'-METHOXYBIPHENYL-4-YL)AMINO]CARBONYL}THIOPHENE-2-CARBOXYLIC ACID,GIUMGVUBDBDTDX-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
104781,6vxs,DB12492,-7.7,Piritramide,IHEHEFLXQFOQJO-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
28126,6cs2,DB07704,-7.7,"6-AMINO-4-[2-(4-METHOXYPHENYL)ETHYL]-1,7-DIHYDRO-8H-IMIDAZO[4,5-G]QUINAZOLIN-8-ONE",UKRVQKUVWNDGMN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
98714,6vxs,DB01264,-7.7,Darunavir,CJBJHOAVZSMMDJ-HEXNFIEUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
128764,6w4h,DB07991,-7.7,N-[(1R)-3-(4-HYDROXYPHENYL)-1-METHYLPROPYL]-2-(2-PHENYL-1H-INDOL-3-YL)ACETAMIDE,APLJSSOXDWUNGV-GOSISDBHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
98544,6vxs,DB01063,-7.7,Acetophenazine,WNTYBHLDCKXEOT-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
121903,6w4b,DB12567,-7.7,Camicinal,RZKDEGZIFSJVNA-IBGZPJMESA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
108273,6vxx,DB07562,-7.7,"N-[4-(2,4-DIMETHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YL]-N',N'-DIMETHYL-BENZENE-1,4-DIAMINE",FGGSNQOBRJVAKL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
26808,6cs2,DB05351,-7.7,Dexlansoprazole,MJIHNNLFOKEZEW-RUZDIDTESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
98523,6vxs,DB01038,-7.7,Carphenazine,XZSMZRXAEFNJCU-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
144575,6w9q,DB05465,-7.7,Tandutinib,UXXQOJXBIDBUAC-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
121905,6w4b,DB12571,-7.7,Rimacalib,MYTIJGWONQOOLC-HNNXBMFYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
98453,6vxs,DB00957,-7.7,Norgestimate,KIQQMECNKUGGKA-NMYWJIRASA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
13274,6lzg,DB15057,-7.7,NUC-1031,NHTKGYOMICWFQZ-KKQYNPQSSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
144141,6w9q,DB04477,-7.7,"N-1,2,3,4-Tetrahydronaphth-1-Yl-2'-[3,5-Dimethoxybenzamido]-2'-Deoxy-Adenosine",FDZQGEIYGFPMOB-ZUURFMEUSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
128574,6w4h,DB07772,-7.7,"(1R)-1-{[(4'-methoxy-1,1'-biphenyl-4-yl)sulfonyl]amino}-2-methylpropylphosphonic acid",BZVYQWLRCHLAGK-QGZVFWFLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
122322,6w4b,DB13246,-7.7,Quinupramine,JCBQCKFFSPGEDY-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
55678,6crv,DB01324,-7.7,Polythiazide,CYLWJCABXYDINA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
135847,6w9c,DB05351,-7.7,Dexlansoprazole,MJIHNNLFOKEZEW-RUZDIDTESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
28017,6cs2,DB07587,-7.7,"N-(1-CYANOCYCLOPROPYL)-3-({[(2S)-5-OXOPYRROLIDIN-2-YL]METHYL}SULFONYL)-N-2-[(1S)-2,2,2-TRIFLUORO-1-(4-FLUOROPHENYL)ETHYL]-L-ALANINAMIDE",JLPXDVXMMYRTKN-ZOBUZTSGSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
128572,6w4h,DB07770,-7.7,5-(4-FLUOROPHENYL)-3-{[(4-METHYLPHENYL)SULFONYL]AMINO}THIOPHENE-2-CARBOXYLIC ACID,DJPFUQBNQLKCAB-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
128567,6w4h,DB07764,-7.7,FLUORESCIN,MURGITYSBWUQTI-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
102270,6vxs,DB07203,-7.7,6-CYCLOHEXYLMETHOXY-2-(3'-CHLOROANILINO) PURINE,OUEGMEMDEAOAEG-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
63080,6crv,DB15097,-7.7,Gefapixant,HLWURFKMDLAKOD-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
98847,6vxs,DB01485,-7.7,4-Hydroxytestosterone,BQOIJSIMMIDHMO-FBPKJDBXSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
135852,6w9c,DB05395,-7.7,Amibegron,RDJQCOBTKKAQAH-FPOVZHCZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
122398,6w4b,DB13347,-7.7,Diphenadione,JYGLAHSAISAEAL-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
63071,6crv,DB15078,-7.7,Rogaratinib,HNLRRJSKGXOYNO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
2386,6lzg,HMDB0036657,-7.7,Epi-alpha-amyrin,FSLPMRQHCOLESF-QJYIJPODSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
98817,6vxs,DB01453,-7.7,Beta-hydroxyfentanyl,JEFVHLMGRUJLET-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
10850,6lzg,DB09181,-7.7,Trefentanil,RJSCINHYBGMIFT-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
108117,6vxx,DB06869,-7.7,1-[2-AMINO-2-CYCLOHEXYL-ACETYL]-PYRROLIDINE-3-CARBOXYLIC ACID 5-CHLORO-2-(2-ETHYLCARBAMOYL-ETHOXY)-BENZYLAMIDE,BMHVHOJXEQTIEA-SIKLNZKXSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
26891,6cs2,DB05738,-7.7,Vapitadine,VQWGYPVNVICKFC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
55702,6crv,DB01359,-7.7,Penbutolol,KQXKVJAGOJTNJS-HNNXBMFYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
135878,6w9c,DB05501,-7.7,AMD-070,WVLHHLRVNDMIAR-IBGZPJMESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
143274,6w9q,DB03300,-7.7,Pterin Cytosine Dinucleotide,WKSPNQYEWZEMMI-FEFZDOOUSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
135895,6w9c,DB05585,-7.7,Verubulin,SNHCRNMVYDHVDT-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
108108,6vxx,DB06858,-7.7,N-cyclooctylglycyl-N-(4-carbamimidoylbenzyl)-L-prolinamide,MMLOIDMSBRJZAE-FQEVSTJZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
11878,6lzg,DB12555,-7.7,Nelotanserin,COSPVUFTLGQDQL-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
26906,6cs2,DB05830,-7.7,Trestolone,YSGQGNQWBLYHPE-CFUSNLFHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
108084,6vxx,DB06826,-7.7,Unoprostone,TVHAZVBUYQMHBC-SNHXEXRGSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
23963,6cs2,DB00248,-7.7,Cabergoline,KORNTPPJEAJQIU-KJXAQDMKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
27975,6cs2,DB00691,-7.7,Moexipril,UWWDHYUMIORJTA-HSQYWUDLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
128505,6w4h,DB07693,-7.7,"N-(3,5-dibromo-4-hydroxyphenyl)-2,6-dimethylbenzamide",IFECSMFQARKPSU-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
98879,6vxs,DB01526,-7.7,4-Androstenediol,BTTWKVFKBPAFDK-LOVVWNRFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
143378,6w9q,DB03446,-7.7,N-Benzyl-3-(alpha-D-galactopyranosyloxy)benzamide,FSMWGHKWKYCPKE-QTVCLEQKSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
135843,6w9c,DB05298,-7.7,Tetomilast,XDBHURGONHZNJF-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
102272,6vxs,DB07205,-7.7,N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,GZJXCRHEMLAMRA-SDBHATRESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
60903,6crv,DB09313,-7.7,Ioxaglic acid,TYYBFXNZMFNZJT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108182,6vxx,DB07197,-7.7,4-BROMO-3-(CARBOXYMETHOXY)-5-(4-HYDROXYPHENYL)THIOPHENE-2-CARBOXYLIC ACID,QZWUMLLRAVGBHC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
23843,6cs2,DB01480,-7.7,Cyprenorphine,VSKIOMHXEUHYSI-KNLIIKEYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
122160,6w4b,DB12973,-7.7,Serlopitant,FLNYCRJBCNNHRH-OIYLJQICSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
26861,6cs2,DB05585,-7.7,Verubulin,SNHCRNMVYDHVDT-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
23856,6cs2,DB01493,-7.7,Ethylestrenol,AOXRBFRFYPMWLR-XGXHKTLJSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
23857,6cs2,DB01496,-7.7,Barbituric acid derivative,DNZPLHRZXUJATK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
128627,6w4h,DB07831,-7.7,"2-{[(6-OXO-1,6-DIHYDROPYRIDIN-3-YL)METHYL]AMINO}-N-[4-PROPYL-3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE",SHSORWZDEKFFLP-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
108172,6vxx,DB07185,-7.7,2-{[(4-CHLOROPHENOXY)ACETYL]AMINO}BENZOIC ACID,LXSDGQYDSDIUPN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
143954,6w9q,DB04215,-7.7,CRA_9076,BVTBOJXEAPSOEB-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
135768,6w9c,DB04930,-7.7,Permethrin,RLLPVAHGXHCWKJ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
55617,6crv,DB01207,-7.7,Ridogrel,GLLPUTYLZIKEGF-HAVVHWLPSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
48796,2fxp,DB03632,-7.7,Argifin,UHBHXSDKGLPPGO-HTDHLNIYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
143930,6w9q,DB04186,-7.7,"N'-(Pyrrolidino[2,1-B]Isoindolin-4-On-8-Yl)-N-(Pyridin-2-Yl)Urea",KLVYMYQTRZCMLE-CYBMUJFWSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
98769,6vxs,DB01393,-7.7,Bezafibrate,IIBYAHWJQTYFKB-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
122200,6w4b,DB13036,-7.7,Ramatroban,LDXDSHIEDAPSSA-OAHLLOKOSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
58401,6crv,DB05025,-7.7,Arimoclomol,SGEIEGAXKLMUIZ-CYBMUJFWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
23878,6cs2,DB01521,-7.7,Clostebol,KCZCIYZKSLLNNH-FBPKJDBXSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
104840,6vxs,DB12582,-7.7,Piperine,MXXWOMGUGJBKIW-YPCIICBESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
135832,6w9c,DB05255,-7.7,Ronacaleret,FQJISUPNMFRIFZ-HXUWFJFHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
143687,6w9q,DB03865,-7.7,6-Chloro-2-(2-Hydroxy-Biphenyl-3-Yl)-1h-Indole-5-Carboxamidine,FEKRWNWZMOSVBX-UHFFFAOYSA-O,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
98801,6vxs,DB01434,-7.7,19-norandrostenedione,JRIZOGLBRPZBLQ-QXUSFIETSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
4595,6lzg,HMDB0052936,-7.7,"TG(18:3(6Z,9Z,12Z)/24:0/18:3(9Z,12Z,15Z))",SLHARRPKIAUULE-VUGHRXNESA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
128584,6w4h,DB07785,-7.7,"1-{(1R,2S)-2-HYDROXY-1-[2-(2-NAPHTHYLOXY)ETHYL]PROPYL}-1H-IMIDAZONE-4-CARBOXAMIDE",UYAJDVNLQJVRHD-SCLBCKFNSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
55587,6crv,DB01176,-7.7,Cyclizine,UVKZSORBKUEBAZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
98786,6vxs,DB01418,-7.7,Acenocoumarol,VABCILAOYCMVPS-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
122246,6w4b,DB13104,-7.7,X-396,ONPGOSVDVDPBCY-CQSZACIVSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
122241,6w4b,DB13097,-7.7,1alpha-Hydroxyvitamin D5,NWFOBODUYTUMNC-VPSCEVSQSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
104832,6vxs,DB12572,-7.7,Pexacerfont,LBWQSAZEYIZZCE-SNVBAGLBSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
122216,6w4b,DB13061,-7.7,MLN8054,HHFBDROWDBDFBR-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
13267,6lzg,DB15047,-7.7,BMS-919373,XGKULQQVQWCASY-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
102281,6vxs,DB07217,-7.7,"N-(3-cyano-4,5,6,7-tetrahydro-1-benzothien-2-yl)-2-fluorobenzamide",YVYPYORTKAIUGJ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
28040,6cs2,DB07614,-7.7,"PHENYL-5-(1H-PYRAZOL-3-YL)-1,3-THIAZOLE",NRAHRUHGPGBWSI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
149227,6w9q,DB15197,-7.7,RSV-604,MTPVBMVUENFFLL-HXUWFJFHSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
98246,6vxs,DB00717,-7.7,Norethisterone,VIKNJXKGJWUCNN-XGXHKTLJSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
157753,6wiq,DB12764,-7.7,ABC-294640,CAOTVXGYTWCKQE-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
163329,7bv1,DB04270,-7.7,(S)-3-(4-(2-Carbazol-9-Yl-Ethoxy)-Phenyl)-2-Ethoxy-Propionic Acid,WUZIMDSVRIBNNI-DEOSSOPVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
77153,6m2n,DB08035,-7.7,"1-TERT-BUTYL-3-(2,5-DIMETHYLBENZYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE",QUPXEJURIFFVSX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
30745,6cs2,DB12921,-7.7,Chlorsulfaquinoxaline,CTSNHMQGVWXIEG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
72196,6m2n,DB00452,-7.7,Framycetin,PGBHMTALBVVCIT-VCIWKGPPSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79181,6m2n,DB12869,-7.7,Eliprodil,GGUSQTSTQSHJAH-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
67424,6lxt,DB06693,-7.7,Mevastatin,AJLFOPYRIVGYMJ-INTXDZFKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
29450,6cs2,DB09201,-7.7,Ciglitazone,YZFWTZACSRHJQD-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
35310,1r42,DB01459,-7.7,Bezitramide,FLKWNFFCSSJANB-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
164731,7bv1,DB08536,-7.7,"3-bromo-5-phenyl-N-(pyrimidin-5-ylmethyl)pyrazolo[1,5-a]pyridin-7-amine",IBUPHWYGVDAASU-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
161551,7bv1,DB15059,-7.7,Aprocitentan,DKULOVKANLVDEA-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
70491,6lxt,DB12732,-7.7,Firategrast,YLFZHHDVRSYTKT-NRFANRHFSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
161547,7bv1,DB15055,-7.7,ABT-639,AGPIHNZOZNKRGT-CYBMUJFWSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
30729,6cs2,DB00982,-7.7,Isotretinoin,SHGAZHPCJJPHSC-XFYACQKRSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
90541,6m71,DB01871,-7.7,[1-(1-Benzyl-3-Hydroxy-2-Oxo-Propylcarbamoyl)-2-Phenyl-Ethyl]-Carbamic Acid Benzyl Ester,OACUXIVGLLCILS-ZEQRLZLVSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
79209,6m2n,DB12906,-7.7,LY-2334737,MEOYFIHNRBNEPI-UXIGCNINSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
72191,6m2n,DB00447,-7.7,Loracarbef,JAPHQRWPEGVNBT-UTUOFQBUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
158300,7bv1,DB00836,-7.7,Loperamide,RDOIQAHITMMDAJ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
163352,7bv1,DB04297,-7.7,"7-[4-(Dimethylamino)Phenyl]-N-Hydroxy-4,6-Dimethyl-7-Oxo-2,4-Heptadienamide",RTKIYFITIVXBLE-QEQCGCAPSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
88828,6m3m,DB14888,-7.7,IQP-0528,UCOAKFIVSAVHLC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81468,6m3m,DB01231,-7.7,Diphenidol,OGAKLTJNUQRZJU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
69440,6lxt,DB09199,-7.7,Netoglitazone,PKWDZWYVIHVNKS-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
77163,6m2n,DB08049,-7.7,"7,8-dihydroxy-4-phenyl-2H-chromen-2-one",JRVIIPJSVKTPBK-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
86823,6m3m,DB11269,-7.7,Diethylamino hydroxybenzoyl hexyl benzoate,FDATWRLUYRHCJE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83566,6m3m,DB04060,-7.7,"(5-Methyl-6-Oxo-1,6-Dihydro-Pyridin-3-Yl)-1,2-Dideoxy-Ribofuranose-5-Monophosphate",MUWYCJQCZPFLFI-IVZWLZJFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
161658,7bv1,DB00231,-7.7,Temazepam,SEQDDYPDSLOBDC-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
67460,6lxt,DB06741,-7.7,Gavestinel,WZBNEZWCNKUOSM-VOTSOKGWSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
164753,7bv1,DB08561,-7.7,"BENZYL 6-BENZYL-5,7-DIOXO-6,7-DIHYDRO-5H-[1,3]THIAZOLO[3,2-C]PYRIMIDINE-2-CARBOXYLATE",PLBINCOCFGQAJM-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
161647,7bv1,DB00218,-7.7,Moxifloxacin,FABPRXSRWADJSP-MEDUHNTESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
88753,6m3m,DB14718,-7.7,Pyrazolam,BGRWSFIQQPVEML-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86857,6m3m,DB11378,-7.7,Buquinolate,LVVXOXRUTDAKFE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
18685,6cs2,HMDB0000698,-7.7,Lithocholic acid glycine conjugate,XBSQTYHEGZTYJE-OETIFKLTSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
74824,6m2n,DB03880,-7.7,Batimastat,XFILPEOLDIKJHX-QYZOEREBSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
165700,7bv1,DB12675,-7.7,PF-04995274,WLLOFQROROXOMO-GOSISDBHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
72208,6m2n,DB00469,-7.7,Tenoxicam,LZNWYQJJBLGYLT-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
68371,6lxt,DB07839,-7.7,"N-2-1,3-BENZOXAZOL-2-YL-3-CYCLOHEXYL-N-{2-[(4-METHOXYPHENYL)AMINO]ETHYL}-L-ALANINAMIDE",VFNWTXUFNNOQHD-QFIPXVFZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
165664,7bv1,DB12622,-7.7,Lupeol,MQYXUWHLBZFQQO-QGTGJCAVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
158253,7bv1,DB00783,-7.7,Estradiol,VOXZDWNPVJITMN-ZBRFXRBCSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
161635,7bv1,DB00203,-7.7,Sildenafil,BNRNXUUZRGQAQC-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
88759,6m3m,DB14732,-7.7,Queuine,WYROLENTHWJFLR-ACLDMZEESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
164738,7bv1,DB08544,-7.7,(S)-Fluoxetine,RTHCYVBBDHJXIQ-INIZCTEOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
70460,6lxt,DB12686,-7.7,PHA-793887,HUXYBQXJVXOMKX-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
74020,6m2n,DB02802,-7.7,5-Aminocarbonyl-3-Nitrophenyl-Alpha-D-Galactopyranose,BYSXBFJVGIOFBO-LNSPPBFMSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
86829,6m3m,DB11279,-7.7,Brilliant green cation,HXCILVUBKWANLN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
164743,7bv1,DB08549,-7.7,"(3R)-METHYLCARBAMOYL-7-SULFOAMINO-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLIC ACID BENZYL ESTER",MFDBNNQUDZFSES-KRWDZBQOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
30727,6cs2,DB12896,-7.7,PSI-352938,PVRFQJIRERYGTQ-DSQUMVBZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
77128,6m2n,DB08009,-7.7,"5-[(E)-(5-CHLORO-2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]-N-[2-(DIETHYLAMINO)ETHYL]-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXAMIDE",XPLJEFSRINKZLC-ATVHPVEESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77123,6m2n,DB08004,-7.7,"(2S)-2-{[3-(3-aminophenyl)imidazo[1,2-b]pyridazin-6-yl]amino}-3-methylbutan-1-ol",PUMVONFFLKPPIM-CQSZACIVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
92475,6m71,DB04461,-7.7,Coproporphyrinogen III,NIUVHXTXUXOFEB-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
35264,1r42,DB01406,-7.7,Danazol,POZRVZJJTULAOH-LHZXLZLDSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
152731,6wiq,DB04452,-7.7,Aminoquinuride,HOUSDILKOJMENG-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
164686,7bv1,DB08486,-7.7,Efaproxiral,BNFRJXLZYUTIII-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
161442,7bv1,DB14055,-7.7,(S)-Warfarin,PJVWKTKQMONHTI-HNNXBMFYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
86674,6m3m,DB09212,-7.7,Loxoprofen,YMBXTVYHTMGZDW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
35259,1r42,DB01395,-7.7,Drospirenone,METQSPRSQINEEU-HXCATZOESA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
70544,6lxt,DB12823,-7.7,Tecarfarin,QFLNTQDOVCLQKW-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
67345,6lxt,DB06510,-7.7,Muraglitazar,IRLWJILLXJGJTD-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
77071,6m2n,DB07944,-7.7,N-{3-METHYL-5-[2-(PYRIDIN-4-YLAMINO)-ETHOXY]-PHENYL}-BENZENESULFONAMIDE,MPTWCWHNLVMCRW-UHFFFAOYSA-O,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
92513,6m71,DB04509,-7.7,N-Methylnaloxonium,PCSQOABIHJXZMR-YNUHATHGSA-O,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
154556,6wiq,DB08010,-7.7,"(3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-[(E)-2-phenylethenyl]-1H-indole-2,3-dione 3-oxime",DDHASJXGNUWZTM-ZLEWNXFRSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
35252,1r42,DB01380,-7.7,Cortisone acetate,ITRJWOMZKQRYTA-RFZYENFJSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
79273,6m2n,DB13008,-7.7,"2,2-bis(4-hydroxy-3-tert-butylphenyl)propane",ZDRSNHRWLQQICP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79281,6m2n,DB13020,-7.7,Apratastat,MAVDNGWEBZTACC-HNNXBMFYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
163450,7bv1,DB04639,-7.7,Biphenylalanine,JCZLABDVDPYLRZ-AWEZNQCLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
164674,7bv1,DB08470,-7.7,"3-(4-fluorophenyl)-5-phenyl-4H-1,2,4-triazole",KMGPJKOKSYGMJD-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
72138,6m2n,DB00383,-7.7,Oxyphencyclimine,DUDKAZCAISNGQN-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
35245,1r42,DB01357,-7.7,Mestranol,IMSSROKUHAOUJS-MJCUULBUSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
31658,6cs2,DB14214,-7.7,Rose bengal lactone,IICCLYANAQEHCI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
72146,6m2n,DB00394,-7.7,Beclomethasone dipropionate,KUVIULQEHSCUHY-XYWKZLDCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
163300,7bv1,DB04226,-7.7,Dihydro-Acarbose,CUAQESWNTOXZJZ-RTNAABQMSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
33662,6cs2,T3D4906,-7.7,Benzoin,ISAOCJYIOMOJEB-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
92447,6m71,DB04421,-7.7,Nicotinamide Adenine Dinucleotide 3-Pentanone Adduct,BZJFKYRGSZWSLT-YLIVDTKOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
158301,7bv1,DB00838,-7.7,Clocortolone,YMTMADLUXIRMGX-RFPWEZLHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
161521,7bv1,DB14998,-7.7,Olorinab,ACSQLTBPYZSGBA-GMXVVIOVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
83633,6m3m,DB04144,-7.7,"Cis-[4,5-Bis-(4-Chlorophenyl)-2-(2-Isopropoxy-4-Methoxyphenyl)-4,5-Dihyd Roimidazol-1-Yl]-Piperazin-1-Yl-Methanone",ZXIPEZDMQNYFOO-WUFINQPMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
30723,6cs2,DB12890,-7.7,Dihydrexidine,BGOQGUHWXBGXJW-YOEHRIQHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
152916,6wiq,DB04690,-7.7,Camptothecin,VSJKWCGYPAHWDS-FQEVSTJZSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
154525,6wiq,DB07975,-7.7,"2-({[3,5-DIFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)CYCLOPENT-1-ENE-1-CARBOXYLIC ACID",VTGXLCZUWFYELR-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
83637,6m3m,DB04150,-7.7,Threonine Derivative,TWMKRGDZEJLDDH-LKXWSVAYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81447,6m3m,DB01204,-7.7,Mitoxantrone,KKZJGLLVHKMTCM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
92409,6m71,DB04366,-7.7,3'-Deoxy 3'-Amino Adenosine-5'-Diphosphate,VKODIDNZKBYXJO-QYYRPYCUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
86687,6m3m,DB09227,-7.7,Barnidipine,VXMOONUMYLCFJD-DHLKQENFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
152873,6wiq,DB04632,-7.7,4-(2-HYDROXYBENZYLAMINO)-N-(3-(4-FLUOROPHENOXY)PHENYL)PIPERIDINE-1-SULFONAMIDE,JHHBGNIRSUTQAS-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
67382,6lxt,DB06604,-7.7,Ilepatril,FXKFFTMLFPWYFH-RDGPPVDQSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
22480,6cs2,HMDB0001533,-7.7,"5,10-Methylene-THF",QYNUQALWYRSVHF-PZORYLMUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
72165,6m2n,DB00417,-7.7,Phenoxymethylpenicillin,BPLBGHOLXOTWMN-MBNYWOFBSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
88840,6m3m,DB14913,-7.7,5-methyl-2'-fluoroarauracil F-18,GBBJCSTXCAQSSJ-MSYRQUNGSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
69417,6lxt,DB09175,-7.7,Mirfentanil,BJZZDOLVVLWFHN-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
164696,7bv1,DB08496,-7.7,(R)-warfarin,PJVWKTKQMONHTI-HNNXBMFYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
164695,7bv1,DB08495,-7.7,4-({4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-2-OXOPIPERAZIN-1-YL}METHYL)BENZENECARBOXIMIDAMIDE,VXONTEUOQXFJJS-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
69410,6lxt,DB09168,-7.7,4-Phenylfentanyl,BXCJXJLHYMWMQU-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
73085,6m2n,DB01565,-7.7,Dihydromorphine,IJVCSMSMFSCRME-KBQPJGBKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
86703,6m3m,DB09246,-7.7,Benmoxin,BEWNZPMDJIGBED-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
67333,6lxt,DB06472,-7.7,Fradafiban,IKZACQMAVUIGPY-HOTGVXAUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
92278,6m71,DB04186,-7.7,"N'-(Pyrrolidino[2,1-B]Isoindolin-4-On-8-Yl)-N-(Pyridin-2-Yl)Urea",KLVYMYQTRZCMLE-CYBMUJFWSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
158227,7bv1,DB00751,-7.7,Epinastine,WHWZLSFABNNENI-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
72283,6m2n,DB00561,-7.7,Doxapram,XFDJYSQDBULQSI-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
88578,6m3m,DB14061,-7.7,Hycanthone,MFZWMTSUNYWVBU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
153224,6wiq,DB05667,-7.7,Levoketoconazole,XMAYWYJOQHXEEK-ZEQKJWHPSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
153222,6wiq,DB05653,-7.7,IRX-5183,PNAWUIKCVQSLFG-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
77389,6m2n,DB08317,-7.7,"5-methyl-6-phenylquinazoline-2,4-diamine",HUCOXWPHDFINIW-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
88580,6m3m,DB14064,-7.7,Emopamil,DWAWDSVKAUWFHC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
77383,6m2n,DB08310,-7.7,"N-[(2R)-2-{[(2S)-2-(1,3-benzoxazol-2-yl)pyrrolidin-1-yl]carbonyl}hexyl]-N-hydroxyformamide",QDDZLTVSNABZIK-ZBFHGGJFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
31573,6cs2,DB01068,-7.7,Clonazepam,DGBIGWXXNGSACT-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
32759,6cs2,T3D3672,-7.7,Aflatoxin M2,OQLKWHFMUPJCJY-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
165603,7bv1,DB12524,-7.7,BI-671800,XEOSTBFUCNZKGS-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
73033,6m2n,DB01511,-7.7,Delorazepam,CHIFCDOIPRCHCF-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
153199,6wiq,DB05524,-7.7,Pelitinib,WVUNYSQLFKLYNI-AATRIKPKSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
28920,6cs2,DB08544,-7.7,(S)-Fluoxetine,RTHCYVBBDHJXIQ-INIZCTEOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
77371,6m2n,DB08297,-7.7,ORTHONITROPHENYL-BETA-D-FUCOPYRANOSIDE,SWRPIVXPHLYETN-BVWHHUJWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79050,6m2n,DB12657,-7.7,JNJ-42396302,BPLVDYJDAVYLRQ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
90668,6m71,DB02046,-7.7,N-[(Furan-2-Yl)Carbonyl]-(S)-Leucyl-(R)-[1-Amino-2(1h-Indol-3-Yl)Ethyl]-Phosphonic Acid,WHPKSASOSKNDPY-PKOBYXMFSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
70378,6lxt,DB12557,-7.7,FK-614,UYGZODVVDUIDDQ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
77366,6m2n,DB08292,-7.7,"(5Z)-12-CHLORO-13,15-DIHYDROXY-4,7,8,9-TETRAHYDRO-2-BENZOXACYCLOTRIDECINE-1,10(3H,11H)-DIONE",AQKZYZQONWDDLS-IWQZZHSRSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
164795,7bv1,DB08613,-7.7,"2,2,2-TRIFLUORO-1-{5-[(3-PHENYL-5,6-DIHYDROIMIDAZO[1,2-A]PYRAZIN-7(8H)-YL)CARBONYL]THIOPHEN-2-YL}ETHANE-1,1-DIOL",OFBFUNBBOQCNFX-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
72285,6m2n,DB00564,-7.7,Carbamazepine,FFGPTBGBLSHEPO-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
165577,7bv1,DB12480,-7.7,Betulinic Acid,QGJZLNKBHJESQX-FZFNOLFKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
86967,6m3m,DB11633,-7.7,Isavuconazole,DDFOUSQFMYRUQK-RCDICMHDSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
72287,6m2n,DB00567,-7.7,Cephalexin,ZAIPMKNFIOOWCQ-UEKVPHQBSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
30888,6cs2,DB13114,-7.7,Amitriptylinoxide,ZPMKQFOGINQDAM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
67582,6lxt,DB06919,-7.7,D-phenylalanyl-N-(3-chlorobenzyl)-L-prolinamide,CJHLRGCXPGIPCB-MOPGFXCFSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
68288,6lxt,DB07747,-7.7,"(3R)-N-(4-CHLOROPHENYL)-3-(HYDROXYMETHYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONAMIDE",YTBGBMPLINFTBQ-OAHLLOKOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
158078,7bv1,DB00351,-7.7,Megestrol acetate,RQZAXGRLVPAYTJ-GQFGMJRRSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
69516,6lxt,DB09313,-7.7,Ioxaglic acid,TYYBFXNZMFNZJT-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
158085,7bv1,DB00358,-7.7,Mefloquine,XEEQGYMUWCZPDN-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
161827,7bv1,DB00648,-7.7,Mitotane,JWBOIMRXGHLCPP-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
77474,6m2n,DB08424,-7.7,"[5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL](3-{[(2R)-2,3-DIHYDROXYPROPYL]OXY}PHENYL)METHANONE",IJDQETGUEUJVTB-HNNXBMFYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
156560,6wiq,DB13307,-7.7,Proscillaridin,MYEJFUXQJGHEQK-ALRJYLEOSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
35405,1r42,DB01564,-7.7,Calusterone,IVFYLRMMHVYGJH-PVPPCFLZSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
165563,7bv1,DB12464,-7.7,Bevenopran,ZGCYVRNZWGUXNQ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
74077,6m2n,DB02872,-7.7,"Cis-[4,5-Bis-(4-Bromophenyl)-2-(2-Ethoxy-4-Methoxyphenyl)-4,5-Dihydroimidazol-1-Yl]-[4-(2-Hydroxyethyl)Piperazin-1-Yl]Methanone",PVRYEWOXWGDQHA-URLMMPGGSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
72295,6m2n,DB00578,-7.7,Carbenicillin,FPPNZSSZRUTDAP-UWFZAAFLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
70368,6lxt,DB12542,-7.7,GSK-356278,AWDJJMXJUOHGLC-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
79025,6m2n,DB12615,-7.7,Plazomicin,IYDYFVUFSPQPPV-PEXOCOHZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
81563,6m3m,DB01416,-7.7,Cefpodoxime,WYUSVOMTXWRGEK-HBWVYFAYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
67555,6lxt,DB06889,-7.7,"3-(1H-tetrazol-5-ylmethyl)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(3H)-one",QSBQXAOOVSQABJ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
88551,6m3m,DB14002,-7.7,D-alpha-Tocopherol acetate,ZAKOWWREFLAJOT-CEFNRUSXSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
77410,6m2n,DB08346,-7.7,"(5Z)-13-CHLORO-14,16-DIHYDROXY-3,4,7,8,9,10-HEXAHYDRO-1H-2-BENZOXACYCLOTETRADECINE-1,11(12H)-DIONE",YUZYDHRGGDTZLG-DUXPYHPUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
68292,6lxt,DB07751,-7.7,"(2S)-1-[4-({6-[(2,6-Difluorophenyl)amino]-4-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol",ZVSBKYYVBCKDBO-HNNXBMFYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
23168,6cs2,HMDB0059746,-7.7,"(1R,2S,5R,6S)-6-(3,4-Dihydroxyphenyl)-2-(3,4-methylenedioxyphenyl)-3,7-dioxabicyclo-[3,3,0]octane",CGEORJKFOZSMEZ-NWZDRYQDSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
81518,6m3m,DB01331,-7.7,Cefoxitin,WZOZEZRFJCJXNZ-ZBFHGGJFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
161756,7bv1,DB00559,-7.7,Bosentan,GJPICJJJRGTNOD-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
158136,7bv1,DB00421,-7.7,Spironolactone,LXMSZDCAJNLERA-ZHYRCANASA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
92221,6m71,DB04114,-7.7,"3-Chloro-9-Ethyl-6,7,8,9,10,11-Hexahydro-7,11-Methanocycloocta[B]Quinolin-12-Amine",QTPHSDHUHXUYFE-NWDGAFQWSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
153099,6wiq,DB04971,-7.7,Reglitazar,QBQLYIISSRXYKL-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
153095,6wiq,DB04960,-7.7,Tipifarnib,PLHJCIYEEKOWNM-HHHXNRCGSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
164773,7bv1,DB08588,-7.7,2-({2-[(3R)-3-AMINOPIPERIDIN-1-YL]-4-OXOQUINAZOLIN-3(4H)-YL}METHYL)BENZONITRILE,OYNURZXTLNNKAP-QGZVFWFLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
33573,6cs2,T3D4821,-7.7,Gentian Violet,LGLFFNDHMLKUMI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
77277,6m2n,DB08172,-7.7,(2Z)-N-(3-chloro-2'-methoxybiphenyl-4-yl)-2-cyano-3-hydroxybut-2-enamide,YUDQXOMZBLEWBH-KAMYIIQDSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
156434,6wiq,DB13093,-7.7,TAK-593,DZFZXPPHBWCXPQ-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
74798,6m2n,DB03844,-7.7,"N-(2,6-Diflouro-Benzyl)-4-Sulfamoyl-Benzamide",ZFNCKGXGCCDDFN-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79092,6m2n,DB12717,-7.7,Mibampator,ULRDYYKSPCRXAJ-KRWDZBQOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
158189,7bv1,DB00705,-7.7,Delavirdine,WHBIGIKBNXZKFE-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
68347,6lxt,DB07812,-7.7,"N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyrrolo[2,3-b]pyridin-4-yl)thiophene-2-carboxamide",TWYNGDRSMHRPSY-MRXNPFEDSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
158210,7bv1,DB00728,-7.7,Rocuronium,YXRDKMPIGHSVRX-OOJCLDBCSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
35356,1r42,DB01513,-7.7,"17Alpha-methyl-3beta,17beta-dihydroxy-5alpha-androstane",QGKQXZFZOIQFBI-UYEYMFBJSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
72233,6m2n,DB00497,-7.7,Oxycodone,BRUQQQPBMZOVGD-XFKAJCMBSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
161697,7bv1,DB00486,-7.7,Nabilone,GECBBEABIDMGGL-RTBURBONSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
153055,6wiq,DB04875,-7.7,Pralnacasan,CXAGHAZMQSCAKJ-WAHHBDPQSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
74036,6m2n,DB02819,-7.7,"Mono-[3,4-Dihydroxy-5-(5-Methyl-Benzoimidazol-1-Yl)-Tetrahydor-Furan-2-Ylmethyl] Ester",HGUDFQQPANTQEU-LPWJVIDDSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
67475,6lxt,DB06771,-7.7,Besifloxacin,QFFGVLORLPOAEC-SNVBAGLBSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
79156,6m2n,DB12825,-7.7,Lefamulin,KPVIXBKIJXZQJX-FCEONZPQSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
72223,6m2n,DB00486,-7.7,Nabilone,GECBBEABIDMGGL-RTBURBONSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
164768,7bv1,DB08580,-7.7,4-bromo-2-{[(2R)-2-(2-chlorobenzyl)pyrrolidin-1-yl]carbonyl}aniline,JEGGWFHNKPRKTO-CQSZACIVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
156413,6wiq,DB13061,-7.7,MLN8054,HHFBDROWDBDFBR-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
81511,6m3m,DB01322,-7.7,Kava,OMNGEVNATYFZGG-BQYQJAHWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
156447,6wiq,DB13109,-7.7,PKI-179,WXUUCRLKXQMWRY-OYRHEFFESA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
165617,7bv1,DB12547,-7.7,LY-2886721,NIDRNVHMMDAAIK-YPMLDQLKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
165621,7bv1,DB12553,-7.7,Fluocinolone,UUOUOERPONYGOS-CLCRDYEYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
73041,6m2n,DB01521,-7.7,Clostebol,KCZCIYZKSLLNNH-FBPKJDBXSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
92141,6m71,DB04005,-7.7,Uridine 5'-triphosphate,PGAVKCOVUIYSFO-XVFCMESISA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
88638,6m3m,DB14196,-7.7,"N-Cyclohexyl-N'-phenyl-1,4-phenylenediamine",ZRMMVODKVLXCBB-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
29415,6cs2,DB09168,-7.7,4-Phenylfentanyl,BXCJXJLHYMWMQU-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
161744,7bv1,DB00547,-7.7,Desoximetasone,VWVSBHGCDBMOOT-IIEHVVJPSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
72259,6m2n,DB00533,-7.7,Rofecoxib,RZJQGNCSTQAWON-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79080,6m2n,DB12704,-7.7,Spiradoline,NYKCGQQJNVPOLU-ONTIZHBOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
37019,1r42,DB03723,-7.7,2'-Deoxy-Thymidine-Beta-L-Rhamnose,ZOSQFDVXNQFKBY-CGAXJHMRSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
158149,7bv1,DB00438,-7.7,Ceftazidime,ORFOPKXBNMVMKC-DWVKKRMSSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
29416,6cs2,DB09169,-7.7,3-Allylfentanyl,BZXKQFFMDLTPJL-LADGPHEKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
158154,7bv1,DB00443,-7.7,Betamethasone,UREBDLICKHMUKA-DVTGEIKXSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
90643,6m71,DB02014,-7.7,"5-(2-Fluoro-5-{(1E)-3-[3-hydroxy-2-(methoxycarbonyl)phenoxy]-1-propen-1-yl}phenyl)-1,2-oxazole-3-carboxylic acid",QKHWJUMLYAYZFS-ONEGZZNKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
92162,6m71,DB04037,-7.7,"N,N-Bis(4-Chlorobenzyl)-1h-1,2,3,4-Tetraazol-5-Amine",UOUXILZUBDIWQU-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
69476,6lxt,DB09239,-7.7,Niguldipine,SVJMLYUFVDMUHP-XIFFEERXSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
70390,6lxt,DB12574,-7.7,LY-295501,VAMFSFIPDOODFH-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
156459,6wiq,DB13126,-7.7,BMS-986115,SRJNRAQUSAVENA-GSHUGGBRSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
73043,6m2n,DB01523,-7.7,Clonitazene,GPZLDQAEBHTMPG-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
15249,6lzg,T3D0062,-7.7,Benzo[k]fluoranthene,HAXBIWFMXWRORI-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
165627,7bv1,DB12562,-7.7,Setipiprant,IHAXLPDVOWLUOS-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
76992,6m2n,DB07851,-7.7,"(3R,4S)-1-(3,4-DIMETHOXYPHENYL)-3-(3-METHYLPHENYL)PIPERIDIN-4-AMINE",DQJXBZGPJVSWFI-ROUUACIJSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
74932,6m2n,DB04022,-7.7,"Guanosine-5',3'-Tetraphosphate",BUFLLCUFNHESEH-UUOKFMHZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
72132,6m2n,DB00377,-7.7,Palonosetron,CPZBLNMUGSZIPR-NVXWUHKLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
29546,6cs2,DB00858,-7.7,Drostanolone,IKXILDNPCZPPRV-RFMGOVQKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
67172,6lxt,DB05959,-7.7,ENMD-1198,YQJWOUQGXATDAE-ACNBBOPNSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
158640,7bv1,DB01734,-7.7,3-(Oxalyl-Amino)-Naphthalene-2-Carboxylic Acid,DQBLKSRRWDWNKQ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
156159,6wiq,DB12494,-7.7,SGI-1776,MHXGEROHKGDZGO-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
68531,6lxt,DB08023,-7.7,"N-cyclohexyl-4-imidazo[1,2-a]pyridin-3-yl-N-methylpyrimidin-2-amine",HYNNWLVWJXWXFO-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
163650,7bv1,DB05676,-7.7,Apremilast,IMOZEMNVLZVGJZ-QGZVFWFLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
161169,7bv1,DB13347,-7.7,Diphenadione,JYGLAHSAISAEAL-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
76670,6m2n,DB07472,-7.7,"(R)-(+)9B-(3-METHYL)PHENYL-2,3-DIHYDROTHIAZOLO[2,3-A]ISOINDOL-5(9BH)-ONE",FQVDJZWFSZSGGA-QGZVFWFLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
163660,7bv1,DB05738,-7.7,Vapitadine,VQWGYPVNVICKFC-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
84144,6m3m,DB04828,-7.7,Zomepirac,ZXVNMYWKKDOREA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84151,6m3m,DB04836,-7.7,Amineptine,ONNOFKFOZAJDHT-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
151529,6wiq,DB02830,-7.7,FR236913,KCCUBLLGAMGDJL-HXUWFJFHSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
161135,7bv1,DB12933,-7.7,RO-4987655,FIMYFEGKMOCQKT-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
79521,6m2n,DB13384,-7.7,Melitracen,GWWLWDURRGNSRS-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
73897,6m2n,DB02632,-7.7,4-nitrophenyl-beta-D-galactoside,IFBHRQDFSNCLOZ-YBXAARCKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
81142,6m3m,DB00857,-7.7,Terbinafine,DOMXUEMWDBAQBQ-WEVVVXLNSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
69271,6lxt,DB08942,-7.7,Isoxicam,YYUAYBYLJSNDCX-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
165967,7bv1,DB13308,-7.7,Oxametacin,AJRNYCDWNITGHF-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
154799,6wiq,DB08299,-7.7,"4-[8-(3-nitrophenyl)-1,7-naphthyridin-6-yl]benzoic acid",QTNUWEKKZHSUQO-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
156166,6wiq,DB12507,-7.7,Atecegatran metoxil,XSNMGLZVFNDDPW-ZWKOTPCHSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
86423,6m3m,DB08824,-7.7,Ioflupane I-123,HXWLAJVUJSVENX-HFIFKADTSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
71996,6m2n,DB00216,-7.7,Eletriptan,PWVXXGRKLHYWKM-LJQANCHMSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
73915,6m2n,DB02656,-7.7,LY-294002,CZQHHVNHHHRRDU-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
67206,6lxt,DB06155,-7.7,Rimonabant,JZCPYUJPEARBJL-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
33821,6cs2,T3D0496,-7.7,"2,3,3',4',5-Pentachlorobiphenyl",PVYBHVJTMRRXLG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
151948,6wiq,DB03383,-7.7,5-Chloro-1h-Indole-2-Carboxylic Acid [1-(4-Fluorobenzyl)-2-(4-Hydroxypiperidin-1yl)-2-Oxoethyl]Amide,YDCGVASFVACWKF-NRFANRHFSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
90314,6m71,DB01572,-7.7,Methyl-1-testosterone,JRNSSSJKIGAFCT-YDSAWKJFSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
92725,6m71,DB04792,-7.7,"2,5-O,O-BIS-{4',4''-AMIDINOPHENYL}-1,4:3,6-DIANHYDRO-D-SORBITOL",CDEVHSIVANGYRI-XMTFNYHQSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
92726,6m71,DB04793,-7.7,"1,4:3,6-Dianhydro-2-O-(3-carbamimidoylphenyl)-5-O-(4-carbamimidoylphenyl)-D-glucitol",DKBAWRNTUZFJKV-XMTFNYHQSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
31732,6cs2,DB14652,-7.7,Clocortolone acetate,ARPLCFGLEYFDCN-CDACMRRYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
89194,6m71,DB00186,-7.7,Lorazepam,DIWRORZWFLOCLC-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
92729,6m71,DB04796,-7.7,Inecalcitol,HHGRMHMXKPQNGF-WNSNRMDMSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
84169,6m3m,DB04860,-7.7,Isatoribine,TZYVRXZQAWPIAB-FCLHUMLKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
76715,6m2n,DB07527,-7.7,"N-[(2R,3S)-3-AMINO-2-HYDROXY-4-PHENYLBUTYL]-4-METHOXY-2,3,6-TRIMETHYLBENZENESULFONAMIDE",HORGTFOBJRCVMO-ZWKOTPCHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
31733,6cs2,DB14653,-7.7,Clocortolone caproate,MMTRTBFDFNRBQO-ANHDKODLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
72017,6m2n,DB00239,-7.7,Oxiconazole,QRJJEGAJXVEBNE-HKOYGPOVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
31734,6cs2,DB14654,-7.7,Bisoxatin acetate,ZCBJDQBSLZREAA-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
84057,6m3m,DB04712,-7.7,ANILINOMETHYL GLUCO-PHENYLIMIDAZOLE,ADKWVGPRAQKVKB-YIYPIFLZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81216,6m3m,DB00940,-7.7,Methantheline,GZHFODJQISUKAY-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
32563,6cs2,T3D1966,-7.7,"2,4',5-Tribromobiphenyl",VQAOFEQEGKHRBC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
165918,7bv1,DB13237,-7.7,Clofoctol,HQVZOORKDNCGCK-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
158585,7bv1,DB01659,-7.7,"3-(1,10-Phenanthrol-2-Yl)-L-Alanine",LODBCIBKOKOGNL-LBPRGKRZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
76704,6m2n,DB07513,-7.7,7-[(3-CHLOROBENZYL)OXY]-4-[(METHYLAMINO)METHYL]-2H-CHROMEN-2-ONE,JMGUSOLCNQVZCT-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
89211,6m71,DB00206,-7.7,Reserpine,QEVHRUUCFGRFIF-MDEJGZGSSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
79528,6m2n,DB13396,-7.7,Neocitrullamon,PAJBBDCZSMDSFL-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
89240,6m71,DB00240,-7.7,Alclometasone,FJXOGVLKCZQRDN-PHCHRAKRSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
158686,7bv1,DB02082,-7.7,Phosphoaminophosphonic Acid Guanylate Ester,UQABYHGXWYXDTK-UUOKFMHZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
163701,7bv1,DB05990,-7.7,Obeticholic acid,ZXERDUOLZKYMJM-ZWECCWDJSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
163706,7bv1,DB06077,-7.7,Lumateperone,HOIIHACBCFLJET-SFTDATJTSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
151344,6wiq,DB02581,-7.7,"5-[2,3-Dichloro-4-(5-{1-[2-(2-Guanidino-4-Methyl-Pentanoylamino)-Acetyl]-Piperidin-4-Yl}-1-Methyl-1h-Pyrazol-3-Yl)-Phenoxymethyl]-Furan-2-Carboxylic Acid",VNZHOIDQBPFEJU-OAQYLSRUSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
86345,6m3m,DB08734,-7.7,"6,6-DIMETHYL-1-[3-(2,4,5-TRICHLOROPHENOXY)PROPOXY]-1,6-DIHYDRO-1,3,5-TRIAZINE-2,4-DIAMINE",MJZJYWCQPMNPRM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
151327,6wiq,DB02555,-7.7,SP4160,VCXMTWSYQSVWRK-AREMUKBSSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
79563,6m2n,DB13439,-7.7,Fenpiprane,JXJPYHDHJZJWRI-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
81101,6m3m,DB00812,-7.7,Phenylbutazone,VYMDGNCVAMGZFE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
31782,6cs2,DB14736,-7.7,Cannabivarin,SVTKBAIRFMXQQF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
76566,6m2n,DB07348,-7.7,Brefeldin A,KQNZDYYTLMIZCT-KQPMLPITSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
81115,6m3m,DB00827,-7.7,Cinoxacin,VDUWPHTZYNWKRN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
151299,6wiq,DB02519,-7.7,Indirubin-5-Sulphonate,IHBOEHLUIBMBMY-YPKPFQOOSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
151280,6wiq,DB02498,-7.7,Carba-Nicotinamide-Adenine-Dinucleotide,DGPLSUKWXXSBCU-VGXGLJSLSA-O,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
35057,1r42,DB01092,-7.7,Ouabain,LPMXVESGRSUGHW-HBYQJFLCSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
158791,7bv1,DB02224,-7.7,Taxifolin,CXQWRCVTCMQVQX-LSDHHAIUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
151254,6wiq,DB02466,-7.7,"4-[3-Oxo-3-(5,5,8,8-Tetramethyl-5,6,7,8-Tetrahydro-Naphthalen-2-Yl)-Propenyl]-Benzoic Acid",ZXQHMEUGMCXKLO-KPKJPENVSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
67103,6lxt,DB05524,-7.7,Pelitinib,WVUNYSQLFKLYNI-AATRIKPKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
68567,6lxt,DB08064,-7.7,N-(3-TERT-BUTYL-1H-PYRAZOL-5-YL)-N'-{4-CHLORO-3-[(PYRIDIN-3-YLOXY)METHYL]PHENYL}UREA,NTMADESEDXKNFZ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
151211,6wiq,DB02411,-7.7,"2-(11-{2-[Benzenesulfonyl-(3-Methyl-Butyl)-Amino]-1-Hydroxy-Ethyl}-6,9-Dioxo-2-Oxa-7,10-Diaza-Bicyclo[11.2.2]Heptadeca-1(16),13(17),14-Trien-8-Yl)-Acetamide, Inhibitor 2",HOUHLOFMBSYNBO-KKUQBAQOSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
17760,6cs2,HMDB0060919,-7.7,Ibuprofen glucuronide,ABOLXXZAJIAUGR-JPMMFUSZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
92848,6m71,DB05035,-7.7,Eprotirome,VPCSYAVXDAUHLT-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
166022,7bv1,DB13586,-7.7,Metandienone,XWALNWXLMVGSFR-HLXURNFRSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
84036,6m3m,DB04681,-7.7,BETA-METHYLLACTOSIDE,FHNIYFZSHCGBPP-ABBMIVAOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
68559,6lxt,DB08056,-7.7,"N-(2,6-dimethylphenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine",KKYYLKPGILUPOA-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
18838,6cs2,HMDB0036323,-7.7,"Secoisolariciresinol 9,9'-diglucoside",SBVBJPHMDABKJV-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
163666,7bv1,DB05796,-7.7,Daglutril,XMQODGUTLZXUGZ-RPBOFIJWSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
86381,6m3m,DB08773,-7.7,RALOXIFENE CORE,MDGWZLQPNOETLH-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
29207,6cs2,DB08860,-7.7,Pitavastatin,VGYFMXBACGZSIL-MCBHFWOFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
84205,6m3m,DB04917,-7.7,Renzapride,YFUAYKVMQVBSNG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
165983,7bv1,DB13325,-7.7,Nifurzide,IDUMOVRJNBNOTR-BIZLIJPVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
84206,6m3m,DB04920,-7.7,Clevidipine,KPBZROQVTHLCDU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84207,6m3m,DB04924,-7.7,Itopride,QQQIECGTIMUVDS-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84247,6m3m,DB05095,-7.7,Cimicoxib,KYXDNECMRLFQMZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
14563,6lzg,T3D4440,-7.7,Protoporphyrin IX,KSFOVUSSGSKXFI-UJJXFSCMSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
67121,6lxt,DB05616,-7.7,"4'-Methylene-5,8,10-trideazaaminopterin",NAWXUBYGYWOOIX-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
156104,6wiq,DB12415,-7.7,Galeterone,PAFKTGFSEFKSQG-PAASFTFBSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
81122,6m3m,DB00834,-7.7,Mifepristone,VKHAHZOOUSRJNA-GCNJZUOMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
68551,6lxt,DB08046,-7.7,2-chloro-5-[(1S)-1-hydroxy-3-oxo-2H-isoindol-1-yl]benzenesulfonamide,JIVPVXMEBJLZRO-AWEZNQCLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
36334,1r42,DB02790,-7.7,Phenyl-Uridine-5'-Diphosphate,ZHUWBKDWWGKIEN-FMKGYKFTSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
30490,6cs2,DB12555,-7.7,Nelotanserin,COSPVUFTLGQDQL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
16520,6cs2,HMDB0002580,-7.7,Taurolithocholic acid 3-sulfate,HSNPMXROZIQAQD-GBURMNQMSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
70740,6lxt,DB13119,-7.7,GSK-364735,QWLNINWUBHHOLU-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
161027,7bv1,DB12417,-7.7,Anagliptin,LDXYBEHACFJIEL-HNNXBMFYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
36883,1r42,DB03523,-7.7,Brequinar,PHEZJEYUWHETKO-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
163685,7bv1,DB05903,-7.7,KOS-1584,XAYAKDZVINDZGB-BMVMHAJPSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
156103,6wiq,DB12414,-7.7,Usistapide,WSYALRNYQFNNGP-WJOKGBTCSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
35138,1r42,DB01184,-7.7,Domperidone,FGXWKSZFVQUSTL-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
70665,6lxt,DB13012,-7.7,AQX-1125,MDEJTPWQNNMAQF-BVMLLJBZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
81221,6m3m,DB00946,-7.7,Phenprocoumon,DQDAYGNAKTZFIW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
152426,6wiq,DB04038,-7.7,Ergosterol,DNVPQKQSNYMLRS-APGDWVJJSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
86598,6m3m,DB09084,-7.7,Benzydamine,CNBGNNVCVSKAQZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
161351,7bv1,DB13855,-7.7,Nifuroxazide,YCWSUKQGVSGXJO-NTUHNPAUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
161343,7bv1,DB13846,-7.7,Pyrrobutamine,WDYYVNNRTDZKAZ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
68446,6lxt,DB07929,-7.7,"N-(TERT-BUTYL)-3,5-DIMETHYL-N'-[(5-METHYL-2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)CARBONYL]BENZOHYDRAZIDE",JGJACZABNQGPMT-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
83833,6m3m,DB04416,-7.7,"R-2-{[4'-Methoxy-(1,1'-Biphenyl)-4-Yl]-Sulfonyl}-Amino-6-Methoxy-Hex-4-Ynoic Acid",QJKGJGURDPRKGW-LJQANCHMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
30645,6cs2,DB12774,-7.7,AZD-8055,KVLFRAWTRWDEDF-IRXDYDNUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
161330,7bv1,DB13828,-7.7,Cyfluthrin,QQODLKZGRKWIFG-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
88982,6m3m,DB15224,-7.7,Lisavanbulin,NIPZLALJRAHABJ-IBGZPJMESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
69370,6lxt,DB09076,-7.7,Umeclidinium,FVTWTVQXNAJTQP-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
35204,1r42,DB01267,-7.7,Paliperidone,PMXMIIMHBWHSKN-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
73136,6m2n,DB01628,-7.7,Etoricoxib,MNJVRJDLRVPLFE-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
73141,6m2n,DB01634,-7.7,2-Oxy-4-Hydroxy-5-(2-Hydrazinopyridine)Phenylalanine,AZUQIXJQZOMXAS-BDAKNGLRSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
154606,6wiq,DB08068,-7.7,N-[4-CHLORO-3-(PYRIDIN-3-YLOXYMETHYL)-PHENYL]-3-FLUORO-,YQJVDUKATDECHF-ICSRJNTNSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
16411,6lzg,DB04131,-7.7,"10-(4-Dimethylamino-5-Hydroxy-6-Methyl-Tetrahydro-Pyran-2-Yloxy)-8-Ethyl-1,8,11-Trihydroxy-7,8,9,10-Tetrahydro-Naphthacene-5,12-Dione",BLGDWFJQIHBUJY-NWJGULHDSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
161292,7bv1,DB13511,-7.7,Clebopride,BVPWJMCABCPUQY-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
31683,6cs2,DB01081,-7.7,Diphenoxylate,HYPPXZBJBPSRLK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
79378,6m2n,DB13182,-7.7,Daidzein,ZQSIJRDFPHDXIC-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
81331,6m3m,DB01073,-7.7,Fludarabine,HBUBKKRHXORPQB-FJFJXFQQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
68464,6lxt,DB07949,-7.7,"({[(3E)-2'-OXO-2',7'-DIHYDRO-2,3'-BIINDOL-3(7H)-YLIDENE]AMINO}OXY)ACETIC ACID",BFQRPTKOSYMPOL-LALPNIDTSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
68450,6lxt,DB07933,-7.7,Erteberel,XIESSJVMWNJCGZ-VKJFTORMSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
72074,6m2n,DB00305,-7.7,Mitomycin,NWIBSHFKIJFRCO-WUDYKRTCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
92621,6m71,DB04645,-7.7,"5-{3-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-2-METHYL-PHENOXY}-PENTANOIC ACID",NJJIFGCFUDDBSP-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
92618,6m71,DB04642,-7.7,"7-{2,6-DICHLORO-4-[3-(2-CHLORO-BENZOYL)-UREIDO]-PHENOXY}-HEPTANOIC ACID",XQTOWNDCHQJXOQ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
158395,7bv1,DB01137,-7.7,Levofloxacin,GSDSWSVVBLHKDQ-JTQLQIEISA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
28683,6cs2,DB08289,-7.7,N-(PARA-GLUTARAMIDOPHENYL-ETHYL)-PIPERIDINIUM-N-OXIDE,RKJXWOJUCCBWSC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
33702,6cs2,T3D0428,-7.7,"3,4',5-Trichlorobiphenyl",SYSBNFJJSJLZMM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
16381,6lzg,DB03984,-7.7,Morpholine-4-Carboxylic Acid [1-(2-Benzylsulfanyl-1-Formyl-Ethylcarbamoyl)-2-Phenyl-Ethyl]-Amide,MWTQNXVXPLTHJB-YADHBBJMSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
72128,6m2n,DB00372,-7.7,Thiethylperazine,XCTYLCDETUVOIP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
31665,6cs2,DB14471,-7.7,2-Ethylhexyl 4-phenylbenzophenone-2'-carboxylate,TWAOKHHZKFMFMD-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
152514,6wiq,DB04154,-7.7,"N-Methyl-N-[3-(6-Phenyl[1,2,4]Triazolo[4,3-B]Pyridazin-3-Yl)Phenyl]Acetamide",ALBWBHNFOJJMCV-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
73127,6m2n,DB01619,-7.7,Phenindamine,ISFHAYSTHMVOJR-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
86631,6m3m,DB09167,-7.7,Dosulepin,PHTUQLWOUWZIMZ-GZTJUZNOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
152430,6wiq,DB04044,-7.7,4-{2-[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid,NAQUAVBNIYTIIS-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
86629,6m3m,DB09151,-7.7,Flutemetamol (18F),VVECGOCJFKTUAX-HUYCHCPVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
67299,6lxt,DB06395,-7.7,Abafungin,TYBHXIFFPVFXQW-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
161371,7bv1,DB13919,-7.7,Candesartan,HTQMVQVXFRQIKW-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
83779,6m3m,DB04336,-7.7,1-(4-Amidinophenyl)-3-(4-Chlorophenyl)Urea,HQWKMDKTTCPCMQ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
156304,6wiq,DB12895,-7.7,TD-139,YGIDGBAHDZEYMT-MQFIMZJJSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
68430,6lxt,DB07909,-7.7,"(1S,2S,5S)2-(4-GLUTARIDYLBENZYL)-5-PHENYL-1-CYCLOHEXANOL",OBWILOKKNDYPLX-HBMCJLEFSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
90419,6m71,DB01708,-7.7,Prasterone,FMGSKLZLMKYGDP-USOAJAOKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
156292,6wiq,DB12706,-7.7,Seletalisib,LNLJHGXOFYUARS-OAQYLSRUSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
163461,7bv1,DB04651,-7.7,BIOTINOL-5-AMP,KBOGUFFJCBPJEH-SQGSUPJISA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
76918,6m2n,DB07768,-7.7,Epitestosterone,MUMGGOZAMZWBJJ-KZYORJDKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
165771,7bv1,DB12986,-7.7,VS-5584,QYBGBLQCOOISAR-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
88503,6m3m,DB13918,-7.7,Diclofop-methyl,BACHBFVBHLGWSL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
163499,7bv1,DB04706,-7.7,"(3BETA,7BETA)-CHOLEST-5-ENE-3,7-DIOL",OYXZMSRRJOYLLO-KGZHIOMZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
73150,6m2n,DB01644,-7.7,"3,6-dihydroxy-xanthene-9-propionic acid",PFQGLFBMMPZYEU-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
72047,6m2n,DB00273,-7.7,Topiramate,KJADKKWYZYXHBB-XBWDGYHZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
83976,6m3m,DB04602,-7.7,PUROMYCIN AMINONUCLEOSIDE-5'-MONOPHOSPHATE,BFPIKGKMRKBBBF-GRIPGOBMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
158524,7bv1,DB01327,-7.7,Cefazolin,MLYYVTUWGNIJIB-BXKDBHETSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
89081,6m3m,DB15427,-7.7,Fialuridine,IPVFGAYTKQKGBM-BYPJNBLXSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
70641,6lxt,DB12972,-7.7,Sepranolone,AURFZBICLPNKBZ-FZCSVUEKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
156227,6wiq,DB12598,-7.7,Nafamostat,MQQNFDZXWVTQEH-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
158527,7bv1,DB01587,-7.7,Ketazolam,PWAJCNITSBZRBL-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
163560,7bv1,DB04792,-7.7,"2,5-O,O-BIS-{4',4''-AMIDINOPHENYL}-1,4:3,6-DIANHYDRO-D-SORBITOL",CDEVHSIVANGYRI-XMTFNYHQSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
36272,1r42,DB02703,-7.7,Fusidic acid,IECPWNUMDGFDKC-MZJAQBGESA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
70635,6lxt,DB12962,-7.7,CP-547632,HXHAJRMTJXHJJZ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
89097,6m3m,DB15457,-7.7,Snubh-nm-333 F-18,QLWFXLJVGCECSV-HUYCHCPVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
72030,6m2n,DB00253,-7.7,Medrysone,GZENKSODFLBBHQ-ILSZZQPISA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
164614,7bv1,DB08207,-7.7,"2-(3,5-DIMETHYLPHENYL)-1,3-BENZOXAZOLE",BIHLSRJPJFOESJ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
70649,6lxt,DB12985,-7.7,Quisinostat,PAWIYAYFNXQGAP-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
79472,6m2n,DB13324,-7.7,Tetrazepam,IQWYAQCHYZHJOS-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
163599,7bv1,DB04838,-7.7,Cyclandelate,WZHCOOQXZCIUNC-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
67214,6lxt,DB06174,-7.7,Noscapine,AKNNEGZIBPJZJG-MSOLQXFVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
161236,7bv1,DB13434,-7.7,Fenticonazole,ZCJYUTQZBAIHBS-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
89163,6m71,DB00153,-7.7,Ergocalciferol,MECHNRXZTMCUDQ-RKHKHRCZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
36289,1r42,DB02723,-7.7,"4-Oxo-2-Phenylmethanesulfonyl-Octahydro-Pyrrolo[1,2-a]Pyrazine-6-Carboxylic Acid [1-(N-Hydroxycarbamimidoyl)-Piperidin-4-Ylmethyl]-Amide",DHTSUHWLPAEEQB-OALUTQOASA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
72032,6m2n,DB00257,-7.7,Clotrimazole,VNFPBHJOKIVQEB-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
164643,7bv1,DB08244,-7.7,"(1S)-1-CYCLOPROPYL-2-[(2S)-4-(2,5-DIFLUOROPHENYL)-2-PHENYL-2,5-DIHYDRO-1H-PYRROL-1-YL]-2-OXOETHANAMINE",VCOUEHUEFUDZIS-PMACEKPBSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
17912,6cs2,HMDB0000534,-7.7,Campestanol,ARYTXMNEANMLMU-XKPVSPJHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
164626,7bv1,DB08223,-7.7,"N-{(1S,2R)-1-BENZYL-3-[(CYCLOPROPYLMETHYL)(2-FURYLSULFONYL)AMINO]-2-HYDROXYPROPYL}-N'-METHYLSUCCINAMIDE",IKOPFHKAECNGQI-VQTJNVASSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
29231,6cs2,DB08899,-7.7,Enzalutamide,WXCXUHSOUPDCQV-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
158466,7bv1,DB01215,-7.7,Estazolam,CDCHDCWJMGXXRH-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
31690,6cs2,DB14569,-7.7,Tedizolid,XFALPSLJIHVRKE-GFCCVEGCSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
70608,6lxt,DB12924,-7.7,Ozenoxacin,XPIJWUTXQAGSLK-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
30621,6cs2,DB00969,-7.7,Alosetron,JSWZEAMFRNKZNL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
76864,6m2n,DB07705,-7.7,"1-[(2S)-2-[(4-CHLOROBENZYL)OXY]-2-(2,4-DICHLOROPHENYL)ETHYL]-1H-IMIDAZOLE",LEZWWPYKPKIXLL-GOSISDBHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
67264,6lxt,DB06272,-7.7,Maxacalcitol,DTXXSJZBSTYZKE-ZDQKKZTESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
83912,6m3m,DB04520,-7.7,"(3s,8ar)-3-(4-Hydroxybenzyl)Hexahydropyrrolo[1,2-a]Pyrazine-1,4-Dione",LSGOTAXPWMCUCK-RYUDHWBXSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83948,6m3m,DB04565,-7.7,4-(Acetylamino)-3-[(Hydroxyacetyl)Amino]Benzoic Acid,CRHJDPGLFDNPOA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
68486,6lxt,DB07974,-7.7,1-{2-[(4-CHLOROPHENYL)AMINO]-2-OXOETHYL}-N-(1-ISOPROPYLPIPERIDIN-4-YL)-1H-INDOLE-2-CARBOXAMIDE,BDLMBQRBNPDCSS-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
67255,6lxt,DB06257,-7.7,HE-2200,OEVZKEVBDIDVOI-YSZCXEEOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
76845,6m2n,DB07683,-7.7,"N-(dibenzo[b,d]thiophen-3-ylsulfonyl)-L-valine",RZWYSEXQXOXWKA-INIZCTEOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
156255,6wiq,DB12649,-7.7,Ibipinabant,AXJQVVLKUYCICH-OAQYLSRUSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
14969,6lzg,T3D4916,-7.7,Fast green FCF,MNEJSIQJOSRAAA-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
67251,6lxt,DB06248,-7.7,Amelubant,SBVYURPQULDJTI-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
20108,6cs2,HMDB0000900,-7.7,Ergocalciferol,MECHNRXZTMCUDQ-RKHKHRCZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
17916,6cs2,HMDB0000546,-7.7,Epietiocholanolone,QGXBDMJGAMFCBF-XRJZGPCZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
29505,6cs2,DB09262,-7.7,Imidafenacin,SQKXYSGRELMAAU-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
86548,6m3m,DB09006,-7.7,Clinofibrate,BMOVQUBVGICXQN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
79430,6m2n,DB13270,-7.7,Dibekacin,JJCQSGDBDPYCEO-XVZSLQNASA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
152250,6wiq,DB03802,-7.7,"1-[4-(Octahydro-Pyrido[1,2-a]Pyrazin-2-Yl)-Phenyl]-2-Phenyl-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol",ZGHFWBDHZZKWSI-LITSAYRRSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
72992,6m2n,DB01462,-7.7,Etonitazene,PXDBZSCGSQSKST-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
164807,7bv1,DB08631,-7.7,"N-(4-CHLOROPHENYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONAMIDE",UVSIFVBCHJEYJP-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
88484,6m3m,DB13855,-7.7,Nifuroxazide,YCWSUKQGVSGXJO-NTUHNPAUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
69764,6lxt,DB11665,-7.7,BMS-690514,CSGQVNMSRKWUSH-IAGOWNOFSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
72837,6m2n,DB01205,-7.7,Flumazenil,OFBIFZUFASYYRE-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
15743,6lzg,DB01026,-7.7,Ketoconazole,XMAYWYJOQHXEEK-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
77948,6m2n,DB09017,-7.7,Brotizolam,UMSGKTJDUHERQW-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
87652,6m3m,DB12643,-7.7,Nelivaptan,NJXZWIIMWNEOGJ-WEWKHQNJSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
77943,6m2n,DB09012,-7.7,Carbazochrome,XSXCZNVKFKNLPR-SDQBBNPISA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
67852,6lxt,DB07235,-7.7,"N-[(1S)-2-AMINO-1-(2,4-DICHLOROBENZYL)ETHYL]-5-[2-(METHYLAMINO)PYRIMIDIN-4-YL]THIOPHENE-2-CARBOXAMIDE",HHOVRZGUSBMKKU-ZDUSSCGKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
87648,6m3m,DB12637,-7.7,Onapristone,IEXUMDBQLIVNHZ-YOUGDJEHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
69760,6lxt,DB11658,-7.7,QAV-680,YOPFAMROKXHVCQ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
70007,6lxt,DB12021,-7.7,Dinaciclib,PIMQWRZWLQKKBJ-SFHVURJKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
164955,7bv1,DB09002,-7.7,Cloperastine,FLNXBVJLPJNOSI-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
82638,6m3m,DB02809,-7.7,"Brodimoprim-4,6-Dicarboxylate",SZAVCZNFKJSWRN-LBPRGKRZSA-M,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88051,6m3m,DB13283,-7.7,Sulfaisodimidine,YZMCKZRAOLZXAZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
82643,6m3m,DB02814,-7.7,3'-Deazo-Thiamin Diphosphate,NWZZJKMZTWGIFE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
164951,7bv1,DB08997,-7.7,Dexetimide,LQQIVYSCPWCSSD-HSZRJFAPSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
18283,6cs2,HMDB0000643,-7.7,Coproporphyrin I,VORBHEGMEBOMMB-JRHDEHKPSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
82095,6m3m,DB02096,-7.7,FR221647,ZUYUIKKHHBEVHL-GFCCVEGCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
70009,6lxt,DB12024,-7.7,PF-04418948,LWJGMYMNSNVCEM-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
74196,6m2n,DB03035,-7.7,"1,8-Di-Hydroxy-4-Nitro-Anthraquinone",RIYCICFDXLNQPV-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
91076,6m71,DB02573,-7.7,"2'-Deoxycytidine-2'-Deoxyadenosine-3',5'-Monophosphate",LYWWDKIADIGKTH-IDMWBNCISA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
67863,6lxt,DB07249,-7.7,"N-(5-chloro-1,3-benzodioxol-4-yl)-6-methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-amine",QHIMVPIOWKYPSO-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
67865,6lxt,DB07251,-7.7,"N'-(3-CHLORO-4-METHOXY-PHENYL)-N-(3,4,5-TRIMETHOXYPHENYL)-1,3,5-TRIAZINE-2,4-DIAMINE",ZVWFECUPYCFYBL-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
88043,6m3m,DB13273,-7.7,Sultopride,UNRHXEPDKXPRTM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
91499,6m71,DB03141,-7.7,"3-{[(5R,6R)-5-Benzyl-6-hydroxy-2,4-bis(4-hydroxybenzyl)-3-oxo-1,2,4-triazepan-1-yl]sulfonyl}benzonitril",UYUWNNRWESUYOB-FIRIVFDPSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
82185,6m3m,DB02218,-7.7,"N-[4-hydroxymethyl-cyclohexan-6-yl-1,2,3-triol]-4,6-dideoxy-4-aminoglucopyranoside",RBZIIHWPZWOIDU-ZCGMLSCUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
69776,6lxt,DB11681,-7.7,Tofimilast,DHCOPPHTVOXDKU-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
31169,6cs2,DB13491,-7.7,Fluperolone,SLVCCRYLKTYUQP-DVTGEIKXSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
77993,6m2n,DB09091,-7.7,Tixocortol,YWDBSCORAARPPF-VWUMJDOOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
31165,6cs2,DB13487,-7.7,Iodine (131I) norcholesterol,QJHZPCLORSPENH-DRTKWHMQSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
74445,6m2n,DB03358,-7.7,7n-Methyl-8-Hydroguanosine-5'-Triphosphate,BUJQMJUTTBGELS-KQYNXXCUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
87698,6m3m,DB12712,-7.7,Pilsicainide,BCQTVJKBTWGHCX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
164985,7bv1,DB09050,-7.7,Ceftolozane,JHFNIHVVXRKLEF-DCZLAGFPSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
72616,6m2n,DB00952,-7.7,Naratriptan,AMKVXSZCKVJAGH-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
91092,6m71,DB02596,-7.7,"Alpha,Beta-Methyleneadenosine-5'-Triphosphate",CAWZRIXWFRFUQB-IOSLPCCCSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
91507,6m71,DB03154,-7.7,{[7-(Difluoro-Phosphono-Methyl)-Naphthalen-2-Yl]-Difluoro-Methyl}-Phosphonic Acid,VHKBLEYUHBIBNR-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
87682,6m3m,DB12686,-7.7,PHA-793887,HUXYBQXJVXOMKX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
91513,6m71,DB03161,-7.7,Thymidine-5'-Diphospho-Beta-D-Xylose,AJUADKZRQSBUAK-KDGZBOQCSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
157418,6wiq,DB15367,-7.7,LY-2623091,YPCLDHGBEKZGEB-RUDKWAFVSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
74451,6m2n,DB03365,-7.7,"4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline",BNDYIYYKEIXHNK-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
154054,6wiq,DB07422,-7.7,(2S)-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]-3-(pentafluorophenoxy)propanamide,MMNRWNREMUMYQG-INIZCTEOSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
82181,6m3m,DB02214,-7.7,"6,7-Dioxo-5h-8-Ribitylaminolumazine",MIBROOURCUHKMD-RPDRRWSUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
72825,6m2n,DB01192,-7.7,Oxymorphone,UQCNKQCJZOAFTQ-ISWURRPUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
157165,6wiq,DB14679,-7.7,Quingestanol acetate,FLGJKPPXEKYCBY-AKCFYGDASA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
67880,6lxt,DB07268,-7.7,2-({2-[(3-HYDROXYPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)BENZAMIDE,QHPKKGUGRGRSGA-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
162862,7bv1,DB03221,-7.7,AL7099A,RMOXCYSVWCHXII-GFCCVEGCSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
165265,7bv1,DB11679,-7.7,Fruquintinib,BALLNEJQLSTPIO-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
82679,6m3m,DB02859,-7.7,Soraphen A,WPMGNXPRKGXGBO-OFQQMTDKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
77851,6m2n,DB08892,-7.7,Arbaclofen Placarbil,JXTAALBWJQJLGN-KSSFIOAISA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
31096,6cs2,DB13403,-7.7,Oxypertine,XCWPUUGSGHNIDZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
28669,6cs2,DB08270,-7.7,"N-(2-AMINOETHYL)-N-2-{(1S)-1-[4'-(AMINOSULFONYL)BIPHENYL-4-YL]-2,2,2-TRIFLUOROETHYL}-L-LEUCINAMIDE",QPXXBNKMAHUXBB-PMACEKPBSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
162182,7bv1,DB01536,-7.7,Androstenedione,AEMFNILZOJDQLW-QAGGRKNESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
32901,6cs2,T3D3825,-7.7,Diclosulam,QNXAVFXEJCPCJO-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
70076,6lxt,DB12122,-7.7,Figopitant,HUTHJVYJUPXHDF-DEOSSOPVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
70078,6lxt,DB12124,-7.7,Namitecan,IBTISPLPBBHVSU-UVOOVGFISA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
88162,6m3m,DB13425,-7.7,Flutrimazole,QHMWCHQXCUNUAK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
74523,6m2n,DB03472,-7.7,Cyclohexyl-Hexyl-Beta-D-Maltoside,WUCWJXGMSXTDAV-QKMCSOCLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
82748,6m3m,DB02950,-7.7,Hymenialdisine,QPCBNXNDVYOBIP-WHFBIAKZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
68111,6lxt,DB07534,-7.7,"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE",BKUMVXIXUVYKDQ-GHXNOFRVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
31089,6cs2,DB13395,-7.7,Eprozinol,QSRHLIUOSXVKTG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
165338,7bv1,DB11951,-7.7,Lemborexant,MUGXRYIUWFITCP-PGRDOPGGSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
82791,6m3m,DB03009,-7.7,2-[(2-Oxo-2-Piperidin-1-Ylethyl)Thio]-6-(Trifluoromethyl)Pyrimidin-4(1h)-One,UDBHGUOSOKOIAX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
78730,6m2n,DB12187,-7.7,Abacavir hydroxyacetate,ZBBZROWQLKCFQK-KOLCDFICSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
68114,6lxt,DB07537,-7.7,"N'-(6-aminopyridin-3-yl)-N-(2-cyclopentylethyl)-4-methyl-benzene-1,3-dicarboxamide",CLEGTVIMOPPIBR-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
81915,6m3m,DB01850,-7.7,"(2s,3s,8s,9s)-3-Amino-9-Methoxy-2,6,8-Trimethyl-10-Phenyldeca-4,6-Dienoic Acid",HJVCHYDYCYBBQX-AWKNMOFVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
82853,6m3m,DB03093,-7.7,"8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine",MWHAHELTVGJGFJ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87496,6m3m,DB12404,-7.7,Remimazolam,CYHWMBVXXDIZNZ-KRWDZBQOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
70096,6lxt,DB12149,-7.7,S-3304,YWCLDDLVLSQGSZ-JOCHJYFZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
162162,7bv1,DB01514,-7.7,Furazabol,RGLLOUBXMOGLDQ-IVEVATEUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
74438,6m2n,DB03348,-7.7,Huperzine B,YYWGABLTRMRUIT-HWWQOWPSSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
82746,6m3m,DB02947,-7.7,2-Fluoro-2'-Deoxyadenosine,ZWPYUXAXLRFWQC-KVQBGUIXSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
77852,6m2n,DB08893,-7.7,Mirabegron,PBAPPPCECJKMCM-IBGZPJMESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
91571,6m71,DB03234,-7.7,"(4'-{[Allyl(Methyl)Amino]Methyl}-1,1'-Biphenyl-4-Yl)(4-Bromophenyl)Methanone",YATCZCSDJCQNAL-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
32942,6cs2,T3D3869,-7.7,Lactofen,CONWAEURSVPLRM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
67839,6lxt,DB07219,-7.7,"BENZYL N-({(2S,3S)-3-[(PROPYLAMINO)CARBONYL]OXIRAN-2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINATE",OMQNYWZURFTFHE-MQBSTWLZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
91576,6m71,DB03239,-7.7,"3',5'-Dinitro-N-Acetyl-L-Thyronine",VZSQTOXQXPKQJX-ZDUSSCGKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
82696,6m3m,DB02883,-7.7,"2',3'-Dideoxycytidine-5'-Monophosphate",RAJMXAZJKUGYGW-POYBYMJQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
67834,6lxt,DB07212,-7.7,N-(7-CARBAMIMIDOYL-NAPHTHALEN-1-YL)-3-HYDROXY-2-METHYL-BENZAMIDE,NNGZRCYXFBHMRM-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
82014,6m3m,DB01987,-7.7,Cocarboxylase,AYEKOFBPNLCAJY-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
77903,6m2n,DB08968,-7.7,Fominoben,KSNNEUZOAFRTDS-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
162290,7bv1,DB01852,-7.7,Kaempherol,IYRMWMYZSQPJKC-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
82737,6m3m,DB02934,-7.7,9-(6-deoxy-alpha-L-talofuranosyl)-6-methylpurine,XJZDIUOABWMPLZ-DSBXBFMBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87619,6m3m,DB12585,-7.7,Ondelopran,QWNDOCKIKKQJNN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81988,6m3m,DB01954,-7.7,Rolipram,HJORMJIFDVBMOB-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
91586,6m71,DB03250,-7.7,"2-(Beta-D-Glucopyranosyl)-5-Methyl-1,3,4-Benzothiazole",WGJFWQVWYRZPEP-KABOQKQYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
31433,6cs2,DB13808,-7.7,Mebhydrolin,FQQIIPAOSKSOJM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
77888,6m2n,DB08951,-7.7,Indoprofen,RJMIEHBSYVWVIN-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
157101,6wiq,DB14568,-7.7,Ivosidenib,WIJZXSAJMHAVGX-DHLKQENFSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
87598,6m3m,DB12554,-7.7,Mebeverine,VYVKHNNGDFVQGA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
72590,6m2n,DB00922,-7.7,Levosimendan,WHXMKTBCFHIYNQ-SECBINFHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
32916,6cs2,T3D3841,-7.7,Fluazifop-P-butyl,VAIZTNZGPYBOGF-CYBMUJFWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
72574,6m2n,DB00906,-7.7,Tiagabine,PBJUNZJWGZTSKL-MRXNPFEDSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
162256,7bv1,DB01810,-7.7,"[1-(1-Methyl-4,5-Dioxo-Pent-2-Enylcarbamoyl)-2-Phenyl-Ethyl]-Carbamic Acid Benzyl Ester",NOXVWFAAXREWMI-GURWAVDKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
157398,6wiq,DB15327,-7.7,Abivertinib,UOFYSRZSLXWIQB-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
82541,6m3m,DB02675,-7.7,(4-Hydroxymaltosephenyl)Glycine,PHPOPZGUOBMSPZ-QHJSCRBTSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
28839,6cs2,DB08461,-7.7,"3-[(4-AMINO-1-TERT-BUTYL-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL)METHYL]PHENOL",QMAIQPBRCNEJAT-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
33035,6cs2,T3D3971,-7.7,1-Hydroxypyrene,CDYIVSAQQUIYKS-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
157324,6wiq,DB15190,-7.7,GLPG-0259,YBFGSJUVEOYPIS-OALUTQOASA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
28799,6cs2,DB08416,-7.7,"(9BETA,13ALPHA,14BETA,17ALPHA)-2-METHOX1TRA-1,3,5(10)-TRIENE-3,17-DIYL DISULFAMATE",AQSNIXKAKUZPSI-SSTWWWIQSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
28798,6cs2,DB08414,-7.7,"6-CHLORO-2-(1-FURO[2,3-C]PYRIDIN-5-YL-ETHYLSULFANYL)-PYRIMIDIN-4-YLAMINE",ATCRIOJPQXDFNY-ZETCQYMHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
87801,6m3m,DB12882,-7.7,Ombrabulin,IXWNTLSTOZFSCM-YVACAVLKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87799,6m3m,DB12879,-7.7,Omigapil,QLMMOGWZCFQAPU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
74275,6m2n,DB03137,-7.7,"8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9-Pent-9h-Purin-6-Ylamine",RMOYVWKKOKERSW-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
15590,6lzg,DB00354,-7.7,Buclizine,MOYGZHXDRJNJEP-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
33091,6cs2,T3D4073,-7.7,Bicuculline,IYGYMKDQCDOMRE-ZWKOTPCHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
78269,6m2n,DB11423,-7.7,Lasalocid,BBMULGJBVDDDNI-OWKLGTHSSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
18367,6cs2,HMDB0029090,-7.7,Tryptophyl-Phenylalanine,IMMPMHKLUUZKAZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
69830,6lxt,DB11764,-7.7,Spebrutinib,KXBDTLQSDKGAEB-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
87776,6m3m,DB12840,-7.7,Pirnabine,AADNQNOXNWEYHS-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
91198,6m71,DB02738,-7.7,Adenosine-5'-Pentaphosphate,WYJWVZZCMBUPSP-KQYNXXCUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
78454,6m2n,DB11783,-7.7,Imidapril,KLZWOWYOHUKJIG-BPUTZDHNSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
162721,7bv1,DB02836,-7.7,Guanosine 5'-Diphosphate 2':3'-Cyclic Monophosphate,NGYWTCOGOZELRS-UUOKFMHZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
78535,6m2n,DB11899,-7.7,MK-8776,GMIZZEXBPRLVIV-SECBINFHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
37241,1r42,DB04006,-7.7,"[2-Amino-6-(2,6-Difluoro-Benzoyl)-Imidazo[1,2-a]Pyridin-3-Yl]-Phenyl-Methanone",WUGJIPFLBOATGL-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
33099,6cs2,T3D4086,-7.7,Chelerythrine,LLEJIEBFSOEYIV-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
87767,6m3m,DB12825,-7.7,Lefamulin,KPVIXBKIJXZQJX-FCEONZPQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
35811,1r42,DB02102,-7.7,DMP450,KYRSNWPSSXSNEP-ZRTHHSRSSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
78541,6m2n,DB11905,-7.7,Sutezolid,FNDDDNOJWPQCBZ-ZDUSSCGKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
15608,6lzg,DB00481,-7.7,Raloxifene,GZUITABIAKMVPG-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
157321,6wiq,DB15186,-7.7,GDC-0084,LGWACEZVCMBSKW-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
31311,6cs2,DB13667,-7.7,Cefozopran,QDUIJCOKQCCXQY-WHJQOFBOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
82333,6m3m,DB02407,-7.7,6-O-Cyclohexylmethyl Guanine,MWGXGTJJAOZBNW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
15623,6lzg,DB00568,-7.7,Cinnarizine,DERZBLKQOCDDDZ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
69862,6lxt,DB11806,-7.7,VTP-194204,BOOOLEGQBVUTKC-NVQSDHBMSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
87868,6m3m,DB12979,-7.7,Nepicastat,YZZVIKDAOTXDEB-JTQLQIEISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
157272,6wiq,DB15085,-7.7,Fulacimstat,JDARDSVOVYVQST-MRXNPFEDSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
165054,7bv1,DB09181,-7.7,Trefentanil,RJSCINHYBGMIFT-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
35850,1r42,DB02154,-7.7,"2,3-Bis-Benzo[1,3]Dioxol-5-Ylmethyl-Succinic Acid",FFYBYVPVYLMLAR-KBPBESRZSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
78379,6m2n,DB11671,-7.7,AZD-4877,SMFXSYMLJDHGIE-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78446,6m2n,DB11770,-7.7,Talinolol,MXFWWQICDIZSOA-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
33055,6cs2,T3D4017,-7.7,Vinblastine,JXLYSJRDGCGARV-XQKSVPLYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
157298,6wiq,DB15133,-7.7,Tepotinib,AHYMHWXQRWRBKT-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
162627,7bv1,DB02507,-7.7,4-Hydroxy-3-[(1s)-3-Oxo-1-Phenylbutyl]-2h-Chromen-2-One,PJVWKTKQMONHTI-HNNXBMFYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
78333,6m2n,DB11560,-7.7,Lesinurad,FGQFOYHRJSUHMR-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
162613,7bv1,DB02491,-7.7,4-[4-(1-Amino-1-Methylethyl)Phenyl]-5-Chloro-N-[4-(2-Morpholin-4-Ylethyl)Phenyl]Pyrimidin-2-Amine,CJSSYVIHFXDFFC-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
69851,6lxt,DB11792,-7.7,Mirodenafil,MIJFNYMSCFYZNY-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
78323,6m2n,DB11537,-7.7,Pirlimycin,HBJOXQRURQPDEX-MHXMMLMNSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
15654,6lzg,DB00694,-7.7,Daunorubicin,STQGQHZAVUOBTE-VGBVRHCVSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
165049,7bv1,DB09175,-7.7,Mirfentanil,BJZZDOLVVLWFHN-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
69906,6lxt,DB11872,-7.7,ZD-6126,UGBMEXLBFDAOGL-INIZCTEOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
87847,6m3m,DB12946,-7.7,"8-cyclopentyl-1,3-dipropylxanthine",FFBDFADSZUINTG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
68123,6lxt,DB07547,-7.7,5-(4-CYANOPHENYL)-3-{[(2-METHYLPHENYL)SULFONYL]AMINO}THIOPHENE-2-CARBOXYLIC ACID,RYXAHMSZLLIPRO-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
31358,6cs2,DB13721,-7.7,Cypermethrin,KAATUXNTWXVJKI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
72771,6m2n,DB01132,-7.7,Pioglitazone,HYAFETHFCAUJAY-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
91147,6m71,DB02669,-7.7,RB106,ZWDQTNWLXALTOV-QYZOEREBSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
162749,7bv1,DB02872,-7.7,"Cis-[4,5-Bis-(4-Bromophenyl)-2-(2-Ethoxy-4-Methoxyphenyl)-4,5-Dihydroimidazol-1-Yl]-[4-(2-Hydroxyethyl)Piperazin-1-Yl]Methanone",PVRYEWOXWGDQHA-URLMMPGGSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
162754,7bv1,DB02880,-7.7,N-[1-(4-Bromophenyl)Ethyl]-5-Fluoro Salicylamide,KFTNEILVDDUXGR-SECBINFHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
87734,6m3m,DB12766,-7.7,Cicletanine,CVKNDPRBJVBDSS-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
32996,6cs2,T3D3926,-7.7,Tebufenpyrad,ZZYSLNWGKKDOML-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
72664,6m2n,DB01009,-7.7,Ketoprofen,DKYWVDODHFEZIM-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
91454,6m71,DB03081,-7.7,Crc200 (Chiron-Behring),ZOXOKTJHZSUHRJ-XZOQPEGZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
78031,6m2n,DB09179,-7.7,R-30490,GARXJOUQUSNOGK-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
165220,7bv1,DB11591,-7.7,Bilastine,ACCMWZWAEFYUGZ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
91157,6m71,DB02684,-7.7,5'-O-(N-(L-Cysteinyl)-Sulfamoyl)Adenosine,FTSDEWPMACCNGN-YTMOPEAISA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
68055,6lxt,DB07468,-7.7,"(3aS)-3a-hydroxy-5-methyl-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one",NJBBBRZNBVLTRZ-GOSISDBHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
18413,6cs2,HMDB0029182,-7.7,4'-O-Methyl-(-)-epicatechin-5-O-sulphate,HRNHDBYAOGNRGL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
78023,6m2n,DB09170,-7.7,??-Hydroxythiofentanyl,GLAAETOTOUGGSB-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
157387,6wiq,DB15305,-7.7,Risdiplam,ASKZRYGFUPSJPN-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
82207,6m3m,DB02247,-7.7,Hydrolyzed Cephalothin,JRYZEMHNDUZNMI-RYUDHWBXSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
67901,6lxt,DB07290,-7.7,(2R)-2-{[(4-FLUORO-3-METHYLPHENYL)SULFONYL]AMINO}-N-HYDROXY-2-TETRAHYDRO-2H-PYRAN-4-YLACETAMIDE,LUCFRFDOOYLALP-CYBMUJFWSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
91104,6m71,DB02611,-7.7,Balanol Analog 1,FZJQHARRQUNVGZ-QZTJIDSGSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
15708,6lzg,DB00897,-7.7,Triazolam,JOFWLTCLBGQGBO-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
164993,7bv1,DB09063,-7.7,Ceritinib,VERWOWGGCGHDQE-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
91472,6m71,DB03103,-7.7,Thymidine-5'- Diphosphate,UJLXYODCHAELLY-XLPZGREQSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
91457,6m71,DB03084,-7.7,"Cyclopropyl-{4-[5-(3,4-Dichlorophenyl)-2-[(1-Methyl)-Piperidin]-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine",XCTKFTOEAKJMII-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
78160,6m2n,DB09495,-7.7,Avobenzone,XNEFYCZVKIDDMS-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
67925,6lxt,DB07315,-7.7,"5-chloro-N-{4-[(1R)-1,2-dihydroxyethyl]phenyl}-1H-indole-2-carboxamide",SHCHFGSUYJUEBR-INIZCTEOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
157208,6wiq,DB14790,-7.7,BPN-14770,KRRGWHSEDYQKDQ-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
82449,6m3m,DB02550,-7.7,"8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-2-Fluoro-9-Pent-4-Ylnyl-9h-Purin-6-Ylamine",KCIOVTSUEXGUFJ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
91176,6m71,DB02706,-7.7,Mercaptocarboxylate Inhibitor,DUKDFMPUZRDWLT-CQSZACIVSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
87763,6m3m,DB12818,-7.7,NM-3,BPZCXUROMKDLGX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
68033,6lxt,DB07441,-7.7,"3-{[(9-CYANO-9,10-DIHYDRO-10-METHYLACRIDIN-9-YL)CARBONYL]AMINO}PROPANOIC ACID",FRBAOMHMZCGBOJ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
78120,6m2n,DB09292,-7.7,Sacubitril,PYNXFZCZUAOOQC-UTKZUKDTSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78115,6m2n,DB09286,-7.7,Pipamperone,AXKPFOAXAHJUAG-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
31218,6cs2,DB13551,-7.7,Cinchophen,YTRMTPPVNRALON-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
31363,6cs2,DB13725,-7.7,Terodiline,UISARWKNNNHPGI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
91346,6m71,DB02932,-7.7,(R)-Bicalutamide,LKJPYSCBVHEWIU-KRWDZBQOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
91165,6m71,DB02694,-7.7,Pantoyl Adenylate,GDPVENOGSVMRJL-FSRKKXLISA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
78557,6m2n,DB11933,-7.7,Riboprine,USVMJSALORZVDV-SDBHATRESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
162736,7bv1,DB02854,-7.7,Aetiocholanolone,QGXBDMJGAMFCBF-BNSUEQOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
82245,6m3m,DB02295,-7.7,"N-[3-(Dimethylamino)Propyl]-2-({[4-({[4-(Formylamino)-1-Methyl-1h-Pyrrol-2-Yl]Carbonyl}Amino)-1-Methyl-1h-Pyrrol-2-Yl]Carbonyl}Amino)-5-Isopropyl-1,3-Thiazole-4-Carboxamide",VDYCDKRATGWFDA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
165184,7bv1,DB11485,-7.7,Ceftiofur,ZBHXIWJRIFEVQY-IHMPYVIRSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
162509,7bv1,DB02363,-7.7,2'-Monophosphoadenosine-5'-Diphosphate,YPTPYQSAVGGMFN-KQYNXXCUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
157361,6wiq,DB15257,-7.7,Milademetan,RYAYYVTWKAOAJF-QISPRATLSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
78053,6m2n,DB09201,-7.7,Ciglitazone,YZFWTZACSRHJQD-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
157366,6wiq,DB15268,-7.7,Afabicin,HFYMDQMXVPJNTH-VQHVLOKHSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
69804,6lxt,DB11725,-7.7,Latrepirdine,JNODQFNWMXFMEV-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
82489,6m3m,DB02607,-7.7,Adenosine Phosphonoacetic Acid,KJNLSEOJEFDELT-JJNLEZRASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
74391,6m2n,DB03288,-7.7,5-Chloro-1h-Indole-2-Carboxylic Acid{[Cyclopentyl-(2-Hydroxy-Ethyl)-Carbamoyl]-Methyl}-Amide,VXABTOCIIZSEPD-QGZVFWFLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
89263,6m71,DB00267,-7.7,Cefmenoxime,HJJDBAOLQAWBMH-YCRCPZNHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
31082,6cs2,DB13384,-7.7,Melitracen,GWWLWDURRGNSRS-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
88174,6m3m,DB13439,-7.7,Fenpiprane,JXJPYHDHJZJWRI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
154269,6wiq,DB07679,-7.7,"(9S,12S)-9-(1-methylethyl)-7,10-dioxo-2-oxa-8,11-diazabicyclo[12.2.2]octadeca-1(16),14,17-triene-12-carboxylic acid",RRAAROKJUVKWAF-RDJZCZTQSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
78914,6m2n,DB12441,-7.7,Tavilermide,DVJXNXPFYJIACK-ULQDDVLXSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
83226,6m3m,DB03606,-7.7,(S)-Rolipram,HJORMJIFDVBMOB-GFCCVEGCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
78928,6m2n,DB12464,-7.7,Bevenopran,ZGCYVRNZWGUXNQ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77631,6m2n,DB08610,-7.7,N-(2-AMINOETHYL)-2-{3-CHLORO-4-[(4-ISOPROPYLBENZYL)OXY]PHENYL} ACETAMIDE,DFXJYVQAAFOZDP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
74640,6m2n,DB03647,-7.7,3-[Isopropyl(4-Methylbenzoyl)Amino]-5-Phenylthiophene-2-Carboxylic Acid,LRHXIDOGMBZJFN-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
157949,6wiq,DB14982,-7.7,Miransertib,HNFMVVHMKGFCMB-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
77619,6m2n,DB08596,-7.7,5'-deoxy-5'-piperidin-1-ylthymidine,GMOUOGHZJCSNOZ-YNEHKIRRSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
165487,7bv1,DB12174,-7.7,CUDC-101,PLIVFNIUGLLCEK-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
153406,6wiq,DB06420,-7.7,Annamycin,CIDNKDMVSINJCG-GKXONYSUSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
36066,1r42,DB02432,-7.7,RU90395,RLLAUERCSKPFGD-VMPREFPWSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
67642,6lxt,DB06994,-7.7,"(2S,3S)-3-{3-[2-chloro-4-(methylsulfonyl)phenyl]-1,2,4-oxadiazol-5-yl}-1-cyclopentylidene-4-cyclopropyl-1-fluorobutan-2-amine",XCCSSVMRGIQMGF-LPHOPBHVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
88402,6m3m,DB13752,-7.7,Tetramethrin,CXBMCYHAMVGWJQ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
32824,6cs2,T3D3737,-7.7,Citreoviridin A,JLSVDPQAIKFBTO-USJRQALFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
165491,7bv1,DB12183,-7.7,Sapitinib,DFJSJLGUIXFDJP-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
67640,6lxt,DB06992,-7.7,"(3,3-dimethylpiperidin-1-yl)(6-(3-fluoro-4-methylphenyl)pyridin-2-yl)methanone",SIDDLTBLAQYZIZ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
161878,7bv1,DB00924,-7.7,Cyclobenzaprine,JURKNVYFZMSNLP-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
165495,7bv1,DB12187,-7.7,Abacavir hydroxyacetate,ZBBZROWQLKCFQK-KOLCDFICSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
88403,6m3m,DB13753,-7.7,Cetiedil,MMNICIJVQJJHHF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87120,6m3m,DB11861,-7.7,Litronesib,YVAFBXLHPINSIK-QHCPKHFHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
78909,6m2n,DB12433,-7.7,SCH-900271,ARJKMWXLIHZLQZ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
91877,6m71,DB03666,-7.7,3'-Azido-3'-Deoxythymidine-5'-Monophosphate,OIFWQOKDSPDILA-XLPZGREQSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
18128,6cs2,HMDB0013139,-7.7,1-Hydroxypyrene,CDYIVSAQQUIYKS-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
163053,7bv1,DB03708,-7.7,Adenosine 5'-phosphosulfate,IRLPACMLTUPBCL-KQYNXXCUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
88280,6m3m,DB13588,-7.7,Naftidrofuryl,KBAFPSLPKGSANY-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
156838,6wiq,DB13756,-7.7,Peruvoside,PMTSPAGBAFCORP-HBUONDEYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
157817,6wiq,DB12875,-7.7,Mavatrep,ORDHXXHTBUZRCN-NTEUORMPSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
28862,6cs2,DB08486,-7.7,Efaproxiral,BNFRJXLZYUTIII-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
72955,6m2n,DB01420,-7.7,Testosterone propionate,PDMMFKSKQVNJMI-BLQWBTBKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
165445,7bv1,DB12113,-7.7,CE-224535,FUCKCIVGBCBZNP-MRXNPFEDSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
16032,6lzg,DB02411,-7.7,"2-(11-{2-[Benzenesulfonyl-(3-Methyl-Butyl)-Amino]-1-Hydroxy-Ethyl}-6,9-Dioxo-2-Oxa-7,10-Diaza-Bicyclo[11.2.2]Heptadeca-1(16),13(17),14-Trien-8-Yl)-Acetamide, Inhibitor 2",HOUHLOFMBSYNBO-KKUQBAQOSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
69583,6lxt,DB11182,-7.7,Rose bengal free acid,VDNLFJGJEQUWRB-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
88405,6m3m,DB13755,-7.7,Iocarmic acid,SMQYOVYWPWASGU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
28765,6cs2,DB00776,-7.7,Oxcarbazepine,CTRLABGOLIVAIY-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
68231,6lxt,DB07679,-7.7,"(9S,12S)-9-(1-methylethyl)-7,10-dioxo-2-oxa-8,11-diazabicyclo[12.2.2]octadeca-1(16),14,17-triene-12-carboxylic acid",RRAAROKJUVKWAF-RDJZCZTQSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
72961,6m2n,DB01426,-7.7,Ajmaline,CJDRUOGAGYHKKD-HEFSZTOGSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
74114,6m2n,DB02919,-7.7,"2,4-Diamino-6-[N-(3',4',5'-Trimethoxybenzyl)-N-Methylamino]Pyrido[2,3-D]Pyrimidine",PUOZHLHNKHRTOW-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
161916,7bv1,DB00969,-7.7,Alosetron,JSWZEAMFRNKZNL-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
35516,1r42,DB01705,-7.7,Bis(5-Amidino-Benzimidazolyl)Methane,QZKOOEFIMWKZPK-UHFFFAOYSA-Q,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
78907,6m2n,DB12430,-7.7,BC-3781,KPVIXBKIJXZQJX-IJUBVZAWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
16097,6lzg,DB02698,-7.7,"N-(M-Trifluoromethylphenyl) Phenoxazine-4,6-Dicarboxylic Acid",NQOOJFXBGLOGTC-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
28877,6cs2,DB08499,-7.7,"N-[3-(2-fluoroethoxy)phenyl]-N'-(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-6-yl)butanediamide",DQXBKUVWJSZHSI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
32829,6cs2,T3D3743,-7.7,Fumitremorgin B,WEIYXEFMCIRZHC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
161928,7bv1,DB00984,-7.7,Nandrolone phenpropionate,UBWXUGDQUBIEIZ-QNTYDACNSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
29266,6cs2,DB08951,-7.7,Indoprofen,RJMIEHBSYVWVIN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
157968,6wiq,DB15399,-7.7,BMS-754807,LQVXSNNAFNGRAH-QHCPKHFHSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
154285,6wiq,DB07698,-7.7,"3-(3-aminophenyl)-N-(3-chlorophenyl)pyrazolo[1,5-a]pyrimidin-5-amine",JDNMRPIWJIDDAY-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
67611,6lxt,DB06953,-7.7,2-CHLORO-5-(3-CHLORO-PHENYL)-6-[(4-CYANO-PHENYL)-(3-METHYL-3H-IMIDAZOL-4-YL)- METHOXYMETHYL]-NICOTINONITRILE,JVWHVGIRXILXMU-XMMPIXPASA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
72335,6m2n,DB00624,-7.7,Testosterone,MUMGGOZAMZWBJJ-DYKIIFRCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
161852,7bv1,DB00678,-7.7,Losartan,PSIFNNKUMBGKDQ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
156687,6wiq,DB13552,-7.7,Trifluperidol,GPMXUUPHFNMNDH-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
78999,6m2n,DB12572,-7.7,Pexacerfont,LBWQSAZEYIZZCE-SNVBAGLBSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
91973,6m71,DB03788,-7.7,GC-24,JYHIGYLGYNCMGI-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
158058,7bv1,DB00324,-7.7,Fluorometholone,FAOZLTXFLGPHNG-KNAQIMQKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
67601,6lxt,DB06940,-7.7,"N-ethyl-4-{[5-(methoxycarbamoyl)-2-methylphenyl]amino}-5-methylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide",ZZTMFGIGOADCFX-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
36090,1r42,DB02466,-7.7,"4-[3-Oxo-3-(5,5,8,8-Tetramethyl-5,6,7,8-Tetrahydro-Naphthalen-2-Yl)-Propenyl]-Benzoic Acid",ZXQHMEUGMCXKLO-KPKJPENVSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
161856,7bv1,DB00683,-7.7,Midazolam,DDLIGBOFAVUZHB-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
153336,6wiq,DB06229,-7.7,Ocaperidone,ZZQNEJILGNNOEP-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
153331,6wiq,DB06212,-7.7,Tolvaptan,GYHCTFXIZSNGJT-XMMPIXPASA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
67595,6lxt,DB06932,-7.7,"10,11-dimethoxy-4-methyldibenzo[c,f]-2,7-naphthyridine-3,6-diamine",NVINUNQBDNEMSY-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
77511,6m2n,DB08467,-7.7,"6-(2,3,4,5,6,7-HEXAHYDRO-2,4,4-TRIMETHYL-1-METYLENEINDEN-2-YL)-3-METHYLHEXA-2,4-DIENOIC ACID",HEVXQLBAMFMFKU-IAZPEVBMSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
161839,7bv1,DB00663,-7.7,Flumethasone,WXURHACBFYSXBI-GQKYHHCASA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
88476,6m3m,DB13846,-7.7,Pyrrobutamine,WDYYVNNRTDZKAZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
74694,6m2n,DB03719,-7.7,N-Ethyl-5'-Carboxamido Adenosine,JADDQZYHOWSFJD-BMYQGPEFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
29382,6cs2,DB00842,-7.7,Oxazepam,ADIMAYPTOBDMTL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
158071,7bv1,DB00343,-7.7,Diltiazem,HSUGRBWQSSZJOP-RTWAWAEBSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
154358,6wiq,DB07783,-7.7,1-((1R)-1-(HYDROXYMETHYL)-3-{6-[(3-PHENYLPROPANOYL)AMINO]-1H-INDOL-1-YL}PROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE,GUYYFMCFEPDDFL-OAQYLSRUSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
88455,6m3m,DB13820,-7.7,Oxomemazine,QTQPVLDZQVPLGV-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
154228,6wiq,DB07629,-7.7,"N-((1R,2S)-2-(5-CHLORO-1H-INDOLE-2-CARBOXAMIDO)CYCLOHEXYL)-5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE-2-CARBOXAMIDE",ARPFWVKYXJZULB-DLBZAZTESA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
165528,7bv1,DB12235,-7.7,Estetrol,AJIPIJNNOJSSQC-NYLIRDPKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
16218,6lzg,DB03234,-7.7,"(4'-{[Allyl(Methyl)Amino]Methyl}-1,1'-Biphenyl-4-Yl)(4-Bromophenyl)Methanone",YATCZCSDJCQNAL-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
88410,6m3m,DB13760,-7.7,Niperotidine,HXRSXEDVVARPHP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83251,6m3m,DB03647,-7.7,3-[Isopropyl(4-Methylbenzoyl)Amino]-5-Phenylthiophene-2-Carboxylic Acid,LRHXIDOGMBZJFN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
74655,6m2n,DB03666,-7.7,3'-Azido-3'-Deoxythymidine-5'-Monophosphate,OIFWQOKDSPDILA-XLPZGREQSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
87057,6m3m,DB11770,-7.7,Talinolol,MXFWWQICDIZSOA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
72350,6m2n,DB00643,-7.7,Mebendazole,OPXLLQIJSORQAM-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
68255,6lxt,DB07707,-7.7,"(9BETA,11ALPHA,13ALPHA,14BETA,17ALPHA)-11-(METHOXYMETHYL)ESTRA-1(10),2,4-TRIENE-3,17-DIOL",LEOPSILMAOYZBO-IUTAEKPZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
88418,6m3m,DB13773,-7.7,Sulfamethoxypyridazine,VLYWMPOKSSWJAL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
165506,7bv1,DB12206,-7.7,N-6022,YVPGZQLRPAGKLA-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
81684,6m3m,DB01553,-7.7,Cloxazolam,ZIXNZOBDFKSQTC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
67621,6lxt,DB06969,-7.7,"2-amino-4-[2,4-dichloro-5-(2-pyrrolidin-1-ylethoxy)phenyl]-N-ethylthieno[2,3-d]pyrimidine-6-carboxamide",WJUNQSYQHHIVFX-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
81678,6m3m,DB01547,-7.7,Drotebanol,LCAHPIFLPICNRW-OPGCRTJHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
77562,6m2n,DB08528,-7.7,"2-AMINO-6-(3,5-DIMETHYLPHENYL)SULFONYLBENZONITRILE",SWGDXLAZBZDUBR-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
72338,6m2n,DB00628,-7.7,Clorazepic acid,XDDJGVMJFWAHJX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
70325,6lxt,DB12474,-7.7,Lynestrenol,YNVGQYHLRCDXFQ-XGXHKTLJSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
81676,6m3m,DB01545,-7.7,Ethyl loflazepate,CUCHJCMWNFEYOM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
68263,6lxt,DB07717,-7.7,"(5S,8R,9S,10S,13R,14S,17S)-13-{2-[(3,5-DIFLUOROBENZYL)OXY]ETHYL}-17-HYDROXY-10-METHYLHEXADECAHYDRO-3H-CYCLOPENTA[A]PHENANTHREN-3-ONE",AJODXHGZHBERGJ-JLYQOUBASA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
163113,7bv1,DB03777,-7.7,Rbt205 Inhibitor,QMGUOJYZJKLOLH-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
30919,6cs2,DB13175,-7.7,Rheinanthrone,OZFQHULMMDWMIV-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
165527,7bv1,DB12234,-7.7,BMS-214662,OLCWFLWEHWLBTO-HSZRJFAPSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
158038,7bv1,DB00301,-7.7,Flucloxacillin,UIOFUWFRIANQPC-JKIFEVAISA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
78972,6m2n,DB12532,-7.7,Oxetacaine,FTLDJPRFCGDUFH-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
87290,6m3m,DB12112,-7.7,Zuretinol acetate,QGNJRVVDBSJHIZ-AQDFTDIISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
15980,6lzg,DB02181,-7.7,2'-Deoxyguanosine-5'-Triphosphate,HAAZLUGHYHWQIW-KVQBGUIXSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
67686,6lxt,DB07042,-7.7,"7-amino-2-tert-butyl-4-{[2-(1H-imidazol-4-yl)ethyl]amino}pyrido[2,3-d]pyrimidine-6-carboxamide",XESUNWBIAADLPI-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
78801,6m2n,DB12286,-7.7,Simendan,WHXMKTBCFHIYNQ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
87454,6m3m,DB12343,-7.7,Temocillin,BVCKFLJARNKCSS-DWPRYXJFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
67778,6lxt,DB07147,-7.7,"methyl (1R,2S)-2-(hydroxycarbamoyl)-1-{4-[(2-methylquinolin-4-yl)methoxy]benzyl}cyclopropanecarboxylate",HJWMYFBKJRVWJY-YKSBVNFPSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
91681,6m71,DB03376,-7.7,'5'-O-(N-(L-Alanyl)-Sulfamoyl)Adenosine,CWWYMWDIYBJVLP-YTMOPEAISA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
81791,6m3m,DB01687,-7.7,beta-Mannobiose,GUBGYTABKSRVRQ-PZPXDAEZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
68163,6lxt,DB07596,-7.7,"(17beta)-17-(cyanomethyl)-2-methox1tra-1(10),2,4-trien-3-yl sulfamate",NTSPHKOMJMBWOU-NNKXXINSSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
70138,6lxt,DB12219,-7.7,GSK-424887,DRXBWLBZWAJIEF-IBGZPJMESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
157683,6wiq,DB12289,-7.7,Darexaban,IJNIQYINMSGIPS-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
162081,7bv1,DB01420,-7.7,Testosterone propionate,PDMMFKSKQVNJMI-BLQWBTBKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
70124,6lxt,DB12194,-7.7,Atamestane,PEPMWUSGRKINHX-TXTPUJOMSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
72488,6m2n,DB00810,-7.7,Biperiden,YSXKPIUOCJLQIE-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
31486,6cs2,DB13873,-7.7,Fenofibric acid,MQOBSOSZFYZQOK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
165378,7bv1,DB12011,-7.7,Fevipiprant,GFPPXZDRVCSVNR-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
88205,6m3m,DB13485,-7.7,Sulfametomidine,QKLSCPPJEVXONT-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
15921,6lzg,DB01906,-7.7,"3-(5-Amino-7-Hydroxy-[1,2,3]Triazolo[4,5-D]Pyrimidin-2-Yl)-Benzoic Acid",KNLLRZNGRRRPEW-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
156946,6wiq,DB13950,-7.7,WIN 55212-2,HQVHOQAKMCMIIM-HXUWFJFHSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
74575,6m2n,DB03549,-7.7,Biotinyl P-Nitroaniline,PORZMUYPQKOFQY-YDHLFZDLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
156944,6wiq,DB13947,-7.7,Testosterone enantate benzilic acid hydrazone,PTVXYACXDYZNID-JKXGKYMWSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
153623,6wiq,DB06922,-7.7,"2-[(1R)-1-carboxy-2-naphthalen-1-ylethyl]-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylic acid",CZNPWASYMRBJCX-GOSISDBHSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
157714,6wiq,DB12327,-7.7,Salvinorin A,OBSYBRPAKCASQB-AGQYDFLVSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
77734,6m2n,DB08734,-7.7,"6,6-DIMETHYL-1-[3-(2,4,5-TRICHLOROPHENOXY)PROPOXY]-1,6-DIHYDRO-1,3,5-TRIAZINE-2,4-DIAMINE",MJZJYWCQPMNPRM-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
91726,6m71,DB03446,-7.7,N-Benzyl-3-(alpha-D-galactopyranosyloxy)benzamide,FSMWGHKWKYCPKE-QTVCLEQKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
37143,1r42,DB03878,-7.7,N-[4-Methyl-3-[[4-(3-Pyridinyl)-2-Pyrimidinyl]Amino]Phenyl]-3-Pyridinecarboxamide,YWQVBESSYLICRX-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
165373,7bv1,DB12006,-7.7,BMS-906024,AYOUDDAETNMCBW-GSHUGGBRSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
67805,6lxt,DB07179,-7.7,"3-((3-bromo-5-o-tolylpyrazolo[1,5-a]pyrimidin-7-ylamino)methyl)pyridine 1-oxide",DXUJQXZHHGJMFM-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
87493,6m3m,DB12400,-7.7,Voxtalisib,RGHYDLZMTYDBDT-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
164926,7bv1,DB08970,-7.7,Fluprednidene,YVHXHNGGPURVOS-SBTDHBFYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
165355,7bv1,DB11979,-7.7,Elagolix,HEAUOKZIVMZVQL-VWLOTQADSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
31450,6cs2,DB13828,-7.7,Cyfluthrin,QQODLKZGRKWIFG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
72531,6m2n,DB00857,-7.7,Terbinafine,DOMXUEMWDBAQBQ-WEVVVXLNSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
87490,6m3m,DB12395,-7.7,Esreboxetine,CBQGYUDMJHNJBX-OALUTQOASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81862,6m3m,DB01780,-7.7,Fusicoccin,KXTYBXCEQOANSX-WYKQKOHHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
77783,6m2n,DB08788,-7.7,"3,6-DIAMINO-5-CYANO-4-(4-ETHOXYPHENYL)THIENO[2,3-B]PYRIDINE-2-CARBOXAMIDE",UOPQHPBCVYHSFF-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
81822,6m3m,DB01729,-7.7,"(1s,3s,4s)-1,3,4-Triphospho-Myo-Inositol",MMWCIQZXVOZEGG-MLQGYMEPSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
154132,6wiq,DB07514,-7.7,"3-(2-aminoquinazolin-6-yl)-1-(3,3-dimethylindolin-6-yl)-4-methylpyridin-2(1H)-one",LHLGUOHREUTYTO-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
91662,6m71,DB03351,-7.7,Sri-9439,KMSATRJZEXNGDP-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
165362,7bv1,DB11990,-7.7,MK-0812,UNVWTBOGMHPKJM-CWKRKGSWSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
69672,6lxt,DB11443,-7.7,Orbifloxacin,QIPQASLPWJVQMH-DTORHVGOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
31453,6cs2,DB13835,-7.7,Caroverine,MSPRUJDUTKRMLM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
15876,6lzg,DB01691,-7.7,Indole Naphthyridinone,VAZMNDXVXVUKFY-JXMROGBWSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
78764,6m2n,DB12236,-7.7,Bexagliflozin,BTCRKOKVYTVOLU-SJSRKZJXSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
164914,7bv1,DB08956,-7.7,Hydroxydione,USPYDUPOCUYHQL-VEVMSBRDSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
72517,6m2n,DB00842,-7.7,Oxazepam,ADIMAYPTOBDMTL-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
81840,6m3m,DB01752,-7.7,S-adenosyl-L-homocysteine,ZJUKTBDSGOFHSH-WFMPWKQPSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87485,6m3m,DB12390,-7.7,MBX-8025,JWHYSEDOYMYMNM-QGZVFWFLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
69684,6lxt,DB11463,-7.7,Sulfanitran,GWBPFRGXNGPPMF-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
15935,6lzg,DB01967,-7.7,"N-{3-[(7ar,12as,12bs)-7-Oxo-1,3,4,6,7,7a,12a,12b-Octahydroindolo[2,3-a]Quinolizin-12(2h)-Yl]Propyl}Propane-2-Sulfonamide",LICJTIDRHJECTD-SFHVURJKSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
22009,6cs2,HMDB0001419,-7.7,24-Hydroxycholesterol,IOWMKBFJCNLRTC-XWXSNNQWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
164868,7bv1,DB08706,-7.7,"(2S)-({(5Z)-5-[(5-ETHYL-2-FURYL)METHYLENE]-4-OXO-4,5-DIHYDRO-1,3-THIAZOL-2-YL}AMINO)(4-FLUOROPHENYL)ACETIC ACID",RNEACARJKXYVND-MZLJFPOFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
87332,6m3m,DB12173,-7.7,Diphencyprone,HCIBTBXNLVOFER-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
154208,6wiq,DB07608,-7.7,N-(5-{[(2S)-4-amino-2-(3-chlorophenyl)butanoyl]amino}-1H-indazol-3-yl)benzamide,JDGOPNUGILVNJZ-IBGZPJMESA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
165420,7bv1,DB12078,-7.7,Enobosarm,JNGVJMBLXIUVRD-SFHVURJKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
83119,6m3m,DB03450,-7.7,Cephalothin Group,UUWFGEKEQSCSMB-IAQYHMDHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
33370,6cs2,T3D4562,-7.7,Heroin,GVGLGOZIDCSQPN-PVHGPHFFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
78876,6m2n,DB12392,-7.7,Resminostat,FECGNJPYVFEKOD-VMPITWQZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
88257,6m3m,DB13554,-7.7,Moperone,AGAHNABIDCTLHW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88266,6m3m,DB13566,-7.7,Sequifenadine,OXDOWGVJMITMJL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
69632,6lxt,DB11371,-7.7,Alfaxalone,DUHUCHOQIDJXAT-OLVMNOGESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
77659,6m2n,DB08646,-7.7,TRW3-(2-AMINO-3-HYDROXY-PROPYL)-6-(N'-CYCLOHEXYL-HYDRAZINO)OCTAHYDRO-INDOL-7-OL,PSUOZWHAKZSNOB-LBPRGKRZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78883,6m2n,DB12401,-7.7,Bromperidol,RKLNONIVDFXQRX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
165423,7bv1,DB12081,-7.7,Anecortave,BCFCRXOJOFDUMZ-ONKRVSLGSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
67701,6lxt,DB07058,-7.7,"5-[1-(4-methoxyphenyl)-1H-benzimidazol-6-yl]-1,3,4-oxadiazole-2(3H)-thione",QBVJMUOTMRYUKR-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
87327,6m3m,DB12163,-7.7,Sarpogrelate,FFYNAVGJSYHHFO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
153510,6wiq,DB06766,-7.7,Alcaftadine,MWTBKTRZPHJQLH-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
91830,6m71,DB03596,-7.7,N-[2-(1h-Indol-5-Yl)-Butyl]-4-Sulfamoyl-Benzamide,FSRPBGBMEKDSIJ-CYBMUJFWSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
35564,1r42,DB01768,-7.7,Methylumbelliferyl Sialic Acid,KKDWIUJBUSOPGC-GKHMPSLRSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
15978,6lzg,DB02164,-7.7,N-Sulfo-Flavin Mononucleotide,ZLPUGFBBLGQWBS-SCRDCRAPSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
33392,6cs2,T3D4585,-7.7,Lormetazepam,FJIKWRGCXUCUIG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
33376,6cs2,T3D4567,-7.7,Delorazepam,CHIFCDOIPRCHCF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
37412,1r42,DB04232,-7.7,N-Hydroxy-1-(4-Methoxyphenyl)Sulfonyl-4-Benzyloxycarbonyl-Piperazine-2-Carboxamide,DNGGPLKVDUPXFN-GOSISDBHSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
154206,6wiq,DB07605,-7.7,"2-({4-[(5-CHLORO-1H-INDOL-2-YL)SULFONYL]PIPERAZIN-1-YL}CARBONYL)THIENO[3,2-B]PYRIDINE 4-OXIDE",DHDQMXPAANQKDC-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
154194,6wiq,DB07588,-7.7,"3,4-DI-1H-INDOL-3-YL-1H-PYRROLE-2,5-DICARBOXYLIC ACID",FZDVNXHYGMEEDT-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
33328,6cs2,T3D4521,-7.7,Novaluron,NJPPVKZQTLUDBO-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
32869,6cs2,T3D3790,-7.7,Acifluorfen,NUFNQYOELLVIPL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
157741,6wiq,DB12743,-7.7,Z-160,VCPMZDWBEWTGNW-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
29351,6cs2,DB09050,-7.7,Ceftolozane,JHFNIHVVXRKLEF-DCZLAGFPSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
20333,6cs2,HMDB0046580,-7.7,"TG(22:0/20:3(5Z,8Z,11Z)/o-18:0)",PLJUCVWMUHTXMN-UVXDFRCHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
31021,6cs2,DB13317,-7.7,Flunoxaprofen,ARPYQKTVRGFPIS-VIFPVBQESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
165398,7bv1,DB12045,-7.7,Mericitabine,MLESJYFEMSJZLZ-MAAOGQSESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
72936,6m2n,DB01393,-7.7,Bezafibrate,IIBYAHWJQTYFKB-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
156928,6wiq,DB13874,-7.7,Enasidenib,DYLUUSLLRIQKOE-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
164873,7bv1,DB08775,-7.7,Nalpha-[(Benzyloxy)carbonyl]-N-[(2S)-4-fluoro-3-oxo-2-butanyl]-L-tyrosinamide,RYABQRLJLIHDIP-KSSFIOAISA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
91749,6m71,DB03477,-7.7,1-Phenylsulfonamide-3-Trifluoromethyl-5-Parabromophenylpyrazole,OYZKFVIVPRQRQQ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
91750,6m71,DB03478,-7.7,2'-O-Acetyl Adenosine-5-Diphosphoribose,BFNOPXRXIQJDHO-DLFWLGJNSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
90860,6m71,DB02300,-7.7,Calcipotriol,LWQQLNNNIPYSNX-UROSTWAQSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
68877,6lxt,DB08441,-7.7,"6-BROMO-13-THIA-2,4,8,12,19-PENTAAZATRICYCLO[12.3.1.1-3,7-]NONADECA-1(18),3(19),4,6,14,16-HEXAENE 13,13-DIOXIDE",AWSQADBSXFTFKL-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
153581,6wiq,DB06876,-7.7,"N-{5-[4-(4-METHYLPIPERAZIN-1-YL)PHENYL]-1H-PYRROLO[2,3-B]PYRIDIN-3-YL}NICOTINAMIDE",YJWJKKXGAPWLGT-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
156917,6wiq,DB13856,-7.7,Fluclorolone,VTWKPILBIUBMDS-OTJLYDAYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
162025,7bv1,DB01095,-7.7,Fluvastatin,FJLGEFLZQAZZCD-JUFISIKESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
154189,6wiq,DB07583,-7.7,"(4R,2S)-5'-(4-(4-CHLOROBENZYLOXY)PYRROLIDIN-2-YLMETHANESULFONYL)ISOQUINOLINE",RLNNFNGBXLTQOB-RBUKOAKNSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
83083,6m3m,DB03396,-7.7,"(E)-(2r,3r,4s,5r)-3,4,5-Trihydroxy-2-Methoxy-8,8-Dimethyl-Non-6-Enoic Acid ((3s,6r)-6-Hydroxy-2-Oxo-Azepan-3-Yl)-Amide",FVBBTOIQETYGOA-SDNORSGYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
156905,6wiq,DB13843,-7.7,Cloprednol,YTJIBEDMAQUYSZ-FDNPDPBUSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
165411,7bv1,DB12063,-7.7,CERC-301,RECBFDWSXWAXHY-IAGOWNOFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
158813,7bv1,DB02253,-7.7,"(1r)-4-[(1e,3e,5e,7z,9e,11z,13e,15e)-17-Hydroxy-3,7,12,16-Tetramethylheptadeca-1,3,5,7,9,11,13,15-Octaen-1-Yl]-3,5,5-Trimethylcyclohex-3-En-1-Ol",FNAJVVMDXCOSFY-VFGOXHQXSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
78403,6m2n,DB11702,-7.7,Antineoplaston A10,OQGRFQCUGLKSAV-JTQLQIEISA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
151149,6wiq,DB02336,-7.7,RU83876,WCMLXBUNHNAMNH-UIOOFZCWSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
159356,7bv1,DB04037,-7.7,"N,N-Bis(4-Chlorobenzyl)-1h-1,2,3,4-Tetraazol-5-Amine",UOUXILZUBDIWQU-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
85584,6m3m,DB07829,-7.7,4-[3-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL]PYRIDINE,BILJSHVAAVZERY-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
73520,6m2n,DB02140,-7.7,N1-(1-Dimethylcarbamoyl-2-Phenyl-Ethyl)-2-Oxo-N4-(2-Pyridin-2-Yl-Ethyl)-Succinamide,ZPFPZRVOBBMZMP-SFHVURJKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80592,6m3m,DB00196,-7.7,Fluconazole,RFHAOTPXVQNOHP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
69068,6lxt,DB08670,-7.7,"METHYL N-[(2S,3R)-3-AMINO-2-HYDROXY-3-(4-ISOPROPYLPHENYL)PROPANOYL]-D-ALANYL-D-LEUCINATE",WIWZNHHLFMPGGO-PIKADFDJSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
80623,6m3m,DB00234,-7.7,Reboxetine,CBQGYUDMJHNJBX-RTBURBONSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
160642,7bv1,DB09216,-7.7,Tolfenamic Acid,YEZNLOUZAIOMLT-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
70974,6lxt,DB13472,-7.7,Cyclofenil,GVOUFPWUYJWQSK-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
90120,6m71,DB01319,-7.7,Fosamprenavir,MLBVMOWEQCZNCC-OEMFJLHTSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
80831,6m3m,DB00482,-7.7,Celecoxib,RZEKVGVHFLEQIL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
159809,7bv1,DB06608,-7.7,Tafenoquine,LBHLFPGPEGDCJG-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160635,7bv1,DB08881,-7.7,Vemurafenib,GPXBXXGIAQBQNI-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160207,7bv1,DB07872,-7.7,5-chloro-N-[(3R)-1-(2-{[2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl]amino}-2-oxoethyl)pyrrolidin-3-yl]thiophene-2-carboxamide,IYGIXVNAMZPBDK-CQSZACIVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
66830,6lxt,DB04705,-7.7,"(3BETA)-CHOLEST-5-ENE-3,25-DIOL",INBGSXNNRGWLJU-ZHHJOTBYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
93490,6m71,DB07011,-7.7,"(3S)-1-(1,3-BENZODIOXOL-5-YLMETHYL)-3-[4-(1H-IMIDAZOL-1-YL)PHENOXY]PIPERIDINE",HHOPJGKEAIIIDF-FQEVSTJZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
30249,6cs2,DB12245,-7.7,Triclabendazole,NQPDXQQQCQDHHW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
89534,6m71,DB00596,-7.7,Ulobetasol,LEHFPXVYPMWYQD-XHIJKXOTSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
89528,6m71,DB00589,-7.7,Lisuride,BKRGVLQUQGGVSM-KBXCAEBGSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
159315,7bv1,DB03980,-7.7,4-(Fluorophenyl)-1-Cyclopropylmethyl-5-(2-Amino-4-Pyrimidinyl)Imidazole,DFEYXQGDDCDXJK-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
31920,6cs2,DB15038,-7.7,Litoxetine,MJJDYOLPMGIWND-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
90125,6m71,DB01326,-7.7,Cefamandole,OLVCFLKTBJRLHI-AXAPSJFSSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
68681,6lxt,DB08192,-7.7,2-(4-CARCOXY-5-ISOPROPYLTHIAZOLYL)BENZOPIPERIDINE,HCUGCUQZFBURHR-LBPRGKRZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
93109,6m71,DB06307,-7.7,Apoptone,CKAXZOYFIHQCBN-JRRMKBMNSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
71495,6lxt,DB14653,-7.7,Clocortolone caproate,MMTRTBFDFNRBQO-ANHDKODLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
89521,6m71,DB00582,-7.7,Voriconazole,BCEHBSKCWLPMDN-MGPLVRAMSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93494,6m71,DB07015,-7.7,"(3R,4R)-4-(pyrrolidin-1-ylcarbonyl)-1-(quinoxalin-2-ylcarbonyl)pyrrolidin-3-amine",XDSKICAQKGYYJF-OLZOCXBDSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
159818,7bv1,DB06624,-7.7,Taranabant,QLYKJCMUNUWAGO-GAJHUEQPSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
79836,6m2n,DB13808,-7.7,Mebhydrolin,FQQIIPAOSKSOJM-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
155855,6wiq,DB11847,-7.7,Cadazolid,XWFCFMXQTBGXQW-GOSISDBHSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
150298,6wiq,DB01180,-7.7,Rescinnamine,SZLZWPPUNLXJEA-LAFLMMDJSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
75770,6m2n,DB05864,-7.7,PPI-2458,QBDVVYNLLXGUGN-XGTBZJOHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
164411,7bv1,DB07801,-7.7,N-butyl-3-{[6-(9H-purin-6-ylamino)hexanoyl]amino}benzamide,WOYITRCGMUXUDE-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
30257,6cs2,DB12259,-7.7,CG-200745,AUGCSOFQTDKPSO-RGVLZGJSSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
29787,6cs2,DB11633,-7.7,Isavuconazole,DDFOUSQFMYRUQK-RCDICMHDSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
80562,6m3m,DB00163,-7.7,Vitamin E,GVJHHUAWPYXKBD-IEOSBIPESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
159383,7bv1,DB04073,-7.7,N-{3-[4-(3-aminopropyl)piperazin-1-yl]propyl}-3-(beta-D-galactopyranosyloxy)-5-nitrobenzamide,UEIGEWJJVQHIAX-DLBZZEGUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
76161,6m2n,DB06884,-7.7,4-HYDROXY-N'-(4-ISOPROPYLBENZYL)BENZOHYDRAZIDE,MFDXHRPPSJRQFX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
73740,6m2n,DB02427,-7.7,"2,4-Diamino-6-[N-(2',5'-Dimethoxybenzyl)-N-Methylamino]Quinazoline",YBJANOUTWRTBDK-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
159431,7bv1,DB04137,-7.7,Guanosine-5'-Triphosphate,XKMLYUALXHKNFT-UUOKFMHZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160546,7bv1,DB08758,-7.7,"IMIDAZO[2,1-A]ISOQUINOLINE-2-CARBOHYDRAZIDE",WSNWYZBDIKCPIG-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93465,6m71,DB06983,-7.7,"(5-phenyl-7-(pyridin-3-ylmethylamino)pyrazolo[1,5-a]pyrimidin-3-yl)methanol",RBLKWWBHDUBPFN-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
85135,6m3m,DB07303,-7.7,"N-3-[3-(5-METHOXYPYRIDIN-3-YL)BENZYL]PYRIDINE-2,3-DIAMINE",PGAWZMRRCVSRIM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
75805,6m2n,DB06133,-7.7,Dimethylcurcumin,ZMGUKFHHNQMKJI-CIOHCNBKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76117,6m2n,DB06829,-7.7,4-BROMO-3-(CARBOXYMETHOXY)-5-[3-(CYCLOHEXYLAMINO)PHENYL]THIOPHENE-2-CARBOXYLIC ACID,RXDVFLTWXCTCEX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80027,6m2n,DB14196,-7.7,"N-Cyclohexyl-N'-phenyl-1,4-phenylenediamine",ZRMMVODKVLXCBB-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
30024,6cs2,DB11948,-7.7,Lapachone,QZPQTZZNNJUOLS-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
84678,6m3m,DB06736,-7.7,Aceclofenac,MNIPYSSQXLZQLJ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
160531,7bv1,DB08742,-7.7,"1,3-CYCLOHEXANEDIOL, 4-METHYLENE-5-[(2E)-[(1S,3AS,7AS)-OCTAHYDRO-1-(5-HYDROXY-5-METHYL-1,3-HEXADIYNYL)-7A-METHYL-4H-INDEN-4-YLIDENE]ETHYLIDENE]-, (1R,3S,5Z)",CEEUUHVULXTFGS-BQXVGYHGSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160528,7bv1,DB08739,-7.7,"2-{3-[(2S)-4,4-difluoro-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]-3-oxopropyl}-isoindole-1,3(2H)-dione",ZSXNPAWXICXNGZ-HNNXBMFYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
155689,6wiq,DB11529,-7.7,Melengestrol,OKHAOBQKCCIRLO-IBVJIVQJSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
166355,7bv1,DB14716,-7.7,Clonazolam,XJRGLCAWBRZUFC-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
155832,6wiq,DB11795,-7.7,GSK-2636771,XTKLTGBKIDQGQL-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
71699,6lxt,DB15108,-7.7,Tipranavir C-14,SUJUHGSWHZTSEU-MWQIXQBFSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
166341,7bv1,DB14674,-7.7,Estramustine phosphate,ADFOJJHRTBFFOF-RBRWEJTLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
80033,6m2n,DB14207,-7.7,Fosinoprilat,WOIWWYDXDVSWAZ-RTWAWAEBSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
84641,6m3m,DB06683,-7.7,Clevudine,GBBJCSTXCAQSSJ-XQXXSGGOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85982,6m3m,DB08297,-7.7,ORTHONITROPHENYL-BETA-D-FUCOPYRANOSIDE,SWRPIVXPHLYETN-BVWHHUJWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
164030,7bv1,DB06991,-7.7,"N-[2-methyl-5-(methylcarbamoyl)phenyl]-2-{[(1R)-1-methylpropyl]amino}-1,3-thiazole-5-carboxamide",OYOUIHFZUAKCEF-LLVKDONJSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
71715,6lxt,DB15137,-7.7,VK-2809,LGGPZDRLTDGYSQ-JADSYQMUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
160215,7bv1,DB07882,-7.7,"4-{4-[2-(1A,7A-DIMETHYL-4-OXY-OCTAHYDRO-1-OXA-4-AZA-CYCLOPROPA[A]NAPHTHALEN-4-YL) -ACETYLAMINO]-PHENYLCARBAMOYL}-BUTYRIC ACID",VFIZFTGABDUGCF-UPVHCHBVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
89543,6m71,DB00607,-7.7,Nafcillin,GPXLMGHLHQJAGZ-JTDSTZFVSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
66829,6lxt,DB04704,-7.7,20-hydroxycholesterol,MCKLJFJEQRYRQT-MGNSQDQZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
75804,6m2n,DB06127,-7.7,Bisegliptin,AKFNKZFJBFQFAA-DIOPXHOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79845,6m2n,DB13821,-7.7,Ceftezole,DZMVCVMFETWNIU-LDYMZIIASA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
73414,6m2n,DB02004,-7.7,"5-(Aminomethyl)-6-(2,4-Dichlorophenyl)-2-(3,5-Dimethoxyphenyl)Pyrimidin-4-Amine",RCJFINNFYUNFGH-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
166320,7bv1,DB14652,-7.7,Clocortolone acetate,ARPLCFGLEYFDCN-CDACMRRYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
34824,1r42,DB00826,-7.7,Natamycin,NCXMLFZGDNKEPB-FFPOYIOWSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
150182,6wiq,DB01047,-7.7,Fluocinonide,WJOHZNCJWYWUJD-IUGZLZTKSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
32061,6cs2,DB01120,-7.7,Gliclazide,BOVGTQGAOIONJV-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
160561,7bv1,DB08775,-7.7,N??-[(Benzyloxy)carbonyl]-N-[(2S)-4-fluoro-3-oxo-2-butanyl]-L-tyrosinamide,RYABQRLJLIHDIP-KSSFIOAISA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
150221,6wiq,DB01092,-7.7,Ouabain,LPMXVESGRSUGHW-HBYQJFLCSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
71009,6lxt,DB13520,-7.7,Metergoline,WZHJKEUHNJHDLS-QTGUNEKASA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
89506,6m71,DB00562,-7.7,Benzthiazide,NDTSRXAMMQDVSW-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
80853,6m3m,DB00508,-7.7,Triflupromazine,XSCGXQMFQXDFCW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
159229,7bv1,DB03608,-7.7,Diminazene,XNYZHCFCZNMTFY-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160164,7bv1,DB07588,-7.7,"3,4-DI-1H-INDOL-3-YL-1H-PYRROLE-2,5-DICARBOXYLIC ACID",FZDVNXHYGMEEDT-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
30315,6cs2,DB12321,-7.7,Ifetroban,BBPRUNPUJIUXSE-DXKRWKNPSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
166505,7bv1,DB15265,-7.7,USL-311,XNUNVQKARNSSEO-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
166218,7bv1,DB14129,-7.7,Macelignan,QDDILOVMGWUNGD-UONOGXRCSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
76301,6m2n,DB07047,-7.7,"2',4'-DICHLORO-4-HYDROXY-1,1'-BIPHENYL-3-CARBOXYLIC ACID",SKAFZYDMDHPPJM-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
31894,6cs2,DB01101,-7.7,Capecitabine,GAGWJHPBXLXJQN-UORFTKCHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
86126,6m3m,DB08472,-7.7,(R)-Fluoxetine,RTHCYVBBDHJXIQ-MRXNPFEDSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
79770,6m2n,DB13721,-7.7,Cypermethrin,KAATUXNTWXVJKI-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
29988,6cs2,DB11901,-7.7,Apalutamide,HJBWBFZLDZWPHF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
160770,7bv1,DB11184,-7.7,Oftasceine,DEGAKNSWVGKMLS-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160165,7bv1,DB07589,-7.7,"N-[1-(AMINOMETHYL)CYCLOPROPYL]-3-(BENZYLSULFONYL)-N-2-[(1S)-2,2,2-TRIFLUORO-1-(4-HYDROXYPHENYL)ETHYL]-L-ALANINAMIDE",DWWVPKCSDHDILN-OALUTQOASA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93513,6m71,DB07036,-7.7,"(3aS,4R,9bR)-2,2-difluoro-4-(4-hydroxyphenyl)-6-(methoxymethyl)-1,2,3,3a,4,9b-hexahydrocyclopenta[c]chromen-8-ol",GPFRMIHXGMVMGF-BZSNNMDCSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
71264,6lxt,DB13857,-7.7,Demegestone,JWAHBTQSSMYISL-MHTWAQMVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
75747,6m2n,DB05708,-7.7,GTS-21,RPYWXZCFYPVCNQ-RVDMUPIBSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
89892,6m71,DB01016,-7.7,Glyburide,ZNNLBTZKUZBEKO-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
80861,6m3m,DB00523,-7.7,Alitretinoin,SHGAZHPCJJPHSC-ZVCIMWCZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
149487,6wiq,DB00223,-7.7,Diflorasone,WXURHACBFYSXBI-XHIJKXOTSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
93540,6m71,DB07065,-7.7,"5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)-3-thiocyanatopyrazolo[1,5-a]pyrimidin-7-amine",AHPKUZJCNHGFQA-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
29973,6cs2,DB11880,-7.7,Acridine Carboxamide,XBGNERSKEKDZDS-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
80874,6m3m,DB00539,-7.7,Toremifene,XFCLJVABOIYOMF-QPLCGJKRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80089,6m2n,DB14635,-7.7,Curcumin sulfate,NEJVQQBBTRFOHB-FCXRPNKRSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
164446,7bv1,DB07839,-7.7,"N-2-1,3-BENZOXAZOL-2-YL-3-CYCLOHEXYL-N-{2-[(4-METHOXYPHENYL)AMINO]ETHYL}-L-ALANINAMIDE",VFNWTXUFNNOQHD-QFIPXVFZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
85210,6m3m,DB07390,-7.7,"2-[3-(5-MERCAPTO-[1,3,4]THIADIAZOL-2-YL)-UREIDO]-N-METHYL-3-PHENYL-PROPIONAMIDE",RKWXKADYTDWZIJ-VIFPVBQESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
73381,6m2n,DB01958,-7.7,"5-[4-Tert-Butylphenylsulfanyl]-2,4-Quinazolinediamine",MNYDVPDMLAJJPB-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
160156,7bv1,DB07578,-7.7,"3-[4-(2-METHYL-IMIDAZO[4,5-C]PYRIDIN-1-YL)BENZYL]-3H-BENZOTHIAZOL-2-ONE",WUOLYUKMMRCXGH-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
17610,6cs2,HMDB0000308,-7.7,3b-Hydroxy-5-cholenoic acid,HIAJCGFYHIANNA-QIZZZRFXSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
166198,7bv1,DB14086,-7.7,Cianidanol,PFTAWBLQPZVEMU-DZGCQCFKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
86132,6m3m,DB08479,-7.7,"N-(3,5-dimethoxyphenyl)imidodicarbonimidic diamide",VQKIGKHIRBCYNE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
29136,6cs2,DB08775,-7.7,N??-[(Benzyloxy)carbonyl]-N-[(2S)-4-fluoro-3-oxo-2-butanyl]-L-tyrosinamide,RYABQRLJLIHDIP-KSSFIOAISA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
32188,6cs2,DB01162,-7.7,Terazosin,VCKUSRYTPJJLNI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
70911,6lxt,DB13386,-7.7,Epimestrol,UHQGCIIQUZBJAE-RRQVMCLOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
32082,6cs2,DB15324,-7.7,ORM-13070 C-11,VGIYMYGMVXPMKV-GWDMYEQXSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
79778,6m2n,DB13729,-7.7,Camostat,XASIMHXSUQUHLV-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
31914,6cs2,DB15031,-7.7,Nemorexant,NBGABHGMJVIVBW-QHCPKHFHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
76255,6m2n,DB06996,-7.7,D-leucyl-N-(4-carbamimidoylbenzyl)-L-prolinamide,XFNMDMGNNKIXBT-CVEARBPZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
166266,7bv1,DB14512,-7.7,Mometasone furoate,WOFMFGQZHJDGCX-ZULDAHANSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
30281,6cs2,DB12284,-7.7,LY-2608204,QIIVJLHCZUTGSD-CUBQBAPOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
160177,7bv1,DB07607,-7.7,4-[5-(3-IODO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-1H-IMIDAZOL-4-YL]-PYRIDINE,RXDZANYWRNIAOR-HHHXNRCGSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
69095,6lxt,DB08705,-7.7,"6-(5-BROMO-2-HYDROXYPHENYL)-2-OXO-4-PHENYL-1,2-DIHYDROPYRIDINE-3-CARBONITRILE",SVSYJTYGPLVUOZ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
149515,6wiq,DB00253,-7.7,Medrysone,GZENKSODFLBBHQ-ILSZZQPISA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
16694,6cs2,HMDB0003555,-7.7,Vitamin K1,MBWXNTAXLNYFJB-LKUDQCMESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
71751,6lxt,DB15207,-7.7,Esaxerenone,NOSNHVJANRODGR-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
76201,6m2n,DB06927,-7.7,[5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-YL]ACETONITRILE,ZKJVCUXZMYKTLT-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
90138,6m71,DB01347,-7.7,Saprisartan,DUEWVPTZCSAMNB-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
89499,6m71,DB00554,-7.7,Piroxicam,QYSPLQLAKJAUJT-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
29655,6cs2,DB11362,-7.7,Selexipag,QXWZQTURMXZVHJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
150396,6wiq,DB01337,-7.7,Pancuronium,GVEAYVLWDAFXET-XGHATYIMSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
155882,6wiq,DB11891,-7.7,CUDC-907,JOWXJLIFIIOYMS-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
164424,7bv1,DB07814,-7.7,Gibberellic acid,IXORZMNAPKEEDV-OBDJNFEBSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
166289,7bv1,DB14584,-7.7,Segesterone,SFLXYFZGKSGFKA-XUDSTZEESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
86048,6m3m,DB08378,-7.7,"4-[4-(2,5-DIOXO-PYRROLIDIN-1-YL)-PHENYLAMINO]-4-HYDROXY-BUTYRIC ACID",SUETUOGYOWOLNJ-NSHDSACASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
30283,6cs2,DB12286,-7.7,Simendan,WHXMKTBCFHIYNQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
16693,6cs2,HMDB0003550,-7.7,Calcidiol,JWUBBDSIWDLEOM-DTOXIADCSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
93074,6m71,DB06230,-7.7,Nalmefene,WJBLNOPPDWQMCH-MBPVOVBZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
30294,6cs2,DB12299,-7.7,Bavisant,BGBVSGSIXIIREO-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
80048,6m2n,DB14476,-7.7,DL-alpha-Tocopherol,GVJHHUAWPYXKBD-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
84551,6m3m,DB06468,-7.7,Cariporide,IWXNYAIICFKCTM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
89722,6m71,DB00823,-7.7,Ethynodiol diacetate,ONKUMRGIYFNPJW-KIEAKMPYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
80508,6m2n,DB09170,-7.7,β-Hydroxythiofentanyl,GLAAETOTOUGGSB-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
84559,6m3m,DB06480,-7.7,Prucalopride,ZPMNHBXQOOVQJL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
73534,6m2n,DB02162,-7.7,5'-O-(N-Ethyl-Sulfamoyl)Adenosine,ONCSLXAPOGUODU-WOUKDFQISA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
30291,6cs2,DB12295,-7.7,Evodenoson,SQJXTUJMBYVDBB-RQXXJAGISA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
154977,6wiq,DB08513,-7.7,[4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENYL]ACETIC ACID,PAIQRYUOBBCBSE-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
86066,6m3m,DB08399,-7.7,PICEATANNOL,CDRPUGZCRXZLFL-OWOJBTEDSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
89904,6m71,DB01030,-7.7,Topotecan,UCFGDBYHRUNTLO-QHCPKHFHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
163973,7bv1,DB06919,-7.7,D-phenylalanyl-N-(3-chlorobenzyl)-L-prolinamide,CJHLRGCXPGIPCB-MOPGFXCFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
150418,6wiq,DB01384,-7.7,Paramethasone,MKPDWECBUAZOHP-AFYJWTTESA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
90153,6m71,DB01380,-7.7,Cortisone acetate,ITRJWOMZKQRYTA-RFZYENFJSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
68942,6lxt,DB08517,-7.7,"(2S)-5-hydroxy-2-(4-hydroxyphenyl)-7-methoxy-2,3-dihydro-4H-chromen-4-one",DJOJDHGQRNZXQQ-AWEZNQCLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
14833,6lzg,T3D4788,-7.7,Simvastatin,RYMZZMVNJRMUDD-HGQWONQESA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
93024,6m71,DB06117,-7.7,"1alpha,24S-Dihydroxyvitamin D2",ODZFJAXAEXQSKL-WRJREGAQSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
89655,6m71,DB00741,-7.7,Hydrocortisone,JYGXADMDTFJGBT-VWUMJDOOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
34172,6cs2,T3D1035,-7.7,Deltamethrin,OWZREIFADZCYQD-NSHGMRRFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
75927,6m2n,DB06436,-7.7,Semaxanib,WUWDLXZGHZSWQZ-WQLSENKSSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
149883,6wiq,DB00700,-7.7,Eplerenone,JUKPWJGBANNWMW-VWBFHTRKSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
160374,7bv1,DB08307,-7.7,"2-{HYDROXY[2-NITRO-4-(TRIFLUOROMETHYL)PHENYL]METHYLENE}CYCLOHEXANE-1,3-DIONE",PMHVFNYNPNKNRO-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
166421,7bv1,DB15099,-7.7,GW-468816,XDKRVNKVAKCFGW-WXWBBQJKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
85759,6m3m,DB08030,-7.7,3-[(4'-cyanobiphenyl-4-yl)oxy]-N-hydroxypropanamide,XZWFHJUEAVOHHG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
149882,6wiq,DB00699,-7.7,Nicergoline,YSEXMKHXIOCEJA-FVFQAYNVSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
79950,6m2n,DB14028,-7.7,Nordazepam,AKPLHCDWDRPJGD-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
159629,7bv1,DB04957,-7.7,Azimilide,MREBEPTUUMTTIA-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
85693,6m3m,DB07958,-7.7,(2-CARBAMOYLMETHYL-5-PROPYL-OCTAHYDRO-INDOL-7-YL)ACETIC ACID,OMLOGGCSARAIGZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
159635,7bv1,DB04975,-7.7,Banoxantrone,YZBAXVICWUUHGG-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
73479,6m2n,DB02089,-7.7,CP-526423,MWWXABBBAPKJDX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
32024,6cs2,DB15221,-7.7,PF-06260414,ZKAVFOXYJCREBQ-SNVBAGLBSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
159709,7bv1,DB05421,-7.7,CP-122721,ZIWFCOIGUNPHPM-HKUYNNGSSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
84935,6m3m,DB07073,-7.7,"5,5-dimethyl-2-morpholin-4-yl-5,6-dihydro-1,3-benzothiazol-7(4H)-one",DZXMARZBAUMWLK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
75459,6m2n,DB04729,-7.7,Gentamicin C1a,VEGXETMJINRLTH-BOZYPMBZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
85677,6m3m,DB07938,-7.7,"5-[[(2R)-2-cyclopropyl-7,8-dimethoxy-chroman-5-yl]methyl]pyrimidine-2,4-diamine",HWJPWWYTGBZDEG-CQSZACIVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
89604,6m71,DB00683,-7.7,Midazolam,DDLIGBOFAVUZHB-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
66744,6lxt,DB04590,-7.7,(2R)-({4-[AMINO(IMINO)METHYL]PHENYL}AMINO){5-ETHOXY-2-FLUORO-3-[(3R)-TETRAHYDROFURAN-3-YLOXY]PHENYL}ACETICACID,PGYOHIAQCFZQDK-AUUYWEPGSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
29762,6cs2,DB00881,-7.7,Quinapril,JSDRRTOADPPCHY-HSQYWUDLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
164125,7bv1,DB07286,-7.7,BMS-564929,KEJORAMIZFOODM-PWSUYJOCSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
164093,7bv1,DB07251,-7.7,"N'-(3-CHLORO-4-METHOXY-PHENYL)-N-(3,4,5-TRIMETHOXYPHENYL)-1,3,5-TRIAZINE-2,4-DIAMINE",ZVWFECUPYCFYBL-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
36705,1r42,DB03276,-7.7,"4-[(10s,14s,18s)-18-(2-Amino-2-Oxoethyl)-14-(1-Naphthylmethyl)-8,17,20-Trioxo-7,16,19-Triazaspiro[5.14]Icos-11-En-10-Yl]Benzylphosphonic Acid",RHYFMOCFCFUTNH-GZNVFMSSSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
160421,7bv1,DB08365,-7.7,"8-bromo-4-(2-chlorophenyl)-N-(2-hydroxyethyl)-6-methyl-1,3-dioxo-1,2,3,6-tetrahydropyrrolo[3,4-e]indole-7-carboxamide",XUAHLMVOYLUYSB-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
155790,6wiq,DB11737,-7.7,Icotinib,QQLKULDARVNMAL-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
71183,6lxt,DB13755,-7.7,Iocarmic acid,SMQYOVYWPWASGU-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
160417,7bv1,DB08360,-7.7,"2-(4-ETHYLPIPERAZIN-1-YL)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE",BIFHJPUTQBOBGJ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
71611,6lxt,DB14898,-7.7,Retagliptin,WIIAMRXFUJLYEF-SNVBAGLBSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
159727,7bv1,DB05498,-7.7,KW-7158,NAFSYPCVPLWHFY-HNNXBMFYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93250,6m71,DB06680,-7.7,Asoprisnil,GJMNAFGEUJBOCE-MEQIQULJSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
79919,6m2n,DB13957,-7.7,J147,HYMZAYGFKNNHDN-SSDVNMTOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
155137,6wiq,DB08709,-7.7,"2,3-diphenyl-1H-indole-7-carboxylic acid",OLUDUXWVPIEHDA-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
84913,6m3m,DB07048,-7.7,"N-[(2R)-5-(aminosulfonyl)-2,3-dihydro-1H-inden-2-yl]-2-propylpentanamide",XBYJCVDSFWJBSM-OAHLLOKOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85806,6m3m,DB08084,-7.7,IDD594,JCZUIWYXULSXSW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84942,6m3m,DB07082,-7.7,"1,1,1,3,3,3-HEXAFLUORO-2-{4-[(2,2,2-TRIFLUOROETHYL)AMINO]PHENYL}PROPAN-2-OL",VHDRSZOHKKZOQF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
155725,6wiq,DB11637,-7.7,Delamanid,XDAOLTSRNUSPPH-XMMPIXPASA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
155734,6wiq,DB11651,-7.7,Dactolisib,JOGKUKXHTYWRGZ-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
85749,6m3m,DB08019,-7.7,"N-{(3R,4S)-4-[(6-amino-4-methylpyridin-2-yl)methyl]pyrrolidin-3-yl}-N'-(3-chlorobenzyl)ethane-1,2-diamine",VWCMAGONQJHIJZ-LPHOPBHVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
166430,7bv1,DB15117,-7.7,Transfluthrin,DDVNRFNDOPPVQJ-HQJQHLMTSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
89624,6m71,DB00705,-7.7,Delavirdine,WHBIGIKBNXZKFE-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
73701,6m2n,DB02382,-7.7,Namn,JOUIQRNQJGXQDC-ZYUZMQFOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
29744,6cs2,DB11519,-7.7,Fluprostenol,WWSWYXNVCBLWNZ-QIZQQNKQSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
85002,6m3m,DB07149,-7.7,"(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluoroethyl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one",LCBAQTCTQXHTJG-ZETCQYMHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
159659,7bv1,DB05104,-7.7,Asimadoline,JHLHNYVMZCADTC-LOSJGSFVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
71568,6lxt,DB14799,-7.7,PF-06821497,RXCVUHMIWHRLDF-HXUWFJFHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
30106,6cs2,DB12059,-7.7,JNJ-40411813,HYOGJHCDLQSAHX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
159669,7bv1,DB05154,-7.7,Pretomanid,ZLHZLMOSPGACSZ-NSHDSACASA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
164111,7bv1,DB07271,-7.7,"4-[(3R)-3-Amino-4-(2,4,5-trifluorophenyl)butanoyl]-3-(2,2,2-trifluoroethyl)-1,4-diazepan-2-one",RMDAPSXWBVPVOG-IAPIXIRKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
149797,6wiq,DB00596,-7.7,Ulobetasol,LEHFPXVYPMWYQD-XHIJKXOTSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
84992,6m3m,DB07139,-7.7,3-[5-(3-nitrophenyl)thiophen-2-yl]propanoic acid,IHKCOKRMJRDWAL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
71147,6lxt,DB13708,-7.7,Fenquizone,DBDTUXMDTSTPQZ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
159680,7bv1,DB05252,-7.7,Fenoxaprop-ethyl,PQKBPHSEKWERTG-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
84977,6m3m,DB07122,-7.7,1-[4-(2-oxo-2-phenylethyl)phenyl]guanidine,MERNPSIIBFTCAI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85004,6m3m,DB07153,-7.7,"6-methyl-5-[3-methyl-3-(3,4,5-trimethoxyphenyl)but-1-yn-1-yl]pyrimidine-2,4-diamine",FJNFXXGWYVMQNA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
93343,6m71,DB06834,-7.7,"N-(2-hydroxy-1,1-dimethylethyl)-1-methyl-3-(1H-pyrrolo[2,3-b]pyridin-2-yl)-1H-indole-5-carboxamide",XZRYCTLOGNCQDG-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
89619,6m71,DB00699,-7.7,Nicergoline,YSEXMKHXIOCEJA-FVFQAYNVSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
159706,7bv1,DB05412,-7.7,Talmapimod,ZMELOYOKMZBMRB-DLBZAZTESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
32018,6cs2,DB15208,-7.7,NOP-1A,MZBCQWLYUQJXKA-KRWDZBQOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
160368,7bv1,DB08301,-7.7,N-({[4-(AMINOSULFONYL)PHENYL]AMINO}CARBONYL)-4-METHYLBENZENESULFONAMIDE,HDCXQTPVTAIPNZ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
73474,6m2n,DB02082,-7.7,Phosphoaminophosphonic Acid Guanylate Ester,UQABYHGXWYXDTK-UUOKFMHZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
32285,6cs2,DB01268,-7.7,Sunitinib,WINHZLLDWRZWRT-ATVHPVEESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
19014,6cs2,HMDB0042261,-7.7,"TG(14:0/24:0/22:2(13Z,16Z))",NDJUOSGUPZFLID-PUAIEPDKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
29735,6cs2,DB11491,-7.7,Sarafloxacin,XBHBWNFJWIASRO-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
84958,6m3m,DB07102,-7.7,(2S)-2-amino-5-oxo-5-[(4-phenylmethoxyphenyl)amino]pentanoic acid,BYSBXIPCDJNEBG-INIZCTEOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
69003,6lxt,DB08590,-7.7,1-(3-HYDROXYPROPYL)-2-[(3-NITROBENZOYL)AMINO]-1H-BENZIMIDAZOL-5-YL PIVALATE,CEAYRKIZESVQSN-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
85698,6m3m,DB07964,-7.7,"(3S)-4-{[4-(BUT-2-YNYLOXY)PHENYL]SULFONYL}-N-HYDROXY-2,2-DIMETHYLTHIOMORPHOLINE-3-CARBOXAMIDE",CVZIHNYAZLXRRS-HNNXBMFYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
29058,6cs2,DB08701,-7.7,"2-(3-BROMOPHENYL)-6-[(2-HYDROXYETHYL)AMINO]-1H-BENZO[DE]ISOQUINOLINE-1,3(2H)-DIONE",JZCUVYNOSDWORZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
85700,6m3m,DB07966,-7.7,[4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]quinazolin-2-yl}amino)phenyl]acetonitrile,NVMCVWOODOWOLT-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
16900,6cs2,HMDB0005030,-7.7,Fexofenadine,RWTNPBWLLIMQHL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
159691,7bv1,DB05294,-7.7,Vandetanib,UHTHHESEBZOYNR-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
75908,6m2n,DB06374,-7.7,Elacestrant,SIFNOOUKXBRGGB-AREMUKBSSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
160371,7bv1,DB08304,-7.7,"(3R)-3-cyclopentyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2-benzothiazine 1,1-dioxide",QZBQVXXESPXFPZ-QGZVFWFLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
89547,6m71,DB00611,-7.7,Butorphanol,IFKLAQQSCNILHL-PWRODBHTSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93382,6m71,DB06883,-7.7,1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-phenylurea,DHNYNLNKNQJSHF-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
85829,6m3m,DB08110,-7.7,"(1R,4S,7AS)-1-(1-FORMYLPROP-1-EN-1-YL)-4-METHOXY-2,4,5,6,7,7A-HEXAHYDRO-1H-ISOINDOLE-3-CARBOXYLIC ACID",ZYKSDPVHVMSKIL-IIHMJNQGSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
73718,6m2n,DB02402,-7.7,"5-(4-Methoxyphenoxy)-2,4-Quinazolinediamine",CPZJZAIZIMCJRC-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80797,6m3m,DB00442,-7.7,Entecavir,QDGZDCVAUDNJFG-FXQIFTODSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
93190,6m71,DB06533,-7.7,Ragaglitazar,WMUIIGVAWPWQAW-XMMPIXPASA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
29086,6cs2,DB08726,-7.7,"5-(7-(4-(4,5-dihydro-2-oxazolyl)phenoxy)heptyl)-3-methyl isoxazole",FKLJPTJMIBLJAV-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
159480,7bv1,DB04471,-7.7,"2-Phenyl-1-[4-(2-Piperidin-1-Yl-Ethoxy)-Phenyl]-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol",FMWVCTJKLAVRPB-MUUNZHRXSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
90050,6m71,DB01195,-7.7,Flecainide,DJBNUMBKLMJRSA-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
29088,6cs2,DB08728,-7.7,"5-(3-(2,6-dichloro-4-(4,5-dihydro-2-oxazolyl)phenoxy)propyl)-3-methyl isoxazole",TUGBWRGTMLOFAX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
90047,6m71,DB01192,-7.7,Oxymorphone,UQCNKQCJZOAFTQ-ISWURRPUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
85096,6m3m,DB07260,-7.7,N-benzyl-4-[(2R)-pyrrolidin-2-ylmethoxy]aniline,HITMFLNAOQIZSN-QGZVFWFLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
73716,6m2n,DB02400,-7.7,"5-Methoxy-1,2-Dimethyl-3-(4-Nitrophenoxymethyl)Indole-4,7-Dione",IBLWSLZYYZHSRG-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
28958,6cs2,DB08588,-7.7,2-({2-[(3R)-3-AMINOPIPERIDIN-1-YL]-4-OXOQUINAZOLIN-3(4H)-YL}METHYL)BENZONITRILE,OYNURZXTLNNKAP-QGZVFWFLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
84814,6m3m,DB06929,-7.7,1-butanoyl-N-(4-carbamimidoylbenzyl)-L-prolinamide,RYAZZWWVNUWKNB-AWEZNQCLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
93205,6m71,DB06582,-7.7,Dextofisopam,RUJBDQSFYCKFAA-HNNXBMFYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
76046,6m2n,DB06708,-7.7,Lumefantrine,DYLGFOYVTXJFJP-MYYYXRDXSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
30034,6cs2,DB11962,-7.7,GSK-1059615,QDITZBLZQQZVEE-YBEGLDIGSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
68796,6lxt,DB08341,-7.7,"4-{[4-{[(1R,2R)-2-(dimethylamino)cyclopentyl]amino}-5-(trifluoromethyl)pyrimidin-2-yl]amino}-N-methylbenzenesulfonamide",CAUFYHKGKDJMQG-HZPDHXFCSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
14472,6lzg,T3D4235,-7.7,Aplysiatoxin,RHJPBGWFGOAEID-BEDNPZBZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
68709,6lxt,DB08230,-7.7,"5,7-DIHYDROXY-2-(3,4,5-TRIHYDROXYPHENYL)-4H-CHROMEN-4-ONE",ARSRJFRKVXALTF-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
84717,6m3m,DB06814,-7.7,Protokylol,LUMAEVHDZXIGEP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
89928,6m71,DB01058,-7.7,Praziquantel,FSVJFNAIGNNGKK-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93175,6m71,DB06497,-7.7,Aplaviroc,GWNOTCOIYUNTQP-FQLXRVMXSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
30201,6cs2,DB00924,-7.7,Cyclobenzaprine,JURKNVYFZMSNLP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
76096,6m2n,DB06794,-7.7,Lodoxamide,RVGLGHVJXCETIO-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
28702,6cs2,DB08308,-7.7,"SUCCINIC ACID MONO-(13-METHYL-3-OXO-2,3,6,7,8,9,10,11,12,13,14,15,16,17-TETRADECAHYDRO-1H-CYCLOPENTA[A]PHENANTHREN-17-YL) ESTER",IRQUJNVGEAJGSD-KIEDKLRZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
89651,6m71,DB00737,-7.7,Meclizine,OCJYIGYOJCODJL-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
79860,6m2n,DB13841,-7.7,Clopenthixol,WFPIAZLQTJBIFN-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
71018,6lxt,DB13533,-7.7,Methylestrenolone,ZXSWTMLNIIZPET-ZOFHRBRSSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
159448,7bv1,DB04429,-7.7,4'-Hydroxyflavanone,ZLHVIYHWWQYJID-HNNXBMFYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
155273,6wiq,DB08881,-7.7,Vemurafenib,GPXBXXGIAQBQNI-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
80001,6m2n,DB14127,-7.7,Sacubitrilat,DOBNVUFHFMVMDB-BEFAXECRSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
84726,6m3m,DB06827,-7.7,Viomycin,GXFAIFRPOKBQRV-GHXCTMGLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
155818,6wiq,DB11778,-7.7,Danusertib,XKFTZKGMDDZMJI-HSZRJFAPSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
29089,6cs2,DB08729,-7.7,"5-ethoxy-4-(1-methyl-7-oxo-3-propyl-6,7-dihydro-1H-pyrazolo[4,3-d]pyrimidin-5-yl)thiophene-2-sulfonamide",FENWRHVHBZQJGW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
66788,6lxt,DB04645,-7.7,"5-{3-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-2-METHYL-PHENOXY}-PENTANOIC ACID",NJJIFGCFUDDBSP-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
80668,6m3m,DB00283,-7.7,Clemastine,YNNUSGIPVFPVBX-NHCUHLMSSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
93419,6m71,DB06923,-7.7,2-(3-METHYLPHENYL)-1H-INDOLE-5-CARBOXIMIDAMIDE,KJUSXMYSVXZFDJ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
159543,7bv1,DB04552,-7.7,Niflumic acid,JZFPYUNJRRFVQU-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
29078,6cs2,DB08719,-7.7,"5-(5-(6-CHLORO-4-(4,5-DIHYDRO-2-OXAZOLYL)PHENOXY)PENTYL)-3-METHYL ISOXAZOLE",FCSKOFQQCWLGMV-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
71532,6lxt,DB14720,-7.7,Brovanexine,DQTRREPKGJIABH-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
30140,6cs2,DB12106,-7.7,PF-06305591,APWZIFIAVVFPNT-PELKAZGASA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
69023,6lxt,DB08613,-7.7,"2,2,2-TRIFLUORO-1-{5-[(3-PHENYL-5,6-DIHYDROIMIDAZO[1,2-A]PYRAZIN-7(8H)-YL)CARBONYL]THIOPHEN-2-YL}ETHANE-1,1-DIOL",OFBFUNBBOQCNFX-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
166401,7bv1,DB14822,-7.7,SB-649868,ZJXIUGNEAIHSBI-IBGZPJMESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
166458,7bv1,DB15170,-7.7,Evobrutinib,QUIWHXQETADMGN-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
159561,7bv1,DB04573,-7.7,Estriol,PROQIPRRNZUXQM-ZXXIGWHRSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
155116,6wiq,DB08683,-7.7,"REL-(9R,12S)-9,10,11,12-TETRAHYDRO-9,12-EPOXY-1H-DIINDOLO[1,2,3-FG:3',2',1'-KL]PYRROLO[3,4-I][1,6]BENZODIAZOCINE-1,3(2H)-DIONE",OTPNDVKVEAIXTI-IYBDPMFKSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
85071,6m3m,DB07232,-7.7,Veliparib,JNAHVYVRKWKWKQ-CYBMUJFWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
90021,6m71,DB01165,-7.7,Ofloxacin,GSDSWSVVBLHKDQ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
79913,6m2n,DB13951,-7.7,Stanolone acetate,ILCTUFVQFCIIDS-NGFSFWIMSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
90019,6m71,DB01162,-7.7,Terazosin,VCKUSRYTPJJLNI-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
155724,6wiq,DB11636,-7.7,Nomegestrol,KZUIYQJTUIACIG-YBZCJVABSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
85051,6m3m,DB07206,-7.7,6-[2-(1H-INDOL-6-YL)ETHYL]PYRIDIN-2-AMINE,OSHSZKRWKLQZBV-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
66761,6lxt,DB04610,-7.7,"7,8-dihydro-6-hydroxymethyl-7-methyl-7-[2-phenylethyl]-pterin",XMFJTCGUDFSWSW-INIZCTEOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
75845,6m2n,DB06211,-7.7,Doripenem,AVAACINZEOAHHE-VFZPANTDSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
68983,6lxt,DB08564,-7.7,(2E)-N-{4-[(3-bromophenyl)amino]quinazolin-6-yl}-4-(dimethylamino)but-2-enamide,ZCIXBBSRVLSRJQ-QPJJXVBHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
29721,6cs2,DB11466,-7.7,Tepoxalin,XYKWNRUXCOIMFZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
34209,6cs2,T3D1128,-7.7,Manganese chloride,OTNYCNDIGKWKTO-RCXJYNBZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
34653,1r42,DB00621,-7.7,Oxandrolone,QSLJIVKCVHQPLV-PEMPUTJUSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
68721,6lxt,DB08244,-7.7,"(1S)-1-CYCLOPROPYL-2-[(2S)-4-(2,5-DIFLUOROPHENYL)-2-PHENYL-2,5-DIHYDRO-1H-PYRROL-1-YL]-2-OXOETHANAMINE",VCOUEHUEFUDZIS-PMACEKPBSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
76032,6m2n,DB06685,-7.7,Laquinimod,GKWPCEFFIHSJOE-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80788,6m3m,DB00432,-7.7,Trifluridine,VSQQQLOSPVPRAZ-RRKCRQDMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
36742,1r42,DB03325,-7.7,Tyrosyladenylate,MJZAZMKENKZBAJ-QTOWJTHWSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
1294,6lzg,HMDB0010335,-7.7,Estriol-3-glucuronide,UZKIAJMSMKLBQE-WTSDUJKYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
34779,1r42,DB00773,-7.7,Etoposide,VJJPUSNTGOMMGY-MRVIYFEKSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
71634,6lxt,DB14941,-7.7,BMS-817399,GTDPZONCGOCXOD-JPYJTQIMSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
85632,6m3m,DB07883,-7.7,(2-AMINO-3-PHENYL-BICYCLO[2.2.1]HEPT-2-YL)-PHENYL-METHANONE,XJQDTOANLAPEIM-JRBPQWBISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
71059,6lxt,DB13591,-7.7,Metopimazine,BQDBKDMTIJBJLA-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
80785,6m3m,DB00427,-7.7,Triprolidine,CBEQULMOCCWAQT-WOJGMQOQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
75405,6m2n,DB04652,-7.7,Corticosterone,OMFXVFTZEKFJBZ-HJTSIMOOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
1300,6lzg,HMDB0010348,-7.7,Dehydroepiandrosterone 3-glucuronide,GLONBVCUAVPJFV-PCDHEYSGSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
79909,6m2n,DB13946,-7.7,Testosterone undecanoate,UDSFVOAUHKGBEK-CNQKSJKFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
154840,6wiq,DB08349,-7.7,"N-cyclopropyl-3-{[1-(2,4-difluorophenyl)-7-methyl-6-oxo-6,7-dihydro-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}-4-methylbenzamide",WMEYCLAVMZKZCS-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
160147,7bv1,DB07567,-7.7,"(2R,3R,4S)-3-(4-HYDROXYPHENYL)-4-METHYL-2-[4-(2-PYRROLIDIN-1-YLETHOXY)PHENYL]CHROMAN-6-OL",XPVKGTWRXBSJKO-LHXLBICKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
85556,6m3m,DB07798,-7.7,"(3R)-3-(FLUOROMETHYL)-N-(3,3,3-TRIFLUOROPROPYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONAMIDE",BBUDQLKRZPRPFD-LLVKDONJSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
79924,6m2n,DB13967,-7.7,Patent Blue,DHAHKSQXIXFZJB-UHFFFAOYSA-O,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
160070,7bv1,DB07477,-7.7,Felbinac,QRZAKQDHEVVFRX-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
92876,6m71,DB05212,-7.7,HE3286,JJKOQZHWYLMASZ-FJWDNACWSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
67003,6lxt,DB04971,-7.7,Reglitazar,QBQLYIISSRXYKL-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
89377,6m71,DB00404,-7.7,Alprazolam,VREFGVBLTWBCJP-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
76407,6m2n,DB07169,-7.7,"5R-(3,4-DICHLOROPHENYLMETHYL)-3-(2-THIOPHENESULFONYLAMINO)-4-OXO-2-THIONOTHIAZOLIDINE",GAOOBYJHWAKZKU-LLVKDONJSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
166119,7bv1,DB13714,-7.7,Xibornol,RNRHMQWZFJXKLZ-JCKWVBRZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
66542,6lxt,DB04315,-7.7,Guanosine-5'-Diphosphate,QGWNDRXFNXRZMB-UUOKFMHZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
17089,6cs2,HMDB0006221,-7.7,13-cis Retinol,FPIPGXGPPPQFEQ-HWCYFHEPSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
28978,6cs2,DB08608,-7.7,"4-({(2R,5S)-2,5-DIMETHYL-4-[(2R)-3,3,3-TRIFLUORO-2-HYDROXY-2-METHYLPROPANOYL]PIPERAZIN-1-YL}CARBONYL)BENZONITRILE",IWFSHKKFDSWNLZ-BWACUDIHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
160872,7bv1,DB11845,-7.7,Lucitanib,CUDVHEFYRIWYQD-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
89370,6m71,DB00396,-7.7,Progesterone,RJKFOVLPORLFTN-LEKSSAKUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
164238,7bv1,DB07415,-7.7,4-[(1S)-1-(3-fluoro-4-methoxyphenyl)-2-(2-methoxy-5-nitrophenyl)ethyl]-1H-imidazol-2-amine,RFLOFHKRBGKCOB-AWEZNQCLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160946,7bv1,DB12303,-7.7,Motolimod,QSPOQCXMGPDIHI-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
163770,7bv1,DB06246,-7.7,Exisulind,MVGSNCBCUWPVDA-MFOYZWKCSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
149252,6w9q,DB15238,-7.7,Olinciguat,YWQFJNWMWZMXRW-HXUWFJFHSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
166591,7bv1,DB15440,-7.7,GSK-3117391,AFDPFLDWOXXHQM-NRFANRHFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
159000,7bv1,DB03010,-7.7,Patupilone,QXRSDHAAWVKZLJ-PVYNADRNSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
166542,7bv1,DB15334,-7.7,Biochanin A,WUADCCWRTIWANL-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
84423,6m3m,DB06150,-7.7,Sulfadimethoxine,ZZORFUFYDOWNEF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
76430,6m2n,DB07195,-7.7,"4-[(1S,2S,5S)-5-(HYDROXYMETHYL)-6,8,9-TRIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL",DTZWKYVREFMAJA-QXWBOSQLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
155985,6wiq,DB12044,-7.7,MK-0893,DNTVJEMGHBIUMW-IBGZPJMESA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
160054,7bv1,DB07456,-7.7,"3-(1H-indol-3-yl)-4-(1-{2-[(2S)-1-methylpyrrolidinyl]ethyl}-1H-indol-3-yl)-1H-pyrrole-2,5-dione",LBFDERUQORUFIN-QGZVFWFLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
68605,6lxt,DB08108,-7.7,N-({6-[(4-CYANOBENZYL)OXY]NAPHTHALEN-2-YL}SULFONYL)-D-GLUTAMIC ACID,PUHRQSFXADUGJW-OAQYLSRUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
80284,6m2n,DB15056,-7.7,Bifenthrin,OMFRMAHOUUJSGP-IRHGGOMRSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79690,6m2n,DB13616,-7.7,Melagatran,DKWNMCUOEDMMIN-PKOBYXMFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
68918,6lxt,DB08490,-7.7,CTS-1027,ROSNVSQTEGHUKU-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
68919,6lxt,DB08491,-7.7,N-HYDROXY-2-[4-(4-PHENOXY-BENZENESULFONYL)-TETRAHYDRO-PYRAN-4-YL]-ACETAMIDE,ARIRIZBKMKMEBD-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
29001,6cs2,DB08635,-7.7,N-(TRANS-4'-NITRO-4-STILBENYL)-N-METHYL-5-AMINO-PENTANOIC ACID,QLLZAVDYYAQESE-AATRIKPKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
32491,6cs2,T3D1849,-7.7,Tau-fluvalinate,INISTDXBRIBGOC-XMMISQBUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
75153,6m2n,DB04315,-7.7,Guanosine-5'-Diphosphate,QGWNDRXFNXRZMB-UUOKFMHZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
159991,7bv1,DB07163,-7.7,5-[(2-AMINOETHYL)AMINO]-6-FLUORO-3-(1H-PYRROL-2-YL)BENZO[CD]INDOL-2(1H)-ONE,CQCXWWWNUFQYJS-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
80243,6m2n,DB14938,-7.7,Flurbiprofen axetil,ALIVXCSEERJYHU-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76521,6m2n,DB07300,-7.7,"2-(1H-imidazol-1-yl)-9-methoxy-8-(2-methoxyethoxy)benzo[c][2,7]naphthyridin-4-amine",QSSGYSRUMIOURP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79718,6m2n,DB13656,-7.7,Eberconazole,MPTJIDOGFUQSQH-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79713,6m2n,DB13649,-7.7,Proquazone,JTIGKVIOEQASGT-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
71888,6lxt,DB03453,-7.7,Methyl (2S)-2-[[2-[(3R)-1-carbamimidoylpiperidin-3-yl]acetyl]amino]-3-[4-(2-phenylethynyl)phenyl]propanoate,MRNGXYMKYHNMLV-PKTZIBPZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
154924,6wiq,DB08450,-7.7,N-1H-indazol-5-yl-2-(6-methylpyridin-2-yl)quinazolin-4-amine,HNHRWNUXTCATSG-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
160866,7bv1,DB11833,-7.7,Basimglurant,UPZWINBEAHDTLA-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
71884,6lxt,DB02639,-7.7,4-methylumbelliferyl alpha-D-glucoside,YUDPTGPSBJVHCN-JZYAIQKZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
160867,7bv1,DB11836,-7.7,Sapanisertib,GYLDXIAOMVERTK-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
85480,6m3m,DB07712,-7.7,3-ETHYL-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL,XBMVVMYGKMGLJX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
29152,6cs2,DB08791,-7.7,"1-[(2-NITROPHENYL)SULFONYL]-1H-PYRROLO[3,2-B]PYRIDINE-6-CARBOXAMIDE",USLOIFPDNUDIEG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
93639,6m71,DB07180,-7.7,"5-[(Z)-(5-Chloro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-N,2,4-trimethyl-1H-pyrrole-3-carboxamide",FIRPCWHHIWFKCD-GHXNOFRVSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
159008,7bv1,DB03022,-7.7,"3-{2,6,8-trioxo-9-[(2R,3S,4R)-2,3,4,5-tetrahydroxypentyl]-1,2,3,6,8,9-hexahydro-7H-purin-7-Yl}propyl dihydrogen phosphate",KPHFGOGGKPGLTM-BHNWBGBOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
71302,6lxt,DB13951,-7.7,Stanolone acetate,ILCTUFVQFCIIDS-NGFSFWIMSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
80388,6m2n,DB15261,-7.7,Butafenacil,JEDYYFXHPAIBGR-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
84323,6m3m,DB05518,-7.7,Managlinat dialanetil,BYKBUQDQTLDNLE-KBPBESRZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81029,6m3m,DB00722,-7.7,Lisinopril,RLAWWYSOJDYHDC-BZSNNMDCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
68922,6lxt,DB08494,-7.7,"S-{2-[(2-chloro-4-sulfamoylphenyl)amino]-2-oxoethyl} 6-methyl-3,4-dihydroquinoline-1(2H)-carbothioate",AWAKIULNKVOBKE-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
80314,6m2n,DB15114,-7.7,Vamorolone,ZYTXTXAMMDTYDQ-DGEXFFLYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
85355,6m3m,DB07560,-7.7,N-[(1S)-2-methyl-1-(pyridin-4-ylcarbamoyl)propyl]cyclohexanecarboxamide,VYLDPSVXLWTIAJ-HNNXBMFYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
164477,7bv1,DB08052,-7.7,"1-cyclopentyl-3-(1H-pyrrolo[2,3-b]pyridin-5-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine",NVRXTLZYXZNATH-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
163886,7bv1,DB06814,-7.7,Protokylol,LUMAEVHDZXIGEP-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
80952,6m3m,DB00631,-7.7,Clofarabine,WDDPHFBMKLOVOX-AYQXTPAHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
76378,6m2n,DB07134,-7.7,"5-(4-CHLORO-5-PHENYL-3-THIENYL)-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDE",LCPRWBWCEGWNKF-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
166549,7bv1,DB15346,-7.7,GLPG-1205,IRBAWVGZNJIROV-SFHVURJKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
76444,6m2n,DB07211,-7.7,(2R)-2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}PROPENE-1-SULFONAMIDE,YMJHMJLNQLVUAV-GHYUOPHCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
67043,6lxt,DB05212,-7.7,HE3286,JJKOQZHWYLMASZ-FJWDNACWSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
163828,7bv1,DB06412,-7.7,Oxymetholone,ICMWWNHDUZJFDW-DHODBPELSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
29164,6cs2,DB08803,-7.7,Tymazoline,QRORCRWSRPKEHR-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
160034,7bv1,DB07212,-7.7,N-(7-CARBAMIMIDOYL-NAPHTHALEN-1-YL)-3-HYDROXY-2-METHYL-BENZAMIDE,NNGZRCYXFBHMRM-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
69208,6lxt,DB08834,-7.7,Tauroursodeoxycholic acid,BHTRKEVKTKCXOH-LBSADWJPSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
149273,6w9q,DB15287,-7.7,Elismetrep,CWEFDWIKLABKBX-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
68609,6lxt,DB08112,-7.7,N-({6-[(4-CYANO-2-FLUOROBENZYL)OXY]NAPHTHALEN-2-YL}SULFONYL)-D-GLUTAMIC ACID,IRJUSGUHNFMVCK-OAQYLSRUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
76499,6m2n,DB07277,-7.7,2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}ETHANESULFONAMIDE,IAUZEBLXCOCAFL-JSGCOSHPSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
89314,6m71,DB00327,-7.7,Hydromorphone,WVLOADHCBXTIJK-YNHQPCIGSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
71848,6lxt,DB15406,-7.7,GLPG-0974,MPMKMQHJHDHPBE-RUZDIDTESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
29854,6cs2,DB11726,-7.7,Encenicline,SSRDSYXGYPJKRR-ZDUSSCGKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
89787,6m71,DB00897,-7.7,Triazolam,JOFWLTCLBGQGBO-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160914,7bv1,DB12264,-7.7,Atevirdine,UCPOMLWZWRTIAA-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
35002,1r42,DB01029,-7.7,Irbesartan,YOSHYTLCDANDAN-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
71849,6lxt,DB15407,-7.7,Acalisib,DOCINCLJNAXZQF-LBPRGKRZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
17040,6cs2,HMDB0005810,-7.7,Eriodictyol,SBHXYTNGIZCORC-ZDUSSCGKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
160923,7bv1,DB12275,-7.7,Seviteronel,ZBRAJOQFSNYJMF-SFHVURJKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
73838,6m2n,DB02550,-7.7,"8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-2-Fluoro-9-Pent-4-Ylnyl-9h-Purin-6-Ylamine",KCIOVTSUEXGUFJ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
163796,7bv1,DB06306,-7.7,Onalespib,IFRGXKKQHBVPCQ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160917,7bv1,DB12268,-7.7,Carmegliptin,GUYMHFIHHOEFOA-ZCPGHIKRSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
159965,7bv1,DB07132,-7.7,1-{2-OXO-3-[(1R)-1-(1H-PYRROL-2-YL)ETHYL]-2H-INDOL-5-YL}UREA,KJDBLWKTHMHALD-QMMMGPOBSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
92894,6m71,DB05295,-7.7,Eldecalcitol,FZEXGDDBXLBRTD-AYIMTCTASA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
85445,6m3m,DB07670,-7.7,4-METHYL-N-METHYL-N-(2-PHENYL-2H-PYRAZOL-3-YL)BENZENESULFONAMIDE,KRHPBWNETCEFGS-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84375,6m3m,DB05824,-7.7,CNS-5161,JHVHEDNLONERHY-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
166575,7bv1,DB15407,-7.7,Acalisib,DOCINCLJNAXZQF-LBPRGKRZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
89785,6m71,DB00894,-7.7,Testolactone,BPEWUONYVDABNZ-DZBHQSCQSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
70793,6lxt,DB13230,-7.7,Gestonorone,GTFUITFQDGVJSK-XGXHKTLJSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
149277,6w9q,DB15292,-7.7,Foliglurax,ZTEDNASHAWNBKQ-NCELDCMTSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
76502,6m2n,DB07280,-7.7,5-[4-(DIMETHYLAMINO)PHENYL]-6-[(6-MORPHOLIN-4-YLPYRIDIN-3-YL)ETHYNYL]PYRIMIDIN-4-AMINE,AINVOEOJEKKMKB-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80959,6m3m,DB00640,-7.7,Adenosine,OIRDTQYFTABQOQ-KQYNXXCUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
17671,6cs2,HMDB0000036,-7.7,Taurocholic acid,WBWWGRHZICKQGZ-HZAMXZRMSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
75564,6m2n,DB04866,-7.7,Halofuginone,LVASCWIMLIKXLA-CABCVRRESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
155392,6wiq,DB09053,-7.7,Ibrutinib,XYFPWWZEPKGCCK-GOSISDBHSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
73622,6m2n,DB02277,-7.7,1-(5-Tert-Butyl-2-Methyl-2h-Pyrazol-3-Yl)-3-(4-Chloro-Phenyl)-Urea,FWIJKWMXNHRSRO-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
34465,1r42,DB00276,-7.7,Amsacrine,XCPGHVQEEXUHNC-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
85465,6m3m,DB07694,-7.7,"2,5-dichloro-N-(3,5-dibromo-4-hydroxyphenyl)benzamide",IFLWCZRMFPKYBN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
158971,7bv1,DB02703,-7.7,Fusidic acid,IECPWNUMDGFDKC-MZJAQBGESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
79644,6m2n,DB13552,-7.7,Trifluperidol,GPMXUUPHFNMNDH-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
159946,7bv1,DB07113,-7.7,"(2S)-6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2-(3,5-DIFLUOROPHENYL)-4-(3-METHOXYPROPYL)-2H-1,4-BENZOXAZIN-3(4H)-ONE",KHZQOXQOUCGGGA-NRFANRHFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
70902,6lxt,DB13371,-7.7,Difenpiramide,PWHROYKAGRUWDQ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
164216,7bv1,DB07390,-7.7,"2-[3-(5-MERCAPTO-[1,3,4]THIADIAZOL-2-YL)-UREIDO]-N-METHYL-3-PHENYL-PROPIONAMIDE",RKWXKADYTDWZIJ-VIFPVBQESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
80264,6m2n,DB15021,-7.7,Leriglitazone,OXVFDZYQLGRLCD-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
84408,6m3m,DB06083,-7.7,Tapinarof,ZISJNXNHJRQYJO-CMDGGOBGSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
68847,6lxt,DB08402,-7.7,"2-[(2,4-DICHLOROBENZOYL)AMINO]-5-(PYRIMIDIN-2-YLOXY)BENZOIC ACID",VNDRRWBKNSHALL-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
164226,7bv1,DB07401,-7.7,METHYL (2Z)-2-(2-{[6-(2-CYANOPHENOXY)PYRIMIDIN-4-YL]OXY}PHENYL)-3-METHOXYACRYLATE,WFDXOXNFNRHQEC-GHRIWEEISA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
85457,6m3m,DB07684,-7.7,5-(DIMETHYLAMINO)-2-NAPHTHALENESULFONIC ACID,VENHBDIMAAXWKI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
163838,7bv1,DB06440,-7.7,Ravuconazole,OPAHEYNNJWPQPX-RCDICMHDSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
73612,6m2n,DB02266,-7.7,Flufenamic Acid,LPEPZBJOKDYZAD-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
163784,7bv1,DB06268,-7.7,Sitaxentan,PHWXUGHIIBDVKD-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
163837,7bv1,DB06436,-7.7,Semaxanib,WUWDLXZGHZSWQZ-WQLSENKSSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
81001,6m3m,DB00692,-7.7,Phentolamine,MRBDMNSDAVCSSF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85334,6m3m,DB07535,-7.7,2-amino-6-[2-(1H-indol-6-yl)ethyl]pyrimidin-4(3H)-one,VRAZIAJSKFRSIP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
90205,6m71,DB01452,-7.7,Diamorphine,GVGLGOZIDCSQPN-PVHGPHFFSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
89756,6m71,DB00860,-7.7,Prednisolone,OIGNJSKKLXVSLS-VWUMJDOOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
85487,6m3m,DB07719,-7.7,"[(3R)-3-(Methylcarbamoyl)-2-{[(2-methyl-2-propanyl)oxy]carbonyl}-1,2,3,4-tetrahydro-7-isoquinolinyl]sulfamic acid",PPSSYXOFPICMQD-CYBMUJFWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81032,6m3m,DB00726,-7.7,Trimipramine,ZSCDBOWYZJWBIY-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
31868,6cs2,DB14906,-7.7,Adafosbuvir,NIJYGVDQZBBONK-SEUXLIJBSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
17637,6cs2,HMDB0000335,-7.7,16a-Hydrox1trone,WPOCIZJTELRQMF-QFXBJFAPSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
16603,6cs2,HMDB0003114,-7.7,Neurosporene,ATCICVFRSJQYDV-XILUKMICSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
23380,6cs2,HMDB0061738,-7.7,Perfluorodecanoic acid,PCIUEQPBYFRTEM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
159175,7bv1,DB03523,-7.7,Brequinar,PHEZJEYUWHETKO-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
76539,6m2n,DB07318,-7.7,"N-[2-(4-AMINO-5,8-DIFLUORO-1,2-DIHYDROQUINAZOLIN-2-YL)ETHYL]-3-FURAMIDE",BOAUWUUBSXECNL-LLVKDONJSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
71366,6lxt,DB14075,-7.7,Imidurea,ZCTXEAQXZGPWFG-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
160985,7bv1,DB12361,-7.7,Piclozotan,URMTUEWUIGOJBW-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
164288,7bv1,DB07654,-7.7,"(5,6-DIPHENYL-FURO[2,3-D]PYRIMIDIN-4-YLAMINO)-ACETIC",VDJWWYRYKMXMKA-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
29622,6cs2,DB11259,-7.7,Diosmetin,MBNGWHIJMBWFHU-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
75239,6m2n,DB04441,-7.7,2-Fluoroadenosine,HBUBKKRHXORPQB-UUOKFMHZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
89739,6m71,DB00842,-7.7,Oxazepam,ADIMAYPTOBDMTL-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
89272,6m71,DB00276,-7.7,Amsacrine,XCPGHVQEEXUHNC-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160139,7bv1,DB07557,-7.7,"(5BETA)-PREGNANE-3,20-DIONE",XMRPGKVKISIQBV-XWOJZHJZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
80886,6m3m,DB00552,-7.7,Pentostatin,FPVKHBSQESCIEP-JQCXWYLXSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
73603,6m2n,DB02255,-7.7,GM6001,NITYDPDXAAFEIT-DYVFJYSZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
84306,6m3m,DB05444,-7.7,Iroxanadine,QWVRTSZDKPRPDF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
159143,7bv1,DB03480,-7.7,Brequinar Analog,WYKKHJQZENLZID-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
17758,6cs2,HMDB0010338,-7.7,11-Oxo-androsterone glucuronide,QTXWOOLAHRQMGZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
86197,6m3m,DB08555,-7.7,"1-(3-bromophenyl)-7-chloro-6-methoxy-3,4-dihydroisoquinoline",IKGXHBGCVQTQBH-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
154955,6wiq,DB08489,-7.7,"N4-HYDROXY-2-ISOBUTYL-N1-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.013,18]NONADECA-12(19),13,15,17-TETRAEN-10-YL)-SUCCINAMIDE",GCBPAPVOMPJQHK-NQIIRXRSSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
163736,7bv1,DB06176,-7.7,Romidepsin,OHRURASPPZQGQM-GCCNXGTGSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
84449,6m3m,DB06200,-7.7,Tedisamil,CTIRHWCPXYGDGF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
93646,6m71,DB07187,-7.7,6-[(5-CHLORO-3-METHYL-1-BENZOFURAN-2-YL)SULFONYL]PYRIDAZIN-3(2H)-ONE,FXFPQPNUMWQRAO-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
70863,6lxt,DB13327,-7.7,Picotamide,KYWCWBXGRWWINE-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
163739,7bv1,DB06185,-7.7,Forodesine,IWKXDMQDITUYRK-KUBHLMPHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
79606,6m2n,DB13501,-7.7,Bendazac,BYFMCKSPFYVMOU-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76537,6m2n,DB07316,-7.7,"N-{1-[(1-carbamoylcyclopropyl)methyl]piperidin-4-yl}-N-cyclopropyl-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide",FAVXIEFZKPJZRT-NRFANRHFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
166158,7bv1,DB13767,-7.7,Vorozole,XLMPPFTZALNBFS-INIZCTEOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
71363,6lxt,DB14069,-7.7,ONT-093,RSJCLODJSVZNQA-BQYQJAHWSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
86173,6m3m,DB08528,-7.7,"2-AMINO-6-(3,5-DIMETHYLPHENYL)SULFONYLBENZONITRILE",SWGDXLAZBZDUBR-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
151144,6wiq,DB02329,-7.7,Carbenoxolone,OBZHEBDUNPOCJG-WBXJDKIVSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
73601,6m2n,DB02253,-7.7,"(1r)-4-[(1e,3e,5e,7z,9e,11z,13e,15e)-17-Hydroxy-3,7,12,16-Tetramethylheptadeca-1,3,5,7,9,11,13,15-Octaen-1-Yl]-3,5,5-Trimethylcyclohex-3-En-1-Ol",FNAJVVMDXCOSFY-VFGOXHQXSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
166027,7bv1,DB13593,-7.7,Zolimidine,VSLIUWLPFRVCDL-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
86336,6m3m,DB08725,-7.7,"(S)-5-(7-(4-(4-Ethyl-4,5-dihydro-2-oxazolyl)phenoxy)heptyl)-3-methylisoxazole",PZDSRPCFNWOUFP-IBGZPJMESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
76544,6m2n,DB07324,-7.7,"3-({2-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)ETHYNYL]BENZYL}AMINO)-1,3-OXAZOL-2(3H)-ONE",ZUJWSOPIDUWELP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
160144,7bv1,DB07563,-7.7,"1-{7-cyclohexyl-6-[4-(4-methylpiperazin-1-yl)benzyl]-7H-pyrrolo[2,3-d]pyrimidin-2-yl}methanamine",GCJSOJRPNOWSEH-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
17168,6cs2,HMDB0006840,-7.7,"4,4-Dimethyl-5a-cholesta-8-en-3b-ol",FYHRVINOXYETMN-HFPXORMNSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
161004,7bv1,DB12389,-7.7,Zamicastat,ZSSLCFLHEFXANG-GOSISDBHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
154841,6wiq,DB08350,-7.7,"5-[3-(2-METHOXYPHENYL)-1H-PYRROLO[2,3-B]PYRIDIN-5-YL]-N,N-DIMETHYLPYRIDINE-3-CARBOXAMIDE",GYQRHHQPEMOLKH-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
66934,6lxt,DB04841,-7.7,Flunarizine,SMANXXCATUTDDT-QPJJXVBHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
159204,7bv1,DB03575,-7.7,Phencyclidine,JTJMJGYZQZDUJJ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
159202,7bv1,DB03572,-7.7,FR230513,URGFTPMACWKJKU-OAHLLOKOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
75598,6m2n,DB04930,-7.7,Permethrin,RLLPVAHGXHCWKJ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
132,6lzg,HMDB0003033,-7.7,Canrenone,UJVLDDZCTMKXJK-WNHSNXHDSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
149237,6w9q,DB15209,-7.7,MK-0736,ORQZQBUNAMJFCY-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
68644,6lxt,DB08150,-7.7,"4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-aminium",RZIDZIGAXXNODG-UHFFFAOYSA-O,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
159886,7bv1,DB07042,-7.7,"7-amino-2-tert-butyl-4-{[2-(1H-imidazol-4-yl)ethyl]amino}pyrido[2,3-d]pyrimidine-6-carboxamide",XESUNWBIAADLPI-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
163941,7bv1,DB06884,-7.7,4-HYDROXY-N'-(4-ISOPROPYLBENZYL)BENZOHYDRAZIDE,MFDXHRPPSJRQFX-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93549,6m71,DB07078,-7.7,"(3Z)-6-(4-HYDROXY-3-METHOXYPHENYL)-3-(1H-PYRROL-2-YLMETHYLENE)-1,3-DIHYDRO-2H-INDOL-2-ONE",AYSXURJZVXBSRV-WJDWOHSUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
34501,1r42,DB00319,-7.7,Piperacillin,IVBHGBMCVLDMKU-GXNBUGAJSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
93551,6m71,DB07080,-7.7,"N-(2,2,2-TRIFLUOROETHYL)-N-{4-[2,2,2-TRIFLUORO-1-HYDROXY-1-(TRIFLUOROMETHYL)ETHYL]PHENYL}BENZENESULFONAMIDE",SGIWFELWJPNFDH-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
76346,6m2n,DB07101,-7.7,PD-0325901,SUDAHWBOROXANE-SECBINFHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
81078,6m3m,DB00784,-7.7,Mefenamic acid,HYYBABOKPJLUIN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
155583,6wiq,DB11275,-7.7,Epicriptine,SBFXHXZNBNFPHV-PXXBSISHSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
29967,6cs2,DB11873,-7.7,Verinurad,YYBOLPLTQDKXPM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
160805,7bv1,DB11750,-7.7,Clobetasol,FCSHDIVRCWTZOX-DVTGEIKXSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
67090,6lxt,DB05465,-7.7,Tandutinib,UXXQOJXBIDBUAC-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
67083,6lxt,DB05442,-7.7,Etiprednol dicloacetate,QAIOVDNCIZSSSF-RFAJLIJZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
155933,6wiq,DB11963,-7.7,Dacomitinib,LVXJQMNHJWSHET-AATRIKPKSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
707,6lzg,HMDB0006840,-7.7,"4,4-Dimethyl-5a-cholesta-8-en-3b-ol",FYHRVINOXYETMN-HFPXORMNSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
85266,6m3m,DB07454,-7.7,(R)-3-BROMO-2-HYDROXY-2-METHYL-N-[4-NITRO-3-(TRIFLUOROMETHYL)PHENYL]PROPANAMIDE,QDSWNDMHSBZXKX-JTQLQIEISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
92995,6m71,DB05884,-7.7,HCV-086,VBRUONUESYTIDA-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
81056,6m3m,DB00756,-7.7,Hexachlorophene,ACGUYXCXAPNIKK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
75631,6m2n,DB05053,-7.7,MB-07803,CTKZZUXRWBCFEI-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
160088,7bv1,DB07498,-7.7,"4-[3-(3-NITROPHENYL)-1,2,4-OXADIAZOL-5-YL]BUTANOIC ACID",LQQYZJRCWBRIMW-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
84441,6m3m,DB06187,-7.7,Valtorcitabine,VFCYZPOEGWLYRM-QCZKYFFMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
32106,6cs2,DB15360,-7.7,"Carfentanil, C-11",YDSDEBIZUNNPOB-JVVVGQRLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
155938,6wiq,DB11968,-7.7,MK-7145,OCKGFTQIICXDQW-ZEQRLZLVSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
73554,6m2n,DB02191,-7.7,"(7as,12ar,12bs)-1,2,3,4,7a,12,12a,12b-Octahydroindolo[2,3-a]Quinolizin-7(6h)-One",PGKUSHWBQJPFOP-LBPRGKRZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
89442,6m71,DB00482,-7.7,Celecoxib,RZEKVGVHFLEQIL-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
159909,7bv1,DB07067,-7.7,"(2S,3S)-3-{3-[4-(METHYLSULFONYL)PHENYL]-1,2,4-OXADIAZOL-5-YL}-1-OXO-1-PYRROLIDIN-1-YLBUTAN-2-AMINE",SQCDMTZMCHZYGO-FZMZJTMJSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
36627,1r42,DB03181,-7.7,"2-[4-(4-Hydroxy-3-Isopropyl-Phenoxy)-3,5-Dimethyl-Phenyl]-2h-[1,2,4]Triazine-3,5-Dione",RXQAVKWRCZYGMV-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
89880,6m71,DB01003,-7.7,Cromoglicic acid,IMZMKUWMOSJXDT-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
86334,6m3m,DB08723,-7.7,"5-(5-(2,6-DICHLORO-4-(4,5-DIHYDRO-2-OXAZOLY)PHENOXY)PENTYL)-3-METHYL ISOXAZOLE",JJDHAOLOHQTGMG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
75630,6m2n,DB05048,-7.7,Cannabinor,GSTZHANFXAKPSE-MXTREEOPSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
150578,6wiq,DB01573,-7.7,Benzylmorphine,RDJGWRFTDZZXSM-RNWLQCGYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
79746,6m2n,DB13686,-7.7,Clometocillin,JKXQBIZCQJLVOS-GSNLGQFWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
66977,6lxt,DB04903,-7.7,Pagoclone,HIUPRQPBWVEQJJ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
75711,6m2n,DB05514,-7.7,Cobiprostone,SDDSJMXGJNWMJY-BRHAQHMBSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
156045,6wiq,DB12128,-7.7,Ulimorelin,WGYPAJVJMXQXTR-ABNZCKJZSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
23299,6cs2,HMDB0060019,-7.7,Sinapinic acid-O-glucuronide isomer,YAIVMBWMHPRYKU-VKAIBYOUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
159926,7bv1,DB07088,-7.7,(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclopentyloxy)ethanoyl)pyrrolidine-2-carboxamide,ZWXWAYUCJVQHOR-KRWDZBQOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
73800,6m2n,DB02504,-7.7,[3-(1-Benzyl-3-Carbamoylmethyl-2-Methyl-1h-Indol-5-Yloxy)-Propyl-]-Phosphonic Acid,AQEYCNKFBRLUOT-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
160112,7bv1,DB07527,-7.7,"N-[(2R,3S)-3-AMINO-2-HYDROXY-4-PHENYLBUTYL]-4-METHOXY-2,3,6-TRIMETHYLBENZENESULFONAMIDE",HORGTFOBJRCVMO-ZWKOTPCHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
75230,6m2n,DB04429,-7.7,4'-Hydroxyflavanone,ZLHVIYHWWQYJID-HNNXBMFYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76376,6m2n,DB07132,-7.7,1-{2-OXO-3-[(1R)-1-(1H-PYRROL-2-YL)ETHYL]-2H-INDOL-5-YL}UREA,KJDBLWKTHMHALD-QMMMGPOBSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
81071,6m3m,DB00775,-7.7,Tirofiban,COKMIXFXJJXBQG-NRFANRHFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
75649,6m2n,DB05154,-7.7,Pretomanid,ZLHZLMOSPGACSZ-NSHDSACASA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
34417,1r42,DB00223,-7.7,Diflorasone,WXURHACBFYSXBI-XHIJKXOTSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
73362,6m2n,DB01938,-7.7,L-Histidine Beta Naphthylamide,DKDILZBBFKZMRO-OAHLLOKOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
101188,6vxs,DB04590,-7.6,(2R)-({4-[AMINO(IMINO)METHYL]PHENYL}AMINO){5-ETHOXY-2-FLUORO-3-[(3R)-TETRAHYDROFURAN-3-YLOXY]PHENYL}ACETICACID,PGYOHIAQCFZQDK-AUUYWEPGSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
61780,6crv,DB12577,-7.6,Fosbretabulin,WDOGQTQEKVLZIJ-WAYWQWQTSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
7452,6lzg,DB00450,-7.6,Droperidol,RMEDXOLNCUSCGS-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
142041,6w9q,DB01669,-7.6,Virginiamycin M1,DAIKHDNSXMZDCU-FQTGFAPKSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
33048,6cs2,T3D3999,-7.6,Perfluorodecanoic acid,PCIUEQPBYFRTEM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
72746,6m2n,DB01102,-7.6,Arbutamine,IIRWWTKISYTTBL-SFHVURJKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
126103,6w4h,DB03365,-7.6,"4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline",BNDYIYYKEIXHNK-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
24203,6cs2,DB01889,-7.6,"16,17-Androstene-3-Ol",KRVXMNNRSSQZJP-PHFHYRSDSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
138084,6w9c,DB09151,-7.6,Flutemetamol (18F),VVECGOCJFKTUAX-HUYCHCPVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
69662,6lxt,DB11427,-7.6,Maropitant,OMPCVMLFFSQFIX-CONSDPRKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
126090,6w4h,DB03348,-7.6,Huperzine B,YYWGABLTRMRUIT-HWWQOWPSSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
157265,6wiq,DB15068,-7.6,Agerafenib,DKNUPRMJNUQNHR-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
32253,6cs2,DB01228,-7.6,Encainide,PJWPNDMDCLXCOM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
123806,6w4h,DB00402,-7.6,Eszopiclone,GBBSUAFBMRNDJC-INIZCTEOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
24781,6cs2,DB02573,-7.6,"2'-Deoxycytidine-2'-Deoxyadenosine-3',5'-Monophosphate",LYWWDKIADIGKTH-IDMWBNCISA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
105923,6vxs,DB14636,-7.6,Triciribine phosphate,URLYINUFLXOMHP-HTVVRFAVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
141589,6w9q,DB01067,-7.6,Glipizide,ZJJXGWJIGJFDTL-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
101215,6vxs,DB04624,-7.6,DERIVATIVE OF AKLANONIC ACID METHYL ESTER (AAME),SIHNJMGWRHPFAZ-XHDPSFHLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
164109,7bv1,DB07269,-7.6,(2S)-2-[3-(AMINOMETHYL)PHENYL]-3-[(R)-[(1R)-1-{[(BENZYLOXY)CARBONYL]AMINO}-2-METHYLPROPYL](HYDROXY)PHOSPHORYL]PROPANOIC ACID,SFUOOKBZBVUDBC-VQTJNVASSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
27263,6cs2,DB06771,-7.6,Besifloxacin,QFFGVLORLPOAEC-SNVBAGLBSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
69646,6lxt,DB11395,-7.6,Deracoxib,WAZQAZKAZLXFMK-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
88192,6m3m,DB13465,-7.6,Ciclobendazole,OXLKOMYHDYVIDM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
155733,6wiq,DB11650,-7.6,HT-0712,ABEJDMOBAFLQNJ-NHCUHLMSSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
156882,6wiq,DB13814,-7.6,Talampicillin,SOROUYSPFADXSN-SUWVAFIASA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
131515,6w4h,DB13844,-7.6,Pipenzolate,WPUKUEMZZRVAKZ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
123374,6w4b,DB15418,-7.6,AZD-9977,MBKYLPOPYYLTNW-ZDUSSCGKSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
89637,6m71,DB00719,-7.6,Azatadine,SEBMTIQKRHYNIT-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
105822,6vxs,DB14097,-7.6,13-cis-12-(3'-Carboxyphenyl)retinoic acid,XKKDQOHDTASHCE-PAZAWXFKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
141464,6w9q,DB00922,-7.6,Levosimendan,WHXMKTBCFHIYNQ-SECBINFHSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
69638,6lxt,DB11385,-7.6,Cefalonium,FMZXNVLFJHCSAF-DNVCBOLYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
138005,6w9c,DB09008,-7.6,Cefaloridine,CZTQZXZIADLWOZ-CRAIPNDOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
162979,7bv1,DB03369,-7.6,9-Aminophenanthrene,KIHQWOBUUIPWAN-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
99167,6vxs,DB01889,-7.6,"16,17-Androstene-3-Ol",KRVXMNNRSSQZJP-PHFHYRSDSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
3367,6lzg,HMDB0046333,-7.6,TG(22:0/18:0/14:1(9Z)),VPROCYYUGRMDKB-IXHOOSMISA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
68993,6lxt,DB08577,-7.6,3-[(3-(2-CARBOXYETHYL)-4-METHYLPYRROL-2-YL)METHYLENE]-2-INDOLINONE,JNDVEAXZWJIOKB-JYRVWZFOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
61800,6crv,DB12614,-7.6,Reparixin,KQDRVXQXKZXMHP-LLVKDONJSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61798,6crv,DB12608,-7.6,Emixustat,WJIGGYYSZBWCGC-MRXNPFEDSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
33049,6cs2,T3D4001,-7.6,Perfluorononanoic acid,UZUFPBIDKMEQEQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
164128,7bv1,DB07289,-7.6,5-[3-(BENZYLAMINO)PHENYL]-4-BROMO-3-(CARBOXYMETHOXY)THIOPHENE-2-CARBOXYLIC ACID,XEQPGVUGYAUMSA-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
101229,6vxs,DB04642,-7.6,"7-{2,6-DICHLORO-4-[3-(2-CHLORO-BENZOYL)-UREIDO]-PHENOXY}-HEPTANOIC ACID",XQTOWNDCHQJXOQ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
99558,6vxs,DB02410,-7.6,"2-Acetyl-3-[(4-Amino-2-Methyl-5-Pyrimidinyl)Methyl]-4-Methyl-5-(4,6,6-Trihydroxy-3,5-Dioxa-4,6-Diphosphahex-1-Yl)Thiazolium Inner Salt P,P'-Dioxide",GYRGKLZCJRVYRV-UHFFFAOYSA-O,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
164126,7bv1,DB07287,-7.6,"2-(2,4-DICHLOROPHENOXY)-5-(PYRIDIN-2-YLMETHYL)PHENOL",AOVDSWPGWPRTSR-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
28818,6cs2,DB08439,-7.6,Parecoxib,TZRHLKRLEZJVIJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
105893,6vxs,DB14544,-7.6,Hydrocortisone valerate,FZCHYNWYXKICIO-FZNHGJLXSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
11512,6lzg,DB12070,-7.6,Letermovir,FWYSMLBETOMXAG-QHCPKHFHSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
123389,6w4b,DB15448,-7.6,Acumapimod,VGUSQKZDZHAAEE-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
123844,6w4h,DB00448,-7.6,Lansoprazole,MJIHNNLFOKEZEW-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
123385,6w4b,DB15444,-7.6,Elexacaftor,MVRHVFSOIWFBTE-INIZCTEOSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
88232,6m3m,DB13523,-7.6,Veralipride,RYJXBGGBZJGVQF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
69844,6lxt,DB11784,-7.6,NRX-1074,DVBUEXCIEIAXPM-PJUQSVSOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
99600,6vxs,DB02463,-7.6,2-(2-Hydroxy-Phenyl)-1h-Indole-5-Carboxamidine,JPGNPKIYCTXJPG-UHFFFAOYSA-O,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
105872,6vxs,DB14214,-7.6,Rose bengal lactone,IICCLYANAQEHCI-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
163033,7bv1,DB03451,-7.6,"1-alpha, 25-dihydroxyl-20-epi-22-oxa-24, 26 ,27-trihomovitamin D3",KLZOTDOJMRMLDX-YBBVPDDNSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
87872,6m3m,DB12986,-7.6,VS-5584,QYBGBLQCOOISAR-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
138095,6w9c,DB09177,-7.6,p-Fluorofentanyl,KXUBAVLIJFTASZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
80664,6m3m,DB00279,-7.6,Liothyronine,AUYYCJSJGJYCDS-LBPRGKRZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
27266,6cs2,DB06777,-7.6,Chenodeoxycholic acid,RUDATBOHQWOJDD-BSWAIDMHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
105920,6vxs,DB14633,-7.6,Prednisolone hemisuccinate,APGDTXUMTIZLCJ-CGVGKPPMSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
89800,6m71,DB00910,-7.6,Paricalcitol,BPKAHTKRCLCHEA-UBFJEZKGSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
123817,6w4h,DB00417,-7.6,Phenoxymethylpenicillin,BPLBGHOLXOTWMN-MBNYWOFBSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
138715,6w9c,DB12161,-7.6,Deutetrabenazine,MKJIEFSOBYUXJB-WEZHFFAMSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
141527,6w9q,DB00998,-7.6,Frovatriptan,XPSQPHWEGNHMSK-SECBINFHSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
73469,6m2n,DB02077,-7.6,L-N(omega)-Nitroarginine-(4R)-Amino-L-Proline Amide,IUFRDGFKAVLPFZ-CSMHCCOUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
125937,6w4h,DB03154,-7.6,{[7-(Difluoro-Phosphono-Methyl)-Naphthalen-2-Yl]-Difluoro-Methyl}-Phosphonic Acid,VHKBLEYUHBIBNR-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
57191,6crv,DB03315,-7.6,Guanosine 3'-monophosphate,ZDPUTNZENXVHJC-UUOKFMHZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
24659,6cs2,DB02432,-7.6,RU90395,RLLAUERCSKPFGD-VMPREFPWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
88243,6m3m,DB13538,-7.6,Guacetisal,HSJFYRYGGKLQBT-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
126001,6w4h,DB03234,-7.6,"(4'-{[Allyl(Methyl)Amino]Methyl}-1,1'-Biphenyl-4-Yl)(4-Bromophenyl)Methanone",YATCZCSDJCQNAL-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
164230,7bv1,DB07405,-7.6,"1-(6-CYANO-3-PYRIDYLCARBONYL)-5',8'-DIFLUOROSPIRO[PIPERIDINE-4,2'(1'H)-QUINAZOLINE]-4'-AMINE",GIZYIOOBBUHOBS-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
82286,6m3m,DB02350,-7.6,"N-Hydroxy-4-[(4-Methoxylphenyl)Sulfonyl]-2,2-Dimethyl-Hexahydro-1,4-Thiazepine-3(S)-Carboxamide",CYYCSKFJEOSZTF-CYBMUJFWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
106169,6vxs,DB15156,-7.6,ABT-072,XMZSTQYSBYEENY-RMKNXTFCSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
157252,6wiq,DB15046,-7.6,LY-2881835,FHRWHNJJQGSCQC-LJAQVGFWSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
123857,6w4h,DB00465,-7.6,Ketorolac,OZWKMVRBQXNZKK-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
162690,7bv1,DB02799,-7.6,N-[2-(1-Maleimidyl)Ethyl]-7-Diethylaminocoumarin-3-Carboxamide,OJBZDUMTXGGVSP-KTKRTIGZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
141842,6w9q,DB01434,-7.6,19-norandrostenedione,JRIZOGLBRPZBLQ-QXUSFIETSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
27703,6cs2,DB07258,-7.6,(R)-pyridin-4-yl[4-(2-pyrrolidin-1-ylethoxy)phenyl]methanol,QQRJWLDQBNAQCC-GOSISDBHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
61651,6crv,DB12391,-7.6,Sagopilone,BFZKMNSQCNVFGM-UCEYFQQTSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106065,6vxs,DB14917,-7.6,Ceralasertib,DTTJKLNXNZAVSM-JYCIKRDWSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
89708,6m71,DB00808,-7.6,Indapamide,NDDAHWYSQHTHNT-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
81995,6m3m,DB01961,-7.6,Cytidine 3'-monophosphate,UOOOPKANIPLQPU-XVFCMESISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
141784,6w9q,DB01336,-7.6,Metocurine,JFXBEKISTKFVAB-AJQTZOPKSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
106057,6vxs,DB14900,-7.6,ISO-1 F-18,QVRVXSZKCXFBTE-KPVNRNJOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
18473,6cs2,HMDB0030021,-7.6,Fucosterol,OSELKOCHBMDKEJ-ZMRGBFEOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
105984,6vxs,DB14736,-7.6,Cannabivarin,SVTKBAIRFMXQQF-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
82194,6m3m,DB02230,-7.6,Immucillin-G,KBIDJCVAURJXFG-PVEDRDFWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
126320,6w4h,DB03682,-7.6,"Dibenzofuran-4,6-Dicarboxylic Acid",HBBGSNOHAGNQRQ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
89741,6m71,DB00844,-7.6,Nalbuphine,NETZHAKZCGBWSS-CEDHKZHLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
138255,6w9c,DB11157,-7.6,Anthralin,NUZWLKWWNNJHPT-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
162785,7bv1,DB02918,-7.6,Zardaverine,HJMQDJPMQIHLPB-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
57291,6crv,DB03458,-7.6,"N(4)-Adenosyl-N(4)-methyl-2,4-diaminobutanoic acid",JISVTSUBJCPLSV-TWBCTODHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
82058,6m3m,DB02047,-7.6,"2-(1,1'-Biphenyl-4-Yl)Propanoic Acid",JALUUBQFLPUJMY-NSHDSACASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
123659,6w4h,DB00229,-7.6,Cefotiam,QYQDKDWGWDOFFU-IUODEOHRSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
157125,6wiq,DB14637,-7.6,Fluprednisolone acetate,CYMBAKFTWRNHPS-APRQOCPKSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
81993,6m3m,DB01959,-7.6,"3,5-Dimethyl-1-(3-Nitrophenyl)-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester",MSYGAHOHLUJIKV-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
68953,6lxt,DB08530,-7.6,"7-BENZYL-1,3-DIMETHYL-8-PIPERAZIN-1-YL-3,7-DIHYDRO-PURINE-2,6-DIONE",QFSMMXJBEBXTJP-UHFFFAOYSA-O,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
32209,6cs2,DB01182,-7.6,Propafenone,JWHAUXFOSRPERK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
99279,6vxs,DB02046,-7.6,N-[(Furan-2-Yl)Carbonyl]-(S)-Leucyl-(R)-[1-Amino-2(1h-Indol-3-Yl)Ethyl]-Phosphonic Acid,WHPKSASOSKNDPY-PKOBYXMFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
13182,6lzg,DB14856,-7.6,PF-05089771,ZYSCOUXLBXGGIM-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
138191,6w9c,DB09305,-7.6,Aptazapine,MNHDDERDSNZCCK-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
101338,6vxs,DB04794,-7.6,Bifonazole,OCAPBUJLXMYKEJ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101421,6vxs,DB04903,-7.6,Pagoclone,HIUPRQPBWVEQJJ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
138500,6w9c,DB11757,-7.6,Istradefylline,IQVRBWUUXZMOPW-PKNBQFBNSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138193,6w9c,DB09313,-7.6,Ioxaglic acid,TYYBFXNZMFNZJT-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
61650,6crv,DB12390,-7.6,MBX-8025,JWHYSEDOYMYMNM-QGZVFWFLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
11569,6lzg,DB12141,-7.6,Gilteritinib,GYQYAJJFPNQOOW-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
81985,6m3m,DB01951,-7.6,Gpi-1046,OQAHHWOPVDDWHD-INIZCTEOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
164160,7bv1,DB07323,-7.6,"2-[({2-[(1Z)-3-(DIMETHYLAMINO)PROP-1-ENYL]-4-FLUOROPHENYL}SULFONYL)AMINO]-5,6,7,8-TETRAHYDRONAPHTHALENE-1-CARBOXYLIC ACID",CTZLIARLNXSXGL-ALCCZGGFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
138488,6w9c,DB11739,-7.6,Vonoprazan,BFDBKMOZYNOTPK-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
126586,6w4h,DB04024,-7.6,N'-L-Seryl-3'-Amino-(3'-Deoxy)-Adenosine,ITDKSTILAWHDJI-AYEBZEFBSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
69727,6lxt,DB11582,-7.6,Thiocolchicoside,LEQAKWQJCITZNK-AXHKHJLKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
138477,6w9c,DB11721,-7.6,Mitoglitazone,IRNJSRAGRIZIHD-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
62708,6crv,DB13989,-7.6,Epitizide,RINBGYCKMGDWPY-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
73552,6m2n,DB02189,-7.6,"2',3'-Dideoxyadenosine-5'-Triphosphate",OAKPWEUQDVLTCN-NKWVEPMBSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
99617,6vxs,DB02485,-7.6,Cytidine-5'-Monophosphate-5-N-Acetylneuraminic Acid,TXCIAUNLDRJGJZ-BILDWYJOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
35936,1r42,DB02269,-7.6,[4-({[5-Benzyloxy-1-(3-Carbamimidoyl-Benzyl)-1h-Indole-2-Carbonyl]-Amino}-Methyl)-Phenyl]-Trimethyl-Ammonium,UFKJQTGPBFWMGT-UHFFFAOYSA-O,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
73540,6m2n,DB02170,-7.6,"1,8-Di-Hydroxy-4-Nitro-Xanthen-9-One",ZOHCDJRFYXKEQW-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
99380,6vxs,DB02181,-7.6,2'-Deoxyguanosine-5'-Triphosphate,HAAZLUGHYHWQIW-KVQBGUIXSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
123617,6w4h,DB00178,-7.6,Ramipril,HDACQVRGBOVJII-JBDAPHQKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
24144,6cs2,DB01820,-7.6,"Compound 12, N-Acetyl-4-[(Carboxycarbonyl)(2-Carboxyphenyl)Amino]-N-Pentyl-1-Napthylalaniamide",UESXELNYBIOROE-QHCPKHFHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
106003,6vxs,DB14775,-7.6,Cavosonstat,BXSZILNGNMDGSL-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
164188,7bv1,DB07354,-7.6,"2,3-DIMETHOXY-12H-[1,3]DIOXOLO[5,6]INDENO[1,2-C]ISOQUINOLIN-6-IUM",LXDREMZQGAILJU-UHFFFAOYSA-O,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
101404,6vxs,DB04876,-7.6,Vildagliptin,SYOKIDBDQMKNDQ-XWTIBIIYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
157150,6wiq,DB14664,-7.6,Difluocortolone pivalate,UWGRWFCLGQWKPR-GSTUPEFVSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
57341,6crv,DB03526,-7.6,AL5927,LRRAIRJIZOLGPR-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
162795,7bv1,DB02930,-7.6,Adenosine 5'-[gamma-thio]triphosphate,NLTUCYMLOPLUHL-KQYNXXCUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
107406,6vxx,DB03263,-7.6,Thiocellobiose,VDQIIPZYLPYPNM-QRZGKKJRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106013,6vxs,DB14801,-7.6,Lanifibranor,OQDQIFQRNZIEEJ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
99370,6vxs,DB02166,-7.6,Propidium,ZDWVWKDAWBGPDN-UHFFFAOYSA-O,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
82130,6m3m,DB02139,-7.6,(2e)-N-Allyl-4-{[3-(4-Bromophenyl)-5-Fluoro-1-Methyl-1h-Indazol-6-Yl]Oxy}-N-Methyl-2-Buten-1-Amine,YDWPQZUWZDRRSE-AATRIKPKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
99344,6vxs,DB02128,-7.6,[1-(3-Hydroxy-2-Oxo-1-Phenethyl-Propylcarbamoyl)2-Phenyl-Ethyl]-Carbamic Acid Pyridin-4-Ylmethyl Ester,QCUBCTPTNWPFBC-ZEQRLZLVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
157128,6wiq,DB14640,-7.6,Isoflupredone acetate,ZOCUOMKMBMEYQV-GSLJADNHSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
138274,6w9c,DB11260,-7.6,Diacetyl benzoyl lathyrol,JPYYWXPAHJBKJX-VWSFRBHVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
99322,6vxs,DB02101,-7.6,"(S,R)-fidarestat",WAAPEIZFCHNLKK-QPUJVOFHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
138402,6w9c,DB11584,-7.6,Pipradrol,XSWHNYGMWWVAIE-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
101354,6vxs,DB04816,-7.6,Dantron,QBPFLULOKWLNNW-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
138396,6w9c,DB11560,-7.6,Lesinurad,FGQFOYHRJSUHMR-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
126397,6w4h,DB03777,-7.6,Rbt205 Inhibitor,QMGUOJYZJKLOLH-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
32182,6cs2,DB01155,-7.6,Gemifloxacin,ZRCVYEYHRGVLOC-HYARGMPZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
32193,6cs2,DB01166,-7.6,Cilostazol,RRGUKTPIGVIEKM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
106032,6vxs,DB14856,-7.6,PF-05089771,ZYSCOUXLBXGGIM-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
62743,6crv,DB14061,-7.6,Hycanthone,MFZWMTSUNYWVBU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87993,6m3m,DB13203,-7.6,Bamifylline,VVUYEFBRTFASAH-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
57323,6crv,DB03503,-7.6,"4-Acetyl-4-Guanidino-6-Methyl(Propyl)Carboxamide-4,5-Dihydro-2h-Pyran-2-Carboxylic Acid",QPJWMZVTNXFTKV-JMJZKYOTSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57329,6crv,DB03509,-7.6,2-(4-Chlorophenyl)-5-Quinoxalinecarboxamide,FLYGLPYJEQPCFY-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
24133,6cs2,DB01809,-7.6,"1-Ter-Butyl-3-P-Tolyl-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine",ZVPDNRVYHLRXLX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
155582,6wiq,DB11274,-7.6,Dihydro-alpha-ergocryptine,PBUNVLRHZGSROC-VTIMJTGVSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
68932,6lxt,DB08504,-7.6,"6-(4-{(1S,2S)-2-AMINO-1-[(DIMETHYLAMINO)CARBONYL]-3-[(3S)-3-FLUOROPYRROLIDIN-1-YL]-3-OXOPROPYL}PHENYL)-1H-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-4-IUM",ZNHVIJAGMFQGMS-IHPCNDPISA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
126450,6w4h,DB03844,-7.6,"N-(2,6-Diflouro-Benzyl)-4-Sulfamoyl-Benzamide",ZFNCKGXGCCDDFN-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
107412,6vxx,DB03273,-7.6,3'-Oxo-Adenosine,MIAZJCOESMXYNJ-XMRAEQSQSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138689,6w9c,DB12123,-7.6,Cinepazide,RCUDFXMNPQNBDU-VOTSOKGWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
126592,6w4h,DB04037,-7.6,"N,N-Bis(4-Chlorobenzyl)-1h-1,2,3,4-Tetraazol-5-Amine",UOUXILZUBDIWQU-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
11566,6lzg,DB12138,-7.6,PF-03715455,VGEXRDWWPSGZDH-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
106122,6vxs,DB15063,-7.6,Inarigivir soproxil,CJCYTUJOSMYXLE-JDLSZIHUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
142024,6w9q,DB01644,-7.6,"3,6-dihydroxy-xanthene-9-propionic acid",PFQGLFBMMPZYEU-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
101459,6vxs,DB05035,-7.6,Eprotirome,VPCSYAVXDAUHLT-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
105941,6vxs,DB14655,-7.6,Drostanolone propionate,NOTIQUSPUUHHEH-UXOVVSIBSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
141647,6w9q,DB01134,-7.6,Desoxycorticosterone pivalate,VVOIQBFMTVCINR-WWMZEODYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
138633,6w9c,DB11948,-7.6,Lapachone,QZPQTZZNNJUOLS-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
28960,6cs2,DB08590,-7.6,1-(3-HYDROXYPROPYL)-2-[(3-NITROBENZOYL)AMINO]-1H-BENZIMIDAZOL-5-YL PIVALATE,CEAYRKIZESVQSN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
62676,6crv,DB13934,-7.6,Ligandrol,OPSIVAKKLQRWKC-VXGBXAGGSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
123431,6w4b,DB00153,-7.6,Ergocalciferol,MECHNRXZTMCUDQ-RKHKHRCZSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
107475,6vxx,DB03651,-7.6,Picric acid,OXNIZHLAWKMVMX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
101265,6vxs,DB04693,-7.6,"(13S)-13-METHYLDODECAHYDRO-1H-CYCLOPENTA[A]PHENANTHRENE-3,17(2H,4H)-DIONE",CRDKSBHJIGNEOH-IMRIKWHGSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
61625,6crv,DB12354,-7.6,Imrecoxib,AXMZZGKKZDJGAZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
11623,6lzg,DB12221,-7.6,Canrenone,UJVLDDZCTMKXJK-WNHSNXHDSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
89767,6m71,DB00873,-7.6,Loteprednol,YPZVAYHNBBHPTO-MXRBDKCISA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
81912,6m3m,DB01843,-7.6,"3-Amino-8,9,10-Trihydroxy-7-Hydroxymethyl-6-Oxa-1,3-Diaza-Spiro[4.5]Decane-2,4-Dione",KLJXQBRQPPSXPZ-WWHASAIZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
32885,6cs2,T3D3809,-7.6,Chlorsulfuron,VJYIFXVZLXQVHO-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
27753,6cs2,DB00162,-7.6,Vitamin A,FPIPGXGPPPQFEQ-OVSJKPMPSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
89786,6m71,DB00896,-7.6,Rimexolone,QTTRZHGPGKRAFB-OOKHYKNYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
32244,6cs2,DB01216,-7.6,Finasteride,DBEPLOCGEIEOCV-WSBQPABSSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
142040,6w9q,DB01668,-7.6,Nanaomycin D,XUWPJKDMEZSVTP-UOSCCXBLSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
155715,6wiq,DB11614,-7.6,Rupatadine,WUZYKBABMWJHDL-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
126702,6w4h,DB04177,-7.6,"4-(3,14-Dihydroxy-10,13-Dimethyl-Hexadecahydro-Cyclopenta[a]Phenanthren-17-Yl)-5h-Furan-2-One",XZTUSOXSLKTKJQ-CESUGQOBSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
126701,6w4h,DB04176,-7.6,"Phosporic Acid Mono-[3,4-Dihydroxy-5-(5-Methoxy-Benzoimidazol-1-Yl)-Tetrahydro-Furan-2-Ylmethyl] Ester",VYUPJUKSTVHSQI-LPWJVIDDSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
105930,6vxs,DB14644,-7.6,Methylprednisolone hemisuccinate,IMBXEJJVJRTNOW-XYMSELFBSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
141618,6w9q,DB01100,-7.6,Pimozide,YVUQSNJEYSNKRX-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
106134,6vxs,DB15091,-7.6,Upadacitinib,WYQFJHHDOKWSHR-MNOVXSKESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
12898,6lzg,DB13993,-7.6,MRK-409,GOIFCXRIFSYPFG-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
69670,6lxt,DB11440,-7.6,Norgestomet,IWSXBCZCPVUWHT-VIFKTUCRSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
36553,1r42,DB03081,-7.6,Crc200 (Chiron-Behring),ZOXOKTJHZSUHRJ-XZOQPEGZSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
69673,6lxt,DB11446,-7.6,Oxfendazole,BEZZFPOZAYTVHN-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
107251,6vxx,DB02766,-7.6,(3r)-3-{[(Benzyloxy)Carbonyl]Amino}-2-Oxo-4-Phenylbutane-1-Diazonium,VLIGBVLLNSWVMI-MRXNPFEDSA-O,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
141641,6w9q,DB01128,-7.6,Bicalutamide,LKJPYSCBVHEWIU-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
88185,6m3m,DB13457,-7.6,Oxaflozane,FVYUQFQCEOZYHZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
106128,6vxs,DB15078,-7.6,Rogaratinib,HNLRRJSKGXOYNO-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
33023,6cs2,T3D3955,-7.6,Tetracycline,OFVLGDICTFRJMM-WESIUVDSSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
35968,1r42,DB02315,-7.6,Cyclic GMP,ZOOGRGPOEVQQDX-UUOKFMHZSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
138118,6w9c,DB09200,-7.6,Rivoglitazone,XMSXOLDPMGMWTH-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
24121,6cs2,DB01792,-7.6,Adenylyl-3'-5'-Phospho-Uridine-3'-Monophosphate,FZCSEXOMUJFOHQ-KPKSGTNCSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
107271,6vxx,DB02798,-7.6,Alpha-Methylene Adenosine Monophosphate,PXSSQXBLDTZHLF-IOSLPCCCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138581,6w9c,DB11873,-7.6,Verinurad,YYBOLPLTQDKXPM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
89676,6m71,DB00768,-7.6,Olopatadine,JBIMVDZLSHOPLA-LSCVHKIXSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
62806,6crv,DB14200,-7.6,Thiohexam,DEQZTKGFXNUBJL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81951,6m3m,DB01903,-7.6,5-Bromo-2'-Deoxyuridine-5'-Monophosphate,LHLHVDBXXZVYJT-RRKCRQDMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
32227,6cs2,DB01198,-7.6,Zopiclone,GBBSUAFBMRNDJC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
12908,6lzg,DB14017,-7.6,H3B-8800,YOIQWBAHJZGRFW-WVRLKXNASA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
69704,6lxt,DB11512,-7.6,Dihydrostreptomycin,ASXBYYWOLISCLQ-HZYVHMACSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
107280,6vxx,DB03102,-7.6,"2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Pyran-3-Carboxylic Acid",SNNOZMNTPOIDSI-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
18498,6cs2,HMDB0030667,-7.6,Chrysoeriol,SCZVLDHREVKTSH-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
62792,6crv,DB14176,-7.6,Benzylparaben,MOZDKDIOPSPTBH-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138181,6w9c,DB09286,-7.6,Pipamperone,AXKPFOAXAHJUAG-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138533,6w9c,DB11801,-7.6,Rapastinel,GIBQQARAXHVEGD-BSOLPCOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
88120,6m3m,DB13367,-7.6,Cloricromen,GYNNRVJJLAVVTQ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
101321,6vxs,DB04771,-7.6,1-GUANIDINO-4-(N-NITRO-BENZOYLAMINO-L-LEUCYL-L-PROLYLAMINO)BUTANE,FIZYZWLGMGGGBJ-OALUTQOASA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
141691,6w9q,DB01184,-7.6,Domperidone,FGXWKSZFVQUSTL-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
99500,6vxs,DB02339,-7.6,Allyl-{6-[3-(4-Bromo-Phenyl)-Benzofuran-6-Yloxy]-Hexyl-}-Methyl-Amin,JYNZIOFUHBJABQ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
81942,6m3m,DB01883,-7.6,N-(Sulfanylacetyl)Tyrosylprolylmethioninamide,LNLWXWOYQHAKTD-ULQDDVLXSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
162938,7bv1,DB03315,-7.6,Guanosine 3'-monophosphate,ZDPUTNZENXVHJC-UUOKFMHZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
138119,6w9c,DB09201,-7.6,Ciglitazone,YZFWTZACSRHJQD-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
89662,6m71,DB00751,-7.6,Epinastine,WHWZLSFABNNENI-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
32896,6cs2,T3D3820,-7.6,Cyprodinil,HAORKNGNJCEJBX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
15566,6lzg,DB00243,-7.6,Ranolazine,XKLMZUWKNUAPSZ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
32237,6cs2,DB01208,-7.6,Sparfloxacin,DZZWHBIBMUVIIW-DTORHVGOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
57392,6crv,DB03606,-7.6,(S)-Rolipram,HJORMJIFDVBMOB-GFCCVEGCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
164204,7bv1,DB07375,-7.6,"5-BETA-ANDROSTANE-3,17-DIONE",RAJWOBJTTGJROA-QJISAEMRSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
69806,6lxt,DB11729,-7.6,GSK-2330672,CZGVOBIGEBDYTP-VSGBNLITSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
123767,6w4h,DB00355,-7.6,Aztreonam,WZPBZJONDBGPKJ-VEHQQRBSSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
101289,6vxs,DB04725,-7.6,Licofelone,UAWXGRJVZSAUSZ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
123766,6w4h,DB00354,-7.6,Buclizine,MOYGZHXDRJNJEP-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
24122,6cs2,DB01793,-7.6,SB-409513,ONVZFCHLOZUXRP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
126633,6w4h,DB04092,-7.6,Apstatin,YVUUZAPYLPWFHE-HXFGRODQSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
105966,6vxs,DB14681,-7.6,Cortisone,MFYSYFVPBJMHGN-ZPOLXVRWSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
80304,6m2n,DB15097,-7.6,Gefapixant,HLWURFKMDLAKOD-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
24177,6cs2,DB01858,-7.6,[1-(4-Fluorobenzyl)Cyclobutyl]Methyl (1s)-1-[Oxo(1h-Pyrazol-5-Ylamino)Acetyl]Pentylcarbamate,QTPYRNAKLBXKNP-SFHVURJKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
27355,6cs2,DB06891,-7.6,"5-{[(4-AMINO-3-CHLORO-5-FLUOROPHENYL)SULFONYL]AMINO}-1,3,4-THIADIAZOLE-2-SULFONAMIDE",HOLJYLOVIHBQHO-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
13124,6lzg,DB14729,-7.6,Rebeccamycin,QEHOIJJIZXRMAN-QZQSLCQPSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
11499,6lzg,DB12052,-7.6,Icariin,TZJALUIVHRYQQB-XLRXWWTNSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
163901,7bv1,DB06834,-7.6,"N-(2-hydroxy-1,1-dimethylethyl)-1-methyl-3-(1H-pyrrolo[2,3-b]pyridin-2-yl)-1H-indole-5-carboxamide",XZRYCTLOGNCQDG-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
124284,6w4h,DB00973,-7.6,Ezetimibe,OLNTVTPDXPETLC-XPWALMASSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
124965,6w4h,DB01861,-7.6,Uridine diphosphate glucose,HSCJRCZFDFQWRP-JZMIEXBBSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
89010,6m3m,DB15284,-7.6,Sulopenem,FLSUCZWOEMTFAQ-PRBGKLEPSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
62105,6crv,DB13090,-7.6,Zidebactam,YCZPXRQPDCXTIO-BBBLOLIVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
124282,6w4h,DB00969,-7.6,Alosetron,JSWZEAMFRNKZNL-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
62096,6crv,DB13077,-7.6,LCB01-0371,QLUWQAFDTNAYPN-LLVKDONJSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
2488,6lzg,HMDB0041768,-7.6,Phloretin 2'-O-glucuronide,YFJJAJIWPWXWJJ-ZFORQUDYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
163462,7bv1,DB04652,-7.6,Corticosterone,OMFXVFTZEKFJBZ-HJTSIMOOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
88977,6m3m,DB15214,-7.6,BMS-986104,BPMMYKAHRIEVDH-VOQZNFBZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
2486,6lzg,HMDB0041761,-7.6,Naringenin 7-O-glucuronide,BDCRTIDKZGEVEN-DNPGXZAYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
139676,6w9c,DB13788,-7.6,Chlorbenzoxamine,VEVSKUJZSMGTMM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139673,6w9c,DB13784,-7.6,Dixyrazine,MSYUMPGNGDNTIQ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
7253,6lzg,DB03495,-7.6,"4,6-Dideoxy-4-{[4,5,6-Trihydroxy-3-(Hydroxymethyl)Cyclohex-2-En-1-Yl]Amino}-Alpha-D-Lyxo-Hexopyranosyl-(1->4)-Alpha-D-Threo-Hexopyranosyl-(1->6)-Alpha-L-Threo-Hexopyranose",FZLCJZILHGFQLM-PISLJJGOSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
124273,6w4h,DB00959,-7.6,Methylprednisolone,VHRSUDSXCMQTMA-PJHHCJLFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
106850,6vxx,DB01394,-7.6,Colchicine,IAKHMKGGTNLKSZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
124268,6w4h,DB00952,-7.6,Naratriptan,AMKVXSZCKVJAGH-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
7249,6lzg,DB03490,-7.6,"3-Pyridin-4-Yl-2,4-Dihydro-Indeno[1,2-.C.]Pyrazole",NHOACLCXCKJMAK-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
69373,6lxt,DB09080,-7.6,Olodaterol,COUYJEVMBVSIHV-SFHVURJKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
163929,7bv1,DB06871,-7.6,17-METHYL-17-ALPHA-DIHYDROEQUILENIN,FQMQOMRDADWGJJ-GBESFXJTSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
125019,6w4h,DB01944,-7.6,(S)-blebbistatin,LZAXPYOBKSJSEX-GOSISDBHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
124313,6w4h,DB01006,-7.6,Letrozole,HPJKCIUCZWXJDR-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
32628,6cs2,T3D2025,-7.6,"3,3',4,5'-Tetrabromobiphenyl",LCVYPBMOMVFNNO-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
89420,6m71,DB00455,-7.6,Loratadine,JCCNYMKQOSZNPW-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
155957,6wiq,DB12001,-7.6,Abemaciclib,UZWDCWONPYILKI-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
80924,6m3m,DB00598,-7.6,Labetalol,SGUAFYQXFOLMHL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
11344,6lzg,DB11836,-7.6,Sapanisertib,GYLDXIAOMVERTK-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
124834,6w4h,DB01689,-7.6,Inhibitor Idd 384,CJKKMQCZOLCXAM-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
139780,6w9c,DB13967,-7.6,Patent Blue,DHAHKSQXIXFZJB-UHFFFAOYSA-O,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
106821,6vxx,DB01332,-7.6,Ceftizoxime,NNULBSISHYWZJU-LLKWHZGFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81299,6m3m,DB01036,-7.6,Tolterodine,OOGJQPCLVADCPB-HXUWFJFHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81306,6m3m,DB01044,-7.6,Gatifloxacin,XUBOMFCQGDBHNK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
124867,6w4h,DB01734,-7.6,3-(Oxalyl-Amino)-Naphthalene-2-Carboxylic Acid,DQBLKSRRWDWNKQ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
139750,6w9c,DB13920,-7.6,Valopicitabine,TVRCRTJYMVTEFS-ICGCPXGVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139746,6w9c,DB13916,-7.6,Toyocamycin,XOKJUSAYZUAMGJ-WOUKDFQISA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
81363,6m3m,DB01110,-7.6,Miconazole,BYBLEWFAAKGYCD-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
62339,6crv,DB13439,-7.6,Fenpiprane,JXJPYHDHJZJWRI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163532,7bv1,DB04754,-7.6,"GUANOSINE-2',3'-O-ETHYLIDENEPHOSPHONATE",HYAPEMYRVFIHDJ-QWEIRQIHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
56847,6crv,DB02862,-7.6,Gluco-Phenylimidazole,DLVNFMROYKHANV-FVCCEPFGSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
89380,6m71,DB00408,-7.6,Loxapine,XJGVXQDUIWGIRW-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
89057,6m3m,DB15380,-7.6,Flutriciclamide F-18,ZVDVQPLDTTXLKI-LSKWOKDISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
89386,6m71,DB00415,-7.6,Ampicillin,AVKUERGKIZMTKX-NJBDSQKTSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
139721,6w9c,DB13846,-7.6,Pyrrobutamine,WDYYVNNRTDZKAZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140682,6w9c,DB13090,-7.6,Zidebactam,YCZPXRQPDCXTIO-BBBLOLIVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
73348,6m2n,DB01920,-7.6,1-O-[O-Nitrophenyl]-Beta-D-Galactopyranose,KUWPCJHYPSUOFW-YBXAARCKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
73160,6m2n,DB01659,-7.6,"3-(1,10-Phenanthrol-2-Yl)-L-Alanine",LODBCIBKOKOGNL-LBPRGKRZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
140687,6w9c,DB13097,-7.6,1alpha-Hydroxyvitamin D5,NWFOBODUYTUMNC-VPSCEVSQSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
124343,6w4h,DB01039,-7.6,Fenofibrate,YMTINGFKWWXKFG-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
56830,6crv,DB02842,-7.6,9-amino-n-[3-(dimethylamino)propyl]acridine-4-carboxamide,VNWAULKXOPRJEL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
125025,6w4h,DB01950,-7.6,"N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thiazol-2-Yl)Urea",YAEMHJKFIIIULI-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
106868,6vxx,DB01420,-7.6,Testosterone propionate,PDMMFKSKQVNJMI-BLQWBTBKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81394,6m3m,DB01146,-7.6,Diphenylpyraline,OWQUZNMMYNAXSL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
106505,6vxx,DB00425,-7.6,Zolpidem,ZAFYATHCZYHLPB-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
24475,6cs2,DB00301,-7.6,Flucloxacillin,UIOFUWFRIANQPC-JKIFEVAISA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
124199,6w4h,DB00875,-7.6,Flupentixol,NJMYODHXAKYRHW-DVZOWYKESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
140902,6w9q,DB00251,-7.6,Terconazole,BLSQLHNBWJLIBQ-OZXSUGGESA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
32671,6cs2,T3D2072,-7.6,"1,2,3,4-Tetrachlorodibenzo-p-dioxin",DJHHDLMTUOLVHY-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
139575,6w9c,DB13657,-7.6,Benorilate,FEJKLNWAOXSSNR-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
156357,6wiq,DB12973,-7.6,Serlopitant,FLNYCRJBCNNHRH-OIYLJQICSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
73102,6m2n,DB01587,-7.6,Ketazolam,PWAJCNITSBZRBL-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
81423,6m3m,DB01179,-7.6,Podofilox,YJGVMLPVUAXIQN-XVVDYKMHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88845,6m3m,DB14921,-7.6,Mavacamten,RLCLASQCAPXVLM-NSHDSACASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
99956,6vxs,DB02930,-7.6,Adenosine 5'-[??-thio]triphosphate,NLTUCYMLOPLUHL-KQYNXXCUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
27640,6cs2,DB07190,-7.6,3-cyclohexyl-D-alanyl-N-(3-chlorobenzyl)-L-prolinamide,JGFCNVHEEMBVJG-MOPGFXCFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
69096,6lxt,DB08706,-7.6,"(2S)-({(5Z)-5-[(5-ETHYL-2-FURYL)METHYLENE]-4-OXO-4,5-DIHYDRO-1,3-THIAZOL-2-YL}AMINO)(4-FLUOROPHENYL)ACETIC ACID",RNEACARJKXYVND-MZLJFPOFSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
163399,7bv1,DB04366,-7.6,3'-Deoxy 3'-Amino Adenosine-5'-Diphosphate,VKODIDNZKBYXJO-QYYRPYCUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
62034,6crv,DB12980,-7.6,CHS-828,BOIPLTNGIAPDBY-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
156370,6wiq,DB12998,-7.6,PF-00217830,QGNOXTFZOLDODX-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
140935,6w9q,DB00288,-7.6,Amcinonide,ILKJAFIWWBXGDU-MOGDOJJUSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
100686,6vxs,DB03917,-7.6,N-Ethyl Retinamide,WKYDOCGICAMTKE-NBIQJRODSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
73079,6m2n,DB01559,-7.6,Clotiazepam,CHBRHODLKOZEPZ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
163383,7bv1,DB04342,-7.6,7-((Carboxy(4-Hydroxyphenyl)Acetyl)Amino)-7-Methoxy-(3-((1-Methyl-1h-Tetrazol-5-Yl)Thio)Methyl)-8-Oxo-5-Oxa-1-Azabicyclo[4.2.0]Oct-2-Ene-2-Carboxylic Acid,JWCSIUVGFCSJCK-LIUKBUMOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
88897,6m3m,DB15058,-7.6,Flutemetamol,VVECGOCJFKTUAX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
155905,6wiq,DB11921,-7.6,Deflazacort,FBHSPRKOSMHSIF-GRMWVWQJSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
163439,7bv1,DB04424,-7.6,RPR128515,XFKVLKLCLYJKNF-MZNJEOGPSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
139594,6w9c,DB13678,-7.6,Dihexyverine,MNSQDVCVWNXBFQ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
27627,6cs2,DB07178,-7.6,5-PENTYL-2-PHENOXYPHENOL,OJLYTHOKCYLPMA-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
125033,6w4h,DB01958,-7.6,"5-[4-Tert-Butylphenylsulfanyl]-2,4-Quinazolinediamine",MNYDVPDMLAJJPB-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
88951,6m3m,DB15167,-7.6,Fallypride,OABRYNHZQBZDMG-INIZCTEOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
125038,6w4h,DB01964,-7.6,AL5424,ZWTSOJQGEWPWGO-NSHDSACASA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
56518,6crv,DB02428,-7.6,Quinaldic Acid,LOAUVZALPPNFOQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
100568,6vxs,DB03767,-7.6,Morpholine-4-Carboxylic Acid [1s-(2-Benzyloxy-1r-Cyano-Ethylcarbamoyl)-3-Methyl-Butyl]Amide,LXEDKIMJQBOMSU-MOPGFXCFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
56896,6crv,DB02925,-7.6,Piretanide,UJEWTUDSLQGTOA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
11208,6lzg,DB11656,-7.6,Rebamipide,ALLWOAVDORUJLA-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
139625,6w9c,DB13720,-7.6,Diphemanil,LCTZPQRFOZKZNK-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
155907,6wiq,DB11923,-7.6,Decoglurant,DMJHZVARRXJSEG-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
139647,6w9c,DB13752,-7.6,Tetramethrin,CXBMCYHAMVGWJQ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
125077,6w4h,DB02019,-7.6,Acetyl Dithranol,IXLRLZOYKJERRA-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
100028,6vxs,DB03034,-7.6,D-Levofloxacin,GSDSWSVVBLHKDQ-SNVBAGLBSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
140872,6w9q,DB00218,-7.6,Moxifloxacin,FABPRXSRWADJSP-MEDUHNTESA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
100572,6vxs,DB03771,-7.6,Allyl-{4-[3-(4-Bromo-Phenyl)-Benzofuran-6-Yloxy]-but-2-Enyl}-Methyl-Amine,KCNKJCHARANTIP-SNAWJCMRSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
124216,6w4h,DB00896,-7.6,Rimexolone,QTTRZHGPGKRAFB-OOKHYKNYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
139607,6w9c,DB13693,-7.6,Sulbenicillin,JETQIUPBHQNHNZ-NJBDSQKTSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
62068,6crv,DB13032,-7.6,Enecadin,SZSHJTJCJOWMHM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88926,6m3m,DB15117,-7.6,Transfluthrin,DDVNRFNDOPPVQJ-HQJQHLMTSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
69387,6lxt,DB09101,-7.6,Elvitegravir,JUZYLCPPVHEVSV-LJQANCHMSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
139596,6w9c,DB13680,-7.6,Naftazone,TZGBBMBARSFJBG-UKTHLTGXSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
24471,6cs2,DB02220,-7.6,AL7089A,RMOXCYSVWCHXII-LBPRGKRZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
18940,6cs2,HMDB0041729,-7.6,(-)-Epicatechin 7-O-glucuronide,FDWDKTKDGDLDTP-BBGDWMAASA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
155979,6wiq,DB12036,-7.6,Naquotinib,QKDCLUARMDUUKN-XMMPIXPASA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
139787,6w9c,DB13988,-7.6,SB-269970,HWKROQUZSKPIKQ-MRXNPFEDSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
163866,7bv1,DB06771,-7.6,Besifloxacin,QFFGVLORLPOAEC-SNVBAGLBSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
156036,6wiq,DB12116,-7.6,Epigallocatechin gallate,WMBWREPUVVBILR-WIYYLYMNSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
140152,6w9c,DB15079,-7.6,Troriluzole,YBZSGIWIPOUSHY-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
156034,6wiq,DB12114,-7.6,Poziotinib,LPFWVDIFUFFKJU-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
124504,6w4h,DB01222,-7.6,Budesonide,VOVIALXJUBGFJZ-KWVAZRHASA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
100194,6vxs,DB03247,-7.6,Flavin mononucleotide,FVTCRASFADXXNN-SCRDCRAPSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
106750,6vxx,DB01205,-7.6,Flumazenil,OFBIFZUFASYYRE-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81135,6m3m,DB00849,-7.6,Methylphenobarbital,ALARQZQTBTVLJV-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
140140,6w9c,DB15056,-7.6,Bifenthrin,OMFRMAHOUUJSGP-IRHGGOMRSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
11272,6lzg,DB11742,-7.6,Ebastine,MJJALKDDGIKVBE-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
140415,6w9c,DB06803,-7.6,Niclosamide,RJMUSRYZPJIFPJ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
100172,6vxs,DB03222,-7.6,dATP,SUYVUBYJARFZHO-RRKCRQDMSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
89231,6m71,DB00231,-7.6,Temazepam,SEQDDYPDSLOBDC-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
124658,6w4h,DB01476,-7.6,Haloxazolam,XDKCGKQHVBOOHC-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
163773,7bv1,DB06249,-7.6,Arzoxifene,MCGDSOGUHLTADD-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
73225,6m2n,DB01748,-7.6,N-Benzyl-4-Sulfamoyl-Benzamide,CZKNSZUJCJHTTM-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
163776,7bv1,DB06257,-7.6,HE-2200,OEVZKEVBDIDVOI-YSZCXEEOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
81178,6m3m,DB00899,-7.6,Remifentanil,ZTVQQQVZCWLTDF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
100154,6vxs,DB03202,-7.6,"2-[5-Methanesulfonylamino-2-(4-Aminophenyl)-6-Oxo-1,6-Dihydro-1-Pyrimidinyl]-N-(3,3,3-Trifluoro-1-Isopropyl-2-Oxopropyl)Acetamide",JWSWTHSJMGVOKE-HNNXBMFYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
106638,6vxx,DB00842,-7.6,Oxazepam,ADIMAYPTOBDMTL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
124679,6w4h,DB01501,-7.6,Difenoxin,UFIVBRCCIRTJTN-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
140441,6w9c,DB06845,-7.6,(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclopentylamino)ethanoyl)pyrrolidine-2-carboxamide,WXYKSWZWRHMJTE-KRWDZBQOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
100223,6vxs,DB03285,-7.6,"2',4,4'-Trihydroxychalcone",DXDRHHKMWQZJHT-FPYGCLRLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
56668,6crv,DB02623,-7.6,Aminophosphonic Acid-Guanylate Ester,ZGPDMUBRWRJAQQ-UUOKFMHZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
100324,6vxs,DB03421,-7.6,"2-Phenethyl-2,3-Dihydro-Phthalazine-1,4-Dione",JSSVIGGKHIJEHO-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
89296,6m71,DB00305,-7.6,Mitomycin,NWIBSHFKIJFRCO-WUDYKRTCSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
124588,6w4h,DB01393,-7.6,Bezafibrate,IIBYAHWJQTYFKB-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
73259,6m2n,DB01791,-7.6,Piclamilast,RRRUXBQSQLKHEL-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
89262,6m71,DB00266,-7.6,Dicoumarol,DOBMPNYZJYQDGZ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
81098,6m3m,DB00809,-7.6,Tropicamide,BGDKAVGWHJFAGW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
7303,6lzg,DB03583,-7.6,"(2e,3s)-3-Hydroxy-5'-[(4-Hydroxypiperidin-1-Yl)Sulfonyl]-3-Methyl-1,3-Dihydro-2,3'-Biindol-2'(1'h)-One",AYOAIABDFUJDKQ-SQJPUDIVSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
106674,6vxx,DB00882,-7.6,Clomifene,GKIRPKYJQBWNGO-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27545,6cs2,DB07091,-7.6,(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclohexyloxy)ethanoyl)pyrrolidine-2-carboxamide,IWPMQJKXKKKSEY-SFHVURJKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
124607,6w4h,DB01420,-7.6,Testosterone propionate,PDMMFKSKQVNJMI-BLQWBTBKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
124608,6w4h,DB01421,-7.6,Paromomycin,UOZODPSAJZTQNH-LSWIJEOBSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
13059,6lzg,DB14633,-7.6,Prednisolone hemisuccinate,APGDTXUMTIZLCJ-CGVGKPPMSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
56754,6crv,DB02740,-7.6,3-Indolebutyric Acid,JTEDVYBZBROSJT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140235,6w9c,DB15411,-7.6,ABP-700,DRAFVCKNYNQOKR-GFCCVEGCSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
32500,6cs2,T3D1857,-7.6,Pyrethrin I,ROVGZAWFACYCSP-WIURDZCKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
73274,6m2n,DB01812,-7.6,Adenosine-3'-5'-Diphosphate,WHTCPDAXWFLDIH-KQYNXXCUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
11288,6lzg,DB11765,-7.6,PF-04991532,GKMLFBRLRVQVJO-ZDUSSCGKSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
89288,6m71,DB00295,-7.6,Morphine,BQJCRHHNABKAKU-KBQPJGBKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
163679,7bv1,DB05861,-7.6,Tasquinimod,ONDYALNGTUAJDX-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
140207,6w9c,DB15347,-7.6,Branebrutinib,VJPPLCNBDLZIFG-ZDUSSCGKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
69233,6lxt,DB08878,-7.6,Aminopterin,TVZGACDUOSZQKY-LBPRGKRZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
140200,6w9c,DB15335,-7.6,Formononetin,HKQYGTCOTHHOMP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
106661,6vxx,DB00867,-7.6,Ritodrine,IOVGROKTTNBUGK-SJCJKPOMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81047,6m3m,DB00745,-7.6,Modafinil,YFGHCGITMMYXAQ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
100306,6vxs,DB03397,-7.6,Uridine-Diphosphate-N-Acetylglucosamine,LFTYTUAZOPRMMI-CFRASDGPSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
140069,6w9c,DB14881,-7.6,Oliceridine,DMNOVGJWPASQDL-OAQYLSRUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
2845,6lzg,HMDB0044200,-7.6,TG(16:0/22:1(13Z)/18:1(11Z)),UBCKVROCLDZVDL-JSPVYFJMSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
140045,6w9c,DB14835,-7.6,SUVN-G3031,LNXDUSQEXVQFGP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
124423,6w4h,DB01132,-7.6,Pioglitazone,HYAFETHFCAUJAY-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
62175,6crv,DB13225,-7.6,Dibenzepin,QPGGEKPRGVJKQB-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27509,6cs2,DB07053,-7.6,2-{5-[3-(7-PROPYL-3-TRIFLUOROMETHYLBENZO[D]ISOXAZOL-6-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID,TWVYNPULGKGJOS-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
106587,6vxx,DB00528,-7.6,Lercanidipine,ZDXUKAKRHYTAKV-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163600,7bv1,DB04839,-7.6,Cyproterone acetate,UWFYSQMTEOIJJG-FDTZYFLXSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
100386,6vxs,DB03510,-7.6,6-O-Phosphoryl Inosine Monophosphate,RXRZOKQPANIEDW-KQYNXXCUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
100104,6vxs,DB03133,-7.6,"2-(Beta-D-Glucopyranosyl)-5-Methyl-1,2,3-Benzimidazole",XIJZORUYQZBFJK-UJPOAAIJSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
80960,6m3m,DB00641,-7.6,Simvastatin,RYMZZMVNJRMUDD-HGQWONQESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
89156,6m71,DB00146,-7.6,Calcifediol,JWUBBDSIWDLEOM-DTOXIADCSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
73188,6m2n,DB01697,-7.6,beta-cellotriose,FYGDTMLNYKFZSV-CSHPIKHBSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
62180,6crv,DB13230,-7.6,Gestonorone,GTFUITFQDGVJSK-XGXHKTLJSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81249,6m3m,DB00980,-7.6,Ramelteon,YLXDSYKOBKBWJQ-LBPRGKRZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
139833,6w9c,DB14075,-7.6,Imidurea,ZCTXEAQXZGPWFG-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
100422,6vxs,DB03572,-7.6,FR230513,URGFTPMACWKJKU-OAHLLOKOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
156208,6wiq,DB12571,-7.6,Rimacalib,MYTIJGWONQOOLC-HNNXBMFYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
106799,6vxx,DB01274,-7.6,Arformoterol,BPZSYCZIITTYBL-YJYMSZOUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106569,6vxx,DB00500,-7.6,Tolmetin,UPSPUYADGBWSHF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27604,6cs2,DB07154,-7.6,"(3R)-4-[(3R)-3-AMINO-4-(2,4,5-TRIFLUOROPHENYL)BUTANOYL]-3-METHYL-1,4-DIAZEPAN-2-ONE",SWKGZJAAGSVROJ-MWLCHTKSSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
124799,6w4h,DB01641,-7.6,"(5z)-2-[(1s,2r)-1-Amino-2-Hydroxypropyl]-5-[(4-Amino-1h-Indol-3-Yl)Methylene]-3-(2-Hydroxyethyl)-3,5-Dihydro-4h-Imidazol-4-One",JUWJATLABHTRDF-JURWUIOISA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
100447,6vxs,DB03605,-7.6,"(2s)-2-[(2,4-Dichloro-Benzoyl)-(3-Trifluoromethyl-Benzyl)-Amino]-3-Phenyl-Propionic Acid",LAJJKGIZTCCOHY-NRFANRHFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
140611,6w9c,DB12532,-7.6,Oxetacaine,FTLDJPRFCGDUFH-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
163856,7bv1,DB06747,-7.6,ginkgolide-M,KDKROYXEHCYLJQ-FJFAJXJPSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
106578,6vxx,DB00514,-7.6,Dextromethorphan,MKXZASYAUGDDCJ-NJAFHUGGSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106463,6vxx,DB00374,-7.6,Treprostinil,PAJMKGZZBBTTOY-ZFORQUDYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140525,6w9c,DB12007,-7.6,Isoflavone,GOMNOOKGLZYEJT-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
124744,6w4h,DB01572,-7.6,Methyl-1-testosterone,JRNSSSJKIGAFCT-YDSAWKJFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
62197,6crv,DB13254,-7.6,Prifinium,ZYEPZINLLPPBMI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140451,6w9c,DB06859,-7.6,N-ALLYL-5-AMIDINOAMINOOXY-PROPYLOXY-3-CHLORO-N-CYCLOPENTYLBENZAMIDE,XWIUMAPBZWNFNV-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
27515,6cs2,DB07059,-7.6,"N-{2-[6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2,2-DIMETHYL-3-OXO-2,3-DIHYDRO-4H-1,4-BENZOXAZIN-4-YL]ETHYL}ACETAMIDE",GBXSOZDYCSBLQX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
56771,6crv,DB02762,-7.6,RU79072,NQLPTOOPFMPCHQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
100353,6vxs,DB03467,-7.6,Naringenin,FTVWIRXFELQLPI-ZDUSSCGKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
73215,6m2n,DB01734,-7.6,3-(Oxalyl-Amino)-Naphthalene-2-Carboxylic Acid,DQBLKSRRWDWNKQ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
139990,6w9c,DB14682,-7.6,Dextrorphan,JAQUASYNZVUNQP-PVAVHDDUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140465,6w9c,DB07277,-7.6,2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}ETHANESULFONAMIDE,IAUZEBLXCOCAFL-JSGCOSHPSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
13050,6lzg,DB14625,-7.6,Meprednisone acetate,RZAMUHXEOMZXET-ABQXZQTJSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
89218,6m71,DB00216,-7.6,Eletriptan,PWVXXGRKLHYWKM-LJQANCHMSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
106787,6vxx,DB01252,-7.6,Mitiglinide,WPGGHFDDFPHPOB-BBWFWOEESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
156172,6wiq,DB12515,-7.6,9-aminocamptothecin,FUXVKZWTXQUGMW-FQEVSTJZSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
140466,6w9c,DB07278,-7.6,2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}ETHENESULFONAMIDE,ACEFOQMQINFMRW-DYCFVMESSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
124439,6w4h,DB01150,-7.6,Cefprozil,WDLWHQDACQUCJR-PBFPGSCMSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
89315,6m71,DB00328,-7.6,Indometacin,CGIGDMFJXJATDK-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
81218,6m3m,DB00942,-7.6,Cycrimine,SWRUZBWLEWHWRI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
89333,6m71,DB00351,-7.6,Megestrol acetate,RQZAXGRLVPAYTJ-GQFGMJRRSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
89335,6m71,DB00353,-7.6,Methylergometrine,UNBRKDKAWYKMIV-QWQRMKEZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
69204,6lxt,DB08828,-7.6,Vismodegib,BPQMGSKTAYIVFO-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
89336,6m71,DB00354,-7.6,Buclizine,MOYGZHXDRJNJEP-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
80968,6m3m,DB00654,-7.6,Latanoprost,GGXICVAJURFBLW-CEYXHVGTSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
56785,6crv,DB02781,-7.6,"4-{(Z)-[2-[3-(Methylsulfanyl)Propanoyl]-5-Oxo-1-(2-Oxoethyl)-1,5-Dihydro-4h-Imidazol-4-Ylidene]Methyl}Benzenolate",POPNGBKQPJVYFV-JLHYYAGUSA-M,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
124729,6w4h,DB01557,-7.6,??-Methylfentanyl,NGTVDHYUFBKWID-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
62619,6crv,DB13819,-7.6,Proxazole,OLTAWOVKGWWERU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
100693,6vxs,DB03926,-7.6,"5-Alpha-Androstane-3-Beta,17-Alpha-Diol",CBMYJHIOYJEBSB-MFXFBURESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
140939,6w9q,DB00294,-7.6,Etonogestrel,GCKFUYQCUCGESZ-BPIQYHPVSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
88428,6m3m,DB13784,-7.6,Dixyrazine,MSYUMPGNGDNTIQ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
123940,6w4h,DB00568,-7.6,Cinnarizine,DERZBLKQOCDDDZ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
141303,6w9q,DB00737,-7.6,Meclizine,OCJYIGYOJCODJL-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
99717,6vxs,DB02615,-7.6,Compound 19,UZOOIPXOYYJULJ-BLIZRMSTSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101024,6vxs,DB04371,-7.6,AL6528,FBBLOSCXOZYUSS-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
123937,6w4h,DB00564,-7.6,Carbamazepine,FFGPTBGBLSHEPO-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
88426,6m3m,DB13782,-7.6,Imipramine oxide,QZIQORUGXBPDSU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
24246,6cs2,DB01950,-7.6,"N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thiazol-2-Yl)Urea",YAEMHJKFIIIULI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
69557,6lxt,DB09534,-7.6,Ecamsule,HEAHZSUCFKFERC-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
62564,6crv,DB13744,-7.6,Piromidic acid,RCIMBBZXSXFZBV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80754,6m3m,DB00391,-7.6,Sulpiride,BGRJTUBHPOOWDU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
155797,6wiq,DB11745,-7.6,Otenabant,UNAZAADNBYXMIV-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
107128,6vxx,DB02324,-7.6,5-Iodo-2'-Deoxyuridine-5'-Monophosphate,WXFYBFRZROJDLL-RRKCRQDMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88411,6m3m,DB13762,-7.6,Dexrabeprazole,YREYEVIYCVEVJK-RUZDIDTESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
69017,6lxt,DB08607,-7.6,"(5R)-5-(4-{[(2R)-6-HYDROXY-2,5,7,8-TETRAMETHYL-3,4-DIHYDRO-2H-CHROMEN-2-YL]METHOXY}BENZYL)-1,3-THIAZOLIDINE-2,4-DIONE",GXPHKUHSUJUWKP-NTKDMRAZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
101069,6vxs,DB04437,-7.6,"Cysteine-Methylene-Carbamoyl-1,10-Phenanthroline",ZFGIPRHDRFOMFO-LBPRGKRZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
141352,6w9q,DB00799,-7.6,Tazarotene,OGQICQVSFDPSEI-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
139026,6w9c,DB12731,-7.6,Daporinad,KPBNHDGDUADAGP-VAWYXSNFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
163090,7bv1,DB03753,-7.6,Flurbiprofen Methyl Ester,CPJBKHZROFMSQM-NSHDSACASA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
11478,6lzg,DB12021,-7.6,Dinaciclib,PIMQWRZWLQKKBJ-SFHVURJKSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
56373,6crv,DB02247,-7.6,Hydrolyzed Cephalothin,JRYZEMHNDUZNMI-RYUDHWBXSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80764,6m3m,DB00401,-7.6,Nisoldipine,VKQFCGNPDRICFG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
28893,6cs2,DB08517,-7.6,"(2S)-5-hydroxy-2-(4-hydroxyphenyl)-7-methoxy-2,3-dihydro-4H-chromen-4-one",DJOJDHGQRNZXQQ-AWEZNQCLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
123956,6w4h,DB00587,-7.6,Cinalukast,BZMKNPGKXJAIDV-VAWYXSNFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
123957,6w4h,DB00588,-7.6,Fluticasone propionate,WMWTYOKRWGGJOA-CENSZEJFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
99748,6vxs,DB02656,-7.6,LY-294002,CZQHHVNHHHRRDU-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
124019,6w4h,DB00665,-7.6,Nilutamide,XWXYUMMDTVBTOU-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
24576,6cs2,DB02342,-7.6,2-Methox1tradiol,CQOQDQWUFQDJMK-SSTWWWIQSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
89571,6m71,DB00641,-7.6,Simvastatin,RYMZZMVNJRMUDD-HGQWONQESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
164065,7bv1,DB07030,-7.6,(5-CHLORO-2-{[(3-NITROBENZYL)AMINO]CARBONYL}PHENOXY)ACETIC ACID,VABIMMIJVWNHFI-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
125664,6w4h,DB02789,-7.6,Pregnenolone,ORNBQBCIOKFOEO-QGVNFLHTSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
73426,6m2n,DB02020,-7.6,Alrestatin,GCUCIFQCGJIRNT-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
123988,6w4h,DB00625,-7.6,Efavirenz,XPOQHMRABVBWPR-ZDUSSCGKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
47403,2fxp,DB01761,-7.6,4-[5-[2-(1-Phenyl-Ethylamino)-Pyrimidin-4-Yl]-1-Methyl-4-(3-Trifluoromethylphenyl)-1h-Imidazol-2-Yl]-Piperidine,QICPQLFMWYQJGX-SFHVURJKSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
139172,6w9c,DB12964,-7.6,Lerisetron,PWWDCRQZITYKDV-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
24240,6cs2,DB01944,-7.6,(S)-blebbistatin,LZAXPYOBKSJSEX-GOSISDBHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
7387,6lzg,DB03723,-7.6,2'-Deoxy-Thymidine-Beta-L-Rhamnose,ZOSQFDVXNQFKBY-CGAXJHMRSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
57093,6crv,DB03196,-7.6,4-Nitrophenyl-Ara,DUYYBTBDYZXISX-UKKRHICBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
36096,1r42,DB02473,-7.6,"6-[N-(1-Isopropyl-3,4-Dihydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine",XRHANBWAKSYPEN-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
57096,6crv,DB03200,-7.6,7-Alpha-D-Ribofuranosyl-Purine-5'-Phosphate,NICKPTPNIMHUHB-DQUBFYRCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81648,6m3m,DB01515,-7.6,Benzoylecgonine,GVGYEFKIHJTNQZ-RFQIPJPRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
123972,6w4h,DB00606,-7.6,Cyclothiazide,BOCUKUHCLICSIY-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
11455,6lzg,DB11992,-7.6,Omarigliptin,MKMPWKUAHLTIBJ-ISTRZQFTSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
62545,6crv,DB13720,-7.6,Diphemanil,LCTZPQRFOZKZNK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
69547,6lxt,DB09488,-7.6,Acrivastine,PWACSDKDOHSSQD-IUTFFREVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
107095,6vxx,DB02277,-7.6,1-(5-Tert-Butyl-2-Methyl-2h-Pyrazol-3-Yl)-3-(4-Chloro-Phenyl)-Urea,FWIJKWMXNHRSRO-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88434,6m3m,DB13792,-7.6,Clopamide,LBXHRAWDUMTPSE-AOOOYVTPSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
123977,6w4h,DB00611,-7.6,Butorphanol,IFKLAQQSCNILHL-PWRODBHTSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
24575,6cs2,DB02341,-7.6,"Mdl 101,146",XQAMVCHQGHAELT-YPAWHYETSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
80741,6m3m,DB00374,-7.6,Treprostinil,PAJMKGZZBBTTOY-ZFORQUDYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
139011,6w9c,DB12710,-7.6,Perazine,WEYVCQFUGFRXOM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
24625,6cs2,DB02398,-7.6,6-[N-(4-(Aminomethyl)Phenyl)Carbamyl]-2-Naphthalenecarboxamidine,NLBDETRVUYOIHQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
81727,6m3m,DB01606,-7.6,Tazobactam,LPQZKKCYTLCDGQ-WEDXCCLWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
32846,6cs2,T3D3760,-7.6,Fumagillin,NGGMYCMLYOUNGM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
27385,6cs2,DB06921,-7.6,(2S)-2-[3-(AMINOMETHYL)PHENYL]-3-[(R)-HYDROXY{(1R)-2-METHYL-1-[(PHENYLSULFONYL)AMINO]PROPYL}PHOSPHORYL]PROPANOIC ACID,FNZHLCNFXRRIIC-RBUKOAKNSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
125883,6w4h,DB03079,-7.6,Alpha-Ribazole-5'-Phosphate Derivative,YPYFPLLZCVEYCS-KKOKHZNYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
62607,6crv,DB13803,-7.6,Xipamide,MTZBBNMLMNBNJL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138885,6w9c,DB12402,-7.6,Pumosetrag,AFUWQWYPPZFWCO-LBPRGKRZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
81734,6m3m,DB01614,-7.6,Acepromazine,NOSIYYJFMPDDSA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
61832,6crv,DB12664,-7.6,Indantadol,MNLULKBKWKTZPE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61830,6crv,DB12662,-7.6,Naveglitazar,OKJHGOPITGTTIM-DEOSSOPVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80728,6m3m,DB00357,-7.6,Aminoglutethimide,ROBVIMPUHSLWNV-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
62608,6crv,DB13804,-7.6,Benzylthiouracil,PNXBXCRWXNESOV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
156865,6wiq,DB13791,-7.6,Penfluridol,MDLAAYDRRZXJIF-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
106186,6vxs,DB15193,-7.6,BMS-955176,XDMUFNNPLXHNKA-ZTESCHFWSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
123881,6w4h,DB00493,-7.6,Cefotaxime,GPRBEKHLDVQUJE-QSWIMTSFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
138844,6w9c,DB12343,-7.6,Temocillin,BVCKFLJARNKCSS-DWPRYXJFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
107197,6vxx,DB02694,-7.6,Pantoyl Adenylate,GDPVENOGSVMRJL-FSRKKXLISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
11497,6lzg,DB12049,-7.6,Dasolampanel etibutil,HPBRMCFZIGUGTK-ZMMAXQRCSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
2459,6lzg,HMDB0000722,-7.6,Lithocholyltaurine,QBYUNVOYXHFVKC-LVMSMGIASA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
123875,6w4h,DB00486,-7.6,Nabilone,GECBBEABIDMGGL-RTBURBONSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
81738,6m3m,DB01619,-7.6,Phenindamine,ISFHAYSTHMVOJR-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88349,6m3m,DB13678,-7.6,Dihexyverine,MNSQDVCVWNXBFQ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
123884,6w4h,DB00496,-7.6,Darifenacin,HXGBXQDTNZMWGS-RUZDIDTESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
81722,6m3m,DB01600,-7.6,Tiaprofenic acid,GUHPRPJDBZHYCJ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
69004,6lxt,DB08591,-7.6,"5-(4-METHOXYBIPHENYL-3-YL)-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDE",IGXKSKWHHHYBFM-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
61862,6crv,DB12710,-7.6,Perazine,WEYVCQFUGFRXOM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138998,6w9c,DB12689,-7.6,Azeliragon,KJNNWYBAOPXVJY-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
155787,6wiq,DB11734,-7.6,Fedovapagon,RUOLFWZIFNQQGH-DEOSSOPVSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
123899,6w4h,DB00519,-7.6,Trandolapril,VXFJYXUZANRPDJ-WTNASJBWSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
138991,6w9c,DB12679,-7.6,WP 1066,VFUAJMPDXIRPKO-LQELWAHVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
125775,6w4h,DB02930,-7.6,Adenosine 5'-[??-thio]triphosphate,NLTUCYMLOPLUHL-KQYNXXCUSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
101088,6vxs,DB04463,-7.6,"3-(4-Amino-1-Tert-Butyl-1h-Pyrazolo[3,4-D]Pyrimidin-3-Yl)Phenol",CPLGZXQPPYRNRC-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
138978,6w9c,DB12661,-7.6,Urapidil,ICMGLRUYEQNHPF-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
11482,6lzg,DB12027,-7.6,Serdemetan,CEGSUK1LWKJP-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
73462,6m2n,DB02069,-7.6,N-(2-Flouro-Benzyl)-4-Sulfamoyl-Benzamide,ULYMHSXFSKOHGH-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
28882,6cs2,DB08504,-7.6,"6-(4-{(1S,2S)-2-AMINO-1-[(DIMETHYLAMINO)CARBONYL]-3-[(3S)-3-FLUOROPYRROLIDIN-1-YL]-3-OXOPROPYL}PHENYL)-1H-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-4-IUM",ZNHVIJAGMFQGMS-IHPCNDPISA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
88374,6m3m,DB13713,-7.6,Quifenadine,PZMAHNDJABQWGS-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
125830,6w4h,DB03005,-7.6,"3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-5-Yl]Hexyl]-Phenanthridinium",ISUOMOOYAOQQPZ-UHFFFAOYSA-O,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
32830,6cs2,T3D3744,-7.6,Fumitremorgin C,DBEYVIGIPJSTOR-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
107173,6vxx,DB02660,-7.6,Filaminast,STTRYQAGHGJXJJ-LICLKQGHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81711,6m3m,DB01582,-7.6,Sulfamethazine,ASWVTGNCAZCNNR-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88365,6m3m,DB13696,-7.6,Bromochlorosalicylanilide,QBSGXIBYUQJHMJ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
101132,6vxs,DB04518,-7.6,"3-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamino]-Phenol",JJDRRZFRTKZLFT-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
138944,6w9c,DB12604,-7.6,Sisomicin,URWAJWIAIPFPJE-YFMIWBNJSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
61844,6crv,DB12681,-7.6,Salirasib,WUILNKCFCLNXOK-CFBAGHHKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
32837,6cs2,T3D3751,-7.6,Aurovertin D,UKPVUEBWITXZRF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
89609,6m71,DB00689,-7.6,Cephaloglycin,FUBBGQLTSCSAON-PBFPGSCMSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
138963,6w9c,DB12638,-7.6,PU-H71,SUPVGFZUWFMATN-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
125628,6w4h,DB02738,-7.6,Adenosine-5'-Pentaphosphate,WYJWVZZCMBUPSP-KQYNXXCUSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
73425,6m2n,DB02019,-7.6,Acetyl Dithranol,IXLRLZOYKJERRA-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
125615,6w4h,DB02717,-7.6,Cellotetraose,LUEWUZLMQUOBSB-HGDSAIHNSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
81482,6m3m,DB01246,-7.6,Alimemazine,ZZHLYYDVIOPZBE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
164000,7bv1,DB06951,-7.6,(3R)-3-ethyl-N-[(4-methylphenyl)sulfonyl]-L-aspartic acid,KPHLTCNXHCHMOW-MNOVXSKESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
28587,6cs2,DB08173,-7.6,5-CHLORO-N-(2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO)ETHYL)THIOPHENE-2-CARBOXAMIDE,UCKHUNHXYMAFQM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
107010,6vxx,DB02166,-7.6,Propidium,ZDWVWKDAWBGPDN-UHFFFAOYSA-O,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106408,6vxx,DB00177,-7.6,Valsartan,ACWBQPMHZXGDFX-QFIPXVFZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
139423,6w9c,DB13445,-7.6,Nepinalone,RVXGRCNWGOHSDE-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
62440,6crv,DB13581,-7.6,Rociverine,XPYLKZZOBVLVHB-QDKIRNHSSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57007,6crv,DB03078,-7.6,PASBN,PWDTUFYQEUEVQD-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163303,7bv1,DB04232,-7.6,N-Hydroxy-1-(4-Methoxyphenyl)Sulfonyl-4-Benzyloxycarbonyl-Piperazine-2-Carboxamide,DNGGPLKVDUPXFN-GOSISDBHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
124107,6w4h,DB00769,-7.6,Hydrocortamate,FWFVLWGEFDIZMJ-FOMYWIRZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
99892,6vxs,DB02848,-7.6,"{4-[3-(6,7-Diethoxy-Quinazolin-4-Ylamino)-Phenyl]-Thiazol-2-Yl}-Methanol",ZJESXGUODSBHSK-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
106394,6vxx,DB00162,-7.6,Vitamin A,FPIPGXGPPPQFEQ-OVSJKPMPSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
124102,6w4h,DB00764,-7.6,Mometasone,QLIIKPVHVRXHRI-CXSFZGCWSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
73051,6m2n,DB01531,-7.6,Desomorphine,LNNWVNGFPYWNQE-GMIGKAJZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
13107,6lzg,DB01089,-7.6,Deserpidine,CVBMAZKKCSYWQR-WCGOZPBSSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
11411,6lzg,DB11934,-7.6,Epelsiban,UWHCWRQFNKUYCG-QUZACWSFSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
164013,7bv1,DB06970,-7.6,"2-CHLORO-N-(3-CYANO-5,6-DIHYDRO-4H-CYCLOPENTA[B]THIOPHEN-2-YL)-5-DIETHYLSULFAMOYL-BENZAMIDE",MZCDQILVXXIMEV-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
106373,6vxx,DB00140,-7.6,Riboflavin,AUNGANRZJHBGPY-SCRDCRAPSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
99869,6vxs,DB02819,-7.6,"Mono-[3,4-Dihydroxy-5-(5-Methyl-Benzoimidazol-1-Yl)-Tetrahydor-Furan-2-Ylmethyl] Ester",HGUDFQQPANTQEU-LPWJVIDDSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
139408,6w9c,DB13428,-7.6,Iobenzamic acid,FJYJNLIEGUTPIJ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
13002,6lzg,DB14207,-7.6,Fosinoprilat,WOIWWYDXDVSWAZ-RTWAWAEBSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
139447,6w9c,DB13481,-7.6,Tenidap,LXIKEPCNDFVJKC-QXMHVHEDSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
155868,6wiq,DB11870,-7.6,RG-4733,OJPLJFIFUQPSJR-INIZCTEOSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
69088,6lxt,DB08697,-7.6,"4-(2-aminoethoxy)-N-(3-chloro-5-piperidin-1-ylphenyl)-3,5-dimethylbenzamide",JDYIYIRPQKMWMM-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
27452,6cs2,DB06996,-7.6,D-leucyl-N-(4-carbamimidoylbenzyl)-L-prolinamide,XFNMDMGNNKIXBT-CVEARBPZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
73386,6m2n,DB01964,-7.6,AL5424,ZWTSOJQGEWPWGO-NSHDSACASA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
139491,6w9c,DB13542,-7.6,Bevonium,UHUMRJKDOOEQIG-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
28930,6cs2,DB08555,-7.6,"1-(3-bromophenyl)-7-chloro-6-methoxy-3,4-dihydroisoquinoline",IKGXHBGCVQTQBH-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
124170,6w4h,DB00843,-7.6,Donepezil,ADEBPBSSDYVVLD-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
106953,6vxx,DB01791,-7.6,Piclamilast,RRRUXBQSQLKHEL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
24314,6cs2,DB02030,-7.6,Alpha-Ribazole-5'-Phosphate,ZMRGXEJKZPRBPJ-SYQHCUMBSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
124163,6w4h,DB00834,-7.6,Mifepristone,VKHAHZOOUSRJNA-GCNJZUOMSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
124160,6w4h,DB00831,-7.6,Trifluoperazine,ZEWQUBUPAILYHI-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
106955,6vxx,DB01793,-7.6,SB-409513,ONVZFCHLOZUXRP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106966,6vxx,DB01810,-7.6,"[1-(1-Methyl-4,5-Dioxo-Pent-2-Enylcarbamoyl)-2-Phenyl-Ethyl]-Carbamic Acid Benzyl Ester",NOXVWFAAXREWMI-GURWAVDKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
125413,6w4h,DB02455,-7.6,Fluoresceinylthioureido,VHJFQSRUDVDTEO-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
140966,6w9q,DB00327,-7.6,Hydromorphone,WVLOADHCBXTIJK-YNHQPCIGSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
81453,6m3m,DB01210,-7.6,Levobunolol,IXHBTMCLRNMKHZ-LBPRGKRZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
61999,6crv,DB12928,-7.6,GET-73,QLZOWJNFLXSDSH-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
32708,6cs2,T3D3615,-7.6,Microcystin-LY,SIGQAYSWORHPPH-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
139473,6w9c,DB13514,-7.6,Pranoprofen,TVQZAMVBTVNYLA-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
125274,6w4h,DB02277,-7.6,1-(5-Tert-Butyl-2-Methyl-2h-Pyrazol-3-Yl)-3-(4-Chloro-Phenyl)-Urea,FWIJKWMXNHRSRO-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
62416,6crv,DB13548,-7.6,Dibrompropamidine,GMJFVGRUYJHMCO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106990,6vxx,DB01838,-7.6,"6,4'-Dihydroxy-3-Methyl-3',5'-Dibromoflavone",GKDYOXMZSXVKPP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
139462,6w9c,DB13501,-7.6,Bendazac,BYFMCKSPFYVMOU-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
69441,6lxt,DB09200,-7.6,Rivoglitazone,XMSXOLDPMGMWTH-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
163975,7bv1,DB06921,-7.6,(2S)-2-[3-(AMINOMETHYL)PHENYL]-3-[(R)-HYDROXY{(1R)-2-METHYL-1-[(PHENYLSULFONYL)AMINO]PROPYL}PHOSPHORYL]PROPANOIC ACID,FNZHLCNFXRRIIC-RBUKOAKNSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
99936,6vxs,DB02905,-7.6,"Phosphoric Acid Mono-[3,4-Dihydroxy-5-(5-Hydroxy-Benzoimidazol-1-Yl)Tetrahydro-Furan-2-Ylmethyl] Ester",BVZASCINAVSQNO-PULFBKJNSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
106330,6vxs,DB02930,-7.6,Adenosine 5'-[gamma-thio]triphosphate,NLTUCYMLOPLUHL-KQYNXXCUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
36160,1r42,DB02551,-7.6,"6-[N-(4-Ethyl-1,2,3,4-Tetrahydro-6-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine",LVNMYQLXKMSQTG-AWEZNQCLSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
88707,6m3m,DB14643,-7.6,Methylprednisolone aceponate,DALKLAYLIPSCQL-YPYQNWSCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
61932,6crv,DB12825,-7.6,Lefamulin,KPVIXBKIJXZQJX-FCEONZPQSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
99781,6vxs,DB02699,-7.6,4-Oxoretinol,PLIUCYCUYQIBDZ-RMWYGNQTSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
139307,6w9c,DB13300,-7.6,Epicillin,RPBAFSBGYDKNRG-NJBDSQKTSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139304,6w9c,DB13294,-7.6,Azidamfenicol,SGRUZFCHLOFYHZ-MWLCHTKSSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
13121,6lzg,DB14723,-7.6,Larotrectinib,NYNZQNWKBKUAII-KBXCAEBGSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
88592,6m3m,DB14083,-7.6,Bisphenol A diglycidyl ether,LCFVJGUPQDGYKZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80804,6m3m,DB00449,-7.6,Dipivefrin,OCUJLLGVOUDECM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
32757,6cs2,T3D3670,-7.6,Aflatoxin G,XWIYFDMXXLINPU-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
100908,6vxs,DB04209,-7.6,Dequalinium,PCSWXVJAIHCTMO-UHFFFAOYSA-P,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
124034,6w4h,DB00683,-7.6,Midazolam,DDLIGBOFAVUZHB-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
56432,6crv,DB02324,-7.6,5-Iodo-2'-Deoxyuridine-5'-Monophosphate,WXFYBFRZROJDLL-RRKCRQDMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
125554,6w4h,DB02640,-7.6,Fumagillin,NGGMYCMLYOUNGM-CSDLUJIJSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
125569,6w4h,DB02658,-7.6,"2,4-Dinitrophenyl 2-Deoxy-2-Fluoro-Beta-D-Allopyranoside",UFSBFVZQJZMIOU-LZQZFOIKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
139248,6w9c,DB13217,-7.6,Fentiazac,JIEKMACRVQTPRC-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
27410,6cs2,DB06947,-7.6,1-[(2R)-2-aminobutanoyl]-N-(4-carbamimidoylbenzyl)-L-prolinamide,YHAMQFKGUUSJMU-KGLIPLIRSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
124032,6w4h,DB00680,-7.6,Moricizine,FUBVWMNBEHXPSU-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
88565,6m3m,DB14033,-7.6,Acetyl sulfisoxazole,JFNWFXVFBDDWCX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81561,6m3m,DB01414,-7.6,Cefacetrile,RRYMAQUWDLIUPV-BXKDBHETSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
139226,6w9c,DB13166,-7.6,Zofenopril,IAIDUHCBNLFXEF-MNEFBYGVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
62516,6crv,DB13680,-7.6,Naftazone,TZGBBMBARSFJBG-UKTHLTGXSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27664,6cs2,DB07217,-7.6,"N-(3-cyano-4,5,6,7-tetrahydro-1-benzothien-2-yl)-2-fluorobenzamide",YVYPYORTKAIUGJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
69508,6lxt,DB09291,-7.6,Rolapitant,FIVSJYGQAIEMOC-ZGNKEGEESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
81545,6m3m,DB01388,-7.6,Mibefradil,HBNPJJILLOYFJU-VMPREFPWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81452,6m3m,DB01209,-7.6,Dezocine,VTMVHDZWSFQSQP-VBNZEHGJSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
100889,6vxs,DB04186,-7.6,"N'-(Pyrrolidino[2,1-B]Isoindolin-4-On-8-Yl)-N-(Pyridin-2-Yl)Urea",KLVYMYQTRZCMLE-CYBMUJFWSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
156472,6wiq,DB13164,-7.6,Olmutinib,FDMQDKQUTRLUBU-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
100848,6vxs,DB04137,-7.6,Guanosine-5'-Triphosphate,XKMLYUALXHKNFT-UUOKFMHZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
648,6lzg,HMDB0000241,-7.6,Protoporphyrin IX,KSFOVUSSGSKXFI-UJJXFSCMSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
139389,6w9c,DB13403,-7.6,Oxypertine,XCWPUUGSGHNIDZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
73412,6m2n,DB02001,-7.6,"5-(4-Morpholin-4-Yl-Phenylsulfanyl)-2,4-Quinazolinediamine",CZLWCJRHDBTCGQ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
124065,6w4h,DB00717,-7.6,Norethisterone,VIKNJXKGJWUCNN-XGXHKTLJSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
107030,6vxx,DB02195,-7.6,"3-(4-Fluorophenyl)-1-Hydroxy-2-(Pyridin-4-Yl)-1h-Pyrrolo[3,2-B]Pyridine",ZSMYZLKEZDYVPI-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163287,7bv1,DB04209,-7.6,Dequalinium,PCSWXVJAIHCTMO-UHFFFAOYSA-P,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
156441,6wiq,DB13101,-7.6,4SC-202,PRXXYMVLYKJITB-IZZDOVSWSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
62484,6crv,DB13642,-7.6,Pridinol,RQXCLMGKHJWMOA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163273,7bv1,DB04194,-7.6,Chitotriose,WZZVUHWLNMNWLW-VFCSDQTKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
139315,6w9c,DB13310,-7.6,Ormeloxifene,XZEUAXYWNKYKPL-WDYNHAJCSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139366,6w9c,DB13368,-7.6,Motretinide,IYIYMCASGKQOCZ-DJRRULDNSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
163262,7bv1,DB04177,-7.6,"4-(3,14-Dihydroxy-10,13-Dimethyl-Hexadecahydro-Cyclopenta[a]Phenanthren-17-Yl)-5h-Furan-2-One",XZTUSOXSLKTKJQ-CESUGQOBSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
24550,6cs2,DB02315,-7.6,Cyclic GMP,ZOOGRGPOEVQQDX-UUOKFMHZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
88656,6m3m,DB14471,-7.6,2-Ethylhexyl 4-phenylbenzophenone-2'-carboxylate,TWAOKHHZKFMFMD-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88642,6m3m,DB14201,-7.6,"2,2'-Dibenzothiazyl disulfide",AFZSMODLJJCVPP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
62488,6crv,DB13648,-7.6,Alcuronium,MUQUYTSLDVKIOF-CHJKCJHBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
156470,6wiq,DB13158,-7.6,Clobetasone,XXIFVOHLGBURIG-OZCCCYNHSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
124050,6w4h,DB00700,-7.6,Eplerenone,JUKPWJGBANNWMW-VWBFHTRKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
99789,6vxs,DB02709,-7.6,Resveratrol,LUKBXSAWLPMMSZ-OWOJBTEDSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
141162,6w9q,DB00568,-7.6,Cinnarizine,DERZBLKQOCDDDZ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
155835,6wiq,DB11799,-7.6,Bictegravir,SOLUWJRYJLAZCX-LYOVBCGYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
12995,6lzg,DB14196,-7.6,"N-Cyclohexyl-N'-phenyl-1,4-phenylenediamine",ZRMMVODKVLXCBB-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
47665,2fxp,DB02112,-7.6,Zk-806450,DZLGSWPXZYDHBD-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
13320,6lzg,DB15138,-7.6,AZD-9496,DFBDRVGWBHBJNR-BBNFHIFMSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
61559,6crv,DB12264,-7.6,Atevirdine,UCPOMLWZWRTIAA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
133572,6w9c,DB01860,-7.6,Cordycepin Triphosphate,NLIHPCYXRYQPSD-BAJZRUMYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
12054,6lzg,DB12812,-7.6,Palomid 529,YEAHTLOYHVWAKW-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
104452,6vxs,DB12022,-7.6,Evatanepag,WOHRHWDYFNWPNG-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
160884,7bv1,DB11865,-7.6,Brivanib alaninate,LTEJRLHKIYCEOX-OCCSQVGLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
86253,6m3m,DB08623,-7.6,"2-[CARBOXY-(2-THIOPHEN-2-YL-ACETYLAMINO)-METHYL]-5-METHYLENE-5,6-DIHYDRO-2H-[1,3]THIAZINE-4-CARBOXYLIC ACID",VBBNCGUNWSPHOY-QWRGUYRKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
60285,6crv,DB08465,-7.6,"2-(3-AMINO-2,5,6-TRIMETHOXYPHENYL)ETHYL 5-CHLORO-2,4-DIHYDROXYBENZOATE",DFYGLJKFZQGYPA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104446,6vxs,DB12011,-7.6,Fevipiprant,GFPPXZDRVCSVNR-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
158992,7bv1,DB02998,-7.6,Metribolone,CCCIJQPRIXGQOE-XWSJACJDSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
133512,6w9c,DB01782,-7.6,"2,6-Dihydroanthra/1,9-Cd/Pyrazol-6-One",ACPOUJIDANTYHO-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
102964,6vxs,DB08012,-7.6,(METHYLPYRIDAZINE PIPERIDINE ETHYLOXYPHENYL)ETHYLACETATE,KCHIOGFOPPOUJC-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102965,6vxs,DB08013,-7.6,(METHYLPYRIDAZINE PIPERIDINE PROPYLOXYPHENYL)ETHYLACETATE,UEIUDEUUVLYRFV-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102966,6vxs,DB08014,-7.6,(METHYLPYRIDAZINE PIPERIDINE BUTYLOXYPHENYL)ETHYLACETATE,AQILFLLHLFBLLG-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
129779,6w4h,DB09313,-7.6,Ioxaglic acid,TYYBFXNZMFNZJT-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
60278,6crv,DB08458,-7.6,(4-BROMOPHENYL)[4-({(2E)-4-[CYCLOPROPYL(METHYL)AMINO]BUT-2-ENYL}OXY)PHENYL]METHANONE,JAZMZJDLZUDIDG-NSCUHMNNSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
129783,6w4h,DB09330,-7.6,Osimertinib,DUYJMQONPNNFPI-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
129820,6w4h,DB09534,-7.6,Ecamsule,HEAHZSUCFKFERC-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
133448,6w9c,DB01697,-7.6,beta-cellotriose,FYGDTMLNYKFZSV-CSHPIKHBSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
133384,6w9c,DB01615,-7.6,Aceprometazine,XLOQNFNTQIRSOX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
102986,6vxs,DB08035,-7.6,"1-TERT-BUTYL-3-(2,5-DIMETHYLBENZYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE",QUPXEJURIFFVSX-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
159054,7bv1,DB03084,-7.6,"Cyclopropyl-{4-[5-(3,4-Dichlorophenyl)-2-[(1-Methyl)-Piperidin]-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine",XCTKFTOEAKJMII-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
84440,6m3m,DB06185,-7.6,Forodesine,IWKXDMQDITUYRK-KUBHLMPHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58953,6crv,DB06902,-7.6,4-(1-methyl-1-phenylethyl)phenol,QBDSZLJBMIMQRS-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86234,6m3m,DB08600,-7.6,"5-CHLORO-8-METHYL-7-(3-METHYL-BUT-2-ENYL)-6,7,8,9-TETRAHYDRO-2H-2,7,9A-TRIAZA-BENZO[CD]AZULENE-1-THIONE",ZNFFMCYSMBXZQU-NSHDSACASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
129732,6w4h,DB09232,-7.6,Cilnidipine,KJEBULYHNRNJTE-DHZHZOJOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
102981,6vxs,DB08030,-7.6,3-[(4'-cyanobiphenyl-4-yl)oxy]-N-hydroxypropanamide,XZWFHJUEAVOHHG-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
60262,6crv,DB08439,-7.6,Parecoxib,TZRHLKRLEZJVIJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84434,6m3m,DB06166,-7.6,Fosdevirine,CGBYTKOSZYQOPV-CCEZBSFNSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
160868,7bv1,DB11837,-7.6,Osilodrostat,USUZGMWDZDXMDG-CYBMUJFWSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
102975,6vxs,DB08023,-7.6,"N-cyclohexyl-4-imidazo[1,2-a]pyridin-3-yl-N-methylpyrimidin-2-amine",HYNNWLVWJXWXFO-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
129847,6w4h,DB11184,-7.6,Oftasceine,DEGAKNSWVGKMLS-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
129833,6w4h,DB11115,-7.6,Ensulizole,UVCJGUGAGLDPAA-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
129895,6w4h,DB11371,-7.6,Alfaxalone,DUHUCHOQIDJXAT-OLVMNOGESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
60254,6crv,DB08430,-7.6,PARA-NITROPHENYL 1-THIO-BETA-D-GLUCOPYRANOSIDE,IXFOBQXJWRLXMD-ZIQFBCGOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
33992,6cs2,T3D0798,-7.6,Fipronil,ZOCSXAVNDGMNBV-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
133601,6w9c,DB01906,-7.6,"3-(5-Amino-7-Hydroxy-[1,2,3]Triazolo[4,5-D]Pyrimidin-2-Yl)-Benzoic Acid",KNLLRZNGRRRPEW-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
71869,6lxt,DB15446,-7.6,Vidofludimus,XPRDUGXOWVXZLL-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
158882,7bv1,DB02586,-7.6,"4,7-Dimethyl-[1,10]Phenanthroline",JIVLDFFWTQYGSR-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
102868,6vxs,DB07901,-7.6,5-CHLORO-6-METHYL-N-(2-PHENYLETHYL)-2-PYRIDIN-2-YLPYRIMIDIN-4-AMINE,HIUOABSWQSUEGK-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102881,6vxs,DB07920,-7.6,N-oxo-2-[(4-phenylphenyl)sulfonylamino]ethanamide,OGRPZMQLAVBWPV-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
133762,6w9c,DB02116,-7.6,Olomoucine,GTVPOLSIJWJJNY-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
160937,7bv1,DB12291,-7.6,Tacedinaline,VAZAPHZUAVEOMC-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
84346,6m3m,DB05644,-7.6,KP-1461,SZWIAFVYPPMZML-YNEHKIRRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84354,6m3m,DB05680,-7.6,Sotirimod,ZXBCLVSLRUWISJ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
129638,6w4h,DB09083,-7.6,Ivabradine,ACRHBAYQBXXRTO-OAQYLSRUSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
84366,6m3m,DB05786,-7.6,Irofulven,NICJCIQSJJKZAH-AWEZNQCLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
158890,7bv1,DB02596,-7.6,"Alpha,Beta-Methyleneadenosine-5'-Triphosphate",CAWZRIXWFRFUQB-IOSLPCCCSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
84371,6m3m,DB05805,-7.6,NS-2359,PGYDXVBZYKQYCS-VPWBDBDCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86292,6m3m,DB08673,-7.6,"4-[(5-ISOPROPYL-1,3-THIAZOL-2-YL)AMINO]BENZENESULFONAMIDE",LPQUJAANWFHCJV-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
158905,7bv1,DB02616,-7.6,FR117016,CKJGKHXCUDWFDC-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
129671,6w4h,DB09166,-7.6,Etizolam,VMZUTJCNQWMAGF-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
102904,6vxs,DB07944,-7.6,N-{3-METHYL-5-[2-(PYRIDIN-4-YLAMINO)-ETHOXY]-PHENYL}-BENZENESULFONAMIDE,MPTWCWHNLVMCRW-UHFFFAOYSA-O,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
133668,6w9c,DB01995,-7.6,5-Methylcytidine-5'-Monophosphate,NJQONZSFUKNYOY-JXOAFFINSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
26499,6cs2,DB04644,-7.6,"4-{4-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-2,3-DIMETHYL-PHENOXY}-BUTYRIC ACID",FCEMCUPAYRPTLS-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
133610,6w9c,DB01922,-7.6,"Maltosyl-Alpha (1,4)-D-Gluconhydroximo-1,5-Lactam",AHRWQUNEPBVNOT-IVJVVCOPSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
86271,6m3m,DB08647,-7.6,TRAZEOLIDE,YUTXECPABXNXPU-DJJJIMSYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
12049,6lzg,DB12804,-7.6,Daniquidone,SRIOCKJKFXAKHK-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
133628,6w9c,DB01945,-7.6,4-Carbamoyl-1-Beta-D-Ribofuranosyl-Imidazolium-5-Olate-5'-Phosphate,KTKAFSMJDTUUAN-UUOKFMHZSA-L,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
129701,6w4h,DB09197,-7.6,Mepiprazole,DOTIMEKVTCOGED-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
158961,7bv1,DB02691,-7.6,Glycocholic acid,RFDAIACWWDREDC-FRVQLJSFSA-M,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160908,7bv1,DB12253,-7.6,GDC-0810,BURHGPHDEVGCEZ-KJGLQBJMSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
158938,7bv1,DB02659,-7.6,Cholic Acid,BHQCQFFYRZLCQQ-OELDTZBJSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
58890,6crv,DB06826,-7.6,Unoprostone,TVHAZVBUYQMHBC-SNHXEXRGSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
129682,6w4h,DB09178,-7.6,Phenaridine,ODPKHHGQKIYCTJ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
102930,6vxs,DB07974,-7.6,1-{2-[(4-CHLOROPHENYL)AMINO]-2-OXOETHYL}-N-(1-ISOPROPYLPIPERIDIN-4-YL)-1H-INDOLE-2-CARBOXAMIDE,BDLMBQRBNPDCSS-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
158921,7bv1,DB02639,-7.6,4-methylumbelliferyl ??-D-glucoside,YUDPTGPSBJVHCN-JZYAIQKZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
133651,6w9c,DB01972,-7.6,Guanosine-5'-Monophosphate,RQFCJASXJCIDSX-UUOKFMHZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
58891,6crv,DB06827,-7.6,Viomycin,GXFAIFRPOKBQRV-GHXCTMGLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
160851,7bv1,DB11817,-7.6,Baricitinib,XUZMWHLSFXCVMG-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
34952,1r42,DB00972,-7.6,Azelastine,MBUVEWMHONZEQD-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
133373,6w9c,DB01603,-7.6,Meticillin,RJQXTJLFIWVMTO-TYNCELHUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
159235,7bv1,DB03619,-7.6,Deoxycholic Acid,KXGVEGMKQFWNSR-LLQZFEROSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160762,7bv1,DB11155,-7.6,Triclocarban,ICUTUKXCWQ1Q-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
103079,6vxs,DB08141,-7.6,"4-{[(2,6-difluorophenyl)carbonyl]amino}-N-[(3S)-piperidin-3-yl]-1H-pyrazole-3-carboxamide",KOMNQBZWMCFDTQ-VIFPVBQESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
160756,7bv1,DB11115,-7.6,Ensulizole,UVCJGUGAGLDPAA-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
86091,6m3m,DB08432,-7.6,THYMIDINE-5'-THIOPHOSPHATE,OJRKJKYGUAALCJ-XLPZGREQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
70928,6lxt,DB13411,-7.6,Lofepramine,SAPNXPWPAUFAJU-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
160733,7bv1,DB09488,-7.6,Acrivastine,PWACSDKDOHSSQD-IUTFFREVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60176,6crv,DB08329,-7.6,Sulthiame,HMHVCUVYZFYAJI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
103088,6vxs,DB08150,-7.6,"4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-aminium",RZIDZIGAXXNODG-UHFFFAOYSA-O,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
86076,6m3m,DB08412,-7.6,6-{4-[HYDROXY-(4-NITRO-PHENOXY)-PHOSPHORYL]-BUTYRYLAMINO}-HEXANOIC ACID,WYHHVZLGTMCKOR-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
22204,6cs2,HMDB0053241,-7.6,"TG(18:3(6Z,9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:2(13Z,16Z))",UIGZHQJJRVXCAK-UZEGLSSWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
133120,6w9c,DB01231,-7.6,Diphenidol,OGAKLTJNUQRZJU-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
59024,6crv,DB06989,-7.6,{4-[2-BENZYL-3-METHOXY-2-(METHOXYCARBONYL)-3-OXOPROPYL]PHENYL}SULFAMIC ACID,SUACYXRSGYYBGT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130085,6w4h,DB11750,-7.6,Clobetasol,FCSHDIVRCWTZOX-DVTGEIKXSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
104369,6vxs,DB11900,-7.6,OC-459,FATGTHLOZSXOBC-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
130089,6w4h,DB11757,-7.6,Istradefylline,IQVRBWUUXZMOPW-PKNBQFBNSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
86062,6m3m,DB08394,-7.6,PARA-NITROPHENYLPHOSPHONOBUTANOYL-GLYCINE,WLNKGRQBMNPVSJ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
104352,6vxs,DB11875,-7.6,"3,3'-diindolylmethane",VFTRKSBEFQDZKX-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
133040,6w9c,DB01139,-7.6,Cefapirin,UQLLWWBDSUHNEB-CZUORRHYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
160683,7bv1,DB09274,-7.6,Artesunate,FIHJKUPKCHIPAT-AHIGJZGOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160684,7bv1,DB09279,-7.6,Fimasartan,AMEROGPZOLAFBN-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
133046,6w9c,DB01146,-7.6,Diphenylpyraline,OWQUZNMMYNAXSL-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
160692,7bv1,DB09289,-7.6,Tianeptine,JICJBGPOMZQUBB-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
17588,6cs2,HMDB0000305,-7.6,Vitamin A,FPIPGXGPPPQFEQ-HWCYFHEPSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
60138,6crv,DB08287,-7.6,"(1R,2R)-N-(2-Aminoethyl)-2-{[(4-methoxyphenyl)sulfonyl]methyl}cyclohexanecarboxamide",QTGNVZPFJQOWFL-XJKSGUPXSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
133068,6w9c,DB01172,-7.6,Kanamycin,SBUJHOSQTJFQJX-NOAMYHISSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
25677,6cs2,DB03671,-7.6,"4-(3,12,14-Trihydroxy-10,13-Dimethyl-Hexadecahydro-Cyclopenta[a]Phenanthren-17-Yl)-5h-Furan-2-One",SHIBSTMRCDJXLN-KCZCNTNESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
103114,6vxs,DB08177,-7.6,(E)-3-(5((5-(4-CHLOROPHENYL)FURAN-2-YL)METHYLENE)-4-OXO-2-THIOXOTHIAZOLIDIN-3-YL)PROPANOIC ACID,YZLFZFALAZYTCI-NTEUORMPSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
71750,6lxt,DB15206,-7.6,Uprifosbuvir,SFPFZQKYPOWCSI-KHFYHRBSSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
159284,7bv1,DB03687,-7.6,4-Diphosphocytidyl-2-C-Methyl-D-Erythritol,YFAUKWZNPVBCFF-XHIBXCGHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
86060,6m3m,DB08392,-7.6,"2-[5,6-BIS-(4-METHOXY-PHENYL)-FURO[2,3-D]PYRIMIDIN-4-YLAMINO]-ETHANOL",ARBUGBBNEFAECO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
160693,7bv1,DB09290,-7.6,Ramosetron,NTHPAPBPFQJABD-LLVKDONJSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
86121,6m3m,DB08466,-7.6,"5-[2-(4-hydroxyphenyl)ethyl]benzene-1,3-diol",HITJFUSPLYBJPE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
159230,7bv1,DB03609,-7.6,3-Deoxyguanosine,OROIAVZITJBGSM-OBXARNEKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
130044,6w4h,DB11687,-7.6,E-6201,MWUFVYLAWAXDHQ-HMNLTAHHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
133280,6w9c,DB01491,-7.6,Dipipanone,SVDHSZFEQYXRDC-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
129958,6w4h,DB11485,-7.6,Ceftiofur,ZBHXIWJRIFEVQY-IHMPYVIRSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
17646,6cs2,HMDB0000347,-7.6,16b-Hydrox1tradiol,PROQIPRRNZUXQM-ZMSHIADSSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
129954,6w4h,DB11478,-7.6,Zeranol,DWTTZBARDOXEAM-GXTWGEPZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
133327,6w9c,DB01547,-7.6,Drotebanol,LCAHPIFLPICNRW-OPGCRTJHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
58964,6crv,DB06914,-7.6,"1-({2-[2-(4-CHLOROPHENYL)ETHYL]-1,3-DIOXOLAN-2-YL}METHYL)-1H-IMIDAZOLE",NPIOYRIZNLPLDH-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
129968,6w4h,DB11518,-7.6,Flunixin,NOOCSNJCXJYGPE-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
159081,7bv1,DB03116,-7.6,5-(1-Carboxy-1-Phosphonooxy-Ethoxyl)-Shikimate-3-Phosphate,QUQKBSPZUVNKIF-JQCUSGDOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
103001,6vxs,DB08054,-7.6,"1-(1-methylethyl)-3-quinolin-6-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine",GEZALMMCQYDFML-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
133364,6w9c,DB01589,-7.6,Quazepam,IKMPWMZBZSAONZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
71810,6lxt,DB15324,-7.6,ORM-13070 C-11,VGIYMYGMVXPMKV-GWDMYEQXSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
86220,6m3m,DB08582,-7.6,"N-(4-bromo-2-{[(3R,5S)-3,5-dimethylpiperidin-1-yl]carbonyl}phenyl)-4-morpholin-4-yl-4-oxobutanamide",DELARNBPJXTDBD-IYBDPMFKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
34017,6cs2,T3D0842,-7.6,"6,7-Dihydroxybergamottin",VDZZXXJFQJNSPL-RVDMUPIBSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
70848,6lxt,DB13310,-7.6,Ormeloxifene,XZEUAXYWNKYKPL-WDYNHAJCSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
25617,6cs2,DB03593,-7.6,N7-Methyl-Guanosine-5'-Monophosphate,AOKQNZVJJXPUQA-KQYNXXCUSA-O,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
25544,6cs2,DB03495,-7.6,"4,6-Dideoxy-4-{[4,5,6-Trihydroxy-3-(Hydroxymethyl)Cyclohex-2-En-1-Yl]Amino}-Alpha-D-Lyxo-Hexopyranosyl-(1->4)-Alpha-D-Threo-Hexopyranosyl-(1->6)-Alpha-L-Threo-Hexopyranose",FZLCJZILHGFQLM-PISLJJGOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
86172,6m3m,DB08526,-7.6,CARBOBENZYLOXY-(L)-LEUCINYL-(L)LEUCINYL METHOXYMETHYLKETONE,LHCNZPLAATYYPI-SLFFLAALSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86170,6m3m,DB08524,-7.6,2-(3-BENZOYLPHENOXY)ETHYL(HYDROXY)FORMAMIDE,ZHFKBNAHHTUQBH-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
130040,6w4h,DB11682,-7.6,Daprodustat,RUEYEZADQJCKGV-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
133180,6w9c,DB01348,-7.6,Spirapril,HRWCVUIFMSZDJS-SZMVWBNQSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
84522,6m3m,DB06397,-7.6,Nicaraven,KTXBOOWDLPUROC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
130034,6w4h,DB11674,-7.6,Equol,ADFCQWZHKCXPAJ-GFCCVEGCSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
133197,6w9c,DB01388,-7.6,Mibefradil,HBNPJJILLOYFJU-VMPREFPWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
130016,6w4h,DB11648,-7.6,Afuresertib,AFJRDFWMXUECEW-LBPRGKRZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
26438,6cs2,DB04574,-7.6,Estrone sulfate,JKKFKPJIXZFSSB-CBZIJGRNSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
130011,6w4h,DB11638,-7.6,Artenimol,BJDCWCLMFKKGEE-HVDUHBCDSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
160787,7bv1,DB11269,-7.6,Diethylamino hydroxybenzoyl hexyl benzoate,FDATWRLUYRHCJE-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
133215,6w9c,DB01416,-7.6,Cefpodoxime,WYUSVOMTXWRGEK-HBWVYFAYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
160799,7bv1,DB11741,-7.6,Famitinib,GKEYKDOLBLYGRB-LGMDPLHJSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
103036,6vxs,DB08095,-7.6,"3-(2-CHLOROPHENYL)-1-(2-{[(1S)-2-HYDROXY-1,2-DIMETHYLPROPYL]AMINO}PYRIMIDIN-4-YL)-1-(4-METHOXYPHENYL)UREA",ZWYFTKPEHRQCCW-HNNXBMFYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
84491,6m3m,DB06282,-7.6,Levocetirizine,ZKLPARSLTMPFCP-OAQYLSRUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58997,6crv,DB06952,-7.6,(2S)-2-HYDROXY-2H-CHROMENE-2-CARBOXYLIC ACID,LGYIZQLNYONEFJ-JTQLQIEISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130009,6w4h,DB11636,-7.6,Nomegestrol,KZUIYQJTUIACIG-YBZCJVABSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
58846,6crv,DB06739,-7.6,Seratrodast,ZBVKEHDGYSLCCC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
133837,6w9c,DB02221,-7.6,"4-(Aminosulfonyl)-N-[(2,4,6-Trifluorophenyl)Methyl]-Benzamide",DVTYOTODFLDHRL-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
129583,6w4h,DB08998,-7.6,Demexiptiline,SEDQWOMFMIJKCU-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
134547,6w9c,DB03221,-7.6,AL7099A,RMOXCYSVWCHXII-GFCCVEGCSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
25438,6cs2,DB03358,-7.6,7n-Methyl-8-Hydroguanosine-5'-Triphosphate,BUJQMJUTTBGELS-KQYNXXCUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
102696,6vxs,DB07704,-7.6,"6-AMINO-4-[2-(4-METHOXYPHENYL)ETHYL]-1,7-DIHYDRO-8H-IMIDAZO[4,5-G]QUINAZOLIN-8-ONE",UKRVQKUVWNDGMN-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
26667,6cs2,DB04845,-7.6,Ixabepilone,FABUFPQFXZVHFB-PVYNADRNSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
6346,6lzg,DB00278,-7.6,Argatroban,KXNPVXPOPUZYGB-IOVMHBDKSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
134512,6w9c,DB03176,-7.6,KB-141,OZYQIQVPUZANTM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
25450,6cs2,DB03370,-7.6,FR239087,HCJYSIGJDKNVRU-TVQRCGJNSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
102703,6vxs,DB07713,-7.6,"(1S)-1-{[(4'-methoxy-1,1'-biphenyl-4-yl)sulfonyl]amino}-2-methylpropylphosphonic acid",BZVYQWLRCHLAGK-KRWDZBQOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
158591,7bv1,DB01668,-7.6,Nanaomycin D,XUWPJKDMEZSVTP-UOSCCXBLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
158603,7bv1,DB01685,-7.6,Topiroxostat,UBVZQGOVTLIHLH-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
71995,6m2n,DB00215,-7.6,Citalopram,WSEQXVZVJXJVFP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
71993,6m2n,DB00213,-7.6,Pantoprazole,IQPSEEYGBUAQFF-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
129226,6w4h,DB08540,-7.6,"2-[4-(2H-1,4-BENZOTHIAZINE-3-YL)-PIPERAZINE-1-LY]-1,3-THIAZOLE-4-CARBOXYLIC ACID ETHYLESTER",AQJQFCRTSWIUCY-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
60504,6crv,DB08728,-7.6,"5-(3-(2,6-dichloro-4-(4,5-dihydro-2-oxazolyl)phenoxy)propyl)-3-methyl isoxazole",TUGBWRGTMLOFAX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
158631,7bv1,DB01720,-7.6,(2z)-2-(Benzoylamino)-3-[4-(2-Bromophenoxy)Phenyl]-2-Propenoic Acid,WLPJLQNKCJWAFL-RGEXLXHISA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
6329,6lzg,DB01941,-7.6,"6-[1-(3,5,5,8,8-Pentamethyl-5,6,7,8-Tetrahydronaphthalen-2-Yl)Cyclopropyl]Pyridine-3-Carboxylic Acid",SLXTWXQUEZSSTJ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
35105,1r42,DB01147,-7.6,Cloxacillin,LQOLIRLGBULYKD-JKIFEVAISA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
26631,6cs2,DB04812,-7.6,Benoxaprofen,MITFXPHMIHQXPI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
161133,7bv1,DB12930,-7.6,Opipramol,YNZFUWZUGRBMHL-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
11992,6lzg,DB12719,-7.6,Turofexorate isopropyl,INASOKQDNHHMRE-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
26635,6cs2,DB04816,-7.6,Dantron,QBPFLULOKWLNNW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
129282,6w4h,DB08609,-7.6,"(2R)-N-{4-[Ethyl(phenyl)sulfamoyl]-2-methylphenyl}-3,3,3-trifluoro-2-hydroxy-2-methylpropanamide",SHEIQJGQDUYUBE-GOSISDBHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
71977,6m2n,DB00192,-7.6,Indecainide,UCEWGESNIULAGX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
134552,6w9c,DB03227,-7.6,Nicotinamide Mononucleotide,DAYLJWODMCOQEW-WYOJIJJFSA-O,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
11989,6lzg,DB12715,-7.6,MSX-122,PXZXYRKDDXKDTK-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
104634,6vxs,DB12286,-7.6,Simendan,WHXMKTBCFHIYNQ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
26653,6cs2,DB04832,-7.6,Zimelidine,OYPPVKRFBIWMSX-SXGWCWSVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
86406,6m3m,DB08801,-7.6,Dimetindene,MVMQESMQSYOVGV-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
129243,6w4h,DB08560,-7.6,3-FLUORO-N-[1-(4-FLUOROPHENYL)-3-(2-THIENYL)-1H-PYRAZOL-5-YL]BENZENESULFONAMIDE,GULUFDCOGAXLEP-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
158650,7bv1,DB01748,-7.6,N-Benzyl-4-Sulfamoyl-Benzamide,CZKNSZUJCJHTTM-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60502,6crv,DB08726,-7.6,"5-(7-(4-(4,5-dihydro-2-oxazolyl)phenoxy)heptyl)-3-methyl isoxazole",FKLJPTJMIBLJAV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104633,6vxs,DB12285,-7.6,Verubecestat,YHYKUSGACIYRML-KRWDZBQOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
134555,6w9c,DB03230,-7.6,Adenosine-5'-Propylphosphate,XAMXMSZRQHPMRX-QYVSTXNMSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
134559,6w9c,DB03235,-7.6,N-{3-[4-(3-aminopropyl)piperazin-1-yl]propyl}-3-(alpha-D-galactopyranosyloxy)-5-nitrobenzamide,UEIGEWJJVQHIAX-MKQKURRLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
72018,6m2n,DB00240,-7.6,Alclometasone,FJXOGVLKCZQRDN-PHCHRAKRSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
58620,6crv,DB06209,-7.6,Prasugrel,DTGLZDAWLRGWQN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
26701,6cs2,DB04886,-7.6,Calanolide A,NIDRYBLTWYFCFV-FMTVUPSXSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
129120,6w4h,DB08416,-7.6,"(9BETA,13ALPHA,14BETA,17ALPHA)-2-METHOX1TRA-1,3,5(10)-TRIENE-3,17-DIYL DISULFAMATE",AQSNIXKAKUZPSI-SSTWWWIQSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
129119,6w4h,DB08414,-7.6,"6-CHLORO-2-(1-FURO[2,3-C]PYRIDIN-5-YL-ETHYLSULFANYL)-PYRIMIDIN-4-YLAMINE",ATCRIOJPQXDFNY-ZETCQYMHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
134694,6w9c,DB03413,-7.6,Deoxyuridine-5'-Diphosphate,QHWZTVCCBMIIKE-SHYZEUOFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
35154,1r42,DB01200,-7.6,Bromocriptine,OZVBMTJYIDMWIL-AYFBDAFISA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
72029,6m2n,DB00252,-7.6,Phenytoin,CXOFVDLJLONNDW-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
129104,6w4h,DB08395,-7.6,2-(ETHOXYMETHYL)-4-(4-FLUOROPHENYL)-3-[2-(2-HYDROXYPHENOXY)PYRIMIDIN-4-YL]ISOXAZOL-5(2H)-ONE,ZSOXFJURLPCSOO-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
129102,6w4h,DB08393,-7.6,"2-[(5,6-DIPHENYLFURO[2,3-D]PYRIMIDIN-4-YL)AMINO]ETHANOL",UQHINZSKNAAVOZ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
129101,6w4h,DB08392,-7.6,"2-[5,6-BIS-(4-METHOXY-PHENYL)-FURO[2,3-D]PYRIMIDIN-4-YLAMINO]-ETHANOL",ARBUGBBNEFAECO-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
134723,6w9c,DB03458,-7.6,"N(4)-Adenosyl-N(4)-methyl-2,4-diaminobutanoic acid",JISVTSUBJCPLSV-TWBCTODHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
72044,6m2n,DB00270,-7.6,Isradipine,HMJIYCCIJYRONP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
129094,6w4h,DB08385,-7.6,4-(quinolin-3-ylmethyl)piperidine-1-carboxylic acid,QUAGUFNCKDDJFZ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
134755,6w9c,DB03503,-7.6,"4-Acetyl-4-Guanidino-6-Methyl(Propyl)Carboxamide-4,5-Dihydro-2h-Pyran-2-Carboxylic Acid",QPJWMZVTNXFTKV-JMJZKYOTSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
86511,6m3m,DB08965,-7.6,Fusafungine,MIZMDSVSLSIMSC-OGLSAIDSSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
134320,6w9c,DB02916,-7.6,"[(2r,3s,4r,5r)-5-(6-Amino-9h-Purin-9-Yl)-3,4-Dihydroxytetrahydro-2-Furanyl]Methyl Sulfamate",GNZLUJQJDPRUTD-KQYNXXCUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
134654,6w9c,DB03358,-7.6,7n-Methyl-8-Hydroguanosine-5'-Triphosphate,BUJQMJUTTBGELS-KQYNXXCUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
134648,6w9c,DB03349,-7.6,8-Bromo-Adenosine-5'-Monophosphate,DNPIJKNXFSPNNY-UUOKFMHZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
134572,6w9c,DB03249,-7.6,2'-O-Methyl-3'-Methyl-3'-Deoxy-Arabinofuranosyl-Thymine-5'-Phosphate,MCXXETKRWYMFCI-TURQNECASA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
129166,6w4h,DB08471,-7.6,"1-(thiophen-2-ylacetyl)-4-(3-thiophen-2-yl-1,2,4-oxadiazol-5-yl)piperidine",SJEVDMFUHCVNPM-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
104664,6vxs,DB12322,-7.6,GW-870086,WUBKGTSFJSEIEM-NSHBDUGJSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
134590,6w9c,DB03273,-7.6,3'-Oxo-Adenosine,MIAZJCOESMXYNJ-XMRAEQSQSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
58636,6crv,DB06246,-7.6,Exisulind,MVGSNCBCUWPVDA-MFOYZWKCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86489,6m3m,DB08936,-7.6,Chlorcyclizine,WFNAKBGANONZEQ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
102657,6vxs,DB07654,-7.6,"(5,6-DIPHENYL-FURO[2,3-D]PYRIMIDIN-4-YLAMINO)-ACETIC",VDJWWYRYKMXMKA-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
12549,6lzg,DB01029,-7.6,Irbesartan,YOSHYTLCDANDAN-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
70660,6lxt,DB13004,-7.6,Mavoglurant,ZFPZEYHRWGMJCV-ZHALLVOQSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
86492,6m3m,DB08941,-7.6,Isoxsuprine,BMUKKTUHUDJSNZ-HBUWYVDXSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
134628,6w9c,DB03322,-7.6,Dexpropranolol,AQHHHDLHHXJYJD-CQSZACIVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
129136,6w4h,DB08436,-7.6,"8-BENZO[1,3]DIOXOL-,5-YLMETHYL-9-BUTYL-9H-",JCDXXNIRWRRGBX-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
70654,6lxt,DB12996,-7.6,Acteoside,FBSKJMQYURKNSU-ZLSOWSIRSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
26697,6cs2,DB04882,-7.6,Edotecarin,QMVPQBFHUJZJCS-NTKFZFFISA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
11976,6lzg,DB12696,-7.6,BMS-582949,GDTQLZHHDRRBEB-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
104351,6vxs,DB11873,-7.6,Verinurad,YYBOLPLTQDKXPM-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
58713,6crv,DB06458,-7.6,Remacemide,YSGASDXSLKIKOD-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
71962,6m2n,DB00175,-7.6,Pravastatin,TUZYXOIXSAXUGO-PZAWKZKUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
17762,6cs2,HMDB0010348,-7.6,Dehydroepiandrosterone 3-glucuronide,GLONBVCUAVPJFV-PCDHEYSGSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
129490,6w4h,DB08867,-7.6,Ulipristal,HKDLNTKNLJPAIY-WKWWZUSTSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
133997,6w9c,DB02431,-7.6,Cytidine-5'-Triphosphate,PCDQPRRSZKQHHS-XVFCMESISA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
133995,6w9c,DB02429,-7.6,4-(Aminosulfonyl)-N-[(4-Fluorophenyl)Methyl]-Benzamide,IXDVPACDZDRCTN-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
84278,6m3m,DB05271,-7.6,Rotigotine,KFQYTPMOWPVWEJ-INIZCTEOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
60399,6crv,DB08600,-7.6,"5-CHLORO-8-METHYL-7-(3-METHYL-BUT-2-ENYL)-6,7,8,9-TETRAHYDRO-2H-2,7,9A-TRIAZA-BENZO[CD]AZULENE-1-THIONE",ZNFFMCYSMBXZQU-NSHDSACASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
129507,6w4h,DB08897,-7.6,Aclidinium,ASMXXROZKSBQIH-VITNCHFBSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
160989,7bv1,DB12367,-7.6,Selurampanel,MCECSFFXUPEPDB-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
70762,6lxt,DB13174,-7.6,Rhein,FCDLCPWAQCPTKC-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
58812,6crv,DB06694,-7.6,Xylometazoline,HUCJFAOMUPXHDK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
158839,7bv1,DB02527,-7.6,Cyclic adenosine monophosphate,IVOMOUWHDPKRLL-KQYNXXCUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
133941,6w9c,DB02367,-7.6,(1n)-4-N-Butoxyphenylsulfonyl-(2r)-N-Hydroxycarboxamido-(4s)-Methanesulfonylamino-Pyrrolidine,ULDXUWXTVRRUND-SWLSCSKDSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
71908,6m2n,DB00118,-7.6,Ademetionine,MEFKEPWMEQBLKI-AIRLBKTGSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
60378,6crv,DB08575,-7.6,"2-[(1S)-1-BENZYL-2-SULFANYLETHYL]-1H-IMIDAZO[4,5-C]PYRIDIN-5-IUM",DCUCDCAIOMIBEA-GFCCVEGCSA-O,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
160969,7bv1,DB12336,-7.6,GDC-0917,HSHPBORBOJIXSQ-HARLFGEKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
129550,6w4h,DB08962,-7.6,Glibornuride,RMTYNAPTNBJHQI-LLDVTBCESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
102834,6vxs,DB07861,-7.6,(2R)-N-hydroxy-3-naphthalen-2-yl-2-[(naphthalen-2-ylsulfonyl)amino]propanamide,MMOUXLMPQFMDRD-JOCHJYFZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
84344,6m3m,DB05626,-7.6,Retaspimycin,OAKGNIRUXAZDQF-TXHRRWQRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
70781,6lxt,DB13217,-7.6,Fentiazac,JIEKMACRVQTPRC-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
58842,6crv,DB06735,-7.6,Enclomiphene,GKIRPKYJQBWNGO-OCEACIFDSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
133863,6w9c,DB02255,-7.6,GM6001,NITYDPDXAAFEIT-DYVFJYSZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
104521,6vxs,DB12123,-7.6,Cinepazide,RCUDFXMNPQNBDU-VOTSOKGWSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
35030,1r42,DB01061,-7.6,Azlocillin,JTWOMNBEOCYFNV-NFFDBFGFSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
129456,6w4h,DB08810,-7.6,Cinitapride,ZDLBNXXKDMLZMF-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
26534,6cs2,DB04689,-7.6,2-{5-[3-(6-BENZOYL-1-PROPYLNAPHTHALEN-2-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID,ZXWVCCFKIRBLDP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
102843,6vxs,DB07870,-7.6,(2S)-2-(4-{[3-CHLORO-5-(TRIFLUOROMETHYL)PYRIDIN-2-YL]OXY}PHENOXY)PROPANOIC ACID,GOCUAJYOYBLQRH-MRVPVSSYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102842,6vxs,DB07869,-7.6,6-CHLORO-4-(CYCLOHEXYLSULFINYL)-3-PROPYLQUINOLIN-2(1H)-ONE,QRBUGQMJMFAHKS-HSZRJFAPSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
58833,6crv,DB06725,-7.6,Lornoxicam,WLHQHAUOOXYABV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
160962,7bv1,DB12322,-7.6,GW-870086,WUBKGTSFJSEIEM-NSHBDUGJSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160968,7bv1,DB12332,-7.6,Rucaparib,HMABYWSNWIZPAG-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
102840,6vxs,DB07867,-7.6,6-CHLORO-4-(CYCLOHEXYLOXY)-3-PROPYLQUINOLIN-2(1H)-ONE,BNZHKKGOSYAQSW-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
25536,6cs2,DB03486,-7.6,Phosphomethylphosphonic Acid Guanosyl Ester,OCJWYBKRHNXUME-KQYNXXCUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
104564,6vxs,DB12188,-7.6,Zicronapine,BYPMJBXPNZMNQD-PZJWPPBQSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
60424,6crv,DB08633,-7.6,TNP-470,MSHZHSPISPJWHW-PVDLLORBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60426,6crv,DB08635,-7.6,N-(TRANS-4'-NITRO-4-STILBENYL)-N-METHYL-5-AMINO-PENTANOIC ACID,QLLZAVDYYAQESE-AATRIKPKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104582,6vxs,DB12219,-7.6,GSK-424887,DRXBWLBZWAJIEF-IBGZPJMESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102780,6vxs,DB07801,-7.6,N-butyl-3-{[6-(9H-purin-6-ylamino)hexanoyl]amino}benzamide,WOYITRCGMUXUDE-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
26600,6cs2,DB04772,-7.6,1-GUANIDINO-4-(N-PHENYLMETHANESULFONYL-L-LEUCYL-L-PROLYLAMINO)BUTANE,DSVCYWOHJLRGMK-PMACEKPBSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
84262,6m3m,DB05186,-7.6,SQ-109,JFIBVDBTCDTBRH-REZTVBANSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
134229,6w9c,DB02738,-7.6,Adenosine-5'-Pentaphosphate,WYJWVZZCMBUPSP-KQYNXXCUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
84258,6m3m,DB05143,-7.6,OXI-4503,GSOXMQLWUDQTNT-WAYWQWQTSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
1139,6lzg,HMDB0007765,-7.6,"DG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/16:0/0:0)",YSSOTPCOKHYQLF-ZOLFRYQZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
86362,6m3m,DB08751,-7.6,"N,N'-DIMETHYL-N-(ACETYL)-N'-(7-NITROBENZ-2-OXA-1,3-DIAZOL-4-YL)ETHYLENEDIAMINE",YSVJZZZGPPWEIC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
26621,6cs2,DB04797,-7.6,Triazolopyridine,OVCXRBARSPBVMC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
161100,7bv1,DB12884,-7.6,Lavoltidine,VTLNPNNUIJHJQB-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
129328,6w4h,DB08664,-7.6,({3-[1-(4-HYDROXY-2-OXO-2H-CHROMEN-3-YL)-PROPYL]-PHENYLCARBAMOYL}-METHYL)-CARBAMIC ACID TERT-BUTYL ESTER,QUQQVMVIWCUYFV-KRWDZBQOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
71956,6m2n,DB00169,-7.6,Cholecalciferol,QYSXJUFSXHHAJI-YRZJJWOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
134297,6w9c,DB02887,-7.6,"2',3'-Dehydro-2',3'-Deoxy-Thymidine 5'-Triphosphate",ODSQODTUNULBHF-JGVFFNPUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
161112,7bv1,DB12900,-7.6,Irdabisant,XUKROCVZGZNGSI-CQSZACIVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
161094,7bv1,DB12877,-7.6,Oxatomide,BAINIUMDFURPJM-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
104611,6vxs,DB12254,-7.6,ABT-751,URCVCIZFVQDVPM-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
129407,6w4h,DB08755,-7.6,N-[(1S)-2-{[(1R)-2-(benzyloxy)-1-cyano-1-methylethyl]amino}-1-(cyclohexylmethyl)-2-oxoethyl]morpholine-4-carboxamide,MQWUTQCRGGBPBT-WIOPSUGQSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
60443,6crv,DB08655,-7.6,"9-ACETYL-2,3,4,9-TETRAHYDRO-1H-CARBAZOL-1-ONE",MIGJEXKBUJPKJF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
16530,6cs2,HMDB0002655,-7.6,Isorhamnetin,IZQSVPBOUDKVDZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
129440,6w4h,DB08794,-7.6,Ethyl biscoumacetate,JCLHQFUTFHUXNN-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
134081,6w9c,DB02538,-7.6,"N-[4-(2-Methylimidazo[1,2-a]Pyridin-3-Yl)-2-Pyrimidinyl]Acetamide",ZCRPPLDDHBLUES-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
134090,6w9c,DB02549,-7.6,3'-O-Acetylthymidine-5'-Diphosphate,UWSIAAWKEICIJY-IVZWLZJFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
26575,6cs2,DB04741,-7.6,Myxothiazol,XKTFQMCPGMTBMD-FYHMSGCOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
70742,6lxt,DB13122,-7.6,Trabodenoson,AQLVRTWKJDTWQQ-SDBHATRESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
104581,6vxs,DB12218,-7.6,AZD-5363,JDUBGYFRJFOXQC-KRWDZBQOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
12513,6lzg,DB13463,-7.6,Oxetorone,VZVRZTZPHOHSCK-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
134113,6w9c,DB02583,-7.6,"N6-(2,5-Dimethoxy-Benzyl)-N6-Methyl-Pyrido[2,3-D]Pyrimidine-2,4,6-Triamine",HZTFNSCZLJLPEO-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
102793,6vxs,DB07814,-7.6,Gibberellic acid,IXORZMNAPKEEDV-OBDJNFEBSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
134120,6w9c,DB02593,-7.6,"7,8-Dihydroxy-1-Methoxy-3-Methyl-10-Oxo-4,10-Dihydro-1h,3h-Pyrano[4,3-B]Chromene-9-Carboxylic Acid",RSFJMLCZHPZXCW-AANKLQPISA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
161016,7bv1,DB12404,-7.6,Remimazolam,CYHWMBVXXDIZNZ-KRWDZBQOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
17764,6cs2,HMDB0010356,-7.6,Estriol 3-sulfate 16-glucuronide,ATNWFRGUDKUYOG-SUPAOECSSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
58768,6crv,DB06603,-7.6,Panobinostat,FPOHNWQLNRZRFC-ZHACJKMWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104574,6vxs,DB12206,-7.6,N-6022,YVPGZQLRPAGKLA-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
159318,7bv1,DB03984,-7.6,Morpholine-4-Carboxylic Acid [1-(2-Benzylsulfanyl-1-Formyl-Ethylcarbamoyl)-2-Phenyl-Ethyl]-Amide,MWTQNXVXPLTHJB-YADHBBJMSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160667,7bv1,DB09246,-7.6,Benmoxin,BEWNZPMDJIGBED-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
86011,6m3m,DB08329,-7.6,Sulthiame,HMHVCUVYZFYAJI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85136,6m3m,DB07304,-7.6,5-[2-(TRIFLUOROMETHOXY)PHENYL]-2-FUROIC ACID,PSLFQKRPFOCZHR-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
159798,7bv1,DB06585,-7.6,Fipamezole,KXSUAWAUCNFBQJ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
71225,6lxt,DB13808,-7.6,Mebhydrolin,FQQIIPAOSKSOJM-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
85137,6m3m,DB07305,-7.6,5-(2-CHLORO-4-NITROPHENYL)-2-FUROIC ACID,HDIHNBCCQWMVBW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
132040,6w4h,DB15261,-7.6,Butafenacil,JEDYYFXHPAIBGR-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130972,6w4h,DB13077,-7.6,LCB01-0371,QLUWQAFDTNAYPN-LLVKDONJSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
160214,7bv1,DB07879,-7.6,"N-hydroxy-5-[(3-phenyl-5,6-dihydroimidazo[1,2-a]pyrazin-7(8H)-yl)carbonyl]thiophene-2-carboxamide",SMSIXMLQOONOQQ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160213,7bv1,DB07878,-7.6,"N-[(1S)-1-{1-[(1R,3E)-1-ACETYLPENT-3-EN-1-YL]-1H-1,2,3-TRIAZOL-4-YL}-1,2-DIMETHYLPROPYL]BENZAMIDE",OEHUTYXPQSSKAK-RVLLMHTFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
132022,6w4h,DB15222,-7.6,GS-6620,YAAQYJCOIFNMKX-RSTNYOGXSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
160205,7bv1,DB07870,-7.6,(2S)-2-(4-{[3-CHLORO-5-(TRIFLUOROMETHYL)PYRIDIN-2-YL]OXY}PHENOXY)PROPANOIC ACID,GOCUAJYOYBLQRH-MRVPVSSYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
103533,6vxs,DB08698,-7.6,"1-[(3S)-5-PHENYL-3-THIOPHEN-2-YL-3H-1,4-BENZODIAZEPIN-2-YL]AZETIDIN-3-OL",BKSGACYTXOQQNI-OAQYLSRUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
71230,6lxt,DB13816,-7.6,Aspoxicillin,BHELIUBJHYAEDK-OAIUPTLZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
160198,7bv1,DB07863,-7.6,2-chloro-5-nitro-N-phenylbenzamide,DNTSIBUQMRRYIU-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
103951,6vxs,DB09290,-7.6,Ramosetron,NTHPAPBPFQJABD-LLVKDONJSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
103547,6vxs,DB08713,-7.6,"2,6-DIMETHYL-1-(3-[3-METHYL-5-ISOXAZOLYL]-PROPANYL)-4-[2N-METHYL-2H-TETRAZOL-5-YL]-PHENOL",RVZKQTQAFHEOKT-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
103948,6vxs,DB09286,-7.6,Pipamperone,AXKPFOAXAHJUAG-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
85171,6m3m,DB07341,-7.6,"octyl 3-amino-3-deoxy-2-O-(2,6-dideoxy-alpha-L-lyxo-hexopyranosyl)-beta-D-galactopyranoside",GHTLMVRROQXELT-HTYYFBMYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
131135,6w4h,DB13337,-7.6,Pheneticillin,NONJJLVGHLVQQM-JHXYUMNGSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
159849,7bv1,DB06693,-7.6,Mevastatin,AJLFOPYRIVGYMJ-INTXDZFKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
131905,6w4h,DB14987,-7.6,Difamilast,VFBILHPIHUPBPZ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
71477,6lxt,DB14634,-7.6,Fluprednidene acetate,DEFOZIFYUBUHHU-IYQKUMFPSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
12243,6lzg,DB13088,-7.6,AZD-0424,MVWATCATLSSVBH-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
59399,6crv,DB07418,-7.6,bis(4-nitrophenyl) hydrogen phosphate,MHSVUSZEHNVFKW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
103980,6vxs,DB09371,-7.6,Norethynodrel,ICTXHFFSOAJUMG-SLHNCBLASA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
59729,6crv,DB07807,-7.6,"(3R,4R,5R)-5-(HYDROXYMETHYL)-1-(3-PHENYLPROPYL)PIPERIDINE-3,4-DIOL",NKARZGURZMIRMA-RBSFLKMASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59386,6crv,DB07402,-7.6,Azapropazone,WOIIIUDZSOLAIW-NSHDSACASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
103937,6vxs,DB09268,-7.6,Picosulfuric acid,UJIDKYTZIQTXPM-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
71486,6lxt,DB14644,-7.6,Methylprednisolone hemisuccinate,IMBXEJJVJRTNOW-XYMSELFBSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
59742,6crv,DB07820,-7.6,"6-(3',5'-DIMETHYLBENZYL)-1-ETHOXYMETHYL-5-ISOPROPYLURACIL",NVGVZWUORYLPAL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
71249,6lxt,DB13841,-7.6,Clopenthixol,WFPIAZLQTJBIFN-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
12237,6lzg,DB13080,-7.6,Roluperidone,RNRYULFRLCBRQS-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
131086,6w4h,DB13275,-7.6,Clorindione,NJDUWAXIURWWLN-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
59784,6crv,DB07868,-7.6,6-CHLORO-4-(CYCLOHEXYLSULFANYL)-3-PROPYLQUINOLIN-2(1H)-ONE,CLKFNGKDJYMUPK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
71515,6lxt,DB14674,-7.6,Estramustine phosphate,ADFOJJHRTBFFOF-RBRWEJTLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
104014,6vxs,DB11115,-7.6,Ensulizole,UVCJGUGAGLDPAA-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
132149,6w4h,DB02930,-7.6,Adenosine 5'-[gamma-thio]triphosphate,NLTUCYMLOPLUHL-KQYNXXCUSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
59311,6crv,DB07314,-7.6,"1-(5-CHLORO-2,4-DIMETHOXYPHENYL)-3-(5-CYANOPYRAZIN-2-YL)UREA",URQYPXQXSVUVRG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
160258,7bv1,DB07935,-7.6,"5-[(5-fluoro-3-methyl-1H-indazol-4-yl)oxy]benzene-1,3-dicarbonitrile",JYAHFMKZJRVTDT-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
104073,6vxs,DB11366,-7.6,Roquinimex,SGOOQMRIPALTEL-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
132168,6w4h,DB13983,-7.6,"5,7,2'-trihydroxy-6,8-dimethoxyflavone",JWOKGWICZPPYPX-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
85072,6m3m,DB07233,-7.6,N-{[4-(but-2-yn-1-yloxy)phenyl]sulfonyl}-5-methyl-D-tryptophan,SFVPXERGVLDWIS-OAQYLSRUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
130873,6w4h,DB12926,-7.6,Cafedrine,UJSKUDDDPKGBJY-WFASDCNBSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
159742,7bv1,DB05562,-7.6,Naluzotan,SPWZXWDPAWDKQE-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
130833,6w4h,DB12869,-7.6,Eliprodil,GGUSQTSTQSHJAH-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
85060,6m3m,DB07218,-7.6,"6-CHLORO-9-HYDROXY-1,3-DIMETHYL-1,9-DIHYDRO-4H-PYRAZOLO[3,4-B]QUINOLIN-4-ONE",AYKGPCNWPACUQV-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59301,6crv,DB07304,-7.6,5-[2-(TRIFLUOROMETHOXY)PHENYL]-2-FUROIC ACID,PSLFQKRPFOCZHR-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
160291,7bv1,DB07973,-7.6,N-(1-ISOPROPYLPIPERIDIN-4-YL)-1-(3-METHOXYBENZYL)-1H-INDOLE-2-CARBOXAMIDE,GIPCBGDQVGKMPO-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
132256,6w9c,DB00213,-7.6,Pantoprazole,IQPSEEYGBUAQFF-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
132257,6w9c,DB00214,-7.6,Torasemide,NGBFQHCMQULJNZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
132219,6w9c,DB00169,-7.6,Cholecalciferol,QYSXJUFSXHHAJI-YRZJJWOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
59720,6crv,DB07797,-7.6,N-[[3-FLUORO-4-ETHOXY-PYRID-2-YL]ETHYL]-N'-[5-CHLORO-PYRIDYL]-THIOUREA,VEBKSFPYWMOUBR-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
132143,6w4h,DB01557,-7.6,alpha-Methylfentanyl,NGTVDHYUFBKWID-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130877,6w4h,DB12930,-7.6,Opipramol,YNZFUWZUGRBMHL-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
103493,6vxs,DB08647,-7.6,TRAZEOLIDE,YUTXECPABXNXPU-DJJJIMSYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
160241,7bv1,DB07917,-7.6,4-(BENZHYDRYLOXY)-1-[3-(1H-TETRAAZOL-5-YL)PROPYL]PIPERIDINE,TZQGXAHOROZEKN-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
85610,6m3m,DB07859,-7.6,4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL)PHENYL]PIPERIDINE,LZMOSYUFVYJEPY-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
25898,6cs2,DB03926,-7.6,"5-Alpha-Androstane-3-Beta,17-Alpha-Diol",CBMYJHIOYJEBSB-MFXFBURESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
25897,6cs2,DB03925,-7.6,Freselestat,HMPQTEPEMQZWQH-QZTJIDSGSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
159782,7bv1,DB06533,-7.6,Ragaglitazar,WMUIIGVAWPWQAW-XMMPIXPASA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
34652,1r42,DB00620,-7.6,Triamcinolone,GFNANZIMVAIWHM-OBYCQNJPSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
160243,7bv1,DB07920,-7.6,N-oxo-2-[(4-phenylphenyl)sulfonylamino]ethanamide,OGRPZMQLAVBWPV-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
85107,6m3m,DB07273,-7.6,1-[(2-AMINO-4-CHLORO-5-METHYLPHENYL)SULFONYL]-L-PROLINE,OWYKAFABUYXQLE-JTQLQIEISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
104026,6vxs,DB11176,-7.6,Zeaxanthin,JKQXZKUSFCKOGQ-QAYBQHTQSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
85617,6m3m,DB07866,-7.6,"(5S)-2-(cyclooctylamino)-5-methyl-5-propyl-1,3-thiazol-4(5H)-one",SBTHYUAUBLEDJY-HNNXBMFYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
12223,6lzg,DB13060,-7.6,CEP-37440,BCSHRERPHLTPEE-NRFANRHFSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
85620,6m3m,DB07869,-7.6,6-CHLORO-4-(CYCLOHEXYLSULFINYL)-3-PROPYLQUINOLIN-2(1H)-ONE,QRBUGQMJMFAHKS-HSZRJFAPSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
130880,6w4h,DB12935,-7.6,Remogliflozin etabonate,UAOCLDQAQNNEAX-ABMICEGHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
85613,6m3m,DB07862,-7.6,"7-(1-ETHYL-PROPYL)-7H-PYRROLO-[3,2-F]QUINAZOLINE-1,3-DIAMINE",GCPJCLJGTVTGRF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
159734,7bv1,DB05524,-7.6,Pelitinib,WVUNYSQLFKLYNI-AATRIKPKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
159863,7bv1,DB06711,-7.6,Naphazoline,CNIIGCLFLJGOGP-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
131874,6w4h,DB14898,-7.6,Retagliptin,WIIAMRXFUJLYEF-SNVBAGLBSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
26078,6cs2,DB04142,-7.6,"3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid Dimethylamide",FEYGJZKVMASWJB-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
131655,6w4h,DB14129,-7.6,Macelignan,QDDILOVMGWUNGD-UONOGXRCSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131394,6w4h,DB13682,-7.6,Cefpirome,DKOQGJHPHLTOJR-WHRDSVKCSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
59525,6crv,DB07565,-7.6,Chloramphenicol succinate,LIRCDOVJWUGTMW-ZWNOBZJWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
12299,6lzg,DB13185,-7.6,Oxabolone cipionate,KHKDIUPVDIEHAH-KXLSUQFWSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
12273,6lzg,DB13126,-7.6,BMS-986115,SRJNRAQUSAVENA-GSHUGGBRSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
85312,6m3m,DB07510,-7.6,"3-fluoro-6-(4-fluorophenyl)-2-hydroxy-6-oxohexa-2,4-dienoic acid",CPZFGNOKCMJZFO-BTHQEHEQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
131419,6w4h,DB13718,-7.6,Hydroquinine,LJOQGZACKSYWCH-WZBLMQSHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
159955,7bv1,DB07122,-7.6,1-[4-(2-oxo-2-phenylethyl)phenyl]guanidine,MERNPSIIBFTCAI-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
159958,7bv1,DB07125,-7.6,"4-(6-{[(1R)-1-(hydroxymethyl)propyl]amino}imidazo[1,2-b]pyridazin-3-yl)benzoic acid",KKZYGUVAFJCULH-CYBMUJFWSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
103671,6vxs,DB08867,-7.6,Ulipristal,HKDLNTKNLJPAIY-WKWWZUSTSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
59548,6crv,DB07593,-7.6,1-(PHENYLMETHYL)CYCLOPENTYL[(1S)-1-FORMYLPENTYL]CARBAMATE,ONABDOMWRCXLPX-KRWDZBQOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
131617,6w4h,DB14059,-7.6,SC-236,NSQNZEUFHPTJME-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131430,6w4h,DB13729,-7.6,Camostat,XASIMHXSUQUHLV-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
26062,6cs2,DB04125,-7.6,N-Alpha-(2-Naphthylsulfonyl)-N(3-Amidino-L-Phenylalaninyl)-4-Acetyl-Piperazine,ZUWBXGHMVKDMQO-DEOSSOPVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
159974,7bv1,DB07143,-7.6,D-phenylalanyl-N-benzyl-L-prolinamide,MEPJWLFTTFHOQO-MOPGFXCFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160029,7bv1,DB07206,-7.6,6-[2-(1H-INDOL-6-YL)ETHYL]PYRIDIN-2-AMINE,OSHSZKRWKLQZBV-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
131513,6w4h,DB13842,-7.6,Etofylline nicotinate,ZWIAODBBEZGVPY-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131527,6w4h,DB13857,-7.6,Demegestone,JWAHBTQSSMYISL-MHTWAQMVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
103724,6vxs,DB08954,-7.6,Ifenprodil,UYNVMODNBIQBMV-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
59581,6crv,DB07633,-7.6,octyl 3-deoxy-2-O-(6-deoxy-alpha-L-galactopyranosyl)-beta-D-xylo-hexopyranoside,FBVFDKBCZLMLQT-PPCMOIRNSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59580,6crv,DB07632,-7.6,"5-(2-chlorophenyl)-1,3,4-thiadiazole-2-sulfonamide",PZVGOWIIHCUHAO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
131483,6w4h,DB13803,-7.6,Xipamide,MTZBBNMLMNBNJL-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
160049,7bv1,DB07451,-7.6,1-(5-BROMO-PYRIDIN-2-YL)-3-[2-(6-FLUORO-2-HYDROXY-3-PROPIONYL-PHENYL)-CYCLOPROPYL]-UREA,VRAJWAGCJIXJHQ-YPMHNXCESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
71372,6lxt,DB14086,-7.6,Cianidanol,PFTAWBLQPZVEMU-DZGCQCFKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
131566,6w4h,DB13952,-7.6,Estradiol acetate,FHXBMXJMKMWVRG-SLHNCBLASA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131569,6w4h,DB13955,-7.6,Estradiol dienanthate,OVAHZPTYWMWNKO-CAHAWPIUSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
71344,6lxt,DB14034,-7.6,Darglitazone,QQKNSPHAFATFNQ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
17094,6cs2,HMDB0006247,-7.6,25-Hydroxycholesterol,INBGSXNNRGWLJU-POAVOMIWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
26055,6cs2,DB04114,-7.6,"3-Chloro-9-Ethyl-6,7,8,9,10,11-Hexahydro-7,11-Methanocycloocta[B]Quinolin-12-Amine",QTPHSDHUHXUYFE-NWDGAFQWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
131581,6w4h,DB13983,-7.6,"5,7,2'-trihydroxy-6,8-dimethoxyflavone",JWOKGWICZPPYPX-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
59575,6crv,DB07627,-7.6,(2S)-4-METHYL-2-(3-PHENYLTHIOUREIDO)-N-((3S)-TETRAHYDRO-2-HYDROXY-3-FURANYL)PENTANAMIDE,DBPWWBMTZYJGGV-KKUMJFAQSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85302,6m3m,DB07498,-7.6,"4-[3-(3-NITROPHENYL)-1,2,4-OXADIAZOL-5-YL]BUTANOIC ACID",LQQYZJRCWBRIMW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
159936,7bv1,DB07102,-7.6,(2S)-2-amino-5-oxo-5-[(4-phenylmethoxyphenyl)amino]pentanoic acid,BYSBXIPCDJNEBG-INIZCTEOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
131688,6w4h,DB14210,-7.6,Moexiprilat,CMPAGYDKASJORH-YSSFQJQWSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
160134,7bv1,DB07550,-7.6,"2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(1-OXIDO-2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUOROPHENYL)METHYL]ACETAMIDE",ZIGSBBKEPNQXRG-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
159896,7bv1,DB07053,-7.6,2-{5-[3-(7-PROPYL-3-TRIFLUOROMETHYLBENZO[D]ISOXAZOL-6-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID,TWVYNPULGKGJOS-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59450,6crv,DB07478,-7.6,"1,1'-BIPHENYL-3,4-DIOL",QDNPCYCBQFHNJC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
103864,6vxs,DB09179,-7.6,R-30490,GARXJOUQUSNOGK-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
103587,6vxs,DB08754,-7.6,"(2E)-3-(3,4-DIHYDROXYPHENYL)-N-[2-(4-HYDROXYPHENYL)ETHYL]ACRYLAMIDE",VSHUQLRHTJOKTA-XBXARRHUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
103867,6vxs,DB09182,-7.6,Benzylfentanyl,POQDXIFVWVZVML-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
131243,6w4h,DB13481,-7.6,Tenidap,LXIKEPCNDFVJKC-QXMHVHEDSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
71285,6lxt,DB13927,-7.6,anle138b,RCQIIBJSUWYYFU-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
85504,6m3m,DB07739,-7.6,"(3R)-3-(FLUOROMETHYL)-7-(THIOMORPHOLIN-4-YLSULFONYL)-1,2,3,4-TETRAHYDROISOQUINOLINE",SBUKSNPHYWXCDG-CYBMUJFWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85219,6m3m,DB07400,-7.6,1-ETHOXYCARBONYL-D-PHE-PRO-2(4-AMINOBUTYL)HYDRAZINE,AEHSFPPTWRQOFS-MSOLQXFVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
160150,7bv1,DB07571,-7.6,"N-2-[(BENZYLOXY)CARBONYL]-N-[(1S,2S)-2-HYDROXY-1-(4-HYDROXYBENZYL)PROPYL]-L-LEUCINAMIDE",ZUWYQZGBCBSHFK-HSQYWUDLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
85511,6m3m,DB07748,-7.6,2-({[4-(TRIFLUOROMETHOXY)PHENYL]SULFONYL}AMINO)ETHYL DIHYDROGEN PHOSPHATE,JDDKDMFCTOZVCJ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
103882,6vxs,DB09197,-7.6,Mepiprazole,DOTIMEKVTCOGED-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
34591,1r42,DB00547,-7.6,Desoximetasone,VWVSBHGCDBMOOT-IIEHVVJPSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
159889,7bv1,DB07046,-7.6,"2-[(2-chloro-4-iodophenyl)amino]-N-{[(2R)-2,3-dihydroxypropyl]oxy}-3,4-difluorobenzamide",FCADPEDUULETPK-SECBINFHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
131875,6w4h,DB14899,-7.6,Tavapadon,AKQXQLUNFKDZBN-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
103855,6vxs,DB09169,-7.6,3-Allylfentanyl,BZXKQFFMDLTPJL-LADGPHEKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
59467,6crv,DB07498,-7.6,"4-[3-(3-NITROPHENYL)-1,2,4-OXADIAZOL-5-YL]BUTANOIC ACID",LQQYZJRCWBRIMW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
131696,6w4h,DB14232,-7.6,Deacetylbisacodyl,LJROKJGQSPMTKB-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131706,6w4h,DB14538,-7.6,Hydrocortisone aceponate,MFBMYAOAMQLLPK-FZNHGJLXSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131342,6w4h,DB13616,-7.6,Melagatran,DKWNMCUOEDMMIN-PKOBYXMFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
103817,6vxs,DB09080,-7.6,Olodaterol,COUYJEVMBVSIHV-SFHVURJKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
34445,1r42,DB00253,-7.6,Medrysone,GZENKSODFLBBHQ-ILSZZQPISA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
131328,6w4h,DB13600,-7.6,Deltamethrin,OWZREIFADZCYQD-NSHGMRRFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
160118,7bv1,DB07533,-7.6,"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]-2-FURYL}-N-METHYLBENZENESULFONAMIDE",FJJJERLTHDXEPT-JYRVWZFOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
85284,6m3m,DB07477,-7.6,Felbinac,QRZAKQDHEVVFRX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
159929,7bv1,DB07091,-7.6,(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclohexyloxy)ethanoyl)pyrrolidine-2-carboxamide,IWPMQJKXKKKSEY-SFHVURJKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
131298,6w4h,DB13554,-7.6,Moperone,AGAHNABIDCTLHW-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131295,6w4h,DB13551,-7.6,Cinchophen,YTRMTPPVNRALON-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
71432,6lxt,DB14221,-7.6,Beclomethasone 17-monopropionate,OHYGPBKGZGRQKT-XGQKBEPLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
59473,6crv,DB07505,-7.6,"N-({(3R,4R)-4-[(benzyloxy)methyl]pyrrolidin-3-yl}methyl)-N-(2-methylpropyl)benzenesulfonamide",DGURGFSAQIBQCO-FGZHOGPDSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
131269,6w4h,DB13514,-7.6,Pranoprofen,TVQZAMVBTVNYLA-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
160080,7bv1,DB07488,-7.6,"{(2Z)-4-AMINO-2-[(4-METHOXYPHENYL)IMINO]-2,3-DIHYDRO-1,3-THIAZOL-5-YL}(4-METHOXYPHENYL)METHANONE",XQKUGFIWKSKCDL-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
134762,6w9c,DB03510,-7.6,6-O-Phosphoryl Inosine Monophosphate,RXRZOKQPANIEDW-KQYNXXCUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
85668,6m3m,DB07929,-7.6,"N-(TERT-BUTYL)-3,5-DIMETHYL-N'-[(5-METHYL-2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)CARBONYL]BENZOHYDRAZIDE",JGJACZABNQGPMT-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
132279,6w9c,DB00238,-7.6,Nevirapine,NQDJXKOVJZTUJA-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
34171,6cs2,T3D1034,-7.6,Cypermethrin,KAATUXNTWXVJKI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
85964,6m3m,DB08272,-7.6,(4S)-4-(2-NAPHTHYLMETHYL)-D-GLUTAMIC ACID,YDWIUFASTTZKNI-UONOGXRCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84721,6m3m,DB06820,-7.6,Sulconazole,AFNXATANNDIXLG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
103225,6vxs,DB08320,-7.6,"DIETHYL (1R,2S,3R,4S)-5,6-BIS(4-HYDROXYPHENYL)-7-OXABICYCLO[2.2.1]HEPT-5-ENE-2,3-DICARBOXYLATE",NHKDFDHHMHBFLG-COPRSSIGSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
159452,7bv1,DB04434,-7.6,Naphthyridine Inhibitor,YRBHUKMLAGQYHS-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
103235,6vxs,DB08331,-7.6,"N-1H-imidazol-2-yl-N'-[4-(1H-imidazol-2-ylamino)phenyl]benzene-1,4-diamine",JHMXUERQMCJRHG-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
84740,6m3m,DB06845,-7.6,(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclopentylamino)ethanoyl)pyrrolidine-2-carboxamide,WXYKSWZWRHMJTE-KRWDZBQOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
71655,6lxt,DB15024,-7.6,Apararenone,AZNHWXAFPBYFGH-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
84750,6m3m,DB06859,-7.6,N-ALLYL-5-AMIDINOAMINOOXY-PROPYLOXY-3-CHLORO-N-CYCLOPENTYLBENZAMIDE,XWIUMAPBZWNFNV-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
132781,6w9c,DB00843,-7.6,Donepezil,ADEBPBSSDYVVLD-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
132780,6w9c,DB00842,-7.6,Oxazepam,ADIMAYPTOBDMTL-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
130398,6w4h,DB12214,-7.6,Luseogliflozin,WHSOLWOTCHFFBK-ZQGJOIPISA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130400,6w4h,DB12218,-7.6,AZD-5363,JDUBGYFRJFOXQC-KRWDZBQOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130401,6w4h,DB12219,-7.6,GSK-424887,DRXBWLBZWAJIEF-IBGZPJMESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
84766,6m3m,DB06878,-7.6,1-[(2R)-2-aminobutanoyl]-N-(3-chlorobenzyl)-L-prolinamide,OTYYXGRJXJFTCD-KGLIPLIRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
6004,6lzg,DB01430,-7.6,Almitrine,OBDOVFRMEYHSQB-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
132753,6w9c,DB00812,-7.6,Phenylbutazone,VYMDGNCVAMGZFE-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
59990,6crv,DB08106,-7.6,N-[(6-butoxynaphthalen-2-yl)sulfonyl]-D-glutamic acid,UAGYXJBYAFGRFR-QGZVFWFLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59997,6crv,DB08113,-7.6,3-pyridin-4-yl-1H-indazole,MSRXUUDVRNWSTN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85896,6m3m,DB08182,-7.6,"4-(4-propoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine",ZHMRPXZRUZLCNL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
12392,6lzg,DB13317,-7.6,Flunoxaprofen,ARPYQKTVRGFPIS-VIFPVBQESA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
130435,6w4h,DB12264,-7.6,Atevirdine,UCPOMLWZWRTIAA-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
132722,6w9c,DB00774,-7.6,Hydroflumethiazide,DMDGGSIALPNSEE-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
71677,6lxt,DB15062,-7.6,Inarigivir,LYMICVBGNUEHGE-FUQPUAIBSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
25764,6cs2,DB03771,-7.6,Allyl-{4-[3-(4-Bromo-Phenyl)-Benzofuran-6-Yloxy]-but-2-Enyl}-Methyl-Amine,KCNKJCHARANTIP-SNAWJCMRSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
130428,6w4h,DB12252,-7.6,PG-701,OKRSVUYYCJPECG-LFGMFVMYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
60014,6crv,DB08132,-7.6,5-hydroxynaphthalene-1-sulfonamide,NFVBVKHGDDDCEA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84798,6m3m,DB06913,-7.6,"(2R,3R)-3-{[3,5-BIS(TRIFLUOROMETHYL)PHENYL]AMINO}-2-CYANO-3-THIOXOPROPANAMIDE",ZTUMRSFHUOBXAC-LHIURRSHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
132742,6w9c,DB00800,-7.6,Fenoldopam,TVURRHSHRRELCG-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
160468,7bv1,DB08424,-7.6,"[5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL](3-{[(2R)-2,3-DIHYDROXYPROPYL]OXY}PHENYL)METHANONE",IJDQETGUEUJVTB-HNNXBMFYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
103245,6vxs,DB08348,-7.6,"N-2-,N-2-DIMETHYL-N-1-(6-OXO-5,6-DIHYDROPHENANTHRIDIN-2-YL)GLYCINAMIDE",UYJZZVDLGDDTCL-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
84820,6m3m,DB06935,-7.6,"2',6'-DIFLUOROBIPHENYL-4-CARBOXYLIC ACID",CWWIIKLXUPZDOG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
160544,7bv1,DB08755,-7.6,N-[(1S)-2-{[(1R)-2-(benzyloxy)-1-cyano-1-methylethyl]amino}-1-(cyclohexylmethyl)-2-oxoethyl]morpholine-4-carboxamide,MQWUTQCRGGBPBT-WIOPSUGQSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59129,6crv,DB07108,-7.6,"4'-FLUORO-1,1'-BIPHENYL-4-CARBOXYLIC ACID",LXWNTLBMNCXRQN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
6038,6lzg,DB01480,-7.6,Cyprenorphine,VSKIOMHXEUHYSI-KNLIIKEYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
60115,6crv,DB08254,-7.6,2-NAPHTHALENESULFONIC ACID,KVBGVZZKJNLNJU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84629,6m3m,DB06654,-7.6,Safinamide,NEMGRZFTLSKBAP-LBPRGKRZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
6089,6lzg,DB01548,-7.6,Diprenorphine,OIJXLIIMXHRJJH-KNLIIKEYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
84627,6m3m,DB06649,-7.6,Priralfinamide,BHJIBOFHEFDSAU-LBPRGKRZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
133005,6w9c,DB01098,-7.6,Rosuvastatin,BPRHUIZQVSMCRT-VEUZHWNKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
160650,7bv1,DB09226,-7.6,RP-5063,PMKMNTBZJOXTJW-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
159363,7bv1,DB04047,-7.6,[Pterin-6-Yl Methanyl]-Phosphonophosphate,AMDUVUKDRBIVAH-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
6101,6lzg,DB01564,-7.6,Calusterone,IVFYLRMMHVYGJH-PVPPCFLZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
133015,6w9c,DB01110,-7.6,Miconazole,BYBLEWFAAKGYCD-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
60120,6crv,DB08259,-7.6,7-{[(CYCLOHEXYLAMINO)CARBONYL]AMINO}HEPTANOIC ACID,GYTIWWDVOFXKPF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130170,6w4h,DB11873,-7.6,Verinurad,YYBOLPLTQDKXPM-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
59065,6crv,DB07034,-7.6,"2,2'-{[9-(HYDROXYIMINO)-9H-FLUORENE-2,7-DIYL]BIS(OXY)}DIACETIC ACID",VOKATEXROYSXDW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
160658,7bv1,DB09235,-7.6,Efonidipine,NSVFSAJIGAJDMR-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
71737,6lxt,DB15187,-7.6,Dubermatinib,YUAALFPUEOYPNX-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
130175,6w4h,DB11880,-7.6,Acridine Carboxamide,XBGNERSKEKDZDS-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130455,6w4h,DB12288,-7.6,Piromelatine,PNTNBIHOAPJYDB-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
132965,6w9c,DB01054,-7.6,Nitrendipine,PVHUJELLJLJGLN-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
84634,6m3m,DB06669,-7.6,Arverapamil,UPKQNCPKPOLASS-AREMUKBSSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
26346,6cs2,DB04468,-7.6,Afimoxifene,TXUZVZSFRXZGTL-QPLCGJKRSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
160551,7bv1,DB08763,-7.6,[N-(BENZYLOXYCARBONYL)AMINO](4-AMIDINOPHENYL)METHANE-PHOSPHONATE,FSNDLCSOLUMYRH-OAHLLOKOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
71708,6lxt,DB15123,-7.6,Dorzagliatin,HMUMWSORCUWQJO-QAPCUYQASA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
103206,6vxs,DB08300,-7.6,"1-methyl-3-naphthalen-2-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine",UOKGZPYGRJDACN-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104268,6vxs,DB11753,-7.6,Rifamycin,HJYYPODYNSCCOU-ODRIEIDWSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104274,6vxs,DB11764,-7.6,Spebrutinib,KXBDTLQSDKGAEB-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
132964,6w9c,DB01053,-7.6,Benzylpenicillin,JGSARLDLIJGVTE-MBNYWOFBSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
130265,6w4h,DB12011,-7.6,Fevipiprant,GFPPXZDRVCSVNR-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130260,6w4h,DB12006,-7.6,BMS-906024,AYOUDDAETNMCBW-GSHUGGBRSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130245,6w4h,DB11985,-7.6,Dapaconazole,FUAHXHWSMYFWGE-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
160604,7bv1,DB08828,-7.6,Vismodegib,BPQMGSKTAYIVFO-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160623,7bv1,DB08860,-7.6,Pitavastatin,VGYFMXBACGZSIL-MCBHFWOFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
70982,6lxt,DB13484,-7.6,Quinbolone,IUVKMZGDUIUOCP-BTNSXGMBSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
104308,6vxs,DB11811,-7.6,Arhalofenate,BJBCSGQLZQGGIQ-QGZVFWFLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
132918,6w9c,DB01000,-7.6,Cyclacillin,HGBLNBBNRORJKI-WCABBAIRSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
59856,6crv,DB07956,-7.6,[1-(3-CHLORO-2-FORMYL-PHENYLCARBAMOYL)-2-METHYL-PROPYL]-CARBAMIC ACID TERT-BUTYL ESTER,GBHYPZDGTWSQFR-AWEZNQCLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
132667,6w9c,DB00708,-7.6,Sufentanil,GGCSSNBKKAUURC-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
25776,6cs2,DB03785,-7.6,"(3r,5r)-7-((1r,2r,6s,8r,8as)-2,6-Dimethyl-8-{[(2r)-2-Methylbutanoyl]Oxy}-1,2,6,7,8,8a-Hexahydronaphthalen-1-Yl)-3,5-Dihydroxyheptanoic Acid",QLJODMDSTUBWDW-BXMDZJJMSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
130600,6w4h,DB12492,-7.6,Piritramide,IHEHEFLXQFOQJO-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
132459,6w9c,DB00452,-7.6,Framycetin,PGBHMTALBVVCIT-VCIWKGPPSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
132458,6w9c,DB00451,-7.6,Levothyroxine,XUIIKFGFIJCVMT-LBPRGKRZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
85728,6m3m,DB07996,-7.6,5-(2-methylpiperazine-1-sulfonyl)isoquinoline,BDVFVCGFMNCYPV-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
71564,6lxt,DB14791,-7.6,GDC-0425,XEZLBMHDUXSICI-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
159654,7bv1,DB05076,-7.6,Fenretinide,AKJHMTWEGVYYSE-FXILSDISSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
26249,6cs2,DB04345,-7.6,Lumichrome,ZJTJUVIJVLLGSP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
132446,6w9c,DB00439,-7.6,Cerivastatin,SEERZIQQUAZTOL-ANMDKAQQSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
34719,1r42,DB00700,-7.6,Eplerenone,JUKPWJGBANNWMW-VWBFHTRKSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
104129,6vxs,DB11464,-7.6,Sulfaquinoxaline,NHZLNPMOSADWGC-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104128,6vxs,DB11463,-7.6,Sulfanitran,GWBPFRGXNGPPMF-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
103386,6vxs,DB08517,-7.6,"(2S)-5-hydroxy-2-(4-hydroxyphenyl)-7-methoxy-2,3-dihydro-4H-chromen-4-one",DJOJDHGQRNZXQQ-AWEZNQCLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
132394,6w9c,DB00376,-7.6,Trihexyphenidyl,HWHLPVGTWGOCJO-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
159687,7bv1,DB05271,-7.6,Rotigotine,KFQYTPMOWPVWEJ-INIZCTEOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160327,7bv1,DB08013,-7.6,(METHYLPYRIDAZINE PIPERIDINE PROPYLOXYPHENYL)ETHYLACETATE,UEIUDEUUVLYRFV-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160326,7bv1,DB08012,-7.6,(METHYLPYRIDAZINE PIPERIDINE ETHYLOXYPHENYL)ETHYLACETATE,KCHIOGFOPPOUJC-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
103402,6vxs,DB08535,-7.6,"3-bromo-5-phenyl-N-(pyridin-3-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",SMIZFGZXFDGISG-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
132292,6w9c,DB00252,-7.6,Phenytoin,CXOFVDLJLONNDW-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
160294,7bv1,DB07976,-7.6,3-{[(3-FLUORO-3'-METHOXYBIPHENYL-4-YL)AMINO]CARBONYL}THIOPHENE-2-CARBOXYLIC ACID,GIUMGVUBDBDTDX-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
130744,6w4h,DB12717,-7.6,Mibampator,ULRDYYKSPCRXAJ-KRWDZBQOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130742,6w4h,DB12715,-7.6,MSX-122,PXZXYRKDDXKDTK-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
85017,6m3m,DB07168,-7.6,[4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-6-(methylamino)pyrimidin-2-yl}amino)phenyl]acetonitrile,MFMSRHREFZCFSN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
104088,6vxs,DB11393,-7.6,Danofloxacin,QMLVECGLEOSESV-RYUDHWBXSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
84947,6m3m,DB07087,-7.6,"4-[(1S,2S,5S,9R)-5-(HYDROXYMETHYL)-8,9-DIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL",YMSZEVAWRFDVQX-GHVWTTSJSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
132321,6w9c,DB00284,-7.6,Acarbose,CEMXHAPUFJOOSV-XGWNLRGSSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
130723,6w4h,DB12686,-7.6,PHA-793887,HUXYBQXJVXOMKX-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
160314,7bv1,DB07999,-7.6,"{4-[(CARBOXYMETHOXY)CARBONYL]-3,3-DIOXIDO-1-OXONAPHTHO[1,2-D]ISOTHIAZOL-2(1H)-YL}ACETIC ACID",IXLBOIRSEDMRPI-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
25851,6cs2,DB03869,-7.6,5'-O-(N-(L-Seryl)-Sulfamoyl)Adenosine,HQXFJGONGJPTLZ-YTMOPEAISA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
159690,7bv1,DB05289,-7.6,Tarenflurbil,SYTBZMRGLBWNTM-SNVBAGLBSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
85706,6m3m,DB07972,-7.6,1-(3-METHYLPHENYL)-1H-BENZIMIDAZOL-5-AMINE,VFSVFGIODYZMOF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
132365,6w9c,DB00341,-7.6,Cetirizine,ZKLPARSLTMPFCP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
66487,6lxt,DB04240,-7.6,"(1S)-1-C-{(2R)-6-[(2R)-2-Butanyl]-5,10-dihydroxy-4-oxo-1,2,3,4-tetrahydro-2-anthracenyl}-5-deoxy-1-O-methyl-D-xylulose",XGORHSPGULYMCV-HHYQQTLHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
132468,6w9c,DB00465,-7.6,Ketorolac,OZWKMVRBQXNZKK-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
84946,6m3m,DB07086,-7.6,"4-[(1S,2S,5S)-5-(HYDROXYMETHYL)-8-METHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL",XXIFNRNIQJKFLP-XHSDSOJGSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85748,6m3m,DB08018,-7.6,"N-{(3S,4S)-4-[(6-AMINO-4-METHYLPYRIDIN-2-YL)METHYL]PYRROLIDIN-3-YL}-N'-(4-CHLOROBENZYL)ETHANE-1,2-DIAMINE",JDRSQGJWTVRNGM-QFBILLFUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
132581,6w9c,DB00604,-7.6,Cisapride,DCSUBABJRXZOMT-IRLDBZIGSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
71615,6lxt,DB14903,-7.6,Rovafovir etalafenamide,OCJRRXHWPBXZSU-BJBBEUPESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
85836,6m3m,DB08118,-7.6,"2-(methylamino)-N-(4-methyl-1,3-thiazol-2-yl)-5-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]benzamide",XRJAKERBMMBUGR-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
132610,6w9c,DB00639,-7.6,Butoconazole,SWLMUYACZKCSHZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
85851,6m3m,DB08134,-7.6,4-[(6-chloropyrazin-2-yl)amino]benzenesulfonamide,RSNSGNZRUMHXAY-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
71079,6lxt,DB13616,-7.6,Melagatran,DKWNMCUOEDMMIN-PKOBYXMFSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
59958,6crv,DB08071,-7.6,"(2S)-1-methyl-2-[(2S,4R)-2-methyl-4-phenylpentyl]piperidine",UEEAJOUBQAEABH-JZXOWHBKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85878,6m3m,DB08162,-7.6,Fasudil,NGOGFTYYXHNFQH-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
104204,6vxs,DB11658,-7.6,QAV-680,YOPFAMROKXHVCQ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
103286,6vxs,DB08397,-7.6,6-(DIFLUORO-PHOSPHONO-METHYL)-NAPHTHALENE-2-CARBOXYLIC ACID,NKGNOWNPXBURRW-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
71067,6lxt,DB13602,-7.6,Promegestone,QFFCYTLOTYIJMR-XMGTWHOFSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
130471,6w4h,DB12308,-7.6,Eltanolone,AURFZBICLPNKBZ-YZRLXODZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
159562,7bv1,DB04574,-7.6,Estrone sulfate,JKKFKPJIXZFSSB-CBZIJGRNSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160434,7bv1,DB08383,-7.6,"4,5-bis(4-methoxyphenyl)-2-thiophen-2-yl-1H-imidazole",XBMULXNXJLWLLD-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59970,6crv,DB08083,-7.6,"2-(1,3-thiazol-4-yl)-1H-benzimidazole-5-sulfonamide",KGMVTZZDGKDTEU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
1301,6lzg,HMDB0010351,-7.6,11-beta-Hydroxyandrosterone-3-glucuronide,BRPLOVMHAFXVOQ-HUMIJZDLSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
104195,6vxs,DB11644,-7.6,Tafamidis,TXEIIPDJKFWEEC-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
160425,7bv1,DB08369,-7.6,1-(biphenyl-4-ylmethyl)-1H-imidazole,DLYMRVCQTVOYEW-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
103347,6vxs,DB08471,-7.6,"1-(thiophen-2-ylacetyl)-4-(3-thiophen-2-yl-1,2,4-oxadiazol-5-yl)piperidine",SJEVDMFUHCVNPM-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
130561,6w4h,DB12433,-7.6,SCH-900271,ARJKMWXLIHZLQZ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
59236,6crv,DB07232,-7.6,Veliparib,JNAHVYVRKWKWKQ-CYBMUJFWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84917,6m3m,DB07052,-7.6,5'-S-ethyl-5'-thioadenosine,HMXHURAGFHWODC-WOUKDFQISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
5961,6lzg,DB01338,-7.6,Pipecuronium,OWWLUIWOFHMHOQ-XGHATYIMSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
84898,6m3m,DB07032,-7.6,2-(4-HYDROXY-PHENYL)BENZOFURAN-5-OL,SNNNDCMXZYWCCI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
160427,7bv1,DB08371,-7.6,PARA-(BENZOYL)-PHENYLALANINE,TVIDEEHSOPHZBR-AWEZNQCLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59210,6crv,DB07199,-7.6,"(2S,4S,5R)-1-(4-TERT-BUTYLBENZOYL)-2-ISOBUTYL-5-(1,3-THIAZOL-2-YL)PYRROLIDINE-2,4-DICARBOXYLIC ACID",SWYJAQWTBADJTB-RHGYRFJNSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
160422,7bv1,DB08366,-7.6,"3-({3-[(1S,4aS,6S,7S,9S,9aR)-1,6-dimethyl-2-oxodecahydro-6,9-epoxy-4a,7-methanobenzo[7]annulen-1-yl]propanoyl}amino)-2,4-dihydroxybenzoic acid",XADCWKSMHQPTGH-OFBLZTNGSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
34747,1r42,DB00734,-7.6,Risperidone,RAPZEAPATHNIPO-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
132543,6w9c,DB00557,-7.6,Hydro1ine,ZQDWXGKKHFNSQK-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
103317,6vxs,DB08436,-7.6,"8-BENZO[1,3]DIOXOL-,5-YLMETHYL-9-BUTYL-9H-",JCDXXNIRWRRGBX-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
130499,6w4h,DB12350,-7.6,Rostafuroxin,AEAPORIZZWBIEX-DTBDINHYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
159600,7bv1,DB04624,-7.6,DERIVATIVE OF AKLANONIC ACID METHYL ESTER (AAME),SIHNJMGWRHPFAZ-XHDPSFHLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
5965,6lzg,DB01347,-7.6,Saprisartan,DUEWVPTZCSAMNB-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
86538,6m3m,DB08994,-7.6,Ditazole,UUCMDZWCRNZCOY-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86540,6m3m,DB08996,-7.6,Dimetacrine,RYQOGSFEJBUZBX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
33791,6cs2,T3D0468,-7.6,"3,3',4,5'-Tetrachlorobiphenyl",QLCTXEMDCZGPCG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
25025,6cs2,DB02869,-7.6,3-amino-5-phenylpentane,ZPXIQFOUPUVVPU-INIZCTEOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
157634,6wiq,DB12225,-7.6,Beclabuvir,ZTTKEBYSXUCBSE-QDFUAKMASA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
101820,6vxs,DB06590,-7.6,Ceftaroline fosamil,ZCCUWMICIWSJIX-NQJJCJBVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
57922,6crv,DB04306,-7.6,"5-[(4-Methylphenyl)Sulfanyl]-2,4-Quinazolinediamine",UOJFGEAPSYQDIP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
35655,1r42,DB01889,-7.6,"16,17-Androstene-3-Ol",KRVXMNNRSSQZJP-PHFHYRSDSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
162127,7bv1,DB01471,-7.6,Bolasterone,IVFYLRMMHVYGJH-VLOLGRDOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
157641,6wiq,DB12234,-7.6,BMS-214662,OLCWFLWEHWLBTO-HSZRJFAPSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
157652,6wiq,DB12247,-7.6,AZD-4547,VRQMAABPASPXMW-HDICACEKSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
61270,6crv,DB11833,-7.6,Basimglurant,UPZWINBEAHDTLA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
162112,7bv1,DB01455,-7.6,19-Nor-5-androstenediol,VVUQRXPUVKXAIO-XFUVECHXSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
70120,6lxt,DB12188,-7.6,Zicronapine,BYPMJBXPNZMNQD-PZJWPPBQSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
127677,6w4h,DB06673,-7.6,Almorexant,DKMACHNQISHMDN-RPLLCQBOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
162110,7bv1,DB01453,-7.6,Beta-hydroxyfentanyl,JEFVHLMGRUJLET-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
162109,7bv1,DB01452,-7.6,Diamorphine,GVGLGOZIDCSQPN-PVHGPHFFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
136989,6w9c,DB07772,-7.6,"(1R)-1-{[(4'-methoxy-1,1'-biphenyl-4-yl)sulfonyl]amino}-2-methylpropylphosphonic acid",BZVYQWLRCHLAGK-QGZVFWFLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
61255,6crv,DB11817,-7.6,Baricitinib,XUZMWHLSFXCVMG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87464,6m3m,DB12359,-7.6,BIIB021,QULDDKSCVCJTPV-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
82959,6m3m,DB03233,-7.6,"Phosphoric Acid Mono-[3-Amino-5-(5-Methyl-2,4-Dioxo-3,4-Dihydro-2h-Pyrimidin-1-Yl)-Tetrahydro-Furan-2-Ylmethyl] Ester",BQZMHQZNZNBJNF-XLPZGREQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
15892,6lzg,DB01772,-7.6,"3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl]-4-(5-Fluoro-1-Methyl-1h-Indol-3-Yl)-Pyrrole-2,5-Dione",RPGZQOOZHIEPJW-HNNXBMFYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
136939,6w9c,DB07715,-7.6,Emodin,RHMXXJGYXNZAPX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
105243,6vxs,DB13240,-7.6,Cymarin,XQCGNURMLWFQJR-ZNDDOCHDSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101888,6vxs,DB06718,-7.6,Stanozolol,LKAJKIOFIWVMDJ-IYRCEVNGSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
162082,7bv1,DB01421,-7.6,Paromomycin,UOZODPSAJZTQNH-LSWIJEOBSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
157630,6wiq,DB12221,-7.6,Canrenone,UJVLDDZCTMKXJK-WNHSNXHDSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
136962,6w9c,DB07742,-7.6,"N-(2,3-DIFLUORO-BENZYL)-4-SULFAMOYL-BENZAMIDE",QASSMVGOSBNFQY-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
105244,6vxs,DB13242,-7.6,Bucladesine,CJGYSWNGNKCJSB-YVLZZHOMSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
162087,7bv1,DB01426,-7.6,Ajmaline,CJDRUOGAGYHKKD-HEFSZTOGSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
82926,6m3m,DB03195,-7.6,"Phosphoric Acid Mono-[3-Fluoro-5-(5-Methyl-2,4-Dioxo-3,4-Dihydro-2h-Pyrimidin-1-Yl)-Tetrahyro-Furan-2-Ylmethyl] Ester",GGCAVPJXJISBOA-XLPZGREQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
25064,6cs2,DB02911,-7.6,"2,4-Diamino-6-Phenyl-5,6,7,8,-Tetrahydropteridine",VEKRIXRQADJFAG-QMMMGPOBSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
82923,6m3m,DB03190,-7.6,"N-Octanoyl-B-D-Fructofuranosyl-a-D-Glucopyranoside,Sucrose Monocaproylate",AWSYOWHJNGZJGU-OASARBKBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
127700,6w4h,DB06710,-7.6,Methyltestosterone,GCKMFJBGXUYNAG-HLXURNFRSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
6810,6lzg,DB00351,-7.6,Megestrol acetate,RQZAXGRLVPAYTJ-GQFGMJRRSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
87491,6m3m,DB12398,-7.6,Naproxen etemesil,JGBUBSOKFSVXKS-LBPRGKRZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
137076,6w9c,DB07869,-7.6,6-CHLORO-4-(CYCLOHEXYLSULFINYL)-3-PROPYLQUINOLIN-2(1H)-ONE,QRBUGQMJMFAHKS-HSZRJFAPSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137084,6w9c,DB07877,-7.6,"8-(6-BROMO-BENZO[1,3]DIOXOL-5-YLSULFANYL)-9-(3-ISOPROPYLAMINO-PROPYL)-ADENINE",MWGWLDJLENCVRQ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
87574,6m3m,DB12518,-7.6,Raclopride,WAOQONBSWFLFPE-VIFPVBQESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
137218,6w9c,DB08033,-7.6,"(5R)-N,N-DIETHYL-5-METHYL-2-[(THIOPHEN-2-YLCARBONYL)AMINO]-4,5,6,7-TETRAHYDRO-1-BENZOTHIOPHENE-3-CARBOXAMIDE",UQKSYQYWUHUIEH-GFCCVEGCSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
162213,7bv1,DB01567,-7.6,Fludiazepam,ROYOYTLGDLIGBX-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
137230,6w9c,DB08049,-7.6,"7,8-dihydroxy-4-phenyl-2H-chromen-2-one",JRVIIPJSVKTPBK-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
105447,6vxs,DB13511,-7.6,Clebopride,BVPWJMCABCPUQY-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
127487,6w4h,DB06195,-7.6,Seliciclib,BTIHMVBBUGXLCJ-OAHLLOKOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
137207,6w9c,DB08021,-7.6,5-bromo-N-(3-chloro-2-(4-(prop-2-ynyl)piperazin-1-yl)phenyl)furan-2-carboxamide,MEFJFXHHHNDHEN-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
162218,7bv1,DB01572,-7.6,Methyl-1-testosterone,JRNSSSJKIGAFCT-YDSAWKJFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
157505,6wiq,DB09235,-7.6,Efonidipine,NSVFSAJIGAJDMR-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
137275,6w9c,DB08100,-7.6,"2,6-dimethyl-4-[(E)-2-phenylethenyl]phenol",PAHKYLUYTGBFNW-CMDGGOBGSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
70041,6lxt,DB12072,-7.6,Orantinib,NHFDRBXTEDBWCZ-ZROIWOOFSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
6887,6lzg,DB02859,-7.6,Soraphen A,WPMGNXPRKGXGBO-OFQQMTDKSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
127471,6w4h,DB06157,-7.6,Istaroxime,MPYLDWFDPHRTEG-PAAYLBSLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
162245,7bv1,DB01793,-7.6,SB-409513,ONVZFCHLOZUXRP-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
11709,6lzg,DB12322,-7.6,GW-870086,WUBKGTSFJSEIEM-NSHBDUGJSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
157697,6wiq,DB12307,-7.6,Foretinib,CXQHYVUVSFXTMY-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
137203,6w9c,DB08017,-7.6,3-METHOXY-6-[4-(3-METHYLPHENYL)-1-PIPERAZINYL]PYRIDAZINE,DDOAUTHWSCUHQA-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137190,6w9c,DB08004,-7.6,"(2S)-2-{[3-(3-aminophenyl)imidazo[1,2-b]pyridazin-6-yl]amino}-3-methylbutan-1-ol",PUMVONFFLKPPIM-CQSZACIVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
57914,6crv,DB04295,-7.6,N-Benzoyl-N'-Beta-D-Glucopyranosyl Urea,JSBCZGSPFATCOV-BZNQNGANSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
157617,6wiq,DB12200,-7.6,Tivantinib,UCEQXRCJXIVODC-PMACEKPBSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
157614,6wiq,DB12194,-7.6,Atamestane,PEPMWUSGRKINHX-TXTPUJOMSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
162135,7bv1,DB01480,-7.6,Cyprenorphine,VSKIOMHXEUHYSI-KNLIIKEYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
127601,6w4h,DB06481,-7.6,Manitimus,IRELROQHIPLASX-SEYXRHQNSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
105360,6vxs,DB13395,-7.6,Eprozinol,QSRHLIUOSXVKTG-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
35685,1r42,DB01940,-7.6,Balanol Analog 2,SQLYTJZXRRDERK-ISKFKSNPSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
72548,6m2n,DB00876,-7.6,Eprosartan,OROAFUQRIXKEMV-LDADJPATSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61326,6crv,DB11919,-7.6,6-O-benzylguanine,KRWMERLEINMZFT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87513,6m3m,DB12425,-7.6,Liothyronine I-131,AUYYCJSJGJYCDS-UMVFHIKJSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
137152,6w9c,DB07962,-7.6,"METHYL N-[(2',4'-DIFLUORO-4-HYDROXY-5-IODOBIPHENYL-3-YL)CARBONYL]-BETA-ALANINATE",ZMRRBWRMQPQQAN-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
72552,6m2n,DB00881,-7.6,Quinapril,JSDRRTOADPPCHY-HSQYWUDLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
162169,7bv1,DB01523,-7.6,Clonitazene,GPZLDQAEBHTMPG-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
24998,6cs2,DB02836,-7.6,Guanosine 5'-Diphosphate 2':3'-Cyclic Monophosphate,NGYWTCOGOZELRS-UUOKFMHZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
105378,6vxs,DB13418,-7.6,Moxestrol,MTMZZIPTQITGCY-OLGWUGKESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
72592,6m2n,DB00924,-7.6,Cyclobenzaprine,JURKNVYFZMSNLP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
101898,6vxs,DB06733,-7.6,Bafilomycin A1,XDHNQDDQEHDUTM-JQWOJBOSSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
72478,6m2n,DB00799,-7.6,Tazarotene,OGQICQVSFDPSEI-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
83157,6m3m,DB03503,-7.6,"4-Acetyl-4-Guanidino-6-Methyl(Propyl)Carboxamide-4,5-Dihydro-2h-Pyran-2-Carboxylic Acid",QPJWMZVTNXFTKV-JMJZKYOTSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
33395,6cs2,T3D4588,-7.6,Nordiazepam,AKPLHCDWDRPJGD-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
87285,6m3m,DB12106,-7.6,PF-06305591,APWZIFIAVVFPNT-PELKAZGASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
127986,6w4h,DB07085,-7.6,2-{[N-(2-ACETYL-5-CHLORO-4-FLUOROPHENYL)GLYCYL]AMINO}BENZOIC ACID,LBMZLHCAPBBOFS-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
136591,6w9c,DB07303,-7.6,"N-3-[3-(5-METHOXYPYRIDIN-3-YL)BENZYL]PYRIDINE-2,3-DIAMINE",PGAWZMRRCVSRIM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
127989,6w4h,DB07088,-7.6,(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclopentyloxy)ethanoyl)pyrrolidine-2-carboxamide,ZWXWAYUCJVQHOR-KRWDZBQOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
136588,6w9c,DB07300,-7.6,"2-(1H-imidazol-1-yl)-9-methoxy-8-(2-methoxyethoxy)benzo[c][2,7]naphthyridin-4-amine",QSSGYSRUMIOURP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
161934,7bv1,DB00991,-7.6,Oxaprozin,OFPXSFXSNFPTHF-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
102037,6vxs,DB06930,-7.6,"N-[amino(imino)methyl]-2-(2,5-diphenyl-1H-pyrrol-1-yl)acetamide",WVLDNAVUCUAGDP-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
136571,6w9c,DB07272,-7.6,"N-(4-AMINO-5-CYANO-6-ETHOXYPYRIDIN-2-YL)-2-(4-BROMO-2,5-DIMETHOXYPHENYL)ACETAMIDE",GKODDLYLEKSDJL-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
102039,6vxs,DB06932,-7.6,"10,11-dimethoxy-4-methyldibenzo[c,f]-2,7-naphthyridine-3,6-diamine",NVINUNQBDNEMSY-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
11793,6lzg,DB12434,-7.6,Steviolbioside,OMHUCGDTACNQEX-OSHKXICASA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
27041,6cs2,DB06306,-7.6,Onalespib,IFRGXKKQHBVPCQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
127996,6w4h,DB07096,-7.6,"6-AMINO-BENZO[DE]ISOQUINOLINE-1,3-DIONE",SSMIFVHARFVINF-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
72386,6m2n,DB00688,-7.6,Mycophenolate mofetil,RTGDFNSFWBGLEC-SYZQJQIISA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
105062,6vxs,DB12937,-7.6,Quercetin-3'-O-phosphate,UWJBYNLLMAPJMM-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
70240,6lxt,DB12357,-7.6,BMS-863233,JJWLXRKVUJDJKG-VIFPVBQESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
128046,6w4h,DB07154,-7.6,"(3R)-4-[(3R)-3-AMINO-4-(2,4,5-TRIFLUOROPHENYL)BUTANOYL]-3-METHYL-1,4-DIAZEPAN-2-ONE",SWKGZJAAGSVROJ-MWLCHTKSSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
136478,6w9c,DB07163,-7.6,5-[(2-AMINOETHYL)AMINO]-6-FLUORO-3-(1H-PYRROL-2-YL)BENZO[CD]INDOL-2(1H)-ONE,CQCXWWWNUFQYJS-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
161921,7bv1,DB00977,-7.6,Ethinylestradiol,BFPYWIDHMRZLRN-SLHNCBLASA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
161922,7bv1,DB00978,-7.6,Lomefloxacin,ZEKZLJVOYLTDKK-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
61110,6crv,DB11561,-7.6,Aminacrine,XJGFWWJLMVZSIG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27035,6cs2,DB06282,-7.6,Levocetirizine,ZKLPARSLTMPFCP-OAQYLSRUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
136611,6w9c,DB07324,-7.6,"3-({2-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)ETHYNYL]BENZYL}AMINO)-1,3-OXAZOL-2(3H)-ONE",ZUJWSOPIDUWELP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
33418,6cs2,T3D4649,-7.6,Mexazolam,ANUCDXCTICZJRH-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
35528,1r42,DB01721,-7.6,Analogue of Indinavir Drug,MJIRDPUZGGHJMX-OIVSQUILSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
128028,6w4h,DB07132,-7.6,1-{2-OXO-3-[(1R)-1-(1H-PYRROL-2-YL)ETHYL]-2H-INDOL-5-YL}UREA,KJDBLWKTHMHALD-QMMMGPOBSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
161926,7bv1,DB00982,-7.6,Isotretinoin,SHGAZHPCJJPHSC-XFYACQKRSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
70253,6lxt,DB12377,-7.6,Relebactam,SMOBCLHAZXOKDQ-ZJUUUORDSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
72383,6m2n,DB00684,-7.6,Tobramycin,NLVFBUXFDBBNBW-PBSUHMDJSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
136539,6w9c,DB07235,-7.6,"N-[(1S)-2-AMINO-1-(2,4-DICHLOROBENZYL)ETHYL]-5-[2-(METHYLAMINO)PYRIMIDIN-4-YL]THIOPHENE-2-CARBOXAMIDE",HHOVRZGUSBMKKU-ZDUSSCGKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
70261,6lxt,DB12388,-7.6,Evocalcet,RZNUIYPHQFXBAN-XLIONFOSSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
105104,6vxs,DB13004,-7.6,Mavoglurant,ZFPZEYHRWGMJCV-ZHALLVOQSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
127947,6w4h,DB07040,-7.6,"2-amino-7-fluoro-5-oxo-5H-chromeno[2,3-b]pyridine-3-carboxamide",GCHMLYYPYFXLQB-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
127934,6w4h,DB07027,-7.6,D-phenylalanyl-N-(3-fluorobenzyl)-L-prolinamide,JGZSVYZIJHGHMA-MOPGFXCFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
136762,6w9c,DB07503,-7.6,"(5E)-5-[(2,2-DIFLUORO-1,3-BENZODIOXOL-5-YL)METHYLENE]-1,3-THIAZOLIDINE-2,4-DIONE",SRLVNYDXMUGOFI-YWEYNIOJSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
33340,6cs2,T3D4533,-7.6,Quinoxyfen,WRPIRSINYZBGPK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
61206,6crv,DB11745,-7.6,Otenabant,UNAZAADNBYXMIV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
157751,6wiq,DB12760,-7.6,GW-493838,ZQYJPMPXQLNTPQ-QCUYGVNKSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
136770,6w9c,DB07512,-7.6,7-[(3-CHLOROBENZYL)OXY]-2-OXO-2H-CHROMENE-4-CARBALDEHYDE,ZOCADHRNWNJARU-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
15939,6lzg,DB02008,-7.6,1-(2-Fluorobenzyl)-3-Butyl-8-(N-Acetyl-4-Aminobenzyl)-Xanthine,JHSHXKJSPVHPCJ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
58013,6crv,DB04438,-7.6,Brivudine monophosphate,LKWCVKAHHUJPQO-PIXDULNESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27075,6cs2,DB06410,-7.6,Doxercalciferol,HKXBNHCUPKIYDM-CGMHZMFXSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
136782,6w9c,DB07527,-7.6,"N-[(2R,3S)-3-AMINO-2-HYDROXY-4-PHENYLBUTYL]-4-METHOXY-2,3,6-TRIMETHYLBENZENESULFONAMIDE",HORGTFOBJRCVMO-ZWKOTPCHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
101907,6vxs,DB06745,-7.6,ginkgolide-C,AMOGMTLMADGEOQ-DTDWCABLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
127799,6w4h,DB06869,-7.6,1-[2-AMINO-2-CYCLOHEXYL-ACETYL]-PYRROLIDINE-3-CARBOXYLIC ACID 5-CHLORO-2-(2-ETHYLCARBAMOYL-ETHOXY)-BENZYLAMIDE,BMHVHOJXEQTIEA-SIKLNZKXSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
105199,6vxs,DB13158,-7.6,Clobetasone,XXIFVOHLGBURIG-OZCCCYNHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
83002,6m3m,DB03288,-7.6,5-Chloro-1h-Indole-2-Carboxylic Acid{[Cyclopentyl-(2-Hydroxy-Ethyl)-Carbamoyl]-Methyl}-Amide,VXABTOCIIZSEPD-QGZVFWFLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
105202,6vxs,DB13165,-7.6,Ripasudil,QSKQVZWVLOIIEV-NSHDSACASA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
105180,6vxs,DB13115,-7.6,Saroglitazar,MRWFZSLZNUJVQW-DEOSSOPVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
28781,6cs2,DB08395,-7.6,2-(ETHOXYMETHYL)-4-(4-FLUOROPHENYL)-3-[2-(2-HYDROXYPHENOXY)PYRIMIDIN-4-YL]ISOXAZOL-5(2H)-ONE,ZSOXFJURLPCSOO-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
136747,6w9c,DB07485,-7.6,"4,4'-cyclohexane-1,1-diyldiphenol",SDDLEVPIDBLVHC-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136743,6w9c,DB07480,-7.6,4-PHOSPHONOOXY-PHENYL-METHYL-[4-PHOSPHONOOXY]BENZEN,LGSCVLKUKMBYNC-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136666,6w9c,DB07390,-7.6,"2-[3-(5-MERCAPTO-[1,3,4]THIADIAZOL-2-YL)-UREIDO]-N-METHYL-3-PHENYL-PROPIONAMIDE",RKWXKADYTDWZIJ-VIFPVBQESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
33375,6cs2,T3D4566,-7.6,Camazepam,PXBVEXGRHZFEOF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
161981,7bv1,DB01044,-7.6,Gatifloxacin,XUBOMFCQGDBHNK-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
157798,6wiq,DB12843,-7.6,Oleandrin,JLPDBLFIVFSOCC-XYXFTTADSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
136690,6w9c,DB07418,-7.6,bis(4-nitrophenyl) hydrogen phosphate,MHSVUSZEHNVFKW-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136695,6w9c,DB07423,-7.6,(2S)-3-[4-(acetylamino)phenoxy]-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide,YVXVTLGIDOACBJ-SFHVURJKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
101936,6vxs,DB06803,-7.6,Niclosamide,RJMUSRYZPJIFPJ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
136696,6w9c,DB07425,-7.6,Sobetirome,QNAZTOHXCZPOSA-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
157781,6wiq,DB12812,-7.6,Palomid 529,YEAHTLOYHVWAKW-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
83098,6m3m,DB03416,-7.6,Thiamine(1+) monophosphate,HZSAJDVWZRBGIF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
70197,6lxt,DB12295,-7.6,Evodenoson,SQJXTUJMBYVDBB-RQXXJAGISA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
136738,6w9c,DB07473,-7.6,"(R)-(+) 5(9BH)-OXO-9B-PHENYL-2,3-DIHYDROTHIAZOLO[2,3-A]ISOINDOL-3-CARBOXYLIC ACID METHYL ESTER",JYIHODAXBBPFQF-MAUKXSAKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
101939,6vxs,DB06814,-7.6,Protokylol,LUMAEVHDZXIGEP-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
33351,6cs2,T3D4544,-7.6,Triadimenol,BAZVSMNPJJMILC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
33362,6cs2,T3D4554,-7.6,Brompheniramine,ZDIGNSYAACHWNL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
157921,6wiq,DB14899,-7.6,Tavapadon,AKQXQLUNFKDZBN-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
57798,6crv,DB04143,-7.6,Indole-3-Glycerol Phosphate,NQEQTYPJSIEPHW-MNOVXSKESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
105463,6vxs,DB13534,-7.6,Gedocarnil,SLYDYLLJUXFULK-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
162580,7bv1,DB02449,-7.6,3-(1h-Indol-3-Yl)-2-[4-(4-Phenyl-Piperidin-1-Yl)-Benzenesulfonylamino]-Propionic Acid,ULOTXPTWJAUGGE-MHZLTWQESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
61506,6crv,DB12187,-7.6,Abacavir hydroxyacetate,ZBBZROWQLKCFQK-KOLCDFICSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
24860,6cs2,DB02669,-7.6,RB106,ZWDQTNWLXALTOV-QYZOEREBSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
12868,6lzg,DB13943,-7.6,Testosterone cypionate,HPFVBGJFAYZEBE-ZLQWOROUSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
6986,6lzg,DB03038,-7.6,LY341770,MXAFDBCLWLMXSI-ZDUSSCGKSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
69927,6lxt,DB11902,-7.6,Gisadenafil,YPFZMBHKIVDSNR-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
137741,6w9c,DB08663,-7.6,4-HYDROXY-7-METHOXY-3-(1-PHENYL-PROPYL)-CHROMEN-2-ONE,CCPGCKQLIHGSCJ-AWEZNQCLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
11680,6lzg,DB12290,-7.6,Puerarin,HKEAFJYKMMKDOR-VPRICQMDSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
61495,6crv,DB12170,-7.6,Veledimex,LZWZPGLVHLSWQX-XMMPIXPASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57612,6crv,DB03894,-7.6,N-Propargyl-1(S)-Aminoindan,RUOKEQAAGRXIBM-LBPRGKRZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57617,6crv,DB03899,-7.6,9-Butyl-8-(4-Methoxybenzyl)-9h-Purin-6-Amine,NVYATAJRTRFKSW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127126,6w4h,DB04753,-7.6,"9-DEAZAINOSINE-2',3'-O-ETHYLIDENEPHOSPHONATE",ZOEDLCUBOBTIHG-USQSKNHBSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
12862,6lzg,DB13936,-7.6,JNJ-28330835,RYBKPGYFXRNMMU-LBPRGKRZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
82410,6m3m,DB02502,-7.6,8-Hydroxy-2'-Deoxyguanosine,HCAJQHYUCKICQH-VPENINKCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
137714,6w9c,DB08633,-7.6,TNP-470,MSHZHSPISPJWHW-PVDLLORBSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
127145,6w4h,DB04778,-7.6,SC45647,LPSXGZAUAOMRNU-FZKQIMNGSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
69935,6lxt,DB11912,-7.6,Lanopepden,SWHNZGMQMGFQGW-MSOLQXFVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
24888,6cs2,DB00348,-7.6,Nitisinone,OUBCNLGXQFSTLU-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
15688,6lzg,DB00836,-7.6,Loperamide,RDOIQAHITMMDAJ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
105650,6vxs,DB13784,-7.6,Dixyrazine,MSYUMPGNGDNTIQ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
105660,6vxs,DB13796,-7.6,Dibunate,WBEBQCINXJDZCX-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
162494,7bv1,DB02342,-7.6,2-Methox1tradiol,CQOQDQWUFQDJMK-SSTWWWIQSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
127173,6w4h,DB04816,-7.6,Dantron,QBPFLULOKWLNNW-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
69925,6lxt,DB11900,-7.6,OC-459,FATGTHLOZSXOBC-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
127159,6w4h,DB04796,-7.6,Inecalcitol,HHGRMHMXKPQNGF-WNSNRMDMSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
137685,6w9c,DB08596,-7.6,5'-deoxy-5'-piperidin-1-ylthymidine,GMOUOGHZJCSNOZ-YNEHKIRRSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137687,6w9c,DB08598,-7.6,"4-CHLORO-8-METHYL-7-(3-METHYL-BUT-2-ENYL)-6,7,8,9-TETRAHYDRO-2H-2,7,9A-TRIAZA-BENZO[CD]AZULENE-1-THIONE",RCSLUNOLLUVOOG-NSHDSACASA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
18345,6cs2,HMDB0029007,-7.6,Phenylalanyl-Tyrosine,FSXRLASFHBWESK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
82459,6m3m,DB02566,-7.6,8-Hydroxy-4-(1-Hydroxyethyl)Quinoline-2-Carboxylic Acid,FCGZNXGKWUHBKD-WKEGUHRASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
101586,6vxs,DB05772,-7.6,Rabeximod,PDNNUMNEXITLCZ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
137702,6w9c,DB08615,-7.6,"2-[4-(DIMETHYLAMINO)PHENYL]-6-HYDROXY-3-METHYL-1,3-BENZOTHIAZOL-3-IUM",NOVJJPLRUMZSDK-UHFFFAOYSA-O,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137680,6w9c,DB08590,-7.6,1-(3-HYDROXYPROPYL)-2-[(3-NITROBENZOYL)AMINO]-1H-BENZIMIDAZOL-5-YL PIVALATE,CEAYRKIZESVQSN-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
157347,6wiq,DB15229,-7.6,CNV-2197944,BLFJGFDZMABYMY-ZDUSSCGKSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
162581,7bv1,DB02450,-7.6,"2-Benzo[1,3]Dioxol-5-Ylmethyl-3-Benzyl-Succinic Acid",ASEJDWRSZYAIOT-GJZGRUSLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
69920,6lxt,DB11893,-7.6,Avagacestat,XEAOPVUAMONVLA-QGZVFWFLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
137911,6w9c,DB08880,-7.6,Teriflunomide,UTNUDOFZCWSZMS-YFHOEESVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
33076,6cs2,T3D4052,-7.6,alpha-Zearalenol,FPQFYIAXQDXNOR-QDKLYSGJSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
137941,6w9c,DB08932,-7.6,Macitentan,JGCMEBMXRHSZKX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
82365,6m3m,DB02447,-7.6,"3,8,9,10-Tetrahydroxy-7-Hydroxymethyl-6-Oxa-1,3-Diaza-Spiro[4.5]Decane-2,4-Dione",IHDZZZHACPJCFJ-WWHASAIZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
61547,6crv,DB12244,-7.6,CP-601927,RNOBTWYQAWEZHH-JGVFFNPUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
69888,6lxt,DB11844,-7.6,Pritelivir,IVZKZONQVYTCKC-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
157315,6wiq,DB15168,-7.6,Cilofexor,KZSKGLFYQAYZCO-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
15636,6lzg,DB00604,-7.6,Cisapride,DCSUBABJRXZOMT-IRLDBZIGSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
162634,7bv1,DB02639,-7.6,4-methylumbelliferyl alpha-D-glucoside,YUDPTGPSBJVHCN-JZYAIQKZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
82348,6m3m,DB02422,-7.6,Methyl-2-S-(Alpha-D-Mannopyranosyl)-2-Thio-Alpha-D-Mannopyranoside,WAYOKHSZGNFKSX-ZEEOCKJESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
69867,6lxt,DB11816,-7.6,Omecamtiv Mecarbil,RFUBTTPMWSKEIW-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
101502,6vxs,DB05288,-7.6,Anecortave acetate,YUWPMEXLKGOSBF-GACAOOTBSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
137968,6w9c,DB08967,-7.6,Dimetotiazine,VWNWVCJGUMZDIU-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137973,6w9c,DB08972,-7.6,Flumequine,DPSPPJIUMHPXMA-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
69883,6lxt,DB11833,-7.6,Basimglurant,UPZWINBEAHDTLA-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
157372,6wiq,DB15282,-7.6,Fluorofuranylnorprogesterone F-18,VJKRBRUNEOHPBS-JQKUZGBFSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
137902,6w9c,DB08864,-7.6,Rilpivirine,YIBOMRUWOWDFLG-ONEGZZNKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
72719,6m2n,DB01071,-7.6,Mequitazine,HOKDBMAJZXIPGC-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
87788,6m3m,DB12861,-7.6,Rimeporide,GROMEQPXDKRRIE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
27241,6cs2,DB06735,-7.6,Enclomiphene,GKIRPKYJQBWNGO-OCEACIFDSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
12873,6lzg,DB13950,-7.6,WIN 55212-2,HQVHOQAKMCMIIM-HXUWFJFHSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
101553,6vxs,DB05552,-7.6,TG100-115,UJIAQDJKSXQLIT-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101552,6vxs,DB05542,-7.6,Naronapride,VGDDOIZXGFJDRC-VJTSUQJLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
137795,6w9c,DB08729,-7.6,"5-ethoxy-4-(1-methyl-7-oxo-3-propyl-6,7-dihydro-1H-pyrazolo[4,3-d]pyrimidin-5-yl)thiophene-2-sulfonamide",FENWRHVHBZQJGW-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
127023,6w4h,DB04609,-7.6,INHIBITOR Q8467 OF DUPONT MERCK,HFLCERPZYCWLSZ-VKONIRKNSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
137799,6w9c,DB08733,-7.6,"(2R,3R)-N^1^-[(1S)-2,2-DIMETHYL-1-(METHYLCARBAMOYL)PROPYL]-N^4^-HYDROXY-2-(2-METHYLPROPYL)-3-{[(1,3-THIAZOL-2-YLCARBONYL)AMINO]METHYL}BUTANEDIAMIDE",GAHIXYNNFMCKFQ-HZSPNIEDSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
127048,6w4h,DB04642,-7.6,"7-{2,6-DICHLORO-4-[3-(2-CHLORO-BENZOYL)-UREIDO]-PHENOXY}-HEPTANOIC ACID",XQTOWNDCHQJXOQ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
137823,6w9c,DB08758,-7.6,"IMIDAZO[2,1-A]ISOQUINOLINE-2-CARBOHYDRAZIDE",WSNWYZBDIKCPIG-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
157323,6wiq,DB15189,-7.6,Birabresib,GNMUEVRJHCWKTO-FQEVSTJZSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
137850,6w9c,DB08789,-7.6,"2-AMINO-4-(2,4-DICHLOROPHENYL)-N-ETHYLTHIENO[2,3-D]PYRIMIDINE-6-CARBOXAMIDE",YPEOXUOUTBMBCX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
101534,6vxs,DB05465,-7.6,Tandutinib,UXXQOJXBIDBUAC-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
127025,6w4h,DB04612,-7.6,"N-METHYLALANYL-3-METHYLVALYL-4-PHENOXY-N-(1,2,3,4-TETRAHYDRONAPHTHALEN-1-YL)PROLINAMIDE",QKPXPZYQPBWDHS-MCJAPYMPSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
18370,6cs2,HMDB0000658,-7.6,CE(16:1(9Z)),HODJWNWCVNUPAQ-XDOSKZMUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
105462,6vxs,DB13533,-7.6,Methylestrenolone,ZXSWTMLNIIZPET-ZOFHRBRSSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
24889,6cs2,DB02703,-7.6,Fusidic acid,IECPWNUMDGFDKC-MZJAQBGESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
57658,6crv,DB03952,-7.6,9-(6-deoxy-beta-D-allofuranosyl)-6-methylpurine,XJZDIUOABWMPLZ-FHQKJXBVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
69995,6lxt,DB12004,-7.6,Briciclib,LXENKEWVEVKKGV-BQYQJAHWSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
137455,6w9c,DB08317,-7.6,"5-methyl-6-phenylquinazoline-2,4-diamine",HUCOXWPHDFINIW-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137451,6w9c,DB08313,-7.6,nocodazole,KYRVNWMVYQXFEU-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
105560,6vxs,DB13667,-7.6,Cefozopran,QDUIJCOKQCCXQY-WHJQOFBOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
61410,6crv,DB12046,-7.6,Atopaxar,QWKAUGRRIXBIPO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
101685,6vxs,DB06230,-7.6,Nalmefene,WJBLNOPPDWQMCH-MBPVOVBZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
82634,6m3m,DB02805,-7.6,Uracil arabinose-3'-phosphate,FOGRQMPFHUHIGU-PXBUCIJWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
137421,6w9c,DB08274,-7.6,"6,7,8,9-TETRAHYDRO-4-HYDROXY-3-(1-PHENYLPROPYL)CYCLOHEPTA[B]PYRAN-2-ONE",YKJXQZGJGDTEOC-AWEZNQCLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
127326,6w4h,DB05316,-7.6,Pimavanserin,RKEWSXXUOLRFBX-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
162349,7bv1,DB01941,-7.6,"6-[1-(3,5,5,8,8-Pentamethyl-5,6,7,8-Tetrahydronaphthalen-2-Yl)Cyclopropyl]Pyridine-3-Carboxylic Acid",SLXTWXQUEZSSTJ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
82666,6m3m,DB02844,-7.6,"S-Adenosyl-1,8-Diamino-3-Thiooctane",SUUGLGYBZXSJAA-SCFUHWHPSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
61386,6crv,DB12008,-7.6,Prexasertib,DOTGPNHGTYJDEP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
101707,6vxs,DB06268,-7.6,Sitaxentan,PHWXUGHIIBDVKD-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
24957,6cs2,DB02789,-7.6,Pregnenolone,ORNBQBCIOKFOEO-QGVNFLHTSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
105514,6vxs,DB13605,-7.6,Phenoperidine,IPOPQVVNCFQFRK-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
57756,6crv,DB04089,-7.6,AL5300,HHPUQNGRNUOYCD-VIFPVBQESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
82685,6m3m,DB02869,-7.6,3-amino-5-phenylpentane,ZPXIQFOUPUVVPU-INIZCTEOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
105478,6vxs,DB13553,-7.6,Carumonam,UIMOJFJSJSIGLV-JNHMLNOCSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
24968,6cs2,DB02804,-7.6,A-98881,PMBZSBGCSQGJAQ-GRKNLSHJSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
101720,6vxs,DB06307,-7.6,Apoptone,CKAXZOYFIHQCBN-JRRMKBMNSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
82701,6m3m,DB02890,-7.6,6-Hydroxyuridine-5'-Phosphate,UDOBICLZEKUKCV-YXZULKJRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87626,6m3m,DB12596,-7.6,Combretastatin,LGZKGOGODCLQHG-CYBMUJFWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
105482,6vxs,DB13557,-7.6,Thiopropazate,AIUHRQHVWSUTGJ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
137463,6w9c,DB08325,-7.6,2-(2-HYDROXYETHYLAMINO)-6-(3-CHLOROANILINO)-9-ISOPROPYLPURINE,XZEFMZCNXDQXOZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137329,6w9c,DB08158,-7.6,"2,4-DINITROPHENYL 2-DEOXY-2-FLUORO-BETA-D-MANNOPYRANOSIDE",UFSBFVZQJZMIOU-IYKVGLELSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
87631,6m3m,DB12605,-7.6,Etripamil,VAZNEHLGJGSQEL-MHZLTWQESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
82694,6m3m,DB02881,-7.6,4-(4-Hydroxy-3-Isopropylphenylthio)-2-Isopropylphenol,NEMLLZAROZVCCE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
127404,6w4h,DB05767,-7.6,Andrographolide,BOJKULTULYSRAS-OTESTREVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
105487,6vxs,DB13564,-7.6,Zipeprol,VSTNNAYSCJQCQI-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
127393,6w4h,DB05676,-7.6,Apremilast,IMOZEMNVLZVGJZ-QGZVFWFLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
162320,7bv1,DB01895,-7.6,Aspartyl-Adenosine-5'-Monophosphate,QPBSGQWTJLPZNF-VWJPMABRSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
137333,6w9c,DB08162,-7.6,Fasudil,NGOGFTYYXHNFQH-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
105568,6vxs,DB13675,-7.6,Metahexamide,XXYTXQGCRQLRHA-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
157439,6wiq,DB06486,-7.6,Enzastaurin,AXRCEOKUDYDWLF-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
87679,6m3m,DB12681,-7.6,Salirasib,WUILNKCFCLNXOK-CFBAGHHKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
137574,6w9c,DB08464,-7.6,"METHYL 3-CHLORO-2-{3-[(2,5-DIHYDROXY-4-METHOXYPHENYL)AMINO]-3-OXOPROPYL}-4,6-DIHYDROXYBENZOATE",GUVWEHNRWHNDRF-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
57696,6crv,DB04005,-7.6,Uridine 5'-triphosphate,PGAVKCOVUIYSFO-XVFCMESISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
137576,6w9c,DB08466,-7.6,"5-[2-(4-hydroxyphenyl)ethyl]benzene-1,3-diol",HITJFUSPLYBJPE-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
127232,6w4h,DB04886,-7.6,Calanolide A,NIDRYBLTWYFCFV-FMTVUPSXSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
11690,6lzg,DB12302,-7.6,CP-724714,LLVZBTWPGQVVLW-SNAWJCMRSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
101610,6vxs,DB05932,-7.6,Denibulin,GAOHLWCIAJNSEE-JTQLQIEISA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
137571,6w9c,DB08461,-7.6,"3-[(4-AMINO-1-TERT-BUTYL-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL)METHYL]PHENOL",QMAIQPBRCNEJAT-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
127221,6w4h,DB04873,-7.6,Piboserod,KVCSJPATKXABRQ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
127220,6w4h,DB04872,-7.6,Osanetant,DZOJBGLFWINFBF-UMSFTDKQSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
162455,7bv1,DB02290,-7.6,"3-{2,6,8-trioxo-9-[(2S,3S,4R)-2,3,4,5-tetrahydroxypentyl]-1,2,3,6,8,9-hexahydro-7H-purin-7-Yl}propyl dihydrogen phosphate",KPHFGOGGKPGLTM-OOZYFLPDSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
82520,6m3m,DB02647,-7.6,N-(5-Cyclopropyl-1h-Pyrazol-3-Yl)Benzamide,LUCORKWTQSQFFU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
57671,6crv,DB03973,-7.6,"3-{2,6,8-trioxo-9-[(2R,3R,4R)-2,3,4,5-tetrahydroxypentyl]-1,2,3,6,8,9-hexahydro-7H-purin-7-Yl}propyl dihydrogen phosphate",KPHFGOGGKPGLTM-ZXFLCMHBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
101602,6vxs,DB05861,-7.6,Tasquinimod,ONDYALNGTUAJDX-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
57661,6crv,DB03956,-7.6,"Inositol 2,4,5-trisphosphate",MMWCIQZXVOZEGG-LKPKBOIGSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87714,6m3m,DB12733,-7.6,Dipraglurant,LZXMUJCJAWVHPZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
101598,6vxs,DB05830,-7.6,Trestolone,YSGQGNQWBLYHPE-CFUSNLFHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
69965,6lxt,DB11958,-7.6,Brivanib,WCWUXEGQKLTGDX-LLVKDONJSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
57698,6crv,DB04007,-7.6,Bromo-WR99210,MPXYCOHVHSXSDC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
101650,6vxs,DB06155,-7.6,Rimonabant,JZCPYUJPEARBJL-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
137497,6w9c,DB08369,-7.6,1-(biphenyl-4-ylmethyl)-1H-imidazole,DLYMRVCQTVOYEW-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137499,6w9c,DB08371,-7.6,PARA-(BENZOYL)-PHENYLALANINE,TVIDEEHSOPHZBR-AWEZNQCLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
127282,6w4h,DB05048,-7.6,Cannabinor,GSTZHANFXAKPSE-MXTREEOPSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
82591,6m3m,DB02743,-7.6,beta-D-galactopyranosyl-(1->4)-beta-D-galactopyranose,GUBGYTABKSRVRQ-WWZHPTPQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
35756,1r42,DB02033,-7.6,"N-(3-Cyclopropyl(5,6,7,8,9,10-Hexahydro-2-Oxo-2h-Cycloocta[B]Pyran-3-Yl)Methyl)Phenylbenzensulfonamide",GDRNWAKVNIROCG-DEOSSOPVSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
72653,6m2n,DB00998,-7.6,Frovatriptan,XPSQPHWEGNHMSK-SECBINFHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
69986,6lxt,DB11990,-7.6,MK-0812,UNVWTBOGMHPKJM-CWKRKGSWSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
69975,6lxt,DB11969,-7.6,Uprosertib,AXTAPYRUEKNRBA-JTQLQIEISA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
11691,6lzg,DB12303,-7.6,Motolimod,QSPOQCXMGPDIHI-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
82571,6m3m,DB02714,-7.6,3'-Uridinemonophosphate,FOGRQMPFHUHIGU-XVFCMESISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
162396,7bv1,DB02001,-7.6,"5-(4-Morpholin-4-Yl-Phenylsulfanyl)-2,4-Quinazolinediamine",CZLWCJRHDBTCGQ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
137530,6w9c,DB08410,-7.6,PARA-NITROBENZYL GLUTARYL GLYCINIC ACID,UCFVFUIGNWHAJJ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
105581,6vxs,DB13689,-7.6,Tacalcitol,BJYLYJCXYAMOFT-RSFVBTMBSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
87684,6m3m,DB12689,-7.6,Azeliragon,KJNNWYBAOPXVJY-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87862,6m3m,DB12971,-7.6,Pactimibe,TXIIZHHIOHVWJD-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136471,6w9c,DB07155,-7.6,(3S)-1-CYCLOHEXYL-5-OXO-N-PHENYLPYRROLIDINE-3-CARBOXAMIDE,BVUSHGJZBZMDML-ZDUSSCGKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
61099,6crv,DB11537,-7.6,Pirlimycin,HBJOXQRURQPDEX-MHXMMLMNSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60804,6crv,DB09175,-7.6,Mirfentanil,BJZZDOLVVLWFHN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
33648,6cs2,T3D4893,-7.6,"5,7-Dihydroxyflavone",RTIXKCRFFJGDFG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
128655,6w4h,DB07863,-7.6,2-chloro-5-nitro-N-phenylbenzamide,DNTSIBUQMRRYIU-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
83659,6m3m,DB04175,-7.6,Mdl-29951,KNBSYZNKEAWABY-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
102376,6vxs,DB07323,-7.6,"2-[({2-[(1Z)-3-(DIMETHYLAMINO)PROP-1-ENYL]-4-FLUOROPHENYL}SULFONYL)AMINO]-5,6,7,8-TETRAHYDRONAPHTHALENE-1-CARBOXYLIC ACID",CTZLIARLNXSXGL-ALCCZGGFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102377,6vxs,DB07324,-7.6,"3-({2-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)ETHYNYL]BENZYL}AMINO)-1,3-OXAZOL-2(3H)-ONE",ZUJWSOPIDUWELP-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
135436,6w9c,DB04468,-7.6,Afimoxifene,TXUZVZSFRXZGTL-QPLCGJKRSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
128678,6w4h,DB07891,-7.6,"4-{[(14beta,17alpha)-3-hydrox1tra-1,3,5(10)-trien-17-yl]oxy}-4-oxobutanoic acid",YJPIDPAGJSWWBE-FNIAAEIWSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
70519,6lxt,DB12780,-7.6,Quinfamide,SBJGFIXQRZOVTO-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
128693,6w4h,DB07909,-7.6,"(1S,2S,5S)2-(4-GLUTARIDYLBENZYL)-5-PHENYL-1-CYCLOHEXANOL",OBWILOKKNDYPLX-HBMCJLEFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
158335,7bv1,DB00876,-7.6,Eprosartan,OROAFUQRIXKEMV-LDADJPATSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
58443,6crv,DB05271,-7.6,Rotigotine,KFQYTPMOWPVWEJ-INIZCTEOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
102409,6vxs,DB07359,-7.6,"3-[(4-fluorophenyl)sulfanyl]-N-(4-methyl-1,3-thiazol-2-yl)-6-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]pyridine-2-carboxamide",SJTQKYKXCYVFHX-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
128707,6w4h,DB07927,-7.6,3-[(4-Carboxy-2-hydroxyphenyl)sulfamoyl]-2-thiophenecarboxylic acid,RDPXXOOKKRIKFN-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
161469,7bv1,DB14867,-7.6,Parsaclisib,ZQPDJCIXJHUERQ-QWRGUYRKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
161467,7bv1,DB14862,-7.6,PF-06815345,QTBYVAZRKWOIDU-FUHWJXTLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60768,6crv,DB09090,-7.6,Pinaverium,DDHUTBKXLWCZCO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
128788,6w4h,DB08017,-7.6,3-METHOXY-6-[4-(3-METHYLPHENYL)-1-PIPERAZINYL]PYRIDAZINE,DDOAUTHWSCUHQA-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
58471,6crv,DB05444,-7.6,Iroxanadine,QWVRTSZDKPRPDF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
17983,6cs2,HMDB0000569,-7.6,Deoxypyridinoline,ZAHDXEIQWWLQQL-IHRRRGAJSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
135279,6w9c,DB04248,-7.6,beta-(1->4)-galactotriose,FYGDTMLNYKFZSV-XJJKTWKOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
60744,6crv,DB09056,-7.6,Amorolfine,MQHLMHIZUIDKOO-AYHJJNSGSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
135289,6w9c,DB04263,-7.6,Geneticin,BRZYSWJRSDMWLG-DJWUNRQOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
86738,6m3m,DB09313,-7.6,Ioxaglic acid,TYYBFXNZMFNZJT-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83703,6m3m,DB04234,-7.6,N2-({[(4-Bromophenyl)Methyl]Oxy}Carbonyl)-N1-[(1s)-1-Formylpentyl]-L-Leucinamide,UEDKSAKLZBMNMA-ROUUACIJSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
33681,6cs2,T3D4923,-7.6,C.I. Food Red 1,DZCOAQKTFAIFRV-FMQUCBEESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
6488,6lzg,DB02205,-7.6,"6-(1,1-Dimethylallyl)-2-(1-Hydroxy-1-Methylethyl)-2,3-Dihydro-7h-Furo[3,2-G]Chromen-7-One",JCDLLLXYAICSQV-INIZCTEOSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
86678,6m3m,DB09216,-7.6,Tolfenamic Acid,YEZNLOUZAIOMLT-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
161453,7bv1,DB14071,-7.6,Desmethylsertraline,SRPXSILJHWNFMK-ZBEGNZNMSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
70535,6lxt,DB12806,-7.6,GSK-1004723,YANGEESWIGIKOP-UUWRZZSWSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
35267,1r42,DB01410,-7.6,Ciclesonide,LUKZNWIVRBCLON-GXOBDPJESA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
158377,7bv1,DB01116,-7.6,Trimethaphan,CHQOEHPMXSHGCL-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
128644,6w4h,DB07851,-7.6,"(3R,4S)-1-(3,4-DIMETHOXYPHENYL)-3-(3-METHYLPHENYL)PIPERIDIN-4-AMINE",DQJXBZGPJVSWFI-ROUUACIJSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
83636,6m3m,DB04149,-7.6,(R)-Rolipram,HJORMJIFDVBMOB-LBPRGKRZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
26858,6cs2,DB05562,-7.6,Naluzotan,SPWZXWDPAWDKQE-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
135645,6w9c,DB04754,-7.6,"GUANOSINE-2',3'-O-ETHYLIDENEPHOSPHONATE",HYAPEMYRVFIHDJ-QWEIRQIHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
35329,1r42,DB01479,-7.6,BA-2664,QGKQXZFZOIQFBI-XSWYFRFISA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
135656,6w9c,DB04769,-7.6,"5-QUINOXALIN-6-YLMETHYLENE-THIAZOLIDINE-2,4-DIONE",SQWZFLMPDUSYGV-POHAHGRESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
135657,6w9c,DB04770,-7.6,"O6-(R)-ROSCOVITINE, R-2-(6-BENZYLOXY-9-ISOPROPYL-9H-PURIN-2-YLAMINO)-BUTAN-1-OL",HGADNQLEUZSUEJ-OAHLLOKOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
104841,6vxs,DB12585,-7.6,Ondelopran,QWNDOCKIKKQJNN-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
72207,6m2n,DB00468,-7.6,Quinine,LOUPRKONTZGTKE-WZBLMQSHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
70461,6lxt,DB12687,-7.6,Vesatolimod,VFOKSTCIRGDTBR-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
70458,6lxt,DB12682,-7.6,Mubritinib,ZTFBIUXIQYRUNT-MDWZMJQESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
33605,6cs2,T3D4852,-7.6,Carmine red,DGQLVPJVXFOQEV-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
58376,6crv,DB04938,-7.6,Ospemifene,LUMKNAVTFCDUIE-VHXPQNKSSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104845,6vxs,DB12591,-7.6,BMS-911543,JCINBYQJBYJGDM-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
161651,7bv1,DB00223,-7.6,Diflorasone,WXURHACBFYSXBI-XHIJKXOTSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
158237,7bv1,DB00764,-7.6,Mometasone,QLIIKPVHVRXHRI-CXSFZGCWSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
135718,6w9c,DB04844,-7.6,Tetrabenazine,MKJIEFSOBYUXJB-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
135692,6w9c,DB04817,-7.6,Metamizole,LVWZTYCIRDMTEY-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
135264,6w9c,DB04200,-7.6,Matairesinol,MATGKVZWFZHCLI-LSDHHAIUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
58385,6crv,DB04957,-7.6,Azimilide,MREBEPTUUMTTIA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
161574,7bv1,DB00136,-7.6,Calcitriol,GMRQFYUYWCNGIN-NKMMMXOESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60819,6crv,DB09191,-7.6,Talsupram,FKHYYOUFMJBLAF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
135541,6w9c,DB04602,-7.6,PUROMYCIN AMINONUCLEOSIDE-5'-MONOPHOSPHATE,BFPIKGKMRKBBBF-GRIPGOBMSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
128612,6w4h,DB07814,-7.6,Gibberellic acid,IXORZMNAPKEEDV-OBDJNFEBSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
135552,6w9c,DB04616,-7.6,TACRINE(8)-4-AMINOQUINOLINE,UNVOAAWEEGAXTN-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
25280,6cs2,DB03176,-7.6,KB-141,OZYQIQVPUZANTM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
86771,6m3m,DB09495,-7.6,Avobenzone,XNEFYCZVKIDDMS-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
60844,6crv,DB09217,-7.6,Firocoxib,FULAPETWGIGNMT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86798,6m3m,DB11155,-7.6,Triclocarban,ICUTUKXCWQ1Q-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
6532,6lzg,DB02277,-7.6,1-(5-Tert-Butyl-2-Methyl-2h-Pyrazol-3-Yl)-3-(4-Chloro-Phenyl)-Urea,FWIJKWMXNHRSRO-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
128589,6w4h,DB07790,-7.6,N-(2-METHOXYETHYL)-4-({4-[2-METHYL-1-(1-METHYLETHYL)-1H-IMIDAZOL-5-YL]PYRIMIDIN-2-YL}AMINO)BENZENESULFONAMIDE,LDXLQEXLXZCYSR-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
135589,6w9c,DB04662,-7.6,OLOMOUCINE II,NDUVSANREQEDRE-CQSZACIVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
135591,6w9c,DB04664,-7.6,Cyclohexyl-pentyl-maltoside,RVTGFZGNOSKUDA-ZNGNCRBCSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
33625,6cs2,T3D0420,-7.6,"2,4',5-Trichlorobiphenyl",VAHKBZSAUKPEOV-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
83607,6m3m,DB04108,-7.6,"(2s,3r)-3-Amino-2-Hydroxy-5-(Ethylsulfanyl)Pentanoyl-((S)-(-)-(1-Naphthyl)Ethyl)Amide",AIIOXZPEXXZCML-KKXDTOCCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
104833,6vxs,DB12573,-7.6,LY-2452473,IHIWYQYVBNODSV-KRWDZBQOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
128512,6w4h,DB07701,-7.6,"1-BENZYL-4-[(5,6-DIMETHOXY-1-INDANON-2-YL)METHYL]PIPERIDINE",ADEBPBSSDYVVLD-HXUWFJFHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
104771,6vxs,DB12476,-7.6,CPG-52852,YZOQZEXYFLXNKA-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104770,6vxs,DB12475,-7.6,Biphenyl dimethyl dicarboxylate,BKRIRZXWWALTPU-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104719,6vxs,DB12405,-7.6,Triciribine,HOGVTUZUJGHKPL-HTVVRFAVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
6420,6lzg,DB02081,-7.6,Bis-Benzamidine,BXYGSMRTHHSAHZ-PMACEKPBSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
6417,6lzg,DB00288,-7.6,Amcinonide,ILKJAFIWWBXGDU-MOGDOJJUSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
128985,6w4h,DB08245,-7.6,1-(2-DEOXY-5-O-PHOSPHONO-BETA-D-ERYTHRO-PENTOFURANOSYL)-5-NITRO-1H-INDOLE,FQCJFJRLZCIFHB-YNEHKIRRSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
102536,6vxs,DB07512,-7.6,7-[(3-CHLOROBENZYL)OXY]-2-OXO-2H-CHROMENE-4-CARBALDEHYDE,ZOCADHRNWNJARU-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
12587,6lzg,DB13556,-7.6,Sulfamazone,BGLHAKAJGYLSOX-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
134933,6w9c,DB03767,-7.6,Morpholine-4-Carboxylic Acid [1s-(2-Benzyloxy-1r-Cyano-Ethylcarbamoyl)-3-Methyl-Butyl]Amide,LXEDKIMJQBOMSU-MOPGFXCFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
129008,6w4h,DB08281,-7.6,"O-[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethyl] (4-bromophenyl)thiocarbamate",BDVAWAILQCYMQE-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
25382,6cs2,DB00402,-7.6,Eszopiclone,GBBSUAFBMRNDJC-INIZCTEOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
129009,6w4h,DB08282,-7.6,"O-[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethyl] (4-chlorophenyl)thiocarbamate",BWRRXOIACQYNEK-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
72078,6m2n,DB00310,-7.6,Chlorthalidone,JIVPVXMEBJLZRO-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
158460,7bv1,DB01208,-7.6,Sparfloxacin,DZZWHBIBMUVIIW-DTORHVGOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
16417,6lzg,DB04158,-7.6,"6-(Adenosine Tetraphosphate-Methyl)-7,8-Dihydropterin",ZKRKFZJAQKKHKL-SUGPNEFASA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
102560,6vxs,DB07539,-7.6,"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZOIC ACID",JLRKRQCTYQGDKJ-GHXNOFRVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102561,6vxs,DB07540,-7.6,"4-{5-[(1Z)-1-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)ETHYL]-2-FURYL}BENZENESULFONAMIDE",AKFVRSQELXTCFW-JYRVWZFOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
83900,6m3m,DB04505,-7.6,"8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-9-Pent-4-Ylnyl-9h-Purin-6-Ylamine",WUJFGZAAFADPSF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
161283,7bv1,DB13499,-7.6,Cefsulodin,SYLKGLMBLAAGSC-QLVMHMETSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
86542,6m3m,DB08998,-7.6,Demexiptiline,SEDQWOMFMIJKCU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
1632,6lzg,HMDB0000601,-7.6,Coprocholic acid,CNWPIIOQKZNXBB-VCVMUKOKSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
134808,6w9c,DB03585,-7.6,Oxyphenbutazone,HFHZKZSRXITVMK-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
72054,6m2n,DB00280,-7.6,Disopyramide,UVTNFZQICZKOEM-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
134815,6w9c,DB03593,-7.6,N7-Methyl-Guanosine-5'-Monophosphate,AOKQNZVJJXPUQA-KQYNXXCUSA-O,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
1633,6lzg,HMDB0012454,-7.6,"3beta,7alpha-Dihydroxy-5-cholestenoate",GYJSAWZGYQXRBS-GRJZKGIBSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
128955,6w4h,DB08207,-7.6,"2-(3,5-DIMETHYLPHENYL)-1,3-BENZOXAZOLE",BIHLSRJPJFOESJ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
72057,6m2n,DB00283,-7.6,Clemastine,YNNUSGIPVFPVBX-NHCUHLMSSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
161271,7bv1,DB13484,-7.6,Quinbolone,IUVKMZGDUIUOCP-BTNSXGMBSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
129039,6w4h,DB08315,-7.6,"2-AMINO-N,N-BIS(PHENYLMETHYL)-1,3-OXAZOLE-5-CARBOXAMIDE",KIJXWOGFYAWTNC-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
58573,6crv,DB06083,-7.6,Tapinarof,ZISJNXNHJRQYJO-CMDGGOBGSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
158472,7bv1,DB01222,-7.6,Budesonide,VOVIALXJUBGFJZ-KWVAZRHASA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
134864,6w9c,DB03666,-7.6,3'-Azido-3'-Deoxythymidine-5'-Monophosphate,OIFWQOKDSPDILA-XLPZGREQSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
129027,6w4h,DB08302,-7.6,3-[5-(2-nitropent-1-en-1-yl)furan-2-yl]benzoic acid,IRHZCQDCMUWUKV-RAXLEYEMSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
102583,6vxs,DB07567,-7.6,"(2R,3R,4S)-3-(4-HYDROXYPHENYL)-4-METHYL-2-[4-(2-PYRROLIDIN-1-YLETHOXY)PHENYL]CHROMAN-6-OL",XPVKGTWRXBSJKO-LHXLBICKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
72090,6m2n,DB00323,-7.6,Tolcapone,MIQPIUSUKVNLNT-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
72093,6m2n,DB00328,-7.6,Indometacin,CGIGDMFJXJATDK-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
161338,7bv1,DB13841,-7.6,Clopenthixol,WFPIAZLQTJBIFN-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
161382,7bv1,DB13939,-7.6,RAD-140,XMBUPPIEVAFYHO-KPZWWZAWSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
158409,7bv1,DB01153,-7.6,Sertaconazole,JLGKQTAYUIMGRK-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
104752,6vxs,DB12447,-7.6,Nadifloxacin,JYJTVFIEFKZWCJ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
135151,6w9c,DB04055,-7.6,"2,3-Dicarboxy-4-(2-Chloro-Phenyl)-1-Ethyl-5-Isopropoxycarbonyl-6-Methyl-Pyridinium",HMSIYRVIPQHZBI-UHFFFAOYSA-O,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
58487,6crv,DB05514,-7.6,Cobiprostone,SDDSJMXGJNWMJY-BRHAQHMBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
158404,7bv1,DB01147,-7.6,Cloxacillin,LQOLIRLGBULYKD-JKIFEVAISA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
158413,7bv1,DB01157,-7.6,Trimetrexate,NOYPYLRCIDNJJB-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
158403,7bv1,DB01146,-7.6,Diphenylpyraline,OWQUZNMMYNAXSL-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
128810,6w4h,DB08041,-7.6,3-BENZYLOXYCARBONYLAMINO-2-HYDROXY-4-PHENYL-BUTYRIC ACID,JXJYTERRLRAUSF-JKSUJKDBSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
104769,6vxs,DB12474,-7.6,Lynestrenol,YNVGQYHLRCDXFQ-XGXHKTLJSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
128800,6w4h,DB08030,-7.6,3-[(4'-cyanobiphenyl-4-yl)oxy]-N-hydroxypropanamide,XZWFHJUEAVOHHG-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
33695,6cs2,T3D4937,-7.6,4-Hydroxytamoxifen,TXUZVZSFRXZGTL-QPLCGJKRSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
158387,7bv1,DB01128,-7.6,Bicalutamide,LKJPYSCBVHEWIU-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
86654,6m3m,DB09191,-7.6,Talsupram,FKHYYOUFMJBLAF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83725,6m3m,DB04265,-7.6,N-acetyl-beta-neuraminic acid,SQVRNKJHWKZAKO-PFQGKNLYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
135249,6w9c,DB04180,-7.6,"4-(Aminosulfonyl)-N-[(2,4-Difluorophenyl)Methyl]-Benzamide",NTDFJEKGSGSXME-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
161377,7bv1,DB13931,-7.6,Netarsudil,OURRXQUGYQRVML-AREMUKBSSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
26782,6cs2,DB05187,-7.6,Elafibranor,AFLFKFHDSCQHOL-IZZDOVSWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
161340,7bv1,DB13843,-7.6,Cloprednol,YTJIBEDMAQUYSZ-FDNPDPBUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
58525,6crv,DB05719,-7.6,Elesclomol,BKJIXTWSNXCKJH-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
128923,6w4h,DB08166,-7.6,"(4R)-7-chloro-9-methyl-1-oxo-1,2,4,9-tetrahydrospiro[beta-carboline-3,4'-piperidine]-4-carbonitrile",LPFQFJAOMCGYCP-GFCCVEGCSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
135028,6w9c,DB03887,-7.6,Alpha-Adenosine Monophosphate,NVOIXARBSSLBAS-CRKDRTNXSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
33738,6cs2,T3D4988,-7.6,"9-(2-Carboxyphenyl)-3,6-bis(diethylamino)xanthylium(1+)",CVAVMIODJQHEEH-UHFFFAOYSA-O,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
102503,6vxs,DB07472,-7.6,"(R)-(+)9B-(3-METHYL)PHENYL-2,3-DIHYDROTHIAZOLO[2,3-A]ISOINDOL-5(9BH)-ONE",FQVDJZWFSZSGGA-QGZVFWFLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
135103,6w9c,DB03987,-7.6,"2,4-Diamino-6-[N-(3',5'-Dimethoxybenzyl)-N-Methylamino]Pyrido[2,3-D]Pyrimidine",XWCCXDBXMCTZPW-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
83818,6m3m,DB04394,-7.6,3-Nitro-4-(2-Oxo-Pyrrolidin-1-Yl)-Benzenesulfonamide,FPCPYSKJIRSWIG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
135056,6w9c,DB03924,-7.6,"5,8-Di-Amino-1,4-Dihydroxy-Anthraquinone",QVEMRPAUHFWHRV-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
72110,6m2n,DB00349,-7.6,Clobazam,CXOXHMZGEKVPMT-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
102499,6vxs,DB07468,-7.6,"(3aS)-3a-hydroxy-5-methyl-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one",NJBBBRZNBVLTRZ-GOSISDBHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
72111,6m2n,DB00351,-7.6,Megestrol acetate,RQZAXGRLVPAYTJ-GQFGMJRRSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
33725,6cs2,T3D4976,-7.6,Clomifene,GKIRPKYJQBWNGO-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
161368,7bv1,DB13916,-7.6,Toyocamycin,XOKJUSAYZUAMGJ-WOUKDFQISA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
128907,6w4h,DB08150,-7.6,"4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-aminium",RZIDZIGAXXNODG-UHFFFAOYSA-O,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
87161,6m3m,DB11919,-7.6,6-O-benzylguanine,KRWMERLEINMZFT-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
128506,6w4h,DB07694,-7.6,"2,5-dichloro-N-(3,5-dibromo-4-hydroxyphenyl)benzamide",IFLWCZRMFPKYBN-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
6556,6lzg,DB02323,-7.6,EM-1745,CKSDYJASHNGOOS-KTXOUVACSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
158032,7bv1,DB00294,-7.6,Etonogestrel,GCKFUYQCUCGESZ-BPIQYHPVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
136261,6w9c,DB06911,-7.6,D-leucyl-N-(3-chlorobenzyl)-L-prolinamide,FHVBVJXZKNCSLP-CVEARBPZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
70340,6lxt,DB12499,-7.6,Clascoterone,GPNHMOZDMYNCPO-PDUMRIMRSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
158040,7bv1,DB00304,-7.6,Desogestrel,RPLCPCMSCLEKRS-BPIQYHPVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
102131,6vxs,DB07043,-7.6,"7-amino-2-tert-butyl-4-(4-pyrimidin-2-ylpiperazin-1-yl)pyrido[2,3-d]pyrimidine-6-carboxamide",CKLCIJCZOIDJQU-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
136222,6w9c,DB06787,-7.6,Hexocyclium,ZRYHPQCHHOKSMD-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
158045,7bv1,DB00310,-7.6,Chlorthalidone,JIVPVXMEBJLZRO-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
16220,6lzg,DB03239,-7.6,"3',5'-Dinitro-N-Acetyl-L-Thyronine",VZSQTOXQXPKQJX-ZDUSSCGKSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
104967,6vxs,DB12787,-7.6,Norethandrolone,ZDHCJEIGTNNEMY-XGXHKTLJSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
87014,6m3m,DB11702,-7.6,Antineoplaston A10,OQGRFQCUGLKSAV-JTQLQIEISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
128200,6w4h,DB07328,-7.6,"METHYL 4-{[({[(2R,5S)-5-{[(2S)-2-(AMINOMETHYL)PYRROLIDIN-1-YL]CARBONYL}PYRROLIDIN-2-YL]METHYL}AMINO)CARBONYL]AMINO}BENZOATE",USDCNOQKDUFKRD-IKGGRYGDSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
25216,6cs2,DB00384,-7.6,Triamterene,FNYLWPVRPXGIIP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
136179,6w9c,DB06712,-7.6,Nilvadipine,FAIIFDPAEUKBEP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136178,6w9c,DB06711,-7.6,Naphazoline,CNIIGCLFLJGOGP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136175,6w9c,DB06708,-7.6,Lumefantrine,DYLGFOYVTXJFJP-MYYYXRDXSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
83333,6m3m,DB03753,-7.6,Flurbiprofen Methyl Ester,CPJBKHZROFMSQM-NSHDSACASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
12694,6lzg,DB13687,-7.6,Niaprazine,RSKQGBFMNPDPLR-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
136083,6w9c,DB06499,-7.6,Furaprofen,ODZUWQAFWMLWCF-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
161794,7bv1,DB00606,-7.6,Cyclothiazide,BOCUKUHCLICSIY-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
86976,6m3m,DB11649,-7.6,Lersivirine,MCPUZZJBAHRIPO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
72306,6m2n,DB00589,-7.6,Lisuride,BKRGVLQUQGGVSM-KBXCAEBGSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
158081,7bv1,DB00354,-7.6,Buclizine,MOYGZHXDRJNJEP-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
70357,6lxt,DB12524,-7.6,BI-671800,XEOSTBFUCNZKGS-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
158027,7bv1,DB00287,-7.6,Travoprost,MKPLKVHSHYCHOC-AHTXBMBWSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
102170,6vxs,DB07088,-7.6,(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclopentyloxy)ethanoyl)pyrrolidine-2-carboxamide,ZWXWAYUCJVQHOR-KRWDZBQOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102162,6vxs,DB07080,-7.6,"N-(2,2,2-TRIFLUOROETHYL)-N-{4-[2,2,2-TRIFLUORO-1-HYDROXY-1-(TRIFLUOROMETHYL)ETHYL]PHENYL}BENZENESULFONAMIDE",SGIWFELWJPNFDH-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104962,6vxs,DB12779,-7.6,Higenamine,WZRCQWQRFZITDX-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
136145,6w9c,DB06649,-7.6,Priralfinamide,BHJIBOFHEFDSAU-LBPRGKRZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
86990,6m3m,DB11671,-7.6,AZD-4877,SMFXSYMLJDHGIE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
102158,6vxs,DB07074,-7.6,6-CARBAMIMIDOYL-4-(3-HYDROXY-2-METHYL-BENZOYLAMINO)-NAPHTHALENE-2-CARBOXYLIC ACID METHYL ESTER,OUBRALHIKGRAMA-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
128213,6w4h,DB07343,-7.6,"4-[4-AMINO-6-(2,6-DICHLORO-PHENOXY)-[1,3,5]TRIAZIN-2-YLAMINO]-BENZONITRILE",NFNNMVVXXITVGD-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
128220,6w4h,DB07351,-7.6,O-(((1R)-((N-(PHENYL-METHOXY-CARBONYL)-ALANYL)-AMINO)METHYL)HYDROXYPHOSPHINYL)3-L-PHENYLLACTATE,ICACWKLCNCPHAM-YJBOKZPZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
128152,6w4h,DB07278,-7.6,2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}ETHENESULFONAMIDE,ACEFOQMQINFMRW-DYCFVMESSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
87050,6m3m,DB11762,-7.6,Marizomib,NGWSFRIPKNWYAO-SHTIJGAHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136289,6w9c,DB06942,-7.6,N-(4-carbamimidoylbenzyl)-1-(3-phenylpropanoyl)-L-prolinamide,RNZKCCPFUWHBFY-IBGZPJMESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
128092,6w4h,DB07206,-7.6,6-[2-(1H-INDOL-6-YL)ETHYL]PYRIDIN-2-AMINE,OSHSZKRWKLQZBV-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
61079,6crv,DB11479,-7.6,Zilpaterol,ZSTCZWJCLIRCOJ-DGCLKSJQSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
25181,6cs2,DB03060,-7.6,Sri-9662,WNDJHUNKXPAREB-PLNGDYQASA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
161884,7bv1,DB00932,-7.6,Tipranavir,SUJUHGSWHZTSEU-FYBSXPHGSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
27016,6cs2,DB06249,-7.6,Arzoxifene,MCGDSOGUHLTADD-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
102098,6vxs,DB07006,-7.6,"9-HYDROXY-6-(3-HYDROXYPROPYL)-4-(2-METHOXYPHENYL)PYRROLO[3,4-C]CARBAZOLE-1,3(2H,6H)-DIONE",AOGOZJCRIFBTTN-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
136385,6w9c,DB07055,-7.6,"2-[2-(1H-tetrazol-5-yl)ethyl]-1H-isoindole-1,3(2H)-dione",DEOJDUHRJBKATO-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136422,6w9c,DB07101,-7.6,PD-0325901,SUDAHWBOROXANE-SECBINFHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136436,6w9c,DB07116,-7.6,1-(2-DEOXY-5-O-PHOSPHONO-BETA-D-ERYTHRO-PENTOFURANOSYL)-4-METHYL-1H-INDOLE,UXXYPWCUINVUHL-BFHYXJOUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
11809,6lzg,DB12459,-7.6,Belotecan,LNHWXBUNXOXMRL-VWLOTQADSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
136441,6w9c,DB07121,-7.6,"4-({4-[(4-AMINOBUT-2-YNYL)OXY]PHENYL}SULFONYL)-N-HYDROXY-2,2-DIMETHYLTHIOMORPHOLINE-3-CARBOXAMIDE",AANXPIMDONQTQF-HNNXBMFYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
33435,6cs2,T3D4668,-7.6,Estradiol,VOXZDWNPVJITMN-ZBRFXRBCSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
136452,6w9c,DB07132,-7.6,1-{2-OXO-3-[(1R)-1-(1H-PYRROL-2-YL)ETHYL]-2H-INDOL-5-YL}UREA,KJDBLWKTHMHALD-QMMMGPOBSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
102076,6vxs,DB06983,-7.6,"(5-phenyl-7-(pyridin-3-ylmethylamino)pyrazolo[1,5-a]pyrimidin-3-yl)methanol",RBLKWWBHDUBPFN-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
128074,6w4h,DB07185,-7.6,2-{[(4-CHLOROPHENOXY)ACETYL]AMINO}BENZOIC ACID,LXSDGQYDSDIUPN-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
4475,6lzg,HMDB0052458,-7.6,"TG(18:2(9Z,12Z)/20:0/20:2n6)",CYKZBIMIYCZCIP-MRTMRHDRSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
102105,6vxs,DB07015,-7.6,"(3R,4R)-4-(pyrrolidin-1-ylcarbonyl)-1-(quinoxalin-2-ylcarbonyl)pyrrolidin-3-amine",XDSKICAQKGYYJF-OLZOCXBDSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
157958,6wiq,DB15009,-7.6,PF-04937319,MASKQITXHVYVFL-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
16188,6lzg,DB03093,-7.6,"8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine",MWHAHELTVGJGFJ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
6660,6lzg,DB02483,-7.6,Etheno-Nad,JCDBQDNBEQHDHK-BSLNIGMPSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
102116,6vxs,DB07028,-7.6,(2-{[(4-BROMO-2-FLUOROBENZYL)AMINO]CARBONYL}-5-CHLOROPHENOXY)ACETIC ACID,ZLIGBZRXAQNUFO-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
87054,6m3m,DB11766,-7.6,AZD-1305,BLLNYXOLLAVTRF-HDICACEKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
102115,6vxs,DB07027,-7.6,D-phenylalanyl-N-(3-fluorobenzyl)-L-prolinamide,JGZSVYZIJHGHMA-MOPGFXCFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
27002,6cs2,DB06228,-7.6,Rivaroxaban,KGFYHTZWPPHNLQ-AWEZNQCLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
128095,6w4h,DB07210,-7.6,"3-bromo-5-phenyl-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",JECHSYMSTXETFI-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
83247,6m3m,DB03641,-7.6,"2'-deoxyuridine 5'-alpha,beta-imido-diphosphate",COFNIXBQVWFHTR-SHYZEUOFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136346,6w9c,DB07013,-7.6,TERT-BUTYL 4-({[4-(BUT-2-YN-1-YLAMINO)PHENYL]SULFONYL}METHYL)-4-[(HYDROXYAMINO)CARBONYL]PIPERIDINE-1-CARBOXYLATE,RXFCFGLSOUOCEA-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
6678,6lzg,DB02510,-7.6,'5'-O-(N-(L-Prolyl)-Sulfamoyl)Adenosine,LKVJEMXWEODCAY-JVEUSOJLSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
128115,6w4h,DB07235,-7.6,"N-[(1S)-2-AMINO-1-(2,4-DICHLOROBENZYL)ETHYL]-5-[2-(METHYLAMINO)PYRIMIDIN-4-YL]THIOPHENE-2-CARBOXAMIDE",HHOVRZGUSBMKKU-ZDUSSCGKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
11816,6lzg,DB12467,-7.6,TU-100,KAYRGFYBCCETPE-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
70308,6lxt,DB12447,-7.6,Nadifloxacin,JYJTVFIEFKZWCJ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
128102,6w4h,DB07219,-7.6,"BENZYL N-({(2S,3S)-3-[(PROPYLAMINO)CARBONYL]OXIRAN-2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINATE",OMQNYWZURFTFHE-MQBSTWLZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
16182,6lzg,DB03081,-7.6,Crc200 (Chiron-Behring),ZOXOKTJHZSUHRJ-XZOQPEGZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
86867,6m3m,DB11394,-7.6,Decoquinate,JHAYEQICABJSTP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
104928,6vxs,DB12721,-7.6,RO-5028442,QZXVLRCMAHJVIP-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
136061,6w9c,DB06446,-7.6,Dotarizine,LRMJAFKKJLRDLE-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
102268,6vxs,DB07200,-7.6,"(2S,4S,5R)-2-ISOBUTYL-5-(2-THIENYL)-1-[4-(TRIFLUOROMETHYL)BENZOYL]PYRROLIDINE-2,4-DICARBOXYLIC ACID",ZNCZVHCYBGHCHA-XPIZARPCSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
135870,6w9c,DB05462,-7.6,Chlorotoxin I-131,YUFAHBUWIVNVNJ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
102269,6vxs,DB07201,-7.6,(2S)-3-[(9H-fluoren-9-ylideneamino)oxy]-2-methylpropanoic acid,ZHFDVDMCVXUGGF-NSHDSACASA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104888,6vxs,DB12663,-7.6,Letrazuril,XQKYUBTUOHHNDV-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
135863,6w9c,DB05431,-7.6,MLN-977,YANONWCPCKIWEC-CABCVRRESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
161726,7bv1,DB00525,-7.6,Tolnaftate,FUSNMLFNXJSCDI-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
26935,6cs2,DB05990,-7.6,Obeticholic acid,ZXERDUOLZKYMJM-ZWECCWDJSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
33564,6cs2,T3D4813,-7.6,Masoprocol,HCZKYJDFEPMADG-TXEJJXNPSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
135844,6w9c,DB05316,-7.6,Pimavanserin,RKEWSXXUOLRFBX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
128419,6w4h,DB07588,-7.6,"3,4-DI-1H-INDOL-3-YL-1H-PYRROLE-2,5-DICARBOXYLIC ACID",FZDVNXHYGMEEDT-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
161721,7bv1,DB00519,-7.6,Trandolapril,VXFJYXUZANRPDJ-WTNASJBWSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
33569,6cs2,T3D4818,-7.6,Bicalutamide,LKJPYSCBVHEWIU-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
158195,7bv1,DB00712,-7.6,Flurbiprofen,SYTBZMRGLBWNTM-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
11870,6lzg,DB12543,-7.6,Samidorphan,RYIDHLJADOKWFM-MAODMQOUSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
86909,6m3m,DB11468,-7.6,Tiamulin,UURAUHCOJAIIRQ-QGLSALSOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
135819,6w9c,DB05154,-7.6,Pretomanid,ZLHZLMOSPGACSZ-NSHDSACASA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
26917,6cs2,DB05903,-7.6,KOS-1584,XAYAKDZVINDZGB-BMVMHAJPSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
102289,6vxs,DB07227,-7.6,4-[(5-{[4-(3-CHLOROPHENYL)-3-OXOPIPERAZIN-1-YL]METHYL}-1H-IMIDAZOL-1-YL)METHYL]BENZONITRILE,JNUGFGAVPBYSHF-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
128497,6w4h,DB07683,-7.6,"N-(dibenzo[b,d]thiophen-3-ylsulfonyl)-L-valine",RZWYSEXQXOXWKA-INIZCTEOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
128494,6w4h,DB07679,-7.6,"(9S,12S)-9-(1-methylethyl)-7,10-dioxo-2-oxa-8,11-diazabicyclo[12.2.2]octadeca-1(16),14,17-triene-12-carboxylic acid",RRAAROKJUVKWAF-RDJZCZTQSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
83527,6m3m,DB04001,-7.6,6-(Oxalyl-Amino)-1h-Indole-5-Carboxylic Acid,AHWMERGBWWROMM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
70430,6lxt,DB12643,-7.6,Nelivaptan,NJXZWIIMWNEOGJ-WEWKHQNJSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
58331,6crv,DB04854,-7.6,Febuxostat,BQSJTQLCZDPROO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
128395,6w4h,DB07559,-7.6,"(2Z)-2-cyano-N-(2,2'-dichlorobiphenyl-4-yl)-3-hydroxybut-2-enamide",DDSLONVJHZPSBB-UVTDQMKNSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
102283,6vxs,DB07219,-7.6,"BENZYL N-({(2S,3S)-3-[(PROPYLAMINO)CARBONYL]OXIRAN-2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINATE",OMQNYWZURFTFHE-MQBSTWLZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
25244,6cs2,DB03133,-7.6,"2-(Beta-D-Glucopyranosyl)-5-Methyl-1,2,3-Benzimidazole",XIJZORUYQZBFJK-UJPOAAIJSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
11873,6lzg,DB12548,-7.6,Sparsentan,WRFHGDPIDHPWIQ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
128471,6w4h,DB07649,-7.6,"(3R,4S)-1-[(4-amino-5H-pyrrolo[3,2-d]pyrimidin-7-yl)methyl]-4-[(benzylsulfanyl)methyl]pyrrolidin-3-ol",DIGGNILBPCEZIV-CVEARBPZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
135796,6w9c,DB05035,-7.6,Eprotirome,VPCSYAVXDAUHLT-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
135806,6w9c,DB05095,-7.6,Cimicoxib,KYXDNECMRLFQMZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
135816,6w9c,DB05137,-7.6,Lobeline,MXYUKLILVYORSK-HBMCJLEFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
158202,7bv1,DB00719,-7.6,Azatadine,SEBMTIQKRHYNIT-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
135889,6w9c,DB05542,-7.6,Naronapride,VGDDOIZXGFJDRC-VJTSUQJLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
83484,6m3m,DB03942,-7.6,Carboxylic PRPP,OICBXEWBKALHHB-MOJAZDJTSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86935,6m3m,DB11540,-7.6,Propiopromazine,ZQTVCQIJTREKSP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86950,6m3m,DB11584,-7.6,Pipradrol,XSWHNYGMWWVAIE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
26950,6cs2,DB06133,-7.6,Dimethylcurcumin,ZMGUKFHHNQMKJI-CIOHCNBKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
11856,6lzg,DB12523,-7.6,Mizolastine,PVLJETXTTWAYEW-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
161771,7bv1,DB00580,-7.6,Valdecoxib,LNPDTQAFDNKSHK-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60953,6crv,DB11096,-7.6,Meradimate,SOXAGEOHPCXXIO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136006,6w9c,DB06276,-7.6,Tanomastat,JXAGDPXECXQWBC-LJQANCHMSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
102221,6vxs,DB07146,-7.6,"2,3-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-B]PYRIDIN-4-AMINE",QUIQCYFSBGOBKE-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
58262,6crv,DB04769,-7.6,"5-QUINOXALIN-6-YLMETHYLENE-THIAZOLIDINE-2,4-DIONE",SQWZFLMPDUSYGV-POHAHGRESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136011,6w9c,DB06292,-7.6,Dapagliflozin,JVHXJTBJCFBINQ-ADAARDCZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
158115,7bv1,DB00396,-7.6,Progesterone,RJKFOVLPORLFTN-LEKSSAKUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
128320,6w4h,DB07470,-7.6,"(3aS)-3a-hydroxy-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one",DOMYOVZXZIZTRD-QGZVFWFLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
28753,6cs2,DB08365,-7.6,"8-bromo-4-(2-chlorophenyl)-N-(2-hydroxyethyl)-6-methyl-1,3-dioxo-1,2,3,6-tetrahydropyrrolo[3,4-e]indole-7-carboxamide",XUAHLMVOYLUYSB-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
128312,6w4h,DB07459,-7.6,4-PHENOXY-N-(PYRIDIN-2-YLMETHYL)BENZAMIDE,HVLSCZSVTCNAQX-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
158104,7bv1,DB00382,-7.6,Tacrine,YLJREFDVOIBQDA-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
102212,6vxs,DB07136,-7.6,(2S)-2-[3-(AMINOMETHYL)PHENYL]-3-{(R)-HYDROXY[(1R)-2-METHYL-1-{[(3-PHENYLPROPYL)SULFONYL]AMINO}PROPYL]PHOSPHORYL}PROPANOIC ACID,WFFOOKSVFDUPDH-FCHUYYIVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102200,6vxs,DB07123,-7.6,N-(4-METHYLBENZOYL)-4-BENZYLPIPERIDINE,DVOLWKZEIDCCES-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
12673,6lzg,DB13667,-7.6,Cefozopran,QDUIJCOKQCCXQY-WHJQOFBOSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
158122,7bv1,DB00404,-7.6,Alprazolam,VREFGVBLTWBCJP-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
161740,7bv1,DB00543,-7.6,Amoxapine,QWGDMFLQWFTERH-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
102253,6vxs,DB07183,-7.6,N-(4-phenoxyphenyl)-2-[(pyridin-4-ylmethyl)amino]nicotinamide,CPVRYQAOUPSUDO-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
158139,7bv1,DB00425,-7.6,Zolpidem,ZAFYATHCZYHLPB-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
135908,6w9c,DB05659,-7.6,Faropenem medoxomil,JQBKWZPHJOEQAO-DVPVEWDBSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
158130,7bv1,DB00414,-7.6,Acetohexamide,VGZSUPCWNCWDAN-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
102239,6vxs,DB07168,-7.6,[4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-6-(methylamino)pyrimidin-2-yl}amino)phenyl]acetonitrile,MFMSRHREFZCFSN-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
6606,6lzg,DB02398,-7.6,6-[N-(4-(Aminomethyl)Phenyl)Carbamyl]-2-Naphthalenecarboxamidine,NLBDETRVUYOIHQ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
83451,6m3m,DB03899,-7.6,9-Butyl-8-(4-Methoxybenzyl)-9h-Purin-6-Amine,NVYATAJRTRFKSW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
104899,6vxs,DB12679,-7.6,WP 1066,VFUAJMPDXIRPKO-LQELWAHVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
161758,7bv1,DB00562,-7.6,Benzthiazide,NDTSRXAMMQDVSW-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
135943,6w9c,DB06152,-7.6,Nylidrin,PTGXAUBQBSGPKF-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
16260,6lzg,DB03421,-7.6,"2-Phenethyl-2,3-Dihydro-Phthalazine-1,4-Dione",JSSVIGGKHIJEHO-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
161764,7bv1,DB00573,-7.6,Fenoprofen,RDJGLLICXDHJDY-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
33532,6cs2,T3D4783,-7.6,Nilutamide,XWXYUMMDTVBTOU-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
102237,6vxs,DB07165,-7.6,N-(5-CHLORO-BENZO[B]THIOPHEN-3-YLMETHYL)-2-[6-CHLORO-OXO-3-(2-PYRIDIN-2-YL-ETHYLAMINO)-2H-PYRAZIN-1-YL]-ACETAMIDE,SOBGXPPOYFFGTK-UGKGYDQZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
142112,6w9q,DB01763,-7.6,7-thionicotinamide-adenine-dinucleotide phosphate,OJNFDOAQUXJWED-NNYOXOHSSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
123870,6w4h,DB00480,-7.6,Lenalidomide,GOTYRUGSSMKFNF-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
73602,6m2n,DB02254,-7.6,Trifluoro-thiamin phosphate,ZIBIECXVPMYJCV-UHFFFAOYSA-M,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
153347,6wiq,DB06248,-7.6,Amelubant,SBVYURPQULDJTI-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
67608,6lxt,DB06948,-7.6,2-ANILINO-6-CYCLOHEXYLMETHOXYPURINE,XWWRLKIBRPJQJX-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
110478,6vxx,DB01643,-7.6,Thymidine monophosphate,GYOZYWVXFNDGLU-XLPZGREQSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
96259,6m71,DB12637,-7.6,Onapristone,IEXUMDBQLIVNHZ-YOUGDJEHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110470,6vxx,DB01634,-7.6,2-Oxy-4-Hydroxy-5-(2-Hydrazinopyridine)Phenylalanine,AZUQIXJQZOMXAS-BDAKNGLRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
20395,6cs2,HMDB0000946,-7.6,Ursodeoxycholic acid,RUDATBOHQWOJDD-UZVSRGJWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
30920,6cs2,DB13177,-7.6,4-methylumbelliferyl beta-D-glucoside,YUDPTGPSBJVHCN-YMILTQATSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
110448,6vxx,DB01610,-7.6,Valganciclovir,WPVFJKSGQUFQAP-GKAPJAKFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77553,6m2n,DB08517,-7.6,"(2S)-5-hydroxy-2-(4-hydroxyphenyl)-7-methoxy-2,3-dihydro-4H-chromen-4-one",DJOJDHGQRNZXQQ-AWEZNQCLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
119104,6w4b,DB06923,-7.6,2-(3-METHYLPHENYL)-1H-INDOLE-5-CARBOXIMIDAMIDE,KJUSXMYSVXZFDJ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
77571,6m2n,DB08537,-7.6,"3-bromo-6-phenyl-N-(pyrimidin-5-ylmethyl)imidazo[1,2-a]pyridin-8-amine",LZLKFNBMXXLTLX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
110436,6vxx,DB01595,-7.6,Nitrazepam,KJONHKAYOJNZEC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77593,6m2n,DB08562,-7.6,4-(4-STYRYL-PHENYLCARBAMOYL)-BUTYRIC ACID,FTXJWRRYLLRFMG-MDZDMXLPSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
30934,6cs2,DB13213,-7.6,Butaperazine,DVLBYTMYSMAKHP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
64883,6lxt,DB02106,-7.6,"[3,5-Dibromo-4-(4-Hydroxy-3-Phenethylcarbamoyl-Phenoxy)-Phenyl]-Acetic Acid",KIRQJXNQGZAKGR-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
96291,6m71,DB12682,-7.6,Mubritinib,ZTFBIUXIQYRUNT-MDWZMJQESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
64881,6lxt,DB02104,-7.6,"2,4-Diamino-5-Methyl-6-[(3,4,5-Trimethoxy-N-Methylanilino)Methyl]Pyrido[2,3-D]Pyrimidine",PEGMMEYCSOZKIT-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
9763,6lzg,DB07889,-7.6,"(2S)-1-(Dimethylamino)-3-(4-{[4-(2-methylimidazo[1,2-a]pyridin-3-yl)-2-pyrimidinyl]amino}phenoxy)-2-propanol",VCPXSBULBDYRLT-SFHVURJKSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
96294,6m71,DB12687,-7.6,Vesatolimod,VFOKSTCIRGDTBR-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
77607,6m2n,DB08580,-7.6,4-bromo-2-{[(2R)-2-(2-chlorobenzyl)pyrrolidin-1-yl]carbonyl}aniline,JEGGWFHNKPRKTO-CQSZACIVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
50221,2fxp,DB06717,-7.6,Fosaprepitant,BARDROPHSZEBKC-OITMNORJSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
153385,6wiq,DB06350,-7.6,Elinogrel,LGSDFTPAICUONK-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
145778,6w9q,DB07753,-7.6,"3',5'-DIFLUOROBIPHENYL-4-CARBOXYLIC ACID",VCEFNMHMLWBFNV-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
96319,6m71,DB12725,-7.6,TD-8954,MZOITCJKGUIQEI-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
165499,7bv1,DB12193,-7.6,Ajulemic acid,YCHYFHOSGQABSW-RTBURBONSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
67632,6lxt,DB06983,-7.6,"(5-phenyl-7-(pyridin-3-ylmethylamino)pyrazolo[1,5-a]pyrimidin-3-yl)methanol",RBLKWWBHDUBPFN-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
119152,6w4b,DB06985,-7.6,2-[({4-[2-(trifluoromethyl)phenyl]piperidin-1-yl}carbonyl)amino]benzoic acid,MEAQCLPMSVEOQF-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
77618,6m2n,DB08595,-7.6,"4-[(1S,2R,5S)-4,4,8-TRIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL",BBZPJHFECDCNGT-BPUTZDHNSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
110372,6vxx,DB01523,-7.6,Clonitazene,GPZLDQAEBHTMPG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
96223,6m71,DB12574,-7.6,LY-295501,VAMFSFIPDOODFH-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110362,6vxx,DB01511,-7.6,Delorazepam,CHIFCDOIPRCHCF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165533,7bv1,DB12241,-7.6,TAK-733,RCLQNICOARASSR-SECBINFHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
77515,6m2n,DB08472,-7.6,(R)-Fluoxetine,RTHCYVBBDHJXIQ-MRXNPFEDSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
92124,6m71,DB03984,-7.6,Morpholine-4-Carboxylic Acid [1-(2-Benzylsulfanyl-1-Formyl-Ethylcarbamoyl)-2-Phenyl-Ethyl]-Amide,MWTQNXVXPLTHJB-YADHBBJMSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96035,6m71,DB12301,-7.6,Doravirine,ZIAOVIPSKUPPQW-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
118859,6w4b,DB06494,-7.6,Sufugolix,UCQSBGOFELXYIN-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
145947,6w9q,DB07946,-7.6,"N-[2-({[amino(imino)methyl]amino}oxy)ethyl]-2-{6-chloro-3-[(2,2-difluoro-2-phenylethyl)amino]-2-fluorophenyl}acetamide",DZEJHPMTDNDECN-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
118867,6w4b,DB06519,-7.6,Edaglitazone,HAAXAFNSRADSMK-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
118886,6w4b,DB06578,-7.6,Tonabersat,XLIIRNOPGJTBJD-ROUUACIJSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
110697,6vxx,DB02116,-7.6,Olomoucine,GTVPOLSIJWJJNY-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165576,7bv1,DB12479,-7.6,Zabofloxacin,ZNPOCLHDJCAZAH-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
118918,6w4b,DB06635,-7.6,Otamixaban,PFGVNLZDWRZPJW-OPAMFIHVSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
77412,6m2n,DB08348,-7.6,"N-2-,N-2-DIMETHYL-N-1-(6-OXO-5,6-DIHYDROPHENANTHRIDIN-2-YL)GLYCINAMIDE",UYJZZVDLGDDTCL-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
96121,6m71,DB12420,-7.6,Diazepinomicin,SALVHVNECODMJP-GNUCVDFRSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
118924,6w4b,DB06652,-7.6,Vicriviroc,CNPVJJQCETWNEU-CYFREDJKSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
74727,6m2n,DB03758,-7.6,Radicicol,WYZWZEOGROVVHK-GTMNPGAYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
92048,6m71,DB03882,-7.6,"5-Alpha-Androstane-3-Beta,17beta-Diol",CBMYJHIOYJEBSB-YSZCXEEOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
67570,6lxt,DB06907,-7.6,"2-(2,6-DICHLOROPHENYL)-1,3-BENZOXAZOLE-6-CARBOXYLIC ACID",XVNRKPCHMYOPPL-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
145875,6w9q,DB07861,-7.6,(2R)-N-hydroxy-3-naphthalen-2-yl-2-[(naphthalen-2-ylsulfonyl)amino]propanamide,MMOUXLMPQFMDRD-JOCHJYFZSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
77455,6m2n,DB08399,-7.6,PICEATANNOL,CDRPUGZCRXZLFL-OWOJBTEDSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
110641,6vxx,DB02046,-7.6,N-[(Furan-2-Yl)Carbonyl]-(S)-Leucyl-(R)-[1-Amino-2(1h-Indol-3-Yl)Ethyl]-Phosphonic Acid,WHPKSASOSKNDPY-PKOBYXMFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
118963,6w4b,DB06721,-7.6,Gimatecan,UIVFUQKYVFCEKJ-OPTOVBNMSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
145853,6w9q,DB07835,-7.6,"N-3-cyclopropyl-N-4-'-(cyclopropylmethyl)-6-methylbiphenyl-3,4'-dicarboxamide",BOPSUAHGQHFKGG-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
77500,6m2n,DB08455,-7.6,Ro 12-7310,CAAFTBWHFUPDGX-OFCLTBKTSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
67586,6lxt,DB06923,-7.6,2-(3-METHYLPHENYL)-1H-INDOLE-5-CARBOXIMIDAMIDE,KJUSXMYSVXZFDJ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
96178,6m71,DB12507,-7.6,Atecegatran metoxil,XSNMGLZVFNDDPW-ZWKOTPCHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110603,6vxx,DB01995,-7.6,5-Methylcytidine-5'-Monophosphate,NJQONZSFUKNYOY-JXOAFFINSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
153307,6wiq,DB06163,-7.6,Plevitrexed,IEJSCSAMMLUINT-NRFANRHFSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
30896,6cs2,DB13122,-7.6,Trabodenoson,AQLVRTWKJDTWQQ-SDBHATRESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
14656,6lzg,T3D4552,-7.6,Eszopiclone,GBBSUAFBMRNDJC-INIZCTEOSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
145849,6w9q,DB07831,-7.6,"2-{[(6-OXO-1,6-DIHYDROPYRIDIN-3-YL)METHYL]AMINO}-N-[4-PROPYL-3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE",SHSORWZDEKFFLP-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
165542,7bv1,DB12430,-7.6,BC-3781,KPVIXBKIJXZQJX-IJUBVZAWSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110545,6vxx,DB01922,-7.6,"Maltosyl-Alpha (1,4)-D-Gluconhydroximo-1,5-Lactam",AHRWQUNEPBVNOT-IVJVVCOPSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110769,6vxx,DB02390,-7.6,5-Bromo-N[2-(Dimethylamino)Ethyl]-9-Aminoacridine-4-Carboxamide,NROQPXQSDDINMC-UHFFFAOYSA-P,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
67643,6lxt,DB06995,-7.6,N-({4-[(2-aminopyridin-4-yl)oxy]-3-fluorophenyl}carbamoyl)-2-(4-fluorophenyl)acetamide,USBSTVPJNQLYEM-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
119193,6w4b,DB07031,-7.6,"3-Fluoro-4-{[(2R)-2-hydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthalenyl)acetyl]amino}benzoic acid",AANFHDFOMFRLLR-LJQANCHMSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
67687,6lxt,DB07043,-7.6,"7-amino-2-tert-butyl-4-(4-pyrimidin-2-ylpiperazin-1-yl)pyrido[2,3-d]pyrimidine-6-carboxamide",CKLCIJCZOIDJQU-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
64723,6lxt,DB01889,-7.6,"16,17-Androstene-3-Ol",KRVXMNNRSSQZJP-PHFHYRSDSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
91811,6m71,DB03572,-7.6,FR230513,URGFTPMACWKJKU-OAHLLOKOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
119320,6w4b,DB07175,-7.6,N-{2-methyl-5-[(6-phenylpyrimidin-4-yl)amino]phenyl}methanesulfonamide,CXQRKICWSCAUGW-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
96575,6m71,DB13122,-7.6,Trabodenoson,AQLVRTWKJDTWQQ-SDBHATRESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
119327,6w4b,DB07183,-7.6,N-(4-phenoxyphenyl)-2-[(pyridin-4-ylmethyl)amino]nicotinamide,CPVRYQAOUPSUDO-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
119330,6w4b,DB07186,-7.6,"4-(4-METHYLPIPERAZIN-1-YL)-N-[5-(2-THIENYLACETYL)-1,5-DIHYDROPYRROLO[3,4-C]PYRAZOL-3-YL]BENZAMIDE",TYYNSDQVFIOSFH-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
110120,6vxx,DB01000,-7.6,Cyclacillin,HGBLNBBNRORJKI-WCABBAIRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110118,6vxx,DB00998,-7.6,Frovatriptan,XPSQPHWEGNHMSK-SECBINFHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
64701,6lxt,DB01860,-7.6,Cordycepin Triphosphate,NLIHPCYXRYQPSD-BAJZRUMYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
110106,6vxx,DB00983,-7.6,Formoterol,BPZSYCZIITTYBL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
74606,6m2n,DB03593,-7.6,N7-Methyl-Guanosine-5'-Monophosphate,AOKQNZVJJXPUQA-KQYNXXCUSA-O,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
119371,6w4b,DB07237,-7.6,{4-[(2R)-pyrrolidin-2-ylmethoxy]phenyl}(4-thiophen-3-ylphenyl)methanone,VUWFJUJWAWMRQN-HXUWFJFHSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
96614,6m71,DB13217,-7.6,Fentiazac,JIEKMACRVQTPRC-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
62852,6crv,DB14596,-7.6,Loteprednol etabonate,DMKSVUSAATWOCU-HROMYWEYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
64685,6lxt,DB01838,-7.6,"6,4'-Dihydroxy-3-Methyl-3',5'-Dibromoflavone",GKDYOXMZSXVKPP-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
110071,6vxx,DB00774,-7.6,Hydroflumethiazide,DMDGGSIALPNSEE-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
9893,6lzg,DB08026,-7.6,"2-{4-[(4-imidazo[1,2-a]pyridin-3-ylpyrimidin-2-yl)amino]piperidin-1-yl}-N-methylacetamide",AJLILYAPRHIFAS-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
96657,6m71,DB13276,-7.6,Idanpramine,HVYGXNYMNHSBGD-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
31008,6cs2,DB13305,-7.6,Tolpropamine,CINROOONPHQHPO-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
77692,6m2n,DB08686,-7.6,"5,6,7,8,9,10-HEXAHYDRO-4-HYDROXY-3-(1-PHENYLPROPYL)CYCLOOCTA[B]PYRAN-2-ONE",UXCLJNSXDNCIIT-HNNXBMFYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
96696,6m71,DB13327,-7.6,Picotamide,KYWCWBXGRWWINE-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
74590,6m2n,DB03573,-7.6,WRR-99,KVZMXOVSHIMGNA-CVEARBPZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
96732,6m71,DB13368,-7.6,Motretinide,IYIYMCASGKQOCZ-DJRRULDNSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96736,6m71,DB13374,-7.6,Vincamine,RXPRRQLKFXBCSJ-GIVPXCGWSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
9916,6lzg,DB08052,-7.6,"1-cyclopentyl-3-(1H-pyrrolo[2,3-b]pyridin-5-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine",NVRXTLZYXZNATH-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
91736,6m71,DB03458,-7.6,"N(4)-Adenosyl-N(4)-methyl-2,4-diaminobutanoic acid",JISVTSUBJCPLSV-TWBCTODHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110002,6vxx,DB00692,-7.6,Phentolamine,MRBDMNSDAVCSSF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
67749,6lxt,DB07116,-7.6,1-(2-DEOXY-5-O-PHOSPHONO-BETA-D-ERYTHRO-PENTOFURANOSYL)-4-METHYL-1H-INDOLE,UXXYPWCUINVUHL-BFHYXJOUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
110176,6vxx,DB01063,-7.6,Acetophenazine,WNTYBHLDCKXEOT-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
96353,6m71,DB12781,-7.6,Balaglitazone,IETKPTYAGKZLKY-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
91831,6m71,DB03598,-7.6,"Al-6629, [2h-Thieno[3,2-E]-1,2-Thiazine-6-Sulfonamide,2-(3-Methoxyphenyl)-3-(4-Morpholinyl)-, 1,1-Dioxide]",XSUAVPPTKHUTDX-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96521,6m71,DB13048,-7.6,PAC-1,YQNRVGJCPCNMKT-LFVJCYFKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96362,6m71,DB12798,-7.6,Relenopride,KGMMSPVVHZGPHL-NRFANRHFSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
29364,6cs2,DB09070,-7.6,Tibolone,WZDGZWOAQTVYBX-XOINTXKNSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
165471,7bv1,DB12148,-7.6,Menatetrenone,DKHGMERMDICWDU-GHDNBGIDSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96383,6m71,DB12833,-7.6,Tandospirone,CEIJFEGBUDEYSX-FZDBZEDMSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
50180,2fxp,DB06638,-7.6,Quarfloxin,WOQIDNWTQOYDLF-CGAIIQECSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
64816,6lxt,DB02021,-7.6,Fidarestat,WAAPEIZFCHNLKK-UFBFGSQYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
110295,6vxx,DB01431,-7.6,Allylestrenol,ATXHVCQZZJYMCF-XUDSTZEESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165467,7bv1,DB12143,-7.6,Rezatomidine,WQXVKEDUCPMRRI-JTQLQIEISA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
91869,6m71,DB03656,-7.6,Tribenuron Methyl,VLCQZHSMCYCDJL-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96402,6m71,DB12868,-7.6,Intoplicine,QROONAIPJKQFMC-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
119224,6w4b,DB07064,-7.6,"(4R)-4-(3-HYDROXYPHENYL)-N,N,7,8-TETRAMETHYL-3,4-DIHYDROISOQUINOLINE-2(1H)-CARBOXAMIDE",HPVCRUIDFODATB-LJQANCHMSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
77650,6m2n,DB08635,-7.6,N-(TRANS-4'-NITRO-4-STILBENYL)-N-METHYL-5-AMINO-PENTANOIC ACID,QLLZAVDYYAQESE-AATRIKPKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
64803,6lxt,DB02004,-7.6,"5-(Aminomethyl)-6-(2,4-Dichlorophenyl)-2-(3,5-Dimethoxyphenyl)Pyrimidin-4-Amine",RCJFINNFYUNFGH-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
110274,6vxx,DB01176,-7.6,Cyclizine,UVKZSORBKUEBAZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77656,6m2n,DB08643,-7.6,2-(2-{2-[(BIPHENYL-4-YLMETHYL)-AMINO]-3-MERCAPTO-PENTANOYLAMINO}-ACETYLAMINO)-3-METHYL-BUTYRIC ACID METHYL ESTER,QFAWBPLETHINFK-UNMCSNQZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
110264,6vxx,DB01165,-7.6,Ofloxacin,GSDSWSVVBLHKDQ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
96442,6m71,DB12925,-7.6,Crolibulin,JXONINOYTKKXQQ-CQSZACIVSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96446,6m71,DB12929,-7.6,JNJ-39220675,IQOWHZHNGJXGHG-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96453,6m71,DB12939,-7.6,Nikkomycin Z,WWJFFVUVFNBJTN-VHDFTHOZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110231,6vxx,DB01127,-7.6,Econazole,LEZWWPYKPKIXLL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165436,7bv1,DB12100,-7.6,Abediterol,SFYAXIFVXBKRPK-QFIPXVFZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
153483,6wiq,DB06721,-7.6,Gimatecan,UIVFUQKYVFCEKJ-OPTOVBNMSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
96461,6m71,DB12949,-7.6,PF-03382792,AGMOFKKOVMRGAK-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96474,6m71,DB12972,-7.6,Sepranolone,AURFZBICLPNKBZ-FZCSVUEKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
74620,6m2n,DB03615,-7.6,Ribostamycin,NSKGQURZWSPSBC-VVPCINPTSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
119290,6w4b,DB07141,-7.6,"5-[(3R)-3-(5-methoxy-4'-methylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",QVXYJVHNRPNRJL-HNNXBMFYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
30992,6cs2,DB13283,-7.6,Sulfaisodimidine,YZMCKZRAOLZXAZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
9849,6lzg,DB07982,-7.6,2-{4-[4-({4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]pyrimidin-2-yl}amino)phenyl]piperazin-1-yl}-2-oxoethanol,PVTKDXZNSUHUMO-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
110184,6vxx,DB01071,-7.6,Mequitazine,HOKDBMAJZXIPGC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
9855,6lzg,DB07987,-7.6,"[2-(5-MERCAPTO-[1,3,4]THIADIAZOL-2-YLCARBAMOYL)-1-PHENYL-ETHYL]-CARBAMIC ACID BENZYL ESTER",AWAKNMKLVLWIIQ-OAHLLOKOSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
9919,6lzg,DB08055,-7.6,"N-(2-chlorophenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine",NNBICZMPIJMWGC-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
50363,2fxp,DB06922,-7.6,"2-[(1R)-1-carboxy-2-naphthalen-1-ylethyl]-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylic acid",CZNPWASYMRBJCX-GOSISDBHSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
9658,6lzg,DB07779,-7.6,N-({(2S)-1-[(3R)-3-AMINO-4-(2-FLUOROPHENYL)BUTANOYL]PYRROLIDIN-2-YL}METHYL)BENZAMIDE,ANQHSFFUNMTTRS-MOPGFXCFSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
146407,6w9q,DB08494,-7.6,"S-{2-[(2-chloro-4-sulfamoylphenyl)amino]-2-oxoethyl} 6-methyl-3,4-dihydroquinoline-1(2H)-carbothioate",AWAKIULNKVOBKE-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
77066,6m2n,DB07938,-7.6,"5-[[(2R)-2-cyclopropyl-7,8-dimethoxy-chroman-5-yl]methyl]pyrimidine-2,4-diamine",HWJPWWYTGBZDEG-CQSZACIVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
111571,6vxx,DB04218,-7.6,1-Deaza-Adenosine,NVUDDRWKCUAERS-PNHWDRBUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
92456,6m71,DB04434,-7.6,Naphthyridine Inhibitor,YRBHUKMLAGQYHS-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
74881,6m2n,DB03952,-7.6,9-(6-deoxy-beta-D-allofuranosyl)-6-methylpurine,XJZDIUOABWMPLZ-FHQKJXBVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
111519,6vxx,DB03980,-7.6,4-(Fluorophenyl)-1-Cyclopropylmethyl-5-(2-Amino-4-Pyrimidinyl)Imidazole,DFEYXQGDDCDXJK-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
95677,6m71,DB11784,-7.6,NRX-1074,DVBUEXCIEIAXPM-PJUQSVSOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
152841,6wiq,DB04591,-7.6,"N-{2,2-DIFLUORO-2-[(2R)-PIPERIDIN-2-YL]ETHYL}-2-[2-(1H-1,2,4-TRIAZOL-1-YL)BENZYL][1,3]OXAZOLO[4,5-C]PYRIDIN-4-AMINE",VYJOAYZRCNHDNG-GOSISDBHSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
20583,6cs2,HMDB0047855,-7.6,"TG(14:1(9Z)/22:0/18:3(9Z,12Z,15Z))",LSLCAMBCQCOKNH-QJGMYCCBSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
146378,6w9q,DB08460,-7.6,"3-{5-[(6-amino-1H-pyrazolo[3,4-b]pyridin-3-yl)methoxy]-2-chlorophenoxy}-5-chlorobenzonitrile",KXDIHAQCVNNLIB-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
67374,6lxt,DB06588,-7.6,Triphendiol,KQCJZAUNKSGEFM-UNMCSNQZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
152854,6wiq,DB04607,-7.6,"PHENYLAMINOIMIDAZO(1,2-ALPHA)PYRIDINE",UQAWGIKJINAKIZ-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
30717,6cs2,DB00192,-7.6,Indecainide,UCEWGESNIULAGX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
77106,6m2n,DB07985,-7.6,+/-METHYL 4-(AMINOIMINOMETHYL)-BETA-[3- INH (AMINOIMINO)PHENYL]BENZENE PENTANOATE,PVALLOSAENRPQO-INIZCTEOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
95716,6m71,DB11833,-7.6,Basimglurant,UPZWINBEAHDTLA-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95717,6m71,DB11836,-7.6,Sapanisertib,GYLDXIAOMVERTK-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
118347,6w4b,DB04704,-7.6,20-hydroxycholesterol,MCKLJFJEQRYRQT-MGNSQDQZSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
118348,6w4b,DB04705,-7.6,"(3BETA)-CHOLEST-5-ENE-3,25-DIOL",INBGSXNNRGWLJU-ZHHJOTBYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
165705,7bv1,DB12685,-7.6,K-134,ULGNGSQNNMKROG-WOJBJXKFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
118351,6w4b,DB04708,-7.6,"(S)-TETRAHYDROFURAN-3-YL (2S,3S)-4-((S)-4-((1R,3R)-3-(2-AMINO-2-OXOETHYL)-2,3-DIHYDRO-1H-INDEN-1-YL)-2-BENZYL-3-OXO-2,3-DIHYDRO-1H-PYRROL-2-YL)-3-HYDROXY-1-PHENYLBUTAN-2-YLCARBAMATE",SYNSHNDQFWMLJW-YZGRCXSVSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
146335,6w9q,DB08407,-7.6,PLATENSIMYCIN,CSOMAHTTWTVBFL-OFBLZTNGSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
118385,6w4b,DB04759,-7.6,"PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-(3-METHYL-BENZYLAMIDE)",GTBUZLPQANSGGE-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
152924,6wiq,DB04703,-7.6,Hesperidin,QUQPHWDTPGMPEX-QJBIFVCTSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
111447,6vxx,DB03883,-7.6,Carboxyethyllumazine,PTYCEIBBGGLADD-PJKMHFRUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111444,6vxx,DB03880,-7.6,Batimastat,XFILPEOLDIKJHX-QYZOEREBSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
152925,6wiq,DB04704,-7.6,20-hydroxycholesterol,MCKLJFJEQRYRQT-MGNSQDQZSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
95747,6m71,DB11885,-7.6,Anlotinib,KSMZEXLVHXZPEF-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
111422,6vxx,DB03851,-7.6,Carbazole Butanoic Acid,HQAKVYGASUTQHH-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
95758,6m71,DB11900,-7.6,OC-459,FATGTHLOZSXOBC-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
146408,6w9q,DB08495,-7.6,4-({4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-2-OXOPIPERAZIN-1-YL}METHYL)BENZENECARBOXIMIDAMIDE,VXONTEUOQXFJJS-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
111419,6vxx,DB03846,-7.6,5-Hydroxymethyluridine-2'-Deoxy-5'-Monophosphate,WEBVWKFGRVLCNS-XLPZGREQSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111601,6vxx,DB04263,-7.6,Geneticin,BRZYSWJRSDMWLG-DJWUNRQOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
146421,6w9q,DB08510,-7.6,5-ALPHA-PREGNANE-3-BETA-OL-HEMISUCCINATE,UVTGFMKBPVLATL-DSOJQRAMSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
146576,6w9q,DB08701,-7.6,"2-(3-BROMOPHENYL)-6-[(2-HYDROXYETHYL)AMINO]-1H-BENZO[DE]ISOQUINOLINE-1,3(2H)-DIONE",JZCUVYNOSDWORZ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
146573,6w9q,DB08697,-7.6,"4-(2-aminoethoxy)-N-(3-chloro-5-piperidin-1-ylphenyl)-3,5-dimethylbenzamide",JDYIYIRPQKMWMM-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
111760,6vxx,DB04482,-7.6,Cmp-2-Keto-3-Deoxy-Octulosonic Acid,YWWJKULNWGRYAS-UOVSKDHASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
117963,6w4b,DB04186,-7.6,"N'-(Pyrrolidino[2,1-B]Isoindolin-4-On-8-Yl)-N-(Pyridin-2-Yl)Urea",KLVYMYQTRZCMLE-CYBMUJFWSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
95581,6m71,DB11638,-7.6,Artenimol,BJDCWCLMFKKGEE-HVDUHBCDSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
92596,6m71,DB04614,-7.6,(R)-tacrine(10)-hupyridone,ROTFGKJJMRTWBD-HHHXNRCGSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
92594,6m71,DB04610,-7.6,"7,8-dihydro-6-hydroxymethyl-7-methyl-7-[2-phenylethyl]-pterin",XMFJTCGUDFSWSW-INIZCTEOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
146524,6w9q,DB08635,-7.6,N-(TRANS-4'-NITRO-4-STILBENYL)-N-METHYL-5-AMINO-PENTANOIC ACID,QLLZAVDYYAQESE-AATRIKPKSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
9445,6lzg,DB07544,-7.6,N'-(5-CHLOROBENZOFURAN-2-CARBONYL)-2-(TRIFLUOROMETHYL)BENZENESULFONOHYDRAZIDE,ZLQBZYKAQQWOTK-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
74934,6m2n,DB04024,-7.6,N'-L-Seryl-3'-Amino-(3'-Deoxy)-Adenosine,ITDKSTILAWHDJI-AYEBZEFBSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
111699,6vxx,DB04400,-7.6,"L-erythro-7,8-dihydrobiopterin",FEMXZDUTFRTWPE-DZSWIPIPSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
65274,6lxt,DB02616,-7.6,FR117016,CKJGKHXCUDWFDC-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
67321,6lxt,DB06446,-7.6,Dotarizine,LRMJAFKKJLRDLE-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
92566,6m71,DB04574,-7.6,Estrone sulfate,JKKFKPJIXZFSSB-CBZIJGRNSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
67325,6lxt,DB06457,-7.6,Tecastemizole,SFOVDSLXFUGAIV-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
53318,2fxp,DB12817,-7.6,Zoliflodacin,ZSWMIFNWDQEXDT-ZESJGQACSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
29474,6cs2,DB09226,-7.6,RP-5063,PMKMNTBZJOXTJW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
95609,6m71,DB11681,-7.6,Tofimilast,DHCOPPHTVOXDKU-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
146467,6w9q,DB08562,-7.6,4-(4-STYRYL-PHENYLCARBAMOYL)-BUTYRIC ACID,FTXJWRRYLLRFMG-MDZDMXLPSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
146466,6w9q,DB08561,-7.6,"BENZYL 6-BENZYL-5,7-DIOXO-6,7-DIHYDRO-5H-[1,3]THIAZOLO[3,2-C]PYRIMIDINE-2-CARBOXYLATE",PLBINCOCFGQAJM-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
152663,6wiq,DB04350,-7.6,Argadin,FOZYKTUSOWWQGR-KNPYFFGGSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
92537,6m71,DB04540,-7.6,Cholesterol,HVYWMOMLDIMFJA-DPAQBDIFSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
146453,6w9q,DB08546,-7.6,"4-[(3AS,4R,7R,8AS,8BR)-2-(1,3-BENZODIOXOL-5-YLMETHYL)-7-HYDROXY-1,3-DIOXODECAHYDROPYRROLO[3,4-A]PYRROLIZIN-4-YL]BENZENECARBOXIMIDAMIDE",CETLUACQMGBMFH-ZALSBGIRSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
165744,7bv1,DB12743,-7.6,Z-160,VCPMZDWBEWTGNW-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
165741,7bv1,DB12740,-7.6,CC-115,GMYLVKUGJMYTFB-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
65252,6lxt,DB02587,-7.6,Colforsin,OHCQJHSOBUTRHG-KGGHGJDLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
53351,2fxp,DB12874,-7.6,Quizartinib,CVWXJKQAOSCOAB-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
67343,6lxt,DB06499,-7.6,Furaprofen,ODZUWQAFWMLWCF-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
152702,6wiq,DB04408,-7.6,Ncs-Chromophore,QZGIWPZCWHMVQL-UIYAJPBUSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
95649,6m71,DB11741,-7.6,Famitinib,GKEYKDOLBLYGRB-LGMDPLHJSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
92127,6m71,DB03987,-7.6,"2,4-Diamino-6-[N-(3',5'-Dimethoxybenzyl)-N-Methylamino]Pyrido[2,3-D]Pyrimidine",XWCCXDBXMCTZPW-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
30735,6cs2,DB12904,-7.6,ZSTK-474,HGVNLRPZOWWDKD-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
118467,6w4b,DB04862,-7.6,Merimepodib,JBPUGFODGPKTDW-SFHVURJKSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
29429,6cs2,DB09182,-7.6,Benzylfentanyl,POQDXIFVWVZVML-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
118683,6w4b,DB05913,-7.6,OSI-930,FGTCROZDHDSNIO-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
111046,6vxx,DB02921,-7.6,(South)-Methanocarba-Thymidine,XRMLXZVSFIBRRJ-PEFMBERDSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
67489,6lxt,DB06800,-7.6,Methylnaltrexone,JVLBPIPGETUEET-WIXLDOGYSA-O,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
29425,6cs2,DB09178,-7.6,Phenaridine,ODPKHHGQKIYCTJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
111031,6vxx,DB02901,-7.6,Stanolone,NVKAWKQGWWIWPM-ABEVXSGRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111025,6vxx,DB02894,-7.6,"Sulfamic Acid 2,3-O-(1-Methylethylidene)-4,5-O-Sulfonyl-Beta-Fructopyranose Ester",GGOAQSGCBDRTHT-JAKMQLQISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
65084,6lxt,DB02375,-7.6,Myricetin,IKMDFBPHZNJCSN-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
95940,6m71,DB12167,-7.6,LY-3023414,ACCFLVVUVBJNGT-AWEZNQCLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
111016,6vxx,DB02883,-7.6,"2',3'-Dideoxycytidine-5'-Monophosphate",RAJMXAZJKUGYGW-POYBYMJQSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
92217,6m71,DB04107,-7.6,[(1-{2[(4-Carbamimidoyl-Phenylamino)-Methyl]-1-Methyl-1h-Benzoimidazol-5-Yl}-Cyclopropyl)-Pyridin-2-Yl-Methyleneaminooxy]-Acetic Acid Ethyl Ester,RNOYCNIZOAIUSV-LSWMGQQCSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
77283,6m2n,DB08179,-7.6,"methyl 4-(2,3-dihydroxy-5-methylphenoxy)-2-hydroxy-6-methylbenzoate",BLXSEOJIXHWXQJ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77286,6m2n,DB08184,-7.6,2-(2-METHYLPHENYL)-1H-INDOLE-5-CARBOXIMIDAMIDE,YOZKTHGEOJHIDP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
118716,6w4b,DB06144,-7.6,Sertindole,GZKLJWGUPQBVJQ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
118724,6w4b,DB06155,-7.6,Rimonabant,JZCPYUJPEARBJL-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
74783,6m2n,DB03823,-7.6,Epigallocatechin,XMOCLSLCDHWDHP-IUODEOHRSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
95961,6m71,DB12203,-7.6,Tozadenant,XNBRWUQWSKXMPW-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
118728,6w4b,DB06160,-7.6,Garenoxacin,NJDRXTDGYFKORP-LLVKDONJSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
118733,6w4b,DB06176,-7.6,Romidepsin,OHRURASPPZQGQM-GCCNXGTGSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
165631,7bv1,DB12567,-7.6,Camicinal,RZKDEGZIFSJVNA-IBGZPJMESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
7774,6lzg,DB04357,-7.6,Pteric Acid,JOAQINSXLLMRCV-UHFFFAOYSA-O,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
53656,2fxp,DB13345,-7.6,Dihydroergocristine,DEQITUUQPICUMR-HJPBWRTMSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
110908,6vxx,DB02562,-7.6,"Quinonoid 7,8-Tetrahydrobiopterin",ZHQJVZLJDXWFFX-RPDRRWSUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
65059,6lxt,DB02342,-7.6,2-Methox1tradiol,CQOQDQWUFQDJMK-SSTWWWIQSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
95991,6m71,DB12242,-7.6,AZD-7762,IAYGCINLNONXHY-LBPRGKRZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
67519,6lxt,DB06847,-7.6,"5-[(3S)-3-(2-methoxybiphenyl-4-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",YYCPXVRHQUEVAW-CQSZACIVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
9650,6lzg,DB07769,-7.6,S-3-(4-FLUOROPHENOXY)-2-HYDROXY-2-METHYL-N-[4-NITRO-3-(TRIFLUOROMETHYL)PHENYL]PROPANAMIDE,KJMFOTCDISOHDX-INIZCTEOSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
110805,6vxx,DB02430,-7.6,Trehalose-6-Phosphate,LABSPYBHMPDTEL-LIZSDCNHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
153189,6wiq,DB05482,-7.6,7-ethyl-10-hydroxycamptothecin,FJHBVJOVLFPMQE-QFIPXVFZSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
9602,6lzg,DB07717,-7.6,"(5S,8R,9S,10S,13R,14S,17S)-13-{2-[(3,5-DIFLUOROBENZYL)OXY]ETHYL}-17-HYDROXY-10-METHYLHEXADECAHYDRO-3H-CYCLOPENTA[A]PHENANTHREN-3-ONE",AJODXHGZHBERGJ-JLYQOUBASA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
77143,6m2n,DB08024,-7.6,1-[2-(S)-AMINO-3-BIPHENYL-4-YL-PROPIONYL]-PYRROLIDINE-2-(S)-CARBONITRILE,MUUVLSCVDXKQQV-OALUTQOASA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77256,6m2n,DB08151,-7.6,"(5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-phenyl-1,6-dioxa-2-azaspiro[4.5]dec-2-ene-8,9,10-triol",YLTDNVVQKRHCJP-RKQHYHRCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
95874,6m71,DB12072,-7.6,Orantinib,NHFDRBXTEDBWCZ-ZROIWOOFSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
152986,6wiq,DB04790,-7.6,"2,5-bis-O-{3-[amino(imino)methyl]phenyl}-1,4:3,6-dianhydro-D-glucitol",IBIUTOFGXGGVKQ-XMTFNYHQSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
77162,6m2n,DB08046,-7.6,2-chloro-5-[(1S)-1-hydroxy-3-oxo-2H-isoindol-1-yl]benzenesulfonamide,JIVPVXMEBJLZRO-AWEZNQCLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
30752,6cs2,DB12928,-7.6,GET-73,QLZOWJNFLXSDSH-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
92331,6m71,DB04258,-7.6,Seocalcitol,LVLLALCJVJNGQQ-SEODYNFXSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
29441,6cs2,DB09193,-7.6,"CP-39,332",HLOCJJORRHQDKS-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
30762,6cs2,DB00986,-7.6,Glycopyrronium,ANGKOCUUWGHLCE-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
165678,7bv1,DB12645,-7.6,Givinostat,YALNUENQHAQXEA-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
77201,6m2n,DB08093,-7.6,3-(1-NAPHTHYLMETHOXY)PYRIDIN-2-AMINE,SZANYTFSQVBOBA-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
118537,6w4b,DB05048,-7.6,Cannabinor,GSTZHANFXAKPSE-MXTREEOPSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
118542,6w4b,DB05087,-7.6,Ganaxolone,PGTVWKLGGCQMBR-FLBATMFCSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
95811,6m71,DB11978,-7.6,Glasdegib,SFNSLLSYNZWZQG-VQIMIIECSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
74827,6m2n,DB03883,-7.6,Carboxyethyllumazine,PTYCEIBBGGLADD-PJKMHFRUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
65148,6lxt,DB02452,-7.6,Thymidine-5'-Triphosphate,NHVNXKFIZYSCEB-XLPZGREQSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
53510,2fxp,DB13109,-7.6,PKI-179,WXUUCRLKXQMWRY-OYRHEFFESA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
111253,6vxx,DB03403,-7.6,Cytidine-5'-Monophosphate,IERHLVCPSMICTF-XVFCMESISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
92303,6m71,DB04216,-7.6,Quercetin,REFJWTPEDVJJIY-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
77215,6m2n,DB08107,-7.6,N-{[6-(PENTYLOXY)NAPHTHALEN-2-YL]SULFONYL}-D-GLUTAMIC ACID,LIGACKDHLKEZFH-GOSISDBHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
118572,6w4b,DB05265,-7.6,Ecabet,IWCWQNVIUXZOMJ-MISYRCLQSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
95829,6m71,DB12005,-7.6,Nirogacestat,VFCRKLWBYMDAED-REWPJTCUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
146182,6w9q,DB08213,-7.6,"1-METHYL-5-(2-PHENOXYMETHYL-PYRROLIDINE-1-SULFONYL)-1H-INDOLE-2,3-DIONE",PFAYCUAUBOGVDX-AWEZNQCLSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
30778,6cs2,DB12964,-7.6,Lerisetron,PWWDCRQZITYKDV-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
111215,6vxx,DB03349,-7.6,8-Bromo-Adenosine-5'-Monophosphate,DNPIJKNXFSPNNY-UUOKFMHZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
146176,6w9q,DB08204,-7.6,3-DIPHENOL-6-NITRO-3H-BENZO[DE]ISOCHROMEN-1-ONE,FLWABCQDXUKNQY-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
77225,6m2n,DB08118,-7.6,"2-(methylamino)-N-(4-methyl-1,3-thiazol-2-yl)-5-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]benzamide",XRJAKERBMMBUGR-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
92285,6m71,DB04196,-7.6,Pteroic Acid,JOAQINSXLLMRCV-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
111183,6vxx,DB03307,-7.6,4-[(6-Amino-4-Pyrimidinyl)Amino]Benzenesulfonamide,FVFVVRPJERUECT-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111162,6vxx,DB03079,-7.6,Alpha-Ribazole-5'-Phosphate Derivative,YPYFPLLZCVEYCS-KKOKHZNYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
118614,6w4b,DB05498,-7.6,KW-7158,NAFSYPCVPLWHFY-HNNXBMFYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
111136,6vxx,DB03046,-7.6,7-Methoxy-8-[1-(Methylsulfonyl)-1h-Pyrazol-4-Yl]Naphthalene-2-Carboximidamide,KQUXAFOLFXHVQN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
118631,6w4b,DB05575,-7.6,Motesanib,RAHBGWKEPAQNFF-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
119423,6w4b,DB07294,-7.6,"3-fluoro-4-[2-hydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8,-tetrahydro-naphtalen-2-yl)-acetylamino]-benzoic acid",AANFHDFOMFRLLR-IBGZPJMESA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
64620,6lxt,DB01755,-7.6,N-[Isoleucinyl]-N'-[Adenosyl]-Diaminosufone,XVTRBLLRODNOJV-VBJYJYTRSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
119439,6w4b,DB07311,-7.6,"18-CHLORO-11,12,13,14-TETRAHYDRO-1H,10H-8,4-(AZENO)-9,15,1,3,6-BENZODIOXATRIAZACYCLOHEPTADECIN-2-ONE",JRSWWYITYIOHOP-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
31309,6cs2,DB13664,-7.6,Formocortal,QNXUUBBKHBYRFW-QWAPGEGQSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
108970,6vxx,DB11843,-7.6,PF-04958242,TTYKUKSFWHEBLI-DLBZAZTESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
20097,6cs2,HMDB0000899,-7.6,Androstanedione,RAJWOBJTTGJROA-WZNAKSSCSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
120353,6w4b,DB08389,-7.6,"6,7-DIMETHOXY-4-[(3R)-3-(2-NAPHTHYLOXY)PYRROLIDIN-1-YL]QUINAZOLINE",UPTQSRGSSJRBKJ-LJQANCHMSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
78414,6m2n,DB11721,-7.6,Mitoglitazone,IRNJSRAGRIZIHD-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
13559,6lzg,DB01219,-7.6,Dantrolene,OZOMQRBLCMDCEG-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
91291,6m71,DB02861,-7.6,"4-(Aminosulfonyl)-N-[(3,4,5-Trifluorophenyl)Methyl]-Benzamide",DEHMSTGBNAXEGX-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
20088,6cs2,HMDB0045911,-7.6,"TG(20:0/18:3(6Z,9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z))",HHWHJJSODCDUKU-RAFXBCCRSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
78431,6m2n,DB11748,-7.6,Benfotiamine,BTNNPSLJPBRMLZ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
120384,6w4b,DB08429,-7.6,N-({(2S)-1-[(3R)-3-amino-4-(3-chlorophenyl)butanoyl]pyrrolidin-2-yl}methyl)-3-(methylsulfonyl)benzamide,QRGBOABBMKYMLG-UXHICEINSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
120393,6w4b,DB08439,-7.6,Parecoxib,TZRHLKRLEZJVIJ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
31329,6cs2,DB13683,-7.6,Quinisocaine,XNMYNYSCEJBRPZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
97460,6m71,DB14932,-7.6,Coleneuramide,CHMRTBYTCBDIRG-JQZMMWJVSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
29306,6cs2,DB08990,-7.6,Eprazinone,BSHWLCACYCVCJE-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
108924,6vxx,DB11395,-7.6,Deracoxib,WAZQAZKAZLXFMK-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
97467,6m71,DB14941,-7.6,BMS-817399,GTDPZONCGOCXOD-JPYJTQIMSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
120410,6w4b,DB08459,-7.6,"3-chloro-5-[2-chloro-5-(1H-pyrazolo[3,4-b]pyridin-3-ylmethoxy)phenoxy]benzonitrile",SVMHTBVIPYVDIL-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
153916,6wiq,DB07265,-7.6,"3-(9-HYDROXY-1,3-DIOXO-4-PHENYL-2,3-DIHYDROPYRROLO[3,4-C]CARBAZOL-6(1H)-YL)PROPANOIC ACID",JDARUOOLJCFUOY-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
37246,1r42,DB04014,-7.6,Alsterpaullone,OLUKILHGKRVDCT-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
165046,7bv1,DB09172,-7.6,Brifentanil,KKMGCTVJCQYQPV-WBVHZDCISA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
108911,6vxx,DB11372,-7.6,Altrenogest,VWAUPFMBXBWEQY-ANULTFPQSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78517,6m2n,DB11872,-7.6,ZD-6126,UGBMEXLBFDAOGL-INIZCTEOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
120441,6w4b,DB08495,-7.6,4-({4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-2-OXOPIPERAZIN-1-YL}METHYL)BENZENECARBOXIMIDAMIDE,VXONTEUOQXFJJS-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
120444,6w4b,DB08498,-7.6,"(1S)-1-(3-chlorophenyl)-2-oxo-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate",OVSAMUIBGQSLDC-INIZCTEOSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
54773,6crv,DB00215,-7.6,Citalopram,WSEQXVZVJXJVFP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
120463,6w4b,DB08521,-7.6,4-[5-(4-FLUORO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-3H-IMIDAZOL-4-YL]-PYRIDINE,CDMGBJANTYXAIV-HHHXNRCGSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
28552,6cs2,DB08141,-7.6,"4-{[(2,6-difluorophenyl)carbonyl]amino}-N-[(3S)-piperidin-3-yl]-1H-pyrazole-3-carboxamide",KOMNQBZWMCFDTQ-VIFPVBQESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
28548,6cs2,DB08136,-7.6,4-(acetylamino)-N-(4-fluorophenyl)-1H-pyrazole-3-carboxamide,CWQKPKYIMQTGJK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
97516,6m71,DB15075,-7.6,4-demethyl-4-cholesteryloxycarbonylpenclomedine,ZJUUIXYKTPSIOH-LEZJFEBPSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
78382,6m2n,DB11674,-7.6,Equol,ADFCQWZHKCXPAJ-GFCCVEGCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
31361,6cs2,DB01047,-7.6,Fluocinonide,WJOHZNCJWYWUJD-IUGZLZTKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
109020,6vxx,DB11915,-7.6,Valbenazine,GEJDGVNQKABXKG-CFKGEZKQSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
74303,6m2n,DB03176,-7.6,KB-141,OZYQIQVPUZANTM-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
67960,6lxt,DB07354,-7.6,"2,3-DIMETHOXY-12H-[1,3]DIOXOLO[5,6]INDENO[1,2-C]ISOQUINOLIN-6-IUM",LXDREMZQGAILJU-UHFFFAOYSA-O,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
97402,6m71,DB14801,-7.6,Lanifibranor,OQDQIFQRNZIEEJ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
120021,6w4b,DB07993,-7.6,"N-3-[3-(1H-INDOL-6-YL)BENZYL]PYRIDINE-2,3-DIAMINE",LPQUIIHPUGDHJK-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
10226,6lzg,DB08400,-7.6,4-(3-{[5-(trifluoromethyl)pyridin-2-yl]oxy}benzyl)piperidine-1-carboxylic acid,KUEKMTNOUPAOBS-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
109276,6vxx,DB13001,-7.6,Tinoridine,PFENFDGYVLAFBR-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165159,7bv1,DB11440,-7.6,Norgestomet,IWSXBCZCPVUWHT-VIFKTUCRSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
54560,2fxp,DB15269,-7.6,ALK-4290,DWKNOLCXIFYNFV-HSZRJFAPSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
10265,6lzg,DB08444,-7.6,"3-[2-bromo-4-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)phenoxy]-5-methylbenzonitrile",YYGZQXRLQMFHDH-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
10270,6lzg,DB08449,-7.6,"2-(3-((4,5,7-trifluorobenzo[d]thiazol-2-yl)methyl)-1H-pyrrolo[2,3-b]pyridin-1-yl)acetic acid",IEVFQDJUDLCOQY-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
120086,6w4b,DB08068,-7.6,N-[4-CHLORO-3-(PYRIDIN-3-YLOXYMETHYL)-PHENYL]-3-FLUORO-,YQJVDUKATDECHF-ICSRJNTNSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
49713,2fxp,DB04842,-7.6,Fluspirilene,QOYHHIBFXOOADH-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
74364,6m2n,DB03250,-7.6,"2-(Beta-D-Glucopyranosyl)-5-Methyl-1,3,4-Benzothiazole",WGJFWQVWYRZPEP-KABOQKQYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
109174,6vxx,DB12476,-7.6,CPG-52852,YZOQZEXYFLXNKA-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78208,6m2n,DB11260,-7.6,Diacetyl benzoyl lathyrol,JPYYWXPAHJBKJX-VWSFRBHVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78218,6m2n,DB11279,-7.6,Brilliant green cation,HXCILVUBKWANLN-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
54598,2fxp,DB15343,-7.6,HM-43239,FZLSDZZNPXXBBB-KDURUIRLSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
31260,6cs2,DB13606,-7.6,Phenazocine,ZQHYKVKNPWDQSL-KNXBSLHKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
10307,6lzg,DB08491,-7.6,N-HYDROXY-2-[4-(4-PHENOXY-BENZENESULFONYL)-TETRAHYDRO-PYRAN-4-YL]-ACETAMIDE,ARIRIZBKMKMEBD-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
120138,6w4b,DB08124,-7.6,"3-{[(2,2-DIOXIDO-1,3-DIHYDRO-2-BENZOTHIEN-5-YL)AMINO]METHYLENE}-5-(1,3-OXAZOL-5-YL)-1,3-DIHYDRO-2H-INDOL-2-ONE",FTQYGMLRLRXBPT-IDUWFGFVSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
120139,6w4b,DB08125,-7.6,"4-{[(2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]AMINO}-N-(1,3-THIAZOL-2-YL)BENZENESULFONAMIDE",BOMPRXSVSIPRDT-PTNGSMBKSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
10335,6lzg,DB08520,-7.6,"(21S)-1AZA-4,4-DIMETHYL-6,19-DIOXA-2,3,7,20-TETRAOXOBICYCLO[19.4.0] PENTACOSANE",VUCSBBBCFXBFFY-IBGZPJMESA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
109101,6vxx,DB12378,-7.6,Apricoxib,JTMITOKKUMVWRT-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
120210,6w4b,DB08207,-7.6,"2-(3,5-DIMETHYLPHENYL)-1,3-BENZOXAZOLE",BIHLSRJPJFOESJ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
109099,6vxx,DB12376,-7.6,Ricolinostat,QGZYDVAGYRLSKP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78295,6m2n,DB11463,-7.6,Sulfanitran,GWBPFRGXNGPPMF-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
120239,6w4b,DB08244,-7.6,"(1S)-1-CYCLOPROPYL-2-[(2S)-4-(2,5-DIFLUOROPHENYL)-2-PHENYL-2,5-DIHYDRO-1H-PYRROL-1-YL]-2-OXOETHANAMINE",VCOUEHUEFUDZIS-PMACEKPBSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
31286,6cs2,DB13635,-7.6,Tiracizine,KJAMZCVTJDTESW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
31295,6cs2,DB01039,-7.6,Fenofibrate,YMTINGFKWWXKFG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
109056,6vxx,DB11967,-7.6,Binimetinib,ACWZRVQXLIRSDF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109036,6vxx,DB11941,-7.6,Tasisulam,WWONFUQGBVOKOF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
67958,6lxt,DB07352,-7.6,Apigenin,KZNIFHPLKGYRTM-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
97525,6m71,DB15096,-7.6,18-methoxycoronaridine,DTJQBBHYRQYDEG-SVBQBFEESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
120486,6w4b,DB08546,-7.6,"4-[(3AS,4R,7R,8AS,8BR)-2-(1,3-BENZODIOXOL-5-YLMETHYL)-7-HYDROXY-1,3-DIOXODECAHYDROPYRROLO[3,4-A]PYRROLIZIN-4-YL]BENZENECARBOXIMIDAMIDE",CETLUACQMGBMFH-ZALSBGIRSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
40373,6lu7,DB08448,-7.6,"(4aS)-5-[(2,4-diaminopteridin-6-yl)methyl]-4a,5-dihydro-2H-dibenzo[b,f]azepin-8-ol",PCBWLKUEKANDCL-INIZCTEOSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40374,6lu7,DB08406,-7.6,"[N-(2,4-DIAMINOPTERIDIN-6-YL)-METHYL]-DIBENZ[B,F]AZEPINE",NXCCIJQEAKMFGW-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40375,6lu7,DB08384,-7.6,2-({4-[4-(pyridin-4-ylmethyl)-1H-pyrazol-3-yl]phenoxy}methyl)quinoline,RQDDHVVAAJVVKM-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40376,6lu7,DB07837,-7.6,"[4-(5-naphthalen-2-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)phenyl]acetic acid",SWXKLXXVFMYMDP-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40377,6lu7,DB07691,-7.6,"2-({[3-(3,4-dihydroisoquinolin-2(1H)-ylsulfonyl)phenyl]carbonyl}amino)benzoic acid",GYILVHHTCYNIOS-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
78708,6m2n,DB12150,-7.6,Pelubiprofen,AUZUGWXLBGZUPP-GXDHUFHOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
40379,6lu7,DB07360,-7.6,"1-{5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)ethyl]-1,3-thiazol-2-yl}-3-[3-(trifluoromethyl)phenyl]urea",JJHXPDTVQKWKHA-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40380,6lu7,DB12740,-7.6,CC-115,GMYLVKUGJMYTFB-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40381,6lu7,DB06944,-7.6,N-(3-cyclopropyl-1H-pyrazol-5-yl)-2-(2-naphthyl)acetamide,RIGZCVNCFXYBEG-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40382,6lu7,DB06486,-7.6,Enzastaurin,AXRCEOKUDYDWLF-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40383,6lu7,DB06134,-7.6,SNS-314,FAYAUAZLLLJJGH-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40384,6lu7,DB04759,-7.6,"PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-(3-METHYL-BENZYLAMIDE)",GTBUZLPQANSGGE-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40385,6lu7,DB03966,-7.6,Clorobiocin,FJAQNRBDVKIIKK-LFLQOBSNSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40386,6lu7,DB03878,-7.6,N-[4-Methyl-3-[[4-(3-Pyridinyl)-2-Pyrimidinyl]Amino]Phenyl]-3-Pyridinecarboxamide,YWQVBESSYLICRX-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40387,6lu7,DB07545,-7.6,N-{3-[(4-{[3-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-2-YL)AMINO]PHENYL}CYCLOPROPANECARBOXAMIDE,RDTDWGQDFJPTPD-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
120780,6w4b,DB08930,-7.6,Dolutegravir,RHWKPHLQXYSBKR-BMIGLBTASA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
29291,6cs2,DB08976,-7.6,Floctafenine,APQPGQGAWABJLN-GFCCVEGCSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
40395,6lu7,DB09195,-7.6,Lorpiprazole,BNRMWKUVWLKDQJ-YJBOKZPZSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40397,6lu7,DB12200,-7.6,Tivantinib,UCEQXRCJXIVODC-PMACEKPBSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
28460,6cs2,DB08049,-7.6,"7,8-dihydroxy-4-phenyl-2H-chromen-2-one",JRVIIPJSVKTPBK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
40399,6lu7,DB15068,-7.6,Agerafenib,DKNUPRMJNUQNHR-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40400,6lu7,DB14870,-7.6,PF-5190457,ZIUDADZJCKGWKR-AREMUKBSSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40401,6lu7,DB14770,-7.6,Lanraplenib,XCIGZBVOUQVIPI-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40402,6lu7,DB13874,-7.6,Enasidenib,DYLUUSLLRIQKOE-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40403,6lu7,DB02112,-7.6,Zk-806450,DZLGSWPXZYDHBD-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
91029,6m71,DB02511,-7.6,2-Hydroxy-5-({1-[(2-Naphthyloxy)Methyl]-3-Oxoprop-1-Enyl}Amino)Tyrosine,PZWMZAFFUAWVDN-CQXYXCHQSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
40406,6lu7,DB03591,-7.6,RU82209,LVZDQVATAQEMCX-NSOVKSMOSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
68107,6lxt,DB07530,-7.6,"(1R,3R)-5-[(2E)-3-{(1S,3R)-2,2,3-trimethyl-3-[6,6,6-trifluoro-5-hydroxy-5-(trifluoromethyl)hex-3-yn-1-yl]cyclopentyl}prop-2-en-1-ylidene]cyclohexane-1,3-diol",PCHUQQNKOFNVDU-OSXMSNBXSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
91025,6m71,DB02507,-7.6,4-Hydroxy-3-[(1s)-3-Oxo-1-Phenylbutyl]-2h-Chromen-2-One,PJVWKTKQMONHTI-HNNXBMFYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
40372,6lu7,DB07145,-7.6,(2R)-N-HYDROXY-2-[(3S)-3-METHYL-3-{4-[(2-METHYLQUINOLIN-4-YL)METHOXY]PHENYL}-2-OXOPYRROLIDIN-1-YL]PROPANAMIDE,YDMIPBHQKFOFQW-NSYGIPOTSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
28545,6cs2,DB08134,-7.6,4-[(6-chloropyrazin-2-yl)amino]benzenesulfonamide,RSNSGNZRUMHXAY-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
120768,6w4b,DB08907,-7.6,Canagliflozin,XTNGUQKDFGDXSJ-ZXGKGEBGSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
78704,6m2n,DB12146,-7.6,Rigosertib,OWBFCJROIKNMGD-BQYQJAHWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
108870,6vxx,DB11221,-7.6,Dioxybenzone,MEZZCSHVIGVWFI-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
91170,6m71,DB02699,-7.6,4-Oxoretinol,PLIUCYCUYQIBDZ-RMWYGNQTSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
64115,6lxt,DB01081,-7.6,Diphenoxylate,HYPPXZBJBPSRLK-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
78570,6m2n,DB11948,-7.6,Lapachone,QZPQTZZNNJUOLS-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
120503,6w4b,DB08569,-7.6,"3-PYRIDIN-4-YL-2,4-DIHYDRO-INDENO[1,2-.C.] PYRAZOLE",VLPMRZSKJUTRBQ-IBGZPJMESA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
54815,6crv,DB00263,-7.6,Sulfisoxazole,NHUHCSRWZMLRLA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
74234,6m2n,DB03083,-7.6,IC261,JBJYTZXCZDNOJW-JLHYYAGUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
28529,6cs2,DB08118,-7.6,"2-(methylamino)-N-(4-methyl-1,3-thiazol-2-yl)-5-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]benzamide",XRJAKERBMMBUGR-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
28527,6cs2,DB08115,-7.6,2-aminoethyl naphthalen-1-ylacetate,PDCSQCHNOPNJMK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
164997,7bv1,DB09070,-7.6,Tibolone,WZDGZWOAQTVYBX-XOINTXKNSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
54835,6crv,DB00283,-7.6,Clemastine,YNNUSGIPVFPVBX-NHCUHLMSSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28523,6cs2,DB08113,-7.6,3-pyridin-4-yl-1H-indazole,MSRXUUDVRNWSTN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
108792,6vxx,DB08968,-7.6,Fominoben,KSNNEUZOAFRTDS-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108782,6vxx,DB08956,-7.6,Hydroxydione,USPYDUPOCUYHQL-VEVMSBRDSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
164991,7bv1,DB09061,-7.6,Cannabidiol,QHMBSVQNZZTUGM-ZWKOTPCHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97530,6m71,DB15105,-7.6,PF-06751979,ZLZUHACSRMOLLV-RAALSFIWSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
120638,6w4b,DB08731,-7.6,"2-[(1R)-2-carboxy-1-(naphthalen-1-ylmethyl)ethyl]-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylic acid",GPOKTQCDBPECSS-MRXNPFEDSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
97533,6m71,DB15109,-7.6,Ingenol disoxate,GLIUZQUNUNICGS-XUBYYPQFSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
13517,6lzg,DB01162,-7.6,Terazosin,VCKUSRYTPJJLNI-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
31401,6cs2,DB13773,-7.6,Sulfamethoxypyridazine,VLYWMPOKSSWJAL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
145125,6w9q,DB06992,-7.6,"(3,3-dimethylpiperidin-1-yl)(6-(3-fluoro-4-methylphenyl)pyridin-2-yl)methanone",SIDDLTBLAQYZIZ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
64100,6lxt,DB01063,-7.6,Acetophenazine,WNTYBHLDCKXEOT-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
78641,6m2n,DB12057,-7.6,ORM-12741,OCUKPFWNSAAHRP-QZTJIDSGSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
164958,7bv1,DB09006,-7.6,Clinofibrate,BMOVQUBVGICXQN-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
120742,6w4b,DB08861,-7.6,DPDPE,MCMMCRYPQBNCPH-WMIMKTLMSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
154078,6wiq,DB07450,-7.6,(R)-minalrestat,BMHZAHGTGIZZCT-LJQANCHMSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
97551,6m71,DB15143,-7.6,PF-06650833,JKDGKIBAOAFRPJ-ZBINZKHDSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
28482,6cs2,DB08072,-7.6,"4-(2-AMINOETHOXY)-3,5-DICHLORO-N-[3-(1-METHYLETHOXY)PHENYL]BENZAMIDE",AYKUIRSGEMLIFT-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
97556,6m71,DB15151,-7.6,RO-6870810,PKQXLRYFPSZKDU-QFIPXVFZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
78706,6m2n,DB12148,-7.6,Menatetrenone,DKHGMERMDICWDU-GHDNBGIDSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
54488,2fxp,DB15126,-7.6,IMG-7289,KQKBMHGOHXOHTD-KKUQBAQOSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
31209,6cs2,DB13542,-7.6,Bevonium,UHUMRJKDOOEQIG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
109342,6vxx,DB13439,-7.6,Fenpiprane,JXJPYHDHJZJWRI-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109857,6vxx,DB00341,-7.6,Cetirizine,ZKLPARSLTMPFCP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
145574,6w9q,DB07508,-7.6,4-(5-BENZENESULFONYLAMINO-1-METHYL-1H-BENZOIMIDAZOL-2-YLMETHYL)-BENZAMIDINE,MEUAVGJWGDPTLF-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
77809,6m2n,DB08819,-7.6,Tafluprost,WSNODXPBBALQOF-VEJSHDCNSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
67816,6lxt,DB07190,-7.6,3-cyclohexyl-D-alanyl-N-(3-chlorobenzyl)-L-prolinamide,JGFCNVHEEMBVJG-MOPGFXCFSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
145549,6w9q,DB07479,-7.6,"(1S)-1,2,3,4-TETRAHYDRO-BENZO[C]PHENANTHRENE-2,3,4-TRIOL",WCUHTHVUZQCBTI-KBAYOESNSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
119573,6w4b,DB07468,-7.6,"(3aS)-3a-hydroxy-5-methyl-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one",NJBBBRZNBVLTRZ-GOSISDBHSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
31092,6cs2,DB13398,-7.6,Oxyfedrine,GDYUVHBMFVMBAF-LIRRHRJNSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
145540,6w9q,DB07468,-7.6,"(3aS)-3a-hydroxy-5-methyl-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one",NJBBBRZNBVLTRZ-GOSISDBHSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
145539,6w9q,DB07467,-7.6,"4-chloro-N-[(2S)-2-methyl-2,3-dihydro-1H-indol-1-yl]-3-sulfamoylbenzamide",NDDAHWYSQHTHNT-JTQLQIEISA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
145535,6w9q,DB07460,-7.6,2-({5-CHLORO-2-[(2-METHOXY-4-MORPHOLIN-4-YLPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)-N-METHYLBENZAMIDE,UYJNQQDJUOUFQJ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
109776,6vxx,DB00243,-7.6,Ranolazine,XKLMZUWKNUAPSZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
64454,6lxt,DB01545,-7.6,Ethyl loflazepate,CUCHJCMWNFEYOM-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
109767,6vxx,DB00234,-7.6,Reboxetine,CBQGYUDMJHNJBX-RTBURBONSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
64450,6lxt,DB01541,-7.6,Boldenone,RSIHSRDYCUFFLA-DYKIIFRCSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
67826,6lxt,DB07203,-7.6,6-CYCLOHEXYLMETHOXY-2-(3'-CHLOROANILINO) PURINE,OUEGMEMDEAOAEG-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
119631,6w4b,DB07536,-7.6,"N-{(1S,2R)-2-hydroxy-1-[(hydroxyamino)carbonyl]propyl}-4-{[4-(morpholin-4-ylmethyl)phenyl]ethynyl}benzamide",FQYBTYFKOHPWQT-VGSWGCGISA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
77876,6m2n,DB08933,-7.6,Luliconazole,YTAOBBFIOAEMLL-REQDGWNSSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
109726,6vxx,DB15212,-7.6,Pemafibrate,ZHKNLJLMDFQVHJ-RUZDIDTESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
10032,6lzg,DB08169,-7.6,(2Z)-N-biphenyl-4-yl-2-cyano-3-cyclopropyl-3-hydroxyprop-2-enamide,CAGGGMPTWTUYHZ-ZCXUNETKSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
119644,6w4b,DB07550,-7.6,"2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(1-OXIDO-2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUOROPHENYL)METHYL]ACETAMIDE",ZIGSBBKEPNQXRG-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
77880,6m2n,DB08940,-7.6,Kebuzone,LGYTZKPVOAIUKX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77883,6m2n,DB08943,-7.6,Isoconazole,MPIPASJGOJYODL-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
153713,6wiq,DB07031,-7.6,"3-Fluoro-4-{[(2R)-2-hydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthalenyl)acetyl]amino}benzoic acid",AANFHDFOMFRLLR-LJQANCHMSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
145488,6w9q,DB07406,-7.6,"(4R)-N-[4-({[2-(DIMETHYLAMINO)ETHYL]AMINO}CARBONYL)-1,3-THIAZOL-2-YL]-4-METHYL-1-OXO-2,3,4,9-TETRAHYDRO-1H-BETA-CARBOLINE-6-CARBOXAMIDE",QWFFPYQWUWLDBV-NSHDSACASA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
64430,6lxt,DB01521,-7.6,Clostebol,KCZCIYZKSLLNNH-FBPKJDBXSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
29338,6cs2,DB00836,-7.6,Loperamide,RDOIQAHITMMDAJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
153723,6wiq,DB07041,-7.6,"N-[2-(2,4-diaminopyrido[2,3-d]pyrimidin-7-yl)-2-methylpropyl]-4-phenoxybenzamide",FDJWFDQRPKKBFA-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
109690,6vxx,DB15143,-7.6,PF-06650833,JKDGKIBAOAFRPJ-ZBINZKHDSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109680,6vxx,DB15123,-7.6,Dorzagliatin,HMUMWSORCUWQJO-QAPCUYQASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
153683,6wiq,DB06997,-7.6,"2-(4-fluorophenyl)-N-{[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]carbamoyl}acetamide",BMPOCDJEXAXXEZ-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
74500,6m2n,DB03435,-7.6,Uridine-5'-Diphosphate,XCCTYIAWTASOJW-XVFCMESISA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
165346,7bv1,DB11964,-7.6,Ilaprazole,HRRXCXABAPSOCP-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
54169,2fxp,DB14128,-7.6,Nadide,BAWFJGJZGIEFAR-NNYOXOHSSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
109978,6vxx,DB00664,-7.6,Sulfametopyrazine,KXRZBTAEDBELFD-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
9929,6lzg,DB08068,-7.6,N-[4-CHLORO-3-(PYRIDIN-3-YLOXYMETHYL)-PHENYL]-3-FLUORO-,YQJVDUKATDECHF-ICSRJNTNSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
153638,6wiq,DB06938,-7.6,4-[[2-[[4-chloro-3-(trifluoromethyl)phenyl]amino]-3H-benzimidazol-5-yl]oxy]-N-methyl-pyridine-2-carboxamide,ZJLSMLDOCGOURY-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
64586,6lxt,DB01708,-7.6,Prasterone,FMGSKLZLMKYGDP-USOAJAOKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
96865,6m71,DB13551,-7.6,Cinchophen,YTRMTPPVNRALON-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
109960,6vxx,DB00640,-7.6,Adenosine,OIRDTQYFTABQOQ-KQYNXXCUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
96867,6m71,DB13553,-7.6,Carumonam,UIMOJFJSJSIGLV-JNHMLNOCSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
119460,6w4b,DB07333,-7.6,"N-(CYCLOPROPYLMETHYL)-4-(METHYLOXY)-3-({5-[3-(3-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-YL}AMINO)BENZENESULFONAMIDE",KRGKAARWVPUWSY-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
119461,6w4b,DB07334,-7.6,"N-[5-(ETHYLSULFONYL)-2-METHOXYPHENYL]-5-[3-(2-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-AMINE",HTIZPBXCJPQDEM-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
67774,6lxt,DB07143,-7.6,D-phenylalanyl-N-benzyl-L-prolinamide,MEPJWLFTTFHOQO-MOPGFXCFSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
119463,6w4b,DB07337,-7.6,"4-[4-AMINO-6-(5-CHLORO-1H-INDOL-4-YLMETHYL)-[1,3,5]TRIAZIN-2-YLAMINO]-BENZONITRILE",SOKOHDQTKSROQZ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
64571,6lxt,DB01689,-7.6,Inhibitor Idd 384,CJKKMQCZOLCXAM-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
145676,6w9q,DB07630,-7.6,"N-((1R,2R)-2-(5-CHLORO-1H-INDOLE-2-CARBOXAMIDO)CYCLOHEXYL)-5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE-2-CARBOXAMIDE",ARPFWVKYXJZULB-IAGOWNOFSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
153654,6wiq,DB06963,-7.6,"3-[3-(3-methyl-6-{[(1S)-1-phenylethyl]amino}-1H-pyrazolo[4,3-c]pyridin-1-yl)phenyl]propanamide",ZFGCLYUGFRNYFE-INIZCTEOSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
96892,6m71,DB13591,-7.6,Metopimazine,BQDBKDMTIJBJLA-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
67779,6lxt,DB07148,-7.6,"(6S)-1-chloro-3-[(4-fluorobenzyl)oxy]-6-(pyrrolidin-1-ylcarbonyl)pyrrolo[1,2-a]pyrazin-4(6H)-one",HPAFVLDARQIHPU-HNNXBMFYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
77736,6m2n,DB08736,-7.6,"S,R-Warfarin alcohol",ZUJMMGHIYSAEOU-DOMZBBRYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
165372,7bv1,DB12005,-7.6,Nirogacestat,VFCRKLWBYMDAED-REWPJTCUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96936,6m71,DB13651,-7.6,Lorajmine,LAHDERDHXJFFJU-ZWNKPRIXSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96940,6m71,DB13656,-7.6,Eberconazole,MPTJIDOGFUQSQH-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
109945,6vxx,DB00622,-7.6,Nicardipine,ZBBHBTPTTSWHBA-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
119500,6w4b,DB07382,-7.6,"N-2-1H-benzimidazol-5-yl-N-4-(3-cyclopropyl-1H-pyrazol-5-yl)pyrimidine-2,4-diamine",WJNBSTLIALIIEW-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
165358,7bv1,DB11985,-7.6,Dapaconazole,FUAHXHWSMYFWGE-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
64521,6lxt,DB01624,-7.6,Zuclopenthixol,WFPIAZLQTJBIFN-DVZOWYKESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
119519,6w4b,DB07404,-7.6,"(1-HYDROXY-1-PHOSPHONO-2-[1,1';3',1'']TERPHENYL-3-YL-ETHYL)-PHOSPHONIC ACID",YXQQNSYZOQHKHD-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
77788,6m2n,DB08794,-7.6,Ethyl biscoumacetate,JCLHQFUTFHUXNN-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77790,6m2n,DB08796,-7.6,Pipazethate,DTVJXCOMJLLMAK-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
145606,6w9q,DB07545,-7.6,N-{3-[(4-{[3-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-2-YL)AMINO]PHENYL}CYCLOPROPANECARBOXAMIDE,RDTDWGQDFJPTPD-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
9953,6lzg,DB08094,-7.6,"(4-AMINO-2-{[1-(METHYLSULFONYL)PIPERIDIN-4-YL]AMINO}PYRIMIDIN-5-YL)(2,3-DIFLUORO-6-METHOXYPHENYL)METHANONE",JRNJNYBQQYBCLE-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
145592,6w9q,DB07530,-7.6,"(1R,3R)-5-[(2E)-3-{(1S,3R)-2,2,3-trimethyl-3-[6,6,6-trifluoro-5-hydroxy-5-(trifluoromethyl)hex-3-yn-1-yl]cyclopentyl}prop-2-en-1-ylidene]cyclohexane-1,3-diol",PCHUQQNKOFNVDU-OSXMSNBXSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
64418,6lxt,DB01503,-7.6,1-Androstenediol,RZFGPAMUAXASRE-YSZCXEEOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
77900,6m2n,DB08965,-7.6,Fusafungine,MIZMDSVSLSIMSC-OGLSAIDSSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
109664,6vxx,DB15096,-7.6,18-methoxycoronaridine,DTJQBBHYRQYDEG-SVBQBFEESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31163,6cs2,DB13484,-7.6,Quinbolone,IUVKMZGDUIUOCP-BTNSXGMBSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
145311,6w9q,DB07203,-7.6,6-CYCLOHEXYLMETHOXY-2-(3'-CHLOROANILINO) PURINE,OUEGMEMDEAOAEG-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
97221,6m71,DB14125,-7.6,Benazeprilat,MADRIHWFJGRSBP-ROUUACIJSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
145307,6w9q,DB07198,-7.6,5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-CARBONITRILE,GGEKOZPXKBYLNK-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
109413,6vxx,DB13541,-7.6,Iprazochrome,XZKVIDLLLOUTSS-ZSOIEALJSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
67883,6lxt,DB07271,-7.6,"4-[(3R)-3-Amino-4-(2,4,5-trifluorophenyl)butanoyl]-3-(2,2,2-trifluoroethyl)-1,4-diazepan-2-one",RMDAPSXWBVPVOG-IAPIXIRKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
97278,6m71,DB14540,-7.6,Hydrocortisone butyrate,BMCQMVFGOVHVNG-TUFAYURCSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
10168,6lzg,DB08331,-7.6,"N-1H-imidazol-2-yl-N'-[4-(1H-imidazol-2-ylamino)phenyl]benzene-1,4-diamine",JHMXUERQMCJRHG-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
145275,6w9q,DB07162,-7.6,4-(3-amino-1H-indazol-5-yl)-N-tert-butylbenzenesulfonamide,KFJCXIOVAGJCKB-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
67898,6lxt,DB07287,-7.6,"2-(2,4-DICHLOROPHENOXY)-5-(PYRIDIN-2-YLMETHYL)PHENOL",AOVDSWPGWPRTSR-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
165238,7bv1,DB11638,-7.6,Artenimol,BJDCWCLMFKKGEE-HVDUHBCDSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97302,6m71,DB14626,-7.6,Pregnenolone acetate,CRRKVZVYZQXICQ-RJJCNJEVSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
119885,6w4b,DB07834,-7.6,"N-(cyclopropylmethyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-4-carboxamide",FOHZGCHKLPIBBX-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
145261,6w9q,DB07145,-7.6,(2R)-N-HYDROXY-2-[(3S)-3-METHYL-3-{4-[(2-METHYLQUINOLIN-4-YL)METHOXY]PHENYL}-2-OXOPYRROLIDIN-1-YL]PROPANAMIDE,YDMIPBHQKFOFQW-NSYGIPOTSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
54441,2fxp,DB15036,-7.6,Sitravatinib,WLAVZAAODLTUSW-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
119903,6w4b,DB07856,-7.6,6-{4-[4-(4-CHLOROPHENYL)PIPERIDIN-4-YL]PHENYL}-9H-PURINE,HPWBHQIUIBFTQC-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
97315,6m71,DB14639,-7.6,Boldenone undecylenate,AHMMSNQYOPMLSX-CNQKSJKFSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
54446,2fxp,DB15047,-7.6,BMS-919373,XGKULQQVQWCASY-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
97319,6m71,DB14644,-7.6,Methylprednisolone hemisuccinate,IMBXEJJVJRTNOW-XYMSELFBSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97323,6m71,DB14648,-7.6,Acetyl simvastatin,OHVWRJDVJRNCPE-BIKFJBPRSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97332,6m71,DB14657,-7.6,Paramethasone acetate,HYRKAAMZBDSJFJ-LFDBJOOHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
78032,6m2n,DB09180,-7.6,Thienylfentanyl,YMRFZDHYDKZXPA-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
109364,6vxx,DB13472,-7.6,Cyclofenil,GVOUFPWUYJWQSK-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78039,6m2n,DB09187,-7.6,Lortalamine,MJRPHRMGEKCADU-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
97345,6m71,DB14671,-7.6,Temazepam acetate,PTWWAHZQIATUFG-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
74414,6m2n,DB03315,-7.6,Guanosine 3'-monophosphate,ZDPUTNZENXVHJC-UUOKFMHZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
97348,6m71,DB14674,-7.6,Estramustine phosphate,ADFOJJHRTBFFOF-RBRWEJTLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
109355,6vxx,DB13459,-7.6,Pecilocin,ZYPGADGCNXOUJP-CXVPHVKISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
97365,6m71,DB14720,-7.6,Brovanexine,DQTRREPKGJIABH-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
91510,6m71,DB03157,-7.6,"N,O-Didansyl-L-Tyrosine",LUBOPDUYHWABFG-NDEPHWFRSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
10163,6lzg,DB08325,-7.6,2-(2-HYDROXYETHYLAMINO)-6-(3-CHLOROANILINO)-9-ISOPROPYLPURINE,XZEFMZCNXDQXOZ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
119841,6w4b,DB07787,-7.6,"5-FLUORO-1-[4-(4-PHENYL-3,6-DIHYDROPYRIDIN-1(2H)-YL)BUTYL]QUINAZOLINE-2,4(1H,3H)-DIONE",PNPFDRCIGCUCMN-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
64350,6lxt,DB01426,-7.6,Ajmaline,CJDRUOGAGYHKKD-HEFSZTOGSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
31123,6cs2,DB13434,-7.6,Fenticonazole,ZCJYUTQZBAIHBS-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
67835,6lxt,DB07215,-7.6,"2-METHYL-2-(4-{[({4-METHYL-2-[4-(TRIFLUOROMETHYL)PHENYL]-1,3-THIAZOL-5-YL}CARBONYL)AMINO]METHYL}PHENOXY)PROPANOIC ACID",ILUPZUOBHCUBKB-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
37350,1r42,DB04154,-7.6,"N-Methyl-N-[3-(6-Phenyl[1,2,4]Triazolo[4,3-B]Pyridazin-3-Yl)Phenyl]Acetamide",ALBWBHNFOJJMCV-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
91572,6m71,DB03235,-7.6,N-{3-[4-(3-aminopropyl)piperazin-1-yl]propyl}-3-(alpha-D-galactopyranosyloxy)-5-nitrobenzamide,UEIGEWJJVQHIAX-MKQKURRLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
165273,7bv1,DB11689,-7.6,Selumetinib,CYOHGALHFOKKQC-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
77917,6m2n,DB08984,-7.6,Etofenamate,XILVEPYQJIOVNB-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
109607,6vxx,DB14471,-7.6,2-Ethylhexyl 4-phenylbenzophenone-2'-carboxylate,TWAOKHHZKFMFMD-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109606,6vxx,DB14232,-7.6,Deacetylbisacodyl,LJROKJGQSPMTKB-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109593,6vxx,DB14201,-7.6,"2,2'-Dibenzothiazyl disulfide",AFZSMODLJJCVPP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77927,6m2n,DB08994,-7.6,Ditazole,UUCMDZWCRNZCOY-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
145406,6w9q,DB07311,-7.6,"18-CHLORO-11,12,13,14-TETRAHYDRO-1H,10H-8,4-(AZENO)-9,15,1,3,6-BENZODIOXATRIAZACYCLOHEPTADECIN-2-ONE",JRSWWYITYIOHOP-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
31141,6cs2,DB13457,-7.6,Oxaflozane,FVYUQFQCEOZYHZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
109542,6vxx,DB14082,-7.6,Betiatide,VDPYMEBVIDZKMD-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
145383,6w9q,DB07287,-7.6,"2-(2,4-DICHLOROPHENOXY)-5-(PYRIDIN-2-YLMETHYL)PHENOL",AOVDSWPGWPRTSR-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
65319,6lxt,DB02675,-7.6,(4-Hydroxymaltosephenyl)Glycine,PHPOPZGUOBMSPZ-QHJSCRBTSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
145380,6w9q,DB07284,-7.6,"N-3-(3-PYRIDIN-3-YLBENZYL)PYRIDINE-2,3-DIAMINE",NQSBHBFOOVYRNM-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
31151,6cs2,DB13470,-7.6,Cefodizime,XDZKBRJLTGRPSS-BGZQYGJUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
67848,6lxt,DB07230,-7.6,3-BROMO-6-HYDROXY-2-(4-HYDROXYPHENYL)-1H-INDEN-1-ONE,DHPCBFMFERFZLR-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
119770,6w4b,DB07704,-7.6,"6-AMINO-4-[2-(4-METHOXYPHENYL)ETHYL]-1,7-DIHYDRO-8H-IMIDAZO[4,5-G]QUINAZOLIN-8-ONE",UKRVQKUVWNDGMN-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
97177,6m71,DB14034,-7.6,Darglitazone,QQKNSPHAFATFNQ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
145364,6w9q,DB07267,-7.6,2-(6-methylpyridin-2-yl)-N-pyridin-4-ylquinazolin-4-amine,JONFDFIXMPXTRH-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
77939,6m2n,DB09008,-7.6,Cefaloridine,CZTQZXZIADLWOZ-CRAIPNDOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
109505,6vxx,DB14013,-7.6,SR-9009,MMJJNHOIVCGAAP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
145354,6w9q,DB07255,-7.6,"N'-(5-CHLORO-1,3-BENZODIOXOL-4-YL)-N-(3-MORPHOLIN-4-YLPHENYL)PYRIMIDINE-2,4-DIAMINE",PNEWIQAEGKQNCE-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
10141,6lzg,DB08303,-7.6,"(3S)-3-cyclopentyl-6-methyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide",CUMKMTBOHBENJI-SFHVURJKSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
97186,6m71,DB14055,-7.6,(S)-Warfarin,PJVWKTKQMONHTI-HNNXBMFYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
54374,2fxp,DB14870,-7.6,PF-5190457,ZIUDADZJCKGWKR-AREMUKBSSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
74456,6m2n,DB03370,-7.6,FR239087,HCJYSIGJDKNVRU-TVQRCGJNSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
97196,6m71,DB14069,-7.6,ONT-093,RSJCLODJSVZNQA-BQYQJAHWSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
91522,6m71,DB03173,-7.6,CRA_10433,CFSQPEBVGUSQII-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
77931,6m2n,DB08998,-7.6,Demexiptiline,SEDQWOMFMIJKCU-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
164932,7bv1,DB08976,-7.6,Floctafenine,APQPGQGAWABJLN-GFCCVEGCSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
67279,6lxt,DB06313,-7.6,BNC105,MYDHDVLPMRNDAZ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
117827,6w4b,DB04006,-7.6,"[2-Amino-6-(2,6-Difluoro-Benzoyl)-Imidazo[1,2-a]Pyridin-3-Yl]-Phenyl-Methanone",WUGJIPFLBOATGL-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
113415,6vxx,DB09166,-7.6,Etizolam,VMZUTJCNQWMAGF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113414,6vxx,DB09151,-7.6,Flutemetamol (18F),VVECGOCJFKTUAX-HUYCHCPVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
94236,6m71,DB07874,-7.6,"(6S)-2-amino-6-(3'-methoxybiphenyl-3-yl)-3,6-dimethyl-5,6-dihydropyrimidin-4(3H)-one",LQOCXPOKEPYGTJ-IBGZPJMESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
114622,6vxx,DB13873,-7.6,Fenofibric acid,MQOBSOSZFYZQOK-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
66083,6lxt,DB03719,-7.6,N-Ethyl-5'-Carboxamido Adenosine,JADDQZYHOWSFJD-BMYQGPEFSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
75954,6m2n,DB06499,-7.6,Furaprofen,ODZUWQAFWMLWCF-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
113389,6vxx,DB09091,-7.6,Tixocortol,YWDBSCORAARPPF-VWUMJDOOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
149935,6wiq,DB00764,-7.6,Mometasone,QLIIKPVHVRXHRI-CXSFZGCWSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
94241,6m71,DB07879,-7.6,"N-hydroxy-5-[(3-phenyl-5,6-dihydroimidazo[1,2-a]pyrazin-7(8H)-yl)carbonyl]thiophene-2-carboxamide",SMSIXMLQOONOQQ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
148319,6w9q,DB13291,-7.6,Cloridarol,KBFBRIPYVVGWRS-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
114640,6vxx,DB13937,-7.6,LGD-3303,OMXGOGXEWUCLFI-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
149988,6wiq,DB00826,-7.6,Natamycin,NCXMLFZGDNKEPB-FFPOYIOWSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
113370,6vxx,DB09068,-7.6,Vortioxetine,YQNWZWMKLDQSAC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113366,6vxx,DB09061,-7.6,Cannabidiol,QHMBSVQNZZTUGM-ZWKOTPCHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75966,6m2n,DB06530,-7.6,Resiquimod,BXNMTOQRYBFHNZ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
94283,6m71,DB07933,-7.6,Erteberel,XIESSJVMWNJCGZ-VKJFTORMSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
149999,6wiq,DB00838,-7.6,Clocortolone,YMTMADLUXIRMGX-RFPWEZLHSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
114681,6vxx,DB14643,-7.6,Methylprednisolone aceponate,DALKLAYLIPSCQL-YPYQNWSCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113344,6vxx,DB09017,-7.6,Brotizolam,UMSGKTJDUHERQW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114693,6vxx,DB14655,-7.6,Drostanolone propionate,NOTIQUSPUUHHEH-UXOVVSIBSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29718,6cs2,DB11462,-7.6,Sulfaethoxypyridazine,FFJIWWBSBCOKLS-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
29714,6cs2,DB11457,-7.6,Rotenone,JUVIOZPCNVVQFO-HBGVWJBISA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
114719,6vxx,DB14682,-7.6,Dextrorphan,JAQUASYNZVUNQP-PVAVHDDUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
94308,6m71,DB07963,-7.6,"N-[(2',4'-DIFLUORO-4-HYDROXY-5-IODOBIPHENYL-3-YL)CARBONYL]-BETA-ALANINE",YZQVXOZCPWWABX-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93215,6m71,DB06604,-7.6,Ilepatril,FXKFFTMLFPWYFH-RDGPPVDQSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
66036,6lxt,DB03656,-7.6,Tribenuron Methyl,VLCQZHSMCYCDJL-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
148201,6w9q,DB13089,-7.6,Enoxolone,MPDGHEJMBKOTSU-YKLVYJNSSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
66786,6lxt,DB04643,-7.6,"4-{3-CHLORO-4-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-PHENOXY}-BUTYRIC ACID",FYQVFMLCZJZZEM-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
76042,6m2n,DB06702,-7.6,Fesoterodine,DCCSDBARQIPTGU-HSZRJFAPSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
94220,6m71,DB07858,-7.6,(2S)-2-(4-chlorophenyl)-2-[4-(1H-pyrazol-4-yl)phenyl]ethanamine,HWVGILTYGZFGLR-KRWDZBQOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
148194,6w9q,DB13078,-7.6,KOSN-1724,JAYGOFBXDFAXBW-CYEKYUJNSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
8659,6lzg,DB06624,-7.6,Taranabant,QLYKJCMUNUWAGO-GAJHUEQPSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
75938,6m2n,DB06460,-7.6,Enrasentan,GLCKXJLCYIJMRB-UPRLRBBYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
66182,6lxt,DB03837,-7.6,Morpholine-4-Carboxylic Acid (1-(3-Benzenesulfonyl-1-Phenethylallylcarbamoyl)-3-Methylbutyl)-Amide,YUMYYTORLYHUFW-ZUDLOMHPSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
114529,6vxx,DB13752,-7.6,Tetramethrin,CXBMCYHAMVGWJQ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
94096,6m71,DB07717,-7.6,"(5S,8R,9S,10S,13R,14S,17S)-13-{2-[(3,5-DIFLUOROBENZYL)OXY]ETHYL}-17-HYDROXY-10-METHYLHEXADECAHYDRO-3H-CYCLOPENTA[A]PHENANTHREN-3-ONE",AJODXHGZHBERGJ-JLYQOUBASA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93322,6m71,DB06800,-7.6,Methylnaltrexone,JVLBPIPGETUEET-WIXLDOGYSA-O,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
114536,6vxx,DB13759,-7.6,Fenpiverinium,QDIYJDPBMZUZEH-UHFFFAOYSA-O,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114541,6vxx,DB13767,-7.6,Vorozole,XLMPPFTZALNBFS-INIZCTEOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
94124,6m71,DB07750,-7.6,"(2R)-1-[4-({4-[(2,5-Dichlorophenyl)amino]-2-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol",GNLAGGCSJGJECE-MRXNPFEDSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
148516,6w9q,DB13551,-7.6,Cinchophen,YTRMTPPVNRALON-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
166431,7bv1,DB15120,-7.6,GSK-239512,YFRBKEVUUCQYOW-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
8648,6lzg,DB06605,-7.6,Apixaban,QNZCBYKSOIHPEH-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
114561,6vxx,DB13792,-7.6,Clopamide,LBXHRAWDUMTPSE-AOOOYVTPSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
94137,6m71,DB07764,-7.6,FLUORESCIN,MURGITYSBWUQTI-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94148,6m71,DB07778,-7.6,FAMOXADONE,PCCSBWNGDMYFCW-QFIPXVFZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93273,6m71,DB06713,-7.6,Norelgestromin,ISHXLNHNDMZNMC-XUDSTZEESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94157,6m71,DB07788,-7.6,"(3R,5Z,8S,9S,11E)-8,9,16-TRIHYDROXY-14-METHOXY-3-METHYL-3,4,9,10-TETRAHYDRO-1H-2-BENZOXACYCLOTETRADECINE-1,7(8H)-DIONE",NEQZWEXWOFPKOT-QHSZRYGNSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
114578,6vxx,DB13815,-7.6,Xenysalate,HLDCSYXMVXILQC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
8097,6lzg,DB00543,-7.6,Amoxapine,QWGDMFLQWFTERH-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
21109,6cs2,HMDB0001170,-7.6,Lathosterol,IZVFFXVYBHFIHY-SKCNUYALSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
94164,6m71,DB07795,-7.6,Fisetin,XHEFDIBZLJXQHF-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
113428,6vxx,DB09180,-7.6,Thienylfentanyl,YMRFZDHYDKZXPA-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
66125,6lxt,DB03768,-7.6,"N-[2-Hydroxy-2-(8-Isopropyl-6,9-Dioxo-2-Oxa-7,10-Diaza-Bicyclo[11.2.2]Heptadeca-1(16),13(17),14-Trien-11-Yl)-Ethyl]-N-(3-Methyl-Butyl)-Benzenesulfonamide,Inhibitor 3",WRUVOSYKHXGAQN-GKRYNVPLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
166425,7bv1,DB15108,-7.6,Tipranavir C-14,SUJUHGSWHZTSEU-MWQIXQBFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94182,6m71,DB07814,-7.6,Gibberellic acid,IXORZMNAPKEEDV-OBDJNFEBSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
30116,6cs2,DB12072,-7.6,Orantinib,NHFDRBXTEDBWCZ-ZROIWOOFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
166422,7bv1,DB15102,-7.6,Pemigatinib,HCDMJFOHIXMBOV-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
8656,6lzg,DB06620,-7.6,Aplindore,DYJIKHYBKVODAC-ZDUSSCGKSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
113423,6vxx,DB09174,-7.6,Lofentanil,IMYHGORQCPYVBZ-NLFFAJNJSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
93260,6m71,DB06697,-7.6,Artemether,SXYIRMFQILZOAM-HVNFFKDJSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
75934,6m2n,DB06454,-7.6,Sarizotan,HKFMQJUJWSFOLY-OAQYLSRUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
148383,6w9q,DB13368,-7.6,Motretinide,IYIYMCASGKQOCZ-DJRRULDNSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
149793,6wiq,DB00591,-7.6,Fluocinolone acetonide,FEBLZLNTKCEFIT-VSXGLTOVSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
66029,6lxt,DB03647,-7.6,3-[Isopropyl(4-Methylbenzoyl)Amino]-5-Phenylthiophene-2-Carboxylic Acid,LRHXIDOGMBZJFN-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
94327,6m71,DB07984,-7.6,2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]-n-[(1S)-1-(hydroxymethyl)propyl]acetamide,GKJWXEORYGBJFS-KRWDZBQOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
113122,6vxx,DB08562,-7.6,4-(4-STYRYL-PHENYLCARBAMOYL)-BUTYRIC ACID,FTXJWRRYLLRFMG-MDZDMXLPSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
166305,7bv1,DB14636,-7.6,Triciribine phosphate,URLYINUFLXOMHP-HTVVRFAVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93134,6m71,DB06401,-7.6,Bazedoxifene,UCJGJABZCDBEDK-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
65945,6lxt,DB03515,-7.6,Equilenin,PDRGHUMCVRDZLQ-WMZOPIPTSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
113100,6vxx,DB08537,-7.6,"3-bromo-6-phenyl-N-(pyrimidin-5-ylmethyl)imidazo[1,2-a]pyridin-8-amine",LZLKFNBMXXLTLX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
147967,6w9q,DB12720,-7.6,Nivocasan,VYFGDLGHHBUDTQ-ZLGUVYLKSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
150295,6wiq,DB01177,-7.6,Idarubicin,XDXDZDZNSLXDNA-TZNDIEGXSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
8779,6lzg,DB06827,-7.6,Viomycin,GXFAIFRPOKBQRV-GHXCTMGLSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
30259,6cs2,DB12262,-7.6,CRS-3123,NNTYBKTXMKBRFA-CQSZACIVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
166300,7bv1,DB14631,-7.6,Prednisolone phosphate,JDOZJEUDSLGTLU-VWUMJDOOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
8793,6lzg,DB06844,-7.6,"4-[(7-OXO-7H-THIAZOLO[5,4-E]INDOL-8-YLMETHYL)-AMINO]-N-PYRIDIN-2-YL-BENZENESULFONAMIDE",MBXKBJLIESPLIK-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
94447,6m71,DB08118,-7.6,"2-(methylamino)-N-(4-methyl-1,3-thiazol-2-yl)-5-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]benzamide",XRJAKERBMMBUGR-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
30261,6cs2,DB12264,-7.6,Atevirdine,UCPOMLWZWRTIAA-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
29664,6cs2,DB11376,-7.6,Azaperone,XTKDAFGWCDAMPY-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
76178,6m2n,DB06903,-7.6,"(1S,3aS,5aR,8aS)-1,7,7-trimethyl-1,2,3,3a,5a,6,7,8-octahydrocyclopenta[c]pentalene-4-carboxylic acid",DCFDRCCHOOORSB-JOXOIDLHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
66867,6lxt,DB04759,-7.6,"PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-(3-METHYL-BENZYLAMIDE)",GTBUZLPQANSGGE-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
94452,6m71,DB08123,-7.6,"N-METHYL-{4-[2-(7-OXO-6,7-DIHYDRO-8H-[1,3]THIAZOLO[5,4-E]INDOL-8-YLIDENE)HYDRAZINO]PHENYL}METHANESULFONAMIDE",GEWPSTLKJDIUHW-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
66869,6lxt,DB04761,-7.6,"PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-[(PYRIDIN-3-YLMETHYL)-AMIDE]",NHPBWKYFMTXWAA-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
147928,6w9q,DB12663,-7.6,Letrazuril,XQKYUBTUOHHNDV-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
166295,7bv1,DB14626,-7.6,Pregnenolone acetate,CRRKVZVYZQXICQ-RJJCNJEVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
113049,6vxx,DB08312,-7.6,"6-CYCLOHEXYLMETHYLOXY-5-NITROSO-PYRIMIDINE-2,4-DIAMINE",DGWXOLHKVGDQLN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76181,6m2n,DB06907,-7.6,"2-(2,6-DICHLOROPHENYL)-1,3-BENZOXAZOLE-6-CARBOXYLIC ACID",XVNRKPCHMYOPPL-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
113046,6vxx,DB08308,-7.6,"SUCCINIC ACID MONO-(13-METHYL-3-OXO-2,3,6,7,8,9,10,11,12,13,14,15,16,17-TETRADECAHYDRO-1H-CYCLOPENTA[A]PHENANTHREN-17-YL) ESTER",IRQUJNVGEAJGSD-KIEDKLRZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
147918,6w9q,DB12649,-7.6,Ibipinabant,AXJQVVLKUYCICH-OAQYLSRUSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
8800,6lzg,DB00158,-7.6,Folic acid,OVBPIULPVIDEAO-LBPRGKRZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
113036,6vxx,DB08297,-7.6,ORTHONITROPHENYL-BETA-D-FUCOPYRANOSIDE,SWRPIVXPHLYETN-BVWHHUJWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
94461,6m71,DB08133,-7.6,N-(4-sulfamoylphenyl)-1H-indazole-3-carboxamide,MNHPHKFLWAPNOV-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
147890,6w9q,DB12598,-7.6,Nafamostat,MQQNFDZXWVTQEH-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
93077,6m71,DB06235,-7.6,Vadimezan,XGOYIMQSIKSOBS-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
113124,6vxx,DB08568,-7.6,(2S)-1-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}-3-PHENYLPROPAN-2-AMINE,BPNUQXPIQBZCMR-IBGZPJMESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
148176,6w9q,DB13053,-7.6,CP-195543,NZQDWKCNBOELAI-KSFYIVLOSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
113130,6vxx,DB08574,-7.6,"(5R)-2-SULFANYL-5-[4-(TRIFLUOROMETHYL)BENZYL]-1,3-THIAZOL-4-ONE",HBYVUUWMCCSRBI-MRVPVSSYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114983,6w4b,DB00307,-7.6,Bexarotene,NAVMQTYZDKMPEU-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
66794,6lxt,DB04652,-7.6,Corticosterone,OMFXVFTZEKFJBZ-HJTSIMOOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
66012,6lxt,DB03622,-7.6,"2-Hydroxy-5-[4-(2-Hydroxy-Ethyl)-Piperidin-1-Yl]-5-Phenyl-1h-Pyrimidine-4,6-Dione",IPBPOBHSNJFRFT-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
114774,6vxx,DB14835,-7.6,SUVN-G3031,LNXDUSQEXVQFGP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114782,6vxx,DB14854,-7.6,TC-6987,UAKZGMMGIMKFMV-RBUKOAKNSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114794,6vxx,DB14875,-7.6,AZD-4017,NCDZABJPWMBMIQ-INIZCTEOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76077,6m2n,DB06751,-7.6,Drotaverine,OMFNSKIUKYOYRG-MOSHPQCFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
113282,6vxx,DB08753,-7.6,"4-{(1E)-3-OXO-3-[(2-PHENYLETHYL)AMINO]PROP-1-EN-1-YL}-1,2-PHENYLENE DIACETATE",GARHCDOTUULBOQ-PKNBQFBNSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113280,6vxx,DB08751,-7.6,"N,N'-DIMETHYL-N-(ACETYL)-N'-(7-NITROBENZ-2-OXA-1,3-DIAZOL-4-YL)ETHYLENEDIAMINE",YSVJZZZGPPWEIC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113272,6vxx,DB08743,-7.6,"2-({8-[(3R)-3-AMINOPIPERIDIN-1-YL]-1,3-DIMETHYL-2,6-DIOXO-1,2,3,6-TETRAHYDRO-7H-PURIN-7-YL}METHYL)BENZONITRILE",XJNKUWDMCBZMTG-OAHLLOKOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113270,6vxx,DB08741,-7.6,"5-[[(2R)-2-cyclopropyl-7,8-dimethoxy-2H-chromen-5-yl]methyl]pyrimidine-2,4-diamine",HWJPWWYTGBZDEG-AWEZNQCLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114828,6vxx,DB14938,-7.6,Flurbiprofen axetil,ALIVXCSEERJYHU-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113263,6vxx,DB08734,-7.6,"6,6-DIMETHYL-1-[3-(2,4,5-TRICHLOROPHENOXY)PROPOXY]-1,6-DIHYDRO-1,3,5-TRIAZINE-2,4-DIAMINE",MJZJYWCQPMNPRM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
150137,6wiq,DB00997,-7.6,Doxorubicin,AOJJSUZBOXZQNB-TZSSRYMLSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
113245,6vxx,DB08715,-7.6,"2,6-DIMETHYL-1-(3-[3-METHYL-5-ISOXAZOLYL]-PROPANYL)-4-[2-METHYL-4-ISOXAZOLYL]-PHENOL",SLPKYEWAKMNCPT-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
7937,6lzg,DB04563,-7.6,CRA_9678,VIZNZQTZRMTYPZ-UHFFFAOYSA-M,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
8724,6lzg,DB06732,-7.6,beta-Naphthoflavone,OUGIDAPQYNCXRA-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
93166,6m71,DB06472,-7.6,Fradafiban,IKZACQMAVUIGPY-HOTGVXAUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
14231,6lzg,T3D3863,-7.6,Imazaquin,CABMTIJINOIHOD-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
150164,6wiq,DB01026,-7.6,Ketoconazole,XMAYWYJOQHXEEK-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
114893,6vxx,DB15347,-7.6,Branebrutinib,VJPPLCNBDLZIFG-ZDUSSCGKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
148059,6w9q,DB12877,-7.6,Oxatomide,BAINIUMDFURPJM-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
23353,6cs2,HMDB0061014,-7.6,para-hydroxyatorvastatin,SOZOATLLFFVAPM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
114905,6vxx,DB15381,-7.6,Menaquinone,HYPYXGZDOYTYDR-HAJWAVTHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29677,6cs2,DB11395,-7.6,Deracoxib,WAZQAZKAZLXFMK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
150203,6wiq,DB01070,-7.6,Dihydrotachysterol,ILYCWAKSDCYMBB-OPCMSESCSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
114944,6vxx,DB15457,-7.6,Snubh-nm-333 F-18,QLWFXLJVGCECSV-HUYCHCPVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
166314,7bv1,DB14646,-7.6,Prednisone acetate,MOVRKLZUVNCBIP-RFZYENFJSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94391,6m71,DB08055,-7.6,"N-(2-chlorophenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine",NNBICZMPIJMWGC-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
150218,6wiq,DB01089,-7.6,Deserpidine,CVBMAZKKCSYWQR-WCGOZPBSSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
113133,6vxx,DB08577,-7.6,3-[(3-(2-CARBOXYETHYL)-4-METHYLPYRROL-2-YL)METHYLENE]-2-INDOLINONE,JNDVEAXZWJIOKB-JYRVWZFOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112988,6vxx,DB08234,-7.6,"5-[3-(2,5-dimethoxyphenyl)prop-1-yn-1-yl]-6-ethylpyrimidine-2,4-diamine",NNFDQABYXZBKRK-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114523,6vxx,DB13739,-7.6,Penamecillin,NLOOMWLTUVBWAW-HLLBOEOZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113516,6vxx,DB09292,-7.6,Sacubitril,PYNXFZCZUAOOQC-UTKZUKDTSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
93579,6m71,DB07113,-7.6,"(2S)-6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2-(3,5-DIFLUOROPHENYL)-4-(3-METHOXYPROPYL)-2H-1,4-BENZOXAZIN-3(4H)-ONE",KHZQOXQOUCGGGA-NRFANRHFSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
14353,6lzg,T3D4019,-7.6,Paclitaxel,RCINICONZNJXQF-MZXODVADSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
8382,6lzg,DB05706,-7.6,13-deoxydoxorubicin,RGVRUQHYQSORBY-JIGXQNLBSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
75689,6m2n,DB05421,-7.6,CP-122721,ZIWFCOIGUNPHPM-HKUYNNGSSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
114094,6vxx,DB12717,-7.6,Mibampator,ULRDYYKSPCRXAJ-KRWDZBQOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
8269,6lzg,DB05105,-7.6,Pleconaril,KQOXLKOJHVFTRN-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
93733,6m71,DB07289,-7.6,5-[3-(BENZYLAMINO)PHENYL]-4-BROMO-3-(CARBOXYMETHOXY)THIOPHENE-2-CARBOXYLIC ACID,XEQPGVUGYAUMSA-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93568,6m71,DB07101,-7.6,PD-0325901,SUDAHWBOROXANE-SECBINFHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93734,6m71,DB07290,-7.6,(2R)-2-{[(4-FLUORO-3-METHYLPHENYL)SULFONYL]AMINO}-N-HYDROXY-2-TETRAHYDRO-2H-PYRAN-4-YLACETAMIDE,LUCFRFDOOYLALP-CYBMUJFWSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
66560,6lxt,DB04342,-7.6,7-((Carboxy(4-Hydroxyphenyl)Acetyl)Amino)-7-Methoxy-(3-((1-Methyl-1h-Tetrazol-5-Yl)Thio)Methyl)-8-Oxo-5-Oxa-1-Azabicyclo[4.2.0]Oct-2-Ene-2-Carboxylic Acid,JWCSIUVGFCSJCK-LIUKBUMOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
75708,6m2n,DB05501,-7.6,AMD-070,WVLHHLRVNDMIAR-IBGZPJMESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
93746,6m71,DB07303,-7.6,"N-3-[3-(5-METHOXYPYRIDIN-3-YL)BENZYL]PYRIDINE-2,3-DIAMINE",PGAWZMRRCVSRIM-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93560,6m71,DB07089,-7.6,N-[amino(imino)methyl]-2-[2-(2-chlorophenyl)-4-(4-propoxyphenyl)-3-thienyl]acetamide,VZSMTBLDWPKVRW-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
166529,7bv1,DB15307,-7.6,Atabecestat,VLLFGVHGKLDDLW-SFHVURJKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
114118,6vxx,DB12752,-7.6,Bucindolol,FBMYKMYQHCBIGU-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
149065,6w9q,DB14844,-7.6,ONC-201,VLULRUCCHYVXOH-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
8399,6lzg,DB05812,-7.6,Abiraterone,GZOSMCIZMLWJML-VJLLXTKPSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
75540,6m2n,DB04836,-7.6,Amineptine,ONNOFKFOZAJDHT-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
29817,6cs2,DB11675,-7.6,Mosapride,YPELFRMCRYSPKZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
8405,6lzg,DB05838,-7.6,OPC-51803,INGXCNVWWKKWOO-LJQANCHMSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
29816,6cs2,DB11674,-7.6,Equol,ADFCQWZHKCXPAJ-GFCCVEGCSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
14396,6lzg,T3D4087,-7.6,Chelidonine,GHKISGDRQRSCII-ZOCIIQOWSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
66392,6lxt,DB04121,-7.6,Guanosine-3'-Monophosphate-5'-Diphosphate,HEYSFDAMRDTCJM-UUOKFMHZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
8416,6lzg,DB05932,-7.6,Denibulin,GAOHLWCIAJNSEE-JTQLQIEISA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
166512,7bv1,DB15281,-7.6,Ravoxertinib,RZUOCXOYPYGSKL-GOSISDBHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
66388,6lxt,DB04114,-7.6,"3-Chloro-9-Ethyl-6,7,8,9,10,11-Hexahydro-7,11-Methanocycloocta[B]Quinolin-12-Amine",QTPHSDHUHXUYFE-NWDGAFQWSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
113833,6vxx,DB12148,-7.6,Menatetrenone,DKHGMERMDICWDU-GHDNBGIDSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113832,6vxx,DB12147,-7.6,Erdafitinib,OLAHOMJCDNXHFI-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75525,6m2n,DB04820,-7.6,Nialamide,NOIIUHRQUVNIDD-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
149316,6w9q,DB15362,-7.6,LSZ-102,SJXNPGGVGZXKKI-NYYWCZLTSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
29809,6cs2,DB11666,-7.6,Buparlisib,CWHUFRVAEUJCEF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
93698,6m71,DB07251,-7.6,"N'-(3-CHLORO-4-METHOXY-PHENYL)-N-(3,4,5-TRIMETHOXYPHENYL)-1,3,5-TRIAZINE-2,4-DIAMINE",ZVWFECUPYCFYBL-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
66527,6lxt,DB04295,-7.6,N-Benzoyl-N'-Beta-D-Glucopyranosyl Urea,JSBCZGSPFATCOV-BZNQNGANSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
93657,6m71,DB07200,-7.6,"(2S,4S,5R)-2-ISOBUTYL-5-(2-THIENYL)-1-[4-(TRIFLUOROMETHYL)BENZOYL]PYRROLIDINE-2,4-DICARBOXYLIC ACID",ZNCZVHCYBGHCHA-XPIZARPCSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
8321,6lzg,DB05414,-7.6,Pipendoxifene,JICOGKJOQXTAIP-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
29900,6cs2,DB11787,-7.6,Ralimetinib,XPPBBJCBDOEXDN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
113963,6vxx,DB12328,-7.6,Cantharidin,DHZBEENLJMYSHQ-XCVPVQRUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114010,6vxx,DB12585,-7.6,Ondelopran,QWNDOCKIKKQJNN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
149207,6w9q,DB15151,-7.6,RO-6870810,PKQXLRYFPSZKDU-QFIPXVFZSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
93645,6m71,DB07186,-7.6,"4-(4-METHYLPIPERAZIN-1-YL)-N-[5-(2-THIENYLACETYL)-1,5-DIHYDROPYRROLO[3,4-C]PYRAZOL-3-YL]BENZAMIDE",TYYNSDQVFIOSFH-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93666,6m71,DB07211,-7.6,(2R)-2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}PROPENE-1-SULFONAMIDE,YMJHMJLNQLVUAV-GHYUOPHCSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
66499,6lxt,DB04259,-7.6,7n-Methyl-8-Hydroguanosine-5'-Monophosphate,ZMWJGXGSWZFZPJ-KQYNXXCUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
75652,6m2n,DB05187,-7.6,Elafibranor,AFLFKFHDSCQHOL-IZZDOVSWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
149190,6w9q,DB15121,-7.6,AT-001,YRGPAXAVTDMKDK-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
149189,6w9q,DB15120,-7.6,GSK-239512,YFRBKEVUUCQYOW-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
66470,6lxt,DB04216,-7.6,Quercetin,REFJWTPEDVJJIY-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
113948,6vxx,DB12310,-7.6,Trehalose,HDTRYLNUVZCQOY-LIZSDCNHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
166584,7bv1,DB15425,-7.6,CYC-065,DLPIYBKBHMZCJI-WBVHZDCISA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
75661,6m2n,DB05253,-7.6,Telapristone acetate,JVBGZFRPTRKSBB-MJBQOYBXSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
114040,6vxx,DB12638,-7.6,PU-H71,SUPVGFZUWFMATN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114042,6vxx,DB12641,-7.6,Tedatioxetine,CVASBKDYSQKLSO-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
8295,6lzg,DB05255,-7.6,Ronacaleret,FQJISUPNMFRIFZ-HXUWFJFHSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
114055,6vxx,DB12661,-7.6,Urapidil,ICMGLRUYEQNHPF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
149280,6w9q,DB15295,-7.6,Tenalisib,HDXDQPRPFRKGKZ-INIZCTEOSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
149282,6w9q,DB15297,-7.6,Petesicatib,KXAAIORSMACJSI-AEFFLSMTSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
149287,6w9q,DB15307,-7.6,Atabecestat,VLLFGVHGKLDDLW-SFHVURJKSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
20,6lzg,HMDB0002326,-7.6,Coumesterol,ZZIALNLLNHEQPJ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
93690,6m71,DB07242,-7.6,"(4R)-7,8-dichloro-1',9-dimethyl-1-oxo-1,2,4,9-tetrahydrospiro[beta-carboline-3,4'-piperidine]-4-carbonitrile",XGUIMGJMQKZRGM-LLVKDONJSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
149137,6w9q,DB15021,-7.6,Leriglitazone,OXVFDZYQLGRLCD-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
113926,6vxx,DB12284,-7.6,LY-2608204,QIIVJLHCZUTGSD-CUBQBAPOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75667,6m2n,DB05271,-7.6,Rotigotine,KFQYTPMOWPVWEJ-INIZCTEOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
114068,6vxx,DB12679,-7.6,WP 1066,VFUAJMPDXIRPKO-LQELWAHVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
93594,6m71,DB07128,-7.6,"N7-BUTYL-N2-(5-CHLORO-2-METHYLPHENYL)-5-METHYL[1,2,4]TRIAZOLO[1,5-A]PYRIMIDINE-2,7-DIAMINE",ZTYBIJUAAWLJNU-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94070,6m71,DB07686,-7.6,"4-{[5-(CYCLOHEXYLAMINO)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE",VPOGRVWIIVMWRI-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
75750,6m2n,DB05737,-7.6,Varespladib methyl,VJYDOJXJUCJUHL-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
166495,7bv1,DB15241,-7.6,Methylsamidorphan,ATCVVCBJNHXIEX-ZAHKBLQYSA-O,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
114387,6vxx,DB13369,-7.6,Benzilone,ZKCWITXZGWUJAV-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75818,6m2n,DB06156,-7.6,Tesofensine,VCVWXKKWDOJNIT-ZOMKSWQUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75482,6m2n,DB04763,-7.6,"1-N-(4-SULFAMOYLPHENYL-ETHYL)-2,4,6-TRIMETHYLPYRIDINIUM",UXBCHTZINZNVRG-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
114403,6vxx,DB13395,-7.6,Eprozinol,QSRHLIUOSXVKTG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29770,6cs2,DB11591,-7.6,Bilastine,ACCMWZWAEFYUGZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
29766,6cs2,DB11577,-7.6,Indigotindisulfonic Acid,CFZXDJWFRVEWSR-BUHFOSPRSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
93969,6m71,DB07563,-7.6,"1-{7-cyclohexyl-6-[4-(4-methylpiperazin-1-yl)benzyl]-7H-pyrrolo[2,3-d]pyrimidin-2-yl}methanamine",GCJSOJRPNOWSEH-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
148752,6w9q,DB13866,-7.6,Etynodiol,JYILPERKVHXLNF-QMNUTNMBSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
93981,6m71,DB07578,-7.6,"3-[4-(2-METHYL-IMIDAZO[4,5-C]PYRIDIN-1-YL)BENZYL]-3H-BENZOTHIAZOL-2-ONE",WUOLYUKMMRCXGH-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
66248,6lxt,DB03925,-7.6,Freselestat,HMPQTEPEMQZWQH-QZTJIDSGSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
113615,6vxx,DB11654,-7.6,T-2000,RRFBTKHQZRCRSS-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113602,6vxx,DB11633,-7.6,Isavuconazole,DDFOUSQFMYRUQK-RCDICMHDSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
149707,6wiq,DB00485,-7.6,Dicloxacillin,YFAGHNZHGGCZAX-JKIFEVAISA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
30066,6cs2,DB12005,-7.6,Nirogacestat,VFCRKLWBYMDAED-REWPJTCUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
94031,6m71,DB07638,-7.6,"(3AS,4R,9BR)-2,2-DIFLUORO-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL",QJSMFUTULGSHNQ-ZOBUZTSGSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
75855,6m2n,DB06235,-7.6,Vadimezan,XGOYIMQSIKSOBS-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
30070,6cs2,DB00912,-7.6,Repaglinide,FAEKWTJYAYMJKF-QHCPKHFHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
113558,6vxx,DB11507,-7.6,Cloprostenol,VJGGHXVGBSZVMZ-QIZQQNKQSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
94041,6m71,DB07649,-7.6,"(3R,4S)-1-[(4-amino-5H-pyrrolo[3,2-d]pyrimidin-7-yl)methyl]-4-[(benzylsulfanyl)methyl]pyrrolidin-3-ol",DIGGNILBPCEZIV-CVEARBPZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
166448,7bv1,DB15149,-7.6,Futibatinib,KEIPNCCJPRMIAX-HNNXBMFYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
148631,6w9q,DB13708,-7.6,Fenquizone,DBDTUXMDTSTPQZ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
8120,6lzg,DB04792,-7.6,"2,5-O,O-BIS-{4',4''-AMIDINOPHENYL}-1,4:3,6-DIANHYDRO-D-SORBITOL",CDEVHSIVANGYRI-XMTFNYHQSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
66206,6lxt,DB03869,-7.6,5'-O-(N-(L-Seryl)-Sulfamoyl)Adenosine,HQXFJGONGJPTLZ-YTMOPEAISA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
8119,6lzg,DB04791,-7.6,"2-O-(4'-AMIDINOPHENYL)-5-O-(3''-AMIDINOPHENYL)-1,4:3,6-DIANHYDRO-D-SORBITOL",DKBAWRNTUZFJKV-BSDSXHPESA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
113522,6vxx,DB09306,-7.6,Metralindole,GVXBHSBKKJRBMS-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
166444,7bv1,DB15143,-7.6,PF-06650833,JKDGKIBAOAFRPJ-ZBINZKHDSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94063,6m71,DB07678,-7.6,"(9ALPHA,13BETA,17BETA)-2-[(1Z)-BUT-1-EN-1-YL]ESTRA-1,3,5(10)-TRIENE-3,17-DIOL",ANAMDWGJXBYJEB-OPWFCKQNSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
75906,6m2n,DB06368,-7.6,Alamifovir,VDBGPMJFHCJMOL-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
93352,6m71,DB06847,-7.6,"5-[(3S)-3-(2-methoxybiphenyl-4-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",YYCPXVRHQUEVAW-CQSZACIVSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
148801,6w9q,DB13981,-7.6,Nomegestrol acetate,IIVBFTNIGYRNQY-YQLZSBIMSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
93833,6m71,DB07403,-7.6,"4-[(3-CHLORO-4-{[(2R)-3,3,3-TRIFLUORO-2-HYDROXY-2-METHYLPROPANOYL]AMINO}PHENYL)SULFONYL]-N,N-DIMETHYLBENZAMIDE",DTDZLJHKVNTQGZ-GOSISDBHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
30033,6cs2,DB11961,-7.6,AZD-1236,SFJFBTPHDHUUPU-OAHLLOKOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
148809,6w9q,DB13993,-7.6,MRK-409,GOIFCXRIFSYPFG-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
93846,6m71,DB07419,-7.6,S-23,SSFVOEAXHZGTRJ-KRWDZBQOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
166492,7bv1,DB15235,-7.6,Di-2-pyridylketone 4-cyclohexyl-4-methyl-3-thiosemicarbazone,GNLZNQJBZNOUBM-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
8184,6lzg,DB04863,-7.6,Lefradafiban,PGCFXITVMNNKON-ROUUACIJSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
149513,6wiq,DB00251,-7.6,Terconazole,BLSQLHNBWJLIBQ-OZXSUGGESA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
93867,6m71,DB07443,-7.6,(2Z)-N-biphenyl-4-yl-2-cyano-3-hydroxybut-2-enamide,MUVPBAIVOHJDOC-VBKFSLOCSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93870,6m71,DB07447,-7.6,5beta-dihydrotestosterone,NVKAWKQGWWIWPM-MISPCMORSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
113778,6vxx,DB12071,-7.6,Vabicaserin,NPTIPEQJIDTVKR-STQMWFEESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
93878,6m71,DB07455,-7.6,"N,N'-[biphenyl-4,4'-diyldi(2R)propane-2,1-diyl]dimethanesulfonamide",ZESUARCHWPARIF-HOTGVXAUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93499,6m71,DB07021,-7.6,"(7R,8R)-8-(2,4,5-trifluorophenyl)-6,7,8,9-tetrahydroimidazo[1,2-a:4,5-c']dipyridin-7-amine",SOSYXEPELJIJHZ-RNCFNFMXSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
14316,6lzg,T3D3952,-7.6,Lymecycline,AHEVKYYGXVEWNO-UEPZRUIBSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
51664,2fxp,DB08450,-7.6,N-1H-indazol-5-yl-2-(6-methylpyridin-2-yl)quinazolin-4-amine,HNHRWNUXTCATSG-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
93888,6m71,DB07468,-7.6,"(3aS)-3a-hydroxy-5-methyl-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one",NJBBBRZNBVLTRZ-GOSISDBHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
8479,6lzg,DB06195,-7.6,Seliciclib,BTIHMVBBUGXLCJ-OAHLLOKOSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
66308,6lxt,DB04005,-7.6,Uridine 5'-triphosphate,PGAVKCOVUIYSFO-XVFCMESISA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
29788,6cs2,DB11636,-7.6,Nomegestrol,KZUIYQJTUIACIG-YBZCJVABSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
93906,6m71,DB07489,-7.6,"4-Amino-2-[(3-chlorophenyl)amino]-5-(4-fluorobenzoyl)-1,3-thiazol-3-ium",WWGPTHOMFHDEEC-UHFFFAOYSA-O,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
66301,6lxt,DB03996,-7.6,"3-[(5s)-1-Acetyl-3-(2-Chlorophenyl)-4,5-Dihydro-1h-Pyrazol-5-Yl]Phenol",QBZAPFWYAPXRGQ-KRWDZBQOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
93480,6m71,DB06999,-7.6,"N-{3-[(5-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)carbonyl]-2,4-difluorophenyl}propane-1-sulfonamide",YZDJQTHVDDOVHR-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93474,6m71,DB06993,-7.6,"(2S,3S)-4-cyclopropyl-3-{(3R,5R)-3-[2-fluoro-4-(methylsulfonyl)phenyl]-1,2,4-oxadiazolidin-5-yl}-1-[(3S)-3-fluoropyrrolidin-1-yl]-1-oxobutan-2-amine",PTAHVQJZNFGPHN-WFWWEWPISA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
166481,7bv1,DB15214,-7.6,BMS-986104,BPMMYKAHRIEVDH-VOQZNFBZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93468,6m71,DB06986,-7.6,"2-CHLORO-N-[(1R,2R)-1-HYDROXY-2,3-DIHYDRO-1H-INDEN-2-YL]-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE",LRHOLHTVXXSIMG-BXUZGUMPSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93931,6m71,DB07519,-7.6,"(6R)-2-amino-6-[2-(3'-methoxybiphenyl-3-yl)ethyl]-3,6-dimethyl-5,6-dihydropyrimidin-4(3H)-one",VDFBMQAUECXNKR-OAQYLSRUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
148845,6w9q,DB14067,-7.6,Dofequidar,KLWUUPVJTLHYIM-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
114359,6vxx,DB13337,-7.6,Pheneticillin,NONJJLVGHLVQQM-JHXYUMNGSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
166478,7bv1,DB15208,-7.6,NOP-1A,MZBCQWLYUQJXKA-KRWDZBQOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
113677,6vxx,DB11748,-7.6,Benfotiamine,BTNNPSLJPBRMLZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29780,6cs2,DB11618,-7.6,Zorubicin,FBTUMDXHSRTGRV-BJISBDEGSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
148811,6w9q,DB13997,-7.6,Baloxavir marboxil,RZVPBGBYGMDSBG-GGAORHGYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
114383,6vxx,DB13364,-7.6,Feprazone,RBBWCVQDXDFISW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
93947,6m71,DB07537,-7.6,"N'-(6-aminopyridin-3-yl)-N-(2-cyclopentylethyl)-4-methyl-benzene-1,3-dicarboxamide",CLEGTVIMOPPIBR-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94474,6m71,DB08147,-7.6,"4-[3-(dibenzylamino)phenyl]-2,4-dioxobutanoic acid",RMWVENXKUQXLPW-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94475,6m71,DB08148,-7.6,"1-[4-(4-chlorophenyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine",QOZMRRGNAZNWDN-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
66893,6lxt,DB04793,-7.6,"1,4:3,6-Dianhydro-2-O-(3-carbamimidoylphenyl)-5-O-(4-carbamimidoylphenyl)-D-glucitol",DKBAWRNTUZFJKV-XMTFNYHQSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
116458,6w4b,DB02187,-7.6,Equilin,WKRLQDKEXYKHJB-HFTRVMKXSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
147242,6w9q,DB11652,-7.6,Tucatinib,SDEAXTCZPQIFQM-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
76645,6m2n,DB07443,-7.6,(2Z)-N-biphenyl-4-yl-2-cyano-3-hydroxybut-2-enamide,MUVPBAIVOHJDOC-VBKFSLOCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
147237,6w9q,DB11645,-7.6,PF-4191834,DVNQWYLVSNPCJZ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
112272,6vxx,DB06910,-7.6,"[4-R-(4-ALPHA,6-BETA,7-BETA]-HEXAHYDRO-5,6-DI(HYDROXY)-1,3-DI(ALLYL)-4,7-BISPHENYLMETHYL)-2H-1,3-DIAZEPINONE",IWJSQELMWLOYSO-LWSSLDFYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165964,7bv1,DB13305,-7.6,Tolpropamine,CINROOONPHQHPO-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
147222,6w9q,DB11614,-7.6,Rupatadine,WUZYKBABMWJHDL-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
9181,6lzg,DB07265,-7.6,"3-(9-HYDROXY-1,3-DIOXO-4-PHENYL-2,3-DIHYDROPYRROLO[3,4-C]CARBAZOL-6(1H)-YL)PROPANOIC ACID",JDARUOOLJCFUOY-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
67146,6lxt,DB05796,-7.6,Daglutril,XMQODGUTLZXUGZ-RPBOFIJWSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
147209,6w9q,DB11562,-7.6,Bicuculline,IYGYMKDQCDOMRE-ZWKOTPCHSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
9189,6lzg,DB07274,-7.6,"N-cyclopropyl-6-[(6,7-dimethoxyquinolin-4-yl)oxy]naphthalene-1-carboxamide",ZATGFXTWDKIEKC-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
95110,6m71,DB08951,-7.6,Indoprofen,RJMIEHBSYVWVIN-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
116571,6w4b,DB02336,-7.6,RU83876,WCMLXBUNHNAMNH-UIOOFZCWSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
76693,6m2n,DB07500,-7.6,(2E)-1-[2-hydroxy-4-methoxy-5-(3-methylbut-2-en-1-yl)phenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one,ZUGCRBMNFSAUOC-YRNVUSSQSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
95127,6m71,DB08970,-7.6,Fluprednidene,YVHXHNGGPURVOS-SBTDHBFYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95128,6m71,DB08971,-7.6,Fluocortolone,GAKMQHDJQHZUTJ-ULHLPKEOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
76695,6m2n,DB07503,-7.6,"(5E)-5-[(2,2-DIFLUORO-1,3-BENZODIOXOL-5-YL)METHYLENE]-1,3-THIAZOLIDINE-2,4-DIONE",SRLVNYDXMUGOFI-YWEYNIOJSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
67166,6lxt,DB05932,-7.6,Denibulin,GAOHLWCIAJNSEE-JTQLQIEISA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
151609,6wiq,DB02932,-7.6,(R)-Bicalutamide,LKJPYSCBVHEWIU-KRWDZBQOSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
112218,6vxx,DB06608,-7.6,Tafenoquine,LBHLFPGPEGDCJG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
67183,6lxt,DB06040,-7.6,Filanesib,LLXISKGBWFTGEI-FQEVSTJZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
92743,6m71,DB04816,-7.6,Dantron,QBPFLULOKWLNNW-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
65489,6lxt,DB02901,-7.6,Stanolone,NVKAWKQGWWIWPM-ABEVXSGRSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
147042,6w9q,DB09534,-7.6,Ecamsule,HEAHZSUCFKFERC-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
30545,6cs2,DB12637,-7.6,Onapristone,IEXUMDBQLIVNHZ-YOUGDJEHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
30546,6cs2,DB12638,-7.6,PU-H71,SUPVGFZUWFMATN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
95180,6m71,DB09038,-7.6,Empagliflozin,OBWASQILIWPZMG-QZMOQZSNSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95182,6m71,DB09040,-7.6,Efinaconazole,NFEZZTICAUWDHU-RDTXWAMCSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
92727,6m71,DB04794,-7.6,Bifonazole,OCAPBUJLXMYKEJ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
116414,6w4b,DB02123,-7.6,Glycochenodeoxycholic Acid,GHCZAUBVMUEKKP-GYPHWSFCSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
30559,6cs2,DB12657,-7.6,JNJ-42396302,BPLVDYJDAVYLRQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
147252,6w9q,DB11670,-7.6,SP-8203,SJZBPVOSFYUHFV-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
112318,6vxx,DB06967,-7.6,"6-ETHYL-5-[9-(3-METHOXYPROPYL)-9H-CARBAZOL-2-YL]PYRIMIDINE-2,4-DIAMINE",MLSVRCGEBXIIQO-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
151100,6wiq,DB02269,-7.6,[4-({[5-Benzyloxy-1-(3-Carbamimidoyl-Benzyl)-1h-Indole-2-Carbonyl]-Amino}-Methyl)-Phenyl]-Trimethyl-Ammonium,UFKJQTGPBFWMGT-UHFFFAOYSA-O,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
112426,6vxx,DB07089,-7.6,N-[amino(imino)methyl]-2-[2-(2-chlorophenyl)-4-(4-propoxyphenyl)-3-thienyl]acetamide,VZSMTBLDWPKVRW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
9088,6lzg,DB07162,-7.6,4-(3-amino-1H-indazol-5-yl)-N-tert-butylbenzenesulfonamide,KFJCXIOVAGJCKB-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
52867,2fxp,DB12138,-7.6,PF-03715455,VGEXRDWWPSGZDH-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
147389,6w9q,DB11870,-7.6,RG-4733,OJPLJFIFUQPSJR-INIZCTEOSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
112398,6vxx,DB07056,-7.6,"2-(6-{[(3-chloro-2-methylphenyl)sulfonyl]amino}pyridin-2-yl)-N,N-diethylacetamide",JNWQLOFSMUGRNY-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
116113,6w4b,DB01720,-7.6,(2z)-2-(Benzoylamino)-3-[4-(2-Bromophenoxy)Phenyl]-2-Propenoic Acid,WLPJLQNKCJWAFL-RGEXLXHISA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
94929,6m71,DB08706,-7.6,"(2S)-({(5Z)-5-[(5-ETHYL-2-FURYL)METHYLENE]-4-OXO-4,5-DIHYDRO-1,3-THIAZOL-2-YL}AMINO)(4-FLUOROPHENYL)ACETIC ACID",RNEACARJKXYVND-MZLJFPOFSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
65603,6lxt,DB03060,-7.6,Sri-9662,WNDJHUNKXPAREB-PLNGDYQASA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
76550,6m2n,DB07330,-7.6,trans-4-(7-carbamoyl-1H-benzimidazol-2-yl)-1-propylpiperidinium,KXSIHXHEHABEJX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76552,6m2n,DB07332,-7.6,"ALPHA-(2,6-DICHLOROPHENYL)-ALPHA-(2-ACETYL-5-METHYLANILINO)ACETAMIDE",CJPLEFFCVDQQFZ-INIZCTEOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
151324,6wiq,DB02551,-7.6,"6-[N-(4-Ethyl-1,2,3,4-Tetrahydro-6-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine",LVNMYQLXKMSQTG-AWEZNQCLSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
116197,6w4b,DB01831,-7.6,Tryptophanyl-5'amp,IFQVDHDRFCKAAW-SQIXAUHQSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
30481,6cs2,DB12543,-7.6,Samidorphan,RYIDHLJADOKWFM-MAODMQOUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
112357,6vxx,DB07012,-7.6,"6-AMINO-3,7-DIHYDRO-IMIDAZO[4,5-G]QUINAZOLIN-8-ONE",VQSMWFVKBKMHTO-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
67114,6lxt,DB05585,-7.6,Verubulin,SNHCRNMVYDHVDT-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
112343,6vxx,DB06996,-7.6,D-leucyl-N-(4-carbamimidoylbenzyl)-L-prolinamide,XFNMDMGNNKIXBT-CVEARBPZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
92809,6m71,DB04898,-7.6,Ximelagatran,ZXIBCJHYVWYIKI-PZJWPPBQSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
76610,6m2n,DB07402,-7.6,Azapropazone,WOIIIUDZSOLAIW-NSHDSACASA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
116249,6w4b,DB01908,-7.6,RU85493,MWEWSHNGVWABKG-SVBPBHIXSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
65562,6lxt,DB02998,-7.6,Metribolone,CCCIJQPRIXGQOE-XWSJACJDSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
116274,6w4b,DB01944,-7.6,(S)-blebbistatin,LZAXPYOBKSJSEX-GOSISDBHSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
67127,6lxt,DB05659,-7.6,Faropenem medoxomil,JQBKWZPHJOEQAO-DVPVEWDBSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
116312,6w4b,DB01990,-7.6,Cholesterol sulfate,BHYOQNUELFTYRT-DPAQBDIFSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
76629,6m2n,DB07425,-7.6,Sobetirome,QNAZTOHXCZPOSA-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
14562,6lzg,T3D4439,-7.6,Protoporphyrinogen IX,UHSGPDMIQQYNAX-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
95058,6m71,DB08864,-7.6,Rilpivirine,YIBOMRUWOWDFLG-ONEGZZNKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
165989,7bv1,DB13333,-7.6,Efloxate,ZVXBAHLOGZCFTP-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
92793,6m71,DB04876,-7.6,Vildagliptin,SYOKIDBDQMKNDQ-XWTIBIIYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
165986,7bv1,DB13329,-7.6,Guaiazulen,FWKQNCXZGNBPFD-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
147419,6w9q,DB11911,-7.6,Galunisertib,IVRXNBXKWIJUQB-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
112124,6vxx,DB06354,-7.6,Tezampanel,ZXFRFPSZAKNPQQ-YTWAJWBKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
146961,6w9q,DB09239,-7.6,Niguldipine,SVJMLYUFVDMUHP-XIFFEERXSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
111966,6vxx,DB04967,-7.6,Lucanthone,FBQPGGIHOFZRGH-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
7827,6lzg,DB04432,-7.6,ZK-805623,ZXIHYCYAQUQHSG-UHFFFAOYSA-O,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
67252,6lxt,DB06249,-7.6,Arzoxifene,MCGDSOGUHLTADD-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
165863,7bv1,DB13122,-7.6,Trabodenoson,AQLVRTWKJDTWQQ-SDBHATRESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
76824,6m2n,DB07654,-7.6,"(5,6-DIPHENYL-FURO[2,3-D]PYRIMIDIN-4-YLAMINO)-ACETIC",VDJWWYRYKMXMKA-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
165856,7bv1,DB13114,-7.6,Amitriptylinoxide,ZPMKQFOGINQDAM-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95429,6m71,DB11259,-7.6,Diosmetin,MBNGWHIJMBWFHU-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
117469,6w4b,DB03523,-7.6,Brequinar,PHEZJEYUWHETKO-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
67271,6lxt,DB06292,-7.6,Dapagliflozin,JVHXJTBJCFBINQ-ADAARDCZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
146712,6w9q,DB08867,-7.6,Ulipristal,HKDLNTKNLJPAIY-WKWWZUSTSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
117544,6w4b,DB03642,-7.6,Benzofuran-2-Carboxylic Acid {(S)-3-Methyl-1-[3-Oxo-1-(Pyridin-2-Ylsulfonyl)Azepan-4-Ylcarbamoyl]Butyl}Amide,VBPPNJCVXGAZDD-PMACEKPBSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
95477,6m71,DB11393,-7.6,Danofloxacin,QMLVECGLEOSESV-RYUDHWBXSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
53212,2fxp,DB12649,-7.6,Ibipinabant,AXJQVVLKUYCICH-OAQYLSRUSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
76870,6m2n,DB07713,-7.6,"(1S)-1-{[(4'-methoxy-1,1'-biphenyl-4-yl)sulfonyl]amino}-2-methylpropylphosphonic acid",BZVYQWLRCHLAGK-KRWDZBQOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
117596,6w4b,DB03712,-7.6,RU85053,CEKLBQMULVLLTD-VMPREFPWSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
95482,6m71,DB11398,-7.6,Diclazuril,ZSZFUDFOPOMEET-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
111887,6vxx,DB04828,-7.6,Zomepirac,ZXVNMYWKKDOREA-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30633,6cs2,DB12752,-7.6,Bucindolol,FBMYKMYQHCBIGU-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
30635,6cs2,DB12758,-7.6,Atreleuton,MMSNEKOTSJRTRI-LLVKDONJSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
76905,6m2n,DB07754,-7.6,N-({(1R)-1-carboxy-2-[(4-fluorobenzyl)sulfanyl]ethyl}carbamoyl)-L-glutamic acid,IDTMSHGCAZPVLC-RYUDHWBXSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
67276,6lxt,DB06307,-7.6,Apoptone,CKAXZOYFIHQCBN-JRRMKBMNSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
53243,2fxp,DB12694,-7.6,CE-326597,UBNMGTSDHSQBEL-PMERELPUSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
146641,6w9q,DB08770,-7.6,"4-{2-[(7-amino-2-furan-2-yl[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-yl)amino]ethyl}phenol",PWTBZOIUWZOPFT-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
95513,6m71,DB11457,-7.6,Rotenone,JUVIOZPCNVVQFO-HBGVWJBISA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
111840,6vxx,DB04769,-7.6,"5-QUINOXALIN-6-YLMETHYLENE-THIAZOLIDINE-2,4-DIONE",SQWZFLMPDUSYGV-POHAHGRESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
67277,6lxt,DB06309,-7.6,Refametinib,RDSACQWTXKSHJT-NSHDSACASA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
146623,6w9q,DB08749,-7.6,3-(2-AMINO-6-BENZOYLQUINAZOLIN-3(4H)-YL)-N-CYCLOHEXYL-N-METHYLPROPANAMIDE,KTRFBFMYAJOXLG-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
67278,6lxt,DB06311,-7.6,Darapladib,WDPFJWLDPVQCAJ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
117819,6w4b,DB03996,-7.6,"3-[(5s)-1-Acetyl-3-(2-Chlorophenyl)-4,5-Dihydro-1h-Pyrazol-5-Yl]Phenol",QBZAPFWYAPXRGQ-KRWDZBQOSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
117422,6w4b,DB03460,-7.6,Violaxanthin,SZCBXWMUOPQSOX-WVJDLNGLSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
30563,6cs2,DB12662,-7.6,Naveglitazar,OKJHGOPITGTTIM-DEOSSOPVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
30605,6cs2,DB12717,-7.6,Mibampator,ULRDYYKSPCRXAJ-KRWDZBQOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
67241,6lxt,DB06230,-7.6,Nalmefene,WJBLNOPPDWQMCH-MBPVOVBZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
165888,7bv1,DB13182,-7.6,Daidzein,ZQSIJRDFPHDXIC-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
76745,6m2n,DB07561,-7.6,(2Z)-2-cyano-N-(3'-ethoxybiphenyl-4-yl)-3-hydroxybut-2-enamide,RPILZQUCBKIPAZ-AQTBWJFISA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
30571,6cs2,DB12670,-7.6,Rolofylline,PJBFVWGQFLYWCB-QUYAXPHCSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
23262,6cs2,HMDB0059980,-7.6,4-Hydroxy-5-(phenyl)-valeric acid-O-glucuronide,IMTGYVWDOAJQQP-UFZVYEDBSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
76749,6m2n,DB07565,-7.6,Chloramphenicol succinate,LIRCDOVJWUGTMW-ZWNOBZJWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
112058,6vxx,DB06195,-7.6,Seliciclib,BTIHMVBBUGXLCJ-OAHLLOKOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
65436,6lxt,DB02834,-7.6,IDD552,ZCAGEXZTORJQDZ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
30582,6cs2,DB12686,-7.6,PHA-793887,HUXYBQXJVXOMKX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
95250,6m71,DB09175,-7.6,Mirfentanil,BJZZDOLVVLWFHN-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
29521,6cs2,DB09289,-7.6,Tianeptine,JICJBGPOMZQUBB-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
65425,6lxt,DB02819,-7.6,"Mono-[3,4-Dihydroxy-5-(5-Methyl-Benzoimidazol-1-Yl)-Tetrahydor-Furan-2-Ylmethyl] Ester",HGUDFQQPANTQEU-LPWJVIDDSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
165869,7bv1,DB13136,-7.6,Fluindione,NASXCEITKQITLD-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
76788,6m2n,DB07615,-7.6,Tranilast,NZHGWWWHIYHZNX-CSKARUKUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76805,6m2n,DB07633,-7.6,octyl 3-deoxy-2-O-(6-deoxy-alpha-L-galactopyranosyl)-beta-D-xylo-hexopyranoside,FBVFDKBCZLMLQT-PPCMOIRNSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
95282,6m71,DB09209,-7.6,Pholcodine,GPFAJKDEDBRFOS-FKQDBXSBSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
92696,6m71,DB04753,-7.6,"9-DEAZAINOSINE-2',3'-O-ETHYLIDENEPHOSPHONATE",ZOEDLCUBOBTIHG-USQSKNHBSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
112019,6vxx,DB06077,-7.6,Lumateperone,HOIIHACBCFLJET-SFTDATJTSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
146857,6w9q,DB09079,-7.6,Nintedanib,XZXHXSATPCNXJR-ZIADKAODSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
23255,6cs2,HMDB0059973,-7.6,"4-Hydroxy-5-(3',5'-dihydroxyphenyl)-valeric acid-O-glucuronide",COBSRKLPDWFDCG-AHLSELSJSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
112010,6vxx,DB05223,-7.6,Pracinostat,JHDKZFFAIZKUCU-ZRDIBKRKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
146840,6w9q,DB09054,-7.6,Idelalisib,IFSDAJWBUCMOAH-HNNXBMFYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
76819,6m2n,DB07649,-7.6,"(3R,4S)-1-[(4-amino-5H-pyrrolo[3,2-d]pyrimidin-7-yl)methyl]-4-[(benzylsulfanyl)methyl]pyrrolidin-3-ol",DIGGNILBPCEZIV-CVEARBPZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
95302,6m71,DB09232,-7.6,Cilnidipine,KJEBULYHNRNJTE-DHZHZOJOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
146831,6w9q,DB09034,-7.6,Suvorexant,JYTNQNCOQXFQPK-MRXNPFEDSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
146825,6w9q,DB09020,-7.6,Bisacodyl,KHOITXIGCFIULA-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
117331,6w4b,DB03331,-7.6,"N-Naphthalen-1-Ylmethyl-2'-[3,5-Dimethoxybenzamido]-2'-Deoxy-Adenosine",OARVXDFNTLYMCJ-JVUUKAHWSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
76822,6m2n,DB07652,-7.6,"1-[2-DEOXYRIBOFURANOSYL]-2,4-DIFLUORO-5-METHYL-BENZENE-5'MONOPHOSPHATE",NMMWBGNJJMNAIJ-QJPTWQEYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
30601,6cs2,DB12713,-7.6,Sotagliflozin,QKDRXGFQVGOQKS-CRSSMBPESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
23253,6cs2,HMDB0059972,-7.6,"4-Hydroxy-5-(3',4'-dihydroxyphenyl)-valeric acid-O-methyl-O-glucuronide",KRZPFELARLSRKT-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
67244,6lxt,DB06235,-7.6,Vadimezan,XGOYIMQSIKSOBS-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
9073,6lzg,DB07145,-7.6,(2R)-N-HYDROXY-2-[(3S)-3-METHYL-3-{4-[(2-METHYLQUINOLIN-4-YL)METHOXY]PHENYL}-2-OXOPYRROLIDIN-1-YL]PROPANAMIDE,YDMIPBHQKFOFQW-NSYGIPOTSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
14127,6lzg,T3D3745,-7.6,Territrem B,PBXNNDFKPQPJBB-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
30449,6cs2,DB12499,-7.6,Clascoterone,GPNHMOZDMYNCPO-PDUMRIMRSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
112771,6vxx,DB07824,-7.6,"4-ethyl-5-methyl-2-(1H-tetrazol-5-yl)-1,2-dihydro-3H-pyrazol-3-one",WAVWUEFMWJZZFB-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
23329,6cs2,HMDB0060056,-7.6,CE(15:1),TWLPMPGSSFTOAZ-VVLOTQQHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
115470,6w4b,DB00894,-7.6,Testolactone,BPEWUONYVDABNZ-DZBHQSCQSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
65837,6lxt,DB03361,-7.6,"2-{(9as)-9a-[(1s)-1-Hydroxyethyl]-2,7-Dimethyl-9a,10-Dihydro-5h-Pyrimido[4,5-D][1,3]Thiazolo[3,2-a]Pyrimidin-8-Yl}Ethyl Trihydrogen Diphosphate",UQFVHIGKDHNMJT-XPTSAGLGSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
147718,6w9q,DB12345,-7.6,MBX-2982,NFTMKHWBOINJGM-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
75237,6m2n,DB04438,-7.6,Brivudine monophosphate,LKWCVKAHHUJPQO-PIXDULNESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75236,6m2n,DB04437,-7.6,"Cysteine-Methylene-Carbamoyl-1,10-Phenanthroline",ZFGIPRHDRFOMFO-LBPRGKRZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
8927,6lzg,DB06992,-7.6,"(3,3-dimethylpiperidin-1-yl)(6-(3-fluoro-4-methylphenyl)pyridin-2-yl)methanone",SIDDLTBLAQYZIZ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
76363,6m2n,DB07119,-7.6,1-CHLORO-6-(4-HYDROXYPHENYL)-2-NAPHTHOL,YHEHVRSGKUYDON-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76364,6m2n,DB07120,-7.6,"N4-(N,N-DIPHENYLCARBAMOYL)-AMINOGUANIDINE",QLXOHIUDKNRVBZ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
147694,6w9q,DB12309,-7.6,GI-181771X,CABBMMXFOOZVMS-PMERELPUSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
147690,6w9q,DB12305,-7.6,Dasotraline,SRPXSILJHWNFMK-MEDUHNTESA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
166146,7bv1,DB13752,-7.6,Tetramethrin,CXBMCYHAMVGWJQ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
8943,6lzg,DB07006,-7.6,"9-HYDROXY-6-(3-HYDROXYPROPYL)-4-(2-METHOXYPHENYL)PYRROLO[3,4-C]CARBAZOLE-1,3(2H,6H)-DIONE",AOGOZJCRIFBTTN-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
65818,6lxt,DB03337,-7.6,1-(2-Amidinophenyl)-3-(Phenoxyphenyl)Urea,ZHCAYBOLUMAUQX-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
66976,6lxt,DB04898,-7.6,Ximelagatran,ZXIBCJHYVWYIKI-PZJWPPBQSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
147675,6w9q,DB12286,-7.6,Simendan,WHXMKTBCFHIYNQ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
115534,6w4b,DB00966,-7.6,Telmisartan,RMMXLENWKUUMAY-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
76372,6m2n,DB07128,-7.6,"N7-BUTYL-N2-(5-CHLORO-2-METHYLPHENYL)-5-METHYL[1,2,4]TRIAZOLO[1,5-A]PYRIMIDINE-2,7-DIAMINE",ZTYBIJUAAWLJNU-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
94632,6m71,DB08346,-7.6,"(5Z)-13-CHLORO-14,16-DIHYDROXY-3,4,7,8,9,10-HEXAHYDRO-1H-2-BENZOXACYCLOTETRADECINE-1,11(12H)-DIONE",YUZYDHRGGDTZLG-DUXPYHPUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
8945,6lzg,DB07008,-7.6,"4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMIDAZOL-1-YL)PHENOXY]PYRIMIDINE",XPXGYINSBORUMM-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
30370,6cs2,DB12398,-7.6,Naproxen etemesil,JGBUBSOKFSVXKS-LBPRGKRZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
94646,6m71,DB08361,-7.6,"2-{[(1R,2S)-2-aminocyclohexyl]amino}-4-[(3-methylphenyl)amino]pyrimidine-5-carboxamide",NZNTWOVDIXCHHS-LSDHHAIUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
147654,6w9q,DB12260,-7.6,Radiprodil,GKGRZLGAQZPEHO-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
166132,7bv1,DB13728,-7.6,Halometasone,GGXMRPUKBWXVHE-MIHLVHIWSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94671,6m71,DB08392,-7.6,"2-[5,6-BIS-(4-METHOXY-PHENYL)-FURO[2,3-D]PYRIMIDIN-4-YLAMINO]-ETHANOL",ARBUGBBNEFAECO-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
115588,6w4b,DB01029,-7.6,Irbesartan,YOSHYTLCDANDAN-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
112683,6vxx,DB07724,-7.6,Indeglitazar,YMPALHOKRBVHOJ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76400,6m2n,DB07161,-7.6,5-phenyl-1H-indazol-3-amine,ZCUSNQPYUNLATP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
147736,6w9q,DB12375,-7.6,Oglemilast,OKFDRAHPFKMAJH-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
166124,7bv1,DB13720,-7.6,Diphemanil,LCTZPQRFOZKZNK-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
65843,6lxt,DB03368,-7.6,"5-Methyl-5-(4-Phenoxy-Phenyl)-Pyrimidine-2,4,6-Trione",RTBMLCLTYAPKIF-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
94554,6m71,DB08244,-7.6,"(1S)-1-CYCLOPROPYL-2-[(2S)-4-(2,5-DIFLUOROPHENYL)-2-PHENYL-2,5-DIHYDRO-1H-PYRROL-1-YL]-2-OXOETHANAMINE",VCOUEHUEFUDZIS-PMACEKPBSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
166276,7bv1,DB14545,-7.6,Hydrocortisone succinate,VWQWXZAWFPZJDA-CGVGKPPMSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
75301,6m2n,DB04520,-7.6,"(3s,8ar)-3-(4-Hydroxybenzyl)Hexahydropyrrolo[1,2-a]Pyrazine-1,4-Dione",LSGOTAXPWMCUCK-RYUDHWBXSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
94480,6m71,DB08153,-7.6,"(5E)-14-CHLORO-15,17-DIHYDROXY-4,7,8,9,10,11-HEXAHYDRO-2-BENZOXACYCLOPENTADECINE-1,12(3H,13H)-DIONE",VZTAZMSAAIUZJV-HWKANZROSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94486,6m71,DB08159,-7.6,"4-(5,11-DIOXO-5H-INDENO[1,2-C]ISOQUINOLIN-6(11H)-YL)BUTANOATE",AHIJTWCJGCWHMT-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
150428,6wiq,DB01406,-7.6,Danazol,POZRVZJJTULAOH-LHZXLZLDSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
147856,6w9q,DB12548,-7.6,Sparsentan,WRFHGDPIDHPWIQ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
112968,6vxx,DB08207,-7.6,"2-(3,5-DIMETHYLPHENYL)-1,3-BENZOXAZOLE",BIHLSRJPJFOESJ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112957,6vxx,DB08192,-7.6,2-(4-CARCOXY-5-ISOPROPYLTHIAZOLYL)BENZOPIPERIDINE,HCUGCUQZFBURHR-LBPRGKRZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
147840,6w9q,DB12523,-7.6,Mizolastine,PVLJETXTTWAYEW-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
94493,6m71,DB08166,-7.6,"(4R)-7-chloro-9-methyl-1-oxo-1,2,4,9-tetrahydrospiro[beta-carboline-3,4'-piperidine]-4-carbonitrile",LPFQFJAOMCGYCP-GFCCVEGCSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
166250,7bv1,DB14209,-7.6,Trandolaprilat,AHYHTSYNOHNUSH-HXFGRODQSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
147822,6w9q,DB12494,-7.6,SGI-1776,MHXGEROHKGDZGO-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
112912,6vxx,DB08142,-7.6,AT-7519,OVPNQJVDAFNBDN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
166242,7bv1,DB14196,-7.6,"N-Cyclohexyl-N'-phenyl-1,4-phenylenediamine",ZRMMVODKVLXCBB-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
128,6lzg,HMDB0003000,-7.6,Lycopene,OAIJSZIZWZSQBC-BOJOQWLHSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
115285,6w4b,DB00678,-7.6,Losartan,PSIFNNKUMBGKDQ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
166216,7bv1,DB14127,-7.6,Sacubitrilat,DOBNVUFHFMVMDB-BEFAXECRSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
112875,6vxx,DB07946,-7.6,"N-[2-({[amino(imino)methyl]amino}oxy)ethyl]-2-{6-chloro-3-[(2,2-difluoro-2-phenylethyl)amino]-2-fluorophenyl}acetamide",DZEJHPMTDNDECN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76310,6m2n,DB07056,-7.6,"2-(6-{[(3-chloro-2-methylphenyl)sulfonyl]amino}pyridin-2-yl)-N,N-diethylacetamide",JNWQLOFSMUGRNY-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75265,6m2n,DB04474,-7.6,1-Anilino-8-Naphthalene Sulfonate,FWEOQOXTVHGIFQ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
112859,6vxx,DB07929,-7.6,"N-(TERT-BUTYL)-3,5-DIMETHYL-N'-[(5-METHYL-2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)CARBONYL]BENZOHYDRAZIDE",JGJACZABNQGPMT-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
147785,6w9q,DB12436,-7.6,Vofopitant,XILNRORTJVDYRH-HKUYNNGSSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
112857,6vxx,DB07927,-7.6,3-[(4-Carboxy-2-hydroxyphenyl)sulfamoyl]-2-thiophenecarboxylic acid,RDPXXOOKKRIKFN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
94542,6m71,DB08230,-7.6,"5,7-DIHYDROXY-2-(3,4,5-TRIHYDROXYPHENYL)-4H-CHROMEN-4-ONE",ARSRJFRKVXALTF-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
52535,2fxp,DB11652,-7.6,Tucatinib,SDEAXTCZPQIFQM-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
66932,6lxt,DB04839,-7.6,Cyproterone acetate,UWFYSQMTEOIJJG-FDTZYFLXSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
93020,6m71,DB06090,-7.6,Bradanicline,OXKRFEWMSWPKKV-GHTZIAJQSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
8884,6lzg,DB06942,-7.6,N-(4-carbamimidoylbenzyl)-1-(3-phenylpropanoyl)-L-prolinamide,RNZKCCPFUWHBFY-IBGZPJMESA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
93016,6m71,DB06040,-7.6,Filanesib,LLXISKGBWFTGEI-FQEVSTJZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
112794,6vxx,DB07851,-7.6,"(3R,4S)-1-(3,4-DIMETHOXYPHENYL)-3-(3-METHYLPHENYL)PIPERIDIN-4-AMINE",DQJXBZGPJVSWFI-ROUUACIJSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
94711,6m71,DB08442,-7.6,"4-{[(2R)-2-(2-methylphenyl)pyrrolidin-1-yl]carbonyl}benzene-1,3-diol",TWODFUZHWYZBHZ-MRXNPFEDSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
112669,6vxx,DB07525,-7.6,"3-(3-methoxybenzyl)-1H-pyrrolo[2,3-b]pyridine",GHQCCHWTDLTMJT-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112666,6vxx,DB07520,-7.6,"N-[1-(AMINOMETHYL)CYCLOPROPYL]-3-(MORPHOLIN-4-YLSULFONYL)-N-2-[(1S)-2,2,2-TRIFLUORO-1-(4-FLUOROPHENYL)ETHYL]-L-ALANINAMIDE",BJIKKEHGGYGGIX-HOTGVXAUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
115818,6w4b,DB01337,-7.6,Pancuronium,GVEAYVLWDAFXET-XGHATYIMSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
94787,6m71,DB08531,-7.6,"5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",CVYWYUAQFJMLEO-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
92893,6m71,DB05294,-7.6,Vandetanib,UHTHHESEBZOYNR-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94796,6m71,DB08540,-7.6,"2-[4-(2H-1,4-BENZOTHIAZINE-3-YL)-PIPERAZINE-1-LY]-1,3-THIAZOLE-4-CARBOXYLIC ACID ETHYLESTER",AQJQFCRTSWIUCY-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
76501,6m2n,DB07279,-7.6,N-ETHYL-N-ISOPROPYL-3-METHYL-5-{[(2S)-2-(PYRIDIN-4-YLAMINO)PROPYL]OXY}BENZAMIDE,JMPSZYHYDMQFEO-KRWDZBQOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
92891,6m71,DB05288,-7.6,Anecortave acetate,YUWPMEXLKGOSBF-GACAOOTBSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
166082,7bv1,DB13667,-7.6,Cefozopran,QDUIJCOKQCCXQY-WHJQOFBOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94798,6m71,DB08543,-7.6,1-[2-HYDROXY-3-(4-CYCLOHEXYL-PHENOXY)-PROPYL]-4-(2-PYRIDYL)-PIPERAZINE,BZJHCQBNFUNZPJ-QFIPXVFZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
92883,6m71,DB05253,-7.6,Telapristone acetate,JVBGZFRPTRKSBB-MJBQOYBXSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
112535,6vxx,DB07363,-7.6,"THIOPHENE-2,5-DISULFONIC ACID 2-AMIDE-5-(4-METHYL-BENZYLAMIDE)",GUNRMHMEAWSZQE-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
147485,6w9q,DB12009,-7.6,GW-406381,NXMZBNYLCVTRGB-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
65689,6lxt,DB03173,-7.6,CRA_10433,CFSQPEBVGUSQII-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
147474,6w9q,DB11995,-7.6,Avatrombopag,OFZJKCQENFPZBH-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
92875,6m71,DB05197,-7.6,Sofalcone,GFWRVVCDTLRWPK-KPKJPENVSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
76511,6m2n,DB07289,-7.6,5-[3-(BENZYLAMINO)PHENYL]-4-BROMO-3-(CARBOXYMETHOXY)THIOPHENE-2-CARBOXYLIC ACID,XEQPGVUGYAUMSA-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
112517,6vxx,DB07343,-7.6,"4-[4-AMINO-6-(2,6-DICHLORO-PHENOXY)-[1,3,5]TRIAZIN-2-YLAMINO]-BENZONITRILE",NFNNMVVXXITVGD-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
94817,6m71,DB08568,-7.6,(2S)-1-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}-3-PHENYLPROPAN-2-AMINE,BPNUQXPIQBZCMR-IBGZPJMESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
112504,6vxx,DB07328,-7.6,"METHYL 4-{[({[(2R,5S)-5-{[(2S)-2-(AMINOMETHYL)PYRROLIDIN-1-YL]CARBONYL}PYRROLIDIN-2-YL]METHYL}AMINO)CARBONYL]AMINO}BENZOATE",USDCNOQKDUFKRD-IKGGRYGDSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
65674,6lxt,DB03154,-7.6,{[7-(Difluoro-Phosphono-Methyl)-Naphthalen-2-Yl]-Difluoro-Methyl}-Phosphonic Acid,VHKBLEYUHBIBNR-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
14131,6lzg,T3D3749,-7.6,Asteltoxin,GPXPJKFETRLRAS-BGSVYHRFSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
67076,6lxt,DB05414,-7.6,Pipendoxifene,JICOGKJOQXTAIP-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
76531,6m2n,DB07310,-7.6,"(5S)-2-{[(1S)-1-(2-fluorophenyl)ethyl]amino}-5-methyl-5-(trifluoromethyl)-1,3-thiazol-4(5H)-one",KNHNFKZUNFPPQE-MADCSZMMSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
23298,6cs2,HMDB0001913,-7.6,Omeprazole,SUBDBMMJDZJVOS-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
147445,6w9q,DB11949,-7.6,Vestipitant,SBBYBXSFWOLDDG-JLTOFOAXSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
94856,6m71,DB08613,-7.6,"2,2,2-TRIFLUORO-1-{5-[(3-PHENYL-5,6-DIHYDROIMIDAZO[1,2-A]PYRAZIN-7(8H)-YL)CARBONYL]THIOPHEN-2-YL}ETHANE-1,1-DIOL",OFBFUNBBOQCNFX-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
112453,6vxx,DB07121,-7.6,"4-({4-[(4-AMINOBUT-2-YNYL)OXY]PHENYL}SULFONYL)-N-HYDROXY-2,2-DIMETHYLTHIOMORPHOLINE-3-CARBOXAMIDE",AANXPIMDONQTQF-HNNXBMFYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
9068,6lzg,DB07140,-7.6,"5-[(3R)-3-(5-methoxybiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",JPENSYBRTSIYGO-AWEZNQCLSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
94863,6m71,DB08622,-7.6,"4-(4-CHLORO-PHENYL)-1-{3-[2-(4-FLUORO-PHENYL)-[1,3]DITHIOLAN-2-YL]-PROPYL}-PIPERIDIN-4-OL",KVDKNVPAAQKHKD-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
75146,6m2n,DB04306,-7.6,"5-[(4-Methylphenyl)Sulfanyl]-2,4-Quinazolinediamine",UOJFGEAPSYQDIP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
150819,6wiq,DB01889,-7.6,"16,17-Androstene-3-Ol",KRVXMNNRSSQZJP-PHFHYRSDSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
9011,6lzg,DB07080,-7.6,"N-(2,2,2-TRIFLUOROETHYL)-N-{4-[2,2,2-TRIFLUORO-1-HYDROXY-1-(TRIFLUOROMETHYL)ETHYL]PHENYL}BENZENESULFONAMIDE",SGIWFELWJPNFDH-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
147529,6w9q,DB12078,-7.6,Enobosarm,JNGVJMBLXIUVRD-SFHVURJKSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
94769,6m71,DB08510,-7.6,5-ALPHA-PREGNANE-3-BETA-OL-HEMISUCCINATE,UVTGFMKBPVLATL-DSOJQRAMSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94725,6m71,DB08459,-7.6,"3-chloro-5-[2-chloro-5-(1H-pyrazolo[3,4-b]pyridin-3-ylmethoxy)phenoxy]benzonitrile",SVMHTBVIPYVDIL-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94726,6m71,DB08460,-7.6,"3-{5-[(6-amino-1H-pyrazolo[3,4-b]pyridin-3-yl)methoxy]-2-chlorophenoxy}-5-chlorobenzonitrile",KXDIHAQCVNNLIB-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
76422,6m2n,DB07185,-7.6,2-{[(4-CHLOROPHENOXY)ACETYL]AMINO}BENZOIC ACID,LXSDGQYDSDIUPN-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
112647,6vxx,DB07498,-7.6,"4-[3-(3-NITROPHENYL)-1,2,4-OXADIAZOL-5-YL]BUTANOIC ACID",LQQYZJRCWBRIMW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76428,6m2n,DB07192,-7.6,(3S)-N-(3-BROMOPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE,MVPIURCUINFSAB-LBPRGKRZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
67015,6lxt,DB05035,-7.6,Eprotirome,VPCSYAVXDAUHLT-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
65743,6lxt,DB03239,-7.6,"3',5'-Dinitro-N-Acetyl-L-Thyronine",VZSQTOXQXPKQJX-ZDUSSCGKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
8977,6lzg,DB07042,-7.6,"7-amino-2-tert-butyl-4-{[2-(1H-imidazol-4-yl)ethyl]amino}pyrido[2,3-d]pyrimidine-6-carboxamide",XESUNWBIAADLPI-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
115680,6w4b,DB01134,-7.6,Desoxycorticosterone pivalate,VVOIQBFMTVCINR-WWMZEODYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
112633,6vxx,DB07481,-7.6,"tert-butyl [(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)methyl]carbamate",RXVQMCMIOHBKNE-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
65738,6lxt,DB03234,-7.6,"(4'-{[Allyl(Methyl)Amino]Methyl}-1,1'-Biphenyl-4-Yl)(4-Bromophenyl)Methanone",YATCZCSDJCQNAL-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
112632,6vxx,DB07480,-7.6,4-PHOSPHONOOXY-PHENYL-METHYL-[4-PHOSPHONOOXY]BENZEN,LGSCVLKUKMBYNC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76440,6m2n,DB07206,-7.6,6-[2-(1H-INDOL-6-YL)ETHYL]PYRIDIN-2-AMINE,OSHSZKRWKLQZBV-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75187,6m2n,DB04366,-7.6,3'-Deoxy 3'-Amino Adenosine-5'-Diphosphate,VKODIDNZKBYXJO-QYYRPYCUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
146616,6w9q,DB08742,-7.6,"1,3-CYCLOHEXANEDIOL, 4-METHYLENE-5-[(2E)-[(1S,3AS,7AS)-OCTAHYDRO-1-(5-HYDROXY-5-METHYL-1,3-HEXADIYNYL)-7A-METHYL-4H-INDEN-4-YLIDENE]ETHYLIDENE]-, (1R,3S,5Z)",CEEUUHVULXTFGS-BQXVGYHGSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
76459,6m2n,DB07230,-7.6,3-BROMO-6-HYDROXY-2-(4-HYDROXYPHENYL)-1H-INDEN-1-ONE,DHPCBFMFERFZLR-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
147572,6w9q,DB12135,-7.6,Elubrixin,YQYFEGTYCUQBEI-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
94751,6m71,DB08490,-7.6,CTS-1027,ROSNVSQTEGHUKU-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
76461,6m2n,DB07233,-7.6,N-{[4-(but-2-yn-1-yloxy)phenyl]sulfonyl}-5-methyl-D-tryptophan,SFVPXERGVLDWIS-OAQYLSRUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
147566,6w9q,DB12128,-7.6,Ulimorelin,WGYPAJVJMXQXTR-ABNZCKJZSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
115724,6w4b,DB01184,-7.6,Domperidone,FGXWKSZFVQUSTL-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
115740,6w4b,DB01200,-7.6,Bromocriptine,OZVBMTJYIDMWIL-AYFBDAFISA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
67026,6lxt,DB05100,-7.6,Prinomastat,YKPYIPVDTNNYCN-INIZCTEOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
67031,6lxt,DB05116,-7.6,Thymectacin,CFBLUORPOFELCE-BACVZHSASA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
94757,6m71,DB08496,-7.6,(R)-warfarin,PJVWKTKQMONHTI-HNNXBMFYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
92897,6m71,DB05327,-7.6,Ranirestat,QCVNMNYRNIMDKV-QGZVFWFLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
76467,6m2n,DB07240,-7.6,3-[(9H-fluoren-9-ylideneamino)oxy]propanoic acid,LASWLEUVWJDDBA-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
30408,6cs2,DB12441,-7.6,Tavilermide,DVJXNXPFYJIACK-ULQDDVLXSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
150809,6wiq,DB01876,-7.6,Bis(5-Amidino-2-Benzimidazolyl)Methanone,VVVXDHROXQUONB-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
112585,6vxx,DB07425,-7.6,Sobetirome,QNAZTOHXCZPOSA-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
147573,6w9q,DB12137,-7.6,GSK-256066,JFHROPTYMMSOLG-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
68117,6lxt,DB07540,-7.6,"4-{5-[(1Z)-1-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)ETHYL]-2-FURYL}BENZENESULFONAMIDE",AKFVRSQELXTCFW-JYRVWZFOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
77679,6m2n,DB08670,-7.6,"METHYL N-[(2S,3R)-3-AMINO-2-HYDROXY-3-(4-ISOPROPYLPHENYL)PROPANOYL]-D-ALANYL-D-LEUCINATE",WIWZNHHLFMPGGO-PIKADFDJSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
131514,6w4h,DB13843,-7.6,Cloprednol,YTJIBEDMAQUYSZ-FDNPDPBUSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
98369,6vxs,DB00862,-7.6,Vardenafil,SECKRCOLJRRGGV-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
89960,6m71,DB01094,-7.6,Hesperetin,AIONOLUJZLIMTK-AWEZNQCLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
164800,7bv1,DB08619,-7.6,Testosterone succinate,CJQNBXFUHQZFOE-VYAQIDIUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
63228,6crv,DB15394,-7.6,gamma-Tocopherol,QUEDXNHFTDJVIY-DQCZWYHMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
74067,6m2n,DB02857,-7.6,Guanosine,NYHBQMYGNKIUIF-UUOKFMHZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79751,6m2n,DB13693,-7.6,Sulbenicillin,JETQIUPBHQNHNZ-NJBDSQKTSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
27831,6cs2,DB07389,-7.6,N-[2-(6-AMINO-4-METHYLPYRIDIN-2-YL)ETHYL]-4-CYANOBENZAMIDE,QINCZVSBLITNRD-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
108116,6vxx,DB06868,-7.6,N-(3-chlorobenzyl)-1-(4-methylpentanoyl)-L-prolinamide,PQUULPKGCNPPBX-INIZCTEOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
63769,6lxt,DB00680,-7.6,Moricizine,FUBVWMNBEHXPSU-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
142986,6w9q,DB02917,-7.6,N-Hydroxy-4-(Methyl{[5-(2-Pyridinyl)-2-Thienyl]Sulfonyl}Amino)Benzamide,LFGYSFPVLMPUPE-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
63767,6lxt,DB00678,-7.6,Losartan,PSIFNNKUMBGKDQ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
164336,7bv1,DB07715,-7.6,Emodin,RHMXXJGYXNZAPX-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
164338,7bv1,DB07717,-7.6,"(5S,8R,9S,10S,13R,14S,17S)-13-{2-[(3,5-DIFLUOROBENZYL)OXY]ETHYL}-17-HYDROXY-10-METHYLHEXADECAHYDRO-3H-CYCLOPENTA[A]PHENANTHREN-3-ONE",AJODXHGZHBERGJ-JLYQOUBASA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
154384,6wiq,DB07811,-7.6,"N-cyclopropyl-2',6-dimethyl-4'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-3-carboxamide",UBVTVSINEVHYSY-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
144808,6w9q,DB06454,-7.6,Sarizotan,HKFMQJUJWSFOLY-OAQYLSRUSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
29221,6cs2,DB08882,-7.6,Linagliptin,LTXREWYXXSTFRX-QGZVFWFLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
142942,6w9q,DB02859,-7.6,Soraphen A,WPMGNXPRKGXGBO-OFQQMTDKSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
68641,6lxt,DB08147,-7.6,"4-[3-(dibenzylamino)phenyl]-2,4-dioxobutanoic acid",RMWVENXKUQXLPW-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
108295,6vxx,DB07589,-7.6,"N-[1-(AMINOMETHYL)CYCLOPROPYL]-3-(BENZYLSULFONYL)-N-2-[(1S)-2,2,2-TRIFLUORO-1-(4-HYDROXYPHENYL)ETHYL]-L-ALANINAMIDE",DWWVPKCSDHDILN-OALUTQOASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
144314,6w9q,DB04704,-7.6,20-hydroxycholesterol,MCKLJFJEQRYRQT-MGNSQDQZSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
55182,6crv,DB00708,-7.6,Sufentanil,GGCSSNBKKAUURC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
10616,6lzg,DB08828,-7.6,Vismodegib,BPQMGSKTAYIVFO-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
121383,6w4b,DB11814,-7.6,PF-03882845,XNULRSOGWPFPBL-REWPJTCUSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
144784,6w9q,DB06395,-7.6,Abafungin,TYBHXIFFPVFXQW-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
123099,6w4b,DB14844,-7.6,ONC-201,VLULRUCCHYVXOH-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
10740,6lzg,DB08997,-7.6,Dexetimide,LQQIVYSCPWCSSD-HSZRJFAPSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
108118,6vxx,DB06870,-7.6,"17-HYDROXY-18A-HOMO-19-NOR-17ALPHA-PREGNA-4,9,11-TRIEN-3-ONE",OXHNQTSIKGHVBH-ANULTFPQSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
121387,6w4b,DB11818,-7.6,Retosiban,PLVGDGRBPMVYPB-FDUHJNRSSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
164329,7bv1,DB07706,-7.6,2-Hydrox1tradiol,DILDHNKDVHLEQB-XSSYPUMDSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
32038,6cs2,DB01118,-7.6,Amiodarone,IYIKLHRQXLHMJQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
154373,6wiq,DB07800,-7.6,N-(2-(((5-CHLORO-2-PYRIDINYL)AMINO)SULFONYL)PHENYL)-4-(2-OXO-1(2H)-PYRIDINYL)BENZAMIDE,MIJGLXFQYBTIFY-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
90327,6m71,DB01591,-7.6,Solifenacin,FBOUYBDGKBSUES-VXKWHMMOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
63003,6crv,DB14904,-7.6,Pimasertib,VIUAUNHCRHHYNE-JTQLQIEISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
121815,6w4b,DB12432,-7.6,CC-401,XDJCLCLBSGGNKS-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
107842,6vxx,DB04689,-7.6,2-{5-[3-(6-BENZOYL-1-PROPYLNAPHTHALEN-2-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID,ZXWVCCFKIRBLDP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
89967,6m71,DB01101,-7.6,Capecitabine,GAGWJHPBXLXJQN-UORFTKCHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
29246,6cs2,DB08922,-7.6,Perospirone,FBVFZWUMDDXLLG-HDICACEKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
27998,6cs2,DB07564,-7.6,"6-amino-2-[(2-morpholin-4-ylethyl)amino]-3,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",JUHXOBNFTFUPKQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
144841,6w9q,DB06532,-7.6,Pafuramidine,UKOQVLAXCBRRGH-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
68316,6lxt,DB07779,-7.6,N-({(2S)-1-[(3R)-3-AMINO-4-(2-FLUOROPHENYL)BUTANOYL]PYRROLIDIN-2-YL}METHYL)BENZAMIDE,ANQHSFFUNMTTRS-MOPGFXCFSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
63724,6lxt,DB00624,-7.6,Testosterone,MUMGGOZAMZWBJJ-DYKIIFRCSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
31702,6cs2,DB14625,-7.6,Meprednisone acetate,RZAMUHXEOMZXET-ABQXZQTJSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
98358,6vxs,DB00850,-7.6,Perphenazine,RGCVKNLCSQQDEP-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
98115,6vxs,DB00559,-7.6,Bosentan,GJPICJJJRGTNOD-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
27994,6cs2,DB07561,-7.6,(2Z)-2-cyano-N-(3'-ethoxybiphenyl-4-yl)-3-hydroxybut-2-enamide,RPILZQUCBKIPAZ-AQTBWJFISA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
90173,6m71,DB01415,-7.6,Ceftibuten,UNJFKXSSGBWRBZ-BJCIPQKHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
55237,6crv,DB00774,-7.6,Hydroflumethiazide,DMDGGSIALPNSEE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
143174,6w9q,DB03173,-7.6,CRA_10433,CFSQPEBVGUSQII-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
98348,6vxs,DB00839,-7.6,Tolazamide,OUDSBRTVNLOZBN-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
68480,6lxt,DB07968,-7.6,N-(2-CHLORO-4-FLUOROBENZOYL)-N'-(5-HYDROXY-2-METHOXYPHENYL)UREA,RFOBTYLRURSVJE-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
68325,6lxt,DB07789,-7.6,"1-[5-methyl-2-(trifluoromethyl)furan-3-yl]-3-[(2Z)-5-(2-{[6-(1H-1,2,4-triazol-3-ylamino)pyrimidin-4-yl]amino}ethyl)-1,3-thiazol-2(3H)-ylidene]urea",KNTGXMNWVXZIMW-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
68314,6lxt,DB07776,-7.6,Flavone,VHBFFQKBGNRLFZ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
144830,6w9q,DB06510,-7.6,Muraglitazar,IRLWJILLXJGJTD-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
27852,6cs2,DB00678,-7.6,Losartan,PSIFNNKUMBGKDQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
121429,6w4b,DB11878,-7.6,Filibuvir,SLVAPEZTBDBAPI-GDLZYMKVSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
32020,6cs2,DB15212,-7.6,Pemafibrate,ZHKNLJLMDFQVHJ-RUZDIDTESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
79948,6m2n,DB14025,-7.6,Clinafloxacin,QGPKADBNRMWEQR-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
121810,6w4b,DB12426,-7.6,Bitopertin,YUUGYIUSCYNSQR-LBPRGKRZSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
144826,6w9q,DB06494,-7.6,Sufugolix,UCQSBGOFELXYIN-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
144250,6w9q,DB04616,-7.6,TACRINE(8)-4-AMINOQUINOLINE,UNVOAAWEEGAXTN-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
55214,6crv,DB00745,-7.6,Modafinil,YFGHCGITMMYXAQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
122429,6w4b,DB13386,-7.6,Epimestrol,UHQGCIIQUZBJAE-RRQVMCLOSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
32015,6cs2,DB15206,-7.6,Uprifosbuvir,SFPFZQKYPOWCSI-KHFYHRBSSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
108115,6vxx,DB06866,-7.6,6-CARBAMIMIDOYL-2-[2-HYDROXY-5-(3-METHOXY-PHENYL)-INDAN-1-YL]-HEXANOIC ACID,NMOUMGFCBOWPAB-RZUBCFFCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
144243,6w9q,DB04607,-7.6,"PHENYLAMINOIMIDAZO(1,2-ALPHA)PYRIDINE",UQAWGIKJINAKIZ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
79941,6m2n,DB14008,-7.6,Hispidulin,IHFBPDAQLQOCBX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
90655,6m71,DB02030,-7.6,Alpha-Ribazole-5'-Phosphate,ZMRGXEJKZPRBPJ-SYQHCUMBSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
143079,6w9q,DB03046,-7.6,7-Methoxy-8-[1-(Methylsulfonyl)-1h-Pyrazol-4-Yl]Naphthalene-2-Carboximidamide,KQUXAFOLFXHVQN-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
79062,6m2n,DB12671,-7.6,Beloranib,ZEZFKUBILQRZCK-MJSCXXSSSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
144779,6w9q,DB06367,-7.6,Relacatib,BWYBBMQLUKXECQ-GIVPXCGWSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
108107,6vxx,DB06857,-7.6,N-(4-CARBAMIMIDOYL-3-CHORO-PHENYL)-2-HYDROXY-3-IODO-5-METHYL-BENZAMIDE,QKGFTDAISIBIBV-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
144777,6w9q,DB06362,-7.6,Becatecarin,JSKFWUPVIZYJMR-UDOAKELVSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
31559,6cs2,DB14028,-7.6,Nordazepam,AKPLHCDWDRPJGD-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
23794,6cs2,DB01431,-7.6,Allylestrenol,ATXHVCQZZJYMCF-XUDSTZEESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
63889,6lxt,DB00823,-7.6,Ethynodiol diacetate,ONKUMRGIYFNPJW-KIEAKMPYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
121311,6w4b,DB11703,-7.6,Acalabrutinib,WDENQIQQYWYTPO-IBGZPJMESA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
62965,6crv,DB14835,-7.6,SUVN-G3031,LNXDUSQEXVQFGP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
63883,6lxt,DB00817,-7.6,Rosoxacin,XBPZXDSZHPDXQU-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
24021,6cs2,DB01674,-7.6,[2-(1-Amino-2-Hydroxy-Propyl)-4-(4-Fluoro-1h-Indol-3-Ylmethyl)-5-Hydroxy-Imidazol-1-Yl]-Acetic Acid,AYMRQIHECFEMIQ-AYVTZFPOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
78940,6m2n,DB12478,-7.6,Piribedil,OQDPVLVUJFGPGQ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
68250,6lxt,DB07702,-7.6,17alpha-Estriol,PROQIPRRNZUXQM-PNVOZDDCSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
108545,6vxx,DB08378,-7.6,"4-[4-(2,5-DIOXO-PYRROLIDIN-1-YL)-PHENYLAMINO]-4-HYDROXY-BUTYRIC ACID",SUETUOGYOWOLNJ-NSHDSACASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
98676,6vxs,DB01212,-7.6,Ceftriaxone,VAAUVRVFOQPIGI-SPQHTLEESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
98414,6vxs,DB00913,-7.6,Anileridine,LKYQLAWMNBFNJT-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
80035,6m2n,DB14209,-7.6,Trandolaprilat,AHYHTSYNOHNUSH-HXFGRODQSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
23797,6cs2,DB01434,-7.6,19-norandrostenedione,JRIZOGLBRPZBLQ-QXUSFIETSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
90306,6m71,DB01564,-7.6,Calusterone,IVFYLRMMHVYGJH-PVPPCFLZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
98423,6vxs,DB00922,-7.6,Levosimendan,WHXMKTBCFHIYNQ-SECBINFHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
74094,6m2n,DB02894,-7.6,"Sulfamic Acid 2,3-O-(1-Methylethylidene)-4,5-O-Sulfonyl-Beta-Fructopyranose Ester",GGOAQSGCBDRTHT-JAKMQLQISA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
97882,6vxs,DB00275,-7.6,Olmesartan,VTRAEEWXHOVJFV-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
108141,6vxx,DB07149,-7.6,"(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluoroethyl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one",LCBAQTCTQXHTJG-ZETCQYMHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
98943,6vxs,DB01599,-7.6,Probucol,FYPMFJGVHOHGLL-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
79499,6m2n,DB13355,-7.6,Visnadine,GVBNSPFBYXGREE-CXWAGAITSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
68528,6lxt,DB08020,-7.6,"(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-6-(METHOXYMETHYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL",RHQLNMNKTIOREN-AOIWGVFYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
142669,6w9q,DB02498,-7.6,Carba-Nicotinamide-Adenine-Dinucleotide,DGPLSUKWXXSBCU-VGXGLJSLSA-O,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
98939,6vxs,DB01594,-7.6,Cinolazepam,XAXMYHMKTCNRRZ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
108571,6vxx,DB08409,-7.6,4-NITRO-BENZYLPHOSPHONOBUTANOYL-GLYCINE,LNMNPGKCSJFAGN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
13393,6lzg,DB15275,-7.6,GDC-0077,SGEUNORSOZVTOL-CABZTGNLSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
13395,6lzg,DB15281,-7.6,Ravoxertinib,RZUOCXOYPYGSKL-GOSISDBHSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
98658,6vxs,DB01192,-7.6,Oxymorphone,UQCNKQCJZOAFTQ-ISWURRPUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
108248,6vxx,DB07276,-7.6,"5-CYANO-N-(2,5-DIMETHOXYBENZYL)-6-ETHOXYPYRIDINE-2-CARBOXAMIDE",VEGKZYFYGCWXMN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108143,6vxx,DB07153,-7.6,"6-methyl-5-[3-methyl-3-(3,4,5-trimethoxyphenyl)but-1-yn-1-yl]pyrimidine-2,4-diamine",FJNFXXGWYVMQNA-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55656,6crv,DB01260,-7.6,Desonide,WBGKWQHBNHJJPZ-LECWWXJVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
74101,6m2n,DB02902,-7.6,3'-Phosphate-Adenosine-5'-Phosphate Sulfate,GACDQMDRPRGCTN-KQYNXXCUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
164834,7bv1,DB08661,-7.6,"1-(2,5-dideoxy-5-pyrrolidin-1-yl-beta-L-erythro-pentofuranosyl)-5-methylpyrimidine-2,4(1H,3H)-dione",XUSBTLVYPZUOAW-WOPDTQHZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
144708,6w9q,DB06194,-7.6,Elocalcitol,LRLWXBHFPGSUOX-GJQYOBCGSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
63447,6lxt,DB00284,-7.6,Acarbose,CEMXHAPUFJOOSV-XGWNLRGSSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
55154,6crv,DB00676,-7.6,Benzyl benzoate,SESFRYSPDFLNCH-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
98938,6vxs,DB01591,-7.6,Solifenacin,FBOUYBDGKBSUES-VXKWHMMOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
121898,6w4b,DB12561,-7.6,WNT-974,XXYGTCZJJLTAGH-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
121357,6w4b,DB11775,-7.6,PF-03758309,AYCPARAPKDAOEN-LJQANCHMSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
98922,6vxs,DB01569,-7.6,Formebolone,AMVODTGMYSRMNP-GNIMZFFESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
121370,6w4b,DB11793,-7.6,Niraparib,PCHKPVIQAHNQLW-CQSZACIVSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
108128,6vxx,DB07134,-7.6,"5-(4-CHLORO-5-PHENYL-3-THIENYL)-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDE",LCPRWBWCEGWNKF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
63239,6crv,DB15411,-7.6,ABP-700,DRAFVCKNYNQOKR-GFCCVEGCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
90729,6m71,DB02123,-7.6,Glycochenodeoxycholic Acid,GHCZAUBVMUEKKP-GYPHWSFCSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
123149,6w4b,DB14937,-7.6,MK-8666,CODQKEMYZZKQAE-QPVYNBJUSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
79481,6m2n,DB13335,-7.6,Pinazepam,MFZOSKPPVCIFMT-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
55175,6crv,DB00699,-7.6,Nicergoline,YSEXMKHXIOCEJA-FVFQAYNVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
98917,6vxs,DB01564,-7.6,Calusterone,IVFYLRMMHVYGJH-PVPPCFLZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
154360,6wiq,DB07786,-7.6,"1-((1R,2S)-1-{2-[2-(4-CHLOROPHENYL)-1,3-BENZOXAZOL-7-YL]ETHYL}-2-HYDROXYPROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE",SMFRBBHLVBWHGB-DJJJIMSYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
63818,6lxt,DB00737,-7.6,Meclizine,OCJYIGYOJCODJL-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
123138,6w4b,DB14916,-7.6,Selonsertib,YIDDLAAKOYYGJG-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
108291,6vxx,DB07585,-7.6,"5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine",YFFJXGRXFASBDL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
68799,6lxt,DB08346,-7.6,"(5Z)-13-CHLORO-14,16-DIHYDROXY-3,4,7,8,9,10-HEXAHYDRO-1H-2-BENZOXACYCLOTETRADECINE-1,11(12H)-DIONE",YUZYDHRGGDTZLG-DUXPYHPUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
28020,6cs2,DB07589,-7.6,"N-[1-(AMINOMETHYL)CYCLOPROPYL]-3-(BENZYLSULFONYL)-N-2-[(1S)-2,2,2-TRIFLUORO-1-(4-HYDROXYPHENYL)ETHYL]-L-ALANINAMIDE",DWWVPKCSDHDILN-OALUTQOASA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
142821,6w9q,DB02698,-7.6,"N-(M-Trifluoromethylphenyl) Phenoxazine-4,6-Dicarboxylic Acid",NQOOJFXBGLOGTC-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
123181,6w4b,DB15036,-7.6,Sitravatinib,WLAVZAAODLTUSW-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
63867,6lxt,DB00799,-7.6,Tazarotene,OGQICQVSFDPSEI-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
98402,6vxs,DB00901,-7.6,Bitolterol,FZGVEKPRDOIXJY-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
29025,6cs2,DB08660,-7.6,"1,2,5,8-tetrahydroxyanthracene-9,10-dione",VBHKTXLEJZIDJF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
55161,6crv,DB00684,-7.6,Tobramycin,NLVFBUXFDBBNBW-PBSUHMDJSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79708,6m2n,DB13642,-7.6,Pridinol,RQXCLMGKHJWMOA-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
121341,6w4b,DB11751,-7.6,Cabotegravir,WCWSTNLSLKSJPK-LKFCYVNXSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
90310,6m71,DB01568,-7.6,Codeine-N-oxide,BDLSDHWCOJPHIE-KFUGMXNISA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
144747,6w9q,DB06267,-7.6,Udenafil,IYFNEFQTYQPVOC-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
144751,6w9q,DB06276,-7.6,Tanomastat,JXAGDPXECXQWBC-LJQANCHMSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
32055,6cs2,DB15279,-7.6,CB-103,WHIWGRCYMQLLAO-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
55476,6crv,DB01048,-7.6,Abacavir,MCGSCOLBFJQGHM-SCZZXKLOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
121347,6w4b,DB11763,-7.6,Momelotinib,ZVHNDZWQTBEVRY-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
89931,6m71,DB01061,-7.6,Azlocillin,JTWOMNBEOCYFNV-NFFDBFGFSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
55679,6crv,DB01325,-7.6,Quinethazone,AGMMTXLNIQSRCG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
73677,6m2n,DB02353,-7.6,Heparin Disaccharide Iii-S,GSYQGRODWXMUOO-GYBHJADLSA-K,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
107914,6vxx,DB05562,-7.6,Naluzotan,SPWZXWDPAWDKQE-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28279,6cs2,DB07861,-7.6,(2R)-N-hydroxy-3-naphthalen-2-yl-2-[(naphthalen-2-ylsulfonyl)amino]propanamide,MMOUXLMPQFMDRD-JOCHJYFZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
143198,6w9q,DB03205,-7.6,Pyrroloquinoline Quinone,MMXZSJMASHPLLR-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
63589,6lxt,DB00457,-7.6,Prazosin,IENZQIKPVFGBNW-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
107973,6vxx,DB05943,-7.6,Resatorvid,LEEIJTHMHDMWLJ-CQSZACIVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107980,6vxx,DB05974,-7.6,Transcrocetinate,PANKHBYNKQNAHN-MQQNZMFNSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
98820,6vxs,DB01456,-7.6,5-androstenedione,SQGZFRITSMYKRH-QAGGRKNESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
73986,6m2n,DB02754,-7.6,"9-Butyl-8-(3,4,5-Trimethoxybenzyl)-9h-Purin-6-Amine",TUOSCZDRWRYPRS-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
23908,6cs2,DB01548,-7.6,Diprenorphine,OIJXLIIMXHRJJH-KNLIIKEYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
79213,6m2n,DB12912,-7.6,Nolatrexed,XHWRWCSCBDLOLM-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79897,6m2n,DB13929,-7.6,Relcovaptan,CEBYCSRFKCEUSW-NAYZPBBASA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
144979,6w9q,DB06809,-7.6,Plerixafor,YIQPUIGJQJDJOS-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
107986,6vxx,DB06649,-7.6,Priralfinamide,BHJIBOFHEFDSAU-LBPRGKRZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79222,6m2n,DB12927,-7.6,Theodrenaline,WMCMJIGLYZDKRN-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
23874,6cs2,DB00239,-7.6,Oxiconazole,QRJJEGAJXVEBNE-HKOYGPOVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
164414,7bv1,DB07804,-7.6,"5-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1H-1,2,4-TRIAZOLE-3-SULFONAMIDE",FKCQUVAGEOSYRU-QWRGUYRKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
143874,6w9q,DB04115,-7.6,Berberine,YBHILYKTIRIUTE-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
98809,6vxs,DB01443,-7.6,19-Nor-5-androstenedione,WELNRNVZXWUOGT-QXUSFIETSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
143869,6w9q,DB04107,-7.6,[(1-{2[(4-Carbamimidoyl-Phenylamino)-Methyl]-1-Methyl-1h-Benzoimidazol-5-Yl}-Cyclopropyl)-Pyridin-2-Yl-Methyleneaminooxy]-Acetic Acid Ethyl Ester,RNOYCNIZOAIUSV-LSWMGQQCSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
10698,6lzg,DB08954,-7.6,Ifenprodil,UYNVMODNBIQBMV-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
63090,6crv,DB15114,-7.6,Vamorolone,ZYTXTXAMMDTYDQ-DGEXFFLYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31980,6cs2,DB15143,-7.6,PF-06650833,JKDGKIBAOAFRPJ-ZBINZKHDSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
121703,6w4b,DB12280,-7.6,AZD-5423,FCNQMDSJHADDFT-WNSKOXEYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
27955,6cs2,DB07520,-7.6,"N-[1-(AMINOMETHYL)CYCLOPROPYL]-3-(MORPHOLIN-4-YLSULFONYL)-N-2-[(1S)-2,2,2-TRIFLUORO-1-(4-FLUOROPHENYL)ETHYL]-L-ALANINAMIDE",BJIKKEHGGYGGIX-HOTGVXAUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
98767,6vxs,DB01388,-7.6,Mibefradil,HBNPJJILLOYFJU-VMPREFPWSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
143511,6w9q,DB03642,-7.6,Benzofuran-2-Carboxylic Acid {(S)-3-Methyl-1-[3-Oxo-1-(Pyridin-2-Ylsulfonyl)Azepan-4-Ylcarbamoyl]Butyl}Amide,VBPPNJCVXGAZDD-PMACEKPBSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
29117,6cs2,DB08754,-7.6,"(2E)-3-(3,4-DIHYDROXYPHENYL)-N-[2-(4-HYDROXYPHENYL)ETHYL]ACRYLAMIDE",VSHUQLRHTJOKTA-XBXARRHUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
121687,6w4b,DB12260,-7.6,Radiprodil,GKGRZLGAQZPEHO-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
23920,6cs2,DB01559,-7.6,Clotiazepam,CHBRHODLKOZEPZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
98220,6vxs,DB00689,-7.6,Cephaloglycin,FUBBGQLTSCSAON-PBFPGSCMSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
79827,6m2n,DB13796,-7.6,Dibunate,WBEBQCINXJDZCX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
122867,6w4b,DB14045,-7.6,Cholesteryl chloride,OTVRYZXVVMZHHW-DPAQBDIFSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
79316,6m2n,DB13070,-7.6,Surinabant,HMXDWDSNPRNUKI-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
164668,7bv1,DB08463,-7.6,(2R)-2-({9-(1-methylethyl)-6-[(4-pyridin-2-ylbenzyl)amino]-9H-purin-2-yl}amino)butan-1-ol,HOCBJBNQIQQQGT-LJQANCHMSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
63599,6lxt,DB00471,-7.6,Montelukast,UCHDWCPVSPXUMX-TZIWLTJVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
121556,6w4b,DB12068,-7.6,T-900607,FSXLOWIFSZNIMV-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
31949,6cs2,DB15091,-7.6,Upadacitinib,WYQFJHHDOKWSHR-MNOVXSKESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
55309,6crv,DB00857,-7.6,Terbinafine,DOMXUEMWDBAQBQ-WEVVVXLNSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55312,6crv,DB00860,-7.6,Prednisolone,OIGNJSKKLXVSLS-VWUMJDOOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55835,6crv,DB01538,-7.6,Acetyldihydrocodeine,LGGDXXJAGWBUSL-BKRJIHRRSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
145039,6w9q,DB06888,-7.6,"(13R,15S)-13-METHYL-16-OXA-8,9,12,22,24-PENTAAZAHEXACYCLO[15.6.2.16,9.1,12,15.0,2,7.0,21,25]HEPTACOSA-1(24),2,4,6,17(25),18,20-HEPTAENE-23,26-DIONE",KBLPHMRCKHFBJB-OLZOCXBDSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
143794,6w9q,DB04006,-7.6,"[2-Amino-6-(2,6-Difluoro-Benzoyl)-Imidazo[1,2-a]Pyridin-3-Yl]-Phenyl-Methanone",WUGJIPFLBOATGL-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
98248,6vxs,DB00719,-7.6,Azatadine,SEBMTIQKRHYNIT-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
145006,6w9q,DB06849,-7.6,"1-[1'-(3-phenylacryloyl)spiro[1-benzofuran-3,4'-piperidin]-5-yl]methanamine",RQWYWHUKHYFIPB-VQHVLOKHSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
29103,6cs2,DB08742,-7.6,"1,3-CYCLOHEXANEDIOL, 4-METHYLENE-5-[(2E)-[(1S,3AS,7AS)-OCTAHYDRO-1-(5-HYDROXY-5-METHYL-1,3-HEXADIYNYL)-7A-METHYL-4H-INDEN-4-YLIDENE]ETHYLIDENE]-, (1R,3S,5Z)",CEEUUHVULXTFGS-BQXVGYHGSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
98775,6vxs,DB01405,-7.6,Temafloxacin,QKDHBVNJCZBTMR-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
155011,6wiq,DB08553,-7.6,"(1E)-5-(1-piperidin-4-yl-3-pyridin-4-yl-1H-pyrazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime",KWEFZSZCLBHIEQ-YYADALCUSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
90106,6m71,DB01268,-7.6,Sunitinib,WINHZLLDWRZWRT-ATVHPVEESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
55331,6crv,DB00882,-7.6,Clomifene,GKIRPKYJQBWNGO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
23734,6cs2,DB01337,-7.6,Pancuronium,GVEAYVLWDAFXET-XGHATYIMSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
164685,7bv1,DB08485,-7.6,"(1S,4S,5S)-1,4,5-TRIHYDROXY-3-[3-(PHENYLTHIO)PHENYL]CYCLOHEX-2-ENE-1-CARBOXYLIC ACID",QMNMNSINKIFYBV-LMMKCTJWSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
55336,6crv,DB00887,-7.6,Bumetanide,MAEIEVLCKWDQJH-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
122728,6w4b,DB13790,-7.6,Fipexide,BFUJHVVEMMWLHC-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
90085,6m71,DB01238,-7.6,Aripiprazole,CEUORZQYGODEFX-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
143762,6w9q,DB03962,-7.6,Nicotinamide 8-Bromo-Adenine Dinucleotide Phosphate,MDKMTCCUJSRQGW-NAJQWHGHSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
98794,6vxs,DB01426,-7.6,Ajmaline,CJDRUOGAGYHKKD-HEFSZTOGSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
55345,6crv,DB00899,-7.6,Remifentanil,ZTVQQQVZCWLTDF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
144982,6w9q,DB06817,-7.6,Raltegravir,CZFFBEXEKNGXKS-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
28236,6cs2,DB07816,-7.6,N-(P-CYANOPHENYL)-N'-DIPHENYLMETHYL-GUANIDINE-ACETIC ACID,KGHMYJFHUHFOGL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
31944,6cs2,DB15079,-7.6,Troriluzole,YBZSGIWIPOUSHY-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
98283,6vxs,DB00764,-7.6,Mometasone,QLIIKPVHVRXHRI-CXSFZGCWSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
90522,6m71,DB01842,-7.6,3'-Phosphate-Adenosine-5'-Diphosphate,GBBWIZKLHXYJOA-KQYNXXCUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
144993,6w9q,DB06831,-7.6,2-((9H-PURIN-6-YLTHIO)METHYL)-5-CHLORO-3-(2-METHOXYPHENYL)QUINAZOLIN-4(3H)-ONE,UMMYTDJYDSTEMB-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
121652,6w4b,DB12211,-7.6,PSI-697,DIEPFYNZGUUVHD-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
55318,6crv,DB00867,-7.6,Ritodrine,IOVGROKTTNBUGK-SJCJKPOMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
121606,6w4b,DB12137,-7.6,GSK-256066,JFHROPTYMMSOLG-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
68401,6lxt,DB07872,-7.6,5-chloro-N-[(3R)-1-(2-{[2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl]amino}-2-oxoethyl)pyrrolidin-3-yl]thiophene-2-carboxamide,IYGIXVNAMZPBDK-CQSZACIVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
90464,6m71,DB01767,-7.6,Hemi-Babim,KKJYVDXDZURHMA-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
36761,1r42,DB03351,-7.6,Sri-9439,KMSATRJZEXNGDP-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
164406,7bv1,DB07795,-7.6,Fisetin,XHEFDIBZLJXQHF-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
73742,6m2n,DB02429,-7.6,4-(Aminosulfonyl)-N-[(4-Fluorophenyl)Methyl]-Benzamide,IXDVPACDZDRCTN-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
10896,6lzg,DB09227,-7.6,Barnidipine,VXMOONUMYLCFJD-DHLKQENFSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
31671,6cs2,DB14512,-7.6,Mometasone furoate,WOFMFGQZHJDGCX-ZULDAHANSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
79800,6m2n,DB13762,-7.6,Dexrabeprazole,YREYEVIYCVEVJK-RUZDIDTESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
90558,6m71,DB01895,-7.6,Aspartyl-Adenosine-5'-Monophosphate,QPBSGQWTJLPZNF-VWJPMABRSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
28208,6cs2,DB07790,-7.6,N-(2-METHOXYETHYL)-4-({4-[2-METHYL-1-(1-METHYLETHYL)-1H-IMIDAZOL-5-YL]PYRIMIDIN-2-YL}AMINO)BENZENESULFONAMIDE,LDXLQEXLXZCYSR-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
79118,6m2n,DB12758,-7.6,Atreleuton,MMSNEKOTSJRTRI-LLVKDONJSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79767,6m2n,DB13718,-7.6,Hydroquinine,LJOQGZACKSYWCH-WZBLMQSHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
68477,6lxt,DB07965,-7.6,6-(cyclohexylamino)-9-[2-(4-methylpiperazin-1-yl)-ethyl]-9H-purine-2-carbonitrile,OGODDSLNRULSMM-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
155138,6wiq,DB08710,-7.6,"(5Z)-5-[(5-ETHYL-2-FURYL)METHYLENE]-2-{[(S)-(4-FLUOROPHENYL)(1H-TETRAZOL-5-YL)METHYL]AMINO}-1,3-THIAZOL-4(5H)-ONE",BKZOQCGDCHOGOQ-MZLJFPOFSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
31896,6cs2,DB14987,-7.6,Difamilast,VFBILHPIHUPBPZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
23944,6cs2,DB01582,-7.6,Sulfamethazine,ASWVTGNCAZCNNR-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
79766,6m2n,DB13717,-7.6,Phenothrin,SBNFWQZLDJGRLK-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
28274,6cs2,DB07857,-7.6,(2R)-2-(4-chlorophenyl)-2-[4-(1H-pyrazol-4-yl)phenyl]ethanamine,HWVGILTYGZFGLR-QGZVFWFLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
23845,6cs2,DB01482,-7.6,Fenethylline,NMCHYWGKBADVMK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
122980,6w4b,DB14583,-7.6,Segesterone acetate,CKFBRGLGTWAVLG-GOMYTPFNSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
79787,6m2n,DB13741,-7.6,Ioglycamic acid,FZDZULUFHNDEDJ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
144079,6w9q,DB04392,-7.6,"Bishydroxy[2h-1-Benzopyran-2-One,1,2-Benzopyrone]",HIZKPJUTKKJDGA-BETUJISGSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
98331,6vxs,DB00821,-7.6,Carprofen,PUXBGTOOZJQSKH-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
122979,6w4b,DB14581,-7.6,CPI-1205,HPODOLXTMDHLLC-QGZVFWFLSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
121505,6w4b,DB11992,-7.6,Omarigliptin,MKMPWKUAHLTIBJ-ISTRZQFTSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
63507,6lxt,DB00358,-7.6,Mefloquine,XEEQGYMUWCZPDN-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
55729,6crv,DB01416,-7.6,Cefpodoxime,WYUSVOMTXWRGEK-HBWVYFAYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
68351,6lxt,DB07816,-7.6,N-(P-CYANOPHENYL)-N'-DIPHENYLMETHYL-GUANIDINE-ACETIC ACID,KGHMYJFHUHFOGL-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
98344,6vxs,DB00834,-7.6,Mifepristone,VKHAHZOOUSRJNA-GCNJZUOMSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
55246,6crv,DB00786,-7.6,Marimastat,OCSMOTCMPXTDND-OUAUKWLOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79401,6m2n,DB13227,-7.6,Tribenoside,ULLNJSBQMBKOJH-VIVFLBMVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
107917,6vxx,DB05585,-7.6,Verubulin,SNHCRNMVYDHVDT-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
144870,6w9q,DB06609,-7.6,Odiparcil,JRHNIQQUVJOPQC-AQNFWKISSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
79090,6m2n,DB12715,-7.6,MSX-122,PXZXYRKDDXKDTK-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
27866,6cs2,DB07425,-7.6,Sobetirome,QNAZTOHXCZPOSA-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
89997,6m71,DB01137,-7.6,Levofloxacin,GSDSWSVVBLHKDQ-JTQLQIEISA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
121487,6w4b,DB11963,-7.6,Dacomitinib,LVXJQMNHJWSHET-AATRIKPKSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
98130,6vxs,DB00580,-7.6,Valdecoxib,LNPDTQAFDNKSHK-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
98137,6vxs,DB00587,-7.6,Cinalukast,BZMKNPGKXJAIDV-VAWYXSNFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
108097,6vxx,DB06843,-7.6,"2',5'-DIDEOXY-ADENOSINE 3'-MONOPHOSPHATE",NFGZMOICZSFFLB-DSYKOEDSSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79382,6m2n,DB13203,-7.6,Bamifylline,VVUYEFBRTFASAH-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
31595,6cs2,DB01070,-7.6,Dihydrotachysterol,ILYCWAKSDCYMBB-OPCMSESCSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
68339,6lxt,DB07804,-7.6,"5-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1H-1,2,4-TRIAZOLE-3-SULFONAMIDE",FKCQUVAGEOSYRU-QWRGUYRKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
122553,6w4b,DB13554,-7.6,Moperone,AGAHNABIDCTLHW-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
123198,6w4b,DB15068,-7.6,Agerafenib,DKNUPRMJNUQNHR-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
108073,6vxx,DB06803,-7.6,Niclosamide,RJMUSRYZPJIFPJ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
98164,6vxs,DB00620,-7.6,Triamcinolone,GFNANZIMVAIWHM-OBYCQNJPSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
108060,6vxx,DB06781,-7.6,Difluprednate,WYQPLTPSGFELIB-JTQPXKBDSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79171,6m2n,DB12853,-7.6,DA-6886,AULLTYAISZREAX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
10711,6lzg,DB08968,-7.6,Fominoben,KSNNEUZOAFRTDS-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
98844,6vxs,DB01482,-7.6,Fenethylline,NMCHYWGKBADVMK-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
98192,6vxs,DB00656,-7.6,Trazodone,PHLBKPHSAVXXEF-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
90146,6m71,DB01357,-7.6,Mestranol,IMSSROKUHAOUJS-MJCUULBUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
68660,6lxt,DB08166,-7.6,"(4R)-7-chloro-9-methyl-1-oxo-1,2,4,9-tetrahydrospiro[beta-carboline-3,4'-piperidine]-4-carbonitrile",LPFQFJAOMCGYCP-GFCCVEGCSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
55597,6crv,DB01186,-7.6,Pergolide,YEHCICAEULNIGD-MZMPZRCHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27965,6cs2,DB07531,-7.6,"4-{5-[(Z)-(2,4-DIOXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE",JNPRTUHVCHGFHJ-GHXNOFRVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
23861,6cs2,DB01500,-7.6,Oxabolone,GXHBCWCMYVTJOW-YGRHGMIBSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
27964,6cs2,DB07530,-7.6,"(1R,3R)-5-[(2E)-3-{(1S,3R)-2,2,3-trimethyl-3-[6,6,6-trifluoro-5-hydroxy-5-(trifluoromethyl)hex-3-yn-1-yl]cyclopentyl}prop-2-en-1-ylidene]cyclohexane-1,3-diol",PCHUQQNKOFNVDU-OSXMSNBXSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
98843,6vxs,DB01481,-7.6,1-Testosterone,OKJCFMUGMSVJBG-ABEVXSGRSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
28203,6cs2,DB07785,-7.6,"1-{(1R,2S)-2-HYDROXY-1-[2-(2-NAPHTHYLOXY)ETHYL]PROPYL}-1H-IMIDAZONE-4-CARBOXAMIDE",UYAJDVNLQJVRHD-SCLBCKFNSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
55894,6crv,DB01607,-7.6,Ticarcillin,OHKOGUYZJXTSFX-KZFFXBSXSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
10706,6lzg,DB08962,-7.6,Glibornuride,RMTYNAPTNBJHQI-LLDVTBCESA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
29235,6cs2,DB08906,-7.6,Fluticasone furoate,XTULMSXFIHGYFS-VLSRWLAYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
107952,6vxx,DB05805,-7.6,NS-2359,PGYDXVBZYKQYCS-VPWBDBDCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
63515,6lxt,DB00370,-7.6,Mirtazapine,RONZAEMNMFQXRA-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
108459,6vxx,DB08014,-7.6,(METHYLPYRIDAZINE PIPERIDINE BUTYLOXYPHENYL)ETHYLACETATE,AQILFLLHLFBLLG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
98745,6vxs,DB01338,-7.6,Pipecuronium,OWWLUIWOFHMHOQ-XGHATYIMSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
68742,6lxt,DB08272,-7.6,(4S)-4-(2-NAPHTHYLMETHYL)-D-GLUTAMIC ACID,YDWIUFASTTZKNI-UONOGXRCSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
98327,6vxs,DB00817,-7.6,Rosoxacin,XBPZXDSZHPDXQU-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
144052,6w9q,DB04350,-7.6,Argadin,FOZYKTUSOWWQGR-KNPYFFGGSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
55918,6crv,DB01634,-7.6,2-Oxy-4-Hydroxy-5-(2-Hydrazinopyridine)Phenylalanine,AZUQIXJQZOMXAS-BDAKNGLRSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
10656,6lzg,DB08893,-7.6,Mirabegron,PBAPPPCECJKMCM-IBGZPJMESA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
23721,6cs2,DB01320,-7.6,Fosphenytoin,XWLUWCNOOVRFPX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
79167,6m2n,DB12846,-7.6,Reproterol,WVLAAKXASPCBGT-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
164374,7bv1,DB07759,-7.6,5-[2-(TRIFLUOROMETHYL)PHENYL]-2-FUROIC ACID,IJPNRBZMRINMMR-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
68368,6lxt,DB07835,-7.6,"N-3-cyclopropyl-N-4-'-(cyclopropylmethyl)-6-methylbiphenyl-3,4'-dicarboxamide",BOPSUAHGQHFKGG-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
28264,6cs2,DB00719,-7.6,Azatadine,SEBMTIQKRHYNIT-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
55913,6crv,DB01628,-7.6,Etoricoxib,MNJVRJDLRVPLFE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
164376,7bv1,DB07761,-7.6,"(2R)-1-[4-({6-[(2,6-Difluorophenyl)amino]-4-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol",ZVSBKYYVBCKDBO-OAHLLOKOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
143390,6w9q,DB03461,-7.6,2'-Monophosphoadenosine 5'-Diphosphoribose,XJLXINKUBYWONI-NNYOXOHSSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
121726,6w4b,DB12308,-7.6,Eltanolone,AURFZBICLPNKBZ-YZRLXODZSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
68617,6lxt,DB08121,-7.6,(2S)-2-(biphenyl-4-yloxy)-3-phenylpropanoic acid,TZTPJJNNACUQQR-FQEVSTJZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
121358,6w4b,DB11778,-7.6,Danusertib,XKFTZKGMDDZMJI-HSZRJFAPSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
143815,6w9q,DB04038,-7.6,Ergosterol,DNVPQKQSNYMLRS-APGDWVJJSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
24089,6cs2,DB01755,-7.6,N-[Isoleucinyl]-N'-[Adenosyl]-Diaminosufone,XVTRBLLRODNOJV-VBJYJYTRSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
63345,6lxt,DB00169,-7.6,Cholecalciferol,QYSXJUFSXHHAJI-YRZJJWOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
73644,6m2n,DB02310,-7.6,"3,5,6,8-Tetramethyl-N-Methyl Phenanthrolinium",FQTUZNACZKILMC-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
142451,6w9q,DB02221,-7.6,"4-(Aminosulfonyl)-N-[(2,4,6-Trifluorophenyl)Methyl]-Benzamide",DVTYOTODFLDHRL-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
108217,6vxx,DB07240,-7.6,3-[(9H-fluoren-9-ylideneamino)oxy]propanoic acid,LASWLEUVWJDDBA-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108628,6vxx,DB08478,-7.6,N-[2-chloro-5-(trifluoromethyl)phenyl]imidodicarbonimidic diamide,IGFTZEOFHWPCDL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
90251,6m71,DB01503,-7.6,1-Androstenediol,RZFGPAMUAXASRE-YSZCXEEOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
107552,6vxx,DB03751,-7.6,2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose,YSYKRGRSMLTJNL-URARBOGNSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
68219,6lxt,DB07665,-7.6,"N-[2-(carbamimidamidooxy)ethyl]-2-{6-cyano-3-[(2,2-difluoro-2-pyridin-2-ylethyl)amino]-2-fluorophenyl}acetamide",STHCHQXQLDMISY-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
62891,6crv,DB14663,-7.6,Ribavirin monophosphate,SDWIOXKHTFOULX-AFCXAGJDSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
63977,6lxt,DB00920,-7.6,Ketotifen,ZCVMWBYGMWKGHF-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
68218,6lxt,DB07664,-7.6,"5-AMINO-3-{[4-(AMINOSULFONYL)PHENYL]AMINO}-N-(2,6-DIFLUOROPHENYL)-1H-1,2,4-TRIAZOLE-1-CARBOTHIOAMIDE",ARIOBGGRZJITQX-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
122202,6w4b,DB13040,-7.6,Gandotinib,SQSZANZGUXWJEA-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
80195,6m2n,DB14849,-7.6,Nebicapone,MRFOLGFFTUGAEB-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
123251,6w4b,DB15173,-7.6,JNJ-42165279,YWGYNGCRVZLMCS-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
31800,6cs2,DB14772,-7.6,DCFBC F-18,IDTMSHGCAZPVLC-STUNTBJNSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
164531,7bv1,DB08112,-7.6,N-({6-[(4-CYANO-2-FLUOROBENZYL)OXY]NAPHTHALEN-2-YL}SULFONYL)-D-GLUTAMIC ACID,IRJUSGUHNFMVCK-OAQYLSRUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
32128,6cs2,DB15410,-7.6,(S)-Propafenone,JWHAUXFOSRPERK-SFHVURJKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
55026,6crv,DB00521,-7.6,Carteolol,LWAFSWPYPHEXKX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
13223,6lzg,DB14929,-7.6,Elsulfavirine,ULTDEARCBRNRGR-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
164860,7bv1,DB08697,-7.6,"4-(2-aminoethoxy)-N-(3-chloro-5-piperidin-1-ylphenyl)-3,5-dimethylbenzamide",JDYIYIRPQKMWMM-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
144635,6w9q,DB05812,-7.6,Abiraterone,GZOSMCIZMLWJML-VJLLXTKPSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
144561,6w9q,DB05414,-7.6,Pipendoxifene,JICOGKJOQXTAIP-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
99085,6vxs,DB01782,-7.6,"2,6-Dihydroanthra/1,9-Cd/Pyrazol-6-One",ACPOUJIDANTYHO-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
13483,6lzg,DB15446,-7.6,Vidofludimus,XPRDUGXOWVXZLL-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
107624,6vxx,DB04102,-7.6,2-Amino-Adenosine,CQKMBZHLOYVGHW-QYYRPYCUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
98542,6vxs,DB01061,-7.6,Azlocillin,JTWOMNBEOCYFNV-NFFDBFGFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
164853,7bv1,DB08686,-7.6,"5,6,7,8,9,10-HEXAHYDRO-4-HYDROXY-3-(1-PHENYLPROPYL)CYCLOOCTA[B]PYRAN-2-ONE",UXCLJNSXDNCIIT-HNNXBMFYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
78811,6m2n,DB12299,-7.6,Bavisant,BGBVSGSIXIIREO-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
90226,6m71,DB01474,-7.6,"17alpha-methyl-3beta,17beta-dihydroxyandrost-4-ene",BNUOCVTVOYWNJC-DTMQFJJTSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
27776,6cs2,DB00671,-7.6,Cefixime,OKBVVJOGVLARMR-QSWIMTSFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
142533,6w9q,DB02329,-7.6,Carbenoxolone,OBZHEBDUNPOCJG-WBXJDKIVSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
108155,6vxx,DB07167,-7.6,5-CYANO-FURAN-2-CARBOXYLIC ACID [5-HYDROXYMETHYL-2-(4-METHYL-PIPERIDIN-1-YL)-PHENYL]-AMIDE,NNPCFFIJVKYGHR-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55081,6crv,DB00586,-7.6,Diclofenac,DCOPUUMXTXDBNB-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
121182,6w4b,DB11429,-7.6,Mibolerone,PTQMMNYJKCSPET-OMHQDGTGSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
98547,6vxs,DB01066,-7.6,Cefditoren,KMIPKYQIOVAHOP-YLGJWRNMSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
99094,6vxs,DB01793,-7.6,SB-409513,ONVZFCHLOZUXRP-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
107541,6vxx,DB03737,-7.6,"4-((3r,4s,5r)-4-Amino-3,5-Dihydroxy-Hex-1-Ynyl)-5-Fluoro-3-[1-(3-Methoxy-1h-Pyrrol-2-Yl)-Meth-(Z)-Ylidene]-1,3-Dihydro-Indol-2-One",RAKYKJWUUUKCCW-MPLBGYFPSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
49330,2fxp,DB04330,-7.6,Bilh 434,KNRVCCXHLSHTFW-HGPRPZRGSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
98969,6vxs,DB01628,-7.6,Etoricoxib,MNJVRJDLRVPLFE-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
10544,6lzg,DB08750,-7.6,"1-[4-(AMINOMETHYL)BENZOYL]-5'-FLUORO-1'H-SPIRO[PIPERIDINE-4,2'-QUINAZOLIN]-4'-AMINE",SFPCNWQWKOUNRT-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
31768,6cs2,DB14714,-7.6,Tenivastatin,XWLXKKNPFMNSFA-HGQWONQESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
144453,6w9q,DB04885,-7.6,Cilansetron,NCNFDKWULDWJDS-OAHLLOKOSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
123241,6w4b,DB15151,-7.6,RO-6870810,PKQXLRYFPSZKDU-QFIPXVFZSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
164858,7bv1,DB08694,-7.6,"9-amino-5-(2-aminopyrimidin-4-yl)pyrido[3',2':4,5]pyrrolo[1,2-c]pyrimidin-4-ol",RTHKPHCVZVYDFN-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
122226,6w4b,DB13074,-7.6,Macimorelin,UJVDJAPJQWZRFR-DHIUTWEWSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
155335,6wiq,DB08973,-7.6,Fluclorolone acetonide,NJNWEGFJCGYWQT-VSXGLTOVSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
90823,6m71,DB02253,-7.6,"(1r)-4-[(1e,3e,5e,7z,9e,11z,13e,15e)-17-Hydroxy-3,7,12,16-Tetramethylheptadeca-1,3,5,7,9,11,13,15-Octaen-1-Yl]-3,5,5-Trimethylcyclohex-3-En-1-Ol",FNAJVVMDXCOSFY-VFGOXHQXSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
31837,6cs2,DB14857,-7.6,Avadomide,RSNPAKAFCAAMBH-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
13413,6lzg,DB15307,-7.6,Atabecestat,VLLFGVHGKLDDLW-SFHVURJKSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
63969,6lxt,DB00912,-7.6,Repaglinide,FAEKWTJYAYMJKF-QHCPKHFHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
78885,6m2n,DB12404,-7.6,Remimazolam,CYHWMBVXXDIZNZ-KRWDZBQOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80056,6m2n,DB14540,-7.6,Hydrocortisone butyrate,BMCQMVFGOVHVNG-TUFAYURCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
29177,6cs2,DB08819,-7.6,Tafluprost,WSNODXPBBALQOF-VEJSHDCNSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
63396,6lxt,DB00229,-7.6,Cefotiam,QYQDKDWGWDOFFU-IUODEOHRSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
79559,6m2n,DB13435,-7.6,Endralazine,ALAXZYHFVBSJKZ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
28654,6cs2,DB08253,-7.6,NAM NAPTHYLAMINOALANINE,DGFMSNJYBBNHCX-LBPRGKRZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
63361,6lxt,DB00186,-7.6,Lorazepam,DIWRORZWFLOCLC-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
142329,6w9q,DB02058,-7.6,SU4984,AZGZGRJOCKSSHA-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
32099,6cs2,DB15348,-7.6,Ampreloxetine,TZIALEBTHQWNAO-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
56125,6crv,DB01920,-7.6,1-O-[O-Nitrophenyl]-Beta-D-Galactopyranose,KUWPCJHYPSUOFW-YBXAARCKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31780,6cs2,DB14734,-7.6,Cannabigerol,QXACEHWTBCFNSA-SFQUDFHCSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
164879,7bv1,DB08903,-7.6,Bedaquiline,QUIJNHUBAXPXFS-XLJNKUFUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
99051,6vxs,DB01737,-7.6,"Nalpha-(2-Naphthylsulfonylglycyl)-3-Amidino-D,L-Phenylalanine-Isopropylester",YAEIKQDHLCFGAA-KRWDZBQOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
68187,6lxt,DB07626,-7.6,"4-(2-aminoethoxy)-N-(3-chloro-2-ethoxy-5-piperidin-1-ylphenyl)-3,5-dimethylbenzamide",CKBBGCJYKCLKHE-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
80155,6m2n,DB14750,-7.6,Cidoxepin,ODQWQRRAPPTVAG-BOPFTXTBSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
32109,6cs2,DB15377,-7.6,ATB-346,YCNMAPLPQYQJFC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
31496,6cs2,DB01061,-7.6,Azlocillin,JTWOMNBEOCYFNV-NFFDBFGFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
121011,6w4b,DB09268,-7.6,Picosulfuric acid,UJIDKYTZIQTXPM-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
74128,6m2n,DB02936,-7.6,4-(1-Benzyl-3-Carbamoylmethyl-2-Methyl-1h-Indol-5-Yloxy)-Butyric Acid,STENXUCYNKOBHJ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
89877,6m71,DB01000,-7.6,Cyclacillin,HGBLNBBNRORJKI-WCABBAIRSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
142375,6w9q,DB02115,-7.6,Daidzin,KYQZWONCHDNPDP-QNDFHXLGSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
107589,6vxx,DB04060,-7.6,"(5-Methyl-6-Oxo-1,6-Dihydro-Pyridin-3-Yl)-1,2-Dideoxy-Ribofuranose-5-Monophosphate",MUWYCJQCZPFLFI-IVZWLZJFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79567,6m2n,DB13445,-7.6,Nepinalone,RVXGRCNWGOHSDE-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
64025,6lxt,DB00978,-7.6,Lomefloxacin,ZEKZLJVOYLTDKK-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
108199,6vxx,DB07218,-7.6,"6-CHLORO-9-HYDROXY-1,3-DIMETHYL-1,9-DIHYDRO-4H-PYRAZOLO[3,4-B]QUINOLIN-4-ONE",AYKGPCNWPACUQV-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31787,6cs2,DB14750,-7.6,Cidoxepin,ODQWQRRAPPTVAG-BOPFTXTBSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
13308,6lzg,DB15120,-7.6,GSK-239512,YFRBKEVUUCQYOW-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
122082,6w4b,DB12857,-7.6,NVP-LEQ-506,POERAARDVFVDLO-QGZVFWFLSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
13229,6lzg,DB14937,-7.6,MK-8666,CODQKEMYZZKQAE-QPVYNBJUSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
62919,6crv,DB14720,-7.6,Brovanexine,DQTRREPKGJIABH-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
68842,6lxt,DB08397,-7.6,6-(DIFLUORO-PHOSPHONO-METHYL)-NAPHTHALENE-2-CARBOXYLIC ACID,NKGNOWNPXBURRW-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
68558,6lxt,DB08055,-7.6,"N-(2-chlorophenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine",NNBICZMPIJMWGC-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
164863,7bv1,DB08701,-7.6,"2-(3-BROMOPHENYL)-6-[(2-HYDROXYETHYL)AMINO]-1H-BENZO[DE]ISOQUINOLINE-1,3(2H)-DIONE",JZCUVYNOSDWORZ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97612,6m71,DB15265,-7.6,USL-311,XNUNVQKARNSSEO-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
28396,6cs2,DB07985,-7.6,+/-METHYL 4-(AMINOIMINOMETHYL)-BETA-[3- INH (AMINOIMINO)PHENYL]BENZENE PENTANOATE,PVALLOSAENRPQO-INIZCTEOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
97689,6m71,DB15418,-7.6,AZD-9977,MBKYLPOPYYLTNW-ZDUSSCGKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
120979,6w4b,DB09223,-7.6,Blonanserin,XVGOZDAJGBALKS-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
144620,6w9q,DB05706,-7.6,13-deoxydoxorubicin,RGVRUQHYQSORBY-JIGXQNLBSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
55032,6crv,DB00528,-7.6,Lercanidipine,ZDXUKAKRHYTAKV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28074,6cs2,DB00700,-7.6,Eplerenone,JUKPWJGBANNWMW-VWBFHTRKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
90883,6m71,DB02333,-7.6,Deoxyuridine-5'-Triphosphate,AHCYMLUZIRLXAA-SHYZEUOFSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
11038,6lzg,DB11263,-7.6,Polydatin,HSTZMXCBWJGKHG-CUYWLFDKSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
29195,6cs2,DB00823,-7.6,Ethynodiol diacetate,ONKUMRGIYFNPJW-KIEAKMPYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
13463,6lzg,DB15408,-7.6,Silmitasertib,MUOKSQABCJCOPU-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
164502,7bv1,DB08080,-7.6,LATRUNCULIN B,NSHPHXHGRHSMIK-JRIKCGFMSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
122035,6w4b,DB12776,-7.6,E-6005,BBTFKAOFCSOZMB-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
63387,6lxt,DB00218,-7.6,Moxifloxacin,FABPRXSRWADJSP-MEDUHNTESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
79592,6m2n,DB13482,-7.6,Dimefline,ZXFQRFXLFWWKLX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
13462,6lzg,DB15407,-7.6,Acalisib,DOCINCLJNAXZQF-LBPRGKRZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
68214,6lxt,DB07655,-7.6,"3-AMINO-3-BENZYL-[4.3.0]BICYCLO-1,6-DIAZANONAN-2-ONE",MPJYGQHMIFDQIN-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
13461,6lzg,DB15406,-7.6,GLPG-0974,MPMKMQHJHDHPBE-RUZDIDTESA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
68211,6lxt,DB07652,-7.6,"1-[2-DEOXYRIBOFURANOSYL]-2,4-DIFLUORO-5-METHYL-BENZENE-5'MONOPHOSPHATE",NMMWBGNJJMNAIJ-QJPTWQEYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
142641,6w9q,DB02463,-7.6,2-(2-Hydroxy-Phenyl)-1h-Indole-5-Carboxamidine,JPGNPKIYCTXJPG-UHFFFAOYSA-O,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
123256,6w4b,DB15189,-7.6,Birabresib,GNMUEVRJHCWKTO-FQEVSTJZSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
120993,6w4b,DB09238,-7.6,Manidipine,ANEBWFXPVPTEET-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
123255,6w4b,DB15187,-7.6,Dubermatinib,YUAALFPUEOYPNX-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
55082,6crv,DB00587,-7.6,Cinalukast,BZMKNPGKXJAIDV-VAWYXSNFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79614,6m2n,DB13511,-7.6,Clebopride,BVPWJMCABCPUQY-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
90961,6m71,DB02424,-7.6,Geldanamycin,QTQAWLPCGQOSGP-KSRBKZBZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
28436,6cs2,DB08023,-7.6,"N-cyclohexyl-4-imidazo[1,2-a]pyridin-3-yl-N-methylpyrimidin-2-amine",HYNNWLVWJXWXFO-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
68875,6lxt,DB08439,-7.6,Parecoxib,TZRHLKRLEZJVIJ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
144514,6w9q,DB05105,-7.6,Pleconaril,KQOXLKOJHVFTRN-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
89857,6m71,DB00977,-7.6,Ethinylestradiol,BFPYWIDHMRZLRN-SLHNCBLASA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
79511,6m2n,DB13369,-7.6,Benzilone,ZKCWITXZGWUJAV-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
154258,6wiq,DB07666,-7.6,"(3R,4S)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE",OAWGQHXWGXOUKV-BEFAXECRSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
56159,6crv,DB01959,-7.6,"3,5-Dimethyl-1-(3-Nitrophenyl)-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester",MSYGAHOHLUJIKV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
144426,6w9q,DB04850,-7.6,Posizolid,HBUJYEUPIIJJOS-PBHICJAKSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
120887,6w4b,DB09075,-7.6,Edoxaban,HGVDHZBSSITLCT-JLJPHGGASA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
90240,6m71,DB01489,-7.6,Camazepam,PXBVEXGRHZFEOF-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
78750,6m2n,DB12220,-7.6,ORG-25935,UEBBYLJZCHTLEG-UTKZUKDTSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
7564,6lzg,DB04014,-7.6,Alsterpaullone,OLUKILHGKRVDCT-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
28106,6cs2,DB07683,-7.6,"N-(dibenzo[b,d]thiophen-3-ylsulfonyl)-L-valine",RZWYSEXQXOXWKA-INIZCTEOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
123343,6w4b,DB15348,-7.6,Ampreloxetine,TZIALEBTHQWNAO-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
107523,6vxx,DB03716,-7.6,5'-Fluoro-5'-Deoxyadenosine,QPVLKMICBYRPSX-KQYNXXCUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
122170,6w4b,DB12988,-7.6,LY-518674,PNHFDVSKDSLUFH-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
154127,6wiq,DB07508,-7.6,4-(5-BENZENESULFONYLAMINO-1-METHYL-1H-BENZOIMIDAZOL-2-YLMETHYL)-BENZAMIDINE,MEUAVGJWGDPTLF-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
164841,7bv1,DB08672,-7.6,4-[(3R)-3-{[2-(4-FLUOROPHENYL)-2-OXOETHYL]AMINO}BUTYL]BENZAMIDE,OIWWNWQZJJKBTR-CYBMUJFWSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
107654,6vxx,DB04142,-7.6,"3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid Dimethylamide",FEYGJZKVMASWJB-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56088,6crv,DB01859,-7.6,4-Diphosphocytidyl-2-C-Methyl-D-Erythritol 2-Phosphate,HTJXTKBIUVFUAR-XHIBXCGHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55095,6crv,DB00603,-7.6,Medroxyprogesterone acetate,PSGAAPLEWMOORI-PEINSRQWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55647,6crv,DB01244,-7.6,Bepridil,UIEATEWHFDRYRU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56154,6crv,DB01954,-7.6,Rolipram,HJORMJIFDVBMOB-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
164513,7bv1,DB08094,-7.6,"(4-AMINO-2-{[1-(METHYLSULFONYL)PIPERIDIN-4-YL]AMINO}PYRIMIDIN-5-YL)(2,3-DIFLUORO-6-METHOXYPHENYL)METHANONE",JRNJNYBQQYBCLE-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97797,6vxs,DB00177,-7.6,Valsartan,ACWBQPMHZXGDFX-QFIPXVFZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
90966,6m71,DB02431,-7.6,Cytidine-5'-Triphosphate,PCDQPRRSZKQHHS-XVFCMESISA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
40425,6lu7,DB00320,-7.6,Dihydroergotamine,LUZRJRNZXALNLM-JGRZULCMSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40424,6lu7,DB01251,-7.6,Gliquidone,LLJFMFZYVVLQKT-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
164919,7bv1,DB08962,-7.6,Glibornuride,RMTYNAPTNBJHQI-LLDVTBCESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97791,6vxs,DB00171,-7.6,ATP,ZKHQWZAMYRWXGA-KQYNXXCUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
68135,6lxt,DB07562,-7.6,"N-[4-(2,4-DIMETHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YL]-N',N'-DIMETHYL-BENZENE-1,4-DIAMINE",FGGSNQOBRJVAKL-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
142155,6w9q,DB01820,-7.6,"Compound 12, N-Acetyl-4-[(Carboxycarbonyl)(2-Carboxyphenyl)Amino]-N-Pentyl-1-Napthylalaniamide",UESXELNYBIOROE-QHCPKHFHSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
164582,7bv1,DB08166,-7.6,"(4R)-7-chloro-9-methyl-1-oxo-1,2,4,9-tetrahydrospiro[beta-carboline-3,4'-piperidine]-4-carbonitrile",LPFQFJAOMCGYCP-GFCCVEGCSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
27765,6cs2,DB00670,-7.6,Pirenzepine,RMHMFHUVIITRHF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
144694,6w9q,DB06159,-7.6,Rubitecan,VHXNKPBCCMUMSW-FQEVSTJZSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
40431,6lu7,DB02830,-7.6,FR236913,KCCUBLLGAMGDJL-HXUWFJFHSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
121195,6w4b,DB11450,-7.6,Pimobendan,GLBJJMFZWDBELO-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
63923,6lxt,DB00860,-7.6,Prednisolone,OIGNJSKKLXVSLS-VWUMJDOOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
28437,6cs2,DB08024,-7.6,1-[2-(S)-AMINO-3-BIPHENYL-4-YL-PROPIONYL]-PYRROLIDINE-2-(S)-CARBONITRILE,MUUVLSCVDXKQQV-OALUTQOASA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
97586,6m71,DB15209,-7.6,MK-0736,ORQZQBUNAMJFCY-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
79676,6m2n,DB13600,-7.6,Deltamethrin,OWZREIFADZCYQD-NSHGMRRFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
90244,6m71,DB01496,-7.6,Barbituric acid derivative,DNZPLHRZXUJATK-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
63934,6lxt,DB00873,-7.6,Loteprednol,YPZVAYHNBBHPTO-MXRBDKCISA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
27801,6cs2,DB07354,-7.6,"2,3-DIMETHOXY-12H-[1,3]DIOXOLO[5,6]INDENO[1,2-C]ISOQUINOLIN-6-IUM",LXDREMZQGAILJU-UHFFFAOYSA-O,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
37165,1r42,DB03903,-7.6,Tmr,KGFLZYXDJDOIEE-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
122146,6w4b,DB12949,-7.6,PF-03382792,AGMOFKKOVMRGAK-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
63335,6lxt,DB00158,-7.6,Folic acid,OVBPIULPVIDEAO-LBPRGKRZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
29214,6cs2,DB08873,-7.6,Boceprevir,LHHCSNFAOIFYRV-DOVBMPENSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
121983,6w4b,DB12694,-7.6,CE-326597,UBNMGTSDHSQBEL-PMERELPUSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
27805,6cs2,DB07358,-7.6,"2-amino-N-(4-methyl-1,3-thiazol-2-yl)-5-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]benzamide",JEBOJMQHVUEKBE-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
121244,6w4b,DB11577,-7.6,Indigotindisulfonic Acid,CFZXDJWFRVEWSR-BUHFOSPRSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
31809,6cs2,DB14791,-7.6,GDC-0425,XEZLBMHDUXSICI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
31816,6cs2,DB01094,-7.6,Hesperetin,AIONOLUJZLIMTK-AWEZNQCLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
108180,6vxx,DB07195,-7.6,"4-[(1S,2S,5S)-5-(HYDROXYMETHYL)-6,8,9-TRIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL",DTZWKYVREFMAJA-QXWBOSQLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
122264,6w4b,DB13132,-7.6,Artemisinin,BLUAFEHZUWYNDE-NNWCWBAJSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
154848,6wiq,DB08358,-7.6,"2-(2-QUINOLIN-3-YLPYRIDIN-4-YL)-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE",OWFLADWRSCINST-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
27775,6cs2,DB07328,-7.6,"METHYL 4-{[({[(2R,5S)-5-{[(2S)-2-(AMINOMETHYL)PYRROLIDIN-1-YL]CARBONYL}PYRROLIDIN-2-YL]METHYL}AMINO)CARBONYL]AMINO}BENZOATE",USDCNOQKDUFKRD-IKGGRYGDSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
121956,6w4b,DB12655,-7.6,Patidegib,HZLFFNCLTRVYJG-WWGOJCOQSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
97584,6m71,DB15207,-7.6,Esaxerenone,NOSNHVJANRODGR-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
63938,6lxt,DB00878,-7.6,Chlorhexidine,GHXZTYHSJHQHIJ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
78791,6m2n,DB12273,-7.6,Ecopipam,DMJWENQHWZZWDF-PKOBYXMFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79633,6m2n,DB13540,-7.6,Isepamicin,UDIIBEDMEYAVNG-ZKFPOVNWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80217,6m2n,DB14888,-7.6,IQP-0528,UCOAKFIVSAVHLC-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
155300,6wiq,DB08930,-7.6,Dolutegravir,RHWKPHLQXYSBKR-BMIGLBTASA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
120888,6w4b,DB09076,-7.6,Umeclidinium,FVTWTVQXNAJTQP-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
7559,6lzg,DB04006,-7.6,"[2-Amino-6-(2,6-Difluoro-Benzoyl)-Imidazo[1,2-a]Pyridin-3-Yl]-Phenyl-Methanone",WUGJIPFLBOATGL-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
122237,6w4b,DB13093,-7.6,TAK-593,DZFZXPPHBWCXPQ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
129808,6w4h,DB09477,-7.5,Enalaprilat,LZFZMUMEGBBDTC-QEJZJMRPSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
163785,7bv1,DB06272,-7.5,Maxacalcitol,DTXXSJZBSTYZKE-ZDQKKZTESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
164505,7bv1,DB08083,-7.5,"2-(1,3-thiazol-4-yl)-1H-benzimidazole-5-sulfonamide",KGMVTZZDGKDTEU-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
26480,6cs2,DB04623,-7.5,"2-ETHOXYETHYL (2S,3S)-4-((S)-2-BENZYL-3-OXO-4-((3AR,8R,8AS)-2-OXO-3,3A,8,8A-TETRAHYDRO-2H-INDENO[1,2-D]OXAZOL-8-YL)-2,3-DIHYDRO-1H-PYRROL-2-YL)-3-HYDROXY-1-PHENYLBUTAN-2-YLCARBAMATE",CGBRFCVAMLJVEA-ZGURCIGKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
112131,6vxx,DB06374,-7.5,Elacestrant,SIFNOOUKXBRGGB-AREMUKBSSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75252,6m2n,DB04460,-7.5,(C8-S)-Hydantocidin 5'-Phosphate,MAXSFYCTFIBEAR-FUIMDIGMSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
115625,6w4b,DB01070,-7.5,Dihydrotachysterol,ILYCWAKSDCYMBB-OPCMSESCSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
84429,6m3m,DB06156,-7.5,Tesofensine,VCVWXKKWDOJNIT-ZOMKSWQUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
31927,6cs2,DB01104,-7.5,Sertraline,VGKDLMBJGBXTGI-SJCJKPOMSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
76359,6m2n,DB07115,-7.5,"N-(4-chlorobenzyl)-N-methylbenzene-1,4-disulfonamide",IPPUTOHDQOYDIL-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
108066,6vxx,DB06794,-7.5,Lodoxamide,RVGLGHVJXCETIO-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104376,6vxs,DB11909,-7.5,Varespladib,BHLXTPHDSZUFHR-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
81007,6m3m,DB00698,-7.5,Nitrofurantoin,NXFQHRVNIOXGAQ-YCRREMRBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
27978,6cs2,DB07543,-7.5,(2S)-1-(9H-Carbazol-4-yloxy)-3-(isopropylamino)propan-2-ol,BQXQGZPYHWWCEB-ZDUSSCGKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
122536,6w4b,DB13533,-7.5,Methylestrenolone,ZXSWTMLNIIZPET-ZOFHRBRSSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
122727,6w4b,DB13788,-7.5,Chlorbenzoxamine,VEVSKUJZSMGTMM-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
30548,6cs2,DB12641,-7.5,Tedatioxetine,CVASBKDYSQKLSO-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
29510,6cs2,DB09274,-7.5,Artesunate,FIHJKUPKCHIPAT-AHIGJZGOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
163961,7bv1,DB06907,-7.5,"2-(2,6-DICHLOROPHENYL)-1,3-BENZOXAZOLE-6-CARBOXYLIC ACID",XVNRKPCHMYOPPL-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
108175,6vxx,DB07188,-7.5,"(3S)-1-CYCLOHEXYL-N-(3,5-DICHLOROPHENYL)-5-OXOPYRROLIDINE-3-CARBOXAMIDE",YUFADRZDHJKVOT-NSHDSACASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163762,7bv1,DB06230,-7.5,Nalmefene,WJBLNOPPDWQMCH-MBPVOVBZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59010,6crv,DB06971,-7.5,"N-{2-[(4'-CYANO-1,1'-BIPHENYL-4-YL)OXY]ETHYL}-N'-HYDROXY-N-METHYLUREA",GVMUNGGWXRKCEU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165876,7bv1,DB13158,-7.5,Clobetasone,XXIFVOHLGBURIG-OZCCCYNHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
79788,6m2n,DB13744,-7.5,Piromidic acid,RCIMBBZXSXFZBV-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
116951,6w4b,DB02830,-7.5,FR236913,KCCUBLLGAMGDJL-HXUWFJFHSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
160880,7bv1,DB11859,-7.5,Brexanolone,AURFZBICLPNKBZ-SYBPFIFISA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
84425,6m3m,DB06152,-7.5,Nylidrin,PTGXAUBQBSGPKF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
79837,6m2n,DB13810,-7.5,Dimemorfan,KBEZZLAAKIIPFK-NJAFHUGGSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
27573,6cs2,DB07121,-7.5,"4-({4-[(4-AMINOBUT-2-YNYL)OXY]PHENYL}SULFONYL)-N-HYDROXY-2,2-DIMETHYLTHIOMORPHOLINE-3-CARBOXAMIDE",AANXPIMDONQTQF-HNNXBMFYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
129126,6w4h,DB08424,-7.5,"[5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL](3-{[(2R)-2,3-DIHYDROXYPROPYL]OXY}PHENYL)METHANONE",IJDQETGUEUJVTB-HNNXBMFYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
26681,6cs2,DB04863,-7.5,Lefradafiban,PGCFXITVMNNKON-ROUUACIJSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
165914,7bv1,DB13230,-7.5,Gestonorone,GTFUITFQDGVJSK-XGXHKTLJSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
129172,6w4h,DB08478,-7.5,N-[2-chloro-5-(trifluoromethyl)phenyl]imidodicarbonimidic diamide,IGFTZEOFHWPCDL-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
30555,6cs2,DB00962,-7.5,Zaleplon,HUNXMJYCHXQEGX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
166192,7bv1,DB14075,-7.5,Imidurea,ZCTXEAQXZGPWFG-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
166189,7bv1,DB13806,-7.5,Linopirdine,YEJCDKJIEMIWRQ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
115633,6w4b,DB01081,-7.5,Diphenoxylate,HYPPXZBJBPSRLK-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
9255,6lzg,DB07337,-7.5,"4-[4-AMINO-6-(5-CHLORO-1H-INDOL-4-YLMETHYL)-[1,3,5]TRIAZIN-2-YLAMINO]-BENZONITRILE",SOKOHDQTKSROQZ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
115385,6w4b,DB00799,-7.5,Tazarotene,OGQICQVSFDPSEI-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
108019,6vxx,DB06711,-7.5,Naphazoline,CNIIGCLFLJGOGP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81025,6m3m,DB00718,-7.5,Adefovir dipivoxil,WOZSCQDILHKSGG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
52651,2fxp,DB11822,-7.5,TMC-647055,UOBYJVFBFSLCTQ-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
26437,6cs2,DB04573,-7.5,Estriol,PROQIPRRNZUXQM-ZXXIGWHRSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
112100,6vxx,DB06276,-7.5,Tanomastat,JXAGDPXECXQWBC-LJQANCHMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76436,6m2n,DB07201,-7.5,(2S)-3-[(9H-fluoren-9-ylideneamino)oxy]-2-methylpropanoic acid,ZHFDVDMCVXUGGF-NSHDSACASA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
163992,7bv1,DB06940,-7.5,"N-ethyl-4-{[5-(methoxycarbamoyl)-2-methylphenyl]amino}-5-methylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide",ZZTMFGIGOADCFX-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
112103,6vxx,DB06282,-7.5,Levocetirizine,ZKLPARSLTMPFCP-OAQYLSRUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
124106,6w4h,DB00768,-7.5,Olopatadine,JBIMVDZLSHOPLA-LSCVHKIXSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
112770,6vxx,DB07823,-7.5,"(2S)-2-[(3aR,4R,7S,7aS)-1,3-dioxooctahydro-2H-4,7-methanoisoindol-2-yl]propanoic acid",REFMTLIXGKZVDF-VRGHQRLXSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
26453,6cs2,DB00527,-7.5,Cinchocaine,PUFQVTATUTYEAL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
56458,6crv,DB02359,-7.5,"9-Butyl-8-(2,5-Dimethoxy-Benzyl)-9h-Purin-6-Ylamine",PPFZLLAIQRZNJE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58630,6crv,DB06234,-7.5,Maribavir,KJFBVJALEQWJBS-XUXIUFHCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30566,6cs2,DB00963,-7.5,Bromfenac,ZBPLOVFIXSTCRZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
129145,6w4h,DB08446,-7.5,"3-[6-bromo-2-fluoro-3-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)phenoxy]-5-chlorobenzonitrile",OHQMEDBYNUAVNE-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
163990,7bv1,DB06936,-7.5,N-(4-carbamimidoylbenzyl)-1-(4-methylpentanoyl)-L-prolinamide,AEKJCSNKYXWOAQ-INIZCTEOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
164005,7bv1,DB06959,-7.5,(2S)-1-(3H-Indol-3-yl)-3-{[5-(6-isoquinolinyl)-3-pyridinyl]oxy}-2-propanamine,BUCZDJYEOAQTHL-KEKNWZKVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
80841,6m3m,DB00494,-7.5,Entacapone,JRURYQJSLYLRLN-BJMVGYQFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
112712,6vxx,DB07759,-7.5,5-[2-(TRIFLUOROMETHYL)PHENYL]-2-FUROIC ACID,IJPNRBZMRINMMR-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112107,6vxx,DB06299,-7.5,Hydronidone,NETTXQJYJRFTFS-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80847,6m3m,DB00500,-7.5,Tolmetin,UPSPUYADGBWSHF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
76365,6m2n,DB07121,-7.5,"4-({4-[(4-AMINOBUT-2-YNYL)OXY]PHENYL}SULFONYL)-N-HYDROXY-2,2-DIMETHYLTHIOMORPHOLINE-3-CARBOXAMIDE",AANXPIMDONQTQF-HNNXBMFYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
129936,6w4h,DB11446,-7.5,Oxfendazole,BEZZFPOZAYTVHN-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
112734,6vxx,DB07785,-7.5,"1-{(1R,2S)-2-HYDROXY-1-[2-(2-NAPHTHYLOXY)ETHYL]PROPYL}-1H-IMIDAZONE-4-CARBOXAMIDE",UYAJDVNLQJVRHD-SCLBCKFNSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
12084,6lzg,DB12863,-7.5,Sivelestat,BTGNGJJLZOIYID-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
71799,6lxt,DB15299,-7.5,AMG-232,DRLCSJFKKILATL-YWCVFVGNSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
160827,7bv1,DB11784,-7.5,NRX-1074,DVBUEXCIEIAXPM-PJUQSVSOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
164004,7bv1,DB06955,-7.5,"3,4-bis(7-chloro-1H-indol-3-yl)-1H-pyrrole-2,5-dicarboxylic acid",OAMCCJASDLMTOO-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
17653,6cs2,HMDB0000359,-7.5,"3alpha,7alpha-Dihydroxycoprostanic acid",ITZYGDKGRKKBSN-HKFUITGCSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
129930,6w4h,DB11433,-7.5,Nequinate,NNOPDLNHPOLRRE-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
164416,7bv1,DB07806,-7.5,"(2R,4S)-2-[(R)-BENZYLCARBAMOYL-PHENYLACETYL-METHYL]-5,5-DIMETHYL-THIAZOLIDINE-4-CARBOXYLIC ACID",UDMBRVGTYILYDX-SVFBPWRDSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
129948,6w4h,DB11464,-7.5,Sulfaquinoxaline,NHZLNPMOSADWGC-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
124480,6w4h,DB01195,-7.5,Flecainide,DJBNUMBKLMJRSA-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
55803,6crv,DB01500,-7.5,Oxabolone,GXHBCWCMYVTJOW-YGRHGMIBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
122620,6w4b,DB13649,-7.5,Proquazone,JTIGKVIOEQASGT-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
163765,7bv1,DB06235,-7.5,Vadimezan,XGOYIMQSIKSOBS-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
112732,6vxx,DB07782,-7.5,4-AMINO-2-TRIFLUOROMETHYL-5-HYDROXYMETHYLPYRIMIDINE PYROPHOSPHATE,UKNJCTHTCAKKNG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
122569,6w4b,DB13579,-7.5,Mepixanox,PYSOHOOUXFWCFF-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
58955,6crv,DB06905,-7.5,"(2S,3S,4E,6E,8S,9S)-3-amino-9-methoxy-2,6,8-trimethyl-10-phenyldeca-4,6-dienoic acid",HJVCHYDYCYBBQX-HLTLHRPFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
124135,6w4h,DB00805,-7.5,Minaprine,LDMWSLGGVTVJPG-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
104436,6vxs,DB12000,-7.5,Apabetalone,NETXMUIMUZJUTB-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
58943,6crv,DB06890,-7.5,(2R)-2-PHENYL-N-PYRIDIN-4-YLBUTANAMIDE,MODBYAQUXXEFRM-CQSZACIVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76347,6m2n,DB07102,-7.5,(2S)-2-amino-5-oxo-5-[(4-phenylmethoxyphenyl)amino]pentanoic acid,BYSBXIPCDJNEBG-INIZCTEOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
164012,7bv1,DB06969,-7.5,"2-amino-4-[2,4-dichloro-5-(2-pyrrolidin-1-ylethoxy)phenyl]-N-ethylthieno[2,3-d]pyrimidine-6-carboxamide",WJUNQSYQHHIVFX-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
27938,6cs2,DB07503,-7.5,"(5E)-5-[(2,2-DIFLUORO-1,3-BENZODIOXOL-5-YL)METHYLENE]-1,3-THIAZOLIDINE-2,4-DIONE",SRLVNYDXMUGOFI-YWEYNIOJSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
112800,6vxx,DB07858,-7.5,(2S)-2-(4-chlorophenyl)-2-[4-(1H-pyrazol-4-yl)phenyl]ethanamine,HWVGILTYGZFGLR-KRWDZBQOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72021,6m2n,DB00243,-7.5,Ranolazine,XKLMZUWKNUAPSZ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
112679,6vxx,DB07535,-7.5,2-amino-6-[2-(1H-indol-6-yl)ethyl]pyrimidin-4(3H)-one,VRAZIAJSKFRSIP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
26476,6cs2,DB04617,-7.5,"(9S)-9-[(8-AMMONIOOCTYL)AMINO]-1,2,3,4,9,10-HEXAHYDROACRIDINIUM",LFBAUYQQFKFFCF-UHFFFAOYSA-P,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
30562,6cs2,DB12661,-7.5,Urapidil,ICMGLRUYEQNHPF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
129841,6w4h,DB11157,-7.5,Anthralin,NUZWLKWWNNJHPT-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
112056,6vxx,DB06193,-7.5,Pixantrone,PEZPMAYDXJQYRV-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104439,6vxs,DB12004,-7.5,Briciclib,LXENKEWVEVKKGV-BQYQJAHWSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
27972,6cs2,DB07538,-7.5,"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}-2-(TRIFLUOROMETHYL)BENZENESULFONAMIDE",RGVVHQNJKUNSFQ-WDZFZDKYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
10821,6lzg,DB09124,-7.5,Medrogestone,HCFSGRMEEXUOSS-JXEXPEPMSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
129907,6w4h,DB11393,-7.5,Danofloxacin,QMLVECGLEOSESV-RYUDHWBXSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
115586,6w4b,DB01026,-7.5,Ketoconazole,XMAYWYJOQHXEEK-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
56639,6crv,DB02586,-7.5,"4,7-Dimethyl-[1,10]Phenanthroline",JIVLDFFWTQYGSR-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163983,7bv1,DB06929,-7.5,1-butanoyl-N-(4-carbamimidoylbenzyl)-L-prolinamide,RYAZZWWVNUWKNB-AWEZNQCLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
164425,7bv1,DB07815,-7.5,GIBBERELLIN A4,RSQSQJNRHICNNH-NFMPGMCNSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
163981,7bv1,DB06927,-7.5,[5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-YL]ACETONITRILE,ZKJVCUXZMYKTLT-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
107023,6vxx,DB02186,-7.5,N-Acetyl-D-Galactosamine 6-Sulfate,WJFVEEAIYIOATH-JAJWTYFOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
116985,6w4b,DB02873,-7.5,"1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperazin-1-Yl-3,4-Dihydroquinazolin-2(1h)-One",YAWZIQKDHQIHOS-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
76395,6m2n,DB07155,-7.5,(3S)-1-CYCLOHEXYL-5-OXO-N-PHENYLPYRROLIDINE-3-CARBOXAMIDE,BVUSHGJZBZMDML-ZDUSSCGKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
104395,6vxs,DB11939,-7.5,Henagliflozin,HYTPDMFFHVZBOR-VNXMGFANSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
166134,7bv1,DB13730,-7.5,Nifurtoinol,UIDWQGRXEVDFCA-XCVCLJGOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
129897,6w4h,DB11376,-7.5,Azaperone,XTKDAFGWCDAMPY-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
84019,6m3m,DB04656,-7.5,"1,3,4-TRIHYDROXY-5-(3-PHENOXYPROPYL)-CYCLOHEXANE-1-CARBOXYLIC A CID",SCUFESRLGCQXRX-DCDXPUDHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
166161,7bv1,DB13772,-7.5,Rufloxacin,NJCJBUHJQLFDSW-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
8950,6lzg,DB07015,-7.5,"(3R,4R)-4-(pyrrolidin-1-ylcarbonyl)-1-(quinoxalin-2-ylcarbonyl)pyrrolidin-3-amine",XDSKICAQKGYYJF-OLZOCXBDSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
26442,6cs2,DB00525,-7.5,Tolnaftate,FUSNMLFNXJSCDI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
51144,2fxp,DB07833,-7.5,"N-(3-cyanophenyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)-4-biphenylcarboxamide",PMMLSQFPBFKLHH-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
12093,6lzg,DB12877,-7.5,Oxatomide,BAINIUMDFURPJM-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
55740,6crv,DB01428,-7.5,Oxybenzone,DXGLGDHPHMLXJC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
129393,6w4h,DB08741,-7.5,"5-[[(2R)-2-cyclopropyl-7,8-dimethoxy-2H-chromen-5-yl]methyl]pyrimidine-2,4-diamine",HWJPWWYTGBZDEG-AWEZNQCLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
33994,6cs2,T3D0800,-7.5,Rotenone,NZVPMEQJVQAGNB-MSOLQXFVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
116500,6w4b,DB02241,-7.5,"8-Benzyl-2-Hydroperoxy-2-(4-Hydroxy-Benzyl)-6-(4-Hydroxy-Phenyl)-2h-Imidazo[1,2-a]Pyrazin-3-One",HOSWCJDTHOAORT-SANMLTNESA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
112266,6vxx,DB06903,-7.5,"(1S,3aS,5aR,8aS)-1,7,7-trimethyl-1,2,3,3a,5a,6,7,8-octahydrocyclopenta[c]pentalene-4-carboxylic acid",DCFDRCCHOOORSB-JOXOIDLHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84279,6m3m,DB05284,-7.5,CA4P,LGZKGOGODCLQHG-ZDUSSCGKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
122238,6w4b,DB13094,-7.5,Pruvanserin,AQRLDDAFYYAIJP-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
7344,6lzg,DB00436,-7.5,Bendroflumethiazide,HDWIHXWEUNVBIY-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
108154,6vxx,DB07165,-7.5,N-(5-CHLORO-BENZO[B]THIOPHEN-3-YLMETHYL)-2-[6-CHLORO-OXO-3-(2-PYRIDIN-2-YL-ETHYLAMINO)-2H-PYRAZIN-1-YL]-ACETAMIDE,SOBGXPPOYFFGTK-UGKGYDQZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29162,6cs2,DB08801,-7.5,Dimetindene,MVMQESMQSYOVGV-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
30511,6cs2,DB00957,-7.5,Norgestimate,KIQQMECNKUGGKA-NMYWJIRASA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
129497,6w4h,DB08880,-7.5,Teriflunomide,UTNUDOFZCWSZMS-YFHOEESVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
112420,6vxx,DB07083,-7.5,beta-phenyl-D-phenylalanyl-N-propyl-L-prolinamide,HZKKJPDVZGOOPU-PZJWPPBQSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
11237,6lzg,DB11692,-7.5,Pavinetant,QYTBBBAHNIWFOD-NRFANRHFSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
116073,6w4b,DB01668,-7.5,Nanaomycin D,XUWPJKDMEZSVTP-UOSCCXBLSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
11258,6lzg,DB11725,-7.5,Latrepirdine,JNODQFNWMXFMEV-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
161105,7bv1,DB12890,-7.5,Dihydrexidine,BGOQGUHWXBGXJW-YOEHRIQHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
58723,6crv,DB06479,-7.5,Propentofylline,RBQOQRRFDPXAGN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
9092,6lzg,DB07165,-7.5,N-(5-CHLORO-BENZO[B]THIOPHEN-3-YLMETHYL)-2-[6-CHLORO-OXO-3-(2-PYRIDIN-2-YL-ETHYLAMINO)-2H-PYRAZIN-1-YL]-ACETAMIDE,SOBGXPPOYFFGTK-UGKGYDQZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
11243,6lzg,DB11698,-7.5,Ipragliflozin,AHFWIQIYAXSLBA-RQXATKFSSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
124418,6w4h,DB01127,-7.5,Econazole,LEZWWPYKPKIXLL-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
76547,6m2n,DB07327,-7.5,"(2-ACETYL-5-METHYLANILINO)(2,6-DIBROMOPHENYL)ACETAMIDE",FELUFXCUIYHAPB-INIZCTEOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
164473,7bv1,DB08046,-7.5,2-chloro-5-[(1S)-1-hydroxy-3-oxo-2H-isoindol-1-yl]benzenesulfonamide,JIVPVXMEBJLZRO-AWEZNQCLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
55674,6crv,DB01298,-7.5,Sulfacytine,SIBQAECNSSQUOD-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80825,6m3m,DB00476,-7.5,Duloxetine,ZEUITGRIYCTCEM-KRWDZBQOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
129527,6w4h,DB08932,-7.5,Macitentan,JGCMEBMXRHSZKX-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
84167,6m3m,DB04857,-7.5,Brasofensine,NRLIFEGHTNUYFL-QJDHNRDASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
104612,6vxs,DB12259,-7.5,CG-200745,AUGCSOFQTDKPSO-RGVLZGJSSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
112487,6vxx,DB07310,-7.5,"(5S)-2-{[(1S)-1-(2-fluorophenyl)ethyl]amino}-5-methyl-5-(trifluoromethyl)-1,3-thiazol-4(5H)-one",KNHNFKZUNFPPQE-MADCSZMMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30438,6cs2,DB12479,-7.5,Zabofloxacin,ZNPOCLHDJCAZAH-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
164465,7bv1,DB07861,-7.5,(2R)-N-hydroxy-3-naphthalen-2-yl-2-[(naphthalen-2-ylsulfonyl)amino]propanamide,MMOUXLMPQFMDRD-JOCHJYFZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
163907,7bv1,DB06843,-7.5,"2',5'-DIDEOXY-ADENOSINE 3'-MONOPHOSPHATE",NFGZMOICZSFFLB-DSYKOEDSSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160960,7bv1,DB12320,-7.5,Palovarotene,YTFHCXIPDIHOIA-DHZHZOJOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
9185,6lzg,DB07270,-7.5,"N-[7-(3-AMINOPHENYL)-5-METHOXY-1,3-BENZOXAZOL-2-YL]-2,5-DICHLOROBENZENESULFONAMIDE",GAYYMURZGLJDCT-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
166060,7bv1,DB13638,-7.5,Cefbuperazone,SMSRCGPDNDCXFR-CYWZMYCQSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
12020,6lzg,DB12758,-7.5,Atreleuton,MMSNEKOTSJRTRI-LLVKDONJSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
55635,6crv,DB01231,-7.5,Diphenidol,OGAKLTJNUQRZJU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
129298,6w4h,DB08631,-7.5,"N-(4-CHLOROPHENYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONAMIDE",UVSIFVBCHJEYJP-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
29556,6cs2,DB09383,-7.5,Meprednisone,PIDANAQULIKBQS-RNUIGHNZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
80901,6m3m,DB00573,-7.5,Fenoprofen,RDJGLLICXDHJDY-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
76534,6m2n,DB07313,-7.5,5-METHYL-2-[(PHENYLSULFONYL)AMINO]BENZOIC ACID,HXQLTRSIZRSFTR-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80912,6m3m,DB00584,-7.5,Enalapril,GBXSMTUPTTWBMN-XIRDDKMYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
122366,6w4b,DB13310,-7.5,Ormeloxifene,XZEUAXYWNKYKPL-WDYNHAJCSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
30520,6cs2,DB12596,-7.5,Combretastatin,LGZKGOGODCLQHG-CYBMUJFWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
28013,6cs2,DB07583,-7.5,"(4R,2S)-5'-(4-(4-CHLOROBENZYLOXY)PYRROLIDIN-2-YLMETHANESULFONYL)ISOQUINOLINE",RLNNFNGBXLTQOB-RBUKOAKNSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
124319,6w4h,DB01012,-7.5,Cinacalcet,VDHAWDNDOKGFTD-MRXNPFEDSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
166045,7bv1,DB13616,-7.5,Melagatran,DKWNMCUOEDMMIN-PKOBYXMFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
56561,6crv,DB02485,-7.5,Cytidine-5'-Monophosphate-5-N-Acetylneuraminic Acid,TXCIAUNLDRJGJZ-BILDWYJOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
129304,6w4h,DB08639,-7.5,Dapivirine,ILAYIAGXTHKHNT-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
124329,6w4h,DB01024,-7.5,Mycophenolic acid,HPNSFSBZBAHARI-RUDMXATFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
108124,6vxx,DB07130,-7.5,4-BROMO-3-(CARBOXYMETHOXY)-5-PHENYLTHIOPHENE-2-CARBOXYLIC ACID,MVDWLRCTJUXCCB-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
115929,6w4b,DB01496,-7.5,Barbituric acid derivative,DNZPLHRZXUJATK-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
84272,6m3m,DB05253,-7.5,Telapristone acetate,JVBGZFRPTRKSBB-MJBQOYBXSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
124350,6w4h,DB01048,-7.5,Abacavir,MCGSCOLBFJQGHM-SCZZXKLOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
129368,6w4h,DB08715,-7.5,"2,6-DIMETHYL-1-(3-[3-METHYL-5-ISOXAZOLYL]-PROPANYL)-4-[2-METHYL-4-ISOXAZOLYL]-PHENOL",SLPKYEWAKMNCPT-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
80958,6m3m,DB00639,-7.5,Butoconazole,SWLMUYACZKCSHZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
112349,6vxx,DB07002,-7.5,4-({4-[(4-methoxypyridin-2-yl)amino]piperidin-1-yl}carbonyl)benzonitrile,SZUVGMCKKLJAFX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163872,7bv1,DB06786,-7.5,Halcinonide,MUQNGPZZQDCDFT-JNQJZLCISA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
163869,7bv1,DB06780,-7.5,Desoxycorticosterone acetate,VPGRYOFKCNULNK-ACXQXYJUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
26602,6cs2,DB04776,-7.5,(2R)-2-({6-[benzyl(methyl)amino]-9-isopropyl-9H-purin-2-yl}amino)butan-1-ol,YPYWONAECUVKHY-MRXNPFEDSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
112337,6vxx,DB06990,-7.5,"4-[(1E,7E)-8-(2,6-DIOXO-1,2,3,6-TETRAHYDROPYRIMIDIN-4-YL)-3,6-DIOXA-2,7-DIAZAOCTA-1,7-DIEN-1-YL]BENZOIC ACID",XHDKIDMFBWLHAX-GONBZBRSSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
129376,6w4h,DB08724,-7.5,5-(5-(4-(5-hydro-4-methyl-2-oxazolyl)phenoxy)pentyl)-3-methyl isoxazole,UXIYKMARWUSIKU-HNNXBMFYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
30486,6cs2,DB12551,-7.5,Idazoxan,HPMRFMKYPGXPEP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
75106,6m2n,DB04254,-7.5,"8-Benzo[1,3]Dioxol-,5-Ylmethyl-9-Butyl-2-Fluoro-9h-Purin-6-Ylamine",ARWHTQLGMWHTAZ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
164481,7bv1,DB08056,-7.5,"N-(2,6-dimethylphenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine",KKYYLKPGILUPOA-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
17765,6cs2,HMDB0010357,-7.5,Tetrahydroaldosterone-3-glucuronide,CGIURIOFMWUPSV-RUQPETGGSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
116324,6w4b,DB02008,-7.5,1-(2-Fluorobenzyl)-3-Butyl-8-(N-Acetyl-4-Aminobenzyl)-Xanthine,JHSHXKJSPVHPCJ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
122267,6w4b,DB13138,-7.5,Neladenoson bialanate,WESNEIGKOAXSGX-VXKWHMMOSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
52924,2fxp,DB12228,-7.5,Telcagepant,CGDZXLJGHVKVIE-DNVCBOLYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
129405,6w4h,DB08753,-7.5,"4-{(1E)-3-OXO-3-[(2-PHENYLETHYL)AMINO]PROP-1-EN-1-YL}-1,2-PHENYLENE DIACETATE",GARHCDOTUULBOQ-PKNBQFBNSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
26599,6cs2,DB04771,-7.5,1-GUANIDINO-4-(N-NITRO-BENZOYLAMINO-L-LEUCYL-L-PROLYLAMINO)BUTANE,FIZYZWLGMGGGBJ-OALUTQOASA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
26592,6cs2,DB04763,-7.5,"1-N-(4-SULFAMOYLPHENYL-ETHYL)-2,4,6-TRIMETHYLPYRIDINIUM",UXBCHTZINZNVRG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
161045,7bv1,DB12792,-7.5,Boscalid,WYEMLYFITZORAB-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
58759,6crv,DB06582,-7.5,Dextofisopam,RUJBDQSFYCKFAA-HNNXBMFYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76625,6m2n,DB07420,-7.5,(1R)-4-(3-phenoxyphenyl)-1-phosphonobutane-1-sulfonic acid,RCGCZPXSRLLKCK-MRXNPFEDSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
116326,6w4b,DB02010,-7.5,Staurosporine,HKSZLNNOFSGOKW-FYTWVXJKSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
129367,6w4h,DB08714,-7.5,"2,6-DIMETHYL-1-(3-[3-METHYL-5-ISOXAZOLYL]-PROPANYL)-4-[4-METHYL-2H-TETRAZOL-2-YL]-PHENOL",DRCNRTRGWUYJBH-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
161015,7bv1,DB12402,-7.5,Pumosetrag,AFUWQWYPPZFWCO-LBPRGKRZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
31850,6cs2,DB01097,-7.5,Leflunomide,VHOGYURTWQBHIL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
165969,7bv1,DB13310,-7.5,Ormeloxifene,XZEUAXYWNKYKPL-WDYNHAJCSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
55643,6crv,DB01240,-7.5,Epoprostenol,KAQKFAOMNZTLHT-OZUDYXHBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112390,6vxx,DB07048,-7.5,"N-[(2R)-5-(aminosulfonyl)-2,3-dihydro-1H-inden-2-yl]-2-propylpentanamide",XBYJCVDSFWJBSM-OAHLLOKOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112389,6vxx,DB07047,-7.5,"2',4'-DICHLORO-4-HYDROXY-1,1'-BIPHENYL-3-CARBOXYLIC ACID",SKAFZYDMDHPPJM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
73325,6m2n,DB01877,-7.5,"N-Hydroxy 1n(4-Methoxyphenyl)Sulfonyl-4-(Z,E-N-Methoxyimino)Pyrrolidine-2r-Carboxamide",OJLWCTMBGWSVFC-JOYOIKCWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
112291,6vxx,DB06929,-7.5,1-butanoyl-N-(4-carbamimidoylbenzyl)-L-prolinamide,RYAZZWWVNUWKNB-AWEZNQCLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75136,6m2n,DB04293,-7.5,7-(2-Amino-2-Phenyl-Acetylamino)-3-Chloro-8-Oxo-1-Aza-Bicyclo[4.2.0]Oct-2-Ene-2-Carboxylic Acid,JAPHQRWPEGVNBT-IJLUTSLNSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
104600,6vxs,DB12239,-7.5,Balicatib,LLCRBOWRJOUJAE-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
26572,6cs2,DB00540,-7.5,Nortriptyline,PHVGLTMQBUFIQQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
124404,6w4h,DB01110,-7.5,Miconazole,BYBLEWFAAKGYCD-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
11244,6lzg,DB11701,-7.5,Amenamevir,MNHNIVNAFBSLLX-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
129442,6w4h,DB08796,-7.5,Pipazethate,DTVJXCOMJLLMAK-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
9118,6lzg,DB07193,-7.5,"(2R,3R)-7-(methylsulfonyl)-3-(2,4,5-trifluorophenyl)-1,2,3,4-tetrahydropyrido[1,2-a]benzimidazol-2-amine",HJJAYSSCWGUPKO-ABAIWWIYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
163882,7bv1,DB06802,-7.5,Nepafenac,QEFAQIPZVLVERP-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
84211,6m3m,DB04938,-7.5,Ospemifene,LUMKNAVTFCDUIE-VHXPQNKSSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
9121,6lzg,DB00656,-7.5,Trazodone,PHLBKPHSAVXXEF-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
84215,6m3m,DB04947,-7.5,Altropane,GTQLIPQFXVKRKJ-UNSMHXHVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
104597,6vxs,DB12236,-7.5,Bexagliflozin,BTCRKOKVYTVOLU-SJSRKZJXSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
73331,6m2n,DB01883,-7.5,N-(Sulfanylacetyl)Tyrosylprolylmethioninamide,LNLWXWOYQHAKTD-ULQDDVLXSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76579,6m2n,DB07363,-7.5,"THIOPHENE-2,5-DISULFONIC ACID 2-AMIDE-5-(4-METHYL-BENZYLAMIDE)",GUNRMHMEAWSZQE-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
122304,6w4b,DB13223,-7.5,Fluocortin,PUWHHWCHAVXSIG-NCLPIGKXSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
129436,6w4h,DB08789,-7.5,"2-AMINO-4-(2,4-DICHLOROPHENYL)-N-ETHYLTHIENO[2,3-D]PYRIMIDINE-6-CARBOXAMIDE",YPEOXUOUTBMBCX-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
166008,7bv1,DB13563,-7.5,Norgestrienone,GVDMJXQHPUYPHP-FYQPLNBISA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
48800,2fxp,DB03638,-7.5,Cytidyl-2'-5'-Phospho-Guanosine,QZDUXDLOEVJGDG-VMIOUTBZSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
112252,6vxx,DB06887,-7.5,"[(3S)-3-(Methylcarbamoyl)-2-{[(2-methyl-2-propanyl)oxy]carbonyl}-1,2,3,4-tetrahydro-7-isoquinolinyl]sulfamic acid",PPSSYXOFPICMQD-ZDUSSCGKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58837,6crv,DB06729,-7.5,Sulfaphenazole,QWCJHSGMANYXCW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104652,6vxs,DB12308,-7.5,Eltanolone,AURFZBICLPNKBZ-YZRLXODZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
164449,7bv1,DB07843,-7.5,5-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1-BENZOTHIOPHENE-2-SULFONAMIDE,LTJNKFUIOOJXNJ-WFASDCNBSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
53027,2fxp,DB12369,-7.5,Sotrastaurin,OAVGBZOFDPFGPJ-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
55716,6crv,DB01399,-7.5,Salsalate,WVYADZUPLLSGPU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
129681,6w4h,DB09177,-7.5,p-Fluorofentanyl,KXUBAVLIJFTASZ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
115784,6w4b,DB01259,-7.5,Lapatinib,BCFGMOOMADDAQU-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
11980,6lzg,DB12706,-7.5,Seletalisib,LNLJHGXOFYUARS-OAQYLSRUSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
104479,6vxs,DB12063,-7.5,CERC-301,RECBFDWSXWAXHY-IAGOWNOFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
9004,6lzg,DB07070,-7.5,(2S)-2-{3-[({[2-fluoro-4-(trifluoromethyl)phenyl]carbonyl}amino)methyl]-4-methoxybenzyl}butanoic acid,BDLLIPYDNFENMY-ZDUSSCGKSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
129676,6w4h,DB09171,-7.5,??-Methylfentanyl,UXIGUKSHASXDNI-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
56514,6crv,DB02422,-7.5,Methyl-2-S-(Alpha-D-Mannopyranosyl)-2-Thio-Alpha-D-Mannopyranoside,WAYOKHSZGNFKSX-ZEEOCKJESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27997,6cs2,DB00693,-7.5,Fluorescein,GNBHRKFJIUUOQI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
166097,7bv1,DB13682,-7.5,Cefpirome,DKOQGJHPHLTOJR-WHRDSVKCSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
129674,6w4h,DB09169,-7.5,3-Allylfentanyl,BZXKQFFMDLTPJL-LADGPHEKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
115798,6w4b,DB01289,-7.5,Glisoxepide,ZKUDBRCEOBOWLF-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
112572,6vxx,DB07408,-7.5,5-(2-NITROPHENYL)-2-FUROIC ACID,XUFDYUSOQQYQRL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84092,6m3m,DB04762,-7.5,N-PYRIDOXYL-D-GLUTAMIC ACID-5'-MONOPHOSPHATE,JMRKOGDJNHPMHS-SNVBAGLBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
163940,7bv1,DB06883,-7.5,1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-phenylurea,DHNYNLNKNQJSHF-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
163936,7bv1,DB06879,-7.5,"5-(4'-AMINO-1'-ETHYL-5',8'-DIFLUORO-1'H-SPIRO[PIPERIDINE-4,2'-QUINAZOLINE]-1-YLCARBONYL)PICOLINONITRILE",QCFIRACCCDFXIP-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
163932,7bv1,DB06874,-7.5,"(6-[4-(AMINOMETHYL)-2,6-DIMETHYLPHENOXY]-2-{[4-(AMINOMETHYL)PHENYL]AMINO}-5-BROMOPYRIMIDIN-4-YL)METHANOL",LSIZSSASMKSUIU-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
104485,6vxs,DB12072,-7.5,Orantinib,NHFDRBXTEDBWCZ-ZROIWOOFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
115754,6w4b,DB01216,-7.5,Finasteride,DBEPLOCGEIEOCV-WSBQPABSSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
27634,6cs2,DB07185,-7.5,2-{[(4-CHLOROPHENOXY)ACETYL]AMINO}BENZOIC ACID,LXSDGQYDSDIUPN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
11979,6lzg,DB12705,-7.5,Cenerimod,KJKKMMMRWISKRF-FQEVSTJZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
9230,6lzg,DB07312,-7.5,"2,5-DICHLORO-N-(5-CHLORO-1,3-BENZOXAZOL-2-YL)BENZENESULFONAMIDE",JCXZHFCBNFFHRC-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
55615,6crv,DB01205,-7.5,Flumazenil,OFBIFZUFASYYRE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163957,7bv1,DB06902,-7.5,4-(1-methyl-1-phenylethyl)phenol,QBDSZLJBMIMQRS-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
163954,7bv1,DB06899,-7.5,"N-{2-[6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2,2-DIMETHYL-3-OXO-2,3-DIHYDRO-4H-1,4-BENZOTHIAZIN-4-YL]ETHYL}ACETAMIDE",RMEVNJZCKDVVND-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
122505,6w4b,DB13490,-7.5,Hidrosmin,XYFLWVOTXWXNAM-WTNNCJBMSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
8983,6lzg,DB07049,-7.5,(2R)-1-[(4-tert-butylphenyl)sulfonyl]-2-methyl-4-(4-nitrophenyl)piperazine,SOFGQQQVQZQJFS-MRXNPFEDSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
72016,6m2n,DB00238,-7.5,Nevirapine,NQDJXKOVJZTUJA-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
26498,6cs2,DB04643,-7.5,"4-{3-CHLORO-4-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-PHENOXY}-BUTYRIC ACID",FYQVFMLCZJZZEM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
108093,6vxx,DB06836,-7.5,"N-(5-{4-Chloro-3-[(2-hydroxyethyl)sulfamoyl]phenyl}-4-methyl-1,3-thiazol-2-yl)acetamide",JFVNFXCESCXMBC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
17880,6cs2,HMDB0000520,-7.5,"5a-Cholestane-3a,7a,12a,25-tetrol",NTIXPPFPXLYJCT-SUGKMTRFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
161188,7bv1,DB13368,-7.5,Motretinide,IYIYMCASGKQOCZ-DJRRULDNSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
112189,6vxx,DB06530,-7.5,Resiquimod,BXNMTOQRYBFHNZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
12050,6lzg,DB12805,-7.5,Ataciguat,PQHLRGARXNPFCF-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
10822,6lzg,DB09128,-7.5,Brexpiprazole,ZKIAIYBUSXZPLP-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
52714,2fxp,DB11913,-7.5,LY-2090314,HRJWTAWVFDCTGO-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
116822,6w4b,DB02656,-7.5,LY-294002,CZQHHVNHHHRRDU-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
29171,6cs2,DB00821,-7.5,Carprofen,PUXBGTOOZJQSKH-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
115735,6w4b,DB01195,-7.5,Flecainide,DJBNUMBKLMJRSA-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
165921,7bv1,DB13242,-7.5,Bucladesine,CJGYSWNGNKCJSB-YVLZZHOMSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
124217,6w4h,DB00897,-7.5,Triazolam,JOFWLTCLBGQGBO-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
56502,6crv,DB02410,-7.5,"2-Acetyl-3-[(4-Amino-2-Methyl-5-Pyrimidinyl)Methyl]-4-Methyl-5-(4,6,6-Trihydroxy-3,5-Dioxa-4,6-Diphosphahex-1-Yl)Thiazolium Inner Salt P,P'-Dioxide",GYRGKLZCJRVYRV-UHFFFAOYSA-O,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58899,6crv,DB06836,-7.5,"N-(5-{4-Chloro-3-[(2-hydroxyethyl)sulfamoyl]phenyl}-4-methyl-1,3-thiazol-2-yl)acetamide",JFVNFXCESCXMBC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
116802,6w4b,DB02629,-7.5,Inhibitor Bea403,LYHLPPXMBKMSSZ-JQFCFGFHSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
73306,6m2n,DB01852,-7.5,Kaempherol,IYRMWMYZSQPJKC-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
165946,7bv1,DB13277,-7.5,Benziodarone,CZCHIEJNWPNBDE-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
104644,6vxs,DB12299,-7.5,Bavisant,BGBVSGSIXIIREO-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
73368,6m2n,DB01945,-7.5,4-Carbamoyl-1-Beta-D-Ribofuranosyl-Imidazolium-5-Olate-5'-Phosphate,KTKAFSMJDTUUAN-UUOKFMHZSA-L,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
129603,6w4h,DB09020,-7.5,Bisacodyl,KHOITXIGCFIULA-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
129242,6w4h,DB08559,-7.5,"N-[(2S,4S,6R)-2-(dihydroxymethyl)-4-hydroxy-3,3-dimethyl-7-oxo-4lambda-4-thia-1-azabicyclo[3.2.0]hept-6-yl]-2-phenylacetamide",WMPGEOZLAYOFHH-MBNYWOFBSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
112220,6vxx,DB06614,-7.5,Peramivir,XRQDFNLINLXZLB-CKIKVBCHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
129598,6w4h,DB09015,-7.5,Canrenoic acid,PBKZPPIHUVSDNM-WNHSNXHDSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
124434,6w4h,DB01145,-7.5,Sulfoxone,NEDPPCHNEOMTJV-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
104518,6vxs,DB12120,-7.5,Avoralstat,TUWMKPVJGGWGNL-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
124430,6w4h,DB01140,-7.5,Cefadroxil,BOEGTKLJZSQCCD-UEKVPHQBSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
112226,6vxx,DB06623,-7.5,Flupirtine,JUUFBMODXQKSTD-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
115883,6w4b,DB01443,-7.5,19-Nor-5-androstenedione,WELNRNVZXWUOGT-QXUSFIETSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
115889,6w4b,DB01451,-7.5,1-Androstenedione,WJIQCDPCDVWDDE-WZNAKSSCSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
79750,6m2n,DB13692,-7.5,Tretoquinol,RGVPOXRFEPSFGH-AWEZNQCLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
55699,6crv,DB01354,-7.5,Heptabarbital,PAZQYDJGLKSCSI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31876,6cs2,DB14924,-7.5,PF-06651600,CBRJPFGIXUFMTM-WDEREUQCSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
76512,6m2n,DB07290,-7.5,(2R)-2-{[(4-FLUORO-3-METHYLPHENYL)SULFONYL]AMINO}-N-HYDROXY-2-TETRAHYDRO-2H-PYRAN-4-YLACETAMIDE,LUCFRFDOOYLALP-CYBMUJFWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
9195,6lzg,DB07280,-7.5,5-[4-(DIMETHYLAMINO)PHENYL]-6-[(6-MORPHOLIN-4-YLPYRIDIN-3-YL)ETHYNYL]PYRIMIDIN-4-AMINE,AINVOEOJEKKMKB-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
116576,6w4b,DB02341,-7.5,"Mdl 101,146",XQAMVCHQGHAELT-YPAWHYETSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
55626,6crv,DB01217,-7.5,Anastrozole,YBBLVLTVTVSKRW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108157,6vxx,DB07169,-7.5,"5R-(3,4-DICHLOROPHENYLMETHYL)-3-(2-THIOPHENESULFONYLAMINO)-4-OXO-2-THIONOTHIAZOLIDINE",GAOOBYJHWAKZKU-LLVKDONJSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112511,6vxx,DB07335,-7.5,"3-[4-AMINO-1-(1-METHYLETHYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL]PHENOL",MWYBBCLGEHZSCP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163915,7bv1,DB06853,-7.5,N-cycloheptylglycyl-N-(4-carbamimidoylbenzyl)-L-prolinamide,BYTJPDBCLWUEBU-IBGZPJMESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
112495,6vxx,DB07318,-7.5,"N-[2-(4-AMINO-5,8-DIFLUORO-1,2-DIHYDROQUINAZOLIN-2-YL)ETHYL]-3-FURAMIDE",BOAUWUUBSXECNL-LLVKDONJSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30423,6cs2,DB12463,-7.5,Semagacestat,PKXWXXPNHIWQHW-RCBQFDQVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
80975,6m3m,DB00662,-7.5,Trimethobenzamide,FEZBIKUBAYAZIU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
76508,6m2n,DB07286,-7.5,BMS-564929,KEJORAMIZFOODM-PWSUYJOCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
163920,7bv1,DB06860,-7.5,"2-(2-chloropyridin-4-yl)-4-methyl-1H-isoindole-1,3(2H)-dione",YDJMWNHJNJVVMM-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
75168,6m2n,DB04336,-7.5,1-(4-Amidinophenyl)-3-(4-Chlorophenyl)Urea,HQWKMDKTTCPCMQ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
71857,6lxt,DB15424,-7.5,Bfpet F-18,QWPLCHDPESWJRN-FNNGWQQSSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
52761,2fxp,DB11986,-7.5,Entrectinib,HAYYBYPASCDWEQ-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
112550,6vxx,DB07383,-7.5,"N-(1-BENZYL-3,3,3-TRIFLUORO-2,2-DIHYDROXY-PROPYL)-ACETAMIDE",NETPVFJEHOGNPJ-JTQLQIEISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28053,6cs2,DB07626,-7.5,"4-(2-aminoethoxy)-N-(3-chloro-2-ethoxy-5-piperidin-1-ylphenyl)-3,5-dimethylbenzamide",CKBBGCJYKCLKHE-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
112208,6vxx,DB06588,-7.5,Triphendiol,KQCJZAUNKSGEFM-UNMCSNQZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58869,6crv,DB06787,-7.5,Hexocyclium,ZRYHPQCHHOKSMD-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
10852,6lzg,DB09183,-7.5,Dasabuvir,NBRBXGKOEOGLOI-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
165929,7bv1,DB13252,-7.5,Tropatepine,JOQKFRLFXDPXHX-HDICACEKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
76703,6m2n,DB07512,-7.5,7-[(3-CHLOROBENZYL)OXY]-2-OXO-2H-CHROMENE-4-CARBALDEHYDE,ZOCADHRNWNJARU-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
30414,6cs2,DB12447,-7.5,Nadifloxacin,JYJTVFIEFKZWCJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
129618,6w4h,DB09054,-7.5,Idelalisib,IFSDAJWBUCMOAH-HNNXBMFYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
116702,6w4b,DB02498,-7.5,Carba-Nicotinamide-Adenine-Dinucleotide,DGPLSUKWXXSBCU-VGXGLJSLSA-O,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
9026,6lzg,DB07095,-7.5,(S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclopentylpropanoyl)pyrrolidine-2-carboxamide,BNCHHUFGEOJCNH-SFHVURJKSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
104638,6vxs,DB12290,-7.5,Puerarin,HKEAFJYKMMKDOR-VPRICQMDSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
164493,7bv1,DB08071,-7.5,"(2S)-1-methyl-2-[(2S,4R)-2-methyl-4-phenylpentyl]piperidine",UEEAJOUBQAEABH-JZXOWHBKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
79754,6m2n,DB13696,-7.5,Bromochlorosalicylanilide,QBSGXIBYUQJHMJ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
112536,6vxx,DB07365,-7.5,NAPHTHALEN-2-YL-3-ALANINE,OFYAYGJCPXRNBL-LBPRGKRZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30535,6cs2,DB12621,-7.5,ST-101,QZWYXEBIQWJXAR-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
80977,6m3m,DB00664,-7.5,Sulfametopyrazine,KXRZBTAEDBELFD-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
28051,6cs2,DB07625,-7.5,"4-(2-aminoethoxy)-N-(2,5-diethoxyphenyl)-3,5-dimethylbenzamide",PHTPPZCTHZHCQD-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
58858,6crv,DB06764,-7.5,Tetryzoline,BYJAVTDNIXVSPW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112214,6vxx,DB06600,-7.5,Nemonoxacin,AVPQPGFLVZTJOR-RYUDHWBXSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163947,7bv1,DB06890,-7.5,(2R)-2-PHENYL-N-PYRIDIN-4-YLBUTANAMIDE,MODBYAQUXXEFRM-CQSZACIVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
31988,6cs2,DB15156,-7.5,ABT-072,XMZSTQYSBYEENY-RMKNXTFCSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
80822,6m3m,DB00472,-7.5,Fluoxetine,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
166482,7bv1,DB15219,-7.5,Tomivosertib,HKTBYUWLRDZAJK-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
114337,6vxx,DB13312,-7.5,Delapril,WOUOLAUOZXOLJQ-MBSDFSHPSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
160219,7bv1,DB07889,-7.5,"(2S)-1-(Dimethylamino)-3-(4-{[4-(2-methylimidazo[1,2-a]pyridin-3-yl)-2-pyrimidinyl]amino}phenoxy)-2-propanol",VCPXSBULBDYRLT-SFHVURJKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
56246,6crv,DB02077,-7.5,L-N(omega)-Nitroarginine-(4R)-Amino-L-Proline Amide,IUFRDGFKAVLPFZ-CSMHCCOUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
164306,7bv1,DB07679,-7.5,"(9S,12S)-9-(1-methylethyl)-7,10-dioxo-2-oxa-8,11-diazabicyclo[12.2.2]octadeca-1(16),14,17-triene-12-carboxylic acid",RRAAROKJUVKWAF-RDJZCZTQSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
123657,6w4h,DB00227,-7.5,Lovastatin,PCZOHLXUXFIOCF-BXMDZJJMSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
114345,6vxx,DB13320,-7.5,Sulfaperin,DZQVFHSCSRACSX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130923,6w4h,DB13004,-7.5,Mavoglurant,ZFPZEYHRWGMJCV-ZHALLVOQSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
59336,6crv,DB07341,-7.5,"octyl 3-amino-3-deoxy-2-O-(2,6-dideoxy-alpha-L-lyxo-hexopyranosyl)-beta-D-galactopyranoside",GHTLMVRROQXELT-HTYYFBMYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30025,6cs2,DB00908,-7.5,Quinidine,LOUPRKONTZGTKE-LHHVKLHASA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
123208,6w4b,DB15091,-7.5,Upadacitinib,WYQFJHHDOKWSHR-MNOVXSKESA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
123677,6w4h,DB00248,-7.5,Cabergoline,KORNTPPJEAJQIU-KJXAQDMKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130910,6w4h,DB12980,-7.5,CHS-828,BOIPLTNGIAPDBY-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
52021,2fxp,DB08896,-7.5,Regorafenib,FNHKPVJBJVTLMP-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
80586,6m3m,DB00190,-7.5,Carbidopa,TZFNLOMSOLWIDK-JTQLQIEISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
26190,6cs2,DB04274,-7.5,"5,4'-Dideoxyflavanone",SWAJPHCXKPCPQZ-AWEZNQCLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
30031,6cs2,DB11958,-7.5,Brivanib,WCWUXEGQKLTGDX-LLVKDONJSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
130904,6w4h,DB12972,-7.5,Sepranolone,AURFZBICLPNKBZ-FZCSVUEKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
123710,6w4h,DB00284,-7.5,Acarbose,CEMXHAPUFJOOSV-XGWNLRGSSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
160255,7bv1,DB07932,-7.5,"dimethyl (1R,4S)-5,6-bis(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hepta-2,5-diene-2,3-dicarboxylate",CRLQCBACIMUGDZ-BGYRXZFFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
32210,6cs2,DB01183,-7.5,Naloxone,UZHSEJADLWPNLE-GRGSLBFTSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
107671,6vxx,DB04163,-7.5,"5-Phenylsulfanyl-2,4-Quinazolinediamine",BUFDQCGCADQQQY-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
123744,6w4h,DB00327,-7.5,Hydromorphone,WVLOADHCBXTIJK-YNHQPCIGSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130878,6w4h,DB12931,-7.5,Fenobam,DWPQODZAOSWNHB-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
75832,6m2n,DB06190,-7.5,Solabegron,LLDXOPKUNJTIRF-QFIPXVFZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
71528,6lxt,DB14715,-7.5,Cinazepam,NQTRBZXDWMDXAQ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
85094,6m3m,DB07258,-7.5,(R)-pyridin-4-yl[4-(2-pyrrolidin-1-ylethoxy)phenyl]methanol,QQRJWLDQBNAQCC-GOSISDBHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
26178,6cs2,DB04259,-7.5,7n-Methyl-8-Hydroguanosine-5'-Monophosphate,ZMWJGXGSWZFZPJ-KQYNXXCUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
26177,6cs2,DB04258,-7.5,Seocalcitol,LVLLALCJVJNGQQ-SEODYNFXSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
103957,6vxs,DB09304,-7.5,Setiptiline,GVPIXRLYKVFFMK-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
113706,6vxx,DB11790,-7.5,Radafaxine,RCOBKSKAZMVBHT-TVQRCGJNSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
103942,6vxs,DB09279,-7.5,Fimasartan,AMEROGPZOLAFBN-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
8460,6lzg,DB06155,-7.5,Rimonabant,JZCPYUJPEARBJL-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
114268,6vxx,DB13217,-7.5,Fentiazac,JIEKMACRVQTPRC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
8465,6lzg,DB06160,-7.5,Garenoxacin,NJDRXTDGYFKORP-LLVKDONJSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
34373,1r42,DB00171,-7.5,ATP,ZKHQWZAMYRWXGA-KQYNXXCUSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
131030,6w4h,DB13182,-7.5,Daidzein,ZQSIJRDFPHDXIC-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
30001,6cs2,DB11917,-7.5,Vatiquinone,LNOVHERIIMJMDG-XZXLULOTSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
114281,6vxx,DB13232,-7.5,Suxibuzone,ONWXNHPOAGOMTG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27731,6cs2,DB00665,-7.5,Nilutamide,XWXYUMMDTVBTOU-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
123645,6w4h,DB00213,-7.5,Pantoprazole,IQPSEEYGBUAQFF-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131022,6w4h,DB13166,-7.5,Zofenopril,IAIDUHCBNLFXEF-MNEFBYGVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
8476,6lzg,DB06190,-7.5,Solabegron,LLDXOPKUNJTIRF-QFIPXVFZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
8478,6lzg,DB06194,-7.5,Elocalcitol,LRLWXBHFPGSUOX-GJQYOBCGSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
80621,6m3m,DB00232,-7.5,Methyclothiazide,CESYKOGBSMNBPD-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
131011,6w4h,DB13136,-7.5,Fluindione,NASXCEITKQITLD-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
8159,6lzg,DB04834,-7.5,Rapacuronium,HTIKWNNIPGXLGM-YLINKJIISA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
131008,6w4h,DB13129,-7.5,Trimegestone,JUNDJWOLDSCTFK-MTZCLOFQSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
107388,6vxx,DB03242,-7.5,P-Aminophenyl-Alpha-D-Galactopyranoside,MIAKOEWBCMPCQR-IIRVCBMXSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80489,6m2n,DB01470,-7.5,alpha-methylthiofentanyl,YPOXDUYRRSUFFG-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
114308,6vxx,DB13273,-7.5,Sultopride,UNRHXEPDKXPRTM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59367,6crv,DB07380,-7.5,"1,1,1-TRIFLUORO-3-ACETAMIDO-4-PHENYL BUTAN-2-ONE(N-ACETYL-L-PHENYLALANYL TRIFLUOROMETHYL KETONE)",JTIIYPHJIDENCW-JTQLQIEISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130986,6w4h,DB13097,-7.5,1alpha-Hydroxyvitamin D5,NWFOBODUYTUMNC-VPSCEVSQSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
123223,6w4b,DB15120,-7.5,GSK-239512,YFRBKEVUUCQYOW-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
32078,6cs2,DB15316,-7.5,Florasulam,QZXATCCPQKOEIH-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
80045,6m2n,DB14471,-7.5,2-Ethylhexyl 4-phenylbenzophenone-2'-carboxylate,TWAOKHHZKFMFMD-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
166487,7bv1,DB15227,-7.5,Tirabrutinib,SEJLPXCPMNSRAM-GOSISDBHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
130968,6w4h,DB13070,-7.5,Surinabant,HMXDWDSNPRNUKI-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
59362,6crv,DB07374,-7.5,Anisomycin,YKJYKKNCCRKFSL-RDBSUJKOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
71501,6lxt,DB14660,-7.5,Trenbolone acetate,CMRJPMODSSEAPL-FYQPLNBISA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
12238,6lzg,DB00997,-7.5,Doxorubicin,AOJJSUZBOXZQNB-TZSSRYMLSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
113658,6vxx,DB11718,-7.5,Encorafenib,CMJCXYNUCSMDBY-ZDUSSCGKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
123753,6w4h,DB00340,-7.5,Metixene,MJFJKKXQDNNUJF-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
123176,6w4b,DB15029,-7.5,AZD-8186,LMJFJIDLEAWOQJ-CQSZACIVSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
27815,6cs2,DB07371,-7.5,3-(10-methyl-9-anthryl)propanoic acid,CKQINRXZVYBCSC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
11013,6lzg,DB11155,-7.5,Triclocarban,ICUTUKXCWQ1Q-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
75457,6m2n,DB04726,-7.5,"7,8,10-TRIMETHYLBENZO[G]PTERIDINE-2,4(3H,10H)-DIONE",KPDQZGKJTJRBGU-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
164319,7bv1,DB07695,-7.5,"N-(3,5-dibromo-4-hydroxyphenyl)-4-hydroxy-3,5-dimethylbenzamide",HHFKUQZPNITQLU-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
30081,6cs2,DB00913,-7.5,Anileridine,LKYQLAWMNBFNJT-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
160298,7bv1,DB07982,-7.5,2-{4-[4-({4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]pyrimidin-2-yl}amino)phenyl]piperazin-1-yl}-2-oxoethanol,PVTKDXZNSUHUMO-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
107740,6vxx,DB04555,-7.5,Cytidine-5'-Diphosphate,ZWIADYZPOWUWEW-XVFCMESISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29750,6cs2,DB11537,-7.5,Pirlimycin,HBJOXQRURQPDEX-MHXMMLMNSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
130735,6w4h,DB12707,-7.5,AR-42,LAMIXXKAWNLXOC-INIZCTEOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
114482,6vxx,DB13684,-7.5,Omoconazole,JMFOSJNGKJCTMJ-ZHZULCJRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
160304,7bv1,DB07988,-7.5,"2-[3-(5-MERCAPTO-[1,3,4]THIADIAZOL-2YL)-UREIDO]-N-METHYL-3-PENTAFLUOROPHENYL-PROPIONAMIDE",HZAXNPDJVFUGDS-BYPYZUCNSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
32240,6cs2,DB01212,-7.5,Ceftriaxone,VAAUVRVFOQPIGI-SPQHTLEESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
56296,6crv,DB02139,-7.5,(2e)-N-Allyl-4-{[3-(4-Bromophenyl)-5-Fluoro-1-Methyl-1h-Indazol-6-Yl]Oxy}-N-Methyl-2-Buten-1-Amine,YDWPQZUWZDRRSE-AATRIKPKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27707,6cs2,DB07262,-7.5,1-{[N-(1-IMINO-GUANIDINO-METHYL)]SULFANYLMETHYL}-3-TRIFLUOROMETHYL-BENZENE,DWJNPCRXBNWCJC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
29747,6cs2,DB11522,-7.5,Isoflupredone,WAIJIHDWAKJCBX-BULBTXNYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
85009,6m3m,DB07158,-7.5,"5-ETHYL-3-METHYL-1,5-DIHYDRO-4H-PYRAZOLO[4,3-C]QUINOLIN-4-ONE",ASEHARDUZDZEKS-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
29030,6cs2,DB08664,-7.5,({3-[1-(4-HYDROXY-2-OXO-2H-CHROMEN-3-YL)-PROPYL]-PHENYLCARBAMOYL}-METHYL)-CARBAMIC ACID TERT-BUTYL ESTER,QUQQVMVIWCUYFV-KRWDZBQOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
130714,6w4h,DB12671,-7.5,Beloranib,ZEZFKUBILQRZCK-MJSCXXSSSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130710,6w4h,DB12666,-7.5,Emapunil,NBMBIEOUVBHEBM-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
160322,7bv1,DB08008,-7.5,"5-methyl-N-[4-(trifluoromethyl)phenyl][1,2,4]triazolo[1,5-a]pyrimidin-7-amine",LRHHXKBKRNNFRV-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
30096,6cs2,DB12046,-7.5,Atopaxar,QWKAUGRRIXBIPO-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
164141,7bv1,DB07303,-7.5,"N-3-[3-(5-METHOXYPYRIDIN-3-YL)BENZYL]PYRIDINE-2,3-DIAMINE",PGAWZMRRCVSRIM-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
26225,6cs2,DB04315,-7.5,Guanosine-5'-Diphosphate,QGWNDRXFNXRZMB-UUOKFMHZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
29743,6cs2,DB11518,-7.5,Flunixin,NOOCSNJCXJYGPE-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
164324,7bv1,DB07701,-7.5,"1-BENZYL-4-[(5,6-DIMETHOXY-1-INDANON-2-YL)METHYL]PIPERIDINE",ADEBPBSSDYVVLD-HXUWFJFHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59274,6crv,DB07276,-7.5,"5-CYANO-N-(2,5-DIMETHOXYBENZYL)-6-ETHOXYPYRIDINE-2-CARBOXAMIDE",VEGKZYFYGCWXMN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114459,6vxx,DB13660,-7.5,Propicillin,HOCWPKXKMNXINF-XQERAMJGSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130770,6w4h,DB12758,-7.5,Atreleuton,MMSNEKOTSJRTRI-LLVKDONJSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
114454,6vxx,DB13653,-7.5,Lorcainide,XHOJAWVAWFHGHL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114449,6vxx,DB13645,-7.5,Ethacizine,PQXGNJKJMFUPPM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
8552,6lzg,DB06362,-7.5,Becatecarin,JSKFWUPVIZYJMR-UDOAKELVSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
107297,6vxx,DB03125,-7.5,"2,4-Diamino-5-(3,4,5-Trimethoxy-Benzyl)-Pyrimidin-1-Ium",IEDVJHCEMCRBQM-UHFFFAOYSA-O,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75843,6m2n,DB06207,-7.5,Silodosin,PNCPYILNMDWPEY-QGZVFWFLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
29764,6cs2,DB11562,-7.5,Bicuculline,IYGYMKDQCDOMRE-ZWKOTPCHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
8565,6lzg,DB06409,-7.5,Morphine glucuronide,GNJCUHZOSOYIEC-GAROZEBRSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
30054,6cs2,DB11990,-7.5,MK-0812,UNVWTBOGMHPKJM-CWKRKGSWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
160259,7bv1,DB07936,-7.5,N-(4-{[(3S)-3-(dimethylamino)pyrrolidin-1-yl]carbonyl}phenyl)-5-fluoro-4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]pyrimidin-2-amine,BACSZMCLZIDTIO-IBGZPJMESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
63,6lzg,HMDB0002639,-7.5,Sulfolithocholylglycine,FHXBAFXQVZOILS-JWOIRZCRSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
160261,7bv1,DB07938,-7.5,"5-[[(2R)-2-cyclopropyl-7,8-dimethoxy-chroman-5-yl]methyl]pyrimidine-2,4-diamine",HWJPWWYTGBZDEG-CQSZACIVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
32071,6cs2,DB15300,-7.5,Hydroquinidine,LJOQGZACKSYWCH-LHHVKLHASA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
27716,6cs2,DB07272,-7.5,"N-(4-AMINO-5-CYANO-6-ETHOXYPYRIDIN-2-YL)-2-(4-BROMO-2,5-DIMETHOXYPHENYL)ACETAMIDE",GKODDLYLEKSDJL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
107682,6vxx,DB04175,-7.5,Mdl-29951,KNBSYZNKEAWABY-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104076,6vxs,DB11371,-7.5,Alfaxalone,DUHUCHOQIDJXAT-OLVMNOGESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
51610,2fxp,DB08386,-7.5,2-{[4-(4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline,VRWJZGHUCOFGPZ-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
114434,6vxx,DB13625,-7.5,Carbuterol,KEMXXQOFIRIICG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130830,6w4h,DB12863,-7.5,Sivelestat,BTGNGJJLZOIYID-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
30061,6cs2,DB11999,-7.5,Vosaroxin,XZAFZXJXZHRNAQ-STQMWFEESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
8578,6lzg,DB06440,-7.5,Ravuconazole,OPAHEYNNJWPQPX-RCDICMHDSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
130813,6w4h,DB12833,-7.5,Tandospirone,CEIJFEGBUDEYSX-FZDBZEDMSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130804,6w4h,DB12818,-7.5,NM-3,BPZCXUROMKDLGX-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130794,6w4h,DB12802,-7.5,Picropodophyllin,YJGVMLPVUAXIQN-HAEOHBJNSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130789,6w4h,DB12792,-7.5,Boscalid,WYEMLYFITZORAB-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
8586,6lzg,DB06457,-7.5,Tecastemizole,SFOVDSLXFUGAIV-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
107270,6vxx,DB02796,-7.5,9-Deazainosine,WKDMPDYUJKSXBW-KBHCAIDQSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30064,6cs2,DB12002,-7.5,AZD-4818,HVTUHSABWJPWNK-SFHVURJKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
130786,6w4h,DB12787,-7.5,Norethandrolone,ZDHCJEIGTNNEMY-XGXHKTLJSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
113579,6vxx,DB11561,-7.5,Aminacrine,XJGFWWJLMVZSIG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85043,6m3m,DB07197,-7.5,4-BROMO-3-(CARBOXYMETHOXY)-5-(4-HYDROXYPHENYL)THIOPHENE-2-CARBOXYLIC ACID,QZWUMLLRAVGBHC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
71540,6lxt,DB14736,-7.5,Cannabivarin,SVTKBAIRFMXQQF-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
71490,6lxt,DB14648,-7.5,Acetyl simvastatin,OHVWRJDVJRNCPE-BIKFJBPRSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
8173,6lzg,DB04849,-7.5,Cediranib,XXJWYDDUDKYVKI-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
123238,6w4b,DB15145,-7.5,Ziresovir,GAAICKUTDBZCMT-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
103781,6vxs,DB09017,-7.5,Brotizolam,UMSGKTJDUHERQW-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
29923,6cs2,DB11817,-7.5,Baricitinib,XUZMWHLSFXCVMG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
123302,6w4b,DB15275,-7.5,GDC-0077,SGEUNORSOZVTOL-CABZTGNLSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
123446,6w4b,DB00169,-7.5,Cholecalciferol,QYSXJUFSXHHAJI-YRZJJWOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
8283,6lzg,DB05186,-7.5,SQ-109,JFIBVDBTCDTBRH-REZTVBANSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
19237,6cs2,HMDB0000761,-7.5,Lithocholic acid,SMEROWZSTRWXGI-HVATVPOCSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
8281,6lzg,DB05171,-7.5,E-2012,PUOAETJYKQITMO-LANLRWRYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
166557,7bv1,DB15360,-7.5,"Carfentanil, C-11",YDSDEBIZUNNPOB-JVVVGQRLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
123292,6w4b,DB15250,-7.5,Vercirnon,JRWROCIMSDXGOZ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
85298,6m3m,DB07492,-7.5,Bromamphenicol,UWOHGNMWBGIRAQ-RKDXNWHRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
113916,6vxx,DB12271,-7.5,ORE-1001,NTCCRGGIJNDEAB-IRXDYDNUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
12272,6lzg,DB13125,-7.5,Lusutrombopag,NOZIJMHMKORZBA-KJCUYJGMSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
166543,7bv1,DB15335,-7.5,Formononetin,HKQYGTCOTHHOMP-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
114086,6vxx,DB12708,-7.5,Sulprostone,UQZVCDCIMBLVNR-TWYODKAFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85289,6m3m,DB07483,-7.5,"1,1'-BIPHENYL-2-SULFINIC ACID",LZCLZDCSBDVAOV-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
12268,6lzg,DB13119,-7.5,GSK-364735,QWLNINWUBHHOLU-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
160063,7bv1,DB07468,-7.5,"(3aS)-3a-hydroxy-5-methyl-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one",NJBBBRZNBVLTRZ-GOSISDBHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
107560,6vxx,DB03759,-7.5,FG-9041,RWVIMCIPOAXUDG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114089,6vxx,DB12712,-7.5,Pilsicainide,BCQTVJKBTWGHCX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
160065,7bv1,DB07470,-7.5,"(3aS)-3a-hydroxy-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one",DOMYOVZXZIZTRD-QGZVFWFLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
32163,6cs2,DB01136,-7.5,Carvedilol,OGHNVEJMJSYVRP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
27785,6cs2,DB07338,-7.5,Acifluorfen,NUFNQYOELLVIPL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
160072,7bv1,DB07479,-7.5,"(1S)-1,2,3,4-TETRAHYDRO-BENZO[C]PHENANTHRENE-2,3,4-TRIOL",WCUHTHVUZQCBTI-KBAYOESNSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
131333,6w4h,DB13605,-7.5,Phenoperidine,IPOPQVVNCFQFRK-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
32165,6cs2,DB01138,-7.5,Sulfinpyrazone,MBGGBVCUIVRRBF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
107567,6vxx,DB03767,-7.5,Morpholine-4-Carboxylic Acid [1s-(2-Benzyloxy-1r-Cyano-Ethylcarbamoyl)-3-Methyl-Butyl]Amide,LXEDKIMJQBOMSU-MOPGFXCFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75693,6m2n,DB05431,-7.5,MLN-977,YANONWCPCKIWEC-CABCVRRESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
59547,6crv,DB07592,-7.5,(2R)-3-Methyl-1-phenyl-2-butanyl [(2S)-1-oxo-2-hexanyl]carbamate,ZLZXUNHJWVLGTE-DLBZAZTESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
123304,6w4b,DB15281,-7.5,Ravoxertinib,RZUOCXOYPYGSKL-GOSISDBHSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
114056,6vxx,DB12662,-7.5,Naveglitazar,OKJHGOPITGTTIM-DEOSSOPVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28972,6cs2,DB08602,-7.5,"3-(2,6-difluorophenyl)-2-(methylthio)quinazolin-4(3H)-one",BFNBJSXMXXQLAW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
113991,6vxx,DB12557,-7.5,FK-614,UYGZODVVDUIDDQ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85372,6m3m,DB07582,-7.5,"N-[(2R,3S)-1-((2S)-2-{[(CYCLOPENTYLAMINO)CARBONYL]AMINO}-3-METHYLBUTANOYL)-2-(1-FORMYL-1-CYCLOBUTYL)PYRROLIDINYL]CYCLOPROPANECARBOXAMIDE",GCDRFILPPBOJLM-UFYCRDLUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
113972,6vxx,DB12347,-7.5,CG-400549,YCLREGRRHGLOAK-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
123357,6w4b,DB15391,-7.5,Elenbecestat,AACUJFVOHGRMTR-DPXNYUHVSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
29893,6cs2,DB11778,-7.5,Danusertib,XKFTZKGMDDZMJI-HSZRJFAPSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
85369,6m3m,DB07577,-7.5,"6-ETHYL-5-PHENYLPYRIMIDINE-2,4-DIAMINE",XREDUPOVEQDQQS-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
160006,7bv1,DB07180,-7.5,"5-[(Z)-(5-Chloro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-N,2,4-trimethyl-1H-pyrrole-3-carboxamide",FIRPCWHHIWFKCD-GHXNOFRVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
103738,6vxs,DB08970,-7.5,Fluprednidene,YVHXHNGGPURVOS-SBTDHBFYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
123341,6w4b,DB15346,-7.5,GLPG-1205,IRBAWVGZNJIROV-SFHVURJKSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
166597,7bv1,DB15448,-7.5,Acumapimod,VGUSQKZDZHAAEE-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
26051,6cs2,DB04108,-7.5,"(2s,3r)-3-Amino-2-Hydroxy-5-(Ethylsulfanyl)Pentanoyl-((S)-(-)-(1-Naphthyl)Ethyl)Amide",AIIOXZPEXXZCML-KKXDTOCCSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
27767,6cs2,DB07319,-7.5,"6-(3-BROMO-2-NAPHTHYL)-1,3,5-TRIAZINE-2,4-DIAMINE",RXSSKAZHCZWJPP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
113961,6vxx,DB12326,-7.5,Antroquinonol,LJTSIMVOOOLKOL-FNRDIUJOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29832,6cs2,DB11694,-7.5,Ilorasertib,WPHKIQPVPYJNAX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
114016,6vxx,DB12594,-7.5,AZD-9056,HSQAARMBHJCUOK-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
103741,6vxs,DB08973,-7.5,Fluclorolone acetonide,NJNWEGFJCGYWQT-VSXGLTOVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
27769,6cs2,DB07322,-7.5,"2-[(PHENYLSULFONYL)AMINO]-5,6,7,8-TETRAHYDRONAPHTHALENE-1-CARBOXYLIC ACID",RRXVUYHFDBLTEL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
131455,6w4h,DB13767,-7.5,Vorozole,XLMPPFTZALNBFS-INIZCTEOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
8308,6lzg,DB05327,-7.5,Ranirestat,QCVNMNYRNIMDKV-QGZVFWFLSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
8353,6lzg,DB05542,-7.5,Naronapride,VGDDOIZXGFJDRC-VJTSUQJLSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
131450,6w4h,DB13759,-7.5,Fenpiverinium,QDIYJDPBMZUZEH-UHFFFAOYSA-O,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
8354,6lzg,DB05552,-7.5,TG100-115,UJIAQDJKSXQLIT-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
131443,6w4h,DB13752,-7.5,Tetramethrin,CXBMCYHAMVGWJQ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
8356,6lzg,DB05562,-7.5,Naluzotan,SPWZXWDPAWDKQE-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
160036,7bv1,DB07216,-7.5,"(11S)-8-CHLORO-11-[1-(METHYLSULFONYL)PIPERIDIN-4-YL]-6-PIPERAZIN-1-YL-11H-BENZO[5,6]CYCLOHEPTA[1,2-B]PYRIDINE",ZMGCFGGMTCMSDP-QHCPKHFHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59552,6crv,DB07598,-7.5,"2,3,6A,7,8,9-HEXAHYDRO-11H-[1,4]DIOXINO[2,3-G]PYRROLO[2,1-B][1,3]BENZOXAZIN-11-ONE",RQEPVMAYUINZRE-GFCCVEGCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
164225,7bv1,DB07400,-7.5,1-ETHOXYCARBONYL-D-PHE-PRO-2(4-AMINOBUTYL)HYDRAZINE,AEHSFPPTWRQOFS-MSOLQXFVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
114052,6vxx,DB12657,-7.5,JNJ-42396302,BPLVDYJDAVYLRQ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56168,6crv,DB01972,-7.5,Guanosine-5'-Monophosphate,RQFCJASXJCIDSX-UUOKFMHZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75548,6m2n,DB04844,-7.5,Tetrabenazine,MKJIEFSOBYUXJB-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80315,6m2n,DB15117,-7.5,Transfluthrin,DDVNRFNDOPPVQJ-HQJQHLMTSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
114105,6vxx,DB12733,-7.5,Dipraglurant,LZXMUJCJAWVHPZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
103879,6vxs,DB09194,-7.5,Etoperidone,IZBNNCFOBMGTQX-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
59431,6crv,DB07454,-7.5,(R)-3-BROMO-2-HYDROXY-2-METHYL-N-[4-NITRO-3-(TRIFLUOROMETHYL)PHENYL]PROPANAMIDE,QDSWNDMHSBZXKX-JTQLQIEISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
51716,2fxp,DB08512,-7.5,"6-amino-2-[(1-naphthylmethyl)amino]-3,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",MCEZMMDIEXECTI-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
29812,6cs2,DB11671,-7.5,AZD-4877,SMFXSYMLJDHGIE-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
123608,6w4h,DB00169,-7.5,Cholecalciferol,QYSXJUFSXHHAJI-YRZJJWOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131147,6w4h,DB13351,-7.5,Piperidolate,KTHVBAZBLKXIHZ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
85209,6m3m,DB07389,-7.5,N-[2-(6-AMINO-4-METHYLPYRIDIN-2-YL)ETHYL]-4-CYANOBENZAMIDE,QINCZVSBLITNRD-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
123610,6w4h,DB00171,-7.5,ATP,ZKHQWZAMYRWXGA-KQYNXXCUSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
113831,6vxx,DB12146,-7.5,Rigosertib,OWBFCJROIKNMGD-BQYQJAHWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
131145,6w4h,DB13349,-7.5,Talastine,LCAAMXMULMCKLJ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
71475,6lxt,DB14632,-7.5,Prednisolone tebutate,HUMXXHTVHHLNRO-KAJVQRHHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
8210,6lzg,DB04892,-7.5,Phenserine,PBHFNBQPZCRWQP-QUCCMNQESA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
113830,6vxx,DB12145,-7.5,AZD-0328,OCKIPDMKGPYYJS-ZDUSSCGKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
8216,6lzg,DB00554,-7.5,Piroxicam,QYSPLQLAKJAUJT-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
32184,6cs2,DB01157,-7.5,Trimetrexate,NOYPYLRCIDNJJB-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
131125,6w4h,DB13325,-7.5,Nifurzide,IDUMOVRJNBNOTR-BIZLIJPVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
103893,6vxs,DB09209,-7.5,Pholcodine,GPFAJKDEDBRFOS-FKQDBXSBSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
131111,6w4h,DB13310,-7.5,Ormeloxifene,XZEUAXYWNKYKPL-WDYNHAJCSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
103903,6vxs,DB09219,-7.5,Bisoxatin,BPKUDUSVDVLOPY-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
113801,6vxx,DB12106,-7.5,PF-06305591,APWZIFIAVVFPNT-PELKAZGASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
164186,7bv1,DB07352,-7.5,Apigenin,KZNIFHPLKGYRTM-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
103908,6vxs,DB09226,-7.5,RP-5063,PMKMNTBZJOXTJW-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
56103,6crv,DB01878,-7.5,Benzophenone,RWCCWEUUXYIKHB-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75754,6m2n,DB05779,-7.5,Oglufanide,LLEUXCDZPQOJMY-AAEUAGOBSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
103920,6vxs,DB09239,-7.5,Niguldipine,SVJMLYUFVDMUHP-XIFFEERXSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
26164,6cs2,DB04239,-7.5,2-Amino-6-Aminomethyl-8-Phenylsulfanylmethyl-3h-Quinazolin-4-One,CBFXRTSHUMEYKQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
75514,6m2n,DB04806,-7.5,(5-BROMO-4-CHLORO-3-INDOLYL)-A-D-MANNOSE,OPIFSICVWOWJMJ-HAAGFXOZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
32084,6cs2,DB15325,-7.5,ONO-8539,ALLLQQUASFFEKP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
113822,6vxx,DB12131,-7.5,Vinpocetine,DDNCQMVWWZOMLN-IRLDBZIGSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130689,6w4h,DB12637,-7.5,Onapristone,IEXUMDBQLIVNHZ-YOUGDJEHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
113836,6vxx,DB12153,-7.5,Citicoline,RZZPDXZPRHQOCG-OJAKKHQRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85218,6m3m,DB07398,-7.5,"2-[(CYCLOPROPYLCARBONYL)AMINO]-4,5,6,7-TETRAHYDRO-1-BENZOTHIOPHENE-3-CARBOXAMIDE",VATFNEMGBRWLHI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
160082,7bv1,DB07490,-7.5,"2-[1-(4-CHLORO-PHENYL)-ETHYL]-4,6-DINITRO-PHENOL",MOZUMFSUQQHSCO-MRVPVSSYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
113883,6vxx,DB12226,-7.5,Terameprocol,ORQFDHFZSMXRLM-IYBDPMFKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
160085,7bv1,DB07493,-7.5,"(2Z)-5'-BROMO-2,3'-BIINDOLE-2',3(1H,1'H)-DIONE AMMONIATE",IEQQJQHHJMQETK-YPKPFQOOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
29950,6cs2,DB11847,-7.5,Cadazolid,XWFCFMXQTBGXQW-GOSISDBHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
114108,6vxx,DB12740,-7.5,CC-115,GMYLVKUGJMYTFB-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
131280,6w4h,DB13532,-7.5,Cyclopenthiazide,BKYKPTRYDKTTJY-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131279,6w4h,DB13531,-7.5,Nicofetamide,DWODOIKZDGJOPQ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
103852,6vxs,DB09166,-7.5,Etizolam,VMZUTJCNQWMAGF-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
71445,6lxt,DB14540,-7.5,Hydrocortisone butyrate,BMCQMVFGOVHVNG-TUFAYURCSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
164282,7bv1,DB07648,-7.5,"(2R)-3-{[(4Z)-5,6-DIPHENYL-6,7-DIHYDRO-4H-PYRROLO[2,3-D]PYRIMIDIN-4-YLIDENE]AMINO}PROPANE-1,2-DIOL",TWEONIHFGKSPLC-MRXNPFEDSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
107607,6vxx,DB04081,-7.5,"(4s-Trans)-4-(Methylamino)-5,6-Dihydro-6-Methyl-4h-Thieno(2,3-B)Thiopyran-2-Sulfonamide-7,7-Dioxide",PYXFWOIZPYXNRU-FSPLSTOPSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75712,6m2n,DB05518,-7.5,Managlinat dialanetil,BYKBUQDQTLDNLE-KBPBESRZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80429,6m2n,DB15338,-7.5,Rovatirelin,WTXWDXWZGJGIHV-URBCHYCLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
114172,6vxx,DB12850,-7.5,Etalocib,YFIZRWPXUYFCSN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
103858,6vxs,DB09172,-7.5,Brifentanil,KKMGCTVJCQYQPV-WBVHZDCISA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
32180,6cs2,DB01153,-7.5,Sertaconazole,JLGKQTAYUIMGRK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
114134,6vxx,DB12783,-7.5,Benserazide,BNQDCRGUHNALGH-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113850,6vxx,DB12179,-7.5,Secoisolariciresinol,PUETUDUXMCLALY-HOTGVXAUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113848,6vxx,DB12173,-7.5,Diphencyprone,HCIBTBXNLVOFER-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
8235,6lzg,DB04954,-7.5,Tecadenoson,OESBDSFYJMDRJY-BAYCTPFLSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
17165,6cs2,HMDB0006759,-7.5,3a-Hydroxy-5b-pregnane-20-one,AURFZBICLPNKBZ-KCZNCWLVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
164192,7bv1,DB07358,-7.5,"2-amino-N-(4-methyl-1,3-thiazol-2-yl)-5-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]benzamide",JEBOJMQHVUEKBE-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
131211,6w4h,DB13435,-7.5,Endralazine,ALAXZYHFVBSJKZ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
123252,6w4b,DB15177,-7.5,VX-659,IGEOJNMYRZUKIK-IBGZPJMESA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
85221,6m3m,DB07402,-7.5,Azapropazone,WOIIIUDZSOLAIW-NSHDSACASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
26130,6cs2,DB00486,-7.5,Nabilone,GECBBEABIDMGGL-RTBURBONSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
113841,6vxx,DB12161,-7.5,Deutetrabenazine,MKJIEFSOBYUXJB-WEZHFFAMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
8228,6lzg,DB04942,-7.5,Tamibarotene,MUTNCGKQJGXKEM-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
103859,6vxs,DB09173,-7.5,Butyrfentanyl,QQOMYEQLWQJRKK-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
130030,6w4h,DB11670,-7.5,SP-8203,SJZBPVOSFYUHFV-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
29742,6cs2,DB11512,-7.5,Dihydrostreptomycin,ASXBYYWOLISCLQ-HZYVHMACSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
104111,6vxs,DB11433,-7.5,Nequinate,NNOPDLNHPOLRRE-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
76145,6m2n,DB06866,-7.5,6-CARBAMIMIDOYL-2-[2-HYDROXY-5-(3-METHOXY-PHENYL)-INDAN-1-YL]-HEXANOIC ACID,NMOUMGFCBOWPAB-RZUBCFFCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
26351,6cs2,DB04474,-7.5,1-Anilino-8-Naphthalene Sulfonate,FWEOQOXTVHGIFQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
113187,6vxx,DB08645,-7.5,"6-CHLORO-3-(DICHLOROMETHYL)-3,4-DIHYDRO-2H-1,2,4-BENZOTHIADIAZINE-7-SULFONAMIDE 1,1-DIOXIDE",LMJSLTNSBFUCMU-MRVPVSSYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130262,6w4h,DB12008,-7.5,Prexasertib,DOTGPNHGTYJDEP-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
31987,6cs2,DB15152,-7.5,TMC-649128,XJBILYMRFVHPJB-XJQUKVTJSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
122882,6w4b,DB14071,-7.5,Desmethylsertraline,SRPXSILJHWNFMK-ZBEGNZNMSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
104276,6vxs,DB11766,-7.5,AZD-1305,BLLNYXOLLAVTRF-HDICACEKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
71717,6lxt,DB15141,-7.5,Deutivacaftor,PURKAOJPTOLRMP-ASMGOKTBSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
166312,7bv1,DB14644,-7.5,Methylprednisolone hemisuccinate,IMBXEJJVJRTNOW-XYMSELFBSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
130242,6w4h,DB11979,-7.5,Elagolix,HEAUOKZIVMZVQL-VWLOTQADSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
71718,6lxt,DB15143,-7.5,PF-06650833,JKDGKIBAOAFRPJ-ZBINZKHDSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
73707,6m2n,DB02390,-7.5,5-Bromo-N[2-(Dimethylamino)Ethyl]-9-Aminoacridine-4-Carboxamide,NROQPXQSDDINMC-UHFFFAOYSA-P,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
30239,6cs2,DB12235,-7.5,Estetrol,AJIPIJNNOJSSQC-NYLIRDPKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
113171,6vxx,DB08623,-7.5,"2-[CARBOXY-(2-THIOPHEN-2-YL-ACETYLAMINO)-METHYL]-5-METHYLENE-5,6-DIHYDRO-2H-[1,3]THIAZINE-4-CARBOXYLIC ACID",VBBNCGUNWSPHOY-QWRGUYRKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79908,6m2n,DB13944,-7.5,Testosterone enanthate,VOCBWIIFXDYGNZ-IXKNJLPQSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
166310,7bv1,DB14641,-7.5,Estriol tripropionate,ONMZMZJEZHMWQL-REUUDLSRSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160625,7bv1,DB08864,-7.5,Rilpivirine,YIBOMRUWOWDFLG-ONEGZZNKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
123970,6w4h,DB00604,-7.5,Cisapride,DCSUBABJRXZOMT-IRLDBZIGSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
12141,6lzg,DB12939,-7.5,Nikkomycin Z,WWJFFVUVFNBJTN-VHDFTHOZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
114998,6w4b,DB00324,-7.5,Fluorometholone,FAOZLTXFLGPHNG-KNAQIMQKSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
56403,6crv,DB02281,-7.5,Formycin,KBHMEHLJSZMEMI-KSYZLYKTSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30244,6cs2,DB12241,-7.5,TAK-733,RCLQNICOARASSR-SECBINFHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
130209,6w4h,DB11933,-7.5,Riboprine,USVMJSALORZVDV-SDBHATRESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
29081,6cs2,DB08722,-7.5,5-(7-(6-chloro-4-(5-hydro-4-methyl-2-oxazolyl)phenoxy)heptyl)-3-methyl isoxazole,WOJFAPUTPSWFLJ-INIZCTEOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
30248,6cs2,DB12244,-7.5,CP-601927,RNOBTWYQAWEZHH-JGVFFNPUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
115021,6w4b,DB00354,-7.5,Buclizine,MOYGZHXDRJNJEP-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
123979,6w4h,DB00613,-7.5,Amodiaquine,OVCDSSHSILBFBN-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
34133,6cs2,T3D0994,-7.5,Phenmedipham,IDOWTHOLJBTAFI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
130274,6w4h,DB12027,-7.5,Serdemetan,CEGSUK1LWKJP-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
107962,6vxx,DB05864,-7.5,PPI-2458,QBDVVYNLLXGUGN-XGTBZJOHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104266,6vxs,DB11750,-7.5,Clobetasol,FCSHDIVRCWTZOX-DVTGEIKXSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
113281,6vxx,DB08752,-7.5,N-[(1S)-2-[(4-cyano-1-methylpiperidin-4-yl)amino]-1-(cyclohexylmethyl)-2-oxoethyl]morpholine-4-carboxamide,IRSOCWQJNYLTDD-SFHVURJKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114811,6vxx,DB14903,-7.5,Rovafovir etalafenamide,OCJRRXHWPBXZSU-BJBBEUPESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104242,6vxs,DB11711,-7.5,Navarixin,IXBYSXNOKFHHDR-QGZVFWFLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
114814,6vxx,DB14913,-7.5,5-methyl-2'-fluoroarauracil F-18,GBBJCSTXCAQSSJ-MSYRQUNGSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84722,6m3m,DB06821,-7.5,Sulfameter,GPTONYMQFTZPKC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
71671,6lxt,DB15052,-7.5,Ansofaxine,QKYBZJLEMOZFFU-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
27680,6cs2,DB07234,-7.5,"3-{[(1R)-1-phenylethyl]amino}-4-(pyridin-4-ylamino)cyclobut-3-ene-1,2-dione",MCBPNFWHHNJTGN-LLVKDONJSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
107939,6vxx,DB05708,-7.5,GTS-21,RPYWXZCFYPVCNQ-RVDMUPIBSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28701,6cs2,DB08307,-7.5,"2-{HYDROXY[2-NITRO-4-(TRIFLUOROMETHYL)PHENYL]METHYLENE}CYCLOHEXANE-1,3-DIONE",PMHVFNYNPNKNRO-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
30203,6cs2,DB12187,-7.5,Abacavir hydroxyacetate,ZBBZROWQLKCFQK-KOLCDFICSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
71673,6lxt,DB15056,-7.5,Bifenthrin,OMFRMAHOUUJSGP-IRHGGOMRSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
166356,7bv1,DB14717,-7.5,Nitrazolam,OYRPNABWTHDOFK-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
114859,6vxx,DB15288,-7.5,Etamicastat,CWWWTTYMUOYSQA-LLVKDONJSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107972,6vxx,DB05939,-7.5,MK-0354,LTQYSJKGRPGMPO-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84715,6m3m,DB06807,-7.5,Phenyl aminosalicylate,DNVVZWSVACQWJE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
8725,6lzg,DB06733,-7.5,Bafilomycin A1,XDHNQDDQEHDUTM-JQWOJBOSSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
160540,7bv1,DB08751,-7.5,"N,N'-DIMETHYL-N-(ACETYL)-N'-(7-NITROBENZ-2-OXA-1,3-DIAZOL-4-YL)ETHYLENEDIAMINE",YSVJZZZGPPWEIC-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
76103,6m2n,DB06803,-7.5,Niclosamide,RJMUSRYZPJIFPJ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
122964,6w4b,DB14541,-7.5,Hydrocortisone cypionate,DLVOSEUFIRPIRM-KAQKJVHQSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
55901,6crv,DB01615,-7.5,Aceprometazine,XLOQNFNTQIRSOX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
166354,7bv1,DB14715,-7.5,Cinazepam,NQTRBZXDWMDXAQ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
130295,6w4h,DB12059,-7.5,JNJ-40411813,HYOGJHCDLQSAHX-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
114887,6vxx,DB15338,-7.5,Rovatirelin,WTXWDXWZGJGIHV-URBCHYCLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
122948,6w4b,DB14218,-7.5,Telotristat,NCLGDOBQAWBXRA-PGRDOPGGSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
8732,6lzg,DB06741,-7.5,Gavestinel,WZBNEZWCNKUOSM-VOTSOKGWSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
27674,6cs2,DB07228,-7.5,1-(5-CHLORO-2-METHOXYPHENYL)-3-{6-[2-(DIMETHYLAMINO)-1-METHYLETHOXY]PYRAZIN-2-YL}UREA,GIAYFZLMPSVQDV-NSHDSACASA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
76122,6m2n,DB06835,-7.5,(2S)-2-[3-(AMINOMETHYL)PHENYL]-3-{(S)-HYDROXY[(1R)-2-METHYL-1-{[(2-PHENYLETHYL)SULFONYL]AMINO}PROPYL]PHOSPHORYL}PROPANOIC ACID,CTQDLSDUHUFBQW-LEWJYISDSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
166327,7bv1,DB14660,-7.5,Trenbolone acetate,CMRJPMODSSEAPL-FYQPLNBISA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
130317,6w4h,DB12093,-7.5,Tetrahydropalmatine,AEQDJSLRWYMAQI-KRWDZBQOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
160503,7bv1,DB08713,-7.5,"2,6-DIMETHYL-1-(3-[3-METHYL-5-ISOXAZOLYL]-PROPANYL)-4-[2N-METHYL-2H-TETRAZOL-5-YL]-PHENOL",RVZKQTQAFHEOKT-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
75325,6m2n,DB04552,-7.5,Niflumic acid,JZFPYUNJRRFVQU-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
164383,7bv1,DB07769,-7.5,S-3-(4-FLUOROPHENOXY)-2-HYDROXY-2-METHYL-N-[4-NITRO-3-(TRIFLUOROMETHYL)PHENYL]PROPANAMIDE,KJMFOTCDISOHDX-INIZCTEOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
107043,6vxx,DB02214,-7.5,"6,7-Dioxo-5h-8-Ribitylaminolumazine",MIBROOURCUHKMD-RPDRRWSUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
122787,6w4b,DB13867,-7.5,Fluticasone,MGNNYOODZCAHBA-GQKYHHCASA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
6150,6lzg,DB00251,-7.5,Terconazole,BLSQLHNBWJLIBQ-OZXSUGGESA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
27660,6cs2,DB07211,-7.5,(2R)-2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}PROPENE-1-SULFONAMIDE,YMJHMJLNQLVUAV-GHYUOPHCSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
160724,7bv1,DB09383,-7.5,Meprednisone,PIDANAQULIKBQS-RNUIGHNZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
26419,6cs2,DB00523,-7.5,Alitretinoin,SHGAZHPCJJPHSC-ZVCIMWCZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
12104,6lzg,DB12888,-7.5,Ezutromid,KSGCNXAZROJSNW-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
107042,6vxx,DB02213,-7.5,Metanitrophenyl-Alpha-D-Galactoside,VCCMGHVCRFMITI-IIRVCBMXSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112973,6vxx,DB08213,-7.5,"1-METHYL-5-(2-PHENOXYMETHYL-PYRROLIDINE-1-SULFONYL)-1H-INDOLE-2,3-DIONE",PFAYCUAUBOGVDX-AWEZNQCLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
122786,6w4b,DB13866,-7.5,Etynodiol,JYILPERKVHXLNF-QMNUTNMBSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
115195,6w4b,DB00568,-7.5,Cinnarizine,DERZBLKQOCDDDZ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
122772,6w4b,DB13846,-7.5,Pyrrobutamine,WDYYVNNRTDZKAZ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
76234,6m2n,DB06971,-7.5,"N-{2-[(4'-CYANO-1,1'-BIPHENYL-4-YL)OXY]ETHYL}-N'-HYDROXY-N-METHYLUREA",GVMUNGGWXRKCEU-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
115214,6w4b,DB00590,-7.5,Doxazosin,RUZYUOTYCVRMRZ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
122746,6w4b,DB13814,-7.5,Talampicillin,SOROUYSPFADXSN-SUWVAFIASA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
115227,6w4b,DB00606,-7.5,Cyclothiazide,BOCUKUHCLICSIY-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
160769,7bv1,DB11182,-7.5,Rose bengal free acid,VDNLFJGJEQUWRB-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
166249,7bv1,DB14208,-7.5,Ramiprilat,KEDYTOTWMPBSLG-HILJTLORSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
8841,6lzg,DB06899,-7.5,"N-{2-[6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2,2-DIMETHYL-3-OXO-2,3-DIHYDRO-4H-1,4-BENZOTHIAZIN-4-YL]ETHYL}ACETAMIDE",RMEVNJZCKDVVND-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
643,6lzg,HMDB0006327,-7.5,Alpha-Tocotrienol,RZFHLOLGZPDCHJ-XZXLULOTSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
27655,6cs2,DB07206,-7.5,6-[2-(1H-INDOL-6-YL)ETHYL]PYRIDIN-2-AMINE,OSHSZKRWKLQZBV-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
115272,6w4b,DB00663,-7.5,Flumethasone,WXURHACBFYSXBI-GQKYHHCASA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
112886,6vxx,DB08113,-7.5,3-pyridin-4-yl-1H-indazole,MSRXUUDVRNWSTN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108006,6vxx,DB06694,-7.5,Xylometazoline,HUCJFAOMUPXHDK-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104374,6vxs,DB11905,-7.5,Sutezolid,FNDDDNOJWPQCBZ-ZDUSSCGKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
115298,6w4b,DB00693,-7.5,Fluorescein,GNBHRKFJIUUOQI-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
124064,6w4h,DB00716,-7.5,Nedocromil,RQTOOFIXOKYGAN-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
160719,7bv1,DB09355,-7.5,Sulfabenzamide,PBCZLFBEBARBBI-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
130107,6w4h,DB11784,-7.5,NRX-1074,DVBUEXCIEIAXPM-PJUQSVSOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
164396,7bv1,DB07785,-7.5,"1-{(1R,2S)-2-HYDROXY-1-[2-(2-NAPHTHYLOXY)ETHYL]PROPYL}-1H-IMIDAZONE-4-CARBOXAMIDE",UYAJDVNLQJVRHD-SCLBCKFNSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
48062,2fxp,DB02629,-7.5,Inhibitor Bea403,LYHLPPXMBKMSSZ-JQFCFGFHSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
160653,7bv1,DB09230,-7.5,Azelnidipine,ZKFQEACEUNWPMT-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
113077,6vxx,DB08348,-7.5,"N-2-,N-2-DIMETHYL-N-1-(6-OXO-5,6-DIHYDROPHENANTHRIDIN-2-YL)GLYCINAMIDE",UYJZZVDLGDDTCL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
73429,6m2n,DB02023,-7.5,8-Oxo-2'-Deoxy-Guanosine-5'-Monophosphate,AQIVLFLYHYFRKU-VPENINKCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
130171,6w4h,DB11875,-7.5,"3,3'-diindolylmethane",VFTRKSBEFQDZKX-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
123990,6w4h,DB00628,-7.5,Clorazepic acid,XDDJGVMJFWAHJX-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
113065,6vxx,DB08329,-7.5,Sulthiame,HMHVCUVYZFYAJI-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80794,6m3m,DB00439,-7.5,Cerivastatin,SEERZIQQUAZTOL-ANMDKAQQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
56411,6crv,DB02295,-7.5,"N-[3-(Dimethylamino)Propyl]-2-({[4-({[4-(Formylamino)-1-Methyl-1h-Pyrrol-2-Yl]Carbonyl}Amino)-1-Methyl-1h-Pyrrol-2-Yl]Carbonyl}Amino)-5-Isopropyl-1,3-Thiazole-4-Carboxamide",VDYCDKRATGWFDA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113057,6vxx,DB08320,-7.5,"DIETHYL (1R,2S,3R,4S)-5,6-BIS(4-HYDROXYPHENYL)-7-OXABICYCLO[2.2.1]HEPT-5-ENE-2,3-DICARBOXYLATE",NHKDFDHHMHBFLG-COPRSSIGSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
34097,6cs2,T3D0955,-7.5,Desmedipham,WZJZMXBKUWKXTQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
124010,6w4h,DB00655,-7.5,Estrone,DNXHEGUUPJUMQT-CBZIJGRNSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
122852,6w4b,DB14017,-7.5,H3B-8800,YOIQWBAHJZGRFW-WVRLKXNASA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
84594,6m3m,DB06582,-7.5,Dextofisopam,RUJBDQSFYCKFAA-HNNXBMFYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
123984,6w4h,DB00621,-7.5,Oxandrolone,QSLJIVKCVHQPLV-PEMPUTJUSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
6124,6lzg,DB01605,-7.5,Pivmecillinam,NPGNOVNWUSPMDP-HLLBOEOZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
629,6lzg,HMDB0006224,-7.5,17-beta-Estradiol-3-glucuronide,MUOHJTRCBBDUOW-BFXFFQJBSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
122841,6w4b,DB13991,-7.5,Pipequaline,AMEWZCMTSIONOX-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
8798,6lzg,DB06850,-7.5,(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclohexylamino)ethanoyl)pyrrolidine-2-carboxamide,RYKFVFFOIYLADT-SFHVURJKSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
26410,6cs2,DB04543,-7.5,"2,6-Diamino-8-(1h-Imidazol-2-Ylsulfanylmethyl)-3h-Quinazoline-4-One",CEWKWXPCQGWWBM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
160695,7bv1,DB09292,-7.5,Sacubitril,PYNXFZCZUAOOQC-UTKZUKDTSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
73725,6m2n,DB02410,-7.5,"2-Acetyl-3-[(4-Amino-2-Methyl-5-Pyrimidinyl)Methyl]-4-Methyl-5-(4,6,6-Trihydroxy-3,5-Dioxa-4,6-Diphosphahex-1-Yl)Thiazolium Inner Salt P,P'-Dioxide",GYRGKLZCJRVYRV-UHFFFAOYSA-O,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
122821,6w4b,DB13952,-7.5,Estradiol acetate,FHXBMXJMKMWVRG-SLHNCBLASA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
113018,6vxx,DB08272,-7.5,(4S)-4-(2-NAPHTHYLMETHYL)-D-GLUTAMIC ACID,YDWIUFASTTZKNI-UONOGXRCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
115156,6w4b,DB00522,-7.5,Bentiromide,SPPTWHFVYKCNNK-FQEVSTJZSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
71749,6lxt,DB15205,-7.5,Capromorelin,KVLLHLWBPNCVNR-SKCUWOTOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
76197,6m2n,DB06923,-7.5,2-(3-METHYLPHENYL)-1H-INDOLE-5-CARBOXIMIDAMIDE,KJUSXMYSVXZFDJ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
113011,6vxx,DB08262,-7.5,"2,6-dicarboxynaphthalene",RXOHFPCZGPKIRD-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113003,6vxx,DB08253,-7.5,NAM NAPTHYLAMINOALANINE,DGFMSNJYBBNHCX-LBPRGKRZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27666,6cs2,DB07219,-7.5,"BENZYL N-({(2S,3S)-3-[(PROPYLAMINO)CARBONYL]OXIRAN-2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINATE",OMQNYWZURFTFHE-MQBSTWLZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
71660,6lxt,DB15033,-7.5,Flortaucipir,GETAAWDSFUCLBS-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
130374,6w4h,DB12174,-7.5,CUDC-101,PLIVFNIUGLLCEK-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130383,6w4h,DB12188,-7.5,Zicronapine,BYPMJBXPNZMNQD-PZJWPPBQSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
107826,6vxx,DB04663,-7.5,"2-KETO-6-PHOSPHATE-D-GLUCONIC ACID, ALPHA-FURANOSE FORM",LXQWHMQOSMCJIZ-ZGEUXELVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
123841,6w4h,DB00445,-7.5,Epirubicin,AOJJSUZBOXZQNB-VTZDEGQISA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
160372,7bv1,DB08305,-7.5,"(3R)-3-cyclopentyl-6-methyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2-benzothiazine 1,1-dioxide",KQAGZLQCEURCKJ-QGZVFWFLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
32033,6cs2,DB15235,-7.5,Di-2-pyridylketone 4-cyclohexyl-4-methyl-3-thiosemicarbazone,GNLZNQJBZNOUBM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
130551,6w4h,DB12420,-7.5,Diazepinomicin,SALVHVNECODMJP-GNUCVDFRSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130548,6w4h,DB12417,-7.5,Anagliptin,LDXYBEHACFJIEL-HNNXBMFYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
75930,6m2n,DB06444,-7.5,Dexanabinol,SSQJFGMEZBFMNV-PMACEKPBSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
130538,6w4h,DB12405,-7.5,Triciribine,HOGVTUZUJGHKPL-HTVVRFAVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
84903,6m3m,DB07037,-7.5,(2S)-1-AMINO-3-[(5-NITROQUINOLIN-8-YL)AMINO]PROPAN-2-OL,MBZPCTWLFNYBND-QMMMGPOBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
5956,6lzg,DB01327,-7.5,Cefazolin,MLYYVTUWGNIJIB-BXKDBHETSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
104182,6vxs,DB11616,-7.5,Pirarubicin,KMSKQZKKOZQFFG-YXRRJAAWSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
130525,6w4h,DB12389,-7.5,Zamicastat,ZSSLCFLHEFXANG-GOSISDBHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
84899,6m3m,DB07033,-7.5,5-HYDROXY-3-[(1R)-1-(1H-PYRROL-2-YL)ETHYL]-2H-INDOL-2-ONE,VWQVBIPGKIAUGA-QMMMGPOBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
164114,7bv1,DB07274,-7.5,"N-cyclopropyl-6-[(6,7-dimethoxyquinolin-4-yl)oxy]naphthalene-1-carboxamide",ZATGFXTWDKIEKC-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
130515,6w4h,DB12376,-7.5,Ricolinostat,QGZYDVAGYRLSKP-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
79943,6m2n,DB14013,-7.5,SR-9009,MMJJNHOIVCGAAP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
113408,6vxx,DB09136,-7.5,Isosulfan blue,YFKDCGWIINMRQY-UHFFFAOYSA-O,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
166417,7bv1,DB15092,-7.5,LY-2624803,UEFWDVMEDFCHGW-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
130505,6w4h,DB12359,-7.5,BIIB021,QULDDKSCVCJTPV-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
123859,6w4h,DB00468,-7.5,Quinine,LOUPRKONTZGTKE-WZBLMQSHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
123861,6w4h,DB00470,-7.5,Dronabinol,CYQFCXCEBYINGO-IAGOWNOFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130501,6w4h,DB12354,-7.5,Imrecoxib,AXMZZGKKZDJGAZ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
166416,7bv1,DB15091,-7.5,Upadacitinib,WYQFJHHDOKWSHR-MNOVXSKESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
166411,7bv1,DB15079,-7.5,Troriluzole,YBZSGIWIPOUSHY-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
107887,6vxx,DB05444,-7.5,Iroxanadine,QWVRTSZDKPRPDF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114638,6vxx,DB13934,-7.5,Ligandrol,OPSIVAKKLQRWKC-VXGBXAGGSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
123038,6w4b,DB14679,-7.5,Quingestanol acetate,FLGJKPPXEKYCBY-AKCFYGDASA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
11130,6lzg,DB11464,-7.5,Sulfaquinoxaline,NHZLNPMOSADWGC-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
27702,6cs2,DB07257,-7.5,"4-(2-chlorophenyl)-8-(2-hydroxyethyl)-6-methylpyrrolo[3,4-e]indole-1,3(2H,6H)-dione",WHMQZCPGFZBLBG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
80673,6m3m,DB00289,-7.5,Atomoxetine,VHGCDTVCOLNTBX-QGZVFWFLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
73681,6m2n,DB02359,-7.5,"9-Butyl-8-(2,5-Dimethoxy-Benzyl)-9h-Purin-6-Ylamine",PPFZLLAIQRZNJE-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
160331,7bv1,DB08017,-7.5,3-METHOXY-6-[4-(3-METHYLPHENYL)-1-PIPERAZINYL]PYRIDAZINE,DDOAUTHWSCUHQA-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
114528,6vxx,DB13750,-7.5,Obidoxime,HIGRLDNHDGYWQJ-UHFFFAOYSA-P,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130680,6w4h,DB12621,-7.5,ST-101,QZWYXEBIQWJXAR-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
104117,6vxs,DB11446,-7.5,Oxfendazole,BEZZFPOZAYTVHN-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
166434,7bv1,DB15123,-7.5,Dorzagliatin,HMUMWSORCUWQJO-QAPCUYQASA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
123798,6w4h,DB00394,-7.5,Beclomethasone dipropionate,KUVIULQEHSCUHY-XYWKZLDCSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
107787,6vxx,DB04615,-7.5,(S)-tacrine(10)-hupyridone,ROTFGKJJMRTWBD-MHZLTWQESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
123128,6w4b,DB14896,-7.5,Selitrectinib,OEBIHOVSAMBXIB-SJKOYZFVSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
34283,1r42,DB00398,-7.5,Sorafenib,MLDQJTXFUGDVEO-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
164327,7bv1,DB07704,-7.5,"6-AMINO-4-[2-(4-METHOXYPHENYL)ETHYL]-1,7-DIHYDRO-8H-IMIDAZO[4,5-G]QUINAZOLIN-8-ONE",UKRVQKUVWNDGMN-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
114545,6vxx,DB13773,-7.5,Sulfamethoxypyridazine,VLYWMPOKSSWJAL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130652,6w4h,DB12573,-7.5,LY-2452473,IHIWYQYVBNODSV-KRWDZBQOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
26247,6cs2,DB04342,-7.5,7-((Carboxy(4-Hydroxyphenyl)Acetyl)Amino)-7-Methoxy-(3-((1-Methyl-1h-Tetrazol-5-Yl)Thio)Methyl)-8-Oxo-5-Oxa-1-Azabicyclo[4.2.0]Oct-2-Ene-2-Carboxylic Acid,JWCSIUVGFCSJCK-LIUKBUMOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
130487,6w4h,DB12327,-7.5,Salvinorin A,OBSYBRPAKCASQB-AGQYDFLVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130649,6w4h,DB12569,-7.5,Tonapofylline,ZWTVVWUOTJRXKM-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
107239,6vxx,DB02752,-7.5,Tosyl-D-Proline,CGPHGPCHVUSFFA-LLVKDONJSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113459,6vxx,DB09212,-7.5,Loxoprofen,YMBXTVYHTMGZDW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107796,6vxx,DB04627,-7.5,Cyclouridine,UUGITDASWNOAGG-CCXZUQQUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114558,6vxx,DB13788,-7.5,Chlorbenzoxamine,VEVSKUJZSMGTMM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113445,6vxx,DB09197,-7.5,Mepiprazole,DOTIMEKVTCOGED-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
166429,7bv1,DB15114,-7.5,Vamorolone,ZYTXTXAMMDTYDQ-DGEXFFLYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
130624,6w4h,DB12532,-7.5,Oxetacaine,FTLDJPRFCGDUFH-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
113436,6vxx,DB09188,-7.5,Amedalin,HBGWAZBZXJBYQD-IBGZPJMESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
166426,7bv1,DB15109,-7.5,Ingenol disoxate,GLIUZQUNUNICGS-XUBYYPQFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
123100,6w4b,DB14845,-7.5,Filgotinib,RIJLVEAXPNLDTC-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
73486,6m2n,DB02098,-7.5,Adenosine-2'-5'-Diphosphate,AEOBEOJCBAYXBA-KQYNXXCUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
114585,6vxx,DB13823,-7.5,Pipemidic acid,JOHZPMXAZQZXHR-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
123092,6w4b,DB14821,-7.5,Macozinone,BJDZBXGJNBMCAV-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
130641,6w4h,DB12557,-7.5,FK-614,UYGZODVVDUIDDQ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
107892,6vxx,DB05462,-7.5,Chlorotoxin I-131,YUFAHBUWIVNVNJ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114646,6vxx,DB13944,-7.5,Testosterone enanthate,VOCBWIIFXDYGNZ-IXKNJLPQSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113382,6vxx,DB09083,-7.5,Ivabradine,ACRHBAYQBXXRTO-OAQYLSRUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
166380,7bv1,DB14769,-7.5,Pamiparib,DENYZIUJOTUUNY-MRXNPFEDSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59178,6crv,DB07163,-7.5,5-[(2-AMINOETHYL)AMINO]-6-FLUORO-3-(1H-PYRROL-2-YL)BENZO[CD]INDOL-2(1H)-ONE,CQCXWWWNUFQYJS-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75386,6m2n,DB04630,-7.5,Aldosterone,PQSUYGKTWSAVDQ-ZVIOFETBSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
130438,6w4h,DB12268,-7.5,Carmegliptin,GUYMHFIHHOEFOA-ZCPGHIKRSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
107921,6vxx,DB05596,-7.5,PRX-03140,SCHKZZSVELPJKU-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
8021,6lzg,DB04662,-7.5,OLOMOUCINE II,NDUVSANREQEDRE-CQSZACIVSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
10939,6lzg,DB09286,-7.5,Pipamperone,AXKPFOAXAHJUAG-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
123886,6w4h,DB00498,-7.5,Phenindione,NFBAXHOPROOJAW-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
104216,6vxs,DB11675,-7.5,Mosapride,YPELFRMCRYSPKZ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
114743,6vxx,DB14755,-7.5,beta-Isosparteine,SLRCCWJSBJZJBV-AJNGGQMLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
164369,7bv1,DB07754,-7.5,N-({(1R)-1-carboxy-2-[(4-fluorobenzyl)sulfanyl]ethyl}carbamoyl)-L-glutamic acid,IDTMSHGCAZPVLC-RYUDHWBXSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
29705,6cs2,DB11443,-7.5,Orbifloxacin,QIPQASLPWJVQMH-DTORHVGOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
130419,6w4h,DB12239,-7.5,Balicatib,LLCRBOWRJOUJAE-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
76025,6m2n,DB06673,-7.5,Almorexant,DKMACHNQISHMDN-RPLLCQBOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
113313,6vxx,DB08789,-7.5,"2-AMINO-4-(2,4-DICHLOROPHENYL)-N-ETHYLTHIENO[2,3-D]PYRIMIDINE-6-CARBOXAMIDE",YPEOXUOUTBMBCX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30182,6cs2,DB12155,-7.5,Napabucasin,DPHUWDIXHNQOSY-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
84795,6m3m,DB06910,-7.5,"[4-R-(4-ALPHA,6-BETA,7-BETA]-HEXAHYDRO-5,6-DI(HYDROXY)-1,3-DI(ALLYL)-4,7-BISPHENYLMETHYL)-2H-1,3-DIAZEPINONE",IWJSQELMWLOYSO-LWSSLDFYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84788,6m3m,DB06902,-7.5,4-(1-methyl-1-phenylethyl)phenol,QBDSZLJBMIMQRS-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
122988,6w4b,DB14627,-7.5,Oxyphenisatin acetate,PHPUXYRXPHEJDF-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
75373,6m2n,DB04612,-7.5,"N-METHYLALANYL-3-METHYLVALYL-4-PHENOXY-N-(1,2,3,4-TETRAHYDRONAPHTHALEN-1-YL)PROLINAMIDE",QKPXPZYQPBWDHS-MCJAPYMPSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
114765,6vxx,DB14801,-7.5,Lanifibranor,OQDQIFQRNZIEEJ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
166365,7bv1,DB14735,-7.5,Cannabichromene,UVOLYTDXHDXWJU-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
27873,6cs2,DB07432,-7.5,"[[(3R,4R,5S,6R)-3-(butanoylamino)-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-ylidene]amino] N-phenylcarbamate",ITVRELFVFCOUMV-ZVZWZHPPSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
107163,6vxx,DB02647,-7.5,N-(5-Cyclopropyl-1h-Pyrazol-3-Yl)Benzamide,LUCORKWTQSQFFU-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113288,6vxx,DB08760,-7.5,(2S)-2-(4-chlorophenoxy)-3-phenylpropanoic acid,CPBLTMSKPQDJPW-AWEZNQCLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30191,6cs2,DB12170,-7.5,Veledimex,LZWZPGLVHLSWQX-XMMPIXPASA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
123904,6w4h,DB00525,-7.5,Tolnaftate,FUSNMLFNXJSCDI-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
34195,6cs2,T3D1061,-7.5,2-[(2E)-2-(Nitromethylene)hydrazino]naphthalene,YYXCMCDLDSISNV-XYOKQWHBSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
130418,6w4h,DB12238,-7.5,MK-0777,QKIWQBLNTSQOLY-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
75445,6m2n,DB04711,-7.5,Iodipamide,FFINMCNLQNTKLU-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
27861,6cs2,DB07421,-7.5,"4-{[(1R,2S)-1,2-dihydroxy-2-methyl-3-(4-nitrophenoxy)propyl]amino}-2-(trifluoromethyl)benzonitrile",INVUBEGZQHQAMY-SJORKVTESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
160448,7bv1,DB08398,-7.5,"2-Amino-1-methyl-6-phenylimidazo(4,5-b)pyridine",UQVKZNNCIHJZLS-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
123034,6w4b,DB14675,-7.5,Temsavir,QRPZBKAMSFHVRW-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
130482,6w4h,DB12321,-7.5,Ifetroban,BBPRUNPUJIUXSE-DXKRWKNPSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
59201,6crv,DB07188,-7.5,"(3S)-1-CYCLOHEXYL-N-(3,5-DICHLOROPHENYL)-5-OXOPYRROLIDINE-3-CARBOXAMIDE",YUFADRZDHJKVOT-NSHDSACASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104197,6vxs,DB11648,-7.5,Afuresertib,AFJRDFWMXUECEW-LBPRGKRZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
73467,6m2n,DB02075,-7.5,"(1s)-1(9-Deazahypoxanthin-9yl)1,4-Dideoxy-1,4-Imino-D-Ribitol-5-Phosphate",VJTAXXUIRYOXBT-KUBHLMPHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
84853,6m3m,DB06982,-7.5,(2S)-8-[(tert-butoxycarbonyl)amino]-2-(1H-indol-3-yl)octanoic acid,AWVCKFLATUTBCX-INIZCTEOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
8061,6lzg,DB04716,-7.5,"2-(1,1-DIMETHYLETHYL)9-FLUORO-3,6-DIHYDRO-7H-BENZ[H]-IMIDAZ[4,5-F]ISOQUINOLIN-7-ONE",VNDWQCSOSCCWIP-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
107903,6vxx,DB05514,-7.5,Cobiprostone,SDDSJMXGJNWMJY-BRHAQHMBSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107904,6vxx,DB05518,-7.5,Managlinat dialanetil,BYKBUQDQTLDNLE-KBPBESRZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130477,6w4h,DB12314,-7.5,Chlorproguanil,ISZNZKHCRKXXAU-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
71619,6lxt,DB14914,-7.5,Flortaucipir F-18,GETAAWDSFUCLBS-SJPDSGJFSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
113355,6vxx,DB09039,-7.5,Eliglustat,FJZZPCZKBUKGGU-AUSIDOKSSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107199,6vxx,DB02696,-7.5,"6-Aminohexyl-Uridine-C1,5'-Diphosphate",MLWJBKPFDKRHBM-FMKGYKFTSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59182,6crv,DB07168,-7.5,[4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-6-(methylamino)pyrimidin-2-yl}amino)phenyl]acetonitrile,MFMSRHREFZCFSN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75971,6m2n,DB06538,-7.5,Robalzotan,MQTUXRKNJYPMCG-CYBMUJFWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
123020,6w4b,DB14661,-7.5,Loperamide oxide,KXVSBTJVTUVNPM-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
130468,6w4h,DB12305,-7.5,Dasotraline,SRPXSILJHWNFMK-MEDUHNTESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
104209,6vxs,DB11666,-7.5,Buparlisib,CWHUFRVAEUJCEF-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
123019,6w4b,DB14660,-7.5,Trenbolone acetate,CMRJPMODSSEAPL-FYQPLNBISA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
55953,6crv,DB01682,-7.5,6'-Methyl-Thiamin Diphosphate,XTYXJYCWAJSHCY-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27860,6cs2,DB07420,-7.5,(1R)-4-(3-phenoxyphenyl)-1-phosphonobutane-1-sulfonic acid,RCGCZPXSRLLKCK-MRXNPFEDSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
130463,6w4h,DB12299,-7.5,Bavisant,BGBVSGSIXIIREO-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
8041,6lzg,DB04690,-7.5,Camptothecin,VSJKWCGYPAHWDS-FQEVSTJZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
123879,6w4h,DB00490,-7.5,Buspirone,QWCRAEMEVRGPNT-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
114709,6vxx,DB14672,-7.5,Oxazepam acetate,FYRWUTOZBRWYCS-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80726,6m3m,DB00355,-7.5,Aztreonam,WZPBZJONDBGPKJ-VEHQQRBSSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
113330,6vxx,DB09002,-7.5,Cloperastine,FLNXBVJLPJNOSI-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59186,6crv,DB07172,-7.5,"(5R,6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid",FTAGQROYQYQRHF-CBVHGRPESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
160433,7bv1,DB08382,-7.5,Gosogliptin,QWEWGXUTRTXFRF-KBPBESRZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
124505,6w4h,DB01224,-7.5,Quetiapine,URKOMYMAXPYINW-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
28443,6cs2,DB08030,-7.5,3-[(4'-cyanobiphenyl-4-yl)oxy]-N-hydroxypropanamide,XZWFHJUEAVOHHG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
17909,6cs2,HMDB0011181,-7.5,Brassicasterol,OILXMJHPFNGGTO-SDMVIZLASA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
57802,6crv,DB04149,-7.5,(R)-Rolipram,HJORMJIFDVBMOB-LBPRGKRZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
119658,6w4b,DB07568,-7.5,"(2S)-2-[(2,1,3-BENZOTHIADIAZOL-4-YLSULFONYL)AMINO]-2-PHENYL-N-PYRIDIN-4-YLACETAMIDE",ADRNPUSZBRQDBG-KRWDZBQOSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
119659,6w4b,DB07570,-7.5,3-CYCLOHEXYL-1-(2-MORPHOLIN-4-YL-2-OXOETHYL)-2-PHENYL-1H-INDOLE-6-CARBOXYLIC ACID,ZKEZEXYKYHYIMQ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
121413,6w4b,DB11853,-7.5,Relugolix,AOMXMOCNKJTRQP-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
125600,6w4h,DB02699,-7.5,4-Oxoretinol,PLIUCYCUYQIBDZ-RMWYGNQTSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
125606,6w4h,DB02706,-7.5,Mercaptocarboxylate Inhibitor,DUKDFMPUZRDWLT-CQSZACIVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
82705,6m3m,DB02894,-7.5,"Sulfamic Acid 2,3-O-(1-Methylethylidene)-4,5-O-Sulfonyl-Beta-Fructopyranose Ester",GGOAQSGCBDRTHT-JAKMQLQISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
119680,6w4b,DB07595,-7.5,"(5Z)-5-(3-BROMOCYCLOHEXA-2,5-DIEN-1-YLIDENE)-N-(PYRIDIN-4-YLMETHYL)-1,5-DIHYDROPYRAZOLO[1,5-A]PYRIMIDIN-7-AMINE",WSIQKQLAGWVKSL-UHFFFAOYSA-O,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
55196,6crv,DB00722,-7.5,Lisinopril,RLAWWYSOJDYHDC-BZSNNMDCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28296,6cs2,DB07877,-7.5,"8-(6-BROMO-BENZO[1,3]DIOXOL-5-YLSULFANYL)-9-(3-ISOPROPYLAMINO-PROPYL)-ADENINE",MWGWLDJLENCVRQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
31124,6cs2,DB13435,-7.5,Endralazine,ALAXZYHFVBSJKZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
11707,6lzg,DB12320,-7.5,Palovarotene,YTFHCXIPDIHOIA-DHZHZOJOSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
119696,6w4b,DB07616,-7.5,"4-{[4-(4-fluoro-3-methylphenyl)-1,3-thiazol-2-yl]amino}-2-hydroxybenzoic acid",LKZZDHKJFDTYCH-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
57803,6crv,DB04150,-7.5,Threonine Derivative,TWMKRGDZEJLDDH-LKXWSVAYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
121385,6w4b,DB11816,-7.5,Omecamtiv Mecarbil,RFUBTTPMWSKEIW-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
109648,6vxx,DB15059,-7.5,Aprocitentan,DKULOVKANLVDEA-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108520,6vxx,DB08083,-7.5,"2-(1,3-thiazol-4-yl)-1H-benzimidazole-5-sulfonamide",KGMVTZZDGKDTEU-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
74485,6m2n,DB03413,-7.5,Deoxyuridine-5'-Diphosphate,QHWZTVCCBMIIKE-SHYZEUOFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
127406,6w4h,DB05779,-7.5,Oglufanide,LLEUXCDZPQOJMY-AAEUAGOBSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
162297,7bv1,DB01861,-7.5,Uridine diphosphate glucose,HSCJRCZFDFQWRP-JZMIEXBBSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
121378,6w4b,DB11804,-7.5,AZD-5672,SCXSQUUTGCWHFU-WJOKGBTCSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
57773,6crv,DB04108,-7.5,"(2s,3r)-3-Amino-2-Hydroxy-5-(Ethylsulfanyl)Pentanoyl-((S)-(-)-(1-Naphthyl)Ethyl)Amide",AIIOXZPEXXZCML-KKXDTOCCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
73000,6m2n,DB01470,-7.5,alpha-methylthiofentanyl,YPOXDUYRRSUFFG-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
27171,6cs2,DB06623,-7.5,Flupirtine,JUUFBMODXQKSTD-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
165267,7bv1,DB11682,-7.5,Daprodustat,RUEYEZADQJCKGV-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
162325,7bv1,DB01906,-7.5,"3-(5-Amino-7-Hydroxy-[1,2,3]Triazolo[4,5-D]Pyrimidin-2-Yl)-Benzoic Acid",KNLLRZNGRRRPEW-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
55181,6crv,DB00706,-7.5,Tamsulosin,DRHKJLXJIQTDTD-OAHLLOKOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
105506,6vxs,DB13596,-7.5,Oxycinchophen,XAPRFLSJBSXESP-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
127417,6w4h,DB05830,-7.5,Trestolone,YSGQGNQWBLYHPE-CFUSNLFHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
109589,6vxx,DB14196,-7.5,"N-Cyclohexyl-N'-phenyl-1,4-phenylenediamine",ZRMMVODKVLXCBB-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
125595,6w4h,DB02694,-7.5,Pantoyl Adenylate,GDPVENOGSVMRJL-FSRKKXLISA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
121414,6w4b,DB11855,-7.5,Revefenacin,FYDWDCIFZSGNBU-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
31093,6cs2,DB13399,-7.5,Terguride,JOAHPSVPXZTVEP-YXJHDRRASA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
127540,6w4h,DB06309,-7.5,Refametinib,RDSACQWTXKSHJT-NSHDSACASA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
108484,6vxx,DB08041,-7.5,3-BENZYLOXYCARBONYLAMINO-2-HYDROXY-4-PHENYL-BUTYRIC ACID,JXJYTERRLRAUSF-JKSUJKDBSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
162181,7bv1,DB01535,-7.5,Carfentanil,YDSDEBIZUNNPOB-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
109782,6vxx,DB00250,-7.5,Dapsone,MQJKPEGWNLWLTK-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
119606,6w4b,DB07507,-7.5,"2-(4-hydroxybiphenyl-3-yl)-4-methyl-1H-isoindole-1,3(2H)-dione",ROMNEYAQUBNRLR-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
29255,6cs2,DB08936,-7.5,Chlorcyclizine,WFNAKBGANONZEQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
127530,6w4h,DB06280,-7.5,Senicapoc,SCTZUZTYRMOMKT-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
125527,6w4h,DB02603,-7.5,1-Amino-6-Cyclohex-3-Enylmethyloxypurine,VPUIDVRYMVIXGO-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
119616,6w4b,DB07519,-7.5,"(6R)-2-amino-6-[2-(3'-methoxybiphenyl-3-yl)ethyl]-3,6-dimethyl-5,6-dihydropyrimidin-4(3H)-one",VDFBMQAUECXNKR-OAQYLSRUSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
125549,6w4h,DB02632,-7.5,4-nitrophenyl-beta-D-galactoside,IFBHRQDFSNCLOZ-YBXAARCKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
27146,6cs2,DB06579,-7.5,Adipiplon,UAMAIHOEGLEXSV-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
33230,6cs2,T3D4343,-7.5,Cholic acid,BHQCQFFYRZLCQQ-OELDTZBJSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
127467,6w4h,DB06153,-7.5,Pizotifen,FIADGNVRKBPQEU-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
74513,6m2n,DB03456,-7.5,N2-[(benzyloxy)carbonyl]-n1-[(3S)-1-cyanopyrrolidin-3-yl]-l-leucinamide,IMTUSTXBVIALBC-SJORKVTESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
162211,7bv1,DB01565,-7.5,Dihydromorphine,IJVCSMSMFSCRME-KBQPJGBKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
127495,6w4h,DB06207,-7.5,Silodosin,PNCPYILNMDWPEY-QGZVFWFLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
162215,7bv1,DB01569,-7.5,Formebolone,AMVODTGMYSRMNP-GNIMZFFESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
119638,6w4b,DB07544,-7.5,N'-(5-CHLOROBENZOFURAN-2-CARBONYL)-2-(TRIFLUOROMETHYL)BENZENESULFONOHYDRAZIDE,ZLQBZYKAQQWOTK-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
119640,6w4b,DB07546,-7.5,[1-(6-{6-[(1-methylethyl)amino]-1H-indazol-1-yl}pyrazin-2-yl)-1H-pyrrol-3-yl]acetic acid,BBYRUZKRFAIQSR-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
72581,6m2n,DB00913,-7.5,Anileridine,LKYQLAWMNBFNJT-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
121422,6w4b,DB11870,-7.5,RG-4733,OJPLJFIFUQPSJR-INIZCTEOSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
82724,6m3m,DB02918,-7.5,Zardaverine,HJMQDJPMQIHLPB-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
79031,6m2n,DB12625,-7.5,Evogliptin,LCDDAGSJHKEABN-MLGOLLRUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
57075,6crv,DB03171,-7.5,Indole-3-Propanol Phosphate,NKEZSFZOUIIZFL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55199,6crv,DB00726,-7.5,Trimipramine,ZSCDBOWYZJWBIY-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163204,7bv1,DB03895,-7.5,Malachite Green,VFCNQNZNPKRXIT-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
125587,6w4h,DB02684,-7.5,5'-O-(N-(L-Cysteinyl)-Sulfamoyl)Adenosine,FTSDEWPMACCNGN-YTMOPEAISA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
165317,7bv1,DB11921,-7.5,Deflazacort,FBHSPRKOSMHSIF-GRMWVWQJSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
127374,6w4h,DB05562,-7.5,Naluzotan,SPWZXWDPAWDKQE-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
127360,6w4h,DB05501,-7.5,AMD-070,WVLHHLRVNDMIAR-IBGZPJMESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
109556,6vxx,DB14109,-7.5,alpha-Arbutin,BJRNKVDFDLYUGJ-ZIQFBCGOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31551,6cs2,DB01066,-7.5,Cefditoren,KMIPKYQIOVAHOP-YLGJWRNMSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
109430,6vxx,DB13559,-7.5,Rimiterol,IYMMESGOJVNCKV-JOYOIKCWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55164,6crv,DB00688,-7.5,Mycophenolate mofetil,RTGDFNSFWBGLEC-SYZQJQIISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
121337,6w4b,DB11745,-7.5,Otenabant,UNAZAADNBYXMIV-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
78981,6m2n,DB12545,-7.5,Indobufen,AYDXAULLCROVIT-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
163107,7bv1,DB03771,-7.5,Allyl-{4-[3-(4-Bromo-Phenyl)-Benzofuran-6-Yloxy]-but-2-Enyl}-Methyl-Amine,KCNKJCHARANTIP-SNAWJCMRSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
11461,6lzg,DB11999,-7.5,Vosaroxin,XZAFZXJXZHRNAQ-STQMWFEESA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
11467,6lzg,DB12006,-7.5,BMS-906024,AYOUDDAETNMCBW-GSHUGGBRSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
10607,6lzg,DB08816,-7.5,Ticagrelor,OEKWJQXRCDYSHL-FNOIDJSQSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
54421,2fxp,DB14989,-7.5,Umbralisib,IUVCFHHAEHNCFT-INIZCTEOSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
31549,6cs2,DB14008,-7.5,Hispidulin,IHFBPDAQLQOCBX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
162409,7bv1,DB02019,-7.5,Acetyl Dithranol,IXLRLZOYKJERRA-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
78012,6m2n,DB09136,-7.5,Isosulfan blue,YFKDCGWIINMRQY-UHFFFAOYSA-O,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
119833,6w4b,DB07778,-7.5,FAMOXADONE,PCCSBWNGDMYFCW-QFIPXVFZSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
78951,6m2n,DB12499,-7.5,Clascoterone,GPNHMOZDMYNCPO-PDUMRIMRSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
119882,6w4b,DB07831,-7.5,"2-{[(6-OXO-1,6-DIHYDROPYRIDIN-3-YL)METHYL]AMINO}-N-[4-PROPYL-3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE",SHSORWZDEKFFLP-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
127239,6w4h,DB04898,-7.5,Ximelagatran,ZXIBCJHYVWYIKI-PZJWPPBQSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
162431,7bv1,DB02047,-7.5,"2-(1,1'-Biphenyl-4-Yl)Propanoic Acid",JALUUBQFLPUJMY-NSHDSACASA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
78018,6m2n,DB09151,-7.5,Flutemetamol (18F),VVECGOCJFKTUAX-HUYCHCPVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
125750,6w4h,DB02898,-7.5,5-{[(2-Amino-9h-Purin-6-Yl)Oxy]Methyl}-2-Pyrrolidinone,UYPMMHCTXQIWDX-RXMQYKEDSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
27397,6cs2,DB06932,-7.5,"10,11-dimethoxy-4-methyldibenzo[c,f]-2,7-naphthyridine-3,6-diamine",NVINUNQBDNEMSY-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
57118,6crv,DB03225,-7.5,D-Tryptophan,QIVBCDIJIAJPQS-SECBINFHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31181,6cs2,DB13506,-7.5,Carfecillin,NZDASSHFKWDBBU-KVMCETHSSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
54432,2fxp,DB15023,-7.5,BMS-791826,DZBKAUMYTFPJIS-QHCPKHFHSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
32817,6cs2,T3D3730,-7.5,Rubratoxin B,ZJTBTDVZNGBSNG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
72655,6m2n,DB01000,-7.5,Cyclacillin,HGBLNBBNRORJKI-WCABBAIRSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
165232,7bv1,DB11622,-7.5,Dehydrocholic acid,OHXPGWPVLFPUSM-KLRNGDHRSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
125753,6w4h,DB02902,-7.5,3'-Phosphate-Adenosine-5'-Phosphate Sulfate,GACDQMDRPRGCTN-KQYNXXCUSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
105584,6vxs,DB13693,-7.5,Sulbenicillin,JETQIUPBHQNHNZ-NJBDSQKTSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
109466,6vxx,DB13611,-7.5,Chlormidazole,WNAQOLSMVPFGTE-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
54386,2fxp,DB14894,-7.5,Galicaftor,QVDYQHXNAQHIKH-TZIWHRDSSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
81660,6m3m,DB01529,-7.5,Dextromoramide,INUNXTSAACVKJS-OAQYLSRUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
119748,6w4b,DB07678,-7.5,"(9ALPHA,13BETA,17BETA)-2-[(1Z)-BUT-1-EN-1-YL]ESTRA-1,3,5(10)-TRIENE-3,17-DIOL",ANAMDWGJXBYJEB-OPWFCKQNSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
127355,6w4h,DB05475,-7.5,Golotimod,CATMPQFFVNKDEY-YPMHNXCESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
108527,6vxx,DB08093,-7.5,3-(1-NAPHTHYLMETHOXY)PYRIDIN-2-AMINE,SZANYTFSQVBOBA-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106253,6vxs,DB15323,-7.5,Trelagliptin,IWYJYHUNXVAVAA-OAHLLOKOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
31144,6cs2,DB13460,-7.5,Ronifibrate,AYJVGKWCGIYEAK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
81617,6m3m,DB01476,-7.5,Haloxazolam,XDKCGKQHVBOOHC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
162352,7bv1,DB01945,-7.5,4-Carbamoyl-1-Beta-D-Ribofuranosyl-Imidazolium-5-Olate-5'-Phosphate,KTKAFSMJDTUUAN-UUOKFMHZSA-L,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
105542,6vxs,DB13643,-7.5,Loprazolam,UTEFBSAVJNEPTR-RGEXLXHISA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
162353,7bv1,DB01946,-7.5,"3-[1-(3-Aminopropyl)-1h-Indol-3-Yl]-4-(1-Methyl-1h-Indol-3-Yl)-1h-Pyrrole-2,5-Dione",UQHKJRCFSLMWIA-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
127329,6w4h,DB05351,-7.5,Dexlansoprazole,MJIHNNLFOKEZEW-RUZDIDTESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
77934,6m2n,DB09002,-7.5,Cloperastine,FLNXBVJLPJNOSI-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
31149,6cs2,DB13469,-7.5,Phanquinone,VLPADTBFADIFKG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
109524,6vxx,DB14050,-7.5,Cannabidivarin,REOZWEGFPHTFEI-JKSUJKDBSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106251,6vxs,DB15317,-7.5,Posiphen,PBHFNBQPZCRWQP-AZUAARDMSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
18291,6cs2,HMDB0028896,-7.5,Histidinyl-Tryptophan,FBTYOQIYBULKEH-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
105554,6vxs,DB13660,-7.5,Propicillin,HOCWPKXKMNXINF-XQERAMJGSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
127310,6w4h,DB05239,-7.5,Cobimetinib,BSMCAPRUBJMWDF-KRWDZBQOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
127306,6w4h,DB05212,-7.5,HE3286,JJKOQZHWYLMASZ-FJWDNACWSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
81639,6m3m,DB01502,-7.5,Diampromide,RXTHKWVSXOIHJS-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
127304,6w4h,DB05187,-7.5,Elafibranor,AFLFKFHDSCQHOL-IZZDOVSWSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
119790,6w4b,DB07728,-7.5,"2-[2-(2-FLUOROPHENYL)PYRIDIN-4-YL]-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE",XJJYJNMNYDNXNO-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
108533,6vxx,DB08099,-7.5,"6-ethyl-5-[(2S)-1-(3-methoxypropyl)-2-phenyl-1,2,3,4-tetrahydroquinolin-7-yl]pyrimidine-2,4-diamine",UOYVKYJWAXJTTE-NRFANRHFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108535,6vxx,DB08101,-7.5,"2,6-dibromo-4-[(E)-2-phenylethenyl]phenol",WMVYUPRIADVLTH-VOTSOKGWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77959,6m2n,DB09039,-7.5,Eliglustat,FJZZPCZKBUKGGU-AUSIDOKSSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
127301,6w4h,DB05154,-7.5,Pretomanid,ZLHZLMOSPGACSZ-NSHDSACASA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
125716,6w4h,DB02854,-7.5,Aetiocholanolone,QGXBDMJGAMFCBF-BNSUEQOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
165254,7bv1,DB11665,-7.5,BMS-690514,CSGQVNMSRKWUSH-IAGOWNOFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
27197,6cs2,DB06678,-7.5,Esmirtazapine,RONZAEMNMFQXRA-MRXNPFEDSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
55168,6crv,DB00692,-7.5,Phentolamine,MRBDMNSDAVCSSF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72556,6m2n,DB00885,-7.5,Pemirolast,HIANJWSAHKJQTH-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
162170,7bv1,DB01524,-7.5,Androstenediol,QADHLRWLCPCEKT-LOVVWNRFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
163244,7bv1,DB04158,-7.5,"6-(Adenosine Tetraphosphate-Methyl)-7,8-Dihydropterin",ZKRKFZJAQKKHKL-SUGPNEFASA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
11431,6lzg,DB11958,-7.5,Brivanib,WCWUXEGQKLTGDX-LLVKDONJSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
105189,6vxs,DB13129,-7.5,Trimegestone,JUNDJWOLDSCTFK-MTZCLOFQSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
83010,6m3m,DB03299,-7.5,N-Succinyl Phenylglycine,GQFHIYFXQQEWME-LLVKDONJSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
31607,6cs2,DB01071,-7.5,Mequitazine,HOKDBMAJZXIPGC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
57985,6crv,DB04396,-7.5,Thiodigalactoside,SYKYBMOFPMXDRQ-ZFDCCPEWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31032,6cs2,DB13329,-7.5,Guaiazulen,FWKQNCXZGNBPFD-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
31602,6cs2,DB14097,-7.5,13-cis-12-(3'-Carboxyphenyl)retinoic acid,XKKDQOHDTASHCE-PAZAWXFKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
57982,6crv,DB04393,-7.5,Soneclosan,BYNQFCJOHGOKSS-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110000,6vxx,DB00690,-7.5,Flurazepam,SAADBVWGJQAEFS-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127789,6w4h,DB06857,-7.5,N-(4-CARBAMIMIDOYL-3-CHORO-PHENYL)-2-HYDROXY-3-IODO-5-METHYL-BENZAMIDE,QKGFTDAISIBIBV-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
165383,7bv1,DB12021,-7.5,Dinaciclib,PIMQWRZWLQKKBJ-SFHVURJKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
127783,6w4h,DB06848,-7.5,"1-(1'-{[3-(methylsulfanyl)-2-benzothiophen-1-yl]carbonyl}spiro[1-benzofuran-3,4'-piperidin]-5-yl)methanamine",VCUDZTCDUDDJGG-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
79130,6m2n,DB12780,-7.5,Quinfamide,SBJGFIXQRZOVTO-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
109986,6vxx,DB00674,-7.5,Galantamine,ASUTZQLVASHGKV-JDFRZJQESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
105187,6vxs,DB13125,-7.5,Lusutrombopag,NOZIJMHMKORZBA-KJCUYJGMSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
6794,6lzg,DB02703,-7.5,Fusidic acid,IECPWNUMDGFDKC-MZJAQBGESA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
72479,6m2n,DB00800,-7.5,Fenoldopam,TVURRHSHRRELCG-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
105205,6vxs,DB13169,-7.5,Nandrolone,NPAGDVCDWIYMMC-IZPLOLCNSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
328,6lzg,HMDB0004483,-7.5,Estrone glucuronide,FJAZVHYPASAQKM-JBAURARKSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
81499,6m3m,DB01280,-7.5,Nelarabine,IXOXBSCIXZEQEQ-UHTZMRCNSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
72480,6m2n,DB00801,-7.5,Halazepam,WYCLKVQLVUQKNZ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
55258,6crv,DB00801,-7.5,Halazepam,WYCLKVQLVUQKNZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72483,6m2n,DB00805,-7.5,Minaprine,LDMWSLGGVTVJPG-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
127752,6w4h,DB06800,-7.5,Methylnaltrexone,JVLBPIPGETUEET-WIXLDOGYSA-O,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
82981,6m3m,DB03257,-7.5,"5-[1-(Acetylamino)-3-Methylbutyl]-2,5-Anhydro-3,4-Dideoxy-4-(Methoxycarbonyl)Pentonic Acid",MUJPWSPVNZGJOW-WRWGMCAJSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
105221,6vxs,DB13213,-7.5,Butaperazine,DVLBYTMYSMAKHP-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
74569,6m2n,DB03535,-7.5,Z-Pro-Prolinal,ORZXYSPOAVJYRU-HOTGVXAUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
127738,6w4h,DB06771,-7.5,Besifloxacin,QFFGVLORLPOAEC-SNVBAGLBSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
119450,6w4b,DB07323,-7.5,"2-[({2-[(1Z)-3-(DIMETHYLAMINO)PROP-1-ENYL]-4-FLUOROPHENYL}SULFONYL)AMINO]-5,6,7,8-TETRAHYDRONAPHTHALENE-1-CARBOXYLIC ACID",CTZLIARLNXSXGL-ALCCZGGFSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
33313,6cs2,T3D4506,-7.5,Fenbuconazole,RQDJADAKIFFEKQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
127813,6w4h,DB06884,-7.5,4-HYDROXY-N'-(4-ISOPROPYLBENZYL)BENZOHYDRAZIDE,MFDXHRPPSJRQFX-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
83022,6m3m,DB03312,-7.5,Brivudine,ODZBBRURCPAEIQ-PIXDULNESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83023,6m3m,DB03313,-7.5,Cephalosporin C,HOKIDJSKDBPKTQ-GLXFQSAKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83109,6m3m,DB03433,-7.5,{3-[(3-Hydroxy-2-Methyl-5-Phosphonooxymethyl-Pyridin-4-Ylmethyl)-Amino]-2-Methyl-Propyl}-Phosphonic Acid,JMZWWHLIKAYMPJ-SSDOTTSWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
29357,6cs2,DB09061,-7.5,Cannabidiol,QHMBSVQNZZTUGM-ZWKOTPCHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
11755,6lzg,DB12391,-7.5,Sagopilone,BFZKMNSQCNVFGM-UCEYFQQTSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
72431,6m2n,DB00739,-7.5,Hetacillin,DXVUYOAEDJXBPY-NFFDBFGFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77675,6m2n,DB08663,-7.5,4-HYDROXY-7-METHOXY-3-(1-PHENYL-PROPYL)-CHROMEN-2-ONE,CCPGCKQLIHGSCJ-AWEZNQCLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
105157,6vxs,DB13083,-7.5,Talarozole,SNFYYXUGUBUECJ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
162000,7bv1,DB01066,-7.5,Cefditoren,KMIPKYQIOVAHOP-YLGJWRNMSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
127865,6w4h,DB06942,-7.5,N-(4-carbamimidoylbenzyl)-1-(3-phenylpropanoyl)-L-prolinamide,RNZKCCPFUWHBFY-IBGZPJMESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
28778,6cs2,DB08392,-7.5,"2-[5,6-BIS-(4-METHOXY-PHENYL)-FURO[2,3-D]PYRIMIDIN-4-YLAMINO]-ETHANOL",ARBUGBBNEFAECO-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
77678,6m2n,DB08669,-7.5,"METHYL N-[(2S,3R)-3-AMINO-2-HYDROXY-3-(4-METHYLPHENYL)PROPANOYL]-D-ALANYL-D-LEUCINATE",BMHZOSJVDHAFEE-SVGFKBNWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
121527,6w4b,DB12024,-7.5,PF-04418948,LWJGMYMNSNVCEM-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
163310,7bv1,DB04240,-7.5,"(1S)-1-C-{(2R)-6-[(2R)-2-Butanyl]-5,10-dihydroxy-4-oxo-1,2,3,4-tetrahydro-2-anthracenyl}-5-deoxy-1-O-methyl-D-xylulose",XGORHSPGULYMCV-HHYQQTLHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
119376,6w4b,DB07244,-7.5,"5-{4-[(3,5-DIFLUOROBENZYL)AMINO]PHENYL}-6-ETHYLPYRIMIDINE-2,4-DIAMINE",SRRWXMSVQYQCRX-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
77686,6m2n,DB08680,-7.5,N-{3-[(E)-(tert-butoxyimino)methyl]-4-chlorophenyl}-2-methylfuran-3-carbimidothioic acid,PLGIIOKXCKDKEU-VXLYETTFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
119379,6w4b,DB07247,-7.5,"[2'-HYDROXY-3'-(1H-PYRROLO[3,2-C]PYRIDIN-2-YL)-BIPHENYL-3-YLMETHYL]-UREA",SRPOHNDQBDHONJ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
106409,6vxx,DB00178,-7.5,Ramipril,HDACQVRGBOVJII-JBDAPHQKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
83066,6m3m,DB03369,-7.5,9-Aminophenanthrene,KIHQWOBUUIPWAN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83047,6m3m,DB03346,-7.5,"3,5,3',5'-Tetrachloro-Biphenyl-4,4'-Diol",YCYDXOVJXVALHY-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
165415,7bv1,DB12070,-7.5,Letermovir,FWYSMLBETOMXAG-QHCPKHFHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
127845,6w4h,DB06919,-7.5,D-phenylalanyl-N-(3-chlorobenzyl)-L-prolinamide,CJHLRGCXPGIPCB-MOPGFXCFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
72444,6m2n,DB00755,-7.5,Tretinoin,SHGAZHPCJJPHSC-YCNIQYBTSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
119384,6w4b,DB07252,-7.5,"3-({4-[(5-chloro-1,3-benzodioxol-4-yl)amino]pyrimidin-2-yl}amino)benzenesulfonamide",TZHCXOMEOHEZDX-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
81496,6m3m,DB01273,-7.5,Varenicline,JQSHBVHOMNKWFT-DTORHVGOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
119386,6w4b,DB07254,-7.5,"N-[3-[[4-[(5-CHLORO-1,3-BENZODIOXOL-4-YL)AMINO]PYRIMIDIN-2-YL]AMINO]PHENYL]METHANESULFONAMIDE",KQGTYXRWSIBDOZ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
81497,6m3m,DB01274,-7.5,Arformoterol,BPZSYCZIITTYBL-YJYMSZOUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
121522,6w4b,DB12015,-7.5,Alpelisib,STUWGJZDJHPWGZ-LBPRGKRZSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
9909,6lzg,DB08042,-7.5,"N-4-methyl-N-4-(3-methyl-1H-indazol-6-yl)-N-2-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine",FLXGQDHYCWXTAI-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
72453,6m2n,DB00767,-7.5,Benzquinamide,JSZILQVIPPROJI-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
83025,6m3m,DB03315,-7.5,Guanosine 3'-monophosphate,ZDPUTNZENXVHJC-UUOKFMHZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
164770,7bv1,DB08582,-7.5,"N-(4-bromo-2-{[(3R,5S)-3,5-dimethylpiperidin-1-yl]carbonyl}phenyl)-4-morpholin-4-yl-4-oxobutanamide",DELARNBPJXTDBD-IYBDPMFKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
121312,6w4b,DB11704,-7.5,Adomeglivant,FASLTMSUPQDLIB-MHZLTWQESA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
28277,6cs2,DB07859,-7.5,4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL)PHENYL]PIPERIDINE,LZMOSYUFVYJEPY-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
106328,6vxs,DB02639,-7.5,4-methylumbelliferyl alpha-D-glucoside,YUDPTGPSBJVHCN-JZYAIQKZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
73039,6m2n,DB01518,-7.5,Benzethidine,UVTBZAWTRVBTMK-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
74538,6m2n,DB03491,-7.5,2'-Deoxyguanosine-5'-Diphosphate,CIKGWCTVFSRMJU-KVQBGUIXSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
82860,6m3m,DB03102,-7.5,"2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Pyran-3-Carboxylic Acid",SNNOZMNTPOIDSI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
119537,6w4b,DB07426,-7.5,"[1-HYDROXY-2-(1,1':3',1''-TERPHENYL-3-YLOXY)ETHANE-1,1-DIYL]BIS(PHOSPHONIC ACID)",NWIARQRYIRVYCM-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
74533,6m2n,DB03486,-7.5,Phosphomethylphosphonic Acid Guanosyl Ester,OCJWYBKRHNXUME-KQYNXXCUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
109877,6vxx,DB00542,-7.5,Benazepril,XPCFTKFZXHTYIP-PMACEKPBSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57916,6crv,DB04297,-7.5,"7-[4-(Dimethylamino)Phenyl]-N-Hydroxy-4,6-Dimethyl-7-Oxo-2,4-Heptadienamide",RTKIYFITIVXBLE-QEQCGCAPSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
105314,6vxs,DB13335,-7.5,Pinazepam,MFZOSKPPVCIFMT-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
32750,6cs2,T3D3663,-7.5,Sterigmatocystin,UTSVPXMQSFGQTM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
74053,6m2n,DB02842,-7.5,9-amino-n-[3-(dimethylamino)propyl]acridine-4-carboxamide,VNWAULKXOPRJEL-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
127635,6w4h,DB06582,-7.5,Dextofisopam,RUJBDQSFYCKFAA-HNNXBMFYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
109862,6vxx,DB00346,-7.5,Alfuzosin,WNMJYKCGWZFFKR-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31083,6cs2,DB13386,-7.5,Epimestrol,UHQGCIIQUZBJAE-RRQVMCLOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
31587,6cs2,DB14071,-7.5,Desmethylsertraline,SRPXSILJHWNFMK-ZBEGNZNMSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
57912,6crv,DB04293,-7.5,7-(2-Amino-2-Phenyl-Acetylamino)-3-Chloro-8-Oxo-1-Aza-Bicyclo[4.2.0]Oct-2-Ene-2-Carboxylic Acid,JAPHQRWPEGVNBT-IJLUTSLNSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
18250,6cs2,HMDB0015044,-7.5,Quinidine,LOUPRKONTZGTKE-LHHVKLHASA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
119563,6w4b,DB07455,-7.5,"N,N'-[biphenyl-4,4'-diyldi(2R)propane-2,1-diyl]dimethanesulfonamide",ZESUARCHWPARIF-HOTGVXAUSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
57898,6crv,DB04275,-7.5,N-acetylserotonin,MVAWJSIDNICKHF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27117,6cs2,DB06499,-7.5,Furaprofen,ODZUWQAFWMLWCF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
165342,7bv1,DB11960,-7.5,Carboxyamidotriazole,WNRZHQBJSXRYJK-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
77821,6m2n,DB08836,-7.5,Temocapril,FIQOFIRCTOWDOW-BJLQDIEVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
10644,6lzg,DB08873,-7.5,Boceprevir,LHHCSNFAOIFYRV-DOVBMPENSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
127576,6w4h,DB06429,-7.5,Talnetant,BIAVGWDGIJKWRM-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
121444,6w4b,DB11901,-7.5,Apalutamide,HJBWBFZLDZWPHF-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
9991,6lzg,DB08130,-7.5,"N-(5-{3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]phenyl}-1,3,4-oxadiazol-2-yl)ethane-1,2-diamine",FPDWDLAITHFTTP-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
109796,6vxx,DB00267,-7.5,Cefmenoxime,HJJDBAOLQAWBMH-YCRCPZNHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109792,6vxx,DB00263,-7.5,Sulfisoxazole,NHUHCSRWZMLRLA-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127558,6w4h,DB06368,-7.5,Alamifovir,VDBGPMJFHCJMOL-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
55224,6crv,DB00758,-7.5,Clopidogrel,GKTWGGQPFAXNFI-HNNXBMFYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79086,6m2n,DB12710,-7.5,Perazine,WEYVCQFUGFRXOM-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
119521,6w4b,DB07406,-7.5,"(4R)-N-[4-({[2-(DIMETHYLAMINO)ETHYL]AMINO}CARBONYL)-1,3-THIAZOL-2-YL]-4-METHYL-1-OXO-2,3,4,9-TETRAHYDRO-1H-BETA-CARBOLINE-6-CARBOXAMIDE",QWFFPYQWUWLDBV-NSHDSACASA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
106302,6vxs,DB15425,-7.5,CYC-065,DLPIYBKBHMZCJI-WBVHZDCISA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
10650,6lzg,DB08881,-7.5,Vemurafenib,GPXBXXGIAQBQNI-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
125444,6w4h,DB02495,-7.5,9-(4-hydroxybutyl)-N2-phenylguanine,JHBXNPBKSPYOFT-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
127703,6w4h,DB06713,-7.5,Norelgestromin,ISHXLNHNDMZNMC-XUDSTZEESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
165375,7bv1,DB12008,-7.5,Prexasertib,DOTGPNHGTYJDEP-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
55249,6crv,DB00790,-7.5,Perindopril,IPVQLZZIHOAWMC-QXKUPLGCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29348,6cs2,DB09047,-7.5,Finafloxacin,FYMHQCNFKNMJAV-HOTGVXAUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
50025,2fxp,DB06240,-7.5,Tariquidar,LGGHDPFKSSRQNS-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
162102,7bv1,DB01443,-7.5,19-Nor-5-androstenedione,WELNRNVZXWUOGT-QXUSFIETSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
127690,6w4h,DB06697,-7.5,Artemether,SXYIRMFQILZOAM-HVNFFKDJSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
119478,6w4b,DB07354,-7.5,"2,3-DIMETHOXY-12H-[1,3]DIOXOLO[5,6]INDENO[1,2-C]ISOQUINOLIN-6-IUM",LXDREMZQGAILJU-UHFFFAOYSA-O,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
119483,6w4b,DB07359,-7.5,"3-[(4-fluorophenyl)sulfanyl]-N-(4-methyl-1,3-thiazol-2-yl)-6-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]pyridine-2-carboxamide",SJTQKYKXCYVFHX-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
72516,6m2n,DB00841,-7.5,Dobutamine,JRWZLRBJNMZMFE-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
164776,7bv1,DB08591,-7.5,"5-(4-METHOXYBIPHENYL-3-YL)-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDE",IGXKSKWHHHYBFM-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
79087,6m2n,DB12712,-7.5,Pilsicainide,BCQTVJKBTWGHCX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
125453,6w4h,DB02505,-7.5,N-(R-Carboxy-Ethyl)-Alpha-(S)-(2-Phenylethyl),JJVQUUYZGJWBPW-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
46615,2fxp,DB00762,-7.5,Irinotecan,UWKQSNNFCGGAFS-XIFFEERXSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
55240,6crv,DB00777,-7.5,Propiomazine,UVOIBTBFPOZKGP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
6818,6lzg,DB00136,-7.5,Calcitriol,GMRQFYUYWCNGIN-NKMMMXOESA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
77743,6m2n,DB08743,-7.5,"2-({8-[(3R)-3-AMINOPIPERIDIN-1-YL]-1,3-DIMETHYL-2,6-DIOXO-1,2,3,6-TETRAHYDRO-7H-PURIN-7-YL}METHYL)BENZONITRILE",XJNKUWDMCBZMTG-OAHLLOKOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
33282,6cs2,T3D4478,-7.5,Bensulfuron-methyl,XMQFTWRPUQYINF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
31064,6cs2,DB13361,-7.5,Trimethyldiphenylpropylamine,NSHMKXVHJBBKTN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
109928,6vxx,DB00601,-7.5,Linezolid,TYZROVQLWOKYKF-ZDUSSCGKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
74553,6m2n,DB03510,-7.5,6-O-Phosphoryl Inosine Monophosphate,RXRZOKQPANIEDW-KQYNXXCUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
105284,6vxs,DB13300,-7.5,Epicillin,RPBAFSBGYDKNRG-NJBDSQKTSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
162125,7bv1,DB01469,-7.5,Acetorphine,LFYBMMHFJIAKFE-PMEKXCSPSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
162126,7bv1,DB01470,-7.5,alpha-methylthiofentanyl,YPOXDUYRRSUFFG-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
127655,6w4h,DB06623,-7.5,Flupirtine,JUUFBMODXQKSTD-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
109907,6vxx,DB00578,-7.5,Carbenicillin,FPPNZSSZRUTDAP-UWFZAAFLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
162130,7bv1,DB01474,-7.5,"17alpha-methyl-3beta,17beta-dihydroxyandrost-4-ene",BNUOCVTVOYWNJC-DTMQFJJTSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
7735,6lzg,DB04298,-7.5,"3-(4-Amino-2-Tert-Butyl-5-Methyl-Phenylsulfanyl)-6-Cyclopentyl-4-Hydroxy-6-[2-(4-Hydroxy-Phenyl)-Ethyl]-5,6-Dihydro-Pyran-2-One",ZEBFKFGJWHOOST-LJAQVGFWSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
127895,6w4h,DB06983,-7.5,"(5-phenyl-7-(pyridin-3-ylmethylamino)pyrazolo[1,5-a]pyrimidin-3-yl)methanol",RBLKWWBHDUBPFN-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
109382,6vxx,DB13496,-7.5,Iprindole,PLIGPBGDXASWPX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109376,6vxx,DB13489,-7.5,Bamipine,VZSXTYKGYWISGQ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
74242,6m2n,DB03093,-7.5,"8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine",MWHAHELTVGJGFJ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
162746,7bv1,DB02869,-7.5,3-amino-5-phenylpentane,ZPXIQFOUPUVVPU-INIZCTEOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
33005,6cs2,T3D3936,-7.5,Triasulfuron,XOPFESVZMSQIKC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
106172,6vxs,DB15163,-7.5,Selatogrel,FYXHWMQPCJOJCH-GMAHTHKFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
31366,6cs2,DB13728,-7.5,Halometasone,GGXMRPUKBWXVHE-MIHLVHIWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
125995,6w4h,DB03227,-7.5,Nicotinamide Mononucleotide,DAYLJWODMCOQEW-WYOJIJJFSA-O,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
105967,6vxs,DB14682,-7.5,Dextrorphan,JAQUASYNZVUNQP-PVAVHDDUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
78564,6m2n,DB11941,-7.5,Tasisulam,WWONFUQGBVOKOF-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
11616,6lzg,DB12211,-7.5,PSI-697,DIEPFYNZGUUVHD-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
31371,6cs2,DB13736,-7.5,Fenoxazoline,GFYSWQDCHLWRMQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
72789,6m2n,DB01153,-7.5,Sertaconazole,JLGKQTAYUIMGRK-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
164880,7bv1,DB08905,-7.5,Formestane,OSVMTWJCGUFAOD-KZQROQTASA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
72937,6m2n,DB01394,-7.5,Colchicine,IAKHMKGGTNLKSZ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
81747,6m3m,DB01628,-7.5,Etoricoxib,MNJVRJDLRVPLFE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
126006,6w4h,DB03239,-7.5,"3',5'-Dinitro-N-Acetyl-L-Thyronine",VZSQTOXQXPKQJX-ZDUSSCGKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
54821,6crv,DB00269,-7.5,Chlorotrianisene,BFPSDSIWYFKGBC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
54825,6crv,DB00273,-7.5,Topiramate,KJADKKWYZYXHBB-XBWDGYHZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108827,6vxx,DB09495,-7.5,Avobenzone,XNEFYCZVKIDDMS-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106166,6vxs,DB15149,-7.5,Futibatinib,KEIPNCCJPRMIAX-HNNXBMFYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
18416,6cs2,HMDB0029190,-7.5,"5-(3',4'-dihydroxyphenyl)-gamma-valerolactone-3'-O-glucuronide",RALBOGKBFZBDKY-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
126016,6w4h,DB03250,-7.5,"2-(Beta-D-Glucopyranosyl)-5-Methyl-1,3,4-Benzothiazole",WGJFWQVWYRZPEP-KABOQKQYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
28836,6cs2,DB08458,-7.5,(4-BROMOPHENYL)[4-({(2E)-4-[CYCLOPROPYL(METHYL)AMINO]BUT-2-ENYL}OXY)PHENYL]METHANONE,JAZMZJDLZUDIDG-NSCUHMNNSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
28518,6cs2,DB08108,-7.5,N-({6-[(4-CYANOBENZYL)OXY]NAPHTHALEN-2-YL}SULFONYL)-D-GLUTAMIC ACID,PUHRQSFXADUGJW-OAQYLSRUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
54852,6crv,DB00305,-7.5,Mitomycin,NWIBSHFKIJFRCO-WUDYKRTCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108783,6vxx,DB08957,-7.5,Hexoprenaline,OXLZNBCNGJWPRV-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78609,6m2n,DB12007,-7.5,Isoflavone,GOMNOOKGLZYEJT-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
72819,6m2n,DB01186,-7.5,Pergolide,YEHCICAEULNIGD-MZMPZRCHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
126553,6w4h,DB03982,-7.5,"Compound 5, 2-(Naphthalen-1-Yl-Oxalyl-Amino)-Benzoicacid",WQWCUHJIERBOSM-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
28528,6cs2,DB08116,-7.5,"(3R)-4-{[(3,4-dihydroxyphenyl)acetyl]oxy}-N-(2-formylindolizin-3-yl)-3-sulfino-D-valine",DEOZLEGRVHDNKC-UGKGYDQZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
28508,6cs2,DB08099,-7.5,"6-ethyl-5-[(2S)-1-(3-methoxypropyl)-2-phenyl-1,2,3,4-tetrahydroquinolin-7-yl]pyrimidine-2,4-diamine",UOYVKYJWAXJTTE-NRFANRHFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
27287,6cs2,DB06816,-7.5,Pyrvinium,QMHSXPLYMTVAMK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
120480,6w4b,DB08539,-7.5,"3-cyclopropyl-5-phenyl-N-(pyridin-3-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",CCDIUVLNHCGSMH-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
78884,6m2n,DB12402,-7.5,Pumosetrag,AFUWQWYPPZFWCO-LBPRGKRZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
11634,6lzg,DB12234,-7.5,BMS-214662,OLCWFLWEHWLBTO-HSZRJFAPSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
31334,6cs2,DB13689,-7.5,Tacalcitol,BJYLYJCXYAMOFT-RSFVBTMBSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
162702,7bv1,DB02812,-7.5,"(2s,4r)-1-Acetyl-N-[(1s)-4-[(Aminoiminomethyl)Amino]-1-(2-Benzothiazolylcarbonyl)Butyl]-4-Hydroxy-2-Pyrrolidinecarboxamide",VXDAVYUFYPFGDX-SNPRPXQTSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
120411,6w4b,DB08460,-7.5,"3-{5-[(6-amino-1H-pyrazolo[3,4-b]pyridin-3-yl)methoxy]-2-chlorophenoxy}-5-chlorobenzonitrile",KXDIHAQCVNNLIB-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
163039,7bv1,DB03458,-7.5,"N(4)-Adenosyl-N(4)-methyl-2,4-diaminobutanoic acid",JISVTSUBJCPLSV-TWBCTODHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
120420,6w4b,DB08470,-7.5,"3-(4-fluorophenyl)-5-phenyl-4H-1,2,4-triazole",KMGPJKOKSYGMJD-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
28561,6cs2,DB08149,-7.5,"1-[4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine",KCWPSUKJCKZEAO-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
126721,6w4h,DB04202,-7.5,Isoformononetin,LNIQZRIHAMVRJA-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
126704,6w4h,DB04180,-7.5,"4-(Aminosulfonyl)-N-[(2,4-Difluorophenyl)Methyl]-Benzamide",NTDFJEKGSGSXME-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
78882,6m2n,DB12400,-7.5,Voxtalisib,RGHYDLZMTYDBDT-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
55058,6crv,DB00557,-7.5,Hydro1ine,ZQDWXGKKHFNSQK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
10554,6lzg,DB08761,-7.5,"(3S,6S)-3,6-bis(4-hydroxybenzyl)piperazine-2,5-dione",NGPCLOGFGKJCBP-HOTGVXAUSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
126655,6w4h,DB04121,-7.5,Guanosine-3'-Monophosphate-5'-Diphosphate,HEYSFDAMRDTCJM-UUOKFMHZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
120443,6w4b,DB08497,-7.5,"(1S)-2-oxo-1-phenyl-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate",NKBDSMREMMRFSI-INIZCTEOSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
121035,6w4b,DB09319,-7.5,Carindacillin,JIRBAUWICKGBFE-MNRDOXJOSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
120446,6w4b,DB08500,-7.5,"(3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(2-naphthyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol",ZCJBDRSKHARECB-PYTCMNEWSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
120454,6w4b,DB08510,-7.5,5-ALPHA-PREGNANE-3-BETA-OL-HEMISUCCINATE,UVTGFMKBPVLATL-DSOJQRAMSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
82266,6m3m,DB02324,-7.5,5-Iodo-2'-Deoxyuridine-5'-Monophosphate,WXFYBFRZROJDLL-RRKCRQDMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
121029,6w4b,DB09298,-7.5,Silibinin,SEBFKMXJBCUCAI-HKTJVKLFSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
28555,6cs2,DB08144,-7.5,"6-(2,6-dibromophenyl)pyrido[2,3-d]pyrimidine-2,7-diamine",HGIPWJYTPOHUGK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
105943,6vxs,DB14657,-7.5,Paramethasone acetate,HYRKAAMZBDSJFJ-LFDBJOOHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
162731,7bv1,DB02848,-7.5,"{4-[3-(6,7-Diethoxy-Quinazolin-4-Ylamino)-Phenyl]-Thiazol-2-Yl}-Methanol",ZJESXGUODSBHSK-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
126672,6w4h,DB04142,-7.5,"3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid Dimethylamide",FEYGJZKVMASWJB-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
28379,6cs2,DB07968,-7.5,N-(2-CHLORO-4-FLUOROBENZOYL)-N'-(5-HYDROXY-2-METHOXYPHENYL)UREA,RFOBTYLRURSVJE-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
55041,6crv,DB00539,-7.5,Toremifene,XFCLJVABOIYOMF-QPLCGJKRSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81746,6m3m,DB01627,-7.5,Lincomycin,OJMMVQQUTAEWLP-KIDUDLJLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
125970,6w4h,DB03199,-7.5,4-Methoxy-E-Rhodomycin T,XSSVYBYWQBNYOH-QJIXERIWSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
105935,6vxs,DB14649,-7.5,Dexamethasone acetate,AKUJBENLRBOFTD-RPRRAYFGSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
126512,6w4h,DB03926,-7.5,"5-Alpha-Androstane-3-Beta,17-Alpha-Diol",CBMYJHIOYJEBSB-MFXFBURESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
126511,6w4h,DB03925,-7.5,Freselestat,HMPQTEPEMQZWQH-QZTJIDSGSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
126510,6w4h,DB03924,-7.5,"5,8-Di-Amino-1,4-Dihydroxy-Anthraquinone",QVEMRPAUHFWHRV-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
82069,6m3m,DB02061,-7.5,Cellobiose,GUBGYTABKSRVRQ-CUHNMECISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
28427,6cs2,DB00738,-7.5,Pentamidine,XDRYMKDFEDOLFX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
82033,6m3m,DB02016,-7.5,R048-8071,CMYCCJYVZIMDFU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81823,6m3m,DB01731,-7.5,(S)-wiskostatin,XUBJEDZHBUPBKL-ZDUSSCGKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
54984,6crv,DB00467,-7.5,Enoxacin,IDYZIJYBMGIQMJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106135,6vxs,DB15092,-7.5,LY-2624803,UEFWDVMEDFCHGW-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
54918,6crv,DB00387,-7.5,Procyclidine,WYDUSKDSKCASEF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
126140,6w4h,DB03417,-7.5,1-(4-Tert-Butylcarbamoyl-Piperazine-1-Carbonyl)-3-(3-Guanidino-Propyl)-4-Oxo-Azetidine-2-Carboxylic Acid,BVNQCAHTTOIOEK-STQMWFEESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
7668,6lzg,DB04186,-7.5,"N'-(Pyrrolidino[2,1-B]Isoindolin-4-On-8-Yl)-N-(Pyridin-2-Yl)Urea",KLVYMYQTRZCMLE-CYBMUJFWSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
78711,6m2n,DB12155,-7.5,Napabucasin,DPHUWDIXHNQOSY-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
10524,6lzg,DB08731,-7.5,"2-[(1R)-2-carboxy-1-(naphthalen-1-ylmethyl)ethyl]-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylic acid",GPOKTQCDBPECSS-MRXNPFEDSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
18497,6cs2,HMDB0030653,-7.5,Cryptochlorogenic acid,GYFFKZTYYAFCTR-JUHZACGLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
108698,6vxx,DB08819,-7.5,Tafluprost,WSNODXPBBALQOF-VEJSHDCNSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
126332,6w4h,DB03701,-7.5,Vanoxerine,NAUWTFJOPJWYOT-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
32917,6cs2,T3D3842,-7.5,Fluazinam,UZCGKGPEKUCDTF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
81886,6m3m,DB01813,-7.5,Pyridoxyl-Glutamic Acid-5'-Monophosphate,JMRKOGDJNHPMHS-JTQLQIEISA-O,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81967,6m3m,DB01931,-7.5,"Dcka, 5,7-Dichlorokynurenic Acid",BGKFPRIGXAVYNX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
108681,6vxx,DB08798,-7.5,Sulfamoxole,CYFLXLSBHQBMFT-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72889,6m2n,DB01283,-7.5,Lumiracoxib,KHPKQFYUPIUARC-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
126220,6w4h,DB03534,-7.5,3-[(Acetyl-Methyl-Amino)-Methyl]-4-Amino-N-Methyl-N-(1-Methyl-1h-Indol-2-Ylmethyl)-Benzamide,AWTBJNJPBKTHEV-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
429,6lzg,HMDB0005000,-7.5,Loratadine,JCCNYMKQOSZNPW-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
106113,6vxs,DB15048,-7.5,Licogliflozin,XFJAMQQAAMJFGB-ZQGJOIPISA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
21881,6cs2,HMDB0001389,-7.5,Melatonin,DRLFMBDRBRZALE-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
126179,6w4h,DB03477,-7.5,1-Phenylsulfonamide-3-Trifluoromethyl-5-Parabromophenylpyrazole,OYZKFVIVPRQRQQ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
126180,6w4h,DB03478,-7.5,2'-O-Acetyl Adenosine-5-Diphosphoribose,BFNOPXRXIQJDHO-DLFWLGJNSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
54964,6crv,DB00442,-7.5,Entecavir,QDGZDCVAUDNJFG-FXQIFTODSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108694,6vxx,DB08811,-7.5,Tofisopam,RUJBDQSFYCKFAA-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106097,6vxs,DB15021,-7.5,Leriglitazone,OXVFDZYQLGRLCD-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
57265,6crv,DB03417,-7.5,1-(4-Tert-Butylcarbamoyl-Piperazine-1-Carbonyl)-3-(3-Guanidino-Propyl)-4-Oxo-Azetidine-2-Carboxylic Acid,BVNQCAHTTOIOEK-STQMWFEESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57304,6crv,DB03477,-7.5,1-Phenylsulfonamide-3-Trifluoromethyl-5-Parabromophenylpyrazole,OYZKFVIVPRQRQQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27324,6cs2,DB06860,-7.5,"2-(2-chloropyridin-4-yl)-4-methyl-1H-isoindole-1,3(2H)-dione",YDJMWNHJNJVVMM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
11588,6lzg,DB00923,-7.5,Ceforanide,SLAYUXIURFNXPG-CRAIPNDOSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
28507,6cs2,DB08098,-7.5,"{[5-(5-nitro-2-furyl)-1,3,4-oxadiazol-2-yl]thio}acetic acid",ITBNJCVIFHSKRL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
164979,7bv1,DB09038,-7.5,Empagliflozin,OBWASQILIWPZMG-QZMOQZSNSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
108769,6vxx,DB08940,-7.5,Kebuzone,LGYTZKPVOAIUKX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
126499,6w4h,DB03909,-7.5,"Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate",UFZTZBNSLXELAL-IOSLPCCCSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
126032,6w4h,DB03272,-7.5,4-Bromo-3-(5'-Carboxy-4'-Chloro-2'-Fluorophenyl)-1-Methyl-5-Trifluoromethyl-Pyrazol,YNMHKERYELPEEF-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
11514,6lzg,DB12072,-7.5,Orantinib,NHFDRBXTEDBWCZ-ZROIWOOFSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
28494,6cs2,DB08083,-7.5,"2-(1,3-thiazol-4-yl)-1H-benzimidazole-5-sulfonamide",KGMVTZZDGKDTEU-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
126042,6w4h,DB03285,-7.5,"2',4,4'-Trihydroxychalcone",DXDRHHKMWQZJHT-FPYGCLRLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
106016,6vxs,DB14810,-7.5,AZD-1656,FJEJHJINOKKDCW-INIZCTEOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
72835,6m2n,DB01203,-7.5,Nadolol,VWPOSFSPZNDTMJ-UCWKZMIHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
164973,7bv1,DB09021,-7.5,Benzoctamine,GNRXCIONJWKSEA-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
72839,6m2n,DB01207,-7.5,Ridogrel,GLLPUTYLZIKEGF-HAVVHWLPSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
162831,7bv1,DB02976,-7.5,Uridine-5'-monophosphate 2-deoxy-2-fluoro-galactopyranosyl-monophosphate ester,NGTCPFGWXMBZEP-KBQKSTHMSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
81752,6m3m,DB01634,-7.5,2-Oxy-4-Hydroxy-5-(2-Hydrazinopyridine)Phenylalanine,AZUQIXJQZOMXAS-BDAKNGLRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
120722,6w4b,DB08828,-7.5,Vismodegib,BPQMGSKTAYIVFO-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
32876,6cs2,T3D3798,-7.5,Bifenazate,VHLKTXFWDRXILV-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
120743,6w4b,DB08864,-7.5,Rilpivirine,YIBOMRUWOWDFLG-ONEGZZNKSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
126447,6w4h,DB03841,-7.5,Y-700,AETHRPHBGJAIBT-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
108656,6vxx,DB08511,-7.5,"6-amino-2-methyl-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",PLJNUNPYZVVIRA-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28483,6cs2,DB08073,-7.5,(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE,YWTBGJGMTBHQTM-IBGZPJMESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
27316,6cs2,DB06851,-7.5,N-(pyridin-3-ylmethyl)aniline,BJXLHKJBRORJJJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
72848,6m2n,DB01217,-7.5,Anastrozole,YBBLVLTVTVSKRW-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
55020,6crv,DB00508,-7.5,Triflupromazine,XSCGXQMFQXDFCW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55019,6crv,DB00507,-7.5,Nitazoxanide,YQNQNVDNTFHQSW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
126391,6w4h,DB03771,-7.5,Allyl-{4-[3-(4-Bromo-Phenyl)-Benzofuran-6-Yloxy]-but-2-Enyl}-Methyl-Amine,KCNKJCHARANTIP-SNAWJCMRSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
106156,6vxs,DB15132,-7.5,AZD-8165,YUHNXUAATAMVKD-PZJWPPBQSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
55009,6crv,DB00495,-7.5,Zidovudine,HBOMLICNUCNMMY-XLPZGREQSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81815,6m3m,DB01716,-7.5,2-Propenyl-N-Acetyl-Neuramic Acid,IUGVDRFIVSPVGO-KXEMTNKZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
164903,7bv1,DB08942,-7.5,Isoxicam,YYUAYBYLJSNDCX-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
163048,7bv1,DB03701,-7.5,Vanoxerine,NAUWTFJOPJWYOT-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
105891,6vxs,DB14542,-7.5,Hydrocortisone phosphate,BGSOJVFOEQLVMH-VWUMJDOOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
105889,6vxs,DB14540,-7.5,Hydrocortisone butyrate,BMCQMVFGOVHVNG-TUFAYURCSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
32856,6cs2,T3D3774,-7.5,Secalonic Acid D,NFZJAYYORNVZNI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
127128,6w4h,DB04756,-7.5,"2-[(3,5-Dichloro-4-trioxidanylphenyl)amino]benzoic acid",SNAMTVTZDPUVRA-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
27229,6cs2,DB06718,-7.5,Stanozolol,LKAJKIOFIWVMDJ-IYRCEVNGSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
109255,6vxx,DB12964,-7.5,Lerisetron,PWWDCRQZITYKDV-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165169,7bv1,DB11457,-7.5,Rotenone,JUVIOZPCNVVQFO-HBGVWJBISA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
54542,2fxp,DB15232,-7.5,Telaglenastat,PRAAPINBUWJLGA-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
127117,6w4h,DB04740,-7.5,MOXALACTAM (HYDROLYZED),ZTOQXKUYWZBJLG-XNAIMREJSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
165162,7bv1,DB11446,-7.5,Oxfendazole,BEZZFPOZAYTVHN-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
49733,2fxp,DB04868,-7.5,Nilotinib,HHZIURLSWUIHRB-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
33101,6cs2,T3D4088,-7.5,Lyngbyatoxin A,KISDGNGREAJPQR-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
165161,7bv1,DB11443,-7.5,Orbifloxacin,QIPQASLPWJVQMH-DTORHVGOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
120064,6w4b,DB08039,-7.5,"(3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE",LOGJQOUIVKBFGH-YBEGLDIGSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
78181,6m2n,DB11115,-7.5,Ensulizole,UVCJGUGAGLDPAA-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
162568,7bv1,DB02431,-7.5,Cytidine-5'-Triphosphate,PCDQPRRSZKQHHS-XVFCMESISA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
31224,6cs2,DB13557,-7.5,Thiopropazate,AIUHRQHVWSUTGJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
125816,6w4h,DB02984,-7.5,"4-[3-Methylsulfanylanilino]-6,7-Dimethoxyquinazoline",FUSDVOSGGMBSMK-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
82394,6m3m,DB02484,-7.5,Cytidine 5'-Diphosphoglycerol,HHPOUCCVONEPRK-CNYIRLTGSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
10262,6lzg,DB08441,-7.5,"6-BROMO-13-THIA-2,4,8,12,19-PENTAAZATRICYCLO[12.3.1.1-3,7-]NONADECA-1(18),3(19),4,6,14,16-HEXAENE 13,13-DIOXIDE",AWSQADBSXFTFKL-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
108610,6vxx,DB08458,-7.5,(4-BROMOPHENYL)[4-({(2E)-4-[CYCLOPROPYL(METHYL)AMINO]BUT-2-ENYL}OXY)PHENYL]METHANONE,JAZMZJDLZUDIDG-NSCUHMNNSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31238,6cs2,DB13579,-7.5,Mepixanox,PYSOHOOUXFWCFF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
105712,6vxs,DB13866,-7.5,Etynodiol,JYILPERKVHXLNF-QMNUTNMBSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
57591,6crv,DB03866,-7.5,Prostaglandin G2,SGUKUZOVHSFKPH-YNNPMVKQSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106204,6vxs,DB15224,-7.5,Lisavanbulin,NIPZLALJRAHABJ-IBGZPJMESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
164847,7bv1,DB08680,-7.5,N-{3-[(E)-(tert-butoxyimino)methyl]-4-chlorophenyl}-2-methylfuran-3-carbimidothioic acid,PLGIIOKXCKDKEU-VXLYETTFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
74363,6m2n,DB03249,-7.5,2'-O-Methyl-3'-Methyl-3'-Deoxy-Arabinofuranosyl-Thymine-5'-Phosphate,MCXXETKRWYMFCI-TURQNECASA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
74111,6m2n,DB02916,-7.5,"[(2r,3s,4r,5r)-5-(6-Amino-9h-Purin-9-Yl)-3,4-Dihydroxytetrahydro-2-Furanyl]Methyl Sulfamate",GNZLUJQJDPRUTD-KQYNXXCUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
20173,6cs2,HMDB0000907,-7.5,Sulfolithocholic acid,AXDXVEYHEODSPN-YPLGJCPNSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
165150,7bv1,DB11426,-7.5,Marbofloxacin,BPFYOAJNDMUVBL-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
10303,6lzg,DB08487,-7.5,3-({4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-2-OXOPIPERAZIN-1-YL}METHYL)BENZENECARBOXIMIDAMIDE,PRMSFVUWLBPPLY-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
10258,6lzg,DB08437,-7.5,Puromycin,RXWNCPJZOCPEPQ-NVWDDTSBSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
72691,6m2n,DB01039,-7.5,Fenofibrate,YMTINGFKWWXKFG-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
106216,6vxs,DB15246,-7.5,Salvianolic acid A,YMGFTDKNIWPMGF-UCPJVGPRSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
55119,6crv,DB00631,-7.5,Clofarabine,WDDPHFBMKLOVOX-AYQXTPAHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
162472,7bv1,DB02316,-7.5,"1-(5-Carboxypentyl)-5-[(2,6-Dichlorobenzyl)Oxy]-1 H-Indole-2-Carboxylic Acid",JTGPYFFQVOIJKR-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
165216,7bv1,DB11582,-7.5,Thiocolchicoside,LEQAKWQJCITZNK-AXHKHJLKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
105645,6vxs,DB13778,-7.5,Cefazedone,VTLCNEGVSVJLDN-MLGOLLRUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
125765,6w4h,DB02918,-7.5,Zardaverine,HJMQDJPMQIHLPB-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
105649,6vxs,DB13783,-7.5,Acemetacin,FSQKKOOTNAMONP-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
109360,6vxx,DB13465,-7.5,Ciclobendazole,OXLKOMYHDYVIDM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
74412,6m2n,DB03313,-7.5,Cephalosporin C,HOKIDJSKDBPKTQ-GLXFQSAKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
121298,6w4b,DB11686,-7.5,Iferanserin,UXIPFQUBOVWAQW-UEBLJOKOSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
82486,6m3m,DB02603,-7.5,1-Amino-6-Cyclohex-3-Enylmethyloxypurine,VPUIDVRYMVIXGO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
108562,6vxx,DB08398,-7.5,"2-Amino-1-methyl-6-phenylimidazo(4,5-b)pyridine",UQVKZNNCIHJZLS-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31203,6cs2,DB13534,-7.5,Gedocarnil,SLYDYLLJUXFULK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
78046,6m2n,DB09194,-7.5,Etoperidone,IZBNNCFOBMGTQX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
127169,6w4h,DB04812,-7.5,Benoxaprofen,MITFXPHMIHQXPI-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
72674,6m2n,DB01021,-7.5,Trichlormethiazide,LMJSLTNSBFUCMU-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
109346,6vxx,DB13445,-7.5,Nepinalone,RVXGRCNWGOHSDE-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
162501,7bv1,DB02353,-7.5,Heparin Disaccharide Iii-S,GSYQGRODWXMUOO-GYBHJADLSA-K,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
31535,6cs2,DB13981,-7.5,Nomegestrol acetate,IIVBFTNIGYRNQY-YQLZSBIMSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
109328,6vxx,DB13077,-7.5,LCB01-0371,QLUWQAFDTNAYPN-LLVKDONJSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108567,6vxx,DB08403,-7.5,METHYLAMINO-PHENYLALANYL-LEUCYL-HYDROXAMIC ACID,MOPRTFSMCQNUCT-CABCVRRESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78077,6m2n,DB09229,-7.5,Aranidipine,NCUCGYYHUFIYNU-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78103,6m2n,DB09262,-7.5,Imidafenacin,SQKXYSGRELMAAU-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
125776,6w4h,DB02932,-7.5,(R)-Bicalutamide,LKJPYSCBVHEWIU-KRWDZBQOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
120006,6w4b,DB07976,-7.5,3-{[(3-FLUORO-3'-METHOXYBIPHENYL-4-YL)AMINO]CARBONYL}THIOPHENE-2-CARBOXYLIC ACID,GIUMGVUBDBDTDX-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
74390,6m2n,DB03285,-7.5,"2',4,4'-Trihydroxychalcone",DXDRHHKMWQZJHT-FPYGCLRLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
127151,6w4h,DB04787,-7.5,Tanaproget,PYVFWTPEBMRKSR-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
121273,6w4b,DB11650,-7.5,HT-0712,ABEJDMOBAFLQNJ-NHCUHLMSSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
109289,6vxx,DB13020,-7.5,Apratastat,MAVDNGWEBZTACC-HNNXBMFYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
105669,6vxs,DB13808,-7.5,Mebhydrolin,FQQIIPAOSKSOJM-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
82458,6m3m,DB02565,-7.5,4-Dimethylamino-N-(6-Hydroxycarbamoyethyl)Benzamide-N-Hydroxy-7-(4-Dimethyla Minobenzoyl)Aminoheptanamide,MXWDSZWTBOCWBK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
18579,6cs2,HMDB0000686,-7.5,Isoursodeoxycholic acid,RUDATBOHQWOJDD-DNMBCGTGSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
164829,7bv1,DB08656,-7.5,5-amino-2-methyl-N-[(1R)-1-naphthalen-1-ylethyl]benzamide,UVERBUNNCOKGNZ-CQSZACIVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
165141,7bv1,DB11409,-7.5,Febantel,HMCCXLBXIJMERM-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
54605,2fxp,DB15356,-7.5,SLV-334,LOFDNSDPZTVIIO-VPUSJEBWSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
11650,6lzg,DB12253,-7.5,GDC-0810,BURHGPHDEVGCEZ-KJGLQBJMSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
120313,6w4b,DB08340,-7.5,"N,N'-DIPHENYLPYRAZOLO[1,5-A][1,3,5]TRIAZINE-2,4-DIAMINE",LLYYAUZAGCZEKV-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
109010,6vxx,DB11902,-7.5,Gisadenafil,YPFZMBHKIVDSNR-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
120325,6w4b,DB08354,-7.5,"2-(4-CHLOROBENZYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE",QCVULERVJOYHCP-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
55071,6crv,DB00576,-7.5,Sulfamethizole,VACCAVUAMIDAGB-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
105790,6vxs,DB14037,-7.5,Madecassic acid,PRAUVHZJPXOEIF-AOLYGAPISA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
108989,6vxx,DB11872,-7.5,ZD-6126,UGBMEXLBFDAOGL-INIZCTEOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81735,6m3m,DB01615,-7.5,Aceprometazine,XLOQNFNTQIRSOX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
28572,6cs2,DB08159,-7.5,"4-(5,11-DIOXO-5H-INDENO[1,2-C]ISOQUINOLIN-6(11H)-YL)BUTANOATE",AHIJTWCJGCWHMT-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
105793,6vxs,DB14045,-7.5,Cholesteryl chloride,OTVRYZXVVMZHHW-DPAQBDIFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
120349,6w4b,DB08385,-7.5,4-(quinolin-3-ylmethyl)piperidine-1-carboxylic acid,QUAGUFNCKDDJFZ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
126885,6w4h,DB04433,-7.5,"N''-{3-[(3s,8ar)-1,4-Dioxooctahydropyrrolo[1,2-a]Pyrazin-3-Yl]Propyl}Guanidine",ZRJHYOXNWCMGMW-YUMQZZPRSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
126882,6w4h,DB04429,-7.5,4'-Hydroxyflavanone,ZLHVIYHWWQYJID-HNNXBMFYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
109040,6vxx,DB11946,-7.5,AZD-1981,JWYIGNODXSRKGP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
33056,6cs2,T3D4018,-7.5,Ouabain,LPMXVESGRSUGHW-HBYQJFLCSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
54728,6crv,DB00162,-7.5,Vitamin A,FPIPGXGPPPQFEQ-OVSJKPMPSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81737,6m3m,DB01618,-7.5,Molindone,KLPWJLBORRMFGK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
120360,6w4b,DB08397,-7.5,6-(DIFLUORO-PHOSPHONO-METHYL)-NAPHTHALENE-2-CARBOXYLIC ACID,NKGNOWNPXBURRW-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
126860,6w4h,DB04395,-7.5,Phosphoaminophosphonic Acid-Adenylate Ester,PVKSNHVPLWYQGJ-FCIPNVEPSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
78425,6m2n,DB11739,-7.5,Vonoprazan,BFDBKMOZYNOTPK-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
120365,6w4b,DB08402,-7.5,"2-[(2,4-DICHLOROBENZOYL)AMINO]-5-(PYRIMIDIN-2-YLOXY)BENZOIC ACID",VNDRRWBKNSHALL-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
120380,6w4b,DB08423,-7.5,[5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL][3-(PIPERIDIN-4-YLOXY)PHENYL]METHANONE,QKZZJXRGCHXIAI-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
55069,6crv,DB00574,-7.5,Fenfluramine,DBGIVFWFUFKIQN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
126821,6w4h,DB04338,-7.5,SB220025,VSPFURGQAYMVAN-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
126820,6w4h,DB04336,-7.5,1-(4-Amidinophenyl)-3-(4-Chlorophenyl)Urea,HQWKMDKTTCPCMQ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
105860,6vxs,DB14196,-7.5,"N-Cyclohexyl-N'-phenyl-1,4-phenylenediamine",ZRMMVODKVLXCBB-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
125902,6w4h,DB03103,-7.5,Thymidine-5'- Diphosphate,UJLXYODCHAELLY-XLPZGREQSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
57470,6crv,DB03718,-7.5,6-Aza-Ump,LRVZOSYMNMNQFR-SHUUEZRQSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
125889,6w4h,DB03086,-7.5,"N'-(2s,3r)-3-Amino-4-Cyclohexyl-2-Hydroxy-Butano-N-(4-Methylphenyl)Hydrazide",IQMLIGOOOFEBAH-CVEARBPZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
120285,6w4b,DB08305,-7.5,"(3R)-3-cyclopentyl-6-methyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2-benzothiazine 1,1-dioxide",KQAGZLQCEURCKJ-QGZVFWFLSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
55072,6crv,DB00577,-7.5,Valaciclovir,HDOVUKNUBWVHOX-QMMMGPOBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
120282,6w4b,DB08302,-7.5,3-[5-(2-nitropent-1-en-1-yl)furan-2-yl]benzoic acid,IRHZCQDCMUWUKV-RAXLEYEMSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
55091,6crv,DB00598,-7.5,Labetalol,SGUAFYQXFOLMHL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
10309,6lzg,DB08493,-7.5,"5-METHYL-3-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.013,18]NONADECA-12(19),13,15,17-TETRAEN-10-YLCARBAMOYL)-HEXANOIC ACID",AKWKBACKRMYPRV-NQIIRXRSSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
10310,6lzg,DB08494,-7.5,"S-{2-[(2-chloro-4-sulfamoylphenyl)amino]-2-oxoethyl} 6-methyl-3,4-dihydroquinoline-1(2H)-carbothioate",AWAKIULNKVOBKE-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
120155,6w4b,DB08143,-7.5,"5-CHLORO-THIOPHENE-2-CARBOXYLIC ACID ((3S,4S)-4-FLUORO- 1-{[2-FLUORO-4-(2-OXO-2H-PYRIDIN-1-YL)-PHENYLCARBAMOYL]-METHYL}-PYRROLIDIN-3-YL)-AMIDE",SXIYSYYSKHUTQQ-RDJZCZTQSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
29321,6cs2,DB09006,-7.5,Clinofibrate,BMOVQUBVGICXQN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
33086,6cs2,T3D4066,-7.5,Ryanodine,JJSYXNQGLHBRRK-YSOSZROBSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
54624,2fxp,DB15403,-7.5,Ziritaxestat,REQQVBGILUTQNN-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
127035,6w4h,DB04626,-7.5,Apramycin,XZNUGFQTQHRASN-XQENGBIVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
127034,6w4h,DB04624,-7.5,DERIVATIVE OF AKLANONIC ACID METHYL ESTER (AAME),SIHNJMGWRHPFAZ-XHDPSFHLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
74343,6m2n,DB03227,-7.5,Nicotinamide Mononucleotide,DAYLJWODMCOQEW-WYOJIJJFSA-O,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78264,6m2n,DB11410,-7.5,Fenbendazole,HDDSHPAODJUKPD-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
33084,6cs2,T3D4064,-7.5,Lycorine,XGVJWXAYKUHDOO-DANNLKNASA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
109116,6vxx,DB12398,-7.5,Naproxen etemesil,JGBUBSOKFSVXKS-LBPRGKRZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57572,6crv,DB03841,-7.5,Y-700,AETHRPHBGJAIBT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165119,7bv1,DB11367,-7.5,Cefroxadine,RDMOROXKXONCAL-UEKVPHQBSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
28356,6cs2,DB07943,-7.5,2-{4-[5-(4-chlorophenyl)-4-pyrimidin-4-yl-1H-pyrazol-3-yl]piperidin-1-yl}-2-oxoethanol,CATQHDWESBRRQA-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
109100,6vxx,DB12377,-7.5,Relebactam,SMOBCLHAZXOKDQ-ZJUUUORDSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
120209,6w4b,DB08204,-7.5,3-DIPHENOL-6-NITRO-3H-BENZO[DE]ISOCHROMEN-1-ONE,FLWABCQDXUKNQY-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
105746,6vxs,DB13951,-7.5,Stanolone acetate,ILCTUFVQFCIIDS-NGFSFWIMSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
28869,6cs2,DB08492,-7.5,(2E)-3-(2-OCT-1-YN-1-YLPHENYL)ACRYLIC ACID,KRDSGPLHVQJFLM-BUHFOSPRSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
78316,6m2n,DB11518,-7.5,Flunixin,NOOCSNJCXJYGPE-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
127007,6w4h,DB04590,-7.5,(2R)-({4-[AMINO(IMINO)METHYL]PHENYL}AMINO){5-ETHOXY-2-FLUORO-3-[(3R)-TETRAHYDROFURAN-3-YLOXY]PHENYL}ACETICACID,PGYOHIAQCFZQDK-AUUYWEPGSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
11665,6lzg,DB12275,-7.5,Seviteronel,ZBRAJOQFSNYJMF-SFHVURJKSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
126977,6w4h,DB04552,-7.5,Niflumic acid,JZFPYUNJRRFVQU-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
120256,6w4b,DB08267,-7.5,"6-amino-4-(2-phenylethyl)-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",PBZAIUVFRISTSZ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
31290,6cs2,DB13642,-7.5,Pridinol,RQXCLMGKHJWMOA-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
165084,7bv1,DB09212,-7.5,Loxoprofen,YMBXTVYHTMGZDW-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
78369,6m2n,DB11654,-7.5,T-2000,RRFBTKHQZRCRSS-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
165071,7bv1,DB09198,-7.5,Lobeglitazone,CHHXEZSCHQVSRE-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
165133,7bv1,DB11393,-7.5,Danofloxacin,QMLVECGLEOSESV-RYUDHWBXSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
58614,6crv,DB06200,-7.5,Tedisamil,CTIRHWCPXYGDGF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110104,6vxx,DB00981,-7.5,Physostigmine,PIJVFDBKTWXHHD-HIFRSBDPSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27064,6cs2,DB06370,-7.5,Indisulam,SETFNECMODOHTO-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
83641,6m3m,DB04155,-7.5,2-Fluoro-2-Deoxy-Beta-D-Galactopyranosyl-Beta-D-Glucopyranose,KWMZPXRIEZDXAQ-QRZGKKJRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
77116,6m2n,DB07995,-7.5,N-[2-(4-BROMOCINNAMYLAMINO)ETHYL]-5-ISOQUINOLINE SULFONAMIDE,ZKZXNDJNWUTGDK-NSCUHMNNSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
31740,6cs2,DB14660,-7.5,Trenbolone acetate,CMRJPMODSSEAPL-FYQPLNBISA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
104816,6vxs,DB12548,-7.5,Sparsentan,WRFHGDPIDHPWIQ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
121913,6w4b,DB12580,-7.5,Tradipitant,CAVRKWRKTNINFF-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
161504,7bv1,DB14934,-7.5,GDC-0927,KJAAPZIFCQQQKX-NDEPHWFRSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
161509,7bv1,DB14941,-7.5,BMS-817399,GTDPZONCGOCXOD-JPYJTQIMSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
111493,6vxx,DB03942,-7.5,Carboxylic PRPP,OICBXEWBKALHHB-MOJAZDJTSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
83624,6m3m,DB04133,-7.5,Degraded Cephaloridine,SFVACKBZMIZHCK-ZWNOBZJWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
111485,6vxx,DB03932,-7.5,LFA703,WPVRNXUYVXQXPY-YFAYRSKXSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
124720,6w4h,DB01548,-7.5,Diprenorphine,OIJXLIIMXHRJJH-KNLIIKEYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
118405,6w4b,DB04785,-7.5,Streptolydigin,KVTPRMV1KLIG-NCAOFHFGSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
163636,7bv1,DB04885,-7.5,Cilansetron,NCNFDKWULDWJDS-OAHLLOKOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
28135,6cs2,DB07714,-7.5,"6-(3-METHYL-1,4-DIOXO-1,4-DIHYDRONAPHTHALEN-2-YL)HEXANOIC ACID",ICGRXHWXPCXIKM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
104826,6vxs,DB12563,-7.5,MK-0686,WZZIQHIQMWJNLU-LLVKDONJSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
108268,6vxx,DB07556,-7.5,N-HYDROXY-2(R)-[[(4-METHOXYPHENYL)SULFONYL](3-PICOLYL)AMINO]-3-METHYLBUTANAMIDE HYDROCHLORIDE,BSIZUMJRKYHEBR-QGZVFWFLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58402,6crv,DB05035,-7.5,Eprotirome,VPCSYAVXDAUHLT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
124736,6w4h,DB01564,-7.5,Calusterone,IVFYLRMMHVYGJH-PVPPCFLZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
83612,6m3m,DB04116,-7.5,Allolactose,DLRVVLDZNNYCBX-VDGMBKLFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
128599,6w4h,DB07801,-7.5,N-butyl-3-{[6-(9H-purin-6-ylamino)hexanoyl]amino}benzamide,WOYITRCGMUXUDE-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
26872,6cs2,DB05644,-7.5,KP-1461,SZWIAFVYPPMZML-YNEHKIRRSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
53439,2fxp,DB13005,-7.5,Rebastinib,WVXNSAVVKYZVOE-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
111411,6vxx,DB03835,-7.5,"N-[(5S,7R,8S,9S,10R)-8,9,10-Trihydroxy-7-(hydroxymethyl)-2,4-dioxo-6-oxa-1,3-diazaspiro[4.5]dec-3-yl]acetamide",MAHIOGAAEAWGLR-UTAYWCBXSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111392,6vxx,DB03812,-7.5,"3-{2,6,8-trioxo-9-[(2S,3R,4R)-2,3,4,5-tetrahydroxypentyl]-1,2,3,6,8,9-hexahydro-7H-purin-7-Yl}propyl dihydrogen phosphate",KPHFGOGGKPGLTM-LKEWCRSYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
74858,6m2n,DB03924,-7.5,"5,8-Di-Amino-1,4-Dihydroxy-Anthraquinone",QVEMRPAUHFWHRV-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
111383,6vxx,DB03800,-7.5,Deoxyuridine monophosphate,JSRLJPSBLDHEIO-SHYZEUOFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108288,6vxx,DB07582,-7.5,"N-[(2R,3S)-1-((2S)-2-{[(CYCLOPENTYLAMINO)CARBONYL]AMINO}-3-METHYLBUTANOYL)-2-(1-FORMYL-1-CYCLOBUTYL)PYRROLIDINYL]CYCLOPROPANECARBOXAMIDE",GCDRFILPPBOJLM-UFYCRDLUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30740,6cs2,DB00983,-7.5,Formoterol,BPZSYCZIITTYBL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
163635,7bv1,DB04884,-7.5,Dapoxetine,USRHYDPUVLEVMC-FQEVSTJZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
55466,6crv,DB01036,-7.5,Tolterodine,OOGJQPCLVADCPB-HXUWFJFHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72174,6m2n,DB00427,-7.5,Triprolidine,CBEQULMOCCWAQT-WOJGMQOQSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
118339,6w4b,DB04693,-7.5,"(13S)-13-METHYLDODECAHYDRO-1H-CYCLOPENTA[A]PHENANTHRENE-3,17(2H,4H)-DIONE",CRDKSBHJIGNEOH-IMRIKWHGSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
118222,6w4b,DB04540,-7.5,Cholesterol,HVYWMOMLDIMFJA-DPAQBDIFSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
104784,6vxs,DB12499,-7.5,Clascoterone,GPNHMOZDMYNCPO-PDUMRIMRSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
11916,6lzg,DB12612,-7.5,Ozanimod,XRVDGNKRPOAQTN-FQEVSTJZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
9479,6lzg,DB07584,-7.5,"N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine",OKGCSZUKOGMZAL-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
27517,6cs2,DB00641,-7.5,Simvastatin,RYMZZMVNJRMUDD-HGQWONQESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
30701,6cs2,DB12863,-7.5,Sivelestat,BTGNGJJLZOIYID-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
83676,6m3m,DB04198,-7.5,Formycin B,MTCJZZBQNCXKAP-KSYZLYKTSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
161463,7bv1,DB14856,-7.5,PF-05089771,ZYSCOUXLBXGGIM-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
77069,6m2n,DB07942,-7.5,2-fluoro-4-[4-(4-fluorophenyl)-1H-pyrazol-3-yl]pyridine,YJCHZVXSPFPKMX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
124696,6w4h,DB01524,-7.5,Androstenediol,QADHLRWLCPCEKT-LOVVWNRFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
9498,6lzg,DB07607,-7.5,4-[5-(3-IODO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-1H-IMIDAZOL-4-YL]-PYRIDINE,RXDZANYWRNIAOR-HHHXNRCGSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
106637,6vxx,DB00841,-7.5,Dobutamine,JRWZLRBJNMZMFE-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
128714,6w4h,DB07934,-7.5,[[CYCLOHEXANESULFONYL-GLYCYL]-3[PYRIDIN-4-YL-AMINOMETHYL]ALANYL]PIPERIDINE,KMUXFASJKPVMGU-HXUWFJFHSA-O,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
121923,6w4b,DB12597,-7.5,ABL-001,VOVZXURTCKPRDQ-CQSZACIVSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
128712,6w4h,DB07932,-7.5,"dimethyl (1R,4S)-5,6-bis(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hepta-2,5-diene-2,3-dicarboxylate",CRLQCBACIMUGDZ-BGYRXZFFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
111514,6vxx,DB03973,-7.5,"3-{2,6,8-trioxo-9-[(2R,3R,4R)-2,3,4,5-tetrahydroxypentyl]-1,2,3,6,8,9-hexahydro-7H-purin-7-Yl}propyl dihydrogen phosphate",KPHFGOGGKPGLTM-ZXFLCMHBSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
26833,6cs2,DB00567,-7.5,Cephalexin,ZAIPMKNFIOOWCQ-UEKVPHQBSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
56760,6crv,DB02749,-7.5,Pyromellitic Acid,CYIDZMCFTVVTJO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56765,6crv,DB02756,-7.5,Pyroquilon,XRJLAOUDSILTFT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
10770,6lzg,DB09038,-7.5,Empagliflozin,OBWASQILIWPZMG-QZMOQZSNSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
11906,6lzg,DB12594,-7.5,AZD-9056,HSQAARMBHJCUOK-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
118324,6w4b,DB04669,-7.5,TRIAZOLOPYRIMIDINE,YWBFPKPWMSWWEA-UHFFFAOYSA-O,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
26838,6cs2,DB05482,-7.5,7-ethyl-10-hydroxycamptothecin,FJHBVJOVLFPMQE-QFIPXVFZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
77104,6m2n,DB07983,-7.5,1-(4-IODOBENZOYL)-5-METHOXY-2-METHYL INDOLE-3-ACETIC ACID,CXBFZYKAVCAPSV-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
128673,6w4h,DB07883,-7.5,(2-AMINO-3-PHENYL-BICYCLO[2.2.1]HEPT-2-YL)-PHENYL-METHANONE,XJQDTOANLAPEIM-JRBPQWBISA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
32556,6cs2,T3D1960,-7.5,"3,4'-Dibromobiphenyl",DLAKCVTXQRIHEY-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
11319,6lzg,DB11805,-7.5,Saracatinib,OUKYUETWWIPKQR-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
30716,6cs2,DB12884,-7.5,Lavoltidine,VTLNPNNUIJHJQB-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
163642,7bv1,DB05626,-7.5,Retaspimycin,OAKGNIRUXAZDQF-TXHRRWQRSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
29445,6cs2,DB09197,-7.5,Mepiprazole,DOTIMEKVTCOGED-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
11334,6lzg,DB11824,-7.5,Tofogliflozin,VWVKUNOPTJGDOB-BDHVOXNPSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
58388,6crv,DB04967,-7.5,Lucanthone,FBQPGGIHOFZRGH-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163572,7bv1,DB04807,-7.5,4-NITROPHENYL-(6-S-ALPHA-D-XYLOPYRANOSYL)-BETA-D-GLUCOPYRANOSIDE,HQYVHBCTLFPWRQ-ZMFOIVQCSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
77226,6m2n,DB08119,-7.5,"1,1,1-TRIFLUORO-3-((N-ACETYL)-L-LEUCYLAMIDO)-4-PHENYL-BUTAN-2-ONE(N-ACETYL-L-LEUCYL-L-PHENYLALANYL TRIFLUOROMETHYL KETONE)",MZNXJCZDQRNGRC-GJZGRUSLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
9579,6lzg,DB07692,-7.5,"1-[(2,6-difluorophenyl)sulfonyl]-4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)piperazine",SHWNKRPMUBFWKE-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
77249,6m2n,DB08144,-7.5,"6-(2,6-dibromophenyl)pyrido[2,3-d]pyrimidine-2,7-diamine",HGIPWJYTPOHUGK-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
74808,6m2n,DB03860,-7.5,"N-Butyl-11-[(7r,8r,9s,13s,14s,17s)-3,17-Dihydroxy-13-Methyl-7,8,9,11,12,13,14,15,16,17-Decahydro-6h-Cyclopenta[a]Phenanthren-7-Yl]-N-Methylundecanamide",BVVFOLSZMQVDKV-KXQIQQEYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
163565,7bv1,DB04797,-7.5,Triazolopyridine,OVCXRBARSPBVMC-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
165646,7bv1,DB12590,-7.5,Indiplon,CBIAWPMZSFFRGN-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
111111,6vxx,DB03009,-7.5,2-[(2-Oxo-2-Piperidin-1-Ylethyl)Thio]-6-(Trifluoromethyl)Pyrimidin-4(1h)-One,UDBHGUOSOKOIAX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55431,6crv,DB00998,-7.5,Frovatriptan,XPSQPHWEGNHMSK-SECBINFHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31712,6cs2,DB14634,-7.5,Fluprednidene acetate,DEFOZIFYUBUHHU-IYQKUMFPSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
118646,6w4b,DB05667,-7.5,Levoketoconazole,XMAYWYJOQHXEEK-ZEQKJWHPSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
9601,6lzg,DB07716,-7.5,"(4Z)-2,8:7,12:11,15:14,18:17,22-PENTAANHYDRO-4,5,6,9,10,13,19,20,21-NONADEOXY-D-ARABINO-D-ALLO-D-ALLO-DOCOSA-4,9,20-TRIENITOL",VDRIXSJOPKVWKM-HXGIDPQASA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
161705,7bv1,DB00495,-7.5,Zidovudine,HBOMLICNUCNMMY-XLPZGREQSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
128519,6w4h,DB07708,-7.5,3-CHLORO-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL,ZNHQDSBJVFFIAK-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
124812,6w4h,DB01659,-7.5,"3-(1,10-Phenanthrol-2-Yl)-L-Alanine",LODBCIBKOKOGNL-LBPRGKRZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
111075,6vxx,DB02957,-7.5,Orotidine-5'-Monophosphate,KYOBSHFOBAOFBF-XVFCMESISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31711,6cs2,DB14633,-7.5,Prednisolone hemisuccinate,APGDTXUMTIZLCJ-CGVGKPPMSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
111059,6vxx,DB02936,-7.5,4-(1-Benzyl-3-Carbamoylmethyl-2-Methyl-1h-Indol-5-Yloxy)-Butyric Acid,STENXUCYNKOBHJ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111054,6vxx,DB02930,-7.5,Adenosine 5'-[gamma-thio]triphosphate,NLTUCYMLOPLUHL-KQYNXXCUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72239,6m2n,DB00504,-7.5,Levallorphan,OZYUPQUCAUTOBP-QXAKKESOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
6569,6lzg,DB02341,-7.5,"Mdl 101,146",XQAMVCHQGHAELT-YPAWHYETSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
77268,6m2n,DB08163,-7.5,5'-{[4-(aminooxy)butyl](methyl)amino}-5'-deoxy-8-ethenyladenosine,XUKYGMIDWKBMIW-IWCJZZDYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
7582,6lzg,DB04044,-7.5,4-{2-[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid,NAQUAVBNIYTIIS-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
31709,6cs2,DB14631,-7.5,Prednisolone phosphate,JDOZJEUDSLGTLU-VWUMJDOOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
118690,6w4b,DB05959,-7.5,ENMD-1198,YQJWOUQGXATDAE-ACNBBOPNSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
118696,6w4b,DB05983,-7.5,Bardoxolone methyl,WPTTVJLTNAWYAO-KPOXMGGZSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
58319,6crv,DB04839,-7.5,Cyproterone acetate,UWFYSQMTEOIJJG-FDTZYFLXSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104877,6vxs,DB12647,-7.5,Tocotrienol,GJJVAFUKOBZPCB-ZGRPYONQSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
161707,7bv1,DB00497,-7.5,Oxycodone,BRUQQQPBMZOVGD-XFKAJCMBSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
72211,6m2n,DB00472,-7.5,Fluoxetine,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
121838,6w4b,DB12467,-7.5,TU-100,KAYRGFYBCCETPE-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
128547,6w4h,DB07742,-7.5,"N-(2,3-DIFLUORO-BENZYL)-4-SULFAMOYL-BENZAMIDE",QASSMVGOSBNFQY-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
32570,6cs2,T3D1973,-7.5,"3,4,4',5-Tetrabromobiphenyl",BQOPMOAYELIJRL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
128579,6w4h,DB07779,-7.5,N-({(2S)-1-[(3R)-3-AMINO-4-(2-FLUOROPHENYL)BUTANOYL]PYRROLIDIN-2-YL}METHYL)BENZAMIDE,ANQHSFFUNMTTRS-MOPGFXCFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
118491,6w4b,DB04891,-7.5,Becocalcidiol,QSLUXQQUPXBIHH-YHSKWIAJSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
128577,6w4h,DB07776,-7.5,Flavone,VHBFFQKBGNRLFZ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
161613,7bv1,DB00177,-7.5,Valsartan,ACWBQPMHZXGDFX-QFIPXVFZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
161614,7bv1,DB00178,-7.5,Ramipril,HDACQVRGBOVJII-JBDAPHQKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
27511,6cs2,DB07055,-7.5,"2-[2-(1H-tetrazol-5-yl)ethyl]-1H-isoindole-1,3(2H)-dione",DEOJDUHRJBKATO-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
74832,6m2n,DB03890,-7.5,N-[2-(1-Formyl-2-Methyl-Propyl)-1-(4-Piperidin-1-Yl-but-2-Enoyl)-Pyrrolidin-3-Yl]-Methanesulfonamide,BSBJWRKWANAVRQ-POTLKAILSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
118529,6w4b,DB05016,-7.5,Ataluren,OOUGLTULBSNHNF-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
108299,6vxx,DB07593,-7.5,1-(PHENYLMETHYL)CYCLOPENTYL[(1S)-1-FORMYLPENTYL]CARBAMATE,ONABDOMWRCXLPX-KRWDZBQOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
128571,6w4h,DB07769,-7.5,S-3-(4-FLUOROPHENOXY)-2-HYDROXY-2-METHYL-N-[4-NITRO-3-(TRIFLUOROMETHYL)PHENYL]PROPANAMIDE,KJMFOTCDISOHDX-INIZCTEOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
121867,6w4b,DB12512,-7.5,Verucerfont,VKHVAUKFLBBZFJ-SFHVURJKSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
73191,6m2n,DB01700,-7.5,AICA ribonucleotide,NOTGFIUVDGNKRI-UUOKFMHZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
111284,6vxx,DB03450,-7.5,Cephalothin Group,UUWFGEKEQSCSMB-IAQYHMDHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
161638,7bv1,DB00206,-7.5,Reserpine,QEVHRUUCFGRFIF-MDEJGZGSSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
128563,6w4h,DB07760,-7.5,"3-[(1E,7E)-8-(2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)-3,6-dioxa-2,7-diazaocta-1,7-dien-1-yl]benzoic acid",TUYDQQMKXSQIQG-GONBZBRSSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
104842,6vxs,DB12587,-7.5,Razupenem,XFGOMLIRJYURLQ-GOKYHWASSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
164603,7bv1,DB08192,-7.5,2-(4-CARCOXY-5-ISOPROPYLTHIAZOLYL)BENZOPIPERIDINE,HCUGCUQZFBURHR-LBPRGKRZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
26880,6cs2,DB05676,-7.5,Apremilast,IMOZEMNVLZVGJZ-QGZVFWFLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
6543,6lzg,DB02300,-7.5,Calcipotriol,LWQQLNNNIPYSNX-UROSTWAQSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
108313,6vxx,DB07613,-7.5,3-phenyl-5-(1H-pyrazol-3-yl)isoxazole,SRSSTOPJERVMRZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81252,6m3m,DB00983,-7.5,Formoterol,BPZSYCZIITTYBL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
111221,6vxx,DB03358,-7.5,7n-Methyl-8-Hydroguanosine-5'-Triphosphate,BUJQMJUTTBGELS-KQYNXXCUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31721,6cs2,DB14641,-7.5,Estriol tripropionate,ONMZMZJEZHMWQL-REUUDLSRSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
124779,6w4h,DB01619,-7.5,Phenindamine,ISFHAYSTHMVOJR-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
31720,6cs2,DB14640,-7.5,Isoflupredone acetate,ZOCUOMKMBMEYQV-GSLJADNHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
106572,6vxx,DB00504,-7.5,Levallorphan,OZYUPQUCAUTOBP-QXAKKESOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104847,6vxs,DB12594,-7.5,AZD-9056,HSQAARMBHJCUOK-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
58372,6crv,DB04924,-7.5,Itopride,QQQIECGTIMUVDS-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165730,7bv1,DB12721,-7.5,RO-5028442,QZXVLRCMAHJVIP-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
118177,6w4b,DB04480,-7.5,"3-(4-Fluorophenyl)-2-(6-Methylpyridin-2-Yl)-5,6-Dihydro-4h-Pyrrolo[1,2-B]Pyrazole",NBDZLUOYAAVYHF-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
104775,6vxs,DB12480,-7.5,Betulinic Acid,QGJZLNKBHJESQX-FZFNOLFKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
161426,7bv1,DB14025,-7.5,Clinafloxacin,QGPKADBNRMWEQR-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
111916,6vxx,DB04864,-7.5,Huperzine A,ZRJBHWIHUMBLCN-YQEJDHNASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
161277,7bv1,DB13491,-7.5,Fluperolone,SLVCCRYLKTYUQP-DVTGEIKXSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
53206,2fxp,DB12640,-7.5,CP-609754,JAHDAIPFBPPQHQ-GDLZYMKVSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
124564,6w4h,DB01338,-7.5,Pipecuronium,OWWLUIWOFHMHOQ-XGHATYIMSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
111902,6vxx,DB04844,-7.5,Tetrabenazine,MKJIEFSOBYUXJB-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
73867,6m2n,DB02593,-7.5,"7,8-Dihydroxy-1-Methoxy-3-Methyl-10-Oxo-4,10-Dihydro-1h,3h-Pyrano[4,3-B]Chromene-9-Carboxylic Acid",RSFJMLCZHPZXCW-AANKLQPISA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
106691,6vxx,DB00902,-7.5,Methdilazine,HTMIBDQKFHUPSX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
122076,6w4b,DB12848,-7.5,PF-04217903,PDMUGYOXRHVNMO-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
117587,6w4b,DB03701,-7.5,Vanoxerine,NAUWTFJOPJWYOT-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
58561,6crv,DB05968,-7.5,PR-104,GZSOKPMDWVRVMG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
26746,6cs2,DB00557,-7.5,Hydro1ine,ZQDWXGKKHFNSQK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
164558,7bv1,DB08142,-7.5,AT-7519,OVPNQJVDAFNBDN-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
108206,6vxx,DB07227,-7.5,4-[(5-{[4-(3-CHLOROPHENYL)-3-OXOPIPERAZIN-1-YL]METHYL}-1H-IMIDAZOL-1-YL)METHYL]BENZONITRILE,JNUGFGAVPBYSHF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111946,6vxx,DB04910,-7.5,Oxibendazole,RAOCRURYZCVHMG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
117652,6w4b,DB03777,-7.5,Rbt205 Inhibitor,QMGUOJYZJKLOLH-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
9399,6lzg,DB07496,-7.5,"1,3-DIPHENYLUREA",GWEHVDNNLFDJLR-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
83870,6m3m,DB04467,-7.5,N-(5'-phosphopyridoxyl)-L-alanine,WACJCHFWJNNBPR-ZETCQYMHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
53241,2fxp,DB12690,-7.5,LY-2584702,FYXRSVDHGLUMHB-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
28081,6cs2,DB07654,-7.5,"(5,6-DIPHENYL-FURO[2,3-D]PYRIMIDIN-4-YLAMINO)-ACETIC",VDJWWYRYKMXMKA-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
128959,6w4h,DB08212,-7.5,1-[2-(3-ACETYL-2-HYDROXY-6-METHOXY-PHENYL)-CYCLOPROPYL]-3-(5-CYANO-PYRIDIN-2-YL)-THIOUREA,FSRLCMRWYUJTNT-UONOGXRCSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
111841,6vxx,DB04770,-7.5,"O6-(R)-ROSCOVITINE, R-2-(6-BENZYLOXY-9-ISOPROPYL-9H-PURIN-2-YLAMINO)-BUTAN-1-OL",HGADNQLEUZSUEJ-OAHLLOKOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
128954,6w4h,DB08204,-7.5,3-DIPHENOL-6-NITRO-3H-BENZO[DE]ISOCHROMEN-1-ONE,FLWABCQDXUKNQY-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
108216,6vxx,DB07239,-7.5,7-(aminomethyl)-6-(2-chlorophenyl)-1-methyl-1H-benzimidazole-5-carbonitrile,YJLVMTVZVJSNHG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
117751,6w4b,DB03903,-7.5,Tmr,KGFLZYXDJDOIEE-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
122038,6w4b,DB12781,-7.5,Balaglitazone,IETKPTYAGKZLKY-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
111836,6vxx,DB04763,-7.5,"1-N-(4-SULFAMOYLPHENYL-ETHYL)-2,4,6-TRIMETHYLPYRIDINIUM",UXBCHTZINZNVRG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
128933,6w4h,DB08177,-7.5,(E)-3-(5((5-(4-CHLOROPHENYL)FURAN-2-YL)METHYLENE)-4-OXO-2-THIOXOTHIAZOLIDIN-3-YL)PROPANOIC ACID,YZLFZFALAZYTCI-NTEUORMPSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
72102,6m2n,DB00341,-7.5,Cetirizine,ZKLPARSLTMPFCP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
128986,6w4h,DB08246,-7.5,"(2S)-4-(2,5-DIFLUOROPHENYL)-N,N-DIMETHYL-2-PHENYL-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDE",WFFMEXQHWXEKBV-SFHVURJKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
129032,6w4h,DB08307,-7.5,"2-{HYDROXY[2-NITRO-4-(TRIFLUOROMETHYL)PHENYL]METHYLENE}CYCLOHEXANE-1,3-DIONE",PMHVFNYNPNKNRO-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
76855,6m2n,DB07695,-7.5,"N-(3,5-dibromo-4-hydroxyphenyl)-4-hydroxy-3,5-dimethylbenzamide",HHFKUQZPNITQLU-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
74990,6m2n,DB04102,-7.5,2-Amino-Adenosine,CQKMBZHLOYVGHW-QYYRPYCUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
81031,6m3m,DB00724,-7.5,Imiquimod,DOUYETYNHWVLEO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
161252,7bv1,DB13457,-7.5,Oxaflozane,FVYUQFQCEOZYHZ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
122151,6w4b,DB12960,-7.5,INCB-9471,ZMCJFJZOSKEMOM-DNKZPPIMSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
117256,6w4b,DB03234,-7.5,"(4'-{[Allyl(Methyl)Amino]Methyl}-1,1'-Biphenyl-4-Yl)(4-Bromophenyl)Methanone",YATCZCSDJCQNAL-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
112018,6vxx,DB06061,-7.5,AZD-8330,RWEVIPRMPFNTLO-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
83978,6m3m,DB04604,-7.5,5-iodotubercidin,WHSIXKUPQCKWBY-IOSLPCCCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
112017,6vxx,DB06040,-7.5,Filanesib,LLXISKGBWFTGEI-FQEVSTJZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
18867,6cs2,HMDB0000717,-7.5,Isolithocholic acid,SMEROWZSTRWXGI-WFVDQZAMSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
9330,6lzg,DB07422,-7.5,(2S)-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]-3-(pentafluorophenoxy)propanamide,MMNRWNREMUMYQG-INIZCTEOSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
83977,6m3m,DB04603,-7.5,2'-DEOXY-5-FORMYLCYTIDINE-5'-MONOPHOSPHATE,HDFNXAHZEYLDBJ-XLPZGREQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81041,6m3m,DB00738,-7.5,Pentamidine,XDRYMKDFEDOLFX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
129092,6w4h,DB08383,-7.5,"4,5-bis(4-methoxyphenyl)-2-thiophen-2-yl-1H-imidazole",XBMULXNXJLWLLD-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
11959,6lzg,DB12672,-7.5,Icaritin,TUUXBSASAQJECY-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
165867,7bv1,DB13132,-7.5,Artemisinin,BLUAFEHZUWYNDE-NNWCWBAJSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
163745,7bv1,DB06195,-7.5,Seliciclib,BTIHMVBBUGXLCJ-OAHLLOKOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
106725,6vxx,DB00939,-7.5,Meclofenamic acid,SBDNJUWAMKYJOX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
33792,6cs2,T3D0470,-7.5,"3,4,4',5-Tetrachlorobiphenyl",BHWVLZJTVIYLIV-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
104695,6vxs,DB12375,-7.5,Oglemilast,OKFDRAHPFKMAJH-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
117360,6w4b,DB03367,-7.5,PF-00356231,VMTJQZUZINLEKC-JOCHJYFZSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
117361,6w4b,DB03368,-7.5,"5-Methyl-5-(4-Phenoxy-Phenyl)-Pyrimidine-2,4,6-Trione",RTBMLCLTYAPKIF-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
104696,6vxs,DB12376,-7.5,Ricolinostat,QGZYDVAGYRLSKP-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
165864,7bv1,DB13125,-7.5,Lusutrombopag,NOZIJMHMKORZBA-KJCUYJGMSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
111974,6vxx,DB05013,-7.5,Ingenol mebutate,VDJHFHXMUKFKET-UXMMOKKRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104700,6vxs,DB12380,-7.5,GDC-0152,WZRFLSDVFPIXOV-LRQRDZAKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
17917,6cs2,HMDB0000550,-7.5,5-Androstenetriol,GUGSXATYPSGVAY-DHKQUUGRSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
26731,6cs2,DB04953,-7.5,Ezogabine,PCOBBVZJEWWZFR-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
11292,6lzg,DB11770,-7.5,Talinolol,MXFWWQICDIZSOA-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
33781,6cs2,T3D0459,-7.5,"2,3',4',5-Tetrachlorobiphenyl",KENZYIHFBRWMOD-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
31792,6cs2,DB14761,-7.5,Remdesivir,RWWYLEGWBNMMLJ-YSOARWBDSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
31774,6cs2,DB14720,-7.5,Brovanexine,DQTRREPKGJIABH-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
55416,6crv,DB00980,-7.5,Ramelteon,YLXDSYKOBKBWJQ-LBPRGKRZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
117832,6w4b,DB04014,-7.5,Alsterpaullone,OLUKILHGKRVDCT-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
117837,6w4b,DB04020,-7.5,"4-(2-{[4-{[3-(4-Chlorophenyl)Propyl]Sulfanyl}-6-(1-Piperazinyl)-1,3,5-Triazin-2-Yl]Amino}Ethyl)Phenol",AIBKIFHSQQYXLG-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
11923,6lzg,DB12622,-7.5,Lupeol,MQYXUWHLBZFQQO-QGTGJCAVSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
27530,6cs2,DB07078,-7.5,"(3Z)-6-(4-HYDROXY-3-METHOXYPHENYL)-3-(1H-PYRROL-2-YLMETHYLENE)-1,3-DIHYDRO-2H-INDOL-2-ONE",AYSXURJZVXBSRV-WJDWOHSUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
128827,6w4h,DB08061,-7.5,4-[3-(4-CHLOROPHENYL)-1H-PYRAZOL-5-YL]PIPERIDINE,GELALLNTKKLQLM-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
6455,6lzg,DB02132,-7.5,Zenarestat,SXONDGSPUVNZLO-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
79527,6m2n,DB13395,-7.5,Eprozinol,QSRHLIUOSXVKTG-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
81152,6m3m,DB00869,-7.5,Dorzolamide,IAVUPMFITXYVAF-XPUUQOCRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83722,6m3m,DB04260,-7.5,"9-(5,5-Difluoro-5-Phosphonopentyl)Guanine",JANQQPWTLXUSCD-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
32542,6cs2,T3D1941,-7.5,"3,5-Dibromobiphenyl",HIHYAKDOWUFGBK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
53330,2fxp,DB12836,-7.5,Grapiprant,HZVLFTCYCLXTGV-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
74919,6m2n,DB04005,-7.5,Uridine 5'-triphosphate,PGAVKCOVUIYSFO-XVFCMESISA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
124661,6w4h,DB01480,-7.5,Cyprenorphine,VSKIOMHXEUHYSI-KNLIIKEYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
73229,6m2n,DB01752,-7.5,S-adenosyl-L-homocysteine,ZJUKTBDSGOFHSH-WFMPWKQPSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77010,6m2n,DB07870,-7.5,(2S)-2-(4-{[3-CHLORO-5-(TRIFLUOROMETHYL)PYRIDIN-2-YL]OXY}PHENOXY)PROPANOIC ACID,GOCUAJYOYBLQRH-MRVPVSSYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
121988,6w4b,DB12705,-7.5,Cenerimod,KJKKMMMRWISKRF-FQEVSTJZSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
31755,6cs2,DB14674,-7.5,Estramustine phosphate,ADFOJJHRTBFFOF-RBRWEJTLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
77021,6m2n,DB07883,-7.5,(2-AMINO-3-PHENYL-BICYCLO[2.2.1]HEPT-2-YL)-PHENYL-METHANONE,XJQDTOANLAPEIM-JRBPQWBISA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
111655,6vxx,DB04335,-7.5,Inosine,UGQMRVRMYYASKQ-KQYNXXCUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31754,6cs2,DB14673,-7.5,Flurandrenolide acetate,AUDPKCCPWYXNEV-XTLNBZDDSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
6473,6lzg,DB02177,-7.5,1-Acetyl-4-(4-{4-[(2-Ethoxyphenyl)Thio]-3-Nitrophenyl}Pyridin-2-Yl)Piperazine,GKGJFUXSTSUKPB-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
81182,6m3m,DB00903,-7.5,Etacrynic acid,AVOLMBLBETYQHX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
26806,6cs2,DB05327,-7.5,Ranirestat,QCVNMNYRNIMDKV-QGZVFWFLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
118134,6w4b,DB04424,-7.5,RPR128515,XFKVLKLCLYJKNF-MZNJEOGPSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
72145,6m2n,DB00393,-7.5,Nimodipine,UIAGMCDKSXEBJQ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
118139,6w4b,DB04432,-7.5,ZK-805623,ZXIHYCYAQUQHSG-UHFFFAOYSA-O,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
118141,6w4b,DB04434,-7.5,Naphthyridine Inhibitor,YRBHUKMLAGQYHS-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
124678,6w4h,DB01500,-7.5,Oxabolone,GXHBCWCMYVTJOW-YGRHGMIBSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
30693,6cs2,DB12853,-7.5,DA-6886,AULLTYAISZREAX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
53361,2fxp,DB12886,-7.5,GSK-1521498,WIEDUMBCZQRGSY-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
26804,6cs2,DB05298,-7.5,Tetomilast,XDBHURGONHZNJF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
108223,6vxx,DB07248,-7.5,"7-PYRIDIN-2-YL-N-(3,4,5-TRIMETHOXYPHENYL)-7H-PYRROLO[2,3-D]PYRIMIDIN-2-AMINE",YENZSPIOXMNEFF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79531,6m2n,DB13399,-7.5,Terguride,JOAHPSVPXZTVEP-YXJHDRRASA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
28442,6cs2,DB08029,-7.5,N-2-(biphenyl-4-ylsulfonyl)-N-hydroxy-N-2-(2-hydroxyethyl)glycinamide,QQDWEVONJRXVDB-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
30647,6cs2,DB12779,-7.5,Higenamine,WZRCQWQRFZITDX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
128911,6w4h,DB08154,-7.5,3-chloro-5-[2-chloro-5-(1H-indazol-3-ylmethoxy)phenoxy]benzonitrile,WHCLIFOVZDANCU-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
111820,6vxx,DB04741,-7.5,Myxothiazol,XKTFQMCPGMTBMD-FYHMSGCOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165783,7bv1,DB13008,-7.5,"2,2-bis(4-hydroxy-3-tert-butylphenyl)propane",ZDRSNHRWLQQICP-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
111797,6vxx,DB04707,-7.5,Hydroxyfasudil,ZAVGJDAFCZAWSZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
128906,6w4h,DB08149,-7.5,"1-[4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine",KCWPSUKJCKZEAO-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
117894,6w4b,DB04098,-7.5,Balanol,XYUFCXJZFZPEJD-PGRDOPGGSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
111789,6vxx,DB04520,-7.5,"(3s,8ar)-3-(4-Hydroxybenzyl)Hexahydropyrrolo[1,2-a]Pyrazine-1,4-Dione",LSGOTAXPWMCUCK-RYUDHWBXSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
161358,7bv1,DB13867,-7.5,Fluticasone,MGNNYOODZCAHBA-GQKYHHCASA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
79557,6m2n,DB13433,-7.5,Simfibrate,JLRNKCZRCMIVKA-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
122024,6w4b,DB12756,-7.5,TAK-901,WKDACQVEJIVHMZ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
22098,6cs2,HMDB0001438,-7.5,25-Hydroxyvitamin D2,KJKIIUAXZGLUND-BJWBXCNSSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
117919,6w4b,DB04131,-7.5,"10-(4-Dimethylamino-5-Hydroxy-6-Methyl-Tetrahydro-Pyran-2-Yloxy)-8-Ethyl-1,8,11-Trihydroxy-7,8,9,10-Tetrahydro-Naphthacene-5,12-Dione",BLGDWFJQIHBUJY-NWJGULHDSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
165776,7bv1,DB12998,-7.5,PF-00217830,QGNOXTFZOLDODX-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
163675,7bv1,DB05830,-7.5,Trestolone,YSGQGNQWBLYHPE-CFUSNLFHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
74944,6m2n,DB04042,-7.5,"2-[4-(Hydroxy-Methoxy-Methyl)-Benzyl]-7-(4-Hydroxymethyl-Benzyl)-1,1-Dioxo-3,6-Bis-Phenoxymethyl-1lambda6-[1,2,7]Thiadiazepane-4,5-Diol",XLJNZONSWKENRP-VABIIVNOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
124635,6w4h,DB01452,-7.5,Diamorphine,GVGLGOZIDCSQPN-PVHGPHFFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
55546,6crv,DB01129,-7.5,Rabeprazole,YREYEVIYCVEVJK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
83736,6m3m,DB04278,-7.5,2-[2-(2-Cyclohexyl-2-Guanidino-Acetylamino)-Acetylamino]-N-(3-Mercapto-Propyl)-Propionamide,YLLNYDDZOMCFDE-SMDDNHRTSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
111748,6vxx,DB04468,-7.5,Afimoxifene,TXUZVZSFRXZGTL-QPLCGJKRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
10795,6lzg,DB09078,-7.5,Lenvatinib,WOSKHXYHFSIKNG-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
111745,6vxx,DB04465,-7.5,Lactose,GUBGYTABKSRVRQ-QKKXKWKRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
122007,6w4b,DB12729,-7.5,ASP-3026,MGGBYMDAPCCKCT-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
76966,6m2n,DB07820,-7.5,"6-(3',5'-DIMETHYLBENZYL)-1-ETHOXYMETHYL-5-ISOPROPYLURACIL",NVGVZWUORYLPAL-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
164570,7bv1,DB08154,-7.5,3-chloro-5-[2-chloro-5-(1H-indazol-3-ylmethoxy)phenoxy]benzonitrile,WHCLIFOVZDANCU-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
111719,6vxx,DB04430,-7.5,3-(4-Phenylamino-Phenylamino)-2-(1h-Tetrazol-5-Yl)-Acrylonitrile,FLPLCJJGNZGOAW-QXMHVHEDSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
128853,6w4h,DB08093,-7.5,3-(1-NAPHTHYLMETHOXY)PYRIDIN-2-AMINE,SZANYTFSQVBOBA-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
58489,6crv,DB05519,-7.5,Budiodarone,ZXOSVKYCXLTVGS-KRWDZBQOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
161391,7bv1,DB13951,-7.5,Stanolone acetate,ILCTUFVQFCIIDS-NGFSFWIMSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
106662,6vxx,DB00869,-7.5,Dorzolamide,IAVUPMFITXYVAF-XPUUQOCRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
74023,6m2n,DB02805,-7.5,Uracil arabinose-3'-phosphate,FOGRQMPFHUHIGU-PXBUCIJWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
28179,6cs2,DB07760,-7.5,"3-[(1E,7E)-8-(2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)-3,6-dioxa-2,7-diazaocta-1,7-dien-1-yl]benzoic acid",TUYDQQMKXSQIQG-GONBZBRSSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
72248,6m2n,DB00521,-7.5,Carteolol,LWAFSWPYPHEXKX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
50193,2fxp,DB06677,-7.5,Clazosentan,LFWCJABOXHSRGC-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
79236,6m2n,DB12946,-7.5,"8-cyclopentyl-1,3-dipropylxanthine",FFBDFADSZUINTG-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
110322,6vxx,DB01463,-7.5,Fencamfamin,IKFBPFGUINLYQI-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
128080,6w4h,DB07192,-7.5,(3S)-N-(3-BROMOPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE,MVPIURCUINFSAB-LBPRGKRZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
83228,6m3m,DB03609,-7.5,3-Deoxyguanosine,OROIAVZITJBGSM-OBXARNEKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
50189,2fxp,DB06666,-7.5,Lixivaptan,PPHTXRNHTVLQED-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
29365,6cs2,DB09071,-7.5,Tasimelteon,PTOIAAWZLUQTIO-GXFFZTMASA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
110301,6vxx,DB01439,-7.5,3-Methylthiofentanyl,SRARDYUHGVMEQI-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
125167,6w4h,DB02132,-7.5,Zenarestat,SXONDGSPUVNZLO-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
73082,6m2n,DB01562,-7.5,1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine,BVURVTVDNWSNFN-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
105034,6vxs,DB12896,-7.5,PSI-352938,PVRFQJIRERYGTQ-DSQUMVBZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
77638,6m2n,DB08618,-7.5,3-(HYDROXY-PHENYL-PHOSPHINOYLOXY)-8-METHYL-8-AZA-BICYCLO[3.2.1]OCTANE-2-CARBOXYLIC ACID METHYL ESTER,WJTKWTJTOSZMKO-PMOUVXMZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
83216,6m3m,DB03592,-7.5,Pterin-6-Yl-Methyl-Monophosphate,AJXFJEHKGGCFNM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81426,6m3m,DB01182,-7.5,Propafenone,JWHAUXFOSRPERK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58142,6crv,DB04603,-7.5,2'-DEOXY-5-FORMYLCYTIDINE-5'-MONOPHOSPHATE,HDFNXAHZEYLDBJ-XLPZGREQSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
10688,6lzg,DB08942,-7.5,Isoxicam,YYUAYBYLJSNDCX-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
106476,6vxx,DB00391,-7.5,Sulpiride,BGRJTUBHPOOWDU-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
9814,6lzg,DB07944,-7.5,N-{3-METHYL-5-[2-(PYRIDIN-4-YLAMINO)-ETHOXY]-PHENYL}-BENZENESULFONAMIDE,MPTWCWHNLVMCRW-UHFFFAOYSA-O,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
119223,6w4b,DB07063,-7.5,"{3-[(4,5,7-TRIFLUORO-1,3-BENZOTHIAZOL-2-YL)METHYL]-1H-INDOL-1-YL}ACETIC ACID",KYHVTMFADJNSGS-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
81446,6m3m,DB01203,-7.5,Nadolol,VWPOSFSPZNDTMJ-UCWKZMIHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
161911,7bv1,DB00963,-7.5,Bromfenac,ZBPLOVFIXSTCRZ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
161914,7bv1,DB00967,-7.5,Desloratadine,JAUOIFJMECXRGI-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
74625,6m2n,DB03626,-7.5,"5-Methoxy-1,2-Dimethyl-3-(Phenoxymethyl)Indole-4,7-Dione",JRPJCFILHCLEJI-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
125203,6w4h,DB02187,-7.5,Equilin,WKRLQDKEXYKHJB-HFTRVMKXSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
125209,6w4h,DB02195,-7.5,"3-(4-Fluorophenyl)-1-Hydroxy-2-(Pyridin-4-Yl)-1h-Pyrrolo[3,2-B]Pyridine",ZSMYZLKEZDYVPI-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
165454,7bv1,DB12124,-7.5,Namitecan,IBTISPLPBBHVSU-UVOOVGFISA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
29360,6cs2,DB00839,-7.5,Tolazamide,OUDSBRTVNLOZBN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
28586,6cs2,DB08172,-7.5,(2Z)-N-(3-chloro-2'-methoxybiphenyl-4-yl)-2-cyano-3-hydroxybut-2-enamide,YUDQXOMZBLEWBH-KAMYIIQDSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
79226,6m2n,DB12931,-7.5,Fenobam,DWPQODZAOSWNHB-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
119240,6w4b,DB07084,-7.5,"N-(6,7,9,10,17,18,20,21-octahydrodibenzo[b,k][1,4,7,10,13,16]hexaoxacyclooctadecin-2-yl)acetamide",YHKGWOJTUMJPNW-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
161885,7bv1,DB00933,-7.5,Mesoridazine,SLVMESMUVMCQIY-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
81420,6m3m,DB01176,-7.5,Cyclizine,UVKZSORBKUEBAZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83268,6m3m,DB03668,-7.5,1-(5'-Phospho-Beta-D-Ribofuranosyl)Barbituric Acid,AODYJUNLDJOADV-YXZULKJRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
108396,6vxx,DB07712,-7.5,3-ETHYL-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL,XBMVVMYGKMGLJX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79257,6m2n,DB12979,-7.5,Nepicastat,YZZVIKDAOTXDEB-JTQLQIEISA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
58183,6crv,DB04655,-7.5,Metoprine,VQJHOPSWBGJHQS-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
119123,6w4b,DB06945,-7.5,N-hydroxy-4-({4-[4-(trifluoromethyl)phenoxy]phenyl}sulfonyl)tetrahydro-2H-pyran-4-carboxamide,FOSWRYKPHVPIDJ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
55334,6crv,DB00885,-7.5,Pemirolast,HIANJWSAHKJQTH-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110408,6vxx,DB01559,-7.5,Clotiazepam,CHBRHODLKOZEPZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
6669,6lzg,DB02491,-7.5,4-[4-(1-Amino-1-Methylethyl)Phenyl]-5-Chloro-N-[4-(2-Morpholin-4-Ylethyl)Phenyl]Pyrimidin-2-Amine,CJSSYVIHFXDFFC-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
121625,6w4b,DB12167,-7.5,LY-3023414,ACCFLVVUVBJNGT-AWEZNQCLSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
105004,6vxs,DB12853,-7.5,DA-6886,AULLTYAISZREAX-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
106506,6vxx,DB00426,-7.5,Famciclovir,GGXKWVWZWMLJEH-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110394,6vxx,DB01545,-7.5,Ethyl loflazepate,CUCHJCMWNFEYOM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
121624,6w4b,DB12165,-7.5,Presatovir,GOFXWTVKPWJNGD-UWJYYQICSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
79251,6m2n,DB12971,-7.5,Pactimibe,TXIIZHHIOHVWJD-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
119141,6w4b,DB06971,-7.5,"N-{2-[(4'-CYANO-1,1'-BIPHENYL-4-YL)OXY]ETHYL}-N'-HYDROXY-N-METHYLUREA",GVMUNGGWXRKCEU-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
73103,6m2n,DB01588,-7.5,Prazepam,MWQCHHACWWAQLJ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
27006,6cs2,DB06234,-7.5,Maribavir,KJFBVJALEQWJBS-XUXIUFHCSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
83232,6m3m,DB03618,-7.5,2-(Acetylamino)-2-Deoxy-4-O-Beta-D-Galactopyranosyl-Alpha-D-Glucopyranose,KFEUJDWYNGMDBV-RCBHQUQDSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
128108,6w4h,DB07227,-7.5,4-[(5-{[4-(3-CHLOROPHENYL)-3-OXOPIPERAZIN-1-YL]METHYL}-1H-IMIDAZOL-1-YL)METHYL]BENZONITRILE,JNUGFGAVPBYSHF-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
31645,6cs2,DB14196,-7.5,"N-Cyclohexyl-N'-phenyl-1,4-phenylenediamine",ZRMMVODKVLXCBB-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
11373,6lzg,DB11877,-7.5,Basmisanil,VCGRFBXVSFAGGA-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
83231,6m3m,DB03615,-7.5,Ribostamycin,NSKGQURZWSPSBC-VVPCINPTSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
105013,6vxs,DB12868,-7.5,Intoplicine,QROONAIPJKQFMC-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
164688,7bv1,DB08488,-7.5,"4-{[(E)-2-(5-CHLOROTHIEN-2-YL)VINYL]SULFONYL}-1-(1H-PYRROLO[3,2-C]PYRIDIN-2-YLMETHYL)PIPERAZIN-2-ONE",PLWVUIRWJVKSSD-XBXARRHUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
119160,6w4b,DB06994,-7.5,"(2S,3S)-3-{3-[2-chloro-4-(methylsulfonyl)phenyl]-1,2,4-oxadiazol-5-yl}-1-cyclopentylidene-4-cyclopropyl-1-fluorobutan-2-amine",XCCSSVMRGIQMGF-LPHOPBHVSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
110368,6vxx,DB01518,-7.5,Benzethidine,UVTBZAWTRVBTMK-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110366,6vxx,DB01515,-7.5,Benzoylecgonine,GVGYEFKIHJTNQZ-RFQIPJPRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72357,6m2n,DB00654,-7.5,Latanoprost,GGXICVAJURFBLW-CEYXHVGTSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
125119,6w4h,DB02075,-7.5,"(1s)-1(9-Deazahypoxanthin-9yl)1,4-Dideoxy-1,4-Imino-D-Ribitol-5-Phosphate",VJTAXXUIRYOXBT-KUBHLMPHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
27037,6cs2,DB06292,-7.5,Dapagliflozin,JVHXJTBJCFBINQ-ADAARDCZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
28764,6cs2,DB08378,-7.5,"4-[4-(2,5-DIOXO-PYRROLIDIN-1-YL)-PHENYLAMINO]-4-HYDROXY-BUTYRIC ACID",SUETUOGYOWOLNJ-NSHDSACASA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
58120,6crv,DB04574,-7.5,Estrone sulfate,JKKFKPJIXZFSSB-CBZIJGRNSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
83150,6m3m,DB03493,-7.5,7-Methylguanosine,OGHAROSJZRTIOK-KQYNXXCUSA-O,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
127952,6w4h,DB07046,-7.5,"2-[(2-chloro-4-iodophenyl)amino]-N-{[(2R)-2,3-dihydroxypropyl]oxy}-3,4-difluorobenzamide",FCADPEDUULETPK-SECBINFHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
6736,6lzg,DB02611,-7.5,Balanol Analog 1,FZJQHARRQUNVGZ-QZTJIDSGSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
127949,6w4h,DB07042,-7.5,"7-amino-2-tert-butyl-4-{[2-(1H-imidazol-4-yl)ethyl]amino}pyrido[2,3-d]pyrimidine-6-carboxamide",XESUNWBIAADLPI-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
161968,7bv1,DB01030,-7.5,Topotecan,UCFGDBYHRUNTLO-QHCPKHFHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
9856,6lzg,DB07988,-7.5,"2-[3-(5-MERCAPTO-[1,3,4]THIADIAZOL-2YL)-UREIDO]-N-METHYL-3-PENTAFLUOROPHENYL-PROPIONAMIDE",HZAXNPDJVFUGDS-BYPYZUCNSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
121554,6w4b,DB12064,-7.5,BMS-777607,VNBRGSXVFBYQNN-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
125300,6w4h,DB02316,-7.5,"1-(5-Carboxypentyl)-5-[(2,6-Dichlorobenzyl)Oxy]-1 H-Indole-2-Carboxylic Acid",JTGPYFFQVOIJKR-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
110173,6vxx,DB01060,-7.5,Amoxicillin,LSQZJLSUYDQPKJ-NJBDSQKTSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
32714,6cs2,T3D3623,-7.5,Sodium cocoyl sarcosinate,KHCOJQDJOCNUGV-UHFFFAOYSA-M,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
33379,6cs2,T3D4570,-7.5,Fludiazepam,ROYOYTLGDLIGBX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
105127,6vxs,DB13039,-7.5,Aminaphthone,YLMPBJUYFTWHKJ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
6742,6lzg,DB02621,-7.5,Latrunculin A,DDVBPZROPPMBLW-IZGXTMSKSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
163348,7bv1,DB04293,-7.5,7-(2-Amino-2-Phenyl-Acetylamino)-3-Chloro-8-Oxo-1-Aza-Bicyclo[4.2.0]Oct-2-Ene-2-Carboxylic Acid,JAPHQRWPEGVNBT-IJLUTSLNSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
28246,6cs2,DB07826,-7.5,2-[4-chloro-2-(phenylcarbonyl)phenoxy]-N-phenylacetamide,DTGVSZSMDOMAEB-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
33377,6cs2,T3D4568,-7.5,Ethyl loflazepate,CUCHJCMWNFEYOM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
9862,6lzg,DB07993,-7.5,"N-3-[3-(1H-INDOL-6-YL)BENZYL]PYRIDINE-2,3-DIAMINE",LPQUIIHPUGDHJK-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
28253,6cs2,DB00718,-7.5,Adefovir dipivoxil,WOZSCQDILHKSGG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
28257,6cs2,DB07838,-7.5,(Z)-3-BENZYL-5-(2-HYDROXY-3-NITROBENZYLIDENE)-2-THIOXOTHIAZOLIDIN-4-ONE,ZTWBCEZQPRYIGY-ZROIWOOFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
110140,6vxx,DB01022,-7.5,Phylloquinone,MBWXNTAXLNYFJB-NKFFZRIASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110126,6vxx,DB01006,-7.5,Letrozole,HPJKCIUCZWXJDR-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
105149,6vxs,DB13070,-7.5,Surinabant,HMXDWDSNPRNUKI-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
125322,6w4h,DB02342,-7.5,2-Methox1tradiol,CQOQDQWUFQDJMK-SSTWWWIQSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
27060,6cs2,DB06362,-7.5,Becatecarin,JSKFWUPVIZYJMR-UDOAKELVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
127907,6w4h,DB06996,-7.5,D-leucyl-N-(4-carbamimidoylbenzyl)-L-prolinamide,XFNMDMGNNKIXBT-CVEARBPZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
31619,6cs2,DB14129,-7.5,Macelignan,QDDILOVMGWUNGD-UONOGXRCSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
31616,6cs2,DB14127,-7.5,Sacubitrilat,DOBNVUFHFMVMDB-BEFAXECRSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
163322,7bv1,DB04259,-7.5,7n-Methyl-8-Hydroguanosine-5'-Monophosphate,ZMWJGXGSWZFZPJ-KQYNXXCUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
127927,6w4h,DB07019,-7.5,"N-[(5R,14R)-5-AMINO-5,14-DIMETHYL-4-OXO-3-OXA-18-AZATRICYCLO[15.3.1.1-7,11-]DOCOSA-1(21),7(22),8,10,17,19-HEXAEN-19-YL]-N-METHYLMETHANESULFONAMIDE",QWDOKZPZLWNULU-MZNJEOGPSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
74017,6m2n,DB02798,-7.5,Alpha-Methylene Adenosine Monophosphate,PXSSQXBLDTZHLF-IOSLPCCCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
121560,6w4b,DB12073,-7.5,Albaconazole,UHIXWHUVLCAJQL-MPBGBICISA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
105085,6vxs,DB12972,-7.5,Sepranolone,AURFZBICLPNKBZ-FZCSVUEKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
58117,6crv,DB04571,-7.5,Trioxsalen,FMHHVULEAZTJMA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163381,7bv1,DB04338,-7.5,SB220025,VSPFURGQAYMVAN-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
83187,6m3m,DB03550,-7.5,Isopenicillin N,MIFYHUACUWQUKT-GTQWGBSQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
110263,6vxx,DB01163,-7.5,Amdinocillin,BWWVAEOLVKTZFQ-NTZNESFSSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
128012,6w4h,DB07116,-7.5,1-(2-DEOXY-5-O-PHOSPHONO-BETA-D-ERYTHRO-PENTOFURANOSYL)-4-METHYL-1H-INDOLE,UXXYPWCUINVUHL-BFHYXJOUSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
110256,6vxx,DB01155,-7.5,Gemifloxacin,ZRCVYEYHRGVLOC-HYARGMPZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110247,6vxx,DB01145,-7.5,Sulfoxone,NEDPPCHNEOMTJV-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165449,7bv1,DB12117,-7.5,Mitometh,MOTIYCLHZZLHHQ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
58111,6crv,DB04563,-7.5,CRA_9678,VIZNZQTZRMTYPZ-UHFFFAOYSA-M,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165447,7bv1,DB12115,-7.5,AZD-9164,FNYFFCOCVNTJCD-NNMXADRKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
31633,6cs2,DB14176,-7.5,Benzylparaben,MOZDKDIOPSPTBH-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
108430,6vxx,DB07983,-7.5,1-(4-IODOBENZOYL)-5-METHOXY-2-METHYL INDOLE-3-ACETIC ACID,CXBFZYKAVCAPSV-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
125248,6w4h,DB02247,-7.5,Hydrolyzed Cephalothin,JRYZEMHNDUZNMI-RYUDHWBXSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
9836,6lzg,DB07968,-7.5,N-(2-CHLORO-4-FLUOROBENZOYL)-N'-(5-HYDROXY-2-METHOXYPHENYL)UREA,RFOBTYLRURSVJE-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
121589,6w4b,DB12115,-7.5,AZD-9164,FNYFFCOCVNTJCD-NNMXADRKSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
119275,6w4b,DB07124,-7.5,"(2S)-1-(6H-INDOL-3-YL)-3-{[5-(7H-PYRAZOLO[3,4-C]PYRIDIN-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE",CCIACUJJBPSOHE-KRWDZBQOSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
119277,6w4b,DB07126,-7.5,O6-CYCLOHEXYLMETHOXY-2-(4'-SULPHAMOYLANILINO) PURINE,OWXORKPNCHJYOF-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
110227,6vxx,DB01123,-7.5,Proflavine,WDVSHHCDHLJJJR-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
121574,6w4b,DB12096,-7.5,PF-05175157,BDXXSFOJPYSYOC-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
110213,6vxx,DB01104,-7.5,Sertraline,VGKDLMBJGBXTGI-SJCJKPOMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72390,6m2n,DB00692,-7.5,Phentolamine,MRBDMNSDAVCSSF-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
110210,6vxx,DB01101,-7.5,Capecitabine,GAGWJHPBXLXJQN-UORFTKCHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110206,6vxx,DB01097,-7.5,Leflunomide,VHOGYURTWQBHIL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
21614,6cs2,HMDB0051084,-7.5,"TG(20:3(5Z,8Z,11Z)/20:1(11Z)/o-18:0)",GCRBDMOHZRWTQB-DLQGIDGISA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
125273,6w4h,DB02276,-7.5,(S)-2-(Phosphonoxy)Caproyl-L-Leucyl-P-Nitroanilide,HARXAJAHMRMERT-HOTGVXAUSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
127984,6w4h,DB07083,-7.5,beta-phenyl-D-phenylalanyl-N-propyl-L-prolinamide,HZKKJPDVZGOOPU-PZJWPPBQSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
105077,6vxs,DB12960,-7.5,INCB-9471,ZMCJFJZOSKEMOM-DNKZPPIMSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
110192,6vxx,DB01082,-7.5,Streptomycin,UCSJYZPVAKXKNQ-HZYVHMACSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27043,6cs2,DB00589,-7.5,Lisuride,BKRGVLQUQGGVSM-KBXCAEBGSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
128147,6w4h,DB07272,-7.5,"N-(4-AMINO-5-CYANO-6-ETHOXYPYRIDIN-2-YL)-2-(4-BROMO-2,5-DIMETHOXYPHENYL)ACETAMIDE",GKODDLYLEKSDJL-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
28223,6cs2,DB07804,-7.5,"5-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1H-1,2,4-TRIAZOLE-3-SULFONAMIDE",FKCQUVAGEOSYRU-QWRGUYRKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
106510,6vxx,DB00432,-7.5,Trifluridine,VSQQQLOSPVPRAZ-RRKCRQDMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
83270,6m3m,DB03670,-7.5,"2-(Oxalyl-Amino)-4,5,6,7-Tetrahydro-Thieno[2,3-C]Pyridine-3-Carboxylic Acid",ZIBMATWHOAGNTR-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
165615,7bv1,DB12543,-7.5,Samidorphan,RYIDHLJADOKWFM-MAODMQOUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110819,6vxx,DB02450,-7.5,"2-Benzo[1,3]Dioxol-5-Ylmethyl-3-Benzyl-Succinic Acid",ASEJDWRSZYAIOT-GJZGRUSLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163497,7bv1,DB04704,-7.5,20-hydroxycholesterol,MCKLJFJEQRYRQT-MGNSQDQZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
77362,6m2n,DB08287,-7.5,"(1R,2R)-N-(2-Aminoethyl)-2-{[(4-methoxyphenyl)sulfonyl]methyl}cyclohexanecarboxamide",QTGNVZPFJQOWFL-XJKSGUPXSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
49013,2fxp,DB03907,-7.5,"N-{3-[5-(6-Amino-Purin-9-Yl)-3,4-Dihydroxy-Tetrahydro-Furan-2-Yl]-Allyl}-2,3-Dihydroxy-5-Nitro-Benzamide",UHHBFOLQOQSPLU-WGRQDFERSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
83436,6m3m,DB03881,-7.5,"(2S,3R,4S,5S)-3,4-Dihydroxy-2-[(methylsulfanyl)methyl]-5-(4-oxo-4,5-dihydro-1H-pyrrolo[3,2-d]pyrimidin-7-yl)pyrrolidinium",CEGIKIXYDFDYDN-RXDXJJGDSA-O,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
110787,6vxx,DB02410,-7.5,"2-Acetyl-3-[(4-Amino-2-Methyl-5-Pyrimidinyl)Methyl]-4-Methyl-5-(4,6,6-Trihydroxy-3,5-Dioxa-4,6-Diphosphahex-1-Yl)Thiazolium Inner Salt P,P'-Dioxide",GYRGKLZCJRVYRV-UHFFFAOYSA-O,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163479,7bv1,DB04678,-7.5,H TYPE II TRISACCHARIDE,PHTAQVMXYWFMHF-QVPNGJTFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
50366,2fxp,DB06925,-7.5,3-(2-AMINOQUINAZOLIN-6-YL)-4-METHYL-N-[3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE,YEIASMOUYNOXGA-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
128343,6w4h,DB07498,-7.5,"4-[3-(3-NITROPHENYL)-1,2,4-OXADIAZOL-5-YL]BUTANOIC ACID",LQQYZJRCWBRIMW-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
106529,6vxx,DB00452,-7.5,Framycetin,PGBHMTALBVVCIT-VCIWKGPPSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
124968,6w4h,DB01865,-7.5,3-(6-Aminopyridin-3-Yl)-N-Methyl-N-[(1-Methyl-1h-Indol-2-Yl)Methyl]Acrylamide,AKFPMLBVLWZSQX-CSKARUKUSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
30848,6cs2,DB13062,-7.5,ME-344,QVCAATSEPLQVBX-FPOVZHCZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
33540,6cs2,T3D4790,-7.5,Estriol,PROQIPRRNZUXQM-ZXXIGWHRSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
104905,6vxs,DB12687,-7.5,Vesatolimod,VFOKSTCIRGDTBR-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
118851,6w4b,DB06472,-7.5,Fradafiban,IKZACQMAVUIGPY-HOTGVXAUSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
104916,6vxs,DB12707,-7.5,AR-42,LAMIXXKAWNLXOC-INIZCTEOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
77394,6m2n,DB08322,-7.5,"2-DEOXY-3,4-BIS-O-[3-(4-HYDROXYPHENYL)PROPANOYL]-L-THREO-PENTARIC ACID",VJLMRHSHSNLOGC-NOPZTHQXSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
56871,6crv,DB02894,-7.5,"Sulfamic Acid 2,3-O-(1-Methylethylidene)-4,5-O-Sulfonyl-Beta-Fructopyranose Ester",GGOAQSGCBDRTHT-JAKMQLQISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
118868,6w4b,DB06521,-7.5,Ertiprotafib,FONCZICQWCUXEB-RUZDIDTESA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
30852,6cs2,DB13065,-7.5,LY-2811376,MJQMRGWYPNIERM-HNNXBMFYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
165586,7bv1,DB12499,-7.5,Clascoterone,GPNHMOZDMYNCPO-PDUMRIMRSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
106524,6vxx,DB00447,-7.5,Loracarbef,JAPHQRWPEGVNBT-UTUOFQBUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
53739,2fxp,DB13454,-7.5,Nicomorphine,HNDXBGYRMHRUFN-CIVUWBIHSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
79359,6m2n,DB13136,-7.5,Fluindione,NASXCEITKQITLD-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
110689,6vxx,DB02106,-7.5,"[3,5-Dibromo-4-(4-Hydroxy-3-Phenethylcarbamoyl-Phenoxy)-Phenyl]-Acetic Acid",KIRQJXNQGZAKGR-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
128318,6w4h,DB07468,-7.5,"(3aS)-3a-hydroxy-5-methyl-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one",NJBBBRZNBVLTRZ-GOSISDBHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
110680,6vxx,DB02097,-7.5,Cytidine,UHDGCWIWMRVCDJ-XVFCMESISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
83410,6m3m,DB03846,-7.5,5-Hydroxymethyluridine-2'-Deoxy-5'-Monophosphate,WEBVWKFGRVLCNS-XLPZGREQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83443,6m3m,DB03890,-7.5,N-[2-(1-Formyl-2-Methyl-Propyl)-1-(4-Piperidin-1-Yl-but-2-Enoyl)-Pyrrolidin-3-Yl]-Methanesulfonamide,BSBJWRKWANAVRQ-POTLKAILSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
118812,6w4b,DB06367,-7.5,Relacatib,BWYBBMQLUKXECQ-GIVPXCGWSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
104896,6vxs,DB12672,-7.5,Icaritin,TUUXBSASAQJECY-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
124858,6w4h,DB01720,-7.5,(2z)-2-(Benzoylamino)-3-[4-(2-Bromophenoxy)Phenyl]-2-Propenoic Acid,WLPJLQNKCJWAFL-RGEXLXHISA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
128426,6w4h,DB07596,-7.5,"(17beta)-17-(cyanomethyl)-2-methox1tra-1(10),2,4-trien-3-yl sulfamate",NTSPHKOMJMBWOU-NNKXXINSSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
56842,6crv,DB02855,-7.5,N-(3-Propylcarbamoyloxirane-2-Carbonyl)-Isoleucyl-Proline,UDNIFTKCMDIXFC-ABHRYQDASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
26932,6cs2,DB00579,-7.5,Mazindol,ZPXSCAKFGYXMGA-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
118705,6w4b,DB06090,-7.5,Bradanicline,OXKRFEWMSWPKKV-GHTZIAJQSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
111014,6vxx,DB02881,-7.5,4-(4-Hydroxy-3-Isopropylphenylthio)-2-Isopropylphenol,NEMLLZAROZVCCE-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
121773,6w4b,DB12379,-7.5,Indirubin,CRDNMYFJWFXOCH-BUHFOSPRSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
72251,6m2n,DB00524,-7.5,Metolazone,AQCHWTWZEMGIFD-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
161730,7bv1,DB00530,-7.5,Erlotinib,AAKJLRGGTJKAMG-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110996,6vxx,DB02855,-7.5,N-(3-Propylcarbamoyloxirane-2-Carbonyl)-Isoleucyl-Proline,UDNIFTKCMDIXFC-ABHRYQDASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77297,6m2n,DB08198,-7.5,"[(4R)-4-(3-HYDROXYPHENYL)-1,6-DIMETHYL-2-THIOXO-1,2,3,4-TETRAHYDROPYRIMIDIN-5-YL](PHENYL)METHANONE",JGBBILLMZPWNFU-QGZVFWFLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79408,6m2n,DB13237,-7.5,Clofoctol,HQVZOORKDNCGCK-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
33557,6cs2,T3D4807,-7.5,Oxybenzone,DXGLGDHPHMLXJC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
81307,6m3m,DB01046,-7.5,Lubiprostone,WGFOBBZOWHGYQH-MXHNKVEKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
128394,6w4h,DB07557,-7.5,"(5BETA)-PREGNANE-3,20-DIONE",XMRPGKVKISIQBV-XWOJZHJZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
79399,6m2n,DB13225,-7.5,Dibenzepin,QPGGEKPRGVJKQB-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
29417,6cs2,DB09170,-7.5,??-Hydroxythiofentanyl,GLAAETOTOUGGSB-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
29230,6cs2,DB08897,-7.5,Aclidinium,ASMXXROZKSBQIH-VITNCHFBSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
163531,7bv1,DB04753,-7.5,"9-DEAZAINOSINE-2',3'-O-ETHYLIDENEPHOSPHONATE",ZOEDLCUBOBTIHG-USQSKNHBSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
118784,6w4b,DB06276,-7.5,Tanomastat,JXAGDPXECXQWBC-LJQANCHMSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
128375,6w4h,DB07535,-7.5,2-amino-6-[2-(1H-indol-6-yl)ethyl]pyrimidin-4(3H)-one,VRAZIAJSKFRSIP-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
118790,6w4b,DB06295,-7.5,Pramiconazole,AEKNYBWUEYNWMJ-QWOOXDRHSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
9637,6lzg,DB07756,-7.5,"1-[3-({[(4-AMINO-5-FLUORO-2-METHYLQUINOLIN-3-YL)METHYL]THIO}METHYL)PHENYL]-2,2,2-TRIFLUOROETHANE-1,1-DIOL",GPBGHVRNVGXPNM-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
77333,6m2n,DB08245,-7.5,1-(2-DEOXY-5-O-PHOSPHONO-BETA-D-ERYTHRO-PENTOFURANOSYL)-5-NITRO-1H-INDOLE,FQCJFJRLZCIFHB-YNEHKIRRSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
72262,6m2n,DB00537,-7.5,Ciprofloxacin,MYSWGUAQZAJSOK-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
73159,6m2n,DB01658,-7.5,1'-Deazo-Thiamin Diphosphate,JHNXLHRDUXBCJW-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
72264,6m2n,DB00540,-7.5,Nortriptyline,PHVGLTMQBUFIQQ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
164640,7bv1,DB08240,-7.5,N-(4-CHLOROPHENYL)-3-(PHOSPHONOOXY)NAPHTHALENE-2-CARBOXAMIDE,RQAQWBFHPMSXKR-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110852,6vxx,DB02493,-7.5,Hydantocidin-5'-Phosphate,HVXIMXHBUJADCC-GTBMBKLPSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165575,7bv1,DB12478,-7.5,Piribedil,OQDPVLVUJFGPGQ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
111021,6vxx,DB02890,-7.5,6-Hydroxyuridine-5'-Phosphate,UDOBICLZEKUKCV-YXZULKJRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
83380,6m3m,DB03809,-7.5,9-Butyl-8-(3-Methoxybenzyl)-9h-Purin-6-Amine,BWLWUGBHOXIUBP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83379,6m3m,DB03808,-7.5,Hexamidine,OQLKNTOKMBVBKV-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
110576,6vxx,DB01958,-7.5,"5-[4-Tert-Butylphenylsulfanyl]-2,4-Quinazolinediamine",MNYDVPDMLAJJPB-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
7598,6lzg,DB04064,-7.5,Nogalaviketone,QHNJNOBWURJIEK-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
28214,6cs2,DB07795,-7.5,Fisetin,XHEFDIBZLJXQHF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
119015,6w4b,DB06817,-7.5,Raltegravir,CZFFBEXEKNGXKS-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
106516,6vxx,DB00439,-7.5,Cerivastatin,SEERZIQQUAZTOL-ANMDKAQQSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
6644,6lzg,DB02455,-7.5,Fluoresceinylthioureido,VHJFQSRUDVDTEO-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
9721,6lzg,DB07843,-7.5,5-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1-BENZOTHIOPHENE-2-SULFONAMIDE,LTJNKFUIOOJXNJ-WFASDCNBSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
56891,6crv,DB02919,-7.5,"2,4-Diamino-6-[N-(3',4',5'-Trimethoxybenzyl)-N-Methylamino]Pyrido[2,3-D]Pyrimidine",PUOZHLHNKHRTOW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79289,6m2n,DB13028,-7.5,Biapenem,MRMBZHPJVKCOMA-YJFSRANCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
128194,6w4h,DB07322,-7.5,"2-[(PHENYLSULFONYL)AMINO]-5,6,7,8-TETRAHYDRONAPHTHALENE-1-CARBOXYLIC ACID",RRXVUYHFDBLTEL-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
6648,6lzg,DB02463,-7.5,2-(2-Hydroxy-Phenyl)-1h-Indole-5-Carboxamidine,JPGNPKIYCTXJPG-UHFFFAOYSA-O,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
83307,6m3m,DB03721,-7.5,N-acetyl-alpha-neuraminic acid,SQVRNKJHWKZAKO-YRMXFSIDSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81369,6m3m,DB01118,-7.5,Amiodarone,IYIKLHRQXLHMJQ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
163454,7bv1,DB04643,-7.5,"4-{3-CHLORO-4-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-PHENOXY}-BUTYRIC ACID",FYQVFMLCZJZZEM-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
83302,6m3m,DB03716,-7.5,5'-Fluoro-5'-Deoxyadenosine,QPVLKMICBYRPSX-KQYNXXCUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
165532,7bv1,DB12239,-7.5,Balicatib,LLCRBOWRJOUJAE-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
128173,6w4h,DB07300,-7.5,"2-(1H-imidazol-1-yl)-9-methoxy-8-(2-methoxyethoxy)benzo[c][2,7]naphthyridin-4-amine",QSSGYSRUMIOURP-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
110485,6vxx,DB01651,-7.5,"Methyl 4,6-O-[(1R)-1-carboxyethylidene]-beta-D-galactopyranoside",ZDZVLEQWFATHTF-IJWOWSJNSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72336,6m2n,DB00625,-7.5,Efavirenz,XPOQHMRABVBWPR-ZDUSSCGKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
163452,7bv1,DB04641,-7.5,"3,7-DIHYDROXYNAPHTHALENE-2-CARBOXYLIC ACID",QMWOUSYSNFCKAZ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
26998,6cs2,DB06213,-7.5,Regadenoson,LZPZPHGJDAGEJZ-AKAIJSEGSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
128161,6w4h,DB07287,-7.5,"2-(2,4-DICHLOROPHENOXY)-5-(PYRIDIN-2-YLMETHYL)PHENOL",AOVDSWPGWPRTSR-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
128158,6w4h,DB07284,-7.5,"N-3-(3-PYRIDIN-3-YLBENZYL)PYRIDINE-2,3-DIAMINE",NQSBHBFOOVYRNM-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
81380,6m3m,DB01130,-7.5,Prednicarbate,FNPXMHRZILFCKX-KAJVQRHHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
119089,6w4b,DB06908,-7.5,"(2S)-3-(1-{[2-(2-CHLOROPHENYL)-5-METHYL-1,3-OXAZOL-4-YL]METHYL}-1H-INDOL-5-YL)-2-ETHOXYPROPANOIC ACID",PAWOPJKHTZCKMT-QFIPXVFZSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
77545,6m2n,DB08507,-7.5,N-[[2-METHYL-4-HYDROXYCARBAMOYL]BUT-4-YL-N]-BENZYL-P-[PHENYL]-P-[METHYL]PHOSPHINAMID,KGUVBHLPMGERAT-NIYFSFCBSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77557,6m2n,DB08522,-7.5,4-(4-FLUOROPHENYL)-1-CYCLOROPROPYLMETHYL-5-(4-PYRIDYL)-IMIDAZOLE,ROKOFZNQCIIJMI-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
128150,6w4h,DB07276,-7.5,"5-CYANO-N-(2,5-DIMETHOXYBENZYL)-6-ETHOXYPYRIDINE-2-CARBOXAMIDE",VEGKZYFYGCWXMN-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
119043,6w4b,DB06856,-7.5,6-FLUORO-2-[2-HYDROXY-3-(2-METHYL-CYCLOHEXYLOXY)-PHENYL]-1H-INDOLE-5-CARBOXAMIDINE,HUYQYLFFFNSAAX-BUXKBTBVSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
74691,6m2n,DB03716,-7.5,5'-Fluoro-5'-Deoxyadenosine,QPVLKMICBYRPSX-KQYNXXCUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
28758,6cs2,DB08369,-7.5,1-(biphenyl-4-ylmethyl)-1H-imidazole,DLYMRVCQTVOYEW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
161833,7bv1,DB00656,-7.5,Trazodone,PHLBKPHSAVXXEF-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
128305,6w4h,DB07452,-7.5,"2,6-diamino-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",WFECBOHPSURSGU-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
55372,6crv,DB00926,-7.5,Etretinate,HQMNCQVAMBCHCO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79350,6m2n,DB13118,-7.5,Paquinimod,DIKSYHCCYVYKRO-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
128304,6w4h,DB07451,-7.5,1-(5-BROMO-PYRIDIN-2-YL)-3-[2-(6-FLUORO-2-HYDROXY-3-PROPIONYL-PHENYL)-CYCLOPROPYL]-UREA,VRAJWAGCJIXJHQ-YPMHNXCESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
161786,7bv1,DB00596,-7.5,Ulobetasol,LEHFPXVYPMWYQD-XHIJKXOTSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
164660,7bv1,DB08267,-7.5,"6-amino-4-(2-phenylethyl)-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",PBZAIUVFRISTSZ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
128298,6w4h,DB07444,-7.5,"6-(3-AMINOPROPYL)-4,9-DIMETHYLPYRROLO[3,4-C]CARBAZOLE-1,3(2H,6H)-DIONE",PKPNSCZPIWCHMW-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
121707,6w4b,DB12285,-7.5,Verubecestat,YHYKUSGACIYRML-KRWDZBQOSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
161792,7bv1,DB00604,-7.5,Cisapride,DCSUBABJRXZOMT-IRLDBZIGSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
118931,6w4b,DB06670,-7.5,Odanacatib,FWIVDMJALNEADT-SFTDATJTSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
77453,6m2n,DB08397,-7.5,6-(DIFLUORO-PHOSPHONO-METHYL)-NAPHTHALENE-2-CARBOXYLIC ACID,NKGNOWNPXBURRW-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
11848,6lzg,DB12512,-7.5,Verucerfont,VKHVAUKFLBBZFJ-SFHVURJKSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
161805,7bv1,DB00620,-7.5,Triamcinolone,GFNANZIMVAIWHM-OBYCQNJPSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
128261,6w4h,DB07401,-7.5,METHYL (2Z)-2-(2-{[6-(2-CYANOPHENOXY)PYRIMIDIN-4-YL]OXY}PHENYL)-3-METHOXYACRYLATE,WFDXOXNFNRHQEC-GHRIWEEISA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
165555,7bv1,DB12448,-7.5,Lifibrol,LNXBEIZREVRNTF-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
128239,6w4h,DB07375,-7.5,"5-BETA-ANDROSTANE-3,17-DIONE",RAJWOBJTTGJROA-QJISAEMRSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
77487,6m2n,DB08440,-7.5,"N-1,10-phenanthrolin-5-ylacetamide",AAJXINSCZMZERD-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
128231,6w4h,DB07363,-7.5,"THIOPHENE-2,5-DISULFONIC ACID 2-AMIDE-5-(4-METHYL-BENZYLAMIDE)",GUNRMHMEAWSZQE-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
163455,7bv1,DB04644,-7.5,"4-{4-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-2,3-DIMETHYL-PHENOXY}-BUTYRIC ACID",FCEMCUPAYRPTLS-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
128227,6w4h,DB07358,-7.5,"2-amino-N-(4-methyl-1,3-thiazol-2-yl)-5-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]benzamide",JEBOJMQHVUEKBE-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
110635,6vxx,DB02038,-7.5,"D-[3-hydroxy-2-methyl-5-phosphonooxymethyl-pyridin-4-ylmethyl]-N,O-cycloserylamide",NNRZSZJOQKAGTO-SECBINFHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79320,6m2n,DB13077,-7.5,LCB01-0371,QLUWQAFDTNAYPN-LLVKDONJSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
128223,6w4h,DB07354,-7.5,"2,3-DIMETHOXY-12H-[1,3]DIOXOLO[5,6]INDENO[1,2-C]ISOQUINOLIN-6-IUM",LXDREMZQGAILJU-UHFFFAOYSA-O,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
110633,6vxx,DB02036,-7.5,"2-(3,4-Dihydro-3-Oxo-2h-Benzo[B][1,4]Thiazin-2-Yl)-N-Hydroxyacetamide",UKDWCJNGBPZOBU-MRVPVSSYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
118972,6w4b,DB06733,-7.5,Bafilomycin A1,XDHNQDDQEHDUTM-JQWOJBOSSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
110618,6vxx,DB02017,-7.5,Imidazole-Derived Cellobiose,CSXOUJBOYXGFCL-OFKZETBZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77505,6m2n,DB08461,-7.5,"3-[(4-AMINO-1-TERT-BUTYL-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL)METHYL]PHENOL",QMAIQPBRCNEJAT-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
121692,6w4b,DB12267,-7.5,Brigatinib,AILRADAXUVEEIR-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
79313,6m2n,DB13065,-7.5,LY-2811376,MJQMRGWYPNIERM-HNNXBMFYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
118922,6w4b,DB06645,-7.5,Anamorelin,VQPFSIRUEPQQPP-MXBOTTGLSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
165764,7bv1,DB12974,-7.5,Roniciclib,UELYDGOOJPRWGF-SRQXXRKNSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160301,7bv1,DB07985,-7.5,+/-METHYL 4-(AMINOIMINOMETHYL)-BETA-[3- INH (AMINOIMINO)PHENYL]BENZENE PENTANOATE,PVALLOSAENRPQO-INIZCTEOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
100692,6vxs,DB03925,-7.5,Freselestat,HMPQTEPEMQZWQH-QZTJIDSGSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
95684,6m71,DB11792,-7.5,Mirodenafil,MIJFNYMSCFYZNY-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
70533,6lxt,DB12804,-7.5,Daniquidone,SRIOCKJKFXAKHK-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
64005,6lxt,DB00952,-7.5,Naratriptan,AMKVXSZCKVJAGH-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
135344,6w9c,DB04336,-7.5,1-(4-Amidinophenyl)-3-(4-Chlorophenyl)Urea,HQWKMDKTTCPCMQ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
146377,6w9q,DB08459,-7.5,"3-chloro-5-[2-chloro-5-(1H-pyrazolo[3,4-b]pyridin-3-ylmethoxy)phenoxy]benzonitrile",SVMHTBVIPYVDIL-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
150541,6wiq,DB01536,-7.5,Androstenedione,AEMFNILZOJDQLW-QAGGRKNESA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
60753,6crv,DB09071,-7.5,Tasimelteon,PTOIAAWZLUQTIO-GXFFZTMASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
99039,6vxs,DB01720,-7.5,(2z)-2-(Benzoylamino)-3-[4-(2-Bromophenoxy)Phenyl]-2-Propenoic Acid,WLPJLQNKCJWAFL-RGEXLXHISA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
23279,6cs2,HMDB0059996,-7.5,Dihydronaringenin-O-sulphate,IKBKWHISHDVLNO-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
99048,6vxs,DB01734,-7.5,3-(Oxalyl-Amino)-Naphthalene-2-Carboxylic Acid,DQBLKSRRWDWNKQ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
69653,6lxt,DB11410,-7.5,Fenbendazole,HDDSHPAODJUKPD-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
86670,6m3m,DB09207,-7.5,AS-8112,DALSFUWTAOKVTF-GFCCVEGCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
94197,6m71,DB07831,-7.5,"2-{[(6-OXO-1,6-DIHYDROPYRIDIN-3-YL)METHYL]AMINO}-N-[4-PROPYL-3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE",SHSORWZDEKFFLP-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
138712,6w9c,DB12155,-7.5,Napabucasin,DPHUWDIXHNQOSY-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
148422,6w9q,DB13422,-7.5,Nicofuranose,FUWFSXZKBMCSKF-ZASNTINBSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
99056,6vxs,DB01745,-7.5,N-Alpha-(2-Naphthylsulfonyl)-N(3-Amidino-L-Phenylalaninyl)Isopipecolinic Acid Methyl Ester,JJLGQWCKMHPBEB-DEOSSOPVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
14069,6lzg,T3D3687,-7.5,Lysergic acid hydroxyethylamide,WYTJZJPVCDWOOI-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
135282,6w9c,DB04254,-7.5,"8-Benzo[1,3]Dioxol-,5-Ylmethyl-9-Butyl-2-Fluoro-9h-Purin-6-Ylamine",ARWHTQLGMWHTAZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
65208,6lxt,DB02527,-7.5,Cyclic adenosine monophosphate,IVOMOUWHDPKRLL-KQYNXXCUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
14771,6lzg,T3D4732,-7.5,Tacrolimus,QJJXYPPXXYFBGM-LJIGMGMYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
95701,6m71,DB11817,-7.5,Baricitinib,XUZMWHLSFXCVMG-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
135277,6w9c,DB04243,-7.5,5-Methyluridine 5'-Monophosphate,IGWHDMPTQKSDTL-JXOAFFINSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
149877,6wiq,DB00694,-7.5,Daunorubicin,STQGQHZAVUOBTE-VGBVRHCVSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
99030,6vxs,DB01708,-7.5,Prasterone,FMGSKLZLMKYGDP-USOAJAOKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
90843,6m71,DB02276,-7.5,(S)-2-(Phosphonoxy)Caproyl-L-Leucyl-P-Nitroanilide,HARXAJAHMRMERT-HOTGVXAUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60769,6crv,DB09091,-7.5,Tixocortol,YWDBSCORAARPPF-VWUMJDOOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
68210,6lxt,DB07651,-7.5,N-ACETYL-L-PHENYLALANYL-4-[DIFLUORO(PHOSPHONO)METHYL]-L-PHENYLALANINAMIDE,KPMMESISHWWXNM-ROUUACIJSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
95671,6m71,DB11774,-7.5,Pazufloxacin,XAGMUUZPGZWTRP-ZETCQYMHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
138622,6w9c,DB11935,-7.5,Flomoxef,UHRBTBZOWWGKMK-DOMZBBRYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
16334,6lzg,DB03777,-7.5,Rbt205 Inhibitor,QMGUOJYZJKLOLH-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
68230,6lxt,DB07678,-7.5,"(9ALPHA,13BETA,17BETA)-2-[(1Z)-BUT-1-EN-1-YL]ESTRA-1,3,5(10)-TRIENE-3,17-DIOL",ANAMDWGJXBYJEB-OPWFCKQNSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
95125,6m71,DB08968,-7.5,Fominoben,KSNNEUZOAFRTDS-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
135501,6w9c,DB04552,-7.5,Niflumic acid,JZFPYUNJRRFVQU-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
88178,6m3m,DB13445,-7.5,Nepinalone,RVXGRCNWGOHSDE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
23333,6cs2,HMDB0060060,-7.5,CE(17:1),RLMIGWIAENJHMP-VLNSMXAJSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
157007,6wiq,DB14068,-7.5,Dexniguldipine,SVJMLYUFVDMUHP-MGBGTMOVSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
15466,6lzg,T3D1033,-7.5,Cyphenothrin,FJDPATXIBIBRIM-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
155355,6wiq,DB08995,-7.5,Diosmin,GZSOSUNBTXMUFQ-YFAPSIMESA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
90917,6m71,DB02375,-7.5,Myricetin,IKMDFBPHZNJCSN-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
68216,6lxt,DB07662,-7.5,N-[4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL]-ACRYLAMIDE,HTUBKQUPEREOGA-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
60790,6crv,DB09144,-7.5,Uridine triacetate,AUFUWRKPQLGTGF-FMKGYKFTSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
101250,6vxs,DB04669,-7.5,TRIAZOLOPYRIMIDINE,YWBFPKPWMSWWEA-UHFFFAOYSA-O,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
99009,6vxs,DB01682,-7.5,6'-Methyl-Thiamin Diphosphate,XTYXJYCWAJSHCY-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
97691,6m71,DB15425,-7.5,CYC-065,DLPIYBKBHMZCJI-WBVHZDCISA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97690,6m71,DB15424,-7.5,Bfpet F-18,QWPLCHDPESWJRN-FNNGWQQSSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
158343,7bv1,DB00885,-7.5,Pemirolast,HIANJWSAHKJQTH-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
70523,6lxt,DB12787,-7.5,Norethandrolone,ZDHCJEIGTNNEMY-XGXHKTLJSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
135412,6w9c,DB04437,-7.5,"Cysteine-Methylene-Carbamoyl-1,10-Phenanthroline",ZFGIPRHDRFOMFO-LBPRGKRZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
142425,6w9q,DB02187,-7.5,Equilin,WKRLQDKEXYKHJB-HFTRVMKXSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
158352,7bv1,DB00897,-7.5,Triazolam,JOFWLTCLBGQGBO-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
135407,6w9c,DB04430,-7.5,3-(4-Phenylamino-Phenylamino)-2-(1h-Tetrazol-5-Yl)-Acrylonitrile,FLPLCJJGNZGOAW-QXMHVHEDSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
70518,6lxt,DB12779,-7.5,Higenamine,WZRCQWQRFZITDX-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
13486,6lzg,DB15448,-7.5,Acumapimod,VGUSQKZDZHAAEE-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
25324,6cs2,DB03227,-7.5,Nicotinamide Mononucleotide,DAYLJWODMCOQEW-WYOJIJJFSA-O,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
102454,6vxs,DB07415,-7.5,4-[(1S)-1-(3-fluoro-4-methoxyphenyl)-2-(2-methoxy-5-nitrophenyl)ethyl]-1H-imidazol-2-amine,RFLOFHKRBGKCOB-AWEZNQCLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
142241,6w9q,DB01944,-7.5,(S)-blebbistatin,LZAXPYOBKSJSEX-GOSISDBHSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
148458,6w9q,DB13472,-7.5,Cyclofenil,GVOUFPWUYJWQSK-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
89869,6m71,DB00990,-7.5,Exemestane,BFYIZQONLCFLEV-DAELLWKTSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
147705,6w9q,DB12322,-7.5,GW-870086,WUBKGTSFJSEIEM-NSHBDUGJSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
97570,6m71,DB15187,-7.5,Dubermatinib,YUAALFPUEOYPNX-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
135092,6w9c,DB03973,-7.5,"3-{2,6,8-trioxo-9-[(2R,3R,4R)-2,3,4,5-tetrahydroxypentyl]-1,2,3,6,8,9-hexahydro-7H-purin-7-Yl}propyl dihydrogen phosphate",KPHFGOGGKPGLTM-ZXFLCMHBSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
68157,6lxt,DB07589,-7.5,"N-[1-(AMINOMETHYL)CYCLOPROPYL]-3-(BENZYLSULFONYL)-N-2-[(1S)-2,2,2-TRIFLUORO-1-(4-HYDROXYPHENYL)ETHYL]-L-ALANINAMIDE",DWWVPKCSDHDILN-OALUTQOASA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
60692,6crv,DB08983,-7.5,Etofibrate,XXRVYAFBUDSLJX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
135082,6w9c,DB03956,-7.5,"Inositol 2,4,5-trisphosphate",MMWCIQZXVOZEGG-LKPKBOIGSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
94595,6m71,DB08300,-7.5,"1-methyl-3-naphthalen-2-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine",UOKGZPYGRJDACN-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
138808,6w9c,DB12293,-7.5,Nefopam,RGPDEAGGEXEMMM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
158417,7bv1,DB01162,-7.5,Terazosin,VCKUSRYTPJJLNI-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
135077,6w9c,DB03950,-7.5,(S)-N-(3-Indol-1-Yl-2-Methyl-Propyl)-4-Sulfamoyl-Benzamide,ZFWHOUCRVSOZJE-AWEZNQCLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
60689,6crv,DB08980,-7.5,Fendiline,NMKSAYKQLCHXDK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
68152,6lxt,DB07584,-7.5,"N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine",OKGCSZUKOGMZAL-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
68150,6lxt,DB07582,-7.5,"N-[(2R,3S)-1-((2S)-2-{[(CYCLOPENTYLAMINO)CARBONYL]AMINO}-3-METHYLBUTANOYL)-2-(1-FORMYL-1-CYCLOBUTYL)PYRROLIDINYL]CYCLOPROPANECARBOXAMIDE",GCDRFILPPBOJLM-UFYCRDLUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
90964,6m71,DB02429,-7.5,4-(Aminosulfonyl)-N-[(4-Fluorophenyl)Methyl]-Benzamide,IXDVPACDZDRCTN-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
66733,6lxt,DB04574,-7.5,Estrone sulfate,JKKFKPJIXZFSSB-CBZIJGRNSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
16392,6lzg,DB04040,-7.5,"N-(2-Morpholin-4-Yl-1-Morpholin-4-Ylmethyl-Ethyl)-3-Nitro-5-(3,4,5-Trihydroxy-6-Hydroxymethyl-Tetrahydro-Pyran-2-Yloxy)-Benzamide",MCMWCTMAKPQTPI-WGNYYXNJSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
89864,6m71,DB00984,-7.5,Nandrolone phenpropionate,UBWXUGDQUBIEIZ-QNTYDACNSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
68142,6lxt,DB07571,-7.5,"N-2-[(BENZYLOXY)CARBONYL]-N-[(1S,2S)-2-HYDROXY-1-(4-HYDROXYBENZYL)PROPYL]-L-LEUCINAMIDE",ZUWYQZGBCBSHFK-HSQYWUDLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
90979,6m71,DB02450,-7.5,"2-Benzo[1,3]Dioxol-5-Ylmethyl-3-Benzyl-Succinic Acid",ASEJDWRSZYAIOT-GJZGRUSLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
147700,6w9q,DB12316,-7.5,9CUAB30,PPGNMFUMZSAZCW-VOYUZAMQSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
69626,6lxt,DB11362,-7.5,Selexipag,QXWZQTURMXZVHJ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
69633,6lxt,DB11372,-7.5,Altrenogest,VWAUPFMBXBWEQY-ANULTFPQSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
97784,6vxs,DB00163,-7.5,Vitamin E,GVJHHUAWPYXKBD-IEOSBIPESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
148457,6w9q,DB13471,-7.5,Nalfurafine,XGZZHZMWIXFATA-UEZBDDGYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
99076,6vxs,DB01768,-7.5,Methylumbelliferyl Sialic Acid,KKDWIUJBUSOPGC-GKHMPSLRSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102456,6vxs,DB07418,-7.5,bis(4-nitrophenyl) hydrogen phosphate,MHSVUSZEHNVFKW-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
158384,7bv1,DB01125,-7.5,Anisindione,XRCFXMGQEVUZFC-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
25332,6cs2,DB03235,-7.5,N-{3-[4-(3-aminopropyl)piperazin-1-yl]propyl}-3-(alpha-D-galactopyranosyloxy)-5-nitrobenzamide,UEIGEWJJVQHIAX-MKQKURRLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
138728,6w9c,DB12184,-7.5,Gepirone,QOIGKGMMAGJZNZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
135236,6w9c,DB04164,-7.5,"1,4-Deoxy-4-((5-Hydroxymethyl-2,3,4-Trihydroxycyclohex-5-Enyl)Amino)Fructose",ZGWNRGISVMYHTF-KKXLKBQTSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
135235,6w9c,DB04163,-7.5,"5-Phenylsulfanyl-2,4-Quinazolinediamine",BUFDQCGCADQQQY-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
102459,6vxs,DB07421,-7.5,"4-{[(1R,2S)-1,2-dihydroxy-2-methyl-3-(4-nitrophenoxy)propyl]amino}-2-(trifluoromethyl)benzonitrile",INVUBEGZQHQAMY-SJORKVTESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
70556,6lxt,DB12846,-7.5,Reproterol,WVLAAKXASPCBGT-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
102462,6vxs,DB07425,-7.5,Sobetirome,QNAZTOHXCZPOSA-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
155390,6wiq,DB09048,-7.5,Netupitant,WAXQNWCZJDTGBU-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
138731,6w9c,DB12187,-7.5,Abacavir hydroxyacetate,ZBBZROWQLKCFQK-KOLCDFICSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
147707,6w9q,DB12325,-7.5,Idasanutlin,TVTXCJFHQKSQQM-LJQIRTBHSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
88208,6m3m,DB13489,-7.5,Bamipine,VZSXTYKGYWISGQ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88214,6m3m,DB13496,-7.5,Iprindole,PLIGPBGDXASWPX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
135197,6w9c,DB04114,-7.5,"3-Chloro-9-Ethyl-6,7,8,9,10,11-Hexahydro-7,11-Methanocycloocta[B]Quinolin-12-Amine",QTPHSDHUHXUYFE-NWDGAFQWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
102477,6vxs,DB07441,-7.5,"3-{[(9-CYANO-9,10-DIHYDRO-10-METHYLACRIDIN-9-YL)CARBONYL]AMINO}PROPANOIC ACID",FRBAOMHMZCGBOJ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
94159,6m71,DB07790,-7.5,N-(2-METHOXYETHYL)-4-({4-[2-METHYL-1-(1-METHYLETHYL)-1H-IMIDAZOL-5-YL]PYRIMIDIN-2-YL}AMINO)BENZENESULFONAMIDE,LDXLQEXLXZCYSR-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
156939,6wiq,DB13927,-7.5,anle138b,RCQIIBJSUWYYFU-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
146349,6w9q,DB08426,-7.5,"THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [2-OXO-1-(1H-PYRROLO[2,3-C]PYRIDIN-2-YLMETHYL)-PYRROLIDIN-3-YL]-AMIDE",PLXOQMHGHDZMSX-AWEZNQCLSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
13492,6lzg,DB15460,-7.5,AGG-523,JWQMTWCFNZSLNR-DEOSSOPVSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
69644,6lxt,DB11393,-7.5,Danofloxacin,QMLVECGLEOSESV-RYUDHWBXSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
70567,6lxt,DB12863,-7.5,Sivelestat,BTGNGJJLZOIYID-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
138782,6w9c,DB12262,-7.5,CRS-3123,NNTYBKTXMKBRFA-CQSZACIVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138790,6w9c,DB12271,-7.5,ORE-1001,NTCCRGGIJNDEAB-IRXDYDNUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138765,6w9c,DB12236,-7.5,Bexagliflozin,BTCRKOKVYTVOLU-SJSRKZJXSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
92999,6m71,DB05932,-7.5,Denibulin,GAOHLWCIAJNSEE-JTQLQIEISA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
135522,6w9c,DB04576,-7.5,Fleroxacin,XBJBPGROQZJDOJ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
68824,6lxt,DB08373,-7.5,"4,4'-BIS([H]METHYLSULFONYL)-2,2',5,5'-TETRACHLOROBIPHENYL",RDBKPLOYRMCFIY-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
63802,6lxt,DB00717,-7.5,Norethisterone,VIKNJXKGJWUCNN-XGXHKTLJSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
70399,6lxt,DB12588,-7.5,AZD-1480,PDOQBOJDRPLBQU-QMMMGPOBSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
98925,6vxs,DB01572,-7.5,Methyl-1-testosterone,JRNSSSJKIGAFCT-YDSAWKJFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
70407,6lxt,DB12601,-7.5,Sonolisib,QIUASFSNWYMDFS-NILGECQDSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
88063,6m3m,DB13303,-7.5,Febarbamate,QHZQILHUJDRDAI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
90696,6m71,DB02082,-7.5,Phosphoaminophosphonic Acid Guanylate Ester,UQABYHGXWYXDTK-UUOKFMHZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
146446,6w9q,DB08538,-7.5,"N-((2-aminopyrimidin-5-yl)methyl)-5-(2,6-difluorophenyl)-3-ethylpyrazolo[1,5-a]pyrimidin-7-amine",HQPVGVSQPQVZLD-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
86914,6m3m,DB11479,-7.5,Zilpaterol,ZSTCZWJCLIRCOJ-DGCLKSJQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
147764,6w9q,DB12410,-7.5,Sabarubicin,VQHRZZISQVWPLK-UIRGBLDSSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
102278,6vxs,DB07212,-7.5,N-(7-CARBAMIMIDOYL-NAPHTHALEN-1-YL)-3-HYDROXY-2-METHYL-BENZAMIDE,NNGZRCYXFBHMRM-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
35371,1r42,DB01530,-7.5,"5alpha-androstane-3alpha,17beta-diol",CBMYJHIOYJEBSB-KHOSGYARSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
158196,7bv1,DB00713,-7.5,Oxacillin,UWYHMGVUTGAWSP-JKIFEVAISA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94268,6m71,DB07917,-7.5,4-(BENZHYDRYLOXY)-1-[3-(1H-TETRAAZOL-5-YL)PROPYL]PIPERIDINE,TZQGXAHOROZEKN-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
135826,6w9c,DB05223,-7.5,Pracinostat,JHDKZFFAIZKUCU-ZRDIBKRKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
97991,6vxs,DB00408,-7.5,Loxapine,XJGVXQDUIWGIRW-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
146445,6w9q,DB08537,-7.5,"3-bromo-6-phenyl-N-(pyrimidin-5-ylmethyl)imidazo[1,2-a]pyridin-8-amine",LZLKFNBMXXLTLX-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
67181,6lxt,DB05992,-7.5,Plinabulin,UNRCMCRRFYFGFX-TYPNBTCFSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
135817,6w9c,DB05143,-7.5,OXI-4503,GSOXMQLWUDQTNT-WAYWQWQTSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
158199,7bv1,DB00716,-7.5,Nedocromil,RQTOOFIXOKYGAN-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
142759,6w9q,DB02616,-7.5,FR117016,CKJGKHXCUDWFDC-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
94246,6m71,DB07889,-7.5,"(2S)-1-(Dimethylamino)-3-(4-{[4-(2-methylimidazo[1,2-a]pyridin-3-yl)-2-pyrimidinyl]amino}phenoxy)-2-propanol",VCPXSBULBDYRLT-SFHVURJKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
142756,6w9q,DB02611,-7.5,Balanol Analog 1,FZJQHARRQUNVGZ-QZTJIDSGSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
98935,6vxs,DB01587,-7.5,Ketazolam,PWAJCNITSBZRBL-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
147766,6w9q,DB12412,-7.5,Gemigliptin,ZWPRRQZNBDYKLH-VIFPVBQESA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
63799,6lxt,DB00714,-7.5,Apomorphine,VMWNQDUVQKEIOC-CYBMUJFWSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
65259,6lxt,DB02596,-7.5,"Alpha,Beta-Methyleneadenosine-5'-Triphosphate",CAWZRIXWFRFUQB-IOSLPCCCSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
68795,6lxt,DB08340,-7.5,"N,N'-DIPHENYLPYRAZOLO[1,5-A][1,3,5]TRIAZINE-2,4-DIAMINE",LLYYAUZAGCZEKV-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
146502,6w9q,DB08607,-7.5,"(5R)-5-(4-{[(2R)-6-HYDROXY-2,5,7,8-TETRAMETHYL-3,4-DIHYDRO-2H-CHROMEN-2-YL]METHOXY}BENZYL)-1,3-THIAZOLIDINE-2,4-DIONE",GXPHKUHSUJUWKP-NTKDMRAZSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
98915,6vxs,DB01562,-7.5,1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine,BVURVTVDNWSNFN-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
94551,6m71,DB08240,-7.5,N-(4-CHLOROPHENYL)-3-(PHOSPHONOOXY)NAPHTHALENE-2-CARBOXAMIDE,RQAQWBFHPMSXKR-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
66772,6lxt,DB04626,-7.5,Apramycin,XZNUGFQTQHRASN-XQENGBIVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
16264,6lzg,DB03446,-7.5,N-Benzyl-3-(alpha-D-galactopyranosyloxy)benzamide,FSMWGHKWKYCPKE-QTVCLEQKSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
65270,6lxt,DB02610,-7.5,"N-(2,3,4,5,6-Pentaflouro-Benzyl)-4-Sulfamoyl-Benzamide",LRKSHOLYETXPGY-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
135926,6w9c,DB05791,-7.5,Perflubron,WTWWXOGTJWMJHI-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
98041,6vxs,DB00469,-7.5,Tenoxicam,LZNWYQJJBLGYLT-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
35402,1r42,DB01561,-7.5,Androstanedione,RAJWOBJTTGJROA-WZNAKSSCSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
98033,6vxs,DB00457,-7.5,Prazosin,IENZQIKPVFGBNW-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102250,6vxs,DB07180,-7.5,"5-[(Z)-(5-Chloro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-N,2,4-trimethyl-1H-pyrrole-3-carboxamide",FIRPCWHHIWFKCD-GHXNOFRVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
88098,6m3m,DB13342,-7.5,Cinepazet,XDUOTWNXVDBCDY-VOTSOKGWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
25236,6cs2,DB03121,-7.5,(1-Benzyl-5-methoxy-2-methyl-1H-indol-3-yl)acetic acid,ZEKCBTQHDTUHRJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
25237,6cs2,DB03124,-7.5,5-[4-(1-Carboxymethyl-2-Oxo-Propylcarbamoyl)-Benzylsulfamoyl]-2-Hydroxy-Benzoic Acid,LBAHOXPDTNUYCX-INIZCTEOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
102261,6vxs,DB07192,-7.5,(3S)-N-(3-BROMOPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE,MVPIURCUINFSAB-LBPRGKRZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
152594,6wiq,DB04258,-7.5,Seocalcitol,LVLLALCJVJNGQQ-SEODYNFXSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
92557,6m71,DB04563,-7.5,CRA_9678,VIZNZQTZRMTYPZ-UHFFFAOYSA-M,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
62989,6crv,DB14881,-7.5,Oliceridine,DMNOVGJWPASQDL-OAQYLSRUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
154370,6wiq,DB07796,-7.5,"(3ASR,4RS,8ASR,8BRS)-4-(2-(4-FLUOROBENZYL)-1,3-DIOXODEACAHYDROPYRROLO[3,4-A] PYRROLIZIN-4-YL)BENZAMIDINE",GJYCQHGTXMVIBG-MUGJNUQGSA-O,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
68291,6lxt,DB07750,-7.5,"(2R)-1-[4-({4-[(2,5-Dichlorophenyl)amino]-2-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol",GNLAGGCSJGJECE-MRXNPFEDSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
60917,6crv,DB09351,-7.5,Levobetaxolol,NWIUTZDMDHAVTP-KRWDZBQOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
102266,6vxs,DB07198,-7.5,5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-CARBONITRILE,GGEKOZPXKBYLNK-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
95610,6m71,DB11682,-7.5,Daprodustat,RUEYEZADQJCKGV-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
13987,6lzg,T3D2107,-7.5,"1,2,3,6,7,9-Hexachlorodibenzo-p-dioxin",BQOHWGKNRKCEFT-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
70383,6lxt,DB12565,-7.5,Abexinostat,MAUCONCHVWBMHK-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
98936,6vxs,DB01588,-7.5,Prazepam,MWQCHHACWWAQLJ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
135764,6w9c,DB04917,-7.5,Renzapride,YFUAYKVMQVBSNG-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
97940,6vxs,DB00346,-7.5,Alfuzosin,WNMJYKCGWZFFKR-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
135669,6w9c,DB04787,-7.5,Tanaproget,PYVFWTPEBMRKSR-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
62956,6crv,DB14801,-7.5,Lanifibranor,OQDQIFQRNZIEEJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
98948,6vxs,DB01605,-7.5,Pivmecillinam,NPGNOVNWUSPMDP-HLLBOEOZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
135659,6w9c,DB04772,-7.5,1-GUANIDINO-4-(N-PHENYLMETHANESULFONYL-L-LEUCYL-L-PROLYLAMINO)BUTANE,DSVCYWOHJLRGMK-PMACEKPBSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
65233,6lxt,DB02559,-7.5,"6-(Octahydro-1h-Indol-1-Ylmethyl)Decahydroquinazoline-2,4-Diamine",HDQIGGQUKAQTGU-SZTTVXCBSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
70472,6lxt,DB12707,-7.5,AR-42,LAMIXXKAWNLXOC-INIZCTEOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
157036,6wiq,DB14128,-7.5,Nadide,BAWFJGJZGIEFAR-NNYOXOHSSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
60845,6crv,DB09218,-7.5,Clonixin,CLOMYZFHNHFSIQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
35981,1r42,DB02331,-7.5,"(2s)-2-[(5-Benzofuran-2-Yl-Thiophen-2-Ylmethyl)-(2,4-Dichloro-Benzoyl)-Amino]-3-Phenyl-Propionic Acid",YBULOUKTPCHXAL-DEOSSOPVSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
86814,6m3m,DB11221,-7.5,Dioxybenzone,MEZZCSHVIGVWFI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
24035,6cs2,DB01690,-7.5,Bis(Adenosine)-5'-Triphosphate,QCICUPZZLIQAPA-XPWFQUROSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
97851,6vxs,DB00240,-7.5,Alclometasone,FJXOGVLKCZQRDN-PHCHRAKRSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
60840,6crv,DB09213,-7.5,Dexibuprofen,HEFNNWSXXWATRW-JTQLQIEISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
135583,6w9c,DB04655,-7.5,Metoprine,VQJHOPSWBGJHQS-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
135575,6w9c,DB04645,-7.5,"5-{3-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-2-METHYL-PHENOXY}-PENTANOIC ACID",NJJIFGCFUDDBSP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
97800,6vxs,DB00180,-7.5,Flunisolide,XSFJVAJPIHIPKU-XWCQMRHXSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
146402,6w9q,DB08489,-7.5,"N4-HYDROXY-2-ISOBUTYL-N1-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.013,18]NONADECA-12(19),13,15,17-TETRAEN-10-YL)-SUCCINAMIDE",GCBPAPVOMPJQHK-NQIIRXRSSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
94225,6m71,DB07863,-7.5,2-chloro-5-nitro-N-phenylbenzamide,DNTSIBUQMRRYIU-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
102343,6vxs,DB07288,-7.5,N-(4-chlorophenyl)-2-[(pyridin-4-ylmethyl)amino]benzamide,GGPZCOONYBPZEW-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
14781,6lzg,T3D4741,-7.5,Aminopterin,TVZGACDUOSZQKY-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
4698,6lzg,HMDB0000121,-7.5,Folic acid,OVBPIULPVIDEAO-LBPRGKRZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
97799,6vxs,DB00179,-7.5,Masoprocol,HCZKYJDFEPMADG-TXEJJXNPSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
60824,6crv,DB09196,-7.5,Lubazodone,HTODIQZHVCHVGM-JTQLQIEISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
67354,6lxt,DB06529,-7.5,Ocinaplon,OQJFBUOFGHPMSR-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
25275,6cs2,DB03171,-7.5,Indole-3-Propanol Phosphate,NKEZSFZOUIIZFL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
155333,6wiq,DB08971,-7.5,Fluocortolone,GAKMQHDJQHZUTJ-ULHLPKEOSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
102309,6vxs,DB07251,-7.5,"N'-(3-CHLORO-4-METHOXY-PHENYL)-N-(3,4,5-TRIMETHOXYPHENYL)-1,3,5-TRIAZINE-2,4-DIAMINE",ZVWFECUPYCFYBL-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
135691,6w9c,DB04816,-7.5,Dantron,QBPFLULOKWLNNW-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
24016,6cs2,DB01668,-7.5,Nanaomycin D,XUWPJKDMEZSVTP-UOSCCXBLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
95636,6m71,DB11721,-7.5,Mitoglitazone,IRNJSRAGRIZIHD-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
135755,6w9c,DB04892,-7.5,Phenserine,PBHFNBQPZCRWQP-QUCCMNQESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
93243,6m71,DB06660,-7.5,Saredutant,PGKXDIMONUAMFR-AREMUKBSSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
135753,6w9c,DB04890,-7.5,Bepotastine,YWGDOWXRIALTES-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
90762,6m71,DB02170,-7.5,"1,8-Di-Hydroxy-4-Nitro-Xanthen-9-One",ZOHCDJRFYXKEQW-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
149946,6wiq,DB00776,-7.5,Oxcarbazepine,CTRLABGOLIVAIY-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
146425,6w9q,DB08514,-7.5,"6-amino-2-[(thiophen-2-ylmethyl)amino]-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",IQKMJWDYMFWZRF-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
135728,6w9c,DB04860,-7.5,Isatoribine,TZYVRXZQAWPIAB-FCLHUMLKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
97919,6vxs,DB00319,-7.5,Piperacillin,IVBHGBMCVLDMKU-GXNBUGAJSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
135726,6w9c,DB04857,-7.5,Brasofensine,NRLIFEGHTNUYFL-QJDHNRDASA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
12939,6lzg,DB14069,-7.5,ONT-093,RSJCLODJSVZNQA-BQYQJAHWSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
90766,6m71,DB02177,-7.5,1-Acetyl-4-(4-{4-[(2-Ethoxyphenyl)Thio]-3-Nitrophenyl}Pyridin-2-Yl)Piperazine,GKGJFUXSTSUKPB-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95650,6m71,DB11742,-7.5,Ebastine,MJJALKDDGIKVBE-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97891,6vxs,DB00284,-7.5,Acarbose,CEMXHAPUFJOOSV-XGWNLRGSSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
147752,6w9q,DB12394,-7.5,Eleclazine,YNUAEEJQYHYLMS-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
67176,6lxt,DB05973,-7.5,Inosine 5'-sulfate,IGYLPKLXFDOQGM-KQYNXXCUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
97863,6vxs,DB00253,-7.5,Medrysone,GZENKSODFLBBHQ-ILSZZQPISA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
138516,6w9c,DB11781,-7.5,Tosedostat,FWFGIHPGRQZWIW-SQNIBIBYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
93249,6m71,DB06678,-7.5,Esmirtazapine,RONZAEMNMFQXRA-MRXNPFEDSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94571,6m71,DB08267,-7.5,"6-amino-4-(2-phenylethyl)-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",PBZAIUVFRISTSZ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
70452,6lxt,DB12672,-7.5,Icaritin,TUUXBSASAQJECY-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
157091,6wiq,DB14541,-7.5,Hydrocortisone cypionate,DLVOSEUFIRPIRM-KAQKJVHQSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
135696,6w9c,DB04821,-7.5,Nomifensine,XXPANQJNYNUNES-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
102296,6vxs,DB07235,-7.5,"N-[(1S)-2-AMINO-1-(2,4-DICHLOROBENZYL)ETHYL]-5-[2-(METHYLAMINO)PYRIMIDIN-4-YL]THIOPHENE-2-CARBOXAMIDE",HHOVRZGUSBMKKU-ZDUSSCGKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
92395,6m71,DB04345,-7.5,Lumichrome,ZJTJUVIJVLLGSP-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
91021,6m71,DB02502,-7.5,8-Hydroxy-2'-Deoxyguanosine,HCAJQHYUCKICQH-VPENINKCSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
149834,6wiq,DB00641,-7.5,Simvastatin,RYMZZMVNJRMUDD-HGQWONQESA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
36110,1r42,DB02491,-7.5,4-[4-(1-Amino-1-Methylethyl)Phenyl]-5-Chloro-N-[4-(2-Morpholin-4-Ylethyl)Phenyl]Pyrimidin-2-Amine,CJSSYVIHFXDFFC-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
134323,6w9c,DB02919,-7.5,"2,4-Diamino-6-[N-(3',4',5'-Trimethoxybenzyl)-N-Methylamino]Pyrido[2,3-D]Pyrimidine",PUOZHLHNKHRTOW-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
153943,6wiq,DB07294,-7.5,"3-fluoro-4-[2-hydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8,-tetrahydro-naphtalen-2-yl)-acetylamino]-benzoic acid",AANFHDFOMFRLLR-IBGZPJMESA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
66215,6lxt,DB03882,-7.5,"5-Alpha-Androstane-3-Beta,17beta-Diol",CBMYJHIOYJEBSB-YSZCXEEOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
68931,6lxt,DB08503,-7.5,"(3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(4-methylphenyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol",HRCKGDOSPBFICB-MZHQWRCYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
147652,6w9q,DB12254,-7.5,ABT-751,URCVCIZFVQDVPM-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
86391,6m3m,DB08784,-7.5,2-(4-CHLORO-PHENYLAMINO)-NICOTINIC ACID,YEXIXVLEDGNAKM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
152983,6wiq,DB04785,-7.5,Streptolydigin,KVTPRMV1KLIG-NCAOFHFGSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
70708,6lxt,DB13074,-7.5,Macimorelin,UJVDJAPJQWZRFR-DHIUTWEWSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
91234,6m71,DB02789,-7.5,Pregnenolone,ORNBQBCIOKFOEO-QGVNFLHTSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
102755,6vxs,DB07772,-7.5,"(1R)-1-{[(4'-methoxy-1,1'-biphenyl-4-yl)sulfonyl]amino}-2-methylpropylphosphonic acid",BZVYQWLRCHLAGK-QGZVFWFLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
62745,6crv,DB14064,-7.5,Emopamil,DWAWDSVKAUWFHC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
134303,6w9c,DB02894,-7.5,"Sulfamic Acid 2,3-O-(1-Methylethylidene)-4,5-O-Sulfonyl-Beta-Fructopyranose Ester",GGOAQSGCBDRTHT-JAKMQLQISA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
97479,6m71,DB14998,-7.5,Olorinab,ACSQLTBPYZSGBA-GMXVVIOVSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94664,6m71,DB08385,-7.5,4-(quinolin-3-ylmethyl)piperidine-1-carboxylic acid,QUAGUFNCKDDJFZ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
148668,6w9q,DB13756,-7.5,Peruvoside,PMTSPAGBAFCORP-HBUONDEYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
60475,6crv,DB08697,-7.5,"4-(2-aminoethoxy)-N-(3-chloro-5-piperidin-1-ylphenyl)-3,5-dimethylbenzamide",JDYIYIRPQKMWMM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
146281,6w9q,DB08341,-7.5,"4-{[4-{[(1R,2R)-2-(dimethylamino)cyclopentyl]amino}-5-(trifluoromethyl)pyrimidin-2-yl]amino}-N-methylbenzenesulfonamide",CAUFYHKGKDJMQG-HZPDHXFCSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
86386,6m3m,DB08778,-7.5,"[4-amino-2-(tert-butylamino)-1,3-thiazol-5-yl](phenyl)methanone",KEHNGAHNKVLUSC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88538,6m3m,DB13978,-7.5,Selisistat,FUZYTVDVLBBXDL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
94669,6m71,DB08390,-7.5,"(6S)-6-CYCLOPENTYL-6-[2-(3-FLUORO-4-ISOPROPOXYPHENYL)ETHYL]-4-HYDROXY-5,6-DIHYDRO-2H-PYRAN-2-ONE",AKNIHFDXRAOPAI-NRFANRHFSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
91242,6m71,DB02802,-7.5,5-Aminocarbonyl-3-Nitrophenyl-Alpha-D-Galactopyranose,BYSXBFJVGIOFBO-LNSPPBFMSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
156514,6wiq,DB13240,-7.5,Cymarin,XQCGNURMLWFQJR-ZNDDOCHDSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
156578,6wiq,DB13327,-7.5,Picotamide,KYWCWBXGRWWINE-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
24140,6cs2,DB00267,-7.5,Cefmenoxime,HJJDBAOLQAWBMH-YCRCPZNHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
97493,6m71,DB15033,-7.5,Flortaucipir,GETAAWDSFUCLBS-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
99348,6vxs,DB02132,-7.5,Zenarestat,SXONDGSPUVNZLO-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
99295,6vxs,DB02069,-7.5,N-(2-Flouro-Benzyl)-4-Sulfamoyl-Benzamide,ULYMHSXFSKOHGH-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
153968,6wiq,DB07321,-7.5,"2,5-DICHLORO-N-[5-METHOXY-7-(6-METHOXYPYRIDIN-3-YL)-1,3-BENZOXAZOL-2-YL]BENZENESULFONAMIDE",KOKQLKWXOFRTHE-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
68035,6lxt,DB07444,-7.5,"6-(3-AMINOPROPYL)-4,9-DIMETHYLPYRROLO[3,4-C]CARBAZOLE-1,3(2H,6H)-DIONE",PKPNSCZPIWCHMW-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
64116,6lxt,DB01082,-7.5,Streptomycin,UCSJYZPVAKXKNQ-HZYVHMACSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
141901,6w9q,DB01501,-7.5,Difenoxin,UFIVBRCCIRTJTN-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
97523,6m71,DB15091,-7.5,Upadacitinib,WYQFJHHDOKWSHR-MNOVXSKESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
88457,6m3m,DB13822,-7.5,Meprotixol,LAYVFLWAVIGDLK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
158648,7bv1,DB01745,-7.5,N-Alpha-(2-Naphthylsulfonyl)-N(3-Amidino-L-Phenylalaninyl)Isopipecolinic Acid Methyl Ester,JJLGQWCKMHPBEB-DEOSSOPVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60499,6crv,DB08723,-7.5,"5-(5-(2,6-DICHLORO-4-(4,5-DIHYDRO-2-OXAZOLY)PHENOXY)PENTYL)-3-METHYL ISOXAZOLE",JJDHAOLOHQTGMG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
13520,6lzg,DB01165,-7.5,Ofloxacin,GSDSWSVVBLHKDQ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
64128,6lxt,DB01095,-7.5,Fluvastatin,FJLGEFLZQAZZCD-JUFISIKESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
158706,7bv1,DB02106,-7.5,"[3,5-Dibromo-4-(4-Hydroxy-3-Phenethylcarbamoyl-Phenoxy)-Phenyl]-Acetic Acid",KIRQJXNQGZAKGR-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
153955,6wiq,DB07307,-7.5,N-cyclopropyl-4-methyl-3-[1-(2-methylphenyl)phthalazin-6-yl]benzamide,GQXMJOSCBRZMKE-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
153945,6wiq,DB07296,-7.5,(5Z)-3-(4-CHLOROPHENYL)-4-HYDROXY-5-(1-NAPHTHYLMETHYLENE)FURAN-2(5H)-ONE,PLGHLEBIWUQEPR-PDGQHHTCSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
93366,6m71,DB06865,-7.5,6-CARBAMIMIDOYL-2-[2-HYDROXY-6-(4-HYDROXY-PHENYL)-INDAN-1-YL]-HEXANOIC ACID,ZSRRBAKATXAISL-LMNJBCLMSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
88471,6m3m,DB13841,-7.5,Clopenthixol,WFPIAZLQTJBIFN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
94047,6m71,DB07655,-7.5,"3-AMINO-3-BENZYL-[4.3.0]BICYCLO-1,6-DIAZANONAN-2-ONE",MPJYGQHMIFDQIN-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
40289,6lu7,DB04842,-7.5,Fluspirilene,QOYHHIBFXOOADH-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
92335,6m71,DB04263,-7.5,Geneticin,BRZYSWJRSDMWLG-DJWUNRQOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
1615,6lzg,HMDB0012242,-7.5,Ketoconazole,XMAYWYJOQHXEEK-ZEQKJWHPSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
148633,6w9q,DB13710,-7.5,Metenolone,ANJQEDFWRSLVBR-VHUDCFPWSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
14079,6lzg,T3D3697,-7.5,Fumonisin B2,UXDPXZQHTDAXOZ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
139171,6w9c,DB12962,-7.5,CP-547632,HXHAJRMTJXHJJZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
134335,6w9c,DB02934,-7.5,9-(6-deoxy-alpha-L-talofuranosyl)-6-methylpurine,XJZDIUOABWMPLZ-DSBXBFMBSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
134358,6w9c,DB02963,-7.5,"(5-Chloropyrazolo[1,5-a]Pyrimidin-7-Yl)-(4-Methanesulfonylphenyl)Amine",LVNXHNRYPADEAD-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
141792,6w9q,DB01349,-7.5,Tasosartan,ADXGNEYLLLSOAR-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
61912,6crv,DB12791,-7.5,Laninamivir,QNRRHYPPQFELSF-CNYIRLTGSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86370,6m3m,DB08760,-7.5,(2S)-2-(4-chlorophenoxy)-3-phenylpropanoic acid,CPBLTMSKPQDJPW-AWEZNQCLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
153899,6wiq,DB07247,-7.5,"[2'-HYDROXY-3'-(1H-PYRROLO[3,2-C]PYRIDIN-2-YL)-BIPHENYL-3-YLMETHYL]-UREA",SRPOHNDQBDHONJ-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
134123,6w9c,DB02596,-7.5,"Alpha,Beta-Methyleneadenosine-5'-Triphosphate",CAWZRIXWFRFUQB-IOSLPCCCSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
92320,6m71,DB04240,-7.5,"(1S)-1-C-{(2R)-6-[(2R)-2-Butanyl]-5,10-dihydroxy-4-oxo-1,2,3,4-tetrahydro-2-anthracenyl}-5-deoxy-1-O-methyl-D-xylulose",XGORHSPGULYMCV-HHYQQTLHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
134122,6w9c,DB02595,-7.5,Bulgecin A,RPNZWZDLNYCCIG-HMMVDTEZSA-O,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
60439,6crv,DB08651,-7.5,3'-THIO-THYMIDINE-5'-PHOSPHATE,BORVFKJZAOEGOO-GJMOJQLCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
93996,6m71,DB07596,-7.5,"(17beta)-17-(cyanomethyl)-2-methox1tra-1(10),2,4-trien-3-yl sulfamate",NTSPHKOMJMBWOU-NNKXXINSSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97419,6m71,DB14854,-7.5,TC-6987,UAKZGMMGIMKFMV-RBUKOAKNSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60431,6crv,DB08642,-7.5,"(2R,6S)-6-{[methyl(3,4,5-trimethoxyphenyl)amino]methyl}-1,2,5,6,7,8-hexahydroquinazoline-2,4-diamine",JJWPLCQODKLEHY-JEOXALJRSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
97417,6m71,DB14849,-7.5,Nebicapone,MRFOLGFFTUGAEB-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
139289,6w9c,DB13274,-7.5,Micronomicin,DNYGXMICFMACRA-XHEDQWPISA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
95799,6m71,DB11960,-7.5,Carboxyamidotriazole,WNRZHQBJSXRYJK-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
134127,6w9c,DB02602,-7.5,AL7182,ICIXQGGQPKFQRL-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
40237,6lu7,DB14675,-7.5,Temsavir,QRPZBKAMSFHVRW-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
28688,6cs2,DB00768,-7.5,Olopatadine,JBIMVDZLSHOPLA-LSCVHKIXSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
95800,6m71,DB11961,-7.5,AZD-1236,SFJFBTPHDHUUPU-OAHLLOKOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
88591,6m3m,DB14082,-7.5,Betiatide,VDPYMEBVIDZKMD-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
40235,6lu7,DB12048,-7.5,Savolitinib,XYDNMOZJKOGZLS-NSHDSACASA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40234,6lu7,DB12318,-7.5,BMS-599626,LUJZZYWHBDHDQX-QFIPXVFZSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
100903,6vxs,DB04204,-7.5,[(4-{4-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Butyl}-Phenyl)-Difluoro-Methyl]-Phosphonic Acid,SRHSAABKYJDBDV-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
134013,6w9c,DB02454,-7.5,5-(6-Amino-9h-Purin-9-Yl)-4-Hydroxytetrahydrofuran-3-Yl Dihydrogen Phosphate,IJEJRDCFMFEDGL-AFEQZKEHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
147254,6w9q,DB11672,-7.5,Curcumin,VFLDPWHFBUODDF-FCXRPNKRSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
40233,6lu7,DB12368,-7.5,AZD-3839,MRXBCEQZNKUUIP-DEOSSOPVSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
66247,6lxt,DB03924,-7.5,"5,8-Di-Amino-1,4-Dihydroxy-Anthraquinone",QVEMRPAUHFWHRV-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
40232,6lu7,DB12457,-7.5,Rimegepant,KRNAOFGYEFKHPB-ANJVHQHFSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40236,6lu7,DB11978,-7.5,Glasdegib,SFNSLLSYNZWZQG-VQIMIIECSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
134451,6w9c,DB03093,-7.5,"8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine",MWHAHELTVGJGFJ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
16526,6cs2,HMDB0002642,-7.5,Ursodeoxycholic acid 3-sulfate,WHMOBEGYTDWMIG-ROKSHQGPSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
92954,6m71,DB05616,-7.5,"4'-Methylene-5,8,10-trideazaaminopterin",NAWXUBYGYWOOIX-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
156501,6wiq,DB13223,-7.5,Fluocortin,PUWHHWCHAVXSIG-NCLPIGKXSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
60464,6crv,DB08682,-7.5,"1-METHYL ETHYL 1-CHLORO-5-[[(5,6DIHYDRO-2-METHYL-1,4-OXATHIIN-3-YL)CARBONYL]AMINO]BENZOATE",FMQGUMRNTBJHEA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
153913,6wiq,DB07261,-7.5,"THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [1-(1-AMINO-ISOQUINOLIN-7-YLMETHYL)-2-OXO-PYRROLDIN-3-YL]-AMIDE",NVKDOURNRJCKJE-INIZCTEOSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
86367,6m3m,DB08757,-7.5,5-(2-chlorophenyl)furan-2-carbohydrazide,XQMRHWSGTVEDFG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
97452,6m71,DB14914,-7.5,Flortaucipir F-18,GETAAWDSFUCLBS-SJPDSGJFSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
99409,6vxs,DB02220,-7.5,AL7089A,RMOXCYSVWCHXII-LBPRGKRZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
70726,6lxt,DB13101,-7.5,4SC-202,PRXXYMVLYKJITB-IZZDOVSWSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
94034,6m71,DB07642,-7.5,"5-{[1-(2-fluorobenzyl)piperidin-4-yl]methoxy}quinazoline-2,4-diamine",GYKIQIOWVKCVBP-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
68940,6lxt,DB08514,-7.5,"6-amino-2-[(thiophen-2-ylmethyl)amino]-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",IQKMJWDYMFWZRF-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
134211,6w9c,DB02712,-7.5,Sorbinil,LXANPKRCLVQAOG-NSHDSACASA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139255,6w9c,DB13225,-7.5,Dibenzepin,QPGGEKPRGVJKQB-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
65785,6lxt,DB03296,-7.5,3'-beta-Sialyl-beta-lactose,CILYIEBUXJIHCO-LPTWSRJFSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
91266,6m71,DB02830,-7.5,FR236913,KCCUBLLGAMGDJL-HXUWFJFHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
134207,6w9c,DB02706,-7.5,Mercaptocarboxylate Inhibitor,DUKDFMPUZRDWLT-CQSZACIVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
95794,6m71,DB11950,-7.5,Teneligliptin,WGRQANOPCQRCME-PMACEKPBSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
139261,6w9c,DB13232,-7.5,Suxibuzone,ONWXNHPOAGOMTG-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
146268,6w9q,DB08322,-7.5,"2-DEOXY-3,4-BIS-O-[3-(4-HYDROXYPHENYL)PROPANOYL]-L-THREO-PENTARIC ACID",VJLMRHSHSNLOGC-NOPZTHQXSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
12518,6lzg,DB13471,-7.5,Nalfurafine,XGZZHZMWIXFATA-UEZBDDGYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
156483,6wiq,DB13185,-7.5,Oxabolone cipionate,KHKDIUPVDIEHAH-KXLSUQFWSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
134172,6w9c,DB02660,-7.5,Filaminast,STTRYQAGHGJXJJ-LICLKQGHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
67992,6lxt,DB07394,-7.5,AUROVERTIN B,QXCOFYWOWZJFEA-YJMRODJJSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
134170,6w9c,DB02658,-7.5,"2,4-Dinitrophenyl 2-Deoxy-2-Fluoro-Beta-D-Allopyranoside",UFSBFVZQJZMIOU-LZQZFOIKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
102785,6vxs,DB07806,-7.5,"(2R,4S)-2-[(R)-BENZYLCARBAMOYL-PHENYLACETYL-METHYL]-5,5-DIMETHYL-THIAZOLIDINE-4-CARBOXYLIC ACID",UDMBRVGTYILYDX-SVFBPWRDSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
37265,1r42,DB04042,-7.5,"2-[4-(Hydroxy-Methoxy-Methyl)-Benzyl]-7-(4-Hydroxymethyl-Benzyl)-1,1-Dioxo-3,6-Bis-Phenoxymethyl-1lambda6-[1,2,7]Thiadiazepane-4,5-Diol",XLJNZONSWKENRP-VABIIVNOSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
134210,6w9c,DB02711,-7.5,"4-{2,6,8-Trioxo-9-[(2S,3R,4R)-2,3,4,5-Tetrahydroxypentyl]-1,2,3,6,8,9-Hexahydro-7h-Purin-7-Yl}Butyl Dihydrogen Phosphate",VBXZSBKAJFXURR-QXFUBDJGSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
91167,6m71,DB02696,-7.5,"6-Aminohexyl-Uridine-C1,5'-Diphosphate",MLWJBKPFDKRHBM-FMKGYKFTSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
68049,6lxt,DB07459,-7.5,4-PHENOXY-N-(PYRIDIN-2-YLMETHYL)BENZAMIDE,HVLSCZSVTCNAQX-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
36082,1r42,DB02455,-7.5,Fluoresceinylthioureido,VHJFQSRUDVDTEO-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
67158,6lxt,DB05861,-7.5,Tasquinimod,ONDYALNGTUAJDX-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
134931,6w9c,DB03753,-7.5,Flurbiprofen Methyl Ester,CPJBKHZROFMSQM-NSHDSACASA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
99144,6vxs,DB01859,-7.5,4-Diphosphocytidyl-2-C-Methyl-D-Erythritol 2-Phosphate,HTJXTKBIUVFUAR-XHIBXCGHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
158459,7bv1,DB01207,-7.5,Ridogrel,GLLPUTYLZIKEGF-HAVVHWLPSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
28597,6cs2,DB08185,-7.5,2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,LCHGAOHLDYRACA-SDBHATRESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
97549,6m71,DB15138,-7.5,AZD-9496,DFBDRVGWBHBJNR-BBNFHIFMSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
134905,6w9c,DB03721,-7.5,N-acetyl-alpha-neuraminic acid,SQVRNKJHWKZAKO-YRMXFSIDSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
66717,6lxt,DB04555,-7.5,Cytidine-5'-Diphosphate,ZWIADYZPOWUWEW-XVFCMESISA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
134894,6w9c,DB03708,-7.5,Adenosine 5'-phosphosulfate,IRLPACMLTUPBCL-KQYNXXCUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
134882,6w9c,DB03691,-7.5,WRR-112,KVZMXOVSHIMGNA-HOTGVXAUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
93325,6m71,DB06803,-7.5,Niclosamide,RJMUSRYZPJIFPJ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
68099,6lxt,DB07520,-7.5,"N-[1-(AMINOMETHYL)CYCLOPROPYL]-3-(MORPHOLIN-4-YLSULFONYL)-N-2-[(1S)-2,2,2-TRIFLUORO-1-(4-FLUOROPHENYL)ETHYL]-L-ALANINAMIDE",BJIKKEHGGYGGIX-HOTGVXAUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
134866,6w9c,DB03668,-7.5,1-(5'-Phospho-Beta-D-Ribofuranosyl)Barbituric Acid,AODYJUNLDJOADV-YXZULKJRSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
89810,6m71,DB00920,-7.5,Ketotifen,ZCVMWBYGMWKGHF-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95734,6m71,DB11865,-7.5,Brivanib alaninate,LTEJRLHKIYCEOX-OCCSQVGLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
134830,6w9c,DB03618,-7.5,2-(Acetylamino)-2-Deoxy-4-O-Beta-D-Galactopyranosyl-Alpha-D-Glucopyranose,KFEUJDWYNGMDBV-RCBHQUQDSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
60628,6crv,DB08893,-7.5,Mirabegron,PBAPPPCECJKMCM-IBGZPJMESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86555,6m3m,DB09013,-7.5,Befunolol,ZPQPDBIHYCBNIG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
158501,7bv1,DB01264,-7.5,Darunavir,CJBJHOAVZSMMDJ-HEXNFIEUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60615,6crv,DB08868,-7.5,Fingolimod,KKGQTZUTZRNORY-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
152921,6wiq,DB04698,-7.5,"N-(1,4-DIHYDRO-5H-TETRAZOL-5-YLIDENE)-9-OXO-9H-XANTHENE-2-SULFONAMIDE",HJWYZPGYPZNDTN-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
68895,6lxt,DB08462,-7.5,N-(4-PHENYLAMINO-QUINAZOLIN-6-YL)-ACRYLAMIDE,JGWHILNNHLDARR-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
86554,6m3m,DB09012,-7.5,Carbazochrome,XSXCZNVKFKNLPR-SDQBBNPISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
89791,6m71,DB00901,-7.5,Bitolterol,FZGVEKPRDOIXJY-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
158469,7bv1,DB01218,-7.5,Halofantrine,FOHHNHSLJDZUGQ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
134775,6w9c,DB03530,-7.5,Acylated Ceftazidime,VEHPZKIFULQYFS-BZXVCXBKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
94611,6m71,DB08317,-7.5,"5-methyl-6-phenylquinazoline-2,4-diamine",HUCOXWPHDFINIW-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
91041,6m71,DB02527,-7.5,Cyclic adenosine monophosphate,IVOMOUWHDPKRLL-KQYNXXCUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
68113,6lxt,DB07536,-7.5,"N-{(1S,2R)-2-hydroxy-1-[(hydroxyamino)carbonyl]propyl}-4-{[4-(morpholin-4-ylmethyl)phenyl]ethynyl}benzamide",FQYBTYFKOHPWQT-VGSWGCGISA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
88274,6m3m,DB13580,-7.5,Succinylsulfathiazole,SKVLYVHULOWXTD-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
40404,6lu7,DB02581,-7.5,"5-[2,3-Dichloro-4-(5-{1-[2-(2-Guanidino-4-Methyl-Pentanoylamino)-Acetyl]-Piperidin-4-Yl}-1-Methyl-1h-Pyrazol-3-Yl)-Phenoxymethyl]-Furan-2-Carboxylic Acid",VNZHOIDQBPFEJU-OAQYLSRUSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
60669,6crv,DB08956,-7.5,Hydroxydione,USPYDUPOCUYHQL-VEVMSBRDSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138846,6w9c,DB12347,-7.5,CG-400549,YCLREGRRHGLOAK-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
40398,6lu7,DB00872,-7.5,Conivaptan,IKENVDNFQMCRTR-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
89858,6m71,DB00978,-7.5,Lomefloxacin,ZEKZLJVOYLTDKK-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
148497,6w9q,DB13528,-7.5,Chlormadinone,VUHJZBBCZGVNDZ-TTYLFXKOSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
134996,6w9c,DB03844,-7.5,"N-(2,6-Diflouro-Benzyl)-4-Sulfamoyl-Benzamide",ZFNCKGXGCCDDFN-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
40396,6lu7,DB02354,-7.5,4-{[1-Methyl-5-(2-Methyl-Benzoimidazol-1-Ylmethyl)-1h-Benzoimidazol-2-Ylmethyl]-Amino}-Benzamidine,IRKPNOLLMNHSOU-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40394,6lu7,DB03082,-7.5,6-[(Z)-Amino(Imino)Methyl]-N-[4-(Aminomethyl)Phenyl]-4-(Pyrimidin-2-Ylamino)-2-Naphthamide,CSWQJKHBMACTGB-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
60654,6crv,DB08936,-7.5,Chlorcyclizine,WFNAKBGANONZEQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
40393,6lu7,DB03276,-7.5,"4-[(10s,14s,18s)-18-(2-Amino-2-Oxoethyl)-14-(1-Naphthylmethyl)-8,17,20-Trioxo-7,16,19-Triazaspiro[5.14]Icos-11-En-10-Yl]Benzylphosphonic Acid",RHYFMOCFCFUTNH-GZNVFMSSSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
93299,6m71,DB06751,-7.5,Drotaverine,OMFNSKIUKYOYRG-MOSHPQCFSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
40392,6lu7,DB03571,-7.5,"3-(5-Amino-7-Hydroxy-[1,2,3]Triazolo[4,5-D]Pyrimidin-2-Yl)-N-(3,5-Dichlorobenzyl)-Benzamide",JMQTXEWNXSPEKX-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
146330,6w9q,DB08400,-7.5,4-(3-{[5-(trifluoromethyl)pyridin-2-yl]oxy}benzyl)piperidine-1-carboxylic acid,KUEKMTNOUPAOBS-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
101168,6vxs,DB04563,-7.5,CRA_9678,VIZNZQTZRMTYPZ-UHFFFAOYSA-M,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
40391,6lu7,DB04011,-7.5,"2'-(4-Dimethylaminophenyl)-5-(4-Methyl-1-Piperazinyl)-2,5'-Bi-Benzimidazole",VMCOQLKKSNQANE-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
92998,6m71,DB05913,-7.5,OSI-930,FGTCROZDHDSNIO-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
40390,6lu7,DB04739,-7.5,4-[(4-METHYL-1-PIPERAZINYL)METHYL]-N-[3-[[4-(3-PYRIDINYL)-2-PYRIMIDINYL]AMINO]PHENYL]-BENZAMIDE,JHMBUEWQJDGKGS-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
89850,6m71,DB00967,-7.5,Desloratadine,JAUOIFJMECXRGI-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
40389,6lu7,DB04760,-7.5,"PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-(4-FLUORO-3-METHYL-BENZYLAMIDE)",PYFRREJCFXFNRR-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40388,6lu7,DB01705,-7.5,Bis(5-Amidino-Benzimidazolyl)Methane,QZKOOEFIMWKZPK-UHFFFAOYSA-Q,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
68861,6lxt,DB08422,-7.5,[PHENYLALANINYL-PROLINYL]-[2-(PYRIDIN-4-YLAMINO)-ETHYL]-AMINE,GEIDRYBJURDUSW-MOPGFXCFSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
102526,6vxs,DB07500,-7.5,(2E)-1-[2-hydroxy-4-methoxy-5-(3-methylbut-2-en-1-yl)phenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one,ZUGCRBMNFSAUOC-YRNVUSSQSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
98066,6vxs,DB00497,-7.5,Oxycodone,BRUQQQPBMZOVGD-XFKAJCMBSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102610,6vxs,DB07602,-7.5,S-{3-[(4-ANILINOQUINAZOLIN-6-YL)AMINO]-3-OXOPROPYL}-L-CYSTEINE,NLVZTRZPMRTVRC-INIZCTEOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
154061,6wiq,DB07430,-7.5,"(10R)-10-methyl-3-(6-methylpyridin-3-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one",CMWRPDHVGMHLSZ-GFCCVEGCSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
23201,6cs2,HMDB0059801,-7.5,9-Hydroxyphenanthrene,DZKIUEHLEXLYKM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
70662,6lxt,DB13008,-7.5,"2,2-bis(4-hydroxy-3-tert-butylphenyl)propane",ZDRSNHRWLQQICP-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
91103,6m71,DB02610,-7.5,"N-(2,3,4,5,6-Pentaflouro-Benzyl)-4-Sulfamoyl-Benzamide",LRKSHOLYETXPGY-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
101063,6vxs,DB04429,-7.5,4'-Hydroxyflavanone,ZLHVIYHWWQYJID-HNNXBMFYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
12547,6lzg,DB13507,-7.5,Poldine,CQRKVVAGMJJJSR-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
156713,6wiq,DB13591,-7.5,Metopimazine,BQDBKDMTIJBJLA-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
94660,6m71,DB08379,-7.5,6-(4-chloro-2-fluoro-3-phenoxybenzyl)pyridazin-3(2H)-one,NOVPOXGMADEKPP-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
86482,6m3m,DB08926,-7.5,Acediasulfone,FKKUMFTYSTZUJG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
146293,6w9q,DB08355,-7.5,"1-methyl-8-(phenylamino)-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxylic acid",ZOBRPBVIEUWYJR-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
149755,6wiq,DB00547,-7.5,Desoximetasone,VWVSBHGCDBMOOT-IIEHVVJPSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
139081,6w9c,DB12825,-7.5,Lefamulin,KPVIXBKIJXZQJX-FCEONZPQSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
94645,6m71,DB08360,-7.5,"2-(4-ETHYLPIPERAZIN-1-YL)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE",BIFHJPUTQBOBGJ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
158576,7bv1,DB01645,-7.5,Genistein,TZBJGXHYKVUXJN-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
68056,6lxt,DB07469,-7.5,"(3aS)-3a-hydroxy-7-methyl-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one",KAJFGRLMKVNMLH-GOSISDBHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
70681,6lxt,DB13032,-7.5,Enecadin,SZSHJTJCJOWMHM-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
12541,6lzg,DB13499,-7.5,Cefsulodin,SYLKGLMBLAAGSC-QLVMHMETSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
25441,6cs2,DB03361,-7.5,"2-{(9as)-9a-[(1s)-1-Hydroxyethyl]-2,7-Dimethyl-9a,10-Dihydro-5h-Pyrimido[4,5-D][1,3]Thiazolo[3,2-a]Pyrimidin-8-Yl}Ethyl Trihydrogen Diphosphate",UQFVHIGKDHNMJT-XPTSAGLGSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
40322,6lu7,DB05678,-7.5,SLx-4090,AZUIUVJESCFSLJ-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
28633,6cs2,DB08230,-7.5,"5,7-DIHYDROXY-2-(3,4,5-TRIHYDROXYPHENYL)-4H-CHROMEN-4-ONE",ARSRJFRKVXALTF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
35122,1r42,DB01167,-7.5,Itraconazole,VHVPQPYKVGDNFY-ZPGVKDDISA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
91137,6m71,DB02656,-7.5,LY-294002,CZQHHVNHHHRRDU-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
91140,6m71,DB02659,-7.5,Cholic Acid,BHQCQFFYRZLCQQ-OELDTZBJSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
141910,6w9q,DB01514,-7.5,Furazabol,RGLLOUBXMOGLDQ-IVEVATEUSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
97528,6m71,DB15099,-7.5,GW-468816,XDKRVNKVAKCFGW-WXWBBQJKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
154012,6wiq,DB07373,-7.5,"ANDROSTA-1,4-DIENE-3,17-DIONE",LUJVUUWNAPIQQI-QAGGRKNESA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
99169,6vxs,DB01895,-7.5,Aspartyl-Adenosine-5'-Monophosphate,QPBSGQWTJLPZNF-VWJPMABRSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
134600,6w9c,DB03288,-7.5,5-Chloro-1h-Indole-2-Carboxylic Acid{[Cyclopentyl-(2-Hydroxy-Ethyl)-Carbamoyl]-Methyl}-Amide,VXABTOCIIZSEPD-QGZVFWFLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
60544,6crv,DB08771,-7.5,"(5R)-2-[(2-fluorophenyl)amino]-5-(1-methylethyl)-1,3-thiazol-4(5H)-one",OJJBBNIYQKFZDK-SNVBAGLBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
24612,6cs2,DB02383,-7.5,Tolrestat,LUBHDINQXIHVLS-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
67143,6lxt,DB05779,-7.5,Oglufanide,LLEUXCDZPQOJMY-AAEUAGOBSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
64103,6lxt,DB01066,-7.5,Cefditoren,KMIPKYQIOVAHOP-YLGJWRNMSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
86527,6m3m,DB08983,-7.5,Etofibrate,XXRVYAFBUDSLJX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
158519,7bv1,DB01320,-7.5,Fosphenytoin,XWLUWCNOOVRFPX-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94082,6m71,DB07701,-7.5,"1-BENZYL-4-[(5,6-DIMETHOXY-1-INDANON-2-YL)METHYL]PIPERIDINE",ADEBPBSSDYVVLD-HXUWFJFHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
16433,6lzg,DB04216,-7.5,Quercetin,REFJWTPEDVJJIY-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
93329,6m71,DB06816,-7.5,Pyrvinium,QMHSXPLYMTVAMK-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
71359,6lxt,DB14065,-7.5,Lomerizine,JQSAYKKFZOSZGJ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
66704,6lxt,DB04540,-7.5,Cholesterol,HVYWMOMLDIMFJA-DPAQBDIFSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
134697,6w9c,DB03417,-7.5,1-(4-Tert-Butylcarbamoyl-Piperazine-1-Carbonyl)-3-(3-Guanidino-Propyl)-4-Oxo-Azetidine-2-Carboxylic Acid,BVNQCAHTTOIOEK-STQMWFEESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
68072,6lxt,DB07488,-7.5,"{(2Z)-4-AMINO-2-[(4-METHOXYPHENYL)IMINO]-2,3-DIHYDRO-1,3-THIAZOL-5-YL}(4-METHOXYPHENYL)METHANONE",XQKUGFIWKSKCDL-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
139005,6w9c,DB12704,-7.5,Spiradoline,NYKCGQQJNVPOLU-ONTIZHBOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
155515,6wiq,DB09378,-7.5,Fluprednisolone,MYYIMZRZXIQBGI-HVIRSNARSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
60569,6crv,DB08799,-7.5,Antazoline,REYFJDPCWQRWAA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
158537,7bv1,DB01602,-7.5,Bacampicillin,PFOLLRNADZZWEX-FFGRCDKISA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
99216,6vxs,DB01960,-7.5,7n-Methyl-8-Hydroguanosine-5'-Diphosphate,QQODJOAVWUWVHJ-KQYNXXCUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
25425,6cs2,DB00408,-7.5,Loxapine,XJGVXQDUIWGIRW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
99220,6vxs,DB01965,-7.5,"2'-Deoxyuridine 5'-Alpha,Beta-Imido-Triphosphate",XZLLMTSKYYYJLH-SHYZEUOFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
16443,6lzg,DB04270,-7.5,(S)-3-(4-(2-Carbazol-9-Yl-Ethoxy)-Phenyl)-2-Ethoxy-Propionic Acid,WUZIMDSVRIBNNI-DEOSSOPVSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
95088,6m71,DB08915,-7.5,Aleglitazar,DAYKLWSKQJBGCS-NRFANRHFSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
154044,6wiq,DB07409,-7.5,"(1-HYDROXY-1-PHOSPHONO-2-[1,1';4',1'']TERPHENYL-3-YL-ETHYL)-PHOSPHONIC ACID",MPBUFKZCEBTBSK-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
68073,6lxt,DB07489,-7.5,"4-Amino-2-[(3-chlorophenyl)amino]-5-(4-fluorobenzoyl)-1,3-thiazol-3-ium",WWGPTHOMFHDEEC-UHFFFAOYSA-O,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
95765,6m71,DB11909,-7.5,Varespladib,BHLXTPHDSZUFHR-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
145133,6w9q,DB07000,-7.5,"N-{2,4-difluoro-3-[(5-pyridin-3-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)carbonyl]phenyl}ethanesulfonamide",ILXJWLWSYAWJKZ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
4539,6lzg,HMDB0052772,-7.5,"TG(18:2(9Z,12Z)/20:4(8Z,11Z,14Z,17Z)/18:3(6Z,9Z,12Z))",OEIVVIBOWKCKQZ-VBJLXMTOSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
98072,6vxs,DB00504,-7.5,Levallorphan,OZYUPQUCAUTOBP-QXAKKESOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
135974,6w9c,DB06211,-7.5,Doripenem,AVAACINZEOAHHE-VFZPANTDSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137867,6w9c,DB08807,-7.5,Bopindolol,UUOJIACWOAYWEZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
36877,1r42,DB03515,-7.5,Equilenin,PDRGHUMCVRDZLQ-WMZOPIPTSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
152001,6wiq,DB03461,-7.5,2'-Monophosphoadenosine 5'-Diphosphoribose,XJLXINKUBYWONI-NNYOXOHSSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
90113,6m71,DB01289,-7.5,Glisoxepide,ZKUDBRCEOBOWLF-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
137138,6w9c,DB07944,-7.5,N-{3-METHYL-5-[2-(PYRIDIN-4-YLAMINO)-ETHOXY]-PHENYL}-BENZENESULFONAMIDE,MPTWCWHNLVMCRW-UHFFFAOYSA-O,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
95416,6m71,DB11182,-7.5,Rose bengal free acid,VDNLFJGJEQUWRB-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
25004,6cs2,DB02844,-7.5,"S-Adenosyl-1,8-Diamino-3-Thiooctane",SUUGLGYBZXSJAA-SCFUHWHPSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
101776,6vxs,DB06471,-7.5,Naxifylline,NJYNSYQBNSDGIQ-RDDCQWBRSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
87803,6m3m,DB12884,-7.5,Lavoltidine,VTLNPNNUIJHJQB-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
93088,6m71,DB06257,-7.5,HE-2200,OEVZKEVBDIDVOI-YSZCXEEOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
69897,6lxt,DB11859,-7.5,Brexanolone,AURFZBICLPNKBZ-SYBPFIFISA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
137122,6w9c,DB07927,-7.5,3-[(4-Carboxy-2-hydroxyphenyl)sulfamoyl]-2-thiophenecarboxylic acid,RDPXXOOKKRIKFN-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
63385,6lxt,DB00216,-7.5,Eletriptan,PWVXXGRKLHYWKM-LJQANCHMSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
90273,6m71,DB01531,-7.5,Desomorphine,LNNWVNGFPYWNQE-GMIGKAJZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
63124,6crv,DB15187,-7.5,Dubermatinib,YUAALFPUEOYPNX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
148028,6w9q,DB12823,-7.5,Tecarfarin,QFLNTQDOVCLQKW-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
65916,6lxt,DB03477,-7.5,1-Phenylsulfonamide-3-Trifluoromethyl-5-Parabromophenylpyrazole,OYZKFVIVPRQRQQ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
152331,6wiq,DB03907,-7.5,"N-{3-[5-(6-Amino-Purin-9-Yl)-3,4-Dihydroxy-Tetrahydro-Furan-2-Yl]-Allyl}-2,3-Dihydroxy-5-Nitro-Benzamide",UHHBFOLQOQSPLU-WGRQDFERSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
90278,6m71,DB01536,-7.5,Androstenedione,AEMFNILZOJDQLW-QAGGRKNESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
147889,6w9q,DB12597,-7.5,ABL-001,VOVZXURTCKPRDQ-CQSZACIVSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
15845,6lzg,DB01532,-7.5,??-Methylacetylfentanyl,OKTLVZBUKMRPLL-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
150398,6wiq,DB01339,-7.5,Vecuronium,BGSZAXLLHYERSY-XQIGCQGXSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
68547,6lxt,DB08041,-7.5,3-BENZYLOXYCARBONYLAMINO-2-HYDROXY-4-PHENYL-BUTYRIC ACID,JXJYTERRLRAUSF-JKSUJKDBSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
144598,6w9q,DB05575,-7.5,Motesanib,RAHBGWKEPAQNFF-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
157596,6wiq,DB12165,-7.5,Presatovir,GOFXWTVKPWJNGD-UWJYYQICSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
24835,6cs2,DB02640,-7.5,Fumagillin,NGGMYCMLYOUNGM-CSDLUJIJSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
70087,6lxt,DB12135,-7.5,Elubrixin,YQYFEGTYCUQBEI-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
154852,6wiq,DB08362,-7.5,"N-(3-(8-CYANO-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZIN-2-YLAMINO)PHENYL)ACETAMIDE",QVKXQLGRDOMAGC-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
101745,6vxs,DB06401,-7.5,Bazedoxifene,UCJGJABZCDBEDK-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
15673,6lzg,DB00769,-7.5,Hydrocortamate,FWFVLWGEFDIZMJ-FOMYWIRZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
15801,6lzg,DB01264,-7.5,Darunavir,CJBJHOAVZSMMDJ-HEXNFIEUSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
13268,6lzg,DB15048,-7.5,Licogliflozin,XFJAMQQAAMJFGB-ZQGJOIPISA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
150395,6wiq,DB01336,-7.5,Metocurine,JFXBEKISTKFVAB-AJQTZOPKSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
155009,6wiq,DB08549,-7.5,"(3R)-METHYLCARBAMOYL-7-SULFOAMINO-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLIC ACID BENZYL ESTER",MFDBNNQUDZFSES-KRWDZBQOSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
143861,6w9q,DB04098,-7.5,Balanol,XYUFCXJZFZPEJD-PGRDOPGGSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
35692,1r42,DB01948,-7.5,"1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperidin-4-Yl-3,4-Dihydroquinolin-2(1h)-One",VXIYTVJEIXMAQF-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
95369,6m71,DB09371,-7.5,Norethynodrel,ICTXHFFSOAJUMG-SLHNCBLASA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
101544,6vxs,DB05514,-7.5,Cobiprostone,SDDSJMXGJNWMJY-BRHAQHMBSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
144652,6w9q,DB05936,-7.5,CVT-6883,KOYXXLLNCXWUNF-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
69907,6lxt,DB11873,-7.5,Verinurad,YYBOLPLTQDKXPM-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
144565,6w9q,DB05423,-7.5,ORG-34517,DFELGYQKEOCHOA-BZAFBGKRSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
157572,6wiq,DB11819,-7.5,ASP-4058,NJNXCJPSMWKXHO-VIFPVBQESA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
157325,6wiq,DB15191,-7.5,MAX-40279,AVIOBQFPAGEICQ-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
137173,6w9c,DB07985,-7.5,+/-METHYL 4-(AMINOIMINOMETHYL)-BETA-[3- INH (AMINOIMINO)PHENYL]BENZENE PENTANOATE,PVALLOSAENRPQO-INIZCTEOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
61332,6crv,DB11932,-7.5,Abametapir,PTRATZCAGVBFIQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
143833,6w9q,DB04064,-7.5,Nogalaviketone,QHNJNOBWURJIEK-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
95382,6m71,DB09495,-7.5,Avobenzone,XNEFYCZVKIDDMS-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
35679,1r42,DB01933,-7.5,7-Hydroxystaurosporine,PBCZSGKMGDDXIJ-HQCWYSJUSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
23881,6cs2,DB01524,-7.5,Androstenediol,QADHLRWLCPCEKT-LOVVWNRFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
70084,6lxt,DB12131,-7.5,Vinpocetine,DDNCQMVWWZOMLN-IRLDBZIGSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
90266,6m71,DB01524,-7.5,Androstenediol,QADHLRWLCPCEKT-LOVVWNRFSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
137187,6w9c,DB08000,-7.5,"2-(CARBOXYMETHYL)-1-OXO-1,2-DIHYDRONAPHTHO[1,2-D]ISOTHIAZOLE-4-CARBOXYLIC ACID 3,3-DIOXIDE",ZTJGXDGAXGWOGR-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
25019,6cs2,DB02859,-7.5,Soraphen A,WPMGNXPRKGXGBO-OFQQMTDKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
144662,6w9q,DB05974,-7.5,Transcrocetinate,PANKHBYNKQNAHN-MQQNZMFNSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
144663,6w9q,DB05983,-7.5,Bardoxolone methyl,WPTTVJLTNAWYAO-KPOXMGGZSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
155037,6wiq,DB08584,-7.5,"6-{[6-(1-methyl-1H-pyrazol-4-yl)[1,2,4]triazolo[4,3-b]pyridazin-3-yl]sulfanyl}quinoline",BCZUAADEACICHN-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
150166,6wiq,DB01029,-7.5,Irbesartan,YOSHYTLCDANDAN-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
61565,6crv,DB12271,-7.5,ORE-1001,NTCCRGGIJNDEAB-IRXDYDNUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
144720,6w9q,DB06212,-7.5,Tolvaptan,GYHCTFXIZSNGJT-XMMPIXPASA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
98421,6vxs,DB00920,-7.5,Ketotifen,ZCVMWBYGMWKGHF-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
8336,6lzg,DB05470,-7.5,VX-702,FYSRKRZDBHOFAY-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
24812,6cs2,DB00341,-7.5,Cetirizine,ZKLPARSLTMPFCP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
137997,6w9c,DB08998,-7.5,Demexiptiline,SEDQWOMFMIJKCU-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
61569,6crv,DB12276,-7.5,Apomine,YLJOVCWVJCDPLN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136920,6w9c,DB07693,-7.5,"N-(3,5-dibromo-4-hydroxyphenyl)-2,6-dimethylbenzamide",IFECSMFQARKPSU-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
14232,6lzg,T3D3864,-7.5,Indoxacarb,VBCVPMMZEGZULK-NRFANRHFSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
94472,6m71,DB08145,-7.5,"6-(2,6-DIMETHOXYPHENYL)PYRIDO[2,3-D]PYRIMIDINE-2,7-DIAMINE",LRPHIAJXODIASX-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
70148,6lxt,DB12230,-7.5,Bunazosin,RHLJLALHBZGAFM-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
143625,6w9q,DB03788,-7.5,GC-24,JYHIGYLGYNCMGI-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
93168,6m71,DB06478,-7.5,Porfiromycin,HRHKSTOGXBBQCB-VFWICMBZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
136881,6w9c,DB07644,-7.5,"5-[(1S)-1-(3-chlorophenyl)ethoxy]quinazoline-2,4-diamine",IDHINEMSCUFEIP-VIFPVBQESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
87404,6m3m,DB12276,-7.5,Apomine,YLJOVCWVJCDPLN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
154718,6wiq,DB08191,-7.5,"4-(5-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl)benzoic acid",KSFDVNIKNYXUIP-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
63108,6crv,DB15147,-7.5,Tinostamustine,GISXTRIGVCKQBX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
66812,6lxt,DB04679,-7.5,H TYPE I TRISACCHARIDE,MGSDFCKWGHNUSM-QVPNGJTFSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
24807,6cs2,DB02607,-7.5,Adenosine Phosphonoacetic Acid,KJNLSEOJEFDELT-JJNLEZRASA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
138013,6w9c,DB09016,-7.5,Butriptyline,ALELTFCQZDXAMQ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
101493,6vxs,DB05252,-7.5,Fenoxaprop-ethyl,PQKBPHSEKWERTG-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
15932,6lzg,DB01946,-7.5,"3-[1-(3-Aminopropyl)-1h-Indol-3-Yl]-4-(1-Methyl-1h-Indol-3-Yl)-1h-Pyrrole-2,5-Dione",UQHKJRCFSLMWIA-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
94370,6m71,DB08030,-7.5,3-[(4'-cyanobiphenyl-4-yl)oxy]-N-hydroxypropanamide,XZWFHJUEAVOHHG-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
101741,6vxs,DB06374,-7.5,Elacestrant,SIFNOOUKXBRGGB-AREMUKBSSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
70137,6lxt,DB12218,-7.5,AZD-5363,JDUBGYFRJFOXQC-KRWDZBQOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
101881,6vxs,DB06710,-7.5,Methyltestosterone,GCKMFJBGXUYNAG-HLXURNFRSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101507,6vxs,DB05316,-7.5,Pimavanserin,RKEWSXXUOLRFBX-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
137060,6w9c,DB07852,-7.5,"1-(3,5-DICHLOROPHENYL)-5-METHYL-1H-1,2,4-TRIAZOLE-3-CARBOXYLIC ACID",CZTNDZALWLHXBA-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
144666,6w9q,DB05992,-7.5,Plinabulin,UNRCMCRRFYFGFX-TYPNBTCFSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
98799,6vxs,DB01431,-7.5,Allylestrenol,ATXHVCQZZJYMCF-XUDSTZEESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
13316,6lzg,DB15132,-7.5,AZD-8165,YUHNXUAATAMVKD-PZJWPPBQSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
157637,6wiq,DB12229,-7.5,Cerlapirdine,NXQGEDVQXVTCDA-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
23444,6cs2,HMDB0061838,-7.5,(-)-alpha-Curcumene,VMYXUZSZMNBRCN-CQSZACIVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
137038,6w9c,DB07826,-7.5,2-[4-chloro-2-(phenylcarbonyl)phenoxy]-N-phenylacetamide,DTGVSZSMDOMAEB-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
101504,6vxs,DB05294,-7.5,Vandetanib,UHTHHESEBZOYNR-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
95208,6m71,DB09083,-7.5,Ivabradine,ACRHBAYQBXXRTO-OAQYLSRUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
146726,6w9q,DB08893,-7.5,Mirabegron,PBAPPPCECJKMCM-IBGZPJMESA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
148066,6w9q,DB12885,-7.5,CF-102,IPSYPUKKXMNCNQ-PFHKOEEOSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
101838,6vxs,DB06625,-7.5,Vipadenant,HQSBCDPYXDGTCL-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
137014,6w9c,DB07801,-7.5,N-butyl-3-{[6-(9H-purin-6-ylamino)hexanoyl]amino}benzamide,WOYITRCGMUXUDE-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
143708,6w9q,DB03893,-7.5,Thionicotinamide-Adenine-Dinucleotide,UQYPZLRUJKCREN-NNYOXOHSSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
25055,6cs2,DB02901,-7.5,Stanolone,NVKAWKQGWWIWPM-ABEVXSGRSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
154763,6wiq,DB08248,-7.5,3-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)-BENZENESULFONAMIDE,BKDUVKJYBJDZQW-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
98444,6vxs,DB00947,-7.5,Fulvestrant,VWUXBMIQPBEWFH-WCCTWKNTSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101851,6vxs,DB06654,-7.5,Safinamide,NEMGRZFTLSKBAP-LBPRGKRZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
94469,6m71,DB08142,-7.5,AT-7519,OVPNQJVDAFNBDN-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
101861,6vxs,DB06680,-7.5,Asoprisnil,GJMNAFGEUJBOCE-MEQIQULJSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
136975,6w9c,DB07757,-7.5,"(9aS)-4-bromo-9a-butyl-7-hydroxy-1,2,9,9a-tetrahydro-3H-fluoren-3-one",FTEBGBCQCYMDPH-KRWDZBQOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
87460,6m3m,DB12354,-7.5,Imrecoxib,AXMZZGKKZDJGAZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
66819,6lxt,DB04689,-7.5,2-{5-[3-(6-BENZOYL-1-PROPYLNAPHTHALEN-2-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID,ZXWVCCFKIRBLDP-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
144680,6w9q,DB06134,-7.5,SNS-314,FAYAUAZLLLJJGH-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
143903,6w9q,DB04154,-7.5,"N-Methyl-N-[3-(6-Phenyl[1,2,4]Triazolo[4,3-B]Pyridazin-3-Yl)Phenyl]Acetamide",ALBWBHNFOJJMCV-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
36851,1r42,DB03480,-7.5,Brequinar Analog,WYKKHJQZENLZID-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
137234,6w9c,DB08053,-7.5,"1-cyclobutyl-3-(3,4-dimethoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine",ITOYZJGFTNTKKR-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
35738,1r42,DB02008,-7.5,1-(2-Fluorobenzyl)-3-Butyl-8-(N-Acetyl-4-Aminobenzyl)-Xanthine,JHSHXKJSPVHPCJ-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
150318,6wiq,DB01200,-7.5,Bromocriptine,OZVBMTJYIDMWIL-AYFBDAFISA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
90155,6m71,DB01384,-7.5,Paramethasone,MKPDWECBUAZOHP-AFYJWTTESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
101693,6vxs,DB06246,-7.5,Exisulind,MVGSNCBCUWPVDA-MFOYZWKCSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
12859,6lzg,DB13930,-7.5,Ulixertinib,KSERXGMCDHOLSS-LJQANCHMSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
157368,6wiq,DB15273,-7.5,VS-4718,IGUBBWJDMLCRIK-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
101694,6vxs,DB06247,-7.5,CX516,ANDGGVOPIJEHOF-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
24885,6cs2,DB02699,-7.5,4-Oxoretinol,PLIUCYCUYQIBDZ-RMWYGNQTSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
157460,6wiq,DB06543,-7.5,Astaxanthin,MQZIGYBFDRPAKN-UWFIBFSHSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
154918,6wiq,DB08444,-7.5,"3-[2-bromo-4-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)phenoxy]-5-methylbenzonitrile",YYGZQXRLQMFHDH-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
93100,6m71,DB06280,-7.5,Senicapoc,SCTZUZTYRMOMKT-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
65401,6lxt,DB02789,-7.5,Pregnenolone,ORNBQBCIOKFOEO-QGVNFLHTSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
157463,6wiq,DB06555,-7.5,Siramesine,XWAONOGAGZNUSF-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
23791,6cs2,DB01428,-7.5,Oxybenzone,DXGLGDHPHMLXJC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
144015,6w9q,DB04298,-7.5,"3-(4-Amino-2-Tert-Butyl-5-Methyl-Phenylsulfanyl)-6-Cyclopentyl-4-Hydroxy-6-[2-(4-Hydroxy-Phenyl)-Ethyl]-5,6-Dihydro-Pyran-2-One",ZEBFKFGJWHOOST-LJAQVGFWSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
143976,6w9q,DB04244,-7.5,(2R)-2-(3-Biphenylyl)-N-{(2R)-2-hydroxy-3-[(2-pyridinylsulfonyl)amino]propyl}-4-methylpentanamide,YCDHZDINQZLSRR-DNQXCXABSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
101699,6vxs,DB06257,-7.5,HE-2200,OEVZKEVBDIDVOI-YSZCXEEOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
137684,6w9c,DB08595,-7.5,"4-[(1S,2R,5S)-4,4,8-TRIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL",BBZPJHFECDCNGT-BPUTZDHNSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
101587,6vxs,DB05779,-7.5,Oglufanide,LLEUXCDZPQOJMY-AAEUAGOBSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
137704,6w9c,DB08618,-7.5,3-(HYDROXY-PHENYL-PHOSPHINOYLOXY)-8-METHYL-8-AZA-BICYCLO[3.2.1]OCTANE-2-CARBOXYLIC ACID METHYL ESTER,WJTKWTJTOSZMKO-PMOUVXMZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
157470,6wiq,DB06581,-7.5,Bevirimat,YJEJKUQEXFSVCJ-WRFMNRASSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
137707,6w9c,DB08622,-7.5,"4-(4-CHLORO-PHENYL)-1-{3-[2-(4-FLUORO-PHENYL)-[1,3]DITHIOLAN-2-YL]-PROPYL}-PIPERIDIN-4-OL",KVDKNVPAAQKHKD-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
69932,6lxt,DB11909,-7.5,Varespladib,BHLXTPHDSZUFHR-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
157477,6wiq,DB06595,-7.5,Midostaurin,BMGQWWVMWDBQGC-IIFHNQTCSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
144017,6w9q,DB04301,-7.5,Bis(5-Amidino-2-Benzimidazolyl)Methane Ketone Hydrate,ZLAHDRAQCSQPOC-UHFFFAOYSA-P,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
137709,6w9c,DB08624,-7.5,BENZOTHIAZOLE,MAJHCCQPIDXPAN-QMMMGPOBSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
154926,6wiq,DB08454,-7.5,N-(5-METHYL-1H-PYRAZOL-3-YL)-2-PHENYLQUINAZOLIN-4-AMINE,JYCUVOXSZBECAY-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
63177,6crv,DB15288,-7.5,Etamicastat,CWWWTTYMUOYSQA-LLVKDONJSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
157388,6wiq,DB15307,-7.5,Atabecestat,VLLFGVHGKLDDLW-SFHVURJKSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
61441,6crv,DB12093,-7.5,Tetrahydropalmatine,AEQDJSLRWYMAQI-KRWDZBQOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
144197,6w9q,DB04549,-7.5,"4-(Aminosulfonyl)-N-[(2,3,4-Trifluorophenyl)Methyl]-Benzamide",AANTYZRUJFNZFI-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
144215,6w9q,DB04571,-7.5,Trioxsalen,FMHHVULEAZTJMA-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
144169,6w9q,DB04514,-7.5,Phosphoric Acid-2'-[2'-Deoxy-Uridine]Ester-5'-Guanosine Ester,DFYLLEBFVZTKHD-VMIOUTBZSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
137582,6w9c,DB08473,-7.5,"5,6-dichloro-1-beta-D-ribofuranosyl-1H-benzimidazole",XHSQDZXAVJRBMX-DDHJBXDOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
154961,6wiq,DB08495,-7.5,4-({4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-2-OXOPIPERAZIN-1-YL}METHYL)BENZENECARBOXIMIDAMIDE,VXONTEUOQXFJJS-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
137586,6w9c,DB08478,-7.5,N-[2-chloro-5-(trifluoromethyl)phenyl]imidodicarbonimidic diamide,IGFTZEOFHWPCDL-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
144225,6w9q,DB04582,-7.5,IMAZAQUIN,CABMTIJINOIHOD-QGZVFWFLSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
147956,6w9q,DB12707,-7.5,AR-42,LAMIXXKAWNLXOC-INIZCTEOSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
61433,6crv,DB12080,-7.5,Ritobegron,VMMYRRFPMAGXNP-BTYIYWSLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
144353,6w9q,DB04760,-7.5,"PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-(4-FLUORO-3-METHYL-BENZYLAMIDE)",PYFRREJCFXFNRR-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
101641,6vxs,DB06140,-7.5,SUVN-502,GWCYPEHWIZXYFZ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
137525,6w9c,DB08403,-7.5,METHYLAMINO-PHENYLALANYL-LEUCYL-HYDROXAMIC ACID,MOPRTFSMCQNUCT-CABCVRRESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137521,6w9c,DB08399,-7.5,PICEATANNOL,CDRPUGZCRXZLFL-OWOJBTEDSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
65419,6lxt,DB02812,-7.5,"(2s,4r)-1-Acetyl-N-[(1s)-4-[(Aminoiminomethyl)Amino]-1-(2-Benzothiazolylcarbonyl)Butyl]-4-Hydroxy-2-Pyrrolidinecarboxamide",VXDAVYUFYPFGDX-SNPRPXQTSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
154965,6wiq,DB08499,-7.5,"N-[3-(2-fluoroethoxy)phenyl]-N'-(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-6-yl)butanediamide",DQXBKUVWJSZHSI-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
144136,6w9q,DB04471,-7.5,"2-Phenyl-1-[4-(2-Piperidin-1-Yl-Ethoxy)-Phenyl]-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol",FMWVCTJKLAVRPB-MUUNZHRXSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
98688,6vxs,DB01228,-7.5,Encainide,PJWPNDMDCLXCOM-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
92711,6m71,DB04772,-7.5,1-GUANIDINO-4-(N-PHENYLMETHANESULFONYL-L-LEUCYL-L-PROLYLAMINO)BUTANE,DSVCYWOHJLRGMK-PMACEKPBSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
137611,6w9c,DB08507,-7.5,N-[[2-METHYL-4-HYDROXYCARBAMOYL]BUT-4-YL-N]-BENZYL-P-[PHENYL]-P-[METHYL]PHOSPHINAMID,KGUVBHLPMGERAT-NIYFSFCBSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
152047,6wiq,DB03523,-7.5,Brequinar,PHEZJEYUWHETKO-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
137623,6w9c,DB08522,-7.5,4-(4-FLUOROPHENYL)-1-CYCLOROPROPYLMETHYL-5-(4-PYRIDYL)-IMIDAZOLE,ROKOFZNQCIIJMI-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
94425,6m71,DB08095,-7.5,"3-(2-CHLOROPHENYL)-1-(2-{[(1S)-2-HYDROXY-1,2-DIMETHYLPROPYL]AMINO}PYRIMIDIN-4-YL)-1-(4-METHOXYPHENYL)UREA",ZWYFTKPEHRQCCW-HNNXBMFYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
13278,6lzg,DB15063,-7.5,Inarigivir soproxil,CJCYTUJOSMYXLE-JDLSZIHUSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
146980,6w9q,DB09272,-7.5,Eluxadoline,QFNHIDANIVGXPE-FNZWTVRRSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
68667,6lxt,DB08173,-7.5,5-CHLORO-N-(2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO)ETHYL)THIOPHENE-2-CARBOXAMIDE,UCKHUNHXYMAFQM-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
90204,6m71,DB01451,-7.5,1-Androstenedione,WJIQCDPCDVWDDE-WZNAKSSCSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95330,6m71,DB09274,-7.5,Artesunate,FIHJKUPKCHIPAT-AHIGJZGOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
98604,6vxs,DB01132,-7.5,Pioglitazone,HYAFETHFCAUJAY-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
98593,6vxs,DB01120,-7.5,Gliclazide,BOVGTQGAOIONJV-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
70032,6lxt,DB12059,-7.5,JNJ-40411813,HYOGJHCDLQSAHX-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
24972,6cs2,DB02808,-7.5,Trifluorofurnesyl Diphosphate,PXLMLAFPAPGGKK-GVCYOOEQSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
137291,6w9c,DB08118,-7.5,"2-(methylamino)-N-(4-methyl-1,3-thiazol-2-yl)-5-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]benzamide",XRJAKERBMMBUGR-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
24973,6cs2,DB02809,-7.5,"Brodimoprim-4,6-Dicarboxylate",SZAVCZNFKJSWRN-LBPRGKRZSA-M,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
101729,6vxs,DB06335,-7.5,Saxagliptin,QGJUIPDUBHWZPV-SGTAVMJGSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
98584,6vxs,DB01108,-7.5,Trilostane,KVJXBPDAXMEYOA-CXANFOAXSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
137733,6w9c,DB08655,-7.5,"9-ACETYL-2,3,4,9-TETRAHYDRO-1H-CARBAZOL-1-ONE",MIGJEXKBUJPKJF-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137281,6w9c,DB08107,-7.5,N-{[6-(PENTYLOXY)NAPHTHALEN-2-YL]SULFONYL}-D-GLUTAMIC ACID,LIGACKDHLKEZFH-GOSISDBHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
65448,6lxt,DB02848,-7.5,"{4-[3-(6,7-Diethoxy-Quinazolin-4-Ylamino)-Phenyl]-Thiazol-2-Yl}-Methanol",ZJESXGUODSBHSK-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
95220,6m71,DB09101,-7.5,Elvitegravir,JUZYLCPPVHEVSV-LJQANCHMSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
137279,6w9c,DB08105,-7.5,N-[(6-butoxynaphthalen-2-yl)sulfonyl]-L-glutamic acid,UAGYXJBYAFGRFR-KRWDZBQOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
90218,6m71,DB01466,-7.5,Ethylmorphine,OGDVEMNWJVYAJL-LEPYJNQMSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
90123,6m71,DB01324,-7.5,Polythiazide,CYLWJCABXYDINA-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
154871,6wiq,DB08387,-7.5,2-{[4-(1-methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline,AZEXWHKOMMASPA-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
137255,6w9c,DB08077,-7.5,"2-[4-({[(3,5-DICHLOROPHENYL)AMINO]CARBONYL}AMINO)PHENOXY]-2-METHYLPROPANOIC ACID",OYJPTSMWFKGZJM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137740,6w9c,DB08662,-7.5,3-[1-(4-BROMO-PHENYL)-2-METHYL-PROPYL]-4-HYDROXY-CHROMEN-2-ONE,KGDWLSFLMSFPSU-INIZCTEOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
90230,6m71,DB01479,-7.5,BA-2664,QGKQXZFZOIQFBI-XSWYFRFISA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
144520,6w9q,DB05137,-7.5,Lobeline,MXYUKLILVYORSK-HBMCJLEFSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
101736,6vxs,DB06362,-7.5,Becatecarin,JSKFWUPVIZYJMR-UDOAKELVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101571,6vxs,DB05659,-7.5,Faropenem medoxomil,JQBKWZPHJOEQAO-DVPVEWDBSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
137745,6w9c,DB08670,-7.5,"METHYL N-[(2S,3R)-3-AMINO-2-HYDROXY-3-(4-ISOPROPYLPHENYL)PROPANOYL]-D-ALANYL-D-LEUCINATE",WIWZNHHLFMPGGO-PIKADFDJSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
68676,6lxt,DB08185,-7.5,2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,LCHGAOHLDYRACA-SDBHATRESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
146839,6w9q,DB09053,-7.5,Ibrutinib,XYFPWWZEPKGCCK-GOSISDBHSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
157357,6wiq,DB15246,-7.5,Salvianolic acid A,YMGFTDKNIWPMGF-UCPJVGPRSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
98609,6vxs,DB01138,-7.5,Sulfinpyrazone,MBGGBVCUIVRRBF-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
137372,6w9c,DB08211,-7.5,5-bromo-3-(pyrrolidin-1-ylsulfonyl)-1H-indole-2-carboxamide,FEPUPYVRZUWCQB-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
101708,6vxs,DB06272,-7.5,Maxacalcitol,DTXXSJZBSTYZKE-ZDQKKZTESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101712,6vxs,DB06281,-7.5,Torcetrapib,CMSGWTNRGKRWGS-NQIIRXRSSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
70016,6lxt,DB12039,-7.5,Epicatechin,PFTAWBLQPZVEMU-UKRRQHHQSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
137353,6w9c,DB08185,-7.5,2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,LCHGAOHLDYRACA-SDBHATRESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
154887,6wiq,DB08406,-7.5,"[N-(2,4-DIAMINOPTERIDIN-6-YL)-METHYL]-DIBENZ[B,F]AZEPINE",NXCCIJQEAKMFGW-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
101584,6vxs,DB05738,-7.5,Vapitadine,VQWGYPVNVICKFC-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
98618,6vxs,DB01148,-7.5,Flavoxate,SPIUTQOUKAMGCX-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
98615,6vxs,DB01145,-7.5,Sulfoxone,NEDPPCHNEOMTJV-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
98611,6vxs,DB01140,-7.5,Cefadroxil,BOEGTKLJZSQCCD-UEKVPHQBSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101715,6vxs,DB06292,-7.5,Dapagliflozin,JVHXJTBJCFBINQ-ADAARDCZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
68675,6lxt,DB08184,-7.5,2-(2-METHYLPHENYL)-1H-INDOLE-5-CARBOXIMIDAMIDE,YOZKTHGEOJHIDP-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
24963,6cs2,DB02799,-7.5,N-[2-(1-Maleimidyl)Ethyl]-7-Diethylaminocoumarin-3-Carboxamide,OJBZDUMTXGGVSP-KTKRTIGZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
61485,6crv,DB12153,-7.5,Citicoline,RZZPDXZPRHQOCG-OJAKKHQRSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
137338,6w9c,DB08167,-7.5,Methylthioninium,RBTBFTRPCNLSDE-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
70025,6lxt,DB12049,-7.5,Dasolampanel etibutil,HPBRMCFZIGUGTK-ZMMAXQRCSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
146934,6w9q,DB09209,-7.5,Pholcodine,GPFAJKDEDBRFOS-FKQDBXSBSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
137323,6w9c,DB08152,-7.5,{(2S)-1-[N-(tert-butoxycarbonyl)glycyl]pyrrolidin-2-yl}methyl (3-chlorophenyl)acetate,ONXGIEJBNQLITK-INIZCTEOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
143944,6w9q,DB04204,-7.5,[(4-{4-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Butyl}-Phenyl)-Difluoro-Methyl]-Phosphonic Acid,SRHSAABKYJDBDV-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
23869,6cs2,DB01511,-7.5,Delorazepam,CHIFCDOIPRCHCF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
157494,6wiq,DB06626,-7.5,Axitinib,RITAVMQDGBJQJZ-FMIVXFBMSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
137315,6w9c,DB08144,-7.5,"6-(2,6-dibromophenyl)pyrido[2,3-d]pyrimidine-2,7-diamine",HGIPWJYTPOHUGK-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
101723,6vxs,DB06313,-7.5,BNC105,MYDHDVLPMRNDAZ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
61365,6crv,DB11978,-7.5,Glasdegib,SFNSLLSYNZWZQG-VQIMIIECSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
137347,6w9c,DB08177,-7.5,(E)-3-(5((5-(4-CHLOROPHENYL)FURAN-2-YL)METHYLENE)-4-OXO-2-THIOXOTHIAZOLIDIN-3-YL)PROPANOIC ACID,YZLFZFALAZYTCI-NTEUORMPSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
102817,6vxs,DB07842,-7.5,(2S)-2-(4-ethylphenoxy)-3-phenylpropanoic acid,CJMVTSLLWMPEKQ-INIZCTEOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
63463,6lxt,DB00305,-7.5,Mitomycin,NWIBSHFKIJFRCO-WUDYKRTCSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
90324,6m71,DB01587,-7.5,Ketazolam,PWAJCNITSBZRBL-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
90518,6m71,DB01838,-7.5,"6,4'-Dihydroxy-3-Methyl-3',5'-Dibromoflavone",GKDYOXMZSXVKPP-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
136342,6w9c,DB07007,-7.5,"(3R)-3-[(1,2,3,4-tetrahydroisoquinolin-7-yloxy)methyl]-2,3-dihydrothieno[2,3-f][1,4]oxazepin-5-amine",UDFXWCLBONUMNA-CYBMUJFWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
145075,6w9q,DB06927,-7.5,[5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-YL]ACETONITRILE,ZKJVCUXZMYKTLT-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
101420,6vxs,DB04898,-7.5,Ximelagatran,ZXIBCJHYVWYIKI-PZJWPPBQSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
63585,6lxt,DB00452,-7.5,Framycetin,PGBHMTALBVVCIT-VCIWKGPPSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
136326,6w9c,DB06991,-7.5,"N-[2-methyl-5-(methylcarbamoyl)phenyl]-2-{[(1R)-1-methylpropyl]amino}-1,3-thiazole-5-carboxamide",OYOUIHFZUAKCEF-LLVKDONJSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
69796,6lxt,DB11706,-7.5,Raxatrigine,JESCETIFNOFKEU-SJORKVTESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
89979,6m71,DB01116,-7.5,Trimethaphan,CHQOEHPMXSHGCL-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
90537,6m71,DB01864,-7.5,5'-Guanosine-Diphosphate-Monothiophosphate,XOFLBQFBSOEHOG-UUOKFMHZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
70321,6lxt,DB12468,-7.5,Pf-04531083,ZRJGMDIPCQOGNI-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
98884,6vxs,DB01531,-7.5,Desomorphine,LNNWVNGFPYWNQE-GMIGKAJZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
88032,6m3m,DB13254,-7.5,Prifinium,ZYEPZINLLPPBMI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136279,6w9c,DB06929,-7.5,1-butanoyl-N-(4-carbamimidoylbenzyl)-L-prolinamide,RYAZZWWVNUWKNB-AWEZNQCLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138270,6w9c,DB11226,-7.5,Ethylhexyl methoxycrylene,WAJCJDLRJVDSSD-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
14000,6lzg,T3D3610,-7.5,Cyanoginosin-LA,DIAQQISRBBDJIM-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
87028,6m3m,DB11729,-7.5,GSK-2330672,CZGVOBIGEBDYTP-VSGBNLITSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
3592,6lzg,HMDB0047892,-7.5,TG(14:1(9Z)/14:1(9Z)/24:1(15Z)),DTWPBANPCJFNIA-QNOCGCPESA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
93039,6m71,DB06155,-7.5,Rimonabant,JZCPYUJPEARBJL-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
101402,6vxs,DB04873,-7.5,Piboserod,KVCSJPATKXABRQ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
146578,6w9q,DB08703,-7.5,"12-(2-hydroxyethyl)-2-(1-methylethoxy)-13,14-dihydronaphtho[2,1-a]pyrrolo[3,4-c]carbazol-5(12H)-one",FGKKIHITEICGMN-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
95168,6m71,DB09015,-7.5,Canrenoic acid,PBKZPPIHUVSDNM-WNHSNXHDSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
68771,6lxt,DB08309,-7.5,3-({2-[(4-{[6-(CYCLOHEXYLMETHOXY)-9H-PURIN-2-YL]AMINO}PHENYL)SULFONYL]ETHYL}AMINO)PROPAN-1-OL,AMFGILNPFBVREA-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
138307,6w9c,DB11367,-7.5,Cefroxadine,RDMOROXKXONCAL-UEKVPHQBSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
145067,6w9q,DB06919,-7.5,D-phenylalanyl-N-(3-chlorobenzyl)-L-prolinamide,CJHLRGCXPGIPCB-MOPGFXCFSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
138226,6w9c,DB09495,-7.5,Avobenzone,XNEFYCZVKIDDMS-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138222,6w9c,DB09477,-7.5,Enalaprilat,LZFZMUMEGBBDTC-QEJZJMRPSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
35487,1r42,DB01668,-7.5,Nanaomycin D,XUWPJKDMEZSVTP-UOSCCXBLSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
145004,6w9q,DB06847,-7.5,"5-[(3S)-3-(2-methoxybiphenyl-4-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",YYCPXVRHQUEVAW-CQSZACIVSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
98266,6vxs,DB00741,-7.5,Hydrocortisone,JYGXADMDTFJGBT-VWUMJDOOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
138158,6w9c,DB09246,-7.5,Benmoxin,BEWNZPMDJIGBED-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138169,6w9c,DB09262,-7.5,Imidafenacin,SQKXYSGRELMAAU-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
15552,6lzg,DB00206,-7.5,Reserpine,QEVHRUUCFGRFIF-MDEJGZGSSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
154557,6wiq,DB08011,-7.5,"(3E)-5-fluoro-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-1H-indole-2,3-dione 3-oxime",DXIHOIDYHQSQKJ-HMMYKYKNSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
23732,6cs2,DB01333,-7.5,Cefradine,RDLPVSKMFDYCOR-UEKVPHQBSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
102091,6vxs,DB06999,-7.5,"N-{3-[(5-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)carbonyl]-2,4-difluorophenyl}propane-1-sulfonamide",YZDJQTHVDDOVHR-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
70300,6lxt,DB12436,-7.5,Vofopitant,XILNRORTJVDYRH-HKUYNNGSSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
138210,6w9c,DB09355,-7.5,Sulfabenzamide,PBCZLFBEBARBBI-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
14060,6lzg,T3D3677,-7.5,Cytochalasin C,NAIODHJWOHMDJX-BBXOWAOSSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
12914,6lzg,DB14029,-7.5,Furafylline,HMZQULPVMKITSP-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
66793,6lxt,DB04651,-7.5,BIOTINOL-5-AMP,KBOGUFFJCBPJEH-SQGSUPJISA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
61081,6crv,DB11481,-7.5,Atipamezole,HSWPZIDYAHLZDD-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
98256,6vxs,DB00728,-7.5,Rocuronium,YXRDKMPIGHSVRX-OOJCLDBCSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
61074,6crv,DB11468,-7.5,Tiamulin,UURAUHCOJAIIRQ-QGLSALSOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
157956,6wiq,DB15003,-7.5,PF-06700841,BUWBRTXGQRBBHG-MJBXVCDLSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
145035,6w9q,DB06884,-7.5,4-HYDROXY-N'-(4-ISOPROPYLBENZYL)BENZOHYDRAZIDE,MFDXHRPPSJRQFX-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
145046,6w9q,DB06897,-7.5,"3-[3-chloro-5-(5-{[(1S)-1-phenylethyl]amino}isoxazolo[5,4-c]pyridin-3-yl)phenyl]propan-1-ol",MMGKIHLBFPJYJL-HNNXBMFYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
63581,6lxt,DB00448,-7.5,Lansoprazole,MJIHNNLFOKEZEW-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
136377,6w9c,DB07047,-7.5,"2',4'-DICHLORO-4-HYDROXY-1,1'-BIPHENYL-3-CARBOXYLIC ACID",SKAFZYDMDHPPJM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
157959,6wiq,DB15011,-7.5,Avacopan,PUKBOVABABRILL-YZNIXAGQSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
154541,6wiq,DB07993,-7.5,"N-3-[3-(1H-INDOL-6-YL)BENZYL]PYRIDINE-2,3-DIAMINE",LPQUIIHPUGDHJK-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
157962,6wiq,DB15385,-7.5,Acebilustat,GERJIEKMNDGSCS-DQEYMECFSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
89982,6m71,DB01120,-7.5,Gliclazide,BOVGTQGAOIONJV-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
138312,6w9c,DB11378,-7.5,Buquinolate,LVVXOXRUTDAKFE-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
143062,6w9q,DB03020,-7.5,5-Beta-D-Ribofuranosylnicotinamide Adenine Dinucleotide,UINNILASBHZOTM-KMXXXSRASA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
63636,6lxt,DB00519,-7.5,Trandolapril,VXFJYXUZANRPDJ-WTNASJBWSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
68331,6lxt,DB07795,-7.5,Fisetin,XHEFDIBZLJXQHF-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
90634,6m71,DB02001,-7.5,"5-(4-Morpholin-4-Yl-Phenylsulfanyl)-2,4-Quinazolinediamine",CZLWCJRHDBTCGQ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
158090,7bv1,DB00367,-7.5,Levonorgestrel,WWYNJERNGUHSAO-XUDSTZEESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
158093,7bv1,DB00370,-7.5,Mirtazapine,RONZAEMNMFQXRA-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
138376,6w9c,DB11507,-7.5,Cloprostenol,VJGGHXVGBSZVMZ-QIZQQNKQSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
65492,6lxt,DB02905,-7.5,"Phosphoric Acid Mono-[3,4-Dihydroxy-5-(5-Hydroxy-Benzoimidazol-1-Yl)Tetrahydro-Furan-2-Ylmethyl] Ester",BVZASCINAVSQNO-PULFBKJNSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
136058,6w9c,DB06442,-7.5,Avasimibe,PTQXTEKSNBVPQJ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
60965,6crv,DB11157,-7.5,Anthralin,NUZWLKWWNNJHPT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
70369,6lxt,DB12543,-7.5,Samidorphan,RYIDHLJADOKWFM-MAODMQOUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
94537,6m71,DB08223,-7.5,"N-{(1S,2R)-1-BENZYL-3-[(CYCLOPROPYLMETHYL)(2-FURYLSULFONYL)AMINO]-2-HYDROXYPROPYL}-N'-METHYLSUCCINAMIDE",IKOPFHKAECNGQI-VQTJNVASSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
66050,6lxt,DB03672,-7.5,9-N-Phenylmethylamino-Tacrine,JYJAEHAURXXPSD-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
148241,6w9q,DB13164,-7.5,Olmutinib,FDMQDKQUTRLUBU-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
66777,6lxt,DB04632,-7.5,4-(2-HYDROXYBENZYLAMINO)-N-(3-(4-FLUOROPHENOXY)PHENYL)PIPERIDINE-1-SULFONAMIDE,JHHBGNIRSUTQAS-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
98906,6vxs,DB01553,-7.5,Cloxazolam,ZIXNZOBDFKSQTC-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
23714,6cs2,HMDB0240252,-7.5,Salicyluric beta-D-glucuronide,OEPADIDIUZTYOX-QKZHPOIUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
35413,1r42,DB01572,-7.5,Methyl-1-testosterone,JRNSSSJKIGAFCT-YDSAWKJFSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
101362,6vxs,DB04824,-7.5,Phenolphthalein,KJFMBFZCATUALV-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
12681,6lzg,DB13675,-7.5,Metahexamide,XXYTXQGCRQLRHA-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
154401,6wiq,DB07830,-7.5,"(4R,5R)-5-AMINO-1-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN-2-ONE",DIRIFWIKLRTNMB-DYVFJYSZSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
60948,6crv,DB11071,-7.5,Phenyl salicylate,ZQBAKBUEJOMQEX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
63745,6lxt,DB00652,-7.5,Pentazocine,VOKSWYLNZZRQPF-GDIGMMSISA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
98080,6vxs,DB00519,-7.5,Trandolapril,VXFJYXUZANRPDJ-WTNASJBWSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
68307,6lxt,DB07768,-7.5,Epitestosterone,MUMGGOZAMZWBJJ-KZYORJDKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
138425,6w9c,DB11644,-7.5,Tafamidis,TXEIIPDJKFWEEC-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
98099,6vxs,DB00543,-7.5,Amoxapine,QWGDMFLQWFTERH-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
16137,6lzg,DB02877,-7.5,Arotinoid acid,FOIVPCKZDPCJJY-JQIJEIRASA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
154423,6wiq,DB07856,-7.5,6-{4-[4-(4-CHLOROPHENYL)PIPERIDIN-4-YL]PHENYL}-9H-PURINE,HPWBHQIUIBFTQC-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
158088,7bv1,DB00365,-7.5,Grepafloxacin,AIJTTZAVMXIJGM-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95573,6m71,DB11619,-7.5,Gestrinone,BJJXHLWLUDYTGC-ANULTFPQSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
140547,6w9c,DB12043,-7.5,Sepetaprost,BKVUSNOUTQMSBE-XCMGCKIWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
98191,6vxs,DB00655,-7.5,Estrone,DNXHEGUUPJUMQT-CBZIJGRNSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102145,6vxs,DB07058,-7.5,"5-[1-(4-methoxyphenyl)-1H-benzimidazol-6-yl]-1,3,4-oxadiazole-2(3H)-thione",QBVJMUOTMRYUKR-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102150,6vxs,DB07064,-7.5,"(4R)-4-(3-HYDROXYPHENYL)-N,N,7,8-TETRAMETHYL-3,4-DIHYDROISOQUINOLINE-2(1H)-CARBOXAMIDE",HPVCRUIDFODATB-LJQANCHMSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
143047,6w9q,DB02998,-7.5,Metribolone,CCCIJQPRIXGQOE-XWSJACJDSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
63658,6lxt,DB00546,-7.5,Adinazolam,GJSLOMWRLALDCT-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
147081,6w9q,DB11259,-7.5,Diosmetin,MBNGWHIJMBWFHU-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
90583,6m71,DB01937,-7.5,Guanosine-2'-Monophosphate,WTIFIAZWCCBCGE-UUOKFMHZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
63666,6lxt,DB00554,-7.5,Piroxicam,QYSPLQLAKJAUJT-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
23973,6cs2,DB01619,-7.5,Phenindamine,ISFHAYSTHMVOJR-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
63708,6lxt,DB00605,-7.5,Sulindac,MLKXDPUZXIRXEP-MFOYZWKCSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
67296,6lxt,DB06370,-7.5,Indisulam,SETFNECMODOHTO-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
66783,6lxt,DB04640,-7.5,"Naphthalene-2,6-disulfonic acid",FITZJYAVATZPMJ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
102180,6vxs,DB07102,-7.5,(2S)-2-amino-5-oxo-5-[(4-phenylmethoxyphenyl)amino]pentanoic acid,BYSBXIPCDJNEBG-INIZCTEOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101376,6vxs,DB04839,-7.5,Cyproterone acetate,UWFYSQMTEOIJJG-FDTZYFLXSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
14794,6lzg,T3D4753,-7.5,Spironolactone,LXMSZDCAJNLERA-ZHYRCANASA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
63684,6lxt,DB00578,-7.5,Carbenicillin,FPPNZSSZRUTDAP-UWFZAAFLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
150006,6wiq,DB00846,-7.5,Flurandrenolide,POPFMWWJOGLOIF-XWCQMRHXSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
16241,6lzg,DB03336,-7.5,BIA,KVIVJQWOYSWCCZ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
146520,6w9q,DB08631,-7.5,"N-(4-CHLOROPHENYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONAMIDE",UVSIFVBCHJEYJP-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
152535,6wiq,DB04177,-7.5,"4-(3,14-Dihydroxy-10,13-Dimethyl-Hexadecahydro-Cyclopenta[a]Phenanthren-17-Yl)-5h-Furan-2-One",XZTUSOXSLKTKJQ-CESUGQOBSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
67316,6lxt,DB06436,-7.5,Semaxanib,WUWDLXZGHZSWQZ-WQLSENKSSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
93223,6m71,DB06620,-7.5,Aplindore,DYJIKHYBKVODAC-ZDUSSCGKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
158077,7bv1,DB00349,-7.5,Clobazam,CXOXHMZGEKVPMT-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
24752,6cs2,DB02538,-7.5,"N-[4-(2-Methylimidazo[1,2-a]Pyridin-3-Yl)-2-Pyrimidinyl]Acetamide",ZCRPPLDDHBLUES-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
98277,6vxs,DB00755,-7.5,Tretinoin,SHGAZHPCJJPHSC-YCNIQYBTSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
147021,6w9q,DB09371,-7.5,Norethynodrel,ICTXHFFSOAJUMG-SLHNCBLASA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
98837,6vxs,DB01474,-7.5,"17alpha-methyl-3beta,17beta-dihydroxyandrost-4-ene",BNUOCVTVOYWNJC-DTMQFJJTSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
68491,6lxt,DB07981,-7.5,2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]-n-[(1R)-1-(hydroxymethyl)propyl]acetamide,GKJWXEORYGBJFS-QGZVFWFLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
150116,6wiq,DB00972,-7.5,Azelastine,MBUVEWMHONZEQD-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
92633,6m71,DB04659,-7.5,"(1S,2S,3R,4S,5S)-2,3,4-TRIHYDROXY-5-(HYDROXYMETHYL)CYCLOHEXYL (1E)-2-PHENYL-N-(SULFOOXY)ETHANIMIDOTHIOATE",LZDZCEOFJWRJIA-GGASBGQWSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
144818,6w9q,DB06472,-7.5,Fradafiban,IKZACQMAVUIGPY-HOTGVXAUSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
23922,6cs2,DB01561,-7.5,Androstanedione,RAJWOBJTTGJROA-WZNAKSSCSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
68488,6lxt,DB07976,-7.5,3-{[(3-FLUORO-3'-METHOXYBIPHENYL-4-YL)AMINO]CARBONYL}THIOPHENE-2-CARBOXYLIC ACID,GIUMGVUBDBDTDX-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
98361,6vxs,DB00854,-7.5,Levorphanol,JAQUASYNZVUNQP-USXIJHARSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
157254,6wiq,DB15048,-7.5,Licogliflozin,XFJAMQQAAMJFGB-ZQGJOIPISA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
23923,6cs2,DB01562,-7.5,1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine,BVURVTVDNWSNFN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
154660,6wiq,DB08126,-7.5,"3-{[4-([AMINO(IMINO)METHYL]AMINOSULFONYL)ANILINO]METHYLENE}-2-OXO-2,3-DIHYDRO-1H-INDOLE",DMCRNUMVSATRTP-LCYFTJDESA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
136739,6w9c,DB07476,-7.5,N-[4-(AMINOSULFONYL)PHENYL]-2-MERCAPTOBENZAMIDE,MRLVIVXGUGNENL-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
90034,6m71,DB01179,-7.5,Podofilox,YJGVMLPVUAXIQN-XVVDYKMHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
143471,6w9q,DB03583,-7.5,"(2e,3s)-3-Hydroxy-5'-[(4-Hydroxypiperidin-1-Yl)Sulfonyl]-3-Methyl-1,3-Dihydro-2,3'-Biindol-2'(1'h)-One",AYOAIABDFUJDKQ-SQJPUDIVSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
12747,6lzg,DB13756,-7.5,Peruvoside,PMTSPAGBAFCORP-HBUONDEYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
151913,6wiq,DB03336,-7.5,BIA,KVIVJQWOYSWCCZ-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
136691,6w9c,DB07419,-7.5,S-23,SSFVOEAXHZGTRJ-KRWDZBQOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
65997,6lxt,DB03596,-7.5,N-[2-(1h-Indol-5-Yl)-Butyl]-4-Sulfamoyl-Benzamide,FSRPBGBMEKDSIJ-CYBMUJFWSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
90339,6m71,DB01607,-7.5,Ticarcillin,OHKOGUYZJXTSFX-KZFFXBSXSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
147851,6w9q,DB12540,-7.5,Lecozotan,NRPQELCNMADTOZ-OAQYLSRUSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
136676,6w9c,DB07401,-7.5,METHYL (2Z)-2-(2-{[6-(2-CYANOPHENOXY)PYRIMIDIN-4-YL]OXY}PHENYL)-3-METHOXYACRYLATE,WFDXOXNFNRHQEC-GHRIWEEISA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136675,6w9c,DB07400,-7.5,1-ETHOXYCARBONYL-D-PHE-PRO-2(4-AMINOBUTYL)HYDRAZINE,AEHSFPPTWRQOFS-MSOLQXFVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
90022,6m71,DB01166,-7.5,Cilostazol,RRGUKTPIGVIEKM-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
144866,6w9q,DB06603,-7.5,Panobinostat,FPOHNWQLNRZRFC-ZHACJKMWSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
155098,6wiq,DB08659,-7.5,2-(hydrazinocarbonyl)-3-phenyl-1H-indole-5-sulfonamide,PPDLAUCFAOODER-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
35567,1r42,DB01774,-7.5,Adenosine-5'-Monophosphate Glucopyranosyl-Monophosphate Ester,WFPZSXYXPSUOPY-ROYWQJLOSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
157770,6wiq,DB12794,-7.5,p-Quaterphenyl,GPRIERYVMZVKTC-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
65350,6lxt,DB02715,-7.5,Compound 18,UZOOIPXOYYJULJ-RHLLTPQKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
4134,6lzg,HMDB0050326,-7.5,TG(20:1(11Z)/15:0/20:3n6),SOCNQOBFARPJBO-NVTXZIGUSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
87383,6m3m,DB12245,-7.5,Triclabendazole,NQPDXQQQCQDHHW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
101906,6vxs,DB06744,-7.5,ginkgolide-B,SQOJOAFXDQDRGF-MMQTXUMRSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
36750,1r42,DB03337,-7.5,1-(2-Amidinophenyl)-3-(Phenoxyphenyl)Urea,ZHCAYBOLUMAUQX-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
138025,6w9c,DB09039,-7.5,Eliglustat,FJZZPCZKBUKGGU-AUSIDOKSSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
13322,6lzg,DB15143,-7.5,PF-06650833,JKDGKIBAOAFRPJ-ZBINZKHDSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
136812,6w9c,DB07561,-7.5,(2Z)-2-cyano-N-(3'-ethoxybiphenyl-4-yl)-3-hydroxybut-2-enamide,RPILZQUCBKIPAZ-AQTBWJFISA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
154686,6wiq,DB08154,-7.5,3-chloro-5-[2-chloro-5-(1H-indazol-3-ylmethoxy)phenoxy]benzonitrile,WHCLIFOVZDANCU-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
90040,6m71,DB01185,-7.5,Fluoxymesterone,YLRFCQOZQXIBAB-RBZZARIASA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
157257,6wiq,DB15055,-7.5,ABT-639,AGPIHNZOZNKRGT-CYBMUJFWSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
101909,6vxs,DB06747,-7.5,ginkgolide-M,KDKROYXEHCYLJQ-FJFAJXJPSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101925,6vxs,DB06786,-7.5,Halcinonide,MUQNGPZZQDCDFT-JNQJZLCISA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
70178,6lxt,DB12271,-7.5,ORE-1001,NTCCRGGIJNDEAB-IRXDYDNUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
148102,6w9q,DB12937,-7.5,Quercetin-3'-O-phosphate,UWJBYNLLMAPJMM-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
68718,6lxt,DB08240,-7.5,N-(4-CHLOROPHENYL)-3-(PHOSPHONOOXY)NAPHTHALENE-2-CARBOXAMIDE,RQAQWBFHPMSXKR-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
146711,6w9q,DB08865,-7.5,Crizotinib,KTEIFNKAUNYNJU-GFCCVEGCSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
98367,6vxs,DB00860,-7.5,Prednisolone,OIGNJSKKLXVSLS-VWUMJDOOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
68496,6lxt,DB07986,-7.5,[4-(4-PHENYL-PIPERIDIN-1-YL)-BENZENESULFONYLAMINO]-ACETIC ACID,GNSLACGSDSJAIQ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
150117,6wiq,DB00973,-7.5,Ezetimibe,OLNTVTPDXPETLC-XPWALMASSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
157760,6wiq,DB12776,-7.5,E-6005,BBTFKAOFCSOZMB-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
157765,6wiq,DB12784,-7.5,NS-018,UQTPDWDAYHAZNT-AWEZNQCLSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
66896,6lxt,DB04796,-7.5,Inecalcitol,HHGRMHMXKPQNGF-WNSNRMDMSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
68722,6lxt,DB08245,-7.5,1-(2-DEOXY-5-O-PHOSPHONO-BETA-D-ERYTHRO-PENTOFURANOSYL)-5-NITRO-1H-INDOLE,FQCJFJRLZCIFHB-YNEHKIRRSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
65351,6lxt,DB02716,-7.5,7-Methyl-Guanosine-5'-Triphosphate,DKVRNHPCAOHRSI-KQYNXXCUSA-O,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
35865,1r42,DB02177,-7.5,1-Acetyl-4-(4-{4-[(2-Ethoxyphenyl)Thio]-3-Nitrophenyl}Pyridin-2-Yl)Piperazine,GKGJFUXSTSUKPB-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
68509,6lxt,DB08000,-7.5,"2-(CARBOXYMETHYL)-1-OXO-1,2-DIHYDRONAPHTHO[1,2-D]ISOTHIAZOLE-4-CARBOXYLIC ACID 3,3-DIOXIDE",ZTJGXDGAXGWOGR-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
101985,6vxs,DB06874,-7.5,"(6-[4-(AMINOMETHYL)-2,6-DIMETHYLPHENOXY]-2-{[4-(AMINOMETHYL)PHENYL]AMINO}-5-BROMOPYRIMIDIN-4-YL)METHANOL",LSIZSSASMKSUIU-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
93056,6m71,DB06194,-7.5,Elocalcitol,LRLWXBHFPGSUOX-GJQYOBCGSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
36958,1r42,DB03642,-7.5,Benzofuran-2-Carboxylic Acid {(S)-3-Methyl-1-[3-Oxo-1-(Pyridin-2-Ylsulfonyl)Azepan-4-Ylcarbamoyl]Butyl}Amide,VBPPNJCVXGAZDD-PMACEKPBSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
70247,6lxt,DB12367,-7.5,Selurampanel,MCECSFFXUPEPDB-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
23948,6cs2,DB01589,-7.5,Quazepam,IKMPWMZBZSAONZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
144960,6w9q,DB06771,-7.5,Besifloxacin,QFFGVLORLPOAEC-SNVBAGLBSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
98294,6vxs,DB00776,-7.5,Oxcarbazepine,CTRLABGOLIVAIY-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
136520,6w9c,DB07211,-7.5,(2R)-2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}PROPENE-1-SULFONAMIDE,YMJHMJLNQLVUAV-GHYUOPHCSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
101436,6vxs,DB04946,-7.5,Iloperidone,XMXHEBAFVSFQEX-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
157898,6wiq,DB13941,-7.5,Piperaquine,UCRHFBCYFMIWHC-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
68755,6lxt,DB08292,-7.5,"(5Z)-12-CHLORO-13,15-DIHYDROXY-4,7,8,9-TETRAHYDRO-2-BENZOXACYCLOTRIDECINE-1,10(3H,11H)-DIONE",AQKZYZQONWDDLS-IWQZZHSRSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
136511,6w9c,DB07200,-7.5,"(2S,4S,5R)-2-ISOBUTYL-5-(2-THIENYL)-1-[4-(TRIFLUOROMETHYL)BENZOYL]PYRROLIDINE-2,4-DICARBOXYLIC ACID",ZNCZVHCYBGHCHA-XPIZARPCSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
102052,6vxs,DB06948,-7.5,2-ANILINO-6-CYCLOHEXYLMETHOXYPURINE,XWWRLKIBRPJQJX-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
66910,6lxt,DB04816,-7.5,Dantron,QBPFLULOKWLNNW-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
148151,6w9q,DB13016,-7.5,LY-2300559,DWQVYDLTPMGYNE-DEOSSOPVSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
98291,6vxs,DB00773,-7.5,Etoposide,VJJPUSNTGOMMGY-MRVIYFEKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
25162,6cs2,DB03035,-7.5,"1,8-Di-Hydroxy-4-Nitro-Anthraquinone",RIYCICFDXLNQPV-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
147810,6w9q,DB12475,-7.5,Biphenyl dimethyl dicarboxylate,BKRIRZXWWALTPU-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
157918,6wiq,DB14895,-7.5,Vibegron,DJXRIQMCROIRCZ-XOEOCAAJSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
65478,6lxt,DB02889,-7.5,"4-O-(4,6-Dideoxy-4-{[4,5,6-Trihydroxy-3-(Hydroxymethyl)Cyclohex-2-En-1-Yl]Amino}-Beta-D-Lyxo-Hexopyranosyl)-Alpha-D-Erythro-Hexopyranose",SNMISNLUIRCRQE-SFSRYZOZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
98287,6vxs,DB00768,-7.5,Olopatadine,JBIMVDZLSHOPLA-LSCVHKIXSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102065,6vxs,DB06969,-7.5,"2-amino-4-[2,4-dichloro-5-(2-pyrrolidin-1-ylethoxy)phenyl]-N-ethylthieno[2,3-d]pyrimidine-6-carboxamide",WJUNQSYQHHIVFX-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
143162,6w9q,DB03157,-7.5,"N,O-Didansyl-L-Tyrosine",LUBOPDUYHWABFG-NDEPHWFRSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
136479,6w9c,DB07164,-7.5,"N-cyclopropyl-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amine",CAGHIASAHLPQMS-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
102066,6vxs,DB06970,-7.5,"2-CHLORO-N-(3-CYANO-5,6-DIHYDRO-4H-CYCLOPENTA[B]THIOPHEN-2-YL)-5-DIETHYLSULFAMOYL-BENZAMIDE",MZCDQILVXXIMEV-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
138143,6w9c,DB09229,-7.5,Aranidipine,NCUCGYYHUFIYNU-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
23952,6cs2,DB00247,-7.5,Methysergide,KPJZHOPZRAFDTN-NQUBZZJWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
136642,6w9c,DB07358,-7.5,"2-amino-N-(4-methyl-1,3-thiazol-2-yl)-5-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]benzamide",JEBOJMQHVUEKBE-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
155164,6wiq,DB08737,-7.5,"(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-9-OL",FSYFYSFYUHBIHE-GLJUWKHASA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
138107,6w9c,DB09189,-7.5,Daledalin,YFAIJBZEDDOCAN-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
24780,6cs2,DB00338,-7.5,Omeprazole,SUBDBMMJDZJVOS-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
69831,6lxt,DB11765,-7.5,PF-04991532,GKMLFBRLRVQVJO-ZDUSSCGKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
87330,6m3m,DB12170,-7.5,Veledimex,LZWZPGLVHLSWQX-XMMPIXPASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136628,6w9c,DB07343,-7.5,"4-[4-AMINO-6-(2,6-DICHLORO-PHENOXY)-[1,3,5]TRIAZIN-2-YLAMINO]-BENZONITRILE",NFNNMVVXXITVGD-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
157801,6wiq,DB12848,-7.5,PF-04217903,PDMUGYOXRHVNMO-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
136619,6w9c,DB07332,-7.5,"ALPHA-(2,6-DICHLOROPHENYL)-ALPHA-(2-ACETYL-5-METHYLANILINO)ACETAMIDE",CJPLEFFCVDQQFZ-INIZCTEOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
66804,6lxt,DB04664,-7.5,Cyclohexyl-pentyl-maltoside,RVTGFZGNOSKUDA-ZNGNCRBCSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
136615,6w9c,DB07328,-7.5,"METHYL 4-{[({[(2R,5S)-5-{[(2S)-2-(AMINOMETHYL)PYRROLIDIN-1-YL]CARBONYL}PYRROLIDIN-2-YL]METHYL}AMINO)CARBONYL]AMINO}BENZOATE",USDCNOQKDUFKRD-IKGGRYGDSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
66003,6lxt,DB03605,-7.5,"(2s)-2-[(2,4-Dichloro-Benzoyl)-(3-Trifluoromethyl-Benzyl)-Amino]-3-Phenyl-Propionic Acid",LAJJKGIZTCCOHY-NRFANRHFSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
98341,6vxs,DB00831,-7.5,Trifluoperazine,ZEWQUBUPAILYHI-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
138093,6w9c,DB09174,-7.5,Lofentanil,IMYHGORQCPYVBZ-NLFFAJNJSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
95518,6m71,DB11464,-7.5,Sulfaquinoxaline,NHZLNPMOSADWGC-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
148138,6w9q,DB12996,-7.5,Acteoside,FBSKJMQYURKNSU-ZLSOWSIRSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
87295,6m3m,DB12117,-7.5,Mitometh,MOTIYCLHZZLHHQ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
138100,6w9c,DB09182,-7.5,Benzylfentanyl,POQDXIFVWVZVML-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
68452,6lxt,DB07935,-7.5,"5-[(5-fluoro-3-methyl-1H-indazol-4-yl)oxy]benzene-1,3-dicarbonitrile",JYAHFMKZJRVTDT-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
98324,6vxs,DB00813,-7.5,Fentanyl,PJMPHNIQZUBGLI-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
143337,6w9q,DB03383,-7.5,5-Chloro-1h-Indole-2-Carboxylic Acid [1-(4-Fluorobenzyl)-2-(4-Hydroxypiperidin-1yl)-2-Oxoethyl]Amide,YDCGVASFVACWKF-NRFANRHFSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
136601,6w9c,DB07313,-7.5,5-METHYL-2-[(PHENYLSULFONYL)AMINO]BENZOIC ACID,HXQLTRSIZRSFTR-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
24775,6cs2,DB02567,-7.5,PD173955,VAARYSWULJUGST-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
63521,6lxt,DB00377,-7.5,Palonosetron,CPZBLNMUGSZIPR-NVXWUHKLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
102026,6vxs,DB06919,-7.5,D-phenylalanyl-N-(3-chlorobenzyl)-L-prolinamide,CJHLRGCXPGIPCB-MOPGFXCFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
98862,6vxs,DB01503,-7.5,1-Androstenediol,RZFGPAMUAXASRE-YSZCXEEOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102030,6vxs,DB06923,-7.5,2-(3-METHYLPHENYL)-1H-INDOLE-5-CARBOXIMIDAMIDE,KJUSXMYSVXZFDJ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
69829,6lxt,DB11763,-7.5,Momelotinib,ZVHNDZWQTBEVRY-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
40231,6lu7,DB12703,-7.5,Omipalisib,CGBJSGAELGCMKE-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
101020,6vxs,DB04366,-7.5,3'-Deoxy 3'-Amino Adenosine-5'-Diphosphate,VKODIDNZKBYXJO-QYYRPYCUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
40230,6lu7,DB15442,-7.5,Trilaciclib,PDGKHKMBHVFCMG-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
14399,6lzg,T3D4103,-7.5,Nantenine,WSVWKHTVFGTTKJ-AWEZNQCLSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
132465,6w9c,DB00459,-7.5,Acitretin,IHUNBGSDBOWDMA-AQFIFDHZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139915,6w9c,DB14543,-7.5,Hydrocortisone probutate,FOGXJPFPZOHSQS-AYVLZSQQSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
93765,6m71,DB07323,-7.5,"2-[({2-[(1Z)-3-(DIMETHYLAMINO)PROP-1-ENYL]-4-FLUOROPHENYL}SULFONYL)AMINO]-5,6,7,8-TETRAHYDRONAPHTHALENE-1-CARBOXYLIC ACID",CTZLIARLNXSXGL-ALCCZGGFSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
85742,6m3m,DB08012,-7.5,(METHYLPYRIDAZINE PIPERIDINE ETHYLOXYPHENYL)ETHYLACETATE,KCHIOGFOPPOUJC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
149025,6w9q,DB14737,-7.5,Cannabinol,VBGLYOIFKLUMQG-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
153149,6wiq,DB05263,-7.5,Caprospinol,VMOZFSWFUBLCNN-AAPULDEBSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
99934,6vxs,DB02902,-7.5,3'-Phosphate-Adenosine-5'-Phosphate Sulfate,GACDQMDRPRGCTN-KQYNXXCUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
139932,6w9c,DB14596,-7.5,Loteprednol etabonate,DMKSVUSAATWOCU-HROMYWEYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
146031,6w9q,DB08039,-7.5,"(3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE",LOGJQOUIVKBFGH-YBEGLDIGSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
139945,6w9c,DB14635,-7.5,Curcumin sulfate,NEJVQQBBTRFOHB-FCXRPNKRSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
23131,6cs2,HMDB0059586,-7.5,Perfluorooctanesulfonic acid,YFSUTJLHUFNCNZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
34718,1r42,DB00699,-7.5,Nicergoline,YSEXMKHXIOCEJA-FVFQAYNVSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
92152,6m71,DB04020,-7.5,"4-(2-{[4-{[3-(4-Chlorophenyl)Propyl]Sulfanyl}-6-(1-Piperazinyl)-1,3,5-Triazin-2-Yl]Amino}Ethyl)Phenol",AIBKIFHSQQYXLG-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
62410,6crv,DB13541,-7.5,Iprazochrome,XZKVIDLLLOUTSS-ZSOIEALJSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
146023,6w9q,DB08031,-7.5,"N-[(13-CYCLOHEXYL-6,7-DIHYDROINDOLO[1,2-D][1,4]BENZOXAZEPIN-10-YL)CARBONYL]-2-METHYL-L-ALANINE",LNQWELVSNCYKDU-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
62408,6crv,DB13538,-7.5,Guacetisal,HSJFYRYGGKLQBT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
34713,1r42,DB00694,-7.5,Daunorubicin,STQGQHZAVUOBTE-VGBVRHCVSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
139959,6w9c,DB14650,-7.5,Menadiol diphosphate,JTNHOVZOOVVGHI-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
149058,6w9q,DB14821,-7.5,Macozinone,BJDZBXGJNBMCAV-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
140946,6w9q,DB00303,-7.5,Ertapenem,JUZNIMUFDBIJCM-ANEDZVCMSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
59893,6crv,DB07996,-7.5,5-(2-methylpiperazine-1-sulfonyl)isoquinoline,BDVFVCGFMNCYPV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
132391,6w9c,DB00372,-7.5,Thiethylperazine,XCTYLCDETUVOIP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
89172,6m71,DB00162,-7.5,Vitamin A,FPIPGXGPPPQFEQ-OVSJKPMPSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
103398,6vxs,DB08531,-7.5,"5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",CVYWYUAQFJMLEO-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
64565,6lxt,DB01682,-7.5,6'-Methyl-Thiamin Diphosphate,XTYXJYCWAJSHCY-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
100385,6vxs,DB03509,-7.5,2-(4-Chlorophenyl)-5-Quinoxalinecarboxamide,FLYGLPYJEQPCFY-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
92189,6m71,DB04073,-7.5,N-{3-[4-(3-aminopropyl)piperazin-1-yl]propyl}-3-(beta-D-galactopyranosyloxy)-5-nitrobenzamide,UEIGEWJJVQHIAX-DLBZZEGUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
156211,6wiq,DB12574,-7.5,LY-295501,VAMFSFIPDOODFH-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
94925,6m71,DB08702,-7.5,"2,5-DIPHENYLFURAN-3,4-DICARBOXYLIC ACID",QPKYPOMZPFDBEZ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
92181,6m71,DB04064,-7.5,Nogalaviketone,QHNJNOBWURJIEK-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93791,6m71,DB07352,-7.5,Apigenin,KZNIFHPLKGYRTM-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
62162,6crv,DB13211,-7.5,Guanoxan,HIUVKVDQFXDZHU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
103335,6vxs,DB08458,-7.5,(4-BROMOPHENYL)[4-({(2E)-4-[CYCLOPROPYL(METHYL)AMINO]BUT-2-ENYL}OXY)PHENYL]METHANONE,JAZMZJDLZUDIDG-NSCUHMNNSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
159613,7bv1,DB04915,-7.5,Idronoxil,ZZUBHVMHNVYXRR-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
103339,6vxs,DB08462,-7.5,N-(4-PHENYLAMINO-QUINAZOLIN-6-YL)-ACRYLAMIDE,JGWHILNNHLDARR-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
95956,6m71,DB12193,-7.5,Ajulemic acid,YCHYFHOSGQABSW-RTBURBONSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
132508,6w9c,DB00514,-7.5,Dextromethorphan,MKXZASYAUGDDCJ-NJAFHUGGSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
66370,6lxt,DB04092,-7.5,Apstatin,YVUUZAPYLPWFHE-HXFGRODQSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
95957,6m71,DB12194,-7.5,Atamestane,PEPMWUSGRKINHX-TXTPUJOMSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
64516,6lxt,DB01619,-7.5,Phenindamine,ISFHAYSTHMVOJR-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
67794,6lxt,DB07167,-7.5,5-CYANO-FURAN-2-CARBOXYLIC ACID [5-HYDROXYMETHYL-2-(4-METHYL-PIPERIDIN-1-YL)-PHENYL]-AMIDE,NNPCFFIJVKYGHR-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
99897,6vxs,DB02854,-7.5,Aetiocholanolone,QGXBDMJGAMFCBF-BNSUEQOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
67793,6lxt,DB07165,-7.5,N-(5-CHLORO-BENZO[B]THIOPHEN-3-YLMETHYL)-2-[6-CHLORO-OXO-3-(2-PYRIDIN-2-YL-ETHYLAMINO)-2H-PYRAZIN-1-YL]-ACETAMIDE,SOBGXPPOYFFGTK-UGKGYDQZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
99901,6vxs,DB02859,-7.5,Soraphen A,WPMGNXPRKGXGBO-OFQQMTDKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
89519,6m71,DB00580,-7.5,Valdecoxib,LNPDTQAFDNKSHK-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
147398,6w9q,DB11883,-7.5,SB-705498,JYILLRHXRVTRSH-GFCCVEGCSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
64540,6lxt,DB01645,-7.5,Genistein,TZBJGXHYKVUXJN-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
69086,6lxt,DB08694,-7.5,"9-amino-5-(2-aminopyrimidin-4-yl)pyrido[3',2':4,5]pyrrolo[1,2-c]pyrimidin-4-ol",RTHKPHCVZVYDFN-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
85751,6m3m,DB08021,-7.5,5-bromo-N-(3-chloro-2-(4-(prop-2-ynyl)piperazin-1-yl)phenyl)furan-2-carboxamide,MEFJFXHHHNDHEN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
132469,6w9c,DB00467,-7.5,Enoxacin,IDYZIJYBMGIQMJ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
145596,6w9q,DB07534,-7.5,"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE",BKUMVXIXUVYKDQ-GHXNOFRVSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
153599,6wiq,DB06897,-7.5,"3-[3-chloro-5-(5-{[(1S)-1-phenylethyl]amino}isoxazolo[5,4-c]pyridin-3-yl)phenyl]propan-1-ol",MMGKIHLBFPJYJL-HNNXBMFYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
153592,6wiq,DB06888,-7.5,"(13R,15S)-13-METHYL-16-OXA-8,9,12,22,24-PENTAAZAHEXACYCLO[15.6.2.16,9.1,12,15.0,2,7.0,21,25]HEPTACOSA-1(24),2,4,6,17(25),18,20-HEPTAENE-23,26-DIONE",KBLPHMRCKHFBJB-OLZOCXBDSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
132270,6w9c,DB00229,-7.5,Cefotiam,QYQDKDWGWDOFFU-IUODEOHRSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
85661,6m3m,DB07922,-7.5,N-oxo-2-(phenylsulfonylamino)ethanamide,LBEMJFIVKDOIBO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
91775,6m71,DB03510,-7.5,6-O-Phosphoryl Inosine Monophosphate,RXRZOKQPANIEDW-KQYNXXCUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
66558,6lxt,DB04338,-7.5,SB220025,VSPFURGQAYMVAN-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
100006,6vxs,DB02998,-7.5,Metribolone,CCCIJQPRIXGQOE-XWSJACJDSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
67051,6lxt,DB05255,-7.5,Ronacaleret,FQJISUPNMFRIFZ-HXUWFJFHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
140877,6w9q,DB00224,-7.5,Indinavir,CBVCZFGXHXORBI-PXQQMZJSSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
146006,6w9q,DB08013,-7.5,(METHYLPYRIDAZINE PIPERIDINE PROPYLOXYPHENYL)ETHYLACETATE,UEIUDEUUVLYRFV-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
71201,6lxt,DB13778,-7.5,Cefazedone,VTLCNEGVSVJLDN-MLGOLLRUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
159739,7bv1,DB05542,-7.5,Naronapride,VGDDOIZXGFJDRC-VJTSUQJLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
103442,6vxs,DB08582,-7.5,"N-(4-bromo-2-{[(3R,5S)-3,5-dimethylpiperidin-1-yl]carbonyl}phenyl)-4-morpholin-4-yl-4-oxobutanamide",DELARNBPJXTDBD-IYBDPMFKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
24391,6cs2,DB02116,-7.5,Olomoucine,GTVPOLSIJWJJNY-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
89229,6m71,DB00229,-7.5,Cefotiam,QYQDKDWGWDOFFU-IUODEOHRSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
140090,6w9c,DB14921,-7.5,Mavacamten,RLCLASQCAPXVLM-NSHDSACASA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140091,6w9c,DB14924,-7.5,PF-06651600,CBRJPFGIXUFMTM-WDEREUQCSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
69277,6lxt,DB08951,-7.5,Indoprofen,RJMIEHBSYVWVIN-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
59833,6crv,DB07929,-7.5,"N-(TERT-BUTYL)-3,5-DIMETHYL-N'-[(5-METHYL-2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)CARBONYL]BENZOHYDRAZIDE",JGJACZABNQGPMT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85639,6m3m,DB07893,-7.5,PHENYL[1-(N-SUCCINYLAMINO)PENTYL]PHOSPHONATE,FJQWWGCHPFSERW-CQSZACIVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
89487,6m71,DB00542,-7.5,Benazepril,XPCFTKFZXHTYIP-PMACEKPBSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
156139,6wiq,DB12465,-7.5,Ketanserin,FPCCSQOGAWCVBH-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
132161,6w4h,DB09171,-7.5,β-Methylfentanyl,UXIGUKSHASXDNI-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
85633,6m3m,DB07884,-7.5,"ISOPROPYL (2S)-2-ETHYL-7-FLUORO-3-OXO-3,4-DIHYDROQUINOXALINE-1(2H)-CARBOXYLATE",KELNNWMENBUHNS-NSHDSACASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
103463,6vxs,DB08609,-7.5,"(2R)-N-{4-[Ethyl(phenyl)sulfamoyl]-2-methylphenyl}-3,3,3-trifluoro-2-hydroxy-2-methylpropanamide",SHEIQJGQDUYUBE-GOSISDBHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
147505,6w9q,DB12043,-7.5,Sepetaprost,BKVUSNOUTQMSBE-XCMGCKIWSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
96747,6m71,DB13393,-7.5,Emetine,AUVVAXYIELKVAI-CKBKHPSWSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96637,6m71,DB13246,-7.5,Quinupramine,JCBQCKFFSPGEDY-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95985,6m71,DB12235,-7.5,Estetrol,AJIPIJNNOJSSQC-NYLIRDPKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
92859,6m71,DB05100,-7.5,Prinomastat,YKPYIPVDTNNYCN-INIZCTEOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93758,6m71,DB07315,-7.5,"5-chloro-N-{4-[(1R)-1,2-dihydroxyethyl]phenyl}-1H-indole-2-carboxamide",SHCHFGSUYJUEBR-INIZCTEOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
149356,6w9q,DB15449,-7.5,Citarinostat,VLIUIBXPEDFJRF-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
140006,6w9c,DB14735,-7.5,Cannabichromene,UVOLYTDXHDXWJU-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
132366,6w9c,DB00342,-7.5,Terfenadine,GUGOEEXESWIERI-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
132362,6w9c,DB00338,-7.5,Omeprazole,SUBDBMMJDZJVOS-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
91742,6m71,DB03467,-7.5,Naringenin,FTVWIRXFELQLPI-ZDUSSCGKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
34694,1r42,DB00673,-7.5,Aprepitant,ATALOFNDEOCMKK-OITMNORJSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
159689,7bv1,DB05288,-7.5,Anecortave acetate,YUWPMEXLKGOSBF-GACAOOTBSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
132351,6w9c,DB00321,-7.5,Amitriptyline,KRMDCWKBEZIMAB-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
64648,6lxt,DB01791,-7.5,Piclamilast,RRRUXBQSQLKHEL-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
16898,6cs2,HMDB0005021,-7.5,Quetiapine,URKOMYMAXPYINW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
140904,6w9q,DB00253,-7.5,Medrysone,GZENKSODFLBBHQ-ILSZZQPISA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
5454,6lzg,HMDB0001897,-7.5,Substance P,ADNPLDHMAVUMIW-SGTHPBLKSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
36308,1r42,DB02755,-7.5,1-3 Sugar Ring of Pentamannosyl 6-Phosphate,HDQMHAJOIVYOIP-NAVBLJQLSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
95971,6m71,DB12219,-7.5,GSK-424887,DRXBWLBZWAJIEF-IBGZPJMESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
159702,7bv1,DB05395,-7.5,Amibegron,RDJQCOBTKKAQAH-FPOVZHCZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
132310,6w9c,DB00273,-7.5,Topiramate,KJADKKWYZYXHBB-XBWDGYHZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
132307,6w9c,DB00270,-7.5,Isradipine,HMJIYCCIJYRONP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
37419,1r42,DB04240,-7.5,"(1S)-1-C-{(2R)-6-[(2R)-2-Butanyl]-5,10-dihydroxy-4-oxo-1,2,3,4-tetrahydro-2-anthracenyl}-5-deoxy-1-O-methyl-D-xylulose",XGORHSPGULYMCV-HHYQQTLHSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
159710,7bv1,DB05422,-7.5,OPC-14523,TZZGTNZBLPCBIS-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
140040,6w9c,DB14820,-7.5,Profoxydim,KRQUFUKTQHISJB-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
96662,6m71,DB13283,-7.5,Sulfaisodimidine,YZMCKZRAOLZXAZ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
66409,6lxt,DB04142,-7.5,"3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid Dimethylamide",FEYGJZKVMASWJB-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
62153,6crv,DB13181,-7.5,Methylbenactyzium,HDAMOICMOAXFLJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
71103,6lxt,DB13651,-7.5,Lorajmine,LAHDERDHXJFFJU-ZWNKPRIXSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
145578,6w9q,DB07513,-7.5,7-[(3-CHLOROBENZYL)OXY]-4-[(METHYLAMINO)METHYL]-2H-CHROMEN-2-ONE,JMGUSOLCNQVZCT-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
97118,6m71,DB13927,-7.5,anle138b,RCQIIBJSUWYYFU-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
145467,6w9q,DB07382,-7.5,"N-2-1H-benzimidazol-5-yl-N-4-(3-cyclopropyl-1H-pyrazol-5-yl)pyrimidine-2,4-diamine",WJNBSTLIALIIEW-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
66611,6lxt,DB04416,-7.5,"R-2-{[4'-Methoxy-(1,1'-Biphenyl)-4-Yl]-Sulfonyl}-Amino-6-Methoxy-Hex-4-Ynoic Acid",QJKGJGURDPRKGW-LJQANCHMSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
67832,6lxt,DB07210,-7.5,"3-bromo-5-phenyl-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",JECHSYMSTXETFI-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
65103,6lxt,DB02398,-7.5,6-[N-(4-(Aminomethyl)Phenyl)Carbamyl]-2-Naphthalenecarboxamidine,NLBDETRVUYOIHQ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
132838,6w9c,DB00907,-7.5,Cocaine,ZPUCINDJVBIVPJ-LJISPDSOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139716,6w9c,DB13841,-7.5,Clopenthixol,WFPIAZLQTJBIFN-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
146094,6w9q,DB08112,-7.5,N-({6-[(4-CYANO-2-FLUOROBENZYL)OXY]NAPHTHALEN-2-YL}SULFONYL)-D-GLUTAMIC ACID,IRJUSGUHNFMVCK-OAQYLSRUSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
132833,6w9c,DB00902,-7.5,Methdilazine,HTMIBDQKFHUPSX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
93848,6m71,DB07421,-7.5,"4-{[(1R,2S)-1,2-dihydroxy-2-methyl-3-(4-nitrophenoxy)propyl]amino}-2-(trifluoromethyl)benzonitrile",INVUBEGZQHQAMY-SJORKVTESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
147533,6w9q,DB12082,-7.5,Vesnarinone,ZVNYJIZDIRKMBF-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
71024,6lxt,DB13542,-7.5,Bevonium,UHUMRJKDOOEQIG-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
71032,6lxt,DB13551,-7.5,Cinchophen,YTRMTPPVNRALON-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
25743,6cs2,DB03751,-7.5,2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose,YSYKRGRSMLTJNL-URARBOGNSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
100494,6vxs,DB03672,-7.5,9-N-Phenylmethylamino-Tacrine,JYJAEHAURXXPSD-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
145479,6w9q,DB07396,-7.5,"1-{2-[3-(2-Chloro-4,5-difluoro-benzoyl)-ureido]-4-fluoro-phenyl}-piperidine-4-carboxylic acid",KAJJGOCSAXKXBD-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
159471,7bv1,DB04461,-7.5,Coproporphyrinogen III,NIUVHXTXUXOFEB-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
145485,6w9q,DB07403,-7.5,"4-[(3-CHLORO-4-{[(2R)-3,3,3-TRIFLUORO-2-HYDROXY-2-METHYLPROPANOYL]AMINO}PHENYL)SULFONYL]-N,N-DIMETHYLBENZAMIDE",DTDZLJHKVNTQGZ-GOSISDBHSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
71036,6lxt,DB13555,-7.5,Prajmaline,UAUHEPXILIZYCU-ALHOSYKFSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
139729,6w9c,DB13855,-7.5,Nifuroxazide,YCWSUKQGVSGXJO-NTUHNPAUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
62507,6crv,DB13671,-7.5,Sulbentine,QFVAWNPSRQWSDU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
69057,6lxt,DB08656,-7.5,5-amino-2-methyl-N-[(1R)-1-naphthalen-1-ylethyl]benzamide,UVERBUNNCOKGNZ-CQSZACIVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
69337,6lxt,DB09017,-7.5,Brotizolam,UMSGKTJDUHERQW-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
155817,6wiq,DB11775,-7.5,PF-03758309,AYCPARAPKDAOEN-LJQANCHMSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
94959,6m71,DB08737,-7.5,"(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-9-OL",FSYFYSFYUHBIHE-GLJUWKHASA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
37353,1r42,DB04158,-7.5,"6-(Adenosine Tetraphosphate-Methyl)-7,8-Dihydropterin",ZKRKFZJAQKKHKL-SUGPNEFASA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
153088,6wiq,DB04946,-7.5,Iloperidone,XMXHEBAFVSFQEX-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
139679,6w9c,DB13792,-7.5,Clopamide,LBXHRAWDUMTPSE-AOOOYVTPSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
147541,6w9q,DB12096,-7.5,PF-05175157,BDXXSFOJPYSYOC-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
60071,6crv,DB08195,-7.5,(1R)-2-[(CYANOMETHYL)AMINO]-1-({[2-(DIFLUOROMETHOXY)BENZYL]SULFONYL}METHYL)-2-OXOETHYL MORPHOLINE-4-CARBOXYLATE,YKWHKILAGONYKL-HNNXBMFYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
159417,7bv1,DB04116,-7.5,Allolactose,DLRVVLDZNNYCBX-VDGMBKLFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
139693,6w9c,DB13810,-7.5,Dimemorfan,KBEZZLAAKIIPFK-NJAFHUGGSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
145410,6w9q,DB07315,-7.5,"5-chloro-N-{4-[(1R)-1,2-dihydroxyethyl]phenyl}-1H-indole-2-carboxamide",SHCHFGSUYJUEBR-INIZCTEOSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
60065,6crv,DB08188,-7.5,Emivirine,MLILORUFDVLTSP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
132888,6w9c,DB00963,-7.5,Bromfenac,ZBPLOVFIXSTCRZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
100510,6vxs,DB03696,-7.5,Lanosterol,CAHGCLMLTWQZNJ-BQNIITSRSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
60060,6crv,DB08180,-7.5,2-[METHYL-(5-GERANYL-4-METHYL-PENT-3-ENYL)-AMINO]-ETHYL-DIPHOSPHATE,OEMBPHBKZPOPBN-NWLVNBMCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
93504,6m71,DB07027,-7.5,D-phenylalanyl-N-(3-fluorobenzyl)-L-prolinamide,JGZSVYZIJHGHMA-MOPGFXCFSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
69035,6lxt,DB08631,-7.5,"N-(4-CHLOROPHENYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONAMIDE",UVSIFVBCHJEYJP-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
85973,6m3m,DB08287,-7.5,"(1R,2R)-N-(2-Aminoethyl)-2-{[(4-methoxyphenyl)sulfonyl]methyl}cyclohexanecarboxamide",QTGNVZPFJQOWFL-XJKSGUPXSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85968,6m3m,DB08282,-7.5,"O-[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethyl] (4-chlorophenyl)thiocarbamate",BWRRXOIACQYNEK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
62537,6crv,DB13711,-7.5,Tritoqualine,IRGJVQIJENCTQF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
64399,6lxt,DB01481,-7.5,1-Testosterone,OKJCFMUGMSVJBG-ABEVXSGRSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
69041,6lxt,DB08639,-7.5,Dapivirine,ILAYIAGXTHKHNT-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
85967,6m3m,DB08281,-7.5,"O-[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethyl] (4-bromophenyl)thiocarbamate",BDVAWAILQCYMQE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
62535,6crv,DB13709,-7.5,Ciclonicate,GQSGZTBDVNUIQS-DGCLKSJQSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
99734,6vxs,DB02639,-7.5,4-methylumbelliferyl ??-D-glucoside,YUDPTGPSBJVHCN-JZYAIQKZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
145427,6w9q,DB07333,-7.5,"N-(CYCLOPROPYLMETHYL)-4-(METHYLOXY)-3-({5-[3-(3-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-YL}AMINO)BENZENESULFONAMIDE",KRGKAARWVPUWSY-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
155812,6wiq,DB11769,-7.5,Funapide,NEBUOXBYNAHKFV-NRFANRHFSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
155814,6wiq,DB11772,-7.5,Pilaralisib,QINPEPAQOBZPOF-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
97123,6m71,DB13936,-7.5,JNJ-28330835,RYBKPGYFXRNMMU-LBPRGKRZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95911,6m71,DB12124,-7.5,Namitecan,IBTISPLPBBHVSU-UVOOVGFISA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
147354,6w9q,DB11818,-7.5,Retosiban,PLVGDGRBPMVYPB-FDUHJNRSSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
132787,6w9c,DB00849,-7.5,Methylphenobarbital,ALARQZQTBTVLJV-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
145541,6w9q,DB07469,-7.5,"(3aS)-3a-hydroxy-7-methyl-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one",KAJFGRLMKVNMLH-GOSISDBHSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
36268,1r42,DB02698,-7.5,"N-(M-Trifluoromethylphenyl) Phenoxazine-4,6-Dicarboxylic Acid",NQOOJFXBGLOGTC-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
64470,6lxt,DB01561,-7.5,Androstanedione,RAJWOBJTTGJROA-WZNAKSSCSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
66605,6lxt,DB04407,-7.5,4-[4-(4-Methyl-2-Methylamino-Thiazol-5-Yl)-Pyrimidin-2-Ylamino]-Phenol,OTMLAWRVLMYMDF-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
146052,6w9q,DB08064,-7.5,N-(3-TERT-BUTYL-1H-PYRAZOL-5-YL)-N'-{4-CHLORO-3-[(PYRIDIN-3-YLOXY)METHYL]PHENYL}UREA,NTMADESEDXKNFZ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
97058,6m71,DB13808,-7.5,Mebhydrolin,FQQIIPAOSKSOJM-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
64477,6lxt,DB01568,-7.5,Codeine-N-oxide,BDLSDHWCOJPHIE-KFUGMXNISA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
66997,6lxt,DB04954,-7.5,Tecadenoson,OESBDSFYJMDRJY-BAYCTPFLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
97056,6m71,DB13806,-7.5,Linopirdine,YEJCDKJIEMIWRQ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
132630,6w9c,DB00665,-7.5,Nilutamide,XWXYUMMDTVBTOU-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
59974,6crv,DB08089,-7.5,LGD-2226,ULBPQWIGZUGPHU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
97053,6m71,DB13803,-7.5,Xipamide,MTZBBNMLMNBNJL-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59965,6crv,DB08078,-7.5,{4-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]phenoxy}acetic acid,HBBVCKCCQCQCTJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
159592,7bv1,DB04614,-7.5,(R)-tacrine(10)-hupyridone,ROTFGKJJMRTWBD-HHHXNRCGSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
159593,7bv1,DB04615,-7.5,(S)-tacrine(10)-hupyridone,ROTFGKJJMRTWBD-MHZLTWQESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
139806,6w9c,DB14028,-7.5,Nordazepam,AKPLHCDWDRPJGD-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
97045,6m71,DB13792,-7.5,Clopamide,LBXHRAWDUMTPSE-AOOOYVTPSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
132590,6w9c,DB00613,-7.5,Amodiaquine,OVCDSSHSILBFBN-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
132579,6w9c,DB00601,-7.5,Linezolid,TYZROVQLWOKYKF-ZDUSSCGKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
71093,6lxt,DB13635,-7.5,Tiracizine,KJAMZCVTJDTESW-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
103305,6vxs,DB08422,-7.5,[PHENYLALANINYL-PROLINYL]-[2-(PYRIDIN-4-YLAMINO)-ETHYL]-AMINE,GEIDRYBJURDUSW-MOPGFXCFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
62454,6crv,DB13602,-7.5,Promegestone,QFFCYTLOTYIJMR-XMGTWHOFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
25798,6cs2,DB03809,-7.5,9-Butyl-8-(3-Methoxybenzyl)-9h-Purin-6-Amine,BWLWUGBHOXIUBP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
92208,6m71,DB04097,-7.5,Uridine-5'-Diphosphate-4-Deoxy-4-Fluoro-Alpha-D-Galactose,OAPPZHVTNHJVAL-JZMIEXBBSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
65710,6lxt,DB03202,-7.5,"2-[5-Methanesulfonylamino-2-(4-Aminophenyl)-6-Oxo-1,6-Dihydro-1-Pyrimidinyl]-N-(3,3,3-Trifluoro-1-Isopropyl-2-Oxopropyl)Acetamide",JWSWTHSJMGVOKE-HNNXBMFYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
95944,6m71,DB12174,-7.5,CUDC-101,PLIVFNIUGLLCEK-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
145533,6w9q,DB07458,-7.5,"3-(1H-indol-3-yl)-4-{1-[2-(1-methylpyrrolidin-2-yl)ethyl]-1H-indol-3-yl}-1H-pyrrole-2,5-dione",LBFDERUQORUFIN-KRWDZBQOSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
92838,6m71,DB04982,-7.5,Talampanel,JACAAXNEHGBPOQ-LLVKDONJSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
99794,6vxs,DB02715,-7.5,Compound 18,UZOOIPXOYYJULJ-RHLLTPQKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
132761,6w9c,DB00821,-7.5,Carprofen,PUXBGTOOZJQSKH-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
141156,6w9q,DB00559,-7.5,Bosentan,GJPICJJJRGTNOD-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
141146,6w9q,DB00549,-7.5,Zafirlukast,YEEZWCHGZNKEEK-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
132746,6w9c,DB00805,-7.5,Minaprine,LDMWSLGGVTVJPG-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
99796,6vxs,DB02717,-7.5,Cellotetraose,LUEWUZLMQUOBSB-HGDSAIHNSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
93516,6m71,DB07039,-7.5,(2S)-N-(4-cyano-3-iodophenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide,RXSZCFAPSDTELY-SFHVURJKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
64445,6lxt,DB01536,-7.5,Androstenedione,AEMFNILZOJDQLW-QAGGRKNESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
71042,6lxt,DB13563,-7.5,Norgestrienone,GVDMJXQHPUYPHP-FYQPLNBISA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
89541,6m71,DB00605,-7.5,Sulindac,MLKXDPUZXIRXEP-MFOYZWKCSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94893,6m71,DB08659,-7.5,2-(hydrazinocarbonyl)-3-phenyl-1H-indole-5-sulfonamide,PPDLAUCFAOODER-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
99830,6vxs,DB02766,-7.5,(3r)-3-{[(Benzyloxy)Carbonyl]Amino}-2-Oxo-4-Phenylbutane-1-Diazonium,VLIGBVLLNSWVMI-MRXNPFEDSA-O,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
71051,6lxt,DB13579,-7.5,Mepixanox,PYSOHOOUXFWCFF-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
25761,6cs2,DB03768,-7.5,"N-[2-Hydroxy-2-(8-Isopropyl-6,9-Dioxo-2-Oxa-7,10-Diaza-Bicyclo[11.2.2]Heptadeca-1(16),13(17),14-Trien-11-Yl)-Ethyl]-N-(3-Methyl-Butyl)-Benzenesulfonamide,Inhibitor 3",WRUVOSYKHXGAQN-GKRYNVPLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
146083,6w9q,DB08101,-7.5,"2,6-dibromo-4-[(E)-2-phenylethenyl]phenol",WMVYUPRIADVLTH-VOTSOKGWSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
159545,7bv1,DB04554,-7.5,8-Bromoadenosine-5'-Diphosphate,KVVVTFSHHQCHNZ-UUOKFMHZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
71057,6lxt,DB13587,-7.5,Mesterolone,UXYRZJKIQKRJCF-TZPFWLJSSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
132710,6w9c,DB00760,-7.5,Meropenem,DMJNNHOOLUXYBV-PQTSNVLCSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139785,6w9c,DB13983,-7.5,"5,7,2'-trihydroxy-6,8-dimethoxyflavone",JWOKGWICZPPYPX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
145530,6w9q,DB07455,-7.5,"N,N'-[biphenyl-4,4'-diyldi(2R)propane-2,1-diyl]dimethanesulfonamide",ZESUARCHWPARIF-HOTGVXAUSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
103270,6vxs,DB08378,-7.5,"4-[4-(2,5-DIOXO-PYRROLIDIN-1-YL)-PHENYLAMINO]-4-HYDROXY-BUTYRIC ACID",SUETUOGYOWOLNJ-NSHDSACASA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
132691,6w9c,DB00736,-7.5,Esomeprazole,SUBDBMMJDZJVOS-DEOSSOPVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
132690,6w9c,DB00735,-7.5,Naftifine,OZGNYLLQHRPOBR-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
146086,6w9q,DB08104,-7.5,"N-(3,5-dibromo-4-hydroxyphenyl)benzamide",HKODPZBPODONGO-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
93727,6m71,DB07283,-7.5,"9-benzyl-2,3,4,9-tetrahydro-1H-carbazole-8-carboxylic acid",VDOXYKGIKBUISK-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
91784,6m71,DB03523,-7.5,Brequinar,PHEZJEYUWHETKO-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
132140,6w4h,DB15460,-7.5,AGG-523,JWQMTWCFNZSLNR-DEOSSOPVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
159923,7bv1,DB07085,-7.5,2-{[N-(2-ACETYL-5-CHLORO-4-FLUOROPHENYL)GLYCYL]AMINO}BENZOIC ACID,LBMZLHCAPBBOFS-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
145794,6w9q,DB07770,-7.5,5-(4-FLUOROPHENYL)-3-{[(4-METHYLPHENYL)SULFONYL]AMINO}THIOPHENE-2-CARBOXYLIC ACID,DJPFUQBNQLKCAB-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
153384,6wiq,DB06347,-7.5,Cenisertib,KSOVGRCOLZZTPF-QMKUDKLTSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
69175,6lxt,DB08791,-7.5,"1-[(2-NITROPHENYL)SULFONYL]-1H-PYRROLO[3,2-B]PYRIDINE-6-CARBOXAMIDE",USLOIFPDNUDIEG-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
131732,6w4h,DB14626,-7.5,Pregnenolone acetate,CRRKVZVYZQXICQ-RJJCNJEVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
96073,6m71,DB12357,-7.5,BMS-863233,JJWLXRKVUJDJKG-VIFPVBQESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
100083,6vxs,DB03103,-7.5,Thymidine-5'- Diphosphate,UJLXYODCHAELLY-XLPZGREQSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
140400,6w9c,DB05969,-7.5,SNS-032,OUSFTKFNBAZUKL-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
153380,6wiq,DB06334,-7.5,Tucidinostat,SZMJVTADHFNAIS-BJMVGYQFSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
100187,6vxs,DB03239,-7.5,"3',5'-Dinitro-N-Acetyl-L-Thyronine",VZSQTOXQXPKQJX-ZDUSSCGKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
153376,6wiq,DB06314,-7.5,SGX-523,BCZUAADEACICHN-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
140409,6w9c,DB06061,-7.5,AZD-8330,RWEVIPRMPFNTLO-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
66469,6lxt,DB04215,-7.5,CRA_9076,BVTBOJXEAPSOEB-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
13072,6lzg,DB14646,-7.5,Prednisone acetate,MOVRKLZUVNCBIP-RFZYENFJSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
131726,6w4h,DB14584,-7.5,Segesterone,SFLXYFZGKSGFKA-XUDSTZEESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
150975,6wiq,DB02102,-7.5,DMP450,KYRSNWPSSXSNEP-ZRTHHSRSSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
62294,6crv,DB13380,-7.5,Difemerine,GUONSMXZEYTWML-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
100157,6vxs,DB03205,-7.5,Pyrroloquinoline Quinone,MMXZSJMASHPLLR-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
159932,7bv1,DB07095,-7.5,(S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclopentylpropanoyl)pyrrolidine-2-carboxamide,BNCHHUFGEOJCNH-SFHVURJKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
131710,6w4h,DB14542,-7.5,Hydrocortisone phosphate,BGSOJVFOEQLVMH-VWUMJDOOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
59661,6crv,DB07730,-7.5,"5-(3-HYDROXYPHENYL)ISOTHIAZOL-3(2H)-ONE 1,1-DIOXIDE",FJABEDRGNJSWCC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
91931,6m71,DB03737,-7.5,"4-((3r,4s,5r)-4-Amino-3,5-Dihydroxy-Hex-1-Ynyl)-5-Fluoro-3-[1-(3-Methoxy-1h-Pyrrol-2-Yl)-Meth-(Z)-Ylidene]-1,3-Dihydro-Indol-2-One",RAKYKJWUUUKCCW-MPLBGYFPSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
156025,6wiq,DB12101,-7.5,CC-220,IXZOHGPZAQLIBH-NRFANRHFSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
64878,6lxt,DB02101,-7.5,"(S,R)-fidarestat",WAAPEIZFCHNLKK-QPUJVOFHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
149196,6w9q,DB15132,-7.5,AZD-8165,YUHNXUAATAMVKD-PZJWPPBQSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
147472,6w9q,DB11992,-7.5,Omarigliptin,MKMPWKUAHLTIBJ-ISTRZQFTSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
100198,6vxs,DB03251,-7.5,RWJ-51084,NQABUEUFRXDDFI-AWEZNQCLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
96334,6m71,DB12746,-7.5,AKN-028,JLRIJKVMMZEKDF-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
100240,6vxs,DB03307,-7.5,4-[(6-Amino-4-Pyrimidinyl)Amino]Benzenesulfonamide,FVFVVRPJERUECT-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
64853,6lxt,DB02071,-7.5,WAY-151693,AINJYWXKBKRQSX-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
67641,6lxt,DB06993,-7.5,"(2S,3S)-4-cyclopropyl-3-{(3R,5R)-3-[2-fluoro-4-(methylsulfonyl)phenyl]-1,2,4-oxadiazolidin-5-yl}-1-[(3S)-3-fluoropyrrolidin-1-yl]-1-oxobutan-2-amine",PTAHVQJZNFGPHN-WFWWEWPISA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
145747,6w9q,DB07716,-7.5,"(4Z)-2,8:7,12:11,15:14,18:17,22-PENTAANHYDRO-4,5,6,9,10,13,19,20,21-NONADEOXY-D-ARABINO-D-ALLO-D-ALLO-DOCOSA-4,9,20-TRIENITOL",VDRIXSJOPKVWKM-HXGIDPQASA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
67079,6lxt,DB05422,-7.5,OPC-14523,TZZGTNZBLPCBIS-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
94809,6m71,DB08556,-7.5,"5'-ACETYL-4-{[(2,4-DIMETHYLPHENYL)SULFONYL]AMINO}-2,2'-BITHIOPHENE-5-CARBOXYLIC ACID",CMHHNHDPPWDNAH-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
71288,6lxt,DB13931,-7.5,Netarsudil,OURRXQUGYQRVML-AREMUKBSSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
91898,6m71,DB03695,-7.5,Piritrexim,VJXSSYDSOJBUAV-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
131781,6w4h,DB14677,-7.5,Gestonorone caproate,XURCMZMFZXXQDJ-UKNJCJGYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
159901,7bv1,DB07058,-7.5,"5-[1-(4-methoxyphenyl)-1H-benzimidazol-6-yl]-1,3,4-oxadiazole-2(3H)-thione",QBVJMUOTMRYUKR-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
149271,6w9q,DB15282,-7.5,Fluorofuranylnorprogesterone F-18,VJKRBRUNEOHPBS-JQKUZGBFSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
140348,6w9c,DB04211,-7.5,"(2R,3R,4R,5R,6R)-3-fluoro-2,4-dihydroxy-5-[(1-hydroxyethylidene)amino]-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid",ALJLGESFXXDPKH-RISWTRDCSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
85498,6m3m,DB07733,-7.5,"1-METHYL-3-TRIFLUOROMETHYL-1H-THIENO[2,3-C]PYRAZOLE-5-CARBOXYLIC ACID (2-MERCAPTO-ETHYL)-AMIDE",HDKGQVZBBSICLG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
67537,6lxt,DB06870,-7.5,"17-HYDROXY-18A-HOMO-19-NOR-17ALPHA-PREGNA-4,9,11-TRIEN-3-ONE",OXHNQTSIKGHVBH-ANULTFPQSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
34570,1r42,DB00522,-7.5,Bentiromide,SPPTWHFVYKCNNK-FQEVSTJZSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
96069,6m71,DB12350,-7.5,Rostafuroxin,AEAPORIZZWBIEX-DTBDINHYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96317,6m71,DB12721,-7.5,RO-5028442,QZXVLRCMAHJVIP-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
140695,6w9c,DB13983,-7.5,"5,7,2'-trihydroxy-6,8-dimethoxyflavone",JWOKGWICZPPYPX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
159906,7bv1,DB07064,-7.5,"(4R)-4-(3-HYDROXYPHENYL)-N,N,7,8-TETRAMETHYL-3,4-DIHYDROISOQUINOLINE-2(1H)-CARBOXAMIDE",HPVCRUIDFODATB-LJQANCHMSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
89298,6m71,DB00307,-7.5,Bexarotene,NAVMQTYZDKMPEU-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
159911,7bv1,DB07070,-7.5,(2S)-2-{3-[({[2-fluoro-4-(trifluoromethyl)phenyl]carbonyl}amino)methyl]-4-methoxybenzyl}butanoic acid,BDLLIPYDNFENMY-ZDUSSCGKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
62273,6crv,DB13353,-7.5,Viminol,ZILPIBYANAFGMS-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
66510,6lxt,DB04274,-7.5,"5,4'-Dideoxyflavanone",SWAJPHCXKPCPQZ-AWEZNQCLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
94816,6m71,DB08564,-7.5,(2E)-N-{4-[(3-bromophenyl)amino]quinazolin-6-yl}-4-(dimethylamino)but-2-enamide,ZCIXBBSRVLSRJQ-QPJJXVBHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
64904,6lxt,DB02132,-7.5,Zenarestat,SXONDGSPUVNZLO-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
89307,6m71,DB00318,-7.5,Codeine,OROGSEYTTFOCAN-DNJOTXNNSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
103696,6vxs,DB08910,-7.5,Pomalidomide,UVSMNLNDYGZFPF-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
67563,6lxt,DB06899,-7.5,"N-{2-[6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2,2-DIMETHYL-3-OXO-2,3-DIHYDRO-4H-1,4-BENZOTHIAZIN-4-YL]ETHYL}ACETAMIDE",RMEVNJZCKDVVND-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
59610,6crv,DB07670,-7.5,4-METHYL-N-METHYL-N-(2-PHENYL-2H-PYRAZOL-3-YL)BENZENESULFONAMIDE,KRHPBWNETCEFGS-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140500,6w9c,DB11967,-7.5,Binimetinib,ACWZRVQXLIRSDF-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
96154,6m71,DB12468,-7.5,Pf-04531083,ZRJGMDIPCQOGNI-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
153287,6wiq,DB06117,-7.5,"1alpha,24S-Dihydroxyvitamin D2",ODZFJAXAEXQSKL-WRJREGAQSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
159989,7bv1,DB07161,-7.5,5-phenyl-1H-indazol-3-amine,ZCUSNQPYUNLATP-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
12285,6lzg,DB13158,-7.5,Clobetasone,XXIFVOHLGBURIG-OZCCCYNHSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
131554,6w4h,DB13937,-7.5,LGD-3303,OMXGOGXEWUCLFI-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
26035,6cs2,DB04092,-7.5,Apstatin,YVUUZAPYLPWFHE-HXFGRODQSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
140526,6w9c,DB12008,-7.5,Prexasertib,DOTGPNHGTYJDEP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
89343,6m71,DB00365,-7.5,Grepafloxacin,AIJTTZAVMXIJGM-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
14374,6lzg,T3D4056,-7.5,Debromoaplysiatoxin,REAZZDPREXHWNV-HJUJCDCNSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
153283,6wiq,DB06090,-7.5,Bradanicline,OXKRFEWMSWPKKV-GHTZIAJQSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
145860,6w9q,DB07844,-7.5,6-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1-BENZOTHIOPHENE-2-SULFONAMIDE,PHLKBODTBJLXRD-WFASDCNBSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
149236,6w9q,DB15208,-7.5,NOP-1A,MZBCQWLYUQJXKA-KRWDZBQOSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
92035,6m71,DB03865,-7.5,6-Chloro-2-(2-Hydroxy-Biphenyl-3-Yl)-1h-Indole-5-Carboxamidine,FEKRWNWZMOSVBX-UHFFFAOYSA-O,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
92052,6m71,DB03887,-7.5,Alpha-Adenosine Monophosphate,NVOIXARBSSLBAS-CRKDRTNXSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96148,6m71,DB12461,-7.5,GLPG-0492,VAJGULUVTFDTAS-GOSISDBHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
85398,6m3m,DB07614,-7.5,"PHENYL-5-(1H-PYRAZOL-3-YL)-1,3-THIAZOLE",NRAHRUHGPGBWSI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
140571,6w9c,DB12468,-7.5,Pf-04531083,ZRJGMDIPCQOGNI-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
67573,6lxt,DB06910,-7.5,"[4-R-(4-ALPHA,6-BETA,7-BETA]-HEXAHYDRO-5,6-DI(HYDROXY)-1,3-DI(ALLYL)-4,7-BISPHENYLMETHYL)-2H-1,3-DIAZEPINONE",IWJSQELMWLOYSO-LWSSLDFYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
131521,6w4h,DB13851,-7.5,Artemotil,NLYNIRQVMRLPIQ-XQLAAWPRSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131584,6w4h,DB13989,-7.5,Epitizide,RINBGYCKMGDWPY-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
140590,6w9c,DB12499,-7.5,Clascoterone,GPNHMOZDMYNCPO-PDUMRIMRSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
92010,6m71,DB03830,-7.5,Phosphorylated Dihydropteroate,DNKVHXNVVYQUDC-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
24351,6cs2,DB02075,-7.5,"(1s)-1(9-Deazahypoxanthin-9yl)1,4-Dideoxy-1,4-Imino-D-Ribitol-5-Phosphate",VJTAXXUIRYOXBT-KUBHLMPHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
96245,6m71,DB12612,-7.5,Ozanimod,XRVDGNKRPOAQTN-FQEVSTJZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
62336,6crv,DB13436,-7.5,Droxypropine,FVYYUBRKVVOOAV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
94818,6m71,DB08569,-7.5,"3-PYRIDIN-4-YL-2,4-DIHYDRO-INDENO[1,2-.C.] PYRAZOLE",VLPMRZSKJUTRBQ-IBGZPJMESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
149242,6w9q,DB15221,-7.5,PF-06260414,ZKAVFOXYJCREBQ-SNVBAGLBSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
69220,6lxt,DB08846,-7.5,Ellagic Acid,AFSDNFLWKVMVRB-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
140458,6w9c,DB06868,-7.5,N-(3-chlorobenzyl)-1-(4-methylpentanoyl)-L-prolinamide,PQUULPKGCNPPBX-INIZCTEOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
131653,6w4h,DB14127,-7.5,Sacubitrilat,DOBNVUFHFMVMDB-BEFAXECRSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
17025,6cs2,HMDB0005770,-7.5,Tuftsin,IESDGNYHXIOKRW-NNFXCFJSSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
92872,6m71,DB05171,-7.5,E-2012,PUOAETJYKQITMO-LANLRWRYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
67549,6lxt,DB06883,-7.5,1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-phenylurea,DHNYNLNKNQJSHF-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
145900,6w9q,DB07891,-7.5,"4-{[(14beta,17alpha)-3-hydrox1tra-1,3,5(10)-trien-17-yl]oxy}-4-oxobutanoic acid",YJPIDPAGJSWWBE-FNIAAEIWSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
131795,6w4h,DB14720,-7.5,Brovanexine,DQTRREPKGJIABH-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
96218,6m71,DB12567,-7.5,Camicinal,RZKDEGZIFSJVNA-IBGZPJMESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
64926,6lxt,DB02166,-7.5,Propidium,ZDWVWKDAWBGPDN-UHFFFAOYSA-O,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
149214,6w9q,DB15168,-7.5,Cilofexor,KZSKGLFYQAYZCO-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
159961,7bv1,DB07128,-7.5,"N7-BUTYL-N2-(5-CHLORO-2-METHYLPHENYL)-5-METHYL[1,2,4]TRIAZOLO[1,5-A]PYRIMIDINE-2,7-DIAMINE",ZTYBIJUAAWLJNU-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96210,6m71,DB12555,-7.5,Nelotanserin,COSPVUFTLGQDQL-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96203,6m71,DB12545,-7.5,Indobufen,AYDXAULLCROVIT-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
103680,6vxs,DB08882,-7.5,Linagliptin,LTXREWYXXSTFRX-QGZVFWFLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
96201,6m71,DB12542,-7.5,GSK-356278,AWDJJMXJUOHGLC-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
149240,6w9q,DB15219,-7.5,Tomivosertib,HKTBYUWLRDZAJK-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
92005,6m71,DB03823,-7.5,Epigallocatechin,XMOCLSLCDHWDHP-IUODEOHRSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
89312,6m71,DB00323,-7.5,Tolcapone,MIQPIUSUKVNLNT-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96190,6m71,DB12524,-7.5,BI-671800,XEOSTBFUCNZKGS-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96103,6m71,DB12399,-7.5,Polmacoxib,IJWPAFMIFNSIGD-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
103199,6vxs,DB08292,-7.5,"(5Z)-12-CHLORO-13,15-DIHYDROXY-4,7,8,9-TETRAHYDRO-2-BENZOXACYCLOTRIDECINE-1,10(3H,11H)-DIONE",AQKZYZQONWDDLS-IWQZZHSRSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
71287,6lxt,DB13930,-7.5,Ulixertinib,KSERXGMCDHOLSS-LJQANCHMSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
159892,7bv1,DB07049,-7.5,(2R)-1-[(4-tert-butylphenyl)sulfonyl]-2-methyl-4-(4-nitrophenyl)piperazine,SOFGQQQVQZQJFS-MRXNPFEDSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93591,6m71,DB07125,-7.5,"4-(6-{[(1R)-1-(hydroxymethyl)propyl]amino}imidazo[1,2-b]pyridazin-3-yl)benzoic acid",KKZYGUVAFJCULH-CYBMUJFWSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
153492,6wiq,DB06733,-7.5,Bafilomycin A1,XDHNQDDQEHDUTM-JQWOJBOSSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
5535,6lzg,HMDB0060022,-7.5,Urolithin A-8-O-glucuronide,KXBXNRJGUDTJQS-FDQIELQPSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
59769,6crv,DB07852,-7.5,"1-(3,5-DICHLOROPHENYL)-5-METHYL-1H-1,2,4-TRIAZOLE-3-CARBOXYLIC ACID",CZTNDZALWLHXBA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
69259,6lxt,DB08922,-7.5,Perospirone,FBVFZWUMDDXLLG-HDICACEKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
85604,6m3m,DB07852,-7.5,"1-(3,5-DICHLOROPHENYL)-5-METHYL-1H-1,2,4-TRIAZOLE-3-CARBOXYLIC ACID",CZTNDZALWLHXBA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
153186,6wiq,DB05465,-7.5,Tandutinib,UXXQOJXBIDBUAC-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
132029,6w4h,DB15235,-7.5,Di-2-pyridylketone 4-cyclohexyl-4-methyl-3-thiosemicarbazone,GNLZNQJBZNOUBM-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
149299,6w9q,DB15333,-7.5,AZD-1386,FPGNKXCEPARJDI-ZDUSSCGKSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
96486,6m71,DB12989,-7.5,Neosaxitoxin,PPEKGEBBBBNZKS-HGRQIUPRSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
25917,6cs2,DB03944,-7.5,"5-[1-(3,4-Dimethoxy-Benzoyl)-1,2,3,4-Tetrahydro-Quinolin-6-Yl]-6-Methyl-3,6-Dihydro-[1,3,4]Thiadiazin-2-One",IZLRMTJLQCLMKF-CYBMUJFWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
64756,6lxt,DB01944,-7.5,(S)-blebbistatin,LZAXPYOBKSJSEX-GOSISDBHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
159807,7bv1,DB06604,-7.5,Ilepatril,FXKFFTMLFPWYFH-RDGPPVDQSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
156085,6wiq,DB12391,-7.5,Sagopilone,BFZKMNSQCNVFGM-UCEYFQQTSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
140217,6w9c,DB15377,-7.5,ATB-346,YCNMAPLPQYQJFC-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
69130,6lxt,DB08741,-7.5,"5-[[(2R)-2-cyclopropyl-7,8-dimethoxy-2H-chromen-5-yl]methyl]pyrimidine-2,4-diamine",HWJPWWYTGBZDEG-AWEZNQCLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
96482,6m71,DB12985,-7.5,Quisinostat,PAWIYAYFNXQGAP-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
85595,6m3m,DB07842,-7.5,(2S)-2-(4-ethylphenoxy)-3-phenylpropanoic acid,CJMVTSLLWMPEKQ-INIZCTEOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
100032,6vxs,DB03039,-7.5,"4-(Aminosulfonyl)-N-[(2,5-Difluorophenyl)Methyl]-Benzamide",KEGUALXMKQVDIO-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
151086,6wiq,DB02253,-7.5,"(1r)-4-[(1e,3e,5e,7z,9e,11z,13e,15e)-17-Hydroxy-3,7,12,16-Tetramethylheptadeca-1,3,5,7,9,11,13,15-Octaen-1-Yl]-3,5,5-Trimethylcyclohex-3-En-1-Ol",FNAJVVMDXCOSFY-VFGOXHQXSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
153187,6wiq,DB05470,-7.5,VX-702,FYSRKRZDBHOFAY-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
131973,6w4h,DB15126,-7.5,IMG-7289,KQKBMHGOHXOHTD-KKUQBAQOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131971,6w4h,DB15123,-7.5,Dorzagliatin,HMUMWSORCUWQJO-QAPCUYQASA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
132052,6w4h,DB15287,-7.5,Elismetrep,CWEFDWIKLABKBX-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
5575,6lzg,HMDB0060464,-7.5,Codeine-6-glucuronide,CRWVOYRJXPDBPM-HSCJLHHPSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
59779,6crv,DB07863,-7.5,2-chloro-5-nitro-N-phenylbenzamide,DNTSIBUQMRRYIU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
159794,7bv1,DB06579,-7.5,Adipiplon,UAMAIHOEGLEXSV-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
64705,6lxt,DB01865,-7.5,3-(6-Aminopyridin-3-Yl)-N-Methyl-N-[(1-Methyl-1h-Indol-2-Yl)Methyl]Acrylamide,AKFPMLBVLWZSQX-CSKARUKUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
132135,6w4h,DB15449,-7.5,Citarinostat,VLIUIBXPEDFJRF-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
153555,6wiq,DB06844,-7.5,"4-[(7-OXO-7H-THIAZOLO[5,4-E]INDOL-8-YLMETHYL)-AMINO]-N-PYRIDIN-2-YL-BENZENESULFONAMIDE",MBXKBJLIESPLIK-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
71213,6lxt,DB13793,-7.5,Vinburnine,WYJAPUKIYAZSEM-MOPGFXCFSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
92863,6m71,DB05107,-7.5,16-Bromoepiandrosterone,CWVMWSZEMZOUPC-JUAXIXHSSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
146005,6w9q,DB08012,-7.5,(METHYLPYRIDAZINE PIPERIDINE ETHYLOXYPHENYL)ETHYLACETATE,KCHIOGFOPPOUJC-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
96008,6m71,DB12268,-7.5,Carmegliptin,GUYMHFIHHOEFOA-ZCPGHIKRSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
69276,6lxt,DB08950,-7.5,Indoramin,JXZZEXZZKAWDSP-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
67702,6lxt,DB07059,-7.5,"N-{2-[6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2,2-DIMETHYL-3-OXO-2,3-DIHYDRO-4H-1,4-BENZOXAZIN-4-YL]ETHYL}ACETAMIDE",GBXSOZDYCSBLQX-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
89484,6m71,DB00537,-7.5,Ciprofloxacin,MYSWGUAQZAJSOK-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
103492,6vxs,DB08646,-7.5,TRW3-(2-AMINO-3-HYDROXY-PROPYL)-6-(N'-CYCLOHEXYL-HYDRAZINO)OCTAHYDRO-INDOL-7-OL,PSUOZWHAKZSNOB-LBPRGKRZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
132095,6w4h,DB15362,-7.5,LSZ-102,SJXNPGGVGZXKKI-NYYWCZLTSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
59787,6crv,DB07871,-7.5,6-CHLORO-4-(CYCLOHEXYLOXY)-3-ISOPROPYLQUINOLIN-2(1H)-ONE,OQCFORGSZJSAEL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
147496,6w9q,DB12027,-7.5,Serdemetan,CEGSUK1LWKJP-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
153176,6wiq,DB05423,-7.5,ORG-34517,DFELGYQKEOCHOA-BZAFBGKRSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
96560,6m71,DB13102,-7.5,AZD-8418,MCPBSUCAISQZQK-JTQLQIEISA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
103501,6vxs,DB08656,-7.5,5-amino-2-methyl-N-[(1R)-1-naphthalen-1-ylethyl]benzamide,UVERBUNNCOKGNZ-CQSZACIVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
67524,6lxt,DB06853,-7.5,N-cycloheptylglycyl-N-(4-carbamimidoylbenzyl)-L-prolinamide,BYTJPDBCLWUEBU-IBGZPJMESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
93590,6m71,DB07124,-7.5,"(2S)-1-(6H-INDOL-3-YL)-3-{[5-(7H-PYRAZOLO[3,4-C]PYRIDIN-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE",CCIACUJJBPSOHE-KRWDZBQOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
132079,6w4h,DB15334,-7.5,Biochanin A,WUADCCWRTIWANL-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
96540,6m71,DB13072,-7.5,GDC-0349,RGJOJUGRHPQXGF-INIZCTEOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96523,6m71,DB13051,-7.5,CH-5132799,JEGHXKRHKHPBJD-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
140143,6w9c,DB15059,-7.5,Aprocitentan,DKULOVKANLVDEA-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
69124,6lxt,DB08735,-7.5,"R,S-Warfarin alcohol",ZUJMMGHIYSAEOU-SWLSCSKDSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
64777,6lxt,DB01967,-7.5,"N-{3-[(7ar,12as,12bs)-7-Oxo-1,3,4,6,7,7a,12a,12b-Octahydroindolo[2,3-a]Quinolizin-12(2h)-Yl]Propyl}Propane-2-Sulfonamide",LICJTIDRHJECTD-SFHVURJKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
62224,6crv,DB13294,-7.5,Azidamfenicol,SGRUZFCHLOFYHZ-MWLCHTKSSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
2481,6lzg,HMDB0041743,-7.5,Hesperetin 3'-O-glucuronide,PJAUEKWZQWLQSU-WDXLFLMVSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
62235,6crv,DB13310,-7.5,Ormeloxifene,XZEUAXYWNKYKPL-WDYNHAJCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
103570,6vxs,DB08737,-7.5,"(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-9-OL",FSYFYSFYUHBIHE-GLJUWKHASA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
13091,6lzg,DB14664,-7.5,Difluocortolone pivalate,UWGRWFCLGQWKPR-GSTUPEFVSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
159875,7bv1,DB06729,-7.5,Sulfaphenazole,QWCJHSGMANYXCW-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
67655,6lxt,DB07007,-7.5,"(3R)-3-[(1,2,3,4-tetrahydroisoquinolin-7-yloxy)methyl]-2,3-dihydrothieno[2,3-f][1,4]oxazepin-5-amine",UDFXWCLBONUMNA-CYBMUJFWSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
64822,6lxt,DB02030,-7.5,Alpha-Ribazole-5'-Phosphate,ZMRGXEJKZPRBPJ-SYQHCUMBSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
96378,6m71,DB12825,-7.5,Lefamulin,KPVIXBKIJXZQJX-FCEONZPQSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
156069,6wiq,DB12368,-7.5,AZD-3839,MRXBCEQZNKUUIP-DEOSSOPVSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
59706,6crv,DB07782,-7.5,4-AMINO-2-TRIFLUOROMETHYL-5-HYDROXYMETHYLPYRIMIDINE PYROPHOSPHATE,UKNJCTHTCAKKNG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
147486,6w9q,DB12010,-7.5,Fostamatinib,GKDRMWXFWHEQQT-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
131849,6w4h,DB14854,-7.5,TC-6987,UAKZGMMGIMKFMV-RBUKOAKNSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
100271,6vxs,DB03348,-7.5,Huperzine B,YYWGABLTRMRUIT-HWWQOWPSSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
103585,6vxs,DB08752,-7.5,N-[(1S)-2-[(4-cyano-1-methylpiperidin-4-yl)amino]-1-(cyclohexylmethyl)-2-oxoethyl]morpholine-4-carboxamide,IRSOCWQJNYLTDD-SFHVURJKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
145722,6w9q,DB07686,-7.5,"4-{[5-(CYCLOHEXYLAMINO)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE",VPOGRVWIIVMWRI-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
89280,6m71,DB00284,-7.5,Acarbose,CEMXHAPUFJOOSV-XGWNLRGSSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
67527,6lxt,DB06858,-7.5,N-cyclooctylglycyl-N-(4-carbamimidoylbenzyl)-L-prolinamide,MMLOIDMSBRJZAE-FQEVSTJZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
131831,6w4h,DB14799,-7.5,PF-06821497,RXCVUHMIWHRLDF-HXUWFJFHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
140732,6w9c,DB15204,-7.5,Fosravuconazole,SYTNEMZCCLUTNX-NPMXOYFQSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
145968,6w9q,DB07971,-7.5,"5-AMINO-2-{4-[(4-AMINOPHENYL)SULFANYL]PHENYL}-1H-ISOINDOLE-1,3(2H)-DIONE",FQQVTDIBUYSVHM-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
140721,6w9c,DB15187,-7.5,Dubermatinib,YUAALFPUEOYPNX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
67534,6lxt,DB06866,-7.5,6-CARBAMIMIDOYL-2-[2-HYDROXY-5-(3-METHOXY-PHENYL)-INDAN-1-YL]-HEXANOIC ACID,NMOUMGFCBOWPAB-RZUBCFFCSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
59697,6crv,DB07771,-7.5,"[(3,7,11-TRIMETHYL-DODECA-2,6,10-TRIENYLOXYCARBAMOYL)-METHYL]-PHOSPHONIC ACID",JAOBYUCYSAOLHS-XGGJEREUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
156044,6wiq,DB12127,-7.5,Sultamicillin,OPYGFNJSCUDTBT-PMLPCWDUSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
131890,6w4h,DB14932,-7.5,Coleneuramide,CHMRTBYTCBDIRG-JQZMMWJVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
96423,6m71,DB12896,-7.5,PSI-352938,PVRFQJIRERYGTQ-DSQUMVBZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
156071,6wiq,DB12371,-7.5,Siponimod,KIHYPELVXPAIDH-HNSNBQBZSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
131895,6w4h,DB14938,-7.5,Flurbiprofen axetil,ALIVXCSEERJYHU-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
140254,6w9c,DB15448,-7.5,Acumapimod,VGUSQKZDZHAAEE-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140258,6w9c,DB15457,-7.5,Snubh-nm-333 F-18,QLWFXLJVGCECSV-HUYCHCPVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
36343,1r42,DB02804,-7.5,A-98881,PMBZSBGCSQGJAQ-GRKNLSHJSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
59740,6crv,DB07818,-7.5,"(2E)-3-(2,4-DICHLOROPHENYL)-N-HYDROXYACRYLAMIDE",LHTLDFWBUPYUDR-DUXPYHPUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
25933,6cs2,DB03966,-7.5,Clorobiocin,FJAQNRBDVKIIKK-LFLQOBSNSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
96449,6m71,DB12933,-7.5,RO-4987655,FIMYFEGKMOCQKT-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
100034,6vxs,DB03041,-7.5,UDP-alpha-D-glucuronic acid,HDYANYHVCAPMJV-LXQIFKJMSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
93695,6m71,DB07248,-7.5,"7-PYRIDIN-2-YL-N-(3,4,5-TRIMETHOXYPHENYL)-7H-PYRROLO[2,3-D]PYRIMIDIN-2-AMINE",YENZSPIOXMNEFF-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
156079,6wiq,DB12382,-7.5,R-306465,MUTBJZVSRNUIHA-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
67062,6lxt,DB05298,-7.5,Tetomilast,XDBHURGONHZNJF-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
64794,6lxt,DB01990,-7.5,Cholesterol sulfate,BHYOQNUELFTYRT-DPAQBDIFSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
147447,6w9q,DB11951,-7.5,Lemborexant,MUGXRYIUWFITCP-PGRDOPGGSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
103558,6vxs,DB08725,-7.5,"(S)-5-(7-(4-(4-Ethyl-4,5-dihydro-2-oxazolyl)phenoxy)heptyl)-3-methylisoxazole",PZDSRPCFNWOUFP-IBGZPJMESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
131909,6w4h,DB14998,-7.5,Olorinab,ACSQLTBPYZSGBA-GMXVVIOVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
66525,6lxt,DB04293,-7.5,7-(2-Amino-2-Phenyl-Acetylamino)-3-Chloro-8-Oxo-1-Aza-Bicyclo[4.2.0]Oct-2-Ene-2-Carboxylic Acid,JAPHQRWPEGVNBT-IJLUTSLNSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
93693,6m71,DB07246,-7.5,"(2R)-2-AMINO-3,3,3-TRIFLUORO-N-HYDROXY-2-{[(4-PHENOXYPHENYL)SULFONYL]METHYL}PROPANAMIDE",MKRPIBSCGZAUCH-OAHLLOKOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96435,6m71,DB12912,-7.5,Nolatrexed,XHWRWCSCBDLOLM-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
89446,6m71,DB00487,-7.5,Pefloxacin,FHFYDNQZQSQIAI-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
85524,6m3m,DB07762,-7.5,4-(N-ACETYLAMINO)-3-[N-(2-ETHYLBUTANOYLAMINO)]BENZOIC ACID,USKXJFHTBQWXCS-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
96431,6m71,DB12906,-7.5,LY-2334737,MEOYFIHNRBNEPI-UXIGCNINSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
67666,6lxt,DB07021,-7.5,"(7R,8R)-8-(2,4,5-trifluorophenyl)-6,7,8,9-tetrahydroimidazo[1,2-a:4,5-c']dipyridin-7-amine",SOSYXEPELJIJHZ-RNCFNFMXSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
24378,6cs2,DB02102,-7.5,DMP450,KYRSNWPSSXSNEP-ZRTHHSRSSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
25943,6cs2,DB03980,-7.5,4-(Fluorophenyl)-1-Cyclopropylmethyl-5-(2-Amino-4-Pyrimidinyl)Imidazole,DFEYXQGDDCDXJK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
94861,6m71,DB08619,-7.5,Testosterone succinate,CJQNBXFUHQZFOE-VYAQIDIUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
159841,7bv1,DB06678,-7.5,Esmirtazapine,RONZAEMNMFQXRA-MRXNPFEDSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
88971,6m3m,DB15205,-7.5,Capromorelin,KVLLHLWBPNCVNR-SKCUWOTOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
91593,6m71,DB03258,-7.5,2'-Deoxycytidine 5'-triphosphate,RGWHQCVHVJXOKC-SHYZEUOFSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
146177,6w9q,DB08207,-7.5,"2-(3,5-DIMETHYLPHENYL)-1,3-BENZOXAZOLE",BIHLSRJPJFOESJ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
97330,6m71,DB14655,-7.5,Drostanolone propionate,NOTIQUSPUUHHEH-UXOVVSIBSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
158914,7bv1,DB02628,-7.5,"1-[3,3-Dimethyl-2-(2-Methylamino-Propionylamino)-Butyryl]-Pyrrolidine-2-Carboxylic Acid(1,2,3,4-Tetrahydro-Naphthalen-1-Yl)-Amide",JUJIMRZGUBTJRV-NASSWSRMSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
67006,6lxt,DB04983,-7.5,Denufosol,FPNPSEMJLALQSA-MIYUEGBISA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
155768,6wiq,DB11698,-7.5,Ipragliflozin,AHFWIQIYAXSLBA-RQXATKFSSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
89672,6m71,DB00764,-7.5,Mometasone,QLIIKPVHVRXHRI-CXSFZGCWSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
141687,6w9q,DB01180,-7.5,Rescinnamine,SZLZWPPUNLXJEA-LAFLMMDJSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
139537,6w9c,DB13605,-7.5,Phenoperidine,IPOPQVVNCFQFRK-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
147323,6w9q,DB11774,-7.5,Pazufloxacin,XAGMUUZPGZWTRP-ZETCQYMHSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
158898,7bv1,DB02607,-7.5,Adenosine Phosphonoacetic Acid,KJNLSEOJEFDELT-JJNLEZRASA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
133707,6w9c,DB02047,-7.5,"2-(1,1'-Biphenyl-4-Yl)Propanoic Acid",JALUUBQFLPUJMY-NSHDSACASA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
62044,6crv,DB13001,-7.5,Tinoridine,PFENFDGYVLAFBR-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
147279,6w9q,DB11704,-7.5,Adomeglivant,FASLTMSUPQDLIB-MHZLTWQESA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
133171,6w9c,DB01332,-7.5,Ceftizoxime,NNULBSISHYWZJU-LLKWHZGFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
36522,1r42,DB03041,-7.5,UDP-alpha-D-glucuronic acid,HDYANYHVCAPMJV-LXQIFKJMSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
95813,6m71,DB11982,-7.5,GDC-0623,RFWVETIZUQEJEF-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93905,6m71,DB07488,-7.5,"{(2Z)-4-AMINO-2-[(4-METHOXYPHENYL)IMINO]-2,3-DIHYDRO-1,3-THIAZOL-5-YL}(4-METHOXYPHENYL)METHANONE",XQKUGFIWKSKCDL-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
159222,7bv1,DB03598,-7.5,"Al-6629, [2h-Thieno[3,2-E]-1,2-Thiazine-6-Sulfonamide,2-(3-Methoxyphenyl)-3-(4-Morpholinyl)-, 1,1-Dioxide]",XSUAVPPTKHUTDX-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
34999,1r42,DB01025,-7.5,Amlexanox,SGRYPYWGNKJSDL-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
139419,6w9c,DB13439,-7.5,Fenpiprane,JXJPYHDHJZJWRI-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
94982,6m71,DB08761,-7.5,"(3S,6S)-3,6-bis(4-hydroxybenzyl)piperazine-2,5-dione",NGPCLOGFGKJCBP-HOTGVXAUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
40188,6lu7,DB04888,-7.5,Bifeprunox,CYGODHVAJQTCBG-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
91418,6m71,DB03035,-7.5,"1,8-Di-Hydroxy-4-Nitro-Anthraquinone",RIYCICFDXLNQPV-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
99616,6vxs,DB02484,-7.5,Cytidine 5'-Diphosphoglycerol,HHPOUCCVONEPRK-CNYIRLTGSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
133214,6w9c,DB01415,-7.5,Ceftibuten,UNJFKXSSGBWRBZ-BJCIPQKHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
145227,6w9q,DB07108,-7.5,"4'-FLUORO-1,1'-BIPHENYL-4-CARBOXYLIC ACID",LXWNTLBMNCXRQN-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
62620,6crv,DB13820,-7.5,Oxomemazine,QTQPVLDZQVPLGV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
102937,6vxs,DB07983,-7.5,1-(4-IODOBENZOYL)-5-METHOXY-2-METHYL INDOLE-3-ACETIC ACID,CXBFZYKAVCAPSV-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
70903,6lxt,DB13374,-7.5,Vincamine,RXPRRQLKFXBCSJ-GIVPXCGWSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
139417,6w9c,DB13437,-7.5,Medazepam,YLCXGBZIZBEVPZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
70806,6lxt,DB13248,-7.5,Phthalylsulfathiazole,PBMSWVPMRUJMPE-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
68971,6lxt,DB08549,-7.5,"(3R)-METHYLCARBAMOYL-7-SULFOAMINO-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLIC ACID BENZYL ESTER",MFDBNNQUDZFSES-KRWDZBQOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
93956,6m71,DB07547,-7.5,5-(4-CYANOPHENYL)-3-{[(2-METHYLPHENYL)SULFONYL]AMINO}THIOPHENE-2-CARBOXYLIC ACID,RYXAHMSZLLIPRO-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
99652,6vxs,DB02527,-7.5,Cyclic adenosine monophosphate,IVOMOUWHDPKRLL-KQYNXXCUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
147271,6w9q,DB11694,-7.5,Ilorasertib,WPHKIQPVPYJNAX-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
37307,1r42,DB04097,-7.5,Uridine-5'-Diphosphate-4-Deoxy-4-Fluoro-Alpha-D-Galactose,OAPPZHVTNHJVAL-JZMIEXBBSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
145262,6w9q,DB07146,-7.5,"2,3-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-B]PYRIDIN-4-AMINE",QUIQCYFSBGOBKE-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
86093,6m3m,DB08434,-7.5,2-METHYLCARBAMOYL-3-(4-PHOSPHONOOXY-PHENYL)-CYCLOPROPANECARBOXYLIC ACID,GIIUHKRUTUSHAB-IVZWLZJFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
139588,6w9c,DB13672,-7.5,Dimethylaminopropionylphenothiazine,POZJNEBUHLZROM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
133780,6w9c,DB02140,-7.5,N1-(1-Dimethylcarbamoyl-2-Phenyl-Ethyl)-2-Oxo-N4-(2-Pyridin-2-Yl-Ethyl)-Succinamide,ZPFPZRVOBBMZMP-SFHVURJKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
145294,6w9q,DB07183,-7.5,N-(4-phenoxyphenyl)-2-[(pyridin-4-ylmethyl)amino]nicotinamide,CPVRYQAOUPSUDO-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
40207,6lu7,DB08584,-7.5,"6-{[6-(1-methyl-1H-pyrazol-4-yl)[1,2,4]triazolo[4,3-b]pyridazin-3-yl]sulfanyl}quinoline",BCZUAADEACICHN-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
94963,6m71,DB08741,-7.5,"5-[[(2R)-2-cyclopropyl-7,8-dimethoxy-2H-chromen-5-yl]methyl]pyrimidine-2,4-diamine",HWJPWWYTGBZDEG-AWEZNQCLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
133807,6w9c,DB02181,-7.5,2'-Deoxyguanosine-5'-Triphosphate,HAAZLUGHYHWQIW-KVQBGUIXSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
93889,6m71,DB07469,-7.5,"(3aS)-3a-hydroxy-7-methyl-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one",KAJFGRLMKVNMLH-GOSISDBHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60157,6crv,DB08308,-7.5,"SUCCINIC ACID MONO-(13-METHYL-3-OXO-2,3,6,7,8,9,10,11,12,13,14,15,16,17-TETRADECAHYDRO-1H-CYCLOPENTA[A]PHENANTHREN-17-YL) ESTER",IRQUJNVGEAJGSD-KIEDKLRZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
99702,6vxs,DB02595,-7.5,Bulgecin A,RPNZWZDLNYCCIG-HMMVDTEZSA-O,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
92785,6m71,DB04865,-7.5,Omacetaxine mepesuccinate,HYFHYPWGAURHIV-JFIAXGOJSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
24472,6cs2,DB02221,-7.5,"4-(Aminosulfonyl)-N-[(2,4,6-Trifluorophenyl)Methyl]-Benzamide",DVTYOTODFLDHRL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
93959,6m71,DB07550,-7.5,"2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(1-OXIDO-2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUOROPHENYL)METHYL]ACETAMIDE",ZIGSBBKEPNQXRG-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
133814,6w9c,DB02191,-7.5,"(7as,12ar,12bs)-1,2,3,4,7a,12,12a,12b-Octahydroindolo[2,3-a]Quinolizin-7(6h)-One",PGKUSHWBQJPFOP-LBPRGKRZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
16699,6cs2,HMDB0003598,-7.5,Retinyl ester,WWDMJSSVVPXVSV-YCNIQYBTSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
40208,6lu7,DB08340,-7.5,"N,N'-DIPHENYLPYRAZOLO[1,5-A][1,3,5]TRIAZINE-2,4-DIAMINE",LLYYAUZAGCZEKV-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
148777,6w9q,DB13939,-7.5,RAD-140,XMBUPPIEVAFYHO-KPZWWZAWSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
13004,6lzg,DB14209,-7.5,Trandolaprilat,AHYHTSYNOHNUSH-HXFGRODQSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
40206,6lu7,DB08815,-7.5,Lurasidone,PQXKDMSYBGKCJA-CVTJIBDQSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
102888,6vxs,DB07927,-7.5,3-[(4-Carboxy-2-hydroxyphenyl)sulfamoyl]-2-thiophenecarboxylic acid,RDPXXOOKKRIKFN-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
62696,6crv,DB13958,-7.5,Trestolone acetate,IVCRCPJOLWECJU-XQVQQVTHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
133727,6w9c,DB02075,-7.5,"(1s)-1(9-Deazahypoxanthin-9yl)1,4-Dideoxy-1,4-Imino-D-Ribitol-5-Phosphate",VJTAXXUIRYOXBT-KUBHLMPHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
62583,6crv,DB13773,-7.5,Sulfamethoxypyridazine,VLYWMPOKSSWJAL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
103087,6vxs,DB08149,-7.5,"1-[4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine",KCWPSUKJCKZEAO-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
133127,6w9c,DB01239,-7.5,Chlorprothixene,WSPOMRSOLSGNFJ-AUWJEWJLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
89602,6m71,DB00680,-7.5,Moricizine,FUBVWMNBEHXPSU-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
156443,6wiq,DB13104,-7.5,X-396,ONPGOSVDVDPBCY-CQSZACIVSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
145270,6w9q,DB07156,-7.5,"(4Z)-6-bromo-4-({[4-(pyrrolidin-1-ylmethyl)phenyl]amino}methylidene)isoquinoline-1,3(2H,4H)-dione",JFEKAVPMVOLVTH-UNOMPAQXSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
40202,6lu7,DB15345,-7.5,GSK-945237,SRICOHRDRMZREQ-MRXNPFEDSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
69467,6lxt,DB09230,-7.5,Azelnidipine,ZKFQEACEUNWPMT-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
97293,6m71,DB14575,-7.5,Eslicarbazepine,BMPDWHIDQYTSHX-AWEZNQCLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
133104,6w9c,DB01209,-7.5,Dezocine,VTMVHDZWSFQSQP-VBNZEHGJSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139358,6w9c,DB13358,-7.5,Cibenzoline,IPOBOOXFSRWSHL-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
133100,6w9c,DB01205,-7.5,Flumazenil,OFBIFZUFASYYRE-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
95868,6m71,DB12063,-7.5,CERC-301,RECBFDWSXWAXHY-IAGOWNOFSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
40204,6lu7,DB06896,-7.5,"1-(4-fluorophenyl)-N-[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]-2-oxo-1,2-dihydropyridine-3-carboxamide",OBSFXHDOLBYWRJ-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
67933,6lxt,DB07324,-7.5,"3-({2-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)ETHYNYL]BENZYL}AMINO)-1,3-OXAZOL-2(3H)-ONE",ZUJWSOPIDUWELP-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
102938,6vxs,DB07984,-7.5,2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]-n-[(1S)-1-(hydroxymethyl)propyl]acetamide,GKJWXEORYGBJFS-KRWDZBQOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
93916,6m71,DB07501,-7.5,(2S)-1-{4-[(4-Anilino-5-bromo-2-pyrimidinyl)amino]phenoxy}-3-(dimethylamino)-2-propanol,MEIJADBULOETOV-KRWDZBQOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
133478,6w9c,DB01737,-7.5,"Nalpha-(2-Naphthylsulfonylglycyl)-3-Amidino-D,L-Phenylalanine-Isopropylester",YAEIKQDHLCFGAA-KRWDZBQOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
60256,6crv,DB08432,-7.5,THYMIDINE-5'-THIOPHOSPHATE,OJRKJKYGUAALCJ-XLPZGREQSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
67457,6lxt,DB06737,-7.5,Zaltoprofen,MUXFZBHBYYYLTH-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
67973,6lxt,DB07371,-7.5,3-(10-methyl-9-anthryl)propanoic acid,CKQINRXZVYBCSC-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
64229,6lxt,DB01208,-7.5,Sparfloxacin,DZZWHBIBMUVIIW-DTORHVGOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
102961,6vxs,DB08009,-7.5,"5-[(E)-(5-CHLORO-2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]-N-[2-(DIETHYLAMINO)ETHYL]-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXAMIDE",XPLJEFSRINKZLC-ATVHPVEESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
133376,6w9c,DB01606,-7.5,Tazobactam,LPQZKKCYTLCDGQ-WEDXCCLWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
16579,6cs2,HMDB0002937,-7.5,Tamarixetin,KQNGHARGJDXHKF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
65739,6lxt,DB03235,-7.5,N-{3-[4-(3-aminopropyl)piperazin-1-yl]propyl}-3-(alpha-D-galactopyranosyloxy)-5-nitrobenzamide,UEIGEWJJVQHIAX-MKQKURRLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
91336,6m71,DB02919,-7.5,"2,4-Diamino-6-[N-(3',4',5'-Trimethoxybenzyl)-N-Methylamino]Pyrido[2,3-D]Pyrimidine",PUOZHLHNKHRTOW-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95833,6m71,DB12009,-7.5,GW-406381,NXMZBNYLCVTRGB-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
133366,6w9c,DB01594,-7.5,Cinolazepam,XAXMYHMKTCNRRZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
148831,6w9q,DB14038,-7.5,beta-Sitosterol,KZJWDPNRJALLNS-VJSFXXLFSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
86251,6m3m,DB08621,-7.5,Thiamphenicol,OTVAEFIXJLOWRX-NXEZZACHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
91344,6m71,DB02929,-7.5,K201,KCWGETCFOVJEPI-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
159051,7bv1,DB03081,-7.5,Crc200 (Chiron-Behring),ZOXOKTJHZSUHRJ-XZOQPEGZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
88802,6m3m,DB14841,-7.5,Centanafadine,HKHCSWPSUSWGLI-CABCVRRESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
150721,6wiq,DB01761,-7.5,4-[5-[2-(1-Phenyl-Ethylamino)-Pyrimidin-4-Yl]-1-Methyl-4-(3-Trifluoromethylphenyl)-1h-Imidazol-2-Yl]-Piperidine,QICPQLFMWYQJGX-SFHVURJKSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
100763,6vxs,DB04020,-7.5,"4-(2-{[4-{[3-(4-Chlorophenyl)Propyl]Sulfanyl}-6-(1-Piperazinyl)-1,3,5-Triazin-2-Yl]Amino}Ethyl)Phenol",AIBKIFHSQQYXLG-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
99559,6vxs,DB02411,-7.5,"2-(11-{2-[Benzenesulfonyl-(3-Methyl-Butyl)-Amino]-1-Hydroxy-Ethyl}-6,9-Dioxo-2-Oxa-7,10-Diaza-Bicyclo[11.2.2]Heptadeca-1(16),13(17),14-Trien-8-Yl)-Acetamide, Inhibitor 2",HOUHLOFMBSYNBO-KKUQBAQOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102976,6vxs,DB08024,-7.5,1-[2-(S)-AMINO-3-BIPHENYL-4-YL-PROPIONYL]-PYRROLIDINE-2-(S)-CARBONITRILE,MUUVLSCVDXKQQV-OALUTQOASA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
36545,1r42,DB03072,-7.5,"2-{3-[4-(4-Fluorophenyl)-3,6-Dihydro-1(2h)-Pyridinyl]Propyl}-8-Methyl-4(3h)-Quinazolinone",LOFDUAJQRUYHBR-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
86243,6m3m,DB08611,-7.5,"2-[(2',3',4'-TRIFLUOROBIPHENYL-2-YL)OXY]ETHANOL",AGXPXFPIOHNDAN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88769,6m3m,DB14755,-7.5,beta-Isosparteine,SLRCCWJSBJZJBV-AJNGGQMLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
67976,6lxt,DB07375,-7.5,"5-BETA-ANDROSTANE-3,17-DIONE",RAJWOBJTTGJROA-QJISAEMRSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
159014,7bv1,DB03034,-7.5,D-Levofloxacin,GSDSWSVVBLHKDQ-SNVBAGLBSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
148833,6w9q,DB14045,-7.5,Cholesteryl chloride,OTVRYZXVVMZHHW-DPAQBDIFSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
159013,7bv1,DB03030,-7.5,4-(2-Thienyl)-1-(4-Methylbenzyl)-1h-Imidazole,UMOFOLLUKPBVQG-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
92302,6m71,DB04215,-7.5,CRA_9076,BVTBOJXEAPSOEB-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
145153,6w9q,DB07024,-7.5,"2-(3,4-DIHYDROXYPHENYL)-8-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-3-HYDROXY-6-METHYL-4H-CHROMEN-4-ONE",CEXBEGBNDJVZPK-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
34968,1r42,DB00990,-7.5,Exemestane,BFYIZQONLCFLEV-DAELLWKTSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
16573,6cs2,HMDB0002902,-7.5,Delta-Tocopherol,GZIFEOYASATJEH-VHFRWLAGSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
145152,6w9q,DB07022,-7.5,3-Hydroxypropyl 3-[(7-carbamimidoyl-1-naphthyl)carbamoyl]benzenesulfonate,PXERBGNIBOFZOW-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
86247,6m3m,DB08615,-7.5,"2-[4-(DIMETHYLAMINO)PHENYL]-6-HYDROXY-3-METHYL-1,3-BENZOTHIAZOL-3-IUM",NOVJJPLRUMZSDK-UHFFFAOYSA-O,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
102969,6vxs,DB08017,-7.5,3-METHOXY-6-[4-(3-METHYLPHENYL)-1-PIPERAZINYL]PYRIDAZINE,DDOAUTHWSCUHQA-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
60147,6crv,DB08297,-7.5,ORTHONITROPHENYL-BETA-D-FUCOPYRANOSIDE,SWRPIVXPHLYETN-BVWHHUJWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
93457,6m71,DB06972,-7.5,"7A-[(4-cyanophenyl)methyl]-6-(3,5-dichlorophenyl)-5-oxo-2,3,5,7A-tetrahydro-1H-pyrrolo[1,2-A]pyrrole-7-carbonitrile",TZCXQSNBTXDAJG-QFIPXVFZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
91323,6m71,DB02902,-7.5,3'-Phosphate-Adenosine-5'-Phosphate Sulfate,GACDQMDRPRGCTN-KQYNXXCUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
103008,6vxs,DB08061,-7.5,4-[3-(4-CHLOROPHENYL)-1H-PYRAZOL-5-YL]PIPERIDINE,GELALLNTKKLQLM-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
139496,6w9c,DB13548,-7.5,Dibrompropamidine,GMJFVGRUYJHMCO-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
67946,6lxt,DB07338,-7.5,Acifluorfen,NUFNQYOELLVIPL-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
70816,6lxt,DB13266,-7.5,Cefatrizine,UOCJDOLVGGIYIQ-PBFPGSCMSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
133603,6w9c,DB01910,-7.5,Sinefungin,LMXOHSDXUQEUSF-YECHIGJVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
14624,6lzg,T3D4521,-7.5,Novaluron,NJPPVKZQTLUDBO-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
97386,6m71,DB14768,-7.5,PF-06459988,ODMXWZROLKITMS-RISCZKNCSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
62673,6crv,DB13929,-7.5,Relcovaptan,CEBYCSRFKCEUSW-NAYZPBBASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
67945,6lxt,DB07337,-7.5,"4-[4-AMINO-6-(5-CHLORO-1H-INDOL-4-YLMETHYL)-[1,3,5]TRIAZIN-2-YLAMINO]-BENZONITRILE",SOKOHDQTKSROQZ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
97384,6m71,DB14765,-7.5,Rivoceranib,WPEWQEMJFLWMLV-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
156411,6wiq,DB13059,-7.5,PF-03814735,RYYNGWLOYLRZLK-RBUKOAKNSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
133271,6w9c,DB01482,-7.5,Fenethylline,NMCHYWGKBADVMK-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
103022,6vxs,DB08078,-7.5,{4-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]phenoxy}acetic acid,HBBVCKCCQCQCTJ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
93473,6m71,DB06992,-7.5,"(3,3-dimethylpiperidin-1-yl)(6-(3-fluoro-4-methylphenyl)pyridin-2-yl)methanone",SIDDLTBLAQYZIZ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
92914,6m71,DB05424,-7.5,Canertinib,OMZCMEYTWSXEPZ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
147605,6w9q,DB12188,-7.5,Zicronapine,BYPMJBXPNZMNQD-PZJWPPBQSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
86212,6m3m,DB08574,-7.5,"(5R)-2-SULFANYL-5-[4-(TRIFLUOROMETHYL)BENZYL]-1,3-THIAZOL-4-ONE",HBYVUUWMCCSRBI-MRVPVSSYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
159154,7bv1,DB03496,-7.5,Alvocidib,BIIVYFLTOXDAOV-YVEFUNNKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
147582,6w9q,DB12150,-7.5,Pelubiprofen,AUZUGWXLBGZUPP-GXDHUFHOSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
132921,6w9c,DB01003,-7.5,Cromoglicic acid,IMZMKUWMOSJXDT-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
141553,6w9q,DB01026,-7.5,Ketoconazole,XMAYWYJOQHXEEK-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
37280,1r42,DB04064,-7.5,Nogalaviketone,QHNJNOBWURJIEK-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
94747,6m71,DB08486,-7.5,Efaproxiral,BNFRJXLZYUTIII-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
92916,6m71,DB05442,-7.5,Etiprednol dicloacetate,QAIOVDNCIZSSSF-RFAJLIJZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
16589,6cs2,HMDB0003000,-7.5,Lycopene,OAIJSZIZWZSQBC-BOJOQWLHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
159133,7bv1,DB03467,-7.5,Naringenin,FTVWIRXFELQLPI-ZDUSSCGKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
62662,6crv,DB13876,-7.5,Brofaromine,WZXHSWVDAYOFPE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
155730,6wiq,DB11645,-7.5,PF-4191834,DVNQWYLVSNPCJZ-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
156399,6wiq,DB13040,-7.5,Gandotinib,SQSZANZGUXWJEA-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
100734,6vxs,DB03982,-7.5,"Compound 5, 2-(Naphthalen-1-Yl-Oxalyl-Amino)-Benzoicacid",WQWCUHJIERBOSM-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
159140,7bv1,DB03477,-7.5,1-Phenylsulfonamide-3-Trifluoromethyl-5-Parabromophenylpyrazole,OYZKFVIVPRQRQQ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
36549,1r42,DB03076,-7.5,AHA047,CGBDAHCDSVOMCF-FYZVQMPESA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
95853,6m71,DB12043,-7.5,Sepetaprost,BKVUSNOUTQMSBE-XCMGCKIWSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
99592,6vxs,DB02452,-7.5,Thymidine-5'-Triphosphate,NHVNXKFIZYSCEB-XLPZGREQSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
133585,6w9c,DB01877,-7.5,"N-Hydroxy 1n(4-Methoxyphenyl)Sulfonyl-4-(Z,E-N-Methoxyimino)Pyrrolidine-2r-Carboxamide",OJLWCTMBGWSVFC-JOYOIKCWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
97255,6m71,DB14207,-7.5,Fosinoprilat,WOIWWYDXDVSWAZ-RTWAWAEBSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94965,6m71,DB08743,-7.5,"2-({8-[(3R)-3-AMINOPIPERIDIN-1-YL]-1,3-DIMETHYL-2,6-DIOXO-1,2,3,6-TETRAHYDRO-7H-PURIN-7-YL}METHYL)BENZONITRILE",XJNKUWDMCBZMTG-OAHLLOKOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
24458,6cs2,DB02205,-7.5,"6-(1,1-Dimethylallyl)-2-(1-Hydroxy-1-Methylethyl)-2,3-Dihydro-7h-Furo[3,2-G]Chromen-7-One",JCDLLLXYAICSQV-INIZCTEOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
85994,6m3m,DB08310,-7.5,"N-[(2R)-2-{[(2S)-2-(1,3-benzoxazol-2-yl)pyrrolidin-1-yl]carbonyl}hexyl]-N-hydroxyformamide",QDDZLTVSNABZIK-ZBFHGGJFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
148766,6w9q,DB13919,-7.5,Candesartan,HTQMVQVXFRQIKW-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
68955,6lxt,DB08532,-7.5,"6-(2-fluorophenyl)-N-(pyridin-3-ylmethyl)imidazo[1,2-a]pyrazin-8-amine",WCNPGRRMPFCHEO-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
34841,1r42,DB00845,-7.5,Clofazimine,WDQPAMHFFCXSNU-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
66620,6lxt,DB04430,-7.5,3-(4-Phenylamino-Phenylamino)-2-(1h-Tetrazol-5-Yl)-Acrylonitrile,FLPLCJJGNZGOAW-QXMHVHEDSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
40218,6lu7,DB06178,-7.5,Talotrexin,NYQPLPNEESYGNO-IBGZPJMESA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
66319,6lxt,DB04020,-7.5,"4-(2-{[4-{[3-(4-Chlorophenyl)Propyl]Sulfanyl}-6-(1-Piperazinyl)-1,3,5-Triazin-2-Yl]Amino}Ethyl)Phenol",AIBKIFHSQQYXLG-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
70972,6lxt,DB13470,-7.5,Cefodizime,XDZKBRJLTGRPSS-BGZQYGJUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
62553,6crv,DB13728,-7.5,Halometasone,GGXMRPUKBWXVHE-MIHLVHIWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
40217,6lu7,DB06240,-7.5,Tariquidar,LGGHDPFKSSRQNS-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
25543,6cs2,DB00421,-7.5,Spironolactone,LXMSZDCAJNLERA-ZHYRCANASA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
145355,6w9q,DB07256,-7.5,"3-({4-[(5-CHLORO-1,3-BENZODIOXOL-4-YL)AMINO]PYRIMIDIN-2-YL}AMINO)BENZAMIDE",ZVQZIVCQLFGXFZ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
70969,6lxt,DB13463,-7.5,Oxetorone,VZVRZTZPHOHSCK-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
139634,6w9c,DB13729,-7.5,Camostat,XASIMHXSUQUHLV-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
86330,6m3m,DB08719,-7.5,"5-(5-(6-CHLORO-4-(4,5-DIHYDRO-2-OXAZOLYL)PHENOXY)PENTYL)-3-METHYL ISOXAZOLE",FCSKOFQQCWLGMV-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
145353,6w9q,DB07254,-7.5,"N-[3-[[4-[(5-CHLORO-1,3-BENZODIOXOL-4-YL)AMINO]PYRIMIDIN-2-YL]AMINO]PHENYL]METHANESULFONAMIDE",KQGTYXRWSIBDOZ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
67859,6lxt,DB07245,-7.5,6-[2-(3'-METHOXYBIPHENYL-3-YL)ETHYL]PYRIDIN-2-AMINE,AEVBKBAFFJKFJZ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
158857,7bv1,DB02549,-7.5,3'-O-Acetylthymidine-5'-Diphosphate,UWSIAAWKEICIJY-IVZWLZJFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
40216,6lu7,DB06314,-7.5,SGX-523,BCZUAADEACICHN-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
102847,6vxs,DB07874,-7.5,"(6S)-2-amino-6-(3'-methoxybiphenyl-3-yl)-3,6-dimethyl-5,6-dihydropyrimidin-4(3H)-one",LQOCXPOKEPYGTJ-IBGZPJMESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
67864,6lxt,DB07250,-7.5,"N'-(5-CHLORO-1,3-BENZODIOXOL-4-YL)-N-(3,4,5- TRIMETHOXYPHENYL)PYRIMIDINE-2,4-DIAMINE",HMKLUOPMOJOUDZ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
133010,6w9c,DB01103,-7.5,Quinacrine,GPKJTRJOBQGKQK-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
91540,6m71,DB03199,-7.5,4-Methoxy-E-Rhodomycin T,XSSVYBYWQBNYOH-QJIXERIWSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
69028,6lxt,DB08619,-7.5,Testosterone succinate,CJQNBXFUHQZFOE-VYAQIDIUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
159338,7bv1,DB04010,-7.5,2-(3'-Methoxyphenyl) Benzimidazole-4-Carboxamide,NVVWVYYHTKCIAE-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
159335,7bv1,DB04005,-7.5,Uridine 5'-triphosphate,PGAVKCOVUIYSFO-XVFCMESISA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60362,6crv,DB08555,-7.5,"1-(3-bromophenyl)-7-chloro-6-methoxy-3,4-dihydroisoquinoline",IKGXHBGCVQTQBH-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
70767,6lxt,DB13182,-7.5,Daidzein,ZQSIJRDFPHDXIC-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
34853,1r42,DB00858,-7.5,Drostanolone,IKXILDNPCZPPRV-RFMGOVQKSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
93965,6m71,DB07559,-7.5,"(2Z)-2-cyano-N-(2,2'-dichlorobiphenyl-4-yl)-3-hydroxybut-2-enamide",DDSLONVJHZPSBB-UVTDQMKNSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
132953,6w9c,DB01038,-7.5,Carphenazine,XZSMZRXAEFNJCU-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
40229,6lu7,DB13676,-7.5,Mosapramine,PXUIZULXJVRBPC-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
66998,6lxt,DB04957,-7.5,Azimilide,MREBEPTUUMTTIA-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
145384,6w9q,DB07288,-7.5,N-(4-chlorophenyl)-2-[(pyridin-4-ylmethyl)amino]benzamide,GGPZCOONYBPZEW-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
40228,6lu7,DB11855,-7.5,Revefenacin,FYDWDCIFZSGNBU-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
12503,6lzg,DB13451,-7.5,Tioclomarol,WRGOVNKNTPWHLZ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
40227,6lu7,DB14845,-7.5,Filgotinib,RIJLVEAXPNLDTC-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
153066,6wiq,DB04888,-7.5,Bifeprunox,CYGODHVAJQTCBG-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
40226,6lu7,DB15013,-7.5,TAK-243,KJDAGXLMHXUAGV-DGWLBADLSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
93970,6m71,DB07564,-7.5,"6-amino-2-[(2-morpholin-4-ylethyl)amino]-3,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",JUHXOBNFTFUPKQ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
40225,6lu7,DB15232,-7.5,Telaglenastat,PRAAPINBUWJLGA-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
2466,6lzg,HMDB0041623,-7.5,N6-Carbamoyl-L-threonyladenosine,GYCVHQYQICRFAX-CKTDUXNWSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
145379,6w9q,DB07283,-7.5,"9-benzyl-2,3,4,9-tetrahydro-1H-carbazole-8-carboxylic acid",VDOXYKGIKBUISK-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
99727,6vxs,DB02628,-7.5,"1-[3,3-Dimethyl-2-(2-Methylamino-Propionylamino)-Butyryl]-Pyrrolidine-2-Carboxylic Acid(1,2,3,4-Tetrahydro-Naphthalen-1-Yl)-Amide",JUJIMRZGUBTJRV-NASSWSRMSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
97170,6m71,DB14025,-7.5,Clinafloxacin,QGPKADBNRMWEQR-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
141276,6w9q,DB00705,-7.5,Delavirdine,WHBIGIKBNXZKFE-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
70763,6lxt,DB13175,-7.5,Rheinanthrone,OZFQHULMMDWMIV-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
40224,6lu7,DB15305,-7.5,Risdiplam,ASKZRYGFUPSJPN-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
62088,6crv,DB13064,-7.5,Tramazoline,QQJLHRRUATVHED-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
102832,6vxs,DB07859,-7.5,4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL)PHENYL]PIPERIDINE,LZMOSYUFVYJEPY-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
92242,6m71,DB04142,-7.5,"3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid Dimethylamide",FEYGJZKVMASWJB-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
40223,6lu7,DB15343,-7.5,HM-43239,FZLSDZZNPXXBBB-KDURUIRLSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
100901,6vxs,DB04201,-7.5,Histidyl-Adenosine Monophosphate,XTFBSLZFYLGYAT-OPYVMVOTSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
40221,6lu7,DB12784,-7.5,NS-018,UQTPDWDAYHAZNT-AWEZNQCLSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40220,6lu7,DB07268,-7.5,2-({2-[(3-HYDROXYPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)BENZAMIDE,QHPKKGUGRGRSGA-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
86335,6m3m,DB08724,-7.5,5-(5-(4-(5-hydro-4-methyl-2-oxazolyl)phenoxy)pentyl)-3-methyl isoxazole,UXIYKMARWUSIKU-HNNXBMFYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
139302,6w9c,DB13291,-7.5,Cloridarol,KBFBRIPYVVGWRS-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
100547,6vxs,DB03742,-7.5,Compound 4-D,TWZNCTCQAGRUGQ-RRPNLBNLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
139644,6w9c,DB13744,-7.5,Piromidic acid,RCIMBBZXSXFZBV-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
40215,6lu7,DB06555,-7.5,Siramesine,XWAONOGAGZNUSF-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
141571,6w9q,DB01047,-7.5,Fluocinonide,WJOHZNCJWYWUJD-IUGZLZTKSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
97195,6m71,DB14068,-7.5,Dexniguldipine,SVJMLYUFVDMUHP-MGBGTMOVSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
88941,6m3m,DB15144,-7.5,Altropane I-123,GTQLIPQFXVKRKJ-HYRAKNMCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
40212,6lu7,DB07255,-7.5,"N'-(5-CHLORO-1,3-BENZODIOXOL-4-YL)-N-(3-MORPHOLIN-4-YLPHENYL)PYRIMIDINE-2,4-DIAMINE",PNEWIQAEGKQNCE-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
64344,6lxt,DB01420,-7.5,Testosterone propionate,PDMMFKSKQVNJMI-BLQWBTBKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
145338,6w9q,DB07237,-7.5,{4-[(2R)-pyrrolidin-2-ylmethoxy]phenyl}(4-thiophen-3-ylphenyl)methanone,VUWFJUJWAWMRQN-HXUWFJFHSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
67023,6lxt,DB05076,-7.5,Fenretinide,AKJHMTWEGVYYSE-FXILSDISSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
40209,6lu7,DB08221,-7.5,N-{4-METHYL-3-[(3-PYRIMIDIN-4-YLPYRIDIN-2-YL)AMINO]PHENYL}-3-(TRIFLUOROMETHYL)BENZAMIDE,NESXBRNDMQUVNG-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40211,6lu7,DB11894,-7.5,Efatutazone,JCYNMRJCUYVDBC-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
16713,6cs2,HMDB0003747,-7.5,Resveratrol,LUKBXSAWLPMMSZ-OWOJBTEDSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
36509,1r42,DB03020,-7.5,5-Beta-D-Ribofuranosylnicotinamide Adenine Dinucleotide,UINNILASBHZOTM-KMXXXSRASA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
145321,6w9q,DB07216,-7.5,"(11S)-8-CHLORO-11-[1-(METHYLSULFONYL)PIPERIDIN-4-YL]-6-PIPERAZIN-1-YL-11H-BENZO[5,6]CYCLOHEPTA[1,2-B]PYRIDINE",ZMGCFGGMTCMSDP-QHCPKHFHSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
146120,6w9q,DB08141,-7.5,"4-{[(2,6-difluorophenyl)carbonyl]amino}-N-[(3S)-piperidin-3-yl]-1H-pyrazole-3-carboxamide",KOMNQBZWMCFDTQ-VIFPVBQESA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
40213,6lu7,DB11911,-7.5,Galunisertib,IVRXNBXKWIJUQB-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
62559,6crv,DB13737,-7.5,Cyclobarbital,WTYGAUXICFETTC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
40210,6lu7,DB07783,-7.5,1-((1R)-1-(HYDROXYMETHYL)-3-{6-[(3-PHENYLPROPANOYL)AMINO]-1H-INDOL-1-YL}PROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE,GUYYFMCFEPDDFL-OAQYLSRUSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
153058,6wiq,DB04879,-7.5,Vatalanib,YCOYDOIWSSHVCK-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
40214,6lu7,DB06817,-7.5,Raltegravir,CZFFBEXEKNGXKS-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
139623,6w9c,DB13718,-7.5,Hydroquinine,LJOQGZACKSYWCH-WZBLMQSHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
86022,6m3m,DB08347,-7.5,4-{[(2S)-3-(tert-butylamino)-2-hydroxypropyl]oxy}-3H-indole-2-carbonitrile,CQEFAUFOQSCRMZ-LBPRGKRZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80914,6m3m,DB00586,-7.4,Diclofenac,DCOPUUMXTXDBNB-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
146964,6w9q,DB09244,-7.4,Pirlindole,IWVRVEIKCBFZNF-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
141925,6w9q,DB01531,-7.4,Desomorphine,LNNWVNGFPYWNQE-GMIGKAJZSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
76744,6m2n,DB07560,-7.4,N-[(1S)-2-methyl-1-(pyridin-4-ylcarbamoyl)propyl]cyclohexanecarboxamide,VYLDPSVXLWTIAJ-HNNXBMFYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
98742,6vxs,DB01333,-7.4,Cefradine,RDLPVSKMFDYCOR-UEKVPHQBSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
123661,6w4h,DB00231,-7.4,Temazepam,SEQDDYPDSLOBDC-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
107447,6vxx,DB03606,-7.4,(S)-Rolipram,HJORMJIFDVBMOB-GFCCVEGCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163925,7bv1,DB06866,-7.4,6-CARBAMIMIDOYL-2-[2-HYDROXY-5-(3-METHOXY-PHENYL)-INDAN-1-YL]-HEXANOIC ACID,NMOUMGFCBOWPAB-RZUBCFFCSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
112113,6vxx,DB06313,-7.4,BNC105,MYDHDVLPMRNDAZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80659,6m3m,DB00274,-7.4,Cefmetazole,SNBUBQHDYVFSQF-HIFRSBDPSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
69193,6lxt,DB08810,-7.4,Cinitapride,ZDLBNXXKDMLZMF-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
32203,6cs2,DB01176,-7.4,Cyclizine,UVKZSORBKUEBAZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
63181,6crv,DB15293,-7.4,Epalrestat,CHNUOJQWGUIOLD-NFZZJPOKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
152015,6wiq,DB03480,-7.4,Brequinar Analog,WYKKHJQZENLZID-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
29114,6cs2,DB08752,-7.4,N-[(1S)-2-[(4-cyano-1-methylpiperidin-4-yl)amino]-1-(cyclohexylmethyl)-2-oxoethyl]morpholine-4-carboxamide,IRSOCWQJNYLTDD-SFHVURJKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
122820,6w4b,DB13951,-7.4,Stanolone acetate,ILCTUFVQFCIIDS-NGFSFWIMSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
155655,6wiq,DB11450,-7.4,Pimobendan,GLBJJMFZWDBELO-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
117088,6w4b,DB03010,-7.4,Patupilone,QXRSDHAAWVKZLJ-PVYNADRNSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
9272,6lzg,DB07354,-7.4,"2,3-DIMETHOXY-12H-[1,3]DIOXOLO[5,6]INDENO[1,2-C]ISOQUINOLIN-6-IUM",LXDREMZQGAILJU-UHFFFAOYSA-O,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
68979,6lxt,DB08559,-7.4,"N-[(2S,4S,6R)-2-(dihydroxymethyl)-4-hydroxy-3,3-dimethyl-7-oxo-4lambda-4-thia-1-azabicyclo[3.2.0]hept-6-yl]-2-phenylacetamide",WMPGEOZLAYOFHH-MBNYWOFBSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
90061,6m71,DB01207,-7.4,Ridogrel,GLLPUTYLZIKEGF-HAVVHWLPSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
29564,6cs2,DB09477,-7.4,Enalaprilat,LZFZMUMEGBBDTC-QEJZJMRPSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
76633,6m2n,DB07429,-7.4,2-({[4-bromo-3-(diethylsulfamoyl)phenyl]carbonyl}amino)benzoic acid,VNOMZKMKBNFCMC-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
155714,6wiq,DB11611,-7.4,Lifitegrast,JFOZKMSJYSPYLN-QHCPKHFHSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
62736,6crv,DB14045,-7.4,Cholesteryl chloride,OTVRYZXVVMZHHW-DPAQBDIFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
141609,6w9q,DB01091,-7.4,Butenafine,ABJKWBDEJIDSJZ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
107989,6vxx,DB06656,-7.4,TAS-106,JFIWEPHGRUDAJN-DYUFWOLASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
122811,6w4b,DB13939,-7.4,RAD-140,XMBUPPIEVAFYHO-KPZWWZAWSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
7334,6lzg,DB00434,-7.4,Cyproheptadine,JJCFRYNCJDLXIK-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
164134,7bv1,DB07295,-7.4,2-[(7-HYDROXY-NAPHTHALEN-1-YL)-OXALYL-AMINO]-BENZOIC ACID,IGOULVZYQKJJKC-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
47949,2fxp,DB02483,-7.4,Etheno-Nad,JCDBQDNBEQHDHK-BSLNIGMPSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
80658,6m3m,DB00273,-7.4,Topiramate,KJADKKWYZYXHBB-XBWDGYHZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
23899,6cs2,DB01540,-7.4,17alpha-methyl-4-hydroxynandrolone,CLNUZOCYKSHICX-FAHHUNKHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
98743,6vxs,DB01336,-7.4,Metocurine,JFXBEKISTKFVAB-AJQTZOPKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
99535,6vxs,DB02383,-7.4,Tolrestat,LUBHDINQXIHVLS-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
29522,6cs2,DB09290,-7.4,Ramosetron,NTHPAPBPFQJABD-LLVKDONJSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
106802,6vxx,DB01283,-7.4,Lumiracoxib,KHPKQFYUPIUARC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29093,6cs2,DB08733,-7.4,"(2R,3R)-N^1^-[(1S)-2,2-DIMETHYL-1-(METHYLCARBAMOYL)PROPYL]-N^4^-HYDROXY-2-(2-METHYLPROPYL)-3-{[(1,3-THIAZOL-2-YLCARBONYL)AMINO]METHYL}BUTANEDIAMIDE",GAHIXYNNFMCKFQ-HZSPNIEDSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
151436,6wiq,DB02703,-7.4,Fusidic acid,IECPWNUMDGFDKC-MZJAQBGESA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
146960,6w9q,DB09238,-7.4,Manidipine,ANEBWFXPVPTEET-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
140577,6w9c,DB12476,-7.4,CPG-52852,YZOQZEXYFLXNKA-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
112052,6vxx,DB06185,-7.4,Forodesine,IWKXDMQDITUYRK-KUBHLMPHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
123540,6w4b,DB03453,-7.4,Methyl (2S)-2-[[2-[(3R)-1-carbamimidoylpiperidin-3-yl]acetyl]amino]-3-[4-(2-phenylethynyl)phenyl]propanoate,MRNGXYMKYHNMLV-PKTZIBPZSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
108081,6vxx,DB06821,-7.4,Sulfameter,GPTONYMQFTZPKC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62658,6crv,DB13871,-7.4,Albendazole oxide,VXTGHWHFYNYFFV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
90159,6m71,DB01394,-7.4,Colchicine,IAKHMKGGTNLKSZ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
30500,6cs2,DB00956,-7.4,Hydrocodone,LLPOLZWFYMWNKH-CMKMFDCUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
69178,6lxt,DB08795,-7.4,Azidocillin,ODFHGIPNGIAMDK-NJBDSQKTSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
55737,6crv,DB01425,-7.4,Alizapride,KSEYRUGYKHXGFW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
13085,6lzg,DB14659,-7.4,Melengestrol acetate,UDKABVSQKJNZBH-DWNQPYOZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
92721,6m71,DB04787,-7.4,Tanaproget,PYVFWTPEBMRKSR-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
140645,6w9c,DB13032,-7.4,Enecadin,SZSHJTJCJOWMHM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
62364,6crv,DB13476,-7.4,Diisopromine,YBJKOPHEJOMRMN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112482,6vxx,DB07305,-7.4,5-(2-CHLORO-4-NITROPHENYL)-2-FUROIC ACID,HDIHNBCCQWMVBW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112308,6vxx,DB06951,-7.4,(3R)-3-ethyl-N-[(4-methylphenyl)sulfonyl]-L-aspartic acid,KPHLTCNXHCHMOW-MNOVXSKESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
123816,6w4h,DB00415,-7.4,Ampicillin,AVKUERGKIZMTKX-NJBDSQKTSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
141580,6w9q,DB01058,-7.4,Praziquantel,FSVJFNAIGNNGKK-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
9159,6lzg,DB07242,-7.4,"(4R)-7,8-dichloro-1',9-dimethyl-1-oxo-1,2,4,9-tetrahydrospiro[beta-carboline-3,4'-piperidine]-4-carbonitrile",XGUIMGJMQKZRGM-LLVKDONJSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
80610,6m3m,DB00219,-7.4,Oxyphenonium,GFRUPHOKLBPHTQ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
151458,6wiq,DB02732,-7.4,Nicotinamide Adenine Dinucleotide Acetone Adduct,SGHBFOOIAAJJMI-YDKVLQLQSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
75096,6m2n,DB04238,-7.4,N-Alpha-(2-Naphthylsulfonyl)-N-(3-Amidino-L-Phenylalaninyl)-D-Pipecolinic Acid,GNANSBQAIRJZPA-XZOQPEGZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
112094,6vxx,DB06264,-7.4,Tolperisone,FSKFPVLPFLJRQB-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
89716,6m71,DB00817,-7.4,Rosoxacin,XBPZXDSZHPDXQU-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
124241,6w4h,DB00921,-7.4,Buprenorphine,RMRJXGBAOAMLHD-IHFGGWKQSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
146992,6w9q,DB09290,-7.4,Ramosetron,NTHPAPBPFQJABD-LLVKDONJSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
69126,6lxt,DB08737,-7.4,"(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-9-OL",FSYFYSFYUHBIHE-GLJUWKHASA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
164173,7bv1,DB07337,-7.4,"4-[4-AMINO-6-(5-CHLORO-1H-INDOL-4-YLMETHYL)-[1,3,5]TRIAZIN-2-YLAMINO]-BENZONITRILE",SOKOHDQTKSROQZ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
140557,6w9c,DB12445,-7.4,Nitroaspirin,IOJUJUOXKXMJNF-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
143564,6w9q,DB03714,-7.4,4-Carbamoyl-4-{[6-(Difluoro-Phosphono-Methyl)-Naphthalene-2-Carbonyl]-Amino}-Butyric Acid,OWWCIKSGGKYNHT-ZDUSSCGKSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
123650,6w4h,DB00218,-7.4,Moxifloxacin,FABPRXSRWADJSP-MEDUHNTESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
36606,1r42,DB03154,-7.4,{[7-(Difluoro-Phosphono-Methyl)-Naphthalen-2-Yl]-Difluoro-Methyl}-Phosphonic Acid,VHKBLEYUHBIBNR-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
90058,6m71,DB01204,-7.4,Mitoxantrone,KKZJGLLVHKMTCM-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
23832,6cs2,DB01469,-7.4,Acetorphine,LFYBMMHFJIAKFE-PMEKXCSPSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
152000,6wiq,DB03460,-7.4,Violaxanthin,SZCBXWMUOPQSOX-WVJDLNGLSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
79894,6m2n,DB13920,-7.4,Valopicitabine,TVRCRTJYMVTEFS-ICGCPXGVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
36554,1r42,DB03082,-7.4,6-[(Z)-Amino(Imino)Methyl]-N-[4-(Aminomethyl)Phenyl]-4-(Pyrimidin-2-Ylamino)-2-Naphthamide,CSWQJKHBMACTGB-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
9071,6lzg,DB07143,-7.4,D-phenylalanyl-N-benzyl-L-prolinamide,MEPJWLFTTFHOQO-MOPGFXCFSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
143639,6w9q,DB03802,-7.4,"1-[4-(Octahydro-Pyrido[1,2-a]Pyrazin-2-Yl)-Phenyl]-2-Phenyl-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol",ZGHFWBDHZZKWSI-LITSAYRRSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
9166,6lzg,DB07250,-7.4,"N'-(5-CHLORO-1,3-BENZODIOXOL-4-YL)-N-(3,4,5- TRIMETHOXYPHENYL)PYRIMIDINE-2,4-DIAMINE",HMKLUOPMOJOUDZ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
27947,6cs2,DB07512,-7.4,7-[(3-CHLOROBENZYL)OXY]-2-OXO-2H-CHROMENE-4-CARBALDEHYDE,ZOCADHRNWNJARU-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
80356,6m2n,DB15201,-7.4,Norbixin,ZVKOASAVGLETCT-UOGKPENDSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
112055,6vxx,DB06190,-7.4,Solabegron,LLDXOPKUNJTIRF-QFIPXVFZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
99426,6vxs,DB02241,-7.4,"8-Benzyl-2-Hydroperoxy-2-(4-Hydroxy-Benzyl)-6-(4-Hydroxy-Phenyl)-2h-Imidazo[1,2-a]Pyrazin-3-One",HOSWCJDTHOAORT-SANMLTNESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
13084,6lzg,DB14657,-7.4,Paramethasone acetate,HYRKAAMZBDSJFJ-LFDBJOOHSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
67221,6lxt,DB06190,-7.4,Solabegron,LLDXOPKUNJTIRF-QFIPXVFZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
29085,6cs2,DB08725,-7.4,"(S)-5-(7-(4-(4-Ethyl-4,5-dihydro-2-oxazolyl)phenoxy)heptyl)-3-methylisoxazole",PZDSRPCFNWOUFP-IBGZPJMESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
117139,6w4b,DB03081,-7.4,Crc200 (Chiron-Behring),ZOXOKTJHZSUHRJ-XZOQPEGZSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
165883,7bv1,DB13174,-7.4,Rhein,FCDLCPWAQCPTKC-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95085,6m71,DB08910,-7.4,Pomalidomide,UVSMNLNDYGZFPF-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95252,6m71,DB09178,-7.4,Phenaridine,ODPKHHGQKIYCTJ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
106869,6vxx,DB01421,-7.4,Paromomycin,UOZODPSAJZTQNH-LSWIJEOBSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
122506,6w4b,DB13491,-7.4,Fluperolone,SLVCCRYLKTYUQP-DVTGEIKXSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
56201,6crv,DB02018,-7.4,Amido Phenyl Pyruvic Acid,ZXBYWYQEQQBMBT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
36784,1r42,DB03383,-7.4,5-Chloro-1h-Indole-2-Carboxylic Acid [1-(4-Fluorobenzyl)-2-(4-Hydroxypiperidin-1yl)-2-Oxoethyl]Amide,YDCGVASFVACWKF-NRFANRHFSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
62337,6crv,DB13437,-7.4,Medazepam,YLCXGBZIZBEVPZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
142,6lzg,HMDB0003114,-7.4,Neurosporene,ATCICVFRSJQYDV-XILUKMICSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
89703,6m71,DB00802,-7.4,Alfentanil,IDBPHNDTYPBSNI-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
13161,6lzg,DB14802,-7.4,ONO-2952,ZBQMTQGDBFZUBG-NRFANRHFSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
9167,6lzg,DB07251,-7.4,"N'-(3-CHLORO-4-METHOXY-PHENYL)-N-(3,4,5-TRIMETHOXYPHENYL)-1,3,5-TRIAZINE-2,4-DIAMINE",ZVWFECUPYCFYBL-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
79855,6m2n,DB13836,-7.4,Metampicillin,FZECHKJQHUVANE-MCYUEQNJSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
115963,6w4b,DB01536,-7.4,Androstenedione,AEMFNILZOJDQLW-QAGGRKNESA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
123550,6w4b,DB09171,-7.4,β-Methylfentanyl,UXIGUKSHASXDNI-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
123624,6w4h,DB00186,-7.4,Lorazepam,DIWRORZWFLOCLC-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
98766,6vxs,DB01384,-7.4,Paramethasone,MKPDWECBUAZOHP-AFYJWTTESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
98764,6vxs,DB01380,-7.4,Cortisone acetate,ITRJWOMZKQRYTA-RFZYENFJSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
36774,1r42,DB03367,-7.4,PF-00356231,VMTJQZUZINLEKC-JOCHJYFZSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
141850,6w9q,DB01443,-7.4,19-Nor-5-androstenedione,WELNRNVZXWUOGT-QXUSFIETSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
73760,6m2n,DB02454,-7.4,5-(6-Amino-9h-Purin-9-Yl)-4-Hydroxytetrahydrofuran-3-Yl Dihydrogen Phosphate,IJEJRDCFMFEDGL-AFEQZKEHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
89368,6m71,DB00394,-7.4,Beclomethasone dipropionate,KUVIULQEHSCUHY-XYWKZLDCSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
69146,6lxt,DB08758,-7.4,"IMIDAZO[2,1-A]ISOQUINOLINE-2-CARBOHYDRAZIDE",WSNWYZBDIKCPIG-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
106835,6vxx,DB01354,-7.4,Heptabarbital,PAZQYDJGLKSCSI-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
68686,6lxt,DB08198,-7.4,"[(4R)-4-(3-HYDROXYPHENYL)-1,6-DIMETHYL-2-THIOXO-1,2,3,4-TETRAHYDROPYRIMIDIN-5-YL](PHENYL)METHANONE",JGBBILLMZPWNFU-QGZVFWFLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
32232,6cs2,DB01204,-7.4,Mitoxantrone,KKZJGLLVHKMTCM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
36775,1r42,DB03368,-7.4,"5-Methyl-5-(4-Phenoxy-Phenyl)-Pyrimidine-2,4,6-Trione",RTBMLCLTYAPKIF-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
56261,6crv,DB02096,-7.4,FR221647,ZUYUIKKHHBEVHL-GFCCVEGCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
123668,6w4h,DB00238,-7.4,Nevirapine,NQDJXKOVJZTUJA-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
122729,6w4b,DB13791,-7.4,Penfluridol,MDLAAYDRRZXJIF-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
2573,6lzg,HMDB0042367,-7.4,TG(14:0/18:1(9Z)/24:0),RUZNGRCQLAJOGE-JAIQLVPXSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
141860,6w9q,DB01455,-7.4,19-Nor-5-androstenediol,VVUQRXPUVKXAIO-XFUVECHXSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
27608,6cs2,DB07158,-7.4,"5-ETHYL-3-METHYL-1,5-DIHYDRO-4H-PYRAZOLO[4,3-C]QUINOLIN-4-ONE",ASEHARDUZDZEKS-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
27930,6cs2,DB00687,-7.4,Fludrocortisone,AAXVEMMRQDVLJB-BULBTXNYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
124304,6w4h,DB00997,-7.4,Doxorubicin,AOJJSUZBOXZQNB-TZSSRYMLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
14561,6lzg,T3D4438,-7.4,Coproporphyrinogen III,NIUVHXTXUXOFEB-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
67139,6lxt,DB05737,-7.4,Varespladib methyl,VJYDOJXJUCJUHL-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
106830,6vxx,DB01348,-7.4,Spirapril,HRWCVUIFMSZDJS-SZMVWBNQSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27940,6cs2,DB07505,-7.4,"N-({(3R,4R)-4-[(benzyloxy)methyl]pyrrolidin-3-yl}methyl)-N-(2-methylpropyl)benzenesulfonamide",DGURGFSAQIBQCO-FGZHOGPDSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
62332,6crv,DB13432,-7.4,Lonazolac,XVUQHFRQHBLHQD-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
99373,6vxs,DB02170,-7.4,"1,8-Di-Hydroxy-4-Nitro-Xanthen-9-One",ZOHCDJRFYXKEQW-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
106820,6vxx,DB01331,-7.4,Cefoxitin,WZOZEZRFJCJXNZ-ZBFHGGJFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108029,6vxx,DB06727,-7.4,Sparteine,SLRCCWJSBJZJBV-ZQDZILKHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
123754,6w4h,DB00341,-7.4,Cetirizine,ZKLPARSLTMPFCP-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
79831,6m2n,DB13803,-7.4,Xipamide,MTZBBNMLMNBNJL-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
155961,6wiq,DB12006,-7.4,BMS-906024,AYOUDDAETNMCBW-GSHUGGBRSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
27935,6cs2,DB07499,-7.4,"N-(4-{[amino(imino)methyl]amino}butyl)-2,4'-bi-1,3-thiazole-4-carboxamide",VSIFMASDYAMOAN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
75097,6m2n,DB04239,-7.4,2-Amino-6-Aminomethyl-8-Phenylsulfanylmethyl-3h-Quinazolin-4-One,CBFXRTSHUMEYKQ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
117080,6w4b,DB02998,-7.4,Metribolone,CCCIJQPRIXGQOE-XWSJACJDSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
164422,7bv1,DB07812,-7.4,"N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyrrolo[2,3-b]pyridin-4-yl)thiophene-2-carboxamide",TWYNGDRSMHRPSY-MRXNPFEDSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
108028,6vxx,DB06726,-7.4,Bufuralol,SSEBTPPFLLCUMN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
19425,6cs2,HMDB0000010,-7.4,2-Methox1trone,WHEUWNKSCXYKBU-QPWUGHHJSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
122667,6w4b,DB13710,-7.4,Metenolone,ANJQEDFWRSLVBR-VHUDCFPWSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
112298,6vxx,DB06936,-7.4,N-(4-carbamimidoylbenzyl)-1-(4-methylpentanoyl)-L-prolinamide,AEKJCSNKYXWOAQ-INIZCTEOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
23300,6cs2,HMDB0060021,-7.4,trans-isoeugenol-O-glucuronide,HBQGHTRBYUFZLV-MIJQFFSFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
143862,6w9q,DB04099,-7.4,Deamido-Nad+,SENPVEZBRZQVST-HISDBWNOSA-O,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
68964,6lxt,DB08542,-7.4,"3,4-dihydroxy-9,10-secoandrosta-1(10),2,4-triene-9,17-dione",YUHVBHDSVLKFNI-NJSLBKSFSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
95081,6m71,DB08905,-7.4,Formestane,OSVMTWJCGUFAOD-KZQROQTASA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
122593,6w4b,DB13610,-7.4,Flumedroxone,CDZJOBWKHSYNMO-SCUQKFFVSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
147281,6w9q,DB11706,-7.4,Raxatrigine,JESCETIFNOFKEU-SJORKVTESA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
164423,7bv1,DB07813,-7.4,GLYCYLALANYL-N-2-NAPHTHYL-L-PROLINEAMIDE,KCELZXZDIUJGNM-GUYCJALGSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
29105,6cs2,DB00814,-7.4,Meloxicam,ZRVUJXDFFKFLMG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
141699,6w9q,DB01192,-7.4,Oxymorphone,UQCNKQCJZOAFTQ-ISWURRPUSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
31929,6cs2,DB15055,-7.4,ABT-639,AGPIHNZOZNKRGT-CYBMUJFWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
23876,6cs2,DB01518,-7.4,Benzethidine,UVTBZAWTRVBTMK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
140703,6w9c,DB15144,-7.4,Altropane I-123,GTQLIPQFXVKRKJ-HYRAKNMCSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
141774,6w9q,DB01322,-7.4,Kava,OMNGEVNATYFZGG-BQYQJAHWSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
107392,6vxx,DB03247,-7.4,Flavin mononucleotide,FVTCRASFADXXNN-SCRDCRAPSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163857,7bv1,DB06751,-7.4,Drotaverine,OMFNSKIUKYOYRG-MOSHPQCFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
79790,6m2n,DB13750,-7.4,Obidoxime,HIGRLDNHDGYWQJ-UHFFFAOYSA-P,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
112283,6vxx,DB06921,-7.4,(2S)-2-[3-(AMINOMETHYL)PHENYL]-3-[(R)-HYDROXY{(1R)-2-METHYL-1-[(PHENYLSULFONYL)AMINO]PROPYL}PHOSPHORYL]PROPANOIC ACID,FNZHLCNFXRRIIC-RBUKOAKNSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75101,6m2n,DB04243,-7.4,5-Methyluridine 5'-Monophosphate,IGWHDMPTQKSDTL-JXOAFFINSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
55844,6crv,DB01547,-7.4,Drotebanol,LCAHPIFLPICNRW-OPGCRTJHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107421,6vxx,DB03285,-7.4,"2',4,4'-Trihydroxychalcone",DXDRHHKMWQZJHT-FPYGCLRLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
147288,6w9q,DB11721,-7.4,Mitoglitazone,IRNJSRAGRIZIHD-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
107314,6vxx,DB03150,-7.4,"2',3'-Dideoxythymidine-5'-Monophosphate",WVNRRNJFRREKAR-JGVFFNPUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
63168,6crv,DB15268,-7.4,Afabicin,HFYMDQMXVPJNTH-VQHVLOKHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
23894,6cs2,DB01536,-7.4,Androstenedione,AEMFNILZOJDQLW-QAGGRKNESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
89445,6m71,DB00486,-7.4,Nabilone,GECBBEABIDMGGL-RTBURBONSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
146955,6w9q,DB09233,-7.4,Cronidipine,CNIJVNPIIHWRRP-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
62679,6crv,DB13938,-7.4,S-40503,YNYAUBNZRZVNLX-KBPBESRZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29530,6cs2,DB09305,-7.4,Aptazapine,MNHDDERDSNZCCK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
99300,6vxs,DB02075,-7.4,"(1s)-1(9-Deazahypoxanthin-9yl)1,4-Dideoxy-1,4-Imino-D-Ribitol-5-Phosphate",VJTAXXUIRYOXBT-KUBHLMPHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
90068,6m71,DB01215,-7.4,Estazolam,CDCHDCWJMGXXRH-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
143726,6w9q,DB03916,-7.4,4-{2-[4-(2-Aminoethyl)Piperazin-1-Yl]Pyridin-4-Yl}-N-(3-Chloro-4-Methylphenyl)Pyrimidin-2-Amine,RHOOHUMOHVIXEF-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
115988,6w4b,DB01561,-7.4,Androstanedione,RAJWOBJTTGJROA-WZNAKSSCSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
68976,6lxt,DB08556,-7.4,"5'-ACETYL-4-{[(2,4-DIMETHYLPHENYL)SULFONYL]AMINO}-2,2'-BITHIOPHENE-5-CARBOXYLIC ACID",CMHHNHDPPWDNAH-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
73517,6m2n,DB02135,-7.4,"4-{2,6,8-Trioxo-9-[(2R,3S,4R)-2,3,4,5-Tetrahydroxypentyl]-1,2,3,6,8,9-Hexahydro-7h-Purin-7-Yl}Butyl Dihydrogen Phosphate",VBXZSBKAJFXURR-MRTMQBJTSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
62674,6crv,DB13930,-7.4,Ulixertinib,KSERXGMCDHOLSS-LJQANCHMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112473,6vxx,DB07295,-7.4,2-[(7-HYDROXY-NAPHTHALEN-1-YL)-OXALYL-AMINO]-BENZOIC ACID,IGOULVZYQKJJKC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
32220,6cs2,DB01192,-7.4,Oxymorphone,UQCNKQCJZOAFTQ-ISWURRPUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
89732,6m71,DB00833,-7.4,Cefaclor,QYIYFLOTGYLRGG-GPCCPHFNSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
116380,6w4b,DB02081,-7.4,Bis-Benzamidine,BXYGSMRTHHSAHZ-PMACEKPBSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
79849,6m2n,DB13825,-7.4,Fedrilate,RDEOYUSTRWNWLX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
123790,6w4h,DB00383,-7.4,Oxyphencyclimine,DUDKAZCAISNGQN-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
147260,6w9q,DB11679,-7.4,Fruquintinib,BALLNEJQLSTPIO-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
52952,2fxp,DB12267,-7.4,Brigatinib,AILRADAXUVEEIR-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
155942,6wiq,DB11978,-7.4,Glasdegib,SFNSLLSYNZWZQG-VQIMIIECSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
68927,6lxt,DB08499,-7.4,"N-[3-(2-fluoroethoxy)phenyl]-N'-(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-6-yl)butanediamide",DQXBKUVWJSZHSI-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
89702,6m71,DB00801,-7.4,Halazepam,WYCLKVQLVUQKNZ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
65453,6lxt,DB02854,-7.4,Aetiocholanolone,QGXBDMJGAMFCBF-BNSUEQOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
124288,6w4h,DB00978,-7.4,Lomefloxacin,ZEKZLJVOYLTDKK-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
163911,7bv1,DB06848,-7.4,"1-(1'-{[3-(methylsulfanyl)-2-benzothiophen-1-yl]carbonyl}spiro[1-benzofuran-3,4'-piperidin]-5-yl)methanamine",VCUDZTCDUDDJGG-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
98757,6vxs,DB01357,-7.4,Mestranol,IMSSROKUHAOUJS-MJCUULBUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
24182,6cs2,DB01864,-7.4,5'-Guanosine-Diphosphate-Monothiophosphate,XOFLBQFBSOEHOG-UUOKFMHZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
124360,6w4h,DB01060,-7.4,Amoxicillin,LSQZJLSUYDQPKJ-NJBDSQKTSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
106815,6vxx,DB01325,-7.4,Quinethazone,AGMMTXLNIQSRCG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
123669,6w4h,DB00239,-7.4,Oxiconazole,QRJJEGAJXVEBNE-HKOYGPOVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
62770,6crv,DB14109,-7.4,alpha-Arbutin,BJRNKVDFDLYUGJ-ZIQFBCGOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
99477,6vxs,DB02310,-7.4,"3,5,6,8-Tetramethyl-N-Methyl Phenanthrolinium",FQTUZNACZKILMC-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
68958,6lxt,DB08535,-7.4,"3-bromo-5-phenyl-N-(pyridin-3-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",SMIZFGZXFDGISG-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
123670,6w4h,DB00240,-7.4,Alclometasone,FJXOGVLKCZQRDN-PHCHRAKRSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
23888,6cs2,DB01530,-7.4,"5alpha-androstane-3alpha,17beta-diol",CBMYJHIOYJEBSB-KHOSGYARSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
95246,6m71,DB09171,-7.4,??-Methylfentanyl,UXIGUKSHASXDNI-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
100064,6vxs,DB03079,-7.4,Alpha-Ribazole-5'-Phosphate Derivative,YPYFPLLZCVEYCS-KKOKHZNYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
163913,7bv1,DB06850,-7.4,(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclohexylamino)ethanoyl)pyrrolidine-2-carboxamide,RYKFVFFOIYLADT-SFHVURJKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
80646,6m3m,DB00261,-7.4,Anagrelide,OTBXOEAOVRKTNQ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
68930,6lxt,DB08502,-7.4,Capravirine,YQXCVAGCMNFUMQ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
31933,6cs2,DB15059,-7.4,Aprocitentan,DKULOVKANLVDEA-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
79847,6m2n,DB13823,-7.4,Pipemidic acid,JOHZPMXAZQZXHR-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
31935,6cs2,DB15063,-7.4,Inarigivir soproxil,CJCYTUJOSMYXLE-JDLSZIHUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
140612,6w9c,DB12533,-7.4,Cevipabulin,ZUZPCOQWSYNWLU-VIFPVBQESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
164167,7bv1,DB07330,-7.4,trans-4-(7-carbamoyl-1H-benzimidazol-2-yl)-1-propylpiperidinium,KXSIHXHEHABEJX-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
89653,6m71,DB00739,-7.4,Hetacillin,DXVUYOAEDJXBPY-NFFDBFGFSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
106811,6vxx,DB01319,-7.4,Fosamprenavir,MLBVMOWEQCZNCC-OEMFJLHTSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140729,6w9c,DB15201,-7.4,Norbixin,ZVKOASAVGLETCT-UOGKPENDSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
163887,7bv1,DB06816,-7.4,Pyrvinium,QMHSXPLYMTVAMK-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
164071,7bv1,DB07036,-7.4,"(3aS,4R,9bR)-2,2-difluoro-4-(4-hydroxyphenyl)-6-(methoxymethyl)-1,2,3,3a,4,9b-hexahydrocyclopenta[c]chromen-8-ol",GPFRMIHXGMVMGF-BZSNNMDCSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
62366,6crv,DB13479,-7.4,Histapyrrodine,MXHODDGKGSGCDI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
99845,6vxs,DB02789,-7.4,Pregnenolone,ORNBQBCIOKFOEO-QGVNFLHTSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
80751,6m3m,DB00387,-7.4,Procyclidine,WYDUSKDSKCASEF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
23271,6cs2,HMDB0059988,-7.4,"5-(3',4'-Dihydroxyphenyl)-gamma-valerolactone-3'-O-methyl-4'-O-glucuronide",CISWUCBSWWHCJB-WWHSGRCBSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
164088,7bv1,DB07246,-7.4,"(2R)-2-AMINO-3,3,3-TRIFLUORO-N-HYDROXY-2-{[(4-PHENOXYPHENYL)SULFONYL]METHYL}PROPANAMIDE",MKRPIBSCGZAUCH-OAHLLOKOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
164090,7bv1,DB07248,-7.4,"7-PYRIDIN-2-YL-N-(3,4,5-TRIMETHOXYPHENYL)-7H-PYRROLO[2,3-D]PYRIMIDIN-2-AMINE",YENZSPIOXMNEFF-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
73675,6m2n,DB02350,-7.4,"N-Hydroxy-4-[(4-Methoxylphenyl)Sulfonyl]-2,2-Dimethyl-Hexahydro-1,4-Thiazepine-3(S)-Carboxamide",CYYCSKFJEOSZTF-CYBMUJFWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
141112,6w9q,DB00502,-7.4,Haloperidol,LNEPOXFFQSENCJ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
10993,6lzg,DB09534,-7.4,Ecamsule,HEAHZSUCFKFERC-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
142293,6w9q,DB02010,-7.4,Staurosporine,HKSZLNNOFSGOKW-FYTWVXJKSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
147364,6w9q,DB11829,-7.4,Ruboxistaurin,ZCBUQCWBWNUWSU-SFHVURJKSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
13222,6lzg,DB14924,-7.4,PF-06651600,CBRJPFGIXUFMTM-WDEREUQCSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
112193,6vxx,DB06536,-7.4,Tesaglitazar,CXGTZJYQWSUFET-IBGZPJMESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
89940,6m71,DB01070,-7.4,Dihydrotachysterol,ILYCWAKSDCYMBB-OPCMSESCSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94927,6m71,DB08704,-7.4,"[[(3R,4R,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-(pentanoylamino)oxan-2-ylidene]amino] N-phenylcarbamate",NUNQIQQEEPOGDJ-JDOAOKHLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
164246,7bv1,DB07425,-7.4,Sobetirome,QNAZTOHXCZPOSA-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
62993,6crv,DB14888,-7.4,IQP-0528,UCOAKFIVSAVHLC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
99707,6vxs,DB02602,-7.4,AL7182,ICIXQGGQPKFQRL-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
107121,6vxx,DB02316,-7.4,"1-(5-Carboxypentyl)-5-[(2,6-Dichlorobenzyl)Oxy]-1 H-Indole-2-Carboxylic Acid",JTGPYFFQVOIJKR-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80167,6m2n,DB14772,-7.4,DCFBC F-18,IDTMSHGCAZPVLC-STUNTBJNSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
123158,6w4b,DB14982,-7.4,Miransertib,HNFMVVHMKGFCMB-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
124048,6w4h,DB00698,-7.4,Nitrofurantoin,NXFQHRVNIOXGAQ-YCRREMRBSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
123947,6w4h,DB00578,-7.4,Carbenicillin,FPPNZSSZRUTDAP-UWFZAAFLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
75069,6m2n,DB04202,-7.4,Isoformononetin,LNIQZRIHAMVRJA-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80756,6m3m,DB00393,-7.4,Nimodipine,UIAGMCDKSXEBJQ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
124053,6w4h,DB00704,-7.4,Naltrexone,DQCKKXVULJGBQN-XFWGSAIBSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
9123,6lzg,DB07198,-7.4,5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-CARBONITRILE,GGEKOZPXKBYLNK-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
112392,6vxx,DB07050,-7.4,"5-[(phenylsulfonyl)amino]-1,3,4-thiadiazole-2-sulfonamide",PWDGTQXZLNDOKS-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
164031,7bv1,DB06992,-7.4,"(3,3-dimethylpiperidin-1-yl)(6-(3-fluoro-4-methylphenyl)pyridin-2-yl)methanone",SIDDLTBLAQYZIZ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
99058,6vxs,DB01748,-7.4,N-Benzyl-4-Sulfamoyl-Benzamide,CZKNSZUJCJHTTM-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
112211,6vxx,DB06594,-7.4,Agomelatine,YJYPHIXNFHFHND-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
123147,6w4b,DB14934,-7.4,GDC-0927,KJAAPZIFCQQQKX-NDEPHWFRSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
92842,6m71,DB05013,-7.4,Ingenol mebutate,VDJHFHXMUKFKET-UXMMOKKRSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
123288,6w4b,DB15242,-7.4,MK-0533,STWITCBWQHTJFJ-XMMPIXPASA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
62566,6crv,DB13750,-7.4,Obidoxime,HIGRLDNHDGYWQJ-UHFFFAOYSA-P,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
36480,1r42,DB02976,-7.4,Uridine-5'-monophosphate 2-deoxy-2-fluoro-galactopyranosyl-monophosphate ester,NGTCPFGWXMBZEP-KBQKSTHMSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
62981,6crv,DB14867,-7.4,Parsaclisib,ZQPDJCIXJHUERQ-QWRGUYRKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
151774,6wiq,DB03159,-7.4,CRA_8696,GAVRMVQHHVMXFD-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
28993,6cs2,DB08624,-7.4,BENZOTHIAZOLE,MAJHCCQPIDXPAN-QMMMGPOBSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
32292,6cs2,DB01288,-7.4,Fenoterol,LSLYOANBFKQKPT-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
89949,6m71,DB01082,-7.4,Streptomycin,UCSJYZPVAKXKNQ-HZYVHMACSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
123094,6w4b,DB14828,-7.4,ABX-464,OZOGDCZJYVSUBR-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
23978,6cs2,DB01623,-7.4,Thiothixene,GFBKORZTTCHDGY-UWVJOHFNSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
164099,7bv1,DB07257,-7.4,"4-(2-chlorophenyl)-8-(2-hydroxyethyl)-6-methylpyrrolo[3,4-e]indole-1,3(2H,6H)-dione",WHMQZCPGFZBLBG-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
107825,6vxx,DB04662,-7.4,OLOMOUCINE II,NDUVSANREQEDRE-CQSZACIVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
141068,6w9q,DB00450,-7.4,Droperidol,RMEDXOLNCUSCGS-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
89961,6m71,DB01095,-7.4,Fluvastatin,FJLGEFLZQAZZCD-JUFISIKESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
107156,6vxx,DB02640,-7.4,Fumagillin,NGGMYCMLYOUNGM-CSDLUJIJSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107827,6vxx,DB04664,-7.4,Cyclohexyl-pentyl-maltoside,RVTGFZGNOSKUDA-ZNGNCRBCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
124096,6w4h,DB00755,-7.4,Tretinoin,SHGAZHPCJJPHSC-YCNIQYBTSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
107832,6vxx,DB04676,-7.4,Dansyllysine,VQPRNSWQIAHPMS-HNNXBMFYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
142984,6w9q,DB02915,-7.4,"4-(2,4-Dimethyl-1,3-thiazol-5-yl)-N-[4-(trifluoromethyl)phenyl]-2-pyrimidinamine",MEZFDQUDLQCVNX-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
68781,6lxt,DB08320,-7.4,"DIETHYL (1R,2S,3R,4S)-5,6-BIS(4-HYDROXYPHENYL)-7-OXABICYCLO[2.2.1]HEPT-5-ENE-2,3-DICARBOXYLATE",NHKDFDHHMHBFLG-COPRSSIGSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
30473,6cs2,DB12533,-7.4,Cevipabulin,ZUZPCOQWSYNWLU-VIFPVBQESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
142998,6w9q,DB02932,-7.4,(R)-Bicalutamide,LKJPYSCBVHEWIU-KRWDZBQOSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
24290,6cs2,DB02001,-7.4,"5-(4-Morpholin-4-Yl-Phenylsulfanyl)-2,4-Quinazolinediamine",CZLWCJRHDBTCGQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
32036,6cs2,DB15241,-7.4,Methylsamidorphan,ATCVVCBJNHXIEX-ZAHKBLQYSA-O,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
123279,6w4b,DB15227,-7.4,Tirabrutinib,SEJLPXCPMNSRAM-GOSISDBHSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
155786,6wiq,DB11732,-7.4,Lasmiditan,XEDHVZKDSYZQBF-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
141074,6w9q,DB00457,-7.4,Prazosin,IENZQIKPVFGBNW-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
155399,6wiq,DB09063,-7.4,Ceritinib,VERWOWGGCGHDQE-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
141357,6w9q,DB00805,-7.4,Minaprine,LDMWSLGGVTVJPG-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
123298,6w4b,DB15266,-7.4,TAK-580,VWMJHAFYPMOMGF-ZCFIWIBFSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
107798,6vxx,DB04630,-7.4,Aldosterone,PQSUYGKTWSAVDQ-ZVIOFETBSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
92830,6m71,DB04954,-7.4,Tecadenoson,OESBDSFYJMDRJY-BAYCTPFLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
123117,6w4b,DB14876,-7.4,TAS-116,NVVPMZUGELHVMH-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
107806,6vxx,DB04640,-7.4,"Naphthalene-2,6-disulfonic acid",FITZJYAVATZPMJ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107811,6vxx,DB04645,-7.4,"5-{3-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-2-METHYL-PHENOXY}-PENTANOIC ACID",NJJIFGCFUDDBSP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
73403,6m2n,DB01987,-7.4,Cocarboxylase,AYEKOFBPNLCAJY-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
123912,6w4h,DB00535,-7.4,Cefdinir,RTXOFQZKPXMALH-GHXIOONMSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
124083,6w4h,DB00739,-7.4,Hetacillin,DXVUYOAEDJXBPY-NFFDBFGFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
24082,6cs2,DB01748,-7.4,N-Benzyl-4-Sulfamoyl-Benzamide,CZKNSZUJCJHTTM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
9233,6lzg,DB07315,-7.4,"5-chloro-N-{4-[(1R)-1,2-dihydroxyethyl]phenyl}-1H-indole-2-carboxamide",SHCHFGSUYJUEBR-INIZCTEOSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
98897,6vxs,DB01544,-7.4,Flunitrazepam,PPTYJKAXVCCBDU-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
62576,6crv,DB13762,-7.4,Dexrabeprazole,YREYEVIYCVEVJK-RUZDIDTESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
98896,6vxs,DB01543,-7.4,18-methyl-19-nortestosterone,FBYZQDCRLYHHHP-ZOFHRBRSSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
99700,6vxs,DB02593,-7.4,"7,8-Dihydroxy-1-Methoxy-3-Methyl-10-Oxo-4,10-Dihydro-1h,3h-Pyrano[4,3-B]Chromene-9-Carboxylic Acid",RSFJMLCZHPZXCW-AANKLQPISA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
73688,6m2n,DB02367,-7.4,(1n)-4-N-Butoxyphenylsulfonyl-(2r)-N-Hydroxycarboxamido-(4s)-Methanesulfonylamino-Pyrrolidine,ULDXUWXTVRRUND-SWLSCSKDSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80812,6m3m,DB00458,-7.4,Imipramine,BCGWQEUPMDMJNV-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
164046,7bv1,DB07007,-7.4,"(3R)-3-[(1,2,3,4-tetrahydroisoquinolin-7-yloxy)methyl]-2,3-dihydrothieno[2,3-f][1,4]oxazepin-5-amine",UDFXWCLBONUMNA-CYBMUJFWSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
36675,1r42,DB03239,-7.4,"3',5'-Dinitro-N-Acetyl-L-Thyronine",VZSQTOXQXPKQJX-ZDUSSCGKSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
142433,6w9q,DB02197,-7.4,"4-[(4-Imidazo[1,2-a]Pyridin-3-Ylpyrimidin-2-Yl)Amino]Benzenesulfonamide",NKORVPQBJCGYEC-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
142590,6w9q,DB02400,-7.4,"5-Methoxy-1,2-Dimethyl-3-(4-Nitrophenoxymethyl)Indole-4,7-Dione",IBLWSLZYYZHSRG-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
65512,6lxt,DB02930,-7.4,Adenosine 5'-[??-thio]triphosphate,NLTUCYMLOPLUHL-KQYNXXCUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
123213,6w4b,DB15099,-7.4,GW-468816,XDKRVNKVAKCFGW-WXWBBQJKSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
124001,6w4h,DB00641,-7.4,Simvastatin,RYMZZMVNJRMUDD-HGQWONQESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
73643,6m2n,DB02307,-7.4,N-(1-Carboxy-3-Phenylpropyl)Phenylalanyl-Alpha-Asparagine,FOJUHLDAXGNCIP-FHWLQOOXSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
62550,6crv,DB13725,-7.4,Terodiline,UISARWKNNNHPGI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29020,6cs2,DB08655,-7.4,"9-ACETYL-2,3,4,9-TETRAHYDRO-1H-CARBAZOL-1-ONE",MIGJEXKBUJPKJF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
62552,6crv,DB13727,-7.4,Azapetine,NYGHGTMKALXFIA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
151318,6wiq,DB02545,-7.4,Fexaramine,VLQTUNDJHLEFEQ-KGENOOAVSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
107667,6vxx,DB04159,-7.4,Beta-Hydroxytryptophane,ITFHGBKXKUVKBW-UWVGGRQHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
98992,6vxs,DB01658,-7.4,1'-Deazo-Thiamin Diphosphate,JHNXLHRDUXBCJW-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
107075,6vxx,DB02254,-7.4,Trifluoro-thiamin phosphate,ZIBIECXVPMYJCV-UHFFFAOYSA-M,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76567,6m2n,DB07350,-7.4,(2E)-N-hydroxy-3-[1-methyl-4-(phenylacetyl)-1H-pyrrol-2-yl]prop-2-enamide,UFQOXIMRSMFQRI-BQYQJAHWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
89581,6m71,DB00656,-7.4,Trazodone,PHLBKPHSAVXXEF-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
80101,6m2n,DB14648,-7.4,Acetyl simvastatin,OHVWRJDVJRNCPE-BIKFJBPRSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
142475,6w9q,DB02253,-7.4,"(1r)-4-[(1e,3e,5e,7z,9e,11z,13e,15e)-17-Hydroxy-3,7,12,16-Tetramethylheptadeca-1,3,5,7,9,11,13,15-Octaen-1-Yl]-3,5,5-Trimethylcyclohex-3-En-1-Ol",FNAJVVMDXCOSFY-VFGOXHQXSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
155336,6wiq,DB08974,-7.4,Flubendazole,CPEUVMUXAHMANV-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
141266,6w9q,DB00694,-7.4,Daunorubicin,STQGQHZAVUOBTE-VGBVRHCVSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
155325,6wiq,DB08962,-7.4,Glibornuride,RMTYNAPTNBJHQI-LLDVTBCESA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
107094,6vxx,DB02276,-7.4,(S)-2-(Phosphonoxy)Caproyl-L-Leucyl-P-Nitroanilide,HARXAJAHMRMERT-HOTGVXAUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107652,6vxx,DB04140,-7.4,1-Benzyl-3-(4-Methoxy-Benzenesulfonyl)-6-Oxo-Hexahydro-Pyrimidine-4-Carboxylic Acid Hydroxyamide,SUSMVCKSLVPRCL-QGZVFWFLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
141265,6w9q,DB00693,-7.4,Fluorescein,GNBHRKFJIUUOQI-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
89592,6m71,DB00670,-7.4,Pirenzepine,RMHMFHUVIITRHF-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
142543,6w9q,DB02341,-7.4,"Mdl 101,146",XQAMVCHQGHAELT-YPAWHYETSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
36499,1r42,DB03005,-7.4,"3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-5-Yl]Hexyl]-Phenanthridinium",ISUOMOOYAOQQPZ-UHFFFAOYSA-O,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
98963,6vxs,DB01622,-7.4,Thioproperazine,VZYCZNZBPPHOFY-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
62934,6crv,DB14755,-7.4,beta-Isosparteine,SLRCCWJSBJZJBV-AJNGGQMLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
141271,6w9q,DB00699,-7.4,Nicergoline,YSEXMKHXIOCEJA-FVFQAYNVSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
123987,6w4h,DB00624,-7.4,Testosterone,MUMGGOZAMZWBJJ-DYKIIFRCSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
80096,6m2n,DB14643,-7.4,Methylprednisolone aceponate,DALKLAYLIPSCQL-YPYQNWSCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
89901,6m71,DB01026,-7.4,Ketoconazole,XMAYWYJOQHXEEK-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
142556,6w9q,DB02360,-7.4,Bis-Napthyl Beta-Ketophosphonic Acid,OFHMUASCSJJNNA-JOCHJYFZSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
50883,2fxp,DB07528,-7.4,3-(2-aminoquinazolin-6-yl)-4-methyl-1-[3-(trifluoromethyl)phenyl]pyridin-2(1H)-one,HXUZQEYFKAZBPX-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
123224,6w4b,DB15121,-7.4,AT-001,YRGPAXAVTDMKDK-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
11173,6lzg,DB11577,-7.4,Indigotindisulfonic Acid,CFZXDJWFRVEWSR-BUHFOSPRSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
65511,6lxt,DB02929,-7.4,K201,KCWGETCFOVJEPI-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
98947,6vxs,DB01604,-7.4,Pivampicillin,ZEMIJUDPLILVNQ-ZXFNITATSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
29024,6cs2,DB08659,-7.4,2-(hydrazinocarbonyl)-3-phenyl-1H-indole-5-sulfonamide,PPDLAUCFAOODER-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
76555,6m2n,DB07335,-7.4,"3-[4-AMINO-1-(1-METHYLETHYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL]PHENOL",MWYBBCLGEHZSCP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
155362,6wiq,DB09003,-7.4,Clocapramine,QAZKXHSIKKNOHH-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
27792,6cs2,DB07345,-7.4,4-(2-aminoethyl)-2-cyclohexylphenol,DOCCSEDGBYCYLS-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
107104,6vxx,DB02290,-7.4,"3-{2,6,8-trioxo-9-[(2S,3S,4R)-2,3,4,5-tetrahydroxypentyl]-1,2,3,6,8,9-hexahydro-7H-purin-7-Yl}propyl dihydrogen phosphate",KPHFGOGGKPGLTM-OOZYFLPDSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
98934,6vxs,DB01586,-7.4,Ursodeoxycholic acid,RUDATBOHQWOJDD-UZVSRGJWSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
80148,6m2n,DB14732,-7.4,Queuine,WYROLENTHWJFLR-ACLDMZEESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
124033,6w4h,DB00682,-7.4,Warfarin,PJVWKTKQMONHTI-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
142401,6w9q,DB02152,-7.4,K-252a,KOZFSFOOLUUIGY-SOLYNIJKSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
13245,6lzg,DB14998,-7.4,Olorinab,ACSQLTBPYZSGBA-GMXVVIOVSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
9204,6lzg,DB07288,-7.4,N-(4-chlorophenyl)-2-[(pyridin-4-ylmethyl)amino]benzamide,GGPZCOONYBPZEW-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
142775,6w9q,DB02639,-7.4,4-methylumbelliferyl ??-D-glucoside,YUDPTGPSBJVHCN-JZYAIQKZSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
151717,6wiq,DB03081,-7.4,Crc200 (Chiron-Behring),ZOXOKTJHZSUHRJ-XZOQPEGZSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
112382,6vxx,DB07039,-7.4,(2S)-N-(4-cyano-3-iodophenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide,RXSZCFAPSDTELY-SFHVURJKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
123949,6w4h,DB00580,-7.4,Valdecoxib,LNPDTQAFDNKSHK-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
164322,7bv1,DB07698,-7.4,"3-(3-aminophenyl)-N-(3-chlorophenyl)pyrazolo[1,5-a]pyrimidin-5-amine",JDNMRPIWJIDDAY-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
107731,6vxx,DB04544,-7.4,1-Deoxy-1-Acetylamino-Beta-D-Gluco-2-Heptulopyranosonamide,BUPVODXECQDZQR-YCOWOFQRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
142789,6w9q,DB02656,-7.4,LY-294002,CZQHHVNHHHRRDU-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
80768,6m3m,DB00406,-7.4,Gentian violet cation,LGLFFNDHMLKUMI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
151688,6wiq,DB03044,-7.4,1-(5-Tert-Butyl-2-P-Tolyl-2h-Pyrazol-3-Yl)-3-[4-(2-Morpholin-4-Yl-Ethoxy)-Naphthalen-1-Yl]-Urea,MVCOAUNKQVWQHZ-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
112215,6vxx,DB06603,-7.4,Panobinostat,FPOHNWQLNRZRFC-ZHACJKMWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
89917,6m71,DB01044,-7.4,Gatifloxacin,XUBOMFCQGDBHNK-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
107672,6vxx,DB04164,-7.4,"1,4-Deoxy-4-((5-Hydroxymethyl-2,3,4-Trihydroxycyclohex-5-Enyl)Amino)Fructose",ZGWNRGISVMYHTF-KKXLKBQTSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
68813,6lxt,DB08361,-7.4,"2-{[(1R,2S)-2-aminocyclohexyl]amino}-4-[(3-methylphenyl)amino]pyrimidine-5-carboxamide",NZNTWOVDIXCHHS-LSDHHAIUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
69046,6lxt,DB08644,-7.4,{1-[2-(1-FORMYL-PROPYL)-3-METHANESULFONYLAMINO-PYRROLIDINE-1-CARBONYL]-2-METHYL-PROPYL}-CARBAMIC ACID TERT-BUTYL ESTER,NOWIRVOXJOWTSQ-FXUDXRNXSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
116689,6w4b,DB02483,-7.4,Etheno-Nad,JCDBQDNBEQHDHK-BSLNIGMPSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
141289,6w9q,DB00719,-7.4,Azatadine,SEBMTIQKRHYNIT-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
573,6lzg,HMDB0005801,-7.4,Kaempferol,IYRMWMYZSQPJKC-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
107699,6vxx,DB04198,-7.4,Formycin B,MTCJZZBQNCXKAP-KSYZLYKTSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
123190,6w4b,DB15055,-7.4,ABT-639,AGPIHNZOZNKRGT-CYBMUJFWSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
9106,6lzg,DB07180,-7.4,"5-[(Z)-(5-Chloro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-N,2,4-trimethyl-1H-pyrrole-3-carboxamide",FIRPCWHHIWFKCD-GHXNOFRVSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
123189,6w4b,DB15052,-7.4,Ansofaxine,QKYBZJLEMOZFFU-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
142728,6w9q,DB02573,-7.4,"2'-Deoxycytidine-2'-Deoxyadenosine-3',5'-Monophosphate",LYWWDKIADIGKTH-IDMWBNCISA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
89890,6m71,DB01013,-7.4,Clobetasol propionate,CBGUOGMQLZIXBE-XGQKBEPLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
27811,6cs2,DB07365,-7.4,NAPHTHALEN-2-YL-3-ALANINE,OFYAYGJCPXRNBL-LBPRGKRZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
18993,6cs2,HMDB0000734,-7.4,Indoleacrylic acid,SXOUIMVOMIGLHO-AATRIKPKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
14118,6lzg,T3D3735,-7.4,Dicumarol,DOBMPNYZJYQDGZ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
53035,2fxp,DB12381,-7.4,Merestinib,QHADVLVFMKEIIP-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
73464,6m2n,DB02071,-7.4,WAY-151693,AINJYWXKBKRQSX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
123073,6w4b,DB14770,-7.4,Lanraplenib,XCIGZBVOUQVIPI-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
9246,6lzg,DB07328,-7.4,"METHYL 4-{[({[(2R,5S)-5-{[(2S)-2-(AMINOMETHYL)PYRROLIDIN-1-YL]CARBONYL}PYRROLIDIN-2-YL]METHYL}AMINO)CARBONYL]AMINO}BENZOATE",USDCNOQKDUFKRD-IKGGRYGDSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
13209,6lzg,DB14899,-7.4,Tavapadon,AKQXQLUNFKDZBN-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
143365,6w9q,DB03421,-7.4,"2-Phenethyl-2,3-Dihydro-Phthalazine-1,4-Dione",JSSVIGGKHIJEHO-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
89488,6m71,DB00543,-7.4,Amoxapine,QWGDMFLQWFTERH-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
52842,2fxp,DB12108,-7.4,Taselisib,BEUQXVWXFDOSAQ-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
155134,6wiq,DB08706,-7.4,"(2S)-({(5Z)-5-[(5-ETHYL-2-FURYL)METHYLENE]-4-OXO-4,5-DIHYDRO-1,3-THIAZOL-2-YL}AMINO)(4-FLUOROPHENYL)ACETIC ACID",RNEACARJKXYVND-MZLJFPOFSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
123367,6w4b,DB15407,-7.4,Acalisib,DOCINCLJNAXZQF-LBPRGKRZSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
112433,6vxx,DB07099,-7.4,N-[4-(benzyloxy)phenyl]glycinamide,YJPUATSIKWOSST-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
68740,6lxt,DB08270,-7.4,"N-(2-AMINOETHYL)-N-2-{(1S)-1-[4'-(AMINOSULFONYL)BIPHENYL-4-YL]-2,2,2-TRIFLUOROETHYL}-L-LEUCINAMIDE",QPXXBNKMAHUXBB-PMACEKPBSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
116875,6w4b,DB02723,-7.4,"4-Oxo-2-Phenylmethanesulfonyl-Octahydro-Pyrrolo[1,2-a]Pyrazine-6-Carboxylic Acid [1-(N-Hydroxycarbamimidoyl)-Piperidin-4-Ylmethyl]-Amide",DHTSUHWLPAEEQB-OALUTQOASA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
123379,6w4b,DB15431,-7.4,M-2698,HXAUJHZZPCBFPN-QGZVFWFLSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
141538,6w9q,DB01009,-7.4,Ketoprofen,DKYWVDODHFEZIM-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
68984,6lxt,DB08568,-7.4,(2S)-1-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}-3-PHENYLPROPAN-2-AMINE,BPNUQXPIQBZCMR-IBGZPJMESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
68894,6lxt,DB08461,-7.4,"3-[(4-AMINO-1-TERT-BUTYL-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL)METHYL]PHENOL",QMAIQPBRCNEJAT-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
143379,6w9q,DB03447,-7.4,Uridylyl-2'-5'-Phospho-Adenosine,QARCCHXXGAIRFS-KPKSGTNCSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
89812,6m71,DB00922,-7.4,Levosimendan,WHXMKTBCFHIYNQ-SECBINFHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
124208,6w4h,DB00885,-7.4,Pemirolast,HIANJWSAHKJQTH-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
142097,6w9q,DB01745,-7.4,N-Alpha-(2-Naphthylsulfonyl)-N(3-Amidino-L-Phenylalaninyl)Isopipecolinic Acid Methyl Ester,JJLGQWCKMHPBEB-DEOSSOPVSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
68878,6lxt,DB08442,-7.4,"4-{[(2R)-2-(2-methylphenyl)pyrrolidin-1-yl]carbonyl}benzene-1,3-diol",TWODFUZHWYZBHZ-MRXNPFEDSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
23951,6cs2,DB01595,-7.4,Nitrazepam,KJONHKAYOJNZEC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
23949,6cs2,DB01591,-7.4,Solifenacin,FBOUYBDGKBSUES-VXKWHMMOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
29060,6cs2,DB00810,-7.4,Biperiden,YSXKPIUOCJLQIE-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
23280,6cs2,HMDB0059997,-7.4,Dihyroxy-1H-indole glucuronide I,IAHCDPVIVIKDFJ-DIACKHNESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
29062,6cs2,DB08704,-7.4,"[[(3R,4R,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-(pentanoylamino)oxan-2-ylidene]amino] N-phenylcarbamate",NUNQIQQEEPOGDJ-JDOAOKHLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
80693,6m3m,DB00315,-7.4,Zolmitriptan,ULSDMUVEXKOYBU-ZDUSSCGKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
23946,6cs2,DB01587,-7.4,Ketazolam,PWAJCNITSBZRBL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
155478,6wiq,DB09199,-7.4,Netoglitazone,PKWDZWYVIHVNKS-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
122996,6w4b,DB14635,-7.4,Curcumin sulfate,NEJVQQBBTRFOHB-FCXRPNKRSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
151906,6wiq,DB03325,-7.4,Tyrosyladenylate,MJZAZMKENKZBAJ-QTOWJTHWSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
164370,7bv1,DB07755,-7.4,"(2S)-1-[4-({4-[(2,5-Dichlorophenyl)amino]-2-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol",GNLAGGCSJGJECE-INIZCTEOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
112432,6vxx,DB07096,-7.4,"6-AMINO-BENZO[DE]ISOQUINOLINE-1,3-DIONE",SSMIFVHARFVINF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107935,6vxx,DB05680,-7.4,Sotirimod,ZXBCLVSLRUWISJ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
23945,6cs2,DB01586,-7.4,Ursodeoxycholic acid,RUDATBOHQWOJDD-UZVSRGJWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
122987,6w4b,DB14626,-7.4,Pregnenolone acetate,CRRKVZVYZQXICQ-RJJCNJEVSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
106932,6vxx,DB01763,-7.4,7-thionicotinamide-adenine-dinucleotide phosphate,OJNFDOAQUXJWED-NNYOXOHSSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
155898,6wiq,DB11911,-7.4,Galunisertib,IVRXNBXKWIJUQB-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
68738,6lxt,DB08267,-7.4,"6-amino-4-(2-phenylethyl)-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",PBZAIUVFRISTSZ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
166036,7bv1,DB13605,-7.4,Phenoperidine,IPOPQVVNCFQFRK-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
36543,1r42,DB03069,-7.4,Cytidine-5'-Diphospho-Beta-D-Xylose,NWSKPSPTJOAICE-OCIMBMBZSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
124228,6w4h,DB00908,-7.4,Quinidine,LOUPRKONTZGTKE-LHHVKLHASA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
155908,6wiq,DB11925,-7.4,Vistusertib,JUSFANSTBFGBAF-IRXDYDNUSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
56185,6crv,DB01995,-7.4,5-Methylcytidine-5'-Monophosphate,NJQONZSFUKNYOY-JXOAFFINSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
36610,1r42,DB03159,-7.4,CRA_8696,GAVRMVQHHVMXFD-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
123462,6w4b,DB00186,-7.4,Lorazepam,DIWRORZWFLOCLC-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
67140,6lxt,DB05738,-7.4,Vapitadine,VQWGYPVNVICKFC-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
143503,6w9q,DB03632,-7.4,Argifin,UHBHXSDKGLPPGO-HTDHLNIYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
107225,6vxx,DB02728,-7.4,7-Hydroxy-2-Oxo-Chromene-3-Carboxylic Acid Ethyl Ester,IETDBZQIWIJQJG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
99575,6vxs,DB02429,-7.4,4-(Aminosulfonyl)-N-[(4-Fluorophenyl)Methyl]-Benzamide,IXDVPACDZDRCTN-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
116925,6w4b,DB02799,-7.4,N-[2-(1-Maleimidyl)Ethyl]-7-Diethylaminocoumarin-3-Carboxamide,OJBZDUMTXGGVSP-KTKRTIGZSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
11214,6lzg,DB11665,-7.4,BMS-690514,CSGQVNMSRKWUSH-IAGOWNOFSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
112134,6vxx,DB06397,-7.4,Nicaraven,KTXBOOWDLPUROC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
67204,6lxt,DB06153,-7.4,Pizotifen,FIADGNVRKBPQEU-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
92801,6m71,DB04885,-7.4,Cilansetron,NCNFDKWULDWJDS-OAHLLOKOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
89473,6m71,DB00524,-7.4,Metolazone,AQCHWTWZEMGIFD-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
89455,6m71,DB00497,-7.4,Oxycodone,BRUQQQPBMZOVGD-XFKAJCMBSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
151476,6wiq,DB02759,-7.4,4-Methylumbelliferyl Chitobiose,UPSFMJHZUCSEHU-JYGUBCOQSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
124187,6w4h,DB00861,-7.4,Diflunisal,HUPFGZXOMWLGNK-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
142005,6w9q,DB01623,-7.4,Thiothixene,GFBKORZTTCHDGY-UWVJOHFNSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
89771,6m71,DB00878,-7.4,Chlorhexidine,GHXZTYHSJHQHIJ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
122966,6w4b,DB14543,-7.4,Hydrocortisone probutate,FOGXJPFPZOHSQS-AYVLZSQQSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
116545,6w4b,DB02300,-7.4,Calcipotriol,LWQQLNNNIPYSNX-UROSTWAQSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
98853,6vxs,DB01491,-7.4,Dipipanone,SVDHSZFEQYXRDC-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
23932,6cs2,DB01570,-7.4,Ohmefentanyl,FRPRNNRJTCONEC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
23931,6cs2,DB01569,-7.4,Formebolone,AMVODTGMYSRMNP-GNIMZFFESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
55903,6crv,DB01618,-7.4,Molindone,KLPWJLBORRMFGK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
98851,6vxs,DB01489,-7.4,Camazepam,PXBVEXGRHZFEOF-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
29079,6cs2,DB08720,-7.4,"5-(5-(4-(4,5-dihydro-2-oxazoly)phenoxy)pentyl)-3-methyl osoxazole",IWZDYGHUSXWPPM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
143426,6w9q,DB03509,-7.4,2-(4-Chlorophenyl)-5-Quinoxalinecarboxamide,FLYGLPYJEQPCFY-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
143430,6w9q,DB03515,-7.4,Equilenin,PDRGHUMCVRDZLQ-WMZOPIPTSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
163946,7bv1,DB06889,-7.4,"3-(1H-tetrazol-5-ylmethyl)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(3H)-one",QSBQXAOOVSQABJ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
99195,6vxs,DB01938,-7.4,L-Histidine Beta Naphthylamide,DKDILZBBFKZMRO-OAHLLOKOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
122910,6w4b,DB14129,-7.4,Macelignan,QDDILOVMGWUNGD-UONOGXRCSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
147216,6w9q,DB11592,-7.4,Nitrocefin,LHNIIDJCEODSHA-OQRUQETBSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
112136,6vxx,DB06403,-7.4,Ambrisentan,OUJTZYPIHDYQMC-LJQANCHMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75038,6m2n,DB04164,-7.4,"1,4-Deoxy-4-((5-Hydroxymethyl-2,3,4-Trihydroxycyclohex-5-Enyl)Amino)Fructose",ZGWNRGISVMYHTF-KKXLKBQTSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
122942,6w4b,DB14209,-7.4,Trandolaprilat,AHYHTSYNOHNUSH-HXFGRODQSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
123350,6w4b,DB15362,-7.4,LSZ-102,SJXNPGGVGZXKKI-NYYWCZLTSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
155892,6wiq,DB11903,-7.4,GW842166,TWQYWUXBZHPIIV-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
147183,6w9q,DB11491,-7.4,Sarafloxacin,XBHBWNFJWIASRO-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
151139,6wiq,DB02323,-7.4,EM-1745,CKSDYJASHNGOOS-KTXOUVACSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
163984,7bv1,DB06930,-7.4,"N-[amino(imino)methyl]-2-(2,5-diphenyl-1H-pyrrol-1-yl)acetamide",WVLDNAVUCUAGDP-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
27845,6cs2,DB07403,-7.4,"4-[(3-CHLORO-4-{[(2R)-3,3,3-TRIFLUORO-2-HYDROXY-2-METHYLPROPANOYL]AMINO}PHENYL)SULFONYL]-N,N-DIMETHYLBENZAMIDE",DTDZLJHKVNTQGZ-GOSISDBHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
124143,6w4h,DB00813,-7.4,Fentanyl,PJMPHNIQZUBGLI-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
98883,6vxs,DB01530,-7.4,"5alpha-androstane-3alpha,17beta-diol",CBMYJHIOYJEBSB-KHOSGYARSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
68769,6lxt,DB08307,-7.4,"2-{HYDROXY[2-NITRO-4-(TRIFLUOROMETHYL)PHENYL]METHYLENE}CYCLOHEXANE-1,3-DIONE",PMHVFNYNPNKNRO-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
140988,6w9q,DB00354,-7.4,Buclizine,MOYGZHXDRJNJEP-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
166028,7bv1,DB13596,-7.4,Oxycinchophen,XAPRFLSJBSXESP-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
164362,7bv1,DB07746,-7.4,3-ETHYL-6-{[(4-FLUOROPHENYL)SULFONYL]AMINO}-2-METHYLBENZOIC ACID,MGUQWAOYPINSIT-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
140987,6w9q,DB00353,-7.4,Methylergometrine,UNBRKDKAWYKMIV-QWQRMKEZSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
143102,6w9q,DB03076,-7.4,AHA047,CGBDAHCDSVOMCF-FYZVQMPESA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
143106,6w9q,DB03081,-7.4,Crc200 (Chiron-Behring),ZOXOKTJHZSUHRJ-XZOQPEGZSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
155767,6wiq,DB11697,-7.4,Pacritinib,HWXVIOGONBBTBY-ONEGZZNKSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
65620,6lxt,DB03079,-7.4,Alpha-Ribazole-5'-Phosphate Derivative,YPYFPLLZCVEYCS-KKOKHZNYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
112160,6vxx,DB06458,-7.4,Remacemide,YSGASDXSLKIKOD-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80213,6m2n,DB14881,-7.4,Oliceridine,DMNOVGJWPASQDL-OAQYLSRUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
95115,6m71,DB08956,-7.4,Hydroxydione,USPYDUPOCUYHQL-VEVMSBRDSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
142195,6w9q,DB01873,-7.4,Epothilone D,XOZIUKBZLSUILX-GIQCAXHBSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
123051,6w4b,DB14723,-7.4,Larotrectinib,NYNZQNWKBKUAII-KBXCAEBGSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
123053,6w4b,DB14726,-7.4,Dabigatran,YBSJFWOBGCMAKL-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
99886,6vxs,DB02842,-7.4,9-amino-n-[3-(dimethylamino)propyl]acridine-4-carboxamide,VNWAULKXOPRJEL-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
107019,6vxx,DB02179,-7.4,O-Trifluoromethylphenyl Anthranilic Acid,ONKHJNFXJDEMNQ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
155859,6wiq,DB11853,-7.4,Relugolix,AOMXMOCNKJTRQP-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
164350,7bv1,DB07732,-7.4,2-[(2-NAPHTHYLSULFONYL)AMINO]ETHYL DIHYDROGEN PHOSPHATE,FCROUVVWZFPGFM-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
123069,6w4b,DB14765,-7.4,Rivoceranib,WPEWQEMJFLWMLV-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
107853,6vxx,DB05253,-7.4,Telapristone acetate,JVBGZFRPTRKSBB-MJBQOYBXSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
65490,6lxt,DB02902,-7.4,3'-Phosphate-Adenosine-5'-Phosphate Sulfate,GACDQMDRPRGCTN-KQYNXXCUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
69090,6lxt,DB08699,-7.4,"1-tert-butyl-3-(3-methylbenzyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine",FYCOTGCSHZKHPR-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
11144,6lzg,DB11491,-7.4,Sarafloxacin,XBHBWNFJWIASRO-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
9094,6lzg,DB07168,-7.4,[4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-6-(methylamino)pyrimidin-2-yl}amino)phenyl]acetonitrile,MFMSRHREFZCFSN-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
147397,6w9q,DB11880,-7.4,Acridine Carboxamide,XBGNERSKEKDZDS-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
123311,6w4b,DB15292,-7.4,Foliglurax,ZTEDNASHAWNBKQ-NCELDCMTSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
27843,6cs2,DB07401,-7.4,METHYL (2Z)-2-(2-{[6-(2-CYANOPHENOXY)PYRIMIDIN-4-YL]OXY}PHENYL)-3-METHOXYACRYLATE,WFDXOXNFNRHQEC-GHRIWEEISA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
62432,6crv,DB13571,-7.4,Pentamycin,AGJUUQSLGVCRQA-SWOUQTJZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
123885,6w4h,DB00497,-7.4,Oxycodone,BRUQQQPBMZOVGD-XFKAJCMBSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
155408,6wiq,DB09076,-7.4,Umeclidinium,FVTWTVQXNAJTQP-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
164102,7bv1,DB07260,-7.4,N-benzyl-4-[(2R)-pyrrolidin-2-ylmethoxy]aniline,HITMFLNAOQIZSN-QGZVFWFLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
79902,6m2n,DB13937,-7.4,LGD-3303,OMXGOGXEWUCLFI-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
67116,6lxt,DB05590,-7.4,Bedoradrine,OANCEOSLKSTLTA-REWPJTCUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
123321,6w4b,DB15307,-7.4,Atabecestat,VLLFGVHGKLDDLW-SFHVURJKSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
147306,6w9q,DB11749,-7.4,(R)-Praziquantel,FSVJFNAIGNNGKK-KRWDZBQOSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
116848,6w4b,DB02691,-7.4,Glycocholic acid,RFDAIACWWDREDC-FRVQLJSFSA-M,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
99944,6vxs,DB02916,-7.4,"[(2r,3s,4r,5r)-5-(6-Amino-9h-Purin-9-Yl)-3,4-Dihydroxytetrahydro-2-Furanyl]Methyl Sulfamate",GNZLUJQJDPRUTD-KQYNXXCUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
141506,6w9q,DB00973,-7.4,Ezetimibe,OLNTVTPDXPETLC-XPWALMASSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
116854,6w4b,DB02698,-7.4,"N-(M-Trifluoromethylphenyl) Phenoxazine-4,6-Dicarboxylic Acid",NQOOJFXBGLOGTC-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
98868,6vxs,DB01513,-7.4,"17Alpha-methyl-3beta,17beta-dihydroxy-5alpha-androstane",QGKQXZFZOIQFBI-UYEYMFBJSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
141509,6w9q,DB00977,-7.4,Ethinylestradiol,BFPYWIDHMRZLRN-SLHNCBLASA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
23959,6cs2,DB01604,-7.4,Pivampicillin,ZEMIJUDPLILVNQ-ZXFNITATSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
62868,6crv,DB14638,-7.4,Diloxanide furoate,BDYYDXJSHYEDGB-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163963,7bv1,DB06909,-7.4,"1-ethyl-N-(phenylmethyl)-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridine-5-carboxamide",QZGJNFBMYYEFGM-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
123854,6w4h,DB00459,-7.4,Acitretin,IHUNBGSDBOWDMA-AQFIFDHZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
89841,6m71,DB00956,-7.4,Hydrocodone,LLPOLZWFYMWNKH-CMKMFDCUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
62394,6crv,DB13515,-7.4,Levomethadone,USSIQXCVUWKGNF-QGZVFWFLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80864,6m3m,DB00527,-7.4,Cinchocaine,PUFQVTATUTYEAL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
155172,6wiq,DB08745,-7.4,4-[[(1E)-2-(4-CHLOROPHENYL)ETHENYL]SULFONYL]-1-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]PIPERAZINONE,QLHUDNKWOSQSMK-CXUHLZMHSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
80700,6m3m,DB00322,-7.4,Floxuridine,ODKNJVUHOIMIIZ-RRKCRQDMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
68863,6lxt,DB08424,-7.4,"[5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL](3-{[(2R)-2,3-DIHYDROXYPROPYL]OXY}PHENYL)METHANONE",IJDQETGUEUJVTB-HNNXBMFYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
164366,7bv1,DB07750,-7.4,"(2R)-1-[4-({4-[(2,5-Dichlorophenyl)amino]-2-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol",GNLAGGCSJGJECE-MRXNPFEDSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
123023,6w4b,DB14664,-7.4,Difluocortolone pivalate,UWGRWFCLGQWKPR-GSTUPEFVSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
123860,6w4h,DB00469,-7.4,Tenoxicam,LZNWYQJJBLGYLT-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
99636,6vxs,DB02507,-7.4,4-Hydroxy-3-[(1s)-3-Oxo-1-Phenylbutyl]-2h-Chromen-2-One,PJVWKTKQMONHTI-HNNXBMFYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
147405,6w9q,DB11893,-7.4,Avagacestat,XEAOPVUAMONVLA-QGZVFWFLSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
30482,6cs2,DB12545,-7.4,Indobufen,AYDXAULLCROVIT-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
99105,6vxs,DB01810,-7.4,"[1-(1-Methyl-4,5-Dioxo-Pent-2-Enylcarbamoyl)-2-Phenyl-Ethyl]-Carbamic Acid Benzyl Ester",NOXVWFAAXREWMI-GURWAVDKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
147316,6w9q,DB11765,-7.4,PF-04991532,GKMLFBRLRVQVJO-ZDUSSCGKSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
80715,6m3m,DB00343,-7.4,Diltiazem,HSUGRBWQSSZJOP-RTWAWAEBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
24312,6cs2,DB00283,-7.4,Clemastine,YNNUSGIPVFPVBX-NHCUHLMSSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
94984,6m71,DB08763,-7.4,[N-(BENZYLOXYCARBONYL)AMINO](4-AMIDINOPHENYL)METHANE-PHOSPHONATE,FSNDLCSOLUMYRH-OAHLLOKOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
124162,6w4h,DB00833,-7.4,Cefaclor,QYIYFLOTGYLRGG-GPCCPHFNSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
24213,6cs2,DB01910,-7.4,Sinefungin,LMXOHSDXUQEUSF-YECHIGJVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
140952,6w9q,DB00310,-7.4,Chlorthalidone,JIVPVXMEBJLZRO-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
80859,6m3m,DB00521,-7.4,Carteolol,LWAFSWPYPHEXKX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
9081,6lzg,DB07154,-7.4,"(3R)-4-[(3R)-3-AMINO-4-(2,4,5-TRIFLUOROPHENYL)BUTANOYL]-3-METHYL-1,4-DIAZEPAN-2-ONE",SWKGZJAAGSVROJ-MWLCHTKSSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
116265,6w4b,DB01933,-7.4,7-Hydroxystaurosporine,PBCZSGKMGDDXIJ-HQCWYSJUSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
76711,6m2n,DB07522,-7.4,"N-[(2R,3S)-3-AMINO-2-HYDROXY-4-PHENYLBUTYL]NAPHTHALENE-2-SULFONAMIDE",QSSWSEQPKCCATQ-VQTJNVASSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
123326,6w4b,DB15319,-7.4,VM4-037,QGYZPMXIVNIGKA-GMAHTHKFSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
151816,6wiq,DB03213,-7.4,Bis(5-Amidino-2-Benzimidazolyl)Methane Ketone,VVVXDHROXQUONB-UHFFFAOYSA-P,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
154964,6wiq,DB08498,-7.4,"(1S)-1-(3-chlorophenyl)-2-oxo-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate",OVSAMUIBGQSLDC-INIZCTEOSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
63640,6lxt,DB00524,-7.4,Metolazone,AQCHWTWZEMGIFD-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
95256,6m71,DB09182,-7.4,Benzylfentanyl,POQDXIFVWVZVML-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
120010,6w4b,DB07982,-7.4,2-{4-[4-({4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]pyrimidin-2-yl}amino)phenyl]piperazin-1-yl}-2-oxoethanol,PVTKDXZNSUHUMO-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
97397,6m71,DB14791,-7.4,GDC-0425,XEZLBMHDUXSICI-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
111201,6vxx,DB03332,-7.4,"5,6-Cyclic-Tetrahydropteridine",XAZOBOCYEGBXHD-GSVOUGTGSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
145177,6w9q,DB07049,-7.4,(2R)-1-[(4-tert-butylphenyl)sulfonyl]-2-methyl-4-(4-nitrophenyl)piperazine,SOFGQQQVQZQJFS-MRXNPFEDSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
145186,6w9q,DB07058,-7.4,"5-[1-(4-methoxyphenyl)-1H-benzimidazol-6-yl]-1,3,4-oxadiazole-2(3H)-thione",QBVJMUOTMRYUKR-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
65129,6lxt,DB02427,-7.4,"2,4-Diamino-6-[N-(2',5'-Dimethoxybenzyl)-N-Methylamino]Quinazoline",YBJANOUTWRTBDK-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
78092,6m2n,DB09246,-7.4,Benmoxin,BEWNZPMDJIGBED-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
109320,6vxx,DB13064,-7.4,Tramazoline,QQJLHRRUATVHED-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78065,6m2n,DB09214,-7.4,Dexketoprofen,DKYWVDODHFEZIM-NSHDSACASA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
109334,6vxx,DB13087,-7.4,Miridesap,HZLAWYIBLZNRFZ-VXGBXAGGSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109337,6vxx,DB13434,-7.4,Fenticonazole,ZCJYUTQZBAIHBS-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
95856,6m71,DB12046,-7.4,Atopaxar,QWKAUGRRIXBIPO-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97374,6m71,DB14737,-7.4,Cannabinol,VBGLYOIFKLUMQG-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95842,6m71,DB12024,-7.4,PF-04418948,LWJGMYMNSNVCEM-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
67937,6lxt,DB07328,-7.4,"METHYL 4-{[({[(2R,5S)-5-{[(2S)-2-(AMINOMETHYL)PYRROLIDIN-1-YL]CARBONYL}PYRROLIDIN-2-YL]METHYL}AMINO)CARBONYL]AMINO}BENZOATE",USDCNOQKDUFKRD-IKGGRYGDSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
118595,6w4b,DB05416,-7.4,Cardarine,YDBLKRPLXZNVNB-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
67932,6lxt,DB07323,-7.4,"2-[({2-[(1Z)-3-(DIMETHYLAMINO)PROP-1-ENYL]-4-FLUOROPHENYL}SULFONYL)AMINO]-5,6,7,8-TETRAHYDRONAPHTHALENE-1-CARBOXYLIC ACID",CTZLIARLNXSXGL-ALCCZGGFSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
31201,6cs2,DB13532,-7.4,Cyclopenthiazide,BKYKPTRYDKTTJY-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
97360,6m71,DB14714,-7.4,Tenivastatin,XWLXKKNPFMNSFA-HGQWONQESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
78045,6m2n,DB09193,-7.4,"CP-39,332",HLOCJJORRHQDKS-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
119953,6w4b,DB07917,-7.4,4-(BENZHYDRYLOXY)-1-[3-(1H-TETRAAZOL-5-YL)PROPYL]PIPERIDINE,TZQGXAHOROZEKN-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
78040,6m2n,DB09188,-7.4,Amedalin,HBGWAZBZXJBYQD-IBGZPJMESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
109366,6vxx,DB13475,-7.4,Furazidin,DECBQELQORZLLP-UAIOPKHMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78036,6m2n,DB09184,-7.4,Edivoxetine,CPBHSHYQQLFAPW-ZWKOTPCHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
67472,6lxt,DB06766,-7.4,Alcaftadine,MWTBKTRZPHJQLH-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
111149,6vxx,DB03065,-7.4,7-Nitroindazole-2-Carboxamidine,GFYAZUABYOOPCN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
97334,6m71,DB14660,-7.4,Trenbolone acetate,CMRJPMODSSEAPL-FYQPLNBISA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
118608,6w4b,DB05465,-7.4,Tandutinib,UXXQOJXBIDBUAC-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
64263,6lxt,DB01252,-7.4,Mitiglinide,WPGGHFDDFPHPOB-BBWFWOEESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
91419,6m71,DB03037,-7.4,Oxidized Acetyl Dithranol,IKFRFGXQHSBCQM-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
153873,6wiq,DB07215,-7.4,"2-METHYL-2-(4-{[({4-METHYL-2-[4-(TRIFLUOROMETHYL)PHENYL]-1,3-THIAZOL-5-YL}CARBONYL)AMINO]METHYL}PHENOXY)PROPANOIC ACID",ILUPZUOBHCUBKB-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
67974,6lxt,DB07373,-7.4,"ANDROSTA-1,4-DIENE-3,17-DIONE",LUJVUUWNAPIQQI-QAGGRKNESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
111252,6vxx,DB03401,-7.4,"1D-myo-inositol 1,4,5-trisphosphate",MMWCIQZXVOZEGG-XJTPDSDZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109179,6vxx,DB12482,-7.4,Acotiamide,TWHZNAUBXFZMCA-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
9564,6lzg,DB07675,-7.4,(2S)-2-ETHOXY-3-{4-[2-(10H-PHENOXAZIN-10-YL)ETHOXY]PHENYL}PROPANOIC ACID,WMUIIGVAWPWQAW-DEOSSOPVSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
78189,6m2n,DB11157,-7.4,Anthralin,NUZWLKWWNNJHPT-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
40180,6lu7,DB06976,-7.4,"1-(5-OXO-2,3,5,9B-TETRAHYDRO-1H-PYRROLO[2,1-A]ISOINDOL-9-YL)-3-(5-PYRROLIDIN-2-YL-1H-PYRAZOL-3-YL)-UREA",IWOOJEZSDPRYAZ-WFASDCNBSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40179,6lu7,DB08387,-7.4,2-{[4-(1-methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline,AZEXWHKOMMASPA-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40178,6lu7,DB07041,-7.4,"N-[2-(2,4-diaminopyrido[2,3-d]pyrimidin-7-yl)-2-methylpropyl]-4-phenoxybenzamide",FDJWFDQRPKKBFA-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40177,6lu7,DB15006,-7.4,Flufenoxuron,RYLHNOVXKPXDIP-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40176,6lu7,DB07203,-7.4,6-CYCLOHEXYLMETHOXY-2-(3'-CHLOROANILINO) PURINE,OUEGMEMDEAOAEG-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
111232,6vxx,DB03370,-7.4,FR239087,HCJYSIGJDKNVRU-TVQRCGJNSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
40175,6lu7,DB07253,-7.4,"N'-(5-chloro-1,3-benzodioxol-4-yl)-N-(3-methylsulfonylphenyl)pyrimidine-2,4-diamine",QTFCKBFCXDAZIU-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40174,6lu7,DB07326,-7.4,"6-chloro-N-pyrimidin-5-yl-3-{[3-(trifluoromethyl)phenyl]amino}-1,2-benzisoxazole-7-carboxamide",FEGRQUWSKADGSP-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40173,6lu7,DB07648,-7.4,"(2R)-3-{[(4Z)-5,6-DIPHENYL-6,7-DIHYDRO-4H-PYRROLO[2,3-D]PYRIMIDIN-4-YLIDENE]AMINO}PROPANE-1,2-DIOL",TWEONIHFGKSPLC-MRXNPFEDSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
111218,6vxx,DB03354,-7.4,"2-(Beta-D-Glucopyranosyl)-5-Methyl-1,3,4-Oxadiazole",HCSFWJQLIPWUFZ-JAJWTYFOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
40172,6lu7,DB07969,-7.4,3-[3-(4-methylpiperazin-1-yl)-7-(trifluoromethyl)quinoxalin-5-yl]phenol,QNCYYRHIUFGGJX-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
109234,6vxx,DB12931,-7.4,Fenobam,DWPQODZAOSWNHB-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
54546,2fxp,DB15238,-7.4,Olinciguat,YWQFJNWMWZMXRW-HXUWFJFHSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
118564,6w4b,DB05234,-7.4,LGD2941,HWLLYFXDDGGHOE-BCSUUIJWSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
120051,6w4b,DB08026,-7.4,"2-{4-[(4-imidazo[1,2-a]pyridin-3-ylpyrimidin-2-yl)amino]piperidin-1-yl}-N-methylacetamide",AJLILYAPRHIFAS-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
111227,6vxx,DB03365,-7.4,"4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline",BNDYIYYKEIXHNK-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
49742,2fxp,DB04881,-7.4,Elacridar,OSFCMRGOZNQUSW-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
120046,6w4b,DB08020,-7.4,"(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-6-(METHOXYMETHYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL",RHQLNMNKTIOREN-AOIWGVFYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
10246,6lzg,DB08424,-7.4,"[5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL](3-{[(2R)-2,3-DIHYDROXYPROPYL]OXY}PHENYL)METHANONE",IJDQETGUEUJVTB-HNNXBMFYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
78144,6m2n,DB09355,-7.4,Sulfabenzamide,PBCZLFBEBARBBI-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
91325,6m71,DB02905,-7.4,"Phosphoric Acid Mono-[3,4-Dihydroxy-5-(5-Hydroxy-Benzoimidazol-1-Yl)Tetrahydro-Furan-2-Ylmethyl] Ester",BVZASCINAVSQNO-PULFBKJNSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
120038,6w4b,DB08012,-7.4,(METHYLPYRIDAZINE PIPERIDINE ETHYLOXYPHENYL)ETHYLACETATE,KCHIOGFOPPOUJC-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
120037,6w4b,DB08011,-7.4,"(3E)-5-fluoro-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-1H-indole-2,3-dione 3-oxime",DXIHOIDYHQSQKJ-HMMYKYKNSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
146194,6w9q,DB08230,-7.4,"5,7-DIHYDROXY-2-(3,4,5-TRIHYDROXYPHENYL)-4H-CHROMEN-4-ONE",ARSRJFRKVXALTF-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
40171,6lu7,DB07026,-7.4,"(1S,5S,7R)-N-7-(BIPHENYL-4-YLMETHYL)-N-3-HYDROXY-6,8-DIOXA-3-AZABICYCLO[3.2.1]OCTANE-3,7-DICARBOXAMIDE",PPLDARNGJSQINK-OKZBNKHCSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
165153,7bv1,DB11429,-7.4,Mibolerone,PTQMMNYJKCSPET-OMHQDGTGSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
119919,6w4b,DB07872,-7.4,5-chloro-N-[(3R)-1-(2-{[2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl]amino}-2-oxoethyl)pyrrolidin-3-yl]thiophene-2-carboxamide,IYGIXVNAMZPBDK-CQSZACIVSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
153050,6wiq,DB04867,-7.4,Lintitript,ILNRQFBVVQUOLP-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
10150,6lzg,DB08313,-7.4,nocodazole,KYRVNWMVYQXFEU-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
64355,6lxt,DB01431,-7.4,Allylestrenol,ATXHVCQZZJYMCF-XUDSTZEESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
67479,6lxt,DB06781,-7.4,Difluprednate,WYQPLTPSGFELIB-JTQPXKBDSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
54378,2fxp,DB14878,-7.4,Liafensine,VCIBGDSRPUOBOG-QFIPXVFZSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
109481,6vxx,DB13957,-7.4,J147,HYMZAYGFKNNHDN-SSDVNMTOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165643,7bv1,DB12585,-7.4,Ondelopran,QWNDOCKIKKQJNN-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
10142,6lzg,DB08304,-7.4,"(3R)-3-cyclopentyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2-benzothiazine 1,1-dioxide",QZBQVXXESPXFPZ-QGZVFWFLSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
10138,6lzg,DB08300,-7.4,"1-methyl-3-naphthalen-2-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine",UOKGZPYGRJDACN-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
165642,7bv1,DB12582,-7.4,Piperine,MXXWOMGUGJBKIW-YPCIICBESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
109506,6vxx,DB14014,-7.4,SR-9011,PPUYOYQTTWJTIU-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165257,7bv1,DB11670,-7.4,SP-8203,SJZBPVOSFYUHFV-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
153760,6wiq,DB07084,-7.4,"N-(6,7,9,10,17,18,20,21-octahydrodibenzo[b,k][1,4,7,10,13,16]hexaoxacyclooctadecin-2-yl)acetamide",YHKGWOJTUMJPNW-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
67853,6lxt,DB07237,-7.4,{4-[(2R)-pyrrolidin-2-ylmethoxy]phenyl}(4-thiophen-3-ylphenyl)methanone,VUWFJUJWAWMRQN-HXUWFJFHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
118634,6w4b,DB05590,-7.4,Bedoradrine,OANCEOSLKSTLTA-REWPJTCUSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
91559,6m71,DB03220,-7.4,FR233623,OODDZQQDDOVCFD-SCLBCKFNSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
119772,6w4b,DB07706,-7.4,2-Hydrox1tradiol,DILDHNKDVHLEQB-XSSYPUMDSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
111095,6vxx,DB02984,-7.4,"4-[3-Methylsulfanylanilino]-6,7-Dimethoxyquinazoline",FUSDVOSGGMBSMK-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
64372,6lxt,DB01452,-7.4,Diamorphine,GVGLGOZIDCSQPN-PVHGPHFFSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
64375,6lxt,DB01455,-7.4,19-Nor-5-androstenediol,VVUQRXPUVKXAIO-XFUVECHXSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
91565,6m71,DB03227,-7.4,Nicotinamide Mononucleotide,DAYLJWODMCOQEW-WYOJIJJFSA-O,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
109529,6vxx,DB14061,-7.4,Hycanthone,MFZWMTSUNYWVBU-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
95902,6m71,DB12113,-7.4,CE-224535,FUCKCIVGBCBZNP-MRXNPFEDSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
49888,2fxp,DB05553,-7.4,Regrelor,NXHAXEBZOXCDKD-XIXRRVGJSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
77257,6m2n,DB08152,-7.4,{(2S)-1-[N-(tert-butoxycarbonyl)glycyl]pyrrolidin-2-yl}methyl (3-chlorophenyl)acetate,ONXGIEJBNQLITK-INIZCTEOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
21531,6cs2,HMDB0050792,-7.4,"TG(20:1(11Z)/20:4(8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))",ZYJWXFJPEXYPPD-YZSRULHISA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
92240,6m71,DB04140,-7.4,1-Benzyl-3-(4-Methoxy-Benzenesulfonyl)-6-Oxo-Hexahydro-Pyrimidine-4-Carboxylic Acid Hydroxyamide,SUSMVCKSLVPRCL-QGZVFWFLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97153,6m71,DB13988,-7.4,SB-269970,HWKROQUZSKPIKQ-MRXNPFEDSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
109558,6vxx,DB14120,-7.4,Phenylethyl resorcinol,PQSXNIMHIHYFEE-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109516,6vxx,DB14033,-7.4,Acetyl sulfisoxazole,JFNWFXVFBDDWCX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
153819,6wiq,DB07152,-7.4,N-[4-(5-fluoro-6-methylpyridin-2-yl)-5-quinoxalin-6-yl-1H-imidazol-2-yl]acetamide,TYPILNNEZPSNTI-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
119823,6w4b,DB07765,-7.4,"METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL](METHYL)AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE",UKCFUFHREWUXJJ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
20242,6cs2,HMDB0046333,-7.4,TG(22:0/18:0/14:1(9Z)),VPROCYYUGRMDKB-IXHOOSMISA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
97317,6m71,DB14641,-7.4,Estriol tripropionate,ONMZMZJEZHMWQL-REUUDLSRSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
31186,6cs2,DB13511,-7.4,Clebopride,BVPWJMCABCPUQY-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
64298,6lxt,DB01333,-7.4,Cefradine,RDLPVSKMFDYCOR-UEKVPHQBSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
153816,6wiq,DB07147,-7.4,"methyl (1R,2S)-2-(hydroxycarbamoyl)-1-{4-[(2-methylquinolin-4-yl)methoxy]benzyl}cyclopropanecarboxylate",HJWMYFBKJRVWJY-YKSBVNFPSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
119899,6w4b,DB07851,-7.4,"(3R,4S)-1-(3,4-DIMETHOXYPHENYL)-3-(3-METHYLPHENYL)PIPERIDIN-4-AMINE",DQJXBZGPJVSWFI-ROUUACIJSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
54439,2fxp,DB15034,-7.4,PRI-724,VHOZWHQPEJGPCC-AZXNYEMZSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
109394,6vxx,DB13512,-7.4,Clefamide,ODCUSWJXZDHLKV-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31182,6cs2,DB13507,-7.4,Poldine,CQRKVVAGMJJJSR-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
97309,6m71,DB14633,-7.4,Prednisolone hemisuccinate,APGDTXUMTIZLCJ-CGVGKPPMSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
30789,6cs2,DB12979,-7.4,Nepicastat,YZZVIKDAOTXDEB-JTQLQIEISA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
67900,6lxt,DB07289,-7.4,5-[3-(BENZYLAMINO)PHENYL]-4-BROMO-3-(CARBOXYMETHOXY)THIOPHENE-2-CARBOXYLIC ACID,XEQPGVUGYAUMSA-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
30790,6cs2,DB12980,-7.4,CHS-828,BOIPLTNGIAPDBY-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
95865,6m71,DB12059,-7.4,JNJ-40411813,HYOGJHCDLQSAHX-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
109433,6vxx,DB13564,-7.4,Zipeprol,VSTNNAYSCJQCQI-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
67891,6lxt,DB07280,-7.4,5-[4-(DIMETHYLAMINO)PHENYL]-6-[(6-MORPHOLIN-4-YLPYRIDIN-3-YL)ETHYNYL]PYRIMIDIN-4-AMINE,AINVOEOJEKKMKB-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
146126,6w9q,DB08147,-7.4,"4-[3-(dibenzylamino)phenyl]-2,4-dioxobutanoic acid",RMWVENXKUQXLPW-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
97277,6m71,DB14539,-7.4,Hydrocortisone acetate,ALEXXDVDDISNDU-JZYPGELDSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
54423,2fxp,DB14995,-7.4,NP-G2-044,XLLRLAABUFOJPC-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
97257,6m71,DB14209,-7.4,Trandolaprilat,AHYHTSYNOHNUSH-HXFGRODQSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
145298,6w9q,DB07187,-7.4,6-[(5-CHLORO-3-METHYL-1-BENZOFURAN-2-YL)SULFONYL]PYRIDAZIN-3(2H)-ONE,FXFPQPNUMWQRAO-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
119862,6w4b,DB07809,-7.4,4-({[4-(3-METHYLBENZOYL)PYRIDIN-2-YL]AMINO}METHYL)BENZENECARBOXIMIDAMIDE,MBJYEMUMDMGQQC-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
109418,6vxx,DB13546,-7.4,Nizofenone,WZGBZLHGOVJDET-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
97223,6m71,DB14127,-7.4,Sacubitrilat,DOBNVUFHFMVMDB-BEFAXECRSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
118628,6w4b,DB05553,-7.4,Regrelor,NXHAXEBZOXCDKD-XIXRRVGJSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
97211,6m71,DB14097,-7.4,13-cis-12-(3'-Carboxyphenyl)retinoic acid,XKKDQOHDTASHCE-PAZAWXFKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
109428,6vxx,DB13557,-7.4,Thiopropazate,AIUHRQHVWSUTGJ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109429,6vxx,DB13558,-7.4,Morclofone,KVCJCEKJKGLBOK-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
145332,6w9q,DB07229,-7.4,"3-{5-[AMINO(IMINIO)METHYL]-1H-INDOL-2-YL}-5-METHOXY-1,1'-BIPHENYL-2-OLATE",MINVOLKUPZPDNX-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
119870,6w4b,DB07817,-7.4,"1-{3-[(4-pyridin-2-ylpiperazin-1-yl)sulfonyl]phenyl}-3-(1,3-thiazol-2-yl)urea",NJPVZSIGDRLLTD-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
97151,6m71,DB13983,-7.4,"5,7,2'-trihydroxy-6,8-dimethoxyflavone",JWOKGWICZPPYPX-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
40181,6lu7,DB06844,-7.4,"4-[(7-OXO-7H-THIAZOLO[5,4-E]INDOL-8-YLMETHYL)-AMINO]-N-PYRIDIN-2-YL-BENZENESULFONAMIDE",MBXKBJLIESPLIK-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
54583,2fxp,DB15310,-7.4,Vactosertib,FJCDSQATIJKQKA-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
64146,6lxt,DB01116,-7.4,Trimethaphan,CHQOEHPMXSHGCL-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
54766,6crv,DB00205,-7.4,Pyrimethamine,WKSAUQYGYAYLPV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
118466,6w4b,DB04861,-7.4,Nebivolol,KOHIRBRYDXPAMZ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
74264,6m2n,DB03121,-7.4,(1-Benzyl-5-methoxy-2-methyl-1H-indol-3-yl)acetic acid,ZEKCBTQHDTUHRJ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
37244,1r42,DB04011,-7.4,"2'-(4-Dimethylaminophenyl)-5-(4-Methyl-1-Piperazinyl)-2,5'-Bi-Benzimidazole",VMCOQLKKSNQANE-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
120432,6w4b,DB08486,-7.4,Efaproxiral,BNFRJXLZYUTIII-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
54758,6crv,DB00195,-7.4,Betaxolol,NWIUTZDMDHAVTP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
74853,6m2n,DB03917,-7.4,N-Ethyl Retinamide,WKYDOCGICAMTKE-NBIQJRODSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
153920,6wiq,DB07270,-7.4,"N-[7-(3-AMINOPHENYL)-5-METHOXY-1,3-BENZOXAZOL-2-YL]-2,5-DICHLOROBENZENESULFONAMIDE",GAYYMURZGLJDCT-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
111343,6vxx,DB03530,-7.4,Acylated Ceftazidime,VEHPZKIFULQYFS-BZXVCXBKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
97475,6m71,DB14987,-7.4,Difamilast,VFBILHPIHUPBPZ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
64174,6lxt,DB01148,-7.4,Flavoxate,SPIUTQOUKAMGCX-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
108922,6vxx,DB11393,-7.4,Danofloxacin,QMLVECGLEOSESV-RYUDHWBXSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
120439,6w4b,DB08493,-7.4,"5-METHYL-3-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.013,18]NONADECA-12(19),13,15,17-TETRAEN-10-YLCARBAMOYL)-HEXANOIC ACID",AKWKBACKRMYPRV-NQIIRXRSSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
37253,1r42,DB04022,-7.4,"Guanosine-5',3'-Tetraphosphate",BUFLLCUFNHESEH-UUOKFMHZSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
64182,6lxt,DB01157,-7.4,Trimetrexate,NOYPYLRCIDNJJB-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
78436,6m2n,DB11755,-7.4,Tetrahydrocannabivarin,ZROLHBHDLIHEMS-HUUCEWRRSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
153915,6wiq,DB07263,-7.4,"[{2-bromo-4-[(2R)-3-oxo-2,3-diphenylpropyl]phenyl}(difluoro)methyl]phosphonic acid",WDTMVBQZDFMOIK-GOSISDBHSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
64186,6lxt,DB01162,-7.4,Terazosin,VCKUSRYTPJJLNI-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
120382,6w4b,DB08426,-7.4,"THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [2-OXO-1-(1H-PYRROLO[2,3-C]PYRIDIN-2-YLMETHYL)-PYRROLIDIN-3-YL]-AMIDE",PLXOQMHGHDZMSX-AWEZNQCLSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
97450,6m71,DB14906,-7.4,Adafosbuvir,NIJYGVDQZBBONK-SEUXLIJBSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
13553,6lzg,DB01212,-7.4,Ceftriaxone,VAAUVRVFOQPIGI-SPQHTLEESA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
31325,6cs2,DB13680,-7.4,Naftazone,TZGBBMBARSFJBG-UKTHLTGXSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
31324,6cs2,DB13679,-7.4,Dexchlorpheniramine,SOYKEARSMXGVTM-HNNXBMFYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
120367,6w4b,DB08406,-7.4,"[N-(2,4-DIAMINOPTERIDIN-6-YL)-METHYL]-DIBENZ[B,F]AZEPINE",NXCCIJQEAKMFGW-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
91258,6m71,DB02819,-7.4,"Mono-[3,4-Dihydroxy-5-(5-Methyl-Benzoimidazol-1-Yl)-Tetrahydor-Furan-2-Ylmethyl] Ester",HGUDFQQPANTQEU-LPWJVIDDSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
165051,7bv1,DB09178,-7.4,Phenaridine,ODPKHHGQKIYCTJ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
91281,6m71,DB02848,-7.4,"{4-[3-(6,7-Diethoxy-Quinazolin-4-Ylamino)-Phenyl]-Thiazol-2-Yl}-Methanol",ZJESXGUODSBHSK-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
146280,6w9q,DB08340,-7.4,"N,N'-DIPHENYLPYRAZOLO[1,5-A][1,3,5]TRIAZINE-2,4-DIAMINE",LLYYAUZAGCZEKV-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
95798,6m71,DB11958,-7.4,Brivanib,WCWUXEGQKLTGDX-LLVKDONJSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
20022,6cs2,HMDB0045742,-7.4,TG(20:0/18:1(9Z)/18:1(11Z)),XPLCSZBQAQAYRD-KMMAEHPZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
40284,6lu7,DB15403,-7.4,Ziritaxestat,REQQVBGILUTQNN-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
165696,7bv1,DB12670,-7.4,Rolofylline,PJBFVWGQFLYWCB-QUYAXPHCSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
31381,6cs2,DB13752,-7.4,Tetramethrin,CXBMCYHAMVGWJQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
37206,1r42,DB03957,-7.4,SP2456,SSSXBBASYYVGCI-HSZRJFAPSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
91116,6m71,DB02628,-7.4,"1-[3,3-Dimethyl-2-(2-Methylamino-Propionylamino)-Butyryl]-Pyrrolidine-2-Carboxylic Acid(1,2,3,4-Tetrahydro-Naphthalen-1-Yl)-Amide",JUJIMRZGUBTJRV-NASSWSRMSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
108811,6vxx,DB09355,-7.4,Sulfabenzamide,PBCZLFBEBARBBI-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
92360,6m71,DB04295,-7.4,N-Benzoyl-N'-Beta-D-Glucopyranosyl Urea,JSBCZGSPFATCOV-BZNQNGANSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
154014,6wiq,DB07375,-7.4,"5-BETA-ANDROSTANE-3,17-DIONE",RAJWOBJTTGJROA-QJISAEMRSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
31375,6cs2,DB13739,-7.4,Penamecillin,NLOOMWLTUVBWAW-HLLBOEOZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
154005,6wiq,DB07362,-7.4,"1-(5-{2-[(1-methyl-1H-pyrazolo[4,3-d]pyrimidin-7-yl)amino]ethyl}-1,3-thiazol-2-yl)-3-[3-(trifluoromethyl)phenyl]urea",UOLCZAFAGDOUFX-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
54820,6crv,DB00268,-7.4,Ropinirole,UHSKFQJFRQCDBE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
154004,6wiq,DB07360,-7.4,"1-{5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)ethyl]-1,3-thiazol-2-yl}-3-[3-(trifluoromethyl)phenyl]urea",JJHXPDTVQKWKHA-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
108844,6vxx,DB11096,-7.4,Meradimate,SOXAGEOHPCXXIO-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
54813,6crv,DB00261,-7.4,Anagrelide,OTBXOEAOVRKTNQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
64143,6lxt,DB01113,-7.4,Papaverine,XQYZDYMELSJDRZ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
31372,6cs2,DB01048,-7.4,Abacavir,MCGSCOLBFJQGHM-SCZZXKLOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
68037,6lxt,DB07447,-7.4,5beta-dihydrotestosterone,NVKAWKQGWWIWPM-MISPCMORSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
23200,6cs2,HMDB0059800,-7.4,4-Hydroxyphenanthrene,SIMYIUXARJLHEA-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
108885,6vxx,DB11279,-7.4,Brilliant green cation,HXCILVUBKWANLN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165690,7bv1,DB12663,-7.4,Letrazuril,XQKYUBTUOHHNDV-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97518,6m71,DB15079,-7.4,Troriluzole,YBZSGIWIPOUSHY-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
67416,6lxt,DB06678,-7.4,Esmirtazapine,RONZAEMNMFQXRA-MRXNPFEDSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
23199,6cs2,HMDB0059799,-7.4,3-Hydroxyphenanthrene,NGPOABOEXMDQBT-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
153944,6wiq,DB07295,-7.4,2-[(7-HYDROXY-NAPHTHALEN-1-YL)-OXALYL-AMINO]-BENZOIC ACID,IGOULVZYQKJJKC-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
68025,6lxt,DB07432,-7.4,"[[(3R,4R,5S,6R)-3-(butanoylamino)-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-ylidene]amino] N-phenylcarbamate",ITVRELFVFCOUMV-ZVZWZHPPSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
77147,6m2n,DB08029,-7.4,N-2-(biphenyl-4-ylsulfonyl)-N-hydroxy-N-2-(2-hydroxyethyl)glycinamide,QQDWEVONJRXVDB-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
40286,6lu7,DB15358,-7.4,JNJ-54175446,CWFVVQFVGMFTBD-SECBINFHSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40285,6lu7,DB15396,-7.4,PF-114,SLIVDYMORZGPLW-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
28557,6cs2,DB08146,-7.4,"7-(2,5-dihydropyrrol-1-yl)-6-phenyl-pyrido[6,5-d]pyrimidin-2-amine",QFWNOFXQNCLFBC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
153973,6wiq,DB07326,-7.4,"6-chloro-N-pyrimidin-5-yl-3-{[3-(trifluoromethyl)phenyl]amino}-1,2-benzisoxazole-7-carboxamide",FEGRQUWSKADGSP-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
40182,6lu7,DB04881,-7.4,Elacridar,OSFCMRGOZNQUSW-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
120354,6w4b,DB08390,-7.4,"(6S)-6-CYCLOPENTYL-6-[2-(3-FLUORO-4-ISOPROPOXYPHENYL)ETHYL]-4-HYDROXY-5,6-DIHYDRO-2H-PYRAN-2-ONE",AKNIHFDXRAOPAI-NRFANRHFSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
10438,6lzg,DB08639,-7.4,Dapivirine,ILAYIAGXTHKHNT-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
40203,6lu7,DB12854,-7.4,BMS-908662,MMNNTJYFHUDSKL-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
54623,2fxp,DB15401,-7.4,Danicopan,PIBARDGJJAGJAJ-NQIIRXRSSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
40201,6lu7,DB08770,-7.4,"4-{2-[(7-amino-2-furan-2-yl[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-yl)amino]ethyl}phenol",PWTBZOIUWZOPFT-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
109131,6vxx,DB12416,-7.4,VTP-27999,NXWASIVXQMMPLM-ZXMXYHOLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
10311,6lzg,DB08495,-7.4,4-({4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-2-OXOPIPERAZIN-1-YL}METHYL)BENZENECARBOXIMIDAMIDE,VXONTEUOQXFJJS-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
40200,6lu7,DB11526,-7.4,Masitinib,WJEOLQLKVOPQFV-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40199,6lu7,DB11969,-7.4,Uprosertib,AXTAPYRUEKNRBA-JTQLQIEISA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40198,6lu7,DB12001,-7.4,Abemaciclib,UZWDCWONPYILKI-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40197,6lu7,DB12121,-7.4,Entospletinib,XSMSNFMDVXXHGJ-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40196,6lu7,DB08241,-7.4,4-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)--BENZAMIDE,RUUOIINPNMNPIU-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40195,6lu7,DB12836,-7.4,Grapiprant,HZVLFTCYCLXTGV-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40194,6lu7,DB08022,-7.4,"(2S)-1,3-benzothiazol-2-yl{2-[(2-pyridin-3-ylethyl)amino]pyrimidin-4-yl}ethanenitrile",RCYPVQCPYKNSTG-OAHLLOKOSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40193,6lu7,DB13022,-7.4,LY-2874455,GKJCVYLDJWTWQU-CXLRFSCWSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
109121,6vxx,DB12404,-7.4,Remimazolam,CYHWMBVXXDIZNZ-KRWDZBQOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111276,6vxx,DB03435,-7.4,Uridine-5'-Diphosphate,XCCTYIAWTASOJW-XVFCMESISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
40191,6lu7,DB13927,-7.4,anle138b,RCQIIBJSUWYYFU-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40190,6lu7,DB14768,-7.4,PF-06459988,ODMXWZROLKITMS-RISCZKNCSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
31254,6cs2,DB13600,-7.4,Deltamethrin,OWZREIFADZCYQD-NSHGMRRFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
165142,7bv1,DB11410,-7.4,Fenbendazole,HDDSHPAODJUKPD-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
23196,6cs2,HMDB0059797,-7.4,1-Hydroxyphenanthrene,GTBXZWADMKOZQJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
40189,6lu7,DB14785,-7.4,Fenebrutinib,WNEODWDFDXWOLU-QHCPKHFHSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
109163,6vxx,DB12463,-7.4,Semagacestat,PKXWXXPNHIWQHW-RCBQFDQVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
40187,6lu7,DB12513,-7.4,Omaveloxolone,RJCWBNBKOKFWNY-IDPLTSGASA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
153024,6wiq,DB04834,-7.4,Rapacuronium,HTIKWNNIPGXLGM-YLINKJIISA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
40186,6lu7,DB07189,-7.4,"(1S,3R,6S)-4-oxo-6-{4-[(2-phenylquinolin-4-yl)methoxy]phenyl}-5-azaspiro[2.4]heptane-1-carboxylic acid",BFZXMIUWGSTUAL-ZSOKXDGFSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40185,6lu7,DB02555,-7.4,SP4160,VCXMTWSYQSVWRK-AREMUKBSSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40184,6lu7,DB03300,-7.4,Pterin Cytosine Dinucleotide,WKSPNQYEWZEMMI-FEFZDOOUSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40183,6lu7,DB04452,-7.4,Aminoquinuride,HOUSDILKOJMENG-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40192,6lu7,DB13791,-7.4,Penfluridol,MDLAAYDRRZXJIF-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
118487,6w4b,DB04886,-7.4,Calanolide A,NIDRYBLTWYFCFV-FMTVUPSXSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
40205,6lu7,DB01761,-7.4,4-[5-[2-(1-Phenyl-Ethylamino)-Pyrimidin-4-Yl]-1-Methyl-4-(3-Trifluoromethylphenyl)-1h-Imidazol-2-Yl]-Piperidine,QICPQLFMWYQJGX-SFHVURJKSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
118541,6w4b,DB05076,-7.4,Fenretinide,AKJHMTWEGVYYSE-FXILSDISSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
152988,6wiq,DB04792,-7.4,"2,5-O,O-BIS-{4',4''-AMIDINOPHENYL}-1,4:3,6-DIANHYDRO-D-SORBITOL",CDEVHSIVANGYRI-XMTFNYHQSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
37266,1r42,DB04044,-7.4,4-{2-[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid,NAQUAVBNIYTIIS-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
165060,7bv1,DB09187,-7.4,Lortalamine,MJRPHRMGEKCADU-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
40244,6lu7,DB14943,-7.4,LGH-447,VRQXRVAKPDCRCI-ZNMIVQPWSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
91311,6m71,DB02889,-7.4,"4-O-(4,6-Dideoxy-4-{[4,5,6-Trihydroxy-3-(Hydroxymethyl)Cyclohex-2-En-1-Yl]Amino}-Beta-D-Lyxo-Hexopyranosyl)-Alpha-D-Erythro-Hexopyranose",SNMISNLUIRCRQE-SFSRYZOZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
108981,6vxx,DB11861,-7.4,Litronesib,YVAFBXLHPINSIK-QHCPKHFHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
118492,6w4b,DB04892,-7.4,Phenserine,PBHFNBQPZCRWQP-QUCCMNQESA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
92318,6m71,DB04238,-7.4,N-Alpha-(2-Naphthylsulfonyl)-N-(3-Amidino-L-Phenylalaninyl)-D-Pipecolinic Acid,GNANSBQAIRJZPA-XZOQPEGZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
120323,6w4b,DB08352,-7.4,"6-[4-(2-fluorophenyl)-1,3-oxazol-5-yl]-N-(1-methylethyl)-1,3-benzothiazol-2-amine",FQYJTHIYAQQJAB-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
235,6lzg,HMDB0003572,-7.4,Rosmarinic acid,DOUMFZQKYFQNTF-WUTVXBCWSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
111300,6vxx,DB03472,-7.4,Cyclohexyl-Hexyl-Beta-D-Maltoside,WUCWJXGMSXTDAV-QKMCSOCLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
120312,6w4b,DB08339,-7.4,"6-(2,6-DICHLOROPHENYL)-2-{[3-(HYDROXYMETHYL)PHENYL]AMINO}-8-METHYLPYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE",ZIQFYVPVJZEOFS-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
109022,6vxx,DB11919,-7.4,6-O-benzylguanine,KRWMERLEINMZFT-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
65156,6lxt,DB02463,-7.4,2-(2-Hydroxy-Phenyl)-1h-Indole-5-Carboxamidine,JPGNPKIYCTXJPG-UHFFFAOYSA-O,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
10380,6lzg,DB08572,-7.4,4-{[4-AMINO-6-(CYCLOHEXYLMETHOXY)-5-NITROSOPYRIMIDIN-2-YL]AMINO}BENZAMIDE,YBKLJTXDSBEVRV-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
23197,6cs2,HMDB0059798,-7.4,2-Hydroxyphenanthrene,YPWLZGITFNGGKW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
78362,6m2n,DB11644,-7.4,Tafamidis,TXEIIPDJKFWEEC-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
40222,6lu7,DB15133,-7.4,Tepotinib,AHYMHWXQRWRBKT-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
31289,6cs2,DB13641,-7.4,Metisazone,DLGSOJOOYHWROO-XYOKQWHBSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
31287,6cs2,DB13638,-7.4,Cefbuperazone,SMSRCGPDNDCXFR-CYWZMYCQSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
97416,6m71,DB14846,-7.4,Bimiralisib,ADGGYDAFIHSYFI-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
120237,6w4b,DB08241,-7.4,4-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)--BENZAMIDE,RUUOIINPNMNPIU-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
77208,6m2n,DB08100,-7.4,"2,6-dimethyl-4-[(E)-2-phenylethenyl]phenol",PAHKYLUYTGBFNW-CMDGGOBGSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
109085,6vxx,DB12354,-7.4,Imrecoxib,AXMZZGKKZDJGAZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
95802,6m71,DB11963,-7.4,Dacomitinib,LVXJQMNHJWSHET-AATRIKPKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
78284,6m2n,DB11446,-7.4,Oxfendazole,BEZZFPOZAYTVHN-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
165122,7bv1,DB11372,-7.4,Altrenogest,VWAUPFMBXBWEQY-ANULTFPQSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
120186,6w4b,DB08174,-7.4,"5-CHLORO-N-((1R,2S)-2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO) CYCLOPENTYL)THIOPHENE-2-CARBOXAMIDE",QCPYHSAHOYXXQK-DLBZAZTESA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
146247,6w9q,DB08300,-7.4,"1-methyl-3-naphthalen-2-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine",UOKGZPYGRJDACN-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
165263,7bv1,DB11676,-7.4,Galidesivir,AMFDITJFBUXZQN-KUBHLMPHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
74477,6m2n,DB03403,-7.4,Cytidine-5'-Monophosphate,IERHLVCPSMICTF-XVFCMESISA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
111065,6vxx,DB02946,-7.4,Carpropamide,RXDMAYSSBPYBFW-RULNRJAQSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110242,6vxx,DB01139,-7.4,Cefapirin,UQLLWWBDSUHNEB-CZUORRHYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
64783,6lxt,DB01975,-7.4,AMPCPR,ZPZRETFSCSWNDT-DBXCYWGHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
74621,6m2n,DB03618,-7.4,2-(Acetylamino)-2-Deoxy-4-O-Beta-D-Galactopyranosyl-Alpha-D-Glucopyranose,KFEUJDWYNGMDBV-RCBHQUQDSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
91844,6m71,DB03619,-7.4,Deoxycholic Acid,KXGVEGMKQFWNSR-LLQZFEROSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
119237,6w4b,DB07081,-7.4,"(2R)-4-[(8R)-8-METHYL-2-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[1,5-A]PYRAZIN-7(8H)-YL]-4-OXO-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE",FDEXEPZGMKFCTG-PSASIEDQSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
91845,6m71,DB03622,-7.4,"2-Hydroxy-5-[4-(2-Hydroxy-Ethyl)-Piperidin-1-Yl]-5-Phenyl-1h-Pyrimidine-4,6-Dione",IPBPOBHSNJFRFT-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110802,6vxx,DB02427,-7.4,"2,4-Diamino-6-[N-(2',5'-Dimethoxybenzyl)-N-Methylamino]Quinazoline",YBJANOUTWRTBDK-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30975,6cs2,DB13258,-7.4,Etofamide,QTRALMGDQMIVFF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
77655,6m2n,DB08642,-7.4,"(2R,6S)-6-{[methyl(3,4,5-trimethoxyphenyl)amino]methyl}-1,2,5,6,7,8-hexahydroquinazoline-2,4-diamine",JJWPLCQODKLEHY-JEOXALJRSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
153190,6wiq,DB05490,-7.4,AMG-131,NMRWDFUZLLQSBN-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
145977,6w9q,DB07982,-7.4,2-{4-[4-({4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]pyrimidin-2-yl}amino)phenyl]piperazin-1-yl}-2-oxoethanol,PVTKDXZNSUHUMO-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
67657,6lxt,DB07011,-7.4,"(3S)-1-(1,3-BENZODIOXOL-5-YLMETHYL)-3-[4-(1H-IMIDAZOL-1-YL)PHENOXY]PIPERIDINE",HHOPJGKEAIIIDF-FQEVSTJZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
96400,6m71,DB12863,-7.4,Sivelestat,BTGNGJJLZOIYID-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
153481,6wiq,DB06717,-7.4,Fosaprepitant,BARDROPHSZEBKC-OITMNORJSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
153448,6wiq,DB06660,-7.4,Saredutant,PGKXDIMONUAMFR-AREMUKBSSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
110784,6vxx,DB02407,-7.4,6-O-Cyclohexylmethyl Guanine,MWGXGTJJAOZBNW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
91879,6m71,DB03668,-7.4,1-(5'-Phospho-Beta-D-Ribofuranosyl)Barbituric Acid,AODYJUNLDJOADV-YXZULKJRSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
9804,6lzg,DB07934,-7.4,[[CYCLOHEXANESULFONYL-GLYCYL]-3[PYRIDIN-4-YL-AMINOMETHYL]ALANYL]PIPERIDINE,KMUXFASJKPVMGU-HXUWFJFHSA-O,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
145717,6w9q,DB07680,-7.4,[(1S)-1-(5-CHLORO-1-BENZOTHIEN-3-YL)-2-(2-NAPHTHYLAMINO)-2-OXOETHYL]PHOSPHONIC ACID,HUJXISJLAPAFBO-IBGZPJMESA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
118843,6w4b,DB06457,-7.4,Tecastemizole,SFOVDSLXFUGAIV-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
64835,6lxt,DB02046,-7.4,N-[(Furan-2-Yl)Carbonyl]-(S)-Leucyl-(R)-[1-Amino-2(1h-Indol-3-Yl)Ethyl]-Phosphonic Acid,WHPKSASOSKNDPY-PKOBYXMFSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
165474,7bv1,DB12153,-7.4,Citicoline,RZZPDXZPRHQOCG-OJAKKHQRSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110329,6vxx,DB01470,-7.4,alpha-methylthiofentanyl,YPOXDUYRRSUFFG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
153409,6wiq,DB06429,-7.4,Talnetant,BIAVGWDGIJKWRM-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
77623,6m2n,DB08600,-7.4,"5-CHLORO-8-METHYL-7-(3-METHYL-BUT-2-ENYL)-6,7,8,9-TETRAHYDRO-2H-2,7,9A-TRIAZA-BENZO[CD]AZULENE-1-THIONE",ZNFFMCYSMBXZQU-NSHDSACASA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
145732,6w9q,DB07698,-7.4,"3-(3-aminophenyl)-N-(3-chlorophenyl)pyrazolo[1,5-a]pyrimidin-5-amine",JDNMRPIWJIDDAY-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
165488,7bv1,DB12179,-7.4,Secoisolariciresinol,PUETUDUXMCLALY-HOTGVXAUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
119175,6w4b,DB07011,-7.4,"(3S)-1-(1,3-BENZODIOXOL-5-YLMETHYL)-3-[4-(1H-IMIDAZOL-1-YL)PHENOXY]PIPERIDINE",HHOPJGKEAIIIDF-FQEVSTJZSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
9809,6lzg,DB00728,-7.4,Rocuronium,YXRDKMPIGHSVRX-OOJCLDBCSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
30945,6cs2,DB13223,-7.4,Fluocortin,PUWHHWCHAVXSIG-NCLPIGKXSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
64780,6lxt,DB01972,-7.4,Guanosine-5'-Monophosphate,RQFCJASXJCIDSX-UUOKFMHZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
96023,6m71,DB12286,-7.4,Simendan,WHXMKTBCFHIYNQ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
9876,6lzg,DB08009,-7.4,"5-[(E)-(5-CHLORO-2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]-N-[2-(DIETHYLAMINO)ETHYL]-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXAMIDE",XPLJEFSRINKZLC-ATVHPVEESA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
9875,6lzg,DB08008,-7.4,"5-methyl-N-[4-(trifluoromethyl)phenyl][1,2,4]triazolo[1,5-a]pyrimidin-7-amine",LRHHXKBKRNNFRV-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
119344,6w4b,DB07203,-7.4,6-CYCLOHEXYLMETHOXY-2-(3'-CHLOROANILINO) PURINE,OUEGMEMDEAOAEG-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
77356,6m2n,DB08281,-7.4,"O-[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethyl] (4-bromophenyl)thiocarbamate",BDVAWAILQCYMQE-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
110155,6vxx,DB01038,-7.4,Carphenazine,XZSMZRXAEFNJCU-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
96578,6m71,DB13129,-7.4,Trimegestone,JUNDJWOLDSCTFK-MTZCLOFQSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96573,6m71,DB13119,-7.4,GSK-364735,QWLNINWUBHHOLU-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
145998,6w9q,DB08005,-7.4,4-{[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino}-N-ethylpiperidine-1-carboxamide,ARMFMDYRYOKSOW-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
9859,6lzg,DB07991,-7.4,N-[(1R)-3-(4-HYDROXYPHENYL)-1-METHYLPROPYL]-2-(2-PHENYL-1H-INDOL-3-YL)ACETAMIDE,APLJSSOXDWUNGV-GOSISDBHSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
96542,6m71,DB13077,-7.4,LCB01-0371,QLUWQAFDTNAYPN-LLVKDONJSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
119306,6w4b,DB07159,-7.4,Tamatinib,NHHQJBCNYHBUSI-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
9854,6lzg,DB07986,-7.4,[4-(4-PHENYL-PIPERIDIN-1-YL)-BENZENESULFONYLAMINO]-ACETIC ACID,GNSLACGSDSJAIQ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
165426,7bv1,DB12084,-7.4,ADP-597,WPDCHTSXOPUOII-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96452,6m71,DB12938,-7.4,Isoxaflutole,OYIKARCXOQLFHF-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
29405,6cs2,DB00844,-7.4,Nalbuphine,NETZHAKZCGBWSS-CEDHKZHLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
67683,6lxt,DB07039,-7.4,(2S)-N-(4-cyano-3-iodophenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide,RXSZCFAPSDTELY-SFHVURJKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
110821,6vxx,DB02452,-7.4,Thymidine-5'-Triphosphate,NHVNXKFIZYSCEB-XLPZGREQSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
64751,6lxt,DB01938,-7.4,L-Histidine Beta Naphthylamide,DKDILZBBFKZMRO-OAHLLOKOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
74616,6m2n,DB03608,-7.4,Diminazene,XNYZHCFCZNMTFY-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
91836,6m71,DB03605,-7.4,"(2s)-2-[(2,4-Dichloro-Benzoyl)-(3-Trifluoromethyl-Benzyl)-Amino]-3-Phenyl-Propionic Acid",LAJJKGIZTCCOHY-NRFANRHFSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
119285,6w4b,DB07134,-7.4,"5-(4-CHLORO-5-PHENYL-3-THIENYL)-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDE",LCPRWBWCEGWNKF-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
165614,7bv1,DB12542,-7.4,GSK-356278,AWDJJMXJUOHGLC-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
118825,6w4b,DB06412,-7.4,Oxymetholone,ICMWWNHDUZJFDW-DHODBPELSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
118827,6w4b,DB06414,-7.4,Etravirine,PYGWGZALEOIKDF-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
96476,6m71,DB12974,-7.4,Roniciclib,UELYDGOOJPRWGF-SRQXXRKNSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
67678,6lxt,DB07034,-7.4,"2,2'-{[9-(HYDROXYIMINO)-9H-FLUORENE-2,7-DIYL]BIS(OXY)}DIACETIC ACID",VOKATEXROYSXDW-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
64776,6lxt,DB01965,-7.4,"2'-Deoxyuridine 5'-Alpha,Beta-Imido-Triphosphate",XZLLMTSKYYYJLH-SHYZEUOFSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
165439,7bv1,DB12106,-7.4,PF-06305591,APWZIFIAVVFPNT-PELKAZGASA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110186,6vxx,DB01074,-7.4,Perhexiline,CYXKNKQEMFBLER-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30834,6cs2,DB13044,-7.4,Gossypol,QBKSWRVVCFFDOT-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
9790,6lzg,DB07920,-7.4,N-oxo-2-[(4-phenylphenyl)sulfonylamino]ethanamide,OGRPZMQLAVBWPV-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
119161,6w4b,DB06995,-7.4,N-({4-[(2-aminopyridin-4-yl)oxy]-3-fluorophenyl}carbamoyl)-2-(4-fluorophenyl)acetamide,USBSTVPJNQLYEM-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
29375,6cs2,DB09083,-7.4,Ivabradine,ACRHBAYQBXXRTO-OAQYLSRUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
165529,7bv1,DB12236,-7.4,Bexagliflozin,BTCRKOKVYTVOLU-SJSRKZJXSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110515,6vxx,DB01872,-7.4,2-deoxy-2-acetamido-beta-D-galactose-4-sulfate,WHCJUIFHMJFEFZ-UIAUGNHASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30909,6cs2,DB13155,-7.4,Esculin,XHCADAYNFIFUHF-TVKJYDDYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
110520,6vxx,DB01877,-7.4,"N-Hydroxy 1n(4-Methoxyphenyl)Sulfonyl-4-(Z,E-N-Methoxyimino)Pyrrolidine-2r-Carboxamide",OJLWCTMBGWSVFC-JOYOIKCWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
67619,6lxt,DB06967,-7.4,"6-ETHYL-5-[9-(3-METHOXYPROPYL)-9H-CARBAZOL-2-YL]PYRIMIDINE-2,4-DIAMINE",MLSVRCGEBXIIQO-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
96233,6m71,DB12590,-7.4,Indiplon,CBIAWPMZSFFRGN-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110548,6vxx,DB01925,-7.4,"2'-Chloro-Biphenyl-2,3-Diol",SNGROCQMAKYWRE-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165534,7bv1,DB12242,-7.4,AZD-7762,IAYGCINLNONXHY-LBPRGKRZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
77520,6m2n,DB08478,-7.4,N-[2-chloro-5-(trifluoromethyl)phenyl]imidodicarbonimidic diamide,IGFTZEOFHWPCDL-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
67599,6lxt,DB06936,-7.4,N-(4-carbamimidoylbenzyl)-1-(4-methylpentanoyl)-L-prolinamide,AEKJCSNKYXWOAQ-INIZCTEOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
77512,6m2n,DB08469,-7.4,"tert-butyl 4-(3-thiophen-2-yl-1,2,4-oxadiazol-5-yl)piperidine-1-carboxylate",METBQPRXNZHZMB-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
110572,6vxx,DB01954,-7.4,Rolipram,HJORMJIFDVBMOB-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110487,6vxx,DB01656,-7.4,Roflumilast,MNDBXUUTURYVHR-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
118913,6w4b,DB06626,-7.4,Axitinib,RITAVMQDGBJQJZ-FMIVXFBMSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
92009,6m71,DB03829,-7.4,Pseudouridine-5'-Monophosphate,MOBMOJGXNHLLIR-GBNDHIKLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
77502,6m2n,DB08458,-7.4,(4-BROMOPHENYL)[4-({(2E)-4-[CYCLOPROPYL(METHYL)AMINO]BUT-2-ENYL}OXY)PHENYL]METHANONE,JAZMZJDLZUDIDG-NSCUHMNNSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
92013,6m71,DB03835,-7.4,"N-[(5S,7R,8S,9S,10R)-8,9,10-Trihydroxy-7-(hydroxymethyl)-2,4-dioxo-6-oxa-1,3-diazaspiro[4.5]dec-3-yl]acetamide",MAHIOGAAEAWGLR-UTAYWCBXSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
77489,6m2n,DB08442,-7.4,"4-{[(2R)-2-(2-methylphenyl)pyrrolidin-1-yl]carbonyl}benzene-1,3-diol",TWODFUZHWYZBHZ-MRXNPFEDSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
153292,6wiq,DB06137,-7.4,KX-01,HUNGUWOZPQBXGX-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
9693,6lzg,DB07812,-7.4,"N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyrrolo[2,3-b]pyridin-4-yl)thiophene-2-carboxamide",TWYNGDRSMHRPSY-MRXNPFEDSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
96149,6m71,DB12463,-7.4,Semagacestat,PKXWXXPNHIWQHW-RCBQFDQVSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
165554,7bv1,DB12447,-7.4,Nadifloxacin,JYJTVFIEFKZWCJ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
145856,6w9q,DB07839,-7.4,"N-2-1,3-BENZOXAZOL-2-YL-3-CYCLOHEXYL-N-{2-[(4-METHOXYPHENYL)AMINO]ETHYL}-L-ALANINAMIDE",VFNWTXUFNNOQHD-QFIPXVFZSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
110637,6vxx,DB02041,-7.4,Isoluminol,HUDPLKWXRLNSPC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110653,6vxx,DB02061,-7.4,Cellobiose,GUBGYTABKSRVRQ-CUHNMECISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
118934,6w4b,DB06678,-7.4,Esmirtazapine,RONZAEMNMFQXRA-MRXNPFEDSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
153268,6wiq,DB05959,-7.4,ENMD-1198,YQJWOUQGXATDAE-ACNBBOPNSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
153309,6wiq,DB06169,-7.4,Indibulin,SOLIIYNRSAWTSQ-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
96052,6m71,DB12321,-7.4,Ifetroban,BBPRUNPUJIUXSE-DXKRWKNPSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110698,6vxx,DB02118,-7.4,CP-271485,CIUMOGWIMXNXSQ-GOSISDBHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
96099,6m71,DB12393,-7.4,Fanapanel,WZMQMKNCWDCCMT-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
145748,6w9q,DB07717,-7.4,"(5S,8R,9S,10S,13R,14S,17S)-13-{2-[(3,5-DIFLUOROBENZYL)OXY]ETHYL}-17-HYDROXY-10-METHYLHEXADECAHYDRO-3H-CYCLOPENTA[A]PHENANTHREN-3-ONE",AJODXHGZHBERGJ-JLYQOUBASA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
110378,6vxx,DB01529,-7.4,Dextromoramide,INUNXTSAACVKJS-OAQYLSRUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
145769,6w9q,DB07742,-7.4,"N-(2,3-DIFLUORO-BENZYL)-4-SULFAMOYL-BENZAMIDE",QASSMVGOSBNFQY-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
118861,6w4b,DB06499,-7.4,Furaprofen,ODZUWQAFWMLWCF-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
96312,6m71,DB12715,-7.4,MSX-122,PXZXYRKDDXKDTK-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
118863,6w4b,DB06510,-7.4,Muraglitazar,IRLWJILLXJGJTD-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
110398,6vxx,DB01549,-7.4,Rolicyclidine,FYOWWXMGDATDQY-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
119134,6w4b,DB06963,-7.4,"3-[3-(3-methyl-6-{[(1S)-1-phenylethyl]amino}-1H-pyrazolo[4,3-c]pyridin-1-yl)phenyl]propanamide",ZFGCLYUGFRNYFE-INIZCTEOSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
165504,7bv1,DB12203,-7.4,Tozadenant,XNBRWUQWSKXMPW-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
145790,6w9q,DB07765,-7.4,"METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL](METHYL)AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE",UKCFUFHREWUXJJ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
9765,6lzg,DB07891,-7.4,"4-{[(14beta,17alpha)-3-hydrox1tra-1,3,5(10)-trien-17-yl]oxy}-4-oxobutanoic acid",YJPIDPAGJSWWBE-FNIAAEIWSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
96292,6m71,DB12685,-7.4,K-134,ULGNGSQNNMKROG-WOJBJXKFSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
119122,6w4b,DB06944,-7.4,N-(3-cyclopropyl-1H-pyrazol-5-yl)-2-(2-naphthyl)acetamide,RIGZCVNCFXYBEG-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
119067,6w4b,DB06883,-7.4,1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-phenylurea,DHNYNLNKNQJSHF-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
91916,6m71,DB03719,-7.4,N-Ethyl-5'-Carboxamido Adenosine,JADDQZYHOWSFJD-BMYQGPEFSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96283,6m71,DB12670,-7.4,Rolofylline,PJBFVWGQFLYWCB-QUYAXPHCSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
67541,6lxt,DB06874,-7.4,"(6-[4-(AMINOMETHYL)-2,6-DIMETHYLPHENOXY]-2-{[4-(AMINOMETHYL)PHENYL]AMINO}-5-BROMOPYRIMIDIN-4-YL)METHANOL",LSIZSSASMKSUIU-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
145812,6w9q,DB07791,-7.4,4-{[4-(1-CYCLOPROPYL-2-METHYL-1H-IMIDAZOL-5-YL)PYRIMIDIN-2-YL]AMINO}-N-METHYLBENZENESULFONAMIDE,MZWCVBFANHIPTJ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
30855,6cs2,DB13070,-7.4,Surinabant,HMXDWDSNPRNUKI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
96085,6m71,DB12376,-7.4,Ricolinostat,QGZYDVAGYRLSKP-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
119097,6w4b,DB06916,-7.4,"N-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-1-[2-(1H-IMIDAZOL-1-YL)-6-METHYLPYRIMIDIN-4-YL]-D-PROLINAMIDE",LBCGUKCXRVUULK-QGZVFWFLSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
9676,6lzg,DB07795,-7.4,Fisetin,XHEFDIBZLJXQHF-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
145821,6w9q,DB07801,-7.4,N-butyl-3-{[6-(9H-purin-6-ylamino)hexanoyl]amino}benzamide,WOYITRCGMUXUDE-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
29398,6cs2,DB09124,-7.4,Medrogestone,HCFSGRMEEXUOSS-JXEXPEPMSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
92115,6m71,DB03970,-7.4,"(7R)-7-(6,7-Dihydro-5H-cyclopenta[d]imidazo[2,1-b][1,3]thiazol-2-yl)-2,7-dihydro-1,4-thiazepine-3,6-dicarboxylic acid",CHNMLWCTGYMVFH-GFCCVEGCSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
67623,6lxt,DB06971,-7.4,"N-{2-[(4'-CYANO-1,1'-BIPHENYL-4-YL)OXY]ETHYL}-N'-HYDROXY-N-METHYLUREA",GVMUNGGWXRKCEU-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
110710,6vxx,DB02132,-7.4,Zenarestat,SXONDGSPUVNZLO-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30914,6cs2,DB13166,-7.4,Zofenopril,IAIDUHCBNLFXEF-MNEFBYGVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
30853,6cs2,DB13066,-7.4,Liarozole,UGFHIPBXIWJXNA-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
110108,6vxx,DB00986,-7.4,Glycopyrronium,ANGKOCUUWGHLCE-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
74769,6m2n,DB03809,-7.4,9-Butyl-8-(3-Methoxybenzyl)-9h-Purin-6-Amine,BWLWUGBHOXIUBP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
64695,6lxt,DB01852,-7.4,Kaempherol,IYRMWMYZSQPJKC-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
97097,6m71,DB13857,-7.4,Demegestone,JWAHBTQSSMYISL-MHTWAQMVSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
153707,6wiq,DB07025,-7.4,3-(5-{[4-(AMINOMETHYL)PIPERIDIN-1-YL]METHYL}-1H-INDOL-2-YL)QUINOLIN-2(1H)-ONE,KBIHHEGEALBUMT-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
64439,6lxt,DB01530,-7.4,"5alpha-androstane-3alpha,17beta-diol",CBMYJHIOYJEBSB-KHOSGYARSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
165309,7bv1,DB11910,-7.4,MK-0249,DDDZBLNULGDPGA-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
10013,6lzg,DB08152,-7.4,{(2S)-1-[N-(tert-butoxycarbonyl)glycyl]pyrrolidin-2-yl}methyl (3-chlorophenyl)acetate,ONXGIEJBNQLITK-INIZCTEOSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
109749,6vxx,DB15261,-7.4,Butafenacil,JEDYYFXHPAIBGR-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165313,7bv1,DB11915,-7.4,Valbenazine,GEJDGVNQKABXKG-CFKGEZKQSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95915,6m71,DB12129,-7.4,Tideglusib,PMJIHLSCWIDGMD-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
29422,6cs2,DB09175,-7.4,Mirfentanil,BJZZDOLVVLWFHN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
74514,6m2n,DB03458,-7.4,"N(4)-Adenosyl-N(4)-methyl-2,4-diaminobutanoic acid",JISVTSUBJCPLSV-TWBCTODHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
64447,6lxt,DB01538,-7.4,Acetyldihydrocodeine,LGGDXXJAGWBUSL-BKRJIHRRSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
10001,6lzg,DB08141,-7.4,"4-{[(2,6-difluorophenyl)carbonyl]amino}-N-[(3S)-piperidin-3-yl]-1H-pyrazole-3-carboxamide",KOMNQBZWMCFDTQ-VIFPVBQESA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
146079,6w9q,DB08097,-7.4,"2-(2,6-DIFLUOROPHENOXY)-N-(2-FLUOROPHENYL)-9-ISOPROPYL-9H-PURIN-8-AMINE",OGWSGDLIXOEZJG-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
97100,6m71,DB13865,-7.4,Dehydroemetine,XXLZPUYGHQWHRN-RPBOFIJWSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
109771,6vxx,DB00238,-7.4,Nevirapine,NQDJXKOVJZTUJA-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
67825,6lxt,DB07201,-7.4,(2S)-3-[(9H-fluoren-9-ylideneamino)oxy]-2-methylpropanoic acid,ZHFDVDMCVXUGGF-NSHDSACASA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
97069,6m71,DB13823,-7.4,Pipemidic acid,JOHZPMXAZQZXHR-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
67822,6lxt,DB07198,-7.4,5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-CARBONITRILE,GGEKOZPXKBYLNK-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
153702,6wiq,DB07019,-7.4,"N-[(5R,14R)-5-AMINO-5,14-DIMETHYL-4-OXO-3-OXA-18-AZATRICYCLO[15.3.1.1-7,11-]DOCOSA-1(21),7(22),8,10,17,19-HEXAEN-19-YL]-N-METHYLMETHANESULFONAMIDE",QWDOKZPZLWNULU-MZNJEOGPSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
119575,6w4b,DB07470,-7.4,"(3aS)-3a-hydroxy-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one",DOMYOVZXZIZTRD-QGZVFWFLSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
145555,6w9q,DB07486,-7.4,"3-({4-[(1E)-3-morpholin-4-yl-3-oxoprop-1-en-1-yl]-2,3-bis(trifluoromethyl)phenyl}sulfanyl)aniline",KLSZVPNVFKKIRD-FNORWQNLSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
153692,6wiq,DB07006,-7.4,"9-HYDROXY-6-(3-HYDROXYPROPYL)-4-(2-METHOXYPHENYL)PYRROLO[3,4-C]CARBAZOLE-1,3(2H,6H)-DIONE",AOGOZJCRIFBTTN-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
37371,1r42,DB04177,-7.4,"4-(3,14-Dihydroxy-10,13-Dimethyl-Hexadecahydro-Cyclopenta[a]Phenanthren-17-Yl)-5h-Furan-2-One",XZTUSOXSLKTKJQ-CESUGQOBSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
97043,6m71,DB13790,-7.4,Fipexide,BFUJHVVEMMWLHC-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
153691,6wiq,DB07005,-7.4,D-phenylalanyl-N-{4-[amino(iminio)methyl]benzyl}-L-prolinamide,VZFTWWJAUZOJDH-MOPGFXCFSA-O,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
109876,6vxx,DB00540,-7.4,Nortriptyline,PHVGLTMQBUFIQQ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
97028,6m71,DB13772,-7.4,Rufloxacin,NJCJBUHJQLFDSW-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
91613,6m71,DB03288,-7.4,5-Chloro-1h-Indole-2-Carboxylic Acid{[Cyclopentyl-(2-Hydroxy-Ethyl)-Carbamoyl]-Methyl}-Amide,VXABTOCIIZSEPD-QGZVFWFLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
111029,6vxx,DB02898,-7.4,5-{[(2-Amino-9h-Purin-6-Yl)Oxy]Methyl}-2-Pyrrolidinone,UYPMMHCTXQIWDX-RXMQYKEDSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110998,6vxx,DB02857,-7.4,Guanosine,NYHBQMYGNKIUIF-UUOKFMHZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
145500,6w9q,DB07421,-7.4,"4-{[(1R,2S)-1,2-dihydroxy-2-methyl-3-(4-nitrophenoxy)propyl]amino}-2-(trifluoromethyl)benzonitrile",INVUBEGZQHQAMY-SJORKVTESA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
119649,6w4b,DB07557,-7.4,"(5BETA)-PREGNANE-3,20-DIONE",XMRPGKVKISIQBV-XWOJZHJZSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
92228,6m71,DB04125,-7.4,N-Alpha-(2-Naphthylsulfonyl)-N(3-Amidino-L-Phenylalaninyl)-4-Acetyl-Piperazine,ZUWBXGHMVKDMQO-DEOSSOPVSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
77923,6m2n,DB08990,-7.4,Eprazinone,BSHWLCACYCVCJE-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77267,6m2n,DB08162,-7.4,Fasudil,NGOGFTYYXHNFQH-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
111056,6vxx,DB02933,-7.4,5'-Deoxy-5'-(Methylthio)-Tubercidin,WBPLMFVTQMIPLW-MFYTUXHUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
145419,6w9q,DB07325,-7.4,N-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)METHYL]-3-{[(E)-(2-OXODIHYDROFURAN-3(2H)-YLIDENE)METHYL]AMINO}BENZENESULFONAMIDE,VCOKUBHAJVTVNG-FMIVXFBMSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
77914,6m2n,DB08981,-7.4,Fenbufen,ZPAKPRAICRBAOD-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
10098,6lzg,DB08247,-7.4,6-(CYCLOHEXYLMETHOXY)-8-ISOPROPYL-9H-PURIN-2-AMINE,JABXNQUXGJTKRO-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
64400,6lxt,DB01482,-7.4,Fenethylline,NMCHYWGKBADVMK-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
92222,6m71,DB04115,-7.4,Berberine,YBHILYKTIRIUTE-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
165278,7bv1,DB11696,-7.4,Racecadotril,ODUOJXZPIYUATO-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
111050,6vxx,DB02925,-7.4,Piretanide,UJEWTUDSLQGTOA-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
119698,6w4b,DB07618,-7.4,"2-(4-(AMINOMETHYL)PIPERIDIN-1-YL)-N-(3_CYCLOHEXYL-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)ACETAMIDE",AITZHKQVQNLKHI-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
77907,6m2n,DB08972,-7.4,Flumequine,DPSPPJIUMHPXMA-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
145498,6w9q,DB07419,-7.4,S-23,SSFVOEAXHZGTRJ-KRWDZBQOSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
111048,6vxx,DB02923,-7.4,"Biphenyl-2,3-Diol",YKOQAAJBYBTSBS-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
119692,6w4b,DB07612,-7.4,6-(3-AMINOPHENYL)-N-(TERT-BUTYL)-2-(TRIFLUOROMETHYL)QUINAZOLIN-4-AMINE,XQKJVNGGVLHNLA-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
97120,6m71,DB13930,-7.4,Ulixertinib,KSERXGMCDHOLSS-LJQANCHMSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
165293,7bv1,DB11721,-7.4,Mitoglitazone,IRNJSRAGRIZIHD-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
165295,7bv1,DB11726,-7.4,Encenicline,SSRDSYXGYPJKRR-ZDUSSCGKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
91583,6m71,DB03247,-7.4,Flavin mononucleotide,FVTCRASFADXXNN-SCRDCRAPSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
109699,6vxx,DB15161,-7.4,Pittsburgh Compound B,ZQAQXZBSGZUUNL-BJUDXGSMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
10042,6lzg,DB08179,-7.4,"methyl 4-(2,3-dihydroxy-5-methylphenoxy)-2-hydroxy-6-methylbenzoate",BLXSEOJIXHWXQJ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
146090,6w9q,DB08108,-7.4,N-({6-[(4-CYANOBENZYL)OXY]NAPHTHALEN-2-YL}SULFONYL)-D-GLUTAMIC ACID,PUHRQSFXADUGJW-OAQYLSRUSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
145478,6w9q,DB07395,-7.4,"4-[3-(2-Chloro-4,5-difluoro-benzoyl)ureido]-3-trifluoromethoxybenzoic acid",NWQGDIBCFLDHDO-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
119654,6w4b,DB07563,-7.4,"1-{7-cyclohexyl-6-[4-(4-methylpiperazin-1-yl)benzyl]-7H-pyrrolo[2,3-d]pyrimidin-2-yl}methanamine",GCJSOJRPNOWSEH-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
118685,6w4b,DB05936,-7.4,CVT-6883,KOYXXLLNCXWUNF-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
67828,6lxt,DB07205,-7.4,N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,GZJXCRHEMLAMRA-SDBHATRESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
153711,6wiq,DB07029,-7.4,"4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMIDAZOL-1-YL)PHENOXY]-6-METHYLPYRIMIDINE",QQBNDYARFVOEGW-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
23610,6cs2,HMDB0094723,-7.4,2-hydroxyphenylpropionylglycine,LGQPWAWSLIEESE-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
64507,6lxt,DB01608,-7.4,Periciazine,LUALIOATIOESLM-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
145605,6w9q,DB07544,-7.4,N'-(5-CHLOROBENZOFURAN-2-CARBONYL)-2-(TRIFLUOROMETHYL)BENZENESULFONOHYDRAZIDE,ZLQBZYKAQQWOTK-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
145607,6w9q,DB07546,-7.4,[1-(6-{6-[(1-methylethyl)amino]-1H-indazol-1-yl}pyrazin-2-yl)-1H-pyrrol-3-yl]acetic acid,BBYRUZKRFAIQSR-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
77715,6m2n,DB08714,-7.4,"2,6-DIMETHYL-1-(3-[3-METHYL-5-ISOXAZOLYL]-PROPANYL)-4-[4-METHYL-2H-TETRAZOL-2-YL]-PHENOL",DRCNRTRGWUYJBH-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
95968,6m71,DB12214,-7.4,Luseogliflozin,WHSOLWOTCHFFBK-ZQGJOIPISA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96761,6m71,DB13411,-7.4,Lofepramine,SAPNXPWPAUFAJU-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110910,6vxx,DB02566,-7.4,8-Hydroxy-4-(1-Hydroxyethyl)Quinoline-2-Carboxylic Acid,FCGZNXGKWUHBKD-WKEGUHRASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31029,6cs2,DB13325,-7.4,Nifurzide,IDUMOVRJNBNOTR-BIZLIJPVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
9907,6lzg,DB08039,-7.4,"(3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE",LOGJQOUIVKBFGH-YBEGLDIGSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
110032,6vxx,DB00724,-7.4,Imiquimod,DOUYETYNHWVLEO-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
119395,6w4b,DB07263,-7.4,"[{2-bromo-4-[(2R)-3-oxo-2,3-diphenylpropyl]phenyl}(difluoro)methyl]phosphonic acid",WDTMVBQZDFMOIK-GOSISDBHSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
64650,6lxt,DB01793,-7.4,SB-409513,ONVZFCHLOZUXRP-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
165408,7bv1,DB12059,-7.4,JNJ-40411813,HYOGJHCDLQSAHX-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
31012,6cs2,DB13309,-7.4,Benproperine,JTUQXGZRVLWBCR-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
77307,6m2n,DB08212,-7.4,1-[2-(3-ACETYL-2-HYDROXY-6-METHOXY-PHENYL)-CYCLOPROPYL]-3-(5-CYANO-PYRIDIN-2-YL)-THIOUREA,FSRLCMRWYUJTNT-UONOGXRCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
119387,6w4b,DB07255,-7.4,"N'-(5-CHLORO-1,3-BENZODIOXOL-4-YL)-N-(3-MORPHOLIN-4-YLPHENYL)PYRIMIDINE-2,4-DIAMINE",PNEWIQAEGKQNCE-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
109993,6vxx,DB00682,-7.4,Warfarin,PJVWKTKQMONHTI-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
118786,6w4b,DB06281,-7.4,Torcetrapib,CMSGWTNRGKRWGS-NQIIRXRSSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
64679,6lxt,DB01831,-7.4,Tryptophanyl-5'amp,IFQVDHDRFCKAAW-SQIXAUHQSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
95981,6m71,DB12230,-7.4,Bunazosin,RHLJLALHBZGAFM-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
91774,6m71,DB03509,-7.4,2-(4-Chlorophenyl)-5-Quinoxalinecarboxamide,FLYGLPYJEQPCFY-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95988,6m71,DB12238,-7.4,MK-0777,QKIWQBLNTSQOLY-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
91778,6m71,DB03515,-7.4,Equilenin,PDRGHUMCVRDZLQ-WMZOPIPTSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
64689,6lxt,DB01842,-7.4,3'-Phosphate-Adenosine-5'-Diphosphate,GBBWIZKLHXYJOA-KQYNXXCUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
165418,7bv1,DB12073,-7.4,Albaconazole,UHIXWHUVLCAJQL-MPBGBICISA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110088,6vxx,DB00961,-7.4,Mepivacaine,INWLQCZOYSRPNW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
54052,2fxp,DB13874,-7.4,Enasidenib,DYLUUSLLRIQKOE-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
31002,6cs2,DB13296,-7.4,Propamidine,WTFXJFJYEJZMFO-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
119360,6w4b,DB07222,-7.4,(3S)-N-(5-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE,RJWMDETWDDESBP-ZDUSSCGKSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
119357,6w4b,DB07219,-7.4,"BENZYL N-({(2S,3S)-3-[(PROPYLAMINO)CARBONYL]OXIRAN-2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINATE",OMQNYWZURFTFHE-MQBSTWLZSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
96601,6m71,DB13185,-7.4,Oxabolone cipionate,KHKDIUPVDIEHAH-KXLSUQFWSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
67728,6lxt,DB07090,-7.4,(3S)-N-(3-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE,NJNMAZNXKKBTPS-ZDUSSCGKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
118771,6w4b,DB06250,-7.4,Fluasterone,VHZXNQKVFDBFIK-NBBHSKLNSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
95966,6m71,DB12210,-7.4,AZD-6280,NVWCZRPXYVDQEE-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
118767,6w4b,DB06246,-7.4,Exisulind,MVGSNCBCUWPVDA-MFOYZWKCSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
95949,6m71,DB12184,-7.4,Gepirone,QOIGKGMMAGJZNZ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
64525,6lxt,DB01628,-7.4,Etoricoxib,MNJVRJDLRVPLFE-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
31071,6cs2,DB13369,-7.4,Benzilone,ZKCWITXZGWUJAV-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
96988,6m71,DB13717,-7.4,Phenothrin,SBNFWQZLDJGRLK-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
165360,7bv1,DB11987,-7.4,GSK-2018682,NFIGDBFIDKDNIG-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96982,6m71,DB13710,-7.4,Metenolone,ANJQEDFWRSLVBR-VHUDCFPWSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96976,6m71,DB13696,-7.4,Bromochlorosalicylanilide,QBSGXIBYUQJHMJ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
64536,6lxt,DB01641,-7.4,"(5z)-2-[(1s,2r)-1-Amino-2-Hydroxypropyl]-5-[(4-Amino-1h-Indol-3-Yl)Methylene]-3-(2-Hydroxyethyl)-3,5-Dihydro-4h-Imidazol-4-One",JUWJATLABHTRDF-JURWUIOISA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
145636,6w9q,DB07583,-7.4,"(4R,2S)-5'-(4-(4-CHLOROBENZYLOXY)PYRROLIDIN-2-YLMETHANESULFONYL)ISOQUINOLINE",RLNNFNGBXLTQOB-RBUKOAKNSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
9937,6lzg,DB08076,-7.4,"4-[1-(2,6-dichlorobenzyl)-2-methyl-1H-imidazol-4-yl]pyrimidin-2-amine",CKSSZTMRRVJNNG-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
153664,6wiq,DB06976,-7.4,"1-(5-OXO-2,3,5,9B-TETRAHYDRO-1H-PYRROLO[2,1-A]ISOINDOL-9-YL)-3-(5-PYRROLIDIN-2-YL-1H-PYRAZOL-3-YL)-UREA",IWOOJEZSDPRYAZ-WFASDCNBSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
74564,6m2n,DB03526,-7.4,AL5927,LRRAIRJIZOLGPR-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
153140,6wiq,DB05220,-7.4,Alisertib,ZLHFILGSQDJULK-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
110958,6vxx,DB02809,-7.4,"Brodimoprim-4,6-Dicarboxylate",SZAVCZNFKJSWRN-LBPRGKRZSA-M,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
96900,6m71,DB13602,-7.4,Promegestone,QFFCYTLOTYIJMR-XMGTWHOFSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96895,6m71,DB13596,-7.4,Oxycinchophen,XAPRFLSJBSXESP-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
165374,7bv1,DB12007,-7.4,Isoflavone,GOMNOOKGLZYEJT-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
109953,6vxx,DB00631,-7.4,Clofarabine,WDDPHFBMKLOVOX-AYQXTPAHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
96889,6m71,DB13586,-7.4,Metandienone,XWALNWXLMVGSFR-HLXURNFRSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
153652,6wiq,DB06959,-7.4,(2S)-1-(3H-Indol-3-yl)-3-{[5-(6-isoquinolinyl)-3-pyridinyl]oxy}-2-propanamine,BUCZDJYEOAQTHL-KEKNWZKVSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
153642,6wiq,DB06944,-7.4,N-(3-cyclopropyl-1H-pyrazol-5-yl)-2-(2-naphthyl)acetamide,RIGZCVNCFXYBEG-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
146036,6w9q,DB08046,-7.4,2-chloro-5-[(1S)-1-hydroxy-3-oxo-2H-isoindol-1-yl]benzenesulfonamide,JIVPVXMEBJLZRO-AWEZNQCLSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
96849,6m71,DB13531,-7.4,Nicofetamide,DWODOIKZDGJOPQ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
119448,6w4b,DB07321,-7.4,"2,5-DICHLORO-N-[5-METHOXY-7-(6-METHOXYPYRIDIN-3-YL)-1,3-BENZOXAZOL-2-YL]BENZENESULFONAMIDE",KOKQLKWXOFRTHE-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
109963,6vxx,DB00645,-7.4,Dyclonine,BZEWSEKUUPWQDQ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110951,6vxx,DB02802,-7.4,5-Aminocarbonyl-3-Nitrophenyl-Alpha-D-Galactopyranose,BYSXBFJVGIOFBO-LNSPPBFMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110932,6vxx,DB02596,-7.4,"Alpha,Beta-Methyleneadenosine-5'-Triphosphate",CAWZRIXWFRFUQB-IOSLPCCCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
96797,6m71,DB13458,-7.4,Thebacon,RRJQTGHQFYTZOW-ILWKUFEGSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
77306,6m2n,DB08211,-7.4,5-bromo-3-(pyrrolidin-1-ylsulfonyl)-1H-indole-2-carboxamide,FEPUPYVRZUWCQB-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
108803,6vxx,DB08981,-7.4,Fenbufen,ZPAKPRAICRBAOD-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
154038,6wiq,DB07403,-7.4,"4-[(3-CHLORO-4-{[(2R)-3,3,3-TRIFLUORO-2-HYDROXY-2-METHYLPROPANOYL]AMINO}PHENYL)SULFONYL]-N,N-DIMETHYLBENZAMIDE",DTDZLJHKVNTQGZ-GOSISDBHSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
108801,6vxx,DB08979,-7.4,Fenspiride,FVNFBBAOMBJTST-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78606,6m2n,DB12004,-7.4,Briciclib,LXENKEWVEVKKGV-BQYQJAHWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
121861,6w4b,DB12505,-7.4,E-7820,LWGUASZLXHYWIV-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
164598,7bv1,DB08185,-7.4,2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,LCHGAOHLDYRACA-SDBHATRESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
79473,6m2n,DB13325,-7.4,Nifurzide,IDUMOVRJNBNOTR-BIZLIJPVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
144794,6w9q,DB06414,-7.4,Etravirine,PYGWGZALEOIKDF-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
79467,6m2n,DB13318,-7.4,Demecolcine,NNJPGOLRFBJNIW-HNNXBMFYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
10736,6lzg,DB08993,-7.4,Enviomycin,HPWIIERXAFODPP-GHBBWTPBSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
108314,6vxx,DB07614,-7.4,"PHENYL-5-(1H-PYRAZOL-3-YL)-1,3-THIAZOLE",NRAHRUHGPGBWSI-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
146709,6w9q,DB08861,-7.4,DPDPE,MCMMCRYPQBNCPH-WMIMKTLMSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
68494,6lxt,DB07984,-7.4,2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]-n-[(1S)-1-(hydroxymethyl)propyl]acetamide,GKJWXEORYGBJFS-KRWDZBQOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
53216,2fxp,DB12655,-7.4,Patidegib,HZLFFNCLTRVYJG-WWGOJCOQSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
165820,7bv1,DB13062,-7.4,ME-344,QVCAATSEPLQVBX-FPOVZHCZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
79451,6m2n,DB13300,-7.4,Epicillin,RPBAFSBGYDKNRG-NJBDSQKTSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
31713,6cs2,DB14635,-7.4,Curcumin sulfate,NEJVQQBBTRFOHB-FCXRPNKRSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
98381,6vxs,DB00876,-7.4,Eprosartan,OROAFUQRIXKEMV-LDADJPATSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
92630,6m71,DB04656,-7.4,"1,3,4-TRIHYDROXY-5-(3-PHENOXYPROPYL)-CYCLOHEXANE-1-CARBOXYLIC A CID",SCUFESRLGCQXRX-DCDXPUDHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95485,6m71,DB11409,-7.4,Febantel,HMCCXLBXIJMERM-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
68483,6lxt,DB07971,-7.4,"5-AMINO-2-{4-[(4-AMINOPHENYL)SULFANYL]PHENYL}-1H-ISOINDOLE-1,3(2H)-DIONE",FQQVTDIBUYSVHM-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
79434,6m2n,DB13275,-7.4,Clorindione,NJDUWAXIURWWLN-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
144842,6w9q,DB06533,-7.4,Ragaglitazar,WMUIIGVAWPWQAW-XMMPIXPASA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
121790,6w4b,DB12401,-7.4,Bromperidol,RKLNONIVDFXQRX-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
95494,6m71,DB11426,-7.4,Marbofloxacin,BPFYOAJNDMUVBL-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
144853,6w9q,DB06578,-7.4,Tonabersat,XLIIRNOPGJTBJD-ROUUACIJSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
79421,6m2n,DB13254,-7.4,Prifinium,ZYEPZINLLPPBMI-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
63488,6lxt,DB00338,-7.4,Omeprazole,SUBDBMMJDZJVOS-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
31701,6cs2,DB14624,-7.4,Nandrolone hydrogen sulfate,SKZMVWBZTQNCKW-IZPLOLCNSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
121778,6w4b,DB12385,-7.4,10-hydroxycamptothecin,HAWSQZCWOQZXHI-FQEVSTJZSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
9398,6lzg,DB07493,-7.4,"(2Z)-5'-BROMO-2,3'-BIINDOLE-2',3(1H,1'H)-DIONE AMMONIATE",IEQQJQHHJMQETK-YPKPFQOOSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
117661,6w4b,DB03791,-7.4,"(3-{3-[[2-Chloro-3-(Trifluoromethyl)Benzyl](2,2-Diphenylethyl)Amino]Propoxy}Phenyl)Acetic Acid",NAXSRXHZFIBFMI-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
92627,6m71,DB04652,-7.4,Corticosterone,OMFXVFTZEKFJBZ-HJTSIMOOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
152364,6wiq,DB03950,-7.4,(S)-N-(3-Indol-1-Yl-2-Methyl-Propyl)-4-Sulfamoyl-Benzamide,ZFWHOUCRVSOZJE-AWEZNQCLSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
121866,6w4b,DB12511,-7.4,Imiglitazar,ULVDFHLHKNJICZ-QCWLDUFUSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
31729,6cs2,DB14649,-7.4,Dexamethasone acetate,AKUJBENLRBOFTD-RPRRAYFGSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
23756,6cs2,DB01380,-7.4,Cortisone acetate,ITRJWOMZKQRYTA-RFZYENFJSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
31753,6cs2,DB14672,-7.4,Oxazepam acetate,FYRWUTOZBRWYCS-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
63418,6lxt,DB00252,-7.4,Phenytoin,CXOFVDLJLONNDW-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
98427,6vxs,DB00926,-7.4,Etretinate,HQMNCQVAMBCHCO-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
79502,6m2n,DB13358,-7.4,Cibenzoline,IPOBOOXFSRWSHL-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
28127,6cs2,DB07705,-7.4,"1-[(2S)-2-[(4-CHLOROBENZYL)OXY]-2-(2,4-DICHLOROPHENYL)ETHYL]-1H-IMIDAZOLE",LEZWWPYKPKIXLL-GOSISDBHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
90296,6m71,DB01554,-7.4,Bolandiol,CMXKUJNZWYTFJN-XFUVECHXSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95470,6m71,DB11380,-7.4,Cambendazole,QZWHWHNCPFEXLL-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
144714,6w9q,DB06202,-7.4,Lasofoxifene,GXESHMAMLJKROZ-IAPPQJPRSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
154753,6wiq,DB08237,-7.4,2'-deoxy-N-(naphthalen-1-ylmethyl)guanosine 5'-(dihydrogen phosphate),COMPKRGNHXOXMN-GVDBMIGSSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
55499,6crv,DB01074,-7.4,Perhexiline,CYXKNKQEMFBLER-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31741,6cs2,DB14661,-7.4,Loperamide oxide,KXVSBTJVTUVNPM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
121918,6w4b,DB12590,-7.4,Indiplon,CBIAWPMZSFFRGN-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
95471,6m71,DB11385,-7.4,Cefalonium,FMZXNVLFJHCSAF-DNVCBOLYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
90307,6m71,DB01565,-7.4,Dihydromorphine,IJVCSMSMFSCRME-KBQPJGBKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
73917,6m2n,DB02658,-7.4,"2,4-Dinitrophenyl 2-Deoxy-2-Fluoro-Beta-D-Allopyranoside",UFSBFVZQJZMIOU-LZQZFOIKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
165824,7bv1,DB13066,-7.4,Liarozole,UGFHIPBXIWJXNA-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
73919,6m2n,DB02660,-7.4,Filaminast,STTRYQAGHGJXJJ-LICLKQGHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
63458,6lxt,DB00298,-7.4,Dapiprazole,RFWZESUMWJKKRN-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
55477,6crv,DB01050,-7.4,Ibuprofen,HEFNNWSXXWATRW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
68516,6lxt,DB08008,-7.4,"5-methyl-N-[4-(trifluoromethyl)phenyl][1,2,4]triazolo[1,5-a]pyrimidin-7-amine",LRHHXKBKRNNFRV-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
121896,6w4b,DB12557,-7.4,FK-614,UYGZODVVDUIDDQ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
121895,6w4b,DB12555,-7.4,Nelotanserin,COSPVUFTLGQDQL-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
108281,6vxx,DB07572,-7.4,3-{[(4-methylphenyl)sulfonyl]amino}propyl pyridin-4-ylcarbamate,ITYCDQJBLCTIID-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
164594,7bv1,DB08179,-7.4,"methyl 4-(2,3-dihydroxy-5-methylphenoxy)-2-hydroxy-6-methylbenzoate",BLXSEOJIXHWXQJ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
90323,6m71,DB01586,-7.4,Ursodeoxycholic acid,RUDATBOHQWOJDD-UZVSRGJWSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
67267,6lxt,DB06280,-7.4,Senicapoc,SCTZUZTYRMOMKT-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
108293,6vxx,DB07587,-7.4,"N-(1-CYANOCYCLOPROPYL)-3-({[(2S)-5-OXOPYRROLIDIN-2-YL]METHYL}SULFONYL)-N-2-[(1S)-2,2,2-TRIFLUORO-1-(4-FLUOROPHENYL)ETHYL]-L-ALANINAMIDE",JLPXDVXMMYRTKN-ZOBUZTSGSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
98405,6vxs,DB00904,-7.4,Ondansetron,FELGMEQIXOGIFQ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
90290,6m71,DB01548,-7.4,Diprenorphine,OIJXLIIMXHRJJH-KNLIIKEYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
63498,6lxt,DB00348,-7.4,Nitisinone,OUBCNLGXQFSTLU-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
121761,6w4b,DB12361,-7.4,Piclozotan,URMTUEWUIGOJBW-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
146628,6w9q,DB08754,-7.4,"(2E)-3-(3,4-DIHYDROXYPHENYL)-N-[2-(4-HYDROXYPHENYL)ETHYL]ACRYLAMIDE",VSHUQLRHTJOKTA-XBXARRHUSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
90445,6m71,DB01745,-7.4,N-Alpha-(2-Naphthylsulfonyl)-N(3-Amidino-L-Phenylalaninyl)Isopipecolinic Acid Methyl Ester,JJLGQWCKMHPBEB-DEOSSOPVSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
23739,6cs2,DB01347,-7.4,Saprisartan,DUEWVPTZCSAMNB-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
152405,6wiq,DB04006,-7.4,"[2-Amino-6-(2,6-Difluoro-Benzoyl)-Imidazo[1,2-a]Pyridin-3-Yl]-Phenyl-Methanone",WUGJIPFLBOATGL-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
79311,6m2n,DB13063,-7.4,Parthenolide,KTEXNACQROZXEV-SLXBATTESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
111838,6vxx,DB04765,-7.4,N-PYRIDOXYL-2-METHYL-L-GLUTAMIC ACID-5'-MONOPHOSPHATE,CNIVMJHNGQZEAY-AWEZNQCLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
121669,6w4b,DB12234,-7.4,BMS-214662,OLCWFLWEHWLBTO-HSZRJFAPSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
79292,6m2n,DB13032,-7.4,Enecadin,SZSHJTJCJOWMHM-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79288,6m2n,DB13027,-7.4,Tucaresol,XEDONBRPTABQFB-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
68424,6lxt,DB07901,-7.4,5-CHLORO-6-METHYL-N-(2-PHENYLETHYL)-2-PYRIDIN-2-YLPYRIMIDIN-4-AMINE,HIUOABSWQSUEGK-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
154581,6wiq,DB08036,-7.4,"6,7,12,13-tetrahydro-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazol-5-one",MEXUTNIFSHFQRG-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
95530,6m71,DB11490,-7.4,Nalorphine,UIQMVEYFGZJHCZ-SSTWWWIQSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
29487,6cs2,DB09239,-7.4,Niguldipine,SVJMLYUFVDMUHP-XIFFEERXSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
28210,6cs2,DB07791,-7.4,4-{[4-(1-CYCLOPROPYL-2-METHYL-1H-IMIDAZOL-5-YL)PYRIMIDIN-2-YL]AMINO}-N-METHYLBENZENESULFONAMIDE,MZWCVBFANHIPTJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
152410,6wiq,DB04014,-7.4,Alsterpaullone,OLUKILHGKRVDCT-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
146617,6w9q,DB08743,-7.4,"2-({8-[(3R)-3-AMINOPIPERIDIN-1-YL]-1,3-DIMETHYL-2,6-DIOXO-1,2,3,6-TETRAHYDRO-7H-PURIN-7-YL}METHYL)BENZONITRILE",XJNKUWDMCBZMTG-OAHLLOKOSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
117829,6w4b,DB04010,-7.4,2-(3'-Methoxyphenyl) Benzimidazole-4-Carboxamide,NVVWVYYHTKCIAE-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
145009,6w9q,DB06853,-7.4,N-cycloheptylglycyl-N-(4-carbamimidoylbenzyl)-L-prolinamide,BYTJPDBCLWUEBU-IBGZPJMESA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
95537,6m71,DB11512,-7.4,Dihydrostreptomycin,ASXBYYWOLISCLQ-HZYVHMACSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95540,6m71,DB11520,-7.4,Hygromycin B,GRRNUXAQVGOGFE-HUCHGKBZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
121629,6w4b,DB12174,-7.4,CUDC-101,PLIVFNIUGLLCEK-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
90494,6m71,DB01810,-7.4,"[1-(1-Methyl-4,5-Dioxo-Pent-2-Enylcarbamoyl)-2-Phenyl-Ethyl]-Carbamic Acid Benzyl Ester",NOXVWFAAXREWMI-GURWAVDKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
146585,6w9q,DB08710,-7.4,"(5Z)-5-[(5-ETHYL-2-FURYL)METHYLENE]-2-{[(S)-(4-FLUOROPHENYL)(1H-TETRAZOL-5-YL)METHYL]AMINO}-1,3-THIAZOL-4(5H)-ONE",BKZOQCGDCHOGOQ-MZLJFPOFSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
76925,6m2n,DB07776,-7.4,Flavone,VHBFFQKBGNRLFZ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
90496,6m71,DB01812,-7.4,Adenosine-3'-5'-Diphosphate,WHTCPDAXWFLDIH-KQYNXXCUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
145066,6w9q,DB06918,-7.4,2-(2-METHYLPHENYL)-1H-INDOLE-6-CARBOXIMIDAMIDE,ZRYXDGAKQGRHFG-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
28234,6cs2,DB07814,-7.4,Gibberellic acid,IXORZMNAPKEEDV-OBDJNFEBSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
117852,6w4b,DB04044,-7.4,4-{2-[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid,NAQUAVBNIYTIIS-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
10694,6lzg,DB08950,-7.4,Indoramin,JXZZEXZZKAWDSP-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
79404,6m2n,DB13230,-7.4,Gestonorone,GTFUITFQDGVJSK-XGXHKTLJSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
63543,6lxt,DB00402,-7.4,Eszopiclone,GBBSUAFBMRNDJC-INIZCTEOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
121695,6w4b,DB12270,-7.4,Losmapimod,KKYABQBFGDZVNQ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
121757,6w4b,DB12355,-7.4,Netazepide,YDZYKNJZCVIKPP-VWLOTQADSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
76909,6m2n,DB07758,-7.4,"5-(2,5-DICHLOROPHENYL)-2-FUROIC ACID",ATAZLMGGQQLRBC-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
144872,6w9q,DB06616,-7.4,Bosutinib,UBPYILGKFZZVDX-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
98343,6vxs,DB00833,-7.4,Cefaclor,QYIYFLOTGYLRGG-GPCCPHFNSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
55395,6crv,DB00953,-7.4,Rizatriptan,ULFRLSNUDGIQQP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31694,6cs2,DB01082,-7.4,Streptomycin,UCSJYZPVAKXKNQ-HZYVHMACSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
63502,6lxt,DB00353,-7.4,Methylergometrine,UNBRKDKAWYKMIV-QWQRMKEZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
165798,7bv1,DB13027,-7.4,Tucaresol,XEDONBRPTABQFB-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
68479,6lxt,DB07967,-7.4,9-CYCLOPENTYL-6-[2-(3-IMIDAZOL-1-YL-PROPOXY)-PHENYLAMINO]-9H-PURINE-2-CARBONITRILE,JJNKDTWKWYLERH-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
165791,7bv1,DB13020,-7.4,Apratastat,MAVDNGWEBZTACC-HNNXBMFYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
121736,6w4b,DB12320,-7.4,Palovarotene,YTFHCXIPDIHOIA-DHZHZOJOSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
68462,6lxt,DB07946,-7.4,"N-[2-({[amino(imino)methyl]amino}oxy)ethyl]-2-{6-chloro-3-[(2,2-difluoro-2-phenylethyl)amino]-2-fluorophenyl}acetamide",DZEJHPMTDNDECN-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
68460,6lxt,DB07944,-7.4,N-{3-METHYL-5-[2-(PYRIDIN-4-YLAMINO)-ETHOXY]-PHENYL}-BENZENESULFONAMIDE,MPTWCWHNLVMCRW-UHFFFAOYSA-O,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
23740,6cs2,DB01348,-7.4,Spirapril,HRWCVUIFMSZDJS-SZMVWBNQSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
68454,6lxt,DB07937,-7.4,"2-butoxy-9-(2,6-difluorobenzyl)-N-(2-morpholin-4-ylethyl)-9H-purin-6-amine",UGZWPZWADDDTRN-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
111845,6vxx,DB04776,-7.4,(2R)-2-({6-[benzyl(methyl)amino]-9-isopropyl-9H-purin-2-yl}amino)butan-1-ol,YPYWONAECUVKHY-MRXNPFEDSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
144920,6w9q,DB06708,-7.4,Lumefantrine,DYLGFOYVTXJFJP-MYYYXRDXSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
95511,6m71,DB11455,-7.4,Robenacoxib,ZEXGDYFACFXQPF-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
144928,6w9q,DB06717,-7.4,Fosaprepitant,BARDROPHSZEBKC-OITMNORJSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
68449,6lxt,DB07932,-7.4,"dimethyl (1R,4S)-5,6-bis(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hepta-2,5-diene-2,3-dicarboxylate",CRLQCBACIMUGDZ-BGYRXZFFSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
144936,6w9q,DB06730,-7.4,Gestodene,SIGSPDASOTUPFS-XUDSTZEESA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
79347,6m2n,DB13115,-7.4,Saroglitazar,MRWFZSLZNUJVQW-DEOSSOPVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
90404,6m71,DB01689,-7.4,Inhibitor Idd 384,CJKKMQCZOLCXAM-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
117753,6w4b,DB03907,-7.4,"N-{3-[5-(6-Amino-Purin-9-Yl)-3,4-Dihydroxy-Tetrahydro-Furan-2-Yl]-Allyl}-2,3-Dihydroxy-5-Nitro-Benzamide",UHHBFOLQOQSPLU-WGRQDFERSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
98313,6vxs,DB00801,-7.4,Halazepam,WYCLKVQLVUQKNZ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
108381,6vxx,DB07694,-7.4,"2,5-dichloro-N-(3,5-dibromo-4-hydroxyphenyl)benzamide",IFLWCZRMFPKYBN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
117759,6w4b,DB03916,-7.4,4-{2-[4-(2-Aminoethyl)Piperazin-1-Yl]Pyridin-4-Yl}-N-(3-Chloro-4-Methylphenyl)Pyrimidin-2-Amine,RHOOHUMOHVIXEF-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
144949,6w9q,DB06746,-7.4,ginkgolide-J,LMEHVEUFNRJAAV-UKWFQYJJSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
164657,7bv1,DB08262,-7.4,"2,6-dicarboxynaphthalene",RXOHFPCZGPKIRD-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
28124,6cs2,DB07702,-7.4,17alpha-Estriol,PROQIPRRNZUXQM-PNVOZDDCSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
121964,6w4b,DB12665,-7.4,Isoquercetin,OVSQVDMCBVZWGM-QSOFNFLRSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
68542,6lxt,DB08035,-7.4,"1-TERT-BUTYL-3-(2,5-DIMETHYLBENZYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE",QUPXEJURIFFVSX-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
31847,6cs2,DB14875,-7.4,AZD-4017,NCDZABJPWMBMIQ-INIZCTEOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
164479,7bv1,DB08054,-7.4,"1-(1-methylethyl)-3-quinolin-6-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine",GEZALMMCQYDFML-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
36826,1r42,DB03447,-7.4,Uridylyl-2'-5'-Phospho-Adenosine,QARCCHXXGAIRFS-KPKSGTNCSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
23788,6cs2,DB01425,-7.4,Alizapride,KSEYRUGYKHXGFW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
68618,6lxt,DB08122,-7.4,"N-METHYL-4-{[(2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]AMINO}BENZENESULFONAMIDE",IKASAFLVQIJQOK-UVTDQMKNSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
23778,6cs2,DB01415,-7.4,Ceftibuten,UNJFKXSSGBWRBZ-BJCIPQKHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
154902,6wiq,DB08426,-7.4,"THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [2-OXO-1-(1H-PYRROLO[2,3-C]PYRIDIN-2-YLMETHYL)-PYRROLIDIN-3-YL]-AMIDE",PLXOQMHGHDZMSX-AWEZNQCLSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
98645,6vxs,DB01179,-7.4,Podofilox,YJGVMLPVUAXIQN-XVVDYKMHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
55644,6crv,DB01241,-7.4,Gemfibrozil,HEMJJKBWTPKOJG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
98633,6vxs,DB01166,-7.4,Cilostazol,RRGUKTPIGVIEKM-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
79673,6m2n,DB13596,-7.4,Oxycinchophen,XAPRFLSJBSXESP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
31841,6cs2,DB14862,-7.4,PF-06815345,QTBYVAZRKWOIDU-FUHWJXTLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
164484,7bv1,DB08059,-7.4,Wortmannin,QDLHCMPXEPAAMD-QAIWCSMKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
79681,6m2n,DB13605,-7.4,Phenoperidine,IPOPQVVNCFQFRK-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79672,6m2n,DB13593,-7.4,Zolimidine,VSLIUWLPFRVCDL-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
63284,6crv,DB07899,-7.4,(2S) N-acetyl-L-alanyl-alphaL-phenylalanyl-chloroethylketone,WABWAIGLGFELMI-FZMZJTMJSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
117307,6w4b,DB03300,-7.4,Pterin Cytosine Dinucleotide,WKSPNQYEWZEMMI-FEFZDOOUSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
28042,6cs2,DB07615,-7.4,Tranilast,NZHGWWWHIYHZNX-CSKARUKUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
122229,6w4b,DB13080,-7.4,Roluperidone,RNRYULFRLCBRQS-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
144459,6w9q,DB04892,-7.4,Phenserine,PBHFNBQPZCRWQP-QUCCMNQESA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
117328,6w4b,DB03325,-7.4,Tyrosyladenylate,MJZAZMKENKZBAJ-QTOWJTHWSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
95312,6m71,DB09244,-7.4,Pirlindole,IWVRVEIKCBFZNF-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
144461,6w9q,DB04898,-7.4,Ximelagatran,ZXIBCJHYVWYIKI-PZJWPPBQSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
31831,6cs2,DB14846,-7.4,Bimiralisib,ADGGYDAFIHSYFI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
9335,6lzg,DB07426,-7.4,"[1-HYDROXY-2-(1,1':3',1''-TERPHENYL-3-YLOXY)ETHANE-1,1-DIYL]BIS(PHOSPHONIC ACID)",NWIARQRYIRVYCM-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
55623,6crv,DB01214,-7.4,Metipranolol,BQIPXWYNLPYNHW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
68614,6lxt,DB08118,-7.4,"2-(methylamino)-N-(4-methyl-1,3-thiazol-2-yl)-5-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]benzamide",XRJAKERBMMBUGR-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
98607,6vxs,DB01136,-7.4,Carvedilol,OGHNVEJMJSYVRP-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
98626,6vxs,DB01157,-7.4,Trimetrexate,NOYPYLRCIDNJJB-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
146820,6w9q,DB09015,-7.4,Canrenoic acid,PBKZPPIHUVSDNM-WNHSNXHDSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
13282,6lzg,DB15071,-7.4,Omidenepag isopropyl,VIQCWEGEHRBLAC-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
144377,6w9q,DB04792,-7.4,"2,5-O,O-BIS-{4',4''-AMIDINOPHENYL}-1,4:3,6-DIANHYDRO-D-SORBITOL",CDEVHSIVANGYRI-XMTFNYHQSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
20729,6cs2,HMDB0048517,-7.4,"TG(16:1(9Z)/20:0/18:4(6Z,9Z,12Z,15Z))",GQZRZDIDOJKGLP-SIPNAMALSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
98717,6vxs,DB01268,-7.4,Sunitinib,WINHZLLDWRZWRT-ATVHPVEESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
112041,6vxx,DB06156,-7.4,Tesofensine,VCVWXKKWDOJNIT-ZOMKSWQUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79761,6m2n,DB13711,-7.4,Tritoqualine,IRGJVQIJENCTQF-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76786,6m2n,DB07613,-7.4,3-phenyl-5-(1H-pyrazol-3-yl)isoxazole,SRSSTOPJERVMRZ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
144230,6w9q,DB04591,-7.4,"N-{2,2-DIFLUORO-2-[(2R)-PIPERIDIN-2-YL]ETHYL}-2-[2-(1H-1,2,4-TRIAZOL-1-YL)BENZYL][1,3]OXAZOLO[4,5-C]PYRIDIN-4-AMINE",VYJOAYZRCNHDNG-GOSISDBHSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
165872,7bv1,DB13143,-7.4,Methallenestril,KHLJKRBMZVNZOC-MRXNPFEDSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
23817,6cs2,DB01456,-7.4,5-androstenedione,SQGZFRITSMYKRH-QAGGRKNESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
63222,6crv,DB15380,-7.4,Flutriciclamide F-18,ZVDVQPLDTTXLKI-LSKWOKDISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
92697,6m71,DB04754,-7.4,"GUANOSINE-2',3'-O-ETHYLIDENEPHOSPHONATE",HYAPEMYRVFIHDJ-QWEIRQIHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
9315,6lzg,DB07404,-7.4,"(1-HYDROXY-1-PHOSPHONO-2-[1,1';3',1'']TERPHENYL-3-YL-ETHYL)-PHOSPHONIC ACID",YXQQNSYZOQHKHD-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
122410,6w4b,DB13360,-7.4,Tolciclate,CANCCLAKQQHLNK-LSDHHAIUSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
144301,6w9q,DB04685,-7.4,"1-{(2S,5S)-4-FLUORO-5-[(TRITYLOXY)METHYL]TETRAHYDROFURAN-2-YL}PYRIMIDINE-2,4(1H,3H)-DIONE",GJNIPWYJQUGERM-BFLUCZKCSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
90188,6m71,DB01431,-7.4,Allylestrenol,ATXHVCQZZJYMCF-XUDSTZEESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
144306,6w9q,DB04693,-7.4,"(13S)-13-METHYLDODECAHYDRO-1H-CYCLOPENTA[A]PHENANTHRENE-3,17(2H,4H)-DIONE",CRDKSBHJIGNEOH-IMRIKWHGSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
154953,6wiq,DB08487,-7.4,3-({4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-2-OXOPIPERAZIN-1-YL}METHYL)BENZENECARBOXIMIDAMIDE,PRMSFVUWLBPPLY-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
112020,6vxx,DB06083,-7.4,Tapinarof,ZISJNXNHJRQYJO-CMDGGOBGSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
68632,6lxt,DB08137,-7.4,(4E)-N-(4-fluorophenyl)-4-[(phenylcarbonyl)imino]-4H-pyrazole-3-carboxamide,ZMWYSLJBNJUCRK-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
23805,6cs2,DB01443,-7.4,19-Nor-5-androstenedione,WELNRNVZXWUOGT-QXUSFIETSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
90178,6m71,DB01421,-7.4,Paromomycin,UOZODPSAJZTQNH-LSWIJEOBSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
92678,6m71,DB04725,-7.4,Licofelone,UAWXGRJVZSAUSZ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
23801,6cs2,DB01439,-7.4,3-Methylthiofentanyl,SRARDYUHGVMEQI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
144372,6w9q,DB04785,-7.4,Streptolydigin,KVTPRMV1KLIG-NCAOFHFGSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
154920,6wiq,DB08446,-7.4,"3-[6-bromo-2-fluoro-3-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)phenoxy]-5-chlorobenzonitrile",OHQMEDBYNUAVNE-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
144375,6w9q,DB04790,-7.4,"2,5-bis-O-{3-[amino(imino)methyl]phenyl}-1,4:3,6-dianhydro-D-glucitol",IBIUTOFGXGGVKQ-XMTFNYHQSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
144376,6w9q,DB04791,-7.4,"2-O-(4'-AMIDINOPHENYL)-5-O-(3''-AMIDINOPHENYL)-1,4:3,6-DIANHYDRO-D-SORBITOL",DKBAWRNTUZFJKV-BSDSXHPESA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
29155,6cs2,DB08795,-7.4,Azidocillin,ODFHGIPNGIAMDK-NJBDSQKTSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
79691,6m2n,DB13617,-7.4,Clorexolone,VPMWFZKOWULPGT-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
73799,6m2n,DB02502,-7.4,8-Hydroxy-2'-Deoxyguanosine,HCAJQHYUCKICQH-VPENINKCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
98606,6vxs,DB01134,-7.4,Desoxycorticosterone pivalate,VVOIQBFMTVCINR-WWMZEODYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
30602,6cs2,DB12714,-7.4,Nerispirdine,BTDHTARYCBHHPJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
63314,6lxt,DB00136,-7.4,Calcitriol,GMRQFYUYWCNGIN-NKMMMXOESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
144590,6w9q,DB05532,-7.4,BMS-488043,DBPMWRYLTBNCCE-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
36874,1r42,DB03510,-7.4,6-O-Phosphoryl Inosine Monophosphate,RXRZOKQPANIEDW-KQYNXXCUSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
90271,6m71,DB01529,-7.4,Dextromoramide,INUNXTSAACVKJS-OAQYLSRUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
154832,6wiq,DB08339,-7.4,"6-(2,6-DICHLOROPHENYL)-2-{[3-(HYDROXYMETHYL)PHENYL]AMINO}-8-METHYLPYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE",ZIQFYVPVJZEOFS-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
28082,6cs2,DB07655,-7.4,"3-AMINO-3-BENZYL-[4.3.0]BICYCLO-1,6-DIAZANONAN-2-ONE",MPJYGQHMIFDQIN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
79561,6m2n,DB13437,-7.4,Medazepam,YLCXGBZIZBEVPZ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
92652,6m71,DB04689,-7.4,2-{5-[3-(6-BENZOYL-1-PROPYLNAPHTHALEN-2-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID,ZXWVCCFKIRBLDP-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
76862,6m2n,DB07703,-7.4,"(3R,4S,5S,7R,9E,11R,12R)-12-ETHYL-4-HYDROXY-3,5,7,11-TETRAMETHYLOXACYCLODODEC-9-ENE-2,8-DIONE",NZUJVBSYQXETNF-PQWITYJESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
90272,6m71,DB01530,-7.4,"5alpha-androstane-3alpha,17beta-diol",CBMYJHIOYJEBSB-KHOSGYARSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
164561,7bv1,DB08145,-7.4,"6-(2,6-DIMETHOXYPHENYL)PYRIDO[2,3-D]PYRIMIDINE-2,7-DIAMINE",LRPHIAJXODIASX-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
146734,6w9q,DB08906,-7.4,Fluticasone furoate,XTULMSXFIHGYFS-VLSRWLAYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
144627,6w9q,DB05772,-7.4,Rabeximod,PDNNUMNEXITLCZ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
98463,6vxs,DB00969,-7.4,Alosetron,JSWZEAMFRNKZNL-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
90268,6m71,DB01526,-7.4,4-Androstenediol,BTTWKVFKBPAFDK-LOVVWNRFSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
122017,6w4b,DB12744,-7.4,CGI-1842,ZXBFYBLSJMEBEP-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
117463,6w4b,DB03515,-7.4,Equilenin,PDRGHUMCVRDZLQ-WMZOPIPTSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
28094,6cs2,DB07670,-7.4,4-METHYL-N-METHYL-N-(2-PHENYL-2H-PYRAZOL-3-YL)BENZENESULFONAMIDE,KRHPBWNETCEFGS-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
90282,6m71,DB01540,-7.4,17alpha-methyl-4-hydroxynandrolone,CLNUZOCYKSHICX-FAHHUNKHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
144656,6w9q,DB05944,-7.4,Varlitinib,UWXSAYUXVSFDBQ-CYBMUJFWSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
144657,6w9q,DB05959,-7.4,ENMD-1198,YQJWOUQGXATDAE-ACNBBOPNSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
122000,6w4b,DB12719,-7.4,Turofexorate isopropyl,INASOKQDNHHMRE-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
55541,6crv,DB01124,-7.4,Tolbutamide,JLRGJRBPOGGCBT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
98452,6vxs,DB00956,-7.4,Hydrocodone,LLPOLZWFYMWNKH-CMKMFDCUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
164574,7bv1,DB08158,-7.4,"2,4-DINITROPHENYL 2-DEOXY-2-FLUORO-BETA-D-MANNOPYRANOSIDE",UFSBFVZQJZMIOU-IYKVGLELSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
55534,6crv,DB01115,-7.4,Nifedipine,HYIMSNHJOBLJNT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
63414,6lxt,DB00248,-7.4,Cabergoline,KORNTPPJEAJQIU-KJXAQDMKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
9373,6lzg,DB07468,-7.4,"(3aS)-3a-hydroxy-5-methyl-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one",NJBBBRZNBVLTRZ-GOSISDBHSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
144679,6w9q,DB06133,-7.4,Dimethylcurcumin,ZMGUKFHHNQMKJI-CIOHCNBKSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
122016,6w4b,DB12743,-7.4,Z-160,VCPMZDWBEWTGNW-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
146744,6w9q,DB08922,-7.4,Perospirone,FBVFZWUMDDXLLG-HDICACEKSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
36866,1r42,DB03501,-7.4,Galactose-uridine-5'-diphosphate,HSCJRCZFDFQWRP-ABVWGUQPSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
98525,6vxs,DB01041,-7.4,Thalidomide,UEJJHQNACJXSKW-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
55614,6crv,DB01204,-7.4,Mitoxantrone,KKZJGLLVHKMTCM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55613,6crv,DB01203,-7.4,Nadolol,VWPOSFSPZNDTMJ-UCWKZMIHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
65389,6lxt,DB02770,-7.4,7-Alpha-D-Ribofuranosyl-2-Aminopurine-5'-Phosphate,UDRQVOJQMHZSIM-PULFBKJNSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
9344,6lzg,DB07435,-7.4,"1,2,3-TRIHYDROXY-1,2,3,4-TETRAHYDROBENZO[A]PYRENE",GFANZDFKCCJYRF-NSISKUIASA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
90221,6m71,DB01469,-7.4,Acetorphine,LFYBMMHFJIAKFE-PMEKXCSPSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
164508,7bv1,DB08087,-7.4,"4-[(7R,7AS)-7-HYDROXY-1,3-DIOXOTETRAHYDRO-1H-PYRROLO[1,2-C]IMIDAZOL-2(3H)-YL]-1-NAPHTHONITRILE",NHBIWLQQJPSMNP-CABCVRRESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
117380,6w4b,DB03397,-7.4,Uridine-Diphosphate-N-Acetylglucosamine,LFTYTUAZOPRMMI-CFRASDGPSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
90232,6m71,DB01481,-7.4,1-Testosterone,OKJCFMUGMSVJBG-ABEVXSGRSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
29183,6cs2,DB00176,-7.4,Fluvoxamine,CJOFXWAVKWHTFT-XSFVSMFZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
144527,6w9q,DB05197,-7.4,Sofalcone,GFWRVVCDTLRWPK-KPKJPENVSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
164519,7bv1,DB08100,-7.4,"2,6-dimethyl-4-[(E)-2-phenylethenyl]phenol",PAHKYLUYTGBFNW-CMDGGOBGSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95345,6m71,DB09299,-7.4,Tenofovir alafenamide,LDEKQSIMHVQZJK-CAQYMETFSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
117411,6w4b,DB03446,-7.4,N-Benzyl-3-(alpha-D-galactopyranosyloxy)benzamide,FSMWGHKWKYCPKE-QTVCLEQKSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
73850,6m2n,DB02568,-7.4,Peldesine,DOHVAKFYAHLCJP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
164525,7bv1,DB08106,-7.4,N-[(6-butoxynaphthalen-2-yl)sulfonyl]-D-glutamic acid,UAGYXJBYAFGRFR-QGZVFWFLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
31803,6cs2,DB14775,-7.4,Cavosonstat,BXSZILNGNMDGSL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
79617,6m2n,DB13514,-7.4,Pranoprofen,TVQZAMVBTVNYLA-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
152200,6wiq,DB03744,-7.4,"Cp403700, (S)-1-{2-[(5-Chloro-1h-Indole-2-Carbonyl)-Amino]-3-Phenyl-Propionyl}-Azetidine-3-Carboxylate",RONLONYAIBUEKT-IBGZPJMESA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
90248,6m71,DB01500,-7.4,Oxabolone,GXHBCWCMYVTJOW-YGRHGMIBSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
90256,6m71,DB01512,-7.4,Hydromorphinol,AABLHGPVOULICI-BRJGLHKUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
117417,6w4b,DB03453,-7.4,Methyl (2S)-2-[[2-[(3R)-1-carbamimidoylpiperidin-3-yl]acetyl]amino]-3-[4-(2-phenylethynyl)phenyl]propanoate,MRNGXYMKYHNMLV-PKTZIBPZSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
164532,7bv1,DB08113,-7.4,3-pyridin-4-yl-1H-indazole,MSRXUUDVRNWSTN-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
73860,6m2n,DB02583,-7.4,"N6-(2,5-Dimethoxy-Benzyl)-N6-Methyl-Pyrido[2,3-D]Pyrimidine-2,4,6-Triamine",HZTFNSCZLJLPEO-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
63353,6lxt,DB00177,-7.4,Valsartan,ACWBQPMHZXGDFX-QFIPXVFZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
122100,6w4b,DB12885,-7.4,CF-102,IPSYPUKKXMNCNQ-PFHKOEEOSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
122093,6w4b,DB12877,-7.4,Oxatomide,BAINIUMDFURPJM-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
152212,6wiq,DB03758,-7.4,Radicicol,WYZWZEOGROVVHK-GTMNPGAYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
146762,6w9q,DB08951,-7.4,Indoprofen,RJMIEHBSYVWVIN-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
146748,6w9q,DB08931,-7.4,Riociguat,WXXSNCNJFUAIDG-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
117866,6w4b,DB04064,-7.4,Nogalaviketone,QHNJNOBWURJIEK-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
9305,6lzg,DB07393,-7.4,"2-(2-PHENYL-3-PYRIDIN-2-YL-4,5,6,7-TETRAHYDRO-2H-ISOPHOSPHINDOL-1-YL)PYRIDINE",GSKNNHAAFLPYHG-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
98245,6vxs,DB00716,-7.4,Nedocromil,RQTOOFIXOKYGAN-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
164703,7bv1,DB08503,-7.4,"(3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(4-methylphenyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol",HRCKGDOSPBFICB-MZHQWRCYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97640,6m71,DB15317,-7.4,Posiphen,PBHFNBQPZCRWQP-AZUAARDMSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
68185,6lxt,DB07624,-7.4,"1-{[(3R)-3-methyl-4-({4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]phenyl}sulfonyl)piperazin-1-yl]methyl}cyclopropanecarboxamide",YJFULAYRAKPBCY-DYVFJYSZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
154169,6wiq,DB07557,-7.4,"(5BETA)-PREGNANE-3,20-DIONE",XMRPGKVKISIQBV-XWOJZHJZSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
13469,6lzg,DB15418,-7.4,AZD-9977,MBKYLPOPYYLTNW-ZDUSSCGKSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
78865,6m2n,DB12378,-7.4,Apricoxib,JTMITOKKUMVWRT-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
164887,7bv1,DB08915,-7.4,Aleglitazar,DAYKLWSKQJBGCS-NRFANRHFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
67385,6lxt,DB06609,-7.4,Odiparcil,JRHNIQQUVJOPQC-AQNFWKISSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
68166,6lxt,DB07602,-7.4,S-{3-[(4-ANILINOQUINAZOLIN-6-YL)AMINO]-3-OXOPROPYL}-L-CYSTEINE,NLVZTRZPMRTVRC-INIZCTEOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
64057,6lxt,DB01013,-7.4,Clobetasol propionate,CBGUOGMQLZIXBE-XGQKBEPLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
120959,6w4b,DB09200,-7.4,Rivoglitazone,XMSXOLDPMGMWTH-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
74135,6m2n,DB02947,-7.4,2-Fluoro-2'-Deoxyadenosine,ZWPYUXAXLRFWQC-KVQBGUIXSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
90923,6m71,DB02382,-7.4,Namn,JOUIQRNQJGXQDC-ZYUZMQFOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
146358,6w9q,DB08436,-7.4,"8-BENZO[1,3]DIOXOL-,5-YLMETHYL-9-BUTYL-9H-",JCDXXNIRWRRGBX-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
97649,6m71,DB15334,-7.4,Biochanin A,WUADCCWRTIWANL-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
10541,6lzg,DB08747,-7.4,"(11R)-10-acetyl-11-(2,4-dichlorophenyl)-6-hydroxy-3,3-dimethyl-2,3,4,5,10,11-hexahydro-1H-dibenzo[b,e][1,4]diazepin-1-one",JJTPPGUNMJMPLY-QFIPXVFZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
78843,6m2n,DB12343,-7.4,Temocillin,BVCKFLJARNKCSS-DWPRYXJFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
28404,6cs2,DB00736,-7.4,Esomeprazole,SUBDBMMJDZJVOS-DEOSSOPVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
31480,6cs2,DB13866,-7.4,Etynodiol,JYILPERKVHXLNF-QMNUTNMBSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
97591,6m71,DB15221,-7.4,PF-06260414,ZKAVFOXYJCREBQ-SNVBAGLBSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
78816,6m2n,DB12305,-7.4,Dasotraline,SRPXSILJHWNFMK-MEDUHNTESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
120931,6w4b,DB09171,-7.4,??-Methylfentanyl,UXIGUKSHASXDNI-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
78806,6m2n,DB12291,-7.4,Tacedinaline,VAZAPHZUAVEOMC-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
146347,6w9q,DB08423,-7.4,[5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL][3-(PIPERIDIN-4-YLOXY)PHENYL]METHANONE,QKZZJXRGCHXIAI-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
28421,6cs2,DB08009,-7.4,"5-[(E)-(5-CHLORO-2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]-N-[2-(DIETHYLAMINO)ETHYL]-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXAMIDE",XPLJEFSRINKZLC-ATVHPVEESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
13495,6lzg,DB01132,-7.4,Pioglitazone,HYAFETHFCAUJAY-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
9515,6lzg,DB07624,-7.4,"1-{[(3R)-3-methyl-4-({4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]phenyl}sulfonyl)piperazin-1-yl]methyl}cyclopropanecarboxamide",YJFULAYRAKPBCY-DYVFJYSZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
120902,6w4b,DB09095,-7.4,Difluocortolone,OGPWIDANBSLJPC-RFPWEZLHSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
31464,6cs2,DB13845,-7.4,Etafenone,OEGDFSLNGABBKJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
31483,6cs2,DB13871,-7.4,Albendazole oxide,VXTGHWHFYNYFFV-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
78789,6m2n,DB12271,-7.4,ORE-1001,NTCCRGGIJNDEAB-IRXDYDNUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
55036,6crv,DB00532,-7.4,Mephenytoin,GMHKMTDVRCWUDX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
146369,6w9q,DB08448,-7.4,"(4aS)-5-[(2,4-diaminopteridin-6-yl)methyl]-4a,5-dihydro-2H-dibenzo[b,f]azepin-8-ol",PCBWLKUEKANDCL-INIZCTEOSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
74113,6m2n,DB02918,-7.4,Zardaverine,HJMQDJPMQIHLPB-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
118276,6w4b,DB04607,-7.4,"PHENYLAMINOIMIDAZO(1,2-ALPHA)PYRIDINE",UQAWGIKJINAKIZ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
90801,6m71,DB02224,-7.4,Taxifolin,CXQWRCVTCMQVQX-LSDHHAIUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97741,6vxs,DB00118,-7.4,Ademetionine,MEFKEPWMEQBLKI-AIRLBKTGSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
97738,6m71,DB13983,-7.4,"5,7,2'-trihydroxy-6,8-dimethoxyflavone",JWOKGWICZPPYPX-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97731,6m71,DB09171,-7.4,β-Methylfentanyl,UXIGUKSHASXDNI-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
77080,6m2n,DB07956,-7.4,[1-(3-CHLORO-2-FORMYL-PHENYLCARBAMOYL)-2-METHYL-PROPYL]-CARBAMIC ACID TERT-BUTYL ESTER,GBHYPZDGTWSQFR-AWEZNQCLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
92440,6m71,DB04409,-7.4,Naphthalene Trisulfonate,ZPBSAMLXSQCSOX-UHFFFAOYSA-K,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
9504,6lzg,DB07613,-7.4,3-phenyl-5-(1H-pyrazol-3-yl)isoxazole,SRSSTOPJERVMRZ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
28362,6cs2,DB00730,-7.4,Thiabendazole,WJCNZQLZVWNLKY-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
77085,6m2n,DB07962,-7.4,"METHYL N-[(2',4'-DIFLUORO-4-HYDROXY-5-IODOBIPHENYL-3-YL)CARBONYL]-BETA-ALANINATE",ZMRRBWRMQPQQAN-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
111524,6vxx,DB03986,-7.4,6-Methyl-Formycin A,UHYKIYIKTWEXSX-LFAOKBQASA-O,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
63979,6lxt,DB00922,-7.4,Levosimendan,WHXMKTBCFHIYNQ-SECBINFHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
28386,6cs2,DB07974,-7.4,1-{2-[(4-CHLOROPHENYL)AMINO]-2-OXOETHYL}-N-(1-ISOPROPYLPIPERIDIN-4-YL)-1H-INDOLE-2-CARBOXAMIDE,BDLMBQRBNPDCSS-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
164861,7bv1,DB08698,-7.4,"1-[(3S)-5-PHENYL-3-THIOPHEN-2-YL-3H-1,4-BENZODIAZEPIN-2-YL]AZETIDIN-3-OL",BKSGACYTXOQQNI-OAQYLSRUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
121117,6w4b,DB11263,-7.4,Polydatin,HSTZMXCBWJGKHG-CUYWLFDKSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
29276,6cs2,DB08961,-7.4,Azosemide,HMEDEBAJARCKCT-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
77086,6m2n,DB07963,-7.4,"N-[(2',4'-DIFLUORO-4-HYDROXY-5-IODOBIPHENYL-3-YL)CARBONYL]-BETA-ALANINE",YZQVXOZCPWWABX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
67372,6lxt,DB06582,-7.4,Dextofisopam,RUJBDQSFYCKFAA-HNNXBMFYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
64000,6lxt,DB00947,-7.4,Fulvestrant,VWUXBMIQPBEWFH-WCCTWKNTSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
95681,6m71,DB11789,-7.4,Hyodeoxycholic Acid,DGABKXLVXPYZII-SIBKNCMHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
74126,6m2n,DB02934,-7.4,9-(6-deoxy-alpha-L-talofuranosyl)-6-methylpurine,XJZDIUOABWMPLZ-DSBXBFMBSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
68203,6lxt,DB07644,-7.4,"5-[(1S)-1-(3-chlorophenyl)ethoxy]quinazoline-2,4-diamine",IDHINEMSCUFEIP-VIFPVBQESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
121031,6w4b,DB09304,-7.4,Setiptiline,GVPIXRLYKVFFMK-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
64008,6lxt,DB00956,-7.4,Hydrocodone,LLPOLZWFYMWNKH-CMKMFDCUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
13443,6lzg,DB15360,-7.4,"Carfentanil, C-11",YDSDEBIZUNNPOB-JVVVGQRLSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
68201,6lxt,DB07642,-7.4,"5-{[1-(2-fluorobenzyl)piperidin-4-yl]methoxy}quinazoline-2,4-diamine",GYKIQIOWVKCVBP-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
90854,6m71,DB02292,-7.4,Irosustat,DSLPMJSGSBLWRE-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
55067,6crv,DB00571,-7.4,Propranolol,AQHHHDLHHXJYJD-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55093,6crv,DB00600,-7.4,Monobenzone,VYQNWZOUAUKGHI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
54985,6crv,DB00468,-7.4,Quinine,LOUPRKONTZGTKE-WZBLMQSHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
154145,6wiq,DB07530,-7.4,"(1R,3R)-5-[(2E)-3-{(1S,3R)-2,2,3-trimethyl-3-[6,6,6-trifluoro-5-hydroxy-5-(trifluoromethyl)hex-3-yn-1-yl]cyclopentyl}prop-2-en-1-ylidene]cyclohexane-1,3-diol",PCHUQQNKOFNVDU-OSXMSNBXSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
10503,6lzg,DB08710,-7.4,"(5Z)-5-[(5-ETHYL-2-FURYL)METHYLENE]-2-{[(S)-(4-FLUOROPHENYL)(1H-TETRAZOL-5-YL)METHYL]AMINO}-1,3-THIAZOL-4(5H)-ONE",BKZOQCGDCHOGOQ-MZLJFPOFSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
54895,6crv,DB00357,-7.4,Aminoglutethimide,ROBVIMPUHSLWNV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
146327,6w9q,DB08397,-7.4,6-(DIFLUORO-PHOSPHONO-METHYL)-NAPHTHALENE-2-CARBOXYLIC ACID,NKGNOWNPXBURRW-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
28608,6cs2,DB08198,-7.4,"[(4R)-4-(3-HYDROXYPHENYL)-1,6-DIMETHYL-2-THIOXO-1,2,3,4-TETRAHYDROPYRIMIDIN-5-YL](PHENYL)METHANONE",JGBBILLMZPWNFU-QGZVFWFLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
111452,6vxx,DB03890,-7.4,N-[2-(1-Formyl-2-Methyl-Propyl)-1-(4-Piperidin-1-Yl-but-2-Enoyl)-Pyrrolidin-3-Yl]-Methanesulfonamide,BSBJWRKWANAVRQ-POTLKAILSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
54885,6crv,DB00346,-7.4,Alfuzosin,WNMJYKCGWZFFKR-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111450,6vxx,DB03887,-7.4,Alpha-Adenosine Monophosphate,NVOIXARBSSLBAS-CRKDRTNXSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
68092,6lxt,DB07512,-7.4,7-[(3-CHLOROBENZYL)OXY]-2-OXO-2H-CHROMENE-4-CARBALDEHYDE,ZOCADHRNWNJARU-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
95739,6m71,DB11872,-7.4,ZD-6126,UGBMEXLBFDAOGL-INIZCTEOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
164974,7bv1,DB09022,-7.4,Benfluorex,CJAVTWRYCDNHSM-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
28495,6cs2,DB08084,-7.4,IDD594,JCZUIWYXULSXSW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
111445,6vxx,DB03881,-7.4,"(2S,3R,4S,5S)-3,4-Dihydroxy-2-[(methylsulfanyl)methyl]-5-(4-oxo-4,5-dihydro-1H-pyrrolo[3,2-d]pyrimidin-7-yl)pyrrolidinium",CEGIKIXYDFDYDN-RXDXJJGDSA-O,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108767,6vxx,DB08936,-7.4,Chlorcyclizine,WFNAKBGANONZEQ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
64095,6lxt,DB01058,-7.4,Praziquantel,FSVJFNAIGNNGKK-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
54874,6crv,DB00333,-7.4,Methadone,USSIQXCVUWKGNF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29301,6cs2,DB08986,-7.4,Etifoxine,IBYCYJFUEJQSMK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
120652,6w4b,DB08745,-7.4,4-[[(1E)-2-(4-CHLOROPHENYL)ETHENYL]SULFONYL]-1-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]PIPERAZINONE,QLHUDNKWOSQSMK-CXUHLZMHSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
78622,6m2n,DB12027,-7.4,Serdemetan,CEGSUK1LWKJP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
108772,6vxx,DB08943,-7.4,Isoconazole,MPIPASJGOJYODL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
64105,6lxt,DB01068,-7.4,Clonazepam,DGBIGWXXNGSACT-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
7674,6lzg,DB04196,-7.4,Pteroic Acid,JOAQINSXLLMRCV-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
91089,6m71,DB02593,-7.4,"7,8-Dihydroxy-1-Methoxy-3-Methyl-10-Oxo-4,10-Dihydro-1h,3h-Pyrano[4,3-B]Chromene-9-Carboxylic Acid",RSFJMLCZHPZXCW-AANKLQPISA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
146302,6w9q,DB08366,-7.4,"3-({3-[(1S,4aS,6S,7S,9S,9aR)-1,6-dimethyl-2-oxodecahydro-6,9-epoxy-4a,7-methanobenzo[7]annulen-1-yl]propanoyl}amino)-2,4-dihydroxybenzoic acid",XADCWKSMHQPTGH-OFBLZTNGSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
77136,6m2n,DB08017,-7.4,3-METHOXY-6-[4-(3-METHYLPHENYL)-1-PIPERAZINYL]PYRIDAZINE,DDOAUTHWSCUHQA-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
120615,6w4b,DB08707,-7.4,"4-[3-(4-chlorophenyl)-2,1-benzisoxazol-5-yl]pyrimidin-2-amine",AQVFETGXIRKVAQ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
145139,6w9q,DB07006,-7.4,"9-HYDROXY-6-(3-HYDROXYPROPYL)-4-(2-METHOXYPHENYL)PYRROLO[3,4-C]CARBAZOLE-1,3(2H,6H)-DIONE",AOGOZJCRIFBTTN-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
120613,6w4b,DB08705,-7.4,"6-(5-BROMO-2-HYDROXYPHENYL)-2-OXO-4-PHENYL-1,2-DIHYDROPYRIDINE-3-CARBONITRILE",SVSYJTYGPLVUOZ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
154045,6wiq,DB07410,-7.4,[2-(3-DIBENZOFURAN-4-YL-PHENYL)-1-HYDROXY-1-PHOSPHONO-ETHYL]-PHOSPHONIC ACID,BYVXAUZOTGITQZ-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
120656,6w4b,DB08749,-7.4,3-(2-AMINO-6-BENZOYLQUINAZOLIN-3(4H)-YL)-N-CYCLOHEXYL-N-METHYLPROPANAMIDE,KTRFBFMYAJOXLG-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
74164,6m2n,DB02984,-7.4,"4-[3-Methylsulfanylanilino]-6,7-Dimethoxyquinazoline",FUSDVOSGGMBSMK-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
145108,6w9q,DB06971,-7.4,"N-{2-[(4'-CYANO-1,1'-BIPHENYL-4-YL)OXY]ETHYL}-N'-HYDROXY-N-METHYLUREA",GVMUNGGWXRKCEU-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
145099,6w9q,DB06959,-7.4,(2S)-1-(3H-Indol-3-yl)-3-{[5-(6-isoquinolinyl)-3-pyridinyl]oxy}-2-propanamine,BUCZDJYEOAQTHL-KEKNWZKVSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
29287,6cs2,DB08972,-7.4,Flumequine,DPSPPJIUMHPXMA-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
154136,6wiq,DB07519,-7.4,"(6R)-2-amino-6-[2-(3'-methoxybiphenyl-3-yl)ethyl]-3,6-dimethyl-5,6-dihydropyrimidin-4(3H)-one",VDFBMQAUECXNKR-OAQYLSRUSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
37155,1r42,DB03893,-7.4,Thionicotinamide-Adenine-Dinucleotide,UQYPZLRUJKCREN-NNYOXOHSSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
64081,6lxt,DB01041,-7.4,Thalidomide,UEJJHQNACJXSKW-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
68137,6lxt,DB07564,-7.4,"6-amino-2-[(2-morpholin-4-ylethyl)amino]-3,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",JUHXOBNFTFUPKQ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
118357,6w4b,DB04716,-7.4,"2-(1,1-DIMETHYLETHYL)9-FLUORO-3,6-DIHYDRO-7H-BENZ[H]-IMIDAZ[4,5-F]ISOQUINOLIN-7-ONE",VNDWQCSOSCCWIP-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
68126,6lxt,DB07550,-7.4,"2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(1-OXIDO-2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUOROPHENYL)METHYL]ACETAMIDE",ZIGSBBKEPNQXRG-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
430,6lzg,HMDB0005006,-7.4,Atorvastatin,XUKUURHRXDUEBC-KAYWLYCHSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
91023,6m71,DB02505,-7.4,N-(R-Carboxy-Ethyl)-Alpha-(S)-(2-Phenylethyl),JJVQUUYZGJWBPW-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
68110,6lxt,DB07533,-7.4,"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]-2-FURYL}-N-METHYLBENZENESULFONAMIDE",FJJJERLTHDXEPT-JYRVWZFOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
111489,6vxx,DB03938,-7.4,Deacetoxycephalosporin-C,NNQIJOYQWYKBOW-JWKOBGCHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78725,6m2n,DB12181,-7.4,Dalcetrapib,YZQLWPMZQVHJED-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
120816,6w4b,DB08974,-7.4,Flubendazole,CPEUVMUXAHMANV-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
78674,6m2n,DB12106,-7.4,PF-06305591,APWZIFIAVVFPNT-PELKAZGASA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
74178,6m2n,DB03005,-7.4,"3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-5-Yl]Hexyl]-Phenanthridinium",ISUOMOOYAOQQPZ-UHFFFAOYSA-O,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
164938,7bv1,DB08984,-7.4,Etofenamate,XILVEPYQJIOVNB-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
146329,6w9q,DB08399,-7.4,PICEATANNOL,CDRPUGZCRXZLFL-OWOJBTEDSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
164944,7bv1,DB08990,-7.4,Eprazinone,BSHWLCACYCVCJE-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
78709,6m2n,DB12153,-7.4,Citicoline,RZZPDXZPRHQOCG-OJAKKHQRSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
54917,6crv,DB00384,-7.4,Triamterene,FNYLWPVRPXGIIP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
91050,6m71,DB02538,-7.4,"N-[4-(2-Methylimidazo[1,2-a]Pyridin-3-Yl)-2-Pyrimidinyl]Acetamide",ZCRPPLDDHBLUES-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97565,6m71,DB15170,-7.4,Evobrutinib,QUIWHXQETADMGN-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
10517,6lzg,DB08724,-7.4,5-(5-(4-(5-hydro-4-methyl-2-oxazolyl)phenoxy)pentyl)-3-methyl isoxazole,UXIYKMARWUSIKU-HNNXBMFYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
120763,6w4b,DB08899,-7.4,Enzalutamide,WXCXUHSOUPDCQV-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
120755,6w4b,DB08883,-7.4,Perampanel,PRMWGUBFXWROHD-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
13509,6lzg,DB01148,-7.4,Flavoxate,SPIUTQOUKAMGCX-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
92393,6m71,DB04342,-7.4,7-((Carboxy(4-Hydroxyphenyl)Acetyl)Amino)-7-Methoxy-(3-((1-Methyl-1h-Tetrazol-5-Yl)Thio)Methyl)-8-Oxo-5-Oxa-1-Azabicyclo[4.2.0]Oct-2-Ene-2-Carboxylic Acid,JWCSIUVGFCSJCK-LIUKBUMOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
108742,6vxx,DB08895,-7.4,Tofacitinib,UJLAWZDWDVHWOW-YPMHNXCESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31437,6cs2,DB13815,-7.4,Xenysalate,HLDCSYXMVXILQC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
78906,6m2n,DB12429,-7.4,CI-1040,GFMMXOIFOQCCGU-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
28348,6cs2,DB07935,-7.4,"5-[(5-fluoro-3-methyl-1H-indazol-4-yl)oxy]benzene-1,3-dicarbonitrile",JYAHFMKZJRVTDT-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
31524,6cs2,DB13956,-7.4,Estradiol valerate,RSEPBGGWRJCQGY-RBRWEJTLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
63676,6lxt,DB00567,-7.4,Cephalexin,ZAIPMKNFIOOWCQ-UEKVPHQBSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
55265,6crv,DB00809,-7.4,Tropicamide,BGDKAVGWHJFAGW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28270,6cs2,DB07852,-7.4,"1-(3,5-DICHLOROPHENYL)-5-METHYL-1H-1,2,4-TRIAZOLE-3-CARBOXYLIC ACID",CZTNDZALWLHXBA-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
63677,6lxt,DB00568,-7.4,Cinnarizine,DERZBLKQOCDDDZ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
92604,6m71,DB04624,-7.4,DERIVATIVE OF AKLANONIC ACID METHYL ESTER (AAME),SIHNJMGWRHPFAZ-XHDPSFHLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
146526,6w9q,DB08639,-7.4,Dapivirine,ILAYIAGXTHKHNT-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
76956,6m2n,DB07810,-7.4,"3-(4-HYDROXYPHENYL)-1-(2,4,6-TRIHYDROXYPHENYL)PROPAN-1-ONE",VGEREEWJJVICBM-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
10651,6lzg,DB08882,-7.4,Linagliptin,LTXREWYXXSTFRX-QGZVFWFLSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
63693,6lxt,DB00587,-7.4,Cinalukast,BZMKNPGKXJAIDV-VAWYXSNFSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
29478,6cs2,DB09231,-7.4,Benidipine,QZVNQOLPLYWLHQ-ZEQKJWHPSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
63695,6lxt,DB00589,-7.4,Lisuride,BKRGVLQUQGGVSM-KBXCAEBGSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
154428,6wiq,DB07861,-7.4,(2R)-N-hydroxy-3-naphthalen-2-yl-2-[(naphthalen-2-ylsulfonyl)amino]propanamide,MMOUXLMPQFMDRD-JOCHJYFZSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
121481,6w4b,DB11952,-7.4,Duvelisib,SJVQHLPISAIATJ-ZDUSSCGKSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
90589,6m71,DB01944,-7.4,(S)-blebbistatin,LZAXPYOBKSJSEX-GOSISDBHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
98120,6vxs,DB00567,-7.4,Cephalexin,ZAIPMKNFIOOWCQ-UEKVPHQBSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
98118,6vxs,DB00564,-7.4,Carbamazepine,FFGPTBGBLSHEPO-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
68323,6lxt,DB07787,-7.4,"5-FLUORO-1-[4-(4-PHENYL-3,6-DIHYDROPYRIDIN-1(2H)-YL)BUTYL]QUINAZOLINE-2,4(1H,3H)-DIONE",PNPFDRCIGCUCMN-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
121472,6w4b,DB11942,-7.4,Selinexor,DEVSOMFAQLZNKR-RJRFIUFISA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
55231,6crv,DB00767,-7.4,Benzquinamide,JSZILQVIPPROJI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
90649,6m71,DB02021,-7.4,Fidarestat,WAAPEIZFCHNLKK-UFBFGSQYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95594,6m71,DB11662,-7.4,Rabusertib,SYYBDNPGDKKJDU-ZDUSSCGKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
31585,6cs2,DB14068,-7.4,Dexniguldipine,SVJMLYUFVDMUHP-MGBGTMOVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
68313,6lxt,DB07775,-7.4,"3',5'-DIBROMO-2',4,4',6'-TETRAHYDROXY AURONE",BRPKBUNFOZFULQ-SGAXSIHGSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
20637,6cs2,HMDB0048039,-7.4,"TG(14:1(9Z)/22:1(13Z)/18:3(9Z,12Z,15Z))",CSWKLJWLTNNDPE-OCOJWXJXSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
164796,7bv1,DB08614,-7.4,"3-[[(METHYLAMINO)SULFONYL]AMINO]-2-OXO-6-PHENYL-N-[3,3,3-TRIFLUORO-1-(1-METHYLETHYL)-2-OXOPHENYL]-1(2H)-PYRIDINE ACETAMIDE",MYFMPKCOIMRDDD-KRWDZBQOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
28287,6cs2,DB07868,-7.4,6-CHLORO-4-(CYCLOHEXYLSULFANYL)-3-PROPYLQUINOLIN-2(1H)-ONE,CLKFNGKDJYMUPK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
121431,6w4b,DB11883,-7.4,SB-705498,JYILLRHXRVTRSH-GFCCVEGCSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
68301,6lxt,DB07761,-7.4,"(2R)-1-[4-({6-[(2,6-Difluorophenyl)amino]-4-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol",ZVSBKYYVBCKDBO-OAHLLOKOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
121478,6w4b,DB11949,-7.4,Vestipitant,SBBYBXSFWOLDDG-JLTOFOAXSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
146486,6w9q,DB08588,-7.4,2-({2-[(3R)-3-AMINOPIPERIDIN-1-YL]-4-OXOQUINAZOLIN-3(4H)-YL}METHYL)BENZONITRILE,OYNURZXTLNNKAP-QGZVFWFLSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
164754,7bv1,DB08562,-7.4,4-(4-STYRYL-PHENYLCARBAMOYL)-BUTYRIC ACID,FTXJWRRYLLRFMG-MDZDMXLPSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
98165,6vxs,DB00621,-7.4,Oxandrolone,QSLJIVKCVHQPLV-PEMPUTJUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
90532,6m71,DB01858,-7.4,[1-(4-Fluorobenzyl)Cyclobutyl]Methyl (1s)-1-[Oxo(1h-Pyrazol-5-Ylamino)Acetyl]Pentylcarbamate,QTPYRNAKLBXKNP-SFHVURJKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
145090,6w9q,DB06945,-7.4,N-hydroxy-4-({4-[4-(trifluoromethyl)phenoxy]phenyl}sulfonyl)tetrahydro-2H-pyran-4-carboxamide,FOSWRYKPHVPIDJ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
90533,6m71,DB01859,-7.4,4-Diphosphocytidyl-2-C-Methyl-D-Erythritol 2-Phosphate,HTJXTKBIUVFUAR-XHIBXCGHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
98241,6vxs,DB00712,-7.4,Flurbiprofen,SYTBZMRGLBWNTM-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
79220,6m2n,DB12925,-7.4,Crolibulin,JXONINOYTKKXQQ-CQSZACIVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
55303,6crv,DB00850,-7.4,Perphenazine,RGCVKNLCSQQDEP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31629,6cs2,DB01074,-7.4,Perhexiline,CYXKNKQEMFBLER-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
98236,6vxs,DB00706,-7.4,Tamsulosin,DRHKJLXJIQTDTD-OAHLLOKOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
164725,7bv1,DB08530,-7.4,"7-BENZYL-1,3-DIMETHYL-8-PIPERAZIN-1-YL-3,7-DIHYDRO-PURINE-2,6-DIONE",QFSMMXJBEBXTJP-UHFFFAOYSA-O,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
68387,6lxt,DB07858,-7.4,(2S)-2-(4-chlorophenyl)-2-[4-(1H-pyrazol-4-yl)phenyl]ethanamine,HWVGILTYGZFGLR-KRWDZBQOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
152472,6wiq,DB04098,-7.4,Balanol,XYUFCXJZFZPEJD-PGRDOPGGSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
10670,6lzg,DB08911,-7.4,Trametinib,LIRYPHYGHXZJBZ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
79192,6m2n,DB12884,-7.4,Lavoltidine,VTLNPNNUIJHJQB-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
63671,6lxt,DB00559,-7.4,Bosentan,GJPICJJJRGTNOD-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
154519,6wiq,DB07969,-7.4,3-[3-(4-methylpiperazin-1-yl)-7-(trifluoromethyl)quinoxalin-5-yl]phenol,QNCYYRHIUFGGJX-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
92607,6m71,DB04628,-7.4,Allosamidin,MDWNFWDBQGOKNZ-XYUDZHFQSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
111786,6vxx,DB04517,-7.4,Dipyrromethane Cofactor,LCAXMKQKEYTFDM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76932,6m2n,DB07785,-7.4,"1-{(1R,2S)-2-HYDROXY-1-[2-(2-NAPHTHYLOXY)ETHYL]PROPYL}-1H-IMIDAZONE-4-CARBOXAMIDE",UYAJDVNLQJVRHD-SCLBCKFNSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
146571,6w9q,DB08694,-7.4,"9-amino-5-(2-aminopyrimidin-4-yl)pyrido[3',2':4,5]pyrrolo[1,2-c]pyrimidin-4-ol",RTHKPHCVZVYDFN-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
68375,6lxt,DB07844,-7.4,6-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1-BENZOTHIOPHENE-2-SULFONAMIDE,PHLKBODTBJLXRD-WFASDCNBSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
98200,6vxs,DB00665,-7.4,Nilutamide,XWXYUMMDTVBTOU-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
10665,6lzg,DB08906,-7.4,Fluticasone furoate,XTULMSXFIHGYFS-VLSRWLAYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
68374,6lxt,DB07843,-7.4,5-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1-BENZOTHIOPHENE-2-SULFONAMIDE,LTJNKFUIOOJXNJ-WFASDCNBSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
121542,6w4b,DB12048,-7.4,Savolitinib,XYDNMOZJKOGZLS-NSHDSACASA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
9436,6lzg,DB07536,-7.4,"N-{(1S,2R)-2-hydroxy-1-[(hydroxyamino)carbonyl]propyl}-4-{[4-(morpholin-4-ylmethyl)phenyl]ethynyl}benzamide",FQYBTYFKOHPWQT-VGSWGCGISA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
63649,6lxt,DB00535,-7.4,Cefdinir,RTXOFQZKPXMALH-GHXIOONMSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
98189,6vxs,DB00652,-7.4,Pentazocine,VOKSWYLNZZRQPF-GDIGMMSISA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
90572,6m71,DB01922,-7.4,"Maltosyl-Alpha (1,4)-D-Gluconhydroximo-1,5-Lactam",AHRWQUNEPBVNOT-IVJVVCOPSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
68381,6lxt,DB07851,-7.4,"(3R,4S)-1-(3,4-DIMETHOXYPHENYL)-3-(3-METHYLPHENYL)PIPERIDIN-4-AMINE",DQJXBZGPJVSWFI-ROUUACIJSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
68295,6lxt,DB07755,-7.4,"(2S)-1-[4-({4-[(2,5-Dichlorophenyl)amino]-2-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol",GNLAGGCSJGJECE-INIZCTEOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
79040,6m2n,DB12641,-7.4,Tedatioxetine,CVASBKDYSQKLSO-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
98035,6vxs,DB00459,-7.4,Acitretin,IHUNBGSDBOWDMA-AQFIFDHZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
154277,6wiq,DB07689,-7.4,"METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE",NYNAFINLHQEHKU-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
63904,6lxt,DB00839,-7.4,Tolazamide,OUDSBRTVNLOZBN-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
97858,6vxs,DB00248,-7.4,Cabergoline,KORNTPPJEAJQIU-KJXAQDMKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
121295,6w4b,DB11682,-7.4,Daprodustat,RUEYEZADQJCKGV-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
63906,6lxt,DB00842,-7.4,Oxazepam,ADIMAYPTOBDMTL-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
55131,6crv,DB00648,-7.4,Mitotane,JWBOIMRXGHLCPP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
121287,6w4b,DB11672,-7.4,Curcumin,VFLDPWHFBUODDF-FCXRPNKRSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
92492,6m71,DB04480,-7.4,"3-(4-Fluorophenyl)-2-(6-Methylpyridin-2-Yl)-5,6-Dihydro-4h-Pyrrolo[1,2-B]Pyrazole",NBDZLUOYAAVYHF-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
121280,6w4b,DB11663,-7.4,Pictilisib,LHNIIDJUOCFXAP-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
95655,6m71,DB11750,-7.4,Clobetasol,FCSHDIVRCWTZOX-DVTGEIKXSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
152747,6wiq,DB04471,-7.4,"2-Phenyl-1-[4-(2-Piperidin-1-Yl-Ethoxy)-Phenyl]-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol",FMWVCTJKLAVRPB-MUUNZHRXSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
10587,6lzg,DB08796,-7.4,Pipazethate,DTVJXCOMJLLMAK-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
55120,6crv,DB00633,-7.4,Dexmedetomidine,CUHVIMMYOGQXCV-NSHDSACASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
164833,7bv1,DB08660,-7.4,"1,2,5,8-tetrahydroxyanthracene-9,10-dione",VBHKTXLEJZIDJF-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
146406,6w9q,DB08493,-7.4,"5-METHYL-3-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.013,18]NONADECA-12(19),13,15,17-TETRAEN-10-YLCARBAMOYL)-HEXANOIC ACID",AKWKBACKRMYPRV-NQIIRXRSSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
78918,6m2n,DB12445,-7.4,Nitroaspirin,IOJUJUOXKXMJNF-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
108590,6vxx,DB08434,-7.4,2-METHYLCARBAMOYL-3-(4-PHOSPHONOOXY-PHENYL)-CYCLOPROPANECARBOXYLIC ACID,GIIUHKRUTUSHAB-IVZWLZJFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
97831,6vxs,DB00218,-7.4,Moxifloxacin,FABPRXSRWADJSP-MEDUHNTESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
121261,6w4b,DB11625,-7.4,Perflenapent,NJCBUSHGCBERSK-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
108595,6vxx,DB08440,-7.4,"N-1,10-phenanthrolin-5-ylacetamide",AAJXINSCZMZERD-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
74108,6m2n,DB02911,-7.4,"2,4-Diamino-6-Phenyl-5,6,7,8,-Tetrahydropteridine",VEKRIXRQADJFAG-QMMMGPOBSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
97819,6vxs,DB00203,-7.4,Sildenafil,BNRNXUUZRGQAQC-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
164842,7bv1,DB08673,-7.4,"4-[(5-ISOPROPYL-1,3-THIAZOL-2-YL)AMINO]BENZENESULFONAMIDE",LPQUJAANWFHCJV-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
108606,6vxx,DB08451,-7.4,N-(QUINOLIN-8-YL)METHANESULFONAMIDE,XYEPUTZVZYUENX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108609,6vxx,DB08457,-7.4,"4-(3,5-DIMETHYLPHENOXY)-5-(FURAN-2-YLMETHYLSULFANYLMETHYL)-3-IODO-6-METHYLPYRIDIN-2(1H)-ONE",YZLKVEDFWLGNQP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
9483,6lzg,DB07588,-7.4,"3,4-DI-1H-INDOL-3-YL-1H-PYRROLE-2,5-DICARBOXYLIC ACID",FZDVNXHYGMEEDT-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
121235,6w4b,DB11551,-7.4,Trenbolone,MEHHPFQKXOUFFV-OWSLCNJRSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
31525,6cs2,DB13957,-7.4,J147,HYMZAYGFKNNHDN-SSDVNMTOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
13398,6lzg,DB15287,-7.4,Elismetrep,CWEFDWIKLABKBX-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
165732,7bv1,DB12725,-7.4,TD-8954,MZOITCJKGUIQEI-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
154278,6wiq,DB07691,-7.4,"2-({[3-(3,4-dihydroisoquinolin-2(1H)-ylsulfonyl)phenyl]carbonyl}amino)benzoic acid",GYILVHHTCYNIOS-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
97911,6vxs,DB00310,-7.4,Chlorthalidone,JIVPVXMEBJLZRO-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
111690,6vxx,DB04386,-7.4,"4,6-O-(1-Carboxyethylidene)-Beta-D-Glucose",QVVFNJUJKXWFAU-CECBSOHTSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31567,6cs2,DB14037,-7.4,Madecassic acid,PRAUVHZJPXOEIF-AOLYGAPISA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
79020,6m2n,DB12605,-7.4,Etripamil,VAZNEHLGJGSQEL-MHZLTWQESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
29259,6cs2,DB08942,-7.4,Isoxicam,YYUAYBYLJSNDCX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
10619,6lzg,DB08833,-7.4,Taurochenodeoxycholic acid,BHTRKEVKTKCXOH-BJLOMENOSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
98020,6vxs,DB00443,-7.4,Betamethasone,UREBDLICKHMUKA-DVTGEIKXSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
63801,6lxt,DB00716,-7.4,Nedocromil,RQTOOFIXOKYGAN-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
65256,6lxt,DB02593,-7.4,"7,8-Dihydroxy-1-Methoxy-3-Methyl-10-Oxo-4,10-Dihydro-1h,3h-Pyrano[4,3-B]Chromene-9-Carboxylic Acid",RSFJMLCZHPZXCW-AANKLQPISA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
154368,6wiq,DB07794,-7.4,"5-(2-PHENYLPYRAZOLO[1,5-A]PYRIDIN-3-YL)-1H-PYRAZOLO[3,4-C]PYRIDAZIN-3-AMINE",XVECMUKVOMUNLE-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
154363,6wiq,DB07789,-7.4,"1-[5-methyl-2-(trifluoromethyl)furan-3-yl]-3-[(2Z)-5-(2-{[6-(1H-1,2,4-triazol-3-ylamino)pyrimidin-4-yl]amino}ethyl)-1,3-thiazol-2(3H)-ylidene]urea",KNTGXMNWVXZIMW-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
97994,6vxs,DB00412,-7.4,Rosiglitazone,YASAKCUCGLMORW-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
9468,6lzg,DB07570,-7.4,3-CYCLOHEXYL-1-(2-MORPHOLIN-4-YL-2-OXOETHYL)-2-PHENYL-1H-INDOLE-6-CARBOXYLIC ACID,ZKEZEXYKYHYIMQ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
154346,6wiq,DB07769,-7.4,S-3-(4-FLUOROPHENOXY)-2-HYDROXY-2-METHYL-N-[4-NITRO-3-(TRIFLUOROMETHYL)PHENYL]PROPANAMIDE,KJMFOTCDISOHDX-INIZCTEOSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
55174,6crv,DB00698,-7.4,Nitrofurantoin,NXFQHRVNIOXGAQ-YCRREMRBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108532,6vxx,DB08098,-7.4,"{[5-(5-nitro-2-furyl)-1,3,4-oxadiazol-2-yl]thio}acetic acid",ITBNJCVIFHSKRL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
68270,6lxt,DB07724,-7.4,Indeglitazar,YMPALHOKRBVHOJ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
92521,6m71,DB04518,-7.4,"3-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamino]-Phenol",JJDRRZFRTKZLFT-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
146440,6w9q,DB08532,-7.4,"6-(2-fluorophenyl)-N-(pyridin-3-ylmethyl)imidazo[1,2-a]pyrazin-8-amine",WCNPGRRMPFCHEO-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
97951,6vxs,DB00358,-7.4,Mefloquine,XEEQGYMUWCZPDN-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
14785,6lzg,T3D4745,-7.4,Norethindrone,VIKNJXKGJWUCNN-XGXHKTLJSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
154311,6wiq,DB07729,-7.4,3-fluoro-N-[3-(1H-tetrazol-5-yl)phenyl]benzamide,GAKOBKPDJJGRIL-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
30687,6cs2,DB12840,-7.4,Pirnabine,AADNQNOXNWEYHS-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
9475,6lzg,DB07578,-7.4,"3-[4-(2-METHYL-IMIDAZO[4,5-C]PYRIDIN-1-YL)BENZYL]-3H-BENZOTHIAZOL-2-ONE",WUOLYUKMMRCXGH-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
152690,6wiq,DB04392,-7.4,"Bishydroxy[2h-1-Benzopyran-2-One,1,2-Benzopyrone]",HIZKPJUTKKJDGA-BETUJISGSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
29469,6cs2,DB09219,-7.4,Bisoxatin,BPKUDUSVDVLOPY-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
97926,6vxs,DB00328,-7.4,Indometacin,CGIGDMFJXJATDK-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
164820,7bv1,DB08646,-7.4,TRW3-(2-AMINO-3-HYDROXY-PROPYL)-6-(N'-CYCLOHEXYL-HYDRAZINO)OCTAHYDRO-INDOL-7-OL,PSUOZWHAKZSNOB-LBPRGKRZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
108543,6vxx,DB08373,-7.4,"4,4'-BIS([H]METHYLSULFONYL)-2,2',5,5'-TETRACHLOROBIPHENYL",RDBKPLOYRMCFIY-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165734,7bv1,DB12728,-7.4,Fenpropidin,MGNFYQILYYYUBS-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
90528,6m71,DB01852,-7.4,Kaempherol,IYRMWMYZSQPJKC-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
124406,6w4h,DB01113,-7.4,Papaverine,XQYZDYMELSJDRZ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131512,6w4h,DB13841,-7.4,Clopenthixol,WFPIAZLQTJBIFN-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
65671,6lxt,DB03148,-7.4,Phosphomethylphosphonic Acid Adenosyl Ester,OLCWZBFDIYXLAA-IOSLPCCCSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
33768,6cs2,T3D0446,-7.4,"2,3,3',5-Tetrachlorobiphenyl",DHDBTLFALXRTLB-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
134909,6w9c,DB03725,-7.4,Phosphomethylphosphonic Acid-Guanylate Ester,PHBDHXOBFUBCJD-KQYNXXCUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
30104,6cs2,DB12057,-7.4,ORM-12741,OCUKPFWNSAAHRP-QZTJIDSGSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
102555,6vxs,DB07534,-7.4,"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE",BKUMVXIXUVYKDQ-GHXNOFRVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
148521,6w9q,DB13556,-7.4,Sulfamazone,BGLHAKAJGYLSOX-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
102554,6vxs,DB07533,-7.4,"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]-2-FURYL}-N-METHYLBENZENESULFONAMIDE",FJJJERLTHDXEPT-JYRVWZFOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
128989,6w4h,DB08250,-7.4,"(5S)-5-(3-AMINOPROPYL)-3-(2,5-DIFLUOROPHENYL)-N-ETHYL-5-PHENYL-4,5-DIHYDRO-1H-PYRAZOLE-1-CARBOXAMIDE",OQMVLDZJPRSNOG-NRFANRHFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
161295,7bv1,DB13514,-7.4,Pranoprofen,TVQZAMVBTVNYLA-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
102537,6vxs,DB07513,-7.4,7-[(3-CHLOROBENZYL)OXY]-4-[(METHYLAMINO)METHYL]-2H-CHROMEN-2-ONE,JMGUSOLCNQVZCT-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102535,6vxs,DB07511,-7.4,"4-(4-methyl-1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)benzonitrile",MVYDBJXCIFMINH-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
149816,6wiq,DB00620,-7.4,Triamcinolone,GFNANZIMVAIWHM-OBYCQNJPSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
8102,6lzg,DB04770,-7.4,"O6-(R)-ROSCOVITINE, R-2-(6-BENZYLOXY-9-ISOPROPYL-9H-PURIN-2-YLAMINO)-BUTAN-1-OL",HGADNQLEUZSUEJ-OAHLLOKOSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
102534,6vxs,DB07510,-7.4,"3-fluoro-6-(4-fluorophenyl)-2-hydroxy-6-oxohexa-2,4-dienoic acid",CPZFGNOKCMJZFO-BTHQEHEQSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
86581,6m3m,DB09061,-7.4,Cannabidiol,QHMBSVQNZZTUGM-ZWKOTPCHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
161284,7bv1,DB13501,-7.4,Bendazac,BYFMCKSPFYVMOU-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
114553,6vxx,DB13782,-7.4,Imipramine oxide,QZIQORUGXBPDSU-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
128960,6w4h,DB08213,-7.4,"1-METHYL-5-(2-PHENOXYMETHYL-PYRROLIDINE-1-SULFONYL)-1H-INDOLE-2,3-DIONE",PFAYCUAUBOGVDX-AWEZNQCLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
158449,7bv1,DB01196,-7.4,Estramustine,FRPJXPJMRWBBIH-RBRWEJTLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
58540,6crv,DB05824,-7.4,CNS-5161,JHVHEDNLONERHY-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
93310,6m71,DB06777,-7.4,Chenodeoxycholic acid,RUDATBOHQWOJDD-BSWAIDMHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94133,6m71,DB07760,-7.4,"3-[(1E,7E)-8-(2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)-3,6-dioxa-2,7-diazaocta-1,7-dien-1-yl]benzoic acid",TUYDQQMKXSQIQG-GONBZBRSSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
72088,6m2n,DB00321,-7.4,Amitriptyline,KRMDCWKBEZIMAB-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
148500,6w9q,DB13531,-7.4,Nicofetamide,DWODOIKZDGJOPQ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
158448,7bv1,DB01195,-7.4,Flecainide,DJBNUMBKLMJRSA-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
158445,7bv1,DB01192,-7.4,Oxymorphone,UQCNKQCJZOAFTQ-ISWURRPUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
58531,6crv,DB05786,-7.4,Irofulven,NICJCIQSJJKZAH-AWEZNQCLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
33747,6cs2,T3D4996,-7.4,"22,23-dihydroavermectin b1b",VARHUCVRRNANBD-PVVXTEPVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
86588,6m3m,DB09071,-7.4,Tasimelteon,PTOIAAWZLUQTIO-GXFFZTMASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
128931,6w4h,DB08174,-7.4,"5-CHLORO-N-((1R,2S)-2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO) CYCLOPENTYL)THIOPHENE-2-CARBOXAMIDE",QCPYHSAHOYXXQK-DLBZAZTESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
148493,6w9q,DB13520,-7.4,Metergoline,WZHJKEUHNJHDLS-QTGUNEKASA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
161315,7bv1,DB13810,-7.4,Dimemorfan,KBEZZLAAKIIPFK-NJAFHUGGSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
70611,6lxt,DB12927,-7.4,Theodrenaline,WMCMJIGLYZDKRN-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
102579,6vxs,DB07562,-7.4,"N-[4-(2,4-DIMETHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YL]-N',N'-DIMETHYL-BENZENE-1,4-DIAMINE",FGGSNQOBRJVAKL-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
83929,6m3m,DB04543,-7.4,"2,6-Diamino-8-(1h-Imidazol-2-Ylsulfanylmethyl)-3h-Quinazoline-4-One",CEWKWXPCQGWWBM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84006,6m3m,DB04641,-7.4,"3,7-DIHYDROXYNAPHTHALENE-2-CARBOXYLIC ACID",QMWOUSYSNFCKAZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
30095,6cs2,DB12045,-7.4,Mericitabine,MLESJYFEMSJZLZ-MAAOGQSESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
70655,6lxt,DB12998,-7.4,PF-00217830,QGNOXTFZOLDODX-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
129134,6w4h,DB08434,-7.4,2-METHYLCARBAMOYL-3-(4-PHOSPHONOOXY-PHENYL)-CYCLOPROPANECARBOXYLIC ACID,GIIUHKRUTUSHAB-IVZWLZJFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
58621,6crv,DB06211,-7.4,Doripenem,AVAACINZEOAHHE-VFZPANTDSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
70650,6lxt,DB12986,-7.4,VS-5584,QYBGBLQCOOISAR-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
28685,6cs2,DB08292,-7.4,"(5Z)-12-CHLORO-13,15-DIHYDROXY-4,7,8,9-TETRAHYDRO-2-BENZOXACYCLOTRIDECINE-1,10(3H,11H)-DIONE",AQKZYZQONWDDLS-IWQZZHSRSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
60574,6crv,DB08804,-7.4,Nandrolone decanoate,JKWKMORAXJQQSR-MOPIKTETSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
129115,6w4h,DB08409,-7.4,4-NITRO-BENZYLPHOSPHONOBUTANOYL-GLYCINE,LNMNPGKCSJFAGN-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
102647,6vxs,DB07644,-7.4,"5-[(1S)-1-(3-chlorophenyl)ethoxy]quinazoline-2,4-diamine",IDHINEMSCUFEIP-VIFPVBQESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
83995,6m3m,DB04627,-7.4,Cyclouridine,UUGITDASWNOAGG-CCXZUQQUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
149770,6wiq,DB00564,-7.4,Carbamazepine,FFGPTBGBLSHEPO-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
134699,6w9c,DB03420,-7.4,"2,4-Deoxy-4-Guanidino-5-N-Acetyl-Neuraminic Acid",DAAUVSVERFXBSX-IHICSVBISA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
66706,6lxt,DB04542,-7.4,3'-Azido-3'-Deoxythymidine-5'-Diphosphate,QOYVAFWJURKBJG-XLPZGREQSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
86510,6m3m,DB08964,-7.4,Gemeprost,KYBOHGVERHWSSV-VNIVIJDLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
70643,6lxt,DB12974,-7.4,Roniciclib,UELYDGOOJPRWGF-SRQXXRKNSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
35164,1r42,DB01212,-7.4,Ceftriaxone,VAAUVRVFOQPIGI-SPQHTLEESA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
134845,6w9c,DB03641,-7.4,"2'-deoxyuridine 5'-alpha,beta-imido-diphosphate",COFNIXBQVWFHTR-SHYZEUOFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
58576,6crv,DB06106,-7.4,AIT-034,FBVDVFULNXWYRF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
129037,6w4h,DB08313,-7.4,nocodazole,KYRVNWMVYQXFEU-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
25404,6cs2,DB00405,-7.4,Dexbrompheniramine,ZDIGNSYAACHWNL-HNNXBMFYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
72053,6m2n,DB00279,-7.4,Liothyronine,AUYYCJSJGJYCDS-LBPRGKRZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
58588,6crv,DB06150,-7.4,Sulfadimethoxine,ZZORFUFYDOWNEF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113442,6vxx,DB09194,-7.4,Etoperidone,IZBNNCFOBMGTQX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
102601,6vxs,DB07589,-7.4,"N-[1-(AMINOMETHYL)CYCLOPROPYL]-3-(BENZYLSULFONYL)-N-2-[(1S)-2,2,2-TRIFLUORO-1-(4-HYDROXYPHENYL)ETHYL]-L-ALANINAMIDE",DWWVPKCSDHDILN-OALUTQOASA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
86537,6m3m,DB08993,-7.4,Enviomycin,HPWIIERXAFODPP-GHBBWTPBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
26723,6cs2,DB04938,-7.4,Ospemifene,LUMKNAVTFCDUIE-VHXPQNKSSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
129085,6w4h,DB08371,-7.4,PARA-(BENZOYL)-PHENYLALANINE,TVIDEEHSOPHZBR-AWEZNQCLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
134747,6w9c,DB03491,-7.4,2'-Deoxyguanosine-5'-Diphosphate,CIKGWCTVFSRMJU-KVQBGUIXSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
161259,7bv1,DB13465,-7.4,Ciclobendazole,OXLKOMYHDYVIDM-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
134742,6w9c,DB03486,-7.4,Phosphomethylphosphonic Acid Guanosyl Ester,OCJWYBKRHNXUME-KQYNXXCUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
134778,6w9c,DB03535,-7.4,Z-Pro-Prolinal,ORZXYSPOAVJYRU-HOTGVXAUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
114508,6vxx,DB13721,-7.4,Cypermethrin,KAATUXNTWXVJKI-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
128927,6w4h,DB08170,-7.4,"(1R)-N,6-DIHYDROXY-7-METHOXY-2-[(4-METHOXYPHENYL)SULFONYL]-1,2,3,4-TETRAHYDROISOQUINOLINE-1-CARBOXAMIDE",AYFCYVLVRYQGME-QGZVFWFLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
114566,6vxx,DB13797,-7.4,Iodocholesterol (131I),FIOAEFCJGZJUPW-ODFYUTSGSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
26796,6cs2,DB05265,-7.4,Ecabet,IWCWQNVIUXZOMJ-MISYRCLQSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
104765,6vxs,DB12468,-7.4,Pf-04531083,ZRJGMDIPCQOGNI-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
6457,6lzg,DB02140,-7.4,N1-(1-Dimethylcarbamoyl-2-Phenyl-Ethyl)-2-Oxo-N4-(2-Pyridin-2-Yl-Ethyl)-Succinamide,ZPFPZRVOBBMZMP-SFHVURJKSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
128815,6w4h,DB08049,-7.4,"7,8-dihydroxy-4-phenyl-2H-chromen-2-one",JRVIIPJSVKTPBK-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
26801,6cs2,DB05289,-7.4,Tarenflurbil,SYTBZMRGLBWNTM-SNVBAGLBSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
102450,6vxs,DB07409,-7.4,"(1-HYDROXY-1-PHOSPHONO-2-[1,1';4',1'']TERPHENYL-3-YL-ETHYL)-PHOSPHONIC ACID",MPBUFKZCEBTBSK-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
66740,6lxt,DB04582,-7.4,IMAZAQUIN,CABMTIJINOIHOD-QGZVFWFLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
135273,6w9c,DB04239,-7.4,2-Amino-6-Aminomethyl-8-Phenylsulfanylmethyl-3h-Quinazolin-4-One,CBFXRTSHUMEYKQ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
104773,6vxs,DB12478,-7.4,Piribedil,OQDPVLVUJFGPGQ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
128773,6w4h,DB08001,-7.4,5-(3-{3-[3-HYDROXY-2-(METHOXYCARBONYL)PHENOXY]PROPENYL}PHENYL)-4-(HYDROXYMETHYL)ISOXAZOLE-3-CARBOXYLIC ACID,DQSRCEFDWMQCCV-GQCTYLIASA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
128772,6w4h,DB08000,-7.4,"2-(CARBOXYMETHYL)-1-OXO-1,2-DIHYDRONAPHTHO[1,2-D]ISOTHIAZOLE-4-CARBOXYLIC ACID 3,3-DIOXIDE",ZTJGXDGAXGWOGR-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
128771,6w4h,DB07999,-7.4,"{4-[(CARBOXYMETHOXY)CARBONYL]-3,3-DIOXIDO-1-OXONAPHTHO[1,2-D]ISOTHIAZOL-2(1H)-YL}ACETIC ACID",IXLBOIRSEDMRPI-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
102445,6vxs,DB07404,-7.4,"(1-HYDROXY-1-PHOSPHONO-2-[1,1';3',1'']TERPHENYL-3-YL-ETHYL)-PHOSPHONIC ACID",YXQQNSYZOQHKHD-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
70550,6lxt,DB12833,-7.4,Tandospirone,CEIJFEGBUDEYSX-FZDBZEDMSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
158394,7bv1,DB01136,-7.4,Carvedilol,OGHNVEJMJSYVRP-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
70543,6lxt,DB12821,-7.4,Perflubutane,KAVGMUDTWQVPDF-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
161438,7bv1,DB14045,-7.4,Cholesteryl chloride,OTVRYZXVVMZHHW-DPAQBDIFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
128754,6w4h,DB07981,-7.4,2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]-n-[(1R)-1-(hydroxymethyl)propyl]acetamide,GKJWXEORYGBJFS-QGZVFWFLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
33680,6cs2,T3D0426,-7.4,"3,4,4'-Trichlorobiphenyl",YZANRISAORXTHU-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
135329,6w9c,DB04315,-7.4,Guanosine-5'-Diphosphate,QGWNDRXFNXRZMB-UUOKFMHZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
28734,6cs2,DB08346,-7.4,"(5Z)-13-CHLORO-14,16-DIHYDROXY-3,4,7,8,9,10-HEXAHYDRO-1H-2-BENZOXACYCLOTETRADECINE-1,11(12H)-DIONE",YUZYDHRGGDTZLG-DUXPYHPUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
25319,6cs2,DB03221,-7.4,AL7099A,RMOXCYSVWCHXII-GFCCVEGCSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
161443,7bv1,DB14059,-7.4,SC-236,NSQNZEUFHPTJME-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
83694,6m3m,DB04218,-7.4,1-Deaza-Adenosine,NVUDDRWKCUAERS-PNHWDRBUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
28735,6cs2,DB08347,-7.4,4-{[(2S)-3-(tert-butylamino)-2-hydroxypropyl]oxy}-3H-indole-2-carbonitrile,CQEFAUFOQSCRMZ-LBPRGKRZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
83687,6m3m,DB04211,-7.4,"(2R,3R,4R,5R,6R)-3-fluoro-2,4-dihydroxy-5-[(1-hydroxyethylidene)amino]-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid",ALJLGESFXXDPKH-RISWTRDCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
128726,6w4h,DB07947,-7.4,ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY)ETHYLAMINO)ETHYL)AMIDE,AUHWQSZMVMMRLM-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
33669,6cs2,T3D0424,-7.4,"3,3',4-Trichlorobiphenyl",JHBVPKZLIBDTJR-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
161464,7bv1,DB14857,-7.4,Avadomide,RSNPAKAFCAAMBH-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
86680,6m3m,DB09218,-7.4,Clonixin,CLOMYZFHNHFSIQ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83700,6m3m,DB04227,-7.4,"9-Amino-2-Deoxy-2,3-Dehydro-N-Acetyl-Neuraminic Acid",VJTPBNUXDULDQD-UFGQHTETSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
60722,6crv,DB09015,-7.4,Canrenoic acid,PBKZPPIHUVSDNM-WNHSNXHDSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
33700,6cs2,T3D4942,-7.4,Fenpropimorph,RYAUSSKQMZRMAI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
135177,6w9c,DB04089,-7.4,AL5300,HHPUQNGRNUOYCD-VIFPVBQESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
75443,6m2n,DB04707,-7.4,Hydroxyfasudil,ZAVGJDAFCZAWSZ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
102509,6vxs,DB07480,-7.4,4-PHOSPHONOOXY-PHENYL-METHYL-[4-PHOSPHONOOXY]BENZEN,LGSCVLKUKMBYNC-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
66727,6lxt,DB04566,-7.4,Inosinic Acid,GRSZFWQUAKGDAV-KQYNXXCUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
60683,6crv,DB08972,-7.4,Flumequine,DPSPPJIUMHPXMA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86602,6m3m,DB09089,-7.4,Trimebutine,LORDFXWUHHSAQU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
94144,6m71,DB07772,-7.4,"(1R)-1-{[(4'-methoxy-1,1'-biphenyl-4-yl)sulfonyl]amino}-2-methylpropylphosphonic acid",BZVYQWLRCHLAGK-QGZVFWFLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
128909,6w4h,DB08152,-7.4,{(2S)-1-[N-(tert-butoxycarbonyl)glycyl]pyrrolidin-2-yl}methyl (3-chlorophenyl)acetate,ONXGIEJBNQLITK-INIZCTEOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
114574,6vxx,DB13808,-7.4,Mebhydrolin,FQQIIPAOSKSOJM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
12596,6lzg,DB13571,-7.4,Pentamycin,AGJUUQSLGVCRQA-SWOUQTJZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
72107,6m2n,DB00346,-7.4,Alfuzosin,WNMJYKCGWZFFKR-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
104739,6vxs,DB12429,-7.4,CI-1040,GFMMXOIFOQCCGU-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
33731,6cs2,T3D4982,-7.4,Dexamethasone,UREBDLICKHMUKA-CXSFZGCWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
161357,7bv1,DB13866,-7.4,Etynodiol,JYILPERKVHXLNF-QMNUTNMBSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
158420,7bv1,DB01166,-7.4,Cilostazol,RRGUKTPIGVIEKM-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
135079,6w9c,DB03952,-7.4,9-(6-deoxy-beta-D-allofuranosyl)-6-methylpurine,XJZDIUOABWMPLZ-FHQKJXBVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
8098,6lzg,DB04764,-7.4,[4-(3-AMINOMETHYL-PHENYL)-PIPERIDIN-1-YL]-(5-PHENETHYL- PYRIDIN-3-YL)-METHANONE,CCLHROFBSWWOQO-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
158419,7bv1,DB01165,-7.4,Ofloxacin,GSDSWSVVBLHKDQ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
135165,6w9c,DB04073,-7.4,N-{3-[4-(3-aminopropyl)piperazin-1-yl]propyl}-3-(beta-D-galactopyranosyloxy)-5-nitrobenzamide,UEIGEWJJVQHIAX-DLBZZEGUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
72130,6m2n,DB00374,-7.4,Treprostinil,PAJMKGZZBBTTOY-ZFORQUDYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
158406,7bv1,DB01149,-7.4,Nefazodone,VRBKIVRKKCLPHA-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
135161,6w9c,DB04069,-7.4,"5,6-Dihydro-Benzo[H]Cinnolin-3-Ylamine",QKVREUJWFZJEJK-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
148455,6w9q,DB13469,-7.4,Phanquinone,VLPADTBFADIFKG-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
83726,6m3m,DB04266,-7.4,"5-(6-D-Ribitylamino-2,4-Dihydroxypyrimidin-5-Yl)-1-Pentyl-Phosphonic Acid",BMATWAHJJFXMFA-AXFHLTTASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
33741,6cs2,T3D4991,-7.4,9-Hydroxyphenanthrene,DZKIUEHLEXLYKM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
113432,6vxx,DB09184,-7.4,Edivoxetine,CPBHSHYQQLFAPW-ZWKOTPCHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
70569,6lxt,DB12868,-7.4,Intoplicine,QROONAIPJKQFMC-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
158411,7bv1,DB01155,-7.4,Gemifloxacin,ZRCVYEYHRGVLOC-HYARGMPZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
135117,6w9c,DB04005,-7.4,Uridine 5'-triphosphate,PGAVKCOVUIYSFO-XVFCMESISA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
83769,6m3m,DB04324,-7.4,Ovalicin,UOXVFQCRPDLSFN-DGXTUMSLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
135102,6w9c,DB03986,-7.4,6-Methyl-Formycin A,UHYKIYIKTWEXSX-LFAOKBQASA-O,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
83778,6m3m,DB04335,-7.4,Inosine,UGQMRVRMYYASKQ-KQYNXXCUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
26792,6cs2,DB05253,-7.4,Telapristone acetate,JVBGZFRPTRKSBB-MJBQOYBXSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
84018,6m3m,DB04655,-7.4,Metoprine,VQJHOPSWBGJHQS-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
134599,6w9c,DB03285,-7.4,"2',4,4'-Trihydroxychalcone",DXDRHHKMWQZJHT-FPYGCLRLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
161214,7bv1,DB13407,-7.4,Nifenazone,BRZANEXCSZCZCI-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
71920,6m2n,DB00131,-7.4,Adenosine phosphate,UDMBCSSLTHHNCD-KQYNXXCUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
104579,6vxs,DB12214,-7.4,Luseogliflozin,WHSOLWOTCHFFBK-ZQGJOIPISA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
26587,6cs2,DB04757,-7.4,"GUANOSINE-2',3'-O-METHYLIDENEPHOSPHONATE",GKAPYWCOOQBBHV-KXSYMAMXSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
129414,6w4h,DB08763,-7.4,[N-(BENZYLOXYCARBONYL)AMINO](4-AMIDINOPHENYL)METHANE-PHOSPHONATE,FSNDLCSOLUMYRH-OAHLLOKOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
129413,6w4h,DB08762,-7.4,O-(((1R)-((N-PHENYLMETHOXYCARBONYL-L-ALANYL)AMINO)ETHYL)HYDROXYPHOSPHONO)-L-BENZYLACETIC ACID,UPJNMOBJDSFRTI-FCEWJHQRSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
158762,7bv1,DB02186,-7.4,N-Acetyl-D-Galactosamine 6-Sulfate,WJFVEEAIYIOATH-JAJWTYFOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
70739,6lxt,DB13118,-7.4,Paquinimod,DIKSYHCCYVYKRO-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
129408,6w4h,DB08757,-7.4,5-(2-chlorophenyl)furan-2-carbohydrazide,XQMRHWSGTVEDFG-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
93375,6m71,DB06875,-7.4,3-(3-FLUORO-4-HYDROXYPHENYL)-7-HYDROXY-1-NAPHTHONITRILE,NSSOSHDCWCMNDM-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94014,6m71,DB07620,-7.4,"2-[(2,4-DICHLORO-5-METHYLPHENYL)SULFONYL]-1,3-DINITRO-5-(TRIFLUOROMETHYL)BENZENE",INAZPZCJNPPHGV-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93374,6m71,DB06874,-7.4,"(6-[4-(AMINOMETHYL)-2,6-DIMETHYLPHENOXY]-2-{[4-(AMINOMETHYL)PHENYL]AMINO}-5-BROMOPYRIMIDIN-4-YL)METHANOL",LSIZSSASMKSUIU-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
6296,6lzg,DB01873,-7.4,Epothilone D,XOZIUKBZLSUILX-GIQCAXHBSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
93371,6m71,DB06871,-7.4,17-METHYL-17-ALPHA-DIHYDROEQUILENIN,FQMQOMRDADWGJJ-GBESFXJTSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
113570,6vxx,DB11541,-7.4,Ractopamine,YJQZYXCXBBCEAQ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
158763,7bv1,DB02187,-7.4,Equilin,WKRLQDKEXYKHJB-HFTRVMKXSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
134201,6w9c,DB02699,-7.4,4-Oxoretinol,PLIUCYCUYQIBDZ-RMWYGNQTSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
75854,6m2n,DB06234,-7.4,Maribavir,KJFBVJALEQWJBS-XUXIUFHCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
30068,6cs2,DB12007,-7.4,Isoflavone,GOMNOOKGLZYEJT-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
58747,6crv,DB06538,-7.4,Robalzotan,MQTUXRKNJYPMCG-CYBMUJFWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
158729,7bv1,DB02135,-7.4,"4-{2,6,8-Trioxo-9-[(2R,3S,4R)-2,3,4,5-Tetrahydroxypentyl]-1,2,3,6,8,9-Hexahydro-7h-Purin-7-Yl}Butyl Dihydrogen Phosphate",VBXZSBKAJFXURR-MRTMQBJTSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
102776,6vxs,DB07796,-7.4,"(3ASR,4RS,8ASR,8BRS)-4-(2-(4-FLUOROBENZYL)-1,3-DIOXODEACAHYDROPYRROLO[3,4-A] PYRROLIZIN-4-YL)BENZAMIDINE",GJYCQHGTXMVIBG-MUGJNUQGSA-O,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104592,6vxs,DB12230,-7.4,Bunazosin,RHLJLALHBZGAFM-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
93367,6m71,DB06866,-7.4,6-CARBAMIMIDOYL-2-[2-HYDROXY-5-(3-METHOXY-PHENYL)-INDAN-1-YL]-HEXANOIC ACID,NMOUMGFCBOWPAB-RZUBCFFCSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
104595,6vxs,DB12234,-7.4,BMS-214662,OLCWFLWEHWLBTO-HSZRJFAPSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
60460,6crv,DB08677,-7.4,N-(5-ISOPROPYL-THIAZOL-2-YL)-2-PYRIDIN-3-YL-ACETAMIDE,WQZOOPQQADNJEG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
161064,7bv1,DB12825,-7.4,Lefamulin,KPVIXBKIJXZQJX-FCEONZPQSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
129357,6w4h,DB08704,-7.4,"[[(3R,4R,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-(pentanoylamino)oxan-2-ylidene]amino] N-phenylcarbamate",NUNQIQQEEPOGDJ-JDOAOKHLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
102770,6vxs,DB07790,-7.4,N-(2-METHOXYETHYL)-4-({4-[2-METHYL-1-(1-METHYLETHYL)-1H-IMIDAZOL-5-YL]PYRIMIDIN-2-YL}AMINO)BENZENESULFONAMIDE,LDXLQEXLXZCYSR-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
134262,6w9c,DB02842,-7.4,9-amino-n-[3-(dimethylamino)propyl]acridine-4-carboxamide,VNWAULKXOPRJEL-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
94035,6m71,DB07643,-7.4,"5-{[1-(2,3-dichlorobenzyl)piperidin-4-yl]methoxy}quinazoline-2,4-diamine",XVLUVRFYGVJKGJ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
148694,6w9q,DB13790,-7.4,Fipexide,BFUJHVVEMMWLHC-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
60430,6crv,DB08641,-7.4,"(2S,3S)-3-FORMYL-2-({[(4-NITROPHENYL)SULFONYL]AMINO}METHYL)PENTANOIC ACID",JPQYVEFTAZEPOD-BXKDBHETSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
93990,6m71,DB07589,-7.4,"N-[1-(AMINOMETHYL)CYCLOPROPYL]-3-(BENZYLSULFONYL)-N-2-[(1S)-2,2,2-TRIFLUORO-1-(4-HYDROXYPHENYL)ETHYL]-L-ALANINAMIDE",DWWVPKCSDHDILN-OALUTQOASA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
12007,6lzg,DB12740,-7.4,CC-115,GMYLVKUGJMYTFB-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
158861,7bv1,DB02554,-7.4,"Sulfoquinovose-Uridine-C1,5'-Diphosphate",FQANCGQCBCUSMI-JZMIEXBBSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
104528,6vxs,DB12131,-7.4,Vinpocetine,DDNCQMVWWZOMLN-IRLDBZIGSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
8561,6lzg,DB06401,-7.4,Bazedoxifene,UCJGJABZCDBEDK-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
113640,6vxx,DB11689,-7.4,Selumetinib,CYOHGALHFOKKQC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
148769,6w9q,DB13927,-7.4,anle138b,RCQIIBJSUWYYFU-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
35039,1r42,DB01070,-7.4,Dihydrotachysterol,ILYCWAKSDCYMBB-OPCMSESCSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
113625,6vxx,DB11671,-7.4,AZD-4877,SMFXSYMLJDHGIE-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
129545,6w4h,DB08956,-7.4,Hydroxydione,USPYDUPOCUYHQL-VEVMSBRDSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
149679,6wiq,DB00450,-7.4,Droperidol,RMEDXOLNCUSCGS-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
104542,6vxs,DB12153,-7.4,Citicoline,RZZPDXZPRHQOCG-OJAKKHQRSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
160978,7bv1,DB12350,-7.4,Rostafuroxin,AEAPORIZZWBIEX-DTBDINHYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
158824,7bv1,DB02266,-7.4,Flufenamic Acid,LPEPZBJOKDYZAD-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
26553,6cs2,DB04712,-7.4,ANILINOMETHYL GLUCO-PHENYLIMIDAZOLE,ADKWVGPRAQKVKB-YIYPIFLZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
60397,6crv,DB08598,-7.4,"4-CHLORO-8-METHYL-7-(3-METHYL-BUT-2-ENYL)-6,7,8,9-TETRAHYDRO-2H-2,7,9A-TRIAZA-BENZO[CD]AZULENE-1-THIONE",RCSLUNOLLUVOOG-NSHDSACASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
129510,6w4h,DB08903,-7.4,Bedaquiline,QUIJNHUBAXPXFS-XLJNKUFUSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
58799,6crv,DB06669,-7.4,Arverapamil,UPKQNCPKPOLASS-AREMUKBSSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
35047,1r42,DB01081,-7.4,Diphenoxylate,HYPPXZBJBPSRLK-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
129447,6w4h,DB08801,-7.4,Dimetindene,MVMQESMQSYOVGV-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
104567,6vxs,DB12193,-7.4,Ajulemic acid,YCHYFHOSGQABSW-RTBURBONSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
70754,6lxt,DB13155,-7.4,Esculin,XHCADAYNFIFUHF-TVKJYDDYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
104563,6vxs,DB12187,-7.4,Abacavir hydroxyacetate,ZBBZROWQLKCFQK-KOLCDFICSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
6288,6lzg,DB01860,-7.4,Cordycepin Triphosphate,NLIHPCYXRYQPSD-BAJZRUMYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
134015,6w9c,DB02456,-7.4,Aracytidine 5'-monophosphate,IERHLVCPSMICTF-CCXZUQQUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
94036,6m71,DB07644,-7.4,"5-[(1S)-1-(3-chlorophenyl)ethoxy]quinazoline-2,4-diamine",IDHINEMSCUFEIP-VIFPVBQESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93396,6m71,DB06899,-7.4,"N-{2-[6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2,2-DIMETHYL-3-OXO-2,3-DIHYDRO-4H-1,4-BENZOTHIAZIN-4-YL]ETHYL}ACETAMIDE",RMEVNJZCKDVVND-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
161012,7bv1,DB12399,-7.4,Polmacoxib,IJWPAFMIFNSIGD-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
8574,6lzg,DB06429,-7.4,Talnetant,BIAVGWDGIJKWRM-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
129488,6w4h,DB08864,-7.4,Rilpivirine,YIBOMRUWOWDFLG-ONEGZZNKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
60402,6crv,DB08604,-7.4,Triclosan,XEFQLINVKFYRCS-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
133978,6w9c,DB02410,-7.4,"2-Acetyl-3-[(4-Amino-2-Methyl-5-Pyrimidinyl)Methyl]-4-Methyl-5-(4,6,6-Trihydroxy-3,5-Dioxa-4,6-Diphosphahex-1-Yl)Thiazolium Inner Salt P,P'-Dioxide",GYRGKLZCJRVYRV-UHFFFAOYSA-O,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
160994,7bv1,DB12376,-7.4,Ricolinostat,QGZYDVAGYRLSKP-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
129473,6w4h,DB08836,-7.4,Temocapril,FIQOFIRCTOWDOW-BJLQDIEVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
86375,6m3m,DB08766,-7.4,Zofenoprilat,UQWLOWFDKAFKAP-WXHSDQCUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
33890,6cs2,T3D0561,-7.4,"2,2',3,3',4,5,5'-Heptachlorobiphenyl",HOPMUCXYRNOABF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
26620,6cs2,DB04796,-7.4,Inecalcitol,HHGRMHMXKPQNGF-WNSNRMDMSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
69,6lzg,HMDB0002655,-7.4,Isorhamnetin,IZQSVPBOUDKVDZ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
94052,6m71,DB07665,-7.4,"N-[2-(carbamimidamidooxy)ethyl]-2-{6-cyano-3-[(2,2-difluoro-2-pyridin-2-ylethyl)amino]-2-fluorophenyl}acetamide",STHCHQXQLDMISY-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
70691,6lxt,DB13052,-7.4,Upamostat,HUASEDVYRABWCV-NDEPHWFRSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
129229,6w4h,DB08544,-7.4,(S)-Fluoxetine,RTHCYVBBDHJXIQ-INIZCTEOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
22132,6cs2,HMDB0001449,-7.4,Allopregnanolone,AURFZBICLPNKBZ-SYBPFIFISA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
84102,6m3m,DB04776,-7.4,(2R)-2-({6-[benzyl(methyl)amino]-9-isopropyl-9H-purin-2-yl}amino)butan-1-ol,YPYWONAECUVKHY-MRXNPFEDSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
93360,6m71,DB06858,-7.4,N-cyclooctylglycyl-N-(4-carbamimidoylbenzyl)-L-prolinamide,MMLOIDMSBRJZAE-FQEVSTJZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
134443,6w9c,DB03083,-7.4,IC261,JBJYTZXCZDNOJW-JLHYYAGUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
102726,6vxs,DB07739,-7.4,"(3R)-3-(FLUOROMETHYL)-7-(THIOMORPHOLIN-4-YLSULFONYL)-1,2,3,4-TETRAHYDROISOQUINOLINE",SBUKSNPHYWXCDG-CYBMUJFWSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104639,6vxs,DB12291,-7.4,Tacedinaline,VAZAPHZUAVEOMC-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
158607,7bv1,DB01689,-7.4,Inhibitor Idd 384,CJKKMQCZOLCXAM-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
33842,6cs2,T3D0515,-7.4,"3,3',4,4',5-Pentachlorobiphenyl",REHONNLQRWTIFF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
129211,6w4h,DB08524,-7.4,2-(3-BENZOYLPHENOXY)ETHYL(HYDROXY)FORMAMIDE,ZHFKBNAHHTUQBH-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
84078,6m3m,DB04742,-7.4,"(2R)-2-{(1R)-2-oxo-1-[(2-thienylacetyl)amino]ethyl}-5,6-dihydro-2h-1,3-thiazine-4-carboxylic acid",QIZKCGBBVPUBJL-ZYHUDNBSSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
161185,7bv1,DB13364,-7.4,Feprazone,RBBWCVQDXDFISW-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
134491,6w9c,DB03148,-7.4,Phosphomethylphosphonic Acid Adenosyl Ester,OLCWZBFDIYXLAA-IOSLPCCCSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
129200,6w4h,DB08511,-7.4,"6-amino-2-methyl-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",PLJNUNPYZVVIRA-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
161211,7bv1,DB13403,-7.4,Oxypertine,XCWPUUGSGHNIDZ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
72020,6m2n,DB00242,-7.4,Cladribine,PTOAARAWEBMLNO-KVQBGUIXSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
158557,7bv1,DB01624,-7.4,Zuclopenthixol,WFPIAZLQTJBIFN-DVZOWYKESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
75446,6m2n,DB04712,-7.4,ANILINOMETHYL GLUCO-PHENYLIMIDAZOLE,ADKWVGPRAQKVKB-YIYPIFLZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
104663,6vxs,DB12321,-7.4,Ifetroban,BBPRUNPUJIUXSE-DXKRWKNPSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
86456,6m3m,DB08880,-7.4,Teriflunomide,UTNUDOFZCWSZMS-YFHOEESVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
134392,6w9c,DB03013,-7.4,Di(N-Acetyl-D-Glucosamine),CDOJPCSDOXYJJF-KSKNGZLJSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
158566,7bv1,DB01634,-7.4,2-Oxy-4-Hydroxy-5-(2-Hydrazinopyridine)Phenylalanine,AZUQIXJQZOMXAS-BDAKNGLRSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
33829,6cs2,T3D0503,-7.4,"2,3,4,4',5-Pentachlorobiphenyl",SXZSFWHOSHAKMN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
17879,6cs2,HMDB0000518,-7.4,Chenodeoxycholic acid,RUDATBOHQWOJDD-BSWAIDMHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
161189,7bv1,DB13369,-7.4,Benzilone,ZKCWITXZGWUJAV-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
58656,6crv,DB06282,-7.4,Levocetirizine,ZKLPARSLTMPFCP-OAQYLSRUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
25449,6cs2,DB03369,-7.4,9-Aminophenanthrene,KIHQWOBUUIPWAN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
134492,6w9c,DB03150,-7.4,"2',3'-Dideoxythymidine-5'-Monophosphate",WVNRRNJFRREKAR-JGVFFNPUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
158572,7bv1,DB01641,-7.4,"(5z)-2-[(1s,2r)-1-Amino-2-Hydroxypropyl]-5-[(4-Amino-1h-Indol-3-Yl)Methylene]-3-(2-Hydroxyethyl)-3,5-Dihydro-4h-Imidazol-4-One",JUWJATLABHTRDF-JURWUIOISA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
128718,6w4h,DB07938,-7.4,"5-[[(2R)-2-cyclopropyl-7,8-dimethoxy-chroman-5-yl]methyl]pyrimidine-2,4-diamine",HWJPWWYTGBZDEG-CQSZACIVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
86404,6m3m,DB08799,-7.4,Antazoline,REYFJDPCWQRWAA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84129,6m3m,DB04813,-7.4,Bithionol,JFIOVJDNOJYLKP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
102763,6vxs,DB07782,-7.4,4-AMINO-2-TRIFLUOROMETHYL-5-HYDROXYMETHYLPYRIMIDINE PYROPHOSPHATE,UKNJCTHTCAKKNG-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
129332,6w4h,DB08672,-7.4,4-[(3R)-3-{[2-(4-FLUOROPHENYL)-2-OXOETHYL]AMINO}BUTYL]BENZAMIDE,OIWWNWQZJJKBTR-CYBMUJFWSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
113562,6vxx,DB11519,-7.4,Fluprostenol,WWSWYXNVCBLWNZ-QIZQQNKQSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
102757,6vxs,DB07775,-7.4,"3',5'-DIBROMO-2',4,4',6'-TETRAHYDROXY AURONE",BRPKBUNFOZFULQ-SGAXSIHGSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
134299,6w9c,DB02890,-7.4,6-Hydroxyuridine-5'-Phosphate,UDOBICLZEKUKCV-YXZULKJRSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
94039,6m71,DB07647,-7.4,"(2R)-1-[(5,6-DIPHENYL-7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)AMINO]PROPAN-2-OL",VBASHTSSQNDDAS-CQSZACIVSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
161125,7bv1,DB12921,-7.4,Chlorsulfaquinoxaline,CTSNHMQGVWXIEG-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
29756,6cs2,DB11551,-7.4,Trenbolone,MEHHPFQKXOUFFV-OWSLCNJRSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
102754,6vxs,DB07771,-7.4,"[(3,7,11-TRIMETHYL-DODECA-2,6,10-TRIENYLOXYCARBAMOYL)-METHYL]-PHOSPHONIC ACID",JAOBYUCYSAOLHS-XGGJEREUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
158681,7bv1,DB02077,-7.4,L-N(omega)-Nitroarginine-(4R)-Amino-L-Proline Amide,IUFRDGFKAVLPFZ-CSMHCCOUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
134318,6w9c,DB02914,-7.4,"(6e)-6-[(2e,4e,6e)-3,7-Dimethylnona-2,4,6,8-Tetraenylidene]-1,5,5-Trimethylcyclohexene",FWNRILWHNGFAIN-OYUWDNMLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
52095,2fxp,DB08995,-7.4,Diosmin,GZSOSUNBTXMUFQ-YFAPSIMESA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
102748,6vxs,DB07764,-7.4,FLUORESCIN,MURGITYSBWUQTI-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
129295,6w4h,DB08624,-7.4,BENZOTHIAZOLE,MAJHCCQPIDXPAN-QMMMGPOBSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
161129,7bv1,DB12926,-7.4,Cafedrine,UJSKUDDDPKGBJY-WFASDCNBSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
11993,6lzg,DB12720,-7.4,Nivocasan,VYFGDLGHHBUDTQ-ZLGUVYLKSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
161130,7bv1,DB12927,-7.4,Theodrenaline,WMCMJIGLYZDKRN-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
114484,6vxx,DB13686,-7.4,Clometocillin,JKXQBIZCQJLVOS-GSNLGQFWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
134353,6w9c,DB02957,-7.4,Orotidine-5'-Monophosphate,KYOBSHFOBAOFBF-XVFCMESISA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
71981,6m2n,DB00196,-7.4,Fluconazole,RFHAOTPXVQNOHP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75889,6m2n,DB06311,-7.4,Darapladib,WDPFJWLDPVQCAJ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
149734,6wiq,DB00522,-7.4,Bentiromide,SPPTWHFVYKCNNK-FQEVSTJZSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
161147,7bv1,DB12949,-7.4,PF-03382792,AGMOFKKOVMRGAK-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
84127,6m3m,DB04808,-7.4,Neamine,SYJXFKPQNSDJLI-HKEUSBCWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
129273,6w4h,DB08598,-7.4,"4-CHLORO-8-METHYL-7-(3-METHYL-BUT-2-ENYL)-6,7,8,9-TETRAHYDRO-2H-2,7,9A-TRIAZA-BENZO[CD]AZULENE-1-THIONE",RCSLUNOLLUVOOG-NSHDSACASA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
26636,6cs2,DB00547,-7.4,Desoximetasone,VWVSBHGCDBMOOT-IIEHVVJPSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
29753,6cs2,DB11541,-7.4,Ractopamine,YJQZYXCXBBCEAQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
70705,6lxt,DB13070,-7.4,Surinabant,HMXDWDSNPRNUKI-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
102747,6vxs,DB07763,-7.4,"(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE",OZZFJGCAYWBVBI-INIZCTEOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
134324,6w9c,DB02921,-7.4,(South)-Methanocarba-Thymidine,XRMLXZVSFIBRRJ-PEFMBERDSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
33871,6cs2,T3D0051,-7.4,Aroclor 1016,RIBGNAJQTOXRDK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
66688,6lxt,DB04518,-7.4,"3-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamino]-Phenol",JJDRRZFRTKZLFT-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
6495,6lzg,DB02217,-7.4,Dpb-T,WTZFKHNHHRPQOU-WSMBLCCSSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
86688,6m3m,DB09229,-7.4,Aranidipine,NCUCGYYHUFIYNU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
72164,6m2n,DB00415,-7.4,Ampicillin,AVKUERGKIZMTKX-NJBDSQKTSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
102132,6vxs,DB07045,-7.4,"(2R,3R,4S,5R)-2-[6-amino-8-[(3,4-dichlorophenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol",VBJKVZXRYLCYGQ-XNIJJKJLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
94313,6m71,DB07968,-7.4,N-(2-CHLORO-4-FLUOROBENZOYL)-N'-(5-HYDROXY-2-METHOXYPHENYL)UREA,RFOBTYLRURSVJE-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
136237,6w9c,DB06884,-7.4,4-HYDROXY-N'-(4-ISOPROPYLBENZYL)BENZOHYDRAZIDE,MFDXHRPPSJRQFX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
33465,6cs2,T3D4714,-7.4,Tamoxifen,NKANXQFJJICGDU-QPLCGJKRSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
61032,6crv,DB11394,-7.4,Decoquinate,JHAYEQICABJSTP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
70341,6lxt,DB12500,-7.4,Fedratinib,JOOXLOJCABQBSG-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
128169,6w4h,DB07295,-7.4,2-[(7-HYDROXY-NAPHTHALEN-1-YL)-OXALYL-AMINO]-BENZOIC ACID,IGOULVZYQKJJKC-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
148195,6w9q,DB13080,-7.4,Roluperidone,RNRYULFRLCBRQS-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
136249,6w9c,DB06898,-7.4,"4-(2-amino-1-methyl-1H-imidazo[4,5-b]pyridin-6-yl)phenol",UGJXOCBVCWTJFP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
161859,7bv1,DB00687,-7.4,Fludrocortisone,AAXVEMMRQDVLJB-BULBTXNYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
128162,6w4h,DB07288,-7.4,N-(4-chlorophenyl)-2-[(pyridin-4-ylmethyl)amino]benzamide,GGPZCOONYBPZEW-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
87024,6m3m,DB11719,-7.4,UK-390957,VCNSPGHSQPMCFF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
104977,6vxs,DB12804,-7.4,Daniquidone,SRIOCKJKFXAKHK-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
69194,6lxt,DB08811,-7.4,Tofisopam,RUJBDQSFYCKFAA-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
136223,6w9c,DB06789,-7.4,Hydroxyprogesterone caproate,DOMWKUIIPQCAJU-LJHIYBGHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
16196,6lzg,DB03124,-7.4,5-[4-(1-Carboxymethyl-2-Oxo-Propylcarbamoyl)-Benzylsulfamoyl]-2-Hydroxy-Benzoic Acid,LBAHOXPDTNUYCX-INIZCTEOSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
87048,6m3m,DB11757,-7.4,Istradefylline,IQVRBWUUXZMOPW-PKNBQFBNSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
157997,6wiq,DB15450,-7.4,PF-05105679,BXNMZRPTQFVRFA-QGZVFWFLSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
25194,6cs2,DB00382,-7.4,Tacrine,YLJREFDVOIBQDA-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
114735,6vxx,DB14735,-7.4,Cannabichromene,UVOLYTDXHDXWJU-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
157991,6wiq,DB15444,-7.4,Elexacaftor,MVRHVFSOIWFBTE-INIZCTEOSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
72348,6m2n,DB00640,-7.4,Adenosine,OIRDTQYFTABQOQ-KQYNXXCUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
93207,6m71,DB06588,-7.4,Triphendiol,KQCJZAUNKSGEFM-UNMCSNQZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
4365,6lzg,HMDB0051386,-7.4,"TG(20:3(5Z,8Z,11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:4(8Z,11Z,14Z,17Z))",MKUDSHOEWNCTAU-WWTGNTJDSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
16184,6lzg,DB03086,-7.4,"N'-(2s,3r)-3-Amino-4-Cyclohexyl-2-Hydroxy-Butano-N-(4-Methylphenyl)Hydrazide",IQMLIGOOOFEBAH-CVEARBPZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
105003,6vxs,DB12850,-7.4,Etalocib,YFIZRWPXUYFCSN-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
128119,6w4h,DB07240,-7.4,3-[(9H-fluoren-9-ylideneamino)oxy]propanoic acid,LASWLEUVWJDDBA-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
136359,6w9c,DB07028,-7.4,(2-{[(4-BROMO-2-FLUOROBENZYL)AMINO]CARBONYL}-5-CHLOROPHENOXY)ACETIC ACID,ZLIGBZRXAQNUFO-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136363,6w9c,DB07032,-7.4,2-(4-HYDROXY-PHENYL)BENZOFURAN-5-OL,SNNNDCMXZYWCCI-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
33450,6cs2,T3D4693,-7.4,Equilin,WKRLQDKEXYKHJB-HFTRVMKXSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
11825,6lzg,DB12477,-7.4,Perfluoro tert-butylcyclohexane,VLTXBOGHSBHSAC-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
11829,6lzg,DB12482,-7.4,Acotiamide,TWHZNAUBXFZMCA-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
158043,7bv1,DB00307,-7.4,Bexarotene,NAVMQTYZDKMPEU-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
58210,6crv,DB04695,-7.4,Farnesyl thiopyrophosphate,MYMLCRQRXFRQGP-YFVJMOTDSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
33512,6cs2,T3D4765,-7.4,Tolazamide,OUDSBRTVNLOZBN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
30158,6cs2,DB00920,-7.4,Ketotifen,ZCVMWBYGMWKGHF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
128288,6w4h,DB07432,-7.4,"[[(3R,4R,5S,6R)-3-(butanoylamino)-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-ylidene]amino] N-phenylcarbamate",ITVRELFVFCOUMV-ZVZWZHPPSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
60979,6crv,DB11221,-7.4,Dioxybenzone,MEZZCSHVIGVWFI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
8037,6lzg,DB04685,-7.4,"1-{(2S,5S)-4-FLUORO-5-[(TRITYLOXY)METHYL]TETRAHYDROFURAN-2-YL}PYRIMIDINE-2,4(1H,3H)-DIONE",GJNIPWYJQUGERM-BFLUCZKCSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
161795,7bv1,DB00607,-7.4,Nafcillin,GPXLMGHLHQJAGZ-JTDSTZFVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
102183,6vxs,DB07105,-7.4,2-[2-(4-CHLORO-PHENYLSULFANYL)-ACETYLAMINO]-3-(4-GUANIDINO-PHENYL)-PROPIONAMIDE,IEEYGOJDTRVYGR-HNNXBMFYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104949,6vxs,DB12752,-7.4,Bucindolol,FBMYKMYQHCBIGU-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
11836,6lzg,DB12494,-7.4,SGI-1776,MHXGEROHKGDZGO-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
83361,6m3m,DB03785,-7.4,"(3r,5r)-7-((1r,2r,6s,8r,8as)-2,6-Dimethyl-8-{[(2r)-2-Methylbutanoyl]Oxy}-1,2,6,7,8,8a-Hexahydronaphthalen-1-Yl)-3,5-Dihydroxyheptanoic Acid",QLJODMDSTUBWDW-BXMDZJJMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83358,6m3m,DB03781,-7.4,"2-[4-(2,4-Dichlorophenoxy)Phenoxy]Propanoic Acid",OOLBCHYXZDXLDS-SECBINFHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
33494,6cs2,T3D4749,-7.4,Levonorgestrel,WWYNJERNGUHSAO-XUDSTZEESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
94293,6m71,DB07944,-7.4,N-{3-METHYL-5-[2-(PYRIDIN-4-YLAMINO)-ETHOXY]-PHENYL}-BENZENESULFONAMIDE,MPTWCWHNLVMCRW-UHFFFAOYSA-O,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
33491,6cs2,T3D4747,-7.4,Cyproterone acetate,UWFYSQMTEOIJJG-FDTZYFLXSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
83339,6m3m,DB03759,-7.4,FG-9041,RWVIMCIPOAXUDG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
128236,6w4h,DB07371,-7.4,3-(10-methyl-9-anthryl)propanoic acid,CKQINRXZVYBCSC-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
94295,6m71,DB07946,-7.4,"N-[2-({[amino(imino)methyl]amino}oxy)ethyl]-2-{6-chloro-3-[(2,2-difluoro-2-phenylethyl)amino]-2-fluorophenyl}acetamide",DZEJHPMTDNDECN-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
72327,6m2n,DB00613,-7.4,Amodiaquine,OVCDSSHSILBFBN-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61028,6crv,DB11389,-7.4,Clorsulon,QOVTVIYTBRHADL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61024,6crv,DB11380,-7.4,Cambendazole,QZWHWHNCPFEXLL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61020,6crv,DB11372,-7.4,Altrenogest,VWAUPFMBXBWEQY-ANULTFPQSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
70348,6lxt,DB12511,-7.4,Imiglitazar,ULVDFHLHKNJICZ-QCWLDUFUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
102151,6vxs,DB07065,-7.4,"5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)-3-thiocyanatopyrazolo[1,5-a]pyrimidin-7-amine",AHPKUZJCNHGFQA-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
166375,7bv1,DB14761,-7.4,Remdesivir,RWWYLEGWBNMMLJ-YSOARWBDSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
136166,6w9c,DB06696,-7.4,Arbekacin,MKKYBZZTJQGVCD-XTCKQBCOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
161830,7bv1,DB00652,-7.4,Pentazocine,VOKSWYLNZZRQPF-GDIGMMSISA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
86995,6m3m,DB11676,-7.4,Galidesivir,AMFDITJFBUXZQN-KUBHLMPHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
61007,6crv,DB11335,-7.4,Ascorbyl glucoside,MLSJBGYKDYSOAE-DCWMUDTNSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
128219,6w4h,DB07350,-7.4,(2E)-N-hydroxy-3-[1-methyl-4-(phenylacetyl)-1H-pyrrol-2-yl]prop-2-enamide,UFQOXIMRSMFQRI-BQYQJAHWSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
94310,6m71,DB07965,-7.4,6-(cyclohexylamino)-9-[2-(4-methylpiperazin-1-yl)-ethyl]-9H-purine-2-carbonitrile,OGODDSLNRULSMM-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93213,6m71,DB06600,-7.4,Nemonoxacin,AVPQPGFLVZTJOR-RYUDHWBXSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
158066,7bv1,DB00338,-7.4,Omeprazole,SUBDBMMJDZJVOS-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
6681,6lzg,DB02519,-7.4,Indirubin-5-Sulphonate,IHBOEHLUIBMBMY-YPKPFQOOSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
157957,6wiq,DB15006,-7.4,Flufenoxuron,RYLHNOVXKPXDIP-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
105011,6vxs,DB12863,-7.4,Sivelestat,BTGNGJJLZOIYID-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
70252,6lxt,DB12376,-7.4,Ricolinostat,QGZYDVAGYRLSKP-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
94353,6m71,DB08012,-7.4,(METHYLPYRIDAZINE PIPERIDINE ETHYLOXYPHENYL)ETHYLACETATE,KCHIOGFOPPOUJC-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
136542,6w9c,DB07239,-7.4,7-(aminomethyl)-6-(2-chlorophenyl)-1-methyl-1H-benzimidazole-5-carbonitrile,YJLVMTVZVJSNHG-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
157851,6wiq,DB13371,-7.4,Difenpiramide,PWHROYKAGRUWDQ-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
27040,6cs2,DB06302,-7.4,Glesatinib,YRCHYHRCBXNYNU-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
70238,6lxt,DB12354,-7.4,Imrecoxib,AXMZZGKKZDJGAZ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
87256,6m3m,DB12061,-7.4,Pardoprunox,YVPUUUDAZYFFQT-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
157827,6wiq,DB12887,-7.4,Tazemetostat,NSQSAUGJQHDYNO-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
102034,6vxs,DB06927,-7.4,[5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-YL]ACETONITRILE,ZKJVCUXZMYKTLT-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
148143,6w9q,DB13003,-7.4,Cortivazol,RKHQGWMMUURILY-UHRZLXHJSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
27042,6cs2,DB06307,-7.4,Apoptone,CKAXZOYFIHQCBN-JRRMKBMNSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
113285,6vxx,DB08757,-7.4,5-(2-chlorophenyl)furan-2-carbohydrazide,XQMRHWSGTVEDFG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
25144,6cs2,DB03009,-7.4,2-[(2-Oxo-2-Piperidin-1-Ylethyl)Thio]-6-(Trifluoromethyl)Pyrimidin-4(1h)-One,UDBHGUOSOKOIAX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
102018,6vxs,DB06911,-7.4,D-leucyl-N-(3-chlorobenzyl)-L-prolinamide,FHVBVJXZKNCSLP-CVEARBPZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
105079,6vxs,DB12962,-7.4,CP-547632,HXHAJRMTJXHJJZ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
76070,6m2n,DB06739,-7.4,Seratrodast,ZBVKEHDGYSLCCC-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
102016,6vxs,DB06909,-7.4,"1-ethyl-N-(phenylmethyl)-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridine-5-carboxamide",QZGJNFBMYYEFGM-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
105130,6vxs,DB13044,-7.4,Gossypol,QBKSWRVVCFFDOT-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101984,6vxs,DB06873,-7.4,"1-((2-HYDROXYETHOXY)METHYL)-5-(3-(BENZYLOXY)BENZYL)PYRIMIDINE-2,4(1H,3H)-DIONE",CSXNPJKDZKLDET-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
150105,6wiq,DB00957,-7.4,Norgestimate,KIQQMECNKUGGKA-NMYWJIRASA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
28775,6cs2,DB08390,-7.4,"(6S)-6-CYCLOPENTYL-6-[2-(3-FLUORO-4-ISOPROPOXYPHENYL)ETHYL]-4-HYDROXY-5,6-DIHYDRO-2H-PYRAN-2-ONE",AKNIHFDXRAOPAI-NRFANRHFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
72404,6m2n,DB00708,-7.4,Sufentanil,GGCSSNBKKAUURC-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
72403,6m2n,DB00706,-7.4,Tamsulosin,DRHKJLXJIQTDTD-OAHLLOKOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
7987,6lzg,DB04623,-7.4,"2-ETHOXYETHYL (2S,3S)-4-((S)-2-BENZYL-3-OXO-4-((3AR,8R,8AS)-2-OXO-3,3A,8,8A-TETRAHYDRO-2H-INDENO[1,2-D]OXAZOL-8-YL)-2,3-DIHYDRO-1H-PYRROL-2-YL)-3-HYDROXY-1-PHENYLBUTAN-2-YLCARBAMATE",CGBRFCVAMLJVEA-ZGURCIGKSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
101994,6vxs,DB06884,-7.4,4-HYDROXY-N'-(4-ISOPROPYLBENZYL)BENZOHYDRAZIDE,MFDXHRPPSJRQFX-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
28767,6cs2,DB08382,-7.4,Gosogliptin,QWEWGXUTRTXFRF-KBPBESRZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
105097,6vxs,DB12989,-7.4,Neosaxitoxin,PPEKGEBBBBNZKS-HGRQIUPRSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
127959,6w4h,DB07053,-7.4,2-{5-[3-(7-PROPYL-3-TRIFLUOROMETHYLBENZO[D]ISOXAZOL-6-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID,TWVYNPULGKGJOS-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
75365,6m2n,DB04602,-7.4,PUROMYCIN AMINONUCLEOSIDE-5'-MONOPHOSPHATE,BFPIKGKMRKBBBF-GRIPGOBMSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
105088,6vxs,DB12977,-7.4,Simenepag isopropyl,MSIIJNOQQWRTFC-GGAORHGYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
105087,6vxs,DB12974,-7.4,Roniciclib,UELYDGOOJPRWGF-SRQXXRKNSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
161961,7bv1,DB01022,-7.4,Phylloquinone,MBWXNTAXLNYFJB-NKFFZRIASA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
58244,6crv,DB04743,-7.4,Nimesulide,HYWYRSMBCFDLJT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72382,6m2n,DB00683,-7.4,Midazolam,DDLIGBOFAVUZHB-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
136525,6w9c,DB07218,-7.4,"6-CHLORO-9-HYDROXY-1,3-DIMETHYL-1,9-DIHYDRO-4H-PYRAZOLO[3,4-B]QUINOLIN-4-ONE",AYKGPCNWPACUQV-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
94330,6m71,DB07987,-7.4,"[2-(5-MERCAPTO-[1,3,4]THIADIAZOL-2-YLCARBAMOYL)-1-PHENYL-ETHYL]-CARBAMIC ACID BENZYL ESTER",AWAKNMKLVLWIIQ-OAHLLOKOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
136386,6w9c,DB07056,-7.4,"2-(6-{[(3-chloro-2-methylphenyl)sulfonyl]amino}pyridin-2-yl)-N,N-diethylacetamide",JNWQLOFSMUGRNY-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
166371,7bv1,DB14753,-7.4,Hydroxystilbamidine,TUESWZZJYCLFNL-DAFODLJHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
35494,1r42,DB01678,-7.4,RU84687,SAFPHFWYRLLBFO-NSOVKSMOSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
157944,6wiq,DB14942,-7.4,BMS-986141,KEEBLYWBELVGPQ-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
11811,6lzg,DB00948,-7.4,Mezlocillin,YPBATNHYBCGSSN-VWPFQQQWSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
33441,6cs2,T3D0403,-7.4,"3,5-Dichlorobiphenyl",QHZSDTDMQZPUKC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
166370,7bv1,DB14750,-7.4,Cidoxepin,ODQWQRRAPPTVAG-BOPFTXTBSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
157939,6wiq,DB14935,-7.4,Serabelisib,BLGWHBSBBJNKJO-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
8005,6lzg,DB04644,-7.4,"4-{4-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-2,3-DIMETHYL-PHENOXY}-BUTYRIC ACID",FCEMCUPAYRPTLS-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
157938,6wiq,DB14934,-7.4,GDC-0927,KJAAPZIFCQQQKX-NDEPHWFRSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
58153,6crv,DB04617,-7.4,"(9S)-9-[(8-AMMONIOOCTYL)AMINO]-1,2,3,4,9,10-HEXAHYDROACRIDINIUM",LFBAUYQQFKFFCF-UHFFFAOYSA-P,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
18126,6cs2,HMDB0000053,-7.4,Androstenedione,AEMFNILZOJDQLW-QAGGRKNESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
150074,6wiq,DB00921,-7.4,Buprenorphine,RMRJXGBAOAMLHD-IHFGGWKQSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
136448,6w9c,DB07128,-7.4,"N7-BUTYL-N2-(5-CHLORO-2-METHYLPHENYL)-5-METHYL[1,2,4]TRIAZOLO[1,5-A]PYRIMIDINE-2,7-DIAMINE",ZTYBIJUAAWLJNU-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
35510,1r42,DB01698,-7.4,Rutin,IKGXIBQEEMLURG-NVPNHPEKSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
33430,6cs2,T3D0402,-7.4,"3,4'-Dichlorobiphenyl",CJDNEKOMKXLSBN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
128016,6w4h,DB07120,-7.4,"N4-(N,N-DIPHENYLCARBAMOYL)-AMINOGUANIDINE",QLXOHIUDKNRVBZ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
136516,6w9c,DB07206,-7.4,6-[2-(1H-INDOL-6-YL)ETHYL]PYRIDIN-2-AMINE,OSHSZKRWKLQZBV-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
128018,6w4h,DB07122,-7.4,1-[4-(2-oxo-2-phenylethyl)phenyl]guanidine,MERNPSIIBFTCAI-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
128019,6w4h,DB07123,-7.4,N-(4-METHYLBENZOYL)-4-BENZYLPIPERIDINE,DVOLWKZEIDCCES-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
72379,6m2n,DB00679,-7.4,Thioridazine,KLBQZWRITKRQQV-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
29700,6cs2,DB11433,-7.4,Nequinate,NNOPDLNHPOLRRE-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
157896,6wiq,DB13939,-7.4,RAD-140,XMBUPPIEVAFYHO-KPZWWZAWSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
157902,6wiq,DB14866,-7.4,Amcasertib,QDWKGEFGLQMDAM-ULJHMMPZSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
83202,6m3m,DB03575,-7.4,Phencyclidine,JTJMJGYZQZDUJJ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
11797,6lzg,DB12441,-7.4,Tavilermide,DVJXNXPFYJIACK-ULQDDVLXSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
76067,6m2n,DB06736,-7.4,Aceclofenac,MNIPYSSQXLZQLJ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
113291,6vxx,DB08763,-7.4,[N-(BENZYLOXYCARBONYL)AMINO](4-AMIDINOPHENYL)METHANE-PHOSPHONATE,FSNDLCSOLUMYRH-OAHLLOKOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
128047,6w4h,DB07155,-7.4,(3S)-1-CYCLOHEXYL-5-OXO-N-PHENYLPYRROLIDINE-3-CARBOXAMIDE,BVUSHGJZBZMDML-ZDUSSCGKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
16117,6lzg,DB02790,-7.4,Phenyl-Uridine-5'-Diphosphate,ZHUWBKDWWGKIEN-FMKGYKFTSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
87180,6m3m,DB11947,-7.4,Pridopidine,YGKUEOZJFIXDGI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58835,6crv,DB06727,-7.4,Sparteine,SLRCCWJSBJZJBV-ZQDZILKHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136078,6w9c,DB06481,-7.4,Manitimus,IRELROQHIPLASX-SEYXRHQNSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
158099,7bv1,DB00377,-7.4,Palonosetron,CPZBLNMUGSZIPR-NVXWUHKLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
83600,6m3m,DB04101,-7.4,"N-[4-(2,4-Dimethyl-1,3-Thiazol-5-Yl)Pyrimidin-2-Yl]-N'-Hydroxyimidoformamide",OVKZTPFHUYGZBI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
158270,7bv1,DB00805,-7.4,Minaprine,LDMWSLGGVTVJPG-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
102334,6vxs,DB07279,-7.4,N-ETHYL-N-ISOPROPYL-3-METHYL-5-{[(2S)-2-(PYRIDIN-4-YLAMINO)PROPYL]OXY}BENZAMIDE,JMPSZYHYDMQFEO-KRWDZBQOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
35325,1r42,DB01474,-7.4,"17alpha-methyl-3beta,17beta-dihydroxyandrost-4-ene",BNUOCVTVOYWNJC-DTMQFJJTSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
60858,6crv,DB09234,-7.4,Darodipine,QERUYFVNIOLCHV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
102315,6vxs,DB07257,-7.4,"4-(2-chlorophenyl)-8-(2-hydroxyethyl)-6-methylpyrrolo[3,4-e]indole-1,3(2H,6H)-dione",WHMQZCPGFZBLBG-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
135661,6w9c,DB04776,-7.4,(2R)-2-({6-[benzyl(methyl)amino]-9-isopropyl-9H-purin-2-yl}amino)butan-1-ol,YPYWONAECUVKHY-MRXNPFEDSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
128566,6w4h,DB07763,-7.4,"(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE",OZZFJGCAYWBVBI-INIZCTEOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
128565,6w4h,DB07762,-7.4,4-(N-ACETYLAMINO)-3-[N-(2-ETHYLBUTANOYLAMINO)]BENZOIC ACID,USKXJFHTBQWXCS-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
35331,1r42,DB01481,-7.4,1-Testosterone,OKJCFMUGMSVJBG-ABEVXSGRSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
16303,6lzg,DB03647,-7.4,3-[Isopropyl(4-Methylbenzoyl)Amino]-5-Phenylthiophene-2-Carboxylic Acid,LRHXIDOGMBZJFN-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
149911,6wiq,DB00734,-7.4,Risperidone,RAPZEAPATHNIPO-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
114621,6vxx,DB13872,-7.4,Lormetazepam,FJIKWRGCXUCUIG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86859,6m3m,DB11380,-7.4,Cambendazole,QZWHWHNCPFEXLL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83601,6m3m,DB04102,-7.4,2-Amino-Adenosine,CQKMBZHLOYVGHW-QYYRPYCUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
102304,6vxs,DB07246,-7.4,"(2R)-2-AMINO-3,3,3-TRIFLUORO-N-HYDROXY-2-{[(4-PHENOXYPHENYL)SULFONYL]METHYL}PROPANAMIDE",MKRPIBSCGZAUCH-OAHLLOKOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102301,6vxs,DB07242,-7.4,"(4R)-7,8-dichloro-1',9-dimethyl-1-oxo-1,2,4,9-tetrahydrospiro[beta-carboline-3,4'-piperidine]-4-carbonitrile",XGUIMGJMQKZRGM-LLVKDONJSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102300,6vxs,DB07240,-7.4,3-[(9H-fluoren-9-ylideneamino)oxy]propanoic acid,LASWLEUVWJDDBA-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
72209,6m2n,DB00470,-7.4,Dronabinol,CYQFCXCEBYINGO-IAGOWNOFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
148347,6w9q,DB13327,-7.4,Picotamide,KYWCWBXGRWWINE-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
26886,6cs2,DB05708,-7.4,GTS-21,RPYWXZCFYPVCNQ-RVDMUPIBSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
83584,6m3m,DB04081,-7.4,"(4s-Trans)-4-(Methylamino)-5,6-Dihydro-6-Methyl-4h-Thieno(2,3-B)Thiopyran-2-Sulfonamide-7,7-Dioxide",PYXFWOIZPYXNRU-FSPLSTOPSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83575,6m3m,DB04070,-7.4,6-Deoxyerythronolide B,HQZOLNNEQAKEHT-IBBGRPSASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
161667,7bv1,DB00240,-7.4,Alclometasone,FJXOGVLKCZQRDN-PHCHRAKRSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
75948,6m2n,DB06480,-7.4,Prucalopride,ZPMNHBXQOOVQJL-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
148332,6w9q,DB13310,-7.4,Ormeloxifene,XZEUAXYWNKYKPL-WDYNHAJCSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
26899,6cs2,DB05804,-7.4,Prasterone sulfate,CZWCKYRVOZZJNM-USOAJAOKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
104861,6vxs,DB12621,-7.4,ST-101,QZWYXEBIQWJXAR-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
83574,6m3m,DB04069,-7.4,"5,6-Dihydro-Benzo[H]Cinnolin-3-Ylamine",QKVREUJWFZJEJK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
72218,6m2n,DB00480,-7.4,Lenalidomide,GOTYRUGSSMKFNF-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
128551,6w4h,DB07747,-7.4,"(3R)-N-(4-CHLOROPHENYL)-3-(HYDROXYMETHYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONAMIDE",YTBGBMPLINFTBQ-OAHLLOKOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
158281,7bv1,DB00817,-7.4,Rosoxacin,XBPZXDSZHPDXQU-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
102335,6vxs,DB07280,-7.4,5-[4-(DIMETHYLAMINO)PHENYL]-6-[(6-MORPHOLIN-4-YLPYRIDIN-3-YL)ETHYNYL]PYRIMIDIN-4-AMINE,AINVOEOJEKKMKB-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
16319,6lzg,DB03725,-7.4,Phosphomethylphosphonic Acid-Guanylate Ester,PHBDHXOBFUBCJD-KQYNXXCUSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
29732,6cs2,DB11485,-7.4,Ceftiofur,ZBHXIWJRIFEVQY-IHMPYVIRSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
135431,6w9c,DB04463,-7.4,"3-(4-Amino-1-Tert-Butyl-1h-Pyrazolo[3,4-D]Pyrimidin-3-Yl)Phenol",CPLGZXQPPYRNRC-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
66098,6lxt,DB03737,-7.4,"4-((3r,4s,5r)-4-Amino-3,5-Dihydroxy-Hex-1-Ynyl)-5-Fluoro-3-[1-(3-Methoxy-1h-Pyrrol-2-Yl)-Meth-(Z)-Ylidene]-1,3-Dihydro-Indol-2-One",RAKYKJWUUUKCCW-MPLBGYFPSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
102388,6vxs,DB07335,-7.4,"3-[4-AMINO-1-(1-METHYLETHYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL]PHENOL",MWYBBCLGEHZSCP-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
60793,6crv,DB09149,-7.4,Florbetapir (18F),YNDIAUKFXKEXSV-CRYLGTRXSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30126,6cs2,DB12084,-7.4,ADP-597,WPDCHTSXOPUOII-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
83657,6m3m,DB04172,-7.4,"[2,4,6-Triisopropyl-Phenylsulfonyl-L-[3-Amidino-Phenylalanine]]-Piperazine-N'-Beta-Alanine",WATXEHGLYJKXOF-NDEPHWFRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
18006,6cs2,HMDB0011637,-7.4,Taurohyocholate,XSOLDPYUICCHJX-RBPXSRGGSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
26846,6cs2,DB05514,-7.4,Cobiprostone,SDDSJMXGJNWMJY-BRHAQHMBSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
128663,6w4h,DB07871,-7.4,6-CHLORO-4-(CYCLOHEXYLOXY)-3-ISOPROPYLQUINOLIN-2(1H)-ONE,OQCFORGSZJSAEL-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
58423,6crv,DB05143,-7.4,OXI-4503,GSOXMQLWUDQTNT-WAYWQWQTSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
102375,6vxs,DB07322,-7.4,"2-[(PHENYLSULFONYL)AMINO]-5,6,7,8-TETRAHYDRONAPHTHALENE-1-CARBOXYLIC ACID",RRXVUYHFDBLTEL-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
12633,6lzg,DB13616,-7.4,Melagatran,DKWNMCUOEDMMIN-PKOBYXMFSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
158319,7bv1,DB00858,-7.4,Drostanolone,IKXILDNPCZPPRV-RFMGOVQKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
161500,7bv1,DB14929,-7.4,Elsulfavirine,ULTDEARCBRNRGR-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
158315,7bv1,DB00854,-7.4,Levorphanol,JAQUASYNZVUNQP-USXIJHARSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
102365,6vxs,DB07311,-7.4,"18-CHLORO-11,12,13,14-TETRAHYDRO-1H,10H-8,4-(AZENO)-9,15,1,3,6-BENZODIOXATRIAZACYCLOHEPTADECIN-2-ONE",JRSWWYITYIOHOP-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
8660,6lzg,DB06625,-7.4,Vipadenant,HQSBCDPYXDGTCL-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
11892,6lzg,DB12574,-7.4,LY-295501,VAMFSFIPDOODFH-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
102350,6vxs,DB07295,-7.4,2-[(7-HYDROXY-NAPHTHALEN-1-YL)-OXALYL-AMINO]-BENZOIC ACID,IGOULVZYQKJJKC-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
94221,6m71,DB07859,-7.4,4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL)PHENYL]PIPERIDINE,LZMOSYUFVYJEPY-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
161539,7bv1,DB15038,-7.4,Litoxetine,MJJDYOLPMGIWND-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
161530,7bv1,DB15024,-7.4,Apararenone,AZNHWXAFPBYFGH-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
83564,6m3m,DB04055,-7.4,"2,3-Dicarboxy-4-(2-Chloro-Phenyl)-1-Ethyl-5-Isopropoxycarbonyl-6-Methyl-Pyridinium",HMSIYRVIPQHZBI-UHFFFAOYSA-O,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
35303,1r42,DB01451,-7.4,1-Androstenedione,WJIQCDPCDVWDDE-WZNAKSSCSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
161517,7bv1,DB14987,-7.4,Difamilast,VFBILHPIHUPBPZ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
128625,6w4h,DB07829,-7.4,4-[3-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL]PYRIDINE,BILJSHVAAVZERY-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
158302,7bv1,DB00839,-7.4,Tolazamide,OUDSBRTVNLOZBN-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
113416,6vxx,DB09167,-7.4,Dosulepin,PHTUQLWOUWZIMZ-GZTJUZNOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
158306,7bv1,DB00844,-7.4,Nalbuphine,NETZHAKZCGBWSS-CEDHKZHLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
11899,6lzg,DB12582,-7.4,Piperine,MXXWOMGUGJBKIW-YPCIICBESA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
30130,6cs2,DB12093,-7.4,Tetrahydropalmatine,AEQDJSLRWYMAQI-KRWDZBQOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
161681,7bv1,DB00257,-7.4,Clotrimazole,VNFPBHJOKIVQEB-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
135732,6w9c,DB04864,-7.4,Huperzine A,ZRJBHWIHUMBLCN-YQEJDHNASA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
149925,6wiq,DB00751,-7.4,Epinastine,WHWZLSFABNNENI-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
94270,6m71,DB07920,-7.4,N-oxo-2-[(4-phenylphenyl)sulfonylamino]ethanamide,OGRPZMQLAVBWPV-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
12663,6lzg,DB13656,-7.4,Eberconazole,MPTJIDOGFUQSQH-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
113364,6vxx,DB09056,-7.4,Amorolfine,MQHLMHIZUIDKOO-AYHJJNSGSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
83480,6m3m,DB03938,-7.4,Deacetoxycephalosporin-C,NNQIJOYQWYKBOW-JWKOBGCHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
104894,6vxs,DB12670,-7.4,Rolofylline,PJBFVWGQFLYWCB-QUYAXPHCSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
135917,6w9c,DB05708,-7.4,GTS-21,RPYWXZCFYPVCNQ-RVDMUPIBSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
25233,6cs2,DB03115,-7.4,"5-Bromo-N-(2,3-Dihydroxypropoxy)-3,4-Difluoro-2-[(2-Fluoro-4-Iodophenyl)Amino]Benzamide",XXSSGBYXSKOLAM-QMMMGPOBSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
66771,6lxt,DB04624,-7.4,DERIVATIVE OF AKLANONIC ACID METHYL ESTER (AAME),SIHNJMGWRHPFAZ-XHDPSFHLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
158125,7bv1,DB00408,-7.4,Loxapine,XJGVXQDUIWGIRW-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
135929,6w9c,DB06106,-7.4,AIT-034,FBVDVFULNXWYRF-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
33538,6cs2,T3D0412,-7.4,"2,3,5-Trichlorobiphenyl",GBUCDGDROYMOAN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
102236,6vxs,DB07164,-7.4,"N-cyclopropyl-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amine",CAGHIASAHLPQMS-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
66057,6lxt,DB03682,-7.4,"Dibenzofuran-4,6-Dicarboxylic Acid",HBBGSNOHAGNQRQ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
161761,7bv1,DB00567,-7.4,Cephalexin,ZAIPMKNFIOOWCQ-UEKVPHQBSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
135959,6w9c,DB06187,-7.4,Valtorcitabine,VFCYZPOEGWLYRM-QCZKYFFMSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
30142,6cs2,DB12109,-7.4,CPI-613,ZYRLHJIMTROTBO-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
166394,7bv1,DB14799,-7.4,PF-06821497,RXCVUHMIWHRLDF-HXUWFJFHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
158102,7bv1,DB00380,-7.4,Dexrazoxane,BMKDZUISNHGIBY-ZETCQYMHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
26966,6cs2,DB06157,-7.4,Istaroxime,MPYLDWFDPHRTEG-PAAYLBSLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
102202,6vxs,DB07125,-7.4,"4-(6-{[(1R)-1-(hydroxymethyl)propyl]amino}imidazo[1,2-b]pyridazin-3-yl)benzoic acid",KKZYGUVAFJCULH-CYBMUJFWSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
113343,6vxx,DB09016,-7.4,Butriptyline,ALELTFCQZDXAMQ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
128319,6w4h,DB07469,-7.4,"(3aS)-3a-hydroxy-7-methyl-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one",KAJFGRLMKVNMLH-GOSISDBHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
16248,6lzg,DB03361,-7.4,"2-{(9as)-9a-[(1s)-1-Hydroxyethyl]-2,7-Dimethyl-9a,10-Dihydro-5h-Pyrimido[4,5-D][1,3]Thiazolo[3,2-a]Pyrimidin-8-Yl}Ethyl Trihydrogen Diphosphate",UQFVHIGKDHNMJT-XPTSAGLGSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
158159,7bv1,DB00448,-7.4,Lansoprazole,MJIHNNLFOKEZEW-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93224,6m71,DB06622,-7.4,7-beta-Hydroxyepiandrosterone,VFPMCLQMAUVEHD-UCPSWNCLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
102218,6vxs,DB07143,-7.4,D-phenylalanyl-N-benzyl-L-prolinamide,MEPJWLFTTFHOQO-MOPGFXCFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
158121,7bv1,DB00402,-7.4,Eszopiclone,GBBSUAFBMRNDJC-INIZCTEOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
135983,6w9c,DB06234,-7.4,Maribavir,KJFBVJALEQWJBS-XUXIUFHCSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
33527,6cs2,T3D0411,-7.4,"2,3,4'-Trichlorobiphenyl",ZMHWQAHZKUPENF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
135977,6w9c,DB06217,-7.4,Vernakalant,VBHQKCBVWWUUKN-KZNAEPCWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
94286,6m71,DB07936,-7.4,N-(4-{[(3S)-3-(dimethylamino)pyrrolidin-1-yl]carbonyl}phenyl)-5-fluoro-4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]pyrimidin-2-amine,BACSZMCLZIDTIO-IBGZPJMESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
75411,6m2n,DB04659,-7.4,"(1S,2S,3R,4S,5S)-2,3,4-TRIHYDROXY-5-(HYDROXYMETHYL)CYCLOHEXYL (1E)-2-PHENYL-N-(SULFOOXY)ETHANIMIDOTHIOATE",LZDZCEOFJWRJIA-GGASBGQWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
60977,6crv,DB11217,-7.4,Arbutin,BJRNKVDFDLYUGJ-RMPHRYRLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
128397,6w4h,DB07561,-7.4,(2Z)-2-cyano-N-(3'-ethoxybiphenyl-4-yl)-3-hydroxybut-2-enamide,RPILZQUCBKIPAZ-AQTBWJFISA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
33558,6cs2,T3D4808,-7.4,Fluorescein,GNBHRKFJIUUOQI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
86868,6m3m,DB11395,-7.4,Deracoxib,WAZQAZKAZLXFMK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
104871,6vxs,DB12638,-7.4,PU-H71,SUPVGFZUWFMATN-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
83532,6m3m,DB04007,-7.4,Bromo-WR99210,MPXYCOHVHSXSDC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
70439,6lxt,DB12657,-7.4,JNJ-42396302,BPLVDYJDAVYLRQ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
135773,6w9c,DB04946,-7.4,Iloperidone,XMXHEBAFVSFQEX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
135774,6w9c,DB04947,-7.4,Altropane,GTQLIPQFXVKRKJ-UNSMHXHVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
128477,6w4h,DB07655,-7.4,"3-AMINO-3-BENZYL-[4.3.0]BICYCLO-1,6-DIAZANONAN-2-ONE",MPJYGQHMIFDQIN-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
66074,6lxt,DB03708,-7.4,Adenosine 5'-phosphosulfate,IRLPACMLTUPBCL-KQYNXXCUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
86904,6m3m,DB11461,-7.4,Sulfachlorpyridazine,XOXHILFPRYWFOD-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
70419,6lxt,DB12623,-7.4,Taprenepag,MFFBXYNKZHTCEY-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
128470,6w4h,DB07648,-7.4,"(2R)-3-{[(4Z)-5,6-DIPHENYL-6,7-DIHYDRO-4H-PYRROLO[2,3-D]PYRIMIDIN-4-YLIDENE]AMINO}PROPANE-1,2-DIOL",TWEONIHFGKSPLC-MRXNPFEDSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
83515,6m3m,DB03986,-7.4,6-Methyl-Formycin A,UHYKIYIKTWEXSX-LFAOKBQASA-O,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
161715,7bv1,DB00507,-7.4,Nitazoxanide,YQNQNVDNTFHQSW-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
135801,6w9c,DB05053,-7.4,MB-07803,CTKZZUXRWBCFEI-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
8670,6lzg,DB06645,-7.4,Anamorelin,VQPFSIRUEPQQPP-MXBOTTGLSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
94257,6m71,DB07901,-7.4,5-CHLORO-6-METHYL-N-(2-PHENYLETHYL)-2-PYRIDIN-2-YLPYRIMIDIN-4-AMINE,HIUOABSWQSUEGK-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93227,6m71,DB06625,-7.4,Vipadenant,HQSBCDPYXDGTCL-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
16267,6lzg,DB03449,-7.4,N-(4-(2-((3-Chlorophenylmethyl)Amino)Ethyl)Phenyl)-2-Thiophecarboxamidine,ZZVGLDBDD1AB-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
72252,6m2n,DB00525,-7.4,Tolnaftate,FUSNMLFNXJSCDI-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
158170,7bv1,DB00461,-7.4,Nabumetone,BLXXJMDCKKHMKV-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
26938,6cs2,DB06040,-7.4,Filanesib,LLXISKGBWFTGEI-FQEVSTJZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
60912,6crv,DB09345,-7.4,Pramocaine,DQKXQSGTHWVTAD-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
158172,7bv1,DB00465,-7.4,Ketorolac,OZWKMVRBQXNZKK-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
128398,6w4h,DB07562,-7.4,"N-[4-(2,4-DIMETHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YL]-N',N'-DIMETHYL-BENZENE-1,4-DIAMINE",FGGSNQOBRJVAKL-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
35377,1r42,DB01536,-7.4,Androstenedione,AEMFNILZOJDQLW-QAGGRKNESA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
8060,6lzg,DB04715,-7.4,IMIDAZOPYRIDAZIN 1,IVUBNTNWKIPCPS-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
135842,6w9c,DB05295,-7.4,Eldecalcitol,FZEXGDDBXLBRTD-AYIMTCTASA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
11869,6lzg,DB12542,-7.4,GSK-356278,AWDJJMXJUOHGLC-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
102273,6vxs,DB07206,-7.4,6-[2-(1H-INDOL-6-YL)ETHYL]PYRIDIN-2-AMINE,OSHSZKRWKLQZBV-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
60902,6crv,DB09306,-7.4,Metralindole,GVXBHSBKKJRBMS-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
26921,6cs2,DB00578,-7.4,Carbenicillin,FPPNZSSZRUTDAP-UWFZAAFLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
83495,6m3m,DB03956,-7.4,"Inositol 2,4,5-trisphosphate",MMWCIQZXVOZEGG-LKPKBOIGSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
71886,6lxt,DB02930,-7.4,Adenosine 5'-[gamma-thio]triphosphate,NLTUCYMLOPLUHL-KQYNXXCUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
133881,6w9c,DB02276,-7.4,(S)-2-(Phosphonoxy)Caproyl-L-Leucyl-P-Nitroanilide,HARXAJAHMRMERT-HOTGVXAUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
158864,7bv1,DB02559,-7.4,"6-(Octahydro-1h-Indol-1-Ylmethyl)Decahydroquinazoline-2,4-Diamine",HDQIGGQUKAQTGU-SZTTVXCBSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
159753,7bv1,DB06465,-7.4,FK-960,XTOKQKWTUYYVAO-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
85638,6m3m,DB07892,-7.4,1-(2-HYDROXYETHYLOXYMETHYL)-6-PHENYL THIOTHYMINE,HDMHBHNRWDNNCD-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
160265,7bv1,DB07943,-7.4,2-{4-[5-(4-chlorophenyl)-4-pyrimidin-4-yl-1H-pyrazol-3-yl]piperidin-1-yl}-2-oxoethanol,CATQHDWESBRRQA-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
103452,6vxs,DB08596,-7.4,5'-deoxy-5'-piperidin-1-ylthymidine,GMOUOGHZJCSNOZ-YNEHKIRRSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
26212,6cs2,DB04298,-7.4,"3-(4-Amino-2-Tert-Butyl-5-Methyl-Phenylsulfanyl)-6-Cyclopentyl-4-Hydroxy-6-[2-(4-Hydroxy-Phenyl)-Ethyl]-5,6-Dihydro-Pyran-2-One",ZEBFKFGJWHOOST-LJAQVGFWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
85660,6m3m,DB07921,-7.4,2-[(4-fluorophenyl)sulfonylamino]-N-oxo-ethanamide,ATANXIMWDMRRIO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
71191,6lxt,DB13766,-7.4,Lidoflazine,ZBIAKUMOEKILTF-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
34320,1r42,DB00443,-7.4,Betamethasone,UREBDLICKHMUKA-DVTGEIKXSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
132240,6w9c,DB00192,-7.4,Indecainide,UCEWGESNIULAGX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
160289,7bv1,DB07971,-7.4,"5-AMINO-2-{4-[(4-AMINOPHENYL)SULFANYL]PHENYL}-1H-ISOINDOLE-1,3(2H)-DIONE",FQQVTDIBUYSVHM-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
8266,6lzg,DB05100,-7.4,Prinomastat,YKPYIPVDTNNYCN-INIZCTEOSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
104077,6vxs,DB11372,-7.4,Altrenogest,VWAUPFMBXBWEQY-ANULTFPQSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
85046,6m3m,DB07200,-7.4,"(2S,4S,5R)-2-ISOBUTYL-5-(2-THIENYL)-1-[4-(TRIFLUOROMETHYL)BENZOYL]PYRROLIDINE-2,4-DICARBOXYLIC ACID",ZNCZVHCYBGHCHA-XPIZARPCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
34315,1r42,DB00438,-7.4,Ceftazidime,ORFOPKXBNMVMKC-DWVKKRMSSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
23383,6cs2,HMDB0061741,-7.4,2-(N-Ethyl-perfluorooctane sulfanamido) acetic acid,CKRXVVGETMYFIO-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
104078,6vxs,DB11376,-7.4,Azaperone,XTKDAFGWCDAMPY-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
130775,6w4h,DB12766,-7.4,Cicletanine,CVKNDPRBJVBDSS-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
75703,6m2n,DB05475,-7.4,Golotimod,CATMPQFFVNKDEY-YPMHNXCESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
93743,6m71,DB07300,-7.4,"2-(1H-imidazol-1-yl)-9-methoxy-8-(2-methoxyethoxy)benzo[c][2,7]naphthyridin-4-amine",QSSGYSRUMIOURP-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
85695,6m3m,DB07961,-7.4,"1-(4-CYANO-PHENYL)-3-[2-(2,6-DICHLORO-PHENYL)-1-IMINO-ETHYL]-THIOUREA",NWKJBFSBEAMDBE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
23382,6cs2,HMDB0061740,-7.4,Perfluorooctane sulfonamide,RRRXPPIDPYTNJG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
132316,6w9c,DB00279,-7.4,Liothyronine,AUYYCJSJGJYCDS-LBPRGKRZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
25858,6cs2,DB03880,-7.4,Batimastat,XFILPEOLDIKJHX-QYZOEREBSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
130725,6w4h,DB12689,-7.4,Azeliragon,KJNNWYBAOPXVJY-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
159698,7bv1,DB05377,-7.4,Chlorfenson,RZXLPPRPEOUENN-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93755,6m71,DB07312,-7.4,"2,5-DICHLORO-N-(5-CHLORO-1,3-BENZOXAZOL-2-YL)BENZENESULFONAMIDE",JCXZHFCBNFFHRC-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
149068,6w9q,DB14849,-7.4,Nebicapone,MRFOLGFFTUGAEB-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
160315,7bv1,DB08000,-7.4,"2-(CARBOXYMETHYL)-1-OXO-1,2-DIHYDRONAPHTHO[1,2-D]ISOTHIAZOLE-4-CARBOXYLIC ACID 3,3-DIOXIDE",ZTJGXDGAXGWOGR-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
130713,6w4h,DB12670,-7.4,Rolofylline,PJBFVWGQFLYWCB-QUYAXPHCSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
104105,6vxs,DB11426,-7.4,Marbofloxacin,BPFYOAJNDMUVBL-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
130779,6w4h,DB12774,-7.4,AZD-8055,KVLFRAWTRWDEDF-IRXDYDNUSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
103469,6vxs,DB08615,-7.4,"2-[4-(DIMETHYLAMINO)PHENYL]-6-HYDROXY-3-METHYL-1,3-BENZOTHIAZOL-3-IUM",NOVJJPLRUMZSDK-UHFFFAOYSA-O,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
85627,6m3m,DB07876,-7.4,(S)-2-METHYL-1-[(4-METHYL-5-ISOQUINOLINE)SULFONYL]-HOMOPIPERAZINE,AWDORCFLUJZUQS-ZDUSSCGKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
114091,6vxx,DB12714,-7.4,Nerispirdine,BTDHTARYCBHHPJ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
12234,6lzg,DB13074,-7.4,Macimorelin,UJVDJAPJQWZRFR-DHIUTWEWSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
103536,6vxs,DB08702,-7.4,"2,5-DIPHENYLFURAN-3,4-DICARBOXYLIC ACID",QPKYPOMZPFDBEZ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
159812,7bv1,DB06616,-7.4,Bosutinib,UBPYILGKFZZVDX-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
159810,7bv1,DB06609,-7.4,Odiparcil,JRHNIQQUVJOPQC-AQNFWKISSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
132013,6w4h,DB15206,-7.4,Uprifosbuvir,SFPFZQKYPOWCSI-KHFYHRBSSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
34361,1r42,DB00158,-7.4,Folic acid,OVBPIULPVIDEAO-LBPRGKRZSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
166550,7bv1,DB15347,-7.4,Branebrutinib,VJPPLCNBDLZIFG-ZDUSSCGKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
25915,6cs2,DB00461,-7.4,Nabumetone,BLXXJMDCKKHMKV-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
26173,6cs2,DB00490,-7.4,Buspirone,QWCRAEMEVRGPNT-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
66438,6lxt,DB04176,-7.4,"Phosporic Acid Mono-[3,4-Dihydroxy-5-(5-Methoxy-Benzoimidazol-1-Yl)-Tetrahydro-Furan-2-Ylmethyl] Ester",VYUPJUKSTVHSQI-LPWJVIDDSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
34628,1r42,DB00590,-7.4,Doxazosin,RUZYUOTYCVRMRZ-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
85605,6m3m,DB07854,-7.4,N-METHYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE,VRGSDHJXBVCQEL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
103958,6vxs,DB09305,-7.4,Aptazapine,MNHDDERDSNZCCK-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
75556,6m2n,DB04857,-7.4,Brasofensine,NRLIFEGHTNUYFL-QJDHNRDASA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
132070,6w4h,DB15317,-7.4,Posiphen,PBHFNBQPZCRWQP-AZUAARDMSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
160221,7bv1,DB07891,-7.4,"4-{[(14beta,17alpha)-3-hydrox1tra-1,3,5(10)-trien-17-yl]oxy}-4-oxobutanoic acid",YJPIDPAGJSWWBE-FNIAAEIWSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
132072,6w4h,DB15323,-7.4,Trelagliptin,IWYJYHUNXVAVAA-OAHLLOKOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
14352,6lzg,T3D4018,-7.4,Ouabain,LPMXVESGRSUGHW-HBYQJFLCSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
85098,6m3m,DB07262,-7.4,1-{[N-(1-IMINO-GUANIDINO-METHYL)]SULFANYLMETHYL}-3-TRIFLUOROMETHYL-BENZENE,DWJNPCRXBNWCJC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59809,6crv,DB07899,-7.4,(2S) N-acetyl-L-alanyl-??L-phenylalanyl-chloroethylketone,WABWAIGLGFELMI-FZMZJTMJSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
132119,6w4h,DB15418,-7.4,AZD-9977,MBKYLPOPYYLTNW-ZDUSSCGKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
104022,6vxs,DB11157,-7.4,Anthralin,NUZWLKWWNNJHPT-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
103479,6vxs,DB08631,-7.4,"N-(4-CHLOROPHENYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONAMIDE",UVSIFVBCHJEYJP-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
130705,6w4h,DB12661,-7.4,Urapidil,ICMGLRUYEQNHPF-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
93710,6m71,DB07263,-7.4,"[{2-bromo-4-[(2R)-3-oxo-2,3-diphenylpropyl]phenyl}(difluoro)methyl]phosphonic acid",WDTMVBQZDFMOIK-GOSISDBHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
132088,6w4h,DB15348,-7.4,Ampreloxetine,TZIALEBTHQWNAO-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
103500,6vxs,DB08655,-7.4,"9-ACETYL-2,3,4,9-TETRAHYDRO-1H-CARBAZOL-1-ONE",MIGJEXKBUJPKJF-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
71512,6lxt,DB14671,-7.4,Temazepam acetate,PTWWAHZQIATUFG-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
103991,6vxs,DB09488,-7.4,Acrivastine,PWACSDKDOHSSQD-IUTFFREVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
103982,6vxs,DB09383,-7.4,Meprednisone,PIDANAQULIKBQS-RNUIGHNZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
149309,6w9q,DB15348,-7.4,Ampreloxetine,TZIALEBTHQWNAO-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
130918,6w4h,DB12998,-7.4,PF-00217830,QGNOXTFZOLDODX-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
149063,6w9q,DB14840,-7.4,Ripretinib,CEFJVGZHQAGLHS-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
160325,7bv1,DB08011,-7.4,"(3E)-5-fluoro-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-1H-indole-2,3-dione 3-oxime",DXIHOIDYHQSQKJ-HMMYKYKNSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
103401,6vxs,DB08534,-7.4,"5-(2-fluorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",ZAIYYXVHGBMLEC-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
103345,6vxs,DB08469,-7.4,"tert-butyl 4-(3-thiophen-2-yl-1,2,4-oxadiazol-5-yl)piperidine-1-carboxylate",METBQPRXNZHZMB-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
93790,6m71,DB07351,-7.4,O-(((1R)-((N-(PHENYL-METHOXY-CARBONYL)-ALANYL)-AMINO)METHYL)HYDROXYPHOSPHINYL)3-L-PHENYLLACTATE,ICACWKLCNCPHAM-YJBOKZPZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
1967,6lzg,HMDB0029249,-7.4,Luteolinidin,GDNIGMNXEKGFIP-UHFFFAOYSA-O,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
34251,1r42,DB00358,-7.4,Mefloquine,XEEQGYMUWCZPDN-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
160388,7bv1,DB08322,-7.4,"2-DEOXY-3,4-BIS-O-[3-(4-HYDROXYPHENYL)PROPANOYL]-L-THREO-PENTARIC ACID",VJLMRHSHSNLOGC-NOPZTHQXSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
132506,6w9c,DB00509,-7.4,Dextrothyroxine,XUIIKFGFIJCVMT-GFCCVEGCSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
71107,6lxt,DB13656,-7.4,Eberconazole,MPTJIDOGFUQSQH-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
84901,6m3m,DB07035,-7.4,"(2E)-3-{3-[(5-ETHYL-3-IODO-6-METHYL-2-OXO-1,2-DIHYDROPYRIDIN-4-YL)OXY]PHENYL}ACRYLONITRILE",XMFUXIRAVPMVRS-FNORWQNLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
71598,6lxt,DB14875,-7.4,AZD-4017,NCDZABJPWMBMIQ-INIZCTEOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
130519,6w4h,DB12380,-7.4,GDC-0152,WZRFLSDVFPIXOV-LRQRDZAKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
93534,6m71,DB07058,-7.4,"5-[1-(4-methoxyphenyl)-1H-benzimidazol-6-yl]-1,3,4-oxadiazole-2(3H)-thione",QBVJMUOTMRYUKR-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
114194,6vxx,DB12884,-7.4,Lavoltidine,VTLNPNNUIJHJQB-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
132526,6w9c,DB00539,-7.4,Toremifene,XFCLJVABOIYOMF-QPLCGJKRSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
160410,7bv1,DB08352,-7.4,"6-[4-(2-fluorophenyl)-1,3-oxazol-5-yl]-N-(1-methylethyl)-1,3-benzothiazol-2-amine",FQYJTHIYAQQJAB-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
5963,6lzg,DB01340,-7.4,Cilazapril,HHHKFGXWKKUNCY-FHWLQOOXSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
132527,6w9c,DB00540,-7.4,Nortriptyline,PHVGLTMQBUFIQQ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
93793,6m71,DB07354,-7.4,"2,3-DIMETHOXY-12H-[1,3]DIOXOLO[5,6]INDENO[1,2-C]ISOQUINOLIN-6-IUM",LXDREMZQGAILJU-UHFFFAOYSA-O,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
85893,6m3m,DB08178,-7.4,"4-(4-methoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine",GGEWEQJWGGJUHO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
130465,6w4h,DB12301,-7.4,Doravirine,ZIAOVIPSKUPPQW-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
132649,6w9c,DB00688,-7.4,Mycophenolate mofetil,RTGDFNSFWBGLEC-SYZQJQIISA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
149490,6wiq,DB00227,-7.4,Lovastatin,PCZOHLXUXFIOCF-BXMDZJJMSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
25781,6cs2,DB00447,-7.4,Loracarbef,JAPHQRWPEGVNBT-UTUOFQBUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
159564,7bv1,DB04576,-7.4,Fleroxacin,XBJBPGROQZJDOJ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
130541,6w4h,DB12408,-7.4,PF-03635659,WGOJWDWKHJHXSV-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
93807,6m71,DB07373,-7.4,"ANDROSTA-1,4-DIENE-3,17-DIONE",LUJVUUWNAPIQQI-QAGGRKNESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
130483,6w4h,DB12322,-7.4,GW-870086,WUBKGTSFJSEIEM-NSHBDUGJSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
132564,6w9c,DB00584,-7.4,Enalapril,GBXSMTUPTTWBMN-XIRDDKMYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
85823,6m3m,DB08104,-7.4,"N-(3,5-dibromo-4-hydroxyphenyl)benzamide",HKODPZBPODONGO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
93522,6m71,DB07046,-7.4,"2-[(2-chloro-4-iodophenyl)amino]-N-{[(2R)-2,3-dihydroxypropyl]oxy}-3,4-difluorobenzamide",FCADPEDUULETPK-SECBINFHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
149000,6w9q,DB14675,-7.4,Temsavir,QRPZBKAMSFHVRW-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
130510,6w4h,DB12367,-7.4,Selurampanel,MCECSFFXUPEPDB-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
132612,6w9c,DB00641,-7.4,Simvastatin,RYMZZMVNJRMUDD-HGQWONQESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
131017,6w4h,DB13155,-7.4,Esculin,XHCADAYNFIFUHF-TVKJYDDYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
85805,6m3m,DB08083,-7.4,"2-(1,3-thiazol-4-yl)-1H-benzimidazole-5-sulfonamide",KGMVTZZDGKDTEU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
132499,6w9c,DB00500,-7.4,Tolmetin,UPSPUYADGBWSHF-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
29959,6cs2,DB00902,-7.4,Methdilazine,HTMIBDQKFHUPSX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
71150,6lxt,DB13711,-7.4,Tritoqualine,IRGJVQIJENCTQF-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
149060,6w9q,DB14828,-7.4,ABX-464,OZOGDCZJYVSUBR-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
149361,6w9q,DB15460,-7.4,AGG-523,JWQMTWCFNZSLNR-DEOSSOPVSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
34703,1r42,DB00683,-7.4,Midazolam,DDLIGBOFAVUZHB-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
25834,6cs2,DB03851,-7.4,Carbazole Butanoic Acid,HQAKVYGASUTQHH-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
149368,6w9q,DB02639,-7.4,4-methylumbelliferyl alpha-D-glucoside,YUDPTGPSBJVHCN-JZYAIQKZSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
159661,7bv1,DB05107,-7.4,16-Bromoepiandrosterone,CWVMWSZEMZOUPC-JUAXIXHSSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
130660,6w4h,DB12585,-7.4,Ondelopran,QWNDOCKIKKQJNN-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130659,6w4h,DB12582,-7.4,Piperine,MXXWOMGUGJBKIW-YPCIICBESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
149046,6w9q,DB14787,-7.4,BMS-830216,YDTUJCNTIMWHPJ-NRFANRHFSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
93761,6m71,DB07318,-7.4,"N-[2-(4-AMINO-5,8-DIFLUORO-1,2-DIHYDROQUINAZOLIN-2-YL)ETHYL]-3-FURAMIDE",BOAUWUUBSXECNL-LLVKDONJSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
103368,6vxs,DB08496,-7.4,(R)-warfarin,PJVWKTKQMONHTI-HNNXBMFYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
130646,6w4h,DB12565,-7.4,Abexinostat,MAUCONCHVWBMHK-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
132454,6w9c,DB00447,-7.4,Loracarbef,JAPHQRWPEGVNBT-UTUOFQBUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
104139,6vxs,DB11485,-7.4,Ceftiofur,ZBHXIWJRIFEVQY-IHMPYVIRSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
113839,6vxx,DB12156,-7.4,Cordycepin,OFEZSBMBBKLLBJ-BAJZRUMYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
71586,6lxt,DB14854,-7.4,TC-6987,UAKZGMMGIMKFMV-RBUKOAKNSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
160375,7bv1,DB08308,-7.4,"SUCCINIC ACID MONO-(13-METHYL-3-OXO-2,3,6,7,8,9,10,11,12,13,14,15,16,17-TETRADECAHYDRO-1H-CYCLOPENTA[A]PHENANTHREN-17-YL) ESTER",IRQUJNVGEAJGSD-KIEDKLRZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
132494,6w9c,DB00495,-7.4,Zidovudine,HBOMLICNUCNMMY-XLPZGREQSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
85762,6m3m,DB08033,-7.4,"(5R)-N,N-DIETHYL-5-METHYL-2-[(THIOPHEN-2-YLCARBONYL)AMINO]-4,5,6,7-TETRAHYDRO-1-BENZOTHIOPHENE-3-CARBOXAMIDE",UQKSYQYWUHUIEH-GFCCVEGCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
132480,6w9c,DB00479,-7.4,Amikacin,LKCWBDHBTVXHDL-RMDFUYIESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
59926,6crv,DB08032,-7.4,"N,N-DIETHYL-2-[(2-THIENYLCARBONYL)AMINO]-4,5,6,7-TETRAHYDRO-1-BENZOTHIOPHENE-3-CARBOXAMIDE",NZTHBWHANVWSRX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
149474,6wiq,DB00206,-7.4,Reserpine,QEVHRUUCFGRFIF-MDEJGZGSSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
103353,6vxs,DB08478,-7.4,N-[2-chloro-5-(trifluoromethyl)phenyl]imidodicarbonimidic diamide,IGFTZEOFHWPCDL-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
159640,7bv1,DB05013,-7.4,Ingenol mebutate,VDJHFHXMUKFKET-UXMMOKKRSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
75534,6m2n,DB04829,-7.4,Lysergic acid diethylamide,VAYOSLLFUXYJDT-RDTXWAMCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
103357,6vxs,DB08485,-7.4,"(1S,4S,5S)-1,4,5-TRIHYDROXY-3-[3-(PHENYLTHIO)PHENYL]CYCLOHEX-2-ENE-1-CARBOXYLIC ACID",QMNMNSINKIFYBV-LMMKCTJWSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
71576,6lxt,DB14828,-7.4,ABX-464,OZOGDCZJYVSUBR-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
93544,6m71,DB07070,-7.4,(2S)-2-{3-[({[2-fluoro-4-(trifluoromethyl)phenyl]carbonyl}amino)methyl]-4-methoxybenzyl}butanoic acid,BDLLIPYDNFENMY-ZDUSSCGKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
159650,7bv1,DB05048,-7.4,Cannabinor,GSTZHANFXAKPSE-MXTREEOPSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160369,7bv1,DB08302,-7.4,3-[5-(2-nitropent-1-en-1-yl)furan-2-yl]benzoic acid,IRHZCQDCMUWUKV-RAXLEYEMSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
29808,6cs2,DB11665,-7.4,BMS-690514,CSGQVNMSRKWUSH-IAGOWNOFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
103953,6vxs,DB09292,-7.4,Sacubitril,PYNXFZCZUAOOQC-UTKZUKDTSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
131987,6w4h,DB15152,-7.4,TMC-649128,XJBILYMRFVHPJB-XJQUKVTJSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
103784,6vxs,DB09020,-7.4,Bisacodyl,KHOITXIGCFIULA-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
149212,6w9q,DB15163,-7.4,Selatogrel,FYXHWMQPCJOJCH-GMAHTHKFSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
131629,6w4h,DB14075,-7.4,Imidurea,ZCTXEAQXZGPWFG-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
149210,6w9q,DB15157,-7.4,Voruciclib,MRPGRAKIAJJGMM-OCCSQVGLSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
103667,6vxs,DB08860,-7.4,Pitavastatin,VGYFMXBACGZSIL-MCBHFWOFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
26002,6cs2,DB04054,-7.4,"9-Butyl-8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine",PASRTKOWXJDFFV-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
103634,6vxs,DB08807,-7.4,Bopindolol,UUOJIACWOAYWEZ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
131683,6w4h,DB14201,-7.4,"2,2'-Dibenzothiazyl disulfide",AFZSMODLJJCVPP-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
160053,7bv1,DB07455,-7.4,"N,N'-[biphenyl-4,4'-diyldi(2R)propane-2,1-diyl]dimethanesulfonamide",ZESUARCHWPARIF-HOTGVXAUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
131373,6w4h,DB13660,-7.4,Propicillin,HOCWPKXKMNXINF-XQERAMJGSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
93661,6m71,DB07205,-7.4,N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,GZJXCRHEMLAMRA-SDBHATRESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93669,6m71,DB07216,-7.4,"(11S)-8-CHLORO-11-[1-(METHYLSULFONYL)PIPERIDIN-4-YL]-6-PIPERAZIN-1-YL-11H-BENZO[5,6]CYCLOHEPTA[1,2-B]PYRIDINE",ZMGCFGGMTCMSDP-QHCPKHFHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160062,7bv1,DB07467,-7.4,"4-chloro-N-[(2S)-2-methyl-2,3-dihydro-1H-indol-1-yl]-3-sulfamoylbenzamide",NDDAHWYSQHTHNT-JTQLQIEISA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
131686,6w4h,DB14208,-7.4,Ramiprilat,KEDYTOTWMPBSLG-HILJTLORSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131627,6w4h,DB14071,-7.4,Desmethylsertraline,SRPXSILJHWNFMK-ZBEGNZNMSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
26083,6cs2,DB04149,-7.4,(R)-Rolipram,HJORMJIFDVBMOB-LBPRGKRZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
131695,6w4h,DB14221,-7.4,Beclomethasone 17-monopropionate,OHYGPBKGZGRQKT-XGQKBEPLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131344,6w4h,DB13618,-7.4,Ipriflavone,SFBODOKJTYAUCM-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
114021,6vxx,DB12604,-7.4,Sisomicin,URWAJWIAIPFPJE-YFMIWBNJSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
131725,6w4h,DB14583,-7.4,Segesterone acetate,CKFBRGLGTWAVLG-GOMYTPFNSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131728,6w4h,DB14596,-7.4,Loteprednol etabonate,DMKSVUSAATWOCU-HROMYWEYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131730,6w4h,DB14624,-7.4,Nandrolone hydrogen sulfate,SKZMVWBZTQNCKW-IZPLOLCNSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131322,6w4h,DB13591,-7.4,Metopimazine,BQDBKDMTIJBJLA-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
59490,6crv,DB07526,-7.4,N-[4-({[5-(DIMETHYLAMINO)-1-NAPHTHYL]SULFONYL}AMINO)BUTYL]-3-SULFANYLPROPANAMIDE,XPCVYJATJSZGJU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
149182,6w9q,DB15106,-7.4,Surufatinib,TTZSNFLLYPYKIL-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
131315,6w4h,DB13580,-7.4,Succinylsulfathiazole,SKVLYVHULOWXTD-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
59488,6crv,DB07524,-7.4,"N-phenyl-1H-pyrrolo[2,3-b]pyridin-3-amine",CQFGXDQUQWRXLE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85275,6m3m,DB07463,-7.4,"(3R,4S)-1-[(4-amino-5H-pyrrolo[3,2-d]pyrimidin-7-yl)methyl]-4-[(butylsulfanyl)methyl]pyrrolidin-3-ol",LTSUEVPGSXUJHT-OLZOCXBDSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
66502,6lxt,DB04263,-7.4,Geneticin,BRZYSWJRSDMWLG-DJWUNRQOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
131301,6w4h,DB13557,-7.4,Thiopropazate,AIUHRQHVWSUTGJ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
113957,6vxx,DB12321,-7.4,Ifetroban,BBPRUNPUJIUXSE-DXKRWKNPSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
131406,6w4h,DB13696,-7.4,Bromochlorosalicylanilide,QBSGXIBYUQJHMJ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
85324,6m3m,DB07525,-7.4,"3-(3-methoxybenzyl)-1H-pyrrolo[2,3-b]pyridine",GHQCCHWTDLTMJT-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
71392,6lxt,DB14129,-7.4,Macelignan,QDDILOVMGWUNGD-UONOGXRCSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
131525,6w4h,DB13855,-7.4,Nifuroxazide,YCWSUKQGVSGXJO-NTUHNPAUSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
85383,6m3m,DB07593,-7.4,1-(PHENYLMETHYL)CYCLOPENTYL[(1S)-1-FORMYLPENTYL]CARBAMATE,ONABDOMWRCXLPX-KRWDZBQOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
159996,7bv1,DB07169,-7.4,"5R-(3,4-DICHLOROPHENYLMETHYL)-3-(2-THIOPHENESULFONYLAMINO)-4-OXO-2-THIONOTHIAZOLIDINE",GAOOBYJHWAKZKU-LLVKDONJSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
131535,6w4h,DB13872,-7.4,Lormetazepam,FJIKWRGCXUCUIG-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
71349,6lxt,DB14045,-7.4,Cholesteryl chloride,OTVRYZXVVMZHHW-DPAQBDIFSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
160011,7bv1,DB07185,-7.4,2-{[(4-CHLOROPHENOXY)ACETYL]AMINO}BENZOIC ACID,LXSDGQYDSDIUPN-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
34493,1r42,DB00310,-7.4,Chlorthalidone,JIVPVXMEBJLZRO-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
131489,6w4h,DB13810,-7.4,Dimemorfan,KBEZZLAAKIIPFK-NJAFHUGGSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131542,6w4h,DB13916,-7.4,Toyocamycin,XOKJUSAYZUAMGJ-WOUKDFQISA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
85410,6m3m,DB07627,-7.4,(2S)-4-METHYL-2-(3-PHENYLTHIOUREIDO)-N-((3S)-TETRAHYDRO-2-HYDROXY-3-FURANYL)PENTANAMIDE,DBPWWBMTZYJGGV-KKUMJFAQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
131476,6w4h,DB13793,-7.4,Vinburnine,WYJAPUKIYAZSEM-MOPGFXCFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
71376,6lxt,DB14093,-7.4,"(1,2,6,7-3H)Testosterone",MUMGGOZAMZWBJJ-JQSYSRDDSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
131565,6w4h,DB13951,-7.4,Stanolone acetate,ILCTUFVQFCIIDS-NGFSFWIMSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131570,6w4h,DB13956,-7.4,Estradiol valerate,RSEPBGGWRJCQGY-RBRWEJTLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131572,6w4h,DB13958,-7.4,Trestolone acetate,IVCRCPJOLWECJU-XQVQQVTHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
149218,6w9q,DB15177,-7.4,VX-659,IGEOJNMYRZUKIK-IBGZPJMESA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
75624,6m2n,DB05022,-7.4,Amonafide,UPALIKSFLSVKIS-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
85325,6m3m,DB07526,-7.4,N-[4-({[5-(DIMETHYLAMINO)-1-NAPHTHYL]SULFONYL}AMINO)BUTYL]-3-SULFANYLPROPANAMIDE,XPCVYJATJSZGJU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
26065,6cs2,DB00479,-7.4,Amikacin,LKCWBDHBTVXHDL-RMDFUYIESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
17027,6cs2,HMDB0005782,-7.4,Hesperetin,AIONOLUJZLIMTK-AWEZNQCLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
159953,7bv1,DB07120,-7.4,"N4-(N,N-DIPHENYLCARBAMOYL)-AMINOGUANIDINE",QLXOHIUDKNRVBZ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
103676,6vxs,DB08877,-7.4,Ruxolitinib,HFNKQEVNSGCOJV-OAHLLOKOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
131431,6w4h,DB13730,-7.4,Nifurtoinol,UIDWQGRXEVDFCA-XCVCLJGOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
93627,6m71,DB07167,-7.4,5-CYANO-FURAN-2-CARBOXYLIC ACID [5-HYDROXYMETHYL-2-(4-METHYL-PIPERIDIN-1-YL)-PHENYL]-AMIDE,NNPCFFIJVKYGHR-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
103688,6vxs,DB08897,-7.4,Aclidinium,ASMXXROZKSBQIH-VITNCHFBSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
8316,6lzg,DB05395,-7.4,Amibegron,RDJQCOBTKKAQAH-FPOVZHCZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
34476,1r42,DB00288,-7.4,Amcinonide,ILKJAFIWWBXGDU-MOGDOJJUSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
131446,6w4h,DB13755,-7.4,Iocarmic acid,SMQYOVYWPWASGU-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
103756,6vxs,DB08990,-7.4,Eprazinone,BSHWLCACYCVCJE-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
149217,6w9q,DB15173,-7.4,JNJ-42165279,YWGYNGCRVZLMCS-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
71388,6lxt,DB14125,-7.4,Benazeprilat,MADRIHWFJGRSBP-ROUUACIJSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
34527,1r42,DB00467,-7.4,Enoxacin,IDYZIJYBMGIQMJ-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
14367,6lzg,T3D4039,-7.4,Gonyautoxin II,ARSXTTJGWGCRRR-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
103831,6vxs,DB09101,-7.4,Elvitegravir,JUZYLCPPVHEVSV-LJQANCHMSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
59667,6crv,DB07737,-7.4,(2S)-4-(4-fluorobenzyl)-N-(3-sulfanylpropyl)piperazine-2-carboxamide,OYTFYWWLBPDTNS-AWEZNQCLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59704,6crv,DB07780,-7.4,Farnesyl diphosphate,VWFJDQUYCIWHTN-YFVJMOTDSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
93682,6m71,DB07232,-7.4,Veliparib,JNAHVYVRKWKWKQ-CYBMUJFWSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
131162,6w4h,DB13368,-7.4,Motretinide,IYIYMCASGKQOCZ-DJRRULDNSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
93613,6m71,DB07149,-7.4,"(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluoroethyl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one",LCBAQTCTQXHTJG-ZETCQYMHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
131855,6w4h,DB14862,-7.4,PF-06815345,QTBYVAZRKWOIDU-FUHWJXTLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
8361,6lzg,DB05590,-7.4,Bedoradrine,OANCEOSLKSTLTA-REWPJTCUSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
131861,6w4h,DB14875,-7.4,AZD-4017,NCDZABJPWMBMIQ-INIZCTEOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
8289,6lzg,DB05234,-7.4,LGD2941,HWLLYFXDDGGHOE-BCSUUIJWSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
71273,6lxt,DB13873,-7.4,Fenofibric acid,MQOBSOSZFYZQOK-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
93687,6m71,DB07238,-7.4,Nesbuvir,WTDWVLJJJOTABN-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
131887,6w4h,DB14924,-7.4,PF-06651600,CBRJPFGIXUFMTM-WDEREUQCSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
103891,6vxs,DB09206,-7.4,Trimazosin,YNZXWQJZEDLQEG-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
59721,6crv,DB07798,-7.4,"(3R)-3-(FLUOROMETHYL)-N-(3,3,3-TRIFLUOROPROPYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONAMIDE",BBUDQLKRZPRPFD-LLVKDONJSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85521,6m3m,DB07759,-7.4,5-[2-(TRIFLUOROMETHYL)PHENYL]-2-FUROIC ACID,IJPNRBZMRINMMR-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
93691,6m71,DB07244,-7.4,"5-{4-[(3,5-DIFLUOROBENZYL)AMINO]PHENYL}-6-ETHYLPYRIMIDINE-2,4-DIAMINE",SRRWXMSVQYQCRX-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
114064,6vxx,DB12671,-7.4,Beloranib,ZEZFKUBILQRZCK-MJSCXXSSSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
71476,6lxt,DB14633,-7.4,Prednisolone hemisuccinate,APGDTXUMTIZLCJ-CGVGKPPMSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
131967,6w4h,DB15117,-7.4,Transfluthrin,DDVNRFNDOPPVQJ-HQJQHLMTSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131039,6w4h,DB13212,-7.4,Phenolsulfonphthalein,BELBBZDIHDAJOR-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
85579,6m3m,DB07823,-7.4,"(2S)-2-[(3aR,4R,7S,7aS)-1,3-dioxooctahydro-2H-4,7-methanoisoindol-2-yl]propanoic acid",REFMTLIXGKZVDF-VRGHQRLXSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59749,6crv,DB07829,-7.4,4-[3-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL]PYRIDINE,BILJSHVAAVZERY-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
103555,6vxs,DB08722,-7.4,5-(7-(6-chloro-4-(5-hydro-4-methyl-2-oxazolyl)phenoxy)heptyl)-3-methyl isoxazole,WOJFAPUTPSWFLJ-INIZCTEOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
113921,6vxx,DB12278,-7.4,Propiverine,QPCVHQBVMYCJOM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
131179,6w4h,DB13395,-7.4,Eprozinol,QSRHLIUOSXVKTG-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
85558,6m3m,DB07801,-7.4,N-butyl-3-{[6-(9H-purin-6-ylamino)hexanoyl]amino}benzamide,WOYITRCGMUXUDE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
131939,6w4h,DB15059,-7.4,Aprocitentan,DKULOVKANLVDEA-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
25937,6cs2,DB03970,-7.4,"(7R)-7-(6,7-Dihydro-5H-cyclopenta[d]imidazo[2,1-b][1,3]thiazol-2-yl)-2,7-dihydro-1,4-thiazepine-3,6-dicarboxylic acid",CHNMLWCTGYMVFH-GFCCVEGCSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
85541,6m3m,DB07782,-7.4,4-AMINO-2-TRIFLUOROMETHYL-5-HYDROXYMETHYLPYRIMIDINE PYROPHOSPHATE,UKNJCTHTCAKKNG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
149131,6w9q,DB15003,-7.4,PF-06700841,BUWBRTXGQRBBHG-MJBXVCDLSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
5615,6lzg,HMDB0061739,-7.4,Perfluorononanoic acid,UZUFPBIDKMEQEQ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
59407,6crv,DB07427,-7.4,2-[(2-methoxy-5-methylphenoxy)methyl]pyridine,AVXQTLSOXWQOHO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
131075,6w4h,DB13256,-7.4,Clothiapine,KAAZGXDPUNNEFN-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
71234,6lxt,DB13821,-7.4,Ceftezole,DZMVCVMFETWNIU-LDYMZIIASA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
149156,6w9q,DB15055,-7.4,ABT-639,AGPIHNZOZNKRGT-CYBMUJFWSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
66456,6lxt,DB04200,-7.4,Matairesinol,MATGKVZWFZHCLI-LSDHHAIUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
149175,6w9q,DB15092,-7.4,LY-2624803,UEFWDVMEDFCHGW-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
149174,6w9q,DB15091,-7.4,Upadacitinib,WYQFJHHDOKWSHR-MNOVXSKESA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
114033,6vxx,DB12625,-7.4,Evogliptin,LCDDAGSJHKEABN-MLGOLLRUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
103851,6vxs,DB09151,-7.4,Flutemetamol (18F),VVECGOCJFKTUAX-HUYCHCPVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
85497,6m3m,DB07732,-7.4,2-[(2-NAPHTHYLSULFONYL)AMINO]ETHYL DIHYDROGEN PHOSPHATE,FCROUVVWZFPGFM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
8304,6lzg,DB05294,-7.4,Vandetanib,UHTHHESEBZOYNR-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
131763,6w4h,DB14659,-7.4,Melengestrol acetate,UDKABVSQKJNZBH-DWNQPYOZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
160093,7bv1,DB07504,-7.4,(2R)-1-{4-[(4-Anilino-5-bromo-2-pyrimidinyl)amino]phenoxy}-3-(dimethylamino)-2-propanol,MEIJADBULOETOV-QGZVFWFLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
166574,7bv1,DB15406,-7.4,GLPG-0974,MPMKMQHJHDHPBE-RUZDIDTESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
85246,6m3m,DB07431,-7.4,"(3R)-3-(aminomethyl)-9-methoxy-1,2,3,4-tetrahydro-5H-[1]benzothieno[3,2-e][1,4]diazepin-5-one",TXYKBKYDFZQOCB-SSDOTTSWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
131260,6w4h,DB13504,-7.4,Cefetamet,MQLRYUCJDNBWMV-GHXIOONMSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
71290,6lxt,DB13936,-7.4,JNJ-28330835,RYBKPGYFXRNMMU-LBPRGKRZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
103592,6vxs,DB08760,-7.4,(2S)-2-(4-chlorophenoxy)-3-phenylpropanoic acid,CPBLTMSKPQDJPW-AWEZNQCLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
26113,6cs2,DB04180,-7.4,"4-(Aminosulfonyl)-N-[(2,4-Difluorophenyl)Methyl]-Benzamide",NTDFJEKGSGSXME-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
71449,6lxt,DB14544,-7.4,Hydrocortisone valerate,FZCHYNWYXKICIO-FZNHGJLXSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
131791,6w4h,DB14715,-7.4,Cinazepam,NQTRBZXDWMDXAQ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
159897,7bv1,DB07054,-7.4,(2R)-1-(DIMETHYLAMINO)-3-{4-[(6-{[2-FLUORO-5-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-4-YL)AMINO]PHENOXY}PROPAN-2-OL,OSCWQKTUILTARV-MRXNPFEDSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
131829,6w4h,DB14793,-7.4,RO-5045337,QBGKPEROWUKSBK-QPPIDDCLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
71465,6lxt,DB14596,-7.4,Loteprednol etabonate,DMKSVUSAATWOCU-HROMYWEYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
131827,6w4h,DB14791,-7.4,GDC-0425,XEZLBMHDUXSICI-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
59440,6crv,DB07463,-7.4,"(3R,4S)-1-[(4-amino-5H-pyrrolo[3,2-d]pyrimidin-7-yl)methyl]-4-[(butylsulfanyl)methyl]pyrrolidin-3-ol",LTSUEVPGSXUJHT-OLZOCXBDSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85226,6m3m,DB07407,-7.4,5-(2-METHOXYPHENYL)-2-FUROIC ACID,CHWVDGYLKPLBES-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
103872,6vxs,DB09187,-7.4,Lortalamine,MJRPHRMGEKCADU-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
159884,7bv1,DB07040,-7.4,"2-amino-7-fluoro-5-oxo-5H-chromeno[2,3-b]pyridine-3-carboxamide",GCHMLYYPYFXLQB-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
85227,6m3m,DB07408,-7.4,5-(2-NITROPHENYL)-2-FUROIC ACID,XUFDYUSOQQYQRL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
131802,6w4h,DB14735,-7.4,Cannabichromene,UVOLYTDXHDXWJU-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
103590,6vxs,DB08758,-7.4,"IMIDAZO[2,1-A]ISOQUINOLINE-2-CARBOHYDRAZIDE",WSNWYZBDIKCPIG-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
160131,7bv1,DB07547,-7.4,5-(4-CYANOPHENYL)-3-{[(2-METHYLPHENYL)SULFONYL]AMINO}THIOPHENE-2-CARBOXYLIC ACID,RYXAHMSZLLIPRO-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
66460,6lxt,DB04205,-7.4,"Thymidine-3',5'-Diphosphate",CSNCBOPUCJOHLS-XLPZGREQSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
131230,6w4h,DB13461,-7.4,Cefcapene,HJJRIJDTIPFROI-NVKITGPLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
149163,6w9q,DB15065,-7.4,PF-06291874,IBDYYOQKQCCSDP-QFIPXVFZSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
25967,6cs2,DB04007,-7.4,Bromo-WR99210,MPXYCOHVHSXSDC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
136651,6w9c,DB07371,-7.4,3-(10-methyl-9-anthryl)propanoic acid,CKQINRXZVYBCSC-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
29980,6cs2,DB11892,-7.4,Prulifloxacin,PWNMXPDKBYZCOO-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
59989,6crv,DB08105,-7.4,N-[(6-butoxynaphthalen-2-yl)sulfonyl]-L-glutamic acid,UAGYXJBYAFGRFR-KRWDZBQOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
129960,6w4h,DB11490,-7.4,Nalorphine,UIQMVEYFGZJHCZ-SSTWWWIQSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
103020,6vxs,DB08076,-7.4,"4-[1-(2,6-dichlorobenzyl)-2-methyl-1H-imidazol-4-yl]pyrimidin-2-amine",CKSSZTMRRVJNNG-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
86188,6m3m,DB08544,-7.4,(S)-Fluoxetine,RTHCYVBBDHJXIQ-INIZCTEOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
17644,6cs2,HMDB0000343,-7.4,2-Hydrox1trone,SWINWPBPEKHUOD-JPVZDGGYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
159165,7bv1,DB03509,-7.4,2-(4-Chlorophenyl)-5-Quinoxalinecarboxamide,FLYGLPYJEQPCFY-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
129955,6w4h,DB11479,-7.4,Zilpaterol,ZSTCZWJCLIRCOJ-DGCLKSJQSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
133309,6w9c,DB01529,-7.4,Dextromoramide,INUNXTSAACVKJS-OAQYLSRUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
113700,6vxx,DB11783,-7.4,Imidapril,KLZWOWYOHUKJIG-BPUTZDHNSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
160830,7bv1,DB11787,-7.4,Ralimetinib,XPPBBJCBDOEXDN-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
14314,6lzg,T3D3950,-7.4,Doxycycline,JBIWCJUYHHGXTC-AKNGSSGZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
70872,6lxt,DB13337,-7.4,Pheneticillin,NONJJLVGHLVQQM-JHXYUMNGSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
104411,6vxs,DB11961,-7.4,AZD-1236,SFJFBTPHDHUUPU-OAHLLOKOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
58967,6crv,DB06917,-7.4,(4-fluorophenyl)(pyridin-4-yl)methanone,WTRWBYGUMQEFFI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30020,6cs2,DB11943,-7.4,Delafloxacin,DYDCPNMLZGFQTM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
34041,6cs2,T3D0901,-7.4,"3,5-Diisopropylphenyl methylcarbamate",CUTUCYVZTGGYDL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
129927,6w4h,DB11429,-7.4,Mibolerone,PTQMMNYJKCSPET-OMHQDGTGSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
104419,6vxs,DB11969,-7.4,Uprosertib,AXTAPYRUEKNRBA-JTQLQIEISA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
30022,6cs2,DB11946,-7.4,AZD-1981,JWYIGNODXSRKGP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
84442,6m3m,DB06188,-7.4,Ispinesib,QJZRFPJCWMNVAV-HHHXNRCGSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
148844,6w9q,DB14066,-7.4,Tetrandrine,WVTKBKWTSCPRNU-KYJUHHDHSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
30023,6cs2,DB11947,-7.4,Pridopidine,YGKUEOZJFIXDGI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
34013,6cs2,T3D0831,-7.4,Isoimperatorin,IGWDEVSBEKYORK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
114352,6vxx,DB13329,-7.4,Guaiazulen,FWKQNCXZGNBPFD-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
149586,6wiq,DB00340,-7.4,Metixene,MJFJKKXQDNNUJF-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
12067,6lzg,DB12833,-7.4,Tandospirone,CEIJFEGBUDEYSX-FZDBZEDMSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
113689,6vxx,DB11766,-7.4,AZD-1305,BLLNYXOLLAVTRF-HDICACEKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
26472,6cs2,DB04614,-7.4,(R)-tacrine(10)-hupyridone,ROTFGKJJMRTWBD-HHHXNRCGSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
104435,6vxs,DB11999,-7.4,Vosaroxin,XZAFZXJXZHRNAQ-STQMWFEESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
70836,6lxt,DB13292,-7.4,Pimethixene,NZLVRVYNQYGMAB-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
159018,7bv1,DB03039,-7.4,"4-(Aminosulfonyl)-N-[(2,5-Difluorophenyl)Methyl]-Benzamide",KEGUALXMKQVDIO-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
148846,6w9q,DB14068,-7.4,Dexniguldipine,SVJMLYUFVDMUHP-MGBGTMOVSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
26447,6cs2,DB04582,-7.4,IMAZAQUIN,CABMTIJINOIHOD-QGZVFWFLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
104399,6vxs,DB11943,-7.4,Delafloxacin,DYDCPNMLZGFQTM-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
70888,6lxt,DB13355,-7.4,Visnadine,GVBNSPFBYXGREE-CXWAGAITSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
70922,6lxt,DB13403,-7.4,Oxypertine,XCWPUUGSGHNIDZ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
133153,6w9c,DB01288,-7.4,Fenoterol,LSLYOANBFKQKPT-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
86113,6m3m,DB08458,-7.4,(4-BROMOPHENYL)[4-({(2E)-4-[CYCLOPROPYL(METHYL)AMINO]BUT-2-ENYL}OXY)PHENYL]METHANONE,JAZMZJDLZUDIDG-NSCUHMNNSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
103070,6vxs,DB08130,-7.4,"N-(5-{3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]phenyl}-1,3,4-oxadiazol-2-yl)ethane-1,2-diamine",FPDWDLAITHFTTP-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
84530,6m3m,DB06413,-7.4,Armodafinil,YFGHCGITMMYXAQ-LJQANCHMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
34058,6cs2,T3D0916,-7.4,Alanycarb,GMAUQNJOSOMMHI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
86127,6m3m,DB08473,-7.4,"5,6-dichloro-1-beta-D-ribofuranosyl-1H-benzimidazole",XHSQDZXAVJRBMX-DDHJBXDOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
130039,6w4h,DB11681,-7.4,Tofimilast,DHCOPPHTVOXDKU-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
93902,6m71,DB07485,-7.4,"4,4'-cyclohexane-1,1-diyldiphenol",SDDLEVPIDBLVHC-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60198,6crv,DB08359,-7.4,2-PHENYLAMINO-4-METHYL-5-ACETYL THIAZOLE,UIIUOFPGDKBCEZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
103059,6vxs,DB08119,-7.4,"1,1,1-TRIFLUORO-3-((N-ACETYL)-L-LEUCYLAMIDO)-4-PHENYL-BUTAN-2-ONE(N-ACETYL-L-LEUCYL-L-PHENYLALANYL TRIFLUOROMETHYL KETONE)",MZNXJCZDQRNGRC-GJZGRUSLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
70910,6lxt,DB13384,-7.4,Melitracen,GWWLWDURRGNSRS-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
130032,6w4h,DB11672,-7.4,Curcumin,VFLDPWHFBUODDF-FCXRPNKRSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
17621,6cs2,HMDB0000315,-7.4,16-a-Hydroxypregnenolone,ZAKJZPQDUPCXSD-YRWKUUEZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
16641,6cs2,HMDB0003312,-7.4,Daidzein,ZQSIJRDFPHDXIC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
130023,6w4h,DB11658,-7.4,QAV-680,YOPFAMROKXHVCQ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
8493,6lzg,DB06213,-7.4,Regadenoson,LZPZPHGJDAGEJZ-AKAIJSEGSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
129975,6w4h,DB11537,-7.4,Pirlimycin,HBJOXQRURQPDEX-MHXMMLMNSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
159179,7bv1,DB03530,-7.4,Acylated Ceftazidime,VEHPZKIFULQYFS-BZXVCXBKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
159180,7bv1,DB03532,-7.4,Phosphomethylphosphonic Acid Guanylate Ester,GXTIEXDFEKYVGY-KQYNXXCUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
86163,6m3m,DB08515,-7.4,"(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE",YVABESCRHMBHJD-FUQNVFFISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
148883,6w9q,DB14152,-7.4,Ginsenosides,NLHQJXWYMZLQJY-SWIZOJJJSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
166485,7bv1,DB15222,-7.4,GS-6620,YAAQYJCOIFNMKX-RSTNYOGXSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
133440,6w9c,DB01687,-7.4,beta-Mannobiose,GUBGYTABKSRVRQ-PZPXDAEZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
166486,7bv1,DB15224,-7.4,Lisavanbulin,NIPZLALJRAHABJ-IBGZPJMESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160797,7bv1,DB11739,-7.4,Vonoprazan,BFDBKMOZYNOTPK-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
130003,6w4h,DB11619,-7.4,Gestrinone,BJJXHLWLUDYTGC-ANULTFPQSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
26430,6cs2,DB00524,-7.4,Metolazone,AQCHWTWZEMGIFD-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
133208,6w9c,DB01408,-7.4,Bambuterol,ANZXOIAKUNOVQU-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
30010,6cs2,DB11933,-7.4,Riboprine,USVMJSALORZVDV-SDBHATRESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
75499,6m2n,DB04787,-7.4,Tanaproget,PYVFWTPEBMRKSR-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
6183,6lzg,DB01689,-7.4,Inhibitor Idd 384,CJKKMQCZOLCXAM-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
133451,6w9c,DB01700,-7.4,AICA ribonucleotide,NOTGFIUVDGNKRI-UUOKFMHZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
104441,6vxs,DB12006,-7.4,BMS-906024,AYOUDDAETNMCBW-GSHUGGBRSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
133464,6w9c,DB01716,-7.4,2-Propenyl-N-Acetyl-Neuramic Acid,IUGVDRFIVSPVGO-KXEMTNKZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
60324,6crv,DB08511,-7.4,"6-amino-2-methyl-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",PLJNUNPYZVVIRA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
93428,6m71,DB06932,-7.4,"10,11-dimethoxy-4-methyldibenzo[c,f]-2,7-naphthyridine-3,6-diamine",NVINUNQBDNEMSY-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93426,6m71,DB06930,-7.4,"N-[amino(imino)methyl]-2-(2,5-diphenyl-1H-pyrrol-1-yl)acetamide",WVLDNAVUCUAGDP-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
29772,6cs2,DB11592,-7.4,Nitrocefin,LHNIIDJCEODSHA-OQRUQETBSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
12490,6lzg,DB13434,-7.4,Fenticonazole,ZCJYUTQZBAIHBS-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
148786,6w9q,DB13951,-7.4,Stanolone acetate,ILCTUFVQFCIIDS-NGFSFWIMSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
6237,6lzg,DB01774,-7.4,Adenosine-5'-Monophosphate Glucopyranosyl-Monophosphate Ester,WFPZSXYXPSUOPY-ROYWQJLOSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
158894,7bv1,DB02602,-7.4,AL7182,ICIXQGGQPKFQRL-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
129658,6w4h,DB09123,-7.4,Dienogest,AZFLJNIPTRTECV-FUMNGEBKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
148781,6w9q,DB13944,-7.4,Testosterone enanthate,VOCBWIIFXDYGNZ-IXKNJLPQSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
58872,6crv,DB06794,-7.4,Lodoxamide,RVGLGHVJXCETIO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
129649,6w4h,DB09097,-7.4,Quinagolide,GDFGTRDCCWFXTG-ZIFCJYIRSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
114404,6vxx,DB13396,-7.4,Neocitrullamon,PAJBBDCZSMDSFL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
70794,6lxt,DB13232,-7.4,Suxibuzone,ONWXNHPOAGOMTG-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
104495,6vxs,DB12085,-7.4,LCL-161,UFPFGVNKHCLJJO-SSKFGXFMSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102893,6vxs,DB07932,-7.4,"dimethyl (1R,4S)-5,6-bis(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hepta-2,5-diene-2,3-dicarboxylate",CRLQCBACIMUGDZ-BGYRXZFFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
129626,6w4h,DB09068,-7.4,Vortioxetine,YQNWZWMKLDQSAC-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
25538,6cs2,DB03488,-7.4,Uridine-5'-diphosphate-2-deoxy-2-fluoro-alpha-D-galactose,NGTCPFGWXMBZEP-NQQHDEILSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
8557,6lzg,DB06374,-7.4,Elacestrant,SIFNOOUKXBRGGB-AREMUKBSSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
133849,6w9c,DB02237,-7.4,Maltotetraose,UYQJCPNSAVWAFU-KVXMBEGHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
25541,6cs2,DB03491,-7.4,2'-Deoxyguanosine-5'-Diphosphate,CIKGWCTVFSRMJU-KVQBGUIXSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
86311,6m3m,DB08698,-7.4,"1-[(3S)-5-PHENYL-3-THIOPHEN-2-YL-3H-1,4-BENZODIAZEPIN-2-YL]AZETIDIN-3-OL",BKSGACYTXOQQNI-OAQYLSRUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
129595,6w4h,DB09012,-7.4,Carbazochrome,XSXCZNVKFKNLPR-SDQBBNPISA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
35000,1r42,DB01026,-7.4,Ketoconazole,XMAYWYJOQHXEEK-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
129600,6w4h,DB09017,-7.4,Brotizolam,UMSGKTJDUHERQW-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
160942,7bv1,DB12299,-7.4,Bavisant,BGBVSGSIXIIREO-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
104513,6vxs,DB12113,-7.4,CE-224535,FUCKCIVGBCBZNP-MRXNPFEDSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
16547,6cs2,HMDB0002728,-7.4,Thyroxine sulfate,QYXIJUZWSSQICT-LBPRGKRZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
86299,6m3m,DB08682,-7.4,"1-METHYL ETHYL 1-CHLORO-5-[[(5,6DIHYDRO-2-METHYL-1,4-OXATHIIN-3-YL)CARBONYL]AMINO]BENZOATE",FMQGUMRNTBJHEA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
149664,6wiq,DB00434,-7.4,Cyproheptadine,JJCFRYNCJDLXIK-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
71865,6lxt,DB15440,-7.4,GSK-3117391,AFDPFLDWOXXHQM-NRFANRHFSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
160943,7bv1,DB12300,-7.4,P-nitrobiphenyl,BAJQRLZAPXASRD-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
103086,6vxs,DB08148,-7.4,"1-[4-(4-chlorophenyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine",QOZMRRGNAZNWDN-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102918,6vxs,DB07962,-7.4,"METHYL N-[(2',4'-DIFLUORO-4-HYDROXY-5-IODOBIPHENYL-3-YL)CARBONYL]-BETA-ALANINATE",ZMRRBWRMQPQQAN-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104476,6vxs,DB12059,-7.4,JNJ-40411813,HYOGJHCDLQSAHX-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
29784,6cs2,DB11622,-7.4,Dehydrocholic acid,OHXPGWPVLFPUSM-KLRNGDHRSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
133485,6w9c,DB01748,-7.4,N-Benzyl-4-Sulfamoyl-Benzamide,CZKNSZUJCJHTTM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
58931,6crv,DB06878,-7.4,1-[(2R)-2-aminobutanoyl]-N-(3-chlorobenzyl)-L-prolinamide,OTYYXGRJXJFTCD-KGLIPLIRSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29782,6cs2,DB11619,-7.4,Gestrinone,BJJXHLWLUDYTGC-ANULTFPQSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
86254,6m3m,DB08624,-7.4,BENZOTHIAZOLE,MAJHCCQPIDXPAN-QMMMGPOBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
158977,7bv1,DB02711,-7.4,"4-{2,6,8-Trioxo-9-[(2S,3R,4R)-2,3,4,5-Tetrahydroxypentyl]-1,2,3,6,8,9-Hexahydro-7h-Purin-7-Yl}Butyl Dihydrogen Phosphate",VBXZSBKAJFXURR-QXFUBDJGSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
129755,6w4h,DB09262,-7.4,Imidafenacin,SQKXYSGRELMAAU-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
149618,6wiq,DB00378,-7.4,Dydrogesterone,JGMOKGBVKVMRFX-HQZYFCCVSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
133575,6w9c,DB01864,-7.4,5'-Guanosine-Diphosphate-Monothiophosphate,XOFLBQFBSOEHOG-UUOKFMHZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
129739,6w4h,DB09239,-7.4,Niguldipine,SVJMLYUFVDMUHP-XIFFEERXSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
114376,6vxx,DB13356,-7.4,Mesulfen,AHXDSVSZEZHDLV-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104462,6vxs,DB12041,-7.4,Mapracorat,VJGFOYBQOIPQFY-XMMPIXPASA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
129728,6w4h,DB09227,-7.4,Barnidipine,VXMOONUMYLCFJD-DHLKQENFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
12468,6lzg,DB13407,-7.4,Nifenazone,BRZANEXCSZCZCI-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
12052,6lzg,DB12808,-7.4,Trifarotene,MFBCDACCJCDGBA-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
133591,6w9c,DB01883,-7.4,N-(Sulfanylacetyl)Tyrosylprolylmethioninamide,LNLWXWOYQHAKTD-ULQDDVLXSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
17676,6cs2,HMDB0000405,-7.4,2-Methox1tradiol,CQOQDQWUFQDJMK-SSTWWWIQSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
158935,7bv1,DB02656,-7.4,LY-294002,CZQHHVNHHHRRDU-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
149643,6wiq,DB00408,-7.4,Loxapine,XJGVXQDUIWGIRW-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
160910,7bv1,DB12259,-7.4,CG-200745,AUGCSOFQTDKPSO-RGVLZGJSSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
129686,6w4h,DB09182,-7.4,Benzylfentanyl,POQDXIFVWVZVML-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
129691,6w4h,DB09187,-7.4,Lortalamine,MJRPHRMGEKCADU-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
104475,6vxs,DB12058,-7.4,Recoflavone,BCPQOBQIVJZOFL-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102919,6vxs,DB07963,-7.4,"N-[(2',4'-DIFLUORO-4-HYDROXY-5-IODOBIPHENYL-3-YL)CARBONYL]-BETA-ALANINE",YZQVXOZCPWWABX-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
66659,6lxt,DB04480,-7.4,"3-(4-Fluorophenyl)-2-(6-Methylpyridin-2-Yl)-5,6-Dihydro-4h-Pyrrolo[1,2-B]Pyrazole",NBDZLUOYAAVYHF-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
148810,6w9q,DB13994,-7.4,AZD-7325,KYDURMHFWXCKMW-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
70812,6lxt,DB13256,-7.4,Clothiapine,KAAZGXDPUNNEFN-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
133621,6w9c,DB01937,-7.4,Guanosine-2'-Monophosphate,WTIFIAZWCCBCGE-UUOKFMHZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
58902,6crv,DB06842,-7.4,(4R)-4-(3-butoxy-4-methoxybenzyl)imidazolidin-2-one,PDMUULPVBYQBBK-GFCCVEGCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
160898,7bv1,DB11886,-7.4,Infigratinib,QADPYRIHXKWUSV-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
104467,6vxs,DB12046,-7.4,Atopaxar,QWKAUGRRIXBIPO-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
17680,6cs2,HMDB0000415,-7.4,"3a,6b,7b-Trihydroxy-5b-cholanoic acid",DKPMWHFRUGMUKF-CRKPLTDNSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
84833,6m3m,DB06953,-7.4,2-CHLORO-5-(3-CHLORO-PHENYL)-6-[(4-CYANO-PHENYL)-(3-METHYL-3H-IMIDAZOL-4-YL)- METHOXYMETHYL]-NICOTINONITRILE,JVWHVGIRXILXMU-XMMPIXPASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
104371,6vxs,DB11902,-7.4,Gisadenafil,YPFZMBHKIVDSNR-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
93486,6m71,DB07005,-7.4,D-phenylalanyl-N-{4-[amino(iminio)methyl]benzyl}-L-prolinamide,VZFTWWJAUZOJDH-MOPGFXCFSA-O,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
71017,6lxt,DB13532,-7.4,Cyclopenthiazide,BKYKPTRYDKTTJY-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
71016,6lxt,DB13531,-7.4,Nicofetamide,DWODOIKZDGJOPQ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
85957,6m3m,DB08262,-7.4,"2,6-dicarboxynaphthalene",RXOHFPCZGPKIRD-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
29796,6cs2,DB11648,-7.4,Afuresertib,AFJRDFWMXUECEW-LBPRGKRZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
130340,6w4h,DB12123,-7.4,Cinepazide,RCUDFXMNPQNBDU-VOTSOKGWSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
103218,6vxs,DB08313,-7.4,nocodazole,KYRVNWMVYQXFEU-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
5295,6lzg,HMDB0055860,-7.4,"TG(22:5(7Z,10Z,13Z,16Z,19Z)/20:3n6/o-18:0)",QUHURZUDLDDFJM-VDBBUMQZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
34168,6cs2,T3D1031,-7.4,Cyfluthrin,QQODLKZGRKWIFG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
132855,6w9c,DB00924,-7.4,Cyclobenzaprine,JURKNVYFZMSNLP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
28708,6cs2,DB08315,-7.4,"2-AMINO-N,N-BIS(PHENYLMETHYL)-1,3-OXAZOLE-5-CARBOXAMIDE",KIJXWOGFYAWTNC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
34165,6cs2,T3D1028,-7.4,Tetramethrin,CXBMCYHAMVGWJQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
71686,6lxt,DB15080,-7.4,ELX-02,KJBRSTPUILEBDR-YBNFDXCTSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
132857,6w9c,DB00926,-7.4,Etretinate,HQMNCQVAMBCHCO-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
34818,1r42,DB00820,-7.4,Tadalafil,WOXKDUGGOYFFRN-IIBYNOLFSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
104245,6vxs,DB11718,-7.4,Encorafenib,CMJCXYNUCSMDBY-ZDUSSCGKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
148964,6w9q,DB14637,-7.4,Fluprednisolone acetate,CYMBAKFTWRNHPS-APRQOCPKSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
130309,6w4h,DB12080,-7.4,Ritobegron,VMMYRRFPMAGXNP-BTYIYWSLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
71690,6lxt,DB15091,-7.4,Upadacitinib,WYQFJHHDOKWSHR-MNOVXSKESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
132863,6w9c,DB00934,-7.4,Maprotiline,QSLMDECMDJKHMQ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
71692,6lxt,DB15096,-7.4,18-methoxycoronaridine,DTJQBBHYRQYDEG-SVBQBFEESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
132867,6w9c,DB00939,-7.4,Meclofenamic acid,SBDNJUWAMKYJOX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
60058,6crv,DB08178,-7.4,"4-(4-methoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine",GGEWEQJWGGJUHO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
132870,6w9c,DB00942,-7.4,Cycrimine,SWRUZBWLEWHWRI-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
71697,6lxt,DB15105,-7.4,PF-06751979,ZLZUHACSRMOLLV-RAALSFIWSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
132873,6w9c,DB00946,-7.4,Phenprocoumon,DQDAYGNAKTZFIW-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
132880,6w9c,DB00953,-7.4,Rizatriptan,ULFRLSNUDGIQQP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
114258,6vxx,DB13203,-7.4,Bamifylline,VVUYEFBRTFASAH-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
71710,6lxt,DB15126,-7.4,IMG-7289,KQKBMHGOHXOHTD-KKUQBAQOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
160573,7bv1,DB08789,-7.4,"2-AMINO-4-(2,4-DICHLOROPHENYL)-N-ETHYLTHIENO[2,3-D]PYRIMIDINE-6-CARBOXAMIDE",YPEOXUOUTBMBCX-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
130276,6w4h,DB12029,-7.4,Chlorogenic Acid,CWVRJTMFETXNAD-JUHZACGLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
160532,7bv1,DB08743,-7.4,"2-({8-[(3R)-3-AMINOPIPERIDIN-1-YL]-1,3-DIMETHYL-2,6-DIOXO-1,2,3,6-TETRAHYDRO-7H-PURIN-7-YL}METHYL)BENZONITRILE",XJNKUWDMCBZMTG-OAHLLOKOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
130360,6w4h,DB12150,-7.4,Pelubiprofen,AUZUGWXLBGZUPP-GXDHUFHOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
16750,6cs2,HMDB0004087,-7.4,"1-Benzyl-1,2,3,4-tetrahydroisoquinoline",YRYCIFUZSUMAAY-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
59156,6crv,DB07138,-7.4,Neflamapimod,VEPKQEUBKLEPRA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
160443,7bv1,DB08392,-7.4,"2-[5,6-BIS-(4-METHOXY-PHENYL)-FURO[2,3-D]PYRIMIDIN-4-YLAMINO]-ETHANOL",ARBUGBBNEFAECO-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93809,6m71,DB07375,-7.4,"5-BETA-ANDROSTANE-3,17-DIONE",RAJWOBJTTGJROA-QJISAEMRSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
103275,6vxs,DB08385,-7.4,4-(quinolin-3-ylmethyl)piperidine-1-carboxylic acid,QUAGUFNCKDDJFZ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
132684,6w9c,DB00726,-7.4,Trimipramine,ZSCDBOWYZJWBIY-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
29804,6cs2,DB11658,-7.4,QAV-680,YOPFAMROKXHVCQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
104215,6vxs,DB11674,-7.4,Equol,ADFCQWZHKCXPAJ-GFCCVEGCSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
132708,6w9c,DB00756,-7.4,Hexachlorophene,ACGUYXCXAPNIKK-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
130431,6w4h,DB12259,-7.4,CG-200745,AUGCSOFQTDKPSO-RGVLZGJSSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
66607,6lxt,DB04409,-7.4,Naphthalene Trisulfonate,ZPBSAMLXSQCSOX-UHFFFAOYSA-K,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
159519,7bv1,DB04520,-7.4,"(3s,8ar)-3-(4-Hydroxybenzyl)Hexahydropyrrolo[1,2-a]Pyrazine-1,4-Dione",LSGOTAXPWMCUCK-RYUDHWBXSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
75521,6m2n,DB04816,-7.4,Dantron,QBPFLULOKWLNNW-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
159509,7bv1,DB04509,-7.4,N-Methylnaloxonium,PCSQOABIHJXZMR-YNUHATHGSA-O,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
85912,6m3m,DB08203,-7.4,"7-[2-METHOXY-1-(METHOXYMETHYL)ETHYL]-7H-PYRROLO[3,2-F] QUINAZOLINE-1,3-DIAMINE",MQTGHZCEDQNMOZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
104221,6vxs,DB11682,-7.4,Daprodustat,RUEYEZADQJCKGV-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
1289,6lzg,HMDB0010318,-7.4,Pregnanediol-3-glucuronide,ZFFFJLDTCLJDHL-JQYCEVDMSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
71642,6lxt,DB14987,-7.4,Difamilast,VFBILHPIHUPBPZ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
60017,6crv,DB08135,-7.4,N-phenyl-1H-pyrazole-3-carboxamide,WMZYZYFPPQOFKY-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130375,6w4h,DB12179,-7.4,Secoisolariciresinol,PUETUDUXMCLALY-HOTGVXAUSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
26321,6cs2,DB00507,-7.4,Nitazoxanide,YQNQNVDNTFHQSW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
17475,6cs2,HMDB0007431,-7.4,"DG(20:2(11Z,14Z)/20:4(5Z,8Z,11Z,14Z)/0:0)",XWQMGVSLXBIWRI-SXIWVUKCSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
25751,6cs2,DB03758,-7.4,Radicicol,WYZWZEOGROVVHK-GTMNPGAYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
29992,6cs2,DB00905,-7.4,Bimatoprost,AQOKCDNYWBIDND-FTOWTWDKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
130387,6w4h,DB12194,-7.4,Atamestane,PEPMWUSGRKINHX-TXTPUJOMSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
159416,7bv1,DB04115,-7.4,Berberine,YBHILYKTIRIUTE-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
26318,6cs2,DB04437,-7.4,"Cysteine-Methylene-Carbamoyl-1,10-Phenanthroline",ZFGIPRHDRFOMFO-LBPRGKRZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
114232,6vxx,DB13129,-7.4,Trimegestone,JUNDJWOLDSCTFK-MTZCLOFQSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
103242,6vxs,DB08345,-7.4,"4-(2-(1H-IMIDAZOL-4-YL)ETHYLAMINO)-2-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE",IWUUKHQIKFHWIW-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
85916,6m3m,DB08210,-7.4,"2-AMINO-4-FLUORO-5-[(1-METHYL-1H-IMIDAZOL-2-YL)SULFANYL]-N-(1,3-THIAZOL-2-YL)BENZAMIDE",YUCYMQBDBXVNCE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
103243,6vxs,DB08346,-7.4,"(5Z)-13-CHLORO-14,16-DIHYDROXY-3,4,7,8,9,10-HEXAHYDRO-1H-2-BENZOXACYCLOTETRADECINE-1,11(12H)-DIONE",YUZYDHRGGDTZLG-DUXPYHPUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
159483,7bv1,DB04474,-7.4,1-Anilino-8-Naphthalene Sulfonate,FWEOQOXTVHGIFQ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
148981,6w9q,DB14655,-7.4,Drostanolone propionate,NOTIQUSPUUHHEH-UXOVVSIBSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
160483,7bv1,DB08442,-7.4,"4-{[(2R)-2-(2-methylphenyl)pyrrolidin-1-yl]carbonyl}benzene-1,3-diol",TWODFUZHWYZBHZ-MRXNPFEDSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
14319,6lzg,T3D3955,-7.4,Tetracycline,OFVLGDICTFRJMM-WESIUVDSSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
8171,6lzg,DB04845,-7.4,Ixabepilone,FABUFPQFXZVHFB-PVYNADRNSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
75756,6m2n,DB05791,-7.4,Perflubron,WTWWXOGTJWMJHI-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
130160,6w4h,DB11859,-7.4,Brexanolone,AURFZBICLPNKBZ-SYBPFIFISA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
70964,6lxt,DB13458,-7.4,Thebacon,RRJQTGHQFYTZOW-ILWKUFEGSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
104341,6vxs,DB11859,-7.4,Brexanolone,AURFZBICLPNKBZ-SYBPFIFISA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
84608,6m3m,DB06614,-7.4,Peramivir,XRQDFNLINLXZLB-CKIKVBCHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
66625,6lxt,DB04437,-7.4,"Cysteine-Methylene-Carbamoyl-1,10-Phenanthroline",ZFGIPRHDRFOMFO-LBPRGKRZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
159321,7bv1,DB03987,-7.4,"2,4-Diamino-6-[N-(3',5'-Dimethoxybenzyl)-N-Methylamino]Pyrido[2,3-D]Pyrimidine",XWCCXDBXMCTZPW-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
130150,6w4h,DB11843,-7.4,PF-04958242,TTYKUKSFWHEBLI-DLBZAZTESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
84599,6m3m,DB06594,-7.4,Agomelatine,YJYPHIXNFHFHND-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
60137,6crv,DB08286,-7.4,NAPHTHYLOXYACETIC ACID,GHRYSOFWKRRLMI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
133042,6w9c,DB01142,-7.4,Doxepin,ODQWQRRAPPTVAG-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
75787,6m2n,DB05973,-7.4,Inosine 5'-sulfate,IGYLPKLXFDOQGM-KQYNXXCUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
130131,6w4h,DB11817,-7.4,Baricitinib,XUZMWHLSFXCVMG-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
133045,6w9c,DB01145,-7.4,Sulfoxone,NEDPPCHNEOMTJV-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
159309,7bv1,DB03970,-7.4,"(7R)-7-(6,7-Dihydro-5H-cyclopenta[d]imidazo[2,1-b][1,3]thiazol-2-yl)-2,7-dihydro-1,4-thiazepine-3,6-dicarboxylic acid",CHNMLWCTGYMVFH-GFCCVEGCSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
8475,6lzg,DB06188,-7.4,Ispinesib,QJZRFPJCWMNVAV-HHHXNRCGSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
148940,6w9q,DB14568,-7.4,Ivosidenib,WIJZXSAJMHAVGX-DHLKQENFSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
160699,7bv1,DB09304,-7.4,Setiptiline,GVPIXRLYKVFFMK-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
159270,7bv1,DB03668,-7.4,1-(5'-Phospho-Beta-D-Ribofuranosyl)Barbituric Acid,AODYJUNLDJOADV-YXZULKJRSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
71754,6lxt,DB15212,-7.4,Pemafibrate,ZHKNLJLMDFQVHJ-RUZDIDTESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
93892,6m71,DB07472,-7.4,"(R)-(+)9B-(3-METHYL)PHENYL-2,3-DIHYDROTHIAZOLO[2,3-A]ISOINDOL-5(9BH)-ONE",FQVDJZWFSZSGGA-QGZVFWFLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
133102,6w9c,DB01207,-7.4,Ridogrel,GLLPUTYLZIKEGF-HAVVHWLPSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
130088,6w4h,DB11755,-7.4,Tetrahydrocannabivarin,ZROLHBHDLIHEMS-HUUCEWRRSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
103104,6vxs,DB08166,-7.4,"(4R)-7-chloro-9-methyl-1-oxo-1,2,4,9-tetrahydrospiro[beta-carboline-3,4'-piperidine]-4-carbonitrile",LPFQFJAOMCGYCP-GFCCVEGCSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
12123,6lzg,DB12914,-7.4,MGL-3196,FDBYIYFVSAHJLY-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
84573,6m3m,DB06523,-7.4,Levovirin,IWUCXVSUMQZMFG-RGDLXGNYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
26415,6cs2,DB04549,-7.4,"4-(Aminosulfonyl)-N-[(2,3,4-Trifluorophenyl)Methyl]-Benzamide",AANTYZRUJFNZFI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
71752,6lxt,DB15208,-7.4,NOP-1A,MZBCQWLYUQJXKA-KRWDZBQOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
148930,6w9q,DB14541,-7.4,Hydrocortisone cypionate,DLVOSEUFIRPIRM-KAQKJVHQSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
93891,6m71,DB07471,-7.4,"5-[5,6-BIS(METHYLOXY)-1H-BENZIMIDAZOL-1-YL]-3-{[1-(2-CHLOROPHENYL)ETHYL]OXY}-2-THIOPHENECARBOXAMIDE",UHCHLTQBLNUYRT-GFCCVEGCSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
130106,6w4h,DB11783,-7.4,Imidapril,KLZWOWYOHUKJIG-BPUTZDHNSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
70938,6lxt,DB13422,-7.4,Nicofuranose,FUWFSXZKBMCSKF-ZASNTINBSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
133092,6w9c,DB01196,-7.4,Estramustine,FRPJXPJMRWBBIH-RBRWEJTLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
86074,6m3m,DB08409,-7.4,4-NITRO-BENZYLPHOSPHONOBUTANOYL-GLYCINE,LNMNPGKCSJFAGN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
66623,6lxt,DB04434,-7.4,Naphthyridine Inhibitor,YRBHUKMLAGQYHS-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
104328,6vxs,DB11836,-7.4,Sapanisertib,GYLDXIAOMVERTK-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
84651,6m3m,DB06700,-7.4,Desvenlafaxine,KYYIDSXMWOZKMP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
114265,6vxx,DB13214,-7.4,Sulfadicramide,XRVJPLDTMUSSDE-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104275,6vxs,DB11765,-7.4,PF-04991532,GKMLFBRLRVQVJO-ZDUSSCGKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
132924,6w9c,DB01006,-7.4,Letrozole,HPJKCIUCZWXJDR-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
104279,6vxs,DB11770,-7.4,Talinolol,MXFWWQICDIZSOA-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
30000,6cs2,DB11915,-7.4,Valbenazine,GEJDGVNQKABXKG-CFKGEZKQSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
104286,6vxs,DB11781,-7.4,Tosedostat,FWFGIHPGRQZWIW-SQNIBIBYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
60081,6crv,DB08210,-7.4,"2-AMINO-4-FLUORO-5-[(1-METHYL-1H-IMIDAZOL-2-YL)SULFANYL]-N-(1,3-THIAZOL-2-YL)BENZAMIDE",YUCYMQBDBXVNCE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130243,6w4h,DB11982,-7.4,GDC-0623,RFWVETIZUQEJEF-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
25719,6cs2,DB03723,-7.4,2'-Deoxy-Thymidine-Beta-L-Rhamnose,ZOSQFDVXNQFKBY-CGAXJHMRSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
103186,6vxs,DB08272,-7.4,(4S)-4-(2-NAPHTHYLMETHYL)-D-GLUTAMIC ACID,YDWIUFASTTZKNI-UONOGXRCSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
34834,1r42,DB00836,-7.4,Loperamide,RDOIQAHITMMDAJ-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
8464,6lzg,DB06159,-7.4,Rubitecan,VHXNKPBCCMUMSW-FQEVSTJZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
159379,7bv1,DB04069,-7.4,"5,6-Dihydro-Benzo[H]Cinnolin-3-Ylamine",QKVREUJWFZJEJK-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
103166,6vxs,DB08245,-7.4,1-(2-DEOXY-5-O-PHOSPHONO-BETA-D-ERYTHRO-PENTOFURANOSYL)-5-NITRO-1H-INDOLE,FQCJFJRLZCIFHB-YNEHKIRRSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
34117,6cs2,T3D0978,-7.4,Karbutilate,OWNAXTAAAQTBSP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
66619,6lxt,DB04429,-7.4,4'-Hydroxyflavanone,ZLHVIYHWWQYJID-HNNXBMFYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
1532,6lzg,HMDB0000570,-7.4,Coproporphyrin III,JWFCYWSMNRLXLX-UJJXFSCMSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
113760,6vxx,DB12045,-7.4,Mericitabine,MLESJYFEMSJZLZ-MAAOGQSESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30002,6cs2,DB11919,-7.4,6-O-benzylguanine,KRWMERLEINMZFT-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
103148,6vxs,DB08223,-7.4,"N-{(1S,2R)-1-BENZYL-3-[(CYCLOPROPYLMETHYL)(2-FURYLSULFONYL)AMINO]-2-HYDROXYPROPYL}-N'-METHYLSUCCINAMIDE",IKOPFHKAECNGQI-VQTJNVASSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
12131,6lzg,DB12927,-7.4,Theodrenaline,WMCMJIGLYZDKRN-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
133004,6w9c,DB01097,-7.4,Leflunomide,VHOGYURTWQBHIL-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
86002,6m3m,DB08319,-7.4,"2'-HYDROXY-1,1'-BIPHENYL-2-SULFINIC ACID",HPKSNFTYZHYEKV-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
132984,6w9c,DB01074,-7.4,Perhexiline,CYXKNKQEMFBLER-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
160645,7bv1,DB09219,-7.4,Bisoxatin,BPKUDUSVDVLOPY-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
84630,6m3m,DB06656,-7.4,TAS-106,JFIWEPHGRUDAJN-DYUFWOLASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
159346,7bv1,DB04020,-7.4,"4-(2-{[4-{[3-(4-Chlorophenyl)Propyl]Sulfanyl}-6-(1-Piperazinyl)-1,3,5-Triazin-2-Yl]Amino}Ethyl)Phenol",AIBKIFHSQQYXLG-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
25705,6cs2,DB03708,-7.4,Adenosine 5'-phosphosulfate,IRLPACMLTUPBCL-KQYNXXCUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
104295,6vxs,DB11792,-7.4,Mirodenafil,MIJFNYMSCFYZNY-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
6078,6lzg,DB01535,-7.4,Carfentanil,YDSDEBIZUNNPOB-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
12136,6lzg,DB12931,-7.4,Fenobam,DWPQODZAOSWNHB-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
101980,6vxs,DB06869,-7.4,1-[2-AMINO-2-CYCLOHEXYL-ACETYL]-PYRROLIDINE-3-CARBOXYLIC ACID 5-CHLORO-2-(2-ETHYLCARBAMOYL-ETHOXY)-BENZYLAMIDE,BMHVHOJXEQTIEA-SIKLNZKXSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
58194,6crv,DB04672,-7.4,"Cyclic 3',5'-thymidine monophosphate",XLPGURCDSRIXFL-JGVFFNPUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
101979,6vxs,DB06868,-7.4,N-(3-chlorobenzyl)-1-(4-methylpentanoyl)-L-prolinamide,PQUULPKGCNPPBX-INIZCTEOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
156820,6wiq,DB13728,-7.4,Halometasone,GGXMRPUKBWXVHE-MIHLVHIWSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
81730,6m3m,DB01610,-7.4,Valganciclovir,WPVFJKSGQUFQAP-GKAPJAKFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
112715,6vxx,DB07762,-7.4,4-(N-ACETYLAMINO)-3-[N-(2-ETHYLBUTANOYLAMINO)]BENZOIC ACID,USKXJFHTBQWXCS-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88310,6m3m,DB13629,-7.4,Mofebutazone,REOJLIXKJWXUGB-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
32845,6cs2,T3D3759,-7.4,Enniatin B1,UQCSETXJXJTMKO-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
138903,6w9c,DB12425,-7.4,Liothyronine I-131,AUYYCJSJGJYCDS-UMVFHIKJSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
11492,6lzg,DB12043,-7.4,Sepetaprost,BKVUSNOUTQMSBE-XCMGCKIWSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
69596,6lxt,DB11259,-7.4,Diosmetin,MBNGWHIJMBWFHU-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
156788,6wiq,DB13685,-7.4,Quingestanol,PCJFRMOEZQQSAX-AIOSZGMZSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
156779,6wiq,DB13676,-7.4,Mosapramine,PXUIZULXJVRBPC-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
138935,6w9c,DB12588,-7.4,AZD-1480,PDOQBOJDRPLBQU-QMMMGPOBSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
101148,6vxs,DB04540,-7.4,Cholesterol,HVYWMOMLDIMFJA-DPAQBDIFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
30365,6cs2,DB12392,-7.4,Resminostat,FECGNJPYVFEKOD-VMPITWQZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
69578,6lxt,DB11157,-7.4,Anthralin,NUZWLKWWNNJHPT-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
88305,6m3m,DB13623,-7.4,Fabomotizole,WWNUCVSRRUDYPP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
66973,6lxt,DB04891,-7.4,Becocalcidiol,QSLUXQQUPXBIHH-YHSKWIAJSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
138956,6w9c,DB12625,-7.4,Evogliptin,LCDDAGSJHKEABN-MLGOLLRUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138965,6w9c,DB12641,-7.4,Tedatioxetine,CVASBKDYSQKLSO-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
52628,2fxp,DB11791,-7.4,Capmatinib,LIOLIMKSCNQPLV-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
76367,6m2n,DB07123,-7.4,N-(4-METHYLBENZOYL)-4-BENZYLPIPERIDINE,DVOLWKZEIDCCES-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
106212,6vxs,DB15238,-7.4,Olinciguat,YWQFJNWMWZMXRW-HXUWFJFHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
88385,6m3m,DB13725,-7.4,Terodiline,UISARWKNNNHPGI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
138975,6w9c,DB12657,-7.4,JNJ-42396302,BPLVDYJDAVYLRQ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
88387,6m3m,DB13727,-7.4,Azapetine,NYGHGTMKALXFIA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
69570,6lxt,DB11115,-7.4,Ensulizole,UVCJGUGAGLDPAA-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
11480,6lzg,DB12024,-7.4,PF-04418948,LWJGMYMNSNVCEM-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
139012,6w9c,DB12712,-7.4,Pilsicainide,BCQTVJKBTWGHCX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139013,6w9c,DB12713,-7.4,Sotagliflozin,QKDRXGFQVGOQKS-CRSSMBPESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
27394,6cs2,DB06930,-7.4,"N-[amino(imino)methyl]-2-(2,5-diphenyl-1H-pyrrol-1-yl)acetamide",WVLDNAVUCUAGDP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
81698,6m3m,DB01567,-7.4,Fludiazepam,ROYOYTLGDLIGBX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
147674,6w9q,DB12285,-7.4,Verubecestat,YHYKUSGACIYRML-KRWDZBQOSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
112707,6vxx,DB07754,-7.4,N-({(1R)-1-carboxy-2-[(4-fluorobenzyl)sulfanyl]ethyl}carbamoyl)-L-glutamic acid,IDTMSHGCAZPVLC-RYUDHWBXSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
150566,6wiq,DB01561,-7.4,Androstanedione,RAJWOBJTTGJROA-WZNAKSSCSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
61829,6crv,DB12661,-7.4,Urapidil,ICMGLRUYEQNHPF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
94589,6m71,DB08293,-7.4,"(5E)-12-CHLORO-13,15-DIHYDROXY-4,7,8,9-TETRAHYDRO-2-BENZOXACYCLOTRIDECINE-1,10(3H,11H)-DIONE",AQKZYZQONWDDLS-HNQUOIGGSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
69661,6lxt,DB11426,-7.4,Marbofloxacin,BPFYOAJNDMUVBL-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
88198,6m3m,DB13475,-7.4,Furazidin,DECBQELQORZLLP-UAIOPKHMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
156950,6wiq,DB13954,-7.4,Estradiol cypionate,UOACKFBJUYNSLK-XRKIENNPSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
138717,6w9c,DB12163,-7.4,Sarpogrelate,FFYNAVGJSYHHFO-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
93005,6m71,DB05959,-7.4,ENMD-1198,YQJWOUQGXATDAE-ACNBBOPNSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
57189,6crv,DB03313,-7.4,Cephalosporin C,HOKIDJSKDBPKTQ-GLXFQSAKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
65834,6lxt,DB03358,-7.4,7n-Methyl-8-Hydroguanosine-5'-Triphosphate,BUJQMJUTTBGELS-KQYNXXCUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
138726,6w9c,DB12181,-7.4,Dalcetrapib,YZQLWPMZQVHJED-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
126037,6w4h,DB03277,-7.4,alpha-maltotriose,FYGDTMLNYKFZSV-PXXRMHSHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
88201,6m3m,DB13479,-7.4,Histapyrrodine,MXHODDGKGSGCDI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
163001,7bv1,DB03403,-7.4,Cytidine-5'-Monophosphate,IERHLVCPSMICTF-XVFCMESISA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
156941,6wiq,DB13930,-7.4,Ulixertinib,KSERXGMCDHOLSS-LJQANCHMSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
11511,6lzg,DB12068,-7.4,T-900607,FSXLOWIFSZNIMV-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
24630,6cs2,DB02402,-7.4,"5-(4-Methoxyphenoxy)-2,4-Quinazolinediamine",CPZJZAIZIMCJRC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
138773,6w9c,DB12245,-7.4,Triclabendazole,NQPDXQQQCQDHHW-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
163015,7bv1,DB03421,-7.4,"2-Phenethyl-2,3-Dihydro-Phthalazine-1,4-Dione",JSSVIGGKHIJEHO-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
27374,6cs2,DB06911,-7.4,D-leucyl-N-(3-chlorobenzyl)-L-prolinamide,FHVBVJXZKNCSLP-CVEARBPZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
101208,6vxs,DB04615,-7.4,(S)-tacrine(10)-hupyridone,ROTFGKJJMRTWBD-MHZLTWQESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
81748,6m3m,DB01629,-7.4,5-fluorouridine,FHIDNBAQOFJWCA-UAKXSSHOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
125967,6w4h,DB03195,-7.4,"Phosphoric Acid Mono-[3-Fluoro-5-(5-Methyl-2,4-Dioxo-3,4-Dihydro-2h-Pyrimidin-1-Yl)-Tetrahyro-Furan-2-Ylmethyl] Ester",GGCAVPJXJISBOA-XLPZGREQSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
81744,6m3m,DB01625,-7.4,Isopropamide,JTPUMZTWMWIVPA-UHFFFAOYSA-O,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
125934,6w4h,DB03148,-7.4,Phosphomethylphosphonic Acid Adenosyl Ester,OLCWZBFDIYXLAA-IOSLPCCCSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
101179,6vxs,DB04576,-7.4,Fleroxacin,XBJBPGROQZJDOJ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
166149,7bv1,DB13755,-7.4,Iocarmic acid,SMQYOVYWPWASGU-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
101174,6vxs,DB04571,-7.4,Trioxsalen,FMHHVULEAZTJMA-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
24634,6cs2,DB02407,-7.4,6-O-Cyclohexylmethyl Guanine,MWGXGTJJAOZBNW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
138850,6w9c,DB12354,-7.4,Imrecoxib,AXMZZGKKZDJGAZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
57158,6crv,DB03273,-7.4,3'-Oxo-Adenosine,MIAZJCOESMXYNJ-XMRAEQSQSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106192,6vxs,DB15204,-7.4,Fosravuconazole,SYTNEMZCCLUTNX-NPMXOYFQSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
138780,6w9c,DB12259,-7.4,CG-200745,AUGCSOFQTDKPSO-RGVLZGJSSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
101232,6vxs,DB04645,-7.4,"5-{3-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-2-METHYL-PHENOXY}-PENTANOIC ACID",NJJIFGCFUDDBSP-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101049,6vxs,DB04407,-7.4,4-[4-(4-Methyl-2-Methylamino-Thiazol-5-Yl)-Pyrimidin-2-Ylamino]-Phenol,OTMLAWRVLMYMDF-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
115555,6w4b,DB00991,-7.4,Oxaprozin,OFPXSFXSNFPTHF-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
88576,6m3m,DB14059,-7.4,SC-236,NSQNZEUFHPTJME-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
57076,6crv,DB03172,-7.4,Tubercidin,HDZZVAMISRMYHH-KCGFPETGSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
100930,6vxs,DB04239,-7.4,2-Amino-6-Aminomethyl-8-Phenylsulfanylmethyl-3h-Quinazolin-4-One,CBFXRTSHUMEYKQ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
163215,7bv1,DB03909,-7.4,"Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate",UFZTZBNSLXELAL-IOSLPCCCSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94672,6m71,DB08393,-7.4,"2-[(5,6-DIPHENYLFURO[2,3-D]PYRIMIDIN-4-YL)AMINO]ETHANOL",UQHINZSKNAAVOZ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
106274,6vxs,DB15359,-7.4,Xanthohumol,ORXQGKIUCDPEAJ-YRNVUSSQSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
81540,6m3m,DB01366,-7.4,Procaterol,FKNXQNWAXFXVNW-BLLLJJGKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
7170,6lzg,DB03337,-7.4,1-(2-Amidinophenyl)-3-(Phenoxyphenyl)Urea,ZHCAYBOLUMAUQX-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
32762,6cs2,T3D3675,-7.4,Zeranol,DWTTZBARDOXEAM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
112688,6vxx,DB07732,-7.4,2-[(2-NAPHTHYLSULFONYL)AMINO]ETHYL DIHYDROGEN PHOSPHATE,FCROUVVWZFPGFM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163227,7bv1,DB03925,-7.4,Freselestat,HMPQTEPEMQZWQH-QZTJIDSGSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
11441,6lzg,DB11968,-7.4,MK-7145,OCKGFTQIICXDQW-ZEQRLZLVSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
61928,6crv,DB12818,-7.4,NM-3,BPZCXUROMKDLGX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
14167,6lzg,T3D3792,-7.4,Amitraz,QXAITBQSYVNQDR-ZIOPAAQOSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
32771,6cs2,T3D3684,-7.4,Ergine,GENAHGKEFJLNJB-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
8957,6lzg,DB07022,-7.4,3-Hydroxypropyl 3-[(7-carbamimidoyl-1-naphthyl)carbamoyl]benzenesulfonate,PXERBGNIBOFZOW-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
88627,6m3m,DB14176,-7.4,Benzylparaben,MOZDKDIOPSPTBH-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
76402,6m2n,DB07163,-7.4,5-[(2-AMINOETHYL)AMINO]-6-FLUORO-3-(1H-PYRROL-2-YL)BENZO[CD]INDOL-2(1H)-ONE,CQCXWWWNUFQYJS-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
139325,6w9c,DB13320,-7.4,Sulfaperin,DZQVFHSCSRACSX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
7185,6lzg,DB03363,-7.4,3-Acetylpyridine Adenine Dinucleotide,KPVQNXLUPNWQHM-RBEMOOQDSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
147622,6w9q,DB12218,-7.4,AZD-5363,JDUBGYFRJFOXQC-KRWDZBQOSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
61947,6crv,DB12853,-7.4,DA-6886,AULLTYAISZREAX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81512,6m3m,DB01324,-7.4,Polythiazide,CYLWJCABXYDINA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
22802,6cs2,HMDB0001849,-7.4,Propranolol,AQHHHDLHHXJYJD-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
61953,6crv,DB12861,-7.4,Rimeporide,GROMEQPXDKRRIE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
8966,6lzg,DB07032,-7.4,2-(4-HYDROXY-PHENYL)BENZOFURAN-5-OL,SNNNDCMXZYWCCI-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
81508,6m3m,DB01299,-7.4,Sulfadoxine,PJSFRIWCGOHTNF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
112657,6vxx,DB07510,-7.4,"3-fluoro-6-(4-fluorophenyl)-2-hydroxy-6-oxohexa-2,4-dienoic acid",CPZFGNOKCMJZFO-BTHQEHEQSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
36154,1r42,DB02545,-7.4,Fexaramine,VLQTUNDJHLEFEQ-KGENOOAVSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
15237,6lzg,T3D0627,-7.4,Tetracene,IFLREYGFSNHWGE-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
8958,6lzg,DB07024,-7.4,"2-(3,4-DIHYDROXYPHENYL)-8-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-3-HYDROXY-6-METHYL-4H-CHROMEN-4-ONE",CEXBEGBNDJVZPK-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
139055,6w9c,DB12780,-7.4,Quinfamide,SBJGFIXQRZOVTO-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
88573,6m3m,DB14050,-7.4,Cannabidivarin,REOZWEGFPHTFEI-JKSUJKDBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81556,6m3m,DB01408,-7.4,Bambuterol,ANZXOIAKUNOVQU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
76381,6m2n,DB07139,-7.4,3-[5-(3-nitrophenyl)thiophen-2-yl]propanoic acid,IHKCOKRMJRDWAL-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
101027,6vxs,DB04376,-7.4,13-Acetylphorbol,SDSVJYOOAPRSDA-RPCQODIISA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101021,6vxs,DB04367,-7.4,Debromohymenialdisine,JYRJOQGKGMHTOO-VURMDHGXSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
139085,6w9c,DB12832,-7.4,Prednimustine,HFVNWDWLWUCIHC-GUPDPFMOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
27400,6cs2,DB06935,-7.4,"2',6'-DIFLUOROBIPHENYL-4-CARBOXYLIC ACID",CWWIIKLXUPZDOG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
27401,6cs2,DB06936,-7.4,N-(4-carbamimidoylbenzyl)-1-(4-methylpentanoyl)-L-prolinamide,AEKJCSNKYXWOAQ-INIZCTEOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
156699,6wiq,DB13571,-7.4,Pentamycin,AGJUUQSLGVCRQA-SWOUQTJZSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
101004,6vxs,DB04342,-7.4,7-((Carboxy(4-Hydroxyphenyl)Acetyl)Amino)-7-Methoxy-(3-((1-Methyl-1h-Tetrazol-5-Yl)Thio)Methyl)-8-Oxo-5-Oxa-1-Azabicyclo[4.2.0]Oct-2-Ene-2-Carboxylic Acid,JWCSIUVGFCSJCK-LIUKBUMOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
139141,6w9c,DB12919,-7.4,T-62,OTZVBZFYMFTYKH-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
125705,6w4h,DB02842,-7.4,9-amino-n-[3-(dimethylamino)propyl]acridine-4-carboxamide,VNWAULKXOPRJEL-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
156642,6wiq,DB13491,-7.4,Fluperolone,SLVCCRYLKTYUQP-DVTGEIKXSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
106250,6vxs,DB15316,-7.4,Florasulam,QZXATCCPQKOEIH-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
156641,6wiq,DB13490,-7.4,Hidrosmin,XYFLWVOTXWXNAM-WTNNCJBMSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
81635,6m3m,DB01498,-7.4,Alphamethadol,QIRAYNIFEOXSPW-YLJYHZDGSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
24572,6cs2,DB02339,-7.4,Allyl-{6-[3-(4-Bromo-Phenyl)-Benzofuran-6-Yloxy]-Hexyl-}-Methyl-Amin,JYNZIOFUHBJABQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
139161,6w9c,DB12946,-7.4,"8-cyclopentyl-1,3-dipropylxanthine",FFBDFADSZUINTG-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
125674,6w4h,DB02804,-7.4,A-98881,PMBZSBGCSQGJAQ-GRKNLSHJSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
7152,6lzg,DB03307,-7.4,4-[(6-Amino-4-Pyrimidinyl)Amino]Benzenesulfonamide,FVFVVRPJERUECT-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
112700,6vxx,DB07746,-7.4,3-ETHYL-6-{[(4-FLUOROPHENYL)SULFONYL]AMINO}-2-METHYLBENZOIC ACID,MGUQWAOYPINSIT-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88497,6m3m,DB13876,-7.4,Brofaromine,WZXHSWVDAYOFPE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
125652,6w4h,DB02770,-7.4,7-Alpha-D-Ribofuranosyl-2-Aminopurine-5'-Phosphate,UDRQVOJQMHZSIM-PULFBKJNSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
81602,6m3m,DB01461,-7.4,Dimenoxadol,RHUWRJWFHUKVED-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81575,6m3m,DB01429,-7.4,Aprindine,NZLBHDRPUJLHCE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
163197,7bv1,DB03886,-7.4,Biopterin,LHQIJBMDNUYRAM-AWFVSMACSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
73011,6m2n,DB01482,-7.4,Fenethylline,NMCHYWGKBADVMK-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
94662,6m71,DB08383,-7.4,"4,5-bis(4-methoxyphenyl)-2-thiophen-2-yl-1H-imidazole",XBMULXNXJLWLLD-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
125614,6w4h,DB02716,-7.4,7-Methyl-Guanosine-5'-Triphosphate,DKVRNHPCAOHRSI-KQYNXXCUSA-O,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
32781,6cs2,T3D3695,-7.4,Lysergol,BIXJFIJYBLJTMK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
92960,6m71,DB05659,-7.4,Faropenem medoxomil,JQBKWZPHJOEQAO-DVPVEWDBSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
88563,6m3m,DB14030,-7.4,PZM21,MEDBIJOVZJEMBI-YOEHRIQHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
100954,6vxs,DB04274,-7.4,"5,4'-Dideoxyflavanone",SWAJPHCXKPCPQZ-AWEZNQCLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
106147,6vxs,DB15114,-7.4,Vamorolone,ZYTXTXAMMDTYDQ-DGEXFFLYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
138691,6w9c,DB12125,-7.4,Dianicline,SUPRUPHAEXPGPF-QWHCGFSZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
156979,6wiq,DB14017,-7.4,H3B-8800,YOIQWBAHJZGRFW-WVRLKXNASA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
106008,6vxs,DB14791,-7.4,GDC-0425,XEZLBMHDUXSICI-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
30320,6cs2,DB12327,-7.4,Salvinorin A,OBSYBRPAKCASQB-AGQYDFLVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
115309,6w4b,DB00705,-7.4,Delavirdine,WHBIGIKBNXZKFE-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
138303,6w9c,DB11362,-7.4,Selexipag,QXWZQTURMXZVHJ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
8866,6lzg,DB06922,-7.4,"2-[(1R)-1-carboxy-2-naphthalen-1-ylethyl]-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylic acid",CZNPWASYMRBJCX-GOSISDBHSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
12920,6lzg,DB14035,-7.4,Englitazone,MVDXXGIBARMXSA-PYUWXLGESA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
166213,7bv1,DB14122,-7.4,Dihydroxymethoxychalcone,NYSZJNUIVUBQMM-BQYQJAHWSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
32965,6cs2,T3D3896,-7.4,Oxyfluorfen,OQMBBFQZGJFLBU-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
101388,6vxs,DB04854,-7.4,Febuxostat,BQSJTQLCZDPROO-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
147793,6w9q,DB12448,-7.4,Lifibrol,LNXBEIZREVRNTF-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
157148,6wiq,DB14662,-7.4,Flunisolide acetate,WEGNFRKBIKYVLC-XTLNBZDDSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
106017,6vxs,DB14820,-7.4,Profoxydim,KRQUFUKTQHISJB-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
32960,6cs2,T3D3891,-7.4,Niclosamide,RJMUSRYZPJIFPJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
61682,6crv,DB12429,-7.4,CI-1040,GFMMXOIFOQCCGU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
69771,6lxt,DB11674,-7.4,Equol,ADFCQWZHKCXPAJ-GFCCVEGCSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
66923,6lxt,DB04829,-7.4,Lysergic acid diethylamide,VAYOSLLFUXYJDT-RDTXWAMCSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
138356,6w9c,DB11461,-7.4,Sulfachlorpyridazine,XOXHILFPRYWFOD-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
88052,6m3m,DB13284,-7.4,Meticrane,FNQQBFNIYODEMB-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
61691,6crv,DB12442,-7.4,Alvespimycin,KUFRQPKVAWMTJO-LMZWQJSESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106022,6vxs,DB14835,-7.4,SUVN-G3031,LNXDUSQEXVQFGP-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
72841,6m2n,DB01209,-7.4,Dezocine,VTMVHDZWSFQSQP-VBNZEHGJSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
88054,6m3m,DB13286,-7.4,Bumadizone,FLWFHHFTIRLFPV-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
162842,7bv1,DB03199,-7.4,4-Methoxy-E-Rhodomycin T,XSSVYBYWQBNYOH-QJIXERIWSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
82090,6m3m,DB02089,-7.4,CP-526423,MWWXABBBAPKJDX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
106027,6vxs,DB14846,-7.4,Bimiralisib,ADGGYDAFIHSYFI-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
82080,6m3m,DB02077,-7.4,L-N(omega)-Nitroarginine-(4R)-Amino-L-Proline Amide,IUFRDGFKAVLPFZ-CSMHCCOUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
57324,6crv,DB03504,-7.4,"9-Butyl-8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-9h-Purin-6-Ylamine",IVPCTHKPOPQMSX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
157139,6wiq,DB14652,-7.4,Clocortolone acetate,ARPLCFGLEYFDCN-CDACMRRYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
106028,6vxs,DB14849,-7.4,Nebicapone,MRFOLGFFTUGAEB-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
147789,6w9q,DB12443,-7.4,Sonedenoson,WUCQGGOGHZRELS-LSCFUAHRSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
157147,6wiq,DB14661,-7.4,Loperamide oxide,KXVSBTJVTUVNPM-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
157135,6wiq,DB14648,-7.4,Acetyl simvastatin,OHVWRJDVJRNCPE-BIKFJBPRSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
106000,6vxs,DB14772,-7.4,DCFBC F-18,IDTMSHGCAZPVLC-STUNTBJNSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
11610,6lzg,DB12203,-7.4,Tozadenant,XNBRWUQWSKXMPW-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
61619,6crv,DB12343,-7.4,Temocillin,BVCKFLJARNKCSS-DWPRYXJFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
69821,6lxt,DB11749,-7.4,(R)-Praziquantel,FSVJFNAIGNNGKK-KRWDZBQOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
101453,6vxs,DB05013,-7.4,Ingenol mebutate,VDJHFHXMUKFKET-UXMMOKKRSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
126667,6w4h,DB04137,-7.4,Guanosine-5'-Triphosphate,XKMLYUALXHKNFT-UUOKFMHZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
138116,6w9c,DB09198,-7.4,Lobeglitazone,CHHXEZSCHQVSRE-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
61629,6crv,DB12359,-7.4,BIIB021,QULDDKSCVCJTPV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
126658,6w4h,DB04125,-7.4,N-Alpha-(2-Naphthylsulfonyl)-N(3-Amidino-L-Phenylalaninyl)-4-Acetyl-Piperazine,ZUWBXGHMVKDMQO-DEOSSOPVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
87934,6m3m,DB13082,-7.4,Nefiracetam,NGHTXZCKLWZPGK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
150467,6wiq,DB01451,-7.4,1-Androstenedione,WJIQCDPCDVWDDE-WZNAKSSCSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
94500,6m71,DB08173,-7.4,5-CHLORO-N-(2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO)ETHYL)THIOPHENE-2-CARBOXAMIDE,UCKHUNHXYMAFQM-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
72783,6m2n,DB01146,-7.4,Diphenylpyraline,OWQUZNMMYNAXSL-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
8851,6lzg,DB06909,-7.4,"1-ethyl-N-(phenylmethyl)-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridine-5-carboxamide",QZGJNFBMYYEFGM-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
138131,6w9c,DB09214,-7.4,Dexketoprofen,DKYWVDODHFEZIM-NSHDSACASA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
24756,6cs2,DB02544,-7.4,"N-(6-{[3-(4-Bromophenyl)-1,2-Benzisothiazol-6-Yl]Oxy}Hexyl)-N-Methylprop-2-En-1-Amine",UCIDPJLYUKNYFZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
112876,6vxx,DB07947,-7.4,ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY)ETHYLAMINO)ETHYL)AMIDE,AUHWQSZMVMMRLM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138141,6w9c,DB09226,-7.4,RP-5063,PMKMNTBZJOXTJW-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
82238,6m3m,DB02282,-7.4,5'-Deoxy-5'-Methylthioadenosine,WUUGFSXJNOTRMR-IOSLPCCCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
138150,6w9c,DB09236,-7.4,Lacidipine,GKQPCPXONLDCMU-CCEZHUSRSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
82237,6m3m,DB02281,-7.4,Formycin,KBHMEHLJSZMEMI-KSYZLYKTSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
94501,6m71,DB08174,-7.4,"5-CHLORO-N-((1R,2S)-2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO) CYCLOPENTYL)THIOPHENE-2-CARBOXAMIDE",QCPYHSAHOYXXQK-DLBZAZTESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
18411,6cs2,HMDB0029179,-7.4,4'-O-methyl-(-)-epicatechin,ZHDMPVIDHWJGTN-CZUORRHYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
94509,6m71,DB08185,-7.4,2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,LCHGAOHLDYRACA-SDBHATRESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93045,6m71,DB06166,-7.4,Fosdevirine,CGBYTKOSZYQOPV-CCEZBSFNSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
147800,6w9q,DB12463,-7.4,Semagacestat,PKXWXXPNHIWQHW-RCBQFDQVSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
8861,6lzg,DB06918,-7.4,2-(2-METHYLPHENYL)-1H-INDOLE-6-CARBOXIMIDAMIDE,ZRYXDGAKQGRHFG-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
126571,6w4h,DB04005,-7.4,Uridine 5'-triphosphate,PGAVKCOVUIYSFO-XVFCMESISA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
69798,6lxt,DB11711,-7.4,Navarixin,IXBYSXNOKFHHDR-QGZVFWFLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
150472,6wiq,DB01456,-7.4,5-androstenedione,SQGZFRITSMYKRH-QAGGRKNESA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
15543,6lzg,DB00169,-7.4,Cholecalciferol,QYSXJUFSXHHAJI-YRZJJWOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
94514,6m71,DB08192,-7.4,2-(4-CARCOXY-5-ISOPROPYLTHIAZOLYL)BENZOPIPERIDINE,HCUGCUQZFBURHR-LBPRGKRZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
138148,6w9c,DB09234,-7.4,Darodipine,QERUYFVNIOLCHV-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138386,6w9c,DB11537,-7.4,Pirlimycin,HBJOXQRURQPDEX-MHXMMLMNSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
69751,6lxt,DB11644,-7.4,Tafamidis,TXEIIPDJKFWEEC-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
28583,6cs2,DB08169,-7.4,(2Z)-N-biphenyl-4-yl-2-cyano-3-cyclopropyl-3-hydroxyprop-2-enamide,CAGGGMPTWTUYHZ-ZCXUNETKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
29630,6cs2,DB00867,-7.4,Ritodrine,IOVGROKTTNBUGK-SJCJKPOMSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
81964,6m3m,DB01925,-7.4,"2'-Chloro-Biphenyl-2,3-Diol",SNGROCQMAKYWRE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
147747,6w9q,DB12389,-7.4,Zamicastat,ZSSLCFLHEFXANG-GOSISDBHSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
166170,7bv1,DB13782,-7.4,Imipramine oxide,QZIQORUGXBPDSU-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
27353,6cs2,DB06889,-7.4,"3-(1H-tetrazol-5-ylmethyl)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(3H)-one",QSBQXAOOVSQABJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
69697,6lxt,DB11490,-7.4,Nalorphine,UIQMVEYFGZJHCZ-SSTWWWIQSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
57243,6crv,DB03386,-7.4,4-Fluorotryptophane,DEBQMEYEKKWIKC-QMMMGPOBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
147746,6w9q,DB12388,-7.4,Evocalcet,RZNUIYPHQFXBAN-XLIONFOSSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
69691,6lxt,DB11478,-7.4,Zeranol,DWTTZBARDOXEAM-GXTWGEPZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
101282,6vxs,DB04715,-7.4,IMIDAZOPYRIDAZIN 1,IVUBNTNWKIPCPS-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
106099,6vxs,DB15024,-7.4,Apararenone,AZNHWXAFPBYFGH-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101275,6vxs,DB04706,-7.4,"(3BETA,7BETA)-CHOLEST-5-ENE-3,7-DIOL",OYXZMSRRJOYLLO-KGZHIOMZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
11547,6lzg,DB12115,-7.4,AZD-9164,FNYFFCOCVNTJCD-NNMXADRKSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
138611,6w9c,DB11915,-7.4,Valbenazine,GEJDGVNQKABXKG-CFKGEZKQSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
65848,6lxt,DB03376,-7.4,'5'-O-(N-(L-Alanyl)-Sulfamoyl)Adenosine,CWWYMWDIYBJVLP-YTMOPEAISA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
138620,6w9c,DB11933,-7.4,Riboprine,USVMJSALORZVDV-SDBHATRESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
72901,6m2n,DB01324,-7.4,Polythiazide,CYLWJCABXYDINA-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
112775,6vxx,DB07829,-7.4,4-[3-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL]PYRIDINE,BILJSHVAAVZERY-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
115456,6w4b,DB00878,-7.4,Chlorhexidine,GHXZTYHSJHQHIJ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
66952,6lxt,DB04865,-7.4,Omacetaxine mepesuccinate,HYFHYPWGAURHIV-JFIAXGOJSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
106119,6vxs,DB15058,-7.4,Flutemetamol,VVECGOCJFKTUAX-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
138644,6w9c,DB12059,-7.4,JNJ-40411813,HYOGJHCDLQSAHX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
81852,6m3m,DB01766,-7.4,Beta-(2-Naphthyl)-Alanine,JPZXHKDZASGCLU-LBPRGKRZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
66958,6lxt,DB04873,-7.4,Piboserod,KVCSJPATKXABRQ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
138652,6w9c,DB12071,-7.4,Vabicaserin,NPTIPEQJIDTVKR-STQMWFEESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
126137,6w4h,DB03413,-7.4,Deoxyuridine-5'-Diphosphate,QHWZTVCCBMIIKE-SHYZEUOFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
112767,6vxx,DB07819,-7.4,(2E)-3-(4-CHLOROPHENYL)-N-HYDROXYACRYLAMIDE,YPYUWBDOEMPXSK-ZZXKWVIFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
101238,6vxs,DB04652,-7.4,Corticosterone,OMFXVFTZEKFJBZ-HJTSIMOOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
106136,6vxs,DB15096,-7.4,18-methoxycoronaridine,DTJQBBHYRQYDEG-SVBQBFEESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
126108,6w4h,DB03370,-7.4,FR239087,HCJYSIGJDKNVRU-TVQRCGJNSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
126175,6w4h,DB03472,-7.4,Cyclohexyl-Hexyl-Beta-D-Maltoside,WUCWJXGMSXTDAV-QKMCSOCLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
115405,6w4b,DB00821,-7.4,Carprofen,PUXBGTOOZJQSKH-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
138519,6w9c,DB11785,-7.4,Anisodamine,WTQYWNWRJNXDEG-RBZJEDDUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
126266,6w4h,DB03605,-7.4,"(2s)-2-[(2,4-Dichloro-Benzoyl)-(3-Trifluoromethyl-Benzyl)-Amino]-3-Phenyl-Propionic Acid",LAJJKGIZTCCOHY-NRFANRHFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
57316,6crv,DB03493,-7.4,7-Methylguanosine,OGHAROSJZRTIOK-KQYNXXCUSA-O,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
93030,6m71,DB06140,-7.4,SUVN-502,GWCYPEHWIZXYFZ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
11587,6lzg,DB12167,-7.4,LY-3023414,ACCFLVVUVBJNGT-AWEZNQCLSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
8883,6lzg,DB06940,-7.4,"N-ethyl-4-{[5-(methoxycarbamoyl)-2-methylphenyl]amino}-5-methylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide",ZZTMFGIGOADCFX-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
57306,6crv,DB03479,-7.4,"8,9,10-Trihydroxy-7-Hydroxymethyl-3-Methyl-6-Oxa-1,3-Diaza-Spiro[4.5]Decane-2,4-Dione",RIUIMUSXAGXXON-FMTWGGRWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
69748,6lxt,DB11638,-7.4,Artenimol,BJDCWCLMFKKGEE-HVDUHBCDSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
57302,6crv,DB03475,-7.4,"1-[4-Carboxy-2-(3-Pentylamino)Phenyl]-5,5'-Di(Hydroxymethyl)Pyrrolidin-2-One",BNIJJJRESBVRNB-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
126346,6w4h,DB03719,-7.4,N-Ethyl-5'-Carboxamido Adenosine,JADDQZYHOWSFJD-BMYQGPEFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
106045,6vxs,DB14879,-7.4,Cefiderocol,DBPPRLRVDVJOCL-FQRUVTKNSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
126342,6w4h,DB03714,-7.4,4-Carbamoyl-4-{[6-(Difluoro-Phosphono-Methyl)-Naphthalene-2-Carbonyl]-Amino}-Butyric Acid,OWWCIKSGGKYNHT-ZDUSSCGKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
11582,6lzg,DB12158,-7.4,Filorexant,NPFDWHQSDBWQLH-QZTJIDSGSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
105134,6vxs,DB13051,-7.4,CH-5132799,JEGHXKRHKHPBJD-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
157120,6wiq,DB14632,-7.4,Prednisolone tebutate,HUMXXHTVHHLNRO-KAJVQRHHSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
69744,6lxt,DB11629,-7.4,Laropiprant,NXFFJDQHYLNEJK-CYBMUJFWSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
115373,6w4b,DB00783,-7.4,Estradiol,VOXZDWNPVJITMN-ZBRFXRBCSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
28847,6cs2,DB08469,-7.4,"tert-butyl 4-(3-thiophen-2-yl-1,2,4-oxadiazol-5-yl)piperidine-1-carboxylate",METBQPRXNZHZMB-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
30333,6cs2,DB12350,-7.4,Rostafuroxin,AEAPORIZZWBIEX-DTBDINHYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
112804,6vxx,DB07862,-7.4,"7-(1-ETHYL-PROPYL)-7H-PYRROLO-[3,2-F]QUINAZOLINE-1,3-DIAMINE",GCPJCLJGTVTGRF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106076,6vxs,DB14938,-7.4,Flurbiprofen axetil,ALIVXCSEERJYHU-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
88108,6m3m,DB13353,-7.4,Viminol,ZILPIBYANAFGMS-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
126275,6w4h,DB03622,-7.4,"2-Hydroxy-5-[4-(2-Hydroxy-Ethyl)-Piperidin-1-Yl]-5-Phenyl-1h-Pyrimidine-4,6-Dione",IPBPOBHSNJFRFT-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
30336,6cs2,DB12354,-7.4,Imrecoxib,AXMZZGKKZDJGAZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
106067,6vxs,DB14921,-7.4,Mavacamten,RLCLASQCAPXVLM-NSHDSACASA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
100832,6vxs,DB04114,-7.4,"3-Chloro-9-Ethyl-6,7,8,9,10,11-Hexahydro-7,11-Methanocycloocta[B]Quinolin-12-Amine",QTPHSDHUHXUYFE-NWDGAFQWSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
138472,6w9c,DB11711,-7.4,Navarixin,IXBYSXNOKFHHDR-QGZVFWFLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
82006,6m3m,DB01976,-7.4,Aminoanthracene,YUENFNPLGJCNRB-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
138462,6w9c,DB11696,-7.4,Racecadotril,ODUOJXZPIYUATO-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
57285,6crv,DB03450,-7.4,Cephalothin Group,UUWFGEKEQSCSMB-IAQYHMDHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
82022,6m3m,DB01998,-7.4,"2-[3,4-Dihydroxy-2-Hydroxymethyl-5-(2-Hydroxy-Nonyl)-Tetrahydro-Furan-2-Yloxy]-6-Hydroxymethyl-Tetra Hydro-Pyran-3,4,5-Triol",IMFJFQAURAFEAH-ZLSOQEJISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
138452,6w9c,DB11683,-7.4,PF-06282999,ICYNYWFGIDGBRD-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
162870,7bv1,DB03230,-7.4,Adenosine-5'-Propylphosphate,XAMXMSZRQHPMRX-QYVSTXNMSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
32926,6cs2,T3D3852,-7.4,Flutolanil,PTCGDEVVHUXTMP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
76294,6m2n,DB07039,-7.4,(2S)-N-(4-cyano-3-iodophenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide,RXSZCFAPSDTELY-SFHVURJKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
57022,6crv,DB03097,-7.4,"Pmp-Hydroxyisoxazole, Pyridoxamine-5-Phosphate-Hydroxyisoxazole",PXWFNGNWQUPGPJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
73049,6m2n,DB01529,-7.4,Dextromoramide,INUNXTSAACVKJS-OAQYLSRUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
147513,6w9q,DB12054,-7.4,BQ-123,VYCMAAOURFJIHD-PJNXIOHISA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
94791,6m71,DB08535,-7.4,"3-bromo-5-phenyl-N-(pyridin-3-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",SMIZFGZXFDGISG-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
139960,6w9c,DB14651,-7.4,Perphenazine enanthate,PWEGQJCIAMJJHC-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
124726,6w4h,DB01554,-7.4,Bolandiol,CMXKUJNZWYTFJN-XFUVECHXSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
69292,6lxt,DB08968,-7.4,Fominoben,KSNNEUZOAFRTDS-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
156177,6wiq,DB12523,-7.4,Mizolastine,PVLJETXTTWAYEW-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
69287,6lxt,DB08962,-7.4,Glibornuride,RMTYNAPTNBJHQI-LLDVTBCESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
100366,6vxs,DB03486,-7.4,Phosphomethylphosphonic Acid Guanosyl Ester,OCJWYBKRHNXUME-KQYNXXCUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
140011,6w9c,DB14750,-7.4,Cidoxepin,ODQWQRRAPPTVAG-BOPFTXTBSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
67042,6lxt,DB05197,-7.4,Sofalcone,GFWRVVCDTLRWPK-KPKJPENVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
140014,6w9c,DB14755,-7.4,beta-Isosparteine,SLRCCWJSBJZJBV-AJNGGQMLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
156162,6wiq,DB12500,-7.4,Fedratinib,JOOXLOJCABQBSG-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
94793,6m71,DB08537,-7.4,"3-bromo-6-phenyl-N-(pyrimidin-5-ylmethyl)imidazo[1,2-a]pyridin-8-amine",LZLKFNBMXXLTLX-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
32555,6cs2,T3D1958,-7.4,"2,2',3,3',5,5'-Hexabromobiphenyl",OIQABQOZOVLYRA-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
139957,6w9c,DB14648,-7.4,Acetyl simvastatin,OHVWRJDVJRNCPE-BIKFJBPRSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
100348,6vxs,DB03460,-7.4,Violaxanthin,SZCBXWMUOPQSOX-WVJDLNGLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
140047,6w9c,DB14841,-7.4,Centanafadine,HKHCSWPSUSWGLI-CABCVRRESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
124695,6w4h,DB01523,-7.4,Clonitazene,GPZLDQAEBHTMPG-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
140073,6w9c,DB14888,-7.4,IQP-0528,UCOAKFIVSAVHLC-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140080,6w9c,DB14900,-7.4,ISO-1 F-18,QVRVXSZKCXFBTE-KPVNRNJOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140082,6w9c,DB14903,-7.4,Rovafovir etalafenamide,OCJRRXHWPBXZSU-BJBBEUPESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
124685,6w4h,DB01511,-7.4,Delorazepam,CHIFCDOIPRCHCF-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
124681,6w4h,DB01503,-7.4,1-Androstenediol,RZFGPAMUAXASRE-YSZCXEEOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
124673,6w4h,DB01493,-7.4,Ethylestrenol,AOXRBFRFYPMWLR-XGXHKTLJSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
100347,6vxs,DB03458,-7.4,"N(4)-Adenosyl-N(4)-methyl-2,4-diaminobutanoic acid",JISVTSUBJCPLSV-TWBCTODHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
140105,6w9c,DB14945,-7.4,Florbenazine F-18,GNKGXQHHUUEYQV-WTHAECTESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
106645,6vxx,DB00849,-7.4,Methylphenobarbital,ALARQZQTBTVLJV-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
124662,6w4h,DB01481,-7.4,1-Testosterone,OKJCFMUGMSVJBG-ABEVXSGRSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
156135,6wiq,DB12459,-7.4,Belotecan,LNHWXBUNXOXMRL-VWLOTQADSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
100342,6vxs,DB03451,-7.4,"1-alpha, 25-dihydroxyl-20-epi-22-oxa-24, 26 ,27-trihomovitamin D3",KLZOTDOJMRMLDX-YBBVPDDNSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
115849,6w4b,DB01405,-7.4,Temafloxacin,QKDHBVNJCZBTMR-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
124656,6w4h,DB01474,-7.4,"17alpha-methyl-3beta,17beta-dihydroxyandrost-4-ene",BNUOCVTVOYWNJC-DTMQFJJTSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
124734,6w4h,DB01562,-7.4,1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine,BVURVTVDNWSNFN-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
106602,6vxx,DB00802,-7.4,Alfentanil,IDBPHNDTYPBSNI-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62139,6crv,DB13153,-7.4,Levomenol,RGZSQWQPBWRIAQ-CABCVRRESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163550,7bv1,DB04778,-7.4,SC45647,LPSXGZAUAOMRNU-FZKQIMNGSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
124802,6w4h,DB01644,-7.4,"3,6-dihydroxy-xanthene-9-propionic acid",PFQGLFBMMPZYEU-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
9009,6lzg,DB07078,-7.4,"(3Z)-6-(4-HYDROXY-3-METHOXYPHENYL)-3-(1H-PYRROL-2-YLMETHYLENE)-1,3-DIHYDRO-2H-INDOL-2-ONE",AYSXURJZVXBSRV-WJDWOHSUSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
147523,6w9q,DB12068,-7.4,T-900607,FSXLOWIFSZNIMV-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
73176,6m2n,DB01682,-7.4,6'-Methyl-Thiamin Diphosphate,XTYXJYCWAJSHCY-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
115813,6w4b,DB01329,-7.4,Cefoperazone,GCFBRXLSHGKWDP-XCGNWRKASA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
147521,6w9q,DB12064,-7.4,BMS-777607,VNBRGSXVFBYQNN-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
124784,6w4h,DB01624,-7.4,Zuclopenthixol,WFPIAZLQTJBIFN-DVZOWYKESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
76498,6m2n,DB07276,-7.4,"5-CYANO-N-(2,5-DIMETHOXYBENZYL)-6-ETHOXYPYRIDINE-2-CARBOXAMIDE",VEGKZYFYGCWXMN-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
106574,6vxx,DB00507,-7.4,Nitazoxanide,YQNQNVDNTFHQSW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81261,6m3m,DB00993,-7.4,Azathioprine,LMEKQMALGUDUQG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
62165,6crv,DB13214,-7.4,Sulfadicramide,XRVJPLDTMUSSDE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163596,7bv1,DB04834,-7.4,Rapacuronium,HTIKWNNIPGXLGM-YLINKJIISA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
124739,6w4h,DB01567,-7.4,Fludiazepam,ROYOYTLGDLIGBX-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
124770,6w4h,DB01608,-7.4,Periciazine,LUALIOATIOESLM-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
62167,6crv,DB13216,-7.4,Oxolamine,IDCHQQSVJAAUQQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
36283,1r42,DB02716,-7.4,7-Methyl-Guanosine-5'-Triphosphate,DKVRNHPCAOHRSI-KQYNXXCUSA-O,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
106583,6vxx,DB00523,-7.4,Alitretinoin,SHGAZHPCJJPHSC-ZVCIMWCZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27505,6cs2,DB07050,-7.4,"5-[(phenylsulfonyl)amino]-1,3,4-thiadiazole-2-sulfonamide",PWDGTQXZLNDOKS-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
139881,6w9c,DB14191,-7.4,Diphenylguanidine,OWRCNXZUPFZXOS-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
32580,6cs2,T3D1982,-7.4,"3,4,4'-Tribromobiphenyl",BYQYWRHKDIPDTI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
150820,6wiq,DB01893,-7.4,N6-Benzyl Adenosine-5'-Diphosphate,MRHGMAGSDAQUFH-LSCFUAHRSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
166090,7bv1,DB13675,-7.4,Metahexamide,XXYTXQGCRQLRHA-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
9016,6lzg,DB07085,-7.4,2-{[N-(2-ACETYL-5-CHLORO-4-FLUOROPHENYL)GLYCYL]AMINO}BENZOIC ACID,LBMZLHCAPBBOFS-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
100383,6vxs,DB03507,-7.4,"6-[3-(4-Morpholinyl)Propyl]-2-(3-Nitrophenyl)-5-Thioxo-5,6,-Dihydro-7h-Thienol[2',3':4,5]Pyrrolo[1,2-C]Imidazol-7-One",UXGUZFZBZPPZGL-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
1753,6lzg,HMDB0000631,-7.4,Deoxycholic acid glycine conjugate,WVULKSPCQVQLCU-ZMBDPXIHSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
89184,6m71,DB00175,-7.4,Pravastatin,TUZYXOIXSAXUGO-PZAWKZKUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
89187,6m71,DB00178,-7.4,Ramipril,HDACQVRGBOVJII-JBDAPHQKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
62183,6crv,DB13234,-7.4,Propanidid,KEJXLQUPYHWCNM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106581,6vxx,DB00521,-7.4,Carteolol,LWAFSWPYPHEXKX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81280,6m3m,DB01015,-7.4,Sulfamethoxazole,JLKIGFTWXXRPMT-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
92884,6m71,DB05255,-7.4,Ronacaleret,FQJISUPNMFRIFZ-HXUWFJFHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
156118,6wiq,DB12432,-7.4,CC-401,XDJCLCLBSGGNKS-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
166080,7bv1,DB13664,-7.4,Formocortal,QNXUUBBKHBYRFW-QWAPGEGQSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
62278,6crv,DB13358,-7.4,Cibenzoline,IPOBOOXFSRWSHL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
166073,7bv1,DB13656,-7.4,Eberconazole,MPTJIDOGFUQSQH-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
163755,7bv1,DB06211,-7.4,Doripenem,AVAACINZEOAHHE-VFZPANTDSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
163760,7bv1,DB06228,-7.4,Rivaroxaban,KGFYHTZWPPHNLQ-AWEZNQCLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
156028,6wiq,DB12108,-7.4,Taselisib,BEUQXVWXFDOSAQ-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
140411,6w9c,DB06083,-7.4,Tapinarof,ZISJNXNHJRQYJO-CMDGGOBGSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140429,6w9c,DB06829,-7.4,4-BROMO-3-(CARBOXYMETHOXY)-5-[3-(CYCLOHEXYLAMINO)PHENYL]THIOPHENE-2-CARBOXYLIC ACID,RXDVFLTWXCTCEX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
67072,6lxt,DB05399,-7.4,Succinobucol,RKSMVPNZHBRNNS-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
156020,6wiq,DB12096,-7.4,PF-05175157,BDXXSFOJPYSYOC-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
69223,6lxt,DB08860,-7.4,Pitavastatin,VGYFMXBACGZSIL-MCBHFWOFSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
147463,6w9q,DB11978,-7.4,Glasdegib,SFNSLLSYNZWZQG-VQIMIIECSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
124464,6w4h,DB01179,-7.4,Podofilox,YJGVMLPVUAXIQN-XVVDYKMHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
94830,6m71,DB08581,-7.4,"4-[(4-bromo-2-{[(3R,5S)-3,5-dimethylpiperidin-1-yl]carbonyl}phenyl)amino]-4-oxobutanoic acid",JSVSGWHGYIDZFX-TXEJJXNPSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
115893,6w4b,DB01455,-7.4,19-Nor-5-androstenediol,VVUQRXPUVKXAIO-XFUVECHXSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
56615,6crv,DB02550,-7.4,"8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-2-Fluoro-9-Pent-4-Ylnyl-9h-Purin-6-Ylamine",KCIOVTSUEXGUFJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163807,7bv1,DB06345,-7.4,AR-9281,HUDQLWBKJOMXSZ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
73312,6m2n,DB01860,-7.4,Cordycepin Triphosphate,NLIHPCYXRYQPSD-BAJZRUMYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
163816,7bv1,DB06368,-7.4,Alamifovir,VDBGPMJFHCJMOL-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
100136,6vxs,DB03176,-7.4,KB-141,OZYQIQVPUZANTM-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
56611,6crv,DB02546,-7.4,Vorinostat,WAEXFXRVDQXREF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
115934,6w4b,DB01501,-7.4,Difenoxin,UFIVBRCCIRTJTN-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
140485,6w9c,DB11433,-7.4,Nequinate,NNOPDLNHPOLRRE-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
76524,6m2n,DB07303,-7.4,"N-3-[3-(5-METHOXYPYRIDIN-3-YL)BENZYL]PYRIDINE-2,3-DIAMINE",PGAWZMRRCVSRIM-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76525,6m2n,DB07304,-7.4,5-[2-(TRIFLUOROMETHOXY)PHENYL]-2-FUROIC ACID,PSLFQKRPFOCZHR-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
89337,6m71,DB00355,-7.4,Aztreonam,WZPBZJONDBGPKJ-VEHQQRBSSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
89340,6m71,DB00358,-7.4,Mefloquine,XEEQGYMUWCZPDN-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
11257,6lzg,DB11721,-7.4,Mitoglitazone,IRNJSRAGRIZIHD-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
124420,6w4h,DB01129,-7.4,Rabeprazole,YREYEVIYCVEVJK-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
115943,6w4b,DB01514,-7.4,Furazabol,RGLLOUBXMOGLDQ-IVEVATEUSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
124445,6w4h,DB01157,-7.4,Trimetrexate,NOYPYLRCIDNJJB-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
140131,6w9c,DB15038,-7.4,Litoxetine,MJJDYOLPMGIWND-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
13069,6lzg,DB14643,-7.4,Methylprednisolone aceponate,DALKLAYLIPSCQL-YPYQNWSCSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
124533,6w4h,DB01264,-7.4,Darunavir,CJBJHOAVZSMMDJ-HEXNFIEUSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
81127,6m3m,DB00841,-7.4,Dobutamine,JRWZLRBJNMZMFE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
156100,6wiq,DB12410,-7.4,Sabarubicin,VQHRZZISQVWPLK-UIRGBLDSSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
69261,6lxt,DB08927,-7.4,Amperozide,NNAIYOXJNVGUOM-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
67058,6lxt,DB05288,-7.4,Anecortave acetate,YUWPMEXLKGOSBF-GACAOOTBSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
69252,6lxt,DB08910,-7.4,Pomalidomide,UVSMNLNDYGZFPF-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
62217,6crv,DB13284,-7.4,Meticrane,FNQQBFNIYODEMB-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62219,6crv,DB13286,-7.4,Bumadizone,FLWFHHFTIRLFPV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
156082,6wiq,DB12388,-7.4,Evocalcet,RZNUIYPHQFXBAN-XLIONFOSSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
163702,7bv1,DB05992,-7.4,Plinabulin,UNRCMCRRFYFGFX-TYPNBTCFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
163704,7bv1,DB06040,-7.4,Filanesib,LLXISKGBWFTGEI-FQEVSTJZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
156081,6wiq,DB12385,-7.4,10-hydroxycamptothecin,HAWSQZCWOQZXHI-FQEVSTJZSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
140263,6w9c,DB01425,-7.4,Alizapride,KSEYRUGYKHXGFW-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
163708,7bv1,DB06090,-7.4,Bradanicline,OXKRFEWMSWPKKV-GHTZIAJQSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
18847,6cs2,HMDB0036648,-7.4,"7-Isopropyl-1,4-dimethylazulene",FWKQNCXZGNBPFD-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
106726,6vxx,DB00940,-7.4,Methantheline,GZHFODJQISUKAY-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
18852,6cs2,HMDB0036811,-7.4,Isopimaric acid,MXYATHGRPJZBNA-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
163732,7bv1,DB06163,-7.4,Plevitrexed,IEJSCSAMMLUINT-NRFANRHFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
81073,6m3m,DB00777,-7.4,Propiomazine,UVOIBTBFPOZKGP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
124566,6w4h,DB01340,-7.4,Cilazapril,HHHKFGXWKKUNCY-FHWLQOOXSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
56696,6crv,DB02660,-7.4,Filaminast,STTRYQAGHGJXJJ-LICLKQGHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
89274,6m71,DB00278,-7.4,Argatroban,KXNPVXPOPUZYGB-IOVMHBDKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
156054,6wiq,DB12345,-7.4,MBX-2982,NFTMKHWBOINJGM-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
89287,6m71,DB00294,-7.4,Etonogestrel,GCKFUYQCUCGESZ-BPIQYHPVSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
140328,6w9c,DB03755,-7.4,"Adenosine-5'-[Beta, Gamma-Methylene]Tetraphosphate",ARRGHMSEJJFDME-IOSLPCCCSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
81057,6m3m,DB00758,-7.4,Clopidogrel,GKTWGGQPFAXNFI-HNNXBMFYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
13064,6lzg,DB00203,-7.4,Sildenafil,BNRNXUUZRGQAQC-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
81049,6m3m,DB00749,-7.4,Etodolac,NNYBQONXHNTVIJ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
32492,6cs2,T3D1850,-7.4,Permethrin,RLLPVAHGXHCWKJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
9031,6lzg,DB07102,-7.4,(2S)-2-amino-5-oxo-5-[(4-phenylmethoxyphenyl)amino]pentanoic acid,BYSBXIPCDJNEBG-INIZCTEOSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
67066,6lxt,DB05351,-7.4,Dexlansoprazole,MJIHNNLFOKEZEW-RUZDIDTESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
27551,6cs2,DB07099,-7.4,N-[4-(benzyloxy)phenyl]glycinamide,YJPUATSIKWOSST-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
7281,6lzg,DB00425,-7.4,Zolpidem,ZAFYATHCZYHLPB-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
163546,7bv1,DB04772,-7.4,1-GUANIDINO-4-(N-PHENYLMETHANESULFONYL-L-LEUCYL-L-PROLYLAMINO)BUTANE,DSVCYWOHJLRGMK-PMACEKPBSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
89079,6m3m,DB15424,-7.4,Bfpet F-18,QWPLCHDPESWJRN-FNNGWQQSSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
28923,6cs2,DB08547,-7.4,PROGESTERONE-11-ALPHA-OL-HEMISUCCINATE,JBBNFGYRYNBDIH-DBGGZKJISA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
88824,6m3m,DB14881,-7.4,Oliceridine,DMNOVGJWPASQDL-OAQYLSRUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
32705,6cs2,T3D3611,-7.4,Microcystin-LF,FEVBMCJUKWWWBT-QVWKUIOOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
163350,7bv1,DB04295,-7.4,N-Benzoyl-N'-Beta-D-Glucopyranosyl Urea,JSBCZGSPFATCOV-BZNQNGANSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
112630,6vxx,DB07478,-7.4,"1,1'-BIPHENYL-3,4-DIOL",QDNPCYCBQFHNJC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88838,6m3m,DB14904,-7.4,Pimasertib,VIUAUNHCRHHYNE-JTQLQIEISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
125235,6w4h,DB02230,-7.4,Immucillin-G,KBIDJCVAURJXFG-PVEDRDFWSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
156373,6wiq,DB13002,-7.4,HKI-357,NERXPXBELDBEPZ-RMKNXTFCSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
153263,6wiq,DB05936,-7.4,CVT-6883,KOYXXLLNCXWUNF-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
139506,6w9c,DB13558,-7.4,Morclofone,KVCJCEKJKGLBOK-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
65735,6lxt,DB03230,-7.4,Adenosine-5'-Propylphosphate,XAMXMSZRQHPMRX-QYVSTXNMSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
100691,6vxs,DB03924,-7.4,"5,8-Di-Amino-1,4-Dihydroxy-Anthraquinone",QVEMRPAUHFWHRV-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
125204,6w4h,DB02189,-7.4,"2',3'-Dideoxyadenosine-5'-Triphosphate",OAKPWEUQDVLTCN-NKWVEPMBSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
156371,6wiq,DB12999,-7.4,MK-6186,FZBAOOQVQXATRL-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
147591,6w9q,DB12165,-7.4,Presatovir,GOFXWTVKPWJNGD-UWJYYQICSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
73078,6m2n,DB01558,-7.4,Bromazepam,VMIYHDSEFNYJSL-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
163388,7bv1,DB04348,-7.4,Taurocholic Acid,WBWWGRHZICKQGZ-HZAMXZRMSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
56938,6crv,DB02980,-7.4,Thymidine-5'-(Dithio)Phosphate,KMPXQZWMYQHTNT-XLPZGREQSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163394,7bv1,DB04357,-7.4,Pteric Acid,JOAQINSXLLMRCV-UHFFFAOYSA-O,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
100690,6vxs,DB03921,-7.4,4-(3-Pyridin-2-Yl-1h-Pyrazol-4-Yl)Quinoline,IBCXZJCWDGCXQT-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
100680,6vxs,DB03909,-7.4,"Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate",UFZTZBNSLXELAL-IOSLPCCCSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
100659,6vxs,DB03882,-7.4,"5-Alpha-Androstane-3-Beta,17beta-Diol",CBMYJHIOYJEBSB-YSZCXEEOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
139528,6w9c,DB13593,-7.4,Zolimidine,VSLIUWLPFRVCDL-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
92909,6m71,DB05414,-7.4,Pipendoxifene,JICOGKJOQXTAIP-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
125163,6w4h,DB02128,-7.4,[1-(3-Hydroxy-2-Oxo-1-Phenethyl-Propylcarbamoyl)2-Phenyl-Ethyl]-Carbamic Acid Pyridin-4-Ylmethyl Ester,QCUBCTPTNWPFBC-ZEQRLZLVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
100641,6vxs,DB03860,-7.4,"N-Butyl-11-[(7r,8r,9s,13s,14s,17s)-3,17-Dihydroxy-13-Methyl-7,8,9,11,12,13,14,15,16,17-Decahydro-6h-Cyclopenta[a]Phenanthren-7-Yl]-N-Methylundecanamide",BVVFOLSZMQVDKV-KXQIQQEYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
62040,6crv,DB12989,-7.4,Neosaxitoxin,PPEKGEBBBBNZKS-HGRQIUPRSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
125154,6w4h,DB02116,-7.4,Olomoucine,GTVPOLSIJWJJNY-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
88850,6m3m,DB14933,-7.4,Nicotinamide riboside,JLEBZPBDRKPWTD-TURQNECASA-O,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81418,6m3m,DB01174,-7.4,Phenobarbital,DDBREPKUVSBGFI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
125198,6w4h,DB02179,-7.4,O-Trifluoromethylphenyl Anthranilic Acid,ONKHJNFXJDEMNQ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
56921,6crv,DB02957,-7.4,Orotidine-5'-Monophosphate,KYOBSHFOBAOFBF-XVFCMESISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27462,6cs2,DB00635,-7.4,Prednisone,XOFYZVNMUHMLCC-ZPOLXVRWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
56966,6crv,DB03022,-7.4,"3-{2,6,8-trioxo-9-[(2R,3S,4R)-2,3,4,5-tetrahydroxypentyl]-1,2,3,6,8,9-hexahydro-7H-purin-7-Yl}propyl dihydrogen phosphate",KPHFGOGGKPGLTM-BHNWBGBOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106352,6vxx,DB00118,-7.4,Ademetionine,MEFKEPWMEQBLKI-AIRLBKTGSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76403,6m2n,DB07164,-7.4,"N-cyclopropyl-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amine",CAGHIASAHLPQMS-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61968,6crv,DB12884,-7.4,Lavoltidine,VTLNPNNUIJHJQB-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
100810,6vxs,DB04086,-7.4,"2',4'-Dinitrophenyl-2deoxy-2-Fluro-B-D-Cellobioside",WFVCNOHOODVBQK-IUBYCILNSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
28664,6cs2,DB08263,-7.4,N-(carboxycarbonyl)-D-phenylalanine,ULQWGBCNOHBNDB-MRVPVSSYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
139414,6w9c,DB13434,-7.4,Fenticonazole,ZCJYUTQZBAIHBS-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139415,6w9c,DB13435,-7.4,Endralazine,ALAXZYHFVBSJKZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
125391,6w4h,DB02424,-7.4,Geldanamycin,QTQAWLPCGQOSGP-KSRBKZBZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
163308,7bv1,DB04238,-7.4,N-Alpha-(2-Naphthylsulfonyl)-N-(3-Amidino-L-Phenylalaninyl)-D-Pipecolinic Acid,GNANSBQAIRJZPA-XZOQPEGZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
112650,6vxx,DB07501,-7.4,(2S)-1-{4-[(4-Anilino-5-bromo-2-pyrimidinyl)amino]phenoxy}-3-(dimethylamino)-2-propanol,MEIJADBULOETOV-KRWDZBQOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
94722,6m71,DB08455,-7.4,Ro 12-7310,CAAFTBWHFUPDGX-OFCLTBKTSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
147609,6w9q,DB12194,-7.4,Atamestane,PEPMWUSGRKINHX-TXTPUJOMSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
100787,6vxs,DB04059,-7.4,8-(Pyrimidin-2-Ylamino)Naphthalene-2-Carboximidamide,GRQLDCHTDNYVQI-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
27445,6cs2,DB06990,-7.4,"4-[(1E,7E)-8-(2,6-DIOXO-1,2,3,6-TETRAHYDROPYRIMIDIN-4-YL)-3,6-DIOXA-2,7-DIAZAOCTA-1,7-DIEN-1-YL]BENZOIC ACID",XHDKIDMFBWLHAX-GONBZBRSSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
88766,6m3m,DB14750,-7.4,Cidoxepin,ODQWQRRAPPTVAG-BOPFTXTBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
139441,6w9c,DB13472,-7.4,Cyclofenil,GVOUFPWUYJWQSK-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
61985,6crv,DB12906,-7.4,LY-2334737,MEOYFIHNRBNEPI-UXIGCNINSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27448,6cs2,DB06993,-7.4,"(2S,3S)-4-cyclopropyl-3-{(3R,5R)-3-[2-fluoro-4-(methylsulfonyl)phenyl]-1,2,4-oxadiazolidin-5-yl}-1-[(3S)-3-fluoropyrrolidin-1-yl]-1-oxobutan-2-amine",PTAHVQJZNFGPHN-WFWWEWPISA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
125353,6w4h,DB02382,-7.4,Namn,JOUIQRNQJGXQDC-ZYUZMQFOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
106431,6vxx,DB00204,-7.4,Dofetilide,IXTMWRCNAAVVAI-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
92933,6m71,DB05514,-7.4,Cobiprostone,SDDSJMXGJNWMJY-BRHAQHMBSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
125337,6w4h,DB02363,-7.4,2'-Monophosphoadenosine-5'-Diphosphate,YPTPYQSAVGGMFN-KQYNXXCUSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
139448,6w9c,DB13482,-7.4,Dimefline,ZXFQRFXLFWWKLX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
106438,6vxx,DB00214,-7.4,Torasemide,NGBFQHCMQULJNZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
139453,6w9c,DB13489,-7.4,Bamipine,VZSXTYKGYWISGQ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
32716,6cs2,T3D3625,-7.4,Imidazolidinyl urea,GAZOQRUEIUBTNF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
156394,6wiq,DB13029,-7.4,MK-0873,JJWKQXNHYDJXKF-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
125299,6w4h,DB02315,-7.4,Cyclic GMP,ZOOGRGPOEVQQDX-UUOKFMHZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
125296,6w4h,DB02310,-7.4,"3,5,6,8-Tetramethyl-N-Methyl Phenanthrolinium",FQTUZNACZKILMC-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
11387,6lzg,DB11899,-7.4,MK-8776,GMIZZEXBPRLVIV-SECBINFHSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
88754,6m3m,DB14720,-7.4,Brovanexine,DQTRREPKGJIABH-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
47571,2fxp,DB01988,-7.4,6((S)-3-Benzylpiperazin-1-Yl)-3-(Naphthalen-2-Yl)-4-(Pyridin-4-Yl)Pyrazine,WFSFNKVFXLIZIY-MHZLTWQESA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
139553,6w9c,DB13627,-7.4,Oxolinic acid,KYGZCKSPAKDVKC-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
163428,7bv1,DB04407,-7.4,4-[4-(4-Methyl-2-Methylamino-Thiazol-5-Yl)-Pyrimidin-2-Ylamino]-Phenol,OTMLAWRVLMYMDF-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
112601,6vxx,DB07443,-7.4,(2Z)-N-biphenyl-4-yl-2-cyano-3-hydroxybut-2-enamide,MUVPBAIVOHJDOC-VBKFSLOCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
92896,6m71,DB05316,-7.4,Pimavanserin,RKEWSXXUOLRFBX-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
124964,6w4h,DB01860,-7.4,Cordycepin Triphosphate,NLIHPCYXRYQPSD-BAJZRUMYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
166099,7bv1,DB13684,-7.4,Omoconazole,JMFOSJNGKJCTMJ-ZHZULCJRSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
156274,6wiq,DB12673,-7.4,ATX-914,ALANRBCCCQEPFZ-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
81339,6m3m,DB01084,-7.4,Emedastine,KBUZBQVCBVDWKX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81334,6m3m,DB01076,-7.4,Atorvastatin,XUKUURHRXDUEBC-KAYWLYCHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
147538,6w9q,DB12092,-7.4,Naftopidil,HRRBJVNMSRJFHQ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
27485,6cs2,DB07030,-7.4,(5-CHLORO-2-{[(3-NITROBENZYL)AMINO]CARBONYL}PHENOXY)ACETIC ACID,VABIMMIJVWNHFI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
8998,6lzg,DB07063,-7.4,"{3-[(4,5,7-TRIFLUORO-1,3-BENZOTHIAZOL-2-YL)METHYL]-1H-INDOL-1-YL}ACETIC ACID",KYHVTMFADJNSGS-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
156270,6wiq,DB12669,-7.4,4SC-203,MAFACRSJGNJHCF-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
14977,6lzg,T3D4923,-7.4,C.I. Food Red 1,DZCOAQKTFAIFRV-FMQUCBEESA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
62116,6crv,DB13105,-7.4,Resolvin E1,AOPOCGPBAIARAV-OTBJXLELSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81321,6m3m,DB01062,-7.4,Oxybutynin,XIQVNETUBQGFHX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
100518,6vxs,DB03708,-7.4,Adenosine 5'-phosphosulfate,IRLPACMLTUPBCL-KQYNXXCUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
94764,6m71,DB08503,-7.4,"(3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(4-methylphenyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol",HRCKGDOSPBFICB-MZHQWRCYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
139717,6w9c,DB13842,-7.4,Etofylline nicotinate,ZWIAODBBEZGVPY-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
124891,6w4h,DB01764,-7.4,Dalfopristin,SUYRLXYYZQTJHF-VMBLUXKRSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
56844,6crv,DB02857,-7.4,Guanosine,NYHBQMYGNKIUIF-UUOKFMHZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
92895,6m71,DB05298,-7.4,Tetomilast,XDBHURGONHZNJF-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
24428,6cs2,DB02166,-7.4,Propidium,ZDWVWKDAWBGPDN-UHFFFAOYSA-O,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
112576,6vxx,DB07413,-7.4,5'-S-[2-(decylamino)ethyl]-5'-thioadenosine,CJIJFWHOTNCRDA-WGQQHEPDSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106547,6vxx,DB00476,-7.4,Duloxetine,ZEUITGRIYCTCEM-KRWDZBQOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
32609,6cs2,T3D2008,-7.4,"2,2',3,3',4,5,5'-Heptabromobiphenyl",ODFOICVBRZRHID-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
36264,1r42,DB02694,-7.4,Pantoyl Adenylate,GDPVENOGSVMRJL-FSRKKXLISA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
124840,6w4h,DB01697,-7.4,beta-cellotriose,FYGDTMLNYKFZSV-CSHPIKHBSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
7278,6lzg,DB03534,-7.4,3-[(Acetyl-Methyl-Amino)-Methyl]-4-Amino-N-Methyl-N-(1-Methyl-1h-Indol-2-Ylmethyl)-Benzamide,AWTBJNJPBKTHEV-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
56832,6crv,DB02844,-7.4,"S-Adenosyl-1,8-Diamino-3-Thiooctane",SUUGLGYBZXSJAA-SCFUHWHPSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
139783,6w9c,DB13978,-7.4,Selisistat,FUZYTVDVLBBXDL-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
166095,7bv1,DB13680,-7.4,Naftazone,TZGBBMBARSFJBG-UKTHLTGXSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
124897,6w4h,DB01772,-7.4,"3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl]-4-(5-Fluoro-1-Methyl-1h-Indol-3-Yl)-Pyrrole-2,5-Dione",RPGZQOOZHIEPJW-HNNXBMFYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
139683,6w9c,DB13796,-7.4,Dibunate,WBEBQCINXJDZCX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
88970,6m3m,DB15204,-7.4,Fosravuconazole,SYTNEMZCCLUTNX-NPMXOYFQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
11363,6lzg,DB11865,-7.4,Brivanib alaninate,LTEJRLHKIYCEOX-OCCSQVGLSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
163430,7bv1,DB04409,-7.4,Naphthalene Trisulfonate,ZPBSAMLXSQCSOX-UHFFFAOYSA-K,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
88873,6m3m,DB15012,-7.4,Farampator,XFVRBYKKGGDPAJ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
76460,6m2n,DB07232,-7.4,Veliparib,JNAHVYVRKWKWKQ-CYBMUJFWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
106498,6vxx,DB00417,-7.4,Phenoxymethylpenicillin,BPLBGHOLXOTWMN-MBNYWOFBSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
51103,2fxp,DB07789,-7.4,"1-[5-methyl-2-(trifluoromethyl)furan-3-yl]-3-[(2Z)-5-(2-{[6-(1H-1,2,4-triazol-3-ylamino)pyrimidin-4-yl]amino}ethyl)-1,3-thiazol-2(3H)-ylidene]urea",KNTGXMNWVXZIMW-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
125116,6w4h,DB02071,-7.4,WAY-151693,AINJYWXKBKRQSX-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
56911,6crv,DB02946,-7.4,Carpropamide,RXDMAYSSBPYBFW-RULNRJAQSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56909,6crv,DB02943,-7.4,N-(4-Aminobutanoyl)-S-(4-Methoxybenzyl)-L-Cysteinylglycine,OMOPDEZZBQHMGS-AWEZNQCLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112620,6vxx,DB07463,-7.4,"(3R,4S)-1-[(4-amino-5H-pyrrolo[3,2-d]pyrimidin-7-yl)methyl]-4-[(butylsulfanyl)methyl]pyrrolidin-3-ol",LTSUEVPGSXUJHT-OLZOCXBDSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
24474,6cs2,DB02224,-7.4,Taxifolin,CXQWRCVTCMQVQX-LSDHHAIUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
156343,6wiq,DB12949,-7.4,PF-03382792,AGMOFKKOVMRGAK-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
69382,6lxt,DB09091,-7.4,Tixocortol,YWDBSCORAARPPF-VWUMJDOOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
73113,6m2n,DB01603,-7.4,Meticillin,RJQXTJLFIWVMTO-TYNCELHUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
32657,6cs2,T3D2059,-7.4,"2,3,7-Trichlorodibenzo-p-dioxin",ZSIZNEVHVVRPFF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
62074,6crv,DB13046,-7.4,Tocladesine,CLLFEJLEDNXZNR-UUOKFMHZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81377,6m3m,DB01127,-7.4,Econazole,LEZWWPYKPKIXLL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
7241,6lzg,DB03476,-7.4,Trans-6-(2-Phenylcyclopropyl)-Naphthalene-2-Carboxamidine,NQRIWXVAIWPBEM-OALUTQOASA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
112603,6vxx,DB07446,-7.4,N-(biphenyl-4-ylsulfonyl)-D-leucine,FBSVJQQVDISETN-QGZVFWFLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
100542,6vxs,DB03737,-7.4,"4-((3r,4s,5r)-4-Amino-3,5-Dihydroxy-Hex-1-Ynyl)-5-Fluoro-3-[1-(3-Methoxy-1h-Pyrrol-2-Yl)-Meth-(Z)-Ylidene]-1,3-Dihydro-Indol-2-One",RAKYKJWUUUKCCW-MPLBGYFPSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
73133,6m2n,DB01625,-7.4,Isopropamide,JTPUMZTWMWIVPA-UHFFFAOYSA-O,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
30404,6cs2,DB12434,-7.4,Steviolbioside,OMHUCGDTACNQEX-OSHKXICASA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
24450,6cs2,DB02195,-7.4,"3-(4-Fluorophenyl)-1-Hydroxy-2-(Pyridin-4-Yl)-1h-Pyrrolo[3,2-B]Pyridine",ZSMYZLKEZDYVPI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
156307,6wiq,DB12899,-7.4,TT-301,ZPJGUEPHFXPAQF-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
15234,6lzg,T3D0622,-7.4,Benzo[j]fluoranthene,KHNYNFUTFKJLDD-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
8994,6lzg,DB07059,-7.4,"N-{2-[6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2,2-DIMETHYL-3-OXO-2,3-DIHYDRO-4H-1,4-BENZOXAZIN-4-YL]ETHYL}ACETAMIDE",GBXSOZDYCSBLQX-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
73124,6m2n,DB01615,-7.4,Aceprometazine,XLOQNFNTQIRSOX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
125039,6w4h,DB01965,-7.4,"2'-Deoxyuridine 5'-Alpha,Beta-Imido-Triphosphate",XZLLMTSKYYYJLH-SHYZEUOFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
125043,6w4h,DB01972,-7.4,Guanosine-5'-Monophosphate,RQFCJASXJCIDSX-UUOKFMHZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
112609,6vxx,DB07452,-7.4,"2,6-diamino-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",WFECBOHPSURSGU-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56894,6crv,DB02923,-7.4,"Biphenyl-2,3-Diol",YKOQAAJBYBTSBS-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81374,6m3m,DB01124,-7.4,Tolbutamide,JLRGJRBPOGGCBT-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
139643,6w9c,DB13741,-7.4,Ioglycamic acid,FZDZULUFHNDEDJ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
27282,6cs2,DB06803,-7.4,Niclosamide,RJMUSRYZPJIFPJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
115365,6w4b,DB00773,-7.4,Etoposide,VJJPUSNTGOMMGY-MRVIYFEKSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
147821,6w9q,DB12492,-7.4,Piritramide,IHEHEFLXQFOQJO-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
137280,6w9c,DB08106,-7.4,N-[(6-butoxynaphthalen-2-yl)sulfonyl]-D-glutamic acid,UAGYXJBYAFGRFR-QGZVFWFLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
127469,6w4h,DB06155,-7.4,Rimonabant,JZCPYUJPEARBJL-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
15774,6lzg,DB01153,-7.4,Sertaconazole,JLGKQTAYUIMGRK-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
137286,6w9c,DB08112,-7.4,N-({6-[(4-CYANO-2-FLUOROBENZYL)OXY]NAPHTHALEN-2-YL}SULFONYL)-D-GLUTAMIC ACID,IRJUSGUHNFMVCK-OAQYLSRUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
82709,6m3m,DB02898,-7.4,5-{[(2-Amino-9h-Purin-6-Yl)Oxy]Methyl}-2-Pyrrolidinone,UYPMMHCTXQIWDX-RXMQYKEDSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
57799,6crv,DB04144,-7.4,"Cis-[4,5-Bis-(4-Chlorophenyl)-2-(2-Isopropoxy-4-Methoxyphenyl)-4,5-Dihyd Roimidazol-1-Yl]-Piperazin-1-Yl-Methanone",ZXIPEZDMQNYFOO-WUFINQPMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127447,6w4h,DB06061,-7.4,AZD-8330,RWEVIPRMPFNTLO-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
82707,6m3m,DB02896,-7.4,Methylthioinosine,ZDRFDHHANOYUTE-IOSLPCCCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
162265,7bv1,DB01820,-7.4,"Compound 12, N-Acetyl-4-[(Carboxycarbonyl)(2-Carboxyphenyl)Amino]-N-Pentyl-1-Napthylalaniamide",UESXELNYBIOROE-QHCPKHFHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
162280,7bv1,DB01838,-7.4,"6,4'-Dihydroxy-3-Methyl-3',5'-Dibromoflavone",GKDYOXMZSXVKPP-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
127439,6w4h,DB05973,-7.4,Inosine 5'-sulfate,IGYLPKLXFDOQGM-KQYNXXCUSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
127438,6w4h,DB05969,-7.4,SNS-032,OUSFTKFNBAZUKL-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
105480,6vxs,DB13555,-7.4,Prajmaline,UAUHEPXILIZYCU-ALHOSYKFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
76164,6m2n,DB06887,-7.4,"[(3S)-3-(Methylcarbamoyl)-2-{[(2-methyl-2-propanyl)oxy]carbonyl}-1,2,3,4-tetrahydro-7-isoquinolinyl]sulfamic acid",PPSSYXOFPICMQD-ZDUSSCGKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
105483,6vxs,DB13558,-7.4,Morclofone,KVCJCEKJKGLBOK-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
27167,6cs2,DB06618,-7.4,Cutamesine,UVSWWUWQVAQPJR-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
61372,6crv,DB11989,-7.4,Benznidazole,CULUWZNBISUWAS-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
137340,6w9c,DB08169,-7.4,(2Z)-N-biphenyl-4-yl-2-cyano-3-cyclopropyl-3-hydroxyprop-2-enamide,CAGGGMPTWTUYHZ-ZCXUNETKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
162303,7bv1,DB01871,-7.4,[1-(1-Benzyl-3-Hydroxy-2-Oxo-Propylcarbamoyl)-2-Phenyl-Ethyl]-Carbamic Acid Benzyl Ester,OACUXIVGLLCILS-ZEQRLZLVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
70018,6lxt,DB12041,-7.4,Mapracorat,VJGFOYBQOIPQFY-XMMPIXPASA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
150461,6wiq,DB01443,-7.4,19-Nor-5-androstenedione,WELNRNVZXWUOGT-QXUSFIETSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
127398,6w4h,DB05706,-7.4,13-deoxydoxorubicin,RGVRUQHYQSORBY-JIGXQNLBSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
82692,6m3m,DB02879,-7.4,"2,3-Di-O-Sulfo-Alpha-D-Glucopyranose",ORUZACWROKWTRH-DVKNGEFBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
82688,6m3m,DB02872,-7.4,"Cis-[4,5-Bis-(4-Bromophenyl)-2-(2-Ethoxy-4-Methoxyphenyl)-4,5-Dihydroimidazol-1-Yl]-[4-(2-Hydroxyethyl)Piperazin-1-Yl]Methanone",PVRYEWOXWGDQHA-URLMMPGGSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
105500,6vxs,DB13586,-7.4,Metandienone,XWALNWXLMVGSFR-HLXURNFRSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
61382,6crv,DB12004,-7.4,Briciclib,LXENKEWVEVKKGV-BQYQJAHWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
137373,6w9c,DB08212,-7.4,1-[2-(3-ACETYL-2-HYDROXY-6-METHOXY-PHENYL)-CYCLOPROPYL]-3-(5-CYANO-PYRIDIN-2-YL)-THIOUREA,FSRLCMRWYUJTNT-UONOGXRCSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137268,6w9c,DB08093,-7.4,3-(1-NAPHTHYLMETHOXY)PYRIDIN-2-AMINE,SZANYTFSQVBOBA-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
147990,6w9q,DB12756,-7.4,TAK-901,WKDACQVEJIVHMZ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
137262,6w9c,DB08084,-7.4,IDD594,JCZUIWYXULSXSW-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
57813,6crv,DB04163,-7.4,"5-Phenylsulfanyl-2,4-Quinazolinediamine",BUFDQCGCADQQQY-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127548,6w4h,DB06335,-7.4,Saxagliptin,QGJUIPDUBHWZPV-SGTAVMJGSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
6864,6lzg,DB02827,-7.4,"7-(1,1-Dioxo-1h-Benzo[D]Isothiazol-3-Yloxymethyl)-2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Pyran-3-Carboxylic Acid",MDYIGSPVMWSFEZ-JTQLQIEISA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
82772,6m3m,DB02980,-7.4,Thymidine-5'-(Dithio)Phosphate,KMPXQZWMYQHTNT-XLPZGREQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
127539,6w4h,DB06307,-7.4,Apoptone,CKAXZOYFIHQCBN-JRRMKBMNSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
101762,6vxs,DB06442,-7.4,Avasimibe,PTQXTEKSNBVPQJ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
61337,6crv,DB11937,-7.4,Kynurenic Acid,HCZHHEIFKROPDY-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
15820,6lzg,DB01405,-7.4,Temafloxacin,QKDHBVNJCZBTMR-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
70063,6lxt,DB12106,-7.4,PF-06305591,APWZIFIAVVFPNT-PELKAZGASA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
94406,6m71,DB08073,-7.4,(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE,YWTBGJGMTBHQTM-IBGZPJMESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94409,6m71,DB08076,-7.4,"4-[1-(2,6-dichlorobenzyl)-2-methyl-1H-imidazol-4-yl]pyrimidin-2-amine",CKSSZTMRRVJNNG-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
15807,6lzg,DB01328,-7.4,Cefonicid,DYAIAHUQIPBDIP-AXAPSJFSSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
113167,6vxx,DB08618,-7.4,3-(HYDROXY-PHENYL-PHOSPHINOYLOXY)-8-METHYL-8-AZA-BICYCLO[3.2.1]OCTANE-2-CARBOXYLIC ACID METHYL ESTER,WJTKWTJTOSZMKO-PMOUVXMZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127516,6w4h,DB06250,-7.4,Fluasterone,VHZXNQKVFDBFIK-NBBHSKLNSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
127515,6w4h,DB06249,-7.4,Arzoxifene,MCGDSOGUHLTADD-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
82736,6m3m,DB02933,-7.4,5'-Deoxy-5'-(Methylthio)-Tubercidin,WBPLMFVTQMIPLW-MFYTUXHUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
162194,7bv1,DB01548,-7.4,Diprenorphine,OIJXLIIMXHRJJH-KNLIIKEYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
162195,7bv1,DB01549,-7.4,Rolicyclidine,FYOWWXMGDATDQY-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
24983,6cs2,DB02819,-7.4,"Mono-[3,4-Dihydroxy-5-(5-Methyl-Benzoimidazol-1-Yl)-Tetrahydor-Furan-2-Ylmethyl] Ester",HGUDFQQPANTQEU-LPWJVIDDSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
6879,6lzg,DB02848,-7.4,"{4-[3-(6,7-Diethoxy-Quinazolin-4-Ylamino)-Phenyl]-Thiazol-2-Yl}-Methanol",ZJESXGUODSBHSK-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
113153,6vxx,DB08602,-7.4,"3-(2,6-difluorophenyl)-2-(methylthio)quinazolin-4(3H)-one",BFNBJSXMXXQLAW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
15792,6lzg,DB01228,-7.4,Encainide,PJWPNDMDCLXCOM-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
162214,7bv1,DB01568,-7.4,Codeine-N-oxide,BDLSDHWCOJPHIE-KFUGMXNISA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
82726,6m3m,DB02921,-7.4,(South)-Methanocarba-Thymidine,XRMLXZVSFIBRRJ-PEFMBERDSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
105439,6vxs,DB13501,-7.4,Bendazac,BYFMCKSPFYVMOU-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101739,6vxs,DB06368,-7.4,Alamifovir,VDBGPMJFHCJMOL-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
127486,6w4h,DB06194,-7.4,Elocalcitol,LRLWXBHFPGSUOX-GJQYOBCGSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
70044,6lxt,DB12078,-7.4,Enobosarm,JNGVJMBLXIUVRD-SFHVURJKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
101734,6vxs,DB06354,-7.4,Tezampanel,ZXFRFPSZAKNPQQ-YTWAJWBKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
137381,6w9c,DB08223,-7.4,"N-{(1S,2R)-1-BENZYL-3-[(CYCLOPROPYLMETHYL)(2-FURYLSULFONYL)AMINO]-2-HYDROXYPROPYL}-N'-METHYLSUCCINAMIDE",IKOPFHKAECNGQI-VQTJNVASSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
127371,6w4h,DB05542,-7.4,Naronapride,VGDDOIZXGFJDRC-VJTSUQJLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
72611,6m2n,DB00947,-7.4,Fulvestrant,VWUXBMIQPBEWFH-WCCTWKNTSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
27199,6cs2,DB06680,-7.4,Asoprisnil,GJMNAFGEUJBOCE-MEQIQULJSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
137467,6w9c,DB08330,-7.4,METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE,VEJCBCPEURAYAS-MEAXDALNSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
127289,6w4h,DB05100,-7.4,Prinomastat,YKPYIPVDTNNYCN-INIZCTEOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
150270,6wiq,DB01148,-7.4,Flavoxate,SPIUTQOUKAMGCX-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
127287,6w4h,DB05087,-7.4,Ganaxolone,PGTVWKLGGCQMBR-FLBATMFCSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
137501,6w9c,DB08373,-7.4,"4,4'-BIS([H]METHYLSULFONYL)-2,2',5,5'-TETRACHLOROBIPHENYL",RDBKPLOYRMCFIY-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
101648,6vxs,DB06153,-7.4,Pizotifen,FIADGNVRKBPQEU-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
72643,6m2n,DB00986,-7.4,Glycopyrronium,ANGKOCUUWGHLCE-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
127273,6w4h,DB05015,-7.4,Belinostat,NCNRHFGMJRPRSK-MDZDMXLPSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
94429,6m71,DB08099,-7.4,"6-ethyl-5-[(2S)-1-(3-methoxypropyl)-2-phenyl-1,2,3,4-tetrahydroquinolin-7-yl]pyrimidine-2,4-diamine",UOYVKYJWAXJTTE-NRFANRHFSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
137540,6w9c,DB08424,-7.4,"[5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL](3-{[(2R)-2,3-DIHYDROXYPROPYL]OXY}PHENYL)METHANONE",IJDQETGUEUJVTB-HNNXBMFYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
127264,6w4h,DB04967,-7.4,Lucanthone,FBQPGGIHOFZRGH-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
162419,7bv1,DB02033,-7.4,"N-(3-Cyclopropyl(5,6,7,8,9,10-Hexahydro-2-Oxo-2h-Cycloocta[B]Pyran-3-Yl)Methyl)Phenylbenzensulfonamide",GDRNWAKVNIROCG-DEOSSOPVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
87700,6m3m,DB12714,-7.4,Nerispirdine,BTDHTARYCBHHPJ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
101630,6vxs,DB06083,-7.4,Tapinarof,ZISJNXNHJRQYJO-CMDGGOBGSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
137550,6w9c,DB08436,-7.4,"8-BENZO[1,3]DIOXOL-,5-YLMETHYL-9-BUTYL-9H-",JCDXXNIRWRRGBX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
127245,6w4h,DB04915,-7.4,Idronoxil,ZZUBHVMHNVYXRR-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
137553,6w9c,DB08440,-7.4,"N-1,10-phenanthrolin-5-ylacetamide",AAJXINSCZMZERD-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137578,6w9c,DB08469,-7.4,"tert-butyl 4-(3-thiophen-2-yl-1,2,4-oxadiazol-5-yl)piperidine-1-carboxylate",METBQPRXNZHZMB-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
15706,6lzg,DB00881,-7.4,Quinapril,JSDRRTOADPPCHY-HSQYWUDLSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
57693,6crv,DB04001,-7.4,6-(Oxalyl-Amino)-1h-Indole-5-Carboxylic Acid,AHWMERGBWWROMM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
162446,7bv1,DB02277,-7.4,1-(5-Tert-Butyl-2-Methyl-2h-Pyrazol-3-Yl)-3-(4-Chloro-Phenyl)-Urea,FWIJKWMXNHRSRO-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
137580,6w9c,DB08471,-7.4,"1-(thiophen-2-ylacetyl)-4-(3-thiophen-2-yl-1,2,4-oxadiazol-5-yl)piperidine",SJEVDMFUHCVNPM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
82530,6m3m,DB02660,-7.4,Filaminast,STTRYQAGHGJXJJ-LICLKQGHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
12854,6lzg,DB13919,-7.4,Candesartan,HTQMVQVXFRQIKW-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
57681,6crv,DB03986,-7.4,6-Methyl-Formycin A,UHYKIYIKTWEXSX-LFAOKBQASA-O,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72662,6m2n,DB01007,-7.4,Tioconazole,QXHHHPZILQDDPS-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
35748,1r42,DB02021,-7.4,Fidarestat,WAAPEIZFCHNLKK-UFBFGSQYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
72640,6m2n,DB00982,-7.4,Isotretinoin,SHGAZHPCJJPHSC-XFYACQKRSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
93132,6m71,DB06395,-7.4,Abafungin,TYBHXIFFPVFXQW-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
82619,6m3m,DB02781,-7.4,"4-{(Z)-[2-[3-(Methylsulfanyl)Propanoyl]-5-Oxo-1-(2-Oxoethyl)-1,5-Dihydro-4h-Imidazol-4-Ylidene]Methyl}Benzenolate",POPNGBKQPJVYFV-JLHYYAGUSA-M,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
82673,6m3m,DB02852,-7.4,Domoic Acid,VZFRNCSOCOPNDB-AOKDLOFSSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
147985,6w9q,DB12746,-7.4,AKN-028,JLRIJKVMMZEKDF-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
70008,6lxt,DB12022,-7.4,Evatanepag,WOHRHWDYFNWPNG-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
93142,6m71,DB06414,-7.4,Etravirine,PYGWGZALEOIKDF-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
157464,6wiq,DB06558,-7.4,Tezosentan,TUYWTLTWNJOZNY-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
105525,6vxs,DB13618,-7.4,Ipriflavone,SFBODOKJTYAUCM-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
137412,6w9c,DB08262,-7.4,"2,6-dicarboxynaphthalene",RXOHFPCZGPKIRD-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
8768,6lzg,DB06809,-7.4,Plerixafor,YIQPUIGJQJDJOS-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
61392,6crv,DB12017,-7.4,Ozagrel,SHZKQBHERIJWAO-AATRIKPKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27184,6cs2,DB06645,-7.4,Anamorelin,VQPFSIRUEPQQPP-MXBOTTGLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
27185,6cs2,DB06649,-7.4,Priralfinamide,BHJIBOFHEFDSAU-LBPRGKRZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
82659,6m3m,DB02835,-7.4,"Alpha-D-Glucose 1,6-Bisphosphate",RWHOZGRAXYWRNX-VFUOTHLCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
105546,6vxs,DB13649,-7.4,Proquazone,JTIGKVIOEQASGT-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
127553,6w4h,DB06354,-7.4,Tezampanel,ZXFRFPSZAKNPQQ-YTWAJWBKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
105547,6vxs,DB13651,-7.4,Lorajmine,LAHDERDHXJFFJU-ZWNKPRIXSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
147982,6w9q,DB12743,-7.4,Z-160,VCPMZDWBEWTGNW-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
137422,6w9c,DB08281,-7.4,"O-[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethyl] (4-bromophenyl)thiocarbamate",BDVAWAILQCYMQE-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
101690,6vxs,DB06237,-7.4,Avanafil,WEAJZXNPAWBCOA-INIZCTEOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
94419,6m71,DB08087,-7.4,"4-[(7R,7AS)-7-HYDROXY-1,3-DIOXOTETRAHYDRO-1H-PYRROLO[1,2-C]IMIDAZOL-2(3H)-YL]-1-NAPHTHONITRILE",NHBIWLQQJPSMNP-CABCVRRESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
35739,1r42,DB02009,-7.4,"L-756,423",AOMZDQMIOCTPQP-QHQMVRJISA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
105558,6vxs,DB13664,-7.4,Formocortal,QNXUUBBKHBYRFW-QWAPGEGQSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
82627,6m3m,DB02796,-7.4,9-Deazainosine,WKDMPDYUJKSXBW-KBHCAIDQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
127312,6w4h,DB05252,-7.4,Fenoxaprop-ethyl,PQKBPHSEKWERTG-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
35740,1r42,DB02010,-7.4,Staurosporine,HKSZLNNOFSGOKW-FYTWVXJKSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
127309,6w4h,DB05234,-7.4,LGD2941,HWLLYFXDDGGHOE-BCSUUIJWSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
105559,6vxs,DB13665,-7.4,Fluanisone,IRYFCWPNDIUQOW-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
137441,6w9c,DB08302,-7.4,3-[5-(2-nitropent-1-en-1-yl)furan-2-yl]benzoic acid,IRHZCQDCMUWUKV-RAXLEYEMSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137449,6w9c,DB08310,-7.4,"N-[(2R)-2-{[(2S)-2-(1,3-benzoxazol-2-yl)pyrrolidin-1-yl]carbonyl}hexyl]-N-hydroxyformamide",QDDZLTVSNABZIK-ZBFHGGJFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
127324,6w4h,DB05295,-7.4,Eldecalcitol,FZEXGDDBXLBRTD-AYIMTCTASA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
127554,6w4h,DB06358,-7.4,Iclaprim,HWJPWWYTGBZDEG-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
14224,6lzg,T3D3856,-7.4,Halosulfuron-methyl,FMGZEUWROYGLAY-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
114956,6w4b,DB00275,-7.4,Olmesartan,VTRAEEWXHOVJFV-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
27077,6cs2,DB06412,-7.4,Oxymetholone,ICMWWNHDUZJFDW-DHODBPELSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
136780,6w9c,DB07525,-7.4,"3-(3-methoxybenzyl)-1H-pyrrolo[2,3-b]pyridine",GHQCCHWTDLTMJT-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
83036,6m3m,DB03332,-7.4,"5,6-Cyclic-Tetrahydropteridine",XAZOBOCYEGBXHD-GSVOUGTGSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
94364,6m71,DB08023,-7.4,"N-cyclohexyl-4-imidazo[1,2-a]pyridin-3-yl-N-methylpyrimidin-2-amine",HYNNWLVWJXWXFO-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
101908,6vxs,DB06746,-7.4,ginkgolide-J,LMEHVEUFNRJAAV-UKWFQYJJSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
52277,2fxp,DB09280,-7.4,Lumacaftor,UFSKUSARDNFIRC-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
136808,6w9c,DB07556,-7.4,N-HYDROXY-2(R)-[[(4-METHOXYPHENYL)SULFONYL](3-PICOLYL)AMINO]-3-METHYLBUTANAMIDE HYDROCHLORIDE,BSIZUMJRKYHEBR-QGZVFWFLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
157729,6wiq,DB12725,-7.4,TD-8954,MZOITCJKGUIQEI-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
136823,6w9c,DB07574,-7.4,"2-MERCAPTO-N-[1,2,3,10-TETRAMETHOXY-9-OXO-5,6,7,9-TETRAHYDRO-BENZO[A]HEPTALEN-7-YL]ACETAMIDE",TYDIWMTWTXFWSY-HNNXBMFYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
6786,6lzg,DB02694,-7.4,Pantoyl Adenylate,GDPVENOGSVMRJL-FSRKKXLISA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
136843,6w9c,DB07598,-7.4,"2,3,6A,7,8,9-HEXAHYDRO-11H-[1,4]DIOXINO[2,3-G]PYRROLO[2,1-B][1,3]BENZOXAZIN-11-ONE",RQEPVMAYUINZRE-GFCCVEGCSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
72471,6m2n,DB00790,-7.4,Perindopril,IPVQLZZIHOAWMC-QXKUPLGCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
148097,6w9q,DB12929,-7.4,JNJ-39220675,IQOWHZHNGJXGHG-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
33322,6cs2,T3D4515,-7.4,Hexythiazox,XGWIJUOSCAQSSV-XHDPSFHLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
136844,6w9c,DB07602,-7.4,S-{3-[(4-ANILINOQUINAZOLIN-6-YL)AMINO]-3-OXOPROPYL}-L-CYSTEINE,NLVZTRZPMRTVRC-INIZCTEOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
157725,6wiq,DB12719,-7.4,Turofexorate isopropyl,INASOKQDNHHMRE-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
136853,6w9c,DB07613,-7.4,3-phenyl-5-(1H-pyrazol-3-yl)isoxazole,SRSSTOPJERVMRZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
15931,6lzg,DB01944,-7.4,(S)-blebbistatin,LZAXPYOBKSJSEX-GOSISDBHSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
33317,6cs2,T3D4511,-7.4,Fluometuron,RZILCCPWPBTYDO-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
162059,7bv1,DB01384,-7.4,Paramethasone,MKPDWECBUAZOHP-AFYJWTTESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
101904,6vxs,DB06741,-7.4,Gavestinel,WZBNEZWCNKUOSM-VOTSOKGWSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
157708,6wiq,DB12320,-7.4,Palovarotene,YTFHCXIPDIHOIA-DHZHZOJOSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
35611,1r42,DB01831,-7.4,Tryptophanyl-5'amp,IFQVDHDRFCKAAW-SQIXAUHQSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
82986,6m3m,DB03263,-7.4,Thiocellobiose,VDQIIPZYLPYPNM-QRZGKKJRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
105218,6vxs,DB13208,-7.4,Prednylidene,WSVOMANDJDYYEY-CWNVBEKCSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
136921,6w9c,DB07694,-7.4,"2,5-dichloro-N-(3,5-dibromo-4-hydroxyphenyl)benzamide",IFLWCZRMFPKYBN-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
57964,6crv,DB04367,-7.4,Debromohymenialdisine,JYRJOQGKGMHTOO-VURMDHGXSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136778,6w9c,DB07522,-7.4,"N-[(2R,3S)-3-AMINO-2-HYDROXY-4-PHENYLBUTYL]NAPHTHALENE-2-SULFONAMIDE",QSSWSEQPKCCATQ-VQTJNVASSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
105173,6vxs,DB13105,-7.4,Resolvin E1,AOPOCGPBAIARAV-OTBJXLELSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101916,6vxs,DB06766,-7.4,Alcaftadine,MWTBKTRZPHJQLH-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
61203,6crv,DB11741,-7.4,Famitinib,GKEYKDOLBLYGRB-LGMDPLHJSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
105147,6vxs,DB13066,-7.4,Liarozole,UGFHIPBXIWJXNA-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
72414,6m2n,DB00718,-7.4,Adefovir dipivoxil,WOZSCQDILHKSGG-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
1882,6lzg,HMDB0029006,-7.4,Phenylalanyl-Tryptophan,JMCOUWKXLXDERB-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
114824,6vxx,DB14933,-7.4,Nicotinamide riboside,JLEBZPBDRKPWTD-TURQNECASA-O,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
166363,7bv1,DB14732,-7.4,Queuine,WYROLENTHWJFLR-ACLDMZEESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
136692,6w9c,DB07420,-7.4,(1R)-4-(3-phenoxyphenyl)-1-phosphonobutane-1-sulfonic acid,RCGCZPXSRLLKCK-MRXNPFEDSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
33366,6cs2,T3D4557,-7.4,Desloratadine,JAUOIFJMECXRGI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
83117,6m3m,DB03448,-7.4,2'-Deoxyuridine 3'-Monophosphate,LXKGKXYIAAKOCT-SHYZEUOFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
148125,6w9q,DB12972,-7.4,Sepranolone,AURFZBICLPNKBZ-FZCSVUEKSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
166357,7bv1,DB14718,-7.4,Pyrazolam,BGRWSFIQQPVEML-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
101963,6vxs,DB06847,-7.4,"5-[(3S)-3-(2-methoxybiphenyl-4-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",YYCPXVRHQUEVAW-CQSZACIVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
113264,6vxx,DB08735,-7.4,"R,S-Warfarin alcohol",ZUJMMGHIYSAEOU-SWLSCSKDSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
157792,6wiq,DB12832,-7.4,Prednimustine,HFVNWDWLWUCIHC-GUPDPFMOSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
57963,6crv,DB04366,-7.4,3'-Deoxy 3'-Amino Adenosine-5'-Diphosphate,VKODIDNZKBYXJO-QYYRPYCUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
105153,6vxs,DB13077,-7.4,LCB01-0371,QLUWQAFDTNAYPN-LLVKDONJSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
94361,6m71,DB08020,-7.4,"(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-6-(METHOXYMETHYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL",RHQLNMNKTIOREN-AOIWGVFYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
58029,6crv,DB04461,-7.4,Coproporphyrinogen III,NIUVHXTXUXOFEB-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
101954,6vxs,DB06834,-7.4,"N-(2-hydroxy-1,1-dimethylethyl)-1-methyl-3-(1H-pyrrolo[2,3-b]pyridin-2-yl)-1H-indole-5-carboxamide",XZRYCTLOGNCQDG-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
127875,6w4h,DB06954,-7.4,"2-(cycloheptylmethyl)-1,1-dioxido-1-benzothiophen-6-yl sulfamate",BIASYWBGUYOWJR-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
157779,6wiq,DB12808,-7.4,Trifarotene,MFBCDACCJCDGBA-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
25109,6cs2,DB02963,-7.4,"(5-Chloropyrazolo[1,5-a]Pyrimidin-7-Yl)-(4-Methanesulfonylphenyl)Amine",LVNXHNRYPADEAD-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
70190,6lxt,DB12286,-7.4,Simendan,WHXMKTBCFHIYNQ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
148117,6w9q,DB12960,-7.4,INCB-9471,ZMCJFJZOSKEMOM-DNKZPPIMSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
76102,6m2n,DB06802,-7.4,Nepafenac,QEFAQIPZVLVERP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
87361,6m3m,DB12220,-7.4,ORG-25935,UEBBYLJZCHTLEG-UTKZUKDTSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
127853,6w4h,DB06927,-7.4,[5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-YL]ACETONITRILE,ZKJVCUXZMYKTLT-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
35582,1r42,DB01793,-7.4,SB-409513,ONVZFCHLOZUXRP-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
33343,6cs2,T3D4535,-7.4,Rimsulfuron,MEFOUWRMVYJCQC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
127885,6w4h,DB06970,-7.4,"2-CHLORO-N-(3-CYANO-5,6-DIHYDRO-4H-CYCLOPENTA[B]THIOPHEN-2-YL)-5-DIETHYLSULFAMOYL-BENZAMIDE",MZCDQILVXXIMEV-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
162467,7bv1,DB02307,-7.4,N-(1-Carboxy-3-Phenylpropyl)Phenylalanyl-Alpha-Asparagine,FOJUHLDAXGNCIP-FHWLQOOXSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
87432,6m3m,DB12310,-7.4,Trehalose,HDTRYLNUVZCQOY-LIZSDCNHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
136931,6w9c,DB07705,-7.4,"1-[(2S)-2-[(4-CHLOROBENZYL)OXY]-2-(2,4-DICHLOROPHENYL)ETHYL]-1H-IMIDAZOLE",LEZWWPYKPKIXLL-GOSISDBHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
61303,6crv,DB11889,-7.4,Lanicemine,FWUQWDCOOWEXRY-ZDUSSCGKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
70097,6lxt,DB12150,-7.4,Pelubiprofen,AUZUGWXLBGZUPP-GXDHUFHOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
127632,6w4h,DB06579,-7.4,Adipiplon,UAMAIHOEGLEXSV-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
137104,6w9c,DB07903,-7.4,"3-[(2,2-DIMETHYLPROPANOYL)AMINO]-N-1,3-THIAZOL-2-YLPYRIDINE-2-CARBOXAMIDE",CAVCWRXFMNCBCM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
105316,6vxs,DB13337,-7.4,Pheneticillin,NONJJLVGHLVQQM-JHXYUMNGSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
157601,6wiq,DB12174,-7.4,CUDC-101,PLIVFNIUGLLCEK-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
105326,6vxs,DB13349,-7.4,Talastine,LCAAMXMULMCKLJ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
127622,6w4h,DB06536,-7.4,Tesaglitazar,CXGTZJYQWSUFET-IBGZPJMESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
94387,6m71,DB08051,-7.4,"(2R)-4-(2-BENZOYL-1,2-DIAZEPAN-1-YL)-4-OXO-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE",XXRHRPGYYNOBHO-QGZVFWFLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
162140,7bv1,DB01485,-7.4,4-Hydroxytestosterone,BQOIJSIMMIDHMO-FBPKJDBXSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
18246,6cs2,HMDB0014839,-7.4,Amprenavir,YMARZQAQMVYCKC-OEMFJLHTSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
101782,6vxs,DB06481,-7.4,Manitimus,IRELROQHIPLASX-SEYXRHQNSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
137121,6w9c,DB07926,-7.4,N-[3-(N'-HYDROXYCARBOXAMIDO)-2-(2-METHYLPROPYL)-PROPANOYL]-O-TYROSINE-N-METHYLAMIDE,QYZPDCGWIJYZMN-ZBFHGGJFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
105343,6vxs,DB13368,-7.4,Motretinide,IYIYMCASGKQOCZ-DJRRULDNSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
75335,6m2n,DB04563,-7.4,CRA_9678,VIZNZQTZRMTYPZ-UHFFFAOYSA-M,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
162152,7bv1,DB01500,-7.4,Oxabolone,GXHBCWCMYVTJOW-YGRHGMIBSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
76148,6m2n,DB06870,-7.4,"17-HYDROXY-18A-HOMO-19-NOR-17ALPHA-PREGNA-4,9,11-TRIEN-3-ONE",OXHNQTSIKGHVBH-ANULTFPQSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
105369,6vxs,DB13407,-7.4,Nifenazone,BRZANEXCSZCZCI-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
127588,6w4h,DB06457,-7.4,Tecastemizole,SFOVDSLXFUGAIV-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
127586,6w4h,DB06454,-7.4,Sarizotan,HKFMQJUJWSFOLY-OAQYLSRUSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
114940,6vxx,DB15448,-7.4,Acumapimod,VGUSQKZDZHAAEE-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
157597,6wiq,DB12167,-7.4,LY-3023414,ACCFLVVUVBJNGT-AWEZNQCLSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
94390,6m71,DB08054,-7.4,"1-(1-methylethyl)-3-quinolin-6-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine",GEZALMMCQYDFML-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
105392,6vxs,DB13435,-7.4,Endralazine,ALAXZYHFVBSJKZ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
148018,6w9q,DB12805,-7.4,Ataciguat,PQHLRGARXNPFCF-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
76151,6m2n,DB06873,-7.4,"1-((2-HYDROXYETHOXY)METHYL)-5-(3-(BENZYLOXY)BENZYL)PYRIMIDINE-2,4(1H,3H)-DIONE",CSXNPJKDZKLDET-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
105400,6vxs,DB13445,-7.4,Nepinalone,RVXGRCNWGOHSDE-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
15857,6lzg,DB01587,-7.4,Ketazolam,PWAJCNITSBZRBL-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
6829,6lzg,DB02759,-7.4,4-Methylumbelliferyl Chitobiose,UPSFMJHZUCSEHU-JYGUBCOQSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
93151,6m71,DB06442,-7.4,Avasimibe,PTQXTEKSNBVPQJ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
28674,6cs2,DB08281,-7.4,"O-[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethyl] (4-bromophenyl)thiocarbamate",BDVAWAILQCYMQE-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
136934,6w9c,DB07708,-7.4,3-CHLORO-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL,ZNHQDSBJVFFIAK-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
127735,6w4h,DB06766,-7.4,Alcaftadine,MWTBKTRZPHJQLH-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
166348,7bv1,DB14681,-7.4,Cortisone,MFYSYFVPBJMHGN-ZPOLXVRWSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
7916,6lzg,DB04540,-7.4,Cholesterol,HVYWMOMLDIMFJA-DPAQBDIFSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
87435,6m3m,DB12313,-7.4,Dopexamine,RYBJORHCUPVNMB-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
127720,6w4h,DB06737,-7.4,Zaltoprofen,MUXFZBHBYYYLTH-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
94375,6m71,DB08035,-7.4,"1-TERT-BUTYL-3-(2,5-DIMETHYLBENZYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE",QUPXEJURIFFVSX-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
157675,6wiq,DB12280,-7.4,AZD-5423,FCNQMDSJHADDFT-WNSKOXEYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
35636,1r42,DB01864,-7.4,5'-Guanosine-Diphosphate-Monothiophosphate,XOFLBQFBSOEHOG-UUOKFMHZSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
127709,6w4h,DB06725,-7.4,Lornoxicam,WLHQHAUOOXYABV-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
101860,6vxs,DB06678,-7.4,Esmirtazapine,RONZAEMNMFQXRA-MRXNPFEDSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
136979,6w9c,DB07761,-7.4,"(2R)-1-[4-({6-[(2,6-Difluorophenyl)amino]-4-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol",ZVSBKYYVBCKDBO-OAHLLOKOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
12765,6lzg,DB13778,-7.4,Cefazedone,VTLCNEGVSVJLDN-MLGOLLRUSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
33301,6cs2,T3D4495,-7.4,Dimethomorph,QNBTYORWCCMPQP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
61258,6crv,DB11820,-7.4,Nifurtimox,ARFHIAQFJWUCFH-IZZDOVSWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127680,6w4h,DB06680,-7.4,Asoprisnil,GJMNAFGEUJBOCE-MEQIQULJSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
136999,6w9c,DB07785,-7.4,"1-{(1R,2S)-2-HYDROXY-1-[2-(2-NAPHTHYLOXY)ETHYL]PROPYL}-1H-IMIDAZONE-4-CARBOXAMIDE",UYAJDVNLQJVRHD-SCLBCKFNSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
101849,6vxs,DB06649,-7.4,Priralfinamide,BHJIBOFHEFDSAU-LBPRGKRZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
127676,6w4h,DB06670,-7.4,Odanacatib,FWIVDMJALNEADT-SFTDATJTSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
148052,6w9q,DB12867,-7.4,Benperidol,FEBOTPHFXYHVPL-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
65978,6lxt,DB03572,-7.4,FR230513,URGFTPMACWKJKU-OAHLLOKOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
148045,6w9q,DB12854,-7.4,BMS-908662,MMNNTJYFHUDSKL-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
72528,6m2n,DB00854,-7.4,Levorphanol,JAQUASYNZVUNQP-USXIJHARSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
101828,6vxs,DB06608,-7.4,Tafenoquine,LBHLFPGPEGDCJG-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
105291,6vxs,DB13309,-7.4,Benproperine,JTUQXGZRVLWBCR-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
25035,6cs2,DB02880,-7.4,N-[1-(4-Bromophenyl)Ethyl]-5-Fluoro Salicylamide,KFTNEILVDDUXGR-SECBINFHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
29683,6cs2,DB11409,-7.4,Febantel,HMCCXLBXIJMERM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
114920,6vxx,DB15410,-7.4,(S)-Propafenone,JWHAUXFOSRPERK-SFHVURJKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
105268,6vxs,DB13276,-7.4,Idanpramine,HVYGXNYMNHSBGD-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
8788,6lzg,DB06837,-7.4,"(2R)-N-4-hydroxy-2-(3-hydroxybenzyl)-N-1-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]butanediamide",VXDKQRWTOJFQKH-BJZITVGISA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
72600,6m2n,DB00934,-7.4,Maprotiline,QSLMDECMDJKHMQ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
93123,6m71,DB06354,-7.4,Tezampanel,ZXFRFPSZAKNPQQ-YTWAJWBKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
11670,6lzg,DB12282,-7.4,Defactinib,FWLMVFUGMHIOAA-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
115145,6w4b,DB00502,-7.4,Haloperidol,LNEPOXFFQSENCJ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
137918,6w9c,DB08893,-7.4,Mirabegron,PBAPPPCECJKMCM-IBGZPJMESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
33077,6cs2,T3D4053,-7.4,beta-Zearalenol,FPQFYIAXQDXNOR-SXIUOJOQSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
101508,6vxs,DB05327,-7.4,Ranirestat,QCVNMNYRNIMDKV-QGZVFWFLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
82371,6m3m,DB02454,-7.4,5-(6-Amino-9h-Purin-9-Yl)-4-Hydroxytetrahydrofuran-3-Yl Dihydrogen Phosphate,IJEJRDCFMFEDGL-AFEQZKEHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
33071,6cs2,T3D4039,-7.4,Gonyautoxin II,ARSXTTJGWGCRRR-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
33070,6cs2,T3D4038,-7.4,Gonyautoxin I,CETRDCWBMBILAL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
137921,6w9c,DB08897,-7.4,Aclidinium,ASMXXROZKSBQIH-VITNCHFBSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
15641,6lzg,DB00623,-7.4,Fluphenazine,PLDUPXSUYLZYBN-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
93079,6m71,DB06237,-7.4,Avanafil,WEAJZXNPAWBCOA-INIZCTEOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
147884,6w9q,DB12590,-7.4,Indiplon,CBIAWPMZSFFRGN-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
27249,6cs2,DB06744,-7.4,ginkgolide-B,SQOJOAFXDQDRGF-MMQTXUMRSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
105781,6vxs,DB14025,-7.4,Clinafloxacin,QGPKADBNRMWEQR-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
27250,6cs2,DB06745,-7.4,ginkgolide-C,AMOGMTLMADGEOQ-DTDWCABLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
126924,6w4h,DB04482,-7.4,Cmp-2-Keto-3-Deoxy-Octulosonic Acid,YWWJKULNWGRYAS-UOVSKDHASA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
66846,6lxt,DB04726,-7.4,"7,8,10-TRIMETHYLBENZO[G]PTERIDINE-2,4(3H,10H)-DIONE",KPDQZGKJTJRBGU-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
101503,6vxs,DB05289,-7.4,Tarenflurbil,SYTBZMRGLBWNTM-SNVBAGLBSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
87848,6m3m,DB12947,-7.4,Doxifluridine,ZWAOHEXOSAUJHY-ZIYNGMLESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
69868,6lxt,DB11817,-7.4,Baricitinib,XUZMWHLSFXCVMG-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
65912,6lxt,DB03472,-7.4,Cyclohexyl-Hexyl-Beta-D-Maltoside,WUCWJXGMSXTDAV-QKMCSOCLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
157319,6wiq,DB15177,-7.4,VX-659,IGEOJNMYRZUKIK-IBGZPJMESA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
126907,6w4h,DB04463,-7.4,"3-(4-Amino-1-Tert-Butyl-1h-Pyrazolo[3,4-D]Pyrimidin-3-Yl)Phenol",CPLGZXQPPYRNRC-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
157322,6wiq,DB15187,-7.4,Dubermatinib,YUAALFPUEOYPNX-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
162585,7bv1,DB02455,-7.4,Fluoresceinylthioureido,VHJFQSRUDVDTEO-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
166293,7bv1,DB14624,-7.4,Nandrolone hydrogen sulfate,SKZMVWBZTQNCKW-IZPLOLCNSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
27236,6cs2,DB06729,-7.4,Sulfaphenazole,QWCJHSGMANYXCW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
137739,6w9c,DB08661,-7.4,"1-(2,5-dideoxy-5-pyrrolidin-1-yl-beta-L-erythro-pentofuranosyl)-5-methylpyrimidine-2,4(1H,3H)-dione",XUSBTLVYPZUOAW-WOPDTQHZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
150391,6wiq,DB01329,-7.4,Cefoperazone,GCFBRXLSHGKWDP-XCGNWRKASA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
61508,6crv,DB12190,-7.4,Faropenem,HGGAKXAHAYOLDJ-FHZUQPTBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
115105,6w4b,DB00455,-7.4,Loratadine,JCCNYMKQOSZNPW-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
147917,6w9q,DB12647,-7.4,Tocotrienol,GJJVAFUKOBZPCB-ZGRPYONQSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
105717,6vxs,DB13873,-7.4,Fenofibric acid,MQOBSOSZFYZQOK-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
162583,7bv1,DB02452,-7.4,Thymidine-5'-Triphosphate,NHVNXKFIZYSCEB-XLPZGREQSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
101557,6vxs,DB05575,-7.4,Motesanib,RAHBGWKEPAQNFF-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
24849,6cs2,DB02656,-7.4,LY-294002,CZQHHVNHHHRRDU-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
127067,6w4h,DB04664,-7.4,Cyclohexyl-pentyl-maltoside,RVTGFZGNOSKUDA-ZNGNCRBCSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
30274,6cs2,DB12279,-7.4,OBP-801,XFLBOEMFLGLWFF-HDXRNPEWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
147910,6w9q,DB12637,-7.4,Onapristone,IEXUMDBQLIVNHZ-YOUGDJEHSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
82385,6m3m,DB02472,-7.4,"6-Hydroxy-7,8-Dihydro Purine Nucleoside",ZWTNXGIZBOQCAJ-KQYNXXCUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
101547,6vxs,DB05524,-7.4,Pelitinib,WVUNYSQLFKLYNI-AATRIKPKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
113029,6vxx,DB08289,-7.4,N-(PARA-GLUTARAMIDOPHENYL-ETHYL)-PIPERIDINIUM-N-OXIDE,RKJXWOJUCCBWSC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
137836,6w9c,DB08773,-7.4,RALOXIFENE CORE,MDGWZLQPNOETLH-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
113027,6vxx,DB08287,-7.4,"(1R,2R)-N-(2-Aminoethyl)-2-{[(4-methoxyphenyl)sulfonyl]methyl}cyclohexanecarboxamide",QTGNVZPFJQOWFL-XJKSGUPXSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
147905,6w9q,DB12627,-7.4,GSK-1292263,AYJRTVVIBJSSKN-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
137856,6w9c,DB08796,-7.4,Pipazethate,DTVJXCOMJLLMAK-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
76192,6m2n,DB06918,-7.4,2-(2-METHYLPHENYL)-1H-INDOLE-6-CARBOXIMIDAMIDE,ZRYXDGAKQGRHFG-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
127098,6w4h,DB04712,-7.4,ANILINOMETHYL GLUCO-PHENYLIMIDAZOLE,ADKWVGPRAQKVKB-YIYPIFLZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
137980,6w9c,DB08981,-7.4,Fenbufen,ZPAKPRAICRBAOD-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
101498,6vxs,DB05265,-7.4,Ecabet,IWCWQNVIUXZOMJ-MISYRCLQSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
65889,6lxt,DB03435,-7.4,Uridine-5'-Diphosphate,XCCTYIAWTASOJW-XVFCMESISA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
12893,6lzg,DB13988,-7.4,SB-269970,HWKROQUZSKPIKQ-MRXNPFEDSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
51260,2fxp,DB07970,-7.4,5-[(2-methyl-5-{[3-(trifluoromethyl)phenyl]carbamoyl}phenyl)amino]pyridine-3-carboxamide,SAAYRHKJHDIDPH-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
72754,6m2n,DB01113,-7.4,Papaverine,XQYZDYMELSJDRZ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
35877,1r42,DB02194,-7.4,"8-Benzyl-2-Hydroxy-2-(4-Hydroxy-Benzyl)-6-(4-Hydroxy-Phenyl)-2h-Imidazo[1,2-a]Pyrazin-3-One",ULLMMKZQNNBLRN-SANMLTNESA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
147852,6w9q,DB12542,-7.4,GSK-356278,AWDJJMXJUOHGLC-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
101474,6vxs,DB05107,-7.4,16-Bromoepiandrosterone,CWVMWSZEMZOUPC-JUAXIXHSSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
112960,6vxx,DB08195,-7.4,(1R)-2-[(CYANOMETHYL)AMINO]-1-({[2-(DIFLUOROMETHOXY)BENZYL]SULFONYL}METHYL)-2-OXOETHYL MORPHOLINE-4-CARBOXYLATE,YKWHKILAGONYKL-HNNXBMFYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
147841,6w9q,DB12524,-7.4,BI-671800,XEOSTBFUCNZKGS-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
150431,6wiq,DB01410,-7.4,Ciclesonide,LUKZNWIVRBCLON-GXOBDPJESA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
35880,1r42,DB02197,-7.4,"4-[(4-Imidazo[1,2-a]Pyridin-3-Ylpyrimidin-2-Yl)Amino]Benzenesulfonamide",NKORVPQBJCGYEC-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
57447,6crv,DB03685,-7.4,Uridine monophosphate,DJJCXFVJDGTHFX-XVFCMESISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
93063,6m71,DB06203,-7.4,Alogliptin,ZSBOMTDTBDDKMP-OAHLLOKOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
33029,6cs2,T3D3964,-7.4,Daidzein,ZQSIJRDFPHDXIC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
105919,6vxs,DB14632,-7.4,Prednisolone tebutate,HUMXXHTVHHLNRO-KAJVQRHHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
166260,7bv1,DB14471,-7.4,2-Ethylhexyl 4-phenylbenzophenone-2'-carboxylate,TWAOKHHZKFMFMD-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
105921,6vxs,DB14634,-7.4,Fluprednidene acetate,DEFOZIFYUBUHHU-IYQKUMFPSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
57434,6crv,DB03668,-7.4,1-(5'-Phospho-Beta-D-Ribofuranosyl)Barbituric Acid,AODYJUNLDJOADV-YXZULKJRSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
157227,6wiq,DB14845,-7.4,Filgotinib,RIJLVEAXPNLDTC-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
72764,6m2n,DB01125,-7.4,Anisindione,XRCFXMGQEVUZFC-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
105932,6vxs,DB14646,-7.4,Prednisone acetate,MOVRKLZUVNCBIP-RFZYENFJSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
147854,6w9q,DB12545,-7.4,Indobufen,AYDXAULLCROVIT-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
28815,6cs2,DB08435,-7.4,"(5E,14E)-11-oxoprosta-5,9,12,14-tetraen-1-oic acid",VHRUMKCAEVRUBK-XOVNXQNQSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
82292,6m3m,DB02359,-7.4,"9-Butyl-8-(2,5-Dimethoxy-Benzyl)-9h-Purin-6-Ylamine",PPFZLLAIQRZNJE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
105878,6vxs,DB14471,-7.4,2-Ethylhexyl 4-phenylbenzophenone-2'-carboxylate,TWAOKHHZKFMFMD-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
105796,6vxs,DB14054,-7.4,Asiatic acid,JXSVIVRDWWRQRT-UYDOISQJSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
105797,6vxs,DB14055,-7.4,(S)-Warfarin,PJVWKTKQMONHTI-HNNXBMFYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
126883,6w4h,DB04430,-7.4,3-(4-Phenylamino-Phenylamino)-2-(1h-Tetrazol-5-Yl)-Acrylonitrile,FLPLCJJGNZGOAW-QXMHVHEDSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
61570,6crv,DB12278,-7.4,Propiverine,QPCVHQBVMYCJOM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
82324,6m3m,DB02397,-7.4,O-(2-Acetamido-2-Deoxy-Alpha-D-Galactopyranosyl)-L-Serine,REDMNGDGDYFZRE-WKWISIMFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
82322,6m3m,DB02395,-7.4,"3-Hydroxymethyl-5-Aziridinyl-1methyl-2-[1h-Indole-4,7-Dione]-Propanol",JCCDRCRHGKFTQS-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
30285,6cs2,DB12288,-7.4,Piromelatine,PNTNBIHOAPJYDB-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
157268,6wiq,DB15075,-7.4,4-demethyl-4-cholesteryloxycarbonylpenclomedine,ZJUUIXYKTPSIOH-LEZJFEBPSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
126848,6w4h,DB04378,-7.4,"3-Amino-N-{4-[2-(2,6-Dimethyl-Phenoxy)-Acetylamino]-3-Hydroxy-1-Isobutyl-5-Phenyl-Pentyl}-Benzamide",APJAEXGNDLFGPD-AWCRTANDSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
72741,6m2n,DB01097,-7.4,Leflunomide,VHOGYURTWQBHIL-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
82318,6m3m,DB02390,-7.4,5-Bromo-N[2-(Dimethylamino)Ethyl]-9-Aminoacridine-4-Carboxamide,NROQPXQSDDINMC-UHFFFAOYSA-P,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
72745,6m2n,DB01101,-7.4,Capecitabine,GAGWJHPBXLXJQN-UORFTKCHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
126840,6w4h,DB04367,-7.4,Debromohymenialdisine,JYRJOQGKGMHTOO-VURMDHGXSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
24800,6cs2,DB00340,-7.4,Metixene,MJFJKKXQDNNUJF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
138037,6w9c,DB09062,-7.4,Cefminox,JSDXOWVAHXDYCU-VXSYNFHWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
76218,6m2n,DB06947,-7.4,1-[(2R)-2-aminobutanoyl]-N-(4-carbamimidoylbenzyl)-L-prolinamide,YHAMQFKGUUSJMU-KGLIPLIRSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
23455,6cs2,HMDB0061851,-7.4,alpha-Copaene,VLXDPFLIRFYIME-XIQJJJERSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
126793,6w4h,DB04298,-7.4,"3-(4-Amino-2-Tert-Butyl-5-Methyl-Phenylsulfanyl)-6-Cyclopentyl-4-Hydroxy-6-[2-(4-Hydroxy-Phenyl)-Ethyl]-5,6-Dihydro-Pyran-2-One",ZEBFKFGJWHOOST-LJAQVGFWSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
162672,7bv1,DB02770,-7.4,7-Alpha-D-Ribofuranosyl-2-Aminopurine-5'-Phosphate,UDRQVOJQMHZSIM-PULFBKJNSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
101487,6vxs,DB05212,-7.4,HE3286,JJKOQZHWYLMASZ-FJWDNACWSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
126788,6w4h,DB04293,-7.4,7-(2-Amino-2-Phenyl-Acetylamino)-3-Chloro-8-Oxo-1-Aza-Bicyclo[4.2.0]Oct-2-Ene-2-Carboxylic Acid,JAPHQRWPEGVNBT-IJLUTSLNSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
105884,6vxs,DB14512,-7.4,Mometasone furoate,WOFMFGQZHJDGCX-ZULDAHANSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
150368,6wiq,DB01267,-7.4,Paliperidone,PMXMIIMHBWHSKN-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
96138,6m71,DB12443,-7.4,Sonedenoson,WUCQGGOGHZRELS-LSCFUAHRSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
69946,6lxt,DB11933,-7.4,Riboprine,USVMJSALORZVDV-SDBHATRESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
27225,6cs2,DB06713,-7.4,Norelgestromin,ISHXLNHNDMZNMC-XUDSTZEESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
113064,6vxx,DB08328,-7.4,PANTOTHENYL-AMINOETHANOL-11-PIVALIC ACID,BUEKNBNKVUKNIB-LBPRGKRZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113056,6vxx,DB08319,-7.4,"2'-HYDROXY-1,1'-BIPHENYL-2-SULFINIC ACID",HPKSNFTYZHYEKV-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
137614,6w9c,DB08511,-7.4,"6-amino-2-methyl-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",PLJNUNPYZVVIRA-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
101585,6vxs,DB05767,-7.4,Andrographolide,BOJKULTULYSRAS-OTESTREVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
137725,6w9c,DB08646,-7.4,TRW3-(2-AMINO-3-HYDROXY-PROPYL)-6-(N'-CYCLOHEXYL-HYDRAZINO)OCTAHYDRO-INDOL-7-OL,PSUOZWHAKZSNOB-LBPRGKRZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
30268,6cs2,DB12271,-7.4,ORE-1001,NTCCRGGIJNDEAB-IRXDYDNUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
127198,6w4h,DB04842,-7.4,Fluspirilene,QOYHHIBFXOOADH-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
162505,7bv1,DB02359,-7.4,"9-Butyl-8-(2,5-Dimethoxy-Benzyl)-9h-Purin-6-Ylamine",PPFZLLAIQRZNJE-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
61490,6crv,DB12161,-7.4,Deutetrabenazine,MKJIEFSOBYUXJB-WEZHFFAMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29661,6cs2,DB11371,-7.4,Alfaxalone,DUHUCHOQIDJXAT-OLVMNOGESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
72707,6m2n,DB01059,-7.4,Norfloxacin,OGJPXUAPXNRGGI-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
101588,6vxs,DB05786,-7.4,Irofulven,NICJCIQSJJKZAH-AWEZNQCLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
137644,6w9c,DB08545,-7.4,(1R)-1-PHENYLETHYL 4-(ACETYLAMINO)BENZYLPHOSPHONATE,YPTMOJMDCPUCJT-ZDUSSCGKSA-M,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137652,6w9c,DB08555,-7.4,"1-(3-bromophenyl)-7-chloro-6-methoxy-3,4-dihydroisoquinoline",IKGXHBGCVQTQBH-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
87736,6m3m,DB12770,-7.4,Lafutidine,KMZQAVXSMUKBPD-DJWKRKHSSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
115086,6w4b,DB00434,-7.4,Cyproheptadine,JJCFRYNCJDLXIK-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
105670,6vxs,DB13810,-7.4,Dimemorfan,KBEZZLAAKIIPFK-NJAFHUGGSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
157365,6wiq,DB15266,-7.4,TAK-580,VWMJHAFYPMOMGF-ZCFIWIBFSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
61479,6crv,DB12145,-7.4,AZD-0328,OCKIPDMKGPYYJS-ZDUSSCGKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
69938,6lxt,DB11917,-7.4,Vatiquinone,LNOVHERIIMJMDG-XZXLULOTSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
137726,6w9c,DB08647,-7.4,TRAZEOLIDE,YUTXECPABXNXPU-DJJJIMSYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
61480,6crv,DB12146,-7.4,Rigosertib,OWBFCJROIKNMGD-BQYQJAHWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
137642,6w9c,DB08543,-7.4,1-[2-HYDROXY-3-(4-CYCLOHEXYL-PHENOXY)-PROPYL]-4-(2-PYRIDYL)-PIPERAZINE,BZJHCQBNFUNZPJ-QFIPXVFZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
2036,6lzg,HMDB0030667,-7.4,Chrysoeriol,SCZVLDHREVKTSH-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
105702,6vxs,DB13851,-7.4,Artemotil,NLYNIRQVMRLPIQ-XQLAAWPRSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
150364,6wiq,DB01261,-7.4,Sitagliptin,MFFMDFFZMYYVKS-SECBINFHSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
76050,6m2n,DB06712,-7.3,Nilvadipine,FAIIFDPAEUKBEP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
65033,6lxt,DB02310,-7.3,"3,5,6,8-Tetramethyl-N-Methyl Phenanthrolinium",FQTUZNACZKILMC-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
95692,6m71,DB11801,-7.3,Rapastinel,GIBQQARAXHVEGD-BSOLPCOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
77379,6m2n,DB08306,-7.3,3-[(3-Nitrophenyl)sulfamoyl]-2-thiophenecarboxylic acid,CITCNTPVKZFUAJ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
95550,6m71,DB11551,-7.3,Trenbolone,MEHHPFQKXOUFFV-OWSLCNJRSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94067,6m71,DB07683,-7.3,"N-(dibenzo[b,d]thiophen-3-ylsulfonyl)-L-valine",RZWYSEXQXOXWKA-INIZCTEOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
74979,6m2n,DB04089,-7.3,AL5300,HHPUQNGRNUOYCD-VIFPVBQESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
14126,6lzg,T3D3744,-7.3,Fumitremorgin C,DBEYVIGIPJSTOR-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
66025,6lxt,DB03641,-7.3,"2'-deoxyuridine 5'-alpha,beta-imido-diphosphate",COFNIXBQVWFHTR-SHYZEUOFSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
113729,6vxx,DB11821,-7.3,Danegaptide,BIZKIHUJGMSVFD-MNOVXSKESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
95089,6m71,DB08916,-7.3,Afatinib,ULXXDDBFHOBEHA-CWDCEQMOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93270,6m71,DB06710,-7.3,Methyltestosterone,GCKMFJBGXUYNAG-HLXURNFRSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93037,6m71,DB06153,-7.3,Pizotifen,FIADGNVRKBPQEU-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
113221,6vxx,DB08686,-7.3,"5,6,7,8,9,10-HEXAHYDRO-4-HYDROXY-3-(1-PHENYLPROPYL)CYCLOOCTA[B]PYRAN-2-ONE",UXCLJNSXDNCIIT-HNNXBMFYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
65021,6lxt,DB02292,-7.3,Irosustat,DSLPMJSGSBLWRE-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
93202,6m71,DB06579,-7.3,Adipiplon,UAMAIHOEGLEXSV-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
9075,6lzg,DB07147,-7.3,"methyl (1R,2S)-2-(hydroxycarbamoyl)-1-{4-[(2-methylquinolin-4-yl)methoxy]benzyl}cyclopropanecarboxylate",HJWMYFBKJRVWJY-YKSBVNFPSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
67290,6lxt,DB06354,-7.3,Tezampanel,ZXFRFPSZAKNPQQ-YTWAJWBKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
8596,6lzg,DB06472,-7.3,Fradafiban,IKZACQMAVUIGPY-HOTGVXAUSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
96038,6m71,DB12305,-7.3,Dasotraline,SRPXSILJHWNFMK-MEDUHNTESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
53203,2fxp,DB12635,-7.3,Aleplasinin,HSXLMAFNWCSZGP-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
76309,6m2n,DB07055,-7.3,"2-[2-(1H-tetrazol-5-yl)ethyl]-1H-isoindole-1,3(2H)-dione",DEOJDUHRJBKATO-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
94894,6m71,DB08660,-7.3,"1,2,5,8-tetrahydroxyanthracene-9,10-dione",VBHKTXLEJZIDJF-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
112172,6vxx,DB06481,-7.3,Manitimus,IRELROQHIPLASX-SEYXRHQNSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
94489,6m71,DB08162,-7.3,Fasudil,NGOGFTYYXHNFQH-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
111909,6vxx,DB04854,-7.3,Febuxostat,BQSJTQLCZDPROO-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76173,6m2n,DB06898,-7.3,"4-(2-amino-1-methyl-1H-imidazo[4,5-b]pyridin-6-yl)phenol",UGJXOCBVCWTJFP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
23321,6cs2,HMDB0060049,-7.3,4-HDoHE,IFRKCNPQVIJFAQ-JGDWKEERSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
94638,6m71,DB08352,-7.3,"6-[4-(2-fluorophenyl)-1,3-oxazol-5-yl]-N-(1-methylethyl)-1,3-benzothiazol-2-amine",FQYJTHIYAQQJAB-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
111912,6vxx,DB04860,-7.3,Isatoribine,TZYVRXZQAWPIAB-FCLHUMLKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77138,6m2n,DB08019,-7.3,"N-{(3R,4S)-4-[(6-amino-4-methylpyridin-2-yl)methyl]pyrrolidin-3-yl}-N'-(3-chlorobenzyl)ethane-1,2-diamine",VWCMAGONQJHIJZ-LPHOPBHVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
67526,6lxt,DB06857,-7.3,N-(4-CARBAMIMIDOYL-3-CHORO-PHENYL)-2-HYDROXY-3-IODO-5-METHYL-BENZAMIDE,QKGFTDAISIBIBV-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
9415,6lzg,DB07513,-7.3,7-[(3-CHLOROBENZYL)OXY]-4-[(METHYLAMINO)METHYL]-2H-CHROMEN-2-ONE,JMGUSOLCNQVZCT-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
67141,6lxt,DB05767,-7.3,Andrographolide,BOJKULTULYSRAS-OTESTREVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
76723,6m2n,DB07535,-7.3,2-amino-6-[2-(1H-indol-6-yl)ethyl]pyrimidin-4(3H)-one,VRAZIAJSKFRSIP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76542,6m2n,DB07322,-7.3,"2-[(PHENYLSULFONYL)AMINO]-5,6,7,8-TETRAHYDRONAPHTHALENE-1-CARBOXYLIC ACID",RRXVUYHFDBLTEL-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
111415,6vxx,DB03841,-7.3,Y-700,AETHRPHBGJAIBT-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111115,6vxx,DB03015,-7.3,"6-Hydroxy-1,6-Dihydro Purine Nucleoside",WGRXVKRHIMUTPD-YOHZANMFSA-O,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
92858,6m71,DB05095,-7.3,Cimicoxib,KYXDNECMRLFQMZ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110816,6vxx,DB02447,-7.3,"3,8,9,10-Tetrahydroxy-7-Hydroxymethyl-6-Oxa-1,3-Diaza-Spiro[4.5]Decane-2,4-Dione",IHDZZZHACPJCFJ-WWHASAIZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
52749,2fxp,DB11965,-7.3,SJG-136,RWZVMMQNDHPRQD-SFTDATJTSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
94596,6m71,DB08301,-7.3,N-({[4-(AMINOSULFONYL)PHENYL]AMINO}CARBONYL)-4-METHYLBENZENESULFONAMIDE,HDCXQTPVTAIPNZ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
76037,6m2n,DB06696,-7.3,Arbekacin,MKKYBZZTJQGVCD-XTCKQBCOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
23268,6cs2,HMDB0059985,-7.3,"5-(3',4',5'-Trihydroxyphenyl)-gamma-valerolactone-3'-O-sulphate",OMISYDASOKPVDK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
92739,6m71,DB04812,-7.3,Benoxaprofen,MITFXPHMIHQXPI-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
9228,6lzg,DB07310,-7.3,"(5S)-2-{[(1S)-1-(2-fluorophenyl)ethyl]amino}-5-methyl-5-(trifluoromethyl)-1,3-thiazol-4(5H)-one",KNHNFKZUNFPPQE-MADCSZMMSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
76123,6m2n,DB06836,-7.3,"N-(5-{4-Chloro-3-[(2-hydroxyethyl)sulfamoyl]phenyl}-4-methyl-1,3-thiazol-2-yl)acetamide",JFVNFXCESCXMBC-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
66290,6lxt,DB03982,-7.3,"Compound 5, 2-(Naphthalen-1-Yl-Oxalyl-Amino)-Benzoicacid",WQWCUHJIERBOSM-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
95459,6m71,DB11362,-7.3,Selexipag,QXWZQTURMXZVHJ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
51878,2fxp,DB08710,-7.3,"(5Z)-5-[(5-ETHYL-2-FURYL)METHYLENE]-2-{[(S)-(4-FLUOROPHENYL)(1H-TETRAZOL-5-YL)METHYL]AMINO}-1,3-THIAZOL-4(5H)-ONE",BKZOQCGDCHOGOQ-MZLJFPOFSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
92391,6m71,DB04338,-7.3,SB220025,VSPFURGQAYMVAN-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
53495,2fxp,DB13089,-7.3,Enoxolone,MPDGHEJMBKOTSU-YKLVYJNSSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
93212,6m71,DB06597,-7.3,Estradiol sulfamate,YXYXCSOJKUAPJI-ZBRFXRBCSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
92605,6m71,DB04626,-7.3,Apramycin,XZNUGFQTQHRASN-XQENGBIVSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93158,6m71,DB06457,-7.3,Tecastemizole,SFOVDSLXFUGAIV-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
66894,6lxt,DB04794,-7.3,Bifonazole,OCAPBUJLXMYKEJ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
112185,6vxx,DB06523,-7.3,Levovirin,IWUCXVSUMQZMFG-RGDLXGNYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
95745,6m71,DB11880,-7.3,Acridine Carboxamide,XBGNERSKEKDZDS-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
111114,6vxx,DB03013,-7.3,Di(N-Acetyl-D-Glucosamine),CDOJPCSDOXYJJF-KSKNGZLJSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113906,6vxx,DB12259,-7.3,CG-200745,AUGCSOFQTDKPSO-RGVLZGJSSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111188,6vxx,DB03313,-7.3,Cephalosporin C,HOKIDJSKDBPKTQ-GLXFQSAKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
96014,6m71,DB12275,-7.3,Seviteronel,ZBRAJOQFSNYJMF-SFHVURJKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
65941,6lxt,DB03509,-7.3,2-(4-Chlorophenyl)-5-Quinoxalinecarboxamide,FLYGLPYJEQPCFY-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
92406,6m71,DB04362,-7.3,Adenosine Diphosphate 5-(Beta-Ethyl)-4-Methyl-Thiazole-2-Carboxylic Acid,VGXBGQACJQRWLV-LKGUXBDMSA-K,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
65037,6lxt,DB02316,-7.3,"1-(5-Carboxypentyl)-5-[(2,6-Dichlorobenzyl)Oxy]-1 H-Indole-2-Carboxylic Acid",JTGPYFFQVOIJKR-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
8621,6lzg,DB06533,-7.3,Ragaglitazar,WMUIIGVAWPWQAW-XMMPIXPASA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
94165,6m71,DB07796,-7.3,"(3ASR,4RS,8ASR,8BRS)-4-(2-(4-FLUOROBENZYL)-1,3-DIOXODEACAHYDROPYRROLO[3,4-A] PYRROLIZIN-4-YL)BENZAMIDINE",GJYCQHGTXMVIBG-MUGJNUQGSA-O,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
76213,6m2n,DB06942,-7.3,N-(4-carbamimidoylbenzyl)-1-(3-phenylpropanoyl)-L-prolinamide,RNZKCCPFUWHBFY-IBGZPJMESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
113503,6vxx,DB09273,-7.3,Doxofylline,HWXIGFIVGWUZAO-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113059,6vxx,DB08322,-7.3,"2-DEOXY-3,4-BIS-O-[3-(4-HYDROXYPHENYL)PROPANOYL]-L-THREO-PENTARIC ACID",VJLMRHSHSNLOGC-NOPZTHQXSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
93101,6m71,DB06281,-7.3,Torcetrapib,CMSGWTNRGKRWGS-NQIIRXRSSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
65619,6lxt,DB03078,-7.3,PASBN,PWDTUFYQEUEVQD-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
95760,6m71,DB11902,-7.3,Gisadenafil,YPFZMBHKIVDSNR-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
14365,6lzg,T3D4032,-7.3,Cyclochlorotine,PMBVHCCVEPYDSN-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
94201,6m71,DB07835,-7.3,"N-3-cyclopropyl-N-4-'-(cyclopropylmethyl)-6-methylbiphenyl-3,4'-dicarboxamide",BOPSUAHGQHFKGG-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110791,6vxx,DB02414,-7.3,"(3s,8ar)-3-(1h-Imidazol-5-Ylmethyl)Hexahydropyrrolo[1,2-a]Pyrazine-1,4-Dione",NAKUGCPAQTUSBE-IUCAKERBSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76930,6m2n,DB07782,-7.3,4-AMINO-2-TRIFLUOROMETHYL-5-HYDROXYMETHYLPYRIMIDINE PYROPHOSPHATE,UKNJCTHTCAKKNG-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75046,6m2n,DB04172,-7.3,"[2,4,6-Triisopropyl-Phenylsulfonyl-L-[3-Amidino-Phenylalanine]]-Piperazine-N'-Beta-Alanine",WATXEHGLYJKXOF-NDEPHWFRSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
92963,6m71,DB05676,-7.3,Apremilast,IMOZEMNVLZVGJZ-QGZVFWFLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
8372,6lzg,DB05653,-7.3,IRX-5183,PNAWUIKCVQSLFG-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
93395,6m71,DB06898,-7.3,"4-(2-amino-1-methyl-1H-imidazo[4,5-b]pyridin-6-yl)phenol",UGJXOCBVCWTJFP-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93599,6m71,DB07133,-7.3,D-phenylalanyl-N-(3-methylbenzyl)-L-prolinamide,CHKWABXWPATIIG-UXHICEINSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
9093,6lzg,DB07167,-7.3,5-CYANO-FURAN-2-CARBOXYLIC ACID [5-HYDROXYMETHYL-2-(4-METHYL-PIPERIDIN-1-YL)-PHENYL]-AMIDE,NNPCFFIJVKYGHR-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
65458,6lxt,DB02861,-7.3,"4-(Aminosulfonyl)-N-[(3,4,5-Trifluorophenyl)Methyl]-Benzamide",DEHMSTGBNAXEGX-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
111316,6vxx,DB03493,-7.3,7-Methylguanosine,OGHAROSJZRTIOK-KQYNXXCUSA-O,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112566,6vxx,DB07402,-7.3,Azapropazone,WOIIIUDZSOLAIW-NSHDSACASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
94921,6m71,DB08697,-7.3,"4-(2-aminoethoxy)-N-(3-chloro-5-piperidin-1-ylphenyl)-3,5-dimethylbenzamide",JDYIYIRPQKMWMM-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
9431,6lzg,DB07531,-7.3,"4-{5-[(Z)-(2,4-DIOXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE",JNPRTUHVCHGFHJ-GHXNOFRVSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
111799,6vxx,DB04711,-7.3,Iodipamide,FFINMCNLQNTKLU-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
66113,6lxt,DB03755,-7.3,"Adenosine-5'-[Beta, Gamma-Methylene]Tetraphosphate",ARRGHMSEJJFDME-IOSLPCCCSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
8795,6lzg,DB06847,-7.3,"5-[(3S)-3-(2-methoxybiphenyl-4-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",YYCPXVRHQUEVAW-CQSZACIVSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
75662,6m2n,DB05255,-7.3,Ronacaleret,FQJISUPNMFRIFZ-HXUWFJFHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77411,6m2n,DB08347,-7.3,4-{[(2S)-3-(tert-butylamino)-2-hydroxypropyl]oxy}-3H-indole-2-carbonitrile,CQEFAUFOQSCRMZ-LBPRGKRZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
65332,6lxt,DB02694,-7.3,Pantoyl Adenylate,GDPVENOGSVMRJL-FSRKKXLISA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
92082,6m71,DB03926,-7.3,"5-Alpha-Androstane-3-Beta,17-Alpha-Diol",CBMYJHIOYJEBSB-MFXFBURESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93053,6m71,DB06188,-7.3,Ispinesib,QJZRFPJCWMNVAV-HHHXNRCGSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93915,6m71,DB07500,-7.3,(2E)-1-[2-hydroxy-4-methoxy-5-(3-methylbut-2-en-1-yl)phenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one,ZUGCRBMNFSAUOC-YRNVUSSQSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93185,6m71,DB06525,-7.3,Ganstigmine,ZOBDWFRKFSPCRB-UNMCSNQZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
112146,6vxx,DB06422,-7.3,Ticalopride,OMLDMGPCWMBPAN-YPMHNXCESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76908,6m2n,DB07757,-7.3,"(9aS)-4-bromo-9a-butyl-7-hydroxy-1,2,9,9a-tetrahydro-3H-fluoren-3-one",FTEBGBCQCYMDPH-KRWDZBQOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
20760,6cs2,HMDB0048573,-7.3,TG(16:1(9Z)/14:1(9Z)/24:1(15Z)),VLLWHKDCWQXIBL-FQVFIEMGSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
8342,6lzg,DB05501,-7.3,AMD-070,WVLHHLRVNDMIAR-IBGZPJMESA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
14470,6lzg,T3D4232,-7.3,Cylindrospermopsin,LHJPHMKIGRLKDR-VDPNAHCISA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
95859,6m71,DB12050,-7.3,LY-3039478,YCBAQKQAINQRFW-UGSOOPFHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93362,6m71,DB06860,-7.3,"2-(2-chloropyridin-4-yl)-4-methyl-1H-isoindole-1,3(2H)-dione",YDJMWNHJNJVVMM-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94430,6m71,DB08100,-7.3,"2,6-dimethyl-4-[(E)-2-phenylethenyl]phenol",PAHKYLUYTGBFNW-CMDGGOBGSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
76093,6m2n,DB06787,-7.3,Hexocyclium,ZRYHPQCHHOKSMD-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
9193,6lzg,DB07278,-7.3,2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}ETHENESULFONAMIDE,ACEFOQMQINFMRW-DYCFVMESSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
67550,6lxt,DB06884,-7.3,4-HYDROXY-N'-(4-ISOPROPYLBENZYL)BENZOHYDRAZIDE,MFDXHRPPSJRQFX-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
94496,6m71,DB08169,-7.3,(2Z)-N-biphenyl-4-yl-2-cyano-3-cyclopropyl-3-hydroxyprop-2-enamide,CAGGGMPTWTUYHZ-ZCXUNETKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96102,6m71,DB12398,-7.3,Naproxen etemesil,JGBUBSOKFSVXKS-LBPRGKRZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
9392,6lzg,DB07488,-7.3,"{(2Z)-4-AMINO-2-[(4-METHOXYPHENYL)IMINO]-2,3-DIHYDRO-1,3-THIAZOL-5-YL}(4-METHOXYPHENYL)METHANONE",XQKUGFIWKSKCDL-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
112905,6vxx,DB08134,-7.3,4-[(6-chloropyrazin-2-yl)amino]benzenesulfonamide,RSNSGNZRUMHXAY-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
9533,6lzg,DB07642,-7.3,"5-{[1-(2-fluorobenzyl)piperidin-4-yl]methoxy}quinazoline-2,4-diamine",GYKIQIOWVKCVBP-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
14650,6lzg,T3D4546,-7.3,Trifloxystrobin,ONCZDRURRATYFI-TVJDWZFNSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
53242,2fxp,DB12693,-7.3,Ritanserin,JUQLTPCYUFPYKE-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
9055,6lzg,DB07125,-7.3,"4-(6-{[(1R)-1-(hydroxymethyl)propyl]amino}imidazo[1,2-b]pyridazin-3-yl)benzoic acid",KKZYGUVAFJCULH-CYBMUJFWSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
112485,6vxx,DB07308,-7.3,5-(2-CHLOROBENZYL)-2-FUROIC ACID,YRUPEIZURHOLHV-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111367,6vxx,DB03573,-7.3,WRR-99,KVZMXOVSHIMGNA-CVEARBPZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111854,6vxx,DB04788,-7.3,Tagetitoxin,UVAAUIDYGIWLMB-HGNFPZBQSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111165,6vxx,DB03083,-7.3,IC261,JBJYTZXCZDNOJW-JLHYYAGUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
96129,6m71,DB12430,-7.3,BC-3781,KPVIXBKIJXZQJX-IJUBVZAWSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
76526,6m2n,DB07305,-7.3,5-(2-CHLORO-4-NITROPHENYL)-2-FUROIC ACID,HDIHNBCCQWMVBW-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
14291,6lzg,T3D3925,-7.3,Tebufenozide,QYPNKSZPJQQLRK-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
75593,6m2n,DB04915,-7.3,Idronoxil,ZZUBHVMHNVYXRR-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
8707,6lzg,DB06710,-7.3,Methyltestosterone,GCKMFJBGXUYNAG-HLXURNFRSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
112481,6vxx,DB07304,-7.3,5-[2-(TRIFLUOROMETHOXY)PHENYL]-2-FUROIC ACID,PSLFQKRPFOCZHR-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77401,6m2n,DB08330,-7.3,METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE,VEJCBCPEURAYAS-MEAXDALNSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
111868,6vxx,DB04806,-7.3,(5-BROMO-4-CHLORO-3-INDOLYL)-A-D-MANNOSE,OPIFSICVWOWJMJ-HAAGFXOZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
93655,6m71,DB07198,-7.3,5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-CARBONITRILE,GGEKOZPXKBYLNK-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
66000,6lxt,DB03601,-7.3,5-deoxyflavanone,FURUXTVZLHCCNA-AWEZNQCLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
94446,6m71,DB08116,-7.3,"(3R)-4-{[(3,4-dihydroxyphenyl)acetyl]oxy}-N-(2-formylindolizin-3-yl)-3-sulfino-D-valine",DEOZLEGRVHDNKC-UGKGYDQZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
112914,6vxx,DB08144,-7.3,"6-(2,6-dibromophenyl)pyrido[2,3-d]pyrimidine-2,7-diamine",HGIPWJYTPOHUGK-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76663,6m2n,DB07462,-7.3,"(3,4-DIHYDROXY-2-NITROPHENYL)(PHENYL)METHANONE",ICLKAUQIPVFHOI-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
14012,6lzg,T3D3625,-7.3,Imidazolidinyl urea,GAZOQRUEIUBTNF-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
66492,6lxt,DB04248,-7.3,beta-(1->4)-galactotriose,FYGDTMLNYKFZSV-XJJKTWKOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
52102,2fxp,DB09003,-7.3,Clocapramine,QAZKXHSIKKNOHH-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
96108,6m71,DB12405,-7.3,Triciribine,HOGVTUZUJGHKPL-HTVVRFAVSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
9539,6lzg,DB00700,-7.3,Eplerenone,JUKPWJGBANNWMW-VWBFHTRKSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
76529,6m2n,DB07308,-7.3,5-(2-CHLOROBENZYL)-2-FUROIC ACID,YRUPEIZURHOLHV-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
53060,2fxp,DB12414,-7.3,Usistapide,WSYALRNYQFNNGP-WJOKGBTCSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
112523,6vxx,DB07350,-7.3,(2E)-N-hydroxy-3-[1-methyl-4-(phenylacetyl)-1H-pyrrol-2-yl]prop-2-enamide,UFQOXIMRSMFQRI-BQYQJAHWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77242,6m2n,DB08136,-7.3,4-(acetylamino)-N-(4-fluorophenyl)-1H-pyrazole-3-carboxamide,CWQKPKYIMQTGJK-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
65874,6lxt,DB03413,-7.3,Deoxyuridine-5'-Diphosphate,QHWZTVCCBMIIKE-SHYZEUOFSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
96076,6m71,DB12361,-7.3,Piclozotan,URMTUEWUIGOJBW-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
76776,6m2n,DB07598,-7.3,"2,3,6A,7,8,9-HEXAHYDRO-11H-[1,4]DIOXINO[2,3-G]PYRROLO[2,1-B][1,3]BENZOXAZIN-11-ONE",RQEPVMAYUINZRE-GFCCVEGCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
94881,6m71,DB08646,-7.3,TRW3-(2-AMINO-3-HYDROXY-PROPYL)-6-(N'-CYCLOHEXYL-HYDRAZINO)OCTAHYDRO-INDOL-7-OL,PSUOZWHAKZSNOB-LBPRGKRZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
76869,6m2n,DB07712,-7.3,3-ETHYL-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL,XBMVVMYGKMGLJX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77150,6m2n,DB08032,-7.3,"N,N-DIETHYL-2-[(2-THIENYLCARBONYL)AMINO]-4,5,6,7-TETRAHYDRO-1-BENZOTHIOPHENE-3-CARBOXAMIDE",NZTHBWHANVWSRX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
94352,6m71,DB08011,-7.3,"(3E)-5-fluoro-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-1H-indole-2,3-dione 3-oxime",DXIHOIDYHQSQKJ-HMMYKYKNSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
75861,6m2n,DB06247,-7.3,CX516,ANDGGVOPIJEHOF-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
66014,6lxt,DB03626,-7.3,"5-Methoxy-1,2-Dimethyl-3-(Phenoxymethyl)Indole-4,7-Dione",JRPJCFILHCLEJI-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
112711,6vxx,DB07758,-7.3,"5-(2,5-DICHLOROPHENYL)-2-FUROIC ACID",ATAZLMGGQQLRBC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
92880,6m71,DB05239,-7.3,Cobimetinib,BSMCAPRUBJMWDF-KRWDZBQOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
52976,2fxp,DB12297,-7.3,GLPG-0187,CXHCNOMGODVIKB-VWLOTQADSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
76063,6m2n,DB06731,-7.3,Seproxetine,WIQRCHMSJFFONW-HNNXBMFYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
65167,6lxt,DB02479,-7.3,(R)-N-(3-Indol-1-Yl-2-Methyl-Propyl)-4-Sulfamoyl-Benzamide,ZFWHOUCRVSOZJE-CQSZACIVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
110750,6vxx,DB02367,-7.3,(1n)-4-N-Butoxyphenylsulfonyl-(2r)-N-Hydroxycarboxamido-(4s)-Methanesulfonylamino-Pyrrolidine,ULDXUWXTVRRUND-SWLSCSKDSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113307,6vxx,DB08781,-7.3,"1-[(2S)-4-(5-BROMO-1H-PYRAZOLO[3,4-B]PYRIDIN-4-YL)MORPHOLIN-2-YL]METHANAMINE",BJUBFXSKTBULRW-ZETCQYMHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112849,6vxx,DB07919,-7.3,7-METHOXY-1-METHYL-9H-BETA-CARBOLINE,BXNJHAXVSOCGBA-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112537,6vxx,DB07366,-7.3,2-[N'-(4-AMINO-BUTYL)-HYDRAZINOCARBONYL]-PYRROLIDINE-1-CARBOXYLIC ACID BENZYL ESTER,MOCIXHUQBOUBAK-HNNXBMFYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
8359,6lzg,DB05585,-7.3,Verubulin,SNHCRNMVYDHVDT-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
93623,6m71,DB07162,-7.3,4-(3-amino-1H-indazol-5-yl)-N-tert-butylbenzenesulfonamide,KFJCXIOVAGJCKB-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95170,6m71,DB09017,-7.3,Brotizolam,UMSGKTJDUHERQW-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94344,6m71,DB08003,-7.3,ISOTHIAZOLIDINONE ANALOG,UILYPHAKDBTKQV-UFYCRDLUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
92116,6m71,DB03973,-7.3,"3-{2,6,8-trioxo-9-[(2R,3R,4R)-2,3,4,5-tetrahydroxypentyl]-1,2,3,6,8,9-hexahydro-7H-purin-7-Yl}propyl dihydrogen phosphate",KPHFGOGGKPGLTM-ZXFLCMHBSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
8616,6lzg,DB06525,-7.3,Ganstigmine,ZOBDWFRKFSPCRB-UNMCSNQZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
93638,6m71,DB07179,-7.3,"3-((3-bromo-5-o-tolylpyrazolo[1,5-a]pyrimidin-7-ylamino)methyl)pyridine 1-oxide",DXUJQXZHHGJMFM-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
111172,6vxx,DB03296,-7.3,3'-beta-Sialyl-beta-lactose,CILYIEBUXJIHCO-LPTWSRJFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
14132,6lzg,T3D3750,-7.3,Aurovertin B,QXCOFYWOWZJFEA-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
92779,6m71,DB04859,-7.3,Zanapezil,PMBLXLOXUGVTGB-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
111386,6vxx,DB03804,-7.3,5-Bromothienyldeoxyuridine,IGUZFFOBAZCVRK-VAOFZXAKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
74964,6m2n,DB04070,-7.3,6-Deoxyerythronolide B,HQZOLNNEQAKEHT-IBBGRPSASA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
67413,6lxt,DB06670,-7.3,Odanacatib,FWIVDMJALNEADT-SFTDATJTSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
66197,6lxt,DB03860,-7.3,"N-Butyl-11-[(7r,8r,9s,13s,14s,17s)-3,17-Dihydroxy-13-Methyl-7,8,9,11,12,13,14,15,16,17-Decahydro-6h-Cyclopenta[a]Phenanthren-7-Yl]-N-Methylundecanamide",BVVFOLSZMQVDKV-KXQIQQEYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
65653,6lxt,DB03121,-7.3,(1-Benzyl-5-methoxy-2-methyl-1H-indol-3-yl)acetic acid,ZEKCBTQHDTUHRJ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
112240,6vxx,DB06874,-7.3,"(6-[4-(AMINOMETHYL)-2,6-DIMETHYLPHENOXY]-2-{[4-(AMINOMETHYL)PHENYL]AMINO}-5-BROMOPYRIMIDIN-4-YL)METHANOL",LSIZSSASMKSUIU-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
94857,6m71,DB08614,-7.3,"3-[[(METHYLAMINO)SULFONYL]AMINO]-2-OXO-6-PHENYL-N-[3,3,3-TRIFLUORO-1-(1-METHYLETHYL)-2-OXOPHENYL]-1(2H)-PYRIDINE ACETAMIDE",MYFMPKCOIMRDDD-KRWDZBQOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
76535,6m2n,DB07314,-7.3,"1-(5-CHLORO-2,4-DIMETHOXYPHENYL)-3-(5-CYANOPYRAZIN-2-YL)UREA",URQYPXQXSVUVRG-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
113252,6vxx,DB08723,-7.3,"5-(5-(2,6-DICHLORO-4-(4,5-DIHYDRO-2-OXAZOLY)PHENOXY)PENTYL)-3-METHYL ISOXAZOLE",JJDHAOLOHQTGMG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
95479,6m71,DB11395,-7.3,Deracoxib,WAZQAZKAZLXFMK-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93670,6m71,DB07217,-7.3,"N-(3-cyano-4,5,6,7-tetrahydro-1-benzothien-2-yl)-2-fluorobenzamide",YVYPYORTKAIUGJ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
75656,6m2n,DB05223,-7.3,Pracinostat,JHDKZFFAIZKUCU-ZRDIBKRKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
113258,6vxx,DB08729,-7.3,"5-ethoxy-4-(1-methyl-7-oxo-3-propyl-6,7-dihydro-1H-pyrazolo[4,3-d]pyrimidin-5-yl)thiophene-2-sulfonamide",FENWRHVHBZQJGW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
74739,6m2n,DB03771,-7.3,Allyl-{4-[3-(4-Bromo-Phenyl)-Benzofuran-6-Yloxy]-but-2-Enyl}-Methyl-Amine,KCNKJCHARANTIP-SNAWJCMRSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
112450,6vxx,DB07118,-7.3,Hymecromone,HSHNITRMYYLLCV-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
51849,2fxp,DB08674,-7.3,"(20S)-19,20,21,22-TETRAHYDRO-19-OXO-5H-18,20-ETHANO-12,14-ETHENO-6,10-METHENO-18H-BENZ[D]IMIDAZO[4,3-K][1,6,9,12]OXATRIAZA-CYCLOOCTADECOSINE-9-CARBONITRILE",USPFJPDEADLGIG-HSZRJFAPSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
111896,6vxx,DB04838,-7.3,Cyclandelate,WZHCOOQXZCIUNC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76242,6m2n,DB06982,-7.3,(2S)-8-[(tert-butoxycarbonyl)amino]-2-(1H-indol-3-yl)octanoic acid,AWVCKFLATUTBCX-INIZCTEOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
66811,6lxt,DB04678,-7.3,H TYPE II TRISACCHARIDE,PHTAQVMXYWFMHF-QVPNGJTFSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
110739,6vxx,DB02353,-7.3,Heparin Disaccharide Iii-S,GSYQGRODWXMUOO-GYBHJADLSA-K,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
8854,6lzg,DB06911,-7.3,D-leucyl-N-(3-chlorobenzyl)-L-prolinamide,FHVBVJXZKNCSLP-CVEARBPZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
110845,6vxx,DB02484,-7.3,Cytidine 5'-Diphosphoglycerol,HHPOUCCVONEPRK-CNYIRLTGSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
65713,6lxt,DB03205,-7.3,Pyrroloquinoline Quinone,MMXZSJMASHPLLR-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
66249,6lxt,DB03926,-7.3,"5-Alpha-Androstane-3-Beta,17-Alpha-Diol",CBMYJHIOYJEBSB-MFXFBURESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
113817,6vxx,DB12125,-7.3,Dianicline,SUPRUPHAEXPGPF-QWHCGFSZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
93932,6m71,DB07520,-7.3,"N-[1-(AMINOMETHYL)CYCLOPROPYL]-3-(MORPHOLIN-4-YLSULFONYL)-N-2-[(1S)-2,2,2-TRIFLUORO-1-(4-FLUOROPHENYL)ETHYL]-L-ALANINAMIDE",BJIKKEHGGYGGIX-HOTGVXAUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
8433,6lzg,DB05992,-7.3,Plinabulin,UNRCMCRRFYFGFX-TYPNBTCFSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
65513,6lxt,DB02932,-7.3,(R)-Bicalutamide,LKJPYSCBVHEWIU-KRWDZBQOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
67491,6lxt,DB06802,-7.3,Nepafenac,QEFAQIPZVLVERP-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
14159,6lzg,T3D3781,-7.3,Verrucosidin,JSVLNARHSWZARV-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
95006,6m71,DB08789,-7.3,"2-AMINO-4-(2,4-DICHLOROPHENYL)-N-ETHYLTHIENO[2,3-D]PYRIMIDINE-6-CARBOXAMIDE",YPEOXUOUTBMBCX-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95926,6m71,DB12146,-7.3,Rigosertib,OWBFCJROIKNMGD-BQYQJAHWSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
113151,6vxx,DB08599,-7.3,N-[(4-methoxyphenyl)sulfonyl]-D-alanine,XTCIPBHRVYICGT-SSDOTTSWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77037,6m2n,DB07903,-7.3,"3-[(2,2-DIMETHYLPROPANOYL)AMINO]-N-1,3-THIAZOL-2-YLPYRIDINE-2-CARBOXAMIDE",CAVCWRXFMNCBCM-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
92806,6m71,DB04891,-7.3,Becocalcidiol,QSLUXQQUPXBIHH-YHSKWIAJSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
13984,6lzg,T3D2099,-7.3,"1,2,3,7,9-Pentachlorodibenzo-p-dioxin",UAOYHTXYVWEPIB-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
66946,6lxt,DB04859,-7.3,Zanapezil,PMBLXLOXUGVTGB-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
111649,6vxx,DB04328,-7.3,Shikimate-3-Phosphate,QYOJSKGCWNAKGW-PBXRRBTRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111554,6vxx,DB04024,-7.3,N'-L-Seryl-3'-Amino-(3'-Deoxy)-Adenosine,ITDKSTILAWHDJI-AYEBZEFBSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
95336,6m71,DB09285,-7.3,Morniflumate,LDXSPUSKBDTEKA-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
111486,6vxx,DB03935,-7.3,"1,4-Dideoxy-O2-Sulfo-Glucuronic Acid",COJBCAMFZDFGFK-TVSWGBMESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76185,6m2n,DB06911,-7.3,D-leucyl-N-(3-chlorobenzyl)-L-prolinamide,FHVBVJXZKNCSLP-CVEARBPZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
92458,6m71,DB04437,-7.3,"Cysteine-Methylene-Carbamoyl-1,10-Phenanthroline",ZFGIPRHDRFOMFO-LBPRGKRZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94459,6m71,DB08130,-7.3,"N-(5-{3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]phenyl}-1,3,4-oxadiazol-2-yl)ethane-1,2-diamine",FPDWDLAITHFTTP-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
112786,6vxx,DB07842,-7.3,(2S)-2-(4-ethylphenoxy)-3-phenylpropanoic acid,CJMVTSLLWMPEKQ-INIZCTEOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111656,6vxx,DB04336,-7.3,1-(4-Amidinophenyl)-3-(4-Chlorophenyl)Urea,HQWKMDKTTCPCMQ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75110,6m2n,DB04259,-7.3,7n-Methyl-8-Hydroguanosine-5'-Monophosphate,ZMWJGXGSWZFZPJ-KQYNXXCUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
20599,6cs2,HMDB0047892,-7.3,TG(14:1(9Z)/14:1(9Z)/24:1(15Z)),DTWPBANPCJFNIA-QNOCGCPESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
113452,6vxx,DB09204,-7.3,Arotinolol,BHIAIPWSVYSKJS-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76391,6m2n,DB07149,-7.3,"(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluoroethyl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one",LCBAQTCTQXHTJG-ZETCQYMHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
92679,6m71,DB04726,-7.3,"7,8,10-TRIMETHYLBENZO[G]PTERIDINE-2,4(3H,10H)-DIONE",KPDQZGKJTJRBGU-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
8546,6lzg,DB06345,-7.3,AR-9281,HUDQLWBKJOMXSZ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
67115,6lxt,DB05586,-7.3,Facinicline,TXCYUSKWBHUVEP-CYBMUJFWSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
112805,6vxx,DB07863,-7.3,2-chloro-5-nitro-N-phenylbenzamide,DNTSIBUQMRRYIU-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
95346,6m71,DB09304,-7.3,Setiptiline,GVPIXRLYKVFFMK-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
8470,6lzg,DB06176,-7.3,Romidepsin,OHRURASPPZQGQM-GCCNXGTGSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
95808,6m71,DB11969,-7.3,Uprosertib,AXTAPYRUEKNRBA-JTQLQIEISA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93311,6m71,DB06780,-7.3,Desoxycorticosterone acetate,VPGRYOFKCNULNK-ACXQXYJUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
9134,6lzg,DB07210,-7.3,"3-bromo-5-phenyl-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",JECHSYMSTXETFI-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
65957,6lxt,DB03534,-7.3,3-[(Acetyl-Methyl-Amino)-Methyl]-4-Amino-N-Methyl-N-(1-Methyl-1h-Indol-2-Ylmethyl)-Benzamide,AWTBJNJPBKTHEV-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
9138,6lzg,DB07216,-7.3,"(11S)-8-CHLORO-11-[1-(METHYLSULFONYL)PIPERIDIN-4-YL]-6-PIPERAZIN-1-YL-11H-BENZO[5,6]CYCLOHEPTA[1,2-B]PYRIDINE",ZMGCFGGMTCMSDP-QHCPKHFHSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
111983,6vxx,DB05047,-7.3,CX717,KFRQROSRKSVROW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
8805,6lzg,DB06858,-7.3,N-cyclooctylglycyl-N-(4-carbamimidoylbenzyl)-L-prolinamide,MMLOIDMSBRJZAE-FQEVSTJZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
94125,6m71,DB07751,-7.3,"(2S)-1-[4-({6-[(2,6-Difluorophenyl)amino]-4-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol",ZVSBKYYVBCKDBO-HNNXBMFYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
77281,6m2n,DB08177,-7.3,(E)-3-(5((5-(4-CHLOROPHENYL)FURAN-2-YL)METHYLENE)-4-OXO-2-THIOXOTHIAZOLIDIN-3-YL)PROPANOIC ACID,YZLFZFALAZYTCI-NTEUORMPSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
93253,6m71,DB06684,-7.3,Vilazodone,SGEGOXDYSFKCPT-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
76341,6m2n,DB07093,-7.3,"{3-[(5-CHLORO-1,3-BENZOTHIAZOL-2-YL)METHYL]-2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL}ACETIC ACID",RQWICELTTDJODO-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
92912,6m71,DB05422,-7.3,OPC-14523,TZZGTNZBLPCBIS-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
92667,6m71,DB04711,-7.3,Iodipamide,FFINMCNLQNTKLU-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
8896,6lzg,DB06955,-7.3,"3,4-bis(7-chloro-1H-indol-3-yl)-1H-pyrrole-2,5-dicarboxylic acid",OAMCCJASDLMTOO-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
92671,6m71,DB04715,-7.3,IMIDAZOPYRIDAZIN 1,IVUBNTNWKIPCPS-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
92203,6m71,DB04092,-7.3,Apstatin,YVUUZAPYLPWFHE-HXFGRODQSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
52689,2fxp,DB11878,-7.3,Filibuvir,SLVAPEZTBDBAPI-GDLZYMKVSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
65956,6lxt,DB03532,-7.3,Phosphomethylphosphonic Acid Guanylate Ester,GXTIEXDFEKYVGY-KQYNXXCUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
113388,6vxx,DB09090,-7.3,Pinaverium,DDHUTBKXLWCZCO-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113410,6vxx,DB09144,-7.3,Uridine triacetate,AUFUWRKPQLGTGF-FMKGYKFTSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113685,6vxx,DB11762,-7.3,Marizomib,NGWSFRIPKNWYAO-SHTIJGAHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
65955,6lxt,DB03530,-7.3,Acylated Ceftazidime,VEHPZKIFULQYFS-BZXVCXBKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
77055,6m2n,DB07927,-7.3,3-[(4-Carboxy-2-hydroxyphenyl)sulfamoyl]-2-thiophenecarboxylic acid,RDPXXOOKKRIKFN-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
93874,6m71,DB07451,-7.3,1-(5-BROMO-PYRIDIN-2-YL)-3-[2-(6-FLUORO-2-HYDROXY-3-PROPIONYL-PHENYL)-CYCLOPROPYL]-UREA,VRAJWAGCJIXJHQ-YPMHNXCESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
9149,6lzg,DB07229,-7.3,"3-{5-[AMINO(IMINIO)METHYL]-1H-INDOL-2-YL}-5-METHOXY-1,1'-BIPHENYL-2-OLATE",MINVOLKUPZPDNX-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
95077,6m71,DB08897,-7.3,Aclidinium,ASMXXROZKSBQIH-VITNCHFBSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
23328,6cs2,HMDB0001920,-7.3,Dextromethorphan,MKXZASYAUGDDCJ-CGTJXYLNSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
93454,6m71,DB06969,-7.3,"2-amino-4-[2,4-dichloro-5-(2-pyrrolidin-1-ylethoxy)phenyl]-N-ethylthieno[2,3-d]pyrimidine-6-carboxamide",WJUNQSYQHHIVFX-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95731,6m71,DB11861,-7.3,Litronesib,YVAFBXLHPINSIK-QHCPKHFHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95043,6m71,DB08836,-7.3,Temocapril,FIQOFIRCTOWDOW-BJLQDIEVSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
8535,6lzg,DB06306,-7.3,Onalespib,IFRGXKKQHBVPCQ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
113127,6vxx,DB08571,-7.3,4-(ACETYLAMINO)-5-AMINO-3-HYDROXYBENZOIC ACID,CALDTVBHJMBRTM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
94718,6m71,DB08449,-7.3,"2-(3-((4,5,7-trifluorobenzo[d]thiazol-2-yl)methyl)-1H-pyrrolo[2,3-b]pyridin-1-yl)acetic acid",IEVFQDJUDLCOQY-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
92947,6m71,DB05585,-7.3,Verubulin,SNHCRNMVYDHVDT-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95074,6m71,DB08893,-7.3,Mirabegron,PBAPPPCECJKMCM-IBGZPJMESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
8652,6lzg,DB00603,-7.3,Medroxyprogesterone acetate,PSGAAPLEWMOORI-PEINSRQWSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
92949,6m71,DB05590,-7.3,Bedoradrine,OANCEOSLKSTLTA-REWPJTCUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
8913,6lzg,DB06977,-7.3,(2S)-1-{[5-(1H-Indazol-5-yl)-3-pyridinyl]oxy}-3-(7aH-indol-3-yl)-2-propanamine,CAASENZOSQYNPX-HSTJUUNISA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
65146,6lxt,DB02450,-7.3,"2-Benzo[1,3]Dioxol-5-Ylmethyl-3-Benzyl-Succinic Acid",ASEJDWRSZYAIOT-GJZGRUSLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
9205,6lzg,DB07289,-7.3,5-[3-(BENZYLAMINO)PHENYL]-4-BROMO-3-(CARBOXYMETHOXY)THIOPHENE-2-CARBOXYLIC ACID,XEQPGVUGYAUMSA-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
76677,6m2n,DB07481,-7.3,"tert-butyl [(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)methyl]carbamate",RXVQMCMIOHBKNE-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
95300,6m71,DB09230,-7.3,Azelnidipine,ZKFQEACEUNWPMT-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
113464,6vxx,DB09217,-7.3,Firocoxib,FULAPETWGIGNMT-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
92494,6m71,DB04482,-7.3,Cmp-2-Keto-3-Deoxy-Octulosonic Acid,YWWJKULNWGRYAS-UOVSKDHASA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
66831,6lxt,DB04706,-7.3,"(3BETA,7BETA)-CHOLEST-5-ENE-3,7-DIOL",OYXZMSRRJOYLLO-KGZHIOMZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
92244,6m71,DB04144,-7.3,"Cis-[4,5-Bis-(4-Chlorophenyl)-2-(2-Isopropoxy-4-Methoxyphenyl)-4,5-Dihyd Roimidazol-1-Yl]-Piperazin-1-Yl-Methanone",ZXIPEZDMQNYFOO-WUFINQPMSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
92799,6m71,DB04883,-7.3,Darusentan,FEJVSJIALLTFRP-LJQANCHMSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
65249,6lxt,DB02583,-7.3,"N6-(2,5-Dimethoxy-Benzyl)-N6-Methyl-Pyrido[2,3-D]Pyrimidine-2,4,6-Triamine",HZTFNSCZLJLPEO-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
65517,6lxt,DB02936,-7.3,4-(1-Benzyl-3-Carbamoylmethyl-2-Methyl-1h-Indol-5-Yloxy)-Butyric Acid,STENXUCYNKOBHJ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
93013,6m71,DB05990,-7.3,Obeticholic acid,ZXERDUOLZKYMJM-ZWECCWDJSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
9333,6lzg,DB07423,-7.3,(2S)-3-[4-(acetylamino)phenoxy]-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide,YVXVTLGIDOACBJ-SFHVURJKSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
112222,6vxx,DB06618,-7.3,Cutamesine,UVSWWUWQVAQPJR-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
66353,6lxt,DB04070,-7.3,6-Deoxyerythronolide B,HQZOLNNEQAKEHT-IBBGRPSASA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
113671,6vxx,DB11739,-7.3,Vonoprazan,BFDBKMOZYNOTPK-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
66960,6lxt,DB04876,-7.3,Vildagliptin,SYOKIDBDQMKNDQ-XWTIBIIYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
53143,2fxp,DB12537,-7.3,Benzodiazepine,SVUOLADPCWQTTE-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
8447,6lzg,DB06133,-7.3,Dimethylcurcumin,ZMGUKFHHNQMKJI-CIOHCNBKSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
112695,6vxx,DB07739,-7.3,"(3R)-3-(FLUOROMETHYL)-7-(THIOMORPHOLIN-4-YLSULFONYL)-1,2,3,4-TETRAHYDROISOQUINOLINE",SBUKSNPHYWXCDG-CYBMUJFWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
66874,6lxt,DB04768,-7.3,Pyrithiamine Pyrophosphate,ZHKSTKOYQKNDSJ-UHFFFAOYSA-O,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
113107,6vxx,DB08545,-7.3,(1R)-1-PHENYLETHYL 4-(ACETYLAMINO)BENZYLPHOSPHONATE,YPTMOJMDCPUCJT-ZDUSSCGKSA-M,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
94239,6m71,DB07877,-7.3,"8-(6-BROMO-BENZO[1,3]DIOXOL-5-YLSULFANYL)-9-(3-ISOPROPYLAMINO-PROPYL)-ADENINE",MWGWLDJLENCVRQ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
66343,6lxt,DB04059,-7.3,8-(Pyrimidin-2-Ylamino)Naphthalene-2-Carboximidamide,GRQLDCHTDNYVQI-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
76680,6m2n,DB07485,-7.3,"4,4'-cyclohexane-1,1-diyldiphenol",SDDLEVPIDBLVHC-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
67239,6lxt,DB06228,-7.3,Rivaroxaban,KGFYHTZWPPHNLQ-AWEZNQCLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
93246,6m71,DB06670,-7.3,Odanacatib,FWIVDMJALNEADT-SFTDATJTSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93437,6m71,DB06944,-7.3,N-(3-cyclopropyl-1H-pyrazol-5-yl)-2-(2-naphthyl)acetamide,RIGZCVNCFXYBEG-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93135,6m71,DB06403,-7.3,Ambrisentan,OUJTZYPIHDYQMC-LJQANCHMSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
66351,6lxt,DB04068,-7.3,Fudp,WLQBZMZTRNPUDL-SHYZEUOFSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
75049,6m2n,DB04176,-7.3,"Phosporic Acid Mono-[3,4-Dihydroxy-5-(5-Methoxy-Benzoimidazol-1-Yl)-Tetrahydro-Furan-2-Ylmethyl] Ester",VYUPJUKSTVHSQI-LPWJVIDDSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76331,6m2n,DB07082,-7.3,"1,1,1,3,3,3-HEXAFLUORO-2-{4-[(2,2,2-TRIFLUOROETHYL)AMINO]PHENYL}PROPAN-2-OL",VHDRSZOHKKZOQF-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
112104,6vxx,DB06288,-7.3,Amisulpride,NTJOBXMMWNYJFB-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
9270,6lzg,DB07352,-7.3,Apigenin,KZNIFHPLKGYRTM-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
75547,6m2n,DB04843,-7.3,Mepenzolate,GKNPSSNBBWDAGH-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
20846,6cs2,HMDB0001081,-7.3,(N-acetylneuraminosyl(a2-6)lactosamine),RPSBVJXBTXEJJG-LURNZOHQSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
111738,6vxx,DB04458,-7.3,"2,2-Dichloro-1-Methanesulfinyl-3-Methyl-Cyclopropanecarboxylic Acid [1-(4-Bromo-Phenyl)-Ethyl]-Amide",VMASMYSTIDDLTO-JOSUJJRFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
23350,6cs2,HMDB0060834,-7.3,N-Acetylserotonin sulfate,UCAJZNVFRVLULS-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
93968,6m71,DB07562,-7.3,"N-[4-(2,4-DIMETHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YL]-N',N'-DIMETHYL-BENZENE-1,4-DIAMINE",FGGSNQOBRJVAKL-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
8568,6lzg,DB06412,-7.3,Oxymetholone,ICMWWNHDUZJFDW-DHODBPELSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
95280,6m71,DB09206,-7.3,Trimazosin,YNZXWQJZEDLQEG-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93565,6m71,DB07095,-7.3,(S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclopentylpropanoyl)pyrrolidine-2-carboxamide,BNCHHUFGEOJCNH-SFHVURJKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
111725,6vxx,DB04438,-7.3,Brivudine monophosphate,LKWCVKAHHUJPQO-PIXDULNESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76018,6m2n,DB06654,-7.3,Safinamide,NEMGRZFTLSKBAP-LBPRGKRZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
95153,6m71,DB08998,-7.3,Demexiptiline,SEDQWOMFMIJKCU-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93561,6m71,DB07090,-7.3,(3S)-N-(3-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE,NJNMAZNXKKBTPS-ZDUSSCGKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
112702,6vxx,DB07748,-7.3,2-({[4-(TRIFLUOROMETHOXY)PHENYL]SULFONYL}AMINO)ETHYL DIHYDROGEN PHOSPHATE,JDDKDMFCTOZVCJ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75338,6m2n,DB04566,-7.3,Inosinic Acid,GRSZFWQUAKGDAV-KQYNXXCUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
111500,6vxx,DB03951,-7.3,N-acetyl-D-glucosamine-6-phosphate,BRGMHAYQAZFZDJ-RTRLPJTCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
51978,2fxp,DB08822,-7.3,Azilsartan medoxomil,QJFSABGVXDWMIW-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
74830,6m2n,DB03887,-7.3,Alpha-Adenosine Monophosphate,NVOIXARBSSLBAS-CRKDRTNXSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
92765,6m71,DB04839,-7.3,Cyproterone acetate,UWFYSQMTEOIJJG-FDTZYFLXSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95403,6m71,DB11115,-7.3,Ensulizole,UVCJGUGAGLDPAA-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93403,6m71,DB06907,-7.3,"2-(2,6-DICHLOROPHENYL)-1,3-BENZOXAZOLE-6-CARBOXYLIC ACID",XVNRKPCHMYOPPL-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
77324,6m2n,DB08235,-7.3,N-[2-(2-methyl-1H-indol-3-yl)ethyl]thiophene-2-carboxamide,ACAKNPKRLPMONU-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76867,6m2n,DB07708,-7.3,3-CHLORO-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL,ZNHQDSBJVFFIAK-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
9001,6lzg,DB07066,-7.3,"2-CHLORO-N-[(3R)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL]-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE",LJAHIGGEXIWVJG-LLVKDONJSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
21057,6cs2,HMDB0049447,-7.3,"TG(18:1(11Z)/20:2n6/22:5(7Z,10Z,13Z,16Z,19Z))",PFAOTZPCSYQOED-UNEUZNPLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
94937,6m71,DB08714,-7.3,"2,6-DIMETHYL-1-(3-[3-METHYL-5-ISOXAZOLYL]-PROPANYL)-4-[4-METHYL-2H-TETRAZOL-2-YL]-PHENOL",DRCNRTRGWUYJBH-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94775,6m71,DB08517,-7.3,"(2S)-5-hydroxy-2-(4-hydroxyphenyl)-7-methoxy-2,3-dihydro-4H-chromen-4-one",DJOJDHGQRNZXQQ-AWEZNQCLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94203,6m71,DB07838,-7.3,(Z)-3-BENZYL-5-(2-HYDROXY-3-NITROBENZYLIDENE)-2-THIOXOTHIAZOLIDIN-4-ONE,ZTWBCEZQPRYIGY-ZROIWOOFSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
112207,6vxx,DB06585,-7.3,Fipamezole,KXSUAWAUCNFBQJ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
93574,6m71,DB07107,-7.3,(1S)-2-(1H-INDOL-3-YL)-1-[({5-[(E)-2-PYRIDIN-4-YLVINYL]PYRIDIN-3-YL}OXY)METHYL]ETHYLAMINE,SGHXFHRRWFLILP-XJDXJNMNSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94677,6m71,DB08399,-7.3,PICEATANNOL,CDRPUGZCRXZLFL-OWOJBTEDSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
112581,6vxx,DB07420,-7.3,(1R)-4-(3-phenoxyphenyl)-1-phosphonobutane-1-sulfonic acid,RCGCZPXSRLLKCK-MRXNPFEDSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
93217,6m71,DB06608,-7.3,Tafenoquine,LBHLFPGPEGDCJG-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
9365,6lzg,DB07457,-7.3,"3-[1-(3-AMINOPROPYL)-1H-INDOL-3-YL]-4-(1H-INDOL-3-YL)-1H-PYRROLE-2,5-DIONE",APYXQTXFRIDSGE-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
93731,6m71,DB07287,-7.3,"2-(2,4-DICHLOROPHENOXY)-5-(PYRIDIN-2-YLMETHYL)PHENOL",AOVDSWPGWPRTSR-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
92144,6m71,DB04010,-7.3,2-(3'-Methoxyphenyl) Benzimidazole-4-Carboxamide,NVVWVYYHTKCIAE-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95578,6m71,DB11633,-7.3,Isavuconazole,DDFOUSQFMYRUQK-RCDICMHDSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95588,6m71,DB11650,-7.3,HT-0712,ABEJDMOBAFLQNJ-NHCUHLMSSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
74772,6m2n,DB03812,-7.3,"3-{2,6,8-trioxo-9-[(2S,3R,4R)-2,3,4,5-tetrahydroxypentyl]-1,2,3,6,8,9-hexahydro-7H-purin-7-Yl}propyl dihydrogen phosphate",KPHFGOGGKPGLTM-LKEWCRSYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76023,6m2n,DB06669,-7.3,Arverapamil,UPKQNCPKPOLASS-AREMUKBSSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75695,6m2n,DB05444,-7.3,Iroxanadine,QWVRTSZDKPRPDF-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
93739,6m71,DB07295,-7.3,2-[(7-HYDROXY-NAPHTHALEN-1-YL)-OXALYL-AMINO]-BENZOIC ACID,IGOULVZYQKJJKC-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
9442,6lzg,DB07540,-7.3,"4-{5-[(1Z)-1-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)ETHYL]-2-FURYL}BENZENESULFONAMIDE",AKFVRSQELXTCFW-JYRVWZFOSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
95990,6m71,DB12241,-7.3,TAK-733,RCLQNICOARASSR-SECBINFHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
53300,2fxp,DB12784,-7.3,NS-018,UQTPDWDAYHAZNT-AWEZNQCLSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
112371,6vxx,DB07028,-7.3,(2-{[(4-BROMO-2-FLUOROBENZYL)AMINO]CARBONYL}-5-CHLOROPHENOXY)ACETIC ACID,ZLIGBZRXAQNUFO-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76140,6m2n,DB06860,-7.3,"2-(2-chloropyridin-4-yl)-4-methyl-1H-isoindole-1,3(2H)-dione",YDJMWNHJNJVVMM-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
94087,6m71,DB07706,-7.3,2-Hydrox1tradiol,DILDHNKDVHLEQB-XSSYPUMDSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94092,6m71,DB07713,-7.3,"(1S)-1-{[(4'-methoxy-1,1'-biphenyl-4-yl)sulfonyl]amino}-2-methylpropylphosphonic acid",BZVYQWLRCHLAGK-KRWDZBQOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
92837,6m71,DB04975,-7.3,Banoxantrone,YZBAXVICWUUHGG-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
9117,6lzg,DB07192,-7.3,(3S)-N-(3-BROMOPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE,MVPIURCUINFSAB-LBPRGKRZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
110957,6vxx,DB02808,-7.3,Trifluorofurnesyl Diphosphate,PXLMLAFPAPGGKK-GVCYOOEQSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
67226,6lxt,DB06199,-7.3,Atrasentan,MOTJMGVDPWRKOC-QPVYNBJUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
113649,6vxx,DB11702,-7.3,Antineoplaston A10,OQGRFQCUGLKSAV-JTQLQIEISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112619,6vxx,DB07462,-7.3,"(3,4-DIHYDROXY-2-NITROPHENYL)(PHENYL)METHANONE",ICLKAUQIPVFHOI-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
9507,6lzg,DB07615,-7.3,Tranilast,NZHGWWWHIYHZNX-CSKARUKUSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
95598,6m71,DB11666,-7.3,Buparlisib,CWHUFRVAEUJCEF-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93257,6m71,DB06693,-7.3,Mevastatin,AJLFOPYRIVGYMJ-INTXDZFKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93415,6m71,DB06919,-7.3,D-phenylalanyl-N-(3-chlorobenzyl)-L-prolinamide,CJHLRGCXPGIPCB-MOPGFXCFSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95962,6m71,DB12204,-7.3,Terbogrel,XUTLOCQNGLJNSA-RGVLZGJSSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94284,6m71,DB07934,-7.3,[[CYCLOHEXANESULFONYL-GLYCYL]-3[PYRIDIN-4-YL-AMINOMETHYL]ALANYL]PIPERIDINE,KMUXFASJKPVMGU-HXUWFJFHSA-O,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
112618,6vxx,DB07461,-7.3,"3-AMINO-3-BENZYL-9-CARBOXAMIDE[4.3.0]BICYCLO-1,6-DIAZANONAN-2-ONE",JVDDTUQPPBUQDD-DZGCQCFKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
66838,6lxt,DB04715,-7.3,IMIDAZOPYRIDAZIN 1,IVUBNTNWKIPCPS-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
113178,6vxx,DB08634,-7.3,6-BENZYL-1-BENZYLOXYMETHYL-5-ISOPROPYL URACIL,KSAAUHMSLCPIEX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
93766,6m71,DB07324,-7.3,"3-({2-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)ETHYNYL]BENZYL}AMINO)-1,3-OXAZOL-2(3H)-ONE",ZUJWSOPIDUWELP-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
75729,6m2n,DB05596,-7.3,PRX-03140,SCHKZZSVELPJKU-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75946,6m2n,DB06478,-7.3,Porfiromycin,HRHKSTOGXBBQCB-VFWICMBZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77303,6m2n,DB08207,-7.3,"2-(3,5-DIMETHYLPHENYL)-1,3-BENZOXAZOLE",BIHLSRJPJFOESJ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
9600,6lzg,DB07715,-7.3,Emodin,RHMXXJGYXNZAPX-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
94399,6m71,DB08063,-7.3,"1-BENZYL-3-(4-METHOXYPHENYLAMINO)-4-PHENYLPYRROLE-2,5-DIONE",HLZMYWLMBBLASX-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
53165,2fxp,DB12571,-7.3,Rimacalib,MYTIJGWONQOOLC-HNNXBMFYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
110986,6vxx,DB02844,-7.3,"S-Adenosyl-1,8-Diamino-3-Thiooctane",SUUGLGYBZXSJAA-SCFUHWHPSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111697,6vxx,DB04396,-7.3,Thiodigalactoside,SYKYBMOFPMXDRQ-ZFDCCPEWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
65732,6lxt,DB03227,-7.3,Nicotinamide Mononucleotide,DAYLJWODMCOQEW-WYOJIJJFSA-O,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
14199,6lzg,T3D3828,-7.3,Difenoconazole,BQYJATMQXGBDHF-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
110954,6vxx,DB02805,-7.3,Uracil arabinose-3'-phosphate,FOGRQMPFHUHIGU-PXBUCIJWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
93414,6m71,DB06918,-7.3,2-(2-METHYLPHENYL)-1H-INDOLE-6-CARBOXIMIDAMIDE,ZRYXDGAKQGRHFG-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93559,6m71,DB07088,-7.3,(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclopentyloxy)ethanoyl)pyrrolidine-2-carboxamide,ZWXWAYUCJVQHOR-KRWDZBQOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110912,6vxx,DB02568,-7.3,Peldesine,DOHVAKFYAHLCJP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
65727,6lxt,DB03221,-7.3,AL7099A,RMOXCYSVWCHXII-GFCCVEGCSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
8472,6lzg,DB06178,-7.3,Talotrexin,NYQPLPNEESYGNO-IBGZPJMESA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
53008,2fxp,DB12339,-7.3,Radezolid,BTTNOGHPGJANSW-IBGZPJMESA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
65189,6lxt,DB02504,-7.3,[3-(1-Benzyl-3-Carbamoylmethyl-2-Methyl-1h-Indol-5-Yloxy)-Propyl-]-Phosphonic Acid,AQEYCNKFBRLUOT-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
94961,6m71,DB08739,-7.3,"2-{3-[(2S)-4,4-difluoro-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]-3-oxopropyl}-isoindole-1,3(2H)-dione",ZSXNPAWXICXNGZ-HNNXBMFYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
113339,6vxx,DB09012,-7.3,Carbazochrome,XSXCZNVKFKNLPR-SDQBBNPISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
74780,6m2n,DB03820,-7.3,"(2s,5r,6r)-6-{[(6r)-6-(Glycylamino)-7-Oxido-7-Oxoheptanoyl]Amino}-3,3-Dimethyl-7-Oxo-4-Thia-1-Azabicyclo[3.2.0]Heptane-2-Carboxylate",LDJWRKFRKCXUDO-RBQWDTSBSA-M,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
94289,6m71,DB07940,-7.3,"9-(3-IODOBENZYLAMINO)-1,2,3,4-TETRAHYDROACRIDINE",ZUCWQTWGZGIYPV-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
75725,6m2n,DB05585,-7.3,Verubulin,SNHCRNMVYDHVDT-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
93556,6m71,DB07085,-7.3,2-{[N-(2-ACETYL-5-CHLORO-4-FLUOROPHENYL)GLYCYL]AMINO}BENZOIC ACID,LBMZLHCAPBBOFS-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
75260,6m2n,DB04468,-7.3,Afimoxifene,TXUZVZSFRXZGTL-QPLCGJKRSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
94094,6m71,DB07715,-7.3,Emodin,RHMXXJGYXNZAPX-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
77305,6m2n,DB08210,-7.3,"2-AMINO-4-FLUORO-5-[(1-METHYL-1H-IMIDAZOL-2-YL)SULFANYL]-N-(1,3-THIAZOL-2-YL)BENZAMIDE",YUCYMQBDBXVNCE-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
67025,6lxt,DB05095,-7.3,Cimicoxib,KYXDNECMRLFQMZ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
111716,6vxx,DB04425,-7.3,"7,8-Dihydroneopterin",YQIFAMYNGGOTFB-XINAWCOVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111710,6vxx,DB04416,-7.3,"R-2-{[4'-Methoxy-(1,1'-Biphenyl)-4-Yl]-Sulfonyl}-Amino-6-Methoxy-Hex-4-Ynoic Acid",QJKGJGURDPRKGW-LJQANCHMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
92904,6m71,DB05395,-7.3,Amibegron,RDJQCOBTKKAQAH-FPOVZHCZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
66576,6lxt,DB04366,-7.3,3'-Deoxy 3'-Amino Adenosine-5'-Diphosphate,VKODIDNZKBYXJO-QYYRPYCUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
66585,6lxt,DB04378,-7.3,"3-Amino-N-{4-[2-(2,6-Dimethyl-Phenoxy)-Acetylamino]-3-Hydroxy-1-Isobutyl-5-Phenyl-Pentyl}-Benzamide",APJAEXGNDLFGPD-AWCRTANDSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
92404,6m71,DB04357,-7.3,Pteric Acid,JOAQINSXLLMRCV-UHFFFAOYSA-O,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
8993,6lzg,DB07058,-7.3,"5-[1-(4-methoxyphenyl)-1H-benzimidazol-6-yl]-1,3,4-oxadiazole-2(3H)-thione",QBVJMUOTMRYUKR-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
110913,6vxx,DB02569,-7.3,"2',3'-Dehydro-2',3'-Deoxy-Thymidine 5'-Diphosphate",LXCAIISEDMYORY-JGVFFNPUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
13196,6lzg,DB01097,-7.3,Leflunomide,VHOGYURTWQBHIL-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
77482,6m2n,DB08434,-7.3,2-METHYLCARBAMOYL-3-(4-PHOSPHONOOXY-PHENYL)-CYCLOPROPANECARBOXYLIC ACID,GIIUHKRUTUSHAB-IVZWLZJFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
27166,6cs2,DB06616,-7.3,Bosutinib,UBPYILGKFZZVDX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
72605,6m2n,DB00940,-7.3,Methantheline,GZHFODJQISUKAY-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
87635,6m3m,DB12614,-7.3,Reparixin,KQDRVXQXKZXMHP-LLVKDONJSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
11703,6lzg,DB12316,-7.3,9CUAB30,PPGNMFUMZSAZCW-VOYUZAMQSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
70011,6lxt,DB12027,-7.3,Serdemetan,CEGSUK1LWKJP-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
87645,6m3m,DB12629,-7.3,"3,5-diiodothyropropionic acid",WONYMNWUJVKVII-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
105524,6vxs,DB13617,-7.3,Clorexolone,VPMWFZKOWULPGT-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
105537,6vxs,DB13635,-7.3,Tiracizine,KJAMZCVTJDTESW-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
82654,6m3m,DB02829,-7.3,4-(Acetylamino)-3-[(Aminoacetyl)Amino]Benzoic Acid,FJGXEWVOOHZQDN-UHFFFAOYSA-O,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
82651,6m3m,DB02824,-7.3,N-Pyridoxyl-Glycine-5-Monophosphate,FEVQWBMNLWUBTF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
57733,6crv,DB04061,-7.3,Alpha-Amino-2-Indanacetic Acid,GUDHMDVRURNAHL-SNVBAGLBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
105552,6vxs,DB13657,-7.3,Benorilate,FEJKLNWAOXSSNR-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
12832,6lzg,DB13856,-7.3,Fluclorolone,VTWKPILBIUBMDS-OTJLYDAYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
69996,6lxt,DB12005,-7.3,Nirogacestat,VFCRKLWBYMDAED-REWPJTCUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
82596,6m3m,DB02752,-7.3,Tosyl-D-Proline,CGPHGPCHVUSFFA-LLVKDONJSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
105573,6vxs,DB13680,-7.3,Naftazone,TZGBBMBARSFJBG-UKTHLTGXSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
27200,6cs2,DB06682,-7.3,Naproxcinod,AKFJWRDCWYYTIG-ZDUSSCGKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
101644,6vxs,DB06148,-7.3,Mianserin,UEQUQVLFIPOEMF-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
27208,6cs2,DB06696,-7.3,Arbekacin,MKKYBZZTJQGVCD-XTCKQBCOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
105473,6vxs,DB13548,-7.3,Dibrompropamidine,GMJFVGRUYJHMCO-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
70031,6lxt,DB12058,-7.3,Recoflavone,BCPQOBQIVJZOFL-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
87613,6m3m,DB12575,-7.3,Ronopterin,NDSDGUULXHNXGA-RPDRRWSUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
70054,6lxt,DB12093,-7.3,Tetrahydropalmatine,AEQDJSLRWYMAQI-KRWDZBQOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
27105,6cs2,DB06471,-7.3,Naxifylline,NJYNSYQBNSDGIQ-RDDCQWBRSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
70100,6lxt,DB12155,-7.3,Napabucasin,DPHUWDIXHNQOSY-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
57903,6crv,DB04280,-7.3,"((2r,3s,5r)-3-Hydroxy-5-(4-Hydroxy-2-Oxo-3,4-Dihydropyrimidin-1(2h)-Yl)-Tetrahydrofuran-2-Yl)Methyldihydrogen Phosphate",ILSIYJVILUIVPM-LXGUWJNJSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72535,6m2n,DB00861,-7.3,Diflunisal,HUPFGZXOMWLGNK-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
82829,6m3m,DB03065,-7.3,7-Nitroindazole-2-Carboxamidine,GFYAZUABYOOPCN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
105336,6vxs,DB13360,-7.3,Tolciclate,CANCCLAKQQHLNK-LSDHHAIUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
105347,6vxs,DB13374,-7.3,Vincamine,RXPRRQLKFXBCSJ-GIVPXCGWSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
82800,6m3m,DB03022,-7.3,"3-{2,6,8-trioxo-9-[(2R,3S,4R)-2,3,4,5-tetrahydroxypentyl]-1,2,3,6,8,9-hexahydro-7H-purin-7-Yl}propyl dihydrogen phosphate",KPHFGOGGKPGLTM-BHNWBGBOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
82795,6m3m,DB03015,-7.3,"6-Hydroxy-1,6-Dihydro Purine Nucleoside",WGRXVKRHIMUTPD-YOHZANMFSA-O,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
11689,6lzg,DB12301,-7.3,Doravirine,ZIAOVIPSKUPPQW-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
105372,6vxs,DB13411,-7.3,Lofepramine,SAPNXPWPAUFAJU-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
57859,6crv,DB04218,-7.3,1-Deaza-Adenosine,NVUDDRWKCUAERS-PNHWDRBUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
25002,6cs2,DB02842,-7.3,9-amino-n-[3-(dimethylamino)propyl]acridine-4-carboxamide,VNWAULKXOPRJEL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
27136,6cs2,DB06538,-7.3,Robalzotan,MQTUXRKNJYPMCG-CYBMUJFWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
72553,6m2n,DB00882,-7.3,Clomifene,GKIRPKYJQBWNGO-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
72560,6m2n,DB00890,-7.3,Dienestrol,NFDFQCUYFHCNBW-SCGPFSFSSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
57852,6crv,DB04211,-7.3,"(2R,3R,4R,5R,6R)-3-fluoro-2,4-dihydroxy-5-[(1-hydroxyethylidene)amino]-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid",ALJLGESFXXDPKH-RISWTRDCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
82745,6m3m,DB02946,-7.3,Carpropamide,RXDMAYSSBPYBFW-RULNRJAQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
82743,6m3m,DB02943,-7.3,N-(4-Aminobutanoyl)-S-(4-Methoxybenzyl)-L-Cysteinylglycine,OMOPDEZZBQHMGS-AWEZNQCLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
105414,6vxs,DB13465,-7.3,Ciclobendazole,OXLKOMYHDYVIDM-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
105389,6vxs,DB13432,-7.3,Lonazolac,XVUQHFRQHBLHQD-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
105306,6vxs,DB13325,-7.3,Nifurzide,IDUMOVRJNBNOTR-BIZLIJPVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
69959,6lxt,DB11948,-7.3,Lapachone,QZPQTZZNNJUOLS-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
69957,6lxt,DB11946,-7.3,AZD-1981,JWYIGNODXSRKGP-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
105733,6vxs,DB13934,-7.3,Ligandrol,OPSIVAKKLQRWKC-VXGBXAGGSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
57576,6crv,DB03846,-7.3,5-Hydroxymethyluridine-2'-Deoxy-5'-Monophosphate,WEBVWKFGRVLCNS-XLPZGREQSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
12878,6lzg,DB13955,-7.3,Estradiol dienanthate,OVAHZPTYWMWNKO-CAHAWPIUSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
101536,6vxs,DB05475,-7.3,Golotimod,CATMPQFFVNKDEY-YPMHNXCESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
105735,6vxs,DB13937,-7.3,LGD-3303,OMXGOGXEWUCLFI-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
27244,6cs2,DB06737,-7.3,Zaltoprofen,MUXFZBHBYYYLTH-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
18372,6cs2,HMDB0029096,-7.3,Tryptophyl-Valine,LWFWZRANSFAJDR-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
57564,6crv,DB03829,-7.3,Pseudouridine-5'-Monophosphate,MOBMOJGXNHLLIR-GBNDHIKLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27246,6cs2,DB06739,-7.3,Seratrodast,ZBVKEHDGYSLCCC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
72728,6m2n,DB01084,-7.3,Emedastine,KBUZBQVCBVDWKX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
11656,6lzg,DB12264,-7.3,Atevirdine,UCPOMLWZWRTIAA-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
18378,6cs2,HMDB0029112,-7.3,Tyrosyl-Phenylalanine,CGWAPUBOXJWXMS-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
27248,6cs2,DB06743,-7.3,Ginkgolide A,FPUXKXIZEIDQKW-VKMVSBOZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
27251,6cs2,DB06746,-7.3,ginkgolide-J,LMEHVEUFNRJAAV-UKWFQYJJSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
82342,6m3m,DB02416,-7.3,"2-Ribofuranosyl-3-Iodo-2,3-Dihydro-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine",IPMOTTQXPAXTMS-CKVFBBIQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
61560,6crv,DB12265,-7.3,Fexinidazole,MIWWSGDADVMLTG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
105804,6vxs,DB14066,-7.3,Tetrandrine,WVTKBKWTSCPRNU-KYJUHHDHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
27260,6cs2,DB06766,-7.3,Alcaftadine,MWTBKTRZPHJQLH-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
105843,6vxs,DB14152,-7.3,Ginsenosides,NLHQJXWYMZLQJY-SWIZOJJJSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
69912,6lxt,DB11880,-7.3,Acridine Carboxamide,XBGNERSKEKDZDS-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
57579,6crv,DB03851,-7.3,Carbazole Butanoic Acid,HQAKVYGASUTQHH-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
105723,6vxs,DB13916,-7.3,Toyocamycin,XOKJUSAYZUAMGJ-WOUKDFQISA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
24852,6cs2,DB02659,-7.3,Cholic Acid,BHQCQFFYRZLCQQ-OELDTZBJSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
61460,6crv,DB12117,-7.3,Mitometh,MOTIYCLHZZLHHQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
105631,6vxs,DB13759,-7.3,Fenpiverinium,QDIYJDPBMZUZEH-UHFFFAOYSA-O,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
82490,6m3m,DB02608,-7.3,N-Acetyl-P-Nitrophenylserinol,PIVQDUYOEIAFDM-GHMZBOCLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
57646,6crv,DB03938,-7.3,Deacetoxycephalosporin-C,NNQIJOYQWYKBOW-JWKOBGCHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
105664,6vxs,DB13803,-7.3,Xipamide,MTZBBNMLMNBNJL-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101589,6vxs,DB05791,-7.3,Perflubron,WTWWXOGTJWMJHI-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
72675,6m2n,DB01022,-7.3,Phylloquinone,MBWXNTAXLNYFJB-NKFFZRIASA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
24882,6cs2,DB02696,-7.3,"6-Aminohexyl-Uridine-C1,5'-Diphosphate",MLWJBKPFDKRHBM-FMKGYKFTSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
82473,6m3m,DB02586,-7.3,"4,7-Dimethyl-[1,10]Phenanthroline",JIVLDFFWTQYGSR-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
105610,6vxs,DB13728,-7.3,Halometasone,GGXMRPUKBWXVHE-MIHLVHIWSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
82443,6m3m,DB02544,-7.3,"N-(6-{[3-(4-Bromophenyl)-1,2-Benzisothiazol-6-Yl]Oxy}Hexyl)-N-Methylprop-2-En-1-Amine",UCIDPJLYUKNYFZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
105688,6vxs,DB13836,-7.3,Metampicillin,FZECHKJQHUVANE-MCYUEQNJSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
105689,6vxs,DB13837,-7.3,Doxefazepam,VOJLELRQLPENHL-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101574,6vxs,DB05676,-7.3,Apremilast,IMOZEMNVLZVGJZ-QGZVFWFLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
72708,6m2n,DB01060,-7.3,Amoxicillin,LSQZJLSUYDQPKJ-NJBDSQKTSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
27234,6cs2,DB06727,-7.3,Sparteine,SLRCCWJSBJZJBV-ZQDZILKHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
57604,6crv,DB03883,-7.3,Carboxyethyllumazine,PTYCEIBBGGLADD-PJKMHFRUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57602,6crv,DB03881,-7.3,"(2S,3R,4S,5S)-3,4-Dihydroxy-2-[(methylsulfanyl)methyl]-5-(4-oxo-4,5-dihydro-1H-pyrrolo[3,2-d]pyrimidin-7-yl)pyrrolidinium",CEGIKIXYDFDYDN-RXDXJJGDSA-O,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
101559,6vxs,DB05586,-7.3,Facinicline,TXCYUSKWBHUVEP-CYBMUJFWSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
105716,6vxs,DB13872,-7.3,Lormetazepam,FJIKWRGCXUCUIG-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
72701,6m2n,DB01053,-7.3,Benzylpenicillin,JGSARLDLIJGVTE-MBNYWOFBSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
72748,6m2n,DB01104,-7.3,Sertraline,VGKDLMBJGBXTGI-SJCJKPOMSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
82871,6m3m,DB03114,-7.3,PAS219,YBEVTZVQKMYQPM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
15862,6lzg,DB01604,-7.3,Pivampicillin,ZEMIJUDPLILVNQ-ZXFNITATSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
70315,6lxt,DB12461,-7.3,GLPG-0492,VAJGULUVTFDTAS-GOSISDBHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
61068,6crv,DB11460,-7.3,Squalene,YYGNTYWPHWGJRM-AAJYLUCBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
70307,6lxt,DB12445,-7.3,Nitroaspirin,IOJUJUOXKXMJNF-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
11813,6lzg,DB12464,-7.3,Bevenopran,ZGCYVRNZWGUXNQ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
102103,6vxs,DB07013,-7.3,TERT-BUTYL 4-({[4-(BUT-2-YN-1-YLAMINO)PHENYL]SULFONYL}METHYL)-4-[(HYDROXYAMINO)CARBONYL]PIPERIDINE-1-CARBOXYLATE,RXFCFGLSOUOCEA-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
58163,6crv,DB04631,-7.3,Atpenin A5,OVULNOOPECCZRG-CIUDSAMLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87107,6m3m,DB11837,-7.3,Osilodrostat,USUZGMWDZDXMDG-CYBMUJFWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
27017,6cs2,DB06250,-7.3,Fluasterone,VHZXNQKVFDBFIK-NBBHSKLNSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
72363,6m2n,DB00661,-7.3,Verapamil,SGTNSNPWRIOYBX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
11803,6lzg,DB12447,-7.3,Nadifloxacin,JYJTVFIEFKZWCJ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
70294,6lxt,DB12428,-7.3,PAC-14028,UKGJZDSUJSPAJL-YPUOHESYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
83212,6m3m,DB03588,-7.3,Diphenylacetic Acid,PYHXGXCGESYPCW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83203,6m3m,DB03576,-7.3,N-Pyridoxyl-Threonine-5-Monophosphate,IZWQBQLGLAKRMN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
70284,6lxt,DB12416,-7.3,VTP-27999,NXWASIVXQMMPLM-ZXMXYHOLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
72375,6m2n,DB00675,-7.3,Tamoxifen,NKANXQFJJICGDU-QPLCGJKRSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
102063,6vxs,DB06967,-7.3,"6-ETHYL-5-[9-(3-METHOXYPROPYL)-9H-CARBAZOL-2-YL]PYRIMIDINE-2,4-DIAMINE",MLSVRCGEBXIIQO-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
83201,6m3m,DB03573,-7.3,WRR-99,KVZMXOVSHIMGNA-CVEARBPZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
16050,6lzg,DB02498,-7.3,Carba-Nicotinamide-Adenine-Dinucleotide,DGPLSUKWXXSBCU-VGXGLJSLSA-O,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
16047,6lzg,DB02479,-7.3,(R)-N-(3-Indol-1-Yl-2-Methyl-Propyl)-4-Sulfamoyl-Benzamide,ZFWHOUCRVSOZJE-CQSZACIVSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
61062,6crv,DB11448,-7.3,Phosmet,LMNZTLDVJIUSHT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
25190,6cs2,DB03069,-7.3,Cytidine-5'-Diphospho-Beta-D-Xylose,NWSKPSPTJOAICE-OCIMBMBZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
72347,6m2n,DB00639,-7.3,Butoconazole,SWLMUYACZKCSHZ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
11827,6lzg,DB12479,-7.3,Zabofloxacin,ZNPOCLHDJCAZAH-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
58257,6crv,DB04762,-7.3,N-PYRIDOXYL-D-GLUTAMIC ACID-5'-MONOPHOSPHATE,JMRKOGDJNHPMHS-SNVBAGLBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
26961,6cs2,DB06153,-7.3,Pizotifen,FIADGNVRKBPQEU-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
104921,6vxs,DB12713,-7.3,Sotagliflozin,QKDRXGFQVGOQKS-CRSSMBPESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
26972,6cs2,DB06174,-7.3,Noscapine,AKNNEGZIBPJZJG-MSOLQXFVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
83378,6m3m,DB03807,-7.3,"1-(2-Chlorophenyl)-3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester",XQCKNCFQOJFQFK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
102186,6vxs,DB07108,-7.3,"4'-FLUORO-1,1'-BIPHENYL-4-CARBOXYLIC ACID",LXWNTLBMNCXRQN-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104936,6vxs,DB12733,-7.3,Dipraglurant,LZXMUJCJAWVHPZ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
16244,6lzg,DB03355,-7.3,5'-O-(N-(L-Threonyl)-Sulfamoyl)Adenosine,UPVAPSGKXAAHBG-CKTDUXNWSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
18090,6cs2,HMDB0000594,-7.3,gamma-Glutamylphenylalanine,XHHOHZPNYFQJKL-QWRGUYRKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
105060,6vxs,DB12933,-7.3,RO-4987655,FIMYFEGKMOCQKT-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104958,6vxs,DB12770,-7.3,Lafutidine,KMZQAVXSMUKBPD-DJWKRKHSSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
83342,6m3m,DB03763,-7.3,5-Methyl-2'-Deoxypseudouridine,AMDJRICBYOAHBZ-XLPZGREQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
102177,6vxs,DB07096,-7.3,"6-AMINO-BENZO[DE]ISOQUINOLINE-1,3-DIONE",SSMIFVHARFVINF-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
26986,6cs2,DB00118,-7.3,Ademetionine,MEFKEPWMEQBLKI-AIRLBKTGSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
60994,6crv,DB11279,-7.3,Brilliant green cation,HXCILVUBKWANLN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
102174,6vxs,DB07093,-7.3,"{3-[(5-CHLORO-1,3-BENZOTHIAZOL-2-YL)METHYL]-2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL}ACETIC ACID",RQWICELTTDJODO-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
61004,6crv,DB11324,-7.3,Nonivamide,RGOVYLWUIBMPGK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
83320,6m3m,DB03737,-7.3,"4-((3r,4s,5r)-4-Amino-3,5-Dihydroxy-Hex-1-Ynyl)-5-Fluoro-3-[1-(3-Methoxy-1h-Pyrrol-2-Yl)-Meth-(Z)-Ylidene]-1,3-Dihydro-Indol-2-One",RAKYKJWUUUKCCW-MPLBGYFPSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
18102,6cs2,HMDB0012798,-7.3,5'-Carboxy-alpha-chromanol,QWPNLVBAEZJBMI-IMFVZPHKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
61031,6crv,DB11393,-7.3,Danofloxacin,QMLVECGLEOSESV-RYUDHWBXSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
83344,6m3m,DB03765,-7.3,2'-cytidylic acid,YQUAKORMLHPSLZ-XVFCMESISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
82872,6m3m,DB03115,-7.3,"5-Bromo-N-(2,3-Dihydroxypropoxy)-3,4-Difluoro-2-[(2-Fluoro-4-Iodophenyl)Amino]Benzamide",XXSSGBYXSKOLAM-QMMMGPOBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
16013,6lzg,DB02315,-7.3,Cyclic GMP,ZOOGRGPOEVQQDX-UUOKFMHZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
83176,6m3m,DB03528,-7.3,9-Beta-D-Xylofuranosyl-Adenine,OIRDTQYFTABQOQ-GAWUUDPSSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
11742,6lzg,DB12376,-7.3,Ricolinostat,QGZYDVAGYRLSKP-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
72447,6m2n,DB00760,-7.3,Meropenem,DMJNNHOOLUXYBV-PQTSNVLCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
70175,6lxt,DB12268,-7.3,Carmegliptin,GUYMHFIHHOEFOA-ZCPGHIKRSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
83018,6m3m,DB03307,-7.3,4-[(6-Amino-4-Pyrimidinyl)Amino]Benzenesulfonamide,FVFVVRPJERUECT-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
57983,6crv,DB04394,-7.3,3-Nitro-4-(2-Oxo-Pyrrolidin-1-Yl)-Benzenesulfonamide,FPCPYSKJIRSWIG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87393,6m3m,DB12263,-7.3,Begacestat,PSXOKXJMVRSARX-SCSAIBSYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
70158,6lxt,DB12242,-7.3,AZD-7762,IAYGCINLNONXHY-LBPRGKRZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
70157,6lxt,DB12241,-7.3,TAK-733,RCLQNICOARASSR-SECBINFHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
27089,6cs2,DB06442,-7.3,Avasimibe,PTQXTEKSNBVPQJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
22602,6cs2,HMDB0054376,-7.3,"TG(22:2(13Z,16Z)/18:0/20:4(8Z,11Z,14Z,17Z))",YOYHAKULCQGNIT-XRNLDNDZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
82947,6m3m,DB03218,-7.3,N-Acetyl-N'-Beta-D-Glucopyranosyl Urea,UQKBNLXZEGBQAF-JAJWTYFOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
105225,6vxs,DB13217,-7.3,Fentiazac,JIEKMACRVQTPRC-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
82946,6m3m,DB03217,-7.3,DPI59,AXIBZLYWMBUYRV-NSHDSACASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
105241,6vxs,DB13237,-7.3,Clofoctol,HQVZOORKDNCGCK-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
70133,6lxt,DB12210,-7.3,AZD-6280,NVWCZRPXYVDQEE-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
82927,6m3m,DB03196,-7.3,4-Nitrophenyl-Ara,DUYYBTBDYZXISX-UKKRHICBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
101848,6vxs,DB06645,-7.3,Anamorelin,VQPFSIRUEPQQPP-MXBOTTGLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
70119,6lxt,DB12187,-7.3,Abacavir hydroxyacetate,ZBBZROWQLKCFQK-KOLCDFICSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
101832,6vxs,DB06618,-7.3,Cutamesine,UVSWWUWQVAQPJR-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
11746,6lzg,DB12380,-7.3,GDC-0152,WZRFLSDVFPIXOV-LRQRDZAKSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
83044,6m3m,DB03342,-7.3,4-(Acetylamino)-3-Guanidinobenzoic Acid,HIXHCUDMJUERSJ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
105167,6vxs,DB13097,-7.3,1alpha-Hydroxyvitamin D5,NWFOBODUYTUMNC-VPSCEVSQSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101922,6vxs,DB06780,-7.3,Desoxycorticosterone acetate,VPGRYOFKCNULNK-ACXQXYJUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
72396,6m2n,DB00698,-7.3,Nitrofurantoin,NXFQHRVNIOXGAQ-YCRREMRBSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
11787,6lzg,DB12428,-7.3,PAC-14028,UKGJZDSUJSPAJL-YPUOHESYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
87307,6m3m,DB12133,-7.3,BLXA4,HEDVTGFTYROYFE-RREUNBNVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
102006,6vxs,DB06898,-7.3,"4-(2-amino-1-methyl-1H-imidazo[4,5-b]pyridin-6-yl)phenol",UGJXOCBVCWTJFP-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
105101,6vxs,DB13001,-7.3,Tinoridine,PFENFDGYVLAFBR-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101999,6vxs,DB06889,-7.3,"3-(1H-tetrazol-5-ylmethyl)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(3H)-one",QSBQXAOOVSQABJ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
83140,6m3m,DB03479,-7.3,"8,9,10-Trihydroxy-7-Hydroxymethyl-3-Methyl-6-Oxa-1,3-Diaza-Spiro[4.5]Decane-2,4-Dione",RIUIMUSXAGXXON-FMTWGGRWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83133,6m3m,DB03471,-7.3,6-Phenyl-4(R)-(7-Phenyl-Heptanoylamino)-Hexanoic Acid,SMNHQYPORNSAQH-HSZRJFAPSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
101977,6vxs,DB06865,-7.3,6-CARBAMIMIDOYL-2-[2-HYDROXY-6-(4-HYDROXY-PHENYL)-INDAN-1-YL]-HEXANOIC ACID,ZSRRBAKATXAISL-LMNJBCLMSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
105074,6vxs,DB12952,-7.3,Methylprednisone,SVYCRJXQZUCUND-PQXSVQADSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
27059,6cs2,DB06358,-7.3,Iclaprim,HWJPWWYTGBZDEG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
72418,6m2n,DB00722,-7.3,Lisinopril,RLAWWYSOJDYHDC-BZSNNMDCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
83124,6m3m,DB03456,-7.3,N2-[(benzyloxy)carbonyl]-n1-[(3S)-1-cyanopyrrolidin-3-yl]-l-leucinamide,IMTUSTXBVIALBC-SJORKVTESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83112,6m3m,DB03437,-7.3,"2-{1-[2-(2-Amino-Thiazol-4-Yl)-2-Methoxyimino-Acetylamino]-2-Oxo-Ethyl}-5,5-Dimethyl-Thiazolidine-4-Carboxylic Acid",YVNKGXXVZIQNIV-RKMXGKDGSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
101964,6vxs,DB06848,-7.3,"1-(1'-{[3-(methylsulfanyl)-2-benzothiophen-1-yl]carbonyl}spiro[1-benzofuran-3,4'-piperidin]-5-yl)methanamine",VCUDZTCDUDDJGG-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101956,6vxs,DB06836,-7.3,"N-(5-{4-Chloro-3-[(2-hydroxyethyl)sulfamoyl]phenyl}-4-methyl-1,3-thiazol-2-yl)acetamide",JFVNFXCESCXMBC-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
83106,6m3m,DB03428,-7.3,SU9516,QNUKRWAIZMBVCU-WCIBSUBMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
101955,6vxs,DB06835,-7.3,(2S)-2-[3-(AMINOMETHYL)PHENYL]-3-{(S)-HYDROXY[(1R)-2-METHYL-1-{[(2-PHENYLETHYL)SULFONYL]AMINO}PROPYL]PHOSPHORYL}PROPANOIC ACID,CTQDLSDUHUFBQW-LEWJYISDSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
87343,6m3m,DB12190,-7.3,Faropenem,HGGAKXAHAYOLDJ-FHZUQPTBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
105162,6vxs,DB13090,-7.3,Zidebactam,YCZPXRQPDCXTIO-BBBLOLIVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101973,6vxs,DB06860,-7.3,"2-(2-chloropyridin-4-yl)-4-methyl-1H-isoindole-1,3(2H)-dione",YDJMWNHJNJVVMM-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
105867,6vxs,DB14208,-7.3,Ramiprilat,KEDYTOTWMPBSLG-HILJTLORSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
82310,6m3m,DB02380,-7.3,2'-Deoxyinosine,VGONTNSXDCQUGY-RRKCRQDMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
57478,6crv,DB03726,-7.3,Purine Riboside-5'-Monophosphate,MCWDCZIDTUQRHK-FDDDBJFASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106261,6vxs,DB15335,-7.3,Formononetin,HKQYGTCOTHHOMP-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
106268,6vxs,DB15347,-7.3,Branebrutinib,VJPPLCNBDLZIFG-ZDUSSCGKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
100913,6vxs,DB04215,-7.3,CRA_9076,BVTBOJXEAPSOEB-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
81543,6m3m,DB01382,-7.3,Glymidine,QFWPJPIVLCBXFJ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81534,6m3m,DB01355,-7.3,Hexobarbital,UYXAWHWODHRRMR-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
57063,6crv,DB03155,-7.3,"1-(2-Deoxy-2-Fluoro-3-O-Phosphono-Beta-L-Ribofuranosyl)Pyrimidine-2,4(1h,3h)-Dione",IFIXUMAFUNKIAA-XVFCMESISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106280,6vxs,DB15381,-7.3,Menaquinone,HYPYXGZDOYTYDR-HAJWAVTHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
100902,6vxs,DB04202,-7.3,Isoformononetin,LNIQZRIHAMVRJA-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
106285,6vxs,DB15394,-7.3,gamma-Tocopherol,QUEDXNHFTDJVIY-DQCZWYHMSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
11432,6lzg,DB11960,-7.3,Carboxyamidotriazole,WNRZHQBJSXRYJK-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
73037,6m2n,DB01515,-7.3,Benzoylecgonine,GVGYEFKIHJTNQZ-RFQIPJPRSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
88599,6m3m,DB14094,-7.3,Tocopherylquinone,LTVDFSLWFKLJDQ-IEOSBIPESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
24554,6cs2,DB02319,-7.3,"5,6-Dihydroxy-Nadp",LRAVAOPKUBJONV-IVCJQJMGSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
11427,6lzg,DB11950,-7.3,Teneligliptin,WGRQANOPCQRCME-PMACEKPBSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
106301,6vxs,DB15424,-7.3,Bfpet F-18,QWPLCHDPESWJRN-FNNGWQQSSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
57039,6crv,DB03116,-7.3,5-(1-Carboxy-1-Phosphonooxy-Ethoxyl)-Shikimate-3-Phosphate,QUQKBSPZUVNKIF-JQCUSGDOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
24551,6cs2,DB00310,-7.3,Chlorthalidone,JIVPVXMEBJLZRO-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
106322,6vxs,DB01470,-7.3,alpha-methylthiofentanyl,YPOXDUYRRSUFFG-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
81501,6m3m,DB01288,-7.3,Fenoterol,LSLYOANBFKQKPT-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
15314,6lzg,T3D0009,-7.3,Benzo[a]pyrene,FMMWHPNWAFZXNH-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
57084,6crv,DB03183,-7.3,"1-(4-Aminophenyl)-3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester",FIEYZIRYXYDMSK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
15327,6lzg,T3D0871,-7.3,Antimony pentasulfide,OEIXRVAJAKPPBU-ALFHTMLSSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
11452,6lzg,DB11987,-7.3,GSK-2018682,NFIGDBFIDKDNIG-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
24629,6cs2,DB00318,-7.3,Codeine,OROGSEYTTFOCAN-DNJOTXNNSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
88298,6m3m,DB13611,-7.3,Chlormidazole,WNAQOLSMVPFGTE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88308,6m3m,DB13627,-7.3,Oxolinic acid,KYGZCKSPAKDVKC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
101131,6vxs,DB04517,-7.3,Dipyrromethane Cofactor,LCAXMKQKEYTFDM-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
88370,6m3m,DB13709,-7.3,Ciclonicate,GQSGZTBDVNUIQS-DGCLKSJQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
101103,6vxs,DB04480,-7.3,"3-(4-Fluorophenyl)-2-(6-Methylpyridin-2-Yl)-5,6-Dihydro-4h-Pyrrolo[1,2-B]Pyrazole",NBDZLUOYAAVYHF-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
106210,6vxs,DB15235,-7.3,Di-2-pyridylketone 4-cyclohexyl-4-methyl-3-thiosemicarbazone,GNLZNQJBZNOUBM-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
61856,6crv,DB12704,-7.3,Spiradoline,NYKCGQQJNVPOLU-ONTIZHBOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57134,6crv,DB03242,-7.3,P-Aminophenyl-Alpha-D-Galactopyranoside,MIAKOEWBCMPCQR-IIRVCBMXSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61966,6crv,DB12882,-7.3,Ombrabulin,IXWNTLSTOZFSCM-YVACAVLKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27391,6cs2,DB06927,-7.3,[5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-YL]ACETONITRILE,ZKJVCUXZMYKTLT-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
88407,6m3m,DB13757,-7.3,Epanolol,YARKMNAWFIMDKV-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
24604,6cs2,DB02375,-7.3,Myricetin,IKMDFBPHZNJCSN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
61868,6crv,DB12717,-7.3,Mibampator,ULRDYYKSPCRXAJ-KRWDZBQOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81689,6m3m,DB01558,-7.3,Bromazepam,VMIYHDSEFNYJSL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
11469,6lzg,DB12008,-7.3,Prexasertib,DOTGPNHGTYJDEP-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
88425,6m3m,DB13781,-7.3,Xamoterol,DXPOSRCHIDYWHW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88441,6m3m,DB13801,-7.3,Muzolimine,RLWRMIYXDPXIEX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
100943,6vxs,DB04259,-7.3,7n-Methyl-8-Hydroguanosine-5'-Monophosphate,ZMWJGXGSWZFZPJ-KQYNXXCUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
106254,6vxs,DB15324,-7.3,ORM-13070 C-11,VGIYMYGMVXPMKV-GWDMYEQXSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
81710,6m3m,DB01581,-7.3,Sulfamerazine,QPPBRPIAZZHUNT-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88275,6m3m,DB13581,-7.3,Rociverine,XPYLKZZOBVLVHB-QDKIRNHSSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
106369,6vxx,DB00136,-7.3,Calcitriol,GMRQFYUYWCNGIN-NKMMMXOESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
69447,6lxt,DB09206,-7.3,Trimazosin,YNZXWQJZEDLQEG-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
100569,6vxs,DB03768,-7.3,"N-[2-Hydroxy-2-(8-Isopropyl-6,9-Dioxo-2-Oxa-7,10-Diaza-Bicyclo[11.2.2]Heptadeca-1(16),13(17),14-Trien-11-Yl)-Ethyl]-N-(3-Methyl-Butyl)-Benzenesulfonamide,Inhibitor 3",WRUVOSYKHXGAQN-GKRYNVPLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
56892,6crv,DB02921,-7.3,(South)-Methanocarba-Thymidine,XRMLXZVSFIBRRJ-PEFMBERDSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88949,6m3m,DB15161,-7.3,Pittsburgh Compound B,ZQAQXZBSGZUUNL-BJUDXGSMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88966,6m3m,DB15198,-7.3,Dextromethadone,USSIQXCVUWKGNF-KRWDZBQOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81358,6m3m,DB01103,-7.3,Quinacrine,GPKJTRJOBQGKQK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
106518,6vxx,DB00441,-7.3,Gemcitabine,SDUQYLNIPVEERB-QPPQHZFASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
73135,6m2n,DB01627,-7.3,Lincomycin,OJMMVQQUTAEWLP-KIDUDLJLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
89007,6m3m,DB15279,-7.3,CB-103,WHIWGRCYMQLLAO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
24438,6cs2,DB02179,-7.3,O-Trifluoromethylphenyl Anthranilic Acid,ONKHJNFXJDEMNQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
100504,6vxs,DB03687,-7.3,4-Diphosphocytidyl-2-C-Methyl-D-Erythritol,YFAUKWZNPVBCFF-XHIBXCGHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
56867,6crv,DB02890,-7.3,6-Hydroxyuridine-5'-Phosphate,UDOBICLZEKUKCV-YXZULKJRSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81332,6m3m,DB01074,-7.3,Perhexiline,CYXKNKQEMFBLER-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
100501,6vxs,DB03682,-7.3,"Dibenzofuran-4,6-Dicarboxylic Acid",HBBGSNOHAGNQRQ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
89021,6m3m,DB15299,-7.3,AMG-232,DRLCSJFKKILATL-YWCVFVGNSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
106534,6vxx,DB00458,-7.3,Imipramine,BCGWQEUPMDMJNV-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81313,6m3m,DB01054,-7.3,Nitrendipine,PVHUJELLJLJGLN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
11350,6lzg,DB00901,-7.3,Bitolterol,FZGVEKPRDOIXJY-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
100493,6vxs,DB03671,-7.3,"4-(3,12,14-Trihydroxy-10,13-Dimethyl-Hexadecahydro-Cyclopenta[a]Phenanthren-17-Yl)-5h-Furan-2-One",SHIBSTMRCDJXLN-KCZCNTNESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
14968,6lzg,T3D4915,-7.3,gamma-Cyclodextrin,GDSRMADSINPKSL-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
88943,6m3m,DB15147,-7.3,Tinostamustine,GISXTRIGVCKQBX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
73117,6m2n,DB01607,-7.3,Ticarcillin,OHKOGUYZJXTSFX-KZFFXBSXSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
27471,6cs2,DB07017,-7.3,"(5S)-2-{[(1S)-1-(4-fluorophenyl)ethyl]amino}-5-(1-hydroxy-1-methylethyl)-5-methyl-1,3-thiazol-4(5H)-one",HYVZYASDRIAOPU-BJOHPYRUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
24468,6cs2,DB02217,-7.3,Dpb-T,WTZFKHNHHRPQOU-WSMBLCCSSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
81493,6m3m,DB01265,-7.3,Telbivudine,IQFYYKKMVGJFEH-CSMHCCOUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
13008,6lzg,DB14214,-7.3,Rose bengal lactone,IICCLYANAQEHCI-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
81476,6m3m,DB01240,-7.3,Epoprostenol,KAQKFAOMNZTLHT-OZUDYXHBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81475,6m3m,DB01239,-7.3,Chlorprothixene,WSPOMRSOLSGNFJ-AUWJEWJLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88760,6m3m,DB14734,-7.3,Cannabigerol,QXACEHWTBCFNSA-SFQUDFHCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
73068,6m2n,DB01548,-7.3,Diprenorphine,OIJXLIIMXHRJJH-KNLIIKEYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
81459,6m3m,DB01217,-7.3,Anastrozole,YBBLVLTVTVSKRW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
11383,6lzg,DB11893,-7.3,Avagacestat,XEAOPVUAMONVLA-QGZVFWFLSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
100755,6vxs,DB04010,-7.3,2-(3'-Methoxyphenyl) Benzimidazole-4-Carboxamide,NVVWVYYHTKCIAE-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
106406,6vxx,DB00175,-7.3,Pravastatin,TUZYXOIXSAXUGO-PZAWKZKUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88817,6m3m,DB14869,-7.3,Remetinostat,XDZAHHULFQIBFE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
62012,6crv,DB12946,-7.3,"8-cyclopentyl-1,3-dipropylxanthine",FFBDFADSZUINTG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
11382,6lzg,DB11892,-7.3,Prulifloxacin,PWNMXPDKBYZCOO-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
56943,6crv,DB02986,-7.3,"N-(2-Thienylmethyl)-2,5-Thiophenedisulfonamide",STOTVDLYLKWVJB-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106468,6vxx,DB00380,-7.3,Dexrazoxane,BMKDZUISNHGIBY-ZETCQYMHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
100657,6vxs,DB03880,-7.3,Batimastat,XFILPEOLDIKJHX-QYZOEREBSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
88878,6m3m,DB15027,-7.3,Adriforant,ISBHYKVAFKTATD-SNVBAGLBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
69393,6lxt,DB09119,-7.3,Eslicarbazepine acetate,QIALRBLEEWJACW-INIZCTEOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
100613,6vxs,DB03820,-7.3,"(2s,5r,6r)-6-{[(6r)-6-(Glycylamino)-7-Oxido-7-Oxoheptanoyl]Amino}-3,3-Dimethyl-7-Oxo-4-Thia-1-Azabicyclo[3.2.0]Heptane-2-Carboxylate",LDJWRKFRKCXUDO-RBQWDTSBSA-M,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
73104,6m2n,DB01589,-7.3,Quazepam,IKMPWMZBZSAONZ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
100726,6vxs,DB03970,-7.3,"(7R)-7-(6,7-Dihydro-5H-cyclopenta[d]imidazo[2,1-b][1,3]thiazol-2-yl)-2,7-dihydro-1,4-thiazepine-3,6-dicarboxylic acid",CHNMLWCTGYMVFH-GFCCVEGCSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
11498,6lzg,DB12050,-7.3,LY-3039478,YCBAQKQAINQRFW-UGSOOPFHSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
88269,6m3m,DB13573,-7.3,Acefylline,HCYFGRCYSCXKNQ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
101197,6vxs,DB04601,-7.3,"4-[(4-O-SULFAMOYLBENZYL)(4-CYANOPHENYL)AMINO]-4H-[1,2,4]-TRIAZOLE",WEXGHQDVDVWOIU-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
105975,6vxs,DB14718,-7.3,Pyrazolam,BGRWSFIQQPVEML-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
105976,6vxs,DB14720,-7.3,Brovanexine,DQTRREPKGJIABH-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
57378,6crv,DB03588,-7.3,Diphenylacetic Acid,PYHXGXCGESYPCW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72798,6m2n,DB01163,-7.3,Amdinocillin,BWWVAEOLVKTZFQ-NTZNESFSSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
15546,6lzg,DB00180,-7.3,Flunisolide,XSFJVAJPIHIPKU-XWCQMRHXSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
18417,6cs2,HMDB0029191,-7.3,"5'-(3',4'-Dihydroxyphenyl)-gamma-valerolactone sulfate",YAXFVDUJDAQPTJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
105982,6vxs,DB14734,-7.3,Cannabigerol,QXACEHWTBCFNSA-SFQUDFHCSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
105985,6vxs,DB14737,-7.3,Cannabinol,VBGLYOIFKLUMQG-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
87988,6m3m,DB13181,-7.3,Methylbenactyzium,HDAMOICMOAXFLJ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
69777,6lxt,DB11682,-7.3,Daprodustat,RUEYEZADQJCKGV-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
18426,6cs2,HMDB0029228,-7.3,4-Methyl-epicatechin,NLCHNUHNZBPKDF-WLZLGPGOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
57349,6crv,DB03543,-7.3,1-(O-Carboxy-Phenylamino)-1-Deoxy-D-Ribulose-5-Phosphate,AULMJMUNCOBRHC-MXWKQRLJSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
18427,6cs2,HMDB0029231,-7.3,3-Methyl-epicatechin,BBDWMQGDVLQOSW-HZPDHXFCSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
18436,6cs2,HMDB0000667,-7.3,L-Thyronine,KKCIOUWDFWQUBT-AWEZNQCLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
101397,6vxs,DB04866,-7.3,Halofuginone,LVASCWIMLIKXLA-CABCVRRESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
61678,6crv,DB12425,-7.3,Liothyronine I-131,AUYYCJSJGJYCDS-UMVFHIKJSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
82102,6m3m,DB02103,-7.3,2-Chlorodideoxyadenosine,FNLILOONPKMGST-NTSWFWBYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
11597,6lzg,DB12184,-7.3,Gepirone,QOIGKGMMAGJZNZ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
12922,6lzg,DB14038,-7.3,beta-Sitosterol,KZJWDPNRJALLNS-VJSFXXLFSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
61640,6crv,DB12377,-7.3,Relebactam,SMOBCLHAZXOKDQ-ZJUUUORDSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
24763,6cs2,DB02550,-7.3,"8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-2-Fluoro-9-Pent-4-Ylnyl-9h-Purin-6-Ylamine",KCIOVTSUEXGUFJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
11619,6lzg,DB12218,-7.3,AZD-5363,JDUBGYFRJFOXQC-KRWDZBQOSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
72777,6m2n,DB01139,-7.3,Cefapirin,UQLLWWBDSUHNEB-CZUORRHYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
27268,6cs2,DB06781,-7.3,Difluprednate,WYQPLTPSGFELIB-JTQPXKBDSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
15610,6lzg,DB00490,-7.3,Buspirone,QWCRAEMEVRGPNT-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
24790,6cs2,DB02587,-7.3,Colforsin,OHCQJHSOBUTRHG-KGGHGJDLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
105892,6vxs,DB14543,-7.3,Hydrocortisone probutate,FOGXJPFPZOHSQS-AYVLZSQQSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
69838,6lxt,DB11774,-7.3,Pazufloxacin,XAGMUUZPGZWTRP-ZETCQYMHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
61601,6crv,DB12314,-7.3,Chlorproguanil,ISZNZKHCRKXXAU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
105904,6vxs,DB14575,-7.3,Eslicarbazepine,BMPDWHIDQYTSHX-AWEZNQCLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
82288,6m3m,DB02353,-7.3,Heparin Disaccharide Iii-S,GSYQGRODWXMUOO-GYBHJADLSA-K,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
101469,6vxs,DB05095,-7.3,Cimicoxib,KYXDNECMRLFQMZ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
82071,6m3m,DB02066,-7.3,N7-Methyl-Formycin A,JRRNRCMIBCSOIH-LFAOKBQASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
11630,6lzg,DB12229,-7.3,Cerlapirdine,NXQGEDVQXVTCDA-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
82284,6m3m,DB02347,-7.3,2-Amino-3-(5-Tert-Butyl-3-(Phosphonomethoxy)-4-Isoxazolyl)Propionic Acid,AGSOOCUNMTYPSE-ZETCQYMHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
87902,6m3m,DB13030,-7.3,2'-fluoro-5-ethylarabinosyluracil,UIYWFOZZIZEEKJ-PXBUCIJWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
82278,6m3m,DB02339,-7.3,Allyl-{6-[3-(4-Bromo-Phenyl)-Benzofuran-6-Yloxy]-Hexyl-}-Methyl-Amin,JYNZIOFUHBJABQ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
69826,6lxt,DB11757,-7.3,Istradefylline,IQVRBWUUXZMOPW-PKNBQFBNSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
105936,6vxs,DB14650,-7.3,Menadiol diphosphate,JTNHOVZOOVVGHI-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
12899,6lzg,DB13994,-7.3,AZD-7325,KYDURMHFWXCKMW-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
69825,6lxt,DB11755,-7.3,Tetrahydrocannabivarin,ZROLHBHDLIHEMS-HUUCEWRRSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
61624,6crv,DB12353,-7.3,Ulodesine,AFNHHLILYQEHKK-BDAKNGLRSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
87955,6m3m,DB13111,-7.3,Chromanol,SEBPXHSZHLFWRL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
105918,6vxs,DB14631,-7.3,Prednisolone phosphate,JDOZJEUDSLGTLU-VWUMJDOOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101371,6vxs,DB04833,-7.3,Methaqualone,JEYCTXHKTXCGPB-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
82070,6m3m,DB02065,-7.3,4-Deoxylactose,DSYGIMVFFQCOQZ-KYYLAPRMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
101347,6vxs,DB04806,-7.3,(5-BROMO-4-CHLORO-3-INDOLYL)-A-D-MANNOSE,OPIFSICVWOWJMJ-HAAGFXOZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
69685,6lxt,DB11464,-7.3,Sulfaquinoxaline,NHZLNPMOSADWGC-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
61761,6crv,DB12551,-7.3,Idazoxan,HPMRFMKYPGXPEP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27360,6cs2,DB06898,-7.3,"4-(2-amino-1-methyl-1H-imidazo[4,5-b]pyridin-6-yl)phenol",UGJXOCBVCWTJFP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
27361,6cs2,DB06899,-7.3,"N-{2-[6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2,2-DIMETHYL-3-OXO-2,3-DIHYDRO-4H-1,4-BENZOTHIAZIN-4-YL]ETHYL}ACETAMIDE",RMEVNJZCKDVVND-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
15467,6lzg,T3D1034,-7.3,Cypermethrin,KAATUXNTWXVJKI-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
72909,6m2n,DB01333,-7.3,Cefradine,RDLPVSKMFDYCOR-UEKVPHQBSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
106117,6vxs,DB15056,-7.3,Bifenthrin,OMFRMAHOUUJSGP-IRHGGOMRSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
24672,6cs2,DB02450,-7.3,"2-Benzo[1,3]Dioxol-5-Ylmethyl-3-Benzyl-Succinic Acid",ASEJDWRSZYAIOT-GJZGRUSLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
88188,6m3m,DB13460,-7.3,Ronifibrate,AYJVGKWCGIYEAK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
101298,6vxs,DB04740,-7.3,MOXALACTAM (HYDROLYZED),ZTOQXKUYWZBJLG-XNAIMREJSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
57213,6crv,DB03346,-7.3,"3,5,3',5'-Tetrachloro-Biphenyl-4,4'-Diol",YCYDXOVJXVALHY-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
15464,6lzg,T3D1031,-7.3,Cyfluthrin,QQODLKZGRKWIFG-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
57202,6crv,DB03332,-7.3,"5,6-Cyclic-Tetrahydropteridine",XAZOBOCYEGBXHD-GSVOUGTGSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57196,6crv,DB03322,-7.3,Dexpropranolol,AQHHHDLHHXJYJD-CQSZACIVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57190,6crv,DB03314,-7.3,5-fluorotryptophan,INPQIVHQSQUEAJ-VIFPVBQESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
101227,6vxs,DB04640,-7.3,"Naphthalene-2,6-disulfonic acid",FITZJYAVATZPMJ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
81750,6m3m,DB01632,-7.3,5-O-phosphono-alpha-D-ribofuranosyl diphosphate,PQGCEDQWHSBAJP-TXICZTDVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88233,6m3m,DB13524,-7.3,Propyphenazone,PXWLVJLKJGVOKE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
11505,6lzg,DB12059,-7.3,JNJ-40411813,HYOGJHCDLQSAHX-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
106180,6vxs,DB15186,-7.3,GDC-0084,LGWACEZVCMBSKW-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
11521,6lzg,DB12082,-7.3,Vesnarinone,ZVNYJIZDIRKMBF-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
70370,6lxt,DB12545,-7.3,Indobufen,AYDXAULLCROVIT-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
18499,6cs2,HMDB0030669,-7.3,3-O-Feruloylquinic acid,ZHBZPCLRULAFBL-HYXAFXHYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
81959,6m3m,DB01920,-7.3,1-O-[O-Nitrophenyl]-Beta-D-Galactopyranose,KUWPCJHYPSUOFW-YBXAARCKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
27322,6cs2,DB06858,-7.3,N-cyclooctylglycyl-N-(4-carbamimidoylbenzyl)-L-prolinamide,MMLOIDMSBRJZAE-FQEVSTJZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
106038,6vxs,DB14867,-7.3,Parsaclisib,ZQPDJCIXJHUERQ-QWRGUYRKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
88059,6m3m,DB13294,-7.3,Azidamfenicol,SGRUZFCHLOFYHZ-MWLCHTKSSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88060,6m3m,DB13296,-7.3,Propamidine,WTFXJFJYEJZMFO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
61711,6crv,DB12473,-7.3,Taurolidine,AJKIRUJIDFJUKJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57290,6crv,DB03456,-7.3,N2-[(benzyloxy)carbonyl]-n1-[(3S)-1-cyanopyrrolidin-3-yl]-l-leucinamide,IMTUSTXBVIALBC-SJORKVTESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72857,6m2n,DB01231,-7.3,Diphenidol,OGAKLTJNUQRZJU-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
69740,6lxt,DB11619,-7.3,Gestrinone,BJJXHLWLUDYTGC-ANULTFPQSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
88078,6m3m,DB13318,-7.3,Demecolcine,NNJPGOLRFBJNIW-HNNXBMFYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88159,6m3m,DB13421,-7.3,Edoxudine,XACKNLSZYYIACO-DJLDLDEBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
101340,6vxs,DB04796,-7.3,Inecalcitol,HHGRMHMXKPQNGF-WNSNRMDMSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
106071,6vxs,DB14932,-7.3,Coleneuramide,CHMRTBYTCBDIRG-JQZMMWJVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
69723,6lxt,DB11561,-7.3,Aminacrine,XJGFWWJLMVZSIG-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
88111,6m3m,DB13356,-7.3,Mesulfen,AHXDSVSZEZHDLV-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
61727,6crv,DB12499,-7.3,Clascoterone,GPNHMOZDMYNCPO-PDUMRIMRSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88145,6m3m,DB13405,-7.3,Mefruside,SMNOERSLNYGGOU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
101315,6vxs,DB04763,-7.3,"1-N-(4-SULFAMOYLPHENYL-ETHYL)-2,4,6-TRIMETHYLPYRIDINIUM",UXBCHTZINZNVRG-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
106082,6vxs,DB14945,-7.3,Florbenazine F-18,GNKGXQHHUUEYQV-WTHAECTESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
11564,6lzg,DB12135,-7.3,Elubrixin,YQYFEGTYCUQBEI-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
57259,6crv,DB03410,-7.3,4-hydroxycoumarin,VXIXUWQIVKSKSA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57277,6crv,DB03435,-7.3,Uridine-5'-Diphosphate,XCCTYIAWTASOJW-XVFCMESISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
102204,6vxs,DB07127,-7.3,"{4-[2,2-BIS(5-METHYL-1,2,4-OXADIAZOL-3-YL)-3-PHENYLPROPYL]PHENYL}SULFAMIC ACID",SXDBFKLPNPUPRI-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
26958,6cs2,DB06150,-7.3,Sulfadimethoxine,ZZORFUFYDOWNEF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
86966,6m3m,DB11629,-7.3,Laropiprant,NXFFJDQHYLNEJK-CYBMUJFWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
71102,6lxt,DB13649,-7.3,Proquazone,JTIGKVIOEQASGT-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
103287,6vxs,DB08398,-7.3,"2-Amino-1-methyl-6-phenylimidazo(4,5-b)pyridine",UQVKZNNCIHJZLS-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
103283,6vxs,DB08393,-7.3,"2-[(5,6-DIPHENYLFURO[2,3-D]PYRIMIDIN-4-YL)AMINO]ETHANOL",UQHINZSKNAAVOZ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
59982,6crv,DB08098,-7.3,"{[5-(5-nitro-2-furyl)-1,3,4-oxadiazol-2-yl]thio}acetic acid",ITBNJCVIFHSKRL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
71062,6lxt,DB13596,-7.3,Oxycinchophen,XAPRFLSJBSXESP-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
25773,6cs2,DB03781,-7.3,"2-[4-(2,4-Dichlorophenoxy)Phenoxy]Propanoic Acid",OOLBCHYXZDXLDS-SECBINFHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
84831,6m3m,DB06951,-7.3,(3R)-3-ethyl-N-[(4-methylphenyl)sulfonyl]-L-aspartic acid,KPHLTCNXHCHMOW-MNOVXSKESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
71632,6lxt,DB14938,-7.3,Flurbiprofen axetil,ALIVXCSEERJYHU-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
17428,6cs2,HMDB0007349,-7.3,"DG(18:4(6Z,9Z,12Z,15Z)/22:2(13Z,16Z)/0:0)",FUDGZBMOORLTCG-FCDTXGFCSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
104212,6vxs,DB11671,-7.3,AZD-4877,SMFXSYMLJDHGIE-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
85900,6m3m,DB08188,-7.3,Emivirine,MLILORUFDVLTSP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
104220,6vxs,DB11681,-7.3,Tofimilast,DHCOPPHTVOXDKU-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
60016,6crv,DB08134,-7.3,4-[(6-chloropyrazin-2-yl)amino]benzenesulfonamide,RSNSGNZRUMHXAY-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
71646,6lxt,DB14998,-7.3,Olorinab,ACSQLTBPYZSGBA-GMXVVIOVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
71039,6lxt,DB13558,-7.3,Morclofone,KVCJCEKJKGLBOK-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
85918,6m3m,DB08212,-7.3,1-[2-(3-ACETYL-2-HYDROXY-6-METHOXY-PHENYL)-CYCLOPROPYL]-3-(5-CYANO-PYRIDIN-2-YL)-THIOUREA,FSRLCMRWYUJTNT-UONOGXRCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
12174,6lzg,DB12988,-7.3,LY-518674,PNHFDVSKDSLUFH-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
25745,6cs2,DB03753,-7.3,Flurbiprofen Methyl Ester,CPJBKHZROFMSQM-NSHDSACASA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
12171,6lzg,DB12986,-7.3,VS-5584,QYBGBLQCOOISAR-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
103322,6vxs,DB08442,-7.3,"4-{[(2R)-2-(2-methylphenyl)pyrrolidin-1-yl]carbonyl}benzene-1,3-diol",TWODFUZHWYZBHZ-MRXNPFEDSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
85819,6m3m,DB08100,-7.3,"2,6-dimethyl-4-[(E)-2-phenylethenyl]phenol",PAHKYLUYTGBFNW-CMDGGOBGSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
71105,6lxt,DB13653,-7.3,Lorcainide,XHOJAWVAWFHGHL-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
85817,6m3m,DB08098,-7.3,"{[5-(5-nitro-2-furyl)-1,3,4-oxadiazol-2-yl]thio}acetic acid",ITBNJCVIFHSKRL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
16893,6cs2,HMDB0005010,-7.3,Sertraline,VGKDLMBJGBXTGI-SJCJKPOMSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
16892,6cs2,HMDB0005007,-7.3,Simvastatin,RYMZZMVNJRMUDD-HGQWONQESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
26246,6cs2,DB00498,-7.3,Phenindione,NFBAXHOPROOJAW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
25830,6cs2,DB03844,-7.3,"N-(2,6-Diflouro-Benzyl)-4-Sulfamoyl-Benzamide",ZFNCKGXGCCDDFN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
25827,6cs2,DB03841,-7.3,Y-700,AETHRPHBGJAIBT-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
25826,6cs2,DB00451,-7.3,Levothyroxine,XUIIKFGFIJCVMT-LBPRGKRZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
71139,6lxt,DB13692,-7.3,Tretoquinol,RGVPOXRFEPSFGH-AWEZNQCLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
71569,6lxt,DB14801,-7.3,Lanifibranor,OQDQIFQRNZIEEJ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
104141,6vxs,DB11490,-7.3,Nalorphine,UIQMVEYFGZJHCZ-SSTWWWIQSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
85950,6m3m,DB08254,-7.3,2-NAPHTHALENESULFONIC ACID,KVBGVZZKJNLNJU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84960,6m3m,DB07104,-7.3,4-amino-N-[4-(benzyloxy)phenyl]butanamide,QTWBKNVNGVYTNZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59244,6crv,DB07242,-7.3,"(4R)-7,8-dichloro-1',9-dimethyl-1-oxo-1,2,4,9-tetrahydrospiro[beta-carboline-3,4'-piperidine]-4-carbonitrile",XGUIMGJMQKZRGM-LLVKDONJSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59242,6crv,DB07239,-7.3,7-(aminomethyl)-6-(2-chlorophenyl)-1-methyl-1H-benzimidazole-5-carbonitrile,YJLVMTVZVJSNHG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85767,6m3m,DB08038,-7.3,"L-alanyl-N-[(1S,2R)-1-benzyl-2-hydroxypropyl]-L-alaninamide",CPAOOGAUUDSJCS-FMSGJZPZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
25813,6cs2,DB03823,-7.3,Epigallocatechin,XMOCLSLCDHWDHP-IUODEOHRSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
71589,6lxt,DB14857,-7.3,Avadomide,RSNPAKAFCAAMBH-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
103341,6vxs,DB08464,-7.3,"METHYL 3-CHLORO-2-{3-[(2,5-DIHYDROXY-4-METHOXYPHENYL)AMINO]-3-OXOPROPYL}-4,6-DIHYDROXYBENZOATE",GUVWEHNRWHNDRF-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
12205,6lzg,DB13032,-7.3,Enecadin,SZSHJTJCJOWMHM-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
104166,6vxs,DB11560,-7.3,Lesinurad,FGQFOYHRJSUHMR-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
103334,6vxs,DB08457,-7.3,"4-(3,5-DIMETHYLPHENOXY)-5-(FURAN-2-YLMETHYLSULFANYLMETHYL)-3-IODO-6-METHYLPYRIDIN-2(1H)-ONE",YZLKVEDFWLGNQP-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
84956,6m3m,DB07099,-7.3,N-[4-(benzyloxy)phenyl]glycinamide,YJPUATSIKWOSST-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
104122,6vxs,DB11455,-7.3,Robenacoxib,ZEXGDYFACFXQPF-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104249,6vxs,DB11726,-7.3,Encenicline,SSRDSYXGYPJKRR-ZDUSSCGKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
25737,6cs2,DB00443,-7.3,Betamethasone,UREBDLICKHMUKA-DVTGEIKXSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
12109,6lzg,DB12896,-7.3,PSI-352938,PVRFQJIRERYGTQ-DSQUMVBZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
104364,6vxs,DB11893,-7.3,Avagacestat,XEAOPVUAMONVLA-QGZVFWFLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
60167,6crv,DB08319,-7.3,"2'-HYDROXY-1,1'-BIPHENYL-2-SULFINIC ACID",HPKSNFTYZHYEKV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
103091,6vxs,DB08153,-7.3,"(5E)-14-CHLORO-15,17-DIHYDROXY-4,7,8,9,10,11-HEXAHYDRO-2-BENZOXACYCLOPENTADECINE-1,12(3H,13H)-DIONE",VZTAZMSAAIUZJV-HWKANZROSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
103080,6vxs,DB08142,-7.3,AT-7519,OVPNQJVDAFNBDN-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
59017,6crv,DB06981,-7.3,(2S)-2-(1H-indol-3-yl)pentanoic acid,QRCBLBWFQJDFJQ-JTQLQIEISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
103047,6vxs,DB08106,-7.3,N-[(6-butoxynaphthalen-2-yl)sulfonyl]-D-glutamic acid,UAGYXJBYAFGRFR-QGZVFWFLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
59012,6crv,DB06973,-7.3,"4,4'-PROPANE-2,2-DIYLDIPHENOL",IISBACLAFKSPIT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60210,6crv,DB08372,-7.3,1-[2-(4-ETHOXY-3-FLUOROPYRIDIN-2-YL)ETHYL]-3-(5-METHYLPYRIDIN-2-YL)THIOUREA,QOVMZMFNTIUFLU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
103040,6vxs,DB08099,-7.3,"6-ethyl-5-[(2S)-1-(3-methoxypropyl)-2-phenyl-1,2,3,4-tetrahydroquinolin-7-yl]pyrimidine-2,4-diamine",UOYVKYJWAXJTTE-NRFANRHFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
70899,6lxt,DB13368,-7.3,Motretinide,IYIYMCASGKQOCZ-DJRRULDNSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
86159,6m3m,DB08511,-7.3,"6-amino-2-methyl-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",PLJNUNPYZVVIRA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
104390,6vxs,DB11933,-7.3,Riboprine,USVMJSALORZVDV-SDBHATRESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
103031,6vxs,DB08089,-7.3,LGD-2226,ULBPQWIGZUGPHU-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
60227,6crv,DB08394,-7.3,PARA-NITROPHENYLPHOSPHONOBUTANOYL-GLYCINE,WLNKGRQBMNPVSJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84478,6m3m,DB06258,-7.3,Bimoclomol,NMOVJBAGBXIKCG-VKAVYKQESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84452,6m3m,DB06203,-7.3,Alogliptin,ZSBOMTDTBDDKMP-OAHLLOKOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84450,6m3m,DB06201,-7.3,Rufinamide,POGQSBRIGCQNEG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
60239,6crv,DB08409,-7.3,4-NITRO-BENZYLPHOSPHONOBUTANOYL-GLYCINE,LNMNPGKCSJFAGN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60162,6crv,DB08314,-7.3,"(2-AMINO-1,3-OXAZOL-5-YL)-(3-BROMOPHENYL)METHANONE",YDCMMVTWXORJGO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
70945,6lxt,DB13432,-7.3,Lonazolac,XVUQHFRQHBLHQD-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
16712,6cs2,HMDB0003733,-7.3,Resolvin D1,OIWTWACQMDFHJG-NJIQAZPPSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
12116,6lzg,DB12904,-7.3,ZSTK-474,HGVNLRPZOWWDKD-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
84698,6m3m,DB06774,-7.3,Capsaicin,YKPUWZUDDOIDPM-SOFGYWHQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
25731,6cs2,DB03737,-7.3,"4-((3r,4s,5r)-4-Amino-3,5-Dihydroxy-Hex-1-Ynyl)-5-Fluoro-3-[1-(3-Methoxy-1h-Pyrrol-2-Yl)-Meth-(Z)-Ylidene]-1,3-Dihydro-Indol-2-One",RAKYKJWUUUKCCW-MPLBGYFPSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
84669,6m3m,DB06726,-7.3,Bufuralol,SSEBTPPFLLCUMN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
60061,6crv,DB08182,-7.3,"4-(4-propoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine",ZHMRPXZRUZLCNL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
71000,6lxt,DB13507,-7.3,Poldine,CQRKVVAGMJJJSR-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
85980,6m3m,DB08295,-7.3,4-HYDROXY-3-NITROPHENYLACETYL-EPSILON-AMINOCAPROIC ACID ANION,XAYGJFACOIKJCT-UHFFFAOYSA-M,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
60076,6crv,DB08202,-7.3,4-({[(4-METHYLPIPERAZIN-1-YL)AMINO]CARBONOTHIOYL}AMINO)BENZENESULFONAMIDE,BPPLIZHQOIGRPZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
70996,6lxt,DB13502,-7.3,Budipine,QIHLUZAFSSMXHQ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
85981,6m3m,DB08296,-7.3,5-(PARA-NITROPHENYL PHOSPHONATE)-PENTANOIC ACID,XVVZSEXTAACTPS-UHFFFAOYSA-M,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
104250,6vxs,DB11729,-7.3,GSK-2330672,CZGVOBIGEBDYTP-VSGBNLITSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
59100,6crv,DB07073,-7.3,"5,5-dimethyl-2-morpholin-4-yl-5,6-dihydro-1,3-benzothiazol-7(4H)-one",DZXMARZBAUMWLK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59087,6crv,DB07057,-7.3,(3S)-1-(2-hydroxyphenyl)-5-oxopyrrolidine-3-carboxylic acid,FPQOSKXLHCTVED-ZETCQYMHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85995,6m3m,DB08312,-7.3,"6-CYCLOHEXYLMETHYLOXY-5-NITROSO-PYRIMIDINE-2,4-DIAMINE",DGWXOLHKVGDQLN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
12418,6lzg,DB13347,-7.3,Diphenadione,JYGLAHSAISAEAL-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
59069,6crv,DB07038,-7.3,2-(cyclohexylamino)benzoic acid,JSXMFCCPQQJLCR-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104327,6vxs,DB11833,-7.3,Basimglurant,UPZWINBEAHDTLA-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104331,6vxs,DB11843,-7.3,PF-04958242,TTYKUKSFWHEBLI-DLBZAZTESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
25691,6cs2,DB03691,-7.3,WRR-112,KVZMXOVSHIMGNA-HOTGVXAUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
59050,6crv,DB07018,-7.3,5-ETHYL-3-[(2-METHOXYETHYL)METHYLAMINO]-6-METHYL-4-(3-METHYLBENZYL)PYRIDIN-2(1H)-ONE,USWKTQVAABDFSY-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
103128,6vxs,DB08195,-7.3,(1R)-2-[(CYANOMETHYL)AMINO]-1-({[2-(DIFLUOROMETHOXY)BENZYL]SULFONYL}METHYL)-2-OXOETHYL MORPHOLINE-4-CARBOXYLATE,YKWHKILAGONYKL-HNNXBMFYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104291,6vxs,DB11787,-7.3,Ralimetinib,XPPBBJCBDOEXDN-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
22302,6cs2,HMDB0053581,-7.3,"TG(20:2n6/18:4(6Z,9Z,12Z,15Z)/22:5(4Z,7Z,10Z,13Z,16Z))",XQBXFBYULTYXBQ-RJJLYDRESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
103378,6vxs,DB08507,-7.3,N-[[2-METHYL-4-HYDROXYCARBAMOYL]BUT-4-YL-N]-BENZYL-P-[PHENYL]-P-[METHYL]PHOSPHINAMID,KGUVBHLPMGERAT-NIYFSFCBSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
59272,6crv,DB07273,-7.3,1-[(2-AMINO-4-CHLORO-5-METHYLPHENYL)SULFONYL]-L-PROLINE,OWYKAFABUYXQLE-JTQLQIEISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
17133,6cs2,HMDB0006580,-7.3,Lacto-N-difucohexaose,PSJVAGXZRSPYJB-UUXGNFCPSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
59489,6crv,DB07525,-7.3,"3-(3-methoxybenzyl)-1H-pyrrolo[2,3-b]pyridine",GHQCCHWTDLTMJT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
71424,6lxt,DB14209,-7.3,Trandolaprilat,AHYHTSYNOHNUSH-HXFGRODQSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
17141,6cs2,HMDB0006602,-7.3,Lacto-N-hexaose,ZDZMLVPSYYRJNI-VHFVHBOSSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
59666,6crv,DB07736,-7.3,(2S)-4-(4-fluorobenzyl)-N-(2-sulfanylethyl)piperazine-2-carboxamide,CEXXKSSFAKABEN-ZDUSSCGKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85496,6m3m,DB07730,-7.3,"5-(3-HYDROXYPHENYL)ISOTHIAZOL-3(2H)-ONE 1,1-DIOXIDE",FJABEDRGNJSWCC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85264,6m3m,DB07452,-7.3,"2,6-diamino-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",WFECBOHPSURSGU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59673,6crv,DB07745,-7.3,2-{[4-(TRIFLUOROMETHOXY)BENZOYL]AMINO}ETHYL DIHYDROGEN PHOSPHATE,YAHFSBJEYPSDPU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59677,6crv,DB07749,-7.3,2-ACETYLAMINO-4-METHYL-PENTANOIC ACID (1-FORMYL-2-PHENYL-ETHYL)-AMIDE,QRDDFQYJOFVDNR-HOTGVXAUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
71433,6lxt,DB14232,-7.3,Deacetylbisacodyl,LJROKJGQSPMTKB-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
85252,6m3m,DB07437,-7.3,"1-((2-HYDROXYETHOXY)METHYL)-5-BENZYLPYRIMIDINE-2,4(1H,3H)-DIONE",SPJAGILXQBHHSZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
26111,6cs2,DB04177,-7.3,"4-(3,14-Dihydroxy-10,13-Dimethyl-Hexadecahydro-Cyclopenta[a]Phenanthren-17-Yl)-5h-Furan-2-One",XZTUSOXSLKTKJQ-CESUGQOBSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
103595,6vxs,DB08763,-7.3,[N-(BENZYLOXYCARBONYL)AMINO](4-AMIDINOPHENYL)METHANE-PHOSPHONATE,FSNDLCSOLUMYRH-OAHLLOKOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
71293,6lxt,DB13939,-7.3,RAD-140,XMBUPPIEVAFYHO-KPZWWZAWSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
59463,6crv,DB07492,-7.3,Bromamphenicol,UWOHGNMWBGIRAQ-RKDXNWHRSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
103860,6vxs,DB09174,-7.3,Lofentanil,IMYHGORQCPYVBZ-NLFFAJNJSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
85231,6m3m,DB07413,-7.3,5'-S-[2-(decylamino)ethyl]-5'-thioadenosine,CJIJFWHOTNCRDA-WGQQHEPDSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
25965,6cs2,DB04005,-7.3,Uridine 5'-triphosphate,PGAVKCOVUIYSFO-XVFCMESISA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
85508,6m3m,DB07745,-7.3,2-{[4-(TRIFLUOROMETHOXY)BENZOYL]AMINO}ETHYL DIHYDROGEN PHOSPHATE,YAHFSBJEYPSDPU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
17129,6cs2,HMDB0000244,-7.3,Riboflavin,AUNGANRZJHBGPY-SCRDCRAPSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
85285,6m3m,DB07478,-7.3,"1,1'-BIPHENYL-3,4-DIOL",QDNPCYCBQFHNJC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
71303,6lxt,DB13952,-7.3,Estradiol acetate,FHXBMXJMKMWVRG-SLHNCBLASA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
85288,6m3m,DB07481,-7.3,"tert-butyl [(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)methyl]carbamate",RXVQMCMIOHBKNE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
103727,6vxs,DB08957,-7.3,Hexoprenaline,OXLZNBCNGJWPRV-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
59583,6crv,DB07635,-7.3,bis(4-hydroxyphenyl)methanone,RXNYJUSEXLAVNQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59602,6crv,DB07661,-7.3,"1,6-DIHYDROXY NAPHTHALENE",FZZQNEVOYIYFPF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
103740,6vxs,DB08972,-7.3,Flumequine,DPSPPJIUMHPXMA-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
103747,6vxs,DB08981,-7.3,Fenbufen,ZPAKPRAICRBAOD-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
59611,6crv,DB07671,-7.3,"2-[1-METHYLHEXYL]-4,6-DINITROPHENOL",RROCMCBQTUYDSD-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85418,6m3m,DB07635,-7.3,bis(4-hydroxyphenyl)methanone,RXNYJUSEXLAVNQ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
71337,6lxt,DB14025,-7.3,Clinafloxacin,QGPKADBNRMWEQR-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
103693,6vxs,DB08906,-7.3,Fluticasone furoate,XTULMSXFIHGYFS-VLSRWLAYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
26136,6cs2,DB04206,-7.3,Nz2-Tryptophan,SNLOIIPRZGMRAB-QMMMGPOBSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
12276,6lzg,DB13135,-7.3,AGN-201904,PPCGSVWOZKNPCX-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
71390,6lxt,DB14127,-7.3,Sacubitrilat,DOBNVUFHFMVMDB-BEFAXECRSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
85317,6m3m,DB07516,-7.3,"(2Z,4E)-3-chloro-2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoic acid",IBJDCVXDXGFGIO-FKTQTOOFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
71318,6lxt,DB13983,-7.3,"5,7,2'-trihydroxy-6,8-dimethoxyflavone",JWOKGWICZPPYPX-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
103631,6vxs,DB08804,-7.3,Nandrolone decanoate,JKWKMORAXJQQSR-MOPIKTETSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
25999,6cs2,DB00472,-7.3,Fluoxetine,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
17127,6cs2,HMDB0006566,-7.3,Lacto-N-tetraose,RBMYDHMFFAVMMM-PLQWBNBWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
103622,6vxs,DB08795,-7.3,Azidocillin,ODFHGIPNGIAMDK-NJBDSQKTSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
71308,6lxt,DB13957,-7.3,J147,HYMZAYGFKNNHDN-SSDVNMTOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
71307,6lxt,DB13956,-7.3,Estradiol valerate,RSEPBGGWRJCQGY-RBRWEJTLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
17034,6cs2,HMDB0005801,-7.3,Kaempferol,IYRMWMYZSQPJKC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
59429,6crv,DB07452,-7.3,"2,6-diamino-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",WFECBOHPSURSGU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
103583,6vxs,DB08750,-7.3,"1-[4-(AMINOMETHYL)BENZOYL]-5'-FLUORO-1'H-SPIRO[PIPERIDINE-4,2'-QUINAZOLIN]-4'-AMINE",SFPCNWQWKOUNRT-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
25958,6cs2,DB00468,-7.3,Quinine,LOUPRKONTZGTKE-WZBLMQSHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
103464,6vxs,DB08610,-7.3,N-(2-AMINOETHYL)-2-{3-CHLORO-4-[(4-ISOPROPYLBENZYL)OXY]PHENYL} ACETAMIDE,DFXJYVQAAFOZDP-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
22312,6cs2,HMDB0053598,-7.3,"TG(20:2n6/20:4(8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z))",DQGFYDHZNGKRQX-ZZYVAGOISA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
71531,6lxt,DB14718,-7.3,Pyrazolam,BGRWSFIQQPVEML-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
103448,6vxs,DB08591,-7.3,"5-(4-METHOXYBIPHENYL-3-YL)-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDE",IGXKSKWHHHYBFM-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
103447,6vxs,DB08590,-7.3,1-(3-HYDROXYPROPYL)-2-[(3-NITROBENZOYL)AMINO]-1H-BENZIMIDAZOL-5-YL PIVALATE,CEAYRKIZESVQSN-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
25876,6cs2,DB03899,-7.3,9-Butyl-8-(4-Methoxybenzyl)-9h-Purin-6-Amine,NVYATAJRTRFKSW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
103441,6vxs,DB08581,-7.3,"4-[(4-bromo-2-{[(3R,5S)-3,5-dimethylpiperidin-1-yl]carbonyl}phenyl)amino]-4-oxobutanoic acid",JSVSGWHGYIDZFX-TXEJJXNPSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
12343,6lzg,DB13252,-7.3,Tropatepine,JOQKFRLFXDPXHX-HDICACEKSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
16918,6cs2,HMDB0005095,-7.3,11-trans-Leukotriene C4,GWNVDXQDILPJIG-CCHJCNDSSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
71209,6lxt,DB13788,-7.3,Chlorbenzoxamine,VEVSKUJZSMGTMM-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
16915,6cs2,HMDB0005084,-7.3,N-Acetyl-leukotriene E4,BGGYAYMMFYBWEX-KDFQUNDDSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
85691,6m3m,DB07956,-7.3,[1-(3-CHLORO-2-FORMYL-PHENYLCARBAMOYL)-2-METHYL-PROPYL]-CARBAMIC ACID TERT-BUTYL ESTER,GBHYPZDGTWSQFR-AWEZNQCLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
104081,6vxs,DB11380,-7.3,Cambendazole,QZWHWHNCPFEXLL-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104090,6vxs,DB11395,-7.3,Deracoxib,WAZQAZKAZLXFMK-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104104,6vxs,DB11425,-7.3,Luprostiol,KFUDFIMHDRJVLV-OZCLATTGSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
103413,6vxs,DB08547,-7.3,PROGESTERONE-11-ALPHA-OL-HEMISUCCINATE,JBBNFGYRYNBDIH-DBGGZKJISA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
59279,6crv,DB07281,-7.3,"N-3-BENZYLPYRIDINE-2,3-DIAMINE",MUKAGFLFIMVSQN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
103404,6vxs,DB08537,-7.3,"3-bromo-6-phenyl-N-(pyrimidin-5-ylmethyl)imidazo[1,2-a]pyridin-8-amine",LZLKFNBMXXLTLX-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
59277,6crv,DB07279,-7.3,N-ETHYL-N-ISOPROPYL-3-METHYL-5-{[(2S)-2-(PYRIDIN-4-YLAMINO)PROPYL]OXY}BENZAMIDE,JMPSZYHYDMQFEO-KRWDZBQOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
103399,6vxs,DB08532,-7.3,"6-(2-fluorophenyl)-N-(pyridin-3-ylmethyl)imidazo[1,2-a]pyrazin-8-amine",WCNPGRRMPFCHEO-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
85022,6m3m,DB07173,-7.3,"7-(5-DEOXY-BETA-D-RIBOFURANOSYL)-5-IODO-7H-PYRROLO[2,3-D]PYRIMIDIN-4-AMINE",NTXUAWGNGBSCRS-TZQXKBMNSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
70868,6lxt,DB13333,-7.3,Efloxate,ZVXBAHLOGZCFTP-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
71210,6lxt,DB13790,-7.3,Fipexide,BFUJHVVEMMWLHC-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
71220,6lxt,DB13803,-7.3,Xipamide,MTZBBNMLMNBNJL-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
85208,6m3m,DB07388,-7.3,ETHYL 4-[(4-METHYLPYRIDIN-2-YL)AMINO]PIPERIDINE-1-CARBOXYLATE,LNRMJBWADUSJTA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
103898,6vxs,DB09214,-7.3,Dexketoprofen,DKYWVDODHFEZIM-NSHDSACASA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
59408,6crv,DB07428,-7.3,4-[(5-methoxy-2-methylphenoxy)methyl]pyridine,MBHBRRBLXCXQKV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
103560,6vxs,DB08727,-7.3,"3-Methyl-5-(7-{4-[(4R)-4-methyl-4,5-dihydro-1,3-oxazol-2-yl]phenoxy}heptyl)-1,2-oxazole",NEAZMARKCJKUMF-QGZVFWFLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
71478,6lxt,DB14635,-7.3,Curcumin sulfate,NEJVQQBBTRFOHB-FCXRPNKRSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
85192,6m3m,DB07366,-7.3,2-[N'-(4-AMINO-BUTYL)-HYDRAZINOCARBONYL]-PYRROLIDINE-1-CARBOXYLIC ACID BENZYL ESTER,MOCIXHUQBOUBAK-HNNXBMFYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
103557,6vxs,DB08724,-7.3,5-(5-(4-(5-hydro-4-methyl-2-oxazolyl)phenoxy)pentyl)-3-methyl isoxazole,UXIYKMARWUSIKU-HNNXBMFYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
71484,6lxt,DB14641,-7.3,Estriol tripropionate,ONMZMZJEZHMWQL-REUUDLSRSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
103939,6vxs,DB09272,-7.3,Eluxadoline,QFNHIDANIVGXPE-FNZWTVRRSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
85615,6m3m,DB07864,-7.3,4-[(CYCLOPROPYLETHYNYL)OXY]-6-FLUORO-3-ISOPROPYLQUINOLIN-2(1H)-ONE,YVJFHKQYMKKIHK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
103548,6vxs,DB08714,-7.3,"2,6-DIMETHYL-1-(3-[3-METHYL-5-ISOXAZOLYL]-PROPANYL)-4-[4-METHYL-2H-TETRAZOL-2-YL]-PHENOL",DRCNRTRGWUYJBH-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
103956,6vxs,DB09299,-7.3,Tenofovir alafenamide,LDEKQSIMHVQZJK-CAQYMETFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
85140,6m3m,DB07308,-7.3,5-(2-CHLOROBENZYL)-2-FUROIC ACID,YRUPEIZURHOLHV-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
103512,6vxs,DB08670,-7.3,"METHYL N-[(2S,3R)-3-AMINO-2-HYDROXY-3-(4-ISOPROPYLPHENYL)PROPANOYL]-D-ALANYL-D-LEUCINATE",WIWZNHHLFMPGGO-PIKADFDJSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
103507,6vxs,DB08662,-7.3,3-[1-(4-BROMO-PHENYL)-2-METHYL-PROPYL]-4-HYDROXY-CHROMEN-2-ONE,KGDWLSFLMSFPSU-INIZCTEOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
12229,6lzg,DB13066,-7.3,Liarozole,UGFHIPBXIWJXNA-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
103977,6vxs,DB09355,-7.3,Sulfabenzamide,PBCZLFBEBARBBI-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
103981,6vxs,DB09378,-7.3,Fluprednisolone,MYYIMZRZXIQBGI-HVIRSNARSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
103986,6vxs,DB09421,-7.3,Protirelin,XNSAINXGIQZQOO-SRVKXCTJSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
25896,6cs2,DB03924,-7.3,"5,8-Di-Amino-1,4-Dihydroxy-Anthraquinone",QVEMRPAUHFWHRV-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
103947,6vxs,DB09285,-7.3,Morniflumate,LDXSPUSKBDTEKA-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
14967,6lzg,T3D4914,-7.3,Fd&c red no. 3,IINNWAYUJNWZRM-UHFFFAOYSA-L,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
70855,6lxt,DB13317,-7.3,Flunoxaprofen,ARPYQKTVRGFPIS-VIFPVBQESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
86217,6m3m,DB08579,-7.3,"4-bromo-2-{[(3R,5S)-3,5-dimethylpiperidin-1-yl]carbonyl}aniline",IUPOWBZLJSPZFT-AOOOYVTPSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
11938,6lzg,DB12645,-7.3,Givinostat,YALNUENQHAQXEA-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
102516,6vxs,DB07488,-7.3,"{(2Z)-4-AMINO-2-[(4-METHOXYPHENYL)IMINO]-2,3-DIHYDRO-1,3-THIAZOL-5-YL}(4-METHOXYPHENYL)METHANONE",XQKUGFIWKSKCDL-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
58529,6crv,DB05772,-7.3,Rabeximod,PDNNUMNEXITLCZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
102513,6vxs,DB07485,-7.3,"4,4'-cyclohexane-1,1-diyldiphenol",SDDLEVPIDBLVHC-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
60675,6crv,DB08964,-7.3,Gemeprost,KYBOHGVERHWSSV-VNIVIJDLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
16404,6lzg,DB04099,-7.3,Deamido-Nad+,SENPVEZBRZQVST-HISDBWNOSA-O,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
25358,6cs2,DB03262,-7.3,"Al-6619, [2h-Thieno[3,2-E]-1,2-Thiazine-6-Sulfonamide,2-(3-Hydroxyphenyl)-3-(4-Morpholinyl)-, 1,1-Dioxide]",PZLYYZPXSSNGJS-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
83820,6m3m,DB04396,-7.3,Thiodigalactoside,SYKYBMOFPMXDRQ-ZFDCCPEWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
16394,6lzg,DB04073,-7.3,N-{3-[4-(3-aminopropyl)piperazin-1-yl]propyl}-3-(beta-D-galactopyranosyloxy)-5-nitrobenzamide,UEIGEWJJVQHIAX-DLBZZEGUSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
58520,6crv,DB05683,-7.3,Iodofiltic acid I-123,NPCIWINHUDIWAV-NSYCNWAXSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58519,6crv,DB05680,-7.3,Sotirimod,ZXBCLVSLRUWISJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104747,6vxs,DB12441,-7.3,Tavilermide,DVJXNXPFYJIACK-ULQDDVLXSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
26786,6cs2,DB05223,-7.3,Pracinostat,JHDKZFFAIZKUCU-ZRDIBKRKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
83738,6m3m,DB04280,-7.3,"((2r,3s,5r)-3-Hydroxy-5-(4-Hydroxy-2-Oxo-3,4-Dihydropyrimidin-1(2h)-Yl)-Tetrahydrofuran-2-Yl)Methyldihydrogen Phosphate",ILSIYJVILUIVPM-LXGUWJNJSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
11924,6lzg,DB12623,-7.3,Taprenepag,MFFBXYNKZHTCEY-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
86649,6m3m,DB09186,-7.3,Nisoxetine,ITJNARMNRKSWTA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
72131,6m2n,DB00376,-7.3,Trihexyphenidyl,HWHLPVGTWGOCJO-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
60721,6crv,DB09014,-7.3,Captodiame,IZLPZXSZLLELBJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72139,6m2n,DB00384,-7.3,Triamterene,FNYLWPVRPXGIIP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
16407,6lzg,DB04115,-7.3,Berberine,YBHILYKTIRIUTE-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
26761,6cs2,DB05076,-7.3,Fenretinide,AKJHMTWEGVYYSE-FXILSDISSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
102528,6vxs,DB07503,-7.3,"(5E)-5-[(2,2-DIFLUORO-1,3-BENZODIOXOL-5-YL)METHYLENE]-1,3-THIAZOLIDINE-2,4-DIONE",SRLVNYDXMUGOFI-YWEYNIOJSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
83849,6m3m,DB04440,-7.3,Nebularine,MRWXACSTFXYYMV-FDDDBJFASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
102660,6vxs,DB07662,-7.3,N-[4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL]-ACRYLAMIDE,HTUBKQUPEREOGA-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
84004,6m3m,DB04639,-7.3,Biphenylalanine,JCZLABDVDPYLRZ-AWEZNQCLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
104680,6vxs,DB12350,-7.3,Rostafuroxin,AEAPORIZZWBIEX-DTBDINHYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102642,6vxs,DB07638,-7.3,"(3AS,4R,9BR)-2,2-DIFLUORO-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL",QJSMFUTULGSHNQ-ZOBUZTSGSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
60582,6crv,DB08814,-7.3,Triflusal,RMWVZGDJPAKBDE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
102631,6vxs,DB07626,-7.3,"4-(2-aminoethoxy)-N-(3-chloro-2-ethoxy-5-piperidin-1-ylphenyl)-3,5-dimethylbenzamide",CKBBGCJYKCLKHE-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102625,6vxs,DB07620,-7.3,"2-[(2,4-DICHLORO-5-METHYLPHENYL)SULFONYL]-1,3-DINITRO-5-(TRIFLUOROMETHYL)BENZENE",INAZPZCJNPPHGV-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102594,6vxs,DB07582,-7.3,"N-[(2R,3S)-1-((2S)-2-{[(CYCLOPENTYLAMINO)CARBONYL]AMINO}-3-METHYLBUTANOYL)-2-(1-FORMYL-1-CYCLOBUTYL)PYRROLIDINYL]CYCLOPROPANECARBOXAMIDE",GCDRFILPPBOJLM-UFYCRDLUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
70614,6lxt,DB12930,-7.3,Opipramol,YNZFUWZUGRBMHL-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
86655,6m3m,DB09192,-7.3,Tandamine,BRPOADLGOFPKKJ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
25388,6cs2,DB03300,-7.3,Pterin Cytosine Dinucleotide,WKSPNQYEWZEMMI-FEFZDOOUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
70606,6lxt,DB12921,-7.3,Chlorsulfaquinoxaline,CTSNHMQGVWXIEG-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
58560,6crv,DB05964,-7.3,Amitifadine,BSMNRYCSBFHEMQ-KCJUWKMLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
26745,6cs2,DB05013,-7.3,Ingenol mebutate,VDJHFHXMUKFKET-UXMMOKKRSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
86580,6m3m,DB09060,-7.3,Avibactam,NDCUAPJVLWFHHB-UHNVWZDZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58556,6crv,DB05939,-7.3,MK-0354,LTQYSJKGRPGMPO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
83869,6m3m,DB04466,-7.3,SR12813,YQLJDECYQDRSBI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58548,6crv,DB05871,-7.3,UC-781,YZHIXLCGPOTQNB-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
83861,6m3m,DB04458,-7.3,"2,2-Dichloro-1-Methanesulfinyl-3-Methyl-Cyclopropanecarboxylic Acid [1-(4-Bromo-Phenyl)-Ethyl]-Amide",VMASMYSTIDDLTO-JOSUJJRFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83860,6m3m,DB04457,-7.3,2'-Deoxyguanosine-5'-Monophosphate,LTFMZDNNPPEQNG-KVQBGUIXSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83892,6m3m,DB04492,-7.3,2-(acetylamino)-2-deoxy-4-O-sulfo-alpha-D-galactopyranose,WHCJUIFHMJFEFZ-YQXRAVKXSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
60556,6crv,DB08784,-7.3,2-(4-CHLORO-PHENYLAMINO)-NICOTINIC ACID,YEXIXVLEDGNAKM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60749,6crv,DB09064,-7.3,Ciprofibrate,KPSRODZRAIWAKH-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
102442,6vxs,DB07401,-7.3,METHYL (2Z)-2-(2-{[6-(2-CYANOPHENOXY)PYRIMIDIN-4-YL]OXY}PHENYL)-3-METHOXYACRYLATE,WFDXOXNFNRHQEC-GHRIWEEISA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
72224,6m2n,DB00487,-7.3,Pefloxacin,FHFYDNQZQSQIAI-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
86869,6m3m,DB11396,-7.3,Dichlorophen,MDNWOSOZYLHTCG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58334,6crv,DB04860,-7.3,Isatoribine,TZYVRXZQAWPIAB-FCLHUMLKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
70427,6lxt,DB12638,-7.3,PU-H71,SUPVGFZUWFMATN-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
83519,6m3m,DB03991,-7.3,"2-Deoxy-2,3-Dehydro-N-Acetyl-Neuraminic Acid",JINJZWSZQKHCIP-UFGQHTETSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58326,6crv,DB04846,-7.3,Celiprolol,JOATXPAWOHTVSZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86908,6m3m,DB11466,-7.3,Tepoxalin,XYKWNRUXCOIMFZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
72242,6m2n,DB00508,-7.3,Triflupromazine,XSCGXQMFQXDFCW-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
72247,6m2n,DB00519,-7.3,Trandolapril,VXFJYXUZANRPDJ-WTNASJBWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
11868,6lzg,DB12540,-7.3,Lecozotan,NRPQELCNMADTOZ-OAQYLSRUSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
83491,6m3m,DB03951,-7.3,N-acetyl-D-glucosamine-6-phosphate,BRGMHAYQAZFZDJ-RTRLPJTCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
72256,6m2n,DB00530,-7.3,Erlotinib,AAKJLRGGTJKAMG-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
83465,6m3m,DB03918,-7.3,"6S-5,6,7,8-Tetrahydrobiopterin",FNKQXYHWGSIFBK-ZMIZWQJLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83442,6m3m,DB03888,-7.3,N-Allyl-6-{[3-(4-bromophenyl)-1-methyl-1H-indazol-6-yl]oxy}-N-methyl-1-hexanamine,FNZKIJOTNKEJBF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
102233,6vxs,DB07161,-7.3,5-phenyl-1H-indazol-3-amine,ZCUSNQPYUNLATP-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102228,6vxs,DB07155,-7.3,(3S)-1-CYCLOHEXYL-5-OXO-N-PHENYLPYRROLIDINE-3-CARBOXAMIDE,BVUSHGJZBZMDML-ZDUSSCGKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102227,6vxs,DB07154,-7.3,"(3R)-4-[(3R)-3-AMINO-4-(2,4,5-TRIFLUOROPHENYL)BUTANOYL]-3-METHYL-1,4-DIAZEPAN-2-ONE",SWKGZJAAGSVROJ-MWLCHTKSSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
83425,6m3m,DB03866,-7.3,Prostaglandin G2,SGUKUZOVHSFKPH-YNNPMVKQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
18073,6cs2,HMDB0012173,-7.3,4Alpha-hydroxymethyl-5alpha-cholesta-8-en-3beta-ol,UPEGTKGKNWDIAN-GYISYUOESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
102292,6vxs,DB07230,-7.3,3-BROMO-6-HYDROXY-2-(4-HYDROXYPHENYL)-1H-INDEN-1-ONE,DHPCBFMFERFZLR-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
11882,6lzg,DB12562,-7.3,Setipiprant,IHAXLPDVOWLUOS-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
26896,6cs2,DB05791,-7.3,Perflubron,WTWWXOGTJWMJHI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
58354,6crv,DB04884,-7.3,Dapoxetine,USRHYDPUVLEVMC-FQEVSTJZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
83689,6m3m,DB04213,-7.3,N-Cyclohexyl-N'-(Propyl)Phenyl Urea,HBTZVNKXMFGOOJ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
60767,6crv,DB09089,-7.3,Trimebutine,LORDFXWUHHSAQU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
26834,6cs2,DB05462,-7.3,Chlorotoxin I-131,YUFAHBUWIVNVNJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
60781,6crv,DB09120,-7.3,Zucapsaicin,YKPUWZUDDOIDPM-VURMDHGXSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58437,6crv,DB05253,-7.3,Telapristone acetate,JVBGZFRPTRKSBB-MJBQOYBXSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
25297,6cs2,DB03199,-7.3,4-Methoxy-E-Rhodomycin T,XSSVYBYWQBNYOH-QJIXERIWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
86718,6m3m,DB09273,-7.3,Doxofylline,HWXIGFIVGWUZAO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
16348,6lzg,DB03823,-7.3,Epigallocatechin,XMOCLSLCDHWDHP-IUODEOHRSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
102368,6vxs,DB07314,-7.3,"1-(5-CHLORO-2,4-DIMETHOXYPHENYL)-3-(5-CYANOPYRAZIN-2-YL)UREA",URQYPXQXSVUVRG-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
83695,6m3m,DB04222,-7.3,Sparsomycin,XKLZIVIOZDNKEQ-CLQLPEFOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83632,6m3m,DB04143,-7.3,Indole-3-Glycerol Phosphate,NQEQTYPJSIEPHW-MNOVXSKESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
102354,6vxs,DB07300,-7.3,"2-(1H-imidazol-1-yl)-9-methoxy-8-(2-methoxyethoxy)benzo[c][2,7]naphthyridin-4-amine",QSSGYSRUMIOURP-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102342,6vxs,DB07287,-7.3,"2-(2,4-DICHLOROPHENOXY)-5-(PYRIDIN-2-YLMETHYL)PHENOL",AOVDSWPGWPRTSR-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
70494,6lxt,DB12739,-7.3,Bindarit,MTHORRSSURHQPZ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
60838,6crv,DB09211,-7.3,Limaprost,OJZYRQPMEIEQFC-UAWLTFRCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60867,6crv,DB09245,-7.3,Toloxatone,MXUNKHLAEDCYJL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
102308,6vxs,DB07250,-7.3,"N'-(5-CHLORO-1,3-BENZODIOXOL-4-YL)-N-(3,4,5- TRIMETHOXYPHENYL)PYRIMIDINE-2,4-DIAMINE",HMKLUOPMOJOUDZ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
60874,6crv,DB09252,-7.3,Pivhydrazine,FWWDFDMCZLOXQI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86863,6m3m,DB11389,-7.3,Clorsulon,QOVTVIYTBRHADL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86864,6m3m,DB11390,-7.3,Coumaphos,BXNANOICGRISHX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
60817,6crv,DB09189,-7.3,Daledalin,YFAIJBZEDDOCAN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60551,6crv,DB08778,-7.3,"[4-amino-2-(tert-butylamino)-1,3-thiazol-5-yl](phenyl)methanone",KEHNGAHNKVLUSC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
102678,6vxs,DB07683,-7.3,"N-(dibenzo[b,d]thiophen-3-ylsulfonyl)-L-valine",RZWYSEXQXOXWKA-INIZCTEOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
58643,6crv,DB06258,-7.3,Bimoclomol,NMOVJBAGBXIKCG-VKAVYKQESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
25558,6cs2,DB03510,-7.3,6-O-Phosphoryl Inosine Monophosphate,RXRZOKQPANIEDW-KQYNXXCUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
71858,6lxt,DB15425,-7.3,CYC-065,DLPIYBKBHMZCJI-WBVHZDCISA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
58871,6crv,DB06793,-7.3,Levopropoxyphene,XLMALTXPSGQGBX-PGRDOPGGSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
102894,6vxs,DB07933,-7.3,Erteberel,XIESSJVMWNJCGZ-VKJFTORMSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
58863,6crv,DB06774,-7.3,Capsaicin,YKPUWZUDDOIDPM-SOFGYWHQSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84345,6m3m,DB05633,-7.3,Glypromate,JJGBXTYGTKWGAT-YUMQZZPRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86306,6m3m,DB08690,-7.3,UBIQUINONE-2,SQQWBSBBCSFQGC-JLHYYAGUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
26529,6cs2,DB00535,-7.3,Cefdinir,RTXOFQZKPXMALH-GHXIOONMSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
25542,6cs2,DB03493,-7.3,7-Methylguanosine,OGHAROSJZRTIOK-KQYNXXCUSA-O,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
16535,6cs2,HMDB0002670,-7.3,Naringenin,FTVWIRXFELQLPI-ZDUSSCGKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
86328,6m3m,DB08717,-7.3,"[(2S)-4-methyl-3-oxo-2,3,4,5-tetrahydro-1H-1,4-benzodiazepin-2-yl]acetic acid",CLWDLBDPVUWYEW-JTQLQIEISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84305,6m3m,DB05442,-7.3,Etiprednol dicloacetate,QAIOVDNCIZSSSF-RFAJLIJZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
104529,6vxs,DB12133,-7.3,BLXA4,HEDVTGFTYROYFE-RREUNBNVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
86331,6m3m,DB08720,-7.3,"5-(5-(4-(4,5-dihydro-2-oxazoly)phenoxy)pentyl)-3-methyl osoxazole",IWZDYGHUSXWPPM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84289,6m3m,DB05377,-7.3,Chlorfenson,RZXLPPRPEOUENN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86332,6m3m,DB08721,-7.3,"5-(5-(2,6-dichloro-4-(4,5-dihydro-2-oxazolyl)phenoxy)pentyl)-3-(hydroxyethyl oxymethyleneoxymethyl) isoxazole",JLSNWEWWUSOSMP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
104537,6vxs,DB12146,-7.3,Rigosertib,OWBFCJROIKNMGD-BQYQJAHWSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
58818,6crv,DB06702,-7.3,Fesoterodine,DCCSDBARQIPTGU-HSZRJFAPSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
71905,6lxt,DB13983,-7.3,"5,7,2'-trihydroxy-6,8-dimethoxyflavone",JWOKGWICZPPYPX-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
102903,6vxs,DB07943,-7.3,2-{4-[5-(4-chlorophenyl)-4-pyrimidin-4-yl-1H-pyrazol-3-yl]piperidin-1-yl}-2-oxoethanol,CATQHDWESBRRQA-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
16551,6cs2,HMDB0002755,-7.3,Myricetin,IKMDFBPHZNJCSN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
12041,6lzg,DB12792,-7.3,Boscalid,WYEMLYFITZORAB-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
58887,6crv,DB06821,-7.3,Sulfameter,GPTONYMQFTZPKC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
12456,6lzg,DB13393,-7.3,Emetine,AUVVAXYIELKVAI-CKBKHPSWSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
25612,6cs2,DB03588,-7.3,Diphenylacetic Acid,PYHXGXCGESYPCW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
60258,6crv,DB08434,-7.3,2-METHYLCARBAMOYL-3-(4-PHOSPHONOOXY-PHENYL)-CYCLOPROPANECARBOXYLIC ACID,GIIUHKRUTUSHAB-IVZWLZJFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60263,6crv,DB08440,-7.3,"N-1,10-phenanthrolin-5-ylacetamide",AAJXINSCZMZERD-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86238,6m3m,DB08606,-7.3,"(3R,4S)-1-[(4-AMINO-5H-PYRROLO[3,2-D]PYRIMIDIN-7-YL)METHYL]-4-[(METHYLSULFANYL)METHYL]PYRROLIDIN-3-OL",NTHMDFGHOCNNOE-ZJUUUORDSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
16572,6cs2,HMDB0002899,-7.3,Ellagic acid,AFSDNFLWKVMVRB-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
102980,6vxs,DB08029,-7.3,N-2-(biphenyl-4-ylsulfonyl)-N-hydroxy-N-2-(2-hydroxyethyl)glycinamide,QQDWEVONJRXVDB-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104443,6vxs,DB12008,-7.3,Prexasertib,DOTGPNHGTYJDEP-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
16567,6cs2,HMDB0002871,-7.3,Phytofluene,OVSVTCFNLSGAMM-CSTSADRFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
12018,6lzg,DB12752,-7.3,Bucindolol,FBMYKMYQHCBIGU-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
26486,6cs2,DB00530,-7.3,Erlotinib,AAKJLRGGTJKAMG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
17665,6cs2,HMDB0000380,-7.3,2-Hydrox1tradiol-3-methyl ether,MMKYSUOJWFKECQ-SSTWWWIQSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
71831,6lxt,DB15360,-7.3,"Carfentanil, C-11",YDSDEBIZUNNPOB-JVVVGQRLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
86259,6m3m,DB08633,-7.3,TNP-470,MSHZHSPISPJWHW-PVDLLORBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
102956,6vxs,DB08004,-7.3,"(2S)-2-{[3-(3-aminophenyl)imidazo[1,2-b]pyridazin-6-yl]amino}-3-methylbutan-1-ol",PUMVONFFLKPPIM-CQSZACIVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
58913,6crv,DB06857,-7.3,N-(4-CARBAMIMIDOYL-3-CHORO-PHENYL)-2-HYDROXY-3-IODO-5-METHYL-BENZAMIDE,QKGFTDAISIBIBV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
102949,6vxs,DB07995,-7.3,N-[2-(4-BROMOCINNAMYLAMINO)ETHYL]-5-ISOQUINOLINE SULFONAMIDE,ZKZXNDJNWUTGDK-NSCUHMNNSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
70810,6lxt,DB13254,-7.3,Prifinium,ZYEPZINLLPPBMI-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
17690,6cs2,HMDB0000429,-7.3,17a-Estradiol,VOXZDWNPVJITMN-SFFUCWETSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
16554,6cs2,HMDB0002780,-7.3,Catechin,PFTAWBLQPZVEMU-DZGCQCFKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
102960,6vxs,DB08008,-7.3,"5-methyl-N-[4-(trifluoromethyl)phenyl][1,2,4]triazolo[1,5-a]pyrimidin-7-amine",LRHHXKBKRNNFRV-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
26550,6cs2,DB00537,-7.3,Ciprofloxacin,MYSWGUAQZAJSOK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
25522,6cs2,DB03467,-7.3,Naringenin,FTVWIRXFELQLPI-ZDUSSCGKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
70761,6lxt,DB13169,-7.3,Nandrolone,NPAGDVCDWIYMMC-IZPLOLCNSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
26629,6cs2,DB04807,-7.3,4-NITROPHENYL-(6-S-ALPHA-D-XYLOPYRANOSYL)-BETA-D-GLUCOPYRANOSIDE,HQYVHBCTLFPWRQ-ZMFOIVQCSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
11994,6lzg,DB12721,-7.3,RO-5028442,QZXVLRCMAHJVIP-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
70703,6lxt,DB13066,-7.3,Liarozole,UGFHIPBXIWJXNA-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
58695,6crv,DB06413,-7.3,Armodafinil,YFGHCGITMMYXAQ-LJQANCHMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
26640,6cs2,DB04820,-7.3,Nialamide,NOIIUHRQUVNIDD-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
102738,6vxs,DB07754,-7.3,N-({(1R)-1-carboxy-2-[(4-fluorobenzyl)sulfanyl]ethyl}carbamoyl)-L-glutamic acid,IDTMSHGCAZPVLC-RYUDHWBXSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102737,6vxs,DB07753,-7.3,"3',5'-DIFLUOROBIPHENYL-4-CARBOXYLIC ACID",VCEFNMHMLWBFNV-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
84137,6m3m,DB04821,-7.3,Nomifensine,XXPANQJNYNUNES-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
16497,6cs2,HMDB0002369,-7.3,9-cis-Retinoic acid,SHGAZHPCJJPHSC-ZVCIMWCZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
58716,6crv,DB06468,-7.3,Cariporide,IWXNYAIICFKCTM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104632,6vxs,DB12284,-7.3,LY-2608204,QIIVJLHCZUTGSD-CUBQBAPOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
22421,6cs2,HMDB0053904,-7.3,"TG(20:3n6/22:2(13Z,16Z)/o-18:0)",ROYJPPZMPGNTCP-VKWATNDDSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
84111,6m3m,DB04788,-7.3,Tagetitoxin,UVAAUIDYGIWLMB-HGNFPZBQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
26654,6cs2,DB04833,-7.3,Methaqualone,JEYCTXHKTXCGPB-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
70690,6lxt,DB13051,-7.3,CH-5132799,JEGHXKRHKHPBJD-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
84097,6m3m,DB04769,-7.3,"5-QUINOXALIN-6-YLMETHYLENE-THIAZOLIDINE-2,4-DIONE",SQWZFLMPDUSYGV-POHAHGRESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
70683,6lxt,DB13039,-7.3,Aminaphthone,YLMPBJUYFTWHKJ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
60527,6crv,DB08751,-7.3,"N,N'-DIMETHYL-N-(ACETYL)-N'-(7-NITROBENZ-2-OXA-1,3-DIAZOL-4-YL)ETHYLENEDIAMINE",YSVJZZZGPPWEIC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86451,6m3m,DB08872,-7.3,Gabapentin enacarbil,TZDUHAJSIBHXDL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
25435,6cs2,DB03355,-7.3,5'-O-(N-(L-Threonyl)-Sulfamoyl)Adenosine,UPVAPSGKXAAHBG-CKTDUXNWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
84136,6m3m,DB04820,-7.3,Nialamide,NOIIUHRQUVNIDD-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
71807,6lxt,DB15317,-7.3,Posiphen,PBHFNBQPZCRWQP-AZUAARDMSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
17815,6cs2,HMDB0000502,-7.3,3-Oxocholic acid,OEKUSRBIIZNLHZ-DJDNIQJZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
60474,6crv,DB08695,-7.3,3-(4-nitrophenyl)-1H-pyrazole,IPIYADCDDIUVPS-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60413,6crv,DB08617,-7.3,"4-(2,2,2-TRIFLUOROETHYL)-L-PHENYLALANINE",VXIZYDKGLBPCAQ-VIFPVBQESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
70758,6lxt,DB13165,-7.3,Ripasudil,QSKQVZWVLOIIEV-NSHDSACASA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
58790,6crv,DB06640,-7.3,Fispemifene,NKZTZAQIKKGTDB-QPLCGJKRSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86339,6m3m,DB08728,-7.3,"5-(3-(2,6-dichloro-4-(4,5-dihydro-2-oxazolyl)phenoxy)propyl)-3-methyl isoxazole",TUGBWRGTMLOFAX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
60429,6crv,DB08640,-7.3,"(2S,3S)-3-FORMYL-2-({[(4-METHYLPHENYL)SULFONYL]AMINO}METHYL)PENTANOIC ACID",IDDWUPNJUMHKFQ-DGCLKSJQSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
102795,6vxs,DB07816,-7.3,N-(P-CYANOPHENYL)-N'-DIPHENYLMETHYL-GUANIDINE-ACETIC ACID,KGHMYJFHUHFOGL-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102789,6vxs,DB07810,-7.3,"3-(4-HYDROXYPHENYL)-1-(2,4,6-TRIHYDROXYPHENYL)PROPAN-1-ONE",VGEREEWJJVICBM-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
84267,6m3m,DB05223,-7.3,Pracinostat,JHDKZFFAIZKUCU-ZRDIBKRKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58764,6crv,DB06594,-7.3,Agomelatine,YJYPHIXNFHFHND-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
102758,6vxs,DB07776,-7.3,Flavone,VHBFFQKBGNRLFZ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
16522,6cs2,HMDB0002586,-7.3,Chenodeoxycholic acid 3-sulfate,WHMOBEGYTDWMIG-BSWAIDMHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
17769,6cs2,HMDB0010368,-7.3,CE(18:0),XHRPOTDGOASDJS-GHOVPUJYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
58754,6crv,DB06575,-7.3,Valomaciclovir,ATSZELKUSAREPW-ZJUUUORDSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58753,6crv,DB06573,-7.3,Rebimastat,GTXSRFUZSLTDFX-HRCADAONSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58749,6crv,DB06548,-7.3,Minodronic acid,VMMKGHQPQIEGSQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
26605,6cs2,DB04778,-7.3,SC45647,LPSXGZAUAOMRNU-FZKQIMNGSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
70727,6lxt,DB13102,-7.3,AZD-8418,MCPBSUCAISQZQK-JTQLQIEISA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
12521,6lzg,DB13475,-7.3,Furazidin,DECBQELQORZLLP-UAIOPKHMSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
104601,6vxs,DB12241,-7.3,TAK-733,RCLQNICOARASSR-SECBINFHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
70718,6lxt,DB13090,-7.3,Zidebactam,YCZPXRQPDCXTIO-BBBLOLIVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
25491,6cs2,DB00415,-7.3,Ampicillin,AVKUERGKIZMTKX-NJBDSQKTSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
77437,6m2n,DB08378,-7.3,"4-[4-(2,5-DIOXO-PYRROLIDIN-1-YL)-PHENYLAMINO]-4-HYDROXY-BUTYRIC ACID",SUETUOGYOWOLNJ-NSHDSACASA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
24420,6cs2,DB00295,-7.3,Morphine,BQJCRHHNABKAKU-KBQPJGBKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
81288,6m3m,DB01024,-7.3,Mycophenolic acid,HPNSFSBZBAHARI-RUDMXATFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
28458,6cs2,DB08046,-7.3,2-chloro-5-[(1S)-1-hydroxy-3-oxo-2H-isoindol-1-yl]benzenesulfonamide,JIVPVXMEBJLZRO-AWEZNQCLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
78716,6m2n,DB12163,-7.3,Sarpogrelate,FFYNAVGJSYHHFO-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
74184,6m2n,DB03015,-7.3,"6-Hydroxy-1,6-Dihydro Purine Nucleoside",WGRXVKRHIMUTPD-YOHZANMFSA-O,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
108729,6vxx,DB08872,-7.3,Gabapentin enacarbil,TZDUHAJSIBHXDL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
54906,6crv,DB00372,-7.3,Thiethylperazine,XCTYLCDETUVOIP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
68093,6lxt,DB07513,-7.3,7-[(3-CHLOROBENZYL)OXY]-4-[(METHYLAMINO)METHYL]-2H-CHROMEN-2-ONE,JMGUSOLCNQVZCT-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
64097,6lxt,DB01060,-7.3,Amoxicillin,LSQZJLSUYDQPKJ-NJBDSQKTSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
78671,6m2n,DB12100,-7.3,Abediterol,SFYAXIFVXBKRPK-QFIPXVFZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78651,6m2n,DB12071,-7.3,Vabicaserin,NPTIPEQJIDTVKR-STQMWFEESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78643,6m2n,DB12059,-7.3,JNJ-40411813,HYOGJHCDLQSAHX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
10497,6lzg,DB08704,-7.3,"[[(3R,4R,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-(pentanoylamino)oxan-2-ylidene]amino] N-phenylcarbamate",NUNQIQQEEPOGDJ-JDOAOKHLSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
68091,6lxt,DB07511,-7.3,"4-(4-methyl-1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)benzonitrile",MVYDBJXCIFMINH-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
91085,6m71,DB02587,-7.3,Colforsin,OHCQJHSOBUTRHG-KGGHGJDLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
19945,6cs2,HMDB0000876,-7.3,Vitamin D3,QYSXJUFSXHHAJI-YRZJJWOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
97536,6m71,DB15114,-7.3,Vamorolone,ZYTXTXAMMDTYDQ-DGEXFFLYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
19956,6cs2,HMDB0000878,-7.3,Ergosterol,DNVPQKQSNYMLRS-KQYMERMZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
108775,6vxx,DB08948,-7.3,Iodamide,VVDGWALACJEJKG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
91100,6m71,DB02607,-7.3,Adenosine Phosphonoacetic Acid,KJNLSEOJEFDELT-JJNLEZRASA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97529,6m71,DB15102,-7.3,Pemigatinib,HCDMJFOHIXMBOV-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
108682,6vxx,DB08799,-7.3,Antazoline,REYFJDPCWQRWAA-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
68125,6lxt,DB07549,-7.3,"2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUORO-3-METHYL-6-PYRIDINYL)METHYL]ACETAMIDE",WOYBPRBUPLYTPY-UHFFFAOYSA-P,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
68134,6lxt,DB07561,-7.3,(2Z)-2-cyano-N-(3'-ethoxybiphenyl-4-yl)-3-hydroxybut-2-enamide,RPILZQUCBKIPAZ-AQTBWJFISA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
13498,6lzg,DB01136,-7.3,Carvedilol,OGHNVEJMJSYVRP-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
74119,6m2n,DB02925,-7.3,Piretanide,UJEWTUDSLQGTOA-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
90811,6m71,DB02237,-7.3,Maltotetraose,UYQJCPNSAVWAFU-KVXMBEGHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
13416,6lzg,DB15316,-7.3,Florasulam,QZXATCCPQKOEIH-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
13417,6lzg,DB15317,-7.3,Posiphen,PBHFNBQPZCRWQP-AZUAARDMSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
63988,6lxt,DB00933,-7.3,Mesoridazine,SLVMESMUVMCQIY-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
90834,6m71,DB02266,-7.3,Flufenamic Acid,LPEPZBJOKDYZAD-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
108639,6vxx,DB08492,-7.3,(2E)-3-(2-OCT-1-YN-1-YLPHENYL)ACRYLIC ACID,KRDSGPLHVQJFLM-BUHFOSPRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
68207,6lxt,DB07648,-7.3,"(2R)-3-{[(4Z)-5,6-DIPHENYL-6,7-DIHYDRO-4H-PYRROLO[2,3-D]PYRIMIDIN-4-YLIDENE]AMINO}PROPANE-1,2-DIOL",TWEONIHFGKSPLC-MRXNPFEDSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
97667,6m71,DB15377,-7.3,ATB-346,YCNMAPLPQYQJFC-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
108791,6vxx,DB08967,-7.3,Dimetotiazine,VWNWVCJGUMZDIU-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
10548,6lzg,DB08754,-7.3,"(2E)-3-(3,4-DIHYDROXYPHENYL)-N-[2-(4-HYDROXYPHENYL)ETHYL]ACRYLAMIDE",VSHUQLRHTJOKTA-XBXARRHUSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
78864,6m2n,DB12377,-7.3,Relebactam,SMOBCLHAZXOKDQ-ZJUUUORDSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
68181,6lxt,DB07620,-7.3,"2-[(2,4-DICHLORO-5-METHYLPHENYL)SULFONYL]-1,3-DINITRO-5-(TRIFLUOROMETHYL)BENZENE",INAZPZCJNPPHGV-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
97610,6m71,DB15261,-7.3,Butafenacil,JEDYYFXHPAIBGR-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
78845,6m2n,DB12347,-7.3,CG-400549,YCLREGRRHGLOAK-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
74144,6m2n,DB02957,-7.3,Orotidine-5'-Monophosphate,KYOBSHFOBAOFBF-XVFCMESISA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78807,6m2n,DB12293,-7.3,Nefopam,RGPDEAGGEXEMMM-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
97587,6m71,DB15212,-7.3,Pemafibrate,ZHKNLJLMDFQVHJ-RUZDIDTESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
64067,6lxt,DB01025,-7.3,Amlexanox,SGRYPYWGNKJSDL-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
28425,6cs2,DB08013,-7.3,(METHYLPYRIDAZINE PIPERIDINE PROPYLOXYPHENYL)ETHYLACETATE,UEIUDEUUVLYRFV-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
97651,6m71,DB15338,-7.3,Rovatirelin,WTXWDXWZGJGIHV-URBCHYCLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
63963,6lxt,DB00906,-7.3,Tiagabine,PBJUNZJWGZTSKL-MRXNPFEDSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
54846,6crv,DB00297,-7.3,Bupivacaine,LEBVLXFERQHONN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78596,6m2n,DB11989,-7.3,Benznidazole,CULUWZNBISUWAS-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
97427,6m71,DB14867,-7.3,Parsaclisib,ZQPDJCIXJHUERQ-QWRGUYRKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
64214,6lxt,DB01192,-7.3,Oxymorphone,UQCNKQCJZOAFTQ-ISWURRPUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
64220,6lxt,DB01198,-7.3,Zopiclone,GBBSUAFBMRNDJC-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
67981,6lxt,DB07381,-7.3,(S)-atrolactic acid,NWCHELUCVWSRRS-VIFPVBQESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
10414,6lzg,DB08609,-7.3,"(2R)-N-{4-[Ethyl(phenyl)sulfamoyl]-2-methylphenyl}-3,3,3-trifluoro-2-hydroxy-2-methylpropanamide",SHEIQJGQDUYUBE-GOSISDBHSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
109003,6vxx,DB11893,-7.3,Avagacestat,XEAOPVUAMONVLA-QGZVFWFLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78384,6m2n,DB11676,-7.3,Galidesivir,AMFDITJFBUXZQN-KUBHLMPHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78380,6m2n,DB11672,-7.3,Curcumin,VFLDPWHFBUODDF-FCXRPNKRSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
109015,6vxx,DB11909,-7.3,Varespladib,BHLXTPHDSZUFHR-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
10398,6lzg,DB08591,-7.3,"5-(4-METHOXYBIPHENYL-3-YL)-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDE",IGXKSKWHHHYBFM-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
10394,6lzg,DB08588,-7.3,2-({2-[(3R)-3-AMINOPIPERIDIN-1-YL]-4-OXOQUINAZOLIN-3(4H)-YL}METHYL)BENZONITRILE,OYNURZXTLNNKAP-QGZVFWFLSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
10373,6lzg,DB08561,-7.3,"BENZYL 6-BENZYL-5,7-DIOXO-6,7-DIHYDRO-5H-[1,3]THIAZOLO[3,2-C]PYRIMIDINE-2-CARBOXYLATE",PLBINCOCFGQAJM-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
10372,6lzg,DB08560,-7.3,3-FLUORO-N-[1-(4-FLUOROPHENYL)-3-(2-THIENYL)-1H-PYRAZOL-5-YL]BENZENESULFONAMIDE,GULUFDCOGAXLEP-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
78324,6m2n,DB11540,-7.3,Propiopromazine,ZQTVCQIJTREKSP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78297,6m2n,DB11466,-7.3,Tepoxalin,XYKWNRUXCOIMFZ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
10336,6lzg,DB08521,-7.3,4-[5-(4-FLUORO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-3H-IMIDAZOL-4-YL]-PYRIDINE,CDMGBJANTYXAIV-HHHXNRCGSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
74338,6m2n,DB03221,-7.3,AL7099A,RMOXCYSVWCHXII-GFCCVEGCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
54632,2fxp,DB15414,-7.3,CM-4307,MLDQJTXFUGDVEO-FIBGUPNXSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
78246,6m2n,DB11378,-7.3,Buquinolate,LVVXOXRUTDAKFE-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
64205,6lxt,DB01183,-7.3,Naloxone,UZHSEJADLWPNLE-GRGSLBFTSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
13561,6lzg,DB01222,-7.3,Budesonide,VOVIALXJUBGFJZ-KWVAZRHASA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
13555,6lzg,DB01215,-7.3,Estazolam,CDCHDCWJMGXXRH-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
28564,6cs2,DB08152,-7.3,{(2S)-1-[N-(tert-butoxycarbonyl)glycyl]pyrrolidin-2-yl}methyl (3-chlorophenyl)acetate,ONXGIEJBNQLITK-INIZCTEOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
74231,6m2n,DB03079,-7.3,Alpha-Ribazole-5'-Phosphate Derivative,YPYFPLLZCVEYCS-KKOKHZNYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
68059,6lxt,DB07472,-7.3,"(R)-(+)9B-(3-METHYL)PHENYL-2,3-DIHYDROTHIAZOLO[2,3-A]ISOINDOL-5(9BH)-ONE",FQVDJZWFSZSGGA-QGZVFWFLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
108854,6vxx,DB11155,-7.3,Triclocarban,ICUTUKXCWQ1Q-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108866,6vxx,DB11201,-7.3,Menthyl salicylate,SJOXEWUZWQYCGL-DVOMOZLQSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
97524,6m71,DB15092,-7.3,LY-2624803,UEFWDVMEDFCHGW-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
54790,6crv,DB00234,-7.3,Reboxetine,CBQGYUDMJHNJBX-RTBURBONSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
54788,6crv,DB00232,-7.3,Methyclothiazide,CESYKOGBSMNBPD-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78550,6m2n,DB11919,-7.3,6-O-benzylguanine,KRWMERLEINMZFT-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
28553,6cs2,DB08142,-7.3,AT-7519,OVPNQJVDAFNBDN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
108805,6vxx,DB08983,-7.3,Etofibrate,XXRVYAFBUDSLJX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
64131,6lxt,DB01098,-7.3,Rosuvastatin,BPRHUIZQVSMCRT-VEUZHWNKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
97497,6m71,DB15038,-7.3,Litoxetine,MJJDYOLPMGIWND-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
28556,6cs2,DB08145,-7.3,"6-(2,6-DIMETHOXYPHENYL)PYRIDO[2,3-D]PYRIMIDINE-2,7-DIAMINE",LRPHIAJXODIASX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
74262,6m2n,DB03116,-7.3,5-(1-Carboxy-1-Phosphonooxy-Ethoxyl)-Shikimate-3-Phosphate,QUQKBSPZUVNKIF-JQCUSGDOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
91222,6m71,DB02770,-7.3,7-Alpha-D-Ribofuranosyl-2-Aminopurine-5'-Phosphate,UDRQVOJQMHZSIM-PULFBKJNSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
108913,6vxx,DB11378,-7.3,Buquinolate,LVVXOXRUTDAKFE-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108915,6vxx,DB11380,-7.3,Cambendazole,QZWHWHNCPFEXLL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
54751,6crv,DB00187,-7.3,Esmolol,AQNDDEOPVVGCPG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
64175,6lxt,DB01149,-7.3,Nefazodone,VRBKIVRKKCLPHA-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
28563,6cs2,DB08151,-7.3,"(5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-phenyl-1,6-dioxa-2-azaspiro[4.5]dec-2-ene-8,9,10-triol",YLTDNVVQKRHCJP-RKQHYHRCSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
74250,6m2n,DB03103,-7.3,Thymidine-5'- Diphosphate,UJLXYODCHAELLY-XLPZGREQSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
20169,6cs2,HMDB0046148,-7.3,"TG(20:0/20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z))",OSJAITDJSAAPCD-BJFZWASFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
63961,6lxt,DB00904,-7.3,Ondansetron,FELGMEQIXOGIFQ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
78902,6m2n,DB12425,-7.3,Liothyronine I-131,AUYYCJSJGJYCDS-UMVFHIKJSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
98204,6vxs,DB00671,-7.3,Cefixime,OKBVVJOGVLARMR-QSWIMTSFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
98198,6vxs,DB00663,-7.3,Flumethasone,WXURHACBFYSXBI-GQKYHHCASA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
79177,6m2n,DB12861,-7.3,Rimeporide,GROMEQPXDKRRIE-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
63651,6lxt,DB00537,-7.3,Ciprofloxacin,MYSWGUAQZAJSOK-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
63674,6lxt,DB00564,-7.3,Carbamazepine,FFGPTBGBLSHEPO-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
98154,6vxs,DB00607,-7.3,Nafcillin,GPXLMGHLHQJAGZ-JTDSTZFVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
28271,6cs2,DB07854,-7.3,N-METHYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE,VRGSDHJXBVCQEL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
55260,6crv,DB00804,-7.3,Dicyclomine,CURUTKGFNZGFSE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
98153,6vxs,DB00606,-7.3,Cyclothiazide,BOCUKUHCLICSIY-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
98151,6vxs,DB00604,-7.3,Cisapride,DCSUBABJRXZOMT-IRLDBZIGSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
108463,6vxx,DB08018,-7.3,"N-{(3S,4S)-4-[(6-AMINO-4-METHYLPYRIDIN-2-YL)METHYL]PYRROLIDIN-3-YL}-N'-(4-CHLOROBENZYL)ETHANE-1,2-DIAMINE",JDRSQGJWTVRNGM-QFBILLFUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
98150,6vxs,DB00603,-7.3,Medroxyprogesterone acetate,PSGAAPLEWMOORI-PEINSRQWSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
98145,6vxs,DB00596,-7.3,Ulobetasol,LEHFPXVYPMWYQD-XHIJKXOTSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
98141,6vxs,DB00591,-7.3,Fluocinolone acetonide,FEBLZLNTKCEFIT-VSXGLTOVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
90627,6m71,DB01990,-7.3,Cholesterol sulfate,BHYOQNUELFTYRT-DPAQBDIFSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
98128,6vxs,DB00578,-7.3,Carbenicillin,FPPNZSSZRUTDAP-UWFZAAFLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
63705,6lxt,DB00601,-7.3,Linezolid,TYZROVQLWOKYKF-ZDUSSCGKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
55248,6crv,DB00788,-7.3,Naproxen,CMWTZPSULFXXJA-VIFPVBQESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
63727,6lxt,DB00628,-7.3,Clorazepic acid,XDDJGVMJFWAHJX-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
98212,6vxs,DB00679,-7.3,Thioridazine,KLBQZWRITKRQQV-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
90556,6m71,DB01889,-7.3,"16,17-Androstene-3-Ol",KRVXMNNRSSQZJP-PHFHYRSDSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
63622,6lxt,DB00497,-7.3,Oxycodone,BRUQQQPBMZOVGD-XFKAJCMBSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
98215,6vxs,DB00683,-7.3,Midazolam,DDLIGBOFAVUZHB-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
28217,6cs2,DB07798,-7.3,"(3R)-3-(FLUOROMETHYL)-N-(3,3,3-TRIFLUOROPROPYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONAMIDE",BBUDQLKRZPRPFD-LLVKDONJSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
55348,6crv,DB00902,-7.3,Methdilazine,HTMIBDQKFHUPSX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
10695,6lzg,DB08951,-7.3,Indoprofen,RJMIEHBSYVWVIN-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
98273,6vxs,DB00751,-7.3,Epinastine,WHWZLSFABNNENI-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
79276,6m2n,DB13012,-7.3,AQX-1125,MDEJTPWQNNMAQF-BVMLLJBZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
63561,6lxt,DB00425,-7.3,Zolpidem,ZAFYATHCZYHLPB-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
79258,6m2n,DB12980,-7.3,CHS-828,BOIPLTNGIAPDBY-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
90483,6m71,DB01793,-7.3,SB-409513,ONVZFCHLOZUXRP-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
108406,6vxx,DB07956,-7.3,[1-(3-CHLORO-2-FORMYL-PHENYLCARBAMOYL)-2-METHYL-PROPYL]-CARBAMIC ACID TERT-BUTYL ESTER,GBHYPZDGTWSQFR-AWEZNQCLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
74055,6m2n,DB02844,-7.3,"S-Adenosyl-1,8-Diamino-3-Thiooctane",SUUGLGYBZXSJAA-SCFUHWHPSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
98261,6vxs,DB00736,-7.3,Esomeprazole,SUBDBMMJDZJVOS-DEOSSOPVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
108411,6vxx,DB07962,-7.3,"METHYL N-[(2',4'-DIFLUORO-4-HYDROXY-5-IODOBIPHENYL-3-YL)CARBONYL]-BETA-ALANINATE",ZMRRBWRMQPQQAN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108413,6vxx,DB07964,-7.3,"(3S)-4-{[4-(BUT-2-YNYLOXY)PHENYL]SULFONYL}-N-HYDROXY-2,2-DIMETHYLTHIOMORPHOLINE-3-CARBOXAMIDE",CVZIHNYAZLXRRS-HNNXBMFYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
68399,6lxt,DB07870,-7.3,(2S)-2-(4-{[3-CHLORO-5-(TRIFLUOROMETHYL)PYRIDIN-2-YL]OXY}PHENOXY)PROPANOIC ACID,GOCUAJYOYBLQRH-MRVPVSSYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
63583,6lxt,DB00450,-7.3,Droperidol,RMEDXOLNCUSCGS-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
63597,6lxt,DB00469,-7.3,Tenoxicam,LZNWYQJJBLGYLT-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
55301,6crv,DB00848,-7.3,Levamisole,HLFSDGLLUJUHTE-SNVBAGLBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
63606,6lxt,DB00479,-7.3,Amikacin,LKCWBDHBTVXHDL-RMDFUYIESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
10672,6lzg,DB08915,-7.3,Aleglitazar,DAYKLWSKQJBGCS-NRFANRHFSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
98221,6vxs,DB00690,-7.3,Flurazepam,SAADBVWGJQAEFS-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
68405,6lxt,DB07876,-7.3,(S)-2-METHYL-1-[(4-METHYL-5-ISOQUINOLINE)SULFONYL]-HOMOPIPERAZINE,AWDORCFLUJZUQS-ZDUSSCGKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
68234,6lxt,DB07683,-7.3,"N-(dibenzo[b,d]thiophen-3-ylsulfonyl)-L-valine",RZWYSEXQXOXWKA-INIZCTEOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
98092,6vxs,DB00533,-7.3,Rofecoxib,RZJQGNCSTQAWON-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
79044,6m2n,DB12647,-7.3,Tocotrienol,GJJVAFUKOBZPCB-ZGRPYONQSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
97924,6vxs,DB00324,-7.3,Fluorometholone,FAOZLTXFLGPHNG-KNAQIMQKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
63868,6lxt,DB00800,-7.3,Fenoldopam,TVURRHSHRRELCG-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
28319,6cs2,DB07903,-7.3,"3-[(2,2-DIMETHYLPROPANOYL)AMINO]-N-1,3-THIAZOL-2-YLPYRIDINE-2-CARBOXAMIDE",CAVCWRXFMNCBCM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
97917,6vxs,DB00317,-7.3,Gefitinib,XGALLCVXEZPNRQ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
97899,6vxs,DB00295,-7.3,Morphine,BQJCRHHNABKAKU-KBQPJGBKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
13390,6lzg,DB15268,-7.3,Afabicin,HFYMDQMXVPJNTH-VQHVLOKHSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
108563,6vxx,DB08399,-7.3,PICEATANNOL,CDRPUGZCRXZLFL-OWOJBTEDSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
90773,6m71,DB02187,-7.3,Equilin,WKRLQDKEXYKHJB-HFTRVMKXSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
90776,6m71,DB02191,-7.3,"(7as,12ar,12bs)-1,2,3,4,7a,12,12a,12b-Octahydroindolo[2,3-a]Quinolizin-7(6h)-One",PGKUSHWBQJPFOP-LBPRGKRZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
55126,6crv,DB00640,-7.3,Adenosine,OIRDTQYFTABQOQ-KQYNXXCUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
90779,6m71,DB02195,-7.3,"3-(4-Fluorophenyl)-1-Hydroxy-2-(Pyridin-4-Yl)-1h-Pyrrolo[3,2-B]Pyridine",ZSMYZLKEZDYVPI-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97835,6vxs,DB00223,-7.3,Diflorasone,WXURHACBFYSXBI-XHIJKXOTSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
97827,6vxs,DB00214,-7.3,Torasemide,NGBFQHCMQULJNZ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
97805,6vxs,DB00186,-7.3,Lorazepam,DIWRORZWFLOCLC-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
55104,6crv,DB00612,-7.3,Bisoprolol,VHYCDWMUTMEGQY-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
97798,6vxs,DB00178,-7.3,Ramipril,HDACQVRGBOVJII-JBDAPHQKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
97795,6vxs,DB00175,-7.3,Pravastatin,TUZYXOIXSAXUGO-PZAWKZKUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
28351,6cs2,DB07938,-7.3,"5-[[(2R)-2-cyclopropyl-7,8-dimethoxy-chroman-5-yl]methyl]pyrimidine-2,4-diamine",HWJPWWYTGBZDEG-CQSZACIVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
97789,6vxs,DB00169,-7.3,Cholecalciferol,QYSXJUFSXHHAJI-YRZJJWOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
97934,6vxs,DB00340,-7.3,Metixene,MJFJKKXQDNNUJF-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
90756,6m71,DB02162,-7.3,5'-O-(N-Ethyl-Sulfamoyl)Adenosine,ONCSLXAPOGUODU-WOUKDFQISA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97942,6vxs,DB00348,-7.3,Nitisinone,OUBCNLGXQFSTLU-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
63850,6lxt,DB00776,-7.3,Oxcarbazepine,CTRLABGOLIVAIY-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
28288,6cs2,DB07869,-7.3,6-CHLORO-4-(CYCLOHEXYLSULFINYL)-3-PROPYLQUINOLIN-2(1H)-ONE,QRBUGQMJMFAHKS-HSZRJFAPSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
98053,6vxs,DB00482,-7.3,Celecoxib,RZEKVGVHFLEQIL-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
98051,6vxs,DB00480,-7.3,Lenalidomide,GOTYRUGSSMKFNF-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
63775,6lxt,DB00688,-7.3,Mycophenolate mofetil,RTGDFNSFWBGLEC-SYZQJQIISA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
63788,6lxt,DB00701,-7.3,Amprenavir,YMARZQAQMVYCKC-OEMFJLHTSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
55198,6crv,DB00724,-7.3,Imiquimod,DOUYETYNHWVLEO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
98025,6vxs,DB00448,-7.3,Lansoprazole,MJIHNNLFOKEZEW-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
108513,6vxx,DB08076,-7.3,"4-[1-(2,6-dichlorobenzyl)-2-methyl-1H-imidazol-4-yl]pyrimidin-2-amine",CKSSZTMRRVJNNG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79018,6m2n,DB12601,-7.3,Sonolisib,QIUASFSNWYMDFS-NILGECQDSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
98085,6vxs,DB00525,-7.3,Tolnaftate,FUSNMLFNXJSCDI-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
79014,6m2n,DB12594,-7.3,AZD-9056,HSQAARMBHJCUOK-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
98011,6vxs,DB00433,-7.3,Prochlorperazine,WIKYUJGCLQQFNW-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
90708,6m71,DB02098,-7.3,Adenosine-2'-5'-Diphosphate,AEOBEOJCBAYXBA-KQYNXXCUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97979,6vxs,DB00394,-7.3,Beclomethasone dipropionate,KUVIULQEHSCUHY-XYWKZLDCSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
79008,6m2n,DB12585,-7.3,Ondelopran,QWNDOCKIKKQJNN-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
90714,6m71,DB02104,-7.3,"2,4-Diamino-5-Methyl-6-[(3,4,5-Trimethoxy-N-Methylanilino)Methyl]Pyrido[2,3-D]Pyrimidine",PEGMMEYCSOZKIT-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
90716,6m71,DB02106,-7.3,"[3,5-Dibromo-4-(4-Hydroxy-3-Phenethylcarbamoyl-Phenoxy)-Phenyl]-Acetic Acid",KIRQJXNQGZAKGR-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
55171,6crv,DB00695,-7.3,Furosemide,ZZUFCTLCJUWOSV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
74082,6m2n,DB02880,-7.3,N-[1-(4-Bromophenyl)Ethyl]-5-Fluoro Salicylamide,KFTNEILVDDUXGR-SECBINFHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
63843,6lxt,DB00768,-7.3,Olopatadine,JBIMVDZLSHOPLA-LSCVHKIXSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
98015,6vxs,DB00438,-7.3,Ceftazidime,ORFOPKXBNMVMKC-DWVKKRMSSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
10304,6lzg,DB08488,-7.3,"4-{[(E)-2-(5-CHLOROTHIEN-2-YL)VINYL]SULFONYL}-1-(1H-PYRROLO[3,2-C]PYRIDIN-2-YLMETHYL)PIPERAZIN-2-ONE",PLWVUIRWJVKSSD-XBXARRHUSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
78241,6m2n,DB11367,-7.3,Cefroxadine,RDMOROXKXONCAL-UEKVPHQBSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
109173,6vxx,DB12475,-7.3,Biphenyl dimethyl dicarboxylate,BKRIRZXWWALTPU-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110129,6vxx,DB01009,-7.3,Ketoprofen,DKYWVDODHFEZIM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77667,6m2n,DB08655,-7.3,"9-ACETYL-2,3,4,9-TETRAHYDRO-1H-CARBAZOL-1-ONE",MIGJEXKBUJPKJF-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
67711,6lxt,DB07070,-7.3,(2S)-2-{3-[({[2-fluoro-4-(trifluoromethyl)phenyl]carbonyl}amino)methyl]-4-methoxybenzyl}butanoic acid,BDLLIPYDNFENMY-ZDUSSCGKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
96576,6m71,DB13125,-7.3,Lusutrombopag,NOZIJMHMKORZBA-KJCUYJGMSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110160,6vxx,DB01044,-7.3,Gatifloxacin,XUBOMFCQGDBHNK-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
96568,6m71,DB13114,-7.3,Amitriptylinoxide,ZPMKQFOGINQDAM-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96551,6m71,DB13090,-7.3,Zidebactam,YCZPXRQPDCXTIO-BBBLOLIVSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
67684,6lxt,DB07040,-7.3,"2-amino-7-fluoro-5-oxo-5H-chromeno[2,3-b]pyridine-3-carboxamide",GCHMLYYPYFXLQB-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
91833,6m71,DB03601,-7.3,5-deoxyflavanone,FURUXTVZLHCCNA-AWEZNQCLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
74615,6m2n,DB03606,-7.3,(S)-Rolipram,HJORMJIFDVBMOB-GFCCVEGCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
110211,6vxx,DB01102,-7.3,Arbutamine,IIRWWTKISYTTBL-SFHVURJKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
74617,6m2n,DB03609,-7.3,3-Deoxyguanosine,OROIAVZITJBGSM-OBXARNEKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77658,6m2n,DB08645,-7.3,"6-CHLORO-3-(DICHLOROMETHYL)-3,4-DIHYDRO-2H-1,2,4-BENZOTHIADIAZINE-7-SULFONAMIDE 1,1-DIOXIDE",LMJSLTNSBFUCMU-MRVPVSSYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
53969,2fxp,DB13766,-7.3,Lidoflazine,ZBIAKUMOEKILTF-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
96483,6m71,DB12986,-7.3,VS-5584,QYBGBLQCOOISAR-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
91838,6m71,DB03608,-7.3,Diminazene,XNYZHCFCZNMTFY-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110233,6vxx,DB01129,-7.3,Rabeprazole,YREYEVIYCVEVJK-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110265,6vxx,DB01166,-7.3,Cilostazol,RRGUKTPIGVIEKM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
64801,6lxt,DB02001,-7.3,"5-(4-Morpholin-4-Yl-Phenylsulfanyl)-2,4-Quinazolinediamine",CZLWCJRHDBTCGQ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
64699,6lxt,DB01858,-7.3,[1-(4-Fluorobenzyl)Cyclobutyl]Methyl (1s)-1-[Oxo(1h-Pyrazol-5-Ylamino)Acetyl]Pentylcarbamate,QTPYRNAKLBXKNP-SFHVURJKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
96596,6m71,DB13175,-7.3,Rheinanthrone,OZFQHULMMDWMIV-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96600,6m71,DB13182,-7.3,Daidzein,ZQSIJRDFPHDXIC-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96607,6m71,DB13208,-7.3,Prednylidene,WSVOMANDJDYYEY-CWNVBEKCSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
67757,6lxt,DB07124,-7.3,"(2S)-1-(6H-INDOL-3-YL)-3-{[5-(7H-PYRAZOLO[3,4-C]PYRIDIN-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE",CCIACUJJBPSOHE-KRWDZBQOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
109984,6vxx,DB00672,-7.3,Chlorpropamide,RKWGIWYCVPQPMF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
91713,6m71,DB03421,-7.3,"2-Phenethyl-2,3-Dihydro-Phthalazine-1,4-Dione",JSSVIGGKHIJEHO-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
109988,6vxx,DB00676,-7.3,Benzyl benzoate,SESFRYSPDFLNCH-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77728,6m2n,DB08728,-7.3,"5-(3-(2,6-dichloro-4-(4,5-dihydro-2-oxazolyl)phenoxy)propyl)-3-methyl isoxazole",TUGBWRGTMLOFAX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
96776,6m71,DB13430,-7.3,Mebutizide,KJLLKLRVCJAFRY-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96773,6m71,DB13425,-7.3,Flutrimazole,QHMWCHQXCUNUAK-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
23132,6cs2,HMDB0059587,-7.3,Perfluorooctanoic acid,SNGREZUHAYWORS-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
96758,6m71,DB13407,-7.3,Nifenazone,BRZANEXCSZCZCI-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96426,6m71,DB12900,-7.3,Irdabisant,XUKROCVZGZNGSI-CQSZACIVSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96750,6m71,DB13396,-7.3,Neocitrullamon,PAJBBDCZSMDSFL-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
77714,6m2n,DB08713,-7.3,"2,6-DIMETHYL-1-(3-[3-METHYL-5-ISOXAZOLYL]-PROPANYL)-4-[2N-METHYL-2H-TETRAZOL-5-YL]-PHENOL",RVZKQTQAFHEOKT-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
96701,6m71,DB13333,-7.3,Efloxate,ZVXBAHLOGZCFTP-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96688,6m71,DB13317,-7.3,Flunoxaprofen,ARPYQKTVRGFPIS-VIFPVBQESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
64660,6lxt,DB01809,-7.3,"1-Ter-Butyl-3-P-Tolyl-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine",ZVPDNRVYHLRXLX-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
67727,6lxt,DB07089,-7.3,N-[amino(imino)methyl]-2-[2-(2-chlorophenyl)-4-(4-propoxyphenyl)-3-thienyl]acetamide,VZSMTBLDWPKVRW-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
67721,6lxt,DB07083,-7.3,beta-phenyl-D-phenylalanyl-N-propyl-L-prolinamide,HZKKJPDVZGOOPU-PZJWPPBQSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
96630,6m71,DB13237,-7.3,Clofoctol,HQVZOORKDNCGCK-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110081,6vxx,DB00952,-7.3,Naratriptan,AMKVXSZCKVJAGH-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
9885,6lzg,DB08017,-7.3,3-METHOXY-6-[4-(3-METHYLPHENYL)-1-PIPERAZINYL]PYRIDAZINE,DDOAUTHWSCUHQA-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
96721,6m71,DB13355,-7.3,Visnadine,GVBNSPFBYXGREE-CXWAGAITSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96809,6m71,DB13475,-7.3,Furazidin,DECBQELQORZLLP-UAIOPKHMSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
23146,6cs2,HMDB0059698,-7.3,Cadalene,VMOJIHDTVZTGDO-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
74636,6m2n,DB03641,-7.3,"2'-deoxyuridine 5'-alpha,beta-imido-diphosphate",COFNIXBQVWFHTR-SHYZEUOFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
9752,6lzg,DB07874,-7.3,"(6S)-2-amino-6-(3'-methoxybiphenyl-3-yl)-3,6-dimethyl-5,6-dihydropyrimidin-4(3H)-one",LQOCXPOKEPYGTJ-IBGZPJMESA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
14663,6lzg,T3D4558,-7.3,Azelastine,MBUVEWMHONZEQD-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
91923,6m71,DB03726,-7.3,Purine Riboside-5'-Monophosphate,MCWDCZIDTUQRHK-FDDDBJFASA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
67622,6lxt,DB06970,-7.3,"2-CHLORO-N-(3-CYANO-5,6-DIHYDRO-4H-CYCLOPENTA[B]THIOPHEN-2-YL)-5-DIETHYLSULFAMOYL-BENZAMIDE",MZCDQILVXXIMEV-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
96260,6m71,DB12638,-7.3,PU-H71,SUPVGFZUWFMATN-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96250,6m71,DB12621,-7.3,ST-101,QZWYXEBIQWJXAR-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110526,6vxx,DB01883,-7.3,N-(Sulfanylacetyl)Tyrosylprolylmethioninamide,LNLWXWOYQHAKTD-ULQDDVLXSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
9725,6lzg,DB07847,-7.3,6-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-(4-MORPHOLINYL)-2-OXO ETHYL]-2-OXO-3-PYRROLIDINYL}-2-NAPHTHALENESULFONAMIDE,ICLOZQFWTRAYPX-LIRRHRJNSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
67604,6lxt,DB06944,-7.3,N-(3-cyclopropyl-1H-pyrazol-5-yl)-2-(2-naphthyl)acetamide,RIGZCVNCFXYBEG-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
64923,6lxt,DB02162,-7.3,5'-O-(N-Ethyl-Sulfamoyl)Adenosine,ONCSLXAPOGUODU-WOUKDFQISA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
110556,6vxx,DB01937,-7.3,Guanosine-2'-Monophosphate,WTIFIAZWCCBCGE-UUOKFMHZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
9718,6lzg,DB07839,-7.3,"N-2-1,3-BENZOXAZOL-2-YL-3-CYCLOHEXYL-N-{2-[(4-METHOXYPHENYL)AMINO]ETHYL}-L-ALANINAMIDE",VFNWTXUFNNOQHD-QFIPXVFZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
67590,6lxt,DB06927,-7.3,[5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-YL]ACETONITRILE,ZKJVCUXZMYKTLT-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
9707,6lzg,DB07826,-7.3,2-[4-chloro-2-(phenylcarbonyl)phenoxy]-N-phenylacetamide,DTGVSZSMDOMAEB-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
110602,6vxx,DB01994,-7.3,"2-(Pyrido[1,2-E]Purin-4-Yl)Amino-Ethanol",QBILBVYKWQWDQJ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110606,6vxx,DB01998,-7.3,"2-[3,4-Dihydroxy-2-Hydroxymethyl-5-(2-Hydroxy-Nonyl)-Tetrahydro-Furan-2-Yloxy]-6-Hydroxymethyl-Tetra Hydro-Pyran-3,4,5-Triol",IMFJFQAURAFEAH-ZLSOQEJISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
96160,6m71,DB12476,-7.3,CPG-52852,YZOQZEXYFLXNKA-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
9694,6lzg,DB07813,-7.3,GLYCYLALANYL-N-2-NAPHTHYL-L-PROLINEAMIDE,KCELZXZDIUJGNM-GUYCJALGSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
110655,6vxx,DB02066,-7.3,N7-Methyl-Formycin A,JRRNRCMIBCSOIH-LFAOKBQASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110446,6vxx,DB01607,-7.3,Ticarcillin,OHKOGUYZJXTSFX-KZFFXBSXSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
96274,6m71,DB12659,-7.3,SJ-733,VKCPFWKTFZAOTO-LEWJYISDSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110443,6vxx,DB01604,-7.3,Pivampicillin,ZEMIJUDPLILVNQ-ZXFNITATSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
64892,6lxt,DB02118,-7.3,CP-271485,CIUMOGWIMXNXSQ-GOSISDBHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
9807,6lzg,DB07937,-7.3,"2-butoxy-9-(2,6-difluorobenzyl)-N-(2-morpholin-4-ylethyl)-9H-purin-6-amine",UGZWPZWADDDTRN-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
91890,6m71,DB03682,-7.3,"Dibenzofuran-4,6-Dicarboxylic Acid",HBBGSNOHAGNQRQ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
91892,6m71,DB03685,-7.3,Uridine monophosphate,DJJCXFVJDGTHFX-XVFCMESISA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110323,6vxx,DB01464,-7.3,Furethidine,NNCOZXNZFLUYGG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
91893,6m71,DB03687,-7.3,4-Diphosphocytidyl-2-C-Methyl-D-Erythritol,YFAUKWZNPVBCFF-XHIBXCGHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96359,6m71,DB12792,-7.3,Boscalid,WYEMLYFITZORAB-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
53903,2fxp,DB13676,-7.3,Mosapramine,PXUIZULXJVRBPC-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
67644,6lxt,DB06996,-7.3,D-leucyl-N-(4-carbamimidoylbenzyl)-L-prolinamide,XFNMDMGNNKIXBT-CVEARBPZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
110340,6vxx,DB01482,-7.3,Fenethylline,NMCHYWGKBADVMK-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
96403,6m71,DB12869,-7.3,Eliprodil,GGUSQTSTQSHJAH-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
9787,6lzg,DB07917,-7.3,4-(BENZHYDRYLOXY)-1-[3-(1H-TETRAAZOL-5-YL)PROPYL]PIPERIDINE,TZQGXAHOROZEKN-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
96327,6m71,DB12739,-7.3,Bindarit,MTHORRSSURHQPZ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
64863,6lxt,DB02082,-7.3,Phosphoaminophosphonic Acid Guanylate Ester,UQABYHGXWYXDTK-UUOKFMHZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
74649,6m2n,DB03658,-7.3,"2-{1-[2-Amino-2-(4-Hydroxy-Phenyl)-Acetylamino]-2-Oxo-Ethyl}-5,5-Dimethyl-Thiazolidine-4-Carboxylic Acid",SMLJDSWXGVMNTH-NRWUCQMLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
96305,6m71,DB12707,-7.3,AR-42,LAMIXXKAWNLXOC-INIZCTEOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96295,6m71,DB12689,-7.3,Azeliragon,KJNNWYBAOPXVJY-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96285,6m71,DB12672,-7.3,Icaritin,TUUXBSASAQJECY-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
77586,6m2n,DB08555,-7.3,"1-(3-bromophenyl)-7-chloro-6-methoxy-3,4-dihydroisoquinoline",IKGXHBGCVQTQBH-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
9755,6lzg,DB07877,-7.3,"8-(6-BROMO-BENZO[1,3]DIOXOL-5-YLSULFANYL)-9-(3-ISOPROPYLAMINO-PROPYL)-ADENINE",MWGWLDJLENCVRQ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
91920,6m71,DB03723,-7.3,2'-Deoxy-Thymidine-Beta-L-Rhamnose,ZOSQFDVXNQFKBY-CGAXJHMRSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
67635,6lxt,DB06986,-7.3,"2-CHLORO-N-[(1R,2R)-1-HYDROXY-2,3-DIHYDRO-1H-INDEN-2-YL]-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE",LRHOLHTVXXSIMG-BXUZGUMPSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
64604,6lxt,DB01734,-7.3,3-(Oxalyl-Amino)-Naphthalene-2-Carboxylic Acid,DQBLKSRRWDWNKQ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
96828,6m71,DB13501,-7.3,Bendazac,BYFMCKSPFYVMOU-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
109966,6vxx,DB00649,-7.3,Stavudine,XNKLLVCARDGLGL-JGVFFNPUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
20217,6cs2,HMDB0000912,-7.3,Succinyladenosine,VKGZCEJTCKHMRL-VWJPMABRSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
10182,6lzg,DB08352,-7.3,"6-[4-(2-fluorophenyl)-1,3-oxazol-5-yl]-N-(1-methylethyl)-1,3-benzothiazol-2-amine",FQYJTHIYAQQJAB-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
67922,6lxt,DB07312,-7.3,"2,5-DICHLORO-N-(5-CHLORO-1,3-BENZOXAZOL-2-YL)BENZENESULFONAMIDE",JCXZHFCBNFFHRC-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
14706,6lzg,T3D4627,-7.3,"7H-Dibenzo[c,g]carbazole",STJXCDGCXVZHDU-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
64303,6lxt,DB01340,-7.3,Cilazapril,HHHKFGXWKKUNCY-FHWLQOOXSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
67897,6lxt,DB07286,-7.3,BMS-564929,KEJORAMIZFOODM-PWSUYJOCSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
78014,6m2n,DB09144,-7.3,Uridine triacetate,AUFUWRKPQLGTGF-FMKGYKFTSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
74436,6m2n,DB03346,-7.3,"3,5,3',5'-Tetrachloro-Biphenyl-4,4'-Diol",YCYDXOVJXVALHY-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
91493,6m71,DB03133,-7.3,"2-(Beta-D-Glucopyranosyl)-5-Methyl-1,2,3-Benzimidazole",XIJZORUYQZBFJK-UJPOAAIJSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
77997,6m2n,DB09097,-7.3,Quinagolide,GDFGTRDCCWFXTG-ZIFCJYIRSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77992,6m2n,DB09090,-7.3,Pinaverium,DDHUTBKXLWCZCO-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
97253,6m71,DB14201,-7.3,"2,2'-Dibenzothiazyl disulfide",AFZSMODLJJCVPP-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
64338,6lxt,DB01413,-7.3,Cefepime,HVFLCNVBZFFHBT-ZKDACBOMSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
54398,2fxp,DB14916,-7.3,Selonsertib,YIDDLAAKOYYGJG-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
109451,6vxx,DB13593,-7.3,Zolimidine,VSLIUWLPFRVCDL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109473,6vxx,DB13623,-7.3,Fabomotizole,WWNUCVSRRUDYPP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
74455,6m2n,DB03369,-7.3,9-Aminophenanthrene,KIHQWOBUUIPWAN-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
91541,6m71,DB03200,-7.3,7-Alpha-D-Ribofuranosyl-Purine-5'-Phosphate,NICKPTPNIMHUHB-DQUBFYRCSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
91543,6m71,DB03202,-7.3,"2-[5-Methanesulfonylamino-2-(4-Aminophenyl)-6-Oxo-1,6-Dihydro-1-Pyrimidinyl]-N-(3,3,3-Trifluoro-1-Isopropyl-2-Oxopropyl)Acetamide",JWSWTHSJMGVOKE-HNNXBMFYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
109371,6vxx,DB13482,-7.3,Dimefline,ZXFQRFXLFWWKLX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
97337,6m71,DB14663,-7.3,Ribavirin monophosphate,SDWIOXKHTFOULX-AFCXAGJDSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
67926,6lxt,DB07316,-7.3,"N-{1-[(1-carbamoylcyclopropyl)methyl]piperidin-4-yl}-N-cyclopropyl-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide",FAVXIEFZKPJZRT-NRFANRHFSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
67934,6lxt,DB07325,-7.3,N-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)METHYL]-3-{[(E)-(2-OXODIHYDROFURAN-3(2H)-YLIDENE)METHYL]AMINO}BENZENESULFONAMIDE,VCOKUBHAJVTVNG-FMIVXFBMSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
54582,2fxp,DB15308,-7.3,Ridinilazole,UHQFBTAJFNVZIV-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
10286,6lzg,DB08467,-7.3,"6-(2,3,4,5,6,7-HEXAHYDRO-2,4,4-TRIMETHYL-1-METYLENEINDEN-2-YL)-3-METHYLHEXA-2,4-DIENOIC ACID",HEVXQLBAMFMFKU-IAZPEVBMSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
78194,6m2n,DB11182,-7.3,Rose bengal free acid,VDNLFJGJEQUWRB-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
109221,6vxx,DB12912,-7.3,Nolatrexed,XHWRWCSCBDLOLM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109236,6vxx,DB12935,-7.3,Remogliflozin etabonate,UAOCLDQAQNNEAX-ABMICEGHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
54543,2fxp,DB15233,-7.3,Avapritinib,DWYRIWUZIJHQKQ-SANMLTNESA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
109243,6vxx,DB12945,-7.3,Dihydralazine,VQKLRVZQQYVIJW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78126,6m2n,DB09306,-7.3,Metralindole,GVXBHSBKKJRBMS-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78125,6m2n,DB09305,-7.3,Aptazapine,MNHDDERDSNZCCK-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
109522,6vxx,DB14045,-7.3,Cholesteryl chloride,OTVRYZXVVMZHHW-DPAQBDIFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
10229,6lzg,DB08402,-7.3,"2-[(2,4-DICHLOROBENZOYL)AMINO]-5-(PYRIMIDIN-2-YLOXY)BENZOIC ACID",VNDRRWBKNSHALL-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
109284,6vxx,DB13012,-7.3,AQX-1125,MDEJTPWQNNMAQF-BVMLLJBZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
64242,6lxt,DB01224,-7.3,Quetiapine,URKOMYMAXPYINW-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
78117,6m2n,DB09289,-7.3,Tianeptine,JICJBGPOMZQUBB-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
67964,6lxt,DB07358,-7.3,"2-amino-N-(4-methyl-1,3-thiazol-2-yl)-5-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]benzamide",JEBOJMQHVUEKBE-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
13583,6lzg,DB01268,-7.3,Sunitinib,WINHZLLDWRZWRT-ATVHPVEESA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
10206,6lzg,DB00776,-7.3,Oxcarbazepine,CTRLABGOLIVAIY-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
91350,6m71,DB02936,-7.3,4-(1-Benzyl-3-Carbamoylmethyl-2-Methyl-1h-Indol-5-Yloxy)-Butyric Acid,STENXUCYNKOBHJ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
78059,6m2n,DB09207,-7.3,AS-8112,DALSFUWTAOKVTF-GFCCVEGCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
109347,6vxx,DB13448,-7.3,Mazaticol,AMHPTVWBZSYFSS-OAGGEKHMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
54517,2fxp,DB15190,-7.3,GLPG-0259,YBFGSJUVEOYPIS-OALUTQOASA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
23614,6cs2,HMDB0094727,-7.3,6-hydroxyphenylpropionylglycine,JORMSVKIHQJDHC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
91561,6m71,DB03222,-7.3,dATP,SUYVUBYJARFZHO-RRKCRQDMSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
109537,6vxx,DB14071,-7.3,Desmethylsertraline,SRPXSILJHWNFMK-ZBEGNZNMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109780,6vxx,DB00248,-7.3,Cabergoline,KORNTPPJEAJQIU-KJXAQDMKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
9993,6lzg,DB08133,-7.3,N-(4-sulfamoylphenyl)-1H-indazole-3-carboxamide,MNHPHKFLWAPNOV-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
109799,6vxx,DB00270,-7.3,Isradipine,HMJIYCCIJYRONP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
9972,6lzg,DB08112,-7.3,N-({6-[(4-CYANO-2-FLUOROBENZYL)OXY]NAPHTHALEN-2-YL}SULFONYL)-D-GLUTAMIC ACID,IRJUSGUHNFMVCK-OAQYLSRUSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
67809,6lxt,DB07183,-7.3,N-(4-phenoxyphenyl)-2-[(pyridin-4-ylmethyl)amino]nicotinamide,CPVRYQAOUPSUDO-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
77795,6m2n,DB08801,-7.3,Dimetindene,MVMQESMQSYOVGV-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
67796,6lxt,DB07169,-7.3,"5R-(3,4-DICHLOROPHENYLMETHYL)-3-(2-THIOPHENESULFONYLAMINO)-4-OXO-2-THIONOTHIAZOLIDINE",GAOOBYJHWAKZKU-LLVKDONJSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
97025,6m71,DB13767,-7.3,Vorozole,XLMPPFTZALNBFS-INIZCTEOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
67795,6lxt,DB07168,-7.3,[4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-6-(methylamino)pyrimidin-2-yl}amino)phenyl]acetonitrile,MFMSRHREFZCFSN-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
77841,6m2n,DB08873,-7.3,Boceprevir,LHHCSNFAOIFYRV-DOVBMPENSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
97009,6m71,DB13741,-7.3,Ioglycamic acid,FZDZULUFHNDEDJ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
109913,6vxx,DB00584,-7.3,Enalapril,GBXSMTUPTTWBMN-XIRDDKMYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
91670,6m71,DB03361,-7.3,"2-{(9as)-9a-[(1s)-1-Hydroxyethyl]-2,7-Dimethyl-9a,10-Dihydro-5h-Pyrimido[4,5-D][1,3]Thiazolo[3,2-a]Pyrimidin-8-Yl}Ethyl Trihydrogen Diphosphate",UQFVHIGKDHNMJT-XPTSAGLGSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96935,6m71,DB13649,-7.3,Proquazone,JTIGKVIOEQASGT-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
64559,6lxt,DB01674,-7.3,[2-(1-Amino-2-Hydroxy-Propyl)-4-(4-Fluoro-1h-Indol-3-Ylmethyl)-5-Hydroxy-Imidazol-1-Yl]-Acetic Acid,AYMRQIHECFEMIQ-AYVTZFPOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
67783,6lxt,DB07154,-7.3,"(3R)-4-[(3R)-3-AMINO-4-(2,4,5-TRIFLUOROPHENYL)BUTANOYL]-3-METHYL-1,4-DIAZEPAN-2-ONE",SWKGZJAAGSVROJ-MWLCHTKSSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
96884,6m71,DB13579,-7.3,Mepixanox,PYSOHOOUXFWCFF-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
64580,6lxt,DB01700,-7.3,AICA ribonucleotide,NOTGFIUVDGNKRI-UUOKFMHZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
91710,6m71,DB03417,-7.3,1-(4-Tert-Butylcarbamoyl-Piperazine-1-Carbonyl)-3-(3-Guanidino-Propyl)-4-Oxo-Azetidine-2-Carboxylic Acid,BVNQCAHTTOIOEK-STQMWFEESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96829,6m71,DB13502,-7.3,Budipine,QIHLUZAFSSMXHQ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
9951,6lzg,DB08092,-7.3,3-fluoro-N-1H-indol-5-yl-5-morpholin-4-ylbenzamide,VMLSXFMXUNVCSK-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
90447,6m71,DB01748,-7.3,N-Benzyl-4-Sulfamoyl-Benzamide,CZKNSZUJCJHTTM-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97078,6m71,DB13837,-7.3,Doxefazepam,VOJLELRQLPENHL-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
109768,6vxx,DB00235,-7.3,Milrinone,PZRHRDRVRGEVNW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
74472,6m2n,DB03396,-7.3,"(E)-(2r,3r,4s,5r)-3,4,5-Trihydroxy-2-Methoxy-8,8-Dimethyl-Non-6-Enoic Acid ((3s,6r)-6-Hydroxy-2-Oxo-Azepan-3-Yl)-Amide",FVBBTOIQETYGOA-SDNORSGYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
97163,6m71,DB14008,-7.3,Hispidulin,IHFBPDAQLQOCBX-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97154,6m71,DB13989,-7.3,Epitizide,RINBGYCKMGDWPY-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
91568,6m71,DB03230,-7.3,Adenosine-5'-Propylphosphate,XAMXMSZRQHPMRX-QYVSTXNMSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97142,6m71,DB13958,-7.3,Trestolone acetate,IVCRCPJOLWECJU-XQVQQVTHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
64395,6lxt,DB01476,-7.3,Haloxazolam,XDKCGKQHVBOOHC-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
64397,6lxt,DB01479,-7.3,BA-2664,QGKQXZFZOIQFBI-XSWYFRFISA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
10091,6lzg,DB08240,-7.3,N-(4-CHLOROPHENYL)-3-(PHOSPHONOOXY)NAPHTHALENE-2-CARBOXAMIDE,RQAQWBFHPMSXKR-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
67837,6lxt,DB07217,-7.3,"N-(3-cyano-4,5,6,7-tetrahydro-1-benzothien-2-yl)-2-fluorobenzamide",YVYPYORTKAIUGJ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
64456,6lxt,DB01547,-7.3,Drotebanol,LCAHPIFLPICNRW-OPGCRTJHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
64410,6lxt,DB01493,-7.3,Ethylestrenol,AOXRBFRFYPMWLR-XGXHKTLJSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
10062,6lzg,DB08204,-7.3,3-DIPHENOL-6-NITRO-3H-BENZO[DE]ISOCHROMEN-1-ONE,FLWABCQDXUKNQY-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
74501,6m2n,DB03437,-7.3,"2-{1-[2-(2-Amino-Thiazol-4-Yl)-2-Methoxyimino-Acetylamino]-2-Oxo-Ethyl}-5,5-Dimethyl-Thiazolidine-4-Carboxylic Acid",YVNKGXXVZIQNIV-RKMXGKDGSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
10039,6lzg,DB08177,-7.3,(E)-3-(5((5-(4-CHLOROPHENYL)FURAN-2-YL)METHYLENE)-4-OXO-2-THIOXOTHIAZOLIDIN-3-YL)PROPANOIC ACID,YZLFZFALAZYTCI-NTEUORMPSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
64433,6lxt,DB01524,-7.3,Androstenediol,QADHLRWLCPCEKT-LOVVWNRFSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
109732,6vxx,DB15224,-7.3,Lisavanbulin,NIPZLALJRAHABJ-IBGZPJMESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
97095,6m71,DB13855,-7.3,Nifuroxazide,YCWSUKQGVSGXJO-NTUHNPAUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
64444,6lxt,DB01535,-7.3,Carfentanil,YDSDEBIZUNNPOB-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
64452,6lxt,DB01543,-7.3,18-methyl-19-nortestosterone,FBYZQDCRLYHHHP-ZOFHRBRSSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
64453,6lxt,DB01544,-7.3,Flunitrazepam,PPTYJKAXVCCBDU-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
97124,6m71,DB13937,-7.3,LGD-3303,OMXGOGXEWUCLFI-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
90437,6m71,DB01734,-7.3,3-(Oxalyl-Amino)-Naphthalene-2-Carboxylic Acid,DQBLKSRRWDWNKQ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
68435,6lxt,DB07917,-7.3,4-(BENZHYDRYLOXY)-1-[3-(1H-TETRAAZOL-5-YL)PROPYL]PIPERIDINE,TZQGXAHOROZEKN-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
98314,6vxs,DB00802,-7.3,Alfentanil,IDBPHNDTYPBSNI-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
62623,6crv,DB13823,-7.3,Pipemidic acid,JOHZPMXAZQZXHR-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
13140,6lzg,DB01092,-7.3,Ouabain,LPMXVESGRSUGHW-HBYQJFLCSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
13143,6lzg,DB14768,-7.3,PF-06459988,ODMXWZROLKITMS-RISCZKNCSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
62635,6crv,DB13840,-7.3,Hydroxyethylpromethazine,PDSVTRQOBUIQBQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62636,6crv,DB13841,-7.3,Clopenthixol,WFPIAZLQTJBIFN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
89634,6m71,DB00716,-7.3,Nedocromil,RQTOOFIXOKYGAN-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
80679,6m3m,DB00297,-7.3,Bupivacaine,LEBVLXFERQHONN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
27698,6cs2,DB00662,-7.3,Trimethobenzamide,FEZBIKUBAYAZIU-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
73480,6m2n,DB02090,-7.3,A Disubstituted Succinyl Caprolactam Hydroxymate Mmp3inhibitor,JLEGVELHGVWFGG-BBWFWOEESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
99573,6vxs,DB02427,-7.3,"2,4-Diamino-6-[N-(2',5'-Dimethoxybenzyl)-N-Methylamino]Quinazoline",YBJANOUTWRTBDK-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
73491,6m2n,DB02103,-7.3,2-Chlorodideoxyadenosine,FNLILOONPKMGST-NTSWFWBYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
107248,6vxx,DB02762,-7.3,RU79072,NQLPTOOPFMPCHQ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80654,6m3m,DB00269,-7.3,Chlorotrianisene,BFPSDSIWYFKGBC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80643,6m3m,DB00257,-7.3,Clotrimazole,VNFPBHJOKIVQEB-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
73502,6m2n,DB02116,-7.3,Olomoucine,GTVPOLSIJWJJNY-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
13158,6lzg,DB14795,-7.3,AZD-3759,MXDSJQHFFDGFDK-CYBMUJFWSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
19048,6cs2,HMDB0000739,-7.3,Isodesmosine,RGXCTRIQQODGIZ-UHFFFAOYSA-O,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
80631,6m3m,DB00242,-7.3,Cladribine,PTOAARAWEBMLNO-KVQBGUIXSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
68963,6lxt,DB08540,-7.3,"2-[4-(2H-1,4-BENZOTHIAZINE-3-YL)-PIPERAZINE-1-LY]-1,3-THIAZOLE-4-CARBOXYLIC ACID ETHYLESTER",AQJQFCRTSWIUCY-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
62622,6crv,DB13822,-7.3,Meprotixol,LAYVFLWAVIGDLK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
99633,6vxs,DB02504,-7.3,[3-(1-Benzyl-3-Carbamoylmethyl-2-Methyl-1h-Indol-5-Yloxy)-Propyl-]-Phosphonic Acid,AQEYCNKFBRLUOT-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
89621,6m71,DB00701,-7.3,Amprenavir,YMARZQAQMVYCKC-OEMFJLHTSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
13134,6lzg,DB14753,-7.3,Hydroxystilbamidine,TUESWZZJYCLFNL-DAFODLJHSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
107039,6vxx,DB02209,-7.3,Pyridoxine phosphate,WHOMFKWHIQZTHY-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
99784,6vxs,DB02703,-7.3,Fusidic acid,IECPWNUMDGFDKC-MZJAQBGESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
99778,6vxs,DB02696,-7.3,"6-Aminohexyl-Uridine-C1,5'-Diphosphate",MLWJBKPFDKRHBM-FMKGYKFTSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
99776,6vxs,DB02694,-7.3,Pantoyl Adenylate,GDPVENOGSVMRJL-FSRKKXLISA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
89554,6m71,DB00621,-7.3,Oxandrolone,QSLJIVKCVHQPLV-PEMPUTJUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
69048,6lxt,DB08646,-7.3,TRW3-(2-AMINO-3-HYDROXY-PROPYL)-6-(N'-CYCLOHEXYL-HYDRAZINO)OCTAHYDRO-INDOL-7-OL,PSUOZWHAKZSNOB-LBPRGKRZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
24263,6cs2,DB01967,-7.3,"N-{3-[(7ar,12as,12bs)-7-Oxo-1,3,4,6,7,7a,12a,12b-Octahydroindolo[2,3-a]Quinolizin-12(2h)-Yl]Propyl}Propane-2-Sulfonamide",LICJTIDRHJECTD-SFHVURJKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
24257,6cs2,DB01960,-7.3,7n-Methyl-8-Hydroguanosine-5'-Diphosphate,QQODJOAVWUWVHJ-KQYNXXCUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
24256,6cs2,DB01959,-7.3,"3,5-Dimethyl-1-(3-Nitrophenyl)-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester",MSYGAHOHLUJIKV-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
68960,6lxt,DB08537,-7.3,"3-bromo-6-phenyl-N-(pyrimidin-5-ylmethyl)imidazo[1,2-a]pyridin-8-amine",LZLKFNBMXXLTLX-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
107069,6vxx,DB02247,-7.3,Hydrolyzed Cephalothin,JRYZEMHNDUZNMI-RYUDHWBXSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62549,6crv,DB13724,-7.3,Nifuratel,SRQKTCXJCCHINN-NYYWCZLTSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80779,6m3m,DB00420,-7.3,Promazine,ZGUGWUXLJSTTMA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
56400,6crv,DB02278,-7.3,"7,8-Dihydro-7,7-Dimethyl-6-Hydroxypterin",JMLQSLXEUWNWFI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
24247,6cs2,DB01951,-7.3,Gpi-1046,OQAHHWOPVDDWHD-INIZCTEOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
107144,6vxx,DB02622,-7.3,2-(Oxalyl-Amino)-Benzoic Acid,QBYNNSFEMMNINN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107151,6vxx,DB02632,-7.3,4-nitrophenyl-beta-D-galactoside,IFBHRQDFSNCLOZ-YBXAARCKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62585,6crv,DB13775,-7.3,Tertatolol,HTWFXPCUFWKXOP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
69008,6lxt,DB08596,-7.3,5'-deoxy-5'-piperidin-1-ylthymidine,GMOUOGHZJCSNOZ-YNEHKIRRSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
99677,6vxs,DB02559,-7.3,"6-(Octahydro-1h-Indol-1-Ylmethyl)Decahydroquinazoline-2,4-Diamine",HDQIGGQUKAQTGU-SZTTVXCBSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
99724,6vxs,DB02623,-7.3,Aminophosphonic Acid-Guanylate Ester,ZGPDMUBRWRJAQQ-UUOKFMHZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
13116,6lzg,DB14716,-7.3,Clonazolam,XJRGLCAWBRZUFC-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
68959,6lxt,DB08536,-7.3,"3-bromo-5-phenyl-N-(pyrimidin-5-ylmethyl)pyrazolo[1,5-a]pyridin-7-amine",IBUPHWYGVDAASU-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
107317,6vxx,DB03155,-7.3,"1-(2-Deoxy-2-Fluoro-3-O-Phosphono-Beta-L-Ribofuranosyl)Pyrimidine-2,4(1h,3h)-Dione",IFIXUMAFUNKIAA-XVFCMESISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
89757,6m71,DB00861,-7.3,Diflunisal,HUPFGZXOMWLGNK-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
80275,6m2n,DB15038,-7.3,Litoxetine,MJJDYOLPMGIWND-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
62837,6crv,DB14545,-7.3,Hydrocortisone succinate,VWQWXZAWFPZJDA-CGVGKPPMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
99174,6vxs,DB01906,-7.3,"3-(5-Amino-7-Hydroxy-[1,2,3]Triazolo[4,5-D]Pyrimidin-2-Yl)-Benzoic Acid",KNLLRZNGRRRPEW-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
27760,6cs2,DB07313,-7.3,5-METHYL-2-[(PHENYLSULFONYL)AMINO]BENZOIC ACID,HXQLTRSIZRSFTR-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
80249,6m2n,DB14945,-7.3,Florbenazine F-18,GNKGXQHHUUEYQV-WTHAECTESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
89822,6m71,DB00934,-7.3,Maprotiline,QSLMDECMDJKHMQ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
99148,6vxs,DB01864,-7.3,5'-Guanosine-Diphosphate-Monothiophosphate,XOFLBQFBSOEHOG-UUOKFMHZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
56162,6crv,DB01962,-7.3,Phosphonotyrosine,DCWXELXMIBXGTH-QMMMGPOBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
99139,6vxs,DB01852,-7.3,Kaempherol,IYRMWMYZSQPJKC-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
62863,6crv,DB14633,-7.3,Prednisolone hemisuccinate,APGDTXUMTIZLCJ-CGVGKPPMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
89828,6m71,DB00941,-7.3,Hexafluronium,HDZAQYPYABGTCL-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
89862,6m71,DB00982,-7.3,Isotretinoin,SHGAZHPCJJPHSC-XFYACQKRSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
107554,6vxx,DB03753,-7.3,Flurbiprofen Methyl Ester,CPJBKHZROFMSQM-NSHDSACASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
68839,6lxt,DB08393,-7.3,"2-[(5,6-DIPHENYLFURO[2,3-D]PYRIMIDIN-4-YL)AMINO]ETHANOL",UQHINZSKNAAVOZ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
68836,6lxt,DB08390,-7.3,"(6S)-6-CYCLOPENTYL-6-[2-(3-FLUORO-4-ISOPROPOXYPHENYL)ETHYL]-4-HYDROXY-5,6-DIHYDRO-2H-PYRAN-2-ONE",AKNIHFDXRAOPAI-NRFANRHFSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
73627,6m2n,DB02282,-7.3,5'-Deoxy-5'-Methylthioadenosine,WUUGFSXJNOTRMR-IOSLPCCCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
56117,6crv,DB01903,-7.3,5-Bromo-2'-Deoxyuridine-5'-Monophosphate,LHLHVDBXXZVYJT-RRKCRQDMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
68834,6lxt,DB08388,-7.3,"5-(2-ETHOXYETHYL)-5-[4-(4-FLUOROPHENOXY)PHENOXY]PYRIMIDINE-2,4,6(1H,3H,5H)-TRIONE",XRSYNYGEEYTXJV-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
11076,6lzg,DB11376,-7.3,Azaperone,XTKDAFGWCDAMPY-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
24120,6cs2,DB01791,-7.3,Piclamilast,RRRUXBQSQLKHEL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
80286,6m2n,DB15058,-7.3,Flutemetamol,VVECGOCJFKTUAX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
56200,6crv,DB02017,-7.3,Imidazole-Derived Cellobiose,CSXOUJBOYXGFCL-OFKZETBZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107330,6vxx,DB03172,-7.3,Tubercidin,HDZZVAMISRMYHH-KCGFPETGSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27725,6cs2,DB07281,-7.3,"N-3-BENZYLPYRIDINE-2,3-DIAMINE",MUKAGFLFIMVSQN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
80599,6m3m,DB00205,-7.3,Pyrimethamine,WKSAUQYGYAYLPV-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80598,6m3m,DB00204,-7.3,Dofetilide,IXTMWRCNAAVVAI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
89688,6m71,DB00783,-7.3,Estradiol,VOXZDWNPVJITMN-ZBRFXRBCSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
99455,6vxs,DB02277,-7.3,1-(5-Tert-Butyl-2-Methyl-2h-Pyrazol-3-Yl)-3-(4-Chloro-Phenyl)-Urea,FWIJKWMXNHRSRO-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
89698,6m71,DB00796,-7.3,Candesartan cilexetil,GHOSNRCGJFBJIB-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
24170,6cs2,DB01850,-7.3,"(2s,3s,8s,9s)-3-Amino-9-Methoxy-2,6,8-Trimethyl-10-Phenyldeca-4,6-Dienoic Acid",HJVCHYDYCYBBQX-AWKNMOFVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
107365,6vxx,DB03216,-7.3,"(1'R,2'S)-9-(2-Hydroxy-3'-Keto-Cyclopenten-1-yl)Adenine",RQPALADHFYHEHK-CHKWXVPMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80615,6m3m,DB00226,-7.3,Guanadrel,HPBNRIOWI1FK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
89700,6m71,DB00799,-7.3,Tazarotene,OGQICQVSFDPSEI-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
99385,6vxs,DB02189,-7.3,"2',3'-Dideoxyadenosine-5'-Triphosphate",OAKPWEUQDVLTCN-NKWVEPMBSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
107411,6vxx,DB03272,-7.3,4-Bromo-3-(5'-Carboxy-4'-Chloro-2'-Fluorophenyl)-1-Methyl-5-Trifluoromethyl-Pyrazol,YNMHKERYELPEEF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62764,6crv,DB14094,-7.3,Tocopherylquinone,LTVDFSLWFKLJDQ-IEOSBIPESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
99323,6vxs,DB02102,-7.3,DMP450,KYRSNWPSSXSNEP-ZRTHHSRSSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
107437,6vxx,DB03592,-7.3,Pterin-6-Yl-Methyl-Monophosphate,AJXFJEHKGGCFNM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56206,6crv,DB02023,-7.3,8-Oxo-2'-Deoxy-Guanosine-5'-Monophosphate,AQIVLFLYHYFRKU-VPENINKCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
99266,6vxs,DB02030,-7.3,Alpha-Ribazole-5'-Phosphate,ZMRGXEJKZPRBPJ-SYQHCUMBSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
99259,6vxs,DB02020,-7.3,Alrestatin,GCUCIFQCGJIRNT-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
62814,6crv,DB14213,-7.3,Perindoprilat,ODAIHABQVKJNIY-PEDHHIEDSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
89728,6m71,DB00829,-7.3,Diazepam,AAOVKJBEBIDNHE-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
69063,6lxt,DB08662,-7.3,3-[1-(4-BROMO-PHENYL)-2-METHYL-PROPYL]-4-HYDROXY-CHROMEN-2-ONE,KGDWLSFLMSFPSU-INIZCTEOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
89540,6m71,DB00604,-7.3,Cisapride,DCSUBABJRXZOMT-IRLDBZIGSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
69066,6lxt,DB08665,-7.3,"6,11-DIHYDRO-11-ETHYL-6-METHYL-9-NITRO-5H-PYRIDO[2,3-B][1,5]BENZODIAZEPIN-5-ONE",YCFJZPGDTZVVSM-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
89265,6m71,DB00269,-7.3,Chlorotrianisene,BFPSDSIWYFKGBC-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
89295,6m71,DB00304,-7.3,Desogestrel,RPLCPCMSCLEKRS-BPIQYHPVSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
62252,6crv,DB13329,-7.3,Guaiazulen,FWKQNCXZGNBPFD-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81046,6m3m,DB00744,-7.3,Zileuton,MWLSOWXNZPKENC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
27563,6cs2,DB07111,-7.3,"(4S,5E,7Z,10Z,13Z,16Z,19Z)-4-hydroxydocosa-5,7,10,13,16,19-hexaenoic acid",IFRKCNPQVIJFAQ-HBUOOPIGSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
100213,6vxs,DB03272,-7.3,4-Bromo-3-(5'-Carboxy-4'-Chloro-2'-Fluorophenyl)-1-Methyl-5-Trifluoromethyl-Pyrazol,YNMHKERYELPEEF-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
100207,6vxs,DB03262,-7.3,"Al-6619, [2h-Thieno[3,2-E]-1,2-Thiazine-6-Sulfonamide,2-(3-Hydroxyphenyl)-3-(4-Morpholinyl)-, 1,1-Dioxide]",PZLYYZPXSSNGJS-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
69225,6lxt,DB08864,-7.3,Rilpivirine,YIBOMRUWOWDFLG-ONEGZZNKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
11279,6lzg,DB11751,-7.3,Cabotegravir,WCWSTNLSLKSJPK-LKFCYVNXSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
100170,6vxs,DB03220,-7.3,FR233623,OODDZQQDDOVCFD-SCLBCKFNSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
24359,6cs2,DB02082,-7.3,Phosphoaminophosphonic Acid Guanylate Ester,UQABYHGXWYXDTK-UUOKFMHZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
13076,6lzg,DB14649,-7.3,Dexamethasone acetate,AKUJBENLRBOFTD-RPRRAYFGSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
18886,6cs2,HMDB0038365,-7.3,(+)-Gallocatechin,XMOCLSLCDHWDHP-SWLSCSKDSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
56625,6crv,DB02566,-7.3,8-Hydroxy-4-(1-Hydroxyethyl)Quinoline-2-Carboxylic Acid,FCGZNXGKWUHBKD-WKEGUHRASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80994,6m3m,DB00684,-7.3,Tobramycin,NLVFBUXFDBBNBW-PBSUHMDJSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80990,6m3m,DB00679,-7.3,Thioridazine,KLBQZWRITKRQQV-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
27600,6cs2,DB07149,-7.3,"(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluoroethyl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one",LCBAQTCTQXHTJG-ZETCQYMHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
106785,6vxx,DB01247,-7.3,Isocarboxazid,XKFPYPQQHFEXRZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
13080,6lzg,DB14653,-7.3,Clocortolone caproate,MMTRTBFDFNRBQO-ANHDKODLSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
24380,6cs2,DB02104,-7.3,"2,4-Diamino-5-Methyl-6-[(3,4,5-Trimethoxy-N-Methylanilino)Methyl]Pyrido[2,3-D]Pyrimidine",PEGMMEYCSOZKIT-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
106681,6vxx,DB00890,-7.3,Dienestrol,NFDFQCUYFHCNBW-SCGPFSFSSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
89251,6m71,DB00252,-7.3,Phenytoin,CXOFVDLJLONNDW-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
69266,6lxt,DB08934,-7.3,Sofosbuvir,TTZHDVOVKQGIBA-IQWMDFIBSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
81268,6m3m,DB01002,-7.3,Levobupivacaine,LEBVLXFERQHONN-INIZCTEOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
27496,6cs2,DB07040,-7.3,"2-amino-7-fluoro-5-oxo-5H-chromeno[2,3-b]pyridine-3-carboxamide",GCHMLYYPYFXLQB-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
89085,6m3m,DB15436,-7.3,Glucoraphanin,GMMLNKINDDUDCF-JRWRFYLSSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
11337,6lzg,DB11828,-7.3,Neratinib,JWNPDZNEKVCWMY-VQHVLOKHSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
106568,6vxx,DB00499,-7.3,Flutamide,MKXKFYHWDHIYRV-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
89147,6m71,DB00136,-7.3,Calcitriol,GMRQFYUYWCNGIN-NKMMMXOESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
89151,6m71,DB00140,-7.3,Riboflavin,AUNGANRZJHBGPY-SCRDCRAPSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
100401,6vxs,DB03534,-7.3,3-[(Acetyl-Methyl-Amino)-Methyl]-4-Amino-N-Methyl-N-(1-Methyl-1h-Indol-2-Ylmethyl)-Benzamide,AWTBJNJPBKTHEV-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
69306,6lxt,DB08984,-7.3,Etofenamate,XILVEPYQJIOVNB-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
100115,6vxs,DB03148,-7.3,Phosphomethylphosphonic Acid Adenosyl Ester,OLCWZBFDIYXLAA-IOSLPCCCSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
81234,6m3m,DB00961,-7.3,Mepivacaine,INWLQCZOYSRPNW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
27512,6cs2,DB07056,-7.3,"2-(6-{[(3-chloro-2-methylphenyl)sulfonyl]amino}pyridin-2-yl)-N,N-diethylacetamide",JNWQLOFSMUGRNY-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
81196,6m3m,DB00917,-7.3,Dinoprostone,XEYBRNLFEZDVAW-ARSRFYASSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
56767,6crv,DB02758,-7.3,Indolylpropionic Acid,GOLXRNDWAUTYKT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56762,6crv,DB02752,-7.3,Tosyl-D-Proline,CGPHGPCHVUSFFA-LLVKDONJSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81193,6m3m,DB00914,-7.3,Phenformin,ICFJFFQQTFMIBG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
69280,6lxt,DB08954,-7.3,Ifenprodil,UYNVMODNBIQBMV-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
27523,6cs2,DB07067,-7.3,"(2S,3S)-3-{3-[4-(METHYLSULFONYL)PHENYL]-1,2,4-OXADIAZOL-5-YL}-1-OXO-1-PYRROLIDIN-1-YLBUTAN-2-AMINE",SQCDMTZMCHZYGO-FZMZJTMJSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
106652,6vxx,DB00857,-7.3,Terbinafine,DOMXUEMWDBAQBQ-WEVVVXLNSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
89239,6m71,DB00239,-7.3,Oxiconazole,QRJJEGAJXVEBNE-HKOYGPOVSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
106591,6vxx,DB00788,-7.3,Naproxen,CMWTZPSULFXXJA-VIFPVBQESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
89348,6m71,DB00370,-7.3,Mirtazapine,RONZAEMNMFQXRA-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
11255,6lzg,DB11718,-7.3,Encorafenib,CMJCXYNUCSMDBY-ZDUSSCGKSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
106793,6vxx,DB01262,-7.3,Decitabine,XAUDJQYHKZQPEU-KVQBGUIXSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
11204,6lzg,DB11650,-7.3,HT-0712,ABEJDMOBAFLQNJ-NHCUHLMSSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
11202,6lzg,DB11648,-7.3,Afuresertib,AFJRDFWMXUECEW-LBPRGKRZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
89491,6m71,DB00546,-7.3,Adinazolam,GJSLOMWRLALDCT-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
62400,6crv,DB13528,-7.3,Chlormadinone,VUHJZBBCZGVNDZ-TTYLFXKOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62402,6crv,DB13530,-7.3,Mepindolol,NXWGWUVGUSFQJC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27641,6cs2,DB07192,-7.3,(3S)-N-(3-BROMOPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE,MVPIURCUINFSAB-LBPRGKRZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
73387,6m2n,DB01965,-7.3,"2'-Deoxyuridine 5'-Alpha,Beta-Imido-Triphosphate",XZLLMTSKYYYJLH-SHYZEUOFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
73391,6m2n,DB01972,-7.3,Guanosine-5'-Monophosphate,RQFCJASXJCIDSX-UUOKFMHZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
106979,6vxx,DB01825,-7.3,2-Amino-8-Methylquinazolin-4(3h)-One,NLLZAHIPYDRNRQ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
13096,6lzg,DB14669,-7.3,Betamethasone phosphate,VQODGRNSFPNSQE-DVTGEIKXSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
24307,6cs2,DB02021,-7.3,Fidarestat,WAAPEIZFCHNLKK-UFBFGSQYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
99922,6vxs,DB02889,-7.3,"4-O-(4,6-Dideoxy-4-{[4,5,6-Trihydroxy-3-(Hydroxymethyl)Cyclohex-2-En-1-Yl]Amino}-Beta-D-Lyxo-Hexopyranosyl)-Alpha-D-Erythro-Hexopyranose",SNMISNLUIRCRQE-SFSRYZOZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
62425,6crv,DB13557,-7.3,Thiopropazate,AIUHRQHVWSUTGJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
73395,6m2n,DB01976,-7.3,Aminoanthracene,YUENFNPLGJCNRB-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
56456,6crv,DB02357,-7.3,Methyl-O3-(Alpha-D-Mannose)-Alpha-D-Mannose,WOKXHOIRHHAHDA-ZEEOCKJESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
89517,6m71,DB00578,-7.3,Carbenicillin,FPPNZSSZRUTDAP-UWFZAAFLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
99910,6vxs,DB02872,-7.3,"Cis-[4,5-Bis-(4-Bromophenyl)-2-(2-Ethoxy-4-Methoxyphenyl)-4,5-Dihydroimidazol-1-Yl]-[4-(2-Hydroxyethyl)Piperazin-1-Yl]Methanone",PVRYEWOXWGDQHA-URLMMPGGSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
56452,6crv,DB02350,-7.3,"N-Hydroxy-4-[(4-Methoxylphenyl)Sulfonyl]-2,2-Dimethyl-Hexahydro-1,4-Thiazepine-3(S)-Carboxamide",CYYCSKFJEOSZTF-CYBMUJFWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56450,6crv,DB02347,-7.3,2-Amino-3-(5-Tert-Butyl-3-(Phosphonomethoxy)-4-Isoxazolyl)Propionic Acid,AGSOOCUNMTYPSE-ZETCQYMHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
89526,6m71,DB00587,-7.3,Cinalukast,BZMKNPGKXJAIDV-VAWYXSNFSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
24305,6cs2,DB02019,-7.3,Acetyl Dithranol,IXLRLZOYKJERRA-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
62911,6crv,DB14701,-7.3,Ethyl 8-hydroxy-alpha-(2-propynylamino)-5-quinolinepropanoate,IQZXIKMXXCLFOK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
100013,6vxs,DB03009,-7.3,2-[(2-Oxo-2-Piperidin-1-Ylethyl)Thio]-6-(Trifluoromethyl)Pyrimidin-4(1h)-One,UDBHGUOSOKOIAX-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
73377,6m2n,DB01954,-7.3,Rolipram,HJORMJIFDVBMOB-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
24346,6cs2,DB02069,-7.3,N-(2-Flouro-Benzyl)-4-Sulfamoyl-Benzamide,ULYMHSXFSKOHGH-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
106801,6vxx,DB01280,-7.3,Nelarabine,IXOXBSCIXZEQEQ-UHTZMRCNSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62331,6crv,DB13431,-7.3,Proglumide,DGMKFQYCZXERLX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
89355,6m71,DB00378,-7.3,Dydrogesterone,JGMOKGBVKVMRFX-HQZYFCCVSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
69173,6lxt,DB08789,-7.3,"2-AMINO-4-(2,4-DICHLOROPHENYL)-N-ETHYLTHIENO[2,3-D]PYRIMIDINE-6-CARBOXAMIDE",YPEOXUOUTBMBCX-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
89387,6m71,DB00417,-7.3,Phenoxymethylpenicillin,BPLBGHOLXOTWMN-MBNYWOFBSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
89394,6m71,DB00425,-7.3,Zolpidem,ZAFYATHCZYHLPB-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
69151,6lxt,DB08763,-7.3,[N-(BENZYLOXYCARBONYL)AMINO](4-AMIDINOPHENYL)METHANE-PHOSPHONATE,FSNDLCSOLUMYRH-OAHLLOKOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
80909,6m3m,DB00581,-7.3,Lactulose,JCQLYHFGKNRPGE-FCVZTGTOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
62373,6crv,DB13489,-7.3,Bamipine,VZSXTYKGYWISGQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80904,6m3m,DB00576,-7.3,Sulfamethizole,VACCAVUAMIDAGB-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
27618,6cs2,DB07169,-7.3,"5R-(3,4-DICHLOROPHENYLMETHYL)-3-(2-THIOPHENESULFONYLAMINO)-4-OXO-2-THIONOTHIAZOLIDINE",GAOOBYJHWAKZKU-LLVKDONJSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
73361,6m2n,DB01937,-7.3,Guanosine-2'-Monophosphate,WTIFIAZWCCBCGE-UUOKFMHZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
106845,6vxx,DB01382,-7.3,Glymidine,QFWPJPIVLCBXFJ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62358,6crv,DB13469,-7.3,Phanquinone,VLPADTBFADIFKG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80891,6m3m,DB00557,-7.3,Hydro1ine,ZQDWXGKKHFNSQK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
56537,6crv,DB02454,-7.3,5-(6-Amino-9h-Purin-9-Yl)-4-Hydroxytetrahydrofuran-3-Yl Dihydrogen Phosphate,IJEJRDCFMFEDGL-AFEQZKEHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106865,6vxx,DB01416,-7.3,Cefpodoxime,WYUSVOMTXWRGEK-HBWVYFAYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
22862,6cs2,HMDB0055235,-7.3,"TG(18:3(9Z,12Z,15Z)/20:3(5Z,8Z,11Z)/20:5(5Z,8Z,11Z,14Z,17Z))",FBORIUPMVVLKEO-MWSZMMAXSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
89449,6m71,DB00490,-7.3,Buspirone,QWCRAEMEVRGPNT-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
89439,6m71,DB00479,-7.3,Amikacin,LKCWBDHBTVXHDL-RMDFUYIESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
24419,6cs2,DB02154,-7.3,"2,3-Bis-Benzo[1,3]Dioxol-5-Ylmethyl-Succinic Acid",FFYBYVPVYLMLAR-KBPBESRZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
68831,6lxt,DB08385,-7.3,4-(quinolin-3-ylmethyl)piperidine-1-carboxylic acid,QUAGUFNCKDDJFZ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
98984,6vxs,DB01645,-7.3,Genistein,TZBJGXHYKVUXJN-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
79634,6m2n,DB13541,-7.3,Iprazochrome,XZKVIDLLLOUTSS-ZSOIEALJSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
13298,6lzg,DB15102,-7.3,Pemigatinib,HCDMJFOHIXMBOV-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
98552,6vxs,DB01071,-7.3,Mequitazine,HOKDBMAJZXIPGC-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
90245,6m71,DB01497,-7.3,Etorphine,CAHCBJPUTCKATP-HBDRVVKHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
28062,6cs2,DB07635,-7.3,bis(4-hydroxyphenyl)methanone,RXNYJUSEXLAVNQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
108184,6vxx,DB07199,-7.3,"(2S,4S,5R)-1-(4-TERT-BUTYLBENZOYL)-2-ISOBUTYL-5-(1,3-THIAZOL-2-YL)PYRROLIDINE-2,4-DICARBOXYLIC ACID",SWYJAQWTBADJTB-RHGYRFJNSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55585,6crv,DB01174,-7.3,Phenobarbital,DDBREPKUVSBGFI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
90257,6m71,DB01513,-7.3,"17Alpha-methyl-3beta,17beta-dihydroxy-5alpha-androstane",QGKQXZFZOIQFBI-UYEYMFBJSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
55582,6crv,DB01171,-7.3,Moclobemide,YHXISWVBGDMDLQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
90261,6m71,DB01518,-7.3,Benzethidine,UVTBZAWTRVBTMK-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
63354,6lxt,DB00178,-7.3,Ramipril,HDACQVRGBOVJII-JBDAPHQKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
79595,6m2n,DB13487,-7.3,Iodine (131I) norcholesterol,QJHZPCLORSPENH-DRTKWHMQSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
98529,6vxs,DB01046,-7.3,Lubiprostone,WGFOBBZOWHGYQH-MXHNKVEKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
98497,6vxs,DB01009,-7.3,Ketoprofen,DKYWVDODHFEZIM-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
90263,6m71,DB01521,-7.3,Clostebol,KCZCIYZKSLLNNH-FBPKJDBXSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
108207,6vxx,DB07228,-7.3,1-(5-CHLORO-2-METHOXYPHENYL)-3-{6-[2-(DIMETHYLAMINO)-1-METHYLETHOXY]PYRAZIN-2-YL}UREA,GIAYFZLMPSVQDV-NSHDSACASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55560,6crv,DB01145,-7.3,Sulfoxone,NEDPPCHNEOMTJV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
98474,6vxs,DB00983,-7.3,Formoterol,BPZSYCZIITTYBL-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
108212,6vxx,DB07234,-7.3,"3-{[(1R)-1-phenylethyl]amino}-4-(pyridin-4-ylamino)cyclobut-3-ene-1,2-dione",MCBPNFWHHNJTGN-LLVKDONJSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
63318,6lxt,DB00140,-7.3,Riboflavin,AUNGANRZJHBGPY-SCRDCRAPSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
108169,6vxx,DB07182,-7.3,(2S)-2-(3-{[AMINO(IMINO)METHYL]AMINO}PHENYL)-3-[(S)-HYDROXY(3-PHENYLPROPYL)PHOSPHORYL]PROPANOIC ACID,HFRHWTYCVGKGIE-KRWDZBQOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
90209,6m71,DB01456,-7.3,5-androstenedione,SQGZFRITSMYKRH-QAGGRKNESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
63309,6lxt,DB00131,-7.3,Adenosine phosphate,UDMBCSSLTHHNCD-KQYNXXCUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
98698,6vxs,DB01240,-7.3,Epoprostenol,KAQKFAOMNZTLHT-OZUDYXHBSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
98692,6vxs,DB01234,-7.3,Dexamethasone,UREBDLICKHMUKA-CXSFZGCWSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
28003,6cs2,DB07571,-7.3,"N-2-[(BENZYLOXY)CARBONYL]-N-[(1S,2S)-2-HYDROXY-1-(4-HYDROXYBENZYL)PROPYL]-L-LEUCINAMIDE",ZUWYQZGBCBSHFK-HSQYWUDLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
68635,6lxt,DB08141,-7.3,"4-{[(2,6-difluorophenyl)carbonyl]amino}-N-[(3S)-piperidin-3-yl]-1H-pyrazole-3-carboxamide",KOMNQBZWMCFDTQ-VIFPVBQESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
10846,6lzg,DB09177,-7.3,p-Fluorofentanyl,KXUBAVLIJFTASZ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
98686,6vxs,DB01224,-7.3,Quetiapine,URKOMYMAXPYINW-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
79740,6m2n,DB13680,-7.3,Naftazone,TZGBBMBARSFJBG-UKTHLTGXSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
90183,6m71,DB01426,-7.3,Ajmaline,CJDRUOGAGYHKKD-HEFSZTOGSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
68628,6lxt,DB08133,-7.3,N-(4-sulfamoylphenyl)-1H-indazole-3-carboxamide,MNHPHKFLWAPNOV-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
28087,6cs2,DB00701,-7.3,Amprenavir,YMARZQAQMVYCKC-OEMFJLHTSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
98632,6vxs,DB01165,-7.3,Ofloxacin,GSDSWSVVBLHKDQ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
98624,6vxs,DB01155,-7.3,Gemifloxacin,ZRCVYEYHRGVLOC-HYARGMPZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
98620,6vxs,DB01150,-7.3,Cefprozil,WDLWHQDACQUCJR-PBFPGSCMSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
55632,6crv,DB01227,-7.3,Levacetylmethadol,XBMIVRRWGCYBTQ-AVRDEDQJSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108158,6vxx,DB07170,-7.3,"5'-FLUORO-2',5'-DIDEOXYADENOSINE",QKUCDAPGYBWICH-RRKCRQDMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79669,6m2n,DB13588,-7.3,Naftidrofuryl,KBAFPSLPKGSANY-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79655,6m2n,DB13566,-7.3,Sequifenadine,OXDOWGVJMITMJL-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
28050,6cs2,DB07624,-7.3,"1-{[(3R)-3-methyl-4-({4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]phenyl}sulfonyl)piperazin-1-yl]methyl}cyclopropanecarboxamide",YJFULAYRAKPBCY-DYVFJYSZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
79654,6m2n,DB13564,-7.3,Zipeprol,VSTNNAYSCJQCQI-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
68613,6lxt,DB08116,-7.3,"(3R)-4-{[(3,4-dihydroxyphenyl)acetyl]oxy}-N-(2-formylindolizin-3-yl)-3-sulfino-D-valine",DEOZLEGRVHDNKC-UGKGYDQZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
108152,6vxx,DB07163,-7.3,5-[(2-AMINOETHYL)AMINO]-6-FLUORO-3-(1H-PYRROL-2-YL)BENZO[CD]INDOL-2(1H)-ONE,CQCXWWWNUFQYJS-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
23811,6cs2,DB01450,-7.3,Dihydroetorphine,BRTSNYPDACNMIP-FAWZKKEFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
28088,6cs2,DB07663,-7.3,"2-[(1R)-1-CARBOXY-2-(4-HYDROXYPHENYL)ETHYL]-1,3-DIOXOISOINDOLINE-5-CARBOXYLIC ACID",QISJEFYTLZTWIQ-CQSZACIVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
79555,6m2n,DB13431,-7.3,Proglumide,DGMKFQYCZXERLX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
90335,6m71,DB01603,-7.3,Meticillin,RJQXTJLFIWVMTO-TYNCELHUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
79443,6m2n,DB13286,-7.3,Bumadizone,FLWFHHFTIRLFPV-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
98354,6vxs,DB00846,-7.3,Flurandrenolide,POPFMWWJOGLOIF-XWCQMRHXSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
108349,6vxx,DB07652,-7.3,"1-[2-DEOXYRIBOFURANOSYL]-2,4-DIFLUORO-5-METHYL-BENZENE-5'MONOPHOSPHATE",NMMWBGNJJMNAIJ-QJPTWQEYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
73945,6m2n,DB02696,-7.3,"6-Aminohexyl-Uridine-C1,5'-Diphosphate",MLWJBKPFDKRHBM-FMKGYKFTSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
10718,6lzg,DB08975,-7.3,Florantyrone,QOBAOSCOLAGPKI-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
73948,6m2n,DB02699,-7.3,4-Oxoretinol,PLIUCYCUYQIBDZ-RMWYGNQTSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
90340,6m71,DB01608,-7.3,Periciazine,LUALIOATIOESLM-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
28186,6cs2,DB00712,-7.3,Flurbiprofen,SYTBZMRGLBWNTM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
55401,6crv,DB00961,-7.3,Mepivacaine,INWLQCZOYSRPNW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28187,6cs2,DB07768,-7.3,Epitestosterone,MUMGGOZAMZWBJJ-KZYORJDKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
10716,6lzg,DB08973,-7.3,Fluclorolone acetonide,NJNWEGFJCGYWQT-VSXGLTOVSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
23741,6cs2,DB00227,-7.3,Lovastatin,PCZOHLXUXFIOCF-BXMDZJJMSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
13329,6lzg,DB15156,-7.3,ABT-072,XMZSTQYSBYEENY-RMKNXTFCSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
55385,6crv,DB00942,-7.3,Cycrimine,SWRUZBWLEWHWRI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
90349,6m71,DB01619,-7.3,Phenindamine,ISFHAYSTHMVOJR-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
108373,6vxx,DB07684,-7.3,5-(DIMETHYLAMINO)-2-NAPHTHALENESULFONIC ACID,VENHBDIMAAXWKI-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28199,6cs2,DB07780,-7.3,Farnesyl diphosphate,VWFJDQUYCIWHTN-YFVJMOTDSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
98316,6vxs,DB00805,-7.3,Minaprine,LDMWSLGGVTVJPG-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
108332,6vxx,DB07633,-7.3,octyl 3-deoxy-2-O-(6-deoxy-alpha-L-galactopyranosyl)-beta-D-xylo-hexopyranoside,FBVFDKBCZLMLQT-PPCMOIRNSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55435,6crv,DB01002,-7.3,Levobupivacaine,LEBVLXFERQHONN-INIZCTEOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79452,6m2n,DB13303,-7.3,Febarbamate,QHZQILHUJDRDAI-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
63481,6lxt,DB00327,-7.3,Hydromorphone,WVLOADHCBXTIJK-YNHQPCIGSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
79534,6m2n,DB13405,-7.3,Mefruside,SMNOERSLNYGGOU-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
63410,6lxt,DB00243,-7.3,Ranolazine,XKLMZUWKNUAPSZ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
90283,6m71,DB01541,-7.3,Boldenone,RSIHSRDYCUFFLA-DYKIIFRCSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
55525,6crv,DB01103,-7.3,Quinacrine,GPKJTRJOBQGKQK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
90303,6m71,DB01561,-7.3,Androstanedione,RAJWOBJTTGJROA-WZNAKSSCSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
108265,6vxx,DB07551,-7.3,"(2S)-2-{[4-chloro-6-(ethylamino)-1,3,5-triazin-2-yl]amino}-2-methylbutanenitrile",IUCVBFHDSFSEIK-JTQLQIEISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
90309,6m71,DB01567,-7.3,Fludiazepam,ROYOYTLGDLIGBX-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
79493,6m2n,DB13349,-7.3,Talastine,LCAAMXMULMCKLJ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
13321,6lzg,DB15141,-7.3,Deutivacaftor,PURKAOJPTOLRMP-ASMGOKTBSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
63398,6lxt,DB00231,-7.3,Temazepam,SEQDDYPDSLOBDC-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
90311,6m71,DB01569,-7.3,Formebolone,AMVODTGMYSRMNP-GNIMZFFESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
98385,6vxs,DB00881,-7.3,Quinapril,JSDRRTOADPPCHY-HSQYWUDLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
98378,6vxs,DB00873,-7.3,Loteprednol,YPZVAYHNBBHPTO-MXRBDKCISA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
63474,6lxt,DB00318,-7.3,Codeine,OROGSEYTTFOCAN-DNJOTXNNSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
79458,6m2n,DB13309,-7.3,Benproperine,JTUQXGZRVLWBCR-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
55449,6crv,DB01018,-7.3,Guanfacine,INJOMKTZOLKMBF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28161,6cs2,DB07742,-7.3,"N-(2,3-DIFLUORO-BENZYL)-4-SULFAMOYL-BENZAMIDE",QASSMVGOSBNFQY-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
63479,6lxt,DB00323,-7.3,Tolcapone,MIQPIUSUKVNLNT-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
55444,6crv,DB01011,-7.3,Metyrapone,FJLBFSROUSIWMA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28165,6cs2,DB07746,-7.3,3-ETHYL-6-{[(4-FLUOROPHENYL)SULFONYL]AMINO}-2-METHYLBENZOIC ACID,MGUQWAOYPINSIT-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
10743,6lzg,DB00834,-7.3,Mifepristone,VKHAHZOOUSRJNA-GCNJZUOMSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
23816,6cs2,DB01455,-7.3,19-Nor-5-androstenediol,VVUQRXPUVKXAIO-XFUVECHXSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
13279,6lzg,DB15065,-7.3,PF-06291874,IBDYYOQKQCCSDP-QFIPXVFZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
23823,6cs2,DB01462,-7.3,Etonitazene,PXDBZSCGSQSKST-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
27826,6cs2,DB07383,-7.3,"N-(1-BENZYL-3,3,3-TRIFLUORO-2,2-DIHYDROXY-PROPYL)-ACETAMIDE",NETPVFJEHOGNPJ-JTQLQIEISA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
68783,6lxt,DB08322,-7.3,"2-DEOXY-3,4-BIS-O-[3-(4-HYDROXYPHENYL)PROPANOYL]-L-THREO-PENTARIC ACID",VJLMRHSHSNLOGC-NOPZTHQXSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
107837,6vxx,DB04681,-7.3,BETA-METHYLLACTOSIDE,FHNIYFZSHCGBPP-ABBMIVAOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
63025,6crv,DB14945,-7.3,Florbenazine F-18,GNKGXQHHUUEYQV-WTHAECTESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27842,6cs2,DB07400,-7.3,1-ETHOXYCARBONYL-D-PHE-PRO-2(4-AMINOBUTYL)HYDRAZINE,AEHSFPPTWRQOFS-MSOLQXFVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
68774,6lxt,DB08313,-7.3,nocodazole,KYRVNWMVYQXFEU-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
68770,6lxt,DB08308,-7.3,"SUCCINIC ACID MONO-(13-METHYL-3-OXO-2,3,6,7,8,9,10,11,12,13,14,15,16,17-TETRADECAHYDRO-1H-CYCLOPENTA[A]PHENANTHREN-17-YL) ESTER",IRQUJNVGEAJGSD-KIEDKLRZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
98877,6vxs,DB01524,-7.3,Androstenediol,QADHLRWLCPCEKT-LOVVWNRFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
55968,6crv,DB01700,-7.3,AICA ribonucleotide,NOTGFIUVDGNKRI-UUOKFMHZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79932,6m2n,DB13989,-7.3,Epitizide,RINBGYCKMGDWPY-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
68763,6lxt,DB08301,-7.3,N-({[4-(AMINOSULFONYL)PHENYL]AMINO}CARBONYL)-4-METHYLBENZENESULFONAMIDE,HDCXQTPVTAIPNZ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
79931,6m2n,DB13988,-7.3,SB-269970,HWKROQUZSKPIKQ-MRXNPFEDSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
23957,6cs2,DB01602,-7.3,Bacampicillin,PFOLLRNADZZWEX-FFGRCDKISA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
68756,6lxt,DB08293,-7.3,"(5E)-12-CHLORO-13,15-DIHYDROXY-4,7,8,9-TETRAHYDRO-2-BENZOXACYCLOTRIDECINE-1,10(3H,11H)-DIONE",AQKZYZQONWDDLS-HNQUOIGGSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
55952,6crv,DB01681,-7.3,Benzene Hexacarboxylic Acid,YDSWCNNOKPMOTP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
98867,6vxs,DB01512,-7.3,Hydromorphinol,AABLHGPVOULICI-BRJGLHKUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
27868,6cs2,DB07427,-7.3,2-[(2-methoxy-5-methylphenoxy)methyl]pyridine,AVXQTLSOXWQOHO-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
68744,6lxt,DB08274,-7.3,"6,7,8,9-TETRAHYDRO-4-HYDROXY-3-(1-PHENYLPROPYL)CYCLOHEPTA[B]PYRAN-2-ONE",YKJXQZGJGDTEOC-AWEZNQCLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
13257,6lzg,DB15029,-7.3,AZD-8186,LMJFJIDLEAWOQJ-CQSZACIVSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
107808,6vxx,DB04642,-7.3,"7-{2,6-DICHLORO-4-[3-(2-CHLORO-BENZOYL)-UREIDO]-PHENOXY}-HEPTANOIC ACID",XQTOWNDCHQJXOQ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
63010,6crv,DB14921,-7.3,Mavacamten,RLCLASQCAPXVLM-NSHDSACASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79968,6m2n,DB14063,-7.3,Dexverapamil,SGTNSNPWRIOYBX-HHHXNRCGSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
107807,6vxx,DB04641,-7.3,"3,7-DIHYDROXYNAPHTHALENE-2-CARBOXYLIC ACID",QMWOUSYSNFCKAZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62937,6crv,DB14763,-7.3,Cycloguanil,QMNFFXRFOJIOKZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107655,6vxx,DB04143,-7.3,Indole-3-Glycerol Phosphate,NQEQTYPJSIEPHW-MNOVXSKESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107659,6vxx,DB04149,-7.3,(R)-Rolipram,HJORMJIFDVBMOB-LBPRGKRZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107660,6vxx,DB04150,-7.3,Threonine Derivative,TWMKRGDZEJLDDH-LKXWSVAYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80043,6m2n,DB14221,-7.3,Beclomethasone 17-monopropionate,OHYGPBKGZGRQKT-XGQKBEPLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
89914,6m71,DB01041,-7.3,Thalidomide,UEJJHQNACJXSKW-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
68812,6lxt,DB08360,-7.3,"2-(4-ETHYLPIPERAZIN-1-YL)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE",BIFHJPUTQBOBGJ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
107683,6vxx,DB04176,-7.3,"Phosporic Acid Mono-[3,4-Dihydroxy-5-(5-Methoxy-Benzoimidazol-1-Yl)-Tetrahydro-Furan-2-Ylmethyl] Ester",VYUPJUKSTVHSQI-LPWJVIDDSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
98937,6vxs,DB01589,-7.3,Quazepam,IKMPWMZBZSAONZ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
79917,6m2n,DB13955,-7.3,Estradiol dienanthate,OVAHZPTYWMWNKO-CAHAWPIUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
89923,6m71,DB01053,-7.3,Benzylpenicillin,JGSARLDLIJGVTE-MBNYWOFBSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
11007,6lzg,DB11115,-7.3,Ensulizole,UVCJGUGAGLDPAA-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
79998,6m2n,DB14122,-7.3,Dihydroxymethoxychalcone,NYSZJNUIVUBQMM-BQYQJAHWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
73672,6m2n,DB02346,-7.3,3'-O-N-Octanoyl-a-D-Glucopyranosyl-B-D-Fructofuranoside,NMVDZWILYFXVBZ-PQJCEUABSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79981,6m2n,DB14083,-7.3,Bisphenol A diglycidyl ether,LCFVJGUPQDGYKZ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
27820,6cs2,DB00675,-7.3,Tamoxifen,NKANXQFJJICGDU-QPLCGJKRSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
68791,6lxt,DB08331,-7.3,"N-1H-imidazol-2-yl-N'-[4-(1H-imidazol-2-ylamino)phenyl]benzene-1,4-diamine",JHMXUERQMCJRHG-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
98911,6vxs,DB01558,-7.3,Bromazepam,VMIYHDSEFNYJSL-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
79975,6m2n,DB14071,-7.3,Desmethylsertraline,SRPXSILJHWNFMK-ZBEGNZNMSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
98898,6vxs,DB01545,-7.3,Ethyl loflazepate,CUCHJCMWNFEYOM-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
107745,6vxx,DB04561,-7.3,"4-Acetamido-2,4-Didexoy-D-Glycero-Beta-D-Galacto-Octopyranosylphosphonic Acid",QITAGYVZDNZULE-HDBWYCHPSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107947,6vxx,DB05786,-7.3,Irofulven,NICJCIQSJJKZAH-AWEZNQCLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27883,6cs2,DB07443,-7.3,(2Z)-N-biphenyl-4-yl-2-cyano-3-hydroxybut-2-enamide,MUVPBAIVOHJDOC-VBKFSLOCSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
55897,6crv,DB01611,-7.3,Hydroxychloroquine,XXSMGPRMXLTPCZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55801,6crv,DB01498,-7.3,Alphamethadol,QIRAYNIFEOXSPW-YLJYHZDGSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79828,6m2n,DB13797,-7.3,Iodocholesterol (131I),FIOAEFCJGZJUPW-ODFYUTSGSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
90136,6m71,DB01340,-7.3,Cilazapril,HHHKFGXWKKUNCY-FHWLQOOXSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
27952,6cs2,DB00689,-7.3,Cephaloglycin,FUBBGQLTSCSAON-PBFPGSCMSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
55782,6crv,DB01475,-7.3,Dioxaphetyl butyrate,LQGIXNQCOXNCRP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27958,6cs2,DB07525,-7.3,"3-(3-methoxybenzyl)-1H-pyrrolo[2,3-b]pyridine",GHQCCHWTDLTMJT-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
73767,6m2n,DB02463,-7.3,2-(2-Hydroxy-Phenyl)-1h-Indole-5-Carboxamidine,JPGNPKIYCTXJPG-UHFFFAOYSA-O,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
55751,6crv,DB01441,-7.3,"5-Methoxy-N,N-diisopropyltryptamine",DNBPMBJFRRVTSJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
13272,6lzg,DB15055,-7.3,ABT-639,AGPIHNZOZNKRGT-CYBMUJFWSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
108031,6vxx,DB06729,-7.3,Sulfaphenazole,QWCJHSGMANYXCW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
14832,6lzg,T3D4787,-7.3,Lovastatin,PCZOHLXUXFIOCF-BXMDZJJMSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
98732,6vxs,DB01320,-7.3,Fosphenytoin,XWLUWCNOOVRFPX-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
10867,6lzg,DB09197,-7.3,Mepiprazole,DOTIMEKVTCOGED-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
23833,6cs2,DB01470,-7.3,alpha-methylthiofentanyl,YPOXDUYRRSUFFG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
98719,6vxs,DB01274,-7.3,Arformoterol,BPZSYCZIITTYBL-YJYMSZOUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
27982,6cs2,DB07547,-7.3,5-(4-CYANOPHENYL)-3-{[(2-METHYLPHENYL)SULFONYL]AMINO}THIOPHENE-2-CARBOXYLIC ACID,RYXAHMSZLLIPRO-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
79763,6m2n,DB13713,-7.3,Quifenadine,PZMAHNDJABQWGS-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
90171,6m71,DB01413,-7.3,Cefepime,HVFLCNVBZFFHBT-ZKDACBOMSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
27992,6cs2,DB07559,-7.3,"(2Z)-2-cyano-N-(2,2'-dichlorobiphenyl-4-yl)-3-hydroxybut-2-enamide",DDSLONVJHZPSBB-UVTDQMKNSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
68645,6lxt,DB08151,-7.3,"(5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-phenyl-1,6-dioxa-2-azaspiro[4.5]dec-2-ene-8,9,10-triol",YLTDNVVQKRHCJP-RKQHYHRCSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
14828,6lzg,T3D4783,-7.3,Nilutamide,XWXYUMMDTVBTOU-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
27795,6cs2,DB07348,-7.3,Brefeldin A,KQNZDYYTLMIZCT-KQPMLPITSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
98772,6vxs,DB01399,-7.3,Salsalate,WVYADZUPLLSGPU-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
90077,6m71,DB01228,-7.3,Encainide,PJWPNDMDCLXCOM-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
55896,6crv,DB01610,-7.3,Valganciclovir,WPVFJKSGQUFQAP-GKAPJAKFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
23925,6cs2,DB01564,-7.3,Calusterone,IVFYLRMMHVYGJH-PVPPCFLZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
27888,6cs2,DB07448,-7.3,(2S)-3-[(R)-[(1S)-1-amino-3-phenylpropyl](hydroxy)phosphoryl]-2-benzylpropanoic acid,QELOIXSGJMIHBZ-MSOLQXFVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
55886,6crv,DB01598,-7.3,Imipenem,ZSKVGTPCRGIANV-ZXFLCMHBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
90038,6m71,DB01183,-7.3,Naloxone,UZHSEJADLWPNLE-GRGSLBFTSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
23918,6cs2,DB00243,-7.3,Ranolazine,XKLMZUWKNUAPSZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
98833,6vxs,DB01470,-7.3,alpha-methylthiofentanyl,YPOXDUYRRSUFFG-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
55869,6crv,DB01572,-7.3,Methyl-1-testosterone,JRNSSSJKIGAFCT-YDSAWKJFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107984,6vxx,DB06640,-7.3,Fispemifene,NKZTZAQIKKGTDB-QPLCGJKRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
10899,6lzg,DB09231,-7.3,Benidipine,QZVNQOLPLYWLHQ-ZEQKJWHPSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
98816,6vxs,DB01452,-7.3,Diamorphine,GVGLGOZIDCSQPN-PVHGPHFFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
79890,6m2n,DB13916,-7.3,Toyocamycin,XOKJUSAYZUAMGJ-WOUKDFQISA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
23900,6cs2,DB01541,-7.3,Boldenone,RSIHSRDYCUFFLA-DYKIIFRCSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
63116,6crv,DB15167,-7.3,Fallypride,OABRYNHZQBZDMG-INIZCTEOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79861,6m2n,DB13842,-7.3,Etofylline nicotinate,ZWIAODBBEZGVPY-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
27911,6cs2,DB07472,-7.3,"(R)-(+)9B-(3-METHYL)PHENYL-2,3-DIHYDROTHIAZOLO[2,3-A]ISOINDOL-5(9BH)-ONE",FQVDJZWFSZSGGA-QGZVFWFLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
27914,6cs2,DB07477,-7.3,Felbinac,QRZAKQDHEVVFRX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
68705,6lxt,DB08224,-7.3,"(1S,7S,8S,8AR)-1,2,3,7,8,8A-HEXAHYDRO-7-METHYL-8-[2-[(2R,4R)-TETRAHYDRO-4-HY DROXY-6-OXO-2H-PYRAN-2-YL]ETHYL]-1-NAPHTHALENOL",WWSNTLOVYSRDEL-TVKPWXLESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
98798,6vxs,DB01430,-7.3,Almitrine,OBDOVFRMEYHSQB-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
90071,6m71,DB01218,-7.3,Halofantrine,FOHHNHSLJDZUGQ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
90053,6m71,DB01198,-7.3,Zopiclone,GBBSUAFBMRNDJC-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93649,6m71,DB07190,-7.3,3-cyclohexyl-D-alanyl-N-(3-chlorobenzyl)-L-prolinamide,JGFCNVHEEMBVJG-MOPGFXCFSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
9007,6lzg,DB07074,-7.3,6-CARBAMIMIDOYL-4-(3-HYDROXY-2-METHYL-BENZOYLAMINO)-NAPHTHALENE-2-CARBOXYLIC ACID METHYL ESTER,OUBRALHIKGRAMA-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
31879,6cs2,DB14932,-7.3,Coleneuramide,CHMRTBYTCBDIRG-JQZMMWJVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
118823,6w4b,DB06409,-7.3,Morphine glucuronide,GNJCUHZOSOYIEC-GAROZEBRSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
118824,6w4b,DB06410,-7.3,Doxercalciferol,HKXBNHCUPKIYDM-CGMHZMFXSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
148969,6w9q,DB14643,-7.3,Methylprednisolone aceponate,DALKLAYLIPSCQL-YPYQNWSCSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
133775,6w9c,DB02132,-7.3,Zenarestat,SXONDGSPUVNZLO-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
159069,7bv1,DB03103,-7.3,Thymidine-5'- Diphosphate,UJLXYODCHAELLY-XLPZGREQSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
32167,6cs2,DB01140,-7.3,Cefadroxil,BOEGTKLJZSQCCD-UEKVPHQBSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
128466,6w4h,DB07644,-7.3,"5-[(1S)-1-(3-chlorophenyl)ethoxy]quinazoline-2,4-diamine",IDHINEMSCUFEIP-VIFPVBQESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
128450,6w4h,DB07626,-7.3,"4-(2-aminoethoxy)-N-(3-chloro-2-ethoxy-5-piperidin-1-ylphenyl)-3,5-dimethylbenzamide",CKBBGCJYKCLKHE-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
32169,6cs2,DB01142,-7.3,Doxepin,ODQWQRRAPPTVAG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
139176,6w9c,DB12971,-7.3,Pactimibe,TXIIZHHIOHVWJD-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
133829,6w9c,DB02213,-7.3,Metanitrophenyl-Alpha-D-Galactoside,VCCMGHVCRFMITI-IIRVCBMXSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
32174,6cs2,DB01147,-7.3,Cloxacillin,LQOLIRLGBULYKD-JKIFEVAISA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
32176,6cs2,DB01149,-7.3,Nefazodone,VRBKIVRKKCLPHA-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
123387,6w4b,DB15446,-7.3,Vidofludimus,XPRDUGXOWVXZLL-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
36847,1r42,DB03476,-7.3,Trans-6-(2-Phenylcyclopropyl)-Naphthalene-2-Carboxamidine,NQRIWXVAIWPBEM-OALUTQOASA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
148960,6w9q,DB14633,-7.3,Prednisolone hemisuccinate,APGDTXUMTIZLCJ-CGVGKPPMSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
127481,6w4h,DB06185,-7.3,Forodesine,IWKXDMQDITUYRK-KUBHLMPHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
139264,6w9c,DB13237,-7.3,Clofoctol,HQVZOORKDNCGCK-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
130966,6w4h,DB13066,-7.3,Liarozole,UGFHIPBXIWJXNA-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
34973,1r42,DB00997,-7.3,Doxorubicin,AOJJSUZBOXZQNB-TZSSRYMLSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
28987,6cs2,DB08617,-7.3,"4-(2,2,2-TRIFLUOROETHYL)-L-PHENYLALANINE",VXIZYDKGLBPCAQ-VIFPVBQESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
159015,7bv1,DB03035,-7.3,"1,8-Di-Hydroxy-4-Nitro-Anthraquinone",RIYCICFDXLNQPV-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
7767,6lzg,DB04348,-7.3,Taurocholic Acid,WBWWGRHZICKQGZ-HZAMXZRMSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
159016,7bv1,DB03037,-7.3,Oxidized Acetyl Dithranol,IKFRFGXQHSBCQM-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
133739,6w9c,DB02089,-7.3,CP-526423,MWWXABBBAPKJDX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
28984,6cs2,DB00802,-7.3,Alfentanil,IDBPHNDTYPBSNI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
128474,6w4h,DB07652,-7.3,"1-[2-DEOXYRIBOFURANOSYL]-2,4-DIFLUORO-5-METHYL-BENZENE-5'MONOPHOSPHATE",NMMWBGNJJMNAIJ-QJPTWQEYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
159024,7bv1,DB03046,-7.3,7-Methoxy-8-[1-(Methylsulfonyl)-1h-Pyrazol-4-Yl]Naphthalene-2-Carboximidamide,KQUXAFOLFXHVQN-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
159033,7bv1,DB03060,-7.3,Sri-9662,WNDJHUNKXPAREB-PLNGDYQASA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
159037,7bv1,DB03065,-7.3,7-Nitroindazole-2-Carboxamidine,GFYAZUABYOOPCN-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
133734,6w9c,DB02082,-7.3,Phosphoaminophosphonic Acid Guanylate Ester,UQABYHGXWYXDTK-UUOKFMHZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139277,6w9c,DB13254,-7.3,Prifinium,ZYEPZINLLPPBMI-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139296,6w9c,DB13283,-7.3,Sulfaisodimidine,YZMCKZRAOLZXAZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
118874,6w4b,DB06532,-7.3,Pafuramidine,UKOQVLAXCBRRGH-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
159136,7bv1,DB03472,-7.3,Cyclohexyl-Hexyl-Beta-D-Maltoside,WUCWJXGMSXTDAV-QKMCSOCLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
34933,1r42,DB00948,-7.3,Mezlocillin,YPBATNHYBCGSSN-VWPFQQQWSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
32250,6cs2,DB01222,-7.3,Budesonide,VOVIALXJUBGFJZ-KWVAZRHASA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
133925,6w9c,DB02346,-7.3,3'-O-N-Octanoyl-a-D-Glucopyranosyl-B-D-Fructofuranoside,NMVDZWILYFXVBZ-PQJCEUABSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
153662,6wiq,DB06972,-7.3,"7A-[(4-cyanophenyl)methyl]-6-(3,5-dichlorophenyl)-5-oxo-2,3,5,7A-tetrahydro-1H-pyrrolo[1,2-A]pyrrole-7-carbonitrile",TZCXQSNBTXDAJG-QFIPXVFZSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
159219,7bv1,DB03593,-7.3,N7-Methyl-Guanosine-5'-Monophosphate,AOKQNZVJJXPUQA-KQYNXXCUSA-O,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
123293,6w4b,DB15254,-7.3,RO-5126766 free base,LMMJFBMMJUMSJS-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
118961,6w4b,DB06717,-7.3,Fosaprepitant,BARDROPHSZEBKC-OITMNORJSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
37389,1r42,DB04201,-7.3,Histidyl-Adenosine Monophosphate,XTFBSLZFYLGYAT-OPYVMVOTSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
139017,6w9c,DB12717,-7.3,Mibampator,ULRDYYKSPCRXAJ-KRWDZBQOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
36836,1r42,DB03460,-7.3,Violaxanthin,SZCBXWMUOPQSOX-WVJDLNGLSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
28955,6cs2,DB08582,-7.3,"N-(4-bromo-2-{[(3R,5S)-3,5-dimethylpiperidin-1-yl]carbonyl}phenyl)-4-morpholin-4-yl-4-oxobutanamide",DELARNBPJXTDBD-IYBDPMFKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
607,6lzg,HMDB0006045,-7.3,Dityrosine,FHOZGLMQYMAREG-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
138997,6w9c,DB12687,-7.3,Vesatolimod,VFOKSTCIRGDTBR-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
164100,7bv1,DB07258,-7.3,(R)-pyridin-4-yl[4-(2-pyrrolidin-1-ylethoxy)phenyl]methanol,QQRJWLDQBNAQCC-GOSISDBHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
138969,6w9c,DB12647,-7.3,Tocotrienol,GJJVAFUKOBZPCB-ZGRPYONQSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
36837,1r42,DB03461,-7.3,2'-Monophosphoadenosine 5'-Diphosphoribose,XJLXINKUBYWONI-NNYOXOHSSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
34912,1r42,DB00923,-7.3,Ceforanide,SLAYUXIURFNXPG-CRAIPNDOSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
36431,1r42,DB02915,-7.3,"4-(2,4-Dimethyl-1,3-thiazol-5-yl)-N-[4-(trifluoromethyl)phenyl]-2-pyrimidinamine",MEZFDQUDLQCVNX-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
159182,7bv1,DB03535,-7.3,Z-Pro-Prolinal,ORZXYSPOAVJYRU-HOTGVXAUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
159166,7bv1,DB03510,-7.3,6-O-Phosphoryl Inosine Monophosphate,RXRZOKQPANIEDW-KQYNXXCUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
145491,6w9q,DB07409,-7.3,"(1-HYDROXY-1-PHOSPHONO-2-[1,1';4',1'']TERPHENYL-3-YL-ETHYL)-PHOSPHONIC ACID",MPBUFKZCEBTBSK-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
139134,6w9c,DB12906,-7.3,LY-2334737,MEOYFIHNRBNEPI-UXIGCNINSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
145492,6w9q,DB07410,-7.3,[2-(3-DIBENZOFURAN-4-YL-PHENYL)-1-HYDROXY-1-PHOSPHONO-ETHYL]-PHOSPHONIC ACID,BYVXAUZOTGITQZ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
133882,6w9c,DB02277,-7.3,1-(5-Tert-Butyl-2-Methyl-2h-Pyrazol-3-Yl)-3-(4-Chloro-Phenyl)-Urea,FWIJKWMXNHRSRO-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
32213,6cs2,DB00215,-7.3,Citalopram,WSEQXVZVJXJVFP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
145495,6w9q,DB07415,-7.3,4-[(1S)-1-(3-fluoro-4-methoxyphenyl)-2-(2-methoxy-5-nitrophenyl)ethyl]-1H-imidazol-2-amine,RFLOFHKRBGKCOB-AWEZNQCLSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
133886,6w9c,DB02281,-7.3,Formycin,KBHMEHLJSZMEMI-KSYZLYKTSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
7758,6lzg,DB04336,-7.3,1-(4-Amidinophenyl)-3-(4-Chlorophenyl)Urea,HQWKMDKTTCPCMQ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
133887,6w9c,DB02282,-7.3,5'-Deoxy-5'-Methylthioadenosine,WUUGFSXJNOTRMR-IOSLPCCCSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
32225,6cs2,DB01196,-7.3,Estramustine,FRPJXPJMRWBBIH-RBRWEJTLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
145502,6w9q,DB07423,-7.3,(2S)-3-[4-(acetylamino)phenoxy]-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide,YVXVTLGIDOACBJ-SFHVURJKSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
164152,7bv1,DB07314,-7.3,"1-(5-CHLORO-2,4-DIMETHOXYPHENYL)-3-(5-CYANOPYRAZIN-2-YL)UREA",URQYPXQXSVUVRG-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
164151,7bv1,DB07313,-7.3,5-METHYL-2-[(PHENYLSULFONYL)AMINO]BENZOIC ACID,HXQLTRSIZRSFTR-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
118914,6w4b,DB06629,-7.3,Zibotentan,FJHHZXWJVIEFGJ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
164241,7bv1,DB07419,-7.3,S-23,SSFVOEAXHZGTRJ-KRWDZBQOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
145534,6w9q,DB07459,-7.3,4-PHENOXY-N-(PYRIDIN-2-YLMETHYL)BENZAMIDE,HVLSCZSVTCNAQX-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
148972,6w9q,DB14646,-7.3,Prednisone acetate,MOVRKLZUVNCBIP-RFZYENFJSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
158974,7bv1,DB02706,-7.3,Mercaptocarboxylate Inhibitor,DUKDFMPUZRDWLT-CQSZACIVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
128517,6w4h,DB07706,-7.3,2-Hydrox1tradiol,DILDHNKDVHLEQB-XSSYPUMDSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
164378,7bv1,DB07763,-7.3,"(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE",OZZFJGCAYWBVBI-INIZCTEOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
149029,6w9q,DB14753,-7.3,Hydroxystilbamidine,TUESWZZJYCLFNL-DAFODLJHSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
158848,7bv1,DB02538,-7.3,"N-[4-(2-Methylimidazo[1,2-a]Pyridin-3-Yl)-2-Pyrimidinyl]Acetamide",ZCRPPLDDHBLUES-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
31994,6cs2,DB01113,-7.3,Papaverine,XQYZDYMELSJDRZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
139410,6w9c,DB13430,-7.3,Mebutizide,KJLLKLRVCJAFRY-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
35044,1r42,DB01076,-7.3,Atorvastatin,XUKUURHRXDUEBC-KAYWLYCHSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
118658,6w4b,DB05738,-7.3,Vapitadine,VQWGYPVNVICKFC-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
118672,6w4b,DB05830,-7.3,Trestolone,YSGQGNQWBLYHPE-CFUSNLFHSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
118674,6w4b,DB05838,-7.3,OPC-51803,INGXCNVWWKKWOO-LJQANCHMSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
123717,6w4h,DB00294,-7.3,Etonogestrel,GCKFUYQCUCGESZ-BPIQYHPVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130095,6w4h,DB11766,-7.3,AZD-1305,BLLNYXOLLAVTRF-HDICACEKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
32010,6cs2,DB15201,-7.3,Norbixin,ZVKOASAVGLETCT-UOGKPENDSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
130098,6w4h,DB11770,-7.3,Talinolol,MXFWWQICDIZSOA-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
145314,6w9q,DB07206,-7.3,6-[2-(1H-INDOL-6-YL)ETHYL]PYRIDIN-2-AMINE,OSHSZKRWKLQZBV-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
50443,2fxp,DB07020,-7.3,"N-{3-[5-(1H-1,2,4-triazol-3-yl)-1H-indazol-3-yl]phenyl}furan-2-carboxamide",LMDMJDCLPIVGQD-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
153681,6wiq,DB06995,-7.3,N-({4-[(2-aminopyridin-4-yl)oxy]-3-fluorophenyl}carbamoyl)-2-(4-fluorophenyl)acetamide,USBSTVPJNQLYEM-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
145291,6w9q,DB07180,-7.3,"5-[(Z)-(5-Chloro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-N,2,4-trimethyl-1H-pyrrole-3-carboxamide",FIRPCWHHIWFKCD-GHXNOFRVSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
139450,6w9c,DB13485,-7.3,Sulfametomidine,QKLSCPPJEVXONT-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
1959,6lzg,HMDB0029222,-7.3,Urolithin A-3-O-glucuronide,KXBXNRJGUDTJQS-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
128522,6w4h,DB07713,-7.3,"(1S)-1-{[(4'-methoxy-1,1'-biphenyl-4-yl)sulfonyl]amino}-2-methylpropylphosphonic acid",BZVYQWLRCHLAGK-KRWDZBQOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
158786,7bv1,DB02218,-7.3,"N-[4-hydroxymethyl-cyclohexan-6-yl-1,2,3-triol]-4,6-dideoxy-4-aminoglucopyranoside",RBZIIHWPZWOIDU-ZCGMLSCUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
158788,7bv1,DB02220,-7.3,AL7089A,RMOXCYSVWCHXII-LBPRGKRZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
158789,7bv1,DB02221,-7.3,"4-(Aminosulfonyl)-N-[(2,4,6-Trifluorophenyl)Methyl]-Benzamide",DVTYOTODFLDHRL-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
158815,7bv1,DB02255,-7.3,GM6001,NITYDPDXAAFEIT-DYVFJYSZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
131024,6w4h,DB13169,-7.3,Nandrolone,NPAGDVCDWIYMMC-IZPLOLCNSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
123751,6w4h,DB00338,-7.3,Omeprazole,SUBDBMMJDZJVOS-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
31960,6cs2,DB15109,-7.3,Ingenol disoxate,GLIUZQUNUNICGS-XUBYYPQFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
155953,6wiq,DB11995,-7.3,Avatrombopag,OFZJKCQENFPZBH-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
158808,7bv1,DB02247,-7.3,Hydrolyzed Cephalothin,JRYZEMHNDUZNMI-RYUDHWBXSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
31961,6cs2,DB01108,-7.3,Trilostane,KVJXBPDAXMEYOA-CXANFOAXSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
123745,6w4h,DB00328,-7.3,Indometacin,CGIGDMFJXJATDK-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
149051,6w9q,DB14795,-7.3,AZD-3759,MXDSJQHFFDGFDK-CYBMUJFWSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
139383,6w9c,DB13395,-7.3,Eprozinol,QSRHLIUOSXVKTG-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
118713,6w4b,DB06134,-7.3,SNS-314,FAYAUAZLLLJJGH-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
118714,6w4b,DB06137,-7.3,KX-01,HUNGUWOZPQBXGX-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
164302,7bv1,DB07675,-7.3,(2S)-2-ETHOXY-3-{4-[2-(10H-PHENOXAZIN-10-YL)ETHOXY]PHENYL}PROPANOIC ACID,WMUIIGVAWPWQAW-DEOSSOPVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
118741,6w4b,DB06194,-7.3,Elocalcitol,LRLWXBHFPGSUOX-GJQYOBCGSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
158944,7bv1,DB02668,-7.3,"Je-2147, Ag1776, Kni-764",CUFQBQOBLVLKRF-RZDMPUFOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
32091,6cs2,DB15338,-7.3,Rovatirelin,WTXWDXWZGJGIHV-URBCHYCLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
145368,6w9q,DB07271,-7.3,"4-[(3R)-3-Amino-4-(2,4,5-trifluorophenyl)butanoyl]-3-(2,2,2-trifluoroethyl)-1,4-diazepan-2-one",RMDAPSXWBVPVOG-IAPIXIRKSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
29008,6cs2,DB08643,-7.3,2-(2-{2-[(BIPHENYL-4-YLMETHYL)-AMINO]-3-MERCAPTO-PENTANOYLAMINO}-ACETYLAMINO)-3-METHYL-BUTYRIC ACID METHYL ESTER,QFAWBPLETHINFK-UNMCSNQZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
164305,7bv1,DB07678,-7.3,"(9ALPHA,13BETA,17BETA)-2-[(1Z)-BUT-1-EN-1-YL]ESTRA-1,3,5(10)-TRIENE-3,17-DIOL",ANAMDWGJXBYJEB-OPWFCKQNSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
133692,6w9c,DB02029,-7.3,N-Cyclohexyl-N'-(4-Iodophenyl)Urea,AQTBUVAFYDVTFD-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
158950,7bv1,DB02675,-7.3,(4-Hydroxymaltosephenyl)Glycine,PHPOPZGUOBMSPZ-QHJSCRBTSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
118783,6w4b,DB06274,-7.3,Alvimopan,UPNUIXSCZBYVBB-JVFUWBCBSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
164281,7bv1,DB07647,-7.3,"(2R)-1-[(5,6-DIPHENYL-7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)AMINO]PROPAN-2-OL",VBASHTSSQNDDAS-CQSZACIVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
32105,6cs2,DB01125,-7.3,Anisindione,XRCFXMGQEVUZFC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
164277,7bv1,DB07643,-7.3,"5-{[1-(2,3-dichlorobenzyl)piperidin-4-yl]methoxy}quinazoline-2,4-diamine",XVLUVRFYGVJKGJ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
148980,6w9q,DB14654,-7.3,Bisoxatin acetate,ZCBJDQBSLZREAA-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
158948,7bv1,DB02673,-7.3,"(4ar,6s,8ar)-11-[8-(1,3-Dioxo-1,3-Dihydro-2h-Isoindol-2-Yl)Octyl]-6-Hydroxy-3-Methoxy-5,6,9,10-Tetrahydro-4ah-[1]Benzofuro[3a,3,2-Ef][2]Benzazepin-11-Ium",VLGAHTYYCHWLNI-BHRZLAGCSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
158922,7bv1,DB02640,-7.3,Fumagillin,NGGMYCMLYOUNGM-CSDLUJIJSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
32072,6cs2,DB01121,-7.3,Phenacemide,XPFRXWCVYUEORT-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
118739,6w4b,DB06190,-7.3,Solabegron,LLDXOPKUNJTIRF-QFIPXVFZSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
7428,6lzg,DB03788,-7.3,GC-24,JYHIGYLGYNCMGI-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
158883,7bv1,DB02587,-7.3,Colforsin,OHCQJHSOBUTRHG-KGGHGJDLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
35018,1r42,DB01047,-7.3,Fluocinonide,WJOHZNCJWYWUJD-IUGZLZTKSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
139374,6w9c,DB13380,-7.3,Difemerine,GUONSMXZEYTWML-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
158887,7bv1,DB02593,-7.3,"7,8-Dihydroxy-1-Methoxy-3-Methyl-10-Oxo-4,10-Dihydro-1h,3h-Pyrano[4,3-B]Chromene-9-Carboxylic Acid",RSFJMLCZHPZXCW-AANKLQPISA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
158889,7bv1,DB02595,-7.3,Bulgecin A,RPNZWZDLNYCCIG-HMMVDTEZSA-O,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
118726,6w4b,DB06157,-7.3,Istaroxime,MPYLDWFDPHRTEG-PAAYLBSLSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
123646,6w4h,DB00214,-7.3,Torasemide,NGBFQHCMQULJNZ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
6888,6lzg,DB02861,-7.3,"4-(Aminosulfonyl)-N-[(3,4,5-Trifluorophenyl)Methyl]-Benzamide",DEHMSTGBNAXEGX-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
36421,1r42,DB02901,-7.3,Stanolone,NVKAWKQGWWIWPM-ABEVXSGRSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
46170,2fxp,DB00224,-7.3,Indinavir,CBVCZFGXHXORBI-PXQQMZJSSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
164309,7bv1,DB07683,-7.3,"N-(dibenzo[b,d]thiophen-3-ylsulfonyl)-L-valine",RZWYSEXQXOXWKA-INIZCTEOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
118729,6w4b,DB06163,-7.3,Plevitrexed,IEJSCSAMMLUINT-NRFANRHFSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
154845,6wiq,DB08354,-7.3,"2-(4-CHLOROBENZYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE",QCVULERVJOYHCP-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
148994,6w9q,DB14669,-7.3,Betamethasone phosphate,VQODGRNSFPNSQE-DVTGEIKXSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
164253,7bv1,DB07432,-7.3,"[[(3R,4R,5S,6R)-3-(butanoylamino)-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-ylidene]amino] N-phenylcarbamate",ITVRELFVFCOUMV-ZVZWZHPPSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
123282,6w4b,DB15232,-7.3,Telaglenastat,PRAAPINBUWJLGA-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
32291,6cs2,DB01283,-7.3,Lumiracoxib,KHPKQFYUPIUARC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
159233,7bv1,DB03615,-7.3,Ribostamycin,NSKGQURZWSPSBC-VVPCINPTSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
163696,7bv1,DB05969,-7.3,SNS-032,OUSFTKFNBAZUKL-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
163693,7bv1,DB05959,-7.3,ENMD-1198,YQJWOUQGXATDAE-ACNBBOPNSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
119284,6w4b,DB07133,-7.3,D-phenylalanyl-N-(3-methylbenzyl)-L-prolinamide,CHKWABXWPATIIG-UXHICEINSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
50143,2fxp,DB06558,-7.3,Tezosentan,TUYWTLTWNJOZNY-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
123059,6w4b,DB14737,-7.3,Cannabinol,VBGLYOIFKLUMQG-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
50142,2fxp,DB06555,-7.3,Siramesine,XWAONOGAGZNUSF-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
119274,6w4b,DB07123,-7.3,N-(4-METHYLBENZOYL)-4-BENZYLPIPERIDINE,DVOLWKZEIDCCES-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
163668,7bv1,DB05804,-7.3,Prasterone sulfate,CZWCKYRVOZZJNM-USOAJAOKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
119289,6w4b,DB07140,-7.3,"5-[(3R)-3-(5-methoxybiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",JPENSYBRTSIYGO-AWEZNQCLSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
128322,6w4h,DB07472,-7.3,"(R)-(+)9B-(3-METHYL)PHENYL-2,3-DIHYDROTHIAZOLO[2,3-A]ISOINDOL-5(9BH)-ONE",FQVDJZWFSZSGGA-QGZVFWFLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
119293,6w4b,DB07144,-7.3,"5-[(3R)-3-(5-methoxy-2',6'-dimethylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",XZXVRKHUCSXVBM-AWEZNQCLSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
163663,7bv1,DB05779,-7.3,Oglufanide,LLEUXCDZPQOJMY-AAEUAGOBSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
123057,6w4b,DB14735,-7.3,Cannabichromene,UVOLYTDXHDXWJU-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
119296,6w4b,DB07147,-7.3,"methyl (1R,2S)-2-(hydroxycarbamoyl)-1-{4-[(2-methylquinolin-4-yl)methoxy]benzyl}cyclopropanecarboxylate",HJWMYFBKJRVWJY-YKSBVNFPSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
32538,6cs2,T3D1938,-7.3,"2,3,3',4,5,5'-Hexabromobiphenyl",SBPKBQJLKKDLLR-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
119297,6w4b,DB07148,-7.3,"(6S)-1-chloro-3-[(4-fluorobenzyl)oxy]-6-(pyrrolidin-1-ylcarbonyl)pyrrolo[1,2-a]pyrazin-4(6H)-one",HPAFVLDARQIHPU-HNNXBMFYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
163707,7bv1,DB06083,-7.3,Tapinarof,ZISJNXNHJRQYJO-CMDGGOBGSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
123076,6w4b,DB14774,-7.3,Balipodect,KVHRYLNQDWXAGI-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
123129,6w4b,DB14898,-7.3,Retagliptin,WIIAMRXFUJLYEF-SNVBAGLBSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
159449,7bv1,DB04430,-7.3,3-(4-Phenylamino-Phenylamino)-2-(1h-Tetrazol-5-Yl)-Acrylonitrile,FLPLCJJGNZGOAW-QXMHVHEDSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
148701,6w9q,DB13797,-7.3,Iodocholesterol (131I),FIOAEFCJGZJUPW-ODFYUTSGSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
134209,6w9c,DB02709,-7.3,Resveratrol,LUKBXSAWLPMMSZ-OWOJBTEDSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138627,6w9c,DB11941,-7.3,Tasisulam,WWONFUQGBVOKOF-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
163740,7bv1,DB06187,-7.3,Valtorcitabine,VFCYZPOEGWLYRM-QCZKYFFMSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
119270,6w4b,DB07119,-7.3,1-CHLORO-6-(4-HYDROXYPHENYL)-2-NAPHTHOL,YHEHVRSGKUYDON-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
34797,1r42,DB00796,-7.3,Candesartan cilexetil,GHOSNRCGJFBJIB-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
159488,7bv1,DB04480,-7.3,"3-(4-Fluorophenyl)-2-(6-Methylpyridin-2-Yl)-5,6-Dihydro-4h-Pyrrolo[1,2-B]Pyrazole",NBDZLUOYAAVYHF-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
148675,6w9q,DB13766,-7.3,Lidoflazine,ZBIAKUMOEKILTF-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
50156,2fxp,DB06595,-7.3,Midostaurin,BMGQWWVMWDBQGC-IIFHNQTCSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
119259,6w4b,DB07107,-7.3,(1S)-2-(1H-INDOL-3-YL)-1-[({5-[(E)-2-PYRIDIN-4-YLVINYL]PYRIDIN-3-YL}OXY)METHYL]ETHYLAMINE,SGHXFHRRWFLILP-XJDXJNMNSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
127513,6w4h,DB06247,-7.3,CX516,ANDGGVOPIJEHOF-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
138598,6w9c,DB11899,-7.3,MK-8776,GMIZZEXBPRLVIV-SECBINFHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138612,6w9c,DB11917,-7.3,Vatiquinone,LNOVHERIIMJMDG-XZXLULOTSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
123054,6w4b,DB14729,-7.3,Rebeccamycin,QEHOIJJIZXRMAN-QZQSLCQPSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
134291,6w9c,DB02880,-7.3,N-[1-(4-Bromophenyl)Ethyl]-5-Fluoro Salicylamide,KFTNEILVDDUXGR-SECBINFHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
119299,6w4b,DB07152,-7.3,N-[4-(5-fluoro-6-methylpyridin-2-yl)-5-quinoxalin-6-yl-1H-imidazol-2-yl]acetamide,TYPILNNEZPSNTI-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
134389,6w9c,DB03009,-7.3,2-[(2-Oxo-2-Piperidin-1-Ylethyl)Thio]-6-(Trifluoromethyl)Pyrimidin-4(1h)-One,UDBHGUOSOKOIAX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
134393,6w9c,DB03015,-7.3,"6-Hydroxy-1,6-Dihydro Purine Nucleoside",WGRXVKRHIMUTPD-YOHZANMFSA-O,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
148529,6w9q,DB13571,-7.3,Pentamycin,AGJUUQSLGVCRQA-SWOUQTJZSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
130898,6w4h,DB12962,-7.3,CP-547632,HXHAJRMTJXHJJZ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
134403,6w9c,DB03030,-7.3,4-(2-Thienyl)-1-(4-Methylbenzyl)-1h-Imidazole,UMOFOLLUKPBVQG-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
128308,6w4h,DB07455,-7.3,"N,N'-[biphenyl-4,4'-diyldi(2R)propane-2,1-diyl]dimethanesulfonamide",ZESUARCHWPARIF-HOTGVXAUSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
163578,7bv1,DB04816,-7.3,Dantron,QBPFLULOKWLNNW-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
134446,6w9c,DB03086,-7.3,"N'-(2s,3r)-3-Amino-4-Cyclohexyl-2-Hydroxy-Butano-N-(4-Methylphenyl)Hydrazide",IQMLIGOOOFEBAH-CVEARBPZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
134459,6w9c,DB03103,-7.3,Thymidine-5'- Diphosphate,UJLXYODCHAELLY-XLPZGREQSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
159636,7bv1,DB04982,-7.3,Talampanel,JACAAXNEHGBPOQ-LLVKDONJSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
134484,6w9c,DB03137,-7.3,"8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9-Pent-9h-Purin-6-Ylamine",RMOYVWKKOKERSW-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
148502,6w9q,DB13533,-7.3,Methylestrenolone,ZXSWTMLNIIZPET-ZOFHRBRSSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
148490,6w9q,DB13514,-7.3,Pranoprofen,TVQZAMVBTVNYLA-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
138357,6w9c,DB11462,-7.3,Sulfaethoxypyridazine,FFJIWWBSBCOKLS-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
119365,6w4b,DB07229,-7.3,"3-{5-[AMINO(IMINIO)METHYL]-1H-INDOL-2-YL}-5-METHOXY-1,1'-BIPHENYL-2-OLATE",MINVOLKUPZPDNX-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
138443,6w9c,DB11672,-7.3,Curcumin,VFLDPWHFBUODDF-FCXRPNKRSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
123018,6w4b,DB14659,-7.3,Melengestrol acetate,UDKABVSQKJNZBH-DWNQPYOZSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
138509,6w9c,DB11770,-7.3,Talinolol,MXFWWQICDIZSOA-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
123049,6w4b,DB14718,-7.3,Pyrazolam,BGRWSFIQQPVEML-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
36444,1r42,DB02930,-7.3,Adenosine 5'-[??-thio]triphosphate,NLTUCYMLOPLUHL-KQYNXXCUSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
163656,7bv1,DB05708,-7.3,GTS-21,RPYWXZCFYPVCNQ-RVDMUPIBSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
130916,6w4h,DB12989,-7.3,Neosaxitoxin,PPEKGEBBBBNZKS-HGRQIUPRSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
119303,6w4b,DB07156,-7.3,"(4Z)-6-bromo-4-({[4-(pyrrolidin-1-ylmethyl)phenyl]amino}methylidene)isoquinoline-1,3(2H,4H)-dione",JFEKAVPMVOLVTH-UNOMPAQXSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
163637,7bv1,DB04886,-7.3,Calanolide A,NIDRYBLTWYFCFV-FMTVUPSXSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
148546,6w9q,DB13596,-7.3,Oxycinchophen,XAPRFLSJBSXESP-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
134317,6w9c,DB02911,-7.3,"2,4-Diamino-6-Phenyl-5,6,7,8,-Tetrahydropteridine",VEKRIXRQADJFAG-QMMMGPOBSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
32562,6cs2,T3D1965,-7.3,"2,3',5-Tribromobiphenyl",HSYRZFKOZZOCNA-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
138546,6w9c,DB11821,-7.3,Danegaptide,BIZKIHUJGMSVFD-MNOVXSKESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
119323,6w4b,DB07179,-7.3,"3-((3-bromo-5-o-tolylpyrazolo[1,5-a]pyrimidin-7-ylamino)methyl)pyridine 1-oxide",DXUJQXZHHGJMFM-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
134328,6w9c,DB02925,-7.3,Piretanide,UJEWTUDSLQGTOA-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
134341,6w9c,DB02943,-7.3,N-(4-Aminobutanoyl)-S-(4-Methoxybenzyl)-L-Cysteinylglycine,OMOPDEZZBQHMGS-AWEZNQCLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138517,6w9c,DB11783,-7.3,Imidapril,KLZWOWYOHUKJIG-BPUTZDHNSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
48514,2fxp,DB03231,-7.3,"3-(5-Amino-7-oxo-3,7-dihydro-2H-[1,2,3]triazolo[4,5-d]pyrimidin-2-yl)-N-(2-{[2-(hydroxymethyl)phenyl]sulfanyl}benzyl)benzamide",IXDQOBDHBWEZOH-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
138675,6w9c,DB12106,-7.3,PF-06305591,APWZIFIAVVFPNT-PELKAZGASA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138680,6w9c,DB12112,-7.3,Zuretinol acetate,QGNJRVVDBSJHIZ-AQDFTDIISA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
130935,6w4h,DB13022,-7.3,LY-2874455,GKJCVYLDJWTWQU-CXLRFSCWSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130940,6w4h,DB13027,-7.3,Tucaresol,XEDONBRPTABQFB-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
48387,2fxp,DB03067,-7.3,"4-{2,4-Bis[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid",VFYAZSTYKPFSFL-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
154952,6wiq,DB08486,-7.3,Efaproxiral,BNFRJXLZYUTIII-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
123244,6w4b,DB15157,-7.3,Voruciclib,MRPGRAKIAJJGMM-OCCSQVGLSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
119054,6w4b,DB06869,-7.3,1-[2-AMINO-2-CYCLOHEXYL-ACETYL]-PYRROLIDINE-3-CARBOXYLIC ACID 5-CHLORO-2-(2-ETHYLCARBAMOYL-ETHOXY)-BENZYLAMIDE,BMHVHOJXEQTIEA-SIKLNZKXSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
138883,6w9c,DB12400,-7.3,Voxtalisib,RGHYDLZMTYDBDT-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
164014,7bv1,DB06971,-7.3,"N-{2-[(4'-CYANO-1,1'-BIPHENYL-4-YL)OXY]ETHYL}-N'-HYDROXY-N-METHYLUREA",GVMUNGGWXRKCEU-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
127493,6w4h,DB06203,-7.3,Alogliptin,ZSBOMTDTBDDKMP-OAHLLOKOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
148876,6w9q,DB14129,-7.3,Macelignan,QDDILOVMGWUNGD-UONOGXRCSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
138866,6w9c,DB12378,-7.3,Apricoxib,JTMITOKKUMVWRT-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
32355,6cs2,T3D1664,-7.3,Methylene diphenyl diisocyanate,UPMLOUAZCHDJJD-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
148862,6w9q,DB14097,-7.3,13-cis-12-(3'-Carboxyphenyl)retinoic acid,XKKDQOHDTASHCE-PAZAWXFKSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
123215,6w4b,DB15105,-7.3,PF-06751979,ZLZUHACSRMOLLV-RAALSFIWSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
34868,1r42,DB00875,-7.3,Flupentixol,NJMYODHXAKYRHW-DVZOWYKESA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
123202,6w4b,DB15078,-7.3,Rogaratinib,HNLRRJSKGXOYNO-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
123234,6w4b,DB15138,-7.3,AZD-9496,DFBDRVGWBHBJNR-BBNFHIFMSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
34884,1r42,DB00894,-7.3,Testolactone,BPEWUONYVDABNZ-DZBHQSCQSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
133971,6w9c,DB02402,-7.3,"5-(4-Methoxyphenoxy)-2,4-Quinazolinediamine",CPZJZAIZIMCJRC-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
123249,6w4b,DB15169,-7.3,H3B-6527,MBWRLLRCTIYXDW-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
138950,6w9c,DB12615,-7.3,Plazomicin,IYDYFVUFSPQPPV-PEXOCOHZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
133954,6w9c,DB02382,-7.3,Namn,JOUIQRNQJGXQDC-ZYUZMQFOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
164085,7bv1,DB07242,-7.3,"(4R)-7,8-dichloro-1',9-dimethyl-1-oxo-1,2,4,9-tetrahydrospiro[beta-carboline-3,4'-piperidine]-4-carbonitrile",XGUIMGJMQKZRGM-LLVKDONJSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
119014,6w4b,DB06816,-7.3,Pyrvinium,QMHSXPLYMTVAMK-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
164081,7bv1,DB07237,-7.3,{4-[(2R)-pyrrolidin-2-ylmethoxy]phenyl}(4-thiophen-3-ylphenyl)methanone,VUWFJUJWAWMRQN-HXUWFJFHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
133955,6w9c,DB02383,-7.3,Tolrestat,LUBHDINQXIHVLS-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
123273,6w4b,DB15214,-7.3,BMS-986104,BPMMYKAHRIEVDH-VOQZNFBZSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
123271,6w4b,DB15209,-7.3,MK-0736,ORQZQBUNAMJFCY-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
119035,6w4b,DB06844,-7.3,"4-[(7-OXO-7H-THIAZOLO[5,4-E]INDOL-8-YLMETHYL)-AMINO]-N-PYRIDIN-2-YL-BENZENESULFONAMIDE",MBXKBJLIESPLIK-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
36825,1r42,DB03446,-7.3,N-Benzyl-3-(alpha-D-galactopyranosyloxy)benzamide,FSMWGHKWKYCPKE-QTVCLEQKSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
621,6lzg,HMDB0006117,-7.3,APGPR Enterostatin,ITZMJCSORYKOSI-AJNGGQMLSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
128405,6w4h,DB07571,-7.3,"N-2-[(BENZYLOXY)CARBONYL]-N-[(1S,2S)-2-HYDROXY-1-(4-HYDROXYBENZYL)PROPYL]-L-LEUCINAMIDE",ZUWYQZGBCBSHFK-HSQYWUDLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
6114,6lzg,DB01581,-7.3,Sulfamerazine,QPPBRPIAZZHUNT-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
164067,7bv1,DB07032,-7.3,2-(4-HYDROXY-PHENYL)BENZOFURAN-5-OL,SNNNDCMXZYWCCI-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
138907,6w9c,DB12429,-7.3,CI-1040,GFMMXOIFOQCCGU-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
123199,6w4b,DB15071,-7.3,Omidenepag isopropyl,VIQCWEGEHRBLAC-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
158776,7bv1,DB02205,-7.3,"6-(1,1-Dimethylallyl)-2-(1-Hydroxy-1-Methylethyl)-2,3-Dihydro-7h-Furo[3,2-G]Chromen-7-One",JCDLLLXYAICSQV-INIZCTEOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
163953,7bv1,DB06898,-7.3,"4-(2-amino-1-methyl-1H-imidazo[4,5-b]pyridin-6-yl)phenol",UGJXOCBVCWTJFP-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
159310,7bv1,DB03973,-7.3,"3-{2,6,8-trioxo-9-[(2R,3R,4R)-2,3,4,5-tetrahydroxypentyl]-1,2,3,6,8,9-hexahydro-7H-purin-7-Yl}propyl dihydrogen phosphate",KPHFGOGGKPGLTM-ZXFLCMHBSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
119158,6w4b,DB06992,-7.3,"(3,3-dimethylpiperidin-1-yl)(6-(3-fluoro-4-methylphenyl)pyridin-2-yl)methanone",SIDDLTBLAQYZIZ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
119159,6w4b,DB06993,-7.3,"(2S,3S)-4-cyclopropyl-3-{(3R,5R)-3-[2-fluoro-4-(methylsulfonyl)phenyl]-1,2,4-oxadiazolidin-5-yl}-1-[(3S)-3-fluoropyrrolidin-1-yl]-1-oxobutan-2-amine",PTAHVQJZNFGPHN-WFWWEWPISA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
123168,6w4b,DB15011,-7.3,Avacopan,PUKBOVABABRILL-YZNIXAGQSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
163868,7bv1,DB06777,-7.3,Chenodeoxycholic acid,RUDATBOHQWOJDD-BSWAIDMHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
119166,6w4b,DB07000,-7.3,"N-{2,4-difluoro-3-[(5-pyridin-3-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)carbonyl]phenyl}ethanesulfonamide",ILXJWLWSYAWJKZ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
123165,6w4b,DB15003,-7.3,PF-06700841,BUWBRTXGQRBBHG-MJBXVCDLSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
123170,6w4b,DB15013,-7.3,TAK-243,KJDAGXLMHXUAGV-DGWLBADLSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
683,6lzg,HMDB0006622,-7.3,Difucosyllacto-N-hexaose a,OAXMVFUPLMUHGJ-JUZXSSEISA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
123155,6w4b,DB14944,-7.3,Tarloxotinib,MUJMYVFVAWFUJL-SNAWJCMRSA-O,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
130187,6w4h,DB11899,-7.3,MK-8776,GMIZZEXBPRLVIV-SECBINFHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
138741,6w9c,DB12204,-7.3,Terbogrel,XUTLOCQNGLJNSA-RGVLZGJSSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
159436,7bv1,DB04142,-7.3,"3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid Dimethylamide",FEYGJZKVMASWJB-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
163822,7bv1,DB06401,-7.3,Bazedoxifene,UCJGJABZCDBEDK-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
145625,6w9q,DB07568,-7.3,"(2S)-2-[(2,1,3-BENZOTHIADIAZOL-4-YLSULFONYL)AMINO]-2-PHENYL-N-PYRIDIN-4-YLACETAMIDE",ADRNPUSZBRQDBG-KRWDZBQOSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
123162,6w4b,DB14993,-7.3,Pyrotinib,SADXACCFNXBCFY-IYNHSRRRSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
154960,6wiq,DB08494,-7.3,"S-{2-[(2-chloro-4-sulfamoylphenyl)amino]-2-oxoethyl} 6-methyl-3,4-dihydroquinoline-1(2H)-carbothioate",AWAKIULNKVOBKE-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
153598,6wiq,DB06896,-7.3,"1-(4-fluorophenyl)-N-[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]-2-oxo-1,2-dihydropyridine-3-carboxamide",OBSFXHDOLBYWRJ-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
134052,6w9c,DB02502,-7.3,8-Hydroxy-2'-Deoxyguanosine,HCAJQHYUCKICQH-VPENINKCSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
148821,6w9q,DB14025,-7.3,Clinafloxacin,QGPKADBNRMWEQR-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
159328,7bv1,DB03996,-7.3,"3-[(5s)-1-Acetyl-3-(2-Chlorophenyl)-4,5-Dihydro-1h-Pyrazol-5-Yl]Phenol",QBZAPFWYAPXRGQ-KRWDZBQOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
134043,6w9c,DB02493,-7.3,Hydantocidin-5'-Phosphate,HVXIMXHBUJADCC-GTBMBKLPSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
153617,6wiq,DB06916,-7.3,"N-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-1-[2-(1H-IMIDAZOL-1-YL)-6-METHYLPYRIMIDIN-4-YL]-D-PROLINAMIDE",LBCGUKCXRVUULK-QGZVFWFLSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
119111,6w4b,DB06930,-7.3,"N-[amino(imino)methyl]-2-(2,5-diphenyl-1H-pyrrol-1-yl)acetamide",WVLDNAVUCUAGDP-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
148791,6w9q,DB13956,-7.3,Estradiol valerate,RSEPBGGWRJCQGY-RBRWEJTLSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
138807,6w9c,DB12291,-7.3,Tacedinaline,VAZAPHZUAVEOMC-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
673,6lzg,HMDB0006581,-7.3,3-Sialyl-N-acetyllactosamine,HUNVSYPDCXFGLB-KROWHOKKSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
34840,1r42,DB00844,-7.3,Nalbuphine,NETZHAKZCGBWSS-CEDHKZHLSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
119119,6w4b,DB06940,-7.3,"N-ethyl-4-{[5-(methoxycarbamoyl)-2-methylphenyl]amino}-5-methylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide",ZZTMFGIGOADCFX-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
155924,6wiq,DB11949,-7.3,Vestipitant,SBBYBXSFWOLDDG-JLTOFOAXSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
130949,6w4h,DB13044,-7.3,Gossypol,QBKSWRVVCFFDOT-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
119130,6w4b,DB06954,-7.3,"2-(cycloheptylmethyl)-1,1-dioxido-1-benzothiophen-6-yl sulfamate",BIASYWBGUYOWJR-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
145601,6w9q,DB07539,-7.3,"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZOIC ACID",JLRKRQCTYQGDKJ-GHXNOFRVSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
32412,6cs2,T3D0167,-7.3,"1,2-Diphenylhydrazine",YBQZXXMEJHZYMB-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
667,6lzg,HMDB0006567,-7.3,Neolactotetraose,RBMYDHMFFAVMMM-PLQWBNBWSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
145263,6w9q,DB07147,-7.3,"methyl (1R,2S)-2-(hydroxycarbamoyl)-1-{4-[(2-methylquinolin-4-yl)methoxy]benzyl}cyclopropanecarboxylate",HJWMYFBKJRVWJY-YKSBVNFPSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
123780,6w4h,DB00372,-7.3,Thiethylperazine,XCTYLCDETUVOIP-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
154805,6wiq,DB08305,-7.3,"(3R)-3-cyclopentyl-6-methyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2-benzothiazine 1,1-dioxide",KQAGZLQCEURCKJ-QGZVFWFLSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
133034,6w9c,DB01132,-7.3,Pioglitazone,HYAFETHFCAUJAY-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
40300,6lu7,DB07729,-7.3,3-fluoro-N-[3-(1H-tetrazol-5-yl)phenyl]benzamide,GAKOBKPDJJGRIL-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
31538,6cs2,DB13988,-7.3,SB-269970,HWKROQUZSKPIKQ-MRXNPFEDSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
40299,6lu7,DB07970,-7.3,5-[(2-methyl-5-{[3-(trifluoromethyl)phenyl]carbamoyl}phenyl)amino]pyridine-3-carboxamide,SAAYRHKJHDIDPH-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
149345,6w9q,DB15431,-7.3,M-2698,HXAUJHZZPCBFPN-QGZVFWFLSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
164828,7bv1,DB08655,-7.3,"9-ACETYL-2,3,4,9-TETRAHYDRO-1H-CARBAZOL-1-ONE",MIGJEXKBUJPKJF-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
158248,7bv1,DB00776,-7.3,Oxcarbazepine,CTRLABGOLIVAIY-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
139976,6w9c,DB14668,-7.3,Dienestrol diacetate,YWLLGDVBTLPARJ-OXAZHYLESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
40297,6lu7,DB11652,-7.3,Tucatinib,SDEAXTCZPQIFQM-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
117515,6w4b,DB03596,-7.3,N-[2-(1h-Indol-5-Yl)-Butyl]-4-Sulfamoyl-Benzamide,FSRPBGBMEKDSIJ-CYBMUJFWSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
31552,6cs2,DB14013,-7.3,SR-9009,MMJJNHOIVCGAAP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
40296,6lu7,DB08031,-7.3,"N-[(13-CYCLOHEXYL-6,7-DIHYDROINDOLO[1,2-D][1,4]BENZOXAZEPIN-10-YL)CARBONYL]-2-METHYL-L-ALANINE",LNQWELVSNCYKDU-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
124252,6w4h,DB00934,-7.3,Maprotiline,QSLMDECMDJKHMQ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
40295,6lu7,DB06997,-7.3,"2-(4-fluorophenyl)-N-{[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]carbamoyl}acetamide",BMPOCDJEXAXXEZ-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40298,6lu7,DB07993,-7.3,"N-3-[3-(1H-INDOL-6-YL)BENZYL]PYRIDINE-2,3-DIAMINE",LPQUIIHPUGDHJK-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
139912,6w9c,DB14540,-7.3,Hydrocortisone butyrate,BMCQMVFGOVHVNG-TUFAYURCSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
152829,6wiq,DB04574,-7.3,Estrone sulfate,JKKFKPJIXZFSSB-CBZIJGRNSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
128623,6w4h,DB07826,-7.3,2-[4-chloro-2-(phenylcarbonyl)phenoxy]-N-phenylacetamide,DTGVSZSMDOMAEB-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
124292,6w4h,DB00982,-7.3,Isotretinoin,SHGAZHPCJJPHSC-XFYACQKRSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
40304,6lu7,DB08133,-7.3,N-(4-sulfamoylphenyl)-1H-indazole-3-carboxamide,MNHPHKFLWAPNOV-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
140118,6w9c,DB15012,-7.3,Farampator,XFVRBYKKGGDPAJ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
31481,6cs2,DB13867,-7.3,Fluticasone,MGNNYOODZCAHBA-GQKYHHCASA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
40303,6lu7,DB07362,-7.3,"1-(5-{2-[(1-methyl-1H-pyrazolo[4,3-d]pyrimidin-7-yl)amino]ethyl}-1,3-thiazol-2-yl)-3-[3-(trifluoromethyl)phenyl]urea",UOLCZAFAGDOUFX-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
117444,6w4b,DB03490,-7.3,"3-Pyridin-4-Yl-2,4-Dihydro-Indeno[1,2-.C.]Pyrazole",NHOACLCXCKJMAK-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
31506,6cs2,DB13937,-7.3,LGD-3303,OMXGOGXEWUCLFI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
29283,6cs2,DB08968,-7.3,Fominoben,KSNNEUZOAFRTDS-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
149411,6wiq,DB00137,-7.3,Lutein,KBPHJBAIARWVSC-RGZFRNHPSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
156057,6wiq,DB12350,-7.3,Rostafuroxin,AEAPORIZZWBIEX-DTBDINHYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
124271,6w4h,DB00956,-7.3,Hydrocodone,LLPOLZWFYMWNKH-CMKMFDCUSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
149382,6w9q,DB09171,-7.3,β-Methylfentanyl,UXIGUKSHASXDNI-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
164866,7bv1,DB08704,-7.3,"[[(3R,4R,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-(pentanoylamino)oxan-2-ylidene]amino] N-phenylcarbamate",NUNQIQQEEPOGDJ-JDOAOKHLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
40301,6lu7,DB07622,-7.3,"1-(3-(2,4-DIMETHYLTHIAZOL-5-YL)-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)-3-(4-METHYLPIPERAZIN-1-YL)UREA",KRKQVGZXTNLQSV-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40302,6lu7,DB07605,-7.3,"2-({4-[(5-CHLORO-1H-INDOL-2-YL)SULFONYL]PIPERAZIN-1-YL}CARBONYL)THIENO[3,2-B]PYRIDINE 4-OXIDE",DHDQMXPAANQKDC-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
117567,6w4b,DB03671,-7.3,"4-(3,12,14-Trihydroxy-10,13-Dimethyl-Hexadecahydro-Cyclopenta[a]Phenanthren-17-Yl)-5h-Furan-2-One",SHIBSTMRCDJXLN-KCZCNTNESA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
7355,6lzg,DB03672,-7.3,9-N-Phenylmethylamino-Tacrine,JYJAEHAURXXPSD-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
40294,6lu7,DB08233,-7.3,6-CYCLOHEXYLMETHYLOXY-2-(4'-HYDROXYANILINO)PURINE,RFSDQDHHBKYQOD-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
164779,7bv1,DB08595,-7.3,"4-[(1S,2R,5S)-4,4,8-TRIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL",BBZPJHFECDCNGT-BPUTZDHNSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
124233,6w4h,DB00913,-7.3,Anileridine,LKYQLAWMNBFNJT-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
133061,6w9c,DB01163,-7.3,Amdinocillin,BWWVAEOLVKTZFQ-NTZNESFSSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
40282,6lu7,DB00966,-7.3,Telmisartan,RMMXLENWKUUMAY-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40281,6lu7,DB01831,-7.3,Tryptophanyl-5'amp,IFQVDHDRFCKAAW-SQIXAUHQSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
31596,6cs2,DB14086,-7.3,Cianidanol,PFTAWBLQPZVEMU-DZGCQCFKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
40283,6lu7,DB00342,-7.3,Terfenadine,GUGOEEXESWIERI-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
35308,1r42,DB01456,-7.3,5-androstenedione,SQGZFRITSMYKRH-QAGGRKNESA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
139822,6w9c,DB14060,-7.3,NS-398,KTDZCOWXCWUPEO-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
152830,6wiq,DB04575,-7.3,Quinestrol,PWZUUYSISTUNDW-VAFBSOEGSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
124232,6w4h,DB00912,-7.3,Repaglinide,FAEKWTJYAYMJKF-QHCPKHFHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131110,6w4h,DB13309,-7.3,Benproperine,JTUQXGZRVLWBCR-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
158321,7bv1,DB00860,-7.3,Prednisolone,OIGNJSKKLXVSLS-VWUMJDOOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
164762,7bv1,DB08574,-7.3,"(5R)-2-SULFANYL-5-[4-(TRIFLUOROMETHYL)BENZYL]-1,3-THIAZOL-4-ONE",HBYVUUWMCCSRBI-MRVPVSSYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
40280,6lu7,DB07261,-7.3,"THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [1-(1-AMINO-ISOQUINOLIN-7-YLMETHYL)-2-OXO-PYRROLDIN-3-YL]-AMIDE",NVKDOURNRJCKJE-INIZCTEOSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40287,6lu7,DB05016,-7.3,Ataluren,OOUGLTULBSNHNF-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
164785,7bv1,DB08602,-7.3,"3-(2,6-difluorophenyl)-2-(methylthio)quinazolin-4(3H)-one",BFNBJSXMXXQLAW-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
164791,7bv1,DB08609,-7.3,"(2R)-N-{4-[Ethyl(phenyl)sulfamoyl]-2-methylphenyl}-3,3,3-trifluoro-2-hydroxy-2-methylpropanamide",SHEIQJGQDUYUBE-GOSISDBHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
40293,6lu7,DB08248,-7.3,3-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)-BENZENESULFONAMIDE,BKDUVKJYBJDZQW-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
117568,6w4b,DB03672,-7.3,9-N-Phenylmethylamino-Tacrine,JYJAEHAURXXPSD-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
40292,6lu7,DB08424,-7.3,"[5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL](3-{[(2R)-2,3-DIHYDROXYPROPYL]OXY}PHENYL)METHANONE",IJDQETGUEUJVTB-HNNXBMFYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
158273,7bv1,DB00808,-7.3,Indapamide,NDDAHWYSQHTHNT-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
40291,6lu7,DB08454,-7.3,N-(5-METHYL-1H-PYRAZOL-3-YL)-2-PHENYLQUINAZOLIN-4-AMINE,JYCUVOXSZBECAY-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
131118,6w4h,DB13317,-7.3,Flunoxaprofen,ARPYQKTVRGFPIS-VIFPVBQESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
154739,6wiq,DB08220,-7.3,"(8alpha,10alpha,13alpha,17beta)-17-[(4-hydroxyphenyl)carbonyl]androsta-3,5-diene-3-carboxylic acid",RPNNXCYIESWDSC-JRZBRKEGSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
139887,6w9c,DB14201,-7.3,"2,2'-Dibenzothiazyl disulfide",AFZSMODLJJCVPP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
40290,6lu7,DB08896,-7.3,Regorafenib,FNHKPVJBJVTLMP-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
164792,7bv1,DB08610,-7.3,N-(2-AMINOETHYL)-2-{3-CHLORO-4-[(4-ISOPROPYLBENZYL)OXY]PHENYL} ACETAMIDE,DFXJYVQAAFOZDP-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
158279,7bv1,DB00814,-7.3,Meloxicam,ZRVUJXDFFKFLMG-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
117658,6w4b,DB03788,-7.3,GC-24,JYHIGYLGYNCMGI-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
29252,6cs2,DB08932,-7.3,Macitentan,JGCMEBMXRHSZKX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
40288,6lu7,DB08006,-7.3,"N-anthracen-2-yl-5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7-amine",OXYDLVAOXASTMW-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
139854,6w9c,DB14122,-7.3,Dihydroxymethoxychalcone,NYSZJNUIVUBQMM-BQYQJAHWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140137,6w9c,DB15050,-7.3,Neopterin,BMQYVXCPAOLZOK-XINAWCOVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
164896,7bv1,DB08932,-7.3,Macitentan,JGCMEBMXRHSZKX-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
124305,6w4h,DB00998,-7.3,Frovatriptan,XPSQPHWEGNHMSK-SECBINFHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
145145,6w9q,DB07014,-7.3,"2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4-methoxybenzyl)sulfanyl]-1,3,4-oxadiazole",TUTZKAQTSPMEBI-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
128698,6w4h,DB07917,-7.3,4-(BENZHYDRYLOXY)-1-[3-(1H-TETRAAZOL-5-YL)PROPYL]PIPERIDINE,TZQGXAHOROZEKN-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
36929,1r42,DB03596,-7.3,N-[2-(1h-Indol-5-Yl)-Butyl]-4-Sulfamoyl-Benzamide,FSRPBGBMEKDSIJ-CYBMUJFWSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
29305,6cs2,DB00833,-7.3,Cefaclor,QYIYFLOTGYLRGG-GPCCPHFNSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
132906,6w9c,DB00986,-7.3,Glycopyrronium,ANGKOCUUWGHLCE-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
132916,6w9c,DB00998,-7.3,Frovatriptan,XPSQPHWEGNHMSK-SECBINFHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
36339,1r42,DB02799,-7.3,N-[2-(1-Maleimidyl)Ethyl]-7-Diethylaminocoumarin-3-Carboxamide,OJBZDUMTXGGVSP-KTKRTIGZSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
140449,6w9c,DB06857,-7.3,N-(4-CARBAMIMIDOYL-3-CHORO-PHENYL)-2-HYDROXY-3-IODO-5-METHYL-BENZAMIDE,QKGFTDAISIBIBV-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
158113,7bv1,DB00394,-7.3,Beclomethasone dipropionate,KUVIULQEHSCUHY-XYWKZLDCSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
116948,6w4b,DB02827,-7.3,"7-(1,1-Dioxo-1h-Benzo[D]Isothiazol-3-Yloxymethyl)-2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Pyran-3-Carboxylic Acid",MDYIGSPVMWSFEZ-JTQLQIEISA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
35414,1r42,DB01573,-7.3,Benzylmorphine,RDJGWRFTDZZXSM-RNWLQCGYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
140399,6w9c,DB05968,-7.3,PR-104,GZSOKPMDWVRVMG-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
31355,6cs2,DB13718,-7.3,Hydroquinine,LJOQGZACKSYWCH-WZBLMQSHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
35410,1r42,DB01569,-7.3,Formebolone,AMVODTGMYSRMNP-GNIMZFFESA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
149556,6wiq,DB00301,-7.3,Flucloxacillin,UIOFUWFRIANQPC-JKIFEVAISA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
116937,6w4b,DB02812,-7.3,"(2s,4r)-1-Acetyl-N-[(1s)-4-[(Aminoiminomethyl)Amino]-1-(2-Benzothiazolylcarbonyl)Butyl]-4-Hydroxy-2-Pyrrolidinecarboxamide",VXDAVYUFYPFGDX-SNPRPXQTSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
127297,6w4h,DB05134,-7.3,Tanespimycin,AYUNIORJHRXIBJ-TXHRRWQRSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
158082,7bv1,DB00355,-7.3,Aztreonam,WZPBZJONDBGPKJ-VEHQQRBSSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
128706,6w4h,DB07926,-7.3,N-[3-(N'-HYDROXYCARBOXAMIDO)-2-(2-METHYLPROPYL)-PROPANOYL]-O-TYROSINE-N-METHYLAMIDE,QYZPDCGWIJYZMN-ZBFHGGJFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
140744,6w9c,DB15224,-7.3,Lisavanbulin,NIPZLALJRAHABJ-IBGZPJMESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
116756,6w4b,DB02567,-7.3,PD173955,VAARYSWULJUGST-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
140711,6w9c,DB15161,-7.3,Pittsburgh Compound B,ZQAQXZBSGZUUNL-BJUDXGSMSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
158036,7bv1,DB00298,-7.3,Dapiprazole,RFWZESUMWJKKRN-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
132881,6w9c,DB00955,-7.3,Netilmicin,CIDUJQMULVCIBT-MQDUPKMGSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140582,6w9c,DB12482,-7.3,Acotiamide,TWHZNAUBXFZMCA-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
35452,1r42,DB01623,-7.3,Thiothixene,GFBKORZTTCHDGY-UWVJOHFNSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
116761,6w4b,DB02573,-7.3,"2'-Deoxycytidine-2'-Deoxyadenosine-3',5'-Monophosphate",LYWWDKIADIGKTH-IDMWBNCISA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
154646,6wiq,DB08111,-7.3,"4-[(6-phenyl[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl]phenol",ZGJYGQLGSXWEMY-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
129933,6w4h,DB11440,-7.3,Norgestomet,IWSXBCZCPVUWHT-VIFKTUCRSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
127294,6w4h,DB05116,-7.3,Thymectacin,CFBLUORPOFELCE-BACVZHSASA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
140477,6w9c,DB09170,-7.3,β-Hydroxythiofentanyl,GLAAETOTOUGGSB-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
153767,6wiq,DB07091,-7.3,(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclohexyloxy)ethanoyl)pyrrolidine-2-carboxamide,IWPMQJKXKKKSEY-SFHVURJKSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
140472,6w9c,DB07284,-7.3,"N-3-(3-PYRIDIN-3-YLBENZYL)PYRIDINE-2,3-DIAMINE",NQSBHBFOOVYRNM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
128709,6w4h,DB07929,-7.3,"N-(TERT-BUTYL)-3,5-DIMETHYL-N'-[(5-METHYL-2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)CARBONYL]BENZOHYDRAZIDE",JGJACZABNQGPMT-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
140384,6w9c,DB05864,-7.3,PPI-2458,QBDVVYNLLXGUGN-XGTBZJOHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
40279,6lu7,DB04690,-7.3,Camptothecin,VSJKWCGYPAHWDS-FQEVSTJZSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
117017,6w4b,DB02915,-7.3,"4-(2,4-Dimethyl-1,3-thiazol-5-yl)-N-[4-(trifluoromethyl)phenyl]-2-pyrimidinamine",MEZFDQUDLQCVNX-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
149508,6wiq,DB00246,-7.3,Ziprasidone,MVWVFYHBGMAFLY-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
164918,7bv1,DB08961,-7.3,Azosemide,HMEDEBAJARCKCT-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
132961,6w9c,DB01048,-7.3,Abacavir,MCGSCOLBFJQGHM-SCZZXKLOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
128645,6w4h,DB07852,-7.3,"1-(3,5-DICHLOROPHENYL)-5-METHYL-1H-1,2,4-TRIAZOLE-3-CARBOXYLIC ACID",CZTNDZALWLHXBA-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
6938,6lzg,DB02932,-7.3,(R)-Bicalutamide,LKJPYSCBVHEWIU-KRWDZBQOSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
149452,6wiq,DB00180,-7.3,Flunisolide,XSFJVAJPIHIPKU-XWCQMRHXSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
127317,6w4h,DB05265,-7.3,Ecabet,IWCWQNVIUXZOMJ-MISYRCLQSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
117238,6w4b,DB03213,-7.3,Bis(5-Amidino-2-Benzimidazolyl)Methane Ketone,VVVXDHROXQUONB-UHFFFAOYSA-P,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
124353,6w4h,DB01053,-7.3,Benzylpenicillin,JGSARLDLIJGVTE-MBNYWOFBSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
164901,7bv1,DB08940,-7.3,Kebuzone,LGYTZKPVOAIUKX-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
149426,6wiq,DB00153,-7.3,Ergocalciferol,MECHNRXZTMCUDQ-RKHKHRCZSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
124347,6w4h,DB01044,-7.3,Gatifloxacin,XUBOMFCQGDBHNK-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
127319,6w4h,DB05271,-7.3,Rotigotine,KFQYTPMOWPVWEJ-INIZCTEOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
158220,7bv1,DB00741,-7.3,Hydrocortisone,JYGXADMDTFJGBT-VWUMJDOOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
35350,1r42,DB01503,-7.3,1-Androstenediol,RZFGPAMUAXASRE-YSZCXEEOSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
149430,6wiq,DB00157,-7.3,NADH,BOPGDPNILDQYTO-NNYOXOHSSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
158188,7bv1,DB00704,-7.3,Naltrexone,DQCKKXVULJGBQN-XFWGSAIBSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
153753,6wiq,DB07076,-7.3,6-[(Z)-AMINO(IMINO)METHYL]-N-[3-(CYCLOPENTYLOXY)PHENYL]-2-NAPHTHAMIDE,FWTQOPWAMQXIMI-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
149485,6wiq,DB00220,-7.3,Nelfinavir,QAGYKUNXZHXKMR-HKWSIXNMSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
124451,6w4h,DB01165,-7.3,Ofloxacin,GSDSWSVVBLHKDQ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
158165,7bv1,DB00455,-7.3,Loratadine,JCCNYMKQOSZNPW-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
132932,6w9c,DB01015,-7.3,Sulfamethoxazole,JLKIGFTWXXRPMT-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
31391,6cs2,DB13759,-7.3,Fenpiverinium,QDIYJDPBMZUZEH-UHFFFAOYSA-O,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
31392,6cs2,DB13760,-7.3,Niperotidine,HXRSXEDVVARPHP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
158169,7bv1,DB00459,-7.3,Acitretin,IHUNBGSDBOWDMA-AQFIFDHZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
164972,7bv1,DB09020,-7.3,Bisacodyl,KHOITXIGCFIULA-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
140347,6w9c,DB04209,-7.3,Dequalinium,PCSWXVJAIHCTMO-UHFFFAOYSA-P,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
129969,6w4h,DB11519,-7.3,Fluprostenol,WWSWYXNVCBLWNZ-QIZQQNKQSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
140342,6w9c,DB04204,-7.3,[(4-{4-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Butyl}-Phenyl)-Difluoro-Methyl]-Phosphonic Acid,SRHSAABKYJDBDV-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
124428,6w4h,DB01138,-7.3,Sulfinpyrazone,MBGGBVCUIVRRBF-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
124421,6w4h,DB01130,-7.3,Prednicarbate,FNPXMHRZILFCKX-KAJVQRHHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
124400,6w4h,DB01104,-7.3,Sertraline,VGKDLMBJGBXTGI-SJCJKPOMSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
124391,6w4h,DB01095,-7.3,Fluvastatin,FJLGEFLZQAZZCD-JUFISIKESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
31434,6cs2,DB13810,-7.3,Dimemorfan,KBEZZLAAKIIPFK-NJAFHUGGSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
149535,6wiq,DB00276,-7.3,Amsacrine,XCPGHVQEEXUHNC-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
148483,6w9q,DB13506,-7.3,Carfecillin,NZDASSHFKWDBBU-KVMCETHSSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
149314,6w9q,DB15359,-7.3,Xanthohumol,ORXQGKIUCDPEAJ-YRNVUSSQSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
6188,6lzg,DB01698,-7.3,Rutin,IKGXIBQEEMLURG-NVPNHPEKSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
31826,6cs2,DB14841,-7.3,Centanafadine,HKHCSWPSUSWGLI-CABCVRRESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
31832,6cs2,DB14849,-7.3,Nebicapone,MRFOLGFFTUGAEB-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
123914,6w4h,DB00537,-7.3,Ciprofloxacin,MYSWGUAQZAJSOK-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
31843,6cs2,DB14867,-7.3,Parsaclisib,ZQPDJCIXJHUERQ-QWRGUYRKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
50553,2fxp,DB07144,-7.3,"5-[(3R)-3-(5-methoxy-2',6'-dimethylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",XZXVRKHUCSXVBM-AWEZNQCLSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
158555,7bv1,DB01622,-7.3,Thioproperazine,VZYCZNZBPPHOFY-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
31819,6cs2,DB14820,-7.3,Profoxydim,KRQUFUKTQHISJB-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
139541,6w9c,DB13609,-7.3,Umifenovir,KCFYEAOKVJSACF-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
118453,6w4b,DB04842,-7.3,Fluspirilene,QOYHHIBFXOOADH-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
29154,6cs2,DB08794,-7.3,Ethyl biscoumacetate,JCLHQFUTFHUXNN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
127408,6w4h,DB05791,-7.3,Perflubron,WTWWXOGTJWMJHI-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
133360,6w9c,DB01582,-7.3,Sulfamethazine,ASWVTGNCAZCNNR-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
31861,6cs2,DB01098,-7.3,Rosuvastatin,BPRHUIZQVSMCRT-VEUZHWNKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
153698,6wiq,DB07014,-7.3,"2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4-methoxybenzyl)sulfanyl]-1,3,4-oxadiazole",TUTZKAQTSPMEBI-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
118450,6w4b,DB04839,-7.3,Cyproterone acetate,UWFYSQMTEOIJJG-FDTZYFLXSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
133377,6w9c,DB01607,-7.3,Ticarcillin,OHKOGUYZJXTSFX-KZFFXBSXSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
145181,6w9q,DB07053,-7.3,2-{5-[3-(7-PROPYL-3-TRIFLUOROMETHYLBENZO[D]ISOXAZOL-6-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID,TWVYNPULGKGJOS-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
164517,7bv1,DB08098,-7.3,"{[5-(5-nitro-2-furyl)-1,3,4-oxadiazol-2-yl]thio}acetic acid",ITBNJCVIFHSKRL-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
139603,6w9c,DB13687,-7.3,Niaprazine,RSKQGBFMNPDPLR-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
40242,6lu7,DB14067,-7.3,Dofequidar,KLWUUPVJTLHYIM-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40241,6lu7,DB14895,-7.3,Vibegron,DJXRIQMCROIRCZ-XOEOCAAJSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40240,6lu7,DB14916,-7.3,Selonsertib,YIDDLAAKOYYGJG-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40239,6lu7,DB15257,-7.3,Milademetan,RYAYYVTWKAOAJF-QISPRATLSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40238,6lu7,DB12561,-7.3,WNT-974,XXYGTCZJJLTAGH-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
155974,6wiq,DB12025,-7.3,Triptolide,DFBIRQPKNDILPW-CIVMWXNOSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
164535,7bv1,DB08116,-7.3,"(3R)-4-{[(3,4-dihydroxyphenyl)acetyl]oxy}-N-(2-formylindolizin-3-yl)-3-sulfino-D-valine",DEOZLEGRVHDNKC-UGKGYDQZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
164526,7bv1,DB08107,-7.3,N-{[6-(PENTYLOXY)NAPHTHALEN-2-YL]SULFONYL}-D-GLUTAMIC ACID,LIGACKDHLKEZFH-GOSISDBHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
123951,6w4h,DB00582,-7.3,Voriconazole,BCEHBSKCWLPMDN-MGPLVRAMSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
133265,6w9c,DB01475,-7.3,Dioxaphetyl butyrate,LQGIXNQCOXNCRP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
149157,6w9q,DB15056,-7.3,Bifenthrin,OMFRMAHOUUJSGP-IRHGGOMRSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
149155,6w9q,DB15052,-7.3,Ansofaxine,QKYBZJLEMOZFFU-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
145168,6w9q,DB07039,-7.3,(2S)-N-(4-cyano-3-iodophenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide,RXSZCFAPSDTELY-SFHVURJKSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
133232,6w9c,DB01439,-7.3,3-Methylthiofentanyl,SRARDYUHGVMEQI-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
153694,6wiq,DB07008,-7.3,"4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMIDAZOL-1-YL)PHENOXY]PYRIMIDINE",XPXGYINSBORUMM-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
123876,6w4h,DB00487,-7.3,Pefloxacin,FHFYDNQZQSQIAI-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
48145,2fxp,DB02741,-7.3,CD564,RWYREGSYPCNZTL-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
123815,6w4h,DB00414,-7.3,Acetohexamide,VGZSUPCWNCWDAN-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131044,6w4h,DB13217,-7.3,Fentiazac,JIEKMACRVQTPRC-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
145245,6w9q,DB07127,-7.3,"{4-[2,2-BIS(5-METHYL-1,2,4-OXADIAZOL-3-YL)-3-PHENYLPROPYL]PHENYL}SULFAMIC ACID",SXDBFKLPNPUPRI-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
152917,6wiq,DB04693,-7.3,"(13S)-13-METHYLDODECAHYDRO-1H-CYCLOPENTA[A]PHENANTHRENE-3,17(2H,4H)-DIONE",CRDKSBHJIGNEOH-IMRIKWHGSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
154804,6wiq,DB08304,-7.3,"(3R)-3-cyclopentyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2-benzothiazine 1,1-dioxide",QZBQVXXESPXFPZ-QGZVFWFLSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
123791,6w4h,DB00384,-7.3,Triamterene,FNYLWPVRPXGIIP-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
145242,6w9q,DB07124,-7.3,"(2S)-1-(6H-INDOL-3-YL)-3-{[5-(7H-PYRAZOLO[3,4-C]PYRIDIN-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE",CCIACUJJBPSOHE-KRWDZBQOSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
123787,6w4h,DB00380,-7.3,Dexrazoxane,BMKDZUISNHGIBY-ZETCQYMHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
145256,6w9q,DB07140,-7.3,"5-[(3R)-3-(5-methoxybiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",JPENSYBRTSIYGO-AWEZNQCLSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
118569,6w4b,DB05255,-7.3,Ronacaleret,FQJISUPNMFRIFZ-HXUWFJFHSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
6895,6lzg,DB02873,-7.3,"1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperazin-1-Yl-3,4-Dihydroquinazolin-2(1h)-One",YAWZIQKDHQIHOS-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
164420,7bv1,DB07810,-7.3,"3-(4-HYDROXYPHENYL)-1-(2,4,6-TRIHYDROXYPHENYL)PROPAN-1-ONE",VGEREEWJJVICBM-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
158746,7bv1,DB02162,-7.3,5'-O-(N-Ethyl-Sulfamoyl)Adenosine,ONCSLXAPOGUODU-WOUKDFQISA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
149072,6w9q,DB14856,-7.3,PF-05089771,ZYSCOUXLBXGGIM-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
128528,6w4h,DB07719,-7.3,"[(3R)-3-(Methylcarbamoyl)-2-{[(2-methyl-2-propanyl)oxy]carbonyl}-1,2,3,4-tetrahydro-7-isoquinolinyl]sulfamic acid",PPSSYXOFPICMQD-CYBMUJFWSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
118553,6w4b,DB05137,-7.3,Lobeline,MXYUKLILVYORSK-HBMCJLEFSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
164440,7bv1,DB07832,-7.3,"4-{4-[(5-hydroxy-2-methylphenyl)amino]quinolin-7-yl}-1,3-thiazole-2-carbaldehyde",VKQPTVJDZIILPG-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
139494,6w9c,DB13545,-7.3,Isobromindione,QFLZIWVSQDZLNW-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
158583,7bv1,DB01656,-7.3,Roflumilast,MNDBXUUTURYVHR-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
130055,6w4h,DB11702,-7.3,Antineoplaston A10,OQGRFQCUGLKSAV-JTQLQIEISA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
164464,7bv1,DB07860,-7.3,(2R)-2-(4-CHLOROPHENYL)-2-PHENYLETHANAMINE,PNKKPFLBOWGVSF-CQSZACIVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
118495,6w4b,DB04903,-7.3,Pagoclone,HIUPRQPBWVEQJJ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
6162,6lzg,DB01659,-7.3,"3-(1,10-Phenanthrol-2-Yl)-L-Alanine",LODBCIBKOKOGNL-LBPRGKRZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
155970,6wiq,DB12020,-7.3,Tecovirimat,CSKDFZIMJXRJGH-VWLPUNTISA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
161069,7bv1,DB12833,-7.3,Tandospirone,CEIJFEGBUDEYSX-FZDBZEDMSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
133401,6w9c,DB01634,-7.3,2-Oxy-4-Hydroxy-5-(2-Hydrazinopyridine)Phenylalanine,AZUQIXJQZOMXAS-BDAKNGLRSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
158666,7bv1,DB01766,-7.3,Beta-(2-Naphthyl)-Alanine,JPZXHKDZASGCLU-LBPRGKRZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
1954,6lzg,HMDB0029190,-7.3,"5-(3',4'-dihydroxyphenyl)-gamma-valerolactone-3'-O-glucuronide",RALBOGKBFZBDKY-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
127427,6w4h,DB05903,-7.3,KOS-1584,XAYAKDZVINDZGB-BMVMHAJPSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
139510,6w9c,DB13564,-7.3,Zipeprol,VSTNNAYSCJQCQI-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
131056,6w4h,DB13230,-7.3,Gestonorone,GTFUITFQDGVJSK-XGXHKTLJSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
118535,6w4b,DB05039,-7.3,Indacaterol,QZZUEBNBZAPZLX-QFIPXVFZSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
139505,6w9c,DB13557,-7.3,Thiopropazate,AIUHRQHVWSUTGJ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
40243,6lu7,DB13040,-7.3,Gandotinib,SQSZANZGUXWJEA-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40245,6lu7,DB12742,-7.3,Amuvatinib,FOFDIMHVKGYHRU-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40246,6lu7,DB15356,-7.3,SLV-334,LOFDNSDPZTVIIO-VPUSJEBWSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
133223,6w9c,DB01428,-7.3,Oxybenzone,DXGLGDHPHMLXJC-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
40271,6lu7,DB03331,-7.3,"N-Naphthalen-1-Ylmethyl-2'-[3,5-Dimethoxybenzamido]-2'-Deoxy-Adenosine",OARVXDFNTLYMCJ-JVUUKAHWSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
46112,2fxp,DB00157,-7.3,NADH,BOPGDPNILDQYTO-NNYOXOHSSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
6537,6lzg,DB00307,-7.3,Bexarotene,NAVMQTYZDKMPEU-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
149291,6w9q,DB15317,-7.3,Posiphen,PBHFNBQPZCRWQP-AZUAARDMSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
158386,7bv1,DB01127,-7.3,Econazole,LEZWWPYKPKIXLL-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
164662,7bv1,DB08270,-7.3,"N-(2-AMINOETHYL)-N-2-{(1S)-1-[4'-(AMINOSULFONYL)BIPHENYL-4-YL]-2,2,2-TRIFLUOROETHYL}-L-LEUCINAMIDE",QPXXBNKMAHUXBB-PMACEKPBSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
31654,6cs2,DB14209,-7.3,Trandolaprilat,AHYHTSYNOHNUSH-HXFGRODQSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
124146,6w4h,DB00817,-7.3,Rosoxacin,XBPZXDSZHPDXQU-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
156008,6wiq,DB12078,-7.3,Enobosarm,JNGVJMBLXIUVRD-SFHVURJKSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
164650,7bv1,DB08254,-7.3,2-NAPHTHALENESULFONIC ACID,KVBGVZZKJNLNJU-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
35237,1r42,DB01347,-7.3,Saprisartan,DUEWVPTZCSAMNB-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
164646,7bv1,DB08247,-7.3,6-(CYCLOHEXYLMETHOXY)-8-ISOPROPYL-9H-PURIN-2-AMINE,JABXNQUXGJTKRO-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
133137,6w9c,DB01252,-7.3,Mitiglinide,WPGGHFDDFPHPOB-BBWFWOEESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
40269,6lu7,DB08930,-7.3,Dolutegravir,RHWKPHLQXYSBKR-BMIGLBTASA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
133130,6w9c,DB01242,-7.3,Clomipramine,GDLIGKIOYRNHDA-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
40272,6lu7,DB11778,-7.3,Danusertib,XKFTZKGMDDZMJI-HSZRJFAPSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40273,6lu7,DB06948,-7.3,2-ANILINO-6-CYCLOHEXYLMETHOXYPURINE,XWWRLKIBRPJQJX-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
149292,6w9q,DB15319,-7.3,VM4-037,QGYZPMXIVNIGKA-GMAHTHKFSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
31614,6cs2,DB14125,-7.3,Benazeprilat,MADRIHWFJGRSBP-ROUUACIJSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
133082,6w9c,DB01186,-7.3,Pergolide,YEHCICAEULNIGD-MZMPZRCHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
124197,6w4h,DB00873,-7.3,Loteprednol,YPZVAYHNBBHPTO-MXRBDKCISA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
158323,7bv1,DB00862,-7.3,Vardenafil,SECKRCOLJRRGGV-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
158329,7bv1,DB00870,-7.3,Suprofen,MDKGKXOCJGEUJW-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
139800,6w9c,DB14014,-7.3,SR-9011,PPUYOYQTTWJTIU-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
117907,6w4b,DB04115,-7.3,Berberine,YBHILYKTIRIUTE-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
133099,6w9c,DB01204,-7.3,Mitoxantrone,KKZJGLLVHKMTCM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
40278,6lu7,DB07159,-7.3,Tamatinib,NHHQJBCNYHBUSI-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40277,6lu7,DB05611,-7.3,Apilimod,HSKAZIJJKRAJAV-KOEQRZSOSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
139796,6w9c,DB14002,-7.3,D-alpha-Tocopherol acetate,ZAKOWWREFLAJOT-CEFNRUSXSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
40276,6lu7,DB06295,-7.3,Pramiconazole,AEKNYBWUEYNWMJ-QWOOXDRHSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40275,6lu7,DB06409,-7.3,Morphine glucuronide,GNJCUHZOSOYIEC-GAROZEBRSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
124167,6w4h,DB00839,-7.3,Tolazamide,OUDSBRTVNLOZBN-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
40274,6lu7,DB06925,-7.3,3-(2-AMINOQUINAZOLIN-6-YL)-4-METHYL-N-[3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE,YEIASMOUYNOXGA-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
139710,6w9c,DB13835,-7.3,Caroverine,MSPRUJDUTKRMLM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
158322,7bv1,DB00861,-7.3,Diflunisal,HUPFGZXOMWLGNK-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
40268,6lu7,DB15382,-7.3,SAR-125844,ODIUNTQOXRXOIV-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
118085,6w4b,DB04350,-7.3,Argadin,FOZYKTUSOWWQGR-KNPYFFGGSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
40252,6lu7,DB11886,-7.3,Infigratinib,QADPYRIHXKWUSV-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40251,6lu7,DB11913,-7.3,LY-2090314,HRJWTAWVFDCTGO-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
35196,1r42,DB01254,-7.3,Dasatinib,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
164586,7bv1,DB08170,-7.3,"(1R)-N,6-DIHYDROXY-7-METHOXY-2-[(4-METHOXYPHENYL)SULFONYL]-1,2,3,4-TETRAHYDROISOQUINOLINE-1-CARBOXAMIDE",AYFCYVLVRYQGME-QGZVFWFLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
31752,6cs2,DB14671,-7.3,Temazepam acetate,PTWWAHZQIATUFG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
40250,6lu7,DB11923,-7.3,Decoglurant,DMJHZVARRXJSEG-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
128570,6w4h,DB07768,-7.3,Epitestosterone,MUMGGOZAMZWBJJ-KZYORJDKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
31763,6cs2,DB14681,-7.3,Cortisone,MFYSYFVPBJMHGN-ZPOLXVRWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
164562,7bv1,DB08146,-7.3,"7-(2,5-dihydropyrrol-1-yl)-6-phenyl-pyrido[6,5-d]pyrimidin-2-amine",QFWNOFXQNCLFBC-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
158475,7bv1,DB01228,-7.3,Encainide,PJWPNDMDCLXCOM-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
40248,6lu7,DB12477,-7.3,Perfluoro tert-butylcyclohexane,VLTXBOGHSBHSAC-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
139632,6w9c,DB13727,-7.3,Azapetine,NYGHGTMKALXFIA-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
31779,6cs2,DB14732,-7.3,Queuine,WYROLENTHWJFLR-ACLDMZEESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
40247,6lu7,DB12535,-7.3,AC-430,DCRWIATZWHLIPN-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40249,6lu7,DB12253,-7.3,GDC-0810,BURHGPHDEVGCEZ-KJGLQBJMSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
164589,7bv1,DB08173,-7.3,5-CHLORO-N-(2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO)ETHYL)THIOPHENE-2-CARBOXAMIDE,UCKHUNHXYMAFQM-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
40253,6lu7,DB12760,-7.3,GW-493838,ZQYJPMPXQLNTPQ-QCUYGVNKSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
152860,6wiq,DB04615,-7.3,(S)-tacrine(10)-hupyridone,ROTFGKJJMRTWBD-MHZLTWQESA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
164637,7bv1,DB08237,-7.3,2'-deoxy-N-(naphthalen-1-ylmethyl)guanosine 5'-(dihydrogen phosphate),COMPKRGNHXOXMN-GVDBMIGSSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
124092,6w4h,DB00751,-7.3,Epinastine,WHWZLSFABNNENI-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
124080,6w4h,DB00736,-7.3,Esomeprazole,SUBDBMMJDZJVOS-DEOSSOPVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
46781,2fxp,DB00950,-7.3,Fexofenadine,RWTNPBWLLIMQHL-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
40263,6lu7,DB15295,-7.3,Tenalisib,HDXDQPRPFRKGKZ-INIZCTEOSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
127381,6w4h,DB05596,-7.3,PRX-03140,SCHKZZSVELPJKU-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
40261,6lu7,DB15265,-7.3,USL-311,XNUNVQKARNSSEO-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
35212,1r42,DB01289,-7.3,Glisoxepide,ZKUDBRCEOBOWLF-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
149258,6w9q,DB15250,-7.3,Vercirnon,JRWROCIMSDXGOZ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
133164,6w9c,DB01324,-7.3,Polythiazide,CYLWJCABXYDINA-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
153743,6wiq,DB07063,-7.3,"{3-[(4,5,7-TRIFLUORO-1,3-BENZOTHIAZOL-2-YL)METHYL]-1H-INDOL-1-YL}ACETIC ACID",KYHVTMFADJNSGS-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
124041,6w4h,DB00691,-7.3,Moexipril,UWWDHYUMIORJTA-HSQYWUDLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
133185,6w9c,DB01354,-7.3,Heptabarbital,PAZQYDJGLKSCSI-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
152856,6wiq,DB04609,-7.3,INHIBITOR Q8467 OF DUPONT MERCK,HFLCERPZYCWLSZ-VKONIRKNSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
31737,6cs2,DB14657,-7.3,Paramethasone acetate,HYRKAAMZBDSJFJ-LFDBJOOHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
131098,6w4h,DB13291,-7.3,Cloridarol,KBFBRIPYVVGWRS-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
163456,7bv1,DB04645,-7.3,"5-{3-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-2-METHYL-PHENOXY}-PENTANOIC ACID",NJJIFGCFUDDBSP-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
119385,6w4b,DB07253,-7.3,"N'-(5-chloro-1,3-benzodioxol-4-yl)-N-(3-methylsulfonylphenyl)pyrimidine-2,4-diamine",QTFCKBFCXDAZIU-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
159682,7bv1,DB05255,-7.3,Ronacaleret,FQJISUPNMFRIFZ-HXUWFJFHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
161809,7bv1,DB00624,-7.3,Testosterone,MUMGGOZAMZWBJJ-DYKIIFRCSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
127970,6w4h,DB07065,-7.3,"5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)-3-thiocyanatopyrazolo[1,5-a]pyrimidin-7-amine",AHPKUZJCNHGFQA-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
33498,6cs2,T3D4753,-7.3,Spironolactone,LXMSZDCAJNLERA-ZHYRCANASA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
161806,7bv1,DB00621,-7.3,Oxandrolone,QSLJIVKCVHQPLV-PEMPUTJUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
155451,6wiq,DB09171,-7.3,??-Methylfentanyl,UXIGUKSHASXDNI-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
147643,6w9q,DB12242,-7.3,AZD-7762,IAYGCINLNONXHY-LBPRGKRZSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
161816,7bv1,DB00633,-7.3,Dexmedetomidine,CUHVIMMYOGQXCV-NSHDSACASA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
161799,7bv1,DB00611,-7.3,Butorphanol,IFKLAQQSCNILHL-PWRODBHTSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
34164,6cs2,T3D1027,-7.3,Resmethrin,VEMKTZHHVJILDY-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
135703,6w9c,DB04828,-7.3,Zomepirac,ZXVNMYWKKDOREA-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
135710,6w9c,DB04836,-7.3,Amineptine,ONNOFKFOZAJDHT-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
161779,7bv1,DB00588,-7.3,Fluticasone propionate,WMWTYOKRWGGJOA-CENSZEJFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
120498,6w4b,DB08560,-7.3,3-FLUORO-N-[1-(4-FLUOROPHENYL)-3-(2-THIENYL)-1H-PYRAZOL-5-YL]BENZENESULFONAMIDE,GULUFDCOGAXLEP-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
135712,6w9c,DB04838,-7.3,Cyclandelate,WZHCOOQXZCIUNC-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
120483,6w4b,DB08543,-7.3,1-[2-HYDROXY-3-(4-CYCLOHEXYL-PHENOXY)-PROPYL]-4-(2-PYRIDYL)-PIPERAZINE,BZJHCQBNFUNZPJ-QFIPXVFZSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
121733,6w4b,DB12316,-7.3,9CUAB30,PPGNMFUMZSAZCW-VOYUZAMQSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
136889,6w9c,DB07652,-7.3,"1-[2-DEOXYRIBOFURANOSYL]-2,4-DIFLUORO-5-METHYL-BENZENE-5'MONOPHOSPHATE",NMMWBGNJJMNAIJ-QJPTWQEYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
135670,6w9c,DB04788,-7.3,Tagetitoxin,UVAAUIDYGIWLMB-HGNFPZBQSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
146722,6w9q,DB08883,-7.3,Perampanel,PRMWGUBFXWROHD-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
120433,6w4b,DB08487,-7.3,3-({4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-2-OXOPIPERAZIN-1-YL}METHYL)BENZENECARBOXIMIDAMIDE,PRMSFVUWLBPPLY-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
121779,6w4b,DB12388,-7.3,Evocalcet,RZNUIYPHQFXBAN-XLIONFOSSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
121770,6w4b,DB12376,-7.3,Ricolinostat,QGZYDVAGYRLSKP-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
33476,6cs2,T3D4733,-7.3,Quinapril,JSDRRTOADPPCHY-HSQYWUDLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
120450,6w4b,DB08504,-7.3,"6-(4-{(1S,2S)-2-AMINO-1-[(DIMETHYLAMINO)CARBONYL]-3-[(3S)-3-FLUOROPYRROLIDIN-1-YL]-3-OXOPROPYL}PHENYL)-1H-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-4-IUM",ZNHVIJAGMFQGMS-IHPCNDPISA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
161818,7bv1,DB00635,-7.3,Prednisone,XOFYZVNMUHMLCC-ZPOLXVRWSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
161845,7bv1,DB00671,-7.3,Cefixime,OKBVVJOGVLARMR-QSWIMTSFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160505,7bv1,DB08715,-7.3,"2,6-DIMETHYL-1-(3-[3-METHYL-5-ISOXAZOLYL]-PROPANYL)-4-[2-METHYL-4-ISOXAZOLYL]-PHENOL",SLPKYEWAKMNCPT-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
120472,6w4b,DB08531,-7.3,"5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",CVYWYUAQFJMLEO-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
33480,6cs2,T3D4737,-7.3,Amiodarone,IYIKLHRQXLHMJQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
33484,6cs2,T3D4740,-7.3,Hexestrol,PBBGSZCBWVPOOL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
160514,7bv1,DB08725,-7.3,"(S)-5-(7-(4-(4-Ethyl-4,5-dihydro-2-oxazolyl)phenoxy)heptyl)-3-methylisoxazole",PZDSRPCFNWOUFP-IBGZPJMESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
155720,6wiq,DB11622,-7.3,Dehydrocholic acid,OHXPGWPVLFPUSM-KLRNGDHRSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
136936,6w9c,DB07712,-7.3,3-ETHYL-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL,XBMVVMYGKMGLJX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
121725,6w4b,DB12307,-7.3,Foretinib,CXQHYVUVSFXTMY-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
136816,6w9c,DB07565,-7.3,Chloramphenicol succinate,LIRCDOVJWUGTMW-ZWNOBZJWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136811,6w9c,DB07560,-7.3,N-[(1S)-2-methyl-1-(pyridin-4-ylcarbamoyl)propyl]cyclohexanecarboxamide,VYLDPSVXLWTIAJ-HNNXBMFYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
146838,6w9q,DB09050,-7.3,Ceftolozane,JHFNIHVVXRKLEF-DCZLAGFPSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
160575,7bv1,DB08791,-7.3,"1-[(2-NITROPHENYL)SULFONYL]-1H-PYRROLO[3,2-B]PYRIDINE-6-CARBOXAMIDE",USLOIFPDNUDIEG-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
6734,6lzg,DB02610,-7.3,"N-(2,3,4,5,6-Pentaflouro-Benzyl)-4-Sulfamoyl-Benzamide",LRKSHOLYETXPGY-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
46561,2fxp,DB00696,-7.3,Ergotamine,XCGSFFUVFURLIX-VFGNJEKYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
33571,6cs2,T3D0415,-7.3,"2,3',5-Trichlorobiphenyl",ONNCPBRWFSKDMQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
135822,6w9c,DB05187,-7.3,Elafibranor,AFLFKFHDSCQHOL-IZZDOVSWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
120583,6w4b,DB08664,-7.3,({3-[1-(4-HYDROXY-2-OXO-2H-CHROMEN-3-YL)-PROPYL]-PHENYLCARBAMOYL}-METHYL)-CARBAMIC ACID TERT-BUTYL ESTER,QUQQVMVIWCUYFV-KRWDZBQOSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
155702,6wiq,DB11562,-7.3,Bicuculline,IYGYMKDQCDOMRE-ZWKOTPCHSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
34106,6cs2,T3D0966,-7.3,Fenasulam,LFDDUUFFHPNIPZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
136730,6w9c,DB07462,-7.3,"(3,4-DIHYDROXY-2-NITROPHENYL)(PHENYL)METHANONE",ICLKAUQIPVFHOI-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136729,6w9c,DB07461,-7.3,"3-AMINO-3-BENZYL-9-CARBOXAMIDE[4.3.0]BICYCLO-1,6-DIAZANONAN-2-ONE",JVDDTUQPPBUQDD-DZGCQCFKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
147579,6w9q,DB12147,-7.3,Erdafitinib,OLAHOMJCDNXHFI-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
161698,7bv1,DB00487,-7.3,Pefloxacin,FHFYDNQZQSQIAI-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
135840,6w9c,DB05289,-7.3,Tarenflurbil,SYTBZMRGLBWNTM-SNVBAGLBSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
160641,7bv1,DB08893,-7.3,Mirabegron,PBAPPPCECJKMCM-IBGZPJMESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
135782,6w9c,DB04967,-7.3,Lucanthone,FBQPGGIHOFZRGH-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
135778,6w9c,DB04954,-7.3,Tecadenoson,OESBDSFYJMDRJY-BAYCTPFLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
34136,6cs2,T3D0998,-7.3,Promacyl,GGRLUNQHANDPSC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
147625,6w9q,DB12221,-7.3,Canrenone,UJVLDDZCTMKXJK-WNHSNXHDSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
121721,6w4b,DB12302,-7.3,CP-724714,LLVZBTWPGQVVLW-SNAWJCMRSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
155716,6wiq,DB11616,-7.3,Pirarubicin,KMSKQZKKOZQFFG-YXRRJAAWSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
127796,6w4h,DB06865,-7.3,6-CARBAMIMIDOYL-2-[2-HYDROXY-6-(4-HYDROXY-PHENYL)-INDAN-1-YL]-HEXANOIC ACID,ZSRRBAKATXAISL-LMNJBCLMSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
33536,6cs2,T3D4787,-7.3,Lovastatin,PCZOHLXUXFIOCF-BXMDZJJMSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
7596,6lzg,DB00146,-7.3,Calcifediol,JWUBBDSIWDLEOM-DTOXIADCSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
28752,6cs2,DB08363,-7.3,1-(9-ethyl-9H-carbazol-3-yl)-N-methylmethanamine,LBPNOEAFWYTTEB-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
147615,6w9q,DB12206,-7.3,N-6022,YVPGZQLRPAGKLA-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
160549,7bv1,DB08761,-7.3,"(3S,6S)-3,6-bis(4-hydroxybenzyl)piperazine-2,5-dione",NGPCLOGFGKJCBP-HOTGVXAUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
120546,6w4b,DB08619,-7.3,Testosterone succinate,CJQNBXFUHQZFOE-VYAQIDIUSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
120553,6w4b,DB08631,-7.3,"N-(4-CHLOROPHENYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONAMIDE",UVSIFVBCHJEYJP-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
153246,6wiq,DB05812,-7.3,Abiraterone,GZOSMCIZMLWJML-VJLLXTKPSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
161743,7bv1,DB00546,-7.3,Adinazolam,GJSLOMWRLALDCT-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
161739,7bv1,DB00542,-7.3,Benazepril,XPCFTKFZXHTYIP-PMACEKPBSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
146804,6w9q,DB08997,-7.3,Dexetimide,LQQIVYSCPWCSSD-HSZRJFAPSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
160484,7bv1,DB08443,-7.3,"2-(1H-pyrrol-1-ylcarbonyl)benzene-1,3,5-triol",RYGSNHBTZDYVSS-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
155435,6wiq,DB09128,-7.3,Brexpiprazole,ZKIAIYBUSXZPLP-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
33462,6cs2,T3D4710,-7.3,Prednisone,XOFYZVNMUHMLCC-ZPOLXVRWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
161860,7bv1,DB00688,-7.3,Mycophenolate mofetil,RTGDFNSFWBGLEC-SYZQJQIISA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
146412,6w9q,DB08499,-7.3,"N-[3-(2-fluoroethoxy)phenyl]-N'-(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-6-yl)butanediamide",DQXBKUVWJSZHSI-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
147728,6w9q,DB12361,-7.3,Piclozotan,URMTUEWUIGOJBW-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
5999,6lzg,DB01425,-7.3,Alizapride,KSEYRUGYKHXGFW-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
33307,6cs2,T3D4501,-7.3,Ethametsulfuron methyl,ZINJLDJMHCUBIP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
162062,7bv1,DB01393,-7.3,Bezafibrate,IIBYAHWJQTYFKB-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
121930,6w4b,DB12612,-7.3,Ozanimod,XRVDGNKRPOAQTN-FQEVSTJZSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
162075,7bv1,DB01413,-7.3,Cefepime,HVFLCNVBZFFHBT-ZKDACBOMSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
33314,6cs2,T3D4507,-7.3,Fenoxaprop-ethyl,PQKBPHSEKWERTG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
121912,6w4b,DB12579,-7.3,JNJ-37822681,UVUYWJWYRLJHEN-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
146443,6w9q,DB08535,-7.3,"3-bromo-5-phenyl-N-(pyridin-3-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",SMIZFGZXFDGISG-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
121902,6w4b,DB12566,-7.3,Decernotinib,ASUGUQWIHMTFJL-QGZVFWFLSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
34266,1r42,DB00378,-7.3,Dydrogesterone,JGMOKGBVKVMRFX-HQZYFCCVSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
135514,6w9c,DB04566,-7.3,Inosinic Acid,GRSZFWQUAKGDAV-KQYNXXCUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137070,6w9c,DB07863,-7.3,2-chloro-5-nitro-N-phenylbenzamide,DNTSIBUQMRRYIU-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
146424,6w9q,DB08513,-7.3,[4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENYL]ACETIC ACID,PAIQRYUOBBCBSE-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
34281,1r42,DB00396,-7.3,Progesterone,RJKFOVLPORLFTN-LEKSSAKUSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
135477,6w9c,DB04520,-7.3,"(3s,8ar)-3-(4-Hydroxybenzyl)Hexahydropyrrolo[1,2-a]Pyrazine-1,4-Dione",LSGOTAXPWMCUCK-RYUDHWBXSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
146403,6w9q,DB08490,-7.3,CTS-1027,ROSNVSQTEGHUKU-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
7561,6lzg,DB04010,-7.3,2-(3'-Methoxyphenyl) Benzimidazole-4-Carboxamide,NVVWVYYHTKCIAE-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
130416,6w4h,DB12236,-7.3,Bexagliflozin,BTCRKOKVYTVOLU-SJSRKZJXSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
137198,6w9c,DB08012,-7.3,(METHYLPYRIDAZINE PIPERIDINE ETHYLOXYPHENYL)ETHYLACETATE,KCHIOGFOPPOUJC-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
155357,6wiq,DB08997,-7.3,Dexetimide,LQQIVYSCPWCSSD-HSZRJFAPSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
162094,7bv1,DB01434,-7.3,19-norandrostenedione,JRIZOGLBRPZBLQ-QXUSFIETSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
128027,6w4h,DB07131,-7.3,(S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclohexylpropanoyl)pyrrolidine-2-carboxamide,DOTBZTLJSXFKCP-IBGZPJMESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
135441,6w9c,DB04474,-7.3,1-Anilino-8-Naphthalene Sulfonate,FWEOQOXTVHGIFQ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
162080,7bv1,DB01419,-7.3,Antrafenine,NWGGKKGAFZIVBJ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
147737,6w9q,DB12376,-7.3,Ricolinostat,QGZYDVAGYRLSKP-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
127715,6w4h,DB06731,-7.3,Seproxetine,WIQRCHMSJFFONW-HNNXBMFYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
36660,1r42,DB03222,-7.3,dATP,SUYVUBYJARFZHO-RRKCRQDMSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
137147,6w9c,DB07956,-7.3,[1-(3-CHLORO-2-FORMYL-PHENYLCARBAMOYL)-2-METHYL-PROPYL]-CARBAMIC ACID TERT-BUTYL ESTER,GBHYPZDGTWSQFR-AWEZNQCLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
135465,6w9c,DB04505,-7.3,"8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-9-Pent-4-Ylnyl-9h-Purin-6-Ylamine",WUJFGZAAFADPSF-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
34302,1r42,DB00421,-7.3,Spironolactone,LXMSZDCAJNLERA-ZHYRCANASA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
162077,7bv1,DB01415,-7.3,Ceftibuten,UNJFKXSSGBWRBZ-BJCIPQKHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
135536,6w9c,DB04597,-7.3,"[4,6-O-(1-CARBOXYETHYLIDENE)-BETA-D-MANNOSE]",QVVFNJUJKXWFAU-BDIBXJNUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136720,6w9c,DB07452,-7.3,"2,6-diamino-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",WFECBOHPSURSGU-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
155388,6wiq,DB09042,-7.3,Tedizolid phosphate,QCGUSIANLFXSGE-GFCCVEGCSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
155403,6wiq,DB09070,-7.3,Tibolone,WZDGZWOAQTVYBX-XOINTXKNSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
135606,6w9c,DB04689,-7.3,2-{5-[3-(6-BENZOYL-1-PROPYLNAPHTHALEN-2-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID,ZXWVCCFKIRBLDP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
49602,2fxp,DB04696,-7.3,"4-CHLORO-3',3''-DIBROMOPHENOL-1,8-NAPHTHALEIN",GFGZCXHXQCQRFP-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
120355,6w4b,DB08391,-7.3,"6,7-DIMETHOXY-4-[(3R)-3-(QUINOXALIN-2-YLOXY)PYRROLIDIN-1-YL]QUINAZOLINE",UBIIFKJMNRPNMT-CQSZACIVSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
33417,6cs2,T3D4648,-7.3,Medazepam,YLCXGBZIZBEVPZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
146627,6w9q,DB08753,-7.3,"4-{(1E)-3-OXO-3-[(2-PHENYLETHYL)AMINO]PROP-1-EN-1-YL}-1,2-PHENYLENE DIACETATE",GARHCDOTUULBOQ-PKNBQFBNSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
136980,6w9c,DB07762,-7.3,4-(N-ACETYLAMINO)-3-[N-(2-ETHYLBUTANOYLAMINO)]BENZOIC ACID,USKXJFHTBQWXCS-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
135601,6w9c,DB04681,-7.3,BETA-METHYLLACTOSIDE,FHNIYFZSHCGBPP-ABBMIVAOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
146634,6w9q,DB08761,-7.3,"(3S,6S)-3,6-bis(4-hydroxybenzyl)piperazine-2,5-dione",NGPCLOGFGKJCBP-HOTGVXAUSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
135629,6w9c,DB04729,-7.3,Gentamicin C1a,VEGXETMJINRLTH-BOZYPMBZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
121799,6w4b,DB12412,-7.3,Gemigliptin,ZWPRRQZNBDYKLH-VIFPVBQESA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
160472,7bv1,DB08430,-7.3,PARA-NITROPHENYL 1-THIO-BETA-D-GLUCOPYRANOSIDE,IXFOBQXJWRLXMD-ZIQFBCGOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
136971,6w9c,DB07753,-7.3,"3',5'-DIFLUOROBIPHENYL-4-CARBOXYLIC ACID",VCEFNMHMLWBFNV-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
120414,6w4b,DB08463,-7.3,(2R)-2-({9-(1-methylethyl)-6-[(4-pyridin-2-ylbenzyl)amino]-9H-purin-2-yl}amino)butan-1-ol,HOCBJBNQIQQQGT-LJQANCHMSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
155737,6wiq,DB11656,-7.3,Rebamipide,ALLWOAVDORUJLA-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
146682,6w9q,DB08816,-7.3,Ticagrelor,OEKWJQXRCDYSHL-FNOIDJSQSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
33415,6cs2,T3D4646,-7.3,Doxefazepam,VOJLELRQLPENHL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
146619,6w9q,DB08745,-7.3,4-[[(1E)-2-(4-CHLOROPHENYL)ETHENYL]SULFONYL]-1-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]PIPERAZINONE,QLHUDNKWOSQSMK-CXUHLZMHSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
161933,7bv1,DB00990,-7.3,Exemestane,BFYIZQONLCFLEV-DAELLWKTSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
146488,6w9q,DB08590,-7.3,1-(3-HYDROXYPROPYL)-2-[(3-NITROBENZOYL)AMINO]-1H-BENZIMIDAZOL-5-YL PIVALATE,CEAYRKIZESVQSN-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
34247,1r42,DB00354,-7.3,Buclizine,MOYGZHXDRJNJEP-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
121875,6w4b,DB12524,-7.3,BI-671800,XEOSTBFUCNZKGS-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
49631,2fxp,DB04739,-7.3,4-[(4-METHYL-1-PIPERAZINYL)METHYL]-N-[3-[[4-(3-PYRIDINYL)-2-PYRIMIDINYL]AMINO]PHENYL]-BENZAMIDE,JHMBUEWQJDGKGS-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
121869,6w4b,DB12515,-7.3,9-aminocamptothecin,FUXVKZWTXQUGMW-FQEVSTJZSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
155758,6wiq,DB11686,-7.3,Iferanserin,UXIPFQUBOVWAQW-UEBLJOKOSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
161977,7bv1,DB01039,-7.3,Fenofibrate,YMTINGFKWWXKFG-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
120324,6w4b,DB08353,-7.3,"2-(CYCLOHEXYLMETHYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE",NCVMTHVSAJMOPI-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
155410,6wiq,DB09079,-7.3,Nintedanib,XZXHXSATPCNXJR-ZIADKAODSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
120326,6w4b,DB08355,-7.3,"1-methyl-8-(phenylamino)-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxylic acid",ZOBRPBVIEUWYJR-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
147666,6w9q,DB12275,-7.3,Seviteronel,ZBRAJOQFSNYJMF-SFHVURJKSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
127990,6w4h,DB07089,-7.3,N-[amino(imino)methyl]-2-[2-(2-chlorophenyl)-4-(4-propoxyphenyl)-3-thienyl]acetamide,VZSMTBLDWPKVRW-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
120335,6w4b,DB08366,-7.3,"3-({3-[(1S,4aS,6S,7S,9S,9aR)-1,6-dimethyl-2-oxodecahydro-6,9-epoxy-4a,7-methanobenzo[7]annulen-1-yl]propanoyl}amino)-2,4-dihydroxybenzoic acid",XADCWKSMHQPTGH-OFBLZTNGSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
130459,6w4h,DB12293,-7.3,Nefopam,RGPDEAGGEXEMMM-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
161939,7bv1,DB00998,-7.3,Frovatriptan,XPSQPHWEGNHMSK-SECBINFHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
121899,6w4b,DB12562,-7.3,Setipiprant,IHAXLPDVOWLUOS-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
120135,6w4b,DB08121,-7.3,(2S)-2-(biphenyl-4-yloxy)-3-phenylpropanoic acid,TZTPJJNNACUQQR-FQEVSTJZSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
147575,6w9q,DB12141,-7.3,Gilteritinib,GYQYAJJFPNQOOW-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
161677,7bv1,DB00251,-7.3,Terconazole,BLSQLHNBWJLIBQ-OZXSUGGESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
127835,6w4h,DB06909,-7.3,"1-ethyl-N-(phenylmethyl)-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridine-5-carboxamide",QZGJNFBMYYEFGM-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
121426,6w4b,DB11875,-7.3,"3,3'-diindolylmethane",VFTRKSBEFQDZKX-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
136454,6w9c,DB07134,-7.3,"5-(4-CHLORO-5-PHENYL-3-THIENYL)-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDE",LCPRWBWCEGWNKF-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136117,6w9c,DB06594,-7.3,Agomelatine,YJYPHIXNFHFHND-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
121418,6w4b,DB11864,-7.3,Preladenant,DTYWJKSSUANMHD-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
121067,6w4b,DB09495,-7.3,Avobenzone,XNEFYCZVKIDDMS-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
136469,6w9c,DB07153,-7.3,"6-methyl-5-[3-methyl-3-(3,4,5-trimethoxyphenyl)but-1-yn-1-yl]pyrimidine-2,4-diamine",FJNFXXGWYVMQNA-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
121415,6w4b,DB11859,-7.3,Brexanolone,AURFZBICLPNKBZ-SYBPFIFISA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
136412,6w9c,DB07087,-7.3,"4-[(1S,2S,5S,9R)-5-(HYDROXYMETHYL)-8,9-DIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL",YMSZEVAWRFDVQX-GHVWTTSJSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
147402,6w9q,DB11890,-7.3,Cilengitide,AMLYAMJWYAIXIA-VWNVYAMZSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
153325,6wiq,DB06202,-7.3,Lasofoxifene,GXESHMAMLJKROZ-IAPPQJPRSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
121151,6w4b,DB11372,-7.3,Altrenogest,VWAUPFMBXBWEQY-ANULTFPQSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
136382,6w9c,DB07052,-7.3,5'-S-ethyl-5'-thioadenosine,HMXHURAGFHWODC-WOUKDFQISA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
36598,1r42,DB03141,-7.3,"3-{[(5R,6R)-5-Benzyl-6-hydroxy-2,4-bis(4-hydroxybenzyl)-3-oxo-1,2,4-triazepan-1-yl]sulfonyl}benzonitril",UYUWNNRWESUYOB-FIRIVFDPSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
28716,6cs2,DB08322,-7.3,"2-DEOXY-3,4-BIS-O-[3-(4-HYDROXYPHENYL)PROPANOYL]-L-THREO-PENTARIC ACID",VJLMRHSHSNLOGC-NOPZTHQXSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
136380,6w9c,DB07050,-7.3,"5-[(phenylsulfonyl)amino]-1,3,4-thiadiazole-2-sulfonamide",PWDGTQXZLNDOKS-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
161268,7bv1,DB13479,-7.3,Histapyrrodine,MXHODDGKGSGCDI-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
33786,6cs2,T3D0463,-7.3,"2,4,4',5-Tetrachlorobiphenyl",TULCXSBAPHCWCF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
5955,6lzg,DB01326,-7.3,Cefamandole,OLVCFLKTBJRLHI-AXAPSJFSSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
120936,6w4b,DB09177,-7.3,p-Fluorofentanyl,KXUBAVLIJFTASZ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
160922,7bv1,DB12273,-7.3,Ecopipam,DMJWENQHWZZWDF-PKOBYXMFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
147449,6w9q,DB11957,-7.3,Idalopirdine,YBAWYTYNMZWMMJ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
161293,7bv1,DB13512,-7.3,Clefamide,ODCUSWJXZDHLKV-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160925,7bv1,DB12278,-7.3,Propiverine,QPCVHQBVMYCJOM-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
121016,6w4b,DB09279,-7.3,Fimasartan,AMEROGPZOLAFBN-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
155650,6wiq,DB11443,-7.3,Orbifloxacin,QIPQASLPWJVQMH-DTORHVGOSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
147138,6w9q,DB11410,-7.3,Fenbendazole,HDDSHPAODJUKPD-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
121452,6w4b,DB11911,-7.3,Galunisertib,IVRXNBXKWIJUQB-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
136487,6w9c,DB07173,-7.3,"7-(5-DEOXY-BETA-D-RIBOFURANOSYL)-5-IODO-7H-PYRROLO[2,3-D]PYRIMIDIN-4-AMINE",NTXUAWGNGBSCRS-TZQXKBMNSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136086,6w9c,DB06512,-7.3,Deramciclane,QOBGWWQAMAPULA-RLLQIKCJSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
121446,6w4b,DB11903,-7.3,GW842166,TWQYWUXBZHPIIV-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
160934,7bv1,DB12288,-7.3,Piromelatine,PNTNBIHOAPJYDB-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
120973,6w4b,DB09215,-7.3,Droxicam,OEHFRZLKGRKFAS-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
147284,6w9q,DB11712,-7.3,Tezacaftor,MJUVRTYWUMPBTR-MRXNPFEDSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
136370,6w9c,DB07039,-7.3,(2S)-N-(4-cyano-3-iodophenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide,RXSZCFAPSDTELY-SFHVURJKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136361,6w9c,DB07030,-7.3,(5-CHLORO-2-{[(3-NITROBENZYL)AMINO]CARBONYL}PHENOXY)ACETIC ACID,VABIMMIJVWNHFI-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136196,6w9c,DB06736,-7.3,Aceclofenac,MNIPYSSQXLZQLJ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
6774,6lzg,DB02675,-7.3,(4-Hydroxymaltosephenyl)Glycine,PHPOPZGUOBMSPZ-QHJSCRBTSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
161143,7bv1,DB12945,-7.3,Dihydralazine,VQKLRVZQQYVIJW-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
161127,7bv1,DB12924,-7.3,Ozenoxacin,XPIJWUTXQAGSLK-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
121277,6w4b,DB11656,-7.3,Rebamipide,ALLWOAVDORUJLA-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
33876,6cs2,T3D0548,-7.3,"2,3,3',4,5,5'-Hexachlorobiphenyl",YZKLGRAIIIGOHB-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
147339,6w9q,DB11795,-7.3,GSK-2636771,XTKLTGBKIDQGQL-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
121322,6w4b,DB11725,-7.3,Latrepirdine,JNODQFNWMXFMEV-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
130536,6w4h,DB12402,-7.3,Pumosetrag,AFUWQWYPPZFWCO-LBPRGKRZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
121314,6w4b,DB11706,-7.3,Raxatrigine,JESCETIFNOFKEU-SJORKVTESA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
136240,6w9c,DB06887,-7.3,"[(3S)-3-(Methylcarbamoyl)-2-{[(2-methyl-2-propanyl)oxy]carbonyl}-1,2,3,4-tetrahydro-7-isoquinolinyl]sulfamic acid",PPSSYXOFPICMQD-ZDUSSCGKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
161075,7bv1,DB12846,-7.3,Reproterol,WVLAAKXASPCBGT-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
147346,6w9q,DB11805,-7.3,Saracatinib,OUKYUETWWIPKQR-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
121304,6w4b,DB11694,-7.3,Ilorasertib,WPHKIQPVPYJNAX-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
121319,6w4b,DB11718,-7.3,Encorafenib,CMJCXYNUCSMDBY-ZDUSSCGKSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
121266,6w4b,DB11638,-7.3,Artenimol,BJDCWCLMFKKGEE-HVDUHBCDSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
121263,6w4b,DB11633,-7.3,Isavuconazole,DDFOUSQFMYRUQK-RCDICMHDSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
147332,6w9q,DB11787,-7.3,Ralimetinib,XPPBBJCBDOEXDN-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
121397,6w4b,DB11829,-7.3,Ruboxistaurin,ZCBUQCWBWNUWSU-SFHVURJKSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
121373,6w4b,DB11796,-7.3,Fostemsavir,SWMDAPWAQQTBOG-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
161181,7bv1,DB13360,-7.3,Tolciclate,CANCCLAKQQHLNK-LSDHHAIUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160976,7bv1,DB12347,-7.3,CG-400549,YCLREGRRHGLOAK-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
147301,6w9q,DB11741,-7.3,Famitinib,GKEYKDOLBLYGRB-LGMDPLHJSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
1786,6lzg,HMDB0000637,-7.3,Chenodeoxycholic acid glycine conjugate,GHCZAUBVMUEKKP-AHBZRTSYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
147380,6w9q,DB11853,-7.3,Relugolix,AOMXMOCNKJTRQP-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
160980,7bv1,DB12354,-7.3,Imrecoxib,AXMZZGKKZDJGAZ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
121355,6w4b,DB11773,-7.3,BMS-903452,OGIAVRWXUPYGGC-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
161173,7bv1,DB13351,-7.3,Piperidolate,KTHVBAZBLKXIHZ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
161011,7bv1,DB12398,-7.3,Naproxen etemesil,JGBUBSOKFSVXKS-LBPRGKRZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
121248,6w4b,DB11591,-7.3,Bilastine,ACCMWZWAEFYUGZ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
136285,6w9c,DB06935,-7.3,"2',6'-DIFLUOROBIPHENYL-4-CARBOXYLIC ACID",CWWIIKLXUPZDOG-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
147322,6w9q,DB11773,-7.3,BMS-903452,OGIAVRWXUPYGGC-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
121260,6w4b,DB11622,-7.3,Dehydrocholic acid,OHXPGWPVLFPUSM-KLRNGDHRSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
130528,6w4h,DB12392,-7.3,Resminostat,FECGNJPYVFEKOD-VMPITWQZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
4487,6lzg,HMDB0052486,-7.3,"TG(18:2(9Z,12Z)/24:0/18:2(9Z,12Z))",WDLBTJHWGYBSCW-ZQQHQYNCSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
147454,6w9q,DB11963,-7.3,Dacomitinib,LVXJQMNHJWSHET-AATRIKPKSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
121496,6w4b,DB11978,-7.3,Glasdegib,SFNSLLSYNZWZQG-VQIMIIECSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
160777,7bv1,DB11219,-7.3,Enzacamene,HEOCBCNFKCOKBX-SDNWHVSQSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
129424,6w4h,DB08775,-7.3,N??-[(Benzyloxy)carbonyl]-N-[(2S)-4-fluoro-3-oxo-2-butanyl]-L-tyrosinamide,RYABQRLJLIHDIP-KSSFIOAISA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
147520,6w9q,DB12063,-7.3,CERC-301,RECBFDWSXWAXHY-IAGOWNOFSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
33642,6cs2,T3D4888,-7.3,Apigenin,KZNIFHPLKGYRTM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
33647,6cs2,T3D0422,-7.3,"2,3',4'-Trichlorobiphenyl",RIMXLXBUOQMDHV-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
120779,6w4b,DB08927,-7.3,Amperozide,NNAIYOXJNVGUOM-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
135933,6w9c,DB06127,-7.3,Bisegliptin,AKFNKZFJBFQFAA-DIOPXHOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
120784,6w4b,DB08934,-7.3,Sofosbuvir,TTZHDVOVKQGIBA-IQWMDFIBSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
120794,6w4b,DB08950,-7.3,Indoramin,JXZZEXZZKAWDSP-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
161490,7bv1,DB14903,-7.3,Rovafovir etalafenamide,OCJRRXHWPBXZSU-BJBBEUPESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
127939,6w4h,DB07032,-7.3,2-(4-HYDROXY-PHENYL)BENZOFURAN-5-OL,SNNNDCMXZYWCCI-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
147516,6w9q,DB12058,-7.3,Recoflavone,BCPQOBQIVJZOFL-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
135962,6w9c,DB06193,-7.3,Pixantrone,PEZPMAYDXJQYRV-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
120805,6w4b,DB08962,-7.3,Glibornuride,RMTYNAPTNBJHQI-LLDVTBCESA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
120787,6w4b,DB08940,-7.3,Kebuzone,LGYTZKPVOAIUKX-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
155686,6wiq,DB11521,-7.3,Imidocarb,SCEVFJUWLLRELN-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
155687,6wiq,DB11522,-7.3,Isoflupredone,WAIJIHDWAKJCBX-BULBTXNYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
120753,6w4b,DB08881,-7.3,Vemurafenib,GPXBXXGIAQBQNI-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
160690,7bv1,DB09286,-7.3,Pipamperone,AXKPFOAXAHJUAG-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160698,7bv1,DB09299,-7.3,Tenofovir alafenamide,LDEKQSIMHVQZJK-CAQYMETFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
161666,7bv1,DB00239,-7.3,Oxiconazole,QRJJEGAJXVEBNE-HKOYGPOVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
155474,6wiq,DB09195,-7.3,Lorpiprazole,BNRMWKUVWLKDQJ-YJBOKZPZSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
161654,7bv1,DB00227,-7.3,Lovastatin,PCZOHLXUXFIOCF-BXMDZJJMSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160723,7bv1,DB09378,-7.3,Fluprednisolone,MYYIMZRZXIQBGI-HVIRSNARSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
120725,6w4b,DB08833,-7.3,Taurochenodeoxycholic acid,BHTRKEVKTKCXOH-BJLOMENOSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
121608,6w4b,DB12141,-7.3,Gilteritinib,GYQYAJJFPNQOOW-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
147539,6w9q,DB12093,-7.3,Tetrahydropalmatine,AEQDJSLRWYMAQI-KRWDZBQOSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
121605,6w4b,DB12135,-7.3,Elubrixin,YQYFEGTYCUQBEI-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
147524,6w9q,DB12070,-7.3,Letermovir,FWYSMLBETOMXAG-QHCPKHFHSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
146898,6w9q,DB09171,-7.3,??-Methylfentanyl,UXIGUKSHASXDNI-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
120744,6w4b,DB08865,-7.3,Crizotinib,KTEIFNKAUNYNJU-GFCCVEGCSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
49090,2fxp,DB04011,-7.3,"2'-(4-Dimethylaminophenyl)-5-(4-Methyl-1-Piperazinyl)-2,5'-Bi-Benzimidazole",VMCOQLKKSNQANE-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
161526,7bv1,DB15012,-7.3,Farampator,XFVRBYKKGGDPAJ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
161480,7bv1,DB14885,-7.3,PF-05180999,CLGCHUKGBICQTE-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
135882,6w9c,DB05518,-7.3,Managlinat dialanetil,BYKBUQDQTLDNLE-KBPBESRZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
135967,6w9c,DB06200,-7.3,Tedisamil,CTIRHWCPXYGDGF-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
160809,7bv1,DB11757,-7.3,Istradefylline,IQVRBWUUXZMOPW-PKNBQFBNSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
6750,6lzg,DB02639,-7.3,4-methylumbelliferyl ??-D-glucoside,YUDPTGPSBJVHCN-JZYAIQKZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
5964,6lzg,DB01342,-7.3,Forasartan,YONOBYIBNBCDSJ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
34014,6cs2,T3D0834,-7.3,Bergamottin,DBMJZOMNXBSRED-OQLLNIDSSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
120873,6w4b,DB09054,-7.3,Idelalisib,IFSDAJWBUCMOAH-HNNXBMFYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
136574,6w9c,DB07276,-7.3,"5-CYANO-N-(2,5-DIMETHOXYBENZYL)-6-ETHOXYPYRIDINE-2-CARBOXAMIDE",VEGKZYFYGCWXMN-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
161379,7bv1,DB13936,-7.3,JNJ-28330835,RYBKPGYFXRNMMU-LBPRGKRZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
127925,6w4h,DB07017,-7.3,"(5S)-2-{[(1S)-1-(4-fluorophenyl)ethyl]amino}-5-(1-hydroxy-1-methylethyl)-5-methyl-1,3-thiazol-4(5H)-one",HYVZYASDRIAOPU-BJOHPYRUSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
161375,7bv1,DB13929,-7.3,Relcovaptan,CEBYCSRFKCEUSW-NAYZPBBASA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
161370,7bv1,DB13918,-7.3,Diclofop-methyl,BACHBFVBHLGWSL-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
36609,1r42,DB03157,-7.3,"N,O-Didansyl-L-Tyrosine",LUBOPDUYHWABFG-NDEPHWFRSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
161362,7bv1,DB13873,-7.3,Fenofibric acid,MQOBSOSZFYZQOK-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
33729,6cs2,T3D4980,-7.3,Atorvastatin,XUKUURHRXDUEBC-UHFFFAOYSA-M,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
147114,6w9q,DB11366,-7.3,Roquinimex,SGOOQMRIPALTEL-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
161353,7bv1,DB13857,-7.3,Demegestone,JWAHBTQSSMYISL-MHTWAQMVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
136572,6w9c,DB07273,-7.3,1-[(2-AMINO-4-CHLORO-5-METHYLPHENYL)SULFONYL]-L-PROLINE,OWYKAFABUYXQLE-JTQLQIEISA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
160845,7bv1,DB11806,-7.3,VTP-194204,BOOOLEGQBVUTKC-NVQSDHBMSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
147469,6w9q,DB11987,-7.3,GSK-2018682,NFIGDBFIDKDNIG-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
120858,6w4b,DB09020,-7.3,Bisacodyl,KHOITXIGCFIULA-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
146995,6w9q,DB09295,-7.3,Talniflumate,ANMLJLFWUCQGKZ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
161461,7bv1,DB14854,-7.3,TC-6987,UAKZGMMGIMKFMV-RBUKOAKNSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
136614,6w9c,DB07327,-7.3,"(2-ACETYL-5-METHYLANILINO)(2,6-DIBROMOPHENYL)ACETAMIDE",FELUFXCUIYHAPB-INIZCTEOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
127825,6w4h,DB06898,-7.3,"4-(2-amino-1-methyl-1H-imidazo[4,5-b]pyridin-6-yl)phenol",UGJXOCBVCWTJFP-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
161459,7bv1,DB14849,-7.3,Nebicapone,MRFOLGFFTUGAEB-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160825,7bv1,DB11781,-7.3,Tosedostat,FWFGIHPGRQZWIW-SQNIBIBYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
121545,6w4b,DB12052,-7.3,Icariin,TZJALUIVHRYQQB-XLRXWWTNSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
161440,7bv1,DB14050,-7.3,Cannabidivarin,REOZWEGFPHTFEI-JKSUJKDBSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
121543,6w4b,DB12049,-7.3,Dasolampanel etibutil,HPBRMCFZIGUGTK-ZMMAXQRCSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
161421,7bv1,DB14013,-7.3,SR-9009,MMJJNHOIVCGAAP-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
136606,6w9c,DB07318,-7.3,"N-[2-(4-AMINO-5,8-DIFLUORO-1,2-DIHYDROQUINAZOLIN-2-YL)ETHYL]-3-FURAMIDE",BOAUWUUBSXECNL-LLVKDONJSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
147477,6w9q,DB12000,-7.3,Apabetalone,NETXMUIMUZJUTB-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
153337,6wiq,DB06230,-7.3,Nalmefene,WJBLNOPPDWQMCH-MBPVOVBZSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
136597,6w9c,DB07309,-7.3,5-BROMO-2-{[(4-CHLOROPHENYL)SULFONYL]AMINO}BENZOIC ACID,JDVLYAYDIMUAAC-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136009,6w9c,DB06282,-7.3,Levocetirizine,ZKLPARSLTMPFCP-OAQYLSRUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
6784,6lzg,DB02691,-7.3,Glycocholic acid,RFDAIACWWDREDC-FRVQLJSFSA-M,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
165079,7bv1,DB09206,-7.3,Trimazosin,YNZXWQJZEDLQEG-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
162113,7bv1,DB01456,-7.3,5-androstenedione,SQGZFRITSMYKRH-QAGGRKNESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
130677,6w4h,DB12615,-7.3,Plazomicin,IYDYFVUFSPQPPV-PEXOCOHZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
163009,7bv1,DB03413,-7.3,Deoxyuridine-5'-Diphosphate,QHWZTVCCBMIIKE-SHYZEUOFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
148165,6w9q,DB13032,-7.3,Enecadin,SZSHJTJCJOWMHM-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
138036,6w9c,DB09061,-7.3,Cannabidiol,QHMBSVQNZZTUGM-ZWKOTPCHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138035,6w9c,DB09060,-7.3,Avibactam,NDCUAPJVLWFHHB-UHNVWZDZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
28850,6cs2,DB08472,-7.3,(R)-Fluoxetine,RTHCYVBBDHJXIQ-MRXNPFEDSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
162975,7bv1,DB03365,-7.3,"4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline",BNDYIYYKEIXHNK-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
138040,6w9c,DB09068,-7.3,Vortioxetine,YQNWZWMKLDQSAC-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
159898,7bv1,DB07055,-7.3,"2-[2-(1H-tetrazol-5-yl)ethyl]-1H-isoindole-1,3(2H)-dione",DEOJDUHRJBKATO-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
153534,6wiq,DB06816,-7.3,Pyrvinium,QMHSXPLYMTVAMK-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
130283,6w4h,DB12043,-7.3,Sepetaprost,BKVUSNOUTQMSBE-XCMGCKIWSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
138000,6w9c,DB09002,-7.3,Cloperastine,FLNXBVJLPJNOSI-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
162931,7bv1,DB03307,-7.3,4-[(6-Amino-4-Pyrimidinyl)Amino]Benzenesulfonamide,FVFVVRPJERUECT-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
159902,7bv1,DB07059,-7.3,"N-{2-[6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2,2-DIMETHYL-3-OXO-2,3-DIHYDRO-4H-1,4-BENZOXAZIN-4-YL]ETHYL}ACETAMIDE",GBXSOZDYCSBLQX-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
145833,6w9q,DB07813,-7.3,GLYCYLALANYL-N-2-NAPHTHYL-L-PROLINEAMIDE,KCELZXZDIUJGNM-GUYCJALGSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
134851,6w9c,DB03650,-7.3,(3e)-3-[(4-Hydroxyphenyl)Imino]-1h-Indol-2(3h)-One,ZJASRZFZRYISET-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
32900,6cs2,T3D3824,-7.3,Diclofop-methyl,BACHBFVBHLGWSL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
28851,6cs2,DB08473,-7.3,"5,6-dichloro-1-beta-D-ribofuranosyl-1H-benzimidazole",XHSQDZXAVJRBMX-DDHJBXDOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
163031,7bv1,DB03449,-7.3,N-(4-(2-((3-Chlorophenylmethyl)Amino)Ethyl)Phenyl)-2-Thiophecarboxamidine,ZZVGLDBDD1AB-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
119568,6w4b,DB07460,-7.3,2-({5-CHLORO-2-[(2-METHOXY-4-MORPHOLIN-4-YLPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)-N-METHYLBENZAMIDE,UYJNQQDJUOUFQJ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
148191,6w9q,DB13072,-7.3,GDC-0349,RGJOJUGRHPQXGF-INIZCTEOSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
134814,6w9c,DB03592,-7.3,Pterin-6-Yl-Methyl-Monophosphate,AJXFJEHKGGCFNM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138074,6w9c,DB09128,-7.3,Brexpiprazole,ZKIAIYBUSXZPLP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
145792,6w9q,DB07768,-7.3,Epitestosterone,MUMGGOZAMZWBJJ-KZYORJDKSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
32842,6cs2,T3D3756,-7.3,Enniatin A,GVDAJJRPXXFXKC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
148166,6w9q,DB13036,-7.3,Ramatroban,LDXDSHIEDAPSSA-OAHLLOKOSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
138058,6w9c,DB09090,-7.3,Pinaverium,DDHUTBKXLWCZCO-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
28864,6cs2,DB00788,-7.3,Naproxen,CMWTZPSULFXXJA-VIFPVBQESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
153535,6wiq,DB06817,-7.3,Raltegravir,CZFFBEXEKNGXKS-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
148172,6w9q,DB13048,-7.3,PAC-1,YQNRVGJCPCNMKT-LFVJCYFKSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
28858,6cs2,DB08479,-7.3,"N-(3,5-dimethoxyphenyl)imidodicarbonimidic diamide",VQKIGKHIRBCYNE-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
36721,1r42,DB03300,-7.3,Pterin Cytosine Dinucleotide,WKSPNQYEWZEMMI-FEFZDOOUSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
148167,6w9q,DB13039,-7.3,Aminaphthone,YLMPBJUYFTWHKJ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
145800,6w9q,DB07778,-7.3,FAMOXADONE,PCCSBWNGDMYFCW-QFIPXVFZSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
159907,7bv1,DB07065,-7.3,"5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)-3-thiocyanatopyrazolo[1,5-a]pyrimidin-7-amine",AHPKUZJCNHGFQA-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
145836,6w9q,DB07816,-7.3,N-(P-CYANOPHENYL)-N'-DIPHENYLMETHYL-GUANIDINE-ACETIC ACID,KGHMYJFHUHFOGL-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
145837,6w9q,DB07817,-7.3,"1-{3-[(4-pyridin-2-ylpiperazin-1-yl)sulfonyl]phenyl}-3-(1,3-thiazol-2-yl)urea",NJPVZSIGDRLLTD-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
119720,6w4b,DB07643,-7.3,"5-{[1-(2,3-dichlorobenzyl)piperidin-4-yl]methoxy}quinazoline-2,4-diamine",XVLUVRFYGVJKGJ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
137875,6w9c,DB08819,-7.3,Tafluprost,WSNODXPBBALQOF-VEJSHDCNSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
145877,6w9q,DB07863,-7.3,2-chloro-5-nitro-N-phenylbenzamide,DNTSIBUQMRRYIU-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
148114,6w9q,DB12952,-7.3,Methylprednisone,SVYCRJXQZUCUND-PQXSVQADSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
153503,6wiq,DB06747,-7.3,ginkgolide-M,KDKROYXEHCYLJQ-FJFAJXJPSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
48686,2fxp,DB03466,-7.3,BMS184394,AYAJZQYENGWICE-QHCPKHFHSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
145869,6w9q,DB07855,-7.3,(S)-1-PHENYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE,CWHMAWBXRCDOEB-HNNXBMFYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
134948,6w9c,DB03785,-7.3,"(3r,5r)-7-((1r,2r,6s,8r,8as)-2,6-Dimethyl-8-{[(2r)-2-Methylbutanoyl]Oxy}-1,2,6,7,8,8a-Hexahydronaphthalen-1-Yl)-3,5-Dihydroxyheptanoic Acid",QLJODMDSTUBWDW-BXMDZJJMSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
32967,6cs2,T3D3898,-7.3,Penoxsulam,SYJGKVOENHZYMQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
134961,6w9c,DB03800,-7.3,Deoxyuridine monophosphate,JSRLJPSBLDHEIO-SHYZEUOFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
122512,6w4b,DB13499,-7.3,Cefsulodin,SYLKGLMBLAAGSC-QLVMHMETSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
122502,6w4b,DB13487,-7.3,Iodine (131I) norcholesterol,QJHZPCLORSPENH-DRTKWHMQSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
122492,6w4b,DB13472,-7.3,Cyclofenil,GVOUFPWUYJWQSK-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
134966,6w9c,DB03808,-7.3,Hexamidine,OQLKNTOKMBVBKV-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
134959,6w9c,DB03798,-7.3,2'-Deoxycytidine-5'-Monophosphate,NCMVOABPESMRCP-SHYZEUOFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
119719,6w4b,DB07642,-7.3,"5-{[1-(2-fluorobenzyl)piperidin-4-yl]methoxy}quinazoline-2,4-diamine",GYKIQIOWVKCVBP-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
145862,6w9q,DB07847,-7.3,6-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-(4-MORPHOLINYL)-2-OXO ETHYL]-2-OXO-3-PYRROLIDINYL}-2-NAPHTHALENESULFONAMIDE,ICLOZQFWTRAYPX-LIRRHRJNSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
122555,6w4b,DB13556,-7.3,Sulfamazone,BGLHAKAJGYLSOX-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
134880,6w9c,DB03687,-7.3,4-Diphosphocytidyl-2-C-Methyl-D-Erythritol,YFAUKWZNPVBCFF-XHIBXCGHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
155850,6wiq,DB11841,-7.3,Entinostat,INVTYAOGFAGBOE-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
137966,6w9c,DB08965,-7.3,Fusafungine,MIZMDSVSLSIMSC-OGLSAIDSSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
153519,6wiq,DB06786,-7.3,Halcinonide,MUQNGPZZQDCDFT-JNQJZLCISA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
119669,6w4b,DB07583,-7.3,"(4R,2S)-5'-(4-(4-CHLOROBENZYLOXY)PYRROLIDIN-2-YLMETHANESULFONYL)ISOQUINOLINE",RLNNFNGBXLTQOB-RBUKOAKNSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
153120,6wiq,DB05087,-7.3,Ganaxolone,PGTVWKLGGCQMBR-FLBATMFCSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
128164,6w4h,DB07290,-7.3,(2R)-2-{[(4-FLUORO-3-METHYLPHENYL)SULFONYL]AMINO}-N-HYDROXY-2-TETRAHYDRO-2H-PYRAN-4-YLACETAMIDE,LUCFRFDOOYLALP-CYBMUJFWSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
127606,6w4h,DB06499,-7.3,Furaprofen,ODZUWQAFWMLWCF-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
162889,7bv1,DB03251,-7.3,RWJ-51084,NQABUEUFRXDDFI-AWEZNQCLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
34553,1r42,DB00496,-7.3,Darifenacin,HXGBXQDTNZMWGS-RUZDIDTESA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
153506,6wiq,DB06755,-7.3,Beta carotene,OENHQHLEOONYIE-JLTXGRSLSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
119688,6w4b,DB07608,-7.3,N-(5-{[(2S)-4-amino-2-(3-chlorophenyl)butanoyl]amino}-1H-indazol-3-yl)benzamide,JDGOPNUGILVNJZ-IBGZPJMESA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
162885,7bv1,DB03247,-7.3,Flavin mononucleotide,FVTCRASFADXXNN-SCRDCRAPSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
122574,6w4b,DB13586,-7.3,Metandienone,XWALNWXLMVGSFR-HLXURNFRSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
49915,2fxp,DB05713,-7.3,LY-517717,VYNKVNDKAOGAAQ-RUZDIDTESA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
128186,6w4h,DB07313,-7.3,5-METHYL-2-[(PHENYLSULFONYL)AMINO]BENZOIC ACID,HXQLTRSIZRSFTR-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
119567,6w4b,DB07459,-7.3,4-PHENOXY-N-(PYRIDIN-2-YLMETHYL)BENZAMIDE,HVLSCZSVTCNAQX-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
122665,6w4b,DB13708,-7.3,Fenquizone,DBDTUXMDTSTPQZ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
32814,6cs2,T3D3727,-7.3,Alternariol,CEBXXEKPIIDJHL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
148402,6w9q,DB13397,-7.3,Prenoxdiazine,PXZDWASDNFWKSD-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
153053,6wiq,DB04872,-7.3,Osanetant,DZOJBGLFWINFBF-UMSFTDKQSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
138253,6w9c,DB11155,-7.3,Triclocarban,ICUTUKXCWQ1Q-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
159731,7bv1,DB05514,-7.3,Cobiprostone,SDDSJMXGJNWMJY-BRHAQHMBSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
148394,6w9q,DB13384,-7.3,Melitracen,GWWLWDURRGNSRS-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
134634,6w9c,DB03332,-7.3,"5,6-Cyclic-Tetrahydropteridine",XAZOBOCYEGBXHD-GSVOUGTGSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
119416,6w4b,DB07287,-7.3,"2-(2,4-DICHLOROPHENOXY)-5-(PYRIDIN-2-YLMETHYL)PHENOL",AOVDSWPGWPRTSR-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
134642,6w9c,DB03342,-7.3,4-(Acetylamino)-3-Guanidinobenzoic Acid,HIXHCUDMJUERSJ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138192,6w9c,DB09306,-7.3,Metralindole,GVXBHSBKKJRBMS-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138156,6w9c,DB09244,-7.3,Pirlindole,IWVRVEIKCBFZNF-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
128270,6w4h,DB07410,-7.3,[2-(3-DIBENZOFURAN-4-YL-PHENYL)-1-HYDROXY-1-PHOSPHONO-ETHYL]-PHOSPHONIC ACID,BYVXAUZOTGITQZ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
48591,2fxp,DB03331,-7.3,"N-Naphthalen-1-Ylmethyl-2'-[3,5-Dimethoxybenzamido]-2'-Deoxy-Adenosine",OARVXDFNTLYMCJ-JVUUKAHWSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
36749,1r42,DB03336,-7.3,BIA,KVIVJQWOYSWCCZ-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
122825,6w4b,DB13956,-7.3,Estradiol valerate,RSEPBGGWRJCQGY-RBRWEJTLSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
34665,1r42,DB00635,-7.3,Prednisone,XOFYZVNMUHMLCC-ZPOLXVRWSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
134623,6w9c,DB03315,-7.3,Guanosine 3'-monophosphate,ZDPUTNZENXVHJC-UUOKFMHZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
159713,7bv1,DB05431,-7.3,MLN-977,YANONWCPCKIWEC-CABCVRRESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
134616,6w9c,DB03307,-7.3,4-[(6-Amino-4-Pyrimidinyl)Amino]Benzenesulfonamide,FVFVVRPJERUECT-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
134524,6w9c,DB03195,-7.3,"Phosphoric Acid Mono-[3-Fluoro-5-(5-Methyl-2,4-Dioxo-3,4-Dihydro-2h-Pyrimidin-1-Yl)-Tetrahyro-Furan-2-Ylmethyl] Ester",GGCAVPJXJISBOA-XLPZGREQSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
50076,2fxp,DB06393,-7.3,Xaliproden,WJJYZXPHLSLMGE-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
138330,6w9c,DB11410,-7.3,Fenbendazole,HDDSHPAODJUKPD-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
148468,6w9q,DB13487,-7.3,Iodine (131I) norcholesterol,QJHZPCLORSPENH-DRTKWHMQSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
148466,6w9q,DB13484,-7.3,Quinbolone,IUVKMZGDUIUOCP-BTNSXGMBSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
148464,6w9q,DB13481,-7.3,Tenidap,LXIKEPCNDFVJKC-QXMHVHEDSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
32663,6cs2,T3D2065,-7.3,"1,3,8-Trichlorodibenzo-p-dioxin",FJAKCOBYQSEWMT-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
122961,6w4b,DB14538,-7.3,Hydrocortisone aceponate,MFBMYAOAMQLLPK-FZNHGJLXSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
134557,6w9c,DB03233,-7.3,"Phosphoric Acid Mono-[3-Amino-5-(5-Methyl-2,4-Dioxo-3,4-Dihydro-2h-Pyrimidin-1-Yl)-Tetrahydro-Furan-2-Ylmethyl] Ester",BQZMHQZNZNBJNF-XLPZGREQSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
127580,6w4h,DB06440,-7.3,Ravuconazole,OPAHEYNNJWPQPX-RCDICMHDSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
163442,7bv1,DB04628,-7.3,Allosamidin,MDWNFWDBQGOKNZ-XYUDZHFQSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
155055,6wiq,DB08607,-7.3,"(5R)-5-(4-{[(2R)-6-HYDROXY-2,5,7,8-TETRAMETHYL-3,4-DIHYDRO-2H-CHROMEN-2-YL]METHOXY}BENZYL)-1,3-THIAZOLIDINE-2,4-DIONE",GXPHKUHSUJUWKP-NTKDMRAZSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
119404,6w4b,DB07274,-7.3,"N-cyclopropyl-6-[(6,7-dimethoxyquinolin-4-yl)oxy]naphthalene-1-carboxamide",ZATGFXTWDKIEKC-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
128281,6w4h,DB07425,-7.3,Sobetirome,QNAZTOHXCZPOSA-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
134605,6w9c,DB03296,-7.3,3'-beta-Sialyl-beta-lactose,CILYIEBUXJIHCO-LPTWSRJFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
163292,7bv1,DB04215,-7.3,CRA_9076,BVTBOJXEAPSOEB-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
122487,6w4b,DB13463,-7.3,Oxetorone,VZVRZTZPHOHSCK-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
159736,7bv1,DB05532,-7.3,BMS-488043,DBPMWRYLTBNCCE-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
50018,2fxp,DB06229,-7.3,Ocaperidone,ZZQNEJILGNNOEP-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
128207,6w4h,DB07335,-7.3,"3-[4-AMINO-1-(1-METHYLETHYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL]PHENOL",MWYBBCLGEHZSCP-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
163176,7bv1,DB03860,-7.3,"N-Butyl-11-[(7r,8r,9s,13s,14s,17s)-3,17-Dihydroxy-13-Methyl-7,8,9,11,12,13,14,15,16,17-Decahydro-6h-Cyclopenta[a]Phenanthren-7-Yl]-N-Methylundecanamide",BVVFOLSZMQVDKV-KXQIQQEYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
159832,7bv1,DB06654,-7.3,Safinamide,NEMGRZFTLSKBAP-LBPRGKRZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
7733,6lzg,DB04295,-7.3,N-Benzoyl-N'-Beta-D-Glucopyranosyl Urea,JSBCZGSPFATCOV-BZNQNGANSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
130868,6w4h,DB12919,-7.3,T-62,OTZVBZFYMFTYKH-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
122702,6w4b,DB13756,-7.3,Peruvoside,PMTSPAGBAFCORP-HBUONDEYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
127590,6w4h,DB06460,-7.3,Enrasentan,GLCKXJLCYIJMRB-UPRLRBBYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
159835,7bv1,DB06660,-7.3,Saredutant,PGKXDIMONUAMFR-AREMUKBSSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
138105,6w9c,DB09187,-7.3,Lortalamine,MJRPHRMGEKCADU-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
148200,6w9q,DB13088,-7.3,AZD-0424,MVWATCATLSSVBH-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
119565,6w4b,DB07457,-7.3,"3-[1-(3-AMINOPROPYL)-1H-INDOL-3-YL]-4-(1H-INDOL-3-YL)-1H-PYRROLE-2,5-DIONE",APYXQTXFRIDSGE-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
138094,6w9c,DB09175,-7.3,Mirfentanil,BJZZDOLVVLWFHN-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
163096,7bv1,DB03759,-7.3,FG-9041,RWVIMCIPOAXUDG-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
138089,6w9c,DB09170,-7.3,??-Hydroxythiofentanyl,GLAAETOTOUGGSB-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
122677,6w4b,DB13721,-7.3,Cypermethrin,KAATUXNTWXVJKI-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
32782,6cs2,T3D3696,-7.3,Costaclavine,VLMZMRDOMOGGFA-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
155881,6wiq,DB11890,-7.3,Cilengitide,AMLYAMJWYAIXIA-VWNVYAMZSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
134718,6w9c,DB03451,-7.3,"1-alpha, 25-dihydroxyl-20-epi-22-oxa-24, 26 ,27-trihomovitamin D3",KLZOTDOJMRMLDX-YBBVPDDNSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
163279,7bv1,DB04200,-7.3,Matairesinol,MATGKVZWFZHCLI-LSDHHAIUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
119492,6w4b,DB07373,-7.3,"ANDROSTA-1,4-DIENE-3,17-DIONE",LUJVUUWNAPIQQI-QAGGRKNESA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
122813,6w4b,DB13941,-7.3,Piperaquine,UCRHFBCYFMIWHC-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
32753,6cs2,T3D3666,-7.3,Aflatoxin M1,MJBWDEQAUQTVKK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
34656,1r42,DB00624,-7.3,Testosterone,MUMGGOZAMZWBJJ-DYKIIFRCSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
155890,6wiq,DB11901,-7.3,Apalutamide,HJBWBFZLDZWPHF-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
163228,7bv1,DB03926,-7.3,"5-Alpha-Androstane-3-Beta,17-Alpha-Diol",CBMYJHIOYJEBSB-MFXFBURESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
127582,6w4h,DB06444,-7.3,Dexanabinol,SSQJFGMEZBFMNV-PMACEKPBSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
145719,6w9q,DB07683,-7.3,"N-(dibenzo[b,d]thiophen-3-ylsulfonyl)-L-valine",RZWYSEXQXOXWKA-INIZCTEOSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
28903,6cs2,DB08528,-7.3,"2-AMINO-6-(3,5-DIMETHYLPHENYL)SULFONYLBENZONITRILE",SWGDXLAZBZDUBR-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
155889,6wiq,DB11900,-7.3,OC-459,FATGTHLOZSXOBC-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
148320,6w9q,DB13292,-7.3,Pimethixene,NZLVRVYNQYGMAB-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
32778,6cs2,T3D3692,-7.3,Agroclavine,XJOOMMHNYOJWCZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
119520,6w4b,DB07405,-7.3,"1-(6-CYANO-3-PYRIDYLCARBONYL)-5',8'-DIFLUOROSPIRO[PIPERIDINE-4,2'(1'H)-QUINAZOLINE]-4'-AMINE",GIZYIOOBBUHOBS-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
155131,6wiq,DB08703,-7.3,"12-(2-hydroxyethyl)-2-(1-methylethoxy)-13,14-dihydronaphtho[2,1-a]pyrrolo[3,4-c]carbazol-5(12H)-one",FGKKIHITEICGMN-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
163283,7bv1,DB04205,-7.3,"Thymidine-3',5'-Diphosphate",CSNCBOPUCJOHLS-XLPZGREQSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
127702,6w4h,DB06712,-7.3,Nilvadipine,FAIIFDPAEUKBEP-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
137800,6w9c,DB08734,-7.3,"6,6-DIMETHYL-1-[3-(2,4,5-TRICHLOROPHENOXY)PROPOXY]-1,6-DIHYDRO-1,3,5-TRIAZINE-2,4-DIAMINE",MJZJYWCQPMNPRM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
159982,7bv1,DB07153,-7.3,"6-methyl-5-[3-methyl-3-(3,4,5-trimethoxyphenyl)but-1-yn-1-yl]pyrimidine-2,4-diamine",FJNFXXGWYVMQNA-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
162345,7bv1,DB01937,-7.3,Guanosine-2'-Monophosphate,WTIFIAZWCCBCGE-UUOKFMHZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
122139,6w4b,DB12941,-7.3,ODM-201,BLIJXOOIHRSQRB-PXYINDEMSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
122131,6w4b,DB12929,-7.3,JNJ-39220675,IQOWHZHNGJXGHG-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
160174,7bv1,DB07602,-7.3,S-{3-[(4-ANILINOQUINAZOLIN-6-YL)AMINO]-3-OXOPROPYL}-L-CYSTEINE,NLVZTRZPMRTVRC-INIZCTEOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
146255,6w9q,DB08308,-7.3,"SUCCINIC ACID MONO-(13-METHYL-3-OXO-2,3,6,7,8,9,10,11,12,13,14,15,16,17-TETRADECAHYDRO-1H-CYCLOPENTA[A]PHENANTHREN-17-YL) ESTER",IRQUJNVGEAJGSD-KIEDKLRZSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
147817,6w9q,DB12483,-7.3,Copanlisib,PZBCKZWLPGJMAO-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
146206,6w9q,DB08244,-7.3,"(1S)-1-CYCLOPROPYL-2-[(2S)-4-(2,5-DIFLUOROPHENYL)-2-PHENYL-2,5-DIHYDRO-1H-PYRROL-1-YL]-2-OXOETHANAMINE",VCOUEHUEFUDZIS-PMACEKPBSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
153453,6wiq,DB06677,-7.3,Clazosentan,LFWCJABOXHSRGC-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
146276,6w9q,DB08331,-7.3,"N-1H-imidazol-2-yl-N'-[4-(1H-imidazol-2-ylamino)phenyl]benzene-1,4-diamine",JHMXUERQMCJRHG-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
160189,7bv1,DB07620,-7.3,"2-[(2,4-DICHLORO-5-METHYLPHENYL)SULFONYL]-1,3-DINITRO-5-(TRIFLUOROMETHYL)BENZENE",INAZPZCJNPPHGV-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
7704,6lzg,DB04240,-7.3,"(1S)-1-C-{(2R)-6-[(2R)-2-Butanyl]-5,10-dihydroxy-4-oxo-1,2,3,4-tetrahydro-2-anthracenyl}-5-deoxy-1-O-methyl-D-xylulose",XGORHSPGULYMCV-HHYQQTLHSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
155314,6wiq,DB08950,-7.3,Indoramin,JXZZEXZZKAWDSP-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
155800,6wiq,DB11750,-7.3,Clobetasol,FCSHDIVRCWTZOX-DVTGEIKXSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
147805,6w9q,DB12468,-7.3,Pf-04531083,ZRJGMDIPCQOGNI-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
130402,6w4h,DB12220,-7.3,ORG-25935,UEBBYLJZCHTLEG-UTKZUKDTSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
137334,6w9c,DB08163,-7.3,5'-{[4-(aminooxy)butyl](methyl)amino}-5'-deoxy-8-ethenyladenosine,XUKYGMIDWKBMIW-IWCJZZDYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
146202,6w9q,DB08239,-7.3,"(2S)-4-(2,5-DIFLUOROPHENYL)-N-METHYL-2-PHENYL-N-PIPERIDIN-4-YL-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDE",NKLVBHMAIMEVEH-QFIPXVFZSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
162346,7bv1,DB01938,-7.3,L-Histidine Beta Naphthylamide,DKDILZBBFKZMRO-OAHLLOKOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
130704,6w4h,DB12659,-7.3,SJ-733,VKCPFWKTFZAOTO-LEWJYISDSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
147873,6w9q,DB12573,-7.3,LY-2452473,IHIWYQYVBNODSV-KRWDZBQOSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
146113,6w9q,DB08133,-7.3,N-(4-sulfamoylphenyl)-1H-indazole-3-carboxamide,MNHPHKFLWAPNOV-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
137445,6w9c,DB08306,-7.3,3-[(3-Nitrophenyl)sulfamoyl]-2-thiophenecarboxylic acid,CITCNTPVKZFUAJ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
128059,6w4h,DB07169,-7.3,"5R-(3,4-DICHLOROPHENYLMETHYL)-3-(2-THIOPHENESULFONYLAMINO)-4-OXO-2-THIONOTHIAZOLIDINE",GAOOBYJHWAKZKU-LLVKDONJSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
34397,1r42,DB00197,-7.3,Troglitazone,GXPHKUHSUJUWKP-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
160169,7bv1,DB07593,-7.3,1-(PHENYLMETHYL)CYCLOPENTYL[(1S)-1-FORMYLPENTYL]CARBAMATE,ONABDOMWRCXLPX-KRWDZBQOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160158,7bv1,DB07582,-7.3,"N-[(2R,3S)-1-((2S)-2-{[(CYCLOPENTYLAMINO)CARBONYL]AMINO}-3-METHYLBUTANOYL)-2-(1-FORMYL-1-CYCLOBUTYL)PYRROLIDINYL]CYCLOPROPANECARBOXAMIDE",GCDRFILPPBOJLM-UFYCRDLUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
128055,6w4h,DB07164,-7.3,"N-cyclopropyl-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amine",CAGHIASAHLPQMS-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
162370,7bv1,DB01964,-7.3,AL5424,ZWTSOJQGEWPWGO-NSHDSACASA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
155801,6wiq,DB11751,-7.3,Cabotegravir,WCWSTNLSLKSJPK-LKFCYVNXSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
146152,6w9q,DB08173,-7.3,5-CHLORO-N-(2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO)ETHYL)THIOPHENE-2-CARBOXAMIDE,UCKHUNHXYMAFQM-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
122159,6w4b,DB12972,-7.3,Sepranolone,AURFZBICLPNKBZ-FZCSVUEKSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
155294,6wiq,DB08916,-7.3,Afatinib,ULXXDDBFHOBEHA-CWDCEQMOSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
146138,6w9q,DB08159,-7.3,"4-(5,11-DIOXO-5H-INDENO[1,2-C]ISOQUINOLIN-6(11H)-YL)BUTANOATE",AHIJTWCJGCWHMT-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
122056,6w4b,DB12812,-7.3,Palomid 529,YEAHTLOYHVWAKW-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
153160,6wiq,DB05327,-7.3,Ranirestat,QCVNMNYRNIMDKV-QGZVFWFLSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
135378,6w9c,DB04386,-7.3,"4,6-O-(1-Carboxyethylidene)-Beta-D-Glucose",QVVFNJUJKXWFAU-CECBSOHTSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
160250,7bv1,DB07927,-7.3,3-[(4-Carboxy-2-hydroxyphenyl)sulfamoyl]-2-thiophenecarboxylic acid,RDPXXOOKKRIKFN-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
147763,6w9q,DB12408,-7.3,PF-03635659,WGOJWDWKHJHXSV-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
130410,6w4h,DB12229,-7.3,Cerlapirdine,NXQGEDVQXVTCDA-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
147757,6w9q,DB12401,-7.3,Bromperidol,RKLNONIVDFXQRX-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
162144,7bv1,DB01489,-7.3,Camazepam,PXBVEXGRHZFEOF-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
137242,6w9c,DB08061,-7.3,4-[3-(4-CHLOROPHENYL)-1H-PYRAZOL-5-YL]PIPERIDINE,GELALLNTKKLQLM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
146322,6w9q,DB08391,-7.3,"6,7-DIMETHOXY-4-[(3R)-3-(QUINOXALIN-2-YLOXY)PYRROLIDIN-1-YL]QUINAZOLINE",UBIIFKJMNRPNMT-CQSZACIVSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
155332,6wiq,DB08970,-7.3,Fluprednidene,YVHXHNGGPURVOS-SBTDHBFYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
146360,6w9q,DB08439,-7.3,Parecoxib,TZRHLKRLEZJVIJ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
135426,6w9c,DB04458,-7.3,"2,2-Dichloro-1-Methanesulfinyl-3-Methyl-Cyclopropanecarboxylic Acid [1-(4-Bromo-Phenyl)-Ethyl]-Amide",VMASMYSTIDDLTO-JOSUJJRFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
146365,6w9q,DB08444,-7.3,"3-[2-bromo-4-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)phenoxy]-5-methylbenzonitrile",YYGZQXRLQMFHDH-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
160256,7bv1,DB07933,-7.3,Erteberel,XIESSJVMWNJCGZ-VKJFTORMSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
33270,6cs2,T3D4447,-7.3,Propionyl-CoA,QAQREVBBADEHPA-UXYNFSPESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
128033,6w4h,DB07139,-7.3,3-[5-(3-nitrophenyl)thiophen-2-yl]propanoic acid,IHKCOKRMJRDWAL-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
137217,6w9c,DB08032,-7.3,"N,N-DIETHYL-2-[(2-THIENYLCARBONYL)AMINO]-4,5,6,7-TETRAHYDRO-1-BENZOTHIOPHENE-3-CARBOXAMIDE",NZTHBWHANVWSRX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
146316,6w9q,DB08385,-7.3,4-(quinolin-3-ylmethyl)piperidine-1-carboxylic acid,QUAGUFNCKDDJFZ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
162160,7bv1,DB01512,-7.3,Hydromorphinol,AABLHGPVOULICI-BRJGLHKUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
146313,6w9q,DB08382,-7.3,Gosogliptin,QWEWGXUTRTXFRF-KBPBESRZSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
122051,6w4b,DB12804,-7.3,Daniquidone,SRIOCKJKFXAKHK-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
147784,6w9q,DB12434,-7.3,Steviolbioside,OMHUCGDTACNQEX-OSHKXICASA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
162187,7bv1,DB01541,-7.3,Boldenone,RSIHSRDYCUFFLA-DYKIIFRCSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
162186,7bv1,DB01540,-7.3,17alpha-methyl-4-hydroxynandrolone,CLNUZOCYKSHICX-FAHHUNKHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
120069,6w4b,DB08046,-7.3,2-chloro-5-[(1S)-1-hydroxy-3-oxo-2H-isoindol-1-yl]benzenesulfonamide,JIVPVXMEBJLZRO-AWEZNQCLSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
120070,6w4b,DB08049,-7.3,"7,8-dihydroxy-4-phenyl-2H-chromen-2-one",JRVIIPJSVKTPBK-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
135398,6w9c,DB04416,-7.3,"R-2-{[4'-Methoxy-(1,1'-Biphenyl)-4-Yl]-Sulfonyl}-Amino-6-Methoxy-Hex-4-Ynoic Acid",QJKGJGURDPRKGW-LJQANCHMSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137308,6w9c,DB08136,-7.3,4-(acetylamino)-N-(4-fluorophenyl)-1H-pyrazole-3-carboxamide,CWQKPKYIMQTGJK-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
146290,6w9q,DB08352,-7.3,"6-[4-(2-fluorophenyl)-1,3-oxazol-5-yl]-N-(1-methylethyl)-1,3-benzothiazol-2-amine",FQYJTHIYAQQJAB-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
146297,6w9q,DB08360,-7.3,"2-(4-ETHYLPIPERAZIN-1-YL)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE",BIFHJPUTQBOBGJ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
122041,6w4b,DB12787,-7.3,Norethandrolone,ZDHCJEIGTNNEMY-XGXHKTLJSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
162172,7bv1,DB01526,-7.3,4-Androstenediol,BTTWKVFKBPAFDK-LOVVWNRFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
127698,6w4h,DB06708,-7.3,Lumefantrine,DYLGFOYVTXJFJP-MYYYXRDXSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
137292,6w9c,DB08119,-7.3,"1,1,1-TRIFLUORO-3-((N-ACETYL)-L-LEUCYLAMIDO)-4-PHENYL-BUTAN-2-ONE(N-ACETYL-L-LEUCYL-L-PHENYLALANYL TRIFLUOROMETHYL KETONE)",MZNXJCZDQRNGRC-GJZGRUSLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
135413,6w9c,DB04438,-7.3,Brivudine monophosphate,LKWCVKAHHUJPQO-PIXDULNESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
162456,7bv1,DB02292,-7.3,Irosustat,DSLPMJSGSBLWRE-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
162468,7bv1,DB02310,-7.3,"3,5,6,8-Tetramethyl-N-Methyl Phenanthrolinium",FQTUZNACZKILMC-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
34401,1r42,DB00203,-7.3,Sildenafil,BNRNXUUZRGQAQC-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
146111,6w9q,DB08130,-7.3,"N-(5-{3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]phenyl}-1,3,4-oxadiazol-2-yl)ethane-1,2-diamine",FPDWDLAITHFTTP-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
148017,6w9q,DB12804,-7.3,Daniquidone,SRIOCKJKFXAKHK-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
34491,1r42,DB00307,-7.3,Bexarotene,NAVMQTYZDKMPEU-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
155824,6wiq,DB11786,-7.3,Pefcalcitol,SVCSMAZYWOQCBW-NVJMFHFGSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
147984,6w9q,DB12745,-7.3,GSK-690693,KGPGFQWBCSZGEL-ZDUSSCGKSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
28821,6cs2,DB08441,-7.3,"6-BROMO-13-THIA-2,4,8,12,19-PENTAAZATRICYCLO[12.3.1.1-3,7-]NONADECA-1(18),3(19),4,6,14,16-HEXAENE 13,13-DIOXIDE",AWSQADBSXFTFKL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
122373,6w4b,DB13317,-7.3,Flunoxaprofen,ARPYQKTVRGFPIS-VIFPVBQESA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
119806,6w4b,DB07747,-7.3,"(3R)-N-(4-CHLOROPHENYL)-3-(HYDROXYMETHYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONAMIDE",YTBGBMPLINFTBQ-OAHLLOKOSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
160025,7bv1,DB07201,-7.3,(2S)-3-[(9H-fluoren-9-ylideneamino)oxy]-2-methylpropanoic acid,ZHFDVDMCVXUGGF-NSHDSACASA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
147979,6w9q,DB12740,-7.3,CC-115,GMYLVKUGJMYTFB-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
127643,6w4h,DB06600,-7.3,Nemonoxacin,AVPQPGFLVZTJOR-RYUDHWBXSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
146004,6w9q,DB08011,-7.3,"(3E)-5-fluoro-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-1H-indole-2,3-dione 3-oxime",DXIHOIDYHQSQKJ-HMMYKYKNSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
147974,6w9q,DB12731,-7.3,Daporinad,KPBNHDGDUADAGP-VAWYXSNFSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
119825,6w4b,DB07768,-7.3,Epitestosterone,MUMGGOZAMZWBJJ-KZYORJDKSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
147965,6w9q,DB12717,-7.3,Mibampator,ULRDYYKSPCRXAJ-KRWDZBQOSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
127640,6w4h,DB06594,-7.3,Agomelatine,YJYPHIXNFHFHND-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
49865,2fxp,DB05454,-7.3,Paliroden,CNEWKIDCGDXBDE-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
162741,7bv1,DB02861,-7.3,"4-(Aminosulfonyl)-N-[(3,4,5-Trifluorophenyl)Methyl]-Benzamide",DEHMSTGBNAXEGX-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
145981,6w9q,DB07986,-7.3,[4-(4-PHENYL-PIPERIDIN-1-YL)-BENZENESULFONYLAMINO]-ACETIC ACID,GNSLACGSDSJAIQ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
2223,6lzg,HMDB0000698,-7.3,Lithocholic acid glycine conjugate,XBSQTYHEGZTYJE-OETIFKLTSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
32985,6cs2,T3D3917,-7.3,Pyrithiobac-sodium,CNILNQMBAHKMFS-UHFFFAOYSA-M,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
155842,6wiq,DB11828,-7.3,Neratinib,JWNPDZNEKVCWMY-VQHVLOKHSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
119757,6w4b,DB07689,-7.3,"METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE",NYNAFINLHQEHKU-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
34510,1r42,DB00445,-7.3,Epirubicin,AOJJSUZBOXZQNB-VTZDEGQISA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
159995,7bv1,DB07168,-7.3,[4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-6-(methylamino)pyrimidin-2-yl}amino)phenyl]acetonitrile,MFMSRHREFZCFSN-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
128134,6w4h,DB07257,-7.3,"4-(2-chlorophenyl)-8-(2-hydroxyethyl)-6-methylpyrrolo[3,4-e]indole-1,3(2H,6H)-dione",WHMQZCPGFZBLBG-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
34506,1r42,DB00324,-7.3,Fluorometholone,FAOZLTXFLGPHNG-KNAQIMQKSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
162775,7bv1,DB02905,-7.3,"Phosphoric Acid Mono-[3,4-Dihydroxy-5-(5-Hydroxy-Benzoimidazol-1-Yl)Tetrahydro-Furan-2-Ylmethyl] Ester",BVZASCINAVSQNO-PULFBKJNSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
145965,6w9q,DB07968,-7.3,N-(2-CHLORO-4-FLUOROBENZOYL)-N'-(5-HYDROXY-2-METHOXYPHENYL)UREA,RFOBTYLRURSVJE-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
119791,6w4b,DB07729,-7.3,3-fluoro-N-[3-(1H-tetrazol-5-yl)phenyl]benzamide,GAKOBKPDJJGRIL-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
134989,6w9c,DB03835,-7.3,"N-[(5S,7R,8S,9S,10R)-8,9,10-Trihydroxy-7-(hydroxymethyl)-2,4-dioxo-6-oxa-1,3-diazaspiro[4.5]dec-3-yl]acetamide",MAHIOGAAEAWGLR-UTAYWCBXSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
119803,6w4b,DB07743,-7.3,"S-[5-(TRIFLUOROMETHYL)-4H-1,2,4-TRIAZOL-3-YL] 5-(PHENYLETHYNYL)FURAN-2-CARBOTHIOATE",VNGWUVBXUIDQTK-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
33000,6cs2,T3D3931,-7.3,Thiabendazole,WJCNZQLZVWNLKY-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
162761,7bv1,DB02889,-7.3,"4-O-(4,6-Dideoxy-4-{[4,5,6-Trihydroxy-3-(Hydroxymethyl)Cyclohex-2-En-1-Yl]Amino}-Beta-D-Lyxo-Hexopyranosyl)-Alpha-D-Erythro-Hexopyranose",SNMISNLUIRCRQE-SFSRYZOZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
127645,6w4h,DB06604,-7.3,Ilepatril,FXKFFTMLFPWYFH-RDGPPVDQSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
162794,7bv1,DB02929,-7.3,K201,KCWGETCFOVJEPI-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
146016,6w9q,DB08023,-7.3,"N-cyclohexyl-4-imidazo[1,2-a]pyridin-3-yl-N-methylpyrimidin-2-amine",HYNNWLVWJXWXFO-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
147951,6w9q,DB12696,-7.3,BMS-582949,GDTQLZHHDRRBEB-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
122262,6w4b,DB13126,-7.3,BMS-986115,SRJNRAQUSAVENA-GSHUGGBRSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
162567,7bv1,DB02430,-7.3,Trehalose-6-Phosphate,LABSPYBHMPDTEL-LIZSDCNHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
122258,6w4b,DB13119,-7.3,GSK-364735,QWLNINWUBHHOLU-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
122235,6w4b,DB13089,-7.3,Enoxolone,MPDGHEJMBKOTSU-YKLVYJNSSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
122234,6w4b,DB13088,-7.3,AZD-0424,MVWATCATLSSVBH-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
147885,6w9q,DB12591,-7.3,BMS-911543,JCINBYQJBYJGDM-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
119902,6w4b,DB07855,-7.3,(S)-1-PHENYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE,CWHMAWBXRCDOEB-HNNXBMFYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
162546,7bv1,DB02407,-7.3,6-O-Cyclohexylmethyl Guanine,MWGXGTJJAOZBNW-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
162531,7bv1,DB02390,-7.3,5-Bromo-N[2-(Dimethylamino)Ethyl]-9-Aminoacridine-4-Carboxamide,NROQPXQSDDINMC-UHFFFAOYSA-P,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
135199,6w9c,DB04116,-7.3,Allolactose,DLRVVLDZNNYCBX-VDGMBKLFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
153482,6wiq,DB06718,-7.3,Stanozolol,LKAJKIOFIWVMDJ-IYRCEVNGSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
155286,6wiq,DB08905,-7.3,Formestane,OSVMTWJCGUFAOD-KZQROQTASA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
36502,1r42,DB03010,-7.3,Patupilone,QXRSDHAAWVKZLJ-PVYNADRNSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
127654,6w4h,DB06622,-7.3,7-beta-Hydroxyepiandrosterone,VFPMCLQMAUVEHD-UCPSWNCLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
49794,2fxp,DB05038,-7.3,Anatibant,XUHBBTKJWIBQMY-MHZLTWQESA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
130718,6w4h,DB12679,-7.3,WP 1066,VFUAJMPDXIRPKO-LQELWAHVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
146065,6w9q,DB08080,-7.3,LATRUNCULIN B,NSHPHXHGRHSMIK-JRIKCGFMSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
135160,6w9c,DB04068,-7.3,Fudp,WLQBZMZTRNPUDL-SHYZEUOFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
119834,6w4b,DB07779,-7.3,N-({(2S)-1-[(3R)-3-AMINO-4-(2-FLUOROPHENYL)BUTANOYL]PYRROLIDIN-2-YL}METHYL)BENZAMIDE,ANQHSFFUNMTTRS-MOPGFXCFSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
122315,6w4b,DB13237,-7.3,Clofoctol,HQVZOORKDNCGCK-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
119843,6w4b,DB07789,-7.3,"1-[5-methyl-2-(trifluoromethyl)furan-3-yl]-3-[(2Z)-5-(2-{[6-(1H-1,2,4-triazol-3-ylamino)pyrimidin-4-yl]amino}ethyl)-1,3-thiazol-2(3H)-ylidene]urea",KNTGXMNWVXZIMW-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
137689,6w9c,DB08600,-7.3,"5-CHLORO-8-METHYL-7-(3-METHYL-BUT-2-ENYL)-6,7,8,9-TETRAHYDRO-2H-2,7,9A-TRIAZA-BENZO[CD]AZULENE-1-THIONE",ZNFFMCYSMBXZQU-NSHDSACASA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
119847,6w4b,DB07793,-7.3,"(2S)-N-[(3S)-1-(2-AMINO-2-OXOETHYL)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL]-2-CHLORO-2H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE",ACSGSLPOHKRZCY-GXTWGEPZSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
137666,6w9c,DB08573,-7.3,3-[(4-CHLOROANILINO)SULFONYL]THIOPHENE-2-CARBOXYLIC ACID,YRWKEEDITQJPCZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
119859,6w4b,DB07806,-7.3,"(2R,4S)-2-[(R)-BENZYLCARBAMOYL-PHENYLACETYL-METHYL]-5,5-DIMETHYL-THIAZOLIDINE-4-CARBOXYLIC ACID",UDMBRVGTYILYDX-SVFBPWRDSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
119866,6w4b,DB07813,-7.3,GLYCYLALANYL-N-2-NAPHTHYL-L-PROLINEAMIDE,KCELZXZDIUJGNM-GUYCJALGSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
146037,6w9q,DB08049,-7.3,"7,8-dihydroxy-4-phenyl-2H-chromen-2-one",JRVIIPJSVKTPBK-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
128099,6w4h,DB07216,-7.3,"(11S)-8-CHLORO-11-[1-(METHYLSULFONYL)PIPERIDIN-4-YL]-6-PIPERAZIN-1-YL-11H-BENZO[5,6]CYCLOHEPTA[1,2-B]PYRIDINE",ZMGCFGGMTCMSDP-QHCPKHFHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
137628,6w9c,DB08528,-7.3,"2-AMINO-6-(3,5-DIMETHYLPHENYL)SULFONYLBENZONITRILE",SWGDXLAZBZDUBR-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
135132,6w9c,DB04024,-7.3,N'-L-Seryl-3'-Amino-(3'-Deoxy)-Adenosine,ITDKSTILAWHDJI-AYEBZEFBSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
33079,6cs2,T3D4059,-7.3,Senecionine,HKODIGSRFALUTA-JTLQZVBZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
128096,6w4h,DB07211,-7.3,(2R)-2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}PROPENE-1-SULFONAMIDE,YMJHMJLNQLVUAV-GHYUOPHCSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
34433,1r42,DB00240,-7.3,Alclometasone,FJXOGVLKCZQRDN-PHCHRAKRSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
127647,6w4h,DB06608,-7.3,Tafenoquine,LBHLFPGPEGDCJG-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
116721,6w4b,DB02519,-7.3,Indirubin-5-Sulphonate,IHBOEHLUIBMBMY-YPKPFQOOSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
136254,6w9c,DB06903,-7.3,"(1S,3aS,5aR,8aS)-1,7,7-trimethyl-1,2,3,3a,5a,6,7,8-octahydrocyclopenta[c]pentalene-4-carboxylic acid",DCFDRCCHOOORSB-JOXOIDLHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
115159,6w4b,DB00525,-7.3,Tolnaftate,FUSNMLFNXJSCDI-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
115535,6w4b,DB00967,-7.3,Desloratadine,JAUOIFJMECXRGI-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
51163,2fxp,DB07856,-7.3,6-{4-[4-(4-CHLOROPHENYL)PIPERIDIN-4-YL]PHENYL}-9H-PURINE,HPWBHQIUIBFTQC-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
157543,6wiq,DB09295,-7.3,Talniflumate,ANMLJLFWUCQGKZ-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
156968,6wiq,DB13991,-7.3,Pipequaline,AMEWZCMTSIONOX-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
129018,6w4h,DB08292,-7.3,"(5Z)-12-CHLORO-13,15-DIHYDROXY-4,7,8,9-TETRAHYDRO-2-BENZOXACYCLOTRIDECINE-1,10(3H,11H)-DIONE",AQKZYZQONWDDLS-IWQZZHSRSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
156252,6wiq,DB12644,-7.3,AZD-2066,SXWHYTICXCLKDG-GFCCVEGCSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
129023,6w4h,DB08297,-7.3,ORTHONITROPHENYL-BETA-D-FUCOPYRANOSIDE,SWRPIVXPHLYETN-BVWHHUJWSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
150269,6wiq,DB01147,-7.3,Cloxacillin,LQOLIRLGBULYKD-JKIFEVAISA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
6225,6lzg,DB01755,-7.3,N-[Isoleucinyl]-N'-[Adenosyl]-Diaminosufone,XVTRBLLRODNOJV-VBJYJYTRSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
30316,6cs2,DB12322,-7.3,GW-870086,WUBKGTSFJSEIEM-NSHBDUGJSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
114473,6vxx,DB13675,-7.3,Metahexamide,XXYTXQGCRQLRHA-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
157503,6wiq,DB09233,-7.3,Cronidipine,CNIJVNPIIHWRRP-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
154158,6wiq,DB07544,-7.3,N'-(5-CHLOROBENZOFURAN-2-CARBONYL)-2-(TRIFLUOROMETHYL)BENZENESULFONOHYDRAZIDE,ZLQBZYKAQQWOTK-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
30319,6cs2,DB12326,-7.3,Antroquinonol,LJTSIMVOOOLKOL-FNRDIUJOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
126478,6w4h,DB03882,-7.3,"5-Alpha-Androstane-3-Beta,17beta-Diol",CBMYJHIOYJEBSB-YSZCXEEOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
166204,7bv1,DB14097,-7.3,13-cis-12-(3'-Carboxyphenyl)retinoic acid,XKKDQOHDTASHCE-PAZAWXFKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
150903,6wiq,DB02009,-7.3,"L-756,423",AOMZDQMIOCTPQP-QHQMVRJISA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
114504,6vxx,DB13717,-7.3,Phenothrin,SBNFWQZLDJGRLK-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165613,7bv1,DB12540,-7.3,Lecozotan,NRPQELCNMADTOZ-OAQYLSRUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
157500,6wiq,DB09171,-7.3,β-Methylfentanyl,UXIGUKSHASXDNI-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
144467,6w9q,DB04915,-7.3,Idronoxil,ZZUBHVMHNVYXRR-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
165572,7bv1,DB12475,-7.3,Biphenyl dimethyl dicarboxylate,BKRIRZXWWALTPU-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
157550,6wiq,DB09319,-7.3,Carindacillin,JIRBAUWICKGBFE-MNRDOXJOSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
125305,6w4h,DB02322,-7.3,Heparin Disaccharide I-S,LRPGJWKAYQRIAQ-GYBHJADLSA-J,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
30869,6cs2,DB13090,-7.3,Zidebactam,YCZPXRQPDCXTIO-BBBLOLIVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
125241,6w4h,DB02237,-7.3,Maltotetraose,UYQJCPNSAVWAFU-KVXMBEGHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
165550,7bv1,DB12442,-7.3,Alvespimycin,KUFRQPKVAWMTJO-LMZWQJSESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
142663,6w9q,DB02491,-7.3,4-[4-(1-Amino-1-Methylethyl)Phenyl]-5-Chloro-N-[4-(2-Morpholin-4-Ylethyl)Phenyl]Pyrimidin-2-Amine,CJSSYVIHFXDFFC-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
131262,6w4h,DB13506,-7.3,Carfecillin,NZDASSHFKWDBBU-KVMCETHSSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
115589,6w4b,DB01030,-7.3,Topotecan,UCFGDBYHRUNTLO-QHCPKHFHSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
157603,6wiq,DB12180,-7.3,Apitolisib,YOVVNQKCSKSHKT-HNNXBMFYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
144444,6w9q,DB04875,-7.3,Pralnacasan,CXAGHAZMQSCAKJ-WAHHBDPQSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
30889,6cs2,DB13115,-7.3,Saroglitazar,MRWFZSLZNUJVQW-DEOSSOPVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
29385,6cs2,DB09095,-7.3,Difluocortolone,OGPWIDANBSLJPC-RFPWEZLHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
51142,2fxp,DB07831,-7.3,"2-{[(6-OXO-1,6-DIHYDROPYRIDIN-3-YL)METHYL]AMINO}-N-[4-PROPYL-3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE",SHSORWZDEKFFLP-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
157496,6wiq,DB06630,-7.3,Anacetrapib,MZZLGJHLQGUVPN-HAWMADMCSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
115585,6w4b,DB01025,-7.3,Amlexanox,SGRYPYWGNKJSDL-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
144454,6w9q,DB04886,-7.3,Calanolide A,NIDRYBLTWYFCFV-FMTVUPSXSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
150906,6wiq,DB02014,-7.3,"5-(2-Fluoro-5-{(1E)-3-[3-hydroxy-2-(methoxycarbonyl)phenoxy]-1-propen-1-yl}phenyl)-1,2-oxazole-3-carboxylic acid",QKHWJUMLYAYZFS-ONEGZZNKSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
132398,6w9c,DB00380,-7.3,Dexrazoxane,BMKDZUISNHGIBY-ZETCQYMHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
35688,1r42,DB01944,-7.3,(S)-blebbistatin,LZAXPYOBKSJSEX-GOSISDBHSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
30306,6cs2,DB12311,-7.3,CP1-1189,DJKNRCWSXSZACF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
154422,6wiq,DB07855,-7.3,(S)-1-PHENYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE,CWHMAWBXRCDOEB-HNNXBMFYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
150200,6wiq,DB01067,-7.3,Glipizide,ZJJXGWJIGJFDTL-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
142616,6w9q,DB02429,-7.3,4-(Aminosulfonyl)-N-[(4-Fluorophenyl)Methyl]-Benzamide,IXDVPACDZDRCTN-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
165567,7bv1,DB12468,-7.3,Pf-04531083,ZRJGMDIPCQOGNI-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
141410,6w9q,DB00862,-7.3,Vardenafil,SECKRCOLJRRGGV-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
131266,6w4h,DB13511,-7.3,Clebopride,BVPWJMCABCPUQY-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
150302,6wiq,DB01184,-7.3,Domperidone,FGXWKSZFVQUSTL-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
144472,6w9q,DB04930,-7.3,Permethrin,RLLPVAHGXHCWKJ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
127181,6w4h,DB04824,-7.3,Phenolphthalein,KJFMBFZCATUALV-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
144545,6w9q,DB05294,-7.3,Vandetanib,UHTHHESEBZOYNR-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
30804,6cs2,DB13004,-7.3,Mavoglurant,ZFPZEYHRWGMJCV-ZHALLVOQSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
144546,6w9q,DB05295,-7.3,Eldecalcitol,FZEXGDDBXLBRTD-AYIMTCTASA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
30360,6cs2,DB12385,-7.3,10-hydroxycamptothecin,HAWSQZCWOQZXHI-FQEVSTJZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
35990,1r42,DB02341,-7.3,"Mdl 101,146",XQAMVCHQGHAELT-YPAWHYETSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
131803,6w4h,DB14736,-7.3,Cannabivarin,SVTKBAIRFMXQQF-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
153895,6wiq,DB07242,-7.3,"(4R)-7,8-dichloro-1',9-dimethyl-1-oxo-1,2,4,9-tetrahydrospiro[beta-carboline-3,4'-piperidine]-4-carbonitrile",XGUIMGJMQKZRGM-LLVKDONJSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
129535,6w4h,DB08943,-7.3,Isoconazole,MPIPASJGOJYODL-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
129060,6w4h,DB08344,-7.3,4-chloro-N-(3-methoxypropyl)-N-[(3S)-1-(2-phenylethyl)piperidin-3-yl]benzamide,OOUGHDJEJNMXSV-QHCPKHFHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
29436,6cs2,DB09188,-7.3,Amedalin,HBGWAZBZXJBYQD-IBGZPJMESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
125409,6w4h,DB02450,-7.3,"2-Benzo[1,3]Dioxol-5-Ylmethyl-3-Benzyl-Succinic Acid",ASEJDWRSZYAIOT-GJZGRUSLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
30782,6cs2,DB12971,-7.3,Pactimibe,TXIIZHHIOHVWJD-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
114564,6vxx,DB13795,-7.3,Brodimoprim,BFCRRLMMHNLSCP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114568,6vxx,DB13801,-7.3,Muzolimine,RLWRMIYXDPXIEX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
129680,6w4h,DB09175,-7.3,Mirfentanil,BJZZDOLVVLWFHN-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
129679,6w4h,DB09174,-7.3,Lofentanil,IMYHGORQCPYVBZ-NLFFAJNJSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
144551,6w9q,DB05351,-7.3,Dexlansoprazole,MJIHNNLFOKEZEW-RUZDIDTESA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
35987,1r42,DB02338,-7.3,Nadph Dihydro-Nicotinamide-Adenine-Dinucleotidephosphate,ACFIXJIJDZMPPO-NNYOXOHSSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
165654,7bv1,DB12604,-7.3,Sisomicin,URWAJWIAIPFPJE-YFMIWBNJSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
129678,6w4h,DB09173,-7.3,Butyrfentanyl,QQOMYEQLWQJRKK-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
165657,7bv1,DB12608,-7.3,Emixustat,WJIGGYYSZBWCGC-MRXNPFEDSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
131808,6w4h,DB14753,-7.3,Hydroxystilbamidine,TUESWZZJYCLFNL-DAFODLJHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
115427,6w4b,DB00845,-7.3,Clofazimine,WDQPAMHFFCXSNU-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
115604,6w4b,DB01047,-7.3,Fluocinonide,WJOHZNCJWYWUJD-IUGZLZTKSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
30355,6cs2,DB12380,-7.3,GDC-0152,WZRFLSDVFPIXOV-LRQRDZAKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
144544,6w9q,DB05289,-7.3,Tarenflurbil,SYTBZMRGLBWNTM-SNVBAGLBSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
156989,6wiq,DB14034,-7.3,Darglitazone,QQKNSPHAFATFNQ-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
46885,2fxp,DB01070,-7.3,Dihydrotachysterol,ILYCWAKSDCYMBB-OPCMSESCSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
114517,6vxx,DB13730,-7.3,Nifurtoinol,UIDWQGRXEVDFCA-XCVCLJGOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
157482,6wiq,DB06605,-7.3,Apixaban,QNZCBYKSOIHPEH-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
114521,6vxx,DB13737,-7.3,Cyclobarbital,WTYGAUXICFETTC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
144491,6w9q,DB04983,-7.3,Denufosol,FPNPSEMJLALQSA-MIYUEGBISA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
141510,6w9q,DB00978,-7.3,Lomefloxacin,ZEKZLJVOYLTDKK-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
29414,6cs2,DB09167,-7.3,Dosulepin,PHTUQLWOUWZIMZ-GZTJUZNOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
125381,6w4h,DB02414,-7.3,"(3s,8ar)-3-(1h-Imidazol-5-Ylmethyl)Hexahydropyrrolo[1,2-a]Pyrazine-1,4-Dione",NAKUGCPAQTUSBE-IUCAKERBSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131782,6w4h,DB14678,-7.3,Norethindrone enanthate,APTGJECXMIKIET-WOSSHHRXSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
125396,6w4h,DB02431,-7.3,Cytidine-5'-Triphosphate,PCDQPRRSZKQHHS-XVFCMESISA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
129705,6w4h,DB09201,-7.3,Ciglitazone,YZFWTZACSRHJQD-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
114526,6vxx,DB13744,-7.3,Piromidic acid,RCIMBBZXSXFZBV-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
129308,6w4h,DB08643,-7.3,2-(2-{2-[(BIPHENYL-4-YLMETHYL)-AMINO]-3-MERCAPTO-PENTANOYLAMINO}-ACETYLAMINO)-3-METHYL-BUTYRIC ACID METHYL ESTER,QFAWBPLETHINFK-UNMCSNQZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131786,6w4h,DB14682,-7.3,Dextrorphan,JAQUASYNZVUNQP-PVAVHDDUSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
115485,6w4b,DB00910,-7.3,Paricalcitol,BPKAHTKRCLCHEA-UBFJEZKGSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
165634,7bv1,DB12572,-7.3,Pexacerfont,LBWQSAZEYIZZCE-SNVBAGLBSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
131800,6w4h,DB14732,-7.3,Queuine,WYROLENTHWJFLR-ACLDMZEESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
35991,1r42,DB02342,-7.3,2-Methox1tradiol,CQOQDQWUFQDJMK-SSTWWWIQSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
125392,6w4h,DB02427,-7.3,"2,4-Diamino-6-[N-(2',5'-Dimethoxybenzyl)-N-Methylamino]Quinazoline",YBJANOUTWRTBDK-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
142512,6w9q,DB02300,-7.3,Calcipotriol,LWQQLNNNIPYSNX-UROSTWAQSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
29623,6cs2,DB11260,-7.3,Diacetyl benzoyl lathyrol,JPYYWXPAHJBKJX-VWSFRBHVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
141552,6w9q,DB01025,-7.3,Amlexanox,SGRYPYWGNKJSDL-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
165659,7bv1,DB12614,-7.3,Reparixin,KQDRVXQXKZXMHP-LLVKDONJSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
152162,6wiq,DB03696,-7.3,Lanosterol,CAHGCLMLTWQZNJ-BQNIITSRSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
156936,6wiq,DB13919,-7.3,Candesartan,HTQMVQVXFRQIKW-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
150048,6wiq,DB00894,-7.3,Testolactone,BPEWUONYVDABNZ-DZBHQSCQSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
35610,1r42,DB01830,-7.3,"{4-[2-Acetylamino-2-(3-Carbamoyl-2-Cyclohexylmethoxy-6,7,8,9-Tetrahydro-5h-Benzocyclohepten-5ylcarbamoyl)-Ethyl]-2-Phosphono-Phenyl}-Phosphonic Acid",SPSGYTWOIGAABK-DQEYMECFSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
30190,6cs2,DB00923,-7.3,Ceforanide,SLAYUXIURFNXPG-CRAIPNDOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
166364,7bv1,DB14734,-7.3,Cannabigerol,QXACEHWTBCFNSA-SFQUDFHCSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
37147,1r42,DB03882,-7.3,"5-Alpha-Androstane-3-Beta,17beta-Diol",CBMYJHIOYJEBSB-YSZCXEEOSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
157696,6wiq,DB12306,-7.3,Cipargamin,CKLPLPZSUQEDRT-WPCRTTGESA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
7045,6lzg,DB03141,-7.3,"3-{[(5R,6R)-5-Benzyl-6-hydroxy-2,4-bis(4-hydroxybenzyl)-3-oxo-1,2,4-triazepan-1-yl]sulfonyl}benzonitril",UYUWNNRWESUYOB-FIRIVFDPSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
29692,6cs2,DB11425,-7.3,Luprostiol,KFUDFIMHDRJVLV-OZCLATTGSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
29690,6cs2,DB11423,-7.3,Lasalocid,BBMULGJBVDDDNI-OWKLGTHSSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
126616,6w4h,DB04070,-7.3,6-Deoxyerythronolide B,HQZOLNNEQAKEHT-IBBGRPSASA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
30207,6cs2,DB12193,-7.3,Ajulemic acid,YCHYFHOSGQABSW-RTBURBONSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
142887,6w9q,DB02790,-7.3,Phenyl-Uridine-5'-Diphosphate,ZHUWBKDWWGKIEN-FMKGYKFTSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
151123,6wiq,DB02300,-7.3,Calcipotriol,LWQQLNNNIPYSNX-UROSTWAQSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
125035,6w4h,DB01960,-7.3,7n-Methyl-8-Hydroguanosine-5'-Diphosphate,QQODJOAVWUWVHJ-KQYNXXCUSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
144378,6w9q,DB04793,-7.3,"1,4:3,6-Dianhydro-2-O-(3-carbamimidoylphenyl)-5-O-(4-carbamimidoylphenyl)-D-glucitol",DKBAWRNTUZFJKV-XMTFNYHQSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
156855,6wiq,DB13778,-7.3,Cefazedone,VTLCNEGVSVJLDN-MLGOLLRUSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
166326,7bv1,DB14659,-7.3,Melengestrol acetate,UDKABVSQKJNZBH-DWNQPYOZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
125040,6w4h,DB01967,-7.3,"N-{3-[(7ar,12as,12bs)-7-Oxo-1,3,4,6,7,7a,12a,12b-Octahydroindolo[2,3-a]Quinolizin-12(2h)-Yl]Propyl}Propane-2-Sulfonamide",LICJTIDRHJECTD-SFHVURJKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
115766,6w4b,DB01234,-7.3,Dexamethasone,UREBDLICKHMUKA-CXSFZGCWSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
157693,6wiq,DB12302,-7.3,CP-724714,LLVZBTWPGQVVLW-SNAWJCMRSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
156382,6wiq,DB13016,-7.3,LY-2300559,DWQVYDLTPMGYNE-DEOSSOPVSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
51628,2fxp,DB08407,-7.3,PLATENSIMYCIN,CSOMAHTTWTVBFL-OFBLZTNGSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
132522,6w9c,DB00533,-7.3,Rofecoxib,RZJQGNCSTQAWON-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
157710,6wiq,DB12322,-7.3,GW-870086,WUBKGTSFJSEIEM-NSHBDUGJSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
144347,6w9q,DB04750,-7.3,OREGON GREEN 488 CARBOXYLATE,BRJCLSQFZSHLRL-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
157742,6wiq,DB12744,-7.3,CGI-1842,ZXBFYBLSJMEBEP-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
46968,2fxp,DB01167,-7.3,Itraconazole,VHVPQPYKVGDNFY-ZPGVKDDISA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
6312,6lzg,DB01910,-7.3,Sinefungin,LMXOHSDXUQEUSF-YECHIGJVSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
124924,6w4h,DB01810,-7.3,"[1-(1-Methyl-4,5-Dioxo-Pent-2-Enylcarbamoyl)-2-Phenyl-Ethyl]-Carbamic Acid Benzyl Ester",NOXVWFAAXREWMI-GURWAVDKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
149998,6wiq,DB00836,-7.3,Loperamide,RDOIQAHITMMDAJ-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
165368,7bv1,DB12000,-7.3,Apabetalone,NETXMUIMUZJUTB-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
131398,6w4h,DB13686,-7.3,Clometocillin,JKXQBIZCQJLVOS-GSNLGQFWSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
151334,6wiq,DB02567,-7.3,PD173955,VAARYSWULJUGST-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
29349,6cs2,DB00838,-7.3,Clocortolone,YMTMADLUXIRMGX-RFPWEZLHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
115840,6w4b,DB01384,-7.3,Paramethasone,MKPDWECBUAZOHP-AFYJWTTESA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
126599,6w4h,DB04047,-7.3,[Pterin-6-Yl Methanyl]-Phosphonophosphate,AMDUVUKDRBIVAH-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131639,6w4h,DB14093,-7.3,"(1,2,6,7-3H)Testosterone",MUMGGOZAMZWBJJ-JQSYSRDDSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
151241,6wiq,DB02449,-7.3,3-(1h-Indol-3-Yl)-2-[4-(4-Phenyl-Piperidin-1-Yl)-Benzenesulfonylamino]-Propionic Acid,ULOTXPTWJAUGGE-MHZLTWQESA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
165376,7bv1,DB12009,-7.3,GW-406381,NXMZBNYLCVTRGB-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
131651,6w4h,DB14125,-7.3,Benazeprilat,MADRIHWFJGRSBP-ROUUACIJSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
47085,2fxp,DB01349,-7.3,Tasosartan,ADXGNEYLLLSOAR-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
124963,6w4h,DB01859,-7.3,4-Diphosphocytidyl-2-C-Methyl-D-Erythritol 2-Phosphate,HTJXTKBIUVFUAR-XHIBXCGHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
150030,6wiq,DB00873,-7.3,Loteprednol,YPZVAYHNBBHPTO-MXRBDKCISA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
124967,6w4h,DB01864,-7.3,5'-Guanosine-Diphosphate-Monothiophosphate,XOFLBQFBSOEHOG-UUOKFMHZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131396,6w4h,DB13684,-7.3,Omoconazole,JMFOSJNGKJCTMJ-ZHZULCJRSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
156206,6wiq,DB12567,-7.3,Camicinal,RZKDEGZIFSJVNA-IBGZPJMESA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
115822,6w4b,DB01342,-7.3,Forasartan,YONOBYIBNBCDSJ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
151274,6wiq,DB02491,-7.3,4-[4-(1-Amino-1-Methylethyl)Phenyl]-5-Chloro-N-[4-(2-Morpholin-4-Ylethyl)Phenyl]Pyrimidin-2-Amine,CJSSYVIHFXDFFC-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
30999,6cs2,DB13291,-7.3,Cloridarol,KBFBRIPYVVGWRS-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
144379,6w9q,DB04794,-7.3,Bifonazole,OCAPBUJLXMYKEJ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
157688,6wiq,DB12297,-7.3,GLPG-0187,CXHCNOMGODVIKB-VWLOTQADSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
129331,6w4h,DB08670,-7.3,"METHYL N-[(2S,3R)-3-AMINO-2-HYDROXY-3-(4-ISOPROPYLPHENYL)PROPANOYL]-D-ALANYL-D-LEUCINATE",WIWZNHHLFMPGGO-PIKADFDJSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131745,6w4h,DB14639,-7.3,Boldenone undecylenate,AHMMSNQYOPMLSX-CNQKSJKFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
126556,6w4h,DB03986,-7.3,6-Methyl-Formycin A,UHYKIYIKTWEXSX-LFAOKBQASA-O,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
126554,6w4h,DB03984,-7.3,Morpholine-4-Carboxylic Acid [1-(2-Benzylsulfanyl-1-Formyl-Ethylcarbamoyl)-2-Phenyl-Ethyl]-Amide,MWTQNXVXPLTHJB-YADHBBJMSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
132437,6w9c,DB00427,-7.3,Triprolidine,CBEQULMOCCWAQT-WOJGMQOQSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
125155,6w4h,DB02118,-7.3,CP-271485,CIUMOGWIMXNXSQ-GOSISDBHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
125171,6w4h,DB02139,-7.3,(2e)-N-Allyl-4-{[3-(4-Bromophenyl)-5-Fluoro-1-Methyl-1h-Indazol-6-Yl]Oxy}-N-Methyl-2-Buten-1-Amine,YDWPQZUWZDRRSE-AATRIKPKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
154152,6wiq,DB07537,-7.3,"N'-(6-aminopyridin-3-yl)-N-(2-cyclopentylethyl)-4-methyl-benzene-1,3-dicarboxamide",CLEGTVIMOPPIBR-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
131370,6w4h,DB13656,-7.3,Eberconazole,MPTJIDOGFUQSQH-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
125172,6w4h,DB02140,-7.3,N1-(1-Dimethylcarbamoyl-2-Phenyl-Ethyl)-2-Oxo-N4-(2-Pyridin-2-Yl-Ethyl)-Succinamide,ZPFPZRVOBBMZMP-SFHVURJKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131378,6w4h,DB13665,-7.3,Fluanisone,IRYFCWPNDIUQOW-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
132426,6w9c,DB00414,-7.3,Acetohexamide,VGZSUPCWNCWDAN-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
144442,6w9q,DB04872,-7.3,Osanetant,DZOJBGLFWINFBF-UMSFTDKQSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
131748,6w4h,DB14643,-7.3,Methylprednisolone aceponate,DALKLAYLIPSCQL-YPYQNWSCSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
125192,6w4h,DB02170,-7.3,"1,8-Di-Hydroxy-4-Nitro-Xanthen-9-One",ZOHCDJRFYXKEQW-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
152503,6wiq,DB04140,-7.3,1-Benzyl-3-(4-Methoxy-Benzenesulfonyl)-6-Oxo-Hexahydro-Pyrimidine-4-Carboxylic Acid Hydroxyamide,SUSMVCKSLVPRCL-QGZVFWFLSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
165524,7bv1,DB12230,-7.3,Bunazosin,RHLJLALHBZGAFM-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
129005,6w4h,DB08272,-7.3,(4S)-4-(2-NAPHTHYLMETHYL)-D-GLUTAMIC ACID,YDWIUFASTTZKNI-UONOGXRCSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
30902,6cs2,DB13136,-7.3,Fluindione,NASXCEITKQITLD-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
129007,6w4h,DB08274,-7.3,"6,7,8,9-TETRAHYDRO-4-HYDROXY-3-(1-PHENYLPROPYL)CYCLOHEPTA[B]PYRAN-2-ONE",YKJXQZGJGDTEOC-AWEZNQCLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
165541,7bv1,DB12429,-7.3,CI-1040,GFMMXOIFOQCCGU-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
126033,6w4h,DB03273,-7.3,3'-Oxo-Adenosine,MIAZJCOESMXYNJ-XMRAEQSQSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131747,6w4h,DB14641,-7.3,Estriol tripropionate,ONMZMZJEZHMWQL-REUUDLSRSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
115622,6w4b,DB01067,-7.3,Glipizide,ZJJXGWJIGJFDTL-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
151041,6wiq,DB02194,-7.3,"8-Benzyl-2-Hydroxy-2-(4-Hydroxy-Benzyl)-6-(4-Hydroxy-Phenyl)-2h-Imidazo[1,2-a]Pyrazin-3-One",ULLMMKZQNNBLRN-SANMLTNESA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
128998,6w4h,DB08262,-7.3,"2,6-dicarboxynaphthalene",RXOHFPCZGPKIRD-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
157687,6wiq,DB12295,-7.3,Evodenoson,SQJXTUJMBYVDBB-RQXXJAGISA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
144381,6w9q,DB04796,-7.3,Inecalcitol,HHGRMHMXKPQNGF-WNSNRMDMSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
166316,7bv1,DB14648,-7.3,Acetyl simvastatin,OHVWRJDVJRNCPE-BIKFJBPRSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
144384,6w9q,DB04800,-7.3,1-METHYL-3-PHENYL-1H-PYRAZOL-5-YLSULFAMIC ACID,OTZLVSGSRPNRFT-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
126582,6w4h,DB04020,-7.3,"4-(2-{[4-{[3-(4-Chlorophenyl)Propyl]Sulfanyl}-6-(1-Piperazinyl)-1,3,5-Triazin-2-Yl]Amino}Ethyl)Phenol",AIBKIFHSQQYXLG-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
165429,7bv1,DB12092,-7.3,Naftopidil,HRRBJVNMSRJFHQ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
131685,6w4h,DB14207,-7.3,Fosinoprilat,WOIWWYDXDVSWAZ-RTWAWAEBSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
165430,7bv1,DB12093,-7.3,Tetrahydropalmatine,AEQDJSLRWYMAQI-KRWDZBQOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
141263,6w9q,DB00691,-7.3,Moexipril,UWWDHYUMIORJTA-HSQYWUDLSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
29668,6cs2,DB11385,-7.3,Cefalonium,FMZXNVLFJHCSAF-DNVCBOLYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
126564,6w4h,DB03996,-7.3,"3-[(5s)-1-Acetyl-3-(2-Chlorophenyl)-4,5-Dihydro-1h-Pyrazol-5-Yl]Phenol",QBZAPFWYAPXRGQ-KRWDZBQOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
157678,6wiq,DB12284,-7.3,LY-2608204,QIIVJLHCZUTGSD-CUBQBAPOSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
125098,6w4h,DB02046,-7.3,N-[(Furan-2-Yl)Carbonyl]-(S)-Leucyl-(R)-[1-Amino-2(1h-Indol-3-Yl)Ethyl]-Phosphonic Acid,WHPKSASOSKNDPY-PKOBYXMFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
142830,6w9q,DB02709,-7.3,Resveratrol,LUKBXSAWLPMMSZ-OWOJBTEDSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
132470,6w9c,DB00468,-7.3,Quinine,LOUPRKONTZGTKE-WZBLMQSHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
115717,6w4b,DB01177,-7.3,Idarubicin,XDXDZDZNSLXDNA-TZNDIEGXSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
150167,6wiq,DB01030,-7.3,Topotecan,UCFGDBYHRUNTLO-QHCPKHFHSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
125114,6w4h,DB02069,-7.3,N-(2-Flouro-Benzyl)-4-Sulfamoyl-Benzamide,ULYMHSXFSKOHGH-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
47113,2fxp,DB01410,-7.3,Ciclesonide,LUKZNWIVRBCLON-GXOBDPJESA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
115683,6w4b,DB01138,-7.3,Sulfinpyrazone,MBGGBVCUIVRRBF-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
165500,7bv1,DB12194,-7.3,Atamestane,PEPMWUSGRKINHX-TXTPUJOMSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
141314,6w9q,DB00751,-7.3,Epinastine,WHWZLSFABNNENI-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
141282,6w9q,DB00712,-7.3,Flurbiprofen,SYTBZMRGLBWNTM-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
156268,6wiq,DB12666,-7.3,Emapunil,NBMBIEOUVBHEBM-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
157448,6wiq,DB06519,-7.3,Edaglitazone,HAAXAFNSRADSMK-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
141612,6w9q,DB01094,-7.3,Hesperetin,AIONOLUJZLIMTK-AWEZNQCLSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
115116,6w4b,DB00470,-7.3,Dronabinol,CYQFCXCEBYINGO-IAGOWNOFSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
29493,6cs2,DB09246,-7.3,Benmoxin,BEWNZPMDJIGBED-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
125801,6w4h,DB02963,-7.3,"(5-Chloropyrazolo[1,5-a]Pyrimidin-7-Yl)-(4-Methanesulfonylphenyl)Amine",LVNXHNRYPADEAD-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
157181,6wiq,DB14729,-7.3,Rebeccamycin,QEHOIJJIZXRMAN-QZQSLCQPSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
157308,6wiq,DB15151,-7.3,RO-6870810,PKQXLRYFPSZKDU-QFIPXVFZSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
35914,1r42,DB02241,-7.3,"8-Benzyl-2-Hydroperoxy-2-(4-Hydroxy-Benzyl)-6-(4-Hydroxy-Phenyl)-2h-Imidazo[1,2-a]Pyrazin-3-One",HOSWCJDTHOAORT-SANMLTNESA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
115095,6w4b,DB00444,-7.3,Teniposide,NRUKOCRGYNPUPR-QBPJDGROSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
51296,2fxp,DB08010,-7.3,"(3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-[(E)-2-phenylethenyl]-1H-indole-2,3-dione 3-oxime",DDHASJXGNUWZTM-ZLEWNXFRSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
145019,6w9q,DB06866,-7.3,6-CARBAMIMIDOYL-2-[2-HYDROXY-5-(3-METHOXY-PHENYL)-INDAN-1-YL]-HEXANOIC ACID,NMOUMGFCBOWPAB-RZUBCFFCSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
125835,6w4h,DB03013,-7.3,Di(N-Acetyl-D-Glucosamine),CDOJPCSDOXYJJF-KSKNGZLJSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
37086,1r42,DB03802,-7.3,"1-[4-(Octahydro-Pyrido[1,2-a]Pyrazin-2-Yl)-Phenyl]-2-Phenyl-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol",ZGHFWBDHZZKWSI-LITSAYRRSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
157200,6wiq,DB14770,-7.3,Lanraplenib,XCIGZBVOUQVIPI-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
166000,7bv1,DB13553,-7.3,Carumonam,UIMOJFJSJSIGLV-JNHMLNOCSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
125847,6w4h,DB03034,-7.3,D-Levofloxacin,GSDSWSVVBLHKDQ-SNVBAGLBSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
165830,7bv1,DB13077,-7.3,LCB01-0371,QLUWQAFDTNAYPN-LLVKDONJSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
127095,6w4h,DB04707,-7.3,Hydroxyfasudil,ZAVGJDAFCZAWSZ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
28646,6cs2,DB00764,-7.3,Mometasone,QLIIKPVHVRXHRI-CXSFZGCWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
145005,6w9q,DB06848,-7.3,"1-(1'-{[3-(methylsulfanyl)-2-benzothiophen-1-yl]carbonyl}spiro[1-benzofuran-3,4'-piperidin]-5-yl)methanamine",VCUDZTCDUDDJGG-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
129604,6w4h,DB09021,-7.3,Benzoctamine,GNRXCIONJWKSEA-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
144998,6w9q,DB06837,-7.3,"(2R)-N-4-hydroxy-2-(3-hydroxybenzyl)-N-1-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]butanediamide",VXDKQRWTOJFQKH-BJZITVGISA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
165976,7bv1,DB13317,-7.3,Flunoxaprofen,ARPYQKTVRGFPIS-VIFPVBQESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
115126,6w4b,DB00481,-7.3,Raloxifene,GZUITABIAKMVPG-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
166004,7bv1,DB13557,-7.3,Thiopropazate,AIUHRQHVWSUTGJ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
5507,6lzg,HMDB0059990,-7.3,"5-(3',4'-Dihydroxyphenyl)-gamma-valerolactone-4'-O-methyl-3'-O-glucuronide",VZGJAVFCUBLIJF-ZOQSEFCISA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
7954,6lzg,DB04582,-7.3,IMAZAQUIN,CABMTIJINOIHOD-QGZVFWFLSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
144667,6w9q,DB06011,-7.3,AMG-222,NVSWJKWHLUTHLP-CPJSRVTESA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
131320,6w4h,DB13587,-7.3,Mesterolone,UXYRZJKIQKRJCF-TZPFWLJSSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
154292,6wiq,DB07706,-7.3,2-Hydrox1tradiol,DILDHNKDVHLEQB-XSSYPUMDSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
144671,6w9q,DB06083,-7.3,Tapinarof,ZISJNXNHJRQYJO-CMDGGOBGSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
153981,6wiq,DB07334,-7.3,"N-[5-(ETHYLSULFONYL)-2-METHOXYPHENYL]-5-[3-(2-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-AMINE",HTIZPBXCJPQDEM-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
47374,2fxp,DB01721,-7.3,Analogue of Indinavir Drug,MJIRDPUZGGHJMX-OIVSQUILSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
129261,6w4h,DB08582,-7.3,"N-(4-bromo-2-{[(3R,5S)-3,5-dimethylpiperidin-1-yl]carbonyl}phenyl)-4-morpholin-4-yl-4-oxobutanamide",DELARNBPJXTDBD-IYBDPMFKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131944,6w4h,DB15071,-7.3,Omidenepag isopropyl,VIQCWEGEHRBLAC-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
165786,7bv1,DB13012,-7.3,AQX-1125,MDEJTPWQNNMAQF-BVMLLJBZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
36206,1r42,DB02616,-7.3,FR117016,CKJGKHXCUDWFDC-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
142052,6w9q,DB01685,-7.3,Topiroxostat,UBVZQGOVTLIHLH-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
126170,6w4h,DB03464,-7.3,Formycin-5'-Monophosphate,PBAHXXBYQACZMA-KSYZLYKTSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
150486,6wiq,DB01471,-7.3,Bolasterone,IVFYLRMMHVYGJH-VLOLGRDOSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
141817,6w9q,DB01406,-7.3,Danazol,POZRVZJJTULAOH-LHZXLZLDSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
6358,6lzg,DB01977,-7.3,6-(N-Phenylcarbamyl)-2-Naphthalenecarboxamidine,AECPTICWHONWNW-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
165808,7bv1,DB13046,-7.3,Tocladesine,CLLFEJLEDNXZNR-UUOKFMHZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
125755,6w4h,DB02905,-7.3,"Phosphoric Acid Mono-[3,4-Dihydroxy-5-(5-Hydroxy-Benzoimidazol-1-Yl)Tetrahydro-Furan-2-Ylmethyl] Ester",BVZASCINAVSQNO-PULFBKJNSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
114819,6vxx,DB14921,-7.3,Mavacamten,RLCLASQCAPXVLM-NSHDSACASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
5503,6lzg,HMDB0059986,-7.3,"5-(3',4',5'-Trihydroxyphenyl)-gamma-valerolactone-4'-O-glucuronide",ATYNVCXMADLPJQ-YSVLGHOVSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
144697,6w9q,DB06166,-7.3,Fosdevirine,CGBYTKOSZYQOPV-CCEZBSFNSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
115130,6w4b,DB00486,-7.3,Nabilone,GECBBEABIDMGGL-RTBURBONSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
152360,6wiq,DB03944,-7.3,"5-[1-(3,4-Dimethoxy-Benzoyl)-1,2,3,4-Tetrahydro-Quinolin-6-Yl]-6-Methyl-3,6-Dihydro-[1,3,4]Thiadiazin-2-One",IZLRMTJLQCLMKF-CYBMUJFWSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
152386,6wiq,DB03982,-7.3,"Compound 5, 2-(Naphthalen-1-Yl-Oxalyl-Amino)-Benzoicacid",WQWCUHJIERBOSM-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
156333,6wiq,DB12937,-7.3,Quercetin-3'-O-phosphate,UWJBYNLLMAPJMM-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
126124,6w4h,DB03396,-7.3,"(E)-(2r,3r,4s,5r)-3,4,5-Trihydroxy-2-Methoxy-8,8-Dimethyl-Non-6-Enoic Acid ((3s,6r)-6-Hydroxy-2-Oxo-Azepan-3-Yl)-Amide",FVBBTOIQETYGOA-SDNORSGYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
7928,6lzg,DB00523,-7.3,Alitretinoin,SHGAZHPCJJPHSC-ZVCIMWCZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
144875,6w9q,DB06620,-7.3,Aplindore,DYJIKHYBKVODAC-ZDUSSCGKSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
165887,7bv1,DB13181,-7.3,Methylbenactyzium,HDAMOICMOAXFLJ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
126085,6w4h,DB03342,-7.3,4-(Acetylamino)-3-Guanidinobenzoic Acid,HIXHCUDMJUERSJ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131356,6w4h,DB13635,-7.3,Tiracizine,KJAMZCVTJDTESW-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
165944,7bv1,DB13275,-7.3,Clorindione,NJDUWAXIURWWLN-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
141965,6w9q,DB01571,-7.3,3-Methylfentanyl,MLQRZXNZHAOCHQ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
157243,6wiq,DB15029,-7.3,AZD-8186,LMJFJIDLEAWOQJ-CQSZACIVSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
126077,6w4h,DB03332,-7.3,"5,6-Cyclic-Tetrahydropteridine",XAZOBOCYEGBXHD-GSVOUGTGSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
129214,6w4h,DB08528,-7.3,"2-AMINO-6-(3,5-DIMETHYLPHENYL)SULFONYLBENZONITRILE",SWGDXLAZBZDUBR-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
156,6lzg,HMDB0003178,-7.3,Heme,KABFMIBPWCXCRK-RGGAHWMASA-L,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
159,6lzg,HMDB0003193,-7.3,Testosterone glucuronide,NIKZPECGCSUSBV-HMAFJQTKSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
114957,6w4b,DB00276,-7.3,Amsacrine,XCPGHVQEEXUHNC-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
132035,6w4h,DB15246,-7.3,Salvianolic acid A,YMGFTDKNIWPMGF-UCPJVGPRSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
132018,6w4h,DB15214,-7.3,BMS-986104,BPMMYKAHRIEVDH-VOQZNFBZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
6254,6lzg,DB00266,-7.3,Dicoumarol,DOBMPNYZJYQDGZ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
157226,6wiq,DB14844,-7.3,ONC-201,VLULRUCCHYVXOH-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
141948,6w9q,DB01554,-7.3,Bolandiol,CMXKUJNZWYTFJN-XFUVECHXSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
114972,6w4b,DB00294,-7.3,Etonogestrel,GCKFUYQCUCGESZ-BPIQYHPVSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
129204,6w4h,DB08515,-7.3,"(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE",YVABESCRHMBHJD-FUQNVFFISA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
30538,6cs2,DB12625,-7.3,Evogliptin,LCDDAGSJHKEABN-MLGOLLRUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
144856,6w9q,DB06581,-7.3,Bevirimat,YJEJKUQEXFSVCJ-WRFMNRASSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
126026,6w4h,DB03262,-7.3,"Al-6619, [2h-Thieno[3,2-E]-1,2-Thiazine-6-Sulfonamide,2-(3-Hydroxyphenyl)-3-(4-Morpholinyl)-, 1,1-Dioxide]",PZLYYZPXSSNGJS-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
157219,6wiq,DB14821,-7.3,Macozinone,BJDZBXGJNBMCAV-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
6323,6lzg,DB00275,-7.3,Olmesartan,VTRAEEWXHOVJFV-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
165882,7bv1,DB13169,-7.3,Nandrolone,NPAGDVCDWIYMMC-IZPLOLCNSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
129591,6w4h,DB09008,-7.3,Cefaloridine,CZTQZXZIADLWOZ-CRAIPNDOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
132094,6w4h,DB15360,-7.3,"Carfentanil, C-11",YDSDEBIZUNNPOB-JVVVGQRLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
144737,6w9q,DB06249,-7.3,Arzoxifene,MCGDSOGUHLTADD-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
129569,6w4h,DB08984,-7.3,Etofenamate,XILVEPYQJIOVNB-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
30514,6cs2,DB12587,-7.3,Razupenem,XFGOMLIRJYURLQ-GOKYHWASSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
29554,6cs2,DB09371,-7.3,Norethynodrel,ICTXHFFSOAJUMG-SLHNCBLASA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
30596,6cs2,DB12708,-7.3,Sulprostone,UQZVCDCIMBLVNR-TWYODKAFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
150521,6wiq,DB01514,-7.3,Furazabol,RGLLOUBXMOGLDQ-IVEVATEUSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
127101,6w4h,DB04715,-7.3,IMIDAZOPYRIDAZIN 1,IVUBNTNWKIPCPS-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
144744,6w9q,DB06263,-7.3,Amrubicin,VJZITPJGSQKZMX-XDPRQOKASA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
132080,6w4h,DB15335,-7.3,Formononetin,HKQYGTCOTHHOMP-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
144929,6w9q,DB06718,-7.3,Stanozolol,LKAJKIOFIWVMDJ-IYRCEVNGSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
154270,6wiq,DB07680,-7.3,[(1S)-1-(5-CHLORO-1-BENZOTHIEN-3-YL)-2-(2-NAPHTHYLAMINO)-2-OXOETHYL]PHOSPHONIC ACID,HUJXISJLAPAFBO-IBGZPJMESA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
7106,6lzg,DB03235,-7.3,N-{3-[4-(3-aminopropyl)piperazin-1-yl]propyl}-3-(alpha-D-galactopyranosyloxy)-5-nitrobenzamide,UEIGEWJJVQHIAX-MKQKURRLSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
129232,6w4h,DB08547,-7.3,PROGESTERONE-11-ALPHA-OL-HEMISUCCINATE,JBBNFGYRYNBDIH-DBGGZKJISA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
125916,6w4h,DB03121,-7.3,(1-Benzyl-5-methoxy-2-methyl-1H-indol-3-yl)acetic acid,ZEKCBTQHDTUHRJ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
154257,6wiq,DB07665,-7.3,"N-[2-(carbamimidamidooxy)ethyl]-2-{6-cyano-3-[(2,2-difluoro-2-pyridin-2-ylethyl)amino]-2-fluorophenyl}acetamide",STHCHQXQLDMISY-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
144760,6w9q,DB06306,-7.3,Onalespib,IFRGXKKQHBVPCQ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
115018,6w4b,DB00351,-7.3,Megestrol acetate,RQZAXGRLVPAYTJ-GQFGMJRRSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
114910,6vxx,DB15394,-7.3,gamma-Tocopherol,QUEDXNHFTDJVIY-DQCZWYHMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
144948,6w9q,DB06745,-7.3,ginkgolide-C,AMOGMTLMADGEOQ-DTDWCABLSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
144786,6w9q,DB06401,-7.3,Bazedoxifene,UCJGJABZCDBEDK-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
144939,6w9q,DB06733,-7.3,Bafilomycin A1,XDHNQDDQEHDUTM-JQWOJBOSSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
152329,6wiq,DB03903,-7.3,Tmr,KGFLZYXDJDOIEE-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
114767,6vxx,DB14808,-7.3,Lumicitabine,MJVKYGMNSQJLIN-KYZVSKTDSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
141805,6w9q,DB01380,-7.3,Cortisone acetate,ITRJWOMZKQRYTA-RFZYENFJSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
126216,6w4h,DB03526,-7.3,AL5927,LRRAIRJIZOLGPR-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
30736,6cs2,DB12906,-7.3,LY-2334737,MEOYFIHNRBNEPI-UXIGCNINSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
29451,6cs2,DB09202,-7.3,Cirazoline,YAORIDZYZDUZCM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
115322,6w4b,DB00719,-7.3,Azatadine,SEBMTIQKRHYNIT-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
132225,6w9c,DB00175,-7.3,Pravastatin,TUZYXOIXSAXUGO-PZAWKZKUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
150775,6wiq,DB01831,-7.3,Tryptophanyl-5'amp,IFQVDHDRFCKAAW-SQIXAUHQSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
129105,6w4h,DB08397,-7.3,6-(DIFLUORO-PHOSPHONO-METHYL)-NAPHTHALENE-2-CARBOXYLIC ACID,NKGNOWNPXBURRW-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
37057,1r42,DB03768,-7.3,"N-[2-Hydroxy-2-(8-Isopropyl-6,9-Dioxo-2-Oxa-7,10-Diaza-Bicyclo[11.2.2]Heptadeca-1(16),13(17),14-Trien-11-Yl)-Ethyl]-N-(3-Methyl-Butyl)-Benzenesulfonamide,Inhibitor 3",WRUVOSYKHXGAQN-GKRYNVPLSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
129111,6w4h,DB08403,-7.3,METHYLAMINO-PHENYLALANYL-LEUCYL-HYDROXAMIC ACID,MOPRTFSMCQNUCT-CABCVRRESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131884,6w4h,DB14917,-7.3,Ceralasertib,DTTJKLNXNZAVSM-JYCIKRDWSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
129555,6w4h,DB08968,-7.3,Fominoben,KSNNEUZOAFRTDS-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
29602,6cs2,DB11160,-7.3,Phenyltoloxamine,IZRPKIZLIFYYKR-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
114633,6vxx,DB13921,-7.3,2'-C-methylcytidine,PPUDLEUZKVJXSZ-VPCXQMTMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165715,7bv1,DB12704,-7.3,Spiradoline,NYKCGQQJNVPOLU-ONTIZHBOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
166103,7bv1,DB13689,-7.3,Tacalcitol,BJYLYJCXYAMOFT-RSFVBTMBSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
129283,6w4h,DB08610,-7.3,N-(2-AMINOETHYL)-2-{3-CHLORO-4-[(4-ISOPROPYLBENZYL)OXY]PHENYL} ACETAMIDE,DFXJYVQAAFOZDP-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
115266,6w4b,DB00656,-7.3,Trazodone,PHLBKPHSAVXXEF-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
131306,6w4h,DB13564,-7.3,Zipeprol,VSTNNAYSCJQCQI-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
154366,6wiq,DB07792,-7.3,"(S)-2-CHLORO-N-(1-(2-(2-HYDROXYETHYLAMINO)-2-OXOETHYL)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL)-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE",VUKPNWLGSLOHIF-AWEZNQCLSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
154186,6wiq,DB07578,-7.3,"3-[4-(2-METHYL-IMIDAZO[4,5-C]PYRIDIN-1-YL)BENZYL]-3H-BENZOTHIAZOL-2-ONE",WUOLYUKMMRCXGH-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
127084,6w4h,DB04693,-7.3,"(13S)-13-METHYLDODECAHYDRO-1H-CYCLOPENTA[A]PHENANTHRENE-3,17(2H,4H)-DIONE",CRDKSBHJIGNEOH-IMRIKWHGSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
30413,6cs2,DB12445,-7.3,Nitroaspirin,IOJUJUOXKXMJNF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
144604,6w9q,DB05608,-7.3,MKC-1,OVSKGTONMLKNPZ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
165707,7bv1,DB12687,-7.3,Vesatolimod,VFOKSTCIRGDTBR-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
126268,6w4h,DB03608,-7.3,Diminazene,XNYZHCFCZNMTFY-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
115334,6w4b,DB00735,-7.3,Naftifine,OZGNYLLQHRPOBR-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
47194,2fxp,DB01501,-7.3,Difenoxin,UFIVBRCCIRTJTN-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
131836,6w4h,DB14820,-7.3,Profoxydim,KRQUFUKTQHISJB-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
129677,6w4h,DB09172,-7.3,Brifentanil,KKMGCTVJCQYQPV-WBVHZDCISA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
157441,6wiq,DB06497,-7.3,Aplaviroc,GWNOTCOIYUNTQP-FQLXRVMXSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
154382,6wiq,DB07809,-7.3,4-({[4-(3-METHYLBENZOYL)PYRIDIN-2-YL]AMINO}METHYL)BENZENECARBOXIMIDAMIDE,MBJYEMUMDMGQQC-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
114584,6vxx,DB13822,-7.3,Meprotixol,LAYVFLWAVIGDLK-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
131365,6w4h,DB13649,-7.3,Proquazone,JTIGKVIOEQASGT-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
152444,6wiq,DB04064,-7.3,Nogalaviketone,QHNJNOBWURJIEK-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
131857,6w4h,DB14867,-7.3,Parsaclisib,ZQPDJCIXJHUERQ-QWRGUYRKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
114592,6vxx,DB13835,-7.3,Caroverine,MSPRUJDUTKRMLM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
115347,6w4b,DB00751,-7.3,Epinastine,WHWZLSFABNNENI-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
141684,6w9q,DB01177,-7.3,Idarubicin,XDXDZDZNSLXDNA-TZNDIEGXSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
125471,6w4h,DB02527,-7.3,Cyclic adenosine monophosphate,IVOMOUWHDPKRLL-KQYNXXCUSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
129670,6w4h,DB09151,-7.3,Flutemetamol (18F),VVECGOCJFKTUAX-HUYCHCPVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
144564,6w9q,DB05422,-7.3,OPC-14523,TZZGTNZBLPCBIS-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
131364,6w4h,DB13648,-7.3,Alcuronium,MUQUYTSLDVKIOF-CHJKCJHBSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
165683,7bv1,DB12654,-7.3,GSK-376501,OIDYMQICWGYEDR-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
127074,6w4h,DB04678,-7.3,H TYPE II TRISACCHARIDE,PHTAQVMXYWFMHF-QVPNGJTFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
157417,6wiq,DB15362,-7.3,LSZ-102,SJXNPGGVGZXKKI-NYYWCZLTSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
166115,7bv1,DB13710,-7.3,Metenolone,ANJQEDFWRSLVBR-VHUDCFPWSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
126323,6w4h,DB03687,-7.3,4-Diphosphocytidyl-2-C-Methyl-D-Erythritol,YFAUKWZNPVBCFF-XHIBXCGHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
157412,6wiq,DB15356,-7.3,SLV-334,LOFDNSDPZTVIIO-VPUSJEBWSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
125503,6w4h,DB02569,-7.3,"2',3'-Dehydro-2',3'-Deoxy-Thymidine 5'-Diphosphate",LXCAIISEDMYORY-JGVFFNPUSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
114597,6vxx,DB13840,-7.3,Hydroxyethylpromethazine,PDSVTRQOBUIQBQ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114324,6vxx,DB13294,-7.3,Azidamfenicol,SGRUZFCHLOFYHZ-MWLCHTKSSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
125567,6w4h,DB02656,-7.3,LY-294002,CZQHHVNHHHRRDU-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
30421,6cs2,DB12461,-7.3,GLPG-0492,VAJGULUVTFDTAS-GOSISDBHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
30439,6cs2,DB12480,-7.3,Betulinic Acid,QGJZLNKBHJESQX-FZFNOLFKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
131927,6w4h,DB15038,-7.3,Litoxetine,MJJDYOLPMGIWND-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131314,6w4h,DB13579,-7.3,Mepixanox,PYSOHOOUXFWCFF-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
6987,6lzg,DB03039,-7.3,"4-(Aminosulfonyl)-N-[(2,5-Difluorophenyl)Methyl]-Benzamide",KEGUALXMKQVDIO-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
131934,6w4h,DB15052,-7.3,Ansofaxine,QKYBZJLEMOZFFU-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
30677,6cs2,DB12825,-7.3,Lefamulin,KPVIXBKIJXZQJX-FCEONZPQSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
144641,6w9q,DB05838,-7.3,OPC-51803,INGXCNVWWKKWOO-LJQANCHMSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
157155,6wiq,DB14669,-7.3,Betamethasone phosphate,VQODGRNSFPNSQE-DVTGEIKXSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
142193,6w9q,DB01871,-7.3,[1-(1-Benzyl-3-Hydroxy-2-Oxo-Propylcarbamoyl)-2-Phenyl-Ethyl]-Carbamic Acid Benzyl Ester,OACUXIVGLLCILS-ZEQRLZLVSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
129141,6w4h,DB08442,-7.3,"4-{[(2R)-2-(2-methylphenyl)pyrrolidin-1-yl]carbonyl}benzene-1,3-diol",TWODFUZHWYZBHZ-MRXNPFEDSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
157140,6wiq,DB14653,-7.3,Clocortolone caproate,MMTRTBFDFNRBQO-ANHDKODLSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
157358,6wiq,DB15247,-7.3,Vorolanib,KMIOJWCYOHBUJS-HAKPAVFJSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
157159,6wiq,DB14673,-7.3,Flurandrenolide acetate,AUDPKCCPWYXNEV-XTLNBZDDSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
165746,7bv1,DB12745,-7.3,GSK-690693,KGPGFQWBCSZGEL-ZDUSSCGKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
166031,7bv1,DB13600,-7.3,Deltamethrin,OWZREIFADZCYQD-NSHGMRRFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
114752,6vxx,DB14772,-7.3,DCFBC F-18,IDTMSHGCAZPVLC-STUNTBJNSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
131938,6w4h,DB15058,-7.3,Flutemetamol,VVECGOCJFKTUAX-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
166023,7bv1,DB13587,-7.3,Mesterolone,UXYRZJKIQKRJCF-TZPFWLJSSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
154300,6wiq,DB07716,-7.3,"(4Z)-2,8:7,12:11,15:14,18:17,22-PENTAANHYDRO-4,5,6,9,10,13,19,20,21-NONADEOXY-D-ARABINO-D-ALLO-D-ALLO-DOCOSA-4,9,20-TRIENITOL",VDRIXSJOPKVWKM-HXGIDPQASA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
30461,6cs2,DB12515,-7.3,9-aminocamptothecin,FUXVKZWTXQUGMW-FQEVSTJZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
29475,6cs2,DB09227,-7.3,Barnidipine,VXMOONUMYLCFJD-DHLKQENFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
144650,6w9q,DB05913,-7.3,OSI-930,FGTCROZDHDSNIO-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
157355,6wiq,DB15242,-7.3,MK-0533,STWITCBWQHTJFJ-XMMPIXPASA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
115253,6w4b,DB00637,-7.3,Astemizole,GXDALQBWZGODGZ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
129623,6w4h,DB09062,-7.3,Cefminox,JSDXOWVAHXDYCU-VXSYNFHWSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
157360,6wiq,DB15254,-7.3,RO-5126766 free base,LMMJFBMMJUMSJS-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
157122,6wiq,DB14634,-7.3,Fluprednidene acetate,DEFOZIFYUBUHHU-IYQKUMFPSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
129650,6w4h,DB09101,-7.3,Elvitegravir,JUZYLCPPVHEVSV-LJQANCHMSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
166076,7bv1,DB13660,-7.3,Propicillin,HOCWPKXKMNXINF-XQERAMJGSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
129645,6w4h,DB09091,-7.3,Tixocortol,YWDBSCORAARPPF-VWUMJDOOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
115239,6w4b,DB00621,-7.3,Oxandrolone,QSLJIVKCVHQPLV-PEMPUTJUSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
132159,6w4h,DB08775,-7.3,Nalpha-[(Benzyloxy)carbonyl]-N-[(2S)-4-fluoro-3-oxo-2-butanyl]-L-tyrosinamide,RYABQRLJLIHDIP-KSSFIOAISA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
141749,6w9q,DB01254,-7.3,Dasatinib,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
125609,6w4h,DB02711,-7.3,"4-{2,6,8-Trioxo-9-[(2S,3R,4R)-2,3,4,5-Tetrahydroxypentyl]-1,2,3,6,8,9-Hexahydro-7h-Purin-7-Yl}Butyl Dihydrogen Phosphate",VBXZSBKAJFXURR-QXFUBDJGSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
166068,7bv1,DB13649,-7.3,Proquazone,JTIGKVIOEQASGT-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
141752,6w9q,DB01260,-7.3,Desonide,WBGKWQHBNHJJPZ-LECWWXJVSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
129633,6w4h,DB09076,-7.3,Umeclidinium,FVTWTVQXNAJTQP-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
8051,6lzg,DB04704,-7.3,20-hydroxycholesterol,MCKLJFJEQRYRQT-MGNSQDQZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
115226,6w4b,DB00605,-7.3,Sulindac,MLKXDPUZXIRXEP-MFOYZWKCSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
125639,6w4h,DB02755,-7.3,1-3 Sugar Ring of Pentamannosyl 6-Phosphate,HDQMHAJOIVYOIP-NAVBLJQLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
157133,6wiq,DB14646,-7.3,Prednisone acetate,MOVRKLZUVNCBIP-RFZYENFJSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
150427,6wiq,DB01405,-7.3,Temafloxacin,QKDHBVNJCZBTMR-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
150439,6wiq,DB01419,-7.3,Antrafenine,NWGGKKGAFZIVBJ-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
125672,6w4h,DB02802,-7.3,5-Aminocarbonyl-3-Nitrophenyl-Alpha-D-Galactopyranose,BYSXBFJVGIOFBO-LNSPPBFMSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
125679,6w4h,DB02809,-7.3,"Brodimoprim-4,6-Dicarboxylate",SZAVCZNFKJSWRN-LBPRGKRZSA-M,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
115204,6w4b,DB00580,-7.3,Valdecoxib,LNPDTQAFDNKSHK-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
153907,6wiq,DB07255,-7.3,"N'-(5-CHLORO-1,3-BENZODIOXOL-4-YL)-N-(3-MORPHOLIN-4-YLPHENYL)PYRIMIDINE-2,4-DIAMINE",PNEWIQAEGKQNCE-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
30684,6cs2,DB00978,-7.3,Lomefloxacin,ZEKZLJVOYLTDKK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
115232,6w4b,DB00611,-7.3,Butorphanol,IFKLAQQSCNILHL-PWRODBHTSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
115862,6w4b,DB01420,-7.3,Testosterone propionate,PDMMFKSKQVNJMI-BLQWBTBKSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
29649,6cs2,DB11336,-7.3,Kinetin,QANMHLXAZMSUEX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
7117,6lzg,DB03251,-7.3,RWJ-51084,NQABUEUFRXDDFI-AWEZNQCLSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
128865,6w4h,DB08105,-7.3,N-[(6-butoxynaphthalen-2-yl)sulfonyl]-L-glutamic acid,UAGYXJBYAFGRFR-KRWDZBQOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
128919,6w4h,DB08162,-7.3,Fasudil,NGOGFTYYXHNFQH-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
124783,6w4h,DB01623,-7.3,Thiothixene,GFBKORZTTCHDGY-UWVJOHFNSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
126990,6w4h,DB04566,-7.3,Inosinic Acid,GRSZFWQUAKGDAV-KQYNXXCUSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
156414,6wiq,DB13062,-7.3,ME-344,QVCAATSEPLQVBX-FPOVZHCZSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
124781,6w4h,DB01621,-7.3,Pipotiazine,JOMHSQGEWSNUKU-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
156494,6wiq,DB13215,-7.3,Sulfobromophthalein,OHTXTCNTQJFRIG-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
37173,1r42,DB03916,-7.3,4-{2-[4-(2-Aminoethyl)Piperazin-1-Yl]Pyridin-4-Yl}-N-(3-Chloro-4-Methylphenyl)Pyrimidin-2-Amine,RHOOHUMOHVIXEF-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
166480,7bv1,DB15212,-7.3,Pemafibrate,ZHKNLJLMDFQVHJ-RUZDIDTESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
132728,6w9c,DB00782,-7.3,Propantheline,VVWYOYDLCMFIEM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
132725,6w9c,DB00777,-7.3,Propiomazine,UVOIBTBFPOZKGP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
114238,6vxx,DB13143,-7.3,Methallenestril,KHLJKRBMZVNZOC-MRXNPFEDSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
132646,6w9c,DB00684,-7.3,Tobramycin,NLVFBUXFDBBNBW-PBSUHMDJSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
51751,2fxp,DB08553,-7.3,"(1E)-5-(1-piperidin-4-yl-3-pyridin-4-yl-1H-pyrazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime",KWEFZSZCLBHIEQ-YYADALCUSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
124713,6w4h,DB01541,-7.3,Boldenone,RSIHSRDYCUFFLA-DYKIIFRCSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
153828,6wiq,DB07162,-7.3,4-(3-amino-1H-indazol-5-yl)-N-tert-butylbenzenesulfonamide,KFJCXIOVAGJCKB-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
157934,6wiq,DB14929,-7.3,Elsulfavirine,ULTDEARCBRNRGR-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
149672,6wiq,DB00443,-7.3,Betamethasone,UREBDLICKHMUKA-DVTGEIKXSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
128795,6w4h,DB08024,-7.3,1-[2-(S)-AMINO-3-BIPHENYL-4-YL-PROPIONYL]-PYRROLIDINE-2-(S)-CARBONITRILE,MUUVLSCVDXKQQV-OALUTQOASA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
6204,6lzg,DB01720,-7.3,(2z)-2-(Benzoylamino)-3-[4-(2-Bromophenoxy)Phenyl]-2-Propenoic Acid,WLPJLQNKCJWAFL-RGEXLXHISA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
37181,1r42,DB03926,-7.3,"5-Alpha-Androstane-3-Beta,17-Alpha-Diol",CBMYJHIOYJEBSB-MFXFBURESA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
143180,6w9q,DB03181,-7.3,"2-[4-(4-Hydroxy-3-Isopropyl-Phenoxy)-3,5-Dimethyl-Phenyl]-2h-[1,2,4]Triazine-3,5-Dione",RXQAVKWRCZYGMV-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
143184,6w9q,DB03186,-7.3,U-Pi-a-Pi,JIAJERGOUFOENU-LNAOLWRRSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
35503,1r42,DB01689,-7.3,Inhibitor Idd 384,CJKKMQCZOLCXAM-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
47050,2fxp,DB01267,-7.3,Paliperidone,PMXMIIMHBWHSKN-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
157808,6wiq,DB12858,-7.3,LY-377604,RBSGUQYXRDKPAE-QFIPXVFZSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
31229,6cs2,DB13563,-7.3,Norgestrienone,GVDMJXQHPUYPHP-FYQPLNBISA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
116150,6w4b,DB01768,-7.3,Methylumbelliferyl Sialic Acid,KKDWIUJBUSOPGC-GKHMPSLRSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
166556,7bv1,DB15359,-7.3,Xanthohumol,ORXQGKIUCDPEAJ-YRNVUSSQSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
154527,6wiq,DB07977,-7.3,"3-({[3,5-DIFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)THIOPHENE-2-CARBOXYLIC ACID",CGNHUSCKOHDSMR-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
124707,6w4h,DB01535,-7.3,Carfentanil,YDSDEBIZUNNPOB-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
157998,6wiq,DB15456,-7.3,Vericiguat,QZFHIXARHDBPBY-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
157931,6wiq,DB14918,-7.3,Branaplam,STWTUEAWRAIWJG-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
124792,6w4h,DB01633,-7.3,Deoxy-2-fluoro-beta-D-cellotrioside,BZNXZJAUEMJQJB-QSCMNUSVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
143424,6w9q,DB03507,-7.3,"6-[3-(4-Morpholinyl)Propyl]-2-(3-Nitrophenyl)-5-Thioxo-5,6,-Dihydro-7h-Thienol[2',3':4,5]Pyrrolo[1,2-C]Imidazol-7-One",UXGUZFZBZPPZGL-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
114138,6vxx,DB12791,-7.3,Laninamivir,QNRRHYPPQFELSF-CNYIRLTGSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31266,6cs2,DB13611,-7.3,Chlormidazole,WNAQOLSMVPFGTE-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
8263,6lzg,DB05076,-7.3,Fenretinide,AKJHMTWEGVYYSE-FXILSDISSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
124698,6w4h,DB01526,-7.3,4-Androstenediol,BTTWKVFKBPAFDK-LOVVWNRFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
29861,6cs2,DB11736,-7.3,PF-00489791,ZUHZNKJIJDAJFD-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
127281,6w4h,DB05047,-7.3,CX717,KFRQROSRKSVROW-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
152712,6wiq,DB04424,-7.3,RPR128515,XFKVLKLCLYJKNF-MZNJEOGPSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
132638,6w9c,DB00675,-7.3,Tamoxifen,NKANXQFJJICGDU-QPLCGJKRSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
154081,6wiq,DB07453,-7.3,2-PHENYL-4H-BENZO[H]CHROMEN-4-ONE,VFMMPHCGEFXGIP-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
166477,7bv1,DB15207,-7.3,Esaxerenone,NOSNHVJANRODGR-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
31189,6cs2,DB13514,-7.3,Pranoprofen,TVQZAMVBTVNYLA-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
131478,6w4h,DB13795,-7.3,Brodimoprim,BFCRRLMMHNLSCP-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
8209,6lzg,DB04891,-7.3,Becocalcidiol,QSLUXQQUPXBIHH-YHSKWIAJSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
131497,6w4h,DB13821,-7.3,Ceftezole,DZMVCVMFETWNIU-LDYMZIIASA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
132730,6w9c,DB00784,-7.3,Mefenamic acid,HYYBABOKPJLUIN-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
154524,6wiq,DB07974,-7.3,1-{2-[(4-CHLOROPHENYL)AMINO]-2-OXOETHYL}-N-(1-ISOPROPYLPIPERIDIN-4-YL)-1H-INDOLE-2-CARBOXAMIDE,BDLMBQRBNPDCSS-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
124703,6w4h,DB01531,-7.3,Desomorphine,LNNWVNGFPYWNQE-GMIGKAJZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
153811,6wiq,DB07142,-7.3,"5-[(3R)-3-(5-methoxy-3',5'-dimethylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",ATFDKOLABYIYCC-INIZCTEOSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
29855,6cs2,DB11729,-7.3,GSK-2330672,CZGVOBIGEBDYTP-VSGBNLITSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
114036,6vxx,DB12629,-7.3,"3,5-diiodothyropropionic acid",WONYMNWUJVKVII-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
151718,6wiq,DB03082,-7.3,6-[(Z)-Amino(Imino)Methyl]-N-[4-(Aminomethyl)Phenyl]-4-(Pyrimidin-2-Ylamino)-2-Naphthamide,CSWQJKHBMACTGB-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
116508,6w4b,DB02253,-7.3,"(1r)-4-[(1e,3e,5e,7z,9e,11z,13e,15e)-17-Hydroxy-3,7,12,16-Tetramethylheptadeca-1,3,5,7,9,11,13,15-Octaen-1-Yl]-3,5,5-Trimethylcyclohex-3-En-1-Ol",FNAJVVMDXCOSFY-VFGOXHQXSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
30090,6cs2,DB12041,-7.3,Mapracorat,VJGFOYBQOIPQFY-XMMPIXPASA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
6294,6lzg,DB01871,-7.3,[1-(1-Benzyl-3-Hydroxy-2-Oxo-Propylcarbamoyl)-2-Phenyl-Ethyl]-Carbamic Acid Benzyl Ester,OACUXIVGLLCILS-ZEQRLZLVSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
156725,6wiq,DB13606,-7.3,Phenazocine,ZQHYKVKNPWDQSL-KNXBSLHKSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
156744,6wiq,DB13631,-7.3,Methoserpidine,ULBNWNUHGJLQHO-VKMIBBQISA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
31230,6cs2,DB13564,-7.3,Zipeprol,VSTNNAYSCJQCQI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
114154,6vxx,DB12818,-7.3,NM-3,BPZCXUROMKDLGX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
143817,6w9q,DB04040,-7.3,"N-(2-Morpholin-4-Yl-1-Morpholin-4-Ylmethyl-Ethyl)-3-Nitro-5-(3,4,5-Trihydroxy-6-Hydroxymethyl-Tetrahydro-Pyran-2-Yloxy)-Benzamide",MCMWCTMAKPQTPI-WGNYYXNJSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
153826,6wiq,DB07159,-7.3,Tamatinib,NHHQJBCNYHBUSI-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
157963,6wiq,DB15391,-7.3,Elenbecestat,AACUJFVOHGRMTR-DPXNYUHVSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
165160,7bv1,DB11442,-7.3,Oleandomycin,RZPAKFUAFGMUPI-QESOVKLGSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
132798,6w9c,DB00861,-7.3,Diflunisal,HUPFGZXOMWLGNK-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
114210,6vxx,DB13097,-7.3,1alpha-Hydroxyvitamin D5,NWFOBODUYTUMNC-VPSCEVSQSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30056,6cs2,DB11994,-7.3,Diacerein,TYNLGDBUJLVSMA-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
144092,6w9q,DB04409,-7.3,Naphthalene Trisulfonate,ZPBSAMLXSQCSOX-UHFFFAOYSA-K,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
154551,6wiq,DB08005,-7.3,4-{[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino}-N-ethylpiperidine-1-carboxamide,ARMFMDYRYOKSOW-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
156188,6wiq,DB12540,-7.3,Lecozotan,NRPQELCNMADTOZ-OAQYLSRUSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
124743,6w4h,DB01571,-7.3,3-Methylfentanyl,MLQRZXNZHAOCHQ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
126755,6w4h,DB04248,-7.3,beta-(1->4)-galactotriose,FYGDTMLNYKFZSV-XJJKTWKOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131507,6w4h,DB13836,-7.3,Metampicillin,FZECHKJQHUVANE-MCYUEQNJSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
157940,6wiq,DB14937,-7.3,MK-8666,CODQKEMYZZKQAE-QPVYNBJUSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
116053,6w4b,DB01640,-7.3,"(5r)-6-(4-{[2-(3-Iodobenzyl)-3-Oxocyclohex-1-En-1-Yl]Amino}Phenyl)-5-Methyl-4,5-Dihydropyridazin-3(2h)-One",QNURTFDBHAQRSI-OAHLLOKOSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
29822,6cs2,DB11682,-7.3,Daprodustat,RUEYEZADQJCKGV-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
126953,6w4h,DB04520,-7.3,"(3s,8ar)-3-(4-Hydroxybenzyl)Hexahydropyrrolo[1,2-a]Pyrazine-1,4-Dione",LSGOTAXPWMCUCK-RYUDHWBXSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
143589,6w9q,DB03744,-7.3,"Cp403700, (S)-1-{2-[(5-Chloro-1h-Indole-2-Carbonyl)-Amino]-3-Phenyl-Propionyl}-Azetidine-3-Carboxylate",RONLONYAIBUEKT-IBGZPJMESA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
151791,6wiq,DB03181,-7.3,"2-[4-(4-Hydroxy-3-Isopropyl-Phenoxy)-3,5-Dimethyl-Phenyl]-2h-[1,2,4]Triazine-3,5-Dione",RXQAVKWRCZYGMV-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
165259,7bv1,DB11672,-7.3,Curcumin,VFLDPWHFBUODDF-FCXRPNKRSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
114193,6vxx,DB12883,-7.3,Eltoprazine,WVLHGCRWEHCIOT-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
144066,6w9q,DB04373,-7.3,"4-Amino-N-{4-[2-(2,6-Dimethyl-Phenoxy)-Acetylamino]-3-Hydroxy-1-Isobutyl-5-Phenyl-Pentyl}-Benzamide",WQUBEIMCFHCJCO-AWCRTANDSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
29332,6cs2,DB09016,-7.3,Butriptyline,ALELTFCQZDXAMQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
8212,6lzg,DB04898,-7.3,Ximelagatran,ZXIBCJHYVWYIKI-PZJWPPBQSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
116408,6w4b,DB02115,-7.3,Daidzin,KYQZWONCHDNPDP-QNDFHXLGSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
124754,6w4h,DB01587,-7.3,Ketazolam,PWAJCNITSBZRBL-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
154576,6wiq,DB08031,-7.3,"N-[(13-CYCLOHEXYL-6,7-DIHYDROINDOLO[1,2-D][1,4]BENZOXAZEPIN-10-YL)CARBONYL]-2-METHYL-L-ALANINE",LNQWELVSNCYKDU-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
141076,6w9q,DB00459,-7.3,Acitretin,IHUNBGSDBOWDMA-AQFIFDHZSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
124764,6w4h,DB01602,-7.3,Bacampicillin,PFOLLRNADZZWEX-FFGRCDKISA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
114173,6vxx,DB12853,-7.3,DA-6886,AULLTYAISZREAX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
132671,6w9c,DB00712,-7.3,Flurbiprofen,SYTBZMRGLBWNTM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
124723,6w4h,DB01551,-7.3,Dihydrocodeine,RBOXVHNMENFORY-DNJOTXNNSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
157973,6wiq,DB15407,-7.3,Acalisib,DOCINCLJNAXZQF-LBPRGKRZSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
128905,6w4h,DB08148,-7.3,"1-[4-(4-chlorophenyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine",QOZMRRGNAZNWDN-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
36170,1r42,DB02567,-7.3,PD173955,VAARYSWULJUGST-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
154084,6wiq,DB07456,-7.3,"3-(1H-indol-3-yl)-4-(1-{2-[(2S)-1-methylpyrrolidinyl]ethyl}-1H-indol-3-yl)-1H-pyrrole-2,5-dione",LBFDERUQORUFIN-QGZVFWFLSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
31126,6cs2,DB13437,-7.3,Medazepam,YLCXGBZIZBEVPZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
131451,6w4h,DB13760,-7.3,Niperotidine,HXRSXEDVVARPHP-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
165282,7bv1,DB11702,-7.3,Antineoplaston A10,OQGRFQCUGLKSAV-JTQLQIEISA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
128769,6w4h,DB07996,-7.3,5-(2-methylpiperazine-1-sulfonyl)isoquinoline,BDVFVCGFMNCYPV-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
157811,6wiq,DB12867,-7.3,Benperidol,FEBOTPHFXYHVPL-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
116466,6w4b,DB02197,-7.3,"4-[(4-Imidazo[1,2-a]Pyridin-3-Ylpyrimidin-2-Yl)Amino]Benzenesulfonamide",NKORVPQBJCGYEC-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
36127,1r42,DB02510,-7.3,'5'-O-(N-(L-Prolyl)-Sulfamoyl)Adenosine,LKVJEMXWEODCAY-JVEUSOJLSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
31232,6cs2,DB13571,-7.3,Pentamycin,AGJUUQSLGVCRQA-SWOUQTJZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
115991,6w4b,DB01564,-7.3,Calusterone,IVFYLRMMHVYGJH-PVPPCFLZSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
131560,6w4h,DB13944,-7.3,Testosterone enanthate,VOCBWIIFXDYGNZ-IXKNJLPQSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
156109,6wiq,DB12420,-7.3,Diazepinomicin,SALVHVNECODMJP-GNUCVDFRSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
128775,6w4h,DB08004,-7.3,"(2S)-2-{[3-(3-aminophenyl)imidazo[1,2-b]pyridazin-6-yl]amino}-3-methylbutan-1-ol",PUMVONFFLKPPIM-CQSZACIVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
157969,6wiq,DB15401,-7.3,Danicopan,PIBARDGJJAGJAJ-NQIIRXRSSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
166537,7bv1,DB15325,-7.3,ONO-8539,ALLLQQUASFFEKP-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
116362,6w4b,DB02058,-7.3,SU4984,AZGZGRJOCKSSHA-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
154579,6wiq,DB08034,-7.3,"(E)-3,4-DIHYDROXY-N'-[(2-METHOXYNAPHTHALEN-1-YL)METHYLENE]BENZOHYDRAZIDE",TVOPERZEGKBKAY-RGVLZGJSSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
157829,6wiq,DB12890,-7.3,Dihydrexidine,BGOQGUHWXBGXJW-YOEHRIQHSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
144047,6w9q,DB04345,-7.3,Lumichrome,ZJTJUVIJVLLGSP-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
152661,6wiq,DB04348,-7.3,Taurocholic Acid,WBWWGRHZICKQGZ-HZAMXZRMSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
151432,6wiq,DB02698,-7.3,"N-(M-Trifluoromethylphenyl) Phenoxazine-4,6-Dicarboxylic Acid",NQOOJFXBGLOGTC-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
124767,6w4h,DB01605,-7.3,Pivmecillinam,NPGNOVNWUSPMDP-HLLBOEOZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
151503,6wiq,DB02799,-7.3,N-[2-(1-Maleimidyl)Ethyl]-7-Diethylaminocoumarin-3-Carboxamide,OJBZDUMTXGGVSP-KTKRTIGZSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
129924,6w4h,DB11426,-7.3,Marbofloxacin,BPFYOAJNDMUVBL-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
156623,6wiq,DB13463,-7.3,Oxetorone,VZVRZTZPHOHSCK-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
114027,6vxx,DB12615,-7.3,Plazomicin,IYDYFVUFSPQPPV-PEXOCOHZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
8306,6lzg,DB05298,-7.3,Tetomilast,XDBHURGONHZNJF-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
131425,6w4h,DB13724,-7.3,Nifuratel,SRQKTCXJCCHINN-NYYWCZLTSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
126904,6w4h,DB04460,-7.3,(C8-S)-Hydantocidin 5'-Phosphate,MAXSFYCTFIBEAR-FUIMDIGMSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
8165,6lzg,DB04839,-7.3,Cyproterone acetate,UWFYSQMTEOIJJG-FDTZYFLXSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
153845,6wiq,DB07181,-7.3,"4'-[(1R)-1-amino-2-(2,5-difluorophenyl)ethyl]biphenyl-3-carboxamide",JYKFWUXBFJJDTP-HXUWFJFHSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
124849,6w4h,DB01708,-7.3,Prasterone,FMGSKLZLMKYGDP-USOAJAOKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
144220,6w9q,DB04576,-7.3,Fleroxacin,XBJBPGROQZJDOJ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
143937,6w9q,DB04196,-7.3,Pteroic Acid,JOAQINSXLLMRCV-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
156093,6wiq,DB12401,-7.3,Bromperidol,RKLNONIVDFXQRX-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
129438,6w4h,DB08791,-7.3,"1-[(2-NITROPHENYL)SULFONYL]-1H-PYRROLO[3,2-B]PYRIDINE-6-CARBOXAMIDE",USLOIFPDNUDIEG-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
129766,6w4h,DB09285,-7.3,Morniflumate,LDXSPUSKBDTEKA-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
149608,6wiq,DB00367,-7.3,Levonorgestrel,WWYNJERNGUHSAO-XUDSTZEESA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
124633,6w4h,DB01450,-7.3,Dihydroetorphine,BRTSNYPDACNMIP-FAWZKKEFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
144245,6w9q,DB04609,-7.3,INHIBITOR Q8467 OF DUPONT MERCK,HFLCERPZYCWLSZ-VKONIRKNSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
129901,6w4h,DB11385,-7.3,Cefalonium,FMZXNVLFJHCSAF-DNVCBOLYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
129770,6w4h,DB09290,-7.3,Ramosetron,NTHPAPBPFQJABD-LLVKDONJSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
154499,6wiq,DB07945,-7.3,"5-(3-carbamoylbenzyl)-5,6,7,8,9,10-hexahydrocyclohepta[b]indole-4-carboxylic acid",GKBQRPKZHUFGOB-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
36065,1r42,DB02431,-7.3,Cytidine-5'-Triphosphate,PCDQPRRSZKQHHS-XVFCMESISA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
36162,1r42,DB02554,-7.3,"Sulfoquinovose-Uridine-C1,5'-Diphosphate",FQANCGQCBCUSMI-JZMIEXBBSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
129909,6w4h,DB11395,-7.3,Deracoxib,WAZQAZKAZLXFMK-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
156149,6wiq,DB12477,-7.3,Perfluoro tert-butylcyclohexane,VLTXBOGHSBHSAC-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
144222,6w9q,DB04578,-7.3,"(S)-2-[(R)-3-amino-4-(2-fluorophenyl)butyryl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide",OEVYDSSAPNIURZ-AEFFLSMTSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
149751,6wiq,DB00543,-7.3,Amoxapine,QWGDMFLQWFTERH-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
165344,7bv1,DB11962,-7.3,GSK-1059615,QDITZBLZQQZVEE-YBEGLDIGSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
29981,6cs2,DB00904,-7.3,Ondansetron,FELGMEQIXOGIFQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
157759,6wiq,DB12774,-7.3,AZD-8055,KVLFRAWTRWDEDF-IRXDYDNUSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
124660,6w4h,DB01479,-7.3,BA-2664,QGKQXZFZOIQFBI-XSWYFRFISA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
29881,6cs2,DB00894,-7.3,Testolactone,BPEWUONYVDABNZ-DZBHQSCQSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
7849,6lzg,DB04461,-7.3,Coproporphyrinogen III,NIUVHXTXUXOFEB-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
165198,7bv1,DB11522,-7.3,Isoflupredone,WAIJIHDWAKJCBX-BULBTXNYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
126888,6w4h,DB04437,-7.3,"Cysteine-Methylene-Carbamoyl-1,10-Phenanthroline",ZFGIPRHDRFOMFO-LBPRGKRZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
151935,6wiq,DB03363,-7.3,3-Acetylpyridine Adenine Dinucleotide,KPVQNXLUPNWQHM-RBEMOOQDSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
129374,6w4h,DB08722,-7.3,5-(7-(6-chloro-4-(5-hydro-4-methyl-2-oxazolyl)phenoxy)heptyl)-3-methyl isoxazole,WOJFAPUTPSWFLJ-INIZCTEOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
116643,6w4b,DB02421,-7.3,Uridine-5'-Diphosphate-Mannose,HSCJRCZFDFQWRP-NYYOCOOHSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
47773,2fxp,DB02258,-7.3,SR11254,RNZIUDLOJHVHLZ-VYIQYICTSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
126700,6w4h,DB04175,-7.3,Mdl-29951,KNBSYZNKEAWABY-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
29986,6cs2,DB11899,-7.3,MK-8776,GMIZZEXBPRLVIV-SECBINFHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
165349,7bv1,DB11967,-7.3,Binimetinib,ACWZRVQXLIRSDF-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
154032,6wiq,DB07396,-7.3,"1-{2-[3-(2-Chloro-4,5-difluoro-benzoyl)-ureido]-4-fluoro-phenyl}-piperidine-4-carboxylic acid",KAJJGOCSAXKXBD-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
90,6lzg,HMDB0002755,-7.3,Myricetin,IKMDFBPHZNJCSN-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
52,6lzg,HMDB0002472,-7.3,"(3a,5b,7a,12a)-24-[(carboxymethyl)amino]-1,12-dihydroxy-24-oxocholan-3-yl-b-D-Glucopyranosiduronic acid",BWWWIHHYPYDOJQ-BSGVGGAOSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
129395,6w4h,DB08743,-7.3,"2-({8-[(3R)-3-AMINOPIPERIDIN-1-YL]-1,3-DIMETHYL-2,6-DIOXO-1,2,3,6-TETRAHYDRO-7H-PURIN-7-YL}METHYL)BENZONITRILE",XJNKUWDMCBZMTG-OAHLLOKOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
115948,6w4b,DB01521,-7.3,Clostebol,KCZCIYZKSLLNNH-FBPKJDBXSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
154605,6wiq,DB08064,-7.3,N-(3-TERT-BUTYL-1H-PYRAZOL-5-YL)-N'-{4-CHLORO-3-[(PYRIDIN-3-YLOXY)METHYL]PHENYL}UREA,NTMADESEDXKNFZ-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
144219,6w9q,DB04575,-7.3,Quinestrol,PWZUUYSISTUNDW-VAFBSOEGSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
128738,6w4h,DB07963,-7.3,"N-[(2',4'-DIFLUORO-4-HYDROXY-5-IODOBIPHENYL-3-YL)CARBONYL]-BETA-ALANINE",YZQVXOZCPWWABX-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
29739,6cs2,DB11507,-7.3,Cloprostenol,VJGGHXVGBSZVMZ-QIZQQNKQSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
143749,6w9q,DB03944,-7.3,"5-[1-(3,4-Dimethoxy-Benzoyl)-1,2,3,4-Tetrahydro-Quinolin-6-Yl]-6-Methyl-3,6-Dihydro-[1,3,4]Thiadiazin-2-One",IZLRMTJLQCLMKF-CYBMUJFWSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
29345,6cs2,DB09039,-7.3,Eliglustat,FJZZPCZKBUKGGU-AUSIDOKSSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
156435,6wiq,DB13094,-7.3,Pruvanserin,AQRLDDAFYYAIJP-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
124896,6w4h,DB01771,-7.3,CRA_10991,QXAURVOBXQBPAP-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
143139,6w9q,DB03124,-7.3,5-[4-(1-Carboxymethyl-2-Oxo-Propylcarbamoyl)-Benzylsulfamoyl]-2-Hydroxy-Benzoic Acid,LBAHOXPDTNUYCX-INIZCTEOSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
114262,6vxx,DB13211,-7.3,Guanoxan,HIUVKVDQFXDZHU-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
131173,6w4h,DB13384,-7.3,Melitracen,GWWLWDURRGNSRS-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
151811,6wiq,DB03207,-7.3,"2-(Biphenyl-4-Sulfonyl)-1,2,3,4-Tetrahydro-Isoquinoline-3-Carboxylic Acid",BNVMUDXGABBWGP-OAQYLSRUSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
31284,6cs2,DB01038,-7.3,Carphenazine,XZSMZRXAEFNJCU-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
132634,6w9c,DB00671,-7.3,Cefixime,OKBVVJOGVLARMR-QSWIMTSFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
132788,6w9c,DB00850,-7.3,Perphenazine,RGCVKNLCSQQDEP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
124793,6w4h,DB01634,-7.3,2-Oxy-4-Hydroxy-5-(2-Hydrazinopyridine)Phenylalanine,AZUQIXJQZOMXAS-BDAKNGLRSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
165183,7bv1,DB11481,-7.3,Atipamezole,HSWPZIDYAHLZDD-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
124639,6w4h,DB01456,-7.3,5-androstenedione,SQGZFRITSMYKRH-QAGGRKNESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
116231,6w4b,DB01876,-7.3,Bis(5-Amidino-2-Benzimidazolyl)Methanone,VVVXDHROXQUONB-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
29719,6cs2,DB11463,-7.3,Sulfanitran,GWBPFRGXNGPPMF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
6456,6lzg,DB00294,-7.3,Etonogestrel,GCKFUYQCUCGESZ-BPIQYHPVSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
154500,6wiq,DB07946,-7.3,"N-[2-({[amino(imino)methyl]amino}oxy)ethyl]-2-{6-chloro-3-[(2,2-difluoro-2-phenylethyl)amino]-2-fluorophenyl}acetamide",DZEJHPMTDNDECN-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
124666,6w4h,DB01485,-7.3,4-Hydroxytestosterone,BQOIJSIMMIDHMO-FBPKJDBXSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
140841,6w9q,DB00180,-7.3,Flunisolide,XSFJVAJPIHIPKU-XWCQMRHXSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
143482,6w9q,DB03596,-7.3,N-[2-(1h-Indol-5-Yl)-Butyl]-4-Sulfamoyl-Benzamide,FSRPBGBMEKDSIJ-CYBMUJFWSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
144218,6w9q,DB04574,-7.3,Estrone sulfate,JKKFKPJIXZFSSB-CBZIJGRNSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
126690,6w4h,DB04164,-7.3,"1,4-Deoxy-4-((5-Hydroxymethyl-2,3,4-Trihydroxycyclohex-5-Enyl)Amino)Fructose",ZGWNRGISVMYHTF-KKXLKBQTSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
154598,6wiq,DB08057,-7.3,"N-(2-chloro-6-methylphenyl)-8-[(3S)-3-methylpiperazin-1-yl]imidazo[1,5-a]quinoxalin-4-amine",VWJPPYCULHDHBB-HNNXBMFYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
140820,6w9q,DB00158,-7.3,Folic acid,OVBPIULPVIDEAO-LBPRGKRZSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
37321,1r42,DB04115,-7.3,Berberine,YBHILYKTIRIUTE-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
128956,6w4h,DB08208,-7.3,"2-[(4-ETHYNYL-2-FLUOROPHENYL)AMINO]-3,4-DIFLUORO-N-(2-HYDROXYETHOXY)BENZAMIDE",AMNKRBRQQAMACZ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
124865,6w4h,DB01732,-7.3,"(4r,5s,6s,7r)-1,3-Dibenzyl-4,7-Bis(Phenoxymethyl)-5,6-Dihydroxy-1,3 Diazepan-2-One",SQBOSZXDOHQFAA-ZRTHHSRSSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
115894,6w4b,DB01456,-7.3,5-androstenedione,SQGZFRITSMYKRH-QAGGRKNESA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
31102,6cs2,DB13411,-7.3,Lofepramine,SAPNXPWPAUFAJU-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
127260,6w4h,DB04954,-7.3,Tecadenoson,OESBDSFYJMDRJY-BAYCTPFLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
156455,6wiq,DB13119,-7.3,GSK-364735,QWLNINWUBHHOLU-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
126713,6w4h,DB04194,-7.3,Chitotriose,WZZVUHWLNMNWLW-VFCSDQTKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
8323,6lzg,DB05421,-7.3,CP-122721,ZIWFCOIGUNPHPM-HKUYNNGSSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
156397,6wiq,DB13036,-7.3,Ramatroban,LDXDSHIEDAPSSA-OAHLLOKOSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
35563,1r42,DB01767,-7.3,Hemi-Babim,KKJYVDXDZURHMA-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
71423,6lxt,DB14208,-7.2,Ramiprilat,KEDYTOTWMPBSLG-HILJTLORSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
103559,6vxs,DB08726,-7.2,"5-(7-(4-(4,5-dihydro-2-oxazolyl)phenoxy)heptyl)-3-methyl isoxazole",FKLJPTJMIBLJAV-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
60731,6crv,DB09028,-7.2,Cytisine,ANJTVLIZGCUXLD-DTWKUNHWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136095,6w9c,DB06530,-7.2,Resiquimod,BXNMTOQRYBFHNZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
71872,6lxt,DB15449,-7.2,Citarinostat,VLIUIBXPEDFJRF-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
94473,6m71,DB08146,-7.2,"7-(2,5-dihydropyrrol-1-yl)-6-phenyl-pyrido[6,5-d]pyrimidin-2-amine",QFWNOFXQNCLFBC-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
11573,6lzg,DB12147,-7.2,Erdafitinib,OLAHOMJCDNXHFI-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
131488,6w4h,DB13808,-7.2,Mebhydrolin,FQQIIPAOSKSOJM-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
105836,6vxs,DB14129,-7.2,Macelignan,QDDILOVMGWUNGD-UONOGXRCSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
126224,6w4h,DB03543,-7.2,1-(O-Carboxy-Phenylamino)-1-Deoxy-D-Ribulose-5-Phosphate,AULMJMUNCOBRHC-MXWKQRLJSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
135245,6w9c,DB04175,-7.2,Mdl-29951,KNBSYZNKEAWABY-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
147418,6w9q,DB11910,-7.2,MK-0249,DDDZBLNULGDPGA-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
34455,1r42,DB00266,-7.2,Dicoumarol,DOBMPNYZJYQDGZ-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
130702,6w4h,DB12657,-7.2,JNJ-42396302,BPLVDYJDAVYLRQ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
55663,6crv,DB01273,-7.2,Varenicline,JQSHBVHOMNKWFT-DTORHVGOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
94852,6m71,DB08609,-7.2,"(2R)-N-{4-[Ethyl(phenyl)sulfamoyl]-2-methylphenyl}-3,3,3-trifluoro-2-hydroxy-2-methylpropanamide",SHEIQJGQDUYUBE-GOSISDBHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
121420,6w4b,DB11867,-7.2,JNJ-39393406,IURMHZBQEYNQOH-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
102193,6vxs,DB07116,-7.2,1-(2-DEOXY-5-O-PHOSPHONO-BETA-D-ERYTHRO-PENTOFURANOSYL)-4-METHYL-1H-INDOLE,UXXYPWCUINVUHL-BFHYXJOUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
94895,6m71,DB08661,-7.2,"1-(2,5-dideoxy-5-pyrrolidin-1-yl-beta-L-erythro-pentofuranosyl)-5-methylpyrimidine-2,4(1H,3H)-dione",XUSBTLVYPZUOAW-WOPDTQHZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160068,7bv1,DB07473,-7.2,"(R)-(+) 5(9BH)-OXO-9B-PHENYL-2,3-DIHYDROTHIAZOLO[2,3-A]ISOINDOL-3-CARBOXYLIC ACID METHYL ESTER",JYIHODAXBBPFQF-MAUKXSAKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
126292,6w4h,DB03647,-7.2,3-[Isopropyl(4-Methylbenzoyl)Amino]-5-Phenylthiophene-2-Carboxylic Acid,LRHXIDOGMBZJFN-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
25936,6cs2,DB00465,-7.2,Ketorolac,OZWKMVRBQXNZKK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
23448,6cs2,HMDB0061843,-7.2,"1R,3Z,9S-2,6,10,10 Tetramethylbicyclo[7.2.0]undeca-2,6-diene",ULWLVRZSZQKPOE-HONFXZPPSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
71880,6lxt,DB01557,-7.2,alpha-Methylfentanyl,NGTVDHYUFBKWID-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
34443,1r42,DB00251,-7.2,Terconazole,BLSQLHNBWJLIBQ-OZXSUGGESA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
92024,6m71,DB03851,-7.2,Carbazole Butanoic Acid,HQAKVYGASUTQHH-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
103780,6vxs,DB09016,-7.2,Butriptyline,ALELTFCQZDXAMQ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102179,6vxs,DB07101,-7.2,PD-0325901,SUDAHWBOROXANE-SECBINFHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
60701,6crv,DB08992,-7.2,Eperisone,SQUNAWUMZGQQJD-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
147423,6w9q,DB11917,-7.2,Vatiquinone,LNOVHERIIMJMDG-XZXLULOTSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
126288,6w4h,DB03641,-7.2,"2'-deoxyuridine 5'-alpha,beta-imido-diphosphate",COFNIXBQVWFHTR-SHYZEUOFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
7084,6lzg,DB03202,-7.2,"2-[5-Methanesulfonylamino-2-(4-Aminophenyl)-6-Oxo-1,6-Dihydro-1-Pyrimidinyl]-N-(3,3,3-Trifluoro-1-Isopropyl-2-Oxopropyl)Acetamide",JWSWTHSJMGVOKE-HNNXBMFYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
122172,6w4b,DB12996,-7.2,Acteoside,FBSKJMQYURKNSU-ZLSOWSIRSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
131468,6w4h,DB13783,-7.2,Acemetacin,FSQKKOOTNAMONP-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
60709,6crv,DB09000,-7.2,Cyamemazine,SLFGIOIONGJGRT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
157113,6wiq,DB14625,-7.2,Meprednisone acetate,RZAMUHXEOMZXET-ABQXZQTJSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
65639,6lxt,DB03103,-7.2,Thymidine-5'- Diphosphate,UJLXYODCHAELLY-XLPZGREQSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
59536,6crv,DB07581,-7.2,5-AMINO-6-CYCLOHEXYL-4-HYDROXY-2-ISOPROPYL-HEXANOIC ACID,SRFUYEFGHOTBHV-IHRRRGAJSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
160930,7bv1,DB12284,-7.2,LY-2608204,QIIVJLHCZUTGSD-CUBQBAPOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
156364,6wiq,DB12985,-7.2,Quisinostat,PAWIYAYFNXQGAP-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
69401,6lxt,DB09136,-7.2,Isosulfan blue,YFKDCGWIINMRQY-UHFFFAOYSA-O,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
34411,1r42,DB00216,-7.2,Eletriptan,PWVXXGRKLHYWKM-LJQANCHMSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
60714,6crv,DB09007,-7.2,Chlorphenoxamine,KKHPNPMTPORSQE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
26072,6cs2,DB04137,-7.2,Guanosine-5'-Triphosphate,XKMLYUALXHKNFT-UUOKFMHZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
127651,6w4h,DB06618,-7.2,Cutamesine,UVSWWUWQVAQPJR-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
11565,6lzg,DB12137,-7.2,GSK-256066,JFHROPTYMMSOLG-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
135187,6w9c,DB04101,-7.2,"N-[4-(2,4-Dimethyl-1,3-Thiazol-5-Yl)Pyrimidin-2-Yl]-N'-Hydroxyimidoformamide",OVKZTPFHUYGZBI-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
126261,6w4h,DB03598,-7.2,"Al-6629, [2h-Thieno[3,2-E]-1,2-Thiazine-6-Sulfonamide,2-(3-Methoxyphenyl)-3-(4-Morpholinyl)-, 1,1-Dioxide]",XSUAVPPTKHUTDX-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
160100,7bv1,DB07512,-7.2,7-[(3-CHLOROBENZYL)OXY]-2-OXO-2H-CHROMENE-4-CARBALDEHYDE,ZOCADHRNWNJARU-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
17156,6cs2,HMDB0006730,-7.2,QYNAD,WKBAPRRMZYHPNB-BXBUPLCLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
60980,6crv,DB11226,-7.2,Ethylhexyl methoxycrylene,WAJCJDLRJVDSSD-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
122253,6w4b,DB13114,-7.2,Amitriptylinoxide,ZPMKQFOGINQDAM-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
89580,6m71,DB00655,-7.2,Estrone,DNXHEGUUPJUMQT-CBZIJGRNSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
135188,6w9c,DB04102,-7.2,2-Amino-Adenosine,CQKMBZHLOYVGHW-QYYRPYCUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
121451,6w4b,DB11910,-7.2,MK-0249,DDDZBLNULGDPGA-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
57264,6crv,DB03416,-7.2,Thiamine(1+) monophosphate,HZSAJDVWZRBGIF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
48771,2fxp,DB03591,-7.2,RU82209,LVZDQVATAQEMCX-NSOVKSMOSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
71448,6lxt,DB14543,-7.2,Hydrocortisone probutate,FOGXJPFPZOHSQS-AYVLZSQQSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
71443,6lxt,DB14538,-7.2,Hydrocortisone aceponate,MFBMYAOAMQLLPK-FZNHGJLXSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
160110,7bv1,DB07525,-7.2,"3-(3-methoxybenzyl)-1H-pyrrolo[2,3-b]pyridine",GHQCCHWTDLTMJT-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
131480,6w4h,DB13797,-7.2,Iodocholesterol (131I),FIOAEFCJGZJUPW-ODFYUTSGSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
122225,6w4b,DB13072,-7.2,GDC-0349,RGJOJUGRHPQXGF-INIZCTEOSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
94868,6m71,DB08631,-7.2,"N-(4-CHLOROPHENYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONAMIDE",UVSIFVBCHJEYJP-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
157131,6wiq,DB14644,-7.2,Methylprednisolone hemisuccinate,IMBXEJJVJRTNOW-XYMSELFBSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
22336,6cs2,HMDB0001495,-7.2,Queuine,WYROLENTHWJFLR-BHNWBGBOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
150680,6wiq,DB01705,-7.2,Bis(5-Amidino-Benzimidazolyl)Methane,QZKOOEFIMWKZPK-UHFFFAOYSA-Q,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
48804,2fxp,DB03642,-7.2,Benzofuran-2-Carboxylic Acid {(S)-3-Methyl-1-[3-Oxo-1-(Pyridin-2-Ylsulfonyl)Azepan-4-Ylcarbamoyl]Butyl}Amide,VBPPNJCVXGAZDD-PMACEKPBSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
160145,7bv1,DB07564,-7.2,"6-amino-2-[(2-morpholin-4-ylethyl)amino]-3,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",JUHXOBNFTFUPKQ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
104149,6vxs,DB11518,-7.2,Flunixin,NOOCSNJCXJYGPE-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
122185,6w4b,DB13016,-7.2,LY-2300559,DWQVYDLTPMGYNE-DEOSSOPVSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
135153,6w9c,DB04060,-7.2,"(5-Methyl-6-Oxo-1,6-Dihydro-Pyridin-3-Yl)-1,2-Dideoxy-Ribofuranose-5-Monophosphate",MUWYCJQCZPFLFI-IVZWLZJFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
67010,6lxt,DB05015,-7.2,Belinostat,NCNRHFGMJRPRSK-MDZDMXLPSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
92911,6m71,DB05421,-7.2,CP-122721,ZIWFCOIGUNPHPM-HKUYNNGSSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
122279,6w4b,DB13169,-7.2,Nandrolone,NPAGDVCDWIYMMC-IZPLOLCNSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
126277,6w4h,DB03626,-7.2,"5-Methoxy-1,2-Dimethyl-3-(Phenoxymethyl)Indole-4,7-Dione",JRPJCFILHCLEJI-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
108472,6vxx,DB08028,-7.2,"BUT-3-ENYL-[5-(4-CHLORO-PHENYL)-3,6-DIHYDRO-[1,3,4]THIADIAZIN-2-YLIDENE]-AMINE",ZVZPCRKQNRRBOQ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
155807,6wiq,DB11763,-7.2,Momelotinib,ZVHNDZWQTBEVRY-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
108148,6vxx,DB07158,-7.2,"5-ETHYL-3-METHYL-1,5-DIHYDRO-4H-PYRAZOLO[4,3-C]QUINOLIN-4-ONE",ASEHARDUZDZEKS-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
121445,6w4b,DB11902,-7.2,Gisadenafil,YPFZMBHKIVDSNR-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
27348,6cs2,DB06885,-7.2,3-[({(1E)-[2-(trifluoromethyl)phenyl]methylidene}amino)oxy]propanoic acid,NBNFAYOWJREHBN-VIZOYTHASA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
57544,6crv,DB03807,-7.2,"1-(2-Chlorophenyl)-3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester",XQCKNCFQOJFQFK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
12319,6lzg,DB13223,-7.2,Fluocortin,PUWHHWCHAVXSIG-NCLPIGKXSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
155802,6wiq,DB11753,-7.2,Rifamycin,HJYYPODYNSCCOU-ODRIEIDWSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
130706,6w4h,DB12662,-7.2,Naveglitazar,OKJHGOPITGTTIM-DEOSSOPVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
85260,6m3m,DB07448,-7.2,(2S)-3-[(R)-[(1S)-1-amino-3-phenylpropyl](hydroxy)phosphoryl]-2-benzylpropanoic acid,QELOIXSGJMIHBZ-MSOLQXFVSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
88080,6m3m,DB13320,-7.2,Sulfaperin,DZQVFHSCSRACSX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
160929,7bv1,DB12283,-7.2,Balapiravir,VKXWOLCNTHXCLF-DXEZIKHYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160098,7bv1,DB07510,-7.2,"3-fluoro-6-(4-fluorophenyl)-2-hydroxy-6-oxohexa-2,4-dienoic acid",CPZFGNOKCMJZFO-BTHQEHEQSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60726,6crv,DB09019,-7.2,Bromhexine,OJGDCBLYJGHCIH-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
102480,6vxs,DB07446,-7.2,N-(biphenyl-4-ylsulfonyl)-D-leucine,FBSVJQQVDISETN-QGZVFWFLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
126269,6w4h,DB03609,-7.2,3-Deoxyguanosine,OROIAVZITJBGSM-OBXARNEKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
2040,6lzg,HMDB0030684,-7.2,Cyanidin 3-glucoside,RKWHWFONKJEUEF-GQUPQBGVSA-O,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
88055,6m3m,DB13288,-7.2,Tromantadine,UXQDWARBDDDTKG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
135150,6w9c,DB04054,-7.2,"9-Butyl-8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine",PASRTKOWXJDFFV-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
153150,6wiq,DB05265,-7.2,Ecabet,IWCWQNVIUXZOMJ-MISYRCLQSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
67509,6lxt,DB06833,-7.2,1-CYCLOHEXYL-N-{[1-(4-METHYLPHENYL)-1H-INDOL-3-YL]METHYL}METHANAMINE,MMIJMYOYKAKQPN-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
151773,6wiq,DB03157,-7.2,"N,O-Didansyl-L-Tyrosine",LUBOPDUYHWABFG-NDEPHWFRSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
10872,6lzg,DB09201,-7.2,Ciglitazone,YZFWTZACSRHJQD-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
102146,6vxs,DB07059,-7.2,"N-{2-[6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2,2-DIMETHYL-3-OXO-2,3-DIHYDRO-4H-1,4-BENZOXAZIN-4-YL]ETHYL}ACETAMIDE",GBXSOZDYCSBLQX-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
148121,6w9q,DB12966,-7.2,Falnidamol,FTFRZXFNZVCRSK-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
22739,6cs2,HMDB0054858,-7.2,"TG(22:4(7Z,10Z,13Z,16Z)/18:4(6Z,9Z,12Z,15Z)/18:3(9Z,12Z,15Z))",AMKVBHVMCBBXNU-OONGJWGHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
17024,6cs2,HMDB0005768,-7.2,Kyotorphin,JXNRXNCCROJZFB-RYUDHWBXSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
69811,6lxt,DB11736,-7.2,PF-00489791,ZUHZNKJIJDAJFD-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
122560,6w4b,DB13563,-7.2,Norgestrienone,GVDMJXQHPUYPHP-FYQPLNBISA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
87944,6m3m,DB13096,-7.2,Gacyclidine,DKFAAPPUYWQKKF-GOEBONIOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
25378,6cs2,DB03288,-7.2,5-Chloro-1h-Indole-2-Carboxylic Acid{[Cyclopentyl-(2-Hydroxy-Ethyl)-Carbamoyl]-Methyl}-Amide,VXABTOCIIZSEPD-QGZVFWFLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
134945,6w9c,DB03781,-7.2,"2-[4-(2,4-Dichlorophenoxy)Phenoxy]Propanoic Acid",OOLBCHYXZDXLDS-SECBINFHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
156348,6wiq,DB12960,-7.2,INCB-9471,ZMCJFJZOSKEMOM-DNKZPPIMSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
159938,7bv1,DB07104,-7.2,4-amino-N-[4-(benzyloxy)phenyl]butanamide,QTWBKNVNGVYTNZ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
25212,6cs2,DB03093,-7.2,"8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine",MWHAHELTVGJGFJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
92973,6m71,DB05738,-7.2,Vapitadine,VQWGYPVNVICKFC-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
134937,6w9c,DB03771,-7.2,Allyl-{4-[3-(4-Bromo-Phenyl)-Benzofuran-6-Yloxy]-but-2-Enyl}-Methyl-Amine,KCNKJCHARANTIP-SNAWJCMRSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
156462,6wiq,DB13135,-7.2,AGN-201904,PPCGSVWOZKNPCX-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
27967,6cs2,DB07533,-7.2,"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]-2-FURYL}-N-METHYLBENZENESULFONAMIDE",FJJJERLTHDXEPT-JYRVWZFOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
88641,6m3m,DB14200,-7.2,Thiohexam,DEQZTKGFXNUBJL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
127623,6w4h,DB06538,-7.2,Robalzotan,MQTUXRKNJYPMCG-CYBMUJFWSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
105813,6vxs,DB14082,-7.2,Betiatide,VDPYMEBVIDZKMD-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
55748,6crv,DB01437,-7.2,Glutethimide,JMBQKKAJIKAWKF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
127093,6w4h,DB04705,-7.2,"(3BETA)-CHOLEST-5-ENE-3,25-DIOL",INBGSXNNRGWLJU-ZHHJOTBYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
122491,6w4b,DB13471,-7.2,Nalfurafine,XGZZHZMWIXFATA-UEZBDDGYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
94369,6m71,DB08029,-7.2,N-2-(biphenyl-4-ylsulfonyl)-N-hydroxy-N-2-(2-hydroxyethyl)glycinamide,QQDWEVONJRXVDB-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
159954,7bv1,DB07121,-7.2,"4-({4-[(4-AMINOBUT-2-YNYL)OXY]PHENYL}SULFONYL)-N-HYDROXY-2,2-DIMETHYLTHIOMORPHOLINE-3-CARBOXAMIDE",AANXPIMDONQTQF-HNNXBMFYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
108534,6vxx,DB08100,-7.2,"2,6-dimethyl-4-[(E)-2-phenylethenyl]phenol",PAHKYLUYTGBFNW-CMDGGOBGSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106130,6vxs,DB15080,-7.2,ELX-02,KJBRSTPUILEBDR-YBNFDXCTSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
156352,6wiq,DB12966,-7.2,Falnidamol,FTFRZXFNZVCRSK-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
147374,6w9q,DB11845,-7.2,Lucitanib,CUDVHEFYRIWYQD-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
11649,6lzg,DB12252,-7.2,PG-701,OKRSVUYYCJPECG-LFGMFVMYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
85446,6m3m,DB07671,-7.2,"2-[1-METHYLHEXYL]-4,6-DINITROPHENOL",RROCMCBQTUYDSD-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
69803,6lxt,DB11721,-7.2,Mitoglitazone,IRNJSRAGRIZIHD-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
121345,6w4b,DB11759,-7.2,Pevonedistat,MPUQHZXIXSTTDU-QXGSTGNESA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
122535,6w4b,DB13532,-7.2,Cyclopenthiazide,BKYKPTRYDKTTJY-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
27976,6cs2,DB07540,-7.2,"4-{5-[(1Z)-1-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)ETHYL]-2-FURYL}BENZENESULFONAMIDE",AKFVRSQELXTCFW-JYRVWZFOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
161005,7bv1,DB12390,-7.2,MBX-8025,JWHYSEDOYMYMNM-QGZVFWFLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
69805,6lxt,DB11726,-7.2,Encenicline,SSRDSYXGYPJKRR-ZDUSSCGKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
147368,6w9q,DB11833,-7.2,Basimglurant,UPZWINBEAHDTLA-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
127847,6w4h,DB06921,-7.2,(2S)-2-[3-(AMINOMETHYL)PHENYL]-3-[(R)-HYDROXY{(1R)-2-METHYL-1-[(PHENYLSULFONYL)AMINO]PROPYL}PHOSPHORYL]PROPANOIC ACID,FNZHLCNFXRRIIC-RBUKOAKNSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
159949,7bv1,DB07116,-7.2,1-(2-DEOXY-5-O-PHOSPHONO-BETA-D-ERYTHRO-PENTOFURANOSYL)-4-METHYL-1H-INDOLE,UXXYPWCUINVUHL-BFHYXJOUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
151995,6wiq,DB03453,-7.2,Methyl (2S)-2-[[2-[(3R)-1-carbamimidoylpiperidin-3-yl]acetyl]amino]-3-[4-(2-phenylethynyl)phenyl]propanoate,MRNGXYMKYHNMLV-PKTZIBPZSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
69067,6lxt,DB08669,-7.2,"METHYL N-[(2S,3R)-3-AMINO-2-HYDROXY-3-(4-METHYLPHENYL)PROPANOYL]-D-ALANYL-D-LEUCINATE",BMHZOSJVDHAFEE-SVGFKBNWSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
131421,6w4h,DB13720,-7.2,Diphemanil,LCTZPQRFOZKZNK-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
108052,6vxx,DB06764,-7.2,Tetryzoline,BYJAVTDNIXVSPW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136225,6w9c,DB06794,-7.2,Lodoxamide,RVGLGHVJXCETIO-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
66982,6lxt,DB04915,-7.2,Idronoxil,ZZUBHVMHNVYXRR-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
11515,6lzg,DB12073,-7.2,Albaconazole,UHIXWHUVLCAJQL-MPBGBICISA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
155853,6wiq,DB11845,-7.2,Lucitanib,CUDVHEFYRIWYQD-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
69077,6lxt,DB08682,-7.2,"1-METHYL ETHYL 1-CHLORO-5-[[(5,6DIHYDRO-2-METHYL-1,4-OXATHIIN-3-YL)CARBONYL]AMINO]BENZOATE",FMQGUMRNTBJHEA-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
28320,6cs2,DB00724,-7.2,Imiquimod,DOUYETYNHWVLEO-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
71291,6lxt,DB13937,-7.2,LGD-3303,OMXGOGXEWUCLFI-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
26269,6cs2,DB04371,-7.2,AL6528,FBBLOSCXOZYUSS-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
55780,6crv,DB01473,-7.2,Betaprodine,UVAZQQHAVMNMHE-CZUORRHYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84240,6m3m,DB05047,-7.2,CX717,KFRQROSRKSVROW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
126059,6w4h,DB03307,-7.2,4-[(6-Amino-4-Pyrimidinyl)Amino]Benzenesulfonamide,FVFVVRPJERUECT-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
127861,6w4h,DB06935,-7.2,"2',6'-DIFLUOROBIPHENYL-4-CARBOXYLIC ACID",CWWIIKLXUPZDOG-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
23256,6cs2,HMDB0059974,-7.2,"4-Hydroxy-5-(3',5'-dihydroxyphenyl)-valeric acid-O-methyl-O-glucuronide",NLJOFAILECLFIF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
134829,6w9c,DB03615,-7.2,Ribostamycin,NSKGQURZWSPSBC-VVPCINPTSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
130796,6w4h,DB12804,-7.2,Daniquidone,SRIOCKJKFXAKHK-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
84236,6m3m,DB05025,-7.2,Arimoclomol,SGEIEGAXKLMUIZ-CYBMUJFWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
36156,1r42,DB02547,-7.2,Guanosine-5'-Diphosphate-Rhamnose,LQEBEXMHBLQMDB-GDJBGNAASA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
84242,6m3m,DB05053,-7.2,MB-07803,CTKZZUXRWBCFEI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
71330,6lxt,DB14008,-7.2,Hispidulin,IHFBPDAQLQOCBX-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
131439,6w4h,DB13741,-7.2,Ioglycamic acid,FZDZULUFHNDEDJ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
94349,6m71,DB08008,-7.2,"5-methyl-N-[4-(trifluoromethyl)phenyl][1,2,4]triazolo[1,5-a]pyrimidin-7-amine",LRHHXKBKRNNFRV-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
130782,6w4h,DB12780,-7.2,Quinfamide,SBJGFIXQRZOVTO-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
94951,6m71,DB08729,-7.2,"5-ethoxy-4-(1-methyl-7-oxo-3-propyl-6,7-dihydro-1H-pyrazolo[4,3-d]pyrimidin-5-yl)thiophene-2-sulfonamide",FENWRHVHBZQJGW-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
105798,6vxs,DB14059,-7.2,SC-236,NSQNZEUFHPTJME-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
69469,6lxt,DB09232,-7.2,Cilnidipine,KJEBULYHNRNJTE-DHZHZOJOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
92975,6m71,DB05772,-7.2,Rabeximod,PDNNUMNEXITLCZ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
102137,6vxs,DB07050,-7.2,"5-[(phenylsulfonyl)amino]-1,3,4-thiadiazole-2-sulfonamide",PWDGTQXZLNDOKS-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
159930,7bv1,DB07093,-7.2,"{3-[(5-CHLORO-1,3-BENZOTHIAZOL-2-YL)METHYL]-2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL}ACETIC ACID",RQWICELTTDJODO-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
126091,6w4h,DB03349,-7.2,8-Bromo-Adenosine-5'-Monophosphate,DNPIJKNXFSPNNY-UUOKFMHZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
69817,6lxt,DB11742,-7.2,Ebastine,MJJALKDDGIKVBE-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
17774,6cs2,HMDB0010373,-7.2,"CE(20:3(5Z,8Z,11Z))",XQWTZYBOKFFMKJ-HXQMAXTDSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
130788,6w4h,DB12791,-7.2,Laninamivir,QNRRHYPPQFELSF-CNYIRLTGSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
94958,6m71,DB08736,-7.2,"S,R-Warfarin alcohol",ZUJMMGHIYSAEOU-DOMZBBRYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
34559,1r42,DB00502,-7.2,Haloperidol,LNEPOXFFQSENCJ-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
106148,6vxs,DB15117,-7.2,Transfluthrin,DDVNRFNDOPPVQJ-HQJQHLMTSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
15261,6lzg,T3D0070,-7.2,Benzofluoranthene,OQDXASJSCOTNQS-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
57199,6crv,DB03327,-7.2,{1-[(3-Hydroxy-Methyl-5-Phosphonooxy-Methyl-Pyridin-4-Ylmethyl)-Amino]-Ethyl}-Phosphonic Acid,WHDCJKAOZPBUAY-SSDOTTSWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
94350,6m71,DB08009,-7.2,"5-[(E)-(5-CHLORO-2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]-N-[2-(DIETHYLAMINO)ETHYL]-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXAMIDE",XPLJEFSRINKZLC-ATVHPVEESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
27372,6cs2,DB06910,-7.2,"[4-R-(4-ALPHA,6-BETA,7-BETA]-HEXAHYDRO-5,6-DI(HYDROXY)-1,3-DI(ALLYL)-4,7-BISPHENYLMETHYL)-2H-1,3-DIAZEPINONE",IWJSQELMWLOYSO-LWSSLDFYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
105707,6vxs,DB13856,-7.2,Fluclorolone,VTWKPILBIUBMDS-OTJLYDAYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
2035,6lzg,HMDB0030653,-7.2,Cryptochlorogenic acid,GYFFKZTYYAFCTR-JUHZACGLSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
147385,6w9q,DB11864,-7.2,Preladenant,DTYWJKSSUANMHD-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
136148,6w9c,DB06656,-7.2,TAS-106,JFIWEPHGRUDAJN-DYUFWOLASA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
160028,7bv1,DB07205,-7.2,N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,GZJXCRHEMLAMRA-SDBHATRESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
7018,6lzg,DB00383,-7.2,Oxyphencyclimine,DUDKAZCAISNGQN-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
69769,6lxt,DB11672,-7.2,Curcumin,VFLDPWHFBUODDF-FCXRPNKRSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
147399,6w9q,DB11885,-7.2,Anlotinib,KSMZEXLVHXZPEF-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
126870,6w4h,DB04409,-7.2,Naphthalene Trisulfonate,ZPBSAMLXSQCSOX-UHFFFAOYSA-K,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
127636,6w4h,DB06585,-7.2,Fipamezole,KXSUAWAUCNFBQJ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
135027,6w9c,DB03886,-7.2,Biopterin,LHQIJBMDNUYRAM-AWFVSMACSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
152035,6wiq,DB03507,-7.2,"6-[3-(4-Morpholinyl)Propyl]-2-(3-Nitrophenyl)-5-Thioxo-5,6,-Dihydro-7h-Thienol[2',3':4,5]Pyrrolo[1,2-C]Imidazol-7-One",UXGUZFZBZPPZGL-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
89560,6m71,DB00628,-7.2,Clorazepic acid,XDDJGVMJFWAHJX-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
155643,6wiq,DB11430,-7.2,Monensin,GAOZTHIDHYLHMS-KEOBGNEYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
160014,7bv1,DB07188,-7.2,"(3S)-1-CYCLOHEXYL-N-(3,5-DICHLOROPHENYL)-5-OXOPYRROLIDINE-3-CARBOXAMIDE",YUFADRZDHJKVOT-NSHDSACASA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
11548,6lzg,DB12116,-7.2,Epigallocatechin gallate,WMBWREPUVVBILR-WIYYLYMNSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
65964,6lxt,DB03549,-7.2,Biotinyl P-Nitroaniline,PORZMUYPQKOFQY-YDHLFZDLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
85365,6m3m,DB07572,-7.2,3-{[(4-methylphenyl)sulfonyl]amino}propyl pyridin-4-ylcarbamate,ITYCDQJBLCTIID-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59741,6crv,DB07819,-7.2,(2E)-3-(4-CHLOROPHENYL)-N-HYDROXYACRYLAMIDE,YPYUWBDOEMPXSK-ZZXKWVIFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
155658,6wiq,DB11457,-7.2,Rotenone,JUVIOZPCNVVQFO-HBGVWJBISA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
11544,6lzg,DB12113,-7.2,CE-224535,FUCKCIVGBCBZNP-MRXNPFEDSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
28015,6cs2,DB07585,-7.2,"5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine",YFFJXGRXFASBDL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
71896,6lxt,DB08775,-7.2,Nalpha-[(Benzyloxy)carbonyl]-N-[(2S)-4-fluoro-3-oxo-2-butanyl]-L-tyrosinamide,RYABQRLJLIHDIP-KSSFIOAISA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
108509,6vxx,DB08072,-7.2,"4-(2-AMINOETHOXY)-3,5-DICHLORO-N-[3-(1-METHYLETHOXY)PHENYL]BENZAMIDE",AYKUIRSGEMLIFT-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
122354,6w4b,DB13292,-7.2,Pimethixene,NZLVRVYNQYGMAB-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
85290,6m3m,DB07484,-7.2,"(2R)-4,4-dihydroxy-5-nitro-2-(phenylmethyl)pentanoic acid",CGGNZMVODZPHHK-SNVBAGLBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
28671,6cs2,DB08272,-7.2,(4S)-4-(2-NAPHTHYLMETHYL)-D-GLUTAMIC ACID,YDWIUFASTTZKNI-UONOGXRCSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
14214,6lzg,T3D3843,-7.2,Flufenacet,IANUJLZYFUDJIH-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
65626,6lxt,DB03086,-7.2,"N'-(2s,3r)-3-Amino-4-Cyclohexyl-2-Hydroxy-Butano-N-(4-Methylphenyl)Hydrazide",IQMLIGOOOFEBAH-CVEARBPZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
55202,6crv,DB00730,-7.2,Thiabendazole,WJCNZQLZVWNLKY-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
147413,6w9q,DB11903,-7.2,GW842166,TWQYWUXBZHPIIV-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
92944,6m71,DB05562,-7.2,Naluzotan,SPWZXWDPAWDKQE-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
55675,6crv,DB01299,-7.2,Sulfadoxine,PJSFRIWCGOHTNF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
126874,6w4h,DB04416,-7.2,"R-2-{[4'-Methoxy-(1,1'-Biphenyl)-4-Yl]-Sulfonyl}-Amino-6-Methoxy-Hex-4-Ynoic Acid",QJKGJGURDPRKGW-LJQANCHMSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
27261,6cs2,DB06769,-7.2,Bendamustine,YTKUWDBFDASYHO-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
147978,6w9q,DB12739,-7.2,Bindarit,MTHORRSSURHQPZ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
127644,6w4h,DB06603,-7.2,Panobinostat,FPOHNWQLNRZRFC-ZHACJKMWSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
122326,6w4b,DB13252,-7.2,Tropatepine,JOQKFRLFXDPXHX-HDICACEKSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
104097,6vxs,DB11410,-7.2,Fenbendazole,HDDSHPAODJUKPD-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
155645,6wiq,DB11433,-7.2,Nequinate,NNOPDLNHPOLRRE-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
57241,6crv,DB03384,-7.2,Fica,JFUIHGAGFMFNRD-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
131458,6w4h,DB13772,-7.2,Rufloxacin,NJCJBUHJQLFDSW-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
14125,6lzg,T3D3743,-7.2,Fumitremorgin B,WEIYXEFMCIRZHC-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
33947,6cs2,T3D0633,-7.2,Acridine,DZBUGLKDJFMEHC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
28301,6cs2,DB07883,-7.2,(2-AMINO-3-PHENYL-BICYCLO[2.2.1]HEPT-2-YL)-PHENYL-METHANONE,XJQDTOANLAPEIM-JRBPQWBISA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
157178,6wiq,DB14723,-7.2,Larotrectinib,NYNZQNWKBKUAII-KBXCAEBGSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
134993,6w9c,DB03841,-7.2,Y-700,AETHRPHBGJAIBT-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
55718,6crv,DB01403,-7.2,Methotrimeprazine,VRQVVMDWGGWHTJ-CQSZACIVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
121379,6w4b,DB11805,-7.2,Saracatinib,OUKYUETWWIPKQR-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
88000,6m3m,DB13214,-7.2,Sulfadicramide,XRVJPLDTMUSSDE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
102524,6vxs,DB07498,-7.2,"4-[3-(3-NITROPHENYL)-1,2,4-OXADIAZOL-5-YL]BUTANOIC ACID",LQQYZJRCWBRIMW-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
12207,6lzg,DB13036,-7.2,Ramatroban,LDXDSHIEDAPSSA-OAHLLOKOSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
103549,6vxs,DB08715,-7.2,"2,6-DIMETHYL-1-(3-[3-METHYL-5-ISOXAZOLYL]-PROPANYL)-4-[2-METHYL-4-ISOXAZOLYL]-PHENOL",SLPKYEWAKMNCPT-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
122481,6w4b,DB13457,-7.2,Oxaflozane,FVYUQFQCEOZYHZ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
59505,6crv,DB07542,-7.2,5-AMINO-6-CYCLOHEXYL-4-HYDROXY-2-ISOBUTYL-HEXANOIC ACID,INCRGCAIRMMQQJ-ILXRZTDVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
17065,6cs2,HMDB0006031,-7.2,11-Ketoetiocholanolone,IUNYGQONJQTULL-UKZLPJRTSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
55722,6crv,DB01408,-7.2,Bambuterol,ANZXOIAKUNOVQU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
103770,6vxs,DB09006,-7.2,Clinofibrate,BMOVQUBVGICXQN-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
85415,6m3m,DB07632,-7.2,"5-(2-chlorophenyl)-1,3,4-thiadiazole-2-sulfonamide",PZVGOWIIHCUHAO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
134970,6w9c,DB03812,-7.2,"3-{2,6,8-trioxo-9-[(2S,3R,4R)-2,3,4,5-tetrahydroxypentyl]-1,2,3,6,8,9-hexahydro-7H-purin-7-Yl}propyl dihydrogen phosphate",KPHFGOGGKPGLTM-LKEWCRSYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
10610,6lzg,DB08822,-7.2,Azilsartan medoxomil,QJFSABGVXDWMIW-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
10609,6lzg,DB08820,-7.2,Ivacaftor,PURKAOJPTOLRMP-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
159980,7bv1,DB07149,-7.2,"(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluoroethyl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one",LCBAQTCTQXHTJG-ZETCQYMHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
26216,6cs2,DB00495,-7.2,Zidovudine,HBOMLICNUCNMMY-XLPZGREQSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
47260,2fxp,DB01573,-7.2,Benzylmorphine,RDJGWRFTDZZXSM-RNWLQCGYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
92176,6m71,DB04059,-7.2,8-(Pyrimidin-2-Ylamino)Naphthalene-2-Carboximidamide,GRQLDCHTDNYVQI-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
17038,6cs2,HMDB0005808,-7.2,Formononetin,HKQYGTCOTHHOMP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
148070,6w9q,DB12890,-7.2,Dihydrexidine,BGOQGUHWXBGXJW-YOEHRIQHSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
17753,6cs2,HMDB0010320,-7.2,Cortolone-3-glucuronide,OKNSFVSKHQJVRN-XAYCFROHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
108113,6vxx,DB06864,-7.2,"2-(3-CARBOXYPROPIONYL)-6-HYDROXY-CYCLOHEXA-2,4-DIENE CARBOXYLIC ACID",QJYRAJSESKVEAE-PSASIEDQSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
150631,6wiq,DB01640,-7.2,"(5r)-6-(4-{[2-(3-Iodobenzyl)-3-Oxocyclohex-1-En-1-Yl]Amino}Phenyl)-5-Methyl-4,5-Dihydropyridazin-3(2h)-One",QNURTFDBHAQRSI-OAHLLOKOSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
126166,6w4h,DB03458,-7.2,"N(4)-Adenosyl-N(4)-methyl-2,4-diaminobutanoic acid",JISVTSUBJCPLSV-TWBCTODHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
108109,6vxx,DB06859,-7.2,N-ALLYL-5-AMIDINOAMINOOXY-PROPYLOXY-3-CHLORO-N-CYCLOPENTYLBENZAMIDE,XWIUMAPBZWNFNV-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
105713,6vxs,DB13867,-7.2,Fluticasone,MGNNYOODZCAHBA-GQKYHHCASA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
160001,7bv1,DB07174,-7.2,"6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-4-(3-METHOXYPROPYL)-2,2-DIMETHYL-2H-1,4-BENZOXAZIN-3(4H)-ONE",WPAPODFGOZXFLG-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
55709,6crv,DB01382,-7.2,Glymidine,QFWPJPIVLCBXFJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
89701,6m71,DB00800,-7.2,Fenoldopam,TVURRHSHRRELCG-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
66992,6lxt,DB04946,-7.2,Iloperidone,XMXHEBAFVSFQEX-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
28695,6cs2,DB08302,-7.2,3-[5-(2-nitropent-1-en-1-yl)furan-2-yl]benzoic acid,IRHZCQDCMUWUKV-RAXLEYEMSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
103772,6vxs,DB09008,-7.2,Cefaloridine,CZTQZXZIADLWOZ-CRAIPNDOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
17072,6cs2,HMDB0006070,-7.2,Pregnanetriol,SCPADBBISMMJAW-HWPIAJDMSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
69780,6lxt,DB11686,-7.2,Iferanserin,UXIPFQUBOVWAQW-UEBLJOKOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
131360,6w4h,DB13642,-7.2,Pridinol,RQXCLMGKHJWMOA-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
67506,6lxt,DB06829,-7.2,4-BROMO-3-(CARBOXYMETHOXY)-5-[3-(CYCLOHEXYLAMINO)PHENYL]THIOPHENE-2-CARBOXYLIC ACID,RXDVFLTWXCTCEX-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
27071,6cs2,DB06403,-7.2,Ambrisentan,OUJTZYPIHDYQMC-LJQANCHMSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
27362,6cs2,DB00624,-7.2,Testosterone,MUMGGOZAMZWBJJ-DYKIIFRCSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
127841,6w4h,DB06915,-7.2,"naphthalene-1,2,4,5,7-pentol",IISYZEMBGRNYTH-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
136128,6w9c,DB06618,-7.2,Cutamesine,UVSWWUWQVAQPJR-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
94476,6m71,DB08149,-7.2,"1-[4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine",KCWPSUKJCKZEAO-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
135794,6w9c,DB05022,-7.2,Amonafide,UPALIKSFLSVKIS-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
103566,6vxs,DB08733,-7.2,"(2R,3R)-N^1^-[(1S)-2,2-DIMETHYL-1-(METHYLCARBAMOYL)PROPYL]-N^4^-HYDROXY-2-(2-METHYLPROPYL)-3-{[(1,3-THIAZOL-2-YLCARBONYL)AMINO]METHYL}BUTANEDIAMIDE",GAHIXYNNFMCKFQ-HZSPNIEDSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
126568,6w4h,DB04001,-7.2,6-(Oxalyl-Amino)-1h-Indole-5-Carboxylic Acid,AHWMERGBWWROMM-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
1296,6lzg,HMDB0010338,-7.2,11-Oxo-androsterone glucuronide,QTXWOOLAHRQMGZ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
7580,6lzg,DB04038,-7.2,Ergosterol,DNVPQKQSNYMLRS-APGDWVJJSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
121812,6w4b,DB12428,-7.2,PAC-14028,UKGJZDSUJSPAJL-YPUOHESYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
131595,6w4h,DB14013,-7.2,SR-9009,MMJJNHOIVCGAAP-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
34070,6cs2,T3D0928,-7.2,Benomyl,RIOXQFHNBCKOKP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
34069,6cs2,T3D0927,-7.2,Benfuracarb,FYZBOYWSHKHDMT-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
59664,6crv,DB07734,-7.2,N-(1-benzylpiperidin-4-yl)-4-sulfanylbutanamide,XNIXPLIQGKQSIE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
103792,6vxs,DB09039,-7.2,Eliglustat,FJZZPCZKBUKGGU-AUSIDOKSSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
89632,6m71,DB00714,-7.2,Apomorphine,VMWNQDUVQKEIOC-CYBMUJFWSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160439,7bv1,DB08388,-7.2,"5-(2-ETHOXYETHYL)-5-[4-(4-FLUOROPHENOXY)PHENOXY]PYRIMIDINE-2,4,6(1H,3H,5H)-TRIONE",XRSYNYGEEYTXJV-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
28239,6cs2,DB07819,-7.2,(2E)-3-(4-CHLOROPHENYL)-N-HYDROXYACRYLAMIDE,YPYUWBDOEMPXSK-ZZXKWVIFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
160436,7bv1,DB08385,-7.2,4-(quinolin-3-ylmethyl)piperidine-1-carboxylic acid,QUAGUFNCKDDJFZ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
135594,6w9c,DB04672,-7.2,"Cyclic 3',5'-thymidine monophosphate",XLPGURCDSRIXFL-JGVFFNPUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
121598,6w4b,DB12127,-7.2,Sultamicillin,OPYGFNJSCUDTBT-PMLPCWDUSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
108324,6vxx,DB07625,-7.2,"4-(2-aminoethoxy)-N-(2,5-diethoxyphenyl)-3,5-dimethylbenzamide",PHTPPZCTHZHCQD-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
151409,6wiq,DB02668,-7.2,"Je-2147, Ag1776, Kni-764",CUFQBQOBLVLKRF-RZDMPUFOSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
28238,6cs2,DB07818,-7.2,"(2E)-3-(2,4-DICHLOROPHENYL)-N-HYDROXYACRYLAMIDE",LHTLDFWBUPYUDR-DUXPYHPUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
57368,6crv,DB03575,-7.2,Phencyclidine,JTJMJGYZQZDUJJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
105924,6vxs,DB14637,-7.2,Fluprednisolone acetate,CYMBAKFTWRNHPS-APRQOCPKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
15138,6lzg,T3D0515,-7.2,"3,3',4,4',5-Pentachlorobiphenyl",REHONNLQRWTIFF-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
94661,6m71,DB08382,-7.2,Gosogliptin,QWEWGXUTRTXFRF-KBPBESRZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160731,7bv1,DB09477,-7.2,Enalaprilat,LZFZMUMEGBBDTC-QEJZJMRPSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
28176,6cs2,DB07757,-7.2,"(9aS)-4-bromo-9a-butyl-7-hydroxy-1,2,9,9a-tetrahydro-3H-fluoren-3-one",FTEBGBCQCYMDPH-KRWDZBQOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
121788,6w4b,DB12399,-7.2,Polmacoxib,IJWPAFMIFNSIGD-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
121796,6w4b,DB12408,-7.2,PF-03635659,WGOJWDWKHJHXSV-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
160478,7bv1,DB08436,-7.2,"8-BENZO[1,3]DIOXOL-,5-YLMETHYL-9-BUTYL-9H-",JCDXXNIRWRRGBX-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
135919,6w9c,DB05719,-7.2,Elesclomol,BKJIXTWSNXCKJH-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
127759,6w4h,DB06816,-7.2,Pyrvinium,QMHSXPLYMTVAMK-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
135587,6w9c,DB04659,-7.2,"(1S,2S,3R,4S,5S)-2,3,4-TRIHYDROXY-5-(HYDROXYMETHYL)CYCLOHEXYL (1E)-2-PHENYL-N-(SULFOOXY)ETHANIMIDOTHIOATE",LZDZCEOFJWRJIA-GGASBGQWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
84790,6m3m,DB06905,-7.2,"(2S,3S,4E,6E,8S,9S)-3-amino-9-methoxy-2,6,8-trimethyl-10-phenyldeca-4,6-dienoic acid",HJVCHYDYCYBBQX-HLTLHRPFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
156895,6wiq,DB13828,-7.2,Cyfluthrin,QQODLKZGRKWIFG-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
121600,6w4b,DB12129,-7.2,Tideglusib,PMJIHLSCWIDGMD-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
160466,7bv1,DB08422,-7.2,[PHENYLALANINYL-PROLINYL]-[2-(PYRIDIN-4-YLAMINO)-ETHYL]-AMINE,GEIDRYBJURDUSW-MOPGFXCFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
88244,6m3m,DB13540,-7.2,Isepamicin,UDIIBEDMEYAVNG-ZKFPOVNWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
108334,6vxx,DB07635,-7.2,bis(4-hydroxyphenyl)methanone,RXNYJUSEXLAVNQ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
131691,6w4h,DB14214,-7.2,Rose bengal lactone,IICCLYANAQEHCI-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
160461,7bv1,DB08414,-7.2,"6-CHLORO-2-(1-FURO[2,3-C]PYRIDIN-5-YL-ETHYLSULFANYL)-PYRIMIDIN-4-YLAMINE",ATCRIOJPQXDFNY-ZETCQYMHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160449,7bv1,DB08399,-7.2,PICEATANNOL,CDRPUGZCRXZLFL-OWOJBTEDSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
14141,6lzg,T3D3759,-7.2,Enniatin B1,UQCSETXJXJTMKO-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
147664,6w9q,DB12272,-7.2,Vidupiprant,PFWVGKROPKKEDW-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
11606,6lzg,DB12194,-7.2,Atamestane,PEPMWUSGRKINHX-TXTPUJOMSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
36078,1r42,DB02450,-7.2,"2-Benzo[1,3]Dioxol-5-Ylmethyl-3-Benzyl-Succinic Acid",ASEJDWRSZYAIOT-GJZGRUSLSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
121873,6w4b,DB12522,-7.2,Toreforant,FCRFVPZAXGJLPW-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
156691,6wiq,DB13556,-7.2,Sulfamazone,BGLHAKAJGYLSOX-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
68996,6lxt,DB08580,-7.2,4-bromo-2-{[(2R)-2-(2-chlorobenzyl)pyrrolidin-1-yl]carbonyl}aniline,JEGGWFHNKPRKTO-CQSZACIVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
94607,6m71,DB08313,-7.2,nocodazole,KYRVNWMVYQXFEU-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
25988,6cs2,DB04037,-7.2,"N,N-Bis(4-Chlorobenzyl)-1h-1,2,3,4-Tetraazol-5-Amine",UOUXILZUBDIWQU-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
121571,6w4b,DB12092,-7.2,Naftopidil,HRRBJVNMSRJFHQ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
121569,6w4b,DB12085,-7.2,LCL-161,UFPFGVNKHCLJJO-SSKFGXFMSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
15458,6lzg,T3D1025,-7.2,Cismethrin,SSUJIHXQXFBEJN-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
67562,6lxt,DB06898,-7.2,"4-(2-amino-1-methyl-1H-imidazo[4,5-b]pyridin-6-yl)phenol",UGJXOCBVCWTJFP-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
59531,6crv,DB07573,-7.2,"(2S)-1-(2,5-dimethylphenoxy)-3-morpholin-4-ylpropan-2-ol",HVMGGHDPXHODHE-AWEZNQCLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60820,6crv,DB09192,-7.2,Tandamine,BRPOADLGOFPKKJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
135540,6w9c,DB04601,-7.2,"4-[(4-O-SULFAMOYLBENZYL)(4-CYANOPHENYL)AMINO]-4H-[1,2,4]-TRIAZOLE",WEXGHQDVDVWOIU-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
84916,6m3m,DB07051,-7.2,"3,5-DIMETHYL-1-PHENYL-1H-PYRAZOLE-4-CARBOXYLIC ACID ETHYL ESTER",BUIZDUYEIRRDAV-UHFFFAOYSA-O,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
135539,6w9c,DB04600,-7.2,"4-[(3-BROMO-4-O-SULFAMOYLBENZYL)(4-CYANOPHENYL)AMINO]-4H-[1,2,4]-TRIAZOLE",GHDKYBCUDPSXGJ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
121893,6w4b,DB12553,-7.2,Fluocinolone,UUOUOERPONYGOS-CLCRDYEYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
88200,6m3m,DB13478,-7.2,Meptazinol,JLICHNCFTLFZJN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
121566,6w4b,DB12082,-7.2,Vesnarinone,ZVNYJIZDIRKMBF-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
126505,6w4h,DB03917,-7.2,N-Ethyl Retinamide,WKYDOCGICAMTKE-NBIQJRODSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
68997,6lxt,DB08581,-7.2,"4-[(4-bromo-2-{[(3R,5S)-3,5-dimethylpiperidin-1-yl]carbonyl}phenyl)amino]-4-oxobutanoic acid",JSVSGWHGYIDZFX-TXEJJXNPSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
147651,6w9q,DB12253,-7.2,GDC-0810,BURHGPHDEVGCEZ-KJGLQBJMSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
57555,6crv,DB03818,-7.2,N-[Tosyl-D-Prolinyl]Amino-Ethanethiol,NWUYDTGYTUQMDG-CYBMUJFWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
94614,6m71,DB08320,-7.2,"DIETHYL (1R,2S,3R,4S)-5,6-BIS(4-HYDROXYPHENYL)-7-OXABICYCLO[2.2.1]HEPT-5-ENE-2,3-DICARBOXYLATE",NHKDFDHHMHBFLG-COPRSSIGSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
135584,6w9c,DB04656,-7.2,"1,3,4-TRIHYDROXY-5-(3-PHENOXYPROPYL)-CYCLOHEXANE-1-CARBOXYLIC A CID",SCUFESRLGCQXRX-DCDXPUDHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
1304,6lzg,HMDB0010359,-7.2,17-Hydroxyandrostane-3-glucuronide,GYNWSIBKBBWJJW-JRTXBCKMSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
88229,6m3m,DB13515,-7.2,Levomethadone,USSIQXCVUWKGNF-QGZVFWFLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84855,6m3m,DB06984,-7.2,"(1R,2R,3R,4S,5R)-4-(BENZYLAMINO)-5-(METHYLTHIO)CYCLOPENTANE-1,2,3-TRIOL",CHTYSDQNKZIWBZ-ZOLYEBIHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
121843,6w4b,DB12474,-7.2,Lynestrenol,YNVGQYHLRCDXFQ-XGXHKTLJSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
89631,6m71,DB00713,-7.2,Oxacillin,UWYHMGVUTGAWSP-JKIFEVAISA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
126546,6w4h,DB03973,-7.2,"3-{2,6,8-trioxo-9-[(2R,3R,4R)-2,3,4,5-tetrahydroxypentyl]-1,2,3,6,8,9-hexahydro-7H-purin-7-Yl}propyl dihydrogen phosphate",KPHFGOGGKPGLTM-ZXFLCMHBSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
60832,6crv,DB09204,-7.2,Arotinolol,BHIAIPWSVYSKJS-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
121863,6w4b,DB12507,-7.2,Atecegatran metoxil,XSNMGLZVFNDDPW-ZWKOTPCHSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
150992,6wiq,DB02123,-7.2,Glycochenodeoxycholic Acid,GHCZAUBVMUEKKP-GYPHWSFCSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
135569,6w9c,DB04639,-7.2,Biphenylalanine,JCZLABDVDPYLRZ-AWEZNQCLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
94624,6m71,DB08331,-7.2,"N-1H-imidazol-2-yl-N'-[4-(1H-imidazol-2-ylamino)phenyl]benzene-1,4-diamine",JHMXUERQMCJRHG-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
84880,6m3m,DB07012,-7.2,"6-AMINO-3,7-DIHYDRO-IMIDAZO[4,5-G]QUINAZOLIN-8-ONE",VQSMWFVKBKMHTO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
160778,7bv1,DB11221,-7.2,Dioxybenzone,MEZZCSHVIGVWFI-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94786,6m71,DB08530,-7.2,"7-BENZYL-1,3-DIMETHYL-8-PIPERAZIN-1-YL-3,7-DIHYDRO-PURINE-2,6-DIONE",QFSMMXJBEBXTJP-UHFFFAOYSA-O,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
12289,6lzg,DB13166,-7.2,Zofenopril,IAIDUHCBNLFXEF-MNEFBYGVSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
84881,6m3m,DB07013,-7.2,TERT-BUTYL 4-({[4-(BUT-2-YN-1-YLAMINO)PHENYL]SULFONYL}METHYL)-4-[(HYDROXYAMINO)CARBONYL]PIPERIDINE-1-CARBOXYLATE,RXFCFGLSOUOCEA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
127746,6w4h,DB06789,-7.2,Hydroxyprogesterone caproate,DOMWKUIIPQCAJU-LJHIYBGHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
102345,6vxs,DB07290,-7.2,(2R)-2-{[(4-FLUORO-3-METHYLPHENYL)SULFONYL]AMINO}-N-HYDROXY-2-TETRAHYDRO-2H-PYRAN-4-YLACETAMIDE,LUCFRFDOOYLALP-CYBMUJFWSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
27308,6cs2,DB06842,-7.2,(4R)-4-(3-butoxy-4-methoxybenzyl)imidazolidin-2-one,PDMUULPVBYQBBK-GFCCVEGCSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
88401,6m3m,DB13750,-7.2,Obidoxime,HIGRLDNHDGYWQJ-UHFFFAOYSA-P,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
7055,6lzg,DB03157,-7.2,"N,O-Didansyl-L-Tyrosine",LUBOPDUYHWABFG-NDEPHWFRSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
94746,6m71,DB08485,-7.2,"(1S,4S,5S)-1,4,5-TRIHYDROXY-3-[3-(PHENYLTHIO)PHENYL]CYCLOHEX-2-ENE-1-CARBOXYLIC ACID",QMNMNSINKIFYBV-LMMKCTJWSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
105934,6vxs,DB14648,-7.2,Acetyl simvastatin,OHVWRJDVJRNCPE-BIKFJBPRSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
12295,6lzg,DB13177,-7.2,4-methylumbelliferyl beta-D-glucoside,YUDPTGPSBJVHCN-YMILTQATSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
131648,6w4h,DB14120,-7.2,Phenylethyl resorcinol,PQSXNIMHIHYFEE-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
60883,6crv,DB09273,-7.2,Doxofylline,HWXIGFIVGWUZAO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
147623,6w9q,DB12219,-7.2,GSK-424887,DRXBWLBZWAJIEF-IBGZPJMESA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
102277,6vxs,DB07211,-7.2,(2R)-2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}PROPENE-1-SULFONAMIDE,YMJHMJLNQLVUAV-GHYUOPHCSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
160593,7bv1,DB08810,-7.2,Cinitapride,ZDLBNXXKDMLZMF-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94709,6m71,DB08440,-7.2,"N-1,10-phenanthrolin-5-ylacetamide",AAJXINSCZMZERD-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160598,7bv1,DB08819,-7.2,Tafluprost,WSNODXPBBALQOF-VEJSHDCNSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
131602,6w4h,DB14028,-7.2,Nordazepam,AKPLHCDWDRPJGD-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
102276,6vxs,DB07210,-7.2,"3-bromo-5-phenyl-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",JECHSYMSTXETFI-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
59644,6crv,DB07711,-7.2,"(2S,3R)-3-(6-amino-9H-purin-9-yl)nonan-2-ol",IOSAAWHGJUZBOG-WDEREUQCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
147585,6w9q,DB12155,-7.2,Napabucasin,DPHUWDIXHNQOSY-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
65766,6lxt,DB03267,-7.2,1-Allyl-3-Butyl-8-(N-Acetyl-4-Aminobenzyl)-Xanthine,XFOWZKUTPKXWIE-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
127017,6w4h,DB04602,-7.2,PUROMYCIN AMINONUCLEOSIDE-5'-MONOPHOSPHATE,BFPIKGKMRKBBBF-GRIPGOBMSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
126652,6w4h,DB04115,-7.2,Berberine,YBHILYKTIRIUTE-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
84674,6m3m,DB06731,-7.2,Seproxetine,WIQRCHMSJFFONW-HNNXBMFYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
121665,6w4b,DB12229,-7.2,Cerlapirdine,NXQGEDVQXVTCDA-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
23169,6cs2,HMDB0059747,-7.2,4-Hydroxy-3-methoxy-cinnamoylglycine,CLGNQAIRBLDHIN-HWKANZROSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
151339,6wiq,DB02573,-7.2,"2'-Deoxycytidine-2'-Deoxyadenosine-3',5'-Monophosphate",LYWWDKIADIGKTH-IDMWBNCISA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
27281,6cs2,DB06802,-7.2,Nepafenac,QEFAQIPZVLVERP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
121683,6w4b,DB12252,-7.2,PG-701,OKRSVUYYCJPECG-LFGMFVMYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
131612,6w4h,DB14045,-7.2,Cholesteryl chloride,OTVRYZXVVMZHHW-DPAQBDIFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
88348,6m3m,DB13677,-7.2,Carboquone,SHHKQEUPHAENFK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
135777,6w9c,DB04953,-7.2,Ezogabine,PCOBBVZJEWWZFR-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
135770,6w9c,DB04938,-7.2,Ospemifene,LUMKNAVTFCDUIE-VHXPQNKSSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
36057,1r42,DB02421,-7.2,Uridine-5'-Diphosphate-Mannose,HSCJRCZFDFQWRP-NYYOCOOHSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
130592,6w4h,DB12478,-7.2,Piribedil,OQDPVLVUJFGPGQ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
65769,6lxt,DB03272,-7.2,4-Bromo-3-(5'-Carboxy-4'-Chloro-2'-Fluorophenyl)-1-Methyl-5-Trifluoromethyl-Pyrazol,YNMHKERYELPEEF-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
88344,6m3m,DB13673,-7.2,Bekanamycin,SKKLOUVUUNMCJE-FQSMHNGLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
131618,6w4h,DB14060,-7.2,NS-398,KTDZCOWXCWUPEO-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
84664,6m3m,DB06716,-7.2,Fospropofol,QVNNONOFASOXQV-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
12208,6lzg,DB13039,-7.2,Aminaphthone,YLMPBJUYFTWHKJ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
151359,6wiq,DB02602,-7.2,AL7182,ICIXQGGQPKFQRL-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
160577,7bv1,DB08794,-7.2,Ethyl biscoumacetate,JCLHQFUTFHUXNN-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
84670,6m3m,DB06727,-7.2,Sparteine,SLRCCWJSBJZJBV-ZQDZILKHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
130632,6w4h,DB12543,-7.2,Samidorphan,RYIDHLJADOKWFM-MAODMQOUSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
108380,6vxx,DB07693,-7.2,"N-(3,5-dibromo-4-hydroxyphenyl)-2,6-dimethylbenzamide",IFECSMFQARKPSU-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
151374,6wiq,DB02621,-7.2,Latrunculin A,DDVBPZROPPMBLW-IZGXTMSKSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
126651,6w4h,DB04114,-7.2,"3-Chloro-9-Ethyl-6,7,8,9,10,11-Hexahydro-7,11-Methanocycloocta[B]Quinolin-12-Amine",QTPHSDHUHXUYFE-NWDGAFQWSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
103684,6vxs,DB08892,-7.2,Arbaclofen Placarbil,JXTAALBWJQJLGN-KSSFIOAISA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
160525,7bv1,DB08736,-7.2,"S,R-Warfarin alcohol",ZUJMMGHIYSAEOU-DOMZBBRYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
135892,6w9c,DB05562,-7.2,Naluzotan,SPWZXWDPAWDKQE-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
25257,6cs2,DB03148,-7.2,Phosphomethylphosphonic Acid Adenosyl Ester,OLCWZBFDIYXLAA-IOSLPCCCSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
28229,6cs2,DB07810,-7.2,"3-(4-HYDROXYPHENYL)-1-(2,4,6-TRIHYDROXYPHENYL)PROPAN-1-ONE",VGEREEWJJVICBM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
89636,6m71,DB00718,-7.2,Adefovir dipivoxil,WOZSCQDILHKSGG-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
102258,6vxs,DB07188,-7.2,"(3S)-1-CYCLOHEXYL-N-(3,5-DICHLOROPHENYL)-5-OXOPYRROLIDINE-3-CARBOXAMIDE",YUFADRZDHJKVOT-NSHDSACASA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
88262,6m3m,DB13559,-7.2,Rimiterol,IYMMESGOJVNCKV-JOYOIKCWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
28183,6cs2,DB07764,-7.2,FLUORESCIN,MURGITYSBWUQTI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
102318,6vxs,DB07260,-7.2,N-benzyl-4-[(2R)-pyrrolidin-2-ylmethoxy]aniline,HITMFLNAOQIZSN-QGZVFWFLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
126607,6w4h,DB04060,-7.2,"(5-Methyl-6-Oxo-1,6-Dihydro-Pyridin-3-Yl)-1,2-Dideoxy-Ribofuranose-5-Monophosphate",MUWYCJQCZPFLFI-IVZWLZJFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
160496,7bv1,DB08458,-7.2,(4-BROMOPHENYL)[4-({(2E)-4-[CYCLOPROPYL(METHYL)AMINO]BUT-2-ENYL}OXY)PHENYL]METHANONE,JAZMZJDLZUDIDG-NSCUHMNNSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160494,7bv1,DB08455,-7.2,Ro 12-7310,CAAFTBWHFUPDGX-OFCLTBKTSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
102255,6vxs,DB07185,-7.2,2-{[(4-CHLOROPHENOXY)ACETYL]AMINO}BENZOIC ACID,LXSDGQYDSDIUPN-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
88390,6m3m,DB13730,-7.2,Nifurtoinol,UIDWQGRXEVDFCA-XCVCLJGOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
156752,6wiq,DB13643,-7.2,Loprazolam,UTEFBSAVJNEPTR-RGEXLXHISA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
160482,7bv1,DB08441,-7.2,"6-BROMO-13-THIA-2,4,8,12,19-PENTAAZATRICYCLO[12.3.1.1-3,7-]NONADECA-1(18),3(19),4,6,14,16-HEXAENE 13,13-DIOXIDE",AWSQADBSXFTFKL-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
135638,6w9c,DB04743,-7.2,Nimesulide,HYWYRSMBCFDLJT-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
11612,6lzg,DB12206,-7.2,N-6022,YVPGZQLRPAGKLA-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
34076,6cs2,T3D0936,-7.2,Butacarb,SLZWBCGZQRRUNG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
135646,6w9c,DB04756,-7.2,"2-[(3,5-Dichloro-4-trioxidanylphenyl)amino]benzoic acid",SNAMTVTZDPUVRA-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
25267,6cs2,DB03161,-7.2,Thymidine-5'-Diphospho-Beta-D-Xylose,AJUADKZRQSBUAK-KDGZBOQCSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
84589,6m3m,DB06575,-7.2,Valomaciclovir,ATSZELKUSAREPW-ZJUUUORDSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
36063,1r42,DB02429,-7.2,4-(Aminosulfonyl)-N-[(4-Fluorophenyl)Methyl]-Benzamide,IXDVPACDZDRCTN-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
57567,6crv,DB03833,-7.2,"2-Prolyl-5-Tert-Butyl-[1,3,4]Oxadiazole",YUKGJYBQODPVBL-ZETCQYMHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
65774,6lxt,DB03277,-7.2,alpha-maltotriose,FYGDTMLNYKFZSV-PXXRMHSHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
156389,6wiq,DB13024,-7.2,MK-8245,UJEAABFSXKCSGI-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
147636,6w9q,DB12234,-7.2,BMS-214662,OLCWFLWEHWLBTO-HSZRJFAPSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
55339,6crv,DB00891,-7.2,Sulfapyridine,GECHUMIMRBOMGK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
57394,6crv,DB03609,-7.2,3-Deoxyguanosine,OROIAVZITJBGSM-OBXARNEKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
94679,6m71,DB08401,-7.2,(2E)-2-({(2S)-2-CARBOXY-2-[(PHENOXYACETYL)AMINO]ETHOXY}IMINO)PENTANEDIOIC ACID,LDNKNKRRFZRLIG-HWQJWEFDSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
103638,6vxs,DB08811,-7.2,Tofisopam,RUJBDQSFYCKFAA-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
131382,6w4h,DB13670,-7.2,Oxantel,VRYKTHBAWRESFI-VOTSOKGWSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
152146,6wiq,DB03672,-7.2,9-N-Phenylmethylamino-Tacrine,JYJAEHAURXXPSD-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
151154,6wiq,DB02341,-7.2,"Mdl 101,146",XQAMVCHQGHAELT-YPAWHYETSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
69607,6lxt,DB11279,-7.2,Brilliant green cation,HXCILVUBKWANLN-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
160522,7bv1,DB08733,-7.2,"(2R,3R)-N^1^-[(1S)-2,2-DIMETHYL-1-(METHYLCARBAMOYL)PROPYL]-N^4^-HYDROXY-2-(2-METHYLPROPYL)-3-{[(1,3-THIAZOL-2-YLCARBONYL)AMINO]METHYL}BUTANEDIAMIDE",GAHIXYNNFMCKFQ-HZSPNIEDSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
12649,6lzg,DB13635,-7.2,Tiracizine,KJAMZCVTJDTESW-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
127800,6w4h,DB06870,-7.2,"17-HYDROXY-18A-HOMO-19-NOR-17ALPHA-PREGNA-4,9,11-TRIEN-3-ONE",OXHNQTSIKGHVBH-ANULTFPQSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
88304,6m3m,DB13619,-7.2,Bornaprine,BDNMABJZSXTKAQ-VCPDFFEISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
126995,6w4h,DB04573,-7.2,Estriol,PROQIPRRNZUXQM-ZXXIGWHRSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130578,6w4h,DB12461,-7.2,GLPG-0492,VAJGULUVTFDTAS-GOSISDBHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
28191,6cs2,DB07772,-7.2,"(1R)-1-{[(4'-methoxy-1,1'-biphenyl-4-yl)sulfonyl]amino}-2-methylpropylphosphonic acid",BZVYQWLRCHLAGK-QGZVFWFLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
135517,6w9c,DB04571,-7.2,Trioxsalen,FMHHVULEAZTJMA-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
59676,6crv,DB07748,-7.2,2-({[4-(TRIFLUOROMETHOXY)PHENYL]SULFONYL}AMINO)ETHYL DIHYDROGEN PHOSPHATE,JDDKDMFCTOZVCJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55480,6crv,DB01054,-7.2,Nitrendipine,PVHUJELLJLJGLN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
88166,6m3m,DB13431,-7.2,Proglumide,DGMKFQYCZXERLX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
12271,6lzg,DB13122,-7.2,Trabodenoson,AQLVRTWKJDTWQQ-SDBHATRESA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
103733,6vxs,DB08965,-7.2,Fusafungine,MIZMDSVSLSIMSC-OGLSAIDSSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
59699,6crv,DB07773,-7.2,5-FLUOROINDOLE PROPANOL PHOSPHATE,YVYGGBFCYXRNKM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
122046,6w4b,DB12796,-7.2,MRX-I,SULYVXZZUMRQAX-NSHDSACASA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
1203,6lzg,HMDB0000380,-7.2,2-Hydrox1tradiol-3-methyl ether,MMKYSUOJWFKECQ-SSTWWWIQSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
105727,6vxs,DB13920,-7.2,Valopicitabine,TVRCRTJYMVTEFS-ICGCPXGVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
131841,6w4h,DB14835,-7.2,SUVN-G3031,LNXDUSQEXVQFGP-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
67572,6lxt,DB06909,-7.2,"1-ethyl-N-(phenylmethyl)-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridine-5-carboxamide",QZGJNFBMYYEFGM-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
102205,6vxs,DB07128,-7.2,"N7-BUTYL-N2-(5-CHLORO-2-METHYLPHENYL)-5-METHYL[1,2,4]TRIAZOLO[1,5-A]PYRIMIDINE-2,7-DIAMINE",ZTYBIJUAAWLJNU-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
71825,6lxt,DB15348,-7.2,Ampreloxetine,TZIALEBTHQWNAO-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
106043,6vxs,DB14876,-7.2,TAS-116,NVVPMZUGELHVMH-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
121488,6w4b,DB11964,-7.2,Ilaprazole,HRRXCXABAPSOCP-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
155785,6wiq,DB11730,-7.2,Ribociclib,RHXHGRAEPCAFML-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
88352,6m3m,DB13681,-7.2,Butalamine,VYWQZAARVNRSTR-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
150852,6wiq,DB01944,-7.2,(S)-blebbistatin,LZAXPYOBKSJSEX-GOSISDBHSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
147791,6w9q,DB12445,-7.2,Nitroaspirin,IOJUJUOXKXMJNF-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
11676,6lzg,DB12286,-7.2,Simendan,WHXMKTBCFHIYNQ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
135404,6w9c,DB04425,-7.2,"7,8-Dihydroneopterin",YQIFAMYNGGOTFB-XINAWCOVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
131804,6w4h,DB14737,-7.2,Cannabinol,VBGLYOIFKLUMQG-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
156563,6wiq,DB13310,-7.2,Ormeloxifene,XZEUAXYWNKYKPL-WDYNHAJCSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
17657,6cs2,HMDB0000365,-7.2,Epiandrosterone,QGXBDMJGAMFCBF-QRIARFFBSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
71816,6lxt,DB15334,-7.2,Biochanin A,WUADCCWRTIWANL-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
71817,6lxt,DB15335,-7.2,Formononetin,HKQYGTCOTHHOMP-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
121504,6w4b,DB11990,-7.2,MK-0812,UNVWTBOGMHPKJM-CWKRKGSWSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
102209,6vxs,DB07132,-7.2,1-{2-OXO-3-[(1R)-1-(1H-PYRROL-2-YL)ETHYL]-2H-INDOL-5-YL}UREA,KJDBLWKTHMHALD-QMMMGPOBSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
135415,6w9c,DB04441,-7.2,2-Fluoroadenosine,HBUBKKRHXORPQB-UUOKFMHZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
121500,6w4b,DB11985,-7.2,Dapaconazole,FUAHXHWSMYFWGE-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
122009,6w4b,DB12732,-7.2,Firategrast,YLFZHHDVRSYTKT-NRFANRHFSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
34360,1r42,DB00157,-7.2,NADH,BOPGDPNILDQYTO-NNYOXOHSSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
160252,7bv1,DB07929,-7.2,"N-(TERT-BUTYL)-3,5-DIMETHYL-N'-[(5-METHYL-2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)CARBONYL]BENZOHYDRAZIDE",JGJACZABNQGPMT-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
67165,6lxt,DB05913,-7.2,OSI-930,FGTCROZDHDSNIO-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
92138,6m71,DB04001,-7.2,6-(Oxalyl-Amino)-1h-Indole-5-Carboxylic Acid,AHWMERGBWWROMM-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160249,7bv1,DB07926,-7.2,N-[3-(N'-HYDROXYCARBOXAMIDO)-2-(2-METHYLPROPYL)-PROPANOYL]-O-TYROSINE-N-METHYLAMIDE,QYZPDCGWIJYZMN-ZBFHGGJFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
71818,6lxt,DB15338,-7.2,Rovatirelin,WTXWDXWZGJGIHV-URBCHYCLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
27319,6cs2,DB06853,-7.2,N-cycloheptylglycyl-N-(4-carbamimidoylbenzyl)-L-prolinamide,BYTJPDBCLWUEBU-IBGZPJMESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
105887,6vxs,DB14538,-7.2,Hydrocortisone aceponate,MFBMYAOAMQLLPK-FZNHGJLXSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
151597,6wiq,DB02917,-7.2,N-Hydroxy-4-(Methyl{[5-(2-Pyridinyl)-2-Thienyl]Sulfonyl}Amino)Benzamide,LFGYSFPVLMPUPE-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
102412,6vxs,DB07363,-7.2,"THIOPHENE-2,5-DISULFONIC ACID 2-AMIDE-5-(4-METHYL-BENZYLAMIDE)",GUNRMHMEAWSZQE-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
69682,6lxt,DB11461,-7.2,Sulfachlorpyridazine,XOXHILFPRYWFOD-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
147798,6w9q,DB12459,-7.2,Belotecan,LNHWXBUNXOXMRL-VWLOTQADSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
130696,6w4h,DB12647,-7.2,Tocotrienol,GJJVAFUKOBZPCB-ZGRPYONQSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
160194,7bv1,DB07625,-7.2,"4-(2-aminoethoxy)-N-(2,5-diethoxyphenyl)-3,5-dimethylbenzamide",PHTPPZCTHZHCQD-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160897,7bv1,DB11885,-7.2,Anlotinib,KSMZEXLVHXZPEF-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
69024,6lxt,DB08614,-7.2,"3-[[(METHYLAMINO)SULFONYL]AMINO]-2-OXO-6-PHENYL-N-[3,3,3-TRIFLUORO-1-(1-METHYLETHYL)-2-OXOPHENYL]-1(2H)-PYRIDINE ACETAMIDE",MYFMPKCOIMRDDD-KRWDZBQOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
85199,6m3m,DB07376,-7.2,5-(DIMETHYLAMINO)-1-NAPHTHALENESULFONIC ACID(DANSYL ACID),BBEQQKBWUHCIOU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85200,6m3m,DB07377,-7.2,"N'-((2S,3R)-3-AMINO-2-HYDROXY-5-(ISOPROPYLSULFANYL)PENTANOYL)-N-3-CHLOROBENZOYL HYDRAZIDE",BYBVYIPUGPZRSX-OLZOCXBDSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
28278,6cs2,DB07860,-7.2,(2R)-2-(4-CHLOROPHENYL)-2-PHENYLETHANAMINE,PNKKPFLBOWGVSF-CQSZACIVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
28060,6cs2,DB07633,-7.2,octyl 3-deoxy-2-O-(6-deoxy-alpha-L-galactopyranosyl)-beta-D-xylo-hexopyranoside,FBVFDKBCZLMLQT-PPCMOIRNSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
135287,6w9c,DB04260,-7.2,"9-(5,5-Difluoro-5-Phosphonopentyl)Guanine",JANQQPWTLXUSCD-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
147833,6w9q,DB12512,-7.2,Verucerfont,VKHVAUKFLBBZFJ-SFHVURJKSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
157103,6wiq,DB14570,-7.2,Hydroxyprogesterone,DBPWSSGDRRHUNT-CEGNMAFCSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
94479,6m71,DB08152,-7.2,{(2S)-1-[N-(tert-butoxycarbonyl)glycyl]pyrrolidin-2-yl}methyl (3-chlorophenyl)acetate,ONXGIEJBNQLITK-INIZCTEOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
147451,6w9q,DB11960,-7.2,Carboxyamidotriazole,WNRZHQBJSXRYJK-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
36203,1r42,DB02611,-7.2,Balanol Analog 1,FZJQHARRQUNVGZ-QZTJIDSGSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
88105,6m3m,DB13350,-7.2,Azanidazole,LHIALLMPKJMSIQ-NSCUHMNNSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84391,6m3m,DB05939,-7.2,MK-0354,LTQYSJKGRPGMPO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
102199,6vxs,DB07122,-7.2,1-[4-(2-oxo-2-phenylethyl)phenyl]guanidine,MERNPSIIBFTCAI-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
160912,7bv1,DB12262,-7.2,CRS-3123,NNTYBKTXMKBRFA-CQSZACIVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
89594,6m71,DB00672,-7.2,Chlorpropamide,RKWGIWYCVPQPMF-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94477,6m71,DB08150,-7.2,"4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-aminium",RZIDZIGAXXNODG-UHFFFAOYSA-O,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
17681,6cs2,HMDB0000416,-7.2,17-Hydroxypregnenolone sulfate,OMOKWYAQVYBHMG-QUPIPBJSSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
12312,6lzg,DB13217,-7.2,Fentiazac,JIEKMACRVQTPRC-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
147829,6w9q,DB12507,-7.2,Atecegatran metoxil,XSNMGLZVFNDDPW-ZWKOTPCHSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
122118,6w4b,DB12910,-7.2,Emicerfont,JFHJGXQFESYQGY-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
35974,1r42,DB02322,-7.2,Heparin Disaccharide I-S,LRPGJWKAYQRIAQ-GYBHJADLSA-J,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
10809,6lzg,DB09095,-7.2,Difluocortolone,OGPWIDANBSLJPC-RFPWEZLHSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
92756,6m71,DB04829,-7.2,Lysergic acid diethylamide,VAYOSLLFUXYJDT-RDTXWAMCSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
69705,6lxt,DB11518,-7.2,Flunixin,NOOCSNJCXJYGPE-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
94831,6m71,DB08582,-7.2,"N-(4-bromo-2-{[(3R,5S)-3,5-dimethylpiperidin-1-yl]carbonyl}phenyl)-4-morpholin-4-yl-4-oxobutanamide",DELARNBPJXTDBD-IYBDPMFKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160193,7bv1,DB07624,-7.2,"1-{[(3R)-3-methyl-4-({4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]phenyl}sulfonyl)piperazin-1-yl]methyl}cyclopropanecarboxamide",YJFULAYRAKPBCY-DYVFJYSZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
147453,6w9q,DB11962,-7.2,GSK-1059615,QDITZBLZQQZVEE-YBEGLDIGSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
88146,6m3m,DB13406,-7.2,Carbutamide,VDTNNGKXZGSZIP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
150812,6wiq,DB01879,-7.2,(S)-2-{Methyl-[2-(Naphthalene-2-Sulfonylamino)-5-(Naphthalene-2-Sulfonyloxy)-Benzoyl]-Amino}-Succinicacid,JOAALZBSMWLOPQ-LJAQVGFWSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
65877,6lxt,DB03417,-7.2,1-(4-Tert-Butylcarbamoyl-Piperazine-1-Carbonyl)-3-(3-Guanidino-Propyl)-4-Oxo-Azetidine-2-Carboxylic Acid,BVNQCAHTTOIOEK-STQMWFEESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
105868,6vxs,DB14209,-7.2,Trandolaprilat,AHYHTSYNOHNUSH-HXFGRODQSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
88141,6m3m,DB13398,-7.2,Oxyfedrine,GDYUVHBMFVMBAF-LIRRHRJNSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
65880,6lxt,DB03421,-7.2,"2-Phenethyl-2,3-Dihydro-Phthalazine-1,4-Dione",JSSVIGGKHIJEHO-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
135334,6w9c,DB04324,-7.2,Ovalicin,UOXVFQCRPDLSFN-DGXTUMSLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
67038,6lxt,DB05154,-7.2,Pretomanid,ZLHZLMOSPGACSZ-NSHDSACASA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
135316,6w9c,DB04297,-7.2,"7-[4-(Dimethylamino)Phenyl]-N-Hydroxy-4,6-Dimethyl-7-Oxo-2,4-Heptadienamide",RTKIYFITIVXBLE-QEQCGCAPSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
135312,6w9c,DB04293,-7.2,7-(2-Amino-2-Phenyl-Acetylamino)-3-Chloro-8-Oxo-1-Aza-Bicyclo[4.2.0]Oct-2-Ene-2-Carboxylic Acid,JAPHQRWPEGVNBT-IJLUTSLNSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
130700,6w4h,DB12654,-7.2,GSK-376501,OIDYMQICWGYEDR-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
160185,7bv1,DB07615,-7.2,Tranilast,NZHGWWWHIYHZNX-CSKARUKUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
34341,1r42,DB00137,-7.2,Lutein,KBPHJBAIARWVSC-RGZFRNHPSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
121999,6w4b,DB12717,-7.2,Mibampator,ULRDYYKSPCRXAJ-KRWDZBQOSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
88180,6m3m,DB13449,-7.2,Proxyphylline,KYHQZNGJUGFTGR-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84964,6m3m,DB07108,-7.2,"4'-FLUORO-1,1'-BIPHENYL-4-CARBOXYLIC ACID",LXWNTLBMNCXRQN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
130667,6w4h,DB12596,-7.2,Combretastatin,LGZKGOGODCLQHG-CYBMUJFWSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
69658,6lxt,DB11423,-7.2,Lasalocid,BBMULGJBVDDDNI-OWKLGTHSSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
12310,6lzg,DB13215,-7.2,Sulfobromophthalein,OHTXTCNTQJFRIG-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
55288,6crv,DB00833,-7.2,Cefaclor,QYIYFLOTGYLRGG-GPCCPHFNSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
147709,6w9q,DB12327,-7.2,Salvinorin A,OBSYBRPAKCASQB-AGQYDFLVSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
27271,6cs2,DB06787,-7.2,Hexocyclium,ZRYHPQCHHOKSMD-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
160818,7bv1,DB11770,-7.2,Talinolol,MXFWWQICDIZSOA-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
156648,6wiq,DB13499,-7.2,Cefsulodin,SYLKGLMBLAAGSC-QLVMHMETSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
135497,6w9c,DB04546,-7.2,3-Deaza-Adenosine,DBZQFUNLCALWDY-PNHWDRBUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
57549,6crv,DB03812,-7.2,"3-{2,6,8-trioxo-9-[(2S,3R,4R)-2,3,4,5-tetrahydroxypentyl]-1,2,3,6,8,9-hexahydro-7H-purin-7-Yl}propyl dihydrogen phosphate",KPHFGOGGKPGLTM-LKEWCRSYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
103713,6vxs,DB08940,-7.2,Kebuzone,LGYTZKPVOAIUKX-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
121935,6w4b,DB12621,-7.2,ST-101,QZWYXEBIQWJXAR-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
121544,6w4b,DB12050,-7.2,LY-3039478,YCBAQKQAINQRFW-UGSOOPFHSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
160831,7bv1,DB11789,-7.2,Hyodeoxycholic Acid,DGABKXLVXPYZII-SIBKNCMHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
5948,6lzg,HMDB0240252,-7.2,Salicyluric beta-D-glucuronide,OEPADIDIUZTYOX-QKZHPOIUSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
28133,6cs2,DB07712,-7.2,3-ETHYL-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL,XBMVVMYGKMGLJX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
27270,6cs2,DB06786,-7.2,Halcinonide,MUQNGPZZQDCDFT-JNQJZLCISA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
153215,6wiq,DB05608,-7.2,MKC-1,OVSKGTONMLKNPZ-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
55506,6crv,DB01084,-7.2,Emedastine,KBUZBQVCBVDWKX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
156653,6wiq,DB13506,-7.2,Carfecillin,NZDASSHFKWDBBU-KVMCETHSSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
160348,7bv1,DB08035,-7.2,"1-TERT-BUTYL-3-(2,5-DIMETHYLBENZYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE",QUPXEJURIFFVSX-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
108276,6vxx,DB07565,-7.2,Chloramphenicol succinate,LIRCDOVJWUGTMW-ZWNOBZJWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108442,6vxx,DB07995,-7.2,N-[2-(4-BROMOCINNAMYLAMINO)ETHYL]-5-ISOQUINOLINE SULFONAMIDE,ZKZXNDJNWUTGDK-NSCUHMNNSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
71584,6lxt,DB14849,-7.2,Nebicapone,MRFOLGFFTUGAEB-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
121565,6w4b,DB12081,-7.2,Anecortave,BCFCRXOJOFDUMZ-ONKRVSLGSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
67136,6lxt,DB05708,-7.2,GTS-21,RPYWXZCFYPVCNQ-RVDMUPIBSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
126987,6w4h,DB04563,-7.2,CRA_9678,VIZNZQTZRMTYPZ-UHFFFAOYSA-M,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
108271,6vxx,DB07560,-7.2,N-[(1S)-2-methyl-1-(pyridin-4-ylcarbamoyl)propyl]cyclohexanecarboxamide,VYLDPSVXLWTIAJ-HNNXBMFYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
105770,6vxs,DB13994,-7.2,AZD-7325,KYDURMHFWXCKMW-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
147508,6w9q,DB12046,-7.2,Atopaxar,QWKAUGRRIXBIPO-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
121907,6w4b,DB12573,-7.2,LY-2452473,IHIWYQYVBNODSV-KRWDZBQOSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
65827,6lxt,DB03348,-7.2,Huperzine B,YYWGABLTRMRUIT-HWWQOWPSSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
47044,2fxp,DB01259,-7.2,Lapatinib,BCFGMOOMADDAQU-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
147688,6w9q,DB12302,-7.2,CP-724714,LLVZBTWPGQVVLW-SNAWJCMRSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
155769,6wiq,DB11701,-7.2,Amenamevir,MNHNIVNAFBSLLX-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
121914,6w4b,DB12582,-7.2,Piperine,MXXWOMGUGJBKIW-YPCIICBESA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
23463,6cs2,HMDB0061860,-7.2,"2-Acetyl-3,5,5,6,8,8-hexamethyl-5,6,7,8- tetrahydronaphthalene",DNRJTBAOUJJKDY-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
155771,6wiq,DB11703,-7.2,Acalabrutinib,WDENQIQQYWYTPO-IBGZPJMESA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
126482,6w4h,DB03887,-7.2,Alpha-Adenosine Monophosphate,NVOIXARBSSLBAS-CRKDRTNXSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
147687,6w9q,DB12301,-7.2,Doravirine,ZIAOVIPSKUPPQW-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
157112,6wiq,DB14624,-7.2,Nandrolone hydrogen sulfate,SKZMVWBZTQNCKW-IZPLOLCNSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
36003,1r42,DB02360,-7.2,Bis-Napthyl Beta-Ketophosphonic Acid,OFHMUASCSJJNNA-JOCHJYFZSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
160323,7bv1,DB08009,-7.2,"5-[(E)-(5-CHLORO-2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]-N-[2-(DIETHYLAMINO)ETHYL]-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXAMIDE",XPLJEFSRINKZLC-ATVHPVEESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
156408,6wiq,DB13055,-7.2,Oteseconazole,IDUYJRXRDSPPRC-NRFANRHFSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
108233,6vxx,DB07258,-7.2,(R)-pyridin-4-yl[4-(2-pyrrolidin-1-ylethoxy)phenyl]methanol,QQRJWLDQBNAQCC-GOSISDBHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
131776,6w4h,DB14672,-7.2,Oxazepam acetate,FYRWUTOZBRWYCS-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
88470,6m3m,DB13840,-7.2,Hydroxyethylpromethazine,PDSVTRQOBUIQBQ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
71541,6lxt,DB14737,-7.2,Cannabinol,VBGLYOIFKLUMQG-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
160280,7bv1,DB07962,-7.2,"METHYL N-[(2',4'-DIFLUORO-4-HYDROXY-5-IODOBIPHENYL-3-YL)CARBONYL]-BETA-ALANINATE",ZMRRBWRMQPQQAN-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
67054,6lxt,DB05265,-7.2,Ecabet,IWCWQNVIUXZOMJ-MISYRCLQSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
94815,6m71,DB08562,-7.2,4-(4-STYRYL-PHENYLCARBAMOYL)-BUTYRIC ACID,FTXJWRRYLLRFMG-MDZDMXLPSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
25303,6cs2,DB03205,-7.2,Pyrroloquinoline Quinone,MMXZSJMASHPLLR-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
59689,6crv,DB07762,-7.2,4-(N-ACETYLAMINO)-3-[N-(2-ETHYLBUTANOYLAMINO)]BENZOIC ACID,USKXJFHTBQWXCS-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
12629,6lzg,DB13610,-7.2,Flumedroxone,CDZJOBWKHSYNMO-SCUQKFFVSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
147464,6w9q,DB11979,-7.2,Elagolix,HEAUOKZIVMZVQL-VWLOTQADSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
1214,6lzg,HMDB0000405,-7.2,2-Methox1tradiol,CQOQDQWUFQDJMK-SSTWWWIQSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
94555,6m71,DB08245,-7.2,1-(2-DEOXY-5-O-PHOSPHONO-BETA-D-ERYTHRO-PENTOFURANOSYL)-5-NITRO-1H-INDOLE,FQCJFJRLZCIFHB-YNEHKIRRSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160257,7bv1,DB07934,-7.2,[[CYCLOHEXANESULFONYL-GLYCYL]-3[PYRIDIN-4-YL-AMINOMETHYL]ALANYL]PIPERIDINE,KMUXFASJKPVMGU-HXUWFJFHSA-O,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
69678,6lxt,DB11455,-7.2,Robenacoxib,ZEXGDYFACFXQPF-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
105888,6vxs,DB14539,-7.2,Hydrocortisone acetate,ALEXXDVDDISNDU-JZYPGELDSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
147751,6w9q,DB12393,-7.2,Fanapanel,WZMQMKNCWDCCMT-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
85065,6m3m,DB07223,-7.2,"METHYL N-({(2S,3S)-3-[(PROPYLAMINO)CARBONYL]OXIRAN-2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINATE",XGWSRLSPWIEMLQ-YTFOTSKYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
160333,7bv1,DB08019,-7.2,"N-{(3R,4S)-4-[(6-amino-4-methylpyridin-2-yl)methyl]pyrrolidin-3-yl}-N'-(3-chlorobenzyl)ethane-1,2-diamine",VWCMAGONQJHIJZ-LPHOPBHVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
135437,6w9c,DB04469,-7.2,"1-(4-Methoxyphenyl)-3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester",ZDSXCFSUGVAQSB-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
28116,6cs2,DB07694,-7.2,"2,5-dichloro-N-(3,5-dibromo-4-hydroxyphenyl)benzamide",IFLWCZRMFPKYBN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
67159,6lxt,DB05864,-7.2,PPI-2458,QBDVVYNLLXGUGN-XGTBZJOHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
156972,6wiq,DB13997,-7.2,Baloxavir marboxil,RZVPBGBYGMDSBG-GGAORHGYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
92058,6m71,DB03895,-7.2,Malachite Green,VFCNQNZNPKRXIT-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
131772,6w4h,DB14668,-7.2,Dienestrol diacetate,YWLLGDVBTLPARJ-OXAZHYLESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
34309,1r42,DB00430,-7.2,Cefpiramide,PWAUCHMQEXVFJR-PMAPCBKXSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
121538,6w4b,DB12043,-7.2,Sepetaprost,BKVUSNOUTQMSBE-XCMGCKIWSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
85019,6m3m,DB07170,-7.2,"5'-FLUORO-2',5'-DIDEOXYADENOSINE",QKUCDAPGYBWICH-RRKCRQDMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
94808,6m71,DB08555,-7.2,"1-(3-bromophenyl)-7-chloro-6-methoxy-3,4-dihydroisoquinoline",IKGXHBGCVQTQBH-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
147476,6w9q,DB11999,-7.2,Vosaroxin,XZAFZXJXZHRNAQ-STQMWFEESA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
34312,1r42,DB00434,-7.2,Cyproheptadine,JJCFRYNCJDLXIK-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
47156,2fxp,DB01459,-7.2,Bezitramide,FLKWNFFCSSJANB-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
57468,6crv,DB03716,-7.2,5'-Fluoro-5'-Deoxyadenosine,QPVLKMICBYRPSX-KQYNXXCUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
150890,6wiq,DB01990,-7.2,Cholesterol sulfate,BHYOQNUELFTYRT-DPAQBDIFSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
49132,2fxp,DB04071,-7.2,Cpad,LFERELMXERXKKQ-KMXXXSRASA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
108235,6vxx,DB07260,-7.2,N-benzyl-4-[(2R)-pyrrolidin-2-ylmethoxy]aniline,HITMFLNAOQIZSN-QGZVFWFLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59685,6crv,DB07758,-7.2,"5-(2,5-DICHLOROPHENYL)-2-FUROIC ACID",ATAZLMGGQQLRBC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
71545,6lxt,DB14753,-7.2,Hydroxystilbamidine,TUESWZZJYCLFNL-DAFODLJHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
84444,6m3m,DB06193,-7.2,Pixantrone,PEZPMAYDXJQYRV-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
94577,6m71,DB08274,-7.2,"6,7,8,9-TETRAHYDRO-4-HYDROXY-3-(1-PHENYLPROPYL)CYCLOHEPTA[B]PYRAN-2-ONE",YKJXQZGJGDTEOC-AWEZNQCLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
71830,6lxt,DB15359,-7.2,Xanthohumol,ORXQGKIUCDPEAJ-YRNVUSSQSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
158016,7bv1,DB00275,-7.2,Olmesartan,VTRAEEWXHOVJFV-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
85503,6m3m,DB07738,-7.2,"N-[1-(5-bromo-2,3-dimethoxybenzyl)piperidin-4-yl]-4-sulfanylbutanamide",HESMISSJMKCCAV-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
15938,6lzg,DB02004,-7.2,"5-(Aminomethyl)-6-(2,4-Dichlorophenyl)-2-(3,5-Dimethoxyphenyl)Pyrimidin-4-Amine",RCJFINNFYUNFGH-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
93685,6m71,DB07235,-7.2,"N-[(1S)-2-AMINO-1-(2,4-DICHLOROBENZYL)ETHYL]-5-[2-(METHYLAMINO)PYRIMIDIN-4-YL]THIOPHENE-2-CARBOXAMIDE",HHOVRZGUSBMKKU-ZDUSSCGKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
158525,7bv1,DB01582,-7.2,Sulfamethazine,ASWVTGNCAZCNNR-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
11157,6lzg,DB11529,-7.2,Melengestrol,OKHAOBQKCCIRLO-IBVJIVQJSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
123933,6w4h,DB00558,-7.2,Zanamivir,ARAIBEBZBOPLMB-UFGQHTETSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
149985,6wiq,DB00823,-7.2,Ethynodiol diacetate,ONKUMRGIYFNPJW-KIEAKMPYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
127399,6w4h,DB05708,-7.2,GTS-21,RPYWXZCFYPVCNQ-RVDMUPIBSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
93238,6m71,DB06649,-7.2,Priralfinamide,BHJIBOFHEFDSAU-LBPRGKRZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
35168,1r42,DB01216,-7.2,Finasteride,DBEPLOCGEIEOCV-WSBQPABSSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
123948,6w4h,DB00579,-7.2,Mazindol,ZPXSCAKFGYXMGA-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
67384,6lxt,DB06608,-7.2,Tafenoquine,LBHLFPGPEGDCJG-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
87382,6m3m,DB12244,-7.2,CP-601927,RNOBTWYQAWEZHH-JGVFFNPUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
132566,6w9c,DB00586,-7.2,Diclofenac,DCOPUUMXTXDBNB-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
89360,6m71,DB00383,-7.2,Oxyphencyclimine,DUDKAZCAISNGQN-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
89354,6m71,DB00377,-7.2,Palonosetron,CPZBLNMUGSZIPR-NVXWUHKLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
86544,6m3m,DB09000,-7.2,Cyamemazine,SLFGIOIONGJGRT-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
132611,6w9c,DB00640,-7.2,Adenosine,OIRDTQYFTABQOQ-KQYNXXCUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
123968,6w4h,DB00601,-7.2,Linezolid,TYZROVQLWOKYKF-ZDUSSCGKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131088,6w4h,DB13277,-7.2,Benziodarone,CZCHIEJNWPNBDE-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
149201,6w9q,DB15141,-7.2,Deutivacaftor,PURKAOJPTOLRMP-ASMGOKTBSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
93241,6m71,DB06656,-7.2,TAS-106,JFIWEPHGRUDAJN-DYUFWOLASA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
67317,6lxt,DB06440,-7.2,Ravuconazole,OPAHEYNNJWPQPX-RCDICMHDSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
123980,6w4h,DB00614,-7.2,Furazolidone,PLHJDBGFXBMTGZ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
93665,6m71,DB07210,-7.2,"3-bromo-5-phenyl-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",JECHSYMSTXETFI-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93678,6m71,DB07227,-7.2,4-[(5-{[4-(3-CHLOROPHENYL)-3-OXOPIPERAZIN-1-YL]METHYL}-1H-IMIDAZOL-1-YL)METHYL]BENZONITRILE,JNUGFGAVPBYSHF-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
70192,6lxt,DB12288,-7.2,Piromelatine,PNTNBIHOAPJYDB-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
27678,6cs2,DB07232,-7.2,Veliparib,JNAHVYVRKWKWKQ-CYBMUJFWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
92414,6m71,DB04373,-7.2,"4-Amino-N-{4-[2-(2,6-Dimethyl-Phenoxy)-Acetylamino]-3-Hydroxy-1-Isobutyl-5-Phenyl-Pentyl}-Benzamide",WQUBEIMCFHCJCO-AWCRTANDSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
158565,7bv1,DB01633,-7.2,Deoxy-2-fluoro-beta-D-cellotrioside,BZNXZJAUEMJQJB-QSCMNUSVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
27683,6cs2,DB07238,-7.2,Nesbuvir,WTDWVLJJJOTABN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
149128,6w9q,DB14993,-7.2,Pyrotinib,SADXACCFNXBCFY-IYNHSRRRSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
158564,7bv1,DB01632,-7.2,5-O-phosphono-alpha-D-ribofuranosyl diphosphate,PQGCEDQWHSBAJP-TXICZTDVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93218,6m71,DB06609,-7.2,Odiparcil,JRHNIQQUVJOPQC-AQNFWKISSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
27482,6cs2,DB07028,-7.2,(2-{[(4-BROMO-2-FLUOROBENZYL)AMINO]CARBONYL}-5-CHLOROPHENOXY)ACETIC ACID,ZLIGBZRXAQNUFO-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
133359,6w9c,DB01581,-7.2,Sulfamerazine,QPPBRPIAZZHUNT-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
16465,6cs2,HMDB0002269,-7.2,Curcumin,VFLDPWHFBUODDF-FCXRPNKRSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
123893,6w4h,DB00507,-7.2,Nitazoxanide,YQNQNVDNTFHQSW-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
16463,6cs2,HMDB0000153,-7.2,Estriol,PROQIPRRNZUXQM-ZXXIGWHRSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
158560,7bv1,DB01627,-7.2,Lincomycin,OJMMVQQUTAEWLP-KIDUDLJLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
133297,6w9c,DB01515,-7.2,Benzoylecgonine,GVGYEFKIHJTNQZ-RFQIPJPRSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
35139,1r42,DB01185,-7.2,Fluoxymesterone,YLRFCQOZQXIBAB-RBZZARIASA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
123908,6w4h,DB00530,-7.2,Erlotinib,AAKJLRGGTJKAMG-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
70170,6lxt,DB12262,-7.2,CRS-3123,NNTYBKTXMKBRFA-CQSZACIVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
133356,6w9c,DB01578,-7.2,Metrizamide,DTZMSDADRKLCQE-RFMXWLSYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
133338,6w9c,DB01558,-7.2,Bromazepam,VMIYHDSEFNYJSL-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
103320,6vxs,DB08440,-7.2,"N-1,10-phenanthrolin-5-ylacetamide",AAJXINSCZMZERD-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
133335,6w9c,DB01555,-7.2,Alphacetylmethadol,XBMIVRRWGCYBTQ-XMSQKQJNSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
93689,6m71,DB07240,-7.2,3-[(9H-fluoren-9-ylideneamino)oxy]propanoic acid,LASWLEUVWJDDBA-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
123921,6w4h,DB00546,-7.2,Adinazolam,GJSLOMWRLALDCT-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
149996,6wiq,DB00834,-7.2,Mifepristone,VKHAHZOOUSRJNA-GCNJZUOMSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
149143,6w9q,DB15031,-7.2,Nemorexant,NBGABHGMJVIVBW-QHCPKHFHSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
93686,6m71,DB07237,-7.2,{4-[(2R)-pyrrolidin-2-ylmethoxy]phenyl}(4-thiophen-3-ylphenyl)methanone,VUWFJUJWAWMRQN-HXUWFJFHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
150004,6wiq,DB00844,-7.2,Nalbuphine,NETZHAKZCGBWSS-CEDHKZHLSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
149113,6w9q,DB14934,-7.2,GDC-0927,KJAAPZIFCQQQKX-NDEPHWFRSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
133224,6w9c,DB01429,-7.2,Aprindine,NZLBHDRPUJLHCE-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
157772,6wiq,DB12798,-7.2,Relenopride,KGMMSPVVHZGPHL-NRFANRHFSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
106564,6vxx,DB00495,-7.2,Zidovudine,HBOMLICNUCNMMY-XLPZGREQSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
93628,6m71,DB07168,-7.2,[4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-6-(methylamino)pyrimidin-2-yl}amino)phenyl]acetonitrile,MFMSRHREFZCFSN-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
66506,6lxt,DB04270,-7.2,(S)-3-(4-(2-Carbazol-9-Yl-Ethoxy)-Phenyl)-2-Ethoxy-Propionic Acid,WUZIMDSVRIBNNI-DEOSSOPVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
86605,6m3m,DB09092,-7.2,Xanthinol,DSFGXPJYDCSWTA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
11178,6lzg,DB11592,-7.2,Nitrocefin,LHNIIDJCEODSHA-OQRUQETBSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
70215,6lxt,DB12316,-7.2,9CUAB30,PPGNMFUMZSAZCW-VOYUZAMQSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
86623,6m3m,DB09136,-7.2,Isosulfan blue,YFKDCGWIINMRQY-UHFFFAOYSA-O,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
133159,6w9c,DB01298,-7.2,Sulfacytine,SIBQAECNSSQUOD-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
103284,6vxs,DB08394,-7.2,PARA-NITROPHENYLPHOSPHONOBUTANOYL-GLYCINE,WLNKGRQBMNPVSJ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
35225,1r42,DB01327,-7.2,Cefazolin,MLYYVTUWGNIJIB-BXKDBHETSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
70570,6lxt,DB12869,-7.2,Eliprodil,GGUSQTSTQSHJAH-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
132629,6w9c,DB00664,-7.2,Sulfametopyrazine,KXRZBTAEDBELFD-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
70217,6lxt,DB12319,-7.2,Benzbromarone,WHQCHUCQKNIQEC-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
89331,6m71,DB00348,-7.2,Nitisinone,OUBCNLGXQFSTLU-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
149270,6w9q,DB15281,-7.2,Ravoxertinib,RZUOCXOYPYGSKL-GOSISDBHSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
35232,1r42,DB01337,-7.2,Pancuronium,GVEAYVLWDAFXET-XGHATYIMSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
124782,6w4h,DB01622,-7.2,Thioproperazine,VZYCZNZBPPHOFY-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
26154,6cs2,DB04226,-7.2,Dihydro-Acarbose,CUAQESWNTOXZJZ-RTNAABQMSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
86639,6m3m,DB09175,-7.2,Mirfentanil,BJZZDOLVVLWFHN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
131100,6w4h,DB13294,-7.2,Azidamfenicol,SGRUZFCHLOFYHZ-MWLCHTKSSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
124119,6w4h,DB00784,-7.2,Mefenamic acid,HYYBABOKPJLUIN-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
35559,1r42,DB01763,-7.2,7-thionicotinamide-adenine-dinucleotide phosphate,OJNFDOAQUXJWED-NNYOXOHSSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
152855,6wiq,DB04608,-7.2,"9-HYDROXY-4-PHENYL-6H-PYRROLO[3,4-C]CARBAZOLE-1,3-DIONE",IAUZTOZLTFSMIE-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
149290,6w9q,DB15316,-7.2,Florasulam,QZXATCCPQKOEIH-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
60187,6crv,DB08347,-7.2,4-{[(2S)-3-(tert-butylamino)-2-hydroxypropyl]oxy}-3H-indole-2-carbonitrile,CQEFAUFOQSCRMZ-LBPRGKRZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
124877,6w4h,DB01748,-7.2,N-Benzyl-4-Sulfamoyl-Benzamide,CZKNSZUJCJHTTM-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
105609,6vxs,DB13727,-7.2,Azapetine,NYGHGTMKALXFIA-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
27176,6cs2,DB00604,-7.2,Cisapride,DCSUBABJRXZOMT-IRLDBZIGSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
70617,6lxt,DB12935,-7.2,Remogliflozin etabonate,UAOCLDQAQNNEAX-ABMICEGHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
59395,6crv,DB07412,-7.2,1-biphenyl-2-ylmethanamine,YHXKXVFQHWJYOD-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106545,6vxx,DB00473,-7.2,Hexylcaine,DKLKMKYDWHYZTD-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
124008,6w4h,DB00652,-7.2,Pentazocine,VOKSWYLNZZRQPF-GDIGMMSISA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
149961,6wiq,DB00796,-7.2,Candesartan cilexetil,GHOSNRCGJFBJIB-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
157777,6wiq,DB12805,-7.2,Ataciguat,PQHLRGARXNPFCF-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
132620,6w9c,DB00654,-7.2,Latanoprost,GGXICVAJURFBLW-CEYXHVGTSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
89352,6m71,DB00374,-7.2,Treprostinil,PAJMKGZZBBTTOY-ZFORQUDYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
103298,6vxs,DB08412,-7.2,6-{4-[HYDROXY-(4-NITRO-PHENOXY)-PHOSPHORYL]-BUTYRYLAMINO}-HEXANOIC ACID,WYHHVZLGTMCKOR-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
5365,6lzg,HMDB0059586,-7.2,Perfluorooctanesulfonic acid,YFSUTJLHUFNCNZ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
70609,6lxt,DB12925,-7.2,Crolibulin,JXONINOYTKKXQQ-CQSZACIVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
16409,6lzg,DB04125,-7.2,N-Alpha-(2-Naphthylsulfonyl)-N(3-Amidino-L-Phenylalaninyl)-4-Acetyl-Piperazine,ZUWBXGHMVKDMQO-DEOSSOPVSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
157787,6wiq,DB12823,-7.2,Tecarfarin,QFLNTQDOVCLQKW-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
67380,6lxt,DB06600,-7.2,Nemonoxacin,AVPQPGFLVZTJOR-RYUDHWBXSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
103048,6vxs,DB08107,-7.2,N-{[6-(PENTYLOXY)NAPHTHALEN-2-YL]SULFONYL}-D-GLUTAMIC ACID,LIGACKDHLKEZFH-GOSISDBHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
156199,6wiq,DB12557,-7.2,FK-614,UYGZODVVDUIDDQ-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
149918,6wiq,DB00741,-7.2,Hydrocortisone,JYGXADMDTFJGBT-VWUMJDOOSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
156002,6wiq,DB12068,-7.2,T-900607,FSXLOWIFSZNIMV-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
124023,6w4h,DB00671,-7.2,Cefixime,OKBVVJOGVLARMR-QSWIMTSFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
149238,6w9q,DB15212,-7.2,Pemafibrate,ZHKNLJLMDFQVHJ-RUZDIDTESA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
35200,1r42,DB01261,-7.2,Sitagliptin,MFFMDFFZMYYVKS-SECBINFHSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
103058,6vxs,DB08118,-7.2,"2-(methylamino)-N-(4-methyl-1,3-thiazol-2-yl)-5-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]benzamide",XRJAKERBMMBUGR-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
35561,1r42,DB01765,-7.2,"(5-Oxo-5,6-Dihydro-Indolo[1,2-a]Quinazolin-7-Yl)-Acetic Acid",INSBKYCYLCEBOD-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
66495,6lxt,DB04254,-7.2,"8-Benzo[1,3]Dioxol-,5-Ylmethyl-9-Butyl-2-Fluoro-9h-Purin-6-Ylamine",ARWHTQLGMWHTAZ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
103297,6vxs,DB08410,-7.2,PARA-NITROBENZYL GLUTARYL GLYCINIC ACID,UCFVFUIGNWHAJJ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
132656,6w9c,DB00695,-7.2,Furosemide,ZZUFCTLCJUWOSV-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
149109,6w9q,DB14929,-7.2,Elsulfavirine,ULTDEARCBRNRGR-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
27686,6cs2,DB07242,-7.2,"(4R)-7,8-dichloro-1',9-dimethyl-1-oxo-1,2,4,9-tetrahydrospiro[beta-carboline-3,4'-piperidine]-4-carbonitrile",XGUIMGJMQKZRGM-LLVKDONJSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
27724,6cs2,DB07280,-7.2,5-[4-(DIMETHYLAMINO)PHENYL]-6-[(6-MORPHOLIN-4-YLPYRIDIN-3-YL)ETHYNYL]PYRIMIDIN-4-AMINE,AINVOEOJEKKMKB-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
123737,6w4h,DB00318,-7.2,Codeine,OROGSEYTTFOCAN-DNJOTXNNSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
59911,6crv,DB08016,-7.2,"4-(6-CHLORO-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDIN-5-YL) BUTYL PHOSPHATE",DAUATIBSDSXXHA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56268,6crv,DB02103,-7.2,2-Chlorodideoxyadenosine,FNLILOONPKMGST-NTSWFWBYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27722,6cs2,DB07278,-7.2,2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}ETHENESULFONAMIDE,ACEFOQMQINFMRW-DYCFVMESSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
93764,6m71,DB07322,-7.2,"2-[(PHENYLSULFONYL)AMINO]-5,6,7,8-TETRAHYDRONAPHTHALENE-1-CARBOXYLIC ACID",RRXVUYHFDBLTEL-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
158825,7bv1,DB02267,-7.2,Argininosuccinate,KDZOASGQNOPSCU-NTSWFWBYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
132449,6w9c,DB00442,-7.2,Entecavir,QDGZDCVAUDNJFG-FXQIFTODSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
127449,6w4h,DB06083,-7.2,Tapinarof,ZISJNXNHJRQYJO-CMDGGOBGSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
157655,6wiq,DB12252,-7.2,PG-701,OKRSVUYYCJPECG-LFGMFVMYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
157656,6wiq,DB12253,-7.2,GDC-0810,BURHGPHDEVGCEZ-KJGLQBJMSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
132448,6w9c,DB00441,-7.2,Gemcitabine,SDUQYLNIPVEERB-QPPQHZFASA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
35642,1r42,DB01873,-7.2,Epothilone D,XOZIUKBZLSUILX-GIQCAXHBSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
56279,6crv,DB02116,-7.2,Olomoucine,GTVPOLSIJWJJNY-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
131239,6w4h,DB13475,-7.2,Furazidin,DECBQELQORZLLP-UAIOPKHMSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
70123,6lxt,DB12193,-7.2,Ajulemic acid,YCHYFHOSGQABSW-RTBURBONSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
158795,7bv1,DB02230,-7.2,Immucillin-G,KBIDJCVAURJXFG-PVEDRDFWSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
105627,6vxs,DB13755,-7.2,Iocarmic acid,SMQYOVYWPWASGU-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
56912,6crv,DB02947,-7.2,2-Fluoro-2'-Deoxyadenosine,ZWPYUXAXLRFWQC-KVQBGUIXSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
132464,6w9c,DB00458,-7.2,Imipramine,BCGWQEUPMDMJNV-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
89414,6m71,DB00448,-7.2,Lansoprazole,MJIHNNLFOKEZEW-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
131237,6w4h,DB13472,-7.2,Cyclofenil,GVOUFPWUYJWQSK-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
70748,6lxt,DB13136,-7.2,Fluindione,NASXCEITKQITLD-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
69161,6lxt,DB08775,-7.2,N??-[(Benzyloxy)carbonyl]-N-[(2S)-4-fluoro-3-oxo-2-butanyl]-L-tyrosinamide,RYABQRLJLIHDIP-KSSFIOAISA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
93160,6m71,DB06460,-7.2,Enrasentan,GLCKXJLCYIJMRB-UPRLRBBYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
67404,6lxt,DB06645,-7.2,Anamorelin,VQPFSIRUEPQQPP-MXBOTTGLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
86333,6m3m,DB08722,-7.2,5-(7-(6-chloro-4-(5-hydro-4-methyl-2-oxazolyl)phenoxy)heptyl)-3-methyl isoxazole,WOJFAPUTPSWFLJ-INIZCTEOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
35036,1r42,DB01067,-7.2,Glipizide,ZJJXGWJIGJFDTL-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
133644,6w9c,DB01961,-7.2,Cytidine 3'-monophosphate,UOOOPKANIPLQPU-XVFCMESISA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
133642,6w9c,DB01959,-7.2,"3,5-Dimethyl-1-(3-Nitrophenyl)-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester",MSYGAHOHLUJIKV-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
105460,6vxs,DB13531,-7.2,Nicofetamide,DWODOIKZDGJOPQ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102935,6vxs,DB07981,-7.2,2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]-n-[(1R)-1-(hydroxymethyl)propyl]acetamide,GKJWXEORYGBJFS-QGZVFWFLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
59370,6crv,DB07383,-7.2,"N-(1-BENZYL-3,3,3-TRIFLUORO-2,2-DIHYDROXY-PROPYL)-ACETAMIDE",NETPVFJEHOGNPJ-JTQLQIEISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
158880,7bv1,DB02583,-7.2,"N6-(2,5-Dimethoxy-Benzyl)-N6-Methyl-Pyrido[2,3-D]Pyrimidine-2,4,6-Triamine",HZTFNSCZLJLPEO-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
102939,6vxs,DB07985,-7.2,+/-METHYL 4-(AMINOIMINOMETHYL)-BETA-[3- INH (AMINOIMINO)PHENYL]BENZENE PENTANOATE,PVALLOSAENRPQO-INIZCTEOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
35657,1r42,DB01895,-7.2,Aspartyl-Adenosine-5'-Monophosphate,QPBSGQWTJLPZNF-VWJPMABRSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
69149,6lxt,DB08761,-7.2,"(3S,6S)-3,6-bis(4-hydroxybenzyl)piperazine-2,5-dione",NGPCLOGFGKJCBP-HOTGVXAUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
127452,6w4h,DB06106,-7.2,AIT-034,FBVDVFULNXWYRF-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
127195,6w4h,DB04839,-7.2,Cyproterone acetate,UWFYSQMTEOIJJG-FDTZYFLXSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
28675,6cs2,DB08282,-7.2,"O-[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethyl] (4-chlorophenyl)thiocarbamate",BWRRXOIACQYNEK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
158871,7bv1,DB02569,-7.2,"2',3'-Dehydro-2',3'-Deoxy-Thymidine 5'-Diphosphate",LXCAIISEDMYORY-JGVFFNPUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
125186,6w4h,DB02162,-7.2,5'-O-(N-Ethyl-Sulfamoyl)Adenosine,ONCSLXAPOGUODU-WOUKDFQISA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
106478,6vxx,DB00393,-7.2,Nimodipine,UIAGMCDKSXEBJQ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56257,6crv,DB02090,-7.2,A Disubstituted Succinyl Caprolactam Hydroxymate Mmp3inhibitor,JLEGVELHGVWFGG-BBWFWOEESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
158870,7bv1,DB02568,-7.2,Peldesine,DOHVAKFYAHLCJP-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
125169,6w4h,DB02135,-7.2,"4-{2,6,8-Trioxo-9-[(2R,3S,4R)-2,3,4,5-Tetrahydroxypentyl]-1,2,3,6,8,9-Hexahydro-7h-Purin-7-Yl}Butyl Dihydrogen Phosphate",VBXZSBKAJFXURR-MRTMQBJTSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
133608,6w9c,DB01920,-7.2,1-O-[O-Nitrophenyl]-Beta-D-Galactopyranose,KUWPCJHYPSUOFW-YBXAARCKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
149024,6w9q,DB14736,-7.2,Cannabivarin,SVTKBAIRFMXQQF-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
87476,6m3m,DB12378,-7.2,Apricoxib,JTMITOKKUMVWRT-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
158866,7bv1,DB02562,-7.2,"Quinonoid 7,8-Tetrahydrobiopterin",ZHQJVZLJDXWFFX-RPDRRWSUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
103365,6vxs,DB08493,-7.2,"5-METHYL-3-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.013,18]NONADECA-12(19),13,15,17-TETRAEN-10-YLCARBAMOYL)-HEXANOIC ACID",AKWKBACKRMYPRV-NQIIRXRSSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
36273,1r42,DB02704,-7.2,"(2r,3r,4r,5r)-3,4-Dihydroxy-N,N'-Bis[(1s,2r)-2-Hydroxy-2,3-Dihydro-1h-Inden-1-Yl]-2,5-Bis(2-Phenylethyl)Hexanediamide",GQKBYZPVKVXMJL-LAFNQVRVSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
16539,6cs2,HMDB0002697,-7.2,19-Norandrosterone,UOUIARGWRPHDBX-AWLYHSJUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
89130,6m71,DB00118,-7.2,Ademetionine,MEFKEPWMEQBLKI-AIRLBKTGSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
70746,6lxt,DB13132,-7.2,Artemisinin,BLUAFEHZUWYNDE-NNWCWBAJSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
157676,6wiq,DB12282,-7.2,Defactinib,FWLMVFUGMHIOAA-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
25600,6cs2,DB03573,-7.2,WRR-99,KVZMXOVSHIMGNA-CVEARBPZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
132505,6w9c,DB00508,-7.2,Triflupromazine,XSCGXQMFQXDFCW-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
15908,6lzg,DB01842,-7.2,3'-Phosphate-Adenosine-5'-Diphosphate,GBBWIZKLHXYJOA-KQYNXXCUSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
6900,6lzg,DB02882,-7.2,Cyanocinnoline,CUWRVIIPSSUUDJ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
59455,6crv,DB07484,-7.2,"(2R)-4,4-dihydroxy-5-nitro-2-(phenylmethyl)pentanoic acid",CGGNZMVODZPHHK-SNVBAGLBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56884,6crv,DB02909,-7.2,5-(2-Chlorophenyl)Furan-2-Carboxylic Acid,PJGGWIHXGHQXMM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
123843,6w4h,DB00447,-7.2,Loracarbef,JAPHQRWPEGVNBT-UTUOFQBUSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
149095,6w9q,DB14898,-7.2,Retagliptin,WIIAMRXFUJLYEF-SNVBAGLBSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
86403,6m3m,DB08798,-7.2,Sulfamoxole,CYFLXLSBHQBMFT-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
125008,6w4h,DB01931,-7.2,"Dcka, 5,7-Dichlorokynurenic Acid",BGKFPRIGXAVYNX-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
133409,6w9c,DB01643,-7.2,Thymidine monophosphate,GYOZYWVXFNDGLU-XLPZGREQSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
103343,6vxs,DB08466,-7.2,"5-[2-(4-hydroxyphenyl)ethyl]benzene-1,3-diol",HITJFUSPLYBJPE-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
125002,6w4h,DB01922,-7.2,"Maltosyl-Alpha (1,4)-D-Gluconhydroximo-1,5-Lactam",AHRWQUNEPBVNOT-IVJVVCOPSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
127416,6w4h,DB05824,-7.2,CNS-5161,JHVHEDNLONERHY-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131227,6w4h,DB13458,-7.2,Thebacon,RRJQTGHQFYTZOW-ILWKUFEGSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
124995,6w4h,DB01910,-7.2,Sinefungin,LMXOHSDXUQEUSF-YECHIGJVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
150063,6wiq,DB00910,-7.2,Paricalcitol,BPKAHTKRCLCHEA-UBFJEZKGSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
149098,6w9q,DB14902,-7.2,JHU-75528 C-11,MCNQUWLLXZZZAC-BJUDXGSMSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
12460,6lzg,DB13397,-7.2,Prenoxdiazine,PXZDWASDNFWKSD-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
150049,6wiq,DB00896,-7.2,Rimexolone,QTTRZHGPGKRAFB-OOKHYKNYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
133386,6w9c,DB01618,-7.2,Molindone,KLPWJLBORRMFGK-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
25610,6cs2,DB03585,-7.2,Oxyphenbutazone,HFHZKZSRXITVMK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
56347,6crv,DB02214,-7.2,"6,7-Dioxo-5h-8-Ribitylaminolumazine",MIBROOURCUHKMD-RPDRRWSUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
157709,6wiq,DB12321,-7.2,Ifetroban,BBPRUNPUJIUXSE-DXKRWKNPSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
11131,6lzg,DB11466,-7.2,Tepoxalin,XYKWNRUXCOIMFZ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
66404,6lxt,DB04137,-7.2,Guanosine-5'-Triphosphate,XKMLYUALXHKNFT-UUOKFMHZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
132504,6w9c,DB00507,-7.2,Nitazoxanide,YQNQNVDNTFHQSW-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
123830,6w4h,DB00433,-7.2,Prochlorperazine,WIKYUJGCLQQFNW-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
70743,6lxt,DB13125,-7.2,Lusutrombopag,NOZIJMHMKORZBA-KJCUYJGMSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
158749,7bv1,DB02166,-7.2,Propidium,ZDWVWKDAWBGPDN-UHFFFAOYSA-O,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
16524,6cs2,HMDB0002639,-7.2,Sulfolithocholylglycine,FHXBAFXQVZOILS-JWOIRZCRSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
157679,6wiq,DB12285,-7.2,Verubecestat,YHYKUSGACIYRML-KRWDZBQOSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
16521,6cs2,HMDB0002581,-7.2,Taurocholic acid 3-sulfate,LKTXOQJJFLAZRW-XVBIMYNNSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
158732,7bv1,DB02140,-7.2,N1-(1-Dimethylcarbamoyl-2-Phenyl-Ethyl)-2-Oxo-N4-(2-Pyridin-2-Yl-Ethyl)-Succinamide,ZPFPZRVOBBMZMP-SFHVURJKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
133489,6w9c,DB01752,-7.2,S-adenosyl-L-homocysteine,ZJUKTBDSGOFHSH-WFMPWKQPSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
27215,6cs2,DB06702,-7.2,Fesoterodine,DCCSDBARQIPTGU-HSZRJFAPSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
86355,6m3m,DB08744,-7.2,"6-methoxy-9-methyl[1,3]dioxolo[4,5-h]quinolin-8(9H)-one",DPXXJCMMMXZVSW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
16518,6cs2,HMDB0002536,-7.2,Isodeoxycholic acid,ZHCAAZIHTDCFJX-QLEQUTGBSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
123785,6w4h,DB00378,-7.2,Dydrogesterone,JGMOKGBVKVMRFX-HQZYFCCVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
149083,6w9q,DB14876,-7.2,TAS-116,NVVPMZUGELHVMH-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
59924,6crv,DB08030,-7.2,3-[(4'-cyanobiphenyl-4-yl)oxy]-N-hydroxypropanamide,XZWFHJUEAVOHHG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
149077,6w9q,DB14866,-7.2,Amcasertib,QDWKGEFGLQMDAM-ULJHMMPZSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
70723,6lxt,DB13097,-7.2,1alpha-Hydroxyvitamin D5,NWFOBODUYTUMNC-VPSCEVSQSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
133475,6w9c,DB01734,-7.2,3-(Oxalyl-Amino)-Naphthalene-2-Carboxylic Acid,DQBLKSRRWDWNKQ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
125055,6w4h,DB01987,-7.2,Cocarboxylase,AYEKOFBPNLCAJY-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
158698,7bv1,DB02098,-7.2,Adenosine-2'-5'-Diphosphate,AEOBEOJCBAYXBA-KQYNXXCUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
123807,6w4h,DB00404,-7.2,Alprazolam,VREFGVBLTWBCJP-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
123809,6w4h,DB00406,-7.2,Gentian violet cation,LGLFFNDHMLKUMI-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
123813,6w4h,DB00412,-7.2,Rosiglitazone,YASAKCUCGLMORW-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
157694,6wiq,DB12303,-7.2,Motolimod,QSPOQCXMGPDIHI-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
70713,6lxt,DB13083,-7.2,Talarozole,SNFYYXUGUBUECJ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
133436,6w9c,DB01682,-7.2,6'-Methyl-Thiamin Diphosphate,XTYXJYCWAJSHCY-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
103344,6vxs,DB08467,-7.2,"6-(2,3,4,5,6,7-HEXAHYDRO-2,4,4-TRIMETHYL-1-METYLENEINDEN-2-YL)-3-METHYLHEXA-2,4-DIENOIC ACID",HEVXQLBAMFMFKU-IAZPEVBMSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
87287,6m3m,DB12109,-7.2,CPI-613,ZYRLHJIMTROTBO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
14387,6lzg,T3D4073,-7.2,Bicuculline,IYGYMKDQCDOMRE-ZWKOTPCHSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
124133,6w4h,DB00802,-7.2,Alfentanil,IDBPHNDTYPBSNI-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
25714,6cs2,DB03719,-7.2,N-Ethyl-5'-Carboxamido Adenosine,JADDQZYHOWSFJD-BMYQGPEFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
26143,6cs2,DB04213,-7.2,N-Cyclohexyl-N'-(Propyl)Phenyl Urea,HBTZVNKXMFGOOJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
124412,6w4h,DB01120,-7.2,Gliclazide,BOVGTQGAOIONJV-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
70304,6lxt,DB12442,-7.2,Alvespimycin,KUFRQPKVAWMTJO-LMZWQJSESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
132937,6w9c,DB01021,-7.2,Trichlormethiazide,LMJSLTNSBFUCMU-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
124427,6w4h,DB01137,-7.2,Levofloxacin,GSDSWSVVBLHKDQ-JTQLQIEISA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
157964,6wiq,DB15393,-7.2,Telatinib,QFCXANHHBCGMAS-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
87071,6m3m,DB11790,-7.2,Radafaxine,RCOBKSKAZMVBHT-TVQRCGJNSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
149674,6wiq,DB00445,-7.2,Epirubicin,AOJJSUZBOXZQNB-VTZDEGQISA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
35382,1r42,DB01541,-7.2,Boldenone,RSIHSRDYCUFFLA-DYKIIFRCSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
70398,6lxt,DB12587,-7.2,Razupenem,XFGOMLIRJYURLQ-GOKYHWASSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
35381,1r42,DB01540,-7.2,17alpha-methyl-4-hydroxynandrolone,CLNUZOCYKSHICX-FAHHUNKHSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
93517,6m71,DB07040,-7.2,"2-amino-7-fluoro-5-oxo-5H-chromeno[2,3-b]pyridine-3-carboxamide",GCHMLYYPYFXLQB-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93405,6m71,DB06909,-7.2,"1-ethyl-N-(phenylmethyl)-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridine-5-carboxamide",QZGJNFBMYYEFGM-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
158158,7bv1,DB00447,-7.2,Loracarbef,JAPHQRWPEGVNBT-UTUOFQBUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
124441,6w4h,DB01153,-7.2,Sertaconazole,JLGKQTAYUIMGRK-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
158157,7bv1,DB00446,-7.2,Chloramphenicol,WIIZWVCIJKGZOK-RKDXNWHRSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
131159,6w4h,DB13364,-7.2,Feprazone,RBBWCVQDXDFISW-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
93507,6m71,DB07030,-7.2,(5-CHLORO-2-{[(3-NITROBENZYL)AMINO]CARBONYL}PHENOXY)ACETIC ACID,VABIMMIJVWNHFI-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
105579,6vxs,DB13686,-7.2,Clometocillin,JKXQBIZCQJLVOS-GSNLGQFWSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
149545,6wiq,DB00287,-7.2,Travoprost,MKPLKVHSHYCHOC-AHTXBMBWSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
149550,6wiq,DB00294,-7.2,Etonogestrel,GCKFUYQCUCGESZ-BPIQYHPVSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
25721,6cs2,DB03725,-7.2,Phosphomethylphosphonic Acid-Guanylate Ester,PHBDHXOBFUBCJD-KQYNXXCUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
86945,6m3m,DB11561,-7.2,Aminacrine,XJGFWWJLMVZSIG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
124437,6w4h,DB01148,-7.2,Flavoxate,SPIUTQOUKAMGCX-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
60037,6crv,DB08156,-7.2,3-[4-(AMINOSULFONYL)PHENYL]PROPANOIC ACID,JUEONDBIBADVGD-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
124601,6w4h,DB01413,-7.2,Cefepime,HVFLCNVBZFFHBT-ZKDACBOMSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
47893,2fxp,DB02411,-7.2,"2-(11-{2-[Benzenesulfonyl-(3-Methyl-Butyl)-Amino]-1-Hydroxy-Ethyl}-6,9-Dioxo-2-Oxa-7,10-Diaza-Bicyclo[11.2.2]Heptadeca-1(16),13(17),14-Trien-8-Yl)-Acetamide, Inhibitor 2",HOUHLOFMBSYNBO-KKUQBAQOSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
124618,6w4h,DB01431,-7.2,Allylestrenol,ATXHVCQZZJYMCF-XUDSTZEESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
66583,6lxt,DB04376,-7.2,13-Acetylphorbol,SDSVJYOOAPRSDA-RPCQODIISA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
124615,6w4h,DB01428,-7.2,Oxybenzone,DXGLGDHPHMLXJC-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
127320,6w4h,DB05284,-7.2,CA4P,LGZKGOGODCLQHG-ZDUSSCGKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
124609,6w4h,DB01422,-7.2,Nitroxoline,RJIWZDNTCBHXAL-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
28681,6cs2,DB08287,-7.2,"(1R,2R)-N-(2-Aminoethyl)-2-{[(4-methoxyphenyl)sulfonyl]methyl}cyclohexanecarboxamide",QTGNVZPFJQOWFL-XJKSGUPXSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
132973,6w9c,DB01062,-7.2,Oxybutynin,XIQVNETUBQGFHX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
93537,6m71,DB07061,-7.2,"1-(CYCLOHEXYLAMINO)-3-(6-METHYL-3,4-DIHYDRO-1H-CARBAZOL-9(2H)-YL)PROPAN-2-OL",AXYFCRIRLKSCRR-SFHVURJKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
106672,6vxx,DB00880,-7.2,Chlorothiazide,JBMKAUGHUNFTOL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106673,6vxx,DB00881,-7.2,Quinapril,JSDRRTOADPPCHY-HSQYWUDLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
124379,6w4h,DB01082,-7.2,Streptomycin,UCSJYZPVAKXKNQ-HZYVHMACSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
158173,7bv1,DB00467,-7.2,Enoxacin,IDYZIJYBMGIQMJ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
132954,6w9c,DB01039,-7.2,Fenofibrate,YMTINGFKWWXKFG-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
60103,6crv,DB08238,-7.2,5-AMINO-NAPHTALENE-2-MONOSULFONATE,UWPJYQYRSWYIGZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27605,6cs2,DB07155,-7.2,(3S)-1-CYCLOHEXYL-5-OXO-N-PHENYLPYRROLIDINE-3-CARBOXAMIDE,BVUSHGJZBZMDML-ZDUSSCGKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
93390,6m71,DB06891,-7.2,"5-{[(4-AMINO-3-CHLORO-5-FLUOROPHENYL)SULFONYL]AMINO}-1,3,4-THIADIAZOLE-2-SULFONAMIDE",HOLJYLOVIHBQHO-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
87093,6m3m,DB11820,-7.2,Nifurtimox,ARFHIAQFJWUCFH-IZZDOVSWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
132939,6w9c,DB01023,-7.2,Felodipine,RZTAMFZIAATZDJ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
124387,6w4h,DB01091,-7.2,Butenafine,ABJKWBDEJIDSJZ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
106803,6vxx,DB01288,-7.2,Fenoterol,LSLYOANBFKQKPT-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
69269,6lxt,DB08940,-7.2,Kebuzone,LGYTZKPVOAIUKX-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
124393,6w4h,DB01097,-7.2,Leflunomide,VHOGYURTWQBHIL-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
132938,6w9c,DB01022,-7.2,Phylloquinone,MBWXNTAXLNYFJB-NKFFZRIASA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
86916,6m3m,DB11481,-7.2,Atipamezole,HSWPZIDYAHLZDD-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
35365,1r42,DB01524,-7.2,Androstenediol,QADHLRWLCPCEKT-LOVVWNRFSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
124320,6w4h,DB01013,-7.2,Clobetasol propionate,CBGUOGMQLZIXBE-XGQKBEPLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
60082,6crv,DB08211,-7.2,5-bromo-3-(pyrrolidin-1-ylsulfonyl)-1H-indole-2-carboxamide,FEPUPYVRZUWCQB-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
124468,6w4h,DB01183,-7.2,Naloxone,UZHSEJADLWPNLE-GRGSLBFTSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
149596,6wiq,DB00351,-7.2,Megestrol acetate,RQZAXGRLVPAYTJ-GQFGMJRRSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
158068,7bv1,DB00340,-7.2,Metixene,MJFJKKXQDNNUJF-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
16197,6lzg,DB03126,-7.2,Mant-Adp,QPKUEBLEGWBRHC-BFHYXJOUSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
124501,6w4h,DB01218,-7.2,Halofantrine,FOHHNHSLJDZUGQ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
11287,6lzg,DB11764,-7.2,Spebrutinib,KXBDTLQSDKGAEB-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
66644,6lxt,DB04463,-7.2,"3-(4-Amino-1-Tert-Butyl-1h-Pyrazolo[3,4-D]Pyrimidin-3-Yl)Phenol",CPLGZXQPPYRNRC-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
158060,7bv1,DB00328,-7.2,Indometacin,CGIGDMFJXJATDK-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
152780,6wiq,DB04514,-7.2,Phosphoric Acid-2'-[2'-Deoxy-Uridine]Ester-5'-Guanosine Ester,DFYLLEBFVZTKHD-VMIOUTBZSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
158059,7bv1,DB00327,-7.2,Hydromorphone,WVLOADHCBXTIJK-YNHQPCIGSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
158055,7bv1,DB00321,-7.2,Amitriptyline,KRMDCWKBEZIMAB-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
106734,6vxx,DB00949,-7.2,Felbamate,WKGXYQFOCVYPAC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
66641,6lxt,DB04460,-7.2,(C8-S)-Hydantocidin 5'-Phosphate,MAXSFYCTFIBEAR-FUIMDIGMSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
158041,7bv1,DB00305,-7.2,Mitomycin,NWIBSHFKIJFRCO-WUDYKRTCSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
124541,6w4h,DB01283,-7.2,Lumiracoxib,KHPKQFYUPIUARC-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
124516,6w4h,DB01239,-7.2,Chlorprothixene,WSPOMRSOLSGNFJ-AUWJEWJLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
132879,6w9c,DB00952,-7.2,Naratriptan,AMKVXSZCKVJAGH-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
69255,6lxt,DB08915,-7.2,Aleglitazar,DAYKLWSKQJBGCS-NRFANRHFSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
59425,6crv,DB07448,-7.2,(2S)-3-[(R)-[(1S)-1-amino-3-phenylpropyl](hydroxy)phosphoryl]-2-benzylpropanoic acid,QELOIXSGJMIHBZ-MSOLQXFVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
105571,6vxs,DB13678,-7.2,Dihexyverine,MNSQDVCVWNXBFQ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
11286,6lzg,DB00894,-7.2,Testolactone,BPEWUONYVDABNZ-DZBHQSCQSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
152717,6wiq,DB04432,-7.2,ZK-805623,ZXIHYCYAQUQHSG-UHFFFAOYSA-O,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
70332,6lxt,DB12482,-7.2,Acotiamide,TWHZNAUBXFZMCA-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
16212,6lzg,DB03220,-7.2,FR233623,OODDZQQDDOVCFD-SCLBCKFNSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
106722,6vxx,DB00935,-7.2,Oxymetazoline,WYWIFABBXFUGLM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
158008,7bv1,DB00267,-7.2,Cefmenoxime,HJJDBAOLQAWBMH-YCRCPZNHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
70316,6lxt,DB12463,-7.2,Semagacestat,PKXWXXPNHIWQHW-RCBQFDQVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
124494,6w4h,DB01210,-7.2,Levobunolol,IXHBTMCLRNMKHZ-LBPRGKRZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
25726,6cs2,DB00442,-7.2,Entecavir,QDGZDCVAUDNJFG-FXQIFTODSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
152710,6wiq,DB04421,-7.2,Nicotinamide Adenine Dinucleotide 3-Pentanone Adduct,BZJFKYRGSZWSLT-YLIVDTKOSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
132925,6w9c,DB01007,-7.2,Tioconazole,QXHHHPZILQDDPS-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
124569,6w4h,DB01348,-7.2,Spirapril,HRWCVUIFMSZDJS-SZMVWBNQSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131146,6w4h,DB13350,-7.2,Azanidazole,LHIALLMPKJMSIQ-NSCUHMNNSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
105577,6vxs,DB13684,-7.2,Omoconazole,JMFOSJNGKJCTMJ-ZHZULCJRSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
149661,6wiq,DB00430,-7.2,Cefpiramide,PWAUCHMQEXVFJR-PMAPCBKXSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
157986,6wiq,DB15435,-7.2,BMS-986158,KGERZPVQIRYWRK-GDLZYMKVSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
124560,6w4h,DB01332,-7.2,Ceftizoxime,NNULBSISHYWZJU-LLKWHZGFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
35426,1r42,DB01591,-7.2,Solifenacin,FBOUYBDGKBSUES-VXKWHMMOSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
158087,7bv1,DB00360,-7.2,Sapropterin,FNKQXYHWGSIFBK-RPDRRWSUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
106758,6vxx,DB01214,-7.2,Metipranolol,BQIPXWYNLPYNHW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
106749,6vxx,DB01204,-7.2,Mitoxantrone,KKZJGLLVHKMTCM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
47845,2fxp,DB02354,-7.2,4-{[1-Methyl-5-(2-Methyl-Benzoimidazol-1-Ylmethyl)-1h-Benzoimidazol-2-Ylmethyl]-Amino}-Benzamidine,IRKPNOLLMNHSOU-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
124487,6w4h,DB01203,-7.2,Nadolol,VWPOSFSPZNDTMJ-UCWKZMIHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
124553,6w4h,DB01324,-7.2,Polythiazide,CYLWJCABXYDINA-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
149561,6wiq,DB00307,-7.2,Bexarotene,NAVMQTYZDKMPEU-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
106755,6vxx,DB01210,-7.2,Levobunolol,IXHBTMCLRNMKHZ-LBPRGKRZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
132844,6w9c,DB00913,-7.2,Anileridine,LKYQLAWMNBFNJT-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
11271,6lzg,DB11741,-7.2,Famitinib,GKEYKDOLBLYGRB-LGMDPLHJSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
103220,6vxs,DB08315,-7.2,"2-AMINO-N,N-BIS(PHENYLMETHYL)-1,3-OXAZOLE-5-CARBOXAMIDE",KIJXWOGFYAWTNC-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
149571,6wiq,DB00319,-7.2,Piperacillin,IVBHGBMCVLDMKU-GXNBUGAJSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
66654,6lxt,DB04474,-7.2,1-Anilino-8-Naphthalene Sulfonate,FWEOQOXTVHGIFQ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
132850,6w9c,DB00919,-7.2,Spectinomycin,UNFWWIHTNXNPBV-WXKVUWSESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
93471,6m71,DB06990,-7.2,"4-[(1E,7E)-8-(2,6-DIOXO-1,2,3,6-TETRAHYDROPYRIMIDIN-4-YL)-3,6-DIOXA-2,7-DIAZAOCTA-1,7-DIEN-1-YL]BENZOIC ACID",XHDKIDMFBWLHAX-GONBZBRSSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
132837,6w9c,DB00906,-7.2,Tiagabine,PBJUNZJWGZTSKL-MRXNPFEDSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
133025,6w9c,DB01123,-7.2,Proflavine,WDVSHHCDHLJJJR-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
156060,6wiq,DB12355,-7.2,Netazepide,YDZYKNJZCVIKPP-VWLOTQADSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
105583,6vxs,DB13692,-7.2,Tretoquinol,RGVPOXRFEPSFGH-AWEZNQCLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
92547,6m71,DB04552,-7.2,Niflumic acid,JZFPYUNJRRFVQU-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
106935,6vxx,DB01766,-7.2,Beta-(2-Naphthyl)-Alanine,JPZXHKDZASGCLU-LBPRGKRZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
133087,6w9c,DB01191,-7.2,Dexfenfluramine,DBGIVFWFUFKIQN-VIFPVBQESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
124755,6w4h,DB01588,-7.2,Prazepam,MWQCHHACWWAQLJ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
152658,6wiq,DB04345,-7.2,Lumichrome,ZJTJUVIJVLLGSP-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
28639,6cs2,DB08235,-7.2,N-[2-(2-methyl-1H-indol-3-yl)ethyl]thiophene-2-carboxamide,ACAKNPKRLPMONU-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
124209,6w4h,DB00886,-7.2,Omapatrilat,LVRLSYPNFFBYCZ-VGWMRTNUSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
132681,6w9c,DB00722,-7.2,Lisinopril,RLAWWYSOJDYHDC-BZSNNMDCSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
156019,6wiq,DB12095,-7.2,Telotristat ethyl,MDSQOJYHHZBZKA-GBXCKJPGSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
70507,6lxt,DB12758,-7.2,Atreleuton,MMSNEKOTSJRTRI-LLVKDONJSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
149843,6wiq,DB00655,-7.2,Estrone,DNXHEGUUPJUMQT-CBZIJGRNSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
158332,7bv1,DB00873,-7.2,Loteprednol,YPZVAYHNBBHPTO-MXRBDKCISA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
152837,6wiq,DB04583,-7.2,"5-Carbamoyl-1,1':4',1''-terphenyl-3-carboxylic acid",LAZPCGBRHLARSI-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
70505,6lxt,DB12752,-7.2,Bucindolol,FBMYKMYQHCBIGU-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
14395,6lzg,T3D4086,-7.2,Chelerythrine,LLEJIEBFSOEYIV-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
124740,6w4h,DB01568,-7.2,Codeine-N-oxide,BDLSDHWCOJPHIE-KFUGMXNISA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
106610,6vxx,DB00811,-7.2,Ribavirin,IWUCXVSUMQZMFG-AFCXAGJDSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
89216,6m71,DB00214,-7.2,Torasemide,NGBFQHCMQULJNZ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
149333,6w9q,DB15407,-7.2,Acalisib,DOCINCLJNAXZQF-LBPRGKRZSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
66724,6lxt,DB04563,-7.2,CRA_9678,VIZNZQTZRMTYPZ-UHFFFAOYSA-M,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
87212,6m3m,DB11998,-7.2,Sorivudine,GCQYYIHYQMVWLT-HQNLTJAPSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
124730,6w4h,DB01558,-7.2,Bromazepam,VMIYHDSEFNYJSL-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
156157,6wiq,DB12491,-7.2,Fasiglifam,BZCALJIHZVNMGJ-HSZRJFAPSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
59999,6crv,DB08115,-7.2,2-aminoethyl naphthalen-1-ylacetate,PDCSQCHNOPNJMK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
12422,6lzg,DB13349,-7.2,Talastine,LCAAMXMULMCKLJ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
127235,6w4h,DB04890,-7.2,Bepotastine,YWGDOWXRIALTES-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
93597,6m71,DB07131,-7.2,(S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclohexylpropanoyl)pyrrolidine-2-carboxamide,DOTBZTLJSXFKCP-IBGZPJMESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
22560,6cs2,HMDB0054253,-7.2,"TG(20:4(5Z,8Z,11Z,14Z)/22:4(7Z,10Z,13Z,16Z)/o-18:0)",IWAAHSCTDZFCMG-SEVCLUMKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
70554,6lxt,DB12840,-7.2,Pirnabine,AADNQNOXNWEYHS-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
48009,2fxp,DB02555,-7.2,SP4160,VCXMTWSYQSVWRK-AREMUKBSSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
92550,6m71,DB04555,-7.2,Cytidine-5'-Diphosphate,ZWIADYZPOWUWEW-XVFCMESISA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
103089,6vxs,DB08151,-7.2,"(5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-phenyl-1,6-dioxa-2-azaspiro[4.5]dec-2-ene-8,9,10-triol",YLTDNVVQKRHCJP-RKQHYHRCSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
106978,6vxx,DB01823,-7.2,Beta-D-Glucopyranose Spirohydantoin,QRXBDPYWCAAAAI-UXDJRKLDSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
149870,6wiq,DB00687,-7.2,Fludrocortisone,AAXVEMMRQDVLJB-BULBTXNYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
16371,6lzg,DB03950,-7.2,(S)-N-(3-Indol-1-Yl-2-Methyl-Propyl)-4-Sulfamoyl-Benzamide,ZFWHOUCRVSOZJE-AWEZNQCLSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
133117,6w9c,DB01227,-7.2,Levacetylmethadol,XBMIVRRWGCYBTQ-AVRDEDQJSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
86667,6m3m,DB09204,-7.2,Arotinolol,BHIAIPWSVYSKJS-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
133112,6w9c,DB01218,-7.2,Halofantrine,FOHHNHSLJDZUGQ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
35544,1r42,DB01745,-7.2,N-Alpha-(2-Naphthylsulfonyl)-N(3-Amidino-L-Phenylalaninyl)Isopipecolinic Acid Methyl Ester,JJLGQWCKMHPBEB-DEOSSOPVSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
86696,6m3m,DB09237,-7.2,Levamlodipine,HTIQEAQVCYTUBX-KRWDZBQOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
36297,1r42,DB02738,-7.2,Adenosine-5'-Pentaphosphate,WYJWVZZCMBUPSP-KQYNXXCUSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
158365,7bv1,DB01101,-7.2,Capecitabine,GAGWJHPBXLXJQN-UORFTKCHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
157863,6wiq,DB13393,-7.2,Emetine,AUVVAXYIELKVAI-CKBKHPSWSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
16035,6lzg,DB02424,-7.2,Geldanamycin,QTQAWLPCGQOSGP-KSRBKZBZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
124168,6w4h,DB00841,-7.2,Dobutamine,JRWZLRBJNMZMFE-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
158360,7bv1,DB00905,-7.2,Bimatoprost,AQOKCDNYWBIDND-FTOWTWDKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
67332,6lxt,DB06471,-7.2,Naxifylline,NJYNSYQBNSDGIQ-RDDCQWBRSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
87234,6m3m,DB12028,-7.2,Broxuridine,WOVKYSAHUYNSMH-RRKCRQDMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
70526,6lxt,DB12792,-7.2,Boscalid,WYEMLYFITZORAB-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
16041,6lzg,DB02452,-7.2,Thymidine-5'-Triphosphate,NHVNXKFIZYSCEB-XLPZGREQSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
12423,6lzg,DB13350,-7.2,Azanidazole,LHIALLMPKJMSIQ-NSCUHMNNSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
86695,6m3m,DB09236,-7.2,Lacidipine,GKQPCPXONLDCMU-CCEZHUSRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
60166,6crv,DB08318,-7.2,"6-(2-phenoxyethoxy)-1,3,5-triazine-2,4-diamine",LRQXUZUFSOQMGU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60145,6crv,DB08295,-7.2,4-HYDROXY-3-NITROPHENYLACETYL-EPSILON-AMINOCAPROIC ACID ANION,XAYGJFACOIKJCT-UHFFFAOYSA-M,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
124717,6w4h,DB01545,-7.2,Ethyl loflazepate,CUCHJCMWNFEYOM-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
149805,6wiq,DB00606,-7.2,Cyclothiazide,BOCUKUHCLICSIY-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
7354,6lzg,DB03671,-7.2,"4-(3,12,14-Trihydroxy-10,13-Dimethyl-Hexadecahydro-Cyclopenta[a]Phenanthren-17-Yl)-5h-Furan-2-One",SHIBSTMRCDJXLN-KCZCNTNESA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
27188,6cs2,DB06654,-7.2,Safinamide,NEMGRZFTLSKBAP-LBPRGKRZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
93359,6m71,DB06857,-7.2,N-(4-CARBAMIMIDOYL-3-CHORO-PHENYL)-2-HYDROXY-3-IODO-5-METHYL-BENZAMIDE,QKGFTDAISIBIBV-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
11227,6lzg,DB11681,-7.2,Tofimilast,DHCOPPHTVOXDKU-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
124648,6w4h,DB01466,-7.2,Ethylmorphine,OGDVEMNWJVYAJL-LEPYJNQMSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
156052,6wiq,DB12137,-7.2,GSK-256066,JFHROPTYMMSOLG-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
92452,6m71,DB04429,-7.2,4'-Hydroxyflavanone,ZLHVIYHWWQYJID-HNNXBMFYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
124277,6w4h,DB00963,-7.2,Bromfenac,ZBPLOVFIXSTCRZ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
149736,6wiq,DB00524,-7.2,Metolazone,AQCHWTWZEMGIFD-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
35343,1r42,DB01496,-7.2,Barbituric acid derivative,DNZPLHRZXUJATK-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
93369,6m71,DB06869,-7.2,1-[2-AMINO-2-CYCLOHEXYL-ACETYL]-PYRROLIDINE-3-CARBOXYLIC ACID 5-CHLORO-2-(2-ETHYLCARBAMOYL-ETHOXY)-BENZYLAMIDE,BMHVHOJXEQTIEA-SIKLNZKXSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
156042,6wiq,DB12124,-7.2,Namitecan,IBTISPLPBBHVSU-UVOOVGFISA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
156136,6wiq,DB12461,-7.2,GLPG-0492,VAJGULUVTFDTAS-GOSISDBHSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
56734,6crv,DB02711,-7.2,"4-{2,6,8-Trioxo-9-[(2S,3R,4R)-2,3,4,5-Tetrahydroxypentyl]-1,2,3,6,8,9-Hexahydro-7h-Purin-7-Yl}Butyl Dihydrogen Phosphate",VBXZSBKAJFXURR-QXFUBDJGSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
35347,1r42,DB01500,-7.2,Oxabolone,GXHBCWCMYVTJOW-YGRHGMIBSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
56551,6crv,DB02472,-7.2,"6-Hydroxy-7,8-Dihydro Purine Nucleoside",ZWTNXGIZBOQCAJ-KQYNXXCUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
158223,7bv1,DB00745,-7.2,Modafinil,YFGHCGITMMYXAQ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
56553,6crv,DB02474,-7.2,Bmsc-0013,YTYAKGJMNHDUDF-UUWLPUTASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
66680,6lxt,DB04509,-7.2,N-Methylnaloxonium,PCSQOABIHJXZMR-YNUHATHGSA-O,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
86877,6m3m,DB11413,-7.2,Florfenicol,AYIRNRDRBQJXIF-NXEZZACHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
35512,1r42,DB01700,-7.2,AICA ribonucleotide,NOTGFIUVDGNKRI-UUOKFMHZSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
93388,6m71,DB06889,-7.2,"3-(1H-tetrazol-5-ylmethyl)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(3H)-one",QSBQXAOOVSQABJ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60124,6crv,DB08264,-7.2,"(1R, 2S)-cis 1,2 dihydroxy-1,2-dihydronaphthalene",QPUHWUSUBHNZCG-VHSXEESVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86878,6m3m,DB11419,-7.2,Haloxon,KULDXINYXFTXMO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
158231,7bv1,DB00755,-7.2,Tretinoin,SHGAZHPCJJPHSC-YCNIQYBTSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
70462,6lxt,DB12689,-7.2,Azeliragon,KJNNWYBAOPXVJY-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
69232,6lxt,DB08877,-7.2,Ruxolitinib,HFNKQEVNSGCOJV-OAHLLOKOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
56531,6crv,DB02447,-7.2,"3,8,9,10-Tetrahydroxy-7-Hydroxymethyl-6-Oxa-1,3-Diaza-Spiro[4.5]Decane-2,4-Dione",IHDZZZHACPJCFJ-WWHASAIZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
103260,6vxs,DB08365,-7.2,"8-bromo-4-(2-chlorophenyl)-N-(2-hydroxyethyl)-6-methyl-1,3-dioxo-1,2,3,6-tetrahydropyrrolo[3,4-e]indole-7-carboxamide",XUAHLMVOYLUYSB-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
70269,6lxt,DB12398,-7.2,Naproxen etemesil,JGBUBSOKFSVXKS-LBPRGKRZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
66562,6lxt,DB04345,-7.2,Lumichrome,ZJTJUVIJVLLGSP-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
124715,6w4h,DB01543,-7.2,18-methyl-19-nortestosterone,FBYZQDCRLYHHHP-ZOFHRBRSSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
56517,6crv,DB02427,-7.2,"2,4-Diamino-6-[N-(2',5'-Dimethoxybenzyl)-N-Methylamino]Quinazoline",YBJANOUTWRTBDK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
93562,6m71,DB07091,-7.2,(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclohexyloxy)ethanoyl)pyrrolidine-2-carboxamide,IWPMQJKXKKKSEY-SFHVURJKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
25684,6cs2,DB03679,-7.2,2-Hydroxy-Tryptophan,VAUYGGXCASQWHK-QMMMGPOBSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
56763,6crv,DB02754,-7.2,"9-Butyl-8-(3,4,5-Trimethoxybenzyl)-9h-Purin-6-Amine",TUOSCZDRWRYPRS-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
124244,6w4h,DB00924,-7.2,Cyclobenzaprine,JURKNVYFZMSNLP-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
103120,6vxs,DB08185,-7.2,2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,LCHGAOHLDYRACA-SDBHATRESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
103125,6vxs,DB08192,-7.2,2-(4-CARCOXY-5-ISOPROPYLTHIAZOLYL)BENZOPIPERIDINE,HCUGCUQZFBURHR-LBPRGKRZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
66712,6lxt,DB04549,-7.2,"4-(Aminosulfonyl)-N-[(2,3,4-Trifluorophenyl)Methyl]-Benzamide",AANTYZRUJFNZFI-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
60010,6crv,DB08127,-7.2,"1,3,3-trimethyl-2-[(1E,3E)-3-methylpenta-1,3-dien-1-yl]cyclohexene",KUEVAPFABUUVHS-AYCKBHPDSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56757,6crv,DB02743,-7.2,beta-D-galactopyranosyl-(1->4)-beta-D-galactopyranose,GUBGYTABKSRVRQ-WWZHPTPQSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
158269,7bv1,DB00804,-7.2,Dicyclomine,CURUTKGFNZGFSE-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
124693,6w4h,DB01521,-7.2,Clostebol,KCZCIYZKSLLNNH-FBPKJDBXSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
69230,6lxt,DB08873,-7.2,Boceprevir,LHHCSNFAOIFYRV-DOVBMPENSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
70274,6lxt,DB12404,-7.2,Remimazolam,CYHWMBVXXDIZNZ-KRWDZBQOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
152677,6wiq,DB04373,-7.2,"4-Amino-N-{4-[2-(2,6-Dimethyl-Phenoxy)-Acetylamino]-3-Hydroxy-1-Isobutyl-5-Phenyl-Pentyl}-Benzamide",WQUBEIMCFHCJCO-AWCRTANDSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
70469,6lxt,DB12704,-7.2,Spiradoline,NYKCGQQJNVPOLU-ONTIZHBOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
70275,6lxt,DB12405,-7.2,Triciribine,HOGVTUZUJGHKPL-HTVVRFAVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
16084,6lzg,DB02628,-7.2,"1-[3,3-Dimethyl-2-(2-Methylamino-Propionylamino)-Butyryl]-Pyrrolidine-2-Carboxylic Acid(1,2,3,4-Tetrahydro-Naphthalen-1-Yl)-Amide",JUJIMRZGUBTJRV-NASSWSRMSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
93328,6m71,DB06814,-7.2,Protokylol,LUMAEVHDZXIGEP-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
131166,6w4h,DB13374,-7.2,Vincamine,RXPRRQLKFXBCSJ-GIVPXCGWSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
93353,6m71,DB06848,-7.2,"1-(1'-{[3-(methylsulfanyl)-2-benzothiophen-1-yl]carbonyl}spiro[1-benzofuran-3,4'-piperidin]-5-yl)methanamine",VCUDZTCDUDDJGG-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93783,6m71,DB07343,-7.2,"4-[4-AMINO-6-(2,6-DICHLORO-PHENOXY)-[1,3,5]TRIAZIN-2-YLAMINO]-BENZONITRILE",NFNNMVVXXITVGD-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
85502,6m3m,DB07737,-7.2,(2S)-4-(4-fluorobenzyl)-N-(3-sulfanylpropyl)piperazine-2-carboxamide,OYTFYWWLBPDTNS-AWEZNQCLSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
56939,6crv,DB02981,-7.2,Vitamin B6 Complexed with 2-Amino-Hexanoic Acid,NHVFCSUYJRWFNW-LBPRGKRZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
156233,6wiq,DB12612,-7.2,Ozanimod,XRVDGNKRPOAQTN-FQEVSTJZSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
127563,6w4h,DB06397,-7.2,Nicaraven,KTXBOOWDLPUROC-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
150453,6wiq,DB01434,-7.2,19-norandrostenedione,JRIZOGLBRPZBLQ-QXUSFIETSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
11471,6lzg,DB12009,-7.2,GW-406381,NXMZBNYLCVTRGB-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
94107,6m71,DB07730,-7.2,"5-(3-HYDROXYPHENYL)ISOTHIAZOL-3(2H)-ONE 1,1-DIOXIDE",FJABEDRGNJSWCC-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
159622,7bv1,DB04944,-7.2,Acadesine,RTRQQBHATOEIAF-UUOKFMHZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
10943,6lzg,DB09291,-7.2,Rolapitant,FIVSJYGQAIEMOC-ZGNKEGEESA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
159618,7bv1,DB04930,-7.2,Permethrin,RLLPVAHGXHCWKJ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
66906,6lxt,DB04812,-7.2,Benoxaprofen,MITFXPHMIHQXPI-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
123013,6w4b,DB14653,-7.2,Clocortolone caproate,MMTRTBFDFNRBQO-ANHDKODLSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
71110,6lxt,DB13660,-7.2,Propicillin,HOCWPKXKMNXINF-XQERAMJGSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
157343,6wiq,DB15221,-7.2,PF-06260414,ZKAVFOXYJCREBQ-SNVBAGLBSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
123004,6w4b,DB14644,-7.2,Methylprednisolone hemisuccinate,IMBXEJJVJRTNOW-XYMSELFBSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
66172,6lxt,DB03823,-7.2,Epigallocatechin,XMOCLSLCDHWDHP-IUODEOHRSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
105401,6vxs,DB13448,-7.2,Mazaticol,AMHPTVWBZSYFSS-OAGGEKHMSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
123021,6w4b,DB14662,-7.2,Flunisolide acetate,WEGNFRKBIKYVLC-XTLNBZDDSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
34744,1r42,DB00728,-7.2,Rocuronium,YXRDKMPIGHSVRX-OOJCLDBCSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
6861,6lzg,DB00358,-7.2,Mefloquine,XEEQGYMUWCZPDN-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
134344,6w9c,DB02947,-7.2,2-Fluoro-2'-Deoxyadenosine,ZWPYUXAXLRFWQC-KVQBGUIXSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
107905,6vxx,DB05519,-7.2,Budiodarone,ZXOSVKYCXLTVGS-KRWDZBQOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
134343,6w9c,DB02946,-7.2,Carpropamide,RXDMAYSSBPYBFW-RULNRJAQSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
159603,7bv1,DB04890,-7.2,Bepotastine,YWGDOWXRIALTES-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
85820,6m3m,DB08101,-7.2,"2,6-dibromo-4-[(E)-2-phenylethenyl]phenol",WMVYUPRIADVLTH-VOTSOKGWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
93055,6m71,DB06193,-7.2,Pixantrone,PEZPMAYDXJQYRV-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
157354,6wiq,DB15241,-7.2,Methylsamidorphan,ATCVVCBJNHXIEX-ZAHKBLQYSA-O,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
69924,6lxt,DB11899,-7.2,MK-8776,GMIZZEXBPRLVIV-SECBINFHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
125734,6w4h,DB02880,-7.2,N-[1-(4-Bromophenyl)Ethyl]-5-Fluoro Salicylamide,KFTNEILVDDUXGR-SECBINFHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
59813,6crv,DB07903,-7.2,"3-[(2,2-DIMETHYLPROPANOYL)AMINO]-N-1,3-THIAZOL-2-YLPYRIDINE-2-CARBOXAMIDE",CAVCWRXFMNCBCM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
94117,6m71,DB07742,-7.2,"N-(2,3-DIFLUORO-BENZYL)-4-SULFAMOYL-BENZAMIDE",QASSMVGOSBNFQY-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93033,6m71,DB06148,-7.2,Mianserin,UEQUQVLFIPOEMF-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
127127,6w4h,DB04754,-7.2,"GUANOSINE-2',3'-O-ETHYLIDENEPHOSPHONATE",HYAPEMYRVFIHDJ-QWEIRQIHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
66139,6lxt,DB03785,-7.2,"(3r,5r)-7-((1r,2r,6s,8r,8as)-2,6-Dimethyl-8-{[(2r)-2-Methylbutanoyl]Oxy}-1,2,6,7,8,8a-Hexahydronaphthalen-1-Yl)-3,5-Dihydroxyheptanoic Acid",QLJODMDSTUBWDW-BXMDZJJMSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
125760,6w4h,DB02911,-7.2,"2,4-Diamino-6-Phenyl-5,6,7,8,-Tetrahydropteridine",VEKRIXRQADJFAG-QMMMGPOBSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
14907,6lzg,T3D4860,-7.2,Allura red AC,UQWIHFJXDRNUDP-FMQUCBEESA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
48551,2fxp,DB03276,-7.2,"4-[(10s,14s,18s)-18-(2-Amino-2-Oxoethyl)-14-(1-Naphthylmethyl)-8,17,20-Trioxo-7,16,19-Triazaspiro[5.14]Icos-11-En-10-Yl]Benzylphosphonic Acid",RHYFMOCFCFUTNH-GZNVFMSSSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
159688,7bv1,DB05284,-7.2,CA4P,LGZKGOGODCLQHG-ZDUSSCGKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
107946,6vxx,DB05779,-7.2,Oglufanide,LLEUXCDZPQOJMY-AAEUAGOBSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
158033,7bv1,DB00295,-7.2,Morphine,BQJCRHHNABKAKU-KBQPJGBKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
148478,6w9q,DB13499,-7.2,Cefsulodin,SYLKGLMBLAAGSC-QLVMHMETSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
25444,6cs2,DB03365,-7.2,"4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline",BNDYIYYKEIXHNK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
123002,6w4b,DB14641,-7.2,Estriol tripropionate,ONMZMZJEZHMWQL-REUUDLSRSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
159672,7bv1,DB05187,-7.2,Elafibranor,AFLFKFHDSCQHOL-IZZDOVSWSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
131324,6w4h,DB13593,-7.2,Zolimidine,VSLIUWLPFRVCDL-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
15662,6lzg,DB00737,-7.2,Meclizine,OCJYIGYOJCODJL-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
134508,6w9c,DB03172,-7.2,Tubercidin,HDZZVAMISRMYHH-KCGFPETGSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
71137,6lxt,DB13689,-7.2,Tacalcitol,BJYLYJCXYAMOFT-RSFVBTMBSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
16867,6cs2,HMDB0004957,-7.2,Ceramide (d18:1/25:0),QHPYSHVSWAOLHS-PVNBSDFKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
34723,1r42,DB00705,-7.2,Delavirdine,WHBIGIKBNXZKFE-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
85744,6m3m,DB08014,-7.2,(METHYLPYRIDAZINE PIPERIDINE BUTYLOXYPHENYL)ETHYLACETATE,AQILFLLHLFBLLG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
102709,6vxs,DB07719,-7.2,"[(3R)-3-(Methylcarbamoyl)-2-{[(2-methyl-2-propanyl)oxy]carbonyl}-1,2,3,4-tetrahydro-7-isoquinolinyl]sulfamic acid",PPSSYXOFPICMQD-CYBMUJFWSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
134470,6w9c,DB03115,-7.2,"5-Bromo-N-(2,3-Dihydroxypropoxy)-3,4-Difluoro-2-[(2-Fluoro-4-Iodophenyl)Amino]Benzamide",XXSSGBYXSKOLAM-QMMMGPOBSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
105685,6vxs,DB13828,-7.2,Cyfluthrin,QQODLKZGRKWIFG-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102719,6vxs,DB07732,-7.2,2-[(2-NAPHTHYLSULFONYL)AMINO]ETHYL DIHYDROGEN PHOSPHATE,FCROUVVWZFPGFM-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
127579,6w4h,DB06436,-7.2,Semaxanib,WUWDLXZGHZSWQZ-WQLSENKSSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
148453,6w9q,DB13463,-7.2,Oxetorone,VZVRZTZPHOHSCK-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
130899,6w4h,DB12964,-7.2,Lerisetron,PWWDCRQZITYKDV-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
34752,1r42,DB00739,-7.2,Hetacillin,DXVUYOAEDJXBPY-NFFDBFGFSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
105415,6vxs,DB13469,-7.2,Phanquinone,VLPADTBFADIFKG-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
93067,6m71,DB06211,-7.2,Doripenem,AVAACINZEOAHHE-VFZPANTDSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
159546,7bv1,DB04555,-7.2,Cytidine-5'-Diphosphate,ZWIADYZPOWUWEW-XVFCMESISA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
71052,6lxt,DB13580,-7.2,Succinylsulfathiazole,SKVLYVHULOWXTD-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
150421,6wiq,DB01393,-7.2,Bezafibrate,IIBYAHWJQTYFKB-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
94049,6m71,DB07662,-7.2,N-[4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL]-ACRYLAMIDE,HTUBKQUPEREOGA-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
157374,6wiq,DB15287,-7.2,Elismetrep,CWEFDWIKLABKBX-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
59829,6crv,DB07925,-7.2,4-(2-HYDROXYPHENYLSULFINYL)-BUTYLPHOSPHONIC ACID,FFIGWLBWBXCVHW-QGZVFWFLSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85910,6m3m,DB08201,-7.2,(1S)-menthyl hexyl phosphonate group,WAVIZOVSJOXCKT-XHSDSOJGSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
66216,6lxt,DB03883,-7.2,Carboxyethyllumazine,PTYCEIBBGGLADD-PJKMHFRUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
94040,6m71,DB07648,-7.2,"(2R)-3-{[(4Z)-5,6-DIPHENYL-6,7-DIHYDRO-4H-PYRROLO[2,3-D]PYRIMIDIN-4-YLIDENE]AMINO}PROPANE-1,2-DIOL",TWEONIHFGKSPLC-MRXNPFEDSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
148615,6w9q,DB13682,-7.2,Cefpirome,DKOQGJHPHLTOJR-WHRDSVKCSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
66219,6lxt,DB03887,-7.2,Alpha-Adenosine Monophosphate,NVOIXARBSSLBAS-CRKDRTNXSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
132160,6w4h,DB09170,-7.2,β-Hydroxythiofentanyl,GLAAETOTOUGGSB-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
127507,6w4h,DB06235,-7.2,Vadimezan,XGOYIMQSIKSOBS-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
150420,6wiq,DB01392,-7.2,Yohimbine,BLGXFZZNTVWLAY-SCYLSFHTSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
66892,6lxt,DB04792,-7.2,"2,5-O,O-BIS-{4',4''-AMIDINOPHENYL}-1,4:3,6-DIANHYDRO-D-SORBITOL",CDEVHSIVANGYRI-XMTFNYHQSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
148696,6w9q,DB13792,-7.2,Clopamide,LBXHRAWDUMTPSE-AOOOYVTPSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
127506,6w4h,DB06234,-7.2,Maribavir,KJFBVJALEQWJBS-XUXIUFHCSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
159456,7bv1,DB04440,-7.2,Nebularine,MRWXACSTFXYYMV-FDDDBJFASA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
132192,6w9c,DB00140,-7.2,Riboflavin,AUNGANRZJHBGPY-SCRDCRAPSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
123097,6w4b,DB14840,-7.2,Ripretinib,CEFJVGZHQAGLHS-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
134213,6w9c,DB02714,-7.2,3'-Uridinemonophosphate,FOGRQMPFHUHIGU-XVFCMESISA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
27829,6cs2,DB07388,-7.2,ETHYL 4-[(4-METHYLPYRIDIN-2-YL)AMINO]PIPERIDINE-1-CARBOXYLATE,LNRMJBWADUSJTA-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
159490,7bv1,DB04482,-7.2,Cmp-2-Keto-3-Deoxy-Octulosonic Acid,YWWJKULNWGRYAS-UOVSKDHASA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
85828,6m3m,DB08109,-7.2,"(1S,4R,7AR)-4-BUTOXY-1-[(1R)-1-FORMYLPROPYL]-2,4,5,6,7,7A-HEXAHYDRO-1H-ISOINDOLE-3-CARBOXYLIC ACID",WRBRCIHZCYLBFW-KYEXWDHISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
159553,7bv1,DB04563,-7.2,CRA_9678,VIZNZQTZRMTYPZ-UHFFFAOYSA-M,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
87746,6m3m,DB12789,-7.2,Dinoprost,PXGPLTODNUVGFL-YNNPMVKQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
153042,6wiq,DB04859,-7.2,Zanapezil,PMBLXLOXUGVTGB-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
11715,6lzg,DB12332,-7.2,Rucaparib,HMABYWSNWIZPAG-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
107895,6vxx,DB05475,-7.2,Golotimod,CATMPQFFVNKDEY-YPMHNXCESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85832,6m3m,DB08113,-7.2,3-pyridin-4-yl-1H-indazole,MSRXUUDVRNWSTN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
69930,6lxt,DB11905,-7.2,Sutezolid,FNDDDNOJWPQCBZ-ZDUSSCGKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
104017,6vxs,DB11125,-7.2,Benzethonium,SIYLLGKDQZGJHK-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
106244,6vxs,DB15300,-7.2,Hydroquinidine,LJOQGZACKSYWCH-LHHVKLHASA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
123040,6w4b,DB14681,-7.2,Cortisone,MFYSYFVPBJMHGN-ZPOLXVRWSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
153038,6wiq,DB04852,-7.2,Implitapide,AMNXBQPRODZJQR-DITALETJSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
132138,6w4h,DB15457,-7.2,Snubh-nm-333 F-18,QLWFXLJVGCECSV-HUYCHCPVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
7149,6lzg,DB00404,-7.2,Alprazolam,VREFGVBLTWBCJP-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
157371,6wiq,DB15281,-7.2,Ravoxertinib,RZUOCXOYPYGSKL-GOSISDBHSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
107885,6vxx,DB05431,-7.2,MLN-977,YANONWCPCKIWEC-CABCVRRESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
105411,6vxs,DB13461,-7.2,Cefcapene,HJJRIJDTIPFROI-NVKITGPLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
105678,6vxs,DB13821,-7.2,Ceftezole,DZMVCVMFETWNIU-LDYMZIIASA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
130920,6w4h,DB13001,-7.2,Tinoridine,PFENFDGYVLAFBR-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
148564,6w9q,DB13617,-7.2,Clorexolone,VPMWFZKOWULPGT-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
92292,6m71,DB04204,-7.2,[(4-{4-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Butyl}-Phenyl)-Difluoro-Methyl]-Phosphonic Acid,SRHSAABKYJDBDV-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
127518,6w4h,DB06257,-7.2,HE-2200,OEVZKEVBDIDVOI-YSZCXEEOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
11454,6lzg,DB11990,-7.2,MK-0812,UNVWTBOGMHPKJM-CWKRKGSWSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
15686,6lzg,DB00831,-7.2,Trifluoperazine,ZEWQUBUPAILYHI-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
59823,6crv,DB07919,-7.2,7-METHOXY-1-METHYL-9H-BETA-CARBOLINE,BXNJHAXVSOCGBA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
34776,1r42,DB00769,-7.2,Hydrocortamate,FWFVLWGEFDIZMJ-FOMYWIRZSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
71061,6lxt,DB13593,-7.2,Zolimidine,VSLIUWLPFRVCDL-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
159590,7bv1,DB04610,-7.2,"7,8-dihydro-6-hydroxymethyl-7-methyl-7-[2-phenylethyl]-pterin",XMFJTCGUDFSWSW-INIZCTEOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
125561,6w4h,DB02647,-7.2,N-(5-Cyclopropyl-1h-Pyrazol-3-Yl)Benzamide,LUCORKWTQSQFFU-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
59803,6crv,DB07892,-7.2,1-(2-HYDROXYETHYLOXYMETHYL)-6-PHENYL THIOTHYMINE,HDMHBHNRWDNNCD-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55900,6crv,DB01614,-7.2,Acepromazine,NOSIYYJFMPDDSA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
6845,6lzg,DB02799,-7.2,N-[2-(1-Maleimidyl)Ethyl]-7-Diethylaminocoumarin-3-Carboxamide,OJBZDUMTXGGVSP-KTKRTIGZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
152319,6wiq,DB03893,-7.2,Thionicotinamide-Adenine-Dinucleotide,UQYPZLRUJKCREN-NNYOXOHSSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
59778,6crv,DB07862,-7.2,"7-(1-ETHYL-PROPYL)-7H-PYRROLO-[3,2-F]QUINAZOLINE-1,3-DIAMINE",GCPJCLJGTVTGRF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
125929,6w4h,DB03141,-7.2,"3-{[(5R,6R)-5-Benzyl-6-hydroxy-2,4-bis(4-hydroxybenzyl)-3-oxo-1,2,4-triazepan-1-yl]sulfonyl}benzonitril",UYUWNNRWESUYOB-FIRIVFDPSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
69859,6lxt,DB11801,-7.2,Rapastinel,GIBQQARAXHVEGD-BSOLPCOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
122685,6w4b,DB13729,-7.2,Camostat,XASIMHXSUQUHLV-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
66951,6lxt,DB04864,-7.2,Huperzine A,ZRJBHWIHUMBLCN-YQEJDHNASA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
122710,6w4b,DB13767,-7.2,Vorozole,XLMPPFTZALNBFS-INIZCTEOSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
134774,6w9c,DB03528,-7.2,9-Beta-D-Xylofuranosyl-Adenine,OIRDTQYFTABQOQ-GAWUUDPSSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
134773,6w9c,DB03526,-7.2,AL5927,LRRAIRJIZOLGPR-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
159816,7bv1,DB06622,-7.2,7-beta-Hydroxyepiandrosterone,VFPMCLQMAUVEHD-UCPSWNCLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
35872,1r42,DB02187,-7.2,Equilin,WKRLQDKEXYKHJB-HFTRVMKXSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
148227,6w9q,DB13125,-7.2,Lusutrombopag,NOZIJMHMKORZBA-KJCUYJGMSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
27927,6cs2,DB07490,-7.2,"2-[1-(4-CHLORO-PHENYL)-ETHYL]-4,6-DINITRO-PHENOL",MOZUMFSUQQHSCO-MRVPVSSYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
148252,6w9q,DB13185,-7.2,Oxabolone cipionate,KHKDIUPVDIEHAH-KXLSUQFWSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
59314,6crv,DB07317,-7.2,(3E)-3-[(phenylamino)methylidene]dihydrofuran-2(3H)-one,BKXNPYSVWOVZGX-CMDGGOBGSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
157280,6wiq,DB15099,-7.2,GW-468816,XDKRVNKVAKCFGW-WXWBBQJKSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
153086,6wiq,DB04942,-7.2,Tamibarotene,MUTNCGKQJGXKEM-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
122735,6w4b,DB13797,-7.2,Iodocholesterol (131I),FIOAEFCJGZJUPW-ODFYUTSGSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
66060,6lxt,DB03687,-7.2,4-Diphosphocytidyl-2-C-Methyl-D-Erythritol,YFAUKWZNPVBCFF-XHIBXCGHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
10901,6lzg,DB09232,-7.2,Cilnidipine,KJEBULYHNRNJTE-DHZHZOJOSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
89505,6m71,DB00561,-7.2,Doxapram,XFDJYSQDBULQSI-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
66065,6lxt,DB03695,-7.2,Piritrexim,VJXSSYDSOJBUAV-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
153075,6wiq,DB04908,-7.2,Flibanserin,PPRRDFIXUUSXRA-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
105363,6vxs,DB13398,-7.2,Oxyfedrine,GDYUVHBMFVMBAF-LIRRHRJNSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
67485,6lxt,DB06794,-7.2,Lodoxamide,RVGLGHVJXCETIO-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
71252,6lxt,DB13844,-7.2,Pipenzolate,WPUKUEMZZRVAKZ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
125971,6w4h,DB03200,-7.2,7-Alpha-D-Ribofuranosyl-Purine-5'-Phosphate,NICKPTPNIMHUHB-DQUBFYRCSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130823,6w4h,DB12853,-7.2,DA-6886,AULLTYAISZREAX-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
108037,6vxx,DB06736,-7.2,Aceclofenac,MNIPYSSQXLZQLJ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
6983,6lzg,DB03034,-7.2,D-Levofloxacin,GSDSWSVVBLHKDQ-SNVBAGLBSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
159876,7bv1,DB06730,-7.2,Gestodene,SIGSPDASOTUPFS-XUDSTZEESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
132032,6w4h,DB15241,-7.2,Methylsamidorphan,ATCVVCBJNHXIEX-ZAHKBLQYSA-O,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
148170,6w9q,DB13044,-7.2,Gossypol,QBKSWRVVCFFDOT-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
35885,1r42,DB02205,-7.2,"6-(1,1-Dimethylallyl)-2-(1-Hydroxy-1-Methylethyl)-2,3-Dihydro-7h-Furo[3,2-G]Chromen-7-One",JCDLLLXYAICSQV-INIZCTEOSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
66972,6lxt,DB04890,-7.2,Bepotastine,YWGDOWXRIALTES-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
5532,6lzg,HMDB0001913,-7.2,Omeprazole,SUBDBMMJDZJVOS-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
89518,6m71,DB00579,-7.2,Mazindol,ZPXSCAKFGYXMGA-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
35879,1r42,DB02196,-7.2,Uridine-Diphosphate-N-Acetylgalactosamine,LFTYTUAZOPRMMI-NESSUJCYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
59776,6crv,DB07860,-7.2,(2R)-2-(4-CHLOROPHENYL)-2-PHENYLETHANAMINE,PNKKPFLBOWGVSF-CQSZACIVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
15600,6lzg,DB00414,-7.2,Acetohexamide,VGZSUPCWNCWDAN-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
105706,6vxs,DB13855,-7.2,Nifuroxazide,YCWSUKQGVSGXJO-NTUHNPAUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
155866,6wiq,DB11867,-7.2,JNJ-39393406,IURMHZBQEYNQOH-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
60616,6crv,DB08872,-7.2,Gabapentin enacarbil,TZDUHAJSIBHXDL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
10892,6lzg,DB09223,-7.2,Blonanserin,XVGOZDAJGBALKS-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
106171,6vxs,DB15161,-7.2,Pittsburgh Compound B,ZQAQXZBSGZUUNL-BJUDXGSMSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
27233,6cs2,DB06726,-7.2,Bufuralol,SSEBTPPFLLCUMN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
27941,6cs2,DB00688,-7.2,Mycophenolate mofetil,RTGDFNSFWBGLEC-SYZQJQIISA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
60612,6crv,DB08864,-7.2,Rilpivirine,YIBOMRUWOWDFLG-ONEGZZNKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
122655,6w4b,DB13689,-7.2,Tacalcitol,BJYLYJCXYAMOFT-RSFVBTMBSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
130856,6w4h,DB12900,-7.2,Irdabisant,XUKROCVZGZNGSI-CQSZACIVSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
85564,6m3m,DB07807,-7.2,"(3R,4R,5R)-5-(HYDROXYMETHYL)-1-(3-PHENYLPROPYL)PIPERIDINE-3,4-DIOL",NKARZGURZMIRMA-RBSFLKMASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85534,6m3m,DB07773,-7.2,5-FLUOROINDOLE PROPANOL PHOSPHATE,YVYGGBFCYXRNKM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
127120,6w4h,DB04743,-7.2,Nimesulide,HYWYRSMBCFDLJT-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
159799,7bv1,DB06588,-7.2,Triphendiol,KQCJZAUNKSGEFM-UNMCSNQZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
125913,6w4h,DB03115,-7.2,"5-Bromo-N-(2,3-Dihydroxypropoxy)-3,4-Difluoro-2-[(2-Fluoro-4-Iodophenyl)Amino]Benzamide",XXSSGBYXSKOLAM-QMMMGPOBSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
157307,6wiq,DB15149,-7.2,Futibatinib,KEIPNCCJPRMIAX-HNNXBMFYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
148380,6w9q,DB13364,-7.2,Feprazone,RBBWCVQDXDFISW-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
85658,6m3m,DB07919,-7.2,7-METHOXY-1-METHYL-9H-BETA-CARBOLINE,BXNJHAXVSOCGBA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
159723,7bv1,DB05475,-7.2,Golotimod,CATMPQFFVNKDEY-YPMHNXCESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
150507,6wiq,DB01496,-7.2,Barbituric acid derivative,DNZPLHRZXUJATK-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
94208,6m71,DB07844,-7.2,6-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1-BENZOTHIOPHENE-2-SULFONAMIDE,PHLKBODTBJLXRD-WFASDCNBSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60550,6crv,DB08777,-7.2,"5,6,7,8-TETRAHYDRO[1]BENZOTHIENO[2,3-D]PYRIMIDIN-4(3H)-ONE",NMMOEJUJKIXUQZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
71174,6lxt,DB13739,-7.2,Penamecillin,NLOOMWLTUVBWAW-HLLBOEOZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
48577,2fxp,DB03311,-7.2,"3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid [4-(Thiazol-2-Ylsulfamoyl)-Phenyl]-Amide",SXKBTDJJEQQEGE-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
87829,6m3m,DB12923,-7.2,Gallopamil,XQLWNAFCTODIRK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
107966,6vxx,DB05885,-7.2,Seletracetam,ANWPENAPCIFDSZ-RQJHMYQMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
66936,6lxt,DB04843,-7.2,Mepenzolate,GKNPSSNBBWDAGH-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
148418,6w9q,DB13418,-7.2,Moxestrol,MTMZZIPTQITGCY-OLGWUGKESA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
122872,6w4b,DB14059,-7.2,SC-236,NSQNZEUFHPTJME-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
94195,6m71,DB07829,-7.2,4-[3-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL]PYRIDINE,BILJSHVAAVZERY-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
134620,6w9c,DB03312,-7.2,Brivudine,ODZBBRURCPAEIQ-PIXDULNESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
71167,6lxt,DB13729,-7.2,Camostat,XASIMHXSUQUHLV-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
15639,6lzg,DB00621,-7.2,Oxandrolone,QSLJIVKCVHQPLV-PEMPUTJUSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
66119,6lxt,DB03761,-7.2,5-Fluoro-2'-Deoxyuridine-5'-Monophosphate,HFEKDTCAMMOLQP-RRKCRQDMSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
122908,6w4b,DB14127,-7.2,Sacubitrilat,DOBNVUFHFMVMDB-BEFAXECRSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
127581,6w4h,DB06442,-7.2,Avasimibe,PTQXTEKSNBVPQJ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
157311,6wiq,DB15157,-7.2,Voruciclib,MRPGRAKIAJJGMM-OCCSQVGLSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
122947,6w4b,DB14217,-7.2,Quinaprilat,FLSLEGPOVLMJMN-YSSFQJQWSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
69386,6lxt,DB09097,-7.2,Quinagolide,GDFGTRDCCWFXTG-ZIFCJYIRSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
125832,6w4h,DB03009,-7.2,2-[(2-Oxo-2-Piperidin-1-Ylethyl)Thio]-6-(Trifluoromethyl)Pyrimidin-4(1h)-One,UDBHGUOSOKOIAX-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
132081,6w4h,DB15338,-7.2,Rovatirelin,WTXWDXWZGJGIHV-URBCHYCLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
134651,6w9c,DB03354,-7.2,"2-(Beta-D-Glucopyranosyl)-5-Methyl-1,3,4-Oxadiazole",HCSFWJQLIPWUFZ-JAJWTYFOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
48588,2fxp,DB03325,-7.2,Tyrosyladenylate,MJZAZMKENKZBAJ-QTOWJTHWSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
28672,6cs2,DB08273,-7.2,4-HYDROXY-5-IODO-3-NITROPHENYLACETYL-EPSILON-AMINOCAPROIC ACID ANION,LKGGMBQFWIIXJM-UHFFFAOYSA-M,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
69872,6lxt,DB11821,-7.2,Danegaptide,BIZKIHUJGMSVFD-MNOVXSKESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
157288,6wiq,DB15114,-7.2,Vamorolone,ZYTXTXAMMDTYDQ-DGEXFFLYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
132093,6w4h,DB15359,-7.2,Xanthohumol,ORXQGKIUCDPEAJ-YRNVUSSQSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
66082,6lxt,DB03718,-7.2,6-Aza-Ump,LRVZOSYMNMNQFR-SHUUEZRQSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
148352,6w9q,DB13333,-7.2,Efloxate,ZVXBAHLOGZCFTP-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
71216,6lxt,DB13796,-7.2,Dibunate,WBEBQCINXJDZCX-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
94232,6m71,DB07870,-7.2,(2S)-2-(4-{[3-CHLORO-5-(TRIFLUOROMETHYL)PYRIDIN-2-YL]OXY}PHENOXY)PROPANOIC ACID,GOCUAJYOYBLQRH-MRVPVSSYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
159760,7bv1,DB06478,-7.2,Porfiromycin,HRHKSTOGXBBQCB-VFWICMBZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
14518,6lzg,T3D4323,-7.2,Coproporphyrin III,JWFCYWSMNRLXLX-UJJXFSCMSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
125866,6w4h,DB03060,-7.2,Sri-9662,WNDJHUNKXPAREB-PLNGDYQASA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
148368,6w9q,DB13351,-7.2,Piperidolate,KTHVBAZBLKXIHZ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
88908,6m3m,DB15080,-7.2,ELX-02,KJBRSTPUILEBDR-YBNFDXCTSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
105387,6vxs,DB13430,-7.2,Mebutizide,KJLLKLRVCJAFRY-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102651,6vxs,DB07648,-7.2,"(2R)-3-{[(4Z)-5,6-DIPHENYL-6,7-DIHYDRO-4H-PYRROLO[2,3-D]PYRIMIDIN-4-YLIDENE]AMINO}PROPANE-1,2-DIOL",TWEONIHFGKSPLC-MRXNPFEDSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
87837,6m3m,DB12931,-7.2,Fenobam,DWPQODZAOSWNHB-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
122816,6w4b,DB13946,-7.2,Testosterone undecanoate,UDSFVOAUHKGBEK-CNQKSJKFSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
125848,6w4h,DB03035,-7.2,"1,8-Di-Hydroxy-4-Nitro-Anthraquinone",RIYCICFDXLNQPV-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
159745,7bv1,DB05585,-7.2,Verubulin,SNHCRNMVYDHVDT-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
46670,2fxp,DB00826,-7.2,Natamycin,NCXMLFZGDNKEPB-FFPOYIOWSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
25424,6cs2,DB03342,-7.2,4-(Acetylamino)-3-Guanidinobenzoic Acid,HIXHCUDMJUERSJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
157301,6wiq,DB15138,-7.2,AZD-9496,DFBDRVGWBHBJNR-BBNFHIFMSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
148366,6w9q,DB13349,-7.2,Talastine,LCAAMXMULMCKLJ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
134660,6w9c,DB03365,-7.2,"4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline",BNDYIYYKEIXHNK-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
15631,6lzg,DB00591,-7.2,Fluocinolone acetonide,FEBLZLNTKCEFIT-VSXGLTOVSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
159454,7bv1,DB04437,-7.2,"Cysteine-Methylene-Carbamoyl-1,10-Phenanthroline",ZFGIPRHDRFOMFO-LBPRGKRZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
134176,6w9c,DB02666,-7.2,(C8-R)-Hydantocidin 5'-Phosphate,MAXSFYCTFIBEAR-OJMIUMIFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
16747,6cs2,HMDB0004081,-7.2,6-Hydroxymelatonin,OMYMRCXOJJZYKE-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
148952,6w9q,DB14625,-7.2,Meprednisone acetate,RZAMUHXEOMZXET-ABQXZQTJSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
87630,6m3m,DB12604,-7.2,Sisomicin,URWAJWIAIPFPJE-YFMIWBNJSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
131273,6w4h,DB13523,-7.2,Veralipride,RYJXBGGBZJGVQF-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
92328,6m71,DB04254,-7.2,"8-Benzo[1,3]Dioxol-,5-Ylmethyl-9-Butyl-2-Fluoro-9h-Purin-6-Ylamine",ARWHTQLGMWHTAZ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
123347,6w4b,DB15358,-7.2,JNJ-54175446,CWFVVQFVGMFTBD-SECBINFHSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
16600,6cs2,HMDB0003080,-7.2,Leukotriene D4,YEESKJGWJFYOOK-IJHYULJSSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
148953,6w9q,DB14626,-7.2,Pregnenolone acetate,CRRKVZVYZQXICQ-RJJCNJEVSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
93119,6m71,DB06345,-7.2,AR-9281,HUDQLWBKJOMXSZ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
106421,6vxx,DB00192,-7.2,Indecainide,UCEWGESNIULAGX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
133856,6w9c,DB02247,-7.2,Hydrolyzed Cephalothin,JRYZEMHNDUZNMI-RYUDHWBXSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
132323,6w9c,DB00287,-7.2,Travoprost,MKPLKVHSHYCHOC-AHTXBMBWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
152497,6wiq,DB04131,-7.2,"10-(4-Dimethylamino-5-Hydroxy-6-Methyl-Tetrahydro-Pyran-2-Yloxy)-8-Ethyl-1,8,11-Trihydroxy-7,8,9,10-Tetrahydro-Naphthacene-5,12-Dione",BLGDWFJQIHBUJY-NWJGULHDSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
148959,6w9q,DB14632,-7.2,Prednisolone tebutate,HUMXXHTVHHLNRO-KAJVQRHHSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
133834,6w9c,DB02218,-7.2,"N-[4-hydroxymethyl-cyclohexan-6-yl-1,2,3-triol]-4,6-dideoxy-4-aminoglucopyranoside",RBZIIHWPZWOIDU-ZCGMLSCUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
23347,6cs2,HMDB0001923,-7.2,Naproxen,CMWTZPSULFXXJA-VIFPVBQESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
27757,6cs2,DB07310,-7.2,"(5S)-2-{[(1S)-1-(2-fluorophenyl)ethyl]amino}-5-methyl-5-(trifluoromethyl)-1,3-thiazol-4(5H)-one",KNHNFKZUNFPPQE-MADCSZMMSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
86213,6m3m,DB08575,-7.2,"2-[(1S)-1-BENZYL-2-SULFANYLETHYL]-1H-IMIDAZO[4,5-C]PYRIDIN-5-IUM",DCUCDCAIOMIBEA-GFCCVEGCSA-O,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
148962,6w9q,DB14635,-7.2,Curcumin sulfate,NEJVQQBBTRFOHB-FCXRPNKRSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
107491,6vxx,DB03670,-7.2,"2-(Oxalyl-Amino)-4,5,6,7-Tetrahydro-Thieno[2,3-C]Pyridine-3-Carboxylic Acid",ZIBMATWHOAGNTR-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
93869,6m71,DB07446,-7.2,N-(biphenyl-4-ylsulfonyl)-D-leucine,FBSVJQQVDISETN-QGZVFWFLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
107481,6vxx,DB03658,-7.2,"2-{1-[2-Amino-2-(4-Hydroxy-Phenyl)-Acetylamino]-2-Oxo-Ethyl}-5,5-Dimethyl-Thiazolidine-4-Carboxylic Acid",SMLJDSWXGVMNTH-NRWUCQMLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
103408,6vxs,DB08542,-7.2,"3,4-dihydroxy-9,10-secoandrosta-1(10),2,4-triene-9,17-dione",YUHVBHDSVLKFNI-NJSLBKSFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
105656,6vxs,DB13792,-7.2,Clopamide,LBXHRAWDUMTPSE-AOOOYVTPSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
93864,6m71,DB07439,-7.2,"1-((2-HYDROXYETHOXY)METHYL)-5-(3-(BENZYLOXY)BENZYL)-6-HYDROXYPYRIMIDINE-2,4(1H,3H)-DIONE",CAWXCABXSPTFRN-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
159131,7bv1,DB03464,-7.2,Formycin-5'-Monophosphate,PBAHXXBYQACZMA-KSYZLYKTSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
27756,6cs2,DB07309,-7.2,5-BROMO-2-{[(4-CHLOROPHENYL)SULFONYL]AMINO}BENZOIC ACID,JDVLYAYDIMUAAC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
132300,6w9c,DB00263,-7.2,Sulfisoxazole,NHUHCSRWZMLRLA-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
125370,6w4h,DB02402,-7.2,"5-(4-Methoxyphenoxy)-2,4-Quinazolinediamine",CPZJZAIZIMCJRC-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
125395,6w4h,DB02430,-7.2,Trehalose-6-Phosphate,LABSPYBHMPDTEL-LIZSDCNHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
125394,6w4h,DB02429,-7.2,4-(Aminosulfonyl)-N-[(4-Fluorophenyl)Methyl]-Benzamide,IXDVPACDZDRCTN-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
123287,6w4b,DB15241,-7.2,Methylsamidorphan,ATCVVCBJNHXIEX-ZAHKBLQYSA-O,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
16640,6cs2,HMDB0003306,-7.2,Phloretin,VGEREEWJJVICBM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
70013,6lxt,DB12029,-7.2,Chlorogenic Acid,CWVRJTMFETXNAD-JUHZACGLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
87636,6m3m,DB12615,-7.2,Plazomicin,IYDYFVUFSPQPPV-PEXOCOHZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
66854,6lxt,DB04740,-7.2,MOXALACTAM (HYDROLYZED),ZTOQXKUYWZBJLG-XNAIMREJSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
133928,6w9c,DB02350,-7.2,"N-Hydroxy-4-[(4-Methoxylphenyl)Sulfonyl]-2,2-Dimethyl-Hexahydro-1,4-Thiazepine-3(S)-Carboxamide",CYYCSKFJEOSZTF-CYBMUJFWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
102836,6vxs,DB07863,-7.2,2-chloro-5-nitro-N-phenylbenzamide,DNTSIBUQMRRYIU-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
148934,6w9q,DB14545,-7.2,Hydrocortisone succinate,VWQWXZAWFPZJDA-CGVGKPPMSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
132298,6w9c,DB00261,-7.2,Anagrelide,OTBXOEAOVRKTNQ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
155939,6wiq,DB11969,-7.2,Uprosertib,AXTAPYRUEKNRBA-JTQLQIEISA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
59357,6crv,DB07366,-7.2,2-[N'-(4-AMINO-BUTYL)-HYDRAZINOCARBONYL]-PYRROLIDINE-1-CARBOXYLIC ACID BENZYL ESTER,MOCIXHUQBOUBAK-HNNXBMFYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56145,6crv,DB01945,-7.2,4-Carbamoyl-1-Beta-D-Ribofuranosyl-Imidazolium-5-Olate-5'-Phosphate,KTKAFSMJDTUUAN-UUOKFMHZSA-L,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
133903,6w9c,DB02307,-7.2,N-(1-Carboxy-3-Phenylpropyl)Phenylalanyl-Alpha-Asparagine,FOJUHLDAXGNCIP-FHWLQOOXSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
34911,1r42,DB00922,-7.2,Levosimendan,WHXMKTBCFHIYNQ-SECBINFHSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
7198,6lzg,DB03388,-7.2,"3-[(2,4-Dichlorobenzoyl)(Isopropyl)Amino]-5-Phenylthiophene-2-Carboxylic Acid",UKNZREOUDLFUFF-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
107539,6vxx,DB03735,-7.2,9-(2-Deoxy-Beta-D-Ribofuranosyl)-6-Methylpurine,SJXRKKYXNZWKDB-DJLDLDEBSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
11405,6lzg,DB11921,-7.2,Deflazacort,FBHSPRKOSMHSIF-GRMWVWQJSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
87633,6m3m,DB12608,-7.2,Emixustat,WJIGGYYSZBWCGC-MRXNPFEDSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
106401,6vxx,DB00170,-7.2,Menadione,MJVAVZPDRWSRRC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
159181,7bv1,DB03534,-7.2,3-[(Acetyl-Methyl-Amino)-Methyl]-4-Amino-N-Methyl-N-(1-Methyl-1h-Indol-2-Ylmethyl)-Benzamide,AWTBJNJPBKTHEV-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
16606,6cs2,HMDB0003128,-7.2,Cortolone,JXCOSKURGJMQSG-AZQJGLEESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
26110,6cs2,DB04176,-7.2,"Phosporic Acid Mono-[3,4-Dihydroxy-5-(5-Methoxy-Benzoimidazol-1-Yl)-Tetrahydro-Furan-2-Ylmethyl] Ester",VYUPJUKSTVHSQI-LPWJVIDDSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
123301,6w4b,DB15273,-7.2,VS-4718,IGUBBWJDMLCRIK-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
133930,6w9c,DB02353,-7.2,Heparin Disaccharide Iii-S,GSYQGRODWXMUOO-GYBHJADLSA-K,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
157501,6wiq,DB09231,-7.2,Benidipine,QZVNQOLPLYWLHQ-ZEQKJWHPSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
102869,6vxs,DB07902,-7.2,"TERT-BUTYL {2-[(1,3-THIAZOL-2-YLAMINO)CARBONYL]PYRIDIN-3-YL}CARBAMATE",QBMYJIFXSXKPFS-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
106452,6vxx,DB00359,-7.2,Sulfadiazine,SEEPANYCNGTZFQ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
148984,6w9q,DB14659,-7.2,Melengestrol acetate,UDKABVSQKJNZBH-DWNQPYOZSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
148985,6w9q,DB14660,-7.2,Trenbolone acetate,CMRJPMODSSEAPL-FYQPLNBISA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
133663,6w9c,DB01987,-7.2,Cocarboxylase,AYEKOFBPNLCAJY-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
92343,6m71,DB04274,-7.2,"5,4'-Dideoxyflavanone",SWAJPHCXKPCPQZ-AWEZNQCLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
123602,6w4h,DB00162,-7.2,Vitamin A,FPIPGXGPPPQFEQ-OVSJKPMPSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
34991,1r42,DB01016,-7.2,Glyburide,ZNNLBTZKUZBEKO-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
157592,6wiq,DB12158,-7.2,Filorexant,NPFDWHQSDBWQLH-QZTJIDSGSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
152958,6wiq,DB04750,-7.2,OREGON GREEN 488 CARBOXYLATE,BRJCLSQFZSHLRL-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
93806,6m71,DB07371,-7.2,3-(10-methyl-9-anthryl)propanoic acid,CKQINRXZVYBCSC-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
107403,6vxx,DB03259,-7.2,"2',6'-Dichloro-Biphenyl-2,6-Diol",MCZUCSAAGDCHHN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
133686,6w9c,DB02020,-7.2,Alrestatin,GCUCIFQCGJIRNT-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
15851,6lzg,DB01562,-7.2,1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine,BVURVTVDNWSNFN-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
133655,6w9c,DB01976,-7.2,Aminoanthracene,YUENFNPLGJCNRB-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
15855,6lzg,DB01571,-7.2,3-Methylfentanyl,MLQRZXNZHAOCHQ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
107394,6vxx,DB03249,-7.2,2'-O-Methyl-3'-Methyl-3'-Deoxy-Arabinofuranosyl-Thymine-5'-Phosphate,MCXXETKRWYMFCI-TURQNECASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
132406,6w9c,DB00391,-7.2,Sulpiride,BGRJTUBHPOOWDU-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
127192,6w4h,DB04836,-7.2,Amineptine,ONNOFKFOZAJDHT-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
27735,6cs2,DB07290,-7.2,(2R)-2-{[(4-FLUORO-3-METHYLPHENYL)SULFONYL]AMINO}-N-HYDROXY-2-TETRAHYDRO-2H-PYRAN-4-YLACETAMIDE,LUCFRFDOOYLALP-CYBMUJFWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
125226,6w4h,DB02218,-7.2,"N-[4-hydroxymethyl-cyclohexan-6-yl-1,2,3-triol]-4,6-dideoxy-4-aminoglucopyranoside",RBZIIHWPZWOIDU-ZCGMLSCUSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
157608,6wiq,DB12186,-7.2,SRT-2104,LAMQVIQMVKWXOC-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
56235,6crv,DB02061,-7.2,Cellobiose,GUBGYTABKSRVRQ-CUHNMECISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
152940,6wiq,DB04724,-7.2,"(S)-2-((S)-3-ISOBUTYL-2,5-DIOXO-4-QUINOLIN-3-YLMETHYL-[1,4]DIAZEPAN-1YL)-N-METHYL-3-NAPHTALEN-2-YL-PROPIONAMIDE",COVPLULNDBDXTN-KYJUHHDHSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
123647,6w4h,DB00215,-7.2,Citalopram,WSEQXVZVJXJVFP-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
70093,6lxt,DB12146,-7.2,Rigosertib,OWBFCJROIKNMGD-BQYQJAHWSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
93124,6m71,DB06358,-7.2,Iclaprim,HWJPWWYTGBZDEG-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60328,6crv,DB08515,-7.2,"(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE",YVABESCRHMBHJD-FUQNVFFISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
158955,7bv1,DB02684,-7.2,5'-O-(N-(L-Cysteinyl)-Sulfamoyl)Adenosine,FTSDEWPMACCNGN-YTMOPEAISA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59468,6crv,DB07499,-7.2,"N-(4-{[amino(imino)methyl]amino}butyl)-2,4'-bi-1,3-thiazole-4-carboxamide",VSIFMASDYAMOAN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
103403,6vxs,DB08536,-7.2,"3-bromo-5-phenyl-N-(pyrimidin-5-ylmethyl)pyrazolo[1,5-a]pyridin-7-amine",IBUPHWYGVDAASU-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
156253,6wiq,DB12645,-7.2,Givinostat,YALNUENQHAQXEA-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
125313,6w4h,DB02333,-7.2,Deoxyuridine-5'-Triphosphate,AHCYMLUZIRLXAA-SHYZEUOFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
102890,6vxs,DB07929,-7.2,"N-(TERT-BUTYL)-3,5-DIMETHYL-N'-[(5-METHYL-2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)CARBONYL]BENZOHYDRAZIDE",JGJACZABNQGPMT-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
123454,6w4b,DB00177,-7.2,Valsartan,ACWBQPMHZXGDFX-QFIPXVFZSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
127186,6w4h,DB04829,-7.2,Lysergic acid diethylamide,VAYOSLLFUXYJDT-RDTXWAMCSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
102896,6vxs,DB07935,-7.2,"5-[(5-fluoro-3-methyl-1H-indazol-4-yl)oxy]benzene-1,3-dicarbonitrile",JYAHFMKZJRVTDT-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
25557,6cs2,DB03509,-7.2,2-(4-Chlorophenyl)-5-Quinoxalinecarboxamide,FLYGLPYJEQPCFY-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
102898,6vxs,DB07937,-7.2,"2-butoxy-9-(2,6-difluorobenzyl)-N-(2-morpholin-4-ylethyl)-9H-purin-6-amine",UGZWPZWADDDTRN-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
157546,6wiq,DB09304,-7.2,Setiptiline,GVPIXRLYKVFFMK-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
89073,6m3m,DB15410,-7.2,(S)-Propafenone,JWHAUXFOSRPERK-SFHVURJKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
11388,6lzg,DB11900,-7.2,OC-459,FATGTHLOZSXOBC-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
36262,1r42,DB02691,-7.2,Glycocholic acid,RFDAIACWWDREDC-FRVQLJSFSA-M,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
57809,6crv,DB04159,-7.2,Beta-Hydroxytryptophane,ITFHGBKXKUVKBW-UWVGGRQHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
132393,6w9c,DB00374,-7.2,Treprostinil,PAJMKGZZBBTTOY-ZFORQUDYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
123518,6w4b,DB00251,-7.2,Terconazole,BLSQLHNBWJLIBQ-OZXSUGGESA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
27745,6cs2,DB07300,-7.2,"2-(1H-imidazol-1-yl)-9-methoxy-8-(2-methoxyethoxy)benzo[c][2,7]naphthyridin-4-amine",QSSGYSRUMIOURP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
157567,6wiq,DB11814,-7.2,PF-03882845,XNULRSOGWPFPBL-REWPJTCUSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
107449,6vxx,DB03609,-7.2,3-Deoxyguanosine,OROIAVZITJBGSM-OBXARNEKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
12351,6lzg,DB13266,-7.2,Cefatrizine,UOCJDOLVGGIYIQ-PBFPGSCMSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
87546,6m3m,DB12473,-7.2,Taurolidine,AJKIRUJIDFJUKJ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
102902,6vxs,DB07942,-7.2,2-fluoro-4-[4-(4-fluorophenyl)-1H-pyrazol-3-yl]pyridine,YJCHZVXSPFPKMX-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
86265,6m3m,DB08641,-7.2,"(2S,3S)-3-FORMYL-2-({[(4-NITROPHENYL)SULFONYL]AMINO}METHYL)PENTANOIC ACID",JPQYVEFTAZEPOD-BXKDBHETSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
159003,7bv1,DB03015,-7.2,"6-Hydroxy-1,6-Dihydro Purine Nucleoside",WGRXVKRHIMUTPD-YOHZANMFSA-O,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59356,6crv,DB07365,-7.2,NAPHTHALEN-2-YL-3-ALANINE,OFYAYGJCPXRNBL-LBPRGKRZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
125411,6w4h,DB02452,-7.2,Thymidine-5'-Triphosphate,NHVNXKFIZYSCEB-XLPZGREQSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
107565,6vxx,DB03765,-7.2,2'-cytidylic acid,YQUAKORMLHPSLZ-XVFCMESISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85970,6m3m,DB08284,-7.2,"O-[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethyl] (4-iodophenyl)thiocarbamate",CYYIBMGIJWXZEP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
7173,6lzg,DB00408,-7.2,Loxapine,XJGVXQDUIWGIRW-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
159415,7bv1,DB04114,-7.2,"3-Chloro-9-Ethyl-6,7,8,9,10,11-Hexahydro-7,11-Methanocycloocta[B]Quinolin-12-Amine",QTPHSDHUHXUYFE-NWDGAFQWSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60432,6crv,DB08643,-7.2,2-(2-{2-[(BIPHENYL-4-YLMETHYL)-AMINO]-3-MERCAPTO-PENTANOYLAMINO}-ACETYLAMINO)-3-METHYL-BUTYRIC ACID METHYL ESTER,QFAWBPLETHINFK-UNMCSNQZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
125530,6w4h,DB02607,-7.2,Adenosine Phosphonoacetic Acid,KJNLSEOJEFDELT-JJNLEZRASA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
35770,1r42,DB02049,-7.2,2-{4-[4-(4-Chloro-Phenoxy)-Benzenesulfonyl]-Tetrahydro-Pyran-4-Yl}-N-Hydroxy-Acetamide,QOPFTBAEAJQKSY-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
152423,6wiq,DB04030,-7.2,"1,3,4,9-Tetrahydro-2-(Hydroxybenzoyl)-9-[(4-Hydroxyphenyl)Methyl]-6-Methoxy-2h-Pyrido[3,4-B]Indole",ADXYEWMDAGIULV-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
69967,6lxt,DB11961,-7.2,AZD-1236,SFJFBTPHDHUUPU-OAHLLOKOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
56059,6crv,DB01821,-7.2,"L-N(Omega)-Nitroarginine-2,4-L-Diaminobutyric Amide",KUZKVXUOMSVPOA-BQBZGAKWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
70984,6lxt,DB13487,-7.2,Iodine (131I) norcholesterol,QJHZPCLORSPENH-DRTKWHMQSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
125515,6w4h,DB02587,-7.2,Colforsin,OHCQJHSOBUTRHG-KGGHGJDLSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
148759,6w9q,DB13876,-7.2,Brofaromine,WZXHSWVDAYOFPE-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
11437,6lzg,DB11964,-7.2,Ilaprazole,HRRXCXABAPSOCP-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
150388,6wiq,DB01326,-7.2,Cefamandole,OLVCFLKTBJRLHI-AXAPSJFSSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
57053,6crv,DB03139,-7.2,"6-[5-(2-Oxo-Hexahydro-Thieno[3,4-D]Imidazol-4-Yl)-Pentanoylamino]-Hexanoic Acid",CMUGHZFPFWNUQT-HUBLWGQQSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107712,6vxx,DB04213,-7.2,N-Cyclohexyl-N'-(Propyl)Phenyl Urea,HBTZVNKXMFGOOJ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
1716,6lzg,HMDB0000054,-7.2,Bilirubin,BPYKTIZUTYGOLE-KDUUSRDASA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
106292,6vxs,DB15406,-7.2,GLPG-0974,MPMKMQHJHDHPBE-RUZDIDTESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
27812,6cs2,DB07366,-7.2,2-[N'-(4-AMINO-BUTYL)-HYDRAZINOCARBONYL]-PYRROLIDINE-1-CARBOXYLIC ACID BENZYL ESTER,MOCIXHUQBOUBAK-HNNXBMFYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
27426,6cs2,DB06970,-7.2,"2-CHLORO-N-(3-CYANO-5,6-DIHYDRO-4H-CYCLOPENTA[B]THIOPHEN-2-YL)-5-DIETHYLSULFAMOYL-BENZAMIDE",MZCDQILVXXIMEV-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
159370,7bv1,DB04059,-7.2,8-(Pyrimidin-2-Ylamino)Naphthalene-2-Carboximidamide,GRQLDCHTDNYVQI-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
132242,6w9c,DB00194,-7.2,Vidarabine,OIRDTQYFTABQOQ-UHTZMRCNSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
93949,6m71,DB07539,-7.2,"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZOIC ACID",JLRKRQCTYQGDKJ-GHXNOFRVSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60419,6crv,DB08624,-7.2,BENZOTHIAZOLE,MAJHCCQPIDXPAN-QMMMGPOBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59846,6crv,DB07943,-7.2,2-{4-[5-(4-chlorophenyl)-4-pyrimidin-4-yl-1H-pyrazol-3-yl]piperidin-1-yl}-2-oxoethanol,CATQHDWESBRRQA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
157414,6wiq,DB15358,-7.2,JNJ-54175446,CWFVVQFVGMFTBD-SECBINFHSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
148751,6w9q,DB13865,-7.2,Dehydroemetine,XXLZPUYGHQWHRN-RPBOFIJWSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
27415,6cs2,DB06954,-7.2,"2-(cycloheptylmethyl)-1,1-dioxido-1-benzothiophen-6-yl sulfamate",BIASYWBGUYOWJR-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
127504,6w4h,DB06230,-7.2,Nalmefene,WJBLNOPPDWQMCH-MBPVOVBZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
71022,6lxt,DB13540,-7.2,Isepamicin,UDIIBEDMEYAVNG-ZKFPOVNWSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
94008,6m71,DB07613,-7.2,3-phenyl-5-(1H-pyrazol-3-yl)isoxazole,SRSSTOPJERVMRZ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
85949,6m3m,DB08253,-7.2,NAM NAPTHYLAMINOALANINE,DGFMSNJYBBNHCX-LBPRGKRZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
123123,6w4b,DB14885,-7.2,PF-05180999,CLGCHUKGBICQTE-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
123125,6w4b,DB14889,-7.2,Derazantinib,KPJDVVCDVBFRMU-AREMUKBSSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
103989,6vxs,DB09477,-7.2,Enalaprilat,LZFZMUMEGBBDTC-QEJZJMRPSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
103457,6vxs,DB08602,-7.2,"3-(2,6-difluorophenyl)-2-(methylthio)quinazolin-4(3H)-one",BFNBJSXMXXQLAW-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
131307,6w4h,DB13566,-7.2,Sequifenadine,OXDOWGVJMITMJL-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
71019,6lxt,DB13534,-7.2,Gedocarnil,SLYDYLLJUXFULK-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
26184,6cs2,DB04266,-7.2,"5-(6-D-Ribitylamino-2,4-Dihydroxypyrimidin-5-Yl)-1-Pentyl-Phosphonic Acid",BMATWAHJJFXMFA-AXFHLTTASA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
159434,7bv1,DB04140,-7.2,1-Benzyl-3-(4-Methoxy-Benzenesulfonyl)-6-Oxo-Hexahydro-Pyrimidine-4-Carboxylic Acid Hydroxyamide,SUSMVCKSLVPRCL-QGZVFWFLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
89467,6m71,DB00514,-7.2,Dextromethorphan,MKXZASYAUGDDCJ-NJAFHUGGSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
107775,6vxx,DB04600,-7.2,"4-[(3-BROMO-4-O-SULFAMOYLBENZYL)(4-CYANOPHENYL)AMINO]-4H-[1,2,4]-TRIAZOLE",GHDKYBCUDPSXGJ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107774,6vxx,DB04599,-7.2,Aniracetam,ZXNRTKGTQJPIJK-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
34813,1r42,DB00814,-7.2,Meloxicam,ZRVUJXDFFKFLMG-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
107772,6vxx,DB04597,-7.2,"[4,6-O-(1-CARBOXYETHYLIDENE)-BETA-D-MANNOSE]",QVVFNJUJKXWFAU-BDIBXJNUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
25884,6cs2,DB03909,-7.2,"Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate",UFZTZBNSLXELAL-IOSLPCCCSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
34815,1r42,DB00817,-7.2,Rosoxacin,XBPZXDSZHPDXQU-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
93984,6m71,DB07583,-7.2,"(4R,2S)-5'-(4-(4-CHLOROBENZYLOXY)PYRROLIDIN-2-YLMETHANESULFONYL)ISOQUINOLINE",RLNNFNGBXLTQOB-RBUKOAKNSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93082,6m71,DB06246,-7.2,Exisulind,MVGSNCBCUWPVDA-MFOYZWKCSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93983,6m71,DB07582,-7.2,"N-[(2R,3S)-1-((2S)-2-{[(CYCLOPENTYLAMINO)CARBONYL]AMINO}-3-METHYLBUTANOYL)-2-(1-FORMYL-1-CYCLOBUTYL)PYRROLIDINYL]CYCLOPROPANECARBOXAMIDE",GCDRFILPPBOJLM-UFYCRDLUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
57067,6crv,DB03160,-7.2,N-Pyridoxyl-7-Keto-8-Aminopelargonic Acid-5'-Monophosphate,YXEXNGWPUWJMIT-NSHDSACASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
157390,6wiq,DB15310,-7.2,Vactosertib,FJCDSQATIJKQKA-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
123132,6w4b,DB14902,-7.2,JHU-75528 C-11,MCNQUWLLXZZZAC-BJUDXGSMSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
156279,6wiq,DB12682,-7.2,Mubritinib,ZTFBIUXIQYRUNT-MDWZMJQESA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
86010,6m3m,DB08328,-7.2,PANTOTHENYL-AMINOETHANOL-11-PIVALIC ACID,BUEKNBNKVUKNIB-LBPRGKRZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
60415,6crv,DB08619,-7.2,Testosterone succinate,CJQNBXFUHQZFOE-VYAQIDIUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
131286,6w4h,DB13541,-7.2,Iprazochrome,XZKVIDLLLOUTSS-ZSOIEALJSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
105432,6vxs,DB13491,-7.2,Fluperolone,SLVCCRYLKTYUQP-DVTGEIKXSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
130954,6w4h,DB13052,-7.2,Upamostat,HUASEDVYRABWCV-NDEPHWFRSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
133957,6w9c,DB02385,-7.2,D-threo-neopterin,BMQYVXCPAOLZOK-INEUFUBQSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
86094,6m3m,DB08435,-7.2,"(5E,14E)-11-oxoprosta-5,9,12,14-tetraen-1-oic acid",VHRUMKCAEVRUBK-XOVNXQNQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
157451,6wiq,DB06525,-7.2,Ganstigmine,ZOBDWFRKFSPCRB-UNMCSNQZSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
93110,6m71,DB06309,-7.2,Refametinib,RDSACQWTXKSHJT-NSHDSACASA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
25517,6cs2,DB03461,-7.2,2'-Monophosphoadenosine 5'-Diphosphoribose,XJLXINKUBYWONI-NNYOXOHSSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
93907,6m71,DB07490,-7.2,"2-[1-(4-CHLORO-PHENYL)-ETHYL]-4,6-DINITRO-PHENOL",MOZUMFSUQQHSCO-MRVPVSSYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
123274,6w4b,DB15219,-7.2,Tomivosertib,HKTBYUWLRDZAJK-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
103424,6vxs,DB08560,-7.2,3-FLUORO-N-[1-(4-FLUOROPHENYL)-3-(2-THIENYL)-1H-PYRAZOL-5-YL]BENZENESULFONAMIDE,GULUFDCOGAXLEP-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
70925,6lxt,DB13407,-7.2,Nifenazone,BRZANEXCSZCZCI-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
123276,6w4b,DB15221,-7.2,PF-06260414,ZKAVFOXYJCREBQ-SNVBAGLBSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
102830,6vxs,DB07857,-7.2,(2R)-2-(4-chlorophenyl)-2-[4-(1H-pyrazol-4-yl)phenyl]ethanamine,HWVGILTYGZFGLR-QGZVFWFLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
59862,6crv,DB07963,-7.2,"N-[(2',4'-DIFLUORO-4-HYDROXY-5-IODOBIPHENYL-3-YL)CARBONYL]-BETA-ALANINE",YZQVXOZCPWWABX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
92597,6m71,DB04615,-7.2,(S)-tacrine(10)-hupyridone,ROTFGKJJMRTWBD-MHZLTWQESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
103960,6vxs,DB09313,-7.2,Ioxaglic acid,TYYBFXNZMFNZJT-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
107578,6vxx,DB03781,-7.2,"2-[4-(2,4-Dichlorophenoxy)Phenoxy]Propanoic Acid",OOLBCHYXZDXLDS-SECBINFHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
14315,6lzg,T3D3951,-7.2,Demeclocycline,FMTDIUIBLCQGJB-SEYHBJAFSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
130962,6w4h,DB13062,-7.2,ME-344,QVCAATSEPLQVBX-FPOVZHCZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
157473,6wiq,DB06588,-7.2,Triphendiol,KQCJZAUNKSGEFM-UNMCSNQZSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
56130,6crv,DB01925,-7.2,"2'-Chloro-Biphenyl-2,3-Diol",SNGROCQMAKYWRE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
133940,6w9c,DB02365,-7.2,"1,10-Phenanthroline",DGEZNRSVGBDHLK-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
87637,6m3m,DB12617,-7.2,Mizoribine,HZQDCMWJEBCWBR-UUOKFMHZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
70918,6lxt,DB13397,-7.2,Prenoxdiazine,PXZDWASDNFWKSD-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
69360,6lxt,DB09062,-7.2,Cefminox,JSDXOWVAHXDYCU-VXSYNFHWSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
157432,6wiq,DB03453,-7.2,Methyl (2S)-2-[[2-[(3R)-1-carbamimidoylpiperidin-3-yl]acetyl]amino]-3-[4-(2-phenylethynyl)phenyl]propanoate,MRNGXYMKYHNMLV-PKTZIBPZSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
11420,6lzg,DB11943,-7.2,Delafloxacin,DYDCPNMLZGFQTM-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
134027,6w9c,DB02472,-7.2,"6-Hydroxy-7,8-Dihydro Purine Nucleoside",ZWTNXGIZBOQCAJ-KQYNXXCUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
56078,6crv,DB01843,-7.2,"3-Amino-8,9,10-Trihydroxy-7-Hydroxymethyl-6-Oxa-1,3-Diaza-Spiro[4.5]Decane-2,4-Dione",KLJXQBRQPPSXPZ-WWHASAIZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86037,6m3m,DB08363,-7.2,1-(9-ethyl-9H-carbazol-3-yl)-N-methylmethanamine,LBPNOEAFWYTTEB-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
27151,6cs2,DB06588,-7.2,Triphendiol,KQCJZAUNKSGEFM-UNMCSNQZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
57043,6crv,DB03125,-7.2,"2,4-Diamino-5-(3,4,5-Trimethoxy-Benzyl)-Pyrimidin-1-Ium",IEDVJHCEMCRBQM-UHFFFAOYSA-O,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
27154,6cs2,DB00601,-7.2,Linezolid,TYZROVQLWOKYKF-ZDUSSCGKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
133996,6w9c,DB02430,-7.2,Trehalose-6-Phosphate,LABSPYBHMPDTEL-LIZSDCNHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
69982,6lxt,DB11985,-7.2,Dapaconazole,FUAHXHWSMYFWGE-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
132244,6w9c,DB00196,-7.2,Fluconazole,RFHAOTPXVQNOHP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
12507,6lzg,DB13457,-7.2,Oxaflozane,FVYUQFQCEOZYHZ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
159297,7bv1,DB03952,-7.2,9-(6-deoxy-beta-D-allofuranosyl)-6-methylpurine,XJZDIUOABWMPLZ-FHQKJXBVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
150376,6wiq,DB01289,-7.2,Glisoxepide,ZKUDBRCEOBOWLF-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
123218,6w4b,DB15109,-7.2,Ingenol disoxate,GLIUZQUNUNICGS-XUBYYPQFSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
103837,6vxs,DB09119,-7.2,Eslicarbazepine acetate,QIALRBLEEWJACW-INIZCTEOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102814,6vxs,DB07838,-7.2,(Z)-3-BENZYL-5-(2-HYDROXY-3-NITROBENZYLIDENE)-2-THIOXOTHIAZOLIDIN-4-ONE,ZTWBCEZQPRYIGY-ZROIWOOFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
93918,6m71,DB07504,-7.2,(2R)-1-{4-[(4-Anilino-5-bromo-2-pyrimidinyl)amino]phenoxy}-3-(dimethylamino)-2-propanol,MEIJADBULOETOV-QGZVFWFLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
123227,6w4b,DB15124,-7.2,PF-05241328,RVTSXVZXEGFIPW-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
123230,6w4b,DB15132,-7.2,AZD-8165,YUHNXUAATAMVKD-PZJWPPBQSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
25509,6cs2,DB03451,-7.2,"1-alpha, 25-dihydroxyl-20-epi-22-oxa-24, 26 ,27-trihomovitamin D3",KLZOTDOJMRMLDX-YBBVPDDNSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
102816,6vxs,DB07841,-7.2,Geranylgeranyl diphosphate,OINNEUNVOZHBOX-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
57037,6crv,DB03114,-7.2,PAS219,YBEVTZVQKMYQPM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
67286,6lxt,DB06345,-7.2,AR-9281,HUDQLWBKJOMXSZ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
69991,6lxt,DB11999,-7.2,Vosaroxin,XZAFZXJXZHRNAQ-STQMWFEESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
69992,6lxt,DB12000,-7.2,Apabetalone,NETXMUIMUZJUTB-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
123243,6w4b,DB15156,-7.2,ABT-072,XMZSTQYSBYEENY-RMKNXTFCSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
125216,6w4h,DB02205,-7.2,"6-(1,1-Dimethylallyl)-2-(1-Hydroxy-1-Methylethyl)-2,3-Dihydro-7h-Furo[3,2-G]Chromen-7-One",JCDLLLXYAICSQV-INIZCTEOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
143682,6w9q,DB03860,-7.2,"N-Butyl-11-[(7r,8r,9s,13s,14s,17s)-3,17-Dihydroxy-13-Methyl-7,8,9,11,12,13,14,15,16,17-Decahydro-6h-Cyclopenta[a]Phenanthren-7-Yl]-N-Methylundecanamide",BVVFOLSZMQVDKV-KXQIQQEYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
12184,6lzg,DB00990,-7.2,Exemestane,BFYIZQONLCFLEV-DAELLWKTSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
121303,6w4b,DB11692,-7.2,Pavinetant,QYTBBBAHNIWFOD-NRFANRHFSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
112243,6vxx,DB06878,-7.2,1-[(2R)-2-aminobutanoyl]-N-(3-chlorobenzyl)-L-prolinamide,OTYYXGRJXJFTCD-KGLIPLIRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
100014,6vxs,DB03010,-7.2,Patupilone,QXRSDHAAWVKZLJ-PVYNADRNSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
90363,6m71,DB01634,-7.2,2-Oxy-4-Hydroxy-5-(2-Hydrazinopyridine)Phenylalanine,AZUQIXJQZOMXAS-BDAKNGLRSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
31275,6cs2,DB13623,-7.2,Fabomotizole,WWNUCVSRRUDYPP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
6483,6lzg,DB00298,-7.2,Dapiprazole,RFWZESUMWJKKRN-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
78293,6m2n,DB11461,-7.2,Sulfachlorpyridazine,XOXHILFPRYWFOD-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
52994,2fxp,DB12318,-7.2,BMS-599626,LUJZZYWHBDHDQX-QFIPXVFZSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
67876,6lxt,DB07262,-7.2,1-{[N-(1-IMINO-GUANIDINO-METHYL)]SULFANYLMETHYL}-3-TRIFLUOROMETHYL-BENZENE,DWJNPCRXBNWCJC-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
140774,6w9c,DB15288,-7.2,Etamicastat,CWWWTTYMUOYSQA-LLVKDONJSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
165115,7bv1,DB11362,-7.2,Selexipag,QXWZQTURMXZVHJ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
78298,6m2n,DB11468,-7.2,Tiamulin,UURAUHCOJAIIRQ-QGLSALSOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
100047,6vxs,DB03060,-7.2,Sri-9662,WNDJHUNKXPAREB-PLNGDYQASA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
140772,6w9c,DB15284,-7.2,Sulopenem,FLSUCZWOEMTFAQ-PRBGKLEPSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
116708,6w4b,DB02505,-7.2,N-(R-Carboxy-Ethyl)-Alpha-(S)-(2-Phenylethyl),JJVQUUYZGJWBPW-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
74319,6m2n,DB03200,-7.2,7-Alpha-D-Ribofuranosyl-Purine-5'-Phosphate,NICKPTPNIMHUHB-DQUBFYRCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
90362,6m71,DB01633,-7.2,Deoxy-2-fluoro-beta-D-cellotrioside,BZNXZJAUEMJQJB-QSCMNUSVSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
78325,6m2n,DB11541,-7.2,Ractopamine,YJQZYXCXBBCEAQ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
116791,6w4b,DB02615,-7.2,Compound 19,UZOOIPXOYYJULJ-BLIZRMSTSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
128723,6w4h,DB07944,-7.2,N-{3-METHYL-5-[2-(PYRIDIN-4-YLAMINO)-ETHOXY]-PHENYL}-BENZENESULFONAMIDE,MPTWCWHNLVMCRW-UHFFFAOYSA-O,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
13438,6lzg,DB15356,-7.2,SLV-334,LOFDNSDPZTVIIO-VPUSJEBWSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
53026,2fxp,DB12368,-7.2,AZD-3839,MRXBCEQZNKUUIP-DEOSSOPVSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
116788,6w4b,DB02610,-7.2,"N-(2,3,4,5,6-Pentaflouro-Benzyl)-4-Sulfamoyl-Benzamide",LRKSHOLYETXPGY-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
62328,6crv,DB13428,-7.2,Iobenzamic acid,FJYJNLIEGUTPIJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78271,6m2n,DB11425,-7.2,Luprostiol,KFUDFIMHDRJVLV-OZCLATTGSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
31302,6cs2,DB13657,-7.2,Benorilate,FEJKLNWAOXSSNR-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
140641,6w9c,DB13027,-7.2,Tucaresol,XEDONBRPTABQFB-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140642,6w9c,DB13028,-7.2,Biapenem,MRMBZHPJVKCOMA-YJFSRANCSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
53017,2fxp,DB12355,-7.2,Netazepide,YDZYKNJZCVIKPP-VWLOTQADSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
90351,6m71,DB01621,-7.2,Pipotiazine,JOMHSQGEWSNUKU-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
20129,6cs2,HMDB0000903,-7.2,Tetrahydrocortisone,SYGWGHVTLUBCEM-SDYDLROXSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
90354,6m71,DB01624,-7.2,Zuclopenthixol,WFPIAZLQTJBIFN-DVZOWYKESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
24343,6cs2,DB00287,-7.2,Travoprost,MKPLKVHSHYCHOC-AHTXBMBWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
128721,6w4h,DB07942,-7.2,2-fluoro-4-[4-(4-fluorophenyl)-1H-pyrazol-3-yl]pyridine,YJCHZVXSPFPKMX-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
11918,6lzg,DB12615,-7.2,Plazomicin,IYDYFVUFSPQPPV-PEXOCOHZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
37320,1r42,DB04114,-7.2,"3-Chloro-9-Ethyl-6,7,8,9,10,11-Hexahydro-7,11-Methanocycloocta[B]Quinolin-12-Amine",QTPHSDHUHXUYFE-NWDGAFQWSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
154624,6wiq,DB08087,-7.2,"4-[(7R,7AS)-7-HYDROXY-1,3-DIOXOTETRAHYDRO-1H-PYRROLO[1,2-C]IMIDAZOL-2(3H)-YL]-1-NAPHTHONITRILE",NHBIWLQQJPSMNP-CABCVRRESA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
140947,6w9q,DB00304,-7.2,Desogestrel,RPLCPCMSCLEKRS-BPIQYHPVSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
165172,7bv1,DB11462,-7.2,Sulfaethoxypyridazine,FFJIWWBSBCOKLS-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
74380,6m2n,DB03272,-7.2,4-Bromo-3-(5'-Carboxy-4'-Chloro-2'-Fluorophenyl)-1-Methyl-5-Trifluoromethyl-Pyrazol,YNMHKERYELPEEF-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
13100,6lzg,DB14673,-7.2,Flurandrenolide acetate,AUDPKCCPWYXNEV-XTLNBZDDSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
78156,6m2n,DB09477,-7.2,Enalaprilat,LZFZMUMEGBBDTC-QEJZJMRPSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78177,6m2n,DB11096,-7.2,Meradimate,SOXAGEOHPCXXIO-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78187,6m2n,DB11155,-7.2,Triclocarban,ICUTUKXCWQ1Q-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
128784,6w4h,DB08013,-7.2,(METHYLPYRIDAZINE PIPERIDINE PROPYLOXYPHENYL)ETHYLACETATE,UEIUDEUUVLYRFV-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
58470,6crv,DB05442,-7.2,Etiprednol dicloacetate,QAIOVDNCIZSSSF-RFAJLIJZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140924,6w9q,DB00276,-7.2,Amsacrine,XCPGHVQEEXUHNC-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
31245,6cs2,DB13587,-7.2,Mesterolone,UXYRZJKIQKRJCF-TZPFWLJSSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
9164,6lzg,DB07248,-7.2,"7-PYRIDIN-2-YL-N-(3,4,5-TRIMETHOXYPHENYL)-7H-PYRROLO[2,3-D]PYRIMIDIN-2-AMINE",YENZSPIOXMNEFF-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
97862,6vxs,DB00252,-7.2,Phenytoin,CXOFVDLJLONNDW-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
116451,6w4b,DB02177,-7.2,1-Acetyl-4-(4-{4-[(2-Ethoxyphenyl)Thio]-3-Nitrophenyl}Pyridin-2-Yl)Piperazine,GKGJFUXSTSUKPB-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
78199,6m2n,DB11201,-7.2,Menthyl salicylate,SJOXEWUZWQYCGL-DVOMOZLQSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78204,6m2n,DB11226,-7.2,Ethylhexyl methoxycrylene,WAJCJDLRJVDSSD-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
31263,6cs2,DB13608,-7.2,Tiocarlide,BWBONKHPVHMQHE-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
9186,6lzg,DB07271,-7.2,"4-[(3R)-3-Amino-4-(2,4,5-trifluorophenyl)butanoyl]-3-(2,2,2-trifluoroethyl)-1,4-diazepan-2-one",RMDAPSXWBVPVOG-IAPIXIRKSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
104776,6vxs,DB12482,-7.2,Acotiamide,TWHZNAUBXFZMCA-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
165127,7bv1,DB11385,-7.2,Cefalonium,FMZXNVLFJHCSAF-DNVCBOLYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
74346,6m2n,DB03230,-7.2,Adenosine-5'-Propylphosphate,XAMXMSZRQHPMRX-QYVSTXNMSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
9180,6lzg,DB00663,-7.2,Flumethasone,WXURHACBFYSXBI-GQKYHHCASA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
165126,7bv1,DB11380,-7.2,Cambendazole,QZWHWHNCPFEXLL-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
62385,6crv,DB13505,-7.2,Emepronium,JEJBJBKVPOWOQK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31256,6cs2,DB13602,-7.2,Promegestone,QFFCYTLOTYIJMR-XMGTWHOFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
9179,6lzg,DB07263,-7.2,"[{2-bromo-4-[(2R)-3-oxo-2,3-diphenylpropyl]phenyl}(difluoro)methyl]phosphonic acid",WDTMVBQZDFMOIK-GOSISDBHSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
112276,6vxx,DB06914,-7.2,"1-({2-[2-(4-CHLOROPHENYL)ETHYL]-1,3-DIOXOLAN-2-YL}METHYL)-1H-IMIDAZOLE",NPIOYRIZNLPLDH-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
97849,6vxs,DB00238,-7.2,Nevirapine,NQDJXKOVJZTUJA-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
128780,6w4h,DB08009,-7.2,"5-[(E)-(5-CHLORO-2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]-N-[2-(DIETHYLAMINO)ETHYL]-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXAMIDE",XPLJEFSRINKZLC-ATVHPVEESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
78212,6m2n,DB11269,-7.2,Diethylamino hydroxybenzoyl hexyl benzoate,FDATWRLUYRHCJE-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
99961,6vxs,DB02936,-7.2,4-(1-Benzyl-3-Carbamoylmethyl-2-Methyl-1h-Indol-5-Yloxy)-Butyric Acid,STENXUCYNKOBHJ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
140960,6w9q,DB00319,-7.2,Piperacillin,IVBHGBMCVLDMKU-GXNBUGAJSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
140538,6w9c,DB12027,-7.2,Serdemetan,CEGSUK1LWKJP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
62314,6crv,DB13410,-7.2,Guanoxabenz,QKIQJNNDIWGVEH-UUILKARUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
117102,6w4b,DB03034,-7.2,D-Levofloxacin,GSDSWSVVBLHKDQ-SNVBAGLBSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
62262,6crv,DB13341,-7.2,Fenozolone,RXOIEVSUURELPG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
26841,6cs2,DB05498,-7.2,KW-7158,NAFSYPCVPLWHFY-HNNXBMFYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
140355,6w9c,DB04218,-7.2,1-Deaza-Adenosine,NVUDDRWKCUAERS-PNHWDRBUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
112084,6vxx,DB06247,-7.2,CX516,ANDGGVOPIJEHOF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
164980,7bv1,DB09039,-7.2,Eliglustat,FJZZPCZKBUKGGU-AUSIDOKSSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
104401,6vxs,DB11946,-7.2,AZD-1981,JWYIGNODXSRKGP-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
164969,7bv1,DB09017,-7.2,Brotizolam,UMSGKTJDUHERQW-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
112059,6vxx,DB06198,-7.2,Alovudine,UXCAQJAQSWSNPQ-XLPZGREQSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
13067,6lzg,DB14640,-7.2,Isoflupredone acetate,ZOCUOMKMBMEYQV-GSLJADNHSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
140337,6w9c,DB03765,-7.2,2'-cytidylic acid,YQUAKORMLHPSLZ-XVFCMESISA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
58427,6crv,DB05186,-7.2,SQ-109,JFIBVDBTCDTBRH-REZTVBANSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
140334,6w9c,DB03761,-7.2,5-Fluoro-2'-Deoxyuridine-5'-Monophosphate,HFEKDTCAMMOLQP-RRKCRQDMSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
97578,6m71,DB15201,-7.2,Norbixin,ZVKOASAVGLETCT-UOGKPENDSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
68493,6lxt,DB07983,-7.2,1-(4-IODOBENZOYL)-5-METHOXY-2-METHYL INDOLE-3-ACETIC ACID,CXBFZYKAVCAPSV-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
428,6lzg,HMDB0004999,-7.2,Loperamide,RDOIQAHITMMDAJ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
13063,6lzg,DB14637,-7.2,Fluprednisolone acetate,CYMBAKFTWRNHPS-APRQOCPKSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
68501,6lxt,DB07991,-7.2,N-[(1R)-3-(4-HYDROXYPHENYL)-1-METHYLPROPYL]-2-(2-PHENYL-1H-INDOL-3-YL)ACETAMIDE,APLJSSOXDWUNGV-GOSISDBHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
31449,6cs2,DB13827,-7.2,Indanazoline,KUCWWEPJRBANHL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
26849,6cs2,DB05524,-7.2,Pelitinib,WVUNYSQLFKLYNI-AATRIKPKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
117213,6w4b,DB03181,-7.2,"2-[4-(4-Hydroxy-3-Isopropyl-Phenoxy)-3,5-Dimethyl-Phenyl]-2h-[1,2,4]Triazine-3,5-Dione",RXQAVKWRCZYGMV-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
112033,6vxx,DB06147,-7.2,Sulfathiazole,JNMRHUJNCSQMMB-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
68495,6lxt,DB07985,-7.2,+/-METHYL 4-(AMINOIMINOMETHYL)-BETA-[3- INH (AMINOIMINO)PHENYL]BENZENE PENTANOATE,PVALLOSAENRPQO-INIZCTEOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
31380,6cs2,DB13750,-7.2,Obidoxime,HIGRLDNHDGYWQJ-UHFFFAOYSA-P,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
128662,6w4h,DB07870,-7.2,(2S)-2-(4-{[3-CHLORO-5-(TRIFLUOROMETHYL)PYRIDIN-2-YL]OXY}PHENOXY)PROPANOIC ACID,GOCUAJYOYBLQRH-MRVPVSSYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
29292,6cs2,DB08979,-7.2,Fenspiride,FVNFBBAOMBJTST-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
100281,6vxs,DB03361,-7.2,"2-{(9as)-9a-[(1s)-1-Hydroxyethyl]-2,7-Dimethyl-9a,10-Dihydro-5h-Pyrimido[4,5-D][1,3]Thiazolo[3,2-a]Pyrimidin-8-Yl}Ethyl Trihydrogen Diphosphate",UQFVHIGKDHNMJT-XPTSAGLGSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
40423,6lu7,DB07665,-7.2,"N-[2-(carbamimidamidooxy)ethyl]-2-{6-cyano-3-[(2,2-difluoro-2-pyridin-2-ylethyl)amino]-2-fluorophenyl}acetamide",STHCHQXQLDMISY-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
31427,6cs2,DB13803,-7.2,Xipamide,MTZBBNMLMNBNJL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
74189,6m2n,DB03022,-7.2,"3-{2,6,8-trioxo-9-[(2R,3S,4R)-2,3,4,5-tetrahydroxypentyl]-1,2,3,6,8,9-hexahydro-7H-purin-7-Yl}propyl dihydrogen phosphate",KPHFGOGGKPGLTM-BHNWBGBOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
26847,6cs2,DB05518,-7.2,Managlinat dialanetil,BYKBUQDQTLDNLE-KBPBESRZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
140294,6w9c,DB02766,-7.2,(3r)-3-{[(Benzyloxy)Carbonyl]Amino}-2-Oxo-4-Phenylbutane-1-Diazonium,VLIGBVLLNSWVMI-MRXNPFEDSA-O,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
9236,6lzg,DB00670,-7.2,Pirenzepine,RMHMFHUVIITRHF-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
117095,6w4b,DB03020,-7.2,5-Beta-D-Ribofuranosylnicotinamide Adenine Dinucleotide,UINNILASBHZOTM-KMXXXSRASA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
9276,6lzg,DB07358,-7.2,"2-amino-N-(4-methyl-1,3-thiazol-2-yl)-5-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]benzamide",JEBOJMQHVUEKBE-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
26456,6cs2,DB04596,-7.2,"4-O-{4,6-O-[(1S)-1-Carboxyethylidene]-??-D-mannopyranosyl}-D-glucopyranuronic acid",GZJXZKGVHLWBOW-AISSFXTFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
112171,6vxx,DB06480,-7.2,Prucalopride,ZPMNHBXQOOVQJL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29310,6cs2,DB08994,-7.2,Ditazole,UUCMDZWCRNZCOY-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
37327,1r42,DB04125,-7.2,N-Alpha-(2-Naphthylsulfonyl)-N(3-Amidino-L-Phenylalaninyl)-4-Acetyl-Piperazine,ZUWBXGHMVKDMQO-DEOSSOPVSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
31323,6cs2,DB13678,-7.2,Dihexyverine,MNSQDVCVWNXBFQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
97650,6m71,DB15335,-7.2,Formononetin,HKQYGTCOTHHOMP-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
116825,6w4b,DB02659,-7.2,Cholic Acid,BHQCQFFYRZLCQQ-OELDTZBJSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
112157,6vxx,DB06454,-7.2,Sarizotan,HKFMQJUJWSFOLY-OAQYLSRUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
68484,6lxt,DB07972,-7.2,1-(3-METHYLPHENYL)-1H-BENZIMIDAZOL-5-AMINE,VFSVFGIODYZMOF-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
20063,6cs2,HMDB0000896,-7.2,Taurodeoxycholic acid,AWDRATDZQPNJFN-VAYUFCLWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
165043,7bv1,DB09169,-7.2,3-Allylfentanyl,BZXKQFFMDLTPJL-LADGPHEKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
74265,6m2n,DB03124,-7.2,5-[4-(1-Carboxymethyl-2-Oxo-Propylcarbamoyl)-Benzylsulfamoyl]-2-Hydroxy-Benzoic Acid,LBAHOXPDTNUYCX-INIZCTEOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
26837,6cs2,DB05475,-7.2,Golotimod,CATMPQFFVNKDEY-YPMHNXCESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
67860,6lxt,DB07246,-7.2,"(2R)-2-AMINO-3,3,3-TRIFLUORO-N-HYDROXY-2-{[(4-PHENOXYPHENYL)SULFONYL]METHYL}PROPANAMIDE",MKRPIBSCGZAUCH-OAHLLOKOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
58435,6crv,DB05246,-7.2,Methsuximide,AJXPJJZHWIXJCJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31350,6cs2,DB01046,-7.2,Lubiprostone,WGFOBBZOWHGYQH-MXHNKVEKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
100183,6vxs,DB03235,-7.2,N-{3-[4-(3-aminopropyl)piperazin-1-yl]propyl}-3-(alpha-D-galactopyranosyloxy)-5-nitrobenzamide,UEIGEWJJVQHIAX-MKQKURRLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
165007,7bv1,DB09083,-7.2,Ivabradine,ACRHBAYQBXXRTO-OAQYLSRUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
78575,6m2n,DB11957,-7.2,Idalopirdine,YBAWYTYNMZWMMJ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
165008,7bv1,DB09084,-7.2,Benzydamine,CNBGNNVCVSKAQZ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
153754,6wiq,DB07078,-7.2,"(3Z)-6-(4-HYDROXY-3-METHOXYPHENYL)-3-(1H-PYRROL-2-YLMETHYLENE)-1,3-DIHYDRO-2H-INDOL-2-ONE",AYSXURJZVXBSRV-WJDWOHSUSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
140378,6w9c,DB05824,-7.2,CNS-5161,JHVHEDNLONERHY-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
31365,6cs2,DB13727,-7.2,Azapetine,NYGHGTMKALXFIA-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
97588,6m71,DB15214,-7.2,BMS-986104,BPMMYKAHRIEVDH-VOQZNFBZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
100197,6vxs,DB03250,-7.2,"2-(Beta-D-Glucopyranosyl)-5-Methyl-1,3,4-Benzothiazole",WGJFWQVWYRZPEP-KABOQKQYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
62276,6crv,DB13356,-7.2,Mesulfen,AHXDSVSZEZHDLV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
67854,6lxt,DB07238,-7.2,Nesbuvir,WTDWVLJJJOTABN-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
116954,6w4b,DB02834,-7.2,IDD552,ZCAGEXZTORJQDZ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
165033,7bv1,DB09136,-7.2,Isosulfan blue,YFKDCGWIINMRQY-UHFFFAOYSA-O,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
154671,6wiq,DB08138,-7.2,"{[(2,6-difluorophenyl)carbonyl]amino}-N-(4-fluorophenyl)-1H-pyrazole-3-carboxamide",BDRDBXXWQDFXEC-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
40456,6lu7,DB06163,-7.2,Plevitrexed,IEJSCSAMMLUINT-NRFANRHFSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
165027,7bv1,DB09123,-7.2,Dienogest,AZFLJNIPTRTECV-FUMNGEBKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
165180,7bv1,DB11478,-7.2,Zeranol,DWTTZBARDOXEAM-GXTWGEPZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
67887,6lxt,DB07276,-7.2,"5-CYANO-N-(2,5-DIMETHOXYBENZYL)-6-ETHOXYPYRIDINE-2-CARBOXAMIDE",VEGKZYFYGCWXMN-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
31212,6cs2,DB13545,-7.2,Isobromindione,QFLZIWVSQDZLNW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
40608,6lu7,DB12138,-7.2,PF-03715455,VGEXRDWWPSGZDH-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
52771,2fxp,DB12001,-7.2,Abemaciclib,UZWDCWONPYILKI-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
115868,6w4b,DB01426,-7.2,Ajmaline,CJDRUOGAGYHKKD-HEFSZTOGSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
153850,6wiq,DB07186,-7.2,"4-(4-METHYLPIPERAZIN-1-YL)-N-[5-(2-THIENYLACETYL)-1,5-DIHYDROPYRROLO[3,4-C]PYRAZOL-3-YL]BENZAMIDE",TYYNSDQVFIOSFH-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
63777,6lxt,DB00690,-7.2,Flurazepam,SAADBVWGJQAEFS-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
13367,6lzg,DB15224,-7.2,Lisavanbulin,NIPZLALJRAHABJ-IBGZPJMESA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
112529,6vxx,DB07356,-7.2,"(1S)-2-[(2S,5R)-2-(AMINOMETHYL)-5-ETHYNYLPYRROLIDIN-1-YL]-1-CYCLOPENTYL-2-OXOETHANAMINE",XYVMJMYCUZCIPB-AVGNSLFASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
115877,6w4b,DB01436,-7.2,Alfacalcidol,OFHCOWSQAMBJIW-AVJTYSNKSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
52781,2fxp,DB12012,-7.2,PF-04457845,BATCTBJIJJEPHM-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
165351,7bv1,DB11969,-7.2,Uprosertib,AXTAPYRUEKNRBA-JTQLQIEISA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
13119,6lzg,DB14718,-7.2,Pyrazolam,BGRWSFIQQPVEML-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
67931,6lxt,DB07322,-7.2,"2-[(PHENYLSULFONYL)AMINO]-5,6,7,8-TETRAHYDRONAPHTHALENE-1-CARBOXYLIC ACID",RRXVUYHFDBLTEL-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
24272,6cs2,DB01976,-7.2,Aminoanthracene,YUENFNPLGJCNRB-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
154494,6wiq,DB07940,-7.2,"9-(3-IODOBENZYLAMINO)-1,2,3,4-TETRAHYDROACRIDINE",ZUCWQTWGZGIYPV-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
62491,6crv,DB13652,-7.2,Bunaftine,WWGZXRYELYWJBD-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
40606,6lu7,DB08538,-7.2,"N-((2-aminopyrimidin-5-yl)methyl)-5-(2,6-difluorophenyl)-3-ethylpyrazolo[1,5-a]pyrimidin-7-amine",HQPVGVSQPQVZLD-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
13117,6lzg,DB14717,-7.2,Nitrazolam,OYRPNABWTHDOFK-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
112469,6vxx,DB07291,-7.2,5-amino-1-(4-chlorophenyl)-1H-pyrazole-4-carbonitrile,WIWSALMJHPGFDY-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
115967,6w4b,DB01540,-7.2,17alpha-methyl-4-hydroxynandrolone,CLNUZOCYKSHICX-FAHHUNKHSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
67928,6lxt,DB07318,-7.2,"N-[2-(4-AMINO-5,8-DIFLUORO-1,2-DIHYDROQUINAZOLIN-2-YL)ETHYL]-3-FURAMIDE",BOAUWUUBSXECNL-LLVKDONJSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
154521,6wiq,DB07971,-7.2,"5-AMINO-2-{4-[(4-AMINOPHENYL)SULFANYL]PHENYL}-1H-ISOINDOLE-1,3(2H)-DIONE",FQQVTDIBUYSVHM-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
128929,6w4h,DB08172,-7.2,(2Z)-N-(3-chloro-2'-methoxybiphenyl-4-yl)-2-cyano-3-hydroxybut-2-enamide,YUDQXOMZBLEWBH-KAMYIIQDSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
98024,6vxs,DB00447,-7.2,Loracarbef,JAPHQRWPEGVNBT-UTUOFQBUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
40609,6lu7,DB12008,-7.2,Prexasertib,DOTGPNHGTYJDEP-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
154516,6wiq,DB07966,-7.2,[4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]quinazolin-2-yl}amino)phenyl]acetonitrile,NVMCVWOODOWOLT-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
77871,6m2n,DB08926,-7.2,Acediasulfone,FKKUMFTYSTZUJG-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
141133,6w9q,DB00533,-7.2,Rofecoxib,RZJQGNCSTQAWON-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
115942,6w4b,DB01513,-7.2,"17Alpha-methyl-3beta,17beta-dihydroxy-5alpha-androstane",QGKQXZFZOIQFBI-UYEYMFBJSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
165334,7bv1,DB11947,-7.2,Pridopidine,YGKUEOZJFIXDGI-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
74525,6m2n,DB03475,-7.2,"1-[4-Carboxy-2-(3-Pentylamino)Phenyl]-5,5'-Di(Hydroxymethyl)Pyrrolidin-2-One",BNIJJJRESBVRNB-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
9042,6lzg,DB07113,-7.2,"(2S)-6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2-(3,5-DIFLUOROPHENYL)-4-(3-METHOXYPROPYL)-2H-1,4-BENZOXAZIN-3(4H)-ONE",KHZQOXQOUCGGGA-NRFANRHFSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
58926,6crv,DB06872,-7.2,"1-((2-HYDROXYETHOXY)METHYL)-5-(PHENYLTHIO)PYRIMIDINE-2,4(1H,3H)-DIONE",YWJXYUXIPSIOGG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
115970,6w4b,DB01543,-7.2,18-methyl-19-nortestosterone,FBYZQDCRLYHHHP-ZOFHRBRSSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
154488,6wiq,DB07933,-7.2,Erteberel,XIESSJVMWNJCGZ-VKJFTORMSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
104457,6vxs,DB12029,-7.2,Chlorogenic Acid,CWVRJTMFETXNAD-JUHZACGLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
67939,6lxt,DB07330,-7.2,trans-4-(7-carbamoyl-1H-benzimidazol-2-yl)-1-propylpiperidinium,KXSIHXHEHABEJX-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
165419,7bv1,DB12074,-7.2,Censavudine,OSYWBJSVKUFFSU-SKDRFNHKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
40623,6lu7,DB14191,-7.2,Diphenylguanidine,OWRCNXZUPFZXOS-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40622,6lu7,DB08674,-7.2,"(20S)-19,20,21,22-TETRAHYDRO-19-OXO-5H-18,20-ETHANO-12,14-ETHENO-6,10-METHENO-18H-BENZ[D]IMIDAZO[4,3-K][1,6,9,12]OXATRIAZA-CYCLOOCTADECOSINE-9-CARBONITRILE",USPFJPDEADLGIG-HSZRJFAPSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
26752,6cs2,DB05035,-7.2,Eprotirome,VPCSYAVXDAUHLT-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
40620,6lu7,DB07796,-7.2,"(3ASR,4RS,8ASR,8BRS)-4-(2-(4-FLUOROBENZYL)-1,3-DIOXODEACAHYDROPYRROLO[3,4-A] PYRROLIZIN-4-YL)BENZAMIDINE",GJYCQHGTXMVIBG-MUGJNUQGSA-O,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40619,6lu7,DB07827,-7.2,"4-{[1-METHYL-2,4-DIOXO-6-(3-PHENYLPROP-1-YN-1-YL)-1,4-DIHYDROQUINAZOLIN-3(2H)-YL]METHYL}BENZOIC ACID",FLTYDFYSVZBKOB-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
115786,6w4b,DB01261,-7.2,Sitagliptin,MFFMDFFZMYYVKS-SECBINFHSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
40618,6lu7,DB07988,-7.2,"2-[3-(5-MERCAPTO-[1,3,4]THIADIAZOL-2YL)-UREIDO]-N-METHYL-3-PENTAFLUOROPHENYL-PROPIONAMIDE",HZAXNPDJVFUGDS-BYPYZUCNSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
52738,2fxp,DB11949,-7.2,Vestipitant,SBBYBXSFWOLDDG-JLTOFOAXSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
165401,7bv1,DB12049,-7.2,Dasolampanel etibutil,HPBRMCFZIGUGTK-ZMMAXQRCSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
63748,6lxt,DB00656,-7.2,Trazodone,PHLBKPHSAVXXEF-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
40617,6lu7,DB08018,-7.2,"N-{(3S,4S)-4-[(6-AMINO-4-METHYLPYRIDIN-2-YL)METHYL]PYRROLIDIN-3-YL}-N'-(4-CHLOROBENZYL)ETHANE-1,2-DIAMINE",JDRSQGJWTVRNGM-QFBILLFUSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
75594,6m2n,DB04917,-7.2,Renzapride,YFUAYKVMQVBSNG-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
31027,6cs2,DB13324,-7.2,Tetrazepam,IQWYAQCHYZHJOS-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
99751,6vxs,DB02659,-7.2,Cholic Acid,BHQCQFFYRZLCQQ-OELDTZBJSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
112571,6vxx,DB07407,-7.2,5-(2-METHOXYPHENYL)-2-FUROIC ACID,CHWVDGYLKPLBES-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
40611,6lu7,DB11637,-7.2,Delamanid,XDAOLTSRNUSPPH-XMMPIXPASA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
99763,6vxs,DB02675,-7.2,(4-Hydroxymaltosephenyl)Glycine,PHPOPZGUOBMSPZ-QHJSCRBTSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
40612,6lu7,DB11521,-7.2,Imidocarb,SCEVFJUWLLRELN-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40613,6lu7,DB12269,-7.2,PF-06273340,BPIWZDNVMQQBQX-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40614,6lu7,DB08553,-7.2,"(1E)-5-(1-piperidin-4-yl-3-pyridin-4-yl-1H-pyrazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime",KWEFZSZCLBHIEQ-YYADALCUSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
77727,6m2n,DB08727,-7.2,"3-Methyl-5-(7-{4-[(4R)-4-methyl-4,5-dihydro-1,3-oxazol-2-yl]phenoxy}heptyl)-1,2-oxazole",NEAZMARKCJKUMF-QGZVFWFLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
40610,6lu7,DB11871,-7.2,PF-00610355,YPHDIMUXXABSSO-YTTGMZPUSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
129744,6w4h,DB09246,-7.2,Benmoxin,BEWNZPMDJIGBED-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
104718,6vxs,DB12404,-7.2,Remimazolam,CYHWMBVXXDIZNZ-KRWDZBQOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
37011,1r42,DB03714,-7.2,4-Carbamoyl-4-{[6-(Difluoro-Phosphono-Methyl)-Naphthalene-2-Carbonyl]-Amino}-Butyric Acid,OWWCIKSGGKYNHT-ZDUSSCGKSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
77720,6m2n,DB08720,-7.2,"5-(5-(4-(4,5-dihydro-2-oxazoly)phenoxy)pentyl)-3-methyl osoxazole",IWZDYGHUSXWPPM-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
40615,6lu7,DB12302,-7.2,CP-724714,LLVZBTWPGQVVLW-SNAWJCMRSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
115812,6w4b,DB01328,-7.2,Cefonicid,DYAIAHUQIPBDIP-AXAPSJFSSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
40616,6lu7,DB08079,-7.2,AMG-208,HEAIZQNMNCHNFD-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
112563,6vxx,DB07398,-7.2,"2-[(CYCLOPROPYLCARBONYL)AMINO]-4,5,6,7-TETRAHYDRO-1-BENZOTHIOPHENE-3-CARBOXAMIDE",VATFNEMGBRWLHI-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
9061,6lzg,DB07131,-7.2,(S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclohexylpropanoyl)pyrrolidine-2-carboxamide,DOTBZTLJSXFKCP-IBGZPJMESA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
165300,7bv1,DB11899,-7.2,MK-8776,GMIZZEXBPRLVIV-SECBINFHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
99853,6vxs,DB02802,-7.2,5-Aminocarbonyl-3-Nitrophenyl-Alpha-D-Galactopyranose,BYSXBFJVGIOFBO-LNSPPBFMSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
128867,6w4h,DB08107,-7.2,N-{[6-(PENTYLOXY)NAPHTHALEN-2-YL]SULFONYL}-D-GLUTAMIC ACID,LIGACKDHLKEZFH-GOSISDBHSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
26790,6cs2,DB05252,-7.2,Fenoxaprop-ethyl,PQKBPHSEKWERTG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
31179,6cs2,DB13504,-7.2,Cefetamet,MQLRYUCJDNBWMV-GHXIOONMSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
9109,6lzg,DB07183,-7.2,N-(4-phenoxyphenyl)-2-[(pyridin-4-ylmethyl)amino]nicotinamide,CPVRYQAOUPSUDO-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
116151,6w4b,DB01771,-7.2,CRA_10991,QXAURVOBXQBPAP-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
78020,6m2n,DB09167,-7.2,Dosulepin,PHTUQLWOUWZIMZ-GZTJUZNOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
99915,6vxs,DB02880,-7.2,N-[1-(4-Bromophenyl)Ethyl]-5-Fluoro Salicylamide,KFTNEILVDDUXGR-SECBINFHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
165230,7bv1,DB11619,-7.2,Gestrinone,BJJXHLWLUDYTGC-ANULTFPQSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
52895,2fxp,DB12185,-7.2,Exatecan,ZVYVPGLRVWUPMP-FYSMJZIKSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
68437,6lxt,DB07920,-7.2,N-oxo-2-[(4-phenylphenyl)sulfonylamino]ethanamide,OGRPZMQLAVBWPV-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
128858,6w4h,DB08098,-7.2,"{[5-(5-nitro-2-furyl)-1,3,4-oxadiazol-2-yl]thio}acetic acid",ITBNJCVIFHSKRL-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
36954,1r42,DB03638,-7.2,Cytidyl-2'-5'-Phospho-Guanosine,QZDUXDLOEVJGDG-VMIOUTBZSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
128846,6w4h,DB08083,-7.2,"2-(1,3-thiazol-4-yl)-1H-benzimidazole-5-sulfonamide",KGMVTZZDGKDTEU-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
116217,6w4b,DB01858,-7.2,[1-(4-Fluorobenzyl)Cyclobutyl]Methyl (1s)-1-[Oxo(1h-Pyrazol-5-Ylamino)Acetyl]Pentylcarbamate,QTPYRNAKLBXKNP-SFHVURJKSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
90400,6m71,DB01685,-7.2,Topiroxostat,UBVZQGOVTLIHLH-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
141000,6w9q,DB00370,-7.2,Mirtazapine,RONZAEMNMFQXRA-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
9130,6lzg,DB07206,-7.2,6-[2-(1H-INDOL-6-YL)ETHYL]PYRIDIN-2-AMINE,OSHSZKRWKLQZBV-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
78074,6m2n,DB09225,-7.2,Zotepine,HDOZVRUNCMBHFH-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
91483,6m71,DB03115,-7.2,"5-Bromo-N-(2,3-Dihydroxypropoxy)-3,4-Difluoro-2-[(2-Fluoro-4-Iodophenyl)Amino]Benzamide",XXSSGBYXSKOLAM-QMMMGPOBSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
116276,6w4b,DB01946,-7.2,"3-[1-(3-Aminopropyl)-1h-Indol-3-Yl]-4-(1-Methyl-1h-Indol-3-Yl)-1h-Pyrrole-2,5-Dione",UQHKJRCFSLMWIA-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
154604,6wiq,DB08063,-7.2,"1-BENZYL-3-(4-METHOXYPHENYLAMINO)-4-PHENYLPYRROLE-2,5-DIONE",HLZMYWLMBBLASX-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
63872,6lxt,DB00805,-7.2,Minaprine,LDMWSLGGVTVJPG-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
90372,6m71,DB01644,-7.2,"3,6-dihydroxy-xanthene-9-propionic acid",PFQGLFBMMPZYEU-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
29329,6cs2,DB09013,-7.2,Befunolol,ZPQPDBIHYCBNIG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
90373,6m71,DB01645,-7.2,Genistein,TZBJGXHYKVUXJN-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
78049,6m2n,DB09197,-7.2,Mepiprazole,DOTIMEKVTCOGED-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
13382,6lzg,DB15250,-7.2,Vercirnon,JRWROCIMSDXGOZ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
116241,6w4b,DB01889,-7.2,"16,17-Androstene-3-Ol",KRVXMNNRSSQZJP-PHFHYRSDSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
140992,6w9q,DB00358,-7.2,Mefloquine,XEEQGYMUWCZPDN-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
52909,2fxp,DB12207,-7.2,Verdinexor,OPAKEJZFFCECPN-XQRVVYSFSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
104426,6vxs,DB11985,-7.2,Dapaconazole,FUAHXHWSMYFWGE-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
97932,6vxs,DB00338,-7.2,Omeprazole,SUBDBMMJDZJVOS-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
63829,6lxt,DB00751,-7.2,Epinastine,WHWZLSFABNNENI-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
141054,6w9q,DB00436,-7.2,Bendroflumethiazide,HDWIHXWEUNVBIY-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
77971,6m2n,DB09062,-7.2,Cefminox,JSDXOWVAHXDYCU-VXSYNFHWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
67913,6lxt,DB07303,-7.2,"N-3-[3-(5-METHOXYPYRIDIN-3-YL)BENZYL]PYRIDINE-2,3-DIAMINE",PGAWZMRRCVSRIM-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
90474,6m71,DB01782,-7.2,"2,6-Dihydroanthra/1,9-Cd/Pyrazol-6-One",ACPOUJIDANTYHO-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
104742,6vxs,DB12433,-7.2,SCH-900271,ARJKMWXLIHZLQZ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
129839,6w4h,DB11155,-7.2,Triclocarban,ICUTUKXCWQ1Q-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
77916,6m2n,DB08983,-7.2,Etofibrate,XXRVYAFBUDSLJX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
165270,7bv1,DB11686,-7.2,Iferanserin,UXIPFQUBOVWAQW-UEBLJOKOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
165261,7bv1,DB11674,-7.2,Equol,ADFCQWZHKCXPAJ-GFCCVEGCSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
116012,6w4b,DB01591,-7.2,Solifenacin,FBOUYBDGKBSUES-VXKWHMMOSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
115998,6w4b,DB01571,-7.2,3-Methylfentanyl,MLQRZXNZHAOCHQ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
141098,6w9q,DB00487,-7.2,Pefloxacin,FHFYDNQZQSQIAI-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
77902,6m2n,DB08967,-7.2,Dimetotiazine,VWNWVCJGUMZDIU-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
9066,6lzg,DB07138,-7.2,Neflamapimod,VEPKQEUBKLEPRA-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
115981,6w4b,DB01554,-7.2,Bolandiol,CMXKUJNZWYTFJN-XFUVECHXSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
112452,6vxx,DB07120,-7.2,"N4-(N,N-DIPHENYLCARBAMOYL)-AMINOGUANIDINE",QLXOHIUDKNRVBZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
115999,6w4b,DB01572,-7.2,Methyl-1-testosterone,JRNSSSJKIGAFCT-YDSAWKJFSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
53128,2fxp,DB12513,-7.2,Omaveloxolone,RJCWBNBKOKFWNY-IDPLTSGASA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
29331,6cs2,DB09015,-7.2,Canrenoic acid,PBKZPPIHUVSDNM-WNHSNXHDSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
112412,6vxx,DB07073,-7.2,"5,5-dimethyl-2-morpholin-4-yl-5,6-dihydro-1,3-benzothiazol-7(4H)-one",DZXMARZBAUMWLK-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
154592,6wiq,DB08051,-7.2,"(2R)-4-(2-BENZOYL-1,2-DIAZEPAN-1-YL)-4-OXO-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE",XXRHRPGYYNOBHO-QGZVFWFLSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
90440,6m71,DB01737,-7.2,"Nalpha-(2-Naphthylsulfonylglycyl)-3-Amidino-D,L-Phenylalanine-Isopropylester",YAEIKQDHLCFGAA-KRWDZBQOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
58504,6crv,DB05592,-7.2,Blarcamesine,BOTHKNZTGGXFEQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
91453,6m71,DB03079,-7.2,Alpha-Ribazole-5'-Phosphate Derivative,YPYFPLLZCVEYCS-KKOKHZNYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
31159,6cs2,DB13481,-7.2,Tenidap,LXIKEPCNDFVJKC-QXMHVHEDSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
141066,6w9q,DB00448,-7.2,Lansoprazole,MJIHNNLFOKEZEW-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
62455,6crv,DB13603,-7.2,Pyrrolnitrin,QJBZDBLBQWFTPZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31156,6cs2,DB13476,-7.2,Diisopromine,YBJKOPHEJOMRMN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
116091,6w4b,DB01691,-7.2,Indole Naphthyridinone,VAZMNDXVXVUKFY-JXMROGBWSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
116089,6w4b,DB01689,-7.2,Inhibitor Idd 384,CJKKMQCZOLCXAM-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
77952,6m2n,DB09021,-7.2,Benzoctamine,GNRXCIONJWKSEA-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
67910,6lxt,DB07300,-7.2,"2-(1H-imidazol-1-yl)-9-methoxy-8-(2-methoxyethoxy)benzo[c][2,7]naphthyridin-4-amine",QSSGYSRUMIOURP-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
141083,6w9q,DB00470,-7.2,Dronabinol,CYQFCXCEBYINGO-IAGOWNOFSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
9090,6lzg,DB00652,-7.2,Pentazocine,VOKSWYLNZZRQPF-GDIGMMSISA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
20250,6cs2,HMDB0000917,-7.2,Ursocholic acid,BHQCQFFYRZLCQQ-UTLSPDKDSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
141244,6w9q,DB00670,-7.2,Pirenzepine,RMHMFHUVIITRHF-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
31454,6cs2,DB13836,-7.2,Metampicillin,FZECHKJQHUVANE-MCYUEQNJSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
28598,6cs2,DB08186,-7.2,(3E)-4-(1-METHYL-1H-INDOL-3-YL)BUT-3-EN-2-ONE,HCYQBFAGILCNRB-BQYQJAHWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
139584,6w9c,DB13668,-7.2,Ipidacrine,YLUSMKAJIQOXPV-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139582,6w9c,DB13665,-7.2,Fluanisone,IRYFCWPNDIUQOW-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
97401,6m71,DB14799,-7.2,PF-06821497,RXCVUHMIWHRLDF-HXUWFJFHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
64244,6lxt,DB01228,-7.2,Encainide,PJWPNDMDCLXCOM-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
100628,6vxs,DB03841,-7.2,Y-700,AETHRPHBGJAIBT-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
79640,6m2n,DB13548,-7.2,Dibrompropamidine,GMJFVGRUYJHMCO-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
13579,6lzg,DB01260,-7.2,Desonide,WBGKWQHBNHJJPZ-LECWWXJVSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
50559,2fxp,DB07152,-7.2,N-[4-(5-fluoro-6-methylpyridin-2-yl)-5-quinoxalin-6-yl-1H-imidazol-2-yl]acetamide,TYPILNNEZPSNTI-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
164499,7bv1,DB08077,-7.2,"2-[4-({[(3,5-DICHLOROPHENYL)AMINO]CARBONYL}AMINO)PHENOXY]-2-METHYLPROPANOIC ACID",OYJPTSMWFKGZJM-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
90286,6m71,DB01544,-7.2,Flunitrazepam,PPTYJKAXVCCBDU-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
79663,6m2n,DB13580,-7.2,Succinylsulfathiazole,SKVLYVHULOWXTD-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
164486,7bv1,DB08061,-7.2,4-[3-(4-CHLOROPHENYL)-1H-PYRAZOL-5-YL]PIPERIDINE,GELALLNTKKLQLM-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
154794,6wiq,DB08293,-7.2,"(5E)-12-CHLORO-13,15-DIHYDROXY-4,7,8,9-TETRAHYDRO-2-BENZOXACYCLOTRIDECINE-1,10(3H,11H)-DIONE",AQKZYZQONWDDLS-HNQUOIGGSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
36889,1r42,DB03534,-7.2,3-[(Acetyl-Methyl-Amino)-Methyl]-4-Amino-N-Methyl-N-(1-Methyl-1h-Indol-2-Ylmethyl)-Benzamide,AWTBJNJPBKTHEV-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
79685,6m2n,DB13609,-7.2,Umifenovir,KCFYEAOKVJSACF-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
31851,6cs2,DB14879,-7.2,Cefiderocol,DBPPRLRVDVJOCL-FQRUVTKNSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
164474,7bv1,DB08049,-7.2,"7,8-dihydroxy-4-phenyl-2H-chromen-2-one",JRVIIPJSVKTPBK-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
100677,6vxs,DB03903,-7.2,Tmr,KGFLZYXDJDOIEE-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
111341,6vxx,DB03526,-7.2,AL5927,LRRAIRJIZOLGPR-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79732,6m2n,DB13672,-7.2,Dimethylaminopropionylphenothiazine,POZJNEBUHLZROM-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
58368,6crv,DB04910,-7.2,Oxibendazole,RAOCRURYZCVHMG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31864,6cs2,DB14900,-7.2,ISO-1 F-18,QVRVXSZKCXFBTE-KPVNRNJOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
91587,6m71,DB03251,-7.2,RWJ-51084,NQABUEUFRXDDFI-AWEZNQCLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
111449,6vxx,DB03886,-7.2,Biopterin,LHQIJBMDNUYRAM-AWFVSMACSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
9538,6lzg,DB07647,-7.2,"(2R)-1-[(5,6-DIPHENYL-7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)AMINO]PROPAN-2-OL",VBASHTSSQNDDAS-CQSZACIVSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
130024,6w4h,DB11662,-7.2,Rabusertib,SYYBDNPGDKKJDU-ZDUSSCGKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
145194,6w9q,DB07067,-7.2,"(2S,3S)-3-{3-[4-(METHYLSULFONYL)PHENYL]-1,2,4-OXADIAZOL-5-YL}-1-OXO-1-PYRROLIDIN-1-YLBUTAN-2-AMINE",SQCDMTZMCHZYGO-FZMZJTMJSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
139525,6w9c,DB13588,-7.2,Naftidrofuryl,KBAFPSLPKGSANY-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
79697,6m2n,DB13627,-7.2,Oxolinic acid,KYGZCKSPAKDVKC-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
36887,1r42,DB03530,-7.2,Acylated Ceftazidime,VEHPZKIFULQYFS-BZXVCXBKSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
97389,6m71,DB14772,-7.2,DCFBC F-18,IDTMSHGCAZPVLC-STUNTBJNSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
145196,6w9q,DB07070,-7.2,(2S)-2-{3-[({[2-fluoro-4-(trifluoromethyl)phenyl]carbonyl}amino)methyl]-4-methoxybenzyl}butanoic acid,BDLLIPYDNFENMY-ZDUSSCGKSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
79738,6m2n,DB13678,-7.2,Dihexyverine,MNSQDVCVWNXBFQ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
145161,6w9q,DB07032,-7.2,2-(4-HYDROXY-PHENYL)BENZOFURAN-5-OL,SNNNDCMXZYWCCI-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
145156,6w9q,DB07027,-7.2,D-phenylalanyl-N-(3-fluorobenzyl)-L-prolinamide,JGZSVYZIJHGHMA-MOPGFXCFSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
79487,6m2n,DB13342,-7.2,Cinepazet,XDUOTWNXVDBCDY-VOTSOKGWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
13556,6lzg,DB01216,-7.2,Finasteride,DBEPLOCGEIEOCV-WSBQPABSSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
40254,6lu7,DB01767,-7.2,Hemi-Babim,KKJYVDXDZURHMA-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
90295,6m71,DB01553,-7.2,Cloxazolam,ZIXNZOBDFKSQTC-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
31742,6cs2,DB14662,-7.2,Flunisolide acetate,WEGNFRKBIKYVLC-XTLNBZDDSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
111593,6vxx,DB04253,-7.2,Tretazicar,WOCXQMCIOTUMJV-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
97435,6m71,DB14881,-7.2,Oliceridine,DMNOVGJWPASQDL-OAQYLSRUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
79503,6m2n,DB13360,-7.2,Tolciclate,CANCCLAKQQHLNK-LSDHHAIUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
53381,2fxp,DB12914,-7.2,MGL-3196,FDBYIYFVSAHJLY-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
26428,6cs2,DB04563,-7.2,CRA_9678,VIZNZQTZRMTYPZ-UHFFFAOYSA-M,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
130014,6w4h,DB11644,-7.2,Tafamidis,TXEIIPDJKFWEEC-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
31776,6cs2,DB14725,-7.2,Cefamandole nafate,RRJHESVQVSRQEX-SUYBPPKGSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
139630,6w9c,DB13725,-7.2,Terodiline,UISARWKNNNHPGI-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139619,6w9c,DB13713,-7.2,Quifenadine,PZMAHNDJABQWGS-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
58380,6crv,DB04947,-7.2,Altropane,GTQLIPQFXVKRKJ-UNSMHXHVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
64218,6lxt,DB01196,-7.2,Estramustine,FRPJXPJMRWBBIH-RBRWEJTLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
79587,6m2n,DB13475,-7.2,Furazidin,DECBQELQORZLLP-UAIOPKHMSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
128557,6w4h,DB07754,-7.2,N-({(1R)-1-carboxy-2-[(4-fluorobenzyl)sulfanyl]ethyl}carbamoyl)-L-glutamic acid,IDTMSHGCAZPVLC-RYUDHWBXSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
73851,6m2n,DB02569,-7.2,"2',3'-Dehydro-2',3'-Deoxy-Thymidine 5'-Diphosphate",LXCAIISEDMYORY-JGVFFNPUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79621,6m2n,DB13523,-7.2,Veralipride,RYJXBGGBZJGVQF-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
154777,6wiq,DB08268,-7.2,"6-AMINO-4-[2-(4-METHYLPHENYL)ETHYL]-1,7-DIHYDRO-8H-IMIDAZO[4,5-G]QUINAZOLIN-8-ONE",SPVJRTJUEVXOMS-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
7799,6lzg,DB04392,-7.2,"Bishydroxy[2h-1-Benzopyran-2-One,1,2-Benzopyrone]",HIZKPJUTKKJDGA-BETUJISGSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
145151,6w9q,DB07021,-7.2,"(7R,8R)-8-(2,4,5-trifluorophenyl)-6,7,8,9-tetrahydroimidazo[1,2-a:4,5-c']dipyridin-7-amine",SOSYXEPELJIJHZ-RNCFNFMXSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
118408,6w4b,DB04790,-7.2,"2,5-bis-O-{3-[amino(imino)methyl]phenyl}-1,4:3,6-dianhydro-D-glucitol",IBIUTOFGXGGVKQ-XMTFNYHQSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
79615,6m2n,DB13512,-7.2,Clefamide,ODCUSWJXZDHLKV-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
64228,6lxt,DB01207,-7.2,Ridogrel,GLLPUTYLZIKEGF-HAVVHWLPSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
97413,6m71,DB14841,-7.2,Centanafadine,HKHCSWPSUSWGLI-CABCVRRESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
118363,6w4b,DB04725,-7.2,Licofelone,UAWXGRJVZSAUSZ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
111504,6vxx,DB03956,-7.2,"Inositol 2,4,5-trisphosphate",MMWCIQZXVOZEGG-LKPKBOIGSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
118349,6w4b,DB04706,-7.2,"(3BETA,7BETA)-CHOLEST-5-ENE-3,7-DIOL",OYXZMSRRJOYLLO-KGZHIOMZSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
111520,6vxx,DB03981,-7.2,"1,4-Dideoxy-5-Dehydro-O2-Sulfo-Glucuronic Acid",VJIMUKBSNUBECH-YKKSOZKNSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
139590,6w9c,DB13674,-7.2,Cridanimod,UOMKBIIXHQIERR-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
40255,6lu7,DB05511,-7.2,Piclidenoson,HUJXGQILHAUCCV-MOROJQBDSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
24498,6cs2,DB00304,-7.2,Desogestrel,RPLCPCMSCLEKRS-BPIQYHPVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
19460,6cs2,HMDB0000797,-7.2,SAICAR,NAQGHJTUZRHGAC-ZZZDFHIKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
29119,6cs2,DB08757,-7.2,5-(2-chlorophenyl)furan-2-carbohydrazide,XQMRHWSGTVEDFG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
118576,6w4b,DB05288,-7.2,Anecortave acetate,YUWPMEXLKGOSBF-GACAOOTBSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
79823,6m2n,DB13792,-7.2,Clopamide,LBXHRAWDUMTPSE-AOOOYVTPSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
31916,6cs2,DB01103,-7.2,Quinacrine,GPKJTRJOBQGKQK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
118581,6w4b,DB05316,-7.2,Pimavanserin,RKEWSXXUOLRFBX-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
111212,6vxx,DB03346,-7.2,"3,5,3',5'-Tetrachloro-Biphenyl-4,4'-Diol",YCYDXOVJXVALHY-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111209,6vxx,DB03342,-7.2,4-(Acetylamino)-3-Guanidinobenzoic Acid,HIXHCUDMJUERSJ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
164415,7bv1,DB07805,-7.2,"3-CHLORO-2,2-DIMETHYL-N-[4-(TRIFLUOROMETHYL)PHENYL]PROPANAMIDE",QCQZFHOGRCQNIH-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
9574,6lzg,DB00704,-7.2,Naltrexone,DQCKKXVULJGBQN-XFWGSAIBSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
97311,6m71,DB14635,-7.2,Curcumin sulfate,NEJVQQBBTRFOHB-FCXRPNKRSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
111195,6vxx,DB03322,-7.2,Dexpropranolol,AQHHHDLHHXJYJD-CQSZACIVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79844,6m2n,DB13820,-7.2,Oxomemazine,QTQPVLDZQVPLGV-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
31932,6cs2,DB15058,-7.2,Flutemetamol,VVECGOCJFKTUAX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
118591,6w4b,DB05408,-7.2,Emricasan,SCVHJVCATBPIHN-SJCJKPOMSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
128523,6w4h,DB07714,-7.2,"6-(3-METHYL-1,4-DIOXO-1,4-DIHYDRONAPHTHALEN-2-YL)HEXANOIC ACID",ICGRXHWXPCXIKM-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
31934,6cs2,DB15062,-7.2,Inarigivir,LYMICVBGNUEHGE-FUQPUAIBSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
164407,7bv1,DB07796,-7.2,"(3ASR,4RS,8ASR,8BRS)-4-(2-(4-FLUOROBENZYL)-1,3-DIOXODEACAHYDROPYRROLO[3,4-A] PYRROLIZIN-4-YL)BENZAMIDINE",GJYCQHGTXMVIBG-MUGJNUQGSA-O,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
111125,6vxx,DB03030,-7.2,4-(2-Thienyl)-1-(4-Methylbenzyl)-1h-Imidazole,UMOFOLLUKPBVQG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130079,6w4h,DB11741,-7.2,Famitinib,GKEYKDOLBLYGRB-LGMDPLHJSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
73722,6m2n,DB02407,-7.2,6-O-Cyclohexylmethyl Guanine,MWGXGTJJAOZBNW-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
118616,6w4b,DB05511,-7.2,Piclidenoson,HUJXGQILHAUCCV-MOROJQBDSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
79865,6m2n,DB13846,-7.2,Pyrrobutamine,WDYYVNNRTDZKAZ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
91603,6m71,DB03273,-7.2,3'-Oxo-Adenosine,MIAZJCOESMXYNJ-XMRAEQSQSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
31905,6cs2,DB01102,-7.2,Arbutamine,IIRWWTKISYTTBL-SFHVURJKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
29092,6cs2,DB08732,-7.2,NALPHA-[(BENZYLOXY)CARBONYL]-N-[(1R)-4-HYDROXY-1-METHYL-2-OXOBUTYL]-L-PHENYLALANINAMIDE,UUOOAGBWJUGBMV-APWZRJJASA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
97295,6m71,DB14583,-7.2,Segesterone acetate,CKFBRGLGTWAVLG-GOMYTPFNSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
9585,6lzg,DB00705,-7.2,Delavirdine,WHBIGIKBNXZKFE-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
551,6lzg,HMDB0005460,-7.2,"TG(18:1(9Z)/18:2(9Z,12Z)/20:1(11Z))",YONCDTJKIZDSKQ-UVIGLXQBSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
97296,6m71,DB14584,-7.2,Segesterone,SFLXYFZGKSGFKA-XUDSTZEESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
64306,6lxt,DB01348,-7.2,Spirapril,HRWCVUIFMSZDJS-SZMVWBNQSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
118596,6w4b,DB05421,-7.2,CP-122721,ZIWFCOIGUNPHPM-HKUYNNGSSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
91599,6m71,DB03267,-7.2,1-Allyl-3-Butyl-8-(N-Acetyl-4-Aminobenzyl)-Xanthine,XFOWZKUTPKXWIE-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
118486,6w4b,DB04885,-7.2,Cilansetron,NCNFDKWULDWJDS-OAHLLOKOSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
128526,6w4h,DB07717,-7.2,"(5S,8R,9S,10S,13R,14S,17S)-13-{2-[(3,5-DIFLUOROBENZYL)OXY]ETHYL}-17-HYDROXY-10-METHYLHEXADECAHYDRO-3H-CYCLOPENTA[A]PHENANTHREN-3-ONE",AJODXHGZHBERGJ-JLYQOUBASA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
128533,6w4h,DB07724,-7.2,Indeglitazar,YMPALHOKRBVHOJ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
111323,6vxx,DB03503,-7.2,"4-Acetyl-4-Guanidino-6-Methyl(Propyl)Carboxamide-4,5-Dihydro-2h-Pyran-2-Carboxylic Acid",QPJWMZVTNXFTKV-JMJZKYOTSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31875,6cs2,DB14921,-7.2,Mavacamten,RLCLASQCAPXVLM-NSHDSACASA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
154803,6wiq,DB08303,-7.2,"(3S)-3-cyclopentyl-6-methyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide",CUMKMTBOHBENJI-SFHVURJKSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
164463,7bv1,DB07859,-7.2,4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL)PHENYL]PIPERIDINE,LZMOSYUFVYJEPY-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
9547,6lzg,DB07655,-7.2,"3-AMINO-3-BENZYL-[4.3.0]BICYCLO-1,6-DIAZANONAN-2-ONE",MPJYGQHMIFDQIN-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
73792,6m2n,DB02495,-7.2,9-(4-hydroxybutyl)-N2-phenylguanine,JHBXNPBKSPYOFT-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
55140,6crv,DB00660,-7.2,Metaxalone,IMWZZHHPURKASS-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111306,6vxx,DB03479,-7.2,"8,9,10-Trihydroxy-7-Hydroxymethyl-3-Methyl-6-Oxa-1,3-Diaza-Spiro[4.5]Decane-2,4-Dione",RIUIMUSXAGXXON-FMTWGGRWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
73790,6m2n,DB02493,-7.2,Hydantocidin-5'-Phosphate,HVXIMXHBUJADCC-GTBMBKLPSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
31881,6cs2,DB14934,-7.2,GDC-0927,KJAAPZIFCQQQKX-NDEPHWFRSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
111299,6vxx,DB03471,-7.2,6-Phenyl-4(R)-(7-Phenyl-Heptanoylamino)-Hexanoic Acid,SMNHQYPORNSAQH-HSZRJFAPSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
139511,6w9c,DB13566,-7.2,Sequifenadine,OXDOWGVJMITMJL-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
118523,6w4b,DB04982,-7.2,Talampanel,JACAAXNEHGBPOQ-LLVKDONJSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
79756,6m2n,DB13701,-7.2,Ioglicic acid,HHFIATHHSBFCBY-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
164458,7bv1,DB07854,-7.2,N-METHYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE,VRGSDHJXBVCQEL-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
145214,6w9q,DB07091,-7.2,(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclohexyloxy)ethanoyl)pyrrolidine-2-carboxamide,IWPMQJKXKKKSEY-SFHVURJKSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
118534,6w4b,DB05038,-7.2,Anatibant,XUHBBTKJWIBQMY-MHZLTWQESA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
29125,6cs2,DB08763,-7.2,[N-(BENZYLOXYCARBONYL)AMINO](4-AMIDINOPHENYL)METHANE-PHOSPHONATE,FSNDLCSOLUMYRH-OAHLLOKOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
111242,6vxx,DB03386,-7.2,4-Fluorotryptophane,DEBQMEYEKKWIKC-QMMMGPOBSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111248,6vxx,DB03396,-7.2,"(E)-(2r,3r,4s,5r)-3,4,5-Trihydroxy-2-Methoxy-8,8-Dimethyl-Non-6-Enoic Acid ((3s,6r)-6-Hydroxy-2-Oxo-Azepan-3-Yl)-Amide",FVBBTOIQETYGOA-SDNORSGYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
139488,6w9c,DB13538,-7.2,Guacetisal,HSJFYRYGGKLQBT-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
118556,6w4b,DB05154,-7.2,Pretomanid,ZLHZLMOSPGACSZ-NSHDSACASA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
68556,6lxt,DB08053,-7.2,"1-cyclobutyl-3-(3,4-dimethoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine",ITOYZJGFTNTKKR-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
73762,6m2n,DB02456,-7.2,Aracytidine 5'-monophosphate,IERHLVCPSMICTF-CCXZUQQUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
111264,6vxx,DB03417,-7.2,1-(4-Tert-Butylcarbamoyl-Piperazine-1-Carbonyl)-3-(3-Guanidino-Propyl)-4-Oxo-Azetidine-2-Carboxylic Acid,BVNQCAHTTOIOEK-STQMWFEESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111271,6vxx,DB03428,-7.2,SU9516,QNUKRWAIZMBVCU-WCIBSUBMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
97326,6m71,DB14651,-7.2,Perphenazine enanthate,PWEGQJCIAMJJHC-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
111277,6vxx,DB03437,-7.2,"2-{1-[2-(2-Amino-Thiazol-4-Yl)-2-Methoxyimino-Acetylamino]-2-Oxo-Ethyl}-5,5-Dimethyl-Thiazolidine-4-Carboxylic Acid",YVNKGXXVZIQNIV-RKMXGKDGSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
145231,6w9q,DB07113,-7.2,"(2S)-6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2-(3,5-DIFLUOROPHENYL)-4-(3-METHOXYPROPYL)-2H-1,4-BENZOXAZIN-3(4H)-ONE",KHZQOXQOUCGGGA-NRFANRHFSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
62011,6crv,DB12945,-7.2,Dihydralazine,VQKLRVZQQYVIJW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79764,6m2n,DB13714,-7.2,Xibornol,RNRHMQWZFJXKLZ-JCKWVBRZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
79779,6m2n,DB13730,-7.2,Nifurtoinol,UIDWQGRXEVDFCA-XCVCLJGOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
67824,6lxt,DB07200,-7.2,"(2S,4S,5R)-2-ISOBUTYL-5-(2-THIENYL)-1-[4-(TRIFLUOROMETHYL)BENZOYL]PYRROLIDINE-2,4-DICARBOXYLIC ACID",ZNCZVHCYBGHCHA-XPIZARPCSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
73923,6m2n,DB02666,-7.2,(C8-R)-Hydantocidin 5'-Phosphate,MAXSFYCTFIBEAR-OJMIUMIFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
40256,6lu7,DB04971,-7.2,Reglitazar,QBQLYIISSRXYKL-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
13519,6lzg,DB00213,-7.2,Pantoprazole,IQPSEEYGBUAQFF-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
29272,6cs2,DB08956,-7.2,Hydroxydione,USPYDUPOCUYHQL-VEVMSBRDSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
74109,6m2n,DB02914,-7.2,"(6e)-6-[(2e,4e,6e)-3,7-Dimethylnona-2,4,6,8-Tetraenylidene]-1,5,5-Trimethylcyclohexene",FWNRILWHNGFAIN-OYUWDNMLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
13052,6lzg,DB14627,-7.2,Oxyphenisatin acetate,PHPUXYRXPHEJDF-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
9376,6lzg,DB07470,-7.2,"(3aS)-3a-hydroxy-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one",DOMYOVZXZIZTRD-QGZVFWFLSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
78915,6m2n,DB12442,-7.2,Alvespimycin,KUFRQPKVAWMTJO-LMZWQJSESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
154723,6wiq,DB08197,-7.2,"(5E,7S)-2-amino-7-(4-fluoro-2-pyridin-3-ylphenyl)-4-methyl-7,8-dihydroquinazolin-5(6H)-one oxime",KYIXUSLGFINPTC-WVFAEZDRSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
164832,7bv1,DB08659,-7.2,2-(hydrazinocarbonyl)-3-phenyl-1H-indole-5-sulfonamide,PPDLAUCFAOODER-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
139916,6w9c,DB14544,-7.2,Hydrocortisone valerate,FZCHYNWYXKICIO-FZNHGJLXSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
117521,6w4b,DB03605,-7.2,"(2s)-2-[(2,4-Dichloro-Benzoyl)-(3-Trifluoromethyl-Benzyl)-Amino]-3-Phenyl-Propionic Acid",LAJJKGIZTCCOHY-NRFANRHFSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
53209,2fxp,DB12644,-7.2,AZD-2066,SXWHYTICXCLKDG-GFCCVEGCSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
58405,6crv,DB05047,-7.2,CX717,KFRQROSRKSVROW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29260,6cs2,DB08943,-7.2,Isoconazole,MPIPASJGOJYODL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
74072,6m2n,DB02866,-7.2,Dansylamide,TYNBFJJKZPTRKS-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
164798,7bv1,DB08617,-7.2,"4-(2,2,2-TRIFLUOROETHYL)-L-PHENYLALANINE",VXIZYDKGLBPCAQ-VIFPVBQESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
31570,6cs2,DB14045,-7.2,Cholesteryl chloride,OTVRYZXVVMZHHW-DPAQBDIFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
50720,2fxp,DB07333,-7.2,"N-(CYCLOPROPYLMETHYL)-4-(METHYLOXY)-3-({5-[3-(3-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-YL}AMINO)BENZENESULFONAMIDE",KRGKAARWVPUWSY-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
50686,2fxp,DB07297,-7.2,"5,6-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-D]PYRIMIDIN-4-AMINE",PTILEOLOGGMFCS-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
9414,6lzg,DB07512,-7.2,7-[(3-CHLOROBENZYL)OXY]-2-OXO-2H-CHROMENE-4-CARBALDEHYDE,ZOCADHRNWNJARU-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
31600,6cs2,DB14093,-7.2,"(1,2,6,7-3H)Testosterone",MUMGGOZAMZWBJJ-JQSYSRDDSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
100426,6vxs,DB03577,-7.2,Alpha-Benzyl-Aminobenzyl-Phosphonic Acid,SLMGIUOAZCYKPE-CQSZACIVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
68522,6lxt,DB08014,-7.2,(METHYLPYRIDAZINE PIPERIDINE BUTYLOXYPHENYL)ETHYLACETATE,AQILFLLHLFBLLG-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
117741,6w4b,DB03893,-7.2,Thionicotinamide-Adenine-Dinucleotide,UQYPZLRUJKCREN-NNYOXOHSSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
9364,6lzg,DB00683,-7.2,Midazolam,DDLIGBOFAVUZHB-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
139837,6w9c,DB14083,-7.2,Bisphenol A diglycidyl ether,LCFVJGUPQDGYKZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
64137,6lxt,DB01104,-7.2,Sertraline,VGKDLMBJGBXTGI-SJCJKPOMSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
100397,6vxs,DB03526,-7.2,AL5927,LRRAIRJIZOLGPR-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
164793,7bv1,DB08611,-7.2,"2-[(2',3',4'-TRIFLUOROBIPHENYL-2-YL)OXY]ETHANOL",AGXPXFPIOHNDAN-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
139859,6w9c,DB14129,-7.2,Macelignan,QDDILOVMGWUNGD-UONOGXRCSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
53227,2fxp,DB12669,-7.2,4SC-203,MAFACRSJGNJHCF-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
117627,6w4b,DB03751,-7.2,2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose,YSYKRGRSMLTJNL-URARBOGNSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
100402,6vxs,DB03535,-7.2,Z-Pro-Prolinal,ORZXYSPOAVJYRU-HOTGVXAUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
79123,6m2n,DB12766,-7.2,Cicletanine,CVKNDPRBJVBDSS-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
29279,6cs2,DB08965,-7.2,Fusafungine,MIZMDSVSLSIMSC-OGLSAIDSSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
90313,6m71,DB01571,-7.2,3-Methylfentanyl,MLQRZXNZHAOCHQ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
6513,6lzg,DB00304,-7.2,Desogestrel,RPLCPCMSCLEKRS-BPIQYHPVSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
64096,6lxt,DB01059,-7.2,Norfloxacin,OGJPXUAPXNRGGI-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
145119,6w9q,DB06985,-7.2,2-[({4-[2-(trifluoromethyl)phenyl]piperidin-1-yl}carbonyl)amino]benzoic acid,MEAQCLPMSVEOQF-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
164913,7bv1,DB08955,-7.2,Ibuproxam,BYPIURIATSUHDW-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
140171,6w9c,DB15117,-7.2,Transfluthrin,DDVNRFNDOPPVQJ-HQJQHLMTSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
154691,6wiq,DB08159,-7.2,"4-(5,11-DIOXO-5H-INDENO[1,2-C]ISOQUINOLIN-6(11H)-YL)BUTANOATE",AHIJTWCJGCWHMT-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
7831,6lzg,DB04437,-7.2,"Cysteine-Methylene-Carbamoyl-1,10-Phenanthroline",ZFGIPRHDRFOMFO-LBPRGKRZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
50773,2fxp,DB07397,-7.2,"(5S)-5-(2-amino-2-oxoethyl)-4-oxo-N-[(3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl)methyl]-3,4,5,6,7,8-hexahydro[1]benzothieno[2,3-d]pyrimidine-2-carboxamide",ITADELAVAWJACR-NSHDSACASA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
91560,6m71,DB03221,-7.2,AL7099A,RMOXCYSVWCHXII-GFCCVEGCSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
50772,2fxp,DB07396,-7.2,"1-{2-[3-(2-Chloro-4,5-difluoro-benzoyl)-ureido]-4-fluoro-phenyl}-piperidine-4-carboxylic acid",KAJJGOCSAXKXBD-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
117347,6w4b,DB03351,-7.2,Sri-9439,KMSATRJZEXNGDP-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
9341,6lzg,DB07432,-7.2,"[[(3R,4R,5S,6R)-3-(butanoylamino)-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-ylidene]amino] N-phenylcarbamate",ITVRELFVFCOUMV-ZVZWZHPPSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
164898,7bv1,DB08934,-7.2,Sofosbuvir,TTZHDVOVKQGIBA-IQWMDFIBSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
9343,6lzg,DB07434,-7.2,HONH-BENZYLMALONYL-L-ALANYLGLYCINE-P-NITROANILIDE,TZWQPWGUQCSKDW-GUYCJALGSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
145138,6w9q,DB07005,-7.2,D-phenylalanyl-N-{4-[amino(iminio)methyl]benzyl}-L-prolinamide,VZFTWWJAUZOJDH-MOPGFXCFSA-O,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
145142,6w9q,DB07011,-7.2,"(3S)-1-(1,3-BENZODIOXOL-5-YLMETHYL)-3-[4-(1H-IMIDAZOL-1-YL)PHENOXY]PIPERIDINE",HHOPJGKEAIIIDF-FQEVSTJZSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
11900,6lzg,DB12585,-7.2,Ondelopran,QWNDOCKIKKQJNN-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
117448,6w4b,DB03496,-7.2,Alvocidib,BIIVYFLTOXDAOV-YVEFUNNKSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
2860,6lzg,HMDB0000010,-7.2,2-Methox1trone,WHEUWNKSCXYKBU-QPWUGHHJSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
164892,7bv1,DB08926,-7.2,Acediasulfone,FKKUMFTYSTZUJG-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
129980,6w4h,DB11551,-7.2,Trenbolone,MEHHPFQKXOUFFV-OWSLCNJRSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
111956,6vxx,DB04944,-7.2,Acadesine,RTRQQBHATOEIAF-UUOKFMHZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
111960,6vxx,DB04951,-7.2,Pirfenidone,ISWRGOKTTBVCFA-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
9358,6lzg,DB07451,-7.2,1-(5-BROMO-PYRIDIN-2-YL)-3-[2-(6-FLUORO-2-HYDROXY-3-PROPIONYL-PHENYL)-CYCLOPROPYL]-UREA,VRAJWAGCJIXJHQ-YPMHNXCESA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
117442,6w4b,DB03488,-7.2,Uridine-5'-diphosphate-2-deoxy-2-fluoro-alpha-D-galactose,NGTCPFGWXMBZEP-NQQHDEILSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
31485,6cs2,DB13872,-7.2,Lormetazepam,FJIKWRGCXUCUIG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
154705,6wiq,DB08173,-7.2,5-CHLORO-N-(2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO)ETHYL)THIOPHENE-2-CARBOXAMIDE,UCKHUNHXYMAFQM-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
153750,6wiq,DB07072,-7.2,"(1S,2R,5S)-5-[3-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7(8H)-YL]-2-(2,4,5-TRIFLUOROPHENYL)CYCLOHEXANAMINE",CNKRZILQBKJWDS-WMFXKJRFSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
9350,6lzg,DB07443,-7.2,(2Z)-N-biphenyl-4-yl-2-cyano-3-hydroxybut-2-enamide,MUVPBAIVOHJDOC-VBKFSLOCSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
50762,2fxp,DB07384,-7.2,1-ACETYL-2-CARBOXYPIPERIDINE,JACZWLDAHFCGCC-ZETCQYMHSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
9347,6lzg,DB07439,-7.2,"1-((2-HYDROXYETHOXY)METHYL)-5-(3-(BENZYLOXY)BENZYL)-6-HYDROXYPYRIMIDINE-2,4(1H,3H)-DIONE",CAWXCABXSPTFRN-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
117434,6w4b,DB03477,-7.2,1-Phenylsulfonamide-3-Trifluoromethyl-5-Parabromophenylpyrazole,OYZKFVIVPRQRQQ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
79125,6m2n,DB12770,-7.2,Lafutidine,KMZQAVXSMUKBPD-DJWKRKHSSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
111822,6vxx,DB04743,-7.2,Nimesulide,HYWYRSMBCFDLJT-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79136,6m2n,DB12791,-7.2,Laninamivir,QNRRHYPPQFELSF-CNYIRLTGSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
31679,6cs2,DB14542,-7.2,Hydrocortisone phosphate,BGSOJVFOEQLVMH-VWUMJDOOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
164649,7bv1,DB08253,-7.2,NAM NAPTHYLAMINOALANINE,DGFMSNJYBBNHCX-LBPRGKRZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
13544,6lzg,DB01195,-7.2,Flecainide,DJBNUMBKLMJRSA-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
67842,6lxt,DB07222,-7.2,(3S)-N-(5-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE,RJWMDETWDDESBP-ZDUSSCGKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
62120,6crv,DB13111,-7.2,Chromanol,SEBPXHSZHLFWRL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
40270,6lu7,DB02269,-7.2,[4-({[5-Benzyloxy-1-(3-Carbamimidoyl-Benzyl)-1h-Indole-2-Carbonyl]-Amino}-Methyl)-Phenyl]-Trimethyl-Ammonium,UFKJQTGPBFWMGT-UHFFFAOYSA-O,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
118075,6w4b,DB04336,-7.2,1-(4-Amidinophenyl)-3-(4-Chlorophenyl)Urea,HQWKMDKTTCPCMQ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
73958,6m2n,DB02712,-7.2,Sorbinil,LXANPKRCLVQAOG-NSHDSACASA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
139705,6w9c,DB13825,-7.2,Fedrilate,RDEOYUSTRWNWLX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
31693,6cs2,DB14575,-7.2,Eslicarbazepine,BMPDWHIDQYTSHX-AWEZNQCLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
29225,6cs2,DB08892,-7.2,Arbaclofen Placarbil,JXTAALBWJQJLGN-KSSFIOAISA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
79424,6m2n,DB13258,-7.2,Etofamide,QTRALMGDQMIVFF-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
40267,6lu7,DB00251,-7.2,Terconazole,BLSQLHNBWJLIBQ-OZXSUGGESA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
139702,6w9c,DB13822,-7.2,Meprotixol,LAYVFLWAVIGDLK-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
40266,6lu7,DB00590,-7.2,Doxazosin,RUZYUOTYCVRMRZ-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
79440,6m2n,DB13283,-7.2,Sulfaisodimidine,YZMCKZRAOLZXAZ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
40265,6lu7,DB00693,-7.2,Fluorescein,GNBHRKFJIUUOQI-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40257,6lu7,DB04477,-7.2,"N-1,2,3,4-Tetrahydronaphth-1-Yl-2'-[3,5-Dimethoxybenzamido]-2'-Deoxy-Adenosine",FDZQGEIYGFPMOB-ZUURFMEUSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
67833,6lxt,DB07211,-7.2,(2R)-2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}PROPENE-1-SULFONAMIDE,YMJHMJLNQLVUAV-GHYUOPHCSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
40258,6lu7,DB03205,-7.2,Pyrroloquinoline Quinone,MMXZSJMASHPLLR-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
100527,6vxs,DB03719,-7.2,N-Ethyl-5'-Carboxamido Adenosine,JADDQZYHOWSFJD-BMYQGPEFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
153744,6wiq,DB07064,-7.2,"(4R)-4-(3-HYDROXYPHENYL)-N,N,7,8-TETRAMETHYL-3,4-DIHYDROISOQUINOLINE-2(1H)-CARBOXAMIDE",HPVCRUIDFODATB-LJQANCHMSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
40259,6lu7,DB02398,-7.2,6-[N-(4-(Aminomethyl)Phenyl)Carbamyl]-2-Naphthalenecarboxamidine,NLBDETRVUYOIHQ-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
79362,6m2n,DB13143,-7.2,Methallenestril,KHLJKRBMZVNZOC-MRXNPFEDSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
40260,6lu7,DB02323,-7.2,EM-1745,CKSDYJASHNGOOS-KTXOUVACSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
13552,6lzg,DB01208,-7.2,Sparfloxacin,DZZWHBIBMUVIIW-DTORHVGOSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
24439,6cs2,DB02181,-7.2,2'-Deoxyguanosine-5'-Triphosphate,HAAZLUGHYHWQIW-KVQBGUIXSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
40262,6lu7,DB01879,-7.2,(S)-2-{Methyl-[2-(Naphthalene-2-Sulfonylamino)-5-(Naphthalene-2-Sulfonyloxy)-Benzoyl]-Amino}-Succinicacid,JOAALZBSMWLOPQ-LJAQVGFWSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
139700,6w9c,DB13820,-7.2,Oxomemazine,QTQPVLDZQVPLGV-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
40264,6lu7,DB01678,-7.2,RU84687,SAFPHFWYRLLBFO-NSOVKSMOSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
111652,6vxx,DB04331,-7.2,Monastrol,LOBCDGHHHHGHFA-LBPRGKRZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31718,6cs2,DB14638,-7.2,Diloxanide furoate,BDYYDXJSHYEDGB-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
164658,7bv1,DB08263,-7.2,N-(carboxycarbonyl)-D-phenylalanine,ULQWGBCNOHBNDB-MRVPVSSYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
118050,6w4b,DB04301,-7.2,Bis(5-Amidino-2-Benzimidazolyl)Methane Ketone Hydrate,ZLAHDRAQCSQPOC-UHFFFAOYSA-P,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
31676,6cs2,DB14539,-7.2,Hydrocortisone acetate,ALEXXDVDDISNDU-JZYPGELDSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
111777,6vxx,DB04505,-7.2,"8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-9-Pent-4-Ylnyl-9h-Purin-6-Ylamine",WUJFGZAAFADPSF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
9434,6lzg,DB07534,-7.2,"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE",BKUMVXIXUVYKDQ-GHXNOFRVSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
31623,6cs2,DB14136,-7.2,(-)-menthol 1-propylene glycol carbonate,FLYJSXDJKBHQAU-IBSWDFHHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
79190,6m2n,DB12882,-7.2,Ombrabulin,IXWNTLSTOZFSCM-YVACAVLKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
164732,7bv1,DB08537,-7.2,"3-bromo-6-phenyl-N-(pyrimidin-5-ylmethyl)imidazo[1,2-a]pyridin-8-amine",LZLKFNBMXXLTLX-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
139808,6w9c,DB14030,-7.2,PZM21,MEDBIJOVZJEMBI-YOEHRIQHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
117957,6w4b,DB04177,-7.2,"4-(3,14-Dihydroxy-10,13-Dimethyl-Hexadecahydro-Cyclopenta[a]Phenanthren-17-Yl)-5h-Furan-2-One",XZTUSOXSLKTKJQ-CESUGQOBSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
100442,6vxs,DB03598,-7.2,"Al-6629, [2h-Thieno[3,2-E]-1,2-Thiazine-6-Sulfonamide,2-(3-Methoxyphenyl)-3-(4-Morpholinyl)-, 1,1-Dioxide]",XSUAVPPTKHUTDX-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
24408,6cs2,DB02139,-7.2,(2e)-N-Allyl-4-{[3-(4-Bromophenyl)-5-Fluoro-1-Methyl-1h-Indazol-6-Yl]Oxy}-N-Methyl-2-Buten-1-Amine,YDWPQZUWZDRRSE-AATRIKPKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
117872,6w4b,DB04071,-7.2,Cpad,LFERELMXERXKKQ-KMXXXSRASA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
74027,6m2n,DB02809,-7.2,"Brodimoprim-4,6-Dicarboxylate",SZAVCZNFKJSWRN-LBPRGKRZSA-M,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
128608,6w4h,DB07810,-7.2,"3-(4-HYDROXYPHENYL)-1-(2,4,6-TRIHYDROXYPHENYL)PROPAN-1-ONE",VGEREEWJJVICBM-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
9421,6lzg,DB07519,-7.2,"(6R)-2-amino-6-[2-(3'-methoxybiphenyl-3-yl)ethyl]-3,6-dimethyl-5,6-dihydropyrimidin-4(3H)-one",VDFBMQAUECXNKR-OAQYLSRUSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
50683,2fxp,DB07294,-7.2,"3-fluoro-4-[2-hydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8,-tetrahydro-naphtalen-2-yl)-acetylamino]-benzoic acid",AANFHDFOMFRLLR-IBGZPJMESA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
64157,6lxt,DB01129,-7.2,Rabeprazole,YREYEVIYCVEVJK-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
64090,6lxt,DB01053,-7.2,Benzylpenicillin,JGSARLDLIJGVTE-MBNYWOFBSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
128597,6w4h,DB07798,-7.2,"(3R)-3-(FLUOROMETHYL)-N-(3,3,3-TRIFLUOROPROPYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONAMIDE",BBUDQLKRZPRPFD-LLVKDONJSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
139788,6w9c,DB13989,-7.2,Epitizide,RINBGYCKMGDWPY-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
31675,6cs2,DB14538,-7.2,Hydrocortisone aceponate,MFBMYAOAMQLLPK-FZNHGJLXSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
90304,6m71,DB01562,-7.2,1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine,BVURVTVDNWSNFN-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
118043,6w4b,DB04293,-7.2,7-(2-Amino-2-Phenyl-Acetylamino)-3-Chloro-8-Oxo-1-Aza-Bicyclo[4.2.0]Oct-2-Ene-2-Carboxylic Acid,JAPHQRWPEGVNBT-IJLUTSLNSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
29238,6cs2,DB08910,-7.2,Pomalidomide,UVSMNLNDYGZFPF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
46113,2fxp,DB00158,-7.2,Folic acid,OVBPIULPVIDEAO-LBPRGKRZSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
111727,6vxx,DB04441,-7.2,2-Fluoroadenosine,HBUBKKRHXORPQB-UUOKFMHZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
164727,7bv1,DB08532,-7.2,"6-(2-fluorophenyl)-N-(pyridin-3-ylmethyl)imidazo[1,2-a]pyrazin-8-amine",WCNPGRRMPFCHEO-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
111731,6vxx,DB04449,-7.2,"5-(3,3-Dihydroxypropeny)-3-Methoxy-Benzene-1,2-Diol",QQVLKPZAOPJJCB-NSCUHMNNSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
153747,6wiq,DB07067,-7.2,"(2S,3S)-3-{3-[4-(METHYLSULFONYL)PHENYL]-1,2,4-OXADIAZOL-5-YL}-1-OXO-1-PYRROLIDIN-1-YLBUTAN-2-AMINE",SQCDMTZMCHZYGO-FZMZJTMJSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
139765,6w9c,DB13946,-7.2,Testosterone undecanoate,UDSFVOAUHKGBEK-CNQKSJKFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
79255,6m2n,DB12977,-7.2,Simenepag isopropyl,MSIIJNOQQWRTFC-GGAORHGYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
164709,7bv1,DB08511,-7.2,"6-amino-2-methyl-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",PLJNUNPYZVVIRA-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
139773,6w9c,DB13955,-7.2,Estradiol dienanthate,OVAHZPTYWMWNKO-CAHAWPIUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
9439,6lzg,DB07539,-7.2,"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZOIC ACID",JLRKRQCTYQGDKJ-GHXNOFRVSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
139756,6w9c,DB13934,-7.2,Ligandrol,OPSIVAKKLQRWKC-VXGBXAGGSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
90608,6m71,DB01964,-7.2,AL5424,ZWTSOJQGEWPWGO-NSHDSACASA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
91405,6m71,DB03013,-7.2,Di(N-Acetyl-D-Glucosamine),CDOJPCSDOXYJJF-KSKNGZLJSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
104715,6vxs,DB12400,-7.2,Voxtalisib,RGHYDLZMTYDBDT-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
166202,7bv1,DB14093,-7.2,"(1,2,6,7-3H)Testosterone",MUMGGOZAMZWBJJ-JQSYSRDDSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
98960,6vxs,DB01619,-7.2,Phenindamine,ISFHAYSTHMVOJR-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
90899,6m71,DB02353,-7.2,Heparin Disaccharide Iii-S,GSYQGRODWXMUOO-GYBHJADLSA-K,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
114512,6vxx,DB13725,-7.2,Terodiline,UISARWKNNNHPGI-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
90897,6m71,DB02350,-7.2,"N-Hydroxy-4-[(4-Methoxylphenyl)Sulfonyl]-2,2-Dimethyl-Hexahydro-1,4-Thiazepine-3(S)-Carboxamide",CYYCSKFJEOSZTF-CYBMUJFWSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
75249,6m2n,DB04457,-7.2,2'-Deoxyguanosine-5'-Monophosphate,LTFMZDNNPPEQNG-KVQBGUIXSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
98581,6vxs,DB01104,-7.2,Sertraline,VGKDLMBJGBXTGI-SJCJKPOMSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
113478,6vxx,DB09234,-7.2,Darodipine,QERUYFVNIOLCHV-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
68057,6lxt,DB07470,-7.2,"(3aS)-3a-hydroxy-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one",DOMYOVZXZIZTRD-QGZVFWFLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
114538,6vxx,DB13762,-7.2,Dexrabeprazole,YREYEVIYCVEVJK-RUZDIDTESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
166171,7bv1,DB13783,-7.2,Acemetacin,FSQKKOOTNAMONP-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
76344,6m2n,DB07096,-7.2,"6-AMINO-BENZO[DE]ISOQUINOLINE-1,3-DIONE",SSMIFVHARFVINF-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
13297,6lzg,DB15099,-7.2,GW-468816,XDKRVNKVAKCFGW-WXWBBQJKSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
144524,6w9q,DB05171,-7.2,E-2012,PUOAETJYKQITMO-LANLRWRYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
90892,6m71,DB02342,-7.2,2-Methox1tradiol,CQOQDQWUFQDJMK-SSTWWWIQSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
129302,6w4h,DB08635,-7.2,N-(TRANS-4'-NITRO-4-STILBENYL)-N-METHYL-5-AMINO-PENTANOIC ACID,QLLZAVDYYAQESE-AATRIKPKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
114555,6vxx,DB13784,-7.2,Dixyrazine,MSYUMPGNGDNTIQ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
129288,6w4h,DB08615,-7.2,"2-[4-(DIMETHYLAMINO)PHENYL]-6-HYDROXY-3-METHYL-1,3-BENZOTHIAZOL-3-IUM",NOVJJPLRUMZSDK-UHFFFAOYSA-O,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
91150,6m71,DB02673,-7.2,"(4ar,6s,8ar)-11-[8-(1,3-Dioxo-1,3-Dihydro-2h-Isoindol-2-Yl)Octyl]-6-Hydroxy-3-Methoxy-5,6,9,10-Tetrahydro-4ah-[1]Benzofuro[3a,3,2-Ef][2]Benzazepin-11-Ium",VLGAHTYYCHWLNI-BHRZLAGCSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
154174,6wiq,DB07563,-7.2,"1-{7-cyclohexyl-6-[4-(4-methylpiperazin-1-yl)benzyl]-7H-pyrrolo[2,3-d]pyrimidin-2-yl}methanamine",GCJSOJRPNOWSEH-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
99021,6vxs,DB01697,-7.2,beta-cellotriose,FYGDTMLNYKFZSV-CSHPIKHBSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
30376,6cs2,DB12405,-7.2,Triciribine,HOGVTUZUJGHKPL-HTVVRFAVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
13232,6lzg,DB14941,-7.2,BMS-817399,GTDPZONCGOCXOD-JPYJTQIMSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
114507,6vxx,DB13720,-7.2,Diphemanil,LCTZPQRFOZKZNK-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76393,6m2n,DB07153,-7.2,"6-methyl-5-[3-methyl-3-(3,4,5-trimethoxyphenyl)but-1-yn-1-yl]pyrimidine-2,4-diamine",FJNFXXGWYVMQNA-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
63351,6lxt,DB00175,-7.2,Pravastatin,TUZYXOIXSAXUGO-PZAWKZKUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
98534,6vxs,DB01053,-7.2,Benzylpenicillin,JGSARLDLIJGVTE-MBNYWOFBSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
113437,6vxx,DB09189,-7.2,Daledalin,YFAIJBZEDDOCAN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
166145,7bv1,DB13750,-7.2,Obidoxime,HIGRLDNHDGYWQJ-UHFFFAOYSA-P,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
142418,6w9q,DB02177,-7.2,1-Acetyl-4-(4-{4-[(2-Ethoxyphenyl)Thio]-3-Nitrophenyl}Pyridin-2-Yl)Piperazine,GKGJFUXSTSUKPB-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
114563,6vxx,DB13794,-7.2,Dimethoxanate,OOVJCSPCMCAXEX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29613,6cs2,DB11207,-7.2,Amiloxate,UBNYRXMKIIGMKK-RMKNXTFCSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
142385,6w9q,DB02128,-7.2,[1-(3-Hydroxy-2-Oxo-1-Phenethyl-Propylcarbamoyl)2-Phenyl-Ethyl]-Carbamic Acid Pyridin-4-Ylmethyl Ester,QCUBCTPTNWPFBC-ZEQRLZLVSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
114497,6vxx,DB13709,-7.2,Ciclonicate,GQSGZTBDVNUIQS-DGCLKSJQSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114488,6vxx,DB13692,-7.2,Tretoquinol,RGVPOXRFEPSFGH-AWEZNQCLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
98670,6vxs,DB01205,-7.2,Flumazenil,OFBIFZUFASYYRE-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
29659,6cs2,DB11367,-7.2,Cefroxadine,RDMOROXKXONCAL-UEKVPHQBSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
114435,6vxx,DB13627,-7.2,Oxolinic acid,KYGZCKSPAKDVKC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
154146,6wiq,DB07531,-7.2,"4-{5-[(Z)-(2,4-DIOXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE",JNPRTUHVCHGFHJ-GHXNOFRVSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
90940,6m71,DB02402,-7.2,"5-(4-Methoxyphenoxy)-2,4-Quinazolinediamine",CPZJZAIZIMCJRC-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
142773,6w9q,DB02636,-7.2,"9-Hydroxy-8-Methoxy-6-Nitro-Phenanthrol[3,4-D][1,3]Dioxole-5-Carboxylic Acid",UCLGCTLOEZZSLA-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
98664,6vxs,DB01198,-7.2,Zopiclone,GBBSUAFBMRNDJC-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
30280,6cs2,DB12283,-7.2,Balapiravir,VKXWOLCNTHXCLF-DXEZIKHYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
113601,6vxx,DB11629,-7.2,Laropiprant,NXFFJDQHYLNEJK-CYBMUJFWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
104544,6vxs,DB12155,-7.2,Napabucasin,DPHUWDIXHNQOSY-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
166273,7bv1,DB14542,-7.2,Hydrocortisone phosphate,BGSOJVFOEQLVMH-VWUMJDOOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
30289,6cs2,DB12293,-7.2,Nefopam,RGPDEAGGEXEMMM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
129524,6w4h,DB08927,-7.2,Amperozide,NNAIYOXJNVGUOM-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
129329,6w4h,DB08665,-7.2,"6,11-DIHYDRO-11-ETHYL-6-METHYL-9-NITRO-5H-PYRIDO[2,3-B][1,5]BENZODIAZEPIN-5-ONE",YCFJZPGDTZVVSM-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
166270,7bv1,DB14539,-7.2,Hydrocortisone acetate,ALEXXDVDDISNDU-JZYPGELDSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
30295,6cs2,DB12300,-7.2,P-nitrobiphenyl,BAJQRLZAPXASRD-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
114446,6vxx,DB13642,-7.2,Pridinol,RQXCLMGKHJWMOA-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76306,6m2n,DB07052,-7.2,5'-S-ethyl-5'-thioadenosine,HMXHURAGFHWODC-WOUKDFQISA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76304,6m2n,DB07050,-7.2,"5-[(phenylsulfonyl)amino]-1,3,4-thiadiazole-2-sulfonamide",PWDGTQXZLNDOKS-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
144462,6w9q,DB04903,-7.2,Pagoclone,HIUPRQPBWVEQJJ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
76300,6m2n,DB07046,-7.2,"2-[(2-chloro-4-iodophenyl)amino]-N-{[(2R)-2,3-dihydroxypropyl]oxy}-3,4-difluorobenzamide",FCADPEDUULETPK-SECBINFHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
113550,6vxx,DB11481,-7.2,Atipamezole,HSWPZIDYAHLZDD-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76287,6m2n,DB07032,-7.2,2-(4-HYDROXY-PHENYL)BENZOFURAN-5-OL,SNNNDCMXZYWCCI-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
63297,6lxt,DB00118,-7.2,Ademetionine,MEFKEPWMEQBLKI-AIRLBKTGSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
114468,6vxx,DB13670,-7.2,Oxantel,VRYKTHBAWRESFI-VOTSOKGWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
98622,6vxs,DB01153,-7.2,Sertaconazole,JLGKQTAYUIMGRK-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
8600,6lzg,DB00596,-7.2,Ulobetasol,LEHFPXVYPMWYQD-XHIJKXOTSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
166263,7bv1,DB14476,-7.2,DL-alpha-Tocopherol,GVJHHUAWPYXKBD-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
154020,6wiq,DB07382,-7.2,"N-2-1H-benzimidazol-5-yl-N-4-(3-cyclopropyl-1H-pyrazol-5-yl)pyrimidine-2,4-diamine",WJNBSTLIALIIEW-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
30299,6cs2,DB12305,-7.2,Dasotraline,SRPXSILJHWNFMK-MEDUHNTESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
144443,6w9q,DB04873,-7.2,Piboserod,KVCSJPATKXABRQ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
144450,6w9q,DB04882,-7.2,Edotecarin,QMVPQBFHUJZJCS-NTKFZFFISA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
62982,6crv,DB14869,-7.2,Remetinostat,XDZAHHULFQIBFE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
144566,6w9q,DB05424,-7.2,Canertinib,OMZCMEYTWSXEPZ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
98524,6vxs,DB01039,-7.2,Fenofibrate,YMTINGFKWWXKFG-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
166055,7bv1,DB13630,-7.2,Bibenzonium,LBRNZQRZDLLIHL-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
113329,6vxx,DB09000,-7.2,Cyamemazine,SLFGIOIONGJGRT-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
98457,6vxs,DB00962,-7.2,Zaleplon,HUNXMJYCHXQEGX-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
98454,6vxs,DB00959,-7.2,Methylprednisolone,VHRSUDSXCMQTMA-PJHHCJLFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
113321,6vxx,DB08992,-7.2,Eperisone,SQUNAWUMZGQQJD-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
166033,7bv1,DB13602,-7.2,Promegestone,QFFCYTLOTYIJMR-XMGTWHOFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
75140,6m2n,DB04297,-7.2,"7-[4-(Dimethylamino)Phenyl]-N-Hydroxy-4,6-Dimethyl-7-Oxo-2,4-Heptadienamide",RTKIYFITIVXBLE-QEQCGCAPSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
166024,7bv1,DB13588,-7.2,Naftidrofuryl,KBAFPSLPKGSANY-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
8004,6lzg,DB04643,-7.2,"4-{3-CHLORO-4-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-PHENOXY}-BUTYRIC ACID",FYQVFMLCZJZZEM-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
142190,6w9q,DB01865,-7.2,3-(6-Aminopyridin-3-Yl)-N-Methyl-N-[(1-Methyl-1h-Indol-2-Yl)Methyl]Acrylamide,AKFPMLBVLWZSQX-CSKARUKUSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
68206,6lxt,DB07647,-7.2,"(2R)-1-[(5,6-DIPHENYL-7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)AMINO]PROPAN-2-OL",VBASHTSSQNDDAS-CQSZACIVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
26643,6cs2,DB04823,-7.2,Oxyphenisatin,SJDACOMXKWHBOW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
142134,6w9q,DB01792,-7.2,Adenylyl-3'-5'-Phospho-Uridine-3'-Monophosphate,FZCSEXOMUJFOHQ-KPKSGTNCSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
98433,6vxs,DB00934,-7.2,Maprotiline,QSLMDECMDJKHMQ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
166005,7bv1,DB13558,-7.2,Morclofone,KVCJCEKJKGLBOK-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
114822,6vxx,DB14930,-7.2,Alovudine F-18,UXCAQJAQSWSNPQ-ZIVQXEJRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
7958,6lzg,DB04590,-7.2,(2R)-({4-[AMINO(IMINO)METHYL]PHENYL}AMINO){5-ETHOXY-2-FLUORO-3-[(3R)-TETRAHYDROFURAN-3-YLOXY]PHENYL}ACETICACID,PGYOHIAQCFZQDK-AUUYWEPGSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
144731,6w9q,DB06237,-7.2,Avanafil,WEAJZXNPAWBCOA-INIZCTEOSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
98409,6vxs,DB00908,-7.2,Quinidine,LOUPRKONTZGTKE-LHHVKLHASA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
113249,6vxx,DB08720,-7.2,"5-(5-(4-(4,5-dihydro-2-oxazoly)phenoxy)pentyl)-3-methyl osoxazole",IWZDYGHUSXWPPM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
129245,6w4h,DB08562,-7.2,4-(4-STYRYL-PHENYLCARBAMOYL)-BUTYRIC ACID,FTXJWRRYLLRFMG-MDZDMXLPSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
58834,6crv,DB06726,-7.2,Bufuralol,SSEBTPPFLLCUMN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
129247,6w4h,DB08568,-7.2,(2S)-1-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}-3-PHENYLPROPAN-2-AMINE,BPNUQXPIQBZCMR-IBGZPJMESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
90844,6m71,DB02277,-7.2,1-(5-Tert-Butyl-2-Methyl-2h-Pyrazol-3-Yl)-3-(4-Chloro-Phenyl)-Urea,FWIJKWMXNHRSRO-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
37109,1r42,DB03830,-7.2,Phosphorylated Dihydropteroate,DNKVHXNVVYQUDC-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
113257,6vxx,DB08728,-7.2,"5-(3-(2,6-dichloro-4-(4,5-dihydro-2-oxazolyl)phenoxy)propyl)-3-methyl isoxazole",TUGBWRGTMLOFAX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
142116,6w9q,DB01767,-7.2,Hemi-Babim,KKJYVDXDZURHMA-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
63432,6lxt,DB00269,-7.2,Chlorotrianisene,BFPSDSIWYFKGBC-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
113262,6vxx,DB08733,-7.2,"(2R,3R)-N^1^-[(1S)-2,2-DIMETHYL-1-(METHYLCARBAMOYL)PROPYL]-N^4^-HYDROXY-2-(2-METHYLPROPYL)-3-{[(1,3-THIAZOL-2-YLCARBONYL)AMINO]METHYL}BUTANEDIAMIDE",GAHIXYNNFMCKFQ-HZSPNIEDSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114834,6vxx,DB14945,-7.2,Florbenazine F-18,GNKGXQHHUUEYQV-WTHAECTESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
99145,6vxs,DB01860,-7.2,Cordycepin Triphosphate,NLIHPCYXRYQPSD-BAJZRUMYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
142113,6w9q,DB01764,-7.2,Dalfopristin,SUYRLXYYZQTJHF-VMBLUXKRSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
68045,6lxt,DB07455,-7.2,"N,N'-[biphenyl-4,4'-diyldi(2R)propane-2,1-diyl]dimethanesulfonamide",ZESUARCHWPARIF-HOTGVXAUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
114700,6vxx,DB14663,-7.2,Ribavirin monophosphate,SDWIOXKHTFOULX-AFCXAGJDSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
90845,6m71,DB02278,-7.2,"7,8-Dihydro-7,7-Dimethyl-6-Hydroxypterin",JMLQSLXEUWNWFI-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
166116,7bv1,DB13711,-7.2,Tritoqualine,IRGJVQIJENCTQF-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
144571,6w9q,DB05450,-7.2,Smilagenin,GMBQZIIUCVWOCD-UQHLGXRBSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
76435,6m2n,DB07200,-7.2,"(2S,4S,5R)-2-ISOBUTYL-5-(2-THIENYL)-1-[4-(TRIFLUOROMETHYL)BENZOYL]PYRROLIDINE-2,4-DICARBOXYLIC ACID",ZNCZVHCYBGHCHA-XPIZARPCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
13303,6lzg,DB01108,-7.2,Trilostane,KVJXBPDAXMEYOA-CXANFOAXSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
166105,7bv1,DB13692,-7.2,Tretoquinol,RGVPOXRFEPSFGH-AWEZNQCLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
29601,6cs2,DB11157,-7.2,Anthralin,NUZWLKWWNNJHPT-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
142353,6w9q,DB02089,-7.2,CP-526423,MWWXABBBAPKJDX-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
142336,6w9q,DB02069,-7.2,N-(2-Flouro-Benzyl)-4-Sulfamoyl-Benzamide,ULYMHSXFSKOHGH-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
76454,6m2n,DB07223,-7.2,"METHYL N-({(2S,3S)-3-[(PROPYLAMINO)CARBONYL]OXIRAN-2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINATE",XGWSRLSPWIEMLQ-YTFOTSKYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
114630,6vxx,DB13918,-7.2,Diclofop-methyl,BACHBFVBHLGWSL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
144576,6w9q,DB05470,-7.2,VX-702,FYSRKRZDBHOFAY-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
90870,6m71,DB02316,-7.2,"1-(5-Carboxypentyl)-5-[(2,6-Dichlorobenzyl)Oxy]-1 H-Indole-2-Carboxylic Acid",JTGPYFFQVOIJKR-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
30400,6cs2,DB00946,-7.2,Phenprocoumon,DQDAYGNAKTZFIW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
8079,6lzg,DB04741,-7.2,Myxothiazol,XKTFQMCPGMTBMD-FYHMSGCOSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
30401,6cs2,DB12430,-7.2,BC-3781,KPVIXBKIJXZQJX-IJUBVZAWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
90866,6m71,DB02310,-7.2,"3,5,6,8-Tetramethyl-N-Methyl Phenanthrolinium",FQTUZNACZKILMC-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
144585,6w9q,DB05514,-7.2,Cobiprostone,SDDSJMXGJNWMJY-BRHAQHMBSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
68041,6lxt,DB07451,-7.2,1-(5-BROMO-PYRIDIN-2-YL)-3-[2-(6-FLUORO-2-HYDROXY-3-PROPIONYL-PHENYL)-CYCLOPROPYL]-UREA,VRAJWAGCJIXJHQ-YPMHNXCESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
98469,6vxs,DB00978,-7.2,Lomefloxacin,ZEKZLJVOYLTDKK-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
8045,6lzg,DB04696,-7.2,"4-CHLORO-3',3''-DIBROMOPHENOL-1,8-NAPHTHALEIN",GFGZCXHXQCQRFP-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
30434,6cs2,DB12475,-7.2,Biphenyl dimethyl dicarboxylate,BKRIRZXWWALTPU-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
90853,6m71,DB02290,-7.2,"3-{2,6,8-trioxo-9-[(2S,3S,4R)-2,3,4,5-tetrahydroxypentyl]-1,2,3,6,8,9-hexahydro-7H-purin-7-Yl}propyl dihydrogen phosphate",KPHFGOGGKPGLTM-OOZYFLPDSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
144613,6w9q,DB05667,-7.2,Levoketoconazole,XMAYWYJOQHXEEK-ZEQKJWHPSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
30437,6cs2,DB12478,-7.2,Piribedil,OQDPVLVUJFGPGQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
166081,7bv1,DB13665,-7.2,Fluanisone,IRYFCWPNDIUQOW-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
166089,7bv1,DB13674,-7.2,Cridanimod,UOMKBIIXHQIERR-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
8057,6lzg,DB04712,-7.2,ANILINOMETHYL GLUCO-PHENYLIMIDAZOLE,ADKWVGPRAQKVKB-YIYPIFLZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
144601,6w9q,DB05590,-7.2,Bedoradrine,OANCEOSLKSTLTA-REWPJTCUSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
142262,6w9q,DB01967,-7.2,"N-{3-[(7ar,12as,12bs)-7-Oxo-1,3,4,6,7,7a,12a,12b-Octahydroindolo[2,3-a]Quinolizin-12(2h)-Yl]Propyl}Propane-2-Sulfonamide",LICJTIDRHJECTD-SFHVURJKSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
29598,6cs2,DB11155,-7.2,Triclocarban,ICUTUKXCWQ1Q-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
76485,6m2n,DB07260,-7.2,N-benzyl-4-[(2R)-pyrrolidin-2-ylmethoxy]aniline,HITMFLNAOQIZSN-QGZVFWFLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
144611,6w9q,DB05653,-7.2,IRX-5183,PNAWUIKCVQSLFG-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
75321,6m2n,DB04546,-7.2,3-Deaza-Adenosine,DBZQFUNLCALWDY-PNHWDRBUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
142835,6w9q,DB02715,-7.2,Compound 18,UZOOIPXOYYJULJ-RHLLTPQKSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
142842,6w9q,DB02723,-7.2,"4-Oxo-2-Phenylmethanesulfonyl-Octahydro-Pyrrolo[1,2-a]Pyrazine-6-Carboxylic Acid [1-(N-Hydroxycarbamimidoyl)-Piperidin-4-Ylmethyl]-Amide",DHTSUHWLPAEEQB-OALUTQOASA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
75733,6m2n,DB05626,-7.2,Retaspimycin,OAKGNIRUXAZDQF-TXHRRWQRSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
143572,6w9q,DB03723,-7.2,2'-Deoxy-Thymidine-Beta-L-Rhamnose,ZOSQFDVXNQFKBY-CGAXJHMRSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
37196,1r42,DB03944,-7.2,"5-[1-(3,4-Dimethoxy-Benzoyl)-1,2,3,4-Tetrahydro-Quinolin-6-Yl]-6-Methyl-3,6-Dihydro-[1,3,4]Thiadiazin-2-One",IZLRMTJLQCLMKF-CYBMUJFWSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
143499,6w9q,DB03626,-7.2,"5-Methoxy-1,2-Dimethyl-3-(Phenoxymethyl)Indole-4,7-Dione",JRPJCFILHCLEJI-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
75743,6m2n,DB05680,-7.2,Sotirimod,ZXBCLVSLRUWISJ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
29977,6cs2,DB11889,-7.2,Lanicemine,FWUQWDCOOWEXRY-ZDUSSCGKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
143926,6w9q,DB04180,-7.2,"4-(Aminosulfonyl)-N-[(2,4-Difluorophenyl)Methyl]-Benzamide",NTDFJEKGSGSXME-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
154093,6wiq,DB07468,-7.2,"(3aS)-3a-hydroxy-5-methyl-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one",NJBBBRZNBVLTRZ-GOSISDBHSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
98841,6vxs,DB01479,-7.2,BA-2664,QGKQXZFZOIQFBI-XSWYFRFISA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
53,6lzg,HMDB0002497,-7.2,Glycochenodeoxycholate-3-sulfate,DKXXSIJHWWVNMO-GYPHWSFCSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
75780,6m2n,DB05939,-7.2,MK-0354,LTQYSJKGRPGMPO-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75785,6m2n,DB05968,-7.2,PR-104,GZSOKPMDWVRVMG-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75788,6m2n,DB05974,-7.2,Transcrocetinate,PANKHBYNKQNAHN-MQQNZMFNSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75500,6m2n,DB04788,-7.2,Tagetitoxin,UVAAUIDYGIWLMB-HGNFPZBQSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75797,6m2n,DB06083,-7.2,Tapinarof,ZISJNXNHJRQYJO-CMDGGOBGSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
113843,6vxx,DB12163,-7.2,Sarpogrelate,FFYNAVGJSYHHFO-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
166471,7bv1,DB15201,-7.2,Norbixin,ZVKOASAVGLETCT-UOGKPENDSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
113815,6vxx,DB12123,-7.2,Cinepazide,RCUDFXMNPQNBDU-VOTSOKGWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
166463,7bv1,DB15187,-7.2,Dubermatinib,YUAALFPUEOYPNX-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
144070,6w9q,DB04378,-7.2,"3-Amino-N-{4-[2-(2,6-Dimethyl-Phenoxy)-Acetylamino]-3-Hydroxy-1-Isobutyl-5-Phenyl-Pentyl}-Benzamide",APJAEXGNDLFGPD-AWCRTANDSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
75838,6m2n,DB06200,-7.2,Tedisamil,CTIRHWCPXYGDGF-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75476,6m2n,DB04756,-7.2,"2-[(3,5-Dichloro-4-trioxidanylphenyl)amino]benzoic acid",SNAMTVTZDPUVRA-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
61,6lzg,HMDB0002586,-7.2,Chenodeoxycholic acid 3-sulfate,WHMOBEGYTDWMIG-BSWAIDMHSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
8388,6lzg,DB05738,-7.2,Vapitadine,VQWGYPVNVICKFC-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
63175,6crv,DB15284,-7.2,Sulopenem,FLSUCZWOEMTFAQ-PRBGKLEPSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30040,6cs2,DB11967,-7.2,Binimetinib,ACWZRVQXLIRSDF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
98856,6vxs,DB01497,-7.2,Etorphine,CAHCBJPUTCKATP-HBDRVVKHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
98854,6vxs,DB01493,-7.2,Ethylestrenol,AOXRBFRFYPMWLR-XGXHKTLJSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
144056,6w9q,DB04357,-7.2,Pteric Acid,JOAQINSXLLMRCV-UHFFFAOYSA-O,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
23853,6cs2,DB01489,-7.2,Camazepam,PXBVEXGRHZFEOF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
143991,6w9q,DB04270,-7.2,(S)-3-(4-(2-Carbazol-9-Yl-Ethoxy)-Phenyl)-2-Ethoxy-Propionic Acid,WUZIMDSVRIBNNI-DEOSSOPVSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
98861,6vxs,DB01502,-7.2,Diampromide,RXTHKWVSXOIHJS-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
29763,6cs2,DB11561,-7.2,Aminacrine,XJGFWWJLMVZSIG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
75530,6m2n,DB04825,-7.2,Prenylamine,IFFPICMESYHZPQ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
114101,6vxx,DB12728,-7.2,Fenpropidin,MGNFYQILYYYUBS-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
154055,6wiq,DB07423,-7.2,(2S)-3-[4-(acetylamino)phenoxy]-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide,YVXVTLGIDOACBJ-SFHVURJKSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
8327,6lzg,DB05431,-7.2,MLN-977,YANONWCPCKIWEC-CABCVRRESA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
143753,6w9q,DB03950,-7.2,(S)-N-(3-Indol-1-Yl-2-Methyl-Propyl)-4-Sulfamoyl-Benzamide,ZFWHOUCRVSOZJE-AWEZNQCLSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
113975,6vxx,DB12353,-7.2,Ulodesine,AFNHHLILYQEHKK-BDAKNGLRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
8326,6lzg,DB05424,-7.2,Canertinib,OMZCMEYTWSXEPZ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
58776,6crv,DB06619,-7.2,Amdoxovir,RLAHNGKRJJEIJL-RFZPGFLSSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114005,6vxx,DB12576,-7.2,AZD-3043,QPUVKSKJCNGSGT-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114006,6vxx,DB12577,-7.2,Fosbretabulin,WDOGQTQEKVLZIJ-WAYWQWQTSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
98793,6vxs,DB01425,-7.2,Alizapride,KSEYRUGYKHXGFW-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
29877,6cs2,DB11757,-7.2,Istradefylline,IQVRBWUUXZMOPW-PKNBQFBNSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
114017,6vxx,DB12596,-7.2,Combretastatin,LGZKGOGODCLQHG-CYBMUJFWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
8350,6lzg,DB05532,-7.2,BMS-488043,DBPMWRYLTBNCCE-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
143776,6w9q,DB03984,-7.2,Morpholine-4-Carboxylic Acid [1-(2-Benzylsulfanyl-1-Formyl-Ethylcarbamoyl)-2-Phenyl-Ethyl]-Amide,MWTQNXVXPLTHJB-YADHBBJMSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
98814,6vxs,DB01450,-7.2,Dihydroetorphine,BRTSNYPDACNMIP-FAWZKKEFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
63106,6crv,DB15144,-7.2,Altropane I-123,GTQLIPQFXVKRKJ-HYRAKNMCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113951,6vxx,DB12313,-7.2,Dopexamine,RYBJORHCUPVNMB-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113949,6vxx,DB12311,-7.2,CP1-1189,DJKNRCWSXSZACF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29814,6cs2,DB00886,-7.2,Omapatrilat,LVRLSYPNFFBYCZ-VGWMRTNUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
143818,6w9q,DB04042,-7.2,"2-[4-(Hydroxy-Methoxy-Methyl)-Benzyl]-7-(4-Hydroxymethyl-Benzyl)-1,1-Dioxo-3,6-Bis-Phenoxymethyl-1lambda6-[1,2,7]Thiadiazepane-4,5-Diol",XLJNZONSWKENRP-VABIIVNOSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
114088,6vxx,DB12710,-7.2,Perazine,WEYVCQFUGFRXOM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113909,6vxx,DB12263,-7.2,Begacestat,PSXOKXJMVRSARX-SCSAIBSYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
26593,6cs2,DB00543,-7.2,Amoxapine,QWGDMFLQWFTERH-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
114072,6vxx,DB12685,-7.2,K-134,ULGNGSQNNMKROG-WOJBJXKFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
143583,6w9q,DB03737,-7.2,"4-((3r,4s,5r)-4-Amino-3,5-Dihydroxy-Hex-1-Ynyl)-5-Fluoro-3-[1-(3-Methoxy-1h-Pyrrol-2-Yl)-Meth-(Z)-Ylidene]-1,3-Dihydro-Indol-2-One",RAKYKJWUUUKCCW-MPLBGYFPSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
23883,6cs2,DB01526,-7.2,4-Androstenediol,BTTWKVFKBPAFDK-LOVVWNRFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
8285,6lzg,DB05197,-7.2,Sofalcone,GFWRVVCDTLRWPK-KPKJPENVSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
29944,6cs2,DB11843,-7.2,PF-04958242,TTYKUKSFWHEBLI-DLBZAZTESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
63132,6crv,DB15201,-7.2,Norbixin,ZVKOASAVGLETCT-UOGKPENDSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29846,6cs2,DB11711,-7.2,Navarixin,IXBYSXNOKFHHDR-QGZVFWFLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
4,6lzg,HMDB0002269,-7.2,Curcumin,VFLDPWHFBUODDF-FCXRPNKRSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
154075,6wiq,DB07447,-7.2,5beta-dihydrotestosterone,NVKAWKQGWWIWPM-MISPCMORSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
23885,6cs2,DB00240,-7.2,Alclometasone,FJXOGVLKCZQRDN-PHCHRAKRSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
143295,6w9q,DB03325,-7.2,Tyrosyladenylate,MJZAZMKENKZBAJ-QTOWJTHWSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
143264,6w9q,DB03285,-7.2,"2',4,4'-Trihydroxychalcone",DXDRHHKMWQZJHT-FPYGCLRLSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
144105,6w9q,DB04430,-7.2,3-(4-Phenylamino-Phenylamino)-2-(1h-Tetrazol-5-Yl)-Acrylonitrile,FLPLCJJGNZGOAW-QXMHVHEDSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
75394,6m2n,DB04640,-7.2,"Naphthalene-2,6-disulfonic acid",FITZJYAVATZPMJ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
129355,6w4h,DB08702,-7.2,"2,5-DIPHENYLFURAN-3,4-DICARBOXYLIC ACID",QPKYPOMZPFDBEZ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
166382,7bv1,DB14772,-7.2,DCFBC F-18,IDTMSHGCAZPVLC-STUNTBJNSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
30169,6cs2,DB00186,-7.2,Lorazepam,DIWRORZWFLOCLC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
8523,6lzg,DB06272,-7.2,Maxacalcitol,DTXXSJZBSTYZKE-ZDQKKZTESA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
30170,6cs2,DB00921,-7.2,Buprenorphine,RMRJXGBAOAMLHD-IHFGGWKQSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
144330,6w9q,DB04725,-7.2,Licofelone,UAWXGRJVZSAUSZ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
154115,6wiq,DB07493,-7.2,"(2Z)-5'-BROMO-2,3'-BIINDOLE-2',3(1H,1'H)-DIONE AMMONIATE",IEQQJQHHJMQETK-YPKPFQOOSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
142921,6w9q,DB02834,-7.2,IDD552,ZCAGEXZTORJQDZ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
26561,6cs2,DB00539,-7.2,Toremifene,XFCLJVABOIYOMF-QPLCGJKRSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
104556,6vxs,DB12179,-7.2,Secoisolariciresinol,PUETUDUXMCLALY-HOTGVXAUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
166366,7bv1,DB14736,-7.2,Cannabivarin,SVTKBAIRFMXQQF-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
76066,6m2n,DB06735,-7.2,Enclomiphene,GKIRPKYJQBWNGO-OCEACIFDSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
98904,6vxs,DB01551,-7.2,Dihydrocodeine,RBOXVHNMENFORY-DNJOTXNNSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
51627,2fxp,DB08406,-7.2,"[N-(2,4-DIAMINOPTERIDIN-6-YL)-METHYL]-DIBENZ[B,F]AZEPINE",NXCCIJQEAKMFGW-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
90962,6m71,DB02427,-7.2,"2,4-Diamino-6-[N-(2',5'-Dimethoxybenzyl)-N-Methylamino]Quinazoline",YBJANOUTWRTBDK-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
8536,6lzg,DB06307,-7.2,Apoptone,CKAXZOYFIHQCBN-JRRMKBMNSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
98672,6vxs,DB01207,-7.2,Ridogrel,GLLPUTYLZIKEGF-HAVVHWLPSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
98920,6vxs,DB01567,-7.2,Fludiazepam,ROYOYTLGDLIGBX-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
23999,6cs2,DB01644,-7.2,"3,6-dihydroxy-xanthene-9-propionic acid",PFQGLFBMMPZYEU-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
76137,6m2n,DB06857,-7.2,N-(4-CARBAMIMIDOYL-3-CHORO-PHENYL)-2-HYDROXY-3-IODO-5-METHYL-BENZAMIDE,QKGFTDAISIBIBV-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
114414,6vxx,DB13410,-7.2,Guanoxabenz,QKIQJNNDIWGVEH-UUILKARUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
144373,6w9q,DB04787,-7.2,Tanaproget,PYVFWTPEBMRKSR-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
144273,6w9q,DB04645,-7.2,"5-{3-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-2-METHYL-PHENOXY}-PENTANOIC ACID",NJJIFGCFUDDBSP-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
23995,6cs2,DB01641,-7.2,"(5z)-2-[(1s,2r)-1-Amino-2-Hydroxypropyl]-5-[(4-Amino-1h-Indol-3-Yl)Methylene]-3-(2-Hydroxyethyl)-3,5-Dihydro-4h-Imidazol-4-One",JUWJATLABHTRDF-JURWUIOISA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
51611,2fxp,DB08387,-7.2,2-{[4-(1-methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline,AZEXWHKOMMASPA-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
154143,6wiq,DB07528,-7.2,3-(2-aminoquinazolin-6-yl)-4-methyl-1-[3-(trifluoromethyl)phenyl]pyridin-2(1H)-one,HXUZQEYFKAZBPX-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
113662,6vxx,DB11726,-7.2,Encenicline,SSRDSYXGYPJKRR-ZDUSSCGKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
63000,6crv,DB14900,-7.2,ISO-1 F-18,QVRVXSZKCXFBTE-KPVNRNJOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
23989,6cs2,DB01634,-7.2,2-Oxy-4-Hydroxy-5-(2-Hydrazinopyridine)Phenylalanine,AZUQIXJQZOMXAS-BDAKNGLRSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
75366,6m2n,DB04603,-7.2,2'-DEOXY-5-FORMYLCYTIDINE-5'-MONOPHOSPHATE,HDFNXAHZEYLDBJ-XLPZGREQSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
166339,7bv1,DB14672,-7.2,Oxazepam acetate,FYRWUTOZBRWYCS-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
29716,6cs2,DB11461,-7.2,Sulfachlorpyridazine,XOXHILFPRYWFOD-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
129495,6w4h,DB08877,-7.2,Ruxolitinib,HFNKQEVNSGCOJV-OAHLLOKOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
26564,6cs2,DB04725,-7.2,Licofelone,UAWXGRJVZSAUSZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
29745,6cs2,DB11520,-7.2,Hygromycin B,GRRNUXAQVGOGFE-HUCHGKBZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
12010,6lzg,DB12743,-7.2,Z-160,VCPMZDWBEWTGNW-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
114253,6vxx,DB13181,-7.2,Methylbenactyzium,HDAMOICMOAXFLJ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
129457,6w4h,DB08811,-7.2,Tofisopam,RUJBDQSFYCKFAA-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
98731,6vxs,DB01319,-7.2,Fosamprenavir,MLBVMOWEQCZNCC-OEMFJLHTSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
154041,6wiq,DB07406,-7.2,"(4R)-N-[4-({[2-(DIMETHYLAMINO)ETHYL]AMINO}CARBONYL)-1,3-THIAZOL-2-YL]-4-METHYL-1-OXO-2,3,4,9-TETRAHYDRO-1H-BETA-CARBOLINE-6-CARBOXAMIDE",QWFFPYQWUWLDBV-NSHDSACASA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
154040,6wiq,DB07405,-7.2,"1-(6-CYANO-3-PYRIDYLCARBONYL)-5',8'-DIFLUOROSPIRO[PIPERIDINE-4,2'(1'H)-QUINAZOLINE]-4'-AMINE",GIZYIOOBBUHOBS-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
129380,6w4h,DB08728,-7.2,"5-(3-(2,6-dichloro-4-(4,5-dihydro-2-oxazolyl)phenoxy)propyl)-3-methyl isoxazole",TUGBWRGTMLOFAX-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
144108,6w9q,DB04434,-7.2,Naphthyridine Inhibitor,YRBHUKMLAGQYHS-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
154094,6wiq,DB07469,-7.2,"(3aS)-3a-hydroxy-7-methyl-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one",KAJFGRLMKVNMLH-GOSISDBHSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
98737,6vxs,DB01327,-7.2,Cefazolin,MLYYVTUWGNIJIB-BXKDBHETSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
8188,6lzg,DB04867,-7.2,Lintitript,ILNRQFBVVQUOLP-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
8191,6lzg,DB04872,-7.2,Osanetant,DZOJBGLFWINFBF-UMSFTDKQSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
129444,6w4h,DB08798,-7.2,Sulfamoxole,CYFLXLSBHQBMFT-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
30082,6cs2,DB12025,-7.2,Triptolide,DFBIRQPKNDILPW-CIVMWXNOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
165994,7bv1,DB13546,-7.2,Nizofenone,WZGBZLHGOVJDET-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
30115,6cs2,DB12071,-7.2,Vabicaserin,NPTIPEQJIDTVKR-STQMWFEESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
28649,6cs2,DB08245,-7.2,1-(2-DEOXY-5-O-PHOSPHONO-BETA-D-ERYTHRO-PENTOFURANOSYL)-5-NITRO-1H-INDOLE,FQCJFJRLZCIFHB-YNEHKIRRSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
144272,6w9q,DB04644,-7.2,"4-{4-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-2,3-DIMETHYL-PHENOXY}-BUTYRIC ACID",FCEMCUPAYRPTLS-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
75999,6m2n,DB06618,-7.2,Cutamesine,UVSWWUWQVAQPJR-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
144271,6w9q,DB04643,-7.2,"4-{3-CHLORO-4-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-PHENOXY}-BUTYRIC ACID",FYQVFMLCZJZZEM-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
75977,6m2n,DB06573,-7.2,Rebimastat,GTXSRFUZSLTDFX-HRCADAONSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
114314,6vxx,DB13279,-7.2,Carbocromen,KLOIYEQEVSIOOO-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
23975,6cs2,DB01620,-7.2,Pheniramine,IJHNSHDBIRRJRN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
30122,6cs2,DB12081,-7.2,Anecortave,BCFCRXOJOFDUMZ-ONKRVSLGSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
58742,6crv,DB06530,-7.2,Resiquimod,BXNMTOQRYBFHNZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
26565,6cs2,DB04726,-7.2,"7,8,10-TRIMETHYLBENZO[G]PTERIDINE-2,4(3H,10H)-DIONE",KPDQZGKJTJRBGU-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
98711,6vxs,DB01260,-7.2,Desonide,WBGKWQHBNHJJPZ-LECWWXJVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
104560,6vxs,DB12184,-7.2,Gepirone,QOIGKGMMAGJZNZ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
83,6lzg,HMDB0002720,-7.2,Gestrinone,BJJXHLWLUDYTGC-ANULTFPQSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
114283,6vxx,DB13234,-7.2,Propanidid,KEJXLQUPYHWCNM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75939,6m2n,DB06465,-7.2,FK-960,XTOKQKWTUYYVAO-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
63223,6crv,DB15381,-7.2,Menaquinone,HYPYXGZDOYTYDR-HAJWAVTHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
129566,6w4h,DB08981,-7.2,Fenbufen,ZPAKPRAICRBAOD-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
114863,6vxx,DB15293,-7.2,Epalrestat,CHNUOJQWGUIOLD-NFZZJPOKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
154236,6wiq,DB07638,-7.2,"(3AS,4R,9BR)-2,2-DIFLUORO-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL",QJSMFUTULGSHNQ-ZOBUZTSGSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
112772,6vxx,DB07825,-7.2,(3S)-1-(4-acetylphenyl)-5-oxopyrrolidine-3-carboxylic acid,SQGYWRZISBCKMW-JTQLQIEISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
52577,2fxp,DB11712,-7.2,Tezacaftor,MJUVRTYWUMPBTR-MRXNPFEDSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
91333,6m71,DB02916,-7.2,"[(2r,3s,4r,5r)-5-(6-Amino-9h-Purin-9-Yl)-3,4-Dihydroxytetrahydro-2-Furanyl]Methyl Sulfamate",GNZLUJQJDPRUTD-KQYNXXCUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
29419,6cs2,DB09172,-7.2,Brifentanil,KKMGCTVJCQYQPV-WBVHZDCISA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
98182,6vxs,DB00641,-7.2,Simvastatin,RYMZZMVNJRMUDD-HGQWONQESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
165629,7bv1,DB12565,-7.2,Abexinostat,MAUCONCHVWBMHK-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
68321,6lxt,DB07785,-7.2,"1-{(1R,2S)-2-HYDROXY-1-[2-(2-NAPHTHYLOXY)ETHYL]PROPYL}-1H-IMIDAZONE-4-CARBOXAMIDE",UYAJDVNLQJVRHD-SCLBCKFNSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
141526,6w9q,DB00997,-7.2,Doxorubicin,AOJJSUZBOXZQNB-TZSSRYMLSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
91371,6m71,DB02963,-7.2,"(5-Chloropyrazolo[1,5-a]Pyrimidin-7-Yl)-(4-Methanesulfonylphenyl)Amine",LVNXHNRYPADEAD-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
141502,6w9q,DB00967,-7.2,Desloratadine,JAUOIFJMECXRGI-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
29411,6cs2,DB09151,-7.2,Flutemetamol (18F),VVECGOCJFKTUAX-HUYCHCPVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
98166,6vxs,DB00622,-7.2,Nicardipine,ZBBHBTPTTSWHBA-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
141495,6w9q,DB00959,-7.2,Methylprednisolone,VHRSUDSXCMQTMA-PJHHCJLFSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
129036,6w4h,DB08312,-7.2,"6-CYCLOHEXYLMETHYLOXY-5-NITROSO-PYRIMIDINE-2,4-DIAMINE",DGWXOLHKVGDQLN-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
74766,6m2n,DB03804,-7.2,5-Bromothienyldeoxyuridine,IGUZFFOBAZCVRK-VAOFZXAKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
129717,6w4h,DB09214,-7.2,Dexketoprofen,DKYWVDODHFEZIM-NSHDSACASA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
74761,6m2n,DB03798,-7.2,2'-Deoxycytidine-5'-Monophosphate,NCMVOABPESMRCP-SHYZEUOFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
29397,6cs2,DB09123,-7.2,Dienogest,AZFLJNIPTRTECV-FUMNGEBKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
30850,6cs2,DB13064,-7.2,Tramazoline,QQJLHRRUATVHED-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
129035,6w4h,DB08310,-7.2,"N-[(2R)-2-{[(2S)-2-(1,3-benzoxazol-2-yl)pyrrolidin-1-yl]carbonyl}hexyl]-N-hydroxyformamide",QDDZLTVSNABZIK-ZBFHGGJFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
74747,6m2n,DB03781,-7.2,"2-[4-(2,4-Dichlorophenoxy)Phenoxy]Propanoic Acid",OOLBCHYXZDXLDS-SECBINFHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77375,6m2n,DB08302,-7.2,3-[5-(2-nitropent-1-en-1-yl)furan-2-yl]benzoic acid,IRHZCQDCMUWUKV-RAXLEYEMSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
112729,6vxx,DB07779,-7.2,N-({(2S)-1-[(3R)-3-AMINO-4-(2-FLUOROPHENYL)BUTANOYL]PYRROLIDIN-2-YL}METHYL)BENZAMIDE,ANQHSFFUNMTTRS-MOPGFXCFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
74791,6m2n,DB03835,-7.2,"N-[(5S,7R,8S,9S,10R)-8,9,10-Trihydroxy-7-(hydroxymethyl)-2,4-dioxo-6-oxa-1,3-diazaspiro[4.5]dec-3-yl]acetamide",MAHIOGAAEAWGLR-UTAYWCBXSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
63673,6lxt,DB00562,-7.2,Benzthiazide,NDTSRXAMMQDVSW-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
8935,6lzg,DB06999,-7.2,"N-{3-[(5-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)carbonyl]-2,4-difluorophenyl}propane-1-sulfonamide",YZDJQTHVDDOVHR-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
154414,6wiq,DB07845,-7.2,"2-fluoro-6-{[2-({2-methoxy-4-[(methylsulfonyl)methyl]phenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide",VGYXXQRDIVRILX-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
141486,6w9q,DB00948,-7.2,Mezlocillin,YPBATNHYBCGSSN-VWPFQQQWSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
8932,6lzg,DB06996,-7.2,D-leucyl-N-(4-carbamimidoylbenzyl)-L-prolinamide,XFNMDMGNNKIXBT-CVEARBPZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
29404,6cs2,DB00178,-7.2,Ramipril,HDACQVRGBOVJII-JBDAPHQKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
77353,6m2n,DB08272,-7.2,(4S)-4-(2-NAPHTHYLMETHYL)-D-GLUTAMIC ACID,YDWIUFASTTZKNI-UONOGXRCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
63672,6lxt,DB00561,-7.2,Doxapram,XFDJYSQDBULQSI-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
58571,6crv,DB06061,-7.2,AZD-8330,RWEVIPRMPFNTLO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
141566,6w9q,DB01041,-7.2,Thalidomide,UEJJHQNACJXSKW-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
154405,6wiq,DB07834,-7.2,"N-(cyclopropylmethyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-4-carboxamide",FOHZGCHKLPIBBX-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
30748,6cs2,DB12925,-7.2,Crolibulin,JXONINOYTKKXQQ-CQSZACIVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
115336,6w4b,DB00737,-7.2,Meclizine,OCJYIGYOJCODJL-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
98214,6vxs,DB00682,-7.2,Warfarin,PJVWKTKQMONHTI-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
30750,6cs2,DB12927,-7.2,Theodrenaline,WMCMJIGLYZDKRN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
99494,6vxs,DB02333,-7.2,Deoxyuridine-5'-Triphosphate,AHCYMLUZIRLXAA-SHYZEUOFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
6380,6lzg,DB02014,-7.2,"5-(2-Fluoro-5-{(1E)-3-[3-hydroxy-2-(methoxycarbonyl)phenoxy]-1-propen-1-yl}phenyl)-1,2-oxazole-3-carboxylic acid",QKHWJUMLYAYZFS-ONEGZZNKSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
77175,6m2n,DB08061,-7.2,4-[3-(4-CHLOROPHENYL)-1H-PYRAZOL-5-YL]PIPERIDINE,GELALLNTKKLQLM-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
112842,6vxx,DB07908,-7.2,7-HYDROXY-4-METHYL-3-(2-HYDROXY-ETHYL)COUMARIN,VCGFYFKJZGIZMX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58605,6crv,DB06185,-7.2,Forodesine,IWKXDMQDITUYRK-KUBHLMPHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
98208,6vxs,DB00675,-7.2,Tamoxifen,NKANXQFJJICGDU-QPLCGJKRSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
26715,6cs2,DB04910,-7.2,Oxibendazole,RAOCRURYZCVHMG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
91312,6m71,DB02890,-7.2,6-Hydroxyuridine-5'-Phosphate,UDOBICLZEKUKCV-YXZULKJRSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
77198,6m2n,DB08089,-7.2,LGD-2226,ULBPQWIGZUGPHU-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
129675,6w4h,DB09170,-7.2,??-Hydroxythiofentanyl,GLAAETOTOUGGSB-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
26719,6cs2,DB04924,-7.2,Itopride,QQQIECGTIMUVDS-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
141645,6w9q,DB01132,-7.2,Pioglitazone,HYAFETHFCAUJAY-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
115383,6w4b,DB00796,-7.2,Candesartan cilexetil,GHOSNRCGJFBJIB-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
153882,6wiq,DB07226,-7.2,"N-[4-(2-CHLOROPHENYL)-1,3-DIOXO-1,2,3,6-TETRAHYDROPYRROLO[3,4-C]CARBAZOL-9-YL]FORMAMIDE",JWZVNUNTFNELHL-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
52569,2fxp,DB11701,-7.2,Amenamevir,MNHNIVNAFBSLLX-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
104474,6vxs,DB12057,-7.2,ORM-12741,OCUKPFWNSAAHRP-QZTJIDSGSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
165649,7bv1,DB12594,-7.2,AZD-9056,HSQAARMBHJCUOK-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
129683,6w4h,DB09179,-7.2,R-30490,GARXJOUQUSNOGK-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
29438,6cs2,DB09190,-7.2,Talopram,LJBBMCNHIUJBDU-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
141569,6w9q,DB01044,-7.2,Gatifloxacin,XUBOMFCQGDBHNK-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
77214,6m2n,DB08106,-7.2,N-[(6-butoxynaphthalen-2-yl)sulfonyl]-D-glutamic acid,UAGYXJBYAFGRFR-QGZVFWFLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
141607,6w9q,DB01089,-7.2,Deserpidine,CVBMAZKKCSYWQR-WCGOZPBSSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
115398,6w4b,DB00813,-7.2,Fentanyl,PJMPHNIQZUBGLI-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
112807,6vxx,DB07865,-7.2,3-(1H-tetrazol-5-ylamino)cyclohex-2-en-1-one,REZXFQGPXQJVJG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
129083,6w4h,DB08369,-7.2,1-(biphenyl-4-ylmethyl)-1H-imidazole,DLYMRVCQTVOYEW-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
153897,6wiq,DB07245,-7.2,6-[2-(3'-METHOXYBIPHENYL-3-YL)ETHYL]PYRIDIN-2-AMINE,AEVBKBAFFJKFJZ-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
90689,6m71,DB02075,-7.2,"(1s)-1(9-Deazahypoxanthin-9yl)1,4-Dideoxy-1,4-Imino-D-Ribitol-5-Phosphate",VJTAXXUIRYOXBT-KUBHLMPHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
68303,6lxt,DB07763,-7.2,"(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE",OZZFJGCAYWBVBI-INIZCTEOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
67950,6lxt,DB07343,-7.2,"4-[4-AMINO-6-(2,6-DICHLORO-PHENOXY)-[1,3,5]TRIAZIN-2-YLAMINO]-BENZONITRILE",NFNNMVVXXITVGD-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
74735,6m2n,DB03767,-7.2,Morpholine-4-Carboxylic Acid [1s-(2-Benzyloxy-1r-Cyano-Ethylcarbamoyl)-3-Methyl-Butyl]Amide,LXEDKIMJQBOMSU-MOPGFXCFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
165573,7bv1,DB12476,-7.2,CPG-52852,YZOQZEXYFLXNKA-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
63716,6lxt,DB00613,-7.2,Amodiaquine,OVCDSSHSILBFBN-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
40637,6lu7,DB12724,-7.2,AZD-7295,MAQDQJWCSSCURR-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
90616,6m71,DB01975,-7.2,AMPCPR,ZPZRETFSCSWNDT-DBXCYWGHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
281,6lzg,HMDB0004068,-7.2,Melanin,XUMBMVFBXHLACL-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
74668,6m2n,DB03682,-7.2,"Dibenzofuran-4,6-Dicarboxylic Acid",HBBGSNOHAGNQRQ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
40636,6lu7,DB12817,-7.2,Zoliflodacin,ZSWMIFNWDQEXDT-ZESJGQACSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
77577,6m2n,DB08544,-7.2,(S)-Fluoxetine,RTHCYVBBDHJXIQ-INIZCTEOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
40635,6lu7,DB12895,-7.2,TD-139,YGIDGBAHDZEYMT-MQFIMZJJSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
30932,6cs2,DB13211,-7.2,Guanoxan,HIUVKVDQFXDZHU-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
40634,6lu7,DB13345,-7.2,Dihydroergocristine,DEQITUUQPICUMR-HJPBWRTMSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
63723,6lxt,DB00623,-7.2,Fluphenazine,PLDUPXSUYLZYBN-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
115676,6w4b,DB01130,-7.2,Prednicarbate,FNPXMHRZILFCKX-KAJVQRHHSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
40633,6lu7,DB13520,-7.2,Metergoline,WZHJKEUHNJHDLS-QTGUNEKASA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
77608,6m2n,DB08581,-7.2,"4-[(4-bromo-2-{[(3R,5S)-3,5-dimethylpiperidin-1-yl]carbonyl}phenyl)amino]-4-oxobutanoic acid",JSVSGWHGYIDZFX-TXEJJXNPSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
165496,7bv1,DB12188,-7.2,Zicronapine,BYPMJBXPNZMNQD-PZJWPPBQSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
74642,6m2n,DB03650,-7.2,(3e)-3-[(4-Hydroxyphenyl)Imino]-1h-Indol-2(3h)-One,ZJASRZFZRYISET-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
30953,6cs2,DB13230,-7.2,Gestonorone,GTFUITFQDGVJSK-XGXHKTLJSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
77663,6m2n,DB08651,-7.2,3'-THIO-THYMIDINE-5'-PHOSPHATE,BORVFKJZAOEGOO-GJMOJQLCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77660,6m2n,DB08647,-7.2,TRAZEOLIDE,YUTXECPABXNXPU-DJJJIMSYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
40626,6lu7,DB15414,-7.2,CM-4307,MLDQJTXFUGDVEO-FIBGUPNXSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40627,6lu7,DB15266,-7.2,TAK-580,VWMJHAFYPMOMGF-ZCFIWIBFSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
141275,6w9q,DB00704,-7.2,Naltrexone,DQCKKXVULJGBQN-XFWGSAIBSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
141283,6w9q,DB00713,-7.2,Oxacillin,UWYHMGVUTGAWSP-JKIFEVAISA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
115658,6w4b,DB01108,-7.2,Trilostane,KVJXBPDAXMEYOA-CXANFOAXSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
40628,6lu7,DB15177,-7.2,VX-659,IGEOJNMYRZUKIK-IBGZPJMESA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
58555,6crv,DB05938,-7.2,Edonerpic,HQNACSFBDBYLJP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
40629,6lu7,DB15039,-7.2,ITI-214,BBIPVJCGIASXJB-PKTZIBPZSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
141297,6w9q,DB00728,-7.2,Rocuronium,YXRDKMPIGHSVRX-OOJCLDBCSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
40630,6lu7,DB12238,-7.2,MK-0777,QKIWQBLNTSQOLY-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40631,6lu7,DB14810,-7.2,AZD-1656,FJEJHJINOKKDCW-INIZCTEOSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
90610,6m71,DB01967,-7.2,"N-{3-[(7ar,12as,12bs)-7-Oxo-1,3,4,6,7,7a,12a,12b-Octahydroindolo[2,3-a]Quinolizin-12(2h)-Yl]Propyl}Propane-2-Sulfonamide",LICJTIDRHJECTD-SFHVURJKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
98095,6vxs,DB00537,-7.2,Ciprofloxacin,MYSWGUAQZAJSOK-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
77561,6m2n,DB08526,-7.2,CARBOBENZYLOXY-(L)-LEUCINYL-(L)LEUCINYL METHOXYMETHYLKETONE,LHCNZPLAATYYPI-SLFFLAALSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
74673,6m2n,DB03691,-7.2,WRR-112,KVZMXOVSHIMGNA-HOTGVXAUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
40638,6lu7,DB12571,-7.2,Rimacalib,MYTIJGWONQOOLC-HNNXBMFYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
51147,2fxp,DB07837,-7.2,"[4-(5-naphthalen-2-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)phenyl]acetic acid",SWXKLXXVFMYMDP-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
77467,6m2n,DB08414,-7.2,"6-CHLORO-2-(1-FURO[2,3-C]PYRIDIN-5-YL-ETHYLSULFANYL)-PYRIMIDIN-4-YLAMINE",ATCRIOJPQXDFNY-ZETCQYMHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
129719,6w4h,DB09216,-7.2,Tolfenamic Acid,YEZNLOUZAIOMLT-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
115571,6w4b,DB01009,-7.2,Ketoprofen,DKYWVDODHFEZIM-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
77459,6m2n,DB08403,-7.2,METHYLAMINO-PHENYLALANYL-LEUCYL-HYDROXAMIC ACID,MOPRTFSMCQNUCT-CABCVRRESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
154416,6wiq,DB07848,-7.2,5-Chloro-N-{(3S)-1-[(2S)-1-(4-morpholinyl)-1-oxo-2-propanyl]-2-oxo-3-pyrrolidinyl}-1H-indole-2-sulfonamide,BHNMMFGOJRIAEZ-LRDDRELGSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
77480,6m2n,DB08432,-7.2,THYMIDINE-5'-THIOPHOSPHATE,OJRKJKYGUAALCJ-XLPZGREQSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
165562,7bv1,DB12463,-7.2,Semagacestat,PKXWXXPNHIWQHW-RCBQFDQVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
77434,6m2n,DB08372,-7.2,1-[2-(4-ETHOXY-3-FLUOROPYRIDIN-2-YL)ETHYL]-3-(5-METHYLPYRIDIN-2-YL)THIOUREA,QOVMZMFNTIUFLU-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77433,6m2n,DB08371,-7.2,PARA-(BENZOYL)-PHENYLALANINE,TVIDEEHSOPHZBR-AWEZNQCLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
74730,6m2n,DB03761,-7.2,5-Fluoro-2'-Deoxyuridine-5'-Monophosphate,HFEKDTCAMMOLQP-RRKCRQDMSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
40658,6lu7,DB06995,-7.2,N-({4-[(2-aminopyridin-4-yl)oxy]-3-fluorophenyl}carbamoyl)-2-(4-fluorophenyl)acetamide,USBSTVPJNQLYEM-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
8944,6lzg,DB07007,-7.2,"(3R)-3-[(1,2,3,4-tetrahydroisoquinolin-7-yloxy)methyl]-2,3-dihydrothieno[2,3-f][1,4]oxazepin-5-amine",UDFXWCLBONUMNA-CYBMUJFWSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
141421,6w9q,DB00875,-7.2,Flupentixol,NJMYODHXAKYRHW-DVZOWYKESA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
99667,6vxs,DB02546,-7.2,Vorinostat,WAEXFXRVDQXREF-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
112856,6vxx,DB07926,-7.2,N-[3-(N'-HYDROXYCARBOXAMIDO)-2-(2-METHYLPROPYL)-PROPANOYL]-O-TYROSINE-N-METHYLAMIDE,QYZPDCGWIJYZMN-ZBFHGGJFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
74701,6m2n,DB03726,-7.2,Purine Riboside-5'-Monophosphate,MCWDCZIDTUQRHK-FDDDBJFASA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
98138,6vxs,DB00588,-7.2,Fluticasone propionate,WMWTYOKRWGGJOA-CENSZEJFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
40639,6lu7,DB15036,-7.2,Sitravatinib,WLAVZAAODLTUSW-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
62570,6crv,DB13755,-7.2,Iocarmic acid,SMQYOVYWPWASGU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
141365,6w9q,DB00813,-7.2,Fentanyl,PJMPHNIQZUBGLI-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
141368,6w9q,DB00817,-7.2,Rosoxacin,XBPZXDSZHPDXQU-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
52671,2fxp,DB11851,-7.2,Bafetinib,ZGBAJMQHJDFTQJ-DEOSSOPVSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
141372,6w9q,DB00821,-7.2,Carprofen,PUXBGTOOZJQSKH-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
98139,6vxs,DB00589,-7.2,Lisuride,BKRGVLQUQGGVSM-KBXCAEBGSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
13129,6lzg,DB01091,-7.2,Butenafine,ABJKWBDEJIDSJZ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
99684,6vxs,DB02569,-7.2,"2',3'-Dehydro-2',3'-Deoxy-Thymidine 5'-Diphosphate",LXCAIISEDMYORY-JGVFFNPUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
30897,6cs2,DB13125,-7.2,Lusutrombopag,NOZIJMHMKORZBA-KJCUYJGMSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
8954,6lzg,DB07019,-7.2,"N-[(5R,14R)-5-AMINO-5,14-DIMETHYL-4-OXO-3-OXA-18-AZATRICYCLO[15.3.1.1-7,11-]DOCOSA-1(21),7(22),8,10,17,19-HEXAEN-19-YL]-N-METHYLMETHANESULFONAMIDE",QWDOKZPZLWNULU-MZNJEOGPSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
58910,6crv,DB06851,-7.2,N-(pyridin-3-ylmethyl)aniline,BJXLHKJBRORJJJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165551,7bv1,DB12443,-7.2,Sonedenoson,WUCQGGOGHZRELS-LSCFUAHRSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
26497,6cs2,DB04642,-7.2,"7-{2,6-DICHLORO-4-[3-(2-CHLORO-BENZOYL)-UREIDO]-PHENOXY}-HEPTANOIC ACID",XQTOWNDCHQJXOQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
112668,6vxx,DB07524,-7.2,"N-phenyl-1H-pyrrolo[2,3-b]pyridin-3-amine",CQFGXDQUQWRXLE-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
139437,6w9c,DB13465,-7.2,Ciclobendazole,OXLKOMYHDYVIDM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
141674,6w9q,DB01166,-7.2,Cilostazol,RRGUKTPIGVIEKM-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
30741,6cs2,DB12912,-7.2,Nolatrexed,XHWRWCSCBDLOLM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
37240,1r42,DB04005,-7.2,Uridine 5'-triphosphate,PGAVKCOVUIYSFO-XVFCMESISA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
29531,6cs2,DB09306,-7.2,Metralindole,GVXBHSBKKJRBMS-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
75021,6m2n,DB04143,-7.2,Indole-3-Glycerol Phosphate,NQEQTYPJSIEPHW-MNOVXSKESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
98321,6vxs,DB00810,-7.2,Biperiden,YSXKPIUOCJLQIE-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
52352,2fxp,DB11145,-7.2,Oxyquinoline,MCJGNVYPOGVAJF-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
98298,6vxs,DB00782,-7.2,Propantheline,VVWYOYDLCMFIEM-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
12030,6lzg,DB12774,-7.2,AZD-8055,KVLFRAWTRWDEDF-IRXDYDNUSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
115025,6w4b,DB00358,-7.2,Mefloquine,XEEQGYMUWCZPDN-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
113098,6vxx,DB08371,-7.2,PARA-(BENZOYL)-PHENYLALANINE,TVIDEEHSOPHZBR-AWEZNQCLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
98288,6vxs,DB00769,-7.2,Hydrocortamate,FWFVLWGEFDIZMJ-FOMYWIRZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
76797,6m2n,DB07625,-7.2,"4-(2-aminoethoxy)-N-(2,5-diethoxyphenyl)-3,5-dimethylbenzamide",PHTPPZCTHZHCQD-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
115033,6w4b,DB00370,-7.2,Mirtazapine,RONZAEMNMFQXRA-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
8783,6lzg,DB06831,-7.2,2-((9H-PURIN-6-YLTHIO)METHYL)-5-CHLORO-3-(2-METHOXYPHENYL)QUINAZOLIN-4(3H)-ONE,UMMYTDJYDSTEMB-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
24136,6cs2,DB01812,-7.2,Adenosine-3'-5'-Diphosphate,WHTCPDAXWFLDIH-KQYNXXCUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
165866,7bv1,DB13129,-7.2,Trimegestone,JUNDJWOLDSCTFK-MTZCLOFQSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
115055,6w4b,DB00396,-7.2,Progesterone,RJKFOVLPORLFTN-LEKSSAKUSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
30600,6cs2,DB12712,-7.2,Pilsicainide,BCQTVJKBTWGHCX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
145030,6w9q,DB06879,-7.2,"5-(4'-AMINO-1'-ETHYL-5',8'-DIFLUORO-1'H-SPIRO[PIPERIDINE-4,2'-QUINAZOLINE]-1-YLCARBONYL)PICOLINONITRILE",QCFIRACCCDFXIP-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
145022,6w9q,DB06870,-7.2,"17-HYDROXY-18A-HOMO-19-NOR-17ALPHA-PREGNA-4,9,11-TRIEN-3-ONE",OXHNQTSIKGHVBH-ANULTFPQSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
165823,7bv1,DB13065,-7.2,LY-2811376,MJQMRGWYPNIERM-HNNXBMFYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
115087,6w4b,DB00436,-7.2,Bendroflumethiazide,HDWIHXWEUNVBIY-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
115083,6w4b,DB00430,-7.2,Cefpiramide,PWAUCHMQEXVFJR-PMAPCBKXSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
141858,6w9q,DB01453,-7.2,Beta-hydroxyfentanyl,JEFVHLMGRUJLET-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
144873,6w9q,DB06618,-7.2,Cutamesine,UVSWWUWQVAQPJR-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
30620,6cs2,DB12739,-7.2,Bindarit,MTHORRSSURHQPZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
30614,6cs2,DB12728,-7.2,Fenpropidin,MGNFYQILYYYUBS-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
99325,6vxs,DB02104,-7.2,"2,4-Diamino-5-Methyl-6-[(3,4,5-Trimethoxy-N-Methylanilino)Methyl]Pyrido[2,3-D]Pyrimidine",PEGMMEYCSOZKIT-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
63553,6lxt,DB00415,-7.2,Ampicillin,AVKUERGKIZMTKX-NJBDSQKTSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
76846,6m2n,DB07684,-7.2,5-(DIMETHYLAMINO)-2-NAPHTHALENESULFONIC ACID,VENHBDIMAAXWKI-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
62772,6crv,DB14120,-7.2,Phenylethyl resorcinol,PQSXNIMHIHYFEE-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
26675,6cs2,DB04857,-7.2,Brasofensine,NRLIFEGHTNUYFL-QJDHNRDASA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
145014,6w9q,DB06860,-7.2,"2-(2-chloropyridin-4-yl)-4-methyl-1H-isoindole-1,3(2H)-dione",YDJMWNHJNJVVMM-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
99353,6vxs,DB02140,-7.2,N1-(1-Dimethylcarbamoyl-2-Phenyl-Ethyl)-2-Oxo-N4-(2-Pyridin-2-Yl-Ethyl)-Succinamide,ZPFPZRVOBBMZMP-SFHVURJKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
75026,6m2n,DB04150,-7.2,Threonine Derivative,TWMKRGDZEJLDDH-LKXWSVAYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
13187,6lzg,DB14862,-7.2,PF-06815345,QTBYVAZRKWOIDU-FUHWJXTLSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
76653,6m2n,DB07452,-7.2,"2,6-diamino-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",WFECBOHPSURSGU-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
63455,6lxt,DB00295,-7.2,Morphine,BQJCRHHNABKAKU-KBQPJGBKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
113210,6vxx,DB08673,-7.2,"4-[(5-ISOPROPYL-1,3-THIAZOL-2-YL)AMINO]BENZENESULFONAMIDE",LPQUJAANWFHCJV-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113207,6vxx,DB08669,-7.2,"METHYL N-[(2S,3R)-3-AMINO-2-HYDROXY-3-(4-METHYLPHENYL)PROPANOYL]-D-ALANYL-D-LEUCINATE",BMHZOSJVDHAFEE-SVGFKBNWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
98390,6vxs,DB00886,-7.2,Omapatrilat,LVRLSYPNFFBYCZ-VGWMRTNUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
114895,6vxx,DB15353,-7.2,Nacubactam,RSBPYSTVZQAADE-RQJHMYQMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165950,7bv1,DB13283,-7.2,Sulfaisodimidine,YZMCKZRAOLZXAZ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
91178,6m71,DB02709,-7.2,Resveratrol,LUKBXSAWLPMMSZ-OWOJBTEDSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
165945,7bv1,DB13276,-7.2,Idanpramine,HVYGXNYMNHSBGD-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
104640,6vxs,DB12293,-7.2,Nefopam,RGPDEAGGEXEMMM-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
76676,6m2n,DB07480,-7.2,4-PHOSPHONOOXY-PHENYL-METHYL-[4-PHOSPHONOOXY]BENZEN,LGSCVLKUKMBYNC-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
114921,6vxx,DB15411,-7.2,ABP-700,DRAFVCKNYNQOKR-GFCCVEGCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
99214,6vxs,DB01958,-7.2,"5-[4-Tert-Butylphenylsulfanyl]-2,4-Quinazolinediamine",MNYDVPDMLAJJPB-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
63473,6lxt,DB00317,-7.2,Gefitinib,XGALLCVXEZPNRQ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
141958,6w9q,DB01564,-7.2,Calusterone,IVFYLRMMHVYGJH-PVPPCFLZSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
99219,6vxs,DB01964,-7.2,AL5424,ZWTSOJQGEWPWGO-NSHDSACASA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
165934,7bv1,DB13258,-7.2,Etofamide,QTRALMGDQMIVFF-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
165895,7bv1,DB13208,-7.2,Prednylidene,WSVOMANDJDYYEY-CWNVBEKCSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
154255,6wiq,DB07663,-7.2,"2-[(1R)-1-CARBOXY-2-(4-HYDROXYPHENYL)ETHYL]-1,3-DIOXOISOINDOLINE-5-CARBOXYLIC ACID",QISJEFYTLZTWIQ-CQSZACIVSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
75037,6m2n,DB04163,-7.2,"5-Phenylsulfanyl-2,4-Quinazolinediamine",BUFDQCGCADQQQY-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
114985,6w4b,DB00310,-7.2,Chlorthalidone,JIVPVXMEBJLZRO-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
165911,7bv1,DB13227,-7.2,Tribenoside,ULLNJSBQMBKOJH-VIVFLBMVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
114980,6w4b,DB00304,-7.2,Desogestrel,RPLCPCMSCLEKRS-BPIQYHPVSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
30565,6cs2,DB12664,-7.2,Indantadol,MNLULKBKWKTZPE-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
113152,6vxx,DB08600,-7.2,"5-CHLORO-8-METHYL-7-(3-METHYL-BUT-2-ENYL)-6,7,8,9-TETRAHYDRO-2H-2,7,9A-TRIAZA-BENZO[CD]AZULENE-1-THIONE",ZNFFMCYSMBXZQU-NSHDSACASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165925,7bv1,DB13246,-7.2,Quinupramine,JCBQCKFFSPGEDY-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
165931,7bv1,DB13254,-7.2,Prifinium,ZYEPZINLLPPBMI-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
24129,6cs2,DB00266,-7.2,Dicoumarol,DOBMPNYZJYQDGZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
165933,7bv1,DB13256,-7.2,Clothiapine,KAAZGXDPUNNEFN-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
144837,6w9q,DB06525,-7.2,Ganstigmine,ZOBDWFRKFSPCRB-UNMCSNQZSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
144833,6w9q,DB06518,-7.2,R-1487,KKKRKRMVJRHDMG-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
153946,6wiq,DB07297,-7.2,"5,6-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-D]PYRIMIDIN-4-AMINE",PTILEOLOGGMFCS-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
13170,6lzg,DB14835,-7.2,SUVN-G3031,LNXDUSQEXVQFGP-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
63580,6lxt,DB00447,-7.2,Loracarbef,JAPHQRWPEGVNBT-UTUOFQBUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
52405,2fxp,DB11363,-7.2,Alectinib,KDGFLJKFZUIJMX-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
58624,6crv,DB06217,-7.2,Vernakalant,VBHQKCBVWWUUKN-KZNAEPCWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29468,6cs2,DB00850,-7.2,Perphenazine,RGCVKNLCSQQDEP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
165727,7bv1,DB12717,-7.2,Mibampator,ULRDYYKSPCRXAJ-KRWDZBQOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
141753,6w9q,DB01261,-7.2,Sitagliptin,MFFMDFFZMYYVKS-SECBINFHSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
74894,6m2n,DB03973,-7.2,"3-{2,6,8-trioxo-9-[(2R,3R,4R)-2,3,4,5-tetrahydroxypentyl]-1,2,3,6,8,9-hexahydro-7H-purin-7-Yl}propyl dihydrogen phosphate",KPHFGOGGKPGLTM-ZXFLCMHBSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
37259,1r42,DB04030,-7.2,"1,3,4,9-Tetrahydro-2-(Hydroxybenzoyl)-9-[(4-Hydroxyphenyl)Methyl]-6-Methoxy-2h-Pyrido[3,4-B]Indole",ADXYEWMDAGIULV-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
112938,6vxx,DB08168,-7.2,7-AMINO-4-METHYL-CHROMEN-2-ONE,GLNDAGDHSLMOKX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77059,6m2n,DB07931,-7.2,Hexestrol,PBBGSZCBWVPOOL-HDICACEKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
13351,6lzg,DB15201,-7.2,Norbixin,ZVKOASAVGLETCT-UOGKPENDSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
112928,6vxx,DB08158,-7.2,"2,4-DINITROPHENYL 2-DEOXY-2-FLUORO-BETA-D-MANNOPYRANOSIDE",UFSBFVZQJZMIOU-IYKVGLELSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165723,7bv1,DB12713,-7.2,Sotagliflozin,QKDRXGFQVGOQKS-CRSSMBPESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
8840,6lzg,DB06898,-7.2,"4-(2-amino-1-methyl-1H-imidazo[4,5-b]pyridin-6-yl)phenol",UGJXOCBVCWTJFP-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
115241,6w4b,DB00623,-7.2,Fluphenazine,PLDUPXSUYLZYBN-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
74884,6m2n,DB03956,-7.2,"Inositol 2,4,5-trisphosphate",MMWCIQZXVOZEGG-LKPKBOIGSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77082,6m2n,DB07958,-7.2,(2-CARBAMOYLMETHYL-5-PROPYL-OCTAHYDRO-INDOL-7-YL)ACETIC ACID,OMLOGGCSARAIGZ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
99465,6vxs,DB02292,-7.2,Irosustat,DSLPMJSGSBLWRE-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
77087,6m2n,DB07964,-7.2,"(3S)-4-{[4-(BUT-2-YNYLOXY)PHENYL]SULFONYL}-N-HYDROXY-2,2-DIMETHYLTHIOMORPHOLINE-3-CARBOXAMIDE",CVZIHNYAZLXRRS-HNNXBMFYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
165689,7bv1,DB12662,-7.2,Naveglitazar,OKJHGOPITGTTIM-DEOSSOPVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
129103,6w4h,DB08394,-7.2,PARA-NITROPHENYLPHOSPHONOBUTANOYL-GLYCINE,WLNKGRQBMNPVSJ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
98219,6vxs,DB00688,-7.2,Mycophenolate mofetil,RTGDFNSFWBGLEC-SYZQJQIISA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
129109,6w4h,DB08401,-7.2,(2E)-2-({(2S)-2-CARBOXY-2-[(PHENOXYACETYL)AMINO]ETHOXY}IMINO)PENTANEDIOIC ACID,LDNKNKRRFZRLIG-HWQJWEFDSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
141721,6w9q,DB01216,-7.2,Finasteride,DBEPLOCGEIEOCV-WSBQPABSSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
153905,6wiq,DB07253,-7.2,"N'-(5-chloro-1,3-benzodioxol-4-yl)-N-(3-methylsulfonylphenyl)pyrimidine-2,4-diamine",QTFCKBFCXDAZIU-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
99436,6vxs,DB02255,-7.2,GM6001,NITYDPDXAAFEIT-DYVFJYSZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
112883,6vxx,DB08110,-7.2,"(1R,4S,7AS)-1-(1-FORMYLPROP-1-EN-1-YL)-4-METHOXY-2,4,5,6,7,7A-HEXAHYDRO-1H-ISOINDOLE-3-CARBOXYLIC ACID",ZYKSDPVHVMSKIL-IIHMJNQGSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165708,7bv1,DB12689,-7.2,Azeliragon,KJNNWYBAOPXVJY-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
112888,6vxx,DB08115,-7.2,2-aminoethyl naphthalen-1-ylacetate,PDCSQCHNOPNJMK-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
112891,6vxx,DB08119,-7.2,"1,1,1-TRIFLUORO-3-((N-ACETYL)-L-LEUCYLAMIDO)-4-PHENYL-BUTAN-2-ONE(N-ACETYL-L-LEUCYL-L-PHENYLALANYL TRIFLUOROMETHYL KETONE)",MZNXJCZDQRNGRC-GJZGRUSLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
141724,6w9q,DB01219,-7.2,Dantrolene,OZOMQRBLCMDCEG-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
68284,6lxt,DB07742,-7.2,"N-(2,3-DIFLUORO-BENZYL)-4-SULFAMOYL-BENZAMIDE",QASSMVGOSBNFQY-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
52488,2fxp,DB11526,-7.2,Masitinib,WJEOLQLKVOPQFV-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
68287,6lxt,DB07746,-7.2,3-ETHYL-6-{[(4-FLUOROPHENYL)SULFONYL]AMINO}-2-METHYLBENZOIC ACID,MGUQWAOYPINSIT-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
165736,7bv1,DB12731,-7.2,Daporinad,KPBNHDGDUADAGP-VAWYXSNFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
58625,6crv,DB06218,-7.2,Lacosamide,VPPJLAIAVCUEMN-GFCCVEGCSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
91275,6m71,DB02842,-7.2,9-amino-n-[3-(dimethylamino)propyl]acridine-4-carboxamide,VNWAULKXOPRJEL-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
165781,7bv1,DB13004,-7.2,Mavoglurant,ZFPZEYHRWGMJCV-ZHALLVOQSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
115166,6w4b,DB00533,-7.2,Rofecoxib,RZJQGNCSTQAWON-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
113004,6vxx,DB08254,-7.2,2-NAPHTHALENESULFONIC ACID,KVBGVZZKJNLNJU-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113005,6vxx,DB08255,-7.2,"(3AR,5R,6S,7R,7AR)-5-(HYDROXYMETHYL)-2-PROPYL-5,6,7,7A-TETRAHYDRO-3AH-PYRANO[3,2-D][1,3]THIAZOLE-6,7-DIOL",QWOPEBCGKASVQP-QXOHVQIXSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62742,6crv,DB14060,-7.2,NS-398,KTDZCOWXCWUPEO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
129164,6w4h,DB08469,-7.2,"tert-butyl 4-(3-thiophen-2-yl-1,2,4-oxadiazol-5-yl)piperidine-1-carboxylate",METBQPRXNZHZMB-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
28584,6cs2,DB08170,-7.2,"(1R)-N,6-DIHYDROXY-7-METHOXY-2-[(4-METHOXYPHENYL)SULFONYL]-1,2,3,4-TETRAHYDROISOQUINOLINE-1-CARBOXAMIDE",AYFCYVLVRYQGME-QGZVFWFLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
68014,6lxt,DB07420,-7.2,(1R)-4-(3-phenoxyphenyl)-1-phosphonobutane-1-sulfonic acid,RCGCZPXSRLLKCK-MRXNPFEDSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
51282,2fxp,DB07994,-7.2,"N-3-[5-(1H-INDOL-6-YL)-2-(PYRIDIN-2-YLMETHOXY)BENZYL]PYRIDINE-2,3-DIAMINE",KMBPJSHPAXOXBT-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
76904,6m2n,DB07753,-7.2,"3',5'-DIFLUOROBIPHENYL-4-CARBOXYLIC ACID",VCEFNMHMLWBFNV-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
165815,7bv1,DB13056,-7.2,Irsogladine,ATCGGEJZONJOCL-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
37081,1r42,DB03797,-7.2,3-Aminomethyl-Pyridinium-Adenine-Dinucleotide,HMCRLFVYYFBZEZ-PLEFRAQWSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
115127,6w4b,DB00482,-7.2,Celecoxib,RZEKVGVHFLEQIL-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
113034,6vxx,DB08295,-7.2,4-HYDROXY-3-NITROPHENYLACETYL-EPSILON-AMINOCAPROIC ACID ANION,XAYGJFACOIKJCT-UHFFFAOYSA-M,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
74963,6m2n,DB04069,-7.2,"5,6-Dihydro-Benzo[H]Cinnolin-3-Ylamine",QKVREUJWFZJEJK-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
141690,6w9q,DB01183,-7.2,Naloxone,UZHSEJADLWPNLE-GRGSLBFTSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
6249,6lzg,DB01793,-7.2,SB-409513,ONVZFCHLOZUXRP-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
99390,6vxs,DB02195,-7.2,"3-(4-Fluorophenyl)-1-Hydroxy-2-(Pyridin-4-Yl)-1h-Pyrrolo[3,2-B]Pyridine",ZSMYZLKEZDYVPI-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
153908,6wiq,DB07256,-7.2,"3-({4-[(5-CHLORO-1,3-BENZODIOXOL-4-YL)AMINO]PYRIMIDIN-2-YL}AMINO)BENZAMIDE",ZVQZIVCQLFGXFZ-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
141758,6w9q,DB01268,-7.2,Sunitinib,WINHZLLDWRZWRT-ATVHPVEESA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
68271,6lxt,DB07726,-7.2,"2-tert-butylbenzene-1,4-diol",BGNXCDMCOKJUMV-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
77016,6m2n,DB07876,-7.2,(S)-2-METHYL-1-[(4-METHYL-5-ISOQUINOLINE)SULFONYL]-HOMOPIPERAZINE,AWDORCFLUJZUQS-ZDUSSCGKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
26692,6cs2,DB04876,-7.2,Vildagliptin,SYOKIDBDQMKNDQ-XWTIBIIYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
68012,6lxt,DB07418,-7.2,bis(4-nitrophenyl) hydrogen phosphate,MHSVUSZEHNVFKW-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
6248,6lzg,DB01792,-7.2,Adenylyl-3'-5'-Phospho-Uridine-3'-Monophosphate,FZCSEXOMUJFOHQ-KPKSGTNCSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
141786,6w9q,DB01338,-7.2,Pipecuronium,OWWLUIWOFHMHOQ-XGHATYIMSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
68265,6lxt,DB07719,-7.2,"[(3R)-3-(Methylcarbamoyl)-2-{[(2-methyl-2-propanyl)oxy]carbonyl}-1,2,3,4-tetrahydro-7-isoquinolinyl]sulfamic acid",PPSSYXOFPICMQD-CYBMUJFWSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
14783,6lzg,T3D4743,-7.2,Ethinyl Estradiol,BFPYWIDHMRZLRN-SLHNCBLASA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
115177,6w4b,DB00547,-7.2,Desoximetasone,VWVSBHGCDBMOOT-IIEHVVJPSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
141790,6w9q,DB01347,-7.2,Saprisartan,DUEWVPTZCSAMNB-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
141798,6w9q,DB01357,-7.2,Mestranol,IMSSROKUHAOUJS-MJCUULBUSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
112992,6vxx,DB08238,-7.2,5-AMINO-NAPHTALENE-2-MONOSULFONATE,UWPJYQYRSWYIGZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
154310,6wiq,DB07728,-7.2,"2-[2-(2-FLUOROPHENYL)PYRIDIN-4-YL]-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE",XJJYJNMNYDNXNO-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
29083,6cs2,DB00812,-7.2,Phenylbutazone,VYMDGNCVAMGZFE-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
126943,6w4h,DB04509,-7.2,N-Methylnaloxonium,PCSQOABIHJXZMR-YNUHATHGSA-O,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
153678,6wiq,DB06992,-7.2,"(3,3-dimethylpiperidin-1-yl)(6-(3-fluoro-4-methylphenyl)pyridin-2-yl)methanone",SIDDLTBLAQYZIZ-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
72575,6m2n,DB00907,-7.2,Cocaine,ZPUCINDJVBIVPJ-LJISPDSOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
65172,6lxt,DB02484,-7.2,Cytidine 5'-Diphosphoglycerol,HHPOUCCVONEPRK-CNYIRLTGSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
120059,6w4b,DB08034,-7.2,"(E)-3,4-DIHYDROXY-N'-[(2-METHOXYNAPHTHALEN-1-YL)METHYLENE]BENZOHYDRAZIDE",TVOPERZEGKBKAY-RGVLZGJSSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
72573,6m2n,DB00905,-7.2,Bimatoprost,AQOKCDNYWBIDND-FTOWTWDKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
7701,6lzg,DB04238,-7.2,N-Alpha-(2-Naphthylsulfonyl)-N-(3-Amidino-L-Phenylalaninyl)-D-Pipecolinic Acid,GNANSBQAIRJZPA-XZOQPEGZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
72570,6m2n,DB00902,-7.2,Methdilazine,HTMIBDQKFHUPSX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
65173,6lxt,DB02485,-7.2,Cytidine-5'-Monophosphate-5-N-Acetylneuraminic Acid,TXCIAUNLDRJGJZ-BILDWYJOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
72567,6m2n,DB00899,-7.2,Remifentanil,ZTVQQQVZCWLTDF-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
162190,7bv1,DB01544,-7.2,Flunitrazepam,PPTYJKAXVCCBDU-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
162189,7bv1,DB01543,-7.2,18-methyl-19-nortestosterone,FBYZQDCRLYHHHP-ZOFHRBRSSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
162184,7bv1,DB01538,-7.2,Acetyldihydrocodeine,LGGDXXJAGWBUSL-BKRJIHRRSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
24966,6cs2,DB02802,-7.2,5-Aminocarbonyl-3-Nitrophenyl-Alpha-D-Galactopyranose,BYSXBFJVGIOFBO-LNSPPBFMSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
146301,6w9q,DB08365,-7.2,"8-bromo-4-(2-chlorophenyl)-N-(2-hydroxyethyl)-6-methyl-1,3-dioxo-1,2,3,6-tetrahydropyrrolo[3,4-e]indole-7-carboxamide",XUAHLMVOYLUYSB-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
82773,6m3m,DB02981,-7.2,Vitamin B6 Complexed with 2-Amino-Hexanoic Acid,NHVFCSUYJRWFNW-LBPRGKRZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
49737,2fxp,DB04875,-7.2,Pralnacasan,CXAGHAZMQSCAKJ-WAHHBDPQSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
109208,6vxx,DB12532,-7.2,Oxetacaine,FTLDJPRFCGDUFH-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
95741,6m71,DB11875,-7.2,"3,3'-diindolylmethane",VFTRKSBEFQDZKX-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
120077,6w4b,DB08056,-7.2,"N-(2,6-dimethylphenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine",KKYYLKPGILUPOA-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
18251,6cs2,HMDB0015144,-7.2,Ketoprofen,DKYWVDODHFEZIM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
120078,6w4b,DB08057,-7.2,"N-(2-chloro-6-methylphenyl)-8-[(3S)-3-methylpiperazin-1-yl]imidazo[1,5-a]quinoxalin-4-amine",VWJPPYCULHDHBB-HNNXBMFYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
162147,7bv1,DB01493,-7.2,Ethylestrenol,AOXRBFRFYPMWLR-XGXHKTLJSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
146332,6w9q,DB08402,-7.2,"2-[(2,4-DICHLOROBENZOYL)AMINO]-5-(PYRIMIDIN-2-YLOXY)BENZOIC ACID",VNDRRWBKNSHALL-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
120084,6w4b,DB08063,-7.2,"1-BENZYL-3-(4-METHOXYPHENYLAMINO)-4-PHENYLPYRROLE-2,5-DIONE",HLZMYWLMBBLASX-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
95704,6m71,DB11820,-7.2,Nifurtimox,ARFHIAQFJWUCFH-IZZDOVSWSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
137215,6w9c,DB08030,-7.2,3-[(4'-cyanobiphenyl-4-yl)oxy]-N-hydroxypropanamide,XZWFHJUEAVOHHG-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
146362,6w9q,DB08441,-7.2,"6-BROMO-13-THIA-2,4,8,12,19-PENTAAZATRICYCLO[12.3.1.1-3,7-]NONADECA-1(18),3(19),4,6,14,16-HEXAENE 13,13-DIOXIDE",AWSQADBSXFTFKL-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
146367,6w9q,DB08446,-7.2,"3-[6-bromo-2-fluoro-3-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)phenoxy]-5-chlorobenzonitrile",OHQMEDBYNUAVNE-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
10297,6lzg,DB08478,-7.2,N-[2-chloro-5-(trifluoromethyl)phenyl]imidodicarbonimidic diamide,IGFTZEOFHWPCDL-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
6710,6lzg,DB02573,-7.2,"2'-Deoxycytidine-2'-Deoxyadenosine-3',5'-Monophosphate",LYWWDKIADIGKTH-IDMWBNCISA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
120123,6w4b,DB08108,-7.2,N-({6-[(4-CYANOBENZYL)OXY]NAPHTHALEN-2-YL}SULFONYL)-D-GLUTAMIC ACID,PUHRQSFXADUGJW-OAQYLSRUSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
49721,2fxp,DB04853,-7.2,Binodenoson,XJFMHMFFBSOEPR-DNZQAUTHSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
82728,6m3m,DB02923,-7.2,"Biphenyl-2,3-Diol",YKOQAAJBYBTSBS-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
95779,6m71,DB11933,-7.2,Riboprine,USVMJSALORZVDV-SDBHATRESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
137349,6w9c,DB08179,-7.2,"methyl 4-(2,3-dihydroxy-5-methylphenoxy)-2-hydroxy-6-methylbenzoate",BLXSEOJIXHWXQJ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
12833,6lzg,DB13857,-7.2,Demegestone,JWAHBTQSSMYISL-MHTWAQMVSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
109321,6vxx,DB13065,-7.2,LY-2811376,MJQMRGWYPNIERM-HNNXBMFYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
155292,6wiq,DB08912,-7.2,Dabrafenib,BFSMGDJOXZAERB-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
82637,6m3m,DB02808,-7.2,Trifluorofurnesyl Diphosphate,PXLMLAFPAPGGKK-GVCYOOEQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
130368,6w4h,DB12163,-7.2,Sarpogrelate,FFYNAVGJSYHHFO-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
10209,6lzg,DB08383,-7.2,"4,5-bis(4-methoxyphenyl)-2-thiophen-2-yl-1H-imidazole",XBMULXNXJLWLLD-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
130379,6w4h,DB12184,-7.2,Gepirone,QOIGKGMMAGJZNZ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
95849,6m71,DB12039,-7.2,Epicatechin,PFTAWBLQPZVEMU-UKRRQHHQSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
58141,6crv,DB04602,-7.2,PUROMYCIN AMINONUCLEOSIDE-5'-MONOPHOSPHATE,BFPIKGKMRKBBBF-GRIPGOBMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72618,6m2n,DB00955,-7.2,Netilmicin,CIDUJQMULVCIBT-MQDUPKMGSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
95828,6m71,DB12004,-7.2,Briciclib,LXENKEWVEVKKGV-BQYQJAHWSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
82671,6m3m,DB02849,-7.2,N-Pyridoxyl-1-Amino-Cyclopropanecarboxylic Acid-5-Monophosphate,ZMHRUAWWUAOOQN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
82678,6m3m,DB02857,-7.2,Guanosine,NYHBQMYGNKIUIF-UUOKFMHZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
146208,6w9q,DB08246,-7.2,"(2S)-4-(2,5-DIFLUOROPHENYL)-N,N-DIMETHYL-2-PHENYL-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDE",WFFMEXQHWXEKBV-SFHVURJKSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
153478,6wiq,DB06713,-7.2,Norelgestromin,ISHXLNHNDMZNMC-XUDSTZEESA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
10225,6lzg,DB08399,-7.2,PICEATANNOL,CDRPUGZCRXZLFL-OWOJBTEDSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
101688,6vxs,DB06235,-7.2,Vadimezan,XGOYIMQSIKSOBS-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
162217,7bv1,DB01571,-7.2,3-Methylfentanyl,MLQRZXNZHAOCHQ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
162229,7bv1,DB01772,-7.2,"3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl]-4-(5-Fluoro-1-Methyl-1h-Indol-3-Yl)-Pyrrole-2,5-Dione",RPGZQOOZHIEPJW-HNNXBMFYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
146279,6w9q,DB08339,-7.2,"6-(2,6-DICHLOROPHENYL)-2-{[3-(HYDROXYMETHYL)PHENYL]AMINO}-8-METHYLPYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE",ZIQFYVPVJZEOFS-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
82718,6m3m,DB02909,-7.2,5-(2-Chlorophenyl)Furan-2-Carboxylic Acid,PJGGWIHXGHQXMM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
109263,6vxx,DB12977,-7.2,Simenepag isopropyl,MSIIJNOQQWRTFC-GGAORHGYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72594,6m2n,DB00926,-7.2,Etretinate,HQMNCQVAMBCHCO-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
72524,6m2n,DB00849,-7.2,Methylphenobarbital,ALARQZQTBTVLJV-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
10232,6lzg,DB08407,-7.2,PLATENSIMYCIN,CSOMAHTTWTVBFL-OFBLZTNGSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
162295,7bv1,DB01859,-7.2,4-Diphosphocytidyl-2-C-Methyl-D-Erythritol 2-Phosphate,HTJXTKBIUVFUAR-XHIBXCGHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
137393,6w9c,DB08238,-7.2,5-AMINO-NAPHTALENE-2-MONOSULFONATE,UWPJYQYRSWYIGZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
101705,6vxs,DB06266,-7.2,Lonidamine,WDRYRZXSPDWGEB-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
137405,6w9c,DB08254,-7.2,2-NAPHTHALENESULFONIC ACID,KVBGVZZKJNLNJU-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
162334,7bv1,DB01922,-7.2,"Maltosyl-Alpha (1,4)-D-Gluconhydroximo-1,5-Lactam",AHRWQUNEPBVNOT-IVJVVCOPSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
130382,6w4h,DB12187,-7.2,Abacavir hydroxyacetate,ZBBZROWQLKCFQK-KOLCDFICSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
137390,6w9c,DB08235,-7.2,N-[2-(2-methyl-1H-indol-3-yl)ethyl]thiophene-2-carboxamide,ACAKNPKRLPMONU-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
12803,6lzg,DB13823,-7.2,Pipemidic acid,JOHZPMXAZQZXHR-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
36668,1r42,DB03231,-7.2,"3-(5-Amino-7-oxo-3,7-dihydro-2H-[1,2,3]triazolo[4,5-d]pyrimidin-2-yl)-N-(2-{[2-(hydroxymethyl)phenyl]sulfanyl}benzyl)benzamide",IXDQOBDHBWEZOH-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
130415,6w4h,DB12235,-7.2,Estetrol,AJIPIJNNOJSSQC-NYLIRDPKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
146428,6w9q,DB08519,-7.2,"N-4-(3-methyl-1H-indazol-6-yl)-N-2-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine",SQQAPOSROFWHIB-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
162043,7bv1,DB01348,-7.2,Spirapril,HRWCVUIFMSZDJS-SZMVWBNQSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
101803,6vxs,DB06536,-7.2,Tesaglitazar,CXGTZJYQWSUFET-IBGZPJMESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
25017,6cs2,DB02857,-7.2,Guanosine,NYHBQMYGNKIUIF-UUOKFMHZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
162035,7bv1,DB01333,-7.2,Cefradine,RDLPVSKMFDYCOR-UEKVPHQBSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
162034,7bv1,DB01332,-7.2,Ceftizoxime,NNULBSISHYWZJU-LLKWHZGFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
137075,6w9c,DB07868,-7.2,6-CHLORO-4-(CYCLOHEXYLSULFANYL)-3-PROPYLQUINOLIN-2(1H)-ONE,CLKFNGKDJYMUPK-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
25021,6cs2,DB02862,-7.2,Gluco-Phenylimidazole,DLVNFMROYKHANV-FVCCEPFGSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
13981,6lzg,T3D2093,-7.2,"1,2,3,7,8-Pentachlorodibenzo-p-dioxin",FSPZPQQWDODWAU-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
28779,6cs2,DB08393,-7.2,"2-[(5,6-DIPHENYLFURO[2,3-D]PYRIMIDIN-4-YL)AMINO]ETHANOL",UQHINZSKNAAVOZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
146444,6w9q,DB08536,-7.2,"3-bromo-5-phenyl-N-(pyrimidin-5-ylmethyl)pyrazolo[1,5-a]pyridin-7-amine",IBUPHWYGVDAASU-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
12783,6lzg,DB13797,-7.2,Iodocholesterol (131I),FIOAEFCJGZJUPW-ODFYUTSGSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
120281,6w4b,DB08301,-7.2,N-({[4-(AMINOSULFONYL)PHENYL]AMINO}CARBONYL)-4-METHYLBENZENESULFONAMIDE,HDCXQTPVTAIPNZ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
101816,6vxs,DB06582,-7.2,Dextofisopam,RUJBDQSFYCKFAA-HNNXBMFYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
33357,6cs2,T3D4549,-7.2,Triticonazole,PPDBOQMNKNNODG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
95613,6m71,DB11686,-7.2,Iferanserin,UXIPFQUBOVWAQW-UEBLJOKOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
65263,6lxt,DB02602,-7.2,AL7182,ICIXQGGQPKFQRL-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
130447,6w4h,DB12279,-7.2,OBP-801,XFLBOEMFLGLWFF-HDXRNPEWSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
155405,6wiq,DB09073,-7.2,Palbociclib,AHJRHEGDXFFMBM-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
59184,6crv,DB07170,-7.2,"5'-FLUORO-2',5'-DIDEOXYADENOSINE",QKUCDAPGYBWICH-RRKCRQDMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
95597,6m71,DB11665,-7.2,BMS-690514,CSGQVNMSRKWUSH-IAGOWNOFSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
109013,6vxx,DB11905,-7.2,Sutezolid,FNDDDNOJWPQCBZ-ZDUSSCGKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
120317,6w4b,DB08346,-7.2,"(5Z)-13-CHLORO-14,16-DIHYDROXY-3,4,7,8,9,10-HEXAHYDRO-1H-2-BENZOXACYCLOTETRADECINE-1,11(12H)-DIONE",YUZYDHRGGDTZLG-DUXPYHPUSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
72462,6m2n,DB00777,-7.2,Propiomazine,UVOIBTBFPOZKGP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
120316,6w4b,DB08345,-7.2,"4-(2-(1H-IMIDAZOL-4-YL)ETHYLAMINO)-2-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE",IWUUKHQIKFHWIW-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
33374,6cs2,T3D0397,-7.2,"2,4'-Dichlorobiphenyl",UFNIBRDIUNVOMX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
109033,6vxx,DB11937,-7.2,Kynurenic Acid,HCZHHEIFKROPDY-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
161984,7bv1,DB01048,-7.2,Abacavir,MCGSCOLBFJQGHM-SCZZXKLOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
156426,6wiq,DB13080,-7.2,Roluperidone,RNRYULFRLCBRQS-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
72421,6m2n,DB00726,-7.2,Trimipramine,ZSCDBOWYZJWBIY-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
83118,6m3m,DB03449,-7.2,N-(4-(2-((3-Chlorophenylmethyl)Amino)Ethyl)Phenyl)-2-Thiophecarboxamidine,ZZVGLDBDD1AB-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83136,6m3m,DB03475,-7.2,"1-[4-Carboxy-2-(3-Pentylamino)Phenyl]-5,5'-Di(Hydroxymethyl)Pyrrolidin-2-One",BNIJJJRESBVRNB-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
95883,6m71,DB12084,-7.2,ADP-597,WPDCHTSXOPUOII-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
146427,6w9q,DB08517,-7.2,"(2S)-5-hydroxy-2-(4-hydroxyphenyl)-7-methoxy-2,3-dihydro-4H-chromen-4-one",DJOJDHGQRNZXQQ-AWEZNQCLSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
128021,6w4h,DB07125,-7.2,"4-(6-{[(1R)-1-(hydroxymethyl)propyl]amino}imidazo[1,2-b]pyridazin-3-yl)benzoic acid",KKZYGUVAFJCULH-CYBMUJFWSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
120136,6w4b,DB08122,-7.2,"N-METHYL-4-{[(2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]AMINO}BENZENESULFONAMIDE",IKASAFLVQIJQOK-UVTDQMKNSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
82920,6m3m,DB03185,-7.2,"1-Beta-Ribofuranosyl-1,3-Diazepinone",MEPCJRCEYSZBDO-FNCVBFRFSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
137195,6w9c,DB08009,-7.2,"5-[(E)-(5-CHLORO-2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]-N-[2-(DIETHYLAMINO)ETHYL]-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXAMIDE",XPLJEFSRINKZLC-ATVHPVEESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
120151,6w4b,DB08138,-7.2,"{[(2,6-difluorophenyl)carbonyl]amino}-N-(4-fluorophenyl)-1H-pyrazole-3-carboxamide",BDRDBXXWQDFXEC-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
61335,6crv,DB11935,-7.2,Flomoxef,UHRBTBZOWWGKMK-DOMZBBRYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72510,6m2n,DB00833,-7.2,Cefaclor,QYIYFLOTGYLRGG-GPCCPHFNSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
3996,6lzg,HMDB0049806,-7.2,"TG(18:1(9Z)/22:0/18:2(9Z,12Z))",IHFWXPSVLCAYTA-NSOUBCFQSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
82945,6m3m,DB03216,-7.2,"(1'R,2'S)-9-(2-Hydroxy-3'-Keto-Cyclopenten-1-yl)Adenine",RQPALADHFYHEHK-CHKWXVPMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
95664,6m71,DB11765,-7.2,PF-04991532,GKMLFBRLRVQVJO-ZDUSSCGKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
18207,6cs2,HMDB0013695,-7.2,Urolithin A,RIUPLDUFZCXCHM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
101769,6vxs,DB06457,-7.2,Tecastemizole,SFOVDSLXFUGAIV-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
54622,2fxp,DB15399,-7.2,BMS-754807,LQVXSNNAFNGRAH-QHCPKHFHSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
120159,6w4b,DB08147,-7.2,"4-[3-(dibenzylamino)phenyl]-2,4-dioxobutanoic acid",RMWVENXKUQXLPW-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
162079,7bv1,DB01418,-7.2,Acenocoumarol,VABCILAOYCMVPS-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
36658,1r42,DB03220,-7.2,FR233623,OODDZQQDDOVCFD-SCLBCKFNSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
120161,6w4b,DB08149,-7.2,"1-[4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine",KCWPSUKJCKZEAO-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
120162,6w4b,DB08150,-7.2,"4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-aminium",RZIDZIGAXXNODG-UHFFFAOYSA-O,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
68838,6lxt,DB08392,-7.2,"2-[5,6-BIS-(4-METHOXY-PHENYL)-FURO[2,3-D]PYRIMIDIN-4-YLAMINO]-ETHANOL",ARBUGBBNEFAECO-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
33315,6cs2,T3D4509,-7.2,Fludioxonil,MUJOIMFVNIBMKC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
61317,6crv,DB11905,-7.2,Sutezolid,FNDDDNOJWPQCBZ-ZDUSSCGKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
146417,6w9q,DB08504,-7.2,"6-(4-{(1S,2S)-2-AMINO-1-[(DIMETHYLAMINO)CARBONYL]-3-[(3S)-3-FLUOROPYRROLIDIN-1-YL]-3-OXOPROPYL}PHENYL)-1H-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-4-IUM",ZNHVIJAGMFQGMS-IHPCNDPISA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
146416,6w9q,DB08503,-7.2,"(3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(4-methylphenyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol",HRCKGDOSPBFICB-MZHQWRCYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
54644,2fxp,DB15442,-7.2,Trilaciclib,PDGKHKMBHVFCMG-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
59174,6crv,DB07158,-7.2,"5-ETHYL-3-METHYL-1,5-DIHYDRO-4H-PYRAZOLO[4,3-C]QUINOLIN-4-ONE",ASEHARDUZDZEKS-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
54642,2fxp,DB15437,-7.2,Rocacetrapib,GBHPDJQHZADVAA-SOKVYYICSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
54639,2fxp,DB15431,-7.2,M-2698,HXAUJHZZPCBFPN-QGZVFWFLSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
137141,6w9c,DB07947,-7.2,ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY)ETHYLAMINO)ETHYL)AMIDE,AUHWQSZMVMMRLM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
10326,6lzg,DB08510,-7.2,5-ALPHA-PREGNANE-3-BETA-OL-HEMISUCCINATE,UVTGFMKBPVLATL-DSOJQRAMSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
72490,6m2n,DB00812,-7.2,Phenylbutazone,VYMDGNCVAMGZFE-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
120182,6w4b,DB08170,-7.2,"(1R)-N,6-DIHYDROXY-7-METHOXY-2-[(4-METHOXYPHENYL)SULFONYL]-1,2,3,4-TETRAHYDROISOQUINOLINE-1-CARBOXAMIDE",AYFCYVLVRYQGME-QGZVFWFLSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
22006,6cs2,HMDB0052686,-7.2,"TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/22:2(13Z,16Z))",ZYYSWIRPQRDPKM-DVUBSJTHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
137136,6w9c,DB07942,-7.2,2-fluoro-4-[4-(4-fluorophenyl)-1H-pyrazol-3-yl]pyridine,YJCHZVXSPFPKMX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137035,6w9c,DB07823,-7.2,"(2S)-2-[(3aR,4R,7S,7aS)-1,3-dioxooctahydro-2H-4,7-methanoisoindol-2-yl]propanoic acid",REFMTLIXGKZVDF-VRGHQRLXSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
82567,6m3m,DB02709,-7.2,Resveratrol,LUKBXSAWLPMMSZ-OWOJBTEDSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
155291,6wiq,DB08911,-7.2,Trametinib,LIRYPHYGHXZJBZ-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
137793,6w9c,DB08727,-7.2,"3-Methyl-5-(7-{4-[(4R)-4-methyl-4,5-dihydro-1,3-oxazol-2-yl]phenoxy}heptyl)-1,2-oxazole",NEAZMARKCJKUMF-QGZVFWFLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137788,6w9c,DB08722,-7.2,5-(7-(6-chloro-4-(5-hydro-4-methyl-2-oxazolyl)phenoxy)heptyl)-3-methyl isoxazole,WOJFAPUTPSWFLJ-INIZCTEOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
155196,6wiq,DB08772,-7.2,"3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL-2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID",BCSVCWVQNOXFGL-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
137786,6w9c,DB08720,-7.2,"5-(5-(4-(4,5-dihydro-2-oxazoly)phenoxy)pentyl)-3-methyl osoxazole",IWZDYGHUSXWPPM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
119750,6w4b,DB07680,-7.2,[(1S)-1-(5-CHLORO-1-BENZOTHIEN-3-YL)-2-(2-NAPHTHYLAMINO)-2-OXOETHYL]PHOSPHONIC ACID,HUJXISJLAPAFBO-IBGZPJMESA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
145938,6w9q,DB07936,-7.2,N-(4-{[(3S)-3-(dimethylamino)pyrrolidin-1-yl]carbonyl}phenyl)-5-fluoro-4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]pyrimidin-2-amine,BACSZMCLZIDTIO-IBGZPJMESA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
82203,6m3m,DB02240,-7.2,Quinacrine mustard,UKOBAUFLOGFCMV-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58185,6crv,DB04657,-7.2,Carboxin,GYSSRZJIHXQEHQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
145945,6w9q,DB07944,-7.2,N-{3-METHYL-5-[2-(PYRIDIN-4-YLAMINO)-ETHOXY]-PHENYL}-BENZENESULFONAMIDE,MPTWCWHNLVMCRW-UHFFFAOYSA-O,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
162781,7bv1,DB02914,-7.2,"(6e)-6-[(2e,4e,6e)-3,7-Dimethylnona-2,4,6,8-Tetraenylidene]-1,5,5-Trimethylcyclohexene",FWNRILWHNGFAIN-OYUWDNMLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
65023,6lxt,DB02295,-7.2,"N-[3-(Dimethylamino)Propyl]-2-({[4-({[4-(Formylamino)-1-Methyl-1h-Pyrrol-2-Yl]Carbonyl}Amino)-1-Methyl-1h-Pyrrol-2-Yl]Carbonyl}Amino)-5-Isopropyl-1,3-Thiazole-4-Carboxamide",VDYCDKRATGWFDA-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
89975,6m71,DB01112,-7.2,Cefuroxime,JFPVXVDWJQMJEE-IZRZKJBUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
119773,6w4b,DB07707,-7.2,"(9BETA,11ALPHA,13ALPHA,14BETA,17ALPHA)-11-(METHOXYMETHYL)ESTRA-1(10),2,4-TRIENE-3,17-DIOL",LEOPSILMAOYZBO-IUTAEKPZSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
10129,6lzg,DB08289,-7.2,N-(PARA-GLUTARAMIDOPHENYL-ETHYL)-PIPERIDINIUM-N-OXIDE,RKJXWOJUCCBWSC-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
145922,6w9q,DB07920,-7.2,N-oxo-2-[(4-phenylphenyl)sulfonylamino]ethanamide,OGRPZMQLAVBWPV-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
32994,6cs2,T3D3924,-7.2,Sulfentrazone,OORLZFUTLGXMEF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
24865,6cs2,DB02675,-7.2,(4-Hydroxymaltosephenyl)Glycine,PHPOPZGUOBMSPZ-QHJSCRBTSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
145979,6w9q,DB07984,-7.2,2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]-n-[(1S)-1-(hydroxymethyl)propyl]acetamide,GKJWXEORYGBJFS-KRWDZBQOSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
89970,6m71,DB01104,-7.2,Sertraline,VGKDLMBJGBXTGI-SJCJKPOMSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
137724,6w9c,DB08645,-7.2,"6-CHLORO-3-(DICHLOROMETHYL)-3,4-DIHYDRO-2H-1,2,4-BENZOTHIADIAZINE-7-SULFONAMIDE 1,1-DIOXIDE",LMJSLTNSBFUCMU-MRVPVSSYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
96025,6m71,DB12288,-7.2,Piromelatine,PNTNBIHOAPJYDB-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
118623,6w4b,DB05532,-7.2,BMS-488043,DBPMWRYLTBNCCE-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
109486,6vxx,DB13967,-7.2,Patent Blue,DHAHKSQXIXFZJB-UHFFFAOYSA-O,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
145982,6w9q,DB07987,-7.2,"[2-(5-MERCAPTO-[1,3,4]THIADIAZOL-2-YLCARBAMOYL)-1-PHENYL-ETHYL]-CARBAMIC ACID BENZYL ESTER",AWAKNMKLVLWIIQ-OAHLLOKOSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
18408,6cs2,HMDB0029175,-7.2,3'-O-methyl-(-)-epicatechin,NJHJXXLBWQXMRO-CZUORRHYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
119811,6w4b,DB07753,-7.2,"3',5'-DIFLUOROBIPHENYL-4-CARBOXYLIC ACID",VCEFNMHMLWBFNV-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
145995,6w9q,DB08001,-7.2,5-(3-{3-[3-HYDROXY-2-(METHOXYCARBONYL)PHENOXY]PROPENYL}PHENYL)-4-(HYDROXYMETHYL)ISOXAZOLE-3-CARBOXYLIC ACID,DQSRCEFDWMQCCV-GQCTYLIASA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
128123,6w4h,DB07246,-7.2,"(2R)-2-AMINO-3,3,3-TRIFLUORO-N-HYDROXY-2-{[(4-PHENOXYPHENYL)SULFONYL]METHYL}PROPANAMIDE",MKRPIBSCGZAUCH-OAHLLOKOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
162737,7bv1,DB02855,-7.2,N-(3-Propylcarbamoyloxirane-2-Carbonyl)-Isoleucyl-Proline,UDNIFTKCMDIXFC-ABHRYQDASA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
82252,6m3m,DB02304,-7.2,Prostaglandin B2,PRFXRIUZNKLRHM-HKVRTXJWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
155216,6wiq,DB08795,-7.2,Azidocillin,ODFHGIPNGIAMDK-NJBDSQKTSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
119735,6w4b,DB07663,-7.2,"2-[(1R)-1-CARBOXY-2-(4-HYDROXYPHENYL)ETHYL]-1,3-DIOXOISOINDOLINE-5-CARBOXYLIC ACID",QISJEFYTLZTWIQ-CQSZACIVSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
145920,6w9q,DB07917,-7.2,4-(BENZHYDRYLOXY)-1-[3-(1H-TETRAAZOL-5-YL)PROPYL]PIPERIDINE,TZQGXAHOROZEKN-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
162800,7bv1,DB02936,-7.2,4-(1-Benzyl-3-Carbamoylmethyl-2-Methyl-1h-Indol-5-Yloxy)-Butyric Acid,STENXUCYNKOBHJ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
137947,6w9c,DB08941,-7.2,Isoxsuprine,BMUKKTUHUDJSNZ-HBUWYVDXSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
13785,6lzg,T3D1847,-7.2,Flucythrinate,GBIHOLCMZGAKNG-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
104975,6vxs,DB12802,-7.2,Picropodophyllin,YJGVMLPVUAXIQN-HAEOHBJNSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
18489,6cs2,HMDB0030180,-7.2,Crustecdysone,NKDFYOWSKOHCCO-YPVLXUMRSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
119681,6w4b,DB07596,-7.2,"(17beta)-17-(cyanomethyl)-2-methox1tra-1(10),2,4-trien-3-yl sulfamate",NTSPHKOMJMBWOU-NNKXXINSSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
119687,6w4b,DB07607,-7.2,4-[5-(3-IODO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-1H-IMIDAZOL-4-YL]-PYRIDINE,RXDZANYWRNIAOR-HHHXNRCGSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
91828,6m71,DB03593,-7.2,N7-Methyl-Guanosine-5'-Monophosphate,AOKQNZVJJXPUQA-KQYNXXCUSA-O,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
130297,6w4h,DB12061,-7.2,Pardoprunox,YVPUUUDAZYFFQT-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
10081,6lzg,DB08230,-7.2,"5,7-DIHYDROXY-2-(3,4,5-TRIHYDROXYPHENYL)-4H-CHROMEN-4-ONE",ARSRJFRKVXALTF-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
137919,6w9c,DB08895,-7.2,Tofacitinib,UJLAWZDWDVHWOW-YPMHNXCESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
162873,7bv1,DB03234,-7.2,"(4'-{[Allyl(Methyl)Amino]Methyl}-1,1'-Biphenyl-4-Yl)(4-Bromophenyl)Methanone",YATCZCSDJCQNAL-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
6037,6lzg,DB01479,-7.2,BA-2664,QGKQXZFZOIQFBI-XSWYFRFISA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
82043,6m3m,DB02029,-7.2,N-Cyclohexyl-N'-(4-Iodophenyl)Urea,AQTBUVAFYDVTFD-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
145863,6w9q,DB07848,-7.2,5-Chloro-N-{(3S)-1-[(2S)-1-(4-morpholinyl)-1-oxo-2-propanyl]-2-oxo-3-pyrrolidinyl}-1H-indole-2-sulfonamide,BHNMMFGOJRIAEZ-LRDDRELGSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
109636,6vxx,DB15038,-7.2,Litoxetine,MJJDYOLPMGIWND-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
10097,6lzg,DB08246,-7.2,"(2S)-4-(2,5-DIFLUOROPHENYL)-N,N-DIMETHYL-2-PHENYL-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDE",WFFMEXQHWXEKBV-SFHVURJKSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
64978,6lxt,DB02237,-7.2,Maltotetraose,UYQJCPNSAVWAFU-KVXMBEGHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
137822,6w9c,DB08757,-7.2,5-(2-chlorophenyl)furan-2-carbohydrazide,XQMRHWSGTVEDFG-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
109592,6vxx,DB14200,-7.2,Thiohexam,DEQZTKGFXNUBJL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
32968,6cs2,T3D3899,-7.2,Perfluorooctanesulfonic acid,YFSUTJLHUFNCNZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
109595,6vxx,DB14207,-7.2,Fosinoprilat,WOIWWYDXDVSWAZ-RTWAWAEBSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
18439,6cs2,HMDB0029500,-7.2,Kaempferol 3-glucuronide,FNTJVYCFNVUBOL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
10114,6lzg,DB08268,-7.2,"6-AMINO-4-[2-(4-METHYLPHENYL)ETHYL]-1,7-DIHYDRO-8H-IMIDAZO[4,5-G]QUINAZOLIN-8-ONE",SPVJRTJUEVXOMS-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
146001,6w9q,DB08008,-7.2,"5-methyl-N-[4-(trifluoromethyl)phenyl][1,2,4]triazolo[1,5-a]pyrimidin-7-amine",LRHHXKBKRNNFRV-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
119730,6w4b,DB07653,-7.2,"N-(5,6-DIPHENYLFURO[2,3-D]PYRIMIDIN-4-YL)GLYCINE",VXTCEUDVOCLEJG-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
155174,6wiq,DB08747,-7.2,"(11R)-10-acetyl-11-(2,4-dichlorophenyl)-6-hydroxy-3,3-dimethyl-2,3,4,5,10,11-hexahydro-1H-dibenzo[b,e][1,4]diazepin-1-one",JJTPPGUNMJMPLY-QFIPXVFZSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
162816,7bv1,DB02957,-7.2,Orotidine-5'-Monophosphate,KYOBSHFOBAOFBF-XVFCMESISA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
6034,6lzg,DB01474,-7.2,"17alpha-methyl-3beta,17beta-dihydroxyandrost-4-ene",BNUOCVTVOYWNJC-DTMQFJJTSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
59131,6crv,DB07110,-7.2,4-(4-FLUOROBENZYL)PIPERIDINE,JLAKCHGEEBPDQI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
137858,6w9c,DB08798,-7.2,Sulfamoxole,CYFLXLSBHQBMFT-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
96128,6m71,DB12429,-7.2,CI-1040,GFMMXOIFOQCCGU-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
101541,6vxs,DB05501,-7.2,AMD-070,WVLHHLRVNDMIAR-IBGZPJMESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
72768,6m2n,DB01129,-7.2,Rabeprazole,YREYEVIYCVEVJK-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
109470,6vxx,DB13617,-7.2,Clorexolone,VPMWFZKOWULPGT-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59138,6crv,DB07118,-7.2,Hymecromone,HSHNITRMYYLLCV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
95952,6m71,DB12187,-7.2,Abacavir hydroxyacetate,ZBBZROWQLKCFQK-KOLCDFICSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
6021,6lzg,DB01456,-7.2,5-androstenedione,SQGZFRITSMYKRH-QAGGRKNESA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
89936,6m71,DB01066,-7.2,Cefditoren,KMIPKYQIOVAHOP-YLGJWRNMSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
109387,6vxx,DB13504,-7.2,Cefetamet,MQLRYUCJDNBWMV-GHXIOONMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109386,6vxx,DB13502,-7.2,Budipine,QIHLUZAFSSMXHQ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130347,6w4h,DB12131,-7.2,Vinpocetine,DDNCQMVWWZOMLN-IRLDBZIGSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
18363,6cs2,HMDB0029082,-7.2,Tryptophyl-Glutamate,PWIQCLSQVQBOQV-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
146071,6w9q,DB08087,-7.2,"4-[(7R,7AS)-7-HYDROXY-1,3-DIOXOTETRAHYDRO-1H-PYRROLO[1,2-C]IMIDAZOL-2(3H)-YL]-1-NAPHTHONITRILE",NHBIWLQQJPSMNP-CABCVRRESA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
119922,6w4b,DB07875,-7.2,"5-Chloro-thiophene-2-carboxylic acid ((3S,4S)-1-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-methyl}-4-hydroxy-pyrrolidin-3-yl)-amide",ARAVOODWJJJNBY-IRXDYDNUSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
61452,6crv,DB12109,-7.2,CPI-613,ZYRLHJIMTROTBO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
12853,6lzg,DB01061,-7.2,Azlocillin,JTWOMNBEOCYFNV-NFFDBFGFSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
155274,6wiq,DB08882,-7.2,Linagliptin,LTXREWYXXSTFRX-QGZVFWFLSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
137577,6w9c,DB08467,-7.2,"6-(2,3,4,5,6,7-HEXAHYDRO-2,4,4-TRIMETHYL-1-METYLENEINDEN-2-YL)-3-METHYLHEXA-2,4-DIENOIC ACID",HEVXQLBAMFMFKU-IAZPEVBMSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
27020,6cs2,DB06258,-7.2,Bimoclomol,NMOVJBAGBXIKCG-VKAVYKQESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
153489,6wiq,DB06730,-7.2,Gestodene,SIGSPDASOTUPFS-XUDSTZEESA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
105025,6vxs,DB12884,-7.2,Lavoltidine,VTLNPNNUIJHJQB-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
146077,6w9q,DB08095,-7.2,"3-(2-CHLOROPHENYL)-1-(2-{[(1S)-2-HYDROXY-1,2-DIMETHYLPROPYL]AMINO}PYRIMIDIN-4-YL)-1-(4-METHOXYPHENYL)UREA",ZWYFTKPEHRQCCW-HNNXBMFYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
58150,6crv,DB04614,-7.2,(R)-tacrine(10)-hupyridone,ROTFGKJJMRTWBD-HHHXNRCGSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
10194,6lzg,DB08365,-7.2,"8-bromo-4-(2-chlorophenyl)-N-(2-hydroxyethyl)-6-methyl-1,3-dioxo-1,2,3,6-tetrahydropyrrolo[3,4-e]indole-7-carboxamide",XUAHLMVOYLUYSB-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
137492,6w9c,DB08363,-7.2,1-(9-ethyl-9H-carbazol-3-yl)-N-methylmethanamine,LBPNOEAFWYTTEB-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
54479,2fxp,DB15110,-7.2,Onvansertib,QHLVBNKYJGBCQJ-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
82509,6m3m,DB02635,-7.2,N-[O-Phosphono-Pyridoxyl]-Isoleucine,GZZDWFDWHXPWJK-QPUJVOFHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
137520,6w9c,DB08398,-7.2,"2-Amino-1-methyl-6-phenylimidazo(4,5-b)pyridine",UQVKZNNCIHJZLS-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
89938,6m71,DB01068,-7.2,Clonazepam,DGBIGWXXNGSACT-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
146103,6w9q,DB08122,-7.2,"N-METHYL-4-{[(2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]AMINO}BENZENESULFONAMIDE",IKASAFLVQIJQOK-UVTDQMKNSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
146102,6w9q,DB08121,-7.2,(2S)-2-(biphenyl-4-yloxy)-3-phenylpropanoic acid,TZTPJJNNACUQQR-FQEVSTJZSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
137533,6w9c,DB08414,-7.2,"6-CHLORO-2-(1-FURO[2,3-C]PYRIDIN-5-YL-ETHYLSULFANYL)-PYRIMIDIN-4-YLAMINE",ATCRIOJPQXDFNY-ZETCQYMHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
68805,6lxt,DB08352,-7.2,"6-[4-(2-fluorophenyl)-1,3-oxazol-5-yl]-N-(1-methylethyl)-1,3-benzothiazol-2-amine",FQYJTHIYAQQJAB-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
24909,6cs2,DB00351,-7.2,Megestrol acetate,RQZAXGRLVPAYTJ-GQFGMJRRSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
65096,6lxt,DB02390,-7.2,5-Bromo-N[2-(Dimethylamino)Ethyl]-9-Aminoacridine-4-Carboxamide,NROQPXQSDDINMC-UHFFFAOYSA-P,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
101627,6vxs,DB06040,-7.2,Filanesib,LLXISKGBWFTGEI-FQEVSTJZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
119974,6w4b,DB07940,-7.2,"9-(3-IODOBENZYLAMINO)-1,2,3,4-TETRAHYDROACRIDINE",ZUCWQTWGZGIYPV-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
162407,7bv1,DB02017,-7.2,Imidazole-Derived Cellobiose,CSXOUJBOYXGFCL-OFKZETBZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
119889,6w4b,DB07839,-7.2,"N-2-1,3-BENZOXAZOL-2-YL-3-CYCLOHEXYL-N-{2-[(4-METHOXYPHENYL)AMINO]ETHYL}-L-ALANINAMIDE",VFNWTXUFNNOQHD-QFIPXVFZSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
10173,6lzg,DB08341,-7.2,"4-{[4-{[(1R,2R)-2-(dimethylamino)cyclopentyl]amino}-5-(trifluoromethyl)pyrimidin-2-yl]amino}-N-methylbenzenesulfonamide",CAUFYHKGKDJMQG-HZPDHXFCSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
137721,6w9c,DB08642,-7.2,"(2R,6S)-6-{[methyl(3,4,5-trimethoxyphenyl)amino]methyl}-1,2,5,6,7,8-hexahydroquinazoline-2,4-diamine",JJWPLCQODKLEHY-JEOXALJRSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
54387,2fxp,DB14895,-7.2,Vibegron,DJXRIQMCROIRCZ-XOEOCAAJSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
82283,6m3m,DB02346,-7.2,3'-O-N-Octanoyl-a-D-Glucopyranosyl-B-D-Fructofuranoside,NMVDZWILYFXVBZ-PQJCEUABSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
33031,6cs2,T3D3967,-7.2,Enterolactone,HVDGDHBAMCBBLR-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
162685,7bv1,DB02790,-7.2,Phenyl-Uridine-5'-Diphosphate,ZHUWBKDWWGKIEN-FMKGYKFTSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
109455,6vxx,DB13600,-7.2,Deltamethrin,OWZREIFADZCYQD-NSHGMRRFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
162669,7bv1,DB02766,-7.2,(3r)-3-{[(Benzyloxy)Carbonyl]Amino}-2-Oxo-4-Phenylbutane-1-Diazonium,VLIGBVLLNSWVMI-MRXNPFEDSA-O,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
128111,6w4h,DB07230,-7.2,3-BROMO-6-HYDROXY-2-(4-HYDROXYPHENYL)-1H-INDEN-1-ONE,DHPCBFMFERFZLR-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
162666,7bv1,DB02762,-7.2,RU79072,NQLPTOOPFMPCHQ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
146008,6w9q,DB08015,-7.2,"(3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-phenyl-1H-indole-2,3-dione 3-oxime",SZYREAUDQRVVLV-DAFNUICNSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
82315,6m3m,DB02385,-7.2,D-threo-neopterin,BMQYVXCPAOLZOK-INEUFUBQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
128109,6w4h,DB07228,-7.2,1-(5-CHLORO-2-METHOXYPHENYL)-3-{6-[2-(DIMETHYLAMINO)-1-METHYLETHOXY]PYRAZIN-2-YL}UREA,GIAYFZLMPSVQDV-NSHDSACASA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
146015,6w9q,DB08022,-7.2,"(2S)-1,3-benzothiazol-2-yl{2-[(2-pyridin-3-ylethyl)amino]pyrimidin-4-yl}ethanenitrile",RCYPVQCPYKNSTG-OAHLLOKOSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
119827,6w4b,DB07770,-7.2,5-(4-FLUOROPHENYL)-3-{[(4-METHYLPHENYL)SULFONYL]AMINO}THIOPHENE-2-CARBOXYLIC ACID,DJPFUQBNQLKCAB-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
119832,6w4b,DB07776,-7.2,Flavone,VHBFFQKBGNRLFZ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
28814,6cs2,DB08434,-7.2,2-METHYLCARBAMOYL-3-(4-PHOSPHONOOXY-PHENYL)-CYCLOPROPANECARBOXYLIC ACID,GIIUHKRUTUSHAB-IVZWLZJFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
119838,6w4b,DB07783,-7.2,1-((1R)-1-(HYDROXYMETHYL)-3-{6-[(3-PHENYLPROPANOYL)AMINO]-1H-INDOL-1-YL}PROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE,GUYYFMCFEPDDFL-OAQYLSRUSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
95953,6m71,DB12188,-7.2,Zicronapine,BYPMJBXPNZMNQD-PZJWPPBQSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
162591,7bv1,DB02463,-7.2,2-(2-Hydroxy-Phenyl)-1h-Indole-5-Carboxamidine,JPGNPKIYCTXJPG-UHFFFAOYSA-O,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
153495,6wiq,DB06737,-7.2,Zaltoprofen,MUXFZBHBYYYLTH-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
162600,7bv1,DB02474,-7.2,Bmsc-0013,YTYAKGJMNHDUDF-UUWLPUTASA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
49822,2fxp,DB05220,-7.2,Alisertib,ZLHFILGSQDJULK-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
119878,6w4b,DB07826,-7.2,2-[4-chloro-2-(phenylcarbonyl)phenoxy]-N-phenylacetamide,DTGVSZSMDOMAEB-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
72720,6m2n,DB01073,-7.2,Fludarabine,HBUBKKRHXORPQB-FJFJXFQQSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
119865,6w4b,DB07812,-7.2,"N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyrrolo[2,3-b]pyridin-4-yl)thiophene-2-carboxamide",TWYNGDRSMHRPSY-MRXNPFEDSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
146033,6w9q,DB08042,-7.2,"N-4-methyl-N-4-(3-methyl-1H-indazol-6-yl)-N-2-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine",FLXGQDHYCWXTAI-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
162614,7bv1,DB02493,-7.2,Hydantocidin-5'-Phosphate,HVXIMXHBUJADCC-GTBMBKLPSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
155242,6wiq,DB08828,-7.2,Vismodegib,BPQMGSKTAYIVFO-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
58171,6crv,DB04641,-7.2,"3,7-DIHYDROXYNAPHTHALENE-2-CARBOXYLIC ACID",QMWOUSYSNFCKAZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
162635,7bv1,DB02717,-7.2,Cellotetraose,LUEWUZLMQUOBSB-HGDSAIHNSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
155238,6wiq,DB08822,-7.2,Azilsartan medoxomil,QJFSABGVXDWMIW-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
155246,6wiq,DB08834,-7.2,Tauroursodeoxycholic acid,BHTRKEVKTKCXOH-LBSADWJPSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
13784,6lzg,T3D1846,-7.2,Fenpropathrin,XQUXKZZNEFRCAW-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
18148,6cs2,HMDB0013302,-7.2,Phenylalanylphenylalanine,GKZIWHRNKRBEOH-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
153377,6wiq,DB06321,-7.2,R-348,IGLNXKVGKIFNBQ-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
72104,6m2n,DB00343,-7.2,Diltiazem,HSUGRBWQSSZJOP-RTWAWAEBSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
102043,6vxs,DB06936,-7.2,N-(4-carbamimidoylbenzyl)-1-(4-methylpentanoyl)-L-prolinamide,AEKJCSNKYXWOAQ-INIZCTEOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
68914,6lxt,DB08486,-7.2,Efaproxiral,BNFRJXLZYUTIII-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
58045,6crv,DB04479,-7.2,4-Nitro-Inden-1-One,UUNZJPCKMDLQPO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
161332,7bv1,DB13835,-7.2,Caroverine,MSPRUJDUTKRMLM-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
83844,6m3m,DB04433,-7.2,"N''-{3-[(3s,8ar)-1,4-Dioxooctahydropyrrolo[1,2-a]Pyrazin-3-Yl]Propyl}Guanidine",ZRJHYOXNWCMGMW-YUMQZZPRSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
28414,6cs2,DB08004,-7.2,"(2S)-2-{[3-(3-aminophenyl)imidazo[1,2-b]pyridazin-6-yl]amino}-3-methylbutan-1-ol",PUMVONFFLKPPIM-CQSZACIVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
161325,7bv1,DB13823,-7.2,Pipemidic acid,JOHZPMXAZQZXHR-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
55004,6crv,DB00489,-7.2,Sotalol,ZBMZVLHSJCTVON-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28412,6cs2,DB08001,-7.2,5-(3-{3-[3-HYDROXY-2-(METHOXYCARBONYL)PHENOXY]PROPENYL}PHENYL)-4-(HYDROXYMETHYL)ISOXAZOLE-3-CARBOXYLIC ACID,DQSRCEFDWMQCCV-GQCTYLIASA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
25159,6cs2,DB03030,-7.2,4-(2-Thienyl)-1-(4-Methylbenzyl)-1h-Imidazole,UMOFOLLUKPBVQG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
28411,6cs2,DB08000,-7.2,"2-(CARBOXYMETHYL)-1-OXO-1,2-DIHYDRONAPHTHO[1,2-D]ISOTHIAZOLE-4-CARBOXYLIC ACID 3,3-DIOXIDE",ZTJGXDGAXGWOGR-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
120935,6w4b,DB09175,-7.2,Mirfentanil,BJZZDOLVVLWFHN-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
28410,6cs2,DB07999,-7.2,"{4-[(CARBOXYMETHOXY)CARBONYL]-3,3-DIOXIDO-1-OXONAPHTHO[1,2-D]ISOTHIAZOL-2(1H)-YL}ACETIC ACID",IXLBOIRSEDMRPI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
72105,6m2n,DB00344,-7.2,Protriptyline,BWPIARFWQZKAIA-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
108667,6vxx,DB08524,-7.2,2-(3-BENZOYLPHENOXY)ETHYL(HYDROXY)FORMAMIDE,ZHFKBNAHHTUQBH-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
161318,7bv1,DB13815,-7.2,Xenysalate,HLDCSYXMVXILQC-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
136533,6w9c,DB07228,-7.2,1-(5-CHLORO-2-METHOXYPHENYL)-3-{6-[2-(DIMETHYLAMINO)-1-METHYLETHOXY]PYRAZIN-2-YL}UREA,GIAYFZLMPSVQDV-NSHDSACASA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
65500,6lxt,DB02916,-7.2,"[(2r,3s,4r,5r)-5-(6-Amino-9h-Purin-9-Yl)-3,4-Dihydroxytetrahydro-2-Furanyl]Methyl Sulfamate",GNZLUJQJDPRUTD-KQYNXXCUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
130529,6w4h,DB12393,-7.2,Fanapanel,WZMQMKNCWDCCMT-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
46497,2fxp,DB00619,-7.2,Imatinib,KTUFNOKKBVMGRW-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
161306,7bv1,DB13532,-7.2,Cyclopenthiazide,BKYKPTRYDKTTJY-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
120957,6w4b,DB09198,-7.2,Lobeglitazone,CHHXEZSCHQVSRE-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
95139,6m71,DB08984,-7.2,Etofenamate,XILVEPYQJIOVNB-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
83872,6m3m,DB04469,-7.2,"1-(4-Methoxyphenyl)-3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester",ZDSXCFSUGVAQSB-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
127909,6w4h,DB06998,-7.2,"[(5R)-5-(2,3-dibromo-5-ethoxy-4-hydroxybenzyl)-4-oxo-2-thioxo-1,3-thiazolidin-3-yl]acetic acid",ABQHPGHMYXJJIV-MRVPVSSYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
25163,6cs2,DB03037,-7.2,Oxidized Acetyl Dithranol,IKFRFGXQHSBCQM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
12721,6lzg,DB01047,-7.2,Fluocinonide,WJOHZNCJWYWUJD-IUGZLZTKSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
33771,6cs2,T3D0449,-7.2,"2,3,4,4'-Tetrachlorobiphenyl",XLDBTRJKXLKYTC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
83905,6m3m,DB04513,-7.2,N-(6-Aminohexyl)-5-Chloro-1-Naphthalenesulfonamide,IDEHCMNLNCJQST-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
14066,6lzg,T3D3683,-7.2,Dihydrocytochalasin B gamma-lactone,VJQJWFGRYRQFRH-RIYZIHGNSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
120913,6w4b,DB09123,-7.2,Dienogest,AZFLJNIPTRTECV-FUMNGEBKSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
68911,6lxt,DB08481,-7.2,"4-METHYL-N-{(5E)-5-[(5-METHYL-2-FURYL)METHYLENE]-4-OXO-4,5-DIHYDRO-1,3-THIAZOL-2-YL}BENZENESULFONAMIDE",MXAPQGDBWFYKKX-ZROIWOOFSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
54980,6crv,DB00459,-7.2,Acitretin,IHUNBGSDBOWDMA-AQFIFDHZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136646,6w9c,DB07363,-7.2,"THIOPHENE-2,5-DISULFONIC ACID 2-AMIDE-5-(4-METHYL-BENZYLAMIDE)",GUNRMHMEAWSZQE-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136622,6w9c,DB07335,-7.2,"3-[4-AMINO-1-(1-METHYLETHYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL]PHENOL",MWYBBCLGEHZSCP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
120812,6w4b,DB08970,-7.2,Fluprednidene,YVHXHNGGPURVOS-SBTDHBFYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
120813,6w4b,DB08971,-7.2,Fluocortolone,GAKMQHDJQHZUTJ-ULHLPKEOSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
18000,6cs2,HMDB0011629,-7.2,"Guanosine 2',3'-cyclic phosphate",UASRYODFRYWBRC-UUOKFMHZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
153349,6wiq,DB06250,-7.2,Fluasterone,VHZXNQKVFDBFIK-NBBHSKLNSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
28454,6cs2,DB08041,-7.2,3-BENZYLOXYCARBONYLAMINO-2-HYDROXY-4-PHENYL-BUTYRIC ACID,JXJYTERRLRAUSF-JKSUJKDBSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
102007,6vxs,DB06899,-7.2,"N-{2-[6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2,2-DIMETHYL-3-OXO-2,3-DIHYDRO-4H-1,4-BENZOTHIAZIN-4-YL]ETHYL}ACETAMIDE",RMEVNJZCKDVVND-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
28736,6cs2,DB08348,-7.2,"N-2-,N-2-DIMETHYL-N-1-(6-OXO-5,6-DIHYDROPHENANTHRIDIN-2-YL)GLYCINAMIDE",UYJZZVDLGDDTCL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
146998,6w9q,DB09304,-7.2,Setiptiline,GVPIXRLYKVFFMK-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
136607,6w9c,DB07319,-7.2,"6-(3-BROMO-2-NAPHTHYL)-1,3,5-TRIAZINE-2,4-DIAMINE",RXSSKAZHCZWJPP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
102012,6vxs,DB06905,-7.2,"(2S,3S,4E,6E,8S,9S)-3-amino-9-methoxy-2,6,8-trimethyl-10-phenyldeca-4,6-dienoic acid",HJVCHYDYCYBBQX-HLTLHRPFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
72152,6m2n,DB00400,-7.2,Griseofulvin,DDUHZTYCFQRHIY-RBHXEPJQSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
161425,7bv1,DB14020,-7.2,Benzoin,ISAOCJYIOMOJEB-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
72140,6m2n,DB00387,-7.2,Procyclidine,WYDUSKDSKCASEF-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
54955,6crv,DB00432,-7.2,Trifluridine,VSQQQLOSPVPRAZ-RRKCRQDMSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
54956,6crv,DB00433,-7.2,Prochlorperazine,WIKYUJGCLQQFNW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61130,6crv,DB11625,-7.2,Perflenapent,NJCBUSHGCBERSK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
120879,6w4b,DB09063,-7.2,Ceritinib,VERWOWGGCGHDQE-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
136589,6w9c,DB07301,-7.2,9H-CARBAZOLE,UJOBWOGCFQCDNV-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
54976,6crv,DB00455,-7.2,Loratadine,JCCNYMKQOSZNPW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
89770,6m71,DB00876,-7.2,Eprosartan,OROAFUQRIXKEMV-LDADJPATSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95173,6m71,DB09020,-7.2,Bisacodyl,KHOITXIGCFIULA-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
161273,7bv1,DB13487,-7.2,Iodine (131I) norcholesterol,QJHZPCLORSPENH-DRTKWHMQSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
54968,6crv,DB00446,-7.2,Chloramphenicol,WIIZWVCIJKGZOK-RKDXNWHRSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
161398,7bv1,DB13958,-7.2,Trestolone acetate,IVCRCPJOLWECJU-XQVQQVTHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
89778,6m71,DB00885,-7.2,Pemirolast,HIANJWSAHKJQTH-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
83724,6m3m,DB04263,-7.2,Geneticin,BRZYSWJRSDMWLG-DJWUNRQOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
72135,6m2n,DB00380,-7.2,Dexrazoxane,BMKDZUISNHGIBY-ZETCQYMHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
28441,6cs2,DB08028,-7.2,"BUT-3-ENYL-[5-(4-CHLORO-PHENYL)-3,6-DIHYDRO-[1,3,4]THIADIAZIN-2-YLIDENE]-AMINE",ZVZPCRKQNRRBOQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
120853,6w4b,DB09015,-7.2,Canrenoic acid,PBKZPPIHUVSDNM-WNHSNXHDSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
120869,6w4b,DB09047,-7.2,Finafloxacin,FYMHQCNFKNMJAV-HOTGVXAUSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
95129,6m71,DB08972,-7.2,Flumequine,DPSPPJIUMHPXMA-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
147152,6w9q,DB11433,-7.2,Nequinate,NNOPDLNHPOLRRE-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
83935,6m3m,DB04551,-7.2,"beta-D-fructofuranose 1,6-bisphosphate",RNBGYGVWRKECFJ-ARQDHWQXSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
58025,6crv,DB04457,-7.2,2'-Deoxyguanosine-5'-Monophosphate,LTFMZDNNPPEQNG-KVQBGUIXSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108617,6vxx,DB08465,-7.2,"2-(3-AMINO-2,5,6-TRIMETHOXYPHENYL)ETHYL 5-CHLORO-2,4-DIHYDROXYBENZOATE",DFYGLJKFZQGYPA-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61057,6crv,DB11440,-7.2,Norgestomet,IWSXBCZCPVUWHT-VIFKTUCRSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
155636,6wiq,DB11423,-7.2,Lasalocid,BBMULGJBVDDDNI-OWKLGTHSSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
121221,6w4b,DB11511,-7.2,Difloxacin,NOCJXYPHIIZEHN-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
94975,6m71,DB08753,-7.2,"4-{(1E)-3-OXO-3-[(2-PHENYLETHYL)AMINO]PROP-1-EN-1-YL}-1,2-PHENYLENE DIACETATE",GARHCDOTUULBOQ-PKNBQFBNSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
28347,6cs2,DB07934,-7.2,[[CYCLOHEXANESULFONYL-GLYCYL]-3[PYRIDIN-4-YL-AMINOMETHYL]ALANYL]PIPERIDINE,KMUXFASJKPVMGU-HXUWFJFHSA-O,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
102120,6vxs,DB07032,-7.2,2-(4-HYDROXY-PHENYL)BENZOFURAN-5-OL,SNNNDCMXZYWCCI-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
130533,6w4h,DB12399,-7.2,Polmacoxib,IJWPAFMIFNSIGD-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
33848,6cs2,T3D0522,-7.2,"2,2',3,3',5,5'-Hexachlorobiphenyl",AJKLKINFZLWHQE-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
61050,6crv,DB11428,-7.2,Medetomidine,CUHVIMMYOGQXCV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136294,6w9c,DB06947,-7.2,1-[(2R)-2-aminobutanoyl]-N-(4-carbamimidoylbenzyl)-L-prolinamide,YHAMQFKGUUSJMU-KGLIPLIRSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
33856,6cs2,T3D0530,-7.2,"2,2',3,4,5,5'-Hexachlorobiphenyl",UCLKLGIYGBLTSM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
14112,6lzg,T3D3729,-7.2,Altertoxin-1,GJIALGLHOBXNAT-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
161159,7bv1,DB13335,-7.2,Pinazepam,MFZOSKPPVCIFMT-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
161154,7bv1,DB12962,-7.2,CP-547632,HXHAJRMTJXHJJZ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
61044,6crv,DB11421,-7.2,Imidacloprid,YWTYJOPNNQFBPC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
121299,6w4b,DB11687,-7.2,E-6201,MWUFVYLAWAXDHQ-HMNLTAHHSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
161079,7bv1,DB12853,-7.2,DA-6886,AULLTYAISZREAX-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
136255,6w9c,DB06905,-7.2,"(2S,3S,4E,6E,8S,9S)-3-amino-9-methoxy-2,6,8-trimethyl-10-phenyldeca-4,6-dienoic acid",HJVCHYDYCYBBQX-HLTLHRPFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
161088,7bv1,DB12868,-7.2,Intoplicine,QROONAIPJKQFMC-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
71951,6m2n,DB00163,-7.2,Vitamin E,GVJHHUAWPYXKBD-IEOSBIPESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
102124,6vxs,DB07036,-7.2,"(3aS,4R,9bR)-2,2-difluoro-4-(4-hydroxyphenyl)-6-(methoxymethyl)-1,2,3,3a,4,9b-hexahydrocyclopenta[c]chromen-8-ol",GPFRMIHXGMVMGF-BZSNNMDCSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
33843,6cs2,T3D0516,-7.2,"3,3',4,5,5'-Pentachlorobiphenyl",MXVAYAXIPRGORY-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
17804,6cs2,HMDB0000501,-7.2,7-Ketocholesterol,YIKKMWSQVKJCOP-QJFKPLHKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
33877,6cs2,T3D0549,-7.2,"2,3,3',4,5,6-Hexachlorobiphenyl",JHJMZCXLJXRCHK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
127870,6w4h,DB06947,-7.2,1-[(2R)-2-aminobutanoyl]-N-(4-carbamimidoylbenzyl)-L-prolinamide,YHAMQFKGUUSJMU-KGLIPLIRSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
161134,7bv1,DB12931,-7.2,Fenobam,DWPQODZAOSWNHB-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
161138,7bv1,DB12938,-7.2,Isoxaflutole,OYIKARCXOQLFHF-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
84161,6m3m,DB04846,-7.2,Celiprolol,JOATXPAWOHTVSZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
10581,6lzg,DB08789,-7.2,"2-AMINO-4-(2,4-DICHLOROPHENYL)-N-ETHYLTHIENO[2,3-D]PYRIMIDINE-6-CARBOXAMIDE",YPEOXUOUTBMBCX-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
104163,6vxs,DB11555,-7.2,Zolazepam,GDSCFOSHSOWNDL-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
105125,6vxs,DB13032,-7.2,Enecadin,SZSHJTJCJOWMHM-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
155610,6wiq,DB11371,-7.2,Alfaxalone,DUHUCHOQIDJXAT-OLVMNOGESA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
12705,6lzg,DB13708,-7.2,Fenquizone,DBDTUXMDTSTPQZ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
147157,6w9q,DB11443,-7.2,Orbifloxacin,QIPQASLPWJVQMH-DTORHVGOSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
147163,6w9q,DB11455,-7.2,Robenacoxib,ZEXGDYFACFXQPF-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
121021,6w4b,DB09285,-7.2,Morniflumate,LDXSPUSKBDTEKA-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
61100,6crv,DB11540,-7.2,Propiopromazine,ZQTVCQIJTREKSP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
155516,6wiq,DB09383,-7.2,Meprednisone,PIDANAQULIKBQS-RNUIGHNZSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
83971,6m3m,DB04597,-7.2,"[4,6-O-(1-CARBOXYETHYLIDENE)-BETA-D-MANNOSE]",QVVFNJUJKXWFAU-BDIBXJNUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
95113,6m71,DB08954,-7.2,Ifenprodil,UYNVMODNBIQBMV-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
83974,6m3m,DB04600,-7.2,"4-[(3-BROMO-4-O-SULFAMOYLBENZYL)(4-CYANOPHENYL)AMINO]-4H-[1,2,4]-TRIAZOLE",GHDKYBCUDPSXGJ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
161263,7bv1,DB13472,-7.2,Cyclofenil,GVOUFPWUYJWQSK-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
136467,6w9c,DB07149,-7.2,"(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluoroethyl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one",LCBAQTCTQXHTJG-ZETCQYMHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
147202,6w9q,DB11551,-7.2,Trenbolone,MEHHPFQKXOUFFV-OWSLCNJRSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
147215,6w9q,DB11591,-7.2,Bilastine,ACCMWZWAEFYUGZ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
136435,6w9c,DB07115,-7.2,"N-(4-chlorobenzyl)-N-methylbenzene-1,4-disulfonamide",IPPUTOHDQOYDIL-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
102088,6vxs,DB06996,-7.2,D-leucyl-N-(4-carbamimidoylbenzyl)-L-prolinamide,XFNMDMGNNKIXBT-CVEARBPZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
161253,7bv1,DB13458,-7.2,Thebacon,RRJQTGHQFYTZOW-ILWKUFEGSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
127901,6w4h,DB06990,-7.2,"4-[(1E,7E)-8-(2,6-DIOXO-1,2,3,6-TETRAHYDROPYRIMIDIN-4-YL)-3,6-DIOXA-2,7-DIAZAOCTA-1,7-DIEN-1-YL]BENZOIC ACID",XHDKIDMFBWLHAX-GONBZBRSSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
55059,6crv,DB00558,-7.2,Zanamivir,ARAIBEBZBOPLMB-UFGQHTETSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136325,6w9c,DB06990,-7.2,"4-[(1E,7E)-8-(2,6-DIOXO-1,2,3,6-TETRAHYDROPYRIMIDIN-4-YL)-3,6-DIOXA-2,7-DIAZAOCTA-1,7-DIEN-1-YL]BENZOIC ACID",XHDKIDMFBWLHAX-GONBZBRSSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
28361,6cs2,DB07949,-7.2,"({[(3E)-2'-OXO-2',7'-DIHYDRO-2,3'-BIINDOL-3(7H)-YLIDENE]AMINO}OXY)ACETIC ACID",BFQRPTKOSYMPOL-LALPNIDTSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
89730,6m71,DB00831,-7.2,Trifluoperazine,ZEWQUBUPAILYHI-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
68934,6lxt,DB08507,-7.2,N-[[2-METHYL-4-HYDROXYCARBAMOYL]BUT-4-YL-N]-BENZYL-P-[PHENYL]-P-[METHYL]PHOSPHINAMID,KGUVBHLPMGERAT-NIYFSFCBSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
161205,7bv1,DB13395,-7.2,Eprozinol,QSRHLIUOSXVKTG-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
147275,6w9q,DB11698,-7.2,Ipragliflozin,AHFWIQIYAXSLBA-RQXATKFSSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
95017,6m71,DB08801,-7.2,Dimetindene,MVMQESMQSYOVGV-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
27065,6cs2,DB00591,-7.2,Fluocinolone acetonide,FEBLZLNTKCEFIT-VSXGLTOVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
108629,6vxx,DB08479,-7.2,"N-(3,5-dimethoxyphenyl)imidodicarbonimidic diamide",VQKIGKHIRBCYNE-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
153335,6wiq,DB06228,-7.2,Rivaroxaban,KGFYHTZWPPHNLQ-AWEZNQCLSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
136411,6w9c,DB07086,-7.2,"4-[(1S,2S,5S)-5-(HYDROXYMETHYL)-8-METHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL",XXIFNRNIQJKFLP-XHSDSOJGSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
155560,6wiq,DB11176,-7.2,Zeaxanthin,JKQXZKUSFCKOGQ-QAYBQHTQSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
155535,6wiq,DB09534,-7.2,Ecamsule,HEAHZSUCFKFERC-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
121075,6w4b,DB09534,-7.2,Ecamsule,HEAHZSUCFKFERC-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
7655,6lzg,DB00482,-7.2,Celecoxib,RZEKVGVHFLEQIL-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
33385,6cs2,T3D0398,-7.2,"2,5-Dichlorobiphenyl",KKQWHYGECTYFIA-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
161492,7bv1,DB14906,-7.2,Adafosbuvir,NIJYGVDQZBBONK-SEUXLIJBSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
146944,6w9q,DB09219,-7.2,Bisoxatin,BPKUDUSVDVLOPY-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
6725,6lzg,DB02596,-7.2,"Alpha,Beta-Methyleneadenosine-5'-Triphosphate",CAWZRIXWFRFUQB-IOSLPCCCSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
153363,6wiq,DB06280,-7.2,Senicapoc,SCTZUZTYRMOMKT-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
120436,6w4b,DB08490,-7.2,CTS-1027,ROSNVSQTEGHUKU-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
83303,6m3m,DB03717,-7.2,"3-Hydroxy-4-(3,4,5-Trihydroxy-Tetrahydro-Pyran-2-Yloxy)-Piperidin-2-One",BHZMHPRIYUPDCT-BQWZOORQSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
120440,6w4b,DB08494,-7.2,"S-{2-[(2-chloro-4-sulfamoylphenyl)amino]-2-oxoethyl} 6-methyl-3,4-dihydroquinoline-1(2H)-carbothioate",AWAKIULNKVOBKE-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
83318,6m3m,DB03735,-7.2,9-(2-Deoxy-Beta-D-Ribofuranosyl)-6-Methylpurine,SJXRKKYXNZWKDB-DJLDLDEBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
10456,6lzg,DB08656,-7.2,5-amino-2-methyl-N-[(1R)-1-naphthalen-1-ylethyl]benzamide,UVERBUNNCOKGNZ-CQSZACIVSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
18096,6cs2,HMDB0012467,-7.2,(-)-Epicatechin sulfate,WTXWEAXATVSZQX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
18094,6cs2,HMDB0000601,-7.2,Coprocholic acid,CNWPIIOQKZNXBB-VCVMUKOKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
54777,6crv,DB00219,-7.2,Oxyphenonium,GFRUPHOKLBPHTQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58088,6crv,DB04537,-7.2,L-Tryptophanamide,JLSKPBDKNIXMBS-VIFPVBQESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
54782,6crv,DB00226,-7.2,Guanadrel,HPBNRIOWI1FK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
33490,6cs2,T3D4746,-7.2,Estrone,DNXHEGUUPJUMQT-CBZIJGRNSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
108887,6vxx,DB11285,-7.2,Ethyl ferulate,ATJVZXXHKSYELS-FNORWQNLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
146718,6w9q,DB08878,-7.2,Aminopterin,TVZGACDUOSZQKY-LBPRGKRZSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
136872,6w9c,DB07633,-7.2,octyl 3-deoxy-2-O-(6-deoxy-alpha-L-galactopyranosyl)-beta-D-xylo-hexopyranoside,FBVFDKBCZLMLQT-PPCMOIRNSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
72301,6m2n,DB00584,-7.2,Enalapril,GBXSMTUPTTWBMN-XIRDDKMYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
161790,7bv1,DB00601,-7.2,Linezolid,TYZROVQLWOKYKF-ZDUSSCGKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
120487,6w4b,DB08547,-7.2,PROGESTERONE-11-ALPHA-OL-HEMISUCCINATE,JBBNFGYRYNBDIH-DBGGZKJISA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
33515,6cs2,T3D4768,-7.2,Flutamide,MKXKFYHWDHIYRV-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
146740,6w9q,DB08915,-7.2,Aleglitazar,DAYKLWSKQJBGCS-NRFANRHFSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
83389,6m3m,DB03818,-7.2,N-[Tosyl-D-Prolinyl]Amino-Ethanethiol,NWUYDTGYTUQMDG-CYBMUJFWSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
161778,7bv1,DB00587,-7.2,Cinalukast,BZMKNPGKXJAIDV-VAWYXSNFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
89821,6m71,DB00933,-7.2,Mesoridazine,SLVMESMUVMCQIY-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
146746,6w9q,DB08927,-7.2,Amperozide,NNAIYOXJNVGUOM-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
72281,6m2n,DB00558,-7.2,Zanamivir,ARAIBEBZBOPLMB-UFGQHTETSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
89816,6m71,DB00926,-7.2,Etretinate,HQMNCQVAMBCHCO-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
161767,7bv1,DB00576,-7.2,Sulfamethizole,VACCAVUAMIDAGB-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
146781,6w9q,DB08972,-7.2,Flumequine,DPSPPJIUMHPXMA-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
83432,6m3m,DB03877,-7.2,AL4623,XACIEZJJSXJZMD-VIFPVBQESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
101901,6vxs,DB06737,-7.2,Zaltoprofen,MUXFZBHBYYYLTH-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
54759,6crv,DB00196,-7.2,Fluconazole,RFHAOTPXVQNOHP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
54757,6crv,DB00194,-7.2,Vidarabine,OIRDTQYFTABQOQ-UHTZMRCNSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
136960,6w9c,DB07739,-7.2,"(3R)-3-(FLUOROMETHYL)-7-(THIOMORPHOLIN-4-YLSULFONYL)-1,2,3,4-TETRAHYDROISOQUINOLINE",SBUKSNPHYWXCDG-CYBMUJFWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
10420,6lzg,DB08614,-7.2,"3-[[(METHYLAMINO)SULFONYL]AMINO]-2-OXO-6-PHENYL-N-[3,3,3-TRIFLUORO-1-(1-METHYLETHYL)-2-OXOPHENYL]-1(2H)-PYRIDINE ACETAMIDE",MYFMPKCOIMRDDD-KRWDZBQOSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
127995,6w4h,DB07095,-7.2,(S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclopentylpropanoyl)pyrrolidine-2-carboxamide,BNCHHUFGEOJCNH-SFHVURJKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
127993,6w4h,DB07093,-7.2,"{3-[(5-CHLORO-1,3-BENZOTHIAZOL-2-YL)METHYL]-2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL}ACETIC ACID",RQWICELTTDJODO-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
65314,6lxt,DB02669,-7.2,RB106,ZWDQTNWLXALTOV-QYZOEREBSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
120346,6w4b,DB08382,-7.2,Gosogliptin,QWEWGXUTRTXFRF-KBPBESRZSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
54716,6crv,DB00150,-7.2,L-Tryptophan,QIVBCDIJIAJPQS-VIFPVBQESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58097,6crv,DB04546,-7.2,3-Deaza-Adenosine,DBZQFUNLCALWDY-PNHWDRBUSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
155434,6wiq,DB09124,-7.2,Medrogestone,HCFSGRMEEXUOSS-JXEXPEPMSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
49606,2fxp,DB04703,-7.2,Hesperidin,QUQPHWDTPGMPEX-QJBIFVCTSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
120352,6w4b,DB08388,-7.2,"5-(2-ETHOXYETHYL)-5-[4-(4-FLUOROPHENOXY)PHENOXY]PYRIMIDINE-2,4,6(1H,3H,5H)-TRIONE",XRSYNYGEEYTXJV-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
10441,6lzg,DB00805,-7.2,Minaprine,LDMWSLGGVTVJPG-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
101850,6vxs,DB06652,-7.2,Vicriviroc,CNPVJJQCETWNEU-CYFREDJKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
68866,6lxt,DB08429,-7.2,N-({(2S)-1-[(3R)-3-amino-4-(3-chlorophenyl)butanoyl]pyrrolidin-2-yl}methyl)-3-(methylsulfonyl)benzamide,QRGBOABBMKYMLG-UXHICEINSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
108946,6vxx,DB11436,-7.2,Nifurpirinol,JQKHJQJVKRFMCO-SNAWJCMRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
89836,6m71,DB00950,-7.2,Fexofenadine,RWTNPBWLLIMQHL-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
120400,6w4b,DB08446,-7.2,"3-[6-bromo-2-fluoro-3-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)phenoxy]-5-chlorobenzonitrile",OHQMEDBYNUAVNE-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
95497,6m71,DB11429,-7.2,Mibolerone,PTQMMNYJKCSPET-OMHQDGTGSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
161861,7bv1,DB00689,-7.2,Cephaloglycin,FUBBGQLTSCSAON-PBFPGSCMSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
146710,6w9q,DB08864,-7.2,Rilpivirine,YIBOMRUWOWDFLG-ONEGZZNKSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
120413,6w4b,DB08462,-7.2,N-(4-PHENYLAMINO-QUINAZOLIN-6-YL)-ACRYLAMIDE,JGWHILNNHLDARR-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
161874,7bv1,DB00920,-7.2,Ketotifen,ZCVMWBYGMWKGHF-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
153371,6wiq,DB06306,-7.2,Onalespib,IFRGXKKQHBVPCQ-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
146684,6w9q,DB08820,-7.2,Ivacaftor,PURKAOJPTOLRMP-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
108839,6vxx,DB11071,-7.2,Phenyl salicylate,ZQBAKBUEJOMQEX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
161875,7bv1,DB00921,-7.2,Buprenorphine,RMRJXGBAOAMLHD-IHFGGWKQSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
25067,6cs2,DB02916,-7.2,"[(2r,3s,4r,5r)-5-(6-Amino-9h-Purin-9-Yl)-3,4-Dihydroxytetrahydro-2-Furanyl]Methyl Sulfamate",GNZLUJQJDPRUTD-KQYNXXCUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
28565,6cs2,DB08153,-7.2,"(5E)-14-CHLORO-15,17-DIHYDROXY-4,7,8,9,10,11-HEXAHYDRO-2-BENZOXACYCLOPENTADECINE-1,12(3H,13H)-DIONE",VZTAZMSAAIUZJV-HWKANZROSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
65343,6lxt,DB02706,-7.2,Mercaptocarboxylate Inhibitor,DUKDFMPUZRDWLT-CQSZACIVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
161886,7bv1,DB00934,-7.2,Maprotiline,QSLMDECMDJKHMQ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
22041,6cs2,HMDB0052754,-7.2,"TG(18:2(9Z,12Z)/18:3(9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))",CCWQXSQVMPACON-RXTLCQEBSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
161890,7bv1,DB00939,-7.2,Meclofenamic acid,SBDNJUWAMKYJOX-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
89832,6m71,DB00946,-7.2,Phenprocoumon,DQDAYGNAKTZFIW-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
155460,6wiq,DB09181,-7.2,Trefentanil,RJSCINHYBGMIFT-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
120521,6w4b,DB08590,-7.2,1-(3-HYDROXYPROPYL)-2-[(3-NITROBENZOYL)AMINO]-1H-BENZIMIDAZOL-5-YL PIVALATE,CEAYRKIZESVQSN-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
120522,6w4b,DB08591,-7.2,"5-(4-METHOXYBIPHENYL-3-YL)-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDE",IGXKSKWHHHYBFM-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
33593,6cs2,T3D0417,-7.2,"2,4,4'-Trichlorobiphenyl",BZTYNSQSZHARAZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
72217,6m2n,DB00479,-7.2,Amikacin,LKCWBDHBTVXHDL-RMDFUYIESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
146895,6w9q,DB09168,-7.2,4-Phenylfentanyl,BXCJXJLHYMWMQU-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
91942,6m71,DB03751,-7.2,2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose,YSYKRGRSMLTJNL-URARBOGNSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
161670,7bv1,DB00243,-7.2,Ranolazine,XKLMZUWKNUAPSZ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
72214,6m2n,DB00476,-7.2,Duloxetine,ZEUITGRIYCTCEM-KRWDZBQOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
120715,6w4b,DB08816,-7.2,Ticagrelor,OEKWJQXRCDYSHL-FNOIDJSQSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
72205,6m2n,DB00465,-7.2,Ketorolac,OZWKMVRBQXNZKK-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
161621,7bv1,DB00186,-7.2,Lorazepam,DIWRORZWFLOCLC-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
72202,6m2n,DB00459,-7.2,Acitretin,IHUNBGSDBOWDMA-AQFIFDHZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
28490,6cs2,DB08080,-7.2,LATRUNCULIN B,NSHPHXHGRHSMIK-JRIKCGFMSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
72199,6m2n,DB00456,-7.2,Cefalotin,XIURVHNZVLADCM-IUODEOHRSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
28486,6cs2,DB08076,-7.2,"4-[1-(2,6-dichlorobenzyl)-2-methyl-1H-imidazol-4-yl]pyrimidin-2-amine",CKSSZTMRRVJNNG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
10499,6lzg,DB08706,-7.2,"(2S)-({(5Z)-5-[(5-ETHYL-2-FURYL)METHYLENE]-4-OXO-4,5-DIHYDRO-1,3-THIAZOL-2-YL}AMINO)(4-FLUOROPHENYL)ACETIC ACID",RNEACARJKXYVND-MZLJFPOFSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
10502,6lzg,DB08709,-7.2,"2,3-diphenyl-1H-indole-7-carboxylic acid",OLUDUXWVPIEHDA-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
89794,6m71,DB00904,-7.2,Ondansetron,FELGMEQIXOGIFQ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
61175,6crv,DB11696,-7.2,Racecadotril,ODUOJXZPIYUATO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
68900,6lxt,DB08467,-7.2,"6-(2,3,4,5,6,7-HEXAHYDRO-2,4,4-TRIMETHYL-1-METYLENEINDEN-2-YL)-3-METHYLHEXA-2,4-DIENOIC ACID",HEVXQLBAMFMFKU-IAZPEVBMSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
120771,6w4b,DB08911,-7.2,Trametinib,LIRYPHYGHXZJBZ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
25125,6cs2,DB02984,-7.2,"4-[3-Methylsulfanylanilino]-6,7-Dimethoxyquinazoline",FUSDVOSGGMBSMK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
95226,6m71,DB09119,-7.2,Eslicarbazepine acetate,QIALRBLEEWJACW-INIZCTEOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
120765,6w4b,DB08903,-7.2,Bedaquiline,QUIJNHUBAXPXFS-XLJNKUFUSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
108734,6vxx,DB08880,-7.2,Teriflunomide,UTNUDOFZCWSZMS-YFHOEESVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
54875,6crv,DB00335,-7.2,Atenolol,METKIMKYRPQLGS-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
95241,6m71,DB09166,-7.2,Etizolam,VMZUTJCNQWMAGF-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
146926,6w9q,DB09200,-7.2,Rivoglitazone,XMSXOLDPMGMWTH-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
91946,6m71,DB03755,-7.2,"Adenosine-5'-[Beta, Gamma-Methylene]Tetraphosphate",ARRGHMSEJJFDME-IOSLPCCCSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
146903,6w9q,DB09177,-7.2,p-Fluorofentanyl,KXUBAVLIJFTASZ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
83618,6m3m,DB04126,-7.2,N-[1-Hydroxycarboxyethyl-Carbonyl]Leucylamino-2-Methyl-Butane,KBIWEWPGBHKYML-RYUDHWBXSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
25119,6cs2,DB02974,-7.2,4-(4-Chlorophenyl)Imidazole,DVKIFCXVRCGAEE-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
95251,6m71,DB09177,-7.2,p-Fluorofentanyl,KXUBAVLIJFTASZ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
65442,6lxt,DB02842,-7.2,9-amino-n-[3-(dimethylamino)propyl]acridine-4-carboxamide,VNWAULKXOPRJEL-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
105121,6vxs,DB13027,-7.2,Tucaresol,XEDONBRPTABQFB-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
161678,7bv1,DB00252,-7.2,Phenytoin,CXOFVDLJLONNDW-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
161685,7bv1,DB00472,-7.2,Fluoxetine,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
120527,6w4b,DB08597,-7.2,"6-[4-(2-piperidin-1-ylethoxy)phenyl]-3-pyridin-4-ylpyrazolo[1,5-a]pyrimidine",XHBVYDAKJHETMP-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
10473,6lzg,DB08677,-7.2,N-(5-ISOPROPYL-THIAZOL-2-YL)-2-PYRIDIN-3-YL-ACETAMIDE,WQZOOPQQADNJEG-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
33543,6cs2,T3D4793,-7.2,Rhodamine 6g,IWWWBRIIGAXLCJ-BGABXYSRSA-O,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
146785,6w9q,DB08976,-7.2,Floctafenine,APQPGQGAWABJLN-GFCCVEGCSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
95341,6m71,DB09291,-7.2,Rolapitant,FIVSJYGQAIEMOC-ZGNKEGEESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
10474,6lzg,DB00808,-7.2,Indapamide,NDDAHWYSQHTHNT-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
54831,6crv,DB00279,-7.2,Liothyronine,AUYYCJSJGJYCDS-LBPRGKRZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
120548,6w4b,DB08622,-7.2,"4-(4-CHLORO-PHENYL)-1-{3-[2-(4-FLUORO-PHENYL)-[1,3]DITHIOLAN-2-YL]-PROPYL}-PIPERIDIN-4-OL",KVDKNVPAAQKHKD-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
83476,6m3m,DB03932,-7.2,LFA703,WPVRNXUYVXQXPY-YFAYRSKXSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
161738,7bv1,DB00540,-7.2,Nortriptyline,PHVGLTMQBUFIQQ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
120559,6w4b,DB08639,-7.2,Dapivirine,ILAYIAGXTHKHNT-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
136758,6w9c,DB07498,-7.2,"4-[3-(3-NITROPHENYL)-1,2,4-OXADIAZOL-5-YL]BUTANOIC ACID",LQQYZJRCWBRIMW-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
120575,6w4b,DB08656,-7.2,5-amino-2-methyl-N-[(1R)-1-naphthalen-1-ylethyl]benzamide,UVERBUNNCOKGNZ-CQSZACIVSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
136749,6w9c,DB07487,-7.2,"(6-METHYL-3,4-DIHYDRO-2H-CHROMEN-2-YL)METHYLPHOSPHINATE",QTHZTDVLJRQOGF-JTQLQIEISA-M,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
161724,7bv1,DB00523,-7.2,Alitretinoin,SHGAZHPCJJPHSC-ZVCIMWCZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
127956,6w4h,DB07050,-7.2,"5-[(phenylsulfonyl)amino]-1,3,4-thiadiazole-2-sulfonamide",PWDGTQXZLNDOKS-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
33568,6cs2,T3D4817,-7.2,Riboflavin,AUNGANRZJHBGPY-SCRDCRAPSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
68889,6lxt,DB08455,-7.2,Ro 12-7310,CAAFTBWHFUPDGX-OFCLTBKTSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
89803,6m71,DB00913,-7.2,Anileridine,LKYQLAWMNBFNJT-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
120646,6w4b,DB08739,-7.2,"2-{3-[(2S)-4,4-difluoro-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]-3-oxopropyl}-isoindole-1,3(2H)-dione",ZSXNPAWXICXNGZ-HNNXBMFYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
153357,6wiq,DB06266,-7.2,Lonidamine,WDRYRZXSPDWGEB-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
22070,6cs2,HMDB0052813,-7.2,"TG(18:2(9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:5(7Z,10Z,13Z,16Z,19Z))",DHGPOFOBMYEFSV-ZCMPECEDSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
46474,2fxp,DB00590,-7.2,Doxazosin,RUZYUOTYCVRMRZ-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
95272,6m71,DB09198,-7.2,Lobeglitazone,CHHXEZSCHQVSRE-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
146858,6w9q,DB09080,-7.2,Olodaterol,COUYJEVMBVSIHV-SFHVURJKSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
161708,7bv1,DB00498,-7.2,Phenindione,NFBAXHOPROOJAW-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
161709,7bv1,DB00499,-7.2,Flutamide,MKXKFYHWDHIYRV-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
120609,6w4b,DB08701,-7.2,"2-(3-BROMOPHENYL)-6-[(2-HYDROXYETHYL)AMINO]-1H-BENZO[DE]ISOQUINOLINE-1,3(2H)-DIONE",JZCUVYNOSDWORZ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
72241,6m2n,DB00507,-7.2,Nitazoxanide,YQNQNVDNTFHQSW-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
72243,6m2n,DB00509,-7.2,Dextrothyroxine,XUIIKFGFIJCVMT-GFCCVEGCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
83497,6m3m,DB03959,-7.2,"N,O6-Disulfo-Glucosamine",DQTRACMFIGDHSN-UKFBFLRUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
72234,6m2n,DB00498,-7.2,Phenindione,NFBAXHOPROOJAW-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
67698,6lxt,DB07055,-7.2,"2-[2-(1H-tetrazol-5-yl)ethyl]-1H-isoindole-1,3(2H)-dione",DEOJDUHRJBKATO-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
109489,6vxx,DB13978,-7.2,Selisistat,FUZYTVDVLBBXDL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
32497,6cs2,T3D1855,-7.2,Jasmolin I,NZKIRHFOLVYKFT-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
163715,7bv1,DB06133,-7.2,Dimethylcurcumin,ZMGUKFHHNQMKJI-CIOHCNBKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
145683,6w9q,DB07638,-7.2,"(3AS,4R,9BR)-2,2-DIFLUORO-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL",QJSMFUTULGSHNQ-ZOBUZTSGSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
64423,6lxt,DB01512,-7.2,Hydromorphinol,AABLHGPVOULICI-BRJGLHKUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
80405,6m2n,DB15293,-7.2,Epalrestat,CHNUOJQWGUIOLD-NFZZJPOKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
164201,7bv1,DB07371,-7.2,3-(10-methyl-9-anthryl)propanoic acid,CKQINRXZVYBCSC-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
58320,6crv,DB04840,-7.2,Debrisoquine,JWPGJSVJDAJRLW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
119278,6w4b,DB07127,-7.2,"{4-[2,2-BIS(5-METHYL-1,2,4-OXADIAZOL-3-YL)-3-PHENYLPROPYL]PHENYL}SULFAMIC ACID",SXDBFKLPNPUPRI-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
110223,6vxx,DB01118,-7.2,Amiodarone,IYIKLHRQXLHMJQ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
9840,6lzg,DB07971,-7.2,"5-AMINO-2-{4-[(4-AMINOPHENYL)SULFANYL]PHENYL}-1H-ISOINDOLE-1,3(2H)-DIONE",FQQVTDIBUYSVHM-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
163690,7bv1,DB05939,-7.2,MK-0354,LTQYSJKGRPGMPO-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
145703,6w9q,DB07664,-7.2,"5-AMINO-3-{[4-(AMINOSULFONYL)PHENYL]AMINO}-N-(2,6-DIFLUOROPHENYL)-1H-1,2,4-TRIAZOLE-1-CARBOTHIOAMIDE",ARIOBGGRZJITQX-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
97117,6m71,DB13921,-7.2,2'-C-methylcytidine,PPUDLEUZKVJXSZ-VPCXQMTMSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
73569,6m2n,DB02213,-7.2,Metanitrophenyl-Alpha-D-Galactoside,VCCMGHVCRFMITI-IIRVCBMXSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
32537,6cs2,T3D1937,-7.2,"2,2',3,4,5,5'-Hexabromobiphenyl",RBEVZFMPNHHLPP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
110212,6vxx,DB01103,-7.2,Quinacrine,GPKJTRJOBQGKQK-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81153,6m3m,DB00870,-7.2,Suprofen,MDKGKXOCJGEUJW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
73570,6m2n,DB02214,-7.2,"6,7-Dioxo-5h-8-Ribitylaminolumazine",MIBROOURCUHKMD-RPDRRWSUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
81162,6m3m,DB00880,-7.2,Chlorothiazide,JBMKAUGHUNFTOL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
59045,6crv,DB07012,-7.2,"6-AMINO-3,7-DIHYDRO-IMIDAZO[4,5-G]QUINAZOLIN-8-ONE",VQSMWFVKBKMHTO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163661,7bv1,DB05767,-7.2,Andrographolide,BOJKULTULYSRAS-OTESTREVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97121,6m71,DB13931,-7.2,Netarsudil,OURRXQUGYQRVML-AREMUKBSSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
9850,6lzg,DB00735,-7.2,Naftifine,OZGNYLLQHRPOBR-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
91661,6m71,DB03349,-7.2,8-Bromo-Adenosine-5'-Monophosphate,DNPIJKNXFSPNNY-UUOKFMHZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
130125,6w4h,DB11806,-7.2,VTP-194204,BOOOLEGQBVUTKC-NVQSDHBMSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
81172,6m3m,DB00891,-7.2,Sulfapyridine,GECHUMIMRBOMGK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
90228,6m71,DB01476,-7.2,Haloxazolam,XDKCGKQHVBOOHC-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110239,6vxx,DB01136,-7.2,Carvedilol,OGHNVEJMJSYVRP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
24683,6cs2,DB00323,-7.2,Tolcapone,MIQPIUSUKVNLNT-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
12138,6lzg,DB12935,-7.2,Remogliflozin etabonate,UAOCLDQAQNNEAX-ABMICEGHSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
110284,6vxx,DB01186,-7.2,Pergolide,YEHCICAEULNIGD-MZMPZRCHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
9815,6lzg,DB07945,-7.2,"5-(3-carbamoylbenzyl)-5,6,7,8,9,10-hexahydrocyclohepta[b]indole-4-carboxylic acid",GKBQRPKZHUFGOB-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
80447,6m2n,DB15381,-7.2,Menaquinone,HYPYXGZDOYTYDR-HAJWAVTHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
91738,6m71,DB03461,-7.2,2'-Monophosphoadenosine 5'-Diphosphoribose,XJLXINKUBYWONI-NNYOXOHSSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
145660,6w9q,DB07613,-7.2,3-phenyl-5-(1H-pyrazol-3-yl)isoxazole,SRSSTOPJERVMRZ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
101002,6vxs,DB04338,-7.2,SB220025,VSPFURGQAYMVAN-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
11871,6lzg,DB12545,-7.2,Indobufen,AYDXAULLCROVIT-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
28940,6cs2,DB08568,-7.2,(2S)-1-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}-3-PHENYLPROPAN-2-AMINE,BPNUQXPIQBZCMR-IBGZPJMESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
163741,7bv1,DB06188,-7.2,Ispinesib,QJZRFPJCWMNVAV-HHHXNRCGSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110276,6vxx,DB01178,-7.2,Chlormezanone,WEQAYVWKMWHEJO-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28934,6cs2,DB08559,-7.2,"N-[(2S,4S,6R)-2-(dihydroxymethyl)-4-hydroxy-3,3-dimethyl-7-oxo-4lambda-4-thia-1-azabicyclo[3.2.0]hept-6-yl]-2-phenylacetamide",WMPGEOZLAYOFHH-MBNYWOFBSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
119226,6w4b,DB07066,-7.2,"2-CHLORO-N-[(3R)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL]-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE",LJAHIGGEXIWVJG-LLVKDONJSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
104919,6vxs,DB12710,-7.2,Perazine,WEYVCQFUGFRXOM-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
128444,6w4h,DB07620,-7.2,"2-[(2,4-DICHLORO-5-METHYLPHENYL)SULFONYL]-1,3-DINITRO-5-(TRIFLUOROMETHYL)BENZENE",INAZPZCJNPPHGV-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
162899,7bv1,DB03263,-7.2,Thiocellobiose,VDQIIPZYLPYPNM-QRZGKKJRSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
119229,6w4b,DB07070,-7.2,(2S)-2-{3-[({[2-fluoro-4-(trifluoromethyl)phenyl]carbonyl}amino)methyl]-4-methoxybenzyl}butanoic acid,BDLLIPYDNFENMY-ZDUSSCGKSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
96890,6m71,DB13587,-7.2,Mesterolone,UXYRZJKIQKRJCF-TZPFWLJSSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110743,6vxx,DB02359,-7.2,"9-Butyl-8-(2,5-Dimethoxy-Benzyl)-9h-Purin-6-Ylamine",PPFZLLAIQRZNJE-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138604,6w9c,DB11905,-7.2,Sutezolid,FNDDDNOJWPQCBZ-ZDUSSCGKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
153590,6wiq,DB06886,-7.2,N-BENZYLOXYCARBONYL-ALA-PRO-3-AMINO-4-PHENYL-BUTAN-2-OL,MACLRJNEKXUAJK-YDLSIGKMSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
110248,6vxx,DB01146,-7.2,Diphenylpyraline,OWQUZNMMYNAXSL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59082,6crv,DB07052,-7.2,5'-S-ethyl-5'-thioadenosine,HMXHURAGFHWODC-WOUKDFQISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
90223,6m71,DB01471,-7.2,Bolasterone,IVFYLRMMHVYGJH-VLOLGRDOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
130134,6w4h,DB11820,-7.2,Nifurtimox,ARFHIAQFJWUCFH-IZZDOVSWSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
81081,6m3m,DB00788,-7.2,Naproxen,CMWTZPSULFXXJA-VIFPVBQESA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
145477,6w9q,DB07394,-7.2,AUROVERTIN B,QXCOFYWOWZJFEA-YJMRODJJSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
104321,6vxs,DB11827,-7.2,Ertugliflozin,MCIACXAZCBVDEE-CUUWFGFTSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
18812,6cs2,HMDB0035789,-7.2,Matairesinol,MATGKVZWFZHCLI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
153672,6wiq,DB06985,-7.2,2-[({4-[2-(trifluoromethyl)phenyl]piperidin-1-yl}carbonyl)amino]benzoic acid,MEAQCLPMSVEOQF-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
101307,6vxs,DB04753,-7.2,"9-DEAZAINOSINE-2',3'-O-ETHYLIDENEPHOSPHONATE",ZOEDLCUBOBTIHG-USQSKNHBSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
138502,6w9c,DB11762,-7.2,Marizomib,NGWSFRIPKNWYAO-SHTIJGAHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
46270,2fxp,DB00342,-7.2,Terfenadine,GUGOEEXESWIERI-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
163595,7bv1,DB04833,-7.2,Methaqualone,JEYCTXHKTXCGPB-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96755,6m71,DB13403,-7.2,Oxypertine,XCWPUUGSGHNIDZ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110115,6vxx,DB00993,-7.2,Azathioprine,LMEKQMALGUDUQG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
96744,6m71,DB13386,-7.2,Epimestrol,UHQGCIIQUZBJAE-RRQVMCLOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
32149,6cs2,DB01129,-7.2,Rabeprazole,YREYEVIYCVEVJK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
138440,6w9c,DB11667,-7.2,2'-cyano-2'-deoxy-1-(beta-D-arabinofuranosyl)cytosine,DCYBPMFXJCWXNB-JWIUVKOKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
26964,6cs2,DB00582,-7.2,Voriconazole,BCEHBSKCWLPMDN-MGPLVRAMSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
96725,6m71,DB13360,-7.2,Tolciclate,CANCCLAKQQHLNK-LSDHHAIUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
73596,6m2n,DB02247,-7.2,Hydrolyzed Cephalothin,JRYZEMHNDUZNMI-RYUDHWBXSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
64661,6lxt,DB01810,-7.2,"[1-(1-Methyl-4,5-Dioxo-Pent-2-Enylcarbamoyl)-2-Phenyl-Ethyl]-Carbamic Acid Benzyl Ester",NOXVWFAAXREWMI-GURWAVDKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
138506,6w9c,DB11766,-7.2,AZD-1305,BLLNYXOLLAVTRF-HDICACEKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
81277,6m3m,DB01011,-7.2,Metyrapone,FJLBFSROUSIWMA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
50099,2fxp,DB06446,-7.2,Dotarizine,LRMJAFKKJLRDLE-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
110103,6vxx,DB00980,-7.2,Ramelteon,YLXDSYKOBKBWJQ-LBPRGKRZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
101348,6vxs,DB04807,-7.2,4-NITROPHENYL-(6-S-ALPHA-D-XYLOPYRANOSYL)-BETA-D-GLUCOPYRANOSIDE,HQYVHBCTLFPWRQ-ZMFOIVQCSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
110099,6vxx,DB00975,-7.2,Dipyridamole,IZEKFCXSFNUWAM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
100917,6vxs,DB04222,-7.2,Sparsomycin,XKLZIVIOZDNKEQ-CLQLPEFOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
64663,6lxt,DB01812,-7.2,Adenosine-3'-5'-Diphosphate,WHTCPDAXWFLDIH-KQYNXXCUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
96673,6m71,DB13300,-7.2,Epicillin,RPBAFSBGYDKNRG-NJBDSQKTSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96669,6m71,DB13292,-7.2,Pimethixene,NZLVRVYNQYGMAB-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
128307,6w4h,DB07454,-7.2,(R)-3-BROMO-2-HYDROXY-2-METHYL-N-[4-NITRO-3-(TRIFLUOROMETHYL)PHENYL]PROPANAMIDE,QDSWNDMHSBZXKX-JTQLQIEISA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
139286,6w9c,DB13270,-7.2,Dibekacin,JJCQSGDBDPYCEO-XVZSLQNASA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
145417,6w9q,DB07323,-7.2,"2-[({2-[(1Z)-3-(DIMETHYLAMINO)PROP-1-ENYL]-4-FLUOROPHENYL}SULFONYL)AMINO]-5,6,7,8-TETRAHYDRONAPHTHALENE-1-CARBOXYLIC ACID",CTZLIARLNXSXGL-ALCCZGGFSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
163514,7bv1,DB04726,-7.2,"7,8,10-TRIMETHYLBENZO[G]PTERIDINE-2,4(3H,10H)-DIONE",KPDQZGKJTJRBGU-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
118999,6w4b,DB06786,-7.2,Halcinonide,MUQNGPZZQDCDFT-JNQJZLCISA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
163753,7bv1,DB06207,-7.2,Silodosin,PNCPYILNMDWPEY-QGZVFWFLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110127,6vxx,DB01007,-7.2,Tioconazole,QXHHHPZILQDDPS-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
97136,6m71,DB13952,-7.2,Estradiol acetate,FHXBMXJMKMWVRG-SLHNCBLASA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
81181,6m3m,DB00902,-7.2,Methdilazine,HTMIBDQKFHUPSX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
68692,6lxt,DB08207,-7.2,"2-(3,5-DIMETHYLPHENYL)-1,3-BENZOXAZOLE",BIHLSRJPJFOESJ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
145435,6w9q,DB07343,-7.2,"4-[4-AMINO-6-(2,6-DICHLORO-PHENOXY)-[1,3,5]TRIAZIN-2-YLAMINO]-BENZONITRILE",NFNNMVVXXITVGD-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
26376,6cs2,DB00518,-7.2,Albendazole,HXHWSAZORRCQMX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
32552,6cs2,T3D1955,-7.2,"2,4'-Dibromobiphenyl",FPYGQQPAMXFHJF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
138561,6w9c,DB11843,-7.2,PF-04958242,TTYKUKSFWHEBLI-DLBZAZTESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
119308,6w4b,DB07162,-7.2,4-(3-amino-1H-indazol-5-yl)-N-tert-butylbenzenesulfonamide,KFJCXIOVAGJCKB-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
110175,6vxx,DB01062,-7.2,Oxybutynin,XIQVNETUBQGFHX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81197,6m3m,DB00918,-7.2,Almotriptan,WKEMJKQOLOHJLZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
91759,6m71,DB03490,-7.2,"3-Pyridin-4-Yl-2,4-Dihydro-Indeno[1,2-.C.]Pyrazole",NHOACLCXCKJMAK-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
81212,6m3m,DB00935,-7.2,Oxymetazoline,WYWIFABBXFUGLM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
50119,2fxp,DB06494,-7.2,Sufugolix,UCQSBGOFELXYIN-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
119336,6w4b,DB07193,-7.2,"(2R,3R)-7-(methylsulfonyl)-3-(2,4,5-trifluorophenyl)-1,2,3,4-tetrahydropyrido[1,2-a]benzimidazol-2-amine",HJJAYSSCWGUPKO-ABAIWWIYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
110163,6vxx,DB01048,-7.2,Abacavir,MCGSCOLBFJQGHM-SCZZXKLOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
24694,6cs2,DB00324,-7.2,Fluorometholone,FAOZLTXFLGPHNG-KNAQIMQKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
96817,6m71,DB13487,-7.2,Iodine (131I) norcholesterol,QJHZPCLORSPENH-DRTKWHMQSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
119331,6w4b,DB07187,-7.2,6-[(5-CHLORO-3-METHYL-1-BENZOFURAN-2-YL)SULFONYL]PYRIDAZIN-3(2H)-ONE,FXFPQPNUMWQRAO-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
101319,6vxs,DB04769,-7.2,"5-QUINOXALIN-6-YLMETHYLENE-THIAZOLIDINE-2,4-DIONE",SQWZFLMPDUSYGV-POHAHGRESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
96813,6m71,DB13481,-7.2,Tenidap,LXIKEPCNDFVJKC-QXMHVHEDSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
80296,6m2n,DB15079,-7.2,Troriluzole,YBZSGIWIPOUSHY-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
37423,1r42,DB04244,-7.2,(2R)-2-(3-Biphenylyl)-N-{(2R)-2-hydroxy-3-[(2-pyridinylsulfonyl)amino]propyl}-4-methylpentanamide,YCDHZDINQZLSRR-DNQXCXABSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
164211,7bv1,DB07383,-7.2,"N-(1-BENZYL-3,3,3-TRIFLUORO-2,2-DIHYDROXY-PROPYL)-ACETAMIDE",NETPVFJEHOGNPJ-JTQLQIEISA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110139,6vxx,DB01021,-7.2,Trichlormethiazide,LMJSLTNSBFUCMU-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
24701,6cs2,DB02484,-7.2,Cytidine 5'-Diphosphoglycerol,HHPOUCCVONEPRK-CNYIRLTGSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
145430,6w9q,DB07337,-7.2,"4-[4-AMINO-6-(5-CHLORO-1H-INDOL-4-YLMETHYL)-[1,3,5]TRIAZIN-2-YLAMINO]-BENZONITRILE",SOKOHDQTKSROQZ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
61724,6crv,DB12492,-7.2,Piritramide,IHEHEFLXQFOQJO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
96832,6m71,DB13506,-7.2,Carfecillin,NZDASSHFKWDBBU-KVMCETHSSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
139288,6w9c,DB13273,-7.2,Sultopride,UNRHXEPDKXPRTM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
24588,6cs2,DB02359,-7.2,"9-Butyl-8-(2,5-Dimethoxy-Benzyl)-9h-Purin-6-Ylamine",PPFZLLAIQRZNJE-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
118889,6w4b,DB06581,-7.2,Bevirimat,YJEJKUQEXFSVCJ-WRFMNRASSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
119056,6w4b,DB06871,-7.2,17-METHYL-17-ALPHA-DIHYDROEQUILENIN,FQMQOMRDADWGJJ-GBESFXJTSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
97083,6m71,DB13842,-7.2,Etofylline nicotinate,ZWIAODBBEZGVPY-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110505,6vxx,DB01682,-7.2,6'-Methyl-Thiamin Diphosphate,XTYXJYCWAJSHCY-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80678,6m3m,DB00296,-7.2,Ropivacaine,ZKMNUMMKYBVTFN-HNNXBMFYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
37402,1r42,DB04216,-7.2,Quercetin,REFJWTPEDVJJIY-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
110500,6vxx,DB01676,-7.2,Trinitrotoluene,SPSSULHKWOKEEL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
139043,6w9c,DB12758,-7.2,Atreleuton,MMSNEKOTSJRTRI-LLVKDONJSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
110642,6vxx,DB02047,-7.2,"2-(1,1'-Biphenyl-4-Yl)Propanoic Acid",JALUUBQFLPUJMY-NSHDSACASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
3286,6lzg,HMDB0000900,-7.2,Ergocalciferol,MECHNRXZTMCUDQ-RKHKHRCZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
101055,6vxs,DB04416,-7.2,"R-2-{[4'-Methoxy-(1,1'-Biphenyl)-4-Yl]-Sulfonyl}-Amino-6-Methoxy-Hex-4-Ynoic Acid",QJKGJGURDPRKGW-LJQANCHMSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
80846,6m3m,DB00499,-7.2,Flutamide,MKXKFYHWDHIYRV-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
119059,6w4b,DB06874,-7.2,"(6-[4-(AMINOMETHYL)-2,6-DIMETHYLPHENOXY]-2-{[4-(AMINOMETHYL)PHENYL]AMINO}-5-BROMOPYRIMIDIN-4-YL)METHANOL",LSIZSSASMKSUIU-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
80854,6m3m,DB00509,-7.2,Dextrothyroxine,XUIIKFGFIJCVMT-GFCCVEGCSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
138865,6w9c,DB12377,-7.2,Relebactam,SMOBCLHAZXOKDQ-ZJUUUORDSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
145512,6w9q,DB07434,-7.2,HONH-BENZYLMALONYL-L-ALANYLGLYCINE-P-NITROANILIDE,TZWQPWGUQCSKDW-GUYCJALGSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
6591,6lzg,DB02375,-7.2,Myricetin,IKMDFBPHZNJCSN-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
119070,6w4b,DB06886,-7.2,N-BENZYLOXYCARBONYL-ALA-PRO-3-AMINO-4-PHENYL-BUTAN-2-OL,MACLRJNEKXUAJK-YDLSIGKMSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
138854,6w9c,DB12359,-7.2,BIIB021,QULDDKSCVCJTPV-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
68639,6lxt,DB08145,-7.2,"6-(2,6-DIMETHOXYPHENYL)PYRIDO[2,3-D]PYRIMIDINE-2,7-DIAMINE",LRPHIAJXODIASX-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
97091,6m71,DB13851,-7.2,Artemotil,NLYNIRQVMRLPIQ-XQLAAWPRSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
68640,6lxt,DB08146,-7.2,"7-(2,5-dihydropyrrol-1-yl)-6-phenyl-pyrido[6,5-d]pyrimidin-2-amine",QFWNOFXQNCLFBC-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
73382,6m2n,DB01959,-7.2,"3,5-Dimethyl-1-(3-Nitrophenyl)-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester",MSYGAHOHLUJIKV-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
14689,6lzg,T3D4586,-7.2,Pinazepam,MFZOSKPPVCIFMT-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
68643,6lxt,DB08149,-7.2,"1-[4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine",KCWPSUKJCKZEAO-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
64496,6lxt,DB01595,-7.2,Nitrazepam,KJONHKAYOJNZEC-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
145525,6w9q,DB07450,-7.2,(R)-minalrestat,BMHZAHGTGIZZCT-LJQANCHMSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
97077,6m71,DB13836,-7.2,Metampicillin,FZECHKJQHUVANE-MCYUEQNJSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
28946,6cs2,DB08574,-7.2,"(5R)-2-SULFANYL-5-[4-(TRIFLUOROMETHYL)BENZYL]-1,3-THIAZOL-4-ONE",HBYVUUWMCCSRBI-MRVPVSSYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
80707,6m3m,DB00333,-7.2,Methadone,USSIQXCVUWKGNF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
32295,6cs2,DB01295,-7.2,Bevantolol,HXLAFSUPPDYFEO-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
64466,6lxt,DB01557,-7.2,??-Methylfentanyl,NGTVDHYUFBKWID-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
80748,6m3m,DB00382,-7.2,Tacrine,YLJREFDVOIBQDA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
164084,7bv1,DB07240,-7.2,3-[(9H-fluoren-9-ylideneamino)oxy]propanoic acid,LASWLEUVWJDDBA-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
164082,7bv1,DB07238,-7.2,Nesbuvir,WTDWVLJJJOTABN-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
164080,7bv1,DB07235,-7.2,"N-[(1S)-2-AMINO-1-(2,4-DICHLOROBENZYL)ETHYL]-5-[2-(METHYLAMINO)PYRIMIDIN-4-YL]THIOPHENE-2-CARBOXAMIDE",HHOVRZGUSBMKKU-ZDUSSCGKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
101098,6vxs,DB04474,-7.2,1-Anilino-8-Naphthalene Sulfonate,FWEOQOXTVHGIFQ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
64468,6lxt,DB01559,-7.2,Clotiazepam,CHBRHODLKOZEPZ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
119027,6w4b,DB06833,-7.2,1-CYCLOHEXYL-N-{[1-(4-METHYLPHENYL)-1H-INDOL-3-YL]METHYL}METHANAMINE,MMIJMYOYKAKQPN-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
145542,6w9q,DB07470,-7.2,"(3aS)-3a-hydroxy-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one",DOMYOVZXZIZTRD-QGZVFWFLSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
154900,6wiq,DB08423,-7.2,[5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL][3-(PIPERIDIN-4-YLOXY)PHENYL]METHANONE,QKZZJXRGCHXIAI-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
64474,6lxt,DB01565,-7.2,Dihydromorphine,IJVCSMSMFSCRME-KBQPJGBKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
154956,6wiq,DB08490,-7.2,CTS-1027,ROSNVSQTEGHUKU-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
32287,6cs2,DB01274,-7.2,Arformoterol,BPZSYCZIITTYBL-YJYMSZOUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
90198,6m71,DB01443,-7.2,19-Nor-5-androstenedione,WELNRNVZXWUOGT-QXUSFIETSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
80789,6m3m,DB00433,-7.2,Prochlorperazine,WIKYUJGCLQQFNW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
128396,6w4h,DB07560,-7.2,N-[(1S)-2-methyl-1-(pyridin-4-ylcarbamoyl)propyl]cyclohexanecarboxamide,VYLDPSVXLWTIAJ-HNNXBMFYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
9722,6lzg,DB07844,-7.2,6-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1-BENZOTHIOPHENE-2-SULFONAMIDE,PHLKBODTBJLXRD-WFASDCNBSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
73423,6m2n,DB02017,-7.2,Imidazole-Derived Cellobiose,CSXOUJBOYXGFCL-OFKZETBZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
164053,7bv1,DB07017,-7.2,"(5S)-2-{[(1S)-1-(4-fluorophenyl)ethyl]amino}-5-(1-hydroxy-1-methylethyl)-5-methyl-1,3-thiazol-4(5H)-one",HYVZYASDRIAOPU-BJOHPYRUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59059,6crv,DB07028,-7.2,(2-{[(4-BROMO-2-FLUOROBENZYL)AMINO]CARBONYL}-5-CHLOROPHENOXY)ACETIC ACID,ZLIGBZRXAQNUFO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80814,6m3m,DB00461,-7.2,Nabumetone,BLXXJMDCKKHMKV-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
154951,6wiq,DB08485,-7.2,"(1S,4S,5S)-1,4,5-TRIHYDROXY-3-[3-(PHENYLTHIO)PHENYL]CYCLOHEX-2-ENE-1-CARBOXYLIC ACID",QMNMNSINKIFYBV-LMMKCTJWSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
68636,6lxt,DB08142,-7.2,AT-7519,OVPNQJVDAFNBDN-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
32282,6cs2,DB01264,-7.2,Darunavir,CJBJHOAVZSMMDJ-HEXNFIEUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
73408,6m2n,DB01995,-7.2,5-Methylcytidine-5'-Monophosphate,NJQONZSFUKNYOY-JXOAFFINSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
153646,6wiq,DB06948,-7.2,2-ANILINO-6-CYCLOHEXYLMETHOXYPURINE,XWWRLKIBRPJQJX-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
110449,6vxx,DB01611,-7.2,Hydroxychloroquine,XXSMGPRMXLTPCZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
90175,6m71,DB01418,-7.2,Acenocoumarol,VABCILAOYCMVPS-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
32251,6cs2,DB01224,-7.2,Quetiapine,URKOMYMAXPYINW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
145610,6w9q,DB07549,-7.2,"2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUORO-3-METHYL-6-PYRIDINYL)METHYL]ACETAMIDE",WOYBPRBUPLYTPY-UHFFFAOYSA-P,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
119178,6w4b,DB07014,-7.2,"2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4-methoxybenzyl)sulfanyl]-1,3,4-oxadiazole",TUTZKAQTSPMEBI-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
163847,7bv1,DB06736,-7.2,Aceclofenac,MNIPYSSQXLZQLJ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
163846,7bv1,DB06457,-7.2,Tecastemizole,SFOVDSLXFUGAIV-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97000,6m71,DB13729,-7.2,Camostat,XASIMHXSUQUHLV-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
154963,6wiq,DB08497,-7.2,"(1S)-2-oxo-1-phenyl-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate",NKBDSMREMMRFSI-INIZCTEOSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
64519,6lxt,DB01622,-7.2,Thioproperazine,VZYCZNZBPPHOFY-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
128347,6w4h,DB07503,-7.2,"(5E)-5-[(2,2-DIFLUORO-1,3-BENZODIOXOL-5-YL)METHYLENE]-1,3-THIAZOLIDINE-2,4-DIONE",SRLVNYDXMUGOFI-YWEYNIOJSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
3366,6lzg,HMDB0046329,-7.2,"TG(22:0/16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))",PSQNMLIGVNKGBS-QCRPGBDUSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
32219,6cs2,DB01191,-7.2,Dexfenfluramine,DBGIVFWFUFKIQN-VIFPVBQESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
128439,6w4h,DB07614,-7.2,"PHENYL-5-(1H-PYRAZOL-3-YL)-1,3-THIAZOLE",NRAHRUHGPGBWSI-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
145624,6w9q,DB07567,-7.2,"(2R,3R,4S)-3-(4-HYDROXYPHENYL)-4-METHYL-2-[4-(2-PYRROLIDIN-1-YLETHOXY)PHENYL]CHROMAN-6-OL",XPVKGTWRXBSJKO-LHXLBICKSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
684,6lzg,HMDB0006631,-7.2,Sialyllacto-N-tetraose c,SXMGGNXBTZBGLU-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
163818,7bv1,DB06374,-7.2,Elacestrant,SIFNOOUKXBRGGB-AREMUKBSSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
138713,6w9c,DB12156,-7.2,Cordycepin,OFEZSBMBBKLLBJ-BAJZRUMYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
32454,6cs2,T3D1798,-7.2,Dibrompropamidine,GMJFVGRUYJHMCO-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
138704,6w9c,DB12145,-7.2,AZD-0328,OCKIPDMKGPYYJS-ZDUSSCGKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
119210,6w4b,DB07049,-7.2,(2R)-1-[(4-tert-butylphenyl)sulfonyl]-2-methyl-4-(4-nitrophenyl)piperazine,SOFGQQQVQZQJFS-MRXNPFEDSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
154982,6wiq,DB08520,-7.2,"(21S)-1AZA-4,4-DIMETHYL-6,19-DIOXA-2,3,7,20-TETRAOXOBICYCLO[19.4.0] PENTACOSANE",VUCSBBBCFXBFFY-IBGZPJMESA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
32206,6cs2,DB01179,-7.2,Podofilox,YJGVMLPVUAXIQN-XVVDYKMHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
9677,6lzg,DB07796,-7.2,"(3ASR,4RS,8ASR,8BRS)-4-(2-(4-FLUOROBENZYL)-1,3-DIOXODEACAHYDROPYRROLO[3,4-A] PYRROLIZIN-4-YL)BENZAMIDINE",GJYCQHGTXMVIBG-MUGJNUQGSA-O,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
145641,6w9q,DB07588,-7.2,"3,4-DI-1H-INDOL-3-YL-1H-PYRROLE-2,5-DICARBOXYLIC ACID",FZDVNXHYGMEEDT-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
163782,7bv1,DB06266,-7.2,Lonidamine,WDRYRZXSPDWGEB-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
163781,7bv1,DB06264,-7.2,Tolperisone,FSKFPVLPFLJRQB-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
163764,7bv1,DB06234,-7.2,Maribavir,KJFBVJALEQWJBS-XUXIUFHCSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
36780,1r42,DB03376,-7.2,'5'-O-(N-(L-Alanyl)-Sulfamoyl)Adenosine,CWWYMWDIYBJVLP-YTMOPEAISA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
26388,6cs2,DB04517,-7.2,Dipyrromethane Cofactor,LCAXMKQKEYTFDM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
138658,6w9c,DB12080,-7.2,Ritobegron,VMMYRRFPMAGXNP-BTYIYWSLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
163863,7bv1,DB06766,-7.2,Alcaftadine,MWTBKTRZPHJQLH-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
138751,6w9c,DB12220,-7.2,ORG-25935,UEBBYLJZCHTLEG-UTKZUKDTSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
64499,6lxt,DB01599,-7.2,Probucol,FYPMFJGVHOHGLL-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
139061,6w9c,DB12791,-7.2,Laninamivir,QNRRHYPPQFELSF-CNYIRLTGSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
145595,6w9q,DB07533,-7.2,"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]-2-FURYL}-N-METHYLBENZENESULFONAMIDE",FJJJERLTHDXEPT-JYRVWZFOSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
110445,6vxx,DB01606,-7.2,Tazobactam,LPQZKKCYTLCDGQ-WEDXCCLWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
18937,6cs2,HMDB0041702,-7.2,"7,8,3',4'-Tetrahydroxyisoflavone",VMOBWBRUROXCOO-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
163931,7bv1,DB06873,-7.2,"1-((2-HYDROXYETHOXY)METHYL)-5-(3-(BENZYLOXY)BENZYL)PYRIMIDINE-2,4(1H,3H)-DIONE",CSXNPJKDZKLDET-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
24596,6cs2,DB00315,-7.2,Zolmitriptan,ULSDMUVEXKOYBU-ZDUSSCGKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
64501,6lxt,DB01602,-7.2,Bacampicillin,PFOLLRNADZZWEX-FFGRCDKISA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
80648,6m3m,DB00263,-7.2,Sulfisoxazole,NHUHCSRWZMLRLA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
119103,6w4b,DB06922,-7.2,"2-[(1R)-1-carboxy-2-naphthalen-1-ylethyl]-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylic acid",CZNPWASYMRBJCX-GOSISDBHSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
110440,6vxx,DB01600,-7.2,Tiaprofenic acid,GUHPRPJDBZHYCJ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61813,6crv,DB12637,-7.2,Onapristone,IEXUMDBQLIVNHZ-YOUGDJEHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
118900,6w4b,DB06604,-7.2,Ilepatril,FXKFFTMLFPWYFH-RDGPPVDQSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
110433,6vxx,DB01589,-7.2,Quazepam,IKMPWMZBZSAONZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80642,6m3m,DB00255,-7.2,Diethylstilbestrol,RGLYKWWBQGJZGM-ISLYRVAYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
138794,6w9c,DB12276,-7.2,Apomine,YLJOVCWVJCDPLN-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
61810,6crv,DB12629,-7.2,"3,5-diiodothyropropionic acid",WONYMNWUJVKVII-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
64502,6lxt,DB01603,-7.2,Meticillin,RJQXTJLFIWVMTO-TYNCELHUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
163890,7bv1,DB06820,-7.2,Sulconazole,AFNXATANNDIXLG-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
145602,6w9q,DB07540,-7.2,"4-{5-[(1Z)-1-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)ETHYL]-2-FURYL}BENZENESULFONAMIDE",AKFVRSQELXTCFW-JYRVWZFOSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
145609,6w9q,DB07548,-7.2,"2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUORO-6-PYRIDINYL)METHYL]ACETAMIDE",JXHWVKOKYDAROD-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
110675,6vxx,DB02090,-7.2,A Disubstituted Succinyl Caprolactam Hydroxymate Mmp3inhibitor,JLEGVELHGVWFGG-BBWFWOEESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
97001,6m71,DB13730,-7.2,Nifurtoinol,UIDWQGRXEVDFCA-XCVCLJGOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
80624,6m3m,DB00235,-7.2,Milrinone,PZRHRDRVRGEVNW-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
9682,6lzg,DB00715,-7.2,Paroxetine,AHOUBRCZNHFOSL-YOEHRIQHSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
164156,7bv1,DB07318,-7.2,"N-[2-(4-AMINO-5,8-DIFLUORO-1,2-DIHYDROQUINAZOLIN-2-YL)ETHYL]-3-FURAMIDE",BOAUWUUBSXECNL-LLVKDONJSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
139077,6w9c,DB12818,-7.2,NM-3,BPZCXUROMKDLGX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
96595,6m71,DB13174,-7.2,Rhein,FCDLCPWAQCPTKC-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
32601,6cs2,T3D2001,-7.2,"2,3',4,5,5'-Pentabromobiphenyl",QGHFNPRLPWJMFO-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
139299,6w9c,DB13286,-7.2,Bumadizone,FLWFHHFTIRLFPV-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
26989,6cs2,DB06200,-7.2,Tedisamil,CTIRHWCPXYGDGF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
81582,6m3m,DB01437,-7.2,Glutethimide,JMBQKKAJIKAWKF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
104270,6vxs,DB11757,-7.2,Istradefylline,IQVRBWUUXZMOPW-PKNBQFBNSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
96328,6m71,DB12740,-7.2,CC-115,GMYLVKUGJMYTFB-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
32065,6cs2,DB15293,-7.2,Epalrestat,CHNUOJQWGUIOLD-NFZZJPOKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
164318,7bv1,DB07694,-7.2,"2,5-dichloro-N-(3,5-dibromo-4-hydroxyphenyl)benzamide",IFLWCZRMFPKYBN-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
145362,6w9q,DB07263,-7.2,"[{2-bromo-4-[(2R)-3-oxo-2,3-diphenylpropyl]phenyl}(difluoro)methyl]phosphonic acid",WDTMVBQZDFMOIK-GOSISDBHSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
138109,6w9c,DB09191,-7.2,Talsupram,FKHYYOUFMJBLAF-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
97182,6m71,DB14045,-7.2,Cholesteryl chloride,OTVRYZXVVMZHHW-DPAQBDIFSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
81616,6m3m,DB01475,-7.2,Dioxaphetyl butyrate,LQGIXNQCOXNCRP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
118727,6w4b,DB06159,-7.2,Rubitecan,VHXNKPBCCMUMSW-FQEVSTJZSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
138108,6w9c,DB09190,-7.2,Talopram,LJBBMCNHIUJBDU-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
155169,6wiq,DB08742,-7.2,"1,3-CYCLOHEXANEDIOL, 4-METHYLENE-5-[(2E)-[(1S,3AS,7AS)-OCTAHYDRO-1-(5-HYDROXY-5-METHYL-1,3-HEXADIYNYL)-7A-METHYL-4H-INDEN-4-YLIDENE]ETHYLIDENE]-, (1R,3S,5Z)",CEEUUHVULXTFGS-BQXVGYHGSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
164325,7bv1,DB07702,-7.2,17alpha-Estriol,PROQIPRRNZUXQM-PNVOZDDCSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
32805,6cs2,T3D3718,-7.2,Trichothecin,LJWZOKOFCBPNAG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
164328,7bv1,DB07705,-7.2,"1-[(2S)-2-[(4-CHLOROBENZYL)OXY]-2-(2,4-DICHLOROPHENYL)ETHYL]-1H-IMIDAZOLE",LEZWWPYKPKIXLL-GOSISDBHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
118718,6w4b,DB06148,-7.2,Mianserin,UEQUQVLFIPOEMF-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
111001,6vxx,DB02862,-7.2,Gluco-Phenylimidazole,DLVNFMROYKHANV-FVCCEPFGSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
24776,6cs2,DB02568,-7.2,Peldesine,DOHVAKFYAHLCJP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
111003,6vxx,DB02866,-7.2,Dansylamide,TYNBFJJKZPTRKS-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
79966,6m2n,DB14060,-7.2,NS-398,KTDZCOWXCWUPEO-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
145773,6w9q,DB07747,-7.2,"(3R)-N-(4-CHLOROPHENYL)-3-(HYDROXYMETHYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONAMIDE",YTBGBMPLINFTBQ-OAHLLOKOSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
90001,6m71,DB01142,-7.2,Doxepin,ODQWQRRAPPTVAG-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
64359,6lxt,DB01436,-7.2,Alfacalcidol,OFHCOWSQAMBJIW-AVJTYSNKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
145343,6w9q,DB07244,-7.2,"5-{4-[(3,5-DIFLUOROBENZYL)AMINO]PHENYL}-6-ETHYLPYRIMIDINE-2,4-DIAMINE",SRRWXMSVQYQCRX-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
81574,6m3m,DB01428,-7.2,Oxybenzone,DXGLGDHPHMLXJC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
109823,6vxx,DB00297,-7.2,Bupivacaine,LEBVLXFERQHONN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163195,7bv1,DB03883,-7.2,Carboxyethyllumazine,PTYCEIBBGGLADD-PJKMHFRUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
64847,6lxt,DB02061,-7.2,Cellobiose,GUBGYTABKSRVRQ-CUHNMECISA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
32756,6cs2,T3D3669,-7.2,Aflatoxin B2,WWSYXEZEXMQWHT-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
118747,6w4b,DB06202,-7.2,Lasofoxifene,GXESHMAMLJKROZ-IAPPQJPRSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
130254,6w4h,DB11999,-7.2,Vosaroxin,XZAFZXJXZHRNAQ-STQMWFEESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
81536,6m3m,DB01359,-7.2,Penbutolol,KQXKVJAGOJTNJS-HNNXBMFYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
32090,6cs2,DB15335,-7.2,Formononetin,HKQYGTCOTHHOMP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
163225,7bv1,DB03921,-7.2,4-(3-Pyridin-2-Yl-1h-Pyrazol-4-Yl)Quinoline,IBCXZJCWDGCXQT-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
164291,7bv1,DB07662,-7.2,N-[4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL]-ACRYLAMIDE,HTUBKQUPEREOGA-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
130258,6w4h,DB12004,-7.2,Briciclib,LXENKEWVEVKKGV-BQYQJAHWSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
119511,6w4b,DB07395,-7.2,"4-[3-(2-Chloro-4,5-difluoro-benzoyl)ureido]-3-trifluoromethoxybenzoic acid",NWQGDIBCFLDHDO-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
145723,6w9q,DB07688,-7.2,"4-{[5-(CYCLOHEXYLOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE",RPJIMTALCNCQLV-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
110937,6vxx,DB02603,-7.2,1-Amino-6-Cyclohex-3-Enylmethyloxypurine,VPUIDVRYMVIXGO-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
9629,6lzg,DB07747,-7.2,"(3R)-N-(4-CHLOROPHENYL)-3-(HYDROXYMETHYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONAMIDE",YTBGBMPLINFTBQ-OAHLLOKOSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
73655,6m2n,DB02324,-7.2,5-Iodo-2'-Deoxyuridine-5'-Monophosphate,WXFYBFRZROJDLL-RRKCRQDMSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
9954,6lzg,DB08095,-7.2,"3-(2-CHLOROPHENYL)-1-(2-{[(1S)-2-HYDROXY-1,2-DIMETHYLPROPYL]AMINO}PYRIMIDIN-4-YL)-1-(4-METHOXYPHENYL)UREA",ZWYFTKPEHRQCCW-HNNXBMFYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
81324,6m3m,DB01065,-7.2,Melatonin,DRLFMBDRBRZALE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
119534,6w4b,DB07422,-7.2,(2S)-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]-3-(pentafluorophenoxy)propanamide,MMNRWNREMUMYQG-INIZCTEOSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
109893,6vxx,DB00558,-7.2,Zanamivir,ARAIBEBZBOPLMB-UFGQHTETSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109892,6vxx,DB00557,-7.2,Hydro1ine,ZQDWXGKKHFNSQK-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
153558,6wiq,DB06848,-7.2,"1-(1'-{[3-(methylsulfanyl)-2-benzothiophen-1-yl]carbonyl}spiro[1-benzofuran-3,4'-piperidin]-5-yl)methanamine",VCUDZTCDUDDJGG-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
32780,6cs2,T3D3694,-7.2,Elymoclavine,DAVNRFCJMIONPO-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
81567,6m3m,DB01421,-7.2,Paromomycin,UOZODPSAJZTQNH-LSWIJEOBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
9624,6lzg,DB07741,-7.2,"4-(1R,3AS,4R,8AS,8BR)-[1-DIFLUOROMETHYL-2-(4-FLUOROBENZYL)-3-OXODECAHYDROPYRROLO[3,4-A]PYRROLIZIN-4-YL]BENZAMIDINE",VPNYXOTTXAXSIH-SXYSDOLCSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
9959,6lzg,DB08100,-7.2,"2,6-dimethyl-4-[(E)-2-phenylethenyl]phenol",PAHKYLUYTGBFNW-CMDGGOBGSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
138115,6w9c,DB09197,-7.2,Mepiprazole,DOTIMEKVTCOGED-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
118731,6w4b,DB06169,-7.2,Indibulin,SOLIIYNRSAWTSQ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
46317,2fxp,DB00398,-7.2,Sorafenib,MLDQJTXFUGDVEO-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
138088,6w9c,DB09169,-7.2,3-Allylfentanyl,BZXKQFFMDLTPJL-LADGPHEKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
164334,7bv1,DB07713,-7.2,"(1S)-1-{[(4'-methoxy-1,1'-biphenyl-4-yl)sulfonyl]amino}-2-methylpropylphosphonic acid",BZVYQWLRCHLAGK-KRWDZBQOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
118704,6w4b,DB06083,-7.2,Tapinarof,ZISJNXNHJRQYJO-CMDGGOBGSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
96275,6m71,DB12661,-7.2,Urapidil,ICMGLRUYEQNHPF-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
10008,6lzg,DB08147,-7.2,"4-[3-(dibenzylamino)phenyl]-2,4-dioxobutanoic acid",RMWVENXKUQXLPW-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
10010,6lzg,DB08149,-7.2,"1-[4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine",KCWPSUKJCKZEAO-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
10011,6lzg,DB08150,-7.2,"4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-aminium",RZIDZIGAXXNODG-UHFFFAOYSA-O,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
96272,6m71,DB12657,-7.2,JNJ-42396302,BPLVDYJDAVYLRQ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
24803,6cs2,DB02602,-7.2,AL7182,ICIXQGGQPKFQRL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
89996,6m71,DB01136,-7.2,Carvedilol,OGHNVEJMJSYVRP-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
111068,6vxx,DB02950,-7.2,Hymenialdisine,QPCBNXNDVYOBIP-WHFBIAKZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
155170,6wiq,DB08743,-7.2,"2-({8-[(3R)-3-AMINOPIPERIDIN-1-YL]-1,3-DIMETHYL-2,6-DIOXO-1,2,3,6-TETRAHYDRO-7H-PURIN-7-YL}METHYL)BENZONITRILE",XJNKUWDMCBZMTG-OAHLLOKOSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
145299,6w9q,DB07188,-7.2,"(3S)-1-CYCLOHEXYL-N-(3,5-DICHLOROPHENYL)-5-OXOPYRROLIDINE-3-CARBOXAMIDE",YUFADRZDHJKVOT-NSHDSACASA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
72907,6m2n,DB01331,-7.2,Cefoxitin,WZOZEZRFJCJXNZ-ZBFHGGJFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
137999,6w9c,DB09000,-7.2,Cyamemazine,SLFGIOIONGJGRT-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
100800,6vxs,DB04073,-7.2,N-{3-[4-(3-aminopropyl)piperazin-1-yl]propyl}-3-(beta-D-galactopyranosyloxy)-5-nitrobenzamide,UEIGEWJJVQHIAX-DLBZZEGUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
97258,6m71,DB14210,-7.2,Moexiprilat,CMPAGYDKASJORH-YSSFQJQWSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
137995,6w9c,DB08996,-7.2,Dimetacrine,RYQOGSFEJBUZBX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137993,6w9c,DB08994,-7.2,Ditazole,UUCMDZWCRNZCOY-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
162915,7bv1,DB03288,-7.2,5-Chloro-1h-Indole-2-Carboxylic Acid{[Cyclopentyl-(2-Hydroxy-Ethyl)-Carbamoyl]-Methyl}-Amide,VXABTOCIIZSEPD-QGZVFWFLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
64326,6lxt,DB01394,-7.2,Colchicine,IAKHMKGGTNLKSZ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
10046,6lzg,DB08185,-7.2,2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,LCHGAOHLDYRACA-SDBHATRESA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
137978,6w9c,DB08979,-7.2,Fenspiride,FVNFBBAOMBJTST-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
96240,6m71,DB12601,-7.2,Sonolisib,QIUASFSNWYMDFS-NILGECQDSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
559,6lzg,HMDB0005474,-7.2,"TG(18:2(9Z,12Z)/18:2(9Z,12Z)/18:2(9Z,12Z))",HBOQXIRUPVQLKX-BBWANDEASA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
10051,6lzg,DB08192,-7.2,2-(4-CARCOXY-5-ISOPROPYLTHIAZOLYL)BENZOPIPERIDINE,HCUGCUQZFBURHR-LBPRGKRZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
118627,6w4b,DB05552,-7.2,TG100-115,UJIAQDJKSXQLIT-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
64919,6lxt,DB02155,-7.2,Balanol Analog 8,XVLMXAUKCDSMMW-YXLARRHKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
32005,6cs2,DB01114,-7.2,Chlorphenamine,SOYKEARSMXGVTM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
50453,2fxp,DB07031,-7.2,"3-Fluoro-4-{[(2R)-2-hydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthalenyl)acetyl]amino}benzoic acid",AANFHDFOMFRLLR-LJQANCHMSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
139403,6w9c,DB13420,-7.2,Thiazinam,CDXCCYNINPIWGE-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
29054,6cs2,DB08695,-7.2,3-(4-nitrophenyl)-1H-pyrazole,IPIYADCDDIUVPS-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
138086,6w9c,DB09167,-7.2,Dosulepin,PHTUQLWOUWZIMZ-GZTJUZNOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
13620,6lzg,T3D0137,-7.2,Chrysene,WDECIBYCCFPHNR-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
96302,6m71,DB12704,-7.2,Spiradoline,NYKCGQQJNVPOLU-ONTIZHBOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
164335,7bv1,DB07714,-7.2,"6-(3-METHYL-1,4-DIOXO-1,4-DIHYDRONAPHTHALEN-2-YL)HEXANOIC ACID",ICGRXHWXPCXIKM-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
64875,6lxt,DB02098,-7.2,Adenosine-2'-5'-Diphosphate,AEOBEOJCBAYXBA-KQYNXXCUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
28881,6cs2,DB08503,-7.2,"(3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(4-methylphenyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol",HRCKGDOSPBFICB-MZHQWRCYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
79954,6m2n,DB14033,-7.2,Acetyl sulfisoxazole,JFNWFXVFBDDWCX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
28880,6cs2,DB08502,-7.2,Capravirine,YQXCVAGCMNFUMQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
119574,6w4b,DB07469,-7.2,"(3aS)-3a-hydroxy-7-methyl-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one",KAJFGRLMKVNMLH-GOSISDBHSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
145788,6w9q,DB07763,-7.2,"(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE",OZZFJGCAYWBVBI-INIZCTEOSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
111027,6vxx,DB02896,-7.2,Methylthioinosine,ZDRFDHHANOYUTE-IOSLPCCCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81719,6m3m,DB01597,-7.2,Cilastatin,DHSUYTOATWAVLW-WFVMDLQDSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
153559,6wiq,DB06849,-7.2,"1-[1'-(3-phenylacryloyl)spiro[1-benzofuran-3,4'-piperidin]-5-yl]methanamine",RQWYWHUKHYFIPB-VQHVLOKHSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
11876,6lzg,DB12553,-7.2,Fluocinolone,UUOUOERPONYGOS-CLCRDYEYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
61598,6crv,DB12311,-7.2,CP1-1189,DJKNRCWSXSZACF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61597,6crv,DB12310,-7.2,Trehalose,HDTRYLNUVZCQOY-LIZSDCNHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
24789,6cs2,DB02586,-7.2,"4,7-Dimethyl-[1,10]Phenanthroline",JIVLDFFWTQYGSR-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
145799,6w9q,DB07776,-7.2,Flavone,VHBFFQKBGNRLFZ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
119602,6w4b,DB07503,-7.2,"(5E)-5-[(2,2-DIFLUORO-1,3-BENZODIOXOL-5-YL)METHYLENE]-1,3-THIAZOLIDINE-2,4-DIONE",SRLVNYDXMUGOFI-YWEYNIOJSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
119610,6w4b,DB07512,-7.2,7-[(3-CHLOROBENZYL)OXY]-2-OXO-2H-CHROMENE-4-CARBALDEHYDE,ZOCADHRNWNJARU-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
101484,6vxs,DB05186,-7.2,SQ-109,JFIBVDBTCDTBRH-REZTVBANSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
97197,6m71,DB14071,-7.2,Desmethylsertraline,SRPXSILJHWNFMK-ZBEGNZNMSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
68577,6lxt,DB08077,-7.2,"2-[4-({[(3,5-DICHLOROPHENYL)AMINO]CARBONYL}AMINO)PHENOXY]-2-METHYLPROPANOIC ACID",OYJPTSMWFKGZJM-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
829,6lzg,HMDB0007165,-7.2,DG(18:0/20:0/0:0),JPKVDETWOQEHQO-KDXMTYKHSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
138053,6w9c,DB09084,-7.2,Benzydamine,CNBGNNVCVSKAQZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
96280,6m71,DB12666,-7.2,Emapunil,NBMBIEOUVBHEBM-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
72960,6m2n,DB01425,-7.2,Alizapride,KSEYRUGYKHXGFW-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
18669,6cs2,HMDB0032610,-7.2,4-Methylbiphenyl,ZZLCFHIKESPLTH-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
28900,6cs2,DB08524,-7.2,2-(3-BENZOYLPHENOXY)ETHYL(HYDROXY)FORMAMIDE,ZHFKBNAHHTUQBH-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
145712,6w9q,DB07675,-7.2,(2S)-2-ETHOXY-3-{4-[2-(10H-PHENOXAZIN-10-YL)ETHOXY]PHENYL}PROPANOIC ACID,WMUIIGVAWPWQAW-DEOSSOPVSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
163451,7bv1,DB04640,-7.2,"Naphthalene-2,6-disulfonic acid",FITZJYAVATZPMJ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
58243,6crv,DB04742,-7.2,"(2R)-2-{(1R)-2-oxo-1-[(2-thienylacetyl)amino]ethyl}-5,6-dihydro-2h-1,3-thiazine-4-carboxylic acid",QIZKCGBBVPUBJL-ZYHUDNBSSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
14676,6lzg,T3D4571,-7.2,Ketazolam,PWAJCNITSBZRBL-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
128294,6w4h,DB07439,-7.2,"1-((2-HYDROXYETHOXY)METHYL)-5-(3-(BENZYLOXY)BENZYL)-6-HYDROXYPYRIMIDINE-2,4(1H,3H)-DIONE",CAWXCABXSPTFRN-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
29000,6cs2,DB08634,-7.2,6-BENZYL-1-BENZYLOXYMETHYL-5-ISOPROPYL URACIL,KSAAUHMSLCPIEX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
153563,6wiq,DB06856,-7.2,6-FLUORO-2-[2-HYDROXY-3-(2-METHYL-CYCLOHEXYLOXY)-PHENYL]-1H-INDOLE-5-CARBOXAMIDINE,HUYQYLFFFNSAAX-BUXKBTBVSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
138311,6w9c,DB11376,-7.2,Azaperone,XTKDAFGWCDAMPY-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
119397,6w4b,DB07267,-7.2,2-(6-methylpyridin-2-yl)-N-pyridin-4-ylquinazolin-4-amine,JONFDFIXMPXTRH-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
110030,6vxx,DB00722,-7.2,Lisinopril,RLAWWYSOJDYHDC-BZSNNMDCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
155047,6wiq,DB08597,-7.2,"6-[4-(2-piperidin-1-ylethoxy)phenyl]-3-pyridin-4-ylpyrazolo[1,5-a]pyrimidine",XHBVYDAKJHETMP-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
32668,6cs2,T3D2069,-7.2,"1,2,7-Trichlorodibenzo-p-dioxin",TXJMXDWFPQSYEQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
6071,6lzg,DB00240,-7.2,Alclometasone,FJXOGVLKCZQRDN-PHCHRAKRSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
110008,6vxx,DB00698,-7.2,Nitrofurantoin,NXFQHRVNIOXGAQ-YCRREMRBSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80156,6m2n,DB14753,-7.2,Hydroxystilbamidine,TUESWZZJYCLFNL-DAFODLJHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
32104,6cs2,DB15359,-7.2,Xanthohumol,ORXQGKIUCDPEAJ-YRNVUSSQSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
9636,6lzg,DB07755,-7.2,"(2S)-1-[4-({4-[(2,5-Dichlorophenyl)amino]-2-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol",GNLAGGCSJGJECE-INIZCTEOSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
118782,6w4b,DB06272,-7.2,Maxacalcitol,DTXXSJZBSTYZKE-ZDQKKZTESA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
73100,6m2n,DB01582,-7.2,Sulfamethazine,ASWVTGNCAZCNNR-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
90236,6m71,DB01485,-7.2,4-Hydroxytestosterone,BQOIJSIMMIDHMO-FBPKJDBXSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
119412,6w4b,DB07283,-7.2,"9-benzyl-2,3,4,9-tetrahydro-1H-carbazole-8-carboxylic acid",VDOXYKGIKBUISK-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
68584,6lxt,DB08084,-7.2,IDD594,JCZUIWYXULSXSW-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
64770,6lxt,DB01958,-7.2,"5-[4-Tert-Butylphenylsulfanyl]-2,4-Quinazolinediamine",MNYDVPDMLAJJPB-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
145371,6w9q,DB07274,-7.2,"N-cyclopropyl-6-[(6,7-dimethoxyquinolin-4-yl)oxy]naphthalene-1-carboxamide",ZATGFXTWDKIEKC-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
119413,6w4b,DB07284,-7.2,"N-3-(3-PYRIDIN-3-YLBENZYL)PYRIDINE-2,3-DIAMINE",NQSBHBFOOVYRNM-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
9918,6lzg,DB08054,-7.2,"1-(1-methylethyl)-3-quinolin-6-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine",GEZALMMCQYDFML-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
81373,6m3m,DB01123,-7.2,Proflavine,WDVSHHCDHLJJJR-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
11841,6lzg,DB12505,-7.2,E-7820,LWGUASZLXHYWIV-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
164259,7bv1,DB07439,-7.2,"1-((2-HYDROXYETHOXY)METHYL)-5-(3-(BENZYLOXY)BENZYL)-6-HYDROXYPYRIMIDINE-2,4(1H,3H)-DIONE",CAWXCABXSPTFRN-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96536,6m71,DB13066,-7.2,Liarozole,UGFHIPBXIWJXNA-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
6566,6lzg,DB02338,-7.2,Nadph Dihydro-Nicotinamide-Adenine-Dinucleotidephosphate,ACFIXJIJDZMPPO-NNYOXOHSSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
6137,6lzg,DB01623,-7.2,Thiothixene,GFBKORZTTCHDGY-UWVJOHFNSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
138380,6w9c,DB11519,-7.2,Fluprostenol,WWSWYXNVCBLWNZ-QIZQQNKQSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139308,6w9c,DB13303,-7.2,Febarbamate,QHZQILHUJDRDAI-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
37384,1r42,DB04196,-7.2,Pteroic Acid,JOAQINSXLLMRCV-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
104923,6vxs,DB12715,-7.2,MSX-122,PXZXYRKDDXKDTK-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
61935,6crv,DB12831,-7.2,Gabexate,YKGYIDJEEQRWQH-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81328,6m3m,DB01069,-7.2,Promethazine,PWWVAXIEGOYWEE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
145407,6w9q,DB07312,-7.2,"2,5-DICHLORO-N-(5-CHLORO-1,3-BENZOXAZOL-2-YL)BENZENESULFONAMIDE",JCXZHFCBNFFHRC-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
64704,6lxt,DB01864,-7.2,5'-Guanosine-Diphosphate-Monothiophosphate,XOFLBQFBSOEHOG-UUOKFMHZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
155021,6wiq,DB08564,-7.2,(2E)-N-{4-[(3-bromophenyl)amino]quinazolin-6-yl}-4-(dimethylamino)but-2-enamide,ZCIXBBSRVLSRJQ-QPJJXVBHSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
96581,6m71,DB13136,-7.2,Fluindione,NASXCEITKQITLD-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
163472,7bv1,DB04664,-7.2,Cyclohexyl-pentyl-maltoside,RVTGFZGNOSKUDA-ZNGNCRBCSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96572,6m71,DB13118,-7.2,Paquinimod,DIKSYHCCYVYKRO-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
64385,6lxt,DB01466,-7.2,Ethylmorphine,OGDVEMNWJVYAJL-LEPYJNQMSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
139314,6w9c,DB13309,-7.2,Benproperine,JTUQXGZRVLWBCR-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
9891,6lzg,DB08023,-7.2,"N-cyclohexyl-4-imidazo[1,2-a]pyridin-3-yl-N-methylpyrimidin-2-amine",HYNNWLVWJXWXFO-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
145398,6w9q,DB07303,-7.2,"N-3-[3-(5-METHOXYPYRIDIN-3-YL)BENZYL]PYRIDINE-2,3-DIAMINE",PGAWZMRRCVSRIM-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
110065,6vxx,DB00767,-7.2,Benzquinamide,JSZILQVIPPROJI-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
96546,6m71,DB13083,-7.2,Talarozole,SNFYYXUGUBUECJ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
163459,7bv1,DB04649,-7.2,TETRAHEDRAL INTERMEDIATE OF BLASTICIDIN S,MVFPGTZTOAHVBP-HXYLPHSESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
130222,6w4h,DB11948,-7.2,Lapachone,QZPQTZZNNJUOLS-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
138342,6w9c,DB11436,-7.2,Nifurpirinol,JQKHJQJVKRFMCO-SNAWJCMRSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
96538,6m71,DB13070,-7.2,Surinabant,HMXDWDSNPRNUKI-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
64730,6lxt,DB01906,-7.2,"3-(5-Amino-7-Hydroxy-[1,2,3]Triazolo[4,5-D]Pyrimidin-2-Yl)-Benzoic Acid",KNLLRZNGRRRPEW-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
163453,7bv1,DB04642,-7.2,"7-{2,6-DICHLORO-4-[3-(2-CHLORO-BENZOYL)-UREIDO]-PHENOXY}-HEPTANOIC ACID",XQTOWNDCHQJXOQ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
109996,6vxx,DB00686,-7.2,Pentosan Polysulfate,FCCNSUIJIOOXEZ-SJYYZXOBSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
96468,6m71,DB12962,-7.2,CP-547632,HXHAJRMTJXHJJZ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
128277,6w4h,DB07420,-7.2,(1R)-4-(3-phenoxyphenyl)-1-phosphonobutane-1-sulfonic acid,RCGCZPXSRLLKCK-MRXNPFEDSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
61944,6crv,DB12847,-7.2,Pyroxamide,PTJGLFIIZFVFJV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81438,6m3m,DB01194,-7.2,Brinzolamide,HCRKCZRJWPKOAR-JTQLQIEISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
163380,7bv1,DB04336,-7.2,1-(4-Amidinophenyl)-3-(4-Chlorophenyl)Urea,HQWKMDKTTCPCMQ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
36856,1r42,DB03488,-7.2,Uridine-5'-diphosphate-2-deoxy-2-fluoro-alpha-D-galactose,NGTCPFGWXMBZEP-NQQHDEILSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
163358,7bv1,DB04306,-7.2,"5-[(4-Methylphenyl)Sulfanyl]-2,4-Quinazolinediamine",UOJFGEAPSYQDIP-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
64792,6lxt,DB01987,-7.2,Cocarboxylase,AYEKOFBPNLCAJY-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
32098,6cs2,DB15347,-7.2,Branebrutinib,VJPPLCNBDLZIFG-ZDUSSCGKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
81478,6m3m,DB01242,-7.2,Clomipramine,GDLIGKIOYRNHDA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
81480,6m3m,DB01244,-7.2,Bepridil,UIEATEWHFDRYRU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
118777,6w4b,DB06263,-7.2,Amrubicin,VJZITPJGSQKZMX-XDPRQOKASA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
164286,7bv1,DB07652,-7.2,"1-[2-DEOXYRIBOFURANOSYL]-2,4-DIFLUORO-5-METHYL-BENZENE-5'MONOPHOSPHATE",NMMWBGNJJMNAIJ-QJPTWQEYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
119451,6w4b,DB07324,-7.2,"3-({2-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)ETHYNYL]BENZYL}AMINO)-1,3-OXAZOL-2(3H)-ONE",ZUJWSOPIDUWELP-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
109959,6vxx,DB00639,-7.2,Butoconazole,SWLMUYACZKCSHZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
119464,6w4b,DB07338,-7.2,Acifluorfen,NUFNQYOELLVIPL-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
155095,6wiq,DB08656,-7.2,5-amino-2-methyl-N-[(1R)-1-naphthalen-1-ylethyl]benzamide,UVERBUNNCOKGNZ-CQSZACIVSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
163295,7bv1,DB04218,-7.2,1-Deaza-Adenosine,NVUDDRWKCUAERS-PNHWDRBUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96387,6m71,DB12840,-7.2,Pirnabine,AADNQNOXNWEYHS-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
119490,6w4b,DB07369,-7.2,"N-(3-chlorophenyl)-N-methyl-2-oxo-3-[(3,4,5-trimethyl-1H-pyrrol-2-yl)methyl]-2H-indole-5-sulfonamide",YMJLSOJLEXWATP-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
164289,7bv1,DB07655,-7.2,"3-AMINO-3-BENZYL-[4.3.0]BICYCLO-1,6-DIAZANONAN-2-ONE",MPJYGQHMIFDQIN-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
67718,6lxt,DB07080,-7.2,"N-(2,2,2-TRIFLUOROETHYL)-N-{4-[2,2,2-TRIFLUORO-1-HYDROXY-1-(TRIFLUOROMETHYL)ETHYL]PHENYL}BENZENESULFONAMIDE",SGIWFELWJPNFDH-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
101426,6vxs,DB04915,-7.2,Idronoxil,ZZUBHVMHNVYXRR-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
96444,6m71,DB12927,-7.2,Theodrenaline,WMCMJIGLYZDKRN-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97074,6m71,DB13828,-7.2,Cyfluthrin,QQODLKZGRKWIFG-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
50050,2fxp,DB06295,-7.2,Pramiconazole,AEKNYBWUEYNWMJ-QWOOXDRHSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
104288,6vxs,DB11784,-7.2,NRX-1074,DVBUEXCIEIAXPM-PJUQSVSOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
138260,6w9c,DB11182,-7.2,Rose bengal free acid,VDNLFJGJEQUWRB-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
32684,6cs2,T3D2092,-7.2,"1,2,3,4,7-Pentachlorodibenzo-p-dioxin",WRNGAZFESPEMCN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
61655,6crv,DB12395,-7.2,Esreboxetine,CBQGYUDMJHNJBX-OALUTQOASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
96459,6m71,DB12947,-7.2,Doxifluridine,ZWAOHEXOSAUJHY-ZIYNGMLESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
81434,6m3m,DB01190,-7.2,Clindamycin,KDLRVYVGXIQJDK-NOWPCOIGSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
32682,6cs2,T3D2089,-7.2,"1,3,7,9-Tetrachlorodibenzo-p-dioxin",JMGYHLJVDHUACM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
68065,6lxt,DB07480,-7.1,4-PHOSPHONOOXY-PHENYL-METHYL-[4-PHOSPHONOOXY]BENZEN,LGSCVLKUKMBYNC-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
59025,6crv,DB06990,-7.1,"4-[(1E,7E)-8-(2,6-DIOXO-1,2,3,6-TETRAHYDROPYRIMIDIN-4-YL)-3,6-DIOXA-2,7-DIAZAOCTA-1,7-DIEN-1-YL]BENZOIC ACID",XHDKIDMFBWLHAX-GONBZBRSSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130516,6w4h,DB12377,-7.1,Relebactam,SMOBCLHAZXOKDQ-ZJUUUORDSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
67606,6lxt,DB06946,-7.1,"(2S,3S)-3-(4-fluorophenyl)-2,3-dihydroxypropanoic acid",DWYLYIVEFVSGCP-YUMQZZPRSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
153665,6wiq,DB06977,-7.1,(2S)-1-{[5-(1H-Indazol-5-yl)-3-pyridinyl]oxy}-3-(7aH-indol-3-yl)-2-propanamine,CAASENZOSQYNPX-HSTJUUNISA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
67609,6lxt,DB06951,-7.1,(3R)-3-ethyl-N-[(4-methylphenyl)sulfonyl]-L-aspartic acid,KPHLTCNXHCHMOW-MNOVXSKESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
91091,6m71,DB02595,-7.1,Bulgecin A,RPNZWZDLNYCCIG-HMMVDTEZSA-O,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
152221,6wiq,DB03768,-7.1,"N-[2-Hydroxy-2-(8-Isopropyl-6,9-Dioxo-2-Oxa-7,10-Diaza-Bicyclo[11.2.2]Heptadeca-1(16),13(17),14-Trien-11-Yl)-Ethyl]-N-(3-Methyl-Butyl)-Benzenesulfonamide,Inhibitor 3",WRUVOSYKHXGAQN-GKRYNVPLSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
67784,6lxt,DB07155,-7.1,(3S)-1-CYCLOHEXYL-5-OXO-N-PHENYLPYRROLIDINE-3-CARBOXAMIDE,BVUSHGJZBZMDML-ZDUSSCGKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
37392,1r42,DB04205,-7.1,"Thymidine-3',5'-Diphosphate",CSNCBOPUCJOHLS-XLPZGREQSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
130570,6w4h,DB12445,-7.1,Nitroaspirin,IOJUJUOXKXMJNF-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
91994,6m71,DB03812,-7.1,"3-{2,6,8-trioxo-9-[(2S,3R,4R)-2,3,4,5-tetrahydroxypentyl]-1,2,3,6,8,9-hexahydro-7H-purin-7-Yl}propyl dihydrogen phosphate",KPHFGOGGKPGLTM-LKEWCRSYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
12197,6lzg,DB13023,-7.1,IPI-493,XYFFWTYOFPSZRM-TWNAANEASA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
152236,6wiq,DB03788,-7.1,GC-24,JYHIGYLGYNCMGI-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
129450,6w4h,DB08804,-7.1,Nandrolone decanoate,JKWKMORAXJQQSR-MOPIKTETSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
12099,6lzg,DB12884,-7.1,Lavoltidine,VTLNPNNUIJHJQB-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
130537,6w4h,DB12404,-7.1,Remimazolam,CYHWMBVXXDIZNZ-KRWDZBQOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
26076,6cs2,DB00480,-7.1,Lenalidomide,GOTYRUGSSMKFNF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
153267,6wiq,DB05944,-7.1,Varlitinib,UWXSAYUXVSFDBQ-CYBMUJFWSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
152107,6wiq,DB03619,-7.1,Deoxycholic Acid,KXGVEGMKQFWNSR-LLQZFEROSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
130105,6w4h,DB11781,-7.1,Tosedostat,FWFGIHPGRQZWIW-SQNIBIBYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
91618,6m71,DB03296,-7.1,3'-beta-Sialyl-beta-lactose,CILYIEBUXJIHCO-LPTWSRJFSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
67390,6lxt,DB06620,-7.1,Aplindore,DYJIKHYBKVODAC-ZDUSSCGKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
67243,6lxt,DB06234,-7.1,Maribavir,KJFBVJALEQWJBS-XUXIUFHCSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
103925,6vxs,DB09246,-7.1,Benmoxin,BEWNZPMDJIGBED-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
59392,6crv,DB07408,-7.1,5-(2-NITROPHENYL)-2-FUROIC ACID,XUFDYUSOQQYQRL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
37373,1r42,DB04180,-7.1,"4-(Aminosulfonyl)-N-[(2,4-Difluorophenyl)Methyl]-Benzamide",NTDFJEKGSGSXME-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
23203,6cs2,HMDB0059803,-7.1,9-Hydroxyfluorene,AFMVESZOYKHDBJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
104577,6vxs,DB12210,-7.1,AZD-6280,NVWCZRPXYVDQEE-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
67593,6lxt,DB06930,-7.1,"N-[amino(imino)methyl]-2-(2,5-diphenyl-1H-pyrrol-1-yl)acetamide",WVLDNAVUCUAGDP-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
152978,6wiq,DB04778,-7.1,SC45647,LPSXGZAUAOMRNU-FZKQIMNGSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
131057,6w4h,DB13232,-7.1,Suxibuzone,ONWXNHPOAGOMTG-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130559,6w4h,DB12430,-7.1,BC-3781,KPVIXBKIJXZQJX-IJUBVZAWSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
129493,6w4h,DB08873,-7.1,Boceprevir,LHHCSNFAOIFYRV-DOVBMPENSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131034,6w4h,DB13203,-7.1,Bamifylline,VVUYEFBRTFASAH-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
152108,6wiq,DB03622,-7.1,"2-Hydroxy-5-[4-(2-Hydroxy-Ethyl)-Piperidin-1-Yl]-5-Phenyl-1h-Pyrimidine-4,6-Dione",IPBPOBHSNJFRFT-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
152912,6wiq,DB04685,-7.1,"1-{(2S,5S)-4-FLUORO-5-[(TRITYLOXY)METHYL]TETRAHYDROFURAN-2-YL}PYRIMIDINE-2,4(1H,3H)-DIONE",GJNIPWYJQUGERM-BFLUCZKCSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
92413,6m71,DB04371,-7.1,AL6528,FBBLOSCXOZYUSS-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
91955,6m71,DB03765,-7.1,2'-cytidylic acid,YQUAKORMLHPSLZ-XVFCMESISA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
129528,6w4h,DB08933,-7.1,Luliconazole,YTAOBBFIOAEMLL-REQDGWNSSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
153686,6wiq,DB07000,-7.1,"N-{2,4-difluoro-3-[(5-pyridin-3-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)carbonyl]phenyl}ethanesulfonamide",ILXJWLWSYAWJKZ-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
37382,1r42,DB04194,-7.1,Chitotriose,WZZVUHWLNMNWLW-VFCSDQTKSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
23162,6cs2,HMDB0059739,-7.1,"1-Ethyl-3,5-diisopropyl-benzene",HWWKORYFZUHZKW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
37200,1r42,DB03950,-7.1,(S)-N-(3-Indol-1-Yl-2-Methyl-Propyl)-4-Sulfamoyl-Benzamide,ZFWHOUCRVSOZJE-AWEZNQCLSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
152093,6wiq,DB03596,-7.1,N-[2-(1h-Indol-5-Yl)-Butyl]-4-Sulfamoyl-Benzamide,FSRPBGBMEKDSIJ-CYBMUJFWSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
129523,6w4h,DB08926,-7.1,Acediasulfone,FKKUMFTYSTZUJG-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
91636,6m71,DB03315,-7.1,Guanosine 3'-monophosphate,ZDPUTNZENXVHJC-UUOKFMHZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
37209,1r42,DB03962,-7.1,Nicotinamide 8-Bromo-Adenine Dinucleotide Phosphate,MDKMTCCUJSRQGW-NAJQWHGHSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
153355,6wiq,DB06263,-7.1,Amrubicin,VJZITPJGSQKZMX-XDPRQOKASA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
67598,6lxt,DB06935,-7.1,"2',6'-DIFLUOROBIPHENYL-4-CARBOXYLIC ACID",CWWIIKLXUPZDOG-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
59546,6crv,DB07591,-7.1,N1-CYCLOPENTYL-N2-(THIAZOL-2-YL)OXALAMIDE,BJHPYHUDDCVBNG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
67791,6lxt,DB07163,-7.1,5-[(2-AMINOETHYL)AMINO]-6-FLUORO-3-(1H-PYRROL-2-YL)BENZO[CD]INDOL-2(1H)-ONE,CQCXWWWNUFQYJS-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
67823,6lxt,DB07199,-7.1,"(2S,4S,5R)-1-(4-TERT-BUTYLBENZOYL)-2-ISOBUTYL-5-(1,3-THIAZOL-2-YL)PYRROLIDINE-2,4-DICARBOXYLIC ACID",SWYJAQWTBADJTB-RHGYRFJNSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
130074,6w4h,DB11736,-7.1,PF-00489791,ZUHZNKJIJDAJFD-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
104150,6vxs,DB11519,-7.1,Fluprostenol,WWSWYXNVCBLWNZ-QIZQQNKQSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
59530,6crv,DB07572,-7.1,3-{[(4-methylphenyl)sulfonyl]amino}propyl pyridin-4-ylcarbamate,ITYCDQJBLCTIID-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
67381,6lxt,DB06603,-7.1,Panobinostat,FPOHNWQLNRZRFC-ZHACJKMWSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
12195,6lzg,DB00991,-7.1,Oxaprozin,OFPXSFXSNFPTHF-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
92020,6m71,DB03844,-7.1,"N-(2,6-Diflouro-Benzyl)-4-Sulfamoyl-Benzamide",ZFNCKGXGCCDDFN-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
152025,6wiq,DB03495,-7.1,"4,6-Dideoxy-4-{[4,5,6-Trihydroxy-3-(Hydroxymethyl)Cyclohex-2-En-1-Yl]Amino}-Alpha-D-Lyxo-Hexopyranosyl-(1->4)-Alpha-D-Threo-Hexopyranosyl-(1->6)-Alpha-L-Threo-Hexopyranose",FZLCJZILHGFQLM-PISLJJGOSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
59534,6crv,DB07577,-7.1,"6-ETHYL-5-PHENYLPYRIMIDINE-2,4-DIAMINE",XREDUPOVEQDQQS-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
14614,6lzg,T3D4512,-7.1,Fluoxastrobin,UFEODZBUAFNAEU-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
92332,6m71,DB04259,-7.1,7n-Methyl-8-Hydroguanosine-5'-Monophosphate,ZMWJGXGSWZFZPJ-KQYNXXCUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
92665,6m71,DB04707,-7.1,Hydroxyfasudil,ZAVGJDAFCZAWSZ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
92560,6m71,DB04566,-7.1,Inosinic Acid,GRSZFWQUAKGDAV-KQYNXXCUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
130571,6w4h,DB12447,-7.1,Nadifloxacin,JYJTVFIEFKZWCJ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
6017,6lzg,DB01450,-7.1,Dihydroetorphine,BRTSNYPDACNMIP-FAWZKKEFSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
153804,6wiq,DB07133,-7.1,D-phenylalanyl-N-(3-methylbenzyl)-L-prolinamide,CHKWABXWPATIIG-UXHICEINSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
131267,6w4h,DB13512,-7.1,Clefamide,ODCUSWJXZDHLKV-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
153562,6wiq,DB06853,-7.1,N-cycloheptylglycyl-N-(4-carbamimidoylbenzyl)-L-prolinamide,BYTJPDBCLWUEBU-IBGZPJMESA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
91487,6m71,DB03124,-7.1,5-[4-(1-Carboxymethyl-2-Oxo-Propylcarbamoyl)-Benzylsulfamoyl]-2-Hydroxy-Benzoic Acid,LBAHOXPDTNUYCX-INIZCTEOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
129925,6w4h,DB11427,-7.1,Maropitant,OMPCVMLFFSQFIX-CONSDPRKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
91837,6m71,DB03606,-7.1,(S)-Rolipram,HJORMJIFDVBMOB-GFCCVEGCSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
153491,6wiq,DB06732,-7.1,beta-Naphthoflavone,OUGIDAPQYNCXRA-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
130249,6w4h,DB11990,-7.1,MK-0812,UNVWTBOGMHPKJM-CWKRKGSWSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130363,6w4h,DB12155,-7.1,Napabucasin,DPHUWDIXHNQOSY-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
104282,6vxs,DB11774,-7.1,Pazufloxacin,XAGMUUZPGZWTRP-ZETCQYMHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
91386,6m71,DB02984,-7.1,"4-[3-Methylsulfanylanilino]-6,7-Dimethoxyquinazoline",FUSDVOSGGMBSMK-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
131259,6w4h,DB13502,-7.1,Budipine,QIHLUZAFSSMXHQ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
6029,6lzg,DB01469,-7.1,Acetorphine,LFYBMMHFJIAKFE-PMEKXCSPSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
130261,6w4h,DB12007,-7.1,Isoflavone,GOMNOOKGLZYEJT-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
92248,6m71,DB04150,-7.1,Threonine Derivative,TWMKRGDZEJLDDH-LKXWSVAYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
92231,6m71,DB04128,-7.1,"5-Nitroso-6-Ribityl-Amino-2,4(1h,3h)-Pyrimidinedione",YMWIHKCBRFEJMH-RPDRRWSUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
131246,6w4h,DB13485,-7.1,Sulfametomidine,QKLSCPPJEVXONT-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
37430,1r42,DB04258,-7.1,Seocalcitol,LVLLALCJVJNGQQ-SEODYNFXSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
130722,6w4h,DB12685,-7.1,K-134,ULGNGSQNNMKROG-WOJBJXKFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
6062,6lzg,DB00239,-7.1,Oxiconazole,QRJJEGAJXVEBNE-HKOYGPOVSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
92260,6m71,DB04164,-7.1,"1,4-Deoxy-4-((5-Hydroxymethyl-2,3,4-Trihydroxycyclohex-5-Enyl)Amino)Fructose",ZGWNRGISVMYHTF-KKXLKBQTSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
152491,6wiq,DB04125,-7.1,N-Alpha-(2-Naphthylsulfonyl)-N(3-Amidino-L-Phenylalaninyl)-4-Acetyl-Piperazine,ZUWBXGHMVKDMQO-DEOSSOPVSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
153865,6wiq,DB07204,-7.1,"(1S)-1-(1H-INDOL-3-YLMETHYL)-2-(2-PYRIDIN-4-YL-[1,7]NAPHTYRIDIN-5-YLOXY)-EHYLAMINE",DQIXTEDFNFZMCM-SFHVURJKSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
12213,6lzg,DB13048,-7.1,PAC-1,YQNRVGJCPCNMKT-LFVJCYFKSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
153904,6wiq,DB07252,-7.1,"3-({4-[(5-chloro-1,3-benzodioxol-4-yl)amino]pyrimidin-2-yl}amino)benzenesulfonamide",TZHCXOMEOHEZDX-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
26102,6cs2,DB04168,-7.1,2-Amino-5-Bromo-6-Phenylpyrimidin-4-Ol,CIUUIPMOFZIWIZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
104028,6vxs,DB11184,-7.1,Oftasceine,DEGAKNSWVGKMLS-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
67862,6lxt,DB07248,-7.1,"7-PYRIDIN-2-YL-N-(3,4,5-TRIMETHOXYPHENYL)-7H-PYRROLO[2,3-D]PYRIMIDIN-2-AMINE",YENZSPIOXMNEFF-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
67730,6lxt,DB07093,-7.1,"{3-[(5-CHLORO-1,3-BENZOTHIAZOL-2-YL)METHYL]-2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL}ACETIC ACID",RQWICELTTDJODO-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
67729,6lxt,DB07091,-7.1,(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclohexyloxy)ethanoyl)pyrrolidine-2-carboxamide,IWPMQJKXKKKSEY-SFHVURJKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
153156,6wiq,DB05294,-7.1,Vandetanib,UHTHHESEBZOYNR-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
6236,6lzg,DB01771,-7.1,CRA_10991,QXAURVOBXQBPAP-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
91296,6m71,DB02869,-7.1,3-amino-5-phenylpentane,ZPXIQFOUPUVVPU-INIZCTEOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
26513,6cs2,DB04659,-7.1,"(1S,2S,3R,4S,5S)-2,3,4-TRIHYDROXY-5-(HYDROXYMETHYL)CYCLOHEXYL (1E)-2-PHENYL-N-(SULFOOXY)ETHANIMIDOTHIOATE",LZDZCEOFJWRJIA-GGASBGQWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
92274,6m71,DB04180,-7.1,"4-(Aminosulfonyl)-N-[(2,4-Difluorophenyl)Methyl]-Benzamide",NTDFJEKGSGSXME-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
131151,6w4h,DB13355,-7.1,Visnadine,GVBNSPFBYXGREE-CXWAGAITSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
153462,6wiq,DB06693,-7.1,Mevastatin,AJLFOPYRIVGYMJ-INTXDZFKSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
23143,6cs2,HMDB0059696,-7.1,"1,2,3,4,Tetrahydro-1,5,7-trimethylnapthalene",VJFBUCVRMBYHAH-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
67297,6lxt,DB06374,-7.1,Elacestrant,SIFNOOUKXBRGGB-AREMUKBSSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
59426,6crv,DB07449,-7.1,N-[(1S)-1-(AMINOCARBONYL)-4-(ETHANIMIDOYLAMINO)BUTYL]BENZAMIDE,LWFFSSMDFWZNNW-LBPRGKRZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
153797,6wiq,DB07126,-7.1,O6-CYCLOHEXYLMETHOXY-2-(4'-SULPHAMOYLANILINO) PURINE,OWXORKPNCHJYOF-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
91768,6m71,DB03503,-7.1,"4-Acetyl-4-Guanidino-6-Methyl(Propyl)Carboxamide-4,5-Dihydro-2h-Pyran-2-Carboxylic Acid",QPJWMZVTNXFTKV-JMJZKYOTSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
153880,6wiq,DB07222,-7.1,(3S)-N-(5-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE,RJWMDETWDDESBP-ZDUSSCGKSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
153872,6wiq,DB07212,-7.1,N-(7-CARBAMIMIDOYL-NAPHTHALEN-1-YL)-3-HYDROXY-2-METHYL-BENZAMIDE,NNGZRCYXFBHMRM-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
153810,6wiq,DB07141,-7.1,"5-[(3R)-3-(5-methoxy-4'-methylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",QVXYJVHNRPNRJL-HNNXBMFYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
104303,6vxs,DB11801,-7.1,Rapastinel,GIBQQARAXHVEGD-BSOLPCOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
131244,6w4h,DB13482,-7.1,Dimefline,ZXFQRFXLFWWKLX-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
129900,6w4h,DB11380,-7.1,Cambendazole,QZWHWHNCPFEXLL-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130832,6w4h,DB12868,-7.1,Intoplicine,QROONAIPJKQFMC-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
58940,6crv,DB06887,-7.1,"[(3S)-3-(Methylcarbamoyl)-2-{[(2-methyl-2-propanyl)oxy]carbonyl}-1,2,3,4-tetrahydro-7-isoquinolinyl]sulfamic acid",PPSSYXOFPICMQD-ZDUSSCGKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
92549,6m71,DB04554,-7.1,8-Bromoadenosine-5'-Diphosphate,KVVVTFSHHQCHNZ-UUOKFMHZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
26119,6cs2,DB00485,-7.1,Dicloxacillin,YFAGHNZHGGCZAX-JKIFEVAISA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
91426,6m71,DB03045,-7.1,Pantothenyl-Aminoethanol-Acetate Pivalic Acid,MILJVOHYMMUVQM-AWEZNQCLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
91421,6m71,DB03039,-7.1,"4-(Aminosulfonyl)-N-[(2,5-Difluorophenyl)Methyl]-Benzamide",KEGUALXMKQVDIO-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
67689,6lxt,DB07046,-7.1,"2-[(2-chloro-4-iodophenyl)amino]-N-{[(2R)-2,3-dihydroxypropyl]oxy}-3,4-difluorobenzamide",FCADPEDUULETPK-SECBINFHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
91411,6m71,DB03022,-7.1,"3-{2,6,8-trioxo-9-[(2R,3S,4R)-2,3,4,5-tetrahydroxypentyl]-1,2,3,6,8,9-hexahydro-7H-purin-7-Yl}propyl dihydrogen phosphate",KPHFGOGGKPGLTM-BHNWBGBOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
131226,6w4h,DB13457,-7.1,Oxaflozane,FVYUQFQCEOZYHZ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
12164,6lzg,DB12974,-7.1,Roniciclib,UELYDGOOJPRWGF-SRQXXRKNSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
129805,6w4h,DB09421,-7.1,Protirelin,XNSAINXGIQZQOO-SRVKXCTJSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
129796,6w4h,DB09355,-7.1,Sulfabenzamide,PBCZLFBEBARBBI-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
12058,6lzg,DB00977,-7.1,Ethinylestradiol,BFPYWIDHMRZLRN-SLHNCBLASA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
153532,6wiq,DB06809,-7.1,Plerixafor,YIQPUIGJQJDJOS-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
129775,6w4h,DB09299,-7.1,Tenofovir alafenamide,LDEKQSIMHVQZJK-CAQYMETFSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
92186,6m71,DB04070,-7.1,6-Deoxyerythronolide B,HQZOLNNEQAKEHT-IBBGRPSASA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
153527,6wiq,DB06800,-7.1,Methylnaltrexone,JVLBPIPGETUEET-WIXLDOGYSA-O,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
104444,6vxs,DB12009,-7.1,GW-406381,NXMZBNYLCVTRGB-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
12062,6lzg,DB12825,-7.1,Lefamulin,KPVIXBKIJXZQJX-FCEONZPQSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
92565,6m71,DB04573,-7.1,Estriol,PROQIPRRNZUXQM-ZXXIGWHRSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
152628,6wiq,DB04301,-7.1,Bis(5-Amidino-2-Benzimidazolyl)Methane Ketone Hydrate,ZLAHDRAQCSQPOC-UHFFFAOYSA-P,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
131180,6w4h,DB13396,-7.1,Neocitrullamon,PAJBBDCZSMDSFL-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130840,6w4h,DB12879,-7.1,Omigapil,QLMMOGWZCFQAPU-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
153502,6wiq,DB06746,-7.1,ginkgolide-J,LMEHVEUFNRJAAV-UKWFQYJJSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
104070,6vxs,DB11362,-7.1,Selexipag,QXWZQTURMXZVHJ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
129730,6w4h,DB09230,-7.1,Azelnidipine,ZKFQEACEUNWPMT-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
67895,6lxt,DB07284,-7.1,"N-3-(3-PYRIDIN-3-YLBENZYL)PYRIDINE-2,3-DIAMINE",NQSBHBFOOVYRNM-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
153142,6wiq,DB05234,-7.1,LGD2941,HWLLYFXDDGGHOE-BCSUUIJWSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
92587,6m71,DB04602,-7.1,PUROMYCIN AMINONUCLEOSIDE-5'-MONOPHOSPHATE,BFPIKGKMRKBBBF-GRIPGOBMSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
130724,6w4h,DB12687,-7.1,Vesatolimod,VFOKSTCIRGDTBR-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
91789,6m71,DB03532,-7.1,Phosphomethylphosphonic Acid Guanylate Ester,GXTIEXDFEKYVGY-KQYNXXCUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
153107,6wiq,DB05016,-7.1,Ataluren,OOUGLTULBSNHNF-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
92568,6m71,DB04576,-7.1,Fleroxacin,XBJBPGROQZJDOJ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
67899,6lxt,DB07288,-7.1,N-(4-chlorophenyl)-2-[(pyridin-4-ylmethyl)amino]benzamide,GGPZCOONYBPZEW-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
130732,6w4h,DB12704,-7.1,Spiradoline,NYKCGQQJNVPOLU-ONTIZHBOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
104074,6vxs,DB11367,-7.1,Cefroxadine,RDMOROXKXONCAL-UEKVPHQBSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
59289,6crv,DB07291,-7.1,5-amino-1-(4-chlorophenyl)-1H-pyrazole-4-carbonitrile,WIWSALMJHPGFDY-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
131233,6w4h,DB13465,-7.1,Ciclobendazole,OXLKOMYHDYVIDM-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131232,6w4h,DB13463,-7.1,Oxetorone,VZVRZTZPHOHSCK-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
67906,6lxt,DB07295,-7.1,2-[(7-HYDROXY-NAPHTHALEN-1-YL)-OXALYL-AMINO]-BENZOIC ACID,IGOULVZYQKJJKC-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
92211,6m71,DB04101,-7.1,"N-[4-(2,4-Dimethyl-1,3-Thiazol-5-Yl)Pyrimidin-2-Yl]-N'-Hydroxyimidoformamide",OVKZTPFHUYGZBI-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
129742,6w4h,DB09244,-7.1,Pirlindole,IWVRVEIKCBFZNF-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
153500,6wiq,DB06744,-7.1,ginkgolide-B,SQOJOAFXDQDRGF-MMQTXUMRSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
129854,6w4h,DB11219,-7.1,Enzacamene,HEOCBCNFKCOKBX-SDNWHVSQSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
153501,6wiq,DB06745,-7.1,ginkgolide-C,AMOGMTLMADGEOQ-DTDWCABLSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
153499,6wiq,DB06743,-7.1,Ginkgolide A,FPUXKXIZEIDQKW-VKMVSBOZSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
37262,1r42,DB04038,-7.1,Ergosterol,DNVPQKQSNYMLRS-APGDWVJJSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
130683,6w4h,DB12625,-7.1,Evogliptin,LCDDAGSJHKEABN-MLGOLLRUSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
58978,6crv,DB06928,-7.1,(2S)-2-{[HYDROXY(4-IODOBENZYL)PHOSPHORYL]METHYL}PENTANEDIOIC ACID,PPTCQJLGUKWAEP-SNVBAGLBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
5978,6lzg,DB01393,-7.1,Bezafibrate,IIBYAHWJQTYFKB-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
91722,6m71,DB03435,-7.1,Uridine-5'-Diphosphate,XCCTYIAWTASOJW-XVFCMESISA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
153749,6wiq,DB07070,-7.1,(2S)-2-{3-[({[2-fluoro-4-(trifluoromethyl)phenyl]carbonyl}amino)methyl]-4-methoxybenzyl}butanoic acid,BDLLIPYDNFENMY-ZDUSSCGKSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
129990,6w4h,DB11582,-7.1,Thiocolchicoside,LEQAKWQJCITZNK-AXHKHJLKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
5980,6lzg,DB00229,-7.1,Cefotiam,QYQDKDWGWDOFFU-IUODEOHRSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
59068,6crv,DB07037,-7.1,(2S)-1-AMINO-3-[(5-NITROQUINOLIN-8-YL)AMINO]PROPAN-2-OL,MBZPCTWLFNYBND-QMMMGPOBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
58996,6crv,DB06951,-7.1,(3R)-3-ethyl-N-[(4-methylphenyl)sulfonyl]-L-aspartic acid,KPHLTCNXHCHMOW-MNOVXSKESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
130944,6w4h,DB13032,-7.1,Enecadin,SZSHJTJCJOWMHM-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
26538,6cs2,DB04695,-7.1,Farnesyl thiopyrophosphate,MYMLCRQRXFRQGP-YFVJMOTDSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
103804,6vxs,DB09062,-7.1,Cefminox,JSDXOWVAHXDYCU-VXSYNFHWSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
67553,6lxt,DB06887,-7.1,"[(3S)-3-(Methylcarbamoyl)-2-{[(2-methyl-2-propanyl)oxy]carbonyl}-1,2,3,4-tetrahydro-7-isoquinolinyl]sulfamic acid",PPSSYXOFPICMQD-ZDUSSCGKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
26536,6cs2,DB04693,-7.1,"(13S)-13-METHYLDODECAHYDRO-1H-CYCLOPENTA[A]PHENANTHRENE-3,17(2H,4H)-DIONE",CRDKSBHJIGNEOH-IMRIKWHGSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
153970,6wiq,DB07323,-7.1,"2-[({2-[(1Z)-3-(DIMETHYLAMINO)PROP-1-ENYL]-4-FLUOROPHENYL}SULFONYL)AMINO]-5,6,7,8-TETRAHYDRONAPHTHALENE-1-CARBOXYLIC ACID",CTZLIARLNXSXGL-ALCCZGGFSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
14613,6lzg,T3D4511,-7.1,Fluometuron,RZILCCPWPBTYDO-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
130190,6w4h,DB11902,-7.1,Gisadenafil,YPFZMBHKIVDSNR-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
67261,6lxt,DB06266,-7.1,Lonidamine,WDRYRZXSPDWGEB-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
92080,6m71,DB03924,-7.1,"5,8-Di-Amino-1,4-Dihydroxy-Anthraquinone",QVEMRPAUHFWHRV-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
68031,6lxt,DB07439,-7.1,"1-((2-HYDROXYETHOXY)METHYL)-5-(3-(BENZYLOXY)BENZYL)-6-HYDROXYPYRIMIDINE-2,4(1H,3H)-DIONE",CAWXCABXSPTFRN-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
153242,6wiq,DB05796,-7.1,Daglutril,XMQODGUTLZXUGZ-RPBOFIJWSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
91729,6m71,DB03449,-7.1,N-(4-(2-((3-Chlorophenylmethyl)Amino)Ethyl)Phenyl)-2-Thiophecarboxamidine,ZZVGLDBDD1AB-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
153972,6wiq,DB07325,-7.1,N-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)METHYL]-3-{[(E)-(2-OXODIHYDROFURAN-3(2H)-YLIDENE)METHYL]AMINO}BENZENESULFONAMIDE,VCOKUBHAJVTVNG-FMIVXFBMSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
153983,6wiq,DB07337,-7.1,"4-[4-AMINO-6-(5-CHLORO-1H-INDOL-4-YLMETHYL)-[1,3,5]TRIAZIN-2-YLAMINO]-BENZONITRILE",SOKOHDQTKSROQZ-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
129559,6w4h,DB08972,-7.1,Flumequine,DPSPPJIUMHPXMA-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
67756,6lxt,DB07123,-7.1,N-(4-METHYLBENZOYL)-4-BENZYLPIPERIDINE,DVOLWKZEIDCCES-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
131092,6w4h,DB13283,-7.1,Sulfaisodimidine,YZMCKZRAOLZXAZ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
154003,6wiq,DB07359,-7.1,"3-[(4-fluorophenyl)sulfanyl]-N-(4-methyl-1,3-thiazol-2-yl)-6-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]pyridine-2-carboxamide",SJTQKYKXCYVFHX-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
104342,6vxs,DB11861,-7.1,Litronesib,YVAFBXLHPINSIK-QHCPKHFHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
6260,6lzg,DB01812,-7.1,Adenosine-3'-5'-Diphosphate,WHTCPDAXWFLDIH-KQYNXXCUSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
104541,6vxs,DB12150,-7.1,Pelubiprofen,AUZUGWXLBGZUPP-GXDHUFHOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
5976,6lzg,DB01388,-7.1,Mibefradil,HBNPJJILLOYFJU-VMPREFPWSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
91570,6m71,DB03233,-7.1,"Phosphoric Acid Mono-[3-Amino-5-(5-Methyl-2,4-Dioxo-3,4-Dihydro-2h-Pyrimidin-1-Yl)-Tetrahydro-Furan-2-Ylmethyl] Ester",BQZMHQZNZNBJNF-XLPZGREQSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
103797,6vxs,DB09050,-7.1,Ceftolozane,JHFNIHVVXRKLEF-DCZLAGFPSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
91139,6m71,DB02658,-7.1,"2,4-Dinitrophenyl 2-Deoxy-2-Fluoro-Beta-D-Allopyranoside",UFSBFVZQJZMIOU-LZQZFOIKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
130478,6w4h,DB12316,-7.1,9CUAB30,PPGNMFUMZSAZCW-VOYUZAMQSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
104205,6vxs,DB11662,-7.1,Rabusertib,SYYBDNPGDKKJDU-ZDUSSCGKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
153028,6wiq,DB04839,-7.1,Cyproterone acetate,UWFYSQMTEOIJJG-FDTZYFLXSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
130950,6w4h,DB13046,-7.1,Tocladesine,CLLFEJLEDNXZNR-UUOKFMHZSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
67758,6lxt,DB07125,-7.1,"4-(6-{[(1R)-1-(hydroxymethyl)propyl]amino}imidazo[1,2-b]pyridazin-3-yl)benzoic acid",KKZYGUVAFJCULH-CYBMUJFWSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
5977,6lzg,DB01392,-7.1,Yohimbine,BLGXFZZNTVWLAY-SCYLSFHTSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
6184,6lzg,DB01690,-7.1,Bis(Adenosine)-5'-Triphosphate,QCICUPZZLIQAPA-XPWFQUROSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
92654,6m71,DB04693,-7.1,"(13S)-13-METHYLDODECAHYDRO-1H-CYCLOPENTA[A]PHENANTHRENE-3,17(2H,4H)-DIONE",CRDKSBHJIGNEOH-IMRIKWHGSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
103801,6vxs,DB09056,-7.1,Amorolfine,MQHLMHIZUIDKOO-AYHJJNSGSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
153359,6wiq,DB06268,-7.1,Sitaxentan,PHWXUGHIIBDVKD-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
131103,6w4h,DB13300,-7.1,Epicillin,RPBAFSBGYDKNRG-NJBDSQKTSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
6259,6lzg,DB01810,-7.1,"[1-(1-Methyl-4,5-Dioxo-Pent-2-Enylcarbamoyl)-2-Phenyl-Ethyl]-Carbamic Acid Benzyl Ester",NOXVWFAAXREWMI-GURWAVDKSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
130193,6w4h,DB11905,-7.1,Sutezolid,FNDDDNOJWPQCBZ-ZDUSSCGKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
129575,6w4h,DB08990,-7.1,Eprazinone,BSHWLCACYCVCJE-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
129576,6w4h,DB08991,-7.1,Epirizole,RHAXSHUQNIEUEY-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
91731,6m71,DB03451,-7.1,"1-alpha, 25-dihydroxyl-20-epi-22-oxa-24, 26 ,27-trihomovitamin D3",KLZOTDOJMRMLDX-YBBVPDDNSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
92459,6m71,DB04438,-7.1,Brivudine monophosphate,LKWCVKAHHUJPQO-PIXDULNESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
153752,6wiq,DB07074,-7.1,6-CARBAMIMIDOYL-4-(3-HYDROXY-2-METHYL-BENZOYLAMINO)-NAPHTHALENE-2-CARBOXYLIC ACID METHYL ESTER,OUBRALHIKGRAMA-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
153918,6wiq,DB07268,-7.1,2-({2-[(3-HYDROXYPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)BENZAMIDE,QHPKKGUGRGRSGA-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
130666,6w4h,DB12594,-7.1,AZD-9056,HSQAARMBHJCUOK-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
152342,6wiq,DB03921,-7.1,4-(3-Pyridin-2-Yl-1h-Pyrazol-4-Yl)Quinoline,IBCXZJCWDGCXQT-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
152344,6wiq,DB03925,-7.1,Freselestat,HMPQTEPEMQZWQH-QZTJIDSGSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
92291,6m71,DB04202,-7.1,Isoformononetin,LNIQZRIHAMVRJA-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
67360,6lxt,DB06538,-7.1,Robalzotan,MQTUXRKNJYPMCG-CYBMUJFWSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
129611,6w4h,DB09039,-7.1,Eliglustat,FJZZPCZKBUKGGU-AUSIDOKSSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
153206,6wiq,DB05553,-7.1,Regrelor,NXHAXEBZOXCDKD-XIXRRVGJSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
129967,6w4h,DB11512,-7.1,Dihydrostreptomycin,ASXBYYWOLISCLQ-HZYVHMACSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
92123,6m71,DB03982,-7.1,"Compound 5, 2-(Naphthalen-1-Yl-Oxalyl-Amino)-Benzoicacid",WQWCUHJIERBOSM-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
153917,6wiq,DB07267,-7.1,2-(6-methylpyridin-2-yl)-N-pyridin-4-ylquinazolin-4-amine,JONFDFIXMPXTRH-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
153205,6wiq,DB05552,-7.1,TG100-115,UJIAQDJKSXQLIT-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
153426,6wiq,DB06469,-7.1,Lestaurtinib,UIARLYUEJFELEN-DMVVYWCZSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
92134,6m71,DB03996,-7.1,"3-[(5s)-1-Acetyl-3-(2-Chlorophenyl)-4,5-Dihydro-1h-Pyrazol-5-Yl]Phenol",QBZAPFWYAPXRGQ-KRWDZBQOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
130220,6w4h,DB11946,-7.1,AZD-1981,JWYIGNODXSRKGP-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
153906,6wiq,DB07254,-7.1,"N-[3-[[4-[(5-CHLORO-1,3-BENZODIOXOL-4-YL)AMINO]PYRIMIDIN-2-YL]AMINO]PHENYL]METHANESULFONAMIDE",KQGTYXRWSIBDOZ-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
91883,6m71,DB03672,-7.1,9-N-Phenylmethylamino-Tacrine,JYJAEHAURXXPSD-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
91871,6m71,DB03658,-7.1,"2-{1-[2-Amino-2-(4-Hydroxy-Phenyl)-Acetylamino]-2-Oxo-Ethyl}-5,5-Dimethyl-Thiazolidine-4-Carboxylic Acid",SMLJDSWXGVMNTH-NRWUCQMLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
130682,6w4h,DB12623,-7.1,Taprenepag,MFFBXYNKZHTCEY-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
67735,6lxt,DB07101,-7.1,PD-0325901,SUDAHWBOROXANE-SECBINFHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
67435,6lxt,DB06708,-7.1,Lumefantrine,DYLGFOYVTXJFJP-MYYYXRDXSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
153403,6wiq,DB06412,-7.1,Oxymetholone,ICMWWNHDUZJFDW-DHODBPELSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
92293,6m71,DB04205,-7.1,"Thymidine-3',5'-Diphosphate",CSNCBOPUCJOHLS-XLPZGREQSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
129985,6w4h,DB11560,-7.1,Lesinurad,FGQFOYHRJSUHMR-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
130651,6w4h,DB12572,-7.1,Pexacerfont,LBWQSAZEYIZZCE-SNVBAGLBSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
91179,6m71,DB02711,-7.1,"4-{2,6,8-Trioxo-9-[(2S,3R,4R)-2,3,4,5-Tetrahydroxypentyl]-1,2,3,6,8,9-Hexahydro-7h-Purin-7-Yl}Butyl Dihydrogen Phosphate",VBXZSBKAJFXURR-QXFUBDJGSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
104392,6vxs,DB11935,-7.1,Flomoxef,UHRBTBZOWWGKMK-DOMZBBRYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
91180,6m71,DB02712,-7.1,Sorbinil,LXANPKRCLVQAOG-NSHDSACASA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
153383,6wiq,DB06346,-7.1,Fiboflapon,DFQGDHBGRSTTHX-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
153238,6wiq,DB05772,-7.1,Rabeximod,PDNNUMNEXITLCZ-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
91740,6m71,DB03464,-7.1,Formycin-5'-Monophosphate,PBAHXXBYQACZMA-KSYZLYKTSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
58845,6crv,DB06738,-7.1,Ketobemidone,ALFGKMXHOUSVAD-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
91912,6m71,DB03714,-7.1,4-Carbamoyl-4-{[6-(Difluoro-Phosphono-Methyl)-Naphthalene-2-Carbonyl]-Amino}-Butyric Acid,OWWCIKSGGKYNHT-ZDUSSCGKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
67639,6lxt,DB06991,-7.1,"N-[2-methyl-5-(methylcarbamoyl)phenyl]-2-{[(1R)-1-methylpropyl]amino}-1,3-thiazole-5-carboxamide",OYOUIHFZUAKCEF-LLVKDONJSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
130441,6w4h,DB12271,-7.1,ORE-1001,NTCCRGGIJNDEAB-IRXDYDNUSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
103814,6vxs,DB09076,-7.1,Umeclidinium,FVTWTVQXNAJTQP-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
68022,6lxt,DB07429,-7.1,2-({[4-bromo-3-(diethylsulfamoyl)phenyl]carbonyl}amino)benzoic acid,VNOMZKMKBNFCMC-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
130661,6w4h,DB12587,-7.1,Razupenem,XFGOMLIRJYURLQ-GOKYHWASSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
153034,6wiq,DB04845,-7.1,Ixabepilone,FABUFPQFXZVHFB-PVYNADRNSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
153924,6wiq,DB07274,-7.1,"N-cyclopropyl-6-[(6,7-dimethoxyquinolin-4-yl)oxy]naphthalene-1-carboxamide",ZATGFXTWDKIEKC-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
12139,6lzg,DB12937,-7.1,Quercetin-3'-O-phosphate,UWJBYNLLMAPJMM-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
92453,6m71,DB04430,-7.1,3-(4-Phenylamino-Phenylamino)-2-(1h-Tetrazol-5-Yl)-Acrylonitrile,FLPLCJJGNZGOAW-QXMHVHEDSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
37417,1r42,DB04238,-7.1,N-Alpha-(2-Naphthylsulfonyl)-N-(3-Amidino-L-Phenylalaninyl)-D-Pipecolinic Acid,GNANSBQAIRJZPA-XZOQPEGZSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
153402,6wiq,DB06410,-7.1,Doxercalciferol,HKXBNHCUPKIYDM-CGMHZMFXSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
131343,6w4h,DB13617,-7.1,Clorexolone,VPMWFZKOWULPGT-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
59383,6crv,DB07398,-7.1,"2-[(CYCLOPROPYLCARBONYL)AMINO]-4,5,6,7-TETRAHYDRO-1-BENZOTHIOPHENE-3-CARBOXAMIDE",VATFNEMGBRWLHI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
102235,6vxs,DB07163,-7.1,5-[(2-AMINOETHYL)AMINO]-6-FLUORO-3-(1H-PYRROL-2-YL)BENZO[CD]INDOL-2(1H)-ONE,CQCXWWWNUFQYJS-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
92715,6m71,DB04778,-7.1,SC45647,LPSXGZAUAOMRNU-FZKQIMNGSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
24501,6cs2,DB02254,-7.1,Trifluoro-thiamin phosphate,ZIBIECXVPMYJCV-UHFFFAOYSA-M,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
145240,6w9q,DB07122,-7.1,1-[4-(2-oxo-2-phenylethyl)phenyl]guanidine,MERNPSIIBFTCAI-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
97325,6m71,DB14650,-7.1,Menadiol diphosphate,JTNHOVZOOVVGHI-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
145246,6w9q,DB07128,-7.1,"N7-BUTYL-N2-(5-CHLORO-2-METHYLPHENYL)-5-METHYL[1,2,4]TRIAZOLO[1,5-A]PYRIMIDINE-2,7-DIAMINE",ZTYBIJUAAWLJNU-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
145249,6w9q,DB07131,-7.1,(S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclohexylpropanoyl)pyrrolidine-2-carboxamide,DOTBZTLJSXFKCP-IBGZPJMESA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
145251,6w9q,DB07133,-7.1,D-phenylalanyl-N-(3-methylbenzyl)-L-prolinamide,CHKWABXWPATIIG-UXHICEINSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
100738,6vxs,DB03987,-7.1,"2,4-Diamino-6-[N-(3',5'-Dimethoxybenzyl)-N-Methylamino]Pyrido[2,3-D]Pyrimidine",XWCCXDBXMCTZPW-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
139474,6w9c,DB13515,-7.1,Levomethadone,USSIQXCVUWKGNF-QGZVFWFLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
100752,6vxs,DB04005,-7.1,Uridine 5'-triphosphate,PGAVKCOVUIYSFO-XVFCMESISA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
145264,6w9q,DB07148,-7.1,"(6S)-1-chloro-3-[(4-fluorobenzyl)oxy]-6-(pyrrolidin-1-ylcarbonyl)pyrrolo[1,2-a]pyrazin-4(6H)-one",HPAFVLDARQIHPU-HNNXBMFYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
24523,6cs2,DB02277,-7.1,1-(5-Tert-Butyl-2-Methyl-2h-Pyrazol-3-Yl)-3-(4-Chloro-Phenyl)-Urea,FWIJKWMXNHRSRO-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
145274,6w9q,DB07161,-7.1,5-phenyl-1H-indazol-3-amine,ZCUSNQPYUNLATP-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
97276,6m71,DB14538,-7.1,Hydrocortisone aceponate,MFBMYAOAMQLLPK-FZNHGJLXSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
100776,6vxs,DB04040,-7.1,"N-(2-Morpholin-4-Yl-1-Morpholin-4-Ylmethyl-Ethyl)-3-Nitro-5-(3,4,5-Trihydroxy-6-Hydroxymethyl-Tetrahydro-Pyran-2-Yloxy)-Benzamide",MCMWCTMAKPQTPI-WGNYYXNJSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
100785,6vxs,DB04054,-7.1,"9-Butyl-8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine",PASRTKOWXJDFFV-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
145211,6w9q,DB07088,-7.1,(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclopentyloxy)ethanoyl)pyrrolidine-2-carboxamide,ZWXWAYUCJVQHOR-KRWDZBQOSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
97266,6m71,DB14232,-7.1,Deacetylbisacodyl,LJROKJGQSPMTKB-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
145208,6w9q,DB07085,-7.1,2-{[N-(2-ACETYL-5-CHLORO-4-FLUOROPHENYL)GLYCYL]AMINO}BENZOIC ACID,LBMZLHCAPBBOFS-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
100673,6vxs,DB03899,-7.1,9-Butyl-8-(4-Methoxybenzyl)-9h-Purin-6-Amine,NVYATAJRTRFKSW-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
97431,6m71,DB14875,-7.1,AZD-4017,NCDZABJPWMBMIQ-INIZCTEOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
13564,6lzg,DB01231,-7.1,Diphenidol,OGAKLTJNUQRZJU-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
139612,6w9c,DB13701,-7.1,Ioglicic acid,HHFIATHHSBFCBY-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
145149,6w9q,DB07019,-7.1,"N-[(5R,14R)-5-AMINO-5,14-DIMETHYL-4-OXO-3-OXA-18-AZATRICYCLO[15.3.1.1-7,11-]DOCOSA-1(21),7(22),8,10,17,19-HEXAEN-19-YL]-N-METHYLMETHANESULFONAMIDE",QWDOKZPZLWNULU-MZNJEOGPSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
100601,6vxs,DB03808,-7.1,Hexamidine,OQLKNTOKMBVBKV-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
139587,6w9c,DB13671,-7.1,Sulbentine,QFVAWNPSRQWSDU-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
100602,6vxs,DB03809,-7.1,9-Butyl-8-(3-Methoxybenzyl)-9h-Purin-6-Amine,BWLWUGBHOXIUBP-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
139549,6w9c,DB13619,-7.1,Bornaprine,BDNMABJZSXTKAQ-VCPDFFEISA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
145182,6w9q,DB07054,-7.1,(2R)-1-(DIMETHYLAMINO)-3-{4-[(6-{[2-FLUORO-5-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-4-YL)AMINO]PHENOXY}PROPAN-2-OL,OSCWQKTUILTARV-MRXNPFEDSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
139543,6w9c,DB13611,-7.1,Chlormidazole,WNAQOLSMVPFGTE-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
145191,6w9q,DB07064,-7.1,"(4R)-4-(3-HYDROXYPHENYL)-N,N,7,8-TETRAMETHYL-3,4-DIHYDROISOQUINOLINE-2(1H)-CARBOXAMIDE",HPVCRUIDFODATB-LJQANCHMSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
97378,6m71,DB14753,-7.1,Hydroxystilbamidine,TUESWZZJYCLFNL-DAFODLJHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97373,6m71,DB14736,-7.1,Cannabivarin,SVTKBAIRFMXQQF-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
145203,6w9q,DB07080,-7.1,"N-(2,2,2-TRIFLUOROETHYL)-N-{4-[2,2,2-TRIFLUORO-1-HYDROXY-1-(TRIFLUOROMETHYL)ETHYL]PHENYL}BENZENESULFONAMIDE",SGIWFELWJPNFDH-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
139519,6w9c,DB13580,-7.1,Succinylsulfathiazole,SKVLYVHULOWXTD-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
13589,6lzg,DB01288,-7.1,Fenoterol,LSLYOANBFKQKPT-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
64323,6lxt,DB01388,-7.1,Mibefradil,HBNPJJILLOYFJU-VMPREFPWSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
97265,6m71,DB14221,-7.1,Beclomethasone 17-monopropionate,OHYGPBKGZGRQKT-XGQKBEPLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97261,6m71,DB14214,-7.1,Rose bengal lactone,IICCLYANAQEHCI-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
139203,6w9c,DB13115,-7.1,Saroglitazar,MRWFZSLZNUJVQW-DEOSSOPVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
61908,6crv,DB12783,-7.1,Benserazide,BNQDCRGUHNALGH-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
145450,6w9q,DB07359,-7.1,"3-[(4-fluorophenyl)sulfanyl]-N-(4-methyl-1,3-thiazol-2-yl)-6-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]pyridine-2-carboxamide",SJTQKYKXCYVFHX-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
24578,6cs2,DB02346,-7.1,3'-O-N-Octanoyl-a-D-Glucopyranosyl-B-D-Fructofuranoside,NMVDZWILYFXVBZ-PQJCEUABSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
100969,6vxs,DB04293,-7.1,7-(2-Amino-2-Phenyl-Acetylamino)-3-Chloro-8-Oxo-1-Aza-Bicyclo[4.2.0]Oct-2-Ene-2-Carboxylic Acid,JAPHQRWPEGVNBT-IJLUTSLNSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
139151,6w9c,DB12931,-7.1,Fenobam,DWPQODZAOSWNHB-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
100979,6vxs,DB04306,-7.1,"5-[(4-Methylphenyl)Sulfanyl]-2,4-Quinazolinediamine",UOJFGEAPSYQDIP-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
145484,6w9q,DB07402,-7.1,Azapropazone,WOIIIUDZSOLAIW-NSHDSACASA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
139146,6w9c,DB12926,-7.1,Cafedrine,UJSKUDDDPKGBJY-WFASDCNBSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
145486,6w9q,DB07404,-7.1,"(1-HYDROXY-1-PHOSPHONO-2-[1,1';3',1'']TERPHENYL-3-YL-ETHYL)-PHOSPHONIC ACID",YXQQNSYZOQHKHD-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
64432,6lxt,DB01523,-7.1,Clonitazene,GPZLDQAEBHTMPG-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
139102,6w9c,DB12861,-7.1,Rimeporide,GROMEQPXDKRRIE-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
64438,6lxt,DB01529,-7.1,Dextromoramide,INUNXTSAACVKJS-OAQYLSRUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
64440,6lxt,DB01531,-7.1,Desomorphine,LNNWVNGFPYWNQE-GMIGKAJZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
64441,6lxt,DB01532,-7.1,??-Methylacetylfentanyl,OKTLVZBUKMRPLL-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
139218,6w9c,DB13143,-7.1,Methallenestril,KHLJKRBMZVNZOC-MRXNPFEDSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
145443,6w9q,DB07352,-7.1,Apigenin,KZNIFHPLKGYRTM-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
139233,6w9c,DB13181,-7.1,Methylbenactyzium,HDAMOICMOAXFLJ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
145441,6w9q,DB07350,-7.1,(2E)-N-hydroxy-3-[1-methyl-4-(phenylacetyl)-1H-pyrrol-2-yl]prop-2-enamide,UFQOXIMRSMFQRI-BQYQJAHWSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
97209,6m71,DB14093,-7.1,"(1,2,6,7-3H)Testosterone",MUMGGOZAMZWBJJ-JQSYSRDDSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97205,6m71,DB14086,-7.1,Cianidanol,PFTAWBLQPZVEMU-DZGCQCFKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
145330,6w9q,DB07227,-7.1,4-[(5-{[4-(3-CHLOROPHENYL)-3-OXOPIPERAZIN-1-YL]METHYL}-1H-IMIDAZOL-1-YL)METHYL]BENZONITRILE,JNUGFGAVPBYSHF-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
139390,6w9c,DB13405,-7.1,Mefruside,SMNOERSLNYGGOU-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
145339,6w9q,DB07238,-7.1,Nesbuvir,WTDWVLJJJOTABN-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
145351,6w9q,DB07252,-7.1,"3-({4-[(5-chloro-1,3-benzodioxol-4-yl)amino]pyrimidin-2-yl}amino)benzenesulfonamide",TZHCXOMEOHEZDX-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
100879,6vxs,DB04172,-7.1,"[2,4,6-Triisopropyl-Phenylsulfonyl-L-[3-Amidino-Phenylalanine]]-Piperazine-N'-Beta-Alanine",WATXEHGLYJKXOF-NDEPHWFRSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
13031,6lzg,DB14545,-7.1,Hydrocortisone succinate,VWQWXZAWFPZJDA-CGVGKPPMSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
145365,6w9q,DB07268,-7.1,2-({2-[(3-HYDROXYPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)BENZAMIDE,QHPKKGUGRGRSGA-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
64373,6lxt,DB01453,-7.1,Beta-hydroxyfentanyl,JEFVHLMGRUJLET-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
145376,6w9q,DB07280,-7.1,5-[4-(DIMETHYLAMINO)PHENYL]-6-[(6-MORPHOLIN-4-YLPYRIDIN-3-YL)ETHYNYL]PYRIMIDIN-4-AMINE,AINVOEOJEKKMKB-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
61940,6crv,DB12838,-7.1,Tetrasul,QUWSDLYBOVGOCW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
97146,6m71,DB13967,-7.1,Patent Blue,DHAHKSQXIXFZJB-UHFFFAOYSA-O,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
145413,6w9q,DB07318,-7.1,"N-[2-(4-AMINO-5,8-DIFLUORO-1,2-DIHYDROQUINAZOLIN-2-YL)ETHYL]-3-FURAMIDE",BOAUWUUBSXECNL-LLVKDONJSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
100900,6vxs,DB04200,-7.1,Matairesinol,MATGKVZWFZHCLI-LSDHHAIUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
97140,6m71,DB13956,-7.1,Estradiol valerate,RSEPBGGWRJCQGY-RBRWEJTLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97176,6m71,DB14033,-7.1,Acetyl sulfisoxazole,JFNWFXVFBDDWCX-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
139648,6w9c,DB13753,-7.1,Cetiedil,MMNICIJVQJJHHF-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139663,6w9c,DB13773,-7.1,Sulfamethoxypyridazine,VLYWMPOKSSWJAL-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139671,6w9c,DB13782,-7.1,Imipramine oxide,QZIQORUGXBPDSU-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
97641,6m71,DB15319,-7.1,VM4-037,QGYZPMXIVNIGKA-GMAHTHKFSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
140423,6w9c,DB06821,-7.1,Sulfameter,GPTONYMQFTZPKC-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140416,6w9c,DB06807,-7.1,Phenyl aminosalicylate,DNVVZWSVACQWJE-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140414,6w9c,DB06802,-7.1,Nepafenac,QEFAQIPZVLVERP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
62286,6crv,DB13368,-7.1,Motretinide,IYIYMCASGKQOCZ-DJRRULDNSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62285,6crv,DB13367,-7.1,Cloricromen,GYNNRVJJLAVVTQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62281,6crv,DB13362,-7.1,Pheneturide,AJOQSQHYDOFIOX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
64053,6lxt,DB01009,-7.1,Ketoprofen,DKYWVDODHFEZIM-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
140373,6w9c,DB05805,-7.1,NS-2359,PGYDXVBZYKQYCS-VPWBDBDCSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
100218,6vxs,DB03277,-7.1,alpha-maltotriose,FYGDTMLNYKFZSV-PXXRMHSHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
100224,6vxs,DB03288,-7.1,5-Chloro-1h-Indole-2-Carboxylic Acid{[Cyclopentyl-(2-Hydroxy-Ethyl)-Carbamoyl]-Methyl}-Amide,VXABTOCIIZSEPD-QGZVFWFLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
100229,6vxs,DB03296,-7.1,3'-beta-Sialyl-beta-lactose,CILYIEBUXJIHCO-LPTWSRJFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
100245,6vxs,DB03313,-7.1,Cephalosporin C,HOKIDJSKDBPKTQ-GLXFQSAKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
97581,6m71,DB15204,-7.1,Fosravuconazole,SYTNEMZCCLUTNX-NPMXOYFQSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
24376,6cs2,DB00131,-7.1,Adenosine phosphate,UDMBCSSLTHHNCD-KQYNXXCUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
64031,6lxt,DB00984,-7.1,Nandrolone phenpropionate,UBWXUGDQUBIEIZ-QNTYDACNSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
97643,6m71,DB15324,-7.1,ORM-13070 C-11,VGIYMYGMVXPMKV-GWDMYEQXSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
64029,6lxt,DB00982,-7.1,Isotretinoin,SHGAZHPCJJPHSC-XFYACQKRSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
140467,6w9c,DB07279,-7.1,N-ETHYL-N-ISOPROPYL-3-METHYL-5-{[(2S)-2-(PYRIDIN-4-YLAMINO)PROPYL]OXY}BENZAMIDE,JMPSZYHYDMQFEO-KRWDZBQOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
97713,6m71,DB01557,-7.1,alpha-Methylfentanyl,NGTVDHYUFBKWID-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
13418,6lzg,DB15319,-7.1,VM4-037,QGYZPMXIVNIGKA-GMAHTHKFSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
62365,6crv,DB13478,-7.1,Meptazinol,JLICHNCFTLFZJN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
63981,6lxt,DB00924,-7.1,Cyclobenzaprine,JURKNVYFZMSNLP-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
2484,6lzg,HMDB0041759,-7.1,Naringenin 4'-O-glucuronide,DFIUUCDSSKATFP-DNPGXZAYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
13420,6lzg,DB15324,-7.1,ORM-13070 C-11,VGIYMYGMVXPMKV-GWDMYEQXSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
13089,6lzg,DB14662,-7.1,Flunisolide acetate,WEGNFRKBIKYVLC-XTLNBZDDSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
64079,6lxt,DB01038,-7.1,Carphenazine,XZSMZRXAEFNJCU-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
2520,6lzg,HMDB0000733,-7.1,Hyodeoxycholic acid,DGABKXLVXPYZII-CDONHWFASA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
97664,6m71,DB15360,-7.1,"Carfentanil, C-11",YDSDEBIZUNNPOB-JVVVGQRLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97657,6m71,DB15347,-7.1,Branebrutinib,VJPPLCNBDLZIFG-ZDUSSCGKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
100108,6vxs,DB03137,-7.1,"8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9-Pent-9h-Purin-6-Ylamine",RMOYVWKKOKERSW-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
13446,6lzg,DB15377,-7.1,ATB-346,YCNMAPLPQYQJFC-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
140491,6w9c,DB11957,-7.1,Idalopirdine,YBAWYTYNMZWMMJ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
62311,6crv,DB13406,-7.1,Carbutamide,VDTNNGKXZGSZIP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
13079,6lzg,DB14652,-7.1,Clocortolone acetate,ARPLCFGLEYFDCN-CDACMRRYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
62347,6crv,DB13452,-7.1,Cadralazine,QLTVVOATEHFXLT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
139048,6w9c,DB12766,-7.1,Cicletanine,CVKNDPRBJVBDSS-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140291,6w9c,DB02762,-7.1,RU79072,NQLPTOOPFMPCHQ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
145098,6w9q,DB06955,-7.1,"3,4-bis(7-chloro-1H-indol-3-yl)-1H-pyrrole-2,5-dicarboxylic acid",OAMCCJASDLMTOO-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
97486,6m71,DB15021,-7.1,Leriglitazone,OXVFDZYQLGRLCD-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
24409,6cs2,DB00294,-7.1,Etonogestrel,GCKFUYQCUCGESZ-BPIQYHPVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
24410,6cs2,DB02140,-7.1,N1-(1-Dimethylcarbamoyl-2-Phenyl-Ethyl)-2-Oxo-N4-(2-Pyridin-2-Yl-Ethyl)-Succinamide,ZPFPZRVOBBMZMP-SFHVURJKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
64156,6lxt,DB01128,-7.1,Bicalutamide,LKJPYSCBVHEWIU-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
100449,6vxs,DB03608,-7.1,Diminazene,XNYZHCFCZNMTFY-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
100469,6vxs,DB03641,-7.1,"2'-deoxyuridine 5'-alpha,beta-imido-diphosphate",COFNIXBQVWFHTR-SHYZEUOFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
100475,6vxs,DB03650,-7.1,(3e)-3-[(4-Hydroxyphenyl)Imino]-1h-Indol-2(3h)-One,ZJASRZFZRYISET-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
100480,6vxs,DB03656,-7.1,Tribenuron Methyl,VLCQZHSMCYCDJL-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
100482,6vxs,DB03658,-7.1,"2-{1-[2-Amino-2-(4-Hydroxy-Phenyl)-Acetylamino]-2-Oxo-Ethyl}-5,5-Dimethyl-Thiazolidine-4-Carboxylic Acid",SMLJDSWXGVMNTH-NRWUCQMLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
100488,6vxs,DB03666,-7.1,3'-Azido-3'-Deoxythymidine-5'-Monophosphate,OIFWQOKDSPDILA-XLPZGREQSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
139748,6w9c,DB13918,-7.1,Diclofop-methyl,BACHBFVBHLGWSL-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
64171,6lxt,DB01145,-7.1,Sulfoxone,NEDPPCHNEOMTJV-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
64176,6lxt,DB01150,-7.1,Cefprozil,WDLWHQDACQUCJR-PBFPGSCMSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
62099,6crv,DB13082,-7.1,Nefiracetam,NGHTXZCKLWZPGK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
97448,6m71,DB14903,-7.1,Rovafovir etalafenamide,OCJRRXHWPBXZSU-BJBBEUPESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
64153,6lxt,DB01125,-7.1,Anisindione,XRCFXMGQEVUZFC-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
13531,6lzg,DB01179,-7.1,Podofilox,YJGVMLPVUAXIQN-XVVDYKMHSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
139894,6w9c,DB14213,-7.1,Perindoprilat,ODAIHABQVKJNIY-PEDHHIEDSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
139904,6w9c,DB14476,-7.1,DL-alpha-Tocopherol,GVJHHUAWPYXKBD-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
13061,6lzg,DB14635,-7.1,Curcumin sulfate,NEJVQQBBTRFOHB-FCXRPNKRSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
13060,6lzg,DB14634,-7.1,Fluprednidene acetate,DEFOZIFYUBUHHU-IYQKUMFPSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
64084,6lxt,DB01044,-7.1,Gatifloxacin,XUBOMFCQGDBHNK-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
140282,6w9c,DB02752,-7.1,Tosyl-D-Proline,CGPHGPCHVUSFFA-LLVKDONJSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
100305,6vxs,DB03396,-7.1,"(E)-(2r,3r,4s,5r)-3,4,5-Trihydroxy-2-Methoxy-8,8-Dimethyl-Non-6-Enoic Acid ((3s,6r)-6-Hydroxy-2-Oxo-Azepan-3-Yl)-Amide",FVBBTOIQETYGOA-SDNORSGYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
145128,6w9q,DB06995,-7.1,N-({4-[(2-aminopyridin-4-yl)oxy]-3-fluorophenyl}carbamoyl)-2-(4-fluorophenyl)acetamide,USBSTVPJNQLYEM-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
62214,6crv,DB13279,-7.1,Carbocromen,KLOIYEQEVSIOOO-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28591,6cs2,DB00756,-7.1,Hexachlorophene,ACGUYXCXAPNIKK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
28638,6cs2,DB08234,-7.1,"5-[3-(2,5-dimethoxyphenyl)prop-1-yn-1-yl]-6-ethylpyrimidine-2,4-diamine",NNFDQABYXZBKRK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
140095,6w9c,DB14933,-7.1,Nicotinamide riboside,JLEBZPBDRKPWTD-TURQNECASA-O,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140083,6w9c,DB14904,-7.1,Pimasertib,VIUAUNHCRHHYNE-JTQLQIEISA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
140023,6w9c,DB14772,-7.1,DCFBC F-18,IDTMSHGCAZPVLC-STUNTBJNSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
100351,6vxs,DB03464,-7.1,Formycin-5'-Monophosphate,PBAHXXBYQACZMA-KSYZLYKTSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
140004,6w9c,DB14732,-7.1,Queuine,WYROLENTHWJFLR-ACLDMZEESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
100360,6vxs,DB03477,-7.1,1-Phenylsulfonamide-3-Trifluoromethyl-5-Parabromophenylpyrazole,OYZKFVIVPRQRQQ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
139994,6w9c,DB14714,-7.1,Tenivastatin,XWLXKKNPFMNSFA-HGQWONQESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
13057,6lzg,DB14631,-7.1,Prednisolone phosphate,JDOZJEUDSLGTLU-VWUMJDOOSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
97753,6vxs,DB00131,-7.1,Adenosine phosphate,UDMBCSSLTHHNCD-KQYNXXCUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
145531,6w9q,DB07456,-7.1,"3-(1H-indol-3-yl)-4-(1-{2-[(2S)-1-methylpyrrolidinyl]ethyl}-1H-indol-3-yl)-1H-pyrrole-2,5-dione",LBFDERUQORUFIN-QGZVFWFLSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
101093,6vxs,DB04468,-7.1,Afimoxifene,TXUZVZSFRXZGTL-QPLCGJKRSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
145801,6w9q,DB07779,-7.1,N-({(2S)-1-[(3R)-3-AMINO-4-(2-FLUOROPHENYL)BUTANOYL]PYRROLIDIN-2-YL}METHYL)BENZAMIDE,ANQHSFFUNMTTRS-MOPGFXCFSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
145806,6w9q,DB07785,-7.1,"1-{(1R,2S)-2-HYDROXY-1-[2-(2-NAPHTHYLOXY)ETHYL]PROPYL}-1H-IMIDAZONE-4-CARBOXAMIDE",UYAJDVNLQJVRHD-SCLBCKFNSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
24804,6cs2,DB02603,-7.1,1-Amino-6-Cyclohex-3-Enylmethyloxypurine,VPUIDVRYMVIXGO-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
96266,6m71,DB12647,-7.1,Tocotrienol,GJJVAFUKOBZPCB-ZGRPYONQSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
138018,6w9c,DB09021,-7.1,Benzoctamine,GNRXCIONJWKSEA-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
96263,6m71,DB12643,-7.1,Nelivaptan,NJXZWIIMWNEOGJ-WEWKHQNJSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
64900,6lxt,DB02128,-7.1,[1-(3-Hydroxy-2-Oxo-1-Phenethyl-Propylcarbamoyl)2-Phenyl-Ethyl]-Carbamic Acid Pyridin-4-Ylmethyl Ester,QCUBCTPTNWPFBC-ZEQRLZLVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
137989,6w9c,DB08990,-7.1,Eprazinone,BSHWLCACYCVCJE-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
96231,6m71,DB12587,-7.1,Razupenem,XFGOMLIRJYURLQ-GOKYHWASSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
64936,6lxt,DB02181,-7.1,2'-Deoxyguanosine-5'-Triphosphate,HAAZLUGHYHWQIW-KVQBGUIXSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
145850,6w9q,DB07832,-7.1,"4-{4-[(5-hydroxy-2-methylphenyl)amino]quinolin-7-yl}-1,3-thiazole-2-carbaldehyde",VKQPTVJDZIILPG-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
64946,6lxt,DB02195,-7.1,"3-(4-Fluorophenyl)-1-Hydroxy-2-(Pyridin-4-Yl)-1h-Pyrrolo[3,2-B]Pyridine",ZSMYZLKEZDYVPI-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
64965,6lxt,DB02220,-7.1,AL7089A,RMOXCYSVWCHXII-LBPRGKRZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
137937,6w9c,DB08926,-7.1,Acediasulfone,FKKUMFTYSTZUJG-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
24826,6cs2,DB02628,-7.1,"1-[3,3-Dimethyl-2-(2-Methylamino-Propionylamino)-Butyryl]-Pyrrolidine-2-Carboxylic Acid(1,2,3,4-Tetrahydro-Naphthalen-1-Yl)-Amide",JUJIMRZGUBTJRV-NASSWSRMSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
96310,6m71,DB12713,-7.1,Sotagliflozin,QKDRXGFQVGOQKS-CRSSMBPESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
101516,6vxs,DB05399,-7.1,Succinobucol,RKSMVPNZHBRNNS-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
64862,6lxt,DB02081,-7.1,Bis-Benzamidine,BXYGSMRTHHSAHZ-PMACEKPBSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
145772,6w9q,DB07746,-7.1,3-ETHYL-6-{[(4-FLUOROPHENYL)SULFONYL]AMINO}-2-METHYLBENZOIC ACID,MGUQWAOYPINSIT-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
24758,6cs2,DB02546,-7.1,Vorinostat,WAEXFXRVDQXREF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
96382,6m71,DB12832,-7.1,Prednimustine,HFVNWDWLWUCIHC-GUPDPFMOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
138133,6w9c,DB09216,-7.1,Tolfenamic Acid,YEZNLOUZAIOMLT-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
145713,6w9q,DB07676,-7.1,"3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)-1H,2'H-2,3'-biindol-2'-one",CKLAPOFDFZKCPB-LBPRGKRZSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
96368,6m71,DB12806,-7.1,GSK-1004723,YANGEESWIGIKOP-UUWRZZSWSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
145715,6w9q,DB07678,-7.1,"(9ALPHA,13BETA,17BETA)-2-[(1Z)-BUT-1-EN-1-YL]ESTRA-1,3,5(10)-TRIENE-3,17-DIOL",ANAMDWGJXBYJEB-OPWFCKQNSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
96366,6m71,DB12804,-7.1,Daniquidone,SRIOCKJKFXAKHK-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
101441,6vxs,DB04954,-7.1,Tecadenoson,OESBDSFYJMDRJY-BAYCTPFLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
145726,6w9q,DB07692,-7.1,"1-[(2,6-difluorophenyl)sulfonyl]-4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)piperazine",SHWNKRPMUBFWKE-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
96352,6m71,DB12780,-7.1,Quinfamide,SBJGFIXQRZOVTO-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
12905,6lzg,DB01066,-7.1,Cefditoren,KMIPKYQIOVAHOP-YLGJWRNMSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
138112,6w9c,DB09194,-7.1,Etoperidone,IZBNNCFOBMGTQX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138111,6w9c,DB09193,-7.1,"CP-39,332",HLOCJJORRHQDKS-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
64851,6lxt,DB02069,-7.1,N-(2-Flouro-Benzyl)-4-Sulfamoyl-Benzamide,ULYMHSXFSKOHGH-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
101458,6vxs,DB05025,-7.1,Arimoclomol,SGEIEGAXKLMUIZ-CYBMUJFWSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
64858,6lxt,DB02077,-7.1,L-N(omega)-Nitroarginine-(4R)-Amino-L-Proline Amide,IUFRDGFKAVLPFZ-CSMHCCOUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
64990,6lxt,DB02253,-7.1,"(1r)-4-[(1e,3e,5e,7z,9e,11z,13e,15e)-17-Hydroxy-3,7,12,16-Tetramethylheptadeca-1,3,5,7,9,11,13,15-Octaen-1-Yl]-3,5,5-Trimethylcyclohex-3-En-1-Ol",FNAJVVMDXCOSFY-VFGOXHQXSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
145889,6w9q,DB07875,-7.1,"5-Chloro-thiophene-2-carboxylic acid ((3S,4S)-1-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-methyl}-4-hydroxy-pyrrolidin-3-yl)-amide",ARAVOODWJJJNBY-IRXDYDNUSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
145892,6w9q,DB07878,-7.1,"N-[(1S)-1-{1-[(1R,3E)-1-ACETYLPENT-3-EN-1-YL]-1H-1,2,3-TRIAZOL-4-YL}-1,2-DIMETHYLPROPYL]BENZAMIDE",OEHUTYXPQSSKAK-RVLLMHTFSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
137659,6w9c,DB08562,-7.1,4-(4-STYRYL-PHENYLCARBAMOYL)-BUTYRIC ACID,FTXJWRRYLLRFMG-MDZDMXLPSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
23538,6cs2,HMDB0062177,-7.1,N-lactoyl-Tyrosine,XBOGARDIMVJTKF-XVKPBYJWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
137627,6w9c,DB08526,-7.1,CARBOBENZYLOXY-(L)-LEUCINYL-(L)LEUCINYL METHOXYMETHYLKETONE,LHCNZPLAATYYPI-SLFFLAALSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
24892,6cs2,DB02706,-7.1,Mercaptocarboxylate Inhibitor,DUKDFMPUZRDWLT-CQSZACIVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
65074,6lxt,DB02363,-7.1,2'-Monophosphoadenosine-5'-Diphosphate,YPTPYQSAVGGMFN-KQYNXXCUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
137610,6w9c,DB08505,-7.1,methyl 4-bromo-N-[8-(hydroxyamino)-8-oxooctanoyl]-L-phenylalaninate,UPYGSQPRAHMDPD-HNNXBMFYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
146062,6w9q,DB08077,-7.1,"2-[4-({[(3,5-DICHLOROPHENYL)AMINO]CARBONYL}AMINO)PHENOXY]-2-METHYLPROPANOIC ACID",OYJPTSMWFKGZJM-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
101603,6vxs,DB05864,-7.1,PPI-2458,QBDVVYNLLXGUGN-XGTBZJOHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101606,6vxs,DB05884,-7.1,HCV-086,VBRUONUESYTIDA-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
65090,6lxt,DB02382,-7.1,Namn,JOUIQRNQJGXQDC-ZYUZMQFOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
137581,6w9c,DB08472,-7.1,(R)-Fluoxetine,RTHCYVBBDHJXIQ-MRXNPFEDSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
95930,6m71,DB12150,-7.1,Pelubiprofen,AUZUGWXLBGZUPP-GXDHUFHOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
101620,6vxs,DB05973,-7.1,Inosine 5'-sulfate,IGYLPKLXFDOQGM-KQYNXXCUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
95927,6m71,DB12147,-7.1,Erdafitinib,OLAHOMJCDNXHFI-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
137567,6w9c,DB08457,-7.1,"4-(3,5-DIMETHYLPHENOXY)-5-(FURAN-2-YLMETHYLSULFANYLMETHYL)-3-IODO-6-METHYLPYRIDIN-2(1H)-ONE",YZLKVEDFWLGNQP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
61472,6crv,DB12133,-7.1,BLXA4,HEDVTGFTYROYFE-RREUNBNVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
24880,6cs2,DB02694,-7.1,Pantoyl Adenylate,GDPVENOGSVMRJL-FSRKKXLISA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
146018,6w9q,DB08026,-7.1,"2-{4-[(4-imidazo[1,2-a]pyridin-3-ylpyrimidin-2-yl)amino]piperidin-1-yl}-N-methylacetamide",AJLILYAPRHIFAS-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
137715,6w9c,DB08634,-7.1,6-BENZYL-1-BENZYLOXYMETHYL-5-ISOPROPYL URACIL,KSAAUHMSLCPIEX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
145898,6w9q,DB07889,-7.1,"(2S)-1-(Dimethylamino)-3-(4-{[4-(2-methylimidazo[1,2-a]pyridin-3-yl)-2-pyrimidinyl]amino}phenoxy)-2-propanol",VCPXSBULBDYRLT-SFHVURJKSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
145909,6w9q,DB07901,-7.1,5-CHLORO-6-METHYL-N-(2-PHENYLETHYL)-2-PYRIDIN-2-YLPYRIMIDIN-4-AMINE,HIUOABSWQSUEGK-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
24845,6cs2,DB00344,-7.1,Protriptyline,BWPIARFWQZKAIA-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
96080,6m71,DB12367,-7.1,Selurampanel,MCECSFFXUPEPDB-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
101558,6vxs,DB05585,-7.1,Verubulin,SNHCRNMVYDHVDT-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
96050,6m71,DB12319,-7.1,Benzbromarone,WHQCHUCQKNIQEC-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
12870,6lzg,DB13946,-7.1,Testosterone undecanoate,UDSFVOAUHKGBEK-CNQKSJKFSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
96389,6m71,DB12846,-7.1,Reproterol,WVLAAKXASPCBGT-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
145964,6w9q,DB07967,-7.1,9-CYCLOPENTYL-6-[2-(3-IMIDAZOL-1-YL-PROPOXY)-PHENYLAMINO]-9H-PURINE-2-CARBONITRILE,JJNKDTWKWYLERH-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
145970,6w9q,DB07973,-7.1,N-(1-ISOPROPYLPIPERIDIN-4-YL)-1-(3-METHOXYBENZYL)-1H-INDOLE-2-CARBOXAMIDE,GIPCBGDQVGKMPO-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
96029,6m71,DB12293,-7.1,Nefopam,RGPDEAGGEXEMMM-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
137727,6w9c,DB08648,-7.1,"(1R,3S,5S,8R)-8-Hydroxy-2-oxabicyclo[3.3.1]non-6-ene-3,5-dicarboxylic acid",KRZHNRULRHECRF-JQCUSGDOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
61488,6crv,DB12156,-7.1,Cordycepin,OFEZSBMBBKLLBJ-BAJZRUMYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
96005,6m71,DB12264,-7.1,Atevirdine,UCPOMLWZWRTIAA-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
146002,6w9q,DB08009,-7.1,"5-[(E)-(5-CHLORO-2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]-N-[2-(DIETHYLAMINO)ETHYL]-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXAMIDE",XPLJEFSRINKZLC-ATVHPVEESA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
146007,6w9q,DB08014,-7.1,(METHYLPYRIDAZINE PIPERIDINE BUTYLOXYPHENYL)ETHYLACETATE,AQILFLLHLFBLLG-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
24858,6cs2,DB02666,-7.1,(C8-R)-Hydantocidin 5'-Phosphate,MAXSFYCTFIBEAR-OJMIUMIFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
96399,6m71,DB12861,-7.1,Rimeporide,GROMEQPXDKRRIE-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96439,6m71,DB12921,-7.1,Chlorsulfaquinoxaline,CTSNHMQGVWXIEG-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96443,6m71,DB12926,-7.1,Cafedrine,UJSKUDDDPKGBJY-WFASDCNBSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
101192,6vxs,DB04596,-7.1,"4-O-{4,6-O-[(1S)-1-Carboxyethylidene]-??-D-mannopyranosyl}-D-glucopyranuronic acid",GZJXZKGVHLWBOW-AISSFXTFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101198,6vxs,DB04602,-7.1,PUROMYCIN AMINONUCLEOSIDE-5'-MONOPHOSPHATE,BFPIKGKMRKBBBF-GRIPGOBMSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
138812,6w9c,DB12299,-7.1,Bavisant,BGBVSGSIXIIREO-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138783,6w9c,DB12263,-7.1,Begacestat,PSXOKXJMVRSARX-SCSAIBSYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
101219,6vxs,DB04630,-7.1,Aldosterone,PQSUYGKTWSAVDQ-ZVIOFETBSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
97007,6m71,DB13739,-7.1,Penamecillin,NLOOMWLTUVBWAW-HLLBOEOZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
24653,6cs2,DB02424,-7.1,Geldanamycin,QTQAWLPCGQOSGP-KSRBKZBZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
24655,6cs2,DB02428,-7.1,Quinaldic Acid,LOAUVZALPPNFOQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
145611,6w9q,DB07550,-7.1,"2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(1-OXIDO-2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUOROPHENYL)METHYL]ACETAMIDE",ZIGSBBKEPNQXRG-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
96989,6m71,DB13718,-7.1,Hydroquinine,LJOQGZACKSYWCH-WZBLMQSHSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
61785,6crv,DB12587,-7.1,Razupenem,XFGOMLIRJYURLQ-GOKYHWASSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
96969,6m71,DB13687,-7.1,Niaprazine,RSKQGBFMNPDPLR-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
64538,6lxt,DB01643,-7.1,Thymidine monophosphate,GYOZYWVXFNDGLU-XLPZGREQSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
96962,6m71,DB13680,-7.1,Naftazone,TZGBBMBARSFJBG-UKTHLTGXSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
3397,6lzg,HMDB0000921,-7.1,Cholestenone,NYOXRYYXRWJDKP-GYKMGIIDSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
97038,6m71,DB13783,-7.1,Acemetacin,FSQKKOOTNAMONP-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
64495,6lxt,DB01594,-7.1,Cinolazepam,XAXMYHMKTCNRRZ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
64493,6lxt,DB01589,-7.1,Quazepam,IKMPWMZBZSAONZ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
101171,6vxs,DB04566,-7.1,Inosinic Acid,GRSZFWQUAKGDAV-KQYNXXCUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
64462,6lxt,DB01553,-7.1,Cloxazolam,ZIXNZOBDFKSQTC-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
138946,6w9c,DB12606,-7.1,Netivudine,QLOCVMVCRJOTTM-SDNRWEOFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
64476,6lxt,DB01567,-7.1,Fludiazepam,ROYOYTLGDLIGBX-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
64479,6lxt,DB01570,-7.1,Ohmefentanyl,FRPRNNRJTCONEC-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
64480,6lxt,DB01571,-7.1,3-Methylfentanyl,MLQRZXNZHAOCHQ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
145557,6w9q,DB07488,-7.1,"{(2Z)-4-AMINO-2-[(4-METHOXYPHENYL)IMINO]-2,3-DIHYDRO-1,3-THIAZOL-5-YL}(4-METHOXYPHENYL)METHANONE",XQKUGFIWKSKCDL-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
145558,6w9q,DB07489,-7.1,"4-Amino-2-[(3-chlorophenyl)amino]-5-(4-fluorobenzoyl)-1,3-thiazol-3-ium",WWGPTHOMFHDEEC-UHFFFAOYSA-O,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
96926,6m71,DB13635,-7.1,Tiracizine,KJAMZCVTJDTESW-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
97055,6m71,DB13805,-7.1,Reposal,MKELYWOVSPVORM-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
138889,6w9c,DB12407,-7.1,Iobitridol,YLPBXIKWXNRACS-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
145562,6w9q,DB07493,-7.1,"(2Z)-5'-BROMO-2,3'-BIINDOLE-2',3(1H,1'H)-DIONE AMMONIATE",IEQQJQHHJMQETK-YPKPFQOOSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
64485,6lxt,DB01578,-7.1,Metrizamide,DTZMSDADRKLCQE-RFMXWLSYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
138881,6w9c,DB12398,-7.1,Naproxen etemesil,JGBUBSOKFSVXKS-LBPRGKRZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
138880,6w9c,DB12395,-7.1,Esreboxetine,CBQGYUDMJHNJBX-OALUTQOASA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
145567,6w9q,DB07500,-7.1,(2E)-1-[2-hydroxy-4-methoxy-5-(3-methylbut-2-en-1-yl)phenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one,ZUGCRBMNFSAUOC-YRNVUSSQSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
13639,6lzg,T3D1649,-7.1,Fluorescein isothiocyanate,MHMNJMPURVTYEJ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
101151,6vxs,DB04543,-7.1,"2,6-Diamino-8-(1h-Imidazol-2-Ylsulfanylmethyl)-3h-Quinazoline-4-One",CEWKWXPCQGWWBM-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101082,6vxs,DB04457,-7.1,2'-Deoxyguanosine-5'-Monophosphate,LTFMZDNNPPEQNG-KVQBGUIXSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
96912,6m71,DB13616,-7.1,Melagatran,DKWNMCUOEDMMIN-PKOBYXMFSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
145675,6w9q,DB07629,-7.1,"N-((1R,2S)-2-(5-CHLORO-1H-INDOLE-2-CARBOXAMIDO)CYCLOHEXYL)-5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE-2-CARBOXAMIDE",ARPFWVKYXJZULB-DLBZAZTESA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
96592,6m71,DB13166,-7.1,Zofenopril,IAIDUHCBNLFXEF-MNEFBYGVSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
101382,6vxs,DB04845,-7.1,Ixabepilone,FABUFPQFXZVHFB-PVYNADRNSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
138348,6w9c,DB11447,-7.1,Phenothiazine,WJFKNYWRSNBZNX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
96524,6m71,DB13052,-7.1,Upamostat,HUASEDVYRABWCV-NDEPHWFRSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
64737,6lxt,DB01920,-7.1,1-O-[O-Nitrophenyl]-Beta-D-Galactopyranose,KUWPCJHYPSUOFW-YBXAARCKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
64739,6lxt,DB01922,-7.1,"Maltosyl-Alpha (1,4)-D-Gluconhydroximo-1,5-Lactam",AHRWQUNEPBVNOT-IVJVVCOPSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
101396,6vxs,DB04865,-7.1,Omacetaxine mepesuccinate,HYFHYPWGAURHIV-JFIAXGOJSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
138297,6w9c,DB11335,-7.1,Ascorbyl glucoside,MLSJBGYKDYSOAE-DCWMUDTNSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
64750,6lxt,DB01937,-7.1,Guanosine-2'-Monophosphate,WTIFIAZWCCBCGE-UUOKFMHZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
13711,6lzg,T3D0168,-7.1,"2,3,4,7,8-Pentachlorodibenzofuran",OGBQILNBLMPPDP-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
64762,6lxt,DB01950,-7.1,"N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thiazol-2-Yl)Urea",YAEMHJKFIIIULI-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
61664,6crv,DB12407,-7.1,Iobitridol,YLPBXIKWXNRACS-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61661,6crv,DB12404,-7.1,Remimazolam,CYHWMBVXXDIZNZ-KRWDZBQOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
61660,6crv,DB12402,-7.1,Pumosetrag,AFUWQWYPPZFWCO-LBPRGKRZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
138262,6w9c,DB11185,-7.1,Sulisobenzone,CXVGEDCSTKKODG-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
101373,6vxs,DB04836,-7.1,Amineptine,ONNOFKFOZAJDHT-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
24721,6cs2,DB02504,-7.1,[3-(1-Benzyl-3-Carbamoylmethyl-2-Methyl-1h-Indol-5-Yloxy)-Propyl-]-Phosphonic Acid,AQEYCNKFBRLUOT-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
138387,6w9c,DB11540,-7.1,Propiopromazine,ZQTVCQIJTREKSP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
64670,6lxt,DB01820,-7.1,"Compound 12, N-Acetyl-4-[(Carboxycarbonyl)(2-Carboxyphenyl)Amino]-N-Pentyl-1-Napthylalaniamide",UESXELNYBIOROE-QHCPKHFHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
101276,6vxs,DB04707,-7.1,Hydroxyfasudil,ZAVGJDAFCZAWSZ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101279,6vxs,DB04712,-7.1,ANILINOMETHYL GLUCO-PHENYLIMIDAZOLE,ADKWVGPRAQKVKB-YIYPIFLZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
3431,6lzg,HMDB0000936,-7.1,Uroporphyrin I,DAFUFNRZWDWXJP-JRHDEHKPSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
96885,6m71,DB13580,-7.1,Succinylsulfathiazole,SKVLYVHULOWXTD-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
145695,6w9q,DB07651,-7.1,N-ACETYL-L-PHENYLALANYL-4-[DIFLUORO(PHOSPHONO)METHYL]-L-PHENYLALANINAMIDE,KPMMESISHWWXNM-ROUUACIJSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
96862,6m71,DB13548,-7.1,Dibrompropamidine,GMJFVGRUYJHMCO-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96852,6m71,DB13534,-7.1,Gedocarnil,SLYDYLLJUXFULK-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96894,6m71,DB13593,-7.1,Zolimidine,VSLIUWLPFRVCDL-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96851,6m71,DB13533,-7.1,Methylestrenolone,ZXSWTMLNIIZPET-ZOFHRBRSSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96837,6m71,DB13512,-7.1,Clefamide,ODCUSWJXZDHLKV-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
61739,6crv,DB12518,-7.1,Raclopride,WAOQONBSWFLFPE-VIFPVBQESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
96807,6m71,DB13472,-7.1,Cyclofenil,GVOUFPWUYJWQSK-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96778,6m71,DB13432,-7.1,Lonazolac,XVUQHFRQHBLHQD-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
96743,6m71,DB13384,-7.1,Melitracen,GWWLWDURRGNSRS-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
12929,6lzg,DB14059,-7.1,SC-236,NSQNZEUFHPTJME-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
24712,6cs2,DB02495,-7.1,9-(4-hydroxybutyl)-N2-phenylguanine,JHBXNPBKSPYOFT-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
101308,6vxs,DB04754,-7.1,"GUANOSINE-2',3'-O-ETHYLIDENEPHOSPHONATE",HYAPEMYRVFIHDJ-QWEIRQIHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
101637,6vxs,DB06127,-7.1,Bisegliptin,AKFNKZFJBFQFAA-DIOPXHOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
97762,6vxs,DB00140,-7.1,Riboflavin,AUNGANRZJHBGPY-SCRDCRAPSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
63946,6lxt,DB00886,-7.1,Omapatrilat,LVRLSYPNFFBYCZ-VGWMRTNUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
98403,6vxs,DB00902,-7.1,Methdilazine,HTMIBDQKFHUPSX-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
98389,6vxs,DB00885,-7.1,Pemirolast,HIANJWSAHKJQTH-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
141976,6w9q,DB01587,-7.1,Ketazolam,PWAJCNITSBZRBL-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
144790,6w9q,DB06409,-7.1,Morphine glucuronide,GNJCUHZOSOYIEC-GAROZEBRSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
144791,6w9q,DB06410,-7.1,Doxercalciferol,HKXBNHCUPKIYDM-CGMHZMFXSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
141975,6w9q,DB01586,-7.1,Ursodeoxycholic acid,RUDATBOHQWOJDD-UZVSRGJWSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
144829,6w9q,DB06506,-7.1,Repinotan,YGYBFMRFXNDIPO-QGZVFWFLSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
99221,6vxs,DB01967,-7.1,"N-{3-[(7ar,12as,12bs)-7-Oxo-1,3,4,6,7,7a,12a,12b-Octahydroindolo[2,3-a]Quinolizin-12(2h)-Yl]Propyl}Propane-2-Sulfonamide",LICJTIDRHJECTD-SFHVURJKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
63490,6lxt,DB00340,-7.1,Metixene,MJFJKKXQDNNUJF-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
63491,6lxt,DB00341,-7.1,Cetirizine,ZKLPARSLTMPFCP-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
99241,6vxs,DB01995,-7.1,5-Methylcytidine-5'-Monophosphate,NJQONZSFUKNYOY-JXOAFFINSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
62802,6crv,DB14195,-7.1,4-(Isopropylamino)diphenylamine,OUBMGJOQLXMSNT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
144864,6w9q,DB06597,-7.1,Estradiol sulfamate,YXYXCSOJKUAPJI-ZBRFXRBCSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
63499,6lxt,DB00349,-7.1,Clobazam,CXOXHMZGEKVPMT-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
98337,6vxs,DB00827,-7.1,Cinoxacin,VDUWPHTZYNWKRN-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
99176,6vxs,DB01910,-7.1,Sinefungin,LMXOHSDXUQEUSF-YECHIGJVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
144935,6w9q,DB06729,-7.1,Sulfaphenazole,QWCJHSGMANYXCW-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
144734,6w9q,DB06246,-7.1,Exisulind,MVGSNCBCUWPVDA-MFOYZWKCSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
98413,6vxs,DB00912,-7.1,Repaglinide,FAEKWTJYAYMJKF-QHCPKHFHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
142232,6w9q,DB01933,-7.1,7-Hydroxystaurosporine,PBCZSGKMGDDXIJ-HQCWYSJUSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
98465,6vxs,DB00973,-7.1,Ezetimibe,OLNTVTPDXPETLC-XPWALMASSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
144639,6w9q,DB05830,-7.1,Trestolone,YSGQGNQWBLYHPE-CFUSNLFHSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
144665,6w9q,DB05990,-7.1,Obeticholic acid,ZXERDUOLZKYMJM-ZWECCWDJSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
142184,6w9q,DB01858,-7.1,[1-(4-Fluorobenzyl)Cyclobutyl]Methyl (1s)-1-[Oxo(1h-Pyrazol-5-Ylamino)Acetyl]Pentylcarbamate,QTPYRNAKLBXKNP-SFHVURJKSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
98449,6vxs,DB00952,-7.1,Naratriptan,AMKVXSZCKVJAGH-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
144672,6w9q,DB06090,-7.1,Bradanicline,OXKRFEWMSWPKKV-GHTZIAJQSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
144691,6w9q,DB06155,-7.1,Rimonabant,JZCPYUJPEARBJL-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
63421,6lxt,DB00257,-7.1,Clotrimazole,VNFPBHJOKIVQEB-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
144693,6w9q,DB06157,-7.1,Istaroxime,MPYLDWFDPHRTEG-PAAYLBSLSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
99143,6vxs,DB01858,-7.1,[1-(4-Fluorobenzyl)Cyclobutyl]Methyl (1s)-1-[Oxo(1h-Pyrazol-5-Ylamino)Acetyl]Pentylcarbamate,QTPYRNAKLBXKNP-SFHVURJKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
98425,6vxs,DB00924,-7.1,Cyclobenzaprine,JURKNVYFZMSNLP-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
99152,6vxs,DB01871,-7.1,[1-(1-Benzyl-3-Hydroxy-2-Oxo-Propylcarbamoyl)-2-Phenyl-Ethyl]-Carbamic Acid Benzyl Ester,OACUXIVGLLCILS-ZEQRLZLVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
142099,6w9q,DB01748,-7.1,N-Benzyl-4-Sulfamoyl-Benzamide,CZKNSZUJCJHTTM-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
142089,6w9q,DB01734,-7.1,3-(Oxalyl-Amino)-Naphthalene-2-Carboxylic Acid,DQBLKSRRWDWNKQ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
142056,6w9q,DB01689,-7.1,Inhibitor Idd 384,CJKKMQCZOLCXAM-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
63526,6lxt,DB00382,-7.1,Tacrine,YLJREFDVOIBQDA-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
141900,6w9q,DB01500,-7.1,Oxabolone,GXHBCWCMYVTJOW-YGRHGMIBSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
144962,6w9q,DB06777,-7.1,Chenodeoxycholic acid,RUDATBOHQWOJDD-BSWAIDMHSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
62728,6crv,DB14030,-7.1,PZM21,MEDBIJOVZJEMBI-YOEHRIQHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
141779,6w9q,DB01328,-7.1,Cefonicid,DYAIAHUQIPBDIP-AXAPSJFSSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
40704,6lu7,DB12999,-7.1,MK-6186,FZBAOOQVQXATRL-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
63595,6lxt,DB00467,-7.1,Enoxacin,IDYZIJYBMGIQMJ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
63596,6lxt,DB00468,-7.1,Quinine,LOUPRKONTZGTKE-WZBLMQSHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
99422,6vxs,DB02237,-7.1,Maltotetraose,UYQJCPNSAVWAFU-KVXMBEGHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
40703,6lu7,DB13095,-7.1,JTK-853,JQLOVYLALGSISI-HXUWFJFHSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
63598,6lxt,DB00470,-7.1,Dronabinol,CYQFCXCEBYINGO-IAGOWNOFSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
40702,6lu7,DB13101,-7.1,4SC-202,PRXXYMVLYKJITB-IZZDOVSWSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
24166,6cs2,DB01842,-7.1,3'-Phosphate-Adenosine-5'-Diphosphate,GBBWIZKLHXYJOA-KQYNXXCUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
40701,6lu7,DB13307,-7.1,Proscillaridin,MYEJFUXQJGHEQK-ALRJYLEOSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40700,6lu7,DB11273,-7.1,Dihydroergocornine,SEALOBQTUQIVGU-QNIJNHAOSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
98222,6vxs,DB00691,-7.1,Moexipril,UWWDHYUMIORJTA-HSQYWUDLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
63605,6lxt,DB00478,-7.1,Rimantadine,UBCHPRBFMUDMNC-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
40699,6lu7,DB13766,-7.1,Lidoflazine,ZBIAKUMOEKILTF-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40705,6lu7,DB12998,-7.1,PF-00217830,QGNOXTFZOLDODX-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
141787,6w9q,DB01339,-7.1,Vecuronium,BGSZAXLLHYERSY-XQIGCQGXSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
63591,6lxt,DB00459,-7.1,Acitretin,IHUNBGSDBOWDMA-AQFIFDHZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
99406,6vxs,DB02217,-7.1,Dpb-T,WTZFKHNHHRPQOU-WSMBLCCSSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
144977,6w9q,DB06803,-7.1,Niclosamide,RJMUSRYZPJIFPJ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
144980,6w9q,DB06814,-7.1,Protokylol,LUMAEVHDZXIGEP-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
99317,6vxs,DB02096,-7.1,FR221647,ZUYUIKKHHBEVHL-GFCCVEGCSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
145003,6w9q,DB06845,-7.1,(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclopentylamino)ethanoyl)pyrrolidine-2-carboxamide,WXYKSWZWRHMJTE-KRWDZBQOSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
145007,6w9q,DB06850,-7.1,(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclohexylamino)ethanoyl)pyrrolidine-2-carboxamide,RYKFVFFOIYLADT-SFHVURJKSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
63566,6lxt,DB00432,-7.1,Trifluridine,VSQQQLOSPVPRAZ-RRKCRQDMSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
62756,6crv,DB14082,-7.1,Betiatide,VDPYMEBVIDZKMD-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
142239,6w9q,DB01941,-7.1,"6-[1-(3,5,5,8,8-Pentamethyl-5,6,7,8-Tetrahydronaphthalen-2-Yl)Cyclopropyl]Pyridine-3-Carboxylic Acid",SLXTWXQUEZSSTJ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
141840,6w9q,DB01431,-7.1,Allylestrenol,ATXHVCQZZJYMCF-XUDSTZEESA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
99379,6vxs,DB02179,-7.1,O-Trifluoromethylphenyl Anthranilic Acid,ONKHJNFXJDEMNQ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
145096,6w9q,DB06953,-7.1,2-CHLORO-5-(3-CHLORO-PHENYL)-6-[(4-CYANO-PHENYL)-(3-METHYL-3H-IMIDAZOL-4-YL)- METHOXYMETHYL]-NICOTINONITRILE,JVWHVGIRXILXMU-XMMPIXPASA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
40707,6lu7,DB14128,-7.1,Nadide,BAWFJGJZGIEFAR-NNYOXOHSSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
141809,6w9q,DB01392,-7.1,Yohimbine,BLGXFZZNTVWLAY-SCYLSFHTSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
99387,6vxs,DB02191,-7.1,"(7as,12ar,12bs)-1,2,3,4,7a,12,12a,12b-Octahydroindolo[2,3-a]Quinolizin-7(6h)-One",PGKUSHWBQJPFOP-LBPRGKRZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
40706,6lu7,DB12985,-7.1,Quisinostat,PAWIYAYFNXQGAP-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
13165,6lzg,DB14820,-7.1,Profoxydim,KRQUFUKTQHISJB-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
141835,6w9q,DB01426,-7.1,Ajmaline,CJDRUOGAGYHKKD-HEFSZTOGSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
24087,6cs2,DB01752,-7.1,S-adenosyl-L-homocysteine,ZJUKTBDSGOFHSH-WFMPWKQPSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
63383,6lxt,DB00214,-7.1,Torasemide,NGBFQHCMQULJNZ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
13311,6lzg,DB15123,-7.1,Dorzagliatin,HMUMWSORCUWQJO-QAPCUYQASA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
143151,6w9q,DB03141,-7.1,"3-{[(5R,6R)-5-Benzyl-6-hydroxy-2,4-bis(4-hydroxybenzyl)-3-oxo-1,2,4-triazepan-1-yl]sulfonyl}benzonitril",UYUWNNRWESUYOB-FIRIVFDPSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
23834,6cs2,DB01471,-7.1,Bolasterone,IVFYLRMMHVYGJH-VLOLGRDOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
98729,6vxs,DB01298,-7.1,Sulfacytine,SIBQAECNSSQUOD-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
98872,6vxs,DB01518,-7.1,Benzethidine,UVTBZAWTRVBTMK-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
98718,6vxs,DB01273,-7.1,Varenicline,JQSHBVHOMNKWFT-DTORHVGOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
98882,6vxs,DB01529,-7.1,Dextromoramide,INUNXTSAACVKJS-OAQYLSRUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
13277,6lzg,DB15062,-7.1,Inarigivir,LYMICVBGNUEHGE-FUQPUAIBSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
143070,6w9q,DB03035,-7.1,"1,8-Di-Hydroxy-4-Nitro-Anthraquinone",RIYCICFDXLNQPV-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
98891,6vxs,DB01538,-7.1,Acetyldihydrocodeine,LGGDXXJAGWBUSL-BKRJIHRRSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
142996,6w9q,DB02929,-7.1,K201,KCWGETCFOVJEPI-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
23813,6cs2,DB01452,-7.1,Diamorphine,GVGLGOZIDCSQPN-PVHGPHFFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
142956,6w9q,DB02880,-7.1,N-[1-(4-Bromophenyl)Ethyl]-5-Fluoro Salicylamide,KFTNEILVDDUXGR-SECBINFHSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
23810,6cs2,DB01447,-7.1,4-Methylaminorex,LJQBMYDFWFGESC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
142943,6w9q,DB02861,-7.1,"4-(Aminosulfonyl)-N-[(3,4,5-Trifluorophenyl)Methyl]-Benzamide",DEHMSTGBNAXEGX-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
144323,6w9q,DB04715,-7.1,IMIDAZOPYRIDAZIN 1,IVUBNTNWKIPCPS-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
144144,6w9q,DB04480,-7.1,"3-(4-Fluorophenyl)-2-(6-Methylpyridin-2-Yl)-5,6-Dihydro-4h-Pyrrolo[1,2-B]Pyrazole",NBDZLUOYAAVYHF-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
98734,6vxs,DB01324,-7.1,Polythiazide,CYLWJCABXYDINA-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
23842,6cs2,DB01479,-7.1,BA-2664,QGKQXZFZOIQFBI-XSWYFRFISA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
98866,6vxs,DB01511,-7.1,Delorazepam,CHIFCDOIPRCHCF-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
143662,6w9q,DB03830,-7.1,Phosphorylated Dihydropteroate,DNKVHXNVVYQUDC-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
98805,6vxs,DB01439,-7.1,3-Methylthiofentanyl,SRARDYUHGVMEQI-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
23889,6cs2,DB01531,-7.1,Desomorphine,LNNWVNGFPYWNQE-GMIGKAJZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
143619,6w9q,DB03777,-7.1,Rbt205 Inhibitor,QMGUOJYZJKLOLH-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
143613,6w9q,DB03771,-7.1,Allyl-{4-[3-(4-Bromo-Phenyl)-Benzofuran-6-Yloxy]-but-2-Enyl}-Methyl-Amine,KCNKJCHARANTIP-SNAWJCMRSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
143601,6w9q,DB03758,-7.1,Radicicol,WYZWZEOGROVVHK-GTMNPGAYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
143598,6w9q,DB03755,-7.1,"Adenosine-5'-[Beta, Gamma-Methylene]Tetraphosphate",ARRGHMSEJJFDME-IOSLPCCCSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
23982,6cs2,DB01627,-7.1,Lincomycin,OJMMVQQUTAEWLP-KIDUDLJLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
143595,6w9q,DB03752,-7.1,P-(2'-Iodo-5'-Thenoyl)Hydrotropic Acid,UIZPHGUBGPJBAR-QMMMGPOBSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
98829,6vxs,DB01466,-7.1,Ethylmorphine,OGDVEMNWJVYAJL-LEPYJNQMSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
143534,6w9q,DB03671,-7.1,"4-(3,12,14-Trihydroxy-10,13-Dimethyl-Hexadecahydro-Cyclopenta[a]Phenanthren-17-Yl)-5h-Furan-2-One",SHIBSTMRCDJXLN-KCZCNTNESA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
143490,6w9q,DB03608,-7.1,Diminazene,XNYZHCFCZNMTFY-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
143942,6w9q,DB04201,-7.1,Histidyl-Adenosine Monophosphate,XTFBSLZFYLGYAT-OPYVMVOTSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
23926,6cs2,DB01565,-7.1,Dihydromorphine,IJVCSMSMFSCRME-KBQPJGBKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
143419,6w9q,DB03501,-7.1,Galactose-uridine-5'-diphosphate,HSCJRCZFDFQWRP-ABVWGUQPSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
143983,6w9q,DB04258,-7.1,Seocalcitol,LVLLALCJVJNGQQ-SEODYNFXSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
23913,6cs2,DB01553,-7.1,Cloxazolam,ZIXNZOBDFKSQTC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
99467,6vxs,DB02295,-7.1,"N-[3-(Dimethylamino)Propyl]-2-({[4-({[4-(Formylamino)-1-Methyl-1h-Pyrrol-2-Yl]Carbonyl}Amino)-1-Methyl-1h-Pyrrol-2-Yl]Carbonyl}Amino)-5-Isopropyl-1,3-Thiazole-4-Carboxamide",VDYCDKRATGWFDA-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
23983,6cs2,DB01628,-7.1,Etoricoxib,MNJVRJDLRVPLFE-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
144331,6w9q,DB04726,-7.1,"7,8,10-TRIMETHYLBENZO[G]PTERIDINE-2,4(3H,10H)-DIONE",KPDQZGKJTJRBGU-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
142432,6w9q,DB02196,-7.1,Uridine-Diphosphate-N-Acetylgalactosamine,LFTYTUAZOPRMMI-NESSUJCYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
98541,6vxs,DB01060,-7.1,Amoxicillin,LSQZJLSUYDQPKJ-NJBDSQKTSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
13239,6lzg,DB01101,-7.1,Capecitabine,GAGWJHPBXLXJQN-UORFTKCHSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
13235,6lzg,DB14944,-7.1,Tarloxotinib,MUJMYVFVAWFUJL-SNAWJCMRSA-O,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
144556,6w9q,DB05395,-7.1,Amibegron,RDJQCOBTKKAQAH-FPOVZHCZSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
142411,6w9q,DB02166,-7.1,Propidium,ZDWVWKDAWBGPDN-UHFFFAOYSA-O,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
142404,6w9q,DB02155,-7.1,Balanol Analog 8,XVLMXAUKCDSMMW-YXLARRHKSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
144558,6w9q,DB05408,-7.1,Emricasan,SCVHJVCATBPIHN-SJCJKPOMSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
142403,6w9q,DB02154,-7.1,"2,3-Bis-Benzo[1,3]Dioxol-5-Ylmethyl-Succinic Acid",FFYBYVPVYLMLAR-KBPBESRZSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
142376,6w9q,DB02116,-7.1,Olomoucine,GTVPOLSIJWJJNY-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
98501,6vxs,DB01013,-7.1,Clobetasol propionate,CBGUOGMQLZIXBE-XGQKBEPLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
144578,6w9q,DB05482,-7.1,7-ethyl-10-hydroxycamptothecin,FJHBVJOVLFPMQE-QFIPXVFZSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
23763,6cs2,DB00229,-7.1,Cefotiam,QYQDKDWGWDOFFU-IUODEOHRSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
142299,6w9q,DB02019,-7.1,Acetyl Dithranol,IXLRLZOYKJERRA-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
98486,6vxs,DB00998,-7.1,Frovatriptan,XPSQPHWEGNHMSK-SECBINFHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
98973,6vxs,DB01633,-7.1,Deoxy-2-fluoro-beta-D-cellotrioside,BZNXZJAUEMJQJB-QSCMNUSVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
142518,6w9q,DB02310,-7.1,"3,5,6,8-Tetramethyl-N-Methyl Phenanthrolinium",FQTUZNACZKILMC-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
144495,6w9q,DB05015,-7.1,Belinostat,NCNRHFGMJRPRSK-MDZDMXLPSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
142544,6w9q,DB02342,-7.1,2-Methox1tradiol,CQOQDQWUFQDJMK-SSTWWWIQSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
142918,6w9q,DB02830,-7.1,FR236913,KCCUBLLGAMGDJL-HXUWFJFHSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
98681,6vxs,DB01217,-7.1,Anastrozole,YBBLVLTVTVSKRW-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
142892,6w9q,DB02799,-7.1,N-[2-(1-Maleimidyl)Ethyl]-7-Diethylaminocoumarin-3-Carboxamide,OJBZDUMTXGGVSP-KTKRTIGZSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
142850,6w9q,DB02738,-7.1,Adenosine-5'-Pentaphosphate,WYJWVZZCMBUPSP-KQYNXXCUSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
98668,6vxs,DB01203,-7.1,Nadolol,VWPOSFSPZNDTMJ-UCWKZMIHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
23785,6cs2,DB00231,-7.1,Temazepam,SEQDDYPDSLOBDC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
98661,6vxs,DB01195,-7.1,Flecainide,DJBNUMBKLMJRSA-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
142920,6w9q,DB02833,-7.1,[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(3-Nitro-Phenyl)-Amine,DYTKVFHLKPDNRW-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
142758,6w9q,DB02615,-7.1,Compound 19,UZOOIPXOYYJULJ-BLIZRMSTSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
98651,6vxs,DB01185,-7.1,Fluoxymesterone,YLRFCQOZQXIBAB-RBZZARIASA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
142737,6w9q,DB02587,-7.1,Colforsin,OHCQJHSOBUTRHG-KGGHGJDLSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
13291,6lzg,DB15091,-7.1,Upadacitinib,WYQFJHHDOKWSHR-MNOVXSKESA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
144439,6w9q,DB04867,-7.1,Lintitript,ILNRQFBVVQUOLP-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
142675,6w9q,DB02505,-7.1,N-(R-Carboxy-Ethyl)-Alpha-(S)-(2-Phenylethyl),JJVQUUYZGJWBPW-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
98608,6vxs,DB01137,-7.1,Levofloxacin,GSDSWSVVBLHKDQ-JTQLQIEISA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
98586,6vxs,DB01112,-7.1,Cefuroxime,JFPVXVDWJQMJEE-IZRZKJBUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
23782,6cs2,DB01420,-7.1,Testosterone propionate,PDMMFKSKQVNJMI-BLQWBTBKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
97783,6vxs,DB00162,-7.1,Vitamin A,FPIPGXGPPPQFEQ-OVSJKPMPSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
63607,6lxt,DB00480,-7.1,Lenalidomide,GOTYRUGSSMKFNF-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
40698,6lu7,DB12588,-7.1,AZD-1480,PDOQBOJDRPLBQU-QMMMGPOBSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
24285,6cs2,DB01994,-7.1,"2-(Pyrido[1,2-E]Purin-4-Yl)Amino-Ethanol",QBILBVYKWQWDQJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
40594,6lu7,DB08345,-7.1,"4-(2-(1H-IMIDAZOL-4-YL)ETHYLAMINO)-2-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE",IWUUKHQIKFHWIW-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40593,6lu7,DB08393,-7.1,"2-[(5,6-DIPHENYLFURO[2,3-D]PYRIMIDIN-4-YL)AMINO]ETHANOL",UQHINZSKNAAVOZ-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40592,6lu7,DB08512,-7.1,"6-amino-2-[(1-naphthylmethyl)amino]-3,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",MCEZMMDIEXECTI-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40591,6lu7,DB08995,-7.1,Diosmin,GZSOSUNBTXMUFQ-YFAPSIMESA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40590,6lu7,DB09233,-7.1,Cronidipine,CNIJVNPIIHWRRP-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
97997,6vxs,DB00415,-7.1,Ampicillin,AVKUERGKIZMTKX-NJBDSQKTSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
99865,6vxs,DB02814,-7.1,3'-Deazo-Thiamin Diphosphate,NWZZJKMZTWGIFE-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
141093,6w9q,DB00481,-7.1,Raloxifene,GZUITABIAKMVPG-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
40589,6lu7,DB07314,-7.1,"1-(5-CHLORO-2,4-DIMETHOXYPHENYL)-3-(5-CYANOPYRAZIN-2-YL)UREA",URQYPXQXSVUVRG-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40588,6lu7,DB02705,-7.1,"6-[N-(1-Isopropyl-1,2,3,4-Tetrahydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine",DARQQJKHXPXSRO-QFIPXVFZSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
63817,6lxt,DB00736,-7.1,Esomeprazole,SUBDBMMJDZJVOS-DEOSSOPVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
40587,6lu7,DB01167,-7.1,Itraconazole,VHVPQPYKVGDNFY-ZPGVKDDISA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40586,6lu7,DB01267,-7.1,Paliperidone,PMXMIIMHBWHSKN-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40585,6lu7,DB01289,-7.1,Glisoxepide,ZKUDBRCEOBOWLF-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40595,6lu7,DB08124,-7.1,"3-{[(2,2-DIOXIDO-1,3-DIHYDRO-2-BENZOTHIEN-5-YL)AMINO]METHYLENE}-5-(1,3-OXAZOL-5-YL)-1,3-DIHYDRO-2H-INDOL-2-ONE",FTQYGMLRLRXBPT-IDUWFGFVSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
97987,6vxs,DB00402,-7.1,Eszopiclone,GBBSUAFBMRNDJC-INIZCTEOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
40596,6lu7,DB05553,-7.1,Regrelor,NXHAXEBZOXCDKD-XIXRRVGJSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
62472,6crv,DB13625,-7.1,Carbuterol,KEMXXQOFIRIICG-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
99791,6vxs,DB02712,-7.1,Sorbinil,LXANPKRCLVQAOG-NSHDSACASA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
40605,6lu7,DB08091,-7.1,3-FLUORO-5-MORPHOLIN-4-YL-N-[3-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-5-YL]BENZAMIDE,HIUFYIOMUILESI-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40604,6lu7,DB00398,-7.1,Sorafenib,MLDQJTXFUGDVEO-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40603,6lu7,DB06963,-7.1,"3-[3-(3-methyl-6-{[(1S)-1-phenylethyl]amino}-1H-pyrazolo[4,3-c]pyridin-1-yl)phenyl]propanamide",ZFGCLYUGFRNYFE-INIZCTEOSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
141136,6w9q,DB00537,-7.1,Ciprofloxacin,MYSWGUAQZAJSOK-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
13369,6lzg,DB15229,-7.1,CNV-2197944,BLFJGFDZMABYMY-ZDUSSCGKSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
40602,6lu7,DB07021,-7.1,"(7R,8R)-8-(2,4,5-trifluorophenyl)-6,7,8,9-tetrahydroimidazo[1,2-a:4,5-c']dipyridin-7-amine",SOSYXEPELJIJHZ-RNCFNFMXSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40601,6lu7,DB07024,-7.1,"2-(3,4-DIHYDROXYPHENYL)-8-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-3-HYDROXY-6-METHYL-4H-CHROMEN-4-ONE",CEXBEGBNDJVZPK-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40600,6lu7,DB07216,-7.1,"(11S)-8-CHLORO-11-[1-(METHYLSULFONYL)PIPERIDIN-4-YL]-6-PIPERAZIN-1-YL-11H-BENZO[5,6]CYCLOHEPTA[1,2-B]PYRIDINE",ZMGCFGGMTCMSDP-QHCPKHFHSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40599,6lu7,DB07256,-7.1,"3-({4-[(5-CHLORO-1,3-BENZODIOXOL-4-YL)AMINO]PYRIMIDIN-2-YL}AMINO)BENZAMIDE",ZVQZIVCQLFGXFZ-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40598,6lu7,DB05608,-7.1,MKC-1,OVSKGTONMLKNPZ-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
62476,6crv,DB13630,-7.1,Bibenzonium,LBRNZQRZDLLIHL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
62475,6crv,DB13629,-7.1,Mofebutazone,REOJLIXKJWXUGB-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
99850,6vxs,DB02798,-7.1,Alpha-Methylene Adenosine Monophosphate,PXSSQXBLDTZHLF-IOSLPCCCSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
62473,6crv,DB13627,-7.1,Oxolinic acid,KYGZCKSPAKDVKC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
40597,6lu7,DB08052,-7.1,"1-cyclopentyl-3-(1H-pyrrolo[2,3-b]pyridin-5-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine",NVRXTLZYXZNATH-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40584,6lu7,DB01405,-7.1,Temafloxacin,QKDHBVNJCZBTMR-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40583,6lu7,DB01698,-7.1,Rutin,IKGXIBQEEMLURG-NVPNHPEKSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40582,6lu7,DB01893,-7.1,N6-Benzyl Adenosine-5'-Diphosphate,MRHGMAGSDAQUFH-LSCFUAHRSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
63869,6lxt,DB00801,-7.1,Halazepam,WYCLKVQLVUQKNZ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
140967,6w9q,DB00328,-7.1,Indometacin,CGIGDMFJXJATDK-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
97918,6vxs,DB00318,-7.1,Codeine,OROGSEYTTFOCAN-DNJOTXNNSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
63881,6lxt,DB00814,-7.1,Meloxicam,ZRVUJXDFFKFLMG-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
99942,6vxs,DB02914,-7.1,"(6e)-6-[(2e,4e,6e)-3,7-Dimethylnona-2,4,6,8-Tetraenylidene]-1,5,5-Trimethylcyclohexene",FWNRILWHNGFAIN-OYUWDNMLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
63895,6lxt,DB00829,-7.1,Diazepam,AAOVKJBEBIDNHE-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
97880,6vxs,DB00273,-7.1,Topiramate,KJADKKWYZYXHBB-XBWDGYHZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
97874,6vxs,DB00267,-7.1,Cefmenoxime,HJJDBAOLQAWBMH-YCRCPZNHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
99946,6vxs,DB02918,-7.1,Zardaverine,HJMQDJPMQIHLPB-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
63899,6lxt,DB00833,-7.1,Cefaclor,QYIYFLOTGYLRGG-GPCCPHFNSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
97850,6vxs,DB00239,-7.1,Oxiconazole,QRJJEGAJXVEBNE-HKOYGPOVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
97842,6vxs,DB00231,-7.1,Temazepam,SEQDDYPDSLOBDC-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
97838,6vxs,DB00227,-7.1,Lovastatin,PCZOHLXUXFIOCF-BXMDZJJMSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
97826,6vxs,DB00213,-7.1,Pantoprazole,IQPSEEYGBUAQFF-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
13400,6lzg,DB01120,-7.1,Gliclazide,BOVGTQGAOIONJV-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
97923,6vxs,DB00323,-7.1,Tolcapone,MIQPIUSUKVNLNT-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
97935,6vxs,DB00341,-7.1,Cetirizine,ZKLPARSLTMPFCP-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
97944,6vxs,DB00351,-7.1,Megestrol acetate,RQZAXGRLVPAYTJ-GQFGMJRRSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
40573,6lu7,DB02009,-7.1,"L-756,423",AOMZDQMIOCTPQP-QHQMVRJISA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
97976,6vxs,DB00391,-7.1,Sulpiride,BGRJTUBHPOOWDU-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
97968,6vxs,DB00380,-7.1,Dexrazoxane,BMKDZUISNHGIBY-ZETCQYMHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
40581,6lu7,DB05835,-7.1,NS-3728,OQRAKHDEGGGWQO-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40580,6lu7,DB02483,-7.1,Etheno-Nad,JCDBQDNBEQHDHK-BSLNIGMPSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40578,6lu7,DB02827,-7.1,"7-(1,1-Dioxo-1h-Benzo[D]Isothiazol-3-Yloxymethyl)-2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Pyran-3-Carboxylic Acid",MDYIGSPVMWSFEZ-JTQLQIEISA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40577,6lu7,DB02915,-7.1,"4-(2,4-Dimethyl-1,3-thiazol-5-yl)-N-[4-(trifluoromethyl)phenyl]-2-pyrimidinamine",MEZFDQUDLQCVNX-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
141028,6w9q,DB00402,-7.1,Eszopiclone,GBBSUAFBMRNDJC-INIZCTEOSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
141159,6w9q,DB00564,-7.1,Carbamazepine,FFGPTBGBLSHEPO-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
63842,6lxt,DB00767,-7.1,Benzquinamide,JSZILQVIPPROJI-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
99916,6vxs,DB02881,-7.1,4-(4-Hydroxy-3-Isopropylphenylthio)-2-Isopropylphenol,NEMLLZAROZVCCE-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
141006,6w9q,DB00377,-7.1,Palonosetron,CPZBLNMUGSZIPR-NVXWUHKLSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
62427,6crv,DB13559,-7.1,Rimiterol,IYMMESGOJVNCKV-JOYOIKCWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
63844,6lxt,DB00769,-7.1,Hydrocortamate,FWFVLWGEFDIZMJ-FOMYWIRZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
40575,6lu7,DB03072,-7.1,"2-{3-[4-(4-Fluorophenyl)-3,6-Dihydro-1(2h)-Pyridinyl]Propyl}-8-Methyl-4(3h)-Quinazolinone",LOFDUAJQRUYHBR-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
140995,6w9q,DB00365,-7.1,Grepafloxacin,AIJTTZAVMXIJGM-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
40574,6lu7,DB04607,-7.1,"PHENYLAMINOIMIDAZO(1,2-ALPHA)PYRIDINE",UQAWGIKJINAKIZ-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40576,6lu7,DB03020,-7.1,5-Beta-D-Ribofuranosylnicotinamide Adenine Dinucleotide,UINNILASBHZOTM-KMXXXSRASA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40607,6lu7,DB00997,-7.1,Doxorubicin,AOJJSUZBOXZQNB-TZSSRYMLSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
98042,6vxs,DB00470,-7.1,Dronabinol,CYQFCXCEBYINGO-IAGOWNOFSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
24269,6cs2,DB01975,-7.1,AMPCPR,ZPZRETFSCSWNDT-DBXCYWGHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
40685,6lu7,DB11847,-7.1,Cadazolid,XWFCFMXQTBGXQW-GOSISDBHSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40684,6lu7,DB11896,-7.1,Gedatolisib,DWZAEMINVBZMHQ-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40683,6lu7,DB12887,-7.1,Tazemetostat,NSQSAUGJQHDYNO-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
63641,6lxt,DB00525,-7.1,Tolnaftate,FUSNMLFNXJSCDI-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
40682,6lu7,DB12134,-7.1,Gepotidacin,PZFAZQUREQIODZ-LJQANCHMSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
63645,6lxt,DB00530,-7.1,Erlotinib,AAKJLRGGTJKAMG-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
141583,6w9q,DB01061,-7.1,Azlocillin,JTWOMNBEOCYFNV-NFFDBFGFSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
40681,6lu7,DB12644,-7.1,AZD-2066,SXWHYTICXCLKDG-GFCCVEGCSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40680,6lu7,DB12371,-7.1,Siponimod,KIHYPELVXPAIDH-HNSNBQBZSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
63648,6lxt,DB00533,-7.1,Rofecoxib,RZJQGNCSTQAWON-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
40679,6lu7,DB12414,-7.1,Usistapide,WSYALRNYQFNNGP-WJOKGBTCSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40678,6lu7,DB12547,-7.1,LY-2886721,NIDRNVHMMDAAIK-YPMLDQLKSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40677,6lu7,DB12550,-7.1,Taladegib,SZBGQDXLNMELTB-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
141556,6w9q,DB01030,-7.1,Topotecan,UCFGDBYHRUNTLO-QHCPKHFHSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
99577,6vxs,DB02431,-7.1,Cytidine-5'-Triphosphate,PCDQPRRSZKQHHS-XVFCMESISA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
40686,6lu7,DB11822,-7.1,TMC-647055,UOBYJVFBFSLCTQ-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40687,6lu7,DB11742,-7.1,Ebastine,MJJALKDDGIKVBE-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40688,6lu7,DB11663,-7.1,Pictilisib,LHNIIDJUOCFXAP-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
13355,6lzg,DB15205,-7.1,Capromorelin,KVLLHLWBPNCVNR-SKCUWOTOSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
40697,6lu7,DB14766,-7.1,Etrasimod,MVGWUTBTXDYMND-QGZVFWFLSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40696,6lu7,DB15106,-7.1,Surufatinib,TTZSNFLLYPYKIL-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40695,6lu7,DB15138,-7.1,AZD-9496,DFBDRVGWBHBJNR-BBNFHIFMSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
141705,6w9q,DB01198,-7.1,Zopiclone,GBBSUAFBMRNDJC-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
13159,6lzg,DB14799,-7.1,PF-06821497,RXCVUHMIWHRLDF-HXUWFJFHSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
98218,6vxs,DB00687,-7.1,Fludrocortisone,AAXVEMMRQDVLJB-BULBTXNYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
40694,6lu7,DB15168,-7.1,Cilofexor,KZSKGLFYQAYZCO-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40676,6lu7,DB12555,-7.1,Nelotanserin,COSPVUFTLGQDQL-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40693,6lu7,DB15233,-7.1,Avapritinib,DWYRIWUZIJHQKQ-SANMLTNESA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
141663,6w9q,DB01153,-7.1,Sertaconazole,JLGKQTAYUIMGRK-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
40692,6lu7,DB15444,-7.1,Elexacaftor,MVRHVFSOIWFBTE-INIZCTEOSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40691,6lu7,DB13556,-7.1,Sulfamazone,BGLHAKAJGYLSOX-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
98211,6vxs,DB00678,-7.1,Losartan,PSIFNNKUMBGKDQ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
63628,6lxt,DB00504,-7.1,Levallorphan,OZYUPQUCAUTOBP-QXAKKESOSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
40690,6lu7,DB12297,-7.1,GLPG-0187,CXHCNOMGODVIKB-VWLOTQADSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
141650,6w9q,DB01138,-7.1,Sulfinpyrazone,MBGGBVCUIVRRBF-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
141665,6w9q,DB01155,-7.1,Gemifloxacin,ZRCVYEYHRGVLOC-HYARGMPZSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
23726,6cs2,DB01327,-7.1,Cefazolin,MLYYVTUWGNIJIB-BXKDBHETSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
23722,6cs2,DB01322,-7.1,Kava,OMNGEVNATYFZGG-BQYQJAHWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
141521,6w9q,DB00990,-7.1,Exemestane,BFYIZQONLCFLEV-DAELLWKTSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
40632,6lu7,DB00445,-7.1,Epirubicin,AOJJSUZBOXZQNB-VTZDEGQISA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
98096,6vxs,DB00539,-7.1,Toremifene,XFCLJVABOIYOMF-QPLCGJKRSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
40625,6lu7,DB00224,-7.1,Indinavir,CBVCZFGXHXORBI-PXQQMZJSSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
40624,6lu7,DB11651,-7.1,Dactolisib,JOGKUKXHTYWRGZ-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
141247,6w9q,DB00673,-7.1,Aprepitant,ATALOFNDEOCMKK-OITMNORJSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
98087,6vxs,DB00528,-7.1,Lercanidipine,ZDXUKAKRHYTAKV-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
141233,6w9q,DB00656,-7.1,Trazodone,PHLBKPHSAVXXEF-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
99742,6vxs,DB02647,-7.1,N-(5-Cyclopropyl-1h-Pyrazol-3-Yl)Benzamide,LUCORKWTQSQFFU-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
24261,6cs2,DB01964,-7.1,AL5424,ZWTSOJQGEWPWGO-NSHDSACASA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
98057,6vxs,DB00487,-7.1,Pefloxacin,FHFYDNQZQSQIAI-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
62517,6crv,DB13681,-7.1,Butalamine,VYWQZAARVNRSTR-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
63770,6lxt,DB00682,-7.1,Warfarin,PJVWKTKQMONHTI-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
62508,6crv,DB13672,-7.1,Dimethylaminopropionylphenothiazine,POZJNEBUHLZROM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
13366,6lzg,DB15222,-7.1,GS-6620,YAAQYJCOIFNMKX-RSTNYOGXSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
63776,6lxt,DB00689,-7.1,Cephaloglycin,FUBBGQLTSCSAON-PBFPGSCMSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
13125,6lzg,DB14732,-7.1,Queuine,WYROLENTHWJFLR-ACLDMZEESA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
141318,6w9q,DB00755,-7.1,Tretinoin,SHGAZHPCJJPHSC-YCNIQYBTSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
98116,6vxs,DB00561,-7.1,Doxapram,XFDJYSQDBULQSI-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
99696,6vxs,DB02587,-7.1,Colforsin,OHCQJHSOBUTRHG-KGGHGJDLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
141490,6w9q,DB00952,-7.1,Naratriptan,AMKVXSZCKVJAGH-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
62629,6crv,DB13832,-7.1,Ranimustine,AHHFEZNOXOZZQA-ZEBDFXRSSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
13358,6lzg,DB15207,-7.1,Esaxerenone,NOSNHVJANRODGR-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
141452,6w9q,DB00910,-7.1,Paricalcitol,BPKAHTKRCLCHEA-UBFJEZKGSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
141447,6w9q,DB00905,-7.1,Bimatoprost,AQOKCDNYWBIDND-FTOWTWDKSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
99625,6vxs,DB02495,-7.1,9-(4-hydroxybutyl)-N2-phenylguanine,JHBXNPBKSPYOFT-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
141446,6w9q,DB00904,-7.1,Ondansetron,FELGMEQIXOGIFQ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
40674,6lu7,DB11968,-7.1,MK-7145,OCKGFTQIICXDQW-ZEQRLZLVSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
62609,6crv,DB13805,-7.1,Reposal,MKELYWOVSPVORM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
40655,6lu7,DB09280,-7.1,Lumacaftor,UFSKUSARDNFIRC-UHFFFAOYSA-N,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,VIRAL PROTEIN,SARS-CoV-3,Replicase polyprotein 1ab
62599,6crv,DB13792,-7.1,Clopamide,LBXHRAWDUMTPSE-AOOOYVTPSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
141405,6w9q,DB00857,-7.1,Terbinafine,DOMXUEMWDBAQBQ-WEVVVXLNSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
62590,6crv,DB13781,-7.1,Xamoterol,DXPOSRCHIDYWHW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
141395,6w9q,DB00846,-7.1,Flurandrenolide,POPFMWWJOGLOIF-XWCQMRHXSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
141393,6w9q,DB00844,-7.1,Nalbuphine,NETZHAKZCGBWSS-CEDHKZHLSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
99695,6vxs,DB02586,-7.1,"4,7-Dimethyl-[1,10]Phenanthroline",JIVLDFFWTQYGSR-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
141426,6w9q,DB00881,-7.1,Quinapril,JSDRRTOADPPCHY-HSQYWUDLSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
146078,6w9q,DB08096,-7.1,"8-(2-CHLOROPHENYLAMINO)-2-(2,6-DIFLUOROPHENYLAMINO)-9-ETHYL-9H-PURINE-1,7-DIIUM",ZWKOUFZHPNIQSH-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
95917,6m71,DB12131,-7.1,Vinpocetine,DDNCQMVWWZOMLN-IRLDBZIGSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
146098,6w9q,DB08116,-7.1,"(3R)-4-{[(3,4-dihydroxyphenyl)acetyl]oxy}-N-(2-formylindolizin-3-yl)-3-sulfino-D-valine",DEOZLEGRVHDNKC-UGKGYDQZSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
103116,6vxs,DB08179,-7.1,"methyl 4-(2,3-dihydroxy-5-methylphenoxy)-2-hydroxy-6-methylbenzoate",BLXSEOJIXHWXQJ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
103119,6vxs,DB08184,-7.1,2-(2-METHYLPHENYL)-1H-INDOLE-5-CARBOXIMIDAMIDE,YOZKTHGEOJHIDP-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
133051,6w9c,DB01151,-7.1,Desipramine,HCYAFALTSJYZDH-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
25686,6cs2,DB03682,-7.1,"Dibenzofuran-4,6-Dicarboxylic Acid",HBBGSNOHAGNQRQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
133033,6w9c,DB01131,-7.1,Proguanil,SSOLNOMRVKKSON-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
103130,6vxs,DB08198,-7.1,"[(4R)-4-(3-HYDROXYPHENYL)-1,6-DIMETHYL-2-THIOXO-1,2,3,4-TETRAHYDROPYRIMIDIN-5-YL](PHENYL)METHANONE",JGBBILLMZPWNFU-QGZVFWFLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
149355,6w9q,DB15448,-7.1,Acumapimod,VGUSQKZDZHAAEE-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
133031,6w9c,DB01129,-7.1,Rabeprazole,YREYEVIYCVEVJK-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
66577,6lxt,DB04367,-7.1,Debromohymenialdisine,JYRJOQGKGMHTOO-VURMDHGXSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
66580,6lxt,DB04371,-7.1,AL6528,FBBLOSCXOZYUSS-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
60123,6crv,DB08263,-7.1,N-(carboxycarbonyl)-D-phenylalanine,ULQWGBCNOHBNDB-MRVPVSSYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
14397,6lzg,T3D4088,-7.1,Lyngbyatoxin A,KISDGNGREAJPQR-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
133017,6w9c,DB01113,-7.1,Papaverine,XQYZDYMELSJDRZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
133009,6w9c,DB01102,-7.1,Arbutamine,IIRWWTKISYTTBL-SFHVURJKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
132983,6w9c,DB01073,-7.1,Fludarabine,HBUBKKRHXORPQB-FJFJXFQQSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
1905,6lzg,HMDB0029090,-7.1,Tryptophyl-Phenylalanine,IMMPMHKLUUZKAZ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
149467,6wiq,DB00197,-7.1,Troglitazone,GXPHKUHSUJUWKP-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
93582,6m71,DB07116,-7.1,1-(2-DEOXY-5-O-PHOSPHONO-BETA-D-ERYTHRO-PENTOFURANOSYL)-4-METHYL-1H-INDOLE,UXXYPWCUINVUHL-BFHYXJOUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93585,6m71,DB07119,-7.1,1-CHLORO-6-(4-HYDROXYPHENYL)-2-NAPHTHOL,YHEHVRSGKUYDON-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93652,6m71,DB07195,-7.1,"4-[(1S,2S,5S)-5-(HYDROXYMETHYL)-6,8,9-TRIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL",DTZWKYVREFMAJA-QXWBOSQLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
149224,6w9q,DB15191,-7.1,MAX-40279,AVIOBQFPAGEICQ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
66490,6lxt,DB04243,-7.1,5-Methyluridine 5'-Monophosphate,IGWHDMPTQKSDTL-JXOAFFINSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
149250,6w9q,DB15235,-7.1,Di-2-pyridylketone 4-cyclohexyl-4-methyl-3-thiosemicarbazone,GNLZNQJBZNOUBM-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
133160,6w9c,DB01299,-7.1,Sulfadoxine,PJSFRIWCGOHTNF-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
149261,6w9q,DB15261,-7.1,Butafenacil,JEDYYFXHPAIBGR-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
93624,6m71,DB07163,-7.1,5-[(2-AMINOETHYL)AMINO]-6-FLUORO-3-(1H-PYRROL-2-YL)BENZO[CD]INDOL-2(1H)-ONE,CQCXWWWNUFQYJS-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
133151,6w9c,DB01280,-7.1,Nelarabine,IXOXBSCIXZEQEQ-UHTZMRCNSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
93622,6m71,DB07161,-7.1,5-phenyl-1H-indazol-3-amine,ZCUSNQPYUNLATP-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93616,6m71,DB07154,-7.1,"(3R)-4-[(3R)-3-AMINO-4-(2,4,5-TRIFLUOROPHENYL)BUTANOYL]-3-METHYL-1,4-DIAZEPAN-2-ONE",SWKGZJAAGSVROJ-MWLCHTKSSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
14382,6lzg,T3D4066,-7.1,Ryanodine,JJSYXNQGLHBRRK-YSOSZROBSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
1917,6lzg,HMDB0029117,-7.1,Tyrosyl-Tyrosine,JAQGKXUEKGKTKX-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
133132,6w9c,DB01244,-7.1,Bepridil,UIEATEWHFDRYRU-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
93607,6m71,DB07143,-7.1,D-phenylalanyl-N-benzyl-L-prolinamide,MEPJWLFTTFHOQO-MOPGFXCFSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
5231,6lzg,HMDB0055594,-7.1,"TG(20:4(8Z,11Z,14Z,17Z)/20:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))",AHELIOBCROQGBQ-GULUJBEHSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
133072,6w9c,DB01176,-7.1,Cyclizine,UVKZSORBKUEBAZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
5269,6lzg,HMDB0055759,-7.1,"TG(20:5(5Z,8Z,11Z,14Z,17Z)/20:3n6/22:6(4Z,7Z,10Z,13Z,16Z,19Z))",GQHFKUZFVPRUHC-NMLWSOOJSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
66603,6lxt,DB04405,-7.1,"2-[2-(1,3-Dioxo-1,3-Dihydro-2h-Isoindol-2-Yl)Ethyl]-4-(4'-Ethoxy-1,1'-Biphenyl-4-Yl)-4-Oxobutanoic Acid",AQYSXARQCHHHLK-NRFANRHFSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
12407,6lzg,DB13335,-7.1,Pinazepam,MFZOSKPPVCIFMT-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
25747,6cs2,DB03755,-7.1,"Adenosine-5'-[Beta, Gamma-Methylene]Tetraphosphate",ARRGHMSEJJFDME-IOSLPCCCSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
149717,6wiq,DB00496,-7.1,Darifenacin,HXGBXQDTNZMWGS-RUZDIDTESA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
93355,6m71,DB06850,-7.1,(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclohexylamino)ethanoyl)pyrrolidine-2-carboxamide,RYKFVFFOIYLADT-SFHVURJKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
132738,6w9c,DB00794,-7.1,Primidone,DQMZLTXERSFNPB-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
93351,6m71,DB06845,-7.1,(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclopentylamino)ethanoyl)pyrrolidine-2-carboxamide,WXYKSWZWRHMJTE-KRWDZBQOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60012,6crv,DB08129,-7.1,(1R)-2-amino-1-[3-(trifluoromethyl)phenyl]ethanol,RRBRWAPWPGAJMA-QMMMGPOBSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
149789,6wiq,DB00587,-7.1,Cinalukast,BZMKNPGKXJAIDV-VAWYXSNFSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
132709,6w9c,DB00758,-7.1,Clopidogrel,GKTWGGQPFAXNFI-HNNXBMFYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
93305,6m71,DB06766,-7.1,Alcaftadine,MWTBKTRZPHJQLH-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
149829,6wiq,DB00635,-7.1,Prednisone,XOFYZVNMUHMLCC-ZPOLXVRWSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
149835,6wiq,DB00643,-7.1,Mebendazole,OPXLLQIJSORQAM-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
93290,6m71,DB06737,-7.1,Zaltoprofen,MUXFZBHBYYYLTH-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93284,6m71,DB06730,-7.1,Gestodene,SIGSPDASOTUPFS-XUDSTZEESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
66737,6lxt,DB04578,-7.1,"(S)-2-[(R)-3-amino-4-(2-fluorophenyl)butyryl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide",OEVYDSSAPNIURZ-AEFFLSMTSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
149858,6wiq,DB00673,-7.1,Aprepitant,ATALOFNDEOCMKK-OITMNORJSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
149683,6wiq,DB00455,-7.1,Loratadine,JCCNYMKQOSZNPW-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
149673,6wiq,DB00444,-7.1,Teniposide,NRUKOCRGYNPUPR-QBPJDGROSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
132816,6w9c,DB00882,-7.1,Clomifene,GKIRPKYJQBWNGO-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
93406,6m71,DB06910,-7.1,"[4-R-(4-ALPHA,6-BETA,7-BETA]-HEXAHYDRO-5,6-DI(HYDROXY)-1,3-DI(ALLYL)-4,7-BISPHENYLMETHYL)-2H-1,3-DIAZEPINONE",IWJSQELMWLOYSO-LWSSLDFYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
132920,6w9c,DB01002,-7.1,Levobupivacaine,LEBVLXFERQHONN-INIZCTEOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
60077,6crv,DB08203,-7.1,"7-[2-METHOXY-1-(METHOXYMETHYL)ETHYL]-7H-PYRROLO[3,2-F] QUINAZOLINE-1,3-DIAMINE",MQTGHZCEDQNMOZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
149569,6wiq,DB00317,-7.1,Gefitinib,XGALLCVXEZPNRQ-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
60064,6crv,DB08186,-7.1,(3E)-4-(1-METHYL-1H-INDOL-3-YL)BUT-3-EN-2-ONE,HCYQBFAGILCNRB-BQYQJAHWSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
93456,6m71,DB06971,-7.1,"N-{2-[(4'-CYANO-1,1'-BIPHENYL-4-YL)OXY]ETHYL}-N'-HYDROXY-N-METHYLUREA",GVMUNGGWXRKCEU-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
132886,6w9c,DB00961,-7.1,Mepivacaine,INWLQCZOYSRPNW-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
132868,6w9c,DB00940,-7.1,Methantheline,GZHFODJQISUKAY-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
93658,6m71,DB07201,-7.1,(2S)-3-[(9H-fluoren-9-ylideneamino)oxy]-2-methylpropanoic acid,ZHFDVDMCVXUGGF-NSHDSACASA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93455,6m71,DB06970,-7.1,"2-CHLORO-N-(3-CYANO-5,6-DIHYDRO-4H-CYCLOPENTA[B]THIOPHEN-2-YL)-5-DIETHYLSULFAMOYL-BENZAMIDE",MZCDQILVXXIMEV-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
103213,6vxs,DB08307,-7.1,"2-{HYDROXY[2-NITRO-4-(TRIFLUOROMETHYL)PHENYL]METHYLENE}CYCLOHEXANE-1,3-DIONE",PMHVFNYNPNKNRO-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
60053,6crv,DB08172,-7.1,(2Z)-N-(3-chloro-2'-methoxybiphenyl-4-yl)-2-cyano-3-hydroxybut-2-enamide,YUDQXOMZBLEWBH-KAMYIIQDSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60049,6crv,DB08168,-7.1,7-AMINO-4-METHYL-CHROMEN-2-ONE,GLNDAGDHSLMOKX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
60043,6crv,DB08162,-7.1,Fasudil,NGOGFTYYXHNFQH-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
149654,6wiq,DB00421,-7.1,Spironolactone,LXMSZDCAJNLERA-ZHYRCANASA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
149665,6wiq,DB00436,-7.1,Bendroflumethiazide,HDWIHXWEUNVBIY-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
60038,6crv,DB08157,-7.1,ETHYL 3-[4-(AMINOSULFONYL)PHENYL]PROPANOATE,OJBJALUJMRMNIR-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
149599,6wiq,DB00354,-7.1,Buclizine,MOYGZHXDRJNJEP-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
103046,6vxs,DB08105,-7.1,N-[(6-butoxynaphthalen-2-yl)sulfonyl]-L-glutamic acid,UAGYXJBYAFGRFR-KRWDZBQOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
133202,6w9c,DB01399,-7.1,Salsalate,WVYADZUPLLSGPU-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
60211,6crv,DB08373,-7.1,"4,4'-BIS([H]METHYLSULFONYL)-2,2',5,5'-TETRACHLOROBIPHENYL",RDBKPLOYRMCFIY-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
148913,6w9q,DB14217,-7.1,Quinaprilat,FLSLEGPOVLMJMN-YSSFQJQWSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
102831,6vxs,DB07858,-7.1,(2S)-2-(4-chlorophenyl)-2-[4-(1H-pyrazol-4-yl)phenyl]ethanamine,HWVGILTYGZFGLR-KRWDZBQOSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
66311,6lxt,DB04010,-7.1,2-(3'-Methoxyphenyl) Benzimidazole-4-Carboxamide,NVVWVYYHTKCIAE-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
133932,6w9c,DB02357,-7.1,Methyl-O3-(Alpha-D-Mannose)-Alpha-D-Mannose,WOKXHOIRHHAHDA-ZEEOCKJESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
1971,6lzg,HMDB0029377,-7.1,Piperine,MXXWOMGUGJBKIW-YPCIICBESA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
133891,6w9c,DB02290,-7.1,"3-{2,6,8-trioxo-9-[(2S,3S,4R)-2,3,4,5-tetrahydroxypentyl]-1,2,3,6,8,9-hexahydro-7H-purin-7-Yl}propyl dihydrogen phosphate",KPHFGOGGKPGLTM-OOZYFLPDSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
102844,6vxs,DB07871,-7.1,6-CHLORO-4-(CYCLOHEXYLOXY)-3-ISOPROPYLQUINOLIN-2(1H)-ONE,OQCFORGSZJSAEL-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
14317,6lzg,T3D3953,-7.1,Oxytetracycline,IWVCMVBTMGNXQD-PXOLEDIWSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
133830,6w9c,DB02214,-7.1,"6,7-Dioxo-5h-8-Ribitylaminolumazine",MIBROOURCUHKMD-RPDRRWSUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
60343,6crv,DB08533,-7.1,"3-methyl-N-(pyridin-4-ylmethyl)imidazo[1,2-a]pyrazin-8-amine",LXRVAGIYXNQOKP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
133720,6w9c,DB02066,-7.1,N7-Methyl-Formycin A,JRRNRCMIBCSOIH-LFAOKBQASA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
93850,6m71,DB07423,-7.1,(2S)-3-[4-(acetylamino)phenoxy]-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide,YVXVTLGIDOACBJ-SFHVURJKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
66352,6lxt,DB04069,-7.1,"5,6-Dihydro-Benzo[H]Cinnolin-3-Ylamine",QKVREUJWFZJEJK-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
148989,6w9q,DB14664,-7.1,Difluocortolone pivalate,UWGRWFCLGQWKPR-GSTUPEFVSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
102917,6vxs,DB07961,-7.1,"1-(4-CYANO-PHENYL)-3-[2-(2,6-DICHLORO-PHENYL)-1-IMINO-ETHYL]-THIOUREA",NWKJBFSBEAMDBE-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
25515,6cs2,DB03458,-7.1,"N(4)-Adenosyl-N(4)-methyl-2,4-diaminobutanoic acid",JISVTSUBJCPLSV-TWBCTODHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
25514,6cs2,DB03456,-7.1,N2-[(benzyloxy)carbonyl]-n1-[(3S)-1-cyanopyrrolidin-3-yl]-l-leucinamide,IMTUSTXBVIALBC-SJORKVTESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
66294,6lxt,DB03987,-7.1,"2,4-Diamino-6-[N-(3',5'-Dimethoxybenzyl)-N-Methylamino]Pyrido[2,3-D]Pyrimidine",XWCCXDBXMCTZPW-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
60401,6crv,DB08603,-7.1,N-[(1S)-5-amino-1-(chloroacetyl)pentyl]-4-methylbenzenesulfonamide,RDFCSSHDJSZMTQ-ZDUSSCGKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
94044,6m71,DB07652,-7.1,"1-[2-DEOXYRIBOFURANOSYL]-2,4-DIFLUORO-5-METHYL-BENZENE-5'MONOPHOSPHATE",NMMWBGNJJMNAIJ-QJPTWQEYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
148643,6w9q,DB13721,-7.1,Cypermethrin,KAATUXNTWXVJKI-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
25486,6cs2,DB03417,-7.1,1-(4-Tert-Butylcarbamoyl-Piperazine-1-Carbonyl)-3-(3-Guanidino-Propyl)-4-Oxo-Azetidine-2-Carboxylic Acid,BVNQCAHTTOIOEK-STQMWFEESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
102778,6vxs,DB07798,-7.1,"(3R)-3-(FLUOROMETHYL)-N-(3,3,3-TRIFLUOROPROPYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONAMIDE",BBUDQLKRZPRPFD-LLVKDONJSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
94010,6m71,DB07615,-7.1,Tranilast,NZHGWWWHIYHZNX-CSKARUKUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
134155,6w9c,DB02640,-7.1,Fumagillin,NGGMYCMLYOUNGM-CSDLUJIJSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
12516,6lzg,DB01025,-7.1,Amlexanox,SGRYPYWGNKJSDL-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
133647,6w9c,DB01965,-7.1,"2'-Deoxyuridine 5'-Alpha,Beta-Imido-Triphosphate",XZLLMTSKYYYJLH-SHYZEUOFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
14301,6lzg,T3D3936,-7.1,Triasulfuron,XOPFESVZMSQIKC-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
134104,6w9c,DB02569,-7.1,"2',3'-Dehydro-2',3'-Deoxy-Thymidine 5'-Diphosphate",LXCAIISEDMYORY-JGVFFNPUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
134091,6w9c,DB02550,-7.1,"8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-2-Fluoro-9-Pent-4-Ylnyl-9h-Purin-6-Ylamine",KCIOVTSUEXGUFJ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
60427,6crv,DB08636,-7.1,2-Hydroxybenzalpyruvate,HMXOGGUFCBUALL-AATRIKPKSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
134045,6w9c,DB02495,-7.1,9-(4-hydroxybutyl)-N2-phenylguanine,JHBXNPBKSPYOFT-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
148856,6w9q,DB14086,-7.1,Cianidanol,PFTAWBLQPZVEMU-DZGCQCFKSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
93925,6m71,DB07512,-7.1,7-[(3-CHLOROBENZYL)OXY]-2-OXO-2H-CHROMENE-4-CARBALDEHYDE,ZOCADHRNWNJARU-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60403,6crv,DB08606,-7.1,"(3R,4S)-1-[(4-AMINO-5H-PYRROLO[3,2-D]PYRIMIDIN-7-YL)METHYL]-4-[(METHYLSULFANYL)METHYL]PYRROLIDIN-3-OL",NTHMDFGHOCNNOE-ZJUUUORDSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
148727,6w9q,DB13835,-7.1,Caroverine,MSPRUJDUTKRMLM-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
59987,6crv,DB08103,-7.1,"2,6-dibromo-4-phenoxyphenol",CRSZEDOZGJPOHP-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
93788,6m71,DB07348,-7.1,Brefeldin A,KQNZDYYTLMIZCT-KQPMLPITSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93778,6m71,DB07337,-7.1,"4-[4-AMINO-6-(5-CHLORO-1H-INDOL-4-YLMETHYL)-[1,3,5]TRIAZIN-2-YLAMINO]-BENZONITRILE",SOKOHDQTKSROQZ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
102984,6vxs,DB08033,-7.1,"(5R)-N,N-DIETHYL-5-METHYL-2-[(THIOPHEN-2-YLCARBONYL)AMINO]-4,5,6,7-TETRAHYDRO-1-BENZOTHIOPHENE-3-CARBOXAMIDE",UQKSYQYWUHUIEH-GFCCVEGCSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
149096,6w9q,DB14899,-7.1,Tavapadon,AKQXQLUNFKDZBN-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
133383,6w9c,DB01614,-7.1,Acepromazine,NOSIYYJFMPDDSA-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
149130,6w9q,DB14998,-7.1,Olorinab,ACSQLTBPYZSGBA-GMXVVIOVSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
1943,6lzg,HMDB0029164,-7.1,(-)-epicatechin-3'-O-glucuronide,ZZTOVZGFHZQEAT-JUZNXHDUSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
133302,6w9c,DB01522,-7.1,Betacetylmethadol,XBMIVRRWGCYBTQ-GCJKJVERSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
25621,6cs2,DB03598,-7.1,"Al-6629, [2h-Thieno[3,2-E]-1,2-Thiazine-6-Sulfonamide,2-(3-Methoxyphenyl)-3-(4-Morpholinyl)-, 1,1-Dioxide]",XSUAVPPTKHUTDX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
133288,6w9c,DB01502,-7.1,Diampromide,RXTHKWVSXOIHJS-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
133284,6w9c,DB01498,-7.1,Alphamethadol,QIRAYNIFEOXSPW-YLJYHZDGSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
149158,6w9q,DB15057,-7.1,NUC-1031,NHTKGYOMICWFQZ-KKQYNPQSSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
66458,6lxt,DB04202,-7.1,Isoformononetin,LNIQZRIHAMVRJA-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
5173,6lzg,HMDB0055393,-7.1,"TG(18:4(6Z,9Z,12Z,15Z)/24:0/18:4(6Z,9Z,12Z,15Z))",XBZRFWSSSDXNCN-YSTZOJCNSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
93675,6m71,DB07222,-7.1,(3S)-N-(5-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE,RJWMDETWDDESBP-ZDUSSCGKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
133227,6w9c,DB01433,-7.1,Methadyl acetate,XBMIVRRWGCYBTQ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
103034,6vxs,DB08093,-7.1,3-(1-NAPHTHYLMETHOXY)PYRIDIN-2-AMINE,SZANYTFSQVBOBA-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
93716,6m71,DB07271,-7.1,"4-[(3R)-3-Amino-4-(2,4,5-trifluorophenyl)butanoyl]-3-(2,2,2-trifluoroethyl)-1,4-diazepan-2-one",RMDAPSXWBVPVOG-IAPIXIRKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93717,6m71,DB07272,-7.1,"N-(4-AMINO-5-CYANO-6-ETHOXYPYRIDIN-2-YL)-2-(4-BROMO-2,5-DIMETHOXYPHENYL)ACETAMIDE",GKODDLYLEKSDJL-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
93732,6m71,DB07288,-7.1,N-(4-chlorophenyl)-2-[(pyridin-4-ylmethyl)amino]benzamide,GGPZCOONYBPZEW-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
149085,6w9q,DB14879,-7.1,Cefiderocol,DBPPRLRVDVJOCL-FQRUVTKNSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
133637,6w9c,DB01954,-7.1,Rolipram,HJORMJIFDVBMOB-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
133634,6w9c,DB01951,-7.1,Gpi-1046,OQAHHWOPVDDWHD-INIZCTEOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
66385,6lxt,DB04108,-7.1,"(2s,3r)-3-Amino-2-Hydroxy-5-(Ethylsulfanyl)Pentanoyl-((S)-(-)-(1-Naphthyl)Ethyl)Amide",AIIOXZPEXXZCML-KKXDTOCCSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
149035,6w9q,DB14765,-7.1,Rivoceranib,WPEWQEMJFLWMLV-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
133586,6w9c,DB01878,-7.1,Benzophenone,RWCCWEUUXYIKHB-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
1964,6lzg,HMDB0029228,-7.1,4-Methyl-epicatechin,NLCHNUHNZBPKDF-WLZLGPGOSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
149067,6w9q,DB14846,-7.1,Bimiralisib,ADGGYDAFIHSYFI-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
66374,6lxt,DB04096,-7.1,"5-Amino-5-Deoxy-Cellobiono-1,5-Lactam",WXSNJJDPPISYEF-ZNLUKOTNSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
93756,6m71,DB07313,-7.1,5-METHYL-2-[(PHENYLSULFONYL)AMINO]BENZOIC ACID,HXQLTRSIZRSFTR-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
133544,6w9c,DB01823,-7.1,Beta-D-Glucopyranose Spirohydantoin,QRXBDPYWCAAAAI-UXDJRKLDSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
12465,6lzg,DB13403,-7.1,Oxypertine,XCWPUUGSGHNIDZ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
133488,6w9c,DB01751,-7.1,"3,3',5,5'-Tetraiodothyroacetic Acid",PPJYSSNKSXAVDB-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
133472,6w9c,DB01731,-7.1,(S)-wiskostatin,XUBJEDZHBUPBKL-ZDUSSCGKSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
149082,6w9q,DB14875,-7.1,AZD-4017,NCDZABJPWMBMIQ-INIZCTEOSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
102972,6vxs,DB08020,-7.1,"(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-6-(METHOXYMETHYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL",RHQLNMNKTIOREN-AOIWGVFYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
14351,6lzg,T3D4017,-7.1,Vinblastine,JXLYSJRDGCGARV-XQKSVPLYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
93752,6m71,DB07309,-7.1,5-BROMO-2-{[(4-CHLOROPHENYL)SULFONYL]AMINO}BENZOIC ACID,JDVLYAYDIMUAAC-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
148621,6w9q,DB13689,-7.1,Tacalcitol,BJYLYJCXYAMOFT-RSFVBTMBSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
59986,6crv,DB08102,-7.1,"3,5-dibromobiphenyl-4-ol",SKQRVOXIIAXXEM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
149886,6wiq,DB00704,-7.1,Naltrexone,DQCKKXVULJGBQN-XFWGSAIBSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
23312,6cs2,HMDB0060041,-7.1,11b-PGE2,XEYBRNLFEZDVAW-YUOXZBOXSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
150843,6wiq,DB01933,-7.1,7-Hydroxystaurosporine,PBCZSGKMGDDXIJ-HQCWYSJUSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
131865,6w4h,DB14881,-7.1,Oliceridine,DMNOVGJWPASQDL-OAQYLSRUSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
150856,6wiq,DB01948,-7.1,"1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperidin-4-Yl-3,4-Dihydroquinolin-2(1h)-One",VXIYTVJEIXMAQF-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
67049,6lxt,DB05252,-7.1,Fenoxaprop-ethyl,PQKBPHSEKWERTG-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
23308,6cs2,HMDB0060031,-7.1,"5-(3',5'-Dihydroxyphenyl)-gamma-valerolactone-O-sulphate-O-methyl",FXGBBWWEXQWRKV-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
131832,6w4h,DB14801,-7.1,Lanifibranor,OQDQIFQRNZIEEJ-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
92887,6m71,DB05265,-7.1,Ecabet,IWCWQNVIUXZOMJ-MISYRCLQSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
103601,6vxs,DB08771,-7.1,"(5R)-2-[(2-fluorophenyl)amino]-5-(1-methylethyl)-1,3-thiazol-4(5H)-one",OJJBBNIYQKFZDK-SNVBAGLBSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
103603,6vxs,DB08773,-7.1,RALOXIFENE CORE,MDGWZLQPNOETLH-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
103605,6vxs,DB08775,-7.1,N??-[(Benzyloxy)carbonyl]-N-[(2S)-4-fluoro-3-oxo-2-butanyl]-L-tyrosinamide,RYABQRLJLIHDIP-KSSFIOAISA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
92871,6m71,DB05154,-7.1,Pretomanid,ZLHZLMOSPGACSZ-NSHDSACASA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59665,6crv,DB07735,-7.1,"N-[1-(2,6-dimethoxybenzyl)piperidin-4-yl]-4-sulfanylbutanamide",MUDVORCZGBAHNA-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
103617,6vxs,DB08789,-7.1,"2-AMINO-4-(2,4-DICHLOROPHENYL)-N-ETHYLTHIENO[2,3-D]PYRIMIDINE-6-CARBOXAMIDE",YPEOXUOUTBMBCX-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
151044,6wiq,DB02197,-7.1,"4-[(4-Imidazo[1,2-a]Pyridin-3-Ylpyrimidin-2-Yl)Amino]Benzenesulfonamide",NKORVPQBJCGYEC-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
103569,6vxs,DB08736,-7.1,"S,R-Warfarin alcohol",ZUJMMGHIYSAEOU-DOMZBBRYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
103623,6vxs,DB08796,-7.1,Pipazethate,DTVJXCOMJLLMAK-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
67029,6lxt,DB05105,-7.1,Pleconaril,KQOXLKOJHVFTRN-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
150691,6wiq,DB01720,-7.1,(2z)-2-(Benzoylamino)-3-[4-(2-Bromophenoxy)Phenyl]-2-Propenoic Acid,WLPJLQNKCJWAFL-RGEXLXHISA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
59759,6crv,DB07841,-7.1,Geranylgeranyl diphosphate,OINNEUNVOZHBOX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
103525,6vxs,DB08686,-7.1,"5,6,7,8,9,10-HEXAHYDRO-4-HYDROXY-3-(1-PHENYLPROPYL)CYCLOOCTA[B]PYRAN-2-ONE",UXCLJNSXDNCIIT-HNNXBMFYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
132008,6w4h,DB15201,-7.1,Norbixin,ZVKOASAVGLETCT-UOGKPENDSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
92972,6m71,DB05737,-7.1,Varespladib methyl,VJYDOJXJUCJUHL-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
131995,6w4h,DB15170,-7.1,Evobrutinib,QUIWHXQETADMGN-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
5565,6lzg,HMDB0060058,-7.1,CE(16:2),OYOAMRKUJRRRSM-FYALRKDYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
131990,6w4h,DB15161,-7.1,Pittsburgh Compound B,ZQAQXZBSGZUUNL-BJUDXGSMSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131956,6w4h,DB15097,-7.1,Gefapixant,HLWURFKMDLAKOD-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
131955,6w4h,DB15096,-7.1,18-methoxycoronaridine,DTJQBBHYRQYDEG-SVBQBFEESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
150603,6wiq,DB01608,-7.1,Periciazine,LUALIOATIOESLM-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
150614,6wiq,DB01621,-7.1,Pipotiazine,JOMHSQGEWSNUKU-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
131948,6w4h,DB15079,-7.1,Troriluzole,YBZSGIWIPOUSHY-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
92941,6m71,DB05542,-7.1,Naronapride,VGDDOIZXGFJDRC-VJTSUQJLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
150682,6wiq,DB01708,-7.1,Prasterone,FMGSKLZLMKYGDP-USOAJAOKSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
103561,6vxs,DB08728,-7.1,"5-(3-(2,6-dichloro-4-(4,5-dihydro-2-oxazolyl)phenoxy)propyl)-3-methyl isoxazole",TUGBWRGTMLOFAX-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
5619,6lzg,HMDB0061743,-7.1,Perfluoroundecanoic acid,SIDINRCMMRKXGQ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
151092,6wiq,DB02259,-7.1,"3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid (4-Sulfamoyl-Phenyl)-Amide",VSYGXLAJQDAWCZ-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
59653,6crv,DB07720,-7.1,Epibatidine,NLPRAJRHRHZCQQ-IVZWLZJFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
103637,6vxs,DB08810,-7.1,Cinitapride,ZDLBNXXKDMLZMF-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
92769,6m71,DB04843,-7.1,Mepenzolate,GKNPSSNBBWDAGH-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
67162,6lxt,DB05884,-7.1,HCV-086,VBRUONUESYTIDA-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
131499,6w4h,DB13823,-7.1,Pipemidic acid,JOHZPMXAZQZXHR-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
92760,6m71,DB04833,-7.1,Methaqualone,JEYCTXHKTXCGPB-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
131496,6w4h,DB13820,-7.1,Oxomemazine,QTQPVLDZQVPLGV-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
59576,6crv,DB07628,-7.1,"6-(2-fluorobenzyl)-2,4-dimethyl-4,6-dihydro-5H-thieno[2',3':4,5]pyrrolo[2,3-d]pyridazin-5-one",IEWYEWDDQWYJLU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
131472,6w4h,DB13788,-7.1,Chlorbenzoxamine,VEVSKUJZSMGTMM-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
151752,6wiq,DB03126,-7.1,Mant-Adp,QPKUEBLEGWBRHC-BFHYXJOUSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
23270,6cs2,HMDB0059987,-7.1,"5-(3',4',5'-Trihydroxyphenyl)-gamma-valerolactone-4'-O-sulphate",NPIMUIQBYBJSBB-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
131452,6w4h,DB13762,-7.1,Dexrabeprazole,YREYEVIYCVEVJK-RUZDIDTESA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
92736,6m71,DB04806,-7.1,(5-BROMO-4-CHLORO-3-INDOLYL)-A-D-MANNOSE,OPIFSICVWOWJMJ-HAAGFXOZSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
67194,6lxt,DB06133,-7.1,Dimethylcurcumin,ZMGUKFHHNQMKJI-CIOHCNBKSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
103759,6vxs,DB08993,-7.1,Enviomycin,HPWIIERXAFODPP-GHBBWTPBSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
151939,6wiq,DB03368,-7.1,"5-Methyl-5-(4-Phenoxy-Phenyl)-Pyrimidine-2,4,6-Trione",RTBMLCLTYAPKIF-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
67212,6lxt,DB06166,-7.1,Fosdevirine,CGBYTKOSZYQOPV-CCEZBSFNSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
67154,6lxt,DB05830,-7.1,Trestolone,YSGQGNQWBLYHPE-CFUSNLFHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
131508,6w4h,DB13837,-7.1,Doxefazepam,VOJLELRQLPENHL-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
14566,6lzg,T3D4447,-7.1,Propionyl-CoA,QAQREVBBADEHPA-UXYNFSPESA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
131571,6w4h,DB13957,-7.1,J147,HYMZAYGFKNNHDN-SSDVNMTOSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
151155,6wiq,DB02342,-7.1,2-Methox1tradiol,CQOQDQWUFQDJMK-SSTWWWIQSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
151170,6wiq,DB02363,-7.1,2'-Monophosphoadenosine-5'-Diphosphate,YPTPYQSAVGGMFN-KQYNXXCUSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
103642,6vxs,DB08819,-7.1,Tafluprost,WSNODXPBBALQOF-VEJSHDCNSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
151199,6wiq,DB02398,-7.1,6-[N-(4-(Aminomethyl)Phenyl)Carbamyl]-2-Naphthalenecarboxamidine,NLBDETRVUYOIHQ-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
92820,6m71,DB04930,-7.1,Permethrin,RLLPVAHGXHCWKJ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
131619,6w4h,DB14061,-7.1,Hycanthone,MFZWMTSUNYWVBU-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
92807,6m71,DB04892,-7.1,Phenserine,PBHFNBQPZCRWQP-QUCCMNQESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
150573,6wiq,DB01568,-7.1,Codeine-N-oxide,BDLSDHWCOJPHIE-KFUGMXNISA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
103678,6vxs,DB08880,-7.1,Teriflunomide,UTNUDOFZCWSZMS-YFHOEESVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
151380,6wiq,DB02629,-7.1,Inhibitor Bea403,LYHLPPXMBKMSSZ-JQFCFGFHSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
103686,6vxs,DB08895,-7.1,Tofacitinib,UJLAWZDWDVHWOW-YPMHNXCESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
131600,6w4h,DB14025,-7.1,Clinafloxacin,QGPKADBNRMWEQR-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
26032,6cs2,DB00476,-7.1,Duloxetine,ZEUITGRIYCTCEM-KRWDZBQOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
151410,6wiq,DB02669,-7.1,RB106,ZWDQTNWLXALTOV-QYZOEREBSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
92791,6m71,DB04873,-7.1,Piboserod,KVCSJPATKXABRQ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59609,6crv,DB07669,-7.1,"2,3-DIMETHYL-1,4-NAPHTHOQUINONE",LGFDNUSAWCHVJN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
59622,6crv,DB07684,-7.1,5-(DIMETHYLAMINO)-2-NAPHTHALENESULFONIC ACID,VENHBDIMAAXWKI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
150546,6wiq,DB01541,-7.1,Boldenone,RSIHSRDYCUFFLA-DYKIIFRCSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
103504,6vxs,DB08659,-7.1,2-(hydrazinocarbonyl)-3-phenyl-1H-indole-5-sulfonamide,PPDLAUCFAOODER-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
12333,6lzg,DB13240,-7.1,Cymarin,XQCGNURMLWFQJR-ZNDDOCHDSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
132440,6w9c,DB00432,-7.1,Trifluridine,VSQQQLOSPVPRAZ-RRKCRQDMSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
132436,6w9c,DB00426,-7.1,Famciclovir,GGXKWVWZWMLJEH-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
132424,6w9c,DB00412,-7.1,Rosiglitazone,YASAKCUCGLMORW-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
132416,6w9c,DB00401,-7.1,Nisoldipine,VKQFCGNPDRICFG-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
59902,6crv,DB08007,-7.1,(2R)-3-{[(BENZYLAMINO)CARBONYL]AMINO}-2-HYDROXYPROPANOIC ACID,KGFDIRSBGRVEFZ-SECBINFHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
103374,6vxs,DB08502,-7.1,Capravirine,YQXCVAGCMNFUMQ-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
132408,6w9c,DB00393,-7.1,Nimodipine,UIAGMCDKSXEBJQ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
132403,6w9c,DB00387,-7.1,Procyclidine,WYDUSKDSKCASEF-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
93152,6m71,DB06444,-7.1,Dexanabinol,SSQJFGMEZBFMNV-PMACEKPBSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
132402,6w9c,DB00384,-7.1,Triamterene,FNYLWPVRPXGIIP-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
93149,6m71,DB06436,-7.1,Semaxanib,WUWDLXZGHZSWQZ-WQLSENKSSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
150236,6wiq,DB01108,-7.1,Trilostane,KVJXBPDAXMEYOA-CXANFOAXSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
66832,6lxt,DB04707,-7.1,Hydroxyfasudil,ZAVGJDAFCZAWSZ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
132382,6w9c,DB00359,-7.1,Sulfadiazine,SEEPANYCNGTZFQ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
150282,6wiq,DB01162,-7.1,Terazosin,VCKUSRYTPJJLNI-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
132462,6w9c,DB00456,-7.1,Cefalotin,XIURVHNZVLADCM-IUODEOHRSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
12360,6lzg,DB13276,-7.1,Idanpramine,HVYGXNYMNHSBGD-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
59916,6crv,DB08021,-7.1,5-bromo-N-(3-chloro-2-(4-(prop-2-ynyl)piperazin-1-yl)phenyl)furan-2-carboxamide,MEFJFXHHHNDHEN-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
93165,6m71,DB06471,-7.1,Naxifylline,NJYNSYQBNSDGIQ-RDDCQWBRSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
149894,6wiq,DB00713,-7.1,Oxacillin,UWYHMGVUTGAWSP-JKIFEVAISA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
93254,6m71,DB06685,-7.1,Laquinimod,GKWPCEFFIHSJOE-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
149914,6wiq,DB00737,-7.1,Meclizine,OCJYIGYOJCODJL-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
149916,6wiq,DB00739,-7.1,Hetacillin,DXVUYOAEDJXBPY-NFFDBFGFSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
149943,6wiq,DB00773,-7.1,Etoposide,VJJPUSNTGOMMGY-MRVIYFEKSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
66763,6lxt,DB04614,-7.1,(R)-tacrine(10)-hupyridone,ROTFGKJJMRTWBD-HHHXNRCGSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
132556,6w9c,DB00576,-7.1,Sulfamethizole,VACCAVUAMIDAGB-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
132368,6w9c,DB00344,-7.1,Protriptyline,BWPIARFWQZKAIA-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
23358,6cs2,HMDB0001924,-7.1,Atenolol,METKIMKYRPQLGS-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
150032,6wiq,DB00875,-7.1,Flupentixol,NJMYODHXAKYRHW-DVZOWYKESA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
103338,6vxs,DB08461,-7.1,"3-[(4-AMINO-1-TERT-BUTYL-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL)METHYL]PHENOL",QMAIQPBRCNEJAT-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
150097,6wiq,DB00948,-7.1,Mezlocillin,YPBATNHYBCGSSN-VWPFQQQWSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
132498,6w9c,DB00499,-7.1,Flutamide,MKXKFYHWDHIYRV-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
93177,6m71,DB06506,-7.1,Repinotan,YGYBFMRFXNDIPO-QGZVFWFLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59922,6crv,DB08028,-7.1,"BUT-3-ENYL-[5-(4-CHLORO-PHENYL)-3,6-DIHYDRO-[1,3,4]THIADIAZIN-2-YLIDENE]-AMINE",ZVZPCRKQNRRBOQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
150155,6wiq,DB01016,-7.1,Glyburide,ZNNLBTZKUZBEKO-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
12372,6lzg,DB13292,-7.1,Pimethixene,NZLVRVYNQYGMAB-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
149865,6wiq,DB00680,-7.1,Moricizine,FUBVWMNBEHXPSU-UHFFFAOYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
132359,6w9c,DB00333,-7.1,Methadone,USSIQXCVUWKGNF-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
150303,6wiq,DB01185,-7.1,Fluoxymesterone,YLRFCQOZQXIBAB-RBZZARIASA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
93052,6m71,DB06187,-7.1,Valtorcitabine,VFCYZPOEGWLYRM-QCZKYFFMSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59812,6crv,DB07902,-7.1,"TERT-BUTYL {2-[(1,3-THIAZOL-2-YLAMINO)CARBONYL]PYRIDIN-3-YL}CARBAMATE",QBMYJIFXSXKPFS-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
93047,6m71,DB06174,-7.1,Noscapine,AKNNEGZIBPJZJG-MSOLQXFVSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
132120,6w4h,DB15424,-7.1,Bfpet F-18,QWPLCHDPESWJRN-FNNGWQQSSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
59805,6crv,DB07894,-7.1,4-(2-HYDROXY-4-FLUOROPHENYLTHIO)-BUTYLPHOSPHONIC ACID,UXOYJQMPYTYCMG-ORCRQEGFSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
150489,6wiq,DB01474,-7.1,"17alpha-methyl-3beta,17beta-dihydroxyandrost-4-ene",BNUOCVTVOYWNJC-DTMQFJJTSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
150494,6wiq,DB01480,-7.1,Cyprenorphine,VSKIOMHXEUHYSI-KNLIIKEYSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
93027,6m71,DB06133,-7.1,Dimethylcurcumin,ZMGUKFHHNQMKJI-CIOHCNBKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
59798,6crv,DB07884,-7.1,"ISOPROPYL (2S)-2-ETHYL-7-FLUORO-3-OXO-3,4-DIHYDROQUINOXALINE-1(2H)-CARBOXYLATE",KELNNWMENBUHNS-NSHDSACASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
5508,6lzg,HMDB0059991,-7.1,5-(3'-Hydroxyphenyl)-gamma-valerolactone-3'-O-glucuronide,GZLRAFFGSYXMES-UAISQINXSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
103488,6vxs,DB08642,-7.1,"(2R,6S)-6-{[methyl(3,4,5-trimethoxyphenyl)amino]methyl}-1,2,5,6,7,8-hexahydroquinazoline-2,4-diamine",JJWPLCQODKLEHY-JEOXALJRSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
103489,6vxs,DB08643,-7.1,2-(2-{2-[(BIPHENYL-4-YLMETHYL)-AMINO]-3-MERCAPTO-PENTANOYLAMINO}-ACETYLAMINO)-3-METHYL-BUTYRIC ACID METHYL ESTER,QFAWBPLETHINFK-UNMCSNQZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
66940,6lxt,DB04849,-7.1,Cediranib,XXJWYDDUDKYVKI-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
132063,6w4h,DB15300,-7.1,Hydroquinidine,LJOQGZACKSYWCH-LHHVKLHASA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
93009,6m71,DB05973,-7.1,Inosine 5'-sulfate,IGYLPKLXFDOQGM-KQYNXXCUSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
66903,6lxt,DB04806,-7.1,(5-BROMO-4-CHLORO-3-INDOLYL)-A-D-MANNOSE,OPIFSICVWOWJMJ-HAAGFXOZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
132141,6w4h,DB01470,-7.1,alpha-methylthiofentanyl,YPOXDUYRRSUFFG-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
103456,6vxs,DB08600,-7.1,"5-CHLORO-8-METHYL-7-(3-METHYL-BUT-2-ENYL)-6,7,8,9-TETRAHYDRO-2H-2,7,9A-TRIAZA-BENZO[CD]AZULENE-1-THIONE",ZNFFMCYSMBXZQU-NSHDSACASA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
66888,6lxt,DB04787,-7.1,Tanaproget,PYVFWTPEBMRKSR-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
132320,6w9c,DB00283,-7.1,Clemastine,YNNUSGIPVFPVBX-NHCUHLMSSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
132317,6w9c,DB00280,-7.1,Disopyramide,UVTNFZQICZKOEM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
93118,6m71,DB06335,-7.1,Saxagliptin,QGJUIPDUBHWZPV-SGTAVMJGSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
103421,6vxs,DB08557,-7.1,"2-[(2-methoxyethyl)amino]-4-(4-oxo-1,2,3,4-tetrahydro-9H-carbazol-9-yl)benzamide",XQKFKSJUBJPOLY-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
14496,6lzg,T3D4281,-7.1,SAICAR,NAQGHJTUZRHGAC-ZZZDFHIKSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
93112,6m71,DB06313,-7.1,BNC105,MYDHDVLPMRNDAZ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
150325,6wiq,DB01208,-7.1,Sparfloxacin,DZZWHBIBMUVIIW-DTORHVGOSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
132343,6w9c,DB00312,-7.1,Pentobarbital,WEXRUCMBJFQVBZ-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
5466,6lzg,HMDB0001898,-7.1,Mesobilirubinogen,OBHRVMZSZIDDEK-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
150366,6wiq,DB01264,-7.1,Darunavir,CJBJHOAVZSMMDJ-HEXNFIEUSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
132275,6w9c,DB00234,-7.1,Reboxetine,CBQGYUDMJHNJBX-RTBURBONSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
132273,6w9c,DB00232,-7.1,Methyclothiazide,CESYKOGBSMNBPD-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
93094,6m71,DB06266,-7.1,Lonidamine,WDRYRZXSPDWGEB-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
103440,6vxs,DB08580,-7.1,4-bromo-2-{[(2R)-2-(2-chlorobenzyl)pyrrolidin-1-yl]carbonyl}aniline,JEGGWFHNKPRKTO-CQSZACIVSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
150397,6wiq,DB01338,-7.1,Pipecuronium,OWWLUIWOFHMHOQ-XGHATYIMSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
66882,6lxt,DB04778,-7.1,SC45647,LPSXGZAUAOMRNU-FZKQIMNGSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
150363,6wiq,DB01260,-7.1,Desonide,WBGKWQHBNHJJPZ-LECWWXJVSA-N,Crystal structure of the co-factor complex of NSP7 and the C-terminal domain of NSP8 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp7-nsp8
94060,6m71,DB07675,-7.1,(2S)-2-ETHOXY-3-{4-[2-(10H-PHENOXAZIN-10-YL)ETHOXY]PHENYL}PROPANOIC ACID,WMUIIGVAWPWQAW-DEOSSOPVSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
148598,6w9q,DB13664,-7.1,Formocortal,QNXUUBBKHBYRFW-QWAPGEGQSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
148565,6w9q,DB13618,-7.1,Ipriflavone,SFBODOKJTYAUCM-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
102025,6vxs,DB06918,-7.1,2-(2-METHYLPHENYL)-1H-INDOLE-6-CARBOXIMIDAMIDE,ZRYXDGAKQGRHFG-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
136592,6w9c,DB07304,-7.1,5-[2-(TRIFLUOROMETHOXY)PHENYL]-2-FUROIC ACID,PSLFQKRPFOCZHR-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
147055,6w9q,DB11115,-7.1,Ensulizole,UVCJGUGAGLDPAA-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
102028,6vxs,DB06921,-7.1,(2S)-2-[3-(AMINOMETHYL)PHENYL]-3-[(R)-HYDROXY{(1R)-2-METHYL-1-[(PHENYLSULFONYL)AMINO]PROPYL}PHOSPHORYL]PROPANOIC ACID,FNZHLCNFXRRIIC-RBUKOAKNSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
147063,6w9q,DB11157,-7.1,Anthralin,NUZWLKWWNNJHPT-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
95161,6m71,DB09008,-7.1,Cefaloridine,CZTQZXZIADLWOZ-CRAIPNDOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
147118,6w9q,DB11372,-7.1,Altrenogest,VWAUPFMBXBWEQY-ANULTFPQSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
61121,6crv,DB11609,-7.1,Normethadone,WCJFBSYALHQBSK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
65497,6lxt,DB02911,-7.1,"2,4-Diamino-6-Phenyl-5,6,7,8,-Tetrahydropteridine",VEKRIXRQADJFAG-QMMMGPOBSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
12726,6lzg,DB13728,-7.1,Halometasone,GGXMRPUKBWXVHE-MIHLVHIWSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
95149,6m71,DB08994,-7.1,Ditazole,UUCMDZWCRNZCOY-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
14067,6lzg,T3D3684,-7.1,Ergine,GENAHGKEFJLNJB-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
147129,6w9q,DB11393,-7.1,Danofloxacin,QMLVECGLEOSESV-RYUDHWBXSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
12718,6lzg,DB13721,-7.1,Cypermethrin,KAATUXNTWXVJKI-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
147223,6w9q,DB11616,-7.1,Pirarubicin,KMSKQZKKOZQFFG-YXRRJAAWSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
147032,6w9q,DB09488,-7.1,Acrivastine,PWACSDKDOHSSQD-IUTFFREVSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
65533,6lxt,DB02957,-7.1,Orotidine-5'-Monophosphate,KYOBSHFOBAOFBF-XVFCMESISA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
136593,6w9c,DB07305,-7.1,5-(2-CHLORO-4-NITROPHENYL)-2-FUROIC ACID,HDIHNBCCQWMVBW-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
102014,6vxs,DB06907,-7.1,"2-(2,6-DICHLOROPHENYL)-1,3-BENZOXAZOLE-6-CARBOXYLIC ACID",XVNRKPCHMYOPPL-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
65412,6lxt,DB02805,-7.1,Uracil arabinose-3'-phosphate,FOGRQMPFHUHIGU-PXBUCIJWSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
101950,6vxs,DB06829,-7.1,4-BROMO-3-(CARBOXYMETHOXY)-5-[3-(CYCLOHEXYLAMINO)PHENYL]THIOPHENE-2-CARBOXYLIC ACID,RXDVFLTWXCTCEX-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
65415,6lxt,DB02808,-7.1,Trifluorofurnesyl Diphosphate,PXLMLAFPAPGGKK-GVCYOOEQSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
95267,6m71,DB09193,-7.1,"CP-39,332",HLOCJJORRHQDKS-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
101960,6vxs,DB06843,-7.1,"2',5'-DIDEOXY-ADENOSINE 3'-MONOPHOSPHATE",NFGZMOICZSFFLB-DSYKOEDSSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
136702,6w9c,DB07431,-7.1,"(3R)-3-(aminomethyl)-9-methoxy-1,2,3,4-tetrahydro-5H-[1]benzothieno[3,2-e][1,4]diazepin-5-one",TXYKBKYDFZQOCB-SSDOTTSWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
146907,6w9q,DB09181,-7.1,Trefentanil,RJSCINHYBGMIFT-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
101970,6vxs,DB06857,-7.1,N-(4-CARBAMIMIDOYL-3-CHORO-PHENYL)-2-HYDROXY-3-IODO-5-METHYL-BENZAMIDE,QKGFTDAISIBIBV-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
136665,6w9c,DB07389,-7.1,N-[2-(6-AMINO-4-METHYLPYRIDIN-2-YL)ETHYL]-4-CYANOBENZAMIDE,QINCZVSBLITNRD-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
101981,6vxs,DB06870,-7.1,"17-HYDROXY-18A-HOMO-19-NOR-17ALPHA-PREGNA-4,9,11-TRIEN-3-ONE",OXHNQTSIKGHVBH-ANULTFPQSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
61160,6crv,DB11676,-7.1,Galidesivir,AMFDITJFBUXZQN-KUBHLMPHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
25128,6cs2,DB00376,-7.1,Trihexyphenidyl,HWHLPVGTWGOCJO-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
65454,6lxt,DB02855,-7.1,N-(3-Propylcarbamoyloxirane-2-Carbonyl)-Isoleucyl-Proline,UDNIFTKCMDIXFC-ABHRYQDASA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
14049,6lzg,T3D3666,-7.1,Aflatoxin M1,MJBWDEQAUQTVKK-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
12735,6lzg,DB13739,-7.1,Penamecillin,NLOOMWLTUVBWAW-HLLBOEOZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
147005,6w9q,DB09330,-7.1,Osimertinib,DUYJMQONPNNFPI-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
136421,6w9c,DB07099,-7.1,N-[4-(benzyloxy)phenyl]glycinamide,YJPUATSIKWOSST-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136420,6w9c,DB07096,-7.1,"6-AMINO-BENZO[DE]ISOQUINOLINE-1,3-DIONE",SSMIFVHARFVINF-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
147244,6w9q,DB11656,-7.1,Rebamipide,ALLWOAVDORUJLA-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
102148,6vxs,DB07061,-7.1,"1-(CYCLOHEXYLAMINO)-3-(6-METHYL-3,4-DIHYDRO-1H-CARBAZOL-9(2H)-YL)PROPAN-2-OL",AXYFCRIRLKSCRR-SFHVURJKSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
136147,6w9c,DB06654,-7.1,Safinamide,NEMGRZFTLSKBAP-LBPRGKRZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136143,6w9c,DB06640,-7.1,Fispemifene,NKZTZAQIKKGTDB-QPLCGJKRSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136132,6w9c,DB06623,-7.1,Flupirtine,JUUFBMODXQKSTD-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
94923,6m71,DB08699,-7.1,"1-tert-butyl-3-(3-methylbenzyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine",FYCOTGCSHZKHPR-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
147395,6w9q,DB11877,-7.1,Basmisanil,VCGRFBXVSFAGGA-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
94914,6m71,DB08686,-7.1,"5,6,7,8,9,10-HEXAHYDRO-4-HYDROXY-3-(1-PHENYLPROPYL)CYCLOOCTA[B]PYRAN-2-ONE",UXCLJNSXDNCIIT-HNNXBMFYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
136126,6w9c,DB06614,-7.1,Peramivir,XRQDFNLINLXZLB-CKIKVBCHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136106,6w9c,DB06573,-7.1,Rebimastat,GTXSRFUZSLTDFX-HRCADAONSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
147420,6w9q,DB11912,-7.1,Lanopepden,SWHNZGMQMGFQGW-MSOLQXFVSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
94870,6m71,DB08633,-7.1,TNP-470,MSHZHSPISPJWHW-PVDLLORBSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
147440,6w9q,DB11943,-7.1,Delafloxacin,DYDCPNMLZGFQTM-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
147446,6w9q,DB11950,-7.1,Teneligliptin,WGRQANOPCQRCME-PMACEKPBSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
136068,6w9c,DB06465,-7.1,FK-960,XTOKQKWTUYYVAO-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
65660,6lxt,DB03133,-7.1,"2-(Beta-D-Glucopyranosyl)-5-Methyl-1,2,3-Benzimidazole",XIJZORUYQZBFJK-UJPOAAIJSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
94957,6m71,DB08735,-7.1,"R,S-Warfarin alcohol",ZUJMMGHIYSAEOU-SWLSCSKDSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
102133,6vxs,DB07046,-7.1,"2-[(2-chloro-4-iodophenyl)amino]-N-{[(2R)-2,3-dihydroxypropyl]oxy}-3,4-difluorobenzamide",FCADPEDUULETPK-SECBINFHSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
136231,6w9c,DB06878,-7.1,1-[(2R)-2-aminobutanoyl]-N-(3-chlorobenzyl)-L-prolinamide,OTYYXGRJXJFTCD-KGLIPLIRSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136264,6w9c,DB06914,-7.1,"1-({2-[2-(4-CHLOROPHENYL)ETHYL]-1,3-DIOXOLAN-2-YL}METHYL)-1H-IMIDAZOLE",NPIOYRIZNLPLDH-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136407,6w9c,DB07082,-7.1,"1,1,1,3,3,3-HEXAFLUORO-2-{4-[(2,2,2-TRIFLUOROETHYL)AMINO]PHENYL}PROPAN-2-OL",VHDRSZOHKKZOQF-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
147250,6w9q,DB11666,-7.1,Buparlisib,CWHUFRVAEUJCEF-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
136400,6w9c,DB07073,-7.1,"5,5-dimethyl-2-morpholin-4-yl-5,6-dihydro-1,3-benzothiazol-7(4H)-one",DZXMARZBAUMWLK-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
102106,6vxs,DB07017,-7.1,"(5S)-2-{[(1S)-1-(4-fluorophenyl)ethyl]amino}-5-(1-hydroxy-1-methylethyl)-5-methyl-1,3-thiazol-4(5H)-one",HYVZYASDRIAOPU-BJOHPYRUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
147256,6w9q,DB11674,-7.1,Equol,ADFCQWZHKCXPAJ-GFCCVEGCSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
136364,6w9c,DB07033,-7.1,5-HYDROXY-3-[(1R)-1-(1H-PYRROL-2-YL)ETHYL]-2H-INDOL-2-ONE,VWQVBIPGKIAUGA-QMMMGPOBSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
95031,6m71,DB08819,-7.1,Tafluprost,WSNODXPBBALQOF-VEJSHDCNSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
65406,6lxt,DB02798,-7.1,Alpha-Methylene Adenosine Monophosphate,PXSSQXBLDTZHLF-IOSLPCCCSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
136345,6w9c,DB07012,-7.1,"6-AMINO-3,7-DIHYDRO-IMIDAZO[4,5-G]QUINAZOLIN-8-ONE",VQSMWFVKBKMHTO-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
147296,6w9q,DB11736,-7.1,PF-00489791,ZUHZNKJIJDAJFD-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
94993,6m71,DB08774,-7.1,"1-[(2S)-4-(5-phenyl-1H-pyrazolo[3,4-b]pyridin-4-yl)morpholin-2-yl]methanamine",YBRZCAKSBYWZTC-ZDUSSCGKSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
136310,6w9c,DB06971,-7.1,"N-{2-[(4'-CYANO-1,1'-BIPHENYL-4-YL)OXY]ETHYL}-N'-HYDROXY-N-METHYLUREA",GVMUNGGWXRKCEU-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
102121,6vxs,DB07033,-7.1,5-HYDROXY-3-[(1R)-1-(1H-PYRROL-2-YL)ETHYL]-2H-INDOL-2-ONE,VWQVBIPGKIAUGA-QMMMGPOBSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
61042,6crv,DB11413,-7.1,Florfenicol,AYIRNRDRBQJXIF-NXEZZACHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
102123,6vxs,DB07035,-7.1,"(2E)-3-{3-[(5-ETHYL-3-IODO-6-METHYL-2-OXO-1,2-DIHYDROPYRIDIN-4-YL)OXY]PHENYL}ACRYLONITRILE",XMFUXIRAVPMVRS-FNORWQNLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
147340,6w9q,DB11796,-7.1,Fostemsavir,SWMDAPWAQQTBOG-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
95011,6m71,DB08795,-7.1,Azidocillin,ODFHGIPNGIAMDK-NJBDSQKTSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
136740,6w9c,DB07477,-7.1,Felbinac,QRZAKQDHEVVFRX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
136744,6w9c,DB07481,-7.1,"tert-butyl [(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)methyl]carbamate",RXVQMCMIOHBKNE-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
146850,6w9q,DB09070,-7.1,Tibolone,WZDGZWOAQTVYBX-XOINTXKNSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
137225,6w9c,DB08041,-7.1,3-BENZYLOXYCARBONYLAMINO-2-HYDROXY-4-PHENYL-BUTYRIC ACID,JXJYTERRLRAUSF-JKSUJKDBSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
137205,6w9c,DB08019,-7.1,"N-{(3R,4S)-4-[(6-amino-4-methylpyridin-2-yl)methyl]pyrrolidin-3-yl}-N'-(3-chlorobenzyl)ethane-1,2-diamine",VWCMAGONQJHIJZ-LPHOPBHVSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
146374,6w9q,DB08455,-7.1,Ro 12-7310,CAAFTBWHFUPDGX-OFCLTBKTSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
137204,6w9c,DB08018,-7.1,"N-{(3S,4S)-4-[(6-AMINO-4-METHYLPYRIDIN-2-YL)METHYL]PYRROLIDIN-3-YL}-N'-(4-CHLOROBENZYL)ETHANE-1,2-DIAMINE",JDRSQGJWTVRNGM-QFBILLFUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
146384,6w9q,DB08466,-7.1,"5-[2-(4-hydroxyphenyl)ethyl]benzene-1,3-diol",HITJFUSPLYBJPE-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
13964,6lzg,T3D2069,-7.1,"1,2,7-Trichlorodibenzo-p-dioxin",TXJMXDWFPQSYEQ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
101760,6vxs,DB06436,-7.1,Semaxanib,WUWDLXZGHZSWQZ-WQLSENKSSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
137184,6w9c,DB07996,-7.1,5-(2-methylpiperazine-1-sulfonyl)isoquinoline,BDVFVCGFMNCYPV-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
65226,6lxt,DB02549,-7.1,3'-O-Acetylthymidine-5'-Diphosphate,UWSIAAWKEICIJY-IVZWLZJFSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
95663,6m71,DB11764,-7.1,Spebrutinib,KXBDTLQSDKGAEB-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
146399,6w9q,DB08486,-7.1,Efaproxiral,BNFRJXLZYUTIII-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
12796,6lzg,DB13816,-7.1,Aspoxicillin,BHELIUBJHYAEDK-OAIUPTLZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
95647,6m71,DB11739,-7.1,Vonoprazan,BFDBKMOZYNOTPK-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
101788,6vxs,DB06506,-7.1,Repinotan,YGYBFMRFXNDIPO-QGZVFWFLSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
137107,6w9c,DB07908,-7.1,7-HYDROXY-4-METHYL-3-(2-HYDROXY-ETHYL)COUMARIN,VCGFYFKJZGIZMX-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
101735,6vxs,DB06358,-7.1,Iclaprim,HWJPWWYTGBZDEG-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
65192,6lxt,DB02507,-7.1,4-Hydroxy-3-[(1s)-3-Oxo-1-Phenylbutyl]-2h-Chromen-2-One,PJVWKTKQMONHTI-HNNXBMFYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
95753,6m71,DB11893,-7.1,Avagacestat,XEAOPVUAMONVLA-QGZVFWFLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95781,6m71,DB11935,-7.1,Flomoxef,UHRBTBZOWWGKMK-DOMZBBRYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
137478,6w9c,DB08348,-7.1,"N-2-,N-2-DIMETHYL-N-1-(6-OXO-5,6-DIHYDROPHENANTHRIDIN-2-YL)GLYCINAMIDE",UYJZZVDLGDDTCL-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
12838,6lzg,DB13867,-7.1,Fluticasone,MGNNYOODZCAHBA-GQKYHHCASA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
12837,6lzg,DB13866,-7.1,Etynodiol,JYILPERKVHXLNF-QMNUTNMBSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
12836,6lzg,DB13865,-7.1,Dehydroemetine,XXLZPUYGHQWHRN-RPBOFIJWSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
101666,6vxs,DB06193,-7.1,Pixantrone,PEZPMAYDXJQYRV-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
146148,6w9q,DB08169,-7.1,(2Z)-N-biphenyl-4-yl-2-cyano-3-cyclopropyl-3-hydroxyprop-2-enamide,CAGGGMPTWTUYHZ-ZCXUNETKSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
146160,6w9q,DB08184,-7.1,2-(2-METHYLPHENYL)-1H-INDOLE-5-CARBOXIMIDAMIDE,YOZKTHGEOJHIDP-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
95629,6m71,DB11706,-7.1,Raxatrigine,JESCETIFNOFKEU-SJORKVTESA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
65131,6lxt,DB02429,-7.1,4-(Aminosulfonyl)-N-[(4-Fluorophenyl)Methyl]-Benzamide,IXDVPACDZDRCTN-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
95844,6m71,DB12027,-7.1,Serdemetan,CEGSUK1LWKJP-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
146211,6w9q,DB08250,-7.1,"(5S)-5-(3-AMINOPROPYL)-3-(2,5-DIFLUOROPHENYL)-N-ETHYL-5-PHENYL-4,5-DIHYDRO-1H-PYRAZOLE-1-CARBOXAMIDE",OQMVLDZJPRSNOG-NRFANRHFSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
95806,6m71,DB11967,-7.1,Binimetinib,ACWZRVQXLIRSDF-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
146248,6w9q,DB08301,-7.1,N-({[4-(AMINOSULFONYL)PHENYL]AMINO}CARBONYL)-4-METHYLBENZENESULFONAMIDE,HDCXQTPVTAIPNZ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
137389,6w9c,DB08234,-7.1,"5-[3-(2,5-dimethoxyphenyl)prop-1-yn-1-yl]-6-ethylpyrimidine-2,4-diamine",NNFDQABYXZBKRK-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
95792,6m71,DB11948,-7.1,Lapachone,QZPQTZZNNJUOLS-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95790,6m71,DB11946,-7.1,AZD-1981,JWYIGNODXSRKGP-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
65133,6lxt,DB02431,-7.1,Cytidine-5'-Triphosphate,PCDQPRRSZKQHHS-XVFCMESISA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
94846,6m71,DB08602,-7.1,"3-(2,6-difluorophenyl)-2-(methylthio)quinazolin-4(3H)-one",BFNBJSXMXXQLAW-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
146449,6w9q,DB08542,-7.1,"3,4-dihydroxy-9,10-secoandrosta-1(10),2,4-triene-9,17-dione",YUHVBHDSVLKFNI-NJSLBKSFSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
146469,6w9q,DB08568,-7.1,(2S)-1-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}-3-PHENYLPROPAN-2-AMINE,BPNUQXPIQBZCMR-IBGZPJMESA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
136953,6w9c,DB07732,-7.1,2-[(2-NAPHTHYLSULFONYL)AMINO]ETHYL DIHYDROGEN PHOSPHATE,FCROUVVWZFPGFM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
95467,6m71,DB11376,-7.1,Azaperone,XTKDAFGWCDAMPY-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95466,6m71,DB11372,-7.1,Altrenogest,VWAUPFMBXBWEQY-ANULTFPQSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
146733,6w9q,DB08905,-7.1,Formestane,OSVMTWJCGUFAOD-KZQROQTASA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
101899,6vxs,DB06735,-7.1,Enclomiphene,GKIRPKYJQBWNGO-OCEACIFDSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
146737,6w9q,DB08910,-7.1,Pomalidomide,UVSMNLNDYGZFPF-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
136871,6w9c,DB07632,-7.1,"5-(2-chlorophenyl)-1,3,4-thiadiazole-2-sulfonamide",PZVGOWIIHCUHAO-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
101903,6vxs,DB06739,-7.1,Seratrodast,ZBVKEHDGYSLCCC-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
136864,6w9c,DB07625,-7.1,"4-(2-aminoethoxy)-N-(2,5-diethoxyphenyl)-3,5-dimethylbenzamide",PHTPPZCTHZHCQD-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
146772,6w9q,DB08962,-7.1,Glibornuride,RMTYNAPTNBJHQI-LLDVTBCESA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
25095,6cs2,DB00372,-7.1,Thiethylperazine,XCTYLCDETUVOIP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
95342,6m71,DB09292,-7.1,Sacubitril,PYNXFZCZUAOOQC-UTKZUKDTSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
146809,6w9q,DB09003,-7.1,Clocapramine,QAZKXHSIKKNOHH-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
146832,6w9q,DB09038,-7.1,Empagliflozin,OBWASQILIWPZMG-QZMOQZSNSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
101929,6vxs,DB06794,-7.1,Lodoxamide,RVGLGHVJXCETIO-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
146705,6w9q,DB08846,-7.1,Ellagic Acid,AFSDNFLWKVMVRB-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
95486,6m71,DB11410,-7.1,Fenbendazole,HDDSHPAODJUKPD-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
25058,6cs2,DB02905,-7.1,"Phosphoric Acid Mono-[3,4-Dihydroxy-5-(5-Hydroxy-Benzoimidazol-1-Yl)Tetrahydro-Furan-2-Ylmethyl] Ester",BVZASCINAVSQNO-PULFBKJNSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
146624,6w9q,DB08750,-7.1,"1-[4-(AMINOMETHYL)BENZOYL]-5'-FLUORO-1'H-SPIRO[PIPERIDINE-4,2'-QUINAZOLIN]-4'-AMINE",SFPCNWQWKOUNRT-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
65267,6lxt,DB02607,-7.1,Adenosine Phosphonoacetic Acid,KJNLSEOJEFDELT-JJNLEZRASA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
95602,6m71,DB11672,-7.1,Curcumin,VFLDPWHFBUODDF-FCXRPNKRSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
25040,6cs2,DB02885,-7.1,4-Imino-5-Methidyl-2-Trifluoromethylpyrimidine,YKFRUALXTUDSBW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
25041,6cs2,DB00367,-7.1,Levonorgestrel,WWYNJERNGUHSAO-XUDSTZEESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
146505,6w9q,DB08610,-7.1,N-(2-AMINOETHYL)-2-{3-CHLORO-4-[(4-ISOPROPYLBENZYL)OXY]PHENYL} ACETAMIDE,DFXJYVQAAFOZDP-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
146533,6w9q,DB08646,-7.1,TRW3-(2-AMINO-3-HYDROXY-PROPYL)-6-(N'-CYCLOHEXYL-HYDRAZINO)OCTAHYDRO-INDOL-7-OL,PSUOZWHAKZSNOB-LBPRGKRZSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
95591,6m71,DB11654,-7.1,T-2000,RRFBTKHQZRCRSS-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
101813,6vxs,DB06579,-7.1,Adipiplon,UAMAIHOEGLEXSV-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
146542,6w9q,DB08656,-7.1,5-amino-2-methyl-N-[(1R)-1-naphthalen-1-ylethyl]benzamide,UVERBUNNCOKGNZ-CQSZACIVSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
146545,6w9q,DB08659,-7.1,2-(hydrazinocarbonyl)-3-phenyl-1H-indole-5-sulfonamide,PPDLAUCFAOODER-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
137023,6w9c,DB07810,-7.1,"3-(4-HYDROXYPHENYL)-1-(2,4,6-TRIHYDROXYPHENYL)PROPAN-1-ONE",VGEREEWJJVICBM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
146588,6w9q,DB08713,-7.1,"2,6-DIMETHYL-1-(3-[3-METHYL-5-ISOXAZOLYL]-PROPANYL)-4-[2N-METHYL-2H-TETRAZOL-5-YL]-PHENOL",RVZKQTQAFHEOKT-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
146590,6w9q,DB08715,-7.1,"2,6-DIMETHYL-1-(3-[3-METHYL-5-ISOXAZOLYL]-PROPANYL)-4-[2-METHYL-4-ISOXAZOLYL]-PHENOL",SLPKYEWAKMNCPT-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
95552,6m71,DB11555,-7.1,Zolazepam,GDSCFOSHSOWNDL-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95539,6m71,DB11519,-7.1,Fluprostenol,WWSWYXNVCBLWNZ-QIZQQNKQSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
95538,6m71,DB11518,-7.1,Flunixin,NOOCSNJCXJYGPE-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
146543,6w9q,DB08657,-7.1,2-(4-(2-((3-(5-(PYRIDIN-2-YLTHIO)THIAZOL-2-YL)UREIDO)METHYL)-1H-IMIDAZOL-4-YL)PHENOXY)ACETIC ACID,SSXCWVOQWRUMGN-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
94837,6m71,DB08591,-7.1,"5-(4-METHOXYBIPHENYL-3-YL)-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDE",IGXKSKWHHHYBFM-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94826,6m71,DB08577,-7.1,3-[(3-(2-CARBOXYETHYL)-4-METHYLPYRROL-2-YL)METHYLENE]-2-INDOLINONE,JNDVEAXZWJIOKB-JYRVWZFOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
60950,6crv,DB11073,-7.1,Cetylpyridinium,NEUSVAOJNUQRTM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
66009,6lxt,DB03615,-7.1,Ribostamycin,NSKGQURZWSPSBC-VVPCINPTSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
134900,6w9c,DB03716,-7.1,5'-Fluoro-5'-Deoxyadenosine,QPVLKMICBYRPSX-KQYNXXCUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
148158,6w9q,DB13024,-7.1,MK-8245,UJEAABFSXKCSGI-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
94345,6m71,DB08004,-7.1,"(2S)-2-{[3-(3-aminophenyl)imidazo[1,2-b]pyridazin-6-yl]amino}-3-methylbutan-1-ol",PUMVONFFLKPPIM-CQSZACIVSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
102582,6vxs,DB07565,-7.1,Chloramphenicol succinate,LIRCDOVJWUGTMW-ZWNOBZJWSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
134824,6w9c,DB03606,-7.1,(S)-Rolipram,HJORMJIFDVBMOB-GFCCVEGCSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
102587,6vxs,DB07572,-7.1,3-{[(4-methylphenyl)sulfonyl]amino}propyl pyridin-4-ylcarbamate,ITYCDQJBLCTIID-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
25401,6cs2,DB03313,-7.1,Cephalosporin C,HOKIDJSKDBPKTQ-GLXFQSAKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
25403,6cs2,DB03315,-7.1,Guanosine 3'-monophosphate,ZDPUTNZENXVHJC-UUOKFMHZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
60614,6crv,DB08867,-7.1,Ulipristal,HKDLNTKNLJPAIY-WKWWZUSTSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
94318,6m71,DB07973,-7.1,N-(1-ISOPROPYLPIPERIDIN-4-YL)-1-(3-METHOXYBENZYL)-1H-INDOLE-2-CARBOXAMIDE,GIPCBGDQVGKMPO-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
102597,6vxs,DB07585,-7.1,"5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine",YFFJXGRXFASBDL-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
12568,6lzg,DB13534,-7.1,Gedocarnil,SLYDYLLJUXFULK-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
12567,6lzg,DB13533,-7.1,Methylestrenolone,ZXSWTMLNIIZPET-ZOFHRBRSSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
148219,6w9q,DB13114,-7.1,Amitriptylinoxide,ZPMKQFOGINQDAM-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
12582,6lzg,DB13551,-7.1,Cinchophen,YTRMTPPVNRALON-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
134910,6w9c,DB03726,-7.1,Purine Riboside-5'-Monophosphate,MCWDCZIDTUQRHK-FDDDBJFASA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
148144,6w9q,DB13004,-7.1,Mavoglurant,ZFPZEYHRWGMJCV-ZHALLVOQSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
66005,6lxt,DB03608,-7.1,Diminazene,XNYZHCFCZNMTFY-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
25355,6cs2,DB03258,-7.1,2'-Deoxycytidine 5'-triphosphate,RGWHQCVHVJXOKC-SHYZEUOFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
135030,6w9c,DB03890,-7.1,N-[2-(1-Formyl-2-Methyl-Propyl)-1-(4-Piperidin-1-Yl-but-2-Enoyl)-Pyrrolidin-3-Yl]-Methanesulfonamide,BSBJWRKWANAVRQ-POTLKAILSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
148002,6w9q,DB12779,-7.1,Higenamine,WZRCQWQRFZITDX-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
102506,6vxs,DB07477,-7.1,Felbinac,QRZAKQDHEVVFRX-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
135025,6w9c,DB03883,-7.1,Carboxyethyllumazine,PTYCEIBBGGLADD-PJKMHFRUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
60677,6crv,DB08966,-7.1,Fursultiamine,JTLXCMOFVBXEKD-FOWTUZBSSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
148007,6w9q,DB12787,-7.1,Norethandrolone,ZDHCJEIGTNNEMY-XGXHKTLJSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
134799,6w9c,DB03573,-7.1,WRR-99,KVZMXOVSHIMGNA-CVEARBPZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
148013,6w9q,DB12798,-7.1,Relenopride,KGMMSPVVHZGPHL-NRFANRHFSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
94384,6m71,DB08046,-7.1,2-chloro-5-[(1S)-1-hydroxy-3-oxo-2H-isoindol-1-yl]benzenesulfonamide,JIVPVXMEBJLZRO-AWEZNQCLSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
14230,6lzg,T3D3862,-7.1,Imazapic,PVSGXWMWNRGTKE-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
148077,6w9q,DB12900,-7.1,Irdabisant,XUKROCVZGZNGSI-CQSZACIVSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
148081,6w9q,DB12904,-7.1,ZSTK-474,HGVNLRPZOWWDKD-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
148084,6w9q,DB12910,-7.1,Emicerfont,JFHJGXQFESYQGY-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
94362,6m71,DB08021,-7.1,5-bromo-N-(3-chloro-2-(4-(prop-2-ynyl)piperazin-1-yl)phenyl)furan-2-carboxamide,MEFJFXHHHNDHEN-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94358,6m71,DB08017,-7.1,3-METHOXY-6-[4-(3-METHYLPHENYL)-1-PIPERAZINYL]PYRIDAZINE,DDOAUTHWSCUHQA-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94385,6m71,DB08049,-7.1,"7,8-dihydroxy-4-phenyl-2H-chromen-2-one",JRVIIPJSVKTPBK-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
135038,6w9c,DB03899,-7.1,9-Butyl-8-(4-Methoxybenzyl)-9h-Purin-6-Amine,NVYATAJRTRFKSW-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
102609,6vxs,DB07598,-7.1,"2,3,6A,7,8,9-HEXAHYDRO-11H-[1,4]DIOXINO[2,3-G]PYRROLO[2,1-B][1,3]BENZOXAZIN-11-ONE",RQEPVMAYUINZRE-GFCCVEGCSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
12562,6lzg,DB13528,-7.1,Chlormadinone,VUHJZBBCZGVNDZ-TTYLFXKOSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
94120,6m71,DB07746,-7.1,3-ETHYL-6-{[(4-FLUOROPHENYL)SULFONYL]AMINO}-2-METHYLBENZOIC ACID,MGUQWAOYPINSIT-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
14280,6lzg,T3D3916,-7.1,Pyriproxyfen,NHDHVHZZCFYRSB-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
134398,6w9c,DB03022,-7.1,"3-{2,6,8-trioxo-9-[(2R,3S,4R)-2,3,4,5-tetrahydroxypentyl]-1,2,3,6,8,9-hexahydro-7H-purin-7-Yl}propyl dihydrogen phosphate",KPHFGOGGKPGLTM-BHNWBGBOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
66176,6lxt,DB03829,-7.1,Pseudouridine-5'-Monophosphate,MOBMOJGXNHLLIR-GBNDHIKLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
12534,6lzg,DB13491,-7.1,Fluperolone,SLVCCRYLKTYUQP-DVTGEIKXSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
134334,6w9c,DB02933,-7.1,5'-Deoxy-5'-(Methylthio)-Tubercidin,WBPLMFVTQMIPLW-MFYTUXHUSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
66180,6lxt,DB03835,-7.1,"N-[(5S,7R,8S,9S,10R)-8,9,10-Trihydroxy-7-(hydroxymethyl)-2,4-dioxo-6-oxa-1,3-diazaspiro[4.5]dec-3-yl]acetamide",MAHIOGAAEAWGLR-UTAYWCBXSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
148545,6w9q,DB13593,-7.1,Zolimidine,VSLIUWLPFRVCDL-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
134322,6w9c,DB02918,-7.1,Zardaverine,HJMQDJPMQIHLPB-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
94085,6m71,DB07704,-7.1,"6-AMINO-4-[2-(4-METHOXYPHENYL)ETHYL]-1,7-DIHYDRO-8H-IMIDAZO[4,5-G]QUINAZOLIN-8-ONE",UKRVQKUVWNDGMN-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
134305,6w9c,DB02896,-7.1,Methylthioinosine,ZDRFDHHANOYUTE-IOSLPCCCSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
148551,6w9q,DB13602,-7.1,Promegestone,QFFCYTLOTYIJMR-XMGTWHOFSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
25480,6cs2,DB00414,-7.1,Acetohexamide,VGZSUPCWNCWDAN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
134292,6w9c,DB02881,-7.1,4-(4-Hydroxy-3-Isopropylphenylthio)-2-Isopropylphenol,NEMLLZAROZVCCE-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
134290,6w9c,DB02879,-7.1,"2,3-Di-O-Sulfo-Alpha-D-Glucopyranose",ORUZACWROKWTRH-DVKNGEFBSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
102699,6vxs,DB07707,-7.1,"(9BETA,11ALPHA,13ALPHA,14BETA,17ALPHA)-11-(METHOXYMETHYL)ESTRA-1(10),2,4-TRIENE-3,17-DIOL",LEOPSILMAOYZBO-IUTAEKPZSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
94141,6m71,DB07769,-7.1,S-3-(4-FLUOROPHENOXY)-2-HYDROXY-2-METHYL-N-[4-NITRO-3-(TRIFLUOROMETHYL)PHENYL]PROPANAMIDE,KJMFOTCDISOHDX-INIZCTEOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
134543,6w9c,DB03216,-7.1,"(1'R,2'S)-9-(2-Hydroxy-3'-Keto-Cyclopenten-1-yl)Adenine",RQPALADHFYHEHK-CHKWXVPMSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
94180,6m71,DB07812,-7.1,"N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyrrolo[2,3-b]pyridin-4-yl)thiophene-2-carboxamide",TWYNGDRSMHRPSY-MRXNPFEDSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
148265,6w9q,DB13217,-7.1,Fentiazac,JIEKMACRVQTPRC-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
66059,6lxt,DB03685,-7.1,Uridine monophosphate,DJJCXFVJDGTHFX-XVFCMESISA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
94277,6m71,DB07927,-7.1,3-[(4-Carboxy-2-hydroxyphenyl)sulfamoyl]-2-thiophenecarboxylic acid,RDPXXOOKKRIKFN-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
134722,6w9c,DB03456,-7.1,N2-[(benzyloxy)carbonyl]-n1-[(3S)-1-cyanopyrrolidin-3-yl]-l-leucinamide,IMTUSTXBVIALBC-SJORKVTESA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
134715,6w9c,DB03448,-7.1,2'-Deoxyuridine 3'-Monophosphate,LXKGKXYIAAKOCT-SHYZEUOFSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
134709,6w9c,DB03435,-7.1,Uridine-5'-Diphosphate,XCCTYIAWTASOJW-XVFCMESISA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
94243,6m71,DB07883,-7.1,(2-AMINO-3-PHENYL-BICYCLO[2.2.1]HEPT-2-YL)-PHENYL-METHANONE,XJQDTOANLAPEIM-JRBPQWBISA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
66044,6lxt,DB03666,-7.1,3'-Azido-3'-Deoxythymidine-5'-Monophosphate,OIFWQOKDSPDILA-XLPZGREQSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
148308,6w9q,DB13276,-7.1,Idanpramine,HVYGXNYMNHSBGD-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
148330,6w9q,DB13308,-7.1,Oxametacin,AJRNYCDWNITGHF-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
134665,6w9c,DB03370,-7.1,FR239087,HCJYSIGJDKNVRU-TVQRCGJNSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
66089,6lxt,DB03725,-7.1,Phosphomethylphosphonic Acid-Guanylate Ester,PHBDHXOBFUBCJD-KQYNXXCUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
66090,6lxt,DB03726,-7.1,Purine Riboside-5'-Monophosphate,MCWDCZIDTUQRHK-FDDDBJFASA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
102665,6vxs,DB07668,-7.1,3-(4-DIETHYLAMINO-2-HYDROXY-PHENYL)-2-METHYL-PROPIONIC ACID,JAEWDFYDSACHDN-CSKARUKUSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
23431,6cs2,HMDB0061824,-7.1,1-Methyl-4-(1-methyl-2-propenyl)-benzene,IRICXAFZMINCTB-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
148429,6w9q,DB13432,-7.1,Lonazolac,XVUQHFRQHBLHQD-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
134686,6w9c,DB03403,-7.1,Cytidine-5'-Monophosphate,IERHLVCPSMICTF-XVFCMESISA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
59551,6crv,DB07597,-7.1,"CIS-(1R,2S)-2-AMINO-1,2,3,4-TETRAHYDRONAPHTHALEN-1-OL",IIMSEFZOOYSTDO-VHSXEESVSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
135052,6w9c,DB03918,-7.1,"6S-5,6,7,8-Tetrahydrobiopterin",FNKQXYHWGSIFBK-ZMIZWQJLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
147963,6w9q,DB12715,-7.1,MSX-122,PXZXYRKDDXKDTK-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
135654,6w9c,DB04765,-7.1,N-PYRIDOXYL-2-METHYL-L-GLUTAMIC ACID-5'-MONOPHOSPHATE,CNIVMJHNGQZEAY-AWEZNQCLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
147650,6w9q,DB12252,-7.1,PG-701,OKRSVUYYCJPECG-LFGMFVMYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
135651,6w9c,DB04762,-7.1,N-PYRIDOXYL-D-GLUTAMIC ACID-5'-MONOPHOSPHATE,JMRKOGDJNHPMHS-SNVBAGLBSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
102325,6vxs,DB07269,-7.1,(2S)-2-[3-(AMINOMETHYL)PHENYL]-3-[(R)-[(1R)-1-{[(BENZYLOXY)CARBONYL]AMINO}-2-METHYLPROPYL](HYDROXY)PHOSPHORYL]PROPANOIC ACID,SFUOOKBZBVUDBC-VQTJNVASSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
65803,6lxt,DB03315,-7.1,Guanosine 3'-monophosphate,ZDPUTNZENXVHJC-UUOKFMHZSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
102333,6vxs,DB07278,-7.1,2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}ETHENESULFONAMIDE,ACEFOQMQINFMRW-DYCFVMESSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
14181,6lzg,T3D3809,-7.1,Chlorsulfuron,VJYIFXVZLXQVHO-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
135596,6w9c,DB04676,-7.1,Dansyllysine,VQPRNSWQIAHPMS-HNNXBMFYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
102338,6vxs,DB07283,-7.1,"9-benzyl-2,3,4,9-tetrahydro-1H-carbazole-8-carboxylic acid",VDOXYKGIKBUISK-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
147669,6w9q,DB12279,-7.1,OBP-801,XFLBOEMFLGLWFF-HDXRNPEWSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
147680,6w9q,DB12291,-7.1,Tacedinaline,VAZAPHZUAVEOMC-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
94619,6m71,DB08325,-7.1,2-(2-HYDROXYETHYLAMINO)-6-(3-CHLOROANILINO)-9-ISOPROPYLPURINE,XZEFMZCNXDQXOZ-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
147682,6w9q,DB12295,-7.1,Evodenoson,SQJXTUJMBYVDBB-RQXXJAGISA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
135542,6w9c,DB04603,-7.1,2'-DEOXY-5-FORMYLCYTIDINE-5'-MONOPHOSPHATE,HDFNXAHZEYLDBJ-XLPZGREQSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
102363,6vxs,DB07309,-7.1,5-BROMO-2-{[(4-CHLOROPHENYL)SULFONYL]AMINO}BENZOIC ACID,JDVLYAYDIMUAAC-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
147618,6w9q,DB12210,-7.1,AZD-6280,NVWCZRPXYVDQEE-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
102293,6vxs,DB07232,-7.1,Veliparib,JNAHVYVRKWKWKQ-CYBMUJFWSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
65753,6lxt,DB03250,-7.1,"2-(Beta-D-Glucopyranosyl)-5-Methyl-1,3,4-Benzothiazole",WGJFWQVWYRZPEP-KABOQKQYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
135748,6w9c,DB04884,-7.1,Dapoxetine,USRHYDPUVLEVMC-FQEVSTJZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
147492,6w9q,DB12021,-7.1,Dinaciclib,PIMQWRZWLQKKBJ-SFHVURJKSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
147495,6w9q,DB12025,-7.1,Triptolide,DFBIRQPKNDILPW-CIVMWXNOSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
135972,6w9c,DB06207,-7.1,Silodosin,PNCPYILNMDWPEY-QGZVFWFLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
65692,6lxt,DB03176,-7.1,KB-141,OZYQIQVPUZANTM-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
135958,6w9c,DB06185,-7.1,Forodesine,IWKXDMQDITUYRK-KUBHLMPHSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
102238,6vxs,DB07167,-7.1,5-CYANO-FURAN-2-CARBOXYLIC ACID [5-HYDROXYMETHYL-2-(4-METHYL-PIPERIDIN-1-YL)-PHENYL]-AMIDE,NNPCFFIJVKYGHR-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
135925,6w9c,DB05786,-7.1,Irofulven,NICJCIQSJJKZAH-AWEZNQCLSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
102364,6vxs,DB07310,-7.1,"(5S)-2-{[(1S)-1-(2-fluorophenyl)ethyl]amino}-5-methyl-5-(trifluoromethyl)-1,3-thiazol-4(5H)-one",KNHNFKZUNFPPQE-MADCSZMMSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
65708,6lxt,DB03200,-7.1,7-Alpha-D-Ribofuranosyl-Purine-5'-Phosphate,NICKPTPNIMHUHB-DQUBFYRCSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
135848,6w9c,DB05377,-7.1,Chlorfenson,RZXLPPRPEOUENN-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
60909,6crv,DB09340,-7.1,Tyropanoic acid,YMOXVLQZFAUUKI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
135837,6w9c,DB05271,-7.1,Rotigotine,KFQYTPMOWPVWEJ-INIZCTEOSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
12661,6lzg,DB13653,-7.1,Lorcainide,XHOJAWVAWFHGHL-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
135795,6w9c,DB05025,-7.1,Arimoclomol,SGEIEGAXKLMUIZ-CYBMUJFWSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
147600,6w9q,DB12183,-7.1,Sapitinib,DFJSJLGUIXFDJP-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
65752,6lxt,DB03249,-7.1,2'-O-Methyl-3'-Methyl-3'-Deoxy-Arabinofuranosyl-Thymine-5'-Phosphate,MCXXETKRWYMFCI-TURQNECASA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
147555,6w9q,DB12114,-7.1,Poziotinib,LPFWVDIFUFFKJU-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
94428,6m71,DB08098,-7.1,"{[5-(5-nitro-2-furyl)-1,3,4-oxadiazol-2-yl]thio}acetic acid",ITBNJCVIFHSKRL-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
25288,6cs2,DB03186,-7.1,U-Pi-a-Pi,JIAJERGOUFOENU-LNAOLWRRSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
135504,6w9c,DB04555,-7.1,Cytidine-5'-Diphosphate,ZWIADYZPOWUWEW-XVFCMESISA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
135290,6w9c,DB04265,-7.1,N-acetyl-beta-neuraminic acid,SQVRNKJHWKZAKO-PFQGKNLYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
94478,6m71,DB08151,-7.1,"(5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-phenyl-1,6-dioxa-2-azaspiro[4.5]dec-2-ene-8,9,10-triol",YLTDNVVQKRHCJP-RKQHYHRCSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
65903,6lxt,DB03458,-7.1,"N(4)-Adenosyl-N(4)-methyl-2,4-diaminobutanoic acid",JISVTSUBJCPLSV-TWBCTODHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
102458,6vxs,DB07420,-7.1,(1R)-4-(3-phenoxyphenyl)-1-phosphonobutane-1-sulfonic acid,RCGCZPXSRLLKCK-MRXNPFEDSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
12608,6lzg,DB13586,-7.1,Metandienone,XWALNWXLMVGSFR-HLXURNFRSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
135223,6w9c,DB04149,-7.1,(R)-Rolipram,HJORMJIFDVBMOB-LBPRGKRZSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
147874,6w9q,DB12574,-7.1,LY-295501,VAMFSFIPDOODFH-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
102466,6vxs,DB07429,-7.1,2-({[4-bromo-3-(diethylsulfamoyl)phenyl]carbonyl}amino)benzoic acid,VNOMZKMKBNFCMC-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102469,6vxs,DB07432,-7.1,"[[(3R,4R,5S,6R)-3-(butanoylamino)-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-ylidene]amino] N-phenylcarbamate",ITVRELFVFCOUMV-ZVZWZHPPSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
94471,6m71,DB08144,-7.1,"6-(2,6-dibromophenyl)pyrido[2,3-d]pyrimidine-2,7-diamine",HGIPWJYTPOHUGK-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
147883,6w9q,DB12588,-7.1,AZD-1480,PDOQBOJDRPLBQU-QMMMGPOBSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
135183,6w9c,DB04096,-7.1,"5-Amino-5-Deoxy-Cellobiono-1,5-Lactam",WXSNJJDPPISYEF-ZNLUKOTNSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
65922,6lxt,DB03486,-7.1,Phosphomethylphosphonic Acid Guanosyl Ester,OCJWYBKRHNXUME-KQYNXXCUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
147946,6w9q,DB12689,-7.1,Azeliragon,KJNNWYBAOPXVJY-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
94435,6m71,DB08105,-7.1,N-[(6-butoxynaphthalen-2-yl)sulfonyl]-L-glutamic acid,UAGYXJBYAFGRFR-KRWDZBQOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94499,6m71,DB08172,-7.1,(2Z)-N-(3-chloro-2'-methoxybiphenyl-4-yl)-2-cyano-3-hydroxybut-2-enamide,YUDQXOMZBLEWBH-KAMYIIQDSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
94508,6m71,DB08184,-7.1,2-(2-METHYLPHENYL)-1H-INDOLE-5-CARBOXIMIDAMIDE,YOZKTHGEOJHIDP-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
147801,6w9q,DB12464,-7.1,Bevenopran,ZGCYVRNZWGUXNQ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
14205,6lzg,T3D3834,-7.1,Etoxazole,IXSZQYVWNJNRAL-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
147704,6w9q,DB12321,-7.1,Ifetroban,BBPRUNPUJIUXSE-DXKRWKNPSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
94593,6m71,DB08297,-7.1,ORTHONITROPHENYL-BETA-D-FUCOPYRANOSIDE,SWRPIVXPHLYETN-BVWHHUJWSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
135474,6w9c,DB04517,-7.1,Dipyrromethane Cofactor,LCAXMKQKEYTFDM-UHFFFAOYSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
94582,6m71,DB08285,-7.1,"(2R)-2-{[4-(benzylamino)-8-(1-methylethyl)pyrazolo[1,5-a][1,3,5]triazin-2-yl]amino}butan-1-ol",SQUNOCMDMIQIQK-OAHLLOKOSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
147741,6w9q,DB12380,-7.1,GDC-0152,WZRFLSDVFPIXOV-LRQRDZAKSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
102383,6vxs,DB07330,-7.1,trans-4-(7-carbamoyl-1H-benzimidazol-2-yl)-1-propylpiperidinium,KXSIHXHEHABEJX-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
94559,6m71,DB08250,-7.1,"(5S)-5-(3-AMINOPROPYL)-3-(2,5-DIFLUOROPHENYL)-N-ETHYL-5-PHENYL-4,5-DIHYDRO-1H-PYRAZOLE-1-CARBOXAMIDE",OQMVLDZJPRSNOG-NRFANRHFSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
147703,6w9q,DB12320,-7.1,Palovarotene,YTFHCXIPDIHOIA-DHZHZOJOSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
94557,6m71,DB08247,-7.1,6-(CYCLOHEXYLMETHOXY)-8-ISOPROPYL-9H-PURIN-2-AMINE,JABXNQUXGJTKRO-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
102408,6vxs,DB07358,-7.1,"2-amino-N-(4-methyl-1,3-thiazol-2-yl)-5-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]benzamide",JEBOJMQHVUEKBE-UHFFFAOYSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
147772,6w9q,DB12419,-7.1,HSD-016,ZWASRJHIEFYJGL-BFUOFWGJSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
147783,6w9q,DB12433,-7.1,SCH-900271,ARJKMWXLIHZLQZ-UHFFFAOYSA-N,Peptide-bound SARS-CoV-2 Nsp9 RNA-replicase,VIRAL PROTEIN,SARS-CoV-1,nsp9 RNA-replicase
135387,6w9c,DB04400,-7.1,"L-erythro-7,8-dihydrobiopterin",FEMXZDUTFRTWPE-DZSWIPIPSA-N,The crystal structure of papain-like protease of SARS CoV-2,HYDROLASE,SARS-CoV-2,PL pro
12620,6lzg,DB13602,-7.1,Promegestone,QFFCYTLOTYIJMR-XMGTWHOFSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
94528,6m71,DB08211,-7.1,5-bromo-3-(pyrrolidin-1-ylsulfonyl)-1H-indole-2-carboxamide,FEPUPYVRZUWCQB-UHFFFAOYSA-N,SARS-Cov-2 RNA-dependent RNA polymerase in complex with cofactors,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
102432,6vxs,DB07390,-7.1,"2-[3-(5-MERCAPTO-[1,3,4]THIADIAZOL-2-YL)-UREIDO]-N-METHYL-3-PHENYL-PROPIONAMIDE",RKWXKADYTDWZIJ-VIFPVBQESA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
102399,6vxs,DB07348,-7.1,Brefeldin A,KQNZDYYTLMIZCT-KQPMLPITSA-N,Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2,VIRAL PROTEIN,SARS-CoV-2,ribose phosphatase of NSP3
68082,6lxt,DB07500,-7.1,(2E)-1-[2-hydroxy-4-methoxy-5-(3-methylbut-2-en-1-yl)phenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one,ZUGCRBMNFSAUOC-YRNVUSSQSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
88493,6m3m,DB13871,-7.1,Albendazole oxide,VXTGHWHFYNYFFV-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
68085,6lxt,DB07504,-7.1,(2R)-1-{4-[(4-Anilino-5-bromo-2-pyrimidinyl)amino]phenoxy}-3-(dimethylamino)-2-propanol,MEIJADBULOETOV-QGZVFWFLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
161557,7bv1,DB00118,-7.1,Ademetionine,MEFKEPWMEQBLKI-AIRLBKTGSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
120738,6w4b,DB08846,-7.1,Ellagic Acid,AFSDNFLWKVMVRB-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
161569,7bv1,DB00131,-7.1,Adenosine phosphate,UDMBCSSLTHHNCD-KQYNXXCUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
161578,7bv1,DB00140,-7.1,Riboflavin,AUNGANRZJHBGPY-SCRDCRAPSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
120674,6w4b,DB08770,-7.1,"4-{2-[(7-amino-2-furan-2-yl[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-yl)amino]ethyl}phenol",PWTBZOIUWZOPFT-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
108770,6vxx,DB08941,-7.1,Isoxsuprine,BMUKKTUHUDJSNZ-HBUWYVDXSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28498,6cs2,DB08089,-7.1,LGD-2226,ULBPQWIGZUGPHU-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
161696,7bv1,DB00485,-7.1,Dicloxacillin,YFAGHNZHGGCZAX-JKIFEVAISA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
28503,6cs2,DB00748,-7.1,Carbinoxamine,OJFSXZCBGQGRNV-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
161701,7bv1,DB00490,-7.1,Buspirone,QWCRAEMEVRGPNT-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
120614,6w4b,DB08706,-7.1,"(2S)-({(5Z)-5-[(5-ETHYL-2-FURYL)METHYLENE]-4-OXO-4,5-DIHYDRO-1,3-THIAZOL-2-YL}AMINO)(4-FLUOROPHENYL)ACETIC ACID",RNEACARJKXYVND-MZLJFPOFSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
161703,7bv1,DB00493,-7.1,Cefotaxime,GPRBEKHLDVQUJE-QSWIMTSFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
7677,6lzg,DB04201,-7.1,Histidyl-Adenosine Monophosphate,XTFBSLZFYLGYAT-OPYVMVOTSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
28517,6cs2,DB08107,-7.1,N-{[6-(PENTYLOXY)NAPHTHALEN-2-YL]SULFONYL}-D-GLUTAMIC ACID,LIGACKDHLKEZFH-GOSISDBHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
120582,6w4b,DB08663,-7.1,4-HYDROXY-7-METHOXY-3-(1-PHENYL-PROPYL)-CHROMEN-2-ONE,CCPGCKQLIHGSCJ-AWEZNQCLSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
161725,7bv1,DB00524,-7.1,Metolazone,AQCHWTWZEMGIFD-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
54842,6crv,DB00292,-7.1,Etomidate,NPUKDXXFDDZOKR-LLVKDONJSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
83473,6m3m,DB03928,-7.1,"Carboxymethylthio-3-(3-Chlorophenyl)-1,2,4-Oxadiazol",BGDMJXZYDKFEGJ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
72263,6m2n,DB00539,-7.1,Toremifene,XFCLJVABOIYOMF-QPLCGJKRSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
120745,6w4b,DB08867,-7.1,Ulipristal,HKDLNTKNLJPAIY-WKWWZUSTSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
108740,6vxx,DB08892,-7.1,Arbaclofen Placarbil,JXTAALBWJQJLGN-KSSFIOAISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
161513,7bv1,DB14945,-7.1,Florbenazine F-18,GNKGXQHHUUEYQV-WTHAECTESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
120766,6w4b,DB08905,-7.1,Formestane,OSVMTWJCGUFAOD-KZQROQTASA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
54973,6crv,DB00451,-7.1,Levothyroxine,XUIIKFGFIJCVMT-LBPRGKRZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28434,6cs2,DB08021,-7.1,5-bromo-N-(3-chloro-2-(4-(prop-2-ynyl)piperazin-1-yl)phenyl)furan-2-carboxamide,MEFJFXHHHNDHEN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
83734,6m3m,DB04276,-7.1,N-[N-[1-Hydroxycarboxyethyl-Carbonyl]Leucylamino-Butyl]-Guanidine,QPQNJAXBPHVASB-QWRGUYRKSA-O,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
161386,7bv1,DB13944,-7.1,Testosterone enanthate,VOCBWIIFXDYGNZ-IXKNJLPQSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
120864,6w4b,DB09034,-7.1,Suvorexant,JYTNQNCOQXFQPK-MRXNPFEDSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
120842,6w4b,DB09003,-7.1,Clocapramine,QAZKXHSIKKNOHH-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
161418,7bv1,DB14002,-7.1,D-alpha-Tocopherol acetate,ZAKOWWREFLAJOT-CEFNRUSXSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
72143,6m2n,DB00391,-7.1,Sulpiride,BGRJTUBHPOOWDU-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
161445,7bv1,DB14061,-7.1,Hycanthone,MFZWMTSUNYWVBU-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
83429,6m3m,DB03870,-7.1,"Ara-Alpha(1,3)-Xyl",XAQWBYJKZNCZPL-DBMHWZGKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
28452,6cs2,DB08038,-7.1,"L-alanyl-N-[(1S,2R)-1-benzyl-2-hydroxypropyl]-L-alaninamide",CPAOOGAUUDSJCS-FMSGJZPZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
72161,6m2n,DB00412,-7.1,Rosiglitazone,YASAKCUCGLMORW-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
120820,6w4b,DB08980,-7.1,Fendiline,NMKSAYKQLCHXDK-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
108695,6vxx,DB08814,-7.1,Triflusal,RMWVZGDJPAKBDE-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
161470,7bv1,DB14869,-7.1,Remetinostat,XDZAHHULFQIBFE-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
108717,6vxx,DB08843,-7.1,GS 0573,XHXFQGAZAVKMFF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
161499,7bv1,DB14924,-7.1,PF-06651600,CBRJPFGIXUFMTM-WDEREUQCSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
54922,6crv,DB00392,-7.1,Profenamine,CDOZDBSBBXSXLB-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
83639,6m3m,DB04152,-7.1,"2-Amino-3-(3-Hydroxy-7,8-Dihydro-6h-Cyclohepta[D]-4-Isoxazolyl)Propionic Acid",HJEPOXZLPHUVFE-ZETCQYMHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
49434,2fxp,DB04477,-7.1,"N-1,2,3,4-Tetrahydronaphth-1-Yl-2'-[3,5-Dimethoxybenzamido]-2'-Deoxy-Adenosine",FDZQGEIYGFPMOB-ZUURFMEUSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
108690,6vxx,DB08807,-7.1,Bopindolol,UUOJIACWOAYWEZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108851,6vxx,DB11125,-7.1,Benzethonium,SIYLLGKDQZGJHK-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72280,6m2n,DB00557,-7.1,Hydro1ine,ZQDWXGKKHFNSQK-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
161773,7bv1,DB00582,-7.1,Voriconazole,BCEHBSKCWLPMDN-MGPLVRAMSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
83174,6m3m,DB03525,-7.1,RU79073,NSJSAHCLJYVEDM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
18141,6cs2,HMDB0013240,-7.1,Indoleacetyl glutamine,DVJIJAYHBZALOJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
33389,6cs2,T3D4581,-7.1,"1-Methyl-6-phenyl-1H-imidazo[4,5-b]pyridin-2-amine",UQVKZNNCIHJZLS-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
10418,6lzg,DB08613,-7.1,"2,2,2-TRIFLUORO-1-{5-[(3-PHENYL-5,6-DIHYDROIMIDAZO[1,2-A]PYRAZIN-7(8H)-YL)CARBONYL]THIOPHEN-2-YL}ETHANE-1,1-DIOL",OFBFUNBBOQCNFX-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
120322,6w4b,DB08351,-7.1,N-cyclopropyl-4-methyl-3-{2-[(2-morpholin-4-ylethyl)amino]quinazolin-6-yl}benzamide,MNEXDVSJIUQQRH-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
49622,2fxp,DB04724,-7.1,"(S)-2-((S)-3-ISOBUTYL-2,5-DIOXO-4-QUINOLIN-3-YLMETHYL-[1,4]DIAZEPAN-1YL)-N-METHYL-3-NAPHTALEN-2-YL-PROPIONAMIDE",COVPLULNDBDXTN-KYJUHHDHSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
83138,6m3m,DB03477,-7.1,1-Phenylsulfonamide-3-Trifluoromethyl-5-Parabromophenylpyrazole,OYZKFVIVPRQRQQ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
49625,2fxp,DB04727,-7.1,"N-(4-{4-AMINO-6-[4-(METHYLOXY)PHENYL]FURO[2,3-D]PYRIMIDIN-5-YL}PHENYL)-N'-[2-FLUORO-5-(TRIFLUOROMETHYL)PHENYL]UREA",FGZIONRFHVNRJB-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
33380,6cs2,T3D4571,-7.1,Ketazolam,PWAJCNITSBZRBL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
161950,7bv1,DB01009,-7.1,Ketoprofen,DKYWVDODHFEZIM-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
18157,6cs2,HMDB0000610,-7.1,"CE(18:2(9Z,12Z))",NAACPBBQTFFYQB-XHDSEGDBSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
33361,6cs2,T3D4553,-7.1,Carbinoxamine,OJFSXZCBGQGRNV-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
10375,6lzg,DB08564,-7.1,(2E)-N-{4-[(3-bromophenyl)amino]quinazolin-6-yl}-4-(dimethylamino)but-2-enamide,ZCIXBBSRVLSRJQ-QPJJXVBHSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
10374,6lzg,DB08562,-7.1,4-(4-STYRYL-PHENYLCARBAMOYL)-BUTYRIC ACID,FTXJWRRYLLRFMG-MDZDMXLPSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
72438,6m2n,DB00749,-7.1,Etodolac,NNYBQONXHNTVIJ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
83068,6m3m,DB03372,-7.1,"3-Mercapto-1-(1,3,4,9-Tetrahydro-B-Carbolin-2-Yl)-Propan-1-One",UGWLHSPOMCORRH-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83053,6m3m,DB03354,-7.1,"2-(Beta-D-Glucopyranosyl)-5-Methyl-1,3,4-Oxadiazole",HCSFWJQLIPWUFZ-JAJWTYFOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
162028,7bv1,DB01098,-7.1,Rosuvastatin,BPRHUIZQVSMCRT-VEUZHWNKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
120280,6w4b,DB08300,-7.1,"1-methyl-3-naphthalen-2-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine",UOKGZPYGRJDACN-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
10360,6lzg,DB08546,-7.1,"4-[(3AS,4R,7R,8AS,8BR)-2-(1,3-BENZODIOXOL-5-YLMETHYL)-7-HYDROXY-1,3-DIOXODECAHYDROPYRROLO[3,4-A]PYRROLIZIN-4-YL]BENZENECARBOXIMIDAMIDE",CETLUACQMGBMFH-ZALSBGIRSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
120296,6w4b,DB08317,-7.1,"5-methyl-6-phenylquinazoline-2,4-diamine",HUCOXWPHDFINIW-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
108679,6vxx,DB08796,-7.1,Pipazethate,DTVJXCOMJLLMAK-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
161941,7bv1,DB01000,-7.1,Cyclacillin,HGBLNBBNRORJKI-WCABBAIRSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
33408,6cs2,T3D0400,-7.1,"3,3'-Dichlorobiphenyl",KTXUOWUHFLBZPW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
120499,6w4b,DB08561,-7.1,"BENZYL 6-BENZYL-5,7-DIOXO-6,7-DIHYDRO-5H-[1,3]THIAZOLO[3,2-C]PYRIMIDINE-2-CARBOXYLATE",PLBINCOCFGQAJM-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
72290,6m2n,DB00573,-7.1,Fenoprofen,RDJGLLICXDHJDY-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
161780,7bv1,DB00589,-7.1,Lisuride,BKRGVLQUQGGVSM-KBXCAEBGSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
120482,6w4b,DB08542,-7.1,"3,4-dihydroxy-9,10-secoandrosta-1(10),2,4-triene-9,17-dione",YUHVBHDSVLKFNI-NJSLBKSFSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
33501,6cs2,T3D4756,-7.1,Triamcinolone,GFNANZIMVAIWHM-OBYCQNJPSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
120475,6w4b,DB08534,-7.1,"5-(2-fluorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",ZAIYYXVHGBMLEC-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
33489,6cs2,T3D4745,-7.1,Norethindrone,VIKNJXKGJWUCNN-XGXHKTLJSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
22046,6cs2,HMDB0052768,-7.1,"TG(18:2(9Z,12Z)/18:4(6Z,9Z,12Z,15Z)/22:5(7Z,10Z,13Z,16Z,19Z))",RCAVHXJASXMRHH-FBFQTTOFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
120431,6w4b,DB08485,-7.1,"(1S,4S,5S)-1,4,5-TRIHYDROXY-3-[3-(PHENYLTHIO)PHENYL]CYCLOHEX-2-ENE-1-CARBOXYLIC ACID",QMNMNSINKIFYBV-LMMKCTJWSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
33406,6cs2,T3D4617,-7.1,Podofilox,YJGVMLPVUAXIQN-XVVDYKMHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
161858,7bv1,DB00686,-7.1,Pentosan Polysulfate,FCCNSUIJIOOXEZ-SJYYZXOBSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
83264,6m3m,DB03662,-7.1,Vitamin B6 Complexed with 2-Amino-Pentanoic Acid,YYAMSLLSQINIQO-NSHDSACASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
28761,6cs2,DB08372,-7.1,1-[2-(4-ETHOXY-3-FLUOROPYRIDIN-2-YL)ETHYL]-3-(5-METHYLPYRIDIN-2-YL)THIOUREA,QOVMZMFNTIUFLU-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
120403,6w4b,DB08449,-7.1,"2-(3-((4,5,7-trifluorobenzo[d]thiazol-2-yl)methyl)-1H-pyrrolo[2,3-b]pyridin-1-yl)acetic acid",IEVFQDJUDLCOQY-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
161876,7bv1,DB00922,-7.1,Levosimendan,WHXMKTBCFHIYNQ-SECBINFHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
33437,6cs2,T3D4672,-7.1,"4,4'-Methylenedianiline",YBRVSVVVWCFQMG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
72367,6m2n,DB00665,-7.1,Nilutamide,XWXYUMMDTVBTOU-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
161906,7bv1,DB00957,-7.1,Norgestimate,KIQQMECNKUGGKA-NMYWJIRASA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
161907,7bv1,DB00959,-7.1,Methylprednisolone,VHRSUDSXCMQTMA-PJHHCJLFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
18133,6cs2,HMDB0013189,-7.1,3-Indole carboxylic acid glucuronide,BDNWJTRKUBXAGH-DOVARBIBSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
83265,6m3m,DB03663,-7.1,"1-[(2-Amino-6,9-Dihydro-1h-Purin-6-Yl)Oxy]-3-Methyl-2-Butanol",BEXUQVHWMLPYKY-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
33341,6cs2,T3D0394,-7.1,"2,3-Dichlorobiphenyl",XOMKZKJEJBZBJJ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
33714,6cs2,T3D4961,-7.1,Deoxycholic acid,KXGVEGMKQFWNSR-TXNNXGFQSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
120889,6w4b,DB09078,-7.1,Lenvatinib,WOSKHXYHFSIKNG-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
121334,6w4b,DB11741,-7.1,Famitinib,GKEYKDOLBLYGRB-LGMDPLHJSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
161052,7bv1,DB12804,-7.1,Daniquidone,SRIOCKJKFXAKHK-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
55158,6crv,DB00680,-7.1,Moricizine,FUBVWMNBEHXPSU-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
17776,6cs2,HMDB0010375,-7.1,"CE(22:5(7Z,10Z,13Z,16Z,19Z))",XOLZNHXNFMEUGA-MCPSVCLNSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
121321,6w4b,DB11721,-7.1,Mitoglitazone,IRNJSRAGRIZIHD-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
121316,6w4b,DB11711,-7.1,Navarixin,IXBYSXNOKFHHDR-QGZVFWFLSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
55147,6crv,DB00669,-7.1,Sumatriptan,KQKPFRSPSRPDEB-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
121309,6w4b,DB11701,-7.1,Amenamevir,MNHNIVNAFBSLLX-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
10602,6lzg,DB00821,-7.1,Carprofen,PUXBGTOOZJQSKH-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
10599,6lzg,DB08807,-7.1,Bopindolol,UUOJIACWOAYWEZ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
84213,6m3m,DB04944,-7.1,Acadesine,RTRQQBHATOEIAF-UUOKFMHZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
71950,6m2n,DB00162,-7.1,Vitamin A,FPIPGXGPPPQFEQ-OVSJKPMPSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
161109,7bv1,DB12896,-7.1,PSI-352938,PVRFQJIRERYGTQ-DSQUMVBZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
161117,7bv1,DB12906,-7.1,LY-2334737,MEOYFIHNRBNEPI-UXIGCNINSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
7642,6lzg,DB00480,-7.1,Lenalidomide,GOTYRUGSSMKFNF-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
108588,6vxx,DB08432,-7.1,THYMIDINE-5'-THIOPHOSPHATE,OJRKJKYGUAALCJ-XLPZGREQSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28338,6cs2,DB07926,-7.1,N-[3-(N'-HYDROXYCARBOXAMIDO)-2-(2-METHYLPROPYL)-PROPANOYL]-O-TYROSINE-N-METHYLAMIDE,QYZPDCGWIJYZMN-ZBFHGGJFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
84142,6m3m,DB04826,-7.1,Thenalidine,KLOHYVOVXOUKQI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
161161,7bv1,DB13337,-7.1,Pheneticillin,NONJJLVGHLVQQM-JHXYUMNGSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
161050,7bv1,DB12802,-7.1,Picropodophyllin,YJGVMLPVUAXIQN-HAEOHBJNSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
161044,7bv1,DB12791,-7.1,Laninamivir,QNRRHYPPQFELSF-CNYIRLTGSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
161026,7bv1,DB12416,-7.1,VTP-27999,NXWASIVXQMMPLM-ZXMXYHOLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
161010,7bv1,DB12395,-7.1,Esreboxetine,CBQGYUDMJHNJBX-OALUTQOASA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
55213,6crv,DB00744,-7.1,Zileuton,MWLSOWXNZPKENC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
160950,7bv1,DB12308,-7.1,Eltanolone,AURFZBICLPNKBZ-YZRLXODZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
71879,6lxt,DB01532,-7.1,alpha-Methylacetylfentanyl,OKTLVZBUKMRPLL-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
33948,6cs2,T3D0061,-7.1,Methoxychlor,IAKOZHOLGAGEJT-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
10637,6lzg,DB08860,-7.1,Pitavastatin,VGYFMXBACGZSIL-MCBHFWOFSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
121419,6w4b,DB11865,-7.1,Brivanib alaninate,LTEJRLHKIYCEOX-OCCSQVGLSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
10625,6lzg,DB00823,-7.1,Ethynodiol diacetate,ONKUMRGIYFNPJW-KIEAKMPYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
160961,7bv1,DB12321,-7.1,Ifetroban,BBPRUNPUJIUXSE-DXKRWKNPSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
17746,6cs2,HMDB0000493,-7.1,"5a-Androstane-3b,17b-diol",CBMYJHIOYJEBSB-YSZCXEEOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
10567,6lzg,DB08775,-7.1,N??-[(Benzyloxy)carbonyl]-N-[(2S)-4-fluoro-3-oxo-2-butanyl]-L-tyrosinamide,RYABQRLJLIHDIP-KSSFIOAISA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
71898,6lxt,DB09171,-7.1,β-Methylfentanyl,UXIGUKSHASXDNI-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
121395,6w4b,DB11827,-7.1,Ertugliflozin,MCIACXAZCBVDEE-CUUWFGFTSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
121382,6w4b,DB11811,-7.1,Arhalofenate,BJBCSGQLZQGGIQ-QGZVFWFLSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
121376,6w4b,DB11800,-7.1,Tivozanib,SPMVMDHWKHCIDT-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
49226,2fxp,DB04190,-7.1,Inhibitor Bea425,AHAVBKNGKPWROK-UMFPTGFGSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
121372,6w4b,DB11795,-7.1,GSK-2636771,XTKLTGBKIDQGQL-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
121365,6w4b,DB11787,-7.1,Ralimetinib,XPPBBJCBDOEXDN-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
121360,6w4b,DB11781,-7.1,Tosedostat,FWFGIHPGRQZWIW-SQNIBIBYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
160982,7bv1,DB12357,-7.1,BMS-863233,JJWLXRKVUJDJKG-VIFPVBQESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
55166,6crv,DB00690,-7.1,Flurazepam,SAADBVWGJQAEFS-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28298,6cs2,DB07878,-7.1,"N-[(1S)-1-{1-[(1R,3E)-1-ACETYLPENT-3-EN-1-YL]-1H-1,2,3-TRIAZOL-4-YL}-1,2-DIMETHYLPROPYL]BENZAMIDE",OEHUTYXPQSSKAK-RVLLMHTFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
121227,6w4b,DB11522,-7.1,Isoflupredone,WAIJIHDWAKJCBX-BULBTXNYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
49300,2fxp,DB04289,-7.1,Genz-10850,YYMZSGIXLQPFAC-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
121226,6w4b,DB11521,-7.1,Imidocarb,SCEVFJUWLLRELN-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
121025,6w4b,DB09290,-7.1,Ramosetron,NTHPAPBPFQJABD-LLVKDONJSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
7659,6lzg,DB04172,-7.1,"[2,4,6-Triisopropyl-Phenylsulfonyl-L-[3-Amidino-Phenylalanine]]-Piperazine-N'-Beta-Alanine",WATXEHGLYJKXOF-NDEPHWFRSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
83932,6m3m,DB04546,-7.1,3-Deaza-Adenosine,DBZQFUNLCALWDY-PNHWDRBUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
120990,6w4b,DB09235,-7.1,Efonidipine,NSVFSAJIGAJDMR-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
161285,7bv1,DB13502,-7.1,Budipine,QIHLUZAFSSMXHQ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
120972,6w4b,DB09214,-7.1,Dexketoprofen,DKYWVDODHFEZIM-NSHDSACASA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
55024,6crv,DB00518,-7.1,Albendazole,HXHWSAZORRCQMX-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
83879,6m3m,DB04478,-7.1,"Cp-166572, 2-Hydroxymethyl-4-(4-N,N-Dimethylaminosulfonyl-1-Piperazino)-Pyrimidine",XDTHNROWHAAVPJ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
108660,6vxx,DB08515,-7.1,"(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE",YVABESCRHMBHJD-FUQNVFFISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
161265,7bv1,DB13475,-7.1,Furazidin,DECBQELQORZLLP-UAIOPKHMSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
161311,7bv1,DB13540,-7.1,Isepamicin,UDIIBEDMEYAVNG-ZKFPOVNWSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
161314,7bv1,DB13808,-7.1,Mebhydrolin,FQQIIPAOSKSOJM-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
161319,7bv1,DB13816,-7.1,Aspoxicillin,BHELIUBJHYAEDK-OAIUPTLZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
108669,6vxx,DB08526,-7.1,CARBOBENZYLOXY-(L)-LEUCINYL-(L)LEUCINYL METHOXYMETHYLKETONE,LHCNZPLAATYYPI-SLFFLAALSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
161323,7bv1,DB13821,-7.1,Ceftezole,DZMVCVMFETWNIU-LDYMZIIASA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
72096,6m2n,DB00333,-7.1,Methadone,USSIQXCVUWKGNF-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
161339,7bv1,DB13842,-7.1,Etofylline nicotinate,ZWIAODBBEZGVPY-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
49384,2fxp,DB04408,-7.1,Ncs-Chromophore,QZGIWPZCWHMVQL-UIYAJPBUSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
83813,6m3m,DB04386,-7.1,"4,6-O-(1-Carboxyethylidene)-Beta-D-Glucose",QVVFNJUJKXWFAU-CECBSOHTSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
108675,6vxx,DB08533,-7.1,"3-methyl-N-(pyridin-4-ylmethyl)imidazo[1,2-a]pyrazin-8-amine",LXRVAGIYXNQOKP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
161312,7bv1,DB13541,-7.1,Iprazochrome,XZKVIDLLLOUTSS-ZSOIEALJSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
54979,6crv,DB00458,-7.1,Imipramine,BCGWQEUPMDMJNV-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
33790,6cs2,T3D0467,-7.1,"3,3',4,5-Tetrachlorobiphenyl",SXFLURRQRFKBNN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
161256,7bv1,DB13461,-7.1,Cefcapene,HJJRIJDTIPFROI-NVKITGPLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
121216,6w4b,DB11491,-7.1,Sarafloxacin,XBHBWNFJWIASRO-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
33845,6cs2,T3D0519,-7.1,"2,2',3,3',4,5'-Hexachlorobiphenyl",YFSLABAYQDPWPF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
28360,6cs2,DB07947,-7.1,ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY)ETHYLAMINO)ETHYL)AMIDE,AUHWQSZMVMMRLM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
33835,6cs2,T3D0509,-7.1,"2,3',4,5,5'-Pentachlorobiphenyl",ZLGYJAIAVPVCNF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
121179,6w4b,DB11426,-7.1,Marbofloxacin,BPFYOAJNDMUVBL-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
33825,6cs2,T3D0500,-7.1,"2,3,3',5,5'-Pentachlorobiphenyl",QMUDLTGWHILKHH-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
55076,6crv,DB00581,-7.1,Lactulose,JCQLYHFGKNRPGE-FCVZTGTOSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108624,6vxx,DB08473,-7.1,"5,6-dichloro-1-beta-D-ribofuranosyl-1H-benzimidazole",XHSQDZXAVJRBMX-DDHJBXDOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72012,6m2n,DB00234,-7.1,Reboxetine,CBQGYUDMJHNJBX-RTBURBONSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
121027,6w4b,DB09292,-7.1,Sacubitril,PYNXFZCZUAOOQC-UTKZUKDTSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
161223,7bv1,DB13418,-7.1,Moxestrol,MTMZZIPTQITGCY-OLGWUGKESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
121094,6w4b,DB11155,-7.1,Triclocarban,ICUTUKXCWQ1Q-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
83988,6m3m,DB04617,-7.1,"(9S)-9-[(8-AMMONIOOCTYL)AMINO]-1,2,3,4,9,10-HEXAHYDROACRIDINIUM",LFBAUYQQFKFFCF-UHFFFAOYSA-P,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
55056,6crv,DB00555,-7.1,Lamotrigine,PYZRQGJRPPTADH-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
121065,6w4b,DB09488,-7.1,Acrivastine,PWACSDKDOHSSQD-IUTFFREVSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
72043,6m2n,DB00269,-7.1,Chlorotrianisene,BFPSDSIWYFKGBC-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
10555,6lzg,DB08762,-7.1,O-(((1R)-((N-PHENYLMETHOXYCARBONYL-L-ALANYL)AMINO)ETHYL)HYDROXYPHOSPHONO)-L-BENZYLACETIC ACID,UPJNMOBJDSFRTI-FCEWJHQRSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
121054,6w4b,DB09371,-7.1,Norethynodrel,ICTXHFFSOAJUMG-SLHNCBLASA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
108643,6vxx,DB08496,-7.1,(R)-warfarin,PJVWKTKQMONHTI-HNNXBMFYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
10551,6lzg,DB08758,-7.1,"IMIDAZO[2,1-A]ISOQUINOLINE-2-CARBOHYDRAZIDE",WSNWYZBDIKCPIG-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
161237,7bv1,DB13435,-7.1,Endralazine,ALAXZYHFVBSJKZ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
108477,6vxx,DB08033,-7.1,"(5R)-N,N-DIETHYL-5-METHYL-2-[(THIOPHEN-2-YLCARBONYL)AMINO]-4,5,6,7-TETRAHYDRO-1-BENZOTHIOPHENE-3-CARBOXAMIDE",UQKSYQYWUHUIEH-GFCCVEGCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
10354,6lzg,DB08540,-7.1,"2-[4-(2H-1,4-BENZOTHIAZINE-3-YL)-PIPERAZINE-1-LY]-1,3-THIAZOLE-4-CARBOXYLIC ACID ETHYLESTER",AQJQFCRTSWIUCY-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
72459,6m2n,DB00774,-7.1,Hydroflumethiazide,DMDGGSIALPNSEE-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
82064,6m3m,DB02056,-7.1,Prostaglandin D2,BHMBVRSPMRCCGG-OUTUXVNYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
162867,7bv1,DB03227,-7.1,Nicotinamide Mononucleotide,DAYLJWODMCOQEW-WYOJIJJFSA-O,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
32938,6cs2,T3D3866,-7.1,Iprodione,ONUFESLQCSAYKA-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
82018,6m3m,DB01994,-7.1,"2-(Pyrido[1,2-E]Purin-4-Yl)Amino-Ethanol",QBILBVYKWQWDQJ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
119675,6w4b,DB07589,-7.1,"N-[1-(AMINOMETHYL)CYCLOPROPYL]-3-(BENZYLSULFONYL)-N-2-[(1S)-2,2,2-TRIFLUORO-1-(4-HYDROXYPHENYL)ETHYL]-L-ALANINAMIDE",DWWVPKCSDHDILN-OALUTQOASA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
32918,6cs2,T3D3843,-7.1,Flufenacet,IANUJLZYFUDJIH-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
32911,6cs2,T3D3836,-7.1,Fenamidone,LMVPQMGRYSRMIW-KRWDZBQOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
109696,6vxx,DB15152,-7.1,TMC-649128,XJBILYMRFVHPJB-XJQUKVTJSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72888,6m2n,DB01280,-7.1,Nelarabine,IXOXBSCIXZEQEQ-UHTZMRCNSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
109701,6vxx,DB15167,-7.1,Fallypride,OABRYNHZQBZDMG-INIZCTEOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72890,6m2n,DB01288,-7.1,Fenoterol,LSLYOANBFKQKPT-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
162909,7bv1,DB03277,-7.1,alpha-maltotriose,FYGDTMLNYKFZSV-PXXRMHSHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
109719,6vxx,DB15203,-7.1,JNJ-26489112,KXSAIQPPGSSNKX-ZETCQYMHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
81895,6m3m,DB01823,-7.1,Beta-D-Glucopyranose Spirohydantoin,QRXBDPYWCAAAAI-UXDJRKLDSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
162966,7bv1,DB03354,-7.1,"2-(Beta-D-Glucopyranosyl)-5-Methyl-1,3,4-Oxadiazole",HCSFWJQLIPWUFZ-JAJWTYFOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
32886,6cs2,T3D3810,-7.1,Cinmethylin,QMTNOLKHSWIQBE-FGTMMUONSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
10021,6lzg,DB08159,-7.1,"4-(5,11-DIOXO-5H-INDENO[1,2-C]ISOQUINOLIN-6(11H)-YL)BUTANOATE",AHIJTWCJGCWHMT-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
32882,6cs2,T3D3805,-7.1,Carfentrazone-ethyl,MLKCGVHIFJBRCD-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
72922,6m2n,DB01354,-7.1,Heptabarbital,PAZQYDJGLKSCSI-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
119721,6w4b,DB07644,-7.1,"5-[(1S)-1-(3-chlorophenyl)ethoxy]quinazoline-2,4-diamine",IDHINEMSCUFEIP-VIFPVBQESA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
162861,7bv1,DB03220,-7.1,FR233623,OODDZQQDDOVCFD-SCLBCKFNSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
32946,6cs2,T3D3875,-7.1,Mesosulfuron-methyl,NIFKBBMCXCMCAO-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
28843,6cs2,DB08464,-7.1,"METHYL 3-CHLORO-2-{3-[(2,5-DIHYDROXY-4-METHOXYPHENYL)AMINO]-3-OXOPROPYL}-4,6-DIHYDROXYBENZOATE",GUVWEHNRWHNDRF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
54366,2fxp,DB14856,-7.1,PF-05089771,ZYSCOUXLBXGGIM-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
109502,6vxx,DB14002,-7.1,D-alpha-Tocopherol acetate,ZAKOWWREFLAJOT-CEFNRUSXSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
82231,6m3m,DB02275,-7.1,"[2-Aminomethyl-5-Oxo-4-(4-Oxo-Cyclohexa-2,5-Dienylmethyl)-4,5-Dihydro-Imidazol-1-Yl] -Acetaldehyde",MONOYMGQJZJGBR-NSHDSACASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
162772,7bv1,DB02901,-7.1,Stanolone,NVKAWKQGWWIWPM-ABEVXSGRSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
119781,6w4b,DB07717,-7.1,"(5S,8R,9S,10S,13R,14S,17S)-13-{2-[(3,5-DIFLUOROBENZYL)OXY]ETHYL}-17-HYDROXY-10-METHYLHEXADECAHYDRO-3H-CYCLOPENTA[A]PHENANTHREN-3-ONE",AJODXHGZHBERGJ-JLYQOUBASA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
28835,6cs2,DB08457,-7.1,"4-(3,5-DIMETHYLPHENOXY)-5-(FURAN-2-YLMETHYLSULFANYLMETHYL)-3-IODO-6-METHYLPYRIDIN-2(1H)-ONE",YZLKVEDFWLGNQP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
109526,6vxx,DB14055,-7.1,(S)-Warfarin,PJVWKTKQMONHTI-HNNXBMFYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109528,6vxx,DB14060,-7.1,NS-398,KTDZCOWXCWUPEO-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
119759,6w4b,DB07692,-7.1,"1-[(2,6-difluorophenyl)sulfonyl]-4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)piperazine",SHWNKRPMUBFWKE-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
81767,6m3m,DB01651,-7.1,"Methyl 4,6-O-[(1R)-1-carboxyethylidene]-beta-D-galactopyranoside",ZDZVLEQWFATHTF-IJWOWSJNSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
119756,6w4b,DB07688,-7.1,"4-{[5-(CYCLOHEXYLOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE",RPJIMTALCNCQLV-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
162786,7bv1,DB02919,-7.1,"2,4-Diamino-6-[N-(3',4',5'-Trimethoxybenzyl)-N-Methylamino]Pyrido[2,3-D]Pyrimidine",PUOZHLHNKHRTOW-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
119745,6w4b,DB07675,-7.1,(2S)-2-ETHOXY-3-{4-[2-(10H-PHENOXAZIN-10-YL)ETHOXY]PHENYL}PROPANOIC ACID,WMUIIGVAWPWQAW-DEOSSOPVSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
162791,7bv1,DB02925,-7.1,Piretanide,UJEWTUDSLQGTOA-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
32973,6cs2,T3D3904,-7.1,Prohexadione-calcium,SAZAPFZGSHYFGB-UHFFFAOYSA-L,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
857,6lzg,HMDB0007194,-7.1,DG(18:1(11Z)/20:0/0:0),LQRQYCOYEWTFKW-QZEPCWIRSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
72823,6m2n,DB01190,-7.1,Clindamycin,KDLRVYVGXIQJDK-NOWPCOIGSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
18431,6cs2,HMDB0029304,-7.1,"3,4-DHPEA-EA",BIWKXNFEOZXNLX-SQOYHTLWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
119734,6w4b,DB07662,-7.1,N-[4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL]-ACRYLAMIDE,HTUBKQUPEREOGA-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
10112,6lzg,DB08267,-7.1,"6-amino-4-(2-phenylethyl)-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",PBZAIUVFRISTSZ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
119752,6w4b,DB07683,-7.1,"N-(dibenzo[b,d]thiophen-3-ylsulfonyl)-L-valine",RZWYSEXQXOXWKA-INIZCTEOSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
72939,6m2n,DB01399,-7.1,Salsalate,WVYADZUPLLSGPU-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
32863,6cs2,T3D3781,-7.1,Verrucosidin,JSVLNARHSWZARV-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
163062,7bv1,DB03719,-7.1,N-Ethyl-5'-Carboxamido Adenosine,JADDQZYHOWSFJD-BMYQGPEFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
109890,6vxx,DB00555,-7.1,Lamotrigine,PYZRQGJRPPTADH-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109902,6vxx,DB00573,-7.1,Fenoprofen,RDJGLLICXDHJDY-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28918,6cs2,DB08542,-7.1,"3,4-dihydroxy-9,10-secoandrosta-1(10),2,4-triene-9,17-dione",YUHVBHDSVLKFNI-NJSLBKSFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
50013,2fxp,DB06212,-7.1,Tolvaptan,GYHCTFXIZSNGJT-XMMPIXPASA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
163249,7bv1,DB04163,-7.1,"5-Phenylsulfanyl-2,4-Quinazolinediamine",BUFDQCGCADQQQY-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
81513,6m3m,DB01325,-7.1,Quinethazone,AGMMTXLNIQSRCG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
163277,7bv1,DB04198,-7.1,Formycin B,MTCJZZBQNCXKAP-KSYZLYKTSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
163290,7bv1,DB04213,-7.1,N-Cyclohexyl-N'-(Propyl)Phenyl Urea,HBTZVNKXMFGOOJ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
119473,6w4b,DB07348,-7.1,Brefeldin A,KQNZDYYTLMIZCT-KQPMLPITSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
109888,6vxx,DB00553,-7.1,Methoxsalen,QXKHYNVANLEOEG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163309,7bv1,DB04239,-7.1,2-Amino-6-Aminomethyl-8-Phenylsulfanylmethyl-3h-Quinazolin-4-One,CBFXRTSHUMEYKQ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
119446,6w4b,DB07318,-7.1,"N-[2-(4-AMINO-5,8-DIFLUORO-1,2-DIHYDROQUINAZOLIN-2-YL)ETHYL]-3-FURAMIDE",BOAUWUUBSXECNL-LLVKDONJSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
163323,7bv1,DB04260,-7.1,"9-(5,5-Difluoro-5-Phosphonopentyl)Guanine",JANQQPWTLXUSCD-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
81432,6m3m,DB01188,-7.1,Ciclopirox,SCKYRAXSEDYPSA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
109987,6vxx,DB00675,-7.1,Tamoxifen,NKANXQFJJICGDU-QPLCGJKRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
119426,6w4b,DB07297,-7.1,"5,6-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-D]PYRIMIDIN-4-AMINE",PTILEOLOGGMFCS-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
32683,6cs2,T3D2090,-7.1,"1,4,6,9-Tetrachlorodibenzo-p-dioxin",QTIIAIRUSSSOHT-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
119417,6w4b,DB07288,-7.1,N-(4-chlorophenyl)-2-[(pyridin-4-ylmethyl)amino]benzamide,GGPZCOONYBPZEW-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
163403,7bv1,DB04371,-7.1,AL6528,FBBLOSCXOZYUSS-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
163406,7bv1,DB04376,-7.1,13-Acetylphorbol,SDSVJYOOAPRSDA-RPCQODIISA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
119449,6w4b,DB07322,-7.1,"2-[(PHENYLSULFONYL)AMINO]-5,6,7,8-TETRAHYDRONAPHTHALENE-1-CARBOXYLIC ACID",RRXVUYHFDBLTEL-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
54368,2fxp,DB14859,-7.1,Fosifloxuridine nafalbenamide,BIOWRMNRHMERIO-ZVAHOJSLSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
49995,2fxp,DB06178,-7.1,Talotrexin,NYQPLPNEESYGNO-IBGZPJMESA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
163193,7bv1,DB03881,-7.1,"(2S,3R,4S,5S)-3,4-Dihydroxy-2-[(methylsulfanyl)methyl]-5-(4-oxo-4,5-dihydro-1H-pyrrolo[3,2-d]pyrimidin-7-yl)pyrrolidinium",CEGIKIXYDFDYDN-RXDXJJGDSA-O,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
119611,6w4b,DB07513,-7.1,7-[(3-CHLOROBENZYL)OXY]-4-[(METHYLAMINO)METHYL]-2H-CHROMEN-2-ONE,JMGUSOLCNQVZCT-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
119595,6w4b,DB07493,-7.1,"(2Z)-5'-BROMO-2,3'-BIINDOLE-2',3(1H,1'H)-DIONE AMMONIATE",IEQQJQHHJMQETK-YPKPFQOOSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
32843,6cs2,T3D3757,-7.1,Enniatin A1,VGOLHAPJYMAXRH-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
163069,7bv1,DB03726,-7.1,Purine Riboside-5'-Monophosphate,MCWDCZIDTUQRHK-FDDDBJFASA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
32835,6cs2,T3D3749,-7.1,Asteltoxin,GPXPJKFETRLRAS-BGSVYHRFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
163095,7bv1,DB03758,-7.1,Radicicol,WYZWZEOGROVVHK-GTMNPGAYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
32815,6cs2,T3D3728,-7.1,Alternariol methyl ether,LCSDQFNUYFTXMT-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
109817,6vxx,DB00289,-7.1,Atomoxetine,VHGCDTVCOLNTBX-QGZVFWFLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109819,6vxx,DB00292,-7.1,Etomidate,NPUKDXXFDDZOKR-LLVKDONJSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109875,6vxx,DB00539,-7.1,Toremifene,XFCLJVABOIYOMF-QPLCGJKRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
9983,6lzg,DB08123,-7.1,"N-METHYL-{4-[2-(7-OXO-6,7-DIHYDRO-8H-[1,3]THIAZOLO[5,4-E]INDOL-8-YLIDENE)HYDRAZINO]PHENYL}METHANESULFONAMIDE",GEWPSTLKJDIUHW-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
9981,6lzg,DB08121,-7.1,(2S)-2-(biphenyl-4-yloxy)-3-phenylpropanoic acid,TZTPJJNNACUQQR-FQEVSTJZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
109829,6vxx,DB00305,-7.1,Mitomycin,NWIBSHFKIJFRCO-WUDYKRTCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163118,7bv1,DB03785,-7.1,"(3r,5r)-7-((1r,2r,6s,8r,8as)-2,6-Dimethyl-8-{[(2r)-2-Methylbutanoyl]Oxy}-1,2,6,7,8,8a-Hexahydronaphthalen-1-Yl)-3,5-Dihydroxyheptanoic Acid",QLJODMDSTUBWDW-BXMDZJJMSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
109837,6vxx,DB00315,-7.1,Zolmitriptan,ULSDMUVEXKOYBU-ZDUSSCGKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163137,7bv1,DB03809,-7.1,9-Butyl-8-(3-Methoxybenzyl)-9h-Purin-6-Amine,BWLWUGBHOXIUBP-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
9968,6lzg,DB08108,-7.1,N-({6-[(4-CYANOBENZYL)OXY]NAPHTHALEN-2-YL}SULFONYL)-D-GLUTAMIC ACID,PUHRQSFXADUGJW-OAQYLSRUSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
81605,6m3m,DB01464,-7.1,Furethidine,NNCOZXNZFLUYGG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
109860,6vxx,DB00344,-7.1,Protriptyline,BWPIARFWQZKAIA-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163192,7bv1,DB03880,-7.1,Batimastat,XFILPEOLDIKJHX-QYZOEREBSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
81680,6m3m,DB01549,-7.1,Rolicyclidine,FYOWWXMGDATDQY-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
83029,6m3m,DB03321,-7.1,"4-Amino-2-Deoxy-2,3-Dehydro-N-Neuraminic Acid",NKENBBIXEGPQLS-UFGQHTETSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
72782,6m2n,DB01145,-7.1,Sulfoxone,NEDPPCHNEOMTJV-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
162740,7bv1,DB02859,-7.1,Soraphen A,WPMGNXPRKGXGBO-OFQQMTDKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
10277,6lzg,DB08458,-7.1,(4-BROMOPHENYL)[4-({(2E)-4-[CYCLOPROPYL(METHYL)AMINO]BUT-2-ENYL}OXY)PHENYL]METHANONE,JAZMZJDLZUDIDG-NSCUHMNNSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
162165,7bv1,DB01518,-7.1,Benzethidine,UVTBZAWTRVBTMK-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
120076,6w4b,DB08055,-7.1,"N-(2-chlorophenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine",NNBICZMPIJMWGC-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
162167,7bv1,DB01521,-7.1,Clostebol,KCZCIYZKSLLNNH-FBPKJDBXSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
10261,6lzg,DB08440,-7.1,"N-1,10-phenanthrolin-5-ylacetamide",AAJXINSCZMZERD-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
109217,6vxx,DB12906,-7.1,LY-2334737,MEOYFIHNRBNEPI-UXIGCNINSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
120072,6w4b,DB08051,-7.1,"(2R)-4-(2-BENZOYL-1,2-DIAZEPAN-1-YL)-4-OXO-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE",XXRHRPGYYNOBHO-QGZVFWFLSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
162205,7bv1,DB01559,-7.1,Clotiazepam,CHBRHODLKOZEPZ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
109244,6vxx,DB12946,-7.1,"8-cyclopentyl-1,3-dipropylxanthine",FFBDFADSZUINTG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
72582,6m2n,DB00914,-7.1,Phenformin,ICFJFFQQTFMIBG-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
10239,6lzg,DB08414,-7.1,"6-CHLORO-2-(1-FURO[2,3-C]PYRIDIN-5-YL-ETHYLSULFANYL)-PYRIMIDIN-4-YLAMINE",ATCRIOJPQXDFNY-ZETCQYMHSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
109266,6vxx,DB12980,-7.1,CHS-828,BOIPLTNGIAPDBY-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
162288,7bv1,DB01850,-7.1,"(2s,3s,8s,9s)-3-Amino-9-Methoxy-2,6,8-Trimethyl-10-Phenyldeca-4,6-Dienoic Acid",HJVCHYDYCYBBQX-AWKNMOFVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
162294,7bv1,DB01858,-7.1,[1-(4-Fluorobenzyl)Cyclobutyl]Methyl (1s)-1-[Oxo(1h-Pyrazol-5-Ylamino)Acetyl]Pentylcarbamate,QTPYRNAKLBXKNP-SFHVURJKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
162300,7bv1,DB01865,-7.1,3-(6-Aminopyridin-3-Yl)-N-Methyl-N-[(1-Methyl-1h-Indol-2-Yl)Methyl]Acrylamide,AKFPMLBVLWZSQX-CSKARUKUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
162310,7bv1,DB01878,-7.1,Benzophenone,RWCCWEUUXYIKHB-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
54521,2fxp,DB15197,-7.1,RSV-604,MTPVBMVUENFFLL-HXUWFJFHSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
120026,6w4b,DB07999,-7.1,"{4-[(CARBOXYMETHOXY)CARBONYL]-3,3-DIOXIDO-1-OXONAPHTHO[1,2-D]ISOTHIAZOL-2(1H)-YL}ACETIC ACID",IXLBOIRSEDMRPI-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
72607,6m2n,DB00942,-7.1,Cycrimine,SWRUZBWLEWHWRI-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
82805,6m3m,DB03030,-7.1,4-(2-Thienyl)-1-(4-Methylbenzyl)-1h-Imidazole,UMOFOLLUKPBVQG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
54580,2fxp,DB15305,-7.1,Risdiplam,ASKZRYGFUPSJPN-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
10289,6lzg,DB08471,-7.1,"1-(thiophen-2-ylacetyl)-4-(3-thiophen-2-yl-1,2,4-oxadiazol-5-yl)piperidine",SJEVDMFUHCVNPM-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
120095,6w4b,DB08077,-7.1,"2-[4-({[(3,5-DICHLOROPHENYL)AMINO]CARBONYL}AMINO)PHENOXY]-2-METHYLPROPANOIC ACID",OYJPTSMWFKGZJM-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
120215,6w4b,DB08213,-7.1,"1-METHYL-5-(2-PHENOXYMETHYL-PYRROLIDINE-1-SULFONYL)-1H-INDOLE-2,3-DIONE",PFAYCUAUBOGVDX-AWEZNQCLSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
33308,6cs2,T3D0391,-7.1,3-Chlorobiphenyl,NMWSKOLWZZWHPL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
18194,6cs2,HMDB0013629,-7.1,PGD2 ethanolamide,KEYDJKSQFDUAGF-YIRKRNQHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
120188,6w4b,DB08177,-7.1,(E)-3-(5((5-(4-CHLOROPHENYL)FURAN-2-YL)METHYLENE)-4-OXO-2-THIOXOTHIAZOLIDIN-3-YL)PROPANOIC ACID,YZLFZFALAZYTCI-NTEUORMPSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
109115,6vxx,DB12395,-7.1,Esreboxetine,CBQGYUDMJHNJBX-OALUTQOASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
10320,6lzg,DB08503,-7.1,"(3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(4-methylphenyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol",HRCKGDOSPBFICB-MZHQWRCYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
72498,6m2n,DB00821,-7.1,Carprofen,PUXBGTOOZJQSKH-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
162089,7bv1,DB01428,-7.1,Oxybenzone,DXGLGDHPHMLXJC-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
54615,2fxp,DB15382,-7.1,SAR-125844,ODIUNTQOXRXOIV-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
10224,6lzg,DB08398,-7.1,"2-Amino-1-methyl-6-phenylimidazo(4,5-b)pyridine",UQVKZNNCIHJZLS-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
109133,6vxx,DB12418,-7.1,Saccharin,CVHZOJJKTDOEJC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
162096,7bv1,DB01436,-7.1,Alfacalcidol,OFHCOWSQAMBJIW-AVJTYSNKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
120146,6w4b,DB08133,-7.1,N-(4-sulfamoylphenyl)-1H-indazole-3-carboxamide,MNHPHKFLWAPNOV-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
162108,7bv1,DB01451,-7.1,1-Androstenedione,WJIQCDPCDVWDDE-WZNAKSSCSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
33273,6cs2,T3D4455,-7.1,S-Adenosylhomocysteine,ZJUKTBDSGOFHSH-WFMPWKQPSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
10302,6lzg,DB08486,-7.1,Efaproxiral,BNFRJXLZYUTIII-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
109157,6vxx,DB12450,-7.1,Propyl Gallate,ZTHYODDOHIVTJV-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28783,6cs2,DB08398,-7.1,"2-Amino-1-methyl-6-phenylimidazo(4,5-b)pyridine",UQVKZNNCIHJZLS-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
162136,7bv1,DB01481,-7.1,1-Testosterone,OKJCFMUGMSVJBG-ABEVXSGRSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
82841,6m3m,DB03078,-7.1,PASBN,PWDTUFYQEUEVQD-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
54611,2fxp,DB15367,-7.1,LY-2623091,YPCLDHGBEKZGEB-RUDKWAFVSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
162337,7bv1,DB01925,-7.1,"2'-Chloro-Biphenyl-2,3-Diol",SNGROCQMAKYWRE-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
28789,6cs2,DB08403,-7.1,METHYLAMINO-PHENYLALANYL-LEUCYL-HYDROXAMIC ACID,MOPRTFSMCQNUCT-CABCVRRESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
120015,6w4b,DB07987,-7.1,"[2-(5-MERCAPTO-[1,3,4]THIADIAZOL-2-YLCARBAMOYL)-1-PHENYL-ETHYL]-CARBAMIC ACID BENZYL ESTER",AWAKNMKLVLWIIQ-OAHLLOKOSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
119925,6w4b,DB07878,-7.1,"N-[(1S)-1-{1-[(1R,3E)-1-ACETYLPENT-3-EN-1-YL]-1H-1,2,3-TRIAZOL-4-YL}-1,2-DIMETHYLPROPYL]BENZAMIDE",OEHUTYXPQSSKAK-RVLLMHTFSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
119918,6w4b,DB07871,-7.1,6-CHLORO-4-(CYCLOHEXYLOXY)-3-ISOPROPYLQUINOLIN-2(1H)-ONE,OQCFORGSZJSAEL-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
119894,6w4b,DB07845,-7.1,"2-fluoro-6-{[2-({2-methoxy-4-[(methylsulfonyl)methyl]phenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide",VGYXXQRDIVRILX-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
54440,2fxp,DB15035,-7.1,Zanubrutinib,RNOAOAWBMHREKO-QFIPXVFZSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
119893,6w4b,DB07844,-7.1,6-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1-BENZOTHIOPHENE-2-SULFONAMIDE,PHLKBODTBJLXRD-WFASDCNBSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
33089,6cs2,T3D4069,-7.1,Phorbol,QGVLYPPODPLXMB-UBTYZVCOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
109400,6vxx,DB13523,-7.1,Veralipride,RYJXBGGBZJGVQF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
54428,2fxp,DB15011,-7.1,Avacopan,PUKBOVABABRILL-YZNIXAGQSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
54426,2fxp,DB15006,-7.1,Flufenoxuron,RYLHNOVXKPXDIP-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
119926,6w4b,DB07879,-7.1,"N-hydroxy-5-[(3-phenyl-5,6-dihydroimidazo[1,2-a]pyrazin-7(8H)-yl)carbonyl]thiophene-2-carboxamide",SMSIXMLQOONOQQ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
72726,6m2n,DB01081,-7.1,Diphenoxylate,HYPPXZBJBPSRLK-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
109411,6vxx,DB13538,-7.1,Guacetisal,HSJFYRYGGKLQBT-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
54417,2fxp,DB14946,-7.1,PCO-371,LDZJFVOUPUFOHX-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
119845,6w4b,DB07791,-7.1,4-{[4-(1-CYCLOPROPYL-2-METHYL-1H-IMIDAZOL-5-YL)PYRIMIDIN-2-YL]AMINO}-N-METHYLBENZENESULFONAMIDE,MZWCVBFANHIPTJ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
119844,6w4b,DB07790,-7.1,N-(2-METHOXYETHYL)-4-({4-[2-METHYL-1-(1-METHYLETHYL)-1H-IMIDAZOL-5-YL]PYRIMIDIN-2-YL}AMINO)BENZENESULFONAMIDE,LDXLQEXLXZCYSR-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
33063,6cs2,T3D4025,-7.1,Hypoglycin B,UYDZYCPIQSRXKU-CIUDSAMLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
82340,6m3m,DB02414,-7.1,"(3s,8ar)-3-(1h-Imidazol-5-Ylmethyl)Hexahydropyrrolo[1,2-a]Pyrazine-1,4-Dione",NAKUGCPAQTUSBE-IUCAKERBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
119821,6w4b,DB07763,-7.1,"(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE",OZZFJGCAYWBVBI-INIZCTEOSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
162673,7bv1,DB02772,-7.1,Sucrose,CZMRCDWAGMRECN-UGDNZRGBSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
162708,7bv1,DB02819,-7.1,"Mono-[3,4-Dihydroxy-5-(5-Methyl-Benzoimidazol-1-Yl)-Tetrahydor-Furan-2-Ylmethyl] Ester",HGUDFQQPANTQEU-LPWJVIDDSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
162607,7bv1,DB02484,-7.1,Cytidine 5'-Diphosphoglycerol,HHPOUCCVONEPRK-CNYIRLTGSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
10143,6lzg,DB08305,-7.1,"(3R)-3-cyclopentyl-6-methyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2-benzothiazine 1,1-dioxide",KQAGZLQCEURCKJ-QGZVFWFLSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
33104,6cs2,T3D4113,-7.1,Aristolochic acid,BBFQZRXNYIEMAW-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
109369,6vxx,DB13479,-7.1,Histapyrrodine,MXHODDGKGSGCDI-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109297,6vxx,DB13028,-7.1,Biapenem,MRMBZHPJVKCOMA-YJFSRANCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
109299,6vxx,DB13030,-7.1,2'-fluoro-5-ethylarabinosyluracil,UIYWFOZZIZEEKJ-PXBUCIJWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
162361,7bv1,DB01954,-7.1,Rolipram,HJORMJIFDVBMOB-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
162366,7bv1,DB01959,-7.1,"3,5-Dimethyl-1-(3-Nitrophenyl)-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester",MSYGAHOHLUJIKV-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
82620,6m3m,DB02783,-7.1,4'-Deoxy-4'-Acetylyamino-Pyridoxal-5'-Phosphate,QYKRUCBLHROXCK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
120001,6w4b,DB07971,-7.1,"5-AMINO-2-{4-[(4-AMINOPHENYL)SULFANYL]PHENYL}-1H-ISOINDOLE-1,3(2H)-DIONE",FQQVTDIBUYSVHM-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
119998,6w4b,DB07968,-7.1,N-(2-CHLORO-4-FLUOROBENZOYL)-N'-(5-HYDROXY-2-METHOXYPHENYL)UREA,RFOBTYLRURSVJE-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
54491,2fxp,DB15133,-7.1,Tepotinib,AHYMHWXQRWRBKT-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
82592,6m3m,DB02745,-7.1,Uridine,DRTQHJPVMGBUCF-XVFCMESISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
119927,6w4b,DB07882,-7.1,"4-{4-[2-(1A,7A-DIMETHYL-4-OXY-OCTAHYDRO-1-OXA-4-AZA-CYCLOPROPA[A]NAPHTHALEN-4-YL) -ACETYLAMINO]-PHENYLCARBAMOYL}-BUTYRIC ACID",VFIZFTGABDUGCF-UPVHCHBVSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
119996,6w4b,DB07966,-7.1,[4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]quinazolin-2-yl}amino)phenyl]acetonitrile,NVMCVWOODOWOLT-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
162470,7bv1,DB02312,-7.1,beta-D-galactose 6-phosphate,NBSCHQHZLSJFNQ-FPRJBGLDSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
119975,6w4b,DB07941,-7.1,PH-797804,KCAJXIDMCNPGHZ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
162525,7bv1,DB02382,-7.1,Namn,JOUIQRNQJGXQDC-ZYUZMQFOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
72688,6m2n,DB01036,-7.1,Tolterodine,OOGJQPCLVADCPB-HXUWFJFHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
82457,6m3m,DB02562,-7.1,"Quinonoid 7,8-Tetrahydrobiopterin",ZHQJVZLJDXWFFX-RPDRRWSUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
119970,6w4b,DB07935,-7.1,"5-[(5-fluoro-3-methyl-1H-indazol-4-yl)oxy]benzene-1,3-dicarbonitrile",JYAHFMKZJRVTDT-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
162542,7bv1,DB02402,-7.1,"5-(4-Methoxyphenoxy)-2,4-Quinazolinediamine",CPZJZAIZIMCJRC-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
82445,6m3m,DB02546,-7.1,Vorinostat,WAEXFXRVDQXREF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
54458,2fxp,DB15068,-7.1,Agerafenib,DKNUPRMJNUQNHR-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
109340,6vxx,DB13437,-7.1,Medazepam,YLCXGBZIZBEVPZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110005,6vxx,DB00695,-7.1,Furosemide,ZZUFCTLCJUWOSV-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
55221,6crv,DB00754,-7.1,Ethotoin,SZQIFWWUIBRPBZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
17706,6cs2,HMDB0000467,-7.1,Nutriacholic acid,DXOCDBGWDZAYRQ-QPVZPPSOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
34706,1r42,DB00687,-7.1,Fludrocortisone,AAXVEMMRQDVLJB-BULBTXNYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
107941,6vxx,DB05719,-7.1,Elesclomol,BKJIXTWSNXCKJH-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
34701,1r42,DB00680,-7.1,Moricizine,FUBVWMNBEHXPSU-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
10927,6lzg,DB09268,-7.1,Picosulfuric acid,UJIDKYTZIQTXPM-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
122965,6w4b,DB14542,-7.1,Hydrocortisone phosphate,BGSOJVFOEQLVMH-VWUMJDOOSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
71152,6lxt,DB13713,-7.1,Quifenadine,PZMAHNDJABQWGS-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
71156,6lxt,DB13718,-7.1,Hydroquinine,LJOQGZACKSYWCH-WZBLMQSHSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
71158,6lxt,DB13720,-7.1,Diphemanil,LCTZPQRFOZKZNK-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
159697,7bv1,DB05351,-7.1,Dexlansoprazole,MJIHNNLFOKEZEW-RUZDIDTESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
34686,1r42,DB00663,-7.1,Flumethasone,WXURHACBFYSXBI-GQKYHHCASA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
34679,1r42,DB00655,-7.1,Estrone,DNXHEGUUPJUMQT-CBZIJGRNSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
122896,6w4b,DB14097,-7.1,13-cis-12-(3'-Carboxyphenyl)retinoic acid,XKKDQOHDTASHCE-PAZAWXFKSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
122894,6w4b,DB14093,-7.1,"(1,2,6,7-3H)Testosterone",MUMGGOZAMZWBJJ-JQSYSRDDSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
85688,6m3m,DB07952,-7.1,N-[1H-INDOL-3-YL-ACETYL]GLYCINE ACID,YDXXLJMIHMIOIF-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
122880,6w4b,DB14068,-7.1,Dexniguldipine,SVJMLYUFVDMUHP-MGBGTMOVSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
16906,6cs2,HMDB0005056,-7.1,Enterodiol,DWONJCNDULPHLV-HOTGVXAUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
16911,6cs2,HMDB0005079,-7.1,"15-Deoxy-d-12,14-PGJ2",VHRUMKCAEVRUBK-GODQJPCRSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
122870,6w4b,DB14054,-7.1,Asiatic acid,JXSVIVRDWWRQRT-UYDOISQJSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
27889,6cs2,DB07449,-7.1,N-[(1S)-1-(AMINOCARBONYL)-4-(ETHANIMIDOYLAMINO)BUTYL]BENZAMIDE,LWFFSSMDFWZNNW-LBPRGKRZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
10932,6lzg,DB09279,-7.1,Fimasartan,AMEROGPZOLAFBN-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
71140,6lxt,DB13693,-7.1,Sulbenicillin,JETQIUPBHQNHNZ-NJBDSQKTSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
107927,6vxx,DB05644,-7.1,KP-1461,SZWIAFVYPPMZML-YNEHKIRRSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
71129,6lxt,DB13680,-7.1,Naftazone,TZGBBMBARSFJBG-UKTHLTGXSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
107886,6vxx,DB05442,-7.1,Etiprednol dicloacetate,QAIOVDNCIZSSSF-RFAJLIJZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
123047,6w4b,DB14716,-7.1,Clonazolam,XJRGLCAWBRZUFC-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
159594,7bv1,DB04616,-7.1,TACRINE(8)-4-AMINOQUINOLINE,UNVOAAWEEGAXTN-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
159595,7bv1,DB04617,-7.1,"(9S)-9-[(8-AMMONIOOCTYL)AMINO]-1,2,3,4,9,10-HEXAHYDROACRIDINIUM",LFBAUYQQFKFFCF-UHFFFAOYSA-P,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
10952,6lzg,DB09319,-7.1,Carindacillin,JIRBAUWICKGBFE-MNRDOXJOSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
34754,1r42,DB00741,-7.1,Hydrocortisone,JYGXADMDTFJGBT-VWUMJDOOSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
159601,7bv1,DB04626,-7.1,Apramycin,XZNUGFQTQHRASN-XQENGBIVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
123031,6w4b,DB14672,-7.1,Oxazepam acetate,FYRWUTOZBRWYCS-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
34749,1r42,DB00736,-7.1,Esomeprazole,SUBDBMMJDZJVOS-DEOSSOPVSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
71177,6lxt,DB13744,-7.1,Piromidic acid,RCIMBBZXSXFZBV-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
55957,6crv,DB01687,-7.1,beta-Mannobiose,GUBGYTABKSRVRQ-PZPXDAEZSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
123017,6w4b,DB14657,-7.1,Paramethasone acetate,HYRKAAMZBDSJFJ-LFDBJOOHSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
16819,6cs2,HMDB0004808,-7.1,7C-aglycone,BCNIZSHMXASUGF-XFFZJAGNSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
16820,6cs2,HMDB0004810,-7.1,5C-aglycone,ALLYVKRLOHDVKI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
123009,6w4b,DB14649,-7.1,Dexamethasone acetate,AKUJBENLRBOFTD-RPRRAYFGSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
123006,6w4b,DB14646,-7.1,Prednisone acetate,MOVRKLZUVNCBIP-RFZYENFJSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
123003,6w4b,DB14643,-7.1,Methylprednisolone aceponate,DALKLAYLIPSCQL-YPYQNWSCSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
85757,6m3m,DB08028,-7.1,"BUT-3-ENYL-[5-(4-CHLORO-PHENYL)-3,6-DIHYDRO-[1,3,4]THIADIAZIN-2-YLIDENE]-AMINE",ZVZPCRKQNRRBOQ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85756,6m3m,DB08027,-7.1,1-(3-chloro-4-methylphenyl)-3-{2-[({5-[(dimethylamino)methyl]-2-furyl}methyl)thio]ethyl}urea,WEYNBWVKOYCCQT-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
159646,7bv1,DB05035,-7.1,Eprotirome,VPCSYAVXDAUHLT-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
10948,6lzg,DB09304,-7.1,Setiptiline,GVPIXRLYKVFFMK-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
159715,7bv1,DB05444,-7.1,Iroxanadine,QWVRTSZDKPRPDF-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
27897,6cs2,DB00683,-7.1,Midazolam,DDLIGBOFAVUZHB-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
71187,6lxt,DB13759,-7.1,Fenpiverinium,QDIYJDPBMZUZEH-UHFFFAOYSA-O,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
71235,6lxt,DB13822,-7.1,Meprotixol,LAYVFLWAVIGDLK-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
71236,6lxt,DB13823,-7.1,Pipemidic acid,JOHZPMXAZQZXHR-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
159817,7bv1,DB06623,-7.1,Flupirtine,JUUFBMODXQKSTD-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
85580,6m3m,DB07824,-7.1,"4-ethyl-5-methyl-2-(1H-tetrazol-5-yl)-1,2-dihydro-3H-pyrazol-3-one",WAVWUEFMWJZZFB-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
71243,6lxt,DB13835,-7.1,Caroverine,MSPRUJDUTKRMLM-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
71245,6lxt,DB13837,-7.1,Doxefazepam,VOJLELRQLPENHL-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
71250,6lxt,DB13842,-7.1,Etofylline nicotinate,ZWIAODBBEZGVPY-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
122670,6w4b,DB13713,-7.1,Quifenadine,PZMAHNDJABQWGS-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
85560,6m3m,DB07803,-7.1,2-phenyl-1H-imidazole-4-carboxylic acid,XCAXKZJNJCKTQH-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85594,6m3m,DB07841,-7.1,Geranylgeranyl diphosphate,OINNEUNVOZHBOX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
34605,1r42,DB00562,-7.1,Benzthiazide,NDTSRXAMMQDVSW-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
159864,7bv1,DB06712,-7.1,Nilvadipine,FAIIFDPAEUKBEP-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
85520,6m3m,DB07758,-7.1,"5-(2,5-DICHLOROPHENYL)-2-FUROIC ACID",ATAZLMGGQQLRBC-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
159865,7bv1,DB06713,-7.1,Norelgestromin,ISHXLNHNDMZNMC-XUDSTZEESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
159881,7bv1,DB07037,-7.1,(2S)-1-AMINO-3-[(5-NITROQUINOLIN-8-YL)AMINO]PROPAN-2-OL,MBZPCTWLFNYBND-QMMMGPOBSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
85501,6m3m,DB07736,-7.1,(2S)-4-(4-fluorobenzyl)-N-(2-sulfanylethyl)piperazine-2-carboxamide,CEXXKSSFAKABEN-ZDUSSCGKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
108040,6vxx,DB06739,-7.1,Seratrodast,ZBVKEHDGYSLCCC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85500,6m3m,DB07735,-7.1,"N-[1-(2,6-dimethoxybenzyl)piperidin-4-yl]-4-sulfanylbutanamide",MUDVORCZGBAHNA-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
159899,7bv1,DB07056,-7.1,"2-(6-{[(3-chloro-2-methylphenyl)sulfonyl]amino}pyridin-2-yl)-N,N-diethylacetamide",JNWQLOFSMUGRNY-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
122589,6w4b,DB13606,-7.1,Phenazocine,ZQHYKVKNPWDQSL-KNXBSLHKSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
34598,1r42,DB00554,-7.1,Piroxicam,QYSPLQLAKJAUJT-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
85871,6m3m,DB08155,-7.1,N-{2-[4-(AMINOSULFONYL)PHENYL]ETHYL}ACETAMIDE,IIMGUEXQORZTID-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
108010,6vxx,DB06700,-7.1,Desvenlafaxine,KYYIDSXMWOZKMP-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
159813,7bv1,DB06618,-7.1,Cutamesine,UVSWWUWQVAQPJR-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
159735,7bv1,DB05531,-7.1,alpha-Pyrrolidinononanophenone,RYJXAZXFWIWTOJ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
122845,6w4b,DB13997,-7.1,Baloxavir marboxil,RZVPBGBYGMDSBG-GGAORHGYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
85654,6m3m,DB07911,-7.1,"(3E)-2,6-DIOXO-6-PHENYLHEX-3-ENOATE",QPGAZPBFRAAJBD-XBXARRHUSA-M,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85651,6m3m,DB07908,-7.1,7-HYDROXY-4-METHYL-3-(2-HYDROXY-ETHYL)COUMARIN,VCGFYFKJZGIZMX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85649,6m3m,DB07906,-7.1,"[(3R)-7-NITRO-1,2,3,4-TETRAHYDROISOQUINOLIN-3-YL]METHANOL",RNUCRXHRBPLYTA-SECBINFHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85648,6m3m,DB07903,-7.1,"3-[(2,2-DIMETHYLPROPANOYL)AMINO]-N-1,3-THIAZOL-2-YLPYRIDINE-2-CARBOXAMIDE",CAVCWRXFMNCBCM-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85644,6m3m,DB07899,-7.1,(2S) N-acetyl-L-alanyl-??L-phenylalanyl-chloroethylketone,WABWAIGLGFELMI-FZMZJTMJSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
122815,6w4b,DB13944,-7.1,Testosterone enanthate,VOCBWIIFXDYGNZ-IXKNJLPQSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
34655,1r42,DB00623,-7.1,Fluphenazine,PLDUPXSUYLZYBN-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
27922,6cs2,DB07485,-7.1,"4,4'-cyclohexane-1,1-diyldiphenol",SDDLEVPIDBLVHC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
34642,1r42,DB00607,-7.1,Nafcillin,GPXLMGHLHQJAGZ-JTDSTZFVSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
34641,1r42,DB00606,-7.1,Cyclothiazide,BOCUKUHCLICSIY-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
10904,6lzg,DB09235,-7.1,Efonidipine,NSVFSAJIGAJDMR-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
55846,6crv,DB01549,-7.1,Rolicyclidine,FYOWWXMGDATDQY-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
122781,6w4b,DB13856,-7.1,Fluclorolone,VTWKPILBIUBMDS-OTJLYDAYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
122769,6w4b,DB13843,-7.1,Cloprednol,YTJIBEDMAQUYSZ-FDNPDPBUSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
107999,6vxx,DB06682,-7.1,Naproxcinod,AKFJWRDCWYYTIG-ZDUSSCGKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108000,6vxx,DB06683,-7.1,Clevudine,GBBJCSTXCAQSSJ-XQXXSGGOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
34629,1r42,DB00591,-7.1,Fluocinolone acetonide,FEBLZLNTKCEFIT-VSXGLTOVSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
122743,6w4b,DB13808,-7.1,Mebhydrolin,FQQIIPAOSKSOJM-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
122785,6w4b,DB13865,-7.1,Dehydroemetine,XXLZPUYGHQWHRN-RPBOFIJWSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
27963,6cs2,DB00690,-7.1,Flurazepam,SAADBVWGJQAEFS-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
107870,6vxx,DB05377,-7.1,Chlorfenson,RZXLPPRPEOUENN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
71070,6lxt,DB13605,-7.1,Phenoperidine,IPOPQVVNCFQFRK-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
123436,6w4b,DB00158,-7.1,Folic acid,OVBPIULPVIDEAO-LBPRGKRZSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
159068,7bv1,DB03102,-7.1,"2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Pyran-3-Carboxylic Acid",SNNOZMNTPOIDSI-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
107476,6vxx,DB03652,-7.1,beta-D-Galactopyranuronic acid,AEMOLEFTQBMNLQ-DTEWXJGMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
16583,6cs2,HMDB0002961,-7.1,Dihydrotestosterone,NVKAWKQGWWIWPM-ABEVXSGRSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
11067,6lzg,DB11362,-7.1,Selexipag,QXWZQTURMXZVHJ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
107498,6vxx,DB03679,-7.1,2-Hydroxy-Tryptophan,VAUYGGXCASQWHK-QMMMGPOBSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
123390,6w4b,DB15449,-7.1,Citarinostat,VLIUIBXPEDFJRF-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
16585,6cs2,HMDB0002984,-7.1,11-Hydroxyandrosterone,PIXFHVWJOVNKQK-PTXZMSDUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
123366,6w4b,DB15406,-7.1,GLPG-0974,MPMKMQHJHDHPBE-RUZDIDTESA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
7458,6lzg,DB03833,-7.1,"2-Prolyl-5-Tert-Butyl-[1,3,4]Oxadiazole",YUKGJYBQODPVBL-ZETCQYMHSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
7461,6lzg,DB03837,-7.1,Morpholine-4-Carboxylic Acid (1-(3-Benzenesulfonyl-1-Phenethylallylcarbamoyl)-3-Methylbutyl)-Amide,YUMYYTORLYHUFW-ZUDLOMHPSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
159169,7bv1,DB03515,-7.1,Equilenin,PDRGHUMCVRDZLQ-WMZOPIPTSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
86178,6m3m,DB08533,-7.1,"3-methyl-N-(pyridin-4-ylmethyl)imidazo[1,2-a]pyrazin-8-amine",LXRVAGIYXNQOKP-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
107524,6vxx,DB03717,-7.1,"3-Hydroxy-4-(3,4,5-Trihydroxy-Tetrahydro-Pyran-2-Yloxy)-Piperidin-2-One",BHZMHPRIYUPDCT-BQWZOORQSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
16615,6cs2,HMDB0003164,-7.1,Chlorogenic acid,CWVRJTMFETXNAD-JUHZACGLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
70896,6lxt,DB13364,-7.1,Feprazone,RBBWCVQDXDFISW-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
159203,7bv1,DB03573,-7.1,WRR-99,KVZMXOVSHIMGNA-CVEARBPZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
86155,6m3m,DB08505,-7.1,methyl 4-bromo-N-[8-(hydroxyamino)-8-oxooctanoyl]-L-phenylalaninate,UPYGSQPRAHMDPD-HNNXBMFYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
107553,6vxx,DB03752,-7.1,P-(2'-Iodo-5'-Thenoyl)Hydrotropic Acid,UIZPHGUBGPJBAR-QMMMGPOBSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
56187,6crv,DB01997,-7.1,3-Bromo-7-Nitroindazole,NFSTZPMYAZRZPC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
123519,6w4b,DB00252,-7.1,Phenytoin,CXOFVDLJLONNDW-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
158976,7bv1,DB02709,-7.1,Resveratrol,LUKBXSAWLPMMSZ-OWOJBTEDSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
11080,6lzg,DB11385,-7.1,Cefalonium,FMZXNVLFJHCSAF-DNVCBOLYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
107329,6vxx,DB03171,-7.1,Indole-3-Propanol Phosphate,NKEZSFZOUIIZFL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
123734,6w4h,DB00315,-7.1,Zolmitriptan,ULSDMUVEXKOYBU-ZDUSSCGKSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
107340,6vxx,DB03185,-7.1,"1-Beta-Ribofuranosyl-1,3-Diazepinone",MEPCJRCEYSZBDO-FNCVBFRFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
123696,6w4h,DB00270,-7.1,Isradipine,HMJIYCCIJYRONP-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
11102,6lzg,DB11423,-7.1,Lasalocid,BBMULGJBVDDDNI-OWKLGTHSSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
86309,6m3m,DB08695,-7.1,3-(4-nitrophenyl)-1H-pyrazole,IPIYADCDDIUVPS-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
86307,6m3m,DB08691,-7.1,"ethyl 3-[(E)-2-amino-1-cyanoethenyl]-6,7-dichloro-1-methyl-1H-indole-2-carboxylate",CXJCGSPAPOTTSF-VURMDHGXSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
107367,6vxx,DB03218,-7.1,N-Acetyl-N'-Beta-D-Glucopyranosyl Urea,UQKBNLXZEGBQAF-JAJWTYFOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
70790,6lxt,DB13227,-7.1,Tribenoside,ULLNJSBQMBKOJH-VIVFLBMVSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
27783,6cs2,DB07335,-7.1,"3-[4-AMINO-1-(1-METHYLETHYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL]PHENOL",MWYBBCLGEHZSCP-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
86295,6m3m,DB08677,-7.1,N-(5-ISOPROPYL-THIAZOL-2-YL)-2-PYRIDIN-3-YL-ACETAMIDE,WQZOOPQQADNJEG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
35003,1r42,DB01030,-7.1,Topotecan,UCFGDBYHRUNTLO-QHCPKHFHSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
11089,6lzg,DB11395,-7.1,Deracoxib,WAZQAZKAZLXFMK-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
34989,1r42,DB01013,-7.1,Clobetasol propionate,CBGUOGMQLZIXBE-XGQKBEPLSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
7439,6lzg,DB00448,-7.1,Lansoprazole,MJIHNNLFOKEZEW-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
56219,6crv,DB02041,-7.1,Isoluminol,HUDPLKWXRLNSPC-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
123572,6w4h,DB00131,-7.1,Adenosine phosphate,UDMBCSSLTHHNCD-KQYNXXCUSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
56217,6crv,DB02038,-7.1,"D-[3-hydroxy-2-methyl-5-phosphonooxymethyl-pyridin-4-ylmethyl]-N,O-cycloserylamide",NNRZSZJOQKAGTO-SECBINFHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107425,6vxx,DB03293,-7.1,9-Methyl Uric Acid,XJEJWDFDVPDMAS-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86272,6m3m,DB08648,-7.1,"(1R,3S,5S,8R)-8-Hydroxy-2-oxabicyclo[3.3.1]non-6-ene-3,5-dicarboxylic acid",KRZHNRULRHECRF-JQCUSGDOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
158917,7bv1,DB02632,-7.1,4-nitrophenyl-beta-D-galactoside,IFBHRQDFSNCLOZ-YBXAARCKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
159228,7bv1,DB03606,-7.1,(S)-Rolipram,HJORMJIFDVBMOB-GFCCVEGCSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
107569,6vxx,DB03769,-7.1,D-Eritadenine,LIEMBEWXEZJEEZ-INEUFUBQSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86130,6m3m,DB08476,-7.1,3-AMINO-AZACYCLOTRIDECAN-2-ONE,CQZLEYBEPASILI-NSHDSACASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85965,6m3m,DB08273,-7.1,4-HYDROXY-5-IODO-3-NITROPHENYLACETYL-EPSILON-AMINOCAPROIC ACID ANION,LKGGMBQFWIIXJM-UHFFFAOYSA-M,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85958,6m3m,DB08263,-7.1,N-(carboxycarbonyl)-D-phenylalanine,ULQWGBCNOHBNDB-MRVPVSSYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
27821,6cs2,DB07377,-7.1,"N'-((2S,3R)-3-AMINO-2-HYDROXY-5-(ISOPROPYLSULFANYL)PENTANOYL)-N-3-CHLOROBENZOYL HYDRAZIDE",BYBVYIPUGPZRSX-OLZOCXBDSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
107776,6vxx,DB04601,-7.1,"4-[(4-O-SULFAMOYLBENZYL)(4-CYANOPHENYL)AMINO]-4H-[1,2,4]-TRIAZOLE",WEXGHQDVDVWOIU-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107777,6vxx,DB04602,-7.1,PUROMYCIN AMINONUCLEOSIDE-5'-MONOPHOSPHATE,BFPIKGKMRKBBBF-GRIPGOBMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
107789,6vxx,DB04617,-7.1,"(9S)-9-[(8-AMMONIOOCTYL)AMINO]-1,2,3,4,9,10-HEXAHYDROACRIDINIUM",LFBAUYQQFKFFCF-UHFFFAOYSA-P,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
123119,6w4b,DB14879,-7.1,Cefiderocol,DBPPRLRVDVJOCL-FQRUVTKNSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
123106,6w4b,DB14856,-7.1,PF-05089771,ZYSCOUXLBXGGIM-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
85934,6m3m,DB08234,-7.1,"5-[3-(2,5-dimethoxyphenyl)prop-1-yn-1-yl]-6-ethylpyrimidine-2,4-diamine",NNFDQABYXZBKRK-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
56062,6crv,DB01825,-7.1,2-Amino-8-Methylquinazolin-4(3h)-One,NLLZAHIPYDRNRQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
85929,6m3m,DB08228,-7.1,"5,8-dimethoxy-1,4-dimethylquinolin-2(1H)-one",FTGZPMFPUDKJBX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85911,6m3m,DB08202,-7.1,4-({[(4-METHYLPIPERAZIN-1-YL)AMINO]CARBONOTHIOYL}AMINO)BENZENESULFONAMIDE,BPPLIZHQOIGRPZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
56005,6crv,DB01751,-7.1,"3,3',5,5'-Tetraiodothyroacetic Acid",PPJYSSNKSXAVDB-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
123077,6w4b,DB14775,-7.1,Cavosonstat,BXSZILNGNMDGSL-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
34787,1r42,DB00783,-7.1,Estradiol,VOXZDWNPVJITMN-ZBRFXRBCSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
123072,6w4b,DB14769,-7.1,Pamiparib,DENYZIUJOTUUNY-MRXNPFEDSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
159551,7bv1,DB04561,-7.1,"4-Acetamido-2,4-Didexoy-D-Glycero-Beta-D-Galacto-Octopyranosylphosphonic Acid",QITAGYVZDNZULE-HDBWYCHPSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
10974,6lzg,DB09383,-7.1,Meprednisone,PIDANAQULIKBQS-RNUIGHNZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
16776,6cs2,HMDB0004305,-7.1,Farnesol,CRDAMVZIKSXKFV-YFVJMOTDSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
55988,6crv,DB01729,-7.1,"(1s,3s,4s)-1,3,4-Triphospho-Myo-Inositol",MMWCIQZXVOZEGG-MLQGYMEPSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
159473,7bv1,DB04463,-7.1,"3-(4-Amino-1-Tert-Butyl-1h-Pyrazolo[3,4-D]Pyrimidin-3-Yl)Phenol",CPLGZXQPPYRNRC-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
107860,6vxx,DB05284,-7.1,CA4P,LGZKGOGODCLQHG-ZDUSSCGKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
70980,6lxt,DB13481,-7.1,Tenidap,LXIKEPCNDFVJKC-QXMHVHEDSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
123177,6w4b,DB15031,-7.1,Nemorexant,NBGABHGMJVIVBW-QHCPKHFHSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
107581,6vxx,DB03785,-7.1,"(3r,5r)-7-((1r,2r,6s,8r,8as)-2,6-Dimethyl-8-{[(2r)-2-Methylbutanoyl]Oxy}-1,2,6,7,8,8a-Hexahydronaphthalen-1-Yl)-3,5-Dihydroxyheptanoic Acid",QLJODMDSTUBWDW-BXMDZJJMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
86101,6m3m,DB08443,-7.1,"2-(1H-pyrrol-1-ylcarbonyl)benzene-1,3,5-triol",RYGSNHBTZDYVSS-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
27789,6cs2,DB07341,-7.1,"octyl 3-amino-3-deoxy-2-O-(2,6-dideoxy-alpha-L-lyxo-hexopyranosyl)-beta-D-galactopyranoside",GHTLMVRROQXELT-HTYYFBMYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
159236,7bv1,DB03622,-7.1,"2-Hydroxy-5-[4-(2-Hydroxy-Ethyl)-Piperidin-1-Yl]-5-Phenyl-1h-Pyrimidine-4,6-Dione",IPBPOBHSNJFRFT-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
70920,6lxt,DB13399,-7.1,Terguride,JOAHPSVPXZTVEP-YXJHDRRASA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
159238,7bv1,DB03626,-7.1,"5-Methoxy-1,2-Dimethyl-3-(Phenoxymethyl)Indole-4,7-Dione",JRPJCFILHCLEJI-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
159249,7bv1,DB03641,-7.1,"2'-deoxyuridine 5'-alpha,beta-imido-diphosphate",COFNIXBQVWFHTR-SHYZEUOFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
107623,6vxx,DB04101,-7.1,"N-[4-(2,4-Dimethyl-1,3-Thiazol-5-Yl)Pyrimidin-2-Yl]-N'-Hydroxyimidoformamide",OVKZTPFHUYGZBI-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
159286,7bv1,DB03691,-7.1,WRR-112,KVZMXOVSHIMGNA-HOTGVXAUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
159332,7bv1,DB04001,-7.1,6-(Oxalyl-Amino)-1h-Indole-5-Carboxylic Acid,AHWMERGBWWROMM-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
107638,6vxx,DB04122,-7.1,beta-D-glucose 6-phosphate,NBSCHQHZLSJFNQ-VFUOTHLCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
70940,6lxt,DB13425,-7.1,Flutrimazole,QHMWCHQXCUNUAK-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
70943,6lxt,DB13430,-7.1,Mebutizide,KJLLKLRVCJAFRY-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
123216,6w4b,DB15106,-7.1,Surufatinib,TTZSNFLLYPYKIL-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
16700,6cs2,HMDB0003601,-7.1,(S)-Reticuline,BHLYRWXGMIUIHG-HNNXBMFYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
70948,6lxt,DB13435,-7.1,Endralazine,ALAXZYHFVBSJKZ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
70950,6lxt,DB13437,-7.1,Medazepam,YLCXGBZIZBEVPZ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
34857,1r42,DB00862,-7.1,Vardenafil,SECKRCOLJRRGGV-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
70963,6lxt,DB13457,-7.1,Oxaflozane,FVYUQFQCEOZYHZ-UHFFFAOYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
70967,6lxt,DB13461,-7.1,Cefcapene,HJJRIJDTIPFROI-NVKITGPLSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
1538,6lzg,HMDB0011629,-7.1,"Guanosine 2',3'-cyclic phosphate",UASRYODFRYWBRC-UUOKFMHZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
160932,7bv1,DB12286,-7.1,Simendan,WHXMKTBCFHIYNQ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
159921,7bv1,DB07083,-7.1,beta-phenyl-D-phenylalanyl-N-propyl-L-prolinamide,HZKKJPDVZGOOPU-PZJWPPBQSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
55770,6crv,DB01463,-7.1,Fencamfamin,IKFBPFGUINLYQI-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108331,6vxx,DB07632,-7.1,"5-(2-chlorophenyl)-1,3,4-thiadiazole-2-sulfonamide",PZVGOWIIHCUHAO-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
160441,7bv1,DB08390,-7.1,"(6S)-6-CYCLOPENTYL-6-[2-(3-FLUORO-4-ISOPROPOXYPHENYL)ETHYL]-4-HYDROXY-5,6-DIHYDRO-2H-PYRAN-2-ONE",AKNIHFDXRAOPAI-NRFANRHFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160444,7bv1,DB08393,-7.1,"2-[(5,6-DIPHENYLFURO[2,3-D]PYRIMIDIN-4-YL)AMINO]ETHANOL",UQHINZSKNAAVOZ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
84813,6m3m,DB06928,-7.1,(2S)-2-{[HYDROXY(4-IODOBENZYL)PHOSPHORYL]METHYL}PENTANEDIOIC ACID,PPTCQJLGUKWAEP-SNVBAGLBSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
121797,6w4b,DB12410,-7.1,Sabarubicin,VQHRZZISQVWPLK-UIRGBLDSSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
55417,6crv,DB00981,-7.1,Physostigmine,PIJVFDBKTWXHHD-HIFRSBDPSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84768,6m3m,DB06880,-7.1,"(1S)-2-[(2S,5R)-2-(AMINOMETHYL)-5-PROP-1-YN-1-YLPYRROLIDIN-1-YL]-1-CYCLOPENTYL-2-OXOETHANAMINE",RIKCMKYTGBHVSX-IHRRRGAJSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
160481,7bv1,DB08440,-7.1,"N-1,10-phenanthrolin-5-ylacetamide",AAJXINSCZMZERD-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
121780,6w4b,DB12389,-7.1,Zamicastat,ZSSLCFLHEFXANG-GOSISDBHSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
160500,7bv1,DB08462,-7.1,N-(4-PHENYLAMINO-QUINAZOLIN-6-YL)-ACRYLAMIDE,JGWHILNNHLDARR-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160504,7bv1,DB08714,-7.1,"2,6-DIMETHYL-1-(3-[3-METHYL-5-ISOXAZOLYL]-PROPANYL)-4-[4-METHYL-2H-TETRAZOL-2-YL]-PHENOL",DRCNRTRGWUYJBH-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
121758,6w4b,DB12357,-7.1,BMS-863233,JJWLXRKVUJDJKG-VIFPVBQESA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
160515,7bv1,DB08726,-7.1,"5-(7-(4-(4,5-dihydro-2-oxazolyl)phenoxy)heptyl)-3-methyl isoxazole",FKLJPTJMIBLJAV-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160518,7bv1,DB08729,-7.1,"5-ethoxy-4-(1-methyl-7-oxo-3-propyl-6,7-dihydro-1H-pyrazolo[4,3-d]pyrimidin-5-yl)thiophene-2-sulfonamide",FENWRHVHBZQJGW-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160521,7bv1,DB08732,-7.1,NALPHA-[(BENZYLOXY)CARBONYL]-N-[(1R)-4-HYDROXY-1-METHYL-2-OXOBUTYL]-L-PHENYLALANINAMIDE,UUOOAGBWJUGBMV-APWZRJJASA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160539,7bv1,DB08750,-7.1,"1-[4-(AMINOMETHYL)BENZOYL]-5'-FLUORO-1'H-SPIRO[PIPERIDINE-4,2'-QUINAZOLIN]-4'-AMINE",SFPCNWQWKOUNRT-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
10714,6lzg,DB08971,-7.1,Fluocortolone,GAKMQHDJQHZUTJ-ULHLPKEOSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
84680,6m3m,DB06738,-7.1,Ketobemidone,ALFGKMXHOUSVAD-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
55379,6crv,DB00935,-7.1,Oxymetazoline,WYWIFABBXFUGLM-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
121826,6w4b,DB12447,-7.1,Nadifloxacin,JYJTVFIEFKZWCJ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
1303,6lzg,HMDB0010357,-7.1,Tetrahydroaldosterone-3-glucuronide,CGIURIOFMWUPSV-RUQPETGGSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
28159,6cs2,DB07739,-7.1,"(3R)-3-(FLUOROMETHYL)-7-(THIOMORPHOLIN-4-YLSULFONYL)-1,2,3,4-TETRAHYDROISOQUINOLINE",SBUKSNPHYWXCDG-CYBMUJFWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
160429,7bv1,DB08373,-7.1,"4,4'-BIS([H]METHYLSULFONYL)-2,2',5,5'-TETRACHLOROBIPHENYL",RDBKPLOYRMCFIY-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
121915,6w4b,DB12585,-7.1,Ondelopran,QWNDOCKIKKQJNN-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
160353,7bv1,DB08284,-7.1,"O-[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethyl] (4-iodophenyl)thiocarbamate",CYYIBMGIJWXZEP-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160360,7bv1,DB08292,-7.1,"(5Z)-12-CHLORO-13,15-DIHYDROXY-4,7,8,9-TETRAHYDRO-2-BENZOXACYCLOTRIDECINE-1,10(3H,11H)-DIONE",AQKZYZQONWDDLS-IWQZZHSRSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
121908,6w4b,DB12574,-7.1,LY-295501,VAMFSFIPDOODFH-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
28142,6cs2,DB00708,-7.1,Sufentanil,GGCSSNBKKAUURC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
160377,7bv1,DB08310,-7.1,"N-[(2R)-2-{[(2S)-2-(1,3-benzoxazol-2-yl)pyrrolidin-1-yl]carbonyl}hexyl]-N-hydroxyformamide",QDDZLTVSNABZIK-ZBFHGGJFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
84922,6m3m,DB07057,-7.1,(3S)-1-(2-hydroxyphenyl)-5-oxopyrrolidine-3-carboxylic acid,FPQOSKXLHCTVED-ZETCQYMHSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
160378,7bv1,DB08312,-7.1,"6-CYCLOHEXYLMETHYLOXY-5-NITROSO-PYRIMIDINE-2,4-DIAMINE",DGWXOLHKVGDQLN-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
121890,6w4b,DB12548,-7.1,Sparsentan,WRFHGDPIDHPWIQ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
121723,6w4b,DB12305,-7.1,Dasotraline,SRPXSILJHWNFMK-MEDUHNTESA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
108283,6vxx,DB07574,-7.1,"2-MERCAPTO-N-[1,2,3,10-TETRAMETHOXY-9-OXO-5,6,7,9-TETRAHYDRO-BENZO[A]HEPTALEN-7-YL]ACETAMIDE",TYDIWMTWTXFWSY-HNNXBMFYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
121889,6w4b,DB12547,-7.1,LY-2886721,NIDRNVHMMDAAIK-YPMLDQLKSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
121885,6w4b,DB12540,-7.1,Lecozotan,NRPQELCNMADTOZ-OAQYLSRUSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
84894,6m3m,DB07028,-7.1,(2-{[(4-BROMO-2-FLUOROBENZYL)AMINO]CARBONYL}-5-CHLOROPHENOXY)ACETIC ACID,ZLIGBZRXAQNUFO-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84885,6m3m,DB07018,-7.1,5-ETHYL-3-[(2-METHOXYETHYL)METHYLAMINO]-6-METHYL-4-(3-METHYLBENZYL)PYRIDIN-2(1H)-ONE,USWKTQVAABDFSY-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84868,6m3m,DB06998,-7.1,"[(5R)-5-(2,3-dibromo-5-ethoxy-4-hydroxybenzyl)-4-oxo-2-thioxo-1,3-thiazolidin-3-yl]acetic acid",ABQHPGHMYXJJIV-MRVPVSSYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
1312,6lzg,HMDB0010373,-7.1,"CE(20:3(5Z,8Z,11Z))",XQWTZYBOKFFMKJ-HXQMAXTDSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
34232,1r42,DB00338,-7.1,Omeprazole,SUBDBMMJDZJVOS-UHFFFAOYSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
55453,6crv,DB01022,-7.1,Phylloquinone,MBWXNTAXLNYFJB-NKFFZRIASA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
22271,6cs2,HMDB0053506,-7.1,"TG(20:2n6/20:3n6/20:4(8Z,11Z,14Z,17Z))",MHNHYVCCWTUPKM-MWTXPWPNSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
108285,6vxx,DB07577,-7.1,"6-ETHYL-5-PHENYLPYRIMIDINE-2,4-DIAMINE",XREDUPOVEQDQQS-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28198,6cs2,DB00713,-7.1,Oxacillin,UWYHMGVUTGAWSP-JKIFEVAISA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
160543,7bv1,DB08754,-7.1,"(2E)-3-(3,4-DIHYDROXYPHENYL)-N-[2-(4-HYDROXYPHENYL)ETHYL]ACRYLAMIDE",VSHUQLRHTJOKTA-XBXARRHUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
55371,6crv,DB00925,-7.1,Phenoxybenzamine,QZVCTJOXCFMACW-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
84464,6m3m,DB06231,-7.1,Caldaret,DCDFLGVJWQIRGH-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
160815,7bv1,DB11766,-7.1,AZD-1305,BLLNYXOLLAVTRF-HDICACEKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160834,7bv1,DB11792,-7.1,Mirodenafil,MIJFNYMSCFYZNY-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
121529,6w4b,DB12027,-7.1,Serdemetan,CEGSUK1LWKJP-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
121519,6w4b,DB12010,-7.1,Fostamatinib,GKDRMWXFWHEQQT-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
121518,6w4b,DB12009,-7.1,GW-406381,NXMZBNYLCVTRGB-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
10652,6lzg,DB08883,-7.1,Perampanel,PRMWGUBFXWROHD-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
160847,7bv1,DB11811,-7.1,Arhalofenate,BJBCSGQLZQGGIQ-QGZVFWFLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
121502,6w4b,DB11987,-7.1,GSK-2018682,NFIGDBFIDKDNIG-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
68084,6lxt,DB07503,-7.1,"(5E)-5-[(2,2-DIFLUORO-1,3-BENZODIOXOL-5-YL)METHYLENE]-1,3-THIAZOLIDINE-2,4-DIONE",SRLVNYDXMUGOFI-YWEYNIOJSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
49154,2fxp,DB04098,-7.1,Balanol,XYUFCXJZFZPEJD-PGRDOPGGSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
160891,7bv1,DB11875,-7.1,"3,3'-diindolylmethane",VFTRKSBEFQDZKX-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160895,7bv1,DB11880,-7.1,Acridine Carboxamide,XBGNERSKEKDZDS-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
84396,6m3m,DB05968,-7.1,PR-104,GZSOKPMDWVRVMG-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
160909,7bv1,DB12254,-7.1,ABT-751,URCVCIZFVQDVPM-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
28281,6cs2,DB07863,-7.1,2-chloro-5-nitro-N-phenylbenzamide,DNTSIBUQMRRYIU-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
71852,6lxt,DB15411,-7.1,ABP-700,DRAFVCKNYNQOKR-GFCCVEGCSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
108471,6vxx,DB08027,-7.1,1-(3-chloro-4-methylphenyl)-3-{2-[({5-[(dimethylamino)methyl]-2-furyl}methyl)thio]ethyl}urea,WEYNBWVKOYCCQT-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28283,6cs2,DB07865,-7.1,3-(1H-tetrazol-5-ylamino)cyclohex-2-en-1-one,REZXFQGPXQJVJG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
1182,6lzg,HMDB0000343,-7.1,2-Hydrox1trone,SWINWPBPEKHUOD-JPVZDGGYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
108466,6vxx,DB08021,-7.1,5-bromo-N-(3-chloro-2-(4-(prop-2-ynyl)piperazin-1-yl)phenyl)furan-2-carboxamide,MEFJFXHHHNDHEN-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
160351,7bv1,DB08282,-7.1,"O-[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethyl] (4-chlorophenyl)thiocarbamate",BWRRXOIACQYNEK-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
84482,6m3m,DB06264,-7.1,Tolperisone,FSKFPVLPFLJRQB-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
10673,6lzg,DB08916,-7.1,Afatinib,ULXXDDBFHOBEHA-CWDCEQMOSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
28201,6cs2,DB07782,-7.1,4-AMINO-2-TRIFLUOROMETHYL-5-HYDROXYMETHYLPYRIMIDINE PYROPHOSPHATE,UKNJCTHTCAKKNG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
55363,6crv,DB00917,-7.1,Dinoprostone,XEYBRNLFEZDVAW-ARSRFYASSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
34137,6cs2,T3D0999,-7.1,Promecarb,DTAPQAJKAFRNJB-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
121684,6w4b,DB12253,-7.1,GDC-0810,BURHGPHDEVGCEZ-KJGLQBJMSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
28216,6cs2,DB07797,-7.1,N-[[3-FLUORO-4-ETHOXY-PYRID-2-YL]ETHYL]-N'-[5-CHLORO-PYRIDYL]-THIOUREA,VEBKSFPYWMOUBR-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
84648,6m3m,DB06696,-7.1,Arbekacin,MKKYBZZTJQGVCD-XTCKQBCOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
160578,7bv1,DB08795,-7.1,Azidocillin,ODFHGIPNGIAMDK-NJBDSQKTSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
121663,6w4b,DB12226,-7.1,Terameprocol,ORQFDHFZSMXRLM-IYBDPMFKSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
121638,6w4b,DB12188,-7.1,Zicronapine,BYPMJBXPNZMNQD-PZJWPPBQSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
34047,6cs2,T3D0906,-7.1,3-tert-Butylphenyl sec-butylcarbamate,CLBKYQXZXVDEPG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
84611,6m3m,DB06619,-7.1,Amdoxovir,RLAHNGKRJJEIJL-RFZPGFLSSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
84584,6m3m,DB06548,-7.1,Minodronic acid,VMMKGHQPQIEGSQ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
160702,7bv1,DB09313,-7.1,Ioxaglic acid,TYYBFXNZMFNZJT-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
55323,6crv,DB00873,-7.1,Loteprednol,YPZVAYHNBBHPTO-MXRBDKCISA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
121602,6w4b,DB12131,-7.1,Vinpocetine,DDNCQMVWWZOMLN-IRLDBZIGSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
10683,6lzg,DB08934,-7.1,Sofosbuvir,TTZHDVOVKQGIBA-IQWMDFIBSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
160771,7bv1,DB11185,-7.1,Sulisobenzone,CXVGEDCSTKKODG-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
22197,6cs2,HMDB0001471,-7.1,Epipregnanolone,AURFZBICLPNKBZ-GRWISUQFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
49100,2fxp,DB04023,-7.1,"Guanosine 5'-(Trihydrogen Diphosphate), P'-D-Mannopyranosyl Ester",DNBSDUDYNPJVCN-ZXTXFPBHSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
34054,6cs2,T3D0913,-7.1,"5,6,7,8-Tetrahydro-1-naphthyl methylcarbamate",FDHRBCMXYSGNPA-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
84595,6m3m,DB06585,-7.1,Fipamezole,KXSUAWAUCNFBQJ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
159927,7bv1,DB07089,-7.1,N-[amino(imino)methyl]-2-[2-(2-chlorophenyl)-4-(4-propoxyphenyl)-3-thienyl]acetamide,VZSMTBLDWPKVRW-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
55498,6crv,DB01073,-7.1,Fludarabine,HBUBKKRHXORPQB-FJFJXFQQSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
108246,6vxx,DB07273,-7.1,1-[(2-AMINO-4-CHLORO-5-METHYLPHENYL)SULFONYL]-L-PROLINE,OWYKAFABUYXQLE-JTQLQIEISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
34481,1r42,DB00295,-7.1,Morphine,BQJCRHHNABKAKU-KBQPJGBKSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
160032,7bv1,DB07210,-7.1,"3-bromo-5-phenyl-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",JECHSYMSTXETFI-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
122342,6w4b,DB13276,-7.1,Idanpramine,HVYGXNYMNHSBGD-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
160033,7bv1,DB07211,-7.1,(2R)-2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}PROPENE-1-SULFONAMIDE,YMJHMJLNQLVUAV-GHYUOPHCSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
122324,6w4b,DB13248,-7.1,Phthalylsulfathiazole,PBMSWVPMRUJMPE-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
160042,7bv1,DB07222,-7.1,(3S)-N-(5-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE,RJWMDETWDDESBP-ZDUSSCGKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
85323,6m3m,DB07524,-7.1,"N-phenyl-1H-pyrrolo[2,3-b]pyridin-3-amine",CQFGXDQUQWRXLE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
160045,7bv1,DB07447,-7.1,5beta-dihydrotestosterone,NVKAWKQGWWIWPM-MISPCMORSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
85303,6m3m,DB07499,-7.1,"N-(4-{[amino(imino)methyl]amino}butyl)-2,4'-bi-1,3-thiazole-4-carboxamide",VSIFMASDYAMOAN-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
10839,6lzg,DB09169,-7.1,3-Allylfentanyl,BZXKQFFMDLTPJL-LADGPHEKSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
55665,6crv,DB01275,-7.1,Hydralazine,RPTUSVTUFVMDQK-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
17128,6cs2,HMDB0006567,-7.1,Neolactotetraose,RBMYDHMFFAVMMM-PLQWBNBWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
71422,6lxt,DB14207,-7.1,Fosinoprilat,WOIWWYDXDVSWAZ-RTWAWAEBSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
160084,7bv1,DB07492,-7.1,Bromamphenicol,UWOHGNMWBGIRAQ-RKDXNWHRSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
85261,6m3m,DB07449,-7.1,N-[(1S)-1-(AMINOCARBONYL)-4-(ETHANIMIDOYLAMINO)BUTYL]BENZAMIDE,LWFFSSMDFWZNNW-LBPRGKRZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
160099,7bv1,DB07511,-7.1,"4-(4-methyl-1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)benzonitrile",MVYDBJXCIFMINH-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
160107,7bv1,DB07520,-7.1,"N-[1-(AMINOMETHYL)CYCLOPROPYL]-3-(MORPHOLIN-4-YLSULFONYL)-N-2-[(1S)-2,2,2-TRIFLUORO-1-(4-FLUOROPHENYL)ETHYL]-L-ALANINAMIDE",BJIKKEHGGYGGIX-HOTGVXAUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
55640,6crv,DB01237,-7.1,Bromodiphenhydramine,NUNIWXHYABYXKF-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
122245,6w4b,DB13102,-7.1,AZD-8418,MCPBSUCAISQZQK-JTQLQIEISA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
10848,6lzg,DB09179,-7.1,R-30490,GARXJOUQUSNOGK-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
122380,6w4b,DB13325,-7.1,Nifurzide,IDUMOVRJNBNOTR-BIZLIJPVSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
28004,6cs2,DB07572,-7.1,3-{[(4-methylphenyl)sulfonyl]amino}propyl pyridin-4-ylcarbamate,ITYCDQJBLCTIID-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
122386,6w4b,DB13333,-7.1,Efloxate,ZVXBAHLOGZCFTP-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
55768,6crv,DB01461,-7.1,Dimenoxadol,RHUWRJWFHUKVED-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
159928,7bv1,DB07090,-7.1,(3S)-N-(3-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE,NJNMAZNXKKBTPS-ZDUSSCGKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
17020,6cs2,HMDB0005474,-7.1,"TG(18:2(9Z,12Z)/18:2(9Z,12Z)/18:2(9Z,12Z))",HBOQXIRUPVQLKX-BBWANDEASA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
159935,7bv1,DB07101,-7.1,PD-0325901,SUDAHWBOROXANE-SECBINFHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
159941,7bv1,DB07107,-7.1,(1S)-2-(1H-INDOL-3-YL)-1-[({5-[(E)-2-PYRIDIN-4-YLVINYL]PYRIDIN-3-YL}OXY)METHYL]ETHYLAMINE,SGHXFHRRWFLILP-XJDXJNMNSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
71313,6lxt,DB13967,-7.1,Patent Blue,DHAHKSQXIXFZJB-UHFFFAOYSA-O,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
48682,2fxp,DB03460,-7.1,Violaxanthin,SZCBXWMUOPQSOX-WVJDLNGLSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
122550,6w4b,DB13551,-7.1,Cinchophen,YTRMTPPVNRALON-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
34543,1r42,DB00485,-7.1,Dicloxacillin,YFAGHNZHGGCZAX-JKIFEVAISA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
17160,6cs2,HMDB0006737,-7.1,"CE(22:2(13Z,16Z))",YSGVSTJGBYXXIM-OVUVNFMNSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
55734,6crv,DB01422,-7.1,Nitroxoline,RJIWZDNTCBHXAL-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
159968,7bv1,DB07136,-7.1,(2S)-2-[3-(AMINOMETHYL)PHENYL]-3-{(R)-HYDROXY[(1R)-2-METHYL-1-{[(3-PHENYLPROPYL)SULFONYL]AMINO}PROPYL]PHOSPHORYL}PROPANOIC ACID,WFFOOKSVFDUPDH-FCHUYYIVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
27989,6cs2,DB07553,-7.1,"9,9,9-TRIFLUORO-8-OXO-N-PHENYLNONANAMIDE",KRCXZGYVOZSCSF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
159992,7bv1,DB07164,-7.1,"N-cyclopropyl-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amine",CAGHIASAHLPQMS-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
71353,6lxt,DB14055,-7.1,(S)-Warfarin,PJVWKTKQMONHTI-HNNXBMFYSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
27995,6cs2,DB07562,-7.1,"N-[4-(2,4-DIMETHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YL]-N',N'-DIMETHYL-BENZENE-1,4-DIAMINE",FGGSNQOBRJVAKL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
122432,6w4b,DB13393,-7.1,Emetine,AUVVAXYIELKVAI-CKBKHPSWSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
160004,7bv1,DB07178,-7.1,5-PENTYL-2-PHENOXYPHENOL,OJLYTHOKCYLPMA-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
122428,6w4b,DB13384,-7.1,Melitracen,GWWLWDURRGNSRS-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
160008,7bv1,DB07182,-7.1,(2S)-2-(3-{[AMINO(IMINO)METHYL]AMINO}PHENYL)-3-[(S)-HYDROXY(3-PHENYLPROPYL)PHOSPHORYL]PROPANOIC ACID,HFRHWTYCVGKGIE-KRWDZBQOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
34531,1r42,DB00471,-7.1,Montelukast,UCHDWCPVSPXUMX-TZIWLTJVSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
160142,7bv1,DB07561,-7.1,(2Z)-2-cyano-N-(3'-ethoxybiphenyl-4-yl)-3-hydroxybut-2-enamide,RPILZQUCBKIPAZ-AQTBWJFISA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
17171,6cs2,HMDB0000248,-7.1,Thyroxine,XUIIKFGFIJCVMT-LBPRGKRZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
160143,7bv1,DB07562,-7.1,"N-[4-(2,4-DIMETHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YL]-N',N'-DIMETHYL-BENZENE-1,4-DIAMINE",FGGSNQOBRJVAKL-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
122047,6w4b,DB12798,-7.1,Relenopride,KGMMSPVVHZGPHL-NRFANRHFSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
10798,6lzg,DB09080,-7.1,Olodaterol,COUYJEVMBVSIHV-SFHVURJKSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
34349,1r42,DB00146,-7.1,Calcifediol,JWUBBDSIWDLEOM-DTOXIADCSA-N,Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2),HYDROLASE,Homo sapiens,ACE2 area with important AAs
71519,6lxt,DB14678,-7.1,Norethindrone enanthate,APTGJECXMIKIET-WOSSHHRXSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
122019,6w4b,DB12746,-7.1,AKN-028,JLRIJKVMMZEKDF-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
71523,6lxt,DB14682,-7.1,Dextrorphan,JAQUASYNZVUNQP-PVAVHDDUSA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
55547,6crv,DB01130,-7.1,Prednicarbate,FNPXMHRZILFCKX-KAJVQRHHSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
122008,6w4b,DB12731,-7.1,Daporinad,KPBNHDGDUADAGP-VAWYXSNFSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
122002,6w4b,DB12721,-7.1,RO-5028442,QZXVLRCMAHJVIP-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
48856,2fxp,DB03712,-7.1,RU85053,CEKLBQMULVLLTD-VMPREFPWSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
122001,6w4b,DB12720,-7.1,Nivocasan,VYFGDLGHHBUDTQ-ZLGUVYLKSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
55539,6crv,DB01121,-7.1,Phenacemide,XPFRXWCVYUEORT-UHFFFAOYSA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
160268,7bv1,DB07946,-7.1,"N-[2-({[amino(imino)methyl]amino}oxy)ethyl]-2-{6-chloro-3-[(2,2-difluoro-2-phenylethyl)amino]-2-fluorophenyl}acetamide",DZEJHPMTDNDECN-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
10784,6lzg,DB09063,-7.1,Ceritinib,VERWOWGGCGHDQE-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
160281,7bv1,DB07963,-7.1,"N-[(2',4'-DIFLUORO-4-HYDROXY-5-IODOBIPHENYL-3-YL)CARBONYL]-BETA-ALANINE",YZQVXOZCPWWABX-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
108237,6vxx,DB07262,-7.1,1-{[N-(1-IMINO-GUANIDINO-METHYL)]SULFANYLMETHYL}-3-TRIFLUOROMETHYL-BENZENE,DWJNPCRXBNWCJC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
121962,6w4b,DB12663,-7.1,Letrazuril,XQKYUBTUOHHNDV-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
85025,6m3m,DB07176,-7.1,5-aminonaphthalene-1-sulfonic acid,DQNAQOYOSRJXFZ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
121944,6w4b,DB12637,-7.1,Onapristone,IEXUMDBQLIVNHZ-YOUGDJEHSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
28130,6cs2,DB07708,-7.1,3-CHLORO-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL,ZNHQDSBJVFFIAK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
71527,6lxt,DB14714,-7.1,Tenivastatin,XWLXKKNPFMNSFA-HGQWONQESA-N,Structure of post fusion core of 2019-nCoV S2 subunit,VIRAL PROTEIN,SARS-CoV-2,S2 unit
121936,6w4b,DB12622,-7.1,Lupeol,MQYXUWHLBZFQQO-QGTGJCAVSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
122052,6w4b,DB12805,-7.1,Ataciguat,PQHLRGARXNPFCF-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
160216,7bv1,DB07883,-7.1,(2-AMINO-3-PHENYL-BICYCLO[2.2.1]HEPT-2-YL)-PHENYL-METHANONE,XJQDTOANLAPEIM-JRBPQWBISA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
122192,6w4b,DB13024,-7.1,MK-8245,UJEAABFSXKCSGI-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
122190,6w4b,DB13022,-7.1,LY-2874455,GKJCVYLDJWTWQU-CXLRFSCWSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
122178,6w4b,DB13004,-7.1,Mavoglurant,ZFPZEYHRWGMJCV-ZHALLVOQSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
122167,6w4b,DB12985,-7.1,Quisinostat,PAWIYAYFNXQGAP-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
10820,6lzg,DB09123,-7.1,Dienogest,AZFLJNIPTRTECV-FUMNGEBKSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
55602,6crv,DB01191,-7.1,Dexfenfluramine,DBGIVFWFUFKIQN-VIFPVBQESA-N,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
122155,6w4b,DB12966,-7.1,Falnidamol,FTFRZXFNZVCRSK-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
85205,6m3m,DB07383,-7.1,"N-(1-BENZYL-3,3,3-TRIFLUORO-2,2-DIHYDROXY-PROPYL)-ACETAMIDE",NETPVFJEHOGNPJ-JTQLQIEISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
122154,6w4b,DB12964,-7.1,Lerisetron,PWWDCRQZITYKDV-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
28079,6cs2,DB07652,-7.1,"1-[2-DEOXYRIBOFURANOSYL]-2,4-DIFLUORO-5-METHYL-BENZENE-5'MONOPHOSPHATE",NMMWBGNJJMNAIJ-QJPTWQEYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
160173,7bv1,DB07598,-7.1,"2,3,6A,7,8,9-HEXAHYDRO-11H-[1,4]DIOXINO[2,3-G]PYRROLO[2,1-B][1,3]BENZOXAZIN-11-ONE",RQEPVMAYUINZRE-GFCCVEGCSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
122126,6w4b,DB12924,-7.1,Ozenoxacin,XPIJWUTXQAGSLK-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
122121,6w4b,DB12914,-7.1,MGL-3196,FDBYIYFVSAHJLY-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
160183,7bv1,DB07613,-7.1,3-phenyl-5-(1H-pyrazol-3-yl)isoxazole,SRSSTOPJERVMRZ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
7545,6lzg,DB03980,-7.1,4-(Fluorophenyl)-1-Cyclopropylmethyl-5-(2-Amino-4-Pyrimidinyl)Imidazole,DFEYXQGDDCDXJK-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
85191,6m3m,DB07365,-7.1,NAPHTHALEN-2-YL-3-ALANINE,OFYAYGJCPXRNBL-LBPRGKRZSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
85184,6m3m,DB07356,-7.1,"(1S)-2-[(2S,5R)-2-(AMINOMETHYL)-5-ETHYNYLPYRROLIDIN-1-YL]-1-CYCLOPENTYL-2-OXOETHANAMINE",XYVMJMYCUZCIPB-AVGNSLFASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
122088,6w4b,DB12869,-7.1,Eliprodil,GGUSQTSTQSHJAH-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
85160,6m3m,DB07329,-7.1,1-[N-4'-NITROBENZYL-N-4'-CARBOXYBUTYLAMINO]METHYLPHOSPHONIC ACID,RWVBLRUMXIXUAR-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
160212,7bv1,DB07877,-7.1,"8-(6-BROMO-BENZO[1,3]DIOXOL-5-YLSULFANYL)-9-(3-ISOPROPYLAMINO-PROPYL)-ADENINE",MWGWLDJLENCVRQ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
85197,6m3m,DB07374,-7.1,Anisomycin,YKJYKKNCCRKFSL-RDBSUJKOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
123740,6w4h,DB00321,-7.1,Amitriptyline,KRMDCWKBEZIMAB-UHFFFAOYSA-N,1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2,VIRAL PROTEIN,SARS-CoV-2,nsp16 - nsp10
81399,6m3m,DB01151,-7.1,Desipramine,HCYAFALTSJYZDH-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
119396,6w4b,DB07265,-7.1,"3-(9-HYDROXY-1,3-DIOXO-4-PHENYL-2,3-DIHYDROPYRROLO[3,4-C]CARBAZOL-6(1H)-YL)PROPANOIC ACID",JDARUOOLJCFUOY-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
115439,6w4b,DB00858,-7.1,Drostanolone,IKXILDNPCZPPRV-RFMGOVQKSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
29427,6cs2,DB09180,-7.1,Thienylfentanyl,YMRFZDHYDKZXPA-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
74802,6m2n,DB03851,-7.1,Carbazole Butanoic Acid,HQAKVYGASUTQHH-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77238,6m2n,DB08132,-7.1,5-hydroxynaphthalene-1-sulfonamide,NFVBVKHGDDDCEA-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
30780,6cs2,DB12967,-7.1,Mitoguazone,MXWHMTNPTTVWDM-VEPASKNESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
8895,6lzg,DB06954,-7.1,"2-(cycloheptylmethyl)-1,1-dioxido-1-benzothiophen-6-yl sulfamate",BIASYWBGUYOWJR-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
77213,6m2n,DB08105,-7.1,N-[(6-butoxynaphthalen-2-yl)sulfonyl]-L-glutamic acid,UAGYXJBYAFGRFR-KRWDZBQOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
74825,6m2n,DB03881,-7.1,"(2S,3R,4S,5S)-3,4-Dihydroxy-2-[(methylsulfanyl)methyl]-5-(4-oxo-4,5-dihydro-1H-pyrrolo[3,2-d]pyrimidin-7-yl)pyrrolidinium",CEGIKIXYDFDYDN-RXDXJJGDSA-O,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
165666,7bv1,DB12625,-7.1,Evogliptin,LCDDAGSJHKEABN-MLGOLLRUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
165673,7bv1,DB12638,-7.1,PU-H71,SUPVGFZUWFMATN-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
74831,6m2n,DB03888,-7.1,N-Allyl-6-{[3-(4-bromophenyl)-1-methyl-1H-indazol-6-yl]oxy}-N-methyl-1-hexanamine,FNZKIJOTNKEJBF-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
165675,7bv1,DB12641,-7.1,Tedatioxetine,CVASBKDYSQKLSO-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
115368,6w4b,DB00776,-7.1,Oxcarbazepine,CTRLABGOLIVAIY-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
115361,6w4b,DB00768,-7.1,Olopatadine,JBIMVDZLSHOPLA-LSCVHKIXSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
77195,6m2n,DB08084,-7.1,IDD594,JCZUIWYXULSXSW-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77189,6m2n,DB08078,-7.1,{4-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]phenoxy}acetic acid,HBBVCKCCQCQCTJ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
74840,6m2n,DB03899,-7.1,9-Butyl-8-(4-Methoxybenzyl)-9h-Purin-6-Amine,NVYATAJRTRFKSW-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
30759,6cs2,DB12938,-7.1,Isoxaflutole,OYIKARCXOQLFHF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
112839,6vxx,DB07903,-7.1,"3-[(2,2-DIMETHYLPROPANOYL)AMINO]-N-1,3-THIAZOL-2-YLPYRIDINE-2-CARBOXAMIDE",CAVCWRXFMNCBCM-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29424,6cs2,DB00846,-7.1,Flurandrenolide,POPFMWWJOGLOIF-XWCQMRHXSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
74795,6m2n,DB03841,-7.1,Y-700,AETHRPHBGJAIBT-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
29421,6cs2,DB09174,-7.1,Lofentanil,IMYHGORQCPYVBZ-NLFFAJNJSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
74787,6m2n,DB03829,-7.1,Pseudouridine-5'-Monophosphate,MOBMOJGXNHLLIR-GBNDHIKLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
112687,6vxx,DB07730,-7.1,"5-(3-HYDROXYPHENYL)ISOTHIAZOL-3(2H)-ONE 1,1-DIOXIDE",FJABEDRGNJSWCC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165553,7bv1,DB12445,-7.1,Nitroaspirin,IOJUJUOXKXMJNF-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
115574,6w4b,DB01012,-7.1,Cinacalcet,VDHAWDNDOKGFTD-MRXNPFEDSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
77454,6m2n,DB08398,-7.1,"2-Amino-1-methyl-6-phenylimidazo(4,5-b)pyridine",UQVKZNNCIHJZLS-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
30873,6cs2,DB00998,-7.1,Frovatriptan,XPSQPHWEGNHMSK-SECBINFHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
77431,6m2n,DB08369,-7.1,1-(biphenyl-4-ylmethyl)-1H-imidazole,DLYMRVCQTVOYEW-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
112710,6vxx,DB07757,-7.1,"(9aS)-4-bromo-9a-butyl-7-hydroxy-1,2,9,9a-tetrahydro-3H-fluoren-3-one",FTEBGBCQCYMDPH-KRWDZBQOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
52624,2fxp,DB11786,-7.1,Pefcalcitol,SVCSMAZYWOQCBW-NVJMFHFGSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
77408,6m2n,DB08344,-7.1,4-chloro-N-(3-methoxypropyl)-N-[(3S)-1-(2-phenylethyl)piperidin-3-yl]benzamide,OOUGHDJEJNMXSV-QHCPKHFHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77183,6m2n,DB08072,-7.1,"4-(2-AMINOETHOXY)-3,5-DICHLORO-N-[3-(1-METHYLETHOXY)PHENYL]BENZAMIDE",AYKUIRSGEMLIFT-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
8942,6lzg,DB00635,-7.1,Prednisone,XOFYZVNMUHMLCC-ZPOLXVRWSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
29395,6cs2,DB09119,-7.1,Eslicarbazepine acetate,QIALRBLEEWJACW-INIZCTEOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
112730,6vxx,DB07780,-7.1,Farnesyl diphosphate,VWFJDQUYCIWHTN-YFVJMOTDSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
74750,6m2n,DB03785,-7.1,"(3r,5r)-7-((1r,2r,6s,8r,8as)-2,6-Dimethyl-8-{[(2r)-2-Methylbutanoyl]Oxy}-1,2,6,7,8,8a-Hexahydronaphthalen-1-Yl)-3,5-Dihydroxyheptanoic Acid",QLJODMDSTUBWDW-BXMDZJJMSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
29409,6cs2,DB09148,-7.1,Florbetaben (18F),NCWZOASIUQVOFA-FWZJPQCDSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
112747,6vxx,DB07798,-7.1,"(3R)-3-(FLUOROMETHYL)-N-(3,3,3-TRIFLUOROPROPYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONAMIDE",BBUDQLKRZPRPFD-LLVKDONJSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77323,6m2n,DB08234,-7.1,"5-[3-(2,5-dimethoxyphenyl)prop-1-yn-1-yl]-6-ethylpyrimidine-2,4-diamine",NNFDQABYXZBKRK-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
112755,6vxx,DB07807,-7.1,"(3R,4R,5R)-5-(HYDROXYMETHYL)-1-(3-PHENYLPROPYL)PIPERIDINE-3,4-DIOL",NKARZGURZMIRMA-RBSFLKMASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165632,7bv1,DB12569,-7.1,Tonapofylline,ZWTVVWUOTJRXKM-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
77301,6m2n,DB08203,-7.1,"7-[2-METHOXY-1-(METHOXYMETHYL)ETHYL]-7H-PYRROLO[3,2-F] QUINAZOLINE-1,3-DIAMINE",MQTGHZCEDQNMOZ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
115519,6w4b,DB00948,-7.1,Mezlocillin,YPBATNHYBCGSSN-VWPFQQQWSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
30755,6cs2,DB12931,-7.1,Fenobam,DWPQODZAOSWNHB-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
77158,6m2n,DB08041,-7.1,3-BENZYLOXYCARBONYLAMINO-2-HYDROXY-4-PHENYL-BUTYRIC ACID,JXJYTERRLRAUSF-JKSUJKDBSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77151,6m2n,DB08033,-7.1,"(5R)-N,N-DIETHYL-5-METHYL-2-[(THIOPHEN-2-YLCARBONYL)AMINO]-4,5,6,7-TETRAHYDRO-1-BENZOTHIOPHENE-3-CARBOXAMIDE",UQKSYQYWUHUIEH-GFCCVEGCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77011,6m2n,DB07871,-7.1,6-CHLORO-4-(CYCLOHEXYLOXY)-3-ISOPROPYLQUINOLIN-2(1H)-ONE,OQCFORGSZJSAEL-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77009,6m2n,DB07869,-7.1,6-CHLORO-4-(CYCLOHEXYLSULFINYL)-3-PROPYLQUINOLIN-2(1H)-ONE,QRBUGQMJMFAHKS-HSZRJFAPSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
52444,2fxp,DB11431,-7.1,Moxidectin,YZBLFMPOMVTDJY-LSGXYNIPSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
115184,6w4b,DB00554,-7.1,Piroxicam,QYSPLQLAKJAUJT-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
77002,6m2n,DB07862,-7.1,"7-(1-ETHYL-PROPYL)-7H-PYRROLO-[3,2-F]QUINAZOLINE-1,3-DIAMINE",GCPJCLJGTVTGRF-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76993,6m2n,DB07852,-7.1,"1-(3,5-DICHLOROPHENYL)-5-METHYL-1H-1,2,4-TRIAZOLE-3-CARBOXYLIC ACID",CZTNDZALWLHXBA-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
165753,7bv1,DB12758,-7.1,Atreleuton,MMSNEKOTSJRTRI-LLVKDONJSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
8814,6lzg,DB06869,-7.1,1-[2-AMINO-2-CYCLOHEXYL-ACETYL]-PYRROLIDINE-3-CARBOXYLIC ACID 5-CHLORO-2-(2-ETHYLCARBAMOYL-ETHOXY)-BENZYLAMIDE,BMHVHOJXEQTIEA-SIKLNZKXSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
74952,6m2n,DB04054,-7.1,"9-Butyl-8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine",PASRTKOWXJDFFV-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
112966,6vxx,DB08203,-7.1,"7-[2-METHOXY-1-(METHOXYMETHYL)ETHYL]-7H-PYRROLO[3,2-F] QUINAZOLINE-1,3-DIAMINE",MQTGHZCEDQNMOZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29486,6cs2,DB09238,-7.1,Manidipine,ANEBWFXPVPTEET-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
76871,6m2n,DB07714,-7.1,"6-(3-METHYL-1,4-DIOXO-1,4-DIHYDRONAPHTHALEN-2-YL)HEXANOIC ACID",ICGRXHWXPCXIKM-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
165822,7bv1,DB13064,-7.1,Tramazoline,QQJLHRRUATVHED-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
115099,6w4b,DB00448,-7.1,Lansoprazole,MJIHNNLFOKEZEW-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
51292,2fxp,DB08006,-7.1,"N-anthracen-2-yl-5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7-amine",OXYDLVAOXASTMW-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
8796,6lzg,DB06848,-7.1,"1-(1'-{[3-(methylsulfanyl)-2-benzothiophen-1-yl]carbonyl}spiro[1-benzofuran-3,4'-piperidin]-5-yl)methanamine",VCUDZTCDUDDJGG-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
113051,6vxx,DB08314,-7.1,"(2-AMINO-1,3-OXAZOL-5-YL)-(3-BROMOPHENYL)METHANONE",YDCMMVTWXORJGO-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
52388,2fxp,DB11288,-7.1,Borneol,DTGKSKDOIYIVQL-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
74985,6m2n,DB04096,-7.1,"5-Amino-5-Deoxy-Cellobiono-1,5-Lactam",WXSNJJDPPISYEF-ZNLUKOTNSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76854,6m2n,DB07694,-7.1,"2,5-dichloro-N-(3,5-dibromo-4-hydroxyphenyl)benzamide",IFLWCZRMFPKYBN-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76913,6m2n,DB07762,-7.1,4-(N-ACETYLAMINO)-3-[N-(2-ETHYLBUTANOYLAMINO)]BENZOIC ACID,USKXJFHTBQWXCS-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
74697,6m2n,DB03722,-7.1,"3,4-Dihydro-5-Methyl-Isoquinolinone",RLLZPXDJYADIEU-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
112965,6vxx,DB08202,-7.1,4-({[(4-METHYLPIPERAZIN-1-YL)AMINO]CARBONOTHIOYL}AMINO)BENZENESULFONAMIDE,BPPLIZHQOIGRPZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77040,6m2n,DB07908,-7.1,7-HYDROXY-4-METHYL-3-(2-HYDROXY-ETHYL)COUMARIN,VCGFYFKJZGIZMX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
165685,7bv1,DB12657,-7.1,JNJ-42396302,BPLVDYJDAVYLRQ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
30744,6cs2,DB12919,-7.1,T-62,OTZVBZFYMFTYKH-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
20565,6cs2,HMDB0047807,-7.1,"TG(14:1(9Z)/18:0/22:4(7Z,10Z,13Z,16Z))",FAEIJJBFHNTKST-FCJLYCLESA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
77133,6m2n,DB08014,-7.1,(METHYLPYRIDAZINE PIPERIDINE BUTYLOXYPHENYL)ETHYLACETATE,AQILFLLHLFBLLG-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
165703,7bv1,DB12681,-7.1,Salirasib,WUILNKCFCLNXOK-CFBAGHHKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
77126,6m2n,DB08007,-7.1,(2R)-3-{[(BENZYLAMINO)CARBONYL]AMINO}-2-HYDROXYPROPANOIC ACID,KGFDIRSBGRVEFZ-SECBINFHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
115316,6w4b,DB00713,-7.1,Oxacillin,UWYHMGVUTGAWSP-JKIFEVAISA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
77117,6m2n,DB07996,-7.1,5-(2-methylpiperazine-1-sulfonyl)isoquinoline,BDVFVCGFMNCYPV-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
115299,6w4b,DB00694,-7.1,Daunorubicin,STQGQHZAVUOBTE-VGBVRHCVSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
112962,6vxx,DB08198,-7.1,"[(4R)-4-(3-HYDROXYPHENYL)-1,6-DIMETHYL-2-THIOXO-1,2,3,4-TETRAHYDROPYRIMIDIN-5-YL](PHENYL)METHANONE",JGBBILLMZPWNFU-QGZVFWFLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165706,7bv1,DB12686,-7.1,PHA-793887,HUXYBQXJVXOMKX-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
112900,6vxx,DB08128,-7.1,"(1S,4R,9S)-5-(trifluoromethyl)-1,2,3,4-tetrahydro-1,4-methanonaphthalen-9-amine",HHIJEPNAHYLKPE-DLLGPJQISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
115257,6w4b,DB00643,-7.1,Mebendazole,OPXLLQIJSORQAM-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
77074,6m2n,DB07947,-7.1,ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY)ETHYLAMINO)ETHYL)AMIDE,AUHWQSZMVMMRLM-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
30706,6cs2,DB00980,-7.1,Ramelteon,YLXDSYKOBKBWJQ-LBPRGKRZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
165724,7bv1,DB12714,-7.1,Nerispirdine,BTDHTARYCBHHPJ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
112937,6vxx,DB08167,-7.1,Methylthioninium,RBTBFTRPCNLSDE-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
115224,6w4b,DB00603,-7.1,Medroxyprogesterone acetate,PSGAAPLEWMOORI-PEINSRQWSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
8828,6lzg,DB06884,-7.1,4-HYDROXY-N'-(4-ISOPROPYLBENZYL)BENZOHYDRAZIDE,MFDXHRPPSJRQFX-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
30690,6cs2,DB12847,-7.1,Pyroxamide,PTJGLFIIZFVFJV-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
112899,6vxx,DB08127,-7.1,"1,3,3-trimethyl-2-[(1E,3E)-3-methylpenta-1,3-dien-1-yl]cyclohexene",KUEVAPFABUUVHS-AYCKBHPDSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
115076,6w4b,DB00421,-7.1,Spironolactone,LXMSZDCAJNLERA-ZHYRCANASA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
74693,6m2n,DB03718,-7.1,6-Aza-Ump,LRVZOSYMNMNQFR-SHUUEZRQSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
51130,2fxp,DB07817,-7.1,"1-{3-[(4-pyridin-2-ylpiperazin-1-yl)sulfonyl]phenyl}-3-(1,3-thiazol-2-yl)urea",NJPVZSIGDRLLTD-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
77925,6m2n,DB08992,-7.1,Eperisone,SQUNAWUMZGQQJD-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
31133,6cs2,DB13445,-7.1,Nepinalone,RVXGRCNWGOHSDE-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
77912,6m2n,DB08979,-7.1,Fenspiride,FVNFBBAOMBJTST-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
31122,6cs2,DB13433,-7.1,Simfibrate,JLRNKCZRCMIVKA-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
31118,6cs2,DB13429,-7.1,Tolonidine,KWBTZIFLQYYPTH-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
31115,6cs2,DB13425,-7.1,Flutrimazole,QHMWCHQXCUNUAK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
165301,7bv1,DB11900,-7.1,OC-459,FATGTHLOZSXOBC-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
9057,6lzg,DB07127,-7.1,"{4-[2,2-BIS(5-METHYL-1,2,4-OXADIAZOL-3-YL)-3-PHENYLPROPYL]PHENYL}SULFAMIC ACID",SXDBFKLPNPUPRI-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
31110,6cs2,DB13419,-7.1,Troxipide,YSIITVVESCNIPR-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
77878,6m2n,DB08936,-7.1,Chlorcyclizine,WFNAKBGANONZEQ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
9053,6lzg,DB07123,-7.1,N-(4-METHYLBENZOYL)-4-BENZYLPIPERIDINE,DVOLWKZEIDCCES-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
74506,6m2n,DB03448,-7.1,2'-Deoxyuridine 3'-Monophosphate,LXKGKXYIAAKOCT-SHYZEUOFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
165308,7bv1,DB11909,-7.1,Varespladib,BHLXTPHDSZUFHR-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
77853,6m2n,DB08895,-7.1,Tofacitinib,UJLAWZDWDVHWOW-YPMHNXCESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
165329,7bv1,DB11941,-7.1,Tasisulam,WWONFUQGBVOKOF-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
77845,6m2n,DB08880,-7.1,Teriflunomide,UTNUDOFZCWSZMS-YFHOEESVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
165335,7bv1,DB11948,-7.1,Lapachone,QZPQTZZNNJUOLS-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
77828,6m2n,DB08843,-7.1,GS 0573,XHXFQGAZAVKMFF-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
165341,7bv1,DB11958,-7.1,Brivanib,WCWUXEGQKLTGDX-LLVKDONJSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
116039,6w4b,DB01624,-7.1,Zuclopenthixol,WFPIAZLQTJBIFN-DVZOWYKESA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
165262,7bv1,DB11675,-7.1,Mosapride,YPELFRMCRYSPKZ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
77944,6m2n,DB09013,-7.1,Befunolol,ZPQPDBIHYCBNIG-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
9091,6lzg,DB07164,-7.1,"N-cyclopropyl-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amine",CAGHIASAHLPQMS-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
9136,6lzg,DB07212,-7.1,N-(7-CARBAMIMIDOYL-NAPHTHALEN-1-YL)-3-HYDROXY-2-METHYL-BENZAMIDE,NNGZRCYXFBHMRM-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
78041,6m2n,DB09189,-7.1,Daledalin,YFAIJBZEDDOCAN-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
112351,6vxx,DB07004,-7.1,2-[(5-hex-1-yn-1-ylfuran-2-yl)carbonyl]-N-methylhydrazinecarbothioamide,CUKZXTKQBXLMDO-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
9129,6lzg,DB07205,-7.1,N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,GZJXCRHEMLAMRA-SDBHATRESA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
165208,7bv1,DB11555,-7.1,Zolazepam,GDSCFOSHSOWNDL-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
31197,6cs2,DB13528,-7.1,Chlormadinone,VUHJZBBCZGVNDZ-TTYLFXKOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
116168,6w4b,DB01793,-7.1,SB-409513,ONVZFCHLOZUXRP-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
31193,6cs2,DB13523,-7.1,Veralipride,RYJXBGGBZJGVQF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
116159,6w4b,DB01782,-7.1,"2,6-Dihydroanthra/1,9-Cd/Pyrazol-6-One",ACPOUJIDANTYHO-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
20303,6cs2,HMDB0046509,-7.1,TG(22:0/18:1(9Z)/16:1(9Z)),LLZPZRGVBKFBKR-GIEBDLEXSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
29327,6cs2,DB00835,-7.1,Brompheniramine,ZDIGNSYAACHWNL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
116149,6w4b,DB01767,-7.1,Hemi-Babim,KKJYVDXDZURHMA-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
165248,7bv1,DB11654,-7.1,T-2000,RRFBTKHQZRCRSS-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
165250,7bv1,DB11658,-7.1,QAV-680,YOPFAMROKXHVCQ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
77987,6m2n,DB09084,-7.1,Benzydamine,CNBGNNVCVSKAQZ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
20239,6cs2,HMDB0000916,-7.1,Uroporphyrin III,VZVFNUAIRVUCEW-UJJXFSCMSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
52877,2fxp,DB12154,-7.1,Itacitinib,KTBSXLIQKWEBRB-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
77970,6m2n,DB09061,-7.1,Cannabidiol,QHMBSVQNZZTUGM-ZWKOTPCHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77968,6m2n,DB09056,-7.1,Amorolfine,MQHLMHIZUIDKOO-AYHJJNSGSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
112394,6vxx,DB07052,-7.1,5'-S-ethyl-5'-thioadenosine,HMXHURAGFHWODC-WOUKDFQISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165235,7bv1,DB11633,-7.1,Isavuconazole,DDFOUSQFMYRUQK-RCDICMHDSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
112508,6vxx,DB07332,-7.1,"ALPHA-(2,6-DICHLOROPHENYL)-ALPHA-(2-ACETYL-5-METHYLANILINO)ACETAMIDE",CJPLEFFCVDQQFZ-INIZCTEOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
115911,6w4b,DB01474,-7.1,"17alpha-methyl-3beta,17beta-dihydroxyandrost-4-ene",BNUOCVTVOYWNJC-DTMQFJJTSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
115873,6w4b,DB01431,-7.1,Allylestrenol,ATXHVCQZZJYMCF-XUDSTZEESA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
30989,6cs2,DB13278,-7.1,Bucetin,LIAWQASKBFCRNR-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
30986,6cs2,DB13275,-7.1,Clorindione,NJDUWAXIURWWLN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
112611,6vxx,DB07454,-7.1,(R)-3-BROMO-2-HYDROXY-2-METHYL-N-[4-NITRO-3-(TRIFLUOROMETHYL)PHENYL]PROPANAMIDE,QDSWNDMHSBZXKX-JTQLQIEISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
8991,6lzg,DB07056,-7.1,"2-(6-{[(3-chloro-2-methylphenyl)sulfonyl]amino}pyridin-2-yl)-N,N-diethylacetamide",JNWQLOFSMUGRNY-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
115720,6w4b,DB01180,-7.1,Rescinnamine,SZLZWPPUNLXJEA-LAFLMMDJSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
165453,7bv1,DB12123,-7.1,Cinepazide,RCUDFXMNPQNBDU-VOTSOKGWSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
29362,6cs2,DB09068,-7.1,Vortioxetine,YQNWZWMKLDQSAC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
29371,6cs2,DB00841,-7.1,Dobutamine,JRWZLRBJNMZMFE-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
165492,7bv1,DB12184,-7.1,Gepirone,QOIGKGMMAGJZNZ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
7868,6lzg,DB04480,-7.1,"3-(4-Fluorophenyl)-2-(6-Methylpyridin-2-Yl)-5,6-Dihydro-4h-Pyrrolo[1,2-B]Pyrazole",NBDZLUOYAAVYHF-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
30938,6cs2,DB13217,-7.1,Fentiazac,JIEKMACRVQTPRC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
165505,7bv1,DB12204,-7.1,Terbogrel,XUTLOCQNGLJNSA-RGVLZGJSSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
52683,2fxp,DB11871,-7.1,PF-00610355,YPHDIMUXXABSSO-YTTGMZPUSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
74670,6m2n,DB03685,-7.1,Uridine monophosphate,DJJCXFVJDGTHFX-XVFCMESISA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
30924,6cs2,DB13185,-7.1,Oxabolone cipionate,KHKDIUPVDIEHAH-KXLSUQFWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
77548,6m2n,DB08511,-7.1,"6-amino-2-methyl-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",PLJNUNPYZVVIRA-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
165523,7bv1,DB12229,-7.1,Cerlapirdine,NXQGEDVQXVTCDA-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
52673,2fxp,DB11853,-7.1,Relugolix,AOMXMOCNKJTRQP-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
165526,7bv1,DB12233,-7.1,Iguratimod,ANMATWQYLIFGOK-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
112662,6vxx,DB07516,-7.1,"(2Z,4E)-3-chloro-2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoic acid",IBJDCVXDXGFGIO-FKTQTOOFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
77601,6m2n,DB08574,-7.1,"(5R)-2-SULFANYL-5-[4-(TRIFLUOROMETHYL)BENZYL]-1,3-THIAZOL-4-ONE",HBYVUUWMCCSRBI-MRVPVSSYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
115616,6w4b,DB01061,-7.1,Azlocillin,JTWOMNBEOCYFNV-NFFDBFGFSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
115759,6w4b,DB01222,-7.1,Budesonide,VOVIALXJUBGFJZ-KWVAZRHASA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
77674,6m2n,DB08662,-7.1,3-[1-(4-BROMO-PHENYL)-2-METHYL-PROPYL]-4-HYDROXY-CHROMEN-2-ONE,KGDWLSFLMSFPSU-INIZCTEOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77775,6m2n,DB08778,-7.1,"[4-amino-2-(tert-butylamino)-1,3-thiazol-5-yl](phenyl)methanone",KEHNGAHNKVLUSC-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
115872,6w4b,DB01430,-7.1,Almitrine,OBDOVFRMEYHSQB-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
74546,6m2n,DB03503,-7.1,"4-Acetyl-4-Guanidino-6-Methyl(Propyl)Carboxamide-4,5-Dihydro-2h-Pyran-2-Carboxylic Acid",QPJWMZVTNXFTKV-JMJZKYOTSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
74547,6m2n,DB03504,-7.1,"9-Butyl-8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-9h-Purin-6-Ylamine",IVPCTHKPOPQMSX-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
77756,6m2n,DB08757,-7.1,5-(2-chlorophenyl)furan-2-carbohydrazide,XQMRHWSGTVEDFG-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
31061,6cs2,DB13358,-7.1,Cibenzoline,IPOBOOXFSRWSHL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
112545,6vxx,DB07377,-7.1,"N'-((2S,3R)-3-AMINO-2-HYDROXY-5-(ISOPROPYLSULFANYL)PENTANOYL)-N-3-CHLOROBENZOYL HYDRAZIDE",BYBVYIPUGPZRSX-OLZOCXBDSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
115838,6w4b,DB01380,-7.1,Cortisone acetate,ITRJWOMZKQRYTA-RFZYENFJSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
31040,6cs2,DB13337,-7.1,Pheneticillin,NONJJLVGHLVQQM-JHXYUMNGSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
74605,6m2n,DB03592,-7.1,Pterin-6-Yl-Methyl-Monophosphate,AJXFJEHKGGCFNM-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
31037,6cs2,DB13335,-7.1,Pinazepam,MFZOSKPPVCIFMT-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
77716,6m2n,DB08715,-7.1,"2,6-DIMETHYL-1-(3-[3-METHYL-5-ISOXAZOLYL]-PROPANYL)-4-[2-METHYL-4-ISOXAZOLYL]-PHENOL",SLPKYEWAKMNCPT-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
31028,6cs2,DB01012,-7.1,Cinacalcet,VDHAWDNDOKGFTD-MRXNPFEDSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
165399,7bv1,DB12046,-7.1,Atopaxar,QWKAUGRRIXBIPO-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
115792,6w4b,DB01273,-7.1,Varenicline,JQSHBVHOMNKWFT-DTORHVGOSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
29355,6cs2,DB09056,-7.1,Amorolfine,MQHLMHIZUIDKOO-AYHJJNSGSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
74593,6m2n,DB03577,-7.1,Alpha-Benzyl-Aminobenzyl-Phosphonic Acid,SLMGIUOAZCYKPE-CQSZACIVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
165417,7bv1,DB12072,-7.1,Orantinib,NHFDRBXTEDBWCZ-ZROIWOOFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
31004,6cs2,DB13300,-7.1,Epicillin,RPBAFSBGYDKNRG-NJBDSQKTSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
112591,6vxx,DB07431,-7.1,"(3R)-3-(aminomethyl)-9-methoxy-1,2,3,4-tetrahydro-5H-[1]benzothieno[3,2-e][1,4]diazepin-5-one",TXYKBKYDFZQOCB-SSDOTTSWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
115823,6w4b,DB01347,-7.1,Saprisartan,DUEWVPTZCSAMNB-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
78056,6m2n,DB09204,-7.1,Arotinolol,BHIAIPWSVYSKJS-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
74989,6m2n,DB04101,-7.1,"N-[4-(2,4-Dimethyl-1,3-Thiazol-5-Yl)Pyrimidin-2-Yl]-N'-Hydroxyimidoformamide",OVKZTPFHUYGZBI-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
115065,6w4b,DB00408,-7.1,Loxapine,XJGVXQDUIWGIRW-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
51595,2fxp,DB08366,-7.1,"3-({3-[(1S,4aS,6S,7S,9S,9aR)-1,6-dimethyl-2-oxodecahydro-6,9-epoxy-4a,7-methanobenzo[7]annulen-1-yl]propanoyl}amino)-2,4-dihydroxybenzoic acid",XADCWKSMHQPTGH-OFBLZTNGSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
166301,7bv1,DB14632,-7.1,Prednisolone tebutate,HUMXXHTVHHLNRO-KAJVQRHHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
113623,6vxx,DB11667,-7.1,2'-cyano-2'-deoxy-1-(beta-D-arabinofuranosyl)cytosine,DCYBPMFXJCWXNB-JWIUVKOKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
166311,7bv1,DB14643,-7.1,Methylprednisolone aceponate,DALKLAYLIPSCQL-YPYQNWSCSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
114426,6vxx,DB13424,-7.1,Clofenotane,YVGGHNCTFXOJCH-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114423,6vxx,DB13420,-7.1,Thiazinam,CDXCCYNINPIWGE-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
166323,7bv1,DB14655,-7.1,Drostanolone propionate,NOTIQUSPUUHHEH-UXOVVSIBSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
8555,6lzg,DB06368,-7.1,Alamifovir,VDBGPMJFHCJMOL-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
166338,7bv1,DB14671,-7.1,Temazepam acetate,PTWWAHZQIATUFG-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
8140,6lzg,DB00547,-7.1,Desoximetasone,VWVSBHGCDBMOOT-IIEHVVJPSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
166358,7bv1,DB14720,-7.1,Brovanexine,DQTRREPKGJIABH-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
75367,6m2n,DB04604,-7.1,5-iodotubercidin,WHSIXKUPQCKWBY-IOSLPCCCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
114370,6vxx,DB13350,-7.1,Azanidazole,LHIALLMPKJMSIQ-NSCUHMNNSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
8527,6lzg,DB06280,-7.1,Senicapoc,SCTZUZTYRMOMKT-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
29701,6cs2,DB11436,-7.1,Nifurpirinol,JQKHJQJVKRFMCO-SNAWJCMRSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
30174,6cs2,DB12146,-7.1,Rigosertib,OWBFCJROIKNMGD-BQYQJAHWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
8524,6lzg,DB06274,-7.1,Alvimopan,UPNUIXSCZBYVBB-JVFUWBCBSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
29717,6cs2,DB00876,-7.1,Eprosartan,OROAFUQRIXKEMV-LDADJPATSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
114319,6vxx,DB13286,-7.1,Bumadizone,FLWFHHFTIRLFPV-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76179,6m2n,DB06905,-7.1,"(2S,3S,4E,6E,8S,9S)-3-amino-9-methoxy-2,6,8-trimethyl-10-phenyldeca-4,6-dienoic acid",HJVCHYDYCYBBQX-HLTLHRPFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76187,6m2n,DB06913,-7.1,"(2R,3R)-3-{[3,5-BIS(TRIFLUOROMETHYL)PHENYL]AMINO}-2-CYANO-3-THIOXOPROPANAMIDE",ZTUMRSFHUOBXAC-LHIURRSHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
166286,7bv1,DB14575,-7.1,Eslicarbazepine,BMPDWHIDQYTSHX-AWEZNQCLSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
76203,6m2n,DB06929,-7.1,1-butanoyl-N-(4-carbamimidoylbenzyl)-L-prolinamide,RYAZZWWVNUWKNB-AWEZNQCLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76349,6m2n,DB07104,-7.1,4-amino-N-[4-(benzyloxy)phenyl]butanamide,QTWBKNVNGVYTNZ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
166162,7bv1,DB13773,-7.1,Sulfamethoxypyridazine,VLYWMPOKSSWJAL-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
8634,6lzg,DB06579,-7.1,Adipiplon,UAMAIHOEGLEXSV-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
76336,6m2n,DB07087,-7.1,"4-[(1S,2S,5S,9R)-5-(HYDROXYMETHYL)-8,9-DIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL",YMSZEVAWRFDVQX-GHVWTTSJSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76335,6m2n,DB07086,-7.1,"4-[(1S,2S,5S)-5-(HYDROXYMETHYL)-8-METHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL",XXIFNRNIQJKFLP-XHSDSOJGSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
30340,6cs2,DB12359,-7.1,BIIB021,QULDDKSCVCJTPV-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
166176,7bv1,DB13790,-7.1,Fipexide,BFUJHVVEMMWLHC-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
8620,6lzg,DB06532,-7.1,Pafuramidine,UKOQVLAXCBRRGH-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
113513,6vxx,DB09289,-7.1,Tianeptine,JICJBGPOMZQUBB-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75955,6m2n,DB06506,-7.1,Repinotan,YGYBFMRFXNDIPO-QGZVFWFLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
114492,6vxx,DB13696,-7.1,Bromochlorosalicylanilide,QBSGXIBYUQJHMJ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
76290,6m2n,DB07035,-7.1,"(2E)-3-{3-[(5-ETHYL-3-IODO-6-METHYL-2-OXO-1,2-DIHYDROPYRIDIN-4-YL)OXY]PHENYL}ACRYLONITRILE",XMFUXIRAVPMVRS-FNORWQNLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76273,6m2n,DB07017,-7.1,"(5S)-2-{[(1S)-1-(4-fluorophenyl)ethyl]amino}-5-(1-hydroxy-1-methylethyl)-5-methyl-1,3-thiazol-4(5H)-one",HYVZYASDRIAOPU-BJOHPYRUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
166259,7bv1,DB14232,-7.1,Deacetylbisacodyl,LJROKJGQSPMTKB-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
8595,6lzg,DB06471,-7.1,Naxifylline,NJYNSYQBNSDGIQ-RDDCQWBRSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
166272,7bv1,DB14541,-7.1,Hydrocortisone cypionate,DLVOSEUFIRPIRM-KAQKJVHQSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
30290,6cs2,DB00934,-7.1,Maprotiline,QSLMDECMDJKHMQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
113584,6vxx,DB11584,-7.1,Pipradrol,XSWHNYGMWWVAIE-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
20980,6cs2,HMDB0049247,-7.1,"TG(18:1(11Z)/16:1(9Z)/18:3(6Z,9Z,12Z))",YOEDLSRYINEBNN-OQMRYGIWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
76210,6m2n,DB06936,-7.1,N-(4-carbamimidoylbenzyl)-1-(4-methylpentanoyl)-L-prolinamide,AEKJCSNKYXWOAQ-INIZCTEOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
114476,6vxx,DB13678,-7.1,Dihexyverine,MNSQDVCVWNXBFQ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114306,6vxx,DB13270,-7.1,Dibekacin,JJCQSGDBDPYCEO-XVZSLQNASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75425,6m2n,DB04681,-7.1,BETA-METHYLLACTOSIDE,FHNIYFZSHCGBPP-ABBMIVAOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
114288,6vxx,DB13243,-7.1,Tiazofurine,FVRDYQYEVDDKCR-DBRKOABJSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
8236,6lzg,DB04957,-7.1,Azimilide,MREBEPTUUMTTIA-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
75510,6m2n,DB04800,-7.1,1-METHYL-3-PHENYL-1H-PYRAZOL-5-YLSULFAMIC ACID,OTZLVSGSRPNRFT-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75760,6m2n,DB05805,-7.1,NS-2359,PGYDXVBZYKQYCS-VPWBDBDCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
29989,6cs2,DB11902,-7.1,Gisadenafil,YPFZMBHKIVDSNR-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
51898,2fxp,DB08731,-7.1,"2-[(1R)-2-carboxy-1-(naphthalen-1-ylmethyl)ethyl]-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylic acid",GPOKTQCDBPECSS-MRXNPFEDSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
51746,2fxp,DB08546,-7.1,"4-[(3AS,4R,7R,8AS,8BR)-2-(1,3-BENZODIOXOL-5-YLMETHYL)-7-HYDROXY-1,3-DIOXODECAHYDROPYRROLO[3,4-A]PYRROLIZIN-4-YL]BENZENECARBOXIMIDAMIDE",CETLUACQMGBMFH-ZALSBGIRSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
29811,6cs2,DB11670,-7.1,SP-8203,SJZBPVOSFYUHFV-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
8264,6lzg,DB05087,-7.1,Ganaxolone,PGTVWKLGGCQMBR-FLBATMFCSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
114090,6vxx,DB12713,-7.1,Sotagliflozin,QKDRXGFQVGOQKS-CRSSMBPESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
75485,6m2n,DB04768,-7.1,Pyrithiamine Pyrophosphate,ZHKSTKOYQKNDSJ-UHFFFAOYSA-O,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
166526,7bv1,DB15300,-7.1,Hydroquinidine,LJOQGZACKSYWCH-LHHVKLHASA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
8307,6lzg,DB05316,-7.1,Pimavanserin,RKEWSXXUOLRFBX-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
75651,6m2n,DB05186,-7.1,SQ-109,JFIBVDBTCDTBRH-REZTVBANSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
113952,6vxx,DB12314,-7.1,Chlorproguanil,ISZNZKHCRKXXAU-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114022,6vxx,DB12605,-7.1,Etripamil,VAZNEHLGJGSQEL-MHZLTWQESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29884,6cs2,DB11766,-7.1,AZD-1305,BLLNYXOLLAVTRF-HDICACEKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
29897,6cs2,DB11784,-7.1,NRX-1074,DVBUEXCIEIAXPM-PJUQSVSOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
29895,6cs2,DB11781,-7.1,Tosedostat,FWFGIHPGRQZWIW-SQNIBIBYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
75604,6m2n,DB04947,-7.1,Altropane,GTQLIPQFXVKRKJ-UNSMHXHVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
166601,7bv1,DB15457,-7.1,Snubh-nm-333 F-18,QLWFXLJVGCECSV-HUYCHCPVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
75542,6m2n,DB04838,-7.1,Cyclandelate,WZHCOOQXZCIUNC-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
166155,7bv1,DB13762,-7.1,Dexrabeprazole,YREYEVIYCVEVJK-RUZDIDTESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
114190,6vxx,DB12879,-7.1,Omigapil,QLMMOGWZCFQAPU-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
8423,6lzg,DB05959,-7.1,ENMD-1198,YQJWOUQGXATDAE-ACNBBOPNSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
75940,6m2n,DB06468,-7.1,Cariporide,IWXNYAIICFKCTM-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75434,6m2n,DB04695,-7.1,Farnesyl thiopyrophosphate,MYMLCRQRXFRQGP-YFVJMOTDSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
166419,7bv1,DB15097,-7.1,Gefapixant,HLWURFKMDLAKOD-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
29734,6cs2,DB11490,-7.1,Nalorphine,UIQMVEYFGZJHCZ-SSTWWWIQSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
8168,6lzg,DB04842,-7.1,Fluspirilene,QOYHHIBFXOOADH-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
75911,6m2n,DB06397,-7.1,Nicaraven,KTXBOOWDLPUROC-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
30093,6cs2,DB12043,-7.1,Sepetaprost,BKVUSNOUTQMSBE-XCMGCKIWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
21324,6cs2,HMDB0001238,-7.1,N-Acetylserotonin,MVAWJSIDNICKHF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
113783,6vxx,DB12079,-7.1,Gefarnate,ZPACYDRSPFRDHO-ROBAGEODSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
8421,6lzg,DB05943,-7.1,Resatorvid,LEEIJTHMHDMWLJ-CQSZACIVSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
30088,6cs2,DB12039,-7.1,Epicatechin,PFTAWBLQPZVEMU-UKRRQHHQSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
166455,7bv1,DB15167,-7.1,Fallypride,OABRYNHZQBZDMG-INIZCTEOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
113798,6vxx,DB12100,-7.1,Abediterol,SFYAXIFVXBKRPK-QFIPXVFZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
8192,6lzg,DB04873,-7.1,Piboserod,KVCSJPATKXABRQ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
8439,6lzg,DB00580,-7.1,Valdecoxib,LNPDTQAFDNKSHK-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
8438,6lzg,DB06083,-7.1,Tapinarof,ZISJNXNHJRQYJO-CMDGGOBGSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
113811,6vxx,DB12117,-7.1,Mitometh,MOTIYCLHZZLHHQ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29767,6cs2,DB11582,-7.1,Thiocolchicoside,LEQAKWQJCITZNK-AXHKHJLKSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
8428,6lzg,DB05974,-7.1,Transcrocetinate,PANKHBYNKQNAHN-MQQNZMFNSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
75833,6m2n,DB06193,-7.1,Pixantrone,PEZPMAYDXJQYRV-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
29758,6cs2,DB11555,-7.1,Zolazepam,GDSCFOSHSOWNDL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
52381,2fxp,DB11273,-7.1,Dihydroergocornine,SEALOBQTUQIVGU-QNIJNHAOSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
29620,6cs2,DB00180,-7.1,Flunisolide,XSFJVAJPIHIPKU-XWCQMRHXSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
30366,6cs2,DB00942,-7.1,Cycrimine,SWRUZBWLEWHWRI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
113177,6vxx,DB08633,-7.1,TNP-470,MSHZHSPISPJWHW-PVDLLORBSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114959,6w4b,DB00278,-7.1,Argatroban,KXNPVXPOPUZYGB-IOVMHBDKSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
113180,6vxx,DB08636,-7.1,2-Hydroxybenzalpyruvate,HMXOGGUFCBUALL-AATRIKPKSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30528,6cs2,DB12608,-7.1,Emixustat,WJIGGYYSZBWCGC-MRXNPFEDSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
114928,6vxx,DB15427,-7.1,Fialuridine,IPVFGAYTKQKGBM-BYPJNBLXSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114922,6vxx,DB15412,-7.1,LB-100,JUQMLSGOTNKJKI-IZUQBHJASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113192,6vxx,DB08651,-7.1,3'-THIO-THYMIDINE-5'-PHOSPHATE,BORVFKJZAOEGOO-GJMOJQLCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
8736,6lzg,DB06746,-7.1,ginkgolide-J,LMEHVEUFNRJAAV-UKWFQYJJSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
8735,6lzg,DB06745,-7.1,ginkgolide-C,AMOGMTLMADGEOQ-DTDWCABLSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
30522,6cs2,DB00959,-7.1,Methylprednisolone,VHRSUDSXCMQTMA-PJHHCJLFSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
7918,6lzg,DB04542,-7.1,3'-Azido-3'-Deoxythymidine-5'-Diphosphate,QOYVAFWJURKBJG-XLPZGREQSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
29551,6cs2,DB09355,-7.1,Sulfabenzamide,PBCZLFBEBARBBI-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
75092,6m2n,DB04234,-7.1,N2-({[(4-Bromophenyl)Methyl]Oxy}Carbonyl)-N1-[(1s)-1-Formylpentyl]-L-Leucinamide,UEDKSAKLZBMNMA-ROUUACIJSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76635,6m2n,DB07431,-7.1,"(3R)-3-(aminomethyl)-9-methoxy-1,2,3,4-tetrahydro-5H-[1]benzothieno[3,2-e][1,4]diazepin-5-one",TXYKBKYDFZQOCB-SSDOTTSWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
114869,6vxx,DB15300,-7.1,Hydroquinidine,LJOQGZACKSYWCH-LHHVKLHASA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
8722,6lzg,DB06730,-7.1,Gestodene,SIGSPDASOTUPFS-XUDSTZEESA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
29561,6cs2,DB09421,-7.1,Protirelin,XNSAINXGIQZQOO-SRVKXCTJSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
165997,7bv1,DB13550,-7.1,Bifemelane,QSQQPMHPCBLLGX-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
30491,6cs2,DB12557,-7.1,FK-614,UYGZODVVDUIDDQ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
113176,6vxx,DB08632,-7.1,"1,3,5-BENZENETRICARBOXYLIC ACID",QMKYBPDZANOJGF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113170,6vxx,DB08622,-7.1,"4-(4-CHLORO-PHENYL)-1-{3-[2-(4-FLUORO-PHENYL)-[1,3]DITHIOLAN-2-YL]-PROPYL}-PIPERIDIN-4-OL",KVDKNVPAAQKHKD-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113169,6vxx,DB08621,-7.1,Thiamphenicol,OTVAEFIXJLOWRX-NXEZZACHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
8739,6lzg,DB00611,-7.1,Butorphanol,IFKLAQQSCNILHL-PWRODBHTSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
115062,6w4b,DB00404,-7.1,Alprazolam,VREFGVBLTWBCJP-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
115037,6w4b,DB00374,-7.1,Treprostinil,PAJMKGZZBBTTOY-ZFORQUDYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
30592,6cs2,DB12704,-7.1,Spiradoline,NYKCGQQJNVPOLU-ONTIZHBOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
115030,6w4b,DB00367,-7.1,Levonorgestrel,WWYNJERNGUHSAO-XUDSTZEESA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
165873,7bv1,DB13153,-7.1,Levomenol,RGZSQWQPBWRIAQ-CABCVRRESA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
76783,6m2n,DB07610,-7.1,"NAPHTHALENE-1,2-DIOL",NXPPAOGUKPJVDI-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
165875,7bv1,DB13155,-7.1,Esculin,XHCADAYNFIFUHF-TVKJYDDYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
75013,6m2n,DB04133,-7.1,Degraded Cephaloridine,SFVACKBZMIZHCK-ZWNOBZJWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76772,6m2n,DB07593,-7.1,1-(PHENYLMETHYL)CYCLOPENTYL[(1S)-1-FORMYLPENTYL]CARBAMATE,ONABDOMWRCXLPX-KRWDZBQOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75111,6m2n,DB04260,-7.1,"9-(5,5-Difluoro-5-Phosphonopentyl)Guanine",JANQQPWTLXUSCD-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
113106,6vxx,DB08544,-7.1,(S)-Fluoxetine,RTHCYVBBDHJXIQ-INIZCTEOSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165880,7bv1,DB13166,-7.1,Zofenopril,IAIDUHCBNLFXEF-MNEFBYGVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
76764,6m2n,DB07585,-7.1,"5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine",YFFJXGRXFASBDL-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76754,6m2n,DB07572,-7.1,3-{[(4-methylphenyl)sulfonyl]amino}propyl pyridin-4-ylcarbamate,ITYCDQJBLCTIID-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
113129,6vxx,DB08573,-7.1,3-[(4-CHLOROANILINO)SULFONYL]THIOPHENE-2-CARBOXYLIC ACID,YRWKEEDITQJPCZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114995,6w4b,DB00321,-7.1,Amitriptyline,KRMDCWKBEZIMAB-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
75025,6m2n,DB04149,-7.1,(R)-Rolipram,HJORMJIFDVBMOB-LBPRGKRZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
8755,6lzg,DB06786,-7.1,Halcinonide,MUQNGPZZQDCDFT-JNQJZLCISA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
30549,6cs2,DB12643,-7.1,Nelivaptan,NJXZWIIMWNEOGJ-WEWKHQNJSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
113165,6vxx,DB08615,-7.1,"2-[4-(DIMETHYLAMINO)PHENYL]-6-HYDROXY-3-METHYL-1,3-BENZOTHIAZOL-3-IUM",NOVJJPLRUMZSDK-UHFFFAOYSA-O,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
115016,6w4b,DB00348,-7.1,Nitisinone,OUBCNLGXQFSTLU-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
29568,6cs2,DB00860,-7.1,Prednisolone,OIGNJSKKLXVSLS-VWUMJDOOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
113255,6vxx,DB08726,-7.1,"5-(7-(4-(4,5-dihydro-2-oxazolyl)phenoxy)heptyl)-3-methyl isoxazole",FKLJPTJMIBLJAV-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29569,6cs2,DB09495,-7.1,Avobenzone,XNEFYCZVKIDDMS-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
166101,7bv1,DB13686,-7.1,Clometocillin,JKXQBIZCQJLVOS-GSNLGQFWSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
114647,6vxx,DB13946,-7.1,Testosterone undecanoate,UDSFVOAUHKGBEK-CNQKSJKFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114632,6vxx,DB13920,-7.1,Valopicitabine,TVRCRTJYMVTEFS-ICGCPXGVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113399,6vxx,DB09118,-7.1,Stiripentol,IBLNKMRFIPWSOY-FNORWQNLSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
30399,6cs2,DB12429,-7.1,CI-1040,GFMMXOIFOQCCGU-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
75188,6m2n,DB04367,-7.1,Debromohymenialdisine,JYRJOQGKGMHTOO-VURMDHGXSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
166113,7bv1,DB13708,-7.1,Fenquizone,DBDTUXMDTSTPQZ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
8089,6lzg,DB04754,-7.1,"GUANOSINE-2',3'-O-ETHYLIDENEPHOSPHONATE",HYAPEMYRVFIHDJ-QWEIRQIHSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
76414,6m2n,DB07176,-7.1,5-aminonaphthalene-1-sulfonic acid,DQNAQOYOSRJXFZ-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
8672,6lzg,DB06652,-7.1,Vicriviroc,CNPVJJQCETWNEU-CYFREDJKSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
21381,6cs2,HMDB0050326,-7.1,TG(20:1(11Z)/15:0/20:3n6),SOCNQOBFARPJBO-NVTXZIGUSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
30386,6cs2,DB12416,-7.1,VTP-27999,NXWASIVXQMMPLM-ZXMXYHOLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
114594,6vxx,DB13837,-7.1,Doxefazepam,VOJLELRQLPENHL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29608,6cs2,DB11185,-7.1,Sulisobenzone,CXVGEDCSTKKODG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
75214,6m2n,DB04405,-7.1,"2-[2-(1,3-Dioxo-1,3-Dihydro-2h-Isoindol-2-Yl)Ethyl]-4-(4'-Ethoxy-1,1'-Biphenyl-4-Yl)-4-Oxobutanoic Acid",AQYSXARQCHHHLK-NRFANRHFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
166140,7bv1,DB13739,-7.1,Penamecillin,NLOOMWLTUVBWAW-HLLBOEOZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
8653,6lzg,DB06616,-7.1,Bosutinib,UBPYILGKFZZVDX-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
114569,6vxx,DB13803,-7.1,Xipamide,MTZBBNMLMNBNJL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
52148,2fxp,DB09076,-7.1,Umeclidinium,FVTWTVQXNAJTQP-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
30369,6cs2,DB12395,-7.1,Esreboxetine,CBQGYUDMJHNJBX-OALUTQOASA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
51493,2fxp,DB08237,-7.1,2'-deoxy-N-(naphthalen-1-ylmethyl)guanosine 5'-(dihydrogen phosphate),COMPKRGNHXOXMN-GVDBMIGSSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
76360,6m2n,DB07116,-7.1,1-(2-DEOXY-5-O-PHOSPHONO-BETA-D-ERYTHRO-PENTOFURANOSYL)-4-METHYL-1H-INDOLE,UXXYPWCUINVUHL-BFHYXJOUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
76495,6m2n,DB07272,-7.1,"N-(4-AMINO-5-CYANO-6-ETHOXYPYRIDIN-2-YL)-2-(4-BROMO-2,5-DIMETHOXYPHENYL)ACETAMIDE",GKODDLYLEKSDJL-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
8677,6lzg,DB06660,-7.1,Saredutant,PGKXDIMONUAMFR-AREMUKBSSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
8710,6lzg,DB06713,-7.1,Norelgestromin,ISHXLNHNDMZNMC-XUDSTZEESA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
20815,6cs2,HMDB0048730,-7.1,TG(16:1(9Z)/24:1(15Z)/20:2n6),ZULRYZCUNGPAHY-BFNALKGSSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
113273,6vxx,DB08744,-7.1,"6-methoxy-9-methyl[1,3]dioxolo[4,5-h]quinolin-8(9H)-one",DPXXJCMMMXZVSW-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
7971,6lzg,DB00528,-7.1,Lercanidipine,ZDXUKAKRHYTAKV-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
75125,6m2n,DB04278,-7.1,2-[2-(2-Cyclohexyl-2-Guanidino-Acetylamino)-Acetylamino]-N-(3-Mercapto-Propyl)-Propionamide,YLLNYDDZOMCFDE-SMDDNHRTSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
75127,6m2n,DB04280,-7.1,"((2r,3s,5r)-3-Hydroxy-5-(4-Hydroxy-2-Oxo-3,4-Dihydropyrimidin-1(2h)-Yl)-Tetrahydrofuran-2-Yl)Methyldihydrogen Phosphate",ILSIYJVILUIVPM-LXGUWJNJSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
114798,6vxx,DB14881,-7.1,Oliceridine,DMNOVGJWPASQDL-OAQYLSRUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
8003,6lzg,DB04642,-7.1,"7-{2,6-DICHLORO-4-[3-(2-CHLORO-BENZOYL)-UREIDO]-PHENOXY}-HEPTANOIC ACID",XQTOWNDCHQJXOQ-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
30466,6cs2,DB00952,-7.1,Naratriptan,AMKVXSZCKVJAGH-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
8069,6lzg,DB04726,-7.1,"7,8,10-TRIMETHYLBENZO[G]PTERIDINE-2,4(3H,10H)-DIONE",KPDQZGKJTJRBGU-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
113303,6vxx,DB08777,-7.1,"5,6,7,8-TETRAHYDRO[1]BENZOTHIENO[2,3-D]PYRIMIDIN-4(3H)-ONE",NMMOEJUJKIXUQZ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114723,6vxx,DB14714,-7.1,Tenivastatin,XWLXKKNPFMNSFA-HGQWONQESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113325,6vxx,DB08996,-7.1,Dimetacrine,RYQOGSFEJBUZBX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
51436,2fxp,DB08164,-7.1,"(3R,4R)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN-3-AMINE",GOBIXGZJSMAOFV-QRWLVFNGSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
114689,6vxx,DB14651,-7.1,Perphenazine enanthate,PWEGQJCIAMJJHC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
114688,6vxx,DB14650,-7.1,Menadiol diphosphate,JTNHOVZOOVVGHI-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
113356,6vxx,DB09040,-7.1,Efinaconazole,NFEZZTICAUWDHU-RDTXWAMCSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
8053,6lzg,DB04706,-7.1,"(3BETA,7BETA)-CHOLEST-5-ENE-3,7-DIOL",OYXZMSRRJOYLLO-KGZHIOMZSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
8055,6lzg,DB04708,-7.1,"(S)-TETRAHYDROFURAN-3-YL (2S,3S)-4-((S)-4-((1R,3R)-3-(2-AMINO-2-OXOETHYL)-2,3-DIHYDRO-1H-INDEN-1-YL)-2-BENZYL-3-OXO-2,3-DIHYDRO-1H-PYRROL-2-YL)-3-HYDROXY-1-PHENYLBUTAN-2-YLCARBAMATE",SYNSHNDQFWMLJW-YZGRCXSVSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
113367,6vxx,DB09062,-7.1,Cefminox,JSDXOWVAHXDYCU-VXSYNFHWSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
166018,7bv1,DB13580,-7.1,Succinylsulfathiazole,SKVLYVHULOWXTD-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
119398,6w4b,DB07268,-7.1,2-({2-[(3-HYDROXYPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)BENZAMIDE,QHPKKGUGRGRSGA-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
74407,6m2n,DB03307,-7.1,4-[(6-Amino-4-Pyrimidinyl)Amino]Benzenesulfonamide,FVFVVRPJERUECT-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
116334,6w4b,DB02021,-7.1,Fidarestat,WAAPEIZFCHNLKK-UFBFGSQYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
110834,6vxx,DB02470,-7.1,D-Glycero-D-Mannopyranose-7-Phosphate,SDADNVAZGVDAIM-QTNLNCNHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110836,6vxx,DB02472,-7.1,"6-Hydroxy-7,8-Dihydro Purine Nucleoside",ZWTNXGIZBOQCAJ-KQYNXXCUSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
28979,6cs2,DB08609,-7.1,"(2R)-N-{4-[Ethyl(phenyl)sulfamoyl]-2-methylphenyl}-3,3,3-trifluoro-2-hydroxy-2-methylpropanamide",SHEIQJGQDUYUBE-GOSISDBHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
28981,6cs2,DB08611,-7.1,"2-[(2',3',4'-TRIFLUOROBIPHENYL-2-YL)OXY]ETHANOL",AGXPXFPIOHNDAN-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
118814,6w4b,DB06370,-7.1,Indisulam,SETFNECMODOHTO-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
164233,7bv1,DB07408,-7.1,5-(2-NITROPHENYL)-2-FUROIC ACID,XUFDYUSOQQYQRL-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
32134,6cs2,DB15424,-7.1,Bfpet F-18,QWPLCHDPESWJRN-FNNGWQQSSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
118799,6w4b,DB06321,-7.1,R-348,IGLNXKVGKIFNBQ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
110865,6vxx,DB02507,-7.1,4-Hydroxy-3-[(1s)-3-Oxo-1-Phenylbutyl]-2h-Chromen-2-One,PJVWKTKQMONHTI-HNNXBMFYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
118796,6w4b,DB06311,-7.1,Darapladib,WDPFJWLDPVQCAJ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
110869,6vxx,DB02511,-7.1,2-Hydroxy-5-({1-[(2-Naphthyloxy)Methyl]-3-Oxoprop-1-Enyl}Amino)Tyrosine,PZWMZAFFUAWVDN-CQXYXCHQSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
80191,6m2n,DB14841,-7.1,Centanafadine,HKHCSWPSUSWGLI-CABCVRRESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
110886,6vxx,DB02532,-7.1,"2,4,6-Triaminoquinazoline",LJBWEZVYRBKOCI-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
118781,6w4b,DB06268,-7.1,Sitaxentan,PHWXUGHIIBDVKD-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
53658,2fxp,DB13347,-7.1,Diphenadione,JYGLAHSAISAEAL-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
50404,2fxp,DB06976,-7.1,"1-(5-OXO-2,3,5,9B-TETRAHYDRO-1H-PYRROLO[2,1-A]ISOINDOL-9-YL)-3-(5-PYRROLIDIN-2-YL-1H-PYRAZOL-3-YL)-UREA",IWOOJEZSDPRYAZ-WFASDCNBSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
164283,7bv1,DB07649,-7.1,"(3R,4S)-1-[(4-amino-5H-pyrrolo[3,2-d]pyrimidin-7-yl)methyl]-4-[(benzylsulfanyl)methyl]pyrrolidin-3-ol",DIGGNILBPCEZIV-CVEARBPZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
118770,6w4b,DB06249,-7.1,Arzoxifene,MCGDSOGUHLTADD-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
118762,6w4b,DB06235,-7.1,Vadimezan,XGOYIMQSIKSOBS-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
118815,6w4b,DB06374,-7.1,Elacestrant,SIFNOOUKXBRGGB-AREMUKBSSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
164220,7bv1,DB07394,-7.1,AUROVERTIN B,QXCOFYWOWZJFEA-YJMRODJJSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
118819,6w4b,DB06401,-7.1,Bazedoxifene,UCJGJABZCDBEDK-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
73583,6m2n,DB02230,-7.1,Immucillin-G,KBIDJCVAURJXFG-PVEDRDFWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
32216,6cs2,DB01188,-7.1,Ciclopirox,SCKYRAXSEDYPSA-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
118897,6w4b,DB06597,-7.1,Estradiol sulfamate,YXYXCSOJKUAPJI-ZBRFXRBCSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
80486,6m2n,DB15457,-7.1,Snubh-nm-333 F-18,QLWFXLJVGCECSV-HUYCHCPVSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80452,6m2n,DB15394,-7.1,gamma-Tocopherol,QUEDXNHFTDJVIY-DQCZWYHMSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
118875,6w4b,DB06533,-7.1,Ragaglitazar,WMUIIGVAWPWQAW-XMMPIXPASA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
164184,7bv1,DB07350,-7.1,(2E)-N-hydroxy-3-[1-methyl-4-(phenylacetyl)-1H-pyrrol-2-yl]prop-2-enamide,UFQOXIMRSMFQRI-BQYQJAHWSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
9665,6lzg,DB07785,-7.1,"1-{(1R,2S)-2-HYDROXY-1-[2-(2-NAPHTHYLOXY)ETHYL]PROPYL}-1H-IMIDAZONE-4-CARBOXAMIDE",UYAJDVNLQJVRHD-SCLBCKFNSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
164196,7bv1,DB07363,-7.1,"THIOPHENE-2,5-DISULFONIC ACID 2-AMIDE-5-(4-METHYL-BENZYLAMIDE)",GUNRMHMEAWSZQE-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
32177,6cs2,DB01150,-7.1,Cefprozil,WDLWHQDACQUCJR-PBFPGSCMSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
73661,6m2n,DB02333,-7.1,Deoxyuridine-5'-Triphosphate,AHCYMLUZIRLXAA-SHYZEUOFSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
118866,6w4b,DB06518,-7.1,R-1487,KKKRKRMVJRHDMG-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
118845,6w4b,DB06460,-7.1,Enrasentan,GLCKXJLCYIJMRB-UPRLRBBYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
80358,6m2n,DB15203,-7.1,JNJ-26489112,KXSAIQPPGSSNKX-ZETCQYMHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80338,6m2n,DB15161,-7.1,Pittsburgh Compound B,ZQAQXZBSGZUUNL-BJUDXGSMSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
73574,6m2n,DB02218,-7.1,"N-[4-hydroxymethyl-cyclohexan-6-yl-1,2,3-triol]-4,6-dideoxy-4-aminoglucopyranoside",RBZIIHWPZWOIDU-ZCGMLSCUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
80330,6m2n,DB15144,-7.1,Altropane I-123,GTQLIPQFXVKRKJ-HYRAKNMCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
28969,6cs2,DB08598,-7.1,"4-CHLORO-8-METHYL-7-(3-METHYL-BUT-2-ENYL)-6,7,8,9-TETRAHYDRO-2H-2,7,9A-TRIAZA-BENZO[CD]AZULENE-1-THIONE",RCSLUNOLLUVOOG-NSHDSACASA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
32166,6cs2,DB01139,-7.1,Cefapirin,UQLLWWBDSUHNEB-CZUORRHYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
19223,6cs2,HMDB0043087,-7.1,"TG(15:0/20:0/20:3(5Z,8Z,11Z))",FFJZQCAVRAQRGO-DMRFSXROSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
118828,6w4b,DB06420,-7.1,Annamycin,CIDNKDMVSINJCG-GKXONYSUSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
28966,6cs2,DB08595,-7.1,"4-[(1S,2R,5S)-4,4,8-TRIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL",BBZPJHFECDCNGT-BPUTZDHNSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
29033,6cs2,DB08670,-7.1,"METHYL N-[(2S,3R)-3-AMINO-2-HYDROXY-3-(4-ISOPROPYLPHENYL)PROPANOYL]-D-ALANYL-D-LEUCINATE",WIWZNHHLFMPGGO-PIKADFDJSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
164330,7bv1,DB07707,-7.1,"(9BETA,11ALPHA,13ALPHA,14BETA,17ALPHA)-11-(METHOXYMETHYL)ESTRA-1(10),2,4-TRIENE-3,17-DIOL",LEOPSILMAOYZBO-IUTAEKPZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
79967,6m2n,DB14061,-7.1,Hycanthone,MFZWMTSUNYWVBU-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
31911,6cs2,DB15027,-7.1,Adriforant,ISBHYKVAFKTATD-SNVBAGLBSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
118565,6w4b,DB05239,-7.1,Cobimetinib,BSMCAPRUBJMWDF-KRWDZBQOSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
118560,6w4b,DB05197,-7.1,Sofalcone,GFWRVVCDTLRWPK-KPKJPENVSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
79799,6m2n,DB13760,-7.1,Niperotidine,HXRSXEDVVARPHP-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
164434,7bv1,DB07825,-7.1,(3S)-1-(4-acetylphenyl)-5-oxopyrrolidine-3-carboxylic acid,SQGYWRZISBCKMW-JTQLQIEISA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
53512,2fxp,DB13113,-7.1,JNJ-38877605,JRWCBEOAFGHNNU-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
118548,6w4b,DB05107,-7.1,16-Bromoepiandrosterone,CWVMWSZEMZOUPC-JUAXIXHSSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
111282,6vxx,DB03448,-7.1,2'-Deoxyuridine 3'-Monophosphate,LXKGKXYIAAKOCT-SHYZEUOFSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
164445,7bv1,DB07838,-7.1,(Z)-3-BENZYL-5-(2-HYDROXY-3-NITROBENZYLIDENE)-2-THIOXOTHIAZOLIDIN-4-ONE,ZTWBCEZQPRYIGY-ZROIWOOFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
118589,6w4b,DB05395,-7.1,Amibegron,RDJQCOBTKKAQAH-FPOVZHCZSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
118547,6w4b,DB05105,-7.1,Pleconaril,KQOXLKOJHVFTRN-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
9554,6lzg,DB07664,-7.1,"5-AMINO-3-{[4-(AMINOSULFONYL)PHENYL]AMINO}-N-(2,6-DIFLUOROPHENYL)-1H-1,2,4-TRIAZOLE-1-CARBOTHIOAMIDE",ARIOBGGRZJITQX-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
9553,6lzg,DB07663,-7.1,"2-[(1R)-1-CARBOXY-2-(4-HYDROXYPHENYL)ETHYL]-1,3-DIOXOISOINDOLINE-5-CARBOXYLIC ACID",QISJEFYTLZTWIQ-CQSZACIVSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
118500,6w4b,DB04915,-7.1,Idronoxil,ZZUBHVMHNVYXRR-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
164467,7bv1,DB08038,-7.1,"L-alanyl-N-[(1S,2R)-1-benzyl-2-hydroxypropyl]-L-alaninamide",CPAOOGAUUDSJCS-FMSGJZPZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
79744,6m2n,DB13684,-7.1,Omoconazole,JMFOSJNGKJCTMJ-ZHZULCJRSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
31867,6cs2,DB14904,-7.1,Pimasertib,VIUAUNHCRHHYNE-JTQLQIEISA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
9540,6lzg,DB07648,-7.1,"(2R)-3-{[(4Z)-5,6-DIPHENYL-6,7-DIHYDRO-4H-PYRROLO[2,3-D]PYRIMIDIN-4-YLIDENE]AMINO}PROPANE-1,2-DIOL",TWEONIHFGKSPLC-MRXNPFEDSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
79734,6m2n,DB13674,-7.1,Cridanimod,UOMKBIIXHQIERR-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
118459,6w4b,DB04850,-7.1,Posizolid,HBUJYEUPIIJJOS-PBHICJAKSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
53499,2fxp,DB13095,-7.1,JTK-853,JQLOVYLALGSISI-HXUWFJFHSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
164154,7bv1,DB07316,-7.1,"N-{1-[(1-carbamoylcyclopropyl)methyl]piperidin-4-yl}-N-cyclopropyl-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide",FAVXIEFZKPJZRT-NRFANRHFSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
29104,6cs2,DB08743,-7.1,"2-({8-[(3R)-3-AMINOPIPERIDIN-1-YL]-1,3-DIMETHYL-2,6-DIOXO-1,2,3,6-TETRAHYDRO-7H-PURIN-7-YL}METHYL)BENZONITRILE",XJNKUWDMCBZMTG-OAHLLOKOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
79848,6m2n,DB13824,-7.1,Enprostil,PTOJVMZPWPAXER-FPXSIRDUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
164333,7bv1,DB07712,-7.1,3-ETHYL-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL,XBMVVMYGKMGLJX-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
118709,6w4b,DB06117,-7.1,"1alpha,24S-Dihydroxyvitamin D2",ODZFJAXAEXQSKL-WRJREGAQSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
79962,6m2n,DB14050,-7.1,Cannabidivarin,REOZWEGFPHTFEI-JKSUJKDBSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
118698,6w4b,DB05990,-7.1,Obeticholic acid,ZXERDUOLZKYMJM-ZWECCWDJSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
118695,6w4b,DB05974,-7.1,Transcrocetinate,PANKHBYNKQNAHN-MQQNZMFNSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
32017,6cs2,DB15207,-7.1,Esaxerenone,NOSNHVJANRODGR-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
79940,6m2n,DB14002,-7.1,D-alpha-Tocopherol acetate,ZAKOWWREFLAJOT-CEFNRUSXSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
118676,6w4b,DB05861,-7.1,Tasquinimod,ONDYALNGTUAJDX-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
73702,6m2n,DB02383,-7.1,Tolrestat,LUBHDINQXIHVLS-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
118594,6w4b,DB05414,-7.1,Pipendoxifene,JICOGKJOQXTAIP-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
111076,6vxx,DB02959,-7.1,Oxitriptan,LDCYZAJDBXYCGN-VIFPVBQESA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31992,6cs2,DB15167,-7.1,Fallypride,OABRYNHZQBZDMG-INIZCTEOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
50463,2fxp,DB07041,-7.1,"N-[2-(2,4-diaminopyrido[2,3-d]pyrimidin-7-yl)-2-methylpropyl]-4-phenoxybenzamide",FDJWFDQRPKKBFA-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
164382,7bv1,DB07768,-7.1,Epitestosterone,MUMGGOZAMZWBJJ-KZYORJDKSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
79900,6m2n,DB13934,-7.1,Ligandrol,OPSIVAKKLQRWKC-VXGBXAGGSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
31972,6cs2,DB01110,-7.1,Miconazole,BYBLEWFAAKGYCD-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
164388,7bv1,DB07775,-7.1,"3',5'-DIBROMO-2',4,4',6'-TETRAHYDROXY AURONE",BRPKBUNFOZFULQ-SGAXSIHGSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
118601,6w4b,DB05442,-7.1,Etiprednol dicloacetate,QAIOVDNCIZSSSF-RFAJLIJZSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
73737,6m2n,DB02422,-7.1,Methyl-2-S-(Alpha-D-Mannopyranosyl)-2-Thio-Alpha-D-Mannopyranoside,WAYOKHSZGNFKSX-ZEEOCKJESA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
9584,6lzg,DB07697,-7.1,"1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-4-[(4-methoxyphenyl)sulfonyl]piperazine",HMGDKYUJSFVHIY-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
111081,6vxx,DB02964,-7.1,"8,9,10-Trihydroxy-7-Hydroxymethyl-2-Thioxo-6-Oxa-1,3-Diaza-Spiro[4.5]Decan-4-One",OEWLGQKSTDZKFN-WWHASAIZSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
29151,6cs2,DB08790,-7.1,1-PHENYL-1H-PYRAZOLE-4-CARBOXYLIC ACID,ZROILLPDIUNLSE-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
21724,6cs2,HMDB0051353,-7.1,"TG(20:3(5Z,8Z,11Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))",YQJWRLLYQMZFTD-RSUVPJRTSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
32258,6cs2,DB01234,-7.1,Dexamethasone,UREBDLICKHMUKA-CXSFZGCWSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
110153,6vxx,DB01036,-7.1,Tolterodine,OOGJQPCLVADCPB-HXUWFJFHSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
119324,6w4b,DB07180,-7.1,"5-[(Z)-(5-Chloro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-N,2,4-trimethyl-1H-pyrrole-3-carboxamide",FIRPCWHHIWFKCD-GHXNOFRVSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
163626,7bv1,DB04873,-7.1,Piboserod,KVCSJPATKXABRQ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
9861,6lzg,DB00736,-7.1,Esomeprazole,SUBDBMMJDZJVOS-DEOSSOPVSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
32544,6cs2,T3D1943,-7.1,"3,3'-Dibromobiphenyl",LPLLWKZDMKTEMV-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
32543,6cs2,T3D1942,-7.1,"3,3',5,5'-Tetrabromobiphenyl",FXJXZYWFJAXIJX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
9845,6lzg,DB07976,-7.1,3-{[(3-FLUORO-3'-METHOXYBIPHENYL-4-YL)AMINO]CARBONYL}THIOPHENE-2-CARBOXYLIC ACID,GIUMGVUBDBDTDX-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
81151,6m3m,DB00867,-7.1,Ritodrine,IOVGROKTTNBUGK-SJCJKPOMSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
9841,6lzg,DB07972,-7.1,1-(3-METHYLPHENYL)-1H-BENZIMIDAZOL-5-AMINE,VFSVFGIODYZMOF-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
163721,7bv1,DB06148,-7.1,Mianserin,UEQUQVLFIPOEMF-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
119247,6w4b,DB07091,-7.1,(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclohexyloxy)ethanoyl)pyrrolidine-2-carboxamide,IWPMQJKXKKKSEY-SFHVURJKSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
81079,6m3m,DB00786,-7.1,Marimastat,OCSMOTCMPXTDND-OUAUKWLOSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
119245,6w4b,DB07089,-7.1,N-[amino(imino)methyl]-2-[2-(2-chlorophenyl)-4-(4-propoxyphenyl)-3-thienyl]acetamide,VZSMTBLDWPKVRW-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
32501,6cs2,T3D1858,-7.1,Pyrethrin II,VJFUPGQZSXIULQ-QYVAASDLSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
119227,6w4b,DB07067,-7.1,"(2S,3S)-3-{3-[4-(METHYLSULFONYL)PHENYL]-1,2,4-OXADIAZOL-5-YL}-1-OXO-1-PYRROLIDIN-1-YLBUTAN-2-AMINE",SQCDMTZMCHZYGO-FZMZJTMJSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
163747,7bv1,DB06199,-7.1,Atrasentan,MOTJMGVDPWRKOC-QPVYNBJUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
119222,6w4b,DB07061,-7.1,"1-(CYCLOHEXYLAMINO)-3-(6-METHYL-3,4-DIHYDRO-1H-CARBAZOL-9(2H)-YL)PROPAN-2-OL",AXYFCRIRLKSCRR-SFHVURJKSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
110292,6vxx,DB01428,-7.1,Oxybenzone,DXGLGDHPHMLXJC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163788,7bv1,DB06280,-7.1,Senicapoc,SCTZUZTYRMOMKT-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
163613,7bv1,DB04857,-7.1,Brasofensine,NRLIFEGHTNUYFL-QJDHNRDASA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
32575,6cs2,T3D1977,-7.1,"3,4-Dibromobiphenyl",XIQSOBZINJQGKX-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
81240,6m3m,DB00968,-7.1,Methyldopa,CJCSPKMFHVPWAR-JTQLQIEISA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
119340,6w4b,DB07198,-7.1,5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-CARBONITRILE,GGEKOZPXKBYLNK-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
81383,6m3m,DB01133,-7.1,Tiludronic acid,DKJJVAGXPKPDRL-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
163449,7bv1,DB04638,-7.1,"2,5-DI-(TERT-BUTYL)-1,4,BENZOHYDROQUINONE",JZODKRWQWUWGCD-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
32660,6cs2,T3D2062,-7.1,"1,4,9-Trichlorodibenzo-p-dioxin",UTTYFTWIJLRXKB-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
73123,6m2n,DB01614,-7.1,Acepromazine,NOSIYYJFMPDDSA-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
81357,6m3m,DB01102,-7.1,Arbutamine,IIRWWTKISYTTBL-SFHVURJKSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
163489,7bv1,DB04693,-7.1,"(13S)-13-METHYLDODECAHYDRO-1H-CYCLOPENTA[A]PHENANTHRENE-3,17(2H,4H)-DIONE",CRDKSBHJIGNEOH-IMRIKWHGSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
163503,7bv1,DB04712,-7.1,ANILINOMETHYL GLUCO-PHENYLIMIDAZOLE,ADKWVGPRAQKVKB-YIYPIFLZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
32623,6cs2,T3D2021,-7.1,"2,3,4,4',5-Pentabromobiphenyl",BUBFPVURMRYUJF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
110083,6vxx,DB00955,-7.1,Netilmicin,CIDUJQMULVCIBT-MQDUPKMGSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163789,7bv1,DB06281,-7.1,Torcetrapib,CMSGWTNRGKRWGS-NQIIRXRSSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
18752,6cs2,HMDB0034227,-7.1,alpha-Tocopherol acetate,ZAKOWWREFLAJOT-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
32620,6cs2,T3D2018,-7.1,4-Monobromobiphenyl,PKJBWOWQJHHAHG-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
163516,7bv1,DB04729,-7.1,Gentamicin C1a,VEGXETMJINRLTH-BOZYPMBZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
163523,7bv1,DB04741,-7.1,Myxothiazol,XKTFQMCPGMTBMD-FYHMSGCOSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
81301,6m3m,DB01038,-7.1,Carphenazine,XZSMZRXAEFNJCU-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
32605,6cs2,T3D2004,-7.1,"3,3',4,5,5'-Pentabromobiphenyl",DZFDQWNBHQDGMZ-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
163548,7bv1,DB04776,-7.1,(2R)-2-({6-[benzyl(methyl)amino]-9-isopropyl-9H-purin-2-yl}amino)butan-1-ol,YPYWONAECUVKHY-MRXNPFEDSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
163567,7bv1,DB04800,-7.1,1-METHYL-3-PHENYL-1H-PYRAZOL-5-YLSULFAMIC ACID,OTZLVSGSRPNRFT-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
163591,7bv1,DB04829,-7.1,Lysergic acid diethylamide,VAYOSLLFUXYJDT-RDTXWAMCSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
9871,6lzg,DB08004,-7.1,"(2S)-2-{[3-(3-aminophenyl)imidazo[1,2-b]pyridazin-6-yl]amino}-3-methylbutan-1-ol",PUMVONFFLKPPIM-CQSZACIVSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
163513,7bv1,DB04725,-7.1,Licofelone,UAWXGRJVZSAUSZ-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
80999,6m3m,DB00690,-7.1,Flurazepam,SAADBVWGJQAEFS-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
110309,6vxx,DB01447,-7.1,4-Methylaminorex,LJQBMYDFWFGESC-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
119189,6w4b,DB07027,-7.1,D-phenylalanyl-N-(3-fluorobenzyl)-L-prolinamide,JGZSVYZIJHGHMA-MOPGFXCFSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
110494,6vxx,DB01667,-7.1,8-azaguanine,LPXQRXLUHJKZIE-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
164010,7bv1,DB06967,-7.1,"6-ETHYL-5-[9-(3-METHOXYPROPYL)-9H-CARBAZOL-2-YL]PYRIMIDINE-2,4-DIAMINE",MLSVRCGEBXIIQO-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
53820,2fxp,DB13563,-7.1,Norgestrienone,GVDMJXQHPUYPHP-FYQPLNBISA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
80796,6m3m,DB00441,-7.1,Gemcitabine,SDUQYLNIPVEERB-QPPQHZFASA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
119037,6w4b,DB06847,-7.1,"5-[(3S)-3-(2-methoxybiphenyl-4-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",YYCPXVRHQUEVAW-CQSZACIVSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
623,6lzg,HMDB0006203,-7.1,5-alpha-Dihydrotestosterone glucuronide,CLQMBSSRTBUNDV-CPKOJWPQSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
164078,7bv1,DB07233,-7.1,N-{[4-(but-2-yn-1-yloxy)phenyl]sulfonyl}-5-methyl-D-tryptophan,SFVPXERGVLDWIS-OAQYLSRUSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
119028,6w4b,DB06834,-7.1,"N-(2-hydroxy-1,1-dimethylethyl)-1-methyl-3-(1H-pyrrolo[2,3-b]pyridin-2-yl)-1H-indole-5-carboxamide",XZRYCTLOGNCQDG-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
9712,6lzg,DB07832,-7.1,"4-{4-[(5-hydroxy-2-methylphenyl)amino]quinolin-7-yl}-1,3-thiazole-2-carbaldehyde",VKQPTVJDZIILPG-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
164001,7bv1,DB06952,-7.1,(2S)-2-HYDROXY-2H-CHROMENE-2-CARBOXYLIC ACID,LGYIZQLNYONEFJ-JTQLQIEISA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
50288,2fxp,DB06834,-7.1,"N-(2-hydroxy-1,1-dimethylethyl)-1-methyl-3-(1H-pyrrolo[2,3-b]pyridin-2-yl)-1H-indole-5-carboxamide",XZRYCTLOGNCQDG-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
73458,6m2n,DB02061,-7.1,Cellobiose,GUBGYTABKSRVRQ-CUHNMECISA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
118996,6w4b,DB06780,-7.1,Desoxycorticosterone acetate,VPGRYOFKCNULNK-ACXQXYJUSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
80730,6m3m,DB00359,-7.1,Sulfadiazine,SEEPANYCNGTZFQ-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
164105,7bv1,DB07263,-7.1,"[{2-bromo-4-[(2R)-3-oxo-2,3-diphenylpropyl]phenyl}(difluoro)methyl]phosphonic acid",WDTMVBQZDFMOIK-GOSISDBHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
9695,6lzg,DB07814,-7.1,Gibberellic acid,IXORZMNAPKEEDV-OBDJNFEBSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
164119,7bv1,DB07280,-7.1,5-[4-(DIMETHYLAMINO)PHENYL]-6-[(6-MORPHOLIN-4-YLPYRIDIN-3-YL)ETHYNYL]PYRIMIDIN-4-AMINE,AINVOEOJEKKMKB-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
80688,6m3m,DB00308,-7.1,Ibutilide,ALOBUEHUHMBRLE-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
118969,6w4b,DB06730,-7.1,Gestodene,SIGSPDASOTUPFS-XUDSTZEESA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
118955,6w4b,DB06710,-7.1,Methyltestosterone,GCKMFJBGXUYNAG-HLXURNFRSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
80747,6m3m,DB00381,-7.1,Amlodipine,HTIQEAQVCYTUBX-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
164129,7bv1,DB07290,-7.1,(2R)-2-{[(4-FLUORO-3-METHYLPHENYL)SULFONYL]AMINO}-N-HYDROXY-2-TETRAHYDRO-2H-PYRAN-4-YLACETAMIDE,LUCFRFDOOYLALP-CYBMUJFWSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
18958,6cs2,HMDB0041905,-7.1,4-Hydroxyphenytoin,XEEDURHPFVXALT-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
119068,6w4b,DB06884,-7.1,4-HYDROXY-N'-(4-ISOPROPYLBENZYL)BENZOHYDRAZIDE,MFDXHRPPSJRQFX-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
163823,7bv1,DB06403,-7.1,Ambrisentan,OUJTZYPIHDYQMC-LJQANCHMSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
80966,6m3m,DB00651,-7.1,Dyphylline,KSCFJBIXMNOVSH-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80965,6m3m,DB00649,-7.1,Stavudine,XNKLLVCARDGLGL-JGVFFNPUSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
80963,6m3m,DB00647,-7.1,Dextropropoxyphene,XLMALTXPSGQGBX-GCJKJVERSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
163848,7bv1,DB06737,-7.1,Zaltoprofen,MUXFZBHBYYYLTH-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
119150,6w4b,DB06983,-7.1,"(5-phenyl-7-(pyridin-3-ylmethylamino)pyrazolo[1,5-a]pyrimidin-3-yl)methanol",RBLKWWBHDUBPFN-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
80926,6m3m,DB00600,-7.1,Monobenzone,VYQNWZOUAUKGHI-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
163897,7bv1,DB06829,-7.1,4-BROMO-3-(CARBOXYMETHOXY)-5-[3-(CYCLOHEXYLAMINO)PHENYL]THIOPHENE-2-CARBOXYLIC ACID,RXDVFLTWXCTCEX-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
80900,6m3m,DB00571,-7.1,Propranolol,AQHHHDLHHXJYJD-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
32363,6cs2,T3D1672,-7.1,"3,3'-Dimethoxybenzidine-4,4'-diisocyanate",QZWKEPYTBWZJJA-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
119126,6w4b,DB06948,-7.1,2-ANILINO-6-CYCLOHEXYLMETHOXYPURINE,XWWRLKIBRPJQJX-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
119113,6w4b,DB06932,-7.1,"10,11-dimethoxy-4-methyldibenzo[c,f]-2,7-naphthyridine-3,6-diamine",NVINUNQBDNEMSY-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
80889,6m3m,DB00555,-7.1,Lamotrigine,PYZRQGJRPPTADH-UHFFFAOYSA-N,Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain,VIRAL PROTEIN,SARS-CoV-2,nucleocapsid protein
119108,6w4b,DB06927,-7.1,[5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-YL]ACETONITRILE,ZKJVCUXZMYKTLT-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
73373,6m2n,DB01950,-7.1,"N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thiazol-2-Yl)Urea",YAEMHJKFIIIULI-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
73374,6m2n,DB01951,-7.1,Gpi-1046,OQAHHWOPVDDWHD-INIZCTEOSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
110453,6vxx,DB01615,-7.1,Aceprometazine,XLOQNFNTQIRSOX-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
163964,7bv1,DB06910,-7.1,"[4-R-(4-ALPHA,6-BETA,7-BETA]-HEXAHYDRO-5,6-DI(HYDROXY)-1,3-DI(ALLYL)-4,7-BISPHENYLMETHYL)-2H-1,3-DIAZEPINONE",IWJSQELMWLOYSO-LWSSLDFYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
163967,7bv1,DB06913,-7.1,"(2R,3R)-3-{[3,5-BIS(TRIFLUOROMETHYL)PHENYL]AMINO}-2-CYANO-3-THIOXOPROPANAMIDE",ZTUMRSFHUOBXAC-LHIURRSHSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
110468,6vxx,DB01632,-7.1,5-O-phosphono-alpha-D-ribofuranosyl diphosphate,PQGCEDQWHSBAJP-TXICZTDVSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
110425,6vxx,DB01578,-7.1,Metrizamide,DTZMSDADRKLCQE-RFMXWLSYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78090,6m2n,DB09244,-7.1,Pirlindole,IWVRVEIKCBFZNF-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
53462,2fxp,DB13040,-7.1,Gandotinib,SQSZANZGUXWJEA-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
31856,6cs2,DB14888,-7.1,IQP-0528,UCOAKFIVSAVHLC-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
9327,6lzg,DB07419,-7.1,S-23,SSFVOEAXHZGTRJ-KRWDZBQOSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
29286,6cs2,DB08971,-7.1,Fluocortolone,GAKMQHDJQHZUTJ-ULHLPKEOSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
164921,7bv1,DB08965,-7.1,Fusafungine,MIZMDSVSLSIMSC-OGLSAIDSSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
117225,6w4b,DB03199,-7.1,4-Methoxy-E-Rhodomycin T,XSSVYBYWQBNYOH-QJIXERIWSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
29288,6cs2,DB08973,-7.1,Fluclorolone acetonide,NJNWEGFJCGYWQT-VSXGLTOVSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
117207,6w4b,DB03173,-7.1,CRA_10433,CFSQPEBVGUSQII-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
112037,6vxx,DB06152,-7.1,Nylidrin,PTGXAUBQBSGPKF-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78712,6m2n,DB12156,-7.1,Cordycepin,OFEZSBMBBKLLBJ-BAJZRUMYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
9306,6lzg,DB07394,-7.1,AUROVERTIN B,QXCOFYWOWZJFEA-YJMRODJJSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
164946,7bv1,DB08992,-7.1,Eperisone,SQUNAWUMZGQQJD-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
112053,6vxx,DB06187,-7.1,Valtorcitabine,VFCYZPOEGWLYRM-QCZKYFFMSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
117129,6w4b,DB03069,-7.1,Cytidine-5'-Diphospho-Beta-D-Xylose,NWSKPSPTJOAICE-OCIMBMBZSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
74194,6m2n,DB03030,-7.1,4-(2-Thienyl)-1-(4-Methylbenzyl)-1h-Imidazole,UMOFOLLUKPBVQG-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
29293,6cs2,DB00177,-7.1,Valsartan,ACWBQPMHZXGDFX-QFIPXVFZSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
31419,6cs2,DB13792,-7.1,Clopamide,LBXHRAWDUMTPSE-AOOOYVTPSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
112062,6vxx,DB06201,-7.1,Rufinamide,POGQSBRIGCQNEG-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
164964,7bv1,DB09012,-7.1,Carbazochrome,XSXCZNVKFKNLPR-SDQBBNPISA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
117106,6w4b,DB03039,-7.1,"4-(Aminosulfonyl)-N-[(2,5-Difluorophenyl)Methyl]-Benzamide",KEGUALXMKQVDIO-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
31387,6cs2,DB13755,-7.1,Iocarmic acid,SMQYOVYWPWASGU-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
9328,6lzg,DB07420,-7.1,(1R)-4-(3-phenoxyphenyl)-1-phosphonobutane-1-sulfonic acid,RCGCZPXSRLLKCK-MRXNPFEDSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
432,6lzg,HMDB0005010,-7.1,Sertraline,VGKDLMBJGBXTGI-SJCJKPOMSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
112001,6vxx,DB05143,-7.1,OXI-4503,GSOXMQLWUDQTNT-WAYWQWQTSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
53151,2fxp,DB12550,-7.1,Taladegib,SZBGQDXLNMELTB-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
164808,7bv1,DB08632,-7.1,"1,3,5-BENZENETRICARBOXYLIC ACID",QMKYBPDZANOJGF-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
164813,7bv1,DB08639,-7.1,Dapivirine,ILAYIAGXTHKHNT-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
74090,6m2n,DB02890,-7.1,6-Hydroxyuridine-5'-Phosphate,UDOBICLZEKUKCV-YXZULKJRSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
164817,7bv1,DB08643,-7.1,2-(2-{2-[(BIPHENYL-4-YLMETHYL)-AMINO]-3-MERCAPTO-PENTANOYLAMINO}-ACETYLAMINO)-3-METHYL-BUTYRIC ACID METHYL ESTER,QFAWBPLETHINFK-UNMCSNQZSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
164824,7bv1,DB08651,-7.1,3'-THIO-THYMIDINE-5'-PHOSPHATE,BORVFKJZAOEGOO-GJMOJQLCSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
74096,6m2n,DB02896,-7.1,Methylthioinosine,ZDRFDHHANOYUTE-IOSLPCCCSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
74098,6m2n,DB02898,-7.1,5-{[(2-Amino-9h-Purin-6-Yl)Oxy]Methyl}-2-Pyrrolidinone,UYPMMHCTXQIWDX-RXMQYKEDSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
164840,7bv1,DB08670,-7.1,"METHYL N-[(2S,3R)-3-AMINO-2-HYDROXY-3-(4-ISOPROPYLPHENYL)PROPANOYL]-D-ALANYL-D-LEUCINATE",WIWZNHHLFMPGGO-PIKADFDJSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
9374,6lzg,DB07469,-7.1,"(3aS)-3a-hydroxy-7-methyl-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one",KAJFGRLMKVNMLH-GOSISDBHSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
31382,6cs2,DB13753,-7.1,Cetiedil,MMNICIJVQJJHHF-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
164859,7bv1,DB08695,-7.1,3-(4-nitrophenyl)-1H-pyrazole,IPIYADCDDIUVPS-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
78874,6m2n,DB12390,-7.1,MBX-8025,JWHYSEDOYMYMNM-QGZVFWFLSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78873,6m2n,DB12389,-7.1,Zamicastat,ZSSLCFLHEFXANG-GOSISDBHSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78853,6m2n,DB12359,-7.1,BIIB021,QULDDKSCVCJTPV-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
31488,6cs2,DB13876,-7.1,Brofaromine,WZXHSWVDAYOFPE-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
117423,6w4b,DB03461,-7.1,2'-Monophosphoadenosine 5'-Diphosphoribose,XJLXINKUBYWONI-NNYOXOHSSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
78825,6m2n,DB12314,-7.1,Chlorproguanil,ISZNZKHCRKXXAU-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
436,6lzg,HMDB0005017,-7.1,Pantoprazole,IQPSEEYGBUAQFF-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
53158,2fxp,DB12561,-7.1,WNT-974,XXYGTCZJJLTAGH-UHFFFAOYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
111985,6vxx,DB05053,-7.1,MB-07803,CTKZZUXRWBCFEI-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31504,6cs2,DB13934,-7.1,Ligandrol,OPSIVAKKLQRWKC-VXGBXAGGSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
116991,6w4b,DB02882,-7.1,Cyanocinnoline,CUWRVIIPSSUUDJ-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
74237,6m2n,DB03086,-7.1,"N'-(2s,3r)-3-Amino-4-Cyclohexyl-2-Hydroxy-Butano-N-(4-Methylphenyl)Hydrazide",IQMLIGOOOFEBAH-CVEARBPZSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
165017,7bv1,DB09096,-7.1,Benzoyl peroxide,OMPJBNCRMGITSC-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
116742,6w4b,DB02547,-7.1,Guanosine-5'-Diphosphate-Rhamnose,LQEBEXMHBLQMDB-GDJBGNAASA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
9206,6lzg,DB07290,-7.1,(2R)-2-{[(4-FLUORO-3-METHYLPHENYL)SULFONYL]AMINO}-N-HYDROXY-2-TETRAHYDRO-2H-PYRAN-4-YLACETAMIDE,LUCFRFDOOYLALP-CYBMUJFWSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
78294,6m2n,DB11462,-7.1,Sulfaethoxypyridazine,FFJIWWBSBCOKLS-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
116587,6w4b,DB02358,-7.1,LY374571,SZHRIPFGZWWRKW-VIFPVBQESA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
31270,6cs2,DB13617,-7.1,Clorexolone,VPMWFZKOWULPGT-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
116573,6w4b,DB02338,-7.1,Nadph Dihydro-Nicotinamide-Adenine-Dinucleotidephosphate,ACFIXJIJDZMPPO-NNYOXOHSSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
74334,6m2n,DB03216,-7.1,"(1'R,2'S)-9-(2-Hydroxy-3'-Keto-Cyclopenten-1-yl)Adenine",RQPALADHFYHEHK-CHKWXVPMSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
116567,6w4b,DB02331,-7.1,"(2s)-2-[(5-Benzofuran-2-Yl-Thiophen-2-Ylmethyl)-(2,4-Dichloro-Benzoyl)-Amino]-3-Phenyl-Propionic Acid",YBULOUKTPCHXAL-DEOSSOPVSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
78273,6m2n,DB11427,-7.1,Maropitant,OMPCVMLFFSQFIX-CONSDPRKSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
31293,6cs2,DB13645,-7.1,Ethacizine,PQXGNJKJMFUPPM-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
116519,6w4b,DB02266,-7.1,Flufenamic Acid,LPEPZBJOKDYZAD-UHFFFAOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
52963,2fxp,DB12280,-7.1,AZD-5423,FCNQMDSJHADDFT-WNSKOXEYSA-N,Solution Structure of the SARS-Coronavirus HR2 Domain,VIRAL PROTEIN,SARS-CoV-2,HR2
112277,6vxx,DB06915,-7.1,"naphthalene-1,2,4,5,7-pentol",IISYZEMBGRNYTH-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
9173,6lzg,DB07257,-7.1,"4-(2-chlorophenyl)-8-(2-hydroxyethyl)-6-methylpyrrolo[3,4-e]indole-1,3(2H,6H)-dione",WHMQZCPGFZBLBG-UHFFFAOYSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
31249,6cs2,DB13593,-7.1,Zolimidine,VSLIUWLPFRVCDL-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
78196,6m2n,DB11185,-7.1,Sulisobenzone,CXVGEDCSTKKODG-UHFFFAOYSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
31244,6cs2,DB13586,-7.1,Metandienone,XWALNWXLMVGSFR-HLXURNFRSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
9162,6lzg,DB07246,-7.1,"(2R)-2-AMINO-3,3,3-TRIFLUORO-N-HYDROXY-2-{[(4-PHENOXYPHENYL)SULFONYL]METHYL}PROPANAMIDE",MKRPIBSCGZAUCH-OAHLLOKOSA-N,Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2,VIRAL PROTEIN,SARS-CoV-4,Spike - human ACE2-SLC6A19 complex
165163,7bv1,DB11447,-7.1,Phenothiazine,WJFKNYWRSNBZNX-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
112309,6vxx,DB06952,-7.1,(2S)-2-HYDROXY-2H-CHROMENE-2-CARBOXYLIC ACID,LGYIZQLNYONEFJ-JTQLQIEISA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165135,7bv1,DB11395,-7.1,Deracoxib,WAZQAZKAZLXFMK-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
31561,6cs2,DB14030,-7.1,PZM21,MEDBIJOVZJEMBI-YOEHRIQHSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
31297,6cs2,DB13651,-7.1,Lorajmine,LAHDERDHXJFFJU-ZWNKPRIXSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
31301,6cs2,DB13656,-7.1,Eberconazole,MPTJIDOGFUQSQH-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
116971,6w4b,DB02854,-7.1,Aetiocholanolone,QGXBDMJGAMFCBF-BNSUEQOYSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
112129,6vxx,DB06368,-7.1,Alamifovir,VDBGPMJFHCJMOL-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
31354,6cs2,DB13717,-7.1,Phenothrin,SBNFWQZLDJGRLK-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
31351,6cs2,DB13713,-7.1,Quifenadine,PZMAHNDJABQWGS-UHFFFAOYSA-N,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles",viral protein/hydrolase,"Severe acute respiratory syndrome-related coronavirus, Escherichia virus T4, Homo sapiens",ACE2 area for S-protein binding
116919,6w4b,DB02789,-7.1,Pregnenolone,ORNBQBCIOKFOEO-QGVNFLHTSA-N,The crystal structure of Nsp9 RNA binding protein of SARS CoV-2,"REPLICATION, VIRAL PROTEIN",SARS-CoV-2,nsp9
112138,6vxx,DB06408,-7.1,Taribavirin,NHKZSTHOYNWEEZ-AFCXAGJDSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
165035,7bv1,DB09144,-7.1,Uridine triacetate,AUFUWRKPQLGTGF-FMKGYKFTSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
165039,7bv1,DB09151,-7.1,Flutemetamol (18F),VVECGOCJFKTUAX-HUYCHCPVSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
165040,7bv1,DB09166,-7.1,Etizolam,VMZUTJCNQWMAGF-UHFFFAOYSA-N,Cryo-EM structure of the apo nsp12-nsp7-nsp8 complex,VIRAL PROTEIN,SARS-CoV-2,nsp12-nsp7-nsp8
112196,6vxx,DB06548,-7.1,Minodronic acid,VMMKGHQPQIEGSQ-UHFFFAOYSA-N,Structure of the SARS-CoV-2 spike glycoprotein (closed state),VIRAL PROTEIN,SARS-CoV-2,spike glycoprotein
78496,6m2n,DB11837,-7.1,Osilodrostat,USUZGMWDZDXMDG-CYBMUJFWSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
78456,6m2n,DB11785,-7.1,Anisodamine,WTQYWNWRJNXDEG-RBZJEDDUSA-N,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,VIRAL PROTEIN,SARS-CoV-2,3CL pro
112162,6vxx,DB06465,-7.1,FK-960,XTOKQKWTUYYVAO-UHFFFAOYSA-N,Structure of th